id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
149915793|NCT01313221|540823972|FG000|Overall Study|Protocol Violation|0|||
149915794|NCT01313221|540823973|FG001|Overall Study|Protocol Violation|1|||
149915795|NCT01313221|540823974|FG002|Overall Study|Protocol Violation|1|||
149915796|NCT01313221|540823972|FG000|Overall Study|Non-compliance|3|||
149915797|NCT01313221|540823973|FG001|Overall Study|Non-compliance|0|||
149915798|NCT01313221|540823974|FG002|Overall Study|Non-compliance|2|||
149915799|NCT01313221|540823972|FG000|Overall Study|Withdrawal by Subject|2|||
149915800|NCT01313221|540823973|FG001|Overall Study|Withdrawal by Subject|3|||
149915801|NCT01313221|540823974|FG002|Overall Study|Withdrawal by Subject|5|||
149915802|NCT01313221|540823972|FG000|Overall Study|Requirement for alternative therapy|0|||
149915803|NCT01313221|540823973|FG001|Overall Study|Requirement for alternative therapy|1|||
149915804|NCT01313221|540823974|FG002|Overall Study|Requirement for alternative therapy|1|||
149915805|NCT01313221|540823972|FG000|Overall Study|Lost to Follow-up|6|||
149915806|NCT01313221|540823973|FG001|Overall Study|Lost to Follow-up|3|||
149915807|NCT01313221|540823974|FG002|Overall Study|Lost to Follow-up|1|||
149915808|NCT01313221|540823972|FG000|Overall Study|Other|1|||
149915809|NCT01313221|540823973|FG001|Overall Study|Other|0|||
149915810|NCT01313221|540823974|FG002|Overall Study|Other|0|||
149915811|NCT01313221|540823972|FG000|Overall Study|Adverse Event|0|||
149915812|NCT01313221|540823973|FG001|Overall Study|Adverse Event|0|||
149915813|NCT01313221|540823974|FG002|Overall Study|Adverse Event|7|||
149915814|NCT01313221|540823972|FG000|Overall Study|Disease progression|0|||
149915815|NCT01313221|540823973|FG001|Overall Study|Disease progression|0|||
149915816|NCT01313221|540823974|FG002|Overall Study|Disease progression|2|||
149915817|NCT01313221|540823972|FG000|Overall Study|Physician Decision|0|||
149915818|NCT01313221|540823973|FG001|Overall Study|Physician Decision|0|||
149915819|NCT01313221|540823974|FG002|Overall Study|Physician Decision|2|||
149915820|NCT01313221|540823972|FG000|Overall Study|Pregnancy|0|||
149915821|NCT01313221|540823973|FG001|Overall Study|Pregnancy|0|||
149915822|NCT01313221|540823974|FG002|Overall Study|Pregnancy|2|||
149915823|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
149915824|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
149915825|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
149915826|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
149915827|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
149802024|NCT00726882|540404307|FG000|Overall Study|Withdrawal by Subject|5|||
149802025|NCT00726882|540404307|FG000|Overall Study|Lost to Follow-up|7|||
149802026|NCT00726882|540404307|FG000|Overall Study|Other|10|||
149802027|NCT00594568|540404308|FG000|Initial Treatment|Adverse Event|51|||
149802028|NCT00594568|540404309|FG001|Initial Treatment|Adverse Event|121|||
149915828|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
149915829|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
149915830|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
149915831|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
149915832|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
149915833|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
149915834|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
149915835|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
149915836|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
149915837|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
149915838|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
149915839|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
149915840|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
149915841|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
149915842|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
149915843|NCT00994214|540823975|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
149915844|NCT00994214|540823976|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
149915845|NCT00994214|540823977|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
149915846|NCT00994214|540823978|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
149915847|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
149915848|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
149915849|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
149915850|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
149915851|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
149915852|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
149915853|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
149915854|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
149915855|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
149802029|NCT00594568|540404310|FG002|Initial Treatment|Adverse Event|144|||
149802030|NCT00594568|540404308|FG000|Initial Treatment|Death|6|||
149915856|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
149915857|NCT01777139|540823980|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
149915858|NCT01777139|540823981|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
149915859|NCT01777139|540823980|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
149915860|NCT01777139|540823981|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
149915861|NCT01777139|540823980|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
149915862|NCT01777139|540823981|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
149915863|NCT03292458|540823985|FG000|Period 1|Adverse Event|2|||
149915864|NCT03292458|540823986|FG001|Period 1|Adverse Event|0|||
149915865|NCT02542293|540823987|FG000|Overall Study|Death|367|||
149915866|NCT02542293|540823988|FG001|Overall Study|Death|377|||
149915867|NCT02542293|540823987|FG000|Overall Study|Withdrawal by Subject|8|||
149915868|NCT02542293|540823988|FG001|Overall Study|Withdrawal by Subject|19|||
149915869|NCT03030118|540823989|FG000|Overall Study|Achieved SLE Diagnosis|11|||
149915870|NCT03030118|540823990|FG001|Overall Study|Achieved SLE Diagnosis|10|||
149915871|NCT03030118|540823989|FG000|Overall Study|Adverse Event|1|||
149915872|NCT03030118|540823990|FG001|Overall Study|Adverse Event|1|||
149915873|NCT03030118|540823989|FG000|Overall Study|Pregnancy|2|||
149915874|NCT03030118|540823990|FG001|Overall Study|Pregnancy|2|||
149915875|NCT03030118|540823989|FG000|Overall Study|Lost to Follow-up|5|||
149915876|NCT03030118|540823990|FG001|Overall Study|Lost to Follow-up|6|||
149915877|NCT03030118|540823989|FG000|Overall Study|Concomitant Medications|1|||
149915878|NCT03030118|540823990|FG001|Overall Study|Concomitant Medications|1|||
149915879|NCT03030118|540823989|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
149915880|NCT03030118|540823990|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
149915881|NCT03030118|540823989|FG000|Overall Study|Other|2|||
149915882|NCT03030118|540823990|FG001|Overall Study|Other|0|||
149915883|NCT03030118|540823989|FG000|Overall Study|Withdrawal by Subject|26|||
149915884|NCT03030118|540823990|FG001|Overall Study|Withdrawal by Subject|21|||
149915885|NCT03030118|540823989|FG000|Overall Study|Protocol Violation|1|||
149915886|NCT03030118|540823990|FG001|Overall Study|Protocol Violation|6|||
150256539|NCT02594163|542074081|FG000|Treatment Period|Progressive disease|2|||
150256540|NCT02594163|542074082|FG001|Treatment Period|Progressive disease|3|||
150256541|NCT02594163|542074081|FG000|Treatment Period|Adverse Event|1|||
150256542|NCT02594163|542074082|FG001|Treatment Period|Adverse Event|5|||
150256543|NCT02594163|542074081|FG000|Treatment Period|Physician Decision|1|||
150256544|NCT02594163|542074082|FG001|Treatment Period|Physician Decision|3|||
150256545|NCT02594163|542074081|FG000|Treatment Period|Study termination by sponsor|2|||
150256546|NCT02594163|542074082|FG001|Treatment Period|Study termination by sponsor|1|||
149915887|NCT04529850|540823991|FG000|Overall Study|Death|2|||
150256547|NCT02594163|542074081|FG000|Treatment Period|Other, Non-AE|1|||
150256548|NCT02594163|542074082|FG001|Treatment Period|Other, Non-AE|0|||
150256549|NCT02594163|542074081|FG000|Follow-up Period|Withdrawal by Subject|0|||
150256550|NCT02594163|542074082|FG001|Follow-up Period|Withdrawal by Subject|1|||
150256551|NCT02594163|542074081|FG000|Follow-up Period|Study Termination by Sponsor|6|||
150256552|NCT02594163|542074082|FG001|Follow-up Period|Study Termination by Sponsor|4|||
150256553|NCT02594163|542074081|FG000|Follow-up Period|Lost to Follow-up|1|||
150256554|NCT02594163|542074082|FG001|Follow-up Period|Lost to Follow-up|0|||
150256555|NCT02594163|542074081|FG000|Follow-up Period|Death|2|||
150256556|NCT02594163|542074082|FG001|Follow-up Period|Death|5|||
150256557|NCT02594163|542074081|FG000|Follow-up Period|Adverse Event|0|||
149915888|NCT04529850|540823991|FG000|Overall Study|Physician Decision|1|||
149915889|NCT04529850|540823991|FG000|Overall Study|Withdrawal by Subject|2|||
149915890|NCT00593606|540823994|FG000|Overall Study|Adverse Event|13|||
149915891|NCT00593606|540823994|FG000|Overall Study|Withdrawal by Subject|1|||
149915892|NCT00593606|540823994|FG000|Overall Study|Protocol Violation|3|||
149915893|NCT00593606|540823994|FG000|Overall Study|Lost to Follow-up|2|||
149915894|NCT00593606|540823994|FG000|Overall Study|Run-In Failure|5|||
149915895|NCT00593606|540823994|FG000|Overall Study|Screen Failure|3|||
149915896|NCT02278367|540823995|FG000|Overall Study|Physician Decision|5|||
149915897|NCT02278367|540823996|FG001|Overall Study|Physician Decision|0|||
149915898|NCT02278367|540823995|FG000|Overall Study|Withdrawal by Subject|5|||
149915899|NCT02278367|540823996|FG001|Overall Study|Withdrawal by Subject|0|||
149915900|NCT04643964|540823998|FG000|Overall Study|Lost to Follow-up|55|||
149915901|NCT04643964|540823999|FG001|Overall Study|Lost to Follow-up|59|||
149915902|NCT04643964|540824000|FG002|Overall Study|Lost to Follow-up|54|||
149915903|NCT04643964|540824001|FG003|Overall Study|Lost to Follow-up|129|||
150256558|NCT02594163|542074082|FG001|Follow-up Period|Adverse Event|1|||
150256559|NCT02594163|542074081|FG000|Follow-up Period|Progressive Disease|2|||
150256560|NCT02594163|542074082|FG001|Follow-up Period|Progressive Disease|0|||
150256561|NCT02594163|542074081|FG000|Follow-up Period|Physician Decision|0|||
150256562|NCT02594163|542074082|FG001|Follow-up Period|Physician Decision|1|||
149915904|NCT04643964|540824002|FG004|Overall Study|Lost to Follow-up|48|||
149915905|NCT04643964|540823998|FG000|Overall Study|Failed attention check|1|||
149915906|NCT04643964|540823999|FG001|Overall Study|Failed attention check|8|||
149915907|NCT04643964|540824000|FG002|Overall Study|Failed attention check|2|||
150256563|NCT02233543|542074085|FG000|Period 1|Withdrawal by Subject|1|||
149915908|NCT04643964|540824001|FG003|Overall Study|Failed attention check|14|||
149915909|NCT04643964|540824002|FG004|Overall Study|Failed attention check|11|||
149915910|NCT02638129|540824003|FG000|Overall Study|Study terminated|28|||
149915911|NCT02638129|540824004|FG001|Overall Study|Study terminated|30|||
149915912|NCT00869557|540824005|FG000|Randomized Phase|Lost to Follow-up|2|||
149915913|NCT00869557|540824006|FG001|Randomized Phase|Lost to Follow-up|1|||
149915914|NCT00869557|540824005|FG000|Randomized Phase|Investigator's Discretion|1|||
149915915|NCT00869557|540824006|FG001|Randomized Phase|Investigator's Discretion|0|||
149802031|NCT00594568|540404309|FG001|Initial Treatment|Death|11|||
149802032|NCT00594568|540404310|FG002|Initial Treatment|Death|15|||
149802033|NCT00594568|540404308|FG000|Initial Treatment|Lost to Follow-up|4|||
149802034|NCT00594568|540404309|FG001|Initial Treatment|Lost to Follow-up|1|||
149802035|NCT00594568|540404310|FG002|Initial Treatment|Lost to Follow-up|4|||
149802036|NCT00594568|540404308|FG000|Initial Treatment|Physician Decision|3|||
149802037|NCT00594568|540404309|FG001|Initial Treatment|Physician Decision|2|||
149802038|NCT00594568|540404310|FG002|Initial Treatment|Physician Decision|4|||
149802039|NCT00594568|540404308|FG000|Initial Treatment|Protocol Violation|2|||
149802040|NCT00594568|540404309|FG001|Initial Treatment|Protocol Violation|2|||
149802041|NCT00594568|540404310|FG002|Initial Treatment|Protocol Violation|5|||
149802042|NCT00594568|540404308|FG000|Initial Treatment|Withdrawal by Subject|25|||
149802043|NCT00594568|540404309|FG001|Initial Treatment|Withdrawal by Subject|31|||
149802044|NCT00594568|540404310|FG002|Initial Treatment|Withdrawal by Subject|46|||
149802045|NCT00594568|540404308|FG000|Initial Treatment|Sponsor decision|193|||
149802046|NCT00594568|540404309|FG001|Initial Treatment|Sponsor decision|142|||
149802047|NCT00594568|540404310|FG002|Initial Treatment|Sponsor decision|147|||
149802048|NCT00594568|540404308|FG000|Initial Treatment|Caregiver decision|21|||
149802049|NCT00594568|540404309|FG001|Initial Treatment|Caregiver decision|36|||
149802050|NCT00594568|540404310|FG002|Initial Treatment|Caregiver decision|36|||
149802051|NCT00594568|540404308|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
149802052|NCT00594568|540404309|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
149802053|NCT00594568|540404310|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
149802054|NCT00594568|540404308|FG000|Initial Treatment|Entry criteria exclusion|0|||
149802055|NCT00594568|540404309|FG001|Initial Treatment|Entry criteria exclusion|1|||
149802056|NCT00594568|540404310|FG002|Initial Treatment|Entry criteria exclusion|1|||
149802057|NCT00594568|540404308|FG000|Delayed Start|Death|0|||
149802058|NCT00594568|540404309|FG001|Delayed Start|Death|0|||
149802059|NCT00594568|540404310|FG002|Delayed Start|Death|1|||
149802060|NCT00594568|540404308|FG000|Delayed Start|Adverse Event|12|||
149802061|NCT00594568|540404309|FG001|Delayed Start|Adverse Event|2|||
149802062|NCT00594568|540404310|FG002|Delayed Start|Adverse Event|2|||
149802063|NCT00594568|540404308|FG000|Delayed Start|Withdrawal by Subject|4|||
149802064|NCT00594568|540404309|FG001|Delayed Start|Withdrawal by Subject|3|||
149802065|NCT00594568|540404310|FG002|Delayed Start|Withdrawal by Subject|0|||
149802066|NCT00594568|540404308|FG000|Delayed Start|Physician Decision|0|||
149802067|NCT00594568|540404309|FG001|Delayed Start|Physician Decision|0|||
149802068|NCT00594568|540404310|FG002|Delayed Start|Physician Decision|1|||
149802069|NCT00594568|540404308|FG000|Delayed Start|Lost to Follow-up|0|||
149802070|NCT00594568|540404309|FG001|Delayed Start|Lost to Follow-up|0|||
149802071|NCT00594568|540404310|FG002|Delayed Start|Lost to Follow-up|1|||
149802072|NCT00594568|540404308|FG000|Delayed Start|Caregiver Decision|5|||
149802073|NCT00594568|540404309|FG001|Delayed Start|Caregiver Decision|6|||
149802074|NCT00594568|540404310|FG002|Delayed Start|Caregiver Decision|2|||
149802075|NCT00594568|540404308|FG000|Delayed Start|Sponsor Decision|77|||
149802076|NCT00594568|540404309|FG001|Delayed Start|Sponsor Decision|66|||
149802077|NCT00594568|540404310|FG002|Delayed Start|Sponsor Decision|59|||
149802078|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
149802079|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
149802080|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
149802081|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
149802082|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
149802083|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
149802084|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
149802085|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
149802086|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
149802087|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
149802088|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
149802089|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
149802090|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
149915916|NCT00869557|540824005|FG000|Randomized Phase|Withdrew Consent|0|||
149915917|NCT00869557|540824006|FG001|Randomized Phase|Withdrew Consent|1|||
149915918|NCT00869557|540824005|FG000|Extension Phase|Adverse Event|2|||
149802091|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
149802092|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
149802093|NCT00594568|540404308|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
149802094|NCT00594568|540404309|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
149802095|NCT00594568|540404310|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
149802096|NCT02526017|540404312|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802097|NCT02526017|540404313|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
150256564|NCT02233543|542074086|FG001|Period 1|Withdrawal by Subject|0|||
150256565|NCT02233543|542074085|FG000|Period 1|Participants required other treatment.|2|||
150256566|NCT02233543|542074086|FG001|Period 1|Participants required other treatment.|3|||
150256567|NCT02233543|542074085|FG000|Period 2|Adverse Event|1|||
150256568|NCT02233543|542074086|FG001|Period 2|Adverse Event|0|||
150256569|NCT02233543|542074085|FG000|Period 2|Participant required other treatment.|0|||
150256570|NCT02233543|542074086|FG001|Period 2|Participant required other treatment.|1|||
150256571|NCT02233543|542074085|FG000|Period 2|COPD exacerbation|1|||
150256572|NCT02233543|542074086|FG001|Period 2|COPD exacerbation|0|||
150256573|NCT00603304|542074087|FG000|Overall Study|Lost to Follow-up|5|||
150256574|NCT00603304|542074088|FG001|Overall Study|Lost to Follow-up|7|||
150256575|NCT00603304|542074087|FG000|Overall Study|Withdrawal by Subject|8|||
150256576|NCT00603304|542074088|FG001|Overall Study|Withdrawal by Subject|5|||
150256577|NCT00603304|542074087|FG000|Overall Study|Protocol Violation|1|||
149802098|NCT02526017|540404314|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802099|NCT02526017|540404315|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802100|NCT02526017|540404316|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
149802101|NCT02526017|540404317|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802102|NCT02526017|540404318|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802103|NCT02526017|540404319|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802104|NCT02526017|540404320|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149802105|NCT01600755|540404322|FG000|Overall Study|Withdrawal by Subject|6|||
149802106|NCT02204449|540404327|FG000|Overall Study|Lost to Follow-up|7|||
149802107|NCT02204449|540404328|FG001|Overall Study|Lost to Follow-up|9|||
149802108|NCT02204449|540404327|FG000|Overall Study|Death|0|||
149802109|NCT02204449|540404328|FG001|Overall Study|Death|1|||
149802110|NCT02204449|540404327|FG000|Overall Study|Withdrawal by Subject|0|||
149802111|NCT02204449|540404328|FG001|Overall Study|Withdrawal by Subject|1|||
149802112|NCT04311411|540404331|FG000|Overall Study|Adverse Event|2|||
149802113|NCT04311411|540404332|FG001|Overall Study|Adverse Event|3|||
149802114|NCT04311411|540404333|FG002|Overall Study|Adverse Event|2|||
149802115|NCT04311411|540404331|FG000|Overall Study|Withdrawal by Subject|3|||
149802116|NCT04311411|540404332|FG001|Overall Study|Withdrawal by Subject|3|||
149802117|NCT04311411|540404333|FG002|Overall Study|Withdrawal by Subject|0|||
149802118|NCT01976663|540404337|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
149802119|NCT01976663|540404337|FG000|Overall Study|Personal Reasons|6|||
149802120|NCT01976663|540404337|FG000|Overall Study|Withdrawal by Subject|4|||
149802121|NCT01976663|540404337|FG000|Overall Study|Screen Failure|3|||
149802122|NCT01976663|540404337|FG000|Overall Study|Adverse Event|2|||
149802123|NCT01976663|540404337|FG000|Overall Study|Lost to Follow-up|3|||
149915919|NCT00869557|540824006|FG001|Extension Phase|Adverse Event|2|||
149915920|NCT00869557|540824005|FG000|Extension Phase|Lack of Efficacy|1|||
149915921|NCT00869557|540824006|FG001|Extension Phase|Lack of Efficacy|0|||
149915922|NCT00869557|540824005|FG000|Extension Phase|Lost to Follow-up|3|||
149915923|NCT00869557|540824006|FG001|Extension Phase|Lost to Follow-up|1|||
149915924|NCT00869557|540824005|FG000|Extension Phase|Investigator's Discretion|2|||
149915925|NCT00869557|540824006|FG001|Extension Phase|Investigator's Discretion|0|||
149915926|NCT00869557|540824005|FG000|Extension Phase|Withdrew Consent|2|||
149915927|NCT00869557|540824006|FG001|Extension Phase|Withdrew Consent|0|||
149915928|NCT02368210|540824010|FG000|Overall Study|Withdrawal by Subject|1|||
149915929|NCT02368210|540824011|FG001|Overall Study|Withdrawal by Subject|0|||
149915930|NCT02368210|540824010|FG000|Overall Study|Adverse Event|0|||
149915931|NCT02368210|540824011|FG001|Overall Study|Adverse Event|1|||
149915932|NCT01492101|540824012|FG000|Overall Study|Death|323|||
149915933|NCT01492101|540824013|FG001|Overall Study|Death|322|||
149915934|NCT01492101|540824012|FG000|Overall Study|Withdrawal by Subject|14|||
149915935|NCT01492101|540824013|FG001|Overall Study|Withdrawal by Subject|18|||
150142903|NCT01816763|541660021|FG000|Overall Study|The main reason for an incomplete survey|4|||
150142904|NCT01816763|541660022|FG001|Overall Study|The main reason for an incomplete survey|15|||
149915936|NCT01492101|540824012|FG000|Overall Study|Lost to Follow-up|0|||
149915937|NCT01492101|540824013|FG001|Overall Study|Lost to Follow-up|2|||
150142905|NCT01816763|541660023|FG002|Overall Study|The main reason for an incomplete survey|11|||
150142906|NCT01186328|541660028|FG000|Overall Study|Death|1|||
150142907|NCT01186328|541660029|FG001|Overall Study|Death|0|||
150142908|NCT01186328|541660030|FG002|Overall Study|Death|0|||
149915938|NCT00316914|540824014|FG000|Overall Study|Withdrawal by Subject|5|||
150142909|NCT02207725|541660034|FG000|Overall Study|Did Not Receive Treatment|0|||
150142910|NCT02207725|541660035|FG001|Overall Study|Did Not Receive Treatment|1|||
150256578|NCT00603304|542074088|FG001|Overall Study|Protocol Violation|0|||
150256579|NCT00603304|542074087|FG000|Overall Study|Adverse Event|4|||
150256580|NCT00603304|542074088|FG001|Overall Study|Adverse Event|2|||
150256581|NCT00603304|542074087|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
149802124|NCT01982942|540404339|FG000|Overall Study|Adverse Event|10|||
149802125|NCT01982942|540404340|FG001|Overall Study|Adverse Event|5|||
149802126|NCT01982942|540404339|FG000|Overall Study|Lost to Follow-up|4|||
149802127|NCT01982942|540404340|FG001|Overall Study|Lost to Follow-up|3|||
149802128|NCT01982942|540404339|FG000|Overall Study|Multiple sclerosis progression|3|||
149802129|NCT01982942|540404340|FG001|Overall Study|Multiple sclerosis progression|2|||
149802130|NCT01982942|540404339|FG000|Overall Study|Wanted to try therapy not permitted|1|||
149802131|NCT01982942|540404340|FG001|Overall Study|Wanted to try therapy not permitted|0|||
149802132|NCT01982942|540404339|FG000|Overall Study|Subject declined future visits|0|||
149802133|NCT01982942|540404340|FG001|Overall Study|Subject declined future visits|1|||
149802134|NCT01982942|540404339|FG000|Overall Study|Left geographical area|2|||
149802135|NCT01982942|540404340|FG001|Overall Study|Left geographical area|0|||
149802136|NCT01982942|540404339|FG000|Overall Study|Too many pills|1|||
149802137|NCT01982942|540404340|FG001|Overall Study|Too many pills|0|||
149802138|NCT01982942|540404339|FG000|Overall Study|MS Relapse|0|||
149802139|NCT01982942|540404340|FG001|Overall Study|MS Relapse|1|||
149802140|NCT01982942|540404339|FG000|Overall Study|Chose to join a stem cell trial|0|||
149802141|NCT01982942|540404340|FG001|Overall Study|Chose to join a stem cell trial|1|||
149802142|NCT01982942|540404339|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
149802143|NCT01982942|540404340|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
149802144|NCT01151085|540404343|FG000|Overall Study|Lost to Follow-up|31|||
149802145|NCT01151085|540404343|FG000|Overall Study|Protocol Violation|25|||
149802146|NCT00003526|540404349|FG000|Overall Study|Not evaluable|6|||
149802147|NCT04196023|540404350|FG000|Overall Study|Withdrawal by Subject|0|||
149802148|NCT04196023|540404351|FG001|Overall Study|Withdrawal by Subject|1|||
149802149|NCT04196023|540404350|FG000|Overall Study|Adverse Event|3|||
149802150|NCT04196023|540404351|FG001|Overall Study|Adverse Event|1|||
149802151|NCT04196023|540404350|FG000|Overall Study|Lost to Follow-up|0|||
149802152|NCT04196023|540404351|FG001|Overall Study|Lost to Follow-up|1|||
149802153|NCT00489411|540404352|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
149802154|NCT00489411|540404353|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
149802155|NCT00489411|540404352|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
149802156|NCT00489411|540404353|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
149802157|NCT00489411|540404352|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
149802158|NCT00489411|540404353|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
149802159|NCT00489411|540404352|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
149802160|NCT00489411|540404353|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
149802161|NCT00489411|540404352|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
149802162|NCT00489411|540404353|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
149802163|NCT01748162|540404355|FG000|Overall Study|no additional croup episodes to evaluate|2|||
149802164|NCT01748162|540404356|FG001|Overall Study|no additional croup episodes to evaluate|2|||
149802165|NCT01748162|540404355|FG000|Overall Study|participant consented but did not begin|0|||
149802166|NCT01748162|540404356|FG001|Overall Study|participant consented but did not begin|1|||
149802167|NCT01748162|540404355|FG000|Overall Study|reasons not available|3|||
149802168|NCT01748162|540404356|FG001|Overall Study|reasons not available|2|||
149802169|NCT03219372|540404357|FG000|Overall Study|Withdrawal by Subject|1|||
149802170|NCT03219372|540404358|FG001|Overall Study|Withdrawal by Subject|0|||
149802171|NCT03841331|540404359|FG000|Overall Study|Withdrawal by Subject|4|||
149802172|NCT03841331|540404360|FG001|Overall Study|Withdrawal by Subject|9|||
150142911|NCT02207725|541660036|FG002|Overall Study|Did Not Receive Treatment|1|||
149915939|NCT00316914|540824015|FG001|Overall Study|Withdrawal by Subject|3|||
149915940|NCT00316914|540824014|FG000|Overall Study|Adverse Event|8|||
149915941|NCT00316914|540824015|FG001|Overall Study|Adverse Event|7|||
149915942|NCT00316914|540824014|FG000|Overall Study|Other Problems|6|||
149915943|NCT00316914|540824015|FG001|Overall Study|Other Problems|11|||
149915944|NCT00316914|540824014|FG000|Overall Study|Missing end of treatment documentation|14|||
149915945|NCT00316914|540824015|FG001|Overall Study|Missing end of treatment documentation|15|||
149915946|NCT01917344|540824022|FG000|Overall Study|Withdrawal by Subject|1|||
149915947|NCT02956057|540824023|FG000|Overall Study|Discontinued intervention|14|||
149915948|NCT02956057|540824024|FG001|Overall Study|Discontinued intervention|10|||
149915949|NCT02956057|540824025|FG002|Overall Study|Discontinued intervention|7|||
149915950|NCT02956057|540824026|FG003|Overall Study|Discontinued intervention|14|||
149915951|NCT02956057|540824027|FG004|Overall Study|Discontinued intervention|4|||
149915952|NCT02956057|540824028|FG005|Overall Study|Discontinued intervention|17|||
149915953|NCT02956057|540824023|FG000|Overall Study|Lost to Follow-up|0|||
149802173|NCT03841331|540404359|FG000|Overall Study|Lost to Follow-up|5|||
149802174|NCT03841331|540404360|FG001|Overall Study|Lost to Follow-up|1|||
149802175|NCT00779857|540404361|FG000|Overall Study|Death|1|||
149802176|NCT00779857|540404361|FG000|Overall Study|Withdrawal by Subject|3|||
149802177|NCT00779857|540404361|FG000|Overall Study|Missed Visit|2|||
149915954|NCT02956057|540824024|FG001|Overall Study|Lost to Follow-up|2|||
149915955|NCT02956057|540824025|FG002|Overall Study|Lost to Follow-up|1|||
150142912|NCT02207725|541660037|FG003|Overall Study|Did Not Receive Treatment|1|||
149915956|NCT02956057|540824026|FG003|Overall Study|Lost to Follow-up|1|||
149802178|NCT04640168|540404362|FG000|Overall Study|Withdrawal by Subject|8|||
149802179|NCT04640168|540404363|FG001|Overall Study|Withdrawal by Subject|7|||
149802180|NCT04640168|540404362|FG000|Overall Study|Lost to Follow-up|1|||
149802181|NCT04640168|540404363|FG001|Overall Study|Lost to Follow-up|0|||
149802182|NCT04640168|540404362|FG000|Overall Study|Enrolled but not treated|12|||
149802183|NCT04640168|540404363|FG001|Overall Study|Enrolled but not treated|12|||
149802184|NCT00442572|540404367|FG000|Overall Study|Relapse|8|||
149802185|NCT00442572|540404368|FG001|Overall Study|Relapse|1|||
149802186|NCT00442572|540404367|FG000|Overall Study|Lost to Follow-up|0|||
149802187|NCT00442572|540404368|FG001|Overall Study|Lost to Follow-up|1|||
149915957|NCT02956057|540824027|FG004|Overall Study|Lost to Follow-up|1|||
149915958|NCT02956057|540824028|FG005|Overall Study|Lost to Follow-up|0|||
149915959|NCT00943670|540824035|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
149915960|NCT00943670|540824035|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
149915961|NCT00943670|540824035|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
149915962|NCT00943670|540824035|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
149915963|NCT00943670|540824035|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
149915964|NCT00943670|540824035|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
149915965|NCT00943670|540824035|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
149915966|NCT00943670|540824035|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
149915967|NCT00943670|540824035|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
149915968|NCT00943670|540824035|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
149915969|NCT01777295|540824036|FG000|Overall Study|Withdrawal by Subject|2|||
149915970|NCT01777295|540824037|FG001|Overall Study|Withdrawal by Subject|2|||
149915971|NCT01777295|540824036|FG000|Overall Study|Pregnancy|0|||
149915972|NCT01777295|540824037|FG001|Overall Study|Pregnancy|1|||
149915973|NCT01777295|540824036|FG000|Overall Study|Personal problem|1|||
149802188|NCT00442572|540404367|FG000|Overall Study|Withdrawal by Subject|0|||
149802189|NCT00442572|540404368|FG001|Overall Study|Withdrawal by Subject|1|||
149802190|NCT01023815|540404369|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
149802191|NCT01023815|540404370|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149802192|NCT01023815|540404371|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149802193|NCT01023815|540404372|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149802194|NCT01023815|540404369|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
149802195|NCT01023815|540404370|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
149802196|NCT01023815|540404371|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
149802197|NCT01023815|540404372|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
149802198|NCT01023815|540404369|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
149802199|NCT01023815|540404370|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
149802200|NCT01023815|540404371|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
149802201|NCT01023815|540404372|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
149915974|NCT01777295|540824037|FG001|Overall Study|Personal problem|0|||
149802202|NCT01023815|540404369|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
149802203|NCT01023815|540404370|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
149802204|NCT01023815|540404371|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
149802205|NCT01023815|540404372|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
149802206|NCT01023815|540404369|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
149802207|NCT01023815|540404370|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
149802208|NCT01023815|540404371|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
149802209|NCT01023815|540404372|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
149802210|NCT01683565|540404378|FG000|Overall Study|Lost to Follow-up|2|||
149802211|NCT01683565|540404379|FG001|Overall Study|Lost to Follow-up|0|||
149802212|NCT01683565|540404378|FG000|Overall Study|Discontinued Intervention|1|||
149802213|NCT01683565|540404379|FG001|Overall Study|Discontinued Intervention|1|||
149802214|NCT04479358|540404380|FG000|Overall Study|Withdrawal by Subject|0|||
149802215|NCT04479358|540404381|FG001|Overall Study|Withdrawal by Subject|0|||
149802216|NCT04479358|540404382|FG002|Overall Study|Withdrawal by Subject|1|||
149802217|NCT04479358|540404383|FG003|Overall Study|Withdrawal by Subject|0|||
149802218|NCT04479358|540404384|FG004|Overall Study|Withdrawal by Subject|0|||
149802219|NCT04479358|540404385|FG005|Overall Study|Withdrawal by Subject|1|||
149802220|NCT04410991|540404395|FG000|Overall Study|Poor compliance to protocol|5|||
149802221|NCT04410991|540404396|FG001|Overall Study|Poor compliance to protocol|4|||
149802222|NCT04410991|540404395|FG000|Overall Study|Withdrawal by Subject|59|||
149802223|NCT04410991|540404396|FG001|Overall Study|Withdrawal by Subject|55|||
149802224|NCT04410991|540404395|FG000|Overall Study|Other|10|||
149915975|NCT01777295|540824036|FG000|Overall Study|Investigator call for AEs check|1|||
149802225|NCT04410991|540404396|FG001|Overall Study|Other|4|||
149802226|NCT00764465|540404397|FG000|Overall Study|Adverse Event|2|||
149802227|NCT00764465|540404398|FG001|Overall Study|Adverse Event|0|||
150142913|NCT01966003|541660039|FG000|Overall Study|Death|43|||
149802228|NCT00764465|540404399|FG002|Overall Study|Adverse Event|0|||
149802229|NCT00764465|540404400|FG003|Overall Study|Adverse Event|1|||
149802230|NCT00764465|540404401|FG004|Overall Study|Adverse Event|1|||
149802231|NCT00764465|540404402|FG005|Overall Study|Adverse Event|1|||
149802232|NCT00764465|540404397|FG000|Overall Study|Withdrawal by Subject|0|||
149802233|NCT00764465|540404398|FG001|Overall Study|Withdrawal by Subject|1|||
149802234|NCT00764465|540404399|FG002|Overall Study|Withdrawal by Subject|1|||
149802235|NCT00764465|540404400|FG003|Overall Study|Withdrawal by Subject|0|||
149802236|NCT00764465|540404401|FG004|Overall Study|Withdrawal by Subject|0|||
149802237|NCT00764465|540404402|FG005|Overall Study|Withdrawal by Subject|0|||
149802238|NCT01195662|540404403|FG000|Double Blind Treatment Period|Adverse Event|4|||
149802239|NCT01195662|540404404|FG001|Double Blind Treatment Period|Adverse Event|1|||
149802240|NCT01195662|540404405|FG002|Double Blind Treatment Period|Adverse Event|2|||
149802241|NCT01195662|540404403|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
149802242|NCT01195662|540404404|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
149802243|NCT01195662|540404405|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
149802244|NCT01195662|540404403|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
149802245|NCT01195662|540404404|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
149802246|NCT01195662|540404405|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
149802247|NCT01195662|540404403|FG000|Double Blind Treatment Period|Administrative reason|2|||
149802248|NCT01195662|540404404|FG001|Double Blind Treatment Period|Administrative reason|1|||
149802249|NCT01195662|540404405|FG002|Double Blind Treatment Period|Administrative reason|1|||
149802250|NCT01195662|540404403|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
149802251|NCT01195662|540404404|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
149802252|NCT01195662|540404405|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
149802253|NCT01195662|540404403|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
149802254|NCT01195662|540404404|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
149802255|NCT01195662|540404405|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
149802256|NCT01195662|540404403|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
149802257|NCT01195662|540404404|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
149802258|NCT01195662|540404405|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
149802259|NCT01195662|540404403|FG000|Double Blind Treatment Period|Non-specified|3|||
149802260|NCT01195662|540404404|FG001|Double Blind Treatment Period|Non-specified|0|||
149802261|NCT01195662|540404405|FG002|Double Blind Treatment Period|Non-specified|0|||
149802262|NCT01195662|540404403|FG000|Double Blind Treatment Period|Missing disposition information|0|||
149802263|NCT01195662|540404404|FG001|Double Blind Treatment Period|Missing disposition information|1|||
149802264|NCT01195662|540404405|FG002|Double Blind Treatment Period|Missing disposition information|1|||
149802265|NCT01195662|540404403|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
149802266|NCT01195662|540404404|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
149802267|NCT01195662|540404405|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
149802268|NCT01195662|540404403|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
149802269|NCT01195662|540404404|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
149802270|NCT01195662|540404405|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
149802271|NCT01250418|540404407|FG000|Overall Study|monitor data failure|1|||
149802272|NCT01250418|540404408|FG001|Overall Study|monitor data failure|1|||
149802273|NCT05966129|540404411|FG000|Overall Study|Death|1|||
149802274|NCT05966129|540404412|FG001|Overall Study|Death|2|||
149802275|NCT05966129|540404411|FG000|Overall Study|Lost to Follow-up|63|||
149802276|NCT05966129|540404412|FG001|Overall Study|Lost to Follow-up|66|||
149802277|NCT05966129|540404411|FG000|Overall Study|Protocol Violation|1|||
149802278|NCT05966129|540404412|FG001|Overall Study|Protocol Violation|0|||
149802279|NCT05966129|540404411|FG000|Overall Study|Withdrawal by Subject|26|||
149802280|NCT05966129|540404412|FG001|Overall Study|Withdrawal by Subject|25|||
149802281|NCT05966129|540404411|FG000|Overall Study|Surgery not completed|63|||
149802282|NCT05966129|540404412|FG001|Overall Study|Surgery not completed|69|||
149802283|NCT05966129|540404411|FG000|Overall Study|Surgery logistics issue|2|||
149802284|NCT05966129|540404412|FG001|Overall Study|Surgery logistics issue|1|||
149802285|NCT01298323|540404413|FG000|Overall Study|Adverse Event|2|||
149802286|NCT01298323|540404414|FG001|Overall Study|Adverse Event|4|||
149802287|NCT01298323|540404413|FG000|Overall Study|Death|11|||
149802288|NCT01298323|540404414|FG001|Overall Study|Death|16|||
149802289|NCT01298323|540404413|FG000|Overall Study|Lost to Follow-up|1|||
149802290|NCT01298323|540404414|FG001|Overall Study|Lost to Follow-up|0|||
149802291|NCT01298323|540404413|FG000|Overall Study|Withdrawal by Subject|6|||
149802292|NCT01298323|540404414|FG001|Overall Study|Withdrawal by Subject|3|||
149802293|NCT01298323|540404413|FG000|Overall Study|Protocol Violation|1|||
149802294|NCT01298323|540404414|FG001|Overall Study|Protocol Violation|0|||
149802295|NCT01298323|540404413|FG000|Overall Study|Other|10|||
149802296|NCT01298323|540404414|FG001|Overall Study|Other|9|||
149802297|NCT01298323|540404413|FG000|Overall Study|Ongoing|55|||
149802298|NCT01298323|540404414|FG001|Overall Study|Ongoing|55|||
149802299|NCT01298323|540404413|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149802300|NCT01298323|540404414|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149802301|NCT01761565|540404415|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
149802302|NCT05182840|540404416|FG000|Run-in Period|Not treated|0|||
149802303|NCT05182840|540404417|FG001|Run-in Period|Not treated|1|||
149802304|NCT05182840|540404418|FG002|Run-in Period|Not treated|0|||
149802305|NCT05182840|540404419|FG003|Run-in Period|Not treated|0|||
149802306|NCT05182840|540404420|FG004|Run-in Period|Not treated|0|||
149802307|NCT05182840|540404421|FG005|Run-in Period|Not treated|0|||
149802308|NCT05182840|540404422|FG006|Run-in Period|Not treated|0|||
149802309|NCT05182840|540404423|FG007|Run-in Period|Not treated|0|||
149802310|NCT05182840|540404424|FG008|Run-in Period|Not treated|0|||
149802311|NCT05182840|540404425|FG009|Run-in Period|Not treated|0|||
149802312|NCT05182840|540404416|FG000|Run-in Period|Other reason but not sponsor termination|14|||
149802313|NCT05182840|540404417|FG001|Run-in Period|Other reason but not sponsor termination|18|||
150256582|NCT00603304|542074088|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
150256583|NCT00603304|542074087|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
150256584|NCT00603304|542074088|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
150256585|NCT00603304|542074087|FG000|Overall Study|Exclusionary Medication|2|||
150256586|NCT00603304|542074088|FG001|Overall Study|Exclusionary Medication|3|||
150256587|NCT00603304|542074087|FG000|Overall Study|Non-Compliant|0|||
150256588|NCT00603304|542074088|FG001|Overall Study|Non-Compliant|1|||
150256589|NCT00603304|542074087|FG000|Overall Study|Moved Away|0|||
150256590|NCT00603304|542074088|FG001|Overall Study|Moved Away|2|||
150256591|NCT00603304|542074087|FG000|Overall Study|Other|2|||
150256592|NCT00603304|542074088|FG001|Overall Study|Other|0|||
150256593|NCT00603304|542074087|FG000|Overall Study|Patient Decision|2|||
150256594|NCT00603304|542074088|FG001|Overall Study|Patient Decision|0|||
150256595|NCT01076192|542074089|FG000|Overall Study|Other|197|||
150256596|NCT01034176|542074090|FG000|Overall Study|Physician Decision|2|||
150256597|NCT01034176|542074091|FG001|Overall Study|Physician Decision|0|||
150256598|NCT01034176|542074090|FG000|Overall Study|Withdrawal by Subject|0|||
150256599|NCT01034176|542074091|FG001|Overall Study|Withdrawal by Subject|1|||
150256600|NCT01034176|542074090|FG000|Overall Study|Lost to Follow-up|0|||
150256601|NCT01034176|542074091|FG001|Overall Study|Lost to Follow-up|1|||
150256602|NCT05087979|542074094|FG000|Overall Study|Converted to general anesthesia|1|||
150256603|NCT05087979|542074095|FG001|Overall Study|Converted to general anesthesia|0|||
150256604|NCT01119105|542074096|FG000|Overall Study|Withdrawal by Subject|1|||
150256605|NCT01119105|542074097|FG001|Overall Study|Withdrawal by Subject|1|||
150256606|NCT01119105|542074098|FG002|Overall Study|Withdrawal by Subject|1|||
149802314|NCT05182840|540404418|FG002|Run-in Period|Other reason but not sponsor termination|0|||
149802315|NCT05182840|540404419|FG003|Run-in Period|Other reason but not sponsor termination|0|||
150256607|NCT01119105|542074096|FG000|Overall Study|Lost to Follow-up|0|||
150256608|NCT01119105|542074097|FG001|Overall Study|Lost to Follow-up|2|||
150256609|NCT01119105|542074098|FG002|Overall Study|Lost to Follow-up|5|||
150256610|NCT01119105|542074096|FG000|Overall Study|Adverse Event|1|||
150256611|NCT01119105|542074097|FG001|Overall Study|Adverse Event|0|||
150256612|NCT01119105|542074098|FG002|Overall Study|Adverse Event|1|||
150256613|NCT01119105|542074096|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
150256614|NCT01119105|542074097|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
150256615|NCT01119105|542074098|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
150256616|NCT01119105|542074096|FG000|Overall Study|Other|1|||
150256617|NCT01119105|542074097|FG001|Overall Study|Other|1|||
150256618|NCT01119105|542074098|FG002|Overall Study|Other|0|||
150256619|NCT01639495|542074099|FG000|Overall Study|Lost to Follow-up|6|||
150256620|NCT01639495|542074099|FG000|Overall Study|Consented but didn't have study catheter|4|||
149802316|NCT05182840|540404420|FG004|Run-in Period|Other reason but not sponsor termination|0|||
149802317|NCT05182840|540404421|FG005|Run-in Period|Other reason but not sponsor termination|0|||
149802318|NCT05182840|540404422|FG006|Run-in Period|Other reason but not sponsor termination|0|||
149802319|NCT05182840|540404423|FG007|Run-in Period|Other reason but not sponsor termination|0|||
149802320|NCT05182840|540404424|FG008|Run-in Period|Other reason but not sponsor termination|0|||
149802321|NCT05182840|540404425|FG009|Run-in Period|Other reason but not sponsor termination|0|||
149802322|NCT05182840|540404416|FG000|Run-in Period|No reason available|2|||
149802323|NCT05182840|540404417|FG001|Run-in Period|No reason available|2|||
149802324|NCT05182840|540404418|FG002|Run-in Period|No reason available|0|||
149802325|NCT05182840|540404419|FG003|Run-in Period|No reason available|0|||
149802326|NCT05182840|540404420|FG004|Run-in Period|No reason available|0|||
149802327|NCT05182840|540404421|FG005|Run-in Period|No reason available|0|||
149802328|NCT05182840|540404422|FG006|Run-in Period|No reason available|0|||
149802329|NCT05182840|540404423|FG007|Run-in Period|No reason available|0|||
149802330|NCT05182840|540404424|FG008|Run-in Period|No reason available|0|||
149802331|NCT05182840|540404425|FG009|Run-in Period|No reason available|0|||
149802332|NCT05182840|540404416|FG000|Run-in Period|Burden of study procedures|2|||
150256621|NCT01639495|542074099|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
149802333|NCT05182840|540404417|FG001|Run-in Period|Burden of study procedures|2|||
149802334|NCT05182840|540404418|FG002|Run-in Period|Burden of study procedures|0|||
149802335|NCT05182840|540404419|FG003|Run-in Period|Burden of study procedures|0|||
149802336|NCT05182840|540404420|FG004|Run-in Period|Burden of study procedures|0|||
149802337|NCT05182840|540404421|FG005|Run-in Period|Burden of study procedures|0|||
149802338|NCT05182840|540404422|FG006|Run-in Period|Burden of study procedures|0|||
149802339|NCT05182840|540404423|FG007|Run-in Period|Burden of study procedures|0|||
149802340|NCT05182840|540404424|FG008|Run-in Period|Burden of study procedures|0|||
149802341|NCT05182840|540404425|FG009|Run-in Period|Burden of study procedures|0|||
149802342|NCT05182840|540404416|FG000|Run-in Period|Change of residence|1|||
149802343|NCT05182840|540404417|FG001|Run-in Period|Change of residence|0|||
149802344|NCT05182840|540404418|FG002|Run-in Period|Change of residence|0|||
149802345|NCT05182840|540404419|FG003|Run-in Period|Change of residence|0|||
149802346|NCT05182840|540404420|FG004|Run-in Period|Change of residence|0|||
149802347|NCT05182840|540404421|FG005|Run-in Period|Change of residence|0|||
149802348|NCT05182840|540404422|FG006|Run-in Period|Change of residence|0|||
149802349|NCT05182840|540404423|FG007|Run-in Period|Change of residence|0|||
149802350|NCT05182840|540404424|FG008|Run-in Period|Change of residence|0|||
149802351|NCT05182840|540404425|FG009|Run-in Period|Change of residence|0|||
149802352|NCT05182840|540404416|FG000|Run-in Period|Adverse Event|5|||
149802353|NCT05182840|540404417|FG001|Run-in Period|Adverse Event|5|||
149802354|NCT05182840|540404418|FG002|Run-in Period|Adverse Event|0|||
149802355|NCT05182840|540404419|FG003|Run-in Period|Adverse Event|0|||
149802356|NCT05182840|540404420|FG004|Run-in Period|Adverse Event|0|||
149802357|NCT05182840|540404421|FG005|Run-in Period|Adverse Event|0|||
149802358|NCT05182840|540404422|FG006|Run-in Period|Adverse Event|0|||
149802359|NCT05182840|540404423|FG007|Run-in Period|Adverse Event|0|||
149802360|NCT05182840|540404424|FG008|Run-in Period|Adverse Event|0|||
149802361|NCT05182840|540404425|FG009|Run-in Period|Adverse Event|0|||
149802362|NCT05182840|540404416|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
149802363|NCT05182840|540404417|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
149802364|NCT05182840|540404418|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802365|NCT05182840|540404419|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802366|NCT05182840|540404420|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802367|NCT05182840|540404421|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802368|NCT05182840|540404422|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802369|NCT05182840|540404423|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802370|NCT05182840|540404424|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802371|NCT05182840|540404425|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149802372|NCT05182840|540404416|FG000|Treatment Period|Reason missing|0|||
149802373|NCT05182840|540404417|FG001|Treatment Period|Reason missing|0|||
149802374|NCT05182840|540404418|FG002|Treatment Period|Reason missing|1|||
149802375|NCT05182840|540404419|FG003|Treatment Period|Reason missing|0|||
149802376|NCT05182840|540404420|FG004|Treatment Period|Reason missing|0|||
149802377|NCT05182840|540404421|FG005|Treatment Period|Reason missing|0|||
149802378|NCT05182840|540404422|FG006|Treatment Period|Reason missing|0|||
149802379|NCT05182840|540404423|FG007|Treatment Period|Reason missing|0|||
149802380|NCT05182840|540404424|FG008|Treatment Period|Reason missing|0|||
149802381|NCT05182840|540404425|FG009|Treatment Period|Reason missing|0|||
149802382|NCT05182840|540404416|FG000|Treatment Period|Other but not sponsor termination|0|||
149802383|NCT05182840|540404417|FG001|Treatment Period|Other but not sponsor termination|0|||
149802384|NCT05182840|540404418|FG002|Treatment Period|Other but not sponsor termination|8|||
149802385|NCT05182840|540404419|FG003|Treatment Period|Other but not sponsor termination|6|||
149802386|NCT05182840|540404420|FG004|Treatment Period|Other but not sponsor termination|6|||
149802387|NCT05182840|540404421|FG005|Treatment Period|Other but not sponsor termination|7|||
149802388|NCT05182840|540404422|FG006|Treatment Period|Other but not sponsor termination|5|||
149802389|NCT05182840|540404423|FG007|Treatment Period|Other but not sponsor termination|8|||
149802390|NCT05182840|540404424|FG008|Treatment Period|Other but not sponsor termination|7|||
149802391|NCT05182840|540404425|FG009|Treatment Period|Other but not sponsor termination|2|||
149802392|NCT05182840|540404416|FG000|Treatment Period|Protocol deviation|0|||
149802393|NCT05182840|540404417|FG001|Treatment Period|Protocol deviation|0|||
149802394|NCT05182840|540404418|FG002|Treatment Period|Protocol deviation|0|||
149802395|NCT05182840|540404419|FG003|Treatment Period|Protocol deviation|0|||
149802396|NCT05182840|540404420|FG004|Treatment Period|Protocol deviation|0|||
149802397|NCT05182840|540404421|FG005|Treatment Period|Protocol deviation|0|||
149802398|NCT05182840|540404422|FG006|Treatment Period|Protocol deviation|0|||
149802399|NCT05182840|540404423|FG007|Treatment Period|Protocol deviation|0|||
149802400|NCT05182840|540404424|FG008|Treatment Period|Protocol deviation|1|||
149802401|NCT05182840|540404425|FG009|Treatment Period|Protocol deviation|0|||
149802402|NCT05182840|540404416|FG000|Treatment Period|No reason available|0|||
149802403|NCT05182840|540404417|FG001|Treatment Period|No reason available|0|||
149802404|NCT05182840|540404418|FG002|Treatment Period|No reason available|0|||
149802405|NCT05182840|540404419|FG003|Treatment Period|No reason available|1|||
149802406|NCT05182840|540404420|FG004|Treatment Period|No reason available|0|||
149802407|NCT05182840|540404421|FG005|Treatment Period|No reason available|2|||
149802408|NCT05182840|540404422|FG006|Treatment Period|No reason available|0|||
149802409|NCT05182840|540404423|FG007|Treatment Period|No reason available|1|||
149802410|NCT05182840|540404424|FG008|Treatment Period|No reason available|0|||
149802411|NCT05182840|540404425|FG009|Treatment Period|No reason available|0|||
149802412|NCT05182840|540404416|FG000|Treatment Period|Burden of study procedures|0|||
149802413|NCT05182840|540404417|FG001|Treatment Period|Burden of study procedures|0|||
149802414|NCT05182840|540404418|FG002|Treatment Period|Burden of study procedures|0|||
149802415|NCT05182840|540404419|FG003|Treatment Period|Burden of study procedures|0|||
149802416|NCT05182840|540404420|FG004|Treatment Period|Burden of study procedures|1|||
149802417|NCT05182840|540404421|FG005|Treatment Period|Burden of study procedures|0|||
149802418|NCT05182840|540404422|FG006|Treatment Period|Burden of study procedures|0|||
149802419|NCT05182840|540404423|FG007|Treatment Period|Burden of study procedures|0|||
149802420|NCT05182840|540404424|FG008|Treatment Period|Burden of study procedures|0|||
149802421|NCT05182840|540404425|FG009|Treatment Period|Burden of study procedures|0|||
149802422|NCT05182840|540404416|FG000|Treatment Period|Change of residence|0|||
149802423|NCT05182840|540404417|FG001|Treatment Period|Change of residence|0|||
149802424|NCT05182840|540404418|FG002|Treatment Period|Change of residence|0|||
149802425|NCT05182840|540404419|FG003|Treatment Period|Change of residence|0|||
149802426|NCT05182840|540404420|FG004|Treatment Period|Change of residence|0|||
149802427|NCT05182840|540404421|FG005|Treatment Period|Change of residence|1|||
149802428|NCT05182840|540404422|FG006|Treatment Period|Change of residence|0|||
149802429|NCT05182840|540404423|FG007|Treatment Period|Change of residence|0|||
149802430|NCT05182840|540404424|FG008|Treatment Period|Change of residence|0|||
149802431|NCT05182840|540404425|FG009|Treatment Period|Change of residence|0|||
149802432|NCT05182840|540404416|FG000|Treatment Period|Adverse Event|0|||
149802433|NCT05182840|540404417|FG001|Treatment Period|Adverse Event|0|||
149802434|NCT05182840|540404418|FG002|Treatment Period|Adverse Event|4|||
149802435|NCT05182840|540404419|FG003|Treatment Period|Adverse Event|16|||
149802436|NCT05182840|540404420|FG004|Treatment Period|Adverse Event|12|||
149802437|NCT05182840|540404421|FG005|Treatment Period|Adverse Event|6|||
149802438|NCT05182840|540404422|FG006|Treatment Period|Adverse Event|4|||
149802439|NCT05182840|540404423|FG007|Treatment Period|Adverse Event|8|||
149802440|NCT05182840|540404424|FG008|Treatment Period|Adverse Event|16|||
149802441|NCT05182840|540404425|FG009|Treatment Period|Adverse Event|5|||
149802442|NCT05182840|540404416|FG000|Treatment Period|Not treated with study drug|0|||
149802443|NCT05182840|540404417|FG001|Treatment Period|Not treated with study drug|0|||
149802444|NCT05182840|540404418|FG002|Treatment Period|Not treated with study drug|0|||
149802445|NCT05182840|540404419|FG003|Treatment Period|Not treated with study drug|1|||
149802446|NCT05182840|540404420|FG004|Treatment Period|Not treated with study drug|0|||
149802447|NCT05182840|540404421|FG005|Treatment Period|Not treated with study drug|0|||
149802448|NCT05182840|540404422|FG006|Treatment Period|Not treated with study drug|1|||
149802449|NCT05182840|540404423|FG007|Treatment Period|Not treated with study drug|1|||
149802450|NCT05182840|540404424|FG008|Treatment Period|Not treated with study drug|0|||
150256622|NCT01639495|542074099|FG000|Overall Study|No radiofrequency energy applied|2|||
150256623|NCT04214600|542074102|FG000|Overall Study|Lost to Follow-up|9|||
150256624|NCT04214600|542074103|FG001|Overall Study|Lost to Follow-up|14|||
150256625|NCT02935452|542074104|FG000|Overall Study|work and life commintment|3|||
150256626|NCT02935452|542074105|FG001|Overall Study|work and life commintment|1|||
150256627|NCT01635920|542074106|FG000|Overall Study|Adverse Event|1|||
150256628|NCT01635920|542074107|FG001|Overall Study|Adverse Event|0|||
150256629|NCT01635920|542074106|FG000|Overall Study|Lost to Follow-up|0|||
150256630|NCT01635920|542074107|FG001|Overall Study|Lost to Follow-up|1|||
150256631|NCT01635920|542074106|FG000|Overall Study|Subject decision|2|||
149802451|NCT05182840|540404425|FG009|Treatment Period|Not treated with study drug|0|||
149802452|NCT02161380|540404426|FG000|Overall Study|Lost to Follow-up|0|||
149802453|NCT02161380|540404427|FG001|Overall Study|Lost to Follow-up|1|||
149802454|NCT02161380|540404428|FG002|Overall Study|Lost to Follow-up|0|||
149802455|NCT02161380|540404429|FG003|Overall Study|Lost to Follow-up|0|||
149802456|NCT04794491|540404441|FG000|Overall Study|Adverse Event|1|||
149802457|NCT04794491|540404441|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
149802458|NCT04794491|540404441|FG000|Overall Study|Noncompliance With Study Intervention|1|||
149802459|NCT04794491|540404441|FG000|Overall Study|Withdrawal by Subject|2|||
149802460|NCT00948896|540404442|FG000|Randomization to 24 Months of Age|Death|1|||
149915976|NCT01777295|540824037|FG001|Overall Study|Investigator call for AEs check|0|||
149802461|NCT00948896|540404443|FG001|Randomization to 24 Months of Age|Death|0|||
149802462|NCT00948896|540404444|FG002|Randomization to 24 Months of Age|Death|0|||
149802463|NCT00948896|540404445|FG003|Randomization to 24 Months of Age|Death|0|||
149802464|NCT00948896|540404446|FG004|Randomization to 24 Months of Age|Death|2|||
149802465|NCT00948896|540404447|FG005|Randomization to 24 Months of Age|Death|1|||
149802466|NCT00948896|540404448|FG006|Randomization to 24 Months of Age|Death|2|||
149802467|NCT00948896|540404449|FG007|Randomization to 24 Months of Age|Death|1|||
149802468|NCT00948896|540404442|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
150256632|NCT01635920|542074107|FG001|Overall Study|Subject decision|0|||
150256633|NCT00686725|542074109|FG000|Overall Study|Adverse Event|1|||
149802469|NCT00948896|540404443|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
149802470|NCT00948896|540404444|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
149802471|NCT00948896|540404445|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
149802472|NCT00948896|540404446|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149802473|NCT00948896|540404447|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
149802474|NCT00948896|540404448|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149802475|NCT00948896|540404449|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149802476|NCT00948896|540404442|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
149802477|NCT00948896|540404443|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
149802478|NCT00948896|540404444|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
149802479|NCT00948896|540404445|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
149802480|NCT00948896|540404446|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149802481|NCT00948896|540404447|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149802482|NCT00948896|540404448|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
149802483|NCT00948896|540404449|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149802484|NCT00948896|540404442|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
149802485|NCT00948896|540404443|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
149802486|NCT00948896|540404444|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
149802487|NCT00948896|540404445|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
149802488|NCT00948896|540404446|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
149802489|NCT00948896|540404447|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
149802490|NCT00948896|540404448|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
149802491|NCT00948896|540404449|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
149802492|NCT00948896|540404442|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149802493|NCT00948896|540404443|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
149802494|NCT00948896|540404444|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
149802495|NCT00948896|540404445|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
149802496|NCT00948896|540404446|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149802497|NCT00948896|540404447|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
149802498|NCT00948896|540404448|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149802499|NCT00948896|540404449|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149802500|NCT00948896|540404442|FG000|24 Months of Age to 36 Months of Age|Death|0|||
149802501|NCT00948896|540404443|FG001|24 Months of Age to 36 Months of Age|Death|2|||
149802502|NCT00948896|540404444|FG002|24 Months of Age to 36 Months of Age|Death|2|||
149802503|NCT00948896|540404445|FG003|24 Months of Age to 36 Months of Age|Death|0|||
149802504|NCT00948896|540404446|FG004|24 Months of Age to 36 Months of Age|Death|0|||
149802505|NCT00948896|540404447|FG005|24 Months of Age to 36 Months of Age|Death|1|||
149802506|NCT00948896|540404448|FG006|24 Months of Age to 36 Months of Age|Death|0|||
149802507|NCT00948896|540404449|FG007|24 Months of Age to 36 Months of Age|Death|0|||
149802508|NCT00948896|540404442|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149802509|NCT00948896|540404443|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149802510|NCT00948896|540404444|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149802511|NCT00948896|540404445|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149802512|NCT00948896|540404446|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149802513|NCT00948896|540404447|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149802514|NCT00948896|540404448|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149802515|NCT00948896|540404449|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149802516|NCT00948896|540404442|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
149802517|NCT00948896|540404443|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149802518|NCT00948896|540404444|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
149802519|NCT00948896|540404445|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149802520|NCT00948896|540404446|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
149802521|NCT00948896|540404447|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149802522|NCT00948896|540404448|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149802523|NCT00948896|540404449|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149802524|NCT00948896|540404442|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802525|NCT00948896|540404443|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802526|NCT00948896|540404444|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
149802527|NCT00948896|540404445|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802528|NCT00948896|540404446|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802529|NCT00948896|540404447|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
149802530|NCT00948896|540404448|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802531|NCT00948896|540404449|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149802532|NCT00948896|540404442|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802533|NCT00948896|540404443|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802534|NCT00948896|540404444|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802535|NCT00948896|540404445|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
149802536|NCT00948896|540404446|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802537|NCT00948896|540404447|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802538|NCT00948896|540404448|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802539|NCT00948896|540404449|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149802540|NCT00945815|540404450|FG000|Overall Study|Death|3|||
149802541|NCT00945815|540404450|FG000|Overall Study|Not protocol specified|1|||
149802542|NCT00945815|540404450|FG000|Overall Study|Ineligible|3|||
149802543|NCT00945815|540404450|FG000|Overall Study|Did not begin protocol therapy|1|||
149802544|NCT01590810|540404453|FG000|Overall Study|Physician Decision|0|||
149802545|NCT01590810|540404454|FG001|Overall Study|Physician Decision|1|||
149802546|NCT01590810|540404455|FG002|Overall Study|Physician Decision|1|||
149802547|NCT01590810|540404456|FG003|Overall Study|Physician Decision|0|||
149802548|NCT01590810|540404457|FG004|Overall Study|Physician Decision|0|||
149802549|NCT02400281|540404458|FG000|Overall Study|Adverse Event|0|||
149802550|NCT02400281|540404459|FG001|Overall Study|Adverse Event|0|||
149802551|NCT02400281|540404460|FG002|Overall Study|Adverse Event|1|||
149802552|NCT02400281|540404461|FG003|Overall Study|Adverse Event|0|||
149802553|NCT02400281|540404462|FG004|Overall Study|Adverse Event|1|||
149802554|NCT02400281|540404463|FG005|Overall Study|Adverse Event|0|||
149802555|NCT02400281|540404458|FG000|Overall Study|Physician Decision|0|||
149802556|NCT02400281|540404459|FG001|Overall Study|Physician Decision|0|||
149802557|NCT02400281|540404460|FG002|Overall Study|Physician Decision|1|||
149802558|NCT02400281|540404461|FG003|Overall Study|Physician Decision|0|||
149802559|NCT02400281|540404462|FG004|Overall Study|Physician Decision|0|||
149802560|NCT02400281|540404463|FG005|Overall Study|Physician Decision|0|||
149802561|NCT00412360|540404464|FG000|Overall Study|Lost to Follow-up|0|||
149802562|NCT00412360|540404465|FG001|Overall Study|Lost to Follow-up|1|||
149802563|NCT00412360|540404464|FG000|Overall Study|Not Transplanted|1|||
149802564|NCT00412360|540404465|FG001|Overall Study|Not Transplanted|2|||
149802565|NCT01396434|540404466|FG000|Overall Study|Lost to Follow-up|1|||
149802566|NCT01396434|540404467|FG001|Overall Study|Lost to Follow-up|0|||
149802567|NCT01396434|540404468|FG002|Overall Study|Lost to Follow-up|0|||
149802568|NCT01396434|540404466|FG000|Overall Study|Other|10|||
149802569|NCT01396434|540404467|FG001|Overall Study|Other|0|||
149802570|NCT01396434|540404468|FG002|Overall Study|Other|0|||
149802571|NCT04678557|540404469|FG000|Overall Study|Withdrawal by Subject|1|||
149802572|NCT04678557|540404470|FG001|Overall Study|Withdrawal by Subject|0|||
149802573|NCT04678557|540404469|FG000|Overall Study|Lack of Efficacy|0|||
149802574|NCT04678557|540404470|FG001|Overall Study|Lack of Efficacy|13|||
149802575|NCT04678557|540404469|FG000|Overall Study|Safety Evaluation|0|||
149802576|NCT04678557|540404470|FG001|Overall Study|Safety Evaluation|1|||
149802577|NCT02260804|540404471|FG000|Induction Study Period|Protocol Violation|2|||
149802578|NCT02260804|540404472|FG001|Induction Study Period|Protocol Violation|0|||
149802579|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
149802580|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
149802581|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
149802582|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
149802583|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
149802584|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
149802585|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
149802586|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
149802587|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
149802588|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
149802589|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
149802590|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
149802591|NCT02260804|540404471|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
149802592|NCT02260804|540404472|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
149802593|NCT02260804|540404471|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
149802594|NCT02260804|540404472|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
149802595|NCT02260804|540404471|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
149802596|NCT02260804|540404472|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
149802597|NCT02260804|540404471|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
149802598|NCT02260804|540404472|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
149802599|NCT00509223|540405951|FG000|Overall Study|Lost to Follow-up|1|||
150256634|NCT00686725|542074110|FG001|Overall Study|Adverse Event|1|||
149802600|NCT00509223|540405952|FG001|Overall Study|Lost to Follow-up|1|||
149802601|NCT00509223|540405951|FG000|Overall Study|Adverse Event|1|||
149802602|NCT00509223|540405952|FG001|Overall Study|Adverse Event|1|||
149802603|NCT00509223|540405951|FG000|Overall Study|Withdrawal by Subject|25|||
149802604|NCT00509223|540405952|FG001|Overall Study|Withdrawal by Subject|6|||
149802605|NCT00509223|540405951|FG000|Overall Study|Including: subject change of address|5|||
149802606|NCT00509223|540405952|FG001|Overall Study|Including: subject change of address|2|||
149802607|NCT00509223|540405951|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
149802608|NCT00509223|540405952|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
149802609|NCT00437294|540405958|FG000|Overall Study|Adverse Event|5|||
149802610|NCT00437294|540405959|FG001|Overall Study|Adverse Event|4|||
149802611|NCT00437294|540405958|FG000|Overall Study|Death|5|||
149802612|NCT00437294|540405959|FG001|Overall Study|Death|2|||
149802613|NCT00437294|540405958|FG000|Overall Study|Physician Decision|0|||
149802614|NCT00437294|540405959|FG001|Overall Study|Physician Decision|3|||
149802615|NCT00437294|540405958|FG000|Overall Study|Withdrawal by Subject|5|||
149802616|NCT00437294|540405959|FG001|Overall Study|Withdrawal by Subject|0|||
149802617|NCT00437294|540405958|FG000|Overall Study|Progressive Disease|19|||
149802618|NCT00437294|540405959|FG001|Overall Study|Progressive Disease|23|||
149802619|NCT00437294|540405958|FG000|Overall Study|Sponsor Decision|8|||
149802620|NCT00437294|540405959|FG001|Overall Study|Sponsor Decision|9|||
149802621|NCT00437294|540405958|FG000|Overall Study|Protocol Violation|0|||
149802622|NCT00437294|540405959|FG001|Overall Study|Protocol Violation|1|||
149802623|NCT00437294|540405958|FG000|Overall Study|Entry criteria not met|1|||
149802624|NCT00437294|540405959|FG001|Overall Study|Entry criteria not met|1|||
149802625|NCT00449761|540405963|FG000|Overall Study|Disease progression|12|||
149802626|NCT00449761|540405963|FG000|Overall Study|Death|5|||
149802627|NCT00449761|540405963|FG000|Overall Study|New cancer therapy|1|||
149802628|NCT01339273|540405964|FG000|Overall Study|Lost to Follow-up|8|||
149802629|NCT01339273|540405965|FG001|Overall Study|Lost to Follow-up|8|||
149802630|NCT01422876|540405966|FG000|Week 24|Lost to Follow-up|1|||
149802631|NCT01422876|540405967|FG001|Week 24|Lost to Follow-up|1|||
149802632|NCT01422876|540405968|FG002|Week 24|Lost to Follow-up|2|||
149802633|NCT01422876|540405969|FG003|Week 24|Lost to Follow-up|4|||
149802634|NCT01422876|540405970|FG004|Week 24|Lost to Follow-up|2|||
149802635|NCT01422876|540405971|FG005|Week 24|Lost to Follow-up|0|||
149802636|NCT01422876|540405972|FG006|Week 24|Lost to Follow-up|1|||
149802637|NCT01422876|540405973|FG007|Week 24|Lost to Follow-up|3|||
149802638|NCT01422876|540405974|FG008|Week 24|Lost to Follow-up|3|||
149802639|NCT01422876|540405975|FG009|Week 24|Lost to Follow-up|4|||
149802640|NCT01422876|540405966|FG000|Week 24|Consent withdrawn|5|||
149802641|NCT01422876|540405967|FG001|Week 24|Consent withdrawn|1|||
149802642|NCT01422876|540405968|FG002|Week 24|Consent withdrawn|3|||
149802643|NCT01422876|540405969|FG003|Week 24|Consent withdrawn|4|||
149802644|NCT01422876|540405970|FG004|Week 24|Consent withdrawn|5|||
149802645|NCT01422876|540405971|FG005|Week 24|Consent withdrawn|6|||
149802646|NCT01422876|540405972|FG006|Week 24|Consent withdrawn|5|||
149802647|NCT01422876|540405973|FG007|Week 24|Consent withdrawn|4|||
149802648|NCT01422876|540405974|FG008|Week 24|Consent withdrawn|3|||
149802649|NCT01422876|540405975|FG009|Week 24|Consent withdrawn|6|||
149802650|NCT01422876|540405966|FG000|Week 24|Death|0|||
149802651|NCT01422876|540405967|FG001|Week 24|Death|1|||
149802652|NCT01422876|540405968|FG002|Week 24|Death|0|||
149802653|NCT01422876|540405969|FG003|Week 24|Death|0|||
149802654|NCT01422876|540405970|FG004|Week 24|Death|0|||
149802655|NCT01422876|540405971|FG005|Week 24|Death|0|||
149802656|NCT01422876|540405972|FG006|Week 24|Death|0|||
149802657|NCT01422876|540405973|FG007|Week 24|Death|0|||
149802658|NCT01422876|540405974|FG008|Week 24|Death|0|||
149802659|NCT01422876|540405975|FG009|Week 24|Death|0|||
149802660|NCT01422876|540405966|FG000|Week 52|Lost to Follow-up|3|||
149802661|NCT01422876|540405967|FG001|Week 52|Lost to Follow-up|5|||
149802662|NCT01422876|540405968|FG002|Week 52|Lost to Follow-up|7|||
149802663|NCT01422876|540405969|FG003|Week 52|Lost to Follow-up|5|||
149802664|NCT01422876|540405970|FG004|Week 52|Lost to Follow-up|8|||
149802665|NCT01422876|540405971|FG005|Week 52|Lost to Follow-up|5|||
149802666|NCT01422876|540405972|FG006|Week 52|Lost to Follow-up|5|||
149802667|NCT01422876|540405973|FG007|Week 52|Lost to Follow-up|8|||
149802668|NCT01422876|540405974|FG008|Week 52|Lost to Follow-up|7|||
149802669|NCT01422876|540405975|FG009|Week 52|Lost to Follow-up|8|||
149802670|NCT01422876|540405966|FG000|Week 52|Consent withdrawn|9|||
149802671|NCT01422876|540405967|FG001|Week 52|Consent withdrawn|4|||
149802672|NCT01422876|540405968|FG002|Week 52|Consent withdrawn|6|||
149802673|NCT01422876|540405969|FG003|Week 52|Consent withdrawn|12|||
149802674|NCT01422876|540405970|FG004|Week 52|Consent withdrawn|7|||
149802675|NCT01422876|540405971|FG005|Week 52|Consent withdrawn|12|||
149802676|NCT01422876|540405972|FG006|Week 52|Consent withdrawn|10|||
149802677|NCT01422876|540405973|FG007|Week 52|Consent withdrawn|12|||
149802678|NCT01422876|540405974|FG008|Week 52|Consent withdrawn|13|||
149802679|NCT01422876|540405975|FG009|Week 52|Consent withdrawn|9|||
149802680|NCT01422876|540405966|FG000|Week 52|Death|0|||
149802681|NCT01422876|540405967|FG001|Week 52|Death|1|||
149802682|NCT01422876|540405968|FG002|Week 52|Death|0|||
149802683|NCT01422876|540405969|FG003|Week 52|Death|1|||
149802684|NCT01422876|540405970|FG004|Week 52|Death|0|||
149802685|NCT01422876|540405971|FG005|Week 52|Death|0|||
149802686|NCT01422876|540405972|FG006|Week 52|Death|1|||
149802687|NCT01422876|540405973|FG007|Week 52|Death|3|||
149802688|NCT01422876|540405974|FG008|Week 52|Death|1|||
149802689|NCT01422876|540405975|FG009|Week 52|Death|0|||
149802690|NCT00536991|540405976|FG000|Overall Study|Withdrawal by Subject|10|||
149802691|NCT00536991|540405976|FG000|Overall Study|Physician Decision|1|||
149802692|NCT00536991|540405976|FG000|Overall Study|patient ineligible|2|||
149802693|NCT00054639|540405977|FG000|Overall Study|Lack of Efficacy|1|||
149802694|NCT00054639|540405977|FG000|Overall Study|Physician Decision|1|||
149802695|NCT01366846|540405982|FG000|Overall Study|Withdrawal by Subject|2|||
149802696|NCT01366846|540405983|FG001|Overall Study|Withdrawal by Subject|0|||
149802697|NCT01366846|540405984|FG002|Overall Study|Withdrawal by Subject|0|||
149802698|NCT01366846|540405985|FG003|Overall Study|Withdrawal by Subject|0|||
149802699|NCT01366846|540405982|FG000|Overall Study|Communication Difficulties|1|||
149802700|NCT01366846|540405983|FG001|Overall Study|Communication Difficulties|4|||
149802701|NCT01366846|540405984|FG002|Overall Study|Communication Difficulties|0|||
149802702|NCT01366846|540405985|FG003|Overall Study|Communication Difficulties|1|||
149802703|NCT01366846|540405982|FG000|Overall Study|Scheduling Conflicts|0|||
149802704|NCT01366846|540405983|FG001|Overall Study|Scheduling Conflicts|0|||
149802705|NCT01366846|540405984|FG002|Overall Study|Scheduling Conflicts|1|||
149802706|NCT01366846|540405985|FG003|Overall Study|Scheduling Conflicts|0|||
149802707|NCT02856282|540405988|FG000|Overall Study|Withdrawal by Subject|1|||
149802708|NCT05299359|540405992|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
149802709|NCT05299359|540405993|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
149802710|NCT05299359|540405992|FG000|Main Part: Day 1 up to Day 366|Other|2|||
149802711|NCT05299359|540405993|FG001|Main Part: Day 1 up to Day 366|Other|0|||
149802712|NCT05299359|540405992|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
149802713|NCT05299359|540405993|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
149802714|NCT05299359|540405992|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
149802715|NCT05299359|540405993|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
149802716|NCT05299359|540405992|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
149802717|NCT05299359|540405993|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
149802718|NCT05299359|540405992|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
149802719|NCT05299359|540405993|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
149802720|NCT05299359|540405992|FG000|Extension Part: Day 1 to Day 366|Other|0|||
149802721|NCT05299359|540405993|FG001|Extension Part: Day 1 to Day 366|Other|1|||
149802722|NCT04780776|540405998|FG000|Titration Week 1-5|Lost to Follow-up|2|||
149802723|NCT04780776|540405999|FG001|Titration Week 1-5|Lost to Follow-up|8|||
149802724|NCT04780776|540405998|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
149802725|NCT04780776|540405999|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
149802726|NCT04780776|540405998|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
149802727|NCT04780776|540405999|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
149802728|NCT03113760|540406000|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
149802729|NCT03113760|540406001|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149915977|NCT00426660|540824038|FG000|Overall Study|Death|14|||
149915978|NCT00426660|540824038|FG000|Overall Study|Adverse Event|23|||
149915979|NCT00426660|540824038|FG000|Overall Study|Insufficient Clinical Response|22|||
149915980|NCT00426660|540824038|FG000|Overall Study|Lost to Follow-up|15|||
149915981|NCT00426660|540824038|FG000|Overall Study|Other|23|||
149915982|NCT00426660|540824038|FG000|Overall Study|Withdrawal by Subject|18|||
149915983|NCT00426660|540824038|FG000|Overall Study|Protocol Violation|1|||
149915984|NCT00426660|540824038|FG000|Overall Study|Enrolled Not Treated|15|||
149915985|NCT00980174|540824039|FG000|Overall Study|Withdrawal by Subject|1|||
149915986|NCT00980174|540824040|FG001|Overall Study|Withdrawal by Subject|4|||
149915987|NCT00980174|540824039|FG000|Overall Study|Adverse Event|0|||
149915988|NCT00980174|540824040|FG001|Overall Study|Adverse Event|3|||
149915989|NCT00980174|540824039|FG000|Overall Study|Ineligibility determined|2|||
149915990|NCT00980174|540824040|FG001|Overall Study|Ineligibility determined|1|||
149915991|NCT00980174|540824039|FG000|Overall Study|Death|1|||
149915992|NCT00980174|540824040|FG001|Overall Study|Death|1|||
149915993|NCT00980174|540824039|FG000|Overall Study|Other|0|||
149915994|NCT00980174|540824040|FG001|Overall Study|Other|1|||
149915995|NCT00337779|540824041|FG000|Overall Study|Withdrawal by Subject|10|||
149915996|NCT00337779|540824042|FG001|Overall Study|Withdrawal by Subject|12|||
149915997|NCT00337779|540824041|FG000|Overall Study|Sponsor decision|1|||
149915998|NCT00337779|540824042|FG001|Overall Study|Sponsor decision|1|||
149915999|NCT00337779|540824041|FG000|Overall Study|Physician Decision|3|||
149916000|NCT00337779|540824042|FG001|Overall Study|Physician Decision|6|||
149916001|NCT00337779|540824041|FG000|Overall Study|Protocol Violation|1|||
149916002|NCT00337779|540824042|FG001|Overall Study|Protocol Violation|1|||
149916003|NCT00337779|540824041|FG000|Overall Study|Lost to Follow-up|6|||
149916004|NCT00337779|540824042|FG001|Overall Study|Lost to Follow-up|5|||
149916005|NCT00337779|540824041|FG000|Overall Study|Adverse Event|28|||
149916006|NCT00337779|540824042|FG001|Overall Study|Adverse Event|51|||
149916007|NCT00337779|540824041|FG000|Overall Study|Pregnancy|3|||
149916008|NCT00337779|540824042|FG001|Overall Study|Pregnancy|2|||
149916009|NCT00337779|540824041|FG000|Overall Study|Death|0|||
149916010|NCT00337779|540824042|FG001|Overall Study|Death|1|||
149916011|NCT00422422|540824043|FG000|Overall Study|Lack of Efficacy|1|||
149916012|NCT00422422|540824043|FG000|Overall Study|Protocol Violation|1|||
149916013|NCT00422422|540824043|FG000|Overall Study|Withdrawal by Subject|2|||
149916014|NCT00422422|540824043|FG000|Overall Study|SAE, non-fatal|1|||
149916015|NCT00422422|540824043|FG000|Overall Study|AE, non-serious non-fatal|5|||
149916016|NCT01389258|540824044|FG000|Overall Study|Lost to Follow-up|5|||
149916017|NCT02943785|540824046|FG000|Overall Study|Adverse Event|112|||
149916018|NCT02943785|540824047|FG001|Overall Study|Adverse Event|97|||
149916019|NCT02943785|540824046|FG000|Overall Study|Withdrawal by Subject|63|||
149916020|NCT02943785|540824047|FG001|Overall Study|Withdrawal by Subject|126|||
149916021|NCT02943785|540824046|FG000|Overall Study|Physician Decision|23|||
149916022|NCT02943785|540824047|FG001|Overall Study|Physician Decision|47|||
149916023|NCT02943785|540824046|FG000|Overall Study|Death|46|||
149916024|NCT02943785|540824047|FG001|Overall Study|Death|46|||
149916025|NCT02943785|540824046|FG000|Overall Study|Lost to Follow-up|1|||
149916026|NCT02943785|540824047|FG001|Overall Study|Lost to Follow-up|0|||
149916027|NCT02943785|540824046|FG000|Overall Study|Other|16|||
149916028|NCT02943785|540824047|FG001|Overall Study|Other|19|||
149916029|NCT02943785|540824046|FG000|Overall Study|Did not receive any study medication|21|||
149916030|NCT02943785|540824047|FG001|Overall Study|Did not receive any study medication|28|||
149916031|NCT03313310|540824048|FG000|Phase 2|Lost to Follow-up|4|||
149916032|NCT03313310|540824049|FG001|Phase 2|Lost to Follow-up|0|||
149916033|NCT03313310|540824048|FG000|Phase 3|Lost to Follow-up|0|||
149916034|NCT03313310|540824049|FG001|Phase 3|Lost to Follow-up|1|||
149916035|NCT01281956|540824050|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
149916036|NCT01281956|540824051|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
149916037|NCT03170609|540824052|FG000|Overall Study|Death|0|||
149916038|NCT03170609|540824053|FG001|Overall Study|Death|0|||
149916039|NCT03170609|540824054|FG002|Overall Study|Death|1|||
149916040|NCT03170609|540824055|FG003|Overall Study|Death|0|||
149916041|NCT03170609|540824056|FG004|Overall Study|Death|0|||
149916042|NCT03170609|540824057|FG005|Overall Study|Death|0|||
149916043|NCT03170609|540824058|FG006|Overall Study|Death|0|||
149916044|NCT03170609|540824052|FG000|Overall Study|Withdrawal by Subject|1|||
149916045|NCT03170609|540824053|FG001|Overall Study|Withdrawal by Subject|2|||
149916046|NCT03170609|540824054|FG002|Overall Study|Withdrawal by Subject|0|||
149916047|NCT03170609|540824055|FG003|Overall Study|Withdrawal by Subject|0|||
149916048|NCT03170609|540824056|FG004|Overall Study|Withdrawal by Subject|0|||
149916049|NCT03170609|540824057|FG005|Overall Study|Withdrawal by Subject|0|||
149916050|NCT03170609|540824058|FG006|Overall Study|Withdrawal by Subject|1|||
149916051|NCT03170609|540824052|FG000|Overall Study|Lost to Follow-up|1|||
149916052|NCT03170609|540824053|FG001|Overall Study|Lost to Follow-up|0|||
149916053|NCT03170609|540824054|FG002|Overall Study|Lost to Follow-up|5|||
149916054|NCT03170609|540824055|FG003|Overall Study|Lost to Follow-up|2|||
149916055|NCT03170609|540824056|FG004|Overall Study|Lost to Follow-up|1|||
149916056|NCT03170609|540824057|FG005|Overall Study|Lost to Follow-up|1|||
149916057|NCT03170609|540824058|FG006|Overall Study|Lost to Follow-up|0|||
149916058|NCT03170609|540824052|FG000|Overall Study|Other|1|||
149916059|NCT03170609|540824053|FG001|Overall Study|Other|0|||
149916060|NCT03170609|540824054|FG002|Overall Study|Other|0|||
149916061|NCT03170609|540824055|FG003|Overall Study|Other|0|||
149916062|NCT03170609|540824056|FG004|Overall Study|Other|0|||
149916063|NCT03170609|540824057|FG005|Overall Study|Other|1|||
149916064|NCT03170609|540824058|FG006|Overall Study|Other|0|||
149916065|NCT01593254|540824060|FG000|Overall Study|Disease progression|2|||
149916066|NCT01593254|540824061|FG001|Overall Study|Disease progression|7|||
149916067|NCT01593254|540824060|FG000|Overall Study|Study drug toxicity|6|||
149916068|NCT01593254|540824061|FG001|Overall Study|Study drug toxicity|20|||
149916069|NCT01593254|540824060|FG000|Overall Study|Death|3|||
149916070|NCT01593254|540824061|FG001|Overall Study|Death|3|||
149916071|NCT01593254|540824060|FG000|Overall Study|AE unrelated to study drug|0|||
149916072|NCT01593254|540824061|FG001|Overall Study|AE unrelated to study drug|1|||
149916073|NCT01593254|540824060|FG000|Overall Study|participant request to discontinue study treatment|1|||
149916074|NCT01593254|540824061|FG001|Overall Study|participant request to discontinue study treatment|3|||
149916075|NCT01593254|540824060|FG000|Overall Study|participant withdrew consent|0|||
149916076|NCT01593254|540824061|FG001|Overall Study|participant withdrew consent|9|||
149916077|NCT01593254|540824060|FG000|Overall Study|lost to follow up|1|||
149916078|NCT01593254|540824061|FG001|Overall Study|lost to follow up|6|||
149916079|NCT01593254|540824060|FG000|Overall Study|maximum clinical benefit|1|||
149916080|NCT01593254|540824061|FG001|Overall Study|maximum clinical benefit|2|||
149916081|NCT01593254|540824060|FG000|Overall Study|Poor/non compliance|1|||
149916082|NCT01593254|540824061|FG001|Overall Study|Poor/non compliance|1|||
149916083|NCT01593254|540824060|FG000|Overall Study|Pregnancy|0|||
149916084|NCT01593254|540824061|FG001|Overall Study|Pregnancy|3|||
149916085|NCT01593254|540824060|FG000|Overall Study|participant no longer meets study criteria|1|||
149916086|NCT01593254|540824061|FG001|Overall Study|participant no longer meets study criteria|1|||
149916087|NCT01593254|540824060|FG000|Overall Study|Admin reason by sponsor|7|||
149916088|NCT01593254|540824061|FG001|Overall Study|Admin reason by sponsor|3|||
149916089|NCT01593254|540824060|FG000|Overall Study|Imatinib treatment failure|2|||
149916090|NCT01593254|540824061|FG001|Overall Study|Imatinib treatment failure|0|||
149916091|NCT01593254|540824060|FG000|Overall Study|Other Reasons|61|||
149916092|NCT01593254|540824061|FG001|Overall Study|Other Reasons|115|||
149916093|NCT01904903|540824066|FG000|Overall Study|Withdrawal by Subject|1|||
149916094|NCT00634049|540824069|FG000|Overall Study|Never received study drug|1|||
149916095|NCT00634049|540824069|FG000|Overall Study|Died prior to receiving study drug|1|||
149916096|NCT00634049|540824069|FG000|Overall Study|Screening failure|1|||
149916097|NCT00314132|540824070|FG000|Overall Study|Lost to Follow-up|3|||
149916098|NCT00314132|540824071|FG001|Overall Study|Lost to Follow-up|13|||
149916099|NCT00314132|540824070|FG000|Overall Study|Withdrawal by Subject|3|||
149916100|NCT00314132|540824071|FG001|Overall Study|Withdrawal by Subject|5|||
149916101|NCT00314132|540824070|FG000|Overall Study|Adverse Event|1|||
149916102|NCT00314132|540824071|FG001|Overall Study|Adverse Event|0|||
149916103|NCT00314132|540824070|FG000|Overall Study|Physician Decision|1|||
149916104|NCT00314132|540824071|FG001|Overall Study|Physician Decision|0|||
149916105|NCT01260584|540824072|FG000|Period 1|Protocol Violation|0|||
149916106|NCT01260584|540824073|FG001|Period 1|Protocol Violation|0|||
149916107|NCT01260584|540824074|FG002|Period 1|Protocol Violation|1|||
149916108|NCT01260584|540824075|FG003|Period 1|Protocol Violation|1|||
149916109|NCT01260584|540824072|FG000|Period 1|Adverse Event|0|||
149916110|NCT01260584|540824073|FG001|Period 1|Adverse Event|0|||
149916111|NCT01260584|540824074|FG002|Period 1|Adverse Event|1|||
149916112|NCT01260584|540824075|FG003|Period 1|Adverse Event|0|||
149916113|NCT01260584|540824072|FG000|Period 2|Protocol Violation|0|||
149916114|NCT01260584|540824073|FG001|Period 2|Protocol Violation|2|||
149916115|NCT01260584|540824074|FG002|Period 2|Protocol Violation|3|||
149916116|NCT01260584|540824075|FG003|Period 2|Protocol Violation|1|||
149916117|NCT01260584|540824072|FG000|Period 2|Adverse Event|1|||
149916118|NCT01260584|540824073|FG001|Period 2|Adverse Event|0|||
149916119|NCT01260584|540824074|FG002|Period 2|Adverse Event|2|||
149916120|NCT01260584|540824075|FG003|Period 2|Adverse Event|0|||
149916121|NCT01260584|540824072|FG000|Period 2|Withdrawal by Subject|0|||
149916122|NCT01260584|540824073|FG001|Period 2|Withdrawal by Subject|1|||
149916123|NCT01260584|540824074|FG002|Period 2|Withdrawal by Subject|0|||
149916124|NCT01260584|540824075|FG003|Period 2|Withdrawal by Subject|0|||
149916125|NCT02918552|540824077|FG000|Overall Study|Failed Pharmacokinetics|1|||
149916126|NCT02918552|540824078|FG001|Overall Study|Failed Pharmacokinetics|0|||
149916127|NCT02918552|540824077|FG000|Overall Study|Withdrawal by Subject|0|||
149916128|NCT02918552|540824078|FG001|Overall Study|Withdrawal by Subject|1|||
149916129|NCT02918552|540824077|FG000|Overall Study|Lost to Follow-up|0|||
149916130|NCT02918552|540824078|FG001|Overall Study|Lost to Follow-up|1|||
149916131|NCT04395274|540824079|FG000|Overall Study|Lost to Follow-up|20|||
149916132|NCT04395274|540824080|FG001|Overall Study|Lost to Follow-up|11|||
149916133|NCT04395274|540824079|FG000|Overall Study|Withdrawal by Subject|13|||
149916134|NCT04395274|540824080|FG001|Overall Study|Withdrawal by Subject|10|||
149916135|NCT04395274|540824079|FG000|Overall Study|Moved Abroad|0|||
149916136|NCT04395274|540824080|FG001|Overall Study|Moved Abroad|1|||
149916137|NCT01592292|540824081|FG000|Overall Study|Follow-up loss|3|||
149916138|NCT01592292|540824082|FG001|Overall Study|Follow-up loss|3|||
149916139|NCT01592292|540824083|FG002|Overall Study|Follow-up loss|1|||
149916140|NCT01592292|540824084|FG003|Overall Study|Follow-up loss|0|||
149916141|NCT01592292|540824081|FG000|Overall Study|Withdrew consent|2|||
149916142|NCT01592292|540824082|FG001|Overall Study|Withdrew consent|1|||
149916143|NCT01592292|540824083|FG002|Overall Study|Withdrew consent|0|||
149916144|NCT01592292|540824084|FG003|Overall Study|Withdrew consent|0|||
149916145|NCT01592292|540824081|FG000|Overall Study|Other|1|||
149916146|NCT01592292|540824082|FG001|Overall Study|Other|1|||
149916147|NCT01592292|540824083|FG002|Overall Study|Other|2|||
149916148|NCT01592292|540824084|FG003|Overall Study|Other|1|||
149916149|NCT03482167|540824085|FG000|Allocated to Intervention|Physician Decision|1|||
149916150|NCT03482167|540824086|FG001|Allocated to Intervention|Physician Decision|2|||
149916151|NCT03482167|540824085|FG000|Received Intervention|Adverse Event|3|||
149916152|NCT03482167|540824086|FG001|Received Intervention|Adverse Event|1|||
149916153|NCT03482167|540824085|FG000|Received Intervention|Physician Decision|1|||
149916154|NCT03482167|540824086|FG001|Received Intervention|Physician Decision|1|||
149916155|NCT03482167|540824085|FG000|Received Intervention|Withdrawal by Subject|1|||
149916156|NCT03482167|540824086|FG001|Received Intervention|Withdrawal by Subject|0|||
149916157|NCT04148287|540824092|FG000|Overall Study|Death|2|||
149916158|NCT02240069|540824094|FG000|Overall Study|Withdrawal by Subject|5|||
149916159|NCT02240069|540824095|FG001|Overall Study|Withdrawal by Subject|5|||
149916160|NCT02240069|540824096|FG002|Overall Study|Withdrawal by Subject|2|||
149916161|NCT01362244|540824097|FG000|Overall Study|Adverse Event|3|||
149916162|NCT01362244|540824098|FG001|Overall Study|Adverse Event|5|||
149916163|NCT01362244|540824097|FG000|Overall Study|Lack of Efficacy|5|||
149916164|NCT01362244|540824098|FG001|Overall Study|Lack of Efficacy|11|||
149916165|NCT01362244|540824097|FG000|Overall Study|Lost to Follow-up|0|||
149916166|NCT01362244|540824098|FG001|Overall Study|Lost to Follow-up|2|||
149916167|NCT01362244|540824097|FG000|Overall Study|Protocol Violation|5|||
149916168|NCT01362244|540824098|FG001|Overall Study|Protocol Violation|1|||
149916169|NCT01362244|540824097|FG000|Overall Study|Withdrawal by Subject|2|||
149916170|NCT01362244|540824098|FG001|Overall Study|Withdrawal by Subject|1|||
149916171|NCT01362244|540824097|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
149916172|NCT01362244|540824098|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
149916173|NCT01362244|540824097|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
150029355|NCT03409796|541244156|FG000|Overall Study|Adverse Event|2|||
149916174|NCT01362244|540824098|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
149916175|NCT02407054|540824101|FG000|Overall Study|Adverse Event|1|||
149916176|NCT02407054|540824102|FG001|Overall Study|Adverse Event|4|||
149916177|NCT02407054|540824103|FG002|Overall Study|Adverse Event|1|||
149916178|NCT02407054|540824101|FG000|Overall Study|Non-compliance with Study|0|||
149916179|NCT02407054|540824102|FG001|Overall Study|Non-compliance with Study|2|||
149916180|NCT02407054|540824103|FG002|Overall Study|Non-compliance with Study|1|||
149916181|NCT02407054|540824101|FG000|Overall Study|Physician Decision|1|||
149916182|NCT02407054|540824102|FG001|Overall Study|Physician Decision|3|||
149916183|NCT02407054|540824103|FG002|Overall Study|Physician Decision|3|||
149916184|NCT02407054|540824101|FG000|Overall Study|Withdrawal by Subject|5|||
149916185|NCT02407054|540824102|FG001|Overall Study|Withdrawal by Subject|9|||
149916186|NCT02407054|540824103|FG002|Overall Study|Withdrawal by Subject|2|||
149916187|NCT04438499|540824107|FG000|Overall Study|Lack of Efficacy|3|||
149975465|NCT00940602|541047851|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
149975466|NCT01378117|541047852|FG000|Overall Study|withdrawal|2|||
149975467|NCT01378117|541047853|FG001|Overall Study|withdrawal|1|||
149975468|NCT01378117|541047854|FG002|Overall Study|withdrawal|2|||
149975469|NCT01378117|541047852|FG000|Overall Study|discharged before med given|2|||
149975470|NCT01378117|541047853|FG001|Overall Study|discharged before med given|0|||
149975471|NCT01378117|541047854|FG002|Overall Study|discharged before med given|1|||
149975472|NCT01463033|541047856|FG000|Overall Study|Lost to Follow-up|4|||
149975473|NCT01463033|541047857|FG001|Overall Study|Lost to Follow-up|4|||
149975474|NCT01463033|541047856|FG000|Overall Study|Death|3|||
149975475|NCT01463033|541047857|FG001|Overall Study|Death|2|||
149975476|NCT01374425|541047862|FG000|Overall Study|Radiographic Disease Progression|86|||
149975477|NCT01374425|541047863|FG001|Overall Study|Radiographic Disease Progression|81|||
149975478|NCT01374425|541047862|FG000|Overall Study|Clinical Disease Progression|9|||
149975479|NCT01374425|541047863|FG001|Overall Study|Clinical Disease Progression|6|||
149975480|NCT01374425|541047862|FG000|Overall Study|Adverse Event|29|||
149975481|NCT01374425|541047863|FG001|Overall Study|Adverse Event|18|||
149975482|NCT01374425|541047862|FG000|Overall Study|Death (Progression of Disease)|1|||
149975483|NCT01374425|541047863|FG001|Overall Study|Death (Progression of Disease)|0|||
149975484|NCT01374425|541047862|FG000|Overall Study|Death (Adverse Event)|2|||
149975485|NCT01374425|541047863|FG001|Overall Study|Death (Adverse Event)|4|||
149975486|NCT01374425|541047862|FG000|Overall Study|Withdrawal by Subject|6|||
149975487|NCT01374425|541047863|FG001|Overall Study|Withdrawal by Subject|7|||
149975488|NCT01374425|541047862|FG000|Overall Study|Refused Treatment|10|||
149975489|NCT01374425|541047863|FG001|Overall Study|Refused Treatment|24|||
149975490|NCT01374425|541047862|FG000|Overall Study|Protocol Violation|2|||
149975491|NCT01374425|541047863|FG001|Overall Study|Protocol Violation|3|||
149975492|NCT01374425|541047862|FG000|Overall Study|Sponsor Decision|0|||
149975493|NCT01374425|541047863|FG001|Overall Study|Sponsor Decision|1|||
149975494|NCT01374425|541047862|FG000|Overall Study|Lost to Follow-up|2|||
149975495|NCT01374425|541047863|FG001|Overall Study|Lost to Follow-up|1|||
149975496|NCT01374425|541047862|FG000|Overall Study|Other|41|||
149975497|NCT01374425|541047863|FG001|Overall Study|Other|43|||
149975498|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
149975499|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
149975500|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
149975501|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
149975502|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
149975503|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
149975504|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
149975505|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
149975506|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
149975507|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
149975508|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
149975509|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
149975510|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
149975511|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
149975512|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
149975513|NCT00546481|541047864|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
149975514|NCT00546481|541047865|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
149975515|NCT00546481|541047866|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
149975516|NCT00546481|541047864|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
149975517|NCT00546481|541047865|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
149975518|NCT00546481|541047866|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
149975519|NCT00546481|541047864|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
149975520|NCT00546481|541047865|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
149975521|NCT00546481|541047866|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
149975522|NCT00546481|541047864|FG000|Maintenance Phase (CERA)|Other Reason|0|||
149975523|NCT00546481|541047865|FG001|Maintenance Phase (CERA)|Other Reason|0|||
149916188|NCT02168777|540826128|FG000|Overall Study|Withdrawal by Subject|1|||
149916189|NCT02168777|540826129|FG001|Overall Study|Withdrawal by Subject|0|||
149916190|NCT02168777|540826130|FG002|Overall Study|Withdrawal by Subject|2|||
149916191|NCT02168777|540826128|FG000|Overall Study|Adverse Event|1|||
149916192|NCT02168777|540826129|FG001|Overall Study|Adverse Event|0|||
149916193|NCT02168777|540826130|FG002|Overall Study|Adverse Event|1|||
149916194|NCT02168777|540826128|FG000|Overall Study|Disease recurrence|0|||
149916195|NCT02168777|540826129|FG001|Overall Study|Disease recurrence|0|||
149916196|NCT02168777|540826130|FG002|Overall Study|Disease recurrence|1|||
149916197|NCT02168777|540826128|FG000|Overall Study|Radiological disease progression|0|||
149916198|NCT02168777|540826129|FG001|Overall Study|Radiological disease progression|5|||
149916199|NCT02168777|540826130|FG002|Overall Study|Radiological disease progression|5|||
149916200|NCT02168777|540826128|FG000|Overall Study|Clinical disease progression|0|||
149916201|NCT02168777|540826129|FG001|Overall Study|Clinical disease progression|1|||
149916202|NCT02168777|540826130|FG002|Overall Study|Clinical disease progression|2|||
149916203|NCT02168777|540826128|FG000|Overall Study|Other reason|0|||
149916204|NCT02168777|540826129|FG001|Overall Study|Other reason|1|||
149916205|NCT02168777|540826130|FG002|Overall Study|Other reason|0|||
149916206|NCT01663857|540826131|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
149916207|NCT01663857|540826132|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
149916208|NCT01663857|540826133|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
149916209|NCT01663857|540826134|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
149916210|NCT01663857|540826131|FG000|Overall Study|Lost to Follow-up|0|||
149916211|NCT01663857|540826132|FG001|Overall Study|Lost to Follow-up|0|||
149916212|NCT01663857|540826133|FG002|Overall Study|Lost to Follow-up|3|||
149916213|NCT01663857|540826134|FG003|Overall Study|Lost to Follow-up|1|||
149916214|NCT01709864|540826135|FG000|Overall Study|Physician Decision|0|||
149916215|NCT01709864|540826136|FG001|Overall Study|Physician Decision|1|||
149916216|NCT01709864|540826135|FG000|Overall Study|subject/guardian decision|5|||
149916217|NCT01709864|540826136|FG001|Overall Study|subject/guardian decision|6|||
149916218|NCT01709864|540826135|FG000|Overall Study|Lost to Follow-up|1|||
149916219|NCT01709864|540826136|FG001|Overall Study|Lost to Follow-up|0|||
149916220|NCT01709864|540826135|FG000|Overall Study|non-compliance with study treatment|1|||
149916221|NCT01709864|540826136|FG001|Overall Study|non-compliance with study treatment|1|||
149916222|NCT01709864|540826135|FG000|Overall Study|Adverse Event|0|||
149916223|NCT01709864|540826136|FG001|Overall Study|Adverse Event|2|||
149916224|NCT01709864|540826135|FG000|Overall Study|Death|0|||
149916225|NCT01709864|540826136|FG001|Overall Study|Death|1|||
149916226|NCT01172808|540826139|FG000|Overall Study|Adverse Event|8|||
149916227|NCT01172808|540826140|FG001|Overall Study|Adverse Event|4|||
149916228|NCT01172808|540826141|FG002|Overall Study|Adverse Event|8|||
149916229|NCT01172808|540826142|FG003|Overall Study|Adverse Event|3|||
149916230|NCT01172808|540826139|FG000|Overall Study|Lack of Efficacy|1|||
149916231|NCT01172808|540826140|FG001|Overall Study|Lack of Efficacy|0|||
149916232|NCT01172808|540826141|FG002|Overall Study|Lack of Efficacy|0|||
149916233|NCT01172808|540826142|FG003|Overall Study|Lack of Efficacy|0|||
149916234|NCT01172808|540826139|FG000|Overall Study|Protocol Violation|2|||
149916235|NCT01172808|540826140|FG001|Overall Study|Protocol Violation|2|||
149916236|NCT01172808|540826141|FG002|Overall Study|Protocol Violation|2|||
149916237|NCT01172808|540826142|FG003|Overall Study|Protocol Violation|0|||
149916238|NCT01172808|540826139|FG000|Overall Study|Lost to Follow-up|0|||
149916239|NCT01172808|540826140|FG001|Overall Study|Lost to Follow-up|1|||
149916240|NCT01172808|540826141|FG002|Overall Study|Lost to Follow-up|1|||
149916241|NCT01172808|540826142|FG003|Overall Study|Lost to Follow-up|3|||
149916242|NCT01172808|540826139|FG000|Overall Study|Withdrawal by Subject|4|||
149916243|NCT01172808|540826140|FG001|Overall Study|Withdrawal by Subject|1|||
149916244|NCT01172808|540826141|FG002|Overall Study|Withdrawal by Subject|3|||
149916245|NCT01172808|540826142|FG003|Overall Study|Withdrawal by Subject|2|||
149916246|NCT01172808|540826139|FG000|Overall Study|Other|6|||
149916247|NCT01172808|540826140|FG001|Overall Study|Other|5|||
149916248|NCT01172808|540826141|FG002|Overall Study|Other|9|||
149916249|NCT01172808|540826142|FG003|Overall Study|Other|7|||
149916250|NCT01066793|540826147|FG000|Overall Study|Death|4|||
149916251|NCT01066793|540826148|FG001|Overall Study|Death|1|||
149916252|NCT01066793|540826149|FG002|Overall Study|Death|1|||
149916253|NCT01066793|540826150|FG003|Overall Study|Death|0|||
149916254|NCT01066793|540826151|FG004|Overall Study|Death|0|||
149916255|NCT01066793|540826152|FG005|Overall Study|Death|0|||
149916256|NCT01066793|540826147|FG000|Overall Study|Lack of Efficacy|2|||
149916257|NCT01066793|540826148|FG001|Overall Study|Lack of Efficacy|1|||
149916258|NCT01066793|540826149|FG002|Overall Study|Lack of Efficacy|0|||
149916259|NCT01066793|540826150|FG003|Overall Study|Lack of Efficacy|0|||
149916260|NCT01066793|540826151|FG004|Overall Study|Lack of Efficacy|0|||
149916261|NCT01066793|540826152|FG005|Overall Study|Lack of Efficacy|0|||
149916262|NCT01066793|540826147|FG000|Overall Study|Lost to Follow-up|180|||
149916263|NCT01066793|540826148|FG001|Overall Study|Lost to Follow-up|39|||
149916264|NCT01066793|540826149|FG002|Overall Study|Lost to Follow-up|82|||
149916265|NCT01066793|540826150|FG003|Overall Study|Lost to Follow-up|16|||
149916266|NCT01066793|540826151|FG004|Overall Study|Lost to Follow-up|0|||
149916267|NCT01066793|540826152|FG005|Overall Study|Lost to Follow-up|1|||
149916268|NCT01066793|540826147|FG000|Overall Study|Physician Decision|3|||
149916269|NCT01066793|540826148|FG001|Overall Study|Physician Decision|0|||
149916270|NCT01066793|540826149|FG002|Overall Study|Physician Decision|0|||
149916271|NCT01066793|540826150|FG003|Overall Study|Physician Decision|0|||
149916272|NCT01066793|540826151|FG004|Overall Study|Physician Decision|0|||
149916273|NCT01066793|540826152|FG005|Overall Study|Physician Decision|0|||
149916274|NCT01066793|540826147|FG000|Overall Study|Protocol Violation|3|||
149916275|NCT01066793|540826148|FG001|Overall Study|Protocol Violation|2|||
149916276|NCT01066793|540826149|FG002|Overall Study|Protocol Violation|2|||
149916277|NCT01066793|540826150|FG003|Overall Study|Protocol Violation|0|||
149916278|NCT01066793|540826151|FG004|Overall Study|Protocol Violation|0|||
149916279|NCT01066793|540826152|FG005|Overall Study|Protocol Violation|0|||
149916280|NCT01066793|540826147|FG000|Overall Study|Withdrawal by Subject|7|||
149916281|NCT01066793|540826148|FG001|Overall Study|Withdrawal by Subject|4|||
149916282|NCT01066793|540826149|FG002|Overall Study|Withdrawal by Subject|1|||
149916283|NCT01066793|540826150|FG003|Overall Study|Withdrawal by Subject|0|||
149916284|NCT01066793|540826151|FG004|Overall Study|Withdrawal by Subject|0|||
149916285|NCT01066793|540826152|FG005|Overall Study|Withdrawal by Subject|0|||
149916286|NCT01066793|540826147|FG000|Overall Study|Early Termination|3|||
149916287|NCT01066793|540826148|FG001|Overall Study|Early Termination|0|||
149916288|NCT01066793|540826149|FG002|Overall Study|Early Termination|0|||
149916289|NCT01066793|540826150|FG003|Overall Study|Early Termination|0|||
149916290|NCT01066793|540826151|FG004|Overall Study|Early Termination|0|||
149916291|NCT01066793|540826152|FG005|Overall Study|Early Termination|0|||
149916292|NCT01066793|540826147|FG000|Overall Study|Lab test not done|7|||
149916293|NCT01066793|540826148|FG001|Overall Study|Lab test not done|0|||
149916294|NCT01066793|540826149|FG002|Overall Study|Lab test not done|0|||
149916295|NCT01066793|540826150|FG003|Overall Study|Lab test not done|1|||
149916296|NCT01066793|540826151|FG004|Overall Study|Lab test not done|0|||
149916297|NCT01066793|540826152|FG005|Overall Study|Lab test not done|0|||
149916298|NCT01066793|540826147|FG000|Overall Study|Miscellaneous|4|||
149916299|NCT01066793|540826148|FG001|Overall Study|Miscellaneous|5|||
149916300|NCT01066793|540826149|FG002|Overall Study|Miscellaneous|6|||
149916301|NCT01066793|540826150|FG003|Overall Study|Miscellaneous|0|||
149916302|NCT01066793|540826151|FG004|Overall Study|Miscellaneous|0|||
149916303|NCT01066793|540826152|FG005|Overall Study|Miscellaneous|0|||
149916304|NCT01066793|540826147|FG000|Overall Study|Non-responders|104|||
149916305|NCT01066793|540826148|FG001|Overall Study|Non-responders|5|||
149916306|NCT01066793|540826149|FG002|Overall Study|Non-responders|11|||
149916307|NCT01066793|540826150|FG003|Overall Study|Non-responders|25|||
149916308|NCT01066793|540826151|FG004|Overall Study|Non-responders|0|||
149916309|NCT01066793|540826152|FG005|Overall Study|Non-responders|0|||
149916310|NCT01066793|540826147|FG000|Overall Study|Other|15|||
149916311|NCT01066793|540826148|FG001|Overall Study|Other|5|||
149916312|NCT01066793|540826149|FG002|Overall Study|Other|6|||
149916313|NCT01066793|540826150|FG003|Overall Study|Other|2|||
149916314|NCT01066793|540826151|FG004|Overall Study|Other|0|||
149916315|NCT01066793|540826152|FG005|Overall Study|Other|0|||
149916316|NCT01066793|540826147|FG000|Overall Study|Relapse|20|||
149916317|NCT01066793|540826148|FG001|Overall Study|Relapse|8|||
149916318|NCT01066793|540826149|FG002|Overall Study|Relapse|2|||
149916319|NCT01066793|540826150|FG003|Overall Study|Relapse|3|||
149916320|NCT01066793|540826151|FG004|Overall Study|Relapse|0|||
149916321|NCT01066793|540826152|FG005|Overall Study|Relapse|0|||
149916322|NCT01066793|540826147|FG000|Overall Study|Result Not Available|1|||
149916323|NCT01066793|540826148|FG001|Overall Study|Result Not Available|0|||
149916324|NCT01066793|540826149|FG002|Overall Study|Result Not Available|0|||
149916325|NCT01066793|540826150|FG003|Overall Study|Result Not Available|0|||
149916326|NCT01066793|540826151|FG004|Overall Study|Result Not Available|0|||
149916327|NCT01066793|540826152|FG005|Overall Study|Result Not Available|0|||
149916328|NCT01066793|540826147|FG000|Overall Study|Treatment Interrupted|1|||
149916329|NCT01066793|540826148|FG001|Overall Study|Treatment Interrupted|1|||
149916330|NCT01066793|540826149|FG002|Overall Study|Treatment Interrupted|0|||
149916331|NCT01066793|540826150|FG003|Overall Study|Treatment Interrupted|0|||
149916332|NCT01066793|540826151|FG004|Overall Study|Treatment Interrupted|0|||
149916333|NCT01066793|540826152|FG005|Overall Study|Treatment Interrupted|0|||
149916334|NCT01066793|540826147|FG000|Overall Study|Treatment Never Started|18|||
149916335|NCT01066793|540826148|FG001|Overall Study|Treatment Never Started|5|||
149916336|NCT01066793|540826149|FG002|Overall Study|Treatment Never Started|4|||
149916337|NCT01066793|540826150|FG003|Overall Study|Treatment Never Started|1|||
149916338|NCT01066793|540826151|FG004|Overall Study|Treatment Never Started|0|||
149916339|NCT01066793|540826152|FG005|Overall Study|Treatment Never Started|0|||
149916340|NCT01066793|540826147|FG000|Overall Study|Treatment Stopped|2|||
149916341|NCT01066793|540826148|FG001|Overall Study|Treatment Stopped|1|||
149916342|NCT01066793|540826149|FG002|Overall Study|Treatment Stopped|0|||
149916343|NCT01066793|540826150|FG003|Overall Study|Treatment Stopped|1|||
149916344|NCT01066793|540826151|FG004|Overall Study|Treatment Stopped|0|||
149916345|NCT01066793|540826152|FG005|Overall Study|Treatment Stopped|0|||
149916346|NCT01911793|540826154|FG000|Overall Study|Physician Decision|1|||
149916347|NCT01911793|540826155|FG001|Overall Study|Physician Decision|5|||
149916348|NCT03774394|540826156|FG000|Overall Study|Withdrawal by Subject|2|||
149916349|NCT03774394|540826157|FG001|Overall Study|Withdrawal by Subject|0|||
149916350|NCT02697916|540826158|FG000|Overall Study|Death|357|||
149916351|NCT02697916|540826159|FG001|Overall Study|Death|315|||
149916352|NCT02697916|540826158|FG000|Overall Study|Withdrawal by Subject|221|||
149916353|NCT02697916|540826159|FG001|Overall Study|Withdrawal by Subject|393|||
149916354|NCT03959488|540826160|FG000|Season 1|Other|6|||
149916355|NCT03959488|540826161|FG001|Season 1|Other|7|||
149916356|NCT03959488|540826162|FG002|Season 1|Other|0|||
149916357|NCT03959488|540826163|FG003|Season 1|Other|0|||
149916358|NCT03959488|540826164|FG004|Season 1|Other|0|||
149916359|NCT03959488|540826160|FG000|Season 1|Withdrawal by parent/guardian|43|||
149916360|NCT03959488|540826161|FG001|Season 1|Withdrawal by parent/guardian|28|||
149916361|NCT03959488|540826162|FG002|Season 1|Withdrawal by parent/guardian|0|||
149916362|NCT03959488|540826163|FG003|Season 1|Withdrawal by parent/guardian|0|||
149916363|NCT03959488|540826164|FG004|Season 1|Withdrawal by parent/guardian|0|||
149916364|NCT03959488|540826160|FG000|Season 1|Due to COVID-19 pandemic|2|||
149916365|NCT03959488|540826161|FG001|Season 1|Due to COVID-19 pandemic|3|||
149916366|NCT03959488|540826162|FG002|Season 1|Due to COVID-19 pandemic|0|||
149916367|NCT03959488|540826163|FG003|Season 1|Due to COVID-19 pandemic|0|||
149916368|NCT03959488|540826164|FG004|Season 1|Due to COVID-19 pandemic|0|||
149916369|NCT03959488|540826160|FG000|Season 1|Lost to Follow-up|17|||
149916370|NCT03959488|540826161|FG001|Season 1|Lost to Follow-up|7|||
149916371|NCT03959488|540826162|FG002|Season 1|Lost to Follow-up|0|||
149916372|NCT03959488|540826163|FG003|Season 1|Lost to Follow-up|0|||
149916373|NCT03959488|540826164|FG004|Season 1|Lost to Follow-up|0|||
149916374|NCT03959488|540826160|FG000|Season 1|Death|5|||
149916375|NCT03959488|540826161|FG001|Season 1|Death|1|||
149916376|NCT03959488|540826162|FG002|Season 1|Death|0|||
149916377|NCT03959488|540826163|FG003|Season 1|Death|0|||
149916378|NCT03959488|540826164|FG004|Season 1|Death|0|||
149916379|NCT03959488|540826160|FG000|Season 2|Other|0|||
149916380|NCT03959488|540826161|FG001|Season 2|Other|0|||
149916381|NCT03959488|540826162|FG002|Season 2|Other|2|||
149916382|NCT03959488|540826163|FG003|Season 2|Other|0|||
149916383|NCT03959488|540826164|FG004|Season 2|Other|0|||
149916384|NCT03959488|540826160|FG000|Season 2|Withdrawal by parent/guardian|0|||
149916385|NCT03959488|540826161|FG001|Season 2|Withdrawal by parent/guardian|0|||
149916386|NCT03959488|540826162|FG002|Season 2|Withdrawal by parent/guardian|3|||
149916387|NCT03959488|540826163|FG003|Season 2|Withdrawal by parent/guardian|1|||
149916388|NCT03959488|540826164|FG004|Season 2|Withdrawal by parent/guardian|1|||
149916389|NCT03959488|540826160|FG000|Season 2|Lost to Follow-up|0|||
149916390|NCT03959488|540826161|FG001|Season 2|Lost to Follow-up|0|||
149916391|NCT03959488|540826162|FG002|Season 2|Lost to Follow-up|1|||
149916392|NCT03959488|540826163|FG003|Season 2|Lost to Follow-up|0|||
149916393|NCT03959488|540826164|FG004|Season 2|Lost to Follow-up|1|||
149916394|NCT00290693|540826165|FG000|Overall Study|Withdrawal by Subject|2|||
149916395|NCT05625477|540826166|FG000|Overall Study|Lost to Follow-up|2|||
149916396|NCT05625477|540826167|FG001|Overall Study|Lost to Follow-up|2|||
149916397|NCT05625477|540826168|FG002|Overall Study|Lost to Follow-up|1|||
149916398|NCT05625477|540826169|FG003|Overall Study|Lost to Follow-up|1|||
149916399|NCT05625477|540826170|FG004|Overall Study|Lost to Follow-up|0|||
149916400|NCT05625477|540826166|FG000|Overall Study|Covid quarantine|1|||
149916401|NCT05625477|540826167|FG001|Overall Study|Covid quarantine|0|||
149916402|NCT05625477|540826168|FG002|Overall Study|Covid quarantine|0|||
149916403|NCT05625477|540826169|FG003|Overall Study|Covid quarantine|0|||
149916404|NCT05625477|540826170|FG004|Overall Study|Covid quarantine|0|||
149916405|NCT04849416|540826171|FG000|Overall Study|Ongoing Treatment|12|||
149916406|NCT04849416|540826172|FG001|Overall Study|Ongoing Treatment|5|||
149916407|NCT04849416|540826173|FG002|Overall Study|Ongoing Treatment|3|||
149916408|NCT04849416|540826171|FG000|Overall Study|On Post-Treatment Follow-up|8|||
149916409|NCT04849416|540826172|FG001|Overall Study|On Post-Treatment Follow-up|9|||
149916410|NCT04849416|540826173|FG002|Overall Study|On Post-Treatment Follow-up|10|||
149916411|NCT04849416|540826171|FG000|Overall Study|Withdrawal by Subject|0|||
149916412|NCT04849416|540826172|FG001|Overall Study|Withdrawal by Subject|0|||
149916413|NCT04849416|540826173|FG002|Overall Study|Withdrawal by Subject|1|||
149916414|NCT04849416|540826171|FG000|Overall Study|Lost to Follow-up|1|||
149916415|NCT04849416|540826172|FG001|Overall Study|Lost to Follow-up|0|||
149916416|NCT04849416|540826173|FG002|Overall Study|Lost to Follow-up|0|||
149916417|NCT02667587|540826180|FG000|Pre-Treatment|Not reported|1|||
149916418|NCT02667587|540826181|FG001|Pre-Treatment|Not reported|0|||
149916419|NCT02667587|540826180|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
149916420|NCT02667587|540826181|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
149916421|NCT02667587|540826180|FG000|Pre-Treatment|Participant withdrew consent|0|||
149916422|NCT02667587|540826181|FG001|Pre-Treatment|Participant withdrew consent|1|||
149916423|NCT02667587|540826180|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
149916424|NCT02667587|540826181|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
149916425|NCT02667587|540826180|FG000|End of Treatment|Disease Progression|193|||
149916426|NCT02667587|540826181|FG001|End of Treatment|Disease Progression|226|||
149916427|NCT02667587|540826180|FG000|End of Treatment|Study Drug Toxicity|75|||
149916428|NCT02667587|540826181|FG001|End of Treatment|Study Drug Toxicity|19|||
149916429|NCT02667587|540826180|FG000|End of Treatment|Death|2|||
149916430|NCT02667587|540826181|FG001|End of Treatment|Death|1|||
149916431|NCT02667587|540826180|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
149916432|NCT02667587|540826181|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
149916433|NCT02667587|540826180|FG000|End of Treatment|participant request to discontinue treatment|33|||
149916434|NCT02667587|540826181|FG001|End of Treatment|participant request to discontinue treatment|35|||
149916435|NCT02667587|540826180|FG000|End of Treatment|participant withdrew consent|5|||
149916436|NCT02667587|540826181|FG001|End of Treatment|participant withdrew consent|6|||
149916437|NCT02667587|540826180|FG000|End of Treatment|Lost to Follow-up|1|||
149916438|NCT02667587|540826181|FG001|End of Treatment|Lost to Follow-up|2|||
149916439|NCT02667587|540826180|FG000|End of Treatment|maximum clinical benefit|4|||
149916440|NCT02667587|540826181|FG001|End of Treatment|maximum clinical benefit|4|||
149916441|NCT02667587|540826180|FG000|End of Treatment|poor or non compliant|0|||
149916442|NCT02667587|540826181|FG001|End of Treatment|poor or non compliant|1|||
149916443|NCT02667587|540826180|FG000|End of Treatment|participant no longer meets study criteria|1|||
149916444|NCT02667587|540826181|FG001|End of Treatment|participant no longer meets study criteria|1|||
149916445|NCT02667587|540826180|FG000|End of Treatment|administrative reason by sponsor|1|||
149916446|NCT02667587|540826181|FG001|End of Treatment|administrative reason by sponsor|29|||
149916447|NCT02667587|540826180|FG000|End of Treatment|other reasonse|21|||
149916448|NCT02667587|540826181|FG001|End of Treatment|other reasonse|10|||
149916449|NCT05940077|540826182|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
149916450|NCT00388297|540826183|FG000|Overall Study|Lost to Follow-up|16|||
149916451|NCT00388297|540826184|FG001|Overall Study|Lost to Follow-up|12|||
149916452|NCT00388297|540826185|FG002|Overall Study|Lost to Follow-up|11|||
149916453|NCT00388297|540826186|FG003|Overall Study|Lost to Follow-up|8|||
149916454|NCT03570554|540826189|FG000|Overall Study|Non-compliance with study drug|0|||
149916455|NCT03570554|540826190|FG001|Overall Study|Non-compliance with study drug|0|||
149916456|NCT03570554|540826191|FG002|Overall Study|Non-compliance with study drug|1|||
149916457|NCT03570554|540826192|FG003|Overall Study|Non-compliance with study drug|0|||
149916458|NCT03570554|540826189|FG000|Overall Study|Adverse Event|0|||
149916459|NCT03570554|540826190|FG001|Overall Study|Adverse Event|0|||
149916460|NCT03570554|540826191|FG002|Overall Study|Adverse Event|0|||
149916461|NCT03570554|540826192|FG003|Overall Study|Adverse Event|1|||
149916462|NCT02719353|540826201|FG000|First Intervention|Physician Decision|0|||
149916463|NCT02719353|540826202|FG001|First Intervention|Physician Decision|1|||
149916464|NCT01420679|540826203|FG000|Overall Study|Disease Progression|3|||
149916465|NCT01420679|540826204|FG001|Overall Study|Disease Progression|2|||
149916466|NCT01420679|540826203|FG000|Overall Study|Adverse Event|4|||
149916467|NCT01420679|540826204|FG001|Overall Study|Adverse Event|0|||
149916468|NCT01420679|540826203|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
149916469|NCT01420679|540826204|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
149916470|NCT01420679|540826203|FG000|Overall Study|Patient Decision|1|||
149916471|NCT01420679|540826204|FG001|Overall Study|Patient Decision|0|||
149916472|NCT01420679|540826203|FG000|Overall Study|Investigator Decision|1|||
149916473|NCT01420679|540826204|FG001|Overall Study|Investigator Decision|2|||
149916474|NCT01420679|540826203|FG000|Overall Study|Sponsor Decision|3|||
149916475|NCT01420679|540826204|FG001|Overall Study|Sponsor Decision|3|||
149916476|NCT01420679|540826203|FG000|Overall Study|Other|1|||
149916477|NCT01420679|540826204|FG001|Overall Study|Other|0|||
149916478|NCT03956615|540826205|FG000|Overall Study|No multiple myeloma confirmed|2|||
149916479|NCT03956615|540826205|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
149916480|NCT03956615|540826205|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
149916481|NCT03956615|540826205|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
149916482|NCT00412217|540826206|FG000|Overall Study|Insufficient Data Available|8|||
149916483|NCT00412217|540826207|FG001|Overall Study|Insufficient Data Available|3|||
149916484|NCT00412217|540826206|FG000|Overall Study|Death|5|||
149916485|NCT00412217|540826207|FG001|Overall Study|Death|4|||
149916486|NCT00412217|540826206|FG000|Overall Study|Disease Progression|2|||
149916487|NCT00412217|540826207|FG001|Overall Study|Disease Progression|3|||
149916488|NCT00412217|540826206|FG000|Overall Study|Investigator Decision|1|||
149916489|NCT00412217|540826207|FG001|Overall Study|Investigator Decision|0|||
149916490|NCT00412217|540826206|FG000|Overall Study|Withdrawal by Subject|2|||
149916491|NCT00412217|540826207|FG001|Overall Study|Withdrawal by Subject|0|||
149916492|NCT00412217|540826206|FG000|Overall Study|Lost to Follow-up|1|||
149916493|NCT00412217|540826207|FG001|Overall Study|Lost to Follow-up|4|||
149916494|NCT00412217|540826206|FG000|Overall Study|Study Terminated by Sponsor|26|||
149916495|NCT00412217|540826207|FG001|Overall Study|Study Terminated by Sponsor|33|||
149916496|NCT00412217|540826206|FG000|Overall Study|Other|1|||
149916497|NCT00412217|540826207|FG001|Overall Study|Other|1|||
149916498|NCT01069419|540826208|FG000|Overall Study|Adverse Event|233|||
149916499|NCT01069419|540826208|FG000|Overall Study|Lack of Efficacy|332|||
149916500|NCT01069419|540826208|FG000|Overall Study|Lost to Follow-up|49|||
149916501|NCT01069419|540826208|FG000|Overall Study|Remission of disease|11|||
149802730|NCT03113760|540406002|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149802731|NCT03113760|540406003|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149802732|NCT03113760|540406000|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
149802733|NCT03113760|540406001|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149802734|NCT03113760|540406002|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149802735|NCT03113760|540406003|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149802736|NCT03113760|540406000|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
149802737|NCT03113760|540406001|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
149802738|NCT03113760|540406002|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
149802739|NCT03113760|540406003|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
149802740|NCT00423137|540406004|FG000|Overall Study|Lost to Follow-up|0|||
149916502|NCT01069419|540826208|FG000|Overall Study|Withdrawal by Subject|34|||
149916503|NCT01069419|540826208|FG000|Overall Study|Other Reason|43|||
149916504|NCT01069419|540826208|FG000|Overall Study|Missing termination information|13|||
149916505|NCT03114657|540826211|FG000|Overall Study|Adverse Event|9|||
149916506|NCT03114657|540826212|FG001|Overall Study|Adverse Event|6|||
149916507|NCT03114657|540826211|FG000|Overall Study|Death|4|||
149916508|NCT03114657|540826212|FG001|Overall Study|Death|0|||
149916509|NCT03114657|540826211|FG000|Overall Study|Multiple Reasons|1|||
149916510|NCT03114657|540826212|FG001|Overall Study|Multiple Reasons|2|||
149916511|NCT03114657|540826211|FG000|Overall Study|Physician Decision|2|||
149916512|NCT03114657|540826212|FG001|Overall Study|Physician Decision|2|||
149916513|NCT03114657|540826211|FG000|Overall Study|Study Terminated By Sponsor|355|||
149916514|NCT03114657|540826212|FG001|Overall Study|Study Terminated By Sponsor|374|||
149916515|NCT03114657|540826211|FG000|Overall Study|Symptomatic Deterioration|0|||
149916516|NCT03114657|540826212|FG001|Overall Study|Symptomatic Deterioration|1|||
149916517|NCT03114657|540826211|FG000|Overall Study|Withdrawal by Subject|28|||
149916518|NCT03114657|540826212|FG001|Overall Study|Withdrawal by Subject|22|||
149916519|NCT00115037|540826213|FG000|Phase1|Lost to Follow-up|16|||
149916520|NCT00115037|540826214|FG001|Phase1|Lost to Follow-up|23|||
149916521|NCT00115037|540826215|FG002|Phase1|Lost to Follow-up|0|||
149916522|NCT00115037|540826216|FG003|Phase1|Lost to Follow-up|0|||
149916523|NCT00115037|540826217|FG004|Phase1|Lost to Follow-up|0|||
149916524|NCT00115037|540826218|FG005|Phase1|Lost to Follow-up|0|||
149916525|NCT00115037|540826213|FG000|Phase1|Withdrawal by Subject|9|||
149916526|NCT00115037|540826214|FG001|Phase1|Withdrawal by Subject|4|||
149916527|NCT00115037|540826215|FG002|Phase1|Withdrawal by Subject|0|||
149916528|NCT00115037|540826216|FG003|Phase1|Withdrawal by Subject|0|||
149916529|NCT00115037|540826217|FG004|Phase1|Withdrawal by Subject|0|||
149916530|NCT00115037|540826218|FG005|Phase1|Withdrawal by Subject|0|||
149916531|NCT00115037|540826213|FG000|Phase2|Death|0|||
149916532|NCT00115037|540826214|FG001|Phase2|Death|0|||
149916533|NCT00115037|540826215|FG002|Phase2|Death|1|||
149916534|NCT00115037|540826216|FG003|Phase2|Death|0|||
149916535|NCT00115037|540826217|FG004|Phase2|Death|0|||
149916536|NCT00115037|540826218|FG005|Phase2|Death|1|||
149916537|NCT00115037|540826213|FG000|Phase2|Withdrawal by Subject|0|||
149916538|NCT00115037|540826214|FG001|Phase2|Withdrawal by Subject|0|||
149916539|NCT00115037|540826215|FG002|Phase2|Withdrawal by Subject|2|||
149916540|NCT00115037|540826216|FG003|Phase2|Withdrawal by Subject|1|||
149916541|NCT00115037|540826217|FG004|Phase2|Withdrawal by Subject|2|||
149916542|NCT00115037|540826218|FG005|Phase2|Withdrawal by Subject|1|||
149916543|NCT00115037|540826213|FG000|Phase2|Lost to Follow-up|0|||
149916544|NCT00115037|540826214|FG001|Phase2|Lost to Follow-up|0|||
149916545|NCT00115037|540826215|FG002|Phase2|Lost to Follow-up|12|||
149916546|NCT00115037|540826216|FG003|Phase2|Lost to Follow-up|14|||
149916547|NCT00115037|540826217|FG004|Phase2|Lost to Follow-up|4|||
149916548|NCT00115037|540826218|FG005|Phase2|Lost to Follow-up|10|||
149916549|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
149916550|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
149916551|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
149916552|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
149916553|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
149916554|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
149916555|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
149916556|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
149916557|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
149916558|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
149916559|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
149916560|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
149916561|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2|Death|0|||
149916562|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2|Death|0|||
149916563|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2|Death|1|||
149916564|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2|Death|0|||
149916565|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
149916566|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
149916567|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
149916568|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
149916569|NCT01179737|540826219|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
149802741|NCT00423137|540406005|FG001|Overall Study|Lost to Follow-up|0|||
149802742|NCT00423137|540406006|FG002|Overall Study|Lost to Follow-up|1|||
149802743|NCT00423137|540406007|FG003|Overall Study|Lost to Follow-up|0|||
149916570|NCT01179737|540826220|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
149916571|NCT01179737|540826221|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
149916572|NCT01179737|540826222|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
149916573|NCT01179737|540826219|FG000|Extension|The study was terminated|3|||
149916574|NCT01179737|540826220|FG001|Extension|The study was terminated|0|||
149916575|NCT01179737|540826221|FG002|Extension|The study was terminated|0|||
149916576|NCT01179737|540826222|FG003|Extension|The study was terminated|0|||
149916577|NCT01546038|540826223|FG000|Overall Study|Death|15|||
149916578|NCT01546038|540826224|FG001|Overall Study|Death|6|||
149916579|NCT01546038|540826225|FG002|Overall Study|Death|4|||
149916580|NCT01546038|540826226|FG003|Overall Study|Death|2|||
149916581|NCT01546038|540826227|FG004|Overall Study|Death|9|||
149916582|NCT01546038|540826228|FG005|Overall Study|Death|3|||
149916583|NCT01546038|540826229|FG006|Overall Study|Death|46|||
149916584|NCT01546038|540826230|FG007|Overall Study|Death|76|||
149916585|NCT01546038|540826231|FG008|Overall Study|Death|39|||
149916586|NCT01546038|540826223|FG000|Overall Study|Lost to Follow-up|0|||
149916587|NCT01546038|540826224|FG001|Overall Study|Lost to Follow-up|0|||
149916588|NCT01546038|540826225|FG002|Overall Study|Lost to Follow-up|0|||
149916589|NCT01546038|540826226|FG003|Overall Study|Lost to Follow-up|0|||
149916590|NCT01546038|540826227|FG004|Overall Study|Lost to Follow-up|1|||
149916591|NCT01546038|540826228|FG005|Overall Study|Lost to Follow-up|0|||
149916592|NCT01546038|540826229|FG006|Overall Study|Lost to Follow-up|2|||
149916593|NCT01546038|540826230|FG007|Overall Study|Lost to Follow-up|1|||
149916594|NCT01546038|540826231|FG008|Overall Study|Lost to Follow-up|0|||
149916595|NCT01546038|540826223|FG000|Overall Study|Withdrawal by Subject|1|||
149916596|NCT01546038|540826224|FG001|Overall Study|Withdrawal by Subject|0|||
149916597|NCT01546038|540826225|FG002|Overall Study|Withdrawal by Subject|0|||
149916598|NCT01546038|540826226|FG003|Overall Study|Withdrawal by Subject|1|||
149916599|NCT01546038|540826227|FG004|Overall Study|Withdrawal by Subject|0|||
149916600|NCT01546038|540826228|FG005|Overall Study|Withdrawal by Subject|1|||
149916601|NCT01546038|540826229|FG006|Overall Study|Withdrawal by Subject|3|||
149916602|NCT01546038|540826230|FG007|Overall Study|Withdrawal by Subject|3|||
149916603|NCT01546038|540826231|FG008|Overall Study|Withdrawal by Subject|1|||
149916604|NCT01546038|540826223|FG000|Overall Study|: Randomized, not treated|0|||
149916605|NCT01546038|540826224|FG001|Overall Study|: Randomized, not treated|0|||
149916606|NCT01546038|540826225|FG002|Overall Study|: Randomized, not treated|0|||
149916607|NCT01546038|540826226|FG003|Overall Study|: Randomized, not treated|0|||
149916608|NCT01546038|540826227|FG004|Overall Study|: Randomized, not treated|0|||
149916609|NCT01546038|540826228|FG005|Overall Study|: Randomized, not treated|0|||
149916610|NCT01546038|540826229|FG006|Overall Study|: Randomized, not treated|2|||
149916611|NCT01546038|540826230|FG007|Overall Study|: Randomized, not treated|4|||
149916612|NCT01546038|540826231|FG008|Overall Study|: Randomized, not treated|3|||
149916613|NCT01398410|540826232|FG000|Overall Study|Adverse Event|12|||
149916614|NCT01398410|540826233|FG001|Overall Study|Adverse Event|16|||
149916615|NCT01398410|540826232|FG000|Overall Study|Participants Choice|8|||
149916616|NCT01398410|540826233|FG001|Overall Study|Participants Choice|11|||
149916617|NCT01398410|540826232|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
149916618|NCT01398410|540826233|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
149916619|NCT01398410|540826232|FG000|Overall Study|Other|36|||
149916620|NCT01398410|540826233|FG001|Overall Study|Other|29|||
149916621|NCT04245202|540826234|FG000|Overall Study|Lack of Efficacy|10|||
149916622|NCT04245202|540826235|FG001|Overall Study|Lack of Efficacy|1|||
149916623|NCT00717275|540826236|FG000|Overall Study|Premature study termination.|3|||
149916624|NCT03515629|540826238|FG000|Overall Study|Death|0|||
149916625|NCT03515629|540826239|FG001|Overall Study|Death|1|||
149916626|NCT03515629|540826240|FG002|Overall Study|Death|1|||
149916627|NCT03515629|540826238|FG000|Overall Study|Progressive disease|0|||
149916628|NCT03515629|540826239|FG001|Overall Study|Progressive disease|1|||
149916629|NCT03515629|540826240|FG002|Overall Study|Progressive disease|0|||
149916630|NCT00424021|540826241|FG000|NCT00046319 Study Period|Adverse Event|1|||
149916631|NCT00424021|540826242|FG001|NCT00046319 Study Period|Adverse Event|0|||
149916632|NCT00424021|540826243|FG002|NCT00046319 Study Period|Adverse Event|1|||
149916633|NCT00424021|540826244|FG003|NCT00046319 Study Period|Adverse Event|1|||
149916634|NCT00424021|540826241|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
149916635|NCT00424021|540826242|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
149916636|NCT00424021|540826243|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
149916637|NCT00424021|540826244|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
149916638|NCT00424021|540826241|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
149916639|NCT00424021|540826242|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
149916640|NCT00424021|540826243|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
149916641|NCT00424021|540826244|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
149916642|NCT00424021|540826241|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
149916643|NCT00424021|540826242|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
149916644|NCT00424021|540826243|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
149916645|NCT00424021|540826244|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
149916646|NCT00424021|540826241|FG000|AMB-220-E Study Period|Adverse Event|1|||
149916647|NCT00424021|540826242|FG001|AMB-220-E Study Period|Adverse Event|1|||
149916648|NCT00424021|540826243|FG002|AMB-220-E Study Period|Adverse Event|3|||
149916649|NCT00424021|540826244|FG003|AMB-220-E Study Period|Adverse Event|7|||
149916650|NCT00424021|540826241|FG000|AMB-220-E Study Period|Death|0|||
149916651|NCT00424021|540826242|FG001|AMB-220-E Study Period|Death|0|||
149916652|NCT00424021|540826243|FG002|AMB-220-E Study Period|Death|1|||
149916653|NCT00424021|540826244|FG003|AMB-220-E Study Period|Death|1|||
149916654|NCT00424021|540826241|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
149916655|NCT00424021|540826242|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
149916656|NCT00424021|540826243|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
149916657|NCT00424021|540826244|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
149916658|NCT00424021|540826241|FG000|AMB-220-E Study Period|Physician Decision|0|||
149916659|NCT00424021|540826242|FG001|AMB-220-E Study Period|Physician Decision|0|||
149916660|NCT00424021|540826243|FG002|AMB-220-E Study Period|Physician Decision|0|||
149916661|NCT00424021|540826244|FG003|AMB-220-E Study Period|Physician Decision|1|||
149916662|NCT01254721|540826245|FG000|Overall Study|Lost to Follow-up|0|||
149916663|NCT01254721|540826246|FG001|Overall Study|Lost to Follow-up|4|||
149916664|NCT01254721|540826245|FG000|Overall Study|Lack of Efficacy|4|||
149916665|NCT01254721|540826246|FG001|Overall Study|Lack of Efficacy|2|||
149916666|NCT01254721|540826245|FG000|Overall Study|Death|0|||
149916667|NCT01254721|540826246|FG001|Overall Study|Death|1|||
149916668|NCT01254721|540826245|FG000|Overall Study|technical problum|1|||
149916669|NCT01254721|540826246|FG001|Overall Study|technical problum|0|||
149916670|NCT01254721|540826245|FG000|Overall Study|Adverse Event|2|||
149916671|NCT01254721|540826246|FG001|Overall Study|Adverse Event|3|||
149916672|NCT01254721|540826245|FG000|Overall Study|Withdrawal by Subject|8|||
149916673|NCT01254721|540826246|FG001|Overall Study|Withdrawal by Subject|11|||
149916674|NCT01254721|540826245|FG000|Overall Study|Wrongly randomization|0|||
149916675|NCT01254721|540826246|FG001|Overall Study|Wrongly randomization|1|||
149916676|NCT03597022|540826248|FG000|Overall Study|Premature termination of the study|7|||
149916677|NCT03597022|540826249|FG001|Overall Study|Premature termination of the study|7|||
149916678|NCT03597022|540826250|FG002|Overall Study|Premature termination of the study|8|||
149916679|NCT03597022|540826248|FG000|Overall Study|Serious adverse event|1|||
149916680|NCT03597022|540826249|FG001|Overall Study|Serious adverse event|1|||
149916681|NCT03597022|540826250|FG002|Overall Study|Serious adverse event|0|||
149916682|NCT00312572|540826251|FG000|Overall Study|Adverse Event|10|||
149916683|NCT00312572|540826252|FG001|Overall Study|Adverse Event|16|||
149916684|NCT00312572|540826251|FG000|Overall Study|Lost to Follow-up|1|||
149916685|NCT00312572|540826252|FG001|Overall Study|Lost to Follow-up|1|||
149916686|NCT00312572|540826251|FG000|Overall Study|Administrative|4|||
149916687|NCT00312572|540826252|FG001|Overall Study|Administrative|2|||
149916688|NCT00312572|540826251|FG000|Overall Study|Lack of Efficacy|1|||
149916689|NCT00312572|540826252|FG001|Overall Study|Lack of Efficacy|2|||
149916690|NCT00904839|540826253|FG000|Overall Study|Adverse Event|0|||
149916691|NCT00904839|540826254|FG001|Overall Study|Adverse Event|5|||
149916692|NCT00904839|540826255|FG002|Overall Study|Adverse Event|4|||
149916693|NCT00904839|540826253|FG000|Overall Study|Protocol Violation|0|||
149916694|NCT00904839|540826254|FG001|Overall Study|Protocol Violation|1|||
149916695|NCT00904839|540826255|FG002|Overall Study|Protocol Violation|1|||
149916696|NCT00904839|540826253|FG000|Overall Study|Lost to Follow-up|0|||
149916697|NCT00904839|540826254|FG001|Overall Study|Lost to Follow-up|1|||
149916698|NCT00904839|540826255|FG002|Overall Study|Lost to Follow-up|2|||
149916699|NCT00904839|540826253|FG000|Overall Study|Withdrawal by Subject|0|||
149916700|NCT00904839|540826254|FG001|Overall Study|Withdrawal by Subject|2|||
149916701|NCT00904839|540826255|FG002|Overall Study|Withdrawal by Subject|0|||
149916702|NCT00904839|540826253|FG000|Overall Study|Not treated|1|||
149916703|NCT00904839|540826254|FG001|Overall Study|Not treated|0|||
149916704|NCT00904839|540826255|FG002|Overall Study|Not treated|1|||
149916705|NCT00904839|540826253|FG000|Overall Study|Other than above|0|||
149916706|NCT00904839|540826254|FG001|Overall Study|Other than above|9|||
149916707|NCT00904839|540826255|FG002|Overall Study|Other than above|7|||
149916708|NCT05385224|540826256|FG000|Overall Study|Unable to swallow capsule|2|||
150256635|NCT00686725|542074109|FG000|Overall Study|Progressive Disease|17|||
149916709|NCT05385224|540826256|FG000|Overall Study|Withdrawal by Subject|2|||
149916710|NCT05385224|540826256|FG000|Overall Study|Did not meet study criteria|1|||
149916711|NCT04521114|540826263|FG000|Overall Study|Lost to Follow-up|1|||
149916712|NCT04521114|540826264|FG001|Overall Study|Lost to Follow-up|2|||
150256636|NCT00686725|542074110|FG001|Overall Study|Progressive Disease|23|||
149916713|NCT04521114|540826265|FG002|Overall Study|Lost to Follow-up|0|||
149916714|NCT04521114|540826263|FG000|Overall Study|Withdrawal by Subject|1|||
149916715|NCT04521114|540826264|FG001|Overall Study|Withdrawal by Subject|2|||
149916716|NCT04521114|540826265|FG002|Overall Study|Withdrawal by Subject|2|||
149916717|NCT04521114|540826263|FG000|Overall Study|Adverse Event|1|||
149916718|NCT04521114|540826264|FG001|Overall Study|Adverse Event|0|||
149916719|NCT04521114|540826265|FG002|Overall Study|Adverse Event|0|||
149916720|NCT04521114|540826263|FG000|Overall Study|Sponsor Wish|1|||
149916721|NCT04521114|540826264|FG001|Overall Study|Sponsor Wish|0|||
149916722|NCT04521114|540826265|FG002|Overall Study|Sponsor Wish|0|||
149916723|NCT04521114|540826263|FG000|Overall Study|Withdrawal of Consent|2|||
149916724|NCT04521114|540826264|FG001|Overall Study|Withdrawal of Consent|2|||
149802744|NCT00423137|540406004|FG000|Overall Study|Protocol Violation|0|||
149802745|NCT00423137|540406005|FG001|Overall Study|Protocol Violation|0|||
149802746|NCT00423137|540406006|FG002|Overall Study|Protocol Violation|0|||
149916725|NCT04521114|540826265|FG002|Overall Study|Withdrawal of Consent|0|||
149916726|NCT00553358|540826266|FG000|Overall Study|Randomized but did not receive treatment|3|||
149916727|NCT00553358|540826267|FG001|Overall Study|Randomized but did not receive treatment|3|||
149916728|NCT00553358|540826268|FG002|Overall Study|Randomized but did not receive treatment|1|||
149916729|NCT00553358|540826266|FG000|Overall Study|Lost to Follow-up|22|||
149916730|NCT00553358|540826267|FG001|Overall Study|Lost to Follow-up|26|||
149916731|NCT00553358|540826268|FG002|Overall Study|Lost to Follow-up|18|||
149916732|NCT00553358|540826266|FG000|Overall Study|Withdrew completely|23|||
149916733|NCT00553358|540826267|FG001|Overall Study|Withdrew completely|33|||
149916734|NCT00553358|540826268|FG002|Overall Study|Withdrew completely|34|||
149916735|NCT00553358|540826266|FG000|Overall Study|Died during clinical follow-up|25|||
149916736|NCT00553358|540826267|FG001|Overall Study|Died during clinical follow-up|29|||
149802747|NCT00423137|540406007|FG003|Overall Study|Protocol Violation|1|||
149916737|NCT00553358|540826268|FG002|Overall Study|Died during clinical follow-up|32|||
149916738|NCT00553358|540826266|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
149916739|NCT00553358|540826267|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
149916740|NCT00553358|540826268|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
149916741|NCT00553358|540826266|FG000|Overall Study|Died after clinical follow-up ended|1|||
149916742|NCT00553358|540826267|FG001|Overall Study|Died after clinical follow-up ended|2|||
149916743|NCT00553358|540826268|FG002|Overall Study|Died after clinical follow-up ended|0|||
149916744|NCT00553358|540826266|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
149916745|NCT00553358|540826267|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
149916746|NCT00553358|540826268|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
149916747|NCT01797094|540826269|FG000|Overall Study|Adverse Event|1|||
149916748|NCT01797094|540826270|FG001|Overall Study|Adverse Event|1|||
149916749|NCT01797094|540826269|FG000|Overall Study|Personal Reasons|4|||
149916750|NCT01797094|540826270|FG001|Overall Study|Personal Reasons|0|||
149916751|NCT01797094|540826269|FG000|Overall Study|Protocol Violation|0|||
149916752|NCT01797094|540826270|FG001|Overall Study|Protocol Violation|1|||
149916753|NCT01797094|540826269|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149916754|NCT01797094|540826270|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149916755|NCT03013985|540826273|FG000|Overall Study|Protocol Violation|2|||
149916756|NCT03013985|540826274|FG001|Overall Study|Protocol Violation|2|||
149916757|NCT03013985|540826273|FG000|Overall Study|Withdrawal by Subject|14|||
149916758|NCT03013985|540826274|FG001|Overall Study|Withdrawal by Subject|17|||
149916759|NCT00076999|540826281|FG000|Overall Study|Adverse Event|2|||
149916760|NCT00076999|540826282|FG001|Overall Study|Adverse Event|8|||
149916761|NCT00076999|540826283|FG002|Overall Study|Adverse Event|6|||
149916762|NCT00076999|540826284|FG003|Overall Study|Adverse Event|0|||
149916763|NCT00076999|540826285|FG004|Overall Study|Adverse Event|2|||
149916764|NCT00076999|540826281|FG000|Overall Study|Protocol Violation|0|||
149916765|NCT00076999|540826282|FG001|Overall Study|Protocol Violation|3|||
149916766|NCT00076999|540826283|FG002|Overall Study|Protocol Violation|4|||
149916767|NCT00076999|540826284|FG003|Overall Study|Protocol Violation|0|||
149916768|NCT00076999|540826285|FG004|Overall Study|Protocol Violation|9|||
149916769|NCT00076999|540826281|FG000|Overall Study|Lost to Follow-up|2|||
149916770|NCT00076999|540826282|FG001|Overall Study|Lost to Follow-up|1|||
149916771|NCT00076999|540826283|FG002|Overall Study|Lost to Follow-up|0|||
149916772|NCT00076999|540826284|FG003|Overall Study|Lost to Follow-up|0|||
149916773|NCT00076999|540826285|FG004|Overall Study|Lost to Follow-up|0|||
149916774|NCT00076999|540826281|FG000|Overall Study|Withdrawal by Subject|0|||
149916775|NCT00076999|540826282|FG001|Overall Study|Withdrawal by Subject|4|||
149916776|NCT00076999|540826283|FG002|Overall Study|Withdrawal by Subject|3|||
149916777|NCT00076999|540826284|FG003|Overall Study|Withdrawal by Subject|0|||
149916778|NCT00076999|540826285|FG004|Overall Study|Withdrawal by Subject|1|||
149916779|NCT00076999|540826281|FG000|Overall Study|Other reason (not specified)|8|||
149916780|NCT00076999|540826282|FG001|Overall Study|Other reason (not specified)|8|||
149916781|NCT00076999|540826283|FG002|Overall Study|Other reason (not specified)|4|||
149916782|NCT00076999|540826284|FG003|Overall Study|Other reason (not specified)|1|||
149916783|NCT00076999|540826285|FG004|Overall Study|Other reason (not specified)|13|||
149916784|NCT01217385|540826287|FG000|Overall Study|Withdrawal by Subject|3|||
149916785|NCT01217385|540826287|FG000|Overall Study|DOSI not performed/not eval|12|||
150256637|NCT00686725|542074109|FG000|Overall Study|Lost to Follow-up|7|||
149916786|NCT01217385|540826287|FG000|Overall Study|Central Path not Available|1|||
149916787|NCT01217385|540826287|FG000|Overall Study|Normal Breast TOI not available|10|||
149916788|NCT00586508|540826289|FG000|Overall Study|Progressive disease|52|||
149916789|NCT00586508|540826290|FG001|Overall Study|Progressive disease|8|||
149916790|NCT00586508|540826289|FG000|Overall Study|Death|0|||
149916791|NCT00586508|540826290|FG001|Overall Study|Death|1|||
149916792|NCT00586508|540826289|FG000|Overall Study|Adverse Event|12|||
149916793|NCT00586508|540826290|FG001|Overall Study|Adverse Event|4|||
149916794|NCT00586508|540826289|FG000|Overall Study|Withdrawal by Subject|4|||
149916795|NCT00586508|540826290|FG001|Overall Study|Withdrawal by Subject|0|||
149916796|NCT02079636|540826291|FG000|Overall Study|Death|2|||
149916797|NCT02079636|540826292|FG001|Overall Study|Death|1|||
149916798|NCT02079636|540826293|FG002|Overall Study|Death|0|||
149916799|NCT02079636|540826294|FG003|Overall Study|Death|5|||
149916800|NCT02079636|540826295|FG004|Overall Study|Death|1|||
149916801|NCT02079636|540826296|FG005|Overall Study|Death|2|||
149916802|NCT02079636|540826297|FG006|Overall Study|Death|1|||
149916803|NCT02079636|540826298|FG007|Overall Study|Death|0|||
149916804|NCT02079636|540826299|FG008|Overall Study|Death|0|||
149916805|NCT02079636|540826300|FG009|Overall Study|Death|0|||
149916806|NCT02079636|540826301|FG010|Overall Study|Death|0|||
149916807|NCT02079636|540826302|FG011|Overall Study|Death|1|||
149916808|NCT02079636|540826303|FG012|Overall Study|Death|1|||
149916809|NCT02079636|540826304|FG013|Overall Study|Death|0|||
149916810|NCT02079636|540826305|FG014|Overall Study|Death|2|||
149916811|NCT02079636|540826291|FG000|Overall Study|Adverse Event|1|||
149916812|NCT02079636|540826292|FG001|Overall Study|Adverse Event|1|||
149916813|NCT02079636|540826293|FG002|Overall Study|Adverse Event|0|||
149916814|NCT02079636|540826294|FG003|Overall Study|Adverse Event|1|||
149916815|NCT02079636|540826295|FG004|Overall Study|Adverse Event|1|||
149916816|NCT02079636|540826296|FG005|Overall Study|Adverse Event|2|||
149916817|NCT02079636|540826297|FG006|Overall Study|Adverse Event|0|||
149916818|NCT02079636|540826298|FG007|Overall Study|Adverse Event|0|||
149916819|NCT02079636|540826299|FG008|Overall Study|Adverse Event|0|||
149916820|NCT02079636|540826300|FG009|Overall Study|Adverse Event|0|||
149916821|NCT02079636|540826301|FG010|Overall Study|Adverse Event|0|||
149916822|NCT02079636|540826302|FG011|Overall Study|Adverse Event|0|||
149916823|NCT02079636|540826303|FG012|Overall Study|Adverse Event|0|||
149916824|NCT02079636|540826304|FG013|Overall Study|Adverse Event|0|||
149916825|NCT02079636|540826305|FG014|Overall Study|Adverse Event|0|||
149916826|NCT02079636|540826291|FG000|Overall Study|Progressive disease|0|||
149916827|NCT02079636|540826292|FG001|Overall Study|Progressive disease|0|||
149916828|NCT02079636|540826293|FG002|Overall Study|Progressive disease|0|||
149916829|NCT02079636|540826294|FG003|Overall Study|Progressive disease|2|||
149916830|NCT02079636|540826295|FG004|Overall Study|Progressive disease|0|||
149916831|NCT02079636|540826296|FG005|Overall Study|Progressive disease|0|||
149916832|NCT02079636|540826297|FG006|Overall Study|Progressive disease|0|||
149916833|NCT02079636|540826298|FG007|Overall Study|Progressive disease|0|||
149916834|NCT02079636|540826299|FG008|Overall Study|Progressive disease|0|||
149916835|NCT02079636|540826300|FG009|Overall Study|Progressive disease|0|||
149916836|NCT02079636|540826301|FG010|Overall Study|Progressive disease|0|||
149916837|NCT02079636|540826302|FG011|Overall Study|Progressive disease|0|||
149916838|NCT02079636|540826303|FG012|Overall Study|Progressive disease|1|||
149916839|NCT02079636|540826304|FG013|Overall Study|Progressive disease|0|||
149916840|NCT02079636|540826305|FG014|Overall Study|Progressive disease|0|||
149916841|NCT02079636|540826291|FG000|Overall Study|Withdrawal by Subject|0|||
149916842|NCT02079636|540826292|FG001|Overall Study|Withdrawal by Subject|0|||
149916843|NCT02079636|540826293|FG002|Overall Study|Withdrawal by Subject|0|||
149916844|NCT02079636|540826294|FG003|Overall Study|Withdrawal by Subject|4|||
149916845|NCT02079636|540826295|FG004|Overall Study|Withdrawal by Subject|0|||
149916846|NCT02079636|540826296|FG005|Overall Study|Withdrawal by Subject|1|||
149916847|NCT02079636|540826297|FG006|Overall Study|Withdrawal by Subject|0|||
149916848|NCT02079636|540826298|FG007|Overall Study|Withdrawal by Subject|0|||
149916849|NCT02079636|540826299|FG008|Overall Study|Withdrawal by Subject|0|||
149916850|NCT02079636|540826300|FG009|Overall Study|Withdrawal by Subject|2|||
149916851|NCT02079636|540826301|FG010|Overall Study|Withdrawal by Subject|1|||
149916852|NCT02079636|540826302|FG011|Overall Study|Withdrawal by Subject|1|||
149916853|NCT02079636|540826303|FG012|Overall Study|Withdrawal by Subject|1|||
149916854|NCT02079636|540826304|FG013|Overall Study|Withdrawal by Subject|0|||
149916855|NCT02079636|540826305|FG014|Overall Study|Withdrawal by Subject|2|||
149916856|NCT02079636|540826291|FG000|Overall Study|Physician Decision|0|||
149916857|NCT02079636|540826292|FG001|Overall Study|Physician Decision|0|||
149916858|NCT02079636|540826293|FG002|Overall Study|Physician Decision|0|||
149916859|NCT02079636|540826294|FG003|Overall Study|Physician Decision|0|||
149916860|NCT02079636|540826295|FG004|Overall Study|Physician Decision|0|||
150256638|NCT00686725|542074110|FG001|Overall Study|Lost to Follow-up|5|||
149916861|NCT02079636|540826296|FG005|Overall Study|Physician Decision|1|||
149916862|NCT02079636|540826297|FG006|Overall Study|Physician Decision|0|||
149916863|NCT02079636|540826298|FG007|Overall Study|Physician Decision|0|||
149916864|NCT02079636|540826299|FG008|Overall Study|Physician Decision|0|||
149916865|NCT02079636|540826300|FG009|Overall Study|Physician Decision|1|||
149916866|NCT02079636|540826301|FG010|Overall Study|Physician Decision|1|||
149916867|NCT02079636|540826302|FG011|Overall Study|Physician Decision|0|||
149916868|NCT02079636|540826303|FG012|Overall Study|Physician Decision|0|||
149916869|NCT02079636|540826304|FG013|Overall Study|Physician Decision|0|||
149916870|NCT02079636|540826305|FG014|Overall Study|Physician Decision|1|||
149916871|NCT02079636|540826291|FG000|Overall Study|Lost to Follow-up|0|||
149916872|NCT02079636|540826292|FG001|Overall Study|Lost to Follow-up|0|||
149916873|NCT02079636|540826293|FG002|Overall Study|Lost to Follow-up|0|||
149916874|NCT02079636|540826294|FG003|Overall Study|Lost to Follow-up|0|||
149916875|NCT02079636|540826295|FG004|Overall Study|Lost to Follow-up|0|||
149916876|NCT02079636|540826296|FG005|Overall Study|Lost to Follow-up|0|||
149916877|NCT02079636|540826297|FG006|Overall Study|Lost to Follow-up|0|||
149916878|NCT02079636|540826298|FG007|Overall Study|Lost to Follow-up|1|||
149916879|NCT02079636|540826299|FG008|Overall Study|Lost to Follow-up|0|||
149916880|NCT02079636|540826300|FG009|Overall Study|Lost to Follow-up|0|||
149916881|NCT02079636|540826301|FG010|Overall Study|Lost to Follow-up|0|||
149916882|NCT02079636|540826302|FG011|Overall Study|Lost to Follow-up|0|||
149916883|NCT02079636|540826303|FG012|Overall Study|Lost to Follow-up|0|||
149916884|NCT02079636|540826304|FG013|Overall Study|Lost to Follow-up|0|||
149916885|NCT02079636|540826305|FG014|Overall Study|Lost to Follow-up|0|||
149916886|NCT03434249|540826306|FG000|Overall Study|Adverse Event|1|||
149916887|NCT03434249|540826307|FG001|Overall Study|Adverse Event|0|||
149916888|NCT03434249|540826306|FG000|Overall Study|Lost to Follow-up|0|||
149916889|NCT03434249|540826307|FG001|Overall Study|Lost to Follow-up|1|||
149916890|NCT03434249|540826306|FG000|Overall Study|Non-compliance of family|2|||
149916891|NCT03434249|540826307|FG001|Overall Study|Non-compliance of family|1|||
149916892|NCT03434249|540826306|FG000|Overall Study|Difficulties in completing daily diary|2|||
149916893|NCT03434249|540826307|FG001|Overall Study|Difficulties in completing daily diary|1|||
149916894|NCT03325894|540826308|FG000|Overall Study|Adverse Event|2|||
149916895|NCT03325894|540826309|FG001|Overall Study|Adverse Event|3|||
149916896|NCT03325894|540826308|FG000|Overall Study|Protocol Violation|1|||
149916897|NCT03325894|540826309|FG001|Overall Study|Protocol Violation|2|||
149916898|NCT03325894|540826308|FG000|Overall Study|Withdrawal by Subject|10|||
149916899|NCT03325894|540826309|FG001|Overall Study|Withdrawal by Subject|6|||
149916900|NCT03325894|540826308|FG000|Overall Study|Lost to Follow-up|4|||
149916901|NCT03325894|540826309|FG001|Overall Study|Lost to Follow-up|9|||
149916902|NCT03325894|540826308|FG000|Overall Study|Lack of Efficacy|8|||
149916903|NCT03325894|540826309|FG001|Overall Study|Lack of Efficacy|14|||
149916904|NCT03325894|540826308|FG000|Overall Study|Study Terminated by Sponsor|38|||
149916905|NCT03325894|540826309|FG001|Overall Study|Study Terminated by Sponsor|43|||
149916906|NCT03325894|540826308|FG000|Overall Study|Other (Not received Treatment)|1|||
149916907|NCT03325894|540826309|FG001|Overall Study|Other (Not received Treatment)|0|||
149916908|NCT00441363|540828356|FG000|Overall Study|Adverse Event|4|||
149916909|NCT00441363|540828357|FG001|Overall Study|Adverse Event|2|||
149916910|NCT00441363|540828356|FG000|Overall Study|Withdrawal by Subject|3|||
149916911|NCT00441363|540828357|FG001|Overall Study|Withdrawal by Subject|4|||
150256639|NCT00686725|542074109|FG000|Overall Study|Death|6|||
149916912|NCT00441363|540828356|FG000|Overall Study|Physician Decision|6|||
149916913|NCT00441363|540828357|FG001|Overall Study|Physician Decision|7|||
149916914|NCT00441363|540828356|FG000|Overall Study|Lost to Follow-up|2|||
149916915|NCT00441363|540828357|FG001|Overall Study|Lost to Follow-up|2|||
149916916|NCT00441363|540828356|FG000|Overall Study|Other|2|||
149916917|NCT00441363|540828357|FG001|Overall Study|Other|0|||
149916918|NCT02437188|540828360|FG000|Overall Study|Randomized but did not receive surgery|4|||
149916919|NCT02437188|540828361|FG001|Overall Study|Randomized but did not receive surgery|8|||
149916920|NCT02437188|540828360|FG000|Overall Study|Adverse Event|0|||
149916921|NCT02437188|540828361|FG001|Overall Study|Adverse Event|1|||
149916922|NCT02290925|540828368|FG000|First Period of Three Months|Lost to Follow-up|2|||
149916923|NCT02290925|540828369|FG001|First Period of Three Months|Lost to Follow-up|1|||
149916924|NCT02290925|540828368|FG000|First Period of Three Months|Death|1|||
149916925|NCT02290925|540828369|FG001|First Period of Three Months|Death|0|||
149916926|NCT02290925|540828368|FG000|First Period of Three Months|Insulin Started|1|||
149916927|NCT02290925|540828369|FG001|First Period of Three Months|Insulin Started|1|||
149916928|NCT02290925|540828368|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
149916929|NCT02290925|540828369|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
149916930|NCT02290925|540828368|FG000|Second Period of 3 Months|insulin started|0|||
149916931|NCT02290925|540828369|FG001|Second Period of 3 Months|insulin started|1|||
149916932|NCT01716520|540828370|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
149916933|NCT01716520|540828371|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
149916934|NCT01716520|540828372|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
149916935|NCT01716520|540828373|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
149916936|NCT01716520|540828374|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
149916937|NCT01716520|540828375|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
149916938|NCT01716520|540828370|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
149916939|NCT01716520|540828371|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916940|NCT01716520|540828372|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
149916941|NCT01716520|540828373|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
149916942|NCT01716520|540828374|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916943|NCT01716520|540828375|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
149916944|NCT01716520|540828370|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149916945|NCT01716520|540828371|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149916946|NCT01716520|540828372|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149916947|NCT01716520|540828373|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149916948|NCT01716520|540828374|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149916949|NCT01716520|540828375|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149916950|NCT01716520|540828370|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
149916951|NCT01716520|540828371|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
149916952|NCT01716520|540828372|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
149916953|NCT01716520|540828373|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
149916954|NCT01716520|540828374|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
149916955|NCT01716520|540828375|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
149916956|NCT01716520|540828370|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149916957|NCT01716520|540828371|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149916958|NCT01716520|540828372|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149916959|NCT01716520|540828373|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149916960|NCT01716520|540828374|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149916961|NCT01716520|540828375|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
149916962|NCT01716520|540828370|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
149916963|NCT01716520|540828371|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
149916964|NCT01716520|540828372|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
149916965|NCT01716520|540828373|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
149916966|NCT01716520|540828374|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
149916967|NCT01716520|540828375|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
149916968|NCT01716520|540828370|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
149916969|NCT01716520|540828371|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
149916970|NCT01716520|540828372|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
149916971|NCT01716520|540828373|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
149916972|NCT01716520|540828374|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
149916973|NCT01716520|540828375|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
149916974|NCT01716520|540828370|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149916975|NCT01716520|540828371|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149916976|NCT01716520|540828372|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149916977|NCT01716520|540828373|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149916978|NCT01716520|540828374|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149916979|NCT01716520|540828375|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149916980|NCT01716520|540828370|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916981|NCT01716520|540828371|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916982|NCT01716520|540828372|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916983|NCT01716520|540828373|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
149916984|NCT01716520|540828374|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916985|NCT01716520|540828375|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
149916986|NCT01716520|540828370|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
149916987|NCT01716520|540828371|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
149916988|NCT01716520|540828372|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
149916989|NCT01716520|540828373|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
149916990|NCT01716520|540828374|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
149916991|NCT01716520|540828375|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
149916992|NCT01716520|540828370|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
149916993|NCT01716520|540828371|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
149916994|NCT01716520|540828372|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
149916995|NCT01716520|540828373|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
149916996|NCT01716520|540828374|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
149916997|NCT01716520|540828375|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
149916998|NCT01716520|540828370|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
149916999|NCT01716520|540828371|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
149917000|NCT01716520|540828372|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
149917001|NCT01716520|540828373|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
149917002|NCT01716520|540828374|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
149917003|NCT01716520|540828375|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
149917004|NCT01716520|540828370|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
149917005|NCT01716520|540828371|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
149917006|NCT01716520|540828372|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
149917007|NCT01716520|540828373|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
149917008|NCT01716520|540828374|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
149917009|NCT01716520|540828375|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
149917010|NCT01716520|540828370|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149917011|NCT01716520|540828371|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149917012|NCT01716520|540828372|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149917013|NCT01716520|540828373|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149917014|NCT01716520|540828374|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149917015|NCT01716520|540828375|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
149917016|NCT01716520|540828370|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149917017|NCT01716520|540828371|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149917018|NCT01716520|540828372|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
149917019|NCT01716520|540828373|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149917020|NCT01716520|540828374|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149917021|NCT01716520|540828375|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149917022|NCT00981058|540828380|FG000|Overall Study|Progressive Disease|38|||
149917023|NCT00981058|540828381|FG001|Overall Study|Progressive Disease|31|||
149917024|NCT00981058|540828380|FG000|Overall Study|Lost to Follow-up|3|||
149917025|NCT00981058|540828381|FG001|Overall Study|Lost to Follow-up|2|||
149917026|NCT00981058|540828380|FG000|Overall Study|Physician Decision|4|||
149917027|NCT00981058|540828381|FG001|Overall Study|Physician Decision|5|||
149917028|NCT00981058|540828380|FG000|Overall Study|Randomization Error|0|||
149917029|NCT00981058|540828381|FG001|Overall Study|Randomization Error|1|||
149917030|NCT00981058|540828380|FG000|Overall Study|Withdrawal by Subject|24|||
149917031|NCT00981058|540828381|FG001|Overall Study|Withdrawal by Subject|22|||
149917032|NCT05916131|540828382|FG000|Overall Study|Lost to Follow-up|0|||
149917033|NCT05916131|540828383|FG001|Overall Study|Lost to Follow-up|0|||
149917034|NCT05916131|540828384|FG002|Overall Study|Lost to Follow-up|1|||
149917035|NCT05916131|540828385|FG003|Overall Study|Lost to Follow-up|0|||
149917036|NCT02305446|540828386|FG000|Overall Study|Adverse Event|1|||
149917037|NCT02696434|540828388|FG000|Overall Study|Adverse Event|3|||
149917038|NCT02696434|540828389|FG001|Overall Study|Adverse Event|1|||
149917039|NCT02696434|540828388|FG000|Overall Study|Lost to Follow-up|5|||
149917040|NCT02696434|540828389|FG001|Overall Study|Lost to Follow-up|4|||
149917041|NCT02696434|540828388|FG000|Overall Study|Withdrawal by Subject|14|||
149917042|NCT02696434|540828389|FG001|Overall Study|Withdrawal by Subject|12|||
149917043|NCT02696434|540828388|FG000|Overall Study|Physician Decision|0|||
149917044|NCT02696434|540828389|FG001|Overall Study|Physician Decision|1|||
149917045|NCT04105010|540828414|FG000|Overall Study|Death|3|||
149917046|NCT04105010|540828415|FG001|Overall Study|Death|1|||
149917047|NCT04105010|540828416|FG002|Overall Study|Death|1|||
149917048|NCT04105010|540828417|FG003|Overall Study|Death|54|||
149917049|NCT04105010|540828414|FG000|Overall Study|Lost to Follow-up|0|||
149917050|NCT04105010|540828415|FG001|Overall Study|Lost to Follow-up|0|||
149917051|NCT04105010|540828416|FG002|Overall Study|Lost to Follow-up|0|||
149917052|NCT04105010|540828417|FG003|Overall Study|Lost to Follow-up|4|||
149917053|NCT04105010|540828414|FG000|Overall Study|Withdrawal by Subject|8|||
149917054|NCT04105010|540828415|FG001|Overall Study|Withdrawal by Subject|1|||
149917055|NCT04105010|540828416|FG002|Overall Study|Withdrawal by Subject|1|||
149917056|NCT04105010|540828417|FG003|Overall Study|Withdrawal by Subject|4|||
149917057|NCT04105010|540828414|FG000|Overall Study|Other reason|4|||
149917058|NCT04105010|540828415|FG001|Overall Study|Other reason|7|||
149917059|NCT04105010|540828416|FG002|Overall Study|Other reason|0|||
149917060|NCT04105010|540828417|FG003|Overall Study|Other reason|19|||
149917061|NCT01211483|540828418|FG000|Phase 1b|Death|6|||
149917062|NCT01211483|540828419|FG001|Phase 1b|Death|0|||
149917063|NCT01211483|540828420|FG002|Phase 1b|Death|0|||
149917064|NCT01211483|540828421|FG003|Phase 1b|Death|0|||
149917065|NCT01211483|540828418|FG000|Phase 1b|Withdrawal by Subject|1|||
149917066|NCT01211483|540828419|FG001|Phase 1b|Withdrawal by Subject|0|||
149917067|NCT01211483|540828420|FG002|Phase 1b|Withdrawal by Subject|0|||
149917068|NCT01211483|540828421|FG003|Phase 1b|Withdrawal by Subject|0|||
149917069|NCT01211483|540828418|FG000|Phase 2|Lost to Follow-up|0|||
149917070|NCT01211483|540828419|FG001|Phase 2|Lost to Follow-up|1|||
149917071|NCT01211483|540828420|FG002|Phase 2|Lost to Follow-up|1|||
149917072|NCT01211483|540828421|FG003|Phase 2|Lost to Follow-up|2|||
149917073|NCT01211483|540828418|FG000|Phase 2|Death|0|||
149917074|NCT01211483|540828419|FG001|Phase 2|Death|64|||
149917075|NCT01211483|540828420|FG002|Phase 2|Death|53|||
149917076|NCT01211483|540828421|FG003|Phase 2|Death|53|||
149917077|NCT01211483|540828418|FG000|Phase 2|Withdrawal by Subject|0|||
149917078|NCT01211483|540828419|FG001|Phase 2|Withdrawal by Subject|1|||
149917079|NCT01211483|540828420|FG002|Phase 2|Withdrawal by Subject|10|||
149917080|NCT01211483|540828421|FG003|Phase 2|Withdrawal by Subject|5|||
149917081|NCT01211483|540828418|FG000|Phase 2|Study terminated by Sponsor|0|||
149917082|NCT01211483|540828419|FG001|Phase 2|Study terminated by Sponsor|6|||
149917083|NCT01211483|540828420|FG002|Phase 2|Study terminated by Sponsor|8|||
149917084|NCT01211483|540828421|FG003|Phase 2|Study terminated by Sponsor|11|||
149917085|NCT00427999|540828426|FG000|Overall Study|Adverse Event|6|||
149917086|NCT00427999|540828426|FG000|Overall Study|Abnormal laboratory values|1|||
149917087|NCT00427999|540828426|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
149917088|NCT00427999|540828426|FG000|Overall Study|Protocol Violation|2|||
149917089|NCT00427999|540828426|FG000|Overall Study|Withdrawal by Subject|9|||
149917090|NCT00427999|540828426|FG000|Overall Study|Death|1|||
149917091|NCT02284568|540828427|FG000|Overall Study|Adverse Event|2|||
149917092|NCT02284568|540828428|FG001|Overall Study|Adverse Event|9|||
149917093|NCT02284568|540828429|FG002|Overall Study|Adverse Event|4|||
149917094|NCT02284568|540828427|FG000|Overall Study|Withdrawal by Subject|22|||
149917095|NCT02284568|540828428|FG001|Overall Study|Withdrawal by Subject|21|||
149917096|NCT02284568|540828429|FG002|Overall Study|Withdrawal by Subject|1|||
149917097|NCT02284568|540828427|FG000|Overall Study|Noncompliance with study drug admin|1|||
149917098|NCT02284568|540828428|FG001|Overall Study|Noncompliance with study drug admin|2|||
149917099|NCT02284568|540828429|FG002|Overall Study|Noncompliance with study drug admin|0|||
149917100|NCT02284568|540828427|FG000|Overall Study|Noncompliance|1|||
149917101|NCT02284568|540828428|FG001|Overall Study|Noncompliance|0|||
149917102|NCT02284568|540828429|FG002|Overall Study|Noncompliance|0|||
149917103|NCT02284568|540828427|FG000|Overall Study|Protocol Violation|0|||
149917104|NCT02284568|540828428|FG001|Overall Study|Protocol Violation|1|||
149917105|NCT02284568|540828429|FG002|Overall Study|Protocol Violation|0|||
149917106|NCT02284568|540828427|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
149917107|NCT02284568|540828428|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
149917108|NCT02284568|540828429|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
149917109|NCT02284568|540828427|FG000|Overall Study|Lost to Follow-up|0|||
149917110|NCT02284568|540828428|FG001|Overall Study|Lost to Follow-up|3|||
149917111|NCT02284568|540828429|FG002|Overall Study|Lost to Follow-up|0|||
149917112|NCT02284568|540828427|FG000|Overall Study|Lack of Efficacy|4|||
149917113|NCT02284568|540828428|FG001|Overall Study|Lack of Efficacy|7|||
149917114|NCT02284568|540828429|FG002|Overall Study|Lack of Efficacy|0|||
149917115|NCT02284568|540828427|FG000|Overall Study|Other|1|||
149917116|NCT02284568|540828428|FG001|Overall Study|Other|2|||
149917117|NCT02284568|540828429|FG002|Overall Study|Other|0|||
149917118|NCT02284568|540828427|FG000|Overall Study|Withdrew before taking study drug|0|||
149917119|NCT02284568|540828428|FG001|Overall Study|Withdrew before taking study drug|1|||
149917120|NCT02284568|540828429|FG002|Overall Study|Withdrew before taking study drug|0|||
149917121|NCT00460265|540828430|FG000|Overall Study|Lost to Follow-up|14|||
149917122|NCT00460265|540828431|FG001|Overall Study|Lost to Follow-up|15|||
149917123|NCT00460265|540828430|FG000|Overall Study|Physician Decision|1|||
149917124|NCT00460265|540828431|FG001|Overall Study|Physician Decision|2|||
149917125|NCT00460265|540828430|FG000|Overall Study|Withdrawal by Subject|10|||
149917126|NCT00460265|540828431|FG001|Overall Study|Withdrawal by Subject|25|||
149917127|NCT00460265|540828430|FG000|Overall Study|Ongoing|60|||
149917128|NCT00460265|540828431|FG001|Overall Study|Ongoing|47|||
149917129|NCT03209518|540828432|FG000|Overall Study|Case Report Forms Uncollected|1|||
149917130|NCT03209518|540828432|FG000|Overall Study|Protocol Deviation|1|||
149917131|NCT01832818|540828433|FG000|Overall Study|Lost to Follow-up|6|||
149917132|NCT00236899|540828434|FG000|Overall Study|Adverse Event (Study Related)|1|||
149917133|NCT00236899|540828435|FG001|Overall Study|Adverse Event (Study Related)|1|||
149917134|NCT00236899|540828436|FG002|Overall Study|Adverse Event (Study Related)|2|||
149917135|NCT00236899|540828437|FG003|Overall Study|Adverse Event (Study Related)|1|||
149917136|NCT00236899|540828434|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
149917137|NCT00236899|540828435|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
149917138|NCT00236899|540828436|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
149917139|NCT00236899|540828437|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
149917140|NCT00236899|540828434|FG000|Overall Study|Death (Study Disease)|1|||
149917141|NCT00236899|540828435|FG001|Overall Study|Death (Study Disease)|4|||
149917142|NCT00236899|540828436|FG002|Overall Study|Death (Study Disease)|0|||
149917143|NCT00236899|540828437|FG003|Overall Study|Death (Study Disease)|0|||
149917144|NCT00236899|540828434|FG000|Overall Study|Death (Not Study Related)|2|||
149917145|NCT00236899|540828435|FG001|Overall Study|Death (Not Study Related)|0|||
149917146|NCT00236899|540828436|FG002|Overall Study|Death (Not Study Related)|0|||
149917147|NCT00236899|540828437|FG003|Overall Study|Death (Not Study Related)|0|||
149917148|NCT00236899|540828434|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
149917149|NCT00236899|540828435|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
149917150|NCT00236899|540828436|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
149917151|NCT00236899|540828437|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
149917152|NCT00236899|540828434|FG000|Overall Study|Lost to Follow-up|0|||
149917153|NCT00236899|540828435|FG001|Overall Study|Lost to Follow-up|1|||
149917154|NCT00236899|540828436|FG002|Overall Study|Lost to Follow-up|0|||
149917155|NCT00236899|540828437|FG003|Overall Study|Lost to Follow-up|0|||
149917156|NCT00236899|540828434|FG000|Overall Study|Entry Criteria Exclusion|0|||
149917157|NCT00236899|540828435|FG001|Overall Study|Entry Criteria Exclusion|1|||
149917158|NCT00236899|540828436|FG002|Overall Study|Entry Criteria Exclusion|1|||
149917159|NCT00236899|540828437|FG003|Overall Study|Entry Criteria Exclusion|0|||
149917160|NCT00236899|540828434|FG000|Overall Study|Protocol Violation|1|||
149917161|NCT00236899|540828435|FG001|Overall Study|Protocol Violation|0|||
149917162|NCT00236899|540828436|FG002|Overall Study|Protocol Violation|0|||
149917163|NCT00236899|540828437|FG003|Overall Study|Protocol Violation|0|||
149917164|NCT00236899|540828434|FG000|Overall Study|Withdrawal by Subject|6|||
149917165|NCT00236899|540828435|FG001|Overall Study|Withdrawal by Subject|4|||
149917166|NCT00236899|540828436|FG002|Overall Study|Withdrawal by Subject|5|||
149917167|NCT00236899|540828437|FG003|Overall Study|Withdrawal by Subject|2|||
149917168|NCT00236899|540828434|FG000|Overall Study|Physician Decision|7|||
149917169|NCT00236899|540828435|FG001|Overall Study|Physician Decision|8|||
149917170|NCT00236899|540828436|FG002|Overall Study|Physician Decision|7|||
149917171|NCT00236899|540828437|FG003|Overall Study|Physician Decision|6|||
149917172|NCT00236899|540828434|FG000|Overall Study|Satisfactory Response|2|||
149917173|NCT00236899|540828435|FG001|Overall Study|Satisfactory Response|0|||
149917174|NCT00236899|540828436|FG002|Overall Study|Satisfactory Response|0|||
149917175|NCT00236899|540828437|FG003|Overall Study|Satisfactory Response|1|||
149917176|NCT00236899|540828434|FG000|Overall Study|Lack of Efficacy|18|||
149917177|NCT00236899|540828435|FG001|Overall Study|Lack of Efficacy|18|||
149917178|NCT00236899|540828436|FG002|Overall Study|Lack of Efficacy|25|||
149917179|NCT00236899|540828437|FG003|Overall Study|Lack of Efficacy|23|||
149917180|NCT02854605|540828438|FG000|Overall Study|Adverse Event|1|||
149917181|NCT02854605|540828439|FG001|Overall Study|Adverse Event|5|||
149917182|NCT02854605|540828440|FG002|Overall Study|Adverse Event|2|||
149917183|NCT02854605|540828438|FG000|Overall Study|Lost to Follow-up|0|||
149917184|NCT02854605|540828439|FG001|Overall Study|Lost to Follow-up|2|||
149917185|NCT02854605|540828440|FG002|Overall Study|Lost to Follow-up|0|||
149917186|NCT02854605|540828438|FG000|Overall Study|Withdrew Consent|1|||
149917187|NCT02854605|540828439|FG001|Overall Study|Withdrew Consent|0|||
149917188|NCT02854605|540828440|FG002|Overall Study|Withdrew Consent|1|||
149917189|NCT02854605|540828438|FG000|Overall Study|Investigator's Discretion|1|||
149917190|NCT02854605|540828439|FG001|Overall Study|Investigator's Discretion|0|||
149917191|NCT02854605|540828440|FG002|Overall Study|Investigator's Discretion|0|||
149917192|NCT02854605|540828438|FG000|Overall Study|Protocol Violation|0|||
149917193|NCT02854605|540828439|FG001|Overall Study|Protocol Violation|0|||
149917194|NCT02854605|540828440|FG002|Overall Study|Protocol Violation|1|||
149917195|NCT00568334|540828441|FG000|Overall Study|Withdrawal by Subject|0|||
149917196|NCT00568334|540828442|FG001|Overall Study|Withdrawal by Subject|1|||
149917197|NCT00568334|540828441|FG000|Overall Study|Lost to Follow-up|1|||
149917198|NCT00568334|540828442|FG001|Overall Study|Lost to Follow-up|0|||
149917199|NCT01897571|540828443|FG000|Overall Study|Lost to Follow-up|3|||
149917200|NCT01897571|540828444|FG001|Overall Study|Lost to Follow-up|0|||
149917201|NCT01897571|540828445|FG002|Overall Study|Lost to Follow-up|0|||
149917202|NCT01897571|540828446|FG003|Overall Study|Lost to Follow-up|0|||
149917203|NCT01897571|540828447|FG004|Overall Study|Lost to Follow-up|2|||
149917204|NCT01897571|540828448|FG005|Overall Study|Lost to Follow-up|0|||
149917205|NCT01897571|540828449|FG006|Overall Study|Lost to Follow-up|0|||
149917206|NCT01897571|540828450|FG007|Overall Study|Lost to Follow-up|0|||
149917207|NCT01897571|540828451|FG008|Overall Study|Lost to Follow-up|1|||
149917208|NCT01897571|540828452|FG009|Overall Study|Lost to Follow-up|2|||
149917209|NCT01897571|540828453|FG010|Overall Study|Lost to Follow-up|4|||
149917210|NCT01897571|540828443|FG000|Overall Study|Withdrawal by Subject|0|||
149917211|NCT01897571|540828444|FG001|Overall Study|Withdrawal by Subject|0|||
149917212|NCT01897571|540828445|FG002|Overall Study|Withdrawal by Subject|0|||
149917213|NCT01897571|540828446|FG003|Overall Study|Withdrawal by Subject|0|||
149917214|NCT01897571|540828447|FG004|Overall Study|Withdrawal by Subject|0|||
149917215|NCT01897571|540828448|FG005|Overall Study|Withdrawal by Subject|0|||
149917216|NCT01897571|540828449|FG006|Overall Study|Withdrawal by Subject|0|||
149917217|NCT01897571|540828450|FG007|Overall Study|Withdrawal by Subject|1|||
149917218|NCT01897571|540828451|FG008|Overall Study|Withdrawal by Subject|4|||
149917219|NCT01897571|540828452|FG009|Overall Study|Withdrawal by Subject|3|||
149917220|NCT01897571|540828453|FG010|Overall Study|Withdrawal by Subject|1|||
149917221|NCT01897571|540828443|FG000|Overall Study|Other|1|||
149917222|NCT01897571|540828444|FG001|Overall Study|Other|0|||
149917223|NCT01897571|540828445|FG002|Overall Study|Other|0|||
149917224|NCT01897571|540828446|FG003|Overall Study|Other|3|||
149917225|NCT01897571|540828447|FG004|Overall Study|Other|3|||
149917226|NCT01897571|540828448|FG005|Overall Study|Other|4|||
149917227|NCT01897571|540828449|FG006|Overall Study|Other|7|||
149917228|NCT01897571|540828450|FG007|Overall Study|Other|0|||
149917229|NCT01897571|540828451|FG008|Overall Study|Other|0|||
149917230|NCT01897571|540828452|FG009|Overall Study|Other|0|||
149917231|NCT01897571|540828453|FG010|Overall Study|Other|0|||
149917232|NCT01897571|540828443|FG000|Overall Study|Enrolled in rollover study|0|||
149917233|NCT01897571|540828444|FG001|Overall Study|Enrolled in rollover study|0|||
149917234|NCT01897571|540828445|FG002|Overall Study|Enrolled in rollover study|0|||
149917235|NCT01897571|540828446|FG003|Overall Study|Enrolled in rollover study|0|||
149917236|NCT01897571|540828447|FG004|Overall Study|Enrolled in rollover study|0|||
149917237|NCT01897571|540828448|FG005|Overall Study|Enrolled in rollover study|0|||
149917238|NCT01897571|540828449|FG006|Overall Study|Enrolled in rollover study|0|||
149917239|NCT01897571|540828450|FG007|Overall Study|Enrolled in rollover study|9|||
149917240|NCT01897571|540828451|FG008|Overall Study|Enrolled in rollover study|7|||
149917241|NCT01897571|540828452|FG009|Overall Study|Enrolled in rollover study|9|||
149917242|NCT01897571|540828453|FG010|Overall Study|Enrolled in rollover study|1|||
149917243|NCT01897571|540828443|FG000|Overall Study|Death|2|||
149917244|NCT01897571|540828444|FG001|Overall Study|Death|2|||
149917245|NCT01897571|540828445|FG002|Overall Study|Death|3|||
149917246|NCT01897571|540828446|FG003|Overall Study|Death|6|||
149917247|NCT01897571|540828447|FG004|Overall Study|Death|7|||
149917248|NCT01897571|540828448|FG005|Overall Study|Death|9|||
149917249|NCT01897571|540828449|FG006|Overall Study|Death|5|||
149917250|NCT01897571|540828450|FG007|Overall Study|Death|22|||
149917251|NCT01897571|540828451|FG008|Overall Study|Death|23|||
149917252|NCT01897571|540828452|FG009|Overall Study|Death|129|||
149917253|NCT01897571|540828453|FG010|Overall Study|Death|59|||
149917254|NCT03217968|540828454|FG000|Overall Study|Withdrawal by Subject|4|||
149917255|NCT03217968|540828454|FG000|Overall Study|Lost to Follow-up|1|||
149917256|NCT03217968|540828454|FG000|Overall Study|Protocol Violation|6|||
149917257|NCT05268016|540828457|FG000|Overall Study|Unacceptable toxicity or AE|2|||
149917258|NCT05268016|540828458|FG001|Overall Study|Unacceptable toxicity or AE|2|||
149917259|NCT05268016|540828459|FG002|Overall Study|Unacceptable toxicity or AE|4|||
149917260|NCT05268016|540828460|FG003|Overall Study|Unacceptable toxicity or AE|3|||
149917261|NCT05268016|540828461|FG004|Overall Study|Unacceptable toxicity or AE|1|||
149917262|NCT05268016|540828457|FG000|Overall Study|Withdrawal by Subject|1|||
149917263|NCT05268016|540828458|FG001|Overall Study|Withdrawal by Subject|3|||
149917264|NCT05268016|540828459|FG002|Overall Study|Withdrawal by Subject|2|||
149917265|NCT05268016|540828460|FG003|Overall Study|Withdrawal by Subject|2|||
149917266|NCT05268016|540828461|FG004|Overall Study|Withdrawal by Subject|1|||
149917267|NCT05268016|540828457|FG000|Overall Study|Lost to Follow-up|4|||
149917268|NCT05268016|540828458|FG001|Overall Study|Lost to Follow-up|7|||
149917269|NCT05268016|540828459|FG002|Overall Study|Lost to Follow-up|1|||
149917270|NCT05268016|540828460|FG003|Overall Study|Lost to Follow-up|3|||
149917271|NCT05268016|540828461|FG004|Overall Study|Lost to Follow-up|5|||
149917272|NCT05268016|540828457|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
149917273|NCT05268016|540828458|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
149917274|NCT05268016|540828459|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
149917275|NCT05268016|540828460|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
149917276|NCT05268016|540828461|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
149917277|NCT05268016|540828457|FG000|Overall Study|Lack of Efficacy|0|||
149917278|NCT05268016|540828458|FG001|Overall Study|Lack of Efficacy|0|||
149917279|NCT05268016|540828459|FG002|Overall Study|Lack of Efficacy|0|||
149917280|NCT05268016|540828460|FG003|Overall Study|Lack of Efficacy|0|||
149917281|NCT05268016|540828461|FG004|Overall Study|Lack of Efficacy|4|||
149917282|NCT05268016|540828457|FG000|Overall Study|Physician Decision|0|||
149917283|NCT05268016|540828458|FG001|Overall Study|Physician Decision|0|||
149917284|NCT05268016|540828459|FG002|Overall Study|Physician Decision|0|||
149917285|NCT05268016|540828460|FG003|Overall Study|Physician Decision|1|||
149917286|NCT05268016|540828461|FG004|Overall Study|Physician Decision|0|||
149917287|NCT05268016|540828457|FG000|Overall Study|Other|1|||
149917288|NCT05268016|540828458|FG001|Overall Study|Other|0|||
149917289|NCT05268016|540828459|FG002|Overall Study|Other|1|||
149917290|NCT05268016|540828460|FG003|Overall Study|Other|2|||
149917291|NCT05268016|540828461|FG004|Overall Study|Other|0|||
149917292|NCT00821015|540828462|FG000|Overall Study|Lost to Follow-up|12|||
149917293|NCT03411902|540828467|FG000|Overall Study|Lost to Follow-up|3|||
149917294|NCT03411902|540828468|FG001|Overall Study|Lost to Follow-up|0|||
149917295|NCT00791492|540828469|FG000|Overall Study|Withdrawal by Subject|1|||
149917296|NCT00791492|540828470|FG001|Overall Study|Withdrawal by Subject|2|||
149917297|NCT00791492|540828469|FG000|Overall Study|Liver transplantation|5|||
149917298|NCT00791492|540828470|FG001|Overall Study|Liver transplantation|1|||
149917299|NCT00090987|540828472|FG000|Overall Study|Adverse Event|5|||
149917300|NCT00090987|540828472|FG000|Overall Study|Lack of Efficacy|7|||
149917301|NCT00090987|540828472|FG000|Overall Study|Withdrawal by Subject|3|||
149917302|NCT00090987|540828472|FG000|Overall Study|alternative therapy|1|||
150256640|NCT00686725|542074110|FG001|Overall Study|Death|3|||
149917303|NCT00090987|540828472|FG000|Overall Study|Non-compliance|4|||
149917304|NCT00090987|540828472|FG000|Overall Study|Incarcerated|1|||
149917305|NCT00990665|540828477|FG000|Overall Study|Unsuccessful Implant|8|||
149917306|NCT00990665|540828477|FG000|Overall Study|Death|29|||
149917307|NCT00990665|540828477|FG000|Overall Study|Heart Transplant|1|||
149917308|NCT00990665|540828477|FG000|Overall Study|Withdrawal by Subject|6|||
149917309|NCT00990665|540828477|FG000|Overall Study|Lost to Follow-up|1|||
149917310|NCT00990665|540828477|FG000|Overall Study|System Explant|3|||
149917311|NCT02603562|540828478|FG000|Overall Study|Lost to Follow-up|1|||
149917312|NCT00270231|540828479|FG000|First Intervention|Lost to Follow-up|1|||
149917313|NCT00270231|540828480|FG001|First Intervention|Lost to Follow-up|1|||
149917314|NCT00270231|540828479|FG000|Washout Period|Lost to Follow-up|1|||
149917315|NCT00270231|540828480|FG001|Washout Period|Lost to Follow-up|0|||
149917316|NCT00270231|540828479|FG000|Second Intervention|Lost to Follow-up|0|||
149917317|NCT00270231|540828480|FG001|Second Intervention|Lost to Follow-up|1|||
149917318|NCT01534208|540828484|FG000|Overall Study|Lost to Follow-up|19|||
149917319|NCT01534208|540828485|FG001|Overall Study|Lost to Follow-up|14|||
149917320|NCT01534208|540828484|FG000|Overall Study|Withdrawal by Subject|6|||
149917321|NCT01534208|540828485|FG001|Overall Study|Withdrawal by Subject|20|||
149917322|NCT01534208|540828484|FG000|Overall Study|Adverse Event|15|||
149917323|NCT01534208|540828485|FG001|Overall Study|Adverse Event|8|||
149917324|NCT01534208|540828484|FG000|Overall Study|Physician Decision|2|||
149917325|NCT01534208|540828485|FG001|Overall Study|Physician Decision|0|||
149917326|NCT01534208|540828484|FG000|Overall Study|Lack of Efficacy|0|||
149917327|NCT01534208|540828485|FG001|Overall Study|Lack of Efficacy|3|||
149917328|NCT01534208|540828484|FG000|Overall Study|Protocol Violation|2|||
149917329|NCT01534208|540828485|FG001|Overall Study|Protocol Violation|2|||
149917330|NCT01534208|540828484|FG000|Overall Study|Sponsor decision|4|||
149917331|NCT01534208|540828485|FG001|Overall Study|Sponsor decision|1|||
149917332|NCT01534208|540828484|FG000|Overall Study|Subject relocation|2|||
149917333|NCT01534208|540828485|FG001|Overall Study|Subject relocation|0|||
149917334|NCT01534208|540828484|FG000|Overall Study|Lab assessment|2|||
149917335|NCT01534208|540828485|FG001|Overall Study|Lab assessment|1|||
149917336|NCT01534208|540828484|FG000|Overall Study|Eligibility error|3|||
149917337|NCT01534208|540828485|FG001|Overall Study|Eligibility error|0|||
149917338|NCT01534208|540828484|FG000|Overall Study|PCP decision|1|||
149917339|NCT01534208|540828485|FG001|Overall Study|PCP decision|0|||
149917340|NCT01534208|540828484|FG000|Overall Study|Needed prohibited meds|1|||
149917341|NCT01534208|540828485|FG001|Overall Study|Needed prohibited meds|0|||
149917342|NCT00574795|540828495|FG000|Infant Series|Withdrawal by Subject|2|||
149917343|NCT00574795|540828495|FG000|Infant Series|Protocol Violation|2|||
149917344|NCT00574795|540828495|FG000|Infant Series|Adverse Event|1|||
149917345|NCT00574795|540828495|FG000|After Infant Series|Withdrawal by Subject|1|||
149917346|NCT00574795|540828495|FG000|After Infant Series|Adverse Event|2|||
149917347|NCT00574795|540828495|FG000|Toddler Dose|Withdrawal by Subject|1|||
149917348|NCT00672841|540828496|FG000|Overall Study|Comfort care|1|||
149917349|NCT00672841|540828497|FG001|Overall Study|Comfort care|4|||
149917350|NCT00672841|540828496|FG000|Overall Study|icteric specimens|0|||
149917351|NCT00672841|540828497|FG001|Overall Study|icteric specimens|3|||
149917352|NCT00672841|540828496|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
149917353|NCT00672841|540828497|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
149917354|NCT00672841|540828496|FG000|Overall Study|Adverse Event|0|||
149917355|NCT00672841|540828497|FG001|Overall Study|Adverse Event|3|||
149917356|NCT00672841|540828496|FG000|Overall Study|Pregnancy|0|||
149917357|NCT00672841|540828497|FG001|Overall Study|Pregnancy|1|||
149917358|NCT02638259|540828498|FG000|Treatment Period 1|Adverse Event|1|||
150256641|NCT00686725|542074109|FG000|Overall Study|Withdrawal by Subject|13|||
149917359|NCT02638259|540828499|FG001|Treatment Period 1|Adverse Event|5|||
149917360|NCT02638259|540828498|FG000|Treatment Period 1|Death|0|||
149917361|NCT02638259|540828499|FG001|Treatment Period 1|Death|1|||
149917362|NCT02638259|540828498|FG000|Treatment Period 1|Lack of Efficacy|0|||
149917363|NCT02638259|540828499|FG001|Treatment Period 1|Lack of Efficacy|1|||
149917364|NCT02638259|540828498|FG000|Treatment Period 1|Protocol Violation|0|||
149917365|NCT02638259|540828499|FG001|Treatment Period 1|Protocol Violation|3|||
149917366|NCT02638259|540828498|FG000|Treatment Period 1|Withdrawal by Subject|4|||
149917367|NCT02638259|540828499|FG001|Treatment Period 1|Withdrawal by Subject|6|||
149917368|NCT02638259|540828498|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
149917369|NCT02638259|540828499|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
149917370|NCT02638259|540828498|FG000|Treatment Period 2|Adverse Event|5|||
149917371|NCT02638259|540828499|FG001|Treatment Period 2|Adverse Event|4|||
149917372|NCT02638259|540828498|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149917373|NCT02638259|540828499|FG001|Treatment Period 2|Withdrawal by Subject|7|||
149917374|NCT03578146|540828501|FG000|Overall Study|Did Not Receive Treatment|1|||
149917375|NCT03578146|540828502|FG001|Overall Study|Did Not Receive Treatment|0|||
149917376|NCT03578146|540828503|FG002|Overall Study|Did Not Receive Treatment|0|||
149917377|NCT03578146|540828504|FG003|Overall Study|Did Not Receive Treatment|0|||
149917378|NCT03578146|540828505|FG004|Overall Study|Did Not Receive Treatment|0|||
149917379|NCT03578146|540828506|FG005|Overall Study|Did Not Receive Treatment|2|||
149917380|NCT03578146|540828501|FG000|Overall Study|Lost to Follow-up|0|||
149917381|NCT03578146|540828502|FG001|Overall Study|Lost to Follow-up|1|||
149917382|NCT03578146|540828503|FG002|Overall Study|Lost to Follow-up|1|||
149917383|NCT03578146|540828504|FG003|Overall Study|Lost to Follow-up|0|||
149917384|NCT03578146|540828505|FG004|Overall Study|Lost to Follow-up|0|||
149917385|NCT03578146|540828506|FG005|Overall Study|Lost to Follow-up|1|||
149917386|NCT04299048|540828507|FG000|Overall Study|Death|1|||
149917387|NCT04299048|540828507|FG000|Overall Study|Global deterioration of health status|2|||
149917388|NCT04299048|540828507|FG000|Overall Study|Enrolled and not treated|1|||
149917389|NCT01717391|540828508|FG000|Overall Study|Withdrawal by Subject|5|||
149917390|NCT01717391|540828508|FG000|Overall Study|Physician Decision|1|||
149917391|NCT01717391|540828508|FG000|Overall Study|FLT technical failure|3|||
149917392|NCT00106639|540828511|FG000|Overall Study|Adverse Event|3|||
149917393|NCT00106639|540828512|FG001|Overall Study|Adverse Event|4|||
149917394|NCT00106639|540828513|FG002|Overall Study|Adverse Event|1|||
149917395|NCT00106639|540828511|FG000|Overall Study|Protocol Violation|0|||
149917396|NCT00106639|540828512|FG001|Overall Study|Protocol Violation|1|||
149917397|NCT00106639|540828513|FG002|Overall Study|Protocol Violation|0|||
149917398|NCT00106639|540828511|FG000|Overall Study|Withdrawal by Subject|0|||
149917399|NCT00106639|540828512|FG001|Overall Study|Withdrawal by Subject|1|||
149917400|NCT00106639|540828513|FG002|Overall Study|Withdrawal by Subject|0|||
149917401|NCT00106639|540828511|FG000|Overall Study|Participant defaulted|0|||
149917402|NCT00106639|540828512|FG001|Overall Study|Participant defaulted|1|||
149917403|NCT00106639|540828513|FG002|Overall Study|Participant defaulted|1|||
149917404|NCT01876979|540828514|FG000|Overall Study|Physician Decision|2|||
149917405|NCT01876979|540828515|FG001|Overall Study|Physician Decision|3|||
149917406|NCT01096589|540828516|FG000|Overall Study|Adverse Event|2|||
149917407|NCT01096589|540828517|FG001|Overall Study|Adverse Event|1|||
149917408|NCT01096589|540828518|FG002|Overall Study|Adverse Event|2|||
149917409|NCT01096589|540828519|FG003|Overall Study|Adverse Event|1|||
149917410|NCT01096589|540828516|FG000|Overall Study|Withdrawal by Subject|2|||
149917411|NCT01096589|540828517|FG001|Overall Study|Withdrawal by Subject|1|||
149917412|NCT01096589|540828518|FG002|Overall Study|Withdrawal by Subject|1|||
149917413|NCT01096589|540828519|FG003|Overall Study|Withdrawal by Subject|1|||
149917414|NCT01096589|540828516|FG000|Overall Study|Compliance with protocol|0|||
149917415|NCT01096589|540828517|FG001|Overall Study|Compliance with protocol|0|||
149917416|NCT01096589|540828518|FG002|Overall Study|Compliance with protocol|1|||
149917417|NCT01096589|540828519|FG003|Overall Study|Compliance with protocol|0|||
149917418|NCT01096589|540828516|FG000|Overall Study|found treatment exhausting|0|||
149917419|NCT01096589|540828517|FG001|Overall Study|found treatment exhausting|0|||
149917420|NCT01096589|540828518|FG002|Overall Study|found treatment exhausting|0|||
149917421|NCT01096589|540828519|FG003|Overall Study|found treatment exhausting|1|||
149917422|NCT00232596|540828521|FG000|6-Week Titration Phase|Adverse Event|6|||
149917423|NCT00232596|540828522|FG001|6-Week Titration Phase|Adverse Event|19|||
149917424|NCT00232596|540828521|FG000|6-Week Titration Phase|Failed to Return|2|||
149917425|NCT00232596|540828522|FG001|6-Week Titration Phase|Failed to Return|1|||
149917426|NCT00232596|540828521|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
149917427|NCT00232596|540828522|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
149917428|NCT00232596|540828521|FG000|6-Week Titration Phase|Protocol Violation|1|||
149917429|NCT00232596|540828522|FG001|6-Week Titration Phase|Protocol Violation|3|||
149917430|NCT00232596|540828521|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
149917431|NCT00232596|540828522|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
149917432|NCT00232596|540828521|FG000|6-Week Titration Phase|Other|3|||
149917433|NCT00232596|540828522|FG001|6-Week Titration Phase|Other|3|||
149917434|NCT00232596|540828521|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
149917435|NCT00232596|540828522|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
149917436|NCT00232596|540828521|FG000|12-Week Maintenance Phase|Adverse Event|7|||
149917437|NCT00232596|540828522|FG001|12-Week Maintenance Phase|Adverse Event|22|||
149917438|NCT00232596|540828521|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
149917439|NCT00232596|540828522|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
149917440|NCT00232596|540828521|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
149917441|NCT00232596|540828522|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
149917442|NCT00232596|540828521|FG000|12-Week Maintenance Phase|Other|1|||
149917443|NCT00232596|540828522|FG001|12-Week Maintenance Phase|Other|3|||
149917444|NCT01712334|540828523|FG000|Treatment Period 1|Randomized in Error|0|||
149917445|NCT01712334|540828524|FG001|Treatment Period 1|Randomized in Error|2|||
149917446|NCT01253174|540828525|FG000|Period 1|Randomized but not treated|0|||
149917447|NCT01253174|540828526|FG001|Period 1|Randomized but not treated|1|||
149917448|NCT01253174|540828527|FG002|Period 1|Randomized but not treated|1|||
149917449|NCT01253174|540828528|FG003|Period 1|Randomized but not treated|0|||
149917450|NCT01253174|540828529|FG004|Period 1|Randomized but not treated|1|||
149917451|NCT01253174|540828530|FG005|Period 1|Randomized but not treated|0|||
149917452|NCT01253174|540828525|FG000|Period 2|Adverse Event|0|||
149917453|NCT01253174|540828526|FG001|Period 2|Adverse Event|0|||
149917454|NCT01253174|540828527|FG002|Period 2|Adverse Event|1|||
149917455|NCT01253174|540828528|FG003|Period 2|Adverse Event|0|||
149917456|NCT01253174|540828529|FG004|Period 2|Adverse Event|0|||
149917457|NCT01253174|540828530|FG005|Period 2|Adverse Event|0|||
149917458|NCT01253174|540828525|FG000|Period 3|Withdrawal by Subject|0|||
149917459|NCT01253174|540828526|FG001|Period 3|Withdrawal by Subject|1|||
149917460|NCT01253174|540828527|FG002|Period 3|Withdrawal by Subject|0|||
149917461|NCT01253174|540828528|FG003|Period 3|Withdrawal by Subject|0|||
149917462|NCT01253174|540828529|FG004|Period 3|Withdrawal by Subject|1|||
149917463|NCT01253174|540828530|FG005|Period 3|Withdrawal by Subject|0|||
149917464|NCT01253174|540828525|FG000|Period 3|Pregnancy|0|||
149917465|NCT01253174|540828526|FG001|Period 3|Pregnancy|0|||
149917466|NCT01253174|540828527|FG002|Period 3|Pregnancy|1|||
149917467|NCT01253174|540828528|FG003|Period 3|Pregnancy|0|||
149917468|NCT01253174|540828529|FG004|Period 3|Pregnancy|0|||
149917469|NCT01253174|540828530|FG005|Period 3|Pregnancy|0|||
149917470|NCT02919267|540828531|FG000|Overall Study|Protocol Violation|0|||
149917471|NCT02919267|540828532|FG001|Overall Study|Protocol Violation|3|||
149917472|NCT02919267|540828533|FG002|Overall Study|Protocol Violation|3|||
149917473|NCT02919267|540828534|FG003|Overall Study|Protocol Violation|4|||
149917474|NCT03467763|540828535|FG000|Overall Study|Lost to Follow-up|1|||
149917475|NCT03467763|540828535|FG000|Overall Study|Protocol Violation|2|||
149917476|NCT00932698|540828538|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
149917477|NCT00932698|540828539|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
149917478|NCT00932698|540828540|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
149917479|NCT00932698|540828541|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
149917480|NCT00932698|540828542|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
149917481|NCT00932698|540828543|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
149917482|NCT00932698|540828544|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
149917483|NCT00932698|540828545|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
149917484|NCT00932698|540828546|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
149917485|NCT00932698|540828547|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
149917486|NCT00932698|540828548|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
149917487|NCT00932698|540828538|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917488|NCT00932698|540828539|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
149917489|NCT00932698|540828540|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917490|NCT00932698|540828541|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
149917491|NCT00932698|540828542|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917492|NCT00932698|540828543|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
149917493|NCT00932698|540828544|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
149917494|NCT00932698|540828545|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917495|NCT00932698|540828546|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917496|NCT00932698|540828547|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917497|NCT00932698|540828548|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
149917498|NCT00932698|540828538|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
149917499|NCT00932698|540828539|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
149917500|NCT00932698|540828540|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
149917501|NCT00932698|540828541|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
149917502|NCT00932698|540828542|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
149917503|NCT00932698|540828543|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
149917504|NCT00932698|540828544|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
149917505|NCT00932698|540828545|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
149917506|NCT00932698|540828546|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
149917507|NCT00932698|540828547|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
149917508|NCT00932698|540828548|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
149917509|NCT00932698|540828538|FG000|Part 1 (Dose Escalation)|Other|0|||
149917510|NCT00932698|540828539|FG001|Part 1 (Dose Escalation)|Other|0|||
149917511|NCT00932698|540828540|FG002|Part 1 (Dose Escalation)|Other|1|||
149917512|NCT00932698|540828541|FG003|Part 1 (Dose Escalation)|Other|0|||
149917513|NCT00932698|540828542|FG004|Part 1 (Dose Escalation)|Other|0|||
149917514|NCT00932698|540828543|FG005|Part 1 (Dose Escalation)|Other|0|||
149917515|NCT00932698|540828544|FG006|Part 1 (Dose Escalation)|Other|1|||
149917516|NCT00932698|540828545|FG007|Part 1 (Dose Escalation)|Other|0|||
149917517|NCT00932698|540828546|FG008|Part 1 (Dose Escalation)|Other|0|||
149917518|NCT00932698|540828547|FG009|Part 1 (Dose Escalation)|Other|0|||
149917519|NCT00932698|540828548|FG010|Part 1 (Dose Escalation)|Other|0|||
149917520|NCT00932698|540828538|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917521|NCT00932698|540828539|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917522|NCT00932698|540828540|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917523|NCT00932698|540828541|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917524|NCT00932698|540828542|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917525|NCT00932698|540828543|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917526|NCT00932698|540828544|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
149917527|NCT00932698|540828545|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
149917528|NCT00932698|540828546|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
149917529|NCT00932698|540828547|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
149917530|NCT00932698|540828548|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
149917531|NCT00932698|540828538|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917532|NCT00932698|540828539|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917533|NCT00932698|540828540|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917534|NCT00932698|540828541|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917535|NCT00932698|540828542|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917536|NCT00932698|540828543|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917537|NCT00932698|540828544|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917538|NCT00932698|540828545|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
149917539|NCT00932698|540828546|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
149917540|NCT00932698|540828547|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
149917541|NCT00932698|540828548|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
149917542|NCT00932698|540828538|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
149917543|NCT00932698|540828539|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
149917544|NCT00932698|540828540|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
149917545|NCT00932698|540828541|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
149917546|NCT00932698|540828542|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
149917547|NCT00932698|540828543|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
149917548|NCT00932698|540828544|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
149917549|NCT00932698|540828545|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
150256642|NCT00686725|542074110|FG001|Overall Study|Withdrawal by Subject|4|||
149917550|NCT00932698|540828546|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
149917551|NCT00932698|540828547|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
149917552|NCT00932698|540828548|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
149917553|NCT04608344|540828549|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
149917554|NCT04608344|540828550|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
149917555|NCT04608344|540828549|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
149917556|NCT04608344|540828550|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
150256643|NCT00686725|542074109|FG000|Overall Study|Protocol Violation|1|||
150256644|NCT00686725|542074110|FG001|Overall Study|Protocol Violation|3|||
149917557|NCT00131365|540828551|FG000|Overall Study|Withdrawal by Subject|1|||
149917558|NCT00131365|540828551|FG000|Overall Study|Alternative treatment|3|||
149917559|NCT05249127|540828552|FG000|Overall Study|Protocol Violation|13|||
149917560|NCT05249127|540828552|FG000|Overall Study|Physician Decision|4|||
149917561|NCT05249127|540828552|FG000|Overall Study|Withdrawal by Subject|2|||
149917562|NCT05249127|540828552|FG000|Overall Study|Participant Non-compliance|1|||
149917563|NCT02908074|540828553|FG000|Overall Study|sponsor/ICON decision|0|||
149917564|NCT02908074|540828554|FG001|Overall Study|sponsor/ICON decision|0|||
149917565|NCT02908074|540828555|FG002|Overall Study|sponsor/ICON decision|1|||
149917566|NCT02908074|540828556|FG003|Overall Study|sponsor/ICON decision|0|||
149917567|NCT02908074|540828557|FG004|Overall Study|sponsor/ICON decision|0|||
149917568|NCT02908074|540828558|FG005|Overall Study|sponsor/ICON decision|0|||
149917569|NCT02908074|540828553|FG000|Overall Study|Protocol Violation|0|||
149917570|NCT02908074|540828554|FG001|Overall Study|Protocol Violation|1|||
149917571|NCT02908074|540828555|FG002|Overall Study|Protocol Violation|0|||
149917572|NCT02908074|540828556|FG003|Overall Study|Protocol Violation|0|||
149917573|NCT02908074|540828557|FG004|Overall Study|Protocol Violation|0|||
149917574|NCT02908074|540828558|FG005|Overall Study|Protocol Violation|0|||
149917575|NCT02908074|540828553|FG000|Overall Study|Adverse Event|5|||
149917576|NCT02908074|540828554|FG001|Overall Study|Adverse Event|2|||
149917577|NCT02908074|540828555|FG002|Overall Study|Adverse Event|0|||
149917578|NCT02908074|540828556|FG003|Overall Study|Adverse Event|0|||
149917579|NCT02908074|540828557|FG004|Overall Study|Adverse Event|1|||
149917580|NCT02908074|540828558|FG005|Overall Study|Adverse Event|0|||
149917581|NCT02908074|540828553|FG000|Overall Study|AESI|1|||
149917582|NCT02908074|540828554|FG001|Overall Study|AESI|0|||
149917583|NCT02908074|540828555|FG002|Overall Study|AESI|1|||
149917584|NCT02908074|540828556|FG003|Overall Study|AESI|0|||
149917585|NCT02908074|540828557|FG004|Overall Study|AESI|1|||
149917586|NCT02908074|540828558|FG005|Overall Study|AESI|0|||
149917587|NCT02908074|540828553|FG000|Overall Study|Discontinuation criteria per protocol|0|||
149917588|NCT02908074|540828554|FG001|Overall Study|Discontinuation criteria per protocol|0|||
149917589|NCT02908074|540828555|FG002|Overall Study|Discontinuation criteria per protocol|1|||
149917590|NCT02908074|540828556|FG003|Overall Study|Discontinuation criteria per protocol|0|||
149917591|NCT02908074|540828557|FG004|Overall Study|Discontinuation criteria per protocol|0|||
149917592|NCT02908074|540828558|FG005|Overall Study|Discontinuation criteria per protocol|1|||
149917593|NCT02908074|540828553|FG000|Overall Study|Withdrawal by Subject|3|||
149917594|NCT02908074|540828554|FG001|Overall Study|Withdrawal by Subject|2|||
149917595|NCT02908074|540828555|FG002|Overall Study|Withdrawal by Subject|2|||
149917596|NCT02908074|540828556|FG003|Overall Study|Withdrawal by Subject|2|||
149917597|NCT02908074|540828557|FG004|Overall Study|Withdrawal by Subject|2|||
149917598|NCT02908074|540828558|FG005|Overall Study|Withdrawal by Subject|2|||
149917599|NCT02908074|540828553|FG000|Overall Study|Lost to Follow-up|0|||
149917600|NCT02908074|540828554|FG001|Overall Study|Lost to Follow-up|1|||
149917601|NCT02908074|540828555|FG002|Overall Study|Lost to Follow-up|1|||
149917602|NCT02908074|540828556|FG003|Overall Study|Lost to Follow-up|1|||
149917603|NCT02908074|540828557|FG004|Overall Study|Lost to Follow-up|0|||
149917604|NCT02908074|540828558|FG005|Overall Study|Lost to Follow-up|1|||
149917605|NCT02073565|540828559|FG000|Cohort A|Withdrawal by Subject|1|||
149917606|NCT02073565|540828560|FG001|Cohort A|Withdrawal by Subject|0|||
149917607|NCT02073565|540828559|FG000|Cohort B|Withdrawal by Subject|1|||
149917608|NCT02073565|540828560|FG001|Cohort B|Withdrawal by Subject|2|||
149917609|NCT02073565|540828559|FG000|Cohort C|Withdrawal by Subject|0|||
149917610|NCT02073565|540828560|FG001|Cohort C|Withdrawal by Subject|2|||
149917611|NCT02073565|540828559|FG000|Cohort C|Lost to Follow-up|0|||
149917612|NCT02073565|540828560|FG001|Cohort C|Lost to Follow-up|2|||
149917613|NCT02227368|540830269|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
149917614|NCT02227368|540830270|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
149917615|NCT02227368|540830269|FG000|Overall Study|Lost to Follow-up|1|||
149917616|NCT02227368|540830270|FG001|Overall Study|Lost to Follow-up|0|||
149917617|NCT02227368|540830269|FG000|Overall Study|Adverse Event|1|||
149917618|NCT02227368|540830270|FG001|Overall Study|Adverse Event|0|||
149917619|NCT06226649|540830283|FG000|Overall Study|Withdrawal by Subject|4|||
149917620|NCT06226649|540830284|FG001|Overall Study|Withdrawal by Subject|1|||
149917621|NCT02614131|540830297|FG000|Overall Study|Withdrawal by Subject|1|||
149917622|NCT02614131|540830298|FG001|Overall Study|Withdrawal by Subject|0|||
149917623|NCT02614131|540830299|FG002|Overall Study|Withdrawal by Subject|0|||
149917624|NCT02614131|540830300|FG003|Overall Study|Withdrawal by Subject|0|||
149917625|NCT02614131|540830301|FG004|Overall Study|Withdrawal by Subject|0|||
149917626|NCT02614131|540830302|FG005|Overall Study|Withdrawal by Subject|0|||
149917627|NCT02614131|540830303|FG006|Overall Study|Withdrawal by Subject|0|||
149917628|NCT02614131|540830297|FG000|Overall Study|Adverse Event|0|||
149917629|NCT02614131|540830298|FG001|Overall Study|Adverse Event|0|||
149917630|NCT02614131|540830299|FG002|Overall Study|Adverse Event|0|||
149917631|NCT02614131|540830300|FG003|Overall Study|Adverse Event|0|||
149917632|NCT02614131|540830301|FG004|Overall Study|Adverse Event|0|||
149917633|NCT02614131|540830302|FG005|Overall Study|Adverse Event|0|||
149917634|NCT02614131|540830303|FG006|Overall Study|Adverse Event|1|||
149917635|NCT02603107|540830304|FG000|Randomized Phase|Withdrew consent|8|||
149917636|NCT02603107|540830305|FG001|Randomized Phase|Withdrew consent|15|||
149917637|NCT02603107|540830304|FG000|Randomized Phase|Lost to Follow-up|1|||
149917638|NCT02603107|540830305|FG001|Randomized Phase|Lost to Follow-up|3|||
149917639|NCT02603107|540830304|FG000|Randomized Phase|Adverse Event|2|||
149917640|NCT02603107|540830305|FG001|Randomized Phase|Adverse Event|0|||
149917641|NCT02603107|540830304|FG000|Randomized Phase|Death|1|||
149917642|NCT02603107|540830305|FG001|Randomized Phase|Death|1|||
149917643|NCT02603107|540830304|FG000|Randomized Phase|Non-compliance with study drug|1|||
149917644|NCT02603107|540830305|FG001|Randomized Phase|Non-compliance with study drug|1|||
149917645|NCT02603107|540830304|FG000|Randomized Phase|Investigator's discretion|0|||
149917646|NCT02603107|540830305|FG001|Randomized Phase|Investigator's discretion|1|||
149917647|NCT02603107|540830304|FG000|Randomized Phase|Lack of Efficacy|1|||
149917648|NCT02603107|540830305|FG001|Randomized Phase|Lack of Efficacy|0|||
149917649|NCT02603107|540830304|FG000|Randomized Phase|Protocol Violation|1|||
149917650|NCT02603107|540830305|FG001|Randomized Phase|Protocol Violation|0|||
149917651|NCT02603107|540830304|FG000|Optional Extension Phase|Lost to Follow-up|3|||
149917652|NCT02603107|540830305|FG001|Optional Extension Phase|Lost to Follow-up|3|||
149917653|NCT02603107|540830304|FG000|Optional Extension Phase|Withdrew consent|3|||
149917654|NCT02603107|540830305|FG001|Optional Extension Phase|Withdrew consent|2|||
149917655|NCT02603107|540830304|FG000|Optional Extension Phase|Investigator's discretion|2|||
149917656|NCT02603107|540830305|FG001|Optional Extension Phase|Investigator's discretion|2|||
149917657|NCT02603107|540830304|FG000|Optional Extension Phase|Pregnancy|0|||
149917658|NCT02603107|540830305|FG001|Optional Extension Phase|Pregnancy|3|||
149917659|NCT02603107|540830304|FG000|Optional Extension Phase|Adverse Event|0|||
149917660|NCT02603107|540830305|FG001|Optional Extension Phase|Adverse Event|2|||
149917661|NCT02603107|540830304|FG000|Optional Extension Phase|Not treated in extension phase|0|||
149917662|NCT02603107|540830305|FG001|Optional Extension Phase|Not treated in extension phase|1|||
149917663|NCT02603107|540830304|FG000|Optional Extension Phase|Protocol Violation|1|||
149917664|NCT02603107|540830305|FG001|Optional Extension Phase|Protocol Violation|0|||
149917665|NCT01887678|540830310|FG000|Overall Study|Adverse Event|4|||
149917666|NCT01887678|540830311|FG001|Overall Study|Adverse Event|6|||
149917667|NCT01887678|540830310|FG000|Overall Study|Exceeded rescue medication dosage|4|||
149917668|NCT01887678|540830311|FG001|Overall Study|Exceeded rescue medication dosage|5|||
149917669|NCT01887678|540830310|FG000|Overall Study|Withdrawal of consent|3|||
149917670|NCT01887678|540830311|FG001|Overall Study|Withdrawal of consent|4|||
149917671|NCT01887678|540830310|FG000|Overall Study|Lost to Follow-up|4|||
149917672|NCT01887678|540830311|FG001|Overall Study|Lost to Follow-up|2|||
149917673|NCT01887678|540830310|FG000|Overall Study|Deterioration of clinical condition|0|||
149917674|NCT01887678|540830311|FG001|Overall Study|Deterioration of clinical condition|4|||
149917675|NCT01887678|540830310|FG000|Overall Study|Lack of Efficacy|1|||
149917676|NCT01887678|540830311|FG001|Overall Study|Lack of Efficacy|2|||
149917677|NCT01887678|540830310|FG000|Overall Study|Non-compliance|0|||
149917678|NCT01887678|540830311|FG001|Overall Study|Non-compliance|3|||
149917679|NCT01887678|540830310|FG000|Overall Study|Specified|1|||
149917680|NCT01887678|540830311|FG001|Overall Study|Specified|2|||
149917681|NCT03677934|540830314|FG000|Overall Study|Adverse Event|1|||
149917682|NCT03677934|540830315|FG001|Overall Study|Adverse Event|1|||
149917683|NCT03677934|540830314|FG000|Overall Study|Death|8|||
149917684|NCT03677934|540830315|FG001|Overall Study|Death|4|||
149917685|NCT03677934|540830314|FG000|Overall Study|Lost to Follow-up|3|||
149917686|NCT03677934|540830315|FG001|Overall Study|Lost to Follow-up|0|||
149917687|NCT03677934|540830314|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149917688|NCT03677934|540830315|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149917689|NCT03677934|540830314|FG000|Overall Study|Physician Decision|0|||
149917690|NCT03677934|540830315|FG001|Overall Study|Physician Decision|1|||
149917691|NCT03677934|540830314|FG000|Overall Study|Withdrawal by Subject|1|||
149917692|NCT03677934|540830315|FG001|Overall Study|Withdrawal by Subject|7|||
149917693|NCT04769739|540830332|FG000|Overall Study|Colorectal cancer obstruction|2|||
149917694|NCT04769739|540830333|FG001|Overall Study|Colorectal cancer obstruction|0|||
149917695|NCT04769739|540830334|FG002|Overall Study|Colorectal cancer obstruction|0|||
149917696|NCT04769739|540830335|FG003|Overall Study|Colorectal cancer obstruction|0|||
149917697|NCT04769739|540830332|FG000|Overall Study|Failed cecal intubation|1|||
149917698|NCT04769739|540830333|FG001|Overall Study|Failed cecal intubation|0|||
149917699|NCT04769739|540830334|FG002|Overall Study|Failed cecal intubation|0|||
149917700|NCT04769739|540830335|FG003|Overall Study|Failed cecal intubation|1|||
149917701|NCT04769739|540830332|FG000|Overall Study|Poor bowel preparation|0|||
149917702|NCT04769739|540830333|FG001|Overall Study|Poor bowel preparation|0|||
149917703|NCT04769739|540830334|FG002|Overall Study|Poor bowel preparation|0|||
149917704|NCT04769739|540830335|FG003|Overall Study|Poor bowel preparation|1|||
149917705|NCT00045734|540830336|FG000|Overall Study|Protocol Violation|1|||
149917706|NCT02069093|540830337|FG000|Overall Study|Disease progression|14|||
149917707|NCT02069093|540830337|FG000|Overall Study|New cancer therapy|1|||
149917708|NCT02069093|540830337|FG000|Overall Study|Death|1|||
149917709|NCT02069093|540830337|FG000|Overall Study|Administrative problems|1|||
149917710|NCT02069093|540830337|FG000|Overall Study|Withdrawal by Subject|2|||
149917711|NCT02069093|540830337|FG000|Overall Study|Abnormal laboratory values|1|||
149917712|NCT02069093|540830337|FG000|Overall Study|Adverse Event|10|||
149917713|NCT00561470|540830341|FG000|Overall Study|Adverse Event|74|||
149917714|NCT00561470|540830342|FG001|Overall Study|Adverse Event|163|||
149917715|NCT00561470|540830341|FG000|Overall Study|Disease progression|437|||
149917716|NCT00561470|540830342|FG001|Overall Study|Disease progression|305|||
149917717|NCT00561470|540830341|FG000|Overall Study|poor compliance to protocol|4|||
149917718|NCT00561470|540830342|FG001|Overall Study|poor compliance to protocol|4|||
149917719|NCT00561470|540830341|FG000|Overall Study|Lost to Follow-up|2|||
149917720|NCT00561470|540830342|FG001|Overall Study|Lost to Follow-up|0|||
149917721|NCT00561470|540830341|FG000|Overall Study|Physician Decision|21|||
149917722|NCT00561470|540830342|FG001|Overall Study|Physician Decision|20|||
149917723|NCT00561470|540830341|FG000|Overall Study|Consent Withdrawn|2|||
149917724|NCT00561470|540830342|FG001|Overall Study|Consent Withdrawn|6|||
149917725|NCT00561470|540830341|FG000|Overall Study|Subject request|43|||
149917726|NCT00561470|540830342|FG001|Overall Study|Subject request|77|||
149917727|NCT00561470|540830341|FG000|Overall Study|Metastatic surgery|10|||
149917728|NCT00561470|540830342|FG001|Overall Study|Metastatic surgery|12|||
149917729|NCT00561470|540830341|FG000|Overall Study|Unauthorized procedure|3|||
149917730|NCT00561470|540830342|FG001|Overall Study|Unauthorized procedure|1|||
149917731|NCT00561470|540830341|FG000|Overall Study|Randomized but not treated|5|||
149917732|NCT00561470|540830342|FG001|Overall Study|Randomized but not treated|5|||
149917733|NCT00561470|540830341|FG000|Overall Study|Missed visit window|1|||
149917734|NCT00561470|540830342|FG001|Overall Study|Missed visit window|4|||
149917735|NCT00561470|540830341|FG000|Overall Study|Planning surgery|1|||
149917736|NCT00561470|540830342|FG001|Overall Study|Planning surgery|1|||
149917737|NCT00561470|540830341|FG000|Overall Study|Ongoing Treatment|11|||
149917738|NCT00561470|540830342|FG001|Overall Study|Ongoing Treatment|14|||
149917739|NCT00335959|540830345|FG000|Overall Study|Adverse Event|2|||
149917740|NCT00335959|540830345|FG000|Overall Study|Ineligible|1|||
149917741|NCT02028169|540830347|FG000|Overall Study|Lost to Follow-up|21|||
149917742|NCT02028169|540830347|FG000|Overall Study|Lack of Efficacy|2|||
149917743|NCT02028169|540830347|FG000|Overall Study|Withdrawal by Subject|2|||
149917744|NCT02028169|540830347|FG000|Overall Study|Adverse Event|1|||
149917745|NCT02028169|540830347|FG000|Overall Study|Cessation of Drug|1|||
149917746|NCT02028169|540830347|FG000|Overall Study|Concomitant Medication Usage|1|||
149917747|NCT01001598|540830348|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
149917748|NCT01001598|540830348|FG000|Overall Study|Adverse Event|1|||
149917749|NCT02450552|540830351|FG000|Overall Study|Withdrawal by Subject|4|||
149917750|NCT02450552|540830352|FG001|Overall Study|Withdrawal by Subject|0|||
149917751|NCT02450552|540830353|FG002|Overall Study|Withdrawal by Subject|4|||
149917752|NCT02450552|540830351|FG000|Overall Study|Physician Decision|1|||
149917753|NCT02450552|540830352|FG001|Overall Study|Physician Decision|0|||
149917754|NCT02450552|540830353|FG002|Overall Study|Physician Decision|1|||
149917755|NCT01969084|540830362|FG000|Overall Study|Adverse Event|0|||
149917756|NCT01969084|540830363|FG001|Overall Study|Adverse Event|1|||
149917757|NCT05079230|540830367|FG000|Overall Study|Study Terminated by Sponsor|101|||
149917758|NCT05079230|540830368|FG001|Overall Study|Study Terminated by Sponsor|102|||
149917759|NCT05079230|540830367|FG000|Overall Study|Death|72|||
149917760|NCT05079230|540830368|FG001|Overall Study|Death|66|||
149917761|NCT05079230|540830367|FG000|Overall Study|Withdrew Consent|16|||
149917762|NCT05079230|540830368|FG001|Overall Study|Withdrew Consent|18|||
149917763|NCT05079230|540830367|FG000|Overall Study|Lost to Follow-up|0|||
149917764|NCT05079230|540830368|FG001|Overall Study|Lost to Follow-up|3|||
149917765|NCT01524783|540830369|FG000|Blinded Period|Adverse Event|64|||
149917766|NCT01524783|540830370|FG001|Blinded Period|Adverse Event|7|||
149917767|NCT01524783|540830371|FG002|Blinded Period|Adverse Event|0|||
149917768|NCT01524783|540830369|FG000|Blinded Period|Disease Progression|89|||
149917769|NCT01524783|540830370|FG001|Blinded Period|Disease Progression|75|||
149917770|NCT01524783|540830371|FG002|Blinded Period|Disease Progression|0|||
149917771|NCT01524783|540830369|FG000|Blinded Period|Withdrawal by Subject|19|||
149917772|NCT01524783|540830370|FG001|Blinded Period|Withdrawal by Subject|6|||
149917773|NCT01524783|540830371|FG002|Blinded Period|Withdrawal by Subject|0|||
149917774|NCT01524783|540830369|FG000|Blinded Period|Protocol deviation|2|||
149917775|NCT01524783|540830370|FG001|Blinded Period|Protocol deviation|1|||
149917776|NCT01524783|540830371|FG002|Blinded Period|Protocol deviation|0|||
149917777|NCT01524783|540830369|FG000|Blinded Period|Death|5|||
149917778|NCT01524783|540830370|FG001|Blinded Period|Death|2|||
149917779|NCT01524783|540830371|FG002|Blinded Period|Death|0|||
149917780|NCT01524783|540830369|FG000|Open-label Period|Disease progression|13|||
149917781|NCT01524783|540830370|FG001|Open-label Period|Disease progression|0|||
149917782|NCT01524783|540830371|FG002|Open-label Period|Disease progression|2|||
149917783|NCT01524783|540830369|FG000|Open-label Period|Administrative problems|5|||
149917784|NCT01524783|540830370|FG001|Open-label Period|Administrative problems|0|||
149917785|NCT01524783|540830371|FG002|Open-label Period|Administrative problems|2|||
149917786|NCT01524783|540830369|FG000|Open-label Period|Adverse Event|5|||
149917787|NCT01524783|540830370|FG001|Open-label Period|Adverse Event|0|||
149917788|NCT01524783|540830371|FG002|Open-label Period|Adverse Event|1|||
149917789|NCT01524783|540830369|FG000|Open-label Period|Withdrawal by Subject|2|||
149917790|NCT01524783|540830370|FG001|Open-label Period|Withdrawal by Subject|0|||
149917791|NCT01524783|540830371|FG002|Open-label Period|Withdrawal by Subject|1|||
149917792|NCT01524783|540830369|FG000|Open-label Period|Protocol deviation|1|||
149917793|NCT01524783|540830370|FG001|Open-label Period|Protocol deviation|0|||
149917794|NCT01524783|540830371|FG002|Open-label Period|Protocol deviation|0|||
149917795|NCT03164265|540830373|FG000|Overall Study|Physician Decision|3|||
149917796|NCT00721279|540830375|FG000|Overall Study|Lack of Efficacy|6|||
149917797|NCT00721279|540830376|FG001|Overall Study|Lack of Efficacy|3|||
149917798|NCT00721279|540830375|FG000|Overall Study|Tolerability insufficient|5|||
149917799|NCT00721279|540830376|FG001|Overall Study|Tolerability insufficient|2|||
149917800|NCT00721279|540830375|FG000|Overall Study|Withdrawal by Subject|13|||
149917801|NCT00721279|540830376|FG001|Overall Study|Withdrawal by Subject|3|||
149917802|NCT00721279|540830375|FG000|Overall Study|Other|12|||
149917803|NCT00721279|540830376|FG001|Overall Study|Other|16|||
149917804|NCT03673345|540830377|FG000|Overall Study|Lost to Follow-up|1|||
149917805|NCT03673345|540830378|FG001|Overall Study|Lost to Follow-up|0|||
149917806|NCT03673345|540830379|FG002|Overall Study|Lost to Follow-up|3|||
149917807|NCT03673345|540830380|FG003|Overall Study|Lost to Follow-up|3|||
149917808|NCT03673345|540830381|FG004|Overall Study|Lost to Follow-up|2|||
149917809|NCT03673345|540830382|FG005|Overall Study|Lost to Follow-up|1|||
149917810|NCT03673345|540830383|FG006|Overall Study|Lost to Follow-up|0|||
149917811|NCT03673345|540830384|FG007|Overall Study|Lost to Follow-up|0|||
149917812|NCT03673345|540830377|FG000|Overall Study|Withdrawal by Subject|1|||
149917813|NCT03673345|540830378|FG001|Overall Study|Withdrawal by Subject|0|||
149917814|NCT03673345|540830379|FG002|Overall Study|Withdrawal by Subject|4|||
149917815|NCT03673345|540830380|FG003|Overall Study|Withdrawal by Subject|2|||
149917816|NCT03673345|540830381|FG004|Overall Study|Withdrawal by Subject|0|||
149917817|NCT03673345|540830382|FG005|Overall Study|Withdrawal by Subject|0|||
149917818|NCT03673345|540830383|FG006|Overall Study|Withdrawal by Subject|0|||
149917819|NCT03673345|540830384|FG007|Overall Study|Withdrawal by Subject|0|||
149917820|NCT03673345|540830377|FG000|Overall Study|Physician Decision|0|||
149917821|NCT03673345|540830378|FG001|Overall Study|Physician Decision|0|||
149917822|NCT03673345|540830379|FG002|Overall Study|Physician Decision|2|||
149917823|NCT03673345|540830380|FG003|Overall Study|Physician Decision|0|||
149917824|NCT03673345|540830381|FG004|Overall Study|Physician Decision|0|||
149917825|NCT03673345|540830382|FG005|Overall Study|Physician Decision|0|||
149917826|NCT03673345|540830383|FG006|Overall Study|Physician Decision|0|||
149917827|NCT03673345|540830384|FG007|Overall Study|Physician Decision|0|||
149917828|NCT05153148|540830385|FG000|Overall Study|Adverse Event|1|||
149917829|NCT05153148|540830386|FG001|Overall Study|Adverse Event|0|||
149917830|NCT05153148|540830387|FG002|Overall Study|Adverse Event|3|||
149917831|NCT05153148|540830388|FG003|Overall Study|Adverse Event|5|||
149917832|NCT05153148|540830385|FG000|Overall Study|Lost to Follow-up|1|||
149917833|NCT05153148|540830386|FG001|Overall Study|Lost to Follow-up|1|||
149917834|NCT05153148|540830387|FG002|Overall Study|Lost to Follow-up|2|||
149917835|NCT05153148|540830388|FG003|Overall Study|Lost to Follow-up|0|||
149917836|NCT05153148|540830385|FG000|Overall Study|Withdrawal by Subject|6|||
149917837|NCT05153148|540830386|FG001|Overall Study|Withdrawal by Subject|8|||
149917838|NCT05153148|540830387|FG002|Overall Study|Withdrawal by Subject|6|||
149917839|NCT05153148|540830388|FG003|Overall Study|Withdrawal by Subject|8|||
149917840|NCT05153148|540830385|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
149917841|NCT05153148|540830386|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
149917842|NCT05153148|540830387|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
149917843|NCT05153148|540830388|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
149917844|NCT05153148|540830385|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
149917845|NCT05153148|540830386|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
149917846|NCT05153148|540830387|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
149917847|NCT05153148|540830388|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
149917848|NCT05153148|540830385|FG000|Overall Study|Reason not Specified|1|||
149917849|NCT05153148|540830386|FG001|Overall Study|Reason not Specified|1|||
149917850|NCT05153148|540830387|FG002|Overall Study|Reason not Specified|1|||
149917851|NCT05153148|540830388|FG003|Overall Study|Reason not Specified|1|||
149917852|NCT02267135|540830389|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
149917853|NCT02267135|540830390|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
149917854|NCT02267135|540830389|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
149917855|NCT02267135|540830390|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
149917856|NCT02267135|540830389|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
149917857|NCT02267135|540830390|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
149917858|NCT02267135|540830389|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
149917859|NCT02267135|540830390|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
149917860|NCT02267135|540830389|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
149917861|NCT02267135|540830390|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
149917862|NCT00900731|540830391|FG000|Overall Study|Adverse Event|31|||
149917863|NCT00900731|540830392|FG001|Overall Study|Adverse Event|27|||
149917864|NCT00900731|540830391|FG000|Overall Study|Withdrawal by Subject|8|||
149917865|NCT00900731|540830392|FG001|Overall Study|Withdrawal by Subject|7|||
149917866|NCT00900731|540830391|FG000|Overall Study|Protocol Deviation|8|||
149917867|NCT00900731|540830392|FG001|Overall Study|Protocol Deviation|11|||
149917868|NCT00900731|540830391|FG000|Overall Study|Administrative Problems|5|||
149917869|NCT00900731|540830392|FG001|Overall Study|Administrative Problems|4|||
149917870|NCT00900731|540830391|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
149917871|NCT00900731|540830392|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
149917872|NCT00900731|540830391|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
149917873|NCT00900731|540830392|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
149917874|NCT00900731|540830391|FG000|Overall Study|Lost to Follow-up|2|||
149917875|NCT00900731|540830392|FG001|Overall Study|Lost to Follow-up|3|||
149917876|NCT00900731|540830391|FG000|Overall Study|Lack of Efficacy|1|||
149917877|NCT00900731|540830392|FG001|Overall Study|Lack of Efficacy|3|||
149917878|NCT00900731|540830391|FG000|Overall Study|Death|0|||
149917879|NCT00900731|540830392|FG001|Overall Study|Death|2|||
149917880|NCT03806231|540830393|FG000|Overall Study|Physician Decision|1|||
149917881|NCT03806231|540830394|FG001|Overall Study|Physician Decision|0|||
149917882|NCT03806231|540830393|FG000|Overall Study|Withdrawal by Subject|1|||
149917883|NCT03806231|540830394|FG001|Overall Study|Withdrawal by Subject|0|||
149917884|NCT03646305|540830395|FG000|Overall Study|Lost to Follow-up|4|||
149917885|NCT03646305|540830396|FG001|Overall Study|Lost to Follow-up|2|||
149917886|NCT03646305|540830397|FG002|Overall Study|Lost to Follow-up|2|||
149917887|NCT03646305|540830398|FG003|Overall Study|Lost to Follow-up|1|||
149917888|NCT03646305|540830395|FG000|Overall Study|Withdrawal by Subject|1|||
149917889|NCT03646305|540830396|FG001|Overall Study|Withdrawal by Subject|0|||
149917890|NCT03646305|540830397|FG002|Overall Study|Withdrawal by Subject|0|||
149917891|NCT03646305|540830398|FG003|Overall Study|Withdrawal by Subject|1|||
149917892|NCT01554176|540830399|FG000|Treatment Phase|Protocol Violation|1|||
149917893|NCT01554176|540830400|FG001|Treatment Phase|Protocol Violation|2|||
149917894|NCT01554176|540830401|FG002|Treatment Phase|Protocol Violation|0|||
149917895|NCT01554176|540830402|FG003|Treatment Phase|Protocol Violation|0|||
149917896|NCT01554176|540830403|FG004|Treatment Phase|Protocol Violation|0|||
149917897|NCT01554176|540830399|FG000|Treatment Phase|Physician Decision|1|||
149917898|NCT01554176|540830400|FG001|Treatment Phase|Physician Decision|1|||
149917899|NCT01554176|540830401|FG002|Treatment Phase|Physician Decision|0|||
149917900|NCT01554176|540830402|FG003|Treatment Phase|Physician Decision|0|||
149917901|NCT01554176|540830403|FG004|Treatment Phase|Physician Decision|0|||
149917902|NCT01554176|540830399|FG000|Treatment Phase|Lack of Efficacy|0|||
149917903|NCT01554176|540830400|FG001|Treatment Phase|Lack of Efficacy|1|||
149917904|NCT01554176|540830401|FG002|Treatment Phase|Lack of Efficacy|0|||
149917905|NCT01554176|540830402|FG003|Treatment Phase|Lack of Efficacy|0|||
149917906|NCT01554176|540830403|FG004|Treatment Phase|Lack of Efficacy|0|||
149917907|NCT01554176|540830399|FG000|Treatment Phase|Adverse event, non-fatal|1|||
149917908|NCT01554176|540830400|FG001|Treatment Phase|Adverse event, non-fatal|1|||
149917909|NCT01554176|540830401|FG002|Treatment Phase|Adverse event, non-fatal|0|||
149917910|NCT01554176|540830402|FG003|Treatment Phase|Adverse event, non-fatal|0|||
149917911|NCT01554176|540830403|FG004|Treatment Phase|Adverse event, non-fatal|0|||
149917912|NCT01554176|540830399|FG000|Treatment Phase|Non-compliance with study drug|1|||
149917913|NCT01554176|540830400|FG001|Treatment Phase|Non-compliance with study drug|0|||
149917914|NCT01554176|540830401|FG002|Treatment Phase|Non-compliance with study drug|0|||
149917915|NCT01554176|540830402|FG003|Treatment Phase|Non-compliance with study drug|0|||
149917916|NCT01554176|540830403|FG004|Treatment Phase|Non-compliance with study drug|0|||
149917917|NCT01554176|540830399|FG000|Treatment Phase|Withdrawal by Subject|1|||
149917918|NCT01554176|540830400|FG001|Treatment Phase|Withdrawal by Subject|0|||
149917919|NCT01554176|540830401|FG002|Treatment Phase|Withdrawal by Subject|0|||
149917920|NCT01554176|540830402|FG003|Treatment Phase|Withdrawal by Subject|0|||
149917921|NCT01554176|540830403|FG004|Treatment Phase|Withdrawal by Subject|0|||
149917922|NCT01554176|540830399|FG000|Treatment Phase|Lost to Follow-up|3|||
149917923|NCT01554176|540830400|FG001|Treatment Phase|Lost to Follow-up|0|||
149917924|NCT01554176|540830401|FG002|Treatment Phase|Lost to Follow-up|0|||
149917925|NCT01554176|540830402|FG003|Treatment Phase|Lost to Follow-up|0|||
149917926|NCT01554176|540830403|FG004|Treatment Phase|Lost to Follow-up|0|||
149917927|NCT01554176|540830399|FG000|Run-out Phase|Protocol Violation|0|||
149917928|NCT01554176|540830400|FG001|Run-out Phase|Protocol Violation|0|||
149917929|NCT01554176|540830401|FG002|Run-out Phase|Protocol Violation|0|||
149917930|NCT01554176|540830402|FG003|Run-out Phase|Protocol Violation|1|||
149917931|NCT01554176|540830403|FG004|Run-out Phase|Protocol Violation|0|||
149917932|NCT02678000|540830404|FG000|PART 2|Adverse Event|0|||
149917933|NCT02678000|540830405|FG001|PART 2|Adverse Event|0|||
149917934|NCT02678000|540830406|FG002|PART 2|Adverse Event|2|||
149917935|NCT02678000|540830407|FG003|PART 2|Adverse Event|1|||
149917936|NCT02678000|540830408|FG004|PART 2|Adverse Event|0|||
149917937|NCT02678000|540830404|FG000|PART 2|Withdrawal by Subject|0|||
149917938|NCT02678000|540830405|FG001|PART 2|Withdrawal by Subject|0|||
149917939|NCT02678000|540830406|FG002|PART 2|Withdrawal by Subject|1|||
149917940|NCT02678000|540830407|FG003|PART 2|Withdrawal by Subject|0|||
149917941|NCT02678000|540830408|FG004|PART 2|Withdrawal by Subject|0|||
149917942|NCT03053427|540830409|FG000|Overall Study|Adverse Event|4|||
149917943|NCT03053427|540830410|FG001|Overall Study|Adverse Event|4|||
149917944|NCT03053427|540830409|FG000|Overall Study|Lack of Efficacy|1|||
149917945|NCT03053427|540830410|FG001|Overall Study|Lack of Efficacy|3|||
149917946|NCT03053427|540830409|FG000|Overall Study|Lost to Follow-up|2|||
149917947|NCT03053427|540830410|FG001|Overall Study|Lost to Follow-up|2|||
149917948|NCT03053427|540830409|FG000|Overall Study|Worsening of the target disease|0|||
149917949|NCT03053427|540830410|FG001|Overall Study|Worsening of the target disease|1|||
149917950|NCT03053427|540830409|FG000|Overall Study|Protocol Deviation|3|||
149917951|NCT03053427|540830410|FG001|Overall Study|Protocol Deviation|3|||
149917952|NCT03053427|540830409|FG000|Overall Study|Withdrawal by Subject|3|||
149917953|NCT03053427|540830410|FG001|Overall Study|Withdrawal by Subject|2|||
149917954|NCT03053427|540830409|FG000|Overall Study|Miscellaneous|0|||
149917955|NCT03053427|540830410|FG001|Overall Study|Miscellaneous|1|||
149917956|NCT02607306|540830413|FG000|Overall Study|Adverse Event|8|||
149917957|NCT02607306|540830414|FG001|Overall Study|Adverse Event|6|||
149917958|NCT02607306|540830415|FG002|Overall Study|Adverse Event|6|||
149917959|NCT02607306|540830413|FG000|Overall Study|Unclassified|1|||
149917960|NCT02607306|540830414|FG001|Overall Study|Unclassified|4|||
149917961|NCT02607306|540830415|FG002|Overall Study|Unclassified|0|||
149917962|NCT02607306|540830413|FG000|Overall Study|Withdrawal by Subject|8|||
149917963|NCT02607306|540830414|FG001|Overall Study|Withdrawal by Subject|10|||
149917964|NCT02607306|540830415|FG002|Overall Study|Withdrawal by Subject|2|||
149917965|NCT02607306|540830413|FG000|Overall Study|Lack of Efficacy|0|||
149917966|NCT02607306|540830414|FG001|Overall Study|Lack of Efficacy|1|||
149917967|NCT02607306|540830415|FG002|Overall Study|Lack of Efficacy|1|||
149917968|NCT02607306|540830413|FG000|Overall Study|Protocol Violation|4|||
149917969|NCT02607306|540830414|FG001|Overall Study|Protocol Violation|2|||
149917970|NCT02607306|540830415|FG002|Overall Study|Protocol Violation|1|||
149917971|NCT02360475|540830420|FG000|Overall Study|Lost to Follow-up|4|||
149917972|NCT02360475|540830421|FG001|Overall Study|Lost to Follow-up|12|||
149917973|NCT02360475|540830422|FG002|Overall Study|Lost to Follow-up|6|||
149917974|NCT02360475|540830423|FG003|Overall Study|Lost to Follow-up|4|||
149917975|NCT02360475|540830420|FG000|Overall Study|Withdrawal by Subject|0|||
149917976|NCT02360475|540830421|FG001|Overall Study|Withdrawal by Subject|1|||
149917977|NCT02360475|540830422|FG002|Overall Study|Withdrawal by Subject|2|||
149917978|NCT02360475|540830423|FG003|Overall Study|Withdrawal by Subject|0|||
149917979|NCT02360475|540830420|FG000|Overall Study|Migrated/moved from study area|0|||
149917980|NCT02360475|540830421|FG001|Overall Study|Migrated/moved from study area|0|||
149917981|NCT02360475|540830422|FG002|Overall Study|Migrated/moved from study area|0|||
149917982|NCT02360475|540830423|FG003|Overall Study|Migrated/moved from study area|1|||
149917983|NCT00463840|540830424|FG000|Overall Study|Disease progression|7|||
149917984|NCT00463840|540830424|FG000|Overall Study|Withdrawal by Subject|2|||
149917985|NCT00463840|540830424|FG000|Overall Study|Adverse Event|3|||
149917986|NCT01653327|540830425|FG000|Overall Study|Withdrawal by Subject|1|||
149917987|NCT02510820|540831898|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149917988|NCT02510820|540831899|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149917989|NCT02510820|540831898|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
149917990|NCT02510820|540831899|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
149917991|NCT03046056|540831900|FG000|Overall Study|Non-responder at Week 10|6|||
149917992|NCT03046056|540831901|FG001|Overall Study|Non-responder at Week 10|6|||
149917993|NCT03046056|540831902|FG002|Overall Study|Non-responder at Week 10|4|||
149917994|NCT03046056|540831900|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
149917995|NCT03046056|540831901|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
149917996|NCT03046056|540831902|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
149917997|NCT03046056|540831900|FG000|Overall Study|Adverse Event|1|||
149917998|NCT03046056|540831901|FG001|Overall Study|Adverse Event|5|||
149917999|NCT03046056|540831902|FG002|Overall Study|Adverse Event|0|||
149918000|NCT03046056|540831900|FG000|Overall Study|Non-compliance With Study Drug|0|||
149918001|NCT03046056|540831901|FG001|Overall Study|Non-compliance With Study Drug|0|||
149918002|NCT03046056|540831902|FG002|Overall Study|Non-compliance With Study Drug|2|||
149918003|NCT03046056|540831900|FG000|Overall Study|Protocol Violation|1|||
149918004|NCT03046056|540831901|FG001|Overall Study|Protocol Violation|1|||
149918005|NCT03046056|540831902|FG002|Overall Study|Protocol Violation|0|||
149918006|NCT03046056|540831900|FG000|Overall Study|Investigator's Discretion|0|||
149918007|NCT03046056|540831901|FG001|Overall Study|Investigator's Discretion|1|||
149918008|NCT03046056|540831902|FG002|Overall Study|Investigator's Discretion|0|||
149918009|NCT03046056|540831900|FG000|Overall Study|Withdrew Consent|1|||
149918010|NCT03046056|540831901|FG001|Overall Study|Withdrew Consent|0|||
149918011|NCT03046056|540831902|FG002|Overall Study|Withdrew Consent|0|||
149918012|NCT03089853|540831903|FG000|Overall Study|Lost to Follow-up|2|||
149918013|NCT03089853|540831904|FG001|Overall Study|Lost to Follow-up|1|||
149918014|NCT00642954|540831905|FG000|Overall Study|Progressive Disease|3|||
149918015|NCT00642954|540831906|FG001|Overall Study|Progressive Disease|3|||
149918016|NCT00642954|540831907|FG002|Overall Study|Progressive Disease|3|||
150256645|NCT00686725|542074109|FG000|Overall Study|Other|1|||
149918017|NCT00642954|540831908|FG003|Overall Study|Progressive Disease|3|||
149918018|NCT00642954|540831909|FG004|Overall Study|Progressive Disease|9|||
149918019|NCT00642954|540831905|FG000|Overall Study|Withdrawal by Subject|0|||
149918020|NCT00642954|540831906|FG001|Overall Study|Withdrawal by Subject|0|||
149918021|NCT00642954|540831907|FG002|Overall Study|Withdrawal by Subject|0|||
149918022|NCT00642954|540831908|FG003|Overall Study|Withdrawal by Subject|0|||
149918023|NCT00642954|540831909|FG004|Overall Study|Withdrawal by Subject|1|||
149918024|NCT00642954|540831905|FG000|Overall Study|Adverse Event|1|||
149918025|NCT00642954|540831906|FG001|Overall Study|Adverse Event|1|||
149918026|NCT00642954|540831907|FG002|Overall Study|Adverse Event|0|||
149918027|NCT00642954|540831908|FG003|Overall Study|Adverse Event|0|||
149918028|NCT00642954|540831909|FG004|Overall Study|Adverse Event|6|||
149918029|NCT02913105|540831910|FG000|Overall Study|Adverse Event|11|||
149918030|NCT02913105|540831911|FG001|Overall Study|Adverse Event|0|||
149918031|NCT02913105|540831912|FG002|Overall Study|Adverse Event|4|||
149918032|NCT02913105|540831910|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149918033|NCT02913105|540831911|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149918034|NCT02913105|540831912|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149918035|NCT02913105|540831910|FG000|Overall Study|Reason Not Specified|3|||
149918036|NCT02913105|540831911|FG001|Overall Study|Reason Not Specified|1|||
149918037|NCT02913105|540831912|FG002|Overall Study|Reason Not Specified|1|||
149918038|NCT02913105|540831910|FG000|Overall Study|Physician Decision|1|||
149918039|NCT02913105|540831911|FG001|Overall Study|Physician Decision|1|||
149918040|NCT02913105|540831912|FG002|Overall Study|Physician Decision|0|||
149918041|NCT02913105|540831910|FG000|Overall Study|Withdrawal by Subject|0|||
149918042|NCT02913105|540831911|FG001|Overall Study|Withdrawal by Subject|3|||
149918043|NCT02913105|540831912|FG002|Overall Study|Withdrawal by Subject|1|||
149918044|NCT01317004|540831913|FG000|Overall Study|Withdrawal by Subject|1|||
149918045|NCT01317004|540831914|FG001|Overall Study|Withdrawal by Subject|4|||
149918046|NCT01317004|540831913|FG000|Overall Study|Protocol Violation|0|||
149918047|NCT01317004|540831914|FG001|Overall Study|Protocol Violation|2|||
149918048|NCT01317004|540831913|FG000|Overall Study|Adverse Event|3|||
149918049|NCT01317004|540831914|FG001|Overall Study|Adverse Event|3|||
149918050|NCT05243563|540831915|FG000|Overall Study|Withdrawal by Subject|1|||
149918051|NCT05243563|540831916|FG001|Overall Study|Withdrawal by Subject|0|||
149918052|NCT05243563|540831915|FG000|Overall Study|Physician Decision|1|||
149918053|NCT05243563|540831916|FG001|Overall Study|Physician Decision|0|||
149918054|NCT04114656|540831917|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
149918055|NCT04114656|540831918|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
149918056|NCT04114656|540831917|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
149918057|NCT04114656|540831918|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
149918058|NCT04114656|540831917|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
149918059|NCT04114656|540831918|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
149918060|NCT04114656|540831917|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
149918061|NCT04114656|540831918|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
149918062|NCT04114656|540831917|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
149918063|NCT04114656|540831918|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
149918064|NCT00703326|540831919|FG000|Overall Study|Lost to Follow-up|47|||
149918065|NCT00703326|540831920|FG001|Overall Study|Lost to Follow-up|18|||
149918066|NCT00703326|540831919|FG000|Overall Study|Withdrawal by Subject|54|||
149918067|NCT00703326|540831920|FG001|Overall Study|Withdrawal by Subject|20|||
149918068|NCT00703326|540831919|FG000|Overall Study|Adverse Event|1|||
149918069|NCT00703326|540831920|FG001|Overall Study|Adverse Event|0|||
149918070|NCT02661061|540831922|FG000|Overall Study|Lack of Efficacy|1|||
149918071|NCT02661061|540831923|FG001|Overall Study|Lack of Efficacy|1|||
149918072|NCT02661061|540831922|FG000|Overall Study|Withdrawal by Subject|1|||
149918073|NCT02661061|540831923|FG001|Overall Study|Withdrawal by Subject|1|||
149918074|NCT01393106|540831924|FG000|Overall Study|Adverse Event|3|||
149918075|NCT01393106|540831924|FG000|Overall Study|Withdrawal by Subject|1|||
149918076|NCT01393106|540831924|FG000|Overall Study|Lack of Efficacy|1|||
149918077|NCT03052920|540831925|FG000|Overall Study|Withdrawal by Subject|1|||
149918078|NCT01980628|540831926|FG000|Overall Study|Adverse Event|12|||
149918079|NCT01980628|540831926|FG000|Overall Study|Physician Decision|5|||
149918080|NCT01980628|540831926|FG000|Overall Study|Withdrawal by Subject|4|||
149918081|NCT01980628|540831926|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
150256646|NCT00686725|542074110|FG001|Overall Study|Other|3|||
149918082|NCT02578940|540831927|FG000|Overall Study|Screening failure|5|||
149918083|NCT02578940|540831927|FG000|Overall Study|Lost to Follow-up|1|||
149918084|NCT01698268|540831929|FG000|Overall Study|Physician Decision|2|||
149918085|NCT01698268|540831930|FG001|Overall Study|Physician Decision|1|||
149918086|NCT03341936|540831932|FG000|Overall Study|Ineligible|1|||
149918087|NCT03341936|540831932|FG000|Overall Study|Disease Progression|2|||
149918088|NCT03341936|540831932|FG000|Overall Study|Withdrew Consent|4|||
149918089|NCT03341936|540831932|FG000|Overall Study|Non-Compliance|1|||
149918090|NCT03341936|540831932|FG000|Overall Study|Physician Decision|1|||
149918091|NCT03341936|540831932|FG000|Overall Study|Withdrawal by Subject|1|||
149918092|NCT03341936|540831932|FG000|Overall Study|Other|1|||
149918093|NCT02131636|540831936|FG000|Overall Study|Personal Reasons|4|||
149918094|NCT02131636|540831937|FG001|Overall Study|Personal Reasons|4|||
149918095|NCT02131636|540831936|FG000|Overall Study|Lost to Follow-up|4|||
149918096|NCT02131636|540831937|FG001|Overall Study|Lost to Follow-up|0|||
149918097|NCT02131636|540831936|FG000|Overall Study|Adverse Event|4|||
149918098|NCT02131636|540831937|FG001|Overall Study|Adverse Event|1|||
149918099|NCT02173379|540831938|FG000|Overall Study|Lost to Follow-up|89|||
149918100|NCT02173379|540831939|FG001|Overall Study|Lost to Follow-up|81|||
149918101|NCT02173379|540831938|FG000|Overall Study|Withdrawal by Subject|24|||
149918102|NCT02173379|540831939|FG001|Overall Study|Withdrawal by Subject|29|||
149918103|NCT02173379|540831938|FG000|Overall Study|Physician Decision|8|||
149918104|NCT02173379|540831939|FG001|Overall Study|Physician Decision|8|||
149918105|NCT02173379|540831938|FG000|Overall Study|Death|75|||
149918106|NCT02173379|540831939|FG001|Overall Study|Death|72|||
149918107|NCT02173379|540831938|FG000|Overall Study|Other Reason|1|||
149918108|NCT02173379|540831939|FG001|Overall Study|Other Reason|0|||
149918109|NCT04767529|540831943|FG000|Overall Study|Adverse Event|0|||
149918110|NCT04767529|540831944|FG001|Overall Study|Adverse Event|4|||
149918111|NCT04767529|540831945|FG002|Overall Study|Adverse Event|3|||
149918112|NCT04767529|540831943|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
149918113|NCT04767529|540831944|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
149918114|NCT04767529|540831945|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
149918115|NCT04767529|540831943|FG000|Overall Study|Required use of a prohibited medication|0|||
149918116|NCT04767529|540831944|FG001|Overall Study|Required use of a prohibited medication|1|||
149918117|NCT04767529|540831945|FG002|Overall Study|Required use of a prohibited medication|0|||
149918118|NCT04767529|540831943|FG000|Overall Study|Withdrawal by Subject|7|||
149918119|NCT04767529|540831944|FG001|Overall Study|Withdrawal by Subject|5|||
149918120|NCT04767529|540831945|FG002|Overall Study|Withdrawal by Subject|4|||
149918121|NCT04767529|540831943|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
149918122|NCT04767529|540831944|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
149918123|NCT04767529|540831945|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
149918124|NCT04767529|540831943|FG000|Overall Study|Lost to Follow-up|0|||
149918125|NCT04767529|540831944|FG001|Overall Study|Lost to Follow-up|2|||
149918126|NCT04767529|540831945|FG002|Overall Study|Lost to Follow-up|3|||
149918127|NCT01636947|540831951|FG000|Overall Study|Not Treated|2|||
149918128|NCT01636947|540831952|FG001|Overall Study|Not Treated|2|||
149918129|NCT01636947|540831951|FG000|Overall Study|Lost to Follow-up|4|||
149918130|NCT01636947|540831952|FG001|Overall Study|Lost to Follow-up|0|||
149918131|NCT01636947|540831951|FG000|Overall Study|Protocol Violation|1|||
149918132|NCT01636947|540831952|FG001|Overall Study|Protocol Violation|1|||
149918133|NCT01636947|540831951|FG000|Overall Study|Withdrawal by Subject|3|||
149918134|NCT01636947|540831952|FG001|Overall Study|Withdrawal by Subject|3|||
149918135|NCT01636947|540831951|FG000|Overall Study|Adverse Event|1|||
149918136|NCT01636947|540831952|FG001|Overall Study|Adverse Event|1|||
149918137|NCT01636947|540831951|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
149918138|NCT01636947|540831952|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
149918139|NCT01955109|540831960|FG000|Overall Study|Adverse Event|2|||
149918140|NCT01955109|540831961|FG001|Overall Study|Adverse Event|0|||
149918141|NCT01955109|540831960|FG000|Overall Study|Participant unwilling to continue|35|||
149918142|NCT01955109|540831961|FG001|Overall Study|Participant unwilling to continue|7|||
149918143|NCT01955109|540831960|FG000|Overall Study|Physician Decision|2|||
149918144|NCT01955109|540831961|FG001|Overall Study|Physician Decision|0|||
149918145|NCT01955109|540831960|FG000|Overall Study|Lost to Follow-up|3|||
149918146|NCT01955109|540831961|FG001|Overall Study|Lost to Follow-up|1|||
149918147|NCT01955109|540831960|FG000|Overall Study|Non-compliance|3|||
149918148|NCT01955109|540831961|FG001|Overall Study|Non-compliance|1|||
149918149|NCT01167634|540831962|FG000|Overall Study|Lost to Follow-up|1|||
149918150|NCT01167634|540831963|FG001|Overall Study|Lost to Follow-up|3|||
149918151|NCT01167634|540831964|FG002|Overall Study|Lost to Follow-up|3|||
149918152|NCT01167634|540831965|FG003|Overall Study|Lost to Follow-up|4|||
149918153|NCT01167634|540831962|FG000|Overall Study|Withdrawal by Subject|1|||
149918154|NCT01167634|540831963|FG001|Overall Study|Withdrawal by Subject|1|||
149918155|NCT01167634|540831964|FG002|Overall Study|Withdrawal by Subject|0|||
149918156|NCT01167634|540831965|FG003|Overall Study|Withdrawal by Subject|0|||
149918157|NCT03003000|540831971|FG000|Overall Study|Adverse Event|1|||
149918158|NCT03003000|540831972|FG001|Overall Study|Adverse Event|2|||
149918159|NCT03003000|540831973|FG002|Overall Study|Adverse Event|3|||
149918160|NCT03003000|540831971|FG000|Overall Study|Lack of Efficacy|1|||
149918161|NCT03003000|540831972|FG001|Overall Study|Lack of Efficacy|0|||
149918162|NCT03003000|540831973|FG002|Overall Study|Lack of Efficacy|0|||
149918163|NCT03003000|540831971|FG000|Overall Study|Non-compliant with protocol|0|||
149918164|NCT03003000|540831972|FG001|Overall Study|Non-compliant with protocol|1|||
149918165|NCT03003000|540831973|FG002|Overall Study|Non-compliant with protocol|1|||
149918166|NCT03003000|540831971|FG000|Overall Study|Refused to continue medication|2|||
149918167|NCT03003000|540831972|FG001|Overall Study|Refused to continue medication|0|||
149918168|NCT03003000|540831973|FG002|Overall Study|Refused to continue medication|0|||
149918169|NCT03003000|540831971|FG000|Overall Study|Other than listed|1|||
149918170|NCT03003000|540831972|FG001|Overall Study|Other than listed|1|||
149918171|NCT03003000|540831973|FG002|Overall Study|Other than listed|1|||
149918172|NCT04933617|540831974|FG000|Dose Escalation|Early closure of study|0|||
149918173|NCT04933617|540831975|FG001|Dose Escalation|Early closure of study|3|||
149918174|NCT04933617|540831976|FG002|Dose Escalation|Early closure of study|0|||
149918175|NCT04933617|540831977|FG003|Dose Escalation|Early closure of study|0|||
149918176|NCT04933617|540831978|FG004|Dose Escalation|Early closure of study|0|||
149918177|NCT00089635|540831979|FG000|Overall Study|Adverse Event|2|||
149918178|NCT00089635|540831979|FG000|Overall Study|Death|17|||
149918179|NCT00089635|540831979|FG000|Overall Study|Disease Progression|12|||
149918180|NCT00089635|540831979|FG000|Overall Study|Lost to Follow-up|3|||
149918181|NCT00089635|540831979|FG000|Overall Study|Withdrawal by Subject|6|||
149918182|NCT00089635|540831979|FG000|Overall Study|Ineligibility determined|1|||
149918183|NCT00089635|540831979|FG000|Overall Study|Other|2|||
149918184|NCT00419159|540831982|FG000|Overall Study|Adverse Event|7|||
149918185|NCT00419159|540831983|FG001|Overall Study|Adverse Event|15|||
149918186|NCT00419159|540831982|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149918187|NCT00419159|540831983|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149918188|NCT00419159|540831982|FG000|Overall Study|Subject's no longer requires study drug|0|||
149918189|NCT00419159|540831983|FG001|Overall Study|Subject's no longer requires study drug|1|||
149918190|NCT00419159|540831982|FG000|Overall Study|Protocol Violation|1|||
149918191|NCT00419159|540831983|FG001|Overall Study|Protocol Violation|0|||
149918192|NCT00419159|540831982|FG000|Overall Study|Withdrawal by Subject|10|||
149918193|NCT00419159|540831983|FG001|Overall Study|Withdrawal by Subject|3|||
149918194|NCT00419159|540831982|FG000|Overall Study|Lost to Follow-up|0|||
149918195|NCT00419159|540831983|FG001|Overall Study|Lost to Follow-up|1|||
149918196|NCT00419159|540831982|FG000|Overall Study|Death|2|||
149918197|NCT00419159|540831983|FG001|Overall Study|Death|2|||
149918198|NCT00419159|540831982|FG000|Overall Study|Disease progression|79|||
149918199|NCT00419159|540831983|FG001|Overall Study|Disease progression|76|||
149918200|NCT02920177|540831988|FG000|Overall Study|Withdrawal by Subject|1|||
149918201|NCT02920177|540831989|FG001|Overall Study|Withdrawal by Subject|1|||
149918202|NCT02920177|540831988|FG000|Overall Study|Physician Decision|1|||
149918203|NCT02920177|540831989|FG001|Overall Study|Physician Decision|0|||
149918204|NCT02920177|540831988|FG000|Overall Study|Lost to Follow-up|0|||
149918205|NCT02920177|540831989|FG001|Overall Study|Lost to Follow-up|1|||
149918206|NCT04907227|540831990|FG000|Overall Study|Death|12|||
149918207|NCT04907227|540831991|FG001|Overall Study|Death|8|||
149918208|NCT04907227|540831990|FG000|Overall Study|Withdrawal by Subject|2|||
149918209|NCT04907227|540831991|FG001|Overall Study|Withdrawal by Subject|2|||
149918210|NCT04907227|540831990|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
149918211|NCT04907227|540831991|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
150029356|NCT03409796|541244157|FG001|Overall Study|Adverse Event|0|||
150029357|NCT03409796|541244156|FG000|Overall Study|Other|0|||
150029358|NCT03409796|541244157|FG001|Overall Study|Other|1|||
150029359|NCT00644423|541244159|FG000|Overall Study|Lost to Follow-up|1|||
150029360|NCT00644423|541244160|FG001|Overall Study|Lost to Follow-up|1|||
150029361|NCT04235140|541244177|FG000|Overall Study|Adverse Event|2|||
150029362|NCT04235140|541244177|FG000|Overall Study|Lost to Follow-up|1|||
150029363|NCT04235140|541244177|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
150029364|NCT04235140|541244177|FG000|Overall Study|Commercial drug is available for participants|7|||
150029365|NCT01751061|541244178|FG000|Overall Study|Death|1|||
150029366|NCT01751061|541244179|FG001|Overall Study|Death|0|||
150029367|NCT01751061|541244178|FG000|Overall Study|patient death|5|||
150029368|NCT01751061|541244179|FG001|Overall Study|patient death|0|||
150029369|NCT01751061|541244178|FG000|Overall Study|Lost to Follow-up|40|||
150029370|NCT01751061|541244179|FG001|Overall Study|Lost to Follow-up|25|||
150029371|NCT01751061|541244178|FG000|Overall Study|patient regained decisional capacity|4|||
150029372|NCT01751061|541244179|FG001|Overall Study|patient regained decisional capacity|8|||
150029373|NCT01751061|541244178|FG000|Overall Study|Withdrawal by Subject|4|||
150029374|NCT01751061|541244179|FG001|Overall Study|Withdrawal by Subject|1|||
150029375|NCT01751061|541244178|FG000|Overall Study|Physician Decision|2|||
150029376|NCT01751061|541244179|FG001|Overall Study|Physician Decision|0|||
149918212|NCT04907227|540831990|FG000|Overall Study|Sponsor Decision|25|||
149918213|NCT04907227|540831991|FG001|Overall Study|Sponsor Decision|30|||
149918214|NCT04907227|540831990|FG000|Overall Study|Physician Decision|1|||
149918215|NCT04907227|540831991|FG001|Overall Study|Physician Decision|0|||
149918216|NCT03723070|540831992|FG000|Overall Study|Lost to Follow-up|2|||
149918217|NCT03723070|540831992|FG000|Overall Study|Physician Decision|1|||
149918218|NCT03723070|540831992|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
149918219|NCT03759366|540831996|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
149918220|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
149918221|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
149918222|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
149918223|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
149918224|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
149918225|NCT03759366|540831996|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
149918226|NCT00539032|540831997|FG000|Overall Study|Withdrawal by Subject|2|||
149918227|NCT00539032|540831998|FG001|Overall Study|Withdrawal by Subject|1|||
149918228|NCT00866333|540832005|FG000|Overall Study|Withdrawal of consent|0|||
149918229|NCT00866333|540832006|FG001|Overall Study|Withdrawal of consent|1|||
149918230|NCT00866333|540832007|FG002|Overall Study|Withdrawal of consent|2|||
149918231|NCT00866333|540832005|FG000|Overall Study|Reason not Specified|3|||
149918232|NCT00866333|540832006|FG001|Overall Study|Reason not Specified|1|||
149918233|NCT00866333|540832007|FG002|Overall Study|Reason not Specified|1|||
149918234|NCT00866333|540832005|FG000|Overall Study|Study Terminated by Sponsor|2|||
149918235|NCT00866333|540832006|FG001|Overall Study|Study Terminated by Sponsor|5|||
149918236|NCT00866333|540832007|FG002|Overall Study|Study Terminated by Sponsor|9|||
149918237|NCT02669082|540832008|FG000|Overall Study|Adverse Event|1|||
149918238|NCT04918355|540832009|FG000|Overall Study|no qualifying health encounter|497|||
149918239|NCT04918355|540832010|FG001|Overall Study|no qualifying health encounter|192|||
149918240|NCT04918355|540832011|FG002|Overall Study|no qualifying health encounter|438|||
149918241|NCT04918355|540832012|FG003|Overall Study|no qualifying health encounter|424|||
149918242|NCT04683939|540832013|FG000|Overall Study|Study termination by the sponsor|0|||
149918243|NCT04683939|540832014|FG001|Overall Study|Study termination by the sponsor|1|||
149918244|NCT04683939|540832015|FG002|Overall Study|Study termination by the sponsor|2|||
149918245|NCT04683939|540832016|FG003|Overall Study|Study termination by the sponsor|2|||
149918246|NCT04683939|540832013|FG000|Overall Study|Death|1|||
149918247|NCT04683939|540832014|FG001|Overall Study|Death|1|||
149918248|NCT04683939|540832015|FG002|Overall Study|Death|2|||
149918249|NCT04683939|540832016|FG003|Overall Study|Death|1|||
149918250|NCT04683939|540832013|FG000|Overall Study|Withdrawal by Subject|1|||
149918251|NCT04683939|540832014|FG001|Overall Study|Withdrawal by Subject|0|||
149918252|NCT04683939|540832015|FG002|Overall Study|Withdrawal by Subject|0|||
149918253|NCT04683939|540832016|FG003|Overall Study|Withdrawal by Subject|0|||
149918254|NCT04683939|540832013|FG000|Overall Study|Physician Decision|1|||
149918255|NCT04683939|540832014|FG001|Overall Study|Physician Decision|0|||
149918256|NCT04683939|540832015|FG002|Overall Study|Physician Decision|0|||
149918257|NCT04683939|540832016|FG003|Overall Study|Physician Decision|0|||
149918258|NCT04683939|540832013|FG000|Overall Study|Lost to Follow-up|0|||
149918259|NCT04683939|540832014|FG001|Overall Study|Lost to Follow-up|1|||
149918260|NCT04683939|540832015|FG002|Overall Study|Lost to Follow-up|0|||
149918261|NCT04683939|540832016|FG003|Overall Study|Lost to Follow-up|0|||
149918262|NCT03041467|540833614|FG000|Overall Study|Death|46|||
149918263|NCT03041467|540833615|FG001|Overall Study|Death|39|||
149918264|NCT03041467|540833614|FG000|Overall Study|Withdrawal by Subject|36|||
149918265|NCT03041467|540833615|FG001|Overall Study|Withdrawal by Subject|37|||
149918266|NCT03041467|540833614|FG000|Overall Study|Lost to Follow-up|6|||
149918267|NCT03041467|540833615|FG001|Overall Study|Lost to Follow-up|8|||
149918268|NCT03041467|540833614|FG000|Overall Study|Declined consent for study extension|21|||
149918269|NCT03041467|540833615|FG001|Overall Study|Declined consent for study extension|33|||
149918270|NCT03041467|540833614|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
149918271|NCT03041467|540833615|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
149918272|NCT02732015|540833616|FG000|Overall Study|Lost to Follow-up|0|||
149918273|NCT02732015|540833617|FG001|Overall Study|Lost to Follow-up|1|||
149918274|NCT01937715|540833622|FG000|Overall Study|Death|0|||
149918275|NCT01937715|540833623|FG001|Overall Study|Death|0|||
149918276|NCT01937715|540833624|FG002|Overall Study|Death|0|||
149918277|NCT01937715|540833625|FG003|Overall Study|Death|1|||
149918278|NCT01937715|540833626|FG004|Overall Study|Death|0|||
149918279|NCT01937715|540833622|FG000|Overall Study|Withdrawal by Subject|0|||
149918280|NCT01937715|540833623|FG001|Overall Study|Withdrawal by Subject|1|||
149918281|NCT01937715|540833624|FG002|Overall Study|Withdrawal by Subject|0|||
149918282|NCT01937715|540833625|FG003|Overall Study|Withdrawal by Subject|0|||
149918283|NCT01937715|540833626|FG004|Overall Study|Withdrawal by Subject|2|||
150256647|NCT00092495|542074111|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
149918284|NCT01937715|540833622|FG000|Overall Study|Other|0|||
149918285|NCT01937715|540833623|FG001|Overall Study|Other|0|||
149918286|NCT01937715|540833624|FG002|Overall Study|Other|0|||
149918287|NCT01937715|540833625|FG003|Overall Study|Other|3|||
149918288|NCT01937715|540833626|FG004|Overall Study|Other|0|||
149918289|NCT00298363|540833629|FG000|Overall Study|Lost to Follow-up|0|||
149918290|NCT00298363|540833630|FG001|Overall Study|Lost to Follow-up|0|||
149918291|NCT00298363|540833631|FG002|Overall Study|Lost to Follow-up|1|||
149918292|NCT00298363|540833629|FG000|Overall Study|Physician Decision|4|||
149918293|NCT00298363|540833630|FG001|Overall Study|Physician Decision|1|||
149918294|NCT00298363|540833631|FG002|Overall Study|Physician Decision|0|||
149918295|NCT00298363|540833629|FG000|Overall Study|Protocol Violation|1|||
149918296|NCT00298363|540833630|FG001|Overall Study|Protocol Violation|1|||
149918297|NCT00298363|540833631|FG002|Overall Study|Protocol Violation|0|||
149918298|NCT00298363|540833629|FG000|Overall Study|Withdrawal by Subject|5|||
149918299|NCT00298363|540833630|FG001|Overall Study|Withdrawal by Subject|1|||
149918300|NCT00298363|540833631|FG002|Overall Study|Withdrawal by Subject|3|||
149918301|NCT00298363|540833629|FG000|Overall Study|Adverse Event|5|||
149918302|NCT00298363|540833630|FG001|Overall Study|Adverse Event|2|||
149918303|NCT00298363|540833631|FG002|Overall Study|Adverse Event|2|||
149918304|NCT00298363|540833629|FG000|Overall Study|Lack of Efficacy|2|||
149918305|NCT00298363|540833630|FG001|Overall Study|Lack of Efficacy|3|||
149918306|NCT00298363|540833631|FG002|Overall Study|Lack of Efficacy|0|||
149918307|NCT00135356|540833632|FG000|Overall Study|Adverse Event|6|||
149918308|NCT00135356|540833633|FG001|Overall Study|Adverse Event|2|||
149918309|NCT00135356|540833632|FG000|Overall Study|Lack of Efficacy|2|||
149918310|NCT00135356|540833633|FG001|Overall Study|Lack of Efficacy|0|||
149918311|NCT00135356|540833632|FG000|Overall Study|Lost to Follow-up|3|||
149918312|NCT00135356|540833633|FG001|Overall Study|Lost to Follow-up|1|||
149918313|NCT00135356|540833632|FG000|Overall Study|Surgery for abdominal fat|1|||
149918314|NCT00135356|540833633|FG001|Overall Study|Surgery for abdominal fat|0|||
149918315|NCT00135356|540833632|FG000|Overall Study|Change in antiviral regimen|0|||
149918316|NCT00135356|540833633|FG001|Overall Study|Change in antiviral regimen|1|||
149918317|NCT00135356|540833632|FG000|Overall Study|Poor/noncompliance|1|||
149918318|NCT00135356|540833633|FG001|Overall Study|Poor/noncompliance|1|||
149918319|NCT00135356|540833632|FG000|Overall Study|No longer meets study criteria|2|||
149918320|NCT00135356|540833633|FG001|Overall Study|No longer meets study criteria|0|||
149918321|NCT00135356|540833632|FG000|Overall Study|Withdrawal by Subject|2|||
149918322|NCT00135356|540833633|FG001|Overall Study|Withdrawal by Subject|4|||
149918323|NCT00153816|540833634|FG000|Overall Study|Death|6|||
149918324|NCT00153816|540833635|FG001|Overall Study|Death|5|||
149918325|NCT00153816|540833636|FG002|Overall Study|Death|4|||
149918326|NCT00153816|540833637|FG003|Overall Study|Death|6|||
149918327|NCT00153816|540833638|FG004|Overall Study|Death|0|||
149918328|NCT00153816|540833639|FG005|Overall Study|Death|2|||
149918329|NCT00153816|540833634|FG000|Overall Study|Lost to Follow-up|7|||
149918330|NCT00153816|540833635|FG001|Overall Study|Lost to Follow-up|8|||
149918331|NCT00153816|540833636|FG002|Overall Study|Lost to Follow-up|5|||
149918332|NCT00153816|540833637|FG003|Overall Study|Lost to Follow-up|8|||
149918333|NCT00153816|540833638|FG004|Overall Study|Lost to Follow-up|7|||
149918334|NCT00153816|540833639|FG005|Overall Study|Lost to Follow-up|9|||
149918335|NCT00153816|540833634|FG000|Overall Study|Withdrawal by Subject|9|||
149918336|NCT00153816|540833635|FG001|Overall Study|Withdrawal by Subject|9|||
149918337|NCT00153816|540833636|FG002|Overall Study|Withdrawal by Subject|9|||
149918338|NCT00153816|540833637|FG003|Overall Study|Withdrawal by Subject|4|||
149918339|NCT00153816|540833638|FG004|Overall Study|Withdrawal by Subject|1|||
149918340|NCT00153816|540833639|FG005|Overall Study|Withdrawal by Subject|5|||
149918341|NCT00153816|540833634|FG000|Overall Study|Follow-up exam not done|8|||
149918342|NCT00153816|540833635|FG001|Overall Study|Follow-up exam not done|7|||
149918343|NCT00153816|540833636|FG002|Overall Study|Follow-up exam not done|11|||
149918344|NCT00153816|540833637|FG003|Overall Study|Follow-up exam not done|10|||
149918345|NCT00153816|540833638|FG004|Overall Study|Follow-up exam not done|8|||
149918346|NCT00153816|540833639|FG005|Overall Study|Follow-up exam not done|9|||
149918347|NCT00153816|540833634|FG000|Overall Study|Follow-up exam done, histology missing|2|||
149918348|NCT00153816|540833635|FG001|Overall Study|Follow-up exam done, histology missing|3|||
149918349|NCT00153816|540833636|FG002|Overall Study|Follow-up exam done, histology missing|3|||
149918350|NCT00153816|540833637|FG003|Overall Study|Follow-up exam done, histology missing|3|||
149918351|NCT00153816|540833638|FG004|Overall Study|Follow-up exam done, histology missing|1|||
149918352|NCT00153816|540833639|FG005|Overall Study|Follow-up exam done, histology missing|2|||
149918353|NCT01533688|540833640|FG000|Overall Study|Withdrawal by Subject|5|||
149918354|NCT01533688|540833641|FG001|Overall Study|Withdrawal by Subject|4|||
149918355|NCT01533688|540833642|FG002|Overall Study|Withdrawal by Subject|3|||
149918356|NCT01533688|540833640|FG000|Overall Study|Medically unstable|1|||
149918357|NCT01533688|540833641|FG001|Overall Study|Medically unstable|3|||
149918358|NCT01533688|540833642|FG002|Overall Study|Medically unstable|3|||
149918359|NCT01533688|540833640|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
149918360|NCT01533688|540833641|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
149918361|NCT01533688|540833642|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
149918362|NCT02263729|540833643|FG000|Overall Study|Lost to Follow-up|1|||
149918363|NCT02263729|540833644|FG001|Overall Study|Lost to Follow-up|1|||
149918364|NCT04591015|540833645|FG000|Overall Study|Death|6|||
149918365|NCT04591015|540833646|FG001|Overall Study|Death|4|||
149918366|NCT04591015|540833645|FG000|Overall Study|Withdrawal by Subject|6|||
149918367|NCT04591015|540833646|FG001|Overall Study|Withdrawal by Subject|3|||
149918368|NCT04591015|540833645|FG000|Overall Study|Lost to Follow-up|16|||
149918369|NCT04591015|540833646|FG001|Overall Study|Lost to Follow-up|11|||
149918370|NCT02509078|540833647|FG000|Overall Study|Protocol Violation|1|||
149918371|NCT02509078|540833648|FG001|Overall Study|Protocol Violation|1|||
149918372|NCT02686814|540833649|FG000|Overall Study|Physician Decision|14|||
149918373|NCT02686814|540833649|FG000|Overall Study|Withdrawal by Subject|4|||
149918374|NCT02686814|540833649|FG000|Overall Study|Death|1|||
149918375|NCT02368886|540833652|FG000|Overall Study|Cancel|1|||
149918376|NCT02368886|540833653|FG001|Overall Study|Cancel|1|||
149918377|NCT02368886|540833654|FG002|Overall Study|Cancel|1|||
149918378|NCT02368886|540833655|FG003|Overall Study|Cancel|3|||
149918379|NCT02368886|540833652|FG000|Overall Study|Ineligible|0|||
149918380|NCT02368886|540833653|FG001|Overall Study|Ineligible|0|||
149918381|NCT02368886|540833654|FG002|Overall Study|Ineligible|0|||
149918382|NCT02368886|540833655|FG003|Overall Study|Ineligible|1|||
149918383|NCT00631163|540833656|FG000|Number of Participants in Year 1|Adverse Event|12|||
149918384|NCT00631163|540833656|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
149918385|NCT00631163|540833656|FG000|Number of Participants in Year 1|Death|6|||
149918386|NCT00631163|540833656|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
149918387|NCT00631163|540833656|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
149918388|NCT00631163|540833656|FG000|Number of Participants in Year 1|Administrative problems|6|||
149918389|NCT00631163|540833656|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
149918390|NCT00631163|540833656|FG000|Number of Participants in Year 2|Adverse Event|1|||
149918391|NCT00631163|540833656|FG000|Number of Participants in Year 2|Protocol Violation|1|||
149918392|NCT00631163|540833656|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
149918393|NCT00253370|540833657|FG000|Overall Study|Adverse Event|18|||
149918394|NCT00253370|540833657|FG000|Overall Study|Disease progression|13|||
149918395|NCT00253370|540833657|FG000|Overall Study|Death|2|||
149918396|NCT00253370|540833657|FG000|Overall Study|Withdrawal by Subject|6|||
149918397|NCT00253370|540833657|FG000|Overall Study|Non-protocol therapy|1|||
149918398|NCT00253370|540833657|FG000|Overall Study|Physician Decision|1|||
149918399|NCT00253370|540833657|FG000|Overall Study|Protocol Violation|1|||
149918400|NCT00253370|540833657|FG000|Overall Study|Abdominal pain due to disease|1|||
149918401|NCT01937884|540833660|FG000|Overall Study|Withdrawal by Subject|1|||
149918402|NCT01937884|540833661|FG001|Overall Study|Withdrawal by Subject|0|||
149918403|NCT00004088|540833662|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
149918404|NCT00004088|540833662|FG000|Overall Study|Withdrawal by Subject|1|||
149918405|NCT00004088|540833662|FG000|Overall Study|Protocol Violation|3|||
149918406|NCT00004088|540833662|FG000|Overall Study|Physician Decision|1|||
149918407|NCT01853696|540833668|FG000|Overall Study|Withdrawal by Subject|1|||
149918408|NCT01853696|540833669|FG001|Overall Study|Withdrawal by Subject|1|||
149918409|NCT01853696|540833668|FG000|Overall Study|Lost to Follow-up|5|||
149918410|NCT01853696|540833669|FG001|Overall Study|Lost to Follow-up|4|||
149918411|NCT02191046|540833680|FG000|Overall Study|low compliance|5|||
149918412|NCT02191046|540833681|FG001|Overall Study|low compliance|1|||
149918413|NCT01964716|540833682|FG000|Overall Study|Withdrawal by Subject|2|||
149918414|NCT01964716|540833683|FG001|Overall Study|Withdrawal by Subject|3|||
149918415|NCT01964716|540833682|FG000|Overall Study|Lost to Follow-up|1|||
149918416|NCT01964716|540833683|FG001|Overall Study|Lost to Follow-up|2|||
149918417|NCT01964716|540833682|FG000|Overall Study|No longer met eligibility criteria|1|||
149918418|NCT01964716|540833683|FG001|Overall Study|No longer met eligibility criteria|1|||
149918419|NCT01964716|540833682|FG000|Overall Study|Death|1|||
149918420|NCT01964716|540833683|FG001|Overall Study|Death|0|||
149918421|NCT02147067|540833684|FG000|Overall Study|Withdrawal by Subject|2|||
149918422|NCT02147067|540833685|FG001|Overall Study|Withdrawal by Subject|2|||
149918423|NCT01693185|540833687|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
149918424|NCT01693185|540833688|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
149918425|NCT01017601|540833691|FG000|Overall Study|Disease Progression|12|||
149918426|NCT01017601|540833692|FG001|Overall Study|Disease Progression|12|||
149918427|NCT01017601|540833691|FG000|Overall Study|Withdrawal by Subject|0|||
149918428|NCT01017601|540833692|FG001|Overall Study|Withdrawal by Subject|1|||
149918429|NCT00187278|540833694|FG000|Overall Study|Protocol Violation|10|||
149918430|NCT00187278|540833695|FG001|Overall Study|Protocol Violation|13|||
149918431|NCT01857102|540833696|FG000|Period 1|No longer meets Eligibility Criteria|0|||
149918432|NCT01857102|540833697|FG001|Period 1|No longer meets Eligibility Criteria|2|||
149918433|NCT01857102|540833696|FG000|Period 1|Lost to Follow-up|0|||
149918434|NCT01857102|540833697|FG001|Period 1|Lost to Follow-up|3|||
149918435|NCT01857102|540833696|FG000|Period 1|Unsatisfactory Lens Fit|1|||
149918436|NCT01857102|540833697|FG001|Period 1|Unsatisfactory Lens Fit|0|||
149918437|NCT01857102|540833696|FG000|Period 1|Unsatisfactory Visual Response|1|||
149918438|NCT01857102|540833697|FG001|Period 1|Unsatisfactory Visual Response|0|||
149918439|NCT01857102|540833696|FG000|Period 1|Physician Decision|1|||
149918440|NCT01857102|540833697|FG001|Period 1|Physician Decision|0|||
149918441|NCT01857102|540833696|FG000|Period 2|Lens Discomfort|1|||
149918442|NCT01857102|540833697|FG001|Period 2|Lens Discomfort|0|||
150029377|NCT00866177|541244182|FG000|Overall Study|Withdrawal by Subject|1|||
149918443|NCT01857102|540833696|FG000|Period 2|Unsatisfactory Lens Fit|1|||
149918444|NCT01857102|540833697|FG001|Period 2|Unsatisfactory Lens Fit|0|||
149918445|NCT00090584|540833701|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
149918446|NCT00090584|540833702|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
149918447|NCT00090584|540833701|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
149918448|NCT00090584|540833702|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
149918449|NCT02735096|540833703|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
149918450|NCT01080391|540833711|FG000|Overall Study|Randomized but not treated|7|||
149918451|NCT01080391|540833712|FG001|Overall Study|Randomized but not treated|4|||
149918452|NCT02117713|540833715|FG000|Week 48|Adverse Event|4|||
149918453|NCT02117713|540833715|FG000|Week 48|Withdrawal by caregiver|2|||
149918454|NCT02117713|540833715|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
149918455|NCT02117713|540833715|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
149918456|NCT02117713|540833715|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
149918457|NCT02117713|540833715|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
149918458|NCT01094782|540833716|FG000|Overall Study|Withdrawal by Subject|5|||
149918459|NCT01094782|540833717|FG001|Overall Study|Withdrawal by Subject|5|||
149918460|NCT01094782|540833718|FG002|Overall Study|Withdrawal by Subject|1|||
149918461|NCT01094782|540833719|FG003|Overall Study|Withdrawal by Subject|5|||
149918462|NCT01094782|540833720|FG004|Overall Study|Withdrawal by Subject|5|||
149918463|NCT01094782|540833721|FG005|Overall Study|Withdrawal by Subject|0|||
149918464|NCT01094782|540833716|FG000|Overall Study|Lost to Follow-up|1|||
149918465|NCT01094782|540833717|FG001|Overall Study|Lost to Follow-up|0|||
149918466|NCT01094782|540833718|FG002|Overall Study|Lost to Follow-up|0|||
149918467|NCT01094782|540833719|FG003|Overall Study|Lost to Follow-up|2|||
149918468|NCT01094782|540833720|FG004|Overall Study|Lost to Follow-up|1|||
149918469|NCT01094782|540833721|FG005|Overall Study|Lost to Follow-up|4|||
149918470|NCT01094782|540833716|FG000|Overall Study|Positive Drug Screen|2|||
149918471|NCT01094782|540833717|FG001|Overall Study|Positive Drug Screen|2|||
149918472|NCT01094782|540833718|FG002|Overall Study|Positive Drug Screen|1|||
149918473|NCT01094782|540833719|FG003|Overall Study|Positive Drug Screen|1|||
149918474|NCT01094782|540833720|FG004|Overall Study|Positive Drug Screen|3|||
149918475|NCT01094782|540833721|FG005|Overall Study|Positive Drug Screen|2|||
149918476|NCT01094782|540833716|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
149918477|NCT01094782|540833717|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
149918478|NCT01094782|540833718|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
149918479|NCT01094782|540833719|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
149918480|NCT01094782|540833720|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
149918481|NCT01094782|540833721|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
149918482|NCT01094782|540833716|FG000|Overall Study|Unable to Complete Questionnaires|0|||
149918483|NCT01094782|540833717|FG001|Overall Study|Unable to Complete Questionnaires|1|||
149918484|NCT01094782|540833718|FG002|Overall Study|Unable to Complete Questionnaires|0|||
150142914|NCT01966003|541660040|FG001|Overall Study|Death|36|||
150142915|NCT01966003|541660039|FG000|Overall Study|Protocol Violation|6|||
150142916|NCT01966003|541660040|FG001|Overall Study|Protocol Violation|4|||
150142917|NCT01966003|541660039|FG000|Overall Study|Lost to Follow-up|4|||
150142918|NCT01966003|541660040|FG001|Overall Study|Lost to Follow-up|3|||
150142919|NCT01966003|541660039|FG000|Overall Study|Physician Decision|12|||
150142920|NCT01966003|541660040|FG001|Overall Study|Physician Decision|13|||
150142921|NCT01966003|541660039|FG000|Overall Study|Withdrawal by Subject|29|||
150142922|NCT01966003|541660040|FG001|Overall Study|Withdrawal by Subject|19|||
150142923|NCT01966003|541660039|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
150142924|NCT01966003|541660040|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
150142925|NCT01966003|541660039|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
150142926|NCT01966003|541660040|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
150142927|NCT01966003|541660039|FG000|Overall Study|Other|1|||
150142928|NCT01966003|541660040|FG001|Overall Study|Other|1|||
150142929|NCT00674570|541660041|FG000|Overall Study|Withdrawal by Subject|0|||
150142930|NCT00674570|541660042|FG001|Overall Study|Withdrawal by Subject|2|||
150142931|NCT00674570|541660043|FG002|Overall Study|Withdrawal by Subject|0|||
150142932|NCT02110732|541660049|FG000|Overall Study|Physician Decision|5|||
150142933|NCT02110732|541660050|FG001|Overall Study|Physician Decision|2|||
150142934|NCT02110732|541660049|FG000|Overall Study|Lost to Follow-up|1|||
150142935|NCT02110732|541660050|FG001|Overall Study|Lost to Follow-up|1|||
150142936|NCT00633932|541660051|FG000|Overall Study|Adverse Event|1|||
150142937|NCT00633932|541660052|FG001|Overall Study|Adverse Event|3|||
150142938|NCT00633932|541660053|FG002|Overall Study|Adverse Event|4|||
150142939|NCT00633932|541660051|FG000|Overall Study|Withdrawal by Subject|3|||
150142940|NCT00633932|541660052|FG001|Overall Study|Withdrawal by Subject|9|||
150142941|NCT00633932|541660053|FG002|Overall Study|Withdrawal by Subject|1|||
150142942|NCT00633932|541660051|FG000|Overall Study|Lost to Follow-up|1|||
150142943|NCT00633932|541660052|FG001|Overall Study|Lost to Follow-up|0|||
150142944|NCT00633932|541660053|FG002|Overall Study|Lost to Follow-up|2|||
150029378|NCT00866177|541244182|FG000|Overall Study|Not Treated|151|||
150142945|NCT00633932|541660051|FG000|Overall Study|Protocol Violation|5|||
150142946|NCT00633932|541660052|FG001|Overall Study|Protocol Violation|2|||
150142947|NCT00633932|541660053|FG002|Overall Study|Protocol Violation|3|||
150142948|NCT00633932|541660051|FG000|Overall Study|Physician Decision|0|||
150142949|NCT00633932|541660052|FG001|Overall Study|Physician Decision|0|||
150142950|NCT00633932|541660053|FG002|Overall Study|Physician Decision|1|||
150142951|NCT00633932|541660051|FG000|Overall Study|Doctor's judgement|1|||
150142952|NCT00633932|541660052|FG001|Overall Study|Doctor's judgement|0|||
150142953|NCT00633932|541660053|FG002|Overall Study|Doctor's judgement|0|||
150142954|NCT00633932|541660051|FG000|Overall Study|Moved Away|1|||
150142955|NCT00633932|541660052|FG001|Overall Study|Moved Away|0|||
149918485|NCT01094782|540833719|FG003|Overall Study|Unable to Complete Questionnaires|0|||
149918486|NCT01094782|540833720|FG004|Overall Study|Unable to Complete Questionnaires|0|||
149918487|NCT01094782|540833721|FG005|Overall Study|Unable to Complete Questionnaires|0|||
149918488|NCT01094782|540833716|FG000|Overall Study|Healthy Subject Had Pain|0|||
149918489|NCT01094782|540833717|FG001|Overall Study|Healthy Subject Had Pain|1|||
149918490|NCT01094782|540833718|FG002|Overall Study|Healthy Subject Had Pain|0|||
149918491|NCT01094782|540833719|FG003|Overall Study|Healthy Subject Had Pain|0|||
150142956|NCT00633932|541660053|FG002|Overall Study|Moved Away|0|||
150142957|NCT00482274|541660054|FG000|Overall Study|Adverse Event|1|||
150142958|NCT04836858|541660055|FG000|Overall Study|Adverse Event|0|||
150142959|NCT04836858|541660056|FG001|Overall Study|Adverse Event|0|||
150142960|NCT04836858|541660057|FG002|Overall Study|Adverse Event|0|||
150142961|NCT04836858|541660058|FG003|Overall Study|Adverse Event|1|||
150142962|NCT04836858|541660055|FG000|Overall Study|Lost to Follow-up|1|||
150142963|NCT04836858|541660056|FG001|Overall Study|Lost to Follow-up|0|||
150142964|NCT04836858|541660057|FG002|Overall Study|Lost to Follow-up|0|||
150142965|NCT04836858|541660058|FG003|Overall Study|Lost to Follow-up|0|||
150142966|NCT04836858|541660055|FG000|Overall Study|Subject/Guardian decision|3|||
150142967|NCT04836858|541660056|FG001|Overall Study|Subject/Guardian decision|0|||
150142968|NCT04836858|541660057|FG002|Overall Study|Subject/Guardian decision|0|||
150142969|NCT04836858|541660058|FG003|Overall Study|Subject/Guardian decision|1|||
150142970|NCT04836858|541660055|FG000|Overall Study|Randomized but not treated|4|||
150142971|NCT04836858|541660056|FG001|Overall Study|Randomized but not treated|0|||
150142972|NCT04836858|541660057|FG002|Overall Study|Randomized but not treated|0|||
150142973|NCT04836858|541660058|FG003|Overall Study|Randomized but not treated|0|||
150142974|NCT04887948|541660062|FG000|Overall Study|Death|1|||
150142975|NCT04887948|541660063|FG001|Overall Study|Death|0|||
150142976|NCT04887948|541660064|FG002|Overall Study|Death|0|||
149918492|NCT01094782|540833720|FG004|Overall Study|Healthy Subject Had Pain|0|||
149918493|NCT01094782|540833721|FG005|Overall Study|Healthy Subject Had Pain|0|||
150142977|NCT04887948|541660062|FG000|Overall Study|Lost to Follow-up|1|||
150142978|NCT04887948|541660063|FG001|Overall Study|Lost to Follow-up|0|||
150142979|NCT04887948|541660064|FG002|Overall Study|Lost to Follow-up|3|||
150142980|NCT04887948|541660062|FG000|Overall Study|Physician Decision|0|||
150142981|NCT04887948|541660063|FG001|Overall Study|Physician Decision|4|||
150142982|NCT04887948|541660064|FG002|Overall Study|Physician Decision|1|||
150142983|NCT04887948|541660062|FG000|Overall Study|Protocol Violation|1|||
150142984|NCT04887948|541660063|FG001|Overall Study|Protocol Violation|1|||
150142985|NCT04887948|541660064|FG002|Overall Study|Protocol Violation|0|||
150142986|NCT04887948|541660062|FG000|Overall Study|Withdrawal by Subject|0|||
150142987|NCT04887948|541660063|FG001|Overall Study|Withdrawal by Subject|6|||
150142988|NCT04887948|541660064|FG002|Overall Study|Withdrawal by Subject|1|||
150142989|NCT04887948|541660062|FG000|Overall Study|No longer met eligibility criteria|1|||
150142990|NCT04887948|541660063|FG001|Overall Study|No longer met eligibility criteria|2|||
150142991|NCT04887948|541660064|FG002|Overall Study|No longer met eligibility criteria|1|||
150142992|NCT04887948|541660062|FG000|Overall Study|Other|2|||
150142993|NCT04887948|541660063|FG001|Overall Study|Other|1|||
150142994|NCT04887948|541660064|FG002|Overall Study|Other|1|||
150142995|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
150142996|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
150142997|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Adverse Event|2|||
150142998|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Adverse Event|5|||
150142999|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
150143000|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
150143001|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
150143002|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
150143003|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Randomized by error|0|||
150143004|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Randomized by error|5|||
150143005|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
150143006|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
150143007|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
150143008|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
149918494|NCT01094782|540833716|FG000|Overall Study|Hypertension|0|||
150143009|NCT02948959|541660065|FG000|52 Weeks Treatment Period|Change of residence location|0|||
150143010|NCT02948959|541660066|FG001|52 Weeks Treatment Period|Change of residence location|1|||
150143011|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
150143012|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
150143013|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
150143014|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
150143015|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
150143016|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
150143017|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
150143018|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
150143019|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
150143020|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
150143021|NCT02948959|541660065|FG000|12 Weeks Follow-up Period|Study site closure|1|||
150143022|NCT02948959|541660066|FG001|12 Weeks Follow-up Period|Study site closure|0|||
150143023|NCT00787319|541660067|FG000|Overall Study|Lost to Follow-up|2|||
150143024|NCT00787319|541660067|FG000|Overall Study|Withdrawal by Subject|15|||
150143025|NCT00787319|541660067|FG000|Overall Study|Adverse Event|3|||
150143026|NCT00787319|541660067|FG000|Overall Study|Objective progression or relapse|30|||
150143027|NCT00787319|541660067|FG000|Overall Study|Lack of Efficacy|1|||
149918495|NCT01094782|540833717|FG001|Overall Study|Hypertension|0|||
149918496|NCT01094782|540833718|FG002|Overall Study|Hypertension|1|||
149918497|NCT01094782|540833719|FG003|Overall Study|Hypertension|0|||
149918498|NCT01094782|540833720|FG004|Overall Study|Hypertension|0|||
149918499|NCT01094782|540833721|FG005|Overall Study|Hypertension|0|||
149918500|NCT01094782|540833716|FG000|Overall Study|Wrong Pain Condition|0|||
149918501|NCT01094782|540833717|FG001|Overall Study|Wrong Pain Condition|0|||
149918502|NCT01094782|540833718|FG002|Overall Study|Wrong Pain Condition|0|||
149918503|NCT01094782|540833719|FG003|Overall Study|Wrong Pain Condition|2|||
149918504|NCT01094782|540833720|FG004|Overall Study|Wrong Pain Condition|1|||
149918505|NCT01094782|540833721|FG005|Overall Study|Wrong Pain Condition|1|||
149918506|NCT01094782|540833716|FG000|Overall Study|Recent Interventional Injection|0|||
149918507|NCT01094782|540833717|FG001|Overall Study|Recent Interventional Injection|0|||
149918508|NCT01094782|540833718|FG002|Overall Study|Recent Interventional Injection|0|||
149918509|NCT01094782|540833719|FG003|Overall Study|Recent Interventional Injection|0|||
149918510|NCT01094782|540833720|FG004|Overall Study|Recent Interventional Injection|0|||
149918511|NCT01094782|540833721|FG005|Overall Study|Recent Interventional Injection|1|||
149918512|NCT01094782|540833716|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
149918513|NCT01094782|540833717|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
149918514|NCT01094782|540833718|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
149918515|NCT01094782|540833719|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
149918516|NCT01094782|540833720|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
149918517|NCT01094782|540833721|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
149918518|NCT01094782|540833716|FG000|Overall Study|Noncompliance With Study Schedule|0|||
149918519|NCT01094782|540833717|FG001|Overall Study|Noncompliance With Study Schedule|0|||
149918520|NCT01094782|540833718|FG002|Overall Study|Noncompliance With Study Schedule|0|||
149918521|NCT01094782|540833719|FG003|Overall Study|Noncompliance With Study Schedule|1|||
149918522|NCT01094782|540833720|FG004|Overall Study|Noncompliance With Study Schedule|0|||
149918523|NCT01094782|540833721|FG005|Overall Study|Noncompliance With Study Schedule|0|||
149918524|NCT00957905|540833727|FG000|Part B|Not Treated|0|||
149918525|NCT00957905|540833728|FG001|Part B|Not Treated|1|||
149918526|NCT00957905|540833727|FG000|Part B|Physician Decision|0|||
149918527|NCT00957905|540833728|FG001|Part B|Physician Decision|1|||
149918528|NCT00957905|540833727|FG000|Part B|Death|0|||
149918529|NCT00957905|540833728|FG001|Part B|Death|1|||
149918530|NCT00957905|540833727|FG000|Part B|Protocol Violation|0|||
149918531|NCT00957905|540833728|FG001|Part B|Protocol Violation|1|||
149918532|NCT02083653|540833729|FG000|Overall Study|Randomized but not Treated|0|||
149918533|NCT02083653|540833730|FG001|Overall Study|Randomized but not Treated|2|||
150143028|NCT00787319|541660067|FG000|Overall Study|Budget exhausted/exceeded|1|||
150143029|NCT00787319|541660067|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
150143030|NCT00787319|541660067|FG000|Overall Study|No health insurance reimbursement|2|||
150143031|NCT00787319|541660067|FG000|Overall Study|Stabilized disease findings|3|||
150143032|NCT00787319|541660067|FG000|Overall Study|Inactive disease|5|||
150143033|NCT02312856|541660068|FG000|Overall Study|Death|1|||
150143034|NCT02312856|541660068|FG000|Overall Study|Lost to Follow-up|3|||
150143035|NCT04415151|541660069|FG000|Overall Study|Death|1|||
150143036|NCT04415151|541660070|FG001|Overall Study|Death|1|||
150143037|NCT04415151|541660069|FG000|Overall Study|Withdrawal by Subject|1|||
150143038|NCT04415151|541660070|FG001|Overall Study|Withdrawal by Subject|0|||
150143039|NCT00409786|541660071|FG000|Overall Study|Withdrawal by Subject|3|||
150143040|NCT00638235|541660072|FG000|Overall Study|Lost to Follow-up|31|||
150143041|NCT00638235|541660073|FG001|Overall Study|Lost to Follow-up|3|||
150143042|NCT00638235|541660074|FG002|Overall Study|Lost to Follow-up|18|||
150143043|NCT00638235|541660075|FG003|Overall Study|Lost to Follow-up|10|||
150143044|NCT00638235|541660076|FG004|Overall Study|Lost to Follow-up|13|||
149918534|NCT02083653|540833731|FG002|Overall Study|Randomized but not Treated|7|||
149918535|NCT02083653|540833729|FG000|Overall Study|Adverse Event|12|||
149918536|NCT02083653|540833730|FG001|Overall Study|Adverse Event|5|||
149918537|NCT02083653|540833731|FG002|Overall Study|Adverse Event|4|||
150143045|NCT00638235|541660077|FG005|Overall Study|Lost to Follow-up|26|||
150143046|NCT00638235|541660078|FG006|Overall Study|Lost to Follow-up|0|||
150143047|NCT00638235|541660079|FG007|Overall Study|Lost to Follow-up|1|||
150143048|NCT00638235|541660080|FG008|Overall Study|Lost to Follow-up|18|||
150143049|NCT01641926|541660087|FG000|Overall Study|Adverse Event|5|||
150143050|NCT01641926|541660088|FG001|Overall Study|Adverse Event|2|||
150143051|NCT01641926|541660089|FG002|Overall Study|Adverse Event|3|||
150143052|NCT01641926|541660090|FG003|Overall Study|Adverse Event|1|||
150143053|NCT01641926|541660087|FG000|Overall Study|Lost to Follow-up|2|||
150143054|NCT01641926|541660088|FG001|Overall Study|Lost to Follow-up|2|||
150143055|NCT01641926|541660089|FG002|Overall Study|Lost to Follow-up|1|||
150143056|NCT01641926|541660090|FG003|Overall Study|Lost to Follow-up|0|||
150143057|NCT01641926|541660087|FG000|Overall Study|Physician Decision|6|||
150143058|NCT01641926|541660088|FG001|Overall Study|Physician Decision|5|||
149918538|NCT02083653|540833729|FG000|Overall Study|Lost to Follow-up|1|||
149918539|NCT02083653|540833730|FG001|Overall Study|Lost to Follow-up|0|||
149918540|NCT02083653|540833731|FG002|Overall Study|Lost to Follow-up|0|||
149918541|NCT02083653|540833729|FG000|Overall Study|Death|2|||
149918542|NCT02083653|540833730|FG001|Overall Study|Death|2|||
149918543|NCT02083653|540833731|FG002|Overall Study|Death|2|||
149918544|NCT02083653|540833729|FG000|Overall Study|Progressive Disease|65|||
149918545|NCT02083653|540833730|FG001|Overall Study|Progressive Disease|73|||
149918546|NCT02083653|540833731|FG002|Overall Study|Progressive Disease|63|||
149918547|NCT02083653|540833729|FG000|Overall Study|Withdrawal by Subject|2|||
150143059|NCT01641926|541660089|FG002|Overall Study|Physician Decision|0|||
150143060|NCT01641926|541660090|FG003|Overall Study|Physician Decision|1|||
150143061|NCT01641926|541660087|FG000|Overall Study|Protocol Violation|1|||
150143062|NCT01641926|541660088|FG001|Overall Study|Protocol Violation|0|||
150143063|NCT01641926|541660089|FG002|Overall Study|Protocol Violation|0|||
150143064|NCT01641926|541660090|FG003|Overall Study|Protocol Violation|1|||
150143065|NCT01641926|541660087|FG000|Overall Study|Withdrawal by Subject|13|||
150143066|NCT01641926|541660088|FG001|Overall Study|Withdrawal by Subject|5|||
150143067|NCT01641926|541660089|FG002|Overall Study|Withdrawal by Subject|6|||
150143068|NCT01641926|541660090|FG003|Overall Study|Withdrawal by Subject|1|||
150143069|NCT01641926|541660087|FG000|Overall Study|Not Treated|1|||
150143070|NCT01641926|541660088|FG001|Overall Study|Not Treated|1|||
150143071|NCT01641926|541660089|FG002|Overall Study|Not Treated|1|||
150143072|NCT01641926|541660090|FG003|Overall Study|Not Treated|0|||
150143073|NCT00708435|541660091|FG000|Overall Study|Death / Serious Adverse Event|10|||
150143074|NCT00708435|541660092|FG001|Overall Study|Death / Serious Adverse Event|5|||
150143075|NCT00708435|541660091|FG000|Overall Study|Lost to Follow-up|9|||
150143076|NCT00708435|541660092|FG001|Overall Study|Lost to Follow-up|4|||
150143077|NCT00708435|541660091|FG000|Overall Study|Withdrawal by Subject|3|||
150143078|NCT00708435|541660092|FG001|Overall Study|Withdrawal by Subject|7|||
150143079|NCT00708435|541660091|FG000|Overall Study|Adverse Event|1|||
150143080|NCT00708435|541660092|FG001|Overall Study|Adverse Event|0|||
150143081|NCT00708435|541660091|FG000|Overall Study|Protocol Violation|0|||
150143082|NCT00708435|541660092|FG001|Overall Study|Protocol Violation|1|||
150143083|NCT00708435|541660091|FG000|Overall Study|Intervention by primary care physician|1|||
150143084|NCT00708435|541660092|FG001|Overall Study|Intervention by primary care physician|0|||
150143085|NCT00708435|541660091|FG000|Overall Study|Refused hospitalization|1|||
150143086|NCT00708435|541660092|FG001|Overall Study|Refused hospitalization|0|||
150143087|NCT01691521|541660093|FG000|Overall Study|Adverse Event|4|||
150143088|NCT01691521|541660094|FG001|Overall Study|Adverse Event|0|||
150143089|NCT01691521|541660095|FG002|Overall Study|Adverse Event|1|||
150143090|NCT01691521|541660093|FG000|Overall Study|Lack of Efficacy|1|||
150143091|NCT01691521|541660094|FG001|Overall Study|Lack of Efficacy|1|||
150143092|NCT01691521|541660095|FG002|Overall Study|Lack of Efficacy|2|||
150143093|NCT01691521|541660093|FG000|Overall Study|Protocol Violation|0|||
150143094|NCT01691521|541660094|FG001|Overall Study|Protocol Violation|3|||
150143095|NCT01691521|541660095|FG002|Overall Study|Protocol Violation|0|||
150143096|NCT01691521|541660093|FG000|Overall Study|Lost to Follow-up|0|||
149918548|NCT02083653|540833730|FG001|Overall Study|Withdrawal by Subject|1|||
149918549|NCT02083653|540833731|FG002|Overall Study|Withdrawal by Subject|2|||
149918550|NCT02083653|540833729|FG000|Overall Study|Other Events|0|||
149918551|NCT02083653|540833730|FG001|Overall Study|Other Events|2|||
149918552|NCT02083653|540833731|FG002|Overall Study|Other Events|2|||
149918553|NCT02083653|540833729|FG000|Overall Study|Reason Missing|0|||
149918554|NCT02083653|540833730|FG001|Overall Study|Reason Missing|0|||
149918555|NCT02083653|540833731|FG002|Overall Study|Reason Missing|4|||
149918556|NCT02073656|540833732|FG000|Primary Study|Lost to Follow-up|6|||
149918557|NCT02073656|540833732|FG000|Primary Study|Death|1|||
149918558|NCT02073656|540833732|FG000|Primary Study|Withdrew Consent|1|||
149918559|NCT02054910|540833740|FG000|Overall Study|Lost to Follow-up|4|||
150143097|NCT01691521|541660094|FG001|Overall Study|Lost to Follow-up|2|||
150143098|NCT01691521|541660095|FG002|Overall Study|Lost to Follow-up|2|||
150143099|NCT01691521|541660093|FG000|Overall Study|Physician Decision|2|||
150143100|NCT01691521|541660094|FG001|Overall Study|Physician Decision|1|||
150143101|NCT01691521|541660095|FG002|Overall Study|Physician Decision|0|||
149918560|NCT02054910|540833741|FG001|Overall Study|Lost to Follow-up|1|||
150143102|NCT01691521|541660093|FG000|Overall Study|Withdrawal by Subject|5|||
150143103|NCT01691521|541660094|FG001|Overall Study|Withdrawal by Subject|9|||
150143104|NCT01691521|541660095|FG002|Overall Study|Withdrawal by Subject|4|||
150143105|NCT02343003|541660096|FG000|Overall Study|Withdrawal by Subject|9|||
150143106|NCT02343003|541660097|FG001|Overall Study|Withdrawal by Subject|4|||
150143107|NCT02343003|541660096|FG000|Overall Study|Lost to Follow-up|5|||
150143108|NCT02343003|541660097|FG001|Overall Study|Lost to Follow-up|1|||
150143109|NCT02343003|541660096|FG000|Overall Study|Protocol Violation|1|||
150143110|NCT02343003|541660097|FG001|Overall Study|Protocol Violation|0|||
150143111|NCT02343003|541660096|FG000|Overall Study|Death|0|||
150143112|NCT02343003|541660097|FG001|Overall Study|Death|1|||
150143113|NCT02343003|541660096|FG000|Overall Study|exclusion criteria met|1|||
150143114|NCT02343003|541660097|FG001|Overall Study|exclusion criteria met|1|||
150143115|NCT02343003|541660096|FG000|Overall Study|terminated by sponsor|2|||
150143116|NCT02343003|541660097|FG001|Overall Study|terminated by sponsor|0|||
150143117|NCT03954743|541660098|FG000|Overall Study|Adverse Event|1|||
150143118|NCT03954743|541660099|FG001|Overall Study|Adverse Event|0|||
150143119|NCT03954743|541660098|FG000|Overall Study|Lost to Follow-up|6|||
150143120|NCT03954743|541660099|FG001|Overall Study|Lost to Follow-up|4|||
150143121|NCT03954743|541660098|FG000|Overall Study|Protocol Violation|1|||
150143122|NCT03954743|541660099|FG001|Overall Study|Protocol Violation|0|||
150143123|NCT03954743|541660098|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
150143124|NCT03954743|541660099|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
150143125|NCT03954743|541660098|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
150143126|NCT03954743|541660099|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150143127|NCT02281760|541660100|FG000|Overall Study|Withdrawal by Subject|1|||
149918561|NCT00432276|540833742|FG000|Overall Study|Hyperglycemic Rescue|44|||
149918562|NCT00432276|540833743|FG001|Overall Study|Hyperglycemic Rescue|87|||
149918563|NCT00432276|540833742|FG000|Overall Study|Adverse Event|13|||
149918564|NCT00432276|540833743|FG001|Overall Study|Adverse Event|16|||
149918565|NCT00432276|540833742|FG000|Overall Study|Protocol Violation|25|||
149918566|NCT00432276|540833743|FG001|Overall Study|Protocol Violation|20|||
150143128|NCT01725386|541660113|FG000|Overall Study|Death|84|||
150143129|NCT01725386|541660114|FG001|Overall Study|Death|40|||
150143130|NCT01725386|541660113|FG000|Overall Study|Lost to Follow-up|81|||
150143131|NCT01725386|541660114|FG001|Overall Study|Lost to Follow-up|6|||
150143132|NCT01725386|541660113|FG000|Overall Study|Withdrawal by Subject|10|||
150143133|NCT01725386|541660114|FG001|Overall Study|Withdrawal by Subject|0|||
150143134|NCT00879996|541660115|FG000|Overall Study|Lost to Follow-up|7|||
150143135|NCT00879996|541660116|FG001|Overall Study|Lost to Follow-up|6|||
150143136|NCT00879996|541660115|FG000|Overall Study|non-compliance|6|||
150143137|NCT00879996|541660116|FG001|Overall Study|non-compliance|4|||
150143138|NCT00879996|541660115|FG000|Overall Study|Physician Decision|1|||
150143139|NCT00879996|541660116|FG001|Overall Study|Physician Decision|2|||
150143140|NCT00879996|541660115|FG000|Overall Study|psychiatric problem|0|||
150143141|NCT00879996|541660116|FG001|Overall Study|psychiatric problem|1|||
150143142|NCT00879996|541660115|FG000|Overall Study|put on parole|1|||
150143143|NCT00879996|541660116|FG001|Overall Study|put on parole|0|||
150143144|NCT04772053|541660126|FG000|Overall Study|Physician Decision|2|||
150143145|NCT04772053|541660126|FG000|Overall Study|Withdrawal by Subject|3|||
150143146|NCT04772053|541660126|FG000|Overall Study|Study Terminated by Sponsor|1|||
150143147|NCT05400746|541660128|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
150143148|NCT05400746|541660129|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
150143149|NCT05400746|541660130|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
150143150|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
150143151|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
150143152|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
150143153|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
150143154|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
150143155|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
150143156|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
150143157|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Physician Decision|4|||
150143158|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Physician Decision|1|||
150143159|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Physician Decision|3|||
150143160|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Physician Decision|0|||
150143161|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Physician Decision|0|||
150143162|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Physician Decision|1|||
149918567|NCT00432276|540833742|FG000|Overall Study|Lost to Follow-up|6|||
149918568|NCT00432276|540833743|FG001|Overall Study|Lost to Follow-up|2|||
149918569|NCT00432276|540833742|FG000|Overall Study|Withdrawal by Subject|25|||
149918570|NCT00432276|540833743|FG001|Overall Study|Withdrawal by Subject|20|||
149918571|NCT00432276|540833742|FG000|Overall Study|Physician Decision|6|||
149918572|NCT00432276|540833743|FG001|Overall Study|Physician Decision|8|||
149918573|NCT00432276|540833742|FG000|Overall Study|Other|2|||
149918574|NCT00432276|540833743|FG001|Overall Study|Other|3|||
149918575|NCT00207727|540833744|FG000|Overall Study|Withdrawal by Subject|0|||
149918576|NCT00207727|540833745|FG001|Overall Study|Withdrawal by Subject|0|||
149918577|NCT00207727|540833746|FG002|Overall Study|Withdrawal by Subject|0|||
149918578|NCT00207727|540833747|FG003|Overall Study|Withdrawal by Subject|0|||
149918579|NCT00207727|540833748|FG004|Overall Study|Withdrawal by Subject|1|||
149918580|NCT00207727|540833744|FG000|Overall Study|Lost to Follow-up|0|||
149918581|NCT00207727|540833745|FG001|Overall Study|Lost to Follow-up|1|||
149918582|NCT00207727|540833746|FG002|Overall Study|Lost to Follow-up|0|||
149918583|NCT00207727|540833747|FG003|Overall Study|Lost to Follow-up|0|||
149918584|NCT00207727|540833748|FG004|Overall Study|Lost to Follow-up|0|||
149918585|NCT00207727|540833744|FG000|Overall Study|Other|38|||
149918586|NCT00207727|540833745|FG001|Overall Study|Other|41|||
150143163|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Physician Decision|0|||
150143164|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Other|0|||
150143165|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Other|1|||
150143166|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Other|0|||
150143167|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Other|0|||
150143168|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Other|0|||
150143169|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Other|0|||
150143170|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Other|0|||
150143171|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143172|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143173|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143174|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143175|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143176|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
150143177|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
150143178|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
150143179|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
150143180|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
150143181|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
150143182|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
150143183|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
150143184|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
150143185|NCT05375955|541660131|FG000|Treatment (12 Weeks)|Pregnancy|0|||
150143186|NCT05375955|541660132|FG001|Treatment (12 Weeks)|Pregnancy|0|||
150143187|NCT05375955|541660133|FG002|Treatment (12 Weeks)|Pregnancy|1|||
150143188|NCT05375955|541660134|FG003|Treatment (12 Weeks)|Pregnancy|0|||
150143189|NCT05375955|541660135|FG004|Treatment (12 Weeks)|Pregnancy|0|||
150143190|NCT05375955|541660136|FG005|Treatment (12 Weeks)|Pregnancy|0|||
150143191|NCT05375955|541660137|FG006|Treatment (12 Weeks)|Pregnancy|0|||
150143192|NCT05375955|541660131|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150143193|NCT05375955|541660132|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150143194|NCT05375955|541660133|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
150256648|NCT00092495|542074112|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
150256649|NCT00092495|542074113|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
150256650|NCT00092495|542074114|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
150256651|NCT00092495|542074115|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
150256652|NCT00092495|542074111|FG000|Base Study Vaccination Period|Extended|0|||
150256653|NCT00092495|542074112|FG001|Base Study Vaccination Period|Extended|0|||
150256654|NCT00092495|542074113|FG002|Base Study Vaccination Period|Extended|0|||
150256655|NCT00092495|542074114|FG003|Base Study Vaccination Period|Extended|1|||
150256656|NCT00092495|542074115|FG004|Base Study Vaccination Period|Extended|0|||
150256657|NCT00092495|542074111|FG000|Base Study Vaccination Period|*Clinical AE|1|||
150256658|NCT00092495|542074112|FG001|Base Study Vaccination Period|*Clinical AE|0|||
150256659|NCT00092495|542074113|FG002|Base Study Vaccination Period|*Clinical AE|1|||
150256660|NCT00092495|542074114|FG003|Base Study Vaccination Period|*Clinical AE|2|||
150256661|NCT00092495|542074115|FG004|Base Study Vaccination Period|*Clinical AE|0|||
150256662|NCT00092495|542074111|FG000|Base Study Vaccination Period|*Other reasons|1|||
150256663|NCT00092495|542074112|FG001|Base Study Vaccination Period|*Other reasons|0|||
150256664|NCT00092495|542074113|FG002|Base Study Vaccination Period|*Other reasons|0|||
150256665|NCT00092495|542074114|FG003|Base Study Vaccination Period|*Other reasons|1|||
150256666|NCT00092495|542074115|FG004|Base Study Vaccination Period|*Other reasons|0|||
150256667|NCT00092495|542074111|FG000|Base Study Vaccination Period|*Pregnancy|0|||
150256668|NCT00092495|542074112|FG001|Base Study Vaccination Period|*Pregnancy|2|||
150256669|NCT00092495|542074113|FG002|Base Study Vaccination Period|*Pregnancy|5|||
150256670|NCT00092495|542074114|FG003|Base Study Vaccination Period|*Pregnancy|7|||
150256671|NCT00092495|542074115|FG004|Base Study Vaccination Period|*Pregnancy|0|||
150256672|NCT00092495|542074111|FG000|Base Study Vaccination Period|Adverse Event|1|||
150256673|NCT00092495|542074112|FG001|Base Study Vaccination Period|Adverse Event|0|||
150256674|NCT00092495|542074113|FG002|Base Study Vaccination Period|Adverse Event|0|||
150256675|NCT00092495|542074114|FG003|Base Study Vaccination Period|Adverse Event|3|||
150256676|NCT00092495|542074115|FG004|Base Study Vaccination Period|Adverse Event|0|||
149918587|NCT00207727|540833746|FG002|Overall Study|Other|41|||
150143195|NCT05375955|541660134|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150143196|NCT05375955|541660135|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150256677|NCT00092495|542074111|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
150256678|NCT00092495|542074112|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
150256679|NCT00092495|542074113|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
150256680|NCT00092495|542074114|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
150256681|NCT00092495|542074115|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
150256682|NCT00092495|542074111|FG000|Base Study Vaccination Period|Moved|3|||
150256683|NCT00092495|542074112|FG001|Base Study Vaccination Period|Moved|1|||
150256684|NCT00092495|542074113|FG002|Base Study Vaccination Period|Moved|2|||
150256685|NCT00092495|542074114|FG003|Base Study Vaccination Period|Moved|2|||
150256686|NCT00092495|542074115|FG004|Base Study Vaccination Period|Moved|0|||
150256687|NCT00092495|542074111|FG000|Base Study Vaccination Period|Other|1|||
150256688|NCT00092495|542074112|FG001|Base Study Vaccination Period|Other|1|||
150256689|NCT00092495|542074113|FG002|Base Study Vaccination Period|Other|0|||
150256690|NCT00092495|542074114|FG003|Base Study Vaccination Period|Other|2|||
150256691|NCT00092495|542074115|FG004|Base Study Vaccination Period|Other|0|||
150256692|NCT00092495|542074111|FG000|Base Study Vaccination Period|Pregnancy|2|||
150256693|NCT00092495|542074112|FG001|Base Study Vaccination Period|Pregnancy|0|||
150256694|NCT00092495|542074113|FG002|Base Study Vaccination Period|Pregnancy|0|||
150256695|NCT00092495|542074114|FG003|Base Study Vaccination Period|Pregnancy|0|||
150256696|NCT00092495|542074115|FG004|Base Study Vaccination Period|Pregnancy|0|||
150256697|NCT00092495|542074111|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
150256698|NCT00092495|542074112|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
150256699|NCT00092495|542074113|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
150256700|NCT00092495|542074114|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
150256701|NCT00092495|542074115|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
150256702|NCT00092495|542074111|FG000|Base Study Vaccination Period|Protocol Violation|1|||
150256703|NCT00092495|542074112|FG001|Base Study Vaccination Period|Protocol Violation|0|||
150256704|NCT00092495|542074113|FG002|Base Study Vaccination Period|Protocol Violation|0|||
150256705|NCT00092495|542074114|FG003|Base Study Vaccination Period|Protocol Violation|0|||
150256706|NCT00092495|542074115|FG004|Base Study Vaccination Period|Protocol Violation|0|||
150256707|NCT00092495|542074111|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
150256708|NCT00092495|542074112|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
150256709|NCT00092495|542074113|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
150256710|NCT00092495|542074114|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
150256711|NCT00092495|542074115|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
150256712|NCT00092495|542074111|FG000|Base Study Follow-up Period|Extended|0|||
150256713|NCT00092495|542074112|FG001|Base Study Follow-up Period|Extended|0|||
150256714|NCT00092495|542074113|FG002|Base Study Follow-up Period|Extended|1|||
150256715|NCT00092495|542074114|FG003|Base Study Follow-up Period|Extended|2|||
150256716|NCT00092495|542074115|FG004|Base Study Follow-up Period|Extended|0|||
150256717|NCT00092495|542074111|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
150256718|NCT00092495|542074112|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
150256719|NCT00092495|542074113|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
150256720|NCT00092495|542074114|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
150256721|NCT00092495|542074115|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
150256722|NCT00092495|542074111|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
150256723|NCT00092495|542074112|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
150256724|NCT00092495|542074113|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
150256725|NCT00092495|542074114|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
150256726|NCT00092495|542074115|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
150256727|NCT04772898|542074120|FG000|Overall Study|Withdrawal by Subject|0|||
150256728|NCT04772898|542074121|FG001|Overall Study|Withdrawal by Subject|1|||
150256729|NCT01004848|542074124|FG000|Overall Study|Lost to Follow-up|55|||
150256730|NCT01004848|542074125|FG001|Overall Study|Lost to Follow-up|45|||
150256731|NCT00768079|542074126|FG000|Overall Study|Lost to Follow-up|2|||
150256732|NCT00768079|542074127|FG001|Overall Study|Lost to Follow-up|0|||
150256733|NCT00768079|542074128|FG002|Overall Study|Lost to Follow-up|4|||
150256734|NCT00768079|542074126|FG000|Overall Study|Participant incarcerated|0|||
150256735|NCT00768079|542074127|FG001|Overall Study|Participant incarcerated|1|||
150256736|NCT00768079|542074128|FG002|Overall Study|Participant incarcerated|0|||
150256737|NCT01498679|542074129|FG000|Overall Study|Adverse Event|1|||
150256738|NCT01498679|542074130|FG001|Overall Study|Adverse Event|4|||
150256739|NCT01498679|542074129|FG000|Overall Study|Lack of Efficacy|72|||
150256740|NCT01498679|542074130|FG001|Overall Study|Lack of Efficacy|12|||
150256741|NCT01498679|542074129|FG000|Overall Study|Protocol Violation|4|||
150256742|NCT01498679|542074130|FG001|Overall Study|Protocol Violation|0|||
150256743|NCT01498679|542074129|FG000|Overall Study|Physician Decision|0|||
150256744|NCT01498679|542074130|FG001|Overall Study|Physician Decision|2|||
150256745|NCT01498679|542074129|FG000|Overall Study|Withdrawal by Subject|12|||
150256746|NCT01498679|542074130|FG001|Overall Study|Withdrawal by Subject|4|||
150256747|NCT00158860|542074134|FG000|Overall Study|Adverse Event|3|||
150256748|NCT00158860|542074135|FG001|Overall Study|Adverse Event|6|||
150256749|NCT00158860|542074134|FG000|Overall Study|Lost to Follow-up|11|||
150256750|NCT00158860|542074135|FG001|Overall Study|Lost to Follow-up|17|||
150256751|NCT00158860|542074134|FG000|Overall Study|Protocol Violation|8|||
150256752|NCT00158860|542074135|FG001|Overall Study|Protocol Violation|23|||
150256753|NCT00158860|542074134|FG000|Overall Study|Withdrawal by Subject|7|||
150256754|NCT00158860|542074135|FG001|Overall Study|Withdrawal by Subject|17|||
150256755|NCT00158860|542074134|FG000|Overall Study|MOVING OUT OF STATE|1|||
150256756|NCT00158860|542074135|FG001|Overall Study|MOVING OUT OF STATE|0|||
150256757|NCT00158860|542074134|FG000|Overall Study|Pregnancy|3|||
150256758|NCT00158860|542074135|FG001|Overall Study|Pregnancy|3|||
150256759|NCT00158860|542074134|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
150256760|NCT00158860|542074135|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
150256761|NCT00158860|542074134|FG000|Overall Study|SPONSOR REQUEST|0|||
150256762|NCT00158860|542074135|FG001|Overall Study|SPONSOR REQUEST|1|||
150256763|NCT00158860|542074134|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
150256764|NCT00158860|542074135|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
150256765|NCT00158860|542074134|FG000|Overall Study|Closed per sponsor|0|||
150256766|NCT00158860|542074135|FG001|Overall Study|Closed per sponsor|1|||
150256767|NCT03047395|542074136|FG000|Overall Study|Adverse Event|142|||
150256768|NCT03047395|542074136|FG000|Overall Study|Withdrawal by Subject|155|||
150256769|NCT03047395|542074136|FG000|Overall Study|Lost to Follow-up|144|||
150256770|NCT03047395|542074136|FG000|Overall Study|COVID-19 Infection|2|||
150256771|NCT03047395|542074136|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
150256772|NCT03047395|542074136|FG000|Overall Study|Other, Not Specified|117|||
150256773|NCT01146782|542074139|FG000|Screening Cohort|Screen Failure|187|||
150256774|NCT01146782|542074139|FG000|Screening Cohort|Lost to Follow-up|4|||
150256775|NCT01146782|542074139|FG000|Screening Cohort|Physician Decision|1|||
150256776|NCT01146782|542074139|FG000|Screening Cohort|Withdrawal by Subject|29|||
150256777|NCT01146782|542074139|FG000|Safety Cohort|Screen Failure|61|||
150256778|NCT01146782|542074139|FG000|Safety Cohort|Withdrawal by Subject|4|||
150256779|NCT01146782|542074139|FG000|Safety Cohort|Control AHI <5|4|||
150256780|NCT01146782|542074139|FG000|Safety Cohort|TST <4 hrs|14|||
150256781|NCT01146782|542074139|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
150256782|NCT01146782|542074139|FG000|Primary Endpoint Cohort|Physician Decision|1|||
150256783|NCT02414932|542074140|FG000|Overall Study|Withdrawal by Subject|2|||
150256784|NCT02414932|542074141|FG001|Overall Study|Withdrawal by Subject|3|||
150256785|NCT02414932|542074140|FG000|Overall Study|Adverse Event|1|||
150256786|NCT02414932|542074141|FG001|Overall Study|Adverse Event|0|||
150256787|NCT00470366|542074142|FG000|Overall Study|Adverse Event|3|||
150256788|NCT00470366|542074142|FG000|Overall Study|Poor compliance|1|||
150256789|NCT01011387|542074143|FG000|Overall Study|Withdrawal by Subject|3|||
150256790|NCT01011387|542074143|FG000|Overall Study|Adverse Event|2|||
150256791|NCT01011387|542074143|FG000|Overall Study|Protocol Violation|1|||
150256792|NCT00438672|542074145|FG000|Overall Study|Lost to Follow-up|7|||
150256793|NCT00438672|542074146|FG001|Overall Study|Lost to Follow-up|9|||
150256794|NCT01942785|542074159|FG000|Overall Study|Adverse Event|2|||
150256795|NCT01942785|542074159|FG000|Overall Study|Withdrawal by Subject|1|||
150256796|NCT01942785|542074159|FG000|Overall Study|Protocol Violation|1|||
150256797|NCT05038163|542074163|FG000|Stage 1|Did not complete survey|374|||
150256798|NCT05038163|542074164|FG001|Stage 1|Did not complete survey|0|||
150256799|NCT05038163|542074165|FG002|Stage 1|Did not complete survey|0|||
150256800|NCT05038163|542074166|FG003|Stage 1|Did not complete survey|0|||
150256801|NCT05038163|542074167|FG004|Stage 1|Did not complete survey|0|||
150256802|NCT05038163|542074168|FG005|Stage 1|Did not complete survey|0|||
150143197|NCT05375955|541660136|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150143198|NCT05375955|541660137|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
150143199|NCT05375955|541660131|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
150143200|NCT05375955|541660132|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
150143201|NCT05375955|541660133|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
150143202|NCT05375955|541660134|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
150143203|NCT05375955|541660135|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
150143204|NCT05375955|541660136|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
150143205|NCT05375955|541660137|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
150143206|NCT05375955|541660131|FG000|Follow-up (up to 5 Weeks)|Other|0|||
150143207|NCT05375955|541660132|FG001|Follow-up (up to 5 Weeks)|Other|1|||
150143208|NCT05375955|541660133|FG002|Follow-up (up to 5 Weeks)|Other|0|||
150143209|NCT05375955|541660134|FG003|Follow-up (up to 5 Weeks)|Other|0|||
150143210|NCT05375955|541660135|FG004|Follow-up (up to 5 Weeks)|Other|0|||
150143211|NCT05375955|541660136|FG005|Follow-up (up to 5 Weeks)|Other|0|||
150143212|NCT05375955|541660137|FG006|Follow-up (up to 5 Weeks)|Other|0|||
150143213|NCT05375955|541660131|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
150143214|NCT05375955|541660132|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
150143215|NCT05375955|541660133|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
150143216|NCT05375955|541660134|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
150143217|NCT05375955|541660135|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
150143218|NCT05375955|541660136|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
150143219|NCT05375955|541660137|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
150256803|NCT05038163|542074163|FG000|Stage 2|Did not complete Stage 2 survey|0|||
150143220|NCT05375955|541660131|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
150143221|NCT05375955|541660132|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
150143222|NCT05375955|541660133|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
150143223|NCT05375955|541660134|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
150143224|NCT05375955|541660135|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
150143225|NCT05375955|541660136|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
150143226|NCT05375955|541660137|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
150143227|NCT05454410|541660138|FG000|Overall Study|Withdrawal by Subject|0|||
150143228|NCT05454410|541660139|FG001|Overall Study|Withdrawal by Subject|0|||
150143229|NCT05454410|541660140|FG002|Overall Study|Withdrawal by Subject|1|||
150143230|NCT05454410|541660141|FG003|Overall Study|Withdrawal by Subject|1|||
150143231|NCT03724396|541660151|FG000|Overall Study|Lost to Follow-up|1|||
150143232|NCT03724396|541660152|FG001|Overall Study|Lost to Follow-up|1|||
150143233|NCT03724396|541660151|FG000|Overall Study|Withdrawal by Subject|1|||
150143234|NCT03724396|541660152|FG001|Overall Study|Withdrawal by Subject|0|||
150143235|NCT03879408|541660153|FG000|Overall Study|Lost to Follow-up|0|||
150143236|NCT03879408|541660154|FG001|Overall Study|Lost to Follow-up|3|||
150143237|NCT03879408|541660155|FG002|Overall Study|Lost to Follow-up|2|||
150143238|NCT03879408|541660156|FG003|Overall Study|Lost to Follow-up|1|||
150143239|NCT03879408|541660157|FG004|Overall Study|Lost to Follow-up|0|||
150143240|NCT03879408|541660153|FG000|Overall Study|Withdrawal by Subject|2|||
150143241|NCT03879408|541660154|FG001|Overall Study|Withdrawal by Subject|1|||
150143242|NCT03879408|541660155|FG002|Overall Study|Withdrawal by Subject|1|||
150143243|NCT03879408|541660156|FG003|Overall Study|Withdrawal by Subject|0|||
150143244|NCT03879408|541660157|FG004|Overall Study|Withdrawal by Subject|1|||
150143245|NCT01320943|541660158|FG000|Overall Study|Lost to Follow-up|1|||
150143246|NCT01320943|541660159|FG001|Overall Study|Lost to Follow-up|0|||
150143247|NCT01320943|541660158|FG000|Overall Study|Physician Decision|0|||
150143248|NCT01320943|541660159|FG001|Overall Study|Physician Decision|1|||
150143249|NCT01320943|541660158|FG000|Overall Study|Randomized but not Treated|0|||
150143250|NCT01320943|541660159|FG001|Overall Study|Randomized but not Treated|1|||
150143251|NCT03489057|541660168|FG000|Overall Study|Lost to Follow-up|16|||
150143252|NCT03489057|541660169|FG001|Overall Study|Lost to Follow-up|16|||
150143253|NCT03489057|541660170|FG002|Overall Study|Lost to Follow-up|14|||
150143254|NCT03489057|541660171|FG003|Overall Study|Lost to Follow-up|14|||
150143255|NCT03489057|541660168|FG000|Overall Study|Withdrawal by Subject|12|||
150143256|NCT03489057|541660169|FG001|Overall Study|Withdrawal by Subject|12|||
150143257|NCT03489057|541660170|FG002|Overall Study|Withdrawal by Subject|8|||
150143258|NCT03489057|541660171|FG003|Overall Study|Withdrawal by Subject|8|||
150143259|NCT03489057|541660168|FG000|Overall Study|Protocol Violation|7|||
150143260|NCT03489057|541660169|FG001|Overall Study|Protocol Violation|7|||
150143261|NCT03489057|541660170|FG002|Overall Study|Protocol Violation|2|||
150143262|NCT03489057|541660171|FG003|Overall Study|Protocol Violation|2|||
150143263|NCT02034708|541660172|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
150143264|NCT02034708|541660173|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
150143265|NCT02034708|541660172|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
150143266|NCT02034708|541660173|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
150143267|NCT02034708|541660172|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
150143268|NCT02034708|541660173|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
150143269|NCT02034708|541660172|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
150143270|NCT02034708|541660173|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
150143271|NCT00654901|541660174|FG000|Overall Study|Lost to Follow-up|1|||
150143272|NCT00654901|541660175|FG001|Overall Study|Lost to Follow-up|0|||
150143273|NCT00654901|541660176|FG002|Overall Study|Lost to Follow-up|1|||
150143274|NCT00654901|541660177|FG003|Overall Study|Lost to Follow-up|0|||
150143275|NCT00654901|541660174|FG000|Overall Study|Withdrawal by Subject|3|||
150143276|NCT00654901|541660175|FG001|Overall Study|Withdrawal by Subject|0|||
150143277|NCT00654901|541660176|FG002|Overall Study|Withdrawal by Subject|1|||
150143278|NCT00654901|541660177|FG003|Overall Study|Withdrawal by Subject|0|||
150143279|NCT05076149|541660178|FG000|Overall Study|Adverse Event|3|||
150143280|NCT05076149|541660179|FG001|Overall Study|Adverse Event|9|||
150143281|NCT05076149|541660178|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
150143282|NCT05076149|541660179|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
150143283|NCT05076149|541660178|FG000|Overall Study|Lost to Follow-up|0|||
150143284|NCT05076149|541660179|FG001|Overall Study|Lost to Follow-up|1|||
150143285|NCT05076149|541660178|FG000|Overall Study|Commercial drug is available for participant|0|||
150143286|NCT05076149|541660179|FG001|Overall Study|Commercial drug is available for participant|1|||
150143287|NCT05076149|541660178|FG000|Overall Study|Other non compliance|1|||
150143288|NCT05076149|541660179|FG001|Overall Study|Other non compliance|1|||
150143289|NCT05076149|541660178|FG000|Overall Study|Physician Decision|0|||
150143290|NCT05076149|541660179|FG001|Overall Study|Physician Decision|1|||
150143291|NCT05076149|541660178|FG000|Overall Study|Other|5|||
150143292|NCT05076149|541660179|FG001|Overall Study|Other|4|||
150143293|NCT05096208|541660180|FG000|Overall Study|Lost to Follow-up|3|||
150143294|NCT05096208|541660181|FG001|Overall Study|Lost to Follow-up|5|||
150143295|NCT05096208|541660182|FG002|Overall Study|Lost to Follow-up|5|||
150143296|NCT05096208|541660183|FG003|Overall Study|Lost to Follow-up|2|||
150143297|NCT05096208|541660180|FG000|Overall Study|Withdrawal by Subject|0|||
150143298|NCT05096208|541660181|FG001|Overall Study|Withdrawal by Subject|1|||
150143299|NCT05096208|541660182|FG002|Overall Study|Withdrawal by Subject|2|||
150143300|NCT05096208|541660183|FG003|Overall Study|Withdrawal by Subject|3|||
150143301|NCT05096208|541660180|FG000|Overall Study|No longer met eligibility criteria|1|||
150143302|NCT05096208|541660181|FG001|Overall Study|No longer met eligibility criteria|0|||
150143303|NCT05096208|541660182|FG002|Overall Study|No longer met eligibility criteria|0|||
150143304|NCT05096208|541660183|FG003|Overall Study|No longer met eligibility criteria|0|||
150256804|NCT05038163|542074164|FG001|Stage 2|Did not complete Stage 2 survey|29|||
150256805|NCT05038163|542074165|FG002|Stage 2|Did not complete Stage 2 survey|30|||
150256806|NCT05038163|542074166|FG003|Stage 2|Did not complete Stage 2 survey|24|||
150256807|NCT05038163|542074167|FG004|Stage 2|Did not complete Stage 2 survey|21|||
150256808|NCT05038163|542074168|FG005|Stage 2|Did not complete Stage 2 survey|100|||
150256809|NCT05453201|542074169|FG000|Overall Study|Withdrawal by Subject|1|||
150256810|NCT03562975|542074170|FG000|Overall Study|Death|1|||
150256811|NCT03562975|542074170|FG000|Overall Study|Lost to Follow-up|1|||
150256812|NCT03562975|542074170|FG000|Overall Study|Withdrawal by Subject|1|||
150256813|NCT01934790|542074171|FG000|Treatment|Adverse Event|3|||
150256814|NCT01934790|542074171|FG000|Treatment|Clinical progression|6|||
150256815|NCT01934790|542074171|FG000|Treatment|Radiological progression|4|||
150256816|NCT01934790|542074171|FG000|Treatment|Withdrawal by Subject|2|||
150256817|NCT01934790|542074171|FG000|Treatment|Study drug never administered|1|||
150256818|NCT01934790|542074171|FG000|Active Follow up|Death|20|||
150256819|NCT01934790|542074171|FG000|Active Follow up|Physician Decision|2|||
150256820|NCT01934790|542074171|FG000|Active Follow up|Progressive disease|1|||
150256821|NCT01934790|542074171|FG000|Active Follow up|Other reason|1|||
150256822|NCT03798691|542074174|FG000|Overall Study|Lost to Follow-up|2|||
150256823|NCT03798691|542074175|FG001|Overall Study|Lost to Follow-up|2|||
150256824|NCT00552929|542074176|FG000|Overall Study|Lost to Follow-up|0|||
150256825|NCT00552929|542074177|FG001|Overall Study|Lost to Follow-up|0|||
150256826|NCT00552929|542074178|FG002|Overall Study|Lost to Follow-up|0|||
150256827|NCT00552929|542074179|FG003|Overall Study|Lost to Follow-up|0|||
150256828|NCT00552929|542074180|FG004|Overall Study|Lost to Follow-up|0|||
150256829|NCT00552929|542074181|FG005|Overall Study|Lost to Follow-up|0|||
150256830|NCT00552929|542074182|FG006|Overall Study|Lost to Follow-up|0|||
150256831|NCT00552929|542074183|FG007|Overall Study|Lost to Follow-up|0|||
150256832|NCT00552929|542074184|FG008|Overall Study|Lost to Follow-up|1|||
150256833|NCT00552929|542074185|FG009|Overall Study|Lost to Follow-up|0|||
150256834|NCT00552929|542074176|FG000|Overall Study|Not Eligible|0|||
150256835|NCT00552929|542074177|FG001|Overall Study|Not Eligible|0|||
150256836|NCT00552929|542074178|FG002|Overall Study|Not Eligible|0|||
150256837|NCT00552929|542074179|FG003|Overall Study|Not Eligible|0|||
150256838|NCT00552929|542074180|FG004|Overall Study|Not Eligible|0|||
150256839|NCT00552929|542074181|FG005|Overall Study|Not Eligible|1|||
150256840|NCT00552929|542074182|FG006|Overall Study|Not Eligible|0|||
150256841|NCT00552929|542074183|FG007|Overall Study|Not Eligible|0|||
150256842|NCT00552929|542074184|FG008|Overall Study|Not Eligible|0|||
150256843|NCT00552929|542074185|FG009|Overall Study|Not Eligible|0|||
150256844|NCT01147536|542074196|FG000|Overall Study|Administrative study close|2|||
150256845|NCT01147536|542074196|FG000|Overall Study|Death|1|||
150256846|NCT01758900|542074199|FG000|Overall Study|difficulty for further intubation|7|||
150256847|NCT01758900|542074200|FG001|Overall Study|difficulty for further intubation|8|||
150256848|NCT03762200|542074202|FG000|Overall Study|Death|2|||
150256849|NCT00935818|542074203|FG000|Overall Study|Withdrawal by Subject|45|||
150256850|NCT00935818|542074204|FG001|Overall Study|Withdrawal by Subject|50|||
150256851|NCT00935818|542074203|FG000|Overall Study|Lost to Follow-up|40|||
150256852|NCT00935818|542074204|FG001|Overall Study|Lost to Follow-up|42|||
150256853|NCT00935818|542074203|FG000|Overall Study|Adverse Event|6|||
150256854|NCT00935818|542074204|FG001|Overall Study|Adverse Event|7|||
150256855|NCT00935818|542074203|FG000|Overall Study|Physician Decision|0|||
150256856|NCT00935818|542074204|FG001|Overall Study|Physician Decision|1|||
150256857|NCT00867308|542074207|FG000|Overall Study|Death|1|||
150256858|NCT00867308|542074208|FG001|Overall Study|Death|0|||
150256859|NCT00867308|542074207|FG000|Overall Study|Adverse Event|1|||
150256860|NCT00867308|542074208|FG001|Overall Study|Adverse Event|4|||
150256861|NCT00867308|542074207|FG000|Overall Study|Lack of Efficacy|6|||
150256862|NCT00867308|542074208|FG001|Overall Study|Lack of Efficacy|12|||
150256863|NCT00867308|542074207|FG000|Overall Study|Withdrawal by Subject|1|||
150256864|NCT00867308|542074208|FG001|Overall Study|Withdrawal by Subject|2|||
150256865|NCT00604825|542074209|FG000|Overall Study|Adverse Event|2|||
150256866|NCT00604825|542074210|FG001|Overall Study|Adverse Event|6|||
150256867|NCT00604825|542074211|FG002|Overall Study|Adverse Event|7|||
150256868|NCT00604825|542074212|FG003|Overall Study|Adverse Event|4|||
150256869|NCT00604825|542074209|FG000|Overall Study|Lost to Follow-up|0|||
150256870|NCT00604825|542074210|FG001|Overall Study|Lost to Follow-up|3|||
150143305|NCT05096208|541660180|FG000|Overall Study|Other|0|||
150143306|NCT05096208|541660181|FG001|Overall Study|Other|0|||
150256871|NCT00604825|542074211|FG002|Overall Study|Lost to Follow-up|1|||
150256872|NCT00604825|542074212|FG003|Overall Study|Lost to Follow-up|0|||
150256873|NCT00604825|542074209|FG000|Overall Study|Protocol Violation|0|||
150256874|NCT00604825|542074210|FG001|Overall Study|Protocol Violation|1|||
150256875|NCT00604825|542074211|FG002|Overall Study|Protocol Violation|0|||
150256876|NCT00604825|542074212|FG003|Overall Study|Protocol Violation|0|||
150256877|NCT00604825|542074209|FG000|Overall Study|Withdrawal by Subject|4|||
150256878|NCT00604825|542074210|FG001|Overall Study|Withdrawal by Subject|3|||
150256879|NCT00604825|542074211|FG002|Overall Study|Withdrawal by Subject|5|||
150256880|NCT00604825|542074212|FG003|Overall Study|Withdrawal by Subject|5|||
150256881|NCT00604825|542074209|FG000|Overall Study|Lack of Efficacy|3|||
150256882|NCT00604825|542074210|FG001|Overall Study|Lack of Efficacy|2|||
150256883|NCT00604825|542074211|FG002|Overall Study|Lack of Efficacy|1|||
150256884|NCT00604825|542074212|FG003|Overall Study|Lack of Efficacy|0|||
150256885|NCT00604825|542074209|FG000|Overall Study|Did not meet eligibility criteria|0|||
150256886|NCT00604825|542074210|FG001|Overall Study|Did not meet eligibility criteria|0|||
150256887|NCT00604825|542074211|FG002|Overall Study|Did not meet eligibility criteria|2|||
150256888|NCT00604825|542074212|FG003|Overall Study|Did not meet eligibility criteria|0|||
150256889|NCT00604825|542074209|FG000|Overall Study|Physician Decision|0|||
150256890|NCT00604825|542074210|FG001|Overall Study|Physician Decision|0|||
150256891|NCT00604825|542074211|FG002|Overall Study|Physician Decision|0|||
150256892|NCT00604825|542074212|FG003|Overall Study|Physician Decision|1|||
150256893|NCT00604825|542074209|FG000|Overall Study|Exclusion criterion met|0|||
150256894|NCT00604825|542074210|FG001|Overall Study|Exclusion criterion met|0|||
150256895|NCT00604825|542074211|FG002|Overall Study|Exclusion criterion met|0|||
150256896|NCT00604825|542074212|FG003|Overall Study|Exclusion criterion met|1|||
150256897|NCT03465904|542074213|FG000|Overall Study|Withdrawal by Subject|9|||
150256898|NCT03465904|542074214|FG001|Overall Study|Withdrawal by Subject|5|||
150256899|NCT03465904|542074213|FG000|Overall Study|Lost to Follow-up|11|||
150256900|NCT03465904|542074214|FG001|Overall Study|Lost to Follow-up|9|||
150256901|NCT03465904|542074213|FG000|Overall Study|Protocol Violation|20|||
150256902|NCT03465904|542074214|FG001|Overall Study|Protocol Violation|15|||
150256903|NCT01506453|542075799|FG000|Overall Study|Withdrawal prior to treatment|0|||
150256904|NCT01506453|542075800|FG001|Overall Study|Withdrawal prior to treatment|2|||
150256905|NCT00117845|542075801|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
150256906|NCT00616902|542075802|FG000|Overall Study|Termination of study|6|||
150256907|NCT00616902|542075803|FG001|Overall Study|Termination of study|6|||
150256908|NCT02680002|542075805|FG000|Overall Study|Lost to Follow-up|5|||
150256909|NCT02680002|542075806|FG001|Overall Study|Lost to Follow-up|1|||
150256910|NCT02680002|542075807|FG002|Overall Study|Lost to Follow-up|4|||
150256911|NCT02680002|542075808|FG003|Overall Study|Lost to Follow-up|2|||
150256912|NCT02680002|542075809|FG004|Overall Study|Lost to Follow-up|0|||
150256913|NCT02680002|542075810|FG005|Overall Study|Lost to Follow-up|2|||
150256914|NCT02680002|542075805|FG000|Overall Study|Physician Decision|5|||
150256915|NCT02680002|542075806|FG001|Overall Study|Physician Decision|1|||
150256916|NCT02680002|542075807|FG002|Overall Study|Physician Decision|1|||
150256917|NCT02680002|542075808|FG003|Overall Study|Physician Decision|1|||
150256918|NCT02680002|542075809|FG004|Overall Study|Physician Decision|1|||
150256919|NCT02680002|542075810|FG005|Overall Study|Physician Decision|1|||
150256920|NCT02680002|542075805|FG000|Overall Study|Protocol Violation|1|||
150256921|NCT02680002|542075806|FG001|Overall Study|Protocol Violation|0|||
150256922|NCT02680002|542075807|FG002|Overall Study|Protocol Violation|1|||
150256923|NCT02680002|542075808|FG003|Overall Study|Protocol Violation|0|||
150256924|NCT02680002|542075809|FG004|Overall Study|Protocol Violation|1|||
150256925|NCT02680002|542075810|FG005|Overall Study|Protocol Violation|2|||
150256926|NCT02680002|542075805|FG000|Overall Study|Withdrawal by Subject|0|||
150256927|NCT02680002|542075806|FG001|Overall Study|Withdrawal by Subject|0|||
150256928|NCT02680002|542075807|FG002|Overall Study|Withdrawal by Subject|1|||
150256929|NCT02680002|542075808|FG003|Overall Study|Withdrawal by Subject|0|||
150256930|NCT02680002|542075809|FG004|Overall Study|Withdrawal by Subject|2|||
150256931|NCT02680002|542075810|FG005|Overall Study|Withdrawal by Subject|2|||
150256932|NCT02680002|542075805|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
149918588|NCT00207727|540833747|FG003|Overall Study|Other|37|||
150256933|NCT02680002|542075806|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
150256934|NCT02680002|542075807|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
150256935|NCT02680002|542075808|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
150256936|NCT02680002|542075809|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
150256937|NCT02680002|542075810|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
150256938|NCT02680002|542075805|FG000|Overall Study|Other|0|||
150256939|NCT02680002|542075806|FG001|Overall Study|Other|1|||
150256940|NCT02680002|542075807|FG002|Overall Study|Other|0|||
150256941|NCT02680002|542075808|FG003|Overall Study|Other|0|||
150256942|NCT02680002|542075809|FG004|Overall Study|Other|1|||
150256943|NCT02680002|542075810|FG005|Overall Study|Other|0|||
150256944|NCT02680002|542075805|FG000|Overall Study|Adverse Event|0|||
150256945|NCT02680002|542075806|FG001|Overall Study|Adverse Event|0|||
150256946|NCT02680002|542075807|FG002|Overall Study|Adverse Event|0|||
150256947|NCT02680002|542075808|FG003|Overall Study|Adverse Event|0|||
150256948|NCT02680002|542075809|FG004|Overall Study|Adverse Event|1|||
150256949|NCT02680002|542075810|FG005|Overall Study|Adverse Event|2|||
150256950|NCT00645801|542075811|FG000|Overall Study|unclear if patient took all the medication.|1|||
150256951|NCT00645801|542075812|FG001|Overall Study|unclear if patient took all the medication.|0|||
150256952|NCT00645801|542075811|FG000|Overall Study|Lost to Follow-up|19|||
150256953|NCT00645801|542075812|FG001|Overall Study|Lost to Follow-up|15|||
150256954|NCT00759915|542075813|FG000|Overall Study|Withdrawal by Subject|1|||
150256955|NCT00759915|542075814|FG001|Overall Study|Withdrawal by Subject|0|||
150256956|NCT00759915|542075813|FG000|Overall Study|Adverse Event|0|||
150256957|NCT00759915|542075814|FG001|Overall Study|Adverse Event|1|||
150256958|NCT03527173|542075815|FG000|Overall Study|Lost to Follow-up|4|||
150256959|NCT03527173|542075816|FG001|Overall Study|Lost to Follow-up|2|||
150256960|NCT03527173|542075815|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
150256961|NCT03527173|542075816|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
150256962|NCT03527173|542075815|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
150256963|NCT03527173|542075816|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
150256964|NCT03527173|542075815|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
150256965|NCT03527173|542075816|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
150256966|NCT01248780|542075819|FG000|Overall Study|Lack of Efficacy|2|||
150256967|NCT01248780|542075820|FG001|Overall Study|Lack of Efficacy|0|||
150256968|NCT01248780|542075819|FG000|Overall Study|Lost to Follow-up|0|||
150256969|NCT01248780|542075820|FG001|Overall Study|Lost to Follow-up|1|||
150256970|NCT01248780|542075819|FG000|Overall Study|Death|0|||
150256971|NCT01248780|542075820|FG001|Overall Study|Death|1|||
150256972|NCT01248780|542075819|FG000|Overall Study|Adverse Event|2|||
150256973|NCT01248780|542075820|FG001|Overall Study|Adverse Event|7|||
150256974|NCT01248780|542075819|FG000|Overall Study|Protocol Violation|1|||
150256975|NCT01248780|542075820|FG001|Overall Study|Protocol Violation|1|||
150256976|NCT01248780|542075819|FG000|Overall Study|Withdrawal by Subject|4|||
150256977|NCT01248780|542075820|FG001|Overall Study|Withdrawal by Subject|4|||
150256978|NCT01248780|542075819|FG000|Overall Study|Not treated|0|||
150256979|NCT01248780|542075820|FG001|Overall Study|Not treated|1|||
150256980|NCT04097301|542075821|FG000|Overall Study|Death|1|||
150256981|NCT04097301|542075821|FG000|Overall Study|Withdrawal by Subject|1|||
150256982|NCT04097301|542075821|FG000|Overall Study|Screening Failure|5|||
150256983|NCT01227577|542075822|FG000|Overall Study|Protocol deviation|3|||
150256984|NCT01227577|542075822|FG000|Overall Study|Death|3|||
150256985|NCT01227577|542075822|FG000|Overall Study|Administrative problems|2|||
150256986|NCT01227577|542075822|FG000|Overall Study|Lost to Follow-up|1|||
150256987|NCT01227577|542075822|FG000|Overall Study|Withdrawal by Subject|4|||
150256988|NCT01227577|542075822|FG000|Overall Study|Lack of Efficacy|5|||
150256989|NCT01227577|542075822|FG000|Overall Study|Adverse Event|17|||
150256990|NCT00107120|542075823|FG000|Overall Study|Adverse Event|4|||
150256991|NCT00107120|542075824|FG001|Overall Study|Adverse Event|1|||
150256992|NCT00107120|542075823|FG000|Overall Study|Lack of Efficacy|5|||
150256993|NCT00107120|542075824|FG001|Overall Study|Lack of Efficacy|5|||
150256994|NCT00107120|542075823|FG000|Overall Study|Protocol Violation|3|||
150256995|NCT00107120|542075824|FG001|Overall Study|Protocol Violation|0|||
150256996|NCT00107120|542075823|FG000|Overall Study|Withdrawal by Subject|8|||
150256997|NCT00107120|542075824|FG001|Overall Study|Withdrawal by Subject|9|||
150256998|NCT00107120|542075823|FG000|Overall Study|Lost to Follow-up|8|||
150256999|NCT00107120|542075824|FG001|Overall Study|Lost to Follow-up|6|||
150257000|NCT00107120|542075823|FG000|Overall Study|Pregnancy|0|||
150257001|NCT00107120|542075824|FG001|Overall Study|Pregnancy|1|||
150257002|NCT00107120|542075823|FG000|Overall Study|moving away from site|1|||
150257003|NCT00107120|542075824|FG001|Overall Study|moving away from site|1|||
150257004|NCT00107120|542075823|FG000|Overall Study|death of parent|0|||
150257005|NCT00107120|542075824|FG001|Overall Study|death of parent|1|||
150257006|NCT03241225|542075825|FG000|Overall Study|Lost to Follow-up|2|||
150257007|NCT03241225|542075826|FG001|Overall Study|Lost to Follow-up|1|||
150257008|NCT03241225|542075825|FG000|Overall Study|Protocol Violation|4|||
150257009|NCT03241225|542075826|FG001|Overall Study|Protocol Violation|1|||
150257010|NCT03241225|542075825|FG000|Overall Study|Withdrawal by Subject|1|||
150257011|NCT03241225|542075826|FG001|Overall Study|Withdrawal by Subject|0|||
150257012|NCT00852540|542075827|FG000|Overall Study|Adverse Event|10|||
150257013|NCT00852540|542075828|FG001|Overall Study|Adverse Event|3|||
150257014|NCT00852540|542075827|FG000|Overall Study|Lack of Efficacy|15|||
150257015|NCT00852540|542075828|FG001|Overall Study|Lack of Efficacy|3|||
150143307|NCT05096208|541660182|FG002|Overall Study|Other|1|||
150257016|NCT00852540|542075827|FG000|Overall Study|Protocol Violation|1|||
150257017|NCT00852540|542075828|FG001|Overall Study|Protocol Violation|2|||
150257018|NCT00852540|542075827|FG000|Overall Study|Lost to Follow-up|2|||
150257019|NCT00852540|542075828|FG001|Overall Study|Lost to Follow-up|3|||
150257020|NCT00852540|542075827|FG000|Overall Study|Investigator Discretion|2|||
150257021|NCT00852540|542075828|FG001|Overall Study|Investigator Discretion|3|||
150257022|NCT00852540|542075827|FG000|Overall Study|Withdrawal by Subject|3|||
150257023|NCT00852540|542075828|FG001|Overall Study|Withdrawal by Subject|1|||
150143308|NCT05096208|541660183|FG003|Overall Study|Other|0|||
150257024|NCT00852540|542075827|FG000|Overall Study|Did Not Receive Study Drug|3|||
150257025|NCT00852540|542075828|FG001|Overall Study|Did Not Receive Study Drug|3|||
150257026|NCT00896051|542075830|FG000|Overall Study|Adverse Event|2|||
150257027|NCT00896051|542075831|FG001|Overall Study|Adverse Event|1|||
150257028|NCT00896051|542075830|FG000|Overall Study|Lost to Follow-up|3|||
150257029|NCT00896051|542075831|FG001|Overall Study|Lost to Follow-up|2|||
150257030|NCT00896051|542075830|FG000|Overall Study|Withdrawal by Subject|3|||
150257031|NCT00896051|542075831|FG001|Overall Study|Withdrawal by Subject|2|||
150257032|NCT00896051|542075830|FG000|Overall Study|Subject noncompliant|1|||
150257033|NCT00896051|542075831|FG001|Overall Study|Subject noncompliant|3|||
150257034|NCT00896051|542075830|FG000|Overall Study|Other|1|||
150257035|NCT00896051|542075831|FG001|Overall Study|Other|1|||
150257036|NCT01813929|542075838|FG000|Overall Study|Withdrawal by Subject|0|||
150257037|NCT01813929|542075839|FG001|Overall Study|Withdrawal by Subject|1|||
150257038|NCT00007345|542075840|FG000|Overall Study|Refused further treatment|0|||
150257039|NCT00007345|542075841|FG001|Overall Study|Refused further treatment|7|||
150257040|NCT00007345|542075840|FG000|Overall Study|Switched to alternative treatment|0|||
150257041|NCT00007345|542075841|FG001|Overall Study|Switched to alternative treatment|3|||
150257042|NCT00007345|542075840|FG000|Overall Study|Intercurrent illness|1|||
150257043|NCT00007345|542075841|FG001|Overall Study|Intercurrent illness|0|||
150257044|NCT00007345|542075840|FG000|Overall Study|Death on study|1|||
150257045|NCT00007345|542075841|FG001|Overall Study|Death on study|1|||
150257046|NCT04433585|542075842|FG000|Overall Study|Withdrawal by Subject|15|||
150257047|NCT04433585|542075843|FG001|Overall Study|Withdrawal by Subject|3|||
150257048|NCT04433585|542075844|FG002|Overall Study|Withdrawal by Subject|15|||
150257049|NCT04433585|542075845|FG003|Overall Study|Withdrawal by Subject|6|||
150257050|NCT04433585|542075842|FG000|Overall Study|Adverse Event|10|||
150257051|NCT04433585|542075843|FG001|Overall Study|Adverse Event|4|||
150257052|NCT04433585|542075844|FG002|Overall Study|Adverse Event|1|||
150257053|NCT04433585|542075845|FG003|Overall Study|Adverse Event|0|||
150257054|NCT04433585|542075842|FG000|Overall Study|Due to the conflict in Ukraine|2|||
150257055|NCT04433585|542075843|FG001|Overall Study|Due to the conflict in Ukraine|1|||
150257056|NCT04433585|542075844|FG002|Overall Study|Due to the conflict in Ukraine|1|||
150257057|NCT04433585|542075845|FG003|Overall Study|Due to the conflict in Ukraine|2|||
150257058|NCT04433585|542075842|FG000|Overall Study|Physician Decision|1|||
150257059|NCT04433585|542075843|FG001|Overall Study|Physician Decision|2|||
150257060|NCT04433585|542075844|FG002|Overall Study|Physician Decision|0|||
150257061|NCT04433585|542075845|FG003|Overall Study|Physician Decision|0|||
150257062|NCT04433585|542075842|FG000|Overall Study|Lost to Follow-up|1|||
150257063|NCT04433585|542075843|FG001|Overall Study|Lost to Follow-up|1|||
150257064|NCT04433585|542075844|FG002|Overall Study|Lost to Follow-up|1|||
150257065|NCT04433585|542075845|FG003|Overall Study|Lost to Follow-up|0|||
150257066|NCT04433585|542075842|FG000|Overall Study|Lack of Efficacy|0|||
150257067|NCT04433585|542075843|FG001|Overall Study|Lack of Efficacy|1|||
150257068|NCT04433585|542075844|FG002|Overall Study|Lack of Efficacy|1|||
150257069|NCT04433585|542075845|FG003|Overall Study|Lack of Efficacy|1|||
150257070|NCT04433585|542075842|FG000|Overall Study|Death|0|||
150257071|NCT04433585|542075843|FG001|Overall Study|Death|1|||
150257072|NCT04433585|542075844|FG002|Overall Study|Death|0|||
150257073|NCT04433585|542075845|FG003|Overall Study|Death|0|||
150257074|NCT02074553|542075846|FG000|Intervention Period 1|Family Emergency|0|||
150257075|NCT02074553|542075847|FG001|Intervention Period 1|Family Emergency|0|||
150257076|NCT02074553|542075848|FG002|Intervention Period 1|Family Emergency|0|||
150257077|NCT02074553|542075849|FG003|Intervention Period 1|Family Emergency|1|||
150257078|NCT02074553|542075850|FG004|Intervention Period 1|Family Emergency|0|||
150257079|NCT02074553|542075851|FG005|Intervention Period 1|Family Emergency|0|||
150257080|NCT02074553|542075852|FG006|Intervention Period 1|Family Emergency|0|||
150257081|NCT02074553|542075853|FG007|Intervention Period 1|Family Emergency|0|||
150257082|NCT02074553|542075846|FG000|Washout Period 1|Adverse Event|1|||
150257083|NCT02074553|542075847|FG001|Washout Period 1|Adverse Event|0|||
150257084|NCT02074553|542075848|FG002|Washout Period 1|Adverse Event|0|||
150257085|NCT02074553|542075849|FG003|Washout Period 1|Adverse Event|0|||
150257086|NCT02074553|542075850|FG004|Washout Period 1|Adverse Event|0|||
150257087|NCT02074553|542075851|FG005|Washout Period 1|Adverse Event|0|||
150257088|NCT02074553|542075852|FG006|Washout Period 1|Adverse Event|0|||
150257089|NCT02074553|542075853|FG007|Washout Period 1|Adverse Event|0|||
150257090|NCT02074553|542075846|FG000|Washout Period 1|Physician Decision|0|||
150257091|NCT02074553|542075847|FG001|Washout Period 1|Physician Decision|0|||
150257092|NCT02074553|542075848|FG002|Washout Period 1|Physician Decision|0|||
150257093|NCT02074553|542075849|FG003|Washout Period 1|Physician Decision|1|||
150257094|NCT02074553|542075850|FG004|Washout Period 1|Physician Decision|0|||
150257095|NCT02074553|542075851|FG005|Washout Period 1|Physician Decision|0|||
150257096|NCT02074553|542075852|FG006|Washout Period 1|Physician Decision|0|||
150257097|NCT02074553|542075853|FG007|Washout Period 1|Physician Decision|0|||
150257098|NCT02074553|542075846|FG000|Washout Period 1|Other|0|||
150257099|NCT02074553|542075847|FG001|Washout Period 1|Other|0|||
150257100|NCT02074553|542075848|FG002|Washout Period 1|Other|0|||
150257101|NCT02074553|542075849|FG003|Washout Period 1|Other|0|||
150257102|NCT02074553|542075850|FG004|Washout Period 1|Other|0|||
150257103|NCT02074553|542075851|FG005|Washout Period 1|Other|1|||
150257104|NCT02074553|542075852|FG006|Washout Period 1|Other|0|||
150257105|NCT02074553|542075853|FG007|Washout Period 1|Other|0|||
150257106|NCT02074553|542075846|FG000|Washout Period 2|Adverse Event|0|||
150257107|NCT02074553|542075847|FG001|Washout Period 2|Adverse Event|0|||
150257108|NCT02074553|542075848|FG002|Washout Period 2|Adverse Event|0|||
150257109|NCT02074553|542075849|FG003|Washout Period 2|Adverse Event|0|||
150257110|NCT02074553|542075850|FG004|Washout Period 2|Adverse Event|0|||
150257111|NCT02074553|542075851|FG005|Washout Period 2|Adverse Event|0|||
150257112|NCT02074553|542075852|FG006|Washout Period 2|Adverse Event|1|||
150257113|NCT02074553|542075853|FG007|Washout Period 2|Adverse Event|0|||
150257114|NCT02074553|542075846|FG000|Washout Period 2|Physician Decision|0|||
150257115|NCT02074553|542075847|FG001|Washout Period 2|Physician Decision|0|||
150257116|NCT02074553|542075848|FG002|Washout Period 2|Physician Decision|0|||
150257117|NCT02074553|542075849|FG003|Washout Period 2|Physician Decision|0|||
150257118|NCT02074553|542075850|FG004|Washout Period 2|Physician Decision|0|||
150257119|NCT02074553|542075851|FG005|Washout Period 2|Physician Decision|1|||
150257120|NCT02074553|542075852|FG006|Washout Period 2|Physician Decision|0|||
150257121|NCT02074553|542075853|FG007|Washout Period 2|Physician Decision|0|||
150257122|NCT02074553|542075846|FG000|Washout Period 2|Lost to Follow-up|0|||
150257123|NCT02074553|542075847|FG001|Washout Period 2|Lost to Follow-up|0|||
150257124|NCT02074553|542075848|FG002|Washout Period 2|Lost to Follow-up|1|||
150257125|NCT02074553|542075849|FG003|Washout Period 2|Lost to Follow-up|0|||
150257126|NCT02074553|542075850|FG004|Washout Period 2|Lost to Follow-up|0|||
150257127|NCT02074553|542075851|FG005|Washout Period 2|Lost to Follow-up|0|||
150257128|NCT02074553|542075852|FG006|Washout Period 2|Lost to Follow-up|0|||
150257129|NCT02074553|542075853|FG007|Washout Period 2|Lost to Follow-up|0|||
150257130|NCT02074553|542075846|FG000|Washout Period 3|Physician Decision|0|||
150257131|NCT02074553|542075847|FG001|Washout Period 3|Physician Decision|0|||
150257132|NCT02074553|542075848|FG002|Washout Period 3|Physician Decision|0|||
150257133|NCT02074553|542075849|FG003|Washout Period 3|Physician Decision|0|||
150257134|NCT02074553|542075850|FG004|Washout Period 3|Physician Decision|0|||
150257135|NCT02074553|542075851|FG005|Washout Period 3|Physician Decision|0|||
150257136|NCT02074553|542075852|FG006|Washout Period 3|Physician Decision|0|||
150257137|NCT02074553|542075853|FG007|Washout Period 3|Physician Decision|1|||
150257138|NCT00194987|542075854|FG000|Overall Study|Withdrawal by Subject|0|||
150257139|NCT00194987|542075855|FG001|Overall Study|Withdrawal by Subject|3|||
150257140|NCT01664598|542075856|FG000|Overall Study|Sponsor Decision|1|||
150257141|NCT01664598|542075856|FG000|Overall Study|Withdrawal of Informed Consent|4|||
150257142|NCT01664598|542075856|FG000|Overall Study|Adverse Event|1|||
150257143|NCT02342743|542075857|FG000|Baseline Period|Withdrawal by Subject|3|||
150257144|NCT02342743|542075857|FG000|Baseline Period|Lost to Follow-up|2|||
150257145|NCT02342743|542075857|FG000|Baseline Period|Change in prophylactic medication|3|||
150257146|NCT02342743|542075857|FG000|Baseline Period|Screening failure regarding baseline|7|||
150257147|NCT02342743|542075857|FG000|Treatment Period|Withdrawal by Subject|2|||
150257148|NCT02342743|542075857|FG000|Treatment Period|Lost to Follow-up|8|||
150257149|NCT02342743|542075857|FG000|Treatment Period|Change in prophylactic medication|1|||
150257150|NCT04875676|542075858|FG000|Overall Study|Lost to Follow-up|1|||
150257151|NCT04875676|542075859|FG001|Overall Study|Lost to Follow-up|0|||
150257152|NCT04875676|542075860|FG002|Overall Study|Lost to Follow-up|0|||
150257153|NCT03103763|542075865|FG000|Overall Study|Death|15|||
150257154|NCT03103763|542075866|FG001|Overall Study|Death|5|||
150257155|NCT03103763|542075867|FG002|Overall Study|Death|5|||
150257156|NCT03103763|542075865|FG000|Overall Study|Withdrawal by Subject|0|||
150257157|NCT03103763|542075866|FG001|Overall Study|Withdrawal by Subject|3|||
150257158|NCT03103763|542075867|FG002|Overall Study|Withdrawal by Subject|2|||
150257159|NCT00938470|542075868|FG000|Overall Study|Disease Progression|3|||
150257160|NCT00938470|542075869|FG001|Overall Study|Disease Progression|0|||
150257161|NCT00938470|542075868|FG000|Overall Study|Alternate Treatment|1|||
150257162|NCT00938470|542075869|FG001|Overall Study|Alternate Treatment|0|||
150257163|NCT00938470|542075868|FG000|Overall Study|Death|3|||
150257164|NCT00938470|542075869|FG001|Overall Study|Death|2|||
150257165|NCT00938470|542075868|FG000|Overall Study|Other Reason|0|||
150257166|NCT00938470|542075869|FG001|Overall Study|Other Reason|1|||
150257167|NCT03245151|542075870|FG000|Overall Study|Withdrawal by Subject|2|||
150257168|NCT03245151|542075871|FG001|Overall Study|Withdrawal by Subject|0|||
150257169|NCT03245151|542075872|FG002|Overall Study|Withdrawal by Subject|0|||
150257170|NCT03245151|542075873|FG003|Overall Study|Withdrawal by Subject|2|||
150257171|NCT03245151|542075874|FG004|Overall Study|Withdrawal by Subject|1|||
150257172|NCT03245151|542075870|FG000|Overall Study|Death|3|||
150257173|NCT03245151|542075871|FG001|Overall Study|Death|14|||
150257174|NCT03245151|542075872|FG002|Overall Study|Death|9|||
150257175|NCT03245151|542075873|FG003|Overall Study|Death|16|||
150257176|NCT03245151|542075874|FG004|Overall Study|Death|7|||
150257177|NCT03245151|542075870|FG000|Overall Study|Sponsor's decision|0|||
150257178|NCT03245151|542075871|FG001|Overall Study|Sponsor's decision|1|||
150257179|NCT03245151|542075872|FG002|Overall Study|Sponsor's decision|0|||
150257180|NCT03245151|542075873|FG003|Overall Study|Sponsor's decision|0|||
150257181|NCT03245151|542075874|FG004|Overall Study|Sponsor's decision|0|||
150257182|NCT01970345|542075876|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
150257183|NCT01970345|542075877|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
150257184|NCT01970345|542075876|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
150257185|NCT01970345|542075877|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
150257186|NCT01552603|542075878|FG000|Overall Study|Physician Decision|1|||
150257187|NCT00618618|542075879|FG000|Overall Study|Patient Request|0|||
150257188|NCT00618618|542075880|FG001|Overall Study|Patient Request|0|||
150257189|NCT00618618|542075881|FG002|Overall Study|Patient Request|2|||
150257190|NCT00618618|542075882|FG003|Overall Study|Patient Request|0|||
150257191|NCT00618618|542075879|FG000|Overall Study|Inability to Complete Study Procedures|0|||
150257192|NCT00618618|542075880|FG001|Overall Study|Inability to Complete Study Procedures|1|||
150257193|NCT00618618|542075881|FG002|Overall Study|Inability to Complete Study Procedures|0|||
150257194|NCT00618618|542075882|FG003|Overall Study|Inability to Complete Study Procedures|0|||
150257195|NCT00618618|542075879|FG000|Overall Study|Lost to Follow-up|3|||
150257196|NCT00618618|542075880|FG001|Overall Study|Lost to Follow-up|0|||
150257197|NCT00618618|542075881|FG002|Overall Study|Lost to Follow-up|0|||
150257198|NCT00618618|542075882|FG003|Overall Study|Lost to Follow-up|1|||
150257199|NCT00618618|542075879|FG000|Overall Study|Non-compliance|1|||
150257200|NCT00618618|542075880|FG001|Overall Study|Non-compliance|1|||
150257201|NCT00618618|542075881|FG002|Overall Study|Non-compliance|0|||
150257202|NCT00618618|542075882|FG003|Overall Study|Non-compliance|0|||
150257203|NCT00618618|542075879|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
150257204|NCT00618618|542075880|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
150257205|NCT00618618|542075881|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
150257206|NCT00618618|542075882|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
150257207|NCT00618618|542075879|FG000|Overall Study|Death|0|||
150257208|NCT00618618|542075880|FG001|Overall Study|Death|1|||
150257209|NCT00618618|542075881|FG002|Overall Study|Death|0|||
150257210|NCT00618618|542075882|FG003|Overall Study|Death|0|||
150257211|NCT04797650|542075888|FG000|Overall Study|Reason Not Specified|5|||
150257212|NCT04797650|542075889|FG001|Overall Study|Reason Not Specified|12|||
150257213|NCT04797650|542075890|FG002|Overall Study|Reason Not Specified|5|||
150257214|NCT04797650|542075888|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
150257215|NCT04797650|542075889|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
150257216|NCT04797650|542075890|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
150257217|NCT04797650|542075888|FG000|Overall Study|Lack of Efficacy|1|||
150257218|NCT04797650|542075889|FG001|Overall Study|Lack of Efficacy|0|||
150257219|NCT04797650|542075890|FG002|Overall Study|Lack of Efficacy|1|||
150257220|NCT04797650|542075888|FG000|Overall Study|Non-compliance with Study Drug|0|||
150257221|NCT04797650|542075889|FG001|Overall Study|Non-compliance with Study Drug|0|||
150257222|NCT04797650|542075890|FG002|Overall Study|Non-compliance with Study Drug|2|||
150257223|NCT04797650|542075888|FG000|Overall Study|Lost to Follow-up|4|||
150257224|NCT04797650|542075889|FG001|Overall Study|Lost to Follow-up|6|||
150257225|NCT04797650|542075890|FG002|Overall Study|Lost to Follow-up|1|||
150257226|NCT00309959|542075891|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
150257227|NCT02947087|542075893|FG000|Overall Study|Withdrawal by Subject|3|||
150257228|NCT02947087|542075894|FG001|Overall Study|Withdrawal by Subject|2|||
150257229|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
150257230|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
150257231|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
150257232|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
150257233|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
150257234|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
150257235|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
150257236|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
150257237|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
150257238|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
150257239|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
150257240|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
150257241|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
150257242|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
150257243|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
150257244|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
150257245|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
150257246|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
150257247|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
150257248|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
150257249|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
150257250|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
150257251|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149918589|NCT00207727|540833748|FG004|Overall Study|Other|33|||
149918590|NCT03611582|540833756|FG000|Overall Study|Adverse Event|26|||
150257252|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
150257253|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
150257254|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
150257255|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
150257256|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
150257257|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
150257258|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
150257259|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
150257260|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
150257261|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
150257262|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
150257263|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
150257264|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
150257265|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
150257266|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
150257267|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
150257268|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
150257269|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
150257270|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
150257271|NCT01160289|542075899|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
150257272|NCT01160289|542075900|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
150257273|NCT01160289|542075901|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
150257274|NCT01160289|542075902|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
150257275|NCT01160289|542075903|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
150257276|NCT01160289|542075904|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
150257277|NCT01160289|542075899|FG000|Post-Randomization Period|Adverse Event|0|||
150257278|NCT01160289|542075900|FG001|Post-Randomization Period|Adverse Event|4|||
150257279|NCT01160289|542075901|FG002|Post-Randomization Period|Adverse Event|4|||
150257280|NCT01160289|542075902|FG003|Post-Randomization Period|Adverse Event|2|||
150257281|NCT01160289|542075903|FG004|Post-Randomization Period|Adverse Event|0|||
150257282|NCT01160289|542075904|FG005|Post-Randomization Period|Adverse Event|0|||
150257283|NCT01160289|542075899|FG000|Post-Randomization Period|Death|0|||
150257284|NCT01160289|542075900|FG001|Post-Randomization Period|Death|0|||
150257285|NCT01160289|542075901|FG002|Post-Randomization Period|Death|0|||
150257286|NCT01160289|542075902|FG003|Post-Randomization Period|Death|1|||
150257287|NCT01160289|542075903|FG004|Post-Randomization Period|Death|0|||
150257288|NCT01160289|542075904|FG005|Post-Randomization Period|Death|0|||
150257289|NCT01160289|542075899|FG000|Post-Randomization Period|Lack of Efficacy|0|||
150257290|NCT01160289|542075900|FG001|Post-Randomization Period|Lack of Efficacy|1|||
150257291|NCT01160289|542075901|FG002|Post-Randomization Period|Lack of Efficacy|0|||
150257292|NCT01160289|542075902|FG003|Post-Randomization Period|Lack of Efficacy|3|||
150257293|NCT01160289|542075903|FG004|Post-Randomization Period|Lack of Efficacy|0|||
150257294|NCT01160289|542075904|FG005|Post-Randomization Period|Lack of Efficacy|0|||
150257295|NCT01160289|542075899|FG000|Post-Randomization Period|Lost to Follow-up|0|||
150257296|NCT01160289|542075900|FG001|Post-Randomization Period|Lost to Follow-up|3|||
150257297|NCT01160289|542075901|FG002|Post-Randomization Period|Lost to Follow-up|2|||
150257298|NCT01160289|542075902|FG003|Post-Randomization Period|Lost to Follow-up|5|||
150257299|NCT01160289|542075903|FG004|Post-Randomization Period|Lost to Follow-up|3|||
150257300|NCT01160289|542075904|FG005|Post-Randomization Period|Lost to Follow-up|4|||
150257301|NCT01160289|542075899|FG000|Post-Randomization Period|Physician Decision|0|||
150257302|NCT01160289|542075900|FG001|Post-Randomization Period|Physician Decision|0|||
150257303|NCT01160289|542075901|FG002|Post-Randomization Period|Physician Decision|1|||
150257304|NCT01160289|542075902|FG003|Post-Randomization Period|Physician Decision|0|||
150257305|NCT01160289|542075903|FG004|Post-Randomization Period|Physician Decision|0|||
150257306|NCT01160289|542075904|FG005|Post-Randomization Period|Physician Decision|0|||
150257307|NCT01160289|542075899|FG000|Post-Randomization Period|Protocol Violation|0|||
150257308|NCT01160289|542075900|FG001|Post-Randomization Period|Protocol Violation|4|||
150257309|NCT01160289|542075901|FG002|Post-Randomization Period|Protocol Violation|2|||
150257310|NCT01160289|542075902|FG003|Post-Randomization Period|Protocol Violation|0|||
150257311|NCT01160289|542075903|FG004|Post-Randomization Period|Protocol Violation|1|||
150257312|NCT01160289|542075904|FG005|Post-Randomization Period|Protocol Violation|3|||
150257313|NCT01160289|542075899|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
150257314|NCT01160289|542075900|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
150257315|NCT01160289|542075901|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
150257316|NCT01160289|542075902|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
150257317|NCT01160289|542075903|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
150257318|NCT01160289|542075904|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
150029379|NCT05635461|541244183|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
150257319|NCT01160289|542075899|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
149918591|NCT03611582|540833757|FG001|Overall Study|Adverse Event|6|||
150257320|NCT01160289|542075900|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
150257321|NCT01160289|542075901|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
150257322|NCT01160289|542075902|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
150257323|NCT01160289|542075903|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
150257324|NCT01160289|542075904|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
150257325|NCT01160289|542075899|FG000|Post-Randomization Period|Sponsor Decision|0|||
150257326|NCT01160289|542075900|FG001|Post-Randomization Period|Sponsor Decision|1|||
150257327|NCT01160289|542075901|FG002|Post-Randomization Period|Sponsor Decision|0|||
150257328|NCT01160289|542075902|FG003|Post-Randomization Period|Sponsor Decision|0|||
150257329|NCT01160289|542075903|FG004|Post-Randomization Period|Sponsor Decision|0|||
150257330|NCT01160289|542075904|FG005|Post-Randomization Period|Sponsor Decision|0|||
150257331|NCT01236534|542075905|FG000|Overall Study|Adverse Event|3|||
150257332|NCT01236534|542075906|FG001|Overall Study|Adverse Event|0|||
150257333|NCT01844687|542075907|FG000|Visit 1|Protocol Violation|3|||
150257334|NCT01844687|542075907|FG000|Visit 1|Lost to Follow-up|5|||
150257335|NCT01844687|542075907|FG000|Visit 2|Withdrawal by Subject|1|||
150257336|NCT01844687|542075907|FG000|Visit 2|Protocol Violation|1|||
150257337|NCT01844687|542075907|FG000|Visit 3|Lost to Follow-up|1|||
150257338|NCT01844687|542075907|FG000|Visit 3|Withdrawal by Subject|3|||
150257339|NCT01844687|542075907|FG000|Visit 3|child care problems|1|||
150257340|NCT01844687|542075907|FG000|Visit 4|Pregnancy|1|||
150257341|NCT01844687|542075907|FG000|Visit 4|Lost to Follow-up|1|||
150257342|NCT01844687|542075907|FG000|Visit 4|Withdrawal by Subject|2|||
150257343|NCT00635427|542075910|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
150257344|NCT00635427|542075911|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
150257345|NCT00635427|542075912|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
150257346|NCT00635427|542075913|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
150257347|NCT00635427|542075914|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
150257348|NCT00635427|542075910|FG000|Overall Study|Death|0|||
150257349|NCT00635427|542075911|FG001|Overall Study|Death|0|||
150257350|NCT00635427|542075912|FG002|Overall Study|Death|0|||
150257351|NCT00635427|542075913|FG003|Overall Study|Death|1|||
150257352|NCT00635427|542075914|FG004|Overall Study|Death|0|||
150257353|NCT00635427|542075910|FG000|Overall Study|Termination Of Study By Sponsor|12|||
150257354|NCT00635427|542075911|FG001|Overall Study|Termination Of Study By Sponsor|6|||
150257355|NCT00635427|542075912|FG002|Overall Study|Termination Of Study By Sponsor|10|||
150257356|NCT00635427|542075913|FG003|Overall Study|Termination Of Study By Sponsor|6|||
150257357|NCT00635427|542075914|FG004|Overall Study|Termination Of Study By Sponsor|6|||
150257358|NCT00635427|542075910|FG000|Overall Study|Withdrawal Of Consent|0|||
150257359|NCT00635427|542075911|FG001|Overall Study|Withdrawal Of Consent|0|||
150257360|NCT00635427|542075912|FG002|Overall Study|Withdrawal Of Consent|0|||
150257361|NCT00635427|542075913|FG003|Overall Study|Withdrawal Of Consent|2|||
150257362|NCT00635427|542075914|FG004|Overall Study|Withdrawal Of Consent|2|||
150257363|NCT00564889|542075915|FG000|Overall Study|Death|7|||
150257364|NCT00564889|542075915|FG000|Overall Study|Adverse Event|12|||
150257365|NCT00564889|542075915|FG000|Overall Study|Alternative treatment|3|||
150257366|NCT00564889|542075915|FG000|Overall Study|Disease progression|3|||
150257367|NCT00564889|542075915|FG000|Overall Study|Other, not specified|4|||
150257368|NCT02624791|542075916|FG000|Overall Study|Withdrawal by Subject|2|||
150257369|NCT02624791|542075917|FG001|Overall Study|Withdrawal by Subject|0|||
150257370|NCT02624791|542075918|FG002|Overall Study|Withdrawal by Subject|0|||
150257371|NCT02624791|542075919|FG003|Overall Study|Withdrawal by Subject|0|||
149918592|NCT03611582|540833756|FG000|Overall Study|Protocol Violation|0|||
149918593|NCT03611582|540833757|FG001|Overall Study|Protocol Violation|1|||
149918594|NCT03611582|540833756|FG000|Overall Study|Pregnancy|1|||
149918595|NCT03611582|540833757|FG001|Overall Study|Pregnancy|2|||
149918596|NCT03611582|540833756|FG000|Overall Study|Lack of Efficacy|0|||
149918597|NCT03611582|540833757|FG001|Overall Study|Lack of Efficacy|1|||
149918598|NCT03611582|540833756|FG000|Overall Study|At the discretion of the investigator|1|||
149918599|NCT03611582|540833757|FG001|Overall Study|At the discretion of the investigator|0|||
149918600|NCT03611582|540833756|FG000|Overall Study|Safety concern as judged by the investigator|1|||
149918601|NCT03611582|540833757|FG001|Overall Study|Safety concern as judged by the investigator|2|||
149918602|NCT03611582|540833756|FG000|Overall Study|Withdrawal by Subject|4|||
149918603|NCT03611582|540833757|FG001|Overall Study|Withdrawal by Subject|3|||
149918604|NCT03611582|540833756|FG000|Overall Study|Lost to Follow-up|18|||
149918605|NCT03611582|540833757|FG001|Overall Study|Lost to Follow-up|7|||
149918606|NCT03611582|540833756|FG000|Overall Study|other|17|||
149918607|NCT03611582|540833757|FG001|Overall Study|other|16|||
150257372|NCT02624791|542075920|FG004|Overall Study|Withdrawal by Subject|0|||
150257373|NCT02624791|542075921|FG005|Overall Study|Withdrawal by Subject|0|||
150257374|NCT00998790|542075922|FG000|Overall Study|Withdrawal by Subject|21|||
150257375|NCT01993927|542075923|FG000|Overall Study|Case Report Forms Uncollected|18|||
150257376|NCT01993927|542075923|FG000|Overall Study|Protocol Violation|11|||
150257377|NCT00287690|542075924|FG000|Overall Study|Protocol Violation|20|||
149918608|NCT01783821|540833758|FG000|Overall Study|Screen Failure|1|||
149918609|NCT01783821|540833759|FG001|Overall Study|Screen Failure|1|||
149918610|NCT02333383|540833760|FG000|Overall Study|Adalimumab discontinuation|21|||
149918611|NCT02333383|540833760|FG000|Overall Study|Lost to Follow-up|15|||
149918612|NCT02333383|540833760|FG000|Overall Study|Withdrawal by Subject|3|||
149918613|NCT02333383|540833760|FG000|Overall Study|Transfer to another hospital|2|||
149918614|NCT04459598|540833761|FG000|Overall Study|Adverse Event|1|||
149918615|NCT04459598|540833762|FG001|Overall Study|Adverse Event|1|||
149918616|NCT04852276|540833763|FG000|Overall Study|Death|2|||
149918617|NCT04852276|540833764|FG001|Overall Study|Death|0|||
150143309|NCT00117156|541660186|FG000|Overall Study|Adverse Event|9|||
150143310|NCT00117156|541660186|FG000|Overall Study|Physician Decision|1|||
150143311|NCT00117156|541660186|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
150143312|NCT01919970|541660187|FG000|Overall Study|Withdrawal by Subject|3|||
150143313|NCT01919970|541660188|FG001|Overall Study|Withdrawal by Subject|0|||
150143314|NCT04043962|541660189|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
150143315|NCT04043962|541660189|FG000|Post-Treatment|Withdrawal by Subject|5|||
150143316|NCT04043962|541660189|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
150177708|NCT02988817|541788179|FG015|Overall Study|Lost to Follow-up|1|||
150177709|NCT02988817|541788180|FG016|Overall Study|Lost to Follow-up|2|||
150177710|NCT02988817|541788181|FG017|Overall Study|Lost to Follow-up|3|||
150177711|NCT02988817|541788182|FG018|Overall Study|Lost to Follow-up|0|||
150177712|NCT02988817|541788183|FG019|Overall Study|Lost to Follow-up|0|||
150177713|NCT02988817|541788164|FG000|Overall Study|Sponsor decision|0|||
150177714|NCT02988817|541788165|FG001|Overall Study|Sponsor decision|0|||
150177715|NCT02988817|541788166|FG002|Overall Study|Sponsor decision|0|||
150177716|NCT02988817|541788167|FG003|Overall Study|Sponsor decision|0|||
150177717|NCT02988817|541788168|FG004|Overall Study|Sponsor decision|0|||
150177718|NCT02988817|541788169|FG005|Overall Study|Sponsor decision|0|||
150177719|NCT02988817|541788170|FG006|Overall Study|Sponsor decision|0|||
150177720|NCT02988817|541788171|FG007|Overall Study|Sponsor decision|0|||
150177721|NCT02988817|541788172|FG008|Overall Study|Sponsor decision|0|||
150177722|NCT02988817|541788173|FG009|Overall Study|Sponsor decision|0|||
150177723|NCT02988817|541788174|FG010|Overall Study|Sponsor decision|0|||
150177724|NCT02988817|541788175|FG011|Overall Study|Sponsor decision|1|||
150177725|NCT02988817|541788176|FG012|Overall Study|Sponsor decision|1|||
150177726|NCT02988817|541788177|FG013|Overall Study|Sponsor decision|2|||
150177727|NCT02988817|541788178|FG014|Overall Study|Sponsor decision|2|||
150177728|NCT02988817|541788179|FG015|Overall Study|Sponsor decision|6|||
150177729|NCT02988817|541788180|FG016|Overall Study|Sponsor decision|2|||
150177730|NCT02988817|541788181|FG017|Overall Study|Sponsor decision|3|||
150177731|NCT02988817|541788182|FG018|Overall Study|Sponsor decision|2|||
150177732|NCT02988817|541788183|FG019|Overall Study|Sponsor decision|7|||
150177733|NCT02988817|541788164|FG000|Overall Study|Physician Decision|0|||
150177734|NCT02988817|541788165|FG001|Overall Study|Physician Decision|0|||
150177735|NCT02988817|541788166|FG002|Overall Study|Physician Decision|0|||
150177736|NCT02988817|541788167|FG003|Overall Study|Physician Decision|0|||
150177737|NCT02988817|541788168|FG004|Overall Study|Physician Decision|0|||
150177738|NCT02988817|541788169|FG005|Overall Study|Physician Decision|0|||
150177739|NCT02988817|541788170|FG006|Overall Study|Physician Decision|0|||
150177740|NCT02988817|541788171|FG007|Overall Study|Physician Decision|0|||
150177741|NCT02988817|541788172|FG008|Overall Study|Physician Decision|0|||
150177742|NCT02988817|541788173|FG009|Overall Study|Physician Decision|0|||
150177743|NCT02988817|541788174|FG010|Overall Study|Physician Decision|0|||
150177744|NCT02988817|541788175|FG011|Overall Study|Physician Decision|0|||
150177745|NCT02988817|541788176|FG012|Overall Study|Physician Decision|0|||
150177746|NCT02988817|541788177|FG013|Overall Study|Physician Decision|0|||
150177747|NCT02988817|541788178|FG014|Overall Study|Physician Decision|0|||
150177748|NCT02988817|541788179|FG015|Overall Study|Physician Decision|1|||
150177749|NCT02988817|541788180|FG016|Overall Study|Physician Decision|0|||
150177750|NCT02988817|541788181|FG017|Overall Study|Physician Decision|0|||
150177751|NCT02988817|541788182|FG018|Overall Study|Physician Decision|1|||
150177752|NCT02988817|541788183|FG019|Overall Study|Physician Decision|1|||
150177753|NCT05082935|541788186|FG000|Overall Study|Lost to Follow-up|549|||
150177754|NCT05082935|541788187|FG001|Overall Study|Lost to Follow-up|631|||
150177755|NCT05082935|541788186|FG000|Overall Study|Withdrawal by Subject|27|||
150177756|NCT05082935|541788187|FG001|Overall Study|Withdrawal by Subject|58|||
150257378|NCT00287690|542075925|FG001|Overall Study|Protocol Violation|26|||
149918618|NCT04852276|540833763|FG000|Overall Study|Lost to Follow-up|15|||
150177757|NCT02379819|541788191|FG000|Overall Study|Withdrawal by Subject|10|||
150177758|NCT02379819|541788191|FG000|Overall Study|Death|2|||
150177759|NCT02379819|541788191|FG000|Overall Study|Lack of Efficacy|1|||
150177760|NCT02379819|541788191|FG000|Overall Study|Lost to Follow-up|1|||
150177761|NCT01839331|541788192|FG000|Overall Study|Early Termination|3|||
150177762|NCT01839331|541788193|FG001|Overall Study|Early Termination|0|||
150177763|NCT01839331|541788194|FG002|Overall Study|Early Termination|1|||
150177764|NCT01839331|541788195|FG003|Overall Study|Early Termination|2|||
150177765|NCT01839331|541788192|FG000|Overall Study|Protocol Violation|1|||
150177766|NCT01839331|541788193|FG001|Overall Study|Protocol Violation|6|||
150257379|NCT04822597|542075928|FG000|Overall Study|Withdrawal by Subject|0|||
150143317|NCT00975221|541662418|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
150143318|NCT00975221|541662419|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
150143319|NCT00975221|541662418|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
150143320|NCT00975221|541662419|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
150143321|NCT00975221|541662418|FG000|Titration Phase (Weeks 1-12)|Other|0|||
150143322|NCT00975221|541662419|FG001|Titration Phase (Weeks 1-12)|Other|1|||
150143323|NCT00975221|541662418|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
150143324|NCT00975221|541662419|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
150143325|NCT00975221|541662418|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
150143326|NCT00975221|541662419|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
150143327|NCT00975221|541662418|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
150143328|NCT00975221|541662419|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
150143329|NCT01862991|541662423|FG000|Overall Study|Lost to Follow-up|2|||
150143330|NCT01862991|541662424|FG001|Overall Study|Lost to Follow-up|1|||
150143331|NCT01862991|541662425|FG002|Overall Study|Lost to Follow-up|1|||
150143332|NCT01862991|541662423|FG000|Overall Study|Protocol Violation|1|||
150143333|NCT01862991|541662424|FG001|Overall Study|Protocol Violation|0|||
150143334|NCT01862991|541662425|FG002|Overall Study|Protocol Violation|0|||
150143335|NCT02762981|541662426|FG000|Overall Study|Adverse Event|2|||
150143336|NCT02762981|541662427|FG001|Overall Study|Adverse Event|3|||
150143337|NCT02762981|541662428|FG002|Overall Study|Adverse Event|1|||
150143338|NCT02762981|541662429|FG003|Overall Study|Adverse Event|1|||
150143339|NCT02762981|541662430|FG004|Overall Study|Adverse Event|3|||
150143340|NCT02762981|541662426|FG000|Overall Study|Physician Decision|0|||
150143341|NCT02762981|541662427|FG001|Overall Study|Physician Decision|1|||
150143342|NCT02762981|541662428|FG002|Overall Study|Physician Decision|0|||
150143343|NCT02762981|541662429|FG003|Overall Study|Physician Decision|0|||
150143344|NCT02762981|541662430|FG004|Overall Study|Physician Decision|1|||
150143345|NCT02762981|541662426|FG000|Overall Study|Disease progression|11|||
150143346|NCT02762981|541662427|FG001|Overall Study|Disease progression|23|||
150143347|NCT02762981|541662428|FG002|Overall Study|Disease progression|4|||
150143348|NCT02762981|541662429|FG003|Overall Study|Disease progression|10|||
150143349|NCT02762981|541662430|FG004|Overall Study|Disease progression|1|||
150143350|NCT02762981|541662426|FG000|Overall Study|Enrolled not treated|1|||
150143351|NCT02762981|541662427|FG001|Overall Study|Enrolled not treated|5|||
150143352|NCT02762981|541662428|FG002|Overall Study|Enrolled not treated|0|||
150143353|NCT02762981|541662429|FG003|Overall Study|Enrolled not treated|2|||
150143354|NCT02762981|541662430|FG004|Overall Study|Enrolled not treated|0|||
150143355|NCT02762981|541662426|FG000|Overall Study|Other|2|||
150143356|NCT02762981|541662427|FG001|Overall Study|Other|3|||
150143357|NCT02762981|541662428|FG002|Overall Study|Other|1|||
150143358|NCT02762981|541662429|FG003|Overall Study|Other|0|||
150143359|NCT02762981|541662430|FG004|Overall Study|Other|0|||
150143360|NCT02762981|541662426|FG000|Overall Study|Missing|1|||
150143361|NCT02762981|541662427|FG001|Overall Study|Missing|0|||
150143362|NCT02762981|541662428|FG002|Overall Study|Missing|0|||
150143363|NCT02762981|541662429|FG003|Overall Study|Missing|0|||
150143364|NCT02762981|541662430|FG004|Overall Study|Missing|0|||
150143365|NCT02762981|541662426|FG000|Overall Study|Withdrawal by Subject|0|||
150143366|NCT02762981|541662427|FG001|Overall Study|Withdrawal by Subject|5|||
150143367|NCT02762981|541662428|FG002|Overall Study|Withdrawal by Subject|1|||
150143368|NCT02762981|541662429|FG003|Overall Study|Withdrawal by Subject|3|||
150143369|NCT02762981|541662430|FG004|Overall Study|Withdrawal by Subject|0|||
150143370|NCT02392611|541662433|FG000|Overall Study|Adverse Event|0|||
150143371|NCT02392611|541662434|FG001|Overall Study|Adverse Event|0|||
150143372|NCT02392611|541662435|FG002|Overall Study|Adverse Event|0|||
150143373|NCT02392611|541662436|FG003|Overall Study|Adverse Event|1|||
150143374|NCT02392611|541662437|FG004|Overall Study|Adverse Event|0|||
150143375|NCT02392611|541662438|FG005|Overall Study|Adverse Event|0|||
150143376|NCT02392611|541662439|FG006|Overall Study|Adverse Event|0|||
150143377|NCT02392611|541662440|FG007|Overall Study|Adverse Event|0|||
150143378|NCT02392611|541662441|FG008|Overall Study|Adverse Event|0|||
150143379|NCT02392611|541662433|FG000|Overall Study|Progressive disease|0|||
150143380|NCT02392611|541662434|FG001|Overall Study|Progressive disease|0|||
150143381|NCT02392611|541662435|FG002|Overall Study|Progressive disease|0|||
150143382|NCT02392611|541662436|FG003|Overall Study|Progressive disease|2|||
150143383|NCT02392611|541662437|FG004|Overall Study|Progressive disease|1|||
150143384|NCT02392611|541662438|FG005|Overall Study|Progressive disease|0|||
150143385|NCT02392611|541662439|FG006|Overall Study|Progressive disease|0|||
150143386|NCT02392611|541662440|FG007|Overall Study|Progressive disease|0|||
150143387|NCT02392611|541662441|FG008|Overall Study|Progressive disease|0|||
150143388|NCT02392611|541662433|FG000|Overall Study|Death|1|||
150143389|NCT02392611|541662434|FG001|Overall Study|Death|0|||
150143390|NCT02392611|541662435|FG002|Overall Study|Death|0|||
150143391|NCT02392611|541662436|FG003|Overall Study|Death|0|||
150143392|NCT02392611|541662437|FG004|Overall Study|Death|0|||
150143393|NCT02392611|541662438|FG005|Overall Study|Death|1|||
150143394|NCT02392611|541662439|FG006|Overall Study|Death|0|||
150143395|NCT02392611|541662440|FG007|Overall Study|Death|0|||
150143396|NCT02392611|541662441|FG008|Overall Study|Death|0|||
150143397|NCT02392611|541662433|FG000|Overall Study|Withdrawal by Subject|0|||
150143398|NCT02392611|541662434|FG001|Overall Study|Withdrawal by Subject|0|||
150143399|NCT02392611|541662435|FG002|Overall Study|Withdrawal by Subject|0|||
150143400|NCT02392611|541662436|FG003|Overall Study|Withdrawal by Subject|1|||
150143401|NCT02392611|541662437|FG004|Overall Study|Withdrawal by Subject|0|||
150143402|NCT02392611|541662438|FG005|Overall Study|Withdrawal by Subject|0|||
150143403|NCT02392611|541662439|FG006|Overall Study|Withdrawal by Subject|0|||
150143404|NCT02392611|541662440|FG007|Overall Study|Withdrawal by Subject|0|||
150143405|NCT02392611|541662441|FG008|Overall Study|Withdrawal by Subject|0|||
150143406|NCT02392611|541662433|FG000|Overall Study|Lost to Follow-up|0|||
150143407|NCT02392611|541662434|FG001|Overall Study|Lost to Follow-up|0|||
150143408|NCT02392611|541662435|FG002|Overall Study|Lost to Follow-up|0|||
150143409|NCT02392611|541662436|FG003|Overall Study|Lost to Follow-up|0|||
150143410|NCT02392611|541662437|FG004|Overall Study|Lost to Follow-up|0|||
150143411|NCT02392611|541662438|FG005|Overall Study|Lost to Follow-up|0|||
150143412|NCT02392611|541662439|FG006|Overall Study|Lost to Follow-up|1|||
150143413|NCT02392611|541662440|FG007|Overall Study|Lost to Follow-up|0|||
150143414|NCT02392611|541662441|FG008|Overall Study|Lost to Follow-up|0|||
150143415|NCT02392611|541662433|FG000|Overall Study|Enrolled, not treated|0|||
150143416|NCT02392611|541662434|FG001|Overall Study|Enrolled, not treated|0|||
150143417|NCT02392611|541662435|FG002|Overall Study|Enrolled, not treated|0|||
150143418|NCT02392611|541662436|FG003|Overall Study|Enrolled, not treated|2|||
150143419|NCT02392611|541662437|FG004|Overall Study|Enrolled, not treated|0|||
150257380|NCT04822597|542075929|FG001|Overall Study|Withdrawal by Subject|1|||
150257381|NCT04822597|542075930|FG002|Overall Study|Withdrawal by Subject|1|||
150257382|NCT04822597|542075931|FG003|Overall Study|Withdrawal by Subject|0|||
150257383|NCT04822597|542075928|FG000|Overall Study|Physician Decision|0|||
150257384|NCT04822597|542075929|FG001|Overall Study|Physician Decision|0|||
150257385|NCT04822597|542075930|FG002|Overall Study|Physician Decision|1|||
150257386|NCT04822597|542075931|FG003|Overall Study|Physician Decision|1|||
150257387|NCT04822597|542075928|FG000|Overall Study|Subject withdrawn after enrollment|0|||
150257388|NCT04822597|542075929|FG001|Overall Study|Subject withdrawn after enrollment|1|||
150257389|NCT04822597|542075930|FG002|Overall Study|Subject withdrawn after enrollment|0|||
150257390|NCT04822597|542075931|FG003|Overall Study|Subject withdrawn after enrollment|1|||
150257391|NCT04822597|542075928|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
150257392|NCT04822597|542075929|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
150257393|NCT04822597|542075930|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
150257394|NCT04822597|542075931|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
150257395|NCT03406078|542075932|FG000|Overall Study|Death|1|||
150257396|NCT03406078|542075933|FG001|Overall Study|Death|0|||
150257397|NCT03406078|542075932|FG000|Overall Study|Lost to Follow-up|0|||
150257398|NCT03406078|542075933|FG001|Overall Study|Lost to Follow-up|1|||
150257399|NCT03406078|542075932|FG000|Overall Study|Withdrawal by Subject|5|||
150257400|NCT03406078|542075933|FG001|Overall Study|Withdrawal by Subject|2|||
150257401|NCT00591851|542075934|FG000|Overall Study|Withdrawal by Subject|3|||
150257402|NCT00591851|542075934|FG000|Overall Study|Adverse Event|2|||
150257403|NCT00591851|542075934|FG000|Overall Study|Progressive Disease|1|||
150257404|NCT05593445|542075939|FG000|12-Week DBVC Period|Adverse Event|1|||
150257405|NCT05593445|542075940|FG001|12-Week DBVC Period|Adverse Event|0|||
150257406|NCT05593445|542075941|FG002|12-Week DBVC Period|Adverse Event|0|||
150257407|NCT05593445|542075942|FG003|12-Week DBVC Period|Adverse Event|0|||
150257408|NCT05593445|542075939|FG000|12-Week DBVC Period|Physician Decision|0|||
150257409|NCT05593445|542075940|FG001|12-Week DBVC Period|Physician Decision|1|||
150257410|NCT05593445|542075941|FG002|12-Week DBVC Period|Physician Decision|0|||
150257411|NCT05593445|542075942|FG003|12-Week DBVC Period|Physician Decision|0|||
150257412|NCT05593445|542075939|FG000|12-Week DBVC Period|Protocol Violation|0|||
150257413|NCT05593445|542075940|FG001|12-Week DBVC Period|Protocol Violation|1|||
150257414|NCT05593445|542075941|FG002|12-Week DBVC Period|Protocol Violation|0|||
150257415|NCT05593445|542075942|FG003|12-Week DBVC Period|Protocol Violation|0|||
150143420|NCT02392611|541662438|FG005|Overall Study|Enrolled, not treated|0|||
150143421|NCT02392611|541662439|FG006|Overall Study|Enrolled, not treated|0|||
150143422|NCT02392611|541662440|FG007|Overall Study|Enrolled, not treated|0|||
150143423|NCT02392611|541662441|FG008|Overall Study|Enrolled, not treated|0|||
150257416|NCT05593445|542075939|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
150257417|NCT05593445|542075940|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
150257418|NCT05593445|542075941|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
150143424|NCT01250119|541662442|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
150257419|NCT05593445|542075942|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
150257420|NCT05593445|542075939|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
150257421|NCT05593445|542075940|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
150257422|NCT05593445|542075941|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
150143425|NCT01250119|541662443|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
150143426|NCT01250119|541662442|FG000|Diagnostic Phase|Participants Not Tested|44|||
150143427|NCT01250119|541662443|FG001|Diagnostic Phase|Participants Not Tested|0|||
150257423|NCT05593445|542075942|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
150257424|NCT05593445|542075939|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
150257425|NCT05593445|542075940|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
150257426|NCT05593445|542075941|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
150257427|NCT05593445|542075942|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
150257428|NCT05593445|542075939|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
150257429|NCT05593445|542075940|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
150257430|NCT05593445|542075941|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
150257431|NCT05593445|542075942|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
150257432|NCT05593445|542075939|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150257433|NCT05593445|542075940|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150257434|NCT05593445|542075941|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
150257435|NCT05593445|542075942|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150257436|NCT05559476|542075943|FG000|Overall Study|Adverse Event|2|||
150257437|NCT05559476|542075944|FG001|Overall Study|Adverse Event|0|||
150257438|NCT05559476|542075943|FG000|Overall Study|Lost to Follow-up|13|||
150257439|NCT05559476|542075944|FG001|Overall Study|Lost to Follow-up|12|||
150257440|NCT05559476|542075943|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
150257441|NCT05559476|542075944|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
150257442|NCT05559476|542075943|FG000|Overall Study|Other|0|||
150257443|NCT05559476|542075944|FG001|Overall Study|Other|2|||
150257444|NCT05110690|542075945|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
150257445|NCT05110690|542075945|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
150257446|NCT05110690|542075945|FG000|Completion of Intervention|Lost to Follow-up|1|||
150257447|NCT05110690|542075945|FG000|Completion of Intervention|Death|1|||
150257448|NCT05110690|542075945|FG000|Completion of Intervention|Withdrawal by Subject|2|||
150143428|NCT01250119|541662442|FG000|Treatment Phase|Progressive Disease|0|||
150257449|NCT03647488|542077893|FG000|Overall Study|Progressive disease|10|||
150257450|NCT03647488|542077894|FG001|Overall Study|Progressive disease|0|||
150257451|NCT03647488|542077895|FG002|Overall Study|Progressive disease|0|||
150257452|NCT03647488|542077893|FG000|Overall Study|Adverse Event|5|||
150257453|NCT03647488|542077894|FG001|Overall Study|Adverse Event|0|||
150257454|NCT03647488|542077895|FG002|Overall Study|Adverse Event|0|||
150257455|NCT03647488|542077893|FG000|Overall Study|Clinical progression|2|||
150257456|NCT03647488|542077894|FG001|Overall Study|Clinical progression|0|||
150257457|NCT03647488|542077895|FG002|Overall Study|Clinical progression|0|||
150257458|NCT03647488|542077893|FG000|Overall Study|Participant refused to take investigational product|1|||
150257459|NCT03647488|542077894|FG001|Overall Study|Participant refused to take investigational product|0|||
150257460|NCT03647488|542077895|FG002|Overall Study|Participant refused to take investigational product|0|||
150257461|NCT00812331|542077896|FG000|Overall Study|Adverse Event|1|||
150257462|NCT00812331|542077897|FG001|Overall Study|Adverse Event|0|||
150257463|NCT00812331|542077898|FG002|Overall Study|Adverse Event|0|||
150257464|NCT00812331|542077899|FG003|Overall Study|Adverse Event|0|||
150257465|NCT00812331|542077900|FG004|Overall Study|Adverse Event|0|||
150257466|NCT03694275|542077901|FG000|Overall Study|Adverse Event|0|||
150257467|NCT03694275|542077902|FG001|Overall Study|Adverse Event|1|||
150257468|NCT03694275|542077901|FG000|Overall Study|Reason not Specified|0|||
150257469|NCT03694275|542077902|FG001|Overall Study|Reason not Specified|1|||
150257470|NCT00153062|542077906|FG000|Overall Study|Death|360|||
150257471|NCT00153062|542077907|FG001|Overall Study|Death|352|||
150257472|NCT00153062|542077908|FG002|Overall Study|Death|369|||
150257473|NCT00153062|542077909|FG003|Overall Study|Death|365|||
150257474|NCT00153062|542077906|FG000|Overall Study|Withdrawal by Subject|14|||
150257475|NCT00153062|542077907|FG001|Overall Study|Withdrawal by Subject|30|||
150257476|NCT00153062|542077908|FG002|Overall Study|Withdrawal by Subject|27|||
150257477|NCT00153062|542077909|FG003|Overall Study|Withdrawal by Subject|28|||
150257478|NCT00153062|542077906|FG000|Overall Study|Lost to Follow-up|12|||
150257479|NCT00153062|542077907|FG001|Overall Study|Lost to Follow-up|20|||
150257480|NCT00153062|542077908|FG002|Overall Study|Lost to Follow-up|15|||
150257481|NCT00153062|542077909|FG003|Overall Study|Lost to Follow-up|16|||
150257482|NCT00153062|542077906|FG000|Overall Study|Adverse Event|0|||
150257483|NCT00153062|542077907|FG001|Overall Study|Adverse Event|1|||
150257484|NCT00153062|542077908|FG002|Overall Study|Adverse Event|1|||
150257485|NCT00153062|542077909|FG003|Overall Study|Adverse Event|0|||
150257486|NCT00153062|542077906|FG000|Overall Study|Protocol Violation|0|||
150257487|NCT00153062|542077907|FG001|Overall Study|Protocol Violation|2|||
150257488|NCT00153062|542077908|FG002|Overall Study|Protocol Violation|1|||
150257489|NCT00153062|542077909|FG003|Overall Study|Protocol Violation|1|||
150257490|NCT00153062|542077906|FG000|Overall Study|No disposition data available|1|||
150257491|NCT00153062|542077907|FG001|Overall Study|No disposition data available|1|||
150257492|NCT00153062|542077908|FG002|Overall Study|No disposition data available|1|||
150257493|NCT00153062|542077909|FG003|Overall Study|No disposition data available|1|||
150257494|NCT00153062|542077906|FG000|Overall Study|Other|0|||
150257495|NCT00153062|542077907|FG001|Overall Study|Other|0|||
150257496|NCT00153062|542077908|FG002|Overall Study|Other|1|||
150257497|NCT00153062|542077909|FG003|Overall Study|Other|0|||
150257498|NCT01589237|542077929|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
150257499|NCT01589237|542077930|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
150257500|NCT01589237|542077931|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
150257501|NCT01589237|542077932|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
150257502|NCT01589237|542077929|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
150257503|NCT01589237|542077930|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
150257504|NCT01589237|542077931|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
150257505|NCT01589237|542077932|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
150257506|NCT01589237|542077929|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
150257507|NCT01589237|542077930|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
150257508|NCT01589237|542077931|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
150257509|NCT01589237|542077932|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
150257510|NCT01589237|542077929|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
150257511|NCT01589237|542077930|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
150257512|NCT01589237|542077931|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
150257513|NCT01589237|542077932|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
150257514|NCT01022268|542077934|FG000|Overall Study|Withdrawal by Subject|1|||
150257515|NCT01022268|542077935|FG001|Overall Study|Withdrawal by Subject|0|||
150257516|NCT01022268|542077934|FG000|Overall Study|Withdrawal by Subject|1|||
150257517|NCT01022268|542077935|FG001|Overall Study|Withdrawal by Subject|0|||
150257518|NCT00734097|542077936|FG000|Screening|Protocol Violation|12|||
150257519|NCT00734097|542077936|FG000|Screening|Withdrawal by Subject|5|||
150257520|NCT00734097|542077936|FG000|Screening|Lost to Follow-up|2|||
150257521|NCT00734097|542077936|FG000|Screening|Unconfirmed pregnancy|1|||
150257522|NCT00734097|542077936|FG000|Open Label|Lost to Follow-up|7|||
150257523|NCT00734097|542077936|FG000|Open Label|Withdrawal by Subject|5|||
150257524|NCT00734097|542077936|FG000|Open Label|Protocol Violation|4|||
150257525|NCT00910689|542077937|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
150257526|NCT00910689|542077938|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
150257527|NCT00910689|542077939|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
150257528|NCT00910689|542077940|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
150257529|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
150257530|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
150257531|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
150257532|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
150257533|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
150257534|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
150257535|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
150257536|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
150257537|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
150257538|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
150257539|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
150257540|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
150257541|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
150257542|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
150257543|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
150257544|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
150257545|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
150143429|NCT01250119|541662443|FG001|Treatment Phase|Progressive Disease|32|||
150143430|NCT01250119|541662442|FG000|Treatment Phase|Death|0|||
150143431|NCT01250119|541662443|FG001|Treatment Phase|Death|2|||
150143432|NCT01250119|541662442|FG000|Treatment Phase|Withdrawal by Subject|0|||
150143433|NCT01250119|541662443|FG001|Treatment Phase|Withdrawal by Subject|1|||
150143434|NCT01250119|541662442|FG000|Treatment Phase|Adverse Event|0|||
150143435|NCT01250119|541662443|FG001|Treatment Phase|Adverse Event|2|||
150143436|NCT01250119|541662442|FG000|Treatment Phase|Unknown reason|0|||
150143437|NCT01250119|541662443|FG001|Treatment Phase|Unknown reason|4|||
150143438|NCT02670538|541662444|FG000|Overall Study|Withdrawal of Consent|8|||
150143439|NCT02670538|541662445|FG001|Overall Study|Withdrawal of Consent|6|||
150143440|NCT02670538|541662446|FG002|Overall Study|Withdrawal of Consent|5|||
150143441|NCT02670538|541662444|FG000|Overall Study|Lost to Follow-up|8|||
150143442|NCT02670538|541662445|FG001|Overall Study|Lost to Follow-up|12|||
150143443|NCT02670538|541662446|FG002|Overall Study|Lost to Follow-up|7|||
150143444|NCT02670538|541662444|FG000|Overall Study|Adverse Event|5|||
150143445|NCT02670538|541662445|FG001|Overall Study|Adverse Event|5|||
150143446|NCT02670538|541662446|FG002|Overall Study|Adverse Event|11|||
150143447|NCT02670538|541662444|FG000|Overall Study|Lack of Efficacy|7|||
150143448|NCT02670538|541662445|FG001|Overall Study|Lack of Efficacy|1|||
150143449|NCT02670538|541662446|FG002|Overall Study|Lack of Efficacy|2|||
150143450|NCT02670538|541662444|FG000|Overall Study|Protocol Violation|3|||
150143451|NCT02670538|541662445|FG001|Overall Study|Protocol Violation|4|||
150143452|NCT02670538|541662446|FG002|Overall Study|Protocol Violation|1|||
150143453|NCT02670538|541662444|FG000|Overall Study|Noncompliance with Study Drug|1|||
150143454|NCT02670538|541662445|FG001|Overall Study|Noncompliance with Study Drug|3|||
150143455|NCT02670538|541662446|FG002|Overall Study|Noncompliance with Study Drug|2|||
150143456|NCT02670538|541662444|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150143457|NCT02670538|541662445|FG001|Overall Study|Other Miscellaneous Reasons|1|||
150143458|NCT02670538|541662446|FG002|Overall Study|Other Miscellaneous Reasons|2|||
150143459|NCT05648357|541662452|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
150143460|NCT00255346|541662453|FG000|Overall Study|Adverse Event|1|||
150143461|NCT00255346|541662454|FG001|Overall Study|Adverse Event|0|||
150143462|NCT00255346|541662455|FG002|Overall Study|Adverse Event|0|||
150143463|NCT00255346|541662456|FG003|Overall Study|Adverse Event|0|||
150143464|NCT00255346|541662457|FG004|Overall Study|Adverse Event|0|||
150257546|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
150257547|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
150257548|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
150143465|NCT00674323|541662458|FG000|Overall Study|Adverse Event|0|||
150143466|NCT00674323|541662459|FG001|Overall Study|Adverse Event|1|||
150143467|NCT00674323|541662460|FG002|Overall Study|Adverse Event|0|||
150143468|NCT00674323|541662458|FG000|Overall Study|Protocol Violation|1|||
150143469|NCT00674323|541662459|FG001|Overall Study|Protocol Violation|0|||
150143470|NCT00674323|541662460|FG002|Overall Study|Protocol Violation|0|||
150143471|NCT02045433|541662470|FG000|Overall Study|Withdrawal by Subject|1|||
150143472|NCT01559454|541662471|FG000|Overall Study|Lost to Follow-up|3|||
150143473|NCT01559454|541662472|FG001|Overall Study|Lost to Follow-up|2|||
150143474|NCT01559454|541662471|FG000|Overall Study|Withdrawal by Subject|0|||
150143475|NCT01559454|541662472|FG001|Overall Study|Withdrawal by Subject|1|||
150143476|NCT01559454|541662471|FG000|Overall Study|Physician Decision|0|||
150143477|NCT01559454|541662472|FG001|Overall Study|Physician Decision|1|||
150143478|NCT01559454|541662471|FG000|Overall Study|Protocol Violation|0|||
150143479|NCT01559454|541662472|FG001|Overall Study|Protocol Violation|1|||
150143480|NCT01559454|541662471|FG000|Overall Study|Lack of Efficacy|0|||
150143481|NCT01559454|541662472|FG001|Overall Study|Lack of Efficacy|1|||
150143482|NCT01932294|541662473|FG000|Overall Study|Death|43|||
150143483|NCT01932294|541662473|FG000|Overall Study|Lost to Follow-up|8|||
150143484|NCT01932294|541662473|FG000|Overall Study|VAD Implantation|20|||
150143485|NCT01932294|541662473|FG000|Overall Study|Heart Transplantation|16|||
150143486|NCT01932294|541662473|FG000|Overall Study|Transferred to other hospitals|12|||
150143487|NCT03075904|541662477|FG000|Overall Study|Physician Decision|3|||
150143488|NCT03075904|541662477|FG000|Overall Study|Need for Medication not Permitted|1|||
150143489|NCT00597714|541662478|FG000|Overall Study|Death|56|||
150143490|NCT00597714|541662479|FG001|Overall Study|Death|46|||
150143491|NCT00597714|541662480|FG002|Overall Study|Death|0|||
150143492|NCT00597714|541662478|FG000|Overall Study|Recipient death|0|||
150143493|NCT00597714|541662479|FG001|Overall Study|Recipient death|0|||
150143494|NCT00597714|541662480|FG002|Overall Study|Recipient death|10|||
150143495|NCT01350141|541662481|FG000|Overall Study|Lost to Follow-up|1|||
150143496|NCT01350141|541662482|FG001|Overall Study|Lost to Follow-up|0|||
150143497|NCT01350141|541662483|FG002|Overall Study|Lost to Follow-up|1|||
150143498|NCT01350141|541662481|FG000|Overall Study|Withdrawal by Subject|1|||
150143499|NCT01350141|541662482|FG001|Overall Study|Withdrawal by Subject|0|||
150143500|NCT01350141|541662483|FG002|Overall Study|Withdrawal by Subject|0|||
150143501|NCT01350141|541662481|FG000|Overall Study|Randomized but not treated|1|||
150143502|NCT01350141|541662482|FG001|Overall Study|Randomized but not treated|0|||
150143503|NCT01350141|541662483|FG002|Overall Study|Randomized but not treated|0|||
150143504|NCT00810082|541662484|FG000|Overall Study|Lost to Follow-up|0|||
150143505|NCT00810082|541662485|FG001|Overall Study|Lost to Follow-up|4|||
150143506|NCT01588990|541662488|FG000|Phase A|Withdrawal by Subject|5|||
150143507|NCT01588990|541662488|FG000|Phase A|Physician Decision|11|||
150143508|NCT01588990|541662488|FG000|Phase A|Other|14|||
150143509|NCT01588990|541662488|FG000|Phase A|Lost to Follow-up|1|||
150143510|NCT01588990|541662488|FG000|Phase A|Death|5|||
150143511|NCT01588990|541662488|FG000|Phase A|Adverse Event|28|||
150143512|NCT01588990|541662488|FG000|Phase A|Still on therapy at end of study|6|||
150143513|NCT01588990|541662488|FG000|Phase B|Adverse Event|2|||
150143514|NCT01588990|541662488|FG000|Phase B|Still on therapy at end of study|5|||
150143515|NCT01588990|541662488|FG000|Phase B|Withdrawal by Subject|3|||
150143516|NCT01588990|541662488|FG000|Phase B|Physician Decision|4|||
150143517|NCT01588990|541662488|FG000|Phase B|Other|2|||
150143518|NCT02367716|541662489|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
150143519|NCT01473381|541662490|FG000|Overall Study|Adverse Event|8|||
150143520|NCT01473381|541662491|FG001|Overall Study|Adverse Event|20|||
150143521|NCT01473381|541662492|FG002|Overall Study|Adverse Event|25|||
150143522|NCT01473381|541662493|FG003|Overall Study|Adverse Event|17|||
150143523|NCT01473381|541662490|FG000|Overall Study|Insufficient Therapeutic Response|10|||
150143524|NCT01473381|541662491|FG001|Overall Study|Insufficient Therapeutic Response|1|||
150143525|NCT01473381|541662492|FG002|Overall Study|Insufficient Therapeutic Response|2|||
150143526|NCT01473381|541662493|FG003|Overall Study|Insufficient Therapeutic Response|3|||
150143527|NCT01473381|541662490|FG000|Overall Study|Protocol Violation|17|||
150143528|NCT01473381|541662491|FG001|Overall Study|Protocol Violation|23|||
150143529|NCT01473381|541662492|FG002|Overall Study|Protocol Violation|19|||
150143530|NCT01473381|541662493|FG003|Overall Study|Protocol Violation|17|||
150143531|NCT01473381|541662490|FG000|Overall Study|Withdrawal of Consent|20|||
150143532|NCT01473381|541662491|FG001|Overall Study|Withdrawal of Consent|21|||
150257549|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
150257550|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
150257551|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
150143533|NCT01473381|541662492|FG002|Overall Study|Withdrawal of Consent|20|||
150143534|NCT01473381|541662493|FG003|Overall Study|Withdrawal of Consent|26|||
150143535|NCT01473381|541662490|FG000|Overall Study|Lost to Follow-up|25|||
150143536|NCT01473381|541662491|FG001|Overall Study|Lost to Follow-up|28|||
150143537|NCT01473381|541662492|FG002|Overall Study|Lost to Follow-up|35|||
150143538|NCT01473381|541662493|FG003|Overall Study|Lost to Follow-up|23|||
150143539|NCT01473381|541662490|FG000|Overall Study|Other Reasons|0|||
150143540|NCT01473381|541662491|FG001|Overall Study|Other Reasons|0|||
150143541|NCT01473381|541662492|FG002|Overall Study|Other Reasons|1|||
150143542|NCT01473381|541662493|FG003|Overall Study|Other Reasons|3|||
150143543|NCT00539643|541662494|FG000|Overall Study|Adverse Event|1|||
150143544|NCT00539643|541662495|FG001|Overall Study|Adverse Event|0|||
150143545|NCT00539643|541662494|FG000|Overall Study|Death|2|||
150143546|NCT00539643|541662495|FG001|Overall Study|Death|1|||
150257552|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
150143547|NCT00539643|541662494|FG000|Overall Study|Physician Decision|3|||
150143548|NCT00539643|541662495|FG001|Overall Study|Physician Decision|1|||
150143549|NCT00539643|541662494|FG000|Overall Study|Withdrawal by Subject|0|||
150143550|NCT00539643|541662495|FG001|Overall Study|Withdrawal by Subject|1|||
150143551|NCT02228395|541662496|FG000|First Intervention Period|No longer willing to participate|1|||
150143552|NCT02228395|541662497|FG001|First Intervention Period|No longer willing to participate|0|||
150143553|NCT02228395|541662498|FG002|First Intervention Period|No longer willing to participate|0|||
150143554|NCT02228395|541662496|FG000|First Intervention Period|Unable to comply with study dates|0|||
150143555|NCT02228395|541662497|FG001|First Intervention Period|Unable to comply with study dates|1|||
150143556|NCT02228395|541662498|FG002|First Intervention Period|Unable to comply with study dates|1|||
150143557|NCT01287520|541662502|FG000|Overall Study|Adverse Event|2|||
150143558|NCT01287520|541662503|FG001|Overall Study|Adverse Event|2|||
150257553|NCT00910689|542077937|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
150257554|NCT00910689|542077938|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
150257555|NCT00910689|542077939|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
150257556|NCT00910689|542077940|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
150257557|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
150257558|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
150143559|NCT01287520|541662504|FG002|Overall Study|Adverse Event|2|||
150143560|NCT01287520|541662505|FG003|Overall Study|Adverse Event|1|||
150143561|NCT01287520|541662506|FG004|Overall Study|Adverse Event|1|||
150143562|NCT01287520|541662507|FG005|Overall Study|Adverse Event|2|||
150143563|NCT01287520|541662508|FG006|Overall Study|Adverse Event|0|||
150143564|NCT01287520|541662509|FG007|Overall Study|Adverse Event|2|||
150143565|NCT01287520|541662510|FG008|Overall Study|Adverse Event|0|||
150143566|NCT01287520|541662502|FG000|Overall Study|Physician Decision|1|||
150143567|NCT01287520|541662503|FG001|Overall Study|Physician Decision|1|||
150143568|NCT01287520|541662504|FG002|Overall Study|Physician Decision|2|||
150143569|NCT01287520|541662505|FG003|Overall Study|Physician Decision|0|||
150143570|NCT01287520|541662506|FG004|Overall Study|Physician Decision|1|||
150143571|NCT01287520|541662507|FG005|Overall Study|Physician Decision|1|||
150143572|NCT01287520|541662508|FG006|Overall Study|Physician Decision|0|||
150143573|NCT01287520|541662509|FG007|Overall Study|Physician Decision|1|||
150143574|NCT01287520|541662510|FG008|Overall Study|Physician Decision|0|||
150143575|NCT01287520|541662502|FG000|Overall Study|Progressive disease|0|||
150143576|NCT01287520|541662503|FG001|Overall Study|Progressive disease|4|||
150143577|NCT01287520|541662504|FG002|Overall Study|Progressive disease|1|||
150143578|NCT01287520|541662505|FG003|Overall Study|Progressive disease|6|||
150143579|NCT01287520|541662506|FG004|Overall Study|Progressive disease|1|||
150143580|NCT01287520|541662507|FG005|Overall Study|Progressive disease|0|||
150143581|NCT01287520|541662508|FG006|Overall Study|Progressive disease|2|||
150143582|NCT01287520|541662509|FG007|Overall Study|Progressive disease|2|||
150143583|NCT01287520|541662510|FG008|Overall Study|Progressive disease|4|||
150143584|NCT01287520|541662502|FG000|Overall Study|Withdrawal by Subject|0|||
150143585|NCT01287520|541662503|FG001|Overall Study|Withdrawal by Subject|0|||
150143586|NCT01287520|541662504|FG002|Overall Study|Withdrawal by Subject|0|||
150143587|NCT01287520|541662505|FG003|Overall Study|Withdrawal by Subject|0|||
150143588|NCT01287520|541662506|FG004|Overall Study|Withdrawal by Subject|0|||
150143589|NCT01287520|541662507|FG005|Overall Study|Withdrawal by Subject|1|||
150143590|NCT01287520|541662508|FG006|Overall Study|Withdrawal by Subject|0|||
150143591|NCT01287520|541662509|FG007|Overall Study|Withdrawal by Subject|0|||
150143592|NCT01287520|541662510|FG008|Overall Study|Withdrawal by Subject|1|||
150143593|NCT03587142|541662511|FG000|Overall Study|Lost to Follow-up|5|||
150143594|NCT03587142|541662512|FG001|Overall Study|Lost to Follow-up|3|||
150143595|NCT03587142|541662511|FG000|Overall Study|Did not complete the f4 visit|3|||
150143596|NCT03587142|541662512|FG001|Overall Study|Did not complete the f4 visit|7|||
150143597|NCT02768662|541662513|FG000|Overall Study|Adverse Event|1|||
150143598|NCT02768662|541662513|FG000|Overall Study|Lost to Follow-up|4|||
150143599|NCT02768662|541662513|FG000|Overall Study|Withdrawal by Subject|3|||
150143600|NCT02768662|541662513|FG000|Overall Study|Study terminated by Sponsor|78|||
150143601|NCT01800201|541662514|FG000|Overall Study|Withdrawal by Subject|2|||
150143602|NCT01800201|541662515|FG001|Overall Study|Withdrawal by Subject|0|||
150143603|NCT01800201|541662514|FG000|Overall Study|patient privacy concerns|1|||
150143604|NCT01800201|541662515|FG001|Overall Study|patient privacy concerns|1|||
150257559|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
150257560|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
150257561|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
150257562|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
150257563|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
150257564|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
150257565|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
150257566|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
150257567|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
150257568|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
150257569|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
150143605|NCT01800201|541662514|FG000|Overall Study|did not want to use device|0|||
150143606|NCT01800201|541662515|FG001|Overall Study|did not want to use device|1|||
150143607|NCT01800201|541662514|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
150143608|NCT01800201|541662515|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
150143609|NCT05061537|541662521|FG000|Treatment Phase|Progressive disease|0|||
150143610|NCT05061537|541662522|FG001|Treatment Phase|Progressive disease|1|||
150143611|NCT05061537|541662523|FG002|Treatment Phase|Progressive disease|2|||
150143612|NCT05061537|541662524|FG003|Treatment Phase|Progressive disease|0|||
150143613|NCT05061537|541662525|FG004|Treatment Phase|Progressive disease|0|||
150143614|NCT05061537|541662521|FG000|Treatment Phase|Adverse Event|0|||
150143615|NCT05061537|541662522|FG001|Treatment Phase|Adverse Event|0|||
150143616|NCT05061537|541662523|FG002|Treatment Phase|Adverse Event|2|||
150143617|NCT05061537|541662524|FG003|Treatment Phase|Adverse Event|0|||
150143618|NCT05061537|541662525|FG004|Treatment Phase|Adverse Event|0|||
150143619|NCT05061537|541662521|FG000|Treatment Phase|Global deterioration of health status|0|||
150143620|NCT05061537|541662522|FG001|Treatment Phase|Global deterioration of health status|1|||
150143621|NCT05061537|541662523|FG002|Treatment Phase|Global deterioration of health status|0|||
150143622|NCT05061537|541662524|FG003|Treatment Phase|Global deterioration of health status|0|||
150143623|NCT05061537|541662525|FG004|Treatment Phase|Global deterioration of health status|0|||
150257570|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
150257571|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
150257572|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
150257573|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
150257574|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
150257575|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
150257576|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
150257577|NCT00910689|542077937|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
150257578|NCT00910689|542077938|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
150257579|NCT00910689|542077939|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
150257580|NCT00910689|542077940|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
150257581|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
150257582|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
150257583|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
150257584|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
150257585|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
150257586|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
150257587|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
150257588|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
150257589|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
150257590|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
150257591|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
150257592|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
150257593|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
150257594|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
150257595|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
150143624|NCT05061537|541662521|FG000|Follow up|Other|2|||
150143625|NCT05061537|541662522|FG001|Follow up|Other|0|||
150143626|NCT05061537|541662523|FG002|Follow up|Other|2|||
150143627|NCT05061537|541662524|FG003|Follow up|Other|0|||
150143628|NCT05061537|541662525|FG004|Follow up|Other|0|||
150143629|NCT05061537|541662521|FG000|Follow up|Study terminated by sponsor|0|||
150143630|NCT05061537|541662522|FG001|Follow up|Study terminated by sponsor|0|||
150143631|NCT05061537|541662523|FG002|Follow up|Study terminated by sponsor|2|||
150143632|NCT05061537|541662524|FG003|Follow up|Study terminated by sponsor|0|||
150143633|NCT05061537|541662525|FG004|Follow up|Study terminated by sponsor|0|||
150143634|NCT05061537|541662521|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
150143635|NCT05061537|541662522|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
150143636|NCT05061537|541662523|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
150143637|NCT05061537|541662524|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
150143638|NCT05061537|541662525|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
150143639|NCT05061537|541662521|FG000|Long-term Follow-up|Death|0|||
150143640|NCT05061537|541662522|FG001|Long-term Follow-up|Death|1|||
150143641|NCT05061537|541662523|FG002|Long-term Follow-up|Death|0|||
150143642|NCT05061537|541662524|FG003|Long-term Follow-up|Death|0|||
150143643|NCT05061537|541662525|FG004|Long-term Follow-up|Death|0|||
150143644|NCT01480596|541662526|FG000|Overall Study|Adverse Event|3|||
150143645|NCT01480596|541662527|FG001|Overall Study|Adverse Event|0|||
150143646|NCT01480596|541662526|FG000|Overall Study|MG exacerbation or change in medication|2|||
150143647|NCT01480596|541662527|FG001|Overall Study|MG exacerbation or change in medication|2|||
150143648|NCT04503096|541662528|FG000|Overall Study|Withdrawal by Subject|3|||
150143649|NCT01576367|541662531|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150143650|NCT01576367|541662531|FG000|Overall Study|Moved to commercial use after 6 months|1|||
150257596|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
150143651|NCT00988221|541662532|FG000|Part I|Adverse Event|0|||
150143652|NCT00988221|541662533|FG001|Part I|Adverse Event|1|||
150143653|NCT00988221|541662534|FG002|Part I|Adverse Event|2|||
150143654|NCT00988221|541662535|FG003|Part I|Adverse Event|0|||
150143655|NCT00988221|541662532|FG000|Part I|Insufficient Therapeutic Response|4|||
150143656|NCT00988221|541662533|FG001|Part I|Insufficient Therapeutic Response|6|||
150257597|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
150257598|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
150257599|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
150257600|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
150257601|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
150257602|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
150257603|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
150257604|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
150257605|NCT00910689|542077937|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
150257606|NCT00910689|542077938|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
150257607|NCT00910689|542077939|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
150257608|NCT00910689|542077940|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
150257609|NCT03207009|542077943|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
150257610|NCT01877837|542077944|FG000|Overall Study|Lost to Follow-up|1|||
150257611|NCT01877837|542077944|FG000|Overall Study|Ineligible|4|||
150257612|NCT00932113|542077947|FG000|Overall Study|Lost to Follow-up|1|||
150257613|NCT00932113|542077948|FG001|Overall Study|Lost to Follow-up|0|||
150257614|NCT01773291|542077949|FG000|Overall Study|Protocol Violation|1|||
150257615|NCT01773291|542077950|FG001|Overall Study|Protocol Violation|0|||
150257616|NCT01773291|542077951|FG002|Overall Study|Protocol Violation|0|||
150257617|NCT01773291|542077949|FG000|Overall Study|Withdrawal by Subject|0|||
150257618|NCT01773291|542077950|FG001|Overall Study|Withdrawal by Subject|0|||
150257619|NCT01773291|542077951|FG002|Overall Study|Withdrawal by Subject|1|||
150257620|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
150143657|NCT00988221|541662534|FG002|Part I|Insufficient Therapeutic Response|5|||
150143658|NCT00988221|541662535|FG003|Part I|Insufficient Therapeutic Response|0|||
150143659|NCT00988221|541662532|FG000|Part I|Refused Treatment|0|||
150143660|NCT00988221|541662533|FG001|Part I|Refused Treatment|2|||
150143661|NCT00988221|541662534|FG002|Part I|Refused Treatment|1|||
150143662|NCT00988221|541662535|FG003|Part I|Refused Treatment|0|||
150143663|NCT00988221|541662532|FG000|Part I|Lost to Follow-up|0|||
150143664|NCT00988221|541662533|FG001|Part I|Lost to Follow-up|1|||
150143665|NCT00988221|541662534|FG002|Part I|Lost to Follow-up|0|||
150143666|NCT00988221|541662535|FG003|Part I|Lost to Follow-up|0|||
150143667|NCT00988221|541662532|FG000|Part II|Adverse Event|1|||
150143668|NCT00988221|541662533|FG001|Part II|Adverse Event|0|||
150143669|NCT00988221|541662534|FG002|Part II|Adverse Event|0|||
150143670|NCT00988221|541662535|FG003|Part II|Adverse Event|1|||
150143671|NCT00988221|541662532|FG000|Part II|Withdrawal by Subject|0|||
150143672|NCT00988221|541662533|FG001|Part II|Withdrawal by Subject|0|||
150143673|NCT00988221|541662534|FG002|Part II|Withdrawal by Subject|2|||
150143674|NCT00988221|541662535|FG003|Part II|Withdrawal by Subject|2|||
150143675|NCT00988221|541662532|FG000|Part II|Reason not Specified|0|||
150143676|NCT00988221|541662533|FG001|Part II|Reason not Specified|0|||
150143677|NCT00988221|541662534|FG002|Part II|Reason not Specified|1|||
150143678|NCT00988221|541662535|FG003|Part II|Reason not Specified|0|||
150143679|NCT00988221|541662532|FG000|Part III|Adverse Event|1|||
150143680|NCT00988221|541662533|FG001|Part III|Adverse Event|0|||
150143681|NCT00988221|541662534|FG002|Part III|Adverse Event|1|||
150143682|NCT00988221|541662535|FG003|Part III|Adverse Event|0|||
150143683|NCT00988221|541662532|FG000|Part III|Insufficient Therapeutic Response|0|||
150143684|NCT00988221|541662533|FG001|Part III|Insufficient Therapeutic Response|1|||
150143685|NCT00988221|541662534|FG002|Part III|Insufficient Therapeutic Response|1|||
150143686|NCT00988221|541662535|FG003|Part III|Insufficient Therapeutic Response|0|||
150143687|NCT00988221|541662532|FG000|Part III|Refused Treatment|0|||
150143688|NCT00988221|541662533|FG001|Part III|Refused Treatment|0|||
150143689|NCT00988221|541662534|FG002|Part III|Refused Treatment|1|||
150143690|NCT00988221|541662535|FG003|Part III|Refused Treatment|0|||
150143691|NCT01346514|541662539|FG000|Overall Study|Lost to Follow-up|19|||
150143692|NCT01346514|541662540|FG001|Overall Study|Lost to Follow-up|30|||
150143693|NCT01346514|541662539|FG000|Overall Study|Withdrawal by Subject|7|||
150143694|NCT01346514|541662540|FG001|Overall Study|Withdrawal by Subject|3|||
150143695|NCT01346514|541662539|FG000|Overall Study|Death|3|||
150257621|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
150257622|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
150143696|NCT01346514|541662540|FG001|Overall Study|Death|4|||
150143697|NCT00909480|541662541|FG000|Overall Study|Adverse Event|5|||
150143698|NCT00909480|541662542|FG001|Overall Study|Adverse Event|3|||
150143699|NCT00909480|541662541|FG000|Overall Study|Protocol Violation|6|||
150143700|NCT00909480|541662542|FG001|Overall Study|Protocol Violation|8|||
150143701|NCT00909480|541662541|FG000|Overall Study|Withdrawal criteria|9|||
150143702|NCT00909480|541662542|FG001|Overall Study|Withdrawal criteria|11|||
150143703|NCT00909480|541662541|FG000|Overall Study|Unclassified|18|||
150143704|NCT00909480|541662542|FG001|Overall Study|Unclassified|19|||
150143705|NCT03528174|541662547|FG000|Overall Study|Adverse Event|1|||
150143706|NCT03528174|541662547|FG000|Overall Study|sensors dislodged|1|||
150143707|NCT00979602|541662554|FG000|Overall Study|Serious Adverse Event|5|||
150143708|NCT00979602|541662555|FG001|Overall Study|Serious Adverse Event|3|||
150143709|NCT00979602|541662554|FG000|Overall Study|Protocol Violation|3|||
150143710|NCT00979602|541662555|FG001|Overall Study|Protocol Violation|0|||
150143711|NCT00979602|541662554|FG000|Overall Study|Withdrawal by Subject|31|||
150143712|NCT00979602|541662555|FG001|Overall Study|Withdrawal by Subject|25|||
150143713|NCT00979602|541662554|FG000|Overall Study|Lost to Follow-up|100|||
150143714|NCT00979602|541662555|FG001|Overall Study|Lost to Follow-up|96|||
150143715|NCT00979602|541662554|FG000|Overall Study|Migrated/moved from study area|3|||
150143716|NCT00979602|541662555|FG001|Overall Study|Migrated/moved from study area|6|||
150143717|NCT00979602|541662554|FG000|Overall Study|Others|3|||
150257623|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
150257624|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
150257625|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
150257626|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
150257627|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
150257628|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
150257629|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
150257630|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
150257631|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
150257632|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
150257633|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
150257634|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
150257635|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
150257636|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
150257637|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
150257638|NCT02480153|542077952|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
150257639|NCT02480153|542077953|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
150257640|NCT02480153|542077954|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
150143718|NCT00979602|541662555|FG001|Overall Study|Others|3|||
150143719|NCT02904902|541662556|FG000|Overall Study|Withdrawal by Subject|1|||
150143720|NCT02712398|541662557|FG000|Overall Study|Withdrawal by Subject|6|||
150143721|NCT02712398|541662557|FG000|Overall Study|Lost to Follow-up|6|||
150143722|NCT02712398|541662557|FG000|Overall Study|Sponsor Decision|1|||
150143723|NCT02712398|541662557|FG000|Overall Study|Physician Decision|1|||
150143724|NCT02712398|541662557|FG000|Overall Study|Death|2|||
150143725|NCT02712398|541662557|FG000|Overall Study|Re-operation|21|||
150143726|NCT02118337|541662568|FG000|Overall Study|Other|1|||
150143727|NCT02118337|541662569|FG001|Overall Study|Other|0|||
150143728|NCT02118337|541662570|FG002|Overall Study|Other|0|||
150143729|NCT02118337|541662571|FG003|Overall Study|Other|0|||
150257641|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
150257642|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
150257643|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
150257644|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
150257645|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
150143730|NCT02118337|541662572|FG004|Overall Study|Other|2|||
150143731|NCT02118337|541662573|FG005|Overall Study|Other|3|||
150143732|NCT02118337|541662574|FG006|Overall Study|Other|1|||
150143733|NCT02118337|541662575|FG007|Overall Study|Other|28|||
150143734|NCT02118337|541662576|FG008|Overall Study|Other|15|||
150143735|NCT02118337|541662568|FG000|Overall Study|Lost to Follow-up|0|||
150143736|NCT02118337|541662569|FG001|Overall Study|Lost to Follow-up|0|||
150143737|NCT02118337|541662570|FG002|Overall Study|Lost to Follow-up|0|||
150143738|NCT02118337|541662571|FG003|Overall Study|Lost to Follow-up|0|||
150143739|NCT02118337|541662572|FG004|Overall Study|Lost to Follow-up|0|||
150143740|NCT02118337|541662573|FG005|Overall Study|Lost to Follow-up|0|||
150143741|NCT02118337|541662574|FG006|Overall Study|Lost to Follow-up|0|||
150143742|NCT02118337|541662575|FG007|Overall Study|Lost to Follow-up|1|||
150143743|NCT02118337|541662576|FG008|Overall Study|Lost to Follow-up|0|||
150143744|NCT02118337|541662568|FG000|Overall Study|Withdrawal by Subject|1|||
150143745|NCT02118337|541662569|FG001|Overall Study|Withdrawal by Subject|3|||
150143746|NCT02118337|541662570|FG002|Overall Study|Withdrawal by Subject|2|||
150143747|NCT02118337|541662571|FG003|Overall Study|Withdrawal by Subject|1|||
150143748|NCT02118337|541662572|FG004|Overall Study|Withdrawal by Subject|2|||
150143749|NCT02118337|541662573|FG005|Overall Study|Withdrawal by Subject|2|||
150143750|NCT02118337|541662574|FG006|Overall Study|Withdrawal by Subject|1|||
150143751|NCT02118337|541662575|FG007|Overall Study|Withdrawal by Subject|4|||
150143752|NCT02118337|541662576|FG008|Overall Study|Withdrawal by Subject|2|||
150143753|NCT02118337|541662568|FG000|Overall Study|Death|2|||
150143754|NCT02118337|541662569|FG001|Overall Study|Death|2|||
150143755|NCT02118337|541662570|FG002|Overall Study|Death|1|||
150143756|NCT02118337|541662571|FG003|Overall Study|Death|2|||
150143757|NCT02118337|541662572|FG004|Overall Study|Death|5|||
150143758|NCT02118337|541662573|FG005|Overall Study|Death|1|||
150143759|NCT02118337|541662574|FG006|Overall Study|Death|2|||
150143760|NCT02118337|541662575|FG007|Overall Study|Death|9|||
150143761|NCT02118337|541662576|FG008|Overall Study|Death|4|||
150143762|NCT03787680|541662577|FG000|Overall Study|Physician Decision|2|||
150143763|NCT03787680|541662578|FG001|Overall Study|Physician Decision|3|||
150143764|NCT03787680|541662577|FG000|Overall Study|Adverse Event|7|||
150143765|NCT03787680|541662578|FG001|Overall Study|Adverse Event|3|||
150143766|NCT03787680|541662577|FG000|Overall Study|Withdrawal by Subject|2|||
150143767|NCT03787680|541662578|FG001|Overall Study|Withdrawal by Subject|1|||
150143768|NCT01490125|541662579|FG000|Period I|Adverse Event|4|||
150143769|NCT01490125|541662580|FG001|Period I|Adverse Event|1|||
150143770|NCT01490125|541662581|FG002|Period I|Adverse Event|1|||
150143771|NCT01490125|541662582|FG003|Period I|Adverse Event|3|||
150143772|NCT01490125|541662583|FG004|Period I|Adverse Event|2|||
150143773|NCT01490125|541662584|FG005|Period I|Adverse Event|4|||
150143774|NCT01490125|541662579|FG000|Period I|Protocol Violation|1|||
150143775|NCT01490125|541662580|FG001|Period I|Protocol Violation|1|||
150143776|NCT01490125|541662581|FG002|Period I|Protocol Violation|1|||
150143777|NCT01490125|541662582|FG003|Period I|Protocol Violation|1|||
150143778|NCT01490125|541662583|FG004|Period I|Protocol Violation|0|||
150143779|NCT01490125|541662584|FG005|Period I|Protocol Violation|0|||
150143780|NCT01490125|541662579|FG000|Period I|Withdrawal by Subject|1|||
150143781|NCT01490125|541662580|FG001|Period I|Withdrawal by Subject|3|||
150143782|NCT01490125|541662581|FG002|Period I|Withdrawal by Subject|2|||
150143783|NCT01490125|541662582|FG003|Period I|Withdrawal by Subject|1|||
150143784|NCT01490125|541662583|FG004|Period I|Withdrawal by Subject|2|||
150143785|NCT01490125|541662584|FG005|Period I|Withdrawal by Subject|1|||
150143786|NCT01490125|541662579|FG000|Period II|Adverse Event|2|||
150143787|NCT01490125|541662580|FG001|Period II|Adverse Event|3|||
150143788|NCT01490125|541662581|FG002|Period II|Adverse Event|2|||
150143789|NCT01490125|541662582|FG003|Period II|Adverse Event|2|||
150143790|NCT01490125|541662583|FG004|Period II|Adverse Event|4|||
150143791|NCT01490125|541662584|FG005|Period II|Adverse Event|2|||
150143792|NCT01490125|541662579|FG000|Period II|Protocol Violation|0|||
150143793|NCT01490125|541662580|FG001|Period II|Protocol Violation|0|||
150143794|NCT01490125|541662581|FG002|Period II|Protocol Violation|1|||
150143795|NCT01490125|541662582|FG003|Period II|Protocol Violation|1|||
150143796|NCT01490125|541662583|FG004|Period II|Protocol Violation|0|||
150143797|NCT01490125|541662584|FG005|Period II|Protocol Violation|0|||
150143798|NCT01490125|541662579|FG000|Period II|Lost to Follow-up|0|||
150143799|NCT01490125|541662580|FG001|Period II|Lost to Follow-up|1|||
150143800|NCT01490125|541662581|FG002|Period II|Lost to Follow-up|0|||
150257646|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
150257647|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
150257648|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
150257649|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
150257650|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
150257651|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
150257652|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
150257653|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
150257654|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
150257655|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
150257656|NCT02480153|542077952|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
150257657|NCT02480153|542077953|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
150257658|NCT02480153|542077954|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
150257659|NCT02480153|542077952|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
150257660|NCT02480153|542077953|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
150257661|NCT02480153|542077954|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
150257662|NCT02480153|542077952|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
150257663|NCT02480153|542077953|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
150257664|NCT02480153|542077954|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
150257665|NCT02480153|542077952|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
150257666|NCT02480153|542077953|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
150257667|NCT02480153|542077954|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
150257668|NCT02480153|542077952|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
150257669|NCT02480153|542077953|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
150257670|NCT02480153|542077954|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
150143801|NCT01490125|541662582|FG003|Period II|Lost to Follow-up|0|||
150143802|NCT01490125|541662583|FG004|Period II|Lost to Follow-up|0|||
150143803|NCT01490125|541662584|FG005|Period II|Lost to Follow-up|0|||
150143804|NCT01490125|541662579|FG000|Period II|Withdrawal by Subject|1|||
150143805|NCT01490125|541662580|FG001|Period II|Withdrawal by Subject|0|||
150143806|NCT01490125|541662581|FG002|Period II|Withdrawal by Subject|0|||
150143807|NCT01490125|541662582|FG003|Period II|Withdrawal by Subject|0|||
150143808|NCT01490125|541662583|FG004|Period II|Withdrawal by Subject|0|||
150143809|NCT01490125|541662584|FG005|Period II|Withdrawal by Subject|0|||
150143810|NCT01490125|541662579|FG000|Period III|Adverse Event|3|||
150143811|NCT01490125|541662580|FG001|Period III|Adverse Event|1|||
150143812|NCT01490125|541662581|FG002|Period III|Adverse Event|0|||
150143813|NCT01490125|541662582|FG003|Period III|Adverse Event|1|||
150143814|NCT01490125|541662583|FG004|Period III|Adverse Event|0|||
150143815|NCT01490125|541662584|FG005|Period III|Adverse Event|0|||
150143816|NCT01490125|541662579|FG000|Period III|Death|0|||
150143817|NCT01490125|541662580|FG001|Period III|Death|0|||
150143818|NCT01490125|541662581|FG002|Period III|Death|0|||
150143819|NCT01490125|541662582|FG003|Period III|Death|1|||
150143820|NCT01490125|541662583|FG004|Period III|Death|0|||
150143821|NCT01490125|541662584|FG005|Period III|Death|0|||
150143822|NCT01490125|541662579|FG000|Period III|Lack of Efficacy|0|||
150143823|NCT01490125|541662580|FG001|Period III|Lack of Efficacy|0|||
150143824|NCT01490125|541662581|FG002|Period III|Lack of Efficacy|0|||
150143825|NCT01490125|541662582|FG003|Period III|Lack of Efficacy|0|||
150143826|NCT01490125|541662583|FG004|Period III|Lack of Efficacy|1|||
150143827|NCT01490125|541662584|FG005|Period III|Lack of Efficacy|0|||
150143828|NCT04522180|541662585|FG000|Overall Study|Investigator judgement|3|||
150143829|NCT04522180|541662586|FG001|Overall Study|Investigator judgement|4|||
150143830|NCT04522180|541662585|FG000|Overall Study|Voluntary withdrawal|1|||
150143831|NCT04522180|541662586|FG001|Overall Study|Voluntary withdrawal|0|||
150143832|NCT04522180|541662585|FG000|Overall Study|Pregnancy|0|||
150143833|NCT04522180|541662586|FG001|Overall Study|Pregnancy|1|||
150143834|NCT04522180|541662585|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
150143835|NCT04522180|541662586|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
150143836|NCT04522180|541662585|FG000|Overall Study|Reason not specified|8|||
150143837|NCT04522180|541662586|FG001|Overall Study|Reason not specified|5|||
150143838|NCT05807919|541662587|FG000|Overall Study|Received antibiotics - excluded|0|||
150143839|NCT05807919|541662588|FG001|Overall Study|Received antibiotics - excluded|1|||
150143840|NCT05807919|541662587|FG000|Overall Study|Withdrawal by Subject|0|||
150143841|NCT05807919|541662588|FG001|Overall Study|Withdrawal by Subject|3|||
150143842|NCT05807919|541662587|FG000|Overall Study|Adverse Event|1|||
150143843|NCT05807919|541662588|FG001|Overall Study|Adverse Event|1|||
150143844|NCT03635489|541662593|FG000|Overall Study|Death|19|||
150143845|NCT03635489|541662594|FG001|Overall Study|Death|13|||
150143846|NCT03635489|541662593|FG000|Overall Study|Lost to Follow-up|1|||
150143847|NCT03635489|541662594|FG001|Overall Study|Lost to Follow-up|2|||
150143848|NCT03635489|541662593|FG000|Overall Study|Withdrawal by Subject|1|||
150143849|NCT03635489|541662594|FG001|Overall Study|Withdrawal by Subject|2|||
150143850|NCT03635489|541662593|FG000|Overall Study|Study Ended by Sponsor|28|||
150143851|NCT03635489|541662594|FG001|Overall Study|Study Ended by Sponsor|34|||
150143852|NCT01368900|541662595|FG000|Overall Study|Lost to Follow-up|7|||
150143853|NCT01931735|541662603|FG000|Randomized Phase|Lost to Follow-up|2|||
150143854|NCT01931735|541662604|FG001|Randomized Phase|Lost to Follow-up|2|||
150143855|NCT01931735|541662605|FG002|Randomized Phase|Lost to Follow-up|5|||
150143856|NCT01931735|541662606|FG003|Randomized Phase|Lost to Follow-up|0|||
150143857|NCT01931735|541662603|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
150143858|NCT01931735|541662604|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
150143859|NCT01931735|541662605|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
150143860|NCT01931735|541662606|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
150143861|NCT01931735|541662603|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
150143862|NCT01931735|541662604|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
150143863|NCT01931735|541662605|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
150143864|NCT01931735|541662606|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
150143865|NCT02719990|541662607|FG000|Overall Study|Physician Decision|2|||
150143866|NCT02719990|541662607|FG000|Overall Study|Withdrawal by Subject|2|||
150143867|NCT02719990|541662607|FG000|Overall Study|Study Terminated By Sponsor|32|||
150143868|NCT00717314|541662608|FG000|Overall Study|Adverse Event|3|||
150143869|NCT00717314|541662609|FG001|Overall Study|Adverse Event|2|||
150143870|NCT00717314|541662608|FG000|Overall Study|Protocol Violation|1|||
150143871|NCT00717314|541662609|FG001|Overall Study|Protocol Violation|0|||
150143872|NCT00717314|541662608|FG000|Overall Study|Lost to Follow-up|1|||
150143873|NCT00717314|541662609|FG001|Overall Study|Lost to Follow-up|5|||
150143874|NCT00717314|541662608|FG000|Overall Study|Withdrawal by Subject|1|||
150143875|NCT00717314|541662609|FG001|Overall Study|Withdrawal by Subject|3|||
150143876|NCT02070484|541662610|FG000|Overall Study|Withdrawal by Subject|1|||
150143877|NCT02070484|541662611|FG001|Overall Study|Withdrawal by Subject|0|||
150143878|NCT01521884|541662612|FG000|Overall Study|Non Responders|10|||
150143879|NCT01521884|541662612|FG000|Overall Study|Adverse Event|5|||
150143880|NCT01521884|541662612|FG000|Overall Study|Pregnancy|1|||
150143881|NCT01521884|541662612|FG000|Overall Study|Withdrawal by Subject|1|||
150143882|NCT01521884|541662612|FG000|Overall Study|Physician Decision|2|||
150143883|NCT01521884|541662612|FG000|Overall Study|Protocol Violation|3|||
150143884|NCT01521884|541662612|FG000|Overall Study|Participant non-eligible|1|||
150143885|NCT01521884|541662612|FG000|Overall Study|Lost to Follow-up|4|||
150143886|NCT02821819|541662613|FG000|Overall Study|Protocol Violation|1|||
150143887|NCT04182880|541662615|FG000|Overall Study|Pregnancy|1|||
150143888|NCT04182880|541662616|FG001|Overall Study|Pregnancy|0|||
150257671|NCT02480153|542077952|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
150257672|NCT02480153|542077953|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
150257673|NCT02480153|542077954|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
150257674|NCT01403610|542077955|FG000|Overall Study|Withdrawal by Subject|2|||
150257675|NCT01403610|542077956|FG001|Overall Study|Withdrawal by Subject|0|||
150257676|NCT01403610|542077957|FG002|Overall Study|Withdrawal by Subject|0|||
150257677|NCT01403610|542077958|FG003|Overall Study|Withdrawal by Subject|0|||
150257678|NCT01403610|542077955|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
150257679|NCT01403610|542077956|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
150257680|NCT01403610|542077957|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
150257681|NCT01403610|542077958|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
150257682|NCT00203476|542077959|FG000|Overall Study|Lost to Follow-up|1|||
150257683|NCT00203476|542077960|FG001|Overall Study|Lost to Follow-up|0|||
150257684|NCT00203476|542077961|FG002|Overall Study|Lost to Follow-up|0|||
150257685|NCT00203476|542077959|FG000|Overall Study|Withdrawal by Subject|0|||
150257686|NCT00203476|542077960|FG001|Overall Study|Withdrawal by Subject|1|||
150257687|NCT00203476|542077961|FG002|Overall Study|Withdrawal by Subject|0|||
150257688|NCT01190514|542077962|FG000|First Intervention (Period 1)|Adverse Event|1|||
150257689|NCT01190514|542077963|FG001|First Intervention (Period 1)|Adverse Event|0|||
150257690|NCT01190514|542077964|FG002|First Intervention (Period 1)|Adverse Event|0|||
150257691|NCT01190514|542077965|FG003|First Intervention (Period 1)|Adverse Event|0|||
150257692|NCT01190514|542077962|FG000|Third Intervention (Period 3)|Adverse Event|1|||
150257693|NCT01190514|542077963|FG001|Third Intervention (Period 3)|Adverse Event|0|||
150257694|NCT01190514|542077964|FG002|Third Intervention (Period 3)|Adverse Event|0|||
150257695|NCT01190514|542077965|FG003|Third Intervention (Period 3)|Adverse Event|0|||
150257696|NCT01775475|542077970|FG000|Overall Study|Death|3|||
150257697|NCT01775475|542077971|FG001|Overall Study|Death|3|||
150257698|NCT01346475|542077972|FG000|First Intervention|Lost to Follow-up|4|||
150257699|NCT01346475|542077973|FG001|First Intervention|Lost to Follow-up|3|||
150257700|NCT00700258|542077980|FG000|Overall Study|Premature discontinuation of documentation|136|||
150257701|NCT00700258|542077980|FG000|Overall Study|Type of study end not documented|1|||
150257702|NCT00700258|542077980|FG000|Overall Study|Lost to Follow-up|81|||
150257703|NCT00700258|542077980|FG000|Overall Study|Premature discontinuation of therapy|1013|||
150257704|NCT00473265|542077981|FG000|Overall Study|Unrelated adverse event|5|||
150257705|NCT00473265|542077981|FG000|Overall Study|Off treatment early|15|||
150257706|NCT01156792|542077982|FG000|Overall Study|Adverse Event|1|||
150257707|NCT01156792|542077982|FG000|Overall Study|Lack of Efficacy|36|||
150257708|NCT01156792|542077982|FG000|Overall Study|Protocol Violation|6|||
150257709|NCT01156792|542077982|FG000|Overall Study|Lost to Follow-up|3|||
150257710|NCT01156792|542077982|FG000|Overall Study|Physician Decision|3|||
150257711|NCT01156792|542077982|FG000|Overall Study|Withdrawal by Subject|9|||
150257712|NCT01156792|542077982|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
150257713|NCT01097707|542077983|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150257714|NCT01097707|542077984|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150257715|NCT01097707|542077985|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150257716|NCT01097707|542077986|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150257717|NCT01097707|542077987|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150257718|NCT01097707|542077983|FG000|Overall Study|Adverse Event|4|||
150257719|NCT01097707|542077984|FG001|Overall Study|Adverse Event|2|||
150257720|NCT01097707|542077985|FG002|Overall Study|Adverse Event|3|||
150257721|NCT01097707|542077986|FG003|Overall Study|Adverse Event|1|||
150257722|NCT01097707|542077987|FG004|Overall Study|Adverse Event|3|||
150257723|NCT01097707|542077983|FG000|Overall Study|Entry Criteria Not Met|2|||
150257724|NCT01097707|542077984|FG001|Overall Study|Entry Criteria Not Met|1|||
150257725|NCT01097707|542077985|FG002|Overall Study|Entry Criteria Not Met|1|||
150257726|NCT01097707|542077986|FG003|Overall Study|Entry Criteria Not Met|0|||
150257727|NCT01097707|542077987|FG004|Overall Study|Entry Criteria Not Met|1|||
150257728|NCT01097707|542077983|FG000|Overall Study|Lack of Efficacy|1|||
150257729|NCT01097707|542077984|FG001|Overall Study|Lack of Efficacy|0|||
150257730|NCT01097707|542077985|FG002|Overall Study|Lack of Efficacy|0|||
150257731|NCT01097707|542077986|FG003|Overall Study|Lack of Efficacy|1|||
150257732|NCT01097707|542077987|FG004|Overall Study|Lack of Efficacy|0|||
150257733|NCT01097707|542077983|FG000|Overall Study|Lost to Follow-up|1|||
150257734|NCT01097707|542077984|FG001|Overall Study|Lost to Follow-up|1|||
150257735|NCT01097707|542077985|FG002|Overall Study|Lost to Follow-up|2|||
150257736|NCT01097707|542077986|FG003|Overall Study|Lost to Follow-up|0|||
150257737|NCT01097707|542077987|FG004|Overall Study|Lost to Follow-up|3|||
150257738|NCT01097707|542077983|FG000|Overall Study|Protocol Violation|2|||
150257739|NCT01097707|542077984|FG001|Overall Study|Protocol Violation|2|||
150257740|NCT01097707|542077985|FG002|Overall Study|Protocol Violation|3|||
150257741|NCT01097707|542077986|FG003|Overall Study|Protocol Violation|2|||
150257742|NCT01097707|542077987|FG004|Overall Study|Protocol Violation|2|||
150257743|NCT01097707|542077983|FG000|Overall Study|Sponsor Decision|31|||
150257744|NCT01097707|542077984|FG001|Overall Study|Sponsor Decision|31|||
150257745|NCT01097707|542077985|FG002|Overall Study|Sponsor Decision|34|||
150257746|NCT01097707|542077986|FG003|Overall Study|Sponsor Decision|35|||
150257747|NCT01097707|542077987|FG004|Overall Study|Sponsor Decision|36|||
150257748|NCT01097707|542077983|FG000|Overall Study|Withdrawal by Subject|3|||
150257749|NCT01097707|542077984|FG001|Overall Study|Withdrawal by Subject|6|||
150257750|NCT01097707|542077985|FG002|Overall Study|Withdrawal by Subject|1|||
150257751|NCT01097707|542077986|FG003|Overall Study|Withdrawal by Subject|4|||
150257752|NCT01097707|542077987|FG004|Overall Study|Withdrawal by Subject|3|||
150257753|NCT01097707|542077983|FG000|Overall Study|Reason unknown|0|||
150257754|NCT01097707|542077984|FG001|Overall Study|Reason unknown|0|||
150257755|NCT01097707|542077985|FG002|Overall Study|Reason unknown|0|||
150257756|NCT01097707|542077986|FG003|Overall Study|Reason unknown|0|||
150257757|NCT01097707|542077987|FG004|Overall Study|Reason unknown|1|||
150257758|NCT03212989|542077988|FG000|Overall Study|Physician Decision|8|||
150257759|NCT04638920|542078003|FG000|Overall Study|Withdrawal by Subject|5|||
150257760|NCT05383508|542078004|FG000|Overall Study|Withdrawal by Subject|1|||
150257761|NCT05383508|542078005|FG001|Overall Study|Withdrawal by Subject|0|||
150257762|NCT05383508|542078006|FG002|Overall Study|Withdrawal by Subject|1|||
150257763|NCT05383508|542078007|FG003|Overall Study|Withdrawal by Subject|1|||
150257764|NCT05383508|542078008|FG004|Overall Study|Withdrawal by Subject|2|||
150257765|NCT05383508|542078009|FG005|Overall Study|Withdrawal by Subject|0|||
150257766|NCT03775434|542078011|FG000|Overall Study|Adverse Event|2|||
150257767|NCT03775434|542078011|FG000|Overall Study|Withdrawal by Subject|1|||
150257768|NCT01621568|542078012|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
150257769|NCT01621568|542078013|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
150257770|NCT01621568|542078012|FG000|Week 5-6 No Treatment|Death|1|||
150257771|NCT01621568|542078013|FG001|Week 5-6 No Treatment|Death|0|||
150257772|NCT01859988|542078014|FG000|Overall Study|Withdrawal by Subject|6|||
150257773|NCT01859988|542078015|FG001|Overall Study|Withdrawal by Subject|3|||
150257774|NCT01859988|542078016|FG002|Overall Study|Withdrawal by Subject|4|||
150257775|NCT01859988|542078017|FG003|Overall Study|Withdrawal by Subject|3|||
150257776|NCT01859988|542078018|FG004|Overall Study|Withdrawal by Subject|2|||
150257777|NCT01859988|542078019|FG005|Overall Study|Withdrawal by Subject|2|||
150257778|NCT01859988|542078014|FG000|Overall Study|Lack of Efficacy|1|||
150257779|NCT01859988|542078015|FG001|Overall Study|Lack of Efficacy|1|||
150257780|NCT01859988|542078016|FG002|Overall Study|Lack of Efficacy|5|||
150257781|NCT01859988|542078017|FG003|Overall Study|Lack of Efficacy|0|||
150257782|NCT01859988|542078018|FG004|Overall Study|Lack of Efficacy|7|||
150257783|NCT01859988|542078019|FG005|Overall Study|Lack of Efficacy|9|||
150257784|NCT01859988|542078014|FG000|Overall Study|Physician Decision|1|||
150257785|NCT01859988|542078015|FG001|Overall Study|Physician Decision|3|||
150257786|NCT01859988|542078016|FG002|Overall Study|Physician Decision|1|||
150257787|NCT01859988|542078017|FG003|Overall Study|Physician Decision|3|||
150257788|NCT01859988|542078018|FG004|Overall Study|Physician Decision|4|||
150257789|NCT01859988|542078019|FG005|Overall Study|Physician Decision|1|||
150257790|NCT01859988|542078014|FG000|Overall Study|Adverse Event|2|||
150257791|NCT01859988|542078015|FG001|Overall Study|Adverse Event|1|||
150257792|NCT01859988|542078016|FG002|Overall Study|Adverse Event|3|||
150257793|NCT01859988|542078017|FG003|Overall Study|Adverse Event|1|||
150257794|NCT01859988|542078018|FG004|Overall Study|Adverse Event|2|||
150257795|NCT01859988|542078019|FG005|Overall Study|Adverse Event|2|||
150257796|NCT01859988|542078014|FG000|Overall Study|Lost to Follow-up|1|||
150257797|NCT01859988|542078015|FG001|Overall Study|Lost to Follow-up|2|||
150257798|NCT01859988|542078016|FG002|Overall Study|Lost to Follow-up|3|||
150257799|NCT01859988|542078017|FG003|Overall Study|Lost to Follow-up|0|||
150257800|NCT01859988|542078018|FG004|Overall Study|Lost to Follow-up|3|||
150257801|NCT01859988|542078019|FG005|Overall Study|Lost to Follow-up|2|||
150257802|NCT01859988|542078014|FG000|Overall Study|Protocol Violation|0|||
150257803|NCT01859988|542078015|FG001|Overall Study|Protocol Violation|0|||
150257804|NCT01859988|542078016|FG002|Overall Study|Protocol Violation|1|||
150257805|NCT01859988|542078017|FG003|Overall Study|Protocol Violation|0|||
150257806|NCT01859988|542078018|FG004|Overall Study|Protocol Violation|0|||
150257807|NCT01859988|542078019|FG005|Overall Study|Protocol Violation|0|||
150257808|NCT01859988|542078014|FG000|Overall Study|Other than specified above|0|||
150257809|NCT01859988|542078015|FG001|Overall Study|Other than specified above|2|||
150257810|NCT01859988|542078016|FG002|Overall Study|Other than specified above|11|||
150257811|NCT01859988|542078017|FG003|Overall Study|Other than specified above|3|||
150257812|NCT01859988|542078018|FG004|Overall Study|Other than specified above|5|||
150257813|NCT01859988|542078019|FG005|Overall Study|Other than specified above|3|||
150257814|NCT01157676|542078025|FG000|Randomization|Death|1|||
150257815|NCT01157676|542078026|FG001|Randomization|Death|1|||
150257816|NCT01157676|542078025|FG000|Randomization|unresectable|2|||
150257817|NCT01157676|542078026|FG001|Randomization|unresectable|3|||
150257818|NCT01157676|542078025|FG000|Randomization|Withdrawal by Subject|17|||
150257819|NCT01157676|542078026|FG001|Randomization|Withdrawal by Subject|13|||
150257820|NCT01157676|542078025|FG000|Randomization|Physician Decision|1|||
150257821|NCT01157676|542078026|FG001|Randomization|Physician Decision|0|||
150257822|NCT01157676|542078025|FG000|Surgery|underwent open cystectomy|0|||
150257823|NCT01157676|542078026|FG001|Surgery|underwent open cystectomy|4|||
150257824|NCT01157676|542078025|FG000|Surgery|converted to open procedure|0|||
150143889|NCT03389477|541662617|FG000|Step 1|Withdrawal by Subject|1|||
150143890|NCT03389477|541662618|FG001|Step 1|Withdrawal by Subject|0|||
150143891|NCT03389477|541662617|FG000|Step 2|Withdrawal by Subject|1|||
150143892|NCT03389477|541662618|FG001|Step 2|Withdrawal by Subject|2|||
150143893|NCT03389477|541662617|FG000|Step 2|Disease progression|1|||
150143894|NCT03389477|541662618|FG001|Step 2|Disease progression|0|||
150143895|NCT03389477|541662617|FG000|Step 2|Death|0|||
150143896|NCT03389477|541662618|FG001|Step 2|Death|1|||
150143897|NCT03389477|541662617|FG000|Step 2|Poor performance status and nutrition|0|||
150143898|NCT03389477|541662618|FG001|Step 2|Poor performance status and nutrition|1|||
150143899|NCT03389477|541662617|FG000|Step 3|Withdrawal after 3 cycles|0|||
150143900|NCT03389477|541662618|FG001|Step 3|Withdrawal after 3 cycles|1|||
150143901|NCT03389477|541662617|FG000|Step 3|Still receiving active treatment|4|||
150143902|NCT03389477|541662618|FG001|Step 3|Still receiving active treatment|0|||
150143903|NCT03389477|541662617|FG000|Step 3|Progressive disease after 2 cycles|1|||
150143904|NCT03389477|541662618|FG001|Step 3|Progressive disease after 2 cycles|0|||
150143905|NCT01806584|541662626|FG000|Overall Study|Adverse Event|2|||
150143906|NCT01806584|541662627|FG001|Overall Study|Adverse Event|1|||
150143907|NCT01806584|541662626|FG000|Overall Study|Death|1|||
150143908|NCT01806584|541662627|FG001|Overall Study|Death|0|||
150143909|NCT01806584|541662626|FG000|Overall Study|Lost to Follow-up|0|||
150143910|NCT01806584|541662627|FG001|Overall Study|Lost to Follow-up|2|||
150143911|NCT01806584|541662626|FG000|Overall Study|Study terminated by sponsor|9|||
150143912|NCT01806584|541662627|FG001|Overall Study|Study terminated by sponsor|14|||
150143913|NCT01806584|541662626|FG000|Overall Study|Withdrawal by Subject|1|||
150143914|NCT01806584|541662627|FG001|Overall Study|Withdrawal by Subject|1|||
150143915|NCT01806584|541662626|FG000|Overall Study|Other unspecified|1|||
150143916|NCT01806584|541662627|FG001|Overall Study|Other unspecified|0|||
150143917|NCT03995784|541662628|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
150143918|NCT00311155|541664561|FG000|Overall Study|Adverse Event|21|||
150143919|NCT00311155|541664561|FG000|Overall Study|Withdrawal by Subject|17|||
150143920|NCT00311155|541664561|FG000|Overall Study|Did not meet entry criteria|55|||
150143921|NCT02764775|541664563|FG000|Overall Study|Death|1|||
150143922|NCT02764775|541664563|FG000|Overall Study|Lost to Follow-up|2|||
150143923|NCT02764775|541664563|FG000|Overall Study|Withdrawal by Subject|3|||
150143924|NCT00429494|541664564|FG000|Overall Study|Withdrawal by Subject|9|||
150143925|NCT00429494|541664564|FG000|Overall Study|Death|6|||
150143926|NCT00976703|541664565|FG000|Overall Study|Physician Decision|1|||
150143927|NCT00976703|541664566|FG001|Overall Study|Physician Decision|1|||
150143928|NCT00976703|541664565|FG000|Overall Study|ineligible for study|2|||
150143929|NCT00976703|541664566|FG001|Overall Study|ineligible for study|2|||
150143930|NCT01992549|541664570|FG000|Overall Study|Lost to Follow-up|2|||
150143931|NCT01992549|541664570|FG000|Overall Study|Serious Adverse Event|1|||
150143932|NCT01992549|541664570|FG000|Overall Study|Product Switch to Extend Half Life|1|||
150143933|NCT00767104|541664574|FG000|Overall Study|Lost to Follow-up|1|||
150143934|NCT00767104|541664575|FG001|Overall Study|Lost to Follow-up|2|||
150143935|NCT00840996|541664576|FG000|Overall Study|Withdrawal by Subject|1|||
150257825|NCT01157676|542078026|FG001|Surgery|converted to open procedure|5|||
150257826|NCT01157676|542078025|FG000|Surgery|underwent robotic cystectomy|1|||
150257827|NCT01157676|542078026|FG001|Surgery|underwent robotic cystectomy|0|||
150257828|NCT00682890|542078027|FG000|Overall Study|Lost to Follow-up|1|||
150257829|NCT00682890|542078028|FG001|Overall Study|Lost to Follow-up|1|||
150257830|NCT00682890|542078027|FG000|Overall Study|subject moved away|0|||
150257831|NCT00682890|542078028|FG001|Overall Study|subject moved away|1|||
150257832|NCT00682890|542078027|FG000|Overall Study|heavy menstrual bleeding|1|||
150257833|NCT00682890|542078028|FG001|Overall Study|heavy menstrual bleeding|0|||
150257834|NCT00141219|542078032|FG000|Overall Study|Protocol violations|5|||
150257835|NCT00141219|542078033|FG001|Overall Study|Protocol violations|4|||
150257836|NCT00141219|542078032|FG000|Overall Study|Adverse Event|8|||
150257837|NCT00141219|542078033|FG001|Overall Study|Adverse Event|6|||
150257838|NCT00141219|542078032|FG000|Overall Study|Lack of Efficacy|5|||
150257839|NCT00141219|542078033|FG001|Overall Study|Lack of Efficacy|4|||
150143936|NCT00840996|541664577|FG001|Overall Study|Withdrawal by Subject|0|||
150143937|NCT04022889|541664578|FG000|Stage 1: Period 1|Adverse Event|1|||
150143938|NCT04022889|541664579|FG001|Stage 1: Period 1|Adverse Event|0|||
150143939|NCT04022889|541664580|FG002|Stage 1: Period 1|Adverse Event|0|||
150143940|NCT04022889|541664578|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
150143941|NCT04022889|541664579|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
150143942|NCT04022889|541664580|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
150143943|NCT04022889|541664578|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
150143944|NCT04022889|541664579|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
150143945|NCT04022889|541664580|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
150257840|NCT00141219|542078032|FG000|Overall Study|Withdrawal by Subject|6|||
150257841|NCT00141219|542078033|FG001|Overall Study|Withdrawal by Subject|2|||
150257842|NCT01506609|542078034|FG000|Overall Study|Adverse Event Related to Progression|0|||
150143946|NCT04022889|541664578|FG000|Stage 2|Screen Failure|0|||
150143947|NCT04022889|541664579|FG001|Stage 2|Screen Failure|0|||
150143948|NCT04022889|541664580|FG002|Stage 2|Screen Failure|3|||
150143949|NCT04022889|541664578|FG000|Stage 2|Ineligible for apheresis donation|0|||
150143950|NCT04022889|541664579|FG001|Stage 2|Ineligible for apheresis donation|0|||
150143951|NCT04022889|541664580|FG002|Stage 2|Ineligible for apheresis donation|2|||
150143952|NCT04022889|541664578|FG000|Stage 2|Adverse Event|0|||
150143953|NCT04022889|541664579|FG001|Stage 2|Adverse Event|0|||
150143954|NCT04022889|541664580|FG002|Stage 2|Adverse Event|2|||
150143955|NCT04022889|541664578|FG000|Stage 2|Protocol Violation|0|||
150143956|NCT04022889|541664579|FG001|Stage 2|Protocol Violation|0|||
150143957|NCT04022889|541664580|FG002|Stage 2|Protocol Violation|1|||
150143958|NCT04022889|541664578|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
150143959|NCT04022889|541664579|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
150143960|NCT04022889|541664580|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
150143961|NCT01900054|541664581|FG000|Overall Study|Physician Decision|1|||
150143962|NCT01900054|541664581|FG000|Overall Study|Withdrawal by Subject|1|||
150143963|NCT03285295|541664586|FG000|Alinity s HBsAg|Protocol Violation|11|||
150143964|NCT03285295|541664587|FG001|Alinity s HBsAg|Protocol Violation|0|||
150143965|NCT03285295|541664588|FG002|Alinity s HBsAg|Protocol Violation|0|||
150143966|NCT03285295|541664589|FG003|Alinity s HBsAg|Protocol Violation|0|||
150143967|NCT03285295|541664590|FG004|Alinity s HBsAg|Protocol Violation|0|||
150143968|NCT03285295|541664586|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
150143969|NCT03285295|541664587|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
150143970|NCT03285295|541664588|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
150143971|NCT03285295|541664589|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
150143972|NCT03285295|541664590|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
150143973|NCT03285295|541664586|FG000|Alinity s HBsAg|No Results Generated|74|||
150143974|NCT03285295|541664587|FG001|Alinity s HBsAg|No Results Generated|6|||
150143975|NCT03285295|541664588|FG002|Alinity s HBsAg|No Results Generated|0|||
150143976|NCT03285295|541664589|FG003|Alinity s HBsAg|No Results Generated|0|||
150143977|NCT03285295|541664590|FG004|Alinity s HBsAg|No Results Generated|0|||
150143978|NCT03285295|541664586|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
150143979|NCT03285295|541664587|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
150143980|NCT03285295|541664588|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
150143981|NCT03285295|541664589|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
150143982|NCT03285295|541664590|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
150143983|NCT03285295|541664586|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
150143984|NCT03285295|541664587|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
150143985|NCT03285295|541664588|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
150143986|NCT03285295|541664589|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
150143987|NCT03285295|541664590|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
150143988|NCT03285295|541664586|FG000|Alinity s HTLV I/II|No Results Generated|70|||
150143989|NCT03285295|541664587|FG001|Alinity s HTLV I/II|No Results Generated|0|||
150143990|NCT03285295|541664588|FG002|Alinity s HTLV I/II|No Results Generated|0|||
150143991|NCT03285295|541664589|FG003|Alinity s HTLV I/II|No Results Generated|0|||
150143992|NCT03285295|541664590|FG004|Alinity s HTLV I/II|No Results Generated|0|||
150143993|NCT03285295|541664586|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
150143994|NCT03285295|541664587|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
150143995|NCT03285295|541664588|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
150143996|NCT03285295|541664589|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
150143997|NCT03285295|541664590|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
150143998|NCT03285295|541664586|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
150143999|NCT03285295|541664587|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
150144000|NCT03285295|541664588|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
150144001|NCT03285295|541664589|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
150144002|NCT03285295|541664590|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
150144003|NCT03285295|541664586|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
150144004|NCT03285295|541664587|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
150144005|NCT03285295|541664588|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
150144006|NCT03285295|541664589|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
150144007|NCT03285295|541664590|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
150144008|NCT03285295|541664586|FG000|Alinity s Anti-HCV|No Results Generated|71|||
150144009|NCT03285295|541664587|FG001|Alinity s Anti-HCV|No Results Generated|0|||
150144010|NCT03285295|541664588|FG002|Alinity s Anti-HCV|No Results Generated|0|||
150144011|NCT03285295|541664589|FG003|Alinity s Anti-HCV|No Results Generated|0|||
150144012|NCT03285295|541664590|FG004|Alinity s Anti-HCV|No Results Generated|0|||
150144013|NCT03285295|541664586|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
150257843|NCT01506609|542078035|FG001|Overall Study|Adverse Event Related to Progression|0|||
150144014|NCT03285295|541664587|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
150144015|NCT03285295|541664588|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
150144016|NCT03285295|541664589|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
150257844|NCT01506609|542078036|FG002|Overall Study|Adverse Event Related to Progression|0|||
150144017|NCT03285295|541664590|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
150144018|NCT03285295|541664586|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
150144019|NCT03285295|541664587|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
150144020|NCT03285295|541664588|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
150144021|NCT03285295|541664589|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
150144022|NCT03285295|541664590|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
150144023|NCT03285295|541664586|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
150144024|NCT03285295|541664587|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
150144025|NCT03285295|541664588|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
150144026|NCT03285295|541664589|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
150144027|NCT03285295|541664590|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
150144028|NCT03285295|541664586|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
150144029|NCT03285295|541664587|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
150144030|NCT03285295|541664588|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
150144031|NCT03285295|541664589|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
150144032|NCT03285295|541664590|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
150144033|NCT03285295|541664586|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
150144034|NCT03285295|541664587|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
150144035|NCT03285295|541664588|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
150144036|NCT03285295|541664589|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
150144037|NCT03285295|541664590|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
150144038|NCT03285295|541664586|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
150144039|NCT03285295|541664587|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
150144040|NCT03285295|541664588|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
150144041|NCT03285295|541664589|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
150144042|NCT03285295|541664590|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
150144043|NCT03285295|541664586|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
150144044|NCT03285295|541664587|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
150144045|NCT03285295|541664588|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
150144046|NCT03285295|541664589|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
150144047|NCT03285295|541664590|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
150144048|NCT03285295|541664586|FG000|Alinity s Anti-HBc|No Results Generated|70|||
150144049|NCT03285295|541664587|FG001|Alinity s Anti-HBc|No Results Generated|0|||
150144050|NCT03285295|541664588|FG002|Alinity s Anti-HBc|No Results Generated|0|||
150144051|NCT03285295|541664589|FG003|Alinity s Anti-HBc|No Results Generated|0|||
150144052|NCT03285295|541664590|FG004|Alinity s Anti-HBc|No Results Generated|0|||
150144053|NCT03285295|541664586|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
150144054|NCT03285295|541664587|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
150144055|NCT03285295|541664588|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
150144056|NCT03285295|541664589|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
150144057|NCT03285295|541664590|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
150144058|NCT03285295|541664586|FG000|Alinity s Chagas|Protocol Violation|76|||
150144059|NCT03285295|541664587|FG001|Alinity s Chagas|Protocol Violation|0|||
150144060|NCT03285295|541664588|FG002|Alinity s Chagas|Protocol Violation|0|||
150144061|NCT03285295|541664589|FG003|Alinity s Chagas|Protocol Violation|0|||
150144062|NCT03285295|541664590|FG004|Alinity s Chagas|Protocol Violation|0|||
150144063|NCT03285295|541664586|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
150144064|NCT03285295|541664587|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
150144065|NCT03285295|541664588|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
150144066|NCT03285295|541664589|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
150144067|NCT03285295|541664590|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
150144068|NCT03285295|541664586|FG000|Alinity s Chagas|No Results Generated|105|||
150144069|NCT03285295|541664587|FG001|Alinity s Chagas|No Results Generated|0|||
150144070|NCT03285295|541664588|FG002|Alinity s Chagas|No Results Generated|0|||
150144071|NCT03285295|541664589|FG003|Alinity s Chagas|No Results Generated|0|||
150144072|NCT03285295|541664590|FG004|Alinity s Chagas|No Results Generated|0|||
150144073|NCT03285295|541664586|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
150144074|NCT03285295|541664587|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
150144075|NCT03285295|541664588|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
150144076|NCT03285295|541664589|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
150144077|NCT03285295|541664590|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
150144078|NCT00957931|541664592|FG000|Overall Study|Death|4|||
150144079|NCT00857805|541664593|FG000|Overall Study|Withdrawal by Subject|1|||
150144080|NCT00857805|541664594|FG001|Overall Study|Withdrawal by Subject|1|||
150144081|NCT01289041|541664595|FG000|Overall Study|Adverse Event|24|||
150144082|NCT01289041|541664595|FG000|Overall Study|Physician Decision|1|||
150144083|NCT01289041|541664595|FG000|Overall Study|Progressive Disease|41|||
150144084|NCT01289041|541664595|FG000|Overall Study|Withdrawal by Subject|3|||
150144085|NCT01289041|541664595|FG000|Overall Study|Death|1|||
150144086|NCT00605319|541664602|FG000|Overall Study|Adverse Event|6|||
150144087|NCT02991482|541664604|FG000|Overall Study|Disease progression|56|||
150144088|NCT02991482|541664605|FG001|Overall Study|Disease progression|47|||
150144089|NCT02991482|541664604|FG000|Overall Study|Death|4|||
150144090|NCT02991482|541664605|FG001|Overall Study|Death|4|||
150144091|NCT02991482|541664604|FG000|Overall Study|Adverse Event|1|||
150144092|NCT02991482|541664605|FG001|Overall Study|Adverse Event|6|||
150144093|NCT02991482|541664604|FG000|Overall Study|Patient decision|1|||
150144094|NCT02991482|541664605|FG001|Overall Study|Patient decision|1|||
150144095|NCT02991482|541664604|FG000|Overall Study|Physician Decision|0|||
150144096|NCT02991482|541664605|FG001|Overall Study|Physician Decision|6|||
150144097|NCT02991482|541664604|FG000|Overall Study|Clinical deterioration|1|||
150144098|NCT02991482|541664605|FG001|Overall Study|Clinical deterioration|0|||
150144099|NCT02991482|541664604|FG000|Overall Study|Patient feeling too unwell|1|||
150144100|NCT02991482|541664605|FG001|Overall Study|Patient feeling too unwell|0|||
150144101|NCT02991482|541664604|FG000|Overall Study|Worsening of performance status|0|||
150144102|NCT02991482|541664605|FG001|Overall Study|Worsening of performance status|1|||
150144103|NCT02991482|541664604|FG000|Overall Study|Death prior to study drug initiation|1|||
150144104|NCT02991482|541664605|FG001|Overall Study|Death prior to study drug initiation|0|||
150144105|NCT02991482|541664604|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
150144106|NCT02991482|541664605|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
150144107|NCT02887989|541664606|FG000|Overall Study|Withdrawal by Subject|8|||
150144108|NCT02887989|541664607|FG001|Overall Study|Withdrawal by Subject|11|||
150144109|NCT02887989|541664606|FG000|Overall Study|Death|1|||
150144110|NCT02887989|541664607|FG001|Overall Study|Death|0|||
150144111|NCT00519896|541664610|FG000|Overall Study|Protocol Violation|1|||
150144112|NCT00519896|541664610|FG000|Overall Study|Adverse Event|1|||
150144113|NCT02341456|541664615|FG000|Overall Study|Disease progression|2|||
150144114|NCT02341456|541664616|FG001|Overall Study|Disease progression|3|||
150144115|NCT02341456|541664617|FG002|Overall Study|Disease progression|1|||
150144116|NCT02341456|541664615|FG000|Overall Study|Death|1|||
150144117|NCT02341456|541664616|FG001|Overall Study|Death|1|||
150144118|NCT02341456|541664617|FG002|Overall Study|Death|1|||
150144119|NCT02341456|541664615|FG000|Overall Study|Withdrawal by Subject|0|||
150144120|NCT02341456|541664616|FG001|Overall Study|Withdrawal by Subject|1|||
150144121|NCT02341456|541664617|FG002|Overall Study|Withdrawal by Subject|1|||
150144122|NCT02341456|541664615|FG000|Overall Study|Moved to local access programme.|0|||
150144123|NCT02341456|541664616|FG001|Overall Study|Moved to local access programme.|1|||
150144124|NCT02341456|541664617|FG002|Overall Study|Moved to local access programme.|1|||
150144125|NCT02341456|541664615|FG000|Overall Study|Physician Decision|1|||
150144126|NCT02341456|541664616|FG001|Overall Study|Physician Decision|0|||
150144127|NCT02341456|541664617|FG002|Overall Study|Physician Decision|0|||
150144128|NCT02508532|541664618|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144129|NCT02508532|541664619|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144130|NCT02508532|541664620|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144131|NCT02508532|541664621|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144132|NCT02508532|541664622|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144133|NCT02508532|541664623|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144134|NCT02508532|541664624|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
150144135|NCT02508532|541664625|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144136|NCT02508532|541664626|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
150144137|NCT02508532|541664618|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144138|NCT02508532|541664619|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144139|NCT02508532|541664620|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144140|NCT02508532|541664621|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144141|NCT02508532|541664622|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144142|NCT02508532|541664623|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144143|NCT02508532|541664624|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144144|NCT02508532|541664625|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
150144145|NCT02508532|541664626|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
150144146|NCT02508532|541664618|FG000|Part 2 - Treatment|Disease Progression|0|||
150144147|NCT02508532|541664619|FG001|Part 2 - Treatment|Disease Progression|0|||
150144148|NCT02508532|541664620|FG002|Part 2 - Treatment|Disease Progression|0|||
150144149|NCT02508532|541664621|FG003|Part 2 - Treatment|Disease Progression|0|||
150144150|NCT02508532|541664622|FG004|Part 2 - Treatment|Disease Progression|0|||
150144151|NCT02508532|541664623|FG005|Part 2 - Treatment|Disease Progression|0|||
150144152|NCT02508532|541664624|FG006|Part 2 - Treatment|Disease Progression|0|||
150144153|NCT02508532|541664625|FG007|Part 2 - Treatment|Disease Progression|0|||
150144154|NCT02508532|541664626|FG008|Part 2 - Treatment|Disease Progression|118|||
150144155|NCT02508532|541664618|FG000|Part 2 - Treatment|Adverse Event|0|||
150144156|NCT02508532|541664619|FG001|Part 2 - Treatment|Adverse Event|0|||
150144157|NCT02508532|541664620|FG002|Part 2 - Treatment|Adverse Event|0|||
150144158|NCT02508532|541664621|FG003|Part 2 - Treatment|Adverse Event|0|||
150144159|NCT02508532|541664622|FG004|Part 2 - Treatment|Adverse Event|0|||
150144160|NCT02508532|541664623|FG005|Part 2 - Treatment|Adverse Event|0|||
150144161|NCT02508532|541664624|FG006|Part 2 - Treatment|Adverse Event|0|||
150144162|NCT02508532|541664625|FG007|Part 2 - Treatment|Adverse Event|0|||
150144163|NCT02508532|541664626|FG008|Part 2 - Treatment|Adverse Event|49|||
150144164|NCT02508532|541664618|FG000|Part 2 - Treatment|Physician Decision|0|||
150144165|NCT02508532|541664619|FG001|Part 2 - Treatment|Physician Decision|0|||
150144166|NCT02508532|541664620|FG002|Part 2 - Treatment|Physician Decision|0|||
150144167|NCT02508532|541664621|FG003|Part 2 - Treatment|Physician Decision|0|||
150144168|NCT02508532|541664622|FG004|Part 2 - Treatment|Physician Decision|0|||
150144169|NCT02508532|541664623|FG005|Part 2 - Treatment|Physician Decision|0|||
150144170|NCT02508532|541664624|FG006|Part 2 - Treatment|Physician Decision|0|||
150144171|NCT02508532|541664625|FG007|Part 2 - Treatment|Physician Decision|0|||
150144172|NCT02508532|541664626|FG008|Part 2 - Treatment|Physician Decision|12|||
150144173|NCT02508532|541664618|FG000|Part 2 - Treatment|Administrative|0|||
150144174|NCT02508532|541664619|FG001|Part 2 - Treatment|Administrative|0|||
150144175|NCT02508532|541664620|FG002|Part 2 - Treatment|Administrative|0|||
150144176|NCT02508532|541664621|FG003|Part 2 - Treatment|Administrative|0|||
150144177|NCT02508532|541664622|FG004|Part 2 - Treatment|Administrative|0|||
150144178|NCT02508532|541664623|FG005|Part 2 - Treatment|Administrative|0|||
150144179|NCT02508532|541664624|FG006|Part 2 - Treatment|Administrative|0|||
150144180|NCT02508532|541664625|FG007|Part 2 - Treatment|Administrative|0|||
150144181|NCT02508532|541664626|FG008|Part 2 - Treatment|Administrative|3|||
150144182|NCT02508532|541664618|FG000|Part 2 - Treatment|Sponsor Decision|0|||
150144183|NCT02508532|541664619|FG001|Part 2 - Treatment|Sponsor Decision|0|||
150144184|NCT02508532|541664620|FG002|Part 2 - Treatment|Sponsor Decision|0|||
150144185|NCT02508532|541664621|FG003|Part 2 - Treatment|Sponsor Decision|0|||
150144186|NCT02508532|541664622|FG004|Part 2 - Treatment|Sponsor Decision|0|||
150144187|NCT02508532|541664623|FG005|Part 2 - Treatment|Sponsor Decision|0|||
150144188|NCT02508532|541664624|FG006|Part 2 - Treatment|Sponsor Decision|0|||
150144189|NCT02508532|541664625|FG007|Part 2 - Treatment|Sponsor Decision|0|||
150144190|NCT02508532|541664626|FG008|Part 2 - Treatment|Sponsor Decision|28|||
150144191|NCT02508532|541664618|FG000|Part 2 - Treatment|Death|0|||
150144192|NCT02508532|541664619|FG001|Part 2 - Treatment|Death|0|||
150144193|NCT02508532|541664620|FG002|Part 2 - Treatment|Death|0|||
150144194|NCT02508532|541664621|FG003|Part 2 - Treatment|Death|0|||
150144195|NCT02508532|541664622|FG004|Part 2 - Treatment|Death|0|||
150144196|NCT02508532|541664623|FG005|Part 2 - Treatment|Death|0|||
150144197|NCT02508532|541664624|FG006|Part 2 - Treatment|Death|0|||
150144198|NCT02508532|541664625|FG007|Part 2 - Treatment|Death|0|||
150144199|NCT02508532|541664626|FG008|Part 2 - Treatment|Death|1|||
150144200|NCT02508532|541664618|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
150144201|NCT02508532|541664619|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
150144202|NCT02508532|541664620|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
150144203|NCT02508532|541664621|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
150144204|NCT02508532|541664622|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
150144205|NCT02508532|541664623|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
150144206|NCT02508532|541664624|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
150144207|NCT02508532|541664625|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
150144208|NCT02508532|541664626|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
150144209|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
150144210|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144211|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144212|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144213|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144214|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144215|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
150144216|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
150144217|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
150144218|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
150144219|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144220|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
150144221|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144222|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144223|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144224|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144225|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
150144226|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
150144227|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Death|0|||
150144228|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Death|4|||
150144229|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Death|2|||
150144230|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Death|4|||
150144231|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Death|3|||
150144232|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Death|0|||
150144233|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Death|0|||
150144234|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Death|1|||
150144235|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Death|111|||
150144236|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
150144237|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
150144238|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
150144239|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
150144240|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
150144241|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
150144242|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
150144243|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
150144244|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
150144245|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144246|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144247|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144248|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144249|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144250|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144251|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144252|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
150144253|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
150144254|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144255|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144256|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
150144257|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144258|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
150144259|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144260|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144261|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
150144262|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
150144263|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144264|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144265|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144266|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144267|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144268|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144269|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144270|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
150144271|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
150144272|NCT02508532|541664618|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
150144273|NCT02508532|541664619|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
150144274|NCT02508532|541664620|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
150144275|NCT02508532|541664621|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
150144276|NCT02508532|541664622|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
150144277|NCT02508532|541664623|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
150144278|NCT02508532|541664624|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
150144279|NCT02508532|541664625|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
150144280|NCT02508532|541664626|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
150144281|NCT00301080|541664629|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
150144282|NCT00301080|541664630|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
150144283|NCT00301080|541664631|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
150144284|NCT00301080|541664632|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
150144285|NCT00301080|541664633|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
150144286|NCT03673462|541664634|FG000|Overall Study|Adverse Event|11|||
150144287|NCT03673462|541664635|FG001|Overall Study|Adverse Event|1|||
150144288|NCT03673462|541664634|FG000|Overall Study|Protocol Violation|25|||
150144289|NCT03673462|541664635|FG001|Overall Study|Protocol Violation|11|||
150144290|NCT03673462|541664634|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
150144291|NCT03673462|541664635|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
150144292|NCT03673462|541664634|FG000|Overall Study|Lost to Follow-up|102|||
150144293|NCT03673462|541664635|FG001|Overall Study|Lost to Follow-up|19|||
150144294|NCT03502616|541664638|FG000|Up to Week 16|Withdrawal by Subject|1|||
150144295|NCT03502616|541664639|FG001|Up to Week 16|Withdrawal by Subject|2|||
150144296|NCT03502616|541664638|FG000|Up to Week 16|Lost to Follow-up|0|||
150144297|NCT03502616|541664639|FG001|Up to Week 16|Lost to Follow-up|1|||
150144298|NCT03502616|541664638|FG000|Up to Week 16|Randomized, but not treated|1|||
150144299|NCT03502616|541664639|FG001|Up to Week 16|Randomized, but not treated|0|||
150144300|NCT03502616|541664638|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
150144301|NCT03502616|541664639|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
150144302|NCT03502616|541664638|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
150144303|NCT03502616|541664639|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
150144304|NCT02917265|541664641|FG000|Overall Study|Physician Decision|1|||
150144305|NCT02917265|541664642|FG001|Overall Study|Physician Decision|0|||
150144306|NCT02917265|541664641|FG000|Overall Study|Withdrawal by Subject|1|||
150144307|NCT02917265|541664642|FG001|Overall Study|Withdrawal by Subject|0|||
150144308|NCT03002038|541664643|FG000|Overall Study|Adverse Event|3|||
150144309|NCT03002038|541664644|FG001|Overall Study|Adverse Event|1|||
150144310|NCT03002038|541664643|FG000|Overall Study|Withdrawal by Subject|8|||
150144311|NCT03002038|541664644|FG001|Overall Study|Withdrawal by Subject|4|||
150144312|NCT03002038|541664643|FG000|Overall Study|Immigration to another region|0|||
150144313|NCT03002038|541664644|FG001|Overall Study|Immigration to another region|2|||
150144314|NCT02002182|541664648|FG000|Overall Study|Withdraw from study|3|||
150144315|NCT02002182|541664649|FG001|Overall Study|Withdraw from study|1|||
150144316|NCT02002182|541664648|FG000|Overall Study|Health Reasons|1|||
150144317|NCT02002182|541664649|FG001|Overall Study|Health Reasons|0|||
150144318|NCT02002182|541664648|FG000|Overall Study|Death|1|||
150144319|NCT02002182|541664649|FG001|Overall Study|Death|0|||
150144320|NCT03107377|541664650|FG000|Overall Study|Adverse Event|3|||
150144321|NCT03107377|541664651|FG001|Overall Study|Adverse Event|3|||
150144322|NCT03107377|541664650|FG000|Overall Study|Protocol Violation|9|||
150144323|NCT03107377|541664651|FG001|Overall Study|Protocol Violation|12|||
150144324|NCT03107377|541664650|FG000|Overall Study|Physician Decision|3|||
150144325|NCT03107377|541664651|FG001|Overall Study|Physician Decision|6|||
150144326|NCT03107377|541664650|FG000|Overall Study|Pregnancy|7|||
150144327|NCT03107377|541664651|FG001|Overall Study|Pregnancy|7|||
150144328|NCT03107377|541664650|FG000|Overall Study|Withdrawal by Subject|16|||
150144329|NCT03107377|541664651|FG001|Overall Study|Withdrawal by Subject|22|||
150144330|NCT03107377|541664650|FG000|Overall Study|Lost to Follow-up|37|||
150144331|NCT03107377|541664651|FG001|Overall Study|Lost to Follow-up|34|||
150144332|NCT03107377|541664650|FG000|Overall Study|Other reason not specified|16|||
150144333|NCT03107377|541664651|FG001|Overall Study|Other reason not specified|15|||
150144334|NCT00453102|541664653|FG000|Overall Study|Withdrawal by Subject|2|||
150144335|NCT04296890|541664654|FG000|Overall Study|Withdrawal by Subject|1|||
150144336|NCT04296890|541664654|FG000|Overall Study|Death|62|||
150144337|NCT04296890|541664654|FG000|Overall Study|Lost to Follow-up|3|||
150144338|NCT04296890|541664654|FG000|Overall Study|Other than specified|2|||
150144339|NCT02237508|541664662|FG000|Overall Study|Withdrawal by Subject|0|||
150144340|NCT02237508|541664663|FG001|Overall Study|Withdrawal by Subject|2|||
150144341|NCT02237508|541664664|FG002|Overall Study|Withdrawal by Subject|0|||
150144342|NCT02237508|541664665|FG003|Overall Study|Withdrawal by Subject|1|||
150144343|NCT02237508|541664666|FG004|Overall Study|Withdrawal by Subject|0|||
150144344|NCT02237508|541664667|FG005|Overall Study|Withdrawal by Subject|1|||
150144345|NCT02237508|541664668|FG006|Overall Study|Withdrawal by Subject|1|||
150144346|NCT02237508|541664669|FG007|Overall Study|Withdrawal by Subject|0|||
150144347|NCT02237508|541664670|FG008|Overall Study|Withdrawal by Subject|1|||
150144348|NCT02237508|541664671|FG009|Overall Study|Withdrawal by Subject|0|||
150144349|NCT02237508|541664662|FG000|Overall Study|Physician Decision|0|||
150144350|NCT02237508|541664663|FG001|Overall Study|Physician Decision|1|||
150144351|NCT02237508|541664664|FG002|Overall Study|Physician Decision|0|||
150144352|NCT02237508|541664665|FG003|Overall Study|Physician Decision|0|||
150144353|NCT02237508|541664666|FG004|Overall Study|Physician Decision|0|||
150144354|NCT02237508|541664667|FG005|Overall Study|Physician Decision|0|||
150144355|NCT02237508|541664668|FG006|Overall Study|Physician Decision|0|||
150144356|NCT02237508|541664669|FG007|Overall Study|Physician Decision|0|||
150144357|NCT02237508|541664670|FG008|Overall Study|Physician Decision|0|||
150144358|NCT02237508|541664671|FG009|Overall Study|Physician Decision|0|||
150144359|NCT02237508|541664662|FG000|Overall Study|Protocol Violation|0|||
150144360|NCT02237508|541664663|FG001|Overall Study|Protocol Violation|0|||
150144361|NCT02237508|541664664|FG002|Overall Study|Protocol Violation|1|||
150144362|NCT02237508|541664665|FG003|Overall Study|Protocol Violation|0|||
150144363|NCT02237508|541664666|FG004|Overall Study|Protocol Violation|0|||
150144364|NCT02237508|541664667|FG005|Overall Study|Protocol Violation|0|||
150144365|NCT02237508|541664668|FG006|Overall Study|Protocol Violation|0|||
150144366|NCT02237508|541664669|FG007|Overall Study|Protocol Violation|0|||
150144367|NCT02237508|541664670|FG008|Overall Study|Protocol Violation|0|||
150144368|NCT02237508|541664671|FG009|Overall Study|Protocol Violation|0|||
150144369|NCT01650519|541664672|FG000|Overall Study|Withdrawal by Subject|1|||
150144370|NCT01650519|541664673|FG001|Overall Study|Withdrawal by Subject|0|||
150144371|NCT05458024|541664674|FG000|Overall Study|Withdrawal by Subject|1|||
150144372|NCT05458024|541664675|FG001|Overall Study|Withdrawal by Subject|1|||
150144373|NCT02954458|541664677|FG000|Overall Study|Adverse Event|0|||
150144374|NCT02954458|541664678|FG001|Overall Study|Adverse Event|0|||
150144375|NCT02954458|541664679|FG002|Overall Study|Adverse Event|0|||
150144376|NCT02954458|541664680|FG003|Overall Study|Adverse Event|1|||
150144377|NCT02954458|541664677|FG000|Overall Study|Withdrawal by Subject|0|||
150144378|NCT02954458|541664678|FG001|Overall Study|Withdrawal by Subject|0|||
150144379|NCT02954458|541664679|FG002|Overall Study|Withdrawal by Subject|0|||
150144380|NCT02954458|541664680|FG003|Overall Study|Withdrawal by Subject|1|||
150144381|NCT02954458|541664677|FG000|Overall Study|Physician Decision|0|||
150144382|NCT02954458|541664678|FG001|Overall Study|Physician Decision|0|||
150144383|NCT02954458|541664679|FG002|Overall Study|Physician Decision|1|||
150144384|NCT02954458|541664680|FG003|Overall Study|Physician Decision|1|||
150144385|NCT02954458|541664677|FG000|Overall Study|Lost to Follow-up|1|||
150144386|NCT02954458|541664678|FG001|Overall Study|Lost to Follow-up|0|||
150144387|NCT02954458|541664679|FG002|Overall Study|Lost to Follow-up|0|||
150144388|NCT02954458|541664680|FG003|Overall Study|Lost to Follow-up|1|||
150144389|NCT02954458|541664677|FG000|Overall Study|Death|0|||
150144390|NCT02954458|541664678|FG001|Overall Study|Death|0|||
150144391|NCT02954458|541664679|FG002|Overall Study|Death|0|||
150144392|NCT02954458|541664680|FG003|Overall Study|Death|1|||
150144393|NCT02954458|541664677|FG000|Overall Study|Other|0|||
150144394|NCT02954458|541664678|FG001|Overall Study|Other|0|||
150144395|NCT02954458|541664679|FG002|Overall Study|Other|0|||
150144396|NCT02954458|541664680|FG003|Overall Study|Other|7|||
150144397|NCT04000594|541664681|FG000|Overall Study|Withdrawal by Subject|1|||
150144398|NCT04000594|541664682|FG001|Overall Study|Withdrawal by Subject|0|||
150144399|NCT04000594|541664683|FG002|Overall Study|Withdrawal by Subject|0|||
150144400|NCT00747123|541664684|FG000|Overall Study|Investigator's request|0|||
150144401|NCT00747123|541664685|FG001|Overall Study|Investigator's request|0|||
150144402|NCT00747123|541664686|FG002|Overall Study|Investigator's request|1|||
150144403|NCT00747123|541664687|FG003|Overall Study|Investigator's request|0|||
150144404|NCT00747123|541664684|FG000|Overall Study|Withdrew consent|0|||
150144405|NCT00747123|541664685|FG001|Overall Study|Withdrew consent|1|||
150144406|NCT00747123|541664686|FG002|Overall Study|Withdrew consent|0|||
150144407|NCT00747123|541664687|FG003|Overall Study|Withdrew consent|0|||
150144408|NCT00747123|541664684|FG000|Overall Study|Adverse Event|0|||
150144409|NCT00747123|541664685|FG001|Overall Study|Adverse Event|1|||
150144410|NCT00747123|541664686|FG002|Overall Study|Adverse Event|0|||
150144411|NCT00747123|541664687|FG003|Overall Study|Adverse Event|1|||
150144412|NCT02277743|541664690|FG000|Overall Study|Protocol Violation|1|||
150144413|NCT02277743|541664691|FG001|Overall Study|Protocol Violation|1|||
150144414|NCT02277743|541664692|FG002|Overall Study|Protocol Violation|1|||
150144415|NCT02277743|541664690|FG000|Overall Study|Adverse Event|10|||
150144416|NCT02277743|541664691|FG001|Overall Study|Adverse Event|6|||
150144417|NCT02277743|541664692|FG002|Overall Study|Adverse Event|6|||
150144418|NCT02277743|541664690|FG000|Overall Study|Lack of Efficacy|11|||
150144419|NCT02277743|541664691|FG001|Overall Study|Lack of Efficacy|4|||
150144420|NCT02277743|541664692|FG002|Overall Study|Lack of Efficacy|3|||
150144421|NCT02277743|541664690|FG000|Overall Study|Other than specified above|18|||
150144422|NCT02277743|541664691|FG001|Overall Study|Other than specified above|5|||
150144423|NCT02277743|541664692|FG002|Overall Study|Other than specified above|16|||
150144424|NCT01224158|541664696|FG000|Overall Study|Withdrawal by Subject|1|||
150144425|NCT01224158|541664697|FG001|Overall Study|Withdrawal by Subject|0|||
150144426|NCT03976466|541664700|FG000|Overall Study|Lost to Follow-up|1|||
150144427|NCT03976466|541664701|FG001|Overall Study|Lost to Follow-up|3|||
150144428|NCT02055157|541664702|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
150144429|NCT02055157|541664703|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
150144430|NCT02055157|541664704|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
150144431|NCT02055157|541664705|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
150144432|NCT02055157|541664702|FG000|Initial 6 Months|Adverse Event|0|||
150144433|NCT02055157|541664703|FG001|Initial 6 Months|Adverse Event|0|||
150144434|NCT02055157|541664704|FG002|Initial 6 Months|Adverse Event|0|||
150144435|NCT02055157|541664705|FG003|Initial 6 Months|Adverse Event|1|||
150144436|NCT02055157|541664702|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
150144437|NCT02055157|541664703|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
150144438|NCT02055157|541664704|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
150144439|NCT02055157|541664705|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
150144440|NCT02055157|541664702|FG000|18-month Extension|Investigator decision|0|||
150144441|NCT02055157|541664703|FG001|18-month Extension|Investigator decision|1|||
150144442|NCT02055157|541664704|FG002|18-month Extension|Investigator decision|0|||
150144443|NCT02055157|541664705|FG003|18-month Extension|Investigator decision|0|||
150144444|NCT02055157|541664702|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
150144445|NCT02055157|541664703|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
150144446|NCT02055157|541664704|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
150144447|NCT02055157|541664705|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
150144448|NCT00943306|541664710|FG000|Overall Study|Physician Decision|1|||
150144449|NCT00943306|541664710|FG000|Overall Study|Death|1|||
150144450|NCT00943306|541664710|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
150144451|NCT00733499|541664711|FG000|Pre-operative|Protocol Violation|0|||
150144452|NCT00733499|541664712|FG001|Pre-operative|Protocol Violation|1|||
150144453|NCT00733499|541664711|FG000|3 Months Follow-up|Death|1|||
150144454|NCT00733499|541664712|FG001|3 Months Follow-up|Death|2|||
150144455|NCT00733499|541664711|FG000|6 Months Follow-up|Death|0|||
150144456|NCT00733499|541664712|FG001|6 Months Follow-up|Death|2|||
150144457|NCT00733499|541664711|FG000|6 Months Follow-up|Adverse Event|0|||
150144458|NCT00733499|541664712|FG001|6 Months Follow-up|Adverse Event|1|||
150144459|NCT00733499|541664711|FG000|12 Months Follow-up|Death|2|||
150144460|NCT00733499|541664712|FG001|12 Months Follow-up|Death|1|||
150144461|NCT00733499|541664711|FG000|24 Months Follow-up|Death|0|||
150144462|NCT00733499|541664712|FG001|24 Months Follow-up|Death|1|||
150144463|NCT00733499|541664711|FG000|5 Year Followup|Adverse Event|2|||
150144464|NCT00733499|541664712|FG001|5 Year Followup|Adverse Event|2|||
150144465|NCT00733499|541664711|FG000|5 Year Followup|Non device related AE|0|||
150144466|NCT00733499|541664712|FG001|5 Year Followup|Non device related AE|1|||
149918619|NCT04852276|540833764|FG001|Overall Study|Lost to Follow-up|9|||
149918620|NCT04852276|540833763|FG000|Overall Study|Withdrawal by Subject|26|||
149918621|NCT04852276|540833764|FG001|Overall Study|Withdrawal by Subject|6|||
149918622|NCT01859949|540835124|FG000|Overall Study|Family Matters|0|||
149918623|NCT01859949|540835125|FG001|Overall Study|Family Matters|1|||
149918624|NCT01859949|540835124|FG000|Overall Study|Physician Decision|2|||
149918625|NCT01859949|540835125|FG001|Overall Study|Physician Decision|4|||
149918626|NCT01859949|540835124|FG000|Overall Study|Withdrawal by Subject|11|||
149918627|NCT01859949|540835125|FG001|Overall Study|Withdrawal by Subject|10|||
149918628|NCT01859949|540835124|FG000|Overall Study|Protocol Violation|1|||
149918629|NCT01859949|540835125|FG001|Overall Study|Protocol Violation|1|||
149918630|NCT01859949|540835124|FG000|Overall Study|Adverse Event|0|||
149918631|NCT01859949|540835125|FG001|Overall Study|Adverse Event|1|||
149918632|NCT01890759|540835126|FG000|Overall Study|Protocol Violation|0|||
149918633|NCT01890759|540835127|FG001|Overall Study|Protocol Violation|2|||
149918634|NCT01890759|540835126|FG000|Overall Study|Lost to Follow-up|0|||
149918635|NCT01890759|540835127|FG001|Overall Study|Lost to Follow-up|2|||
149918636|NCT01890759|540835126|FG000|Overall Study|Withdrawal by Subject|2|||
149918637|NCT01890759|540835127|FG001|Overall Study|Withdrawal by Subject|8|||
149918638|NCT01344759|540835128|FG000|Overall Study|Patients failed to reach sedation level|0|||
149918639|NCT01344759|540835129|FG001|Overall Study|Patients failed to reach sedation level|2|||
149918640|NCT05437640|540835133|FG000|Washout (1 Week)|Adverse Event|1|||
149918641|NCT05437640|540835134|FG001|Washout (1 Week)|Adverse Event|0|||
149918642|NCT02474355|540835135|FG000|Overall Study|Other|43|||
149918643|NCT02474355|540835135|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
149918644|NCT02474355|540835135|FG000|Overall Study|Lost to Follow-up|98|||
149918645|NCT02474355|540835135|FG000|Overall Study|Withdrawal by Subject|124|||
149918646|NCT02474355|540835135|FG000|Overall Study|Death|1361|||
149918647|NCT04228965|540835138|FG000|Overall Study|Lost to Follow-up|26|||
149918648|NCT04228965|540835139|FG001|Overall Study|Lost to Follow-up|11|||
149918649|NCT04228965|540835138|FG000|Overall Study|Withdrawal by Subject|18|||
149918650|NCT04228965|540835139|FG001|Overall Study|Withdrawal by Subject|5|||
149918651|NCT00734656|540835142|FG000|Lab Session 1|Withdrawal by Subject|2|||
149918652|NCT00734656|540835143|FG001|Lab Session 1|Withdrawal by Subject|0|||
149918653|NCT00734656|540835144|FG002|Lab Session 1|Withdrawal by Subject|0|||
149918654|NCT00734656|540835145|FG003|Lab Session 1|Withdrawal by Subject|0|||
149918655|NCT00734656|540835142|FG000|Washout 1|Withdrawal by Subject|1|||
149918656|NCT00734656|540835143|FG001|Washout 1|Withdrawal by Subject|5|||
149918657|NCT00734656|540835144|FG002|Washout 1|Withdrawal by Subject|2|||
149918658|NCT00734656|540835145|FG003|Washout 1|Withdrawal by Subject|3|||
149918659|NCT00734656|540835142|FG000|Lab Session 2|Withdrawal by Subject|1|||
149918660|NCT00734656|540835143|FG001|Lab Session 2|Withdrawal by Subject|0|||
149918661|NCT00734656|540835144|FG002|Lab Session 2|Withdrawal by Subject|0|||
149918662|NCT00734656|540835145|FG003|Lab Session 2|Withdrawal by Subject|1|||
149918663|NCT00734656|540835142|FG000|Washout 2|Withdrawal by Subject|1|||
149918664|NCT00734656|540835143|FG001|Washout 2|Withdrawal by Subject|1|||
149918665|NCT00734656|540835144|FG002|Washout 2|Withdrawal by Subject|1|||
149918666|NCT00734656|540835145|FG003|Washout 2|Withdrawal by Subject|0|||
149918667|NCT00734656|540835142|FG000|Washout 3|Withdrawal by Subject|1|||
149918668|NCT00734656|540835143|FG001|Washout 3|Withdrawal by Subject|0|||
149918669|NCT00734656|540835144|FG002|Washout 3|Withdrawal by Subject|0|||
149918670|NCT00734656|540835145|FG003|Washout 3|Withdrawal by Subject|1|||
149918671|NCT00734656|540835142|FG000|Lab Session 4|Withdrawal by Subject|0|||
149918672|NCT00734656|540835143|FG001|Lab Session 4|Withdrawal by Subject|0|||
149918673|NCT00734656|540835144|FG002|Lab Session 4|Withdrawal by Subject|0|||
149918674|NCT00734656|540835145|FG003|Lab Session 4|Withdrawal by Subject|1|||
149918675|NCT03214679|540835147|FG000|Overall Study|Lost to Follow-up|12|||
149918676|NCT03214679|540835148|FG001|Overall Study|Lost to Follow-up|14|||
149918677|NCT03214679|540835147|FG000|Overall Study|not eligible|2|||
149918678|NCT03214679|540835148|FG001|Overall Study|not eligible|0|||
149918679|NCT03015194|540835151|FG000|Overall Study|Death|10|||
149918680|NCT03015194|540835151|FG000|Overall Study|Withdrawal by Subject|2|||
149918681|NCT01754766|540835158|FG000|Overall Study|Personal reasons|1|||
149918682|NCT01754766|540835159|FG001|Overall Study|Personal reasons|1|||
149918683|NCT01754766|540835160|FG002|Overall Study|Personal reasons|0|||
149918684|NCT02469168|540835161|FG000|Overall Study|Trial closed|1|||
149918685|NCT02469168|540835162|FG001|Overall Study|Trial closed|0|||
149918686|NCT00433017|540835163|FG000|Overall Study|Adverse Event|5|||
149918687|NCT00433017|540835164|FG001|Overall Study|Adverse Event|3|||
149918688|NCT00433017|540835163|FG000|Overall Study|Withdrawal by Subject|4|||
149918689|NCT00433017|540835164|FG001|Overall Study|Withdrawal by Subject|5|||
149918690|NCT00433017|540835163|FG000|Overall Study|Lost to Follow-up|3|||
149918691|NCT00433017|540835164|FG001|Overall Study|Lost to Follow-up|4|||
149918692|NCT00433017|540835163|FG000|Overall Study|Administrative problems|80|||
149918693|NCT00433017|540835164|FG001|Overall Study|Administrative problems|86|||
149918694|NCT00433017|540835163|FG000|Overall Study|Protocol Violation|1|||
149918695|NCT00433017|540835164|FG001|Overall Study|Protocol Violation|0|||
149918696|NCT00433017|540835163|FG000|Overall Study|Death|2|||
149918697|NCT00433017|540835164|FG001|Overall Study|Death|2|||
150144467|NCT00733499|541664711|FG000|5 Year Followup|Revision of Study Implant|0|||
150144468|NCT00733499|541664712|FG001|5 Year Followup|Revision of Study Implant|1|||
150144469|NCT00733499|541664711|FG000|5 Year Followup|Lost to Follow-up|2|||
150144470|NCT00733499|541664712|FG001|5 Year Followup|Lost to Follow-up|0|||
150144471|NCT00733499|541664711|FG000|5 Year Followup|Death|13|||
150144472|NCT00733499|541664712|FG001|5 Year Followup|Death|19|||
150144473|NCT00733499|541664711|FG000|5 Year Followup|missing, unable to locate|0|||
150144474|NCT00733499|541664712|FG001|5 Year Followup|missing, unable to locate|1|||
150144475|NCT00733499|541664711|FG000|5 Year Followup|Withdrawal by Subject|4|||
150144476|NCT00733499|541664712|FG001|5 Year Followup|Withdrawal by Subject|1|||
150144477|NCT00733499|541664711|FG000|10 Year Followup|Death|9|||
150144478|NCT00733499|541664712|FG001|10 Year Followup|Death|7|||
150144479|NCT00733499|541664711|FG000|10 Year Followup|Adverse Event|3|||
150144480|NCT00733499|541664712|FG001|10 Year Followup|Adverse Event|3|||
150144481|NCT00733499|541664711|FG000|10 Year Followup|Lost to Follow-up|3|||
150144482|NCT00733499|541664712|FG001|10 Year Followup|Lost to Follow-up|2|||
150144483|NCT00733499|541664711|FG000|10 Year Followup|Withdrawal by Subject|5|||
150144484|NCT00733499|541664712|FG001|10 Year Followup|Withdrawal by Subject|5|||
150144485|NCT00733499|541664711|FG000|10 Year Followup|missing, unable to locate|0|||
150144486|NCT00733499|541664712|FG001|10 Year Followup|missing, unable to locate|2|||
150144487|NCT00733980|541664713|FG000|Overall Study|Adverse Event|5|||
150144488|NCT00733980|541664714|FG001|Overall Study|Adverse Event|2|||
150144489|NCT00733980|541664713|FG000|Overall Study|Lack of Efficacy|0|||
150144490|NCT00733980|541664714|FG001|Overall Study|Lack of Efficacy|1|||
150144491|NCT00733980|541664713|FG000|Overall Study|Protocol Violation|2|||
150144492|NCT00733980|541664714|FG001|Overall Study|Protocol Violation|1|||
150144493|NCT00733980|541664713|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
150144494|NCT00733980|541664714|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
150144495|NCT00733980|541664713|FG000|Overall Study|Lost to Follow-up|6|||
150144496|NCT00733980|541664714|FG001|Overall Study|Lost to Follow-up|11|||
150144497|NCT00733980|541664713|FG000|Overall Study|Physician Decision|2|||
150144498|NCT00733980|541664714|FG001|Overall Study|Physician Decision|3|||
150144499|NCT00733980|541664713|FG000|Overall Study|Withdrawal by Subject|6|||
150144500|NCT00733980|541664714|FG001|Overall Study|Withdrawal by Subject|2|||
150144501|NCT02739347|541664715|FG000|Overall Study|Adverse Event|3|||
150144502|NCT02739347|541664716|FG001|Overall Study|Adverse Event|0|||
150144503|NCT02739347|541664715|FG000|Overall Study|Protocol Violation|0|||
150144504|NCT02739347|541664716|FG001|Overall Study|Protocol Violation|1|||
150144505|NCT02739347|541664715|FG000|Overall Study|Lost to Follow-up|0|||
150144506|NCT02739347|541664716|FG001|Overall Study|Lost to Follow-up|2|||
150144507|NCT02404389|541664717|FG000|Overall Study|Adverse Event|1|||
150144508|NCT02404389|541664718|FG001|Overall Study|Adverse Event|0|||
150144509|NCT02404389|541664719|FG002|Overall Study|Adverse Event|1|||
150144510|NCT02404389|541664720|FG003|Overall Study|Adverse Event|0|||
150144511|NCT02404389|541664721|FG004|Overall Study|Adverse Event|2|||
150144512|NCT02404389|541664717|FG000|Overall Study|Subject/guardian decision|1|||
150144513|NCT02404389|541664718|FG001|Overall Study|Subject/guardian decision|0|||
150144514|NCT02404389|541664719|FG002|Overall Study|Subject/guardian decision|0|||
150144515|NCT02404389|541664720|FG003|Overall Study|Subject/guardian decision|1|||
150144516|NCT02404389|541664721|FG004|Overall Study|Subject/guardian decision|1|||
150144517|NCT01126060|541664725|FG000|Overall Study|Protocol Violation|0|||
150144518|NCT01126060|541664726|FG001|Overall Study|Protocol Violation|2|||
150144519|NCT02658630|541664727|FG000|Overall Study|Withdrawal by Subject|4|||
150144520|NCT01062763|541666814|FG000|Overall Study|Adverse Event|3|||
150144521|NCT01062763|541666815|FG001|Overall Study|Adverse Event|4|||
150144522|NCT00369681|541666824|FG000|Overall Study|Death|1|||
150144523|NCT02387216|541666827|FG000|Overall Study|Progressive disease|2|||
150144524|NCT02387216|541666828|FG001|Overall Study|Progressive disease|0|||
150144525|NCT02387216|541666827|FG000|Overall Study|Withdrawal by Subject|3|||
150144526|NCT02387216|541666828|FG001|Overall Study|Withdrawal by Subject|5|||
150144527|NCT02387216|541666827|FG000|Overall Study|Physician Decision|2|||
150144528|NCT02387216|541666828|FG001|Overall Study|Physician Decision|0|||
150144529|NCT02387216|541666827|FG000|Overall Study|Sponsor Decision|28|||
150144530|NCT02387216|541666828|FG001|Overall Study|Sponsor Decision|12|||
150144531|NCT02387216|541666827|FG000|Overall Study|Death|60|||
150144532|NCT02387216|541666828|FG001|Overall Study|Death|23|||
150144533|NCT02387216|541666827|FG000|Overall Study|Other|5|||
150144534|NCT02387216|541666828|FG001|Overall Study|Other|4|||
150144535|NCT02387216|541666827|FG000|Overall Study|Lost to Follow-up|0|||
150144536|NCT02387216|541666828|FG001|Overall Study|Lost to Follow-up|3|||
150144537|NCT04359771|541666829|FG000|Overall Study|Lack of Efficacy|2|||
150144538|NCT04359771|541666830|FG001|Overall Study|Lack of Efficacy|2|||
150144539|NCT04041440|541666831|FG000|Overall Study|Withdrawal by Subject|0|||
150144540|NCT04041440|541666832|FG001|Overall Study|Withdrawal by Subject|1|||
150144541|NCT04041440|541666831|FG000|Overall Study|Lost to Follow-up|0|||
150144542|NCT04041440|541666832|FG001|Overall Study|Lost to Follow-up|1|||
150144543|NCT02306265|541666833|FG000|Overall Study|Withdrawal by Subject|1|||
150144544|NCT04251065|541666843|FG000|Overall Study|Death|2|||
150144545|NCT04251065|541666843|FG000|Overall Study|Lack of Efficacy|3|||
150144546|NCT04251065|541666843|FG000|Overall Study|Death|1|||
150144547|NCT01216163|541666844|FG000|Overall Study|Withdrawal by Subject|1|||
150144548|NCT01216163|541666845|FG001|Overall Study|Withdrawal by Subject|1|||
150144549|NCT01216163|541666846|FG002|Overall Study|Withdrawal by Subject|0|||
150144550|NCT01552954|541666848|FG000|Overall Study|Adverse Event|1|||
150144551|NCT01552954|541666849|FG001|Overall Study|Adverse Event|2|||
150144552|NCT01552954|541666848|FG000|Overall Study|Lost to Follow-up|1|||
150144553|NCT01552954|541666849|FG001|Overall Study|Lost to Follow-up|1|||
150144554|NCT01552954|541666848|FG000|Overall Study|Withdrawal by Subject|1|||
150144555|NCT01552954|541666849|FG001|Overall Study|Withdrawal by Subject|1|||
150144556|NCT01552954|541666848|FG000|Overall Study|Protocol Violation|1|||
150144557|NCT01552954|541666849|FG001|Overall Study|Protocol Violation|2|||
150144558|NCT01552954|541666848|FG000|Overall Study|diagnosed DM|1|||
150144559|NCT01552954|541666849|FG001|Overall Study|diagnosed DM|0|||
150144560|NCT01778556|541666850|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
150144561|NCT01778556|541666851|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
150144562|NCT01778556|541666850|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150144563|NCT01778556|541666851|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
150144564|NCT01778556|541666850|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
150144565|NCT01778556|541666851|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
150144566|NCT01778556|541666850|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
150144567|NCT01778556|541666851|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
150144568|NCT00576732|541666853|FG000|DOUBLE BLIND|Adverse Event|0|||
150144569|NCT00576732|541666854|FG001|DOUBLE BLIND|Adverse Event|0|||
150144570|NCT00576732|541666855|FG002|DOUBLE BLIND|Adverse Event|1|||
150144571|NCT00576732|541666856|FG003|DOUBLE BLIND|Adverse Event|0|||
150144572|NCT00576732|541666857|FG004|DOUBLE BLIND|Adverse Event|0|||
150144573|NCT00576732|541666858|FG005|DOUBLE BLIND|Adverse Event|0|||
150144574|NCT00576732|541666853|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
150144575|NCT00576732|541666854|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
150144576|NCT00576732|541666855|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
150144577|NCT00576732|541666856|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
150144578|NCT00576732|541666857|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
150144579|NCT00576732|541666858|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
150144580|NCT00576732|541666853|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
150144581|NCT00576732|541666854|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
150144582|NCT00576732|541666855|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
150144583|NCT00576732|541666856|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
150144584|NCT00576732|541666857|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
150144585|NCT00576732|541666858|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
150144586|NCT00576732|541666853|FG000|DOUBLE BLIND|OTHER|0|||
150144587|NCT00576732|541666854|FG001|DOUBLE BLIND|OTHER|2|||
150144588|NCT00576732|541666855|FG002|DOUBLE BLIND|OTHER|1|||
150144589|NCT00576732|541666856|FG003|DOUBLE BLIND|OTHER|0|||
150144590|NCT00576732|541666857|FG004|DOUBLE BLIND|OTHER|0|||
150144591|NCT00576732|541666858|FG005|DOUBLE BLIND|OTHER|0|||
150144592|NCT00576732|541666853|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
150144593|NCT00576732|541666854|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
150144594|NCT00576732|541666855|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
150144595|NCT00576732|541666856|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
150144596|NCT00576732|541666857|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
150144597|NCT00576732|541666858|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
150144598|NCT00576732|541666853|FG000|DOUBLE BLIND|Protocol Violation|1|||
150144599|NCT00576732|541666854|FG001|DOUBLE BLIND|Protocol Violation|0|||
150144600|NCT00576732|541666855|FG002|DOUBLE BLIND|Protocol Violation|0|||
150144601|NCT00576732|541666856|FG003|DOUBLE BLIND|Protocol Violation|0|||
150144602|NCT00576732|541666857|FG004|DOUBLE BLIND|Protocol Violation|0|||
150144603|NCT00576732|541666858|FG005|DOUBLE BLIND|Protocol Violation|0|||
150144604|NCT00576732|541666853|FG000|OPEN LABEL|Adverse Event|0|||
150144605|NCT00576732|541666854|FG001|OPEN LABEL|Adverse Event|0|||
150144606|NCT00576732|541666855|FG002|OPEN LABEL|Adverse Event|0|||
150144607|NCT00576732|541666856|FG003|OPEN LABEL|Adverse Event|4|||
150144608|NCT00576732|541666857|FG004|OPEN LABEL|Adverse Event|0|||
150144609|NCT00576732|541666858|FG005|OPEN LABEL|Adverse Event|1|||
150144610|NCT00576732|541666853|FG000|OPEN LABEL|Lost to Follow-up|0|||
150144611|NCT00576732|541666854|FG001|OPEN LABEL|Lost to Follow-up|0|||
150144612|NCT00576732|541666855|FG002|OPEN LABEL|Lost to Follow-up|0|||
150144613|NCT00576732|541666856|FG003|OPEN LABEL|Lost to Follow-up|2|||
150144614|NCT00576732|541666857|FG004|OPEN LABEL|Lost to Follow-up|1|||
150144615|NCT00576732|541666858|FG005|OPEN LABEL|Lost to Follow-up|1|||
150144616|NCT00576732|541666853|FG000|OPEN LABEL|Withdrawal by Subject|0|||
150144617|NCT00576732|541666854|FG001|OPEN LABEL|Withdrawal by Subject|0|||
150144618|NCT00576732|541666855|FG002|OPEN LABEL|Withdrawal by Subject|0|||
150144619|NCT00576732|541666856|FG003|OPEN LABEL|Withdrawal by Subject|1|||
150144620|NCT00576732|541666857|FG004|OPEN LABEL|Withdrawal by Subject|0|||
150144621|NCT00576732|541666858|FG005|OPEN LABEL|Withdrawal by Subject|1|||
150144622|NCT00576732|541666853|FG000|OPEN LABEL|OTHER|0|||
150144623|NCT00576732|541666854|FG001|OPEN LABEL|OTHER|0|||
150144624|NCT00576732|541666855|FG002|OPEN LABEL|OTHER|0|||
150144625|NCT00576732|541666856|FG003|OPEN LABEL|OTHER|0|||
150144626|NCT00576732|541666857|FG004|OPEN LABEL|OTHER|0|||
150144627|NCT00576732|541666858|FG005|OPEN LABEL|OTHER|2|||
150144628|NCT00576732|541666853|FG000|OPEN LABEL|Lack of Efficacy|0|||
150144629|NCT00576732|541666854|FG001|OPEN LABEL|Lack of Efficacy|0|||
150144630|NCT00576732|541666855|FG002|OPEN LABEL|Lack of Efficacy|0|||
150144631|NCT00576732|541666856|FG003|OPEN LABEL|Lack of Efficacy|2|||
150144632|NCT00576732|541666857|FG004|OPEN LABEL|Lack of Efficacy|2|||
150144633|NCT00576732|541666858|FG005|OPEN LABEL|Lack of Efficacy|3|||
150144634|NCT00576732|541666853|FG000|OPEN LABEL|Protocol Violation|0|||
150144635|NCT00576732|541666854|FG001|OPEN LABEL|Protocol Violation|0|||
150144636|NCT00576732|541666855|FG002|OPEN LABEL|Protocol Violation|0|||
150144637|NCT00576732|541666856|FG003|OPEN LABEL|Protocol Violation|2|||
150144638|NCT00576732|541666857|FG004|OPEN LABEL|Protocol Violation|1|||
150144639|NCT00576732|541666858|FG005|OPEN LABEL|Protocol Violation|0|||
150144640|NCT01235403|541666860|FG000|Overall Study|Adverse Event|14|||
150144641|NCT01235403|541666860|FG000|Overall Study|Lost to Follow-up|2|||
150144642|NCT01235403|541666860|FG000|Overall Study|Withdrawal by Subject|4|||
150144643|NCT01235403|541666860|FG000|Overall Study|Lack of Efficacy|2|||
150144644|NCT01235403|541666860|FG000|Overall Study|Other reasons for premature termination|4|||
150144645|NCT02978443|541666863|FG000|Overall Study|Withdrawal by Subject|1|||
150144646|NCT02978443|541666863|FG000|Overall Study|Adverse Event|3|||
150144647|NCT02978443|541666863|FG000|Overall Study|Disease Progression on study|6|||
150144648|NCT02978443|541666863|FG000|Overall Study|Death|1|||
150144649|NCT02978443|541666863|FG000|Overall Study|Physician Decision|1|||
150144650|NCT02978443|541666863|FG000|Overall Study|Switch to alternative therapy|1|||
150144651|NCT02978443|541666863|FG000|Overall Study|Refused further treatment|1|||
150144652|NCT02296190|541666864|FG000|Overall Study|Lost to Follow-up|0|||
150144653|NCT02296190|541666865|FG001|Overall Study|Lost to Follow-up|0|||
150144654|NCT02296190|541666866|FG002|Overall Study|Lost to Follow-up|0|||
150144655|NCT02296190|541666867|FG003|Overall Study|Lost to Follow-up|0|||
150144656|NCT02296190|541666868|FG004|Overall Study|Lost to Follow-up|1|||
150144657|NCT02296190|541666869|FG005|Overall Study|Lost to Follow-up|0|||
150144658|NCT02296190|541666864|FG000|Overall Study|Failure to induce PSVT|6|||
150144659|NCT02296190|541666865|FG001|Overall Study|Failure to induce PSVT|10|||
150144660|NCT02296190|541666866|FG002|Overall Study|Failure to induce PSVT|5|||
150144661|NCT02296190|541666867|FG003|Overall Study|Failure to induce PSVT|13|||
150144662|NCT02296190|541666868|FG004|Overall Study|Failure to induce PSVT|8|||
150144663|NCT02296190|541666869|FG005|Overall Study|Failure to induce PSVT|0|||
150144664|NCT02296190|541666864|FG000|Overall Study|Physician Decision|1|||
150144665|NCT02296190|541666865|FG001|Overall Study|Physician Decision|1|||
150257845|NCT01506609|542078037|FG003|Overall Study|Adverse Event Related to Progression|3|||
150257846|NCT01506609|542078038|FG004|Overall Study|Adverse Event Related to Progression|7|||
150144666|NCT02296190|541666866|FG002|Overall Study|Physician Decision|0|||
150144667|NCT02296190|541666867|FG003|Overall Study|Physician Decision|1|||
150144668|NCT02296190|541666868|FG004|Overall Study|Physician Decision|2|||
150144669|NCT02296190|541666869|FG005|Overall Study|Physician Decision|0|||
150144670|NCT02296190|541666864|FG000|Overall Study|Withdrawal by Subject|0|||
150144671|NCT02296190|541666865|FG001|Overall Study|Withdrawal by Subject|1|||
150144672|NCT02296190|541666866|FG002|Overall Study|Withdrawal by Subject|0|||
150144673|NCT02296190|541666867|FG003|Overall Study|Withdrawal by Subject|0|||
150144674|NCT02296190|541666868|FG004|Overall Study|Withdrawal by Subject|0|||
150144675|NCT02296190|541666869|FG005|Overall Study|Withdrawal by Subject|0|||
150144676|NCT02296190|541666864|FG000|Overall Study|PSVT < 5 minutes|5|||
150144677|NCT02296190|541666865|FG001|Overall Study|PSVT < 5 minutes|6|||
150144678|NCT02296190|541666866|FG002|Overall Study|PSVT < 5 minutes|6|||
150144679|NCT02296190|541666867|FG003|Overall Study|PSVT < 5 minutes|6|||
150144680|NCT02296190|541666868|FG004|Overall Study|PSVT < 5 minutes|5|||
150144681|NCT02296190|541666869|FG005|Overall Study|PSVT < 5 minutes|0|||
150144682|NCT02296190|541666864|FG000|Overall Study|Patient was given Propofol|0|||
150144683|NCT02296190|541666865|FG001|Overall Study|Patient was given Propofol|1|||
150144684|NCT02296190|541666866|FG002|Overall Study|Patient was given Propofol|0|||
150257847|NCT01506609|542078039|FG005|Overall Study|Adverse Event Related to Progression|3|||
150257848|NCT01506609|542078034|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
150257849|NCT01506609|542078035|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
150257850|NCT01506609|542078036|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
150257851|NCT01506609|542078037|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
150257852|NCT01506609|542078038|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
150144685|NCT02296190|541666867|FG003|Overall Study|Patient was given Propofol|1|||
150144686|NCT02296190|541666868|FG004|Overall Study|Patient was given Propofol|0|||
150144687|NCT02296190|541666869|FG005|Overall Study|Patient was given Propofol|0|||
150144688|NCT02296190|541666864|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
150144689|NCT02296190|541666865|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
150144690|NCT02296190|541666866|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
150144691|NCT02296190|541666867|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
150144692|NCT02296190|541666868|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
150144693|NCT02296190|541666869|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
150144694|NCT02296190|541666864|FG000|Overall Study|Blood pressure <100 after sedation|0|||
150144695|NCT02296190|541666865|FG001|Overall Study|Blood pressure <100 after sedation|0|||
150144696|NCT02296190|541666866|FG002|Overall Study|Blood pressure <100 after sedation|0|||
150144697|NCT02296190|541666867|FG003|Overall Study|Blood pressure <100 after sedation|1|||
150144698|NCT02296190|541666868|FG004|Overall Study|Blood pressure <100 after sedation|0|||
150144699|NCT02296190|541666869|FG005|Overall Study|Blood pressure <100 after sedation|0|||
150144700|NCT02296190|541666864|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
150144701|NCT02296190|541666865|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
150144702|NCT02296190|541666866|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
150144703|NCT02296190|541666867|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
150144704|NCT02296190|541666868|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
150144705|NCT02296190|541666869|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
150144706|NCT02296190|541666864|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
150144707|NCT02296190|541666865|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
150144708|NCT02296190|541666866|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
150144709|NCT02296190|541666867|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
150144710|NCT02296190|541666868|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
150144711|NCT02296190|541666869|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
150144712|NCT02296190|541666864|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
150144713|NCT02296190|541666865|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
150144714|NCT02296190|541666866|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
150144715|NCT02296190|541666867|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
150144716|NCT02296190|541666868|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
150144717|NCT02296190|541666869|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
150144718|NCT02296190|541666864|FG000|Overall Study|Lab result not available in time|1|||
150144719|NCT02296190|541666865|FG001|Overall Study|Lab result not available in time|0|||
150144720|NCT02296190|541666866|FG002|Overall Study|Lab result not available in time|0|||
150144721|NCT02296190|541666867|FG003|Overall Study|Lab result not available in time|0|||
150144722|NCT02296190|541666868|FG004|Overall Study|Lab result not available in time|0|||
150144723|NCT02296190|541666869|FG005|Overall Study|Lab result not available in time|0|||
150144724|NCT02087501|541666871|FG000|Overall Study|Death|7|||
150144725|NCT02087501|541666871|FG000|Overall Study|Open repair of aneurysm|1|||
150144726|NCT02087501|541666871|FG000|Overall Study|Lost to Follow-up|2|||
150144727|NCT00094328|541666872|FG000|Overall Study|Lost to Follow-up|1|||
150144728|NCT03682705|541666873|FG000|Overall Study|Adverse Event|1|||
150144729|NCT03682705|541666874|FG001|Overall Study|Adverse Event|1|||
150144730|NCT03682705|541666875|FG002|Overall Study|Adverse Event|1|||
150144731|NCT03682705|541666876|FG003|Overall Study|Adverse Event|0|||
150144732|NCT03682705|541666877|FG004|Overall Study|Adverse Event|1|||
150144733|NCT03682705|541666878|FG005|Overall Study|Adverse Event|1|||
150144734|NCT03682705|541666873|FG000|Overall Study|Withdrawal by Subject|1|||
150144735|NCT03682705|541666874|FG001|Overall Study|Withdrawal by Subject|3|||
150144736|NCT03682705|541666875|FG002|Overall Study|Withdrawal by Subject|2|||
150144737|NCT03682705|541666876|FG003|Overall Study|Withdrawal by Subject|4|||
150144738|NCT03682705|541666877|FG004|Overall Study|Withdrawal by Subject|0|||
150144739|NCT03682705|541666878|FG005|Overall Study|Withdrawal by Subject|1|||
150144740|NCT03682705|541666873|FG000|Overall Study|Other, not specified|0|||
150144741|NCT03682705|541666874|FG001|Overall Study|Other, not specified|0|||
150257853|NCT01506609|542078039|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
150257854|NCT01506609|542078034|FG000|Overall Study|Withdrawal by Subject|0|||
150257855|NCT01506609|542078035|FG001|Overall Study|Withdrawal by Subject|0|||
150257856|NCT01506609|542078036|FG002|Overall Study|Withdrawal by Subject|0|||
150257857|NCT01506609|542078037|FG003|Overall Study|Withdrawal by Subject|9|||
150257858|NCT01506609|542078038|FG004|Overall Study|Withdrawal by Subject|7|||
150257859|NCT01506609|542078039|FG005|Overall Study|Withdrawal by Subject|7|||
150257860|NCT01506609|542078034|FG000|Overall Study|Lost to Follow-up|0|||
150257861|NCT01506609|542078035|FG001|Overall Study|Lost to Follow-up|0|||
150257862|NCT01506609|542078036|FG002|Overall Study|Lost to Follow-up|0|||
150257863|NCT01506609|542078037|FG003|Overall Study|Lost to Follow-up|1|||
150257864|NCT01506609|542078038|FG004|Overall Study|Lost to Follow-up|2|||
150257865|NCT01506609|542078039|FG005|Overall Study|Lost to Follow-up|0|||
150257866|NCT01506609|542078034|FG000|Overall Study|Sponsor Discontinued Study|0|||
150257867|NCT01506609|542078035|FG001|Overall Study|Sponsor Discontinued Study|0|||
150257868|NCT01506609|542078036|FG002|Overall Study|Sponsor Discontinued Study|0|||
150257869|NCT01506609|542078037|FG003|Overall Study|Sponsor Discontinued Study|2|||
150257870|NCT01506609|542078038|FG004|Overall Study|Sponsor Discontinued Study|2|||
150257871|NCT01506609|542078039|FG005|Overall Study|Sponsor Discontinued Study|0|||
150257872|NCT01506609|542078034|FG000|Overall Study|Progressive Disease per Protocol|1|||
150144742|NCT03682705|541666875|FG002|Overall Study|Other, not specified|0|||
150144743|NCT03682705|541666876|FG003|Overall Study|Other, not specified|1|||
150144744|NCT03682705|541666877|FG004|Overall Study|Other, not specified|2|||
150144745|NCT03682705|541666878|FG005|Overall Study|Other, not specified|0|||
150144746|NCT03682705|541666873|FG000|Overall Study|Lost to Follow-up|0|||
150144747|NCT03682705|541666874|FG001|Overall Study|Lost to Follow-up|0|||
150257873|NCT01506609|542078035|FG001|Overall Study|Progressive Disease per Protocol|0|||
150257874|NCT01506609|542078036|FG002|Overall Study|Progressive Disease per Protocol|0|||
150257875|NCT01506609|542078037|FG003|Overall Study|Progressive Disease per Protocol|64|||
150257876|NCT01506609|542078038|FG004|Overall Study|Progressive Disease per Protocol|57|||
150257877|NCT01506609|542078039|FG005|Overall Study|Progressive Disease per Protocol|74|||
150257878|NCT01506609|542078034|FG000|Overall Study|Other, Not Specified|0|||
150257879|NCT01506609|542078035|FG001|Overall Study|Other, Not Specified|0|||
150257880|NCT01506609|542078036|FG002|Overall Study|Other, Not Specified|0|||
150257881|NCT01506609|542078037|FG003|Overall Study|Other, Not Specified|10|||
150257882|NCT01506609|542078038|FG004|Overall Study|Other, Not Specified|7|||
150257883|NCT01506609|542078039|FG005|Overall Study|Other, Not Specified|3|||
150257884|NCT01506609|542078034|FG000|Overall Study|Missing / Unknown Reason|1|||
150257885|NCT01506609|542078035|FG001|Overall Study|Missing / Unknown Reason|0|||
150257886|NCT01506609|542078036|FG002|Overall Study|Missing / Unknown Reason|1|||
150257887|NCT01506609|542078037|FG003|Overall Study|Missing / Unknown Reason|4|||
150257888|NCT01506609|542078038|FG004|Overall Study|Missing / Unknown Reason|4|||
150257889|NCT01506609|542078039|FG005|Overall Study|Missing / Unknown Reason|2|||
150257890|NCT01324440|542078044|FG000|Overall Study|Subject moved|0|||
150257891|NCT01324440|542078045|FG001|Overall Study|Subject moved|1|||
150257892|NCT02884908|542078046|FG000|Overall Study|Lost to Follow-up|13|||
150257893|NCT02884908|542078047|FG001|Overall Study|Lost to Follow-up|18|||
150257894|NCT00938860|542078048|FG000|Overall Study|Adverse Event|2|||
150257895|NCT00938860|542078049|FG001|Overall Study|Adverse Event|1|||
150257896|NCT00938860|542078048|FG000|Overall Study|Abnormal laboratory values|2|||
150257897|NCT00938860|542078049|FG001|Overall Study|Abnormal laboratory values|2|||
150257898|NCT00938860|542078048|FG000|Overall Study|Withdrawal by Subject|11|||
150257899|NCT00938860|542078049|FG001|Overall Study|Withdrawal by Subject|8|||
150257900|NCT00938860|542078048|FG000|Overall Study|Lost to Follow-up|4|||
150257901|NCT00938860|542078049|FG001|Overall Study|Lost to Follow-up|4|||
150257902|NCT00938860|542078048|FG000|Overall Study|Administration problems|2|||
150257903|NCT00938860|542078049|FG001|Overall Study|Administration problems|0|||
150257904|NCT00938860|542078048|FG000|Overall Study|Death|1|||
150257905|NCT00938860|542078049|FG001|Overall Study|Death|1|||
150257906|NCT00938860|542078048|FG000|Overall Study|Protocol Violation|3|||
150257907|NCT00938860|542078049|FG001|Overall Study|Protocol Violation|1|||
150257908|NCT01605019|542078050|FG000|Overall Study|pt did not meet transplant endpoint|3|||
150257909|NCT01605019|542078051|FG001|Overall Study|pt did not meet transplant endpoint|0|||
150257910|NCT00468559|542078055|FG000|Open-label Treatment Phase|Adverse Event|5|||
150257911|NCT00468559|542078056|FG001|Open-label Treatment Phase|Adverse Event|0|||
150257912|NCT00468559|542078057|FG002|Open-label Treatment Phase|Adverse Event|0|||
150257913|NCT00468559|542078055|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
150257914|NCT00468559|542078056|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
150257915|NCT00468559|542078057|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
150257916|NCT00468559|542078055|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
150257917|NCT00468559|542078056|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
150257918|NCT00468559|542078057|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
150257919|NCT00468559|542078055|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
150257920|NCT00468559|542078056|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
150257921|NCT00468559|542078057|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
150257922|NCT00468559|542078055|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
150257923|NCT00468559|542078056|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
150257924|NCT00468559|542078057|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
150257925|NCT00324116|542078058|FG000|Overall Study|Adverse Event|5|||
150257926|NCT00324116|542078058|FG000|Overall Study|Lack of Efficacy|17|||
150257927|NCT00324116|542078058|FG000|Overall Study|Withdrawal by Subject|5|||
150257928|NCT00324116|542078058|FG000|Overall Study|Other|5|||
150257929|NCT02703259|542078059|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
150257930|NCT02703259|542078060|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
150257931|NCT02703259|542078059|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
150257932|NCT02703259|542078060|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
150257933|NCT02703259|542078059|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
150257934|NCT02703259|542078060|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
150257935|NCT01642251|542078063|FG000|Overall Study|Progressive disease|0|||
150257936|NCT01642251|542078064|FG001|Overall Study|Progressive disease|0|||
150257937|NCT01642251|542078065|FG002|Overall Study|Progressive disease|3|||
150257938|NCT01642251|542078066|FG003|Overall Study|Progressive disease|3|||
150257939|NCT01642251|542078063|FG000|Overall Study|Adverse Event|0|||
150257940|NCT01642251|542078064|FG001|Overall Study|Adverse Event|0|||
150257941|NCT01642251|542078065|FG002|Overall Study|Adverse Event|5|||
150257942|NCT01642251|542078066|FG003|Overall Study|Adverse Event|4|||
150257943|NCT01642251|542078063|FG000|Overall Study|Death|0|||
150257944|NCT01642251|542078064|FG001|Overall Study|Death|0|||
150257945|NCT01642251|542078065|FG002|Overall Study|Death|1|||
150257946|NCT01642251|542078066|FG003|Overall Study|Death|3|||
150257947|NCT01642251|542078063|FG000|Overall Study|Withdrawal by Subject|0|||
150257948|NCT01642251|542078064|FG001|Overall Study|Withdrawal by Subject|0|||
150257949|NCT01642251|542078065|FG002|Overall Study|Withdrawal by Subject|1|||
150257950|NCT01642251|542078066|FG003|Overall Study|Withdrawal by Subject|3|||
150257951|NCT01642251|542078063|FG000|Overall Study|Alternative therapy|0|||
150257952|NCT01642251|542078064|FG001|Overall Study|Alternative therapy|0|||
150257953|NCT01642251|542078065|FG002|Overall Study|Alternative therapy|0|||
150257954|NCT01642251|542078066|FG003|Overall Study|Alternative therapy|2|||
150257955|NCT01642251|542078063|FG000|Overall Study|Other complicating disease|0|||
150257956|NCT01642251|542078064|FG001|Overall Study|Other complicating disease|0|||
150257957|NCT01642251|542078065|FG002|Overall Study|Other complicating disease|1|||
150257958|NCT01642251|542078066|FG003|Overall Study|Other complicating disease|0|||
150257959|NCT01642251|542078063|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
150257960|NCT01642251|542078064|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
150257961|NCT01642251|542078065|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
150257962|NCT01642251|542078066|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
150257963|NCT00895154|542078068|FG000|Overall Study|Lost to Follow-up|1|||
150257964|NCT00895154|542078069|FG001|Overall Study|Lost to Follow-up|1|||
150257965|NCT00895154|542078068|FG000|Overall Study|Withdrawal by Subject|0|||
150257966|NCT00895154|542078069|FG001|Overall Study|Withdrawal by Subject|1|||
150257967|NCT01605916|542078072|FG000|Overall Study|Adverse Event|1|||
150257968|NCT01605916|542078073|FG001|Overall Study|Adverse Event|0|||
150257969|NCT01605916|542078074|FG002|Overall Study|Adverse Event|0|||
150257970|NCT01605916|542078075|FG003|Overall Study|Adverse Event|1|||
150257971|NCT01605916|542078076|FG004|Overall Study|Adverse Event|0|||
150257972|NCT01605916|542078072|FG000|Overall Study|Lack of Efficacy|2|||
150257973|NCT01605916|542078073|FG001|Overall Study|Lack of Efficacy|3|||
150257974|NCT01605916|542078074|FG002|Overall Study|Lack of Efficacy|3|||
150257975|NCT01605916|542078075|FG003|Overall Study|Lack of Efficacy|5|||
150257976|NCT01605916|542078076|FG004|Overall Study|Lack of Efficacy|4|||
150257977|NCT01605916|542078072|FG000|Overall Study|Withdrawal by Subject|1|||
150257978|NCT01605916|542078073|FG001|Overall Study|Withdrawal by Subject|1|||
150257979|NCT01605916|542078074|FG002|Overall Study|Withdrawal by Subject|0|||
150257980|NCT01605916|542078075|FG003|Overall Study|Withdrawal by Subject|0|||
150257981|NCT01605916|542078076|FG004|Overall Study|Withdrawal by Subject|2|||
150257982|NCT00540046|542078077|FG000|Overall Study|Lost to Follow-up|33|||
150257983|NCT00540046|542078078|FG001|Overall Study|Lost to Follow-up|23|||
150257984|NCT01021215|542078079|FG000|Overall Study|Lost to Follow-up|3|||
150257985|NCT01021215|542078080|FG001|Overall Study|Lost to Follow-up|0|||
150257986|NCT01103362|542078081|FG000|Overall Study|study terminated|596|||
150257987|NCT02533531|542078082|FG000|Overall Study|Device did not turn on|1|||
150257988|NCT02047903|542078083|FG000|Overall Study|Adverse Event|14|||
150257989|NCT02047903|542078083|FG000|Overall Study|Serious adverse event|10|||
150257990|NCT02047903|542078083|FG000|Overall Study|Withdrawal by Subject|16|||
150257991|NCT02047903|542078083|FG000|Overall Study|Lost to Follow-up|4|||
150257992|NCT02047903|542078083|FG000|Overall Study|Reason not listed|6|||
150257993|NCT02047903|542078083|FG000|Overall Study|Not Treated|9|||
150257994|NCT01942590|542078084|FG000|Overall Study|Withdrawal by Subject|0|||
150257995|NCT01942590|542078085|FG001|Overall Study|Withdrawal by Subject|1|||
150257996|NCT01942590|542078084|FG000|Overall Study|Adverse Event|1|||
150257997|NCT01942590|542078085|FG001|Overall Study|Adverse Event|0|||
150257998|NCT01688830|542078086|FG000|Overall Study|Lost to Follow-up|0|||
150144748|NCT03682705|541666875|FG002|Overall Study|Lost to Follow-up|0|||
150144749|NCT03682705|541666876|FG003|Overall Study|Lost to Follow-up|0|||
150144750|NCT03682705|541666877|FG004|Overall Study|Lost to Follow-up|3|||
150144751|NCT03682705|541666878|FG005|Overall Study|Lost to Follow-up|0|||
150144752|NCT01483937|541666879|FG000|Overall Study|Withdrawal by Subject|4|||
150144753|NCT01483937|541666880|FG001|Overall Study|Withdrawal by Subject|3|||
150144754|NCT02213328|541666881|FG000|Overall Study|Withdrawal by Subject|10|||
150144755|NCT02213328|541666881|FG000|Overall Study|Physician Decision|2|||
150257999|NCT01688830|542078087|FG001|Overall Study|Lost to Follow-up|0|||
150258000|NCT01688830|542078088|FG002|Overall Study|Lost to Follow-up|0|||
150258001|NCT01688830|542078089|FG003|Overall Study|Lost to Follow-up|0|||
150144756|NCT02213328|541666881|FG000|Overall Study|Lost to Follow-up|16|||
150258002|NCT01688830|542078090|FG004|Overall Study|Lost to Follow-up|0|||
150258003|NCT01688830|542078091|FG005|Overall Study|Lost to Follow-up|0|||
150258004|NCT01688830|542078092|FG006|Overall Study|Lost to Follow-up|0|||
150258005|NCT01688830|542078093|FG007|Overall Study|Lost to Follow-up|0|||
150258006|NCT01688830|542078094|FG008|Overall Study|Lost to Follow-up|0|||
150144757|NCT00265330|541666882|FG000|Overall Study|Adverse Event|41|||
150144758|NCT00265330|541666882|FG000|Overall Study|Lost to Follow-up|8|||
150258007|NCT01688830|542078095|FG009|Overall Study|Lost to Follow-up|0|||
150258008|NCT01688830|542078096|FG010|Overall Study|Lost to Follow-up|1|||
150258009|NCT01688830|542078097|FG011|Overall Study|Lost to Follow-up|0|||
150258010|NCT01688830|542078098|FG012|Overall Study|Lost to Follow-up|0|||
150258011|NCT01688830|542078099|FG013|Overall Study|Lost to Follow-up|0|||
150258012|NCT01688830|542078100|FG014|Overall Study|Lost to Follow-up|0|||
150258013|NCT01688830|542078101|FG015|Overall Study|Lost to Follow-up|0|||
150258014|NCT01688830|542078102|FG016|Overall Study|Lost to Follow-up|0|||
150258015|NCT01688830|542078103|FG017|Overall Study|Lost to Follow-up|0|||
150258016|NCT01688830|542078104|FG018|Overall Study|Lost to Follow-up|0|||
150144759|NCT00265330|541666882|FG000|Overall Study|Withdrawal by Subject|34|||
150144760|NCT00265330|541666882|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
150144761|NCT00265330|541666882|FG000|Overall Study|Lack of Efficacy|4|||
150144762|NCT00265330|541666882|FG000|Overall Study|Family Scheduling Conflicts|1|||
150258017|NCT01688830|542078105|FG019|Overall Study|Lost to Follow-up|0|||
150258018|NCT01688830|542078106|FG020|Overall Study|Lost to Follow-up|0|||
150258019|NCT01285609|542078107|FG000|Randomized|Progressive Disease|41|||
150144763|NCT00265330|541666882|FG000|Overall Study|Began Taking Formulary Geodon|1|||
150144764|NCT00265330|541666882|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
150144765|NCT00265330|541666882|FG000|Overall Study|Site Closed by Sponsor|1|||
150144766|NCT00265330|541666882|FG000|Overall Study|Principal Investigators Request|1|||
150144767|NCT00265330|541666882|FG000|Overall Study|Withdrew Consent|1|||
150144768|NCT00265330|541666882|FG000|Overall Study|Protocol Violation|1|||
150144769|NCT00990340|541666883|FG000|First 14-day Treatment|Not Compliant|2|||
150144770|NCT00990340|541666884|FG001|First 14-day Treatment|Not Compliant|1|||
150144771|NCT00990340|541666883|FG000|First 14-day Treatment|Lost to Follow-up|2|||
150144772|NCT00990340|541666884|FG001|First 14-day Treatment|Lost to Follow-up|1|||
150144773|NCT00990340|541666883|FG000|First 14-day Treatment|Protocol Violation|2|||
150144774|NCT00990340|541666884|FG001|First 14-day Treatment|Protocol Violation|2|||
150144775|NCT04615182|541666885|FG000|Overall Study|Re-transplanted|2|||
150144776|NCT04615182|541666885|FG000|Overall Study|Protocol Violation|6|||
150144777|NCT04615182|541666885|FG000|Overall Study|Death|6|||
150144778|NCT04615182|541666885|FG000|Overall Study|Death and protocol violation|1|||
150144779|NCT00402337|541666886|FG000|Overall Study|Adverse Event|0|||
150144780|NCT00402337|541666887|FG001|Overall Study|Adverse Event|2|||
150144781|NCT00402337|541666888|FG002|Overall Study|Adverse Event|2|||
150144782|NCT00402337|541666889|FG003|Overall Study|Adverse Event|3|||
150144783|NCT00402337|541666890|FG004|Overall Study|Adverse Event|2|||
150144784|NCT00402337|541666886|FG000|Overall Study|Noncompliance|0|||
150144785|NCT00402337|541666887|FG001|Overall Study|Noncompliance|0|||
150144786|NCT00402337|541666888|FG002|Overall Study|Noncompliance|0|||
150144787|NCT00402337|541666889|FG003|Overall Study|Noncompliance|0|||
150144788|NCT00402337|541666890|FG004|Overall Study|Noncompliance|2|||
150144789|NCT00402337|541666886|FG000|Overall Study|Withdrawal by Subject|5|||
150144790|NCT00402337|541666887|FG001|Overall Study|Withdrawal by Subject|3|||
150144791|NCT00402337|541666888|FG002|Overall Study|Withdrawal by Subject|1|||
150144792|NCT00402337|541666889|FG003|Overall Study|Withdrawal by Subject|6|||
150144793|NCT00402337|541666890|FG004|Overall Study|Withdrawal by Subject|4|||
150144794|NCT00402337|541666886|FG000|Overall Study|Lost to Follow-up|0|||
150144795|NCT00402337|541666887|FG001|Overall Study|Lost to Follow-up|0|||
150144796|NCT00402337|541666888|FG002|Overall Study|Lost to Follow-up|1|||
150144797|NCT00402337|541666889|FG003|Overall Study|Lost to Follow-up|2|||
150144798|NCT00402337|541666890|FG004|Overall Study|Lost to Follow-up|0|||
150144799|NCT00402337|541666886|FG000|Overall Study|Physician Decision|0|||
150144800|NCT00402337|541666887|FG001|Overall Study|Physician Decision|0|||
150144801|NCT00402337|541666888|FG002|Overall Study|Physician Decision|0|||
150144802|NCT00402337|541666889|FG003|Overall Study|Physician Decision|1|||
150144803|NCT00402337|541666890|FG004|Overall Study|Physician Decision|0|||
150144804|NCT00402337|541666886|FG000|Overall Study|Other Reason|0|||
150144805|NCT00402337|541666887|FG001|Overall Study|Other Reason|1|||
150144806|NCT00402337|541666888|FG002|Overall Study|Other Reason|0|||
150258020|NCT01285609|542078108|FG001|Randomized|Progressive Disease|61|||
150258021|NCT01285609|542078107|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
150258022|NCT01285609|542078108|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
150258023|NCT01285609|542078107|FG000|Randomized|Study Drug Toxicity|13|||
150258024|NCT01285609|542078108|FG001|Randomized|Study Drug Toxicity|14|||
150258025|NCT01285609|542078107|FG000|Randomized|Death|5|||
150258026|NCT01285609|542078108|FG001|Randomized|Death|7|||
150258027|NCT01285609|542078107|FG000|Randomized|Withdrawal by Subject|8|||
150258028|NCT01285609|542078108|FG001|Randomized|Withdrawal by Subject|11|||
150258029|NCT01285609|542078107|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
150258030|NCT01285609|542078108|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
150258031|NCT01285609|542078107|FG000|Randomized|Undisclosed Reasons|1|||
150258032|NCT01285609|542078108|FG001|Randomized|Undisclosed Reasons|0|||
150258033|NCT01285609|542078107|FG000|Randomized|Randomized but not Treated|4|||
150144807|NCT00402337|541666889|FG003|Overall Study|Other Reason|0|||
150144808|NCT00402337|541666890|FG004|Overall Study|Other Reason|0|||
150144809|NCT03565068|541666891|FG000|Overall Study|Protocol Violation|0|||
150144810|NCT03565068|541666892|FG001|Overall Study|Protocol Violation|0|||
150258034|NCT01285609|542078108|FG001|Randomized|Randomized but not Treated|4|||
150258035|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
150258036|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
150258037|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
150144811|NCT03565068|541666893|FG002|Overall Study|Protocol Violation|0|||
150144812|NCT03565068|541666894|FG003|Overall Study|Protocol Violation|0|||
150144813|NCT03565068|541666895|FG004|Overall Study|Protocol Violation|1|||
150144814|NCT03565068|541666896|FG005|Overall Study|Protocol Violation|0|||
150258038|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
150258039|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
150258040|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
150258041|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
150258042|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
150258043|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Death|11|||
150258044|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Death|3|||
150258045|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
150258046|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
150258047|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Not Reported|0|||
150258048|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Not Reported|2|||
150258049|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
150258050|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
150258051|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
150258052|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
150258053|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
150258054|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
150258055|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
150258056|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
150258057|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
150258058|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
150258059|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
150258060|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
150258061|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
150258062|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
150258063|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
150258064|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
150258065|NCT01285609|542078107|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
150258066|NCT01285609|542078108|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
150258067|NCT01285609|542078107|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
150258068|NCT01285609|542078108|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
150258069|NCT02502799|542080139|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
150258070|NCT02502799|542080140|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
150258071|NCT02502799|542080141|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
150258072|NCT02502799|542080142|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
150258073|NCT02502799|542080139|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
150144815|NCT03565068|541666897|FG006|Overall Study|Protocol Violation|0|||
150144816|NCT03565068|541666898|FG007|Overall Study|Protocol Violation|1|||
150144817|NCT03565068|541666899|FG008|Overall Study|Protocol Violation|0|||
150144818|NCT03565068|541666891|FG000|Overall Study|Sponsor decision|0|||
150144819|NCT03565068|541666892|FG001|Overall Study|Sponsor decision|0|||
150144820|NCT03565068|541666893|FG002|Overall Study|Sponsor decision|0|||
150144821|NCT03565068|541666894|FG003|Overall Study|Sponsor decision|0|||
150144822|NCT03565068|541666895|FG004|Overall Study|Sponsor decision|1|||
150144823|NCT03565068|541666896|FG005|Overall Study|Sponsor decision|1|||
150144824|NCT03565068|541666897|FG006|Overall Study|Sponsor decision|0|||
150144825|NCT03565068|541666898|FG007|Overall Study|Sponsor decision|0|||
150144826|NCT03565068|541666899|FG008|Overall Study|Sponsor decision|0|||
150144827|NCT03565068|541666891|FG000|Overall Study|Withdrawal by Subject|0|||
150144828|NCT03565068|541666892|FG001|Overall Study|Withdrawal by Subject|0|||
150144829|NCT03565068|541666893|FG002|Overall Study|Withdrawal by Subject|1|||
150144830|NCT03565068|541666894|FG003|Overall Study|Withdrawal by Subject|0|||
150144831|NCT03565068|541666895|FG004|Overall Study|Withdrawal by Subject|2|||
150144832|NCT03565068|541666896|FG005|Overall Study|Withdrawal by Subject|0|||
150144833|NCT03565068|541666897|FG006|Overall Study|Withdrawal by Subject|1|||
150144834|NCT03565068|541666898|FG007|Overall Study|Withdrawal by Subject|5|||
150144835|NCT03565068|541666899|FG008|Overall Study|Withdrawal by Subject|1|||
150144836|NCT03565068|541666891|FG000|Overall Study|Physician Decision|0|||
150144837|NCT03565068|541666892|FG001|Overall Study|Physician Decision|0|||
150144838|NCT03565068|541666893|FG002|Overall Study|Physician Decision|0|||
150144839|NCT03565068|541666894|FG003|Overall Study|Physician Decision|0|||
150144840|NCT03565068|541666895|FG004|Overall Study|Physician Decision|0|||
150144841|NCT03565068|541666896|FG005|Overall Study|Physician Decision|0|||
150144842|NCT03565068|541666897|FG006|Overall Study|Physician Decision|0|||
150144843|NCT03565068|541666898|FG007|Overall Study|Physician Decision|1|||
150144844|NCT03565068|541666899|FG008|Overall Study|Physician Decision|0|||
150258074|NCT02502799|542080140|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
150258075|NCT02502799|542080141|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
150258076|NCT02502799|542080142|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
150144845|NCT03565068|541666891|FG000|Overall Study|Lost to Follow-up|0|||
150144846|NCT03565068|541666892|FG001|Overall Study|Lost to Follow-up|0|||
150144847|NCT03565068|541666893|FG002|Overall Study|Lost to Follow-up|0|||
150144848|NCT03565068|541666894|FG003|Overall Study|Lost to Follow-up|0|||
150144849|NCT03565068|541666895|FG004|Overall Study|Lost to Follow-up|0|||
150144850|NCT03565068|541666896|FG005|Overall Study|Lost to Follow-up|0|||
150144851|NCT03565068|541666897|FG006|Overall Study|Lost to Follow-up|0|||
150144852|NCT03565068|541666898|FG007|Overall Study|Lost to Follow-up|1|||
150144853|NCT03565068|541666899|FG008|Overall Study|Lost to Follow-up|0|||
150144854|NCT05778526|541666900|FG000|Overall Study|Lost to Follow-up|0|||
150144855|NCT05778526|541666901|FG001|Overall Study|Lost to Follow-up|1|||
150144856|NCT05778526|541666902|FG002|Overall Study|Lost to Follow-up|3|||
150144857|NCT05778526|541666900|FG000|Overall Study|Protocol Violation|0|||
150144858|NCT05778526|541666901|FG001|Overall Study|Protocol Violation|0|||
150144859|NCT05778526|541666902|FG002|Overall Study|Protocol Violation|8|||
150144860|NCT01436201|541666903|FG000|Overall Study|Adverse Event|2|||
150144861|NCT01436201|541666903|FG000|Overall Study|Withdrawal by Subject|1|||
150144862|NCT01436201|541666903|FG000|Overall Study|Protocol Violation|1|||
150144863|NCT00263328|541666904|FG000|Overall Study|Death|0|||
150144864|NCT00263328|541666905|FG001|Overall Study|Death|0|||
150144865|NCT00263328|541666906|FG002|Overall Study|Death|1|||
150144866|NCT00263328|541666904|FG000|Overall Study|Lost to Follow-up|1|||
150144867|NCT00263328|541666905|FG001|Overall Study|Lost to Follow-up|1|||
150144868|NCT00263328|541666906|FG002|Overall Study|Lost to Follow-up|0|||
150144869|NCT00263328|541666904|FG000|Overall Study|Withdrawal by Subject|3|||
150144870|NCT00263328|541666905|FG001|Overall Study|Withdrawal by Subject|0|||
150144871|NCT00263328|541666906|FG002|Overall Study|Withdrawal by Subject|1|||
150144872|NCT00263328|541666904|FG000|Overall Study|Other|3|||
150144873|NCT00263328|541666905|FG001|Overall Study|Other|0|||
150144874|NCT00263328|541666906|FG002|Overall Study|Other|1|||
150144875|NCT00263328|541666904|FG000|Overall Study|Adverse Event|1|||
150144876|NCT00263328|541666905|FG001|Overall Study|Adverse Event|1|||
150144877|NCT00263328|541666906|FG002|Overall Study|Adverse Event|4|||
150144878|NCT02613221|541666911|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
150144879|NCT02613221|541666911|FG000|Overall Study|Adverse Event|2|||
150144880|NCT02613221|541666911|FG000|Overall Study|Voluntary Discontinuation|1|||
150144881|NCT02613221|541666911|FG000|Overall Study|Delayed Treatment|1|||
150144882|NCT02613221|541666911|FG000|Overall Study|Enrolled but Not Treated|1|||
150144883|NCT01301274|541666912|FG000|Overall Study|Physician Decision|2|||
150144884|NCT01301274|541666913|FG001|Overall Study|Physician Decision|1|||
150144885|NCT01893827|541666914|FG000|Overall Study|Lost to Follow-up|19|||
150144886|NCT01893827|541666915|FG001|Overall Study|Lost to Follow-up|26|||
150144887|NCT02917941|541666916|FG000|Treatment Period|Adverse Event|11|||
150144888|NCT02917941|541666916|FG000|Treatment Period|Progressive Disease|11|||
150144889|NCT02917941|541666916|FG000|Treatment Period|Reason not Specified|2|||
150144890|NCT02917941|541666916|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
150144891|NCT02917941|541666916|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
150144892|NCT00399763|541666917|FG000|Overall Study|Lost to Follow-up|2|||
150144893|NCT00399763|541666918|FG001|Overall Study|Lost to Follow-up|3|||
150144894|NCT00445679|541666931|FG000|Overall Study|Adverse Event|22|||
150144895|NCT00445679|541666932|FG001|Overall Study|Adverse Event|12|||
150144896|NCT00445679|541666933|FG002|Overall Study|Adverse Event|30|||
150144897|NCT00445679|541666934|FG003|Overall Study|Adverse Event|19|||
150144898|NCT00445679|541666931|FG000|Overall Study|Failed to return|1|||
150144899|NCT00445679|541666932|FG001|Overall Study|Failed to return|3|||
150144900|NCT00445679|541666933|FG002|Overall Study|Failed to return|2|||
150144901|NCT00445679|541666934|FG003|Overall Study|Failed to return|2|||
150144902|NCT00445679|541666931|FG000|Overall Study|Physician Decision|0|||
150144903|NCT00445679|541666932|FG001|Overall Study|Physician Decision|0|||
150144904|NCT00445679|541666933|FG002|Overall Study|Physician Decision|1|||
150144905|NCT00445679|541666934|FG003|Overall Study|Physician Decision|0|||
150144906|NCT00445679|541666931|FG000|Overall Study|Lost to Follow-up|10|||
150144907|NCT00445679|541666932|FG001|Overall Study|Lost to Follow-up|6|||
150144908|NCT00445679|541666933|FG002|Overall Study|Lost to Follow-up|6|||
150144909|NCT00445679|541666934|FG003|Overall Study|Lost to Follow-up|5|||
150144910|NCT00445679|541666931|FG000|Overall Study|Compliance|3|||
150144911|NCT00445679|541666932|FG001|Overall Study|Compliance|2|||
150144912|NCT00445679|541666933|FG002|Overall Study|Compliance|1|||
150144913|NCT00445679|541666934|FG003|Overall Study|Compliance|2|||
150144914|NCT00445679|541666931|FG000|Overall Study|Withdrawal of Informed Consent|0|||
150144915|NCT00445679|541666932|FG001|Overall Study|Withdrawal of Informed Consent|0|||
150144916|NCT00445679|541666933|FG002|Overall Study|Withdrawal of Informed Consent|1|||
150144917|NCT00445679|541666934|FG003|Overall Study|Withdrawal of Informed Consent|0|||
150144918|NCT00445679|541666931|FG000|Overall Study|Protocol Violation|2|||
150144919|NCT00445679|541666932|FG001|Overall Study|Protocol Violation|3|||
150144920|NCT00445679|541666933|FG002|Overall Study|Protocol Violation|3|||
150144921|NCT00445679|541666934|FG003|Overall Study|Protocol Violation|1|||
150144922|NCT00445679|541666931|FG000|Overall Study|Withdrawal by Subject|8|||
150144923|NCT00445679|541666932|FG001|Overall Study|Withdrawal by Subject|14|||
150144924|NCT00445679|541666933|FG002|Overall Study|Withdrawal by Subject|20|||
150144925|NCT00445679|541666934|FG003|Overall Study|Withdrawal by Subject|18|||
150144926|NCT00445679|541666931|FG000|Overall Study|Lack of Efficacy|2|||
150144927|NCT00445679|541666932|FG001|Overall Study|Lack of Efficacy|6|||
150144928|NCT00445679|541666933|FG002|Overall Study|Lack of Efficacy|2|||
150144929|NCT00445679|541666934|FG003|Overall Study|Lack of Efficacy|0|||
150144930|NCT01353222|541666938|FG000|Overall Study|Death|30|||
150144931|NCT01353222|541666939|FG001|Overall Study|Death|30|||
150144932|NCT01353222|541666938|FG000|Overall Study|Withdrawal by Subject|8|||
150144933|NCT01353222|541666939|FG001|Overall Study|Withdrawal by Subject|5|||
150144934|NCT01353222|541666938|FG000|Overall Study|Study Terminated|31|||
150144935|NCT01353222|541666939|FG001|Overall Study|Study Terminated|37|||
150144936|NCT01353222|541666938|FG000|Overall Study|Site closed research department|1|||
150144937|NCT01353222|541666939|FG001|Overall Study|Site closed research department|0|||
150144938|NCT01654601|541666940|FG000|1st Administration|Withdrawal by Subject|2|||
150144939|NCT01654601|541666941|FG001|1st Administration|Withdrawal by Subject|0|||
150144940|NCT01654601|541666940|FG000|1st Administration|Protocol Violation|0|||
150144941|NCT01654601|541666941|FG001|1st Administration|Protocol Violation|2|||
150144942|NCT01654601|541666940|FG000|2nd Administration|Adverse Event|1|||
150144943|NCT01654601|541666941|FG001|2nd Administration|Adverse Event|0|||
150144944|NCT01654601|541666940|FG000|2nd Administration|Protocol Violation|0|||
150144945|NCT01654601|541666941|FG001|2nd Administration|Protocol Violation|1|||
150144946|NCT02636270|541666942|FG000|Overall Study|Adverse Event|1|||
150144947|NCT02636270|541666943|FG001|Overall Study|Adverse Event|0|||
150144948|NCT02636270|541666944|FG002|Overall Study|Adverse Event|0|||
150144949|NCT02636270|541666942|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
150144950|NCT02636270|541666943|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
150144951|NCT02636270|541666944|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
150144952|NCT01119898|541666945|FG000|Overall Study|Adverse Event|4|||
150144953|NCT01119898|541666946|FG001|Overall Study|Adverse Event|5|||
150144954|NCT01119898|541666945|FG000|Overall Study|Withdrawal by Subject|1|||
150144955|NCT01119898|541666946|FG001|Overall Study|Withdrawal by Subject|4|||
150144956|NCT01119898|541666945|FG000|Overall Study|Lack of Efficacy|0|||
150144957|NCT01119898|541666946|FG001|Overall Study|Lack of Efficacy|2|||
150144958|NCT01119898|541666945|FG000|Overall Study|Protocol Violation|1|||
150144959|NCT01119898|541666946|FG001|Overall Study|Protocol Violation|1|||
150144960|NCT01119898|541666945|FG000|Overall Study|Medical procedure|1|||
150144961|NCT01119898|541666946|FG001|Overall Study|Medical procedure|0|||
150144962|NCT01119898|541666945|FG000|Overall Study|Randomized in error did not participate|1|||
150144963|NCT01119898|541666946|FG001|Overall Study|Randomized in error did not participate|0|||
150144964|NCT01833143|541666947|FG000|Overall Study|Not Treated|1|||
150144965|NCT00909428|541666948|FG000|Overall Study|Lost to Follow-up|13|||
150144966|NCT00909428|541666949|FG001|Overall Study|Lost to Follow-up|10|||
150144967|NCT00909428|541666950|FG002|Overall Study|Lost to Follow-up|9|||
150144968|NCT03021668|541666951|FG000|Overall Study|Physician Decision|0|||
150144969|NCT03021668|541666952|FG001|Overall Study|Physician Decision|1|||
150144970|NCT02217280|541666953|FG000|Overall Study|Withdrawal by Subject|2|||
150144971|NCT02217280|541666953|FG000|Overall Study|Post-consent sceen fail|2|||
150144972|NCT01933880|541666954|FG000|Overall Study|Withdrawal by Subject|5|||
150144973|NCT01933880|541666955|FG001|Overall Study|Withdrawal by Subject|0|||
150144974|NCT01933880|541666954|FG000|Overall Study|Lack of Efficacy|1|||
150144975|NCT01933880|541666955|FG001|Overall Study|Lack of Efficacy|0|||
150144976|NCT01933880|541666954|FG000|Overall Study|Concomitant medication Interference|0|||
150144977|NCT01933880|541666955|FG001|Overall Study|Concomitant medication Interference|1|||
150144978|NCT01933880|541666954|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
150144979|NCT01933880|541666955|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
150144980|NCT01933880|541666954|FG000|Overall Study|Other|4|||
150144981|NCT01933880|541666955|FG001|Overall Study|Other|0|||
150144982|NCT01933880|541666954|FG000|Overall Study|Protocol Violation|1|||
150144983|NCT01933880|541666955|FG001|Overall Study|Protocol Violation|0|||
150144984|NCT00510458|541666956|FG000|Overall Study|5 year not evaluable/missed|21|||
150144985|NCT00510458|541666956|FG000|Overall Study|Death|1|||
150144986|NCT00510458|541666956|FG000|Overall Study|Terminated|14|||
150144987|NCT00510458|541666956|FG000|Overall Study|Lost to Follow-up|6|||
150144988|NCT00510458|541666956|FG000|Overall Study|Withdrawal by Subject|3|||
150144989|NCT00510458|541666956|FG000|Overall Study|Revision|2|||
150144990|NCT02569710|541666957|FG000|Overall Study|Adverse Event|1|||
150144991|NCT02569710|541666958|FG001|Overall Study|Adverse Event|0|||
150144992|NCT02569710|541666959|FG002|Overall Study|Adverse Event|0|||
150144993|NCT02569710|541666960|FG003|Overall Study|Adverse Event|0|||
150144994|NCT02569710|541666961|FG004|Overall Study|Adverse Event|0|||
150144995|NCT02569710|541666962|FG005|Overall Study|Adverse Event|0|||
150144996|NCT02569710|541666963|FG006|Overall Study|Adverse Event|0|||
150144997|NCT02569710|541666964|FG007|Overall Study|Adverse Event|0|||
150144998|NCT02569710|541666965|FG008|Overall Study|Adverse Event|0|||
150144999|NCT02569710|541666966|FG009|Overall Study|Adverse Event|0|||
150145000|NCT02569710|541666957|FG000|Overall Study|Lost to Follow-up|0|||
150145001|NCT02569710|541666958|FG001|Overall Study|Lost to Follow-up|0|||
150145002|NCT02569710|541666959|FG002|Overall Study|Lost to Follow-up|0|||
150145003|NCT02569710|541666960|FG003|Overall Study|Lost to Follow-up|0|||
150145004|NCT02569710|541666961|FG004|Overall Study|Lost to Follow-up|0|||
150145005|NCT02569710|541666962|FG005|Overall Study|Lost to Follow-up|0|||
150145006|NCT02569710|541666963|FG006|Overall Study|Lost to Follow-up|1|||
150145007|NCT02569710|541666964|FG007|Overall Study|Lost to Follow-up|0|||
150145008|NCT02569710|541666965|FG008|Overall Study|Lost to Follow-up|1|||
150145009|NCT02569710|541666966|FG009|Overall Study|Lost to Follow-up|0|||
150145010|NCT02569710|541666957|FG000|Overall Study|Virologic failure|0|||
150145011|NCT02569710|541666958|FG001|Overall Study|Virologic failure|0|||
150145012|NCT02569710|541666959|FG002|Overall Study|Virologic failure|0|||
150145013|NCT02569710|541666960|FG003|Overall Study|Virologic failure|0|||
150145014|NCT02569710|541666961|FG004|Overall Study|Virologic failure|1|||
150258077|NCT02502799|542080139|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
150258078|NCT02502799|542080140|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
150258079|NCT02502799|542080141|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
150258080|NCT02502799|542080142|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
150258081|NCT02502799|542080139|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
150258082|NCT02502799|542080140|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
150258083|NCT02502799|542080141|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
150258084|NCT02502799|542080142|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
150258085|NCT02502799|542080139|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
150258086|NCT02502799|542080140|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
150258087|NCT02502799|542080141|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
150258088|NCT02502799|542080142|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
150258089|NCT01290029|542080149|FG000|Overall Study|Other|2|||
150258090|NCT02924428|542080150|FG000|Overall Study|Adverse Event|1|||
150258091|NCT02924428|542080151|FG001|Overall Study|Adverse Event|0|||
150258092|NCT02924428|542080150|FG000|Overall Study|Physician Decision|1|||
150258093|NCT02924428|542080151|FG001|Overall Study|Physician Decision|0|||
150258094|NCT02924428|542080150|FG000|Overall Study|Lost to Follow-up|2|||
150258095|NCT02924428|542080151|FG001|Overall Study|Lost to Follow-up|4|||
150258096|NCT02924428|542080150|FG000|Overall Study|Pregnancy|0|||
150258097|NCT02924428|542080151|FG001|Overall Study|Pregnancy|1|||
150258098|NCT00512317|542080154|FG000|Overall Study|Insufficient clinical response|36|||
150258099|NCT00512317|542080154|FG000|Overall Study|Withdrawal by Subject|23|||
150258100|NCT00512317|542080154|FG000|Overall Study|Sponsor closure of study|21|||
150258101|NCT00512317|542080154|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
150258102|NCT00512317|542080154|FG000|Overall Study|Adverse Event|13|||
150258103|NCT00512317|542080154|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
150258104|NCT00512317|542080154|FG000|Overall Study|Lost to Follow-up|2|||
150258105|NCT00512317|542080154|FG000|Overall Study|Other|2|||
150258106|NCT01491672|542080155|FG000|Overall Study|Lost to Follow-up|0|||
150258107|NCT01491672|542080156|FG001|Overall Study|Lost to Follow-up|4|||
150258108|NCT01491672|542080157|FG002|Overall Study|Lost to Follow-up|1|||
150258109|NCT01491672|542080155|FG000|Overall Study|Withdrawal by Subject|6|||
150258110|NCT01491672|542080156|FG001|Overall Study|Withdrawal by Subject|7|||
150258111|NCT01491672|542080157|FG002|Overall Study|Withdrawal by Subject|0|||
150258112|NCT01491672|542080155|FG000|Overall Study|Adverse Event|8|||
150258113|NCT01491672|542080156|FG001|Overall Study|Adverse Event|10|||
150258114|NCT01491672|542080157|FG002|Overall Study|Adverse Event|4|||
150258115|NCT01491672|542080155|FG000|Overall Study|Disease progression|42|||
150258116|NCT01491672|542080156|FG001|Overall Study|Disease progression|34|||
150258117|NCT01491672|542080157|FG002|Overall Study|Disease progression|6|||
150258118|NCT01491672|542080155|FG000|Overall Study|Protocol deviation|0|||
150258119|NCT01491672|542080156|FG001|Overall Study|Protocol deviation|1|||
150258120|NCT01491672|542080157|FG002|Overall Study|Protocol deviation|0|||
150258121|NCT01491672|542080155|FG000|Overall Study|Death|0|||
150258122|NCT01491672|542080156|FG001|Overall Study|Death|4|||
150258123|NCT01491672|542080157|FG002|Overall Study|Death|0|||
150258124|NCT03064035|542080160|FG000|Overall Study|Did not receive allocated intervention|4|||
150258125|NCT03064035|542080161|FG001|Overall Study|Did not receive allocated intervention|2|||
150258126|NCT03064035|542080160|FG000|Overall Study|Lost to Follow-up|1|||
150145015|NCT02569710|541666962|FG005|Overall Study|Virologic failure|0|||
150145016|NCT02569710|541666963|FG006|Overall Study|Virologic failure|1|||
150145017|NCT02569710|541666964|FG007|Overall Study|Virologic failure|0|||
150258127|NCT03064035|542080161|FG001|Overall Study|Lost to Follow-up|1|||
150258128|NCT01143038|542080162|FG000|Overall Study|Withdrawal by Subject|4|||
150145018|NCT02569710|541666965|FG008|Overall Study|Virologic failure|0|||
150145019|NCT02569710|541666966|FG009|Overall Study|Virologic failure|0|||
150258129|NCT01143038|542080162|FG000|Overall Study|Requirement for alternative therapy|5|||
150258130|NCT01143038|542080162|FG000|Overall Study|Adverse Event|3|||
150258131|NCT01143038|542080162|FG000|Overall Study|Lost to Follow-up|2|||
150258132|NCT01143038|542080162|FG000|Overall Study|Protocol Deviation|1|||
150258133|NCT01143038|542080162|FG000|Overall Study|Death|1|||
150258134|NCT02336178|542080163|FG000|Overall Study|Lost to Follow-up|1|||
150258135|NCT02336178|542080163|FG000|Overall Study|Protocol Violation|1|||
150258136|NCT02336178|542080163|FG000|Overall Study|Withdrawal by Subject|1|||
150145020|NCT02569710|541666957|FG000|Overall Study|Withdrawal by Subject|0|||
150258137|NCT02336178|542080163|FG000|Overall Study|Other|1|||
150258138|NCT00618982|542080164|FG000|Overall Study|Adverse Event|23|||
150258139|NCT00618982|542080164|FG000|Overall Study|Withdrawal by Subject|1|||
150258140|NCT00618982|542080164|FG000|Overall Study|Protocol Violation|1|||
150258141|NCT00618982|542080164|FG000|Overall Study|ongoing, still treated with study med.|25|||
150258142|NCT03310268|542080165|FG000|Overall Study|(Not specified)|1|||
150258143|NCT03310268|542080166|FG001|Overall Study|(Not specified)|5|||
150258144|NCT03310268|542080167|FG002|Overall Study|(Not specified)|0|||
150258145|NCT00706433|542080173|FG000|Overall Study|Lost to Follow-up|3|||
150258146|NCT00706433|542080174|FG001|Overall Study|Lost to Follow-up|1|||
150258147|NCT00706433|542080175|FG002|Overall Study|Lost to Follow-up|6|||
150258148|NCT00706433|542080176|FG003|Overall Study|Lost to Follow-up|0|||
150258149|NCT00706433|542080173|FG000|Overall Study|Withdrawal by Subject|1|||
150258150|NCT00706433|542080174|FG001|Overall Study|Withdrawal by Subject|2|||
150258151|NCT00706433|542080175|FG002|Overall Study|Withdrawal by Subject|3|||
150258152|NCT00706433|542080176|FG003|Overall Study|Withdrawal by Subject|1|||
150258153|NCT00706433|542080173|FG000|Overall Study|Adverse Event|0|||
150258154|NCT00706433|542080174|FG001|Overall Study|Adverse Event|0|||
150258155|NCT00706433|542080175|FG002|Overall Study|Adverse Event|1|||
150258156|NCT00706433|542080176|FG003|Overall Study|Adverse Event|0|||
150258157|NCT00706433|542080173|FG000|Overall Study|Protocol Violation|1|||
150258158|NCT00706433|542080174|FG001|Overall Study|Protocol Violation|0|||
150258159|NCT00706433|542080175|FG002|Overall Study|Protocol Violation|0|||
150258160|NCT00706433|542080176|FG003|Overall Study|Protocol Violation|0|||
150258161|NCT00706433|542080173|FG000|Overall Study|new job|0|||
150258162|NCT00706433|542080174|FG001|Overall Study|new job|0|||
150258163|NCT00706433|542080175|FG002|Overall Study|new job|0|||
150258164|NCT00706433|542080176|FG003|Overall Study|new job|1|||
150258165|NCT01236365|542080178|FG000|Overall Study|Lost to Follow-up|0|||
150258166|NCT01236365|542080179|FG001|Overall Study|Lost to Follow-up|2|||
150258167|NCT01236365|542080178|FG000|Overall Study|Moved Out of State|1|||
150258168|NCT01236365|542080179|FG001|Overall Study|Moved Out of State|0|||
150258169|NCT01236365|542080178|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
150258170|NCT01236365|542080179|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
150258171|NCT04289051|542080180|FG000|Overall Study|Lost to Follow-up|0|||
150258172|NCT04289051|542080181|FG001|Overall Study|Lost to Follow-up|0|||
150258173|NCT04289051|542080182|FG002|Overall Study|Lost to Follow-up|2|||
150258174|NCT01183234|542080183|FG000|First Intervention|Adverse Event|1|||
150258175|NCT01183234|542080184|FG001|First Intervention|Adverse Event|0|||
149918698|NCT00433017|540835163|FG000|Overall Study|Subject no longer requires study drug|1|||
150177767|NCT01839331|541788194|FG002|Overall Study|Protocol Violation|4|||
150177768|NCT01839331|541788195|FG003|Overall Study|Protocol Violation|3|||
150177769|NCT03752151|541788196|FG000|Overall Study|Withdrawal by Subject|1|||
150177770|NCT03752151|541788196|FG000|Overall Study|Protocol Violation|1|||
150177771|NCT03074331|541788198|FG000|Overall Study|Enrolled but Not Treated|1|||
150177772|NCT03074331|541788198|FG000|Overall Study|Lost to Follow-up|5|||
150177773|NCT03074331|541788198|FG000|Overall Study|Withdrew Consent|1|||
150177774|NCT03451721|541788199|FG000|Overall Study|Death|1|||
150177775|NCT00350792|541788200|FG000|Overall Study|Adverse Event|11|||
150177776|NCT00350792|541788200|FG000|Overall Study|Death from Study Disease|1|||
150177777|NCT00350792|541788200|FG000|Overall Study|Death from Study Drug Toxicity|1|||
150177778|NCT00350792|541788200|FG000|Overall Study|Death Not Study Drug Related|2|||
150177779|NCT00350792|541788200|FG000|Overall Study|Protocol Violation|1|||
150177780|NCT00350792|541788200|FG000|Overall Study|Withdrawal by Subject|4|||
150177781|NCT00350792|541788200|FG000|Overall Study|Physician Decision|2|||
150177782|NCT00350792|541788200|FG000|Overall Study|Lack of Efficacy|11|||
150177783|NCT01546753|541788201|FG000|Overall Study|anxiety|1|||
150177784|NCT01546753|541788202|FG001|Overall Study|anxiety|1|||
150177785|NCT01546753|541788201|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
150177786|NCT01546753|541788202|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
150177787|NCT00960141|541788203|FG000|Overall Study|Adverse Event|4|||
150177788|NCT00960141|541788204|FG001|Overall Study|Adverse Event|8|||
150177789|NCT00960141|541788205|FG002|Overall Study|Adverse Event|2|||
150177790|NCT00960141|541788203|FG000|Overall Study|Lack of Efficacy|3|||
150177791|NCT00960141|541788204|FG001|Overall Study|Lack of Efficacy|4|||
150177792|NCT00960141|541788205|FG002|Overall Study|Lack of Efficacy|2|||
150177793|NCT00960141|541788203|FG000|Overall Study|Lost to Follow-up|1|||
150177794|NCT00960141|541788204|FG001|Overall Study|Lost to Follow-up|0|||
150177795|NCT00960141|541788205|FG002|Overall Study|Lost to Follow-up|0|||
150177796|NCT00960141|541788203|FG000|Overall Study|Protocol Violation|1|||
150177797|NCT00960141|541788204|FG001|Overall Study|Protocol Violation|3|||
150177798|NCT00960141|541788205|FG002|Overall Study|Protocol Violation|2|||
150177799|NCT00960141|541788203|FG000|Overall Study|Withdrawal by Subject|1|||
150177800|NCT00960141|541788204|FG001|Overall Study|Withdrawal by Subject|2|||
150177801|NCT00960141|541788205|FG002|Overall Study|Withdrawal by Subject|1|||
150177802|NCT03036813|541788207|FG000|Overall Study|Adverse Event|6|||
150177803|NCT03036813|541788208|FG001|Overall Study|Adverse Event|11|||
150177804|NCT03036813|541788209|FG002|Overall Study|Adverse Event|6|||
150258176|NCT00822172|542080185|FG000|Overall Study|Adverse Event|10|||
150258177|NCT00822172|542080186|FG001|Overall Study|Adverse Event|12|||
150258178|NCT00822172|542080185|FG000|Overall Study|Death|1|||
150258179|NCT00822172|542080186|FG001|Overall Study|Death|0|||
150258180|NCT00822172|542080185|FG000|Overall Study|Lost to Follow-up|3|||
150258181|NCT00822172|542080186|FG001|Overall Study|Lost to Follow-up|1|||
150258182|NCT00822172|542080185|FG000|Overall Study|Withdrawal by Subject|1|||
150258183|NCT00822172|542080186|FG001|Overall Study|Withdrawal by Subject|4|||
150258184|NCT00822172|542080185|FG000|Overall Study|site closed|0|||
150258185|NCT00822172|542080186|FG001|Overall Study|site closed|1|||
150258186|NCT00822172|542080185|FG000|Overall Study|Other|0|||
150258187|NCT00822172|542080186|FG001|Overall Study|Other|1|||
150258188|NCT00545051|542080187|FG000|Overall Study|Adverse Event|7|||
150258189|NCT00545051|542080188|FG001|Overall Study|Adverse Event|3|||
150258190|NCT00545051|542080187|FG000|Overall Study|Death|1|||
150258191|NCT00545051|542080188|FG001|Overall Study|Death|0|||
150258192|NCT00545051|542080187|FG000|Overall Study|Violation of inclusion/exclusion|0|||
150258193|NCT00545051|542080188|FG001|Overall Study|Violation of inclusion/exclusion|2|||
150258194|NCT00545051|542080187|FG000|Overall Study|Protocol Violation|1|||
150258195|NCT00545051|542080188|FG001|Overall Study|Protocol Violation|0|||
150258196|NCT00545051|542080187|FG000|Overall Study|Withdrawal by Subject|0|||
150258197|NCT00545051|542080188|FG001|Overall Study|Withdrawal by Subject|1|||
150258198|NCT00545051|542080187|FG000|Overall Study|Administrative reasons|0|||
150258199|NCT00545051|542080188|FG001|Overall Study|Administrative reasons|1|||
150258200|NCT01375114|542080189|FG000|Overall Study|Lost to Follow-up|1|||
150258201|NCT01375114|542080190|FG001|Overall Study|Lost to Follow-up|0|||
150258202|NCT01375114|542080191|FG002|Overall Study|Lost to Follow-up|1|||
150258203|NCT01375114|542080189|FG000|Overall Study|Disease Progression|3|||
150258204|NCT01375114|542080190|FG001|Overall Study|Disease Progression|2|||
150258205|NCT01375114|542080191|FG002|Overall Study|Disease Progression|2|||
150258206|NCT01375114|542080189|FG000|Overall Study|Patient Changed Mind|0|||
150258207|NCT01375114|542080190|FG001|Overall Study|Patient Changed Mind|0|||
150258208|NCT01375114|542080191|FG002|Overall Study|Patient Changed Mind|2|||
150258209|NCT01375114|542080189|FG000|Overall Study|Pruritus|0|||
150258210|NCT01375114|542080190|FG001|Overall Study|Pruritus|0|||
150258211|NCT01375114|542080191|FG002|Overall Study|Pruritus|1|||
150258212|NCT01375114|542080189|FG000|Overall Study|Restlessness|0|||
150258213|NCT01375114|542080190|FG001|Overall Study|Restlessness|0|||
150258214|NCT01375114|542080191|FG002|Overall Study|Restlessness|1|||
150258215|NCT01375114|542080189|FG000|Overall Study|Diarrhea|0|||
150258216|NCT01375114|542080190|FG001|Overall Study|Diarrhea|0|||
150258217|NCT01375114|542080191|FG002|Overall Study|Diarrhea|1|||
150258218|NCT01375114|542080189|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
150258219|NCT01375114|542080190|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
150258220|NCT01375114|542080191|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
150258221|NCT01375114|542080189|FG000|Overall Study|Nausea|0|||
150258222|NCT01375114|542080190|FG001|Overall Study|Nausea|1|||
150258223|NCT01375114|542080191|FG002|Overall Study|Nausea|0|||
150258224|NCT01375114|542080189|FG000|Overall Study|Increased AST/ALT|0|||
150258225|NCT01375114|542080190|FG001|Overall Study|Increased AST/ALT|1|||
150258226|NCT01375114|542080191|FG002|Overall Study|Increased AST/ALT|0|||
150258227|NCT01375114|542080189|FG000|Overall Study|Vaginal Hemorrhage|0|||
150258228|NCT01375114|542080190|FG001|Overall Study|Vaginal Hemorrhage|1|||
150258229|NCT01375114|542080191|FG002|Overall Study|Vaginal Hemorrhage|0|||
150258230|NCT01375114|542080189|FG000|Overall Study|Family problem|0|||
150258231|NCT01375114|542080190|FG001|Overall Study|Family problem|1|||
150258232|NCT01375114|542080191|FG002|Overall Study|Family problem|0|||
150258233|NCT01375114|542080189|FG000|Overall Study|Protocol Violation|2|||
150258234|NCT01375114|542080190|FG001|Overall Study|Protocol Violation|0|||
150258235|NCT01375114|542080191|FG002|Overall Study|Protocol Violation|0|||
150258236|NCT01888900|542080192|FG000|Overall Study|failed treatment|0|||
150258237|NCT01888900|542080193|FG001|Overall Study|failed treatment|2|||
150258238|NCT03271021|542080194|FG000|Overall Study|Adverse Event|3|||
150258239|NCT03271021|542080195|FG001|Overall Study|Adverse Event|2|||
150258240|NCT03271021|542080194|FG000|Overall Study|Withdrawal by Subject|36|||
150258241|NCT03271021|542080195|FG001|Overall Study|Withdrawal by Subject|53|||
150258242|NCT03271021|542080194|FG000|Overall Study|Lost to Follow-up|34|||
150258243|NCT03271021|542080195|FG001|Overall Study|Lost to Follow-up|39|||
150258244|NCT03271021|542080194|FG000|Overall Study|Protocol Violation|6|||
150258245|NCT03271021|542080195|FG001|Overall Study|Protocol Violation|4|||
150258246|NCT03271021|542080194|FG000|Overall Study|Abnormal Lab Results|1|||
150258247|NCT03271021|542080195|FG001|Overall Study|Abnormal Lab Results|0|||
150258248|NCT03271021|542080194|FG000|Overall Study|Miscellaneous|9|||
150258249|NCT03271021|542080195|FG001|Overall Study|Miscellaneous|8|||
150258250|NCT03606668|542080198|FG000|Overall Study|Screen Failure|1|||
150258251|NCT03606668|542080198|FG000|Overall Study|Lost to Follow-up|1|||
150258252|NCT00495586|542080202|FG000|Overall Study|Withdrawal by Subject|4|||
150258253|NCT00495586|542080203|FG001|Overall Study|Withdrawal by Subject|4|||
150258254|NCT03038438|542080204|FG000|Overall Study|Death|3|||
150258255|NCT03038438|542080204|FG000|Overall Study|Lost to Follow-up|8|||
150258256|NCT03038438|542080204|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
150258257|NCT03038438|542080204|FG000|Overall Study|Withdrawal by Subject|5|||
150258258|NCT03038438|542080204|FG000|Overall Study|No 36-Month Follow-Up|18|||
150258259|NCT03215810|542080205|FG000|Overall Study|Still responding to nivolumab|1|||
150258260|NCT03215810|542080205|FG000|Overall Study|Insufficient TIL growth|1|||
150258261|NCT03215810|542080205|FG000|Overall Study|Decline in performance status|1|||
150258262|NCT03215810|542080205|FG000|Overall Study|Withdrawal by Subject|1|||
150258263|NCT02038543|542080208|FG000|Overall Study|Screen Failure|0|||
150258264|NCT02038543|542080209|FG001|Overall Study|Screen Failure|0|||
150258265|NCT02038543|542080210|FG002|Overall Study|Screen Failure|0|||
150258266|NCT02038543|542080211|FG003|Overall Study|Screen Failure|1|||
150258267|NCT02038543|542080208|FG000|Overall Study|Withdrawal by Subject|0|||
150258268|NCT02038543|542080209|FG001|Overall Study|Withdrawal by Subject|0|||
150258269|NCT02038543|542080210|FG002|Overall Study|Withdrawal by Subject|0|||
150258270|NCT02038543|542080211|FG003|Overall Study|Withdrawal by Subject|1|||
150258271|NCT03406260|542080212|FG000|Period 1|Adverse Event|0|||
150258272|NCT03406260|542080213|FG001|Period 1|Adverse Event|0|||
150258273|NCT03406260|542080214|FG002|Period 1|Adverse Event|0|||
150258274|NCT03406260|542080215|FG003|Period 1|Adverse Event|0|||
150258275|NCT03406260|542080216|FG004|Period 1|Adverse Event|1|||
150258276|NCT03406260|542080217|FG005|Period 1|Adverse Event|0|||
150258277|NCT02647866|542080218|FG000|Overall Study|Adverse Event|0|||
150258278|NCT02647866|542080219|FG001|Overall Study|Adverse Event|0|||
150258279|NCT02647866|542080220|FG002|Overall Study|Adverse Event|2|||
150258280|NCT02647866|542080221|FG003|Overall Study|Adverse Event|2|||
150258281|NCT02647866|542080222|FG004|Overall Study|Adverse Event|1|||
150258282|NCT02647866|542080218|FG000|Overall Study|Disease Worsening|3|||
150258283|NCT02647866|542080219|FG001|Overall Study|Disease Worsening|1|||
150258284|NCT02647866|542080220|FG002|Overall Study|Disease Worsening|0|||
150258285|NCT02647866|542080221|FG003|Overall Study|Disease Worsening|0|||
150258286|NCT02647866|542080222|FG004|Overall Study|Disease Worsening|1|||
150258287|NCT02647866|542080218|FG000|Overall Study|Withdrawal by Subject|1|||
150258288|NCT02647866|542080219|FG001|Overall Study|Withdrawal by Subject|1|||
150258289|NCT02647866|542080220|FG002|Overall Study|Withdrawal by Subject|2|||
150258290|NCT02647866|542080221|FG003|Overall Study|Withdrawal by Subject|4|||
150258291|NCT02647866|542080222|FG004|Overall Study|Withdrawal by Subject|4|||
150258292|NCT02647866|542080218|FG000|Overall Study|Physician Decision|0|||
150258293|NCT02647866|542080219|FG001|Overall Study|Physician Decision|1|||
150258294|NCT02647866|542080220|FG002|Overall Study|Physician Decision|1|||
150258295|NCT02647866|542080221|FG003|Overall Study|Physician Decision|0|||
150258296|NCT02647866|542080222|FG004|Overall Study|Physician Decision|2|||
150258297|NCT02647866|542080218|FG000|Overall Study|Death|0|||
150258298|NCT02647866|542080219|FG001|Overall Study|Death|1|||
150258299|NCT02647866|542080220|FG002|Overall Study|Death|0|||
150258300|NCT02647866|542080221|FG003|Overall Study|Death|0|||
150258301|NCT02647866|542080222|FG004|Overall Study|Death|0|||
150258302|NCT02647866|542080218|FG000|Overall Study|Subject moved to different country|1|||
150258303|NCT02647866|542080219|FG001|Overall Study|Subject moved to different country|0|||
150258304|NCT02647866|542080220|FG002|Overall Study|Subject moved to different country|0|||
150258305|NCT02647866|542080221|FG003|Overall Study|Subject moved to different country|0|||
150258306|NCT02647866|542080222|FG004|Overall Study|Subject moved to different country|0|||
150258307|NCT01029652|542080226|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
150258308|NCT01029652|542080227|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
150258309|NCT01029652|542080226|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
150258310|NCT01029652|542080227|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
150258311|NCT01029652|542080226|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
150258312|NCT01029652|542080227|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
150258313|NCT01029652|542080226|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
150258314|NCT01029652|542080227|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
150258315|NCT01029652|542080226|FG000|Core Study (0-12 Weeks)|Death|0|||
150258316|NCT01029652|542080227|FG001|Core Study (0-12 Weeks)|Death|1|||
150258317|NCT01029652|542080226|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
150258318|NCT01029652|542080227|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
149802748|NCT00423137|540406004|FG000|Overall Study|Adverse Event Study disease worse|1|||
149802749|NCT00423137|540406005|FG001|Overall Study|Adverse Event Study disease worse|0|||
149802750|NCT00423137|540406006|FG002|Overall Study|Adverse Event Study disease worse|3|||
149802751|NCT00423137|540406007|FG003|Overall Study|Adverse Event Study disease worse|1|||
149802752|NCT00423137|540406004|FG000|Overall Study|Adverse Event Other|0|||
149802753|NCT00423137|540406005|FG001|Overall Study|Adverse Event Other|0|||
149802754|NCT00423137|540406006|FG002|Overall Study|Adverse Event Other|2|||
149802755|NCT00423137|540406007|FG003|Overall Study|Adverse Event Other|0|||
149802756|NCT01243762|540406008|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149802757|NCT01243762|540406009|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
150258319|NCT01029652|542080226|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
150258320|NCT01029652|542080227|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
150258321|NCT01029652|542080226|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
150258322|NCT01029652|542080227|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
150258323|NCT01029652|542080226|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
150258324|NCT01029652|542080227|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
150258325|NCT01029652|542080226|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
150258326|NCT01029652|542080227|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
150258327|NCT01029652|542080226|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
150258328|NCT01029652|542080227|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
150258329|NCT01029652|542080226|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
150258330|NCT01029652|542080227|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
150258331|NCT02313233|542080231|FG000|Overall Study|Withdrawal by Subject|1|||
150258332|NCT02313233|542080232|FG001|Overall Study|Withdrawal by Subject|2|||
150258333|NCT02313233|542080231|FG000|Overall Study|Administrative reason|1|||
150258334|NCT02313233|542080232|FG001|Overall Study|Administrative reason|1|||
150258335|NCT02095951|542080233|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
150258336|NCT02095951|542080234|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
150258337|NCT03618823|542080235|FG000|Overall Study|Lost to Follow-up|63|||
150258338|NCT03618823|542080236|FG001|Overall Study|Lost to Follow-up|61|||
150258339|NCT02399254|542080237|FG000|Overall Study|Physician Decision|2|||
150258340|NCT02930226|542080238|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
150258341|NCT02930226|542080239|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
150258342|NCT02930226|542080240|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
150258343|NCT02930226|542080241|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
150258344|NCT02930226|542080242|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
150258345|NCT02930226|542080243|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
150258346|NCT00577473|542080246|FG000|Overall Study|Protocol Violation|1|||
150258347|NCT00577473|542080247|FG001|Overall Study|Protocol Violation|4|||
150258348|NCT00577473|542080246|FG000|Overall Study|Adverse Event|8|||
150258349|NCT00577473|542080247|FG001|Overall Study|Adverse Event|5|||
150258350|NCT00577473|542080246|FG000|Overall Study|Withdrawal by Subject|2|||
150258351|NCT00577473|542080247|FG001|Overall Study|Withdrawal by Subject|6|||
150258352|NCT00577473|542080246|FG000|Overall Study|Physician Decision|2|||
150258353|NCT00577473|542080247|FG001|Overall Study|Physician Decision|2|||
150258354|NCT00577473|542080246|FG000|Overall Study|Lack of Efficacy|8|||
150258355|NCT00577473|542080247|FG001|Overall Study|Lack of Efficacy|7|||
150258356|NCT02595073|542080250|FG000|Overall Study|Progressive Disease|0|||
150258357|NCT02595073|542080251|FG001|Overall Study|Progressive Disease|1|||
150258358|NCT02595073|542080250|FG000|Overall Study|Protocol Violation|2|||
150258359|NCT02595073|542080251|FG001|Overall Study|Protocol Violation|0|||
150258360|NCT01990560|542080252|FG000|Overall Study|Withdrawal by Subject|1|||
150258361|NCT01801735|542080258|FG000|Overall Study|Adverse Event|79|||
150258362|NCT01801735|542080258|FG000|Overall Study|Lack of Efficacy|28|||
150258363|NCT01801735|542080258|FG000|Overall Study|Withdrawal by Subject|27|||
150258364|NCT01801735|542080258|FG000|Overall Study|Protocol Violation|25|||
150258365|NCT01801735|542080258|FG000|Overall Study|Lost to Follow-up|15|||
150258366|NCT01801735|542080258|FG000|Overall Study|Non-compliance with Trial Drug|13|||
150258367|NCT01801735|542080258|FG000|Overall Study|Physician Decision|3|||
150258368|NCT01801735|542080258|FG000|Overall Study|Death|1|||
150258369|NCT01801735|542080258|FG000|Overall Study|Other, including site closure|19|||
150258370|NCT02084056|542080259|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
150258371|NCT02084056|542080260|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
150258372|NCT02084056|542080261|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
150258373|NCT02084056|542080262|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
150258374|NCT02084056|542080259|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
150258375|NCT02084056|542080260|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
150258376|NCT02084056|542080261|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
150258377|NCT02084056|542080262|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
150258378|NCT01293487|542080264|FG000|Overall Study|Lost to Follow-up|0|||
150258379|NCT01293487|542080265|FG001|Overall Study|Lost to Follow-up|0|||
150258380|NCT01293487|542080266|FG002|Overall Study|Lost to Follow-up|0|||
150258381|NCT01293487|542080267|FG003|Overall Study|Lost to Follow-up|1|||
150258382|NCT01293487|542080268|FG004|Overall Study|Lost to Follow-up|0|||
150258383|NCT01293487|542080269|FG005|Overall Study|Lost to Follow-up|0|||
150258384|NCT01293487|542080270|FG006|Overall Study|Lost to Follow-up|0|||
150258385|NCT01293487|542080271|FG007|Overall Study|Lost to Follow-up|0|||
150258386|NCT01293487|542080264|FG000|Overall Study|Withdrawal by Subject|0|||
150258387|NCT01293487|542080265|FG001|Overall Study|Withdrawal by Subject|0|||
150258388|NCT01293487|542080266|FG002|Overall Study|Withdrawal by Subject|0|||
150258389|NCT01293487|542080267|FG003|Overall Study|Withdrawal by Subject|0|||
150258390|NCT01293487|542080268|FG004|Overall Study|Withdrawal by Subject|0|||
150258391|NCT01293487|542080269|FG005|Overall Study|Withdrawal by Subject|0|||
150258392|NCT01293487|542080270|FG006|Overall Study|Withdrawal by Subject|0|||
150258393|NCT01293487|542080271|FG007|Overall Study|Withdrawal by Subject|2|||
150258394|NCT01153958|542080273|FG000|Overall Study|Study Terminated|36|||
150258395|NCT01153958|542080274|FG001|Overall Study|Study Terminated|32|||
150258396|NCT01226095|542080277|FG000|Overall Study|Poor compliance|1|||
150258397|NCT00911768|542080283|FG000|Overall Study|Protocol Violation|5|||
150258398|NCT00911768|542080284|FG001|Overall Study|Protocol Violation|4|||
150258399|NCT00911768|542080283|FG000|Overall Study|Withdrawal by Subject|1|||
150258400|NCT00911768|542080284|FG001|Overall Study|Withdrawal by Subject|0|||
150258401|NCT03616977|542080288|FG000|Period 1|Physician Decision|0|||
150258402|NCT03616977|542080289|FG001|Period 1|Physician Decision|1|||
150258403|NCT03616977|542080288|FG000|Period 3|Adverse Event|1|||
150258404|NCT03616977|542080289|FG001|Period 3|Adverse Event|1|||
150258405|NCT00515853|542080290|FG000|Overall Study|Lost to Follow-up|9|||
150258406|NCT00515853|542080291|FG001|Overall Study|Lost to Follow-up|13|||
150258407|NCT00515853|542080290|FG000|Overall Study|Withdrawal by Subject|6|||
150258408|NCT00515853|542080291|FG001|Overall Study|Withdrawal by Subject|4|||
150258409|NCT02631577|542080297|FG000|Overall Study|Death|1|||
150258410|NCT02631577|542080298|FG001|Overall Study|Death|7|||
150258411|NCT02631577|542080297|FG000|Overall Study|Withdrawal by Subject|0|||
150258412|NCT02631577|542080298|FG001|Overall Study|Withdrawal by Subject|3|||
150258413|NCT00979134|542080299|FG000|Overall Study|Disease progression|18|||
150258414|NCT00979134|542080300|FG001|Overall Study|Disease progression|2|||
150258415|NCT00979134|542080301|FG002|Overall Study|Disease progression|5|||
150258416|NCT00979134|542080299|FG000|Overall Study|Adverse Event|0|||
150258417|NCT00979134|542080300|FG001|Overall Study|Adverse Event|0|||
150258418|NCT00979134|542080301|FG002|Overall Study|Adverse Event|2|||
150258419|NCT00979134|542080299|FG000|Overall Study|Withdrawal by Subject|1|||
150258420|NCT00979134|542080300|FG001|Overall Study|Withdrawal by Subject|1|||
150258421|NCT00979134|542080301|FG002|Overall Study|Withdrawal by Subject|2|||
150258422|NCT00979134|542080299|FG000|Overall Study|Lost to Follow-up|2|||
150258423|NCT00979134|542080300|FG001|Overall Study|Lost to Follow-up|2|||
150258424|NCT00979134|542080301|FG002|Overall Study|Lost to Follow-up|0|||
150258425|NCT00979134|542080299|FG000|Overall Study|Death|4|||
150258426|NCT00979134|542080300|FG001|Overall Study|Death|0|||
150258427|NCT00979134|542080301|FG002|Overall Study|Death|26|||
150258428|NCT00979134|542080299|FG000|Overall Study|Other|8|||
150258429|NCT00979134|542080300|FG001|Overall Study|Other|1|||
150258430|NCT00979134|542080301|FG002|Overall Study|Other|5|||
150258431|NCT02359877|542082306|FG000|Overall Study|Withdrawal by Subject|1|||
150258432|NCT02359877|542082307|FG001|Overall Study|Withdrawal by Subject|0|||
150258433|NCT02359877|542082308|FG002|Overall Study|Withdrawal by Subject|0|||
150258434|NCT02359877|542082309|FG003|Overall Study|Withdrawal by Subject|2|||
150258435|NCT02359877|542082306|FG000|Overall Study|Adverse Event|0|||
150258436|NCT02359877|542082307|FG001|Overall Study|Adverse Event|0|||
150258437|NCT02359877|542082308|FG002|Overall Study|Adverse Event|0|||
150258438|NCT02359877|542082309|FG003|Overall Study|Adverse Event|1|||
150258439|NCT00189488|542082311|FG000|Overall Study|Ineligibility determined|1|||
150258440|NCT00189488|542082312|FG001|Overall Study|Ineligibility determined|0|||
150258441|NCT00189488|542082311|FG000|Overall Study|Protocol deviation|2|||
150258442|NCT00189488|542082312|FG001|Overall Study|Protocol deviation|1|||
150258443|NCT00189488|542082311|FG000|Overall Study|Adverse Event|2|||
150258444|NCT00189488|542082312|FG001|Overall Study|Adverse Event|1|||
150258445|NCT00189488|542082311|FG000|Overall Study|Withdrawal by Subject|2|||
150258446|NCT00189488|542082312|FG001|Overall Study|Withdrawal by Subject|6|||
150258447|NCT00189488|542082311|FG000|Overall Study|Disease progression|2|||
150258448|NCT00189488|542082312|FG001|Overall Study|Disease progression|4|||
150258449|NCT00189488|542082311|FG000|Overall Study|Administrative Decision|0|||
150258450|NCT00189488|542082312|FG001|Overall Study|Administrative Decision|2|||
150258451|NCT00189488|542082311|FG000|Overall Study|Death|5|||
150258452|NCT00189488|542082312|FG001|Overall Study|Death|8|||
150258453|NCT00189488|542082311|FG000|Overall Study|Other|1|||
150258454|NCT00189488|542082312|FG001|Overall Study|Other|0|||
150258455|NCT02349425|542082313|FG000|Period 1|Adverse Event|1|||
150258456|NCT02349425|542082314|FG001|Period 1|Adverse Event|1|||
150258457|NCT02349425|542082315|FG002|Period 1|Adverse Event|0|||
150258458|NCT02349425|542082316|FG003|Period 1|Adverse Event|0|||
150258459|NCT02349425|542082313|FG000|Period 2|Adverse Event|0|||
150258460|NCT02349425|542082314|FG001|Period 2|Adverse Event|1|||
150258461|NCT02349425|542082315|FG002|Period 2|Adverse Event|1|||
150258462|NCT02349425|542082316|FG003|Period 2|Adverse Event|0|||
150258463|NCT02186223|542082317|FG000|Overall Study|Not eligible for device placement|6|||
150258464|NCT02186223|542082317|FG000|Overall Study|Unable to obtain femoral access|3|||
150258465|NCT02186223|542082317|FG000|Overall Study|Death|3|||
150258466|NCT02186223|542082317|FG000|Overall Study|Device in place less than 48 hours|9|||
150258467|NCT00252733|542082318|FG000|Overall Study|Withdrawal by Subject|73|||
150258468|NCT00252733|542082319|FG001|Overall Study|Withdrawal by Subject|67|||
150258469|NCT00252733|542082318|FG000|Overall Study|Death|7|||
150258470|NCT00252733|542082319|FG001|Overall Study|Death|5|||
150258471|NCT00252733|542082318|FG000|Overall Study|Lost to Follow-up|12|||
150258472|NCT00252733|542082319|FG001|Overall Study|Lost to Follow-up|6|||
150258473|NCT00252733|542082318|FG000|Overall Study|Multiple Reasons|14|||
150258474|NCT00252733|542082319|FG001|Overall Study|Multiple Reasons|14|||
150258475|NCT00717067|542082320|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
150258476|NCT00717067|542082321|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
150258477|NCT00717067|542082322|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
150258478|NCT00717067|542082323|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
150258479|NCT00717067|542082324|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
150258480|NCT02090959|542082325|FG000|Overall Study|Withdrawal by Subject|10|||
150258481|NCT02090959|542082325|FG000|Overall Study|Adverse Event|1|||
150258482|NCT02090959|542082325|FG000|Overall Study|Investigator decision|2|||
150258483|NCT02090959|542082325|FG000|Overall Study|Study termination|6|||
150258484|NCT02090959|542082325|FG000|Overall Study|Enrolled but not treated|1|||
150258485|NCT02090959|542082325|FG000|Overall Study|Transfer for compassionate use medicine|4|||
150258486|NCT02090959|542082325|FG000|Overall Study|Move to medical need program|3|||
150258487|NCT02090959|542082325|FG000|Overall Study|Entered in to other study|34|||
150258488|NCT02090959|542082325|FG000|Overall Study|Switched to commercial supply|88|||
150258489|NCT02090959|542082325|FG000|Overall Study|Other than specified|2|||
150258490|NCT02808143|542082328|FG000|Maintenance Phase|Disease recurrence|1|||
150258491|NCT02808143|542082329|FG001|Maintenance Phase|Disease recurrence|3|||
150258492|NCT02808143|542082328|FG000|Maintenance Phase|Disease progression|1|||
150258493|NCT02808143|542082329|FG001|Maintenance Phase|Disease progression|2|||
150258494|NCT02808143|542082328|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
150258495|NCT02808143|542082329|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
150258496|NCT02808143|542082328|FG000|Survival Follow-Up|Disease recurrence|0|||
150258497|NCT02808143|542082329|FG001|Survival Follow-Up|Disease recurrence|2|||
150258498|NCT02808143|542082328|FG000|Survival Follow-Up|Adverse Event|0|||
150258499|NCT02808143|542082329|FG001|Survival Follow-Up|Adverse Event|1|||
150258500|NCT02808143|542082328|FG000|Survival Follow-Up|Death|1|||
150258501|NCT02808143|542082329|FG001|Survival Follow-Up|Death|0|||
150258502|NCT00522873|542082330|FG000|Overall Study|Adverse Event|41|||
150258503|NCT00522873|542082331|FG001|Overall Study|Adverse Event|26|||
150258504|NCT00522873|542082330|FG000|Overall Study|Withdrawal by Subject|20|||
150258505|NCT00522873|542082331|FG001|Overall Study|Withdrawal by Subject|9|||
150258506|NCT00522873|542082330|FG000|Overall Study|Protocol Violation|14|||
150258507|NCT00522873|542082331|FG001|Overall Study|Protocol Violation|4|||
150258508|NCT00522873|542082330|FG000|Overall Study|Lost to Follow-up|11|||
150258509|NCT00522873|542082331|FG001|Overall Study|Lost to Follow-up|3|||
150258510|NCT00522873|542082330|FG000|Overall Study|Personal Reasons|8|||
150258511|NCT00522873|542082331|FG001|Overall Study|Personal Reasons|1|||
150258512|NCT00522873|542082330|FG000|Overall Study|Medication Errors|1|||
150258513|NCT00522873|542082331|FG001|Overall Study|Medication Errors|1|||
150258514|NCT00522873|542082330|FG000|Overall Study|Never Received Medication|1|||
150258515|NCT00522873|542082331|FG001|Overall Study|Never Received Medication|0|||
150258516|NCT00657020|542082332|FG000|PERIOD 1|Adverse Event|0|||
150258517|NCT00657020|542082333|FG001|PERIOD 1|Adverse Event|1|||
150258518|NCT02029846|542082336|FG000|Overall Study|n=1 each arm|1|||
150258519|NCT02029846|542082337|FG001|Overall Study|n=1 each arm|1|||
150258520|NCT02966301|542082338|FG000|Overall Study|Death|2|||
150258521|NCT02966301|542082338|FG000|Overall Study|Withdrawal by Subject|1|||
150258522|NCT00370331|542082344|FG000|Overall Study|Adverse Event|4|||
150258523|NCT00370331|542082345|FG001|Overall Study|Adverse Event|13|||
150258524|NCT00370331|542082344|FG000|Overall Study|Withdrawal by Subject|2|||
150258525|NCT00370331|542082345|FG001|Overall Study|Withdrawal by Subject|4|||
150258526|NCT00370331|542082344|FG000|Overall Study|Lost to Follow-up|0|||
150258527|NCT00370331|542082345|FG001|Overall Study|Lost to Follow-up|3|||
150258528|NCT00370331|542082344|FG000|Overall Study|Lack of Efficacy|0|||
150258529|NCT00370331|542082345|FG001|Overall Study|Lack of Efficacy|1|||
150258530|NCT00370331|542082344|FG000|Overall Study|Non-compliance|0|||
150258531|NCT00370331|542082345|FG001|Overall Study|Non-compliance|1|||
150258532|NCT00370331|542082344|FG000|Overall Study|Protocol Violation|1|||
150258533|NCT00370331|542082345|FG001|Overall Study|Protocol Violation|1|||
150258534|NCT01874431|542082346|FG000|Overall Study|Physician Decision|0|||
150258535|NCT01874431|542082347|FG001|Overall Study|Physician Decision|0|||
150258536|NCT01874431|542082348|FG002|Overall Study|Physician Decision|1|||
150258537|NCT01874431|542082349|FG003|Overall Study|Physician Decision|0|||
150258538|NCT01874431|542082350|FG004|Overall Study|Physician Decision|0|||
150258539|NCT01874431|542082351|FG005|Overall Study|Physician Decision|0|||
150258540|NCT01874431|542082352|FG006|Overall Study|Physician Decision|0|||
150258541|NCT01874431|542082353|FG007|Overall Study|Physician Decision|0|||
150258542|NCT01874431|542082346|FG000|Overall Study|Adverse Event|5|||
150258543|NCT01874431|542082347|FG001|Overall Study|Adverse Event|4|||
150258544|NCT01874431|542082348|FG002|Overall Study|Adverse Event|6|||
150258545|NCT01874431|542082349|FG003|Overall Study|Adverse Event|5|||
150258546|NCT01874431|542082350|FG004|Overall Study|Adverse Event|2|||
150258547|NCT01874431|542082351|FG005|Overall Study|Adverse Event|8|||
150258548|NCT01874431|542082352|FG006|Overall Study|Adverse Event|2|||
150258549|NCT01874431|542082353|FG007|Overall Study|Adverse Event|3|||
150258550|NCT01874431|542082346|FG000|Overall Study|Protocol Violation|1|||
150258551|NCT01874431|542082347|FG001|Overall Study|Protocol Violation|1|||
150258552|NCT01874431|542082348|FG002|Overall Study|Protocol Violation|1|||
150258553|NCT01874431|542082349|FG003|Overall Study|Protocol Violation|0|||
150258554|NCT01874431|542082350|FG004|Overall Study|Protocol Violation|3|||
150258555|NCT01874431|542082351|FG005|Overall Study|Protocol Violation|2|||
150258556|NCT01874431|542082352|FG006|Overall Study|Protocol Violation|1|||
150258557|NCT01874431|542082353|FG007|Overall Study|Protocol Violation|1|||
150258558|NCT01874431|542082346|FG000|Overall Study|Non-compliance|0|||
150258559|NCT01874431|542082347|FG001|Overall Study|Non-compliance|0|||
150258560|NCT01874431|542082348|FG002|Overall Study|Non-compliance|0|||
150258561|NCT01874431|542082349|FG003|Overall Study|Non-compliance|0|||
150258562|NCT01874431|542082350|FG004|Overall Study|Non-compliance|1|||
150258563|NCT01874431|542082351|FG005|Overall Study|Non-compliance|0|||
150258564|NCT01874431|542082352|FG006|Overall Study|Non-compliance|1|||
150258565|NCT01874431|542082353|FG007|Overall Study|Non-compliance|0|||
150258566|NCT01874431|542082346|FG000|Overall Study|Logistical difficulties|0|||
150258567|NCT01874431|542082347|FG001|Overall Study|Logistical difficulties|0|||
150258568|NCT01874431|542082348|FG002|Overall Study|Logistical difficulties|0|||
150258569|NCT01874431|542082349|FG003|Overall Study|Logistical difficulties|0|||
150258570|NCT01874431|542082350|FG004|Overall Study|Logistical difficulties|0|||
150258571|NCT01874431|542082351|FG005|Overall Study|Logistical difficulties|0|||
150258572|NCT01874431|542082352|FG006|Overall Study|Logistical difficulties|1|||
150258573|NCT01874431|542082353|FG007|Overall Study|Logistical difficulties|0|||
150258574|NCT01874431|542082346|FG000|Overall Study|Withdrawal by Subject|0|||
150258575|NCT01874431|542082347|FG001|Overall Study|Withdrawal by Subject|0|||
150258576|NCT01874431|542082348|FG002|Overall Study|Withdrawal by Subject|1|||
150258577|NCT01874431|542082349|FG003|Overall Study|Withdrawal by Subject|2|||
150258578|NCT01874431|542082350|FG004|Overall Study|Withdrawal by Subject|1|||
150258579|NCT01874431|542082351|FG005|Overall Study|Withdrawal by Subject|1|||
150258580|NCT01874431|542082352|FG006|Overall Study|Withdrawal by Subject|3|||
150258581|NCT01874431|542082353|FG007|Overall Study|Withdrawal by Subject|0|||
150258582|NCT01874431|542082346|FG000|Overall Study|Sponsor decision|0|||
150258583|NCT01874431|542082347|FG001|Overall Study|Sponsor decision|0|||
150258584|NCT01874431|542082348|FG002|Overall Study|Sponsor decision|0|||
150258585|NCT01874431|542082349|FG003|Overall Study|Sponsor decision|0|||
150258586|NCT01874431|542082350|FG004|Overall Study|Sponsor decision|1|||
150258587|NCT01874431|542082351|FG005|Overall Study|Sponsor decision|0|||
150258588|NCT01874431|542082352|FG006|Overall Study|Sponsor decision|0|||
150258589|NCT01874431|542082353|FG007|Overall Study|Sponsor decision|0|||
150258590|NCT01874431|542082346|FG000|Overall Study|Lost to Follow-up|0|||
150258591|NCT01874431|542082347|FG001|Overall Study|Lost to Follow-up|0|||
150258592|NCT01874431|542082348|FG002|Overall Study|Lost to Follow-up|1|||
150258593|NCT01874431|542082349|FG003|Overall Study|Lost to Follow-up|0|||
150258594|NCT01874431|542082350|FG004|Overall Study|Lost to Follow-up|0|||
150258595|NCT01874431|542082351|FG005|Overall Study|Lost to Follow-up|0|||
150258596|NCT01874431|542082352|FG006|Overall Study|Lost to Follow-up|0|||
150258597|NCT01874431|542082353|FG007|Overall Study|Lost to Follow-up|0|||
150258598|NCT02937454|542082356|FG000|Overall Study|Adverse Event|0|||
150258599|NCT02937454|542082357|FG001|Overall Study|Adverse Event|1|||
150258600|NCT02937454|542082356|FG000|Overall Study|Death|98|||
150258601|NCT02937454|542082357|FG001|Overall Study|Death|95|||
150258602|NCT02937454|542082356|FG000|Overall Study|Lost to Follow-up|1|||
150258603|NCT02937454|542082357|FG001|Overall Study|Lost to Follow-up|1|||
150258604|NCT02937454|542082356|FG000|Overall Study|Physician Decision|0|||
150258605|NCT02937454|542082357|FG001|Overall Study|Physician Decision|1|||
150258606|NCT02937454|542082356|FG000|Overall Study|Protocol Violation|6|||
150258607|NCT02937454|542082357|FG001|Overall Study|Protocol Violation|10|||
150258608|NCT02937454|542082356|FG000|Overall Study|Withdrawal by Subject|27|||
150258609|NCT02937454|542082357|FG001|Overall Study|Withdrawal by Subject|15|||
150258610|NCT02937454|542082356|FG000|Overall Study|Other|8|||
150258611|NCT02937454|542082357|FG001|Overall Study|Other|5|||
150258612|NCT01474434|542082359|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
150258613|NCT01474434|542082360|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
150258614|NCT01474434|542082361|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
150258615|NCT01474434|542082362|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
150258616|NCT01474434|542082359|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
150258617|NCT01474434|542082360|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
150258618|NCT01474434|542082361|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
150258619|NCT01474434|542082362|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
150258620|NCT01474434|542082359|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
150258621|NCT01474434|542082360|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
150258622|NCT01474434|542082361|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
150258623|NCT01474434|542082362|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
150258624|NCT00993668|542082366|FG000|Single-Blind Period|Adverse Event|1|||
150258625|NCT00993668|542082367|FG001|Single-Blind Period|Adverse Event|1|||
150258626|NCT00993668|542082366|FG000|Single-Blind Period|Lack of Efficacy|0|||
150258627|NCT00993668|542082367|FG001|Single-Blind Period|Lack of Efficacy|1|||
150258628|NCT00993668|542082366|FG000|Single-Blind Period|Lost to Follow-up|3|||
150258629|NCT00993668|542082367|FG001|Single-Blind Period|Lost to Follow-up|1|||
150258630|NCT00993668|542082366|FG000|Open-Label Period|Adverse Event|9|||
150258631|NCT00993668|542082367|FG001|Open-Label Period|Adverse Event|8|||
150258632|NCT00993668|542082366|FG000|Open-Label Period|Lack of Efficacy|4|||
150258633|NCT00993668|542082367|FG001|Open-Label Period|Lack of Efficacy|3|||
150258634|NCT00993668|542082366|FG000|Open-Label Period|Withdrawal by Subject|4|||
150258635|NCT00993668|542082367|FG001|Open-Label Period|Withdrawal by Subject|3|||
150258636|NCT00993668|542082366|FG000|Open-Label Period|Lost to Follow-up|6|||
150258637|NCT00993668|542082367|FG001|Open-Label Period|Lost to Follow-up|1|||
150258638|NCT02207569|542082368|FG000|1-Month|Death|6|||
150258639|NCT02207569|542082368|FG000|1-Month|Withdrawal by Subject|2|||
150258640|NCT02207569|542082368|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
150258641|NCT02207569|542082368|FG000|6-Month|Death|8|||
150258642|NCT02207569|542082368|FG000|6-Month|Withdrawal by Subject|2|||
150258643|NCT02207569|542082368|FG000|12-Month|Death|14|||
150258644|NCT02207569|542082368|FG000|12-Month|Withdrawal by Subject|2|||
150258645|NCT02207569|542082368|FG000|24-Month|Death|23|||
150258646|NCT02207569|542082368|FG000|24-Month|Withdrawal by Subject|3|||
150258647|NCT02207569|542082368|FG000|36-Month|Death|23|||
150258648|NCT02207569|542082368|FG000|36-Month|Withdrawal by Subject|4|||
150258649|NCT02207569|542082368|FG000|48-Month|Death|25|||
150258650|NCT02207569|542082368|FG000|48-Month|Withdrawal by Subject|2|||
150258651|NCT02207569|542082368|FG000|48-Month|Lost to Follow-up|4|||
150258652|NCT02207569|542082368|FG000|60-Month|Death|1|||
150258653|NCT02207569|542082368|FG000|60-Month|Lost to Follow-up|1|||
150258654|NCT02207569|542082368|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
150258655|NCT02207569|542082368|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
150258656|NCT01014143|542082370|FG000|Second Intervention|Lost to Follow-up|2|||
150258657|NCT01014143|542082371|FG001|Second Intervention|Lost to Follow-up|0|||
150258658|NCT01014143|542082372|FG002|Second Intervention|Lost to Follow-up|0|||
150258659|NCT00523640|542082375|FG000|Overall Study|Death|1|||
150258660|NCT00652327|542082376|FG000|Overall Study|Adverse Event|0|||
150258661|NCT00652327|542082377|FG001|Overall Study|Adverse Event|2|||
150258662|NCT00652327|542082376|FG000|Overall Study|Lost to Follow-up|0|||
150258663|NCT00652327|542082377|FG001|Overall Study|Lost to Follow-up|3|||
150258664|NCT01076647|542082378|FG000|Overall Study|Adverse Event|4|||
150258665|NCT01076647|542082379|FG001|Overall Study|Adverse Event|1|||
150258666|NCT01076647|542082378|FG000|Overall Study|Lack of Efficacy|0|||
150258667|NCT01076647|542082379|FG001|Overall Study|Lack of Efficacy|1|||
150258668|NCT01076647|542082378|FG000|Overall Study|Protocol Violation|7|||
150258669|NCT01076647|542082379|FG001|Overall Study|Protocol Violation|9|||
150258670|NCT01076647|542082378|FG000|Overall Study|Withdrawal criteria|2|||
150258671|NCT01076647|542082379|FG001|Overall Study|Withdrawal criteria|2|||
150258672|NCT01076647|542082378|FG000|Overall Study|Unclassified|12|||
150258673|NCT01076647|542082379|FG001|Overall Study|Unclassified|12|||
150258674|NCT02081417|542082385|FG000|Overall Study|Lost to Follow-up|26|||
150258675|NCT02081417|542082386|FG001|Overall Study|Lost to Follow-up|23|||
150258676|NCT02081417|542082385|FG000|Overall Study|Moved Away|1|||
150258677|NCT02081417|542082386|FG001|Overall Study|Moved Away|2|||
150258678|NCT02081417|542082385|FG000|Overall Study|Incarcerated|2|||
150258679|NCT02081417|542082386|FG001|Overall Study|Incarcerated|2|||
150258680|NCT02081417|542082385|FG000|Overall Study|Death|4|||
150258681|NCT02081417|542082386|FG001|Overall Study|Death|3|||
150258682|NCT02081417|542082385|FG000|Overall Study|Withdrawal by Subject|4|||
150258683|NCT02081417|542082386|FG001|Overall Study|Withdrawal by Subject|0|||
150258684|NCT02081417|542082385|FG000|Overall Study|Admitted to Residential Treatment|2|||
150258685|NCT02081417|542082386|FG001|Overall Study|Admitted to Residential Treatment|0|||
150258686|NCT02081417|542082385|FG000|Overall Study|Did not start treatment|17|||
150258687|NCT02081417|542082386|FG001|Overall Study|Did not start treatment|21|||
150258688|NCT01577745|542082388|FG000|Overall Study|Withdrawal by Subject|0|||
150258689|NCT01577745|542082389|FG001|Overall Study|Withdrawal by Subject|1|||
150258690|NCT01577745|542082390|FG002|Overall Study|Withdrawal by Subject|0|||
150258691|NCT01577745|542082391|FG003|Overall Study|Withdrawal by Subject|3|||
150258692|NCT01577745|542082392|FG004|Overall Study|Withdrawal by Subject|2|||
150258693|NCT01577745|542082393|FG005|Overall Study|Withdrawal by Subject|0|||
150258694|NCT01577745|542082388|FG000|Overall Study|Death|3|||
150258695|NCT01577745|542082389|FG001|Overall Study|Death|2|||
150258696|NCT01577745|542082390|FG002|Overall Study|Death|2|||
150258697|NCT01577745|542082391|FG003|Overall Study|Death|1|||
150258698|NCT01577745|542082392|FG004|Overall Study|Death|1|||
150258699|NCT01577745|542082393|FG005|Overall Study|Death|3|||
150258700|NCT01577745|542082388|FG000|Overall Study|Physician Decision|0|||
150258701|NCT01577745|542082389|FG001|Overall Study|Physician Decision|0|||
150258702|NCT01577745|542082390|FG002|Overall Study|Physician Decision|0|||
150258703|NCT01577745|542082391|FG003|Overall Study|Physician Decision|1|||
150258704|NCT01577745|542082392|FG004|Overall Study|Physician Decision|1|||
150258705|NCT01577745|542082393|FG005|Overall Study|Physician Decision|0|||
150258706|NCT01577745|542082388|FG000|Overall Study|Lost to Follow-up|0|||
150258707|NCT01577745|542082389|FG001|Overall Study|Lost to Follow-up|0|||
150258708|NCT01577745|542082390|FG002|Overall Study|Lost to Follow-up|0|||
150258709|NCT01577745|542082391|FG003|Overall Study|Lost to Follow-up|0|||
150258710|NCT01577745|542082392|FG004|Overall Study|Lost to Follow-up|0|||
150258711|NCT01577745|542082393|FG005|Overall Study|Lost to Follow-up|1|||
150258712|NCT01577745|542082388|FG000|Overall Study|Alternative Therapy|0|||
150258713|NCT01577745|542082389|FG001|Overall Study|Alternative Therapy|0|||
150258714|NCT01577745|542082390|FG002|Overall Study|Alternative Therapy|0|||
150258715|NCT01577745|542082391|FG003|Overall Study|Alternative Therapy|1|||
150258716|NCT01577745|542082392|FG004|Overall Study|Alternative Therapy|1|||
150258717|NCT01577745|542082393|FG005|Overall Study|Alternative Therapy|0|||
150258718|NCT00862719|542082397|FG000|Overall Study|Disease Progression|5|||
150258719|NCT00862719|542082398|FG001|Overall Study|Disease Progression|0|||
150258720|NCT00862719|542082399|FG002|Overall Study|Disease Progression|1|||
150258721|NCT00862719|542082400|FG003|Overall Study|Disease Progression|0|||
150258722|NCT00862719|542082397|FG000|Overall Study|Death|5|||
150258723|NCT00862719|542082398|FG001|Overall Study|Death|6|||
150258724|NCT00862719|542082399|FG002|Overall Study|Death|1|||
150258725|NCT00862719|542082400|FG003|Overall Study|Death|1|||
150258726|NCT00862719|542082397|FG000|Overall Study|Engraftment failure|0|||
150258727|NCT00862719|542082398|FG001|Overall Study|Engraftment failure|0|||
150258728|NCT00862719|542082399|FG002|Overall Study|Engraftment failure|1|||
150258729|NCT00862719|542082400|FG003|Overall Study|Engraftment failure|0|||
150258730|NCT00862719|542082397|FG000|Overall Study|Veno-Occlusive Disease|0|||
150258731|NCT00862719|542082398|FG001|Overall Study|Veno-Occlusive Disease|0|||
150258732|NCT00862719|542082399|FG002|Overall Study|Veno-Occlusive Disease|1|||
150258733|NCT00862719|542082400|FG003|Overall Study|Veno-Occlusive Disease|0|||
150258734|NCT01737827|542082401|FG000|Overall Study|Adverse Event|3|||
150258735|NCT01737827|542082402|FG001|Overall Study|Adverse Event|6|||
150258736|NCT01737827|542082403|FG002|Overall Study|Adverse Event|0|||
150258737|NCT01737827|542082401|FG000|Overall Study|Lost to Follow-up|0|||
150258738|NCT01737827|542082402|FG001|Overall Study|Lost to Follow-up|1|||
150258739|NCT01737827|542082403|FG002|Overall Study|Lost to Follow-up|0|||
150258740|NCT01737827|542082401|FG000|Overall Study|Physician Decision|0|||
150258741|NCT01737827|542082402|FG001|Overall Study|Physician Decision|2|||
150258742|NCT01737827|542082403|FG002|Overall Study|Physician Decision|0|||
150258743|NCT01737827|542082401|FG000|Overall Study|Progressive Disease|5|||
150258744|NCT01737827|542082402|FG001|Overall Study|Progressive Disease|16|||
150258745|NCT01737827|542082403|FG002|Overall Study|Progressive Disease|2|||
150258746|NCT01737827|542082401|FG000|Overall Study|Study Terminated by Sponsor|0|||
150258747|NCT01737827|542082402|FG001|Overall Study|Study Terminated by Sponsor|1|||
150258748|NCT01737827|542082403|FG002|Overall Study|Study Terminated by Sponsor|0|||
150258749|NCT01737827|542082401|FG000|Overall Study|Subject/Guardian Decision|0|||
150258750|NCT01737827|542082402|FG001|Overall Study|Subject/Guardian Decision|2|||
150258751|NCT01737827|542082403|FG002|Overall Study|Subject/Guardian Decision|0|||
150258752|NCT01451827|542082404|FG000|Overall Study|Adverse Event|2|||
150258753|NCT01451827|542082405|FG001|Overall Study|Adverse Event|0|||
150258754|NCT01451827|542082406|FG002|Overall Study|Adverse Event|1|||
150258755|NCT01451827|542082407|FG003|Overall Study|Adverse Event|1|||
150258756|NCT01451827|542082404|FG000|Overall Study|Protocol deviation|1|||
150258757|NCT01451827|542082405|FG001|Overall Study|Protocol deviation|0|||
150258758|NCT01451827|542082406|FG002|Overall Study|Protocol deviation|0|||
150258759|NCT01451827|542082407|FG003|Overall Study|Protocol deviation|0|||
150258760|NCT01451827|542082404|FG000|Overall Study|Lost to Follow-up|0|||
150258761|NCT01451827|542082405|FG001|Overall Study|Lost to Follow-up|3|||
150258762|NCT01451827|542082406|FG002|Overall Study|Lost to Follow-up|0|||
150258763|NCT01451827|542082407|FG003|Overall Study|Lost to Follow-up|2|||
150258764|NCT01451827|542082404|FG000|Overall Study|Participant met withdrawal criteria|0|||
150258765|NCT01451827|542082405|FG001|Overall Study|Participant met withdrawal criteria|2|||
150258766|NCT01451827|542082406|FG002|Overall Study|Participant met withdrawal criteria|0|||
150258767|NCT01451827|542082407|FG003|Overall Study|Participant met withdrawal criteria|0|||
150258768|NCT01451827|542082404|FG000|Overall Study|Withdrawal by Subject|0|||
150258769|NCT01451827|542082405|FG001|Overall Study|Withdrawal by Subject|0|||
150258770|NCT01451827|542082406|FG002|Overall Study|Withdrawal by Subject|1|||
150258771|NCT01451827|542082407|FG003|Overall Study|Withdrawal by Subject|1|||
150258772|NCT01034163|542082409|FG000|Overall Study|Treatment completed as per protocol|8|||
150258773|NCT01034163|542082410|FG001|Overall Study|Treatment completed as per protocol|7|||
150258774|NCT01034163|542082409|FG000|Overall Study|Withdrawal by Subject|8|||
150258775|NCT01034163|542082410|FG001|Overall Study|Withdrawal by Subject|2|||
150258776|NCT01034163|542082409|FG000|Overall Study|Protocol deviation|1|||
150258777|NCT01034163|542082410|FG001|Overall Study|Protocol deviation|0|||
150258778|NCT01034163|542082409|FG000|Overall Study|Disease progression|3|||
150258779|NCT01034163|542082410|FG001|Overall Study|Disease progression|4|||
150258780|NCT01034163|542082409|FG000|Overall Study|Adverse Event|6|||
150258781|NCT01034163|542082410|FG001|Overall Study|Adverse Event|0|||
150258782|NCT01034163|542082409|FG000|Overall Study|Administrative problems|0|||
150258783|NCT01034163|542082410|FG001|Overall Study|Administrative problems|1|||
150258784|NCT01034163|542082409|FG000|Overall Study|Abnormal laboratory value|1|||
150258785|NCT01034163|542082410|FG001|Overall Study|Abnormal laboratory value|0|||
150258786|NCT02424734|542082411|FG000|Overall Study|Treatment stopped to be discharged home|2|||
150258787|NCT02424734|542082412|FG001|Overall Study|Treatment stopped to be discharged home|2|||
150258788|NCT02424734|542082413|FG002|Overall Study|Treatment stopped to be discharged home|0|||
150258789|NCT00528645|542082414|FG000|Overall Study|Adverse Event|3|||
150258790|NCT01445301|542082415|FG000|Overall Study|Adverse Event|15|||
150258791|NCT01445301|542082416|FG001|Overall Study|Adverse Event|25|||
150258792|NCT01445301|542082417|FG002|Overall Study|Adverse Event|4|||
150258793|NCT01445301|542082415|FG000|Overall Study|Lack of Efficacy|0|||
150258794|NCT01445301|542082416|FG001|Overall Study|Lack of Efficacy|1|||
150258795|NCT01445301|542082417|FG002|Overall Study|Lack of Efficacy|0|||
150258796|NCT01445301|542082415|FG000|Overall Study|Protocol Violation|1|||
150258797|NCT01445301|542082416|FG001|Overall Study|Protocol Violation|0|||
150258798|NCT01445301|542082417|FG002|Overall Study|Protocol Violation|0|||
150258799|NCT01445301|542082415|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
150145021|NCT02569710|541666958|FG001|Overall Study|Withdrawal by Subject|0|||
150145022|NCT02569710|541666959|FG002|Overall Study|Withdrawal by Subject|0|||
150258800|NCT01445301|542082416|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
150258801|NCT01445301|542082417|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
150258802|NCT01445301|542082415|FG000|Overall Study|Physician Decision|0|||
149802758|NCT01243762|540406010|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149802759|NCT01243762|540406011|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149802760|NCT01243762|540406012|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
149918699|NCT00433017|540835164|FG001|Overall Study|Subject no longer requires study drug|1|||
150258803|NCT01445301|542082416|FG001|Overall Study|Physician Decision|2|||
150258804|NCT01445301|542082417|FG002|Overall Study|Physician Decision|0|||
150258805|NCT01445301|542082415|FG000|Overall Study|Withdrawal by Subject|5|||
150258806|NCT01445301|542082416|FG001|Overall Study|Withdrawal by Subject|6|||
150258807|NCT01445301|542082417|FG002|Overall Study|Withdrawal by Subject|4|||
150258808|NCT00752557|542082418|FG000|Overall Study|Withdrawal by Subject|4|||
150258809|NCT00752557|542082419|FG001|Overall Study|Withdrawal by Subject|3|||
150258810|NCT00752557|542082420|FG002|Overall Study|Withdrawal by Subject|3|||
150258811|NCT00752557|542082418|FG000|Overall Study|Unspecified resaons|0|||
150258812|NCT00752557|542082419|FG001|Overall Study|Unspecified resaons|2|||
150258813|NCT00752557|542082420|FG002|Overall Study|Unspecified resaons|2|||
150258814|NCT00752557|542082418|FG000|Overall Study|Lost to Follow-up|1|||
150258815|NCT00752557|542082419|FG001|Overall Study|Lost to Follow-up|0|||
150258816|NCT00752557|542082420|FG002|Overall Study|Lost to Follow-up|1|||
150258817|NCT02150343|542082421|FG000|Overall Study|Adverse Event|2|||
150258818|NCT02150343|542082422|FG001|Overall Study|Adverse Event|0|||
150258819|NCT02150343|542082423|FG002|Overall Study|Adverse Event|1|||
150258820|NCT02150343|542082424|FG003|Overall Study|Adverse Event|1|||
150258821|NCT02150343|542082421|FG000|Overall Study|Withdrawal by Subject|13|||
150258822|NCT02150343|542082422|FG001|Overall Study|Withdrawal by Subject|10|||
150258823|NCT02150343|542082423|FG002|Overall Study|Withdrawal by Subject|9|||
150258824|NCT02150343|542082424|FG003|Overall Study|Withdrawal by Subject|4|||
150258825|NCT02150343|542082421|FG000|Overall Study|Lost to Follow-up|4|||
150258826|NCT02150343|542082422|FG001|Overall Study|Lost to Follow-up|4|||
150258827|NCT02150343|542082423|FG002|Overall Study|Lost to Follow-up|2|||
150258828|NCT02150343|542082424|FG003|Overall Study|Lost to Follow-up|3|||
150258829|NCT02150343|542082421|FG000|Overall Study|Other|2|||
150258830|NCT02150343|542082422|FG001|Overall Study|Other|6|||
150258831|NCT02150343|542082423|FG002|Overall Study|Other|0|||
150258832|NCT02150343|542082424|FG003|Overall Study|Other|2|||
150258833|NCT02729753|542082425|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
150258834|NCT02729753|542082426|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
150258835|NCT01090427|542082427|FG000|After Controlled Period|Death|0|||
150258836|NCT01090427|542082428|FG001|After Controlled Period|Death|0|||
150258837|NCT01090427|542082429|FG002|After Controlled Period|Death|0|||
150258838|NCT01090427|542082430|FG003|After Controlled Period|Death|0|||
150258839|NCT01090427|542082431|FG004|After Controlled Period|Death|0|||
150258840|NCT01090427|542082432|FG005|After Controlled Period|Death|1|||
150258841|NCT01090427|542082433|FG006|After Controlled Period|Death|0|||
150258842|NCT01090427|542082427|FG000|After Controlled Period|Lack of Efficacy|0|||
150258843|NCT01090427|542082428|FG001|After Controlled Period|Lack of Efficacy|0|||
150258844|NCT01090427|542082429|FG002|After Controlled Period|Lack of Efficacy|0|||
150258845|NCT01090427|542082430|FG003|After Controlled Period|Lack of Efficacy|0|||
150258846|NCT01090427|542082431|FG004|After Controlled Period|Lack of Efficacy|0|||
150258847|NCT01090427|542082432|FG005|After Controlled Period|Lack of Efficacy|3|||
150258848|NCT01090427|542082433|FG006|After Controlled Period|Lack of Efficacy|2|||
150258849|NCT01090427|542082427|FG000|After Controlled Period|Adverse Event|0|||
150258850|NCT01090427|542082428|FG001|After Controlled Period|Adverse Event|0|||
150258851|NCT01090427|542082429|FG002|After Controlled Period|Adverse Event|0|||
150258852|NCT01090427|542082430|FG003|After Controlled Period|Adverse Event|2|||
150258853|NCT01090427|542082431|FG004|After Controlled Period|Adverse Event|0|||
150258854|NCT01090427|542082432|FG005|After Controlled Period|Adverse Event|1|||
150258855|NCT01090427|542082433|FG006|After Controlled Period|Adverse Event|0|||
150258856|NCT01154010|542082434|FG000|Overall Study|Lost to Follow-up|0|||
150258857|NCT01154010|542082435|FG001|Overall Study|Lost to Follow-up|1|||
150258858|NCT02413333|542082441|FG000|Period 1|Adverse Event|1|||
150258859|NCT02413333|542082442|FG001|Period 1|Adverse Event|0|||
150258860|NCT02413333|542082441|FG000|Period 1|Reason Not Specified|0|||
150258861|NCT02413333|542082442|FG001|Period 1|Reason Not Specified|1|||
150258862|NCT02413333|542082441|FG000|Period 2|Protocol Deviation|1|||
150258863|NCT02413333|542082442|FG001|Period 2|Protocol Deviation|0|||
150258864|NCT01465347|542082443|FG000|Overall Study|Withdrawal by Subject|1|||
150258865|NCT01465347|542082444|FG001|Overall Study|Withdrawal by Subject|1|||
150258866|NCT01465347|542082443|FG000|Overall Study|Physician Decision|0|||
150258867|NCT01465347|542082444|FG001|Overall Study|Physician Decision|1|||
150258868|NCT01465347|542082443|FG000|Overall Study|Admitted to hospice|0|||
150258869|NCT01465347|542082444|FG001|Overall Study|Admitted to hospice|1|||
150258870|NCT02996474|542082445|FG000|Overall Study|Physician Decision|5|||
150258871|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
150258872|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
150258873|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
150258874|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
150258875|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
150258876|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
150258877|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
150258878|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
150258879|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
150258880|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
150258881|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
150258882|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
150258883|NCT04493502|542082446|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
150258884|NCT04493502|542082447|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
150258885|NCT04493502|542082446|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
150258886|NCT04493502|542082447|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
150258887|NCT04493502|542082446|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
150258888|NCT04493502|542082447|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
150258889|NCT04493502|542082446|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
150258890|NCT04493502|542082447|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
150258891|NCT04493502|542082446|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
150258892|NCT04493502|542082447|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
150258893|NCT04493502|542082446|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
150258894|NCT04493502|542082447|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
150258895|NCT04493502|542082446|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
150258896|NCT04493502|542082447|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
150258897|NCT02891837|542082448|FG000|Overall Study|Lost to Follow-up|2|||
150258898|NCT02891837|542082449|FG001|Overall Study|Lost to Follow-up|0|||
150258899|NCT02891837|542082448|FG000|Overall Study|Withdrawal by Subject|1|||
150258900|NCT02891837|542082449|FG001|Overall Study|Withdrawal by Subject|0|||
150258901|NCT01048671|542082457|FG000|Overall Study|Protocol Violation|0|||
150258902|NCT01048671|542082458|FG001|Overall Study|Protocol Violation|1|||
150258903|NCT01048671|542082459|FG002|Overall Study|Protocol Violation|1|||
150258904|NCT03538301|542082463|FG000|Overall Study|Adverse Event|1|||
150258905|NCT03538301|542082464|FG001|Overall Study|Adverse Event|4|||
150258906|NCT03538301|542082465|FG002|Overall Study|Adverse Event|4|||
150258907|NCT03538301|542082463|FG000|Overall Study|Death|1|||
150258908|NCT03538301|542082464|FG001|Overall Study|Death|1|||
150258909|NCT03538301|542082465|FG002|Overall Study|Death|0|||
150258910|NCT03538301|542082463|FG000|Overall Study|Physician Decision|0|||
150258911|NCT03538301|542082464|FG001|Overall Study|Physician Decision|1|||
150258912|NCT03538301|542082465|FG002|Overall Study|Physician Decision|0|||
150258913|NCT03538301|542082463|FG000|Overall Study|Protocol Violation|0|||
150258914|NCT03538301|542082464|FG001|Overall Study|Protocol Violation|0|||
150258915|NCT03538301|542082465|FG002|Overall Study|Protocol Violation|1|||
150258916|NCT03538301|542082463|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
150258917|NCT03538301|542082464|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
150258918|NCT03538301|542082465|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
150258919|NCT03965351|542082466|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
150258920|NCT03965351|542082467|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
150258921|NCT03965351|542082466|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
150258922|NCT03965351|542082467|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
150145023|NCT02569710|541666960|FG003|Overall Study|Withdrawal by Subject|0|||
150258923|NCT00943111|542082468|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
150258924|NCT00943111|542082469|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
150258925|NCT00943111|542082470|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
150258926|NCT00943111|542082468|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
150258927|NCT00943111|542082469|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
150258928|NCT00943111|542082470|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
150258929|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
150258930|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
150258931|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
150258932|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
150258933|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
150258934|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
150258935|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
150258936|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
150258937|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
150258938|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
150258939|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
150258940|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
150258941|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
150258942|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
150258943|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
150258944|NCT00943111|542082468|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
150258945|NCT00943111|542082469|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
150258946|NCT00943111|542082470|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
150258947|NCT02859324|542082471|FG000|Overall Study|Death|4|||
150258948|NCT02859324|542082472|FG001|Overall Study|Death|6|||
150258949|NCT02859324|542082473|FG002|Overall Study|Death|5|||
150258950|NCT02859324|542082471|FG000|Overall Study|Other reasons|3|||
150258951|NCT02859324|542082472|FG001|Overall Study|Other reasons|3|||
150258952|NCT02859324|542082473|FG002|Overall Study|Other reasons|0|||
150258953|NCT05326815|542082475|FG000|Overall Study|Withdrawal by Subject|3|||
150258954|NCT05326815|542082475|FG000|Overall Study|Did not complete required labs|6|||
150258955|NCT05326815|542082475|FG000|Overall Study|Screen fail- abnormal labs|5|||
150258956|NCT05917470|542082476|FG000|Overall Study|Progressive Disease|1|||
150258957|NCT05917470|542082477|FG001|Overall Study|Progressive Disease|1|||
150258958|NCT05917470|542082478|FG002|Overall Study|Progressive Disease|2|||
150258959|NCT05917470|542082479|FG003|Overall Study|Progressive Disease|3|||
150258960|NCT05917470|542082480|FG004|Overall Study|Progressive Disease|1|||
150258961|NCT05917470|542082481|FG005|Overall Study|Progressive Disease|1|||
150258962|NCT05917470|542082482|FG006|Overall Study|Progressive Disease|0|||
150258963|NCT05917470|542082483|FG007|Overall Study|Progressive Disease|0|||
150258964|NCT05917470|542082476|FG000|Overall Study|Withdrawal by Subject|0|||
150258965|NCT05917470|542082477|FG001|Overall Study|Withdrawal by Subject|0|||
150258966|NCT05917470|542082478|FG002|Overall Study|Withdrawal by Subject|1|||
150258967|NCT05917470|542082479|FG003|Overall Study|Withdrawal by Subject|0|||
150258968|NCT05917470|542082480|FG004|Overall Study|Withdrawal by Subject|0|||
150258969|NCT05917470|542082481|FG005|Overall Study|Withdrawal by Subject|0|||
150258970|NCT05917470|542082482|FG006|Overall Study|Withdrawal by Subject|0|||
150258971|NCT05917470|542082483|FG007|Overall Study|Withdrawal by Subject|0|||
150258972|NCT05917470|542082476|FG000|Overall Study|Sponsor Decision|0|||
150258973|NCT05917470|542082477|FG001|Overall Study|Sponsor Decision|0|||
150258974|NCT05917470|542082478|FG002|Overall Study|Sponsor Decision|1|||
150258975|NCT05917470|542082479|FG003|Overall Study|Sponsor Decision|0|||
150258976|NCT05917470|542082480|FG004|Overall Study|Sponsor Decision|2|||
150258977|NCT05917470|542082481|FG005|Overall Study|Sponsor Decision|1|||
150258978|NCT05917470|542082482|FG006|Overall Study|Sponsor Decision|3|||
150258979|NCT05917470|542082483|FG007|Overall Study|Sponsor Decision|3|||
150258980|NCT05917470|542082476|FG000|Overall Study|Adverse Event|0|||
150258981|NCT05917470|542082477|FG001|Overall Study|Adverse Event|0|||
150258982|NCT05917470|542082478|FG002|Overall Study|Adverse Event|0|||
150258983|NCT05917470|542082479|FG003|Overall Study|Adverse Event|0|||
150258984|NCT05917470|542082480|FG004|Overall Study|Adverse Event|0|||
150258985|NCT05917470|542082481|FG005|Overall Study|Adverse Event|1|||
150258986|NCT05917470|542082482|FG006|Overall Study|Adverse Event|0|||
150258987|NCT05917470|542082483|FG007|Overall Study|Adverse Event|0|||
150258988|NCT02334423|542085093|FG000|Overall Study|Protocol Violation|10|||
150258989|NCT02334423|542085094|FG001|Overall Study|Protocol Violation|3|||
150258990|NCT02292927|542085099|FG000|Overall Study|Protocol Violation|13|||
150258991|NCT02292927|542085100|FG001|Overall Study|Protocol Violation|7|||
150258992|NCT01656733|542085104|FG000|Overall Study|No permission to collect birth outcomes|0|||
150258993|NCT01656733|542085105|FG001|Overall Study|No permission to collect birth outcomes|1|||
150258994|NCT01656733|542085104|FG000|Overall Study|Delivery at another hospital|0|||
150258995|NCT01656733|542085105|FG001|Overall Study|Delivery at another hospital|2|||
150258996|NCT01656733|542085104|FG000|Overall Study|Spontaneous abortion|0|||
150258997|NCT01656733|542085105|FG001|Overall Study|Spontaneous abortion|1|||
150258998|NCT01065844|542085106|FG000|Overall Study|Adverse Event|5|||
150258999|NCT02224690|542085107|FG000|Overall Study|Adverse Event|8|||
150259000|NCT02224690|542085108|FG001|Overall Study|Adverse Event|1|||
150259001|NCT02224690|542085107|FG000|Overall Study|Met Withdrawal Criteria|4|||
150259002|NCT02224690|542085108|FG001|Overall Study|Met Withdrawal Criteria|0|||
150259003|NCT02224690|542085107|FG000|Overall Study|Use of G-tube|1|||
150259004|NCT02224690|542085108|FG001|Overall Study|Use of G-tube|0|||
150259005|NCT02224690|542085107|FG000|Overall Study|Did not meet eligibility criteria|1|||
150259006|NCT02224690|542085108|FG001|Overall Study|Did not meet eligibility criteria|0|||
150259007|NCT00825916|542085109|FG000|Overall Study|Lost to Follow-up|4|||
150259008|NCT00825916|542085110|FG001|Overall Study|Lost to Follow-up|2|||
150259009|NCT00825916|542085111|FG002|Overall Study|Lost to Follow-up|1|||
150259010|NCT02962960|542085112|FG000|Overall Study|Withdrawal by Subject|1|||
150259011|NCT02962960|542085113|FG001|Overall Study|Withdrawal by Subject|1|||
150259012|NCT02962960|542085114|FG002|Overall Study|Withdrawal by Subject|0|||
150259013|NCT02962960|542085112|FG000|Overall Study|Adverse Event|1|||
150259014|NCT02962960|542085113|FG001|Overall Study|Adverse Event|1|||
150259015|NCT02962960|542085114|FG002|Overall Study|Adverse Event|0|||
150259016|NCT02962960|542085112|FG000|Overall Study|Protocol Violation|1|||
150259017|NCT02962960|542085113|FG001|Overall Study|Protocol Violation|0|||
150259018|NCT02962960|542085114|FG002|Overall Study|Protocol Violation|0|||
150259019|NCT02054741|542085115|FG000|Overall Study|Protocol Violation|13|||
150259020|NCT02054741|542085116|FG001|Overall Study|Protocol Violation|2|||
150259021|NCT02054741|542085115|FG000|Overall Study|Withdrawal by Subject|10|||
150259022|NCT02054741|542085116|FG001|Overall Study|Withdrawal by Subject|5|||
150259023|NCT02054741|542085115|FG000|Overall Study|Death|94|||
150259024|NCT02054741|542085116|FG001|Overall Study|Death|90|||
150259025|NCT02054741|542085115|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
150259026|NCT02054741|542085116|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
150259027|NCT04223830|542085120|FG000|Overall Study|Lost to Follow-up|9|||
150259028|NCT04223830|542085120|FG000|Overall Study|Adverse Event|1|||
150259029|NCT01806623|542085121|FG000|Overall Study|Withdrawal by Subject|1|||
150259030|NCT01806623|542085121|FG000|Overall Study|Adverse Event|1|||
150259031|NCT01806623|542085121|FG000|Overall Study|Did not meet the inclusion criteria|56|||
150259032|NCT01964924|542085122|FG000|Trametinib Monotherapy|Progression|19|||
150259033|NCT01964924|542085123|FG001|Trametinib Monotherapy|Progression|0|||
150259034|NCT01528345|542085124|FG000|Overall Study|Adverse Event|10|||
150259035|NCT01528345|542085125|FG001|Overall Study|Adverse Event|1|||
150259036|NCT01528345|542085124|FG000|Overall Study|Death|1|||
150259037|NCT01528345|542085125|FG001|Overall Study|Death|1|||
150259038|NCT01528345|542085124|FG000|Overall Study|Non-compliance with study treatment|1|||
150259039|NCT01528345|542085125|FG001|Overall Study|Non-compliance with study treatment|0|||
150259040|NCT01528345|542085124|FG000|Overall Study|Progressive Disease|26|||
150259041|NCT01528345|542085125|FG001|Overall Study|Progressive Disease|40|||
150259042|NCT01528345|542085124|FG000|Overall Study|Study Terminated by Sponsor|4|||
150259043|NCT01528345|542085125|FG001|Overall Study|Study Terminated by Sponsor|8|||
150259044|NCT01528345|542085124|FG000|Overall Study|Subject/Guardian Decision|5|||
150259045|NCT01528345|542085125|FG001|Overall Study|Subject/Guardian Decision|0|||
150259046|NCT00190749|542085130|FG000|Overall Study|Lost to Follow-up|8|||
150259047|NCT00190749|542085131|FG001|Overall Study|Lost to Follow-up|11|||
150259048|NCT00190749|542085130|FG000|Overall Study|Withdrawal by Subject|10|||
150259049|NCT00190749|542085131|FG001|Overall Study|Withdrawal by Subject|6|||
150259050|NCT00190749|542085130|FG000|Overall Study|Protocol Violation|5|||
150259051|NCT00190749|542085131|FG001|Overall Study|Protocol Violation|4|||
150259052|NCT00190749|542085130|FG000|Overall Study|Adverse Event|0|||
150259053|NCT00190749|542085131|FG001|Overall Study|Adverse Event|5|||
150259054|NCT00190749|542085130|FG000|Overall Study|Lack of Efficacy|2|||
150259055|NCT00190749|542085131|FG001|Overall Study|Lack of Efficacy|3|||
150259056|NCT00190749|542085130|FG000|Overall Study|Reason Not Specified|0|||
150259057|NCT00190749|542085131|FG001|Overall Study|Reason Not Specified|2|||
150259058|NCT00190749|542085130|FG000|Overall Study|Sponsor Decision|1|||
150259059|NCT00190749|542085131|FG001|Overall Study|Sponsor Decision|0|||
150259060|NCT00439231|542085132|FG000|Overall Study|Lack of Efficacy|28|||
150259061|NCT00709852|542085133|FG000|Period 1|Adverse Event|2|||
150259062|NCT00709852|542085134|FG001|Period 1|Adverse Event|0|||
150259063|NCT00709852|542085133|FG000|Period 1|Withdrawal by Subject|4|||
150259064|NCT00709852|542085134|FG001|Period 1|Withdrawal by Subject|2|||
150259065|NCT00709852|542085133|FG000|Period 1|Protocol Violation|1|||
150259066|NCT00709852|542085134|FG001|Period 1|Protocol Violation|0|||
150259067|NCT00709852|542085133|FG000|Period 1|Defective scanner|0|||
150259068|NCT00709852|542085134|FG001|Period 1|Defective scanner|1|||
150259069|NCT00709852|542085133|FG000|Period 1|Lost to Follow-up|1|||
150259070|NCT00709852|542085134|FG001|Period 1|Lost to Follow-up|0|||
150259071|NCT00709852|542085133|FG000|Period 2|Protocol Violation|4|||
150259072|NCT00709852|542085134|FG001|Period 2|Protocol Violation|1|||
150259073|NCT00709852|542085133|FG000|Period 2|Adverse Event|1|||
150259074|NCT00709852|542085134|FG001|Period 2|Adverse Event|1|||
150259075|NCT00709852|542085133|FG000|Period 2|Lost to Follow-up|1|||
150259076|NCT00709852|542085134|FG001|Period 2|Lost to Follow-up|0|||
150259077|NCT00709852|542085133|FG000|Period 2|No 72-hour follow-up|3|||
150259078|NCT00709852|542085134|FG001|Period 2|No 72-hour follow-up|0|||
150259079|NCT03814187|542085135|FG000|Overall Study|Sponsor's Administrative Decision|0|||
150259080|NCT03814187|542085136|FG001|Overall Study|Sponsor's Administrative Decision|0|||
150259081|NCT03814187|542085137|FG002|Overall Study|Sponsor's Administrative Decision|272|||
150259082|NCT03814187|542085135|FG000|Overall Study|Death|80|||
150259083|NCT03814187|542085136|FG001|Overall Study|Death|81|||
150259084|NCT03814187|542085137|FG002|Overall Study|Death|4|||
150259085|NCT03814187|542085135|FG000|Overall Study|Withdrew Consent|77|||
150259086|NCT03814187|542085136|FG001|Overall Study|Withdrew Consent|78|||
150259087|NCT03814187|542085137|FG002|Overall Study|Withdrew Consent|2|||
150259088|NCT03814187|542085135|FG000|Overall Study|Lost to Follow-up|47|||
150259089|NCT03814187|542085136|FG001|Overall Study|Lost to Follow-up|52|||
150259090|NCT03814187|542085137|FG002|Overall Study|Lost to Follow-up|1|||
150259091|NCT03814187|542085135|FG000|Overall Study|Adverse Event|22|||
150259092|NCT03814187|542085136|FG001|Overall Study|Adverse Event|23|||
150259093|NCT03814187|542085137|FG002|Overall Study|Adverse Event|0|||
150259094|NCT03814187|542085135|FG000|Overall Study|Physician Decision|7|||
150259095|NCT03814187|542085136|FG001|Overall Study|Physician Decision|4|||
150259096|NCT03814187|542085137|FG002|Overall Study|Physician Decision|2|||
150259097|NCT03814187|542085135|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
150259098|NCT03814187|542085136|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
150259099|NCT03814187|542085137|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
150259100|NCT03814187|542085135|FG000|Overall Study|Other reasons|34|||
150259101|NCT03814187|542085136|FG001|Overall Study|Other reasons|40|||
150259102|NCT03814187|542085137|FG002|Overall Study|Other reasons|2|||
150259103|NCT00296400|542085138|FG000|Overall Study|Adverse Event|7|||
150259104|NCT00296400|542085139|FG001|Overall Study|Adverse Event|7|||
150259105|NCT00296400|542085140|FG002|Overall Study|Adverse Event|7|||
150259106|NCT00296400|542085138|FG000|Overall Study|Withdrawal by Subject|5|||
150259107|NCT00296400|542085139|FG001|Overall Study|Withdrawal by Subject|6|||
150259108|NCT00296400|542085140|FG002|Overall Study|Withdrawal by Subject|2|||
150259109|NCT00296400|542085138|FG000|Overall Study|Incorrect enrollment|2|||
150259110|NCT00296400|542085139|FG001|Overall Study|Incorrect enrollment|0|||
150259111|NCT00296400|542085140|FG002|Overall Study|Incorrect enrollment|0|||
150259112|NCT00296400|542085138|FG000|Overall Study|Protocol Violation|1|||
150259113|NCT00296400|542085139|FG001|Overall Study|Protocol Violation|1|||
150259114|NCT00296400|542085140|FG002|Overall Study|Protocol Violation|1|||
150259115|NCT00296400|542085138|FG000|Overall Study|Lost to Follow-up|1|||
150259116|NCT00296400|542085139|FG001|Overall Study|Lost to Follow-up|1|||
150259117|NCT00296400|542085140|FG002|Overall Study|Lost to Follow-up|2|||
150259118|NCT00296400|542085138|FG000|Overall Study|Study specific discontinuation criteria|0|||
150259119|NCT00296400|542085139|FG001|Overall Study|Study specific discontinuation criteria|0|||
150259120|NCT00296400|542085140|FG002|Overall Study|Study specific discontinuation criteria|1|||
150259121|NCT00296400|542085138|FG000|Overall Study|Visit 10 was performed earlier|0|||
150259122|NCT00296400|542085139|FG001|Overall Study|Visit 10 was performed earlier|1|||
150259123|NCT00296400|542085140|FG002|Overall Study|Visit 10 was performed earlier|0|||
150259124|NCT00296400|542085138|FG000|Overall Study|Pregnancy|1|||
150259125|NCT00296400|542085139|FG001|Overall Study|Pregnancy|2|||
150259126|NCT00296400|542085140|FG002|Overall Study|Pregnancy|0|||
150259127|NCT01014533|542085144|FG000|Overall Study|Protocol Violation|3|||
150259128|NCT01014533|542085145|FG001|Overall Study|Protocol Violation|2|||
150259129|NCT01014533|542085144|FG000|Overall Study|Withdrawal by Subject|2|||
150259130|NCT01014533|542085145|FG001|Overall Study|Withdrawal by Subject|0|||
150259131|NCT01014533|542085144|FG000|Overall Study|unable to come to appointment|0|||
150259132|NCT01014533|542085145|FG001|Overall Study|unable to come to appointment|3|||
150259133|NCT00412061|542085147|FG000|Double Blind Phase|Disease Progression|101|||
150259134|NCT00412061|542085148|FG001|Double Blind Phase|Disease Progression|154|||
150259135|NCT00412061|542085147|FG000|Double Blind Phase|Adverse Event|61|||
150259136|NCT00412061|542085148|FG001|Double Blind Phase|Adverse Event|16|||
150259137|NCT00412061|542085147|FG000|Double Blind Phase|Final Primary Analysis|26|||
150259138|NCT00412061|542085148|FG001|Double Blind Phase|Final Primary Analysis|14|||
150259139|NCT00412061|542085147|FG000|Double Blind Phase|Withdrawal by Subject|18|||
150259140|NCT00412061|542085148|FG001|Double Blind Phase|Withdrawal by Subject|20|||
150259141|NCT00412061|542085147|FG000|Double Blind Phase|Death|6|||
150259142|NCT00412061|542085148|FG001|Double Blind Phase|Death|3|||
150259143|NCT00412061|542085147|FG000|Double Blind Phase|Protocol Violation|3|||
150259144|NCT00412061|542085148|FG001|Double Blind Phase|Protocol Violation|4|||
150259145|NCT00412061|542085147|FG000|Double Blind Phase|New Cander Therapy|1|||
150259146|NCT00412061|542085148|FG001|Double Blind Phase|New Cander Therapy|1|||
150259147|NCT00412061|542085147|FG000|Double Blind Phase|Lost to Follow-up|0|||
150259148|NCT00412061|542085148|FG001|Double Blind Phase|Lost to Follow-up|1|||
150259149|NCT00412061|542085147|FG000|Open Label Phase|Disease Progression|0|||
150259150|NCT00412061|542085148|FG001|Open Label Phase|Disease Progression|86|||
150259151|NCT00412061|542085147|FG000|Open Label Phase|Adverse Event|0|||
150259152|NCT00412061|542085148|FG001|Open Label Phase|Adverse Event|46|||
150259153|NCT00412061|542085147|FG000|Open Label Phase|Withdrawal by Subject|0|||
150259154|NCT00412061|542085148|FG001|Open Label Phase|Withdrawal by Subject|15|||
150259155|NCT00412061|542085147|FG000|Open Label Phase|Administrative Problems|0|||
150259156|NCT00412061|542085148|FG001|Open Label Phase|Administrative Problems|13|||
150259157|NCT00412061|542085147|FG000|Open Label Phase|Death|0|||
150259158|NCT00412061|542085148|FG001|Open Label Phase|Death|7|||
150259159|NCT00412061|542085147|FG000|Open Label Phase|Lost to Follow-up|0|||
150259160|NCT00412061|542085148|FG001|Open Label Phase|Lost to Follow-up|2|||
150259161|NCT00412061|542085147|FG000|Open Label Phase|New Cancer Therapy|0|||
150259162|NCT00412061|542085148|FG001|Open Label Phase|New Cancer Therapy|1|||
150259163|NCT02689518|542085149|FG000|Overall Study|Withdrawal by Subject|3|||
150259164|NCT02433340|542085152|FG000|Overall Study|Adverse Event|0|||
150259165|NCT02433340|542085153|FG001|Overall Study|Adverse Event|0|||
150259166|NCT02433340|542085154|FG002|Overall Study|Adverse Event|1|||
150259167|NCT02433340|542085155|FG003|Overall Study|Adverse Event|0|||
150259168|NCT02433340|542085152|FG000|Overall Study|Withdrawal by Subject|1|||
150259169|NCT02433340|542085153|FG001|Overall Study|Withdrawal by Subject|0|||
150259170|NCT02433340|542085154|FG002|Overall Study|Withdrawal by Subject|1|||
150259171|NCT02433340|542085155|FG003|Overall Study|Withdrawal by Subject|2|||
150259172|NCT02433340|542085152|FG000|Overall Study|Lost to Follow-up|0|||
150259173|NCT02433340|542085153|FG001|Overall Study|Lost to Follow-up|1|||
150259174|NCT02433340|542085154|FG002|Overall Study|Lost to Follow-up|0|||
150259175|NCT02433340|542085155|FG003|Overall Study|Lost to Follow-up|0|||
150259176|NCT02433340|542085152|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
150259177|NCT02433340|542085153|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
150259178|NCT02433340|542085154|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
150259179|NCT02433340|542085155|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
150259180|NCT02433340|542085152|FG000|Overall Study|Other|0|||
150259181|NCT02433340|542085153|FG001|Overall Study|Other|1|||
150259182|NCT02433340|542085154|FG002|Overall Study|Other|0|||
150259183|NCT02433340|542085155|FG003|Overall Study|Other|0|||
150259184|NCT01178385|542085156|FG000|Overall Study|Withdrawal by Subject|2|||
150259185|NCT01178385|542085157|FG001|Overall Study|Withdrawal by Subject|0|||
150259186|NCT00985946|542085162|FG000|Overall Study|Lost to Follow-up|6|||
150259187|NCT00985946|542085162|FG000|Overall Study|Withdrawal by Subject|1|||
150259188|NCT02679508|542085166|FG000|Healing Phase|Protocol Violation|1|||
150259189|NCT02679508|542085167|FG001|Healing Phase|Protocol Violation|1|||
150259190|NCT02679508|542085166|FG000|Healing Phase|Lost to Follow-up|1|||
150259191|NCT02679508|542085167|FG001|Healing Phase|Lost to Follow-up|0|||
150259192|NCT02679508|542085166|FG000|Maintenance Phase|Adverse Event|12|||
150259193|NCT02679508|542085167|FG001|Maintenance Phase|Adverse Event|2|||
150259194|NCT02679508|542085166|FG000|Maintenance Phase|Lost to Follow-up|0|||
150259195|NCT02679508|542085167|FG001|Maintenance Phase|Lost to Follow-up|1|||
150259196|NCT02679508|542085166|FG000|Maintenance Phase|Withdrawal by Subject|15|||
150259197|NCT02679508|542085167|FG001|Maintenance Phase|Withdrawal by Subject|8|||
150259198|NCT02679508|542085166|FG000|Maintenance Phase|Other|5|||
150259199|NCT02679508|542085167|FG001|Maintenance Phase|Other|4|||
150259200|NCT00928018|542085170|FG000|Overall Study|Withdrawal by Subject|1|||
150259201|NCT00928018|542085171|FG001|Overall Study|Withdrawal by Subject|0|||
150259202|NCT02665338|542085172|FG000|Overall Study|Withdrawal by Subject|0|||
150259203|NCT02665338|542085173|FG001|Overall Study|Withdrawal by Subject|1|||
150259204|NCT02008877|542085174|FG000|Overall Study|Inevaluable|0|||
150259205|NCT02008877|542085175|FG001|Overall Study|Inevaluable|1|||
150259206|NCT02008877|542085176|FG002|Overall Study|Inevaluable|0|||
150259207|NCT01049217|542085177|FG000|Overall Study|Adverse Event|2|||
150259208|NCT01049217|542085178|FG001|Overall Study|Adverse Event|1|||
150259209|NCT01049217|542085177|FG000|Overall Study|Lack of Efficacy|1|||
150259210|NCT01049217|542085178|FG001|Overall Study|Lack of Efficacy|1|||
150259211|NCT01049217|542085177|FG000|Overall Study|Lost to Follow-up|3|||
150259212|NCT01049217|542085178|FG001|Overall Study|Lost to Follow-up|8|||
150259213|NCT01049217|542085177|FG000|Overall Study|Withdrawal by Subject|4|||
150259214|NCT01049217|542085178|FG001|Overall Study|Withdrawal by Subject|3|||
150259215|NCT01049217|542085177|FG000|Overall Study|Protocol Violation|1|||
150259216|NCT01049217|542085178|FG001|Overall Study|Protocol Violation|3|||
150259217|NCT01049217|542085177|FG000|Overall Study|Pregnancy|1|||
150259218|NCT01049217|542085178|FG001|Overall Study|Pregnancy|0|||
150259219|NCT01049217|542085177|FG000|Overall Study|Study Terminated by Sponsor|43|||
150259220|NCT01049217|542085178|FG001|Overall Study|Study Terminated by Sponsor|43|||
150259221|NCT01049217|542085177|FG000|Overall Study|Other|1|||
150259222|NCT01049217|542085178|FG001|Overall Study|Other|2|||
150259223|NCT01049217|542085177|FG000|Overall Study|Randomized but not Treated|0|||
150259224|NCT01049217|542085178|FG001|Overall Study|Randomized but not Treated|2|||
150259225|NCT00998335|542085179|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
150259226|NCT00998335|542085180|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
150259227|NCT03149549|542085181|FG000|Study Discontinuation--Treatment Period|Death|0|||
150259228|NCT03149549|542085182|FG001|Study Discontinuation--Treatment Period|Death|0|||
150259229|NCT03149549|542085183|FG002|Study Discontinuation--Treatment Period|Death|0|||
150259230|NCT03149549|542085184|FG003|Study Discontinuation--Treatment Period|Death|1|||
150259231|NCT03149549|542085185|FG004|Study Discontinuation--Treatment Period|Death|2|||
150259232|NCT03149549|542085186|FG005|Study Discontinuation--Treatment Period|Death|1|||
150259233|NCT03149549|542085187|FG006|Study Discontinuation--Treatment Period|Death|1|||
150259234|NCT03149549|542085188|FG007|Study Discontinuation--Treatment Period|Death|2|||
150259235|NCT03149549|542085189|FG008|Study Discontinuation--Treatment Period|Death|4|||
150259236|NCT03149549|542085190|FG009|Study Discontinuation--Treatment Period|Death|1|||
150259237|NCT03149549|542085191|FG010|Study Discontinuation--Treatment Period|Death|0|||
150259238|NCT03149549|542085192|FG011|Study Discontinuation--Treatment Period|Death|0|||
150259239|NCT03149549|542085193|FG012|Study Discontinuation--Treatment Period|Death|1|||
150259240|NCT03149549|542085181|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259241|NCT03149549|542085182|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259242|NCT03149549|542085183|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259243|NCT03149549|542085184|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259244|NCT03149549|542085185|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259245|NCT03149549|542085186|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259246|NCT03149549|542085187|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259247|NCT03149549|542085188|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
150259248|NCT03149549|542085189|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259249|NCT03149549|542085190|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259250|NCT03149549|542085191|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259251|NCT03149549|542085192|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
150259252|NCT03149549|542085193|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
150259253|NCT03149549|542085181|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259254|NCT03149549|542085182|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259255|NCT03149549|542085183|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259256|NCT03149549|542085184|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
150259257|NCT03149549|542085185|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
150259258|NCT03149549|542085186|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
150259259|NCT03149549|542085187|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
150259260|NCT03149549|542085188|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259261|NCT03149549|542085189|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
150259262|NCT03149549|542085190|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259263|NCT03149549|542085191|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259264|NCT03149549|542085192|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259265|NCT03149549|542085193|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
150259266|NCT03149549|542085181|FG000|Study Discontinuation--Treatment Period|Other|0|||
150259267|NCT03149549|542085182|FG001|Study Discontinuation--Treatment Period|Other|0|||
150259268|NCT03149549|542085183|FG002|Study Discontinuation--Treatment Period|Other|0|||
150259269|NCT03149549|542085184|FG003|Study Discontinuation--Treatment Period|Other|0|||
150259270|NCT03149549|542085185|FG004|Study Discontinuation--Treatment Period|Other|0|||
150259271|NCT03149549|542085186|FG005|Study Discontinuation--Treatment Period|Other|0|||
150259272|NCT03149549|542085187|FG006|Study Discontinuation--Treatment Period|Other|0|||
150259273|NCT03149549|542085188|FG007|Study Discontinuation--Treatment Period|Other|1|||
150259274|NCT03149549|542085189|FG008|Study Discontinuation--Treatment Period|Other|0|||
150259275|NCT03149549|542085190|FG009|Study Discontinuation--Treatment Period|Other|1|||
150259276|NCT03149549|542085191|FG010|Study Discontinuation--Treatment Period|Other|0|||
150259277|NCT03149549|542085192|FG011|Study Discontinuation--Treatment Period|Other|0|||
150259278|NCT03149549|542085193|FG012|Study Discontinuation--Treatment Period|Other|0|||
150259279|NCT03149549|542085181|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259280|NCT03149549|542085182|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259281|NCT03149549|542085183|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259282|NCT03149549|542085184|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259283|NCT03149549|542085185|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259284|NCT03149549|542085186|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
150259285|NCT03149549|542085187|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
150259286|NCT03149549|542085188|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259287|NCT03149549|542085189|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
150259288|NCT03149549|542085190|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259289|NCT03149549|542085191|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259290|NCT03149549|542085192|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259291|NCT03149549|542085193|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
150259292|NCT03149549|542085181|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259293|NCT03149549|542085182|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259294|NCT03149549|542085183|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259295|NCT03149549|542085184|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259296|NCT03149549|542085185|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
150259297|NCT03149549|542085186|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259298|NCT03149549|542085187|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259299|NCT03149549|542085188|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
150259300|NCT03149549|542085189|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
150259301|NCT03149549|542085190|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259302|NCT03149549|542085191|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
150259303|NCT03149549|542085192|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
150259304|NCT03149549|542085193|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
150259305|NCT03149549|542085181|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259306|NCT03149549|542085182|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259307|NCT03149549|542085183|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259308|NCT03149549|542085184|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259309|NCT03149549|542085185|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
150259310|NCT03149549|542085186|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259311|NCT03149549|542085187|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259312|NCT03149549|542085188|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
150259313|NCT03149549|542085189|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
150259314|NCT03149549|542085190|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
150259315|NCT03149549|542085191|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
150259316|NCT03149549|542085192|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
150259317|NCT03149549|542085193|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
150259318|NCT03149549|542085181|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
150259319|NCT03149549|542085182|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
150259320|NCT03149549|542085183|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
150259321|NCT03149549|542085184|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
150259322|NCT03149549|542085185|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
150259323|NCT03149549|542085186|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
150259324|NCT03149549|542085187|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
150259325|NCT03149549|542085188|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
150259326|NCT03149549|542085189|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
150259327|NCT03149549|542085190|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
150259328|NCT03149549|542085191|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
150259329|NCT03149549|542085192|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
150259330|NCT03149549|542085193|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
150259331|NCT03149549|542085181|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
150259332|NCT03149549|542085182|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
150259333|NCT03149549|542085183|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
150259334|NCT03149549|542085184|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
150259335|NCT03149549|542085185|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
150259336|NCT03149549|542085186|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
150259337|NCT03149549|542085187|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
150259338|NCT03149549|542085188|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
150259339|NCT03149549|542085189|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
150259340|NCT03149549|542085190|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
150259341|NCT03149549|542085191|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
150259342|NCT03149549|542085192|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
150259343|NCT03149549|542085193|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
150259344|NCT01892540|542085196|FG000|Overall Study|Did not complete PET/MRI|0|||
150259345|NCT01892540|542085197|FG001|Overall Study|Did not complete PET/MRI|0|||
150259346|NCT01892540|542085198|FG002|Overall Study|Did not complete PET/MRI|2|||
150259347|NCT01892540|542085196|FG000|Overall Study|Did not fit in scanner|0|||
150259348|NCT01892540|542085197|FG001|Overall Study|Did not fit in scanner|0|||
150259349|NCT01892540|542085198|FG002|Overall Study|Did not fit in scanner|1|||
150259350|NCT01370590|542085199|FG000|Period 1|Adverse Event|8|||
150259351|NCT01370590|542085200|FG001|Period 1|Adverse Event|4|||
150259352|NCT01370590|542085199|FG000|Period 1|Lost to Follow-up|2|||
150259353|NCT01370590|542085200|FG001|Period 1|Lost to Follow-up|2|||
150259354|NCT01370590|542085199|FG000|Period 1|Protocol Violation|2|||
150259355|NCT01370590|542085200|FG001|Period 1|Protocol Violation|2|||
150259356|NCT01370590|542085199|FG000|Period 1|Withdrawal by Subject|4|||
150259357|NCT01370590|542085200|FG001|Period 1|Withdrawal by Subject|2|||
150259358|NCT01370590|542085199|FG000|Period 1|Could not access randomization system|0|||
150259359|NCT01370590|542085200|FG001|Period 1|Could not access randomization system|1|||
150259360|NCT01370590|542085199|FG000|Crossover Washout Period|Adverse Event|1|||
150259361|NCT01370590|542085200|FG001|Crossover Washout Period|Adverse Event|4|||
150259362|NCT01370590|542085199|FG000|Crossover Washout Period|Lost to Follow-up|2|||
150259363|NCT01370590|542085200|FG001|Crossover Washout Period|Lost to Follow-up|0|||
150259364|NCT01370590|542085199|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
150259365|NCT01370590|542085200|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
150259366|NCT01370590|542085199|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
150259367|NCT01370590|542085200|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
150259368|NCT01370590|542085199|FG000|Period 2|Adverse Event|0|||
150259369|NCT01370590|542085200|FG001|Period 2|Adverse Event|1|||
150259370|NCT01370590|542085199|FG000|Period 2|Withdrawal by Subject|1|||
150259371|NCT01370590|542085200|FG001|Period 2|Withdrawal by Subject|1|||
150259372|NCT05172050|542085201|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
150259373|NCT05172050|542085202|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
150259374|NCT05172050|542085203|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
150259375|NCT05172050|542085201|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
150259376|NCT05172050|542085202|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
150259377|NCT05172050|542085203|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
150259378|NCT05172050|542085201|FG000|Overall Study|Other|2|||
150259379|NCT05172050|542085202|FG001|Overall Study|Other|2|||
150259380|NCT05172050|542085203|FG002|Overall Study|Other|1|||
150259381|NCT04617275|542085208|FG000|Treatment Period|Adverse Event|1|||
150259382|NCT04617275|542085209|FG001|Treatment Period|Adverse Event|6|||
150259383|NCT04617275|542085210|FG002|Treatment Period|Adverse Event|4|||
150259384|NCT04617275|542085211|FG003|Treatment Period|Adverse Event|6|||
150259385|NCT04617275|542085212|FG004|Treatment Period|Adverse Event|7|||
149918700|NCT01306214|540835165|FG000|Overall Study|Death|0|||
150259386|NCT04617275|542085213|FG005|Treatment Period|Adverse Event|8|||
150259387|NCT04617275|542085214|FG006|Treatment Period|Adverse Event|0|||
150259388|NCT04617275|542085215|FG007|Treatment Period|Adverse Event|12|||
150259389|NCT04617275|542085208|FG000|Treatment Period|Lost to Follow-up|0|||
150259390|NCT04617275|542085209|FG001|Treatment Period|Lost to Follow-up|0|||
150259391|NCT04617275|542085210|FG002|Treatment Period|Lost to Follow-up|2|||
150259392|NCT04617275|542085211|FG003|Treatment Period|Lost to Follow-up|0|||
150259393|NCT04617275|542085212|FG004|Treatment Period|Lost to Follow-up|0|||
150259394|NCT04617275|542085213|FG005|Treatment Period|Lost to Follow-up|3|||
150259395|NCT04617275|542085214|FG006|Treatment Period|Lost to Follow-up|0|||
150259396|NCT04617275|542085215|FG007|Treatment Period|Lost to Follow-up|2|||
150259397|NCT04617275|542085208|FG000|Treatment Period|No longer meets eligibility criteria|0|||
150259398|NCT04617275|542085209|FG001|Treatment Period|No longer meets eligibility criteria|0|||
150259399|NCT04617275|542085210|FG002|Treatment Period|No longer meets eligibility criteria|0|||
150259400|NCT04617275|542085211|FG003|Treatment Period|No longer meets eligibility criteria|1|||
150259401|NCT04617275|542085212|FG004|Treatment Period|No longer meets eligibility criteria|0|||
150259402|NCT04617275|542085213|FG005|Treatment Period|No longer meets eligibility criteria|0|||
150259403|NCT04617275|542085214|FG006|Treatment Period|No longer meets eligibility criteria|0|||
150259404|NCT04617275|542085215|FG007|Treatment Period|No longer meets eligibility criteria|0|||
150259405|NCT04617275|542085208|FG000|Treatment Period|Other|0|||
150259406|NCT04617275|542085209|FG001|Treatment Period|Other|1|||
150259407|NCT04617275|542085210|FG002|Treatment Period|Other|0|||
150259408|NCT04617275|542085211|FG003|Treatment Period|Other|0|||
150259409|NCT04617275|542085212|FG004|Treatment Period|Other|0|||
150259410|NCT04617275|542085213|FG005|Treatment Period|Other|0|||
150259411|NCT04617275|542085214|FG006|Treatment Period|Other|0|||
150259412|NCT04617275|542085215|FG007|Treatment Period|Other|0|||
150259413|NCT04617275|542085208|FG000|Treatment Period|Withdrawal by Subject|2|||
150259414|NCT04617275|542085209|FG001|Treatment Period|Withdrawal by Subject|0|||
150259415|NCT04617275|542085210|FG002|Treatment Period|Withdrawal by Subject|0|||
150259416|NCT04617275|542085211|FG003|Treatment Period|Withdrawal by Subject|2|||
150259417|NCT04617275|542085212|FG004|Treatment Period|Withdrawal by Subject|2|||
150259418|NCT04617275|542085213|FG005|Treatment Period|Withdrawal by Subject|0|||
150259419|NCT04617275|542085214|FG006|Treatment Period|Withdrawal by Subject|1|||
150259420|NCT04617275|542085215|FG007|Treatment Period|Withdrawal by Subject|2|||
150259421|NCT04617275|542085208|FG000|Follow-up Period|Adverse Event|1|||
150259422|NCT04617275|542085209|FG001|Follow-up Period|Adverse Event|1|||
150259423|NCT04617275|542085210|FG002|Follow-up Period|Adverse Event|2|||
150259424|NCT04617275|542085211|FG003|Follow-up Period|Adverse Event|3|||
150259425|NCT04617275|542085212|FG004|Follow-up Period|Adverse Event|4|||
150259426|NCT04617275|542085213|FG005|Follow-up Period|Adverse Event|3|||
150259427|NCT04617275|542085214|FG006|Follow-up Period|Adverse Event|0|||
150259428|NCT04617275|542085215|FG007|Follow-up Period|Adverse Event|3|||
150259429|NCT04617275|542085208|FG000|Follow-up Period|Lost to Follow-up|0|||
150259430|NCT04617275|542085209|FG001|Follow-up Period|Lost to Follow-up|1|||
150259431|NCT04617275|542085210|FG002|Follow-up Period|Lost to Follow-up|2|||
150259432|NCT04617275|542085211|FG003|Follow-up Period|Lost to Follow-up|0|||
150259433|NCT04617275|542085212|FG004|Follow-up Period|Lost to Follow-up|0|||
150259434|NCT04617275|542085213|FG005|Follow-up Period|Lost to Follow-up|4|||
150259435|NCT04617275|542085214|FG006|Follow-up Period|Lost to Follow-up|0|||
150259436|NCT04617275|542085215|FG007|Follow-up Period|Lost to Follow-up|3|||
150259437|NCT04617275|542085208|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
150259438|NCT04617275|542085209|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
150029380|NCT05635461|541244184|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
150145024|NCT02569710|541666961|FG004|Overall Study|Withdrawal by Subject|0|||
149802761|NCT01243762|540406013|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
149918701|NCT01306214|540835166|FG001|Overall Study|Death|0|||
149918702|NCT01306214|540835167|FG002|Overall Study|Death|1|||
149918703|NCT01306214|540835165|FG000|Overall Study|Lost to Follow-up|3|||
149918704|NCT01306214|540835166|FG001|Overall Study|Lost to Follow-up|5|||
149918705|NCT01306214|540835167|FG002|Overall Study|Lost to Follow-up|4|||
149918706|NCT01306214|540835165|FG000|Overall Study|Withdrawal by Subject|24|||
149918707|NCT01306214|540835166|FG001|Overall Study|Withdrawal by Subject|22|||
149918708|NCT01306214|540835167|FG002|Overall Study|Withdrawal by Subject|16|||
149918709|NCT01306214|540835165|FG000|Overall Study|Not treated|1|||
149918710|NCT01306214|540835166|FG001|Overall Study|Not treated|1|||
149918711|NCT01306214|540835167|FG002|Overall Study|Not treated|1|||
149918712|NCT01760447|540835168|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
150145025|NCT02569710|541666962|FG005|Overall Study|Withdrawal by Subject|1|||
150145026|NCT02569710|541666963|FG006|Overall Study|Withdrawal by Subject|0|||
150145027|NCT02569710|541666964|FG007|Overall Study|Withdrawal by Subject|0|||
150145028|NCT02569710|541666965|FG008|Overall Study|Withdrawal by Subject|0|||
150145029|NCT02569710|541666966|FG009|Overall Study|Withdrawal by Subject|0|||
150145030|NCT01125722|541666969|FG000|Overall Study|Withdrawal by Subject|2|||
150145031|NCT01125722|541666970|FG001|Overall Study|Withdrawal by Subject|1|||
150145032|NCT01125722|541666969|FG000|Overall Study|Lost to Follow-up|1|||
150145033|NCT01125722|541666970|FG001|Overall Study|Lost to Follow-up|0|||
150145034|NCT00709059|541666976|FG000|Overall Study|Lost to Follow-up|34|||
150145035|NCT00709059|541666976|FG000|Overall Study|Withdrawal by Subject|19|||
150145036|NCT00709059|541666976|FG000|Overall Study|Physician Decision|7|||
150145037|NCT00709059|541666976|FG000|Overall Study|Disease complication|3|||
150145038|NCT00709059|541666976|FG000|Overall Study|Side effects|20|||
150145039|NCT00709059|541666976|FG000|Overall Study|Serious side effects|11|||
150145040|NCT01396317|541666977|FG000|Overall Study|Adverse Event|1|||
150145041|NCT01396317|541666978|FG001|Overall Study|Adverse Event|0|||
150145042|NCT01786330|541666979|FG000|Overall Study|Withdrawal by Subject|0|||
150145043|NCT01786330|541666980|FG001|Overall Study|Withdrawal by Subject|1|||
150145044|NCT01786330|541666979|FG000|Overall Study|Lost to Follow-up|0|||
150145045|NCT01786330|541666980|FG001|Overall Study|Lost to Follow-up|1|||
150145046|NCT01786330|541666979|FG000|Overall Study|Excluded intraoperatively|0|||
150145047|NCT01786330|541666980|FG001|Overall Study|Excluded intraoperatively|1|||
150145048|NCT01786330|541666979|FG000|Overall Study|Protocol Violation|1|||
150145049|NCT01786330|541666980|FG001|Overall Study|Protocol Violation|0|||
150145050|NCT02172625|541666981|FG000|Overall Study|Adverse Event|0|||
150145051|NCT02172625|541666982|FG001|Overall Study|Adverse Event|1|||
150145052|NCT02172625|541666981|FG000|Overall Study|Pregnancy|0|||
150145053|NCT02172625|541666982|FG001|Overall Study|Pregnancy|1|||
150145054|NCT02172625|541666981|FG000|Overall Study|car accident|0|||
150145055|NCT02172625|541666982|FG001|Overall Study|car accident|1|||
150145056|NCT03315130|541666983|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
150145057|NCT03315130|541666984|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
150145058|NCT03315130|541666985|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
150145059|NCT03315130|541666986|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
150145060|NCT03315130|541666983|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
150145061|NCT03315130|541666984|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
150145062|NCT03315130|541666985|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
150145063|NCT03315130|541666986|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
150145064|NCT03315130|541666983|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
150145065|NCT03315130|541666984|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
150145066|NCT03315130|541666985|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
150145067|NCT03315130|541666986|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
150145068|NCT03315130|541666983|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
150145069|NCT03315130|541666984|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
150145070|NCT03315130|541666985|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
150145071|NCT03315130|541666986|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
150145072|NCT03315130|541666983|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
150145073|NCT03315130|541666984|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
150145074|NCT03315130|541666985|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
150145075|NCT03315130|541666986|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
150145076|NCT03315130|541666983|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
150145077|NCT03315130|541666984|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
150145078|NCT03315130|541666985|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
150145079|NCT03315130|541666986|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
150145080|NCT02944656|541666994|FG000|Overall Study|No longer eligible|3|||
150145081|NCT02944656|541666995|FG001|Overall Study|No longer eligible|0|||
150145082|NCT02944656|541666994|FG000|Overall Study|Lost to Follow-up|7|||
150145083|NCT02944656|541666995|FG001|Overall Study|Lost to Follow-up|10|||
150145084|NCT02243631|541668400|FG000|Overall Study|no synovial fluid on second aspirate|0|||
150145085|NCT02243631|541668401|FG001|Overall Study|no synovial fluid on second aspirate|1|||
150145086|NCT01590771|541668408|FG000|Overall Study|Other Protocol Specified Criteria|5|||
150145087|NCT01590771|541668409|FG001|Overall Study|Other Protocol Specified Criteria|14|||
150145088|NCT01590771|541668408|FG000|Overall Study|Withdrawal by Subject|8|||
150145089|NCT01590771|541668409|FG001|Overall Study|Withdrawal by Subject|15|||
150145090|NCT01590771|541668408|FG000|Overall Study|Protocol Violation|1|||
150145091|NCT01590771|541668409|FG001|Overall Study|Protocol Violation|2|||
150145092|NCT01590771|541668408|FG000|Overall Study|Lost to Follow-up|1|||
150145093|NCT01590771|541668409|FG001|Overall Study|Lost to Follow-up|1|||
150145094|NCT01590771|541668408|FG000|Overall Study|Lack of Efficacy|1|||
150145095|NCT01590771|541668409|FG001|Overall Study|Lack of Efficacy|0|||
150145096|NCT01590771|541668408|FG000|Overall Study|Adverse Event|3|||
150145097|NCT01590771|541668409|FG001|Overall Study|Adverse Event|7|||
150145098|NCT01785628|541668412|FG000|Overall Study|Lost to Follow-up|2|||
150145099|NCT01785628|541668413|FG001|Overall Study|Lost to Follow-up|3|||
150145100|NCT03015116|541668414|FG000|Overall Study|Lost to Follow-up|3|||
150145101|NCT03015116|541668415|FG001|Overall Study|Lost to Follow-up|0|||
150145102|NCT03015116|541668416|FG002|Overall Study|Lost to Follow-up|2|||
150145103|NCT03015116|541668414|FG000|Overall Study|Withdrawal by Subject|3|||
150145104|NCT03015116|541668415|FG001|Overall Study|Withdrawal by Subject|1|||
150145105|NCT03015116|541668416|FG002|Overall Study|Withdrawal by Subject|0|||
150145106|NCT03015116|541668414|FG000|Overall Study|Subject has New Medical Status|1|||
150145107|NCT03015116|541668415|FG001|Overall Study|Subject has New Medical Status|0|||
149918713|NCT01760447|540835169|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
149918714|NCT01760447|540835170|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
149918715|NCT01760447|540835171|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
149918716|NCT01760447|540835168|FG000|Weeks 0-20|Withdrawal by Subject|2|||
149918717|NCT01760447|540835169|FG001|Weeks 0-20|Withdrawal by Subject|0|||
149918718|NCT01760447|540835170|FG002|Weeks 0-20|Withdrawal by Subject|1|||
149918719|NCT01760447|540835171|FG003|Weeks 0-20|Withdrawal by Subject|0|||
149918720|NCT01760447|540835168|FG000|Weeks 0-20|Lost to Follow-up|1|||
149918721|NCT01760447|540835169|FG001|Weeks 0-20|Lost to Follow-up|0|||
149918722|NCT01760447|540835170|FG002|Weeks 0-20|Lost to Follow-up|1|||
149918723|NCT01760447|540835171|FG003|Weeks 0-20|Lost to Follow-up|1|||
149918724|NCT01760447|540835168|FG000|Weeks 0-20|Randomized but not treated|0|||
149918725|NCT01760447|540835169|FG001|Weeks 0-20|Randomized but not treated|0|||
149918726|NCT01760447|540835170|FG002|Weeks 0-20|Randomized but not treated|2|||
149918727|NCT01760447|540835171|FG003|Weeks 0-20|Randomized but not treated|0|||
149918728|NCT01760447|540835168|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
149918729|NCT01760447|540835169|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
149918730|NCT01760447|540835170|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
149918731|NCT01760447|540835171|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
149918732|NCT01760447|540835168|FG000|Weeks 20-54|Withdrawal by Subject|2|||
149918733|NCT01760447|540835169|FG001|Weeks 20-54|Withdrawal by Subject|1|||
149918734|NCT01760447|540835170|FG002|Weeks 20-54|Withdrawal by Subject|1|||
149918735|NCT01760447|540835171|FG003|Weeks 20-54|Withdrawal by Subject|2|||
149918736|NCT01760447|540835168|FG000|Weeks 20-54|Lost to Follow-up|0|||
149918737|NCT01760447|540835169|FG001|Weeks 20-54|Lost to Follow-up|0|||
149918738|NCT01760447|540835170|FG002|Weeks 20-54|Lost to Follow-up|1|||
149918739|NCT01760447|540835171|FG003|Weeks 20-54|Lost to Follow-up|2|||
149918740|NCT03742258|540835174|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
149918741|NCT03742258|540835175|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
149918742|NCT03742258|540835176|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
149918743|NCT03742258|540835174|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
149918744|NCT03742258|540835175|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
149918745|NCT03742258|540835176|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
149918746|NCT03742258|540835174|FG000|Survival Follow-Up|Still in Follow-up|0|||
149918747|NCT03742258|540835175|FG001|Survival Follow-Up|Still in Follow-up|0|||
149918748|NCT03742258|540835176|FG002|Survival Follow-Up|Still in Follow-up|2|||
149918749|NCT01380691|540835177|FG000|Washout (7 Days)|Protocol Violation|0|||
149918750|NCT01380691|540835178|FG001|Washout (7 Days)|Protocol Violation|0|||
149918751|NCT01380691|540835179|FG002|Washout (7 Days)|Protocol Violation|0|||
149918752|NCT01380691|540835180|FG003|Washout (7 Days)|Protocol Violation|1|||
149918753|NCT01380691|540835177|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
149918754|NCT01380691|540835178|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
149918755|NCT01380691|540835179|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
149918756|NCT01380691|540835180|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
149918757|NCT02536781|540835181|FG000|Overall Study|Lost to Follow-up|2|||
149918758|NCT02536781|540835182|FG001|Overall Study|Lost to Follow-up|0|||
149918759|NCT03423147|540835183|FG000|Overall Study|Lost to Follow-up|5|||
149918760|NCT03423147|540835184|FG001|Overall Study|Lost to Follow-up|8|||
150145108|NCT03015116|541668416|FG002|Overall Study|Subject has New Medical Status|0|||
150145109|NCT03015116|541668414|FG000|Overall Study|Physician Decision|0|||
150145110|NCT03015116|541668415|FG001|Overall Study|Physician Decision|1|||
150145111|NCT03015116|541668416|FG002|Overall Study|Physician Decision|0|||
150145112|NCT02200939|541668420|FG000|Overall Study|Participant withdrew consent|0|||
150145113|NCT02200939|541668421|FG001|Overall Study|Participant withdrew consent|1|||
150145114|NCT02200939|541668420|FG000|Overall Study|Lost to Follow-up|2|||
150145115|NCT02200939|541668421|FG001|Overall Study|Lost to Follow-up|9|||
150145116|NCT02200939|541668420|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
150145117|NCT02200939|541668421|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
150145118|NCT00553202|541668424|FG000|Overall Study|Death|16|||
150145119|NCT00553202|541668424|FG000|Overall Study|Lost to Follow-up|1|||
150145120|NCT00553202|541668424|FG000|Overall Study|Physician Decision|28|||
150145121|NCT00553202|541668424|FG000|Overall Study|Withdrawal by Subject|1|||
150145122|NCT00553202|541668424|FG000|Overall Study|No donor identified|16|||
150145123|NCT00553202|541668424|FG000|Overall Study|Fails to meet organ function|6|||
150145124|NCT03239873|541668425|FG000|Overall Study|Lost to Follow-up|15|||
150145125|NCT03239873|541668426|FG001|Overall Study|Lost to Follow-up|16|||
150145126|NCT03239873|541668425|FG000|Overall Study|Physician Decision|1|||
150145127|NCT03239873|541668426|FG001|Overall Study|Physician Decision|0|||
150145128|NCT03239873|541668425|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
150145129|NCT03239873|541668426|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
150145130|NCT03239873|541668425|FG000|Overall Study|Withdrawal by Subject|2|||
150145131|NCT03239873|541668426|FG001|Overall Study|Withdrawal by Subject|0|||
150145132|NCT03239873|541668425|FG000|Overall Study|Contraindication to study medication|1|||
150145133|NCT03239873|541668426|FG001|Overall Study|Contraindication to study medication|0|||
150145134|NCT03239873|541668425|FG000|Overall Study|Protocol Violation|1|||
150145135|NCT03239873|541668426|FG001|Overall Study|Protocol Violation|0|||
150145136|NCT00768430|541668437|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
150145137|NCT00768430|541668438|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
150145138|NCT01478113|541668439|FG000|Overall Study|Withdrawal by Subject|0|||
150145139|NCT01478113|541668440|FG001|Overall Study|Withdrawal by Subject|1|||
150145140|NCT01478113|541668439|FG000|Overall Study|Physician Decision|1|||
150145141|NCT01478113|541668440|FG001|Overall Study|Physician Decision|0|||
150145142|NCT03585296|541668444|FG000|Overall Study|Adverse Event|1|||
150145143|NCT03585296|541668444|FG000|Overall Study|Lost to Follow-up|2|||
150145144|NCT03585296|541668444|FG000|Overall Study|Withdrawal by Subject|2|||
150145145|NCT00041756|541668445|FG000|Overall Study|Adverse Event|4|||
150145146|NCT00041756|541668446|FG001|Overall Study|Adverse Event|10|||
150145147|NCT00041756|541668447|FG002|Overall Study|Adverse Event|6|||
150145148|NCT00041756|541668448|FG003|Overall Study|Adverse Event|11|||
150145149|NCT00041756|541668449|FG004|Overall Study|Adverse Event|34|||
150145150|NCT00041756|541668445|FG000|Overall Study|Protocol Violation|1|||
150145151|NCT00041756|541668446|FG001|Overall Study|Protocol Violation|1|||
150145152|NCT00041756|541668447|FG002|Overall Study|Protocol Violation|2|||
150145153|NCT00041756|541668448|FG003|Overall Study|Protocol Violation|2|||
150145154|NCT00041756|541668449|FG004|Overall Study|Protocol Violation|1|||
149918761|NCT03423147|540835183|FG000|Overall Study|Withdrawal by Subject|1|||
149918762|NCT03423147|540835184|FG001|Overall Study|Withdrawal by Subject|0|||
149918763|NCT03423147|540835183|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
149918764|NCT03423147|540835184|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
149918765|NCT03423147|540835183|FG000|Overall Study|Age < 18|1|||
149918766|NCT03423147|540835184|FG001|Overall Study|Age < 18|0|||
149918767|NCT03423147|540835183|FG000|Overall Study|No Trial of Labor|0|||
149918768|NCT03423147|540835184|FG001|Overall Study|No Trial of Labor|1|||
149918769|NCT01048099|540835185|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
149918770|NCT01048099|540835185|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
149918771|NCT00508157|540835186|FG000|Overall Study|Adverse Event|0|||
149918772|NCT00508157|540835187|FG001|Overall Study|Adverse Event|1|||
149918773|NCT00508157|540835186|FG000|Overall Study|Subject Withdrew Consent|1|||
149918774|NCT00508157|540835187|FG001|Overall Study|Subject Withdrew Consent|0|||
149918775|NCT00508157|540835186|FG000|Overall Study|Lost to Follow-up|1|||
149918776|NCT00508157|540835187|FG001|Overall Study|Lost to Follow-up|0|||
149918777|NCT00508157|540835186|FG000|Overall Study|Subject no longer met study criteria|0|||
149918778|NCT00508157|540835187|FG001|Overall Study|Subject no longer met study criteria|1|||
149918779|NCT00508157|540835186|FG000|Overall Study|Other known cause|0|||
149918780|NCT00508157|540835187|FG001|Overall Study|Other known cause|1|||
149918781|NCT01987232|540835188|FG000|Overall Study|Ongoing in Study|0|||
149918782|NCT01987232|540835189|FG001|Overall Study|Ongoing in Study|0|||
149918783|NCT01987232|540835190|FG002|Overall Study|Ongoing in Study|0|||
149918784|NCT01987232|540835191|FG003|Overall Study|Ongoing in Study|1|||
149918785|NCT01987232|540835192|FG004|Overall Study|Ongoing in Study|0|||
149918786|NCT01731470|540835194|FG000|Overall Study|Withdrawal by Subject|1|||
149918787|NCT01731470|540835194|FG000|Overall Study|Did not meet study criteria|1|||
149918788|NCT01952080|540835195|FG000|Overall Study|Withdrawal by Subject|0|||
149918789|NCT01952080|540835196|FG001|Overall Study|Withdrawal by Subject|0|||
149918790|NCT01952080|540835197|FG002|Overall Study|Withdrawal by Subject|0|||
149918791|NCT01952080|540835198|FG003|Overall Study|Withdrawal by Subject|1|||
149918792|NCT01952080|540835195|FG000|Overall Study|Protocol Non-compliance|0|||
149918793|NCT01952080|540835196|FG001|Overall Study|Protocol Non-compliance|1|||
149918794|NCT01952080|540835197|FG002|Overall Study|Protocol Non-compliance|0|||
149918795|NCT01952080|540835198|FG003|Overall Study|Protocol Non-compliance|0|||
149918796|NCT02258334|540835199|FG000|Overall Study|Adverse Event|1|||
149918797|NCT02258334|540835200|FG001|Overall Study|Adverse Event|0|||
149918798|NCT02258334|540835201|FG002|Overall Study|Adverse Event|0|||
149918799|NCT02258334|540835202|FG003|Overall Study|Adverse Event|0|||
149918800|NCT03564795|540835205|FG000|Overall Study|Withdrawal by Subject|3|||
149918801|NCT03564795|540835205|FG000|Overall Study|Lost to Follow-up|6|||
149918802|NCT03564795|540835205|FG000|Overall Study|Physician Decision|2|||
149918803|NCT00862459|540835206|FG000|Overall Study|Lost to Follow-up|1|||
149918804|NCT00862459|540835207|FG001|Overall Study|Lost to Follow-up|2|||
149918805|NCT00862459|540835208|FG002|Overall Study|Lost to Follow-up|2|||
149918806|NCT00862459|540835206|FG000|Overall Study|Protocol Violation|1|||
149918807|NCT00862459|540835207|FG001|Overall Study|Protocol Violation|0|||
149918808|NCT00862459|540835208|FG002|Overall Study|Protocol Violation|0|||
149918809|NCT00862459|540835206|FG000|Overall Study|Withdrawal by Subject|1|||
149918810|NCT00862459|540835207|FG001|Overall Study|Withdrawal by Subject|1|||
149918811|NCT00862459|540835208|FG002|Overall Study|Withdrawal by Subject|3|||
150145155|NCT00041756|541668445|FG000|Overall Study|Withdrawal by Subject|3|||
150145156|NCT00041756|541668446|FG001|Overall Study|Withdrawal by Subject|3|||
150145157|NCT00041756|541668447|FG002|Overall Study|Withdrawal by Subject|4|||
150145158|NCT00041756|541668448|FG003|Overall Study|Withdrawal by Subject|2|||
150145159|NCT00041756|541668449|FG004|Overall Study|Withdrawal by Subject|3|||
150145160|NCT00041756|541668445|FG000|Overall Study|Lost to Follow-up|0|||
150145161|NCT00041756|541668446|FG001|Overall Study|Lost to Follow-up|1|||
150145162|NCT00041756|541668447|FG002|Overall Study|Lost to Follow-up|0|||
150145163|NCT00041756|541668448|FG003|Overall Study|Lost to Follow-up|1|||
150145164|NCT00041756|541668449|FG004|Overall Study|Lost to Follow-up|0|||
150145165|NCT00041756|541668445|FG000|Overall Study|Unable to meet protocol criteria|0|||
150145166|NCT00041756|541668446|FG001|Overall Study|Unable to meet protocol criteria|0|||
150145167|NCT00041756|541668447|FG002|Overall Study|Unable to meet protocol criteria|1|||
150145168|NCT00041756|541668448|FG003|Overall Study|Unable to meet protocol criteria|0|||
150145169|NCT00041756|541668449|FG004|Overall Study|Unable to meet protocol criteria|1|||
150145170|NCT00041756|541668445|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
150145171|NCT00041756|541668446|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
150145172|NCT00041756|541668447|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
150145173|NCT00041756|541668448|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
150145174|NCT00041756|541668449|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
150145175|NCT00462670|541668452|FG000|Overall Study|Adverse Event|3|||
150145176|NCT00462670|541668453|FG001|Overall Study|Adverse Event|5|||
150145177|NCT00462670|541668452|FG000|Overall Study|Lack of Efficacy|1|||
150145178|NCT00462670|541668453|FG001|Overall Study|Lack of Efficacy|0|||
150145179|NCT00462670|541668452|FG000|Overall Study|Protocol Violation|1|||
150145180|NCT00462670|541668453|FG001|Overall Study|Protocol Violation|0|||
150145181|NCT00462670|541668452|FG000|Overall Study|Resolution of signs and symptoms|0|||
150145182|NCT00462670|541668453|FG001|Overall Study|Resolution of signs and symptoms|2|||
150145183|NCT02002884|541668454|FG000|Main Period (MP)|Other|0|||
150145184|NCT02002884|541668455|FG001|Main Period (MP)|Other|3|||
150145185|NCT02002884|541668456|FG002|Main Period (MP)|Other|3|||
150145186|NCT02002884|541668457|FG003|Main Period (MP)|Other|0|||
150145187|NCT02002884|541668454|FG000|Main Period (MP)|Adverse Event|0|||
149918812|NCT00862459|540835206|FG000|Overall Study|Adverse Event|0|||
150145188|NCT02002884|541668455|FG001|Main Period (MP)|Adverse Event|1|||
150145189|NCT02002884|541668456|FG002|Main Period (MP)|Adverse Event|1|||
150145190|NCT02002884|541668457|FG003|Main Period (MP)|Adverse Event|0|||
150145191|NCT02002884|541668454|FG000|Main Period (MP)|Withdrawal by Subject|6|||
150145192|NCT02002884|541668455|FG001|Main Period (MP)|Withdrawal by Subject|2|||
150145193|NCT02002884|541668456|FG002|Main Period (MP)|Withdrawal by Subject|2|||
150145194|NCT02002884|541668457|FG003|Main Period (MP)|Withdrawal by Subject|0|||
150145195|NCT02002884|541668454|FG000|Main Period (MP)|Lost to Follow-up|0|||
150145196|NCT02002884|541668455|FG001|Main Period (MP)|Lost to Follow-up|0|||
150145197|NCT02002884|541668456|FG002|Main Period (MP)|Lost to Follow-up|2|||
150145198|NCT02002884|541668457|FG003|Main Period (MP)|Lost to Follow-up|0|||
150145199|NCT02002884|541668454|FG000|Open-Label Extension Period (OLEX)|Other|0|||
150145200|NCT02002884|541668455|FG001|Open-Label Extension Period (OLEX)|Other|0|||
150145201|NCT02002884|541668456|FG002|Open-Label Extension Period (OLEX)|Other|0|||
150145202|NCT02002884|541668457|FG003|Open-Label Extension Period (OLEX)|Other|24|||
150145203|NCT02002884|541668454|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
150145204|NCT02002884|541668455|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
150145205|NCT02002884|541668456|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
150145206|NCT02002884|541668457|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
150145207|NCT02002884|541668454|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
150145208|NCT02002884|541668455|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
150145209|NCT02002884|541668456|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
150145210|NCT02002884|541668457|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
150145211|NCT02002884|541668454|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
150145212|NCT02002884|541668455|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
150145213|NCT02002884|541668456|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
150145214|NCT02002884|541668457|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
150145215|NCT02002884|541668454|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
150145216|NCT02002884|541668455|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
150145217|NCT02002884|541668456|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
150145218|NCT02002884|541668457|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
150145219|NCT02966002|541668458|FG000|Overall Study|Withdrawal by Subject|2|||
150145220|NCT02966002|541668458|FG000|Overall Study|Adverse Event|1|||
150145221|NCT02966002|541668458|FG000|Overall Study|Lost to Follow-up|1|||
150145222|NCT02291432|541668459|FG000|Overall Study|Withdrawal by Subject|2|||
150145223|NCT02145078|541668462|FG000|Overall Study|Death|1|||
150145224|NCT02145078|541668462|FG000|Overall Study|Reason not given|3|||
150145225|NCT03327402|541668463|FG000|Overall Study|Withdrawal by Subject|1|||
150145226|NCT03327402|541668463|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
150145227|NCT01454830|541668466|FG000|Overall Study|Withdrawal by Subject|4|||
150145228|NCT01454830|541668467|FG001|Overall Study|Withdrawal by Subject|4|||
150145229|NCT01454830|541668466|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
150145230|NCT01454830|541668467|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
150145231|NCT01454830|541668466|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
150145232|NCT01454830|541668467|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
150145233|NCT01454830|541668466|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
150145234|NCT01454830|541668467|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
150145235|NCT01454830|541668466|FG000|Overall Study|Withdrawal - no polysomnography|3|||
150145236|NCT01454830|541668467|FG001|Overall Study|Withdrawal - no polysomnography|2|||
150145237|NCT01785563|541668468|FG000|Overall Study|Physician Decision|10|||
150145238|NCT01785563|541668468|FG000|Overall Study|Withdrawal by Subject|1|||
150145239|NCT01785563|541668468|FG000|Overall Study|Protocol Violation|2|||
150145240|NCT01616771|541668471|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
150145241|NCT00744328|541668472|FG000|Overall Study|Lost to Follow-up|2|||
150145242|NCT00744328|541668473|FG001|Overall Study|Lost to Follow-up|5|||
150145243|NCT00744328|541668474|FG002|Overall Study|Lost to Follow-up|3|||
150145244|NCT00744328|541668472|FG000|Overall Study|Withdrawal by Subject|5|||
150145245|NCT00744328|541668473|FG001|Overall Study|Withdrawal by Subject|3|||
150145246|NCT00744328|541668474|FG002|Overall Study|Withdrawal by Subject|4|||
150145247|NCT00744328|541668472|FG000|Overall Study|Found ineligible after randomization|0|||
150145248|NCT00744328|541668473|FG001|Overall Study|Found ineligible after randomization|0|||
150145249|NCT00744328|541668474|FG002|Overall Study|Found ineligible after randomization|1|||
150145250|NCT02091739|541668479|FG000|MP: 16 Weeks|Adverse Event|1|||
150145251|NCT02091739|541668480|FG001|MP: 16 Weeks|Adverse Event|1|||
150145252|NCT02091739|541668481|FG002|MP: 16 Weeks|Adverse Event|1|||
150145253|NCT02091739|541668482|FG003|MP: 16 Weeks|Adverse Event|0|||
150145254|NCT02091739|541668483|FG004|MP: 16 Weeks|Adverse Event|0|||
150145255|NCT02091739|541668479|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
150145256|NCT02091739|541668480|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
150145257|NCT02091739|541668481|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
150145258|NCT02091739|541668482|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
150145259|NCT02091739|541668483|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
150145260|NCT02091739|541668479|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
150145261|NCT02091739|541668480|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
150145262|NCT02091739|541668481|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
150145263|NCT02091739|541668482|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
150145264|NCT02091739|541668483|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
150145265|NCT02091739|541668479|FG000|EP: 48 Weeks|Other|0|||
150145266|NCT02091739|541668480|FG001|EP: 48 Weeks|Other|0|||
150145267|NCT02091739|541668481|FG002|EP: 48 Weeks|Other|0|||
150145268|NCT02091739|541668482|FG003|EP: 48 Weeks|Other|1|||
150145269|NCT02091739|541668483|FG004|EP: 48 Weeks|Other|0|||
150145270|NCT02091739|541668479|FG000|EP: 48 Weeks|Death|0|||
150145271|NCT02091739|541668480|FG001|EP: 48 Weeks|Death|0|||
150145272|NCT02091739|541668481|FG002|EP: 48 Weeks|Death|0|||
150145273|NCT02091739|541668482|FG003|EP: 48 Weeks|Death|3|||
150145274|NCT02091739|541668483|FG004|EP: 48 Weeks|Death|2|||
150145275|NCT02091739|541668479|FG000|EP: 48 Weeks|Adverse Event|0|||
150145276|NCT02091739|541668480|FG001|EP: 48 Weeks|Adverse Event|0|||
150145277|NCT02091739|541668481|FG002|EP: 48 Weeks|Adverse Event|0|||
150145278|NCT02091739|541668482|FG003|EP: 48 Weeks|Adverse Event|2|||
150145279|NCT02091739|541668483|FG004|EP: 48 Weeks|Adverse Event|6|||
150145280|NCT02091739|541668479|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
150145281|NCT02091739|541668480|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
150145282|NCT02091739|541668481|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
150145283|NCT02091739|541668482|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
150145284|NCT02091739|541668483|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
150145285|NCT01905046|541668490|FG000|Months 13-24|Withdrawal by Subject|10|||
150145286|NCT01905046|541668491|FG001|Months 13-24|Withdrawal by Subject|10|||
150145287|NCT01905046|541668490|FG000|Months 13-24|Adverse Event|3|||
150145288|NCT01905046|541668491|FG001|Months 13-24|Adverse Event|2|||
150145289|NCT01905046|541668490|FG000|Months 13-24|Protocol Violation|3|||
150145290|NCT01905046|541668491|FG001|Months 13-24|Protocol Violation|3|||
150145291|NCT01905046|541668490|FG000|Months 13-24|Physician Decision|1|||
150145292|NCT01905046|541668491|FG001|Months 13-24|Physician Decision|0|||
150145293|NCT05672680|541668492|FG000|Overall Study|Patient Did Not Complete the Form|5|||
150145294|NCT05672680|541668493|FG001|Overall Study|Patient Did Not Complete the Form|4|||
150145295|NCT05672680|541668492|FG000|Overall Study|Procedure Aborted|1|||
150145296|NCT05672680|541668493|FG001|Overall Study|Procedure Aborted|0|||
150145297|NCT00779779|541668501|FG000|Overall Study|Adverse Event|1|||
150145298|NCT00779779|541668501|FG000|Overall Study|Protocol Violation|14|||
150145299|NCT00779779|541668501|FG000|Overall Study|Withdrawal by Subject|4|||
150145300|NCT00779779|541668501|FG000|Overall Study|Lost to Follow-up|5|||
150145301|NCT01395823|541668502|FG000|Overall Study|Death|4|||
150145302|NCT01395823|541668503|FG001|Overall Study|Death|4|||
150145303|NCT01395823|541668502|FG000|Overall Study|Physician Decision|3|||
150145304|NCT01395823|541668503|FG001|Overall Study|Physician Decision|1|||
150145305|NCT01395823|541668502|FG000|Overall Study|Lost to Follow-up|1|||
150145306|NCT01395823|541668503|FG001|Overall Study|Lost to Follow-up|0|||
150145307|NCT01395823|541668502|FG000|Overall Study|Transplant|1|||
150145308|NCT01395823|541668503|FG001|Overall Study|Transplant|0|||
150145309|NCT01395823|541668502|FG000|Overall Study|GI symptoms|1|||
150145310|NCT01395823|541668503|FG001|Overall Study|GI symptoms|0|||
150145311|NCT01395823|541668502|FG000|Overall Study|Withdrawal by Subject|5|||
150145312|NCT01395823|541668503|FG001|Overall Study|Withdrawal by Subject|4|||
149802762|NCT01243762|540406014|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149802763|NCT01243762|540406008|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149802764|NCT01243762|540406009|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
149802765|NCT01243762|540406010|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
150145313|NCT03300570|541668504|FG000|Overall Study|Adverse Event|0|||
150145314|NCT03300570|541668505|FG001|Overall Study|Adverse Event|1|||
150145315|NCT03300570|541668504|FG000|Overall Study|Withdrawal by Subject|1|||
150145316|NCT03300570|541668505|FG001|Overall Study|Withdrawal by Subject|0|||
150145317|NCT03300570|541668504|FG000|Overall Study|Inadequate bowel prep|1|||
150145318|NCT03300570|541668505|FG001|Overall Study|Inadequate bowel prep|0|||
150145319|NCT00116272|541668506|FG000|Overall Study|Lost to Follow-up|11|||
150145320|NCT00116272|541668507|FG001|Overall Study|Lost to Follow-up|6|||
150145321|NCT03188120|541668508|FG000|Overall Study|Adverse Event|4|||
150145322|NCT03188120|541668508|FG000|Overall Study|Insufficient Effectiveness|8|||
150145323|NCT03188120|541668508|FG000|Overall Study|Improved|12|||
150145324|NCT03188120|541668508|FG000|Overall Study|Lost to Follow-up|7|||
150145325|NCT03188120|541668508|FG000|Overall Study|Other than specified|3|||
150145326|NCT03188120|541668508|FG000|Overall Study|No visit after the first visit|13|||
150145327|NCT02178566|541668517|FG000|Overall Study|patient did not complete due to noncompliance|0|||
150145328|NCT02178566|541668518|FG001|Overall Study|patient did not complete due to noncompliance|1|||
150145329|NCT00682643|541668519|FG000|Overall Study|Adverse Event|12|||
150145330|NCT00682643|541668520|FG001|Overall Study|Adverse Event|23|||
150145331|NCT00682643|541668519|FG000|Overall Study|Lack of Efficacy|2|||
150145332|NCT00682643|541668520|FG001|Overall Study|Lack of Efficacy|0|||
150145333|NCT00682643|541668519|FG000|Overall Study|Protocol Violation|38|||
150145334|NCT00682643|541668520|FG001|Overall Study|Protocol Violation|76|||
150145335|NCT00682643|541668519|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
150145336|NCT00682643|541668520|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
150145337|NCT00682643|541668519|FG000|Overall Study|Lost to Follow-up|1|||
150145338|NCT00682643|541668520|FG001|Overall Study|Lost to Follow-up|6|||
150145339|NCT00682643|541668519|FG000|Overall Study|Physician Decision|2|||
150145340|NCT00682643|541668520|FG001|Overall Study|Physician Decision|6|||
150145341|NCT00682643|541668519|FG000|Overall Study|Withdrawal by Subject|19|||
150145342|NCT00682643|541668520|FG001|Overall Study|Withdrawal by Subject|53|||
150145343|NCT00682643|541668519|FG000|Overall Study|Did Not Receive Study Drug|1|||
149802766|NCT01243762|540406011|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
150145344|NCT00682643|541668520|FG001|Overall Study|Did Not Receive Study Drug|1|||
150145345|NCT01875185|541668521|FG000|Overall Study|study was terminated|52|||
150145346|NCT01875185|541668522|FG001|Overall Study|study was terminated|48|||
150145347|NCT00085202|541668523|FG000|Overall Study|Still on therapy|2|||
150145348|NCT00085202|541668524|FG001|Overall Study|Still on therapy|0|||
150145349|NCT00085202|541668523|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
150145350|NCT00085202|541668524|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
150145351|NCT00085202|541668523|FG000|Overall Study|Excessive toxicity|6|||
150145352|NCT00085202|541668524|FG001|Overall Study|Excessive toxicity|5|||
149802767|NCT01243762|540406012|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149802768|NCT01243762|540406013|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149802769|NCT01243762|540406014|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149802770|NCT01243762|540406008|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
149802771|NCT01243762|540406009|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
149802772|NCT01243762|540406010|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
149918813|NCT00862459|540835207|FG001|Overall Study|Adverse Event|1|||
149802773|NCT01243762|540406011|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
149802774|NCT01243762|540406012|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
149802775|NCT01243762|540406013|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
149918814|NCT00862459|540835208|FG002|Overall Study|Adverse Event|0|||
149918815|NCT00862459|540835206|FG000|Overall Study|Personal reasons|1|||
149918816|NCT00862459|540835207|FG001|Overall Study|Personal reasons|0|||
149802776|NCT01243762|540406014|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
149802777|NCT01243762|540406008|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802778|NCT01243762|540406009|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
149802779|NCT01243762|540406010|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802780|NCT01243762|540406011|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802781|NCT01243762|540406012|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802782|NCT01243762|540406013|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802783|NCT01243762|540406014|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149802784|NCT01243762|540406008|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149802785|NCT01243762|540406009|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
149802786|NCT01243762|540406010|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149918817|NCT00862459|540835208|FG002|Overall Study|Personal reasons|0|||
149918818|NCT00862459|540835206|FG000|Overall Study|Operation|1|||
149918819|NCT00862459|540835207|FG001|Overall Study|Operation|1|||
149918820|NCT00862459|540835208|FG002|Overall Study|Operation|0|||
149918821|NCT00862459|540835206|FG000|Overall Study|Intravenous (IV) site problems|1|||
149918822|NCT00862459|540835207|FG001|Overall Study|Intravenous (IV) site problems|0|||
149918823|NCT00862459|540835208|FG002|Overall Study|Intravenous (IV) site problems|1|||
149918824|NCT00862459|540835206|FG000|Overall Study|Unable to hold still for imaging|0|||
149918825|NCT00862459|540835207|FG001|Overall Study|Unable to hold still for imaging|1|||
149918826|NCT00862459|540835208|FG002|Overall Study|Unable to hold still for imaging|0|||
149918827|NCT00862459|540835206|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
149918828|NCT00862459|540835207|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
149918829|NCT00862459|540835208|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
149918830|NCT00862459|540835206|FG000|Overall Study|Administrative problems|0|||
149918831|NCT00862459|540835207|FG001|Overall Study|Administrative problems|1|||
149918832|NCT00862459|540835208|FG002|Overall Study|Administrative problems|0|||
149918833|NCT00564395|540835213|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
149918834|NCT00564395|540835214|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
149918835|NCT00564395|540835213|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
149918836|NCT00564395|540835214|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
149918837|NCT02208050|540835215|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
149918838|NCT02208050|540835216|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
149918839|NCT00477607|540835219|FG000|Overall Study|Lost to Follow-up|7|||
149918840|NCT00477607|540835220|FG001|Overall Study|Lost to Follow-up|7|||
149918841|NCT00467961|540835221|FG000|Overall Study|Technical Failures|5|||
149918842|NCT00467961|540835221|FG000|Overall Study|Disease Progression|2|||
149918843|NCT02429310|540835223|FG000|Overall Study|Lost to Follow-up|1|||
149918844|NCT02429310|540835224|FG001|Overall Study|Lost to Follow-up|2|||
149918845|NCT02429310|540835223|FG000|Overall Study|Protocol Violation|1|||
149918846|NCT02429310|540835224|FG001|Overall Study|Protocol Violation|1|||
149918847|NCT00394433|540835225|FG000|Overall Study|Adverse Event|2|||
149918848|NCT00394433|540835225|FG000|Overall Study|Alternative Therapy|1|||
149918849|NCT00594386|540835228|FG000|Overall Study|Major protocol violation|2|||
149918850|NCT00594386|540835228|FG000|Overall Study|Lack of Efficacy|12|||
149918851|NCT00594386|540835228|FG000|Overall Study|Adverse Event|68|||
149918852|NCT00594386|540835228|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
149918853|NCT00594386|540835228|FG000|Overall Study|Subject withdrew consent|35|||
149918854|NCT00594386|540835228|FG000|Overall Study|Study ended per sponsor|115|||
149918855|NCT00594386|540835228|FG000|Overall Study|Lost to Follow-up|6|||
149918856|NCT00594386|540835228|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
149918857|NCT00594386|540835228|FG000|Overall Study|Other: Subject moved to Seattle|1|||
149918858|NCT00594386|540835228|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
149918859|NCT00594386|540835228|FG000|Overall Study|Other: Study terminated per investigator|2|||
149918860|NCT00594386|540835228|FG000|Overall Study|Other: Sponsor closure of study|1|||
149918861|NCT00594386|540835228|FG000|Overall Study|Other: Site terminated participation|1|||
149802787|NCT01243762|540406011|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149802788|NCT01243762|540406012|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149802789|NCT01243762|540406013|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149802790|NCT01243762|540406014|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
149802791|NCT01243762|540406008|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
149802792|NCT01243762|540406009|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
149802793|NCT01243762|540406010|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
149802794|NCT01243762|540406011|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
149802795|NCT01243762|540406012|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
149802796|NCT01243762|540406013|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
149802797|NCT01243762|540406014|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
149802798|NCT01243762|540406008|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149802799|NCT01243762|540406009|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
149802800|NCT01243762|540406010|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149802801|NCT01243762|540406011|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149802802|NCT01243762|540406012|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
149802803|NCT01243762|540406013|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149802804|NCT01243762|540406014|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149802805|NCT01243762|540406008|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149802806|NCT01243762|540406009|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149802807|NCT01243762|540406010|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149802808|NCT01243762|540406011|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
149802809|NCT01243762|540406012|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
149802810|NCT01243762|540406013|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149802811|NCT01243762|540406014|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149802812|NCT02059265|540406015|FG000|Overall Study|Ineligible|4|||
149802813|NCT03605758|540406023|FG000|Overall Study|Lost to Follow-up|2|||
149802814|NCT03605758|540406024|FG001|Overall Study|Lost to Follow-up|1|||
149802815|NCT03605758|540406023|FG000|Overall Study|Illness|0|||
149802816|NCT03605758|540406024|FG001|Overall Study|Illness|1|||
149802817|NCT03605758|540406023|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
149802818|NCT03605758|540406024|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
149802819|NCT04753606|540406027|FG000|Overall Study|Adverse Event|1|||
149802820|NCT04753606|540406028|FG001|Overall Study|Adverse Event|0|||
149802821|NCT04753606|540406029|FG002|Overall Study|Adverse Event|0|||
149802822|NCT04366258|540406036|FG000|Baseline Assessments|Screen Failure|21|||
149802823|NCT04366258|540406036|FG000|Baseline Assessments|Early Termination|3|||
149802824|NCT01725217|540406037|FG000|Overall Study|Withdrawal by Subject|1|||
149802825|NCT01725217|540406038|FG001|Overall Study|Withdrawal by Subject|0|||
149802826|NCT01725217|540406039|FG002|Overall Study|Withdrawal by Subject|0|||
149802827|NCT02940392|540406044|FG000|Overall Study|Lost to Follow-up|3|||
149802828|NCT02940392|540406044|FG000|Overall Study|Retreatment|3|||
149802829|NCT02940392|540406044|FG000|Overall Study|Death|2|||
149802830|NCT03205046|540406046|FG000|Overall Study|Death|10|||
149802831|NCT03205046|540406047|FG001|Overall Study|Death|6|||
149802832|NCT03205046|540406046|FG000|Overall Study|Withdrawal by Subject|1|||
149802833|NCT03205046|540406047|FG001|Overall Study|Withdrawal by Subject|2|||
149802834|NCT03205046|540406046|FG000|Overall Study|Lost to Follow-up|0|||
149802835|NCT03205046|540406047|FG001|Overall Study|Lost to Follow-up|1|||
149802836|NCT03205046|540406046|FG000|Overall Study|Study terminated by sponsor|2|||
149802837|NCT03205046|540406047|FG001|Overall Study|Study terminated by sponsor|1|||
149802838|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
149802839|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
149802840|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
149802841|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
149802842|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
149802843|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Death|1|||
149802844|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Death|0|||
149802845|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Death|0|||
149802846|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Death|0|||
149802847|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Death|0|||
150145353|NCT00085202|541668523|FG000|Overall Study|Non-specified|3|||
150145354|NCT00085202|541668524|FG001|Overall Study|Non-specified|5|||
150145355|NCT00085202|541668523|FG000|Overall Study|Withdrawal by Subject|2|||
150145356|NCT00085202|541668524|FG001|Overall Study|Withdrawal by Subject|1|||
149802848|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
149802849|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
149802850|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
150145357|NCT00085202|541668523|FG000|Overall Study|Physician Decision|4|||
150145358|NCT00085202|541668524|FG001|Overall Study|Physician Decision|1|||
150145359|NCT00085202|541668523|FG000|Overall Study|Progressive disease|1|||
150145360|NCT00085202|541668524|FG001|Overall Study|Progressive disease|11|||
150145361|NCT03238300|541668525|FG000|Baseline (Before Intervention)|Physician Decision|0|||
150145362|NCT03238300|541668526|FG001|Baseline (Before Intervention)|Physician Decision|1|||
150145363|NCT03238300|541668525|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
150145364|NCT03238300|541668526|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
150145365|NCT03238300|541668525|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
150145366|NCT03238300|541668526|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
150145367|NCT03238300|541668525|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
150145368|NCT03238300|541668526|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
150145369|NCT00110890|541668533|FG000|Overall Study|Adverse Event|30|||
150145370|NCT00110890|541668534|FG001|Overall Study|Adverse Event|7|||
150145371|NCT00110890|541668533|FG000|Overall Study|Death|16|||
150145372|NCT00110890|541668534|FG001|Overall Study|Death|9|||
150145373|NCT00110890|541668533|FG000|Overall Study|Lost to Follow-up|3|||
150145374|NCT00110890|541668534|FG001|Overall Study|Lost to Follow-up|1|||
150145375|NCT00110890|541668533|FG000|Overall Study|Physician Decision|4|||
150145376|NCT00110890|541668534|FG001|Overall Study|Physician Decision|5|||
150145377|NCT00110890|541668533|FG000|Overall Study|Withdrawal by Subject|17|||
150145378|NCT00110890|541668534|FG001|Overall Study|Withdrawal by Subject|5|||
150145379|NCT00110890|541668533|FG000|Overall Study|Protocol Deviation|1|||
150145380|NCT00110890|541668534|FG001|Overall Study|Protocol Deviation|0|||
150145381|NCT00110890|541668533|FG000|Overall Study|Noncompliance|10|||
150145382|NCT00110890|541668534|FG001|Overall Study|Noncompliance|0|||
150145383|NCT00110890|541668533|FG000|Overall Study|Kidney Transplant|16|||
150145384|NCT00110890|541668534|FG001|Overall Study|Kidney Transplant|12|||
150145385|NCT00110890|541668533|FG000|Overall Study|Invest. Product Commercially Available|217|||
150145386|NCT00110890|541668534|FG001|Overall Study|Invest. Product Commercially Available|110|||
150145387|NCT00110890|541668533|FG000|Overall Study|Other|34|||
150145388|NCT00110890|541668534|FG001|Overall Study|Other|23|||
150145389|NCT00110890|541668533|FG000|Overall Study|Ineligibility determined|3|||
150145390|NCT00110890|541668534|FG001|Overall Study|Ineligibility determined|0|||
150145391|NCT00110890|541668533|FG000|Overall Study|Requirement for alternative therapy|0|||
150145392|NCT00110890|541668534|FG001|Overall Study|Requirement for alternative therapy|1|||
150145393|NCT00110890|541668533|FG000|Overall Study|Disease progression|0|||
150145394|NCT00110890|541668534|FG001|Overall Study|Disease progression|1|||
150145395|NCT00110890|541668533|FG000|Overall Study|Parathyroidectomy|0|||
149802851|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
149802852|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
149802853|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
149802854|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
149802855|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
149802856|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
149802857|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
149802858|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149802859|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
149802860|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
149802861|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149802862|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149802863|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
149802864|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
149802865|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
149802866|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
149802867|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
150145396|NCT00110890|541668534|FG001|Overall Study|Parathyroidectomy|1|||
150145397|NCT00110890|541668533|FG000|Overall Study|Did not enter follow-up phase|10|||
150145398|NCT00110890|541668534|FG001|Overall Study|Did not enter follow-up phase|4|||
150145399|NCT04512066|541668535|FG000|Double-blind Treatment Period|Adverse Event|6|||
150145400|NCT04512066|541668536|FG001|Double-blind Treatment Period|Adverse Event|4|||
150145401|NCT04512066|541668537|FG002|Double-blind Treatment Period|Adverse Event|5|||
150145402|NCT04512066|541668538|FG003|Double-blind Treatment Period|Adverse Event|1|||
150145403|NCT04512066|541668539|FG004|Double-blind Treatment Period|Adverse Event|0|||
150145404|NCT04512066|541668540|FG005|Double-blind Treatment Period|Adverse Event|0|||
150145405|NCT04512066|541668535|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
150145406|NCT04512066|541668536|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
149802868|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
149802869|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
149802870|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149802871|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149802872|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149802873|NCT00634933|540406048|FG000|Part A: Baseline to Week 24|Other|1|||
149802874|NCT00634933|540406049|FG001|Part A: Baseline to Week 24|Other|8|||
149802875|NCT00634933|540406050|FG002|Part A: Baseline to Week 24|Other|5|||
149802876|NCT00634933|540406051|FG003|Part A: Baseline to Week 24|Other|0|||
149802877|NCT00634933|540406052|FG004|Part A: Baseline to Week 24|Other|0|||
149802878|NCT00634933|540406048|FG000|Between Part A and Part B|Physician Decision|0|||
149802879|NCT00634933|540406049|FG001|Between Part A and Part B|Physician Decision|1|||
149802880|NCT00634933|540406050|FG002|Between Part A and Part B|Physician Decision|0|||
149802881|NCT00634933|540406051|FG003|Between Part A and Part B|Physician Decision|0|||
149802882|NCT00634933|540406052|FG004|Between Part A and Part B|Physician Decision|0|||
149802883|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
149802884|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
149802885|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
149802886|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
149802887|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
149802888|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
149802889|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
149802890|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
149802891|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
149802892|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
149802893|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
149802894|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
149802895|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
149802896|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
149802897|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
149802898|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
149802899|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
149802900|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
149802901|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
149802902|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
149802903|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
149802904|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
149802905|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
149802906|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
149802907|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
149802908|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149802909|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
149802910|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
149802911|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149802912|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149802913|NCT00634933|540406048|FG000|Part B: Week 24 to Week 52|Other|0|||
149802914|NCT00634933|540406049|FG001|Part B: Week 24 to Week 52|Other|0|||
149802915|NCT00634933|540406050|FG002|Part B: Week 24 to Week 52|Other|5|||
149802916|NCT00634933|540406051|FG003|Part B: Week 24 to Week 52|Other|0|||
149802917|NCT00634933|540406052|FG004|Part B: Week 24 to Week 52|Other|1|||
149802918|NCT02219477|540406055|FG000|Overall Study|Adverse Event|0|||
149802919|NCT02219477|540406056|FG001|Overall Study|Adverse Event|1|||
149802920|NCT02219477|540406057|FG002|Overall Study|Adverse Event|1|||
149802921|NCT02219477|540406055|FG000|Overall Study|Withdrawal by Subject|0|||
149802922|NCT02219477|540406056|FG001|Overall Study|Withdrawal by Subject|1|||
149802923|NCT02219477|540406057|FG002|Overall Study|Withdrawal by Subject|0|||
149802924|NCT03522506|540406058|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149802925|NCT03522506|540406059|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149802926|NCT03522506|540406060|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149802927|NCT03522506|540406061|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149802928|NCT03522506|540406058|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149802929|NCT03522506|540406059|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149802930|NCT03522506|540406060|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149802931|NCT03522506|540406061|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
149802932|NCT05643573|540406062|FG000|Overall Study|Adverse Event|117|||
149802933|NCT05643573|540406063|FG001|Overall Study|Adverse Event|90|||
149802934|NCT05643573|540406062|FG000|Overall Study|Death|53|||
149802935|NCT05643573|540406063|FG001|Overall Study|Death|57|||
149802936|NCT05643573|540406062|FG000|Overall Study|Lost to Follow-up|6|||
149802937|NCT05643573|540406063|FG001|Overall Study|Lost to Follow-up|3|||
149802938|NCT05643573|540406062|FG000|Overall Study|Other|18|||
149802939|NCT05643573|540406063|FG001|Overall Study|Other|15|||
149802940|NCT05643573|540406062|FG000|Overall Study|Outcome event|64|||
149802941|NCT05643573|540406063|FG001|Overall Study|Outcome event|36|||
149802942|NCT05643573|540406062|FG000|Overall Study|Physician Decision|33|||
149802943|NCT05643573|540406063|FG001|Overall Study|Physician Decision|19|||
149802944|NCT05643573|540406062|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
149802945|NCT05643573|540406063|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
149802946|NCT05643573|540406062|FG000|Overall Study|Site terminated by sponsor|10|||
149802947|NCT05643573|540406063|FG001|Overall Study|Site terminated by sponsor|10|||
149802948|NCT05643573|540406062|FG000|Overall Study|Study terminated by sponsor|1|||
149802949|NCT05643573|540406063|FG001|Overall Study|Study terminated by sponsor|0|||
149802950|NCT05643573|540406062|FG000|Overall Study|Withdrawal by Subject|178|||
149802951|NCT05643573|540406063|FG001|Overall Study|Withdrawal by Subject|130|||
149802952|NCT04409262|540406065|FG000|Overall Study|Adverse Event|0|||
149802953|NCT04409262|540406066|FG001|Overall Study|Adverse Event|2|||
149802954|NCT04409262|540406065|FG000|Overall Study|Death|55|||
149802955|NCT04409262|540406066|FG001|Overall Study|Death|97|||
149802956|NCT04409262|540406065|FG000|Overall Study|Lost to Follow-up|12|||
149802957|NCT04409262|540406066|FG001|Overall Study|Lost to Follow-up|23|||
149802958|NCT04409262|540406065|FG000|Overall Study|Lack of Staff|0|||
149802959|NCT04409262|540406066|FG001|Overall Study|Lack of Staff|1|||
149802960|NCT04409262|540406065|FG000|Overall Study|Protocol Violation|3|||
149802961|NCT04409262|540406066|FG001|Overall Study|Protocol Violation|1|||
149802962|NCT04409262|540406065|FG000|Overall Study|Withdrawal by Subject|5|||
149802963|NCT04409262|540406066|FG001|Overall Study|Withdrawal by Subject|10|||
149802964|NCT03205605|540406067|FG000|Overall Study|Withdrawal by Subject|1|||
149802965|NCT02396849|540406068|FG000|Overall Study|Lost to Follow-up|1|||
149802966|NCT02396849|540406069|FG001|Overall Study|Lost to Follow-up|1|||
149802967|NCT02396849|540406068|FG000|Overall Study|Did not tolerate intervention|1|||
149802968|NCT02396849|540406069|FG001|Overall Study|Did not tolerate intervention|1|||
149802969|NCT03328325|540406072|FG000|Overall Study|Lost to Follow-up|4|||
149802970|NCT03328325|540406072|FG000|Overall Study|Physician Decision|1|||
149802971|NCT03328325|540406072|FG000|Overall Study|Withdrawal by Subject|3|||
149802972|NCT03328325|540406072|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
149802973|NCT00931515|540406075|FG000|Overall Study|Lost to Follow-up|2|||
149802974|NCT00931515|540406076|FG001|Overall Study|Lost to Follow-up|5|||
149802975|NCT03655951|540406077|FG000|Overall Study|Lost to Follow-up|39|||
149802976|NCT03655951|540406078|FG001|Overall Study|Lost to Follow-up|20|||
149802977|NCT03655951|540406077|FG000|Overall Study|Withdrawal by Subject|0|||
149802978|NCT03655951|540406078|FG001|Overall Study|Withdrawal by Subject|1|||
149802979|NCT03145207|540406083|FG000|Overall Study|volunteer started taking allergy shots|1|||
149802980|NCT03145207|540406083|FG000|Overall Study|baseline blood pressure high|1|||
149802981|NCT00157157|540406087|FG000|Overall Study|Withdrawal by Subject|6|||
149802982|NCT00157157|540406087|FG000|Overall Study|Physician Decision|1|||
149802983|NCT00157157|540406087|FG000|Overall Study|Lost to Follow-up|1|||
149802984|NCT00157157|540406087|FG000|Overall Study|Enrolled in another study|1|||
149802985|NCT00157157|540406087|FG000|Overall Study|Met exclusion criteria|1|||
149802986|NCT00157157|540406087|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
149802987|NCT01473602|540408086|FG000|Overall Study|Adverse Event|1|||
149802988|NCT01473602|540408087|FG001|Overall Study|Adverse Event|2|||
149802989|NCT01473602|540408086|FG000|Overall Study|Death|0|||
149802990|NCT01473602|540408087|FG001|Overall Study|Death|1|||
149802991|NCT01473602|540408086|FG000|Overall Study|Lost to Follow-up|1|||
149802992|NCT01473602|540408087|FG001|Overall Study|Lost to Follow-up|1|||
149802993|NCT01473602|540408086|FG000|Overall Study|Withdrawal by Subject|5|||
149802994|NCT01473602|540408087|FG001|Overall Study|Withdrawal by Subject|4|||
149802995|NCT01473602|540408086|FG000|Overall Study|Physician Decision|1|||
149802996|NCT01473602|540408087|FG001|Overall Study|Physician Decision|0|||
149802997|NCT00560573|540408088|FG000|Overall Study|Death|4|||
149802998|NCT00560573|540408089|FG001|Overall Study|Death|1|||
149802999|NCT00560573|540408090|FG002|Overall Study|Death|4|||
149803000|NCT00560573|540408091|FG003|Overall Study|Death|5|||
149803001|NCT00560573|540408092|FG004|Overall Study|Death|1|||
149803002|NCT00560573|540408093|FG005|Overall Study|Death|10|||
149803003|NCT00560573|540408088|FG000|Overall Study|Lost to Follow-up|0|||
149803004|NCT00560573|540408089|FG001|Overall Study|Lost to Follow-up|0|||
149803005|NCT00560573|540408090|FG002|Overall Study|Lost to Follow-up|0|||
149803006|NCT00560573|540408091|FG003|Overall Study|Lost to Follow-up|1|||
149803007|NCT00560573|540408092|FG004|Overall Study|Lost to Follow-up|1|||
149803008|NCT00560573|540408093|FG005|Overall Study|Lost to Follow-up|0|||
149803009|NCT00560573|540408088|FG000|Overall Study|Withdrawal by Subject|0|||
149803010|NCT00560573|540408089|FG001|Overall Study|Withdrawal by Subject|0|||
149803011|NCT00560573|540408090|FG002|Overall Study|Withdrawal by Subject|0|||
149803012|NCT00560573|540408091|FG003|Overall Study|Withdrawal by Subject|1|||
149803013|NCT00560573|540408092|FG004|Overall Study|Withdrawal by Subject|1|||
149803014|NCT00560573|540408093|FG005|Overall Study|Withdrawal by Subject|0|||
149803015|NCT00560573|540408088|FG000|Overall Study|Other|2|||
149803016|NCT00560573|540408089|FG001|Overall Study|Other|2|||
149803017|NCT00560573|540408090|FG002|Overall Study|Other|2|||
149803018|NCT00560573|540408091|FG003|Overall Study|Other|3|||
149803019|NCT00560573|540408092|FG004|Overall Study|Other|3|||
150145407|NCT04512066|541668537|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
150145408|NCT04512066|541668538|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
150145409|NCT04512066|541668539|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
150145410|NCT04512066|541668540|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
150145411|NCT04512066|541668535|FG000|Double-blind Treatment Period|Physician Decision|1|||
150145412|NCT04512066|541668536|FG001|Double-blind Treatment Period|Physician Decision|0|||
150145413|NCT04512066|541668537|FG002|Double-blind Treatment Period|Physician Decision|1|||
150145414|NCT04512066|541668538|FG003|Double-blind Treatment Period|Physician Decision|0|||
150145415|NCT04512066|541668539|FG004|Double-blind Treatment Period|Physician Decision|0|||
149803020|NCT00560573|540408093|FG005|Overall Study|Other|3|||
150145416|NCT04512066|541668540|FG005|Double-blind Treatment Period|Physician Decision|0|||
150145417|NCT04512066|541668535|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
150145418|NCT04512066|541668536|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
150145419|NCT04512066|541668537|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
150145420|NCT04512066|541668538|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
150145421|NCT04512066|541668539|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
150145422|NCT04512066|541668540|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
150145423|NCT04512066|541668535|FG000|Extension Period|Adverse Event|0|||
150145424|NCT04512066|541668536|FG001|Extension Period|Adverse Event|1|||
150145425|NCT04512066|541668537|FG002|Extension Period|Adverse Event|4|||
150145426|NCT04512066|541668538|FG003|Extension Period|Adverse Event|3|||
150145427|NCT04512066|541668539|FG004|Extension Period|Adverse Event|1|||
150145428|NCT04512066|541668540|FG005|Extension Period|Adverse Event|3|||
150145429|NCT04512066|541668535|FG000|Extension Period|Death|0|||
150145430|NCT04512066|541668536|FG001|Extension Period|Death|0|||
149803021|NCT00560573|540408088|FG000|Overall Study|Enrolled, not treated|0|||
149803022|NCT00560573|540408089|FG001|Overall Study|Enrolled, not treated|0|||
149803023|NCT00560573|540408090|FG002|Overall Study|Enrolled, not treated|0|||
149803024|NCT00560573|540408091|FG003|Overall Study|Enrolled, not treated|0|||
149803025|NCT00560573|540408092|FG004|Overall Study|Enrolled, not treated|1|||
149803026|NCT00560573|540408093|FG005|Overall Study|Enrolled, not treated|0|||
149803027|NCT02506101|540408095|FG000|Overall Study|Transportation issues|1|||
149803028|NCT02506101|540408096|FG001|Overall Study|Transportation issues|0|||
149803029|NCT02506101|540408095|FG000|Overall Study|No enrollment and staff unavailability|1|||
149803030|NCT02506101|540408096|FG001|Overall Study|No enrollment and staff unavailability|0|||
149803031|NCT01308476|540408097|FG000|Overall Study|Lost to Follow-up|2|||
149803032|NCT01308476|540408098|FG001|Overall Study|Lost to Follow-up|2|||
149803033|NCT01308476|540408097|FG000|Overall Study|Other|1|||
150145431|NCT04512066|541668537|FG002|Extension Period|Death|0|||
150145432|NCT04512066|541668538|FG003|Extension Period|Death|0|||
150145433|NCT04512066|541668539|FG004|Extension Period|Death|0|||
149803034|NCT01308476|540408098|FG001|Overall Study|Other|0|||
149803035|NCT02696382|540408099|FG000|Overall Study|Death|7|||
149803036|NCT02696382|540408100|FG001|Overall Study|Death|2|||
149803037|NCT02696382|540408099|FG000|Overall Study|Withdrawal by Subject|5|||
149803038|NCT02696382|540408100|FG001|Overall Study|Withdrawal by Subject|12|||
149803039|NCT02696382|540408099|FG000|Overall Study|Lost to Follow-up|4|||
149803040|NCT02696382|540408100|FG001|Overall Study|Lost to Follow-up|7|||
149803041|NCT03246152|540408102|FG000|Overall Study|Lost to Follow-up|2|||
149803042|NCT03246152|540408102|FG000|Overall Study|Protocol Violation|1|||
149803043|NCT04359758|540408109|FG000|Overall Study|Protocol Violation|3|||
149803044|NCT04359758|540408110|FG001|Overall Study|Protocol Violation|2|||
149803045|NCT03358407|540408111|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803046|NCT03358407|540408112|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803047|NCT03358407|540408113|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
149803048|NCT03358407|540408114|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803049|NCT03358407|540408115|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803050|NCT03358407|540408116|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803051|NCT03358407|540408117|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803052|NCT03358407|540408118|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803053|NCT03358407|540408119|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803054|NCT03358407|540408120|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149803055|NCT03358407|540408111|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803056|NCT03358407|540408112|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803057|NCT03358407|540408113|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803058|NCT03358407|540408114|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
150145434|NCT04512066|541668540|FG005|Extension Period|Death|1|||
150145435|NCT04512066|541668535|FG000|Extension Period|Lack of Efficacy|0|||
150145436|NCT04512066|541668536|FG001|Extension Period|Lack of Efficacy|4|||
150145437|NCT04512066|541668537|FG002|Extension Period|Lack of Efficacy|4|||
150145438|NCT04512066|541668538|FG003|Extension Period|Lack of Efficacy|1|||
150145439|NCT04512066|541668539|FG004|Extension Period|Lack of Efficacy|3|||
150145440|NCT04512066|541668540|FG005|Extension Period|Lack of Efficacy|3|||
150145441|NCT04512066|541668535|FG000|Extension Period|Lost to Follow-up|0|||
149803059|NCT03358407|540408115|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149803060|NCT03358407|540408116|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803061|NCT03358407|540408117|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803062|NCT03358407|540408118|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803063|NCT03358407|540408119|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803064|NCT03358407|540408120|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803065|NCT03358407|540408111|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803066|NCT03358407|540408112|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803067|NCT03358407|540408113|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803068|NCT03358407|540408114|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803069|NCT03358407|540408115|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803070|NCT03358407|540408116|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
149803071|NCT03358407|540408117|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803072|NCT03358407|540408118|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
149803073|NCT03358407|540408119|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803074|NCT03358407|540408120|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149803075|NCT03358407|540408111|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803076|NCT03358407|540408112|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803077|NCT03358407|540408113|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803078|NCT03358407|540408114|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803079|NCT03358407|540408115|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803080|NCT03358407|540408116|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
149803081|NCT03358407|540408117|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803082|NCT03358407|540408118|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
149803083|NCT03358407|540408119|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803084|NCT03358407|540408120|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149803085|NCT03358407|540408111|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803086|NCT03358407|540408112|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803087|NCT03358407|540408113|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803088|NCT03358407|540408114|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803089|NCT03358407|540408115|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803090|NCT03358407|540408116|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149803091|NCT03358407|540408117|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149803092|NCT03358407|540408118|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803093|NCT03358407|540408119|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803094|NCT03358407|540408120|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149803095|NCT03358407|540408111|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803096|NCT03358407|540408112|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803097|NCT03358407|540408113|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803098|NCT03358407|540408114|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803099|NCT03358407|540408115|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803100|NCT03358407|540408116|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
149803101|NCT03358407|540408117|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
149803102|NCT03358407|540408118|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
149803103|NCT03358407|540408119|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803104|NCT03358407|540408120|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149803105|NCT00483574|540408121|FG000|Overall Study|Adverse Event|6|||
149803106|NCT00483574|540408122|FG001|Overall Study|Adverse Event|0|||
149803107|NCT00483574|540408121|FG000|Overall Study|Protocol Violation|28|||
149803108|NCT00483574|540408122|FG001|Overall Study|Protocol Violation|9|||
149803109|NCT00483574|540408121|FG000|Overall Study|Lost to Follow-up|16|||
149803110|NCT00483574|540408122|FG001|Overall Study|Lost to Follow-up|4|||
149803111|NCT00483574|540408121|FG000|Overall Study|Withdrawal by Subject|52|||
149803112|NCT00483574|540408122|FG001|Overall Study|Withdrawal by Subject|0|||
149803113|NCT01012609|540408124|FG000|Overall Study|Withdrawal by Subject|1|||
149803114|NCT01012609|540408125|FG001|Overall Study|Withdrawal by Subject|1|||
149803115|NCT04983589|540408127|FG000|Overall Study|Withdrawal by Subject|0|||
149803116|NCT04983589|540408128|FG001|Overall Study|Withdrawal by Subject|3|||
149803117|NCT04983589|540408127|FG000|Overall Study|COVID-19 Infection|1|||
149803118|NCT04983589|540408128|FG001|Overall Study|COVID-19 Infection|0|||
149803119|NCT04983589|540408127|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
149803120|NCT04983589|540408128|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
149803121|NCT00924820|540408129|FG000|Overall Study|Death|2|||
149803122|NCT00924820|540408129|FG000|Overall Study|Ineligible, Screen Failure|5|||
149803123|NCT00585468|540408130|FG000|First Intervention|Withdrawal by Subject|1|||
149918862|NCT00594386|540835228|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
150145442|NCT04512066|541668536|FG001|Extension Period|Lost to Follow-up|1|||
150145443|NCT04512066|541668537|FG002|Extension Period|Lost to Follow-up|5|||
150145444|NCT04512066|541668538|FG003|Extension Period|Lost to Follow-up|2|||
150145445|NCT04512066|541668539|FG004|Extension Period|Lost to Follow-up|3|||
150145446|NCT04512066|541668540|FG005|Extension Period|Lost to Follow-up|2|||
150145447|NCT04512066|541668535|FG000|Extension Period|Non-compliance with study drug|0|||
150145448|NCT04512066|541668536|FG001|Extension Period|Non-compliance with study drug|1|||
150145449|NCT04512066|541668537|FG002|Extension Period|Non-compliance with study drug|0|||
150145450|NCT04512066|541668538|FG003|Extension Period|Non-compliance with study drug|0|||
150145451|NCT04512066|541668539|FG004|Extension Period|Non-compliance with study drug|0|||
150145452|NCT04512066|541668540|FG005|Extension Period|Non-compliance with study drug|1|||
150145453|NCT04512066|541668535|FG000|Extension Period|Other|0|||
150145454|NCT04512066|541668536|FG001|Extension Period|Other|2|||
150145455|NCT04512066|541668537|FG002|Extension Period|Other|0|||
150145456|NCT04512066|541668538|FG003|Extension Period|Other|0|||
150145457|NCT04512066|541668539|FG004|Extension Period|Other|0|||
150145458|NCT04512066|541668540|FG005|Extension Period|Other|0|||
150145459|NCT04512066|541668535|FG000|Extension Period|Physician Decision|0|||
150145460|NCT04512066|541668536|FG001|Extension Period|Physician Decision|2|||
150145461|NCT04512066|541668537|FG002|Extension Period|Physician Decision|0|||
150145462|NCT04512066|541668538|FG003|Extension Period|Physician Decision|1|||
150145463|NCT04512066|541668539|FG004|Extension Period|Physician Decision|1|||
150145464|NCT04512066|541668540|FG005|Extension Period|Physician Decision|0|||
150145465|NCT04512066|541668535|FG000|Extension Period|Withdrawal by Subject|0|||
150145466|NCT04512066|541668536|FG001|Extension Period|Withdrawal by Subject|3|||
150145467|NCT04512066|541668537|FG002|Extension Period|Withdrawal by Subject|7|||
150145468|NCT04512066|541668538|FG003|Extension Period|Withdrawal by Subject|11|||
150145469|NCT04512066|541668539|FG004|Extension Period|Withdrawal by Subject|8|||
150145470|NCT04512066|541668540|FG005|Extension Period|Withdrawal by Subject|4|||
150145471|NCT03403426|541668541|FG000|Overall Study|Death|1|||
150145472|NCT03403426|541668541|FG000|Overall Study|Lost to Follow-up|2|||
150145473|NCT03520400|541668542|FG000|Overall Study|Physician Decision|15|||
150145474|NCT03520400|541668543|FG001|Overall Study|Physician Decision|7|||
150145475|NCT00116844|541668546|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
150145476|NCT00116844|541668547|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
150145477|NCT00116844|541668546|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
150145478|NCT00116844|541668547|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
150145479|NCT00116844|541668546|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
150145480|NCT00116844|541668547|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
150145481|NCT00116844|541668546|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
150145482|NCT00116844|541668547|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
150145483|NCT00116844|541668546|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
150145484|NCT00116844|541668547|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
150145485|NCT00116844|541668546|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
150145486|NCT00116844|541668547|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
150145487|NCT00116844|541668546|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
150145488|NCT00116844|541668547|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
150145489|NCT00116844|541668546|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
150145490|NCT00116844|541668547|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
150145491|NCT00116844|541668546|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
150145492|NCT00116844|541668547|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
150145493|NCT00524030|541668548|FG000|Overall Study|Lack of Efficacy|10|||
150145494|NCT00524030|541668549|FG001|Overall Study|Lack of Efficacy|24|||
150145495|NCT00524030|541668548|FG000|Overall Study|Lost to Follow-up|0|||
150145496|NCT00524030|541668549|FG001|Overall Study|Lost to Follow-up|2|||
150145497|NCT00524030|541668548|FG000|Overall Study|Withdrawal by Subject|3|||
150145498|NCT00524030|541668549|FG001|Overall Study|Withdrawal by Subject|8|||
150145499|NCT00524030|541668548|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
150145500|NCT00524030|541668549|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
150145501|NCT00524030|541668548|FG000|Overall Study|Protocol Violation|0|||
150145502|NCT00524030|541668549|FG001|Overall Study|Protocol Violation|1|||
149803124|NCT00585468|540408131|FG001|First Intervention|Withdrawal by Subject|1|||
149803125|NCT00978120|540408136|FG000|Overall Study|Death|0|||
149803126|NCT00978120|540408137|FG001|Overall Study|Death|0|||
149803127|NCT00978120|540408138|FG002|Overall Study|Death|0|||
149803128|NCT00978120|540408139|FG003|Overall Study|Death|1|||
149803129|NCT00978120|540408136|FG000|Overall Study|Lost to Follow-up|0|||
149803130|NCT00978120|540408137|FG001|Overall Study|Lost to Follow-up|0|||
149803131|NCT00978120|540408138|FG002|Overall Study|Lost to Follow-up|3|||
149803132|NCT00978120|540408139|FG003|Overall Study|Lost to Follow-up|0|||
149803133|NCT00978120|540408136|FG000|Overall Study|Withdrawal by Subject|2|||
149803134|NCT00978120|540408137|FG001|Overall Study|Withdrawal by Subject|0|||
149803135|NCT00978120|540408138|FG002|Overall Study|Withdrawal by Subject|0|||
149803136|NCT00978120|540408139|FG003|Overall Study|Withdrawal by Subject|0|||
149803137|NCT00978120|540408136|FG000|Overall Study|Moved out of state|0|||
149803138|NCT00978120|540408137|FG001|Overall Study|Moved out of state|0|||
149803139|NCT00978120|540408138|FG002|Overall Study|Moved out of state|0|||
149803140|NCT00978120|540408139|FG003|Overall Study|Moved out of state|1|||
149803141|NCT03253809|540408140|FG000|Overall Study|Unable to obtain study related data|14|||
149803142|NCT03992456|540408141|FG000|Overall Study|Withdrawal by Subject|1|||
149803143|NCT03992456|540408142|FG001|Overall Study|Withdrawal by Subject|0|||
149803144|NCT03992456|540408141|FG000|Overall Study|Disease progression|4|||
149803145|NCT03992456|540408142|FG001|Overall Study|Disease progression|5|||
149803146|NCT03992456|540408141|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
149803147|NCT03992456|540408142|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
149803148|NCT00762073|540408145|FG000|Overall Study|Lack of Efficacy|1|||
149803149|NCT00762073|540408146|FG001|Overall Study|Lack of Efficacy|1|||
149803150|NCT00762073|540408147|FG002|Overall Study|Lack of Efficacy|0|||
149803151|NCT00762073|540408148|FG003|Overall Study|Lack of Efficacy|0|||
149803152|NCT00762073|540408145|FG000|Overall Study|Adverse Event|1|||
149803153|NCT00762073|540408146|FG001|Overall Study|Adverse Event|0|||
149803154|NCT00762073|540408147|FG002|Overall Study|Adverse Event|1|||
149803155|NCT00762073|540408148|FG003|Overall Study|Adverse Event|1|||
149803156|NCT00762073|540408145|FG000|Overall Study|Significant Subject Noncompliance|0|||
149803157|NCT00762073|540408146|FG001|Overall Study|Significant Subject Noncompliance|1|||
149803158|NCT00762073|540408147|FG002|Overall Study|Significant Subject Noncompliance|0|||
149803159|NCT00762073|540408148|FG003|Overall Study|Significant Subject Noncompliance|1|||
149803160|NCT00762073|540408145|FG000|Overall Study|Withdrawal by Subject|1|||
149803161|NCT00762073|540408146|FG001|Overall Study|Withdrawal by Subject|2|||
149803162|NCT00762073|540408147|FG002|Overall Study|Withdrawal by Subject|1|||
149803163|NCT00762073|540408148|FG003|Overall Study|Withdrawal by Subject|1|||
149803164|NCT00762073|540408145|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
149803165|NCT00762073|540408146|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
149803166|NCT00762073|540408147|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
149803167|NCT00762073|540408148|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
149803168|NCT01068418|540408149|FG000|Overall Study|Physician Decision|12|||
149803169|NCT03155269|540408150|FG000|Overall Study|Withdrawal by Subject|4|||
149803170|NCT03155269|540408151|FG001|Overall Study|Withdrawal by Subject|5|||
149803171|NCT03155269|540408150|FG000|Overall Study|Lost to Follow-up|1|||
149803172|NCT03155269|540408151|FG001|Overall Study|Lost to Follow-up|2|||
149803173|NCT00910000|540408152|FG000|Overall Study|Adverse Event|0|||
149803174|NCT00910000|540408153|FG001|Overall Study|Adverse Event|3|||
149803175|NCT00910000|540408154|FG002|Overall Study|Adverse Event|2|||
149803176|NCT00910000|540408155|FG003|Overall Study|Adverse Event|2|||
149803177|NCT00910000|540408156|FG004|Overall Study|Adverse Event|0|||
149803178|NCT00910000|540408157|FG005|Overall Study|Adverse Event|1|||
149803179|NCT00910000|540408152|FG000|Overall Study|Withdrawal by Subject|0|||
149803180|NCT00910000|540408153|FG001|Overall Study|Withdrawal by Subject|0|||
149803181|NCT00910000|540408154|FG002|Overall Study|Withdrawal by Subject|1|||
149803182|NCT00910000|540408155|FG003|Overall Study|Withdrawal by Subject|0|||
149803183|NCT00910000|540408156|FG004|Overall Study|Withdrawal by Subject|1|||
149803184|NCT00910000|540408157|FG005|Overall Study|Withdrawal by Subject|0|||
149803185|NCT04637815|540408158|FG000|Overall Study|Death|1|||
149803186|NCT04637815|540408159|FG001|Overall Study|Death|0|||
149803187|NCT04637815|540408158|FG000|Overall Study|Lost to Follow-up|5|||
149803188|NCT04637815|540408159|FG001|Overall Study|Lost to Follow-up|2|||
149803189|NCT01977625|540408160|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
150145503|NCT00524030|541668548|FG000|Overall Study|Pregnancy|1|||
150145504|NCT00524030|541668549|FG001|Overall Study|Pregnancy|0|||
149803190|NCT01977625|540408161|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149803191|NCT01977625|540408160|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
149803192|NCT01977625|540408161|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
149803193|NCT02594384|540408162|FG000|Overall Study|Disease Progression|3|||
149803194|NCT02594384|540408163|FG001|Overall Study|Disease Progression|7|||
149803195|NCT02594384|540408164|FG002|Overall Study|Disease Progression|0|||
149803196|NCT02594384|540408165|FG003|Overall Study|Disease Progression|2|||
149803197|NCT02594384|540408166|FG004|Overall Study|Disease Progression|2|||
149803198|NCT02594384|540408167|FG005|Overall Study|Disease Progression|12|||
150145505|NCT00524030|541668548|FG000|Overall Study|Adverse Event|3|||
150145506|NCT00524030|541668549|FG001|Overall Study|Adverse Event|21|||
149803199|NCT02594384|540408168|FG006|Overall Study|Disease Progression|5|||
149803200|NCT02594384|540408169|FG007|Overall Study|Disease Progression|5|||
149803201|NCT02594384|540408162|FG000|Overall Study|Adverse Event|0|||
149803202|NCT02594384|540408163|FG001|Overall Study|Adverse Event|1|||
149803203|NCT02594384|540408164|FG002|Overall Study|Adverse Event|4|||
149803204|NCT02594384|540408165|FG003|Overall Study|Adverse Event|1|||
149803205|NCT02594384|540408166|FG004|Overall Study|Adverse Event|0|||
149803206|NCT02594384|540408167|FG005|Overall Study|Adverse Event|6|||
149803207|NCT02594384|540408168|FG006|Overall Study|Adverse Event|1|||
149803208|NCT02594384|540408169|FG007|Overall Study|Adverse Event|1|||
149803209|NCT02594384|540408162|FG000|Overall Study|Withdrawal by Subject|0|||
149803210|NCT02594384|540408163|FG001|Overall Study|Withdrawal by Subject|0|||
149803211|NCT02594384|540408164|FG002|Overall Study|Withdrawal by Subject|0|||
149803212|NCT02594384|540408165|FG003|Overall Study|Withdrawal by Subject|1|||
149803213|NCT02594384|540408166|FG004|Overall Study|Withdrawal by Subject|0|||
149803214|NCT02594384|540408167|FG005|Overall Study|Withdrawal by Subject|0|||
149803215|NCT02594384|540408168|FG006|Overall Study|Withdrawal by Subject|0|||
149803216|NCT02594384|540408169|FG007|Overall Study|Withdrawal by Subject|1|||
149803217|NCT02594384|540408162|FG000|Overall Study|Physician Decision|0|||
149803218|NCT02594384|540408163|FG001|Overall Study|Physician Decision|0|||
150145507|NCT00524030|541668548|FG000|Overall Study|Death|0|||
150145508|NCT00524030|541668549|FG001|Overall Study|Death|1|||
150145509|NCT04398537|541668550|FG000|Overall Study|Physician Decision|10|||
150145510|NCT04398537|541668551|FG001|Overall Study|Physician Decision|15|||
150145511|NCT03722264|541669957|FG000|Overall Study|Physician Decision|3|||
150145512|NCT01486758|541669958|FG000|Overall Study|Lost to Follow-up|0|||
150145513|NCT01486758|541669959|FG001|Overall Study|Lost to Follow-up|1|||
150145514|NCT02254408|541669970|FG000|Overall Study|Randomized But Not Treated|1|||
150145515|NCT02254408|541669971|FG001|Overall Study|Randomized But Not Treated|3|||
150145516|NCT02254408|541669970|FG000|Overall Study|Adverse Event|1|||
150145517|NCT02254408|541669971|FG001|Overall Study|Adverse Event|0|||
150145518|NCT02254408|541669970|FG000|Overall Study|Death|2|||
150145519|NCT02254408|541669971|FG001|Overall Study|Death|3|||
150145520|NCT02254408|541669970|FG000|Overall Study|Investigator's Discretion|0|||
150145521|NCT02254408|541669971|FG001|Overall Study|Investigator's Discretion|1|||
150145522|NCT02254408|541669970|FG000|Overall Study|Withdrawal by Subject|3|||
150145523|NCT02254408|541669971|FG001|Overall Study|Withdrawal by Subject|3|||
150145524|NCT02254408|541669970|FG000|Overall Study|Lost to Follow-up|1|||
150145525|NCT02254408|541669971|FG001|Overall Study|Lost to Follow-up|0|||
150145526|NCT03980184|541669973|FG000|Overall Study|Dropped out before treatment|2|||
150145527|NCT03980184|541669974|FG001|Overall Study|Dropped out before treatment|2|||
150145528|NCT03980184|541669973|FG000|Overall Study|Lost to Follow-up|11|||
150145529|NCT03980184|541669974|FG001|Overall Study|Lost to Follow-up|13|||
150145530|NCT00584805|541669976|FG000|Overall Study|No longer at risk of exposure|39|||
150145531|NCT00584805|541669976|FG000|Overall Study|Relocation|36|||
150145532|NCT00584805|541669976|FG000|Overall Study|Withdrawal by Subject|18|||
150145533|NCT00584805|541669976|FG000|Overall Study|Non-compliance|1|||
150145534|NCT00584805|541669976|FG000|Overall Study|Lost to follow up|3|||
150145535|NCT00584805|541669976|FG000|Overall Study|Screen failures|2|||
150145536|NCT01077362|541669977|FG000|Overall Study|Lack of Efficacy|13|||
150145537|NCT01077362|541669978|FG001|Overall Study|Lack of Efficacy|8|||
150145538|NCT01077362|541669979|FG002|Overall Study|Lack of Efficacy|10|||
149803219|NCT02594384|540408164|FG002|Overall Study|Physician Decision|0|||
149803220|NCT02594384|540408165|FG003|Overall Study|Physician Decision|0|||
149803221|NCT02594384|540408166|FG004|Overall Study|Physician Decision|0|||
149803222|NCT02594384|540408167|FG005|Overall Study|Physician Decision|1|||
149803223|NCT02594384|540408168|FG006|Overall Study|Physician Decision|2|||
149803224|NCT02594384|540408169|FG007|Overall Study|Physician Decision|0|||
149803225|NCT02594384|540408162|FG000|Overall Study|Progressive Leukocytosis|0|||
149803226|NCT02594384|540408163|FG001|Overall Study|Progressive Leukocytosis|0|||
149803227|NCT02594384|540408164|FG002|Overall Study|Progressive Leukocytosis|1|||
149803228|NCT02594384|540408165|FG003|Overall Study|Progressive Leukocytosis|0|||
149803229|NCT02594384|540408166|FG004|Overall Study|Progressive Leukocytosis|0|||
150145539|NCT01077362|541669977|FG000|Overall Study|Lost to Follow-up|1|||
150145540|NCT01077362|541669978|FG001|Overall Study|Lost to Follow-up|0|||
150145541|NCT01077362|541669979|FG002|Overall Study|Lost to Follow-up|3|||
150145542|NCT01077362|541669977|FG000|Overall Study|Adverse Event|12|||
150145543|NCT01077362|541669978|FG001|Overall Study|Adverse Event|7|||
150145544|NCT01077362|541669979|FG002|Overall Study|Adverse Event|4|||
150145545|NCT01077362|541669977|FG000|Overall Study|Withdrawal by Subject|5|||
150145546|NCT01077362|541669978|FG001|Overall Study|Withdrawal by Subject|3|||
150145547|NCT01077362|541669979|FG002|Overall Study|Withdrawal by Subject|5|||
150145548|NCT01077362|541669977|FG000|Overall Study|Other|0|||
150145549|NCT01077362|541669978|FG001|Overall Study|Other|1|||
149803230|NCT02594384|540408167|FG005|Overall Study|Progressive Leukocytosis|0|||
150145550|NCT01077362|541669979|FG002|Overall Study|Other|2|||
150145551|NCT03097861|541669984|FG000|Overall Study|Adverse Event|3|||
149803231|NCT02594384|540408168|FG006|Overall Study|Progressive Leukocytosis|0|||
149803232|NCT02594384|540408169|FG007|Overall Study|Progressive Leukocytosis|0|||
149803233|NCT02594384|540408162|FG000|Overall Study|Lack of Efficacy|0|||
149803234|NCT02594384|540408163|FG001|Overall Study|Lack of Efficacy|0|||
149803235|NCT02594384|540408164|FG002|Overall Study|Lack of Efficacy|0|||
149803236|NCT02594384|540408165|FG003|Overall Study|Lack of Efficacy|0|||
149803237|NCT02594384|540408166|FG004|Overall Study|Lack of Efficacy|1|||
149803238|NCT02594384|540408167|FG005|Overall Study|Lack of Efficacy|0|||
149803239|NCT02594384|540408168|FG006|Overall Study|Lack of Efficacy|0|||
149803240|NCT02594384|540408169|FG007|Overall Study|Lack of Efficacy|0|||
149803241|NCT02594384|540408162|FG000|Overall Study|Substantial noncompliance|0|||
149803242|NCT02594384|540408163|FG001|Overall Study|Substantial noncompliance|0|||
149803243|NCT02594384|540408164|FG002|Overall Study|Substantial noncompliance|0|||
149803244|NCT02594384|540408165|FG003|Overall Study|Substantial noncompliance|0|||
149803245|NCT02594384|540408166|FG004|Overall Study|Substantial noncompliance|0|||
149803246|NCT02594384|540408167|FG005|Overall Study|Substantial noncompliance|0|||
149803247|NCT02594384|540408168|FG006|Overall Study|Substantial noncompliance|1|||
149803248|NCT02594384|540408169|FG007|Overall Study|Substantial noncompliance|0|||
149803249|NCT03919669|540408173|FG000|Overall Study|Withdrawal by Subject|1|||
149803250|NCT03919669|540408174|FG001|Overall Study|Withdrawal by Subject|0|||
149803251|NCT03919669|540408175|FG002|Overall Study|Withdrawal by Subject|0|||
149803252|NCT02319642|540408176|FG000|Overall Study|Adverse Event|2|||
149803253|NCT02319642|540408177|FG001|Overall Study|Adverse Event|4|||
149803254|NCT02319642|540408176|FG000|Overall Study|Lack of Efficacy|1|||
149803255|NCT02319642|540408177|FG001|Overall Study|Lack of Efficacy|1|||
149803256|NCT02319642|540408176|FG000|Overall Study|Withdrawal by Subject|1|||
149803257|NCT02319642|540408177|FG001|Overall Study|Withdrawal by Subject|1|||
149803258|NCT01265875|540408178|FG000|Overall Study|Uncooperative/unreliable|1|||
149803259|NCT04409509|540408179|FG000|Overall Study|Failure to meet randomization requirement|1|||
149803260|NCT04409509|540408180|FG001|Overall Study|Failure to meet randomization requirement|0|||
150145552|NCT03097861|541669985|FG001|Overall Study|Adverse Event|8|||
150145553|NCT03097861|541669986|FG002|Overall Study|Adverse Event|4|||
149803261|NCT04409509|540408179|FG000|Overall Study|Adverse Event|0|||
149803262|NCT04409509|540408180|FG001|Overall Study|Adverse Event|1|||
149803263|NCT04409509|540408179|FG000|Overall Study|Death|11|||
149803264|NCT04409509|540408180|FG001|Overall Study|Death|10|||
149803265|NCT04409509|540408179|FG000|Overall Study|Non-compliance with study drug|0|||
149803266|NCT04409509|540408180|FG001|Overall Study|Non-compliance with study drug|1|||
149803267|NCT04409509|540408179|FG000|Overall Study|Lost to Follow-up|0|||
149803268|NCT04409509|540408180|FG001|Overall Study|Lost to Follow-up|3|||
149803269|NCT04409509|540408179|FG000|Overall Study|Withdrawal by Subject|0|||
149803270|NCT04409509|540408180|FG001|Overall Study|Withdrawal by Subject|3|||
149803271|NCT04409509|540408179|FG000|Overall Study|Randomized by mistake|0|||
149803272|NCT04409509|540408180|FG001|Overall Study|Randomized by mistake|1|||
149803273|NCT04409509|540408179|FG000|Overall Study|Other|1|||
149803274|NCT04409509|540408180|FG001|Overall Study|Other|1|||
149803275|NCT02331680|540408183|FG000|Overall Study|Adverse Event|3|||
149803276|NCT02331680|540408184|FG001|Overall Study|Adverse Event|0|||
149803277|NCT02331680|540408185|FG002|Overall Study|Adverse Event|2|||
149803278|NCT02331680|540408183|FG000|Overall Study|Physician Decision|1|||
149803279|NCT02331680|540408184|FG001|Overall Study|Physician Decision|1|||
149803280|NCT02331680|540408185|FG002|Overall Study|Physician Decision|2|||
149803281|NCT02331680|540408183|FG000|Overall Study|Withdrawal by Subject|0|||
149803282|NCT02331680|540408184|FG001|Overall Study|Withdrawal by Subject|1|||
149803283|NCT02331680|540408185|FG002|Overall Study|Withdrawal by Subject|2|||
149803284|NCT02331680|540408183|FG000|Overall Study|Met withdrawal criteria|2|||
149803285|NCT02331680|540408184|FG001|Overall Study|Met withdrawal criteria|2|||
149803286|NCT02331680|540408185|FG002|Overall Study|Met withdrawal criteria|5|||
149803287|NCT02331680|540408183|FG000|Overall Study|Non-compliance with study drug|0|||
149803288|NCT02331680|540408184|FG001|Overall Study|Non-compliance with study drug|0|||
149803289|NCT02331680|540408185|FG002|Overall Study|Non-compliance with study drug|1|||
149803290|NCT02331680|540408183|FG000|Overall Study|Protocol Violation|0|||
149803291|NCT02331680|540408184|FG001|Overall Study|Protocol Violation|0|||
149803292|NCT02331680|540408185|FG002|Overall Study|Protocol Violation|3|||
149803293|NCT05147311|540408186|FG000|Overall Study|Did not complete survey|2|||
149803294|NCT05147311|540408187|FG001|Overall Study|Did not complete survey|1|||
149803295|NCT05147311|540408186|FG000|Overall Study|Patient too sick|1|||
149803296|NCT05147311|540408187|FG001|Overall Study|Patient too sick|2|||
149803297|NCT05147311|540408186|FG000|Overall Study|Death|0|||
149803298|NCT05147311|540408187|FG001|Overall Study|Death|1|||
149803299|NCT05147311|540408186|FG000|Overall Study|Declined survey|1|||
149803300|NCT05147311|540408187|FG001|Overall Study|Declined survey|0|||
149803301|NCT00145795|540408189|FG000|Overall Study|Adverse Event|1|||
149803302|NCT00145795|540408190|FG001|Overall Study|Adverse Event|0|||
149803303|NCT04505592|540408191|FG000|Overall Study|Death|2|||
149803304|NCT04505592|540408192|FG001|Overall Study|Death|1|||
149803305|NCT03480243|540408194|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
150145554|NCT03097861|541669984|FG000|Overall Study|Investigator Decision|0|||
150145555|NCT03097861|541669985|FG001|Overall Study|Investigator Decision|1|||
150145556|NCT03097861|541669986|FG002|Overall Study|Investigator Decision|0|||
150145557|NCT03097861|541669984|FG000|Overall Study|Lost to Follow-up|0|||
150145558|NCT03097861|541669985|FG001|Overall Study|Lost to Follow-up|7|||
150145559|NCT03097861|541669986|FG002|Overall Study|Lost to Follow-up|1|||
150145560|NCT03097861|541669984|FG000|Overall Study|Withdrawal by Subject|1|||
150145561|NCT03097861|541669985|FG001|Overall Study|Withdrawal by Subject|5|||
150145562|NCT03097861|541669986|FG002|Overall Study|Withdrawal by Subject|3|||
150145563|NCT03097861|541669984|FG000|Overall Study|Reason not provided|3|||
150145564|NCT03097861|541669985|FG001|Overall Study|Reason not provided|1|||
150145565|NCT03097861|541669986|FG002|Overall Study|Reason not provided|1|||
150145566|NCT04399356|541669987|FG000|Overall Study|Lost to Follow-up|1|||
150145567|NCT04399356|541669988|FG001|Overall Study|Lost to Follow-up|1|||
150145568|NCT04399356|541669987|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
150145569|NCT04399356|541669988|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
150145570|NCT04399356|541669987|FG000|Overall Study|Withdrawal by Subject|1|||
150145571|NCT04399356|541669988|FG001|Overall Study|Withdrawal by Subject|0|||
150145572|NCT02247804|541669989|FG000|Treatment Period 1|Adverse Event|9|||
150145573|NCT02247804|541669990|FG001|Treatment Period 1|Adverse Event|2|||
150145574|NCT02247804|541669991|FG002|Treatment Period 1|Adverse Event|0|||
150145575|NCT02247804|541669989|FG000|Treatment Period 1|Lack of Efficacy|0|||
150145576|NCT02247804|541669990|FG001|Treatment Period 1|Lack of Efficacy|0|||
150145577|NCT02247804|541669991|FG002|Treatment Period 1|Lack of Efficacy|2|||
150145578|NCT02247804|541669989|FG000|Treatment Period 1|Lost to Follow-up|1|||
150145579|NCT02247804|541669990|FG001|Treatment Period 1|Lost to Follow-up|0|||
150145580|NCT02247804|541669991|FG002|Treatment Period 1|Lost to Follow-up|2|||
150145581|NCT02247804|541669989|FG000|Treatment Period 1|Personal Reasons|7|||
150145582|NCT02247804|541669990|FG001|Treatment Period 1|Personal Reasons|1|||
150145583|NCT02247804|541669991|FG002|Treatment Period 1|Personal Reasons|2|||
150145584|NCT02247804|541669989|FG000|Treatment Period 1|Protocol Deviation|0|||
150145585|NCT02247804|541669990|FG001|Treatment Period 1|Protocol Deviation|0|||
150145586|NCT02247804|541669991|FG002|Treatment Period 1|Protocol Deviation|1|||
150145587|NCT02247804|541669989|FG000|Treatment Period 1|Randomized but not Treated|5|||
150145588|NCT02247804|541669990|FG001|Treatment Period 1|Randomized but not Treated|1|||
150145589|NCT02247804|541669991|FG002|Treatment Period 1|Randomized but not Treated|1|||
150145590|NCT02247804|541669989|FG000|Treatment Period 2|Adverse Event|6|||
150145591|NCT02247804|541669990|FG001|Treatment Period 2|Adverse Event|3|||
150145592|NCT02247804|541669991|FG002|Treatment Period 2|Adverse Event|3|||
150145593|NCT02247804|541669989|FG000|Treatment Period 2|Lack of Efficacy|0|||
150145594|NCT02247804|541669990|FG001|Treatment Period 2|Lack of Efficacy|0|||
150145595|NCT02247804|541669991|FG002|Treatment Period 2|Lack of Efficacy|1|||
150145596|NCT02247804|541669989|FG000|Treatment Period 2|Lost to Follow-up|0|||
150145597|NCT02247804|541669990|FG001|Treatment Period 2|Lost to Follow-up|1|||
149803306|NCT03480243|540408194|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
149803307|NCT02388906|540408203|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
149803308|NCT02388906|540408204|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
149803309|NCT02388906|540408203|FG000|Treatment Period|Disease progression|121|||
149803310|NCT02388906|540408204|FG001|Treatment Period|Disease progression|100|||
149803311|NCT02388906|540408203|FG000|Treatment Period|Study drug toxicity|41|||
149803312|NCT02388906|540408204|FG001|Treatment Period|Study drug toxicity|208|||
149803313|NCT02388906|540408203|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
149803314|NCT02388906|540408204|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
149803315|NCT02388906|540408203|FG000|Treatment Period|Participant request to stop treatment|5|||
149803316|NCT02388906|540408204|FG001|Treatment Period|Participant request to stop treatment|9|||
149803317|NCT02388906|540408203|FG000|Treatment Period|Participant withdrew consent|2|||
149803318|NCT02388906|540408204|FG001|Treatment Period|Participant withdrew consent|3|||
149803319|NCT02388906|540408203|FG000|Treatment Period|Poor/non-compliance|0|||
149803320|NCT02388906|540408204|FG001|Treatment Period|Poor/non-compliance|1|||
149803321|NCT02388906|540408203|FG000|Treatment Period|Participant no longer meets study criteria|0|||
149803322|NCT02388906|540408204|FG001|Treatment Period|Participant no longer meets study criteria|1|||
149803323|NCT02388906|540408203|FG000|Treatment Period|Other reasons|3|||
149803324|NCT02388906|540408204|FG001|Treatment Period|Other reasons|3|||
149803325|NCT05770401|540408213|FG000|Overall Study|Lost to Follow-up|5|||
149803326|NCT05770401|540408214|FG001|Overall Study|Lost to Follow-up|4|||
149803327|NCT00402298|540408215|FG000|Overall Study|Withdrawal by Subject|1|||
149803328|NCT00402298|540408216|FG001|Overall Study|Withdrawal by Subject|0|||
149803329|NCT04784455|540408217|FG000|Overall Study|Death|4|||
149803330|NCT04298229|540408220|FG000|Overall Study|Physician Decision|1|||
149803331|NCT04298229|540408221|FG001|Overall Study|Physician Decision|1|||
150145598|NCT02247804|541669991|FG002|Treatment Period 2|Lost to Follow-up|1|||
150145599|NCT02247804|541669989|FG000|Treatment Period 2|Personal Reasons|2|||
150145600|NCT02247804|541669990|FG001|Treatment Period 2|Personal Reasons|1|||
150145601|NCT02247804|541669991|FG002|Treatment Period 2|Personal Reasons|1|||
150145602|NCT02247804|541669989|FG000|Treatment Period 2|Reason not Specified|0|||
150145603|NCT02247804|541669990|FG001|Treatment Period 2|Reason not Specified|0|||
149803332|NCT04298229|540408220|FG000|Overall Study|Withdrawal by Subject|1|||
149803333|NCT04298229|540408221|FG001|Overall Study|Withdrawal by Subject|1|||
149803334|NCT04298229|540408220|FG000|Overall Study|Did not receive IV loop diuretics|2|||
149803335|NCT04298229|540408221|FG001|Overall Study|Did not receive IV loop diuretics|0|||
149803336|NCT00071006|540408222|FG000|Overall Study|Lack of Efficacy|7|||
149803337|NCT00071006|540408222|FG000|Overall Study|Adverse Event|1|||
149803338|NCT00071006|540408222|FG000|Overall Study|Withdrawal by Subject|1|||
149803339|NCT00071006|540408222|FG000|Overall Study|Other|3|||
149803340|NCT05261126|540408227|FG000|Overall Study|Death|0|||
149803341|NCT05261126|540408228|FG001|Overall Study|Death|0|||
149803342|NCT05261126|540408229|FG002|Overall Study|Death|1|||
149803343|NCT05261126|540408230|FG003|Overall Study|Death|0|||
149803344|NCT05261126|540408231|FG004|Overall Study|Death|0|||
149803345|NCT05261126|540408227|FG000|Overall Study|Lost to Follow-up|0|||
149803346|NCT05261126|540408228|FG001|Overall Study|Lost to Follow-up|0|||
149803347|NCT05261126|540408229|FG002|Overall Study|Lost to Follow-up|0|||
149803348|NCT05261126|540408230|FG003|Overall Study|Lost to Follow-up|0|||
149803349|NCT05261126|540408231|FG004|Overall Study|Lost to Follow-up|1|||
149803350|NCT05261126|540408227|FG000|Overall Study|Physician Decision|1|||
149803351|NCT05261126|540408228|FG001|Overall Study|Physician Decision|0|||
149803352|NCT05261126|540408229|FG002|Overall Study|Physician Decision|0|||
149803353|NCT05261126|540408230|FG003|Overall Study|Physician Decision|0|||
149803354|NCT05261126|540408231|FG004|Overall Study|Physician Decision|0|||
149803355|NCT05261126|540408227|FG000|Overall Study|Screen Failure|0|||
149803356|NCT05261126|540408228|FG001|Overall Study|Screen Failure|0|||
149803357|NCT05261126|540408229|FG002|Overall Study|Screen Failure|0|||
149803358|NCT05261126|540408230|FG003|Overall Study|Screen Failure|0|||
149803359|NCT05261126|540408231|FG004|Overall Study|Screen Failure|1|||
149803360|NCT05261126|540408227|FG000|Overall Study|Withdrawal by Subject|1|||
149803361|NCT05261126|540408228|FG001|Overall Study|Withdrawal by Subject|0|||
149803362|NCT05261126|540408229|FG002|Overall Study|Withdrawal by Subject|1|||
149803363|NCT05261126|540408230|FG003|Overall Study|Withdrawal by Subject|1|||
149803364|NCT05261126|540408231|FG004|Overall Study|Withdrawal by Subject|0|||
149803365|NCT05261126|540408227|FG000|Overall Study|Not Recorded|0|||
149803366|NCT05261126|540408228|FG001|Overall Study|Not Recorded|0|||
149803367|NCT05261126|540408229|FG002|Overall Study|Not Recorded|0|||
149803368|NCT05261126|540408230|FG003|Overall Study|Not Recorded|1|||
149803369|NCT05261126|540408231|FG004|Overall Study|Not Recorded|0|||
149803370|NCT05939388|540408232|FG000|Overall Study|Lost to Follow-up|1|||
149803371|NCT03901274|540408233|FG000|Overall Study|Lost to Follow-up|120|||
149803372|NCT03901274|540408234|FG001|Overall Study|Lost to Follow-up|124|||
149803373|NCT03901274|540408233|FG000|Overall Study|Withdrawal by Subject|0|||
149803374|NCT03901274|540408234|FG001|Overall Study|Withdrawal by Subject|6|||
149803375|NCT05570604|540408235|FG000|Overall Study|Lost to Follow-up|1|||
149803376|NCT05570604|540408236|FG001|Overall Study|Lost to Follow-up|5|||
149803377|NCT05570604|540408235|FG000|Overall Study|Illness|2|||
149803378|NCT05570604|540408236|FG001|Overall Study|Illness|2|||
149803379|NCT04527380|540408239|FG000|Overall Study|Lack of Efficacy|0|||
149803380|NCT04527380|540408240|FG001|Overall Study|Lack of Efficacy|1|||
149803381|NCT04527380|540408239|FG000|Overall Study|Withdrawal by Subject|1|||
149803382|NCT04527380|540408240|FG001|Overall Study|Withdrawal by Subject|0|||
149803383|NCT00938366|540408254|FG000|Overall Study|Withdrawal by Subject|1|||
150145604|NCT02247804|541669991|FG002|Treatment Period 2|Reason not Specified|2|||
150145605|NCT02247804|541669989|FG000|Treatment Period 3|Adverse Event|4|||
150145606|NCT02247804|541669990|FG001|Treatment Period 3|Adverse Event|3|||
150145607|NCT02247804|541669991|FG002|Treatment Period 3|Adverse Event|3|||
150145608|NCT02247804|541669989|FG000|Treatment Period 3|Lack of Efficacy|0|||
150145609|NCT02247804|541669990|FG001|Treatment Period 3|Lack of Efficacy|1|||
150145610|NCT02247804|541669991|FG002|Treatment Period 3|Lack of Efficacy|0|||
150145611|NCT02247804|541669989|FG000|Treatment Period 3|Lost to Follow-up|1|||
150145612|NCT02247804|541669990|FG001|Treatment Period 3|Lost to Follow-up|2|||
150145613|NCT02247804|541669991|FG002|Treatment Period 3|Lost to Follow-up|2|||
150145614|NCT02247804|541669989|FG000|Treatment Period 3|Personal Reasons|4|||
150145615|NCT02247804|541669990|FG001|Treatment Period 3|Personal Reasons|3|||
150145616|NCT02247804|541669991|FG002|Treatment Period 3|Personal Reasons|2|||
150145617|NCT02247804|541669989|FG000|Treatment Period 3|Reason not Specified|2|||
150145618|NCT02247804|541669990|FG001|Treatment Period 3|Reason not Specified|1|||
150145619|NCT02247804|541669991|FG002|Treatment Period 3|Reason not Specified|3|||
150145620|NCT01827254|541669992|FG000|Overall Study|Death|10|||
150145621|NCT01827254|541669992|FG000|Overall Study|Case report form not completed|4|||
149803384|NCT00938366|540408255|FG001|Overall Study|Withdrawal by Subject|0|||
150145622|NCT01827254|541669992|FG000|Overall Study|Invalidated centre|3|||
149803385|NCT01869959|540408260|FG000|Randomization Period|Physician Decision|0|||
150145623|NCT01827254|541669992|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
150145624|NCT01827254|541669992|FG000|Overall Study|Did not complete re-challenge|1|||
149803386|NCT01869959|540408261|FG001|Randomization Period|Physician Decision|0|||
149803387|NCT01869959|540408262|FG002|Randomization Period|Physician Decision|0|||
149803388|NCT01869959|540408263|FG003|Randomization Period|Physician Decision|0|||
150145625|NCT01827254|541669992|FG000|Overall Study|Disease progression|36|||
150145626|NCT01827254|541669992|FG000|Overall Study|Intolerance to treatment|4|||
150145627|NCT01350505|541669993|FG000|Overall Study|Lost to Follow-up|4|||
150145628|NCT01834222|541669994|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
150145629|NCT01054573|541669995|FG000|Overall Study|Adverse Event|1|||
150145630|NCT01054573|541669996|FG001|Overall Study|Adverse Event|0|||
150145631|NCT01054573|541669997|FG002|Overall Study|Adverse Event|1|||
150145632|NCT01054573|541669998|FG003|Overall Study|Adverse Event|1|||
150145633|NCT01054573|541669995|FG000|Overall Study|Lost to Follow-up|0|||
150145634|NCT01054573|541669996|FG001|Overall Study|Lost to Follow-up|2|||
150145635|NCT01054573|541669997|FG002|Overall Study|Lost to Follow-up|0|||
150145636|NCT01054573|541669998|FG003|Overall Study|Lost to Follow-up|0|||
150145637|NCT01054573|541669995|FG000|Overall Study|Withdrawal by Subject|0|||
150145638|NCT01054573|541669996|FG001|Overall Study|Withdrawal by Subject|2|||
150145639|NCT01054573|541669997|FG002|Overall Study|Withdrawal by Subject|2|||
149803389|NCT01869959|540408264|FG004|Randomization Period|Physician Decision|1|||
149803390|NCT01869959|540408260|FG000|Treatment Period|Adverse Event|1|||
149803391|NCT01869959|540408261|FG001|Treatment Period|Adverse Event|0|||
149803392|NCT01869959|540408262|FG002|Treatment Period|Adverse Event|3|||
149803393|NCT01869959|540408263|FG003|Treatment Period|Adverse Event|1|||
149803394|NCT01869959|540408264|FG004|Treatment Period|Adverse Event|0|||
149803395|NCT01869959|540408260|FG000|Treatment Period|Sponsor decision|0|||
149803396|NCT01869959|540408261|FG001|Treatment Period|Sponsor decision|1|||
149803397|NCT01869959|540408262|FG002|Treatment Period|Sponsor decision|0|||
149803398|NCT01869959|540408263|FG003|Treatment Period|Sponsor decision|1|||
149803399|NCT01869959|540408264|FG004|Treatment Period|Sponsor decision|0|||
149803400|NCT01869959|540408260|FG000|Treatment Period|Withdrawal by Subject|0|||
149803401|NCT01869959|540408261|FG001|Treatment Period|Withdrawal by Subject|1|||
149803402|NCT01869959|540408262|FG002|Treatment Period|Withdrawal by Subject|0|||
149803403|NCT01869959|540408263|FG003|Treatment Period|Withdrawal by Subject|0|||
149803404|NCT01869959|540408264|FG004|Treatment Period|Withdrawal by Subject|0|||
149803405|NCT01965600|540408265|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
149803406|NCT01965600|540408266|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
149803407|NCT01965600|540408267|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
149803408|NCT01965600|540408268|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
149803409|NCT01965600|540408265|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149803410|NCT01965600|540408266|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
149803411|NCT01965600|540408267|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149803412|NCT01965600|540408268|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149803413|NCT01965600|540408265|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
149803414|NCT01965600|540408266|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149803415|NCT01965600|540408267|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149803416|NCT01965600|540408268|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149803417|NCT01965600|540408265|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
149803418|NCT01965600|540408266|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
149803419|NCT01965600|540408267|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
149803420|NCT01965600|540408268|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
149803421|NCT01965600|540408265|FG000|Second Intervention|Study terminated by Sponsor|0|||
149803422|NCT01965600|540408266|FG001|Second Intervention|Study terminated by Sponsor|0|||
149803423|NCT01965600|540408267|FG002|Second Intervention|Study terminated by Sponsor|2|||
149803424|NCT01965600|540408268|FG003|Second Intervention|Study terminated by Sponsor|2|||
149918863|NCT00594386|540835228|FG000|Overall Study|Other: Loss of drivers license|1|||
149918864|NCT03417024|540835229|FG000|Overall Study|Study Termination prior to follow-up|11|||
149918865|NCT03417024|540835229|FG000|Overall Study|Physician Decision|2|||
149918866|NCT01324570|540835233|FG000|Overall Study|Adverse Event|4|||
149918867|NCT01324570|540835234|FG001|Overall Study|Adverse Event|7|||
149918868|NCT01324570|540835233|FG000|Overall Study|Withdrawal by Subject|0|||
149918869|NCT01324570|540835234|FG001|Overall Study|Withdrawal by Subject|3|||
149918870|NCT01324570|540835233|FG000|Overall Study|Lack of Efficacy|0|||
149918871|NCT01324570|540835234|FG001|Overall Study|Lack of Efficacy|1|||
149918872|NCT01324570|540835233|FG000|Overall Study|Confirmed or suspected diversion|0|||
149918873|NCT01324570|540835234|FG001|Overall Study|Confirmed or suspected diversion|1|||
149918874|NCT01324570|540835233|FG000|Overall Study|Administrative|0|||
149918875|NCT01324570|540835234|FG001|Overall Study|Administrative|2|||
149918876|NCT00505661|540835237|FG000|Overall Study|Not Eligible|4|||
149918877|NCT01907217|540835238|FG000|Overall Study|Withdrawal by Subject|0|||
149918878|NCT01907217|540835239|FG001|Overall Study|Withdrawal by Subject|2|||
149918879|NCT01764659|540835240|FG000|Overall Study|Death|1|||
149918880|NCT01764659|540835240|FG000|Overall Study|Physician Decision|1|||
150145640|NCT01054573|541669998|FG003|Overall Study|Withdrawal by Subject|1|||
150145641|NCT03812536|541669999|FG000|Overall Study|Protocol Violation|2|||
150145642|NCT03812536|541670000|FG001|Overall Study|Protocol Violation|0|||
150145643|NCT03812536|541669999|FG000|Overall Study|Withdrawal by Subject|1|||
149803425|NCT00563706|540410591|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
149803426|NCT00563706|540410592|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149803427|NCT00563706|540410593|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149803428|NCT00563706|540410594|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149803429|NCT00563706|540410595|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149803430|NCT00563706|540410596|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149803431|NCT00563706|540410597|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149803432|NCT00563706|540410598|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149803433|NCT00563706|540410599|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
149803434|NCT00563706|540410591|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149803435|NCT00563706|540410592|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149803436|NCT00563706|540410593|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149803437|NCT00563706|540410594|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
149803438|NCT00563706|540410595|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149803439|NCT00563706|540410596|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149803440|NCT00563706|540410597|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149803441|NCT00563706|540410598|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
149803442|NCT00563706|540410599|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149803443|NCT00563706|540410591|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
149803444|NCT00563706|540410592|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149803445|NCT00563706|540410593|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
149803446|NCT00563706|540410594|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
149803447|NCT00563706|540410595|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
149803448|NCT00563706|540410596|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149803449|NCT00563706|540410597|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
149803450|NCT00563706|540410598|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
149803451|NCT00563706|540410599|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149803452|NCT00563706|540410591|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
149803453|NCT00563706|540410592|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803454|NCT00563706|540410593|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803455|NCT00563706|540410594|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803456|NCT00563706|540410595|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803457|NCT00563706|540410596|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803458|NCT00563706|540410597|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803459|NCT00563706|540410598|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
149803460|NCT00563706|540410599|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149803461|NCT00563706|540410591|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803462|NCT00563706|540410592|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803463|NCT00563706|540410593|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803464|NCT00563706|540410594|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803465|NCT00563706|540410595|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803466|NCT00563706|540410596|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803467|NCT00563706|540410597|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149803468|NCT00563706|540410598|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
149803469|NCT00563706|540410599|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
149803470|NCT03280628|540410602|FG000|Overall Study|Lost to Follow-up|8|||
149803471|NCT03280628|540410603|FG001|Overall Study|Lost to Follow-up|6|||
149803472|NCT03280628|540410604|FG002|Overall Study|Lost to Follow-up|11|||
149803473|NCT03839693|540410611|FG000|Overall Study|Lost to Follow-up|0|||
149803474|NCT03839693|540410612|FG001|Overall Study|Lost to Follow-up|2|||
149803475|NCT03839693|540410613|FG002|Overall Study|Lost to Follow-up|2|||
149803476|NCT03839693|540410611|FG000|Overall Study|Withdrawal by Subject|1|||
149803477|NCT03839693|540410612|FG001|Overall Study|Withdrawal by Subject|0|||
149803478|NCT03839693|540410613|FG002|Overall Study|Withdrawal by Subject|2|||
149803479|NCT03839693|540410611|FG000|Overall Study|subject moved out of the area|1|||
149803480|NCT03839693|540410612|FG001|Overall Study|subject moved out of the area|0|||
149803481|NCT03839693|540410613|FG002|Overall Study|subject moved out of the area|0|||
149803482|NCT00700115|540410622|FG000|Overall Study|Withdrawal by Subject|1|||
149803483|NCT00700115|540410623|FG001|Overall Study|Withdrawal by Subject|0|||
149803484|NCT00700115|540410622|FG000|Overall Study|Lost to Follow-up|0|||
149803485|NCT00700115|540410623|FG001|Overall Study|Lost to Follow-up|1|||
149803486|NCT02983305|540410624|FG000|Overall Study|incomplete data|2|||
149803487|NCT02983305|540410625|FG001|Overall Study|incomplete data|0|||
149803488|NCT00822237|540410626|FG000|Dose 1 Vaccination|Not vaccinated|3|||
149803489|NCT00822237|540410627|FG001|Dose 1 Vaccination|Not vaccinated|0|||
149803490|NCT00822237|540410626|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
149803491|NCT00822237|540410627|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
150145644|NCT03812536|541670000|FG001|Overall Study|Withdrawal by Subject|1|||
150145645|NCT00152009|541670001|FG000|Overall Study|Adverse Event|9|||
150145646|NCT00152009|541670002|FG001|Overall Study|Adverse Event|13|||
150145647|NCT00152009|541670003|FG002|Overall Study|Adverse Event|20|||
150145648|NCT00152009|541670004|FG003|Overall Study|Adverse Event|1|||
150145649|NCT00152009|541670001|FG000|Overall Study|Protocol Violation|3|||
150145650|NCT00152009|541670002|FG001|Overall Study|Protocol Violation|0|||
150145651|NCT00152009|541670003|FG002|Overall Study|Protocol Violation|0|||
150145652|NCT00152009|541670004|FG003|Overall Study|Protocol Violation|1|||
150145653|NCT00152009|541670001|FG000|Overall Study|Withdrawal by Subject|2|||
150145654|NCT00152009|541670002|FG001|Overall Study|Withdrawal by Subject|3|||
150145655|NCT00152009|541670003|FG002|Overall Study|Withdrawal by Subject|4|||
150145656|NCT00152009|541670004|FG003|Overall Study|Withdrawal by Subject|9|||
150145657|NCT00152009|541670001|FG000|Overall Study|Lost to Follow-up|2|||
150145658|NCT00152009|541670002|FG001|Overall Study|Lost to Follow-up|4|||
150145659|NCT00152009|541670003|FG002|Overall Study|Lost to Follow-up|3|||
150145660|NCT00152009|541670004|FG003|Overall Study|Lost to Follow-up|3|||
150145661|NCT00152009|541670001|FG000|Overall Study|Lack of Efficacy|8|||
150145662|NCT00152009|541670002|FG001|Overall Study|Lack of Efficacy|6|||
150145663|NCT00152009|541670003|FG002|Overall Study|Lack of Efficacy|7|||
150145664|NCT00152009|541670004|FG003|Overall Study|Lack of Efficacy|15|||
150145665|NCT00152009|541670001|FG000|Overall Study|ECG abnormalities|2|||
150145666|NCT00152009|541670002|FG001|Overall Study|ECG abnormalities|2|||
150145667|NCT00152009|541670003|FG002|Overall Study|ECG abnormalities|2|||
150145668|NCT00152009|541670004|FG003|Overall Study|ECG abnormalities|1|||
150145669|NCT00152009|541670001|FG000|Overall Study|Sponsor's decision|3|||
150145670|NCT00152009|541670002|FG001|Overall Study|Sponsor's decision|3|||
150145671|NCT00152009|541670003|FG002|Overall Study|Sponsor's decision|1|||
150145672|NCT00152009|541670004|FG003|Overall Study|Sponsor's decision|3|||
150145673|NCT01306201|541670005|FG000|Overall Study|Arrhythmia|4|||
150145674|NCT01306201|541670005|FG000|Overall Study|Files could not be processed|3|||
150145675|NCT01306201|541670005|FG000|Overall Study|Files unreadable|3|||
150145676|NCT04702568|541670006|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
150145677|NCT04702568|541670007|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
150145678|NCT04702568|541670006|FG000|Overall Study|Pregnancy|1|||
150145679|NCT04702568|541670007|FG001|Overall Study|Pregnancy|0|||
150145680|NCT04702568|541670006|FG000|Overall Study|Bone marrow transplant|1|||
149803492|NCT00822237|540410626|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
149803493|NCT00822237|540410627|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
149803494|NCT00822237|540410626|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
149803495|NCT00822237|540410627|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
149803496|NCT00822237|540410626|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
149803497|NCT00822237|540410627|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
149803498|NCT00347776|540410628|FG000|1.5 Month Follow-up|Death|2|||
149803499|NCT00347776|540410629|FG001|1.5 Month Follow-up|Death|0|||
149803500|NCT00347776|540410630|FG002|1.5 Month Follow-up|Death|0|||
149803501|NCT00347776|540410628|FG000|1.5 Month Follow-up|reached the endpoint|12|||
149803502|NCT00347776|540410629|FG001|1.5 Month Follow-up|reached the endpoint|8|||
149803503|NCT00347776|540410630|FG002|1.5 Month Follow-up|reached the endpoint|12|||
149803504|NCT00347776|540410628|FG000|6 Month Follow-up|Death|2|||
149803505|NCT00347776|540410629|FG001|6 Month Follow-up|Death|1|||
149803506|NCT00347776|540410630|FG002|6 Month Follow-up|Death|3|||
149803507|NCT00347776|540410628|FG000|6 Month Follow-up|reached endpont|20|||
149803508|NCT00347776|540410629|FG001|6 Month Follow-up|reached endpont|12|||
149803509|NCT00347776|540410630|FG002|6 Month Follow-up|reached endpont|15|||
149803510|NCT00347776|540410628|FG000|12 Month Follow-up|Lost to Follow-up|7|||
149803511|NCT00347776|540410629|FG001|12 Month Follow-up|Lost to Follow-up|6|||
149803512|NCT00347776|540410630|FG002|12 Month Follow-up|Lost to Follow-up|6|||
149803513|NCT00347776|540410628|FG000|12 Month Follow-up|Death|3|||
149803514|NCT00347776|540410629|FG001|12 Month Follow-up|Death|4|||
149803515|NCT00347776|540410630|FG002|12 Month Follow-up|Death|4|||
149803516|NCT00347776|540410628|FG000|12 Month Follow-up|Reached endpoint|13|||
150145681|NCT04702568|541670007|FG001|Overall Study|Bone marrow transplant|0|||
149803517|NCT00347776|540410629|FG001|12 Month Follow-up|Reached endpoint|6|||
150145682|NCT04702568|541670006|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
150145683|NCT04702568|541670007|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
150145684|NCT04702568|541670006|FG000|Overall Study|Withdrawal by Subject|0|||
150145685|NCT04702568|541670007|FG001|Overall Study|Withdrawal by Subject|2|||
149803518|NCT00347776|540410630|FG002|12 Month Follow-up|Reached endpoint|9|||
149803519|NCT04621227|540410635|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
149803520|NCT04621227|540410635|FG000|Period 3 (29 Days)|Adverse Event|1|||
149803521|NCT04621227|540410635|FG000|Period 8 (2 Days)|Adverse Event|1|||
149803522|NCT00938392|540410636|FG000|Overall Study|Adverse Event|0|||
149803523|NCT00938392|540410637|FG001|Overall Study|Adverse Event|1|||
149803524|NCT00938392|540410636|FG000|Overall Study|Withdrawal by Subject|0|||
150145686|NCT00393523|541670008|FG000|Overall Study|Lost to Follow-up|0|||
150145687|NCT00393523|541670009|FG001|Overall Study|Lost to Follow-up|0|||
150145688|NCT00393523|541670010|FG002|Overall Study|Lost to Follow-up|0|||
150145689|NCT00393523|541670011|FG003|Overall Study|Lost to Follow-up|2|||
150145690|NCT00393523|541670012|FG004|Overall Study|Lost to Follow-up|1|||
150145691|NCT00393523|541670008|FG000|Overall Study|Protocol Violation|6|||
150145692|NCT00393523|541670009|FG001|Overall Study|Protocol Violation|2|||
150145693|NCT00393523|541670010|FG002|Overall Study|Protocol Violation|0|||
150145694|NCT00393523|541670011|FG003|Overall Study|Protocol Violation|1|||
150145695|NCT00393523|541670012|FG004|Overall Study|Protocol Violation|0|||
150145696|NCT00393523|541670008|FG000|Overall Study|Withdrawal by Subject|6|||
150145697|NCT00393523|541670009|FG001|Overall Study|Withdrawal by Subject|7|||
150145698|NCT00393523|541670010|FG002|Overall Study|Withdrawal by Subject|2|||
150145699|NCT00393523|541670011|FG003|Overall Study|Withdrawal by Subject|3|||
150145700|NCT00393523|541670012|FG004|Overall Study|Withdrawal by Subject|0|||
150145701|NCT00393523|541670008|FG000|Overall Study|Difficulties in specimen collection|0|||
150145702|NCT00393523|541670009|FG001|Overall Study|Difficulties in specimen collection|0|||
150145703|NCT00393523|541670010|FG002|Overall Study|Difficulties in specimen collection|1|||
150145704|NCT00393523|541670011|FG003|Overall Study|Difficulties in specimen collection|0|||
150145705|NCT00393523|541670012|FG004|Overall Study|Difficulties in specimen collection|0|||
150145706|NCT00393523|541670008|FG000|Overall Study|Vaccine supply issue|0|||
150145707|NCT00393523|541670009|FG001|Overall Study|Vaccine supply issue|0|||
150145708|NCT00393523|541670010|FG002|Overall Study|Vaccine supply issue|1|||
150145709|NCT00393523|541670011|FG003|Overall Study|Vaccine supply issue|0|||
150145710|NCT00393523|541670012|FG004|Overall Study|Vaccine supply issue|0|||
150145711|NCT01735396|541670016|FG000|Overall Study|not evaluable|1|||
150145712|NCT00423852|541670021|FG000|Overall Study|Removed pior to the high-dose portion|3|||
150145713|NCT00980005|541670022|FG000|Overall Study|Withdrawal by Subject|6|||
150145714|NCT00980005|541670023|FG001|Overall Study|Withdrawal by Subject|17|||
150145715|NCT00980005|541670022|FG000|Overall Study|Lost to Follow-up|37|||
150145716|NCT00980005|541670023|FG001|Overall Study|Lost to Follow-up|43|||
150145717|NCT00980005|541670022|FG000|Overall Study|Other|4|||
150145718|NCT00980005|541670023|FG001|Overall Study|Other|3|||
150145719|NCT00572624|541670024|FG000|Overall Study|Lost to Follow-up|10|||
150145720|NCT00572624|541670025|FG001|Overall Study|Lost to Follow-up|4|||
150145721|NCT00572624|541670024|FG000|Overall Study|Wanted to do a different diet program|1|||
150145722|NCT00572624|541670025|FG001|Overall Study|Wanted to do a different diet program|0|||
150145723|NCT00572624|541670024|FG000|Overall Study|Medication change|1|||
150145724|NCT00572624|541670025|FG001|Overall Study|Medication change|0|||
150145725|NCT00572624|541670024|FG000|Overall Study|Started a new job-- no time for study|1|||
150145726|NCT00572624|541670025|FG001|Overall Study|Started a new job-- no time for study|0|||
150145727|NCT00572624|541670024|FG000|Overall Study|Admitted to being a smoker|1|||
150145728|NCT00572624|541670025|FG001|Overall Study|Admitted to being a smoker|0|||
150145729|NCT00572624|541670024|FG000|Overall Study|Refused to do the stress test|1|||
150145730|NCT00572624|541670025|FG001|Overall Study|Refused to do the stress test|0|||
150145731|NCT00572624|541670024|FG000|Overall Study|Problem with vascular access|1|||
150145732|NCT00572624|541670025|FG001|Overall Study|Problem with vascular access|0|||
150145733|NCT00572624|541670024|FG000|Overall Study|Health issues unrelated to the study|1|||
150145734|NCT00572624|541670025|FG001|Overall Study|Health issues unrelated to the study|0|||
150145735|NCT04145037|541670026|FG000|Overall Study|Study terminated|2|||
150145736|NCT04145037|541670027|FG001|Overall Study|Study terminated|0|||
150145737|NCT04145037|541670026|FG000|Overall Study|Withdrawal by Subject|1|||
150145738|NCT04145037|541670027|FG001|Overall Study|Withdrawal by Subject|0|||
150145739|NCT04145037|541670026|FG000|Overall Study|Lost to Follow-up|1|||
150145740|NCT04145037|541670027|FG001|Overall Study|Lost to Follow-up|0|||
150145741|NCT00098254|541670032|FG000|Overall Study|Adverse Event|2|||
150145742|NCT00098254|541670032|FG000|Overall Study|Death|1|||
150145743|NCT00744263|541670035|FG000|Overall Study|Death|3006|||
150145744|NCT00744263|541670036|FG001|Overall Study|Death|3005|||
150145745|NCT00744263|541670035|FG000|Overall Study|Lost to Follow-up|2038|||
150145746|NCT00744263|541670036|FG001|Overall Study|Lost to Follow-up|2135|||
150145747|NCT00744263|541670035|FG000|Overall Study|Withdrawal by Subject|166|||
150145748|NCT00744263|541670036|FG001|Overall Study|Withdrawal by Subject|150|||
150145749|NCT00744263|541670035|FG000|Overall Study|Physician Decision|20|||
150145750|NCT00744263|541670036|FG001|Overall Study|Physician Decision|23|||
150145751|NCT00744263|541670035|FG000|Overall Study|Protocol Violation|3|||
150145752|NCT00744263|541670036|FG001|Overall Study|Protocol Violation|5|||
150145753|NCT00744263|541670035|FG000|Overall Study|Adverse Event|1|||
150145754|NCT00744263|541670036|FG001|Overall Study|Adverse Event|0|||
150145755|NCT00744263|541670035|FG000|Overall Study|Other|2|||
150145756|NCT00744263|541670036|FG001|Overall Study|Other|2|||
150145757|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
150145758|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
150145759|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
150145760|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
150145761|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
150145762|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
150145763|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
149803525|NCT00938392|540410637|FG001|Overall Study|Withdrawal by Subject|1|||
149803526|NCT00938392|540410636|FG000|Overall Study|Lost to Follow-up|2|||
149803527|NCT00938392|540410637|FG001|Overall Study|Lost to Follow-up|2|||
149803528|NCT02916056|540410638|FG000|Overall Study|Adverse Event|6|||
149803529|NCT02916056|540410638|FG000|Overall Study|Lost to Follow-up|1|||
149803530|NCT02916056|540410638|FG000|Overall Study|Other|12|||
149803531|NCT02916056|540410638|FG000|Overall Study|Protocol Violation|1|||
149803532|NCT02916056|540410638|FG000|Overall Study|Withdrawal by Subject|8|||
149803533|NCT02916056|540410638|FG000|Overall Study|Study Terminated by Sponsor|269|||
149803534|NCT00124709|540410639|FG000|Overall Study|Randomized but did not take medication|3|||
149803535|NCT00124709|540410640|FG001|Overall Study|Randomized but did not take medication|1|||
149803536|NCT00124709|540410639|FG000|Overall Study|Adverse Event|3|||
149803537|NCT00124709|540410640|FG001|Overall Study|Adverse Event|0|||
149803538|NCT00124709|540410639|FG000|Overall Study|Lack of Efficacy|5|||
149803539|NCT00124709|540410640|FG001|Overall Study|Lack of Efficacy|10|||
149803540|NCT00124709|540410639|FG000|Overall Study|Protocol Violation|3|||
149803541|NCT00124709|540410640|FG001|Overall Study|Protocol Violation|5|||
149803542|NCT00124709|540410639|FG000|Overall Study|Withdrawal by Subject|127|||
149803543|NCT00124709|540410640|FG001|Overall Study|Withdrawal by Subject|136|||
149803544|NCT00124709|540410639|FG000|Overall Study|Lost to Follow-up|114|||
149803545|NCT00124709|540410640|FG001|Overall Study|Lost to Follow-up|120|||
149803546|NCT00122954|540410641|FG000|Overall Study|Withdrawal by Subject|2|||
149803547|NCT00122954|540410642|FG001|Overall Study|Withdrawal by Subject|2|||
149803548|NCT00122954|540410641|FG000|Overall Study|Protocol Violation|0|||
149803549|NCT00122954|540410642|FG001|Overall Study|Protocol Violation|1|||
149803550|NCT01728376|540410643|FG000|Overall Study|Adverse Event|1|||
149803551|NCT01728376|540410644|FG001|Overall Study|Adverse Event|1|||
149803552|NCT01728376|540410645|FG002|Overall Study|Adverse Event|1|||
149803553|NCT01728376|540410646|FG003|Overall Study|Adverse Event|1|||
149803554|NCT01728376|540410647|FG004|Overall Study|Adverse Event|1|||
149803555|NCT01728376|540410648|FG005|Overall Study|Adverse Event|0|||
149803556|NCT01728376|540410643|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
149803557|NCT01728376|540410644|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
149803558|NCT01728376|540410645|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
149803559|NCT01728376|540410646|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
149803560|NCT01728376|540410647|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
149803561|NCT01728376|540410648|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
149803562|NCT01728376|540410643|FG000|Overall Study|No relevant bacteria|2|||
149803563|NCT01728376|540410644|FG001|Overall Study|No relevant bacteria|0|||
149803564|NCT01728376|540410645|FG002|Overall Study|No relevant bacteria|0|||
149803565|NCT01728376|540410646|FG003|Overall Study|No relevant bacteria|0|||
149803566|NCT01728376|540410647|FG004|Overall Study|No relevant bacteria|1|||
149803567|NCT01728376|540410648|FG005|Overall Study|No relevant bacteria|1|||
149803568|NCT01728376|540410643|FG000|Overall Study|Did not receive treatment|0|||
149803569|NCT01728376|540410644|FG001|Overall Study|Did not receive treatment|1|||
149803570|NCT01728376|540410645|FG002|Overall Study|Did not receive treatment|0|||
149803571|NCT01728376|540410646|FG003|Overall Study|Did not receive treatment|0|||
149803572|NCT01728376|540410647|FG004|Overall Study|Did not receive treatment|0|||
149803573|NCT01728376|540410648|FG005|Overall Study|Did not receive treatment|0|||
149803574|NCT01728376|540410643|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149803575|NCT01728376|540410644|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149803576|NCT01728376|540410645|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149803577|NCT01728376|540410646|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
149803578|NCT01728376|540410647|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149803579|NCT01728376|540410648|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
149803580|NCT04341727|540410659|FG000|Overall Study|Withdrawal by Subject|0|||
149803581|NCT04341727|540410660|FG001|Overall Study|Withdrawal by Subject|0|||
149803582|NCT04341727|540410661|FG002|Overall Study|Withdrawal by Subject|1|||
149803583|NCT04341727|540410662|FG003|Overall Study|Withdrawal by Subject|0|||
149803584|NCT04341727|540410659|FG000|Overall Study|Lost to Follow-up|0|||
149803585|NCT04341727|540410660|FG001|Overall Study|Lost to Follow-up|0|||
149803586|NCT04341727|540410661|FG002|Overall Study|Lost to Follow-up|0|||
149803587|NCT04341727|540410662|FG003|Overall Study|Lost to Follow-up|1|||
149803588|NCT05604521|540410663|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
149803589|NCT05604521|540410664|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
149803590|NCT05604521|540410663|FG000|Overall Study|Adverse Event|1|||
149803591|NCT05604521|540410664|FG001|Overall Study|Adverse Event|0|||
149803592|NCT00057330|540410665|FG000|Overall Study|Adverse Event|9|||
149803593|NCT00057330|540410666|FG001|Overall Study|Adverse Event|12|||
149803594|NCT00057330|540410665|FG000|Overall Study|Death|1|||
149803595|NCT00057330|540410666|FG001|Overall Study|Death|0|||
149803596|NCT00057330|540410665|FG000|Overall Study|Protocol Violation|1|||
149803597|NCT00057330|540410666|FG001|Overall Study|Protocol Violation|1|||
149803598|NCT00057330|540410665|FG000|Overall Study|Withdrawal by Subject|115|||
149918881|NCT01210352|540835241|FG000|Overall Study|Adverse Event|0|||
150145764|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
150145765|NCT01336621|541670042|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
150145766|NCT01336621|541670042|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
150145767|NCT01336621|541670042|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
150145768|NCT01336621|541670042|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
150145769|NCT01336621|541670042|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
150145770|NCT01336621|541670042|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
150145771|NCT02130284|541670050|FG000|Overall Study|Withdrawal by Subject|3|||
150145772|NCT02130284|541670050|FG000|Overall Study|Subject Withdrew Consent|1|||
150145773|NCT02130284|541670050|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
150145774|NCT02130284|541670050|FG000|Overall Study|Subject was screened as backup for study|3|||
150145775|NCT02130284|541670050|FG000|Overall Study|Screen Failure|1|||
150145776|NCT01435655|541670054|FG000|Overall Study|Death|2|||
150145777|NCT01435655|541670054|FG000|Overall Study|Other|1|||
150145778|NCT01686581|541670055|FG000|Overall Study|Side-effects or Health Problems|15|||
150145779|NCT01686581|541670055|FG000|Overall Study|Lack of Efficacy|90|||
150145780|NCT01686581|541670055|FG000|Overall Study|Participant Concerned about Risks|6|||
150145781|NCT01686581|541670055|FG000|Overall Study|Thinks Injections Too Painful|8|||
150145782|NCT01686581|541670055|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
150145783|NCT01686581|541670055|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
150145784|NCT01686581|541670055|FG000|Overall Study|Thinks it is Inconvenient|17|||
150145785|NCT01686581|541670055|FG000|Overall Study|Other Miscellaneous Reasons|36|||
150145786|NCT01686581|541670055|FG000|Overall Study|Reason Missing|1|||
150145787|NCT01975220|541670056|FG000|Test Period 1|Not treated|0|||
150145788|NCT01975220|541670057|FG001|Test Period 1|Not treated|1|||
150145789|NCT01975220|541670058|FG002|Test Period 1|Not treated|0|||
150145790|NCT01975220|541670059|FG003|Test Period 1|Not treated|0|||
150145791|NCT01975220|541670060|FG004|Test Period 1|Not treated|0|||
150145792|NCT01975220|541670061|FG005|Test Period 1|Not treated|0|||
150145793|NCT02839343|541670062|FG000|Overall Study|Withdrawal by Subject|3|||
150145794|NCT02839343|541670063|FG001|Overall Study|Withdrawal by Subject|1|||
150145795|NCT02839343|541670062|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
150145796|NCT02839343|541670063|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
150145797|NCT02839343|541670062|FG000|Overall Study|Adverse Event|1|||
150145798|NCT02839343|541670063|FG001|Overall Study|Adverse Event|0|||
150145799|NCT01852058|541670066|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
150145800|NCT01852058|541670067|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145801|NCT01852058|541670068|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145802|NCT01852058|541670069|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145803|NCT01852058|541670070|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145804|NCT01852058|541670071|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145805|NCT01852058|541670072|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145806|NCT01852058|541670073|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145807|NCT01852058|541670074|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145808|NCT01852058|541670075|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145809|NCT01852058|541670076|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145810|NCT01852058|541670077|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
150145811|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145812|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145813|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145814|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145815|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
150145816|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145817|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145818|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145819|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145820|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145821|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145822|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
150145823|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145824|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145825|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145826|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145827|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
150145828|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
150145829|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145830|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145831|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145832|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149803599|NCT00057330|540410666|FG001|Overall Study|Withdrawal by Subject|84|||
149803600|NCT00057330|540410665|FG000|Overall Study|Lost to Follow-up|745|||
149803601|NCT00057330|540410666|FG001|Overall Study|Lost to Follow-up|617|||
149803602|NCT00057330|540410665|FG000|Overall Study|Physician Decision|1|||
149803603|NCT00057330|540410666|FG001|Overall Study|Physician Decision|0|||
149803604|NCT00057330|540410665|FG000|Overall Study|Other|260|||
150145833|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145834|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
150145835|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145836|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145837|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145838|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145839|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
150145840|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145841|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145842|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145843|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145844|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145845|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145846|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
150145847|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145848|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145849|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145850|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145851|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
150145852|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
150145853|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145854|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145855|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145856|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145857|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145858|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
150145859|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145860|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145861|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145862|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
150145863|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145864|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149803605|NCT00057330|540410666|FG001|Overall Study|Other|206|||
149803606|NCT01491737|540410667|FG000|Overall Study|Withdrawal by Subject|20|||
149803607|NCT01491737|540410668|FG001|Overall Study|Withdrawal by Subject|17|||
149803608|NCT01491737|540410667|FG000|Overall Study|Lost to Follow-up|2|||
149803609|NCT01491737|540410668|FG001|Overall Study|Lost to Follow-up|10|||
149803610|NCT01491737|540410667|FG000|Overall Study|Death|63|||
149803611|NCT01491737|540410668|FG001|Overall Study|Death|57|||
149803612|NCT01491737|540410667|FG000|Overall Study|Study Termination by Sponsor|36|||
149803613|NCT01491737|540410668|FG001|Overall Study|Study Termination by Sponsor|36|||
149803614|NCT01491737|540410667|FG000|Overall Study|Reason Not Specified|8|||
149803615|NCT01491737|540410668|FG001|Overall Study|Reason Not Specified|9|||
149803616|NCT03110107|540410671|FG000|Treatment Period|Disease Progression|3|||
149803617|NCT03110107|540410672|FG001|Treatment Period|Disease Progression|9|||
149803618|NCT03110107|540410673|FG002|Treatment Period|Disease Progression|8|||
149803619|NCT03110107|540410674|FG003|Treatment Period|Disease Progression|11|||
149803620|NCT03110107|540410675|FG004|Treatment Period|Disease Progression|8|||
149803621|NCT03110107|540410676|FG005|Treatment Period|Disease Progression|4|||
149803622|NCT03110107|540410677|FG006|Treatment Period|Disease Progression|6|||
149803623|NCT03110107|540410678|FG007|Treatment Period|Disease Progression|7|||
149803624|NCT03110107|540410679|FG008|Treatment Period|Disease Progression|2|||
149803625|NCT03110107|540410680|FG009|Treatment Period|Disease Progression|10|||
149803626|NCT03110107|540410681|FG010|Treatment Period|Disease Progression|5|||
149803627|NCT03110107|540410682|FG011|Treatment Period|Disease Progression|2|||
149803628|NCT03110107|540410683|FG012|Treatment Period|Disease Progression|0|||
149803629|NCT03110107|540410684|FG013|Treatment Period|Disease Progression|5|||
149803630|NCT03110107|540410685|FG014|Treatment Period|Disease Progression|14|||
149803631|NCT03110107|540410686|FG015|Treatment Period|Disease Progression|14|||
149803632|NCT03110107|540410687|FG016|Treatment Period|Disease Progression|4|||
149803633|NCT03110107|540410688|FG017|Treatment Period|Disease Progression|3|||
149803634|NCT03110107|540410689|FG018|Treatment Period|Disease Progression|16|||
149803635|NCT03110107|540410690|FG019|Treatment Period|Disease Progression|14|||
149803636|NCT03110107|540410691|FG020|Treatment Period|Disease Progression|12|||
149803637|NCT03110107|540410692|FG021|Treatment Period|Disease Progression|16|||
149803638|NCT03110107|540410693|FG022|Treatment Period|Disease Progression|18|||
149803639|NCT03110107|540410694|FG023|Treatment Period|Disease Progression|13|||
149803640|NCT03110107|540410695|FG024|Treatment Period|Disease Progression|16|||
149803641|NCT03110107|540410696|FG025|Treatment Period|Disease Progression|31|||
149803642|NCT03110107|540410671|FG000|Treatment Period|Study drug toxicity|1|||
149803643|NCT03110107|540410672|FG001|Treatment Period|Study drug toxicity|0|||
149803644|NCT03110107|540410673|FG002|Treatment Period|Study drug toxicity|1|||
149803645|NCT03110107|540410674|FG003|Treatment Period|Study drug toxicity|2|||
149803646|NCT03110107|540410675|FG004|Treatment Period|Study drug toxicity|0|||
149803647|NCT03110107|540410676|FG005|Treatment Period|Study drug toxicity|3|||
150145865|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145866|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145867|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145868|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145869|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145870|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
150145871|NCT01852058|541670066|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145872|NCT01852058|541670067|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145873|NCT01852058|541670068|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145874|NCT01852058|541670069|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145875|NCT01852058|541670070|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
150145876|NCT01852058|541670071|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
150145877|NCT01852058|541670072|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145878|NCT01852058|541670073|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145879|NCT01852058|541670074|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145880|NCT01852058|541670075|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145881|NCT01852058|541670076|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145882|NCT01852058|541670077|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
150145883|NCT01852058|541670066|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145884|NCT01852058|541670067|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145885|NCT01852058|541670068|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145886|NCT01852058|541670069|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145887|NCT01852058|541670070|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145888|NCT01852058|541670071|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145889|NCT01852058|541670072|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145890|NCT01852058|541670073|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
150145891|NCT01852058|541670074|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145892|NCT01852058|541670075|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145893|NCT01852058|541670076|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145894|NCT01852058|541670077|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
150145895|NCT01852058|541670066|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145896|NCT01852058|541670067|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145897|NCT01852058|541670068|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145898|NCT01852058|541670069|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145899|NCT01852058|541670070|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145900|NCT01852058|541670071|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145901|NCT01852058|541670072|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145902|NCT01852058|541670073|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145903|NCT01852058|541670074|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
150145904|NCT01852058|541670075|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145905|NCT01852058|541670076|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145906|NCT01852058|541670077|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
150145907|NCT00661661|541670078|FG000|Overall Study|Adverse Event|99|||
150145908|NCT00661661|541670079|FG001|Overall Study|Adverse Event|24|||
150145909|NCT00661661|541670078|FG000|Overall Study|Lack of Efficacy|3|||
150145910|NCT00661661|541670079|FG001|Overall Study|Lack of Efficacy|2|||
150145911|NCT00661661|541670078|FG000|Overall Study|Lost to Follow-up|0|||
150145912|NCT00661661|541670079|FG001|Overall Study|Lost to Follow-up|1|||
150145913|NCT00661661|541670078|FG000|Overall Study|Withdrawal by Subject|15|||
150145914|NCT00661661|541670079|FG001|Overall Study|Withdrawal by Subject|5|||
150145915|NCT00661661|541670078|FG000|Overall Study|Other|22|||
150145916|NCT00661661|541670079|FG001|Overall Study|Other|7|||
150145917|NCT00661661|541670078|FG000|Overall Study|Not assigned treatment|1|||
149803648|NCT03110107|540410677|FG006|Treatment Period|Study drug toxicity|1|||
149803649|NCT03110107|540410678|FG007|Treatment Period|Study drug toxicity|1|||
149803650|NCT03110107|540410679|FG008|Treatment Period|Study drug toxicity|3|||
149803651|NCT03110107|540410680|FG009|Treatment Period|Study drug toxicity|2|||
149803652|NCT03110107|540410681|FG010|Treatment Period|Study drug toxicity|0|||
149803653|NCT03110107|540410682|FG011|Treatment Period|Study drug toxicity|2|||
149803654|NCT03110107|540410683|FG012|Treatment Period|Study drug toxicity|0|||
149803655|NCT03110107|540410684|FG013|Treatment Period|Study drug toxicity|0|||
149803656|NCT03110107|540410685|FG014|Treatment Period|Study drug toxicity|2|||
150145918|NCT00661661|541670079|FG001|Overall Study|Not assigned treatment|0|||
150145919|NCT01657266|541670080|FG000|Overall Study|Lost to Follow-up|2|||
150145920|NCT01657266|541670081|FG001|Overall Study|Lost to Follow-up|2|||
150145921|NCT01657266|541670080|FG000|Overall Study|Adverse Event|2|||
149803657|NCT03110107|540410686|FG015|Treatment Period|Study drug toxicity|3|||
149803658|NCT03110107|540410687|FG016|Treatment Period|Study drug toxicity|3|||
149803659|NCT03110107|540410688|FG017|Treatment Period|Study drug toxicity|3|||
149803660|NCT03110107|540410689|FG018|Treatment Period|Study drug toxicity|1|||
149803661|NCT03110107|540410690|FG019|Treatment Period|Study drug toxicity|2|||
149803662|NCT03110107|540410691|FG020|Treatment Period|Study drug toxicity|2|||
149803663|NCT03110107|540410692|FG021|Treatment Period|Study drug toxicity|0|||
149803664|NCT03110107|540410693|FG022|Treatment Period|Study drug toxicity|2|||
149803665|NCT03110107|540410694|FG023|Treatment Period|Study drug toxicity|6|||
149803666|NCT03110107|540410695|FG024|Treatment Period|Study drug toxicity|7|||
149803667|NCT03110107|540410696|FG025|Treatment Period|Study drug toxicity|6|||
149803668|NCT03110107|540410671|FG000|Treatment Period|Death|0|||
149803669|NCT03110107|540410672|FG001|Treatment Period|Death|0|||
149803670|NCT03110107|540410673|FG002|Treatment Period|Death|0|||
149803671|NCT03110107|540410674|FG003|Treatment Period|Death|0|||
149803672|NCT03110107|540410675|FG004|Treatment Period|Death|0|||
149803673|NCT03110107|540410676|FG005|Treatment Period|Death|0|||
149803674|NCT03110107|540410677|FG006|Treatment Period|Death|0|||
149803675|NCT03110107|540410678|FG007|Treatment Period|Death|0|||
149803676|NCT03110107|540410679|FG008|Treatment Period|Death|0|||
149803677|NCT03110107|540410680|FG009|Treatment Period|Death|0|||
150145922|NCT01657266|541670081|FG001|Overall Study|Adverse Event|3|||
150145923|NCT03474549|541670082|FG000|Overall Study|Death|31|||
149803678|NCT03110107|540410681|FG010|Treatment Period|Death|0|||
149803679|NCT03110107|540410682|FG011|Treatment Period|Death|0|||
149803680|NCT03110107|540410683|FG012|Treatment Period|Death|1|||
149803681|NCT03110107|540410684|FG013|Treatment Period|Death|0|||
149803682|NCT03110107|540410685|FG014|Treatment Period|Death|0|||
149803683|NCT03110107|540410686|FG015|Treatment Period|Death|0|||
149803684|NCT03110107|540410687|FG016|Treatment Period|Death|0|||
149803685|NCT03110107|540410688|FG017|Treatment Period|Death|0|||
149803686|NCT03110107|540410689|FG018|Treatment Period|Death|0|||
149803687|NCT03110107|540410690|FG019|Treatment Period|Death|0|||
149803688|NCT03110107|540410691|FG020|Treatment Period|Death|0|||
149803689|NCT03110107|540410692|FG021|Treatment Period|Death|0|||
149803690|NCT03110107|540410693|FG022|Treatment Period|Death|0|||
149803691|NCT03110107|540410694|FG023|Treatment Period|Death|0|||
149803692|NCT03110107|540410695|FG024|Treatment Period|Death|0|||
149803693|NCT03110107|540410696|FG025|Treatment Period|Death|0|||
149803694|NCT03110107|540410671|FG000|Treatment Period|Adverse Event|0|||
149803695|NCT03110107|540410672|FG001|Treatment Period|Adverse Event|0|||
149803696|NCT03110107|540410673|FG002|Treatment Period|Adverse Event|1|||
149803697|NCT03110107|540410674|FG003|Treatment Period|Adverse Event|0|||
149803698|NCT03110107|540410675|FG004|Treatment Period|Adverse Event|0|||
149803699|NCT03110107|540410676|FG005|Treatment Period|Adverse Event|2|||
149803700|NCT03110107|540410677|FG006|Treatment Period|Adverse Event|0|||
149803701|NCT03110107|540410678|FG007|Treatment Period|Adverse Event|2|||
149803702|NCT03110107|540410679|FG008|Treatment Period|Adverse Event|0|||
149803703|NCT03110107|540410680|FG009|Treatment Period|Adverse Event|1|||
149803704|NCT03110107|540410681|FG010|Treatment Period|Adverse Event|0|||
149803705|NCT03110107|540410682|FG011|Treatment Period|Adverse Event|0|||
149803706|NCT03110107|540410683|FG012|Treatment Period|Adverse Event|0|||
149803707|NCT03110107|540410684|FG013|Treatment Period|Adverse Event|0|||
149803708|NCT03110107|540410685|FG014|Treatment Period|Adverse Event|0|||
149803709|NCT03110107|540410686|FG015|Treatment Period|Adverse Event|2|||
149803710|NCT03110107|540410687|FG016|Treatment Period|Adverse Event|0|||
149803711|NCT03110107|540410688|FG017|Treatment Period|Adverse Event|1|||
150145924|NCT03474549|541670082|FG000|Overall Study|Lost to Follow-up|4|||
149803712|NCT03110107|540410689|FG018|Treatment Period|Adverse Event|2|||
149803713|NCT03110107|540410690|FG019|Treatment Period|Adverse Event|1|||
149803714|NCT03110107|540410691|FG020|Treatment Period|Adverse Event|4|||
149803715|NCT03110107|540410692|FG021|Treatment Period|Adverse Event|2|||
150145925|NCT03474549|541670082|FG000|Overall Study|Withdrawal by Subject|2|||
150145926|NCT03573908|541670083|FG000|Treatment Period|Adverse Event|4|||
150145927|NCT03573908|541670084|FG001|Treatment Period|Adverse Event|9|||
149803716|NCT03110107|540410693|FG022|Treatment Period|Adverse Event|2|||
149803717|NCT03110107|540410694|FG023|Treatment Period|Adverse Event|2|||
149803718|NCT03110107|540410695|FG024|Treatment Period|Adverse Event|2|||
149803719|NCT03110107|540410696|FG025|Treatment Period|Adverse Event|4|||
149918882|NCT01210352|540835242|FG001|Overall Study|Adverse Event|0|||
150145928|NCT03573908|541670085|FG002|Treatment Period|Adverse Event|0|||
150145929|NCT03573908|541670086|FG003|Treatment Period|Adverse Event|0|||
150145930|NCT03573908|541670087|FG004|Treatment Period|Adverse Event|0|||
150145931|NCT03573908|541670083|FG000|Treatment Period|Protocol Violation|1|||
150145932|NCT03573908|541670084|FG001|Treatment Period|Protocol Violation|0|||
150145933|NCT03573908|541670085|FG002|Treatment Period|Protocol Violation|0|||
150145934|NCT03573908|541670086|FG003|Treatment Period|Protocol Violation|0|||
150145935|NCT03573908|541670087|FG004|Treatment Period|Protocol Violation|0|||
150145936|NCT03573908|541670083|FG000|Treatment Period|Withdrawal by Subject|7|||
150145937|NCT03573908|541670084|FG001|Treatment Period|Withdrawal by Subject|5|||
150145938|NCT03573908|541670085|FG002|Treatment Period|Withdrawal by Subject|0|||
150145939|NCT03573908|541670086|FG003|Treatment Period|Withdrawal by Subject|0|||
150145940|NCT03573908|541670087|FG004|Treatment Period|Withdrawal by Subject|0|||
150145941|NCT03573908|541670083|FG000|Treatment Period|Lost to Follow-up|7|||
150145942|NCT03573908|541670084|FG001|Treatment Period|Lost to Follow-up|6|||
150145943|NCT03573908|541670085|FG002|Treatment Period|Lost to Follow-up|0|||
150145944|NCT03573908|541670086|FG003|Treatment Period|Lost to Follow-up|0|||
150145945|NCT03573908|541670087|FG004|Treatment Period|Lost to Follow-up|0|||
150145946|NCT03573908|541670083|FG000|Treatment Period|Pregnancy|1|||
150145947|NCT03573908|541670084|FG001|Treatment Period|Pregnancy|0|||
150145948|NCT03573908|541670085|FG002|Treatment Period|Pregnancy|0|||
150145949|NCT03573908|541670086|FG003|Treatment Period|Pregnancy|0|||
150145950|NCT03573908|541670087|FG004|Treatment Period|Pregnancy|0|||
150145951|NCT03573908|541670083|FG000|Treatment Period|Other, Not Specified|4|||
150145952|NCT03573908|541670084|FG001|Treatment Period|Other, Not Specified|6|||
150145953|NCT03573908|541670085|FG002|Treatment Period|Other, Not Specified|0|||
150145954|NCT03573908|541670086|FG003|Treatment Period|Other, Not Specified|0|||
150145955|NCT03573908|541670087|FG004|Treatment Period|Other, Not Specified|0|||
150145956|NCT03573908|541670083|FG000|Randomized Withdrawal Period|Adverse Event|0|||
150145957|NCT03573908|541670084|FG001|Randomized Withdrawal Period|Adverse Event|0|||
150145958|NCT03573908|541670085|FG002|Randomized Withdrawal Period|Adverse Event|3|||
150145959|NCT03573908|541670086|FG003|Randomized Withdrawal Period|Adverse Event|0|||
150145960|NCT03573908|541670087|FG004|Randomized Withdrawal Period|Adverse Event|0|||
150145961|NCT03573908|541670083|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
150145962|NCT03573908|541670084|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
150145963|NCT03573908|541670085|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
150145964|NCT03573908|541670086|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
150145965|NCT03573908|541670087|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
150145966|NCT03573908|541670083|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
150145967|NCT03573908|541670084|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
150145968|NCT03573908|541670085|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
150145969|NCT03573908|541670086|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
150145970|NCT03573908|541670087|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
150145971|NCT03573908|541670083|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
150145972|NCT03573908|541670084|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
150145973|NCT03573908|541670085|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
150145974|NCT03573908|541670086|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
150145975|NCT03573908|541670087|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
150145976|NCT04006925|541670088|FG000|Overall Study|Side effects|2|||
149803720|NCT03110107|540410671|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
149803721|NCT03110107|540410672|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
149803722|NCT03110107|540410673|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
149803723|NCT03110107|540410674|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
149803724|NCT03110107|540410675|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
149803725|NCT03110107|540410676|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
149803726|NCT03110107|540410677|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
149803727|NCT03110107|540410678|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
149803728|NCT03110107|540410679|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
150145977|NCT04006925|541670089|FG001|Overall Study|Side effects|0|||
150145978|NCT02089230|541670090|FG000|Overall Study|Death|0|||
150145979|NCT02089230|541670091|FG001|Overall Study|Death|0|||
150145980|NCT02089230|541670092|FG002|Overall Study|Death|2|||
150145981|NCT02089230|541670090|FG000|Overall Study|Seeking Alternative Therapy|0|||
150145982|NCT02089230|541670091|FG001|Overall Study|Seeking Alternative Therapy|0|||
150145983|NCT02089230|541670092|FG002|Overall Study|Seeking Alternative Therapy|4|||
150145984|NCT00386308|541672235|FG000|Overall Study|Adverse Event|3|||
150145985|NCT00386308|541672236|FG001|Overall Study|Adverse Event|3|||
150145986|NCT00386308|541672235|FG000|Overall Study|Protocol Violation|2|||
150145987|NCT00386308|541672236|FG001|Overall Study|Protocol Violation|5|||
150145988|NCT00386308|541672235|FG000|Overall Study|Lack of Efficacy|0|||
150145989|NCT00386308|541672236|FG001|Overall Study|Lack of Efficacy|2|||
150145990|NCT00386308|541672235|FG000|Overall Study|Lost to Follow-up|10|||
149803729|NCT03110107|540410680|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
149803730|NCT03110107|540410681|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
149803731|NCT03110107|540410682|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
149803732|NCT03110107|540410683|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
149803733|NCT03110107|540410684|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
149803734|NCT03110107|540410685|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
149803735|NCT03110107|540410686|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
149803736|NCT03110107|540410687|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
149803737|NCT03110107|540410688|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
149803738|NCT03110107|540410689|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
149803739|NCT03110107|540410690|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
149803740|NCT03110107|540410691|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
149803741|NCT03110107|540410692|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
149803742|NCT03110107|540410693|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
149803743|NCT03110107|540410694|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
149803744|NCT03110107|540410695|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
149803745|NCT03110107|540410696|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
149803746|NCT03110107|540410671|FG000|Treatment Period|Participant withdrew consent|0|||
149803747|NCT03110107|540410672|FG001|Treatment Period|Participant withdrew consent|0|||
149803748|NCT03110107|540410673|FG002|Treatment Period|Participant withdrew consent|1|||
149803749|NCT03110107|540410674|FG003|Treatment Period|Participant withdrew consent|0|||
149803750|NCT03110107|540410675|FG004|Treatment Period|Participant withdrew consent|4|||
149803751|NCT03110107|540410676|FG005|Treatment Period|Participant withdrew consent|3|||
149803752|NCT03110107|540410677|FG006|Treatment Period|Participant withdrew consent|0|||
149803753|NCT03110107|540410678|FG007|Treatment Period|Participant withdrew consent|0|||
149803754|NCT03110107|540410679|FG008|Treatment Period|Participant withdrew consent|0|||
149803755|NCT03110107|540410680|FG009|Treatment Period|Participant withdrew consent|1|||
149803756|NCT03110107|540410681|FG010|Treatment Period|Participant withdrew consent|0|||
149803757|NCT03110107|540410682|FG011|Treatment Period|Participant withdrew consent|0|||
149803758|NCT03110107|540410683|FG012|Treatment Period|Participant withdrew consent|0|||
149803759|NCT03110107|540410684|FG013|Treatment Period|Participant withdrew consent|0|||
149803760|NCT03110107|540410685|FG014|Treatment Period|Participant withdrew consent|0|||
149803761|NCT03110107|540410686|FG015|Treatment Period|Participant withdrew consent|0|||
149803762|NCT03110107|540410687|FG016|Treatment Period|Participant withdrew consent|0|||
149803763|NCT03110107|540410688|FG017|Treatment Period|Participant withdrew consent|0|||
149803764|NCT03110107|540410689|FG018|Treatment Period|Participant withdrew consent|0|||
149803765|NCT03110107|540410690|FG019|Treatment Period|Participant withdrew consent|1|||
149803766|NCT03110107|540410691|FG020|Treatment Period|Participant withdrew consent|0|||
149803767|NCT03110107|540410692|FG021|Treatment Period|Participant withdrew consent|2|||
149803768|NCT03110107|540410693|FG022|Treatment Period|Participant withdrew consent|0|||
149803769|NCT03110107|540410694|FG023|Treatment Period|Participant withdrew consent|0|||
149803770|NCT03110107|540410695|FG024|Treatment Period|Participant withdrew consent|0|||
149803771|NCT03110107|540410696|FG025|Treatment Period|Participant withdrew consent|2|||
149803772|NCT03110107|540410671|FG000|Treatment Period|Participants no longer meets study criteria|0|||
149803773|NCT03110107|540410672|FG001|Treatment Period|Participants no longer meets study criteria|0|||
149803774|NCT03110107|540410673|FG002|Treatment Period|Participants no longer meets study criteria|0|||
149803775|NCT03110107|540410674|FG003|Treatment Period|Participants no longer meets study criteria|0|||
149803776|NCT03110107|540410675|FG004|Treatment Period|Participants no longer meets study criteria|0|||
149803777|NCT03110107|540410676|FG005|Treatment Period|Participants no longer meets study criteria|0|||
149803778|NCT03110107|540410677|FG006|Treatment Period|Participants no longer meets study criteria|0|||
149803779|NCT03110107|540410678|FG007|Treatment Period|Participants no longer meets study criteria|0|||
149803780|NCT03110107|540410679|FG008|Treatment Period|Participants no longer meets study criteria|0|||
149803781|NCT03110107|540410680|FG009|Treatment Period|Participants no longer meets study criteria|0|||
149803782|NCT03110107|540410681|FG010|Treatment Period|Participants no longer meets study criteria|0|||
149803783|NCT03110107|540410682|FG011|Treatment Period|Participants no longer meets study criteria|0|||
149803784|NCT03110107|540410683|FG012|Treatment Period|Participants no longer meets study criteria|0|||
149803785|NCT03110107|540410684|FG013|Treatment Period|Participants no longer meets study criteria|0|||
149803786|NCT03110107|540410685|FG014|Treatment Period|Participants no longer meets study criteria|0|||
149803787|NCT03110107|540410686|FG015|Treatment Period|Participants no longer meets study criteria|0|||
149803788|NCT03110107|540410687|FG016|Treatment Period|Participants no longer meets study criteria|0|||
149918883|NCT01210352|540835243|FG002|Overall Study|Adverse Event|0|||
150145991|NCT00386308|541672236|FG001|Overall Study|Lost to Follow-up|6|||
150145992|NCT00386308|541672235|FG000|Overall Study|Withdrawal by Subject|6|||
150145993|NCT00386308|541672236|FG001|Overall Study|Withdrawal by Subject|2|||
150145994|NCT00386308|541672235|FG000|Overall Study|Other Event|8|||
149803789|NCT03110107|540410688|FG017|Treatment Period|Participants no longer meets study criteria|0|||
149803790|NCT03110107|540410689|FG018|Treatment Period|Participants no longer meets study criteria|0|||
149803791|NCT03110107|540410690|FG019|Treatment Period|Participants no longer meets study criteria|0|||
149803792|NCT03110107|540410691|FG020|Treatment Period|Participants no longer meets study criteria|0|||
149803793|NCT03110107|540410692|FG021|Treatment Period|Participants no longer meets study criteria|0|||
149803794|NCT03110107|540410693|FG022|Treatment Period|Participants no longer meets study criteria|0|||
149803795|NCT03110107|540410694|FG023|Treatment Period|Participants no longer meets study criteria|1|||
149803796|NCT03110107|540410695|FG024|Treatment Period|Participants no longer meets study criteria|0|||
149803797|NCT03110107|540410696|FG025|Treatment Period|Participants no longer meets study criteria|0|||
149803798|NCT03110107|540410671|FG000|Treatment Period|Other Reasons|0|||
149803799|NCT03110107|540410672|FG001|Treatment Period|Other Reasons|0|||
149803800|NCT03110107|540410673|FG002|Treatment Period|Other Reasons|1|||
149803801|NCT03110107|540410674|FG003|Treatment Period|Other Reasons|1|||
149803802|NCT03110107|540410675|FG004|Treatment Period|Other Reasons|0|||
149803803|NCT03110107|540410676|FG005|Treatment Period|Other Reasons|1|||
149803804|NCT03110107|540410677|FG006|Treatment Period|Other Reasons|0|||
149803805|NCT03110107|540410678|FG007|Treatment Period|Other Reasons|0|||
149803806|NCT03110107|540410679|FG008|Treatment Period|Other Reasons|0|||
149803807|NCT03110107|540410680|FG009|Treatment Period|Other Reasons|0|||
149803808|NCT03110107|540410681|FG010|Treatment Period|Other Reasons|0|||
149803809|NCT03110107|540410682|FG011|Treatment Period|Other Reasons|0|||
149803810|NCT03110107|540410683|FG012|Treatment Period|Other Reasons|0|||
149803811|NCT03110107|540410684|FG013|Treatment Period|Other Reasons|0|||
149803812|NCT03110107|540410685|FG014|Treatment Period|Other Reasons|0|||
149803813|NCT03110107|540410686|FG015|Treatment Period|Other Reasons|0|||
149803814|NCT03110107|540410687|FG016|Treatment Period|Other Reasons|0|||
149803815|NCT03110107|540410688|FG017|Treatment Period|Other Reasons|0|||
149803816|NCT03110107|540410689|FG018|Treatment Period|Other Reasons|0|||
149803817|NCT03110107|540410690|FG019|Treatment Period|Other Reasons|0|||
149803818|NCT03110107|540410691|FG020|Treatment Period|Other Reasons|0|||
149803819|NCT03110107|540410692|FG021|Treatment Period|Other Reasons|0|||
149803820|NCT03110107|540410693|FG022|Treatment Period|Other Reasons|0|||
149803821|NCT03110107|540410694|FG023|Treatment Period|Other Reasons|0|||
149803822|NCT03110107|540410695|FG024|Treatment Period|Other Reasons|1|||
149803823|NCT03110107|540410696|FG025|Treatment Period|Other Reasons|0|||
149803824|NCT00812968|540410697|FG000|Overall Study|Relapse after erythroid response|6|||
149803825|NCT00812968|540410697|FG000|Overall Study|Disease progression|1|||
149803826|NCT00812968|540410697|FG000|Overall Study|No further treatment required|1|||
149803827|NCT00812968|540410697|FG000|Overall Study|Study closed due to marketing approval|3|||
149803828|NCT00494234|540410698|FG000|Overall Study|Withdrawal by Subject|1|||
149803829|NCT00494234|540410699|FG001|Overall Study|Withdrawal by Subject|0|||
149803830|NCT00494234|540410698|FG000|Overall Study|Disease progression|11|||
149803831|NCT00494234|540410699|FG001|Overall Study|Disease progression|8|||
149803832|NCT00494234|540410698|FG000|Overall Study|Death|2|||
149803833|NCT00494234|540410699|FG001|Overall Study|Death|1|||
149803834|NCT00505765|540410701|FG000|Overall Study|Withdrawal by Subject|1|||
149803835|NCT00505765|540410702|FG001|Overall Study|Withdrawal by Subject|0|||
149803836|NCT00505765|540410703|FG002|Overall Study|Withdrawal by Subject|0|||
149803837|NCT00505765|540410701|FG000|Overall Study|Adverse Event|1|||
149803838|NCT00505765|540410702|FG001|Overall Study|Adverse Event|2|||
149803839|NCT00505765|540410703|FG002|Overall Study|Adverse Event|0|||
149803840|NCT00505765|540410701|FG000|Overall Study|Noncompliance|0|||
149803841|NCT00505765|540410702|FG001|Overall Study|Noncompliance|1|||
149803842|NCT00505765|540410703|FG002|Overall Study|Noncompliance|3|||
149803843|NCT02743117|540410704|FG000|Overall Study|Lost to Follow-up|0|||
149803844|NCT02743117|540410705|FG001|Overall Study|Lost to Follow-up|1|||
149803845|NCT02743117|540410704|FG000|Overall Study|Other|1|||
149803846|NCT02743117|540410705|FG001|Overall Study|Other|0|||
150145995|NCT00386308|541672236|FG001|Overall Study|Other Event|1|||
150145996|NCT02746575|541672237|FG000|Overall Study|Surgery cancelled or time chaned|13|||
149803847|NCT01207219|540410706|FG000|Overall Study|changed diagnosis during study period|5|||
149803848|NCT01207219|540410707|FG001|Overall Study|changed diagnosis during study period|3|||
149803849|NCT01207219|540410708|FG002|Overall Study|changed diagnosis during study period|1|||
149803850|NCT01207219|540410706|FG000|Overall Study|Lost to Follow-up|6|||
149803851|NCT01207219|540410707|FG001|Overall Study|Lost to Follow-up|8|||
149803852|NCT01207219|540410708|FG002|Overall Study|Lost to Follow-up|6|||
149803853|NCT01453296|540410709|FG000|Treatment Period 1|Adverse Event|0|||
149803854|NCT01453296|540410710|FG001|Treatment Period 1|Adverse Event|1|||
149803855|NCT01453296|540410709|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
150145997|NCT02746575|541672237|FG000|Overall Study|Received epidural|10|||
150145998|NCT02746575|541672237|FG000|Overall Study|Withdrawal by Subject|3|||
149803856|NCT01453296|540410710|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
149803857|NCT01453296|540410709|FG000|Treatment Period 2|Adverse Event|1|||
149803858|NCT01453296|540410710|FG001|Treatment Period 2|Adverse Event|0|||
149803859|NCT01453296|540410709|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149803860|NCT01453296|540410710|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149803861|NCT00620776|540410711|FG000|Overall Study|Did not receive treatment|3|||
149803862|NCT00620776|540410712|FG001|Overall Study|Did not receive treatment|5|||
149803863|NCT00620776|540410711|FG000|Overall Study|Adverse Event|2|||
149803864|NCT00620776|540410712|FG001|Overall Study|Adverse Event|3|||
149803865|NCT00620776|540410711|FG000|Overall Study|Lack of Efficacy|2|||
149803866|NCT00620776|540410712|FG001|Overall Study|Lack of Efficacy|1|||
149803867|NCT00620776|540410711|FG000|Overall Study|Lost to Follow-up|2|||
149803868|NCT00620776|540410712|FG001|Overall Study|Lost to Follow-up|5|||
149803869|NCT00620776|540410711|FG000|Overall Study|Withdrawal by Subject|3|||
149803870|NCT00620776|540410712|FG001|Overall Study|Withdrawal by Subject|2|||
149803871|NCT00183170|540410716|FG000|First Intervention|Did not complete study|1|||
149803872|NCT00183170|540410717|FG001|First Intervention|Did not complete study|0|||
149803873|NCT00183170|540410716|FG000|First Intervention|Did not meet targeted BrAC|1|||
149803874|NCT00183170|540410717|FG001|First Intervention|Did not meet targeted BrAC|0|||
149803875|NCT00183170|540410716|FG000|Washout 1 Week|Did not complete study|6|||
149803876|NCT00183170|540410717|FG001|Washout 1 Week|Did not complete study|8|||
149803877|NCT00183170|540410716|FG000|Second Intervention|Did not complete study|1|||
149803878|NCT00183170|540410717|FG001|Second Intervention|Did not complete study|0|||
149803879|NCT00183170|540410716|FG000|Second Intervention|Did not meet targeted BrAC|0|||
149803880|NCT00183170|540410717|FG001|Second Intervention|Did not meet targeted BrAC|2|||
149803881|NCT00761969|540410718|FG000|Overall Study|Death|112|||
149803882|NCT00761969|540410719|FG001|Overall Study|Death|47|||
149803883|NCT00761969|540410718|FG000|Overall Study|Lost to Follow-up|88|||
149803884|NCT00761969|540410719|FG001|Overall Study|Lost to Follow-up|93|||
149803885|NCT00483119|540410724|FG000|Overall Study|Adverse Event|0|||
149803886|NCT00483119|540410725|FG001|Overall Study|Adverse Event|1|||
149803887|NCT00483119|540410724|FG000|Overall Study|Physician Decision|1|||
149803888|NCT00483119|540410725|FG001|Overall Study|Physician Decision|0|||
149803889|NCT04668066|540410726|FG000|Part 1: Treatment Phase|Adverse Event|0|||
149803890|NCT04668066|540410727|FG001|Part 1: Treatment Phase|Adverse Event|0|||
149803891|NCT04668066|540410728|FG002|Part 1: Treatment Phase|Adverse Event|0|||
149803892|NCT04668066|540410729|FG003|Part 1: Treatment Phase|Adverse Event|0|||
149803893|NCT04668066|540410730|FG004|Part 1: Treatment Phase|Adverse Event|0|||
149803894|NCT04668066|540410731|FG005|Part 1: Treatment Phase|Adverse Event|0|||
149803895|NCT04668066|540410732|FG006|Part 1: Treatment Phase|Adverse Event|0|||
149803896|NCT04668066|540410733|FG007|Part 1: Treatment Phase|Adverse Event|0|||
149803897|NCT04668066|540410734|FG008|Part 1: Treatment Phase|Adverse Event|0|||
149803898|NCT04668066|540410735|FG009|Part 1: Treatment Phase|Adverse Event|0|||
149803899|NCT04668066|540410736|FG010|Part 1: Treatment Phase|Adverse Event|0|||
149803900|NCT04668066|540410737|FG011|Part 1: Treatment Phase|Adverse Event|1|||
149803901|NCT04668066|540410738|FG012|Part 1: Treatment Phase|Adverse Event|1|||
149803902|NCT04668066|540410739|FG013|Part 1: Treatment Phase|Adverse Event|0|||
149803903|NCT04668066|540410740|FG014|Part 1: Treatment Phase|Adverse Event|0|||
149803904|NCT04668066|540410741|FG015|Part 1: Treatment Phase|Adverse Event|0|||
149803905|NCT04668066|540410742|FG016|Part 1: Treatment Phase|Adverse Event|0|||
149803906|NCT04668066|540410743|FG017|Part 1: Treatment Phase|Adverse Event|0|||
149803907|NCT04668066|540410744|FG018|Part 1: Treatment Phase|Adverse Event|0|||
149803908|NCT04668066|540410726|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803909|NCT04668066|540410727|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803910|NCT04668066|540410728|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
149803911|NCT04668066|540410729|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803912|NCT04668066|540410730|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803913|NCT04668066|540410731|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803914|NCT04668066|540410732|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803915|NCT04668066|540410733|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803916|NCT04668066|540410734|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803917|NCT04668066|540410735|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803918|NCT04668066|540410736|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803919|NCT04668066|540410737|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803920|NCT04668066|540410738|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803921|NCT04668066|540410739|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803922|NCT04668066|540410740|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803923|NCT04668066|540410741|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803924|NCT04668066|540410742|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803925|NCT04668066|540410743|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803926|NCT04668066|540410744|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
149803927|NCT04668066|540410726|FG000|Part 1: Treatment Phase|Other|0|||
149803928|NCT04668066|540410727|FG001|Part 1: Treatment Phase|Other|0|||
149803929|NCT04668066|540410728|FG002|Part 1: Treatment Phase|Other|0|||
149803930|NCT04668066|540410729|FG003|Part 1: Treatment Phase|Other|0|||
149803931|NCT04668066|540410730|FG004|Part 1: Treatment Phase|Other|0|||
149803932|NCT04668066|540410731|FG005|Part 1: Treatment Phase|Other|0|||
149803933|NCT04668066|540410732|FG006|Part 1: Treatment Phase|Other|0|||
149803934|NCT04668066|540410733|FG007|Part 1: Treatment Phase|Other|0|||
149803935|NCT04668066|540410734|FG008|Part 1: Treatment Phase|Other|0|||
149803936|NCT04668066|540410735|FG009|Part 1: Treatment Phase|Other|0|||
149803937|NCT04668066|540410736|FG010|Part 1: Treatment Phase|Other|0|||
150145999|NCT02746575|541672237|FG000|Overall Study|Bradycardia/hypotension|9|||
150146000|NCT02746575|541672237|FG000|Overall Study|Study paused|8|||
150146001|NCT02746575|541672237|FG000|Overall Study|put on beta-blocker|3|||
150146002|NCT02746575|541672237|FG000|Overall Study|type of surgery|1|||
150146003|NCT02746575|541672237|FG000|Overall Study|typ of surgery|1|||
150146004|NCT02746575|541672237|FG000|Overall Study|PI unavailable|1|||
150146005|NCT02746575|541672237|FG000|Overall Study|Unknown history of CVA|1|||
150146006|NCT04567693|541672238|FG000|Overall Study|Death|0|||
150146007|NCT04567693|541672239|FG001|Overall Study|Death|0|||
150146008|NCT04567693|541672240|FG002|Overall Study|Death|2|||
150146009|NCT04567693|541672238|FG000|Overall Study|Lost to Follow-up|1|||
150146010|NCT04567693|541672239|FG001|Overall Study|Lost to Follow-up|0|||
150146011|NCT04567693|541672240|FG002|Overall Study|Lost to Follow-up|2|||
150146012|NCT04567693|541672238|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
150146013|NCT04567693|541672239|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
150146014|NCT04567693|541672240|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
150146015|NCT00720902|541672241|FG000|Overall Study|Withdrawal by Subject|1|||
150146016|NCT00720902|541672242|FG001|Overall Study|Withdrawal by Subject|0|||
150146017|NCT00720902|541672241|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
150146018|NCT00720902|541672242|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
150146019|NCT04867785|541672243|FG000|Overall Study|Adverse Event|1|||
150146020|NCT04867785|541672244|FG001|Overall Study|Adverse Event|0|||
150146021|NCT04867785|541672245|FG002|Overall Study|Adverse Event|1|||
150146022|NCT04867785|541672246|FG003|Overall Study|Adverse Event|0|||
150146023|NCT04867785|541672247|FG004|Overall Study|Adverse Event|0|||
150146024|NCT04867785|541672248|FG005|Overall Study|Adverse Event|0|||
150146025|NCT04867785|541672249|FG006|Overall Study|Adverse Event|0|||
150146026|NCT04867785|541672250|FG007|Overall Study|Adverse Event|2|||
150146027|NCT04867785|541672243|FG000|Overall Study|Lost to Follow-up|4|||
150146028|NCT04867785|541672244|FG001|Overall Study|Lost to Follow-up|4|||
150146029|NCT04867785|541672245|FG002|Overall Study|Lost to Follow-up|3|||
150146030|NCT04867785|541672246|FG003|Overall Study|Lost to Follow-up|2|||
150146031|NCT04867785|541672247|FG004|Overall Study|Lost to Follow-up|0|||
150146032|NCT04867785|541672248|FG005|Overall Study|Lost to Follow-up|1|||
150146033|NCT04867785|541672249|FG006|Overall Study|Lost to Follow-up|0|||
150146034|NCT04867785|541672250|FG007|Overall Study|Lost to Follow-up|1|||
150146035|NCT04867785|541672243|FG000|Overall Study|Withdrawal by Subject|6|||
150146036|NCT04867785|541672244|FG001|Overall Study|Withdrawal by Subject|2|||
150146037|NCT04867785|541672245|FG002|Overall Study|Withdrawal by Subject|2|||
150146038|NCT04867785|541672246|FG003|Overall Study|Withdrawal by Subject|1|||
150146039|NCT04867785|541672247|FG004|Overall Study|Withdrawal by Subject|2|||
150146040|NCT04867785|541672248|FG005|Overall Study|Withdrawal by Subject|0|||
150146041|NCT04867785|541672249|FG006|Overall Study|Withdrawal by Subject|2|||
150146042|NCT04867785|541672250|FG007|Overall Study|Withdrawal by Subject|5|||
150146043|NCT04867785|541672243|FG000|Overall Study|Physician Decision|0|||
150146044|NCT04867785|541672244|FG001|Overall Study|Physician Decision|0|||
150146045|NCT04867785|541672245|FG002|Overall Study|Physician Decision|0|||
150146046|NCT04867785|541672246|FG003|Overall Study|Physician Decision|0|||
150146047|NCT04867785|541672247|FG004|Overall Study|Physician Decision|0|||
150146048|NCT04867785|541672248|FG005|Overall Study|Physician Decision|0|||
150146049|NCT04867785|541672249|FG006|Overall Study|Physician Decision|0|||
150146050|NCT04867785|541672250|FG007|Overall Study|Physician Decision|1|||
150146051|NCT04867785|541672243|FG000|Overall Study|Inadvertent Enrollment|0|||
150146052|NCT04867785|541672244|FG001|Overall Study|Inadvertent Enrollment|0|||
150146053|NCT04867785|541672245|FG002|Overall Study|Inadvertent Enrollment|0|||
150146054|NCT04867785|541672246|FG003|Overall Study|Inadvertent Enrollment|1|||
150146055|NCT04867785|541672247|FG004|Overall Study|Inadvertent Enrollment|1|||
150146056|NCT04867785|541672248|FG005|Overall Study|Inadvertent Enrollment|0|||
150146057|NCT04867785|541672249|FG006|Overall Study|Inadvertent Enrollment|0|||
150146058|NCT04867785|541672250|FG007|Overall Study|Inadvertent Enrollment|1|||
150146059|NCT04867785|541672243|FG000|Overall Study|Eligibility Criteria Not Met|0|||
150146060|NCT04867785|541672244|FG001|Overall Study|Eligibility Criteria Not Met|0|||
150146061|NCT04867785|541672245|FG002|Overall Study|Eligibility Criteria Not Met|0|||
150146062|NCT04867785|541672246|FG003|Overall Study|Eligibility Criteria Not Met|0|||
150146063|NCT04867785|541672247|FG004|Overall Study|Eligibility Criteria Not Met|0|||
150146064|NCT04867785|541672248|FG005|Overall Study|Eligibility Criteria Not Met|0|||
150146065|NCT04867785|541672249|FG006|Overall Study|Eligibility Criteria Not Met|0|||
150146066|NCT04867785|541672250|FG007|Overall Study|Eligibility Criteria Not Met|1|||
150146067|NCT02959671|541672251|FG000|Overall Study|Adverse Event|2|||
150146068|NCT02959671|541672251|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
150146069|NCT02494921|541672256|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
150146070|NCT02494921|541672257|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
150146071|NCT02494921|541672258|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
150146072|NCT02494921|541672259|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
150146073|NCT02494921|541672260|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
150146074|NCT02494921|541672256|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
150146075|NCT02494921|541672257|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
150146076|NCT02494921|541672258|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
150146077|NCT02494921|541672259|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
150146078|NCT02494921|541672260|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
150146079|NCT02494921|541672256|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
150146080|NCT02494921|541672257|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
150146081|NCT02494921|541672258|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
150146082|NCT02494921|541672259|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
150146083|NCT02494921|541672260|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
150146084|NCT04105972|541672261|FG000|Overall Study|Adverse Event|2|||
150146085|NCT04105972|541672262|FG001|Overall Study|Adverse Event|1|||
150146086|NCT00067990|541672264|FG000|Overall Study|Death|5|||
150146087|NCT00067990|541672265|FG001|Overall Study|Death|7|||
150146088|NCT00067990|541672264|FG000|Overall Study|ESRD, Non IF/TA|1|||
150146089|NCT00067990|541672265|FG001|Overall Study|ESRD, Non IF/TA|3|||
150146090|NCT00067990|541672264|FG000|Overall Study|Withdrawal by Subject|4|||
150146091|NCT00067990|541672265|FG001|Overall Study|Withdrawal by Subject|12|||
150146092|NCT03810313|541672272|FG000|Overall Study|Study terminated by sponsor|164|||
150146093|NCT03810313|541672273|FG001|Overall Study|Study terminated by sponsor|159|||
150146094|NCT03810313|541672272|FG000|Overall Study|Subject decision|10|||
150146095|NCT03810313|541672273|FG001|Overall Study|Subject decision|11|||
150146096|NCT03810313|541672272|FG000|Overall Study|Lost to Follow-up|3|||
150146097|NCT03810313|541672273|FG001|Overall Study|Lost to Follow-up|3|||
150146098|NCT03810313|541672272|FG000|Overall Study|Adverse Event|2|||
150146099|NCT03810313|541672273|FG001|Overall Study|Adverse Event|1|||
150146100|NCT03810313|541672272|FG000|Overall Study|Death|2|||
150146101|NCT03810313|541672273|FG001|Overall Study|Death|1|||
150146102|NCT03810313|541672272|FG000|Overall Study|Physician Decision|0|||
150146103|NCT03810313|541672273|FG001|Overall Study|Physician Decision|1|||
150146104|NCT01111838|541672282|FG000|Overall Study|Patient Ineligible|2|||
150146105|NCT01111838|541672282|FG000|Overall Study|Not Treated|3|||
150146106|NCT01111838|541672282|FG000|Overall Study|Clinical deterioration|1|||
150146107|NCT01111838|541672282|FG000|Overall Study|Other Complicating Disease|1|||
150146108|NCT02567825|541672283|FG000|Overall Study|No follow-up post-randomization|5|||
150146109|NCT02567825|541672284|FG001|Overall Study|No follow-up post-randomization|1|||
150146110|NCT02567825|541672283|FG000|Overall Study|Follow-up less than 23 months|16|||
150146111|NCT02567825|541672284|FG001|Overall Study|Follow-up less than 23 months|20|||
150146112|NCT01872910|541672289|FG000|Overall Study|Lost to Follow-up|2|||
150146113|NCT01872910|541672290|FG001|Overall Study|Lost to Follow-up|0|||
150146114|NCT01872910|541672291|FG002|Overall Study|Lost to Follow-up|2|||
150146115|NCT01872910|541672292|FG003|Overall Study|Lost to Follow-up|0|||
150146116|NCT01872910|541672293|FG004|Overall Study|Lost to Follow-up|0|||
150146117|NCT01872910|541672294|FG005|Overall Study|Lost to Follow-up|0|||
150146118|NCT00154310|541672295|FG000|Overall Study|Adverse Event|19|||
150146119|NCT00154310|541672296|FG001|Overall Study|Adverse Event|9|||
150146120|NCT00154310|541672295|FG000|Overall Study|Lack of Efficacy|5|||
150146121|NCT00154310|541672296|FG001|Overall Study|Lack of Efficacy|4|||
150146122|NCT00154310|541672295|FG000|Overall Study|Protocol Violation|4|||
150146123|NCT00154310|541672296|FG001|Overall Study|Protocol Violation|2|||
150146124|NCT00154310|541672295|FG000|Overall Study|Withdrawal by Subject|9|||
150146125|NCT00154310|541672296|FG001|Overall Study|Withdrawal by Subject|3|||
150146126|NCT00154310|541672295|FG000|Overall Study|Lost to Follow-up|0|||
150146127|NCT00154310|541672296|FG001|Overall Study|Lost to Follow-up|8|||
150146128|NCT00154310|541672295|FG000|Overall Study|Administrative problems|0|||
150146129|NCT00154310|541672296|FG001|Overall Study|Administrative problems|1|||
150146130|NCT00154310|541672295|FG000|Overall Study|Death|0|||
150146131|NCT00154310|541672296|FG001|Overall Study|Death|1|||
150146132|NCT01540565|541672297|FG000|Overall Study|Ineligible|2|||
150146133|NCT03469349|541672298|FG000|Overall Study|Withdrawal by Subject|1|||
150146134|NCT03469349|541672299|FG001|Overall Study|Withdrawal by Subject|3|||
150146135|NCT03469349|541672298|FG000|Overall Study|Progressive Disease|0|||
150146136|NCT03469349|541672299|FG001|Overall Study|Progressive Disease|1|||
150146137|NCT03469349|541672298|FG000|Overall Study|Lost to Follow-up|2|||
150146138|NCT03469349|541672299|FG001|Overall Study|Lost to Follow-up|2|||
150146139|NCT03469349|541672298|FG000|Overall Study|Adverse Event|2|||
150146140|NCT03469349|541672299|FG001|Overall Study|Adverse Event|4|||
150146141|NCT02086162|541672301|FG000|Overall Study|Withdrawal by Subject|4|||
150146142|NCT02086162|541672302|FG001|Overall Study|Withdrawal by Subject|4|||
150146143|NCT02086162|541672301|FG000|Overall Study|moved|1|||
150146144|NCT02086162|541672302|FG001|Overall Study|moved|1|||
150146145|NCT02086162|541672301|FG000|Overall Study|Lost to Follow-up|4|||
150146146|NCT02086162|541672302|FG001|Overall Study|Lost to Follow-up|2|||
150146147|NCT02086162|541672301|FG000|Overall Study|Death|1|||
150146148|NCT02086162|541672302|FG001|Overall Study|Death|0|||
150146149|NCT03447730|541672303|FG000|Overall Study|Adverse Event|0|||
150146150|NCT03447730|541672304|FG001|Overall Study|Adverse Event|2|||
150146151|NCT03447730|541672305|FG002|Overall Study|Adverse Event|0|||
150146152|NCT05266963|541672306|FG000|Drug Period A|Withdrawal by Subject|0|||
150146153|NCT05266963|541672307|FG001|Drug Period A|Withdrawal by Subject|1|||
149803938|NCT04668066|540410737|FG011|Part 1: Treatment Phase|Other|1|||
149803939|NCT04668066|540410738|FG012|Part 1: Treatment Phase|Other|0|||
149803940|NCT04668066|540410739|FG013|Part 1: Treatment Phase|Other|0|||
149803941|NCT04668066|540410740|FG014|Part 1: Treatment Phase|Other|0|||
149803942|NCT04668066|540410741|FG015|Part 1: Treatment Phase|Other|0|||
149803943|NCT04668066|540410742|FG016|Part 1: Treatment Phase|Other|0|||
149803944|NCT04668066|540410743|FG017|Part 1: Treatment Phase|Other|0|||
149803945|NCT04668066|540410744|FG018|Part 1: Treatment Phase|Other|0|||
149803946|NCT04668066|540410726|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803947|NCT04668066|540410727|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803948|NCT04668066|540410728|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803949|NCT04668066|540410729|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803950|NCT04668066|540410730|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803951|NCT04668066|540410731|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803952|NCT04668066|540410732|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803953|NCT04668066|540410733|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803954|NCT04668066|540410734|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803955|NCT04668066|540410735|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803956|NCT04668066|540410736|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803957|NCT04668066|540410737|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803958|NCT04668066|540410738|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
149803959|NCT04668066|540410739|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803960|NCT04668066|540410740|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803961|NCT04668066|540410741|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
149803962|NCT04668066|540410742|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803963|NCT04668066|540410743|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803964|NCT04668066|540410744|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149803965|NCT04668066|540410726|FG000|Part 1: Follow-Up|Adverse Event|0|||
149803966|NCT04668066|540410727|FG001|Part 1: Follow-Up|Adverse Event|0|||
149803967|NCT04668066|540410728|FG002|Part 1: Follow-Up|Adverse Event|0|||
149803968|NCT04668066|540410729|FG003|Part 1: Follow-Up|Adverse Event|0|||
149803969|NCT04668066|540410730|FG004|Part 1: Follow-Up|Adverse Event|0|||
149803970|NCT04668066|540410731|FG005|Part 1: Follow-Up|Adverse Event|0|||
149803971|NCT04668066|540410732|FG006|Part 1: Follow-Up|Adverse Event|0|||
149803972|NCT04668066|540410733|FG007|Part 1: Follow-Up|Adverse Event|0|||
149803973|NCT04668066|540410734|FG008|Part 1: Follow-Up|Adverse Event|0|||
149803974|NCT04668066|540410735|FG009|Part 1: Follow-Up|Adverse Event|0|||
149803975|NCT04668066|540410736|FG010|Part 1: Follow-Up|Adverse Event|0|||
149803976|NCT04668066|540410737|FG011|Part 1: Follow-Up|Adverse Event|1|||
149803977|NCT04668066|540410738|FG012|Part 1: Follow-Up|Adverse Event|0|||
149803978|NCT04668066|540410739|FG013|Part 1: Follow-Up|Adverse Event|0|||
149803979|NCT04668066|540410740|FG014|Part 1: Follow-Up|Adverse Event|0|||
149803980|NCT04668066|540410741|FG015|Part 1: Follow-Up|Adverse Event|0|||
149803981|NCT04668066|540410742|FG016|Part 1: Follow-Up|Adverse Event|0|||
149803982|NCT04668066|540410743|FG017|Part 1: Follow-Up|Adverse Event|0|||
149803983|NCT04668066|540410744|FG018|Part 1: Follow-Up|Adverse Event|0|||
149803984|NCT04668066|540410726|FG000|Part 1: Follow-Up|Other|0|||
149803985|NCT04668066|540410727|FG001|Part 1: Follow-Up|Other|0|||
149803986|NCT04668066|540410728|FG002|Part 1: Follow-Up|Other|0|||
149803987|NCT04668066|540410729|FG003|Part 1: Follow-Up|Other|0|||
149803988|NCT04668066|540410730|FG004|Part 1: Follow-Up|Other|0|||
149803989|NCT04668066|540410731|FG005|Part 1: Follow-Up|Other|0|||
149803990|NCT04668066|540410732|FG006|Part 1: Follow-Up|Other|0|||
149803991|NCT04668066|540410733|FG007|Part 1: Follow-Up|Other|0|||
149803992|NCT04668066|540410734|FG008|Part 1: Follow-Up|Other|0|||
149803993|NCT04668066|540410735|FG009|Part 1: Follow-Up|Other|0|||
149803994|NCT04668066|540410736|FG010|Part 1: Follow-Up|Other|0|||
149803995|NCT04668066|540410737|FG011|Part 1: Follow-Up|Other|1|||
149803996|NCT04668066|540410738|FG012|Part 1: Follow-Up|Other|1|||
149803997|NCT04668066|540410739|FG013|Part 1: Follow-Up|Other|0|||
149803998|NCT04668066|540410740|FG014|Part 1: Follow-Up|Other|0|||
150146154|NCT04091360|541672308|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146155|NCT04091360|541672309|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146156|NCT04091360|541672310|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149803999|NCT04668066|540410741|FG015|Part 1: Follow-Up|Other|0|||
149804000|NCT04668066|540410742|FG016|Part 1: Follow-Up|Other|0|||
149804001|NCT04668066|540410743|FG017|Part 1: Follow-Up|Other|0|||
149804002|NCT04668066|540410744|FG018|Part 1: Follow-Up|Other|0|||
149804003|NCT04668066|540410726|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804004|NCT04668066|540410727|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804005|NCT04668066|540410728|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804006|NCT04668066|540410729|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804007|NCT04668066|540410730|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804008|NCT04668066|540410731|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804009|NCT04668066|540410732|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804010|NCT04668066|540410733|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
150146157|NCT04091360|541672311|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146158|NCT04091360|541672312|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146159|NCT04091360|541672313|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146160|NCT04091360|541672314|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146161|NCT04091360|541672315|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
150146162|NCT04091360|541672316|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
150146163|NCT04091360|541672317|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
150146164|NCT04091360|541672308|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146165|NCT04091360|541672309|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146166|NCT04091360|541672310|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146167|NCT04091360|541672311|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146168|NCT04091360|541672312|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146169|NCT04091360|541672313|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146170|NCT04091360|541672314|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
150146171|NCT04091360|541672315|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
150146172|NCT04091360|541672316|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146173|NCT04091360|541672317|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
150146174|NCT04091360|541672308|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146175|NCT04091360|541672309|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146176|NCT04091360|541672310|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146177|NCT04091360|541672311|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146178|NCT04091360|541672312|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146179|NCT04091360|541672313|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146180|NCT04091360|541672314|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
150146181|NCT04091360|541672315|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146182|NCT04091360|541672316|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
150146183|NCT04091360|541672317|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
150146184|NCT00525265|541672324|FG000|Overall Study|Protocol Violation|1|||
150146185|NCT00525265|541672325|FG001|Overall Study|Protocol Violation|0|||
150146186|NCT01107743|541672326|FG000|Overall Study|Protocol Violation|46|||
150146187|NCT00308737|541672327|FG000|Overall Study|Adverse Event|104|||
150146188|NCT00308737|541672328|FG001|Overall Study|Adverse Event|9|||
150146189|NCT00308737|541672329|FG002|Overall Study|Adverse Event|0|||
150146190|NCT00308737|541672327|FG000|Overall Study|Death|4|||
150146191|NCT00308737|541672328|FG001|Overall Study|Death|3|||
150146192|NCT00308737|541672329|FG002|Overall Study|Death|0|||
150146193|NCT00308737|541672327|FG000|Overall Study|Lost to Follow-up|56|||
150146194|NCT00308737|541672328|FG001|Overall Study|Lost to Follow-up|80|||
150146195|NCT00308737|541672329|FG002|Overall Study|Lost to Follow-up|5|||
150146196|NCT00308737|541672327|FG000|Overall Study|Physician Decision|15|||
150146197|NCT00308737|541672328|FG001|Overall Study|Physician Decision|2|||
150146198|NCT00308737|541672329|FG002|Overall Study|Physician Decision|1|||
150146199|NCT00308737|541672327|FG000|Overall Study|Protocol Violation|34|||
150146200|NCT00308737|541672328|FG001|Overall Study|Protocol Violation|9|||
150146201|NCT00308737|541672329|FG002|Overall Study|Protocol Violation|5|||
150146202|NCT00308737|541672327|FG000|Overall Study|Withdrawal by Subject|218|||
150146203|NCT00308737|541672328|FG001|Overall Study|Withdrawal by Subject|166|||
150146204|NCT00308737|541672329|FG002|Overall Study|Withdrawal by Subject|18|||
150146205|NCT00308737|541672327|FG000|Overall Study|Various|32|||
150146206|NCT00308737|541672328|FG001|Overall Study|Various|20|||
150146207|NCT00308737|541672329|FG002|Overall Study|Various|8|||
150146208|NCT01913639|541672330|FG000|Overall Study|Not Eligible|3|||
150146209|NCT01225822|541672340|FG000|Overall Study|Adverse Event|13|||
150146210|NCT01225822|541672341|FG001|Overall Study|Adverse Event|31|||
150146211|NCT01225822|541672342|FG002|Overall Study|Adverse Event|18|||
150146212|NCT01225822|541672343|FG003|Overall Study|Adverse Event|23|||
150146213|NCT01225822|541672344|FG004|Overall Study|Adverse Event|14|||
150146214|NCT01225822|541672340|FG000|Overall Study|Protocol Violation|6|||
150146215|NCT01225822|541672341|FG001|Overall Study|Protocol Violation|8|||
150146216|NCT01225822|541672342|FG002|Overall Study|Protocol Violation|6|||
150146217|NCT01225822|541672343|FG003|Overall Study|Protocol Violation|7|||
150146218|NCT01225822|541672344|FG004|Overall Study|Protocol Violation|4|||
150146219|NCT01225822|541672340|FG000|Overall Study|Lost to Follow-up|0|||
150146220|NCT01225822|541672341|FG001|Overall Study|Lost to Follow-up|0|||
150146221|NCT01225822|541672342|FG002|Overall Study|Lost to Follow-up|0|||
150146222|NCT01225822|541672343|FG003|Overall Study|Lost to Follow-up|1|||
150146223|NCT01225822|541672344|FG004|Overall Study|Lost to Follow-up|0|||
150146224|NCT01225822|541672340|FG000|Overall Study|Withdrawal by Subject|6|||
150146225|NCT01225822|541672341|FG001|Overall Study|Withdrawal by Subject|7|||
150146226|NCT01225822|541672342|FG002|Overall Study|Withdrawal by Subject|7|||
150146227|NCT01225822|541672343|FG003|Overall Study|Withdrawal by Subject|11|||
150146228|NCT01225822|541672344|FG004|Overall Study|Withdrawal by Subject|6|||
150146229|NCT01225822|541672340|FG000|Overall Study|Other|13|||
150146230|NCT01225822|541672341|FG001|Overall Study|Other|10|||
150146231|NCT01225822|541672342|FG002|Overall Study|Other|7|||
150146232|NCT01225822|541672343|FG003|Overall Study|Other|10|||
150146233|NCT01225822|541672344|FG004|Overall Study|Other|7|||
150146234|NCT00130793|541672345|FG000|Overall Study|Lost to Follow-up|1|||
150146235|NCT00130793|541672346|FG001|Overall Study|Lost to Follow-up|4|||
150146236|NCT00130793|541672345|FG000|Overall Study|Withdrew consent|2|||
150146237|NCT00130793|541672346|FG001|Overall Study|Withdrew consent|0|||
150146238|NCT00211237|541672347|FG000|Baseline|Withdrew|1|||
150146239|NCT00211237|541672348|FG001|Baseline|Withdrew|3|||
150146240|NCT00211237|541672349|FG002|Baseline|Withdrew|0|||
150146241|NCT00211237|541672347|FG000|Baseline|Refused random assignment|1|||
150146242|NCT00211237|541672348|FG001|Baseline|Refused random assignment|0|||
150146243|NCT00211237|541672349|FG002|Baseline|Refused random assignment|0|||
150146244|NCT00211237|541672347|FG000|1 Month|Death|2|||
150146245|NCT00211237|541672348|FG001|1 Month|Death|1|||
150146246|NCT00211237|541672349|FG002|1 Month|Death|0|||
150146247|NCT00211237|541672347|FG000|1 Month|Lost to Follow-up|0|||
150146248|NCT00211237|541672348|FG001|1 Month|Lost to Follow-up|2|||
150146249|NCT00211237|541672349|FG002|1 Month|Lost to Follow-up|0|||
150146250|NCT00211237|541672347|FG000|1 Month|Withdrew|0|||
150146251|NCT00211237|541672348|FG001|1 Month|Withdrew|4|||
150146252|NCT00211237|541672349|FG002|1 Month|Withdrew|0|||
150146253|NCT00211237|541672347|FG000|1 Month|Additional surgery needed|1|||
150146254|NCT00211237|541672348|FG001|1 Month|Additional surgery needed|0|||
150146255|NCT00211237|541672349|FG002|1 Month|Additional surgery needed|0|||
150146256|NCT00211237|541672347|FG000|1 Month|Non-medical problem|0|||
150146257|NCT00211237|541672348|FG001|1 Month|Non-medical problem|2|||
150146258|NCT00211237|541672349|FG002|1 Month|Non-medical problem|0|||
150146259|NCT00211237|541672347|FG000|3 Months|Death|7|||
150146260|NCT00211237|541672348|FG001|3 Months|Death|3|||
150146261|NCT00211237|541672349|FG002|3 Months|Death|0|||
150146262|NCT00211237|541672347|FG000|3 Months|Could not comply with protocol|1|||
150146263|NCT00211237|541672348|FG001|3 Months|Could not comply with protocol|0|||
150146264|NCT00211237|541672349|FG002|3 Months|Could not comply with protocol|0|||
150146265|NCT00211237|541672347|FG000|3 Months|Withdrew|0|||
150146266|NCT00211237|541672348|FG001|3 Months|Withdrew|1|||
150146267|NCT00211237|541672349|FG002|3 Months|Withdrew|0|||
150146268|NCT00211237|541672347|FG000|3 Months|Non-medical problem|0|||
150146269|NCT00211237|541672348|FG001|3 Months|Non-medical problem|0|||
150146270|NCT00211237|541672349|FG002|3 Months|Non-medical problem|1|||
150146271|NCT00211237|541672347|FG000|6 Months|Death|6|||
150146272|NCT00211237|541672348|FG001|6 Months|Death|0|||
150146273|NCT00211237|541672349|FG002|6 Months|Death|3|||
150146274|NCT00211237|541672347|FG000|6 Months|Lost to Follow-up|2|||
150146275|NCT00211237|541672348|FG001|6 Months|Lost to Follow-up|0|||
150146276|NCT00211237|541672349|FG002|6 Months|Lost to Follow-up|0|||
150146277|NCT00211237|541672347|FG000|6 Months|Could not comply with protocol|0|||
150146278|NCT00211237|541672348|FG001|6 Months|Could not comply with protocol|2|||
150146279|NCT00211237|541672349|FG002|6 Months|Could not comply with protocol|0|||
150146280|NCT00211237|541672347|FG000|12 Months|Death|8|||
150146281|NCT00211237|541672348|FG001|12 Months|Death|2|||
150146282|NCT00211237|541672349|FG002|12 Months|Death|3|||
150146283|NCT00211237|541672347|FG000|12 Months|Lost to Follow-up|1|||
150146284|NCT00211237|541672348|FG001|12 Months|Lost to Follow-up|0|||
150146285|NCT00211237|541672349|FG002|12 Months|Lost to Follow-up|1|||
150146286|NCT00211237|541672347|FG000|12 Months|Withdrew|0|||
150146287|NCT00211237|541672348|FG001|12 Months|Withdrew|0|||
150146288|NCT00211237|541672349|FG002|12 Months|Withdrew|1|||
150146289|NCT00211237|541672347|FG000|12 Months|unrelated medical problem|0|||
150146290|NCT00211237|541672348|FG001|12 Months|unrelated medical problem|0|||
150146291|NCT00211237|541672349|FG002|12 Months|unrelated medical problem|1|||
150146292|NCT01290822|541672350|FG000|Overall Study|Withdrawal by Subject|1|||
150146293|NCT01290822|541672350|FG000|Overall Study|Physician Decision|10|||
150146294|NCT01003639|541672351|FG000|Overall Study|Lost to Follow-up|6|||
150146295|NCT01003639|541672352|FG001|Overall Study|Lost to Follow-up|9|||
150146296|NCT01003639|541672351|FG000|Overall Study|Withdrawal by Subject|9|||
150146297|NCT01003639|541672352|FG001|Overall Study|Withdrawal by Subject|5|||
150146298|NCT01003639|541672351|FG000|Overall Study|Lack of Efficacy|1|||
150146299|NCT01003639|541672352|FG001|Overall Study|Lack of Efficacy|6|||
150146300|NCT01003639|541672351|FG000|Overall Study|Adverse Event|0|||
150146301|NCT01003639|541672352|FG001|Overall Study|Adverse Event|1|||
150146302|NCT01003639|541672351|FG000|Overall Study|Protocol Violation|0|||
150146303|NCT01003639|541672352|FG001|Overall Study|Protocol Violation|1|||
150146304|NCT01003639|541672351|FG000|Overall Study|Physician Decision|1|||
150146305|NCT01003639|541672352|FG001|Overall Study|Physician Decision|0|||
150146306|NCT01515189|541672353|FG000|Induction|Disease Progression|109|||
150146307|NCT01515189|541672354|FG001|Induction|Disease Progression|155|||
150146308|NCT01515189|541672353|FG000|Induction|Study drug toxicity|86|||
150146309|NCT01515189|541672354|FG001|Induction|Study drug toxicity|36|||
150146310|NCT01515189|541672353|FG000|Induction|Death|24|||
150146311|NCT01515189|541672354|FG001|Induction|Death|17|||
150146312|NCT01515189|541672353|FG000|Induction|Adverse Event|14|||
150146313|NCT01515189|541672354|FG001|Induction|Adverse Event|9|||
150146314|NCT01515189|541672353|FG000|Induction|Withdrawal by Subject|3|||
150146315|NCT01515189|541672354|FG001|Induction|Withdrawal by Subject|9|||
150146316|NCT01515189|541672353|FG000|Induction|No longer meets study criteria|0|||
150146317|NCT01515189|541672354|FG001|Induction|No longer meets study criteria|2|||
150146318|NCT01515189|541672353|FG000|Induction|Lost to Follow-up|1|||
150146319|NCT01515189|541672354|FG001|Induction|Lost to Follow-up|0|||
150146320|NCT01515189|541672353|FG000|Induction|Other|0|||
150146321|NCT01515189|541672354|FG001|Induction|Other|4|||
150146322|NCT01515189|541672353|FG000|First Re-Induction Phase|Disease progression|6|||
150146323|NCT01515189|541672354|FG001|First Re-Induction Phase|Disease progression|14|||
150146324|NCT01515189|541672353|FG000|First Re-Induction Phase|Study drug toxicity|5|||
150146325|NCT01515189|541672354|FG001|First Re-Induction Phase|Study drug toxicity|0|||
150146326|NCT01515189|541672353|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
150146327|NCT01515189|541672354|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
150146328|NCT01515189|541672353|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
150146329|NCT01515189|541672354|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
150146330|NCT01515189|541672353|FG000|First Re-Induction Phase|Other|1|||
150146331|NCT01515189|541672354|FG001|First Re-Induction Phase|Other|0|||
150146332|NCT04078035|541672355|FG000|Session 2|Lost to Follow-up|3|||
150146333|NCT04078035|541672356|FG001|Session 2|Lost to Follow-up|1|||
150146334|NCT04078035|541672355|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
150146335|NCT04078035|541672356|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
150146336|NCT05644353|541672359|FG000|Overall Study|Physician Decision|1|||
150146337|NCT05644353|541672360|FG001|Overall Study|Physician Decision|0|||
150146338|NCT05644353|541672361|FG002|Overall Study|Physician Decision|0|||
150146339|NCT05644353|541672362|FG003|Overall Study|Physician Decision|0|||
150146340|NCT05644353|541672363|FG004|Overall Study|Physician Decision|0|||
150146341|NCT05644353|541672364|FG005|Overall Study|Physician Decision|0|||
150146342|NCT05644353|541672359|FG000|Overall Study|Protocol Violation|1|||
150146343|NCT05644353|541672360|FG001|Overall Study|Protocol Violation|0|||
150146344|NCT05644353|541672361|FG002|Overall Study|Protocol Violation|0|||
150146345|NCT05644353|541672362|FG003|Overall Study|Protocol Violation|0|||
150146346|NCT05644353|541672363|FG004|Overall Study|Protocol Violation|0|||
150146347|NCT05644353|541672364|FG005|Overall Study|Protocol Violation|0|||
150146348|NCT05644353|541672359|FG000|Overall Study|Withdrawal by Subject|0|||
150146349|NCT05644353|541672360|FG001|Overall Study|Withdrawal by Subject|2|||
150146350|NCT05644353|541672361|FG002|Overall Study|Withdrawal by Subject|0|||
150146351|NCT05644353|541672362|FG003|Overall Study|Withdrawal by Subject|0|||
150146352|NCT05644353|541672363|FG004|Overall Study|Withdrawal by Subject|1|||
150146353|NCT05644353|541672364|FG005|Overall Study|Withdrawal by Subject|0|||
150146354|NCT05644353|541672359|FG000|Overall Study|Lost to Follow-up|0|||
150146355|NCT05644353|541672360|FG001|Overall Study|Lost to Follow-up|0|||
150146356|NCT05644353|541672361|FG002|Overall Study|Lost to Follow-up|1|||
150146357|NCT05644353|541672362|FG003|Overall Study|Lost to Follow-up|0|||
150146358|NCT05644353|541672363|FG004|Overall Study|Lost to Follow-up|0|||
150146359|NCT05644353|541672364|FG005|Overall Study|Lost to Follow-up|0|||
150146360|NCT03500640|541672365|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
150146361|NCT03500640|541672366|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
150146362|NCT03500640|541672367|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
150146363|NCT03500640|541672365|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
150146364|NCT03500640|541672366|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
150146365|NCT03500640|541672367|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
150146366|NCT03500640|541672365|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
150146367|NCT03500640|541672366|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
150146368|NCT03500640|541672367|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
150146369|NCT03500640|541672365|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
150146370|NCT03500640|541672366|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
150146371|NCT03500640|541672367|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
150146372|NCT03500640|541672365|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
150146373|NCT03500640|541672366|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
149804011|NCT04668066|540410734|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804012|NCT04668066|540410735|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804013|NCT04668066|540410736|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804014|NCT04668066|540410737|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804015|NCT04668066|540410738|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
149804016|NCT04668066|540410739|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804017|NCT04668066|540410740|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804018|NCT04668066|540410741|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
149804019|NCT04668066|540410742|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804020|NCT04668066|540410743|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804021|NCT04668066|540410744|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
149804022|NCT04668066|540410726|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804023|NCT04668066|540410727|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
150146374|NCT03500640|541672367|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
150146375|NCT03500640|541672365|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
150146376|NCT03500640|541672366|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
150146377|NCT03500640|541672367|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
149804024|NCT04668066|540410728|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804025|NCT04668066|540410729|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804026|NCT04668066|540410730|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804027|NCT04668066|540410731|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804028|NCT04668066|540410732|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804029|NCT04668066|540410733|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804030|NCT04668066|540410734|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804031|NCT04668066|540410735|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804032|NCT04668066|540410736|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804033|NCT04668066|540410737|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804034|NCT04668066|540410738|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804035|NCT04668066|540410739|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804036|NCT04668066|540410740|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804037|NCT04668066|540410741|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804038|NCT04668066|540410742|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804039|NCT04668066|540410743|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149804040|NCT04668066|540410744|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
149804041|NCT04668066|540410726|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804042|NCT04668066|540410727|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804043|NCT04668066|540410728|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804044|NCT04668066|540410729|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804045|NCT04668066|540410730|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804046|NCT04668066|540410731|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804047|NCT04668066|540410732|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804048|NCT04668066|540410733|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804049|NCT04668066|540410734|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804050|NCT04668066|540410735|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804051|NCT04668066|540410736|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804052|NCT04668066|540410737|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804053|NCT04668066|540410738|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804054|NCT04668066|540410739|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804055|NCT04668066|540410740|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804056|NCT04668066|540410741|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804057|NCT04668066|540410742|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804058|NCT04668066|540410743|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
149804059|NCT04668066|540410744|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
149804060|NCT04668066|540410726|FG000|Part 2: Treatment Phase|Other|0|||
149804061|NCT04668066|540410727|FG001|Part 2: Treatment Phase|Other|0|||
149804062|NCT04668066|540410728|FG002|Part 2: Treatment Phase|Other|0|||
149804063|NCT04668066|540410729|FG003|Part 2: Treatment Phase|Other|0|||
149804064|NCT04668066|540410730|FG004|Part 2: Treatment Phase|Other|0|||
149804065|NCT04668066|540410731|FG005|Part 2: Treatment Phase|Other|0|||
149804066|NCT04668066|540410732|FG006|Part 2: Treatment Phase|Other|0|||
149804067|NCT04668066|540410733|FG007|Part 2: Treatment Phase|Other|0|||
149804068|NCT04668066|540410734|FG008|Part 2: Treatment Phase|Other|0|||
149804069|NCT04668066|540410735|FG009|Part 2: Treatment Phase|Other|0|||
149804070|NCT04668066|540410736|FG010|Part 2: Treatment Phase|Other|0|||
149804071|NCT04668066|540410737|FG011|Part 2: Treatment Phase|Other|0|||
149804072|NCT04668066|540410738|FG012|Part 2: Treatment Phase|Other|0|||
149804073|NCT04668066|540410739|FG013|Part 2: Treatment Phase|Other|0|||
149804074|NCT04668066|540410740|FG014|Part 2: Treatment Phase|Other|0|||
149804075|NCT04668066|540410741|FG015|Part 2: Treatment Phase|Other|0|||
149804076|NCT04668066|540410742|FG016|Part 2: Treatment Phase|Other|0|||
149804077|NCT04668066|540410743|FG017|Part 2: Treatment Phase|Other|0|||
149804078|NCT04668066|540410744|FG018|Part 2: Treatment Phase|Other|1|||
149804079|NCT04668066|540410726|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804080|NCT04668066|540410727|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804081|NCT04668066|540410728|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804082|NCT04668066|540410729|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804083|NCT04668066|540410730|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804084|NCT04668066|540410731|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804085|NCT04668066|540410732|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804086|NCT04668066|540410733|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
150146378|NCT03500640|541672365|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
150146379|NCT03500640|541672366|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
149804087|NCT04668066|540410734|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804088|NCT04668066|540410735|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804089|NCT04668066|540410736|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804090|NCT04668066|540410737|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804091|NCT04668066|540410738|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804092|NCT04668066|540410739|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804093|NCT04668066|540410740|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804094|NCT04668066|540410741|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804095|NCT04668066|540410742|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804096|NCT04668066|540410743|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
149804097|NCT04668066|540410744|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
149804098|NCT02369874|540410745|FG000|Overall Study|Lost to Follow-up|2|||
149804099|NCT02369874|540410746|FG001|Overall Study|Lost to Follow-up|2|||
149804100|NCT02369874|540410747|FG002|Overall Study|Lost to Follow-up|2|||
149804101|NCT02369874|540410745|FG000|Overall Study|Withdrawal by Subject|7|||
149804102|NCT02369874|540410746|FG001|Overall Study|Withdrawal by Subject|9|||
149804103|NCT02369874|540410747|FG002|Overall Study|Withdrawal by Subject|27|||
149804104|NCT02369874|540410745|FG000|Overall Study|Miscellaneous|1|||
149804105|NCT02369874|540410746|FG001|Overall Study|Miscellaneous|1|||
149804106|NCT02369874|540410747|FG002|Overall Study|Miscellaneous|0|||
149804107|NCT02369874|540410745|FG000|Overall Study|On Treatment/Off Study|34|||
149804108|NCT02369874|540410746|FG001|Overall Study|On Treatment/Off Study|45|||
149804109|NCT02369874|540410747|FG002|Overall Study|On Treatment/Off Study|32|||
149804110|NCT00596466|540410748|FG000|Overall Study|Lack of Efficacy|5|||
149804111|NCT00596466|540410748|FG000|Overall Study|Adverse Event|4|||
149804112|NCT00596466|540410748|FG000|Overall Study|Withdrawal by Subject|2|||
149804113|NCT00596466|540410748|FG000|Overall Study|Protocol Violation|2|||
149804114|NCT00596466|540410748|FG000|Overall Study|Unpecified|2|||
149804115|NCT00596466|540410748|FG000|Overall Study|Enrolled, not treated|2|||
149804116|NCT01891669|540410749|FG000|Overall Study|Death|0|||
149804117|NCT01891669|540410750|FG001|Overall Study|Death|0|||
149804118|NCT01891669|540410751|FG002|Overall Study|Death|0|||
149804119|NCT01891669|540410752|FG003|Overall Study|Death|0|||
149804120|NCT01891669|540410753|FG004|Overall Study|Death|0|||
149804121|NCT01891669|540410754|FG005|Overall Study|Death|0|||
149804122|NCT01891669|540410755|FG006|Overall Study|Death|0|||
149804123|NCT01891669|540410756|FG007|Overall Study|Death|1|||
149804124|NCT01891669|540410757|FG008|Overall Study|Death|0|||
149804125|NCT01891669|540410758|FG009|Overall Study|Death|1|||
149804126|NCT01891669|540410749|FG000|Overall Study|Withdrawal by Subject|1|||
149804127|NCT01891669|540410750|FG001|Overall Study|Withdrawal by Subject|1|||
149804128|NCT01891669|540410751|FG002|Overall Study|Withdrawal by Subject|0|||
149804129|NCT01891669|540410752|FG003|Overall Study|Withdrawal by Subject|0|||
149804130|NCT01891669|540410753|FG004|Overall Study|Withdrawal by Subject|0|||
149804131|NCT01891669|540410754|FG005|Overall Study|Withdrawal by Subject|0|||
149804132|NCT01891669|540410755|FG006|Overall Study|Withdrawal by Subject|1|||
149804133|NCT01891669|540410756|FG007|Overall Study|Withdrawal by Subject|2|||
149804134|NCT01891669|540410757|FG008|Overall Study|Withdrawal by Subject|1|||
149804135|NCT01891669|540410758|FG009|Overall Study|Withdrawal by Subject|1|||
149804136|NCT01891669|540410749|FG000|Overall Study|Other|1|||
149804137|NCT01891669|540410750|FG001|Overall Study|Other|0|||
149804138|NCT01891669|540410751|FG002|Overall Study|Other|0|||
149804139|NCT01891669|540410752|FG003|Overall Study|Other|0|||
149804140|NCT01891669|540410753|FG004|Overall Study|Other|0|||
149804141|NCT01891669|540410754|FG005|Overall Study|Other|0|||
149804142|NCT01891669|540410755|FG006|Overall Study|Other|0|||
149804143|NCT01891669|540410756|FG007|Overall Study|Other|1|||
149804144|NCT01891669|540410757|FG008|Overall Study|Other|0|||
149804145|NCT01891669|540410758|FG009|Overall Study|Other|0|||
149804146|NCT01015118|540410759|FG000|Overall Study|Protocol Violation|5|||
149804147|NCT01015118|540410760|FG001|Overall Study|Protocol Violation|6|||
149804148|NCT01015118|540410759|FG000|Overall Study|Withdrawal by Subject|103|||
149804149|NCT01015118|540410760|FG001|Overall Study|Withdrawal by Subject|27|||
149804150|NCT01015118|540410759|FG000|Overall Study|Other Adverse Event (AE)|141|||
149804151|NCT01015118|540410760|FG001|Overall Study|Other Adverse Event (AE)|33|||
149804152|NCT01015118|540410759|FG000|Overall Study|Worsening or AE of underlying disease|5|||
149804153|NCT01015118|540410760|FG001|Overall Study|Worsening or AE of underlying disease|4|||
149804154|NCT01015118|540410759|FG000|Overall Study|Progressive disease|364|||
149804155|NCT01015118|540410760|FG001|Overall Study|Progressive disease|229|||
149804156|NCT01015118|540410759|FG000|Overall Study|Not treated|9|||
149804157|NCT01015118|540410760|FG001|Overall Study|Not treated|5|||
149804158|NCT01015118|540410759|FG000|Overall Study|Other than stated above|42|||
149804159|NCT01015118|540410760|FG001|Overall Study|Other than stated above|23|||
149804160|NCT04365387|540410761|FG000|Overall Study|Adverse Event|4|||
149804161|NCT04365387|540410762|FG001|Overall Study|Adverse Event|2|||
149804162|NCT04365387|540410761|FG000|Overall Study|Participants request|14|||
149804163|NCT04365387|540410762|FG001|Overall Study|Participants request|14|||
149804164|NCT04365387|540410761|FG000|Overall Study|Lost to Follow-up|8|||
149804165|NCT04365387|540410762|FG001|Overall Study|Lost to Follow-up|5|||
149804166|NCT04365387|540410761|FG000|Overall Study|Protocol deviation|3|||
149804167|NCT04365387|540410762|FG001|Overall Study|Protocol deviation|4|||
150146380|NCT03500640|541672367|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
149804168|NCT04365387|540410761|FG000|Overall Study|Participant compliance with visit schedule|1|||
149804169|NCT04365387|540410762|FG001|Overall Study|Participant compliance with visit schedule|0|||
149804170|NCT04365387|540410761|FG000|Overall Study|Participant incarcerated|1|||
149804171|NCT04365387|540410762|FG001|Overall Study|Participant incarcerated|0|||
150146381|NCT03500640|541672365|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
150146382|NCT03500640|541672366|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
150146383|NCT03500640|541672367|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
150146384|NCT03500640|541672365|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
150146385|NCT03500640|541672366|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
150146386|NCT03500640|541672367|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
150146387|NCT03500640|541672365|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
150146388|NCT03500640|541672366|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
150146389|NCT03500640|541672367|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
150146390|NCT03929562|541672374|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
150146391|NCT03929562|541672375|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
150146392|NCT03929562|541672374|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
150146393|NCT03929562|541672375|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
150146394|NCT03929562|541672374|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
150146395|NCT03929562|541672375|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
150146396|NCT01036022|541672377|FG000|Overall Study|Adverse Event|1|||
150146397|NCT01036022|541672378|FG001|Overall Study|Adverse Event|3|||
150146398|NCT01036022|541672379|FG002|Overall Study|Adverse Event|2|||
150146399|NCT01036022|541672380|FG003|Overall Study|Adverse Event|1|||
150146400|NCT01036022|541672381|FG004|Overall Study|Adverse Event|0|||
150146401|NCT01036022|541672382|FG005|Overall Study|Adverse Event|2|||
150146402|NCT01036022|541672377|FG000|Overall Study|Lack of Efficacy|1|||
150146403|NCT01036022|541672378|FG001|Overall Study|Lack of Efficacy|1|||
150146404|NCT01036022|541672379|FG002|Overall Study|Lack of Efficacy|1|||
150146405|NCT01036022|541672380|FG003|Overall Study|Lack of Efficacy|0|||
150146406|NCT01036022|541672381|FG004|Overall Study|Lack of Efficacy|1|||
150146407|NCT01036022|541672382|FG005|Overall Study|Lack of Efficacy|1|||
150146408|NCT01036022|541672377|FG000|Overall Study|Physician Decision|0|||
150146409|NCT01036022|541672378|FG001|Overall Study|Physician Decision|0|||
150146410|NCT01036022|541672379|FG002|Overall Study|Physician Decision|1|||
150146411|NCT01036022|541672380|FG003|Overall Study|Physician Decision|0|||
150146412|NCT01036022|541672381|FG004|Overall Study|Physician Decision|0|||
150146413|NCT01036022|541672382|FG005|Overall Study|Physician Decision|0|||
150146414|NCT01036022|541672377|FG000|Overall Study|Withdrawal by Subject|0|||
150146415|NCT01036022|541672378|FG001|Overall Study|Withdrawal by Subject|0|||
150146416|NCT01036022|541672379|FG002|Overall Study|Withdrawal by Subject|0|||
150146417|NCT01036022|541672380|FG003|Overall Study|Withdrawal by Subject|1|||
150146418|NCT01036022|541672381|FG004|Overall Study|Withdrawal by Subject|2|||
150146419|NCT01036022|541672382|FG005|Overall Study|Withdrawal by Subject|0|||
150146420|NCT02487095|541672386|FG000|Dose Expansion|Unable to scan/restage participant|0|||
150146421|NCT02487095|541672387|FG001|Dose Expansion|Unable to scan/restage participant|0|||
150146422|NCT02487095|541672388|FG002|Dose Expansion|Unable to scan/restage participant|0|||
150146423|NCT02487095|541672389|FG003|Dose Expansion|Unable to scan/restage participant|0|||
150146424|NCT02487095|541672390|FG004|Dose Expansion|Unable to scan/restage participant|1|||
150146425|NCT01279343|541672395|FG000|Overall Study|Did not receive treatment|2|||
150146426|NCT01279343|541672396|FG001|Overall Study|Did not receive treatment|6|||
150146427|NCT04534114|541672397|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
150146428|NCT04534114|541672398|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
150146429|NCT04534114|541672399|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
150146430|NCT04534114|541672400|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
150146431|NCT04534114|541672397|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
150146432|NCT04534114|541672398|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
150146433|NCT04534114|541672399|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
150146434|NCT04534114|541672400|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
150146435|NCT04534114|541672397|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
150146436|NCT04534114|541672398|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
150146437|NCT04534114|541672399|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
150146438|NCT04534114|541672400|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
150146439|NCT04534114|541672397|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
150146440|NCT04534114|541672398|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
150146441|NCT04534114|541672399|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
150146442|NCT04534114|541672400|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
150146443|NCT04534114|541672397|FG000|Main Treatment Period|Physician Decision|0|||
150146444|NCT04534114|541672398|FG001|Main Treatment Period|Physician Decision|0|||
150146445|NCT04534114|541672399|FG002|Main Treatment Period|Physician Decision|0|||
150146446|NCT04534114|541672400|FG003|Main Treatment Period|Physician Decision|1|||
150146447|NCT04534114|541672397|FG000|Main Treatment Period|Death|1|||
150146448|NCT04534114|541672398|FG001|Main Treatment Period|Death|0|||
150146449|NCT04534114|541672399|FG002|Main Treatment Period|Death|0|||
150146450|NCT04534114|541672400|FG003|Main Treatment Period|Death|1|||
150146451|NCT04534114|541672397|FG000|Main Treatment Period|Other reason|1|||
150146452|NCT04534114|541672398|FG001|Main Treatment Period|Other reason|1|||
150146453|NCT04534114|541672399|FG002|Main Treatment Period|Other reason|0|||
149804172|NCT04365387|540410761|FG000|Overall Study|Participant moved out of town (relocated)|0|||
149804173|NCT04365387|540410762|FG001|Overall Study|Participant moved out of town (relocated)|1|||
149804174|NCT04365387|540410761|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
149804175|NCT04365387|540410762|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
149804176|NCT04365387|540410761|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
149804177|NCT04365387|540410762|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
149804178|NCT00480077|540410763|FG000|Overall Study|Death|19|||
149804179|NCT00480077|540410764|FG001|Overall Study|Death|15|||
149804180|NCT00480077|540410763|FG000|Overall Study|early exit|12|||
149804181|NCT00480077|540410764|FG001|Overall Study|early exit|11|||
149804182|NCT00262119|540410765|FG000|Overall Study|Lost to Follow-up|38|||
149804183|NCT00262119|540410766|FG001|Overall Study|Lost to Follow-up|51|||
149804184|NCT00262119|540410767|FG002|Overall Study|Lost to Follow-up|42|||
149804185|NCT00262119|540410765|FG000|Overall Study|Death|20|||
149804186|NCT00262119|540410766|FG001|Overall Study|Death|19|||
149804187|NCT00262119|540410767|FG002|Overall Study|Death|16|||
149804188|NCT00859313|540410768|FG000|Overall Study|Lack of Efficacy|2|||
149804189|NCT00859313|540410768|FG000|Overall Study|Adverse Event|1|||
149804190|NCT00859313|540410768|FG000|Overall Study|staff error|1|||
149804191|NCT01215968|540410769|FG000|Overall Study|Adverse Event|0|||
149804192|NCT01215968|540410770|FG001|Overall Study|Adverse Event|2|||
149804193|NCT01215968|540410769|FG000|Overall Study|Protocol Violation|2|||
149804194|NCT01215968|540410770|FG001|Overall Study|Protocol Violation|4|||
149804195|NCT01215968|540410769|FG000|Overall Study|Not received study drug|0|||
149804196|NCT01215968|540410770|FG001|Overall Study|Not received study drug|1|||
149804197|NCT02500732|540410771|FG000|Overall Study|Physician Decision|0|||
149804198|NCT02500732|540410772|FG001|Overall Study|Physician Decision|1|||
149804199|NCT01958619|540410773|FG000|Overall Study|Protocol Violation|2|||
149804200|NCT01958619|540410774|FG001|Overall Study|Protocol Violation|0|||
149804201|NCT01958619|540410775|FG002|Overall Study|Protocol Violation|1|||
149804202|NCT01958619|540410776|FG003|Overall Study|Protocol Violation|0|||
149804203|NCT03759340|540410779|FG000|Overall Study|Adverse Event|2|||
149804204|NCT03759340|540410779|FG000|Overall Study|Lost to Follow-up|1|||
149804205|NCT03759340|540410779|FG000|Overall Study|Withdrawal by Subject|15|||
149804206|NCT03759340|540410779|FG000|Overall Study|Study Terminated by Sponsor|38|||
149804207|NCT01054443|540410780|FG000|Overall Study|Withdrawal by Subject|0|||
149804208|NCT01054443|540410781|FG001|Overall Study|Withdrawal by Subject|0|||
149804209|NCT01054443|540410782|FG002|Overall Study|Withdrawal by Subject|0|||
149804210|NCT01054443|540410783|FG003|Overall Study|Withdrawal by Subject|1|||
149804211|NCT00985114|540410785|FG000|Overall Study|Adverse Event|1|||
149804212|NCT00985114|540410786|FG001|Overall Study|Adverse Event|0|||
149804213|NCT00985114|540410785|FG000|Overall Study|Withdrawal by Subject|0|||
149804214|NCT00985114|540410786|FG001|Overall Study|Withdrawal by Subject|2|||
149804215|NCT02950831|540410787|FG000|Overall Study|Lost to Follow-up|1|||
149804216|NCT02950831|540410787|FG000|Overall Study|Withdrawal by Subject|3|||
149804217|NCT02950831|540410787|FG000|Overall Study|stimulation trail failure|5|||
149804218|NCT01119118|540410788|FG000|Overall Study|Adverse Event|1|||
149804219|NCT01676818|540410791|FG000|Overall Study|Physician Decision|1|||
149804220|NCT01676818|540410791|FG000|Overall Study|Withdrawal by Subject|1|||
149804221|NCT02207413|540410797|FG000|Overall Study|Withdrawal by Subject|1|||
149804222|NCT02207413|540410798|FG001|Overall Study|Withdrawal by Subject|0|||
149804223|NCT02207413|540410799|FG002|Overall Study|Withdrawal by Subject|0|||
149804224|NCT02207413|540410800|FG003|Overall Study|Withdrawal by Subject|0|||
149804225|NCT02207413|540410801|FG004|Overall Study|Withdrawal by Subject|3|||
149804226|NCT02207413|540410802|FG005|Overall Study|Withdrawal by Subject|7|||
149804227|NCT02207413|540410797|FG000|Overall Study|Lost to Follow-up|0|||
149804228|NCT02207413|540410798|FG001|Overall Study|Lost to Follow-up|0|||
149804229|NCT02207413|540410799|FG002|Overall Study|Lost to Follow-up|0|||
149804230|NCT02207413|540410800|FG003|Overall Study|Lost to Follow-up|1|||
149804231|NCT02207413|540410801|FG004|Overall Study|Lost to Follow-up|1|||
149804232|NCT02207413|540410802|FG005|Overall Study|Lost to Follow-up|5|||
149804233|NCT02207413|540410797|FG000|Overall Study|Adverse Event|0|||
149804234|NCT02207413|540410798|FG001|Overall Study|Adverse Event|0|||
149804235|NCT02207413|540410799|FG002|Overall Study|Adverse Event|0|||
149804236|NCT02207413|540410800|FG003|Overall Study|Adverse Event|0|||
149804237|NCT02207413|540410801|FG004|Overall Study|Adverse Event|2|||
149804238|NCT02207413|540410802|FG005|Overall Study|Adverse Event|1|||
149804239|NCT02207413|540410797|FG000|Overall Study|Migrated/moved from study area|0|||
149804240|NCT02207413|540410798|FG001|Overall Study|Migrated/moved from study area|0|||
149804241|NCT02207413|540410799|FG002|Overall Study|Migrated/moved from study area|0|||
149804242|NCT02207413|540410800|FG003|Overall Study|Migrated/moved from study area|0|||
149804243|NCT02207413|540410801|FG004|Overall Study|Migrated/moved from study area|1|||
149804244|NCT02207413|540410802|FG005|Overall Study|Migrated/moved from study area|0|||
149804245|NCT04075656|540410803|FG000|Overall Study|Withdrawal by Subject|5|||
149804246|NCT04075656|540410804|FG001|Overall Study|Withdrawal by Subject|5|||
149804247|NCT01361308|540412334|FG000|Overall Study|Withdrawal by Subject|9|||
150146454|NCT04534114|541672400|FG003|Main Treatment Period|Other reason|0|||
150146455|NCT04534114|541672397|FG000|Main Treatment Period|Participant decision|1|||
150146456|NCT04534114|541672398|FG001|Main Treatment Period|Participant decision|3|||
150146457|NCT04534114|541672399|FG002|Main Treatment Period|Participant decision|3|||
150146458|NCT04534114|541672400|FG003|Main Treatment Period|Participant decision|1|||
150146459|NCT04534114|541672397|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
150146460|NCT04534114|541672398|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
150146461|NCT04534114|541672399|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
150146462|NCT04534114|541672400|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
150146463|NCT04534114|541672397|FG000|Main Treatment Period|Adverse Event|4|||
150146464|NCT04534114|541672398|FG001|Main Treatment Period|Adverse Event|2|||
150146465|NCT04534114|541672399|FG002|Main Treatment Period|Adverse Event|1|||
150146466|NCT04534114|541672400|FG003|Main Treatment Period|Adverse Event|2|||
150146467|NCT04534114|541672397|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
150146468|NCT04534114|541672398|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
150146469|NCT04534114|541672399|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
150146470|NCT04534114|541672400|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
150146471|NCT04534114|541672397|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
150146472|NCT04534114|541672398|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
150146473|NCT04534114|541672399|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
150146474|NCT04534114|541672400|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
150146475|NCT04534114|541672397|FG000|Extension Treatment Period|Other reason|0|||
150146476|NCT04534114|541672398|FG001|Extension Treatment Period|Other reason|1|||
150146477|NCT04534114|541672399|FG002|Extension Treatment Period|Other reason|0|||
150146478|NCT04534114|541672400|FG003|Extension Treatment Period|Other reason|0|||
150146479|NCT04534114|541672397|FG000|Extension Treatment Period|Death|0|||
150146480|NCT04534114|541672398|FG001|Extension Treatment Period|Death|0|||
150146481|NCT04534114|541672399|FG002|Extension Treatment Period|Death|1|||
150146482|NCT04534114|541672400|FG003|Extension Treatment Period|Death|2|||
149804248|NCT01361308|540412335|FG001|Overall Study|Withdrawal by Subject|13|||
149804249|NCT01361308|540412334|FG000|Overall Study|Physician Decision|3|||
149804250|NCT01361308|540412335|FG001|Overall Study|Physician Decision|3|||
149804251|NCT01361308|540412334|FG000|Overall Study|Lack of Efficacy|2|||
149804252|NCT01361308|540412335|FG001|Overall Study|Lack of Efficacy|0|||
149804253|NCT01361308|540412334|FG000|Overall Study|Protocol Violation|1|||
149804254|NCT01361308|540412335|FG001|Overall Study|Protocol Violation|0|||
149804255|NCT01361308|540412334|FG000|Overall Study|Lost to Follow-up|5|||
149804256|NCT01361308|540412335|FG001|Overall Study|Lost to Follow-up|4|||
149804257|NCT01361308|540412334|FG000|Overall Study|Adverse Event|8|||
149804258|NCT01361308|540412335|FG001|Overall Study|Adverse Event|4|||
149804259|NCT01361308|540412334|FG000|Overall Study|Eligibility Criteria Not Met|2|||
149804260|NCT01361308|540412335|FG001|Overall Study|Eligibility Criteria Not Met|3|||
149804261|NCT01361308|540412334|FG000|Overall Study|Failed C-SSRS|5|||
149804262|NCT01361308|540412335|FG001|Overall Study|Failed C-SSRS|2|||
149804263|NCT01361308|540412334|FG000|Overall Study|Other|0|||
149804264|NCT01361308|540412335|FG001|Overall Study|Other|1|||
149804265|NCT02503215|540412336|FG000|Overall Study|Unable to wear compression stockings|1|||
149804266|NCT02503215|540412336|FG000|Overall Study|Unable to use positive airway pressure|2|||
149804267|NCT00706901|540412337|FG000|Overall Study|Lost to Follow-up|2|||
149804268|NCT00706901|540412338|FG001|Overall Study|Lost to Follow-up|3|||
149804269|NCT00706901|540412339|FG002|Overall Study|Lost to Follow-up|2|||
149804270|NCT00706901|540412337|FG000|Overall Study|Withdrawal by Subject|4|||
149804271|NCT00706901|540412338|FG001|Overall Study|Withdrawal by Subject|2|||
149804272|NCT00706901|540412339|FG002|Overall Study|Withdrawal by Subject|5|||
149804273|NCT00706901|540412337|FG000|Overall Study|In Jail|1|||
149804274|NCT00706901|540412338|FG001|Overall Study|In Jail|0|||
149804275|NCT00706901|540412339|FG002|Overall Study|In Jail|1|||
149804276|NCT00706901|540412337|FG000|Overall Study|Death|1|||
149804277|NCT00706901|540412338|FG001|Overall Study|Death|0|||
149804278|NCT00706901|540412339|FG002|Overall Study|Death|0|||
150146483|NCT04534114|541672397|FG000|Extension Treatment Period|Adverse Event|0|||
149804279|NCT03433482|540412340|FG000|Overall Study|Lost to Follow-up|1|||
149804280|NCT03433482|540412341|FG001|Overall Study|Lost to Follow-up|0|||
149804281|NCT03433482|540412342|FG002|Overall Study|Lost to Follow-up|1|||
149804282|NCT03433482|540412343|FG003|Overall Study|Lost to Follow-up|1|||
149804283|NCT03433482|540412340|FG000|Overall Study|Withdrawal by Subject|0|||
149804284|NCT03433482|540412341|FG001|Overall Study|Withdrawal by Subject|0|||
150146484|NCT04534114|541672398|FG001|Extension Treatment Period|Adverse Event|1|||
150146485|NCT04534114|541672399|FG002|Extension Treatment Period|Adverse Event|0|||
149804285|NCT03433482|540412342|FG002|Overall Study|Withdrawal by Subject|1|||
149804286|NCT03433482|540412343|FG003|Overall Study|Withdrawal by Subject|0|||
149804287|NCT03433482|540412340|FG000|Overall Study|Unknown reason|0|||
149804288|NCT03433482|540412341|FG001|Overall Study|Unknown reason|0|||
149804289|NCT03433482|540412342|FG002|Overall Study|Unknown reason|2|||
150146486|NCT04534114|541672400|FG003|Extension Treatment Period|Adverse Event|1|||
150146487|NCT04534114|541672397|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
150146488|NCT04534114|541672398|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
150146489|NCT04534114|541672399|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
150146490|NCT04534114|541672400|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
150146491|NCT03287414|541672401|FG000|Treatment Epoch|Adverse Event|0|||
150146492|NCT03287414|541672402|FG001|Treatment Epoch|Adverse Event|1|||
150146493|NCT03287414|541672401|FG000|Treatment Epoch|Study terminated by sponsor|2|||
150146494|NCT03287414|541672402|FG001|Treatment Epoch|Study terminated by sponsor|2|||
150146495|NCT03287414|541672401|FG000|Treatment Epoch|Subject/Guardian decision|4|||
150146496|NCT03287414|541672402|FG001|Treatment Epoch|Subject/Guardian decision|0|||
150146497|NCT03287414|541672401|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
150146498|NCT03287414|541672402|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
150146499|NCT03287414|541672401|FG000|Treatment Epoch|Withdrawal by Subject|1|||
150146500|NCT03287414|541672402|FG001|Treatment Epoch|Withdrawal by Subject|0|||
150146501|NCT03287414|541672401|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
150146502|NCT03287414|541672402|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
150146503|NCT03287414|541672401|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
150146504|NCT03287414|541672402|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
150146505|NCT04395183|541672405|FG000|Overall Study|Withdrawal by Subject|1|||
150146506|NCT04395183|541672406|FG001|Overall Study|Withdrawal by Subject|0|||
150146507|NCT04395183|541672407|FG002|Overall Study|Withdrawal by Subject|2|||
150146508|NCT04395183|541672408|FG003|Overall Study|Withdrawal by Subject|2|||
150146509|NCT01008475|541672409|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
150146510|NCT01008475|541672410|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
150146511|NCT01008475|541672411|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
150146512|NCT01008475|541672412|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
150146513|NCT01008475|541672413|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
150146514|NCT01008475|541672414|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
150146515|NCT01008475|541672415|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
150146516|NCT02668016|541672416|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
150146517|NCT02668016|541672416|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
150146518|NCT02668016|541672416|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
150146519|NCT02668016|541672416|FG000|Month 4|Withdrawal due to severe symptoms|1|||
150146520|NCT02668016|541672416|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
150146521|NCT02668016|541672416|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
150146522|NCT02668016|541672416|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
150146523|NCT02668016|541672416|FG000|Month 6|Withdrawal due to severe symptoms|2|||
150146524|NCT02668016|541672416|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
150146525|NCT02668016|541672416|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
150146526|NCT02668016|541672416|FG000|Month 8|Withdrawal due to severe symptoms|1|||
150146527|NCT02668016|541672416|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
150146528|NCT02668016|541672416|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
150146529|NCT02668016|541672416|FG000|Month 10|Withdrawal due to severe symptoms|1|||
150146530|NCT02668016|541672416|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
150146531|NCT00738101|541672433|FG000|Overall Study|Physician Decision|5|||
150146532|NCT00738101|541672433|FG000|Overall Study|Death|1|||
150146533|NCT00738101|541672433|FG000|Overall Study|Repeat enrollment|1|||
150146534|NCT02969525|541672437|FG000|Double-Blind Period|Adverse Event|0|||
150146535|NCT02969525|541672438|FG001|Double-Blind Period|Adverse Event|0|||
150146536|NCT02969525|541672439|FG002|Double-Blind Period|Adverse Event|1|||
150146537|NCT02969525|541672440|FG003|Double-Blind Period|Adverse Event|1|||
150146538|NCT02969525|541672441|FG004|Double-Blind Period|Adverse Event|0|||
150146539|NCT02969525|541672442|FG005|Double-Blind Period|Adverse Event|0|||
150146540|NCT02969525|541672443|FG006|Double-Blind Period|Adverse Event|0|||
150146541|NCT02969525|541672444|FG007|Double-Blind Period|Adverse Event|0|||
150146542|NCT02969525|541672445|FG008|Double-Blind Period|Adverse Event|0|||
150146543|NCT02969525|541672446|FG009|Double-Blind Period|Adverse Event|0|||
150146544|NCT02969525|541672447|FG010|Double-Blind Period|Adverse Event|0|||
150146545|NCT02969525|541672448|FG011|Double-Blind Period|Adverse Event|0|||
150146546|NCT02969525|541672437|FG000|Double-Blind Period|LOW EGFR|0|||
150146547|NCT02969525|541672438|FG001|Double-Blind Period|LOW EGFR|0|||
150146548|NCT02969525|541672439|FG002|Double-Blind Period|LOW EGFR|0|||
150146549|NCT02969525|541672440|FG003|Double-Blind Period|LOW EGFR|1|||
150146550|NCT02969525|541672441|FG004|Double-Blind Period|LOW EGFR|0|||
150146551|NCT02969525|541672442|FG005|Double-Blind Period|LOW EGFR|0|||
150146552|NCT02969525|541672443|FG006|Double-Blind Period|LOW EGFR|0|||
150146553|NCT02969525|541672444|FG007|Double-Blind Period|LOW EGFR|0|||
150146554|NCT02969525|541672445|FG008|Double-Blind Period|LOW EGFR|0|||
150146555|NCT02969525|541672446|FG009|Double-Blind Period|LOW EGFR|0|||
150146556|NCT02969525|541672447|FG010|Double-Blind Period|LOW EGFR|0|||
150146557|NCT02969525|541672448|FG011|Double-Blind Period|LOW EGFR|0|||
150146558|NCT02969525|541672437|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
150146559|NCT02969525|541672438|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146560|NCT02969525|541672439|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146561|NCT02969525|541672440|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
150146562|NCT02969525|541672441|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146563|NCT02969525|541672442|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146564|NCT02969525|541672443|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146565|NCT02969525|541672444|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146566|NCT02969525|541672445|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146567|NCT02969525|541672446|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146568|NCT02969525|541672447|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146569|NCT02969525|541672448|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
150146570|NCT02969525|541672437|FG000|Dose-Blind Period|Adverse Event|0|||
150146571|NCT02969525|541672438|FG001|Dose-Blind Period|Adverse Event|0|||
150146572|NCT02969525|541672439|FG002|Dose-Blind Period|Adverse Event|0|||
150146573|NCT02969525|541672440|FG003|Dose-Blind Period|Adverse Event|0|||
150146574|NCT02969525|541672441|FG004|Dose-Blind Period|Adverse Event|0|||
150146575|NCT02969525|541672442|FG005|Dose-Blind Period|Adverse Event|0|||
150146576|NCT02969525|541672443|FG006|Dose-Blind Period|Adverse Event|0|||
150146577|NCT02969525|541672444|FG007|Dose-Blind Period|Adverse Event|0|||
150146578|NCT02969525|541672445|FG008|Dose-Blind Period|Adverse Event|0|||
150146579|NCT02969525|541672446|FG009|Dose-Blind Period|Adverse Event|1|||
150146580|NCT02969525|541672447|FG010|Dose-Blind Period|Adverse Event|1|||
150146581|NCT02969525|541672448|FG011|Dose-Blind Period|Adverse Event|1|||
150146582|NCT02969525|541672437|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
150146583|NCT02969525|541672438|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
150146584|NCT02969525|541672439|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
150146585|NCT02969525|541672440|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
150146586|NCT02969525|541672441|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
149804290|NCT03433482|540412343|FG003|Overall Study|Unknown reason|0|||
149804291|NCT01646268|540412344|FG000|Overall Study|Adverse Event|6|||
149804292|NCT01646268|540412345|FG001|Overall Study|Adverse Event|7|||
149804293|NCT01646268|540412344|FG000|Overall Study|Lack of Efficacy|1|||
149804294|NCT01646268|540412345|FG001|Overall Study|Lack of Efficacy|3|||
149804295|NCT01646268|540412344|FG000|Overall Study|Protocol Violation|0|||
149804296|NCT01646268|540412345|FG001|Overall Study|Protocol Violation|1|||
149804297|NCT01646268|540412344|FG000|Overall Study|Withdrawal by Subject|2|||
149804298|NCT01646268|540412345|FG001|Overall Study|Withdrawal by Subject|5|||
149804299|NCT01646268|540412344|FG000|Overall Study|Other|2|||
149804300|NCT01646268|540412345|FG001|Overall Study|Other|0|||
149804301|NCT01519635|540412350|FG000|Overall Study|Withdrawal by Subject|0|||
149804302|NCT01519635|540412351|FG001|Overall Study|Withdrawal by Subject|1|||
149804303|NCT01519635|540412350|FG000|Overall Study|No possibility to put a catheter|1|||
149804304|NCT01519635|540412351|FG001|Overall Study|No possibility to put a catheter|2|||
149804305|NCT04478994|540412352|FG000|Overall Study|Withdrawal by Subject|1|||
149804306|NCT04478994|540412353|FG001|Overall Study|Withdrawal by Subject|1|||
149804307|NCT00518531|540412354|FG000|Treatment Period 1|Adverse Event|5|||
149804308|NCT00518531|540412355|FG001|Treatment Period 1|Adverse Event|0|||
149804309|NCT00518531|540412354|FG000|Treatment Period 1|Lost to Follow-up|5|||
149804310|NCT00518531|540412355|FG001|Treatment Period 1|Lost to Follow-up|3|||
149804311|NCT00518531|540412354|FG000|Treatment Period 1|Physician Decision|1|||
149804312|NCT00518531|540412355|FG001|Treatment Period 1|Physician Decision|0|||
149804313|NCT00518531|540412354|FG000|Treatment Period 1|Protocol Violation|2|||
149804314|NCT00518531|540412355|FG001|Treatment Period 1|Protocol Violation|0|||
149804315|NCT00518531|540412354|FG000|Treatment Period 1|Withdrawal by Subject|4|||
149804316|NCT00518531|540412355|FG001|Treatment Period 1|Withdrawal by Subject|6|||
149804317|NCT00518531|540412354|FG000|Treatment Period 1|Early crossover|1|||
149804318|NCT00518531|540412355|FG001|Treatment Period 1|Early crossover|3|||
149804319|NCT00518531|540412354|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149804320|NCT00518531|540412355|FG001|Treatment Period 2|Withdrawal by Subject|8|||
149804321|NCT00518531|540412354|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
149804322|NCT00518531|540412355|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
149804323|NCT00518531|540412354|FG000|Treatment Period 2|Adverse Event|1|||
150146587|NCT02969525|541672442|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
150146588|NCT02969525|541672443|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
150146589|NCT02969525|541672444|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
150146590|NCT02969525|541672445|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
149804324|NCT00518531|540412355|FG001|Treatment Period 2|Adverse Event|7|||
149804325|NCT00518531|540412354|FG000|Treatment Period 2|Protocol-specified criteria|0|||
149804326|NCT00518531|540412355|FG001|Treatment Period 2|Protocol-specified criteria|1|||
149804327|NCT00518531|540412354|FG000|Treatment Period 2|Non-compliance|1|||
150146591|NCT02969525|541672446|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
150146592|NCT02969525|541672447|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
150146593|NCT02969525|541672448|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
150146594|NCT02969525|541672437|FG000|Dose-Blind Period|Non-cooperating patient|0|||
150146595|NCT02969525|541672438|FG001|Dose-Blind Period|Non-cooperating patient|0|||
150146596|NCT02969525|541672439|FG002|Dose-Blind Period|Non-cooperating patient|0|||
150146597|NCT02969525|541672440|FG003|Dose-Blind Period|Non-cooperating patient|0|||
150146598|NCT02969525|541672441|FG004|Dose-Blind Period|Non-cooperating patient|0|||
150146599|NCT02969525|541672442|FG005|Dose-Blind Period|Non-cooperating patient|0|||
150146600|NCT02969525|541672443|FG006|Dose-Blind Period|Non-cooperating patient|0|||
150146601|NCT02969525|541672444|FG007|Dose-Blind Period|Non-cooperating patient|0|||
150146602|NCT02969525|541672445|FG008|Dose-Blind Period|Non-cooperating patient|0|||
150146603|NCT02969525|541672446|FG009|Dose-Blind Period|Non-cooperating patient|0|||
150146604|NCT02969525|541672447|FG010|Dose-Blind Period|Non-cooperating patient|0|||
150146605|NCT02969525|541672448|FG011|Dose-Blind Period|Non-cooperating patient|1|||
150146606|NCT02969525|541672437|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146607|NCT02969525|541672438|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146608|NCT02969525|541672439|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146609|NCT02969525|541672440|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146610|NCT02969525|541672441|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146611|NCT02969525|541672442|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146612|NCT02969525|541672443|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146613|NCT02969525|541672444|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146614|NCT02969525|541672445|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146615|NCT02969525|541672446|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146616|NCT02969525|541672447|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
150146617|NCT02969525|541672448|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
150146618|NCT03445065|541672449|FG000|Overall Study|Withdrawal by Subject|3|||
150146619|NCT03445065|541672450|FG001|Overall Study|Withdrawal by Subject|6|||
150146620|NCT03445065|541672451|FG002|Overall Study|Withdrawal by Subject|2|||
150146621|NCT03445065|541672452|FG003|Overall Study|Withdrawal by Subject|2|||
150146622|NCT03445065|541672449|FG000|Overall Study|Other|4|||
150146623|NCT03445065|541672450|FG001|Overall Study|Other|3|||
150146624|NCT03445065|541672451|FG002|Overall Study|Other|3|||
150146625|NCT03445065|541672452|FG003|Overall Study|Other|1|||
150146626|NCT03535337|541672453|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
150146627|NCT03535337|541672454|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
150146628|NCT03535337|541672455|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
150146629|NCT03535337|541672456|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
150146630|NCT03535337|541672457|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
150146631|NCT03535337|541672458|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
150146632|NCT03535337|541672459|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
150146633|NCT03535337|541672460|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
150146634|NCT03535337|541672461|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
150146635|NCT03535337|541672462|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
150146636|NCT01598298|541672463|FG000|Overall Study|Not eligible|5|||
150146637|NCT01598298|541672464|FG001|Overall Study|Not eligible|5|||
150146638|NCT01598298|541672463|FG000|Overall Study|Adverse Event|21|||
150146639|NCT01598298|541672464|FG001|Overall Study|Adverse Event|19|||
150146640|NCT01598298|541672463|FG000|Overall Study|Progression/relapse|0|||
150146641|NCT01598298|541672464|FG001|Overall Study|Progression/relapse|2|||
150146642|NCT01598298|541672463|FG000|Overall Study|Withdrawal by Subject|10|||
150146643|NCT01598298|541672464|FG001|Overall Study|Withdrawal by Subject|15|||
150146644|NCT01598298|541672463|FG000|Overall Study|Other reason (not protocol specified)|4|||
150146645|NCT01598298|541672464|FG001|Overall Study|Other reason (not protocol specified)|0|||
150146646|NCT00976482|541673686|FG000|Overall Study|Death|208|||
150146647|NCT00976482|541673686|FG000|Overall Study|Withdrawal by Subject|45|||
150146648|NCT00976482|541673686|FG000|Overall Study|Center terminated|1|||
150146649|NCT00976482|541673686|FG000|Overall Study|Protocol Violation|5|||
150146650|NCT03462706|541673689|FG000|Overall Study|Polyp was pedunculated|1|||
150146651|NCT03462706|541673690|FG001|Overall Study|Polyp was pedunculated|0|||
150146652|NCT03462706|541673691|FG002|Overall Study|Polyp was pedunculated|1|||
150146653|NCT03462706|541673692|FG003|Overall Study|Polyp was pedunculated|0|||
150146654|NCT03462706|541673689|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
150146655|NCT03462706|541673690|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
150146656|NCT03462706|541673691|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
150146657|NCT03462706|541673692|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
150146658|NCT01161472|541673698|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
150146659|NCT01161472|541673699|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
150146660|NCT01161472|541673700|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
150146661|NCT01161472|541673701|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
150146662|NCT02914184|541673702|FG000|Overall Study|Lost to Follow-up|7|||
150146663|NCT02914184|541673703|FG001|Overall Study|Lost to Follow-up|10|||
149804328|NCT00518531|540412355|FG001|Treatment Period 2|Non-compliance|2|||
149804329|NCT00457249|540412356|FG000|Overall Study|Lost to Follow-up|3|||
149804330|NCT00457249|540412357|FG001|Overall Study|Lost to Follow-up|0|||
149804331|NCT00457249|540412356|FG000|Overall Study|Protocol Violation|4|||
149804332|NCT00457249|540412357|FG001|Overall Study|Protocol Violation|1|||
149804333|NCT00457249|540412356|FG000|Overall Study|Withdrawal by Subject|3|||
149804334|NCT00457249|540412357|FG001|Overall Study|Withdrawal by Subject|1|||
149804335|NCT00457249|540412356|FG000|Overall Study|Serious Adverse Events|2|||
149804336|NCT00457249|540412357|FG001|Overall Study|Serious Adverse Events|0|||
149804337|NCT04888377|540412360|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
149804338|NCT04888377|540412361|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
149804339|NCT04888377|540412360|FG000|Overall Study|Physician Decision|6|||
149804340|NCT04888377|540412361|FG001|Overall Study|Physician Decision|6|||
149804341|NCT04888377|540412360|FG000|Overall Study|Withdrawal by Subject|7|||
149804342|NCT04888377|540412361|FG001|Overall Study|Withdrawal by Subject|3|||
149804343|NCT00526162|540412362|FG000|Overall Study|Device not implanted|3|||
149804344|NCT05279807|540412363|FG000|Overall Study|Withdrawal by Subject|1|||
149804345|NCT05279807|540412364|FG001|Overall Study|Withdrawal by Subject|0|||
149804346|NCT05279807|540412363|FG000|Overall Study|Adverse Event|0|||
149804347|NCT05279807|540412364|FG001|Overall Study|Adverse Event|1|||
149804348|NCT05279807|540412363|FG000|Overall Study|Laboratory Abnormal Results|1|||
149804349|NCT05279807|540412364|FG001|Overall Study|Laboratory Abnormal Results|0|||
149804350|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149804351|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
149804352|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
149804353|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804354|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804355|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804356|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804357|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804358|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
149804359|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
149804360|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804361|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804362|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804363|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804364|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
149804365|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
149804366|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
149804367|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804368|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804369|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804370|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804371|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
149804372|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
149804373|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
149804374|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804375|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804376|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804377|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804378|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
149804379|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804380|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804381|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804382|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804383|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804384|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149804385|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804386|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804387|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
149804388|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804389|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804390|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804391|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149804392|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149804393|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
150146664|NCT02914184|541673704|FG002|Overall Study|Lost to Follow-up|8|||
150146665|NCT02914184|541673705|FG003|Overall Study|Lost to Follow-up|7|||
150146666|NCT02914184|541673702|FG000|Overall Study|Withdrawal by Subject|4|||
150146667|NCT02914184|541673703|FG001|Overall Study|Withdrawal by Subject|2|||
150146668|NCT02914184|541673704|FG002|Overall Study|Withdrawal by Subject|7|||
150146669|NCT02914184|541673705|FG003|Overall Study|Withdrawal by Subject|3|||
150146670|NCT02914184|541673702|FG000|Overall Study|Other|1|||
150146671|NCT02914184|541673703|FG001|Overall Study|Other|0|||
150146672|NCT02914184|541673704|FG002|Overall Study|Other|0|||
150146673|NCT02914184|541673705|FG003|Overall Study|Other|0|||
150146674|NCT02914184|541673702|FG000|Overall Study|Migrated/moved from the study area|2|||
150146675|NCT02914184|541673703|FG001|Overall Study|Migrated/moved from the study area|1|||
150146676|NCT02914184|541673704|FG002|Overall Study|Migrated/moved from the study area|2|||
150146677|NCT02914184|541673705|FG003|Overall Study|Migrated/moved from the study area|1|||
150146678|NCT00798174|541673706|FG000|Overall Study|inability to implant azygos coil|3|||
150146679|NCT00798174|541673707|FG001|Overall Study|inability to implant azygos coil|3|||
150146680|NCT00798174|541673706|FG000|Overall Study|Inability to sedate for DFT testing|1|||
150146681|NCT00798174|541673707|FG001|Overall Study|Inability to sedate for DFT testing|0|||
150146682|NCT00802659|541673708|FG000|Overall Study|Physician Decision|0|||
150146683|NCT00802659|541673709|FG001|Overall Study|Physician Decision|1|||
150146684|NCT00802659|541673710|FG002|Overall Study|Physician Decision|0|||
150146685|NCT00802659|541673711|FG003|Overall Study|Physician Decision|0|||
150146686|NCT03093428|541673712|FG000|Overall Study|Not eligible for treatment|2|||
150146687|NCT03093428|541673713|FG001|Overall Study|Not eligible for treatment|1|||
150146688|NCT03093428|541673712|FG000|Overall Study|Progression|14|||
150146689|NCT03093428|541673713|FG001|Overall Study|Progression|4|||
150146690|NCT03093428|541673712|FG000|Overall Study|Death|1|||
150146691|NCT03093428|541673713|FG001|Overall Study|Death|0|||
150146692|NCT03093428|541673712|FG000|Overall Study|Adverse Event|1|||
150146693|NCT03093428|541673713|FG001|Overall Study|Adverse Event|0|||
150146694|NCT03093428|541673712|FG000|Overall Study|Withdrawal by Subject|1|||
150146695|NCT03093428|541673713|FG001|Overall Study|Withdrawal by Subject|1|||
150146696|NCT03820323|541673718|FG000|Overall Study|Lost to Follow-up|2|||
150146697|NCT03820323|541673719|FG001|Overall Study|Lost to Follow-up|1|||
150146698|NCT03820323|541673718|FG000|Overall Study|Missed 12-month visit|22|||
150146699|NCT03820323|541673719|FG001|Overall Study|Missed 12-month visit|14|||
150146700|NCT03820323|541673718|FG000|Overall Study|Death|2|||
150146701|NCT03820323|541673719|FG001|Overall Study|Death|1|||
150146702|NCT03820323|541673718|FG000|Overall Study|Transferred out|13|||
150146703|NCT03820323|541673719|FG001|Overall Study|Transferred out|11|||
150146704|NCT03820323|541673718|FG000|Overall Study|Terminated|0|||
150146705|NCT03820323|541673719|FG001|Overall Study|Terminated|3|||
150146706|NCT03820323|541673718|FG000|Overall Study|Withdrawal by Subject|1|||
150146707|NCT03820323|541673719|FG001|Overall Study|Withdrawal by Subject|6|||
150146708|NCT02912468|541673723|FG000|Overall Study|Adverse Event|3|||
150146709|NCT02912468|541673724|FG001|Overall Study|Adverse Event|2|||
150146710|NCT02912468|541673723|FG000|Overall Study|Withdrawal by Subject|6|||
150146711|NCT02912468|541673724|FG001|Overall Study|Withdrawal by Subject|2|||
150146712|NCT02912468|541673723|FG000|Overall Study|Randomized and not treated|0|||
150146713|NCT02912468|541673724|FG001|Overall Study|Randomized and not treated|1|||
150146714|NCT00692406|541673726|FG000|Overall Study|PI dropped, bad data|57|||
150146715|NCT02597933|541673727|FG000|Overall Study|Withdrawal by Subject|7|||
150146716|NCT02597933|541673728|FG001|Overall Study|Withdrawal by Subject|5|||
150146717|NCT02597933|541673727|FG000|Overall Study|Protocol Violation|2|||
150146718|NCT02597933|541673728|FG001|Overall Study|Protocol Violation|2|||
150146719|NCT02597933|541673727|FG000|Overall Study|Adverse Event|20|||
150146720|NCT02597933|541673728|FG001|Overall Study|Adverse Event|28|||
150146721|NCT02597933|541673727|FG000|Overall Study|Not treated|2|||
150146722|NCT02597933|541673728|FG001|Overall Study|Not treated|2|||
150146723|NCT02597933|541673727|FG000|Overall Study|Other than stated above|7|||
150146724|NCT02597933|541673728|FG001|Overall Study|Other than stated above|14|||
150146725|NCT01617005|541673733|FG000|Overall Study|Pregnancy|1|||
150146726|NCT01617005|541673733|FG000|Overall Study|Lack of motivation for treatment|1|||
150146727|NCT01320735|541673737|FG000|Overall Study|Adverse Event|3|||
150146728|NCT01320735|541673737|FG000|Overall Study|Withdrawal by Subject|3|||
150146729|NCT01320735|541673737|FG000|Overall Study|Lost to Follow-up|13|||
150146730|NCT01320735|541673737|FG000|Overall Study|Administrative Reason|6|||
150146731|NCT01320735|541673737|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
150146732|NCT01320735|541673737|FG000|Overall Study|Protocol Violation|1|||
150146733|NCT01320735|541673737|FG000|Overall Study|Other|1|||
150146734|NCT01320735|541673737|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
150146735|NCT01320735|541673737|FG000|Overall Study|Investigator Unable to be Contacted|17|||
150146736|NCT04599101|541673738|FG000|Overall Study|Lost to Follow-up|5|||
150146737|NCT04599101|541673739|FG001|Overall Study|Lost to Follow-up|5|||
150146738|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
150146739|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
150146740|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
150146741|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
150146742|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
150146743|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
150146744|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
150146745|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
150146746|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
150146747|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
150146748|NCT02307513|541673740|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
150146749|NCT02307513|541673741|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
150146750|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
150146751|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
150146752|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
150146753|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
150146754|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
150146755|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
150146756|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
150146757|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
150146758|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
150146759|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
150146760|NCT02307513|541673740|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
150146761|NCT02307513|541673741|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
150146762|NCT02307513|541673740|FG000|Long-term Extension|Physician Decision|1|||
150146763|NCT02307513|541673741|FG001|Long-term Extension|Physician Decision|0|||
150146764|NCT05952297|541673743|FG000|Overall Study|Withdrawal by Subject|1|||
150146765|NCT05952297|541673744|FG001|Overall Study|Withdrawal by Subject|0|||
150146766|NCT02100722|541673745|FG000|Overall Study|Withdrawal pre-procedure|4|||
150146767|NCT02100722|541673746|FG001|Overall Study|Withdrawal pre-procedure|9|||
150146768|NCT02100722|541673745|FG000|Overall Study|Withdrawal post-procedure|0|||
149804394|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
149804395|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149804396|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149804397|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149804398|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149804399|NCT04242446|540412369|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804400|NCT04242446|540412370|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
149804401|NCT04242446|540412371|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
149804402|NCT04242446|540412372|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804403|NCT04242446|540412373|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804404|NCT04242446|540412374|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804405|NCT04242446|540412375|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804406|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804407|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804408|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804409|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
149804410|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
149804411|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
149804412|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
149804413|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804414|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804415|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804416|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
149804417|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
149804418|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
149804419|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
149804420|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804421|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804422|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804423|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149804424|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149804425|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149804426|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149804427|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149804428|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149918884|NCT01210352|540835244|FG003|Overall Study|Adverse Event|0|||
150146769|NCT02100722|541673746|FG001|Overall Study|Withdrawal post-procedure|3|||
149804429|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149804430|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149804431|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
149804432|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149804433|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149804434|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804435|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804436|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804437|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
149804438|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
149804439|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
149804440|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
149804441|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804442|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804443|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804444|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
149804445|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804446|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804447|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149804448|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804449|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804450|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804451|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804452|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
149804453|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804454|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149804455|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804456|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804457|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804458|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804459|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
149804460|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804461|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149804462|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804463|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804464|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804465|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804466|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
149804467|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804468|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149804469|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804470|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804471|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804472|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804473|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
149804474|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804475|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149804476|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149804477|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149804478|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149804479|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149804480|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
149804481|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149804482|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
150146770|NCT02100722|541673745|FG000|Overall Study|Lost to Follow-up|2|||
150146771|NCT02100722|541673746|FG001|Overall Study|Lost to Follow-up|2|||
150146772|NCT02100722|541673745|FG000|Overall Study|Continuing on study|751|||
150146773|NCT02100722|541673746|FG001|Overall Study|Continuing on study|729|||
150146774|NCT02541383|541673749|FG000|Overall Study|Death|50|||
150146775|NCT02541383|541673750|FG001|Overall Study|Death|37|||
150146776|NCT02541383|541673751|FG002|Overall Study|Death|48|||
150146777|NCT02541383|541673752|FG003|Overall Study|Death|41|||
150146778|NCT02541383|541673753|FG004|Overall Study|Death|21|||
150146779|NCT02541383|541673754|FG005|Overall Study|Death|25|||
150146780|NCT02541383|541673749|FG000|Overall Study|Lost to Follow-up|5|||
150146781|NCT02541383|541673750|FG001|Overall Study|Lost to Follow-up|3|||
150146782|NCT02541383|541673751|FG002|Overall Study|Lost to Follow-up|1|||
150146783|NCT02541383|541673752|FG003|Overall Study|Lost to Follow-up|1|||
150146784|NCT02541383|541673753|FG004|Overall Study|Lost to Follow-up|3|||
150146785|NCT02541383|541673754|FG005|Overall Study|Lost to Follow-up|0|||
150146786|NCT02541383|541673749|FG000|Overall Study|Consent withdrawn|5|||
150146787|NCT02541383|541673750|FG001|Overall Study|Consent withdrawn|6|||
150146788|NCT02541383|541673751|FG002|Overall Study|Consent withdrawn|1|||
150146789|NCT02541383|541673752|FG003|Overall Study|Consent withdrawn|1|||
150146790|NCT02541383|541673753|FG004|Overall Study|Consent withdrawn|0|||
150146791|NCT02541383|541673754|FG005|Overall Study|Consent withdrawn|0|||
150146792|NCT02541383|541673749|FG000|Overall Study|Sponsor's decision|1|||
150146793|NCT02541383|541673750|FG001|Overall Study|Sponsor's decision|1|||
150146794|NCT02541383|541673751|FG002|Overall Study|Sponsor's decision|0|||
150146795|NCT02541383|541673752|FG003|Overall Study|Sponsor's decision|0|||
150146796|NCT02541383|541673753|FG004|Overall Study|Sponsor's decision|0|||
150146797|NCT02541383|541673754|FG005|Overall Study|Sponsor's decision|0|||
150146798|NCT05796518|541673755|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
150146799|NCT01535274|541673756|FG000|Overall Study|Determined to be ineligible|0|||
150146800|NCT01535274|541673757|FG001|Overall Study|Determined to be ineligible|1|||
150146801|NCT01535274|541673756|FG000|Overall Study|Misallocated to propofol intervention|0|||
150146802|NCT01535274|541673757|FG001|Overall Study|Misallocated to propofol intervention|1|||
150146803|NCT02690077|541673758|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
150146804|NCT02690077|541673759|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
150146805|NCT02690077|541673758|FG000|Overall Study|Withdrawal by Subject|0|||
150146806|NCT02690077|541673759|FG001|Overall Study|Withdrawal by Subject|5|||
150146807|NCT02690077|541673758|FG000|Overall Study|Excluded by IRB|0|||
150146808|NCT02690077|541673759|FG001|Overall Study|Excluded by IRB|2|||
150146809|NCT00594217|541673760|FG000|Overall Study|Withdrawal by Subject|1|||
150146810|NCT00594217|541673761|FG001|Overall Study|Withdrawal by Subject|3|||
150146811|NCT04186403|541673762|FG000|Overall Study|Adverse Event|1|||
150146812|NCT04186403|541673763|FG001|Overall Study|Adverse Event|8|||
150146813|NCT04186403|541673762|FG000|Overall Study|Lost to Follow-up|7|||
150146814|NCT04186403|541673763|FG001|Overall Study|Lost to Follow-up|3|||
150146815|NCT04186403|541673762|FG000|Overall Study|Physician Decision|1|||
150146816|NCT04186403|541673763|FG001|Overall Study|Physician Decision|0|||
150146817|NCT04186403|541673762|FG000|Overall Study|Withdrawal by Subject|7|||
150146818|NCT04186403|541673763|FG001|Overall Study|Withdrawal by Subject|8|||
150146819|NCT04186403|541673762|FG000|Overall Study|Other: Not Related to Covid-19|3|||
150146820|NCT04186403|541673763|FG001|Overall Study|Other: Not Related to Covid-19|0|||
150146821|NCT01407354|541673764|FG000|First Intervention|Withdrawal by Subject|0|||
150146822|NCT01407354|541673765|FG001|First Intervention|Withdrawal by Subject|2|||
150146823|NCT01407354|541673764|FG000|First Intervention|Adverse Event|1|||
150146824|NCT01407354|541673765|FG001|First Intervention|Adverse Event|0|||
150146825|NCT01407354|541673764|FG000|First Intervention|Physician Decision|1|||
150146826|NCT01407354|541673765|FG001|First Intervention|Physician Decision|0|||
150146827|NCT00405639|541673767|FG000|Overall Study|Withdrawal by Subject|1|||
150146828|NCT00405639|541673768|FG001|Overall Study|Withdrawal by Subject|0|||
150146829|NCT00405639|541673767|FG000|Overall Study|Adverse Event|1|||
150146830|NCT00405639|541673768|FG001|Overall Study|Adverse Event|0|||
150146831|NCT00405639|541673767|FG000|Overall Study|Seizure prior to receiving BNP|1|||
150146832|NCT00405639|541673768|FG001|Overall Study|Seizure prior to receiving BNP|0|||
150146833|NCT00612534|541673769|FG000|Overall Study|Adverse Event|0|||
150146834|NCT00612534|541673770|FG001|Overall Study|Adverse Event|4|||
150146835|NCT00612534|541673771|FG002|Overall Study|Adverse Event|2|||
150146836|NCT00612534|541673772|FG003|Overall Study|Adverse Event|1|||
150146837|NCT00612534|541673769|FG000|Overall Study|Lack of Efficacy|13|||
150146838|NCT00612534|541673770|FG001|Overall Study|Lack of Efficacy|12|||
150146839|NCT00612534|541673771|FG002|Overall Study|Lack of Efficacy|5|||
150146840|NCT00612534|541673772|FG003|Overall Study|Lack of Efficacy|16|||
150146841|NCT00612534|541673769|FG000|Overall Study|Other Reason|0|||
150146842|NCT00612534|541673770|FG001|Overall Study|Other Reason|1|||
150146843|NCT00612534|541673771|FG002|Overall Study|Other Reason|0|||
150146844|NCT00612534|541673772|FG003|Overall Study|Other Reason|0|||
150146845|NCT03108157|541673773|FG000|Overall Study|Protocol Violation|15|||
150146846|NCT03108157|541673774|FG001|Overall Study|Protocol Violation|4|||
150146847|NCT02223754|541673775|FG000|Period 1|Adverse Event|1|||
150146848|NCT02223754|541673776|FG001|Period 1|Adverse Event|0|||
150146849|NCT02223754|541673775|FG000|Period 1|Lost to Follow-up|0|||
150146850|NCT02223754|541673776|FG001|Period 1|Lost to Follow-up|1|||
150146851|NCT02223754|541673775|FG000|Period 1|Protocol Violation|2|||
150146852|NCT02223754|541673776|FG001|Period 1|Protocol Violation|4|||
150146853|NCT02223754|541673775|FG000|Period 1|Withdrawal by Subject|0|||
150146854|NCT02223754|541673776|FG001|Period 1|Withdrawal by Subject|4|||
150146855|NCT02223754|541673775|FG000|Period 1|Test Article No Longer Available|1|||
150146856|NCT02223754|541673776|FG001|Period 1|Test Article No Longer Available|5|||
149804483|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804484|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804485|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804486|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804487|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804488|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
149804489|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149804490|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804491|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804492|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804493|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804494|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804495|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
149804496|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149804497|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804498|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804499|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804500|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804501|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804502|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149804503|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
149804504|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804505|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804506|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804507|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804508|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804509|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149804510|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
149804511|NCT04242446|540412369|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804512|NCT04242446|540412370|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804513|NCT04242446|540412371|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804514|NCT04242446|540412372|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804515|NCT04242446|540412373|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804516|NCT04242446|540412374|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149804517|NCT04242446|540412375|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
149804518|NCT03587116|540412376|FG000|Overall Study|Lost to Follow-up|0|||
149804519|NCT03587116|540412377|FG001|Overall Study|Lost to Follow-up|1|||
149804520|NCT03587116|540412376|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
149804521|NCT03587116|540412377|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
149804522|NCT03587116|540412376|FG000|Overall Study|Withdrawal by Subject|4|||
149804523|NCT03587116|540412377|FG001|Overall Study|Withdrawal by Subject|0|||
149804524|NCT05993299|540412381|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
149804525|NCT05993299|540412381|FG000|Overall Study|Ongoing|4|||
149804526|NCT05644756|540412382|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
149804527|NCT05644756|540412382|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
149804528|NCT03985982|540412386|FG000|Double-Blind Phase|Lost to Follow-up|4|||
149804529|NCT03985982|540412387|FG001|Double-Blind Phase|Lost to Follow-up|3|||
149804530|NCT03985982|540412388|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149804531|NCT03985982|540412386|FG000|Double-Blind Phase|Physician Decision|1|||
150146857|NCT02223754|541673775|FG000|Period 1|Unsatisfactory Visual Response|0|||
150146858|NCT02223754|541673776|FG001|Period 1|Unsatisfactory Visual Response|1|||
150146859|NCT02223754|541673775|FG000|Period 2|Adverse Event|0|||
150146860|NCT02223754|541673776|FG001|Period 2|Adverse Event|1|||
150146861|NCT02223754|541673775|FG000|Period 2|Protocol Violation|1|||
149804532|NCT03985982|540412387|FG001|Double-Blind Phase|Physician Decision|0|||
149804533|NCT03985982|540412388|FG002|Double-Blind Phase|Physician Decision|0|||
149804534|NCT03985982|540412386|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
149804535|NCT03985982|540412387|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
149804536|NCT03985982|540412388|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
149804537|NCT03985982|540412386|FG000|Double-Blind Phase|COVID-19|1|||
149804538|NCT03985982|540412387|FG001|Double-Blind Phase|COVID-19|0|||
149804539|NCT03985982|540412388|FG002|Double-Blind Phase|COVID-19|0|||
149804540|NCT03985982|540412386|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
149804541|NCT03985982|540412387|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
149804542|NCT03985982|540412388|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
149804543|NCT03985982|540412386|FG000|Open-Label Phase|Lost to Follow-up|0|||
149804544|NCT03985982|540412387|FG001|Open-Label Phase|Lost to Follow-up|0|||
149804545|NCT03985982|540412388|FG002|Open-Label Phase|Lost to Follow-up|13|||
149804546|NCT03985982|540412386|FG000|Open-Label Phase|Physician Decision|0|||
149804547|NCT03985982|540412387|FG001|Open-Label Phase|Physician Decision|0|||
149804548|NCT03985982|540412388|FG002|Open-Label Phase|Physician Decision|2|||
149804549|NCT03985982|540412386|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149804550|NCT03985982|540412387|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149804551|NCT03985982|540412388|FG002|Open-Label Phase|Withdrawal by Subject|11|||
149804552|NCT03526549|540412390|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
149804553|NCT03526549|540412391|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
149804554|NCT03526549|540412390|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
149804555|NCT03526549|540412391|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
149804556|NCT03526549|540412390|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
149804557|NCT03526549|540412391|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
149804558|NCT03526549|540412390|FG000|Open-label Phase|Adverse Event|4|||
149804559|NCT03526549|540412391|FG001|Open-label Phase|Adverse Event|0|||
149804560|NCT03526549|540412390|FG000|Open-label Phase|Withdrawal by Subject|54|||
149804561|NCT03526549|540412391|FG001|Open-label Phase|Withdrawal by Subject|0|||
149804562|NCT03526549|540412390|FG000|Open-label Phase|Lost to Follow-up|35|||
149804563|NCT03526549|540412391|FG001|Open-label Phase|Lost to Follow-up|0|||
149804564|NCT03526549|540412390|FG000|Open-label Phase|Other than Specified|5|||
149804565|NCT03526549|540412391|FG001|Open-label Phase|Other than Specified|0|||
149804566|NCT05981365|540412392|FG000|Period 1|Adverse Event|1|||
149804567|NCT05981365|540412393|FG001|Period 1|Adverse Event|0|||
149804568|NCT03927989|540412397|FG000|Overall Study|Withdrawal by Subject|0|||
149804569|NCT03927989|540412398|FG001|Overall Study|Withdrawal by Subject|1|||
149804570|NCT02593175|540412399|FG000|Overall Study|Adverse Event|5|||
149804571|NCT02593175|540412399|FG000|Overall Study|Disease progression|4|||
149804572|NCT00478933|540412403|FG000|Overall Study|Protocol Violation|22|||
149804573|NCT00478933|540412403|FG000|Overall Study|Informed consent not verified|3|||
149804574|NCT00478933|540412403|FG000|Overall Study|Inadequate data available|53|||
149804575|NCT01298362|540412408|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
149804576|NCT01298362|540412409|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
149804577|NCT00455923|540412422|FG000|Overall Study|Pregnancy|0|||
149804578|NCT00455923|540412423|FG001|Overall Study|Pregnancy|2|||
149804579|NCT00455923|540412422|FG000|Overall Study|Other|3|||
149804580|NCT00455923|540412423|FG001|Overall Study|Other|1|||
149804581|NCT02686749|540412424|FG000|Overall Study|terminated for poor enrollment|2|||
149804582|NCT02686749|540412425|FG001|Overall Study|terminated for poor enrollment|2|||
149804583|NCT00145119|540412430|FG000|Overall Study|Death|45|||
149804584|NCT02951130|540412431|FG000|Overall Study|Protocol Violation|1|||
149804585|NCT02951130|540412432|FG001|Overall Study|Protocol Violation|1|||
149804586|NCT03795233|540412433|FG000|Overall Study|Withdrawal by Subject|2|||
149804587|NCT03795233|540412434|FG001|Overall Study|Withdrawal by Subject|1|||
149804588|NCT03795233|540412433|FG000|Overall Study|Lost to Follow-up|1|||
149804589|NCT03795233|540412434|FG001|Overall Study|Lost to Follow-up|0|||
149804590|NCT03795233|540412433|FG000|Overall Study|Death|1|||
149804591|NCT03795233|540412434|FG001|Overall Study|Death|0|||
149804592|NCT02756182|540412435|FG000|Overall Study|StudyTechnical Difficulties|4|||
149804593|NCT02711306|540412438|FG000|Overall Study|Withdrawal by Subject|2|||
149804594|NCT02711306|540412439|FG001|Overall Study|Withdrawal by Subject|2|||
149804595|NCT01100073|540413833|FG000|Overall Study|Lack of Efficacy|4|||
149804596|NCT01100073|540413833|FG000|Overall Study|Insufficient Tolerability|21|||
149804597|NCT01100073|540413833|FG000|Overall Study|Withdrawal by Subject|13|||
149804598|NCT01100073|540413833|FG000|Overall Study|Lost to Follow-up|39|||
149804599|NCT01100073|540413833|FG000|Overall Study|Lack of effect + patient's wish|2|||
149804600|NCT01100073|540413833|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
149804601|NCT01100073|540413833|FG000|Overall Study|Other|8|||
149804602|NCT01100073|540413833|FG000|Overall Study|Missing|5|||
149804603|NCT00299546|540413834|FG000|Overall Study|Death|3|||
149804604|NCT00299546|540413835|FG001|Overall Study|Death|2|||
149804605|NCT00299546|540413836|FG002|Overall Study|Death|0|||
150146862|NCT02223754|541673776|FG001|Period 2|Protocol Violation|0|||
150146863|NCT02223754|541673775|FG000|Period 2|Lens Discomfort|1|||
150146864|NCT02223754|541673776|FG001|Period 2|Lens Discomfort|1|||
150146865|NCT02223754|541673775|FG000|Period 2|Lost to Follow-up|1|||
150146866|NCT02223754|541673776|FG001|Period 2|Lost to Follow-up|0|||
150146867|NCT02223754|541673775|FG000|Period 2|Test Article No Longer Available|0|||
150146868|NCT02223754|541673776|FG001|Period 2|Test Article No Longer Available|1|||
150146869|NCT01122381|541673779|FG000|Overall Study|study terminated early|0|||
150146870|NCT01122381|541673780|FG001|Overall Study|study terminated early|1|||
150146871|NCT02395133|541673781|FG000|Overall Study|Adverse Event|4|||
150146872|NCT02395133|541673782|FG001|Overall Study|Adverse Event|1|||
150146873|NCT02395133|541673783|FG002|Overall Study|Adverse Event|3|||
150146874|NCT02395133|541673784|FG003|Overall Study|Adverse Event|0|||
150146875|NCT02395133|541673781|FG000|Overall Study|Lack of Efficacy|1|||
150146876|NCT02395133|541673782|FG001|Overall Study|Lack of Efficacy|0|||
150146877|NCT02395133|541673783|FG002|Overall Study|Lack of Efficacy|1|||
150146878|NCT02395133|541673784|FG003|Overall Study|Lack of Efficacy|1|||
150146879|NCT02395133|541673781|FG000|Overall Study|Protocol Violation|1|||
150146880|NCT02395133|541673782|FG001|Overall Study|Protocol Violation|1|||
150146881|NCT02395133|541673783|FG002|Overall Study|Protocol Violation|0|||
150146882|NCT02395133|541673784|FG003|Overall Study|Protocol Violation|3|||
150146883|NCT02395133|541673781|FG000|Overall Study|Lost to Follow-up|0|||
150146884|NCT02395133|541673782|FG001|Overall Study|Lost to Follow-up|1|||
150146885|NCT02395133|541673783|FG002|Overall Study|Lost to Follow-up|1|||
150146886|NCT02395133|541673784|FG003|Overall Study|Lost to Follow-up|0|||
150146887|NCT02395133|541673781|FG000|Overall Study|Pregnancy|0|||
150146888|NCT02395133|541673782|FG001|Overall Study|Pregnancy|0|||
150146889|NCT02395133|541673783|FG002|Overall Study|Pregnancy|3|||
150146890|NCT02395133|541673784|FG003|Overall Study|Pregnancy|0|||
150146891|NCT02395133|541673781|FG000|Overall Study|Consent withdrawn with no reason given|1|||
150146892|NCT02395133|541673782|FG001|Overall Study|Consent withdrawn with no reason given|3|||
150146893|NCT02395133|541673783|FG002|Overall Study|Consent withdrawn with no reason given|0|||
150146894|NCT02395133|541673784|FG003|Overall Study|Consent withdrawn with no reason given|2|||
150146895|NCT02395133|541673781|FG000|Overall Study|Consent withdrawn with personal reason|0|||
150146896|NCT02395133|541673782|FG001|Overall Study|Consent withdrawn with personal reason|1|||
150146897|NCT02395133|541673783|FG002|Overall Study|Consent withdrawn with personal reason|0|||
150146898|NCT02395133|541673784|FG003|Overall Study|Consent withdrawn with personal reason|3|||
150146899|NCT02395133|541673781|FG000|Overall Study|Sponsor decision|2|||
150146900|NCT02395133|541673782|FG001|Overall Study|Sponsor decision|0|||
150146901|NCT02395133|541673783|FG002|Overall Study|Sponsor decision|0|||
150146902|NCT02395133|541673784|FG003|Overall Study|Sponsor decision|1|||
150146903|NCT02395133|541673781|FG000|Overall Study|Other than specified above|5|||
150146904|NCT02395133|541673782|FG001|Overall Study|Other than specified above|2|||
150146905|NCT02395133|541673783|FG002|Overall Study|Other than specified above|2|||
150146906|NCT02395133|541673784|FG003|Overall Study|Other than specified above|4|||
150146907|NCT00962247|541673787|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
150146908|NCT00962247|541673787|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
150146909|NCT02946918|541673792|FG000|Overall Study|Patient unblinded himself|1|||
150146910|NCT02946918|541673793|FG001|Overall Study|Patient unblinded himself|0|||
150146911|NCT02946918|541673792|FG000|Overall Study|Physician Decision|0|||
150146912|NCT02946918|541673793|FG001|Overall Study|Physician Decision|2|||
150146913|NCT02946918|541673792|FG000|Overall Study|Ran out of study medication|0|||
150146914|NCT02946918|541673793|FG001|Overall Study|Ran out of study medication|1|||
150146915|NCT01861522|541673794|FG000|Overall Study|Adverse Event|1|||
150146916|NCT01861522|541673795|FG001|Overall Study|Adverse Event|0|||
150146917|NCT01861522|541673794|FG000|Overall Study|Withdrawal by Subject|2|||
150146918|NCT01861522|541673795|FG001|Overall Study|Withdrawal by Subject|0|||
150146919|NCT00069784|541673796|FG000|Overall Study|Adverse Event|105|||
150146920|NCT00069784|541673797|FG001|Overall Study|Adverse Event|0|||
150146921|NCT00069784|541673796|FG000|Overall Study|Withdrawal by Subject|1090|||
150146922|NCT00069784|541673797|FG001|Overall Study|Withdrawal by Subject|0|||
150146923|NCT00069784|541673796|FG000|Overall Study|Other|17|||
150146924|NCT00069784|541673797|FG001|Overall Study|Other|0|||
150146925|NCT01555164|541673802|FG000|Overall Study|Adverse Event|5|||
150146926|NCT01555164|541673803|FG001|Overall Study|Adverse Event|7|||
150146927|NCT01555164|541673802|FG000|Overall Study|Hyperglycemia|0|||
150146928|NCT01555164|541673803|FG001|Overall Study|Hyperglycemia|1|||
150146929|NCT01555164|541673802|FG000|Overall Study|Investigator's Discretion|2|||
150146930|NCT01555164|541673803|FG001|Overall Study|Investigator's Discretion|2|||
150146931|NCT01555164|541673802|FG000|Overall Study|Lost to Follow-up|4|||
150146932|NCT01555164|541673803|FG001|Overall Study|Lost to Follow-up|3|||
150146933|NCT01555164|541673802|FG000|Overall Study|Protocol Violation|9|||
150146934|NCT01555164|541673803|FG001|Overall Study|Protocol Violation|5|||
150146935|NCT01555164|541673802|FG000|Overall Study|Subject Non-compliance|14|||
150146936|NCT01555164|541673803|FG001|Overall Study|Subject Non-compliance|6|||
150146937|NCT01555164|541673802|FG000|Overall Study|Subject Withdrew Consent|6|||
150146938|NCT01555164|541673803|FG001|Overall Study|Subject Withdrew Consent|11|||
150146939|NCT00926003|541673804|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
150146940|NCT00926003|541673805|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
149804606|NCT00299546|540413834|FG000|Overall Study|Lost to Follow-up|2|||
149804607|NCT00299546|540413835|FG001|Overall Study|Lost to Follow-up|2|||
149804608|NCT00299546|540413836|FG002|Overall Study|Lost to Follow-up|5|||
149804609|NCT00299546|540413834|FG000|Overall Study|Adverse Event|37|||
149804610|NCT00299546|540413835|FG001|Overall Study|Adverse Event|22|||
149804611|NCT00299546|540413836|FG002|Overall Study|Adverse Event|27|||
149804612|NCT00299546|540413834|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
149804613|NCT00299546|540413835|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
150146941|NCT00926003|541673806|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
150146942|NCT00926003|541673804|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
150146943|NCT00926003|541673805|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
150146944|NCT00926003|541673806|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
150146945|NCT03203694|541673807|FG000|Overall Study|Withdrawal by Subject|2|||
150146946|NCT03203694|541673808|FG001|Overall Study|Withdrawal by Subject|0|||
150146947|NCT03203694|541673809|FG002|Overall Study|Withdrawal by Subject|0|||
150146948|NCT03203694|541673810|FG003|Overall Study|Withdrawal by Subject|0|||
150146949|NCT03203694|541673811|FG004|Overall Study|Withdrawal by Subject|0|||
150146950|NCT03203694|541673812|FG005|Overall Study|Withdrawal by Subject|0|||
150146951|NCT03443713|541673813|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
150146952|NCT03443713|541673814|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
150146953|NCT03443713|541673815|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
150146954|NCT01672853|541673818|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
150146955|NCT01672853|541673819|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
150146956|NCT01672853|541673820|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
150146957|NCT01672853|541673818|FG000|Overall Study|Pregnancy|0|||
150146958|NCT01672853|541673819|FG001|Overall Study|Pregnancy|1|||
150146959|NCT01672853|541673820|FG002|Overall Study|Pregnancy|0|||
150146960|NCT01672853|541673818|FG000|Overall Study|Investigator's Discretion|1|||
150146961|NCT01672853|541673819|FG001|Overall Study|Investigator's Discretion|0|||
150146962|NCT01672853|541673820|FG002|Overall Study|Investigator's Discretion|0|||
150146963|NCT01672853|541673818|FG000|Overall Study|Withdrew Consent|5|||
150146964|NCT01672853|541673819|FG001|Overall Study|Withdrew Consent|5|||
150146965|NCT01672853|541673820|FG002|Overall Study|Withdrew Consent|5|||
150146966|NCT01672853|541673818|FG000|Overall Study|Adverse Event|4|||
150146967|NCT01672853|541673819|FG001|Overall Study|Adverse Event|6|||
150146968|NCT01672853|541673820|FG002|Overall Study|Adverse Event|8|||
150146969|NCT01672853|541673818|FG000|Overall Study|Lost to Follow-up|0|||
150146970|NCT01672853|541673819|FG001|Overall Study|Lost to Follow-up|1|||
150146971|NCT01672853|541673820|FG002|Overall Study|Lost to Follow-up|0|||
150146972|NCT01672853|541673818|FG000|Overall Study|Randomized but Never Treated|0|||
150146973|NCT01672853|541673819|FG001|Overall Study|Randomized but Never Treated|0|||
150146974|NCT01672853|541673820|FG002|Overall Study|Randomized but Never Treated|1|||
150146975|NCT02073097|541673823|FG000|Overall Study|Adverse Event|0|||
150146976|NCT02073097|541673824|FG001|Overall Study|Adverse Event|0|||
150146977|NCT02073097|541673825|FG002|Overall Study|Adverse Event|0|||
150146978|NCT02073097|541673826|FG003|Overall Study|Adverse Event|0|||
150146979|NCT02073097|541673827|FG004|Overall Study|Adverse Event|0|||
150146980|NCT02073097|541673828|FG005|Overall Study|Adverse Event|0|||
150146981|NCT02073097|541673829|FG006|Overall Study|Adverse Event|0|||
150146982|NCT02073097|541673830|FG007|Overall Study|Adverse Event|2|||
150146983|NCT02073097|541673823|FG000|Overall Study|Withdrawal by Subject|0|||
150146984|NCT02073097|541673824|FG001|Overall Study|Withdrawal by Subject|0|||
150146985|NCT02073097|541673825|FG002|Overall Study|Withdrawal by Subject|0|||
150146986|NCT02073097|541673826|FG003|Overall Study|Withdrawal by Subject|0|||
150146987|NCT02073097|541673827|FG004|Overall Study|Withdrawal by Subject|0|||
150146988|NCT02073097|541673828|FG005|Overall Study|Withdrawal by Subject|0|||
150146989|NCT02073097|541673829|FG006|Overall Study|Withdrawal by Subject|0|||
150146990|NCT02073097|541673830|FG007|Overall Study|Withdrawal by Subject|2|||
150146991|NCT02073097|541673823|FG000|Overall Study|Death|0|||
150146992|NCT02073097|541673824|FG001|Overall Study|Death|0|||
150146993|NCT02073097|541673825|FG002|Overall Study|Death|0|||
150146994|NCT02073097|541673826|FG003|Overall Study|Death|0|||
150146995|NCT02073097|541673827|FG004|Overall Study|Death|0|||
150146996|NCT02073097|541673828|FG005|Overall Study|Death|0|||
150146997|NCT02073097|541673829|FG006|Overall Study|Death|0|||
150146998|NCT02073097|541673830|FG007|Overall Study|Death|1|||
150146999|NCT02073097|541673823|FG000|Overall Study|Physician Decision|0|||
150147000|NCT02073097|541673824|FG001|Overall Study|Physician Decision|0|||
150147001|NCT02073097|541673825|FG002|Overall Study|Physician Decision|0|||
150147002|NCT02073097|541673826|FG003|Overall Study|Physician Decision|0|||
150147003|NCT02073097|541673827|FG004|Overall Study|Physician Decision|0|||
150147004|NCT02073097|541673828|FG005|Overall Study|Physician Decision|0|||
150147005|NCT02073097|541673829|FG006|Overall Study|Physician Decision|0|||
149804614|NCT00299546|540413836|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
150147006|NCT02073097|541673830|FG007|Overall Study|Physician Decision|1|||
150147007|NCT00474929|541675658|FG000|Overall Study|Withdrawal by Subject|0|||
150147008|NCT00474929|541675659|FG001|Overall Study|Withdrawal by Subject|1|||
150147009|NCT00474929|541675660|FG002|Overall Study|Withdrawal by Subject|0|||
150147010|NCT00474929|541675661|FG003|Overall Study|Withdrawal by Subject|0|||
150147011|NCT00474929|541675662|FG004|Overall Study|Withdrawal by Subject|0|||
150147012|NCT00474929|541675658|FG000|Overall Study|Unrelated medical condition|0|||
150147013|NCT00474929|541675659|FG001|Overall Study|Unrelated medical condition|0|||
150147014|NCT00474929|541675660|FG002|Overall Study|Unrelated medical condition|1|||
150147015|NCT00474929|541675661|FG003|Overall Study|Unrelated medical condition|0|||
150147016|NCT00474929|541675662|FG004|Overall Study|Unrelated medical condition|0|||
150147017|NCT00474929|541675658|FG000|Overall Study|Physician Decision|0|||
150147018|NCT00474929|541675659|FG001|Overall Study|Physician Decision|0|||
150147019|NCT00474929|541675660|FG002|Overall Study|Physician Decision|1|||
150147020|NCT00474929|541675661|FG003|Overall Study|Physician Decision|2|||
150147021|NCT00474929|541675662|FG004|Overall Study|Physician Decision|0|||
150147022|NCT03029247|541675663|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
150147023|NCT03029247|541675664|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
150147024|NCT03029247|541675663|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
150147025|NCT03029247|541675664|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
150147026|NCT03029247|541675663|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
150147027|NCT03029247|541675664|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
150147028|NCT03029247|541675663|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
150147029|NCT03029247|541675664|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
150147030|NCT02593305|541675665|FG000|Post 1|Comparison only group. No intervention.|0|||
150147031|NCT02593305|541675666|FG001|Post 1|Comparison only group. No intervention.|0|||
150147032|NCT02593305|541675667|FG002|Post 1|Comparison only group. No intervention.|10|||
150147033|NCT01993017|541675668|FG000|Overall Study|Death|23|||
150147034|NCT01993017|541675669|FG001|Overall Study|Death|26|||
150147035|NCT01993017|541675670|FG002|Overall Study|Death|18|||
150147036|NCT01993017|541675668|FG000|Overall Study|Could not be contacted|43|||
150147037|NCT01993017|541675669|FG001|Overall Study|Could not be contacted|42|||
150147038|NCT01993017|541675670|FG002|Overall Study|Could not be contacted|38|||
150147039|NCT01993017|541675668|FG000|Overall Study|Dropped out|19|||
150147040|NCT01993017|541675669|FG001|Overall Study|Dropped out|6|||
150147041|NCT01993017|541675670|FG002|Overall Study|Dropped out|11|||
150147042|NCT01993017|541675668|FG000|Overall Study|Other reasons|17|||
150147043|NCT01993017|541675669|FG001|Overall Study|Other reasons|11|||
150147044|NCT01993017|541675670|FG002|Overall Study|Other reasons|7|||
150147045|NCT01993017|541675668|FG000|Overall Study|Ineligible after randomization|4|||
150147046|NCT01993017|541675669|FG001|Overall Study|Ineligible after randomization|5|||
150147047|NCT01993017|541675670|FG002|Overall Study|Ineligible after randomization|5|||
150147048|NCT00068380|541675671|FG000|Overall Study|Withdrawal by Subject|3|||
150147049|NCT00068380|541675671|FG000|Overall Study|Adverse Event|2|||
150147050|NCT01976364|541675672|FG000|Main Study (36 Months)|Adverse Event|63|||
150147051|NCT01976364|541675673|FG001|Main Study (36 Months)|Adverse Event|0|||
150147052|NCT01976364|541675674|FG002|Main Study (36 Months)|Adverse Event|0|||
150147053|NCT01976364|541675672|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
150147054|NCT01976364|541675673|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
150147055|NCT01976364|541675674|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
150147056|NCT01976364|541675672|FG000|Main Study (36 Months)|Other|13|||
150147057|NCT01976364|541675673|FG001|Main Study (36 Months)|Other|0|||
150147058|NCT01976364|541675674|FG002|Main Study (36 Months)|Other|0|||
150147059|NCT01976364|541675672|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
150147060|NCT01976364|541675673|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
150147061|NCT01976364|541675674|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
150147062|NCT01976364|541675672|FG000|Main Study (36 Months)|Medication error|1|||
150147063|NCT01976364|541675673|FG001|Main Study (36 Months)|Medication error|0|||
150147064|NCT01976364|541675674|FG002|Main Study (36 Months)|Medication error|0|||
150147065|NCT01976364|541675672|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
150147066|NCT01976364|541675673|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
150147067|NCT01976364|541675674|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
150147068|NCT01976364|541675672|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
149804615|NCT00299546|540413834|FG000|Overall Study|Other|24|||
149804616|NCT00299546|540413835|FG001|Overall Study|Other|26|||
150147069|NCT01976364|541675673|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
150147070|NCT01976364|541675674|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
150147071|NCT01976364|541675672|FG000|Main Study (36 Months)|Protocol Violation|13|||
150147072|NCT01976364|541675673|FG001|Main Study (36 Months)|Protocol Violation|0|||
150147073|NCT01976364|541675674|FG002|Main Study (36 Months)|Protocol Violation|0|||
150147074|NCT01976364|541675672|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
150147075|NCT01976364|541675673|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
150147076|NCT01976364|541675674|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
150147077|NCT01976364|541675672|FG000|Main Study (36 Months)|Death|5|||
150147078|NCT01976364|541675673|FG001|Main Study (36 Months)|Death|0|||
150147079|NCT01976364|541675674|FG002|Main Study (36 Months)|Death|0|||
149804617|NCT00299546|540413836|FG002|Overall Study|Other|19|||
150147080|NCT01976364|541675672|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
150147081|NCT01976364|541675673|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
150147082|NCT01976364|541675674|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
150147083|NCT01976364|541675672|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
150147084|NCT01976364|541675673|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
150147085|NCT01976364|541675674|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
150147086|NCT01976364|541675672|FG000|Sub-study (12 Months)|Protocol Violation|0|||
150147087|NCT01976364|541675673|FG001|Sub-study (12 Months)|Protocol Violation|1|||
150147088|NCT01976364|541675674|FG002|Sub-study (12 Months)|Protocol Violation|1|||
150147089|NCT01976364|541675672|FG000|Sub-study (12 Months)|Adverse Event|0|||
150147090|NCT01976364|541675673|FG001|Sub-study (12 Months)|Adverse Event|4|||
150147091|NCT01976364|541675674|FG002|Sub-study (12 Months)|Adverse Event|3|||
150147092|NCT02757521|541675675|FG000|Overall Study|Adverse Event|1|||
150147093|NCT02757521|541675676|FG001|Overall Study|Adverse Event|0|||
150147094|NCT01190215|541675677|FG000|Up to Month 6|Lost to Follow-up|2|||
150147095|NCT01190215|541675678|FG001|Up to Month 6|Lost to Follow-up|0|||
150147096|NCT00003511|541675679|FG000|Overall Study|Not evaluable|4|||
150147097|NCT01683994|541675703|FG000|Overall Study|Withdrawal by Subject|1|||
150147098|NCT01683994|541675704|FG001|Overall Study|Withdrawal by Subject|0|||
150147099|NCT01683994|541675705|FG002|Overall Study|Withdrawal by Subject|0|||
150147100|NCT01683994|541675706|FG003|Overall Study|Withdrawal by Subject|1|||
150147101|NCT01683994|541675707|FG004|Overall Study|Withdrawal by Subject|0|||
150147102|NCT01683994|541675703|FG000|Overall Study|Intercurrent illness|0|||
150147103|NCT01683994|541675704|FG001|Overall Study|Intercurrent illness|0|||
150147104|NCT01683994|541675705|FG002|Overall Study|Intercurrent illness|0|||
150147105|NCT01683994|541675706|FG003|Overall Study|Intercurrent illness|2|||
150147106|NCT01683994|541675707|FG004|Overall Study|Intercurrent illness|1|||
150147107|NCT00999661|541675708|FG000|Overall Study|Lost to Follow-up|59|||
150147108|NCT00999661|541675708|FG000|Overall Study|Adverse Event|1|||
150147109|NCT00999661|541675708|FG000|Overall Study|Withdrawal by Subject|1|||
150147110|NCT00999661|541675708|FG000|Overall Study|Not meeting eligibility criteria|9|||
150147111|NCT00917267|541675709|FG000|Overall Study|Adverse Event|15|||
150147112|NCT00917267|541675710|FG001|Overall Study|Adverse Event|36|||
150147113|NCT00917267|541675709|FG000|Overall Study|Physician Decision|2|||
150147114|NCT00917267|541675710|FG001|Overall Study|Physician Decision|4|||
150147115|NCT00917267|541675709|FG000|Overall Study|Protocol Violation|9|||
150147116|NCT00917267|541675710|FG001|Overall Study|Protocol Violation|18|||
150147117|NCT00917267|541675709|FG000|Overall Study|Withdrawal by Subject|5|||
150147118|NCT00917267|541675710|FG001|Overall Study|Withdrawal by Subject|12|||
150147119|NCT00917267|541675709|FG000|Overall Study|Lost to follow up|0|||
150147120|NCT00917267|541675710|FG001|Overall Study|Lost to follow up|2|||
150147121|NCT00917267|541675709|FG000|Overall Study|Entry Criteria Not Met|1|||
150147122|NCT00917267|541675710|FG001|Overall Study|Entry Criteria Not Met|0|||
150147123|NCT00917267|541675709|FG000|Overall Study|Sponsor Decision|5|||
150147124|NCT00917267|541675710|FG001|Overall Study|Sponsor Decision|5|||
150147125|NCT00917267|541675709|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
150147126|NCT00917267|541675710|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
150147127|NCT00312858|541675712|FG000|Overall Study|Adverse Event|0|||
150147128|NCT00312858|541675713|FG001|Overall Study|Adverse Event|1|||
150147129|NCT00312858|541675712|FG000|Overall Study|Lost to Follow-up|25|||
150147130|NCT00312858|541675713|FG001|Overall Study|Lost to Follow-up|42|||
150147131|NCT00312858|541675712|FG000|Overall Study|Protocol Violation|3|||
150147132|NCT00312858|541675713|FG001|Overall Study|Protocol Violation|8|||
150147133|NCT00312858|541675712|FG000|Overall Study|Withdraw by Participant|20|||
150147134|NCT00312858|541675713|FG001|Overall Study|Withdraw by Participant|20|||
150147135|NCT00312858|541675712|FG000|Overall Study|Participant Moved|11|||
150147136|NCT00312858|541675713|FG001|Overall Study|Participant Moved|10|||
150147137|NCT00312858|541675712|FG000|Overall Study|Other|9|||
150147138|NCT00312858|541675713|FG001|Overall Study|Other|12|||
150147139|NCT03638635|541675714|FG000|Initial Hospitalization|Study terminated prematurely|0|||
150147140|NCT03638635|541675715|FG001|Initial Hospitalization|Study terminated prematurely|1|||
150147141|NCT03638635|541675714|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
150147142|NCT03638635|541675715|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
150147143|NCT03638635|541675714|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
150147144|NCT03638635|541675715|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
150147145|NCT02318719|541675718|FG000|Double-blind Phase|Adverse Event|7|||
150147146|NCT02318719|541675719|FG001|Double-blind Phase|Adverse Event|6|||
150147147|NCT02318719|541675720|FG002|Double-blind Phase|Adverse Event|12|||
150147148|NCT02318719|541675721|FG003|Double-blind Phase|Adverse Event|4|||
150147149|NCT02318719|541675722|FG004|Double-blind Phase|Adverse Event|0|||
150147150|NCT02318719|541675718|FG000|Double-blind Phase|Lack of Efficacy|5|||
150147151|NCT02318719|541675719|FG001|Double-blind Phase|Lack of Efficacy|0|||
150147152|NCT02318719|541675720|FG002|Double-blind Phase|Lack of Efficacy|1|||
150147153|NCT02318719|541675721|FG003|Double-blind Phase|Lack of Efficacy|1|||
150147154|NCT02318719|541675722|FG004|Double-blind Phase|Lack of Efficacy|0|||
150147155|NCT02318719|541675718|FG000|Double-blind Phase|Protocol Violation|0|||
150147156|NCT02318719|541675719|FG001|Double-blind Phase|Protocol Violation|1|||
150147157|NCT02318719|541675720|FG002|Double-blind Phase|Protocol Violation|3|||
150147158|NCT02318719|541675721|FG003|Double-blind Phase|Protocol Violation|0|||
150147159|NCT02318719|541675722|FG004|Double-blind Phase|Protocol Violation|0|||
150147160|NCT02318719|541675718|FG000|Double-blind Phase|Withdrawal by Subject|25|||
150147161|NCT02318719|541675719|FG001|Double-blind Phase|Withdrawal by Subject|7|||
150147162|NCT02318719|541675720|FG002|Double-blind Phase|Withdrawal by Subject|9|||
150147163|NCT02318719|541675721|FG003|Double-blind Phase|Withdrawal by Subject|10|||
150147164|NCT02318719|541675722|FG004|Double-blind Phase|Withdrawal by Subject|0|||
150147165|NCT02318719|541675718|FG000|Double-blind Phase|Other|1|||
150147166|NCT02318719|541675719|FG001|Double-blind Phase|Other|2|||
150147167|NCT02318719|541675720|FG002|Double-blind Phase|Other|0|||
150147168|NCT02318719|541675721|FG003|Double-blind Phase|Other|0|||
150147169|NCT02318719|541675722|FG004|Double-blind Phase|Other|0|||
150147170|NCT02318719|541675718|FG000|Open-label Extension Phase|Adverse Event|0|||
150147171|NCT02318719|541675719|FG001|Open-label Extension Phase|Adverse Event|0|||
150147172|NCT02318719|541675720|FG002|Open-label Extension Phase|Adverse Event|0|||
150147173|NCT02318719|541675721|FG003|Open-label Extension Phase|Adverse Event|0|||
150147174|NCT02318719|541675722|FG004|Open-label Extension Phase|Adverse Event|15|||
150147175|NCT02318719|541675718|FG000|Open-label Extension Phase|Death|0|||
150147176|NCT02318719|541675719|FG001|Open-label Extension Phase|Death|0|||
150147177|NCT02318719|541675720|FG002|Open-label Extension Phase|Death|0|||
150147178|NCT02318719|541675721|FG003|Open-label Extension Phase|Death|0|||
150147179|NCT02318719|541675722|FG004|Open-label Extension Phase|Death|1|||
150147180|NCT02318719|541675718|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
150147181|NCT02318719|541675719|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
150147182|NCT02318719|541675720|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
150147183|NCT02318719|541675721|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
150147184|NCT02318719|541675722|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
150147185|NCT02318719|541675718|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
150147186|NCT02318719|541675719|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
150147187|NCT02318719|541675720|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
150147188|NCT02318719|541675721|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
150147189|NCT02318719|541675722|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
150147190|NCT02318719|541675718|FG000|Open-label Extension Phase|Other|0|||
150147191|NCT02318719|541675719|FG001|Open-label Extension Phase|Other|0|||
150147192|NCT02318719|541675720|FG002|Open-label Extension Phase|Other|0|||
150147193|NCT02318719|541675721|FG003|Open-label Extension Phase|Other|0|||
150147194|NCT02318719|541675722|FG004|Open-label Extension Phase|Other|7|||
150147195|NCT00432835|541675726|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
150147196|NCT00432835|541675727|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
150147197|NCT00289770|541675728|FG000|Year 15|Withdrawal by Subject|1|||
150147198|NCT00423293|541675729|FG000|Overall Study|Ineligible / No protocol treatment|11|||
150147199|NCT05340751|541675736|FG000|Overall Study|Physician Decision|3|||
150147200|NCT01014975|541675737|FG000|Overall Study|Withdrawal by Subject|1|||
150147201|NCT01014975|541675738|FG001|Overall Study|Withdrawal by Subject|0|||
150147202|NCT01014975|541675739|FG002|Overall Study|Withdrawal by Subject|1|||
150147203|NCT01014975|541675737|FG000|Overall Study|Death|3|||
150147204|NCT01014975|541675738|FG001|Overall Study|Death|3|||
150147205|NCT01014975|541675739|FG002|Overall Study|Death|4|||
150147206|NCT01014975|541675737|FG000|Overall Study|Lost to Follow-up|0|||
150147207|NCT01014975|541675738|FG001|Overall Study|Lost to Follow-up|0|||
150147208|NCT01014975|541675739|FG002|Overall Study|Lost to Follow-up|1|||
150147209|NCT01336634|541675742|FG000|Overall Study|Study closed/terminated|5|||
150147210|NCT01336634|541675743|FG001|Overall Study|Study closed/terminated|6|||
150147211|NCT01336634|541675744|FG002|Overall Study|Study closed/terminated|6|||
150147212|NCT01336634|541675742|FG000|Overall Study|Lost to Follow-up|2|||
150147213|NCT01336634|541675743|FG001|Overall Study|Lost to Follow-up|1|||
150147214|NCT01336634|541675744|FG002|Overall Study|Lost to Follow-up|1|||
150147215|NCT01336634|541675742|FG000|Overall Study|Physician Decision|1|||
150147216|NCT01336634|541675743|FG001|Overall Study|Physician Decision|1|||
150147217|NCT01336634|541675744|FG002|Overall Study|Physician Decision|0|||
150147218|NCT01336634|541675742|FG000|Overall Study|Withdrawal by Subject|6|||
150147219|NCT01336634|541675743|FG001|Overall Study|Withdrawal by Subject|0|||
150147220|NCT01336634|541675744|FG002|Overall Study|Withdrawal by Subject|2|||
150147221|NCT02176421|541675747|FG000|Overall Study|Lost to Follow-up|4|||
150147222|NCT02176421|541675747|FG000|Overall Study|Adverse Event|1|||
150147223|NCT02632786|541675750|FG000|Overall Study|Adverse Event|2|||
150147224|NCT02632786|541675751|FG001|Overall Study|Adverse Event|1|||
150147225|NCT02632786|541675750|FG000|Overall Study|Death|3|||
150147226|NCT02632786|541675751|FG001|Overall Study|Death|2|||
150147227|NCT02632786|541675750|FG000|Overall Study|Physician Decision|5|||
150147228|NCT02632786|541675751|FG001|Overall Study|Physician Decision|4|||
150147229|NCT02632786|541675750|FG000|Overall Study|Withdrawal by Subject|1|||
150147230|NCT02632786|541675751|FG001|Overall Study|Withdrawal by Subject|0|||
150147231|NCT04250337|541675752|FG000|Overall Study|Adverse Event|0|||
150147232|NCT04250337|541675753|FG001|Overall Study|Adverse Event|3|||
150147233|NCT04250337|541675752|FG000|Overall Study|Lack of Efficacy|1|||
150147234|NCT04250337|541675753|FG001|Overall Study|Lack of Efficacy|3|||
150147235|NCT04250337|541675752|FG000|Overall Study|Physician Decision|1|||
150147236|NCT04250337|541675753|FG001|Overall Study|Physician Decision|0|||
150147237|NCT04250337|541675752|FG000|Overall Study|Protocol Deviation|2|||
150147238|NCT04250337|541675753|FG001|Overall Study|Protocol Deviation|2|||
150147239|NCT04250337|541675752|FG000|Overall Study|Withdrawal by Subject|4|||
150147240|NCT04250337|541675753|FG001|Overall Study|Withdrawal by Subject|3|||
150147241|NCT00474175|541675760|FG000|Overall Study|Lack of Efficacy|0|||
150147242|NCT00474175|541675761|FG001|Overall Study|Lack of Efficacy|0|||
150147243|NCT00474175|541675762|FG002|Overall Study|Lack of Efficacy|1|||
150147244|NCT00474175|541675760|FG000|Overall Study|Withdrawal by Subject|0|||
150147245|NCT00474175|541675761|FG001|Overall Study|Withdrawal by Subject|1|||
150147246|NCT00474175|541675762|FG002|Overall Study|Withdrawal by Subject|1|||
150147247|NCT00474175|541675760|FG000|Overall Study|Ineligible|1|||
150147248|NCT00474175|541675761|FG001|Overall Study|Ineligible|3|||
150147249|NCT00474175|541675762|FG002|Overall Study|Ineligible|1|||
150147250|NCT00474175|541675760|FG000|Overall Study|Protocol Violation|0|||
150147251|NCT00474175|541675761|FG001|Overall Study|Protocol Violation|2|||
150147252|NCT00474175|541675762|FG002|Overall Study|Protocol Violation|1|||
150147253|NCT00474175|541675760|FG000|Overall Study|Administrative|0|||
150147254|NCT00474175|541675761|FG001|Overall Study|Administrative|1|||
150147255|NCT00474175|541675762|FG002|Overall Study|Administrative|0|||
150147256|NCT01619787|541675763|FG000|Overall Study|Lost to Follow-up|5|||
150147257|NCT03101241|541675764|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
150147258|NCT03101241|541675765|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
150147259|NCT03101241|541675764|FG000|Overall Study|Participant withdrew consent|3|||
150147260|NCT03101241|541675765|FG001|Overall Study|Participant withdrew consent|1|||
150147261|NCT03101241|541675764|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
150147262|NCT03101241|541675765|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
150147263|NCT03101241|541675764|FG000|Overall Study|Lost to Follow-up|2|||
150147264|NCT03101241|541675765|FG001|Overall Study|Lost to Follow-up|0|||
150147265|NCT03101241|541675764|FG000|Overall Study|Lack of Efficacy|0|||
150147266|NCT03101241|541675765|FG001|Overall Study|Lack of Efficacy|1|||
150147267|NCT03101241|541675764|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
150147268|NCT03101241|541675765|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
150147269|NCT01003184|541675766|FG000|Overall Study|Adverse Event|12|||
150147270|NCT01003184|541675767|FG001|Overall Study|Adverse Event|5|||
150147271|NCT01003184|541675766|FG000|Overall Study|Lost to Follow-up|1|||
150147272|NCT01003184|541675767|FG001|Overall Study|Lost to Follow-up|0|||
150147273|NCT01003184|541675766|FG000|Overall Study|Loss of glucose control|1|||
150147274|NCT01003184|541675767|FG001|Overall Study|Loss of glucose control|1|||
150147275|NCT01003184|541675766|FG000|Overall Study|Protocol Violation|3|||
150147276|NCT01003184|541675767|FG001|Overall Study|Protocol Violation|0|||
150147277|NCT01003184|541675766|FG000|Overall Study|Withdrawal by Subject|1|||
150147278|NCT01003184|541675767|FG001|Overall Study|Withdrawal by Subject|6|||
150147279|NCT01003184|541675766|FG000|Overall Study|Physician Decision|1|||
150147280|NCT01003184|541675767|FG001|Overall Study|Physician Decision|0|||
150147281|NCT04848662|541675768|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
150147282|NCT04848662|541675769|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
150147283|NCT00284089|541675772|FG000|Multiple Dose Phase|Adverse Event|1|||
150147284|NCT00284089|541675773|FG001|Multiple Dose Phase|Adverse Event|0|||
150147285|NCT00284089|541675774|FG002|Multiple Dose Phase|Adverse Event|1|||
150147286|NCT00284089|541675775|FG003|Multiple Dose Phase|Adverse Event|1|||
150147287|NCT00284089|541675772|FG000|Multiple Dose Phase|Protocol Violation|0|||
150147288|NCT00284089|541675773|FG001|Multiple Dose Phase|Protocol Violation|0|||
150147289|NCT00284089|541675774|FG002|Multiple Dose Phase|Protocol Violation|1|||
150147290|NCT00284089|541675775|FG003|Multiple Dose Phase|Protocol Violation|0|||
150147291|NCT00284089|541675772|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
150147292|NCT00284089|541675773|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
150147293|NCT00284089|541675774|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
150147294|NCT00284089|541675775|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
150147295|NCT00284089|541675772|FG000|Multiple Dose Phase|Death|0|||
150147296|NCT00284089|541675773|FG001|Multiple Dose Phase|Death|0|||
150147297|NCT00284089|541675774|FG002|Multiple Dose Phase|Death|1|||
150147298|NCT00284089|541675775|FG003|Multiple Dose Phase|Death|1|||
150147299|NCT00284089|541675772|FG000|Extension Phase|Adverse Event|0|||
150147300|NCT00284089|541675773|FG001|Extension Phase|Adverse Event|0|||
150147301|NCT00284089|541675774|FG002|Extension Phase|Adverse Event|2|||
150147302|NCT00284089|541675775|FG003|Extension Phase|Adverse Event|2|||
150147303|NCT00284089|541675772|FG000|Extension Phase|condition no longer requires study drug|2|||
150147304|NCT00284089|541675773|FG001|Extension Phase|condition no longer requires study drug|0|||
150147305|NCT00284089|541675774|FG002|Extension Phase|condition no longer requires study drug|2|||
150147306|NCT00284089|541675775|FG003|Extension Phase|condition no longer requires study drug|7|||
150147307|NCT00284089|541675772|FG000|Extension Phase|Protocol Violation|0|||
150147308|NCT00284089|541675773|FG001|Extension Phase|Protocol Violation|0|||
150147309|NCT00284089|541675774|FG002|Extension Phase|Protocol Violation|1|||
150147310|NCT00284089|541675775|FG003|Extension Phase|Protocol Violation|0|||
150147311|NCT00284089|541675772|FG000|Extension Phase|Withdrawal by Subject|0|||
150147312|NCT00284089|541675773|FG001|Extension Phase|Withdrawal by Subject|0|||
150147313|NCT00284089|541675774|FG002|Extension Phase|Withdrawal by Subject|1|||
150147314|NCT00284089|541675775|FG003|Extension Phase|Withdrawal by Subject|3|||
150147315|NCT00089895|541675776|FG000|Overall Study|Consent Withdrawn|11|||
150147316|NCT00089895|541675777|FG001|Overall Study|Consent Withdrawn|14|||
150147317|NCT00089895|541675776|FG000|Overall Study|Technical reason|7|||
150147318|NCT00089895|541675777|FG001|Overall Study|Technical reason|2|||
150147319|NCT00089895|541675776|FG000|Overall Study|Surgery|0|||
150147320|NCT00089895|541675777|FG001|Overall Study|Surgery|1|||
150147321|NCT00089895|541675776|FG000|Overall Study|Bleeding|0|||
150147322|NCT00089895|541675777|FG001|Overall Study|Bleeding|2|||
150147323|NCT00089895|541675776|FG000|Overall Study|Physician Decision|3|||
150147324|NCT00089895|541675777|FG001|Overall Study|Physician Decision|7|||
150147325|NCT00089895|541675776|FG000|Overall Study|Exclusion criteria met|6|||
150147326|NCT00089895|541675777|FG001|Overall Study|Exclusion criteria met|6|||
150147327|NCT00089895|541675776|FG000|Overall Study|Not otherwise specified|4|||
150147328|NCT00089895|541675777|FG001|Overall Study|Not otherwise specified|8|||
150147329|NCT00089895|541675776|FG000|Overall Study|Missing|4|||
150147330|NCT00089895|541675777|FG001|Overall Study|Missing|2|||
150147331|NCT01013792|541675778|FG000|Overall Study|Study suspended|2|||
150147332|NCT01013792|541675779|FG001|Overall Study|Study suspended|1|||
150147333|NCT01013792|541675778|FG000|Overall Study|Adverse Event|0|||
150147334|NCT01013792|541675779|FG001|Overall Study|Adverse Event|3|||
150147335|NCT01013792|541675778|FG000|Overall Study|Lost to Follow-up|0|||
150147336|NCT01013792|541675779|FG001|Overall Study|Lost to Follow-up|1|||
150147337|NCT02667886|541675780|FG000|Dose Escalation (Part A)|Adverse Event|1|||
150147338|NCT02667886|541675781|FG001|Dose Escalation (Part A)|Adverse Event|3|||
150147339|NCT02667886|541675782|FG002|Dose Escalation (Part A)|Adverse Event|1|||
150147340|NCT02667886|541675783|FG003|Dose Escalation (Part A)|Adverse Event|0|||
150147341|NCT02667886|541675784|FG004|Dose Escalation (Part A)|Adverse Event|0|||
150147342|NCT02667886|541675780|FG000|Dose Escalation (Part A)|Disease Progression|1|||
150147343|NCT02667886|541675781|FG001|Dose Escalation (Part A)|Disease Progression|4|||
150147344|NCT02667886|541675782|FG002|Dose Escalation (Part A)|Disease Progression|3|||
150147345|NCT02667886|541675783|FG003|Dose Escalation (Part A)|Disease Progression|0|||
150147346|NCT02667886|541675784|FG004|Dose Escalation (Part A)|Disease Progression|0|||
150147347|NCT02667886|541675780|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
150147348|NCT02667886|541675781|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
150147349|NCT02667886|541675782|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
150147350|NCT02667886|541675783|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
150147351|NCT02667886|541675784|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
150147352|NCT02667886|541675780|FG000|Dose Expansion (Part B)|Adverse Event|0|||
150147353|NCT02667886|541675781|FG001|Dose Expansion (Part B)|Adverse Event|0|||
150147354|NCT02667886|541675782|FG002|Dose Expansion (Part B)|Adverse Event|0|||
150147355|NCT02667886|541675783|FG003|Dose Expansion (Part B)|Adverse Event|9|||
150147356|NCT02667886|541675784|FG004|Dose Expansion (Part B)|Adverse Event|0|||
150147357|NCT02667886|541675780|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
150147358|NCT02667886|541675781|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
150147359|NCT02667886|541675782|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
150147360|NCT02667886|541675783|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
150147361|NCT02667886|541675784|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
150147362|NCT02667886|541675780|FG000|Dose Expansion (Part B)|Disease Progression|0|||
150147363|NCT02667886|541675781|FG001|Dose Expansion (Part B)|Disease Progression|0|||
150147364|NCT02667886|541675782|FG002|Dose Expansion (Part B)|Disease Progression|0|||
150147365|NCT02667886|541675783|FG003|Dose Expansion (Part B)|Disease Progression|38|||
150147366|NCT02667886|541675784|FG004|Dose Expansion (Part B)|Disease Progression|0|||
150147367|NCT02667886|541675780|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
150147368|NCT02667886|541675781|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
150147369|NCT02667886|541675782|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
150147370|NCT02667886|541675783|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
150147371|NCT02667886|541675784|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
150147372|NCT02667886|541675780|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
150147373|NCT02667886|541675781|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
150147374|NCT02667886|541675782|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
150147375|NCT02667886|541675783|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
150147376|NCT02667886|541675784|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
150147377|NCT02667886|541675780|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
150147378|NCT02667886|541675781|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
150147379|NCT02667886|541675782|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
150147380|NCT02667886|541675783|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
150147381|NCT02667886|541675784|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
150147382|NCT02778399|541675785|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
150147383|NCT02778399|541675786|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
150147384|NCT02778399|541675787|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
150147385|NCT02778399|541675788|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
150147386|NCT02778399|541675789|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
150147387|NCT02778399|541675790|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
150147388|NCT02778399|541675785|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
150147389|NCT02778399|541675786|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
150147390|NCT02778399|541675787|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
150147391|NCT02778399|541675788|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
150147392|NCT02778399|541675789|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
150147393|NCT02778399|541675790|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
150147394|NCT02778399|541675785|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
150147395|NCT02778399|541675786|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
150147396|NCT02778399|541675787|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
150147397|NCT02778399|541675788|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
150147398|NCT02778399|541675789|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
150147399|NCT02778399|541675790|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
150147400|NCT02778399|541675785|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
150147401|NCT02778399|541675786|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
150147402|NCT02778399|541675787|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
150147403|NCT02778399|541675788|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
150147404|NCT02778399|541675789|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
150147405|NCT02778399|541675790|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
150147406|NCT02778399|541675785|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
150147407|NCT02778399|541675786|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
150147408|NCT02778399|541675787|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
150147409|NCT02778399|541675788|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
150147410|NCT02778399|541675789|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
150147411|NCT02778399|541675790|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
150147412|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
150147413|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
150147414|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
150147415|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
150147416|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
150147417|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
150147418|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
150147419|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
150147420|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
150147421|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
150147422|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
150147423|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
150147424|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
150147425|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
150147426|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
150147427|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
150147428|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
150147429|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
150147430|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
150147431|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
150147432|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
150147433|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
150147434|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
150147435|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
150147436|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
150147437|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
150147438|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
150147439|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
150147440|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
150147441|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
150147442|NCT02778399|541675785|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
150147443|NCT02778399|541675786|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
150147444|NCT02778399|541675787|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
150147445|NCT02778399|541675788|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
150147446|NCT02778399|541675789|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
150147447|NCT02778399|541675790|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
150147448|NCT00736489|541675806|FG000|Period 1|Lost to Follow-up|1|||
150147449|NCT00736489|541675807|FG001|Period 1|Lost to Follow-up|0|||
150147450|NCT00736489|541675808|FG002|Period 1|Lost to Follow-up|0|||
150147451|NCT00736489|541675809|FG003|Period 1|Lost to Follow-up|0|||
150147452|NCT00736489|541675810|FG004|Period 1|Lost to Follow-up|0|||
150147453|NCT00736489|541675811|FG005|Period 1|Lost to Follow-up|0|||
150147454|NCT00736489|541675806|FG000|Period 1|Withdrawal by Subject|0|||
150147455|NCT00736489|541675807|FG001|Period 1|Withdrawal by Subject|0|||
150147456|NCT00736489|541675808|FG002|Period 1|Withdrawal by Subject|0|||
150147457|NCT00736489|541675809|FG003|Period 1|Withdrawal by Subject|0|||
150147458|NCT00736489|541675810|FG004|Period 1|Withdrawal by Subject|0|||
150147459|NCT00736489|541675811|FG005|Period 1|Withdrawal by Subject|1|||
150147460|NCT02234063|541675822|FG000|Overall Study|Lost to Follow-up|235|||
150147461|NCT02234063|541675823|FG001|Overall Study|Lost to Follow-up|42|||
150147462|NCT02234063|541675822|FG000|Overall Study|Withdrawal by Subject|20|||
150147463|NCT02234063|541675823|FG001|Overall Study|Withdrawal by Subject|1|||
150147464|NCT02716038|541675824|FG000|Overall Study|Not evaluable|1|||
150147465|NCT02716038|541675824|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
150147466|NCT02716038|541675824|FG000|Overall Study|Unresectable|3|||
150147467|NCT02669095|541675828|FG000|Overall Study|Adverse Event|1|||
150147468|NCT02669095|541675829|FG001|Overall Study|Adverse Event|0|||
150147469|NCT02669095|541675828|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
150147470|NCT02669095|541675829|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
150147471|NCT02669095|541675828|FG000|Overall Study|Torn Lens|0|||
150147472|NCT02669095|541675829|FG001|Overall Study|Torn Lens|1|||
150147473|NCT02669095|541675828|FG000|Overall Study|Visit 5 assessments not completed|0|||
150147474|NCT02669095|541675829|FG001|Overall Study|Visit 5 assessments not completed|1|||
150147475|NCT00886639|541675833|FG000|Overall Study|acute exacerbation|14|||
150147476|NCT00886639|541675833|FG000|Overall Study|non-compliance|2|||
150147477|NCT01871558|541675834|FG000|Overall Study|Other reason|0|||
150147478|NCT01871558|541675835|FG001|Overall Study|Other reason|1|||
150147479|NCT01871558|541675834|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
150147480|NCT01871558|541675835|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
150147481|NCT01871558|541675834|FG000|Overall Study|Withdrawal by Subject|2|||
150147482|NCT01871558|541675835|FG001|Overall Study|Withdrawal by Subject|0|||
150147483|NCT01709305|541675838|FG000|Phase 1|Clinical Adverse Event|80|||
150147484|NCT01709305|541675839|FG001|Phase 1|Clinical Adverse Event|0|||
150147485|NCT01709305|541675840|FG002|Phase 1|Clinical Adverse Event|0|||
150147486|NCT01709305|541675841|FG003|Phase 1|Clinical Adverse Event|0|||
150147487|NCT01709305|541675842|FG004|Phase 1|Clinical Adverse Event|0|||
150147488|NCT01709305|541675838|FG000|Phase 1|Death|2|||
150147489|NCT01709305|541675839|FG001|Phase 1|Death|0|||
150147490|NCT01709305|541675840|FG002|Phase 1|Death|0|||
150147491|NCT01709305|541675841|FG003|Phase 1|Death|0|||
150147492|NCT01709305|541675842|FG004|Phase 1|Death|0|||
150147493|NCT01709305|541675838|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
150147494|NCT01709305|541675839|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
150147495|NCT01709305|541675840|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
150147496|NCT01709305|541675841|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
150147497|NCT01709305|541675842|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
150147498|NCT01709305|541675838|FG000|Phase 1|Laboratory Adverse Event|16|||
150147499|NCT01709305|541675839|FG001|Phase 1|Laboratory Adverse Event|0|||
150147500|NCT01709305|541675840|FG002|Phase 1|Laboratory Adverse Event|0|||
150147501|NCT01709305|541675841|FG003|Phase 1|Laboratory Adverse Event|0|||
150147502|NCT01709305|541675842|FG004|Phase 1|Laboratory Adverse Event|0|||
150147503|NCT01709305|541675838|FG000|Phase 1|Lost to Follow-up|147|||
150147504|NCT01709305|541675839|FG001|Phase 1|Lost to Follow-up|0|||
150147505|NCT01709305|541675840|FG002|Phase 1|Lost to Follow-up|0|||
150147506|NCT01709305|541675841|FG003|Phase 1|Lost to Follow-up|0|||
150147507|NCT01709305|541675842|FG004|Phase 1|Lost to Follow-up|0|||
150147508|NCT01709305|541675838|FG000|Phase 1|Travel, moving, etc.|30|||
150147509|NCT01709305|541675839|FG001|Phase 1|Travel, moving, etc.|0|||
150147510|NCT01709305|541675840|FG002|Phase 1|Travel, moving, etc.|0|||
150147511|NCT01709305|541675841|FG003|Phase 1|Travel, moving, etc.|0|||
150147512|NCT01709305|541675842|FG004|Phase 1|Travel, moving, etc.|0|||
150147513|NCT01709305|541675838|FG000|Phase 1|Physician Decision|13|||
149804618|NCT00299546|540413834|FG000|Overall Study|Not treated|0|||
149804619|NCT00299546|540413835|FG001|Overall Study|Not treated|1|||
149804620|NCT00299546|540413836|FG002|Overall Study|Not treated|1|||
150147514|NCT01709305|541675839|FG001|Phase 1|Physician Decision|0|||
150147515|NCT01709305|541675840|FG002|Phase 1|Physician Decision|0|||
150147516|NCT01709305|541675841|FG003|Phase 1|Physician Decision|0|||
150147517|NCT01709305|541675842|FG004|Phase 1|Physician Decision|0|||
150147518|NCT01709305|541675838|FG000|Phase 1|Protocol Violation|118|||
150147519|NCT01709305|541675839|FG001|Phase 1|Protocol Violation|0|||
150147520|NCT01709305|541675840|FG002|Phase 1|Protocol Violation|0|||
150147521|NCT01709305|541675841|FG003|Phase 1|Protocol Violation|0|||
150147522|NCT01709305|541675842|FG004|Phase 1|Protocol Violation|0|||
150147523|NCT01709305|541675838|FG000|Phase 1|Withdrawal by Subject|218|||
150147524|NCT01709305|541675839|FG001|Phase 1|Withdrawal by Subject|0|||
150147525|NCT01709305|541675840|FG002|Phase 1|Withdrawal by Subject|0|||
150147526|NCT01709305|541675841|FG003|Phase 1|Withdrawal by Subject|0|||
150147527|NCT01709305|541675842|FG004|Phase 1|Withdrawal by Subject|0|||
149918885|NCT01210352|540835245|FG004|Overall Study|Adverse Event|0|||
150147528|NCT01709305|541675838|FG000|Phase 2|Clinical Adverse Event|0|||
150147529|NCT01709305|541675839|FG001|Phase 2|Clinical Adverse Event|10|||
150147530|NCT01709305|541675840|FG002|Phase 2|Clinical Adverse Event|10|||
150147531|NCT01709305|541675841|FG003|Phase 2|Clinical Adverse Event|6|||
150147532|NCT01709305|541675842|FG004|Phase 2|Clinical Adverse Event|11|||
150147533|NCT01709305|541675838|FG000|Phase 2|Death|0|||
150147534|NCT01709305|541675839|FG001|Phase 2|Death|0|||
150147535|NCT01709305|541675840|FG002|Phase 2|Death|1|||
150147536|NCT01709305|541675841|FG003|Phase 2|Death|0|||
150147537|NCT01709305|541675842|FG004|Phase 2|Death|0|||
150147538|NCT01709305|541675838|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
150147539|NCT01709305|541675839|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
150147540|NCT01709305|541675840|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
150147541|NCT01709305|541675841|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
150147542|NCT01709305|541675842|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
150147543|NCT01709305|541675838|FG000|Phase 2|Laboratory Adverse Event|0|||
150147544|NCT01709305|541675839|FG001|Phase 2|Laboratory Adverse Event|1|||
150147545|NCT01709305|541675840|FG002|Phase 2|Laboratory Adverse Event|0|||
150147546|NCT01709305|541675841|FG003|Phase 2|Laboratory Adverse Event|1|||
150147547|NCT01709305|541675842|FG004|Phase 2|Laboratory Adverse Event|1|||
150147548|NCT01709305|541675838|FG000|Phase 2|Lost to Follow-up|0|||
150147549|NCT01709305|541675839|FG001|Phase 2|Lost to Follow-up|10|||
150147550|NCT01709305|541675840|FG002|Phase 2|Lost to Follow-up|6|||
150147551|NCT01709305|541675841|FG003|Phase 2|Lost to Follow-up|9|||
150147552|NCT01709305|541675842|FG004|Phase 2|Lost to Follow-up|5|||
150147553|NCT01709305|541675838|FG000|Phase 2|Travel, moving, etc.|0|||
150147554|NCT01709305|541675839|FG001|Phase 2|Travel, moving, etc.|2|||
150147555|NCT01709305|541675840|FG002|Phase 2|Travel, moving, etc.|3|||
150147556|NCT01709305|541675841|FG003|Phase 2|Travel, moving, etc.|3|||
150147557|NCT01709305|541675842|FG004|Phase 2|Travel, moving, etc.|5|||
150147558|NCT01709305|541675838|FG000|Phase 2|Physician Decision|0|||
150147559|NCT01709305|541675839|FG001|Phase 2|Physician Decision|2|||
150147560|NCT01709305|541675840|FG002|Phase 2|Physician Decision|0|||
150147561|NCT01709305|541675841|FG003|Phase 2|Physician Decision|1|||
150147562|NCT01709305|541675842|FG004|Phase 2|Physician Decision|2|||
150147563|NCT01709305|541675838|FG000|Phase 2|Protocol Violation|0|||
150147564|NCT01709305|541675839|FG001|Phase 2|Protocol Violation|19|||
150147565|NCT01709305|541675840|FG002|Phase 2|Protocol Violation|19|||
150147566|NCT01709305|541675841|FG003|Phase 2|Protocol Violation|13|||
150147567|NCT01709305|541675842|FG004|Phase 2|Protocol Violation|9|||
150147568|NCT01709305|541675838|FG000|Phase 2|Withdrawal by Subject|0|||
150147569|NCT01709305|541675839|FG001|Phase 2|Withdrawal by Subject|8|||
150147570|NCT01709305|541675840|FG002|Phase 2|Withdrawal by Subject|6|||
150147571|NCT01709305|541675841|FG003|Phase 2|Withdrawal by Subject|15|||
150147572|NCT01709305|541675842|FG004|Phase 2|Withdrawal by Subject|12|||
150147573|NCT03518658|541677655|FG000|Overall Study|Other|51|||
150147574|NCT03518658|541677656|FG001|Overall Study|Other|0|||
150147575|NCT00649389|541677657|FG000|Overall Study|Adverse Event|22|||
150147576|NCT00649389|541677658|FG001|Overall Study|Adverse Event|46|||
150147577|NCT00649389|541677659|FG002|Overall Study|Adverse Event|38|||
150147578|NCT00649389|541677660|FG003|Overall Study|Adverse Event|48|||
150147579|NCT00649389|541677657|FG000|Overall Study|Lost to Follow-up|15|||
150147580|NCT00649389|541677658|FG001|Overall Study|Lost to Follow-up|17|||
150147581|NCT00649389|541677659|FG002|Overall Study|Lost to Follow-up|21|||
150147582|NCT00649389|541677660|FG003|Overall Study|Lost to Follow-up|26|||
150147583|NCT00649389|541677657|FG000|Overall Study|Protocol Violation|11|||
150147584|NCT00649389|541677658|FG001|Overall Study|Protocol Violation|13|||
150147585|NCT00649389|541677659|FG002|Overall Study|Protocol Violation|9|||
150147586|NCT00649389|541677660|FG003|Overall Study|Protocol Violation|8|||
150147587|NCT00649389|541677657|FG000|Overall Study|Withdrawal by Subject|20|||
150147588|NCT00649389|541677658|FG001|Overall Study|Withdrawal by Subject|21|||
150147589|NCT00649389|541677659|FG002|Overall Study|Withdrawal by Subject|19|||
150147590|NCT00649389|541677660|FG003|Overall Study|Withdrawal by Subject|23|||
150147591|NCT00649389|541677657|FG000|Overall Study|Other|3|||
150147592|NCT00649389|541677658|FG001|Overall Study|Other|9|||
150147593|NCT00649389|541677659|FG002|Overall Study|Other|1|||
150147594|NCT00649389|541677660|FG003|Overall Study|Other|6|||
150147595|NCT00453310|541677663|FG000|Overall Study|Progression of Disease|10|||
150147596|NCT01806740|541677664|FG000|Overall Study|Withdrawal by Subject|4|||
150147597|NCT01806740|541677664|FG000|Overall Study|Physician Decision|1|||
150147598|NCT01806740|541677664|FG000|Overall Study|Patient's refusal of treatment|1|||
150147599|NCT04666922|541677665|FG000|Overall Study|Withdrawal by Subject|1|||
150147600|NCT04666922|541677666|FG001|Overall Study|Withdrawal by Subject|0|||
150147601|NCT04666922|541677667|FG002|Overall Study|Withdrawal by Subject|0|||
150147602|NCT04666922|541677668|FG003|Overall Study|Withdrawal by Subject|0|||
150147603|NCT04666922|541677669|FG004|Overall Study|Withdrawal by Subject|0|||
150147604|NCT04666922|541677670|FG005|Overall Study|Withdrawal by Subject|0|||
150147605|NCT04666922|541677671|FG006|Overall Study|Withdrawal by Subject|0|||
150147606|NCT01382940|541677674|FG000|Overall Study|Adverse Event|19|||
150147607|NCT01382940|541677674|FG000|Overall Study|Lost to Follow-up|4|||
149804621|NCT03099265|540413837|FG000|Overall Study|Adverse Event|1|||
150147608|NCT01382940|541677674|FG000|Overall Study|Physician Decision|7|||
150147609|NCT01382940|541677674|FG000|Overall Study|Withdrawal by Subject|23|||
150147610|NCT01382940|541677674|FG000|Overall Study|Protocol Violation|20|||
150147611|NCT00244374|541677677|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
150147612|NCT00244374|541677678|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
150147613|NCT00244374|541677679|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
150147614|NCT00244374|541677680|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
150147615|NCT00244374|541677681|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
150147616|NCT00244374|541677677|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
150147617|NCT00244374|541677678|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
150147618|NCT00244374|541677679|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
150147619|NCT00244374|541677680|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
150147620|NCT00244374|541677681|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
150147621|NCT00244374|541677677|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
150147622|NCT00244374|541677678|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
150147623|NCT00244374|541677679|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
150147624|NCT00244374|541677680|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
150147625|NCT00244374|541677681|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
150147626|NCT00244374|541677677|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
150147627|NCT00244374|541677678|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
150147628|NCT00244374|541677679|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
150147629|NCT00244374|541677680|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
150147630|NCT00244374|541677681|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
150147631|NCT00244374|541677677|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
150147632|NCT00244374|541677678|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
150147633|NCT00244374|541677679|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
150147634|NCT00244374|541677680|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
150147635|NCT00244374|541677681|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
150147636|NCT00244374|541677677|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
150147637|NCT00244374|541677678|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
150147638|NCT00244374|541677679|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
150147639|NCT00244374|541677680|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
150147640|NCT00244374|541677681|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
150147641|NCT00244374|541677677|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
150147642|NCT00244374|541677678|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
150147643|NCT00244374|541677679|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
150147644|NCT00244374|541677680|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
150147645|NCT00244374|541677681|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
150147646|NCT00244374|541677677|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
150147647|NCT00244374|541677678|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
150147648|NCT00244374|541677679|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
150147649|NCT00244374|541677680|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
150147650|NCT00244374|541677681|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
150147651|NCT00244374|541677677|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
150147652|NCT00244374|541677678|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
150147653|NCT00244374|541677679|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
150147654|NCT00244374|541677680|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
150147655|NCT00244374|541677681|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
150147656|NCT02105636|541677685|FG000|Pre-Treatment|Disease Progression|1|||
150147657|NCT02105636|541677686|FG001|Pre-Treatment|Disease Progression|0|||
150147658|NCT02105636|541677685|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
150147659|NCT02105636|541677686|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
150147660|NCT02105636|541677685|FG000|Pre-Treatment|Participant withdrew consent|0|||
150147661|NCT02105636|541677686|FG001|Pre-Treatment|Participant withdrew consent|6|||
150147662|NCT02105636|541677685|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
150147663|NCT02105636|541677686|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
149804622|NCT00968539|540413841|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
150147664|NCT02105636|541677685|FG000|Treatment|Study Drug Toxicity|14|||
150147665|NCT02105636|541677686|FG001|Treatment|Study Drug Toxicity|10|||
150147666|NCT02105636|541677685|FG000|Treatment|Adverse event unrelated to study drug|19|||
150147667|NCT02105636|541677686|FG001|Treatment|Adverse event unrelated to study drug|3|||
150147668|NCT02105636|541677685|FG000|Treatment|Participant request to discontinue study treatment|8|||
150147669|NCT02105636|541677686|FG001|Treatment|Participant request to discontinue study treatment|6|||
150147670|NCT02105636|541677685|FG000|Treatment|Participant withdrew consent|5|||
150147671|NCT02105636|541677686|FG001|Treatment|Participant withdrew consent|1|||
150147672|NCT02105636|541677685|FG000|Treatment|Lost to Follow-up|1|||
150147673|NCT02105636|541677686|FG001|Treatment|Lost to Follow-up|0|||
150147674|NCT02105636|541677685|FG000|Treatment|Maximum Clinical Benefit|1|||
150147675|NCT02105636|541677686|FG001|Treatment|Maximum Clinical Benefit|3|||
150147676|NCT02105636|541677685|FG000|Treatment|Poor/Non-compliance|0|||
150147677|NCT02105636|541677686|FG001|Treatment|Poor/Non-compliance|1|||
150147678|NCT02105636|541677685|FG000|Treatment|Participant no longer meets study criteria|1|||
150147679|NCT02105636|541677686|FG001|Treatment|Participant no longer meets study criteria|0|||
150147680|NCT02105636|541677685|FG000|Treatment|Other reasons|1|||
150147681|NCT02105636|541677686|FG001|Treatment|Other reasons|0|||
150147682|NCT02105636|541677685|FG000|Treatment|Disease Progression|185|||
150147683|NCT02105636|541677686|FG001|Treatment|Disease Progression|87|||
150147684|NCT03661996|541677693|FG000|Overall Study|Adverse Event|0|||
150147685|NCT03661996|541677694|FG001|Overall Study|Adverse Event|0|||
150147686|NCT03661996|541677695|FG002|Overall Study|Adverse Event|1|||
150147687|NCT03661996|541677696|FG003|Overall Study|Adverse Event|1|||
150147688|NCT03661996|541677697|FG004|Overall Study|Adverse Event|0|||
150147689|NCT03661996|541677693|FG000|Overall Study|Lost to Follow-up|5|||
150147690|NCT03661996|541677694|FG001|Overall Study|Lost to Follow-up|1|||
150147691|NCT03661996|541677695|FG002|Overall Study|Lost to Follow-up|2|||
150147692|NCT03661996|541677696|FG003|Overall Study|Lost to Follow-up|2|||
150147693|NCT03661996|541677697|FG004|Overall Study|Lost to Follow-up|6|||
150147694|NCT03661996|541677693|FG000|Overall Study|Physician Decision|1|||
150147695|NCT03661996|541677694|FG001|Overall Study|Physician Decision|1|||
150147696|NCT03661996|541677695|FG002|Overall Study|Physician Decision|1|||
150147697|NCT03661996|541677696|FG003|Overall Study|Physician Decision|2|||
150147698|NCT03661996|541677697|FG004|Overall Study|Physician Decision|0|||
150147699|NCT03661996|541677693|FG000|Overall Study|Protocol Violation|0|||
150147700|NCT03661996|541677694|FG001|Overall Study|Protocol Violation|0|||
150147701|NCT03661996|541677695|FG002|Overall Study|Protocol Violation|0|||
150147702|NCT03661996|541677696|FG003|Overall Study|Protocol Violation|0|||
150147703|NCT03661996|541677697|FG004|Overall Study|Protocol Violation|1|||
150147704|NCT03661996|541677693|FG000|Overall Study|Withdrawal by Subject|3|||
150147705|NCT03661996|541677694|FG001|Overall Study|Withdrawal by Subject|5|||
150147706|NCT03661996|541677695|FG002|Overall Study|Withdrawal by Subject|1|||
150147707|NCT03661996|541677696|FG003|Overall Study|Withdrawal by Subject|7|||
150147708|NCT03661996|541677697|FG004|Overall Study|Withdrawal by Subject|7|||
150147709|NCT03661996|541677693|FG000|Overall Study|Sponsors Decision|2|||
150147710|NCT03661996|541677694|FG001|Overall Study|Sponsors Decision|0|||
150147711|NCT03661996|541677695|FG002|Overall Study|Sponsors Decision|0|||
150147712|NCT03661996|541677696|FG003|Overall Study|Sponsors Decision|0|||
150147713|NCT03661996|541677697|FG004|Overall Study|Sponsors Decision|0|||
150147714|NCT03661996|541677693|FG000|Overall Study|Other|1|||
150147715|NCT03661996|541677694|FG001|Overall Study|Other|1|||
150147716|NCT03661996|541677695|FG002|Overall Study|Other|1|||
150147717|NCT03661996|541677696|FG003|Overall Study|Other|1|||
150147718|NCT03661996|541677697|FG004|Overall Study|Other|0|||
150147719|NCT03321513|541677698|FG000|Overall Study|Death|11|||
150147720|NCT03321513|541677699|FG001|Overall Study|Death|5|||
150147721|NCT03321513|541677698|FG000|Overall Study|Withdrawal by Subject|5|||
150147722|NCT03321513|541677699|FG001|Overall Study|Withdrawal by Subject|10|||
150147723|NCT03321513|541677698|FG000|Overall Study|Lost to Follow-up|10|||
150147724|NCT03321513|541677699|FG001|Overall Study|Lost to Follow-up|11|||
150147725|NCT02960763|541677700|FG000|Step 1|Withdrawal by Subject|10|||
150147726|NCT02960763|541677701|FG001|Step 1|Withdrawal by Subject|8|||
150147727|NCT02960763|541677702|FG002|Step 1|Withdrawal by Subject|13|||
150147728|NCT02960763|541677703|FG003|Step 1|Withdrawal by Subject|0|||
150147729|NCT02960763|541677704|FG004|Step 1|Withdrawal by Subject|0|||
150147730|NCT02960763|541677700|FG000|Step 1|Lost to Follow-up|7|||
150147731|NCT02960763|541677701|FG001|Step 1|Lost to Follow-up|9|||
150147732|NCT02960763|541677702|FG002|Step 1|Lost to Follow-up|12|||
150147733|NCT02960763|541677703|FG003|Step 1|Lost to Follow-up|0|||
150147734|NCT02960763|541677704|FG004|Step 1|Lost to Follow-up|0|||
150147735|NCT02960763|541677700|FG000|Step 1|Death|1|||
150147736|NCT02960763|541677701|FG001|Step 1|Death|1|||
150147737|NCT02960763|541677702|FG002|Step 1|Death|1|||
150147738|NCT02960763|541677703|FG003|Step 1|Death|0|||
150147739|NCT02960763|541677704|FG004|Step 1|Death|0|||
150147740|NCT02960763|541677700|FG000|Step 1|Investigator discretion|1|||
150147741|NCT02960763|541677701|FG001|Step 1|Investigator discretion|0|||
150147742|NCT02960763|541677702|FG002|Step 1|Investigator discretion|1|||
150147743|NCT02960763|541677703|FG003|Step 1|Investigator discretion|0|||
150147744|NCT02960763|541677704|FG004|Step 1|Investigator discretion|0|||
150147745|NCT02960763|541677700|FG000|Step 1|Other|0|||
150147746|NCT02960763|541677701|FG001|Step 1|Other|0|||
150147747|NCT02960763|541677702|FG002|Step 1|Other|1|||
150147748|NCT02960763|541677703|FG003|Step 1|Other|0|||
150147749|NCT02960763|541677704|FG004|Step 1|Other|0|||
150147750|NCT02960763|541677700|FG000|Step 2|Withdrawal by Subject|0|||
150147751|NCT02960763|541677701|FG001|Step 2|Withdrawal by Subject|0|||
150147752|NCT02960763|541677702|FG002|Step 2|Withdrawal by Subject|0|||
150147753|NCT02960763|541677703|FG003|Step 2|Withdrawal by Subject|7|||
150147754|NCT02960763|541677704|FG004|Step 2|Withdrawal by Subject|3|||
150147755|NCT02960763|541677700|FG000|Step 2|Lost to Follow-up|0|||
150147756|NCT02960763|541677701|FG001|Step 2|Lost to Follow-up|0|||
150147757|NCT02960763|541677702|FG002|Step 2|Lost to Follow-up|0|||
150147758|NCT02960763|541677703|FG003|Step 2|Lost to Follow-up|4|||
150147759|NCT02960763|541677704|FG004|Step 2|Lost to Follow-up|1|||
150147760|NCT02960763|541677700|FG000|Step 2|Investigator discretion|0|||
150147761|NCT02960763|541677701|FG001|Step 2|Investigator discretion|0|||
150147762|NCT02960763|541677702|FG002|Step 2|Investigator discretion|0|||
150147763|NCT02960763|541677703|FG003|Step 2|Investigator discretion|0|||
150147764|NCT02960763|541677704|FG004|Step 2|Investigator discretion|1|||
150147765|NCT01863043|541677706|FG000|Overall Study|Death|6|||
150147766|NCT01863043|541677707|FG001|Overall Study|Death|1|||
150147767|NCT01863043|541677706|FG000|Overall Study|Withdrawal by Subject|0|||
150147768|NCT01863043|541677707|FG001|Overall Study|Withdrawal by Subject|2|||
150147769|NCT01863043|541677706|FG000|Overall Study|Adverse Event|7|||
150147770|NCT01863043|541677707|FG001|Overall Study|Adverse Event|8|||
150147771|NCT01863043|541677706|FG000|Overall Study|exclusion criteria found after enrollment|0|||
150147772|NCT01863043|541677707|FG001|Overall Study|exclusion criteria found after enrollment|1|||
150147773|NCT03377790|541677708|FG000|Overall Study|Withdrawal by Subject|1|||
150147774|NCT03377790|541677709|FG001|Overall Study|Withdrawal by Subject|0|||
150147775|NCT03377790|541677708|FG000|Overall Study|Adverse Event|1|||
150147776|NCT03377790|541677709|FG001|Overall Study|Adverse Event|0|||
150147777|NCT03377790|541677708|FG000|Overall Study|Lost to Follow-up|0|||
150147778|NCT03377790|541677709|FG001|Overall Study|Lost to Follow-up|2|||
150147779|NCT03377790|541677708|FG000|Overall Study|Randomized but not treated|1|||
150147780|NCT03377790|541677709|FG001|Overall Study|Randomized but not treated|0|||
150147781|NCT03377790|541677708|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
150147782|NCT03377790|541677709|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
150147783|NCT01928225|541677710|FG000|Overall Study|Pregnancy|1|||
150147784|NCT01928225|541677711|FG001|Overall Study|Pregnancy|0|||
150147785|NCT01928225|541677710|FG000|Overall Study|basaloid cervical cancer|1|||
150147786|NCT01928225|541677711|FG001|Overall Study|basaloid cervical cancer|0|||
150147787|NCT01928225|541677710|FG000|Overall Study|Lost to Follow-up|1|||
150147788|NCT01928225|541677711|FG001|Overall Study|Lost to Follow-up|3|||
150147789|NCT02440594|541677715|FG000|Overall Study|Lost to Follow-up|34|||
150147790|NCT02440594|541677716|FG001|Overall Study|Lost to Follow-up|33|||
150147791|NCT02440594|541677717|FG002|Overall Study|Lost to Follow-up|54|||
150147792|NCT02440594|541677718|FG003|Overall Study|Lost to Follow-up|47|||
150147793|NCT02440594|541677719|FG004|Overall Study|Lost to Follow-up|5|||
150147794|NCT02440594|541677720|FG005|Overall Study|Lost to Follow-up|4|||
150147795|NCT02440594|541677721|FG006|Overall Study|Lost to Follow-up|28|||
150147796|NCT02440594|541677722|FG007|Overall Study|Lost to Follow-up|48|||
150147797|NCT02440594|541677715|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
150147798|NCT02440594|541677716|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
150147799|NCT02440594|541677717|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
150147800|NCT02440594|541677718|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
150147801|NCT02440594|541677719|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
150147802|NCT02440594|541677720|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
150147803|NCT02440594|541677721|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
150147804|NCT02440594|541677722|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
150147805|NCT02440594|541677715|FG000|Overall Study|Withdrawal by Subject|81|||
150147806|NCT02440594|541677716|FG001|Overall Study|Withdrawal by Subject|67|||
150147807|NCT02440594|541677717|FG002|Overall Study|Withdrawal by Subject|59|||
150147808|NCT02440594|541677718|FG003|Overall Study|Withdrawal by Subject|38|||
150147809|NCT02440594|541677719|FG004|Overall Study|Withdrawal by Subject|2|||
150147810|NCT02440594|541677720|FG005|Overall Study|Withdrawal by Subject|2|||
150147811|NCT02440594|541677721|FG006|Overall Study|Withdrawal by Subject|7|||
150147812|NCT02440594|541677722|FG007|Overall Study|Withdrawal by Subject|7|||
150147813|NCT02440594|541677715|FG000|Overall Study|Administratively w/drawn|3|||
150147814|NCT02440594|541677716|FG001|Overall Study|Administratively w/drawn|2|||
150147815|NCT02440594|541677717|FG002|Overall Study|Administratively w/drawn|0|||
150147816|NCT02440594|541677718|FG003|Overall Study|Administratively w/drawn|0|||
150147817|NCT02440594|541677719|FG004|Overall Study|Administratively w/drawn|0|||
150147818|NCT02440594|541677720|FG005|Overall Study|Administratively w/drawn|0|||
150147819|NCT02440594|541677721|FG006|Overall Study|Administratively w/drawn|2|||
150147820|NCT02440594|541677722|FG007|Overall Study|Administratively w/drawn|1|||
150147821|NCT00152763|541677723|FG000|Overall Study|Death|4|||
150147822|NCT00152763|541677724|FG001|Overall Study|Death|1|||
150147823|NCT00152763|541677725|FG002|Overall Study|Death|2|||
150147824|NCT00152763|541677726|FG003|Overall Study|Death|1|||
150147825|NCT00152763|541677723|FG000|Overall Study|Lost to Follow-up|6|||
150147826|NCT00152763|541677724|FG001|Overall Study|Lost to Follow-up|4|||
150147827|NCT00152763|541677725|FG002|Overall Study|Lost to Follow-up|2|||
150147828|NCT00152763|541677726|FG003|Overall Study|Lost to Follow-up|13|||
150147829|NCT04741802|541677727|FG000|Overall Study|Death|1|||
150147830|NCT04741802|541677727|FG000|Overall Study|Lost to Follow-up|11|||
150147831|NCT04498247|541677728|FG000|Overall Study|Lost to Follow-up|0|||
150147832|NCT04498247|541677729|FG001|Overall Study|Lost to Follow-up|0|||
150147833|NCT04498247|541677730|FG002|Overall Study|Lost to Follow-up|0|||
150147834|NCT04498247|541677731|FG003|Overall Study|Lost to Follow-up|1|||
150147835|NCT04498247|541677732|FG004|Overall Study|Lost to Follow-up|0|||
150147836|NCT04498247|541677733|FG005|Overall Study|Lost to Follow-up|0|||
150147837|NCT04498247|541677734|FG006|Overall Study|Lost to Follow-up|0|||
150147838|NCT04498247|541677735|FG007|Overall Study|Lost to Follow-up|0|||
150147839|NCT04498247|541677728|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
150147840|NCT04498247|541677729|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147841|NCT04498247|541677730|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147842|NCT04498247|541677731|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147843|NCT04498247|541677732|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147844|NCT04498247|541677733|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147845|NCT04498247|541677734|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147846|NCT04498247|541677735|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
150147847|NCT04498247|541677728|FG000|Overall Study|Withdrawal by Subject|0|||
150147848|NCT04498247|541677729|FG001|Overall Study|Withdrawal by Subject|8|||
150147849|NCT04498247|541677730|FG002|Overall Study|Withdrawal by Subject|0|||
150147850|NCT04498247|541677731|FG003|Overall Study|Withdrawal by Subject|7|||
150147851|NCT04498247|541677732|FG004|Overall Study|Withdrawal by Subject|0|||
150147852|NCT04498247|541677733|FG005|Overall Study|Withdrawal by Subject|0|||
150147853|NCT04498247|541677734|FG006|Overall Study|Withdrawal by Subject|1|||
150147854|NCT04498247|541677735|FG007|Overall Study|Withdrawal by Subject|0|||
150147855|NCT04498247|541677728|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
150147856|NCT04498247|541677729|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
150147857|NCT04498247|541677730|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
150147858|NCT04498247|541677731|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
150147859|NCT04498247|541677732|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
150147860|NCT04498247|541677733|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
150147861|NCT04498247|541677734|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
150147862|NCT04498247|541677735|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
150147863|NCT00669903|541677736|FG000|Overall Study|Adverse Event|0|||
150147864|NCT00669903|541677737|FG001|Overall Study|Adverse Event|1|||
150147865|NCT00669903|541677738|FG002|Overall Study|Adverse Event|3|||
150147866|NCT00669903|541677739|FG003|Overall Study|Adverse Event|1|||
150147867|NCT00669903|541677736|FG000|Overall Study|Withdrawal by Subject|0|||
150147868|NCT00669903|541677737|FG001|Overall Study|Withdrawal by Subject|2|||
150147869|NCT00669903|541677738|FG002|Overall Study|Withdrawal by Subject|2|||
150147870|NCT00669903|541677739|FG003|Overall Study|Withdrawal by Subject|2|||
150147871|NCT00669903|541677736|FG000|Overall Study|Lost to Follow-up|1|||
150147872|NCT00669903|541677737|FG001|Overall Study|Lost to Follow-up|1|||
150147873|NCT00669903|541677738|FG002|Overall Study|Lost to Follow-up|0|||
150147874|NCT00669903|541677739|FG003|Overall Study|Lost to Follow-up|1|||
150147875|NCT00669903|541677736|FG000|Overall Study|Protocol Violation|0|||
150147876|NCT00669903|541677737|FG001|Overall Study|Protocol Violation|1|||
150147877|NCT00669903|541677738|FG002|Overall Study|Protocol Violation|0|||
150147878|NCT00669903|541677739|FG003|Overall Study|Protocol Violation|0|||
150147879|NCT01678820|541677740|FG000|Overall Study|Study Terminated by Sponsor|45|||
150147880|NCT01678820|541677741|FG001|Overall Study|Study Terminated by Sponsor|43|||
150147881|NCT01678820|541677742|FG002|Overall Study|Study Terminated by Sponsor|43|||
150147882|NCT01678820|541677740|FG000|Overall Study|Withdrawal by Subject|2|||
150147883|NCT01678820|541677741|FG001|Overall Study|Withdrawal by Subject|5|||
150147884|NCT01678820|541677742|FG002|Overall Study|Withdrawal by Subject|2|||
150147885|NCT01678820|541677740|FG000|Overall Study|Protocol Specified Criteria|2|||
150147886|NCT01678820|541677741|FG001|Overall Study|Protocol Specified Criteria|3|||
150147887|NCT01678820|541677742|FG002|Overall Study|Protocol Specified Criteria|1|||
150147888|NCT01678820|541677740|FG000|Overall Study|Adverse Event|2|||
150147889|NCT01678820|541677741|FG001|Overall Study|Adverse Event|2|||
150147890|NCT01678820|541677742|FG002|Overall Study|Adverse Event|2|||
150147891|NCT01678820|541677740|FG000|Overall Study|Lost to Follow-up|7|||
150147892|NCT01678820|541677741|FG001|Overall Study|Lost to Follow-up|2|||
150147893|NCT01678820|541677742|FG002|Overall Study|Lost to Follow-up|2|||
150147894|NCT01678820|541677740|FG000|Overall Study|Non-compliance with study drug|0|||
150147895|NCT01678820|541677741|FG001|Overall Study|Non-compliance with study drug|1|||
150147896|NCT01678820|541677742|FG002|Overall Study|Non-compliance with study drug|0|||
150147897|NCT01678820|541677740|FG000|Overall Study|Physician Decision|0|||
150147898|NCT01678820|541677741|FG001|Overall Study|Physician Decision|0|||
150147899|NCT01678820|541677742|FG002|Overall Study|Physician Decision|1|||
150147900|NCT01678820|541677740|FG000|Overall Study|Protocol Violation|4|||
150147901|NCT01678820|541677741|FG001|Overall Study|Protocol Violation|5|||
150147902|NCT01678820|541677742|FG002|Overall Study|Protocol Violation|4|||
150147903|NCT01678820|541677740|FG000|Overall Study|Not treated with double-blind study drug|0|||
150147904|NCT01678820|541677741|FG001|Overall Study|Not treated with double-blind study drug|2|||
150147905|NCT01678820|541677742|FG002|Overall Study|Not treated with double-blind study drug|2|||
150147906|NCT01381874|541677743|FG000|Overall Study|Lost to Follow-up|1|||
150147907|NCT01381874|541677744|FG001|Overall Study|Lost to Follow-up|1|||
150147908|NCT01381874|541677745|FG002|Overall Study|Lost to Follow-up|0|||
150147909|NCT01381874|541677743|FG000|Overall Study|Withdrawal by Subject|9|||
150147910|NCT01381874|541677744|FG001|Overall Study|Withdrawal by Subject|10|||
150147911|NCT01381874|541677745|FG002|Overall Study|Withdrawal by Subject|9|||
150147912|NCT01381874|541677743|FG000|Overall Study|Other|67|||
150147913|NCT01381874|541677744|FG001|Overall Study|Other|52|||
150147914|NCT01381874|541677745|FG002|Overall Study|Other|67|||
150147915|NCT04488003|541677746|FG000|Assessed for Eligibility|Screen Failure|24|||
150147916|NCT04488003|541677747|FG001|Assessed for Eligibility|Screen Failure|0|||
150147917|NCT04488003|541677748|FG002|Assessed for Eligibility|Screen Failure|0|||
150147918|NCT04488003|541677746|FG000|Assessed for Eligibility|Adverse Event|1|||
150147919|NCT04488003|541677747|FG001|Assessed for Eligibility|Adverse Event|0|||
150147920|NCT04488003|541677748|FG002|Assessed for Eligibility|Adverse Event|0|||
150147921|NCT04488003|541677746|FG000|Assessed for Eligibility|Death|1|||
150147922|NCT04488003|541677747|FG001|Assessed for Eligibility|Death|0|||
150147923|NCT04488003|541677748|FG002|Assessed for Eligibility|Death|0|||
150147924|NCT04488003|541677746|FG000|Assessed for Eligibility|Physician Decision|1|||
150147925|NCT04488003|541677747|FG001|Assessed for Eligibility|Physician Decision|0|||
150147926|NCT04488003|541677748|FG002|Assessed for Eligibility|Physician Decision|0|||
150147927|NCT04488003|541677746|FG000|Allocated to Treatment|Progressive Disease|51|||
150147928|NCT04488003|541677747|FG001|Allocated to Treatment|Progressive Disease|0|||
150147929|NCT04488003|541677748|FG002|Allocated to Treatment|Progressive Disease|0|||
150147930|NCT04488003|541677746|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
150147931|NCT04488003|541677747|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
150147932|NCT04488003|541677748|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
150147933|NCT04488003|541677746|FG000|Allocated to Treatment|Adverse Event|6|||
150147934|NCT04488003|541677747|FG001|Allocated to Treatment|Adverse Event|0|||
150147935|NCT04488003|541677748|FG002|Allocated to Treatment|Adverse Event|0|||
150147936|NCT04488003|541677746|FG000|Allocated to Treatment|Other|5|||
150147937|NCT04488003|541677747|FG001|Allocated to Treatment|Other|0|||
150147938|NCT04488003|541677748|FG002|Allocated to Treatment|Other|0|||
150147939|NCT04488003|541677746|FG000|Allocated to Treatment|Physician Decision|4|||
150147940|NCT04488003|541677747|FG001|Allocated to Treatment|Physician Decision|0|||
150147941|NCT04488003|541677748|FG002|Allocated to Treatment|Physician Decision|0|||
150147942|NCT04488003|541677746|FG000|Allocated to Treatment|Death|4|||
150147943|NCT04488003|541677747|FG001|Allocated to Treatment|Death|0|||
150147944|NCT04488003|541677748|FG002|Allocated to Treatment|Death|0|||
150147945|NCT01248962|541677751|FG000|Overall Study|Withdrawal by Subject|1|||
150147946|NCT01248962|541677752|FG001|Overall Study|Withdrawal by Subject|1|||
150147947|NCT01248962|541677751|FG000|Overall Study|Adverse Event|2|||
150147948|NCT01248962|541677752|FG001|Overall Study|Adverse Event|1|||
150147949|NCT01248962|541677751|FG000|Overall Study|Complete Response after 4 Cycles|1|||
150147950|NCT01248962|541677752|FG001|Overall Study|Complete Response after 4 Cycles|0|||
150147951|NCT01248962|541677751|FG000|Overall Study|Complete Response after 3 Cycles|0|||
150147952|NCT01248962|541677752|FG001|Overall Study|Complete Response after 3 Cycles|1|||
150147953|NCT01248962|541677751|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
150147954|NCT01248962|541677752|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
150147955|NCT00245856|541677754|FG000|Period Two|Withdrawal by Subject|0|||
150147956|NCT00245856|541677755|FG001|Period Two|Withdrawal by Subject|1|||
150147957|NCT00557622|541677756|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
150147958|NCT00557622|541677757|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
150147959|NCT00557622|541677756|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
150147960|NCT00557622|541677757|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
150147961|NCT00557622|541677756|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
150147962|NCT00557622|541677757|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
150147963|NCT01539863|541677758|FG000|Overall Study|Lost to Follow-up|5|||
150147964|NCT01539863|541677759|FG001|Overall Study|Lost to Follow-up|4|||
150147965|NCT02693834|541677760|FG000|Baseline Measurement|Withdrawal by Subject|1|||
149804623|NCT00968539|540413842|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150147966|NCT02693834|541677761|FG001|Baseline Measurement|Withdrawal by Subject|0|||
150147967|NCT02693834|541677760|FG000|Baseline Measurement|Adverse Event|1|||
150147968|NCT02693834|541677761|FG001|Baseline Measurement|Adverse Event|0|||
150147969|NCT02693834|541677760|FG000|Week 2 Practice|Adverse Event|0|||
150147970|NCT02693834|541677761|FG001|Week 2 Practice|Adverse Event|1|||
150147971|NCT01468922|541677762|FG000|Overall Study|Screening failure|0|||
150147972|NCT01468922|541677763|FG001|Overall Study|Screening failure|0|||
150147973|NCT01468922|541677764|FG002|Overall Study|Screening failure|0|||
150147974|NCT01468922|541677765|FG003|Overall Study|Screening failure|0|||
150147975|NCT01468922|541677766|FG004|Overall Study|Screening failure|0|||
150147976|NCT01468922|541677767|FG005|Overall Study|Screening failure|0|||
150147977|NCT01468922|541677768|FG006|Overall Study|Screening failure|0|||
150147978|NCT01468922|541677769|FG007|Overall Study|Screening failure|0|||
150147979|NCT01468922|541677770|FG008|Overall Study|Screening failure|1|||
150147980|NCT01468922|541677762|FG000|Overall Study|Per patient choice|1|||
150147981|NCT01468922|541677763|FG001|Overall Study|Per patient choice|0|||
150147982|NCT01468922|541677764|FG002|Overall Study|Per patient choice|0|||
150147983|NCT01468922|541677765|FG003|Overall Study|Per patient choice|0|||
150147984|NCT01468922|541677766|FG004|Overall Study|Per patient choice|0|||
150147985|NCT01468922|541677767|FG005|Overall Study|Per patient choice|0|||
150147986|NCT01468922|541677768|FG006|Overall Study|Per patient choice|0|||
150147987|NCT01468922|541677769|FG007|Overall Study|Per patient choice|0|||
150147988|NCT01468922|541677770|FG008|Overall Study|Per patient choice|0|||
150147989|NCT01468922|541677762|FG000|Overall Study|Switched to alternative treatment|1|||
150147990|NCT01468922|541677763|FG001|Overall Study|Switched to alternative treatment|0|||
150147991|NCT01468922|541677764|FG002|Overall Study|Switched to alternative treatment|0|||
150147992|NCT01468922|541677765|FG003|Overall Study|Switched to alternative treatment|0|||
150147993|NCT01468922|541677766|FG004|Overall Study|Switched to alternative treatment|1|||
150147994|NCT01468922|541677767|FG005|Overall Study|Switched to alternative treatment|0|||
150147995|NCT01468922|541677768|FG006|Overall Study|Switched to alternative treatment|0|||
150147996|NCT01468922|541677769|FG007|Overall Study|Switched to alternative treatment|0|||
150147997|NCT01468922|541677770|FG008|Overall Study|Switched to alternative treatment|0|||
150147998|NCT01468922|541677762|FG000|Overall Study|Enrolled on new protocol|0|||
150147999|NCT01468922|541677763|FG001|Overall Study|Enrolled on new protocol|0|||
150148000|NCT01468922|541677764|FG002|Overall Study|Enrolled on new protocol|0|||
150148001|NCT01468922|541677765|FG003|Overall Study|Enrolled on new protocol|0|||
150148002|NCT01468922|541677766|FG004|Overall Study|Enrolled on new protocol|1|||
150148003|NCT01468922|541677767|FG005|Overall Study|Enrolled on new protocol|0|||
150148004|NCT01468922|541677768|FG006|Overall Study|Enrolled on new protocol|0|||
150148005|NCT01468922|541677769|FG007|Overall Study|Enrolled on new protocol|0|||
150148006|NCT01468922|541677770|FG008|Overall Study|Enrolled on new protocol|0|||
150148007|NCT01468922|541677762|FG000|Overall Study|Adverse Event|0|||
150148008|NCT01468922|541677763|FG001|Overall Study|Adverse Event|0|||
150148009|NCT01468922|541677764|FG002|Overall Study|Adverse Event|0|||
150148010|NCT01468922|541677765|FG003|Overall Study|Adverse Event|0|||
150148011|NCT01468922|541677766|FG004|Overall Study|Adverse Event|0|||
150148012|NCT01468922|541677767|FG005|Overall Study|Adverse Event|0|||
150148013|NCT01468922|541677768|FG006|Overall Study|Adverse Event|0|||
150148014|NCT01468922|541677769|FG007|Overall Study|Adverse Event|1|||
150148015|NCT01468922|541677770|FG008|Overall Study|Adverse Event|0|||
150148016|NCT01468922|541677762|FG000|Overall Study|Infection of blood|0|||
150148017|NCT01468922|541677763|FG001|Overall Study|Infection of blood|0|||
150148018|NCT01468922|541677764|FG002|Overall Study|Infection of blood|0|||
150148019|NCT01468922|541677765|FG003|Overall Study|Infection of blood|0|||
150148020|NCT01468922|541677766|FG004|Overall Study|Infection of blood|0|||
150148021|NCT01468922|541677767|FG005|Overall Study|Infection of blood|0|||
150148022|NCT01468922|541677768|FG006|Overall Study|Infection of blood|0|||
150148023|NCT01468922|541677769|FG007|Overall Study|Infection of blood|1|||
150148024|NCT01468922|541677770|FG008|Overall Study|Infection of blood|0|||
150148025|NCT01468922|541677762|FG000|Overall Study|Patient choice - surgery|0|||
150148026|NCT01468922|541677763|FG001|Overall Study|Patient choice - surgery|0|||
150148027|NCT01468922|541677764|FG002|Overall Study|Patient choice - surgery|0|||
150148028|NCT01468922|541677765|FG003|Overall Study|Patient choice - surgery|0|||
150148029|NCT01468922|541677766|FG004|Overall Study|Patient choice - surgery|0|||
150148030|NCT01468922|541677767|FG005|Overall Study|Patient choice - surgery|0|||
150148031|NCT01468922|541677768|FG006|Overall Study|Patient choice - surgery|0|||
150148032|NCT01468922|541677769|FG007|Overall Study|Patient choice - surgery|1|||
150148033|NCT01468922|541677770|FG008|Overall Study|Patient choice - surgery|0|||
150148034|NCT01468922|541677762|FG000|Overall Study|Refused further treatment|0|||
150148035|NCT01468922|541677763|FG001|Overall Study|Refused further treatment|0|||
150148036|NCT01468922|541677764|FG002|Overall Study|Refused further treatment|0|||
150148037|NCT01468922|541677765|FG003|Overall Study|Refused further treatment|0|||
150148038|NCT01468922|541677766|FG004|Overall Study|Refused further treatment|0|||
150148039|NCT01468922|541677767|FG005|Overall Study|Refused further treatment|0|||
150148040|NCT01468922|541677768|FG006|Overall Study|Refused further treatment|0|||
150148041|NCT01468922|541677769|FG007|Overall Study|Refused further treatment|1|||
150148042|NCT01468922|541677770|FG008|Overall Study|Refused further treatment|0|||
150148043|NCT01923389|541677771|FG000|Overall Study|Protocol Violation|1|||
150148044|NCT01923389|541677772|FG001|Overall Study|Protocol Violation|0|||
150148045|NCT03662997|541677779|FG000|Overall Study|Adverse Event|0|||
150148046|NCT03662997|541677780|FG001|Overall Study|Adverse Event|2|||
150148047|NCT03662997|541677781|FG002|Overall Study|Adverse Event|0|||
150148048|NCT03662997|541677782|FG003|Overall Study|Adverse Event|0|||
150148049|NCT00007475|541677783|FG000|Overall Study|Withdrawal by Subject|1|||
150148050|NCT00007475|541677784|FG001|Overall Study|Withdrawal by Subject|0|||
150148051|NCT00007475|541677785|FG002|Overall Study|Withdrawal by Subject|0|||
150148052|NCT00007475|541677786|FG003|Overall Study|Withdrawal by Subject|0|||
150148053|NCT00007475|541677783|FG000|Overall Study|Adverse Event|3|||
150148054|NCT00007475|541677784|FG001|Overall Study|Adverse Event|0|||
150148055|NCT00007475|541677785|FG002|Overall Study|Adverse Event|0|||
150148056|NCT00007475|541677786|FG003|Overall Study|Adverse Event|0|||
150148057|NCT01719224|541677787|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
150148058|NCT01719224|541677788|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
150148059|NCT00152971|541677790|FG000|Overall Study|Adverse Event|12|||
150148060|NCT00152971|541677791|FG001|Overall Study|Adverse Event|10|||
150148061|NCT00152971|541677792|FG002|Overall Study|Adverse Event|9|||
150148062|NCT00152971|541677790|FG000|Overall Study|Protocol Violation|10|||
150148063|NCT00152971|541677791|FG001|Overall Study|Protocol Violation|11|||
150148064|NCT00152971|541677792|FG002|Overall Study|Protocol Violation|8|||
150148065|NCT00152971|541677790|FG000|Overall Study|Lost to Follow-up|17|||
150148066|NCT00152971|541677791|FG001|Overall Study|Lost to Follow-up|14|||
150148067|NCT00152971|541677792|FG002|Overall Study|Lost to Follow-up|13|||
150148068|NCT00152971|541677790|FG000|Overall Study|Withdrawal by Subject|9|||
150148069|NCT00152971|541677791|FG001|Overall Study|Withdrawal by Subject|8|||
150148070|NCT00152971|541677792|FG002|Overall Study|Withdrawal by Subject|14|||
150148071|NCT00152971|541677790|FG000|Overall Study|Other|3|||
150148072|NCT00152971|541677791|FG001|Overall Study|Other|5|||
150148073|NCT00152971|541677792|FG002|Overall Study|Other|5|||
150148074|NCT00152971|541677790|FG000|Treatment|Adverse Event|49|||
150148075|NCT00152971|541677791|FG001|Treatment|Adverse Event|40|||
150148076|NCT00152971|541677792|FG002|Treatment|Adverse Event|54|||
150148077|NCT00152971|541677790|FG000|Treatment|Protocol Violation|8|||
150148078|NCT00152971|541677791|FG001|Treatment|Protocol Violation|6|||
150148079|NCT00152971|541677792|FG002|Treatment|Protocol Violation|10|||
150148080|NCT00152971|541677790|FG000|Treatment|Lost to Follow-up|1|||
150148081|NCT00152971|541677791|FG001|Treatment|Lost to Follow-up|2|||
150148082|NCT00152971|541677792|FG002|Treatment|Lost to Follow-up|1|||
150148083|NCT00152971|541677790|FG000|Treatment|Withdrawal by Subject|4|||
150148084|NCT00152971|541677791|FG001|Treatment|Withdrawal by Subject|4|||
150148085|NCT00152971|541677792|FG002|Treatment|Withdrawal by Subject|5|||
150148086|NCT00152971|541677790|FG000|Treatment|Other|9|||
150148087|NCT00152971|541677791|FG001|Treatment|Other|11|||
150148088|NCT00152971|541677792|FG002|Treatment|Other|10|||
150148089|NCT00675506|541677793|FG000|Overall Study|Lost to Follow-up|1|||
150148090|NCT00675506|541677794|FG001|Overall Study|Lost to Follow-up|5|||
150148091|NCT00675506|541677793|FG000|Overall Study|Lost interest|3|||
150148092|NCT00675506|541677794|FG001|Overall Study|Lost interest|5|||
149804624|NCT00326118|540413843|FG000|Active Phase|Withdrawal by Subject|4|||
149804625|NCT00326118|540413844|FG001|Active Phase|Withdrawal by Subject|1|||
150148093|NCT00675506|541677793|FG000|Overall Study|Elevated fasting glucose|2|||
150148094|NCT00675506|541677794|FG001|Overall Study|Elevated fasting glucose|1|||
150148095|NCT00675506|541677793|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
150148096|NCT00675506|541677794|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
150148097|NCT00675506|541677793|FG000|Overall Study|Elevated IGF-1|2|||
150148098|NCT00675506|541677794|FG001|Overall Study|Elevated IGF-1|0|||
150148099|NCT00675506|541677793|FG000|Overall Study|Hypersensitivity Reaction|1|||
150148100|NCT00675506|541677794|FG001|Overall Study|Hypersensitivity Reaction|0|||
150148101|NCT00675506|541677793|FG000|Overall Study|Disclosed history of cancer|1|||
150148102|NCT00675506|541677794|FG001|Overall Study|Disclosed history of cancer|0|||
150148103|NCT00675506|541677793|FG000|Overall Study|Declined participation|1|||
150148104|NCT00675506|541677794|FG001|Overall Study|Declined participation|0|||
150148105|NCT00675506|541677793|FG000|Overall Study|Schedule conflict|0|||
150148106|NCT00675506|541677794|FG001|Overall Study|Schedule conflict|1|||
150148107|NCT03151395|541677795|FG000|Overall Study|Adverse Event|2|||
150148108|NCT03151395|541677795|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
150148109|NCT03151395|541677795|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
150148110|NCT03151395|541677795|FG000|Overall Study|Unspecified reason|4|||
150148111|NCT02494206|541677809|FG000|Overall Study|Adverse Event|1|||
150148112|NCT02494206|541677809|FG000|Overall Study|Disease Progression|1|||
150148113|NCT04986982|541677812|FG000|Overall Study|Withdrawal by Subject|3|||
150148114|NCT04986982|541677813|FG001|Overall Study|Withdrawal by Subject|1|||
150148115|NCT04986982|541677812|FG000|Overall Study|Lack of Efficacy|0|||
150148116|NCT04986982|541677813|FG001|Overall Study|Lack of Efficacy|2|||
150148117|NCT04986982|541677812|FG000|Overall Study|Ineligibility|3|||
150148118|NCT04986982|541677813|FG001|Overall Study|Ineligibility|0|||
150148119|NCT04986982|541677812|FG000|Overall Study|Adverse Event|4|||
150148120|NCT04986982|541677813|FG001|Overall Study|Adverse Event|4|||
150148121|NCT04986982|541677812|FG000|Overall Study|Lost to Follow-up|0|||
150148122|NCT04986982|541677813|FG001|Overall Study|Lost to Follow-up|1|||
150148123|NCT04986982|541677812|FG000|Overall Study|Sponsor's discretion|1|||
150148124|NCT04986982|541677813|FG001|Overall Study|Sponsor's discretion|0|||
150148125|NCT05229653|541677814|FG000|Overall Study|Lost to Follow-up|1|||
150148126|NCT05229653|541677815|FG001|Overall Study|Lost to Follow-up|0|||
150148127|NCT01845974|541677816|FG000|Overall Study|screen failure|1|||
150148128|NCT01845974|541677817|FG001|Overall Study|screen failure|0|||
150148129|NCT02759185|541677818|FG000|Stage 1|Adverse Event|0|||
150148130|NCT02759185|541677819|FG001|Stage 1|Adverse Event|1|||
150148131|NCT02759185|541677820|FG002|Stage 1|Adverse Event|3|||
150148132|NCT02759185|541677821|FG003|Stage 1|Adverse Event|0|||
150148133|NCT02759185|541677822|FG004|Stage 1|Adverse Event|0|||
150148134|NCT02759185|541677823|FG005|Stage 1|Adverse Event|0|||
150148135|NCT02759185|541677824|FG006|Stage 1|Adverse Event|0|||
149804626|NCT01741259|540413845|FG000|Overall Study|Protocol Violation|6|||
149804627|NCT01741259|540413846|FG001|Overall Study|Protocol Violation|4|||
149804628|NCT01741259|540413845|FG000|Overall Study|Withdrawal by Subject|0|||
149804629|NCT01741259|540413846|FG001|Overall Study|Withdrawal by Subject|2|||
149804630|NCT02094573|540413853|FG000|Overall Study|Adverse Event|4|||
149804631|NCT02094573|540413854|FG001|Overall Study|Adverse Event|14|||
149804632|NCT02094573|540413853|FG000|Overall Study|Clinical Progressive Disease|9|||
149804633|NCT02094573|540413854|FG001|Overall Study|Clinical Progressive Disease|13|||
149804634|NCT02094573|540413853|FG000|Overall Study|Death|11|||
149804635|NCT02094573|540413854|FG001|Overall Study|Death|3|||
149804636|NCT02094573|540413853|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
149804637|NCT02094573|540413854|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
149804638|NCT02094573|540413853|FG000|Overall Study|Non-compliance with Study Drug|1|||
149804639|NCT02094573|540413854|FG001|Overall Study|Non-compliance with Study Drug|1|||
149804640|NCT02094573|540413853|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
149804641|NCT02094573|540413854|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
149804642|NCT02094573|540413853|FG000|Overall Study|Physician Decision|4|||
149804643|NCT02094573|540413854|FG001|Overall Study|Physician Decision|4|||
149804644|NCT02094573|540413853|FG000|Overall Study|Site Terminated by Sponsor|10|||
149804645|NCT02094573|540413854|FG001|Overall Study|Site Terminated by Sponsor|17|||
149804646|NCT02094573|540413853|FG000|Overall Study|Withdrawal by Subject|6|||
149804647|NCT02094573|540413854|FG001|Overall Study|Withdrawal by Subject|8|||
149804648|NCT02094573|540413853|FG000|Overall Study|Randomized but not Treated|3|||
149804649|NCT02094573|540413854|FG001|Overall Study|Randomized but not Treated|0|||
149804650|NCT00643006|540413855|FG000|Overall Study|Lost to Follow-up|5|||
149804651|NCT00643006|540413856|FG001|Overall Study|Lost to Follow-up|4|||
149804652|NCT03772574|540413857|FG000|Overall Study|Protocol Violation|2|||
149804653|NCT03772574|540413858|FG001|Overall Study|Protocol Violation|0|||
149804654|NCT03772574|540413859|FG002|Overall Study|Protocol Violation|0|||
149804655|NCT03772574|540413857|FG000|Overall Study|Discomfort|0|||
149804656|NCT03772574|540413858|FG001|Overall Study|Discomfort|5|||
149804657|NCT03772574|540413859|FG002|Overall Study|Discomfort|4|||
149804658|NCT03586427|540413862|FG000|Overall Study|Lost to Follow-up|0|||
149804659|NCT03586427|540413863|FG001|Overall Study|Lost to Follow-up|3|||
149804660|NCT03586427|540413864|FG002|Overall Study|Lost to Follow-up|1|||
149804661|NCT03586427|540413865|FG003|Overall Study|Lost to Follow-up|3|||
149804662|NCT03586427|540413866|FG004|Overall Study|Lost to Follow-up|3|||
149804663|NCT03586427|540413862|FG000|Overall Study|Withdrawal by Subject|0|||
149804664|NCT03586427|540413863|FG001|Overall Study|Withdrawal by Subject|1|||
149804665|NCT03586427|540413864|FG002|Overall Study|Withdrawal by Subject|2|||
149804666|NCT03586427|540413865|FG003|Overall Study|Withdrawal by Subject|1|||
149804667|NCT03586427|540413866|FG004|Overall Study|Withdrawal by Subject|1|||
149804668|NCT03586427|540413862|FG000|Overall Study|Adverse Event|0|||
149804669|NCT03586427|540413863|FG001|Overall Study|Adverse Event|0|||
149804670|NCT03586427|540413864|FG002|Overall Study|Adverse Event|1|||
149804671|NCT03586427|540413865|FG003|Overall Study|Adverse Event|0|||
149804672|NCT03586427|540413866|FG004|Overall Study|Adverse Event|0|||
149804673|NCT03586427|540413862|FG000|Overall Study|Protocol Violation|0|||
149804674|NCT03586427|540413863|FG001|Overall Study|Protocol Violation|0|||
149804675|NCT03586427|540413864|FG002|Overall Study|Protocol Violation|1|||
149804676|NCT03586427|540413865|FG003|Overall Study|Protocol Violation|0|||
149804677|NCT03586427|540413866|FG004|Overall Study|Protocol Violation|1|||
149804678|NCT03586427|540413862|FG000|Overall Study|Noncompliance with study drug|0|||
149804679|NCT03586427|540413863|FG001|Overall Study|Noncompliance with study drug|0|||
149804680|NCT03586427|540413864|FG002|Overall Study|Noncompliance with study drug|1|||
149804681|NCT03586427|540413865|FG003|Overall Study|Noncompliance with study drug|0|||
149804682|NCT03586427|540413866|FG004|Overall Study|Noncompliance with study drug|0|||
149804683|NCT03193996|540413869|FG000|Overall Study|Withdrawal by Subject|4|||
150148136|NCT02759185|541677818|FG000|Stage 1|Withdrawal by Subject|1|||
149804684|NCT03193996|540413869|FG000|Overall Study|Lost to Follow-up|4|||
149804685|NCT03193996|540413869|FG000|Overall Study|Physician Decision|2|||
149804686|NCT03193996|540413869|FG000|Overall Study|Pregnancy|1|||
149804687|NCT03193996|540413869|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
149804688|NCT03193996|540413869|FG000|Overall Study|Complicating disease|1|||
149804689|NCT00593385|540413872|FG000|Overall Study|Death|14|||
149804690|NCT00593385|540413872|FG000|Overall Study|Lost to Follow-up|17|||
149918886|NCT01210352|540835246|FG005|Overall Study|Adverse Event|0|||
150148137|NCT02759185|541677819|FG001|Stage 1|Withdrawal by Subject|0|||
150148138|NCT02759185|541677820|FG002|Stage 1|Withdrawal by Subject|0|||
149804691|NCT00593385|540413872|FG000|Overall Study|Withdrawal by Subject|9|||
149804692|NCT01471197|540413873|FG000|Overall Study|Disease Progression|4|||
149804693|NCT01471197|540413874|FG001|Overall Study|Disease Progression|2|||
149804694|NCT01471197|540413873|FG000|Overall Study|Death|1|||
149804695|NCT01471197|540413874|FG001|Overall Study|Death|0|||
149804696|NCT01471197|540413873|FG000|Overall Study|Study Drug Toxicity|1|||
149804697|NCT01471197|540413874|FG001|Overall Study|Study Drug Toxicity|0|||
149804698|NCT00924313|540413877|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
149804699|NCT01283009|540413878|FG000|Overall Study|Death|83|||
149804700|NCT01283009|540413879|FG001|Overall Study|Death|78|||
150148139|NCT02759185|541677821|FG003|Stage 1|Withdrawal by Subject|0|||
150148140|NCT02759185|541677822|FG004|Stage 1|Withdrawal by Subject|0|||
150148141|NCT02759185|541677823|FG005|Stage 1|Withdrawal by Subject|0|||
150148142|NCT02759185|541677824|FG006|Stage 1|Withdrawal by Subject|0|||
150148143|NCT02759185|541677818|FG000|Stage 2|Adverse Event|0|||
150148144|NCT02759185|541677819|FG001|Stage 2|Adverse Event|0|||
150148145|NCT02759185|541677820|FG002|Stage 2|Adverse Event|0|||
150148146|NCT02759185|541677821|FG003|Stage 2|Adverse Event|0|||
150148147|NCT02759185|541677822|FG004|Stage 2|Adverse Event|1|||
150148148|NCT02759185|541677823|FG005|Stage 2|Adverse Event|2|||
150148149|NCT02759185|541677824|FG006|Stage 2|Adverse Event|0|||
150148150|NCT02759185|541677818|FG000|Stage 2|Withdrawal by Subject|0|||
150148151|NCT02759185|541677819|FG001|Stage 2|Withdrawal by Subject|0|||
150148152|NCT02759185|541677820|FG002|Stage 2|Withdrawal by Subject|0|||
150148153|NCT02759185|541677821|FG003|Stage 2|Withdrawal by Subject|0|||
150148154|NCT02759185|541677822|FG004|Stage 2|Withdrawal by Subject|1|||
150148155|NCT02759185|541677823|FG005|Stage 2|Withdrawal by Subject|1|||
150148156|NCT02759185|541677824|FG006|Stage 2|Withdrawal by Subject|1|||
150148157|NCT01807650|541677827|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
150148158|NCT01807650|541677827|FG000|Overall Study|Adverse Event|5|||
150148159|NCT01807650|541677827|FG000|Overall Study|Other|2|||
150148160|NCT01103960|541677830|FG000|Overall Study|Adverse Event|2|||
150148161|NCT01103960|541677831|FG001|Overall Study|Adverse Event|1|||
150148162|NCT01103960|541677830|FG000|Overall Study|Withdrawal by Subject|2|||
150148163|NCT01103960|541677831|FG001|Overall Study|Withdrawal by Subject|1|||
150148164|NCT01103960|541677830|FG000|Overall Study|Other|1|||
150148165|NCT01103960|541677831|FG001|Overall Study|Other|0|||
150148166|NCT02294474|541677832|FG000|Overall Study|Adverse Event|7|||
150148167|NCT02294474|541677833|FG001|Overall Study|Adverse Event|7|||
150148168|NCT02294474|541677832|FG000|Overall Study|Lack of Efficacy|2|||
150148169|NCT02294474|541677833|FG001|Overall Study|Lack of Efficacy|1|||
150148170|NCT02294474|541677832|FG000|Overall Study|Protocol Violation|4|||
150148171|NCT02294474|541677833|FG001|Overall Study|Protocol Violation|2|||
150148172|NCT02294474|541677832|FG000|Overall Study|Other than specified above|12|||
150148173|NCT02294474|541677833|FG001|Overall Study|Other than specified above|12|||
150148174|NCT00118898|541677835|FG000|Overall Study|Death|6|||
150148175|NCT00118898|541677836|FG001|Overall Study|Death|11|||
150148176|NCT00118898|541677837|FG002|Overall Study|Death|6|||
150148177|NCT00118898|541677838|FG003|Overall Study|Death|8|||
150148178|NCT00118898|541677835|FG000|Overall Study|Lost to Follow-up|26|||
150148179|NCT00118898|541677836|FG001|Overall Study|Lost to Follow-up|34|||
150148180|NCT00118898|541677837|FG002|Overall Study|Lost to Follow-up|33|||
150148181|NCT00118898|541677838|FG003|Overall Study|Lost to Follow-up|33|||
150148182|NCT00118898|541677835|FG000|Overall Study|Withdrawal by Subject|10|||
150148183|NCT00118898|541677836|FG001|Overall Study|Withdrawal by Subject|5|||
150148184|NCT00118898|541677837|FG002|Overall Study|Withdrawal by Subject|8|||
150148185|NCT00118898|541677838|FG003|Overall Study|Withdrawal by Subject|8|||
150148186|NCT00118898|541677835|FG000|Overall Study|Site Closure|33|||
150148187|NCT00118898|541677836|FG001|Overall Study|Site Closure|31|||
150148188|NCT00118898|541677837|FG002|Overall Study|Site Closure|28|||
150148189|NCT00118898|541677838|FG003|Overall Study|Site Closure|37|||
150148190|NCT00118898|541677835|FG000|Overall Study|Severe debilitation|1|||
150148191|NCT00118898|541677836|FG001|Overall Study|Severe debilitation|4|||
150148192|NCT00118898|541677837|FG002|Overall Study|Severe debilitation|6|||
150148193|NCT00118898|541677838|FG003|Overall Study|Severe debilitation|4|||
150148194|NCT00118898|541677835|FG000|Overall Study|Not compliant with requirements|11|||
150148195|NCT00118898|541677836|FG001|Overall Study|Not compliant with requirements|13|||
150148196|NCT00118898|541677837|FG002|Overall Study|Not compliant with requirements|11|||
150148197|NCT00118898|541677838|FG003|Overall Study|Not compliant with requirements|11|||
150148198|NCT00118898|541677835|FG000|Overall Study|Not able to get to clinic|34|||
150148199|NCT00118898|541677836|FG001|Overall Study|Not able to get to clinic|43|||
150148200|NCT00118898|541677837|FG002|Overall Study|Not able to get to clinic|31|||
150148201|NCT00118898|541677838|FG003|Overall Study|Not able to get to clinic|40|||
150148202|NCT01338012|541677841|FG000|Overall Study|Death|4|||
150148203|NCT01338012|541677841|FG000|Overall Study|Study terminated|4|||
150148204|NCT02714205|541677842|FG000|Overall Study|Cannot tolerate medication|1|||
150148205|NCT02714205|541677843|FG001|Overall Study|Cannot tolerate medication|0|||
150148206|NCT02714205|541677842|FG000|Overall Study|Adverse Event|2|||
150148207|NCT02714205|541677843|FG001|Overall Study|Adverse Event|0|||
150148208|NCT02714205|541677842|FG000|Overall Study|Too busy|1|||
150148209|NCT02714205|541677843|FG001|Overall Study|Too busy|0|||
150148210|NCT02714205|541677842|FG000|Overall Study|Incomplete outcome data|0|||
150148211|NCT02714205|541677843|FG001|Overall Study|Incomplete outcome data|1|||
150148212|NCT05879198|541677844|FG000|Overall Study|Lost to Follow-up|1|||
150148213|NCT03813147|541677845|FG000|Overall Study|Lack of Efficacy|4|||
150148214|NCT03813147|541677846|FG001|Overall Study|Lack of Efficacy|4|||
150148215|NCT03813147|541677845|FG000|Overall Study|Physician Decision|2|||
150148216|NCT03813147|541677846|FG001|Overall Study|Physician Decision|1|||
150148217|NCT01693692|541677847|FG000|Overall Study|Withdrawal by Subject|12|||
150148218|NCT01693692|541677848|FG001|Overall Study|Withdrawal by Subject|10|||
150148219|NCT01693692|541677849|FG002|Overall Study|Withdrawal by Subject|11|||
150148220|NCT01693692|541677847|FG000|Overall Study|Adverse Event|7|||
150148221|NCT01693692|541677848|FG001|Overall Study|Adverse Event|14|||
150148222|NCT01693692|541677849|FG002|Overall Study|Adverse Event|9|||
150148223|NCT01693692|541677847|FG000|Overall Study|Physician Decision|0|||
150148224|NCT01693692|541677848|FG001|Overall Study|Physician Decision|0|||
150148225|NCT01693692|541677849|FG002|Overall Study|Physician Decision|1|||
150148226|NCT01693692|541677847|FG000|Overall Study|Protocol Violation|5|||
150148227|NCT01693692|541677848|FG001|Overall Study|Protocol Violation|4|||
150148228|NCT01693692|541677849|FG002|Overall Study|Protocol Violation|6|||
150148229|NCT01693692|541677847|FG000|Overall Study|Lost to Follow-up|2|||
150148230|NCT01693692|541677848|FG001|Overall Study|Lost to Follow-up|2|||
150148231|NCT01693692|541677849|FG002|Overall Study|Lost to Follow-up|3|||
150148232|NCT01693692|541677847|FG000|Overall Study|Other|4|||
150148233|NCT01693692|541677848|FG001|Overall Study|Other|4|||
150148234|NCT01693692|541677849|FG002|Overall Study|Other|6|||
150148235|NCT02906683|541679886|FG000|Overall Study|Adverse Event|0|||
150148236|NCT02906683|541679887|FG001|Overall Study|Adverse Event|1|||
150148237|NCT02906683|541679888|FG002|Overall Study|Adverse Event|0|||
150148238|NCT02906683|541679886|FG000|Overall Study|Physician Decision|0|||
150148239|NCT02906683|541679887|FG001|Overall Study|Physician Decision|1|||
150148240|NCT02906683|541679888|FG002|Overall Study|Physician Decision|1|||
150148241|NCT02906683|541679886|FG000|Overall Study|Withdrawal by Subject|0|||
150148242|NCT02906683|541679887|FG001|Overall Study|Withdrawal by Subject|2|||
150148243|NCT02906683|541679888|FG002|Overall Study|Withdrawal by Subject|1|||
150148244|NCT02906683|541679886|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
150148245|NCT02906683|541679887|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
150148246|NCT02906683|541679888|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
150148247|NCT02906683|541679886|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
150148248|NCT02906683|541679887|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
150148249|NCT02906683|541679888|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
150148250|NCT01167179|541679891|FG000|Overall Study|disease recurrence|4|||
150148251|NCT01167179|541679892|FG001|Overall Study|disease recurrence|4|||
150148252|NCT01167179|541679891|FG000|Overall Study|Death|4|||
150148253|NCT01167179|541679892|FG001|Overall Study|Death|10|||
150148254|NCT01167179|541679891|FG000|Overall Study|Withdrawal by Subject|1|||
150148255|NCT01167179|541679892|FG001|Overall Study|Withdrawal by Subject|2|||
150148256|NCT01167179|541679891|FG000|Overall Study|diverse|6|||
150148257|NCT01167179|541679892|FG001|Overall Study|diverse|5|||
150148258|NCT00663117|541679893|FG000|Overall Study|Lack of Efficacy|1|||
150148259|NCT00663117|541679894|FG001|Overall Study|Lack of Efficacy|0|||
150148260|NCT01158378|541679895|FG000|Overall Study|Death|4|||
150148261|NCT01158378|541679896|FG001|Overall Study|Death|5|||
150148262|NCT01158378|541679895|FG000|Overall Study|Lost to Follow-up|2|||
150148263|NCT01158378|541679896|FG001|Overall Study|Lost to Follow-up|4|||
150148264|NCT01158378|541679895|FG000|Overall Study|Withdrawal by Subject|4|||
150148265|NCT01158378|541679896|FG001|Overall Study|Withdrawal by Subject|0|||
150148266|NCT02769065|541679897|FG000|Overall Study|Voluntary Withdrawal|1|||
150148267|NCT02769065|541679898|FG001|Overall Study|Voluntary Withdrawal|0|||
150148268|NCT02769065|541679899|FG002|Overall Study|Voluntary Withdrawal|0|||
150148269|NCT02769065|541679900|FG003|Overall Study|Voluntary Withdrawal|0|||
150148270|NCT02769065|541679901|FG004|Overall Study|Voluntary Withdrawal|0|||
149804701|NCT01283009|540413878|FG000|Overall Study|Study ended early|23|||
149804702|NCT01283009|540413879|FG001|Overall Study|Study ended early|26|||
149804703|NCT01283009|540413878|FG000|Overall Study|Withdrawal by Subject|10|||
149804704|NCT01283009|540413879|FG001|Overall Study|Withdrawal by Subject|8|||
150148271|NCT02769065|541679902|FG005|Overall Study|Voluntary Withdrawal|0|||
150148272|NCT02769065|541679903|FG006|Overall Study|Voluntary Withdrawal|0|||
150148273|NCT02769065|541679904|FG007|Overall Study|Voluntary Withdrawal|0|||
150148274|NCT02769065|541679905|FG008|Overall Study|Voluntary Withdrawal|0|||
150148275|NCT02769065|541679906|FG009|Overall Study|Voluntary Withdrawal|0|||
150148276|NCT02769065|541679907|FG010|Overall Study|Voluntary Withdrawal|0|||
150148277|NCT02769065|541679908|FG011|Overall Study|Voluntary Withdrawal|0|||
150148278|NCT02769065|541679909|FG012|Overall Study|Voluntary Withdrawal|0|||
149804705|NCT01283009|540413878|FG000|Overall Study|Physician Decision|1|||
149804706|NCT01283009|540413879|FG001|Overall Study|Physician Decision|1|||
149804707|NCT01283009|540413878|FG000|Overall Study|Lost to Follow-up|1|||
150148279|NCT02769065|541679910|FG013|Overall Study|Voluntary Withdrawal|0|||
150148280|NCT02769065|541679911|FG014|Overall Study|Voluntary Withdrawal|0|||
150148281|NCT02769065|541679912|FG015|Overall Study|Voluntary Withdrawal|0|||
150148282|NCT02769065|541679913|FG016|Overall Study|Voluntary Withdrawal|0|||
150148283|NCT02769065|541679914|FG017|Overall Study|Voluntary Withdrawal|0|||
150148284|NCT02769065|541679915|FG018|Overall Study|Voluntary Withdrawal|0|||
150148285|NCT02769065|541679916|FG019|Overall Study|Voluntary Withdrawal|0|||
150148286|NCT02769065|541679917|FG020|Overall Study|Voluntary Withdrawal|0|||
150148287|NCT02769065|541679918|FG021|Overall Study|Voluntary Withdrawal|0|||
150148288|NCT02769065|541679919|FG022|Overall Study|Voluntary Withdrawal|0|||
150148289|NCT02769065|541679920|FG023|Overall Study|Voluntary Withdrawal|0|||
150148290|NCT02769065|541679921|FG024|Overall Study|Voluntary Withdrawal|0|||
150148291|NCT02769065|541679922|FG025|Overall Study|Voluntary Withdrawal|0|||
150148292|NCT02769065|541679923|FG026|Overall Study|Voluntary Withdrawal|0|||
150148293|NCT02769065|541679924|FG027|Overall Study|Voluntary Withdrawal|0|||
150148294|NCT02769065|541679925|FG028|Overall Study|Voluntary Withdrawal|0|||
150148295|NCT02769065|541679926|FG029|Overall Study|Voluntary Withdrawal|0|||
150148296|NCT02769065|541679897|FG000|Overall Study|Reason Not Specified|0|||
150148297|NCT02769065|541679898|FG001|Overall Study|Reason Not Specified|0|||
150148298|NCT02769065|541679899|FG002|Overall Study|Reason Not Specified|0|||
150148299|NCT02769065|541679900|FG003|Overall Study|Reason Not Specified|0|||
150148300|NCT02769065|541679901|FG004|Overall Study|Reason Not Specified|0|||
150148301|NCT02769065|541679902|FG005|Overall Study|Reason Not Specified|0|||
150148302|NCT02769065|541679903|FG006|Overall Study|Reason Not Specified|1|||
150148303|NCT02769065|541679904|FG007|Overall Study|Reason Not Specified|0|||
150148304|NCT02769065|541679905|FG008|Overall Study|Reason Not Specified|0|||
150148305|NCT02769065|541679906|FG009|Overall Study|Reason Not Specified|0|||
150148306|NCT02769065|541679907|FG010|Overall Study|Reason Not Specified|0|||
150148307|NCT02769065|541679908|FG011|Overall Study|Reason Not Specified|0|||
150148308|NCT02769065|541679909|FG012|Overall Study|Reason Not Specified|0|||
150148309|NCT02769065|541679910|FG013|Overall Study|Reason Not Specified|0|||
150148310|NCT02769065|541679911|FG014|Overall Study|Reason Not Specified|0|||
150148311|NCT02769065|541679912|FG015|Overall Study|Reason Not Specified|0|||
150148312|NCT02769065|541679913|FG016|Overall Study|Reason Not Specified|0|||
150148313|NCT02769065|541679914|FG017|Overall Study|Reason Not Specified|0|||
150148314|NCT02769065|541679915|FG018|Overall Study|Reason Not Specified|0|||
150148315|NCT02769065|541679916|FG019|Overall Study|Reason Not Specified|0|||
150148316|NCT02769065|541679917|FG020|Overall Study|Reason Not Specified|0|||
150148317|NCT02769065|541679918|FG021|Overall Study|Reason Not Specified|0|||
150148318|NCT02769065|541679919|FG022|Overall Study|Reason Not Specified|0|||
150148319|NCT02769065|541679920|FG023|Overall Study|Reason Not Specified|0|||
150148320|NCT02769065|541679921|FG024|Overall Study|Reason Not Specified|0|||
150148321|NCT02769065|541679922|FG025|Overall Study|Reason Not Specified|0|||
150148322|NCT02769065|541679923|FG026|Overall Study|Reason Not Specified|0|||
150148323|NCT02769065|541679924|FG027|Overall Study|Reason Not Specified|0|||
150148324|NCT02769065|541679925|FG028|Overall Study|Reason Not Specified|0|||
150148325|NCT02769065|541679926|FG029|Overall Study|Reason Not Specified|0|||
150148326|NCT02769065|541679897|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148327|NCT02769065|541679898|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148328|NCT02769065|541679899|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148329|NCT02769065|541679900|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148330|NCT02769065|541679901|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148331|NCT02769065|541679902|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148332|NCT02769065|541679903|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
149804708|NCT01283009|540413879|FG001|Overall Study|Lost to Follow-up|0|||
150148333|NCT02769065|541679904|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148334|NCT02769065|541679905|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
149804709|NCT01283009|540413878|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
149804710|NCT01283009|540413879|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
149804711|NCT05102162|540413880|FG000|Overall Study|Withdrawal by Subject|3|||
149804712|NCT05102162|540413881|FG001|Overall Study|Withdrawal by Subject|0|||
149804713|NCT05102162|540413880|FG000|Overall Study|Baseline cultures negative|4|||
149804714|NCT05102162|540413881|FG001|Overall Study|Baseline cultures negative|2|||
149804715|NCT05102162|540413880|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
149804716|NCT05102162|540413881|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
149804717|NCT05102162|540413880|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
150148335|NCT02769065|541679906|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148336|NCT02769065|541679907|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
150148337|NCT02769065|541679908|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148338|NCT02769065|541679909|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148339|NCT02769065|541679910|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148340|NCT02769065|541679911|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148341|NCT02769065|541679912|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148342|NCT02769065|541679913|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
149804718|NCT05102162|540413881|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
149804719|NCT01353586|540413882|FG000|Overall Study|Procedure terminated prior to ablation|3|||
149804720|NCT01353586|540413883|FG001|Overall Study|Procedure terminated prior to ablation|0|||
149804721|NCT01353586|540413882|FG000|Overall Study|Never had insertion of study catheter|4|||
149804722|NCT01353586|540413883|FG001|Overall Study|Never had insertion of study catheter|1|||
149804723|NCT01353586|540413882|FG000|Overall Study|Neurological exam not done|0|||
150148343|NCT02769065|541679914|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148344|NCT02769065|541679915|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148345|NCT02769065|541679916|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148346|NCT02769065|541679917|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148347|NCT02769065|541679918|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148348|NCT02769065|541679919|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148349|NCT02769065|541679920|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148350|NCT02769065|541679921|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148351|NCT02769065|541679922|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148352|NCT02769065|541679923|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148353|NCT02769065|541679924|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148354|NCT02769065|541679925|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148355|NCT02769065|541679926|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
150148356|NCT03017235|541679927|FG000|Overall Study|Withdrawal by Subject|4|||
150148357|NCT03017235|541679928|FG001|Overall Study|Withdrawal by Subject|3|||
150148358|NCT03017235|541679927|FG000|Overall Study|Lost to Follow-up|2|||
150148359|NCT03017235|541679928|FG001|Overall Study|Lost to Follow-up|7|||
150148360|NCT03017235|541679927|FG000|Overall Study|Adverse Event|0|||
150148361|NCT03017235|541679928|FG001|Overall Study|Adverse Event|1|||
150148362|NCT03017235|541679927|FG000|Overall Study|Protocol Violation|2|||
150148363|NCT03017235|541679928|FG001|Overall Study|Protocol Violation|1|||
150148364|NCT03017235|541679927|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
150148365|NCT03017235|541679928|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
150148366|NCT02593539|541679933|FG000|Overall Study|Adverse Event|1|||
150148367|NCT00437125|541679934|FG000|Overall Study|Adverse Event|12|||
150148368|NCT00437125|541679934|FG000|Overall Study|Death|1|||
150148369|NCT00437125|541679934|FG000|Overall Study|Clinical Relapse|1|||
150148370|NCT00437125|541679934|FG000|Overall Study|Lack of Efficacy|1|||
150148371|NCT00437125|541679934|FG000|Overall Study|Lost to Follow-up|1|||
150148372|NCT00437125|541679934|FG000|Overall Study|Withdrawal by Subject|13|||
150148373|NCT00437125|541679934|FG000|Overall Study|Withdrawal by Caregiver|2|||
150148374|NCT00437125|541679934|FG000|Overall Study|Physician Decision|1|||
150148375|NCT02248961|541679935|FG000|Overall Study|Adverse Event|1|||
150148376|NCT02248961|541679936|FG001|Overall Study|Adverse Event|0|||
150148377|NCT02248961|541679935|FG000|Overall Study|Withdrawal by Subject|1|||
150148378|NCT02248961|541679936|FG001|Overall Study|Withdrawal by Subject|2|||
150148379|NCT02248961|541679935|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
150148380|NCT02248961|541679936|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
150148381|NCT02531295|541679939|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
150148382|NCT02531295|541679940|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
150148383|NCT02531295|541679941|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
150148384|NCT02531295|541679942|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
150148385|NCT02531295|541679943|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
150148386|NCT02531295|541679944|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
150148387|NCT02791490|541679946|FG000|Overall Study|Lost to Follow-up|1|||
150148388|NCT02791490|541679947|FG001|Overall Study|Lost to Follow-up|2|||
150148389|NCT02791490|541679946|FG000|Overall Study|Withdrawal by Subject|2|||
150148390|NCT02791490|541679947|FG001|Overall Study|Withdrawal by Subject|6|||
150148391|NCT01189890|541679948|FG000|Overall Study|Adverse Event|3|||
150148392|NCT01189890|541679949|FG001|Overall Study|Adverse Event|4|||
150148393|NCT01189890|541679948|FG000|Overall Study|Lack of Efficacy|7|||
150148394|NCT01189890|541679949|FG001|Overall Study|Lack of Efficacy|2|||
150148395|NCT01189890|541679948|FG000|Overall Study|Lost to Follow-up|1|||
150148396|NCT01189890|541679949|FG001|Overall Study|Lost to Follow-up|7|||
150148397|NCT01189890|541679948|FG000|Overall Study|Protocol Violation|1|||
150148398|NCT01189890|541679949|FG001|Overall Study|Protocol Violation|5|||
150148399|NCT01189890|541679948|FG000|Overall Study|Withdrawal by Subject|15|||
150148400|NCT01189890|541679949|FG001|Overall Study|Withdrawal by Subject|11|||
150148401|NCT01189890|541679948|FG000|Overall Study|Non Compliance|0|||
150148402|NCT01189890|541679949|FG001|Overall Study|Non Compliance|1|||
150148403|NCT01189890|541679948|FG000|Overall Study|Physician Decision|5|||
150148404|NCT01189890|541679949|FG001|Overall Study|Physician Decision|4|||
150148405|NCT01189890|541679948|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
150148406|NCT01189890|541679949|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
150148407|NCT02802319|541679952|FG000|Overall Study|Physician Decision|2|||
150148408|NCT02802319|541679953|FG001|Overall Study|Physician Decision|1|||
150148409|NCT02802319|541679952|FG000|Overall Study|Lost to Follow-up|0|||
150148410|NCT02802319|541679953|FG001|Overall Study|Lost to Follow-up|4|||
150148411|NCT04651114|541679954|FG000|Overall Study|Withdrawal by Subject|8|||
150148412|NCT00077636|541679955|FG000|Overall Study|Refused Treatment|9|||
150148413|NCT00077636|541679956|FG001|Overall Study|Refused Treatment|31|||
150148414|NCT00077636|541679955|FG000|Overall Study|Admin|3|||
150148415|NCT00077636|541679956|FG001|Overall Study|Admin|3|||
150148416|NCT00077636|541679955|FG000|Overall Study|Withdrawal by Subject|2|||
150148417|NCT00077636|541679956|FG001|Overall Study|Withdrawal by Subject|2|||
150148418|NCT00077636|541679955|FG000|Overall Study|Adverse Event|17|||
150148419|NCT00077636|541679956|FG001|Overall Study|Adverse Event|34|||
150148420|NCT00077636|541679955|FG000|Overall Study|Protocol Violation|0|||
150148421|NCT00077636|541679956|FG001|Overall Study|Protocol Violation|2|||
150148422|NCT00077636|541679955|FG000|Overall Study|Lost to Follow-up|10|||
150148423|NCT00077636|541679956|FG001|Overall Study|Lost to Follow-up|18|||
150148424|NCT00077636|541679955|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
150148425|NCT00077636|541679956|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
150148426|NCT01923896|541679961|FG000|Overall Study|Adverse Event|1|||
150148427|NCT01923896|541679962|FG001|Overall Study|Adverse Event|0|||
150148428|NCT00592319|541679963|FG000|Overall Study|Lost to Follow-up|0|||
150148429|NCT00592319|541679964|FG001|Overall Study|Lost to Follow-up|3|||
150148430|NCT04399551|541679970|FG000|Overall Study|Adverse Event|15|||
150148431|NCT04399551|541679970|FG000|Overall Study|Withdrawal by Subject|6|||
150148432|NCT04399551|541679970|FG000|Overall Study|Physician Decision|3|||
150148433|NCT04399551|541679970|FG000|Overall Study|Lost to Follow-up|2|||
150148434|NCT04399551|541679970|FG000|Overall Study|Protocol Deviation|2|||
150148435|NCT01642602|541679985|FG000|Overall Study|Adverse Event|2|||
150148436|NCT01112514|541679986|FG000|Overall Study|Lost to Follow-up|1|||
150148437|NCT01118455|541679987|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
150148438|NCT01118455|541679988|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
150148439|NCT01973491|541679989|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
150148440|NCT01973491|541679989|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
150148441|NCT01973491|541679989|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
150148442|NCT01987596|541679993|FG000|Overall Study|Physician Decision|1|||
150148443|NCT01987596|541679994|FG001|Overall Study|Physician Decision|0|||
150148444|NCT01987596|541679993|FG000|Overall Study|Progressive Disease; missing all period|0|||
150148445|NCT01987596|541679994|FG001|Overall Study|Progressive Disease; missing all period|1|||
150148446|NCT01129336|541679995|FG000|Overall Study|Protocol Violation|1|||
150148447|NCT01129336|541679996|FG001|Overall Study|Protocol Violation|0|||
150148448|NCT01129336|541679995|FG000|Overall Study|Disease Progression|1|||
150148449|NCT01129336|541679996|FG001|Overall Study|Disease Progression|4|||
149804724|NCT01353586|540413883|FG001|Overall Study|Neurological exam not done|1|||
149804725|NCT05027958|540413884|FG000|Overall Study|Lost to Follow-up|1|||
149804726|NCT05027958|540413885|FG001|Overall Study|Lost to Follow-up|1|||
149804727|NCT05027958|540413884|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
149804728|NCT05027958|540413885|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
149804729|NCT05027958|540413884|FG000|Overall Study|Physician Decision|1|||
150148450|NCT01129336|541679995|FG000|Overall Study|Lost to Follow-up|1|||
150148451|NCT01129336|541679996|FG001|Overall Study|Lost to Follow-up|0|||
150148452|NCT01129336|541679995|FG000|Overall Study|Withdrawal by Subject|7|||
150148453|NCT01129336|541679996|FG001|Overall Study|Withdrawal by Subject|4|||
150148454|NCT01129336|541679995|FG000|Overall Study|Adverse Event|0|||
150148455|NCT01129336|541679996|FG001|Overall Study|Adverse Event|1|||
150148456|NCT01129336|541679995|FG000|Overall Study|Missing Study Completion Status|2|||
150148457|NCT01129336|541679996|FG001|Overall Study|Missing Study Completion Status|3|||
150148458|NCT01129336|541679995|FG000|Overall Study|Death|0|||
150148459|NCT01129336|541679996|FG001|Overall Study|Death|4|||
150148460|NCT00569803|541679997|FG000|Overall Study|Lost to Follow-up|1|||
150148461|NCT00569803|541679998|FG001|Overall Study|Lost to Follow-up|0|||
150148462|NCT00569803|541679999|FG002|Overall Study|Lost to Follow-up|0|||
150148463|NCT00569803|541680000|FG003|Overall Study|Lost to Follow-up|0|||
150148464|NCT00569803|541680001|FG004|Overall Study|Lost to Follow-up|0|||
150148465|NCT00569803|541680002|FG005|Overall Study|Lost to Follow-up|0|||
150148466|NCT00569803|541680003|FG006|Overall Study|Lost to Follow-up|0|||
150148467|NCT00569803|541680004|FG007|Overall Study|Lost to Follow-up|0|||
150148468|NCT00569803|541679997|FG000|Overall Study|injection syringe leaked during dosing|0|||
150148469|NCT00569803|541679998|FG001|Overall Study|injection syringe leaked during dosing|0|||
150148470|NCT00569803|541679999|FG002|Overall Study|injection syringe leaked during dosing|0|||
149804730|NCT05027958|540413885|FG001|Overall Study|Physician Decision|4|||
150148471|NCT00569803|541680000|FG003|Overall Study|injection syringe leaked during dosing|1|||
150148472|NCT00569803|541680001|FG004|Overall Study|injection syringe leaked during dosing|0|||
150148473|NCT00569803|541680002|FG005|Overall Study|injection syringe leaked during dosing|0|||
150148474|NCT00569803|541680003|FG006|Overall Study|injection syringe leaked during dosing|0|||
150148475|NCT00569803|541680004|FG007|Overall Study|injection syringe leaked during dosing|0|||
150148476|NCT00569803|541679997|FG000|Overall Study|Withdrawal by Subject|0|||
150148477|NCT00569803|541679998|FG001|Overall Study|Withdrawal by Subject|0|||
150148478|NCT00569803|541679999|FG002|Overall Study|Withdrawal by Subject|0|||
150148479|NCT00569803|541680000|FG003|Overall Study|Withdrawal by Subject|0|||
149804731|NCT05027958|540413884|FG000|Overall Study|Adverse Event|0|||
150148480|NCT00569803|541680001|FG004|Overall Study|Withdrawal by Subject|0|||
150148481|NCT00569803|541680002|FG005|Overall Study|Withdrawal by Subject|0|||
150148482|NCT00569803|541680003|FG006|Overall Study|Withdrawal by Subject|0|||
150148483|NCT00569803|541680004|FG007|Overall Study|Withdrawal by Subject|1|||
150148484|NCT01993823|541680005|FG000|Overall Study|Requested by the patient|6|||
150148485|NCT01993823|541680006|FG001|Overall Study|Requested by the patient|11|||
150148486|NCT01993823|541680005|FG000|Overall Study|Protocol Violation|0|||
150148487|NCT01993823|541680006|FG001|Overall Study|Protocol Violation|1|||
150148488|NCT01993823|541680005|FG000|Overall Study|Lost to Follow-up|1|||
150148489|NCT01993823|541680006|FG001|Overall Study|Lost to Follow-up|4|||
150148490|NCT01622348|541680008|FG000|Overall Study|Withdrawal by Subject|1|||
150148491|NCT01622348|541680009|FG001|Overall Study|Withdrawal by Subject|0|||
150148492|NCT01622348|541680010|FG002|Overall Study|Withdrawal by Subject|1|||
150148493|NCT00791921|541680013|FG000|Overall Study|Protocol planed|24|||
150148494|NCT00791921|541680014|FG001|Overall Study|Protocol planed|88|||
150148495|NCT00791921|541680013|FG000|Overall Study|Withdrawal by Subject|1|||
150148496|NCT00791921|541680014|FG001|Overall Study|Withdrawal by Subject|2|||
150148497|NCT00791921|541680013|FG000|Overall Study|Adverse Event|8|||
150148498|NCT00791921|541680014|FG001|Overall Study|Adverse Event|2|||
150148499|NCT00791921|541680013|FG000|Overall Study|Lack of Efficacy|0|||
150148500|NCT00791921|541680014|FG001|Overall Study|Lack of Efficacy|2|||
150148501|NCT00791921|541680013|FG000|Overall Study|Lack of study drug administration|1|||
150148502|NCT00791921|541680014|FG001|Overall Study|Lack of study drug administration|1|||
150148503|NCT00791921|541680013|FG000|Overall Study|Reason other than those above|0|||
150148504|NCT00791921|541680014|FG001|Overall Study|Reason other than those above|1|||
150148505|NCT04537897|541680018|FG000|Overall Study|Other than listed|0|||
150148506|NCT04537897|541680019|FG001|Overall Study|Other than listed|0|||
150148507|NCT04537897|541680020|FG002|Overall Study|Other than listed|0|||
150148508|NCT04537897|541680021|FG003|Overall Study|Other than listed|0|||
150148509|NCT04537897|541680022|FG004|Overall Study|Other than listed|0|||
150148510|NCT04537897|541680023|FG005|Overall Study|Other than listed|0|||
150148511|NCT04537897|541680024|FG006|Overall Study|Other than listed|1|||
150148512|NCT04537897|541680025|FG007|Overall Study|Other than listed|0|||
150148513|NCT04537897|541680026|FG008|Overall Study|Other than listed|0|||
150148514|NCT04537897|541680018|FG000|Overall Study|Adverse Event|0|||
150148515|NCT04537897|541680019|FG001|Overall Study|Adverse Event|0|||
150148516|NCT04537897|541680020|FG002|Overall Study|Adverse Event|0|||
150148517|NCT04537897|541680021|FG003|Overall Study|Adverse Event|1|||
150148518|NCT04537897|541680022|FG004|Overall Study|Adverse Event|0|||
150148519|NCT04537897|541680023|FG005|Overall Study|Adverse Event|0|||
150148520|NCT04537897|541680024|FG006|Overall Study|Adverse Event|0|||
150148521|NCT04537897|541680025|FG007|Overall Study|Adverse Event|0|||
150148522|NCT04537897|541680026|FG008|Overall Study|Adverse Event|0|||
150148523|NCT04537897|541680018|FG000|Overall Study|Withdrawal by Subject|0|||
150148524|NCT04537897|541680019|FG001|Overall Study|Withdrawal by Subject|1|||
150148525|NCT04537897|541680020|FG002|Overall Study|Withdrawal by Subject|0|||
150148526|NCT04537897|541680021|FG003|Overall Study|Withdrawal by Subject|0|||
150148527|NCT04537897|541680022|FG004|Overall Study|Withdrawal by Subject|0|||
150148528|NCT04537897|541680023|FG005|Overall Study|Withdrawal by Subject|0|||
150148529|NCT04537897|541680024|FG006|Overall Study|Withdrawal by Subject|0|||
150148530|NCT04537897|541680025|FG007|Overall Study|Withdrawal by Subject|0|||
150148531|NCT04537897|541680026|FG008|Overall Study|Withdrawal by Subject|0|||
150148532|NCT00178256|541680029|FG000|Overall Study|Adverse Event|2|||
150148533|NCT00178256|541680030|FG001|Overall Study|Adverse Event|0|||
150148534|NCT00178256|541680031|FG002|Overall Study|Adverse Event|0|||
150148535|NCT00178256|541680032|FG003|Overall Study|Adverse Event|0|||
149804732|NCT05027958|540413885|FG001|Overall Study|Adverse Event|1|||
149804733|NCT02242942|540413896|FG000|Overall Study|Death|17|||
150148536|NCT00178256|541680029|FG000|Overall Study|Death|0|||
149804734|NCT02242942|540413897|FG001|Overall Study|Death|20|||
149804735|NCT02242942|540413898|FG002|Overall Study|Death|2|||
150148537|NCT00178256|541680030|FG001|Overall Study|Death|1|||
150148538|NCT00178256|541680031|FG002|Overall Study|Death|0|||
150148539|NCT00178256|541680032|FG003|Overall Study|Death|1|||
150148540|NCT00178256|541680029|FG000|Overall Study|Cancer progression|2|||
150148541|NCT00178256|541680030|FG001|Overall Study|Cancer progression|0|||
150148542|NCT00178256|541680031|FG002|Overall Study|Cancer progression|0|||
150148543|NCT00178256|541680032|FG003|Overall Study|Cancer progression|1|||
150148544|NCT01763788|541680033|FG000|Overall Study|Lost to Follow-up|0|||
150148545|NCT01763788|541680034|FG001|Overall Study|Lost to Follow-up|0|||
150148546|NCT01763788|541680035|FG002|Overall Study|Lost to Follow-up|1|||
150148547|NCT01763788|541680036|FG003|Overall Study|Lost to Follow-up|0|||
150148548|NCT03321006|541680037|FG000|Overall Study|Death|1|||
150148549|NCT03321006|541680038|FG001|Overall Study|Death|0|||
149804736|NCT02242942|540413896|FG000|Overall Study|Physician Decision|1|||
149804737|NCT02242942|540413897|FG001|Overall Study|Physician Decision|0|||
150148550|NCT03321006|541680037|FG000|Overall Study|Lack of Efficacy|1|||
150148551|NCT03321006|541680038|FG001|Overall Study|Lack of Efficacy|0|||
150148552|NCT03303469|541680039|FG000|Overall Study|Lost to Follow-up|2|||
150148553|NCT03560258|541680042|FG000|Overall Study|Lost to Follow-up|3|||
150148554|NCT03560258|541680043|FG001|Overall Study|Lost to Follow-up|0|||
150148555|NCT03560258|541680044|FG002|Overall Study|Lost to Follow-up|0|||
150148556|NCT03560258|541680042|FG000|Overall Study|Protocol Violation|0|||
150148557|NCT03560258|541680043|FG001|Overall Study|Protocol Violation|1|||
150148558|NCT03560258|541680044|FG002|Overall Study|Protocol Violation|0|||
150148559|NCT03560258|541680042|FG000|Overall Study|Withdrawal by Subject|0|||
150148560|NCT03560258|541680043|FG001|Overall Study|Withdrawal by Subject|0|||
150148561|NCT03560258|541680044|FG002|Overall Study|Withdrawal by Subject|1|||
150148562|NCT01460160|541680045|FG000|Treatment Phase|Lack of Efficacy|3|||
150148563|NCT01460160|541680045|FG000|Treatment Phase|Study Drug Toxicity|2|||
150148564|NCT01460160|541680045|FG000|Treatment Phase|Adverse Event|8|||
150148565|NCT01460160|541680045|FG000|Treatment Phase|Withdrawal by Subject|4|||
150148566|NCT01460160|541680045|FG000|Treatment Phase|Death|2|||
150148567|NCT01460160|541680045|FG000|Treatment Phase|Other reasons|9|||
150148568|NCT01460160|541680045|FG000|Follow-up Phase|Withdrawal by Subject|4|||
150148569|NCT01460160|541680045|FG000|Follow-up Phase|Death|14|||
150148570|NCT01460160|541680045|FG000|Follow-up Phase|Lost to Follow-up|7|||
150148571|NCT01460160|541680045|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
150148572|NCT01460160|541680045|FG000|Follow-up Phase|Other and not reported reasons|5|||
150148573|NCT03893825|541680046|FG000|Overall Study|Death|2|||
150148574|NCT03893825|541680047|FG001|Overall Study|Death|1|||
150148575|NCT03893825|541680046|FG000|Overall Study|Adverse Event|0|||
149804738|NCT02242942|540413898|FG002|Overall Study|Physician Decision|0|||
149804739|NCT02242942|540413896|FG000|Overall Study|Withdrawal by Subject|8|||
149804740|NCT02242942|540413897|FG001|Overall Study|Withdrawal by Subject|10|||
149804741|NCT02242942|540413898|FG002|Overall Study|Withdrawal by Subject|0|||
149804742|NCT02242942|540413896|FG000|Overall Study|On-going in Study|190|||
149804743|NCT02242942|540413897|FG001|Overall Study|On-going in Study|186|||
149804744|NCT02242942|540413898|FG002|Overall Study|On-going in Study|11|||
149804745|NCT04882085|540413899|FG000|Overall Study|Death|6|||
149804746|NCT04882085|540413900|FG001|Overall Study|Death|9|||
149804747|NCT04882085|540413899|FG000|Overall Study|Withdrawal by Subject|0|||
149804748|NCT04882085|540413900|FG001|Overall Study|Withdrawal by Subject|3|||
149804749|NCT04882085|540413899|FG000|Overall Study|Randomized not treated|1|||
149804750|NCT04882085|540413900|FG001|Overall Study|Randomized not treated|0|||
149804751|NCT04455620|540413907|FG000|Overall Study|Withdrawal by Subject|0|||
149804752|NCT04455620|540413908|FG001|Overall Study|Withdrawal by Subject|0|||
149804753|NCT04455620|540413909|FG002|Overall Study|Withdrawal by Subject|2|||
149804754|NCT04455620|540413910|FG003|Overall Study|Withdrawal by Subject|0|||
149804755|NCT04455620|540413911|FG004|Overall Study|Withdrawal by Subject|1|||
149804756|NCT04455620|540413907|FG000|Overall Study|Lost to Follow-up|0|||
149804757|NCT04455620|540413908|FG001|Overall Study|Lost to Follow-up|0|||
149804758|NCT04455620|540413909|FG002|Overall Study|Lost to Follow-up|1|||
149804759|NCT04455620|540413910|FG003|Overall Study|Lost to Follow-up|1|||
149804760|NCT04455620|540413911|FG004|Overall Study|Lost to Follow-up|0|||
149804761|NCT04455620|540413907|FG000|Overall Study|Death|1|||
149804762|NCT04455620|540413908|FG001|Overall Study|Death|6|||
149804763|NCT04455620|540413909|FG002|Overall Study|Death|20|||
149804764|NCT04455620|540413910|FG003|Overall Study|Death|1|||
149804765|NCT04455620|540413911|FG004|Overall Study|Death|7|||
149804766|NCT04455620|540413907|FG000|Overall Study|Study Termination|0|||
149804767|NCT04455620|540413908|FG001|Overall Study|Study Termination|2|||
149804768|NCT04455620|540413909|FG002|Overall Study|Study Termination|1|||
149804769|NCT04455620|540413910|FG003|Overall Study|Study Termination|0|||
149804770|NCT04455620|540413911|FG004|Overall Study|Study Termination|6|||
149804771|NCT05681715|540413913|FG000|Training Period (6-weeks)|Adverse Event|3|||
149804772|NCT05681715|540413914|FG001|Training Period (6-weeks)|Adverse Event|0|||
149804773|NCT05681715|540413915|FG002|Training Period (6-weeks)|Adverse Event|0|||
149804774|NCT05681715|540413913|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
149804775|NCT05681715|540413914|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
149804776|NCT05681715|540413915|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
149804777|NCT05681715|540413913|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
149804778|NCT05681715|540413914|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
150148576|NCT03893825|541680047|FG001|Overall Study|Adverse Event|2|||
150148577|NCT03893825|541680046|FG000|Overall Study|Withdrawal by Subject|19|||
149804779|NCT05681715|540413915|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
149804780|NCT05681715|540413913|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
149804781|NCT05681715|540413914|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
149918887|NCT01210352|540835247|FG006|Overall Study|Adverse Event|0|||
150148578|NCT03893825|541680047|FG001|Overall Study|Withdrawal by Subject|21|||
150148579|NCT03893825|541680046|FG000|Overall Study|Protocol deviation|1|||
150148580|NCT03893825|541680047|FG001|Overall Study|Protocol deviation|0|||
150148581|NCT03893825|541680046|FG000|Overall Study|Lost to Follow-up|10|||
150148582|NCT03893825|541680047|FG001|Overall Study|Lost to Follow-up|10|||
150148583|NCT03893825|541680046|FG000|Overall Study|Other than specified|7|||
149804782|NCT05681715|540413915|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
149804783|NCT05681715|540413913|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
149804784|NCT05681715|540413914|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
149804785|NCT05681715|540413915|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
149804786|NCT05681715|540413913|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
149804787|NCT05681715|540413914|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
149804788|NCT05681715|540413915|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
149804789|NCT05681715|540413913|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
149804790|NCT05681715|540413914|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
149804791|NCT05681715|540413915|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
149804792|NCT05681715|540413913|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
149804793|NCT05681715|540413914|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
149804794|NCT05681715|540413915|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
149804795|NCT05116241|540413916|FG000|Study|Withdrawal by Subject|5|||
149804796|NCT05116241|540413917|FG001|Study|Withdrawal by Subject|2|||
149804797|NCT05116241|540413918|FG002|Study|Withdrawal by Subject|1|||
149804798|NCT05116241|540413916|FG000|Study|Lost to Follow-up|0|||
149804799|NCT05116241|540413917|FG001|Study|Lost to Follow-up|2|||
149804800|NCT05116241|540413918|FG002|Study|Lost to Follow-up|2|||
149804801|NCT02268214|540413921|FG000|Overall Study|Subject no longer meets study criteria|0|||
149804802|NCT02268214|540413922|FG001|Overall Study|Subject no longer meets study criteria|2|||
149804803|NCT02268214|540413923|FG002|Overall Study|Subject no longer meets study criteria|0|||
149804804|NCT02268214|540413921|FG000|Overall Study|Pregnancy|2|||
149804805|NCT02268214|540413922|FG001|Overall Study|Pregnancy|2|||
149804806|NCT02268214|540413923|FG002|Overall Study|Pregnancy|1|||
149804807|NCT02268214|540413921|FG000|Overall Study|Lost to Follow-up|3|||
149804808|NCT02268214|540413922|FG001|Overall Study|Lost to Follow-up|3|||
149804809|NCT02268214|540413923|FG002|Overall Study|Lost to Follow-up|4|||
149804810|NCT02268214|540413921|FG000|Overall Study|Lack of Efficacy|1|||
149804811|NCT02268214|540413922|FG001|Overall Study|Lack of Efficacy|0|||
149804812|NCT02268214|540413923|FG002|Overall Study|Lack of Efficacy|2|||
149804813|NCT02268214|540413921|FG000|Overall Study|Adverse Event|11|||
149804814|NCT02268214|540413922|FG001|Overall Study|Adverse Event|14|||
149804815|NCT02268214|540413923|FG002|Overall Study|Adverse Event|9|||
149804816|NCT02268214|540413921|FG000|Overall Study|Withdrawal by Subject|4|||
149804817|NCT02268214|540413922|FG001|Overall Study|Withdrawal by Subject|5|||
149804818|NCT02268214|540413923|FG002|Overall Study|Withdrawal by Subject|10|||
149804819|NCT02268214|540413921|FG000|Overall Study|Subject request to discontinue treatment|10|||
149804820|NCT02268214|540413922|FG001|Overall Study|Subject request to discontinue treatment|8|||
149804821|NCT02268214|540413923|FG002|Overall Study|Subject request to discontinue treatment|6|||
149804822|NCT02268214|540413921|FG000|Overall Study|Poor/non-compliance|2|||
149804823|NCT02268214|540413922|FG001|Overall Study|Poor/non-compliance|1|||
149804824|NCT02268214|540413923|FG002|Overall Study|Poor/non-compliance|2|||
149804825|NCT02268214|540413921|FG000|Overall Study|Other reasons|7|||
149804826|NCT02268214|540413922|FG001|Overall Study|Other reasons|3|||
149804827|NCT02268214|540413923|FG002|Overall Study|Other reasons|3|||
149804828|NCT02268214|540413921|FG000|Overall Study|Not entering long-term period|2|||
149804829|NCT02268214|540413922|FG001|Overall Study|Not entering long-term period|3|||
149804830|NCT02268214|540413923|FG002|Overall Study|Not entering long-term period|5|||
149804831|NCT04584294|540413927|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
149804832|NCT04584294|540413928|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
149804833|NCT04584294|540413927|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
149804834|NCT04584294|540413928|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
149804835|NCT04584294|540413927|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
149804836|NCT04584294|540413928|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
149804837|NCT04584294|540413927|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
149804838|NCT04584294|540413928|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
149804839|NCT04584294|540413927|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
149804840|NCT04584294|540413928|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
149918888|NCT01210352|540835248|FG007|Overall Study|Adverse Event|2|||
149804841|NCT04584294|540413927|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
149804842|NCT04584294|540413928|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
149804843|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149804844|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149804845|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
149804846|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149918889|NCT01210352|540835249|FG008|Overall Study|Adverse Event|1|||
149918890|NCT01210352|540835241|FG000|Overall Study|Lack of Efficacy|0|||
149918891|NCT01210352|540835242|FG001|Overall Study|Lack of Efficacy|0|||
149804847|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804848|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804849|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149804850|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804851|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804852|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
149804853|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804854|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804855|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804856|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149804857|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
149804858|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804859|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
149804860|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804861|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804862|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804863|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149804864|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
149804865|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804866|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
149804867|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804868|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804869|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804870|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149804871|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
149804872|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
149804873|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
149804874|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804875|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804876|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804877|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149804878|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804879|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804880|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
149804881|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804882|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804883|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804884|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149804885|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804886|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804887|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
149804888|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804889|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804890|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804891|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149804892|NCT04242498|540413931|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804893|NCT04242498|540413932|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
149804894|NCT04242498|540413933|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
149804895|NCT04242498|540413934|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804896|NCT04242498|540413935|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804897|NCT04242498|540413936|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804898|NCT04242498|540413937|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149804899|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804900|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804901|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804902|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149804903|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
149804904|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
149804905|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
149804906|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804907|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804908|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804909|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149804910|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
149804911|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
149804912|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
149804913|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804914|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804915|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804916|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804917|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149804918|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149804919|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149804920|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149804921|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149804922|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149804923|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149804924|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149804925|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
149804926|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149804927|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804928|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804929|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149804930|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
149804931|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
149804932|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
149804933|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
149804934|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804935|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804936|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804937|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804938|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
149804939|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804940|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149804941|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804942|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804943|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804944|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804945|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804946|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
149804947|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149804948|NCT04242498|540413931|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149804949|NCT04242498|540413932|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149804950|NCT04242498|540413933|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149804951|NCT04242498|540413934|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149804952|NCT04242498|540413935|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149804953|NCT04242498|540413936|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
149804954|NCT04242498|540413937|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
149804955|NCT01003691|540413938|FG000|Overall Study|Adverse Event|0|||
149804956|NCT01003691|540413939|FG001|Overall Study|Adverse Event|0|||
149804957|NCT01003691|540413940|FG002|Overall Study|Adverse Event|0|||
149804958|NCT01003691|540413941|FG003|Overall Study|Adverse Event|1|||
149804959|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
149804960|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
149804961|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
149804962|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
149804963|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
149804964|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
149918892|NCT01210352|540835243|FG002|Overall Study|Lack of Efficacy|0|||
150148584|NCT03893825|541680047|FG001|Overall Study|Other than specified|6|||
149804965|NCT00828009|540413951|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
149804966|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
149804967|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
149804968|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Death|1|||
149804969|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
149804970|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
149804971|NCT00828009|540413951|FG000|Step 2 - Maintenance Therapy|Other|1|||
149804972|NCT01656850|540415247|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
149804973|NCT01656850|540415248|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
149804974|NCT00396318|540415249|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
149804975|NCT00602927|540415250|FG000|Period 1: 13 Days|Protocol Violation|2|||
149804976|NCT00602927|540415251|FG001|Period 1: 13 Days|Protocol Violation|4|||
149804977|NCT00602927|540415250|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
149804978|NCT00602927|540415251|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
149804979|NCT00602927|540415250|FG000|Period 1: 13 Days|Time|1|||
149804980|NCT00602927|540415251|FG001|Period 1: 13 Days|Time|0|||
149804981|NCT00602927|540415250|FG000|Period 1: 13 Days|Claustrophobia|0|||
149804982|NCT00602927|540415251|FG001|Period 1: 13 Days|Claustrophobia|1|||
149804983|NCT00602927|540415250|FG000|Period 2: 14 Days|Protocol Violation|0|||
149804984|NCT00602927|540415251|FG001|Period 2: 14 Days|Protocol Violation|2|||
149804985|NCT00602927|540415250|FG000|Period 3: 13 Days|Protocol Violation|0|||
149804986|NCT00602927|540415251|FG001|Period 3: 13 Days|Protocol Violation|1|||
149804987|NCT00602927|540415250|FG000|Period 3: 13 Days|MRI data quality|2|||
149804988|NCT00602927|540415251|FG001|Period 3: 13 Days|MRI data quality|2|||
149804989|NCT02074982|540415258|FG000|Overall Study|Adverse Event|15|||
149804990|NCT02074982|540415259|FG001|Overall Study|Adverse Event|7|||
149804991|NCT02074982|540415258|FG000|Overall Study|Lack of Efficacy|6|||
149804992|NCT02074982|540415259|FG001|Overall Study|Lack of Efficacy|1|||
149804993|NCT02074982|540415258|FG000|Overall Study|Lost to Follow-up|9|||
149804994|NCT02074982|540415259|FG001|Overall Study|Lost to Follow-up|10|||
149804995|NCT02074982|540415258|FG000|Overall Study|Non-compliance with study treatment|0|||
149804996|NCT02074982|540415259|FG001|Overall Study|Non-compliance with study treatment|2|||
149804997|NCT02074982|540415258|FG000|Overall Study|Physician Decision|1|||
149804998|NCT02074982|540415259|FG001|Overall Study|Physician Decision|1|||
149804999|NCT02074982|540415258|FG000|Overall Study|Pregnancy|1|||
149805000|NCT02074982|540415259|FG001|Overall Study|Pregnancy|2|||
149805001|NCT02074982|540415258|FG000|Overall Study|Protocol deviation|4|||
149805002|NCT02074982|540415259|FG001|Overall Study|Protocol deviation|3|||
149805003|NCT02074982|540415258|FG000|Overall Study|Technical problems|0|||
149805004|NCT02074982|540415259|FG001|Overall Study|Technical problems|2|||
149805005|NCT02074982|540415258|FG000|Overall Study|Subject/guardian decision|15|||
149805006|NCT02074982|540415259|FG001|Overall Study|Subject/guardian decision|24|||
149805007|NCT02074982|540415258|FG000|Overall Study|Death|0|||
149805008|NCT02074982|540415259|FG001|Overall Study|Death|2|||
149805009|NCT02525627|540415262|FG000|Overall Study|Revision|1|||
149805010|NCT02525627|540415263|FG001|Overall Study|Revision|1|||
149805011|NCT02525627|540415262|FG000|Overall Study|Withdrawal by Subject|1|||
149805012|NCT02525627|540415263|FG001|Overall Study|Withdrawal by Subject|2|||
149805013|NCT02525627|540415262|FG000|Overall Study|Death|1|||
149805014|NCT02525627|540415263|FG001|Overall Study|Death|0|||
149805015|NCT02525627|540415262|FG000|Overall Study|Site terminated|11|||
149805016|NCT02525627|540415263|FG001|Overall Study|Site terminated|10|||
149805017|NCT02875340|540415264|FG000|Overall Study|Death|2|||
149805018|NCT02875340|540415264|FG000|Overall Study|Withdrawal by Subject|2|||
149805019|NCT02875340|540415264|FG000|Overall Study|Physician Decision|3|||
149805020|NCT02875340|540415264|FG000|Overall Study|Adverse Event|1|||
149805021|NCT01160770|540415265|FG000|Overall Study|Adverse Event|10|||
149805022|NCT01160770|540415265|FG000|Overall Study|Protocol Violation|2|||
149805023|NCT01160770|540415265|FG000|Overall Study|Subject/parent/caregiver request|33|||
149805024|NCT01160770|540415265|FG000|Overall Study|Physician Decision|1|||
149805025|NCT01160770|540415265|FG000|Overall Study|Lost to Follow-up|7|||
149805026|NCT01160770|540415265|FG000|Overall Study|Study termination or sponsor request|1|||
149805027|NCT01160770|540415265|FG000|Overall Study|Death|9|||
149805028|NCT01160770|540415265|FG000|Overall Study|Lack of Efficacy|15|||
149805029|NCT01160770|540415265|FG000|Overall Study|Other Reasons|1|||
149805030|NCT01432600|540415268|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
149805031|NCT01432600|540415269|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
149805032|NCT01432600|540415270|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
149805033|NCT02411110|540415273|FG000|Treatment Period 1|Adverse Event|4|||
149805034|NCT02411110|540415274|FG001|Treatment Period 1|Adverse Event|2|||
149805035|NCT02411110|540415273|FG000|Treatment Period 1|Lost to Follow-up|1|||
149805036|NCT02411110|540415274|FG001|Treatment Period 1|Lost to Follow-up|0|||
149805037|NCT02411110|540415273|FG000|Treatment Period 1|Personal Reasons|2|||
149805038|NCT02411110|540415274|FG001|Treatment Period 1|Personal Reasons|5|||
149805039|NCT02411110|540415273|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
149805040|NCT02411110|540415274|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
149805041|NCT02411110|540415273|FG000|Treatment Period 2|Adverse Event|1|||
149805042|NCT02411110|540415274|FG001|Treatment Period 2|Adverse Event|0|||
149805043|NCT02411110|540415273|FG000|Treatment Period 2|Lost to Follow-up|0|||
149805044|NCT02411110|540415274|FG001|Treatment Period 2|Lost to Follow-up|2|||
149805045|NCT02411110|540415273|FG000|Treatment Period 2|Personal Reasons|0|||
149805046|NCT02411110|540415274|FG001|Treatment Period 2|Personal Reasons|2|||
149805047|NCT02871921|540415279|FG000|Overall Study|Withdrawal by Subject|34|||
149805048|NCT02871921|540415280|FG001|Overall Study|Withdrawal by Subject|27|||
149805049|NCT02871921|540415281|FG002|Overall Study|Withdrawal by Subject|27|||
149805050|NCT02871921|540415282|FG003|Overall Study|Withdrawal by Subject|30|||
149805051|NCT00320801|540415283|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
149805052|NCT00320801|540415284|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
149805053|NCT00320801|540415285|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
149805054|NCT00320801|540415286|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
149805055|NCT00320801|540415283|FG000|Open-label Run-in Period|Adverse Event|33|||
149805056|NCT00320801|540415284|FG001|Open-label Run-in Period|Adverse Event|0|||
149805057|NCT00320801|540415285|FG002|Open-label Run-in Period|Adverse Event|0|||
149805058|NCT00320801|540415286|FG003|Open-label Run-in Period|Adverse Event|0|||
149805059|NCT00320801|540415283|FG000|Open-label Run-in Period|Administrative|10|||
149805060|NCT00320801|540415284|FG001|Open-label Run-in Period|Administrative|0|||
149805061|NCT00320801|540415285|FG002|Open-label Run-in Period|Administrative|0|||
149805062|NCT00320801|540415286|FG003|Open-label Run-in Period|Administrative|0|||
149805063|NCT00320801|540415283|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
149805064|NCT00320801|540415284|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
149805065|NCT00320801|540415285|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
149805066|NCT00320801|540415286|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
149805067|NCT00320801|540415283|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
149805068|NCT00320801|540415284|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
149805069|NCT00320801|540415285|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
149805070|NCT00320801|540415286|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
149805071|NCT00320801|540415283|FG000|Open-label Run-in Period|Did not qualify|1|||
149805072|NCT00320801|540415284|FG001|Open-label Run-in Period|Did not qualify|0|||
149805073|NCT00320801|540415285|FG002|Open-label Run-in Period|Did not qualify|0|||
149805074|NCT00320801|540415286|FG003|Open-label Run-in Period|Did not qualify|0|||
149805075|NCT00320801|540415283|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149805076|NCT00320801|540415284|FG001|Double-blind Phase|Withdrawal by Subject|0|||
149805077|NCT00320801|540415285|FG002|Double-blind Phase|Withdrawal by Subject|1|||
149805078|NCT00320801|540415286|FG003|Double-blind Phase|Withdrawal by Subject|0|||
149805079|NCT00320801|540415283|FG000|Double-blind Phase|Adverse Event|0|||
149805080|NCT00320801|540415284|FG001|Double-blind Phase|Adverse Event|2|||
149805081|NCT00320801|540415285|FG002|Double-blind Phase|Adverse Event|8|||
149805082|NCT00320801|540415286|FG003|Double-blind Phase|Adverse Event|0|||
149805083|NCT00320801|540415283|FG000|Double-blind Phase|Administrative|0|||
149805084|NCT00320801|540415284|FG001|Double-blind Phase|Administrative|0|||
149805085|NCT00320801|540415285|FG002|Double-blind Phase|Administrative|4|||
149805086|NCT00320801|540415286|FG003|Double-blind Phase|Administrative|0|||
149805087|NCT00320801|540415283|FG000|Double-blind Phase|Lack of Efficacy|0|||
149805088|NCT00320801|540415284|FG001|Double-blind Phase|Lack of Efficacy|9|||
149805089|NCT00320801|540415285|FG002|Double-blind Phase|Lack of Efficacy|1|||
149805090|NCT00320801|540415286|FG003|Double-blind Phase|Lack of Efficacy|0|||
149805091|NCT00320801|540415283|FG000|Extension Phase|Withdrawal by Subject|0|||
149805092|NCT00320801|540415284|FG001|Extension Phase|Withdrawal by Subject|0|||
149805093|NCT00320801|540415285|FG002|Extension Phase|Withdrawal by Subject|0|||
149805094|NCT00320801|540415286|FG003|Extension Phase|Withdrawal by Subject|6|||
149805095|NCT00320801|540415283|FG000|Extension Phase|Adverse Event|0|||
149805096|NCT00320801|540415284|FG001|Extension Phase|Adverse Event|0|||
149805097|NCT00320801|540415285|FG002|Extension Phase|Adverse Event|0|||
149805098|NCT00320801|540415286|FG003|Extension Phase|Adverse Event|8|||
149805099|NCT00320801|540415283|FG000|Extension Phase|Administrative|0|||
149805100|NCT00320801|540415284|FG001|Extension Phase|Administrative|0|||
149805101|NCT00320801|540415285|FG002|Extension Phase|Administrative|0|||
149805102|NCT00320801|540415286|FG003|Extension Phase|Administrative|29|||
149805103|NCT00320801|540415283|FG000|Extension Phase|Lack of Efficacy|0|||
149805104|NCT00320801|540415284|FG001|Extension Phase|Lack of Efficacy|0|||
149805105|NCT00320801|540415285|FG002|Extension Phase|Lack of Efficacy|0|||
149805106|NCT00320801|540415286|FG003|Extension Phase|Lack of Efficacy|2|||
149805107|NCT00320801|540415283|FG000|Extension Phase|Lost to Follow-up|0|||
149805108|NCT00320801|540415284|FG001|Extension Phase|Lost to Follow-up|0|||
149805109|NCT00320801|540415285|FG002|Extension Phase|Lost to Follow-up|0|||
149805110|NCT00320801|540415286|FG003|Extension Phase|Lost to Follow-up|3|||
149805111|NCT00491322|540415288|FG000|Overall Study|Protocol Violation|1|||
149805112|NCT00491322|540415289|FG001|Overall Study|Protocol Violation|0|||
149805113|NCT00491322|540415288|FG000|Overall Study|Pregnancy|0|||
149805114|NCT00491322|540415289|FG001|Overall Study|Pregnancy|1|||
149805115|NCT00807040|540415292|FG000|Overall Study|Death|24|||
149805116|NCT00807040|540415293|FG001|Overall Study|Death|29|||
149805117|NCT00807040|540415292|FG000|Overall Study|Withdrawal by Subject|8|||
149805118|NCT00807040|540415293|FG001|Overall Study|Withdrawal by Subject|6|||
149805119|NCT00807040|540415292|FG000|Overall Study|Lost to Follow-up|4|||
149805120|NCT00807040|540415293|FG001|Overall Study|Lost to Follow-up|6|||
149805121|NCT00890409|540415298|FG000|Overall Study|Lost to Follow-up|20|||
149805122|NCT00890409|540415299|FG001|Overall Study|Lost to Follow-up|21|||
149805123|NCT02353572|540415300|FG000|Overall Study|Withdrawal by Subject|1|||
149805124|NCT02353572|540415300|FG000|Overall Study|Study terminated|2|||
149805125|NCT01870921|540415302|FG000|Overall Study|Subject decision|80|||
149805126|NCT01870921|540415302|FG000|Overall Study|Severe non-compliance to protocol|7|||
149805127|NCT01870921|540415302|FG000|Overall Study|Subject Lost to Follow up|2|||
149805128|NCT01870921|540415302|FG000|Overall Study|Other|1|||
149805129|NCT02060188|540415303|FG000|Overall Study|Disease Progression|36|||
149805130|NCT02060188|540415304|FG001|Overall Study|Disease Progression|42|||
149805131|NCT02060188|540415305|FG002|Overall Study|Disease Progression|8|||
149805132|NCT02060188|540415306|FG003|Overall Study|Disease Progression|5|||
149805133|NCT02060188|540415307|FG004|Overall Study|Disease Progression|6|||
149805134|NCT02060188|540415308|FG005|Overall Study|Disease Progression|3|||
149805135|NCT02060188|540415309|FG006|Overall Study|Disease Progression|23|||
149805136|NCT02060188|540415310|FG007|Overall Study|Disease Progression|20|||
149805137|NCT02060188|540415311|FG008|Overall Study|Disease Progression|43|||
149805138|NCT02060188|540415303|FG000|Overall Study|Study Drug Toxicity|10|||
149805139|NCT02060188|540415304|FG001|Overall Study|Study Drug Toxicity|18|||
149805140|NCT02060188|540415305|FG002|Overall Study|Study Drug Toxicity|7|||
149805141|NCT02060188|540415306|FG003|Overall Study|Study Drug Toxicity|4|||
149805142|NCT02060188|540415307|FG004|Overall Study|Study Drug Toxicity|3|||
149805143|NCT02060188|540415308|FG005|Overall Study|Study Drug Toxicity|0|||
149805144|NCT02060188|540415309|FG006|Overall Study|Study Drug Toxicity|2|||
149805145|NCT02060188|540415310|FG007|Overall Study|Study Drug Toxicity|5|||
149805146|NCT02060188|540415311|FG008|Overall Study|Study Drug Toxicity|0|||
149805147|NCT02060188|540415303|FG000|Overall Study|Adverse event unrelated to study drug|2|||
149805148|NCT02060188|540415304|FG001|Overall Study|Adverse event unrelated to study drug|5|||
149805149|NCT02060188|540415305|FG002|Overall Study|Adverse event unrelated to study drug|6|||
149805150|NCT02060188|540415306|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149805151|NCT02060188|540415307|FG004|Overall Study|Adverse event unrelated to study drug|1|||
149805152|NCT02060188|540415308|FG005|Overall Study|Adverse event unrelated to study drug|0|||
149805153|NCT02060188|540415309|FG006|Overall Study|Adverse event unrelated to study drug|4|||
149805154|NCT02060188|540415310|FG007|Overall Study|Adverse event unrelated to study drug|4|||
149805155|NCT02060188|540415311|FG008|Overall Study|Adverse event unrelated to study drug|1|||
149805156|NCT02060188|540415303|FG000|Overall Study|Participant request to discontinue study treatment|7|||
149805157|NCT02060188|540415304|FG001|Overall Study|Participant request to discontinue study treatment|7|||
149805158|NCT02060188|540415305|FG002|Overall Study|Participant request to discontinue study treatment|4|||
149805159|NCT02060188|540415306|FG003|Overall Study|Participant request to discontinue study treatment|0|||
149805160|NCT02060188|540415307|FG004|Overall Study|Participant request to discontinue study treatment|0|||
149805161|NCT02060188|540415308|FG005|Overall Study|Participant request to discontinue study treatment|0|||
149805162|NCT02060188|540415309|FG006|Overall Study|Participant request to discontinue study treatment|1|||
149805163|NCT02060188|540415310|FG007|Overall Study|Participant request to discontinue study treatment|1|||
149805164|NCT02060188|540415311|FG008|Overall Study|Participant request to discontinue study treatment|0|||
149805165|NCT02060188|540415303|FG000|Overall Study|Participant withdrew consent|3|||
149805166|NCT02060188|540415304|FG001|Overall Study|Participant withdrew consent|0|||
149805167|NCT02060188|540415305|FG002|Overall Study|Participant withdrew consent|0|||
149805168|NCT02060188|540415306|FG003|Overall Study|Participant withdrew consent|0|||
149805169|NCT02060188|540415307|FG004|Overall Study|Participant withdrew consent|0|||
149805170|NCT02060188|540415308|FG005|Overall Study|Participant withdrew consent|0|||
149805171|NCT02060188|540415309|FG006|Overall Study|Participant withdrew consent|0|||
149805172|NCT02060188|540415310|FG007|Overall Study|Participant withdrew consent|0|||
149805173|NCT02060188|540415311|FG008|Overall Study|Participant withdrew consent|0|||
149805174|NCT02060188|540415303|FG000|Overall Study|Maximum clinical benefit|13|||
149805175|NCT02060188|540415304|FG001|Overall Study|Maximum clinical benefit|38|||
149805176|NCT02060188|540415305|FG002|Overall Study|Maximum clinical benefit|19|||
149805177|NCT02060188|540415306|FG003|Overall Study|Maximum clinical benefit|0|||
149805178|NCT02060188|540415307|FG004|Overall Study|Maximum clinical benefit|0|||
149805179|NCT02060188|540415308|FG005|Overall Study|Maximum clinical benefit|0|||
149805180|NCT02060188|540415309|FG006|Overall Study|Maximum clinical benefit|0|||
149805181|NCT02060188|540415310|FG007|Overall Study|Maximum clinical benefit|10|||
149805182|NCT02060188|540415311|FG008|Overall Study|Maximum clinical benefit|0|||
149805183|NCT02060188|540415303|FG000|Overall Study|Other reason|3|||
149805184|NCT02060188|540415304|FG001|Overall Study|Other reason|7|||
149805185|NCT02060188|540415305|FG002|Overall Study|Other reason|0|||
149805186|NCT02060188|540415306|FG003|Overall Study|Other reason|1|||
149805187|NCT02060188|540415307|FG004|Overall Study|Other reason|0|||
149805188|NCT02060188|540415308|FG005|Overall Study|Other reason|0|||
149805189|NCT02060188|540415309|FG006|Overall Study|Other reason|0|||
149805190|NCT02060188|540415310|FG007|Overall Study|Other reason|9|||
149805191|NCT02060188|540415311|FG008|Overall Study|Other reason|0|||
150148585|NCT02006121|541680051|FG000|Double Blind Phase|Adverse Event|6|||
149805192|NCT02060188|540415303|FG000|Overall Study|Death|0|||
149805193|NCT02060188|540415304|FG001|Overall Study|Death|1|||
149805194|NCT02060188|540415305|FG002|Overall Study|Death|0|||
149805195|NCT02060188|540415306|FG003|Overall Study|Death|0|||
149805196|NCT02060188|540415307|FG004|Overall Study|Death|0|||
149805197|NCT02060188|540415308|FG005|Overall Study|Death|0|||
149805198|NCT02060188|540415309|FG006|Overall Study|Death|0|||
149805199|NCT02060188|540415310|FG007|Overall Study|Death|1|||
149805200|NCT02060188|540415311|FG008|Overall Study|Death|0|||
149805201|NCT02060188|540415303|FG000|Overall Study|Administrative reasons by sponsor|0|||
149805202|NCT02060188|540415304|FG001|Overall Study|Administrative reasons by sponsor|1|||
149805203|NCT02060188|540415305|FG002|Overall Study|Administrative reasons by sponsor|0|||
149805204|NCT02060188|540415306|FG003|Overall Study|Administrative reasons by sponsor|0|||
149805205|NCT02060188|540415307|FG004|Overall Study|Administrative reasons by sponsor|0|||
149805206|NCT02060188|540415308|FG005|Overall Study|Administrative reasons by sponsor|0|||
149805207|NCT02060188|540415309|FG006|Overall Study|Administrative reasons by sponsor|0|||
149805208|NCT02060188|540415310|FG007|Overall Study|Administrative reasons by sponsor|0|||
149805209|NCT02060188|540415311|FG008|Overall Study|Administrative reasons by sponsor|0|||
149805210|NCT02060188|540415303|FG000|Overall Study|Lost to Follow-up|0|||
149805211|NCT02060188|540415304|FG001|Overall Study|Lost to Follow-up|0|||
149805212|NCT02060188|540415305|FG002|Overall Study|Lost to Follow-up|1|||
149805213|NCT02060188|540415306|FG003|Overall Study|Lost to Follow-up|0|||
149805214|NCT02060188|540415307|FG004|Overall Study|Lost to Follow-up|0|||
149805215|NCT02060188|540415308|FG005|Overall Study|Lost to Follow-up|0|||
149805216|NCT02060188|540415309|FG006|Overall Study|Lost to Follow-up|0|||
149805217|NCT02060188|540415310|FG007|Overall Study|Lost to Follow-up|0|||
149805218|NCT02060188|540415311|FG008|Overall Study|Lost to Follow-up|0|||
149805219|NCT05455684|540415317|FG000|Overall Study|Withdrawal by Subject|7|||
149805220|NCT05455684|540415318|FG001|Overall Study|Withdrawal by Subject|4|||
149805221|NCT05455684|540415317|FG000|Overall Study|Lost to Follow-up|3|||
149805222|NCT05455684|540415318|FG001|Overall Study|Lost to Follow-up|3|||
149805223|NCT05455684|540415317|FG000|Overall Study|Adverse Event|2|||
149805224|NCT05455684|540415318|FG001|Overall Study|Adverse Event|3|||
149805225|NCT05455684|540415317|FG000|Overall Study|Protocol Violation|1|||
149805226|NCT05455684|540415318|FG001|Overall Study|Protocol Violation|1|||
149805227|NCT05455684|540415317|FG000|Overall Study|Non-Compliant with study drug|0|||
149805228|NCT05455684|540415318|FG001|Overall Study|Non-Compliant with study drug|1|||
149805229|NCT05455684|540415317|FG000|Overall Study|Other|1|||
149805230|NCT05455684|540415318|FG001|Overall Study|Other|2|||
149805231|NCT05455684|540415317|FG000|Overall Study|Randomized but not treated|1|||
149805232|NCT05455684|540415318|FG001|Overall Study|Randomized but not treated|0|||
149805233|NCT05204563|540415319|FG000|Overall Study|Other than Specified|2|||
149805234|NCT05204563|540415320|FG001|Overall Study|Other than Specified|1|||
149805235|NCT05204563|540415319|FG000|Overall Study|Death|18|||
149805236|NCT05204563|540415320|FG001|Overall Study|Death|4|||
149805237|NCT05204563|540415319|FG000|Overall Study|Lost to Follow-up|6|||
149805238|NCT05204563|540415320|FG001|Overall Study|Lost to Follow-up|3|||
149805239|NCT05204563|540415319|FG000|Overall Study|Withdrawal by Subject|12|||
149805240|NCT05204563|540415320|FG001|Overall Study|Withdrawal by Subject|3|||
149805241|NCT05204563|540415319|FG000|Overall Study|Enrolled, Not Treated|1|||
149805242|NCT05204563|540415320|FG001|Overall Study|Enrolled, Not Treated|0|||
149805243|NCT04411641|540415321|FG000|DB Period|Other|7|||
149805244|NCT04411641|540415322|FG001|DB Period|Other|27|||
149805245|NCT04411641|540415323|FG002|DB Period|Other|0|||
149805246|NCT04411641|540415324|FG003|DB Period|Other|0|||
149805247|NCT04411641|540415321|FG000|DB Period|Withdrawal by Subject|67|||
149805248|NCT04411641|540415322|FG001|DB Period|Withdrawal by Subject|122|||
149805249|NCT04411641|540415323|FG002|DB Period|Withdrawal by Subject|0|||
149805250|NCT04411641|540415324|FG003|DB Period|Withdrawal by Subject|0|||
149805251|NCT04411641|540415321|FG000|DB Period|Progressive disease|76|||
149805252|NCT04411641|540415322|FG001|DB Period|Progressive disease|116|||
149805253|NCT04411641|540415323|FG002|DB Period|Progressive disease|0|||
149805254|NCT04411641|540415324|FG003|DB Period|Progressive disease|0|||
149805255|NCT04411641|540415321|FG000|DB Period|Poor compliance to protocol|1|||
149805256|NCT04411641|540415322|FG001|DB Period|Poor compliance to protocol|5|||
149805257|NCT04411641|540415323|FG002|DB Period|Poor compliance to protocol|0|||
149805258|NCT04411641|540415324|FG003|DB Period|Poor compliance to protocol|0|||
149805259|NCT04411641|540415321|FG000|DB Period|Lack of Efficacy|19|||
149805260|NCT04411641|540415322|FG001|DB Period|Lack of Efficacy|19|||
149805261|NCT04411641|540415323|FG002|DB Period|Lack of Efficacy|0|||
149805262|NCT04411641|540415324|FG003|DB Period|Lack of Efficacy|0|||
149805263|NCT04411641|540415321|FG000|DB Period|Adverse Event|13|||
149805264|NCT04411641|540415322|FG001|DB Period|Adverse Event|29|||
149805265|NCT04411641|540415323|FG002|DB Period|Adverse Event|0|||
149805266|NCT04411641|540415324|FG003|DB Period|Adverse Event|0|||
149805267|NCT04411641|540415321|FG000|DB Period|Randomized and not treated|2|||
149805268|NCT04411641|540415322|FG001|DB Period|Randomized and not treated|2|||
149805269|NCT04411641|540415323|FG002|DB Period|Randomized and not treated|0|||
149805270|NCT04411641|540415324|FG003|DB Period|Randomized and not treated|0|||
149805271|NCT04411641|540415321|FG000|OL|Withdrawal by Subject|0|||
149805272|NCT04411641|540415322|FG001|OL|Withdrawal by Subject|0|||
149805273|NCT04411641|540415323|FG002|OL|Withdrawal by Subject|6|||
149805274|NCT04411641|540415324|FG003|OL|Withdrawal by Subject|17|||
149805275|NCT04411641|540415321|FG000|OL|Progressive disease|0|||
149805276|NCT04411641|540415322|FG001|OL|Progressive disease|0|||
149805277|NCT04411641|540415323|FG002|OL|Progressive disease|1|||
149805278|NCT04411641|540415324|FG003|OL|Progressive disease|2|||
149805279|NCT04411641|540415321|FG000|OL|Poor compliance to protocol|0|||
149805280|NCT04411641|540415322|FG001|OL|Poor compliance to protocol|0|||
149805281|NCT04411641|540415323|FG002|OL|Poor compliance to protocol|1|||
149805282|NCT04411641|540415324|FG003|OL|Poor compliance to protocol|0|||
149805283|NCT04411641|540415321|FG000|OL|Adverse Event|0|||
149805284|NCT04411641|540415322|FG001|OL|Adverse Event|0|||
149805285|NCT04411641|540415323|FG002|OL|Adverse Event|1|||
149805286|NCT04411641|540415324|FG003|OL|Adverse Event|0|||
149805287|NCT04411641|540415321|FG000|OL|Other|0|||
149805288|NCT04411641|540415322|FG001|OL|Other|0|||
149805289|NCT04411641|540415323|FG002|OL|Other|0|||
149805290|NCT04411641|540415324|FG003|OL|Other|6|||
149805291|NCT04342390|540415332|FG000|Overall Study|Lost to Follow-up|3|||
149805292|NCT04342390|540415333|FG001|Overall Study|Lost to Follow-up|0|||
149805293|NCT01233284|540415349|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
149805294|NCT01233284|540415350|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149805295|NCT01233284|540415351|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149805296|NCT01233284|540415352|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149805297|NCT01233284|540415353|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149805298|NCT01233284|540415349|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149805299|NCT01233284|540415350|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
149805300|NCT01233284|540415351|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149805301|NCT01233284|540415352|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149805302|NCT01233284|540415353|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149805303|NCT01233284|540415349|FG000|Period 1 (4 Weeks)|Other|0|||
149805304|NCT01233284|540415350|FG001|Period 1 (4 Weeks)|Other|0|||
149805305|NCT01233284|540415351|FG002|Period 1 (4 Weeks)|Other|1|||
149805306|NCT01233284|540415352|FG003|Period 1 (4 Weeks)|Other|0|||
149805307|NCT01233284|540415353|FG004|Period 1 (4 Weeks)|Other|0|||
149805308|NCT01233284|540415349|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
149805309|NCT01233284|540415350|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
149805310|NCT01233284|540415351|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
149805311|NCT01233284|540415352|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
149805312|NCT01233284|540415353|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
149805313|NCT01233284|540415349|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149805314|NCT01233284|540415350|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149805315|NCT01233284|540415351|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
149805316|NCT01233284|540415352|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149805317|NCT01233284|540415353|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149805318|NCT01233284|540415349|FG000|Period 3 (4 Weeks)|Other|0|||
149805319|NCT01233284|540415350|FG001|Period 3 (4 Weeks)|Other|0|||
149805320|NCT01233284|540415351|FG002|Period 3 (4 Weeks)|Other|0|||
149805321|NCT01233284|540415352|FG003|Period 3 (4 Weeks)|Other|1|||
149805322|NCT01233284|540415353|FG004|Period 3 (4 Weeks)|Other|0|||
149805323|NCT01233284|540415349|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
149805324|NCT01233284|540415350|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
149805325|NCT01233284|540415351|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
150148586|NCT02006121|541680052|FG001|Double Blind Phase|Adverse Event|0|||
149805326|NCT01233284|540415352|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
149805327|NCT01233284|540415353|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
149805328|NCT01233284|540415349|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
149805329|NCT01233284|540415350|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
149805330|NCT01233284|540415351|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
149805331|NCT01233284|540415352|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
149805332|NCT01233284|540415353|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
149805333|NCT05403502|540415355|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
149805334|NCT05403502|540415355|FG000|Humalog Lead-In Period|Physician Decision|2|||
149805335|NCT05403502|540415355|FG000|Humalog Lead-In Period|Protocol Violation|1|||
149805336|NCT05403502|540415355|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
149805337|NCT05403502|540415355|FG000|Lyumjev Treatment Period|Physician Decision|2|||
149805338|NCT01058707|540415356|FG000|Overall Study|Disease Progression|15|||
149805339|NCT01058707|540415357|FG001|Overall Study|Disease Progression|20|||
149805340|NCT01058707|540415358|FG002|Overall Study|Disease Progression|20|||
149805341|NCT01058707|540415359|FG003|Overall Study|Disease Progression|15|||
149805342|NCT01058707|540415360|FG004|Overall Study|Disease Progression|23|||
149805343|NCT01058707|540415361|FG005|Overall Study|Disease Progression|10|||
149805344|NCT01058707|540415362|FG006|Overall Study|Disease Progression|12|||
149805345|NCT01058707|540415356|FG000|Overall Study|Adverse Event|11|||
149805346|NCT01058707|540415357|FG001|Overall Study|Adverse Event|4|||
149805347|NCT01058707|540415358|FG002|Overall Study|Adverse Event|7|||
149805348|NCT01058707|540415359|FG003|Overall Study|Adverse Event|6|||
149805349|NCT01058707|540415360|FG004|Overall Study|Adverse Event|7|||
149805350|NCT01058707|540415361|FG005|Overall Study|Adverse Event|3|||
149805351|NCT01058707|540415362|FG006|Overall Study|Adverse Event|1|||
149805352|NCT01058707|540415356|FG000|Overall Study|Subject Decision|5|||
149805353|NCT01058707|540415357|FG001|Overall Study|Subject Decision|3|||
149805354|NCT01058707|540415358|FG002|Overall Study|Subject Decision|3|||
149805355|NCT01058707|540415359|FG003|Overall Study|Subject Decision|1|||
149805356|NCT01058707|540415360|FG004|Overall Study|Subject Decision|2|||
149805357|NCT01058707|540415361|FG005|Overall Study|Subject Decision|3|||
149805358|NCT01058707|540415362|FG006|Overall Study|Subject Decision|6|||
149805359|NCT01058707|540415356|FG000|Overall Study|Lost to Follow-up|0|||
149805360|NCT01058707|540415357|FG001|Overall Study|Lost to Follow-up|0|||
149805361|NCT01058707|540415358|FG002|Overall Study|Lost to Follow-up|1|||
149805362|NCT01058707|540415359|FG003|Overall Study|Lost to Follow-up|0|||
149805363|NCT01058707|540415360|FG004|Overall Study|Lost to Follow-up|0|||
149805364|NCT01058707|540415361|FG005|Overall Study|Lost to Follow-up|0|||
149805365|NCT01058707|540415362|FG006|Overall Study|Lost to Follow-up|0|||
149805366|NCT01058707|540415356|FG000|Overall Study|Reason Not Specified|0|||
149805367|NCT01058707|540415357|FG001|Overall Study|Reason Not Specified|3|||
149805368|NCT01058707|540415358|FG002|Overall Study|Reason Not Specified|2|||
149805369|NCT01058707|540415359|FG003|Overall Study|Reason Not Specified|0|||
149805370|NCT01058707|540415360|FG004|Overall Study|Reason Not Specified|7|||
149805371|NCT01058707|540415361|FG005|Overall Study|Reason Not Specified|1|||
149805372|NCT01058707|540415362|FG006|Overall Study|Reason Not Specified|7|||
149805373|NCT00167414|540415363|FG000|Overall Study|Death|10|||
149805374|NCT04814654|540415368|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
149805375|NCT04814654|540415369|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
149805376|NCT04814654|540415370|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
149805377|NCT01875731|540415371|FG000|Overall Study|Fail to obtain lab sample|1|||
149805378|NCT01875731|540415372|FG001|Overall Study|Fail to obtain lab sample|0|||
149805379|NCT03417102|540415373|FG000|Overall Study|Adverse Event|0|||
149805380|NCT03417102|540415374|FG001|Overall Study|Adverse Event|1|||
149805381|NCT03417102|540415373|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
149805382|NCT03417102|540415374|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
149805383|NCT03417102|540415373|FG000|Overall Study|Other|0|||
149805384|NCT03417102|540415374|FG001|Overall Study|Other|1|||
149805385|NCT03188991|540415375|FG000|Overall Study|Withdrawal by Subject|0|||
149805386|NCT03188991|540415376|FG001|Overall Study|Withdrawal by Subject|0|||
149805387|NCT03188991|540415377|FG002|Overall Study|Withdrawal by Subject|0|||
149805388|NCT03188991|540415378|FG003|Overall Study|Withdrawal by Subject|1|||
149805389|NCT03255226|540416777|FG000|Overall Study|Adverse Event|2|||
149805390|NCT03255226|540416777|FG000|Overall Study|Physician Decision|3|||
149805391|NCT03255226|540416777|FG000|Overall Study|Withdrawal by Subject|1|||
149805392|NCT03255226|540416777|FG000|Overall Study|Serum or blood sodium increased|4|||
149805393|NCT03255226|540416777|FG000|Overall Study|Serum or blood potassium increased|4|||
149805394|NCT00685763|540416778|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
149805395|NCT00685763|540416778|FG000|Overall Study|Protocol Violation|1|||
149805396|NCT00242567|540416779|FG000|Overall Study|Adverse Event|70|||
149805397|NCT00242567|540416780|FG001|Overall Study|Adverse Event|43|||
149805398|NCT00242567|540416779|FG000|Overall Study|Disease Progression|17|||
149805399|NCT00242567|540416780|FG001|Overall Study|Disease Progression|22|||
149805400|NCT00242567|540416779|FG000|Overall Study|Symptomatic deterioration|9|||
149805401|NCT00242567|540416780|FG001|Overall Study|Symptomatic deterioration|3|||
149805402|NCT00242567|540416779|FG000|Overall Study|Lack of Efficacy|2|||
149805403|NCT00242567|540416780|FG001|Overall Study|Lack of Efficacy|2|||
149805404|NCT00242567|540416779|FG000|Overall Study|Lost to Follow-up|9|||
149805405|NCT00242567|540416780|FG001|Overall Study|Lost to Follow-up|19|||
149805406|NCT00242567|540416779|FG000|Overall Study|Withdrawal by Subject|33|||
149805407|NCT00242567|540416780|FG001|Overall Study|Withdrawal by Subject|28|||
149805408|NCT00242567|540416779|FG000|Overall Study|Protocol Violation|12|||
149805409|NCT00242567|540416780|FG001|Overall Study|Protocol Violation|12|||
149805410|NCT00242567|540416779|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
149805411|NCT00242567|540416780|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
149805412|NCT00242567|540416779|FG000|Overall Study|Other|14|||
149805413|NCT00242567|540416780|FG001|Overall Study|Other|9|||
149805414|NCT01817764|540416781|FG000|Overall Study|Adverse Event|7|||
149805415|NCT01817764|540416782|FG001|Overall Study|Adverse Event|10|||
149805416|NCT01817764|540416781|FG000|Overall Study|Lack of Efficacy|9|||
149805417|NCT01817764|540416782|FG001|Overall Study|Lack of Efficacy|7|||
149805418|NCT01817764|540416781|FG000|Overall Study|Protocol Violation|7|||
149805419|NCT01817764|540416782|FG001|Overall Study|Protocol Violation|5|||
149805420|NCT01817764|540416781|FG000|Overall Study|Lost to Follow-up|1|||
149805421|NCT01817764|540416782|FG001|Overall Study|Lost to Follow-up|4|||
149805422|NCT01817764|540416781|FG000|Overall Study|Withdrawal by Subject|10|||
149805423|NCT01817764|540416782|FG001|Overall Study|Withdrawal by Subject|12|||
149805424|NCT01301625|540416788|FG000|Overall Study|Death|5|||
149805425|NCT01301625|540416788|FG000|Overall Study|Not Due|21|||
149805426|NCT01301625|540416788|FG000|Overall Study|Expected|8|||
149805427|NCT01301625|540416788|FG000|Overall Study|Lost to Follow-up|1|||
149805428|NCT00337727|540416789|FG000|Overall Study|Adverse Event|5|||
149805429|NCT00337727|540416790|FG001|Overall Study|Adverse Event|3|||
149805430|NCT00337727|540416789|FG000|Overall Study|Lost to Follow-up|5|||
149805431|NCT00337727|540416790|FG001|Overall Study|Lost to Follow-up|4|||
149805432|NCT00337727|540416789|FG000|Overall Study|Physician Decision|1|||
149805433|NCT00337727|540416790|FG001|Overall Study|Physician Decision|0|||
149805434|NCT00337727|540416789|FG000|Overall Study|Protocol Violation|4|||
149805435|NCT00337727|540416790|FG001|Overall Study|Protocol Violation|0|||
149805436|NCT00337727|540416789|FG000|Overall Study|Withdrawal by Subject|3|||
149805437|NCT00337727|540416790|FG001|Overall Study|Withdrawal by Subject|5|||
149805438|NCT06067191|540416793|FG000|Overall Study|Withdrawal by Subject|0|||
149805439|NCT06067191|540416794|FG001|Overall Study|Withdrawal by Subject|1|||
149805440|NCT00625846|540416796|FG000|Overall Study|Withdrawal by Subject|2|||
149805441|NCT00625846|540416797|FG001|Overall Study|Withdrawal by Subject|0|||
149805442|NCT00625846|540416798|FG002|Overall Study|Withdrawal by Subject|1|||
149805443|NCT00625846|540416799|FG003|Overall Study|Withdrawal by Subject|2|||
149805444|NCT01833897|540416805|FG000|Overall Study|Lack of Efficacy|1|||
149805445|NCT00669110|540416806|FG000|Overall Study|Adverse Event|4|||
149805446|NCT00669110|540416807|FG001|Overall Study|Adverse Event|3|||
149805447|NCT00669110|540416806|FG000|Overall Study|Caregiver request|3|||
149805448|NCT00669110|540416807|FG001|Overall Study|Caregiver request|2|||
149805449|NCT00669110|540416806|FG000|Overall Study|Physician Decision|0|||
149805450|NCT00669110|540416807|FG001|Overall Study|Physician Decision|1|||
149805451|NCT00669110|540416806|FG000|Overall Study|Lost to Follow-up|1|||
149805452|NCT00669110|540416807|FG001|Overall Study|Lost to Follow-up|0|||
149805453|NCT00669110|540416806|FG000|Overall Study|Protocol Violation|0|||
149805454|NCT00669110|540416807|FG001|Overall Study|Protocol Violation|5|||
149805455|NCT00669110|540416806|FG000|Overall Study|Withdrawal by Subject|0|||
149805456|NCT00669110|540416807|FG001|Overall Study|Withdrawal by Subject|2|||
149805457|NCT01244516|540416808|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
149805458|NCT01244516|540416809|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
149805459|NCT01244516|540416810|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
149805460|NCT01244516|540416808|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
149805461|NCT01244516|540416809|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
149805462|NCT01244516|540416810|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
149805463|NCT01244516|540416808|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
149805464|NCT01244516|540416809|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
149805465|NCT01244516|540416810|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
149805466|NCT01244516|540416808|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
149805467|NCT01244516|540416809|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
149805468|NCT01244516|540416810|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
149805469|NCT01244516|540416808|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
149805470|NCT01244516|540416809|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
149805471|NCT01244516|540416810|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
149805472|NCT01244516|540416808|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
149805473|NCT01244516|540416809|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
149805474|NCT01244516|540416810|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
149805475|NCT01244516|540416808|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
149805476|NCT01244516|540416809|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
149805477|NCT01244516|540416810|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
149805478|NCT02335411|540416814|FG000|Overall Study|Death|223|||
149805479|NCT02335411|540416815|FG001|Overall Study|Death|22|||
149805480|NCT02335411|540416816|FG002|Overall Study|Death|26|||
149805481|NCT02335411|540416814|FG000|Overall Study|Physician Decision|3|||
149805482|NCT02335411|540416815|FG001|Overall Study|Physician Decision|0|||
149805483|NCT02335411|540416816|FG002|Overall Study|Physician Decision|0|||
149805484|NCT02335411|540416814|FG000|Overall Study|Protocol Violation|1|||
149805485|NCT02335411|540416815|FG001|Overall Study|Protocol Violation|0|||
149805486|NCT02335411|540416816|FG002|Overall Study|Protocol Violation|0|||
149805487|NCT02335411|540416814|FG000|Overall Study|Withdrawal by Subject|11|||
149805488|NCT02335411|540416815|FG001|Overall Study|Withdrawal by Subject|0|||
149805489|NCT02335411|540416816|FG002|Overall Study|Withdrawal by Subject|3|||
149805490|NCT02335411|540416814|FG000|Overall Study|Sponsor Decision|12|||
149805491|NCT02335411|540416815|FG001|Overall Study|Sponsor Decision|3|||
149805492|NCT02335411|540416816|FG002|Overall Study|Sponsor Decision|2|||
149805493|NCT02335411|540416814|FG000|Overall Study|Adverse Event|9|||
149805494|NCT02335411|540416815|FG001|Overall Study|Adverse Event|0|||
150148587|NCT02006121|541680051|FG000|Double Blind Phase|Lack of Efficacy|1|||
149805495|NCT02335411|540416816|FG002|Overall Study|Adverse Event|0|||
149805496|NCT03075826|540416818|FG000|Overall Study|Withdrawal by Subject|1|||
149805497|NCT03075826|540416818|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
149805498|NCT04456998|540416821|FG000|Overall Study|Adverse Event|0|||
149805499|NCT04456998|540416822|FG001|Overall Study|Adverse Event|4|||
149805500|NCT04456998|540416821|FG000|Overall Study|Protocol Deviation|0|||
149805501|NCT04456998|540416822|FG001|Overall Study|Protocol Deviation|1|||
149805502|NCT04456998|540416821|FG000|Overall Study|Withdrawal by Subject|0|||
149805503|NCT04456998|540416822|FG001|Overall Study|Withdrawal by Subject|1|||
149805504|NCT03707145|540416823|FG000|Overall Study|Lost to Follow-up|0|||
149805505|NCT03707145|540416824|FG001|Overall Study|Lost to Follow-up|1|||
149805506|NCT03707145|540416825|FG002|Overall Study|Lost to Follow-up|1|||
149805507|NCT03707145|540416826|FG003|Overall Study|Lost to Follow-up|0|||
149805508|NCT04221477|540416827|FG000|Overall Study|Adverse Event|1|||
149805509|NCT04221477|540416828|FG001|Overall Study|Adverse Event|1|||
149805510|NCT04221477|540416827|FG000|Overall Study|Death|5|||
149805511|NCT04221477|540416828|FG001|Overall Study|Death|4|||
149805512|NCT04221477|540416827|FG000|Overall Study|Lack of Efficacy|1|||
149805513|NCT04221477|540416828|FG001|Overall Study|Lack of Efficacy|2|||
149805514|NCT04221477|540416827|FG000|Overall Study|Lost to Follow-up|1|||
149805515|NCT04221477|540416828|FG001|Overall Study|Lost to Follow-up|2|||
149805516|NCT04221477|540416827|FG000|Overall Study|Non-compliance with Study Drug|1|||
149805517|NCT04221477|540416828|FG001|Overall Study|Non-compliance with Study Drug|0|||
149805518|NCT04221477|540416827|FG000|Overall Study|Reason not Specified|0|||
149805519|NCT04221477|540416828|FG001|Overall Study|Reason not Specified|5|||
149805520|NCT04221477|540416827|FG000|Overall Study|Physician Decision|0|||
149805521|NCT04221477|540416828|FG001|Overall Study|Physician Decision|6|||
149805522|NCT04221477|540416827|FG000|Overall Study|Withdrawal by Subject|10|||
149805523|NCT04221477|540416828|FG001|Overall Study|Withdrawal by Subject|14|||
149805524|NCT04221477|540416827|FG000|Overall Study|Ongoing in the Study|116|||
149805525|NCT04221477|540416828|FG001|Overall Study|Ongoing in the Study|102|||
149805526|NCT05012943|540416830|FG000|Overall Study|Adverse Event|2|||
149805527|NCT05012943|540416831|FG001|Overall Study|Adverse Event|1|||
149805528|NCT05012943|540416832|FG002|Overall Study|Adverse Event|0|||
149805529|NCT05012943|540416830|FG000|Overall Study|Withdrawal by Subject|1052|||
149805530|NCT05012943|540416831|FG001|Overall Study|Withdrawal by Subject|1006|||
149805531|NCT05012943|540416832|FG002|Overall Study|Withdrawal by Subject|20|||
149805532|NCT05012943|540416830|FG000|Overall Study|Death|25|||
149805533|NCT05012943|540416831|FG001|Overall Study|Death|17|||
149805534|NCT05012943|540416832|FG002|Overall Study|Death|4|||
149805535|NCT05012943|540416830|FG000|Overall Study|Lost to Follow-up|11|||
149805536|NCT05012943|540416831|FG001|Overall Study|Lost to Follow-up|24|||
149805537|NCT05012943|540416832|FG002|Overall Study|Lost to Follow-up|3|||
149805538|NCT05012943|540416830|FG000|Overall Study|Physician Decision|1|||
149805539|NCT05012943|540416831|FG001|Overall Study|Physician Decision|1|||
149805540|NCT05012943|540416832|FG002|Overall Study|Physician Decision|0|||
149805541|NCT05012943|540416830|FG000|Overall Study|Other than Specified|2|||
149805542|NCT05012943|540416831|FG001|Overall Study|Other than Specified|1|||
149805543|NCT05012943|540416832|FG002|Overall Study|Other than Specified|0|||
149805544|NCT04228107|540416833|FG000|Overall Study|Protocol Violation|1|||
149805545|NCT04228107|540416834|FG001|Overall Study|Protocol Violation|0|||
149805546|NCT04228107|540416833|FG000|Overall Study|Withdrawal by Subject|6|||
149805547|NCT04228107|540416834|FG001|Overall Study|Withdrawal by Subject|0|||
149805548|NCT04228107|540416833|FG000|Overall Study|Lost to Follow-up|18|||
149805549|NCT04228107|540416834|FG001|Overall Study|Lost to Follow-up|0|||
149805550|NCT04228107|540416833|FG000|Overall Study|No controller use data|1|||
149805551|NCT04228107|540416834|FG001|Overall Study|No controller use data|0|||
149805552|NCT04228107|540416833|FG000|Overall Study|No medication data collected|1|||
149805553|NCT04228107|540416834|FG001|Overall Study|No medication data collected|0|||
149805554|NCT00400985|540416835|FG000|Overall Study|Withdrawal by Subject|5|||
149805555|NCT00400985|540416835|FG000|Overall Study|system modification|8|||
149805556|NCT00400985|540416835|FG000|Overall Study|Death|30|||
149805557|NCT00400985|540416835|FG000|Overall Study|Lost to Follow-up|9|||
149805558|NCT00965562|540416836|FG000|Overall Study|Lost to Follow-up|1|||
149805559|NCT00965562|540416837|FG001|Overall Study|Lost to Follow-up|2|||
149805560|NCT00965562|540416838|FG002|Overall Study|Lost to Follow-up|3|||
149805561|NCT00965562|540416836|FG000|Overall Study|Withdrawal by Subject|2|||
149805562|NCT00965562|540416837|FG001|Overall Study|Withdrawal by Subject|2|||
149805563|NCT00965562|540416838|FG002|Overall Study|Withdrawal by Subject|0|||
149805564|NCT03792633|540416839|FG000|Overall Study|Alternative Treatment|17|||
149805565|NCT03792633|540416840|FG001|Overall Study|Alternative Treatment|19|||
149805566|NCT03792633|540416839|FG000|Overall Study|Death|2|||
149805567|NCT03792633|540416840|FG001|Overall Study|Death|0|||
149805568|NCT03792633|540416839|FG000|Overall Study|Disease progression|8|||
149805569|NCT03792633|540416840|FG001|Overall Study|Disease progression|9|||
149805570|NCT03792633|540416839|FG000|Overall Study|Lost to Follow-up|1|||
149805571|NCT03792633|540416840|FG001|Overall Study|Lost to Follow-up|1|||
149805572|NCT03792633|540416839|FG000|Overall Study|Screen fail|1|||
149805573|NCT03792633|540416840|FG001|Overall Study|Screen fail|0|||
149805574|NCT03792633|540416839|FG000|Overall Study|Second malignancy|0|||
149805575|NCT03792633|540416840|FG001|Overall Study|Second malignancy|1|||
149805576|NCT05048875|540416842|FG000|Overall Study|Withdrawal by Subject|1|||
149805577|NCT05048875|540416843|FG001|Overall Study|Withdrawal by Subject|0|||
149805578|NCT05048875|540416844|FG002|Overall Study|Withdrawal by Subject|0|||
149805579|NCT05048875|540416845|FG003|Overall Study|Withdrawal by Subject|0|||
149805580|NCT05048875|540416846|FG004|Overall Study|Withdrawal by Subject|0|||
149805581|NCT05048875|540416847|FG005|Overall Study|Withdrawal by Subject|0|||
149805582|NCT05048875|540416848|FG006|Overall Study|Withdrawal by Subject|0|||
149805583|NCT05048875|540416849|FG007|Overall Study|Withdrawal by Subject|0|||
149805584|NCT05048875|540416842|FG000|Overall Study|Adverse Event|0|||
149805585|NCT05048875|540416843|FG001|Overall Study|Adverse Event|0|||
149805586|NCT05048875|540416844|FG002|Overall Study|Adverse Event|0|||
149805587|NCT05048875|540416845|FG003|Overall Study|Adverse Event|1|||
149805588|NCT05048875|540416846|FG004|Overall Study|Adverse Event|0|||
149805589|NCT05048875|540416847|FG005|Overall Study|Adverse Event|0|||
149805590|NCT05048875|540416848|FG006|Overall Study|Adverse Event|0|||
149805591|NCT05048875|540416849|FG007|Overall Study|Adverse Event|0|||
149805592|NCT04755283|540416850|FG000|Overall Study|Withdrawal by Subject|14|||
149805593|NCT04755283|540416851|FG001|Overall Study|Withdrawal by Subject|3|||
149805594|NCT04755283|540416852|FG002|Overall Study|Withdrawal by Subject|6|||
149805595|NCT04755283|540416850|FG000|Overall Study|Lost to Follow-up|0|||
149805596|NCT04755283|540416851|FG001|Overall Study|Lost to Follow-up|0|||
149805597|NCT04755283|540416852|FG002|Overall Study|Lost to Follow-up|1|||
149805598|NCT04755283|540416850|FG000|Overall Study|Death|31|||
149805599|NCT04755283|540416851|FG001|Overall Study|Death|36|||
149805600|NCT04755283|540416852|FG002|Overall Study|Death|34|||
149805601|NCT04410978|540416866|FG000|Overall Study|Poor compliance to protocol|2|||
149805602|NCT04410978|540416867|FG001|Overall Study|Poor compliance to protocol|4|||
149805603|NCT04410978|540416866|FG000|Overall Study|Withdrawal by Subject|64|||
149805604|NCT04410978|540416867|FG001|Overall Study|Withdrawal by Subject|66|||
149805605|NCT04410978|540416866|FG000|Overall Study|Other|6|||
149805606|NCT04410978|540416867|FG001|Overall Study|Other|7|||
149805607|NCT04410978|540416866|FG000|Overall Study|Missing study status|1|||
149805608|NCT04410978|540416867|FG001|Overall Study|Missing study status|0|||
149805609|NCT02684162|540416870|FG000|Overall Study|Physician Decision|0|||
149805610|NCT02684162|540416871|FG001|Overall Study|Physician Decision|1|||
149805611|NCT02684162|540416872|FG002|Overall Study|Physician Decision|0|||
149805612|NCT05153629|540416873|FG000|Overall Study|Withdrawal by Subject|0|||
149805613|NCT05153629|540416874|FG001|Overall Study|Withdrawal by Subject|2|||
149805614|NCT04089566|540416879|FG000|Overall Study|Death|0|||
149805615|NCT04089566|540416880|FG001|Overall Study|Death|6|||
149805616|NCT04089566|540416881|FG002|Overall Study|Death|10|||
149805617|NCT04089566|540416882|FG003|Overall Study|Death|0|||
149805618|NCT04089566|540416883|FG004|Overall Study|Death|0|||
149805619|NCT04089566|540416884|FG005|Overall Study|Death|0|||
149805620|NCT04089566|540416879|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
149805621|NCT04089566|540416880|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
149805622|NCT04089566|540416881|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
149805623|NCT04089566|540416882|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
149805624|NCT04089566|540416883|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
149805625|NCT04089566|540416884|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
149805626|NCT04089566|540416879|FG000|Overall Study|Reason not Specified|0|||
149805627|NCT04089566|540416880|FG001|Overall Study|Reason not Specified|4|||
149805628|NCT04089566|540416881|FG002|Overall Study|Reason not Specified|4|||
149805629|NCT04089566|540416882|FG003|Overall Study|Reason not Specified|1|||
149805630|NCT04089566|540416883|FG004|Overall Study|Reason not Specified|0|||
149805631|NCT04089566|540416884|FG005|Overall Study|Reason not Specified|0|||
149805632|NCT01083121|540416885|FG000|Overall Study|Use of Humira outside the approved label|81|||
149805633|NCT03743571|540416891|FG000|Overall Study|Withdrawal by Subject|1|||
149805634|NCT03743571|540416892|FG001|Overall Study|Withdrawal by Subject|1|||
149805635|NCT03743571|540416891|FG000|Overall Study|Lost to Follow-up|1|||
149805636|NCT03743571|540416892|FG001|Overall Study|Lost to Follow-up|2|||
149805637|NCT04115488|540416893|FG000|Overall Study|Adverse Event|8|||
149805638|NCT04115488|540416894|FG001|Overall Study|Adverse Event|4|||
149805639|NCT04115488|540416893|FG000|Overall Study|Withdrawal by Subject|3|||
149805640|NCT04115488|540416894|FG001|Overall Study|Withdrawal by Subject|6|||
149805641|NCT04115488|540416893|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
149805642|NCT04115488|540416894|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
149805643|NCT04115488|540416893|FG000|Overall Study|Patient 's location change|1|||
149805644|NCT04115488|540416894|FG001|Overall Study|Patient 's location change|0|||
149805645|NCT04115488|540416893|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
149805646|NCT04115488|540416894|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
149805647|NCT00885677|540416895|FG000|Overall Study|Death|40|||
149805648|NCT00885677|540416896|FG001|Overall Study|Death|34|||
149805649|NCT00885677|540416895|FG000|Overall Study|Lost to Follow-up|15|||
149805650|NCT00885677|540416896|FG001|Overall Study|Lost to Follow-up|13|||
149805651|NCT00885677|540416895|FG000|Overall Study|Protocol Violation|54|||
149805652|NCT00885677|540416896|FG001|Overall Study|Protocol Violation|54|||
149805653|NCT00885677|540416895|FG000|Overall Study|premature study closure|41|||
149805654|NCT00885677|540416896|FG001|Overall Study|premature study closure|44|||
149805655|NCT00885677|540416895|FG000|Overall Study|device/lead revision or replacement|7|||
149805656|NCT00885677|540416896|FG001|Overall Study|device/lead revision or replacement|6|||
149805657|NCT00885677|540416895|FG000|Overall Study|Heart transplantation|1|||
149805658|NCT00885677|540416896|FG001|Overall Study|Heart transplantation|0|||
149805659|NCT00885677|540416895|FG000|Overall Study|Inclusion/exclusion not met|25|||
149805660|NCT00885677|540416896|FG001|Overall Study|Inclusion/exclusion not met|27|||
149805661|NCT00795886|540416899|FG000|Overall Study|Death|10|||
149805662|NCT00157820|540416902|FG000|Randomized|Physician Decision|4|||
149805663|NCT00157820|540416903|FG001|Randomized|Physician Decision|2|||
149805664|NCT00157820|540416904|FG002|Randomized|Physician Decision|3|||
149805665|NCT00157820|540416902|FG000|Randomized|Withdrawal by Subject|1|||
149805666|NCT00157820|540416903|FG001|Randomized|Withdrawal by Subject|2|||
149805667|NCT00157820|540416904|FG002|Randomized|Withdrawal by Subject|3|||
149805668|NCT00157820|540416902|FG000|Randomized|Protocol Violation|2|||
149805669|NCT00157820|540416903|FG001|Randomized|Protocol Violation|1|||
149805670|NCT00157820|540416904|FG002|Randomized|Protocol Violation|2|||
149805671|NCT00157820|540416902|FG000|1st 8 Month|Death|7|||
149805672|NCT00157820|540416903|FG001|1st 8 Month|Death|8|||
149805673|NCT00157820|540416904|FG002|1st 8 Month|Death|3|||
149805674|NCT00157820|540416902|FG000|1st 8 Month|Lost to Follow-up|1|||
149805675|NCT00157820|540416903|FG001|1st 8 Month|Lost to Follow-up|2|||
149805676|NCT00157820|540416904|FG002|1st 8 Month|Lost to Follow-up|1|||
149805677|NCT00157820|540416902|FG000|1st 8 Month|Premature cross-over|0|||
149805678|NCT00157820|540416903|FG001|1st 8 Month|Premature cross-over|2|||
149805679|NCT00157820|540416904|FG002|1st 8 Month|Premature cross-over|2|||
149805680|NCT00157820|540416902|FG000|2nd 8 Months|Death|3|||
149805681|NCT00157820|540416903|FG001|2nd 8 Months|Death|1|||
149805682|NCT00157820|540416904|FG002|2nd 8 Months|Death|3|||
149805683|NCT00157820|540416902|FG000|2nd 8 Months|Lost to Follow-up|1|||
149805684|NCT00157820|540416903|FG001|2nd 8 Months|Lost to Follow-up|5|||
149805685|NCT00157820|540416904|FG002|2nd 8 Months|Lost to Follow-up|2|||
149805686|NCT00157820|540416902|FG000|2nd 8 Months|Premature cross-over|1|||
149805687|NCT00157820|540416903|FG001|2nd 8 Months|Premature cross-over|7|||
149805688|NCT00157820|540416904|FG002|2nd 8 Months|Premature cross-over|9|||
149805689|NCT02674568|540418869|FG000|Overall Study|Withdrawal by Subject|5|||
149805690|NCT02674568|540418869|FG000|Overall Study|Death|303|||
149805691|NCT02674568|540418869|FG000|Overall Study|Physician Decision|2|||
149805692|NCT02674568|540418869|FG000|Overall Study|Lost to Follow-up|9|||
149805693|NCT02674568|540418869|FG000|Overall Study|Other, Not Specified|20|||
149805694|NCT01118949|540418872|FG000|Overall Study|Adverse Event|5|||
149805695|NCT01118949|540418872|FG000|Overall Study|Withdrawal by Subject|4|||
149805696|NCT03457727|540418881|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
149805697|NCT03457727|540418882|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
149805698|NCT03457727|540418883|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
149805699|NCT03457727|540418884|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
149805700|NCT00464308|540418885|FG000|Overall Study|Adverse Event|22|||
149805701|NCT00464308|540418886|FG001|Overall Study|Adverse Event|27|||
149805702|NCT00464308|540418887|FG002|Overall Study|Adverse Event|16|||
149805703|NCT00464308|540418885|FG000|Overall Study|Lost to Follow-up|29|||
149805704|NCT00464308|540418886|FG001|Overall Study|Lost to Follow-up|19|||
149805705|NCT00464308|540418887|FG002|Overall Study|Lost to Follow-up|20|||
149805706|NCT00464308|540418885|FG000|Overall Study|Patient discontinued and other reasons|17|||
149805707|NCT00464308|540418886|FG001|Overall Study|Patient discontinued and other reasons|17|||
149805708|NCT00464308|540418887|FG002|Overall Study|Patient discontinued and other reasons|23|||
149805709|NCT00464308|540418885|FG000|Overall Study|Physician Decision|1|||
149805710|NCT00464308|540418886|FG001|Overall Study|Physician Decision|0|||
149805711|NCT00464308|540418887|FG002|Overall Study|Physician Decision|0|||
149805712|NCT01721200|540418888|FG000|Overall Study|Lost to Follow-up|3|||
149805713|NCT01721200|540418889|FG001|Overall Study|Lost to Follow-up|5|||
149805714|NCT00630994|540418890|FG000|Overall Study|Adverse Event|1|||
149805715|NCT00630994|540418890|FG000|Overall Study|Disease Progression|1|||
149805716|NCT00630994|540418890|FG000|Overall Study|Lack of Efficacy|1|||
149805717|NCT00630994|540418890|FG000|Overall Study|Other|1|||
149805718|NCT03533608|540418891|FG000|Overall Study|Withdrawal by Subject|3|||
149805719|NCT03533608|540418891|FG000|Overall Study|Physician Decision|2|||
149805720|NCT03286426|540418892|FG000|Overall Study|Physician Decision|3|||
149805721|NCT05553600|540418893|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
149805722|NCT05553600|540418894|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
149805723|NCT05553600|540418895|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
149805724|NCT05553600|540418896|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
149805725|NCT05553600|540418893|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
149805726|NCT05553600|540418894|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
149805727|NCT05553600|540418895|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
149805728|NCT05553600|540418896|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
149805729|NCT05553600|540418893|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
149805730|NCT05553600|540418894|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
149805731|NCT05553600|540418895|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
149805732|NCT05553600|540418896|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
149805733|NCT05553600|540418893|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
149805734|NCT05553600|540418894|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
149805735|NCT05553600|540418895|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
149805736|NCT05553600|540418896|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
149805737|NCT05553600|540418893|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
149805738|NCT05553600|540418894|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
149805739|NCT05553600|540418895|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
149805740|NCT05553600|540418896|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
149805741|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
149805742|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
149805743|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
149805744|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
149805745|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
149805746|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
149805747|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
149805748|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
149805749|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
149805750|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
149805751|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
149805752|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
149805753|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
149805754|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
149805755|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
149805756|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
149805757|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
149805758|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
149805759|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
149805760|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
149805761|NCT05553600|540418893|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
149805762|NCT05553600|540418894|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
149805763|NCT05553600|540418895|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
149805764|NCT05553600|540418896|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
149805765|NCT05553600|540418893|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
149805766|NCT05553600|540418894|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
149805767|NCT05553600|540418895|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
149805768|NCT05553600|540418896|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
149805769|NCT04930536|540418897|FG000|Overall Study|Adverse Event|1|||
149805770|NCT04930536|540418898|FG001|Overall Study|Adverse Event|0|||
149805771|NCT04930536|540418897|FG000|Overall Study|Disease Progression|2|||
149805772|NCT04930536|540418898|FG001|Overall Study|Disease Progression|0|||
149805773|NCT04930536|540418897|FG000|Overall Study|Patient Decision|4|||
149805774|NCT04930536|540418898|FG001|Overall Study|Patient Decision|2|||
149805775|NCT04930536|540418897|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
149805776|NCT04930536|540418898|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
149805777|NCT04292171|540418899|FG000|Overall Study|Pharmacy error|2|||
149805778|NCT04292171|540418900|FG001|Overall Study|Pharmacy error|0|||
149805779|NCT04292171|540418899|FG000|Overall Study|Delivered prior to procedure|0|||
149805780|NCT04292171|540418900|FG001|Overall Study|Delivered prior to procedure|1|||
149805781|NCT02116309|540418902|FG000|Overall Study|Lost to Follow-up|0|||
149805782|NCT02116309|540418903|FG001|Overall Study|Lost to Follow-up|1|||
149805783|NCT00471237|540418904|FG000|Overall Study|Adverse Event|6|||
149805784|NCT00471237|540418905|FG001|Overall Study|Adverse Event|5|||
149805785|NCT00471237|540418906|FG002|Overall Study|Adverse Event|4|||
149805786|NCT00471237|540418907|FG003|Overall Study|Adverse Event|8|||
149805787|NCT00471237|540418908|FG004|Overall Study|Adverse Event|7|||
149805788|NCT00471237|540418909|FG005|Overall Study|Adverse Event|5|||
149805789|NCT00471237|540418910|FG006|Overall Study|Adverse Event|0|||
149805790|NCT00471237|540418904|FG000|Overall Study|Lost to Follow-up|1|||
149805791|NCT00471237|540418905|FG001|Overall Study|Lost to Follow-up|1|||
149805792|NCT00471237|540418906|FG002|Overall Study|Lost to Follow-up|0|||
149805793|NCT00471237|540418907|FG003|Overall Study|Lost to Follow-up|2|||
149805794|NCT00471237|540418908|FG004|Overall Study|Lost to Follow-up|3|||
149805795|NCT00471237|540418909|FG005|Overall Study|Lost to Follow-up|0|||
150148588|NCT02006121|541680052|FG001|Double Blind Phase|Lack of Efficacy|16|||
150148589|NCT02006121|541680051|FG000|Double Blind Phase|Withdrawal by Subject|3|||
149805796|NCT00471237|540418910|FG006|Overall Study|Lost to Follow-up|0|||
149805797|NCT00471237|540418904|FG000|Overall Study|Protocol Violation|3|||
149805798|NCT00471237|540418905|FG001|Overall Study|Protocol Violation|6|||
149805799|NCT00471237|540418906|FG002|Overall Study|Protocol Violation|3|||
149805800|NCT00471237|540418907|FG003|Overall Study|Protocol Violation|2|||
149805801|NCT00471237|540418908|FG004|Overall Study|Protocol Violation|2|||
149805802|NCT00471237|540418909|FG005|Overall Study|Protocol Violation|4|||
149805803|NCT00471237|540418910|FG006|Overall Study|Protocol Violation|1|||
149918893|NCT01210352|540835244|FG003|Overall Study|Lack of Efficacy|0|||
149805804|NCT00471237|540418904|FG000|Overall Study|Withdrawal by Subject|8|||
149805805|NCT00471237|540418905|FG001|Overall Study|Withdrawal by Subject|6|||
149805806|NCT00471237|540418906|FG002|Overall Study|Withdrawal by Subject|5|||
149805807|NCT00471237|540418907|FG003|Overall Study|Withdrawal by Subject|8|||
149805808|NCT00471237|540418908|FG004|Overall Study|Withdrawal by Subject|7|||
149805809|NCT00471237|540418909|FG005|Overall Study|Withdrawal by Subject|4|||
149805810|NCT00471237|540418910|FG006|Overall Study|Withdrawal by Subject|2|||
149805811|NCT00471237|540418904|FG000|Overall Study|Sponsor terminated study|20|||
149805812|NCT00471237|540418905|FG001|Overall Study|Sponsor terminated study|23|||
149805813|NCT00471237|540418906|FG002|Overall Study|Sponsor terminated study|19|||
149805814|NCT00471237|540418907|FG003|Overall Study|Sponsor terminated study|22|||
149805815|NCT00471237|540418908|FG004|Overall Study|Sponsor terminated study|18|||
149805816|NCT00471237|540418909|FG005|Overall Study|Sponsor terminated study|24|||
149805817|NCT00471237|540418910|FG006|Overall Study|Sponsor terminated study|0|||
149805818|NCT00471237|540418904|FG000|Overall Study|Non-compliance|0|||
149805819|NCT00471237|540418905|FG001|Overall Study|Non-compliance|1|||
149805820|NCT00471237|540418906|FG002|Overall Study|Non-compliance|0|||
149805821|NCT00471237|540418907|FG003|Overall Study|Non-compliance|1|||
149805822|NCT00471237|540418908|FG004|Overall Study|Non-compliance|0|||
149805823|NCT00471237|540418909|FG005|Overall Study|Non-compliance|0|||
149805824|NCT00471237|540418910|FG006|Overall Study|Non-compliance|0|||
149805825|NCT00471237|540418904|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
149805826|NCT00471237|540418905|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
149805827|NCT00471237|540418906|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
149805828|NCT00471237|540418907|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
149805829|NCT00471237|540418908|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
149805830|NCT00471237|540418909|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
149805831|NCT00471237|540418910|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
149805832|NCT00471237|540418904|FG000|Overall Study|Early stopping due to non-efficacy|1|||
149805833|NCT00471237|540418905|FG001|Overall Study|Early stopping due to non-efficacy|0|||
149805834|NCT00471237|540418906|FG002|Overall Study|Early stopping due to non-efficacy|0|||
149805835|NCT00471237|540418907|FG003|Overall Study|Early stopping due to non-efficacy|0|||
149805836|NCT00471237|540418908|FG004|Overall Study|Early stopping due to non-efficacy|1|||
149805837|NCT00471237|540418909|FG005|Overall Study|Early stopping due to non-efficacy|0|||
149805838|NCT00471237|540418910|FG006|Overall Study|Early stopping due to non-efficacy|0|||
149805839|NCT00471237|540418904|FG000|Overall Study|Participant planned to travel to abraod|1|||
149805840|NCT00471237|540418905|FG001|Overall Study|Participant planned to travel to abraod|0|||
149805841|NCT00471237|540418906|FG002|Overall Study|Participant planned to travel to abraod|0|||
149805842|NCT00471237|540418907|FG003|Overall Study|Participant planned to travel to abraod|0|||
149805843|NCT00471237|540418908|FG004|Overall Study|Participant planned to travel to abraod|0|||
149805844|NCT00471237|540418909|FG005|Overall Study|Participant planned to travel to abraod|1|||
149805845|NCT00471237|540418910|FG006|Overall Study|Participant planned to travel to abraod|0|||
149805846|NCT00471237|540418904|FG000|Overall Study|High parathyroid hormone|0|||
149805847|NCT00471237|540418905|FG001|Overall Study|High parathyroid hormone|0|||
149805848|NCT00471237|540418906|FG002|Overall Study|High parathyroid hormone|1|||
149805849|NCT00471237|540418907|FG003|Overall Study|High parathyroid hormone|0|||
149805850|NCT00471237|540418908|FG004|Overall Study|High parathyroid hormone|0|||
149805851|NCT00471237|540418909|FG005|Overall Study|High parathyroid hormone|0|||
149805852|NCT00471237|540418910|FG006|Overall Study|High parathyroid hormone|0|||
149805853|NCT00471237|540418904|FG000|Overall Study|Participant lost medication|0|||
149805854|NCT00471237|540418905|FG001|Overall Study|Participant lost medication|0|||
149805855|NCT00471237|540418906|FG002|Overall Study|Participant lost medication|0|||
149805856|NCT00471237|540418907|FG003|Overall Study|Participant lost medication|0|||
149805857|NCT00471237|540418908|FG004|Overall Study|Participant lost medication|1|||
149805858|NCT00471237|540418909|FG005|Overall Study|Participant lost medication|0|||
149805859|NCT00471237|540418910|FG006|Overall Study|Participant lost medication|0|||
149805860|NCT00471237|540418904|FG000|Overall Study|Administration of prohibited medicine|0|||
149805861|NCT00471237|540418905|FG001|Overall Study|Administration of prohibited medicine|0|||
149805862|NCT00471237|540418906|FG002|Overall Study|Administration of prohibited medicine|0|||
149805863|NCT00471237|540418907|FG003|Overall Study|Administration of prohibited medicine|0|||
149805864|NCT00471237|540418908|FG004|Overall Study|Administration of prohibited medicine|1|||
149805865|NCT00471237|540418909|FG005|Overall Study|Administration of prohibited medicine|0|||
149805866|NCT00471237|540418910|FG006|Overall Study|Administration of prohibited medicine|0|||
149805867|NCT00471237|540418904|FG000|Overall Study|Participant shifted residence|0|||
149805868|NCT00471237|540418905|FG001|Overall Study|Participant shifted residence|0|||
149805869|NCT00471237|540418906|FG002|Overall Study|Participant shifted residence|0|||
149805870|NCT00471237|540418907|FG003|Overall Study|Participant shifted residence|0|||
149805871|NCT00471237|540418908|FG004|Overall Study|Participant shifted residence|1|||
149805872|NCT00471237|540418909|FG005|Overall Study|Participant shifted residence|0|||
149805873|NCT00471237|540418910|FG006|Overall Study|Participant shifted residence|0|||
149805874|NCT00471237|540418904|FG000|Overall Study|Participant's decision|0|||
149805875|NCT00471237|540418905|FG001|Overall Study|Participant's decision|0|||
150148590|NCT02006121|541680052|FG001|Double Blind Phase|Withdrawal by Subject|4|||
150148591|NCT02006121|541680051|FG000|Double Blind Phase|Non-compliance with study drug|1|||
150148592|NCT02006121|541680052|FG001|Double Blind Phase|Non-compliance with study drug|3|||
150148593|NCT02006121|541680051|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
150148594|NCT02006121|541680052|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
150148595|NCT02006121|541680051|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
150148596|NCT02006121|541680052|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
150148597|NCT02006121|541680051|FG000|Open Label Phase|Adverse Event|15|||
150148598|NCT02006121|541680052|FG001|Open Label Phase|Adverse Event|0|||
150148599|NCT02006121|541680051|FG000|Open Label Phase|Lack of Efficacy|2|||
150148600|NCT02006121|541680052|FG001|Open Label Phase|Lack of Efficacy|0|||
150148601|NCT02006121|541680051|FG000|Open Label Phase|Protocol Violation|2|||
150148602|NCT02006121|541680052|FG001|Open Label Phase|Protocol Violation|0|||
150148603|NCT02006121|541680051|FG000|Open Label Phase|Withdrawal by Subject|3|||
150148604|NCT02006121|541680052|FG001|Open Label Phase|Withdrawal by Subject|0|||
150148605|NCT02006121|541680051|FG000|Open Label Phase|Non-compliance with study drug|3|||
150148606|NCT02006121|541680052|FG001|Open Label Phase|Non-compliance with study drug|0|||
150148607|NCT01737996|541680061|FG000|Overall Study|Adverse Event|0|||
150148608|NCT01737996|541680062|FG001|Overall Study|Adverse Event|1|||
150148609|NCT01737996|541680063|FG002|Overall Study|Adverse Event|1|||
150148610|NCT01737996|541680061|FG000|Overall Study|Withdrawal by Subject|0|||
150148611|NCT01737996|541680062|FG001|Overall Study|Withdrawal by Subject|0|||
150148612|NCT01737996|541680063|FG002|Overall Study|Withdrawal by Subject|1|||
150148613|NCT03000673|541680064|FG000|Overall Study|Withdrawal by Subject|1|||
150148614|NCT03000673|541680065|FG001|Overall Study|Withdrawal by Subject|0|||
150148615|NCT03000673|541680066|FG002|Overall Study|Withdrawal by Subject|0|||
150148616|NCT03000673|541680067|FG003|Overall Study|Withdrawal by Subject|0|||
150148617|NCT01512745|541680069|FG000|Overall Study|Adverse Event|22|||
150148618|NCT01512745|541680070|FG001|Overall Study|Adverse Event|3|||
150148619|NCT01512745|541680069|FG000|Overall Study|Death|9|||
150148620|NCT01512745|541680070|FG001|Overall Study|Death|13|||
150148621|NCT01512745|541680069|FG000|Overall Study|Withdrawal by Subject|2|||
150148622|NCT01512745|541680070|FG001|Overall Study|Withdrawal by Subject|2|||
150148623|NCT01512745|541680069|FG000|Overall Study|Lost to Follow-up|4|||
150148624|NCT01512745|541680070|FG001|Overall Study|Lost to Follow-up|0|||
150148625|NCT01512745|541680069|FG000|Overall Study|Lack of Efficacy|2|||
150148626|NCT01512745|541680070|FG001|Overall Study|Lack of Efficacy|2|||
150148627|NCT01512745|541680069|FG000|Overall Study|Protocol Violation|1|||
150148628|NCT01512745|541680070|FG001|Overall Study|Protocol Violation|0|||
150148629|NCT02357810|541680071|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
150148630|NCT02357810|541680071|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
150148631|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Adverse Event|5|||
150148632|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
150148633|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
150148634|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
150148635|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Death|1|||
150148636|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Physician Decision|1|||
150148637|NCT02357810|541680071|FG000|Reached 12 Weeks Response|Other|1|||
150148638|NCT02357810|541680071|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
150148639|NCT02357810|541680071|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
150148640|NCT02357810|541680071|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
150148641|NCT02357810|541680071|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
150148642|NCT02357810|541680071|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
150148643|NCT02357810|541680071|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
150148644|NCT03679767|541680072|FG000|Overall Study|Death|16|||
150148645|NCT03679767|541680073|FG001|Overall Study|Death|11|||
150148646|NCT03679767|541680074|FG002|Overall Study|Death|17|||
150148647|NCT03679767|541680075|FG003|Overall Study|Death|10|||
150148648|NCT03679767|541680072|FG000|Overall Study|Lost to Follow-up|1|||
150148649|NCT03679767|541680073|FG001|Overall Study|Lost to Follow-up|1|||
150148650|NCT03679767|541680074|FG002|Overall Study|Lost to Follow-up|1|||
150148651|NCT03679767|541680075|FG003|Overall Study|Lost to Follow-up|1|||
150148652|NCT03679767|541680072|FG000|Overall Study|Withdrawal by Subject|0|||
150148653|NCT03679767|541680073|FG001|Overall Study|Withdrawal by Subject|0|||
150148654|NCT03679767|541680074|FG002|Overall Study|Withdrawal by Subject|0|||
150148655|NCT03679767|541680075|FG003|Overall Study|Withdrawal by Subject|1|||
150148656|NCT03679767|541680072|FG000|Overall Study|Follow-up Completed|18|||
150148657|NCT03679767|541680073|FG001|Overall Study|Follow-up Completed|11|||
150148658|NCT03679767|541680074|FG002|Overall Study|Follow-up Completed|11|||
150148659|NCT03679767|541680075|FG003|Overall Study|Follow-up Completed|20|||
150148660|NCT03679767|541680072|FG000|Overall Study|Entered Hospice Care|0|||
150148661|NCT03679767|541680073|FG001|Overall Study|Entered Hospice Care|0|||
150148662|NCT03679767|541680074|FG002|Overall Study|Entered Hospice Care|0|||
150148663|NCT03679767|541680075|FG003|Overall Study|Entered Hospice Care|1|||
150148664|NCT03679767|541680072|FG000|Overall Study|Progressive Disease|0|||
149805876|NCT00471237|540418906|FG002|Overall Study|Participant's decision|0|||
149805877|NCT00471237|540418907|FG003|Overall Study|Participant's decision|0|||
149805878|NCT00471237|540418908|FG004|Overall Study|Participant's decision|0|||
149805879|NCT00471237|540418909|FG005|Overall Study|Participant's decision|1|||
149805880|NCT00471237|540418910|FG006|Overall Study|Participant's decision|0|||
149805881|NCT00848965|540418911|FG000|Overall Study|Adverse Event|1|||
149805882|NCT00848965|540418911|FG000|Overall Study|Withdrawal by Subject|1|||
149805883|NCT03710824|540418912|FG000|Overall Study|Withdrawal by Subject|1|||
149805884|NCT03710824|540418912|FG000|Overall Study|Lost to Follow-up|3|||
149805885|NCT03710824|540418912|FG000|Overall Study|Adverse Event|25|||
149805886|NCT03710824|540418912|FG000|Overall Study|Treatment discontinuation|2|||
149805887|NCT02329834|540418913|FG000|Overall Study|Physician Decision|1|||
149805888|NCT02329834|540418914|FG001|Overall Study|Physician Decision|0|||
149805889|NCT01605370|540418917|FG000|Overall Study|Adverse Event|1|||
149805890|NCT01605370|540418918|FG001|Overall Study|Adverse Event|0|||
149805891|NCT01976104|540418919|FG000|Overall Study|Adverse Event|0|||
149805892|NCT01976104|540418920|FG001|Overall Study|Adverse Event|0|||
149805893|NCT01976104|540418921|FG002|Overall Study|Adverse Event|1|||
149805894|NCT01976104|540418922|FG003|Overall Study|Adverse Event|0|||
149805895|NCT01976104|540418919|FG000|Overall Study|Lost to Follow-up|3|||
149805896|NCT01976104|540418920|FG001|Overall Study|Lost to Follow-up|0|||
149805897|NCT01976104|540418921|FG002|Overall Study|Lost to Follow-up|1|||
149805898|NCT01976104|540418922|FG003|Overall Study|Lost to Follow-up|1|||
149805899|NCT01976104|540418919|FG000|Overall Study|Subject Choice|0|||
149805900|NCT01976104|540418920|FG001|Overall Study|Subject Choice|1|||
149805901|NCT01976104|540418921|FG002|Overall Study|Subject Choice|0|||
149805902|NCT01976104|540418922|FG003|Overall Study|Subject Choice|1|||
149805903|NCT01976104|540418919|FG000|Overall Study|Withdrawal by Subject|3|||
149805904|NCT01976104|540418920|FG001|Overall Study|Withdrawal by Subject|0|||
149805905|NCT01976104|540418921|FG002|Overall Study|Withdrawal by Subject|0|||
149805906|NCT01976104|540418922|FG003|Overall Study|Withdrawal by Subject|1|||
149805907|NCT01976104|540418919|FG000|Overall Study|Other|0|||
149805908|NCT01976104|540418920|FG001|Overall Study|Other|1|||
149805909|NCT01976104|540418921|FG002|Overall Study|Other|0|||
149805910|NCT01976104|540418922|FG003|Overall Study|Other|0|||
149805911|NCT02181673|540418927|FG000|Up to Week 24|Adverse Event|2|||
149805912|NCT02181673|540418928|FG001|Up to Week 24|Adverse Event|0|||
149805913|NCT02181673|540418929|FG002|Up to Week 24|Adverse Event|3|||
149805914|NCT02181673|540418927|FG000|Up to Week 24|Death|1|||
149805915|NCT02181673|540418928|FG001|Up to Week 24|Death|0|||
149805916|NCT02181673|540418929|FG002|Up to Week 24|Death|0|||
149805917|NCT02181673|540418927|FG000|Up to Week 24|Lack of Efficacy|1|||
149805918|NCT02181673|540418928|FG001|Up to Week 24|Lack of Efficacy|0|||
149805919|NCT02181673|540418929|FG002|Up to Week 24|Lack of Efficacy|0|||
149805920|NCT02181673|540418927|FG000|Up to Week 24|Lost to Follow-up|1|||
149805921|NCT02181673|540418928|FG001|Up to Week 24|Lost to Follow-up|0|||
149805922|NCT02181673|540418929|FG002|Up to Week 24|Lost to Follow-up|0|||
149805923|NCT02181673|540418927|FG000|Up to Week 24|Physician Decision|0|||
149805924|NCT02181673|540418928|FG001|Up to Week 24|Physician Decision|0|||
149805925|NCT02181673|540418929|FG002|Up to Week 24|Physician Decision|3|||
149805926|NCT02181673|540418927|FG000|Up to Week 24|Withdrawal by Subject|10|||
149805927|NCT02181673|540418928|FG001|Up to Week 24|Withdrawal by Subject|0|||
149805928|NCT02181673|540418929|FG002|Up to Week 24|Withdrawal by Subject|1|||
149805929|NCT02181673|540418927|FG000|Up to Week 24|Other|2|||
149805930|NCT02181673|540418928|FG001|Up to Week 24|Other|0|||
149805931|NCT02181673|540418929|FG002|Up to Week 24|Other|3|||
149805932|NCT02181673|540418927|FG000|Up to Week 24|Randomized not Treated|0|||
149805933|NCT02181673|540418928|FG001|Up to Week 24|Randomized not Treated|0|||
149805934|NCT02181673|540418929|FG002|Up to Week 24|Randomized not Treated|1|||
149805935|NCT02181673|540418927|FG000|Week 24-Week 60|Adverse Event|0|||
149805936|NCT02181673|540418928|FG001|Week 24-Week 60|Adverse Event|4|||
149805937|NCT02181673|540418929|FG002|Week 24-Week 60|Adverse Event|10|||
149805938|NCT02181673|540418927|FG000|Week 24-Week 60|Other|0|||
149805939|NCT02181673|540418928|FG001|Week 24-Week 60|Other|2|||
149805940|NCT02181673|540418929|FG002|Week 24-Week 60|Other|1|||
149805941|NCT02181673|540418927|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
149805942|NCT02181673|540418928|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
149805943|NCT02181673|540418929|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
149805944|NCT02181673|540418927|FG000|Week 24-Week 60|Pregnancy|0|||
149918894|NCT01210352|540835245|FG004|Overall Study|Lack of Efficacy|0|||
149805945|NCT02181673|540418928|FG001|Week 24-Week 60|Pregnancy|0|||
149805946|NCT02181673|540418929|FG002|Week 24-Week 60|Pregnancy|1|||
149805947|NCT02181673|540418927|FG000|Week 24-Week 60|Lack of Efficacy|0|||
149805948|NCT02181673|540418928|FG001|Week 24-Week 60|Lack of Efficacy|0|||
149805949|NCT02181673|540418929|FG002|Week 24-Week 60|Lack of Efficacy|1|||
149805950|NCT02181673|540418927|FG000|Week 24-Week 60|Lost to Follow-up|0|||
149805951|NCT02181673|540418928|FG001|Week 24-Week 60|Lost to Follow-up|0|||
149805952|NCT02181673|540418929|FG002|Week 24-Week 60|Lost to Follow-up|1|||
149805953|NCT02181673|540418927|FG000|Week 24-Week 60|Physician Decision|0|||
149805954|NCT02181673|540418928|FG001|Week 24-Week 60|Physician Decision|0|||
149918895|NCT01210352|540835246|FG005|Overall Study|Lack of Efficacy|0|||
149805955|NCT02181673|540418929|FG002|Week 24-Week 60|Physician Decision|1|||
149805956|NCT00326625|540418930|FG000|Overall Study|Adverse Event|20|||
149805957|NCT00326625|540418931|FG001|Overall Study|Adverse Event|9|||
149805958|NCT00326625|540418930|FG000|Overall Study|Withdrawal by Subject|15|||
149805959|NCT00326625|540418931|FG001|Overall Study|Withdrawal by Subject|12|||
149805960|NCT00326625|540418930|FG000|Overall Study|Death|18|||
149805961|NCT00326625|540418931|FG001|Overall Study|Death|16|||
149805962|NCT00326625|540418930|FG000|Overall Study|Lost to Follow-up|1|||
149805963|NCT00326625|540418931|FG001|Overall Study|Lost to Follow-up|0|||
149805964|NCT00326625|540418930|FG000|Overall Study|prescheduled medical intervention|0|||
149805965|NCT00326625|540418931|FG001|Overall Study|prescheduled medical intervention|1|||
149805966|NCT04764669|540418934|FG000|Overall Study|Adverse Event|1|||
149805967|NCT04764669|540418935|FG001|Overall Study|Adverse Event|0|||
149805968|NCT04764669|540418936|FG002|Overall Study|Adverse Event|1|||
149805969|NCT04764669|540418937|FG003|Overall Study|Adverse Event|0|||
149805970|NCT04764669|540418934|FG000|Overall Study|Subject Choice|0|||
149805971|NCT04764669|540418935|FG001|Overall Study|Subject Choice|0|||
149805972|NCT04764669|540418936|FG002|Overall Study|Subject Choice|1|||
149805973|NCT04764669|540418937|FG003|Overall Study|Subject Choice|0|||
149805974|NCT04764669|540418934|FG000|Overall Study|Withdrawal by Subject|2|||
149805975|NCT04764669|540418935|FG001|Overall Study|Withdrawal by Subject|0|||
149805976|NCT04764669|540418936|FG002|Overall Study|Withdrawal by Subject|0|||
149805977|NCT04764669|540418937|FG003|Overall Study|Withdrawal by Subject|0|||
149805978|NCT00806416|540418946|FG000|Period 1 - Part I|Adverse Event|0|||
149805979|NCT00806416|540418947|FG001|Period 1 - Part I|Adverse Event|1|||
149805980|NCT00806416|540418948|FG002|Period 1 - Part I|Adverse Event|0|||
149805981|NCT00806416|540418949|FG003|Period 1 - Part I|Adverse Event|0|||
149805982|NCT00806416|540418946|FG000|Period 1 - Part I|Lost to Follow-up|0|||
149805983|NCT00806416|540418947|FG001|Period 1 - Part I|Lost to Follow-up|2|||
149805984|NCT00806416|540418948|FG002|Period 1 - Part I|Lost to Follow-up|0|||
149805985|NCT00806416|540418949|FG003|Period 1 - Part I|Lost to Follow-up|0|||
149805986|NCT00806416|540418946|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
149805987|NCT00806416|540418947|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
149805988|NCT00806416|540418948|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
149805989|NCT00806416|540418949|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
149805990|NCT00806416|540418946|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
149805991|NCT00806416|540418947|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
149805992|NCT00806416|540418948|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
149805993|NCT00806416|540418949|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
149805994|NCT03664024|540418957|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
149805995|NCT03664024|540418957|FG000|Overall Study|Lost to Follow-up|2|||
149805996|NCT03664024|540418957|FG000|Overall Study|Withdrawal by Subject|2|||
149805997|NCT03664024|540418957|FG000|Overall Study|Death|80|||
149805998|NCT01157065|540418958|FG000|Overall Study|Death|0|||
149805999|NCT01157065|540418959|FG001|Overall Study|Death|1|||
149806000|NCT05275673|540418962|FG000|Overall Study|Study Termination by Sponsor|2|||
149806001|NCT05275673|540418963|FG001|Overall Study|Study Termination by Sponsor|3|||
149806002|NCT05275673|540418962|FG000|Overall Study|Death|1|||
149806003|NCT05275673|540418963|FG001|Overall Study|Death|0|||
149806004|NCT05275673|540418962|FG000|Overall Study|Withdrawal by Subject|1|||
149806005|NCT05275673|540418963|FG001|Overall Study|Withdrawal by Subject|0|||
149806006|NCT02325739|540418964|FG000|Phase I Part|Adverse Event|1|||
149806007|NCT02325739|540418965|FG001|Phase I Part|Adverse Event|0|||
149806008|NCT02325739|540418966|FG002|Phase I Part|Adverse Event|1|||
149806009|NCT02325739|540418967|FG003|Phase I Part|Adverse Event|2|||
149806010|NCT02325739|540418968|FG004|Phase I Part|Adverse Event|3|||
149806011|NCT02325739|540418969|FG005|Phase I Part|Adverse Event|1|||
149806012|NCT02325739|540418970|FG006|Phase I Part|Adverse Event|0|||
149806013|NCT02325739|540418971|FG007|Phase I Part|Adverse Event|2|||
149806014|NCT02325739|540418972|FG008|Phase I Part|Adverse Event|0|||
149806015|NCT02325739|540418973|FG009|Phase I Part|Adverse Event|0|||
149806016|NCT02325739|540418974|FG010|Phase I Part|Adverse Event|0|||
149806017|NCT02325739|540418964|FG000|Phase I Part|Progressive disease|9|||
149806018|NCT02325739|540418965|FG001|Phase I Part|Progressive disease|6|||
149806019|NCT02325739|540418966|FG002|Phase I Part|Progressive disease|3|||
149806020|NCT02325739|540418967|FG003|Phase I Part|Progressive disease|23|||
149806021|NCT02325739|540418968|FG004|Phase I Part|Progressive disease|14|||
149806022|NCT02325739|540418969|FG005|Phase I Part|Progressive disease|6|||
149806023|NCT02325739|540418970|FG006|Phase I Part|Progressive disease|6|||
149806024|NCT02325739|540418971|FG007|Phase I Part|Progressive disease|3|||
149806025|NCT02325739|540418972|FG008|Phase I Part|Progressive disease|0|||
149806026|NCT02325739|540418973|FG009|Phase I Part|Progressive disease|0|||
149806027|NCT02325739|540418974|FG010|Phase I Part|Progressive disease|0|||
149806028|NCT02325739|540418964|FG000|Phase I Part|Subject/guardian decision|1|||
149806029|NCT02325739|540418965|FG001|Phase I Part|Subject/guardian decision|0|||
149806030|NCT02325739|540418966|FG002|Phase I Part|Subject/guardian decision|1|||
149918896|NCT01210352|540835247|FG006|Overall Study|Lack of Efficacy|1|||
149806031|NCT02325739|540418967|FG003|Phase I Part|Subject/guardian decision|1|||
149806032|NCT02325739|540418968|FG004|Phase I Part|Subject/guardian decision|0|||
149806033|NCT02325739|540418969|FG005|Phase I Part|Subject/guardian decision|0|||
149806034|NCT02325739|540418970|FG006|Phase I Part|Subject/guardian decision|0|||
149806035|NCT02325739|540418971|FG007|Phase I Part|Subject/guardian decision|1|||
149806036|NCT02325739|540418972|FG008|Phase I Part|Subject/guardian decision|0|||
149806037|NCT02325739|540418973|FG009|Phase I Part|Subject/guardian decision|0|||
149806038|NCT02325739|540418974|FG010|Phase I Part|Subject/guardian decision|0|||
149806039|NCT02325739|540418964|FG000|Phase I Part|Death|0|||
149806040|NCT02325739|540418965|FG001|Phase I Part|Death|0|||
149806041|NCT02325739|540418966|FG002|Phase I Part|Death|0|||
149806042|NCT02325739|540418967|FG003|Phase I Part|Death|0|||
149806043|NCT02325739|540418968|FG004|Phase I Part|Death|2|||
149806044|NCT02325739|540418969|FG005|Phase I Part|Death|0|||
149806045|NCT02325739|540418970|FG006|Phase I Part|Death|0|||
149806046|NCT02325739|540418971|FG007|Phase I Part|Death|0|||
149806047|NCT02325739|540418972|FG008|Phase I Part|Death|0|||
149806048|NCT02325739|540418973|FG009|Phase I Part|Death|0|||
149806049|NCT02325739|540418974|FG010|Phase I Part|Death|0|||
149806050|NCT02325739|540418964|FG000|Phase II Part|Adverse Event|0|||
149806051|NCT02325739|540418965|FG001|Phase II Part|Adverse Event|0|||
149806052|NCT02325739|540418966|FG002|Phase II Part|Adverse Event|0|||
149806053|NCT02325739|540418967|FG003|Phase II Part|Adverse Event|0|||
149806054|NCT02325739|540418968|FG004|Phase II Part|Adverse Event|0|||
149806055|NCT02325739|540418969|FG005|Phase II Part|Adverse Event|0|||
149806056|NCT02325739|540418970|FG006|Phase II Part|Adverse Event|0|||
149806057|NCT02325739|540418971|FG007|Phase II Part|Adverse Event|0|||
149806058|NCT02325739|540418972|FG008|Phase II Part|Adverse Event|4|||
149806059|NCT02325739|540418973|FG009|Phase II Part|Adverse Event|5|||
149806060|NCT02325739|540418974|FG010|Phase II Part|Adverse Event|1|||
149806061|NCT02325739|540418964|FG000|Phase II Part|Physician Decision|0|||
149806062|NCT02325739|540418965|FG001|Phase II Part|Physician Decision|0|||
149806063|NCT02325739|540418966|FG002|Phase II Part|Physician Decision|0|||
149806064|NCT02325739|540418967|FG003|Phase II Part|Physician Decision|0|||
149806065|NCT02325739|540418968|FG004|Phase II Part|Physician Decision|0|||
149806066|NCT02325739|540418969|FG005|Phase II Part|Physician Decision|0|||
149806067|NCT02325739|540418970|FG006|Phase II Part|Physician Decision|0|||
149806068|NCT02325739|540418971|FG007|Phase II Part|Physician Decision|0|||
149806069|NCT02325739|540418972|FG008|Phase II Part|Physician Decision|0|||
149806070|NCT02325739|540418973|FG009|Phase II Part|Physician Decision|1|||
149806071|NCT02325739|540418974|FG010|Phase II Part|Physician Decision|0|||
149806072|NCT02325739|540418964|FG000|Phase II Part|Progressive disease|0|||
149806073|NCT02325739|540418965|FG001|Phase II Part|Progressive disease|0|||
149806074|NCT02325739|540418966|FG002|Phase II Part|Progressive disease|0|||
149806075|NCT02325739|540418967|FG003|Phase II Part|Progressive disease|0|||
149806076|NCT02325739|540418968|FG004|Phase II Part|Progressive disease|0|||
149806077|NCT02325739|540418969|FG005|Phase II Part|Progressive disease|0|||
149806078|NCT02325739|540418970|FG006|Phase II Part|Progressive disease|0|||
149806079|NCT02325739|540418971|FG007|Phase II Part|Progressive disease|0|||
149806080|NCT02325739|540418972|FG008|Phase II Part|Progressive disease|22|||
149806081|NCT02325739|540418973|FG009|Phase II Part|Progressive disease|29|||
149806082|NCT02325739|540418974|FG010|Phase II Part|Progressive disease|18|||
149806083|NCT02325739|540418964|FG000|Phase II Part|Subject/guardian decision|0|||
149806084|NCT02325739|540418965|FG001|Phase II Part|Subject/guardian decision|0|||
149806085|NCT02325739|540418966|FG002|Phase II Part|Subject/guardian decision|0|||
149806086|NCT02325739|540418967|FG003|Phase II Part|Subject/guardian decision|0|||
149806087|NCT02325739|540418968|FG004|Phase II Part|Subject/guardian decision|0|||
149806088|NCT02325739|540418969|FG005|Phase II Part|Subject/guardian decision|0|||
149806089|NCT02325739|540418970|FG006|Phase II Part|Subject/guardian decision|0|||
149806090|NCT02325739|540418971|FG007|Phase II Part|Subject/guardian decision|0|||
149806091|NCT02325739|540418972|FG008|Phase II Part|Subject/guardian decision|4|||
149806092|NCT02325739|540418973|FG009|Phase II Part|Subject/guardian decision|1|||
149806093|NCT02325739|540418974|FG010|Phase II Part|Subject/guardian decision|1|||
149806094|NCT03426995|540418975|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806095|NCT03426995|540418976|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806096|NCT03426995|540418977|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
149806097|NCT03426995|540418978|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806098|NCT03426995|540418979|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806099|NCT03426995|540418980|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806100|NCT03426995|540418981|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806101|NCT03426995|540418982|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806102|NCT03426995|540418983|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
150148665|NCT03679767|541680073|FG001|Overall Study|Progressive Disease|0|||
149806103|NCT03426995|540418984|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806104|NCT03426995|540418985|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806105|NCT03426995|540418986|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806106|NCT03426995|540418987|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
150148666|NCT03679767|541680074|FG002|Overall Study|Progressive Disease|0|||
149806107|NCT03426995|540418988|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806108|NCT03426995|540418989|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806109|NCT03426995|540418990|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806110|NCT03426995|540418991|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806111|NCT03426995|540418992|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806112|NCT03426995|540418993|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
149806113|NCT03426995|540418975|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806114|NCT03426995|540418976|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806115|NCT03426995|540418977|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806116|NCT03426995|540418978|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806117|NCT03426995|540418979|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806118|NCT03426995|540418980|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
149806119|NCT03426995|540418981|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806120|NCT03426995|540418982|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806121|NCT03426995|540418983|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806122|NCT03426995|540418984|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806123|NCT03426995|540418985|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806124|NCT03426995|540418986|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806125|NCT03426995|540418987|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806126|NCT03426995|540418988|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806127|NCT03426995|540418989|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806128|NCT03426995|540418990|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806129|NCT03426995|540418991|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806130|NCT03426995|540418992|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806131|NCT03426995|540418993|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149806132|NCT03426995|540418975|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806133|NCT03426995|540418976|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806134|NCT03426995|540418977|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806135|NCT03426995|540418978|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806136|NCT03426995|540418979|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
149806137|NCT03426995|540418980|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
149806138|NCT03426995|540418981|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806139|NCT03426995|540418982|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806140|NCT03426995|540418983|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806141|NCT03426995|540418984|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806142|NCT03426995|540418985|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806143|NCT03426995|540418986|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806144|NCT03426995|540418987|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806145|NCT03426995|540418988|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806146|NCT03426995|540418989|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806147|NCT03426995|540418990|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806148|NCT03426995|540418991|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806149|NCT03426995|540418992|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806150|NCT03426995|540418993|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
149806151|NCT03426995|540418975|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806152|NCT03426995|540418976|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806153|NCT03426995|540418977|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806154|NCT03426995|540418978|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806155|NCT03426995|540418979|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806156|NCT03426995|540418980|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806157|NCT03426995|540418981|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806158|NCT03426995|540418982|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806159|NCT03426995|540418983|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806160|NCT03426995|540418984|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806161|NCT03426995|540418985|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
149806162|NCT03426995|540418986|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806163|NCT03426995|540418987|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806164|NCT03426995|540418988|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806165|NCT03426995|540418989|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806166|NCT03426995|540418990|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806167|NCT03426995|540418991|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806168|NCT03426995|540418992|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806169|NCT03426995|540418993|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
149806170|NCT03426995|540418975|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806171|NCT03426995|540418976|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806172|NCT03426995|540418977|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806173|NCT03426995|540418978|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806174|NCT03426995|540418979|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806175|NCT03426995|540418980|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806176|NCT03426995|540418981|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806177|NCT03426995|540418982|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
149806178|NCT03426995|540418983|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806179|NCT03426995|540418984|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806180|NCT03426995|540418985|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806181|NCT03426995|540418986|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806182|NCT03426995|540418987|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806183|NCT03426995|540418988|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806184|NCT03426995|540418989|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806185|NCT03426995|540418990|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806186|NCT03426995|540418991|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806187|NCT03426995|540418992|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806188|NCT03426995|540418993|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
149806189|NCT03426995|540418975|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806190|NCT03426995|540418976|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806191|NCT03426995|540418977|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806192|NCT03426995|540418978|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806193|NCT03426995|540418979|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806194|NCT03426995|540418980|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806195|NCT03426995|540418981|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806196|NCT03426995|540418982|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806197|NCT03426995|540418983|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806198|NCT03426995|540418984|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806199|NCT03426995|540418985|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806200|NCT03426995|540418986|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806201|NCT03426995|540418987|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806202|NCT03426995|540418988|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806203|NCT03426995|540418989|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
149806204|NCT03426995|540418990|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
149806205|NCT03426995|540418991|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
150148667|NCT03679767|541680075|FG003|Overall Study|Progressive Disease|1|||
150148668|NCT05408468|541680076|FG000|Overall Study|Lost to Follow-up|3|||
150148669|NCT05408468|541680077|FG001|Overall Study|Lost to Follow-up|1|||
150148670|NCT05408468|541680076|FG000|Overall Study|Physician Decision|1|||
150148671|NCT05408468|541680077|FG001|Overall Study|Physician Decision|0|||
150148672|NCT05408468|541680076|FG000|Overall Study|Overwhelmed by clinical situation|3|||
150148673|NCT05408468|541680077|FG001|Overall Study|Overwhelmed by clinical situation|0|||
150148674|NCT05408468|541680076|FG000|Overall Study|Personal illness precluding participation|1|||
150148675|NCT05408468|541680077|FG001|Overall Study|Personal illness precluding participation|0|||
150148676|NCT05408468|541680076|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
150148677|NCT05408468|541680077|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
150148678|NCT02781506|541681677|FG000|Overall Study|Adverse Event|5|||
150148679|NCT01340482|541681678|FG000|Overall Study|Adverse Event|2|||
150148680|NCT01340482|541681679|FG001|Overall Study|Adverse Event|0|||
150148681|NCT01340482|541681680|FG002|Overall Study|Adverse Event|0|||
150148682|NCT04424290|541681681|FG000|Overall Study|Not treated|0|||
150148683|NCT04424290|541681682|FG001|Overall Study|Not treated|0|||
150148684|NCT04424290|541681683|FG002|Overall Study|Not treated|1|||
150148685|NCT04424290|541681684|FG003|Overall Study|Not treated|0|||
150148686|NCT04424290|541681685|FG004|Overall Study|Not treated|1|||
150148687|NCT04424290|541681681|FG000|Overall Study|Adverse Event|0|||
150148688|NCT04424290|541681682|FG001|Overall Study|Adverse Event|0|||
150148689|NCT04424290|541681683|FG002|Overall Study|Adverse Event|0|||
150148690|NCT04424290|541681684|FG003|Overall Study|Adverse Event|2|||
150148691|NCT04424290|541681685|FG004|Overall Study|Adverse Event|0|||
150148692|NCT04424290|541681681|FG000|Overall Study|Withdrawal by Subject|0|||
150148693|NCT04424290|541681682|FG001|Overall Study|Withdrawal by Subject|0|||
150148694|NCT04424290|541681683|FG002|Overall Study|Withdrawal by Subject|0|||
150148695|NCT04424290|541681684|FG003|Overall Study|Withdrawal by Subject|0|||
150148696|NCT04424290|541681685|FG004|Overall Study|Withdrawal by Subject|1|||
150148697|NCT04424290|541681681|FG000|Overall Study|Other than listed|0|||
150148698|NCT04424290|541681682|FG001|Overall Study|Other than listed|0|||
150148699|NCT04424290|541681683|FG002|Overall Study|Other than listed|0|||
150148700|NCT04424290|541681684|FG003|Overall Study|Other than listed|1|||
150148701|NCT04424290|541681685|FG004|Overall Study|Other than listed|0|||
150148702|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
150148703|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
150148704|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
149806206|NCT03426995|540418992|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806207|NCT03426995|540418993|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
149806208|NCT03426995|540418975|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806209|NCT03426995|540418976|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806210|NCT03426995|540418977|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806211|NCT03426995|540418978|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806212|NCT03426995|540418979|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806213|NCT03426995|540418980|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806214|NCT03426995|540418981|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806215|NCT03426995|540418982|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806216|NCT03426995|540418983|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806217|NCT03426995|540418984|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806218|NCT03426995|540418985|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806219|NCT03426995|540418986|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806220|NCT03426995|540418987|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806221|NCT03426995|540418988|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806222|NCT03426995|540418989|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
149806223|NCT03426995|540418990|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
149806224|NCT03426995|540418991|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806225|NCT03426995|540418992|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806226|NCT03426995|540418993|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
149806227|NCT00227591|540418994|FG000|Overall Study|Withdrawal by Subject|1|||
149806228|NCT04150107|540418997|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
149806229|NCT04150107|540418998|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
149806230|NCT04150107|540418997|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
149806231|NCT04150107|540418998|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
149806232|NCT00650806|540418999|FG000|Overall Study|Adverse Event|0|||
149806233|NCT00650806|540419000|FG001|Overall Study|Adverse Event|5|||
149806234|NCT00650806|540419001|FG002|Overall Study|Adverse Event|3|||
149806235|NCT00650806|540419002|FG003|Overall Study|Adverse Event|4|||
149806236|NCT00650806|540418999|FG000|Overall Study|Lost to Follow-up|7|||
149806237|NCT00650806|540419000|FG001|Overall Study|Lost to Follow-up|6|||
149806238|NCT00650806|540419001|FG002|Overall Study|Lost to Follow-up|11|||
149806239|NCT00650806|540419002|FG003|Overall Study|Lost to Follow-up|10|||
149806240|NCT00650806|540418999|FG000|Overall Study|Protocol Violation|0|||
149806241|NCT00650806|540419000|FG001|Overall Study|Protocol Violation|0|||
149806242|NCT00650806|540419001|FG002|Overall Study|Protocol Violation|0|||
149806243|NCT00650806|540419002|FG003|Overall Study|Protocol Violation|1|||
149806244|NCT00650806|540418999|FG000|Overall Study|Pregnancy|0|||
149806245|NCT00650806|540419000|FG001|Overall Study|Pregnancy|0|||
149806246|NCT00650806|540419001|FG002|Overall Study|Pregnancy|0|||
149806247|NCT00650806|540419002|FG003|Overall Study|Pregnancy|1|||
149806248|NCT00650806|540418999|FG000|Overall Study|Withdrawal by Subject|7|||
149806249|NCT00650806|540419000|FG001|Overall Study|Withdrawal by Subject|5|||
149806250|NCT00650806|540419001|FG002|Overall Study|Withdrawal by Subject|8|||
149806251|NCT00650806|540419002|FG003|Overall Study|Withdrawal by Subject|6|||
149806252|NCT00650806|540418999|FG000|Overall Study|Noncompliance with study drug regimen|1|||
149806253|NCT00650806|540419000|FG001|Overall Study|Noncompliance with study drug regimen|1|||
149806254|NCT00650806|540419001|FG002|Overall Study|Noncompliance with study drug regimen|0|||
149806255|NCT00650806|540419002|FG003|Overall Study|Noncompliance with study drug regimen|0|||
149806256|NCT00650806|540418999|FG000|Overall Study|Study terminated by sponsor|2|||
149806257|NCT00650806|540419000|FG001|Overall Study|Study terminated by sponsor|3|||
149806258|NCT00650806|540419001|FG002|Overall Study|Study terminated by sponsor|5|||
149806259|NCT00650806|540419002|FG003|Overall Study|Study terminated by sponsor|4|||
149806260|NCT00650806|540418999|FG000|Overall Study|Other|1|||
149806261|NCT00650806|540419000|FG001|Overall Study|Other|1|||
149806262|NCT00650806|540419001|FG002|Overall Study|Other|2|||
149806263|NCT00650806|540419002|FG003|Overall Study|Other|0|||
149806264|NCT00605839|540419009|FG000|Overall Study|Protocol Violation|1|||
149806265|NCT00605839|540419010|FG001|Overall Study|Protocol Violation|0|||
149806266|NCT00605839|540419011|FG002|Overall Study|Protocol Violation|0|||
149806267|NCT03917654|540419012|FG000|Year 1|Withdrawal by Subject|1|||
149806268|NCT03917654|540419013|FG001|Year 1|Withdrawal by Subject|0|||
149806269|NCT03917654|540419014|FG002|Year 1|Withdrawal by Subject|0|||
149806270|NCT03917654|540419015|FG003|Year 1|Withdrawal by Subject|0|||
149806271|NCT03917654|540419016|FG004|Year 1|Withdrawal by Subject|0|||
149806272|NCT03917654|540419017|FG005|Year 1|Withdrawal by Subject|1|||
149806273|NCT03917654|540419018|FG006|Year 1|Withdrawal by Subject|6|||
149806274|NCT03917654|540419019|FG007|Year 1|Withdrawal by Subject|2|||
149806275|NCT03917654|540419020|FG008|Year 1|Withdrawal by Subject|5|||
149806276|NCT03917654|540419021|FG009|Year 1|Withdrawal by Subject|3|||
149806277|NCT03917654|540419022|FG010|Year 1|Withdrawal by Subject|1|||
149806278|NCT03917654|540419023|FG011|Year 1|Withdrawal by Subject|0|||
149806279|NCT03917654|540419012|FG000|Year 1|Travel|0|||
149806280|NCT03917654|540419013|FG001|Year 1|Travel|1|||
149806281|NCT03917654|540419014|FG002|Year 1|Travel|1|||
149806282|NCT03917654|540419015|FG003|Year 1|Travel|0|||
149806283|NCT03917654|540419016|FG004|Year 1|Travel|4|||
149806284|NCT03917654|540419017|FG005|Year 1|Travel|4|||
149806285|NCT03917654|540419018|FG006|Year 1|Travel|10|||
149806286|NCT03917654|540419019|FG007|Year 1|Travel|8|||
149806287|NCT03917654|540419020|FG008|Year 1|Travel|2|||
149806288|NCT03917654|540419021|FG009|Year 1|Travel|5|||
149806289|NCT03917654|540419022|FG010|Year 1|Travel|3|||
149806290|NCT03917654|540419023|FG011|Year 1|Travel|3|||
149806291|NCT03917654|540419012|FG000|Year 1|Subject moved away from site|0|||
149806292|NCT03917654|540419013|FG001|Year 1|Subject moved away from site|1|||
149806293|NCT03917654|540419014|FG002|Year 1|Subject moved away from site|0|||
149806294|NCT03917654|540419015|FG003|Year 1|Subject moved away from site|0|||
149806295|NCT03917654|540419016|FG004|Year 1|Subject moved away from site|0|||
149806296|NCT03917654|540419017|FG005|Year 1|Subject moved away from site|0|||
149806297|NCT03917654|540419018|FG006|Year 1|Subject moved away from site|1|||
149806298|NCT03917654|540419019|FG007|Year 1|Subject moved away from site|2|||
149806299|NCT03917654|540419020|FG008|Year 1|Subject moved away from site|1|||
149806300|NCT03917654|540419021|FG009|Year 1|Subject moved away from site|0|||
149806301|NCT03917654|540419022|FG010|Year 1|Subject moved away from site|0|||
149806302|NCT03917654|540419023|FG011|Year 1|Subject moved away from site|3|||
149806303|NCT03917654|540419012|FG000|Year 1|Spouse/Family member request|0|||
149806304|NCT03917654|540419013|FG001|Year 1|Spouse/Family member request|0|||
149806305|NCT03917654|540419014|FG002|Year 1|Spouse/Family member request|1|||
149806306|NCT03917654|540419015|FG003|Year 1|Spouse/Family member request|0|||
149806307|NCT03917654|540419016|FG004|Year 1|Spouse/Family member request|1|||
149806308|NCT03917654|540419017|FG005|Year 1|Spouse/Family member request|0|||
149806309|NCT03917654|540419018|FG006|Year 1|Spouse/Family member request|0|||
149806310|NCT03917654|540419019|FG007|Year 1|Spouse/Family member request|2|||
149806311|NCT03917654|540419020|FG008|Year 1|Spouse/Family member request|0|||
149806312|NCT03917654|540419021|FG009|Year 1|Spouse/Family member request|0|||
149806313|NCT03917654|540419022|FG010|Year 1|Spouse/Family member request|0|||
149806314|NCT03917654|540419023|FG011|Year 1|Spouse/Family member request|1|||
149806315|NCT03917654|540419012|FG000|Year 1|Death|0|||
149806316|NCT03917654|540419013|FG001|Year 1|Death|0|||
149806317|NCT03917654|540419014|FG002|Year 1|Death|0|||
149806318|NCT03917654|540419015|FG003|Year 1|Death|0|||
149806319|NCT03917654|540419016|FG004|Year 1|Death|0|||
149806320|NCT03917654|540419017|FG005|Year 1|Death|0|||
149806321|NCT03917654|540419018|FG006|Year 1|Death|0|||
149806322|NCT03917654|540419019|FG007|Year 1|Death|0|||
149806323|NCT03917654|540419020|FG008|Year 1|Death|1|||
149806324|NCT03917654|540419021|FG009|Year 1|Death|1|||
149806325|NCT03917654|540419022|FG010|Year 1|Death|0|||
149806326|NCT03917654|540419023|FG011|Year 1|Death|0|||
149806327|NCT03917654|540419012|FG000|Year 1|Lost to Follow-up|0|||
149806328|NCT03917654|540419013|FG001|Year 1|Lost to Follow-up|0|||
149806329|NCT03917654|540419014|FG002|Year 1|Lost to Follow-up|0|||
149806330|NCT03917654|540419015|FG003|Year 1|Lost to Follow-up|0|||
149806331|NCT03917654|540419016|FG004|Year 1|Lost to Follow-up|0|||
149806332|NCT03917654|540419017|FG005|Year 1|Lost to Follow-up|0|||
149806333|NCT03917654|540419018|FG006|Year 1|Lost to Follow-up|2|||
149806334|NCT03917654|540419019|FG007|Year 1|Lost to Follow-up|0|||
149806335|NCT03917654|540419020|FG008|Year 1|Lost to Follow-up|0|||
149806336|NCT03917654|540419021|FG009|Year 1|Lost to Follow-up|0|||
149806337|NCT03917654|540419022|FG010|Year 1|Lost to Follow-up|0|||
149806338|NCT03917654|540419023|FG011|Year 1|Lost to Follow-up|0|||
149806339|NCT03917654|540419012|FG000|Year 1|Missed visits|0|||
149806340|NCT03917654|540419013|FG001|Year 1|Missed visits|0|||
149806341|NCT03917654|540419014|FG002|Year 1|Missed visits|0|||
149806342|NCT03917654|540419015|FG003|Year 1|Missed visits|0|||
149806343|NCT03917654|540419016|FG004|Year 1|Missed visits|0|||
149806344|NCT03917654|540419017|FG005|Year 1|Missed visits|0|||
149806345|NCT03917654|540419018|FG006|Year 1|Missed visits|0|||
149806346|NCT03917654|540419019|FG007|Year 1|Missed visits|0|||
149806347|NCT03917654|540419020|FG008|Year 1|Missed visits|0|||
150148705|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
149806348|NCT03917654|540419021|FG009|Year 1|Missed visits|0|||
149806349|NCT03917654|540419022|FG010|Year 1|Missed visits|1|||
149806350|NCT03917654|540419023|FG011|Year 1|Missed visits|1|||
149806351|NCT03917654|540419012|FG000|Year 1|Pregnancy|0|||
149806352|NCT03917654|540419013|FG001|Year 1|Pregnancy|0|||
149806353|NCT03917654|540419014|FG002|Year 1|Pregnancy|0|||
149806354|NCT03917654|540419015|FG003|Year 1|Pregnancy|0|||
149806355|NCT03917654|540419016|FG004|Year 1|Pregnancy|0|||
149806356|NCT03917654|540419017|FG005|Year 1|Pregnancy|0|||
149806357|NCT03917654|540419018|FG006|Year 1|Pregnancy|0|||
149806358|NCT03917654|540419019|FG007|Year 1|Pregnancy|1|||
149806359|NCT03917654|540419020|FG008|Year 1|Pregnancy|0|||
149806360|NCT03917654|540419021|FG009|Year 1|Pregnancy|1|||
149806361|NCT03917654|540419022|FG010|Year 1|Pregnancy|0|||
149806362|NCT03917654|540419023|FG011|Year 1|Pregnancy|0|||
149806363|NCT03917654|540419012|FG000|Year 2|Travel|1|||
149806364|NCT03917654|540419013|FG001|Year 2|Travel|0|||
149806365|NCT03917654|540419014|FG002|Year 2|Travel|0|||
149806366|NCT03917654|540419015|FG003|Year 2|Travel|0|||
149806367|NCT03917654|540419016|FG004|Year 2|Travel|1|||
149806368|NCT03917654|540419017|FG005|Year 2|Travel|1|||
149806369|NCT03917654|540419018|FG006|Year 2|Travel|2|||
149806370|NCT03917654|540419019|FG007|Year 2|Travel|1|||
149806371|NCT03917654|540419020|FG008|Year 2|Travel|0|||
149806372|NCT03917654|540419021|FG009|Year 2|Travel|1|||
149806373|NCT03917654|540419022|FG010|Year 2|Travel|0|||
149806374|NCT03917654|540419023|FG011|Year 2|Travel|1|||
149806375|NCT03917654|540419012|FG000|Year 2|Married|1|||
149806376|NCT03917654|540419013|FG001|Year 2|Married|0|||
149806377|NCT03917654|540419014|FG002|Year 2|Married|0|||
149806378|NCT03917654|540419015|FG003|Year 2|Married|0|||
149806379|NCT03917654|540419016|FG004|Year 2|Married|0|||
149806380|NCT03917654|540419017|FG005|Year 2|Married|0|||
149806381|NCT03917654|540419018|FG006|Year 2|Married|1|||
149806382|NCT03917654|540419019|FG007|Year 2|Married|1|||
149806383|NCT03917654|540419020|FG008|Year 2|Married|0|||
149806384|NCT03917654|540419021|FG009|Year 2|Married|0|||
149806385|NCT03917654|540419022|FG010|Year 2|Married|0|||
149806386|NCT03917654|540419023|FG011|Year 2|Married|0|||
149806387|NCT03917654|540419012|FG000|Year 2|Subject moved away from site|1|||
149806388|NCT03917654|540419013|FG001|Year 2|Subject moved away from site|0|||
149806389|NCT03917654|540419014|FG002|Year 2|Subject moved away from site|0|||
149806390|NCT03917654|540419015|FG003|Year 2|Subject moved away from site|0|||
149806391|NCT03917654|540419016|FG004|Year 2|Subject moved away from site|1|||
149806392|NCT03917654|540419017|FG005|Year 2|Subject moved away from site|0|||
149806393|NCT03917654|540419018|FG006|Year 2|Subject moved away from site|2|||
149806394|NCT03917654|540419019|FG007|Year 2|Subject moved away from site|3|||
149806395|NCT03917654|540419020|FG008|Year 2|Subject moved away from site|0|||
149806396|NCT03917654|540419021|FG009|Year 2|Subject moved away from site|2|||
149806397|NCT03917654|540419022|FG010|Year 2|Subject moved away from site|0|||
149806398|NCT03917654|540419023|FG011|Year 2|Subject moved away from site|1|||
149806399|NCT03917654|540419012|FG000|Year 2|Year 2 Screening failure|0|||
149806400|NCT03917654|540419013|FG001|Year 2|Year 2 Screening failure|1|||
149806401|NCT03917654|540419014|FG002|Year 2|Year 2 Screening failure|0|||
149806402|NCT03917654|540419015|FG003|Year 2|Year 2 Screening failure|0|||
149806403|NCT03917654|540419016|FG004|Year 2|Year 2 Screening failure|2|||
149806404|NCT03917654|540419017|FG005|Year 2|Year 2 Screening failure|0|||
149806405|NCT03917654|540419018|FG006|Year 2|Year 2 Screening failure|4|||
149806406|NCT03917654|540419019|FG007|Year 2|Year 2 Screening failure|3|||
149806407|NCT03917654|540419020|FG008|Year 2|Year 2 Screening failure|10|||
149806408|NCT03917654|540419021|FG009|Year 2|Year 2 Screening failure|2|||
149806409|NCT03917654|540419022|FG010|Year 2|Year 2 Screening failure|1|||
149806410|NCT03917654|540419023|FG011|Year 2|Year 2 Screening failure|1|||
149806411|NCT03917654|540419012|FG000|Year 2|Death|0|||
149806412|NCT03917654|540419013|FG001|Year 2|Death|0|||
149806413|NCT03917654|540419014|FG002|Year 2|Death|0|||
149806414|NCT03917654|540419015|FG003|Year 2|Death|0|||
149806415|NCT03917654|540419016|FG004|Year 2|Death|0|||
149806416|NCT03917654|540419017|FG005|Year 2|Death|1|||
149806417|NCT03917654|540419018|FG006|Year 2|Death|0|||
149806418|NCT03917654|540419019|FG007|Year 2|Death|0|||
149806419|NCT03917654|540419020|FG008|Year 2|Death|1|||
149806420|NCT03917654|540419021|FG009|Year 2|Death|1|||
149806421|NCT03917654|540419022|FG010|Year 2|Death|0|||
149806422|NCT03917654|540419023|FG011|Year 2|Death|0|||
149806423|NCT03917654|540419012|FG000|Year 2|Withdrawal by Subject|0|||
149806424|NCT03917654|540419013|FG001|Year 2|Withdrawal by Subject|0|||
149806425|NCT03917654|540419014|FG002|Year 2|Withdrawal by Subject|0|||
149806426|NCT03917654|540419015|FG003|Year 2|Withdrawal by Subject|0|||
149806427|NCT03917654|540419016|FG004|Year 2|Withdrawal by Subject|0|||
149806428|NCT03917654|540419017|FG005|Year 2|Withdrawal by Subject|0|||
149806429|NCT03917654|540419018|FG006|Year 2|Withdrawal by Subject|3|||
149806430|NCT03917654|540419019|FG007|Year 2|Withdrawal by Subject|0|||
149806431|NCT03917654|540419020|FG008|Year 2|Withdrawal by Subject|2|||
149806432|NCT03917654|540419021|FG009|Year 2|Withdrawal by Subject|5|||
149806433|NCT03917654|540419022|FG010|Year 2|Withdrawal by Subject|0|||
149806434|NCT03917654|540419023|FG011|Year 2|Withdrawal by Subject|0|||
149806435|NCT03917654|540419012|FG000|Year 2|Spouse/family member request|0|||
149806436|NCT03917654|540419013|FG001|Year 2|Spouse/family member request|0|||
149806437|NCT03917654|540419014|FG002|Year 2|Spouse/family member request|0|||
149806438|NCT03917654|540419015|FG003|Year 2|Spouse/family member request|0|||
149806439|NCT03917654|540419016|FG004|Year 2|Spouse/family member request|0|||
149806440|NCT03917654|540419017|FG005|Year 2|Spouse/family member request|0|||
149806441|NCT03917654|540419018|FG006|Year 2|Spouse/family member request|1|||
149806442|NCT03917654|540419019|FG007|Year 2|Spouse/family member request|0|||
149806443|NCT03917654|540419020|FG008|Year 2|Spouse/family member request|0|||
149806444|NCT03917654|540419021|FG009|Year 2|Spouse/family member request|0|||
149806445|NCT03917654|540419022|FG010|Year 2|Spouse/family member request|0|||
149806446|NCT03917654|540419023|FG011|Year 2|Spouse/family member request|0|||
149806447|NCT03917654|540419012|FG000|Year 2|Lost to Follow-up|0|||
149806448|NCT03917654|540419013|FG001|Year 2|Lost to Follow-up|0|||
149806449|NCT03917654|540419014|FG002|Year 2|Lost to Follow-up|0|||
149806450|NCT03917654|540419015|FG003|Year 2|Lost to Follow-up|0|||
149806451|NCT03917654|540419016|FG004|Year 2|Lost to Follow-up|0|||
149806452|NCT03917654|540419017|FG005|Year 2|Lost to Follow-up|0|||
149806453|NCT03917654|540419018|FG006|Year 2|Lost to Follow-up|1|||
149806454|NCT03917654|540419019|FG007|Year 2|Lost to Follow-up|0|||
149806455|NCT03917654|540419020|FG008|Year 2|Lost to Follow-up|1|||
149806456|NCT03917654|540419021|FG009|Year 2|Lost to Follow-up|0|||
149806457|NCT03917654|540419022|FG010|Year 2|Lost to Follow-up|0|||
149806458|NCT03917654|540419023|FG011|Year 2|Lost to Follow-up|1|||
149806459|NCT03917654|540419012|FG000|Year 2|Adverse Event|0|||
149806460|NCT03917654|540419013|FG001|Year 2|Adverse Event|0|||
149806461|NCT03917654|540419014|FG002|Year 2|Adverse Event|0|||
149806462|NCT03917654|540419015|FG003|Year 2|Adverse Event|0|||
149806463|NCT03917654|540419016|FG004|Year 2|Adverse Event|0|||
149806464|NCT03917654|540419017|FG005|Year 2|Adverse Event|0|||
149806465|NCT03917654|540419018|FG006|Year 2|Adverse Event|0|||
149806466|NCT03917654|540419019|FG007|Year 2|Adverse Event|0|||
149806467|NCT03917654|540419020|FG008|Year 2|Adverse Event|0|||
149806468|NCT03917654|540419021|FG009|Year 2|Adverse Event|1|||
149806469|NCT03917654|540419022|FG010|Year 2|Adverse Event|0|||
149806470|NCT03917654|540419023|FG011|Year 2|Adverse Event|0|||
149806471|NCT01489865|540419027|FG000|Overall Study|Progression of Disease|4|||
149806472|NCT01489865|540419028|FG001|Overall Study|Progression of Disease|2|||
149806473|NCT01489865|540419029|FG002|Overall Study|Progression of Disease|2|||
149806474|NCT01489865|540419030|FG003|Overall Study|Progression of Disease|3|||
149806475|NCT01489865|540419031|FG004|Overall Study|Progression of Disease|1|||
149806476|NCT01489865|540419032|FG005|Overall Study|Progression of Disease|6|||
149806477|NCT01489865|540419033|FG006|Overall Study|Progression of Disease|3|||
149806478|NCT01489865|540419034|FG007|Overall Study|Progression of Disease|0|||
149806479|NCT01489865|540419035|FG008|Overall Study|Progression of Disease|23|||
149806480|NCT01489865|540419027|FG000|Overall Study|Adverse Event|2|||
149806481|NCT01489865|540419028|FG001|Overall Study|Adverse Event|0|||
149806482|NCT01489865|540419029|FG002|Overall Study|Adverse Event|0|||
149806483|NCT01489865|540419030|FG003|Overall Study|Adverse Event|0|||
149806484|NCT01489865|540419031|FG004|Overall Study|Adverse Event|1|||
149806485|NCT01489865|540419032|FG005|Overall Study|Adverse Event|0|||
149806486|NCT01489865|540419033|FG006|Overall Study|Adverse Event|2|||
149806487|NCT01489865|540419034|FG007|Overall Study|Adverse Event|0|||
149806488|NCT01489865|540419035|FG008|Overall Study|Adverse Event|5|||
149806489|NCT01489865|540419027|FG000|Overall Study|Death|0|||
149806490|NCT01489865|540419028|FG001|Overall Study|Death|1|||
149806491|NCT01489865|540419029|FG002|Overall Study|Death|0|||
149806492|NCT01489865|540419030|FG003|Overall Study|Death|0|||
149806493|NCT01489865|540419031|FG004|Overall Study|Death|1|||
149806494|NCT01489865|540419032|FG005|Overall Study|Death|0|||
149806495|NCT01489865|540419033|FG006|Overall Study|Death|0|||
149806496|NCT01489865|540419034|FG007|Overall Study|Death|0|||
149806497|NCT01489865|540419035|FG008|Overall Study|Death|2|||
149806498|NCT01489865|540419027|FG000|Overall Study|Withdrawal by Subject|0|||
149806499|NCT01489865|540419028|FG001|Overall Study|Withdrawal by Subject|0|||
149806500|NCT01489865|540419029|FG002|Overall Study|Withdrawal by Subject|0|||
149806501|NCT01489865|540419030|FG003|Overall Study|Withdrawal by Subject|0|||
149806502|NCT01489865|540419031|FG004|Overall Study|Withdrawal by Subject|0|||
149806503|NCT01489865|540419032|FG005|Overall Study|Withdrawal by Subject|1|||
149806504|NCT01489865|540419033|FG006|Overall Study|Withdrawal by Subject|1|||
149806505|NCT01489865|540419034|FG007|Overall Study|Withdrawal by Subject|0|||
149806506|NCT01489865|540419035|FG008|Overall Study|Withdrawal by Subject|2|||
149806507|NCT01489865|540419027|FG000|Overall Study|Shifted|0|||
149806508|NCT01489865|540419028|FG001|Overall Study|Shifted|0|||
149806509|NCT01489865|540419029|FG002|Overall Study|Shifted|1|||
149806510|NCT01489865|540419030|FG003|Overall Study|Shifted|0|||
149806511|NCT01489865|540419031|FG004|Overall Study|Shifted|0|||
149806512|NCT01489865|540419032|FG005|Overall Study|Shifted|0|||
149806513|NCT01489865|540419033|FG006|Overall Study|Shifted|0|||
149806514|NCT01489865|540419034|FG007|Overall Study|Shifted|0|||
149806515|NCT01489865|540419035|FG008|Overall Study|Shifted|0|||
149806516|NCT00972309|540419036|FG000|Overall Study|Switched to alternative treatment|0|||
149806517|NCT00972309|540419037|FG001|Overall Study|Switched to alternative treatment|2|||
149806518|NCT00972309|540419036|FG000|Overall Study|Refused further treatment|0|||
149806519|NCT00972309|540419037|FG001|Overall Study|Refused further treatment|1|||
149806520|NCT00972309|540419036|FG000|Overall Study|Late determination of ineligibility|0|||
149806521|NCT00972309|540419037|FG001|Overall Study|Late determination of ineligibility|1|||
149806522|NCT00972309|540419036|FG000|Overall Study|Second malignancy|1|||
149806523|NCT00972309|540419037|FG001|Overall Study|Second malignancy|1|||
149806524|NCT00972309|540419036|FG000|Overall Study|Visa issues|0|||
149806525|NCT00972309|540419037|FG001|Overall Study|Visa issues|1|||
149806526|NCT00972309|540419036|FG000|Overall Study|Secondary cancer (SCC)|0|||
149806527|NCT00972309|540419037|FG001|Overall Study|Secondary cancer (SCC)|1|||
149806528|NCT00972309|540419036|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
149806529|NCT00972309|540419037|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
149806530|NCT00972309|540419036|FG000|Overall Study|Lost to Follow-up|1|||
149806531|NCT00972309|540419037|FG001|Overall Study|Lost to Follow-up|1|||
149806532|NCT00972309|540419036|FG000|Overall Study|Disease progression on study|10|||
149806533|NCT00972309|540419037|FG001|Overall Study|Disease progression on study|4|||
149806534|NCT01593761|540419038|FG000|Overall Study|Lost to Follow-up|1|||
149806535|NCT01593761|540419038|FG000|Overall Study|culture negative for MRSA at baseline|5|||
149806536|NCT01593761|540419038|FG000|Overall Study|positive for hepatitis C virus|1|||
149806537|NCT01593761|540419038|FG000|Overall Study|secondary cellulitis|1|||
149806538|NCT05554471|540419039|FG000|Overall Study|Physician Decision|2|||
149806539|NCT05554471|540419040|FG001|Overall Study|Physician Decision|1|||
149806540|NCT05554471|540419039|FG000|Overall Study|Lost to Follow-up|2|||
149806541|NCT05554471|540419040|FG001|Overall Study|Lost to Follow-up|1|||
149806542|NCT05554471|540419039|FG000|Overall Study|Death|0|||
149806543|NCT05554471|540419040|FG001|Overall Study|Death|1|||
149806544|NCT02576951|540419042|FG000|Overall Study|Lost to Follow-up|0|||
149806545|NCT02576951|540419043|FG001|Overall Study|Lost to Follow-up|0|||
149806546|NCT02576951|540419044|FG002|Overall Study|Lost to Follow-up|2|||
149806547|NCT02576951|540419045|FG003|Overall Study|Lost to Follow-up|2|||
149806548|NCT02576951|540419042|FG000|Overall Study|Withdrawal by Subject|1|||
149806549|NCT02576951|540419043|FG001|Overall Study|Withdrawal by Subject|0|||
149806550|NCT02576951|540419044|FG002|Overall Study|Withdrawal by Subject|0|||
149806551|NCT02576951|540419045|FG003|Overall Study|Withdrawal by Subject|2|||
149806552|NCT02576951|540419042|FG000|Overall Study|Protocol Violation|0|||
149806553|NCT02576951|540419043|FG001|Overall Study|Protocol Violation|0|||
149806554|NCT02576951|540419044|FG002|Overall Study|Protocol Violation|0|||
149806555|NCT02576951|540419045|FG003|Overall Study|Protocol Violation|1|||
149806556|NCT00223990|540419049|FG000|Overall Study|Moved from area|2|||
149806557|NCT00223990|540419050|FG001|Overall Study|Moved from area|1|||
149806558|NCT00223990|540419049|FG000|Overall Study|Withdrawal by Subject|4|||
149806559|NCT00223990|540419050|FG001|Overall Study|Withdrawal by Subject|8|||
149806560|NCT00223990|540419049|FG000|Overall Study|Lost to Follow-up|1|||
149806561|NCT00223990|540419050|FG001|Overall Study|Lost to Follow-up|0|||
149806562|NCT01319994|540420669|FG000|Overall Study|Protocol Violation|7|||
149806563|NCT01319994|540420670|FG001|Overall Study|Protocol Violation|6|||
149806564|NCT01340794|540420671|FG000|Overall Study|Withdrawal by Subject|0|||
149806565|NCT01340794|540420672|FG001|Overall Study|Withdrawal by Subject|1|||
149806566|NCT01808508|540420676|FG000|Overall Study|Lost to Follow-up|1|||
149806567|NCT01808508|540420677|FG001|Overall Study|Lost to Follow-up|0|||
149806568|NCT01808508|540420678|FG002|Overall Study|Lost to Follow-up|0|||
149806569|NCT03387423|540420683|FG000|Overall Study|Lost to Follow-up|16|||
149806570|NCT03387423|540420684|FG001|Overall Study|Lost to Follow-up|12|||
149806571|NCT03387423|540420685|FG002|Overall Study|Lost to Follow-up|1|||
149806572|NCT03387423|540420686|FG003|Overall Study|Lost to Follow-up|0|||
149806573|NCT03387423|540420683|FG000|Overall Study|Other|0|||
149806574|NCT03387423|540420684|FG001|Overall Study|Other|3|||
149806575|NCT03387423|540420685|FG002|Overall Study|Other|0|||
149806576|NCT03387423|540420686|FG003|Overall Study|Other|0|||
149806577|NCT03387423|540420683|FG000|Overall Study|Administrative Reason|166|||
149806578|NCT03387423|540420684|FG001|Overall Study|Administrative Reason|89|||
149806579|NCT03387423|540420685|FG002|Overall Study|Administrative Reason|17|||
149806580|NCT03387423|540420686|FG003|Overall Study|Administrative Reason|19|||
149806581|NCT03387423|540420683|FG000|Overall Study|Revocation Consent|76|||
149806582|NCT03387423|540420684|FG001|Overall Study|Revocation Consent|32|||
149806583|NCT03387423|540420685|FG002|Overall Study|Revocation Consent|3|||
149806584|NCT03387423|540420686|FG003|Overall Study|Revocation Consent|5|||
149806585|NCT03862807|540420687|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
149806586|NCT00798707|540420688|FG000|Overall Study|Adverse Event|6|||
149806587|NCT00798707|540420689|FG001|Overall Study|Adverse Event|8|||
149806588|NCT00798707|540420690|FG002|Overall Study|Adverse Event|8|||
149806589|NCT00798707|540420688|FG000|Overall Study|Failed to return|2|||
149806590|NCT00798707|540420689|FG001|Overall Study|Failed to return|2|||
149806591|NCT00798707|540420690|FG002|Overall Study|Failed to return|0|||
149806592|NCT00798707|540420688|FG000|Overall Study|Investigator|0|||
149806593|NCT00798707|540420689|FG001|Overall Study|Investigator|1|||
149806594|NCT00798707|540420690|FG002|Overall Study|Investigator|2|||
149806595|NCT00798707|540420688|FG000|Overall Study|Lack of Efficacy|2|||
149806596|NCT00798707|540420689|FG001|Overall Study|Lack of Efficacy|2|||
149806597|NCT00798707|540420690|FG002|Overall Study|Lack of Efficacy|1|||
149806598|NCT00798707|540420688|FG000|Overall Study|Lost to Follow-up|5|||
149806599|NCT00798707|540420689|FG001|Overall Study|Lost to Follow-up|6|||
149806600|NCT00798707|540420690|FG002|Overall Study|Lost to Follow-up|6|||
149806601|NCT00798707|540420688|FG000|Overall Study|Other|0|||
149806602|NCT00798707|540420689|FG001|Overall Study|Other|1|||
149806603|NCT00798707|540420690|FG002|Overall Study|Other|0|||
149806604|NCT00798707|540420688|FG000|Overall Study|Protocol Violation|4|||
149806605|NCT00798707|540420689|FG001|Overall Study|Protocol Violation|0|||
149806606|NCT00798707|540420690|FG002|Overall Study|Protocol Violation|2|||
149806607|NCT00798707|540420688|FG000|Overall Study|Withdrawal by Subject|3|||
149806608|NCT00798707|540420689|FG001|Overall Study|Withdrawal by Subject|8|||
149806609|NCT00798707|540420690|FG002|Overall Study|Withdrawal by Subject|2|||
149806610|NCT00798707|540420688|FG000|Overall Study|Randomized not treated|4|||
149918897|NCT01210352|540835248|FG007|Overall Study|Lack of Efficacy|0|||
149806611|NCT00798707|540420689|FG001|Overall Study|Randomized not treated|5|||
149806612|NCT00798707|540420690|FG002|Overall Study|Randomized not treated|1|||
149806613|NCT01473589|540420693|FG000|Overall Study|Adverse Event|1|||
149806614|NCT01473589|540420694|FG001|Overall Study|Adverse Event|1|||
149806615|NCT01473589|540420693|FG000|Overall Study|Death|2|||
149806616|NCT01473589|540420694|FG001|Overall Study|Death|0|||
149806617|NCT01473589|540420693|FG000|Overall Study|Lost to Follow-up|2|||
149806618|NCT01473589|540420694|FG001|Overall Study|Lost to Follow-up|2|||
149806619|NCT01473589|540420693|FG000|Overall Study|Protocol Violation|1|||
149806620|NCT01473589|540420694|FG001|Overall Study|Protocol Violation|0|||
149806621|NCT01473589|540420693|FG000|Overall Study|Withdrawal by Subject|5|||
149806622|NCT01473589|540420694|FG001|Overall Study|Withdrawal by Subject|11|||
149806623|NCT01473589|540420693|FG000|Overall Study|Physician Decision|0|||
149806624|NCT01473589|540420694|FG001|Overall Study|Physician Decision|1|||
149806625|NCT01473589|540420693|FG000|Overall Study|Entry criteria not met|0|||
149806626|NCT01473589|540420694|FG001|Overall Study|Entry criteria not met|1|||
149806627|NCT00929201|540420695|FG000|Period 1|Withdrawal by Subject|0|||
149806628|NCT00929201|540420696|FG001|Period 1|Withdrawal by Subject|1|||
149806629|NCT01513759|540420700|FG000|Overall Study|Protocol Violation|4|||
149806630|NCT01513759|540420700|FG000|Overall Study|Death during catheter placement|1|||
149806631|NCT03606109|540420701|FG000|Overall Study|Lost to Follow-up|2|||
149806632|NCT03606109|540420702|FG001|Overall Study|Lost to Follow-up|1|||
149806633|NCT03722849|540420709|FG000|Overall Study|Withdrawal by Subject|1|||
149806634|NCT03722849|540420710|FG001|Overall Study|Withdrawal by Subject|1|||
149806635|NCT03514121|540420711|FG000|Overall Study|Withdrawal by Subject|0|||
149806636|NCT03514121|540420712|FG001|Overall Study|Withdrawal by Subject|0|||
149806637|NCT03514121|540420713|FG002|Overall Study|Withdrawal by Subject|0|||
149806638|NCT03514121|540420714|FG003|Overall Study|Withdrawal by Subject|0|||
149806639|NCT03514121|540420715|FG004|Overall Study|Withdrawal by Subject|1|||
149806640|NCT03514121|540420716|FG005|Overall Study|Withdrawal by Subject|2|||
149806641|NCT03514121|540420717|FG006|Overall Study|Withdrawal by Subject|1|||
149806642|NCT03514121|540420718|FG007|Overall Study|Withdrawal by Subject|1|||
149806643|NCT03514121|540420719|FG008|Overall Study|Withdrawal by Subject|7|||
149806644|NCT03514121|540420720|FG009|Overall Study|Withdrawal by Subject|2|||
149806645|NCT03514121|540420711|FG000|Overall Study|Death|0|||
149806646|NCT03514121|540420712|FG001|Overall Study|Death|0|||
149806647|NCT03514121|540420713|FG002|Overall Study|Death|0|||
149806648|NCT03514121|540420714|FG003|Overall Study|Death|0|||
149806649|NCT03514121|540420715|FG004|Overall Study|Death|0|||
149806650|NCT03514121|540420716|FG005|Overall Study|Death|3|||
149806651|NCT03514121|540420717|FG006|Overall Study|Death|2|||
149806652|NCT03514121|540420718|FG007|Overall Study|Death|1|||
149806653|NCT03514121|540420719|FG008|Overall Study|Death|26|||
149806654|NCT03514121|540420720|FG009|Overall Study|Death|3|||
149806655|NCT03514121|540420711|FG000|Overall Study|Lost to Follow-up|0|||
149806656|NCT03514121|540420712|FG001|Overall Study|Lost to Follow-up|0|||
149806657|NCT03514121|540420713|FG002|Overall Study|Lost to Follow-up|1|||
149806658|NCT03514121|540420714|FG003|Overall Study|Lost to Follow-up|0|||
149806659|NCT03514121|540420715|FG004|Overall Study|Lost to Follow-up|0|||
149806660|NCT03514121|540420716|FG005|Overall Study|Lost to Follow-up|0|||
149806661|NCT03514121|540420717|FG006|Overall Study|Lost to Follow-up|0|||
149806662|NCT03514121|540420718|FG007|Overall Study|Lost to Follow-up|0|||
149806663|NCT03514121|540420719|FG008|Overall Study|Lost to Follow-up|1|||
149806664|NCT03514121|540420720|FG009|Overall Study|Lost to Follow-up|0|||
149806665|NCT03514121|540420711|FG000|Overall Study|Adverse Event|0|||
149806666|NCT03514121|540420712|FG001|Overall Study|Adverse Event|0|||
149806667|NCT03514121|540420713|FG002|Overall Study|Adverse Event|0|||
149806668|NCT03514121|540420714|FG003|Overall Study|Adverse Event|0|||
149806669|NCT03514121|540420715|FG004|Overall Study|Adverse Event|0|||
149806670|NCT03514121|540420716|FG005|Overall Study|Adverse Event|0|||
149806671|NCT03514121|540420717|FG006|Overall Study|Adverse Event|1|||
149806672|NCT03514121|540420718|FG007|Overall Study|Adverse Event|0|||
149806673|NCT03514121|540420719|FG008|Overall Study|Adverse Event|0|||
149806674|NCT03514121|540420720|FG009|Overall Study|Adverse Event|0|||
149806675|NCT03514121|540420711|FG000|Overall Study|Other|0|||
149806676|NCT03514121|540420712|FG001|Overall Study|Other|1|||
149806677|NCT03514121|540420713|FG002|Overall Study|Other|1|||
149806678|NCT03514121|540420714|FG003|Overall Study|Other|0|||
149806679|NCT03514121|540420715|FG004|Overall Study|Other|1|||
149806680|NCT03514121|540420716|FG005|Overall Study|Other|2|||
149806681|NCT03514121|540420717|FG006|Overall Study|Other|3|||
149806682|NCT03514121|540420718|FG007|Overall Study|Other|2|||
149806683|NCT03514121|540420719|FG008|Overall Study|Other|7|||
149806684|NCT03514121|540420720|FG009|Overall Study|Other|3|||
149806685|NCT03514121|540420711|FG000|Overall Study|Study termination by Sponsor|0|||
149806686|NCT03514121|540420712|FG001|Overall Study|Study termination by Sponsor|0|||
149806687|NCT03514121|540420713|FG002|Overall Study|Study termination by Sponsor|0|||
149806688|NCT03514121|540420714|FG003|Overall Study|Study termination by Sponsor|0|||
149806689|NCT03514121|540420715|FG004|Overall Study|Study termination by Sponsor|0|||
149806690|NCT03514121|540420716|FG005|Overall Study|Study termination by Sponsor|0|||
149806691|NCT03514121|540420717|FG006|Overall Study|Study termination by Sponsor|0|||
149806692|NCT03514121|540420718|FG007|Overall Study|Study termination by Sponsor|0|||
149806693|NCT03514121|540420719|FG008|Overall Study|Study termination by Sponsor|11|||
149806694|NCT03514121|540420720|FG009|Overall Study|Study termination by Sponsor|3|||
149806695|NCT03514121|540420711|FG000|Overall Study|Investigator decision|0|||
149806696|NCT03514121|540420712|FG001|Overall Study|Investigator decision|0|||
149806697|NCT03514121|540420713|FG002|Overall Study|Investigator decision|0|||
149806698|NCT03514121|540420714|FG003|Overall Study|Investigator decision|0|||
149806699|NCT03514121|540420715|FG004|Overall Study|Investigator decision|0|||
149806700|NCT03514121|540420716|FG005|Overall Study|Investigator decision|0|||
149806701|NCT03514121|540420717|FG006|Overall Study|Investigator decision|0|||
149806702|NCT03514121|540420718|FG007|Overall Study|Investigator decision|0|||
149806703|NCT03514121|540420719|FG008|Overall Study|Investigator decision|1|||
149806704|NCT03514121|540420720|FG009|Overall Study|Investigator decision|0|||
149806705|NCT04633434|540420724|FG000|Overall Study|Lost to Follow-up|32|||
149806706|NCT04633434|540420725|FG001|Overall Study|Lost to Follow-up|32|||
149806707|NCT00297882|540420729|FG000|Day 14|Lack of Efficacy|12|||
149806708|NCT00297882|540420730|FG001|Day 14|Lack of Efficacy|49|||
149806709|NCT00297882|540420729|FG000|Day 28|Lost to Follow-up|13|||
149806710|NCT00297882|540420730|FG001|Day 28|Lost to Follow-up|23|||
149806711|NCT00297882|540420729|FG000|Day 28|Lack of Efficacy|3|||
149806712|NCT00297882|540420730|FG001|Day 28|Lack of Efficacy|0|||
149806713|NCT04242264|540420731|FG000|Overall Study|Lost to Follow-up|2|||
149806714|NCT04242264|540420732|FG001|Overall Study|Lost to Follow-up|2|||
149806715|NCT04242264|540420733|FG002|Overall Study|Lost to Follow-up|1|||
149806716|NCT04242264|540420734|FG003|Overall Study|Lost to Follow-up|1|||
149806717|NCT04242264|540420731|FG000|Overall Study|Withdrawal by Subject|1|||
149806718|NCT04242264|540420732|FG001|Overall Study|Withdrawal by Subject|0|||
149806719|NCT04242264|540420733|FG002|Overall Study|Withdrawal by Subject|0|||
149806720|NCT04242264|540420734|FG003|Overall Study|Withdrawal by Subject|0|||
149806721|NCT00348348|540420736|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
149806722|NCT00348348|540420737|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
149806723|NCT00348348|540420736|FG000|Overall Study|Lack of Efficacy|1|||
149806724|NCT00348348|540420737|FG001|Overall Study|Lack of Efficacy|1|||
149806725|NCT00348348|540420736|FG000|Overall Study|Lost to Follow-up|8|||
149806726|NCT00348348|540420737|FG001|Overall Study|Lost to Follow-up|10|||
149806727|NCT00348348|540420736|FG000|Overall Study|Withdrawal by Subject|4|||
149806728|NCT00348348|540420737|FG001|Overall Study|Withdrawal by Subject|1|||
149806729|NCT00348348|540420736|FG000|Overall Study|Other|7|||
149806730|NCT00348348|540420737|FG001|Overall Study|Other|4|||
149806731|NCT00348348|540420736|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
149806732|NCT00348348|540420737|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
149806733|NCT00348348|540420736|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
149806734|NCT00348348|540420737|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
149806735|NCT00348348|540420736|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
149806736|NCT00348348|540420737|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
149806737|NCT00348348|540420736|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
149806738|NCT00348348|540420737|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
149806739|NCT00348348|540420736|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
149806740|NCT00348348|540420737|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
149806741|NCT00348348|540420736|FG000|Overall Study|Adverse event probably related to study|1|||
149806742|NCT00348348|540420737|FG001|Overall Study|Adverse event probably related to study|0|||
149806743|NCT00578448|540420738|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
149806744|NCT00578448|540420738|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
149806745|NCT00578448|540420738|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
149806746|NCT00578448|540420738|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
149806747|NCT01317199|540420739|FG000|Dose-escalation Phase 1|Physician Decision|5|||
149806748|NCT01317199|540420740|FG001|Dose-escalation Phase 1|Physician Decision|0|||
149806749|NCT01317199|540420741|FG002|Dose-escalation Phase 1|Physician Decision|0|||
149806750|NCT01317199|540420742|FG003|Dose-escalation Phase 1|Physician Decision|0|||
149806751|NCT01317199|540420739|FG000|Dose-escalation Phase 1|Disease progression|1|||
149806752|NCT01317199|540420740|FG001|Dose-escalation Phase 1|Disease progression|0|||
149806753|NCT01317199|540420741|FG002|Dose-escalation Phase 1|Disease progression|0|||
149806754|NCT01317199|540420742|FG003|Dose-escalation Phase 1|Disease progression|0|||
149806755|NCT01317199|540420739|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
149806756|NCT01317199|540420740|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
149806757|NCT01317199|540420741|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
149806758|NCT01317199|540420742|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
149806759|NCT01317199|540420739|FG000|Randomized Phase 2|Disease progression|0|||
149806760|NCT01317199|540420740|FG001|Randomized Phase 2|Disease progression|3|||
149806761|NCT01317199|540420741|FG002|Randomized Phase 2|Disease progression|7|||
149806762|NCT01317199|540420742|FG003|Randomized Phase 2|Disease progression|5|||
149806763|NCT01317199|540420739|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
149806764|NCT01317199|540420740|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
149806765|NCT01317199|540420741|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
149806766|NCT01317199|540420742|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
149806767|NCT01317199|540420739|FG000|Randomized Phase 2|Adverse Event|0|||
149806768|NCT01317199|540420740|FG001|Randomized Phase 2|Adverse Event|0|||
149806769|NCT01317199|540420741|FG002|Randomized Phase 2|Adverse Event|0|||
149806770|NCT01317199|540420742|FG003|Randomized Phase 2|Adverse Event|1|||
149806771|NCT01317199|540420739|FG000|Randomized Phase 2|Comorbidities|0|||
149806772|NCT01317199|540420740|FG001|Randomized Phase 2|Comorbidities|2|||
149806773|NCT01317199|540420741|FG002|Randomized Phase 2|Comorbidities|2|||
149806774|NCT01317199|540420742|FG003|Randomized Phase 2|Comorbidities|2|||
149806775|NCT01317199|540420739|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
149806776|NCT01317199|540420740|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
149806777|NCT01317199|540420741|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
149806778|NCT01317199|540420742|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
149806779|NCT01317199|540420739|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
149806780|NCT01317199|540420740|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
149806781|NCT01317199|540420741|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
149806782|NCT01317199|540420742|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
149806783|NCT01317199|540420739|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
149806784|NCT01317199|540420740|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
149806785|NCT01317199|540420741|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
149806786|NCT01317199|540420742|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
149806787|NCT01317199|540420739|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
149806788|NCT01317199|540420740|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
149806789|NCT01317199|540420741|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
149806790|NCT01317199|540420742|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
149806791|NCT01353209|540420743|FG000|Overall Study|Adverse Event|1|||
149806792|NCT01353209|540420744|FG001|Overall Study|Adverse Event|1|||
149806793|NCT03237325|540420752|FG000|Overall Study|Lost to Follow-up|3|||
149806794|NCT03237325|540420753|FG001|Overall Study|Lost to Follow-up|5|||
149806795|NCT03237325|540420752|FG000|Overall Study|Physician Decision|2|||
149806796|NCT03237325|540420753|FG001|Overall Study|Physician Decision|4|||
149806797|NCT03237325|540420752|FG000|Overall Study|Withdrawal by Subject|9|||
149806798|NCT03237325|540420753|FG001|Overall Study|Withdrawal by Subject|12|||
149806799|NCT03237325|540420752|FG000|Overall Study|Noncompliance with Study Procedures|1|||
149806800|NCT03237325|540420753|FG001|Overall Study|Noncompliance with Study Procedures|1|||
149806801|NCT03237325|540420752|FG000|Overall Study|Termination by Sponsor|0|||
149806802|NCT03237325|540420753|FG001|Overall Study|Termination by Sponsor|1|||
149806803|NCT03237325|540420752|FG000|Overall Study|Reason other than described|0|||
149806804|NCT03237325|540420753|FG001|Overall Study|Reason other than described|2|||
149806805|NCT02684370|540420754|FG000|Part A|Adverse Event|2|||
149806806|NCT02684370|540420755|FG001|Part A|Adverse Event|0|||
149806807|NCT02684370|540420756|FG002|Part A|Adverse Event|1|||
149806808|NCT02684370|540420757|FG003|Part A|Adverse Event|0|||
149806809|NCT02684370|540420758|FG004|Part A|Adverse Event|0|||
149806810|NCT02684370|540420759|FG005|Part A|Adverse Event|0|||
149806811|NCT02684370|540420754|FG000|Part A|Lost to Follow-up|1|||
149806812|NCT02684370|540420755|FG001|Part A|Lost to Follow-up|1|||
149806813|NCT02684370|540420756|FG002|Part A|Lost to Follow-up|0|||
149806814|NCT02684370|540420757|FG003|Part A|Lost to Follow-up|0|||
149806815|NCT02684370|540420758|FG004|Part A|Lost to Follow-up|0|||
149806816|NCT02684370|540420759|FG005|Part A|Lost to Follow-up|0|||
149806817|NCT02684370|540420754|FG000|Part A|Subject Withdrawal|1|||
149806818|NCT02684370|540420755|FG001|Part A|Subject Withdrawal|0|||
149806819|NCT02684370|540420756|FG002|Part A|Subject Withdrawal|3|||
149806820|NCT02684370|540420757|FG003|Part A|Subject Withdrawal|0|||
149806821|NCT02684370|540420758|FG004|Part A|Subject Withdrawal|0|||
149806822|NCT02684370|540420759|FG005|Part A|Subject Withdrawal|0|||
149806823|NCT02684370|540420754|FG000|Part A|Other|0|||
149806824|NCT02684370|540420755|FG001|Part A|Other|0|||
149806825|NCT02684370|540420756|FG002|Part A|Other|1|||
149806826|NCT02684370|540420757|FG003|Part A|Other|0|||
149806827|NCT02684370|540420758|FG004|Part A|Other|0|||
149806828|NCT02684370|540420759|FG005|Part A|Other|0|||
149806829|NCT02684370|540420754|FG000|Part B|Adverse Event|0|||
149806830|NCT02684370|540420755|FG001|Part B|Adverse Event|0|||
149806831|NCT02684370|540420756|FG002|Part B|Adverse Event|0|||
149806832|NCT02684370|540420757|FG003|Part B|Adverse Event|0|||
149806833|NCT02684370|540420758|FG004|Part B|Adverse Event|2|||
149806834|NCT02684370|540420759|FG005|Part B|Adverse Event|1|||
149806835|NCT02684370|540420754|FG000|Part B|Lost to Follow-up|0|||
149806836|NCT02684370|540420755|FG001|Part B|Lost to Follow-up|0|||
149806837|NCT02684370|540420756|FG002|Part B|Lost to Follow-up|0|||
149806838|NCT02684370|540420757|FG003|Part B|Lost to Follow-up|1|||
149806839|NCT02684370|540420758|FG004|Part B|Lost to Follow-up|2|||
149806840|NCT02684370|540420759|FG005|Part B|Lost to Follow-up|5|||
149806841|NCT02684370|540420754|FG000|Part B|Subject Withdrawal|0|||
149806842|NCT02684370|540420755|FG001|Part B|Subject Withdrawal|0|||
149806843|NCT02684370|540420756|FG002|Part B|Subject Withdrawal|0|||
149806844|NCT02684370|540420757|FG003|Part B|Subject Withdrawal|1|||
149806845|NCT02684370|540420758|FG004|Part B|Subject Withdrawal|1|||
149806846|NCT02684370|540420759|FG005|Part B|Subject Withdrawal|2|||
149806847|NCT00627094|540420761|FG000|Overall Study|Adverse Event|8|||
149806848|NCT00627094|540420762|FG001|Overall Study|Adverse Event|7|||
149806849|NCT00627094|540420761|FG000|Overall Study|Lost to Follow-up|1|||
149806850|NCT00627094|540420762|FG001|Overall Study|Lost to Follow-up|0|||
149806851|NCT00627094|540420761|FG000|Overall Study|Withdrawal by Subject|1|||
149806852|NCT00627094|540420762|FG001|Overall Study|Withdrawal by Subject|1|||
149806853|NCT00627094|540420761|FG000|Overall Study|ulcer healed|1|||
149806854|NCT00627094|540420762|FG001|Overall Study|ulcer healed|7|||
149806855|NCT00627094|540420761|FG000|Overall Study|Other reason|1|||
149806856|NCT00627094|540420762|FG001|Overall Study|Other reason|0|||
149806857|NCT01165424|540420768|FG000|Overall Study|Clinical adverse experiences|1|||
149806858|NCT01165424|540420768|FG000|Overall Study|Laboratory adverse experiences|1|||
149806859|NCT01165424|540420768|FG000|Overall Study|Did not meet entry criteria|1|||
149806860|NCT01165424|540420768|FG000|Overall Study|Participant moved (relocated)|1|||
149806861|NCT04139642|540420769|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
149806862|NCT04139642|540420770|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
149806863|NCT00433771|540420773|FG000|Overall Study|screen fail|14|||
149806864|NCT00433771|540420773|FG000|Overall Study|Treated and later found to be ineligible|2|||
149806865|NCT00433771|540420773|FG000|Overall Study|Death|2|||
149806866|NCT00433771|540420773|FG000|Overall Study|Failure to deploy stent|1|||
149806867|NCT03733301|540420774|FG000|Overall Study|Screen Fail|1|||
149806868|NCT03733301|540420775|FG001|Overall Study|Screen Fail|0|||
149806869|NCT03733301|540420776|FG002|Overall Study|Screen Fail|0|||
149806870|NCT03733301|540420774|FG000|Overall Study|Non-compliance|1|||
149806871|NCT03733301|540420775|FG001|Overall Study|Non-compliance|0|||
149806872|NCT03733301|540420776|FG002|Overall Study|Non-compliance|0|||
149806873|NCT03733301|540420774|FG000|Overall Study|Lack of Efficacy|2|||
149806874|NCT03733301|540420775|FG001|Overall Study|Lack of Efficacy|3|||
149806875|NCT03733301|540420776|FG002|Overall Study|Lack of Efficacy|0|||
149806876|NCT03733301|540420774|FG000|Overall Study|Adverse Event|0|||
149806877|NCT03733301|540420775|FG001|Overall Study|Adverse Event|1|||
149806878|NCT03733301|540420776|FG002|Overall Study|Adverse Event|3|||
149806879|NCT03733301|540420774|FG000|Overall Study|Withdrawal by Subject|3|||
149806880|NCT03733301|540420775|FG001|Overall Study|Withdrawal by Subject|5|||
149806881|NCT03733301|540420776|FG002|Overall Study|Withdrawal by Subject|1|||
149806882|NCT01965431|540420779|FG000|Overall Study|Adverse Event|0|||
149806883|NCT01965431|540420780|FG001|Overall Study|Adverse Event|1|||
149806884|NCT01965431|540420781|FG002|Overall Study|Adverse Event|0|||
149806885|NCT01965431|540420782|FG003|Overall Study|Adverse Event|0|||
149806886|NCT01965431|540420783|FG004|Overall Study|Adverse Event|0|||
149806887|NCT01965431|540420784|FG005|Overall Study|Adverse Event|0|||
149806888|NCT01965431|540420779|FG000|Overall Study|Other than stated above|6|||
149806889|NCT01965431|540420780|FG001|Overall Study|Other than stated above|5|||
149806890|NCT01965431|540420781|FG002|Overall Study|Other than stated above|6|||
149806891|NCT01965431|540420782|FG003|Overall Study|Other than stated above|6|||
149806892|NCT01965431|540420783|FG004|Overall Study|Other than stated above|6|||
149806893|NCT01965431|540420784|FG005|Overall Study|Other than stated above|6|||
149806894|NCT04635631|540420785|FG000|Overall Study|Adverse Event|1|||
149806895|NCT04635631|540420785|FG000|Overall Study|Progressive disease|13|||
149806896|NCT04635631|540420785|FG000|Overall Study|Withdrawal by Subject|1|||
149806897|NCT00577031|540420786|FG000|Overall Study|Adverse Event|52|||
149806898|NCT00577031|540420786|FG000|Overall Study|Progression of disease|93|||
149806899|NCT00577031|540420786|FG000|Overall Study|Protocol Violation|5|||
149806900|NCT00577031|540420786|FG000|Overall Study|Participant withdrew consent|13|||
149806901|NCT00577031|540420786|FG000|Overall Study|Participant non-compliance|5|||
149806902|NCT00577031|540420786|FG000|Overall Study|Need for surgery|17|||
149806903|NCT00577031|540420786|FG000|Overall Study|Medical decision|14|||
149806904|NCT00577031|540420786|FG000|Overall Study|Death|6|||
149806905|NCT00943826|540420787|FG000|Concurrent Phase|Adverse Event|50|||
149806906|NCT00943826|540420788|FG001|Concurrent Phase|Adverse Event|27|||
149806907|NCT00943826|540420787|FG000|Concurrent Phase|Withdrew consent|3|||
149806908|NCT00943826|540420788|FG001|Concurrent Phase|Withdrew consent|7|||
149806909|NCT00943826|540420787|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
149806910|NCT00943826|540420788|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
149806911|NCT00943826|540420787|FG000|Concurrent Phase|Administrative reasons|2|||
149806912|NCT00943826|540420788|FG001|Concurrent Phase|Administrative reasons|1|||
149806913|NCT00943826|540420787|FG000|Concurrent Phase|Protocol Violation|1|||
149806914|NCT00943826|540420788|FG001|Concurrent Phase|Protocol Violation|0|||
149806915|NCT00943826|540420787|FG000|Maintenance Phase|Adverse Event|31|||
149806916|NCT00943826|540420788|FG001|Maintenance Phase|Adverse Event|30|||
149806917|NCT00943826|540420787|FG000|Maintenance Phase|Withdrew consent|2|||
149806918|NCT00943826|540420788|FG001|Maintenance Phase|Withdrew consent|4|||
149806919|NCT00943826|540420787|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
149806920|NCT00943826|540420788|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
149806921|NCT00943826|540420787|FG000|Maintenance Phase|Administrative reasons|4|||
149806922|NCT00943826|540420788|FG001|Maintenance Phase|Administrative reasons|1|||
149806923|NCT00943826|540420787|FG000|Maintenance Phase|Failure to return|0|||
149806924|NCT00943826|540420788|FG001|Maintenance Phase|Failure to return|1|||
149806925|NCT00943826|540420787|FG000|Monotherapy Phase|Adverse Event|42|||
149806926|NCT00943826|540420788|FG001|Monotherapy Phase|Adverse Event|5|||
149806927|NCT00943826|540420787|FG000|Monotherapy Phase|Administrative reasons|11|||
149806928|NCT00943826|540420788|FG001|Monotherapy Phase|Administrative reasons|5|||
149806929|NCT00943826|540420787|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
149806930|NCT00943826|540420788|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
149806931|NCT00943826|540420787|FG000|Monotherapy Phase|Withdrew Consent|2|||
149806932|NCT00943826|540420788|FG001|Monotherapy Phase|Withdrew Consent|3|||
149806933|NCT00943826|540420787|FG000|Monotherapy Phase|Failure to return|2|||
149806934|NCT00943826|540420788|FG001|Monotherapy Phase|Failure to return|1|||
149806935|NCT00943826|540420787|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
149806936|NCT00943826|540420788|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
149806937|NCT00943826|540420787|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
149806938|NCT00943826|540420788|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
149806939|NCT00943826|540420787|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
149806940|NCT00943826|540420788|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
149806941|NCT00943826|540420787|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
149806942|NCT00943826|540420788|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
149806943|NCT00557830|540420790|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
149806944|NCT00557830|540420791|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
149806945|NCT00557830|540420792|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
149806946|NCT00557830|540420790|FG000|Screening Treatment Phase|Adverse Event|2|||
149806947|NCT00557830|540420791|FG001|Screening Treatment Phase|Adverse Event|0|||
149806948|NCT00557830|540420792|FG002|Screening Treatment Phase|Adverse Event|0|||
149806949|NCT00557830|540420790|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
149806950|NCT00557830|540420791|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
149806951|NCT00557830|540420792|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
149806952|NCT00127192|540420793|FG000|Overall Study|Adverse Event|0|||
149806953|NCT00127192|540420794|FG001|Overall Study|Adverse Event|1|||
149806954|NCT00127192|540420795|FG002|Overall Study|Adverse Event|1|||
149806955|NCT00127192|540420796|FG003|Overall Study|Adverse Event|1|||
149806956|NCT00127192|540420797|FG004|Overall Study|Adverse Event|0|||
149806957|NCT00127192|540420793|FG000|Overall Study|Lack of Efficacy|2|||
149806958|NCT00127192|540420794|FG001|Overall Study|Lack of Efficacy|0|||
149806959|NCT00127192|540420795|FG002|Overall Study|Lack of Efficacy|0|||
149806960|NCT00127192|540420796|FG003|Overall Study|Lack of Efficacy|0|||
149806961|NCT00127192|540420797|FG004|Overall Study|Lack of Efficacy|2|||
149806962|NCT00127192|540420793|FG000|Overall Study|Withdrawal by Subject|0|||
149806963|NCT00127192|540420794|FG001|Overall Study|Withdrawal by Subject|0|||
149806964|NCT00127192|540420795|FG002|Overall Study|Withdrawal by Subject|1|||
149806965|NCT00127192|540420796|FG003|Overall Study|Withdrawal by Subject|0|||
149806966|NCT00127192|540420797|FG004|Overall Study|Withdrawal by Subject|3|||
149806967|NCT00127192|540420793|FG000|Overall Study|Adverse event in pre-treatment period|1|||
149806968|NCT00127192|540420794|FG001|Overall Study|Adverse event in pre-treatment period|0|||
149806969|NCT00127192|540420795|FG002|Overall Study|Adverse event in pre-treatment period|0|||
149806970|NCT00127192|540420796|FG003|Overall Study|Adverse event in pre-treatment period|0|||
149806971|NCT00127192|540420797|FG004|Overall Study|Adverse event in pre-treatment period|0|||
149806972|NCT01856257|540420798|FG000|Overall Study|Death|2|||
149806973|NCT01856257|540420799|FG001|Overall Study|Death|0|||
149806974|NCT01856257|540420800|FG002|Overall Study|Death|0|||
149806975|NCT01856257|540420801|FG003|Overall Study|Death|0|||
149806976|NCT01856257|540420798|FG000|Overall Study|Physician Decision|0|||
149806977|NCT01856257|540420799|FG001|Overall Study|Physician Decision|0|||
149806978|NCT01856257|540420800|FG002|Overall Study|Physician Decision|0|||
149806979|NCT01856257|540420801|FG003|Overall Study|Physician Decision|1|||
149806980|NCT01856257|540420798|FG000|Overall Study|Withdrawal by Subject|1|||
149806981|NCT01856257|540420799|FG001|Overall Study|Withdrawal by Subject|1|||
149806982|NCT01856257|540420800|FG002|Overall Study|Withdrawal by Subject|0|||
149806983|NCT01856257|540420801|FG003|Overall Study|Withdrawal by Subject|0|||
149806984|NCT01856257|540420798|FG000|Overall Study|Donor complication|0|||
149806985|NCT01856257|540420799|FG001|Overall Study|Donor complication|0|||
149806986|NCT01856257|540420800|FG002|Overall Study|Donor complication|0|||
149806987|NCT01856257|540420801|FG003|Overall Study|Donor complication|1|||
149806988|NCT04935931|540420802|FG000|Overall Study|Withdrawal by Subject|1|||
149806989|NCT00077766|540420803|FG000|Overall Study|Adverse Event|1|||
149806990|NCT00077766|540420804|FG001|Overall Study|Adverse Event|1|||
149806991|NCT00077766|540420803|FG000|Overall Study|Withdrawal by Subject|4|||
149806992|NCT00077766|540420804|FG001|Overall Study|Withdrawal by Subject|3|||
149806993|NCT00077766|540420803|FG000|Overall Study|Death|12|||
149806994|NCT00077766|540420804|FG001|Overall Study|Death|10|||
149806995|NCT00077766|540420803|FG000|Overall Study|Lost to Follow-up|2|||
149806996|NCT00077766|540420804|FG001|Overall Study|Lost to Follow-up|0|||
149806997|NCT00077766|540420803|FG000|Overall Study|Protocol Violation|1|||
149806998|NCT00077766|540420804|FG001|Overall Study|Protocol Violation|0|||
149806999|NCT00077766|540420803|FG000|Overall Study|Kidney Transplantation|9|||
149807000|NCT00077766|540420804|FG001|Overall Study|Kidney Transplantation|5|||
149807001|NCT00077766|540420803|FG000|Overall Study|Transplantation|5|||
149807002|NCT00077766|540420804|FG001|Overall Study|Transplantation|1|||
149807003|NCT00077766|540420803|FG000|Overall Study|Investigators Discretion|1|||
149807004|NCT00077766|540420804|FG001|Overall Study|Investigators Discretion|0|||
149807005|NCT00077766|540420803|FG000|Overall Study|Participant's decision|1|||
149807006|NCT00077766|540420804|FG001|Overall Study|Participant's decision|0|||
149807007|NCT00077766|540420803|FG000|Overall Study|Dialysis Discontinued|1|||
149807008|NCT00077766|540420804|FG001|Overall Study|Dialysis Discontinued|0|||
149807009|NCT00077766|540420803|FG000|Overall Study|Dialysis|0|||
149807010|NCT00077766|540420804|FG001|Overall Study|Dialysis|1|||
149807011|NCT00077766|540420803|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
149807012|NCT00077766|540420804|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
149807013|NCT00077766|540420803|FG000|Overall Study|Started Nocturnal Dialysis|0|||
149807014|NCT00077766|540420804|FG001|Overall Study|Started Nocturnal Dialysis|1|||
149807015|NCT00077766|540420803|FG000|Overall Study|Stop Dialysis|0|||
149807016|NCT00077766|540420804|FG001|Overall Study|Stop Dialysis|1|||
149807017|NCT00077766|540420803|FG000|Overall Study|Participants Vacation|2|||
149807018|NCT00077766|540420804|FG001|Overall Study|Participants Vacation|1|||
149807019|NCT01886105|540420805|FG000|Overall Study|Lack of Efficacy|3|||
149807020|NCT02057549|540420809|FG000|Overall Study|Lost to Follow-up|1|||
149807021|NCT02057549|540420810|FG001|Overall Study|Lost to Follow-up|0|||
149807022|NCT02057549|540420809|FG000|Overall Study|Physician Decision|1|||
149807023|NCT02057549|540420810|FG001|Overall Study|Physician Decision|0|||
149807024|NCT02057549|540420809|FG000|Overall Study|Withdrawal by Subject|1|||
149807025|NCT02057549|540420810|FG001|Overall Study|Withdrawal by Subject|0|||
149807026|NCT01360021|540420811|FG000|Overall Study|Eligibility criteria + other|2|||
149807027|NCT01360021|540420812|FG001|Overall Study|Eligibility criteria + other|1|||
149807028|NCT01360021|540420813|FG002|Overall Study|Eligibility criteria + other|1|||
149807029|NCT01360021|540420811|FG000|Overall Study|Protocol Violation|0|||
149807030|NCT01360021|540420812|FG001|Overall Study|Protocol Violation|0|||
149807031|NCT01360021|540420813|FG002|Overall Study|Protocol Violation|1|||
149807032|NCT01360021|540420811|FG000|Overall Study|Withdrawal by Subject|4|||
149807033|NCT01360021|540420812|FG001|Overall Study|Withdrawal by Subject|0|||
149807034|NCT01360021|540420813|FG002|Overall Study|Withdrawal by Subject|2|||
149807035|NCT01360021|540420811|FG000|Overall Study|Adverse Event|2|||
149807036|NCT01360021|540420812|FG001|Overall Study|Adverse Event|3|||
149807037|NCT01360021|540420813|FG002|Overall Study|Adverse Event|3|||
149807038|NCT03843775|540420814|FG000|Overall Study|Adverse Event|1|||
149807039|NCT03843775|540420815|FG001|Overall Study|Adverse Event|1|||
149807040|NCT03843775|540420814|FG000|Overall Study|Lack of Efficacy|2|||
149807041|NCT03843775|540420815|FG001|Overall Study|Lack of Efficacy|6|||
149807042|NCT03843775|540420814|FG000|Overall Study|Withdrawal by Subject|0|||
149807043|NCT03843775|540420815|FG001|Overall Study|Withdrawal by Subject|1|||
149807044|NCT00530621|540420819|FG000|Overall Study|Adverse Event|11|||
149807045|NCT00530621|540420820|FG001|Overall Study|Adverse Event|8|||
149807046|NCT00530621|540420819|FG000|Overall Study|Physician Decision|2|||
149807047|NCT00530621|540420820|FG001|Overall Study|Physician Decision|4|||
149807048|NCT00530621|540420819|FG000|Overall Study|Progressive Disease (PD)|47|||
149807049|NCT00530621|540420820|FG001|Overall Study|Progressive Disease (PD)|40|||
149807050|NCT00530621|540420819|FG000|Overall Study|Sponsor Decision|12|||
149807051|NCT00530621|540420820|FG001|Overall Study|Sponsor Decision|15|||
149807052|NCT00530621|540420819|FG000|Overall Study|Subject Decision|4|||
149807053|NCT00530621|540420820|FG001|Overall Study|Subject Decision|7|||
149807054|NCT00530621|540420819|FG000|Overall Study|Death|3|||
149807055|NCT00530621|540420820|FG001|Overall Study|Death|6|||
149807056|NCT00530621|540420819|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
149807057|NCT00530621|540420820|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
149807058|NCT02596009|540420821|FG000|Overall Study|Administrative problems|0|||
149807059|NCT02596009|540420822|FG001|Overall Study|Administrative problems|1|||
149807060|NCT02596009|540420823|FG002|Overall Study|Administrative problems|0|||
149807061|NCT02596009|540420824|FG003|Overall Study|Administrative problems|0|||
149807062|NCT02596009|540420825|FG004|Overall Study|Administrative problems|0|||
149807063|NCT02596009|540420826|FG005|Overall Study|Administrative problems|0|||
149807064|NCT02255422|540420829|FG000|Overall Study|Withdrawal by Subject|0|||
149807065|NCT02255422|540420830|FG001|Overall Study|Withdrawal by Subject|0|||
149807066|NCT02255422|540420831|FG002|Overall Study|Withdrawal by Subject|0|||
149807067|NCT02255422|540420832|FG003|Overall Study|Withdrawal by Subject|0|||
149807068|NCT02255422|540420833|FG004|Overall Study|Withdrawal by Subject|0|||
149807069|NCT02255422|540420834|FG005|Overall Study|Withdrawal by Subject|0|||
149807070|NCT02255422|540420835|FG006|Overall Study|Withdrawal by Subject|2|||
149807071|NCT02255422|540420829|FG000|Overall Study|Lost to Follow-up|0|||
150148706|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
150148707|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
150148708|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Death|0|||
150148709|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Death|1|||
150148710|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Adverse Event|11|||
150148711|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Adverse Event|11|||
150148712|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
150148713|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
150148714|NCT02936037|541681686|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150148715|NCT02936037|541681687|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
150148716|NCT02936037|541681686|FG000|Open Label Extension|Adverse Event|0|||
150148717|NCT02936037|541681687|FG001|Open Label Extension|Adverse Event|3|||
150148718|NCT02936037|541681686|FG000|Open Label Extension|Other|0|||
150148719|NCT02936037|541681687|FG001|Open Label Extension|Other|3|||
150148720|NCT02936037|541681686|FG000|Open Label Extension|Withdrawal by Subject|0|||
150148721|NCT02936037|541681687|FG001|Open Label Extension|Withdrawal by Subject|4|||
150148722|NCT03545113|541681688|FG000|Overall Study|Surgery Cancelled|1|||
150148723|NCT03545113|541681689|FG001|Overall Study|Surgery Cancelled|0|||
150148724|NCT03545113|541681688|FG000|Overall Study|Death|1|||
150148725|NCT03545113|541681689|FG001|Overall Study|Death|0|||
150148726|NCT03545113|541681688|FG000|Overall Study|Adverse Event|2|||
150148727|NCT03545113|541681689|FG001|Overall Study|Adverse Event|0|||
150148728|NCT03545113|541681688|FG000|Overall Study|Received different surgery|1|||
150148729|NCT03545113|541681689|FG001|Overall Study|Received different surgery|0|||
150148730|NCT00235443|541681690|FG000|Overall Study|Adverse Event|4|||
150148731|NCT00235443|541681691|FG001|Overall Study|Adverse Event|12|||
150148732|NCT00235443|541681692|FG002|Overall Study|Adverse Event|17|||
150148733|NCT00235443|541681693|FG003|Overall Study|Adverse Event|44|||
150148734|NCT00235443|541681694|FG004|Overall Study|Adverse Event|10|||
150148735|NCT00235443|541681695|FG005|Overall Study|Adverse Event|15|||
150148736|NCT00235443|541681690|FG000|Overall Study|Lack of Efficacy|0|||
150148737|NCT00235443|541681691|FG001|Overall Study|Lack of Efficacy|1|||
150148738|NCT00235443|541681692|FG002|Overall Study|Lack of Efficacy|5|||
150148739|NCT00235443|541681693|FG003|Overall Study|Lack of Efficacy|12|||
150148740|NCT00235443|541681694|FG004|Overall Study|Lack of Efficacy|2|||
150148741|NCT00235443|541681695|FG005|Overall Study|Lack of Efficacy|9|||
150148742|NCT00235443|541681690|FG000|Overall Study|Withdrawal by Subject|3|||
150148743|NCT00235443|541681691|FG001|Overall Study|Withdrawal by Subject|9|||
150148744|NCT00235443|541681692|FG002|Overall Study|Withdrawal by Subject|25|||
150148745|NCT00235443|541681693|FG003|Overall Study|Withdrawal by Subject|24|||
150148746|NCT00235443|541681694|FG004|Overall Study|Withdrawal by Subject|10|||
150148747|NCT00235443|541681695|FG005|Overall Study|Withdrawal by Subject|12|||
150148748|NCT00235443|541681690|FG000|Overall Study|Lost to Follow-up|0|||
150148749|NCT00235443|541681691|FG001|Overall Study|Lost to Follow-up|8|||
150148750|NCT00235443|541681692|FG002|Overall Study|Lost to Follow-up|6|||
150148751|NCT00235443|541681693|FG003|Overall Study|Lost to Follow-up|6|||
150148752|NCT00235443|541681694|FG004|Overall Study|Lost to Follow-up|4|||
150148753|NCT00235443|541681695|FG005|Overall Study|Lost to Follow-up|3|||
150148754|NCT00235443|541681690|FG000|Overall Study|Unsatisfactory compliance|0|||
150148755|NCT00235443|541681691|FG001|Overall Study|Unsatisfactory compliance|2|||
150148756|NCT00235443|541681692|FG002|Overall Study|Unsatisfactory compliance|3|||
150148757|NCT00235443|541681693|FG003|Overall Study|Unsatisfactory compliance|4|||
150148758|NCT00235443|541681694|FG004|Overall Study|Unsatisfactory compliance|1|||
150148759|NCT00235443|541681695|FG005|Overall Study|Unsatisfactory compliance|0|||
150148760|NCT00235443|541681690|FG000|Overall Study|Other reasons for premature termination|1|||
150148761|NCT00235443|541681691|FG001|Overall Study|Other reasons for premature termination|6|||
150148762|NCT00235443|541681692|FG002|Overall Study|Other reasons for premature termination|6|||
150148763|NCT00235443|541681693|FG003|Overall Study|Other reasons for premature termination|7|||
150148764|NCT00235443|541681694|FG004|Overall Study|Other reasons for premature termination|3|||
150148765|NCT00235443|541681695|FG005|Overall Study|Other reasons for premature termination|6|||
150148766|NCT02032173|541681696|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
150148767|NCT01017120|541681699|FG000|Overall Study|Adverse Event|9|||
150148768|NCT01017120|541681700|FG001|Overall Study|Adverse Event|0|||
150148769|NCT01017120|541681699|FG000|Overall Study|Lost to Follow-up|13|||
150148770|NCT01017120|541681700|FG001|Overall Study|Lost to Follow-up|11|||
150148771|NCT01017120|541681699|FG000|Overall Study|Lack of Efficacy|1|||
150148772|NCT01017120|541681700|FG001|Overall Study|Lack of Efficacy|0|||
150148773|NCT01017120|541681699|FG000|Overall Study|Withdrawal by Subject|39|||
150148774|NCT01017120|541681700|FG001|Overall Study|Withdrawal by Subject|21|||
150148775|NCT01017120|541681699|FG000|Overall Study|Pregnancy|1|||
150148776|NCT01017120|541681700|FG001|Overall Study|Pregnancy|1|||
150148777|NCT01017120|541681699|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
150148778|NCT01017120|541681700|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
150148779|NCT01017120|541681699|FG000|Overall Study|Relocated Out of Town|0|||
150148780|NCT01017120|541681700|FG001|Overall Study|Relocated Out of Town|2|||
150148781|NCT01017120|541681699|FG000|Overall Study|Protocol Violation|1|||
149807072|NCT02255422|540420830|FG001|Overall Study|Lost to Follow-up|0|||
149807073|NCT02255422|540420831|FG002|Overall Study|Lost to Follow-up|1|||
149807074|NCT02255422|540420832|FG003|Overall Study|Lost to Follow-up|0|||
149807075|NCT02255422|540420833|FG004|Overall Study|Lost to Follow-up|0|||
149807076|NCT02255422|540420834|FG005|Overall Study|Lost to Follow-up|0|||
149807077|NCT02255422|540420835|FG006|Overall Study|Lost to Follow-up|0|||
149807078|NCT02062385|540420836|FG000|Overall Study|Adverse Event|19|||
149807079|NCT02062385|540420837|FG001|Overall Study|Adverse Event|13|||
149807080|NCT02062385|540420838|FG002|Overall Study|Adverse Event|1|||
149807081|NCT02062385|540420839|FG003|Overall Study|Adverse Event|0|||
149807082|NCT02062385|540420836|FG000|Overall Study|Protocol Violation|1|||
149807083|NCT02062385|540420837|FG001|Overall Study|Protocol Violation|0|||
149807084|NCT02062385|540420838|FG002|Overall Study|Protocol Violation|0|||
149807085|NCT02062385|540420839|FG003|Overall Study|Protocol Violation|0|||
149807086|NCT02062385|540420836|FG000|Overall Study|Incomplete EPI by database lock|2|||
149807087|NCT02062385|540420837|FG001|Overall Study|Incomplete EPI by database lock|0|||
149807088|NCT02062385|540420838|FG002|Overall Study|Incomplete EPI by database lock|0|||
149807089|NCT02062385|540420839|FG003|Overall Study|Incomplete EPI by database lock|0|||
149807090|NCT02062385|540420836|FG000|Overall Study|Moved|10|||
149807091|NCT02062385|540420837|FG001|Overall Study|Moved|11|||
149807092|NCT02062385|540420838|FG002|Overall Study|Moved|1|||
149807093|NCT02062385|540420839|FG003|Overall Study|Moved|0|||
149807094|NCT02062385|540420836|FG000|Overall Study|Withdrawn by parent/guardian|46|||
149807095|NCT02062385|540420837|FG001|Overall Study|Withdrawn by parent/guardian|41|||
149807096|NCT02062385|540420838|FG002|Overall Study|Withdrawn by parent/guardian|9|||
149807097|NCT02062385|540420839|FG003|Overall Study|Withdrawn by parent/guardian|8|||
149807098|NCT02062385|540420836|FG000|Overall Study|Death|0|||
149807099|NCT02062385|540420837|FG001|Overall Study|Death|0|||
149807100|NCT02062385|540420838|FG002|Overall Study|Death|0|||
149807101|NCT02062385|540420839|FG003|Overall Study|Death|1|||
149807102|NCT02062385|540420836|FG000|Overall Study|Lost to Follow-up|0|||
149807103|NCT02062385|540420837|FG001|Overall Study|Lost to Follow-up|0|||
149807104|NCT02062385|540420838|FG002|Overall Study|Lost to Follow-up|1|||
149807105|NCT02062385|540420839|FG003|Overall Study|Lost to Follow-up|0|||
149807106|NCT03222856|540420840|FG000|Overall Study|Adverse Event|6|||
149807107|NCT03222856|540420840|FG000|Overall Study|Death|1|||
149807108|NCT01035229|540422782|FG000|Overall Study|Adverse Event|61|||
149807109|NCT01035229|540422783|FG001|Overall Study|Adverse Event|14|||
149807110|NCT01035229|540422782|FG000|Overall Study|Withdrawal by Subject|20|||
149807111|NCT01035229|540422783|FG001|Overall Study|Withdrawal by Subject|7|||
149807112|NCT01035229|540422782|FG000|Overall Study|Lost to Follow-up|1|||
149807113|NCT01035229|540422783|FG001|Overall Study|Lost to Follow-up|0|||
149807114|NCT01035229|540422782|FG000|Overall Study|Administrative problems|1|||
149807115|NCT01035229|540422783|FG001|Overall Study|Administrative problems|1|||
149807116|NCT01035229|540422782|FG000|Overall Study|Death|13|||
149807117|NCT01035229|540422783|FG001|Overall Study|Death|5|||
149807118|NCT01035229|540422782|FG000|Overall Study|New cancer therapy|2|||
149807119|NCT01035229|540422783|FG001|Overall Study|New cancer therapy|0|||
149807120|NCT01035229|540422782|FG000|Overall Study|Protocol Violation|0|||
149807121|NCT01035229|540422783|FG001|Overall Study|Protocol Violation|2|||
149807122|NCT01035229|540422782|FG000|Overall Study|Sponsor's decision to end study|3|||
149807123|NCT01035229|540422783|FG001|Overall Study|Sponsor's decision to end study|3|||
149807124|NCT01035229|540422782|FG000|Overall Study|Disease Progression|261|||
149807125|NCT01035229|540422783|FG001|Overall Study|Disease Progression|152|||
149807126|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
149807127|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
149807128|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
150148782|NCT01017120|541681700|FG001|Overall Study|Protocol Violation|0|||
150148783|NCT01017120|541681699|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
150148784|NCT01017120|541681700|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
150148785|NCT01912222|541681703|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
150148786|NCT01912222|541681704|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
150148787|NCT01912222|541681705|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
150148788|NCT01912222|541681703|FG000|Part B: Treatment Period|Progressive disease|10|||
150148789|NCT01912222|541681704|FG001|Part B: Treatment Period|Progressive disease|12|||
150148790|NCT01912222|541681705|FG002|Part B: Treatment Period|Progressive disease|15|||
150148791|NCT01912222|541681703|FG000|Part B: Treatment Period|Adverse Event|1|||
149807129|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
149807130|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
149807131|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
149807132|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
149807133|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
149807134|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
149807135|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
149807136|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
150148792|NCT01912222|541681704|FG001|Part B: Treatment Period|Adverse Event|2|||
149807137|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
149807138|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
149807139|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
149807140|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
149807141|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
149807142|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
149807143|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
149807144|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
149807145|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
149807146|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
149807147|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
149807148|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
149807149|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
149807150|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
149807151|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
149807152|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
149807153|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
149807154|NCT01299272|540422789|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
149807155|NCT01299272|540422790|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
149807156|NCT01299272|540422791|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
149807157|NCT01299272|540422792|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
149807158|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
149807159|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
149807160|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
149807161|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
149807162|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
149807163|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
149807164|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
149807165|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
149807166|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
149807167|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
149807168|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
149807169|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
149807170|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
149807171|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
149807172|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
149807173|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
149807174|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
149807175|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
149807176|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
149807177|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
149807178|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
149807179|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
149807180|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
149807181|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
149807182|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
149807183|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
149807184|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
149807185|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
149807186|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
149807187|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
149807188|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
149807189|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
149807190|NCT01299272|540422789|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
149807191|NCT01299272|540422790|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
149807192|NCT01299272|540422791|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
149807193|NCT01299272|540422792|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
149807194|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
149807195|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
149807196|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
149807197|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
149807198|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
149807199|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
149807200|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
149807201|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
149807202|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
149807203|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
149807204|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
149807205|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
149807206|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
149807207|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
149807208|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
149807209|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
149807210|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
149807211|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
149807212|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
149807213|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
149807214|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
149807215|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
149807216|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
149807217|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
149807218|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
149807219|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
149807220|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
149807221|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
149807222|NCT01299272|540422789|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
149807223|NCT01299272|540422790|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
149807224|NCT01299272|540422791|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
149807225|NCT01299272|540422792|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
149807226|NCT03926728|540422793|FG000|Overall Study|Withdrawal by Subject|0|||
149807227|NCT03926728|540422794|FG001|Overall Study|Withdrawal by Subject|1|||
149807228|NCT03926728|540422795|FG002|Overall Study|Withdrawal by Subject|1|||
149807229|NCT03926728|540422796|FG003|Overall Study|Withdrawal by Subject|0|||
149807230|NCT03926728|540422797|FG004|Overall Study|Withdrawal by Subject|0|||
149807231|NCT03926728|540422798|FG005|Overall Study|Withdrawal by Subject|1|||
149807232|NCT03926728|540422799|FG006|Overall Study|Withdrawal by Subject|1|||
149807233|NCT03926728|540422800|FG007|Overall Study|Withdrawal by Subject|0|||
149807234|NCT03926728|540422801|FG008|Overall Study|Withdrawal by Subject|0|||
149807235|NCT03926728|540422802|FG009|Overall Study|Withdrawal by Subject|1|||
149807236|NCT03926728|540422803|FG010|Overall Study|Withdrawal by Subject|0|||
149807237|NCT03926728|540422804|FG011|Overall Study|Withdrawal by Subject|0|||
149807238|NCT03669640|540422805|FG000|Overall Study|Study Terminated by Sponsor|0|||
149807239|NCT03669640|540422806|FG001|Overall Study|Study Terminated by Sponsor|0|||
149807240|NCT03669640|540422807|FG002|Overall Study|Study Terminated by Sponsor|0|||
149807241|NCT03669640|540422808|FG003|Overall Study|Study Terminated by Sponsor|0|||
149807242|NCT03669640|540422809|FG004|Overall Study|Study Terminated by Sponsor|1|||
149807243|NCT03669640|540422810|FG005|Overall Study|Study Terminated by Sponsor|0|||
149807244|NCT03669640|540422805|FG000|Overall Study|Lost to Follow-up|0|||
149807245|NCT03669640|540422806|FG001|Overall Study|Lost to Follow-up|0|||
149807246|NCT03669640|540422807|FG002|Overall Study|Lost to Follow-up|2|||
149807247|NCT03669640|540422808|FG003|Overall Study|Lost to Follow-up|0|||
149807248|NCT03669640|540422809|FG004|Overall Study|Lost to Follow-up|0|||
149807249|NCT03669640|540422810|FG005|Overall Study|Lost to Follow-up|0|||
149807250|NCT03669640|540422805|FG000|Overall Study|Death|0|||
149807251|NCT03669640|540422806|FG001|Overall Study|Death|0|||
149807252|NCT03669640|540422807|FG002|Overall Study|Death|1|||
149807253|NCT03669640|540422808|FG003|Overall Study|Death|0|||
149807254|NCT03669640|540422809|FG004|Overall Study|Death|0|||
149807255|NCT03669640|540422810|FG005|Overall Study|Death|0|||
149807256|NCT03669640|540422805|FG000|Overall Study|Withdrawal by Subject|1|||
149807257|NCT03669640|540422806|FG001|Overall Study|Withdrawal by Subject|2|||
149807258|NCT03669640|540422807|FG002|Overall Study|Withdrawal by Subject|1|||
149807259|NCT03669640|540422808|FG003|Overall Study|Withdrawal by Subject|0|||
149807260|NCT03669640|540422809|FG004|Overall Study|Withdrawal by Subject|1|||
149807261|NCT03669640|540422810|FG005|Overall Study|Withdrawal by Subject|3|||
149807262|NCT03669640|540422805|FG000|Overall Study|Protocol Violation|1|||
150148793|NCT01912222|541681705|FG002|Part B: Treatment Period|Adverse Event|3|||
150148794|NCT01912222|541681703|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
149807263|NCT03669640|540422806|FG001|Overall Study|Protocol Violation|0|||
149807264|NCT03669640|540422807|FG002|Overall Study|Protocol Violation|0|||
149807265|NCT03669640|540422808|FG003|Overall Study|Protocol Violation|0|||
149807266|NCT03669640|540422809|FG004|Overall Study|Protocol Violation|0|||
149807267|NCT03669640|540422810|FG005|Overall Study|Protocol Violation|0|||
149807268|NCT03669640|540422805|FG000|Overall Study|Physician Decision|0|||
149807269|NCT03669640|540422806|FG001|Overall Study|Physician Decision|2|||
149807270|NCT03669640|540422807|FG002|Overall Study|Physician Decision|0|||
149807271|NCT03669640|540422808|FG003|Overall Study|Physician Decision|0|||
149807272|NCT03669640|540422809|FG004|Overall Study|Physician Decision|0|||
149807273|NCT03669640|540422810|FG005|Overall Study|Physician Decision|0|||
149807274|NCT03669640|540422805|FG000|Overall Study|Disease Relapse|1|||
149807275|NCT03669640|540422806|FG001|Overall Study|Disease Relapse|0|||
149807276|NCT03669640|540422807|FG002|Overall Study|Disease Relapse|0|||
149807277|NCT03669640|540422808|FG003|Overall Study|Disease Relapse|0|||
149807278|NCT03669640|540422809|FG004|Overall Study|Disease Relapse|0|||
149807279|NCT03669640|540422810|FG005|Overall Study|Disease Relapse|0|||
149807280|NCT03669640|540422805|FG000|Overall Study|Adverse Event|2|||
149807281|NCT03669640|540422806|FG001|Overall Study|Adverse Event|1|||
149807282|NCT03669640|540422807|FG002|Overall Study|Adverse Event|0|||
149807283|NCT03669640|540422808|FG003|Overall Study|Adverse Event|0|||
149807284|NCT03669640|540422809|FG004|Overall Study|Adverse Event|1|||
149807285|NCT03669640|540422810|FG005|Overall Study|Adverse Event|0|||
149807286|NCT03993288|540422811|FG000|Overall Study|Lost to Follow-up|2|||
149807287|NCT03993288|540422812|FG001|Overall Study|Lost to Follow-up|1|||
149807288|NCT03993288|540422811|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
149807289|NCT03993288|540422812|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
149807290|NCT03993288|540422811|FG000|Overall Study|wrong randomization|0|||
149807291|NCT03993288|540422812|FG001|Overall Study|wrong randomization|1|||
149807292|NCT03993288|540422811|FG000|Overall Study|improper enrollment|0|||
149807293|NCT03993288|540422812|FG001|Overall Study|improper enrollment|1|||
149807294|NCT03993288|540422811|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
149807295|NCT03993288|540422812|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
149807296|NCT03993288|540422811|FG000|Overall Study|developed SAE|2|||
149807297|NCT03993288|540422812|FG001|Overall Study|developed SAE|0|||
149807298|NCT03993288|540422811|FG000|Overall Study|consent withdrawal|1|||
149807299|NCT03993288|540422812|FG001|Overall Study|consent withdrawal|0|||
149807300|NCT03993288|540422811|FG000|Overall Study|did not follow the treatment schedule|1|||
149807301|NCT03993288|540422812|FG001|Overall Study|did not follow the treatment schedule|0|||
149807302|NCT03993288|540422811|FG000|Overall Study|did not follow the treatment regimen|1|||
149807303|NCT03993288|540422812|FG001|Overall Study|did not follow the treatment regimen|0|||
149807304|NCT03993288|540422811|FG000|Overall Study|Adverse Event|1|||
149807305|NCT03993288|540422812|FG001|Overall Study|Adverse Event|0|||
149807306|NCT03993288|540422811|FG000|Overall Study|Withdrawal by Subject|1|||
149807307|NCT03993288|540422812|FG001|Overall Study|Withdrawal by Subject|1|||
149807308|NCT00366678|540422813|FG000|Infant Series|Withdrawal by Subject|8|||
149807309|NCT00366678|540422814|FG001|Infant Series|Withdrawal by Subject|6|||
149807310|NCT00366678|540422815|FG002|Infant Series|Withdrawal by Subject|0|||
149807311|NCT00366678|540422813|FG000|Infant Series|Protocol Violation|4|||
149807312|NCT00366678|540422814|FG001|Infant Series|Protocol Violation|3|||
149807313|NCT00366678|540422815|FG002|Infant Series|Protocol Violation|0|||
149807314|NCT00366678|540422813|FG000|Infant Series|Failed to return|1|||
149807315|NCT00366678|540422814|FG001|Infant Series|Failed to return|1|||
149807316|NCT00366678|540422815|FG002|Infant Series|Failed to return|0|||
149807317|NCT00366678|540422813|FG000|Infant Series|Adverse Event|1|||
149807318|NCT00366678|540422814|FG001|Infant Series|Adverse Event|0|||
149807319|NCT00366678|540422815|FG002|Infant Series|Adverse Event|0|||
149807320|NCT00366678|540422813|FG000|After Infant|Withdrawal by Subject|8|||
149807321|NCT00366678|540422814|FG001|After Infant|Withdrawal by Subject|4|||
149807322|NCT00366678|540422815|FG002|After Infant|Withdrawal by Subject|0|||
149807323|NCT00366678|540422813|FG000|After Infant|Lost to Follow-up|2|||
149807324|NCT00366678|540422814|FG001|After Infant|Lost to Follow-up|1|||
149807325|NCT00366678|540422815|FG002|After Infant|Lost to Follow-up|0|||
149807326|NCT00366678|540422813|FG000|After Infant|Failed to return|5|||
149807327|NCT00366678|540422814|FG001|After Infant|Failed to return|5|||
149807328|NCT00366678|540422815|FG002|After Infant|Failed to return|0|||
149807329|NCT00366678|540422813|FG000|After Infant|Adverse Event|1|||
149807330|NCT00366678|540422814|FG001|After Infant|Adverse Event|0|||
149807331|NCT00366678|540422815|FG002|After Infant|Adverse Event|0|||
149807332|NCT00366678|540422813|FG000|After Infant|Protocol Violation|1|||
149807333|NCT00366678|540422814|FG001|After Infant|Protocol Violation|0|||
149807334|NCT00366678|540422815|FG002|After Infant|Protocol Violation|0|||
149807335|NCT00366678|540422813|FG000|Toddler Dose|Protocol Violation|2|||
149807336|NCT00366678|540422814|FG001|Toddler Dose|Protocol Violation|1|||
149807337|NCT00366678|540422815|FG002|Toddler Dose|Protocol Violation|0|||
149807338|NCT00366678|540422813|FG000|Toddler Dose|Failed to return|1|||
149807339|NCT00366678|540422814|FG001|Toddler Dose|Failed to return|0|||
149807340|NCT00366678|540422815|FG002|Toddler Dose|Failed to return|0|||
149807341|NCT00366678|540422813|FG000|Toddler Dose|Withdrawal by Subject|1|||
149807342|NCT00366678|540422814|FG001|Toddler Dose|Withdrawal by Subject|0|||
149807343|NCT00366678|540422815|FG002|Toddler Dose|Withdrawal by Subject|0|||
149807344|NCT00366678|540422813|FG000|Toddler Dose|protocol deviation|1|||
149807345|NCT00366678|540422814|FG001|Toddler Dose|protocol deviation|0|||
149807346|NCT00366678|540422815|FG002|Toddler Dose|protocol deviation|0|||
149807347|NCT03286400|540422822|FG000|Overall Study|Death|10|||
149807348|NCT03286400|540422822|FG000|Overall Study|Lost to Follow-up|10|||
149807349|NCT03286400|540422822|FG000|Overall Study|Physician Decision|1|||
149807350|NCT03286400|540422822|FG000|Overall Study|Scheduling difficulty|4|||
149807351|NCT00826176|540422829|FG000|Overall Study|Lost to Follow-up|1|||
149807352|NCT00826176|540422830|FG001|Overall Study|Lost to Follow-up|0|||
149807353|NCT00826176|540422829|FG000|Overall Study|Subject Withdrew Consent|3|||
149807354|NCT00826176|540422830|FG001|Overall Study|Subject Withdrew Consent|0|||
149807355|NCT00826176|540422829|FG000|Overall Study|Administrative|9|||
149807356|NCT00826176|540422830|FG001|Overall Study|Administrative|0|||
149807357|NCT00740480|540422831|FG000|Overall Study|Adverse Event|1|||
149807358|NCT00740480|540422831|FG000|Overall Study|Physician Decision|1|||
149807359|NCT03079869|540422836|FG000|Overall Study|Adverse Event|6|||
149807360|NCT03079869|540422837|FG001|Overall Study|Adverse Event|8|||
149807361|NCT03079869|540422836|FG000|Overall Study|Withdrawal by Subject|4|||
150148795|NCT01912222|541681704|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
149807362|NCT03079869|540422837|FG001|Overall Study|Withdrawal by Subject|1|||
149807363|NCT03079869|540422836|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
149807364|NCT03079869|540422837|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
149807365|NCT00568776|540422842|FG000|Overall Study|Adverse Event|8|||
149807366|NCT00568776|540422843|FG001|Overall Study|Adverse Event|8|||
149807367|NCT00568776|540422844|FG002|Overall Study|Adverse Event|10|||
149807368|NCT00568776|540422845|FG003|Overall Study|Adverse Event|8|||
149807369|NCT00568776|540422842|FG000|Overall Study|Death|0|||
149807370|NCT00568776|540422843|FG001|Overall Study|Death|1|||
149807371|NCT00568776|540422844|FG002|Overall Study|Death|4|||
149807372|NCT00568776|540422845|FG003|Overall Study|Death|3|||
149807373|NCT00568776|540422842|FG000|Overall Study|Physician Decision|0|||
149807374|NCT00568776|540422843|FG001|Overall Study|Physician Decision|2|||
149807375|NCT00568776|540422844|FG002|Overall Study|Physician Decision|0|||
149807376|NCT00568776|540422845|FG003|Overall Study|Physician Decision|0|||
149807377|NCT00568776|540422842|FG000|Overall Study|Lack of Efficacy|2|||
149807378|NCT00568776|540422843|FG001|Overall Study|Lack of Efficacy|2|||
149807379|NCT00568776|540422844|FG002|Overall Study|Lack of Efficacy|2|||
149807380|NCT00568776|540422845|FG003|Overall Study|Lack of Efficacy|4|||
149807381|NCT00568776|540422842|FG000|Overall Study|Lost to Follow-up|1|||
149807382|NCT00568776|540422843|FG001|Overall Study|Lost to Follow-up|1|||
149807383|NCT00568776|540422844|FG002|Overall Study|Lost to Follow-up|1|||
149807384|NCT00568776|540422845|FG003|Overall Study|Lost to Follow-up|1|||
149807385|NCT00568776|540422842|FG000|Overall Study|Protocol Violation|1|||
149807386|NCT00568776|540422843|FG001|Overall Study|Protocol Violation|0|||
149807387|NCT00568776|540422844|FG002|Overall Study|Protocol Violation|1|||
149807388|NCT00568776|540422845|FG003|Overall Study|Protocol Violation|1|||
149807389|NCT00568776|540422842|FG000|Overall Study|Withdrawal by Subject|13|||
149807390|NCT00568776|540422843|FG001|Overall Study|Withdrawal by Subject|15|||
149807391|NCT00568776|540422844|FG002|Overall Study|Withdrawal by Subject|13|||
149807392|NCT00568776|540422845|FG003|Overall Study|Withdrawal by Subject|7|||
149807393|NCT00568776|540422842|FG000|Overall Study|Loss of Caregiver|0|||
149807394|NCT00568776|540422843|FG001|Overall Study|Loss of Caregiver|2|||
149807395|NCT00568776|540422844|FG002|Overall Study|Loss of Caregiver|1|||
149807396|NCT00568776|540422845|FG003|Overall Study|Loss of Caregiver|2|||
149807397|NCT00568776|540422842|FG000|Overall Study|Sponsor Decision|2|||
149807398|NCT00568776|540422843|FG001|Overall Study|Sponsor Decision|2|||
149807399|NCT00568776|540422844|FG002|Overall Study|Sponsor Decision|41|||
149807400|NCT00568776|540422845|FG003|Overall Study|Sponsor Decision|42|||
149807401|NCT00568776|540422842|FG000|Overall Study|Miscellaeneous|3|||
149807402|NCT00568776|540422843|FG001|Overall Study|Miscellaeneous|3|||
149807403|NCT00568776|540422844|FG002|Overall Study|Miscellaeneous|1|||
149807404|NCT00568776|540422845|FG003|Overall Study|Miscellaeneous|4|||
149807405|NCT01005680|540422846|FG000|Overall Study|Lost to Follow-up|4|||
149807406|NCT01005680|540422847|FG001|Overall Study|Lost to Follow-up|6|||
149807407|NCT01005680|540422846|FG000|Overall Study|Withdrawal by Subject|1|||
149807408|NCT01005680|540422847|FG001|Overall Study|Withdrawal by Subject|4|||
149807409|NCT01005680|540422846|FG000|Overall Study|Physician Decision|1|||
150148796|NCT01912222|541681705|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
149807410|NCT01005680|540422847|FG001|Overall Study|Physician Decision|1|||
149807411|NCT04484805|540422864|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
150148797|NCT00603265|541681706|FG000|Overall Study|Adverse Event|2|||
149807412|NCT04484805|540422865|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
149807413|NCT04484805|540422864|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
149807414|NCT04484805|540422865|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
149807415|NCT02118896|540422866|FG000|Overall Study|Death|4|||
149807416|NCT02118896|540422867|FG001|Overall Study|Death|0|||
150148798|NCT00603265|541681707|FG001|Overall Study|Adverse Event|11|||
149807417|NCT02118896|540422868|FG002|Overall Study|Death|4|||
149807418|NCT02118896|540422869|FG003|Overall Study|Death|6|||
149807419|NCT02118896|540422870|FG004|Overall Study|Death|3|||
149807420|NCT02118896|540422871|FG005|Overall Study|Death|1|||
149807421|NCT02118896|540422872|FG006|Overall Study|Death|0|||
149807422|NCT02118896|540422873|FG007|Overall Study|Death|0|||
150148799|NCT00603265|541681708|FG002|Overall Study|Adverse Event|1|||
149807423|NCT02118896|540422874|FG008|Overall Study|Death|0|||
149807424|NCT02118896|540422875|FG009|Overall Study|Death|0|||
149807425|NCT02118896|540422866|FG000|Overall Study|Adverse Event|5|||
149807426|NCT02118896|540422867|FG001|Overall Study|Adverse Event|4|||
149807427|NCT02118896|540422868|FG002|Overall Study|Adverse Event|4|||
149807428|NCT02118896|540422869|FG003|Overall Study|Adverse Event|5|||
149807429|NCT02118896|540422870|FG004|Overall Study|Adverse Event|5|||
149807430|NCT02118896|540422871|FG005|Overall Study|Adverse Event|9|||
149807431|NCT02118896|540422872|FG006|Overall Study|Adverse Event|1|||
149807432|NCT02118896|540422873|FG007|Overall Study|Adverse Event|1|||
149807433|NCT02118896|540422874|FG008|Overall Study|Adverse Event|4|||
149807434|NCT02118896|540422875|FG009|Overall Study|Adverse Event|0|||
149807435|NCT02118896|540422866|FG000|Overall Study|Consent withdrawn|2|||
149807436|NCT02118896|540422867|FG001|Overall Study|Consent withdrawn|0|||
149807437|NCT02118896|540422868|FG002|Overall Study|Consent withdrawn|3|||
149807438|NCT02118896|540422869|FG003|Overall Study|Consent withdrawn|4|||
149807439|NCT02118896|540422870|FG004|Overall Study|Consent withdrawn|1|||
149807440|NCT02118896|540422871|FG005|Overall Study|Consent withdrawn|4|||
149807441|NCT02118896|540422872|FG006|Overall Study|Consent withdrawn|0|||
149807442|NCT02118896|540422873|FG007|Overall Study|Consent withdrawn|0|||
149807443|NCT02118896|540422874|FG008|Overall Study|Consent withdrawn|0|||
149807444|NCT02118896|540422875|FG009|Overall Study|Consent withdrawn|0|||
149807445|NCT02118896|540422866|FG000|Overall Study|Non-compliance|2|||
149807446|NCT02118896|540422867|FG001|Overall Study|Non-compliance|1|||
149807447|NCT02118896|540422868|FG002|Overall Study|Non-compliance|1|||
149807448|NCT02118896|540422869|FG003|Overall Study|Non-compliance|5|||
149807449|NCT02118896|540422870|FG004|Overall Study|Non-compliance|0|||
149807450|NCT02118896|540422871|FG005|Overall Study|Non-compliance|1|||
149807451|NCT02118896|540422872|FG006|Overall Study|Non-compliance|0|||
149807452|NCT02118896|540422873|FG007|Overall Study|Non-compliance|1|||
149807453|NCT02118896|540422874|FG008|Overall Study|Non-compliance|0|||
149807454|NCT02118896|540422875|FG009|Overall Study|Non-compliance|0|||
149807455|NCT02118896|540422866|FG000|Overall Study|Pregnancy|1|||
149807456|NCT02118896|540422867|FG001|Overall Study|Pregnancy|1|||
149807457|NCT02118896|540422868|FG002|Overall Study|Pregnancy|0|||
149807458|NCT02118896|540422869|FG003|Overall Study|Pregnancy|0|||
149807459|NCT02118896|540422870|FG004|Overall Study|Pregnancy|1|||
149807460|NCT02118896|540422871|FG005|Overall Study|Pregnancy|3|||
149807461|NCT02118896|540422872|FG006|Overall Study|Pregnancy|1|||
149807462|NCT02118896|540422873|FG007|Overall Study|Pregnancy|0|||
149807463|NCT02118896|540422874|FG008|Overall Study|Pregnancy|0|||
149807464|NCT02118896|540422875|FG009|Overall Study|Pregnancy|0|||
149807465|NCT02118896|540422866|FG000|Overall Study|Lost to Follow-up|1|||
149807466|NCT02118896|540422867|FG001|Overall Study|Lost to Follow-up|2|||
149807467|NCT02118896|540422868|FG002|Overall Study|Lost to Follow-up|1|||
149807468|NCT02118896|540422869|FG003|Overall Study|Lost to Follow-up|0|||
149807469|NCT02118896|540422870|FG004|Overall Study|Lost to Follow-up|2|||
149807470|NCT02118896|540422871|FG005|Overall Study|Lost to Follow-up|1|||
149807471|NCT02118896|540422872|FG006|Overall Study|Lost to Follow-up|0|||
149807472|NCT02118896|540422873|FG007|Overall Study|Lost to Follow-up|0|||
149807473|NCT02118896|540422874|FG008|Overall Study|Lost to Follow-up|0|||
149807474|NCT02118896|540422875|FG009|Overall Study|Lost to Follow-up|0|||
149807475|NCT02118896|540422866|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
149807476|NCT02118896|540422867|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
149807477|NCT02118896|540422868|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
149807478|NCT02118896|540422869|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
149807479|NCT02118896|540422870|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
149807480|NCT02118896|540422871|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
149807481|NCT02118896|540422872|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
149807482|NCT02118896|540422873|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
149807483|NCT02118896|540422874|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
149807484|NCT02118896|540422875|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
149807485|NCT02118896|540422866|FG000|Overall Study|Prohibited medication|0|||
149807486|NCT02118896|540422867|FG001|Overall Study|Prohibited medication|0|||
149807487|NCT02118896|540422868|FG002|Overall Study|Prohibited medication|0|||
149807488|NCT02118896|540422869|FG003|Overall Study|Prohibited medication|0|||
149807489|NCT02118896|540422870|FG004|Overall Study|Prohibited medication|1|||
149807490|NCT02118896|540422871|FG005|Overall Study|Prohibited medication|3|||
149807491|NCT02118896|540422872|FG006|Overall Study|Prohibited medication|0|||
149807492|NCT02118896|540422873|FG007|Overall Study|Prohibited medication|0|||
149807493|NCT02118896|540422874|FG008|Overall Study|Prohibited medication|0|||
149807494|NCT02118896|540422875|FG009|Overall Study|Prohibited medication|0|||
149807495|NCT02118896|540422866|FG000|Overall Study|Miscellaneous|1|||
149807496|NCT02118896|540422867|FG001|Overall Study|Miscellaneous|2|||
149807497|NCT02118896|540422868|FG002|Overall Study|Miscellaneous|0|||
149807498|NCT02118896|540422869|FG003|Overall Study|Miscellaneous|2|||
149807499|NCT02118896|540422870|FG004|Overall Study|Miscellaneous|0|||
149807500|NCT02118896|540422871|FG005|Overall Study|Miscellaneous|4|||
149807501|NCT02118896|540422872|FG006|Overall Study|Miscellaneous|0|||
149807502|NCT02118896|540422873|FG007|Overall Study|Miscellaneous|0|||
149807503|NCT02118896|540422874|FG008|Overall Study|Miscellaneous|0|||
149807504|NCT02118896|540422875|FG009|Overall Study|Miscellaneous|0|||
149807505|NCT03292731|540422876|FG000|Overall Study|Protocol Violation|4|||
149807506|NCT03292731|540422877|FG001|Overall Study|Protocol Violation|11|||
149807507|NCT03292731|540422878|FG002|Overall Study|Protocol Violation|1|||
149807508|NCT04221373|540422879|FG000|Overall Study|Physician Decision|4|||
149807509|NCT04221373|540422880|FG001|Overall Study|Physician Decision|0|||
149807510|NCT00138658|540422887|FG000|Overall Study|Adverse Event|23|||
149807511|NCT00138658|540422887|FG000|Overall Study|Death|1|||
149807512|NCT00138658|540422887|FG000|Overall Study|Disease Progression|21|||
149807513|NCT00138658|540422887|FG000|Overall Study|Physician Decision|11|||
149807514|NCT00138658|540422887|FG000|Overall Study|Withdrawal by Subject|5|||
149807515|NCT02050373|540422893|FG000|Overall Study|Adverse Event|4|||
149807516|NCT02050373|540422894|FG001|Overall Study|Adverse Event|7|||
149807517|NCT02050373|540422893|FG000|Overall Study|Death|3|||
149807518|NCT02050373|540422894|FG001|Overall Study|Death|3|||
149807519|NCT01067339|540422895|FG000|Overall Study|Withdrawal by Subject|6|||
149807520|NCT01067339|540422896|FG001|Overall Study|Withdrawal by Subject|5|||
149807521|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
149807522|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
149807523|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
149807524|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
149807525|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
149807526|NCT01179191|540422897|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
149807527|NCT01179191|540422897|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
149807528|NCT01179191|540422897|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
149807529|NCT01179191|540422897|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
149807530|NCT01179191|540422897|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
149807531|NCT01179191|540422897|FG000|Maintenance Phase (8 Weeks)|Other|66|||
149807532|NCT00572910|540422898|FG000|Overall Study|Adverse Event|1|||
149807533|NCT00572910|540422899|FG001|Overall Study|Adverse Event|2|||
149807534|NCT00572910|540422900|FG002|Overall Study|Adverse Event|0|||
149807535|NCT00572910|540422901|FG003|Overall Study|Adverse Event|2|||
149807536|NCT00572910|540422902|FG004|Overall Study|Adverse Event|0|||
149807537|NCT00572910|540422903|FG005|Overall Study|Adverse Event|0|||
149807538|NCT00572910|540422904|FG006|Overall Study|Adverse Event|4|||
149807539|NCT00572910|540422905|FG007|Overall Study|Adverse Event|2|||
149807540|NCT00572910|540422906|FG008|Overall Study|Adverse Event|1|||
149807541|NCT00572910|540422907|FG009|Overall Study|Adverse Event|3|||
149807542|NCT00572910|540422908|FG010|Overall Study|Adverse Event|2|||
149807543|NCT00572910|540422898|FG000|Overall Study|Lost to Follow-up|0|||
149807544|NCT00572910|540422899|FG001|Overall Study|Lost to Follow-up|1|||
149807545|NCT00572910|540422900|FG002|Overall Study|Lost to Follow-up|1|||
149807546|NCT00572910|540422901|FG003|Overall Study|Lost to Follow-up|2|||
149807547|NCT00572910|540422902|FG004|Overall Study|Lost to Follow-up|1|||
149807548|NCT00572910|540422903|FG005|Overall Study|Lost to Follow-up|0|||
149807549|NCT00572910|540422904|FG006|Overall Study|Lost to Follow-up|0|||
149807550|NCT00572910|540422905|FG007|Overall Study|Lost to Follow-up|0|||
149807551|NCT00572910|540422906|FG008|Overall Study|Lost to Follow-up|0|||
149807552|NCT00572910|540422907|FG009|Overall Study|Lost to Follow-up|1|||
149807553|NCT00572910|540422908|FG010|Overall Study|Lost to Follow-up|0|||
149807554|NCT00572910|540422898|FG000|Overall Study|Withdrawal by Subject|3|||
149807555|NCT00572910|540422899|FG001|Overall Study|Withdrawal by Subject|0|||
149807556|NCT00572910|540422900|FG002|Overall Study|Withdrawal by Subject|1|||
149807557|NCT00572910|540422901|FG003|Overall Study|Withdrawal by Subject|0|||
149807558|NCT00572910|540422902|FG004|Overall Study|Withdrawal by Subject|1|||
149807559|NCT00572910|540422903|FG005|Overall Study|Withdrawal by Subject|3|||
149807560|NCT00572910|540422904|FG006|Overall Study|Withdrawal by Subject|0|||
149807561|NCT00572910|540422905|FG007|Overall Study|Withdrawal by Subject|2|||
149807562|NCT00572910|540422906|FG008|Overall Study|Withdrawal by Subject|2|||
149807563|NCT00572910|540422907|FG009|Overall Study|Withdrawal by Subject|2|||
149807564|NCT00572910|540422908|FG010|Overall Study|Withdrawal by Subject|1|||
149807565|NCT01260194|540422909|FG000|Overall Study|Withdrawal of Consent|1|||
149807566|NCT01803464|540422910|FG000|Overall Study|Incomplete data|0|||
149807567|NCT01803464|540422911|FG001|Overall Study|Incomplete data|0|||
149807568|NCT01803464|540422912|FG002|Overall Study|Incomplete data|4|||
149807569|NCT01803464|540422913|FG003|Overall Study|Incomplete data|0|||
149918898|NCT01210352|540835249|FG008|Overall Study|Lack of Efficacy|0|||
149807570|NCT01803464|540422910|FG000|Overall Study|Withdrawal by Subject|1|||
149807571|NCT01803464|540422911|FG001|Overall Study|Withdrawal by Subject|0|||
149807572|NCT01803464|540422912|FG002|Overall Study|Withdrawal by Subject|0|||
149807573|NCT01803464|540422913|FG003|Overall Study|Withdrawal by Subject|0|||
149807574|NCT02860039|540422916|FG000|Overall Study|Death|4|||
149807575|NCT02860039|540422917|FG001|Overall Study|Death|0|||
149807576|NCT02860039|540422916|FG000|Overall Study|Lost to Follow-up|2|||
149807577|NCT02860039|540422917|FG001|Overall Study|Lost to Follow-up|2|||
149807578|NCT02860039|540422916|FG000|Overall Study|Protocol Violation|3|||
149918899|NCT01210352|540835241|FG000|Overall Study|Physician Decision|0|||
149807579|NCT02860039|540422917|FG001|Overall Study|Protocol Violation|1|||
149807580|NCT02860039|540422916|FG000|Overall Study|Withdrawal by Subject|1|||
150148800|NCT00603265|541681706|FG000|Overall Study|Withdrawal by Subject|1|||
150148801|NCT00603265|541681707|FG001|Overall Study|Withdrawal by Subject|2|||
150148802|NCT00603265|541681708|FG002|Overall Study|Withdrawal by Subject|1|||
150148803|NCT00603265|541681706|FG000|Overall Study|Lack of Efficacy|3|||
150148804|NCT00603265|541681707|FG001|Overall Study|Lack of Efficacy|0|||
150148805|NCT00603265|541681708|FG002|Overall Study|Lack of Efficacy|3|||
150148806|NCT00603265|541681706|FG000|Overall Study|Lost to Follow-up|0|||
150148807|NCT00603265|541681707|FG001|Overall Study|Lost to Follow-up|1|||
150148808|NCT00603265|541681708|FG002|Overall Study|Lost to Follow-up|0|||
150148809|NCT00603265|541681706|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
150148810|NCT00603265|541681707|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
150148811|NCT00603265|541681708|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
150148812|NCT00603265|541681706|FG000|Overall Study|Participant Left Country, No Responses|0|||
150148813|NCT00603265|541681707|FG001|Overall Study|Participant Left Country, No Responses|1|||
150148814|NCT00603265|541681708|FG002|Overall Study|Participant Left Country, No Responses|0|||
150148815|NCT00603265|541681706|FG000|Overall Study|Protocol Violation|1|||
150148816|NCT00603265|541681707|FG001|Overall Study|Protocol Violation|0|||
150148817|NCT00603265|541681708|FG002|Overall Study|Protocol Violation|0|||
150148818|NCT02961881|541681710|FG000|Overall Study|Adverse Event|1|||
150148819|NCT02961881|541681711|FG001|Overall Study|Adverse Event|2|||
150148820|NCT02961881|541681712|FG002|Overall Study|Adverse Event|2|||
150148821|NCT02961881|541681713|FG003|Overall Study|Adverse Event|0|||
150148822|NCT02961881|541681714|FG004|Overall Study|Adverse Event|1|||
150148823|NCT02961881|541681710|FG000|Overall Study|Participant request|0|||
150148824|NCT02961881|541681711|FG001|Overall Study|Participant request|2|||
150148825|NCT02961881|541681712|FG002|Overall Study|Participant request|0|||
150148826|NCT02961881|541681713|FG003|Overall Study|Participant request|0|||
150148827|NCT02961881|541681714|FG004|Overall Study|Participant request|0|||
150148828|NCT02961881|541681710|FG000|Overall Study|Disease progression|1|||
150148829|NCT02961881|541681711|FG001|Overall Study|Disease progression|0|||
150148830|NCT02961881|541681712|FG002|Overall Study|Disease progression|1|||
150148831|NCT02961881|541681713|FG003|Overall Study|Disease progression|0|||
150148832|NCT02961881|541681714|FG004|Overall Study|Disease progression|0|||
150148833|NCT00854295|541681715|FG000|Overall Study|Death|7|||
150148834|NCT00854295|541681716|FG001|Overall Study|Death|0|||
150148835|NCT00854295|541681717|FG002|Overall Study|Death|1|||
150148836|NCT00854295|541681718|FG003|Overall Study|Death|1|||
150148837|NCT00854295|541681715|FG000|Overall Study|Adverse Event|6|||
150148838|NCT00854295|541681716|FG001|Overall Study|Adverse Event|1|||
150148839|NCT00854295|541681717|FG002|Overall Study|Adverse Event|1|||
150148840|NCT00854295|541681718|FG003|Overall Study|Adverse Event|3|||
150148841|NCT00854295|541681715|FG000|Overall Study|Lost to Follow-up|18|||
150148842|NCT00854295|541681716|FG001|Overall Study|Lost to Follow-up|5|||
150148843|NCT00854295|541681717|FG002|Overall Study|Lost to Follow-up|21|||
150148844|NCT00854295|541681718|FG003|Overall Study|Lost to Follow-up|21|||
150148845|NCT00854295|541681715|FG000|Overall Study|Physician Decision|10|||
150148846|NCT00854295|541681716|FG001|Overall Study|Physician Decision|0|||
150148847|NCT00854295|541681717|FG002|Overall Study|Physician Decision|0|||
150148848|NCT00854295|541681718|FG003|Overall Study|Physician Decision|0|||
150148849|NCT00709592|541681719|FG000|Overall Study|Unable to proceed to transplant|0|||
150148850|NCT00709592|541681720|FG001|Overall Study|Unable to proceed to transplant|1|||
150148851|NCT00451217|541681722|FG000|Overall Study|Lost to Follow-up|0|||
150148852|NCT00451217|541681723|FG001|Overall Study|Lost to Follow-up|1|||
150148853|NCT00451217|541681724|FG002|Overall Study|Lost to Follow-up|1|||
150148854|NCT00451217|541681725|FG003|Overall Study|Lost to Follow-up|1|||
150148855|NCT00451217|541681722|FG000|Overall Study|Withdrawal by Subject|1|||
150148856|NCT00451217|541681723|FG001|Overall Study|Withdrawal by Subject|0|||
150148857|NCT00451217|541681724|FG002|Overall Study|Withdrawal by Subject|0|||
150148858|NCT00451217|541681725|FG003|Overall Study|Withdrawal by Subject|0|||
150148859|NCT00451217|541681722|FG000|Overall Study|Not Treated|1|||
150148860|NCT00451217|541681723|FG001|Overall Study|Not Treated|1|||
150148861|NCT00451217|541681724|FG002|Overall Study|Not Treated|3|||
150148862|NCT00451217|541681725|FG003|Overall Study|Not Treated|4|||
150148863|NCT03154359|541681726|FG000|Overall Study|Adverse Event|1|||
150148864|NCT03154359|541681726|FG000|Overall Study|Lack of Efficacy|2|||
150148865|NCT03154359|541681726|FG000|Overall Study|Lost to Follow-up|3|||
150148866|NCT03154359|541681726|FG000|Overall Study|Physician Decision|3|||
149807581|NCT02860039|540422917|FG001|Overall Study|Withdrawal by Subject|0|||
149807582|NCT02860039|540422916|FG000|Overall Study|Not otherwise eligible|1|||
149807583|NCT02860039|540422917|FG001|Overall Study|Not otherwise eligible|1|||
150148867|NCT03154359|541681726|FG000|Overall Study|Protocol Violation|4|||
150148868|NCT03154359|541681726|FG000|Overall Study|Withdrawal by Subject|5|||
150148869|NCT03154359|541681726|FG000|Overall Study|Disruption of study due to COVID-19|4|||
150148870|NCT04668989|541681728|FG000|First Intervention|Covid-19 related self-isolation|0|||
150148871|NCT04668989|541681729|FG001|First Intervention|Covid-19 related self-isolation|1|||
150148872|NCT04668989|541681728|FG000|Second Intervention|Adverse Event|0|||
150148873|NCT04668989|541681729|FG001|Second Intervention|Adverse Event|1|||
149807584|NCT01102972|540422921|FG000|Overall Study|Adverse Event|8|||
149807585|NCT01102972|540422922|FG001|Overall Study|Adverse Event|2|||
149807586|NCT01102972|540422921|FG000|Overall Study|Lack of Efficacy|2|||
149807587|NCT01102972|540422922|FG001|Overall Study|Lack of Efficacy|1|||
149807588|NCT01102972|540422921|FG000|Overall Study|Protocol Violation|1|||
149807589|NCT01102972|540422922|FG001|Overall Study|Protocol Violation|0|||
149807590|NCT01102972|540422921|FG000|Overall Study|Lost to Follow-up|10|||
149807591|NCT01102972|540422922|FG001|Overall Study|Lost to Follow-up|5|||
149807592|NCT01102972|540422921|FG000|Overall Study|Investigator Discretion|2|||
149807593|NCT01102972|540422922|FG001|Overall Study|Investigator Discretion|0|||
149807594|NCT01102972|540422921|FG000|Overall Study|Withdrawal by Subject|6|||
149807595|NCT01102972|540422922|FG001|Overall Study|Withdrawal by Subject|6|||
149807596|NCT04611152|540422927|FG000|Overall Study|Adverse Event|9|||
149807597|NCT04611152|540422928|FG001|Overall Study|Adverse Event|8|||
149807598|NCT04611152|540422927|FG000|Overall Study|Non-compliance with study schedule|1|||
149807599|NCT04611152|540422928|FG001|Overall Study|Non-compliance with study schedule|3|||
149807600|NCT04611152|540422927|FG000|Overall Study|Withdrawal by Subject|5|||
149807601|NCT04611152|540422928|FG001|Overall Study|Withdrawal by Subject|6|||
149807602|NCT04611152|540422927|FG000|Overall Study|Lost to Follow-up|11|||
149807603|NCT04611152|540422928|FG001|Overall Study|Lost to Follow-up|2|||
149807604|NCT00602667|540422929|FG000|Overall Study|Still on Therapy|0|||
149807605|NCT00602667|540422930|FG001|Overall Study|Still on Therapy|2|||
149807606|NCT00602667|540422931|FG002|Overall Study|Still on Therapy|2|||
149807607|NCT00602667|540422929|FG000|Overall Study|Death|0|||
149807608|NCT00602667|540422930|FG001|Overall Study|Death|1|||
149807609|NCT00602667|540422931|FG002|Overall Study|Death|1|||
149807610|NCT00602667|540422929|FG000|Overall Study|Family request|3|||
149807611|NCT00602667|540422930|FG001|Overall Study|Family request|25|||
149807612|NCT00602667|540422931|FG002|Overall Study|Family request|6|||
149807613|NCT00602667|540422929|FG000|Overall Study|Excessive toxicity|1|||
149807614|NCT00602667|540422930|FG001|Overall Study|Excessive toxicity|1|||
149807615|NCT00602667|540422931|FG002|Overall Study|Excessive toxicity|0|||
149807616|NCT00602667|540422929|FG000|Overall Study|Second malignancy|0|||
149807617|NCT00602667|540422930|FG001|Overall Study|Second malignancy|1|||
149807618|NCT00602667|540422931|FG002|Overall Study|Second malignancy|0|||
149807619|NCT00602667|540422929|FG000|Overall Study|Physician Decision|2|||
149807620|NCT00602667|540422930|FG001|Overall Study|Physician Decision|3|||
149807621|NCT00602667|540422931|FG002|Overall Study|Physician Decision|8|||
149807622|NCT00602667|540422929|FG000|Overall Study|Progressive disease|13|||
149807623|NCT00602667|540422930|FG001|Overall Study|Progressive disease|48|||
149807624|NCT00602667|540422931|FG002|Overall Study|Progressive disease|45|||
149807625|NCT00602667|540422929|FG000|Overall Study|Progressive disease prior to therapy|0|||
149807626|NCT00602667|540422930|FG001|Overall Study|Progressive disease prior to therapy|0|||
149807627|NCT00602667|540422931|FG002|Overall Study|Progressive disease prior to therapy|1|||
149807628|NCT03179462|540422937|FG000|Overall Study|screening failure|1|||
149807629|NCT03179462|540422938|FG001|Overall Study|screening failure|2|||
149807630|NCT03179462|540422939|FG002|Overall Study|screening failure|0|||
149807631|NCT04636437|540422943|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
149807632|NCT04636437|540422944|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
149807633|NCT04636437|540422945|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
149807634|NCT04636437|540422943|FG000|Overall Study|Started weight loss drug/program|2|||
149807635|NCT04636437|540422944|FG001|Overall Study|Started weight loss drug/program|1|||
149807636|NCT04636437|540422945|FG002|Overall Study|Started weight loss drug/program|1|||
149807637|NCT04636437|540422943|FG000|Overall Study|Lost to Follow-up|3|||
149807638|NCT04636437|540422944|FG001|Overall Study|Lost to Follow-up|1|||
149807639|NCT04636437|540422945|FG002|Overall Study|Lost to Follow-up|4|||
149807640|NCT04636437|540422943|FG000|Overall Study|Participant or physician decision|3|||
149807641|NCT04636437|540422944|FG001|Overall Study|Participant or physician decision|1|||
149807642|NCT04636437|540422945|FG002|Overall Study|Participant or physician decision|1|||
149807643|NCT00816166|540422946|FG000|Overall Study|Lost to Follow-up|6|||
149807644|NCT00816166|540422947|FG001|Overall Study|Lost to Follow-up|10|||
149807645|NCT00816166|540422946|FG000|Overall Study|Death|4|||
149807646|NCT00816166|540422947|FG001|Overall Study|Death|2|||
149807647|NCT01071278|540422948|FG000|Overall Study|Premature Discontinuation|254|||
149807648|NCT01071278|540422948|FG000|Overall Study|Completion Status Unknown|459|||
149807649|NCT02851069|540422949|FG000|Overall Study|Failure to Return|3|||
149807650|NCT02851069|540422949|FG000|Overall Study|Other|3|||
149807651|NCT00352664|540422950|FG000|Overall Study|Withdrawal by Subject|7|||
149807652|NCT00352664|540422951|FG001|Overall Study|Withdrawal by Subject|0|||
149807653|NCT02146365|540422952|FG000|Overall Study|Lost to Follow-up|2|||
149807654|NCT02146365|540422953|FG001|Overall Study|Lost to Follow-up|1|||
149807655|NCT02146365|540422954|FG002|Overall Study|Lost to Follow-up|3|||
149807656|NCT02146365|540422955|FG003|Overall Study|Lost to Follow-up|3|||
149807657|NCT02146365|540422956|FG004|Overall Study|Lost to Follow-up|1|||
149807658|NCT02146365|540422957|FG005|Overall Study|Lost to Follow-up|1|||
149807659|NCT02146365|540422958|FG006|Overall Study|Lost to Follow-up|0|||
149807660|NCT02146365|540422959|FG007|Overall Study|Lost to Follow-up|1|||
149807661|NCT02146365|540422952|FG000|Overall Study|Withdrawal by Subject|1|||
149807662|NCT02146365|540422953|FG001|Overall Study|Withdrawal by Subject|2|||
149807663|NCT02146365|540422954|FG002|Overall Study|Withdrawal by Subject|1|||
149807664|NCT02146365|540422955|FG003|Overall Study|Withdrawal by Subject|5|||
149807665|NCT02146365|540422956|FG004|Overall Study|Withdrawal by Subject|1|||
149807666|NCT02146365|540422957|FG005|Overall Study|Withdrawal by Subject|0|||
149807667|NCT02146365|540422958|FG006|Overall Study|Withdrawal by Subject|0|||
149807668|NCT02146365|540422959|FG007|Overall Study|Withdrawal by Subject|0|||
149807669|NCT02146365|540422952|FG000|Overall Study|Unable to Comply with Protocol|0|||
149807670|NCT02146365|540422953|FG001|Overall Study|Unable to Comply with Protocol|1|||
149807671|NCT02146365|540422954|FG002|Overall Study|Unable to Comply with Protocol|1|||
149807672|NCT02146365|540422955|FG003|Overall Study|Unable to Comply with Protocol|0|||
149807673|NCT02146365|540422956|FG004|Overall Study|Unable to Comply with Protocol|0|||
149807674|NCT02146365|540422957|FG005|Overall Study|Unable to Comply with Protocol|0|||
149807675|NCT02146365|540422958|FG006|Overall Study|Unable to Comply with Protocol|0|||
149807676|NCT02146365|540422959|FG007|Overall Study|Unable to Comply with Protocol|0|||
149807677|NCT02146365|540422952|FG000|Overall Study|Other|1|||
149807678|NCT02146365|540422953|FG001|Overall Study|Other|0|||
149807679|NCT02146365|540422954|FG002|Overall Study|Other|2|||
149807680|NCT02146365|540422955|FG003|Overall Study|Other|1|||
149807681|NCT02146365|540422956|FG004|Overall Study|Other|0|||
149807682|NCT02146365|540422957|FG005|Overall Study|Other|0|||
149807683|NCT02146365|540422958|FG006|Overall Study|Other|0|||
149807684|NCT02146365|540422959|FG007|Overall Study|Other|0|||
149807685|NCT01525407|540422962|FG000|Overall Study|Change in recipient treatment plan|2|||
149807686|NCT01525407|540422963|FG001|Overall Study|Change in recipient treatment plan|2|||
149807687|NCT01525407|540422962|FG000|Overall Study|Withdrawal by Subject|0|||
149807688|NCT01525407|540422963|FG001|Overall Study|Withdrawal by Subject|1|||
149807689|NCT01525407|540422962|FG000|Overall Study|Transplant was delayed|0|||
149807690|NCT01525407|540422963|FG001|Overall Study|Transplant was delayed|1|||
149807691|NCT01525407|540422962|FG000|Overall Study|Delay in Transplant|1|||
149807692|NCT01525407|540422963|FG001|Overall Study|Delay in Transplant|0|||
149807693|NCT01721369|540422964|FG000|Overall Study|Not initial etiological diagnosis|12|||
149807694|NCT03505606|540424398|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
149807695|NCT03505606|540424399|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
149807696|NCT03505606|540424400|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
149807697|NCT03505606|540424398|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
149807698|NCT03505606|540424399|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
149807699|NCT03505606|540424400|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
149807700|NCT03505606|540424398|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
149807701|NCT03505606|540424399|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
149807702|NCT03505606|540424400|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
149807703|NCT03505606|540424398|FG000|Overall Study|Poor compliance with refractive correction|0|||
149807704|NCT03505606|540424399|FG001|Overall Study|Poor compliance with refractive correction|0|||
149807705|NCT03505606|540424400|FG002|Overall Study|Poor compliance with refractive correction|1|||
149807706|NCT03505606|540424398|FG000|Overall Study|Insufficient anisometropia|0|||
149807707|NCT03505606|540424399|FG001|Overall Study|Insufficient anisometropia|0|||
149807708|NCT03505606|540424400|FG002|Overall Study|Insufficient anisometropia|2|||
149807709|NCT03505606|540424398|FG000|Overall Study|Ectopia Lentis|0|||
149807710|NCT03505606|540424399|FG001|Overall Study|Ectopia Lentis|0|||
149807711|NCT03505606|540424400|FG002|Overall Study|Ectopia Lentis|1|||
149807712|NCT03505606|540424398|FG000|Overall Study|alternation of amblyopic eye|0|||
149807713|NCT03505606|540424399|FG001|Overall Study|alternation of amblyopic eye|1|||
149807714|NCT03505606|540424400|FG002|Overall Study|alternation of amblyopic eye|0|||
149807715|NCT02087865|540424401|FG000|Overall Study|Withdrawal by Subject|6|||
149807716|NCT02087865|540424402|FG001|Overall Study|Withdrawal by Subject|0|||
149807717|NCT02087865|540424403|FG002|Overall Study|Withdrawal by Subject|1|||
149807718|NCT02087865|540424401|FG000|Overall Study|Lost to Follow-up|0|||
149807719|NCT02087865|540424402|FG001|Overall Study|Lost to Follow-up|0|||
149807720|NCT02087865|540424403|FG002|Overall Study|Lost to Follow-up|1|||
149807721|NCT02087865|540424401|FG000|Overall Study|Drug Non-compliance|0|||
149807722|NCT02087865|540424402|FG001|Overall Study|Drug Non-compliance|2|||
149807723|NCT02087865|540424403|FG002|Overall Study|Drug Non-compliance|0|||
149807724|NCT02087865|540424401|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
149807725|NCT02087865|540424402|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
149807726|NCT02087865|540424403|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
149807727|NCT01017731|540424406|FG000|Overall Study|Lost to Follow-up|2|||
149807728|NCT01017731|540424406|FG000|Overall Study|Withdrawal by Subject|3|||
149807729|NCT01017731|540424406|FG000|Overall Study|Physician Decision|2|||
149807730|NCT01017731|540424406|FG000|Overall Study|Adverse Event|1|||
149807731|NCT00648739|540424408|FG000|Overall Study|Adverse Event|1|||
149807732|NCT00648739|540424409|FG001|Overall Study|Adverse Event|0|||
149807733|NCT00648739|540424410|FG002|Overall Study|Adverse Event|1|||
149807734|NCT00648739|540424411|FG003|Overall Study|Adverse Event|2|||
149807735|NCT00648739|540424412|FG004|Overall Study|Adverse Event|1|||
149807736|NCT00648739|540424413|FG005|Overall Study|Adverse Event|0|||
149807737|NCT00648739|540424414|FG006|Overall Study|Adverse Event|0|||
149807738|NCT00648739|540424408|FG000|Overall Study|Withdrawal by Subject|1|||
149807739|NCT00648739|540424409|FG001|Overall Study|Withdrawal by Subject|0|||
149807740|NCT00648739|540424410|FG002|Overall Study|Withdrawal by Subject|1|||
149807741|NCT00648739|540424411|FG003|Overall Study|Withdrawal by Subject|0|||
149807742|NCT00648739|540424412|FG004|Overall Study|Withdrawal by Subject|0|||
149807743|NCT00648739|540424413|FG005|Overall Study|Withdrawal by Subject|2|||
149807744|NCT00648739|540424414|FG006|Overall Study|Withdrawal by Subject|0|||
149807745|NCT00648739|540424408|FG000|Overall Study|Lack of Efficacy|0|||
149807746|NCT00648739|540424409|FG001|Overall Study|Lack of Efficacy|0|||
149807747|NCT00648739|540424410|FG002|Overall Study|Lack of Efficacy|0|||
149807748|NCT00648739|540424411|FG003|Overall Study|Lack of Efficacy|0|||
149807749|NCT00648739|540424412|FG004|Overall Study|Lack of Efficacy|1|||
149807750|NCT00648739|540424413|FG005|Overall Study|Lack of Efficacy|2|||
149807751|NCT00648739|540424414|FG006|Overall Study|Lack of Efficacy|0|||
149807752|NCT00648739|540424408|FG000|Overall Study|Investigator Considered it Advisable|0|||
149807753|NCT00648739|540424409|FG001|Overall Study|Investigator Considered it Advisable|0|||
149807754|NCT00648739|540424410|FG002|Overall Study|Investigator Considered it Advisable|0|||
149807755|NCT00648739|540424411|FG003|Overall Study|Investigator Considered it Advisable|0|||
149807756|NCT00648739|540424412|FG004|Overall Study|Investigator Considered it Advisable|0|||
149807757|NCT00648739|540424413|FG005|Overall Study|Investigator Considered it Advisable|1|||
149807758|NCT00648739|540424414|FG006|Overall Study|Investigator Considered it Advisable|1|||
149807759|NCT00648739|540424408|FG000|Overall Study|Death|0|||
149807760|NCT00648739|540424409|FG001|Overall Study|Death|1|||
149807761|NCT00648739|540424410|FG002|Overall Study|Death|0|||
149807762|NCT00648739|540424411|FG003|Overall Study|Death|0|||
149807763|NCT00648739|540424412|FG004|Overall Study|Death|0|||
149807764|NCT00648739|540424413|FG005|Overall Study|Death|0|||
149807765|NCT00648739|540424414|FG006|Overall Study|Death|0|||
149807766|NCT00648739|540424408|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
149807767|NCT00648739|540424409|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
149807768|NCT00648739|540424410|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
149807769|NCT00648739|540424411|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
149807770|NCT00648739|540424412|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
149807771|NCT00648739|540424413|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
149807772|NCT00648739|540424414|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
149807773|NCT00648739|540424408|FG000|Overall Study|Follow-up Visits Not Completed|0|||
150148874|NCT05033743|541681733|FG000|Overall Study|Lost to Follow-up|1|||
150148875|NCT05033743|541681733|FG000|Overall Study|Protocol Violation|2|||
150148876|NCT05033743|541681733|FG000|Overall Study|Withdrawal by Subject|1|||
150148877|NCT01592695|541681734|FG000|Overall Study|Lost to Follow-up|8|||
150148878|NCT01592695|541681735|FG001|Overall Study|Lost to Follow-up|4|||
150148879|NCT00422799|541681736|FG000|Overall Study|Withdrawal by Subject|6|||
150148880|NCT00422799|541681736|FG000|Overall Study|Adverse Event|7|||
150148881|NCT01965158|541681737|FG000|Overall Study|Adverse Event|14|||
150148882|NCT01965158|541681738|FG001|Overall Study|Adverse Event|5|||
150148883|NCT01965158|541681737|FG000|Overall Study|Withdrawal by Subject|16|||
150148884|NCT01965158|541681738|FG001|Overall Study|Withdrawal by Subject|24|||
150148885|NCT01965158|541681737|FG000|Overall Study|Lost to Follow-up|7|||
150148886|NCT01965158|541681738|FG001|Overall Study|Lost to Follow-up|5|||
150148887|NCT01965158|541681737|FG000|Overall Study|Protocol Violation|1|||
150148888|NCT01965158|541681738|FG001|Overall Study|Protocol Violation|1|||
150148889|NCT01965158|541681737|FG000|Overall Study|Other - Miscellaneous|3|||
150148890|NCT01965158|541681738|FG001|Overall Study|Other - Miscellaneous|0|||
150148891|NCT00467142|541681742|FG000|Overall Study|Withdrawal by Subject|1|||
150148892|NCT00467142|541681742|FG000|Overall Study|Adverse Event|1|||
150148893|NCT00467142|541681742|FG000|Overall Study|Protocol Violation|1|||
150148894|NCT00919893|541681743|FG000|Overall Study|Protocol Violation|19|||
150148895|NCT00919893|541681744|FG001|Overall Study|Protocol Violation|9|||
150148896|NCT03029780|541681752|FG000|Overall Study|Disease Progression|20|||
149807774|NCT00648739|540424409|FG001|Overall Study|Follow-up Visits Not Completed|1|||
149807775|NCT00648739|540424410|FG002|Overall Study|Follow-up Visits Not Completed|0|||
149807776|NCT00648739|540424411|FG003|Overall Study|Follow-up Visits Not Completed|0|||
150148897|NCT03029780|541681753|FG001|Overall Study|Disease Progression|22|||
150148898|NCT03029780|541681752|FG000|Overall Study|Study Drug Toxicity|15|||
150148899|NCT03029780|541681753|FG001|Overall Study|Study Drug Toxicity|11|||
150148900|NCT03029780|541681752|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
149807777|NCT00648739|540424412|FG004|Overall Study|Follow-up Visits Not Completed|0|||
149807778|NCT00648739|540424413|FG005|Overall Study|Follow-up Visits Not Completed|0|||
149807779|NCT00648739|540424414|FG006|Overall Study|Follow-up Visits Not Completed|0|||
149807780|NCT00698009|540424415|FG000|Overall Study|Withdrawal by Subject|1|||
149807781|NCT00564486|540424416|FG000|Overall Study|Adverse Event|0|||
149807782|NCT00564486|540424417|FG001|Overall Study|Adverse Event|1|||
149807783|NCT00564486|540424418|FG002|Overall Study|Adverse Event|0|||
149807784|NCT00564486|540424419|FG003|Overall Study|Adverse Event|0|||
149807785|NCT00564486|540424416|FG000|Overall Study|Withdrawal by Subject|4|||
149807786|NCT00564486|540424417|FG001|Overall Study|Withdrawal by Subject|0|||
149807787|NCT00564486|540424418|FG002|Overall Study|Withdrawal by Subject|0|||
149807788|NCT00564486|540424419|FG003|Overall Study|Withdrawal by Subject|5|||
149807789|NCT00564486|540424416|FG000|Overall Study|Subject refused to have blood drawn|0|||
149807790|NCT00564486|540424417|FG001|Overall Study|Subject refused to have blood drawn|0|||
149807791|NCT00564486|540424418|FG002|Overall Study|Subject refused to have blood drawn|1|||
149807792|NCT00564486|540424419|FG003|Overall Study|Subject refused to have blood drawn|0|||
149807793|NCT00564486|540424416|FG000|Overall Study|Lost to Follow-up|3|||
149807794|NCT00564486|540424417|FG001|Overall Study|Lost to Follow-up|0|||
149807795|NCT00564486|540424418|FG002|Overall Study|Lost to Follow-up|2|||
149807796|NCT00564486|540424419|FG003|Overall Study|Lost to Follow-up|2|||
149807797|NCT04362761|540424424|FG000|Part A (48 Weeks)|Adverse Event|2|||
149807798|NCT04362761|540424424|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
149807799|NCT04362761|540424424|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
149807800|NCT04362761|540424424|FG000|Part A (48 Weeks)|Other|5|||
149807801|NCT04362761|540424424|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
149807802|NCT04362761|540424424|FG000|Part B (86 Weeks)|Other|4|||
149807803|NCT02729545|540424427|FG000|Overall Study|Pregnancy|1|||
149807804|NCT02729545|540424428|FG001|Overall Study|Pregnancy|1|||
149807805|NCT02729545|540424427|FG000|Overall Study|Lost to Follow-up|0|||
149807806|NCT02729545|540424428|FG001|Overall Study|Lost to Follow-up|1|||
149807807|NCT02729545|540424427|FG000|Overall Study|Withdrawal by Subject|2|||
149807808|NCT02729545|540424428|FG001|Overall Study|Withdrawal by Subject|3|||
149807809|NCT00915473|540424429|FG000|Screening|Withdrawal by Subject|1|||
149807810|NCT00915473|540424430|FG001|Screening|Withdrawal by Subject|0|||
149807811|NCT00915473|540424429|FG000|4-week Follow Up|Lost to Follow-up|1|||
149807812|NCT00915473|540424430|FG001|4-week Follow Up|Lost to Follow-up|5|||
149807813|NCT01389024|540424431|FG000|Overall Study|Withdrawal by Subject|0|||
149807814|NCT01389024|540424432|FG001|Overall Study|Withdrawal by Subject|1|||
149807815|NCT01389024|540424431|FG000|Overall Study|Lost to Follow-up|1|||
149807816|NCT01389024|540424432|FG001|Overall Study|Lost to Follow-up|0|||
149807817|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
149807818|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
149807819|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
149807820|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Death|1|||
149807821|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
149807822|NCT00529802|540424437|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
149807823|NCT00529802|540424437|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
149807824|NCT01325701|540424442|FG000|Overall Study|Adverse Event|12|||
149807825|NCT01325701|540424443|FG001|Overall Study|Adverse Event|0|||
149807826|NCT01325701|540424442|FG000|Overall Study|Protocol Violation|1|||
149807827|NCT01325701|540424443|FG001|Overall Study|Protocol Violation|0|||
149807828|NCT01325701|540424442|FG000|Overall Study|Physician Decision|2|||
149807829|NCT01325701|540424443|FG001|Overall Study|Physician Decision|2|||
149807830|NCT01325701|540424442|FG000|Overall Study|Withdrawal by Subject|2|||
149807831|NCT01325701|540424443|FG001|Overall Study|Withdrawal by Subject|1|||
149807832|NCT01325701|540424442|FG000|Overall Study|Rollerover Extension Study|4|||
149807833|NCT01325701|540424443|FG001|Overall Study|Rollerover Extension Study|0|||
149807834|NCT00388674|540424444|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
149807835|NCT00388674|540424445|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
149807836|NCT00388674|540424444|FG000|Initial Treatment|Adverse Event|22|||
149807837|NCT00388674|540424445|FG001|Initial Treatment|Adverse Event|87|||
149807838|NCT00388674|540424444|FG000|Initial Treatment|Death|215|||
149807839|NCT00388674|540424445|FG001|Initial Treatment|Death|216|||
149807840|NCT00388674|540424444|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
149807841|NCT00388674|540424445|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
149807842|NCT00388674|540424444|FG000|Initial Treatment|HCC|12|||
149807843|NCT00388674|540424445|FG001|Initial Treatment|HCC|20|||
149807844|NCT00388674|540424444|FG000|Initial Treatment|Lost to Follow-up|526|||
149807845|NCT00388674|540424445|FG001|Initial Treatment|Lost to Follow-up|624|||
149807846|NCT00388674|540424444|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
149807847|NCT00388674|540424445|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
149807848|NCT00388674|540424444|FG000|Initial Treatment|Never Treated with Study Medication|1|||
149807849|NCT00388674|540424445|FG001|Initial Treatment|Never Treated with Study Medication|7|||
149807850|NCT00388674|540424444|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
149807851|NCT00388674|540424445|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
149807852|NCT00388674|540424444|FG000|Initial Treatment|Not Defined|125|||
149807853|NCT00388674|540424445|FG001|Initial Treatment|Not Defined|172|||
149807854|NCT00388674|540424444|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
149918900|NCT01210352|540835242|FG001|Overall Study|Physician Decision|0|||
149807855|NCT00388674|540424445|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
149807856|NCT00388674|540424444|FG000|Initial Treatment|Pregnancy|26|||
149807857|NCT00388674|540424445|FG001|Initial Treatment|Pregnancy|16|||
149807858|NCT00388674|540424444|FG000|Initial Treatment|Study Drug Toxicity|5|||
149807859|NCT00388674|540424445|FG001|Initial Treatment|Study Drug Toxicity|92|||
149807860|NCT00388674|540424444|FG000|Initial Treatment|Participant Request|501|||
149807861|NCT00388674|540424445|FG001|Initial Treatment|Participant Request|673|||
149807862|NCT00388674|540424444|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
149807863|NCT00388674|540424445|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
149807864|NCT00388674|540424444|FG000|Initial Treatment|Not Reported|10|||
149807865|NCT00388674|540424445|FG001|Initial Treatment|Not Reported|12|||
149807866|NCT00388674|540424444|FG000|End of Study|Administrative Reason By Sponsor|299|||
149807867|NCT00388674|540424445|FG001|End of Study|Administrative Reason By Sponsor|253|||
149807868|NCT00388674|540424444|FG000|End of Study|Death|239|||
149807869|NCT00388674|540424445|FG001|End of Study|Death|262|||
149807870|NCT00388674|540424444|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
149807871|NCT00388674|540424445|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
149807872|NCT00388674|540424444|FG000|End of Study|HCC|8|||
149807873|NCT00388674|540424445|FG001|End of Study|HCC|7|||
149807874|NCT00388674|540424444|FG000|End of Study|Lost to Follow-up|587|||
149807875|NCT00388674|540424445|FG001|End of Study|Lost to Follow-up|715|||
149807876|NCT00388674|540424444|FG000|End of Study|Malignancy (Non-HCC)|1|||
149807877|NCT00388674|540424445|FG001|End of Study|Malignancy (Non-HCC)|1|||
149807878|NCT00388674|540424444|FG000|End of Study|Non-Study Related Comorbidities|3|||
149807879|NCT00388674|540424445|FG001|End of Study|Non-Study Related Comorbidities|4|||
149807880|NCT00388674|540424444|FG000|End of Study|Not Defined|135|||
149807881|NCT00388674|540424445|FG001|End of Study|Not Defined|214|||
149807882|NCT00388674|540424444|FG000|End of Study|Participant Withdrew Consent|437|||
149807883|NCT00388674|540424445|FG001|End of Study|Participant Withdrew Consent|673|||
149807884|NCT00388674|540424444|FG000|End of Study|No Off-Treatment Status Data|22|||
149807885|NCT00388674|540424445|FG001|End of Study|No Off-Treatment Status Data|30|||
149807886|NCT00388674|540424444|FG000|End of Study|Not Reported|0|||
149807887|NCT00388674|540424445|FG001|End of Study|Not Reported|1|||
149807888|NCT03576131|540424446|FG000|Overall Study|Investigator decision|0|||
149807889|NCT03576131|540424447|FG001|Overall Study|Investigator decision|0|||
149807890|NCT03576131|540424448|FG002|Overall Study|Investigator decision|0|||
149807891|NCT03576131|540424449|FG003|Overall Study|Investigator decision|1|||
149807892|NCT03576131|540424450|FG004|Overall Study|Investigator decision|0|||
149807893|NCT03576131|540424451|FG005|Overall Study|Investigator decision|1|||
149807894|NCT03576131|540424452|FG006|Overall Study|Investigator decision|0|||
149807895|NCT03576131|540424453|FG007|Overall Study|Investigator decision|0|||
149807896|NCT03576131|540424446|FG000|Overall Study|Withdrawal by Subject|1|||
149807897|NCT03576131|540424447|FG001|Overall Study|Withdrawal by Subject|1|||
149807898|NCT03576131|540424448|FG002|Overall Study|Withdrawal by Subject|0|||
149807899|NCT03576131|540424449|FG003|Overall Study|Withdrawal by Subject|1|||
149807900|NCT03576131|540424450|FG004|Overall Study|Withdrawal by Subject|2|||
149807901|NCT03576131|540424451|FG005|Overall Study|Withdrawal by Subject|3|||
149807902|NCT03576131|540424452|FG006|Overall Study|Withdrawal by Subject|1|||
149807903|NCT03576131|540424453|FG007|Overall Study|Withdrawal by Subject|0|||
149807904|NCT03576131|540424446|FG000|Overall Study|Death|3|||
149807905|NCT03576131|540424447|FG001|Overall Study|Death|3|||
149807906|NCT03576131|540424448|FG002|Overall Study|Death|1|||
149807907|NCT03576131|540424449|FG003|Overall Study|Death|5|||
149807908|NCT03576131|540424450|FG004|Overall Study|Death|4|||
149807909|NCT03576131|540424451|FG005|Overall Study|Death|1|||
149807910|NCT03576131|540424452|FG006|Overall Study|Death|0|||
149807911|NCT03576131|540424453|FG007|Overall Study|Death|1|||
149807912|NCT03576131|540424446|FG000|Overall Study|New anti-cancer treatment|5|||
149807913|NCT03576131|540424447|FG001|Overall Study|New anti-cancer treatment|1|||
149807914|NCT03576131|540424448|FG002|Overall Study|New anti-cancer treatment|2|||
149807915|NCT03576131|540424449|FG003|Overall Study|New anti-cancer treatment|3|||
149807916|NCT03576131|540424450|FG004|Overall Study|New anti-cancer treatment|0|||
149807917|NCT03576131|540424451|FG005|Overall Study|New anti-cancer treatment|0|||
149807918|NCT03576131|540424452|FG006|Overall Study|New anti-cancer treatment|0|||
149807919|NCT03576131|540424453|FG007|Overall Study|New anti-cancer treatment|0|||
149807920|NCT03576131|540424446|FG000|Overall Study|Unspecified reason|0|||
149807921|NCT03576131|540424447|FG001|Overall Study|Unspecified reason|0|||
149807922|NCT03576131|540424448|FG002|Overall Study|Unspecified reason|1|||
149807923|NCT03576131|540424449|FG003|Overall Study|Unspecified reason|1|||
149807924|NCT03576131|540424450|FG004|Overall Study|Unspecified reason|1|||
149807925|NCT03576131|540424451|FG005|Overall Study|Unspecified reason|1|||
149807926|NCT03576131|540424452|FG006|Overall Study|Unspecified reason|0|||
149807927|NCT03576131|540424453|FG007|Overall Study|Unspecified reason|0|||
149807928|NCT03576131|540424446|FG000|Overall Study|Subject non-compliance|0|||
149807929|NCT03576131|540424447|FG001|Overall Study|Subject non-compliance|0|||
149807930|NCT03576131|540424448|FG002|Overall Study|Subject non-compliance|0|||
149807931|NCT03576131|540424449|FG003|Overall Study|Subject non-compliance|0|||
149807932|NCT03576131|540424450|FG004|Overall Study|Subject non-compliance|0|||
149807933|NCT03576131|540424451|FG005|Overall Study|Subject non-compliance|1|||
149807934|NCT03576131|540424452|FG006|Overall Study|Subject non-compliance|0|||
149807935|NCT03576131|540424453|FG007|Overall Study|Subject non-compliance|0|||
149807936|NCT00996632|540424456|FG000|Overall Study|Physician Decision|0|||
149807937|NCT00996632|540424457|FG001|Overall Study|Physician Decision|0|||
149807938|NCT00539006|540424464|FG000|Pre-treatment|Other|0|||
149807939|NCT00539006|540424465|FG001|Pre-treatment|Other|1|||
149807940|NCT00539006|540424466|FG002|Pre-treatment|Other|0|||
149807941|NCT00539006|540424467|FG003|Pre-treatment|Other|0|||
149807942|NCT00539006|540424464|FG000|Treatment Period 1|Lost to Follow-up|0|||
149807943|NCT00539006|540424465|FG001|Treatment Period 1|Lost to Follow-up|0|||
149807944|NCT00539006|540424466|FG002|Treatment Period 1|Lost to Follow-up|1|||
149807945|NCT00539006|540424467|FG003|Treatment Period 1|Lost to Follow-up|0|||
149807946|NCT00539006|540424464|FG000|Treatment Period 1|Protocol Violation|0|||
149807947|NCT00539006|540424465|FG001|Treatment Period 1|Protocol Violation|0|||
149807948|NCT00539006|540424466|FG002|Treatment Period 1|Protocol Violation|1|||
149807949|NCT00539006|540424467|FG003|Treatment Period 1|Protocol Violation|0|||
149807950|NCT00539006|540424464|FG000|Treatment Period 1|Lack of Efficacy|0|||
149807951|NCT00539006|540424465|FG001|Treatment Period 1|Lack of Efficacy|0|||
149807952|NCT00539006|540424466|FG002|Treatment Period 1|Lack of Efficacy|0|||
149807953|NCT00539006|540424467|FG003|Treatment Period 1|Lack of Efficacy|1|||
149807954|NCT00539006|540424464|FG000|Washout|Adverse Event|2|||
149807955|NCT00539006|540424465|FG001|Washout|Adverse Event|1|||
149807956|NCT00539006|540424466|FG002|Washout|Adverse Event|0|||
149807957|NCT00539006|540424467|FG003|Washout|Adverse Event|0|||
149807958|NCT00539006|540424464|FG000|Washout|Protocol Violation|1|||
149807959|NCT00539006|540424465|FG001|Washout|Protocol Violation|1|||
149807960|NCT00539006|540424466|FG002|Washout|Protocol Violation|0|||
149807961|NCT00539006|540424467|FG003|Washout|Protocol Violation|0|||
149807962|NCT00539006|540424464|FG000|Washout|Withdrawal by Subject|0|||
149807963|NCT00539006|540424465|FG001|Washout|Withdrawal by Subject|2|||
149807964|NCT00539006|540424466|FG002|Washout|Withdrawal by Subject|0|||
149807965|NCT00539006|540424467|FG003|Washout|Withdrawal by Subject|0|||
149807966|NCT00539006|540424464|FG000|Washout|Failed to meet continuation criteria|16|||
149807967|NCT00539006|540424465|FG001|Washout|Failed to meet continuation criteria|5|||
149807968|NCT00539006|540424466|FG002|Washout|Failed to meet continuation criteria|14|||
149807969|NCT00539006|540424467|FG003|Washout|Failed to meet continuation criteria|6|||
149807970|NCT00539006|540424464|FG000|Washout|Other|1|||
149807971|NCT00539006|540424465|FG001|Washout|Other|1|||
149807972|NCT00539006|540424466|FG002|Washout|Other|2|||
149807973|NCT00539006|540424467|FG003|Washout|Other|3|||
149807974|NCT00539006|540424464|FG000|Treatment Period 2|Protocol Violation|1|||
149807975|NCT00539006|540424465|FG001|Treatment Period 2|Protocol Violation|0|||
149807976|NCT00539006|540424466|FG002|Treatment Period 2|Protocol Violation|0|||
149807977|NCT00539006|540424467|FG003|Treatment Period 2|Protocol Violation|0|||
149807978|NCT00539006|540424464|FG000|Treatment Period 2|Other|0|||
149807979|NCT00539006|540424465|FG001|Treatment Period 2|Other|1|||
149807980|NCT00539006|540424466|FG002|Treatment Period 2|Other|0|||
149807981|NCT00539006|540424467|FG003|Treatment Period 2|Other|0|||
149807982|NCT00769132|540424470|FG000|Period 1|Adverse Event|1|||
149807983|NCT00769132|540424471|FG001|Period 1|Adverse Event|0|||
149807984|NCT00769132|540424472|FG002|Period 1|Adverse Event|0|||
149807985|NCT00769132|540424473|FG003|Period 1|Adverse Event|1|||
149807986|NCT00769132|540424470|FG000|Period 2|Withdrawal by Subject|0|||
149807987|NCT00769132|540424471|FG001|Period 2|Withdrawal by Subject|0|||
149807988|NCT00769132|540424472|FG002|Period 2|Withdrawal by Subject|0|||
149807989|NCT00769132|540424473|FG003|Period 2|Withdrawal by Subject|1|||
149807990|NCT00769132|540424470|FG000|Period 3|Withdrawal by Subject|1|||
149807991|NCT00769132|540424471|FG001|Period 3|Withdrawal by Subject|0|||
149807992|NCT00769132|540424472|FG002|Period 3|Withdrawal by Subject|0|||
149807993|NCT00769132|540424473|FG003|Period 3|Withdrawal by Subject|0|||
149807994|NCT00769132|540424470|FG000|Period 4|Withdrawal by Subject|0|||
149807995|NCT00769132|540424471|FG001|Period 4|Withdrawal by Subject|1|||
149807996|NCT00769132|540424472|FG002|Period 4|Withdrawal by Subject|0|||
149807997|NCT00769132|540424473|FG003|Period 4|Withdrawal by Subject|0|||
149807998|NCT02230332|540424474|FG000|Overall Study|Adverse Event|2|||
149807999|NCT02230332|540424475|FG001|Overall Study|Adverse Event|1|||
149808000|NCT02230332|540424474|FG000|Overall Study|Lost to Follow-up|1|||
149808001|NCT02230332|540424475|FG001|Overall Study|Lost to Follow-up|0|||
149808002|NCT02230332|540424474|FG000|Overall Study|Protocol Violation|1|||
149808003|NCT02230332|540424475|FG001|Overall Study|Protocol Violation|0|||
149808004|NCT00877799|540424477|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
149808005|NCT00877799|540424478|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
149808006|NCT00877799|540424479|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
149808007|NCT00877799|540424480|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
149808008|NCT00877799|540424481|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
149808009|NCT00877799|540424477|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
149808010|NCT00877799|540424478|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
149808011|NCT00877799|540424479|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
149808012|NCT00877799|540424480|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
149808013|NCT00877799|540424481|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
149808014|NCT00877799|540424477|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
149808015|NCT00877799|540424478|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
149808016|NCT00877799|540424479|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
149808017|NCT00877799|540424480|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
149808018|NCT00877799|540424481|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
149808019|NCT00877799|540424477|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
149808020|NCT00877799|540424478|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
149808021|NCT00877799|540424479|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
149808022|NCT00877799|540424480|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
149808023|NCT00877799|540424481|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
149808024|NCT00877799|540424477|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
149808025|NCT00877799|540424478|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
149808026|NCT00877799|540424479|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
149808027|NCT00877799|540424480|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
149808028|NCT00877799|540424481|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
149808029|NCT04054011|540424482|FG000|Overall Study|COVID|3|||
149808030|NCT00592007|540424483|FG000|Overall Study|Withdrawal by Subject|1|||
149808031|NCT00592007|540424483|FG000|Overall Study|patient ineligible (out of lab range)|1|||
149808032|NCT00595127|540424484|FG000|Overall Study|Death|6|||
149808033|NCT00595127|540424484|FG000|Overall Study|Relapsed|3|||
149808034|NCT00595127|540424484|FG000|Overall Study|joined another trial|1|||
149808035|NCT00538473|540424485|FG000|Overall Study|Adverse Event|1|||
149808036|NCT00538473|540424486|FG001|Overall Study|Adverse Event|0|||
149808037|NCT01569074|540424487|FG000|Overall Study|Study stopped|6|||
149808038|NCT01569074|540424488|FG001|Overall Study|Study stopped|6|||
149808039|NCT01569074|540424489|FG002|Overall Study|Study stopped|8|||
149808040|NCT01569074|540424490|FG003|Overall Study|Study stopped|7|||
149808041|NCT01569074|540424491|FG004|Overall Study|Study stopped|7|||
149808042|NCT01569074|540424487|FG000|Overall Study|Study-specific discontinuation criteria|0|||
149808043|NCT01569074|540424488|FG001|Overall Study|Study-specific discontinuation criteria|1|||
149808044|NCT01569074|540424489|FG002|Overall Study|Study-specific discontinuation criteria|0|||
149808045|NCT01569074|540424490|FG003|Overall Study|Study-specific discontinuation criteria|0|||
149808046|NCT01569074|540424491|FG004|Overall Study|Study-specific discontinuation criteria|0|||
149808047|NCT01569074|540424487|FG000|Overall Study|Severe non-compliance to protocol|0|||
149808048|NCT01569074|540424488|FG001|Overall Study|Severe non-compliance to protocol|0|||
149808049|NCT01569074|540424489|FG002|Overall Study|Severe non-compliance to protocol|1|||
149808050|NCT01569074|540424490|FG003|Overall Study|Severe non-compliance to protocol|0|||
149808051|NCT01569074|540424491|FG004|Overall Study|Severe non-compliance to protocol|0|||
149808052|NCT01569074|540424487|FG000|Overall Study|eg change in circumstances|0|||
149808053|NCT01569074|540424488|FG001|Overall Study|eg change in circumstances|2|||
149808054|NCT01569074|540424489|FG002|Overall Study|eg change in circumstances|0|||
149808055|NCT01569074|540424490|FG003|Overall Study|eg change in circumstances|1|||
149808056|NCT01569074|540424491|FG004|Overall Study|eg change in circumstances|1|||
149808057|NCT01569074|540424487|FG000|Overall Study|Adverse Event|1|||
149808058|NCT01569074|540424488|FG001|Overall Study|Adverse Event|0|||
149808059|NCT01569074|540424489|FG002|Overall Study|Adverse Event|3|||
149808060|NCT01569074|540424490|FG003|Overall Study|Adverse Event|0|||
149808061|NCT01569074|540424491|FG004|Overall Study|Adverse Event|0|||
149808062|NCT00203892|540424497|FG000|Overall Study|Physician Decision|1|||
149808063|NCT00203892|540424498|FG001|Overall Study|Physician Decision|2|||
149808064|NCT00203892|540424499|FG002|Overall Study|Physician Decision|0|||
149808065|NCT00203892|540424497|FG000|Overall Study|Death|1|||
149808066|NCT00203892|540424498|FG001|Overall Study|Death|0|||
149808067|NCT00203892|540424499|FG002|Overall Study|Death|0|||
149808068|NCT01036594|540424508|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
149808069|NCT01036594|540424509|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
149808070|NCT01036594|540424508|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
149808071|NCT01036594|540424509|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
149808072|NCT01036594|540424508|FG000|Week 12 Evaluation|Adverse Event|5|||
149808073|NCT01036594|540424509|FG001|Week 12 Evaluation|Adverse Event|0|||
149808074|NCT01036594|540424508|FG000|Week 12 Evaluation|Physician Decision|1|||
149808075|NCT01036594|540424509|FG001|Week 12 Evaluation|Physician Decision|0|||
149808076|NCT01036594|540424508|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
149808077|NCT01036594|540424509|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
149808078|NCT01036594|540424508|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
149808079|NCT01036594|540424509|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
149808080|NCT01036594|540424508|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
149808081|NCT01036594|540424509|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
149808082|NCT01036594|540424508|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
149808083|NCT01036594|540424509|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
149808084|NCT01036594|540424508|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
149808085|NCT01036594|540424509|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
149808086|NCT03466060|540424510|FG000|Period 1|Test Lens Damage|0|||
149808087|NCT03466060|540424511|FG001|Period 1|Test Lens Damage|2|||
149808088|NCT03466060|540424512|FG002|Period 1|Test Lens Damage|0|||
149808089|NCT03466060|540424513|FG003|Period 1|Test Lens Damage|0|||
149808090|NCT03466060|540424514|FG004|Period 1|Test Lens Damage|0|||
149808091|NCT03466060|540424515|FG005|Period 1|Test Lens Damage|0|||
149808092|NCT03466060|540424510|FG000|Period 1|Withdrawal by Subject|0|||
149808093|NCT03466060|540424511|FG001|Period 1|Withdrawal by Subject|0|||
149808094|NCT03466060|540424512|FG002|Period 1|Withdrawal by Subject|2|||
149808095|NCT03466060|540424513|FG003|Period 1|Withdrawal by Subject|0|||
149808096|NCT03466060|540424514|FG004|Period 1|Withdrawal by Subject|0|||
149808097|NCT03466060|540424515|FG005|Period 1|Withdrawal by Subject|0|||
149808098|NCT03466060|540424510|FG000|Period 1|Lost to Follow-up|0|||
149808099|NCT03466060|540424511|FG001|Period 1|Lost to Follow-up|0|||
149808100|NCT03466060|540424512|FG002|Period 1|Lost to Follow-up|0|||
149808101|NCT03466060|540424513|FG003|Period 1|Lost to Follow-up|1|||
149808102|NCT03466060|540424514|FG004|Period 1|Lost to Follow-up|0|||
149808103|NCT03466060|540424515|FG005|Period 1|Lost to Follow-up|0|||
149808104|NCT03466060|540424510|FG000|Period 1|Grade 2 Conjunctivitis|0|||
149808105|NCT03466060|540424511|FG001|Period 1|Grade 2 Conjunctivitis|0|||
149808106|NCT03466060|540424512|FG002|Period 1|Grade 2 Conjunctivitis|1|||
149808107|NCT03466060|540424513|FG003|Period 1|Grade 2 Conjunctivitis|0|||
149808108|NCT03466060|540424514|FG004|Period 1|Grade 2 Conjunctivitis|0|||
149808109|NCT03466060|540424515|FG005|Period 1|Grade 2 Conjunctivitis|0|||
149808110|NCT03466060|540424510|FG000|Period 2|Lens Handling Difficulties|0|||
149808111|NCT03466060|540424511|FG001|Period 2|Lens Handling Difficulties|0|||
149808112|NCT03466060|540424512|FG002|Period 2|Lens Handling Difficulties|1|||
149808113|NCT03466060|540424513|FG003|Period 2|Lens Handling Difficulties|0|||
149808114|NCT03466060|540424514|FG004|Period 2|Lens Handling Difficulties|0|||
149808115|NCT03466060|540424515|FG005|Period 2|Lens Handling Difficulties|0|||
149808116|NCT00244881|540424517|FG000|Overall Study|Withdrawal by Subject|3|||
149808117|NCT03345485|540424518|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
149808118|NCT03345485|540424519|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
149808119|NCT03345485|540424520|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
149808120|NCT03345485|540424521|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
149808121|NCT03345485|540424522|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
149808122|NCT03345485|540424523|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
149808123|NCT03345485|540424524|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
149808124|NCT03345485|540424525|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
149808125|NCT03345485|540424526|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
149808126|NCT03345485|540424527|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
149808127|NCT03345485|540424528|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
149808128|NCT03345485|540424529|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
149808129|NCT03345485|540424530|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
149808130|NCT01610284|540424531|FG000|Randomization Phase|Adverse Event|1|||
149808131|NCT01610284|540424532|FG001|Randomization Phase|Adverse Event|0|||
149808132|NCT01610284|540424531|FG000|Randomization Phase|Physician Decision|1|||
149808133|NCT01610284|540424532|FG001|Randomization Phase|Physician Decision|1|||
149808134|NCT01610284|540424531|FG000|Randomization Phase|Death|0|||
149808135|NCT01610284|540424532|FG001|Randomization Phase|Death|1|||
149808136|NCT01610284|540424531|FG000|Treatment Phase|Adverse Event|80|||
149808137|NCT01610284|540424532|FG001|Treatment Phase|Adverse Event|12|||
149808138|NCT01610284|540424531|FG000|Treatment Phase|Lost to Follow-up|1|||
149808139|NCT01610284|540424532|FG001|Treatment Phase|Lost to Follow-up|0|||
149808140|NCT01610284|540424531|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
149808141|NCT01610284|540424532|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
149808142|NCT01610284|540424531|FG000|Treatment Phase|Physician Decision|27|||
149808143|NCT01610284|540424532|FG001|Treatment Phase|Physician Decision|24|||
149808144|NCT01610284|540424531|FG000|Treatment Phase|Progressive Disease|377|||
149808145|NCT01610284|540424532|FG001|Treatment Phase|Progressive Disease|486|||
149808146|NCT01610284|540424531|FG000|Treatment Phase|Protocol Deviation|2|||
149808147|NCT01610284|540424532|FG001|Treatment Phase|Protocol Deviation|3|||
149808148|NCT01610284|540424531|FG000|Treatment Phase|Study terminated by Sponsor|18|||
149808149|NCT01610284|540424532|FG001|Treatment Phase|Study terminated by Sponsor|15|||
149808150|NCT01610284|540424531|FG000|Treatment Phase|Subject/Guardian Decision|55|||
149808151|NCT01610284|540424532|FG001|Treatment Phase|Subject/Guardian Decision|23|||
149808152|NCT01610284|540424531|FG000|Treatment Phase|Death|6|||
149808153|NCT01610284|540424532|FG001|Treatment Phase|Death|5|||
149808154|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
149808155|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149808156|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
149808157|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
149808158|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
149808159|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
149808160|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
149808161|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
149808162|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
149808163|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
149808164|NCT01610284|540424531|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
149808165|NCT01610284|540424532|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
149808166|NCT01125358|540424536|FG000|Overall Study|Adverse Event|3|||
149808167|NCT01125358|540424537|FG001|Overall Study|Adverse Event|0|||
149808168|NCT01125358|540424538|FG002|Overall Study|Adverse Event|0|||
149808169|NCT01125358|540424539|FG003|Overall Study|Adverse Event|2|||
149808170|NCT01125358|540424536|FG000|Overall Study|Perceived Lack of Efficacy|6|||
149808171|NCT01125358|540424537|FG001|Overall Study|Perceived Lack of Efficacy|3|||
149808172|NCT01125358|540424538|FG002|Overall Study|Perceived Lack of Efficacy|7|||
149808173|NCT01125358|540424539|FG003|Overall Study|Perceived Lack of Efficacy|4|||
149808174|NCT01125358|540424536|FG000|Overall Study|Protocol Violation|1|||
149808175|NCT01125358|540424537|FG001|Overall Study|Protocol Violation|0|||
149808176|NCT01125358|540424538|FG002|Overall Study|Protocol Violation|0|||
149808177|NCT01125358|540424539|FG003|Overall Study|Protocol Violation|0|||
149808178|NCT01125358|540424536|FG000|Overall Study|Sponsor Decision|0|||
149808179|NCT01125358|540424537|FG001|Overall Study|Sponsor Decision|0|||
149808180|NCT01125358|540424538|FG002|Overall Study|Sponsor Decision|1|||
149808181|NCT01125358|540424539|FG003|Overall Study|Sponsor Decision|1|||
149808182|NCT01125358|540424536|FG000|Overall Study|Withdrawal by Subject|2|||
149808183|NCT01125358|540424537|FG001|Overall Study|Withdrawal by Subject|1|||
149808184|NCT01125358|540424538|FG002|Overall Study|Withdrawal by Subject|1|||
149808185|NCT01125358|540424539|FG003|Overall Study|Withdrawal by Subject|1|||
149808186|NCT01060007|540424540|FG000|Overall Study|Withdrawal by Subject|1|||
149808187|NCT01060007|540424540|FG000|Overall Study|Inevaluable for response at surgery|3|||
149808188|NCT05168657|540424541|FG000|Overall Study|Adverse Event|0|||
149808189|NCT05168657|540424542|FG001|Overall Study|Adverse Event|0|||
149808190|NCT05168657|540424543|FG002|Overall Study|Adverse Event|1|||
149808191|NCT05168657|540424544|FG003|Overall Study|Adverse Event|0|||
149808192|NCT05168657|540424545|FG004|Overall Study|Adverse Event|0|||
149808193|NCT05168657|540424546|FG005|Overall Study|Adverse Event|0|||
149808194|NCT05168657|540424547|FG006|Overall Study|Adverse Event|0|||
149808195|NCT05168657|540424548|FG007|Overall Study|Adverse Event|0|||
149808196|NCT03539952|540424556|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
149808197|NCT03539952|540424557|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
149808198|NCT03539952|540424556|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
149808199|NCT03539952|540424557|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
149808200|NCT03539952|540424556|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
149808201|NCT03539952|540424557|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
149808202|NCT03539952|540424556|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
149808203|NCT03539952|540424557|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
149808204|NCT03539952|540424556|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
149808205|NCT03539952|540424557|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
149808206|NCT03539952|540424556|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
149808207|NCT03539952|540424557|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
149808208|NCT03539952|540424556|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
149808209|NCT03539952|540424557|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
149808210|NCT02184988|540424558|FG000|Overall Study|Pregnancy|2|||
149808211|NCT02184988|540424558|FG000|Overall Study|Adverse Event|2|||
149808212|NCT02184988|540424558|FG000|Overall Study|moving away/travelling/unable to complet|6|||
149808213|NCT02184988|540424558|FG000|Overall Study|work scheduling issues|4|||
149808214|NCT02184988|540424558|FG000|Overall Study|various other reasons|9|||
149808215|NCT02184988|540424558|FG000|Overall Study|Lost to Follow-up|32|||
149808216|NCT03075215|540424559|FG000|12-Month Primary Endpoint|Death|152|||
149808217|NCT03075215|540424559|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
149808218|NCT03075215|540424559|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
149808219|NCT03075215|540424559|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
149808220|NCT01821391|540424560|FG000|Overall Study|Adverse Event|1|||
149808221|NCT01821391|540424561|FG001|Overall Study|Adverse Event|0|||
149808222|NCT01843660|540424562|FG000|Overall Study|Other|30|||
149808223|NCT01977482|540424563|FG000|Overall Study|Adverse Event|0|||
149808224|NCT01977482|540424564|FG001|Overall Study|Adverse Event|1|||
149808225|NCT01977482|540424565|FG002|Overall Study|Adverse Event|1|||
149808226|NCT01977482|540424566|FG003|Overall Study|Adverse Event|0|||
149808227|NCT01977482|540424567|FG004|Overall Study|Adverse Event|2|||
149808228|NCT01977482|540424568|FG005|Overall Study|Adverse Event|0|||
149918901|NCT01210352|540835243|FG002|Overall Study|Physician Decision|0|||
149918902|NCT01210352|540835244|FG003|Overall Study|Physician Decision|0|||
149808229|NCT01977482|540424563|FG000|Overall Study|Lost to Follow-up|1|||
149808230|NCT01977482|540424564|FG001|Overall Study|Lost to Follow-up|0|||
149808231|NCT01977482|540424565|FG002|Overall Study|Lost to Follow-up|0|||
149808232|NCT01977482|540424566|FG003|Overall Study|Lost to Follow-up|0|||
149808233|NCT01977482|540424567|FG004|Overall Study|Lost to Follow-up|0|||
149808234|NCT01977482|540424568|FG005|Overall Study|Lost to Follow-up|0|||
149808235|NCT01977482|540424563|FG000|Overall Study|Physician Decision|0|||
149808236|NCT01977482|540424564|FG001|Overall Study|Physician Decision|1|||
149808237|NCT01977482|540424565|FG002|Overall Study|Physician Decision|0|||
149808238|NCT01977482|540424566|FG003|Overall Study|Physician Decision|0|||
149808239|NCT01977482|540424567|FG004|Overall Study|Physician Decision|0|||
149808240|NCT01977482|540424568|FG005|Overall Study|Physician Decision|0|||
149808241|NCT01977482|540424563|FG000|Overall Study|Protocol Violation|0|||
149808242|NCT01977482|540424564|FG001|Overall Study|Protocol Violation|0|||
149808243|NCT01977482|540424565|FG002|Overall Study|Protocol Violation|1|||
149808244|NCT01977482|540424566|FG003|Overall Study|Protocol Violation|0|||
149808245|NCT01977482|540424567|FG004|Overall Study|Protocol Violation|0|||
149808246|NCT01977482|540424568|FG005|Overall Study|Protocol Violation|0|||
149808247|NCT01977482|540424563|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
149808248|NCT01977482|540424564|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
149808249|NCT01977482|540424565|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
149808250|NCT01977482|540424566|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
149808251|NCT01977482|540424567|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
149808252|NCT01977482|540424568|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
149808253|NCT01977482|540424563|FG000|Overall Study|Withdrawal by Subject|2|||
149808254|NCT01977482|540424564|FG001|Overall Study|Withdrawal by Subject|4|||
149808255|NCT01977482|540424565|FG002|Overall Study|Withdrawal by Subject|1|||
149808256|NCT01977482|540424566|FG003|Overall Study|Withdrawal by Subject|3|||
149808257|NCT01977482|540424567|FG004|Overall Study|Withdrawal by Subject|1|||
149808258|NCT01977482|540424568|FG005|Overall Study|Withdrawal by Subject|5|||
149808259|NCT00209560|540424569|FG000|Overall Study|Lack of Efficacy|1|||
149808260|NCT00209560|540424570|FG001|Overall Study|Lack of Efficacy|0|||
149808261|NCT01608321|540424577|FG000|Overall Study|Withdrawal by Subject|1|||
149808262|NCT01608321|540424578|FG001|Overall Study|Withdrawal by Subject|0|||
149808263|NCT01392469|540426080|FG000|Overall Study|Adverse Event|2|||
149808264|NCT01392469|540426080|FG000|Overall Study|Withdrawal by Subject|1|||
149808265|NCT01392469|540426080|FG000|Overall Study|Protocol Violation|1|||
149808266|NCT03443973|540426093|FG000|Double-blind Treatment Period|Adverse Event|5|||
149808267|NCT03443973|540426094|FG001|Double-blind Treatment Period|Adverse Event|19|||
149808268|NCT03443973|540426095|FG002|Double-blind Treatment Period|Adverse Event|0|||
149808269|NCT03443973|540426096|FG003|Double-blind Treatment Period|Adverse Event|0|||
149808270|NCT03443973|540426093|FG000|Double-blind Treatment Period|Death|5|||
149808271|NCT03443973|540426094|FG001|Double-blind Treatment Period|Death|7|||
149808272|NCT03443973|540426095|FG002|Double-blind Treatment Period|Death|0|||
149808273|NCT03443973|540426096|FG003|Double-blind Treatment Period|Death|0|||
149808274|NCT03443973|540426093|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
149808275|NCT03443973|540426094|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
149808276|NCT03443973|540426095|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
149808277|NCT03443973|540426096|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
149808278|NCT03443973|540426093|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149808279|NCT03443973|540426094|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
149808280|NCT03443973|540426095|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
149808281|NCT03443973|540426096|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
149808282|NCT03443973|540426093|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
149808283|NCT03443973|540426094|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
149808284|NCT03443973|540426095|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
149808285|NCT03443973|540426096|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
149808286|NCT03443973|540426093|FG000|Double-blind Treatment Period|Physician Decision|5|||
149808287|NCT03443973|540426094|FG001|Double-blind Treatment Period|Physician Decision|6|||
149808288|NCT03443973|540426095|FG002|Double-blind Treatment Period|Physician Decision|0|||
149808289|NCT03443973|540426096|FG003|Double-blind Treatment Period|Physician Decision|0|||
149808290|NCT03443973|540426093|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
149808291|NCT03443973|540426094|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
149808292|NCT03443973|540426095|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
149808293|NCT03443973|540426096|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
149808294|NCT03443973|540426093|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
149808295|NCT03443973|540426094|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
149808296|NCT03443973|540426095|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149808297|NCT03443973|540426096|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
149808298|NCT03443973|540426093|FG000|Open-label Extension Period|Reason Not Specified|0|||
149808299|NCT03443973|540426094|FG001|Open-label Extension Period|Reason Not Specified|0|||
149808300|NCT03443973|540426095|FG002|Open-label Extension Period|Reason Not Specified|3|||
149808301|NCT03443973|540426096|FG003|Open-label Extension Period|Reason Not Specified|0|||
149808302|NCT03443973|540426093|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
149808303|NCT03443973|540426094|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
149808304|NCT03443973|540426095|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
149808305|NCT03443973|540426096|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
149808306|NCT01956123|540426097|FG000|COS Cycle 2|Protocol Violation|8|||
149808307|NCT01956123|540426098|FG001|COS Cycle 2|Protocol Violation|3|||
149808308|NCT01956123|540426099|FG002|COS Cycle 2|Protocol Violation|0|||
149808309|NCT01956123|540426100|FG003|COS Cycle 2|Protocol Violation|0|||
149808310|NCT01956123|540426097|FG000|COS Cycle 2|Adverse Event|3|||
149808311|NCT01956123|540426098|FG001|COS Cycle 2|Adverse Event|4|||
149808312|NCT01956123|540426099|FG002|COS Cycle 2|Adverse Event|0|||
149808313|NCT01956123|540426100|FG003|COS Cycle 2|Adverse Event|0|||
149808314|NCT01956123|540426097|FG000|COS Cycle 2|Personal Reasons|2|||
149808315|NCT01956123|540426098|FG001|COS Cycle 2|Personal Reasons|0|||
149808316|NCT01956123|540426099|FG002|COS Cycle 2|Personal Reasons|0|||
149808317|NCT01956123|540426100|FG003|COS Cycle 2|Personal Reasons|0|||
149808318|NCT01956123|540426097|FG000|COS Cycle 2|Withdrawal by Subject|1|||
149808319|NCT01956123|540426098|FG001|COS Cycle 2|Withdrawal by Subject|0|||
149808320|NCT01956123|540426099|FG002|COS Cycle 2|Withdrawal by Subject|0|||
149808321|NCT01956123|540426100|FG003|COS Cycle 2|Withdrawal by Subject|0|||
149808322|NCT01956123|540426097|FG000|COS Cycle 3|Protocol Violation|0|||
149808323|NCT01956123|540426098|FG001|COS Cycle 3|Protocol Violation|0|||
149808324|NCT01956123|540426099|FG002|COS Cycle 3|Protocol Violation|2|||
149808325|NCT01956123|540426100|FG003|COS Cycle 3|Protocol Violation|1|||
149808326|NCT01956123|540426097|FG000|COS Cycle 3|Adverse Event|0|||
149808327|NCT01956123|540426098|FG001|COS Cycle 3|Adverse Event|0|||
149808328|NCT01956123|540426099|FG002|COS Cycle 3|Adverse Event|3|||
149808329|NCT01956123|540426100|FG003|COS Cycle 3|Adverse Event|0|||
149808330|NCT01956123|540426097|FG000|COS Cycle 3|Personal Reasons|0|||
149808331|NCT01956123|540426098|FG001|COS Cycle 3|Personal Reasons|0|||
149808332|NCT01956123|540426099|FG002|COS Cycle 3|Personal Reasons|1|||
149808333|NCT01956123|540426100|FG003|COS Cycle 3|Personal Reasons|0|||
149808334|NCT01956123|540426097|FG000|COS Cycle 3|Withdrawal by Subject|0|||
149808335|NCT01956123|540426098|FG001|COS Cycle 3|Withdrawal by Subject|0|||
149808336|NCT01956123|540426099|FG002|COS Cycle 3|Withdrawal by Subject|0|||
149808337|NCT01956123|540426100|FG003|COS Cycle 3|Withdrawal by Subject|1|||
149808338|NCT00398632|540426103|FG000|Overall Study|Withdrawal by Subject|1|||
149808339|NCT00398632|540426103|FG000|Overall Study|Lack of Efficacy|1|||
149808340|NCT00267020|540426104|FG000|Overall Study|Adverse Event|22|||
149808341|NCT00267020|540426105|FG001|Overall Study|Adverse Event|5|||
149808342|NCT00267020|540426104|FG000|Overall Study|Death|2|||
149808343|NCT00267020|540426105|FG001|Overall Study|Death|1|||
149808344|NCT00267020|540426104|FG000|Overall Study|Withdrawal by Subject|17|||
149808345|NCT00267020|540426105|FG001|Overall Study|Withdrawal by Subject|7|||
149808346|NCT00267020|540426104|FG000|Overall Study|Physician Decision|3|||
149808347|NCT00267020|540426105|FG001|Overall Study|Physician Decision|2|||
149808348|NCT00267020|540426104|FG000|Overall Study|Disease Progression|39|||
149808349|NCT00267020|540426105|FG001|Overall Study|Disease Progression|25|||
149808350|NCT00267020|540426104|FG000|Overall Study|Unrelated Complication|1|||
149808351|NCT00267020|540426105|FG001|Overall Study|Unrelated Complication|1|||
149808352|NCT00267020|540426104|FG000|Overall Study|Sponsor Request|1|||
149808353|NCT00267020|540426105|FG001|Overall Study|Sponsor Request|0|||
149808354|NCT00267020|540426104|FG000|Overall Study|Other|1|||
149808355|NCT00267020|540426105|FG001|Overall Study|Other|2|||
149808356|NCT00640614|540426106|FG000|Overall Study|Lost to Follow-up|1|||
149808357|NCT00640614|540426107|FG001|Overall Study|Lost to Follow-up|0|||
149808358|NCT02209454|540426110|FG000|Second Period|Adverse Event|1|||
149808359|NCT02209454|540426111|FG001|Second Period|Adverse Event|0|||
149918903|NCT01210352|540835245|FG004|Overall Study|Physician Decision|0|||
149808360|NCT02545868|540426112|FG000|Overall Study|Lack of Efficacy|1|||
149808361|NCT02545868|540426113|FG001|Overall Study|Lack of Efficacy|1|||
149808362|NCT02545868|540426114|FG002|Overall Study|Lack of Efficacy|0|||
149808363|NCT02545868|540426112|FG000|Overall Study|Lost to Follow-up|1|||
149808364|NCT02545868|540426113|FG001|Overall Study|Lost to Follow-up|5|||
149808365|NCT02545868|540426114|FG002|Overall Study|Lost to Follow-up|1|||
149808366|NCT02545868|540426112|FG000|Overall Study|Non-compliance|1|||
149808367|NCT02545868|540426113|FG001|Overall Study|Non-compliance|1|||
149808368|NCT02545868|540426114|FG002|Overall Study|Non-compliance|1|||
149808369|NCT02545868|540426112|FG000|Overall Study|Treatment change|21|||
149808370|NCT02545868|540426113|FG001|Overall Study|Treatment change|19|||
149808371|NCT02545868|540426114|FG002|Overall Study|Treatment change|22|||
149808372|NCT02545868|540426112|FG000|Overall Study|Physician Decision|1|||
149808373|NCT02545868|540426113|FG001|Overall Study|Physician Decision|1|||
149808374|NCT02545868|540426114|FG002|Overall Study|Physician Decision|1|||
149808375|NCT02545868|540426112|FG000|Overall Study|Withdrawal by Subject|6|||
149808376|NCT02545868|540426113|FG001|Overall Study|Withdrawal by Subject|7|||
149808377|NCT02545868|540426114|FG002|Overall Study|Withdrawal by Subject|9|||
149808378|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
149808379|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
149808380|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
149808381|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
149808382|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
149808383|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
149808384|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
149808385|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
149808386|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
149808387|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
149808388|NCT01777191|540426115|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
149808389|NCT01777191|540426116|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
149808390|NCT01777191|540426115|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
149808391|NCT01777191|540426116|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
149808392|NCT01777191|540426115|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
149808393|NCT01777191|540426116|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
149808394|NCT01777191|540426115|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
149808395|NCT01777191|540426116|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
149808396|NCT01777191|540426115|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
149808397|NCT01777191|540426116|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
149808398|NCT01777191|540426115|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
149808399|NCT01777191|540426116|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
149808400|NCT04465916|540426121|FG000|Overall Study|Withdrawal by Subject|0|||
149808401|NCT04465916|540426122|FG001|Overall Study|Withdrawal by Subject|1|||
149808402|NCT01856686|540426123|FG000|Overall Study|Lost to Follow-up|5|||
149808403|NCT01856686|540426124|FG001|Overall Study|Lost to Follow-up|11|||
149808404|NCT00468312|540426125|FG000|Overall Study|Adverse Event|2|||
149808405|NCT00468312|540426126|FG001|Overall Study|Adverse Event|1|||
149808406|NCT00468312|540426125|FG000|Overall Study|Lack of Efficacy|0|||
149808407|NCT00468312|540426126|FG001|Overall Study|Lack of Efficacy|1|||
149808408|NCT00468312|540426125|FG000|Overall Study|Withdrawal by Subject|0|||
149808409|NCT00468312|540426126|FG001|Overall Study|Withdrawal by Subject|1|||
149808410|NCT00468312|540426125|FG000|Overall Study|Protocol Violation|2|||
149808411|NCT00468312|540426126|FG001|Overall Study|Protocol Violation|1|||
149808412|NCT00468312|540426125|FG000|Overall Study|Did not meet protocol eligibility|0|||
149808413|NCT00468312|540426126|FG001|Overall Study|Did not meet protocol eligibility|1|||
149808414|NCT02886494|540426137|FG000|Overall Study|Adverse Event|1|||
149808415|NCT02886494|540426138|FG001|Overall Study|Adverse Event|0|||
149808416|NCT02886494|540426137|FG000|Overall Study|Withdrawal by Subject|12|||
149808417|NCT02886494|540426138|FG001|Overall Study|Withdrawal by Subject|3|||
149808418|NCT02886494|540426137|FG000|Overall Study|Protocol Violation|4|||
149808419|NCT02886494|540426138|FG001|Overall Study|Protocol Violation|1|||
149808420|NCT00916617|540426139|FG000|Overall Study|Adverse Event|3|||
149808421|NCT00916617|540426140|FG001|Overall Study|Adverse Event|2|||
149808422|NCT00916617|540426141|FG002|Overall Study|Adverse Event|6|||
149808423|NCT00916617|540426142|FG003|Overall Study|Adverse Event|3|||
149808424|NCT00916617|540426139|FG000|Overall Study|Withdrawal by Subject|3|||
149808425|NCT00916617|540426140|FG001|Overall Study|Withdrawal by Subject|2|||
149808426|NCT00916617|540426141|FG002|Overall Study|Withdrawal by Subject|0|||
149808427|NCT00916617|540426142|FG003|Overall Study|Withdrawal by Subject|1|||
149808428|NCT00916617|540426139|FG000|Overall Study|Caregiver Request|3|||
149808429|NCT00916617|540426140|FG001|Overall Study|Caregiver Request|2|||
149808430|NCT00916617|540426141|FG002|Overall Study|Caregiver Request|1|||
149808431|NCT00916617|540426142|FG003|Overall Study|Caregiver Request|0|||
149808432|NCT00916617|540426139|FG000|Overall Study|Physician Decision|1|||
149808433|NCT00916617|540426140|FG001|Overall Study|Physician Decision|1|||
149808434|NCT00916617|540426141|FG002|Overall Study|Physician Decision|0|||
149808435|NCT00916617|540426142|FG003|Overall Study|Physician Decision|0|||
149808436|NCT00916617|540426139|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
149808437|NCT00916617|540426140|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
149808438|NCT00916617|540426141|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
149808439|NCT00916617|540426142|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
149808440|NCT00916617|540426139|FG000|Overall Study|Lost to Follow-up|2|||
149808441|NCT00916617|540426140|FG001|Overall Study|Lost to Follow-up|1|||
149808442|NCT00916617|540426141|FG002|Overall Study|Lost to Follow-up|0|||
149808443|NCT00916617|540426142|FG003|Overall Study|Lost to Follow-up|0|||
149808444|NCT00916617|540426139|FG000|Overall Study|Lack of Efficacy|1|||
149808445|NCT00916617|540426140|FG001|Overall Study|Lack of Efficacy|0|||
149808446|NCT00916617|540426141|FG002|Overall Study|Lack of Efficacy|0|||
149808447|NCT00916617|540426142|FG003|Overall Study|Lack of Efficacy|0|||
149808448|NCT00916617|540426139|FG000|Overall Study|Other|2|||
149808449|NCT00916617|540426140|FG001|Overall Study|Other|0|||
149808450|NCT00916617|540426141|FG002|Overall Study|Other|0|||
149808451|NCT00916617|540426142|FG003|Overall Study|Other|2|||
149808452|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
149808453|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
149808454|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
149808455|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
149808456|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
149918904|NCT01210352|540835246|FG005|Overall Study|Physician Decision|0|||
149808457|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
149808458|NCT00566631|540426144|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
149808459|NCT00566631|540426144|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
149808460|NCT00566631|540426144|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
149808461|NCT00566631|540426144|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
149808462|NCT00566631|540426144|FG000|Part 2: Extension Phase|Adverse Event|11|||
149808463|NCT00566631|540426144|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
149808464|NCT00566631|540426144|FG000|Part 2: Extension Phase|Death|1|||
149808465|NCT00566631|540426144|FG000|Part 2: Extension Phase|Other|5|||
149808466|NCT02723786|540426145|FG000|Overall Study|Lost to Follow-up|1|||
149808467|NCT03170271|540426148|FG000|Overall Study|Adverse Event|7|||
149808468|NCT03170271|540426149|FG001|Overall Study|Adverse Event|2|||
149808469|NCT03170271|540426148|FG000|Overall Study|Lost to Follow-up|0|||
149808470|NCT03170271|540426149|FG001|Overall Study|Lost to Follow-up|1|||
149808471|NCT03170271|540426148|FG000|Overall Study|Physician Decision|1|||
149808472|NCT03170271|540426149|FG001|Overall Study|Physician Decision|0|||
149808473|NCT03170271|540426148|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
149808474|NCT03170271|540426149|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
149808475|NCT03170271|540426148|FG000|Overall Study|Withdrawal by Subject|17|||
149808476|NCT03170271|540426149|FG001|Overall Study|Withdrawal by Subject|5|||
149808477|NCT03170271|540426148|FG000|Overall Study|Other|2|||
149808478|NCT03170271|540426149|FG001|Overall Study|Other|2|||
149808479|NCT03170271|540426148|FG000|Overall Study|Randomized in error|4|||
149808480|NCT03170271|540426149|FG001|Overall Study|Randomized in error|0|||
149808481|NCT01984229|540426154|FG000|Safety Follow-up Period|Adverse Event|1|||
149808482|NCT01984229|540426155|FG001|Safety Follow-up Period|Adverse Event|1|||
149808483|NCT01984229|540426154|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
149808484|NCT01984229|540426155|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
149808485|NCT01418365|540426156|FG000|First Intervention|Withdrawal by Subject|0|||
149808486|NCT01418365|540426157|FG001|First Intervention|Withdrawal by Subject|1|||
149808487|NCT01418365|540426156|FG000|First Intervention|Non-compliance|1|||
149808488|NCT01418365|540426157|FG001|First Intervention|Non-compliance|0|||
149808489|NCT01418365|540426156|FG000|Second Intervention|Withdrawal by Subject|0|||
149808490|NCT01418365|540426157|FG001|Second Intervention|Withdrawal by Subject|1|||
149808491|NCT03319368|540426162|FG000|Overall Study|Discharge swabs not collected from resident|57|||
149808492|NCT03319368|540426163|FG001|Overall Study|Discharge swabs not collected from resident|46|||
149808493|NCT00824993|540426168|FG000|Overall Study|Withdrawal by Subject|1|||
149808494|NCT00824993|540426169|FG001|Overall Study|Withdrawal by Subject|1|||
149808495|NCT00824993|540426168|FG000|Overall Study|Malignancy Relapse|9|||
149808496|NCT00824993|540426169|FG001|Overall Study|Malignancy Relapse|10|||
149808497|NCT00824993|540426168|FG000|Overall Study|Rapid Bone Loss|0|||
149808498|NCT00824993|540426169|FG001|Overall Study|Rapid Bone Loss|1|||
149808499|NCT00824993|540426168|FG000|Overall Study|Non-Compliant|2|||
149808500|NCT00824993|540426169|FG001|Overall Study|Non-Compliant|1|||
149808501|NCT00824993|540426168|FG000|Overall Study|Insurance Issue|2|||
149808502|NCT00824993|540426169|FG001|Overall Study|Insurance Issue|1|||
149808503|NCT00824993|540426168|FG000|Overall Study|Death|0|||
149808504|NCT00824993|540426169|FG001|Overall Study|Death|3|||
149808505|NCT00518011|540426170|FG000|Overall Study|Death|1|||
150148901|NCT03029780|541681753|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
150148902|NCT03029780|541681752|FG000|Overall Study|Participant request to discontinue study treatment|4|||
150148903|NCT03029780|541681753|FG001|Overall Study|Participant request to discontinue study treatment|1|||
150148904|NCT03029780|541681752|FG000|Overall Study|Maximum clinical benefit|1|||
150148905|NCT03029780|541681753|FG001|Overall Study|Maximum clinical benefit|0|||
150148906|NCT03029780|541681752|FG000|Overall Study|Participant no longer meets study criteria|0|||
150148907|NCT03029780|541681753|FG001|Overall Study|Participant no longer meets study criteria|1|||
150148908|NCT03029780|541681752|FG000|Overall Study|Other reasons|6|||
150148909|NCT03029780|541681753|FG001|Overall Study|Other reasons|6|||
150148910|NCT03029780|541681752|FG000|Overall Study|Not reported|1|||
150148911|NCT03029780|541681753|FG001|Overall Study|Not reported|1|||
150148912|NCT03029780|541681752|FG000|Overall Study|Death|2|||
150148913|NCT03029780|541681753|FG001|Overall Study|Death|6|||
150148914|NCT00197028|541681754|FG000|Overall Study|Adverse Event|2|||
150148915|NCT00197028|541681755|FG001|Overall Study|Adverse Event|2|||
150148916|NCT00197028|541681754|FG000|Overall Study|Protocol Violation|2|||
150148917|NCT00197028|541681755|FG001|Overall Study|Protocol Violation|1|||
150148918|NCT00197028|541681754|FG000|Overall Study|Withdrawal by Subject|8|||
150148919|NCT00197028|541681755|FG001|Overall Study|Withdrawal by Subject|12|||
149808506|NCT00518011|540426171|FG001|Overall Study|Death|1|||
149808507|NCT00518011|540426170|FG000|Overall Study|Adverse Event|2|||
149808508|NCT00518011|540426171|FG001|Overall Study|Adverse Event|3|||
149808509|NCT00518011|540426170|FG000|Overall Study|Disease Progression|2|||
149808510|NCT00518011|540426171|FG001|Overall Study|Disease Progression|2|||
149808511|NCT00518011|540426170|FG000|Overall Study|Other Reasons|3|||
149808512|NCT00518011|540426171|FG001|Overall Study|Other Reasons|2|||
149808513|NCT00518011|540426170|FG000|Overall Study|Withdrawal by Subject|1|||
150148920|NCT00197028|541681754|FG000|Overall Study|Lost to Follow-up|1|||
149808514|NCT00518011|540426171|FG001|Overall Study|Withdrawal by Subject|0|||
149808515|NCT03409328|540426172|FG000|Overall Study|Lost to Follow-up|6|||
149808516|NCT03409328|540426173|FG001|Overall Study|Lost to Follow-up|3|||
149808517|NCT02998645|540426174|FG000|Treatment Period 1|Adverse Event|6|||
149808518|NCT02998645|540426174|FG000|Treatment Period 1|Death|5|||
149808519|NCT02998645|540426174|FG000|Treatment Period 1|Technical Problems|4|||
149808520|NCT02998645|540426174|FG000|Treatment Period 1|Lack of Efficacy|2|||
149808521|NCT02998645|540426174|FG000|Treatment Period 1|Progressive disease|1|||
149808522|NCT02998645|540426174|FG000|Treatment Period 1|Subject/guardian decision|1|||
149808523|NCT02998645|540426174|FG000|Treatment Period 2|Lack of Efficacy|5|||
149808524|NCT02998645|540426174|FG000|Treatment Period 2|Adverse Event|2|||
149808525|NCT02998645|540426174|FG000|Treatment Period 2|Progressive disease|2|||
149808526|NCT02998645|540426174|FG000|Treatment Period 2|Physician Decision|1|||
149808527|NCT03701516|540426175|FG000|Period 1|Lost to Follow-up|0|||
149808528|NCT03701516|540426176|FG001|Period 1|Lost to Follow-up|1|||
149808529|NCT03701516|540426175|FG000|Period 1|Adverse Event|0|||
149808530|NCT03701516|540426176|FG001|Period 1|Adverse Event|2|||
149808531|NCT03701516|540426175|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
149808532|NCT03701516|540426176|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
149808533|NCT03701516|540426175|FG000|Period 1|Non Compliance to Protocol|2|||
149808534|NCT03701516|540426176|FG001|Period 1|Non Compliance to Protocol|1|||
149808535|NCT03701516|540426175|FG000|Period 1|Withdrawal by Subject|0|||
149808536|NCT03701516|540426176|FG001|Period 1|Withdrawal by Subject|1|||
149808537|NCT03701516|540426175|FG000|Period 2|failed to meet all eligibility creiteria|1|||
149808538|NCT03701516|540426176|FG001|Period 2|failed to meet all eligibility creiteria|0|||
149808539|NCT03701516|540426175|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
149808540|NCT03701516|540426176|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
149808541|NCT03930615|540426177|FG000|Overall Study|Death|9|||
149808542|NCT03930615|540426178|FG001|Overall Study|Death|3|||
149808543|NCT03930615|540426177|FG000|Overall Study|Lost to Follow-up|1|||
149808544|NCT03930615|540426178|FG001|Overall Study|Lost to Follow-up|2|||
149808545|NCT03930615|540426177|FG000|Overall Study|Physician Decision|3|||
149808546|NCT03930615|540426178|FG001|Overall Study|Physician Decision|4|||
149808547|NCT03930615|540426177|FG000|Overall Study|Withdrawal by Subject|13|||
149808548|NCT03930615|540426178|FG001|Overall Study|Withdrawal by Subject|2|||
149808549|NCT03930615|540426177|FG000|Overall Study|Not treated|1|||
149808550|NCT03930615|540426178|FG001|Overall Study|Not treated|1|||
149808551|NCT03644927|540426180|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
149808552|NCT03644927|540426181|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
149808553|NCT00956813|540426182|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
149808554|NCT00956813|540426183|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
149808555|NCT00956813|540426182|FG000|Flaxseed and Placebo|Ineligible|3|||
149808556|NCT00956813|540426183|FG001|Flaxseed and Placebo|Ineligible|1|||
149808557|NCT02864953|540426184|FG000|Overall Study|Adverse Event|22|||
149808558|NCT02864953|540426185|FG001|Overall Study|Adverse Event|19|||
149808559|NCT02864953|540426184|FG000|Overall Study|Withdrawal by Subject|1|||
149808560|NCT02864953|540426185|FG001|Overall Study|Withdrawal by Subject|0|||
149808561|NCT02864953|540426184|FG000|Overall Study|Physician Decision|4|||
149808562|NCT02864953|540426185|FG001|Overall Study|Physician Decision|2|||
149808563|NCT02864953|540426184|FG000|Overall Study|Death|3|||
149808564|NCT02864953|540426185|FG001|Overall Study|Death|13|||
149808565|NCT02864953|540426184|FG000|Overall Study|Reason not specified|14|||
149808566|NCT02864953|540426185|FG001|Overall Study|Reason not specified|12|||
149808567|NCT02864953|540426184|FG000|Overall Study|Withdrew Prior to Dosing|9|||
149808568|NCT02864953|540426185|FG001|Overall Study|Withdrew Prior to Dosing|8|||
149808569|NCT00981019|540426186|FG000|Overall Study|Did not respond|65|||
149808570|NCT00981019|540426186|FG000|Overall Study|Did not match target population|94|||
149808571|NCT00981019|540426186|FG000|Overall Study|Inadvertent exclusion|239|||
149808572|NCT00981019|540426186|FG000|Overall Study|Hit the survey after closure|79|||
149808573|NCT00358670|540426187|FG000|Overall Study|Adverse Event|26|||
149808574|NCT00358670|540426188|FG001|Overall Study|Adverse Event|29|||
149808575|NCT00358670|540426187|FG000|Overall Study|Lack of Efficacy|20|||
149808576|NCT00358670|540426188|FG001|Overall Study|Lack of Efficacy|23|||
149808577|NCT00358670|540426187|FG000|Overall Study|Protocol Violation|6|||
149808578|NCT00358670|540426188|FG001|Overall Study|Protocol Violation|9|||
149808579|NCT00358670|540426187|FG000|Overall Study|Lost to Follow-up|4|||
149808580|NCT00358670|540426188|FG001|Overall Study|Lost to Follow-up|5|||
149808581|NCT00358670|540426187|FG000|Overall Study|Withdrawal by Subject|13|||
149808582|NCT00358670|540426188|FG001|Overall Study|Withdrawal by Subject|24|||
149808583|NCT00358670|540426187|FG000|Overall Study|Protocol Defined Clinical Event|0|||
149808584|NCT00358670|540426188|FG001|Overall Study|Protocol Defined Clinical Event|1|||
149808585|NCT00358670|540426187|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
149808586|NCT00358670|540426188|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
149808587|NCT00358670|540426187|FG000|Overall Study|Administrative|153|||
149808588|NCT00358670|540426188|FG001|Overall Study|Administrative|125|||
149808589|NCT05083559|540426189|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
150148921|NCT00197028|541681755|FG001|Overall Study|Lost to Follow-up|0|||
150148922|NCT00197028|541681754|FG000|Overall Study|Other|3|||
150148923|NCT00197028|541681755|FG001|Overall Study|Other|6|||
150148924|NCT03066622|541681758|FG000|Overall Study|Lost to Follow-up|24|||
150148925|NCT03066622|541681759|FG001|Overall Study|Lost to Follow-up|25|||
150148926|NCT03066622|541681758|FG000|Overall Study|Withdrawal by Subject|2|||
150148927|NCT03066622|541681759|FG001|Overall Study|Withdrawal by Subject|1|||
150148928|NCT00641719|541681760|FG000|Overall Study|Lack of Efficacy|1|||
150148929|NCT00641719|541681761|FG001|Overall Study|Lack of Efficacy|2|||
150148930|NCT00641719|541681760|FG000|Overall Study|Adverse Event|24|||
150148931|NCT00641719|541681761|FG001|Overall Study|Adverse Event|29|||
150148932|NCT00641719|541681760|FG000|Overall Study|Withdrawal by Subject|4|||
150148933|NCT00641719|541681761|FG001|Overall Study|Withdrawal by Subject|4|||
150148934|NCT00641719|541681760|FG000|Overall Study|Reason Not Specified|1|||
150148935|NCT00641719|541681761|FG001|Overall Study|Reason Not Specified|2|||
150148936|NCT03283696|541681790|FG000|Overall Study|Physician Decision|5|||
150148937|NCT03283696|541681791|FG001|Overall Study|Physician Decision|6|||
150148938|NCT03283696|541681790|FG000|Overall Study|Withdrawal by Subject|2|||
150148939|NCT03283696|541681791|FG001|Overall Study|Withdrawal by Subject|0|||
150148940|NCT02761629|541681797|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
150148941|NCT02761629|541681798|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
150148942|NCT02761629|541681797|FG000|Overall Study|Insufficient Therapeutic Response|2|||
150148943|NCT02761629|541681798|FG001|Overall Study|Insufficient Therapeutic Response|7|||
150148944|NCT02761629|541681797|FG000|Overall Study|Failure to Return|2|||
150148945|NCT02761629|541681798|FG001|Overall Study|Failure to Return|4|||
150148946|NCT02761629|541681797|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
150148947|NCT02761629|541681798|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
150148948|NCT02761629|541681797|FG000|Overall Study|Protocol Violation|2|||
150148949|NCT02761629|541681798|FG001|Overall Study|Protocol Violation|2|||
150148950|NCT02761629|541681797|FG000|Overall Study|Withdrawal by Subject|0|||
150148951|NCT02761629|541681798|FG001|Overall Study|Withdrawal by Subject|3|||
150148952|NCT02761629|541681797|FG000|Overall Study|Other|0|||
150148953|NCT02761629|541681798|FG001|Overall Study|Other|2|||
150148954|NCT02761629|541681797|FG000|Overall Study|Lost to Follow-up|4|||
150148955|NCT02761629|541681798|FG001|Overall Study|Lost to Follow-up|1|||
150148956|NCT02761629|541681797|FG000|Overall Study|Randomized But Not Treated|8|||
150148957|NCT02761629|541681798|FG001|Overall Study|Randomized But Not Treated|4|||
150148958|NCT00562978|541681799|FG000|Overall Study|Patient had imaging dose only|1|||
150148959|NCT00562978|541681800|FG001|Overall Study|Patient had imaging dose only|11|||
150148960|NCT00936221|541681801|FG000|Overall Study|Withdrawal by Subject|1|||
150148961|NCT00936221|541681802|FG001|Overall Study|Withdrawal by Subject|1|||
150148962|NCT01348776|541681803|FG000|Overall Study|Lost to Follow-up|3|||
150148963|NCT04362137|541681807|FG000|Overall Study|Death|9|||
150148964|NCT04362137|541681808|FG001|Overall Study|Death|3|||
150148965|NCT04362137|541681807|FG000|Overall Study|Patient decision|6|||
150148966|NCT04362137|541681808|FG001|Overall Study|Patient decision|3|||
150148967|NCT04362137|541681807|FG000|Overall Study|Adverse Event|1|||
150148968|NCT04362137|541681808|FG001|Overall Study|Adverse Event|0|||
150148969|NCT04362137|541681807|FG000|Overall Study|Lost to Follow-up|1|||
150148970|NCT04362137|541681808|FG001|Overall Study|Lost to Follow-up|0|||
150148971|NCT04362137|541681807|FG000|Overall Study|Protocol deviation|1|||
150148972|NCT04362137|541681808|FG001|Overall Study|Protocol deviation|0|||
150148973|NCT02204579|541681814|FG000|Overall Study|Screen failures|2|||
150148974|NCT03176238|541681817|FG000|Overall Study|Unacceptable AEs|15|||
150148975|NCT03176238|541681818|FG001|Overall Study|Unacceptable AEs|8|||
150148976|NCT03176238|541681817|FG000|Overall Study|Abnormal lab value(s)|2|||
150148977|NCT03176238|541681818|FG001|Overall Study|Abnormal lab value(s)|0|||
150148978|NCT03176238|541681817|FG000|Overall Study|Inter-current illness|0|||
150148979|NCT03176238|541681818|FG001|Overall Study|Inter-current illness|1|||
150148980|NCT03176238|541681817|FG000|Overall Study|Consent withdrawal|14|||
150148981|NCT03176238|541681818|FG001|Overall Study|Consent withdrawal|2|||
150148982|NCT03176238|541681817|FG000|Overall Study|Lost to Follow-up|3|||
150148983|NCT03176238|541681818|FG001|Overall Study|Lost to Follow-up|0|||
150148984|NCT03176238|541681817|FG000|Overall Study|Administrative problems|1|||
150148985|NCT03176238|541681818|FG001|Overall Study|Administrative problems|0|||
150148986|NCT03176238|541681817|FG000|Overall Study|Death|3|||
150148987|NCT03176238|541681818|FG001|Overall Study|Death|0|||
150148988|NCT03176238|541681817|FG000|Overall Study|Disease Progression|133|||
150148989|NCT03176238|541681818|FG001|Overall Study|Disease Progression|22|||
149808590|NCT05083559|540426190|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
149808591|NCT05083559|540426189|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
150148990|NCT03176238|541681817|FG000|Overall Study|Tx duration completed per EAP|0|||
150148991|NCT03176238|541681818|FG001|Overall Study|Tx duration completed per EAP|1|||
150148992|NCT03176238|541681817|FG000|Overall Study|Patient is switched to commercial drug|16|||
150148993|NCT03176238|541681818|FG001|Overall Study|Patient is switched to commercial drug|1|||
150148994|NCT03176238|541681817|FG000|Overall Study|Protocol Violation|1|||
150148995|NCT03176238|541681818|FG001|Overall Study|Protocol Violation|0|||
150148996|NCT03176238|541681817|FG000|Overall Study|Changes in the patient's condition|2|||
150148997|NCT03176238|541681818|FG001|Overall Study|Changes in the patient's condition|1|||
150148998|NCT03176238|541681817|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
150148999|NCT03176238|541681818|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
150149000|NCT03556358|541681819|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
150149001|NCT03556358|541681820|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
150149002|NCT03556358|541681819|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
150149003|NCT03556358|541681820|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
150149004|NCT03556358|541681819|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
150149005|NCT03556358|541681820|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
150149006|NCT03556358|541681819|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
150149007|NCT03556358|541681820|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
150149008|NCT03556358|541681819|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
150149009|NCT03556358|541681820|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
150149010|NCT03556358|541681819|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
150149011|NCT03556358|541681820|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
150149012|NCT03556358|541681819|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
150149013|NCT03556358|541681820|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
150149014|NCT01065350|541681822|FG000|Overall Study|Received incorrect drug allocation|0|||
150149015|NCT01065350|541681823|FG001|Overall Study|Received incorrect drug allocation|1|||
150149016|NCT02875834|541681826|FG000|Open-label Phase|Withdrawal by Subject|3|||
150149017|NCT02875834|541681827|FG001|Open-label Phase|Withdrawal by Subject|0|||
150149018|NCT02875834|541681828|FG002|Open-label Phase|Withdrawal by Subject|0|||
150149019|NCT02875834|541681829|FG003|Open-label Phase|Withdrawal by Subject|0|||
150149020|NCT02875834|541681826|FG000|Open-label Phase|(Not collected)|4|||
150149021|NCT02875834|541681827|FG001|Open-label Phase|(Not collected)|0|||
150149022|NCT02875834|541681828|FG002|Open-label Phase|(Not collected)|0|||
150149023|NCT02875834|541681829|FG003|Open-label Phase|(Not collected)|0|||
150149024|NCT02875834|541681826|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
150149025|NCT02875834|541681827|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
150149026|NCT02875834|541681828|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
150149027|NCT02875834|541681829|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
150149028|NCT02875834|541681826|FG000|Randomized Treatment Phase|Protocol Violation|0|||
150149029|NCT02875834|541681827|FG001|Randomized Treatment Phase|Protocol Violation|2|||
150149030|NCT02875834|541681828|FG002|Randomized Treatment Phase|Protocol Violation|0|||
150149031|NCT02875834|541681829|FG003|Randomized Treatment Phase|Protocol Violation|0|||
150149032|NCT02875834|541681826|FG000|Randomized Treatment Phase|(Not collected)|0|||
150149033|NCT02875834|541681827|FG001|Randomized Treatment Phase|(Not collected)|9|||
150149034|NCT02875834|541681828|FG002|Randomized Treatment Phase|(Not collected)|10|||
150149035|NCT02875834|541681829|FG003|Randomized Treatment Phase|(Not collected)|9|||
150149036|NCT05200936|541681831|FG000|Overall Study|Withdrawal by Subject|2|||
150149037|NCT05200936|541681832|FG001|Overall Study|Withdrawal by Subject|2|||
150149038|NCT05200936|541681831|FG000|Overall Study|Lost to Follow-up|2|||
150149039|NCT05200936|541681832|FG001|Overall Study|Lost to Follow-up|0|||
150149040|NCT05200936|541681831|FG000|Overall Study|Pregnancy|0|||
150149041|NCT05200936|541681832|FG001|Overall Study|Pregnancy|1|||
150149042|NCT00539279|541681833|FG000|Treatment|Withdrawal by Subject|10|||
150149043|NCT00539279|541681834|FG001|Treatment|Withdrawal by Subject|8|||
150149044|NCT00539279|541681833|FG000|Treatment|Death|1|||
150149045|NCT00539279|541681834|FG001|Treatment|Death|0|||
150149046|NCT00539279|541681833|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
150149047|NCT00539279|541681834|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
150149048|NCT00539279|541681833|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
150149049|NCT00539279|541681834|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
150149050|NCT00885352|541683175|FG000|Overall Study|Adverse Event|2|||
150149051|NCT00885352|541683176|FG001|Overall Study|Adverse Event|3|||
150149052|NCT00885352|541683175|FG000|Overall Study|Lost to Follow-up|2|||
150149053|NCT00885352|541683176|FG001|Overall Study|Lost to Follow-up|2|||
150149054|NCT00885352|541683175|FG000|Overall Study|Physician Decision|0|||
150149055|NCT00885352|541683176|FG001|Overall Study|Physician Decision|3|||
150149056|NCT00885352|541683175|FG000|Overall Study|Protocol Violation|0|||
150149057|NCT00885352|541683176|FG001|Overall Study|Protocol Violation|2|||
150149058|NCT00885352|541683175|FG000|Overall Study|Withdrawal by Subject|1|||
150149059|NCT00885352|541683176|FG001|Overall Study|Withdrawal by Subject|5|||
150149060|NCT00885352|541683175|FG000|Overall Study|Contradiction to study medication|0|||
150149061|NCT00885352|541683176|FG001|Overall Study|Contradiction to study medication|2|||
150149062|NCT00885352|541683175|FG000|Overall Study|Excluded medication|2|||
150149063|NCT00885352|541683176|FG001|Overall Study|Excluded medication|2|||
150149064|NCT00885352|541683175|FG000|Overall Study|Lab abnormalities|1|||
150149065|NCT00885352|541683176|FG001|Overall Study|Lab abnormalities|1|||
150149066|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
150149067|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
150149068|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
150149069|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
150149070|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
150149071|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
150149072|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
150149073|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
150149074|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
150149075|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
150149076|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
150149077|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
150149078|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
150149079|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
150149080|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
150149081|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
150149082|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
150149083|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
150149084|NCT00365378|541683177|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
150149085|NCT00365378|541683178|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
150149086|NCT00365378|541683179|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
150149087|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
150149088|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
150149089|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
150149090|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
150149091|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
150149092|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
150149093|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
150149094|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
150149095|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
150149096|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
150149097|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
150149098|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
150149099|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
150149100|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
150149101|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
150149102|NCT00365378|541683177|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
150149103|NCT00365378|541683178|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
150149104|NCT00365378|541683179|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
150149105|NCT00365378|541683177|FG000|Extension|Adverse Event|0|||
150149106|NCT00365378|541683178|FG001|Extension|Adverse Event|0|||
150149107|NCT00365378|541683179|FG002|Extension|Adverse Event|1|||
150149108|NCT00365378|541683177|FG000|Extension|Moved|0|||
150149109|NCT00365378|541683178|FG001|Extension|Moved|0|||
150149110|NCT00365378|541683179|FG002|Extension|Moved|8|||
150149111|NCT00365378|541683177|FG000|Extension|Lost to Follow-up|0|||
150149112|NCT00365378|541683178|FG001|Extension|Lost to Follow-up|0|||
150149113|NCT00365378|541683179|FG002|Extension|Lost to Follow-up|57|||
150149114|NCT00365378|541683177|FG000|Extension|Protocol Violation|0|||
150149115|NCT00365378|541683178|FG001|Extension|Protocol Violation|0|||
150149116|NCT00365378|541683179|FG002|Extension|Protocol Violation|2|||
150149117|NCT00365378|541683177|FG000|Extension|Withdrawal by Subject|0|||
150149118|NCT00365378|541683178|FG001|Extension|Withdrawal by Subject|0|||
150149119|NCT00365378|541683179|FG002|Extension|Withdrawal by Subject|98|||
150149120|NCT00365378|541683177|FG000|Extension|Other|0|||
150149121|NCT00365378|541683178|FG001|Extension|Other|0|||
150149122|NCT00365378|541683179|FG002|Extension|Other|31|||
150149123|NCT04161807|541683182|FG000|Overall Study|Withdrawal by Subject|2|||
150149124|NCT04161807|541683182|FG000|Overall Study|Performed only 1 treatment|2|||
150149125|NCT00251927|541683186|FG000|Overall Study|Adverse Event|3|||
150149126|NCT00251927|541683187|FG001|Overall Study|Adverse Event|15|||
150149127|NCT00251927|541683186|FG000|Overall Study|Lack of Efficacy|22|||
150149128|NCT00251927|541683187|FG001|Overall Study|Lack of Efficacy|16|||
149808592|NCT05083559|540426190|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
150149129|NCT00251927|541683186|FG000|Overall Study|Lost to Follow-up|22|||
150149130|NCT00251927|541683187|FG001|Overall Study|Lost to Follow-up|8|||
150149131|NCT00251927|541683186|FG000|Overall Study|Protocol Violation|1|||
150149132|NCT00251927|541683187|FG001|Overall Study|Protocol Violation|2|||
150149133|NCT00251927|541683186|FG000|Overall Study|Pregnancy|2|||
149808593|NCT05083559|540426189|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
150149134|NCT00251927|541683187|FG001|Overall Study|Pregnancy|0|||
150149135|NCT00251927|541683186|FG000|Overall Study|Withdrawal by Subject|40|||
149808594|NCT05083559|540426190|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
150149136|NCT00251927|541683187|FG001|Overall Study|Withdrawal by Subject|25|||
150149137|NCT00251927|541683186|FG000|Overall Study|Study-specific discont. achieved|13|||
150149138|NCT00251927|541683187|FG001|Overall Study|Study-specific discont. achieved|2|||
150149139|NCT00251927|541683186|FG000|Overall Study|Study procedure non-compliance|5|||
150149140|NCT00251927|541683187|FG001|Overall Study|Study procedure non-compliance|6|||
150149141|NCT00452413|541683191|FG000|Overall Study|Progressive Disease|4|||
150149142|NCT00452413|541683192|FG001|Overall Study|Progressive Disease|11|||
150149143|NCT00452413|541683193|FG002|Overall Study|Progressive Disease|30|||
150149144|NCT00452413|541683191|FG000|Overall Study|Withdrawal by Subject|0|||
150149145|NCT00452413|541683192|FG001|Overall Study|Withdrawal by Subject|1|||
150149146|NCT00452413|541683193|FG002|Overall Study|Withdrawal by Subject|4|||
150149147|NCT00452413|541683191|FG000|Overall Study|Adverse Event|0|||
150149148|NCT00452413|541683192|FG001|Overall Study|Adverse Event|0|||
150149149|NCT00452413|541683193|FG002|Overall Study|Adverse Event|5|||
150149150|NCT00452413|541683191|FG000|Overall Study|Physician Decision|0|||
150149151|NCT00452413|541683192|FG001|Overall Study|Physician Decision|0|||
150149152|NCT00452413|541683193|FG002|Overall Study|Physician Decision|4|||
150149153|NCT00452413|541683191|FG000|Overall Study|Death due to study disease|0|||
150149154|NCT00452413|541683192|FG001|Overall Study|Death due to study disease|0|||
150149155|NCT00452413|541683193|FG002|Overall Study|Death due to study disease|2|||
150149156|NCT00452413|541683191|FG000|Overall Study|Death due to adverse event (AE)|0|||
150149157|NCT00452413|541683192|FG001|Overall Study|Death due to adverse event (AE)|0|||
150149158|NCT00452413|541683193|FG002|Overall Study|Death due to adverse event (AE)|1|||
150149159|NCT00452413|541683191|FG000|Overall Study|On treatment|0|||
150149160|NCT00452413|541683192|FG001|Overall Study|On treatment|0|||
150149161|NCT00452413|541683193|FG002|Overall Study|On treatment|3|||
150149162|NCT03119610|541683195|FG000|Overall Study|Adverse Event|1|||
150149163|NCT03119610|541683196|FG001|Overall Study|Adverse Event|0|||
150149164|NCT03119610|541683195|FG000|Overall Study|Lost to Follow-up|0|||
150149165|NCT03119610|541683196|FG001|Overall Study|Lost to Follow-up|1|||
150149166|NCT02765490|541683205|FG000|Overall Study|Lost to Follow-up|1|||
150149167|NCT02765490|541683206|FG001|Overall Study|Lost to Follow-up|1|||
150149168|NCT02765490|541683205|FG000|Overall Study|Other|0|||
150149169|NCT02765490|541683206|FG001|Overall Study|Other|1|||
150149170|NCT02765490|541683205|FG000|Overall Study|Death|0|||
150149171|NCT02765490|541683206|FG001|Overall Study|Death|1|||
150149172|NCT03237013|541683207|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
150149173|NCT03237013|541683208|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
150149174|NCT03237013|541683209|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
150149175|NCT00258440|541683214|FG000|Overall Study|Withdrawal by Subject|0|||
150149176|NCT00258440|541683215|FG001|Overall Study|Withdrawal by Subject|0|||
150149177|NCT00258440|541683216|FG002|Overall Study|Withdrawal by Subject|1|||
150149178|NCT00737061|541683217|FG000|Waiting Period|Lost to Follow-up|6|||
150149179|NCT00737061|541683217|FG000|Waiting Period|Withdrawal by Subject|1|||
150149180|NCT00737061|541683217|FG000|Waiting Period|Bilateral placement failure|34|||
150149181|NCT00737061|541683217|FG000|Waiting Period|Deemed patent following HSG|26|||
150149182|NCT00737061|541683217|FG000|Waiting Period|Alternative contraception failure|3|||
150149183|NCT00737061|541683217|FG000|Waiting Period|Elected surgical tubal ligation|5|||
150149184|NCT00737061|541683217|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
150149185|NCT00737061|541683217|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
150149186|NCT00737061|541683217|FG000|1 Year Wearing Period|Discontinued reilance|3|||
150149187|NCT00737061|541683217|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
149808595|NCT00905437|540426193|FG000|Overall Study|Adverse Event|3|||
149808596|NCT00905437|540426194|FG001|Overall Study|Adverse Event|2|||
149808597|NCT00905437|540426193|FG000|Overall Study|Lost to Follow-up|0|||
149808598|NCT00905437|540426194|FG001|Overall Study|Lost to Follow-up|1|||
149808599|NCT00905437|540426193|FG000|Overall Study|Withdrawal by Subject|0|||
149808600|NCT00905437|540426194|FG001|Overall Study|Withdrawal by Subject|1|||
149808601|NCT00905437|540426193|FG000|Overall Study|Other|5|||
149808602|NCT00905437|540426194|FG001|Overall Study|Other|6|||
149808603|NCT03252015|540426197|FG000|Overall Study|Withdrawal by Subject|0|||
150149188|NCT06173570|541683222|FG000|Overall Study|Adverse Event|1|||
150149189|NCT06173570|541683223|FG001|Overall Study|Adverse Event|0|||
150149190|NCT06173570|541683224|FG002|Overall Study|Adverse Event|0|||
150149191|NCT06173570|541683225|FG003|Overall Study|Adverse Event|2|||
150149192|NCT06173570|541683226|FG004|Overall Study|Adverse Event|0|||
150149193|NCT06173570|541683222|FG000|Overall Study|Lost to Follow-up|1|||
150149194|NCT06173570|541683223|FG001|Overall Study|Lost to Follow-up|0|||
150149195|NCT06173570|541683224|FG002|Overall Study|Lost to Follow-up|0|||
150149196|NCT06173570|541683225|FG003|Overall Study|Lost to Follow-up|0|||
150149197|NCT06173570|541683226|FG004|Overall Study|Lost to Follow-up|2|||
150149198|NCT06173570|541683222|FG000|Overall Study|Protocol Violation|0|||
150149199|NCT06173570|541683223|FG001|Overall Study|Protocol Violation|2|||
150149200|NCT06173570|541683224|FG002|Overall Study|Protocol Violation|0|||
150149201|NCT06173570|541683225|FG003|Overall Study|Protocol Violation|0|||
150149202|NCT06173570|541683226|FG004|Overall Study|Protocol Violation|1|||
150149203|NCT06173570|541683222|FG000|Overall Study|Withdrawal by Subject|0|||
149808604|NCT03252015|540426198|FG001|Overall Study|Withdrawal by Subject|1|||
150149204|NCT06173570|541683223|FG001|Overall Study|Withdrawal by Subject|1|||
150149205|NCT06173570|541683224|FG002|Overall Study|Withdrawal by Subject|1|||
150149206|NCT06173570|541683225|FG003|Overall Study|Withdrawal by Subject|1|||
150149207|NCT06173570|541683226|FG004|Overall Study|Withdrawal by Subject|1|||
150149208|NCT06173570|541683222|FG000|Overall Study|Non-compliance with Study Drug|1|||
150149209|NCT06173570|541683223|FG001|Overall Study|Non-compliance with Study Drug|0|||
150149210|NCT06173570|541683224|FG002|Overall Study|Non-compliance with Study Drug|0|||
150149211|NCT06173570|541683225|FG003|Overall Study|Non-compliance with Study Drug|0|||
150149212|NCT06173570|541683226|FG004|Overall Study|Non-compliance with Study Drug|0|||
150149213|NCT06173570|541683222|FG000|Overall Study|Screen Failure|0|||
150149214|NCT06173570|541683223|FG001|Overall Study|Screen Failure|0|||
150149215|NCT06173570|541683224|FG002|Overall Study|Screen Failure|0|||
150149216|NCT06173570|541683225|FG003|Overall Study|Screen Failure|0|||
150149217|NCT06173570|541683226|FG004|Overall Study|Screen Failure|1|||
150149218|NCT06173570|541683222|FG000|Overall Study|Other|2|||
150149219|NCT06173570|541683223|FG001|Overall Study|Other|1|||
150149220|NCT06173570|541683224|FG002|Overall Study|Other|0|||
150149221|NCT06173570|541683225|FG003|Overall Study|Other|2|||
150149222|NCT06173570|541683226|FG004|Overall Study|Other|0|||
150149223|NCT01844115|541683227|FG000|Overall Study|Adverse Event|4|||
150149224|NCT01844115|541683228|FG001|Overall Study|Adverse Event|22|||
150149225|NCT01844115|541683227|FG000|Overall Study|Lack of Efficacy|1|||
150149226|NCT01844115|541683228|FG001|Overall Study|Lack of Efficacy|4|||
150149227|NCT01844115|541683227|FG000|Overall Study|Protocol Violation|12|||
150149228|NCT01844115|541683228|FG001|Overall Study|Protocol Violation|10|||
150149229|NCT01844115|541683227|FG000|Overall Study|Withdrawal by Subject|11|||
150149230|NCT01844115|541683228|FG001|Overall Study|Withdrawal by Subject|11|||
150149231|NCT01844115|541683227|FG000|Overall Study|Lost to Follow-up|11|||
150149232|NCT01844115|541683228|FG001|Overall Study|Lost to Follow-up|10|||
150149233|NCT01844115|541683227|FG000|Overall Study|Pregnancy|0|||
150149234|NCT01844115|541683228|FG001|Overall Study|Pregnancy|1|||
150149235|NCT00366301|541683229|FG000|Overall Study|Lost to Follow-up|4|||
150149236|NCT00366301|541683230|FG001|Overall Study|Lost to Follow-up|4|||
150149237|NCT00366301|541683231|FG002|Overall Study|Lost to Follow-up|3|||
150149238|NCT00366301|541683232|FG003|Overall Study|Lost to Follow-up|7|||
150149239|NCT00366301|541683229|FG000|Overall Study|Withdrawal by Subject|4|||
150149240|NCT00366301|541683230|FG001|Overall Study|Withdrawal by Subject|2|||
150149241|NCT00366301|541683231|FG002|Overall Study|Withdrawal by Subject|1|||
150149242|NCT00366301|541683232|FG003|Overall Study|Withdrawal by Subject|1|||
150149243|NCT01372605|541683233|FG000|Overall Study|Death|1|||
150149244|NCT01372605|541683234|FG001|Overall Study|Death|2|||
150149245|NCT01372605|541683233|FG000|Overall Study|Lost to Follow-up|2|||
150149246|NCT01372605|541683234|FG001|Overall Study|Lost to Follow-up|1|||
150149247|NCT01372605|541683233|FG000|Overall Study|Withdrawal by Subject|4|||
150149248|NCT01372605|541683234|FG001|Overall Study|Withdrawal by Subject|7|||
150149249|NCT01372605|541683233|FG000|Overall Study|Moved|3|||
150149250|NCT01372605|541683234|FG001|Overall Study|Moved|0|||
150149251|NCT01372605|541683233|FG000|Overall Study|Changed medical home|2|||
150149252|NCT01372605|541683234|FG001|Overall Study|Changed medical home|0|||
150149253|NCT01108510|541683235|FG000|Overall Study|Randomized but Not Treated|5|||
150149254|NCT01108510|541683236|FG001|Overall Study|Randomized but Not Treated|1|||
150149255|NCT01108510|541683235|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
150149256|NCT01108510|541683236|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
150149257|NCT01108510|541683235|FG000|Overall Study|Adverse Event|26|||
150149258|NCT01108510|541683236|FG001|Overall Study|Adverse Event|19|||
150149259|NCT01108510|541683235|FG000|Overall Study|Lost to Follow-up|20|||
150149260|NCT01108510|541683236|FG001|Overall Study|Lost to Follow-up|17|||
150149261|NCT01108510|541683235|FG000|Overall Study|Withdrew Consent|21|||
150149262|NCT01108510|541683236|FG001|Overall Study|Withdrew Consent|15|||
150149263|NCT01108510|541683235|FG000|Overall Study|Investigator's Discretion|12|||
150149264|NCT01108510|541683236|FG001|Overall Study|Investigator's Discretion|10|||
150149265|NCT01108510|541683235|FG000|Overall Study|Participant Noncompliance|5|||
150149266|NCT01108510|541683236|FG001|Overall Study|Participant Noncompliance|7|||
150149267|NCT01108510|541683235|FG000|Overall Study|Lack of Efficacy|3|||
150149268|NCT01108510|541683236|FG001|Overall Study|Lack of Efficacy|0|||
149918905|NCT01210352|540835247|FG006|Overall Study|Physician Decision|0|||
150149269|NCT01108510|541683235|FG000|Overall Study|Pregnancy|0|||
150149270|NCT01108510|541683236|FG001|Overall Study|Pregnancy|3|||
150149271|NCT01108510|541683235|FG000|Overall Study|Death|1|||
150149272|NCT01108510|541683236|FG001|Overall Study|Death|1|||
150149273|NCT00210119|541683237|FG000|Overall Study|Protocol Violation|1|||
150149274|NCT00210119|541683237|FG000|Overall Study|Withdrawal by Subject|1|||
150149275|NCT00951509|541683238|FG000|Overall Study|Withdrawal by Subject|2|||
150149276|NCT01830881|541683242|FG000|Overall Study|Changed decision to have an abortion|0|||
150149277|NCT01830881|541683243|FG001|Overall Study|Changed decision to have an abortion|1|||
150149278|NCT03125941|541683244|FG000|Overall Study|did not receive intervention|1|||
150149279|NCT03125941|541683245|FG001|Overall Study|did not receive intervention|2|||
150149280|NCT00734214|541683246|FG000|Overall Study|Withdrawal by Subject|3|||
150149281|NCT00734214|541683247|FG001|Overall Study|Withdrawal by Subject|4|||
150149282|NCT00734214|541683246|FG000|Overall Study|MD withdrawal|1|||
150149283|NCT00734214|541683247|FG001|Overall Study|MD withdrawal|0|||
149808605|NCT03252015|540426199|FG002|Overall Study|Withdrawal by Subject|1|||
149808606|NCT03252015|540426200|FG003|Overall Study|Withdrawal by Subject|0|||
149808607|NCT03252015|540426197|FG000|Overall Study|Adverse Event|1|||
149808608|NCT03252015|540426198|FG001|Overall Study|Adverse Event|0|||
149808609|NCT03252015|540426199|FG002|Overall Study|Adverse Event|0|||
149808610|NCT03252015|540426200|FG003|Overall Study|Adverse Event|1|||
149808611|NCT03128931|540426201|FG000|Overall Study|Physician Decision|1|||
149808612|NCT03128931|540426201|FG000|Overall Study|Equipment Issues|3|||
149808613|NCT04993339|540426202|FG000|Overall Study|Lost to Follow-up|0|||
149808614|NCT04993339|540426203|FG001|Overall Study|Lost to Follow-up|1|||
149808615|NCT04993339|540426202|FG000|Overall Study|no MRI scan|3|||
149808616|NCT04993339|540426203|FG001|Overall Study|no MRI scan|1|||
149808617|NCT00903409|540426204|FG000|Overall Study|Adverse Event|11|||
149808618|NCT00903409|540426205|FG001|Overall Study|Adverse Event|9|||
149808619|NCT00903409|540426204|FG000|Overall Study|Non-compliance with Protocol|1|||
149808620|NCT00903409|540426205|FG001|Overall Study|Non-compliance with Protocol|1|||
149808621|NCT00903409|540426204|FG000|Overall Study|Laboratory Abnormality|2|||
149808622|NCT00903409|540426205|FG001|Overall Study|Laboratory Abnormality|0|||
149808623|NCT00903409|540426204|FG000|Overall Study|Withdrawal by Subject|8|||
149808624|NCT00903409|540426205|FG001|Overall Study|Withdrawal by Subject|8|||
149808625|NCT00903409|540426204|FG000|Overall Study|Other|2|||
149808626|NCT00903409|540426205|FG001|Overall Study|Other|3|||
149808627|NCT00903409|540426204|FG000|Overall Study|Lost to Follow-up|2|||
149808628|NCT00903409|540426205|FG001|Overall Study|Lost to Follow-up|6|||
149808629|NCT00797316|540426206|FG000|Overall Study|Administrative problems|1|||
149808630|NCT00797316|540426207|FG001|Overall Study|Administrative problems|0|||
149808631|NCT00797316|540426206|FG000|Overall Study|Adverse Event|5|||
149808632|NCT00797316|540426207|FG001|Overall Study|Adverse Event|3|||
149808633|NCT00797316|540426206|FG000|Overall Study|Lost to Follow-up|4|||
149808634|NCT00797316|540426207|FG001|Overall Study|Lost to Follow-up|8|||
149808635|NCT00797316|540426206|FG000|Overall Study|Protocol Deviation|1|||
149808636|NCT00797316|540426207|FG001|Overall Study|Protocol Deviation|2|||
149808637|NCT00797316|540426206|FG000|Overall Study|Patient withdrew consent|12|||
149808638|NCT00797316|540426207|FG001|Overall Study|Patient withdrew consent|6|||
149808639|NCT00797316|540426206|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149808640|NCT00797316|540426207|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
149808641|NCT01126359|540426219|FG000|First Intervention (20-minutes)|Physician Decision|0|||
149808642|NCT01126359|540426220|FG001|First Intervention (20-minutes)|Physician Decision|1|||
149808643|NCT02332655|540426221|FG000|Overall Study|Lack of Efficacy|1|||
149808644|NCT01819467|540427772|FG000|Overall Study|Physician Decision|20|||
149808645|NCT01819467|540427773|FG001|Overall Study|Physician Decision|9|||
149808646|NCT03256526|540427774|FG000|Overall Study|Adverse Event|1|||
149808647|NCT03256526|540427775|FG001|Overall Study|Adverse Event|0|||
149808648|NCT03256526|540427776|FG002|Overall Study|Adverse Event|1|||
149808649|NCT03256526|540427774|FG000|Overall Study|Lost to Follow-up|1|||
149808650|NCT03256526|540427775|FG001|Overall Study|Lost to Follow-up|0|||
149808651|NCT03256526|540427776|FG002|Overall Study|Lost to Follow-up|2|||
149808652|NCT01607398|540427777|FG000|Overall Study|Adverse Event|0|||
149808653|NCT01607398|540427778|FG001|Overall Study|Adverse Event|2|||
149808654|NCT01607398|540427777|FG000|Overall Study|Severe COPD|2|||
149808655|NCT01607398|540427778|FG001|Overall Study|Severe COPD|0|||
149808656|NCT00602979|540427779|FG000|Overall Study|Lost to Follow-up|3|||
149808657|NCT00602979|540427780|FG001|Overall Study|Lost to Follow-up|2|||
149808658|NCT00602979|540427781|FG002|Overall Study|Lost to Follow-up|3|||
149808659|NCT00602979|540427782|FG003|Overall Study|Lost to Follow-up|2|||
149808660|NCT00602979|540427783|FG004|Overall Study|Lost to Follow-up|3|||
149808661|NCT00602979|540427779|FG000|Overall Study|Failed Intubation|0|||
149808662|NCT00602979|540427780|FG001|Overall Study|Failed Intubation|1|||
149808663|NCT00602979|540427781|FG002|Overall Study|Failed Intubation|0|||
149808664|NCT00602979|540427782|FG003|Overall Study|Failed Intubation|1|||
149808665|NCT00602979|540427783|FG004|Overall Study|Failed Intubation|0|||
149808666|NCT01461369|540427786|FG000|Overall Study|Lack of Efficacy|2|||
150149284|NCT00582491|541683248|FG000|Overall Study|Withdrawal by Subject|1|||
149808667|NCT01461369|540427787|FG001|Overall Study|Lack of Efficacy|0|||
150149285|NCT00582491|541683249|FG001|Overall Study|Withdrawal by Subject|0|||
149808668|NCT01461369|540427788|FG002|Overall Study|Lack of Efficacy|6|||
149808669|NCT01461369|540427786|FG000|Overall Study|Lost to Follow-up|0|||
149808670|NCT01461369|540427787|FG001|Overall Study|Lost to Follow-up|0|||
149808671|NCT01461369|540427788|FG002|Overall Study|Lost to Follow-up|3|||
149808672|NCT01461369|540427786|FG000|Overall Study|Adverse Event|9|||
149808673|NCT01461369|540427787|FG001|Overall Study|Adverse Event|12|||
149808674|NCT01461369|540427788|FG002|Overall Study|Adverse Event|4|||
150149286|NCT01425632|541683250|FG000|Overall Study|Adverse Event|0|||
150149287|NCT01425632|541683251|FG001|Overall Study|Adverse Event|1|||
149808675|NCT01461369|540427786|FG000|Overall Study|Protocol Violation|1|||
149918906|NCT01210352|540835248|FG007|Overall Study|Physician Decision|1|||
149808676|NCT01461369|540427787|FG001|Overall Study|Protocol Violation|2|||
149808677|NCT01461369|540427788|FG002|Overall Study|Protocol Violation|2|||
149808678|NCT01461369|540427786|FG000|Overall Study|Withdrawal by Subject|1|||
150149288|NCT01425632|541683252|FG002|Overall Study|Adverse Event|1|||
149808679|NCT01461369|540427787|FG001|Overall Study|Withdrawal by Subject|3|||
149808680|NCT01461369|540427788|FG002|Overall Study|Withdrawal by Subject|2|||
149808681|NCT00734617|540427791|FG000|Overall Study|Adverse Event|4|||
149808682|NCT00734617|540427792|FG001|Overall Study|Adverse Event|7|||
149808683|NCT00734617|540427791|FG000|Overall Study|Withdrawal by Subject|103|||
149808684|NCT00734617|540427792|FG001|Overall Study|Withdrawal by Subject|95|||
149808685|NCT00499252|540427800|FG000|Overall Study|Adverse Event|3|||
149808686|NCT00499252|540427800|FG000|Overall Study|Refused further treatment|2|||
149808687|NCT00499252|540427800|FG000|Overall Study|Ineligible|4|||
149808688|NCT00499252|540427800|FG000|Overall Study|<no further label>|3|||
149808689|NCT01612780|540427815|FG000|Overall Study|Treatment not completed|1|||
149808690|NCT01612780|540427815|FG000|Overall Study|Withdrawal by Subject|5|||
149808691|NCT00556166|540427816|FG000|Overall Study|Withdrawal by Subject|1|||
149808692|NCT03020966|540427819|FG000|Overall Study|Withdrawal by Subject|2|||
149808693|NCT03020966|540427820|FG001|Overall Study|Withdrawal by Subject|0|||
149808694|NCT00962013|540427830|FG000|Overall Study|Did not have surgery|1|||
149808695|NCT00962013|540427830|FG000|Overall Study|Death|8|||
149808696|NCT00962013|540427830|FG000|Overall Study|Lost to Follow-up|12|||
149808697|NCT00962013|540427830|FG000|Overall Study|Unable/Unwilling to return|6|||
149808698|NCT00962013|540427830|FG000|Overall Study|Withdrawal by Subject|8|||
149808699|NCT00962013|540427830|FG000|Overall Study|Removal of study device|3|||
149808700|NCT00962013|540427830|FG000|Overall Study|Site Termination|24|||
149808701|NCT00962013|540427830|FG000|Overall Study|No 5 year evaluation|6|||
149808702|NCT00424632|540427831|FG000|Overall Study|Death|0|||
149808703|NCT00424632|540427832|FG001|Overall Study|Death|0|||
149808704|NCT00424632|540427833|FG002|Overall Study|Death|0|||
149808705|NCT00424632|540427834|FG003|Overall Study|Death|0|||
149808706|NCT00424632|540427835|FG004|Overall Study|Death|0|||
149808707|NCT00424632|540427836|FG005|Overall Study|Death|2|||
149808708|NCT00424632|540427837|FG006|Overall Study|Death|0|||
149808709|NCT00424632|540427838|FG007|Overall Study|Death|0|||
149808710|NCT00424632|540427839|FG008|Overall Study|Death|0|||
149808711|NCT00424632|540427840|FG009|Overall Study|Death|0|||
149808712|NCT00424632|540427831|FG000|Overall Study|Adverse Event|0|||
149808713|NCT00424632|540427832|FG001|Overall Study|Adverse Event|0|||
149808714|NCT00424632|540427833|FG002|Overall Study|Adverse Event|0|||
149808715|NCT00424632|540427834|FG003|Overall Study|Adverse Event|0|||
149808716|NCT00424632|540427835|FG004|Overall Study|Adverse Event|0|||
149808717|NCT00424632|540427836|FG005|Overall Study|Adverse Event|0|||
149808718|NCT00424632|540427837|FG006|Overall Study|Adverse Event|0|||
149808719|NCT00424632|540427838|FG007|Overall Study|Adverse Event|0|||
149808720|NCT00424632|540427839|FG008|Overall Study|Adverse Event|3|||
149808721|NCT00424632|540427840|FG009|Overall Study|Adverse Event|2|||
149808722|NCT00424632|540427831|FG000|Overall Study|Global deterioration of health status|0|||
149808723|NCT00424632|540427832|FG001|Overall Study|Global deterioration of health status|0|||
149808724|NCT00424632|540427833|FG002|Overall Study|Global deterioration of health status|0|||
149808725|NCT00424632|540427834|FG003|Overall Study|Global deterioration of health status|1|||
149808726|NCT00424632|540427835|FG004|Overall Study|Global deterioration of health status|1|||
149808727|NCT00424632|540427836|FG005|Overall Study|Global deterioration of health status|0|||
149808728|NCT00424632|540427837|FG006|Overall Study|Global deterioration of health status|0|||
149808729|NCT00424632|540427838|FG007|Overall Study|Global deterioration of health status|0|||
149808730|NCT00424632|540427839|FG008|Overall Study|Global deterioration of health status|0|||
149808731|NCT00424632|540427840|FG009|Overall Study|Global deterioration of health status|0|||
149808732|NCT00424632|540427831|FG000|Overall Study|Objective progression or relapse|1|||
149808733|NCT00424632|540427832|FG001|Overall Study|Objective progression or relapse|1|||
149808734|NCT00424632|540427833|FG002|Overall Study|Objective progression or relapse|1|||
149808735|NCT00424632|540427834|FG003|Overall Study|Objective progression or relapse|2|||
149808736|NCT00424632|540427835|FG004|Overall Study|Objective progression or relapse|2|||
149808737|NCT00424632|540427836|FG005|Overall Study|Objective progression or relapse|13|||
149808738|NCT00424632|540427837|FG006|Overall Study|Objective progression or relapse|7|||
149808739|NCT00424632|540427838|FG007|Overall Study|Objective progression or relapse|3|||
149808740|NCT00424632|540427839|FG008|Overall Study|Objective progression or relapse|12|||
149808741|NCT00424632|540427840|FG009|Overall Study|Objective progression or relapse|4|||
149808742|NCT00424632|540427831|FG000|Overall Study|Other|0|||
149808743|NCT00424632|540427832|FG001|Overall Study|Other|0|||
149808744|NCT00424632|540427833|FG002|Overall Study|Other|0|||
149808745|NCT00424632|540427834|FG003|Overall Study|Other|1|||
149808746|NCT00424632|540427835|FG004|Overall Study|Other|0|||
149808747|NCT00424632|540427836|FG005|Overall Study|Other|0|||
149808748|NCT00424632|540427837|FG006|Overall Study|Other|0|||
149808749|NCT00424632|540427838|FG007|Overall Study|Other|0|||
149808750|NCT00424632|540427839|FG008|Overall Study|Other|1|||
149808751|NCT00424632|540427840|FG009|Overall Study|Other|0|||
149808752|NCT02628418|540427841|FG000|Overall Study|Lost to Follow-up|1|||
149808753|NCT02628418|540427842|FG001|Overall Study|Lost to Follow-up|2|||
149808754|NCT03159611|540427848|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
149808755|NCT03159611|540427849|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
149808756|NCT03159611|540427848|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
149808757|NCT03159611|540427849|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
149808758|NCT03159611|540427848|FG000|Overall Study|Protocol Violation|7|||
149808759|NCT03159611|540427849|FG001|Overall Study|Protocol Violation|4|||
149808760|NCT03159611|540427848|FG000|Overall Study|Adverse Event|1|||
149808761|NCT03159611|540427849|FG001|Overall Study|Adverse Event|0|||
149808762|NCT03159611|540427848|FG000|Overall Study|Withdrawal by Subject|1|||
149808763|NCT03159611|540427849|FG001|Overall Study|Withdrawal by Subject|1|||
149808764|NCT03159611|540427848|FG000|Overall Study|Non-compliance with protocol requirement|3|||
149808765|NCT03159611|540427849|FG001|Overall Study|Non-compliance with protocol requirement|2|||
149808766|NCT03159611|540427848|FG000|Overall Study|Inability to perform procedures|1|||
149808767|NCT03159611|540427849|FG001|Overall Study|Inability to perform procedures|0|||
149808768|NCT02072174|540427852|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
149808769|NCT02072174|540427853|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
149808770|NCT02072174|540427852|FG000|Overall Study|Protocol Violation|16|||
149808771|NCT02072174|540427853|FG001|Overall Study|Protocol Violation|23|||
149808772|NCT02072174|540427852|FG000|Overall Study|Physician Decision|0|||
149808773|NCT02072174|540427853|FG001|Overall Study|Physician Decision|1|||
149808774|NCT02072174|540427852|FG000|Overall Study|Non-compliance with protocol requirement|2|||
149808775|NCT02072174|540427853|FG001|Overall Study|Non-compliance with protocol requirement|0|||
149808776|NCT05674721|540427854|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
149808777|NCT05674721|540427855|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
149808778|NCT05674721|540427854|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
149808779|NCT05674721|540427855|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
149808780|NCT03506425|540427866|FG000|Overall Study|Adverse Event|1|||
149808781|NCT03506425|540427867|FG001|Overall Study|Adverse Event|3|||
149808782|NCT03506425|540427868|FG002|Overall Study|Adverse Event|0|||
149808783|NCT03506425|540427866|FG000|Overall Study|Death|1|||
149808784|NCT03506425|540427867|FG001|Overall Study|Death|0|||
149808785|NCT03506425|540427868|FG002|Overall Study|Death|0|||
149808786|NCT03506425|540427866|FG000|Overall Study|Withdrawal by Subject|0|||
149808787|NCT03506425|540427867|FG001|Overall Study|Withdrawal by Subject|0|||
149808788|NCT03506425|540427868|FG002|Overall Study|Withdrawal by Subject|1|||
149808789|NCT00440193|540427872|FG000|Treatment Period|Adverse Event|74|||
149808790|NCT00440193|540427873|FG001|Treatment Period|Adverse Event|67|||
149808791|NCT00440193|540427872|FG000|Treatment Period|Death|19|||
149808792|NCT00440193|540427873|FG001|Treatment Period|Death|22|||
149808793|NCT00440193|540427872|FG000|Treatment Period|Lack of Efficacy|0|||
149808794|NCT00440193|540427873|FG001|Treatment Period|Lack of Efficacy|1|||
149808795|NCT00440193|540427872|FG000|Treatment Period|Lost to Follow-up|12|||
149808796|NCT00440193|540427873|FG001|Treatment Period|Lost to Follow-up|18|||
149808797|NCT00440193|540427872|FG000|Treatment Period|Physician Decision|3|||
149808798|NCT00440193|540427873|FG001|Treatment Period|Physician Decision|6|||
149808799|NCT00440193|540427872|FG000|Treatment Period|Protocol Violation|16|||
149808800|NCT00440193|540427873|FG001|Treatment Period|Protocol Violation|19|||
149808801|NCT00440193|540427872|FG000|Treatment Period|Withdrawal by Subject|36|||
149808802|NCT00440193|540427873|FG001|Treatment Period|Withdrawal by Subject|77|||
149808803|NCT00440193|540427872|FG000|Treatment Period|Clinical endpoint reached|28|||
149808804|NCT00440193|540427873|FG001|Treatment Period|Clinical endpoint reached|25|||
149808805|NCT00440193|540427872|FG000|Treatment Period|Study terminated by sponsor|102|||
149808806|NCT00440193|540427873|FG001|Treatment Period|Study terminated by sponsor|94|||
149808807|NCT00440193|540427872|FG000|Treatment Period|Protocol driven decision point|2|||
149808808|NCT00440193|540427873|FG001|Treatment Period|Protocol driven decision point|2|||
149808809|NCT00440193|540427872|FG000|Treatment Period|Switch to commercial drug|0|||
149808810|NCT00440193|540427873|FG001|Treatment Period|Switch to commercial drug|2|||
149808811|NCT00440193|540427872|FG000|Treatment Period|Technical problems|1|||
149808812|NCT00440193|540427873|FG001|Treatment Period|Technical problems|1|||
150149289|NCT01425632|541683250|FG000|Overall Study|Physician Decision|1|||
150149290|NCT01425632|541683251|FG001|Overall Study|Physician Decision|0|||
150149291|NCT01425632|541683252|FG002|Overall Study|Physician Decision|0|||
150149292|NCT01425632|541683250|FG000|Overall Study|Protocol Violation|0|||
150149293|NCT01425632|541683251|FG001|Overall Study|Protocol Violation|0|||
150149294|NCT01425632|541683252|FG002|Overall Study|Protocol Violation|2|||
149808813|NCT00440193|540427872|FG000|Treatment Period|Participant convenience|5|||
149808814|NCT00440193|540427873|FG001|Treatment Period|Participant convenience|2|||
149808815|NCT00440193|540427872|FG000|Treatment Period|Participant did not receive treatment|7|||
149808816|NCT00440193|540427873|FG001|Treatment Period|Participant did not receive treatment|13|||
149808817|NCT00440193|540427872|FG000|Treatment Period|Site closed by investigator|0|||
149808818|NCT00440193|540427873|FG001|Treatment Period|Site closed by investigator|2|||
149808819|NCT00440193|540427872|FG000|Observational Period|Adverse Event|2|||
149808820|NCT00440193|540427873|FG001|Observational Period|Adverse Event|2|||
149808821|NCT00440193|540427872|FG000|Observational Period|Death|15|||
149808822|NCT00440193|540427873|FG001|Observational Period|Death|20|||
149808823|NCT00440193|540427872|FG000|Observational Period|Lost to Follow-up|12|||
150149295|NCT01425632|541683250|FG000|Overall Study|Withdrawal by Subject|0|||
149808824|NCT00440193|540427873|FG001|Observational Period|Lost to Follow-up|8|||
149808825|NCT00440193|540427872|FG000|Observational Period|Protocol Violation|1|||
149808826|NCT00440193|540427873|FG001|Observational Period|Protocol Violation|0|||
149808827|NCT00440193|540427872|FG000|Observational Period|Withdrawal by Subject|11|||
149808828|NCT00440193|540427873|FG001|Observational Period|Withdrawal by Subject|8|||
149808829|NCT00440193|540427872|FG000|Observational Period|Physician Decision|1|||
149808830|NCT00440193|540427873|FG001|Observational Period|Physician Decision|0|||
149808831|NCT00440193|540427872|FG000|Observational Period|Clinical endpoint reached|1|||
149808832|NCT00440193|540427873|FG001|Observational Period|Clinical endpoint reached|0|||
149808833|NCT00440193|540427872|FG000|Observational Period|Participant convenience|2|||
149808834|NCT00440193|540427873|FG001|Observational Period|Participant convenience|0|||
149808835|NCT00834366|540427874|FG000|Treatment Period 1|Adverse Event|1|||
149808836|NCT00834366|540427875|FG001|Treatment Period 1|Adverse Event|1|||
149808837|NCT03014570|540427878|FG000|Overall Study|COVID-19 Restrictions|38|||
149808838|NCT03014570|540427879|FG001|Overall Study|COVID-19 Restrictions|24|||
149808839|NCT03014570|540427878|FG000|Overall Study|Death|70|||
149808840|NCT03014570|540427879|FG001|Overall Study|Death|79|||
149808841|NCT03014570|540427878|FG000|Overall Study|Transfer from facility|11|||
149808842|NCT03014570|540427879|FG001|Overall Study|Transfer from facility|14|||
149808843|NCT03014570|540427878|FG000|Overall Study|Hospitalized|5|||
149808844|NCT03014570|540427879|FG001|Overall Study|Hospitalized|3|||
149808845|NCT03014570|540427878|FG000|Overall Study|Transfer within facility|1|||
149808846|NCT03014570|540427879|FG001|Overall Study|Transfer within facility|0|||
149808847|NCT03014570|540427878|FG000|Overall Study|Site refusal|0|||
149808848|NCT03014570|540427879|FG001|Overall Study|Site refusal|11|||
149808849|NCT00090259|540427880|FG000|Overall Study|Lost to Follow-up|30|||
149808850|NCT00090259|540427881|FG001|Overall Study|Lost to Follow-up|26|||
149808851|NCT00090259|540427880|FG000|Overall Study|Withdrawal by Subject|21|||
149808852|NCT00090259|540427881|FG001|Overall Study|Withdrawal by Subject|15|||
149808853|NCT00090259|540427880|FG000|Overall Study|Investigator site closed|11|||
149808854|NCT00090259|540427881|FG001|Overall Study|Investigator site closed|7|||
149808855|NCT02380248|540427886|FG000|Overall Study|Lost to Follow-up|11|||
149808856|NCT02380248|540427886|FG000|Overall Study|Withdrawal by Subject|3|||
149808857|NCT01275170|540427889|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
149808858|NCT01275170|540427890|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808859|NCT01275170|540427891|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808860|NCT01275170|540427892|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808861|NCT01275170|540427893|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808862|NCT01275170|540427894|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808863|NCT01275170|540427895|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808864|NCT01275170|540427896|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
149808865|NCT00865306|540427897|FG000|Controlled Trial|Lost to Follow-up|1|||
149808866|NCT00865306|540427898|FG001|Controlled Trial|Lost to Follow-up|1|||
149808867|NCT00865306|540427897|FG000|Controlled Trial|Difficulty commuting|2|||
149808868|NCT00865306|540427898|FG001|Controlled Trial|Difficulty commuting|0|||
149808869|NCT00865306|540427897|FG000|Controlled Trial|Improved btw baseline and first session|1|||
149808870|NCT00865306|540427898|FG001|Controlled Trial|Improved btw baseline and first session|0|||
149808871|NCT00865306|540427897|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
149808872|NCT00865306|540427898|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
149808873|NCT00865306|540427897|FG000|Controlled Trial|Withdrawal by Subject|0|||
149808874|NCT00865306|540427898|FG001|Controlled Trial|Withdrawal by Subject|1|||
149808875|NCT02704130|540427900|FG000|Overall Study|Physician Decision|5|||
149808876|NCT02704130|540427901|FG001|Overall Study|Physician Decision|3|||
149808877|NCT01306968|540427906|FG000|Overall Study|Lost to Follow-up|1|||
149808878|NCT01306968|540427907|FG001|Overall Study|Lost to Follow-up|1|||
149808879|NCT01306968|540427908|FG002|Overall Study|Lost to Follow-up|0|||
149808880|NCT01306968|540427909|FG003|Overall Study|Lost to Follow-up|0|||
149808881|NCT01306968|540427906|FG000|Overall Study|Physician Decision|0|||
149808882|NCT01306968|540427907|FG001|Overall Study|Physician Decision|1|||
149808883|NCT01306968|540427908|FG002|Overall Study|Physician Decision|0|||
149808884|NCT01306968|540427909|FG003|Overall Study|Physician Decision|0|||
149808885|NCT01306968|540427906|FG000|Overall Study|Relocated and left active duty|0|||
150149296|NCT01425632|541683251|FG001|Overall Study|Withdrawal by Subject|0|||
149808886|NCT01306968|540427907|FG001|Overall Study|Relocated and left active duty|1|||
149808887|NCT01306968|540427908|FG002|Overall Study|Relocated and left active duty|1|||
149808888|NCT01306968|540427909|FG003|Overall Study|Relocated and left active duty|1|||
149808889|NCT01306968|540427906|FG000|Overall Study|Withdrew - time commitment|0|||
149808890|NCT01306968|540427907|FG001|Overall Study|Withdrew - time commitment|0|||
149808891|NCT01306968|540427908|FG002|Overall Study|Withdrew - time commitment|0|||
149808892|NCT01306968|540427909|FG003|Overall Study|Withdrew - time commitment|2|||
149808893|NCT01306968|540427906|FG000|Overall Study|Withdrew over privacy concerns|0|||
149808894|NCT01306968|540427907|FG001|Overall Study|Withdrew over privacy concerns|0|||
149808895|NCT01306968|540427908|FG002|Overall Study|Withdrew over privacy concerns|0|||
149808896|NCT01306968|540427909|FG003|Overall Study|Withdrew over privacy concerns|1|||
149808897|NCT01381068|540427910|FG000|Overall Study|Death|1|||
149808898|NCT01381068|540427911|FG001|Overall Study|Death|0|||
149808899|NCT00690573|540427915|FG000|Overall Study|Lack of Efficacy|8|||
149808900|NCT00690573|540427915|FG000|Overall Study|Withdrawal by Subject|1|||
149808901|NCT00902486|540427918|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
149808902|NCT00902486|540427919|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
149808903|NCT00902486|540427920|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
149808904|NCT00902486|540427921|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
149808905|NCT00902486|540427922|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
149808906|NCT00902486|540427923|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
149808907|NCT00902486|540427918|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
149808908|NCT00902486|540427919|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
149808909|NCT00902486|540427920|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
149808910|NCT00902486|540427921|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
149808911|NCT00902486|540427922|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
149808912|NCT00902486|540427923|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
149808913|NCT00902486|540427918|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
149808914|NCT00902486|540427919|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
149808915|NCT00902486|540427920|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
149808916|NCT00902486|540427921|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
149808917|NCT00902486|540427922|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
149808918|NCT00902486|540427923|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
149808919|NCT00902486|540427918|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
149808920|NCT00902486|540427919|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
149808921|NCT00902486|540427920|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
149808922|NCT00902486|540427921|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
149808923|NCT00902486|540427922|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
149808924|NCT00902486|540427923|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
149808925|NCT00902486|540427918|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
149808926|NCT00902486|540427919|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
149808927|NCT00902486|540427920|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
149808928|NCT00902486|540427921|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
149808929|NCT00902486|540427922|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
149808930|NCT00902486|540427923|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
149808931|NCT00902486|540427918|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
149808932|NCT00902486|540427919|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
149808933|NCT00902486|540427920|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
149808934|NCT00902486|540427921|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
149808935|NCT00902486|540427922|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
149808936|NCT00902486|540427923|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
149808937|NCT00902486|540427918|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
149808938|NCT00902486|540427919|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
149808939|NCT00902486|540427920|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
149808940|NCT00902486|540427921|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
149808941|NCT00902486|540427922|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
149808942|NCT00902486|540427923|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
149808943|NCT00902486|540427918|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
149808944|NCT00902486|540427919|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
149808945|NCT00902486|540427920|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
149808946|NCT00902486|540427921|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
149808947|NCT00902486|540427922|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
149808948|NCT00902486|540427923|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
149808949|NCT00902486|540427918|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
149808950|NCT00902486|540427919|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
149808951|NCT00902486|540427920|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
149808952|NCT00902486|540427921|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
149808953|NCT00902486|540427922|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
149808954|NCT00902486|540427923|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
149808955|NCT00902486|540427918|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
149808956|NCT00902486|540427919|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
149808957|NCT00902486|540427920|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
149808958|NCT00902486|540427921|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
149808959|NCT00902486|540427922|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
149808960|NCT00902486|540427923|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
150149297|NCT01425632|541683252|FG002|Overall Study|Withdrawal by Subject|1|||
149808961|NCT00902486|540427918|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
149808962|NCT00902486|540427919|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
149808963|NCT00902486|540427920|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
149808964|NCT00902486|540427921|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
149808965|NCT00902486|540427922|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
149808966|NCT00902486|540427923|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
149808967|NCT01298661|540427924|FG000|Overall Study|Withdrawal by Subject|2|||
149808968|NCT01298661|540427925|FG001|Overall Study|Withdrawal by Subject|0|||
149808969|NCT01298661|540427926|FG002|Overall Study|Withdrawal by Subject|2|||
149808970|NCT01563029|540429089|FG000|Overall Study|Adverse Event|1|||
149808971|NCT01563029|540429090|FG001|Overall Study|Adverse Event|0|||
149808972|NCT01563029|540429091|FG002|Overall Study|Adverse Event|1|||
149808973|NCT01563029|540429092|FG003|Overall Study|Adverse Event|2|||
149808974|NCT01563029|540429093|FG004|Overall Study|Adverse Event|1|||
149808975|NCT01563029|540429089|FG000|Overall Study|Lack of Efficacy|42|||
149808976|NCT01563029|540429090|FG001|Overall Study|Lack of Efficacy|16|||
149808977|NCT01563029|540429091|FG002|Overall Study|Lack of Efficacy|23|||
149808978|NCT01563029|540429092|FG003|Overall Study|Lack of Efficacy|21|||
149808979|NCT01563029|540429093|FG004|Overall Study|Lack of Efficacy|19|||
149808980|NCT01563029|540429089|FG000|Overall Study|Protocol Violation|1|||
149808981|NCT01563029|540429090|FG001|Overall Study|Protocol Violation|2|||
149808982|NCT01563029|540429091|FG002|Overall Study|Protocol Violation|3|||
149808983|NCT01563029|540429092|FG003|Overall Study|Protocol Violation|1|||
149808984|NCT01563029|540429093|FG004|Overall Study|Protocol Violation|3|||
149808985|NCT01563029|540429089|FG000|Overall Study|Protocol defined stopping criteria|1|||
149808986|NCT01563029|540429090|FG001|Overall Study|Protocol defined stopping criteria|0|||
149808987|NCT01563029|540429091|FG002|Overall Study|Protocol defined stopping criteria|0|||
149808988|NCT01563029|540429092|FG003|Overall Study|Protocol defined stopping criteria|0|||
149808989|NCT01563029|540429093|FG004|Overall Study|Protocol defined stopping criteria|0|||
149808990|NCT01563029|540429089|FG000|Overall Study|Lost to Follow-up|1|||
149808991|NCT01563029|540429090|FG001|Overall Study|Lost to Follow-up|0|||
149808992|NCT01563029|540429091|FG002|Overall Study|Lost to Follow-up|1|||
149808993|NCT01563029|540429092|FG003|Overall Study|Lost to Follow-up|1|||
149808994|NCT01563029|540429093|FG004|Overall Study|Lost to Follow-up|1|||
149808995|NCT01563029|540429089|FG000|Overall Study|Physician Decision|3|||
149808996|NCT01563029|540429090|FG001|Overall Study|Physician Decision|5|||
149808997|NCT01563029|540429091|FG002|Overall Study|Physician Decision|2|||
149808998|NCT01563029|540429092|FG003|Overall Study|Physician Decision|4|||
149808999|NCT01563029|540429093|FG004|Overall Study|Physician Decision|2|||
149809000|NCT01563029|540429089|FG000|Overall Study|Withdrawal by Subject|4|||
149809001|NCT01563029|540429090|FG001|Overall Study|Withdrawal by Subject|1|||
149809002|NCT01563029|540429091|FG002|Overall Study|Withdrawal by Subject|3|||
149809003|NCT01563029|540429092|FG003|Overall Study|Withdrawal by Subject|4|||
149809004|NCT01563029|540429093|FG004|Overall Study|Withdrawal by Subject|3|||
149809005|NCT01569594|540429094|FG000|Overall Study|Physician Decision|4|||
149809006|NCT01569594|540429094|FG000|Overall Study|Death|13|||
149809007|NCT01569594|540429094|FG000|Overall Study|Lost to Follow-up|22|||
149809008|NCT01569594|540429094|FG000|Overall Study|Adverse Event|2|||
149809009|NCT01569594|540429094|FG000|Overall Study|Withdrawal by Subject|13|||
149809010|NCT01569594|540429094|FG000|Overall Study|Other|4|||
149809011|NCT01569594|540429094|FG000|Overall Study|No ECM used|9|||
149809012|NCT03069365|540429095|FG000|Overall Study|Adverse Event|1|||
149809013|NCT02861534|540429096|FG000|Overall Study|Death|541|||
149809014|NCT02861534|540429097|FG001|Overall Study|Death|552|||
149809015|NCT02861534|540429096|FG000|Overall Study|Lost to Follow-up|14|||
149809016|NCT02861534|540429097|FG001|Overall Study|Lost to Follow-up|14|||
149809017|NCT02861534|540429096|FG000|Overall Study|Site Terminated by Sponsor|4|||
149809018|NCT02861534|540429097|FG001|Overall Study|Site Terminated by Sponsor|3|||
149809019|NCT02861534|540429096|FG000|Overall Study|Withdrawal by Subject|15|||
149809020|NCT02861534|540429097|FG001|Overall Study|Withdrawal by Subject|18|||
149809021|NCT02780115|540429098|FG000|Overall Study|Withdrawal by Subject|0|||
149809022|NCT02780115|540429099|FG001|Overall Study|Withdrawal by Subject|1|||
149918907|NCT01210352|540835249|FG008|Overall Study|Physician Decision|2|||
149918908|NCT01210352|540835241|FG000|Overall Study|Withdrawal by Subject|0|||
149918909|NCT01210352|540835242|FG001|Overall Study|Withdrawal by Subject|0|||
149918910|NCT01210352|540835243|FG002|Overall Study|Withdrawal by Subject|1|||
149918911|NCT01210352|540835244|FG003|Overall Study|Withdrawal by Subject|0|||
149918912|NCT01210352|540835245|FG004|Overall Study|Withdrawal by Subject|0|||
149918913|NCT01210352|540835246|FG005|Overall Study|Withdrawal by Subject|0|||
149918914|NCT01210352|540835247|FG006|Overall Study|Withdrawal by Subject|1|||
149918915|NCT01210352|540835248|FG007|Overall Study|Withdrawal by Subject|0|||
149918916|NCT01210352|540835249|FG008|Overall Study|Withdrawal by Subject|1|||
149918917|NCT01210352|540835241|FG000|Overall Study|Patient Discharged Early|0|||
149918918|NCT01210352|540835242|FG001|Overall Study|Patient Discharged Early|0|||
149918919|NCT01210352|540835243|FG002|Overall Study|Patient Discharged Early|1|||
149809023|NCT02780115|540429100|FG002|Overall Study|Withdrawal by Subject|1|||
149809024|NCT02780115|540429101|FG003|Overall Study|Withdrawal by Subject|0|||
150149298|NCT00406419|541683253|FG000|Overall Study|Death|3|||
150149299|NCT00406419|541683254|FG001|Overall Study|Death|1|||
150149300|NCT00406419|541683255|FG002|Overall Study|Death|4|||
150149301|NCT00406419|541683253|FG000|Overall Study|Protocol Violation|6|||
150149302|NCT00406419|541683254|FG001|Overall Study|Protocol Violation|2|||
150149303|NCT00406419|541683255|FG002|Overall Study|Protocol Violation|5|||
150149304|NCT00406419|541683253|FG000|Overall Study|Study Terminated by Sponsor|260|||
150149305|NCT00406419|541683254|FG001|Overall Study|Study Terminated by Sponsor|288|||
149809025|NCT02780115|540429102|FG004|Overall Study|Withdrawal by Subject|0|||
149809026|NCT02780115|540429098|FG000|Overall Study|Adverse Event|0|||
149809027|NCT02780115|540429099|FG001|Overall Study|Adverse Event|0|||
149809028|NCT02780115|540429100|FG002|Overall Study|Adverse Event|0|||
149809029|NCT02780115|540429101|FG003|Overall Study|Adverse Event|1|||
149809030|NCT02780115|540429102|FG004|Overall Study|Adverse Event|1|||
149809031|NCT02086968|540429106|FG000|Overall Study|Adverse Event|1|||
149809032|NCT02086968|540429107|FG001|Overall Study|Adverse Event|5|||
149809033|NCT02086968|540429106|FG000|Overall Study|Lost to Follow-up|2|||
150149306|NCT00406419|541683255|FG002|Overall Study|Study Terminated by Sponsor|282|||
150149307|NCT00406419|541683253|FG000|Overall Study|Withdrawal by Subject|17|||
150149308|NCT00406419|541683254|FG001|Overall Study|Withdrawal by Subject|24|||
150149309|NCT00406419|541683255|FG002|Overall Study|Withdrawal by Subject|26|||
149809034|NCT02086968|540429107|FG001|Overall Study|Lost to Follow-up|3|||
149809035|NCT02086968|540429106|FG000|Overall Study|Study drug received outside protocol|0|||
149809036|NCT02086968|540429107|FG001|Overall Study|Study drug received outside protocol|1|||
149809037|NCT02086968|540429106|FG000|Overall Study|Physician Decision|4|||
149809038|NCT02086968|540429107|FG001|Overall Study|Physician Decision|0|||
149809039|NCT02086968|540429106|FG000|Overall Study|Withdrawal by Subject|1|||
149809040|NCT02086968|540429107|FG001|Overall Study|Withdrawal by Subject|4|||
149809041|NCT03387735|540429111|FG000|Overall Study|Lost to Follow-up|4|||
149809042|NCT03387735|540429112|FG001|Overall Study|Lost to Follow-up|8|||
149809043|NCT03387735|540429111|FG000|Overall Study|Death|4|||
149809044|NCT03387735|540429112|FG001|Overall Study|Death|8|||
149809045|NCT00537056|540429113|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
149809046|NCT01257737|540429114|FG000|Overall Study|Lost to Follow-up|1|||
149809047|NCT01257737|540429115|FG001|Overall Study|Lost to Follow-up|2|||
149809048|NCT01257737|540429114|FG000|Overall Study|Liver transplant|1|||
149809049|NCT01257737|540429115|FG001|Overall Study|Liver transplant|0|||
149809050|NCT01257737|540429114|FG000|Overall Study|Relocation out of the country|0|||
149809051|NCT01257737|540429115|FG001|Overall Study|Relocation out of the country|1|||
149809052|NCT01257737|540429114|FG000|Overall Study|Withdrew from study|0|||
149809053|NCT01257737|540429115|FG001|Overall Study|Withdrew from study|1|||
149809054|NCT02985515|540429116|FG000|Olfaction Testing|Lost to Follow-up|0|||
149809055|NCT02985515|540429117|FG001|Olfaction Testing|Lost to Follow-up|5|||
149809056|NCT02985515|540429116|FG000|Olfaction Testing|Protocol Violation|0|||
149809057|NCT02985515|540429117|FG001|Olfaction Testing|Protocol Violation|3|||
149809058|NCT03359473|540429118|FG000|Overall Study|Adverse Event|0|||
149809059|NCT03359473|540429119|FG001|Overall Study|Adverse Event|2|||
149809060|NCT03359473|540429120|FG002|Overall Study|Adverse Event|5|||
149809061|NCT03359473|540429121|FG003|Overall Study|Adverse Event|3|||
149809062|NCT03359473|540429118|FG000|Overall Study|Lost to Follow-up|0|||
149809063|NCT03359473|540429119|FG001|Overall Study|Lost to Follow-up|1|||
150149310|NCT00406419|541683253|FG000|Overall Study|Lack of Efficacy|12|||
150149311|NCT00406419|541683254|FG001|Overall Study|Lack of Efficacy|1|||
150149312|NCT00406419|541683255|FG002|Overall Study|Lack of Efficacy|6|||
150149313|NCT00406419|541683253|FG000|Overall Study|Non-Compliance with Study Drug|5|||
150149314|NCT00406419|541683254|FG001|Overall Study|Non-Compliance with Study Drug|6|||
150149315|NCT00406419|541683255|FG002|Overall Study|Non-Compliance with Study Drug|3|||
149809064|NCT03359473|540429120|FG002|Overall Study|Lost to Follow-up|0|||
149809065|NCT03359473|540429121|FG003|Overall Study|Lost to Follow-up|0|||
149809066|NCT03359473|540429118|FG000|Overall Study|Physician Decision|0|||
149809067|NCT03359473|540429119|FG001|Overall Study|Physician Decision|1|||
149809068|NCT03359473|540429120|FG002|Overall Study|Physician Decision|0|||
149809069|NCT03359473|540429121|FG003|Overall Study|Physician Decision|1|||
149809070|NCT03359473|540429118|FG000|Overall Study|Withdrawal by Subject|1|||
149809071|NCT03359473|540429119|FG001|Overall Study|Withdrawal by Subject|2|||
150149316|NCT00406419|541683253|FG000|Overall Study|Adverse Event|10|||
150149317|NCT00406419|541683254|FG001|Overall Study|Adverse Event|12|||
149809072|NCT03359473|540429120|FG002|Overall Study|Withdrawal by Subject|1|||
149809073|NCT03359473|540429121|FG003|Overall Study|Withdrawal by Subject|0|||
149809074|NCT03359473|540429118|FG000|Overall Study|Protocol-defined stopping criteria|1|||
149809075|NCT03359473|540429119|FG001|Overall Study|Protocol-defined stopping criteria|0|||
149809076|NCT03359473|540429120|FG002|Overall Study|Protocol-defined stopping criteria|0|||
149809077|NCT03359473|540429121|FG003|Overall Study|Protocol-defined stopping criteria|1|||
149809078|NCT05302414|540429122|FG000|Pretest to Posttest|Lost to Follow-up|12|||
149809079|NCT05302414|540429123|FG001|Pretest to Posttest|Lost to Follow-up|8|||
149809080|NCT05302414|540429124|FG002|Pretest to Posttest|Lost to Follow-up|8|||
150149318|NCT00406419|541683255|FG002|Overall Study|Adverse Event|16|||
150149319|NCT00406419|541683253|FG000|Overall Study|Lost to Follow-up|11|||
149809081|NCT05302414|540429122|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
149809082|NCT05302414|540429123|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
149809083|NCT05302414|540429124|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
149809084|NCT00742859|540429125|FG000|Overall Study|Adverse Event|5|||
149809085|NCT00742859|540429126|FG001|Overall Study|Adverse Event|6|||
149809086|NCT00742859|540429127|FG002|Overall Study|Adverse Event|3|||
149809087|NCT00742859|540429128|FG003|Overall Study|Adverse Event|1|||
149809088|NCT00742859|540429125|FG000|Overall Study|Death|1|||
149809089|NCT00742859|540429126|FG001|Overall Study|Death|0|||
149809090|NCT00742859|540429127|FG002|Overall Study|Death|0|||
149809091|NCT00742859|540429128|FG003|Overall Study|Death|1|||
149809092|NCT00742859|540429125|FG000|Overall Study|Physician Decision|1|||
149809093|NCT00742859|540429126|FG001|Overall Study|Physician Decision|2|||
149809094|NCT00742859|540429127|FG002|Overall Study|Physician Decision|0|||
149809095|NCT00742859|540429128|FG003|Overall Study|Physician Decision|0|||
149809096|NCT00742859|540429125|FG000|Overall Study|Withdrawal by Subject|4|||
149809097|NCT00742859|540429126|FG001|Overall Study|Withdrawal by Subject|2|||
149809098|NCT00742859|540429127|FG002|Overall Study|Withdrawal by Subject|4|||
149809099|NCT00742859|540429128|FG003|Overall Study|Withdrawal by Subject|1|||
149809100|NCT00742859|540429125|FG000|Overall Study|Endpoint|0|||
149809101|NCT00742859|540429126|FG001|Overall Study|Endpoint|1|||
149809102|NCT00742859|540429127|FG002|Overall Study|Endpoint|1|||
149809103|NCT00742859|540429128|FG003|Overall Study|Endpoint|2|||
149809104|NCT00742859|540429125|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
149809105|NCT00742859|540429126|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
149809106|NCT00742859|540429127|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
149809107|NCT00742859|540429128|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
149809108|NCT00742859|540429125|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
149809109|NCT00742859|540429126|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
149809110|NCT00742859|540429127|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
149809111|NCT00742859|540429128|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
149809112|NCT00742859|540429125|FG000|Overall Study|Sponsor request patient out of town|0|||
149809113|NCT00742859|540429126|FG001|Overall Study|Sponsor request patient out of town|0|||
149809114|NCT00742859|540429127|FG002|Overall Study|Sponsor request patient out of town|1|||
149809115|NCT00742859|540429128|FG003|Overall Study|Sponsor request patient out of town|1|||
149809116|NCT00742859|540429125|FG000|Overall Study|Site error|0|||
149809117|NCT00742859|540429126|FG001|Overall Study|Site error|0|||
149809118|NCT00742859|540429127|FG002|Overall Study|Site error|1|||
149809119|NCT00742859|540429128|FG003|Overall Study|Site error|1|||
149809120|NCT00445458|540429132|FG000|Overall Study|Disease Progression|3|||
149809121|NCT00445458|540429133|FG001|Overall Study|Disease Progression|4|||
149809122|NCT00445458|540429134|FG002|Overall Study|Disease Progression|54|||
149809123|NCT00445458|540429135|FG003|Overall Study|Disease Progression|27|||
149809124|NCT00445458|540429132|FG000|Overall Study|Withdrawal by Subject|0|||
149809125|NCT00445458|540429133|FG001|Overall Study|Withdrawal by Subject|0|||
149809126|NCT00445458|540429134|FG002|Overall Study|Withdrawal by Subject|7|||
149809127|NCT00445458|540429135|FG003|Overall Study|Withdrawal by Subject|0|||
149809128|NCT00445458|540429132|FG000|Overall Study|Adverse Event|0|||
149809129|NCT00445458|540429133|FG001|Overall Study|Adverse Event|0|||
149809130|NCT00445458|540429134|FG002|Overall Study|Adverse Event|3|||
149809131|NCT00445458|540429135|FG003|Overall Study|Adverse Event|0|||
149809132|NCT00445458|540429132|FG000|Overall Study|Death|0|||
149809133|NCT00445458|540429133|FG001|Overall Study|Death|1|||
149809134|NCT00445458|540429134|FG002|Overall Study|Death|2|||
149809135|NCT00445458|540429135|FG003|Overall Study|Death|0|||
149809136|NCT00445458|540429132|FG000|Overall Study|Physician Decision|0|||
149809137|NCT00445458|540429133|FG001|Overall Study|Physician Decision|0|||
149918920|NCT01210352|540835244|FG003|Overall Study|Patient Discharged Early|0|||
150149320|NCT00406419|541683254|FG001|Overall Study|Lost to Follow-up|10|||
149809138|NCT00445458|540429134|FG002|Overall Study|Physician Decision|1|||
149809139|NCT00445458|540429135|FG003|Overall Study|Physician Decision|1|||
149809140|NCT00445458|540429132|FG000|Overall Study|Surgery|0|||
149809141|NCT00445458|540429133|FG001|Overall Study|Surgery|0|||
149809142|NCT00445458|540429134|FG002|Overall Study|Surgery|1|||
149809143|NCT00445458|540429135|FG003|Overall Study|Surgery|0|||
149809144|NCT01071083|540429136|FG000|Overall Study|Adverse Event|1|||
149809145|NCT01071083|540429137|FG001|Overall Study|Adverse Event|0|||
149809146|NCT01071083|540429138|FG002|Overall Study|Adverse Event|1|||
149809147|NCT01071083|540429139|FG003|Overall Study|Adverse Event|0|||
149809148|NCT01071083|540429140|FG004|Overall Study|Adverse Event|1|||
149918921|NCT01210352|540835245|FG004|Overall Study|Patient Discharged Early|0|||
150149321|NCT00406419|541683255|FG002|Overall Study|Lost to Follow-up|5|||
149809149|NCT01071083|540429136|FG000|Overall Study|Withdrawal by Subject|3|||
149809150|NCT01071083|540429137|FG001|Overall Study|Withdrawal by Subject|0|||
149809151|NCT01071083|540429138|FG002|Overall Study|Withdrawal by Subject|2|||
149809152|NCT01071083|540429139|FG003|Overall Study|Withdrawal by Subject|0|||
149809153|NCT01071083|540429140|FG004|Overall Study|Withdrawal by Subject|3|||
149809154|NCT01071083|540429136|FG000|Overall Study|Physician Decision|1|||
149809155|NCT01071083|540429137|FG001|Overall Study|Physician Decision|0|||
149809156|NCT01071083|540429138|FG002|Overall Study|Physician Decision|0|||
149809157|NCT01071083|540429139|FG003|Overall Study|Physician Decision|1|||
149809158|NCT01071083|540429140|FG004|Overall Study|Physician Decision|1|||
149809159|NCT01071083|540429136|FG000|Overall Study|Early Rescue|1|||
149809160|NCT01071083|540429137|FG001|Overall Study|Early Rescue|0|||
149809161|NCT01071083|540429138|FG002|Overall Study|Early Rescue|0|||
149809162|NCT01071083|540429139|FG003|Overall Study|Early Rescue|0|||
149809163|NCT01071083|540429140|FG004|Overall Study|Early Rescue|1|||
149809164|NCT01071083|540429136|FG000|Overall Study|Subject Moved|0|||
149809165|NCT01071083|540429137|FG001|Overall Study|Subject Moved|1|||
149809166|NCT01071083|540429138|FG002|Overall Study|Subject Moved|0|||
149809167|NCT01071083|540429139|FG003|Overall Study|Subject Moved|0|||
149809168|NCT01071083|540429140|FG004|Overall Study|Subject Moved|0|||
149809169|NCT01071083|540429136|FG000|Overall Study|Images Not Usable (Motion)|0|||
149809170|NCT01071083|540429137|FG001|Overall Study|Images Not Usable (Motion)|1|||
149809171|NCT01071083|540429138|FG002|Overall Study|Images Not Usable (Motion)|0|||
149809172|NCT01071083|540429139|FG003|Overall Study|Images Not Usable (Motion)|0|||
149809173|NCT01071083|540429140|FG004|Overall Study|Images Not Usable (Motion)|0|||
149809174|NCT01071083|540429136|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
149809175|NCT01071083|540429137|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
149809176|NCT01071083|540429138|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
149809177|NCT01071083|540429139|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
149809178|NCT01071083|540429140|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
149809179|NCT01071083|540429136|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
149809180|NCT01071083|540429137|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
149809181|NCT01071083|540429138|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
149809182|NCT01071083|540429139|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
149809183|NCT01071083|540429140|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
149809184|NCT01071083|540429136|FG000|Overall Study|Subject Refused to Continue|1|||
149809185|NCT01071083|540429137|FG001|Overall Study|Subject Refused to Continue|0|||
149809186|NCT01071083|540429138|FG002|Overall Study|Subject Refused to Continue|0|||
149809187|NCT01071083|540429139|FG003|Overall Study|Subject Refused to Continue|0|||
149809188|NCT01071083|540429140|FG004|Overall Study|Subject Refused to Continue|0|||
149809189|NCT04732728|540429141|FG000|Overall Study|Death|12|||
149809190|NCT04732728|540429141|FG000|Overall Study|Withdrawn|136|||
149809191|NCT01523301|540429142|FG000|Overall Study|Adverse Event|25|||
149809192|NCT01523301|540429143|FG001|Overall Study|Adverse Event|16|||
149809193|NCT01523301|540429142|FG000|Overall Study|Lack of Efficacy|0|||
149809194|NCT01523301|540429143|FG001|Overall Study|Lack of Efficacy|2|||
149809195|NCT01523301|540429142|FG000|Overall Study|Protocol Violation|3|||
149809196|NCT01523301|540429143|FG001|Overall Study|Protocol Violation|4|||
149809197|NCT01523301|540429142|FG000|Overall Study|Lost to Follow-up|1|||
149809198|NCT01523301|540429143|FG001|Overall Study|Lost to Follow-up|0|||
149809199|NCT01523301|540429142|FG000|Overall Study|Withdrawal by Subject|6|||
149809200|NCT01523301|540429143|FG001|Overall Study|Withdrawal by Subject|8|||
149809201|NCT01523301|540429142|FG000|Overall Study|Other Reason|0|||
149809202|NCT01523301|540429143|FG001|Overall Study|Other Reason|2|||
149809203|NCT00728988|540429144|FG000|Overall Study|Not Treated|2|||
149809204|NCT00728988|540429145|FG001|Overall Study|Not Treated|2|||
149809205|NCT00728988|540429144|FG000|Overall Study|Death|1|||
149809206|NCT00728988|540429145|FG001|Overall Study|Death|1|||
149809207|NCT00728988|540429144|FG000|Overall Study|Adverse Event|3|||
149809208|NCT00728988|540429145|FG001|Overall Study|Adverse Event|2|||
149809209|NCT00728988|540429144|FG000|Overall Study|Other|85|||
149809210|NCT00728988|540429145|FG001|Overall Study|Other|77|||
149809211|NCT00728988|540429144|FG000|Overall Study|Withdrawal by Subject|2|||
149809212|NCT00728988|540429145|FG001|Overall Study|Withdrawal by Subject|6|||
149809213|NCT05013749|540429149|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
149809214|NCT05013749|540429150|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
149809215|NCT05013749|540429149|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
150149322|NCT02340520|541683258|FG000|Overall Study|Lost to Follow-up|1|||
149809216|NCT05013749|540429150|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
149809217|NCT02017535|540429153|FG000|Overall Study|Withdrawal by Subject|1|||
149809218|NCT02017535|540429154|FG001|Overall Study|Withdrawal by Subject|0|||
149809219|NCT02017535|540429155|FG002|Overall Study|Withdrawal by Subject|0|||
150149323|NCT02340520|541683258|FG000|Overall Study|Patient did not take drug as specified|1|||
149809220|NCT02017535|540429156|FG003|Overall Study|Withdrawal by Subject|0|||
149809221|NCT02426125|540429157|FG000|Overall Study|Lost to Follow-up|14|||
149809222|NCT02426125|540429158|FG001|Overall Study|Lost to Follow-up|12|||
149809223|NCT02426125|540429157|FG000|Overall Study|Withdrawal by Subject|13|||
149809224|NCT02426125|540429158|FG001|Overall Study|Withdrawal by Subject|14|||
149809225|NCT02426125|540429157|FG000|Overall Study|Death|185|||
149809226|NCT02426125|540429158|FG001|Overall Study|Death|200|||
149809227|NCT02426125|540429157|FG000|Overall Study|Randomized, But Never Treated|5|||
150149324|NCT02340520|541683258|FG000|Overall Study|Withdrawal by Subject|1|||
149809228|NCT02426125|540429158|FG001|Overall Study|Randomized, But Never Treated|2|||
149809229|NCT00938015|540429159|FG000|Overall Study|Death|2|||
149809230|NCT00938015|540429159|FG000|Overall Study|Lost to Follow-up|32|||
149809231|NCT00938015|540429159|FG000|Overall Study|Adverse Event|32|||
149809232|NCT00938015|540429159|FG000|Overall Study|Non-responder|52|||
149809233|NCT00938015|540429159|FG000|Overall Study|Reason not related to Etanercept|29|||
149809234|NCT02341482|540429160|FG000|Overall Study|Adverse Event|1|||
149809235|NCT03186794|540429161|FG000|Overall Study|Physician Decision|2|||
149809236|NCT03186794|540429161|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
149809237|NCT00478673|540429163|FG000|30-Days Post-Procedure|Death|2|||
149809238|NCT00478673|540429163|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
149809239|NCT00478673|540429163|FG000|30-Days Post-Procedure|Missed Visit|7|||
149809240|NCT00478673|540429163|FG000|12-Months Post-Procedure|Death|23|||
149809241|NCT00478673|540429163|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
149809242|NCT00478673|540429163|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
149809243|NCT00478673|540429163|FG000|12-Months Post-Procedure|Missed Visit|25|||
149809244|NCT00478673|540429163|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
149809245|NCT04797637|540429164|FG000|Overall Study|Lost to Follow-up|23|||
149809246|NCT04797637|540429165|FG001|Overall Study|Lost to Follow-up|32|||
149809247|NCT04797637|540429164|FG000|Overall Study|Withdrawal by Subject|0|||
149809248|NCT04797637|540429165|FG001|Overall Study|Withdrawal by Subject|1|||
149809249|NCT00960687|540429166|FG000|Washout Period of 7 Days|Adverse Event|3|||
149809250|NCT00960687|540429167|FG001|Washout Period of 7 Days|Adverse Event|2|||
149809251|NCT00960687|540429166|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149809252|NCT00960687|540429167|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149809253|NCT02362646|540429168|FG000|Overall Study|Death|15|||
149809254|NCT02362646|540429169|FG001|Overall Study|Death|8|||
149809255|NCT02362646|540429168|FG000|Overall Study|Withdrawal by Subject|2|||
149809256|NCT02362646|540429169|FG001|Overall Study|Withdrawal by Subject|2|||
149809257|NCT02362646|540429168|FG000|Overall Study|received transplant|21|||
149809258|NCT02362646|540429169|FG001|Overall Study|received transplant|14|||
149809259|NCT01216319|540429171|FG000|Overall Study|Lost to Follow-up|2|||
149809260|NCT01216319|540429171|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
149809261|NCT02666768|540429175|FG000|Overall Study|Withdrawal by Subject|4|||
149809262|NCT01023022|540429176|FG000|Overall Study|Death|5|||
149809263|NCT01023022|540429176|FG000|Overall Study|Lost to Follow-up|7|||
149809264|NCT01023022|540429176|FG000|Overall Study|due to technical issues|2|||
149809265|NCT03728257|540429177|FG000|Overall Study|Death|3|||
149809266|NCT03728257|540429178|FG001|Overall Study|Death|0|||
149809267|NCT03428217|540429179|FG000|Overall Study|Death|89|||
149809268|NCT03428217|540429180|FG001|Overall Study|Death|93|||
149809269|NCT03428217|540429179|FG000|Overall Study|Withdrawal by Subject|8|||
149809270|NCT03428217|540429180|FG001|Overall Study|Withdrawal by Subject|7|||
149809271|NCT03428217|540429179|FG000|Overall Study|Lost to Follow-up|1|||
149809272|NCT03428217|540429180|FG001|Overall Study|Lost to Follow-up|3|||
149809273|NCT03428217|540429179|FG000|Overall Study|Study terminated by sponsor|124|||
149809274|NCT03428217|540429180|FG001|Overall Study|Study terminated by sponsor|118|||
149809275|NCT03428217|540429179|FG000|Overall Study|Other, Not Specified|1|||
149809276|NCT03428217|540429180|FG001|Overall Study|Other, Not Specified|0|||
149809277|NCT03889197|540429181|FG000|Overall Study|Withdrawal by Subject|1|||
149809278|NCT03889197|540429182|FG001|Overall Study|Withdrawal by Subject|0|||
149809279|NCT03889197|540429181|FG000|Overall Study|Physician Decision|0|||
149809280|NCT03889197|540429182|FG001|Overall Study|Physician Decision|1|||
149809281|NCT03889197|540429181|FG000|Overall Study|met exclusion criteria|0|||
149809282|NCT03889197|540429182|FG001|Overall Study|met exclusion criteria|1|||
149809283|NCT03889197|540429181|FG000|Overall Study|Protocol Violation|1|||
149809284|NCT03889197|540429182|FG001|Overall Study|Protocol Violation|0|||
149809285|NCT05246111|540429183|FG000|Period 01|NOT ELIGIBLE IC5|1|||
149809286|NCT05246111|540429184|FG001|Period 01|NOT ELIGIBLE IC5|0|||
149809287|NCT01329562|540429185|FG000|Overall Study|Protocol Violation|5|||
149809288|NCT01329562|540429186|FG001|Overall Study|Protocol Violation|3|||
150149325|NCT01121484|541683259|FG000|Overall Study|Adverse Event|12|||
150149326|NCT01121484|541683260|FG001|Overall Study|Adverse Event|5|||
150149327|NCT01121484|541683259|FG000|Overall Study|Lack of Efficacy|3|||
149809289|NCT01329562|540429185|FG000|Overall Study|Lost to Follow-up|1|||
149809290|NCT01329562|540429186|FG001|Overall Study|Lost to Follow-up|1|||
149809291|NCT01329562|540429185|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
149809292|NCT01329562|540429186|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
149809293|NCT01329562|540429185|FG000|Overall Study|Physician Decision|0|||
149809294|NCT01329562|540429186|FG001|Overall Study|Physician Decision|1|||
149809295|NCT03151226|540429187|FG000|Overall Study|Withdrawal by Subject|2|||
149809296|NCT03151226|540429187|FG000|Overall Study|not wear device correctly|1|||
149809297|NCT00061568|540429188|FG000|Overall Study|Lost to Follow-up|12|||
149809298|NCT00061568|540429189|FG001|Overall Study|Lost to Follow-up|0|||
149809299|NCT00061568|540429188|FG000|Overall Study|Death|6|||
149809300|NCT00061568|540429189|FG001|Overall Study|Death|0|||
149809301|NCT00061568|540429188|FG000|Overall Study|Withdrawal by Subject|1|||
149809302|NCT00061568|540429189|FG001|Overall Study|Withdrawal by Subject|0|||
149809303|NCT00402779|540429192|FG000|Overall Study|Screen Failure|77|||
149809304|NCT00402779|540429193|FG001|Overall Study|Screen Failure|76|||
149809305|NCT03239340|540429194|FG000|Overall Study|Other|26|||
149809306|NCT03239340|540429194|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
149809307|NCT03239340|540429194|FG000|Overall Study|Death|40|||
149809308|NCT03239340|540429194|FG000|Overall Study|Lost to Follow-up|2|||
149809309|NCT03239340|540429194|FG000|Overall Study|Physician Decision|16|||
149809310|NCT03239340|540429194|FG000|Overall Study|Withdrawal by Subject|27|||
149809311|NCT00777920|540429199|FG000|Overall Study|Adverse Event|39|||
149809312|NCT00777920|540429199|FG000|Overall Study|Withdrawal of Consent|4|||
149809313|NCT00777920|540429199|FG000|Overall Study|Lost to Follow-up|1|||
149809314|NCT00777920|540429199|FG000|Overall Study|Investigator's discretion|1|||
149809315|NCT00777920|540429199|FG000|Overall Study|Clinical status did not improve|1|||
149809316|NCT00777920|540429199|FG000|Overall Study|Other, not specified|4|||
149809317|NCT02392377|540429200|FG000|Overall Study|Withdrawal by Subject|0|||
149809318|NCT02392377|540429201|FG001|Overall Study|Withdrawal by Subject|1|||
149809319|NCT00526227|540429202|FG000|Overall Study|Device not implanted|1|||
149809320|NCT00526227|540429202|FG000|Overall Study|Death|1|||
149809321|NCT05378269|540431621|FG000|Overall Study|Protocol Violation|1|||
149809322|NCT05378269|540431622|FG001|Overall Study|Protocol Violation|0|||
149809323|NCT05378269|540431623|FG002|Overall Study|Protocol Violation|2|||
149809324|NCT05378269|540431624|FG003|Overall Study|Protocol Violation|0|||
149809325|NCT05378269|540431625|FG004|Overall Study|Protocol Violation|0|||
149809326|NCT00684645|540431626|FG000|Overall Study|Death|2|||
149809327|NCT00684645|540431626|FG000|Overall Study|Progressive disease|67|||
149809328|NCT00684645|540431626|FG000|Overall Study|Adverse Event|27|||
149809329|NCT00684645|540431626|FG000|Overall Study|Lost to Follow-up|3|||
149809330|NCT00684645|540431626|FG000|Overall Study|Other|15|||
149809331|NCT01186744|540431627|FG000|Overall Study|Lack of Efficacy|156|||
149809332|NCT01186744|540431628|FG001|Overall Study|Lack of Efficacy|99|||
149809333|NCT01186744|540431629|FG002|Overall Study|Lack of Efficacy|0|||
149809334|NCT01186744|540431630|FG003|Overall Study|Lack of Efficacy|2|||
149809335|NCT01186744|540431631|FG004|Overall Study|Lack of Efficacy|2|||
149809336|NCT01186744|540431632|FG005|Overall Study|Lack of Efficacy|5|||
149809337|NCT01186744|540431627|FG000|Overall Study|Protocol Violation|1|||
149809338|NCT01186744|540431628|FG001|Overall Study|Protocol Violation|2|||
149809339|NCT01186744|540431629|FG002|Overall Study|Protocol Violation|0|||
149809340|NCT01186744|540431630|FG003|Overall Study|Protocol Violation|1|||
149809341|NCT01186744|540431631|FG004|Overall Study|Protocol Violation|1|||
149809342|NCT01186744|540431632|FG005|Overall Study|Protocol Violation|2|||
149809343|NCT01186744|540431627|FG000|Overall Study|Lost to Follow-up|15|||
149809344|NCT01186744|540431628|FG001|Overall Study|Lost to Follow-up|16|||
149809345|NCT01186744|540431629|FG002|Overall Study|Lost to Follow-up|2|||
149809346|NCT01186744|540431630|FG003|Overall Study|Lost to Follow-up|1|||
149809347|NCT01186744|540431631|FG004|Overall Study|Lost to Follow-up|1|||
149809348|NCT01186744|540431632|FG005|Overall Study|Lost to Follow-up|4|||
149809349|NCT01186744|540431627|FG000|Overall Study|Screen failure|1|||
149809350|NCT01186744|540431628|FG001|Overall Study|Screen failure|1|||
149809351|NCT01186744|540431629|FG002|Overall Study|Screen failure|0|||
149809352|NCT01186744|540431630|FG003|Overall Study|Screen failure|1|||
149809353|NCT01186744|540431631|FG004|Overall Study|Screen failure|0|||
149809354|NCT01186744|540431632|FG005|Overall Study|Screen failure|0|||
149809355|NCT01186744|540431627|FG000|Overall Study|Withdrawal by Subject|14|||
149809356|NCT01186744|540431628|FG001|Overall Study|Withdrawal by Subject|10|||
149809357|NCT01186744|540431629|FG002|Overall Study|Withdrawal by Subject|2|||
149809358|NCT01186744|540431630|FG003|Overall Study|Withdrawal by Subject|5|||
149809359|NCT01186744|540431631|FG004|Overall Study|Withdrawal by Subject|0|||
149809360|NCT01186744|540431632|FG005|Overall Study|Withdrawal by Subject|6|||
149809361|NCT01186744|540431627|FG000|Overall Study|Study terminated by Sponsor|1|||
150149328|NCT01121484|541683260|FG001|Overall Study|Lack of Efficacy|11|||
150149329|NCT01121484|541683259|FG000|Overall Study|Lost to Follow-up|5|||
150149330|NCT01121484|541683260|FG001|Overall Study|Lost to Follow-up|9|||
150149331|NCT01121484|541683259|FG000|Overall Study|Physician Decision|0|||
150149332|NCT01121484|541683260|FG001|Overall Study|Physician Decision|3|||
150149333|NCT01121484|541683259|FG000|Overall Study|Protocol Violation|1|||
149809362|NCT01186744|540431628|FG001|Overall Study|Study terminated by Sponsor|0|||
149809363|NCT01186744|540431629|FG002|Overall Study|Study terminated by Sponsor|0|||
149809364|NCT01186744|540431630|FG003|Overall Study|Study terminated by Sponsor|0|||
149809365|NCT01186744|540431631|FG004|Overall Study|Study terminated by Sponsor|0|||
149809366|NCT01186744|540431632|FG005|Overall Study|Study terminated by Sponsor|0|||
149809367|NCT01186744|540431627|FG000|Overall Study|Other|9|||
149809368|NCT01186744|540431628|FG001|Overall Study|Other|10|||
149809369|NCT01186744|540431629|FG002|Overall Study|Other|1|||
149809370|NCT01186744|540431630|FG003|Overall Study|Other|2|||
149809371|NCT01186744|540431631|FG004|Overall Study|Other|1|||
149809372|NCT01186744|540431632|FG005|Overall Study|Other|5|||
149809373|NCT01186744|540431627|FG000|Overall Study|Adverse Event|10|||
149809374|NCT01186744|540431628|FG001|Overall Study|Adverse Event|14|||
149809375|NCT01186744|540431629|FG002|Overall Study|Adverse Event|1|||
149809376|NCT01186744|540431630|FG003|Overall Study|Adverse Event|0|||
149809377|NCT01186744|540431631|FG004|Overall Study|Adverse Event|1|||
149809378|NCT01186744|540431632|FG005|Overall Study|Adverse Event|4|||
149809379|NCT01186744|540431627|FG000|Overall Study|Death|1|||
149809380|NCT01186744|540431628|FG001|Overall Study|Death|0|||
149809381|NCT01186744|540431629|FG002|Overall Study|Death|0|||
149809382|NCT01186744|540431630|FG003|Overall Study|Death|0|||
149809383|NCT01186744|540431631|FG004|Overall Study|Death|0|||
149809384|NCT01186744|540431632|FG005|Overall Study|Death|0|||
149809385|NCT02325401|540431635|FG000|Overall Study|Withdrawal by Subject|0|||
149809386|NCT02325401|540431636|FG001|Overall Study|Withdrawal by Subject|1|||
149809387|NCT02325401|540431637|FG002|Overall Study|Withdrawal by Subject|1|||
149809388|NCT03284424|540431639|FG000|Overall Study|Death|70|||
149809389|NCT03284424|540431640|FG001|Overall Study|Death|24|||
149809390|NCT03284424|540431639|FG000|Overall Study|Lost to Follow-up|3|||
149809391|NCT03284424|540431640|FG001|Overall Study|Lost to Follow-up|1|||
149809392|NCT03284424|540431639|FG000|Overall Study|Physician Decision|1|||
149809393|NCT03284424|540431640|FG001|Overall Study|Physician Decision|2|||
149809394|NCT03284424|540431639|FG000|Overall Study|Withdrawal by Subject|4|||
149809395|NCT03284424|540431640|FG001|Overall Study|Withdrawal by Subject|5|||
149809396|NCT03284424|540431639|FG000|Overall Study|Sponsor's decision|27|||
149809397|NCT03284424|540431640|FG001|Overall Study|Sponsor's decision|22|||
149809398|NCT03349437|540431643|FG000|Screening|Screen Fail|4|||
149809399|NCT03349437|540431644|FG001|Screening|Screen Fail|0|||
149809400|NCT03349437|540431645|FG002|Screening|Screen Fail|0|||
149809401|NCT03349437|540431643|FG000|Screening|Withdrawn|1|||
149809402|NCT03349437|540431644|FG001|Screening|Withdrawn|0|||
149809403|NCT03349437|540431645|FG002|Screening|Withdrawn|0|||
149809404|NCT03976076|540431646|FG000|Overall Study|Withdrawal by Subject|2|||
149809405|NCT00765999|540431647|FG000|Overall Study|Adverse Event|203|||
149809406|NCT00765999|540431647|FG000|Overall Study|Insufficient Therapeutic Response|100|||
149809407|NCT00765999|540431647|FG000|Overall Study|Protocol Violation|95|||
149809408|NCT00765999|540431647|FG000|Overall Study|Consent Withdrawn|202|||
149809409|NCT00765999|540431647|FG000|Overall Study|Lost to Follow-up|131|||
149809410|NCT00765999|540431647|FG000|Overall Study|Study Terminated by Sponsor|2|||
149809411|NCT00765999|540431647|FG000|Overall Study|Other Miscellaneous Reasons|51|||
149809412|NCT02367729|540431648|FG000|Overall Study|Organic disorder diagnosed|2|||
149809413|NCT02367729|540431649|FG001|Overall Study|Organic disorder diagnosed|1|||
149809414|NCT02367729|540431648|FG000|Overall Study|Adverse Event|1|||
149809415|NCT02367729|540431649|FG001|Overall Study|Adverse Event|2|||
149809416|NCT02367729|540431648|FG000|Overall Study|Withdrawal by Subject|0|||
149809417|NCT02367729|540431649|FG001|Overall Study|Withdrawal by Subject|5|||
149809418|NCT03692078|540431650|FG000|Overall Study|Adverse Event|0|||
149809419|NCT03692078|540431651|FG001|Overall Study|Adverse Event|0|||
149809420|NCT03692078|540431652|FG002|Overall Study|Adverse Event|0|||
149809421|NCT03692078|540431653|FG003|Overall Study|Adverse Event|0|||
149809422|NCT03692078|540431654|FG004|Overall Study|Adverse Event|0|||
149809423|NCT03692078|540431655|FG005|Overall Study|Adverse Event|1|||
149809424|NCT03692078|540431656|FG006|Overall Study|Adverse Event|0|||
149809425|NCT03692078|540431650|FG000|Overall Study|Enrollment Closed|5|||
149809426|NCT03692078|540431651|FG001|Overall Study|Enrollment Closed|0|||
149809427|NCT03692078|540431652|FG002|Overall Study|Enrollment Closed|0|||
149809428|NCT03692078|540431653|FG003|Overall Study|Enrollment Closed|0|||
149809429|NCT03692078|540431654|FG004|Overall Study|Enrollment Closed|0|||
149809430|NCT03692078|540431655|FG005|Overall Study|Enrollment Closed|0|||
149809431|NCT03692078|540431656|FG006|Overall Study|Enrollment Closed|0|||
149809432|NCT03692078|540431650|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
149809433|NCT03692078|540431651|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
149809434|NCT03692078|540431652|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
149809435|NCT03692078|540431653|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
149809436|NCT03692078|540431654|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
149809437|NCT03692078|540431655|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
149809438|NCT03692078|540431656|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
149809439|NCT03692078|540431650|FG000|Overall Study|Withdrawal by Subject|0|||
149809440|NCT03692078|540431651|FG001|Overall Study|Withdrawal by Subject|2|||
150149334|NCT01121484|541683260|FG001|Overall Study|Protocol Violation|0|||
149809441|NCT03692078|540431652|FG002|Overall Study|Withdrawal by Subject|0|||
149809442|NCT03692078|540431653|FG003|Overall Study|Withdrawal by Subject|1|||
149809443|NCT03692078|540431654|FG004|Overall Study|Withdrawal by Subject|5|||
149809444|NCT03692078|540431655|FG005|Overall Study|Withdrawal by Subject|3|||
149809445|NCT03692078|540431656|FG006|Overall Study|Withdrawal by Subject|3|||
149809446|NCT05723835|540431659|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
149809447|NCT05723835|540431660|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
149809448|NCT05723835|540431661|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
149809449|NCT05723835|540431662|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
149809450|NCT05723835|540431663|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
149809451|NCT05723835|540431664|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
149809452|NCT05723835|540431665|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
149809453|NCT05723835|540431666|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
149809454|NCT05226286|540431667|FG000|Overall Study|Screen failures prior to implant|62|||
149809455|NCT05226286|540431667|FG000|Overall Study|Withdrawal by Subject|13|||
149809456|NCT05226286|540431667|FG000|Overall Study|Lost to Follow-up|3|||
149809457|NCT05226286|540431667|FG000|Overall Study|Physician Decision|1|||
149809458|NCT05226286|540431667|FG000|Overall Study|Adverse Event|1|||
149809459|NCT05226286|540431667|FG000|Overall Study|Death|1|||
149809460|NCT05226286|540431667|FG000|Overall Study|Device explant with no planned replacement|1|||
149809461|NCT05226286|540431667|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
149809462|NCT05226286|540431667|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
149809463|NCT00457418|540431668|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
149809464|NCT00457418|540431668|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
149809465|NCT00457418|540431668|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
149809466|NCT00457418|540431668|FG000|Post PK Maintenance|Adverse Event|10|||
149809467|NCT00457418|540431668|FG000|Post PK Maintenance|Progression of Disease|6|||
149809468|NCT00457418|540431668|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
149809469|NCT00457418|540431668|FG000|Post PK Maintenance|Lost to Follow-up|1|||
149809470|NCT04854707|540431670|FG000|Overall Study|Lack of Efficacy|78|||
149809471|NCT04854707|540431671|FG001|Overall Study|Lack of Efficacy|59|||
149809472|NCT04854707|540431672|FG002|Overall Study|Lack of Efficacy|30|||
149809473|NCT01346501|540431676|FG000|Overall Study|Initiated Other Biological Agents|3|||
149809474|NCT01346501|540431677|FG001|Overall Study|Initiated Other Biological Agents|1|||
149809475|NCT01346501|540431676|FG000|Overall Study|Other|8|||
149809476|NCT01346501|540431677|FG001|Overall Study|Other|12|||
149809477|NCT04101721|540431678|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
149809478|NCT04101721|540431679|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
149809479|NCT04101721|540431678|FG000|Overall Study|Death|0|||
149809480|NCT04101721|540431679|FG001|Overall Study|Death|1|||
149809481|NCT04101721|540431678|FG000|Overall Study|Lost to Follow-up|0|||
149809482|NCT04101721|540431679|FG001|Overall Study|Lost to Follow-up|3|||
149809483|NCT02564952|540431682|FG000|Overall Study|Adverse Event|6|||
149809484|NCT02564952|540431682|FG000|Overall Study|Lost to Follow-up|1|||
149809485|NCT02564952|540431682|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
149809486|NCT02564952|540431682|FG000|Overall Study|Withdrawal by Subject|1|||
149809487|NCT02564952|540431682|FG000|Overall Study|Low Efficacy|1|||
149809488|NCT02564952|540431682|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
149809489|NCT00756652|540431683|FG000|Original Phase|Withdrawal by Subject|864|||
149809490|NCT00756652|540431684|FG001|Original Phase|Withdrawal by Subject|23|||
149809491|NCT00756652|540431683|FG000|Original Phase|Lost to Follow-up|601|||
149809492|NCT00756652|540431684|FG001|Original Phase|Lost to Follow-up|0|||
149809493|NCT00756652|540431683|FG000|Original Phase|Other Discontinuation|797|||
149809494|NCT00756652|540431684|FG001|Original Phase|Other Discontinuation|5|||
149809495|NCT00756652|540431683|FG000|Original Phase|Participant Noncompliance|18622|||
149809496|NCT00756652|540431684|FG001|Original Phase|Participant Noncompliance|424|||
149809497|NCT00756652|540431683|FG000|Original Phase|Unknown Discontinuation Reason|2|||
149809498|NCT00756652|540431684|FG001|Original Phase|Unknown Discontinuation Reason|0|||
149809499|NCT00756652|540431683|FG000|Original Phase|Participants without data|3259|||
149809500|NCT00756652|540431684|FG001|Original Phase|Participants without data|466|||
149809501|NCT00756652|540431683|FG000|Original Phase|Death|168|||
149809502|NCT00756652|540431684|FG001|Original Phase|Death|1|||
149809503|NCT00756652|540431683|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
149809504|NCT00756652|540431684|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
149809505|NCT00756652|540431683|FG000|Re-Op Phase|Withdrawal by Subject|62|||
149809506|NCT00756652|540431684|FG001|Re-Op Phase|Withdrawal by Subject|0|||
149809507|NCT00756652|540431683|FG000|Re-Op Phase|Death|6|||
149809508|NCT00756652|540431684|FG001|Re-Op Phase|Death|0|||
149809509|NCT00756652|540431683|FG000|Re-Op Phase|Lost to Follow-up|340|||
149809510|NCT00756652|540431684|FG001|Re-Op Phase|Lost to Follow-up|0|||
149809511|NCT00756652|540431683|FG000|Re-Op Phase|Site Closed|2454|||
149809512|NCT00756652|540431684|FG001|Re-Op Phase|Site Closed|0|||
149809513|NCT00756652|540431683|FG000|Re-Op Phase|Withdrawn after explant|14|||
149809514|NCT00756652|540431684|FG001|Re-Op Phase|Withdrawn after explant|0|||
149809515|NCT01215955|540431693|FG000|Overall Study|Adverse Event|1|||
149809516|NCT01215955|540431694|FG001|Overall Study|Adverse Event|4|||
149809517|NCT01215955|540431695|FG002|Overall Study|Adverse Event|2|||
149809518|NCT01215955|540431696|FG003|Overall Study|Adverse Event|3|||
149809519|NCT01215955|540431693|FG000|Overall Study|Death|2|||
149809520|NCT01215955|540431694|FG001|Overall Study|Death|0|||
149809521|NCT01215955|540431695|FG002|Overall Study|Death|1|||
149809522|NCT01215955|540431696|FG003|Overall Study|Death|3|||
149809523|NCT01215955|540431693|FG000|Overall Study|Entry Criteria Not Met|1|||
149809524|NCT01215955|540431694|FG001|Overall Study|Entry Criteria Not Met|3|||
149809525|NCT01215955|540431695|FG002|Overall Study|Entry Criteria Not Met|4|||
149809526|NCT01215955|540431696|FG003|Overall Study|Entry Criteria Not Met|7|||
149809527|NCT01215955|540431693|FG000|Overall Study|Lack of Efficacy|1|||
149809528|NCT01215955|540431694|FG001|Overall Study|Lack of Efficacy|2|||
149809529|NCT01215955|540431695|FG002|Overall Study|Lack of Efficacy|1|||
149809530|NCT01215955|540431696|FG003|Overall Study|Lack of Efficacy|0|||
149809531|NCT01215955|540431693|FG000|Overall Study|Lost to Follow-up|4|||
149809532|NCT01215955|540431694|FG001|Overall Study|Lost to Follow-up|4|||
149809533|NCT01215955|540431695|FG002|Overall Study|Lost to Follow-up|8|||
149809534|NCT01215955|540431696|FG003|Overall Study|Lost to Follow-up|9|||
149809535|NCT01215955|540431693|FG000|Overall Study|Physician Decision|4|||
149809536|NCT01215955|540431694|FG001|Overall Study|Physician Decision|10|||
149809537|NCT01215955|540431695|FG002|Overall Study|Physician Decision|8|||
149809538|NCT01215955|540431696|FG003|Overall Study|Physician Decision|11|||
149809539|NCT01215955|540431693|FG000|Overall Study|Protocol Violation|17|||
149809540|NCT01215955|540431694|FG001|Overall Study|Protocol Violation|13|||
149809541|NCT01215955|540431695|FG002|Overall Study|Protocol Violation|8|||
149809542|NCT01215955|540431696|FG003|Overall Study|Protocol Violation|8|||
149809543|NCT01215955|540431693|FG000|Overall Study|Sponsor Decision|1|||
149809544|NCT01215955|540431694|FG001|Overall Study|Sponsor Decision|2|||
149809545|NCT01215955|540431695|FG002|Overall Study|Sponsor Decision|0|||
149809546|NCT01215955|540431696|FG003|Overall Study|Sponsor Decision|1|||
149809547|NCT01215955|540431693|FG000|Overall Study|Withdrawal by Subject|14|||
149809548|NCT01215955|540431694|FG001|Overall Study|Withdrawal by Subject|15|||
149809549|NCT01215955|540431695|FG002|Overall Study|Withdrawal by Subject|13|||
149809550|NCT01215955|540431696|FG003|Overall Study|Withdrawal by Subject|9|||
149809551|NCT01215955|540431693|FG000|Overall Study|Quality Issues|0|||
149809552|NCT01215955|540431694|FG001|Overall Study|Quality Issues|0|||
149809553|NCT01215955|540431695|FG002|Overall Study|Quality Issues|3|||
149809554|NCT01215955|540431696|FG003|Overall Study|Quality Issues|2|||
149809555|NCT00038467|540431697|FG000|Overall Study|Adverse Event|170|||
149809556|NCT00038467|540431698|FG001|Overall Study|Adverse Event|145|||
149809557|NCT00038467|540431697|FG000|Overall Study|Withdrawal by Subject|150|||
149809558|NCT00038467|540431698|FG001|Overall Study|Withdrawal by Subject|107|||
149809559|NCT00038467|540431697|FG000|Overall Study|Protocol Violation|19|||
149809560|NCT00038467|540431698|FG001|Overall Study|Protocol Violation|22|||
149809561|NCT00038467|540431697|FG000|Overall Study|Death|22|||
149809562|NCT00038467|540431698|FG001|Overall Study|Death|16|||
149809563|NCT00038467|540431697|FG000|Overall Study|Lost to Follow-up|15|||
149809564|NCT00038467|540431698|FG001|Overall Study|Lost to Follow-up|10|||
149809565|NCT00038467|540431697|FG000|Overall Study|Recurrence|109|||
149809566|NCT00038467|540431698|FG001|Overall Study|Recurrence|179|||
149809567|NCT00038467|540431697|FG000|Overall Study|Randomized, but not treated|31|||
149809568|NCT00038467|540431698|FG001|Overall Study|Randomized, but not treated|35|||
149809569|NCT00038467|540431697|FG000|Overall Study|Other|26|||
149809570|NCT00038467|540431698|FG001|Overall Study|Other|28|||
149809571|NCT03972709|540431699|FG000|Overall Study|Withdrawal by Subject|18|||
149809572|NCT03972709|540431700|FG001|Overall Study|Withdrawal by Subject|7|||
149809573|NCT03972709|540431701|FG002|Overall Study|Withdrawal by Subject|14|||
149809574|NCT03972709|540431699|FG000|Overall Study|Study Terminated by Sponsor|48|||
149809575|NCT03972709|540431700|FG001|Overall Study|Study Terminated by Sponsor|25|||
149809576|NCT03972709|540431701|FG002|Overall Study|Study Terminated by Sponsor|50|||
149809577|NCT03972709|540431699|FG000|Overall Study|Physician Decision|1|||
149809578|NCT03972709|540431700|FG001|Overall Study|Physician Decision|0|||
149809579|NCT03972709|540431701|FG002|Overall Study|Physician Decision|0|||
149809580|NCT03972709|540431699|FG000|Overall Study|COVID-19|0|||
149809581|NCT03972709|540431700|FG001|Overall Study|COVID-19|1|||
149809582|NCT03972709|540431701|FG002|Overall Study|COVID-19|1|||
149809583|NCT03972709|540431699|FG000|Overall Study|Lost to Follow-up|6|||
149809584|NCT03972709|540431700|FG001|Overall Study|Lost to Follow-up|1|||
149809585|NCT03972709|540431701|FG002|Overall Study|Lost to Follow-up|2|||
149809586|NCT03972709|540431699|FG000|Overall Study|Death|5|||
149809587|NCT03972709|540431700|FG001|Overall Study|Death|1|||
150149335|NCT01121484|541683259|FG000|Overall Study|Withdrawal by Subject|8|||
150149336|NCT01121484|541683260|FG001|Overall Study|Withdrawal by Subject|7|||
149809588|NCT03972709|540431701|FG002|Overall Study|Death|4|||
149809589|NCT03972709|540431699|FG000|Overall Study|Adverse Event|3|||
149809590|NCT03972709|540431700|FG001|Overall Study|Adverse Event|1|||
149918922|NCT01210352|540835246|FG005|Overall Study|Patient Discharged Early|0|||
149809591|NCT03972709|540431701|FG002|Overall Study|Adverse Event|4|||
150149337|NCT01121484|541683259|FG000|Overall Study|Discontinuation of study by sponsor|0|||
149809592|NCT03972709|540431699|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
149809593|NCT03972709|540431700|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
149809594|NCT03972709|540431701|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
149809595|NCT03972709|540431699|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
149809596|NCT03972709|540431700|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
149809597|NCT03972709|540431701|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
149809598|NCT03972709|540431699|FG000|Overall Study|Subject Unable to be Contacted|0|||
149809599|NCT03972709|540431700|FG001|Overall Study|Subject Unable to be Contacted|1|||
149809600|NCT03972709|540431701|FG002|Overall Study|Subject Unable to be Contacted|0|||
149809601|NCT03972709|540431699|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
149809602|NCT03972709|540431700|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
149809603|NCT03972709|540431701|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
149809604|NCT03972709|540431699|FG000|Overall Study|Subject Moved|0|||
149809605|NCT03972709|540431700|FG001|Overall Study|Subject Moved|1|||
149809606|NCT03972709|540431701|FG002|Overall Study|Subject Moved|0|||
149809607|NCT03972709|540431699|FG000|Overall Study|Missed Study Visits|1|||
149809608|NCT03972709|540431700|FG001|Overall Study|Missed Study Visits|0|||
149809609|NCT03972709|540431701|FG002|Overall Study|Missed Study Visits|0|||
149809610|NCT01339000|540431702|FG000|Overall Study|study closed due to lack of drug supply|1|||
149809611|NCT01339000|540431703|FG001|Overall Study|study closed due to lack of drug supply|0|||
149809612|NCT01393626|540431704|FG000|Overall Study|Adverse Event|2|||
149809613|NCT01393626|540431705|FG001|Overall Study|Adverse Event|1|||
149809614|NCT01393626|540431706|FG002|Overall Study|Adverse Event|5|||
149809615|NCT01393626|540431707|FG003|Overall Study|Adverse Event|0|||
149809616|NCT01393626|540431704|FG000|Overall Study|Did not meet entrance criteria|1|||
149809617|NCT01393626|540431705|FG001|Overall Study|Did not meet entrance criteria|0|||
149809618|NCT01393626|540431706|FG002|Overall Study|Did not meet entrance criteria|0|||
149809619|NCT01393626|540431707|FG003|Overall Study|Did not meet entrance criteria|0|||
149809620|NCT01393626|540431704|FG000|Overall Study|Lack of Efficacy|6|||
149809621|NCT01393626|540431705|FG001|Overall Study|Lack of Efficacy|6|||
149809622|NCT01393626|540431706|FG002|Overall Study|Lack of Efficacy|4|||
149809623|NCT01393626|540431707|FG003|Overall Study|Lack of Efficacy|1|||
149809624|NCT01393626|540431704|FG000|Overall Study|Lost to Follow-up|1|||
149809625|NCT01393626|540431705|FG001|Overall Study|Lost to Follow-up|1|||
150149338|NCT01121484|541683260|FG001|Overall Study|Discontinuation of study by sponsor|1|||
150149339|NCT01121484|541683259|FG000|Overall Study|Other|3|||
150149340|NCT01121484|541683260|FG001|Overall Study|Other|3|||
150149341|NCT01121484|541683259|FG000|Overall Study|Randomized, not treated|1|||
150149342|NCT01121484|541683260|FG001|Overall Study|Randomized, not treated|4|||
150149343|NCT03915951|541683261|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
150149344|NCT03915951|541683262|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
150149345|NCT03915951|541683261|FG000|Overall Study|Adverse Event|12|||
150149346|NCT03915951|541683262|FG001|Overall Study|Adverse Event|6|||
150149347|NCT03915951|541683261|FG000|Overall Study|Disease progression (radiological)|17|||
150149348|NCT03915951|541683262|FG001|Overall Study|Disease progression (radiological)|15|||
150149349|NCT03915951|541683261|FG000|Overall Study|Disease progression (clinical)|4|||
150149350|NCT03915951|541683262|FG001|Overall Study|Disease progression (clinical)|1|||
150149351|NCT03915951|541683261|FG000|Overall Study|Patient decision|0|||
150149352|NCT03915951|541683262|FG001|Overall Study|Patient decision|4|||
150149353|NCT03915951|541683261|FG000|Overall Study|Investigator decision|0|||
150149354|NCT03915951|541683262|FG001|Overall Study|Investigator decision|1|||
150149355|NCT03915951|541683261|FG000|Overall Study|Consent withdrawn|1|||
150149356|NCT03915951|541683262|FG001|Overall Study|Consent withdrawn|1|||
150149357|NCT03915951|541683261|FG000|Overall Study|Death|0|||
150149358|NCT03915951|541683262|FG001|Overall Study|Death|3|||
150149359|NCT00447954|541683265|FG000|Overall Study|Adverse Event|0|||
150149360|NCT00447954|541683266|FG001|Overall Study|Adverse Event|2|||
150149361|NCT00447954|541683267|FG002|Overall Study|Adverse Event|0|||
150149362|NCT00447954|541683265|FG000|Overall Study|Withdrawal by Subject|0|||
150149363|NCT00447954|541683266|FG001|Overall Study|Withdrawal by Subject|1|||
150149364|NCT00447954|541683267|FG002|Overall Study|Withdrawal by Subject|1|||
150149365|NCT00447954|541683265|FG000|Overall Study|Lost to Follow-up|0|||
150149366|NCT00447954|541683266|FG001|Overall Study|Lost to Follow-up|1|||
150149367|NCT00447954|541683267|FG002|Overall Study|Lost to Follow-up|0|||
150149368|NCT00447954|541683265|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
150149369|NCT00447954|541683266|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
150149370|NCT00447954|541683267|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
150149371|NCT03916744|541683268|FG000|Overall Study|Withdrawal by Subject|0|||
150149372|NCT03916744|541683269|FG001|Overall Study|Withdrawal by Subject|1|||
150149373|NCT03916744|541683270|FG002|Overall Study|Withdrawal by Subject|2|||
149809626|NCT01393626|540431706|FG002|Overall Study|Lost to Follow-up|1|||
150149374|NCT04524598|541683271|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
150149375|NCT04524598|541683272|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
150149376|NCT04524598|541683273|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
149809627|NCT01393626|540431707|FG003|Overall Study|Lost to Follow-up|0|||
149809628|NCT01393626|540431704|FG000|Overall Study|Withdrawal by Subject|6|||
149809629|NCT01393626|540431705|FG001|Overall Study|Withdrawal by Subject|4|||
149809630|NCT01393626|540431706|FG002|Overall Study|Withdrawal by Subject|0|||
150149377|NCT04524598|541683274|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
150149378|NCT04524598|541683275|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
150149379|NCT04524598|541683271|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
150177805|NCT03036813|541788207|FG000|Overall Study|Withdrawal by Subject|12|||
149809631|NCT01393626|540431707|FG003|Overall Study|Withdrawal by Subject|0|||
149809632|NCT01393626|540431704|FG000|Overall Study|Other|1|||
149809633|NCT01393626|540431705|FG001|Overall Study|Other|0|||
149809634|NCT01393626|540431706|FG002|Overall Study|Other|0|||
149809635|NCT01393626|540431707|FG003|Overall Study|Other|0|||
149809636|NCT01393626|540431704|FG000|Overall Study|Protocol Violation|1|||
149809637|NCT01393626|540431705|FG001|Overall Study|Protocol Violation|0|||
149809638|NCT01393626|540431706|FG002|Overall Study|Protocol Violation|2|||
149809639|NCT01393626|540431707|FG003|Overall Study|Protocol Violation|0|||
149809640|NCT02858076|540431708|FG000|Overall Study|Death|6|||
149809641|NCT02858076|540431709|FG001|Overall Study|Death|3|||
149809642|NCT02858076|540431708|FG000|Overall Study|Withdrawal by Subject|1|||
149809643|NCT02858076|540431709|FG001|Overall Study|Withdrawal by Subject|5|||
149809644|NCT02858076|540431708|FG000|Overall Study|Lost to Follow-up|2|||
149809645|NCT02858076|540431709|FG001|Overall Study|Lost to Follow-up|7|||
149809646|NCT02858076|540431708|FG000|Overall Study|Completed Out of Window|1|||
149809647|NCT02858076|540431709|FG001|Overall Study|Completed Out of Window|3|||
149809648|NCT00664066|540431719|FG000|Overall Study|Study terminated|3|||
149809649|NCT02575807|540431721|FG000|Overall Study|Death|8|||
149809650|NCT02575807|540431722|FG001|Overall Study|Death|3|||
149809651|NCT02575807|540431723|FG002|Overall Study|Death|7|||
149809652|NCT02575807|540431724|FG003|Overall Study|Death|0|||
149809653|NCT02575807|540431725|FG004|Overall Study|Death|1|||
149809654|NCT02575807|540431721|FG000|Overall Study|Study terminated by Sponsor|0|||
149809655|NCT02575807|540431722|FG001|Overall Study|Study terminated by Sponsor|1|||
149809656|NCT02575807|540431723|FG002|Overall Study|Study terminated by Sponsor|7|||
149809657|NCT02575807|540431724|FG003|Overall Study|Study terminated by Sponsor|0|||
149809658|NCT02575807|540431725|FG004|Overall Study|Study terminated by Sponsor|1|||
149809659|NCT02575807|540431721|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
149809660|NCT02575807|540431722|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
149809661|NCT02575807|540431723|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
149809662|NCT02575807|540431724|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
149809663|NCT02575807|540431725|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
149809664|NCT02575807|540431721|FG000|Overall Study|Terminated due to physician decision|0|||
149809665|NCT02575807|540431722|FG001|Overall Study|Terminated due to physician decision|0|||
149809666|NCT02575807|540431723|FG002|Overall Study|Terminated due to physician decision|1|||
149809667|NCT02575807|540431724|FG003|Overall Study|Terminated due to physician decision|0|||
149809668|NCT02575807|540431725|FG004|Overall Study|Terminated due to physician decision|0|||
149809669|NCT02575807|540431721|FG000|Overall Study|Subject ineligible - medical implant|0|||
149809670|NCT02575807|540431722|FG001|Overall Study|Subject ineligible - medical implant|0|||
149809671|NCT02575807|540431723|FG002|Overall Study|Subject ineligible - medical implant|0|||
149809672|NCT02575807|540431724|FG003|Overall Study|Subject ineligible - medical implant|1|||
149809673|NCT02575807|540431725|FG004|Overall Study|Subject ineligible - medical implant|0|||
149809674|NCT02575807|540431721|FG000|Overall Study|Withdrawal by Subject|0|||
149809675|NCT02575807|540431722|FG001|Overall Study|Withdrawal by Subject|0|||
149809676|NCT02575807|540431723|FG002|Overall Study|Withdrawal by Subject|1|||
149809677|NCT02575807|540431724|FG003|Overall Study|Withdrawal by Subject|1|||
149809678|NCT02575807|540431725|FG004|Overall Study|Withdrawal by Subject|2|||
149809679|NCT02180659|540431726|FG000|Overall Study|Adverse Event|1|||
149809680|NCT02180659|540431727|FG001|Overall Study|Adverse Event|0|||
149809681|NCT02180659|540431726|FG000|Overall Study|Lost to Follow-up|4|||
149809682|NCT02180659|540431727|FG001|Overall Study|Lost to Follow-up|2|||
149809683|NCT02180659|540431726|FG000|Overall Study|Subject incarcerated during conduct|1|||
149809684|NCT02180659|540431727|FG001|Overall Study|Subject incarcerated during conduct|0|||
149809685|NCT02180659|540431726|FG000|Overall Study|Withdrawal by Subject|0|||
149809686|NCT02180659|540431727|FG001|Overall Study|Withdrawal by Subject|2|||
149809687|NCT02180659|540431726|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
149809688|NCT02180659|540431727|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
150149380|NCT04524598|541683272|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
150149381|NCT04524598|541683273|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149382|NCT04524598|541683274|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149383|NCT04524598|541683275|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149384|NCT04524598|541683271|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
149809689|NCT03000075|540431728|FG000|Part A|Adverse Event|4|||
149809690|NCT03000075|540431729|FG001|Part A|Adverse Event|0|||
149809691|NCT03000075|540431730|FG002|Part A|Adverse Event|0|||
149809692|NCT03000075|540431731|FG003|Part A|Adverse Event|0|||
149809693|NCT03000075|540431732|FG004|Part A|Adverse Event|0|||
149809694|NCT03000075|540431733|FG005|Part A|Adverse Event|0|||
149809695|NCT03000075|540431734|FG006|Part A|Adverse Event|0|||
149809696|NCT03000075|540431728|FG000|Part B|Not dosed due to AE|0|||
149809697|NCT03000075|540431729|FG001|Part B|Not dosed due to AE|0|||
149809698|NCT03000075|540431730|FG002|Part B|Not dosed due to AE|0|||
149809699|NCT03000075|540431731|FG003|Part B|Not dosed due to AE|0|||
149809700|NCT03000075|540431732|FG004|Part B|Not dosed due to AE|0|||
149809701|NCT03000075|540431733|FG005|Part B|Not dosed due to AE|2|||
149809702|NCT03000075|540431734|FG006|Part B|Not dosed due to AE|1|||
149809703|NCT03000075|540431728|FG000|Part B|Adverse Event|0|||
149809704|NCT03000075|540431729|FG001|Part B|Adverse Event|0|||
149809705|NCT03000075|540431730|FG002|Part B|Adverse Event|0|||
149809706|NCT03000075|540431731|FG003|Part B|Adverse Event|0|||
149809707|NCT03000075|540431732|FG004|Part B|Adverse Event|1|||
149809708|NCT03000075|540431733|FG005|Part B|Adverse Event|0|||
149809709|NCT03000075|540431734|FG006|Part B|Adverse Event|0|||
149809710|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
149809711|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
149809712|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Death|5|||
149809713|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Death|2|||
149809714|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
149809715|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
149809716|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
149809717|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
149809718|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
149809719|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
149809720|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Relapse|1|||
149809721|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Relapse|0|||
149809722|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
149809723|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
149809724|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
149809725|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
149809726|NCT00111007|540431735|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
149809727|NCT00111007|540431736|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
149809728|NCT00111007|540431735|FG000|Active Follow-up|Adverse Event|1|||
149809729|NCT00111007|540431736|FG001|Active Follow-up|Adverse Event|0|||
149809730|NCT00111007|540431735|FG000|Active Follow-up|Death|2|||
149809731|NCT00111007|540431736|FG001|Active Follow-up|Death|0|||
149809732|NCT00111007|540431735|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
149809733|NCT00111007|540431736|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
149809734|NCT00111007|540431735|FG000|Long Term Follow-up|Death|34|||
149809735|NCT00111007|540431736|FG001|Long Term Follow-up|Death|39|||
149809736|NCT00111007|540431735|FG000|Long Term Follow-up|Lost to Follow-up|1|||
149809737|NCT00111007|540431736|FG001|Long Term Follow-up|Lost to Follow-up|1|||
149809738|NCT00111007|540431735|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
149809739|NCT00111007|540431736|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
149809740|NCT00111007|540431735|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
149809741|NCT00111007|540431736|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
149809742|NCT00111007|540431735|FG000|Long Term Follow-up|Missing|10|||
149809743|NCT00111007|540431736|FG001|Long Term Follow-up|Missing|3|||
149809744|NCT01495793|540431737|FG000|Overall Study|Lost to Follow-up|1|||
149809745|NCT01495793|540431737|FG000|Overall Study|Violation of inclusion criteria|1|||
149809746|NCT01154673|540431743|FG000|Overall Study|Lost to Follow-up|1|||
149809747|NCT01154673|540431744|FG001|Overall Study|Lost to Follow-up|0|||
149809748|NCT01154673|540431743|FG000|Overall Study|moved out of province|1|||
149809749|NCT01154673|540431744|FG001|Overall Study|moved out of province|0|||
149809750|NCT03083639|540431746|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
149809751|NCT03083639|540431747|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
149809752|NCT03083639|540431746|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
149809753|NCT03083639|540431747|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
149809754|NCT00929864|540431753|FG000|Overall Study|Death|1|||
149809755|NCT00929864|540431754|FG001|Overall Study|Death|1|||
149809756|NCT00929864|540431753|FG000|Overall Study|Adverse Event|11|||
149809757|NCT00929864|540431754|FG001|Overall Study|Adverse Event|30|||
149809758|NCT00929864|540431753|FG000|Overall Study|Lack of Efficacy|19|||
149809759|NCT00929864|540431754|FG001|Overall Study|Lack of Efficacy|16|||
149809760|NCT00929864|540431753|FG000|Overall Study|Lost to Follow-up|7|||
149809761|NCT00929864|540431754|FG001|Overall Study|Lost to Follow-up|12|||
149809762|NCT00929864|540431753|FG000|Overall Study|Withdrawal by Subject|20|||
149809763|NCT00929864|540431754|FG001|Overall Study|Withdrawal by Subject|9|||
149809764|NCT00929864|540431753|FG000|Overall Study|No longer met criteria|2|||
149809765|NCT00929864|540431754|FG001|Overall Study|No longer met criteria|1|||
149809766|NCT00929864|540431753|FG000|Overall Study|Poor or non-compliance|3|||
149809767|NCT00929864|540431754|FG001|Overall Study|Poor or non-compliance|3|||
149809768|NCT00929864|540431753|FG000|Overall Study|Pregnancy|0|||
149809769|NCT00929864|540431754|FG001|Overall Study|Pregnancy|3|||
149809770|NCT00929864|540431753|FG000|Overall Study|Administrative reason by Sponsor|1|||
149809771|NCT00929864|540431754|FG001|Overall Study|Administrative reason by Sponsor|1|||
149809772|NCT00929864|540431753|FG000|Overall Study|Non-specified|2|||
149809773|NCT00929864|540431754|FG001|Overall Study|Non-specified|7|||
150149385|NCT04524598|541683272|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
150149386|NCT04524598|541683273|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
150149387|NCT04524598|541683274|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
150149388|NCT04524598|541683275|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
150149389|NCT04524598|541683271|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
150149390|NCT04524598|541683272|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
150149391|NCT04524598|541683273|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
150149392|NCT04524598|541683274|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
150149393|NCT04524598|541683275|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
150149394|NCT04524598|541683271|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149395|NCT04524598|541683272|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149396|NCT04524598|541683273|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
150149397|NCT04524598|541683274|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
150149398|NCT04524598|541683275|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149399|NCT04524598|541683271|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
150149400|NCT04524598|541683272|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
150149401|NCT04524598|541683273|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
150149402|NCT04524598|541683274|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
150149403|NCT04524598|541683275|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
150149404|NCT04524598|541683271|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149405|NCT04524598|541683272|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149406|NCT04524598|541683273|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149407|NCT04524598|541683274|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
150149408|NCT04524598|541683275|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
150149409|NCT05067933|541683279|FG000|Overall Study|Withdrawal by Subject|2|||
150149410|NCT05067933|541683280|FG001|Overall Study|Withdrawal by Subject|0|||
150149411|NCT05067933|541683281|FG002|Overall Study|Withdrawal by Subject|0|||
150149412|NCT05067933|541683282|FG003|Overall Study|Withdrawal by Subject|0|||
149809774|NCT03940742|540431757|FG000|Overall Study|Lost to Follow-up|0|||
149809775|NCT03940742|540431758|FG001|Overall Study|Lost to Follow-up|0|||
149809776|NCT03940742|540431759|FG002|Overall Study|Lost to Follow-up|0|||
149809777|NCT03940742|540431760|FG003|Overall Study|Lost to Follow-up|1|||
149809778|NCT00621309|540431761|FG000|Overall Study|Withdrawal by Subject|2|||
149809779|NCT00621309|540431762|FG001|Overall Study|Withdrawal by Subject|0|||
149809780|NCT00621309|540431763|FG002|Overall Study|Withdrawal by Subject|1|||
149809781|NCT00621309|540431764|FG003|Overall Study|Withdrawal by Subject|1|||
149809782|NCT00621309|540431765|FG004|Overall Study|Withdrawal by Subject|1|||
149809783|NCT00621309|540431766|FG005|Overall Study|Withdrawal by Subject|1|||
149809784|NCT02061293|540431778|FG000|Overall Study|Elevated Blood Pressure|1|||
149809785|NCT02061293|540431779|FG001|Overall Study|Elevated Blood Pressure|1|||
149809786|NCT00483717|540431780|FG000|Overall Study|Protocol Violation|5|||
150149413|NCT05067933|541683283|FG004|Overall Study|Withdrawal by Subject|0|||
149809787|NCT00483717|540431781|FG001|Overall Study|Protocol Violation|7|||
149809788|NCT00483717|540431780|FG000|Overall Study|Time of dosing missing|1|||
149809789|NCT00483717|540431781|FG001|Overall Study|Time of dosing missing|1|||
149809790|NCT00483717|540431780|FG000|Overall Study|No treatment for migraine|16|||
149809791|NCT00483717|540431781|FG001|Overall Study|No treatment for migraine|13|||
149809792|NCT00483717|540431780|FG000|Overall Study|Lost to Follow-up|1|||
149809793|NCT00483717|540431781|FG001|Overall Study|Lost to Follow-up|0|||
149809794|NCT00483717|540431780|FG000|Overall Study|Withdrawal by Subject|1|||
149809795|NCT00483717|540431781|FG001|Overall Study|Withdrawal by Subject|0|||
149809796|NCT00604175|540431782|FG000|Entry Through Week 28|Death|2|||
149809797|NCT00604175|540431783|FG001|Entry Through Week 28|Death|0|||
149809798|NCT00604175|540431784|FG002|Entry Through Week 28|Death|0|||
149809799|NCT00604175|540431782|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
149809800|NCT00604175|540431783|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
149809801|NCT00604175|540431784|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
149809802|NCT00604175|540431782|FG000|Entry Through Week 28|Lost to Follow-up|4|||
149809803|NCT00604175|540431783|FG001|Entry Through Week 28|Lost to Follow-up|3|||
149809804|NCT00604175|540431784|FG002|Entry Through Week 28|Lost to Follow-up|0|||
149809805|NCT00604175|540431782|FG000|Entry Through Week 28|Ineligible|1|||
149809806|NCT00604175|540431783|FG001|Entry Through Week 28|Ineligible|0|||
149809807|NCT00604175|540431784|FG002|Entry Through Week 28|Ineligible|0|||
149809808|NCT00604175|540431782|FG000|Entry Through Week 28|Did not start intervention|2|||
149809809|NCT00604175|540431783|FG001|Entry Through Week 28|Did not start intervention|0|||
149809810|NCT00604175|540431784|FG002|Entry Through Week 28|Did not start intervention|1|||
149809811|NCT00604175|540431782|FG000|Week 29 Through Week 72|Death|0|||
149809812|NCT00604175|540431783|FG001|Week 29 Through Week 72|Death|0|||
149809813|NCT00604175|540431784|FG002|Week 29 Through Week 72|Death|1|||
149809814|NCT00604175|540431782|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
150149414|NCT05067933|541683284|FG005|Overall Study|Withdrawal by Subject|0|||
150149415|NCT05067933|541683279|FG000|Overall Study|Lost to Follow-up|1|||
150149416|NCT05067933|541683280|FG001|Overall Study|Lost to Follow-up|1|||
150149417|NCT05067933|541683281|FG002|Overall Study|Lost to Follow-up|1|||
150149418|NCT05067933|541683282|FG003|Overall Study|Lost to Follow-up|2|||
150149419|NCT05067933|541683283|FG004|Overall Study|Lost to Follow-up|1|||
150149420|NCT05067933|541683284|FG005|Overall Study|Lost to Follow-up|0|||
149809815|NCT00604175|540431783|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
149809816|NCT00604175|540431784|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
149809817|NCT00604175|540431782|FG000|Week 29 Through Week 72|Site closure|0|||
149809818|NCT00604175|540431783|FG001|Week 29 Through Week 72|Site closure|1|||
149809819|NCT00604175|540431784|FG002|Week 29 Through Week 72|Site closure|0|||
149809820|NCT00604175|540431782|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
149809821|NCT00604175|540431783|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
149809822|NCT00604175|540431784|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
149809823|NCT03353415|540431785|FG000|Masked CGM Wear|Lost to Follow-up|2|||
149809824|NCT03353415|540431785|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
149809825|NCT00975000|540431786|FG000|Overall Study|Other|1|||
149809826|NCT00975000|540431787|FG001|Overall Study|Other|0|||
149809827|NCT00975000|540431786|FG000|Overall Study|Adverse Event|1|||
149809828|NCT00975000|540431787|FG001|Overall Study|Adverse Event|1|||
149809829|NCT00975000|540431786|FG000|Overall Study|Withdrawal by Subject|2|||
149809830|NCT00975000|540431787|FG001|Overall Study|Withdrawal by Subject|2|||
149809831|NCT00975000|540431786|FG000|Overall Study|Lost to Follow-up|0|||
149809832|NCT00975000|540431787|FG001|Overall Study|Lost to Follow-up|1|||
149809833|NCT00975000|540431786|FG000|Overall Study|Protocol-specified Criteria|1|||
149809834|NCT00975000|540431787|FG001|Overall Study|Protocol-specified Criteria|0|||
149809835|NCT00975000|540431786|FG000|Overall Study|Non-compliance|0|||
149809836|NCT00975000|540431787|FG001|Overall Study|Non-compliance|1|||
149809837|NCT00359073|540433462|FG000|Overall Study|Withdrawal by Subject|1|||
149809838|NCT00359073|540433463|FG001|Overall Study|Withdrawal by Subject|1|||
149809839|NCT00359073|540433462|FG000|Overall Study|Eligibility criteria no longer met|3|||
149809840|NCT00359073|540433463|FG001|Overall Study|Eligibility criteria no longer met|0|||
149809841|NCT00359073|540433462|FG000|Overall Study|developed RV16 antibody|0|||
149809842|NCT00359073|540433463|FG001|Overall Study|developed RV16 antibody|1|||
149809843|NCT01371006|540433464|FG000|Overall Study|Adverse Event|1|||
149809844|NCT01371006|540433465|FG001|Overall Study|Adverse Event|0|||
149809845|NCT00891527|540433466|FG000|Overall Study|Withdrawal by Subject|2|||
149809846|NCT03515837|540433468|FG000|Overall Study|Death|219|||
149809847|NCT03515837|540433469|FG001|Overall Study|Death|227|||
149809848|NCT03515837|540433468|FG000|Overall Study|Lost to Follow-up|0|||
149809849|NCT03515837|540433469|FG001|Overall Study|Lost to Follow-up|1|||
149809850|NCT03515837|540433468|FG000|Overall Study|Withdrawal by Subject|0|||
149809851|NCT03515837|540433469|FG001|Overall Study|Withdrawal by Subject|4|||
149809852|NCT03515837|540433468|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
149809853|NCT03515837|540433469|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
149809854|NCT01964898|540433470|FG000|Overall Study|ineligible post-randomization|1|||
149809855|NCT01964898|540433471|FG001|Overall Study|ineligible post-randomization|1|||
149809856|NCT01964898|540433470|FG000|Overall Study|did not receive the allocated interventi|2|||
149809857|NCT01964898|540433471|FG001|Overall Study|did not receive the allocated interventi|1|||
149809858|NCT01964898|540433470|FG000|Overall Study|Lost to Follow-up|3|||
149809859|NCT01964898|540433471|FG001|Overall Study|Lost to Follow-up|5|||
149809860|NCT01964898|540433470|FG000|Overall Study|Withdrawal by Subject|1|||
149809861|NCT01964898|540433471|FG001|Overall Study|Withdrawal by Subject|0|||
149809862|NCT02957682|540433474|FG000|Overall Study|Adverse Event|64|||
149809863|NCT02957682|540433475|FG001|Overall Study|Adverse Event|67|||
149809864|NCT02957682|540433474|FG000|Overall Study|Poor Compliance to Protocol|30|||
149809865|NCT02957682|540433475|FG001|Overall Study|Poor Compliance to Protocol|26|||
149809866|NCT02957682|540433474|FG000|Overall Study|Physician Decision|4|||
149809867|NCT02957682|540433475|FG001|Overall Study|Physician Decision|4|||
149809868|NCT02957682|540433474|FG000|Overall Study|Study Terminated by Sponsor|4|||
149809869|NCT02957682|540433475|FG001|Overall Study|Study Terminated by Sponsor|3|||
149809870|NCT02957682|540433474|FG000|Overall Study|Subject Moved|10|||
149809871|NCT02957682|540433475|FG001|Overall Study|Subject Moved|16|||
149809872|NCT02957682|540433474|FG000|Overall Study|Withdrawal by Subject|64|||
150149421|NCT05067933|541683279|FG000|Overall Study|Miscellaneous|1|||
150149422|NCT05067933|541683280|FG001|Overall Study|Miscellaneous|0|||
149809873|NCT02957682|540433475|FG001|Overall Study|Withdrawal by Subject|33|||
149809874|NCT02957682|540433474|FG000|Overall Study|Related to IMP Administration|3|||
149809875|NCT02957682|540433475|FG001|Overall Study|Related to IMP Administration|6|||
149809876|NCT02957682|540433474|FG000|Overall Study|Non-disclosed|16|||
149809877|NCT02957682|540433475|FG001|Overall Study|Non-disclosed|12|||
149809878|NCT02957682|540433474|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
149809879|NCT02957682|540433475|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
150149423|NCT05067933|541683281|FG002|Overall Study|Miscellaneous|0|||
150149424|NCT05067933|541683282|FG003|Overall Study|Miscellaneous|0|||
149809880|NCT02953262|540433482|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
149809881|NCT02953262|540433483|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
149809882|NCT02953262|540433484|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
149809883|NCT02953262|540433485|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
149809884|NCT00934622|540433486|FG000|Overall Study|Lost to Follow-up|7|||
149809885|NCT00934622|540433486|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
149809886|NCT02406742|540433487|FG000|Overall Study|Progression of Disease|5|||
149809887|NCT02406742|540433488|FG001|Overall Study|Progression of Disease|1|||
149809888|NCT02406742|540433489|FG002|Overall Study|Progression of Disease|6|||
149809889|NCT02406742|540433487|FG000|Overall Study|Adverse Event|3|||
149809890|NCT02406742|540433488|FG001|Overall Study|Adverse Event|0|||
149809891|NCT02406742|540433489|FG002|Overall Study|Adverse Event|2|||
149809892|NCT02406742|540433487|FG000|Overall Study|Death|1|||
149809893|NCT02406742|540433488|FG001|Overall Study|Death|0|||
149809894|NCT02406742|540433489|FG002|Overall Study|Death|0|||
149809895|NCT02406742|540433487|FG000|Overall Study|Lack of Efficacy|0|||
149809896|NCT02406742|540433488|FG001|Overall Study|Lack of Efficacy|0|||
149809897|NCT02406742|540433489|FG002|Overall Study|Lack of Efficacy|1|||
149809898|NCT02406742|540433487|FG000|Overall Study|Withdrawal by Participant|1|||
149809899|NCT02406742|540433488|FG001|Overall Study|Withdrawal by Participant|2|||
149809900|NCT02406742|540433489|FG002|Overall Study|Withdrawal by Participant|0|||
149809901|NCT02406742|540433487|FG000|Overall Study|Physician Decision|1|||
149809902|NCT02406742|540433488|FG001|Overall Study|Physician Decision|2|||
149809903|NCT02406742|540433489|FG002|Overall Study|Physician Decision|1|||
149809904|NCT02406742|540433487|FG000|Overall Study|Transition to other treatment|2|||
149809905|NCT02406742|540433488|FG001|Overall Study|Transition to other treatment|0|||
149809906|NCT02406742|540433489|FG002|Overall Study|Transition to other treatment|1|||
149809907|NCT02406742|540433487|FG000|Overall Study|Other Reasons|1|||
149809908|NCT02406742|540433488|FG001|Overall Study|Other Reasons|11|||
149809909|NCT02406742|540433489|FG002|Overall Study|Other Reasons|5|||
149809910|NCT00759174|540433494|FG000|Overall Study|Other|0|||
149809911|NCT00759174|540433495|FG001|Overall Study|Other|2|||
149809912|NCT01890109|540433496|FG000|Overall Study|Withdrawal by Subject|0|||
149809913|NCT01890109|540433497|FG001|Overall Study|Withdrawal by Subject|3|||
149809914|NCT01890109|540433496|FG000|Overall Study|Lost to Follow-up|1|||
149809915|NCT01890109|540433497|FG001|Overall Study|Lost to Follow-up|2|||
149809916|NCT01643928|540433498|FG000|Overall Study|Lost to Follow-up|1|||
149809917|NCT01643928|540433499|FG001|Overall Study|Lost to Follow-up|0|||
149809918|NCT01643928|540433500|FG002|Overall Study|Lost to Follow-up|2|||
149809919|NCT01643928|540433501|FG003|Overall Study|Lost to Follow-up|0|||
149809920|NCT01643928|540433502|FG004|Overall Study|Lost to Follow-up|0|||
149809921|NCT01643928|540433498|FG000|Overall Study|Withdrawal by Subject|2|||
149809922|NCT01643928|540433499|FG001|Overall Study|Withdrawal by Subject|0|||
149809923|NCT01643928|540433500|FG002|Overall Study|Withdrawal by Subject|0|||
150149425|NCT05067933|541683283|FG004|Overall Study|Miscellaneous|0|||
150149426|NCT05067933|541683284|FG005|Overall Study|Miscellaneous|0|||
150149427|NCT05067933|541683279|FG000|Overall Study|Death|0|||
150149428|NCT05067933|541683280|FG001|Overall Study|Death|0|||
150149429|NCT05067933|541683281|FG002|Overall Study|Death|0|||
150149430|NCT05067933|541683282|FG003|Overall Study|Death|1|||
150149431|NCT05067933|541683283|FG004|Overall Study|Death|0|||
150149432|NCT05067933|541683284|FG005|Overall Study|Death|0|||
150149433|NCT03311230|541683285|FG000|Overall Study|Withdrawal by Subject|1|||
150149434|NCT03311230|541683286|FG001|Overall Study|Withdrawal by Subject|4|||
150149435|NCT03311230|541683287|FG002|Overall Study|Withdrawal by Subject|2|||
150149436|NCT03311230|541683288|FG003|Overall Study|Withdrawal by Subject|7|||
150149437|NCT03311230|541683285|FG000|Overall Study|Unrelated injury|0|||
150149438|NCT03311230|541683286|FG001|Overall Study|Unrelated injury|1|||
149809924|NCT01643928|540433501|FG003|Overall Study|Withdrawal by Subject|1|||
149809925|NCT01643928|540433502|FG004|Overall Study|Withdrawal by Subject|0|||
149809926|NCT01643928|540433498|FG000|Overall Study|Pregnancy|0|||
150149439|NCT03311230|541683287|FG002|Overall Study|Unrelated injury|0|||
150149440|NCT03311230|541683288|FG003|Overall Study|Unrelated injury|0|||
149809927|NCT01643928|540433499|FG001|Overall Study|Pregnancy|0|||
149809928|NCT01643928|540433500|FG002|Overall Study|Pregnancy|0|||
149809929|NCT01643928|540433501|FG003|Overall Study|Pregnancy|1|||
149809930|NCT01643928|540433502|FG004|Overall Study|Pregnancy|0|||
149809931|NCT01643928|540433498|FG000|Overall Study|Other|5|||
149809932|NCT01643928|540433499|FG001|Overall Study|Other|1|||
149809933|NCT01643928|540433500|FG002|Overall Study|Other|1|||
149809934|NCT01643928|540433501|FG003|Overall Study|Other|0|||
150149441|NCT03342053|541683289|FG000|Overall Study|Adverse Event|2|||
150149442|NCT03342053|541683290|FG001|Overall Study|Adverse Event|0|||
150149443|NCT03342053|541683289|FG000|Overall Study|Withdrawal by Subject|0|||
150149444|NCT03342053|541683290|FG001|Overall Study|Withdrawal by Subject|1|||
149809935|NCT01643928|540433502|FG004|Overall Study|Other|0|||
149809936|NCT01643928|540433498|FG000|Overall Study|Adverse Event|2|||
150149445|NCT01302938|541683291|FG000|Overall Study|Withdrawal by Subject|1|||
149809937|NCT01643928|540433499|FG001|Overall Study|Adverse Event|1|||
149809938|NCT01643928|540433500|FG002|Overall Study|Adverse Event|0|||
149809939|NCT01643928|540433501|FG003|Overall Study|Adverse Event|1|||
149809940|NCT01643928|540433502|FG004|Overall Study|Adverse Event|2|||
149809941|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
149809942|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
149809943|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
149809944|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
149809945|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
149809946|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
149809947|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
149809948|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
149809949|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
149809950|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
149809951|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
149809952|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
149809953|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
149809954|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
149809955|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
149809956|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
149809957|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
149809958|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
149809959|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
149809960|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
149809961|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
149809962|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
149809963|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
149809964|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
149809965|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
149809966|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
149809967|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
149809968|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
149809969|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
149809970|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
149809971|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
149809972|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
149809973|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
149809974|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
149809975|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
149809976|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
149809977|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
149809978|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
149809979|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
149809980|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
149809981|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
149809982|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
149809983|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
149809984|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
149809985|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
149809986|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
149809987|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
149809988|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
149809989|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
149809990|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
149809991|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
149809992|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
149809993|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
149809994|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
149809995|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
149809996|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
149809997|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
150149446|NCT01302938|541683292|FG001|Overall Study|Withdrawal by Subject|0|||
150149447|NCT01302938|541683291|FG000|Overall Study|Adverse Event|1|||
150149448|NCT01302938|541683292|FG001|Overall Study|Adverse Event|0|||
150149449|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
150149450|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
150149451|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
150149452|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
150149453|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
150149454|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
150149455|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
150149456|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
150149457|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
150149458|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149809998|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
149809999|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
149810000|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
149810001|NCT03395197|540433505|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
149810002|NCT03395197|540433506|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
149810003|NCT03395197|540433507|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
149810004|NCT03395197|540433508|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
149810005|NCT03395197|540433509|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
149810006|NCT03395197|540433510|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
150149459|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
150149460|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149810007|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Death|0|||
150149461|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
150149462|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149810008|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Death|0|||
149810009|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Death|0|||
149810010|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Death|0|||
149810011|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Death|1|||
149810012|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Death|4|||
149810013|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
149810014|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
149810015|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
149810016|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
149810017|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
149810018|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
149810019|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
149810020|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
149810021|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
149810022|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
149810023|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
150149463|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
150149464|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
150149465|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
150149466|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149810024|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
149810025|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
149810026|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
149810027|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
149810028|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
149810029|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
150149467|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150149468|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150149469|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150149470|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
150149471|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
150149472|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
150149473|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149810030|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
149810031|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
149810032|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
149810033|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
149810034|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
150149474|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
150149475|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
150149476|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
150149477|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
150149478|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
150149479|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
150149480|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
150149481|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
150149482|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149810035|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
149810036|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
150149483|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
150149484|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
150149485|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
150149486|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
149810037|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
149810038|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
149810039|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
149810040|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
149810041|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
149810042|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
149810043|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
149810044|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
149810045|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
149810046|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
149810047|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
149810048|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
149810049|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Other|0|||
149810050|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Other|0|||
149810051|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Other|0|||
149810052|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Other|0|||
149810053|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Other|3|||
149810054|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Other|3|||
149810055|NCT03395197|540433505|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
149810056|NCT03395197|540433506|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
149810057|NCT03395197|540433507|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
149810058|NCT03395197|540433508|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
149810059|NCT03395197|540433509|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
150149487|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150149488|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150149489|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150149490|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150149491|NCT04921969|541683298|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
150149492|NCT04921969|541683299|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
150149493|NCT04921969|541683300|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
150149494|NCT04921969|541683301|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
150149495|NCT04921969|541683302|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
150149496|NCT04921969|541683303|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
150149497|NCT04921969|541683304|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
150149498|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149499|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149500|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149501|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149502|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149503|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
150149504|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
150149505|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150149506|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149810060|NCT03395197|540433510|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
149810061|NCT00602641|540433511|FG000|Overall Study|Never started protocol therapy|6|||
149810062|NCT00602641|540433512|FG001|Overall Study|Never started protocol therapy|2|||
150149507|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149810063|NCT00602641|540433511|FG000|Overall Study|Still on treatment at time of analysis|8|||
149810064|NCT00602641|540433512|FG001|Overall Study|Still on treatment at time of analysis|15|||
149810065|NCT00602641|540433511|FG000|Overall Study|Adverse Event|62|||
149810066|NCT00602641|540433512|FG001|Overall Study|Adverse Event|53|||
150149508|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
150149509|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150149510|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
149810067|NCT00602641|540433511|FG000|Overall Study|Disease progression|38|||
149810068|NCT00602641|540433512|FG001|Overall Study|Disease progression|55|||
149810069|NCT00602641|540433511|FG000|Overall Study|Death|6|||
149810070|NCT00602641|540433512|FG001|Overall Study|Death|5|||
149810071|NCT00602641|540433511|FG000|Overall Study|Withdrawal by Subject|15|||
149810072|NCT00602641|540433512|FG001|Overall Study|Withdrawal by Subject|12|||
149810073|NCT00602641|540433511|FG000|Overall Study|Alternative therapy|5|||
149810074|NCT00602641|540433512|FG001|Overall Study|Alternative therapy|2|||
149810075|NCT00602641|540433511|FG000|Overall Study|Other Complicating Disease|5|||
149810076|NCT00602641|540433512|FG001|Overall Study|Other Complicating Disease|2|||
149810077|NCT00602641|540433511|FG000|Overall Study|Physician Decision|5|||
149810078|NCT00602641|540433512|FG001|Overall Study|Physician Decision|4|||
149810079|NCT00602641|540433511|FG000|Overall Study|Administrative Closure|1|||
149810080|NCT00602641|540433512|FG001|Overall Study|Administrative Closure|1|||
149810081|NCT00602641|540433511|FG000|Overall Study|Other|3|||
149810082|NCT00602641|540433512|FG001|Overall Study|Other|1|||
149810083|NCT01988337|540433516|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
149810084|NCT04701658|540433517|FG000|Overall Study|Lost to Follow-up|6|||
149810085|NCT01785472|540433518|FG000|Overall Study|Adverse Event|5|||
149810086|NCT01785472|540433519|FG001|Overall Study|Adverse Event|4|||
149810087|NCT01785472|540433520|FG002|Overall Study|Adverse Event|6|||
149810088|NCT01785472|540433518|FG000|Overall Study|Lack of Efficacy|2|||
149810089|NCT01785472|540433519|FG001|Overall Study|Lack of Efficacy|0|||
149810090|NCT01785472|540433520|FG002|Overall Study|Lack of Efficacy|1|||
149810091|NCT01785472|540433518|FG000|Overall Study|Lost to Follow-up|1|||
149810092|NCT01785472|540433519|FG001|Overall Study|Lost to Follow-up|2|||
149810093|NCT01785472|540433520|FG002|Overall Study|Lost to Follow-up|0|||
149810094|NCT01785472|540433518|FG000|Overall Study|Physician Decision|1|||
149810095|NCT01785472|540433519|FG001|Overall Study|Physician Decision|1|||
149810096|NCT01785472|540433520|FG002|Overall Study|Physician Decision|1|||
149810097|NCT01785472|540433518|FG000|Overall Study|Protocol deviation|0|||
149810098|NCT01785472|540433519|FG001|Overall Study|Protocol deviation|2|||
149810099|NCT01785472|540433520|FG002|Overall Study|Protocol deviation|2|||
149810100|NCT01785472|540433518|FG000|Overall Study|Subject/guardian decision|15|||
149810101|NCT01785472|540433519|FG001|Overall Study|Subject/guardian decision|10|||
149810102|NCT01785472|540433520|FG002|Overall Study|Subject/guardian decision|11|||
149810103|NCT01785472|540433518|FG000|Overall Study|Technical problems|0|||
149810104|NCT01785472|540433519|FG001|Overall Study|Technical problems|0|||
149810105|NCT01785472|540433520|FG002|Overall Study|Technical problems|1|||
149810106|NCT03099161|540433523|FG000|Overall Study|Adverse Event|0|||
149810107|NCT03099161|540433524|FG001|Overall Study|Adverse Event|0|||
149810108|NCT03099161|540433525|FG002|Overall Study|Adverse Event|2|||
149810109|NCT03099161|540433523|FG000|Overall Study|Physician Decision|2|||
149810110|NCT03099161|540433524|FG001|Overall Study|Physician Decision|0|||
149810111|NCT03099161|540433525|FG002|Overall Study|Physician Decision|0|||
149810112|NCT03099161|540433523|FG000|Overall Study|Progressive Disease|1|||
149810113|NCT03099161|540433524|FG001|Overall Study|Progressive Disease|4|||
149810114|NCT03099161|540433525|FG002|Overall Study|Progressive Disease|1|||
149810115|NCT00110084|540433526|FG000|Overall Study|Adverse Event|9|||
149810116|NCT00110084|540433526|FG000|Overall Study|Death|1|||
149810117|NCT00110084|540433526|FG000|Overall Study|Patient Refusal|10|||
149810118|NCT00110084|540433526|FG000|Overall Study|Alternate Therapy|5|||
149810119|NCT00110084|540433526|FG000|Overall Study|Intercurrent Illness|1|||
149810120|NCT00110084|540433526|FG000|Overall Study|Other|2|||
149810121|NCT05511428|540433528|FG000|Overall Study|Withdrawal by Subject|1|||
149810122|NCT05511428|540433528|FG000|Overall Study|Adverse Event|1|||
149810123|NCT00943384|540433529|FG000|Overall Study|Dispositioned prior to treatment|23|||
149810124|NCT00943384|540433529|FG000|Overall Study|Treated off protocol-protocol violation|5|||
149810125|NCT00943384|540433529|FG000|Overall Study|Lost to Follow-up|16|||
149810126|NCT00943384|540433529|FG000|Overall Study|Withdrawal by Subject|5|||
149810127|NCT04088734|540433530|FG000|Overall Study|Other, Not Specified|5|||
149810128|NCT00096200|540433531|FG000|Overall Study|Adverse Event|0|||
149810129|NCT00096200|540433532|FG001|Overall Study|Adverse Event|4|||
149810130|NCT00096200|540433533|FG002|Overall Study|Adverse Event|0|||
149810131|NCT00096200|540433531|FG000|Overall Study|Withdrawal by Subject|1|||
149810132|NCT00096200|540433532|FG001|Overall Study|Withdrawal by Subject|2|||
149810133|NCT00096200|540433533|FG002|Overall Study|Withdrawal by Subject|0|||
149810134|NCT00096200|540433531|FG000|Overall Study|Ineligible pathology|0|||
149810135|NCT00096200|540433532|FG001|Overall Study|Ineligible pathology|1|||
149810136|NCT00096200|540433533|FG002|Overall Study|Ineligible pathology|0|||
149810137|NCT03611751|540433534|FG000|Pre-treatment|Randomized but not treated|1|||
149810138|NCT03611751|540433535|FG001|Pre-treatment|Randomized but not treated|1|||
149810139|NCT03611751|540433536|FG002|Pre-treatment|Randomized but not treated|0|||
149810140|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
149810141|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
149810142|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
149810143|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
149810144|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
149810145|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
149810146|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
149810147|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
149810148|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
149810149|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
149810150|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
149810151|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
149810152|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
149810153|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
149810154|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
149810155|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
149810156|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
149810157|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
149810158|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
149810159|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
149810160|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
149810161|NCT03611751|540433534|FG000|Treatment Week 0 - Week 16|Death|0|||
149810162|NCT03611751|540433535|FG001|Treatment Week 0 - Week 16|Death|0|||
149810163|NCT03611751|540433536|FG002|Treatment Week 0 - Week 16|Death|1|||
149810164|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
149810165|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
149810166|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
149810167|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
149810168|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
149810169|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
149810170|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
149810171|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
149810172|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
149810173|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
149810174|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
149810175|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
149810176|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
149810177|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
149810178|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
149810179|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
149810180|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
149810181|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
149810182|NCT03611751|540433534|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
149810183|NCT03611751|540433535|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
149810184|NCT03611751|540433536|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
149810185|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
149810186|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
149810187|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
149810188|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
149810189|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
149810190|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
149810191|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
149810192|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
149810193|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
149810194|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
149810195|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
149810196|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
149810197|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
149810198|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
149810199|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
149810200|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
149810201|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
149810202|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
149810203|NCT03611751|540433534|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
149810204|NCT03611751|540433535|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
149810205|NCT03611751|540433536|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
149810206|NCT05004181|540433537|FG000|Overall Study|Withdrawal of consent|0|||
149810207|NCT05004181|540433538|FG001|Overall Study|Withdrawal of consent|0|||
150149511|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
149810208|NCT05004181|540433539|FG002|Overall Study|Withdrawal of consent|1|||
149810209|NCT05004181|540433540|FG003|Overall Study|Withdrawal of consent|3|||
149810210|NCT05004181|540433541|FG004|Overall Study|Withdrawal of consent|3|||
149810211|NCT05004181|540433542|FG005|Overall Study|Withdrawal of consent|0|||
149810212|NCT05004181|540433543|FG006|Overall Study|Withdrawal of consent|30|||
149810213|NCT05004181|540433544|FG007|Overall Study|Withdrawal of consent|9|||
149810214|NCT05004181|540433545|FG008|Overall Study|Withdrawal of consent|3|||
149810215|NCT05004181|540433546|FG009|Overall Study|Withdrawal of consent|2|||
149810216|NCT05004181|540433547|FG010|Overall Study|Withdrawal of consent|5|||
149810217|NCT05004181|540433548|FG011|Overall Study|Withdrawal of consent|1|||
149810218|NCT05004181|540433537|FG000|Overall Study|Lost to Follow-up|2|||
149810219|NCT05004181|540433538|FG001|Overall Study|Lost to Follow-up|4|||
149810220|NCT05004181|540433539|FG002|Overall Study|Lost to Follow-up|2|||
149810221|NCT05004181|540433540|FG003|Overall Study|Lost to Follow-up|3|||
149810222|NCT05004181|540433541|FG004|Overall Study|Lost to Follow-up|5|||
149810223|NCT05004181|540433542|FG005|Overall Study|Lost to Follow-up|2|||
149810224|NCT05004181|540433543|FG006|Overall Study|Lost to Follow-up|15|||
149810225|NCT05004181|540433544|FG007|Overall Study|Lost to Follow-up|12|||
149810226|NCT05004181|540433545|FG008|Overall Study|Lost to Follow-up|38|||
149810227|NCT05004181|540433546|FG009|Overall Study|Lost to Follow-up|6|||
149810228|NCT05004181|540433547|FG010|Overall Study|Lost to Follow-up|6|||
149810229|NCT05004181|540433548|FG011|Overall Study|Lost to Follow-up|0|||
149810230|NCT05004181|540433537|FG000|Overall Study|Death|0|||
149810231|NCT05004181|540433538|FG001|Overall Study|Death|0|||
149810232|NCT05004181|540433539|FG002|Overall Study|Death|0|||
149810233|NCT05004181|540433540|FG003|Overall Study|Death|0|||
149810234|NCT05004181|540433541|FG004|Overall Study|Death|0|||
149810235|NCT05004181|540433542|FG005|Overall Study|Death|0|||
149810236|NCT05004181|540433543|FG006|Overall Study|Death|1|||
149810237|NCT05004181|540433544|FG007|Overall Study|Death|0|||
149810238|NCT05004181|540433545|FG008|Overall Study|Death|2|||
149810239|NCT05004181|540433546|FG009|Overall Study|Death|0|||
149810240|NCT05004181|540433547|FG010|Overall Study|Death|0|||
149810241|NCT05004181|540433548|FG011|Overall Study|Death|0|||
149810242|NCT05004181|540433537|FG000|Overall Study|Physician Decision|0|||
149810243|NCT05004181|540433538|FG001|Overall Study|Physician Decision|0|||
149810244|NCT05004181|540433539|FG002|Overall Study|Physician Decision|0|||
149810245|NCT05004181|540433540|FG003|Overall Study|Physician Decision|0|||
149810246|NCT05004181|540433541|FG004|Overall Study|Physician Decision|0|||
149810247|NCT05004181|540433542|FG005|Overall Study|Physician Decision|0|||
149810248|NCT05004181|540433543|FG006|Overall Study|Physician Decision|2|||
149810249|NCT05004181|540433544|FG007|Overall Study|Physician Decision|0|||
149810250|NCT05004181|540433545|FG008|Overall Study|Physician Decision|7|||
149810251|NCT05004181|540433546|FG009|Overall Study|Physician Decision|0|||
149810252|NCT05004181|540433547|FG010|Overall Study|Physician Decision|0|||
149810253|NCT05004181|540433548|FG011|Overall Study|Physician Decision|0|||
149810254|NCT05004181|540433537|FG000|Overall Study|Withdrawal by Subject|2|||
149810255|NCT05004181|540433538|FG001|Overall Study|Withdrawal by Subject|3|||
149810256|NCT05004181|540433539|FG002|Overall Study|Withdrawal by Subject|2|||
149810257|NCT05004181|540433540|FG003|Overall Study|Withdrawal by Subject|2|||
149810258|NCT05004181|540433541|FG004|Overall Study|Withdrawal by Subject|4|||
149810259|NCT05004181|540433542|FG005|Overall Study|Withdrawal by Subject|2|||
149810260|NCT05004181|540433543|FG006|Overall Study|Withdrawal by Subject|4|||
149810261|NCT05004181|540433544|FG007|Overall Study|Withdrawal by Subject|22|||
149810262|NCT05004181|540433545|FG008|Overall Study|Withdrawal by Subject|8|||
149810263|NCT05004181|540433546|FG009|Overall Study|Withdrawal by Subject|1|||
149810264|NCT05004181|540433547|FG010|Overall Study|Withdrawal by Subject|3|||
149810265|NCT05004181|540433548|FG011|Overall Study|Withdrawal by Subject|2|||
149810266|NCT05004181|540433537|FG000|Overall Study|Protocol Violation|2|||
149810267|NCT05004181|540433538|FG001|Overall Study|Protocol Violation|3|||
149810268|NCT05004181|540433539|FG002|Overall Study|Protocol Violation|0|||
149810269|NCT05004181|540433540|FG003|Overall Study|Protocol Violation|0|||
149810270|NCT05004181|540433541|FG004|Overall Study|Protocol Violation|1|||
149810271|NCT05004181|540433542|FG005|Overall Study|Protocol Violation|0|||
149810272|NCT05004181|540433543|FG006|Overall Study|Protocol Violation|16|||
149810273|NCT05004181|540433544|FG007|Overall Study|Protocol Violation|18|||
149810274|NCT05004181|540433545|FG008|Overall Study|Protocol Violation|2|||
149810275|NCT05004181|540433546|FG009|Overall Study|Protocol Violation|2|||
149810276|NCT05004181|540433547|FG010|Overall Study|Protocol Violation|2|||
149810277|NCT05004181|540433548|FG011|Overall Study|Protocol Violation|1|||
149810278|NCT05004181|540433537|FG000|Overall Study|Not further specified|1|||
149810279|NCT05004181|540433538|FG001|Overall Study|Not further specified|0|||
149810280|NCT05004181|540433539|FG002|Overall Study|Not further specified|0|||
149810281|NCT05004181|540433540|FG003|Overall Study|Not further specified|0|||
149810282|NCT05004181|540433541|FG004|Overall Study|Not further specified|0|||
150149512|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149810283|NCT05004181|540433542|FG005|Overall Study|Not further specified|0|||
149810284|NCT05004181|540433543|FG006|Overall Study|Not further specified|1|||
149810285|NCT05004181|540433544|FG007|Overall Study|Not further specified|0|||
149810286|NCT05004181|540433545|FG008|Overall Study|Not further specified|2|||
149810287|NCT05004181|540433546|FG009|Overall Study|Not further specified|1|||
149810288|NCT05004181|540433547|FG010|Overall Study|Not further specified|0|||
149810289|NCT05004181|540433548|FG011|Overall Study|Not further specified|1|||
149810290|NCT03868059|540433550|FG000|Overall Study|Adverse Event|3|||
149810291|NCT03868059|540433550|FG000|Overall Study|Lost to Follow-up|3|||
149810292|NCT03868059|540433550|FG000|Overall Study|Withdrawal by Subject|6|||
149810293|NCT04066894|540433551|FG000|Overall Study|Lack of Efficacy|1|||
149810294|NCT04066894|540433551|FG000|Overall Study|Screen Failure|1|||
149810295|NCT04278872|540433552|FG000|Overall Study|Adverse Event|1|||
149810296|NCT04278872|540433553|FG001|Overall Study|Adverse Event|0|||
150149513|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
150149514|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
150149515|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
150149516|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
150149517|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
150149518|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
150149519|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
150149520|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
150149521|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
150149522|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
150149523|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
150149524|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
150149525|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
150149526|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149810297|NCT04278872|540433552|FG000|Overall Study|Protocol Violation|0|||
149810298|NCT04278872|540433553|FG001|Overall Study|Protocol Violation|1|||
149810299|NCT04278872|540433552|FG000|Overall Study|Study Termination|2|||
149810300|NCT04278872|540433553|FG001|Overall Study|Study Termination|0|||
149810301|NCT01283282|540433558|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
149810302|NCT01283282|540433559|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
149810303|NCT01283282|540433558|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
149810304|NCT01283282|540433559|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
149810305|NCT01283282|540433558|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
149810306|NCT01283282|540433559|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
149810307|NCT00096031|540433560|FG000|Overall Study|Adverse Event|3|||
149810308|NCT00096031|540433560|FG000|Overall Study|Lack of Efficacy|42|||
149810309|NCT00096031|540433560|FG000|Overall Study|Death|4|||
149810310|NCT00096031|540433560|FG000|Overall Study|Withdrawal by Subject|1|||
149810311|NCT00096031|540433560|FG000|Overall Study|Ineligible|8|||
149810312|NCT00096031|540433560|FG000|Overall Study|Not protocol specified|5|||
149810313|NCT00083226|540433561|FG000|Overall Study|Lack of Efficacy|19|||
149810314|NCT00083226|540433561|FG000|Overall Study|Adverse Event|9|||
149810315|NCT00083226|540433561|FG000|Overall Study|Death|4|||
149810316|NCT00083226|540433561|FG000|Overall Study|Withdrawal by Subject|4|||
149810317|NCT00083226|540433561|FG000|Overall Study|Other|2|||
149810318|NCT00083226|540433561|FG000|Overall Study|ineligible or not receiving treatment|4|||
149810319|NCT00909857|540433562|FG000|Overall Study|Withdrawal by Subject|6|||
149810320|NCT00909857|540433563|FG001|Overall Study|Withdrawal by Subject|10|||
149810321|NCT00909857|540433562|FG000|Overall Study|Adverse Event|5|||
149810322|NCT00909857|540433563|FG001|Overall Study|Adverse Event|5|||
149810323|NCT00909857|540433562|FG000|Overall Study|Lost to Follow-up|2|||
149810324|NCT00909857|540433563|FG001|Overall Study|Lost to Follow-up|5|||
149810325|NCT00909857|540433562|FG000|Overall Study|Protocol Violation|2|||
149810326|NCT00909857|540433563|FG001|Overall Study|Protocol Violation|1|||
149810327|NCT00909857|540433562|FG000|Overall Study|Pregnancy|1|||
149810328|NCT00909857|540433563|FG001|Overall Study|Pregnancy|0|||
150149527|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
150149528|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
150149529|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
150149530|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
150149531|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
150149532|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
150149533|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
150149534|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
150149535|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
150149536|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
150149537|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
150149538|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
150149539|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
149810329|NCT00909857|540433562|FG000|Overall Study|Other|1|||
149810330|NCT00909857|540433563|FG001|Overall Study|Other|0|||
149810331|NCT00909857|540433562|FG000|Overall Study|Did not receive study medication|19|||
149810332|NCT00909857|540433563|FG001|Overall Study|Did not receive study medication|24|||
149810333|NCT03878108|540433564|FG000|Overall Study|Adverse Event|1|||
149810334|NCT03878108|540433565|FG001|Overall Study|Adverse Event|0|||
149810335|NCT01682681|540433572|FG000|Overall Study|Lack of Efficacy|62|||
149810336|NCT01682681|540433572|FG000|Overall Study|Withdrawal by Subject|1|||
149810337|NCT01682681|540433572|FG000|Overall Study|Moved to other hospital|10|||
149810338|NCT01682681|540433572|FG000|Overall Study|Lost to Follow-up|174|||
149810339|NCT01682681|540433572|FG000|Overall Study|Adverse Event|46|||
150149540|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149810340|NCT01682681|540433572|FG000|Overall Study|tapering of topiramate|5|||
149810341|NCT01682681|540433572|FG000|Overall Study|Other|21|||
149810342|NCT01682681|540433572|FG000|Overall Study|Low compliance|13|||
149810343|NCT02044094|540433575|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
149810344|NCT02044094|540433575|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
149810345|NCT02044094|540433575|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
149810346|NCT02044094|540433575|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
149810347|NCT02044094|540433575|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
149810348|NCT02044094|540433575|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
149810349|NCT02044094|540433575|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
149810350|NCT02044094|540433575|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
149810351|NCT03205163|540433576|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
149810352|NCT03205163|540433577|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
149810353|NCT00005879|540433578|FG000|Overall Study|Withdrawal by Subject|8|||
149810354|NCT00005879|540433579|FG001|Overall Study|Withdrawal by Subject|10|||
149810355|NCT01238172|540433580|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
149810356|NCT01238172|540433581|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
149810357|NCT01238172|540433580|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
149810358|NCT01238172|540433581|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
149810359|NCT05022121|540433582|FG000|Overall Study|Lack of Efficacy|1|||
149810360|NCT05022121|540433583|FG001|Overall Study|Lack of Efficacy|0|||
149810361|NCT05022121|540433582|FG000|Overall Study|Lost to Follow-up|0|||
149810362|NCT05022121|540433583|FG001|Overall Study|Lost to Follow-up|2|||
149810363|NCT04502862|540433584|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
149810364|NCT04502862|540433585|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
149810365|NCT04502862|540433584|FG000|Overall Study|Withdrawal by Subject|1|||
149810366|NCT04502862|540433585|FG001|Overall Study|Withdrawal by Subject|0|||
149810367|NCT04502862|540433584|FG000|Overall Study|Adverse Event|1|||
149810368|NCT04502862|540433585|FG001|Overall Study|Adverse Event|1|||
149810369|NCT00391092|540434770|FG000|Overall Study|Death|78|||
149810370|NCT00391092|540434771|FG001|Overall Study|Death|81|||
149810371|NCT00391092|540434770|FG000|Overall Study|Lost to Follow-up|13|||
149810372|NCT00391092|540434771|FG001|Overall Study|Lost to Follow-up|18|||
149810373|NCT00391092|540434770|FG000|Overall Study|Alive on treatment|29|||
149810374|NCT00391092|540434771|FG001|Overall Study|Alive on treatment|33|||
149810375|NCT00391092|540434770|FG000|Overall Study|Alive in follow-up|88|||
149810376|NCT00391092|540434771|FG001|Overall Study|Alive in follow-up|84|||
149810377|NCT00858234|540434772|FG000|Overall Study|Adverse Event|6|||
149810378|NCT00858234|540434772|FG000|Overall Study|Progressive disease|2|||
149810379|NCT00858234|540434772|FG000|Overall Study|Status unknown|1|||
149810380|NCT02428231|540434775|FG000|Overall Study|Other|10|||
149810381|NCT02428231|540434776|FG001|Overall Study|Other|16|||
149810382|NCT02428231|540434775|FG000|Overall Study|Required Symptomatic Therapy|0|||
149810383|NCT02428231|540434776|FG001|Overall Study|Required Symptomatic Therapy|1|||
149810384|NCT02428231|540434775|FG000|Overall Study|Adverse Event|3|||
149810385|NCT02428231|540434776|FG001|Overall Study|Adverse Event|0|||
149810386|NCT01652573|540434777|FG000|Overall Study|Adverse Event|0|||
149810387|NCT01652573|540434778|FG001|Overall Study|Adverse Event|1|||
149810388|NCT01052038|540434782|FG000|Overall Study|Lost to Follow-up|2|||
149810389|NCT01052038|540434783|FG001|Overall Study|Lost to Follow-up|3|||
149810390|NCT01052038|540434784|FG002|Overall Study|Lost to Follow-up|1|||
149810391|NCT01052038|540434782|FG000|Overall Study|Protocol Violation|2|||
149810392|NCT01052038|540434783|FG001|Overall Study|Protocol Violation|3|||
149810393|NCT01052038|540434784|FG002|Overall Study|Protocol Violation|3|||
149810394|NCT03901352|540434785|FG000|Double-blind Phase|Adverse Event|6|||
149810395|NCT03901352|540434786|FG001|Double-blind Phase|Adverse Event|4|||
149810396|NCT03901352|540434785|FG000|Double-blind Phase|Death|1|||
149810397|NCT03901352|540434786|FG001|Double-blind Phase|Death|0|||
149810398|NCT03901352|540434785|FG000|Double-blind Phase|Lack of Efficacy|0|||
149810399|NCT03901352|540434786|FG001|Double-blind Phase|Lack of Efficacy|1|||
150149541|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
150149542|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
150149543|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
150149544|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149810400|NCT03901352|540434785|FG000|Double-blind Phase|Protocol Violation|0|||
149810401|NCT03901352|540434786|FG001|Double-blind Phase|Protocol Violation|1|||
150149545|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
150149546|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
149810402|NCT03901352|540434785|FG000|Double-blind Phase|Withdrawal by Subject|10|||
149810403|NCT03901352|540434786|FG001|Double-blind Phase|Withdrawal by Subject|8|||
149810404|NCT03901352|540434785|FG000|Open-label Extension Phase|Adverse Event|24|||
149810405|NCT03901352|540434786|FG001|Open-label Extension Phase|Adverse Event|0|||
149810406|NCT03901352|540434785|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
149810407|NCT03901352|540434786|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
149810408|NCT03901352|540434785|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
149810409|NCT03901352|540434786|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
149810410|NCT03901352|540434785|FG000|Open-label Extension Phase|Other|1|||
149810411|NCT03901352|540434786|FG001|Open-label Extension Phase|Other|0|||
149810412|NCT01615822|540434789|FG000|Period 1|Withdrawal by Subject|0|||
149810413|NCT01615822|540434790|FG001|Period 1|Withdrawal by Subject|1|||
149810414|NCT01615822|540434791|FG002|Period 1|Withdrawal by Subject|0|||
149810415|NCT01615822|540434789|FG000|Period 1|Adverse Event|1|||
149810416|NCT01615822|540434790|FG001|Period 1|Adverse Event|1|||
149810417|NCT01615822|540434791|FG002|Period 1|Adverse Event|0|||
149810418|NCT01615822|540434789|FG000|Period 2|Lost to Follow-up|0|||
149810419|NCT01615822|540434790|FG001|Period 2|Lost to Follow-up|1|||
149810420|NCT01615822|540434791|FG002|Period 2|Lost to Follow-up|2|||
149810421|NCT03981614|540434792|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
149810422|NCT03981614|540434793|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
149810423|NCT03981614|540434794|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
149810424|NCT03901339|540434795|FG000|Overall Study|Death|220|||
149810425|NCT03901339|540434796|FG001|Overall Study|Death|192|||
149810426|NCT03901339|540434795|FG000|Overall Study|Informed consent withdrawn|13|||
149810427|NCT03901339|540434796|FG001|Overall Study|Informed consent withdrawn|40|||
149810428|NCT03901339|540434795|FG000|Overall Study|Sponsor request|30|||
149810429|NCT03901339|540434796|FG001|Overall Study|Sponsor request|23|||
149810430|NCT03901339|540434795|FG000|Overall Study|Reason not specified|5|||
149810431|NCT03901339|540434796|FG001|Overall Study|Reason not specified|7|||
149810432|NCT03901339|540434795|FG000|Overall Study|Lost to Follow-up|4|||
149810433|NCT03901339|540434796|FG001|Overall Study|Lost to Follow-up|7|||
149810434|NCT03901339|540434795|FG000|Overall Study|Covid19|0|||
149810435|NCT03901339|540434796|FG001|Overall Study|Covid19|2|||
149810436|NCT02742818|540434797|FG000|Overall Study|Adverse Event|0|||
149810437|NCT02742818|540434798|FG001|Overall Study|Adverse Event|1|||
149810438|NCT02742818|540434797|FG000|Overall Study|Protocol Violation|0|||
149810439|NCT02742818|540434798|FG001|Overall Study|Protocol Violation|1|||
149810440|NCT02643394|540434799|FG000|Overall Study|Protocol Violation|4|||
149810441|NCT02643394|540434800|FG001|Overall Study|Protocol Violation|5|||
149810442|NCT00835068|540434803|FG000|Overall Study|Death|1|||
149810443|NCT00835068|540434804|FG001|Overall Study|Death|0|||
149810444|NCT00835068|540434803|FG000|Overall Study|Adverse Event|0|||
149810445|NCT00835068|540434804|FG001|Overall Study|Adverse Event|1|||
149810446|NCT00835068|540434803|FG000|Overall Study|Other|8|||
149810447|NCT00835068|540434804|FG001|Overall Study|Other|0|||
149810448|NCT00835068|540434803|FG000|Overall Study|Withdrawal by Subject|1|||
149810449|NCT00835068|540434804|FG001|Overall Study|Withdrawal by Subject|0|||
149810450|NCT04971226|540434807|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
149810451|NCT04971226|540434808|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
149810452|NCT04971226|540434809|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
149810453|NCT04971226|540434810|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
149810454|NCT04971226|540434807|FG000|Overall Study|Adverse Event|6|||
149810455|NCT04971226|540434808|FG001|Overall Study|Adverse Event|5|||
149810456|NCT04971226|540434809|FG002|Overall Study|Adverse Event|11|||
149810457|NCT04971226|540434810|FG003|Overall Study|Adverse Event|10|||
149810458|NCT04971226|540434807|FG000|Overall Study|Progressive disease|2|||
149810459|NCT04971226|540434808|FG001|Overall Study|Progressive disease|0|||
149810460|NCT04971226|540434809|FG002|Overall Study|Progressive disease|3|||
149810461|NCT04971226|540434810|FG003|Overall Study|Progressive disease|1|||
149810462|NCT04971226|540434807|FG000|Overall Study|Protocol Deviation|1|||
149810463|NCT04971226|540434808|FG001|Overall Study|Protocol Deviation|0|||
149810464|NCT04971226|540434809|FG002|Overall Study|Protocol Deviation|1|||
149810465|NCT04971226|540434810|FG003|Overall Study|Protocol Deviation|1|||
149810466|NCT04971226|540434807|FG000|Overall Study|Subject Decision|0|||
149810467|NCT04971226|540434808|FG001|Overall Study|Subject Decision|1|||
149810468|NCT04971226|540434809|FG002|Overall Study|Subject Decision|1|||
149810469|NCT04971226|540434810|FG003|Overall Study|Subject Decision|1|||
149810470|NCT04971226|540434807|FG000|Overall Study|Pregnancy|0|||
149810471|NCT04971226|540434808|FG001|Overall Study|Pregnancy|0|||
149810472|NCT04971226|540434809|FG002|Overall Study|Pregnancy|0|||
149810473|NCT04971226|540434810|FG003|Overall Study|Pregnancy|1|||
149810474|NCT04971226|540434807|FG000|Overall Study|Participants not treated|1|||
149810475|NCT04971226|540434808|FG001|Overall Study|Participants not treated|0|||
149810476|NCT04971226|540434809|FG002|Overall Study|Participants not treated|2|||
149810477|NCT04971226|540434810|FG003|Overall Study|Participants not treated|1|||
149810478|NCT04439149|540434811|FG000|Overall Study|Ineligible|1|||
149810479|NCT04439149|540434811|FG000|Overall Study|Never start protocol therapy|1|||
149810480|NCT04439149|540434811|FG000|Overall Study|Adverse Event|4|||
149810481|NCT04439149|540434811|FG000|Overall Study|Disease Progression|14|||
149810482|NCT04439149|540434811|FG000|Overall Study|Complicating disease|1|||
149810483|NCT04439149|540434811|FG000|Overall Study|Withdrawal by Subject|3|||
149810484|NCT05264506|540434814|FG000|Overall Study|Adverse Event|59|||
149810485|NCT05264506|540434814|FG000|Overall Study|Lost to Follow-up|204|||
149810486|NCT05264506|540434814|FG000|Overall Study|Protocol Violation|185|||
149810487|NCT05264506|540434814|FG000|Overall Study|Pregnancy|60|||
149810488|NCT05264506|540434814|FG000|Overall Study|Physician Decision|6|||
149810489|NCT05264506|540434814|FG000|Overall Study|Non-compliance with Study Drug|29|||
149810490|NCT05264506|540434814|FG000|Overall Study|Study termination|677|||
149810491|NCT05264506|540434814|FG000|Overall Study|Withdrawal by Subject|208|||
150149547|NCT04921969|541683298|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
150149548|NCT04921969|541683299|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
150149549|NCT04921969|541683300|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
150149550|NCT04921969|541683301|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
150149551|NCT04921969|541683302|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
150149552|NCT04921969|541683303|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
150149553|NCT04921969|541683304|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
150149554|NCT04287868|541683305|FG000|Overall Study|Screening fail|1|||
150149555|NCT04287868|541683306|FG001|Overall Study|Screening fail|0|||
150149556|NCT01282476|541684595|FG000|Overall Study|Death|11|||
150149557|NCT01811563|541684600|FG000|Overall Study|Lost to Follow-up|5|||
150149558|NCT01811563|541684601|FG001|Overall Study|Lost to Follow-up|2|||
149810492|NCT05264506|540434814|FG000|Overall Study|Discontinued prior treatment|89|||
149810493|NCT02032823|540434822|FG000|Overall Study|Death|75|||
149810494|NCT02032823|540434823|FG001|Overall Study|Death|109|||
149810495|NCT02032823|540434822|FG000|Overall Study|Lost to Follow-up|18|||
149810496|NCT02032823|540434823|FG001|Overall Study|Lost to Follow-up|17|||
149810497|NCT02032823|540434822|FG000|Overall Study|Withdrawal by Subject|70|||
149810498|NCT02032823|540434823|FG001|Overall Study|Withdrawal by Subject|53|||
149810499|NCT02032823|540434822|FG000|Overall Study|Ongoing study at data cut-off|755|||
149810500|NCT02032823|540434823|FG001|Overall Study|Ongoing study at data cut-off|731|||
149810501|NCT02032823|540434822|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
149810502|NCT02032823|540434823|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
149810503|NCT05919823|540434824|FG000|Pre-Treatment Period|Screen failure|1|||
149810504|NCT05919823|540434825|FG001|Pre-Treatment Period|Screen failure|0|||
149810505|NCT05919823|540434826|FG002|Pre-Treatment Period|Screen failure|0|||
149810506|NCT05919823|540434827|FG003|Pre-Treatment Period|Screen failure|0|||
149810507|NCT05919823|540434824|FG000|Pre-Treatment Period|Protocol Violation|0|||
149810508|NCT05919823|540434825|FG001|Pre-Treatment Period|Protocol Violation|1|||
149810509|NCT05919823|540434826|FG002|Pre-Treatment Period|Protocol Violation|0|||
149810510|NCT05919823|540434827|FG003|Pre-Treatment Period|Protocol Violation|0|||
149810511|NCT05919823|540434824|FG000|Double-Blind Period|Adverse Event|8|||
149810512|NCT05919823|540434825|FG001|Double-Blind Period|Adverse Event|9|||
149810513|NCT05919823|540434826|FG002|Double-Blind Period|Adverse Event|0|||
149810514|NCT05919823|540434827|FG003|Double-Blind Period|Adverse Event|0|||
149810515|NCT05919823|540434824|FG000|Double-Blind Period|Protocol Violation|2|||
149810516|NCT05919823|540434825|FG001|Double-Blind Period|Protocol Violation|1|||
149810517|NCT05919823|540434826|FG002|Double-Blind Period|Protocol Violation|0|||
149810518|NCT05919823|540434827|FG003|Double-Blind Period|Protocol Violation|0|||
149810519|NCT05919823|540434824|FG000|Double-Blind Period|Participant withdrew consent|11|||
149810520|NCT05919823|540434825|FG001|Double-Blind Period|Participant withdrew consent|7|||
149810521|NCT05919823|540434826|FG002|Double-Blind Period|Participant withdrew consent|0|||
149810522|NCT05919823|540434827|FG003|Double-Blind Period|Participant withdrew consent|0|||
149810523|NCT05919823|540434824|FG000|Double-Blind Period|Other reasons|2|||
149810524|NCT05919823|540434825|FG001|Double-Blind Period|Other reasons|3|||
149810525|NCT05919823|540434826|FG002|Double-Blind Period|Other reasons|0|||
149810526|NCT05919823|540434827|FG003|Double-Blind Period|Other reasons|0|||
149810527|NCT05919823|540434824|FG000|Open Label Period|Adverse Event|0|||
149810528|NCT05919823|540434825|FG001|Open Label Period|Adverse Event|0|||
149810529|NCT05919823|540434826|FG002|Open Label Period|Adverse Event|2|||
149810530|NCT05919823|540434827|FG003|Open Label Period|Adverse Event|4|||
149810531|NCT05919823|540434824|FG000|Open Label Period|Lost to Follow-up|0|||
149810532|NCT05919823|540434825|FG001|Open Label Period|Lost to Follow-up|0|||
149810533|NCT05919823|540434826|FG002|Open Label Period|Lost to Follow-up|1|||
149810534|NCT05919823|540434827|FG003|Open Label Period|Lost to Follow-up|0|||
150149559|NCT01811563|541684600|FG000|Overall Study|Incorrect Randomization procedure|0|||
150149560|NCT01811563|541684601|FG001|Overall Study|Incorrect Randomization procedure|1|||
150149561|NCT01087723|541684602|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
149810535|NCT05919823|540434824|FG000|Open Label Period|Protocol Violation|0|||
149810536|NCT05919823|540434825|FG001|Open Label Period|Protocol Violation|0|||
149810537|NCT05919823|540434826|FG002|Open Label Period|Protocol Violation|0|||
149810538|NCT05919823|540434827|FG003|Open Label Period|Protocol Violation|1|||
149810539|NCT05919823|540434824|FG000|Open Label Period|Participant withdrew consent|0|||
149810540|NCT05919823|540434825|FG001|Open Label Period|Participant withdrew consent|0|||
149810541|NCT05919823|540434826|FG002|Open Label Period|Participant withdrew consent|8|||
149810542|NCT05919823|540434827|FG003|Open Label Period|Participant withdrew consent|6|||
149810543|NCT05919823|540434824|FG000|Open Label Period|Death|0|||
149810544|NCT05919823|540434825|FG001|Open Label Period|Death|0|||
149810545|NCT05919823|540434826|FG002|Open Label Period|Death|0|||
150149562|NCT01087723|541684603|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
149810546|NCT05919823|540434827|FG003|Open Label Period|Death|1|||
149810547|NCT05919823|540434824|FG000|Open Label Period|Other reasons|0|||
149810548|NCT05919823|540434825|FG001|Open Label Period|Other reasons|0|||
149810549|NCT05919823|540434826|FG002|Open Label Period|Other reasons|9|||
149810550|NCT05919823|540434827|FG003|Open Label Period|Other reasons|5|||
149810551|NCT04521608|540434828|FG000|Overall Study|Death|8|||
149810552|NCT04521608|540434829|FG001|Overall Study|Death|9|||
149810553|NCT04521608|540434828|FG000|Overall Study|Withdrawal by Subject|25|||
149810554|NCT04521608|540434829|FG001|Overall Study|Withdrawal by Subject|18|||
149810555|NCT04521608|540434828|FG000|Overall Study|Disease Progression|3|||
149810556|NCT04521608|540434829|FG001|Overall Study|Disease Progression|10|||
149810557|NCT04521608|540434828|FG000|Overall Study|Complicating Disease|6|||
149810558|NCT04521608|540434829|FG001|Overall Study|Complicating Disease|3|||
149810559|NCT04521608|540434828|FG000|Overall Study|Lost Contact|25|||
149810560|NCT04521608|540434829|FG001|Overall Study|Lost Contact|27|||
149810561|NCT04521608|540434828|FG000|Overall Study|Ineligible|1|||
149810562|NCT04521608|540434829|FG001|Overall Study|Ineligible|0|||
149810563|NCT04521608|540434828|FG000|Overall Study|Refused Further Study Participation|13|||
149810564|NCT04521608|540434829|FG001|Overall Study|Refused Further Study Participation|7|||
149810565|NCT02588651|540434830|FG000|Overall Study|Adverse Event|1|||
149810566|NCT02588651|540434830|FG000|Overall Study|Withdrawal by Subject|2|||
149810567|NCT02588651|540434830|FG000|Overall Study|Death|1|||
149810568|NCT02588651|540434830|FG000|Overall Study|Lack of Efficacy|13|||
149810569|NCT02588651|540434830|FG000|Overall Study|Lost to Follow-up|1|||
149810570|NCT02588651|540434830|FG000|Overall Study|Physician Decision|1|||
149810571|NCT02588651|540434830|FG000|Overall Study|Disease progression|2|||
149810572|NCT04083378|540434833|FG000|Overall Study|Death|18|||
149810573|NCT04083378|540434834|FG001|Overall Study|Death|4|||
149810574|NCT04083378|540434833|FG000|Overall Study|Lost to Follow-up|4|||
149810575|NCT04083378|540434834|FG001|Overall Study|Lost to Follow-up|0|||
149810576|NCT04803214|540434835|FG000|Overall Study|Adverse Event|1|||
149810577|NCT04803214|540434836|FG001|Overall Study|Adverse Event|0|||
149810578|NCT04803214|540434835|FG000|Overall Study|Withdrawal by Subject|1|||
149810579|NCT04803214|540434836|FG001|Overall Study|Withdrawal by Subject|2|||
149810580|NCT04803214|540434835|FG000|Overall Study|Lost to Follow-up|2|||
149810581|NCT04803214|540434836|FG001|Overall Study|Lost to Follow-up|4|||
149810582|NCT04803214|540434835|FG000|Overall Study|Physician Decision|1|||
149810583|NCT04803214|540434836|FG001|Overall Study|Physician Decision|1|||
149810584|NCT04803214|540434835|FG000|Overall Study|Missed 12 month visit|0|||
149810585|NCT04803214|540434836|FG001|Overall Study|Missed 12 month visit|3|||
149810586|NCT00644228|540434837|FG000|Randomization & Eligibility|Ineligible|31|||
149810587|NCT00644228|540434838|FG001|Randomization & Eligibility|Ineligible|21|||
149810588|NCT00644228|540434837|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
149810589|NCT00644228|540434838|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
149810590|NCT00644228|540434837|FG000|Randomization & Eligibility|Invalid Consent|0|||
149810591|NCT00644228|540434838|FG001|Randomization & Eligibility|Invalid Consent|1|||
149810592|NCT00644228|540434837|FG000|Induction Therapy|Adverse Event|22|||
149810593|NCT00644228|540434838|FG001|Induction Therapy|Adverse Event|55|||
149810594|NCT00644228|540434837|FG000|Induction Therapy|Withdrawal by Subject|10|||
149810595|NCT00644228|540434838|FG001|Induction Therapy|Withdrawal by Subject|3|||
149810596|NCT00644228|540434837|FG000|Induction Therapy|Progression/Relapse|24|||
149810597|NCT00644228|540434838|FG001|Induction Therapy|Progression/Relapse|12|||
149810598|NCT00644228|540434837|FG000|Induction Therapy|Death|3|||
149810599|NCT00644228|540434838|FG001|Induction Therapy|Death|7|||
149810600|NCT00644228|540434837|FG000|Induction Therapy|Not Protocol-Specified|24|||
149810601|NCT00644228|540434838|FG001|Induction Therapy|Not Protocol-Specified|28|||
149810602|NCT00644228|540434837|FG000|Maintenance|Adverse Event|27|||
149810603|NCT00644228|540434838|FG001|Maintenance|Adverse Event|31|||
149810604|NCT00644228|540434837|FG000|Maintenance|Withdrawal by Subject|6|||
149810605|NCT00644228|540434838|FG001|Maintenance|Withdrawal by Subject|4|||
149810606|NCT00644228|540434837|FG000|Maintenance|Progression/Relapse|67|||
149810607|NCT00644228|540434838|FG001|Maintenance|Progression/Relapse|42|||
149810608|NCT00644228|540434837|FG000|Maintenance|Death|3|||
149810609|NCT00644228|540434838|FG001|Maintenance|Death|3|||
149810610|NCT00644228|540434837|FG000|Maintenance|Not Protocol-Specified|14|||
149810611|NCT00644228|540434838|FG001|Maintenance|Not Protocol-Specified|15|||
149810612|NCT00644228|540434837|FG000|Maintenance|On Treatment|26|||
149810613|NCT00644228|540434838|FG001|Maintenance|On Treatment|40|||
149810614|NCT06078124|540434839|FG000|Overall Study|Lost to Follow-up|14|||
149810615|NCT06078124|540434840|FG001|Overall Study|Lost to Follow-up|14|||
149810616|NCT05824273|540434841|FG000|Overall Study|Lost to Follow-up|16|||
149810617|NCT05824273|540434842|FG001|Overall Study|Lost to Follow-up|13|||
149810618|NCT02736695|540434843|FG000|Overall Study|Ineligible|6|||
149810619|NCT02736695|540434844|FG001|Overall Study|Ineligible|0|||
149810620|NCT00285012|540434845|FG000|Assigned to Study Treatment (Tx)|Other|2|||
149810621|NCT00285012|540434846|FG001|Assigned to Study Treatment (Tx)|Other|3|||
149810622|NCT00285012|540434845|FG000|Received Study Tx|Death|2|||
149810623|NCT00285012|540434846|FG001|Received Study Tx|Death|1|||
149810624|NCT00285012|540434845|FG000|Received Study Tx|Adverse Event|5|||
149810625|NCT00285012|540434846|FG001|Received Study Tx|Adverse Event|11|||
149810626|NCT00285012|540434845|FG000|Received Study Tx|Lack of Efficacy|0|||
149810627|NCT00285012|540434846|FG001|Received Study Tx|Lack of Efficacy|3|||
149810628|NCT00285012|540434845|FG000|Received Study Tx|Lost to Follow-up|29|||
149810629|NCT00285012|540434846|FG001|Received Study Tx|Lost to Follow-up|31|||
149810630|NCT00285012|540434845|FG000|Received Study Tx|Withdrawal by Subject|31|||
149810631|NCT00285012|540434846|FG001|Received Study Tx|Withdrawal by Subject|43|||
149810632|NCT00285012|540434845|FG000|Received Study Tx|Other|5|||
149810633|NCT00285012|540434846|FG001|Received Study Tx|Other|5|||
149810634|NCT04050293|540434850|FG000|Overall Study|Lost to Follow-up|1|||
149810635|NCT04050293|540434851|FG001|Overall Study|Lost to Follow-up|2|||
149810636|NCT04050293|540434850|FG000|Overall Study|Withdrawal by Subject|2|||
149810637|NCT04050293|540434851|FG001|Overall Study|Withdrawal by Subject|0|||
149810638|NCT05631093|540434854|FG000|Overall Study|Death|0|||
149810639|NCT05631093|540434855|FG001|Overall Study|Death|1|||
149810640|NCT05631093|540434854|FG000|Overall Study|Lost to Follow-up|1|||
149810641|NCT05631093|540434855|FG001|Overall Study|Lost to Follow-up|2|||
149810642|NCT05631093|540434854|FG000|Overall Study|Physician Decision|1|||
149810643|NCT05631093|540434855|FG001|Overall Study|Physician Decision|0|||
149810644|NCT05631093|540434854|FG000|Overall Study|Withdrawal by Subject|4|||
149810645|NCT05631093|540434855|FG001|Overall Study|Withdrawal by Subject|1|||
149810646|NCT05631093|540434854|FG000|Overall Study|Ongoing|353|||
149810647|NCT05631093|540434855|FG001|Overall Study|Ongoing|177|||
149810648|NCT05631093|540434854|FG000|Overall Study|Adverse Event|0|||
149810649|NCT05631093|540434855|FG001|Overall Study|Adverse Event|1|||
149810650|NCT04223193|540434858|FG000|Overall Study|Adverse Event|6|||
149810651|NCT04223193|540434859|FG001|Overall Study|Adverse Event|36|||
149810652|NCT04223193|540434858|FG000|Overall Study|Lack of Efficacy|2|||
149810653|NCT04223193|540434859|FG001|Overall Study|Lack of Efficacy|2|||
149810654|NCT04223193|540434858|FG000|Overall Study|Lost to Follow-up|1|||
149810655|NCT04223193|540434859|FG001|Overall Study|Lost to Follow-up|1|||
149810656|NCT04223193|540434858|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
150149563|NCT01087723|541684602|FG000|Overall Study|Withdrawal by Subject|10|||
150149564|NCT01087723|541684603|FG001|Overall Study|Withdrawal by Subject|13|||
150149565|NCT01087723|541684602|FG000|Overall Study|Physician Decision|2|||
150149566|NCT01087723|541684603|FG001|Overall Study|Physician Decision|0|||
150149567|NCT01087723|541684602|FG000|Overall Study|Lost to Follow-up|1|||
150149568|NCT01087723|541684603|FG001|Overall Study|Lost to Follow-up|4|||
150149569|NCT01087723|541684602|FG000|Overall Study|Reason Not Specified|1|||
150149570|NCT01087723|541684603|FG001|Overall Study|Reason Not Specified|2|||
150149571|NCT00806624|541684604|FG000|Overall Study|Adverse Event|2|||
150149572|NCT00806624|541684605|FG001|Overall Study|Adverse Event|8|||
150149573|NCT00806624|541684606|FG002|Overall Study|Adverse Event|0|||
150149574|NCT00806624|541684604|FG000|Overall Study|Death|0|||
150149575|NCT00806624|541684605|FG001|Overall Study|Death|1|||
150149576|NCT00806624|541684606|FG002|Overall Study|Death|1|||
150149577|NCT00806624|541684604|FG000|Overall Study|Lost to Follow-up|1|||
150149578|NCT00806624|541684605|FG001|Overall Study|Lost to Follow-up|0|||
150149579|NCT00806624|541684606|FG002|Overall Study|Lost to Follow-up|1|||
150149580|NCT00806624|541684604|FG000|Overall Study|Withdrawal by Subject|6|||
150149581|NCT00806624|541684605|FG001|Overall Study|Withdrawal by Subject|3|||
150149582|NCT00806624|541684606|FG002|Overall Study|Withdrawal by Subject|3|||
150149583|NCT00806624|541684604|FG000|Overall Study|discontinued before start of treatment|0|||
150149584|NCT00806624|541684605|FG001|Overall Study|discontinued before start of treatment|0|||
150149585|NCT00806624|541684606|FG002|Overall Study|discontinued before start of treatment|1|||
150149586|NCT00636792|541684607|FG000|Overall Study|Adverse Event|16|||
150149587|NCT00636792|541684607|FG000|Overall Study|Physician Decision|7|||
150149588|NCT00636792|541684607|FG000|Overall Study|Progressive Disease|4|||
150149589|NCT00636792|541684607|FG000|Overall Study|Withdrawal by Subject|3|||
150149590|NCT00636792|541684607|FG000|Overall Study|Other|3|||
150149591|NCT01235975|541684608|FG000|Overall Study|Serious Adverse Event|0|||
150149592|NCT01235975|541684609|FG001|Overall Study|Serious Adverse Event|1|||
149810657|NCT04223193|540434859|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
149810658|NCT04223193|540434858|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
149810659|NCT04223193|540434859|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
149810660|NCT04223193|540434858|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149810661|NCT04223193|540434859|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149810662|NCT04223193|540434858|FG000|Overall Study|Physician Decision|0|||
149810663|NCT04223193|540434859|FG001|Overall Study|Physician Decision|1|||
149810664|NCT04223193|540434858|FG000|Overall Study|Protocol Violation|1|||
150149593|NCT01235975|541684608|FG000|Overall Study|Withdrawal by Subject|8|||
149810665|NCT04223193|540434859|FG001|Overall Study|Protocol Violation|1|||
149810666|NCT04223193|540434858|FG000|Overall Study|Site Terminated by Sponsor|1|||
149810667|NCT04223193|540434859|FG001|Overall Study|Site Terminated by Sponsor|3|||
149810668|NCT04223193|540434858|FG000|Overall Study|Withdrawal by Subject|5|||
150149594|NCT01235975|541684609|FG001|Overall Study|Withdrawal by Subject|2|||
150149595|NCT01235975|541684608|FG000|Overall Study|Migrated/moved from study area|2|||
150149596|NCT01235975|541684609|FG001|Overall Study|Migrated/moved from study area|1|||
150149597|NCT01235975|541684608|FG000|Overall Study|Lost to Follow-up|7|||
150149598|NCT01235975|541684609|FG001|Overall Study|Lost to Follow-up|3|||
150149599|NCT00708305|541684616|FG000|Period 1|Protocol Violation|1|||
150149600|NCT00708305|541684617|FG001|Period 1|Protocol Violation|0|||
150149601|NCT00708305|541684618|FG002|Period 1|Protocol Violation|1|||
150149602|NCT00708305|541684619|FG003|Period 1|Protocol Violation|0|||
150149603|NCT00708305|541684616|FG000|Period 1|Other Reason|0|||
150149604|NCT00708305|541684617|FG001|Period 1|Other Reason|0|||
150149605|NCT00708305|541684618|FG002|Period 1|Other Reason|0|||
150149606|NCT00708305|541684619|FG003|Period 1|Other Reason|2|||
150149607|NCT00708305|541684616|FG000|Period 2|Lost to Follow-up|0|||
150149608|NCT00708305|541684617|FG001|Period 2|Lost to Follow-up|1|||
150149609|NCT00708305|541684618|FG002|Period 2|Lost to Follow-up|0|||
150149610|NCT00708305|541684619|FG003|Period 2|Lost to Follow-up|0|||
150149611|NCT00708305|541684616|FG000|Period 2|Protocol Violation|0|||
150149612|NCT00708305|541684617|FG001|Period 2|Protocol Violation|1|||
150149613|NCT00708305|541684618|FG002|Period 2|Protocol Violation|0|||
150149614|NCT00708305|541684619|FG003|Period 2|Protocol Violation|0|||
150149615|NCT00708305|541684616|FG000|Period 2|Other Reason|1|||
150149616|NCT00708305|541684617|FG001|Period 2|Other Reason|0|||
150149617|NCT00708305|541684618|FG002|Period 2|Other Reason|0|||
150149618|NCT00708305|541684619|FG003|Period 2|Other Reason|1|||
150149619|NCT00708305|541684616|FG000|Period 3|Protocol Violation|0|||
150149620|NCT00708305|541684617|FG001|Period 3|Protocol Violation|2|||
150149621|NCT00708305|541684618|FG002|Period 3|Protocol Violation|0|||
150149622|NCT00708305|541684619|FG003|Period 3|Protocol Violation|0|||
150149623|NCT00708305|541684616|FG000|Period 3|Other Reason|1|||
150149624|NCT00708305|541684617|FG001|Period 3|Other Reason|0|||
150149625|NCT00708305|541684618|FG002|Period 3|Other Reason|0|||
150149626|NCT00708305|541684619|FG003|Period 3|Other Reason|0|||
150149627|NCT00192023|541684626|FG000|Period III - Double-Blind|Adverse Event|3|||
149810669|NCT04223193|540434859|FG001|Overall Study|Withdrawal by Subject|6|||
149810670|NCT04223193|540434858|FG000|Overall Study|Other|3|||
149810671|NCT04223193|540434859|FG001|Overall Study|Other|6|||
149810672|NCT03193190|540434862|FG000|Stage 1|Arm Terminated by Sponsor|0|||
149810673|NCT03193190|540434863|FG001|Stage 1|Arm Terminated by Sponsor|0|||
149810674|NCT03193190|540434864|FG002|Stage 1|Arm Terminated by Sponsor|0|||
149810675|NCT03193190|540434865|FG003|Stage 1|Arm Terminated by Sponsor|1|||
149810676|NCT03193190|540434866|FG004|Stage 1|Arm Terminated by Sponsor|0|||
149810677|NCT03193190|540434867|FG005|Stage 1|Arm Terminated by Sponsor|2|||
149810678|NCT03193190|540434868|FG006|Stage 1|Arm Terminated by Sponsor|0|||
149810679|NCT03193190|540434869|FG007|Stage 1|Arm Terminated by Sponsor|0|||
149810680|NCT03193190|540434870|FG008|Stage 1|Arm Terminated by Sponsor|0|||
149810681|NCT03193190|540434871|FG009|Stage 1|Arm Terminated by Sponsor|0|||
149810682|NCT03193190|540434872|FG010|Stage 1|Arm Terminated by Sponsor|0|||
149810683|NCT03193190|540434873|FG011|Stage 1|Arm Terminated by Sponsor|0|||
149810684|NCT03193190|540434874|FG012|Stage 1|Arm Terminated by Sponsor|0|||
149810685|NCT03193190|540434875|FG013|Stage 1|Arm Terminated by Sponsor|0|||
149810686|NCT03193190|540434876|FG014|Stage 1|Arm Terminated by Sponsor|0|||
149810687|NCT03193190|540434877|FG015|Stage 1|Arm Terminated by Sponsor|0|||
149810688|NCT03193190|540434862|FG000|Stage 1|Death|22|||
149810689|NCT03193190|540434863|FG001|Stage 1|Death|8|||
149810690|NCT03193190|540434864|FG002|Stage 1|Death|23|||
149810691|NCT03193190|540434865|FG003|Stage 1|Death|14|||
149810692|NCT03193190|540434866|FG004|Stage 1|Death|34|||
149810693|NCT03193190|540434867|FG005|Stage 1|Death|28|||
149810694|NCT03193190|540434868|FG006|Stage 1|Death|19|||
149810695|NCT03193190|540434869|FG007|Stage 1|Death|21|||
149810696|NCT03193190|540434870|FG008|Stage 1|Death|14|||
149810697|NCT03193190|540434871|FG009|Stage 1|Death|10|||
149810698|NCT03193190|540434872|FG010|Stage 1|Death|59|||
149810699|NCT03193190|540434873|FG011|Stage 1|Death|14|||
149810700|NCT03193190|540434874|FG012|Stage 1|Death|14|||
149810701|NCT03193190|540434875|FG013|Stage 1|Death|0|||
149810702|NCT03193190|540434876|FG014|Stage 1|Death|0|||
149810703|NCT03193190|540434877|FG015|Stage 1|Death|0|||
149810704|NCT03193190|540434862|FG000|Stage 1|Lost to Follow-up|2|||
149810705|NCT03193190|540434863|FG001|Stage 1|Lost to Follow-up|1|||
149810706|NCT03193190|540434864|FG002|Stage 1|Lost to Follow-up|1|||
149810707|NCT03193190|540434865|FG003|Stage 1|Lost to Follow-up|0|||
149918923|NCT01210352|540835247|FG006|Overall Study|Patient Discharged Early|0|||
149810708|NCT03193190|540434866|FG004|Stage 1|Lost to Follow-up|0|||
149810709|NCT03193190|540434867|FG005|Stage 1|Lost to Follow-up|0|||
149810710|NCT03193190|540434868|FG006|Stage 1|Lost to Follow-up|1|||
149810711|NCT03193190|540434869|FG007|Stage 1|Lost to Follow-up|0|||
150149628|NCT00192023|541684627|FG001|Period III - Double-Blind|Adverse Event|0|||
150149629|NCT00192023|541684626|FG000|Period III - Double-Blind|Physician Decision|2|||
150149630|NCT00192023|541684627|FG001|Period III - Double-Blind|Physician Decision|0|||
150149631|NCT00192023|541684626|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
150149632|NCT00192023|541684627|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
150149633|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
150149634|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
150149635|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
150149636|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
149810712|NCT03193190|540434870|FG008|Stage 1|Lost to Follow-up|0|||
149810713|NCT03193190|540434871|FG009|Stage 1|Lost to Follow-up|0|||
149810714|NCT03193190|540434872|FG010|Stage 1|Lost to Follow-up|0|||
149810715|NCT03193190|540434873|FG011|Stage 1|Lost to Follow-up|0|||
149810716|NCT03193190|540434874|FG012|Stage 1|Lost to Follow-up|0|||
149810717|NCT03193190|540434875|FG013|Stage 1|Lost to Follow-up|0|||
149810718|NCT03193190|540434876|FG014|Stage 1|Lost to Follow-up|0|||
149810719|NCT03193190|540434877|FG015|Stage 1|Lost to Follow-up|0|||
149810720|NCT03193190|540434862|FG000|Stage 1|Reason not Specified|1|||
149810721|NCT03193190|540434863|FG001|Stage 1|Reason not Specified|0|||
149810722|NCT03193190|540434864|FG002|Stage 1|Reason not Specified|0|||
149810723|NCT03193190|540434865|FG003|Stage 1|Reason not Specified|1|||
149810724|NCT03193190|540434866|FG004|Stage 1|Reason not Specified|0|||
149810725|NCT03193190|540434867|FG005|Stage 1|Reason not Specified|1|||
149810726|NCT03193190|540434868|FG006|Stage 1|Reason not Specified|2|||
149810727|NCT03193190|540434869|FG007|Stage 1|Reason not Specified|2|||
149810728|NCT03193190|540434870|FG008|Stage 1|Reason not Specified|0|||
149810729|NCT03193190|540434871|FG009|Stage 1|Reason not Specified|1|||
149810730|NCT03193190|540434872|FG010|Stage 1|Reason not Specified|3|||
149810731|NCT03193190|540434873|FG011|Stage 1|Reason not Specified|0|||
149810732|NCT03193190|540434874|FG012|Stage 1|Reason not Specified|1|||
149810733|NCT03193190|540434875|FG013|Stage 1|Reason not Specified|0|||
149810734|NCT03193190|540434876|FG014|Stage 1|Reason not Specified|0|||
149810735|NCT03193190|540434877|FG015|Stage 1|Reason not Specified|0|||
149810736|NCT03193190|540434862|FG000|Stage 1|Physician Decision|0|||
149810737|NCT03193190|540434863|FG001|Stage 1|Physician Decision|0|||
149810738|NCT03193190|540434864|FG002|Stage 1|Physician Decision|0|||
149810739|NCT03193190|540434865|FG003|Stage 1|Physician Decision|0|||
149810740|NCT03193190|540434866|FG004|Stage 1|Physician Decision|0|||
149810741|NCT03193190|540434867|FG005|Stage 1|Physician Decision|0|||
149810742|NCT03193190|540434868|FG006|Stage 1|Physician Decision|0|||
149810743|NCT03193190|540434869|FG007|Stage 1|Physician Decision|0|||
149810744|NCT03193190|540434870|FG008|Stage 1|Physician Decision|0|||
149810745|NCT03193190|540434871|FG009|Stage 1|Physician Decision|0|||
149810746|NCT03193190|540434872|FG010|Stage 1|Physician Decision|0|||
149810747|NCT03193190|540434873|FG011|Stage 1|Physician Decision|1|||
149810748|NCT03193190|540434874|FG012|Stage 1|Physician Decision|0|||
149810749|NCT03193190|540434875|FG013|Stage 1|Physician Decision|0|||
149810750|NCT03193190|540434876|FG014|Stage 1|Physician Decision|0|||
149810751|NCT03193190|540434877|FG015|Stage 1|Physician Decision|0|||
149810752|NCT03193190|540434862|FG000|Stage 1|Progressive Disease|1|||
149810753|NCT03193190|540434863|FG001|Stage 1|Progressive Disease|0|||
149810754|NCT03193190|540434864|FG002|Stage 1|Progressive Disease|0|||
149810755|NCT03193190|540434865|FG003|Stage 1|Progressive Disease|0|||
149810756|NCT03193190|540434866|FG004|Stage 1|Progressive Disease|0|||
149810757|NCT03193190|540434867|FG005|Stage 1|Progressive Disease|0|||
149810758|NCT03193190|540434868|FG006|Stage 1|Progressive Disease|0|||
149810759|NCT03193190|540434869|FG007|Stage 1|Progressive Disease|0|||
149810760|NCT03193190|540434870|FG008|Stage 1|Progressive Disease|0|||
149810761|NCT03193190|540434871|FG009|Stage 1|Progressive Disease|0|||
149810762|NCT03193190|540434872|FG010|Stage 1|Progressive Disease|0|||
149810763|NCT03193190|540434873|FG011|Stage 1|Progressive Disease|0|||
149810764|NCT03193190|540434874|FG012|Stage 1|Progressive Disease|0|||
149810765|NCT03193190|540434875|FG013|Stage 1|Progressive Disease|0|||
149810766|NCT03193190|540434876|FG014|Stage 1|Progressive Disease|0|||
149810767|NCT03193190|540434877|FG015|Stage 1|Progressive Disease|0|||
149810768|NCT03193190|540434862|FG000|Stage 1|Study Terminated By Sponsor|3|||
149810769|NCT03193190|540434863|FG001|Stage 1|Study Terminated By Sponsor|0|||
149810770|NCT03193190|540434864|FG002|Stage 1|Study Terminated By Sponsor|0|||
149810771|NCT03193190|540434865|FG003|Stage 1|Study Terminated By Sponsor|0|||
149810772|NCT03193190|540434866|FG004|Stage 1|Study Terminated By Sponsor|6|||
149810773|NCT03193190|540434867|FG005|Stage 1|Study Terminated By Sponsor|0|||
149810774|NCT03193190|540434868|FG006|Stage 1|Study Terminated By Sponsor|0|||
149810775|NCT03193190|540434869|FG007|Stage 1|Study Terminated By Sponsor|0|||
149810776|NCT03193190|540434870|FG008|Stage 1|Study Terminated By Sponsor|0|||
149810777|NCT03193190|540434871|FG009|Stage 1|Study Terminated By Sponsor|0|||
149810778|NCT03193190|540434872|FG010|Stage 1|Study Terminated By Sponsor|0|||
149810779|NCT03193190|540434873|FG011|Stage 1|Study Terminated By Sponsor|0|||
149810780|NCT03193190|540434874|FG012|Stage 1|Study Terminated By Sponsor|0|||
149810781|NCT03193190|540434875|FG013|Stage 1|Study Terminated By Sponsor|0|||
149810782|NCT03193190|540434876|FG014|Stage 1|Study Terminated By Sponsor|0|||
149810783|NCT03193190|540434877|FG015|Stage 1|Study Terminated By Sponsor|0|||
149810784|NCT03193190|540434862|FG000|Stage 1|Withdrawal by Subject|6|||
149810785|NCT03193190|540434863|FG001|Stage 1|Withdrawal by Subject|0|||
149810786|NCT03193190|540434864|FG002|Stage 1|Withdrawal by Subject|1|||
149810787|NCT03193190|540434865|FG003|Stage 1|Withdrawal by Subject|0|||
149810788|NCT03193190|540434866|FG004|Stage 1|Withdrawal by Subject|2|||
149810789|NCT03193190|540434867|FG005|Stage 1|Withdrawal by Subject|0|||
149810790|NCT03193190|540434868|FG006|Stage 1|Withdrawal by Subject|3|||
149810791|NCT03193190|540434869|FG007|Stage 1|Withdrawal by Subject|2|||
149810792|NCT03193190|540434870|FG008|Stage 1|Withdrawal by Subject|2|||
149810793|NCT03193190|540434871|FG009|Stage 1|Withdrawal by Subject|4|||
149810794|NCT03193190|540434872|FG010|Stage 1|Withdrawal by Subject|9|||
149810795|NCT03193190|540434873|FG011|Stage 1|Withdrawal by Subject|1|||
149810796|NCT03193190|540434874|FG012|Stage 1|Withdrawal by Subject|0|||
149810797|NCT03193190|540434875|FG013|Stage 1|Withdrawal by Subject|0|||
149810798|NCT03193190|540434876|FG014|Stage 1|Withdrawal by Subject|0|||
149810799|NCT03193190|540434877|FG015|Stage 1|Withdrawal by Subject|0|||
149810800|NCT03193190|540434862|FG000|Stage 2|Death|0|||
149810801|NCT03193190|540434863|FG001|Stage 2|Death|0|||
149810802|NCT03193190|540434864|FG002|Stage 2|Death|0|||
149810803|NCT03193190|540434865|FG003|Stage 2|Death|0|||
149810804|NCT03193190|540434866|FG004|Stage 2|Death|0|||
149810805|NCT03193190|540434867|FG005|Stage 2|Death|0|||
149810806|NCT03193190|540434868|FG006|Stage 2|Death|0|||
149810807|NCT03193190|540434869|FG007|Stage 2|Death|0|||
149810808|NCT03193190|540434870|FG008|Stage 2|Death|0|||
149810809|NCT03193190|540434871|FG009|Stage 2|Death|0|||
149810810|NCT03193190|540434872|FG010|Stage 2|Death|0|||
149810811|NCT03193190|540434873|FG011|Stage 2|Death|0|||
149810812|NCT03193190|540434874|FG012|Stage 2|Death|0|||
149810813|NCT03193190|540434875|FG013|Stage 2|Death|14|||
149810814|NCT03193190|540434876|FG014|Stage 2|Death|4|||
149810815|NCT03193190|540434877|FG015|Stage 2|Death|1|||
149810816|NCT03193190|540434862|FG000|Stage 2|Lost to Follow-up|0|||
149810817|NCT03193190|540434863|FG001|Stage 2|Lost to Follow-up|0|||
149810818|NCT03193190|540434864|FG002|Stage 2|Lost to Follow-up|0|||
149810819|NCT03193190|540434865|FG003|Stage 2|Lost to Follow-up|0|||
149810820|NCT03193190|540434866|FG004|Stage 2|Lost to Follow-up|0|||
149810821|NCT03193190|540434867|FG005|Stage 2|Lost to Follow-up|0|||
149810822|NCT03193190|540434868|FG006|Stage 2|Lost to Follow-up|0|||
149810823|NCT03193190|540434869|FG007|Stage 2|Lost to Follow-up|0|||
149810824|NCT03193190|540434870|FG008|Stage 2|Lost to Follow-up|0|||
149810825|NCT03193190|540434871|FG009|Stage 2|Lost to Follow-up|0|||
149810826|NCT03193190|540434872|FG010|Stage 2|Lost to Follow-up|0|||
149810827|NCT03193190|540434873|FG011|Stage 2|Lost to Follow-up|0|||
149810828|NCT03193190|540434874|FG012|Stage 2|Lost to Follow-up|0|||
149810829|NCT03193190|540434875|FG013|Stage 2|Lost to Follow-up|0|||
149810830|NCT03193190|540434876|FG014|Stage 2|Lost to Follow-up|1|||
149810831|NCT03193190|540434877|FG015|Stage 2|Lost to Follow-up|0|||
149810832|NCT03193190|540434862|FG000|Stage 2|Withdrawal by Subject|0|||
149810833|NCT03193190|540434863|FG001|Stage 2|Withdrawal by Subject|0|||
149810834|NCT03193190|540434864|FG002|Stage 2|Withdrawal by Subject|0|||
149810835|NCT03193190|540434865|FG003|Stage 2|Withdrawal by Subject|0|||
149810836|NCT03193190|540434866|FG004|Stage 2|Withdrawal by Subject|0|||
149810837|NCT03193190|540434867|FG005|Stage 2|Withdrawal by Subject|0|||
149810838|NCT03193190|540434868|FG006|Stage 2|Withdrawal by Subject|0|||
149810839|NCT03193190|540434869|FG007|Stage 2|Withdrawal by Subject|0|||
149810840|NCT03193190|540434870|FG008|Stage 2|Withdrawal by Subject|0|||
149810841|NCT03193190|540434871|FG009|Stage 2|Withdrawal by Subject|0|||
149810842|NCT03193190|540434872|FG010|Stage 2|Withdrawal by Subject|0|||
149810843|NCT03193190|540434873|FG011|Stage 2|Withdrawal by Subject|0|||
149810844|NCT03193190|540434874|FG012|Stage 2|Withdrawal by Subject|0|||
149810845|NCT03193190|540434875|FG013|Stage 2|Withdrawal by Subject|1|||
149810846|NCT03193190|540434876|FG014|Stage 2|Withdrawal by Subject|1|||
149810847|NCT03193190|540434877|FG015|Stage 2|Withdrawal by Subject|0|||
149810848|NCT03532295|540434878|FG000|Overall Study|Did not start treatment|0|||
149810849|NCT03532295|540434879|FG001|Overall Study|Did not start treatment|2|||
149810850|NCT03732677|540434883|FG000|Overall Study|Terminated the study|154|||
149810851|NCT03732677|540434884|FG001|Overall Study|Terminated the study|197|||
149810852|NCT03732677|540434883|FG000|Overall Study|Continuing study off treatment|379|||
149810853|NCT03732677|540434884|FG001|Overall Study|Continuing study off treatment|333|||
149810854|NCT02949219|540434891|FG000|Overall Study|Withdrawal by Subject|1|||
149810855|NCT05257109|540434899|FG000|Overall Study|Withdrawal by Subject|1|||
149810856|NCT05257109|540434900|FG001|Overall Study|Withdrawal by Subject|0|||
149810857|NCT05257109|540434901|FG002|Overall Study|Withdrawal by Subject|0|||
149810858|NCT05257109|540434902|FG003|Overall Study|Withdrawal by Subject|0|||
149810859|NCT02038959|540435663|FG000|Overall Study|Withdrawal by Subject|6|||
149810860|NCT02038959|540435664|FG001|Overall Study|Withdrawal by Subject|8|||
149810861|NCT00819091|540435670|FG000|Overall Study|Adverse Event|3|||
149810862|NCT00819091|540435671|FG001|Overall Study|Adverse Event|5|||
149810863|NCT00819091|540435670|FG000|Overall Study|Protocol Violation|0|||
149810864|NCT00819091|540435671|FG001|Overall Study|Protocol Violation|1|||
149810865|NCT00819091|540435670|FG000|Overall Study|Lost to Follow-up|2|||
149810866|NCT00819091|540435671|FG001|Overall Study|Lost to Follow-up|0|||
149810867|NCT00819091|540435670|FG000|Overall Study|Withdrawal by Subject|1|||
149810868|NCT00819091|540435671|FG001|Overall Study|Withdrawal by Subject|2|||
149810869|NCT00819091|540435670|FG000|Overall Study|Other|1|||
149810870|NCT00819091|540435671|FG001|Overall Study|Other|2|||
149810871|NCT03911960|540435673|FG000|Overall Study|Lost to Follow-up|5|||
149810872|NCT03911960|540435674|FG001|Overall Study|Lost to Follow-up|3|||
149810873|NCT00424515|540435677|FG000|Overall Study|Progressive Disease|10|||
149810874|NCT00424515|540435678|FG001|Overall Study|Progressive Disease|11|||
149810875|NCT00424515|540435677|FG000|Overall Study|Adverse Event|0|||
149810876|NCT00424515|540435678|FG001|Overall Study|Adverse Event|1|||
149810877|NCT00424515|540435677|FG000|Overall Study|Intercurrent Illness|0|||
149810878|NCT00424515|540435678|FG001|Overall Study|Intercurrent Illness|1|||
149810879|NCT00424515|540435677|FG000|Overall Study|Withdrawal by Subject|1|||
149810880|NCT00424515|540435678|FG001|Overall Study|Withdrawal by Subject|0|||
149810881|NCT00080288|540435679|FG000|Overall Study|Adverse Event|7|||
149810882|NCT00080288|540435680|FG001|Overall Study|Adverse Event|4|||
149810883|NCT00080288|540435679|FG000|Overall Study|Lost to Follow-up|3|||
149810884|NCT00080288|540435680|FG001|Overall Study|Lost to Follow-up|5|||
149810885|NCT00080288|540435679|FG000|Overall Study|Physician Decision|6|||
149810886|NCT00080288|540435680|FG001|Overall Study|Physician Decision|2|||
149810887|NCT00080288|540435679|FG000|Overall Study|Withdrawal by Subject|3|||
149810888|NCT00080288|540435680|FG001|Overall Study|Withdrawal by Subject|16|||
149810889|NCT00080288|540435679|FG000|Overall Study|Miscellaneous|11|||
149810890|NCT00080288|540435680|FG001|Overall Study|Miscellaneous|11|||
149810891|NCT02576054|540435681|FG000|Overall Study|Withdrawal by Subject|1|||
149810892|NCT00791154|540435682|FG000|Overall Study|Noncompliance|0|||
149810893|NCT00791154|540435683|FG001|Overall Study|Noncompliance|1|||
149810894|NCT00791154|540435684|FG002|Overall Study|Noncompliance|0|||
149810895|NCT00791154|540435685|FG003|Overall Study|Noncompliance|0|||
149810896|NCT00791154|540435686|FG004|Overall Study|Noncompliance|1|||
149810897|NCT00791154|540435687|FG005|Overall Study|Noncompliance|1|||
149810898|NCT00791154|540435688|FG006|Overall Study|Noncompliance|1|||
149810899|NCT00791154|540435682|FG000|Overall Study|Adverse Event|0|||
149810900|NCT00791154|540435683|FG001|Overall Study|Adverse Event|0|||
149810901|NCT00791154|540435684|FG002|Overall Study|Adverse Event|0|||
149810902|NCT00791154|540435685|FG003|Overall Study|Adverse Event|0|||
149810903|NCT00791154|540435686|FG004|Overall Study|Adverse Event|2|||
149810904|NCT00791154|540435687|FG005|Overall Study|Adverse Event|0|||
149810905|NCT00791154|540435688|FG006|Overall Study|Adverse Event|1|||
149810906|NCT00791154|540435682|FG000|Overall Study|Full Consent withdrawn|1|||
149810907|NCT00791154|540435683|FG001|Overall Study|Full Consent withdrawn|3|||
149810908|NCT00791154|540435684|FG002|Overall Study|Full Consent withdrawn|0|||
149810909|NCT00791154|540435685|FG003|Overall Study|Full Consent withdrawn|0|||
149810910|NCT00791154|540435686|FG004|Overall Study|Full Consent withdrawn|1|||
149810911|NCT00791154|540435687|FG005|Overall Study|Full Consent withdrawn|3|||
149810912|NCT00791154|540435688|FG006|Overall Study|Full Consent withdrawn|1|||
149810913|NCT00791154|540435682|FG000|Overall Study|Lost to Follow-up|0|||
149810914|NCT00791154|540435683|FG001|Overall Study|Lost to Follow-up|0|||
149810915|NCT00791154|540435684|FG002|Overall Study|Lost to Follow-up|0|||
149810916|NCT00791154|540435685|FG003|Overall Study|Lost to Follow-up|1|||
149810917|NCT00791154|540435686|FG004|Overall Study|Lost to Follow-up|2|||
149810918|NCT00791154|540435687|FG005|Overall Study|Lost to Follow-up|0|||
149810919|NCT00791154|540435688|FG006|Overall Study|Lost to Follow-up|4|||
149810920|NCT00791154|540435682|FG000|Overall Study|Death|5|||
149810921|NCT00791154|540435683|FG001|Overall Study|Death|4|||
149810922|NCT00791154|540435684|FG002|Overall Study|Death|4|||
149810923|NCT00791154|540435685|FG003|Overall Study|Death|7|||
149810924|NCT00791154|540435686|FG004|Overall Study|Death|54|||
149810925|NCT00791154|540435687|FG005|Overall Study|Death|54|||
149810926|NCT00791154|540435688|FG006|Overall Study|Death|52|||
149810927|NCT00791154|540435682|FG000|Overall Study|Other event|0|||
149810928|NCT00791154|540435683|FG001|Overall Study|Other event|0|||
149810929|NCT00791154|540435684|FG002|Overall Study|Other event|2|||
149810930|NCT00791154|540435685|FG003|Overall Study|Other event|0|||
149810931|NCT00791154|540435686|FG004|Overall Study|Other event|2|||
149810932|NCT00791154|540435687|FG005|Overall Study|Other event|4|||
149810933|NCT00791154|540435688|FG006|Overall Study|Other event|2|||
149810934|NCT01787188|540435695|FG000|Overall Study|Adverse Event|2|||
149810935|NCT01787188|540435696|FG001|Overall Study|Adverse Event|4|||
149810936|NCT01787188|540435697|FG002|Overall Study|Adverse Event|6|||
149810937|NCT01787188|540435695|FG000|Overall Study|Lack of Efficacy|7|||
149810938|NCT01787188|540435696|FG001|Overall Study|Lack of Efficacy|3|||
149810939|NCT01787188|540435697|FG002|Overall Study|Lack of Efficacy|5|||
149810940|NCT01787188|540435695|FG000|Overall Study|Non-compliance with Study Drug|0|||
149810941|NCT01787188|540435696|FG001|Overall Study|Non-compliance with Study Drug|1|||
149810942|NCT01787188|540435697|FG002|Overall Study|Non-compliance with Study Drug|0|||
149810943|NCT01787188|540435695|FG000|Overall Study|Withdrawal by Subject|4|||
149810944|NCT01787188|540435696|FG001|Overall Study|Withdrawal by Subject|3|||
149810945|NCT01787188|540435697|FG002|Overall Study|Withdrawal by Subject|2|||
149810946|NCT01787188|540435695|FG000|Overall Study|Protocol Violation|3|||
149810947|NCT01787188|540435696|FG001|Overall Study|Protocol Violation|2|||
149810948|NCT01787188|540435697|FG002|Overall Study|Protocol Violation|3|||
149810949|NCT01787188|540435695|FG000|Overall Study|Lost to Follow-up|1|||
149810950|NCT01787188|540435696|FG001|Overall Study|Lost to Follow-up|2|||
149810951|NCT01787188|540435697|FG002|Overall Study|Lost to Follow-up|2|||
149810952|NCT01787188|540435695|FG000|Overall Study|Other, including patient moved|0|||
149810953|NCT01787188|540435696|FG001|Overall Study|Other, including patient moved|3|||
149810954|NCT01787188|540435697|FG002|Overall Study|Other, including patient moved|0|||
149810955|NCT05349188|540435698|FG000|Overall Study|Withdrawal by Subject|1|||
150149637|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
150149638|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
150149639|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
150149640|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
150149641|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
150149642|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
150149643|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
150149644|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
150149645|NCT00192023|541684626|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
150149646|NCT00192023|541684627|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
150149647|NCT00114634|541684628|FG000|Overall Study|failure to return forms|3|||
150149648|NCT02572817|541684629|FG000|Overall Study|Death|6|||
150149649|NCT02572817|541684630|FG001|Overall Study|Death|3|||
150149650|NCT02572817|541684629|FG000|Overall Study|Lost to Follow-up|3|||
150149651|NCT02572817|541684630|FG001|Overall Study|Lost to Follow-up|3|||
150149652|NCT02310126|541684639|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
150149653|NCT02310126|541684640|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
150149654|NCT02310126|541684639|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
150149655|NCT02310126|541684640|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
150149656|NCT02441946|541684641|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
150149657|NCT02441946|541684642|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
150149658|NCT02441946|541684643|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
150149659|NCT02441946|541684641|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
150149660|NCT02441946|541684642|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
150149661|NCT02441946|541684643|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
150149662|NCT02441946|541684641|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
150149663|NCT02441946|541684642|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
150149664|NCT02441946|541684643|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
150149665|NCT02441946|541684641|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
150149666|NCT02441946|541684642|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
150149667|NCT02441946|541684643|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
150149668|NCT02441946|541684641|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
150149669|NCT02441946|541684642|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
150149670|NCT02441946|541684643|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
150149671|NCT02441946|541684641|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
150149672|NCT02441946|541684642|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
150149673|NCT02441946|541684643|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
150149674|NCT02441946|541684641|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
150149675|NCT02441946|541684642|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
150149676|NCT02441946|541684643|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
150149677|NCT02441946|541684641|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
150149678|NCT02441946|541684642|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
150149679|NCT02441946|541684643|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
150149680|NCT02441946|541684641|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
150149681|NCT02441946|541684642|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
150149682|NCT02441946|541684643|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
150149683|NCT02441946|541684641|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
150149684|NCT02441946|541684642|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
150149685|NCT02441946|541684643|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
150149686|NCT02441946|541684641|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
150149687|NCT02441946|541684642|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
150149688|NCT02441946|541684643|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
150149689|NCT00439179|541684644|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
150149690|NCT00439179|541684645|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
150149691|NCT00439179|541684646|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
150149692|NCT00439179|541684647|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
150149693|NCT00758160|541684655|FG000|Overall Study|No Longer Requires Study Medication|4|||
150149694|NCT00758160|541684655|FG000|Overall Study|Administration Problems|3|||
150149695|NCT00758160|541684655|FG000|Overall Study|Adverse Event|15|||
150149696|NCT00758160|541684655|FG000|Overall Study|Lack of Efficacy|10|||
150149697|NCT00758160|541684655|FG000|Overall Study|Lost to Follow-up|14|||
149810956|NCT05349188|540435699|FG001|Overall Study|Withdrawal by Subject|0|||
149810957|NCT03829462|540435700|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
149810958|NCT03829462|540435701|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
149810959|NCT03829462|540435700|FG000|Overall Study|No treatment due to progression disease|0|||
150149698|NCT00758160|541684655|FG000|Overall Study|Protocol Violation|12|||
150149699|NCT00758160|541684655|FG000|Overall Study|Withdrawal by Subject|8|||
150149700|NCT00545363|541684656|FG000|Overall Study|Adverse Event|6|||
150149701|NCT00545363|541684657|FG001|Overall Study|Adverse Event|7|||
150149702|NCT00545363|541684656|FG000|Overall Study|Withdrawal by Subject|6|||
150149703|NCT00545363|541684657|FG001|Overall Study|Withdrawal by Subject|5|||
150149704|NCT00545363|541684656|FG000|Overall Study|Non-compliance|3|||
150149705|NCT00545363|541684657|FG001|Overall Study|Non-compliance|1|||
150149706|NCT00545363|541684656|FG000|Overall Study|Did not meet entry criteria|1|||
150149707|NCT00545363|541684657|FG001|Overall Study|Did not meet entry criteria|1|||
150149708|NCT00545363|541684656|FG000|Overall Study|Lost to Follow-up|2|||
150149709|NCT00545363|541684657|FG001|Overall Study|Lost to Follow-up|0|||
150149710|NCT00545363|541684656|FG000|Overall Study|Other|1|||
150149711|NCT00545363|541684657|FG001|Overall Study|Other|1|||
150149712|NCT01258660|541684658|FG000|Overall Study|Adverse Event|2|||
150149713|NCT01258660|541684659|FG001|Overall Study|Adverse Event|4|||
150149714|NCT01258660|541684658|FG000|Overall Study|Withdrawal by Subject|3|||
150149715|NCT01258660|541684659|FG001|Overall Study|Withdrawal by Subject|0|||
150149716|NCT01258660|541684658|FG000|Overall Study|due to relocation|2|||
150149717|NCT01258660|541684659|FG001|Overall Study|due to relocation|0|||
150149718|NCT01258660|541684658|FG000|Overall Study|Protocol Violation|0|||
150149719|NCT01258660|541684659|FG001|Overall Study|Protocol Violation|1|||
150149720|NCT01258660|541684658|FG000|Overall Study|Invalid for primary analysis data set|4|||
150149721|NCT01258660|541684659|FG001|Overall Study|Invalid for primary analysis data set|6|||
150149722|NCT05064735|541684666|FG000|Overall Study|Withdrawal by Subject|7|||
150149723|NCT05064735|541684667|FG001|Overall Study|Withdrawal by Subject|8|||
150149724|NCT05064735|541684666|FG000|Overall Study|Lost to Follow-up|7|||
150149725|NCT05064735|541684667|FG001|Overall Study|Lost to Follow-up|2|||
150149726|NCT05064735|541684666|FG000|Overall Study|Physician Decision|2|||
150149727|NCT05064735|541684667|FG001|Overall Study|Physician Decision|1|||
150149728|NCT05064735|541684666|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
150149729|NCT05064735|541684667|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
150149730|NCT05064735|541684666|FG000|Overall Study|Site Closure|7|||
150149731|NCT05064735|541684667|FG001|Overall Study|Site Closure|2|||
150149732|NCT01396395|541684668|FG000|Overall Study|Withdrawal by Subject|10|||
150149733|NCT01396395|541684669|FG001|Overall Study|Withdrawal by Subject|12|||
150149734|NCT01396395|541684668|FG000|Overall Study|Protocol Violation|3|||
150149735|NCT01396395|541684669|FG001|Overall Study|Protocol Violation|1|||
150149736|NCT01396395|541684668|FG000|Overall Study|Adverse Event|10|||
150149737|NCT01396395|541684669|FG001|Overall Study|Adverse Event|2|||
150149738|NCT01396395|541684668|FG000|Overall Study|Lost to Follow-up|17|||
150149739|NCT01396395|541684669|FG001|Overall Study|Lost to Follow-up|11|||
150149740|NCT01396395|541684668|FG000|Overall Study|Other|0|||
150149741|NCT01396395|541684669|FG001|Overall Study|Other|1|||
150149742|NCT03691948|541684670|FG000|Overall Study|Lost to Follow-up|1|||
150149743|NCT03691948|541684671|FG001|Overall Study|Lost to Follow-up|3|||
150149744|NCT01370005|541684672|FG000|Overall Study|Not treated|1|||
150149745|NCT01370005|541684673|FG001|Overall Study|Not treated|0|||
150149746|NCT01370005|541684674|FG002|Overall Study|Not treated|0|||
150149747|NCT01370005|541684672|FG000|Overall Study|Adverse Event|5|||
150149748|NCT01370005|541684673|FG001|Overall Study|Adverse Event|5|||
150149749|NCT01370005|541684674|FG002|Overall Study|Adverse Event|6|||
150149750|NCT01370005|541684672|FG000|Overall Study|Lack of Efficacy|1|||
150149751|NCT01370005|541684673|FG001|Overall Study|Lack of Efficacy|0|||
150149752|NCT01370005|541684674|FG002|Overall Study|Lack of Efficacy|0|||
150149753|NCT01370005|541684672|FG000|Overall Study|Non compliant with protocol|0|||
150149754|NCT01370005|541684673|FG001|Overall Study|Non compliant with protocol|1|||
150149755|NCT01370005|541684674|FG002|Overall Study|Non compliant with protocol|2|||
150149756|NCT01370005|541684672|FG000|Overall Study|Lost to Follow-up|1|||
150149757|NCT01370005|541684673|FG001|Overall Study|Lost to Follow-up|1|||
150149758|NCT01370005|541684674|FG002|Overall Study|Lost to Follow-up|1|||
150149759|NCT01370005|541684672|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
150149760|NCT01370005|541684673|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
150149761|NCT01370005|541684674|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
149810960|NCT03829462|540435701|FG001|Overall Study|No treatment due to progression disease|1|||
149810961|NCT06065176|540435702|FG000|Overall Study|Lost to Follow-up|11|||
149810962|NCT06065176|540435703|FG001|Overall Study|Lost to Follow-up|11|||
149810963|NCT06065176|540435704|FG002|Overall Study|Lost to Follow-up|10|||
150149762|NCT01370005|541684672|FG000|Overall Study|Other reason not defined above|3|||
150149763|NCT01370005|541684673|FG001|Overall Study|Other reason not defined above|0|||
150149764|NCT01370005|541684674|FG002|Overall Study|Other reason not defined above|2|||
150149765|NCT02009696|541684675|FG000|Overall Study|Withdrawal by Subject|2|||
150149766|NCT01018563|541684676|FG000|Overall Study|Termination of the study by Sponsor|2|||
150149767|NCT01018563|541684677|FG001|Overall Study|Termination of the study by Sponsor|1|||
150149768|NCT02344537|541684678|FG000|Overall Study|Protocol Violation|1|||
150149769|NCT02344537|541684679|FG001|Overall Study|Protocol Violation|1|||
150149770|NCT02344537|541684678|FG000|Overall Study|Subject started another treatment after wk 6|1|||
150149771|NCT02344537|541684679|FG001|Overall Study|Subject started another treatment after wk 6|0|||
150149772|NCT02344537|541684678|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
150149773|NCT02344537|541684679|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
150149774|NCT04844970|541684682|FG000|Overall Study|Adverse Event|0|||
149810964|NCT06065176|540435702|FG000|Overall Study|Withdrawal by Subject|1|||
150149775|NCT04844970|541684683|FG001|Overall Study|Adverse Event|1|||
150149776|NCT04844970|541684682|FG000|Overall Study|Withdrawal by Subject|2|||
150149777|NCT04844970|541684683|FG001|Overall Study|Withdrawal by Subject|0|||
149810965|NCT06065176|540435703|FG001|Overall Study|Withdrawal by Subject|1|||
149810966|NCT06065176|540435704|FG002|Overall Study|Withdrawal by Subject|2|||
149810967|NCT06065176|540435702|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
149810968|NCT06065176|540435703|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
149810969|NCT06065176|540435704|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
149810970|NCT04644237|540435709|FG000|Overall Study|Death|4|||
149810971|NCT04644237|540435710|FG001|Overall Study|Death|2|||
149810972|NCT04644237|540435709|FG000|Overall Study|Adverse Event|18|||
149810973|NCT04644237|540435710|FG001|Overall Study|Adverse Event|19|||
149810974|NCT04644237|540435709|FG000|Overall Study|Progressive Disease|61|||
149810975|NCT04644237|540435710|FG001|Overall Study|Progressive Disease|23|||
149810976|NCT04644237|540435709|FG000|Overall Study|Clinical Progression|4|||
149810977|NCT04644237|540435710|FG001|Overall Study|Clinical Progression|1|||
149810978|NCT04644237|540435709|FG000|Overall Study|Withdrawal by Subject|4|||
149810979|NCT04644237|540435710|FG001|Overall Study|Withdrawal by Subject|2|||
149810980|NCT04644237|540435709|FG000|Overall Study|Physician Decision|4|||
149810981|NCT04644237|540435710|FG001|Overall Study|Physician Decision|0|||
149810982|NCT04644237|540435709|FG000|Overall Study|Other|6|||
149810983|NCT04644237|540435710|FG001|Overall Study|Other|3|||
149810984|NCT04644237|540435709|FG000|Overall Study|Randomized but not Treated|1|||
149810985|NCT04644237|540435710|FG001|Overall Study|Randomized but not Treated|0|||
149810986|NCT03131817|540435711|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
149810987|NCT03494816|540435713|FG000|Overall Study|Protocol Violation|2|||
149810988|NCT03494816|540435713|FG000|Overall Study|Physician Decision|2|||
149810989|NCT03494816|540435713|FG000|Overall Study|Did not start trial treatment|1|||
149810990|NCT03494816|540435713|FG000|Overall Study|Adverse Event|1|||
149810991|NCT05838755|540435716|FG000|Overall Study|Adverse Event|1|||
149810992|NCT05838755|540435717|FG001|Overall Study|Adverse Event|0|||
149810993|NCT05838755|540435718|FG002|Overall Study|Adverse Event|0|||
149810994|NCT05838755|540435716|FG000|Overall Study|Lack of Efficacy|1|||
149810995|NCT05838755|540435717|FG001|Overall Study|Lack of Efficacy|0|||
149810996|NCT05838755|540435718|FG002|Overall Study|Lack of Efficacy|1|||
149810997|NCT05838755|540435716|FG000|Overall Study|Lost to Follow-up|0|||
149810998|NCT05838755|540435717|FG001|Overall Study|Lost to Follow-up|1|||
149810999|NCT05838755|540435718|FG002|Overall Study|Lost to Follow-up|4|||
149811000|NCT05838755|540435716|FG000|Overall Study|Withdrawal by Subject|0|||
149811001|NCT05838755|540435717|FG001|Overall Study|Withdrawal by Subject|2|||
149811002|NCT05838755|540435718|FG002|Overall Study|Withdrawal by Subject|0|||
149811003|NCT05838755|540435716|FG000|Overall Study|Study terminated by sponsor|26|||
149811004|NCT05838755|540435717|FG001|Overall Study|Study terminated by sponsor|27|||
149811005|NCT05838755|540435718|FG002|Overall Study|Study terminated by sponsor|26|||
149811006|NCT05838755|540435716|FG000|Overall Study|Randomized, not treated|2|||
149811007|NCT05838755|540435717|FG001|Overall Study|Randomized, not treated|0|||
149811008|NCT05838755|540435718|FG002|Overall Study|Randomized, not treated|1|||
149811009|NCT05838755|540435716|FG000|Overall Study|Pregnancy|0|||
149811010|NCT05838755|540435717|FG001|Overall Study|Pregnancy|1|||
149811011|NCT05838755|540435718|FG002|Overall Study|Pregnancy|0|||
149811012|NCT04439110|540435719|FG000|Overall Study|Ineligible|2|||
149811013|NCT04439110|540435719|FG000|Overall Study|Adverse Event|4|||
149811014|NCT04439110|540435719|FG000|Overall Study|Death|2|||
149811015|NCT04439110|540435719|FG000|Overall Study|Disease proression|25|||
149811016|NCT04439110|540435719|FG000|Overall Study|Withdrawal by Subject|1|||
149811017|NCT04439110|540435719|FG000|Overall Study|Alternative therapy|1|||
149811018|NCT04439110|540435719|FG000|Overall Study|Other complicating disease|1|||
149811019|NCT04439110|540435719|FG000|Overall Study|Personal reasons|1|||
149811020|NCT04439110|540435719|FG000|Overall Study|Still on treatment|1|||
149811021|NCT00131937|540435720|FG000|Overall Study|Adverse Event|3|||
149811022|NCT00131937|540435720|FG000|Overall Study|Withdrawal by Subject|2|||
149811023|NCT00131937|540435720|FG000|Overall Study|Physician Decision|1|||
149811024|NCT00131937|540435720|FG000|Overall Study|Disease Progression|7|||
149811025|NCT00131937|540435720|FG000|Overall Study|Alternative therapy|1|||
149811026|NCT04647253|540435727|FG000|Overall Study|Death ≤ 365 Days|16|||
149811027|NCT04647253|540435728|FG001|Overall Study|Death ≤ 365 Days|7|||
150149778|NCT00856661|541684684|FG000|Overall Study|Death|15|||
149811028|NCT04647253|540435727|FG000|Overall Study|Physician Decision|0|||
150149779|NCT00856661|541684685|FG001|Overall Study|Death|18|||
149811029|NCT04647253|540435728|FG001|Overall Study|Physician Decision|1|||
149811030|NCT04647253|540435727|FG000|Overall Study|Withdrawal by Subject|7|||
149811031|NCT04647253|540435728|FG001|Overall Study|Withdrawal by Subject|2|||
149811032|NCT04647253|540435727|FG000|Overall Study|Missed 12-Month Visit|9|||
149811033|NCT04647253|540435728|FG001|Overall Study|Missed 12-Month Visit|7|||
149811034|NCT04647253|540435727|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
149811035|NCT04647253|540435728|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
150149780|NCT00856661|541684684|FG000|Overall Study|Protocol Violation|2|||
150149781|NCT00856661|541684685|FG001|Overall Study|Protocol Violation|1|||
150149782|NCT00856661|541684684|FG000|Overall Study|Withdrawal by Subject|1|||
150149783|NCT00856661|541684685|FG001|Overall Study|Withdrawal by Subject|2|||
150149784|NCT00856661|541684684|FG000|Overall Study|Lost to Follow-up|1|||
150149785|NCT00856661|541684685|FG001|Overall Study|Lost to Follow-up|3|||
150149786|NCT00856661|541684684|FG000|Overall Study|Physician Judgement|8|||
150149787|NCT00856661|541684685|FG001|Overall Study|Physician Judgement|5|||
150149788|NCT02120664|541684686|FG000|Overall Study|Withdrawal by Subject|0|||
150149789|NCT02120664|541684687|FG001|Overall Study|Withdrawal by Subject|0|||
150149790|NCT02120664|541684688|FG002|Overall Study|Withdrawal by Subject|0|||
150149791|NCT02120664|541684689|FG003|Overall Study|Withdrawal by Subject|1|||
150149792|NCT02120664|541684690|FG004|Overall Study|Withdrawal by Subject|0|||
150149793|NCT02460263|541684691|FG000|Transition Period|Withdrawal by Subject|1|||
150149794|NCT02460263|541684691|FG000|Transition Period|Death|1|||
150149795|NCT02306122|541684692|FG000|Initial Physician Randomization|Physician Decision|0|||
150149796|NCT02306122|541684693|FG001|Initial Physician Randomization|Physician Decision|0|||
150149797|NCT02306122|541684694|FG002|Initial Physician Randomization|Physician Decision|0|||
150149798|NCT02306122|541684695|FG003|Initial Physician Randomization|Physician Decision|0|||
150149799|NCT02306122|541684696|FG004|Initial Physician Randomization|Physician Decision|0|||
150149800|NCT02306122|541684697|FG005|Initial Physician Randomization|Physician Decision|0|||
150149801|NCT02306122|541684698|FG006|Initial Physician Randomization|Physician Decision|0|||
150149802|NCT02306122|541684699|FG007|Initial Physician Randomization|Physician Decision|0|||
150149803|NCT02306122|541684700|FG008|Initial Physician Randomization|Physician Decision|1|||
150149804|NCT02306122|541684701|FG009|Initial Physician Randomization|Physician Decision|0|||
150149805|NCT02306122|541684702|FG010|Initial Physician Randomization|Physician Decision|0|||
150149806|NCT01351025|541684703|FG000|Week 0 - 20|Lost to Follow-up|2|||
150149807|NCT01351025|541684704|FG001|Week 0 - 20|Lost to Follow-up|1|||
150149808|NCT01351025|541684703|FG000|Week 0 - 20|Withdrawal by Subject|1|||
150149809|NCT01351025|541684704|FG001|Week 0 - 20|Withdrawal by Subject|0|||
150149810|NCT01351025|541684703|FG000|Week 24 - 44|Lost to Follow-up|0|||
150149811|NCT01351025|541684704|FG001|Week 24 - 44|Lost to Follow-up|2|||
150149812|NCT01351025|541684703|FG000|Week 24 - 44|Site closed|0|||
150149813|NCT01351025|541684704|FG001|Week 24 - 44|Site closed|1|||
150149814|NCT01351025|541684703|FG000|Week 24 - 44|unable to get to clinic|1|||
150149815|NCT01351025|541684704|FG001|Week 24 - 44|unable to get to clinic|1|||
150149816|NCT02638623|541684706|FG000|Overall Study|Surgery timing|5|||
150149817|NCT02638623|541684707|FG001|Overall Study|Surgery timing|6|||
150149818|NCT02638623|541684706|FG000|Overall Study|Not given intervention|2|||
150149819|NCT02638623|541684707|FG001|Overall Study|Not given intervention|0|||
150149820|NCT00180713|541684708|FG000|Overall Study|Withdrawal by Subject|2|||
150149821|NCT00180713|541684709|FG001|Overall Study|Withdrawal by Subject|0|||
150149822|NCT00180713|541684708|FG000|Overall Study|Adverse Event|3|||
150149823|NCT00180713|541684709|FG001|Overall Study|Adverse Event|3|||
150149824|NCT05295732|541684714|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
150149825|NCT05295732|541684715|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
150149826|NCT05295732|541684716|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
150149827|NCT05295732|541684717|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
150149828|NCT05295732|541684718|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
150149829|NCT05295732|541684714|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
150149830|NCT05295732|541684715|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
150149831|NCT05295732|541684716|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
150149832|NCT05295732|541684717|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
150149833|NCT05295732|541684718|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
150149834|NCT04152343|541684719|FG000|Overall Study|Transplanted|5|||
150149835|NCT04152343|541684719|FG000|Overall Study|Death|20|||
150149836|NCT04152343|541684719|FG000|Overall Study|Lost to Follow-up|3|||
150149837|NCT00550550|541684720|FG000|Overall Study|Adverse Event|13|||
150149838|NCT00550550|541684721|FG001|Overall Study|Adverse Event|5|||
150149839|NCT00550550|541684720|FG000|Overall Study|Treatment Failure|0|||
150149840|NCT00550550|541684721|FG001|Overall Study|Treatment Failure|1|||
150149841|NCT00550550|541684720|FG000|Overall Study|Lost to Follow-up|4|||
150149842|NCT00550550|541684721|FG001|Overall Study|Lost to Follow-up|0|||
150149843|NCT00550550|541684720|FG000|Overall Study|Withdrawal by Subject|10|||
150149844|NCT00550550|541684721|FG001|Overall Study|Withdrawal by Subject|8|||
150149845|NCT00550550|541684720|FG000|Overall Study|Protocol Violation|5|||
150149846|NCT00550550|541684721|FG001|Overall Study|Protocol Violation|14|||
150149847|NCT00550550|541684720|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
150149848|NCT00550550|541684721|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
150149849|NCT00550550|541684720|FG000|Overall Study|Randomized But Not Treated|1|||
150149850|NCT00550550|541684721|FG001|Overall Study|Randomized But Not Treated|0|||
150149851|NCT00118092|541684722|FG000|Overall Study|Withdrawal by Subject|1|||
150149852|NCT00118092|541684722|FG000|Overall Study|Protocol Violation|1|||
150149853|NCT00591864|541684727|FG000|Overall Study|Incomplete Imaging|5|||
150149854|NCT02459093|541684728|FG000|Overall Study|Protocol Violation|6|||
150149855|NCT02459093|541684729|FG001|Overall Study|Protocol Violation|11|||
150149856|NCT02459093|541684728|FG000|Overall Study|Lost to Follow-up|6|||
150149857|NCT02459093|541684729|FG001|Overall Study|Lost to Follow-up|7|||
150149858|NCT01965938|541684730|FG000|Overall Study|Withdrawal by Subject|1|||
150149859|NCT01965938|541684731|FG001|Overall Study|Withdrawal by Subject|0|||
150149860|NCT02090634|541684732|FG000|Overall Study|Lost to Follow-up|0|||
150149861|NCT02090634|541684733|FG001|Overall Study|Lost to Follow-up|1|||
150149862|NCT02090634|541684732|FG000|Overall Study|Death|0|||
150149863|NCT02090634|541684733|FG001|Overall Study|Death|1|||
150149864|NCT02090634|541684732|FG000|Overall Study|Protocol Violation|3|||
150149865|NCT02090634|541684733|FG001|Overall Study|Protocol Violation|1|||
150149866|NCT02090634|541684732|FG000|Overall Study|Adverse Event|2|||
150149867|NCT02090634|541684733|FG001|Overall Study|Adverse Event|0|||
150149868|NCT02736968|541684737|FG000|Overall Study|Lost to Follow-up|0|||
150149869|NCT02736968|541684738|FG001|Overall Study|Lost to Follow-up|0|||
150149870|NCT02736968|541684739|FG002|Overall Study|Lost to Follow-up|0|||
150149871|NCT02736968|541684740|FG003|Overall Study|Lost to Follow-up|0|||
150149872|NCT02736968|541684741|FG004|Overall Study|Lost to Follow-up|0|||
150149873|NCT02736968|541684742|FG005|Overall Study|Lost to Follow-up|0|||
150149874|NCT02736968|541684743|FG006|Overall Study|Lost to Follow-up|5|||
150149875|NCT02736968|541684744|FG007|Overall Study|Lost to Follow-up|2|||
150149876|NCT02736968|541684737|FG000|Overall Study|COVID-19 Pandemic|0|||
150149877|NCT02736968|541684738|FG001|Overall Study|COVID-19 Pandemic|0|||
150149878|NCT02736968|541684739|FG002|Overall Study|COVID-19 Pandemic|0|||
150149879|NCT02736968|541684740|FG003|Overall Study|COVID-19 Pandemic|0|||
150149880|NCT02736968|541684741|FG004|Overall Study|COVID-19 Pandemic|0|||
150149881|NCT02736968|541684742|FG005|Overall Study|COVID-19 Pandemic|0|||
150149882|NCT02736968|541684743|FG006|Overall Study|COVID-19 Pandemic|2|||
150149883|NCT02736968|541684744|FG007|Overall Study|COVID-19 Pandemic|0|||
150149884|NCT02736968|541684737|FG000|Overall Study|Withdrawal by Subject|0|||
150149885|NCT02736968|541684738|FG001|Overall Study|Withdrawal by Subject|0|||
150149886|NCT02736968|541684739|FG002|Overall Study|Withdrawal by Subject|0|||
150149887|NCT02736968|541684740|FG003|Overall Study|Withdrawal by Subject|0|||
150149888|NCT02736968|541684741|FG004|Overall Study|Withdrawal by Subject|0|||
150149889|NCT02736968|541684742|FG005|Overall Study|Withdrawal by Subject|0|||
150149890|NCT02736968|541684743|FG006|Overall Study|Withdrawal by Subject|1|||
150149891|NCT02736968|541684744|FG007|Overall Study|Withdrawal by Subject|0|||
150149892|NCT00171873|541684745|FG000|Overall Study|Withdrawal by Subject|4|||
150149893|NCT00171873|541684746|FG001|Overall Study|Withdrawal by Subject|2|||
150149894|NCT00171873|541684745|FG000|Overall Study|Adverse Event|5|||
150149895|NCT00171873|541684746|FG001|Overall Study|Adverse Event|0|||
150149896|NCT00171873|541684745|FG000|Overall Study|Switched to Octreotide|0|||
150149897|NCT00171873|541684746|FG001|Overall Study|Switched to Octreotide|1|||
150149898|NCT02041923|541684747|FG000|Overall Study|Lost to Follow-up|26|||
150149899|NCT02041923|541684748|FG001|Overall Study|Lost to Follow-up|30|||
150149900|NCT00621296|541684755|FG000|Overall Study|Adverse Event|2|||
150149901|NCT00621296|541684755|FG000|Overall Study|Lack of Efficacy|1|||
150149902|NCT00621296|541684755|FG000|Overall Study|Physician Decision|7|||
150149903|NCT00621296|541684755|FG000|Overall Study|Unmatch Criteria|1|||
150149904|NCT00621296|541684755|FG000|Overall Study|Stopping Criteria|3|||
150149905|NCT00384059|541684756|FG000|Infant Series|Not consented|2|||
150149906|NCT00384059|541684757|FG001|Infant Series|Not consented|6|||
150149907|NCT00384059|541684756|FG000|Infant Series|Withdrawal by Subject|2|||
150149908|NCT00384059|541684757|FG001|Infant Series|Withdrawal by Subject|2|||
150149909|NCT00384059|541684756|FG000|Infant Series|Adverse Event|1|||
150149910|NCT00384059|541684757|FG001|Infant Series|Adverse Event|2|||
150149911|NCT00384059|541684756|FG000|Infant Series|Protocol Violation|1|||
150149912|NCT00384059|541684757|FG001|Infant Series|Protocol Violation|2|||
150149913|NCT00384059|541684756|FG000|Infant Series|Lost to Follow-up|0|||
150149914|NCT00384059|541684757|FG001|Infant Series|Lost to Follow-up|1|||
150149915|NCT00384059|541684756|FG000|After Infant Series|Protocol Violation|2|||
150149916|NCT00384059|541684757|FG001|After Infant Series|Protocol Violation|3|||
150149917|NCT00384059|541684756|FG000|After Infant Series|Withdrawal by Subject|2|||
150149918|NCT00384059|541684757|FG001|After Infant Series|Withdrawal by Subject|2|||
150149919|NCT00384059|541684756|FG000|After Infant Series|Failed to Return|0|||
150149920|NCT00384059|541684757|FG001|After Infant Series|Failed to Return|2|||
150149921|NCT00384059|541684756|FG000|After Infant Series|Adverse Event|0|||
150149922|NCT00384059|541684757|FG001|After Infant Series|Adverse Event|1|||
150149923|NCT00384059|541684756|FG000|After Infant Series|Physician Decision|0|||
150149924|NCT00384059|541684757|FG001|After Infant Series|Physician Decision|1|||
150149925|NCT00384059|541684756|FG000|After Infant Series|Lost to Follow-up|0|||
150149926|NCT00384059|541684757|FG001|After Infant Series|Lost to Follow-up|1|||
150149927|NCT00384059|541684756|FG000|Toddler Dose|Lost to Follow-up|1|||
150149928|NCT00384059|541684757|FG001|Toddler Dose|Lost to Follow-up|1|||
150149929|NCT00384059|541684756|FG000|Toddler Dose|Failed to return|0|||
150149930|NCT00384059|541684757|FG001|Toddler Dose|Failed to return|1|||
150149931|NCT00381641|541684760|FG000|Overall Study|Withdrawal by Subject|0|||
150149932|NCT00381641|541684761|FG001|Overall Study|Withdrawal by Subject|2|||
150149933|NCT01267825|541686428|FG000|Overall Study|study terminated. no data collected.|1|||
150149934|NCT01267825|541686429|FG001|Overall Study|study terminated. no data collected.|0|||
150149935|NCT04249336|541686430|FG000|Overall Study|Lost to Follow-up|3|||
150149936|NCT04249336|541686431|FG001|Overall Study|Lost to Follow-up|3|||
150149937|NCT04249336|541686432|FG002|Overall Study|Lost to Follow-up|3|||
150149938|NCT04249336|541686433|FG003|Overall Study|Lost to Follow-up|3|||
150149939|NCT01242176|541686434|FG000|Washout Period of 7 Days|Adverse Event|0|||
150149940|NCT01242176|541686435|FG001|Washout Period of 7 Days|Adverse Event|2|||
150149941|NCT01242176|541686434|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
150149942|NCT01242176|541686435|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
150149943|NCT00871351|541686436|FG000|Overall Study|Withdrawal by Subject|1|||
150149944|NCT00871351|541686437|FG001|Overall Study|Withdrawal by Subject|0|||
150149945|NCT00871351|541686438|FG002|Overall Study|Withdrawal by Subject|0|||
150149946|NCT00871351|541686436|FG000|Overall Study|Adverse Event|3|||
150149947|NCT00871351|541686437|FG001|Overall Study|Adverse Event|1|||
150149948|NCT00871351|541686438|FG002|Overall Study|Adverse Event|0|||
150149949|NCT02291289|541686440|FG000|Induction Treatment|Withdrawal by Subject|0|||
150149950|NCT02291289|541686441|FG001|Induction Treatment|Withdrawal by Subject|0|||
150149951|NCT02291289|541686442|FG002|Induction Treatment|Withdrawal by Subject|0|||
150149952|NCT02291289|541686443|FG003|Induction Treatment|Withdrawal by Subject|24|||
150149953|NCT02291289|541686444|FG004|Induction Treatment|Withdrawal by Subject|0|||
150149954|NCT02291289|541686445|FG005|Induction Treatment|Withdrawal by Subject|0|||
150149955|NCT02291289|541686446|FG006|Induction Treatment|Withdrawal by Subject|0|||
150149956|NCT02291289|541686447|FG007|Induction Treatment|Withdrawal by Subject|0|||
150149957|NCT02291289|541686448|FG008|Induction Treatment|Withdrawal by Subject|0|||
150149958|NCT02291289|541686449|FG009|Induction Treatment|Withdrawal by Subject|18|||
150149959|NCT02291289|541686450|FG010|Induction Treatment|Withdrawal by Subject|0|||
150149960|NCT02291289|541686451|FG011|Induction Treatment|Withdrawal by Subject|0|||
150149961|NCT02291289|541686452|FG012|Induction Treatment|Withdrawal by Subject|0|||
150149962|NCT02291289|541686440|FG000|Induction Treatment|Adverse Event|0|||
150149963|NCT02291289|541686441|FG001|Induction Treatment|Adverse Event|0|||
150149964|NCT02291289|541686442|FG002|Induction Treatment|Adverse Event|0|||
150149965|NCT02291289|541686443|FG003|Induction Treatment|Adverse Event|3|||
150149966|NCT02291289|541686444|FG004|Induction Treatment|Adverse Event|0|||
150149967|NCT02291289|541686445|FG005|Induction Treatment|Adverse Event|0|||
150149968|NCT02291289|541686446|FG006|Induction Treatment|Adverse Event|0|||
150149969|NCT02291289|541686447|FG007|Induction Treatment|Adverse Event|0|||
150149970|NCT02291289|541686448|FG008|Induction Treatment|Adverse Event|0|||
150149971|NCT02291289|541686449|FG009|Induction Treatment|Adverse Event|1|||
150149972|NCT02291289|541686450|FG010|Induction Treatment|Adverse Event|0|||
150149973|NCT02291289|541686451|FG011|Induction Treatment|Adverse Event|0|||
150149974|NCT02291289|541686452|FG012|Induction Treatment|Adverse Event|0|||
150149975|NCT02291289|541686440|FG000|Induction Treatment|Death|25|||
150149976|NCT02291289|541686441|FG001|Induction Treatment|Death|0|||
150149977|NCT02291289|541686442|FG002|Induction Treatment|Death|0|||
150149978|NCT02291289|541686443|FG003|Induction Treatment|Death|111|||
150149979|NCT02291289|541686444|FG004|Induction Treatment|Death|0|||
150149980|NCT02291289|541686445|FG005|Induction Treatment|Death|0|||
150149981|NCT02291289|541686446|FG006|Induction Treatment|Death|1|||
150149982|NCT02291289|541686447|FG007|Induction Treatment|Death|0|||
150149983|NCT02291289|541686448|FG008|Induction Treatment|Death|0|||
150149984|NCT02291289|541686449|FG009|Induction Treatment|Death|82|||
150149985|NCT02291289|541686450|FG010|Induction Treatment|Death|0|||
149811036|NCT02706353|540435731|FG000|Dose Level 1|Disease Progression|1|||
150149986|NCT02291289|541686451|FG011|Induction Treatment|Death|0|||
150149987|NCT02291289|541686452|FG012|Induction Treatment|Death|0|||
149811037|NCT02706353|540435732|FG001|Dose Level 1|Disease Progression|0|||
149811038|NCT02706353|540435733|FG002|Dose Level 1|Disease Progression|0|||
150149988|NCT02291289|541686440|FG000|Induction Treatment|Lost to Follow-up|1|||
150149989|NCT02291289|541686441|FG001|Induction Treatment|Lost to Follow-up|0|||
150149990|NCT02291289|541686442|FG002|Induction Treatment|Lost to Follow-up|0|||
150149991|NCT02291289|541686443|FG003|Induction Treatment|Lost to Follow-up|12|||
150149992|NCT02291289|541686444|FG004|Induction Treatment|Lost to Follow-up|0|||
150149993|NCT02291289|541686445|FG005|Induction Treatment|Lost to Follow-up|0|||
150149994|NCT02291289|541686446|FG006|Induction Treatment|Lost to Follow-up|0|||
150149995|NCT02291289|541686447|FG007|Induction Treatment|Lost to Follow-up|0|||
150149996|NCT02291289|541686448|FG008|Induction Treatment|Lost to Follow-up|0|||
150149997|NCT02291289|541686449|FG009|Induction Treatment|Lost to Follow-up|9|||
150149998|NCT02291289|541686450|FG010|Induction Treatment|Lost to Follow-up|0|||
150149999|NCT02291289|541686451|FG011|Induction Treatment|Lost to Follow-up|0|||
150150000|NCT02291289|541686452|FG012|Induction Treatment|Lost to Follow-up|0|||
150150001|NCT02291289|541686440|FG000|Induction Treatment|Non-Compliance|0|||
150150002|NCT02291289|541686441|FG001|Induction Treatment|Non-Compliance|0|||
150150003|NCT02291289|541686442|FG002|Induction Treatment|Non-Compliance|0|||
150150004|NCT02291289|541686443|FG003|Induction Treatment|Non-Compliance|1|||
150150005|NCT02291289|541686444|FG004|Induction Treatment|Non-Compliance|0|||
150150006|NCT02291289|541686445|FG005|Induction Treatment|Non-Compliance|0|||
150150007|NCT02291289|541686446|FG006|Induction Treatment|Non-Compliance|0|||
150150008|NCT02291289|541686447|FG007|Induction Treatment|Non-Compliance|0|||
150150009|NCT02291289|541686448|FG008|Induction Treatment|Non-Compliance|0|||
150150010|NCT02291289|541686449|FG009|Induction Treatment|Non-Compliance|1|||
150150011|NCT02291289|541686450|FG010|Induction Treatment|Non-Compliance|0|||
150150012|NCT02291289|541686451|FG011|Induction Treatment|Non-Compliance|0|||
150150013|NCT02291289|541686452|FG012|Induction Treatment|Non-Compliance|0|||
150150014|NCT02291289|541686440|FG000|Induction Treatment|Reason Not Specified|0|||
150150015|NCT02291289|541686441|FG001|Induction Treatment|Reason Not Specified|0|||
150150016|NCT02291289|541686442|FG002|Induction Treatment|Reason Not Specified|0|||
150150017|NCT02291289|541686443|FG003|Induction Treatment|Reason Not Specified|4|||
150150018|NCT02291289|541686444|FG004|Induction Treatment|Reason Not Specified|0|||
150150019|NCT02291289|541686445|FG005|Induction Treatment|Reason Not Specified|0|||
150150020|NCT02291289|541686446|FG006|Induction Treatment|Reason Not Specified|0|||
150150021|NCT02291289|541686447|FG007|Induction Treatment|Reason Not Specified|0|||
150150022|NCT02291289|541686448|FG008|Induction Treatment|Reason Not Specified|0|||
150150023|NCT02291289|541686449|FG009|Induction Treatment|Reason Not Specified|7|||
150150024|NCT02291289|541686450|FG010|Induction Treatment|Reason Not Specified|0|||
150150025|NCT02291289|541686451|FG011|Induction Treatment|Reason Not Specified|0|||
150150026|NCT02291289|541686452|FG012|Induction Treatment|Reason Not Specified|0|||
150150027|NCT02291289|541686440|FG000|Induction Treatment|Physician Decision|0|||
150150028|NCT02291289|541686441|FG001|Induction Treatment|Physician Decision|0|||
150150029|NCT02291289|541686442|FG002|Induction Treatment|Physician Decision|0|||
150150030|NCT02291289|541686443|FG003|Induction Treatment|Physician Decision|3|||
150150031|NCT02291289|541686444|FG004|Induction Treatment|Physician Decision|0|||
150150032|NCT02291289|541686445|FG005|Induction Treatment|Physician Decision|0|||
150150033|NCT02291289|541686446|FG006|Induction Treatment|Physician Decision|0|||
150150034|NCT02291289|541686447|FG007|Induction Treatment|Physician Decision|0|||
150150035|NCT02291289|541686448|FG008|Induction Treatment|Physician Decision|0|||
150150036|NCT02291289|541686449|FG009|Induction Treatment|Physician Decision|1|||
150150037|NCT02291289|541686450|FG010|Induction Treatment|Physician Decision|0|||
150150038|NCT02291289|541686451|FG011|Induction Treatment|Physician Decision|0|||
150150039|NCT02291289|541686452|FG012|Induction Treatment|Physician Decision|0|||
150150040|NCT02291289|541686440|FG000|Induction Treatment|Protocol Violation|0|||
150150041|NCT02291289|541686441|FG001|Induction Treatment|Protocol Violation|0|||
150150042|NCT02291289|541686442|FG002|Induction Treatment|Protocol Violation|0|||
150150043|NCT02291289|541686443|FG003|Induction Treatment|Protocol Violation|3|||
150150044|NCT02291289|541686444|FG004|Induction Treatment|Protocol Violation|0|||
150150045|NCT02291289|541686445|FG005|Induction Treatment|Protocol Violation|0|||
150150046|NCT02291289|541686446|FG006|Induction Treatment|Protocol Violation|0|||
150150047|NCT02291289|541686447|FG007|Induction Treatment|Protocol Violation|0|||
150150048|NCT02291289|541686448|FG008|Induction Treatment|Protocol Violation|0|||
150150049|NCT02291289|541686449|FG009|Induction Treatment|Protocol Violation|2|||
150150050|NCT02291289|541686450|FG010|Induction Treatment|Protocol Violation|0|||
150150051|NCT02291289|541686451|FG011|Induction Treatment|Protocol Violation|0|||
150150052|NCT02291289|541686452|FG012|Induction Treatment|Protocol Violation|0|||
150150053|NCT02291289|541686440|FG000|Induction Treatment|Missing|4|||
150150054|NCT02291289|541686441|FG001|Induction Treatment|Missing|0|||
150150055|NCT02291289|541686442|FG002|Induction Treatment|Missing|0|||
150150056|NCT02291289|541686443|FG003|Induction Treatment|Missing|14|||
150150057|NCT02291289|541686444|FG004|Induction Treatment|Missing|0|||
150150058|NCT02291289|541686445|FG005|Induction Treatment|Missing|0|||
150150059|NCT02291289|541686446|FG006|Induction Treatment|Missing|0|||
150150060|NCT02291289|541686447|FG007|Induction Treatment|Missing|0|||
150150061|NCT02291289|541686448|FG008|Induction Treatment|Missing|0|||
150150062|NCT02291289|541686449|FG009|Induction Treatment|Missing|54|||
150150063|NCT02291289|541686450|FG010|Induction Treatment|Missing|0|||
150150064|NCT02291289|541686451|FG011|Induction Treatment|Missing|0|||
150150065|NCT02291289|541686452|FG012|Induction Treatment|Missing|0|||
150150066|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150067|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150068|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150069|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150070|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
150150071|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
150150072|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150073|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150074|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150075|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150076|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
150150077|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
150150078|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150150079|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Death|0|||
150150080|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Death|29|||
150150081|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Death|16|||
150150082|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Death|0|||
150150083|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Death|188|||
150150084|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Death|107|||
150150085|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Death|0|||
150150086|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Death|1|||
150150087|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Death|1|||
150150088|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Death|0|||
150150089|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Death|46|||
150150090|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Death|19|||
150150091|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Death|0|||
150150092|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Adverse Event|0|||
150150093|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Adverse Event|0|||
150150094|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Adverse Event|0|||
150150095|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Adverse Event|0|||
150150096|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Adverse Event|1|||
150150097|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Adverse Event|1|||
150150098|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Adverse Event|0|||
150150099|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Adverse Event|0|||
150150100|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Adverse Event|0|||
150150101|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Adverse Event|0|||
150150102|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Adverse Event|0|||
150150103|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Adverse Event|0|||
150150104|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Adverse Event|0|||
150150105|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150106|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
150150107|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150108|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150109|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
150150110|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
150150111|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150112|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
150150113|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150114|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150115|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
150150116|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
150150117|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
150150118|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
150150119|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
150150120|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
150150121|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
150150122|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
150150123|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
150150124|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
150150125|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
150150126|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
150150127|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
150150128|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
150150129|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
150150130|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
150150131|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Physician Decision|0|||
150150132|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Physician Decision|2|||
150150133|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Physician Decision|0|||
150150134|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Physician Decision|0|||
150150135|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Physician Decision|3|||
150150136|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Physician Decision|0|||
150150137|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Physician Decision|0|||
150150138|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Physician Decision|0|||
150150139|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Physician Decision|0|||
150150140|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Physician Decision|0|||
150150141|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Physician Decision|1|||
150150142|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Physician Decision|3|||
150150143|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Physician Decision|0|||
150150144|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Not Treated|0|||
150150145|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Not Treated|0|||
150150146|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Not Treated|2|||
150150147|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Not Treated|0|||
150150148|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Not Treated|0|||
150150149|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Not Treated|0|||
150150150|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Not Treated|0|||
150150151|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Not Treated|0|||
150150152|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Not Treated|0|||
150150153|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Not Treated|0|||
150150154|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Not Treated|0|||
150150155|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Not Treated|0|||
150150156|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Not Treated|0|||
150150157|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150158|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
150150159|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150160|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150161|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150162|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150163|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150164|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150165|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150166|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150167|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150168|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150169|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
150150170|NCT02291289|541686440|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
150150171|NCT02291289|541686441|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
150150172|NCT02291289|541686442|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
150150173|NCT02291289|541686443|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
150150174|NCT02291289|541686444|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
150150175|NCT02291289|541686445|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
150150176|NCT02291289|541686446|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
150150177|NCT02291289|541686447|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
150150178|NCT02291289|541686448|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
150150179|NCT02291289|541686449|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
150150180|NCT02291289|541686450|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
150150181|NCT02291289|541686451|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
150150182|NCT02291289|541686452|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
150150183|NCT02291289|541686440|FG000|Early Disease Progression|Death|0|||
150150184|NCT02291289|541686441|FG001|Early Disease Progression|Death|0|||
150150185|NCT02291289|541686442|FG002|Early Disease Progression|Death|0|||
150150186|NCT02291289|541686443|FG003|Early Disease Progression|Death|0|||
150150187|NCT02291289|541686444|FG004|Early Disease Progression|Death|0|||
150150188|NCT02291289|541686445|FG005|Early Disease Progression|Death|0|||
150150189|NCT02291289|541686446|FG006|Early Disease Progression|Death|0|||
150150190|NCT02291289|541686447|FG007|Early Disease Progression|Death|0|||
150150191|NCT02291289|541686448|FG008|Early Disease Progression|Death|0|||
150150192|NCT02291289|541686449|FG009|Early Disease Progression|Death|0|||
150150193|NCT02291289|541686450|FG010|Early Disease Progression|Death|0|||
150150194|NCT02291289|541686451|FG011|Early Disease Progression|Death|0|||
150150195|NCT02291289|541686452|FG012|Early Disease Progression|Death|10|||
150150196|NCT02291289|541686440|FG000|Early Disease Progression|Lost to Follow-up|0|||
150150197|NCT02291289|541686441|FG001|Early Disease Progression|Lost to Follow-up|0|||
150150198|NCT02291289|541686442|FG002|Early Disease Progression|Lost to Follow-up|0|||
150150199|NCT02291289|541686443|FG003|Early Disease Progression|Lost to Follow-up|0|||
150150200|NCT02291289|541686444|FG004|Early Disease Progression|Lost to Follow-up|0|||
150150201|NCT02291289|541686445|FG005|Early Disease Progression|Lost to Follow-up|0|||
150150202|NCT02291289|541686446|FG006|Early Disease Progression|Lost to Follow-up|0|||
150150203|NCT02291289|541686447|FG007|Early Disease Progression|Lost to Follow-up|0|||
150150204|NCT02291289|541686448|FG008|Early Disease Progression|Lost to Follow-up|0|||
150150205|NCT02291289|541686449|FG009|Early Disease Progression|Lost to Follow-up|0|||
150150206|NCT02291289|541686450|FG010|Early Disease Progression|Lost to Follow-up|0|||
150150207|NCT02291289|541686451|FG011|Early Disease Progression|Lost to Follow-up|0|||
150150208|NCT02291289|541686452|FG012|Early Disease Progression|Lost to Follow-up|1|||
150150209|NCT01868035|541686457|FG000|Overall Study|Lost to Follow-up|3|||
150150210|NCT01868035|541686457|FG000|Overall Study|Withdrawal by Subject|1|||
150150211|NCT01868035|541686457|FG000|Overall Study|Progressive Disease|2|||
150150212|NCT01868035|541686457|FG000|Overall Study|Non-compliance|1|||
150150213|NCT00154063|541686464|FG000|Overall Study|Adverse Event|4|||
150150214|NCT00154063|541686465|FG001|Overall Study|Adverse Event|8|||
150150215|NCT00154063|541686464|FG000|Overall Study|Protocol Violation|1|||
150150216|NCT00154063|541686465|FG001|Overall Study|Protocol Violation|1|||
149811039|NCT02706353|540435734|FG003|Dose Level 1|Disease Progression|0|||
149811040|NCT02706353|540435735|FG004|Dose Level 1|Disease Progression|0|||
150150217|NCT00154063|541686464|FG000|Overall Study|Investigator or Sponsor Request|0|||
150150218|NCT00154063|541686465|FG001|Overall Study|Investigator or Sponsor Request|1|||
150150219|NCT00154063|541686464|FG000|Overall Study|Withdrawal by Subject|4|||
150150220|NCT00154063|541686465|FG001|Overall Study|Withdrawal by Subject|9|||
150150221|NCT00154063|541686464|FG000|Overall Study|Other|3|||
150150222|NCT00154063|541686465|FG001|Overall Study|Other|3|||
150150223|NCT01804673|541686466|FG000|Overall Study|Adverse Event|4|||
150150224|NCT01804673|541686466|FG000|Overall Study|Withdrawal by Subject|1|||
150150225|NCT01804673|541686466|FG000|Overall Study|Lack of Efficacy|9|||
150150226|NCT01804673|541686466|FG000|Overall Study|Change to Oral Therapy|37|||
150150227|NCT01804673|541686466|FG000|Overall Study|No Further Therapy Required|84|||
150150228|NCT01804673|541686466|FG000|Overall Study|Use of Prohibited Medication|1|||
150150229|NCT01804673|541686466|FG000|Overall Study|Other|4|||
150150230|NCT01857934|541686474|FG000|Overall Study|Relapse or progression|2|||
150150231|NCT01857934|541686474|FG000|Overall Study|Unacceptable toxicity|3|||
150150232|NCT01857934|541686474|FG000|Overall Study|Unwillingness or inability to comply|2|||
150150233|NCT01857934|541686474|FG000|Overall Study|Physician Decision|3|||
150150234|NCT01024959|541686475|FG000|Overall Study|ineligible|12|||
150150235|NCT01024959|541686475|FG000|Overall Study|results not evaluable|12|||
150150236|NCT01024959|541686475|FG000|Overall Study|missing results required for analysis|17|||
150150237|NCT00313911|541686476|FG000|Overall Study|Serious adverse event|6|||
150150238|NCT00313911|541686477|FG001|Overall Study|Serious adverse event|1|||
150150239|NCT00313911|541686476|FG000|Overall Study|Adverse Event|2|||
150150240|NCT00313911|541686477|FG001|Overall Study|Adverse Event|3|||
150150241|NCT00313911|541686476|FG000|Overall Study|Protocol Violation|19|||
150150242|NCT00313911|541686477|FG001|Overall Study|Protocol Violation|10|||
150150243|NCT00313911|541686476|FG000|Overall Study|Lost to Follow-up|27|||
150150244|NCT00313911|541686477|FG001|Overall Study|Lost to Follow-up|14|||
150150245|NCT00313911|541686476|FG000|Overall Study|Withdrawal by Subject|39|||
150150246|NCT00313911|541686477|FG001|Overall Study|Withdrawal by Subject|12|||
150150247|NCT00313911|541686476|FG000|Overall Study|Did not meet age criteria|1|||
150150248|NCT00313911|541686477|FG001|Overall Study|Did not meet age criteria|1|||
150150249|NCT01912781|541686480|FG000|Overall Study|Withdrawal by Subject|2|||
150150250|NCT01912781|541686481|FG001|Overall Study|Withdrawal by Subject|0|||
150150251|NCT00684762|541686484|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
150150252|NCT00684762|541686485|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
150150253|NCT02111213|541686489|FG000|Overall Study|Withdrawal by Subject|3|||
150150254|NCT02111213|541686490|FG001|Overall Study|Withdrawal by Subject|2|||
150150255|NCT02111213|541686489|FG000|Overall Study|Lost to Follow-up|3|||
150150256|NCT02111213|541686490|FG001|Overall Study|Lost to Follow-up|4|||
150150257|NCT02153359|541686491|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
150150258|NCT02153359|541686492|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
150150259|NCT04192630|541686493|FG000|Overall Study|Discontinued before surgery|2|||
150150260|NCT04192630|541686494|FG001|Overall Study|Discontinued before surgery|0|||
150150261|NCT04192630|541686493|FG000|Overall Study|Discontinued after surgery|5|||
150150262|NCT04192630|541686494|FG001|Overall Study|Discontinued after surgery|3|||
150150263|NCT01193582|541686495|FG000|Vaccination Series|Withdrawal by Subject|11|||
150150264|NCT01193582|541686496|FG001|Vaccination Series|Withdrawal by Subject|13|||
150150265|NCT01193582|541686497|FG002|Vaccination Series|Withdrawal by Subject|8|||
150150266|NCT01193582|541686498|FG003|Vaccination Series|Withdrawal by Subject|3|||
150150267|NCT01193582|541686495|FG000|12 Month Follow-up|Death|0|||
150150268|NCT01193582|541686496|FG001|12 Month Follow-up|Death|0|||
149811041|NCT02706353|540435736|FG005|Dose Level 1|Disease Progression|0|||
149811042|NCT02706353|540435731|FG000|Dose Level 3|Disease Progression|0|||
149811043|NCT02706353|540435732|FG001|Dose Level 3|Disease Progression|0|||
149811044|NCT02706353|540435733|FG002|Dose Level 3|Disease Progression|2|||
149811045|NCT02706353|540435734|FG003|Dose Level 3|Disease Progression|0|||
149811046|NCT02706353|540435735|FG004|Dose Level 3|Disease Progression|0|||
149811047|NCT02706353|540435736|FG005|Dose Level 3|Disease Progression|0|||
149811048|NCT02706353|540435731|FG000|Dose Level 4|Disease Progression|0|||
149811049|NCT02706353|540435732|FG001|Dose Level 4|Disease Progression|0|||
149811050|NCT02706353|540435733|FG002|Dose Level 4|Disease Progression|0|||
149811051|NCT02706353|540435734|FG003|Dose Level 4|Disease Progression|1|||
149811052|NCT02706353|540435735|FG004|Dose Level 4|Disease Progression|0|||
150150269|NCT01193582|541686497|FG002|12 Month Follow-up|Death|1|||
149811053|NCT02706353|540435736|FG005|Dose Level 4|Disease Progression|0|||
149811054|NCT02706353|540435731|FG000|Dose Level 4|Toxicity|0|||
149811055|NCT02706353|540435732|FG001|Dose Level 4|Toxicity|0|||
149811056|NCT02706353|540435733|FG002|Dose Level 4|Toxicity|0|||
149811057|NCT02706353|540435734|FG003|Dose Level 4|Toxicity|1|||
149811058|NCT02706353|540435735|FG004|Dose Level 4|Toxicity|0|||
149811059|NCT02706353|540435736|FG005|Dose Level 4|Toxicity|0|||
149811060|NCT02706353|540435731|FG000|Dose Level 4|Death|0|||
150150270|NCT01193582|541686498|FG003|12 Month Follow-up|Death|0|||
150150271|NCT01193582|541686495|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
150150272|NCT01193582|541686496|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
150150273|NCT01193582|541686497|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
150150274|NCT01193582|541686498|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
150150275|NCT01775930|541686502|FG000|Overall Study|Futility stopping boundary met|1|||
150150276|NCT01208415|541686503|FG000|Overall Study|Death|1|||
150150277|NCT01208415|541686503|FG000|Overall Study|Lost to Follow-up|2|||
150150278|NCT01208415|541686503|FG000|Overall Study|Withdrawal by Subject|3|||
150150279|NCT01208415|541686503|FG000|Overall Study|Device not placed|1|||
150150280|NCT01208415|541686503|FG000|Overall Study|Still be eligible for follow-up|33|||
150150281|NCT01115491|541686504|FG000|Overall Study|Death|22|||
150150282|NCT01115491|541686504|FG000|Overall Study|Adverse Event|3|||
150150283|NCT01115491|541686504|FG000|Overall Study|Lost to Follow-up|3|||
150150284|NCT01115491|541686504|FG000|Overall Study|Withdrawal by Subject|1|||
150150285|NCT01115491|541686504|FG000|Overall Study|Physician Decision|1|||
150150286|NCT03856996|541686505|FG000|Overall Study|Withdrawal by Subject|1|||
150150287|NCT03856996|541686506|FG001|Overall Study|Withdrawal by Subject|0|||
150150288|NCT03856996|541686505|FG000|Overall Study|Lost to Follow-up|0|||
150150289|NCT03856996|541686506|FG001|Overall Study|Lost to Follow-up|1|||
150150290|NCT03856996|541686505|FG000|Overall Study|Adverse Event|1|||
150150291|NCT03856996|541686506|FG001|Overall Study|Adverse Event|1|||
150150292|NCT03856996|541686505|FG000|Overall Study|Other|1|||
150150293|NCT03856996|541686506|FG001|Overall Study|Other|0|||
150150294|NCT01586338|541686509|FG000|Overall Study|Adverse Event|3|||
150150295|NCT01586338|541686509|FG000|Overall Study|Lost to Follow-up|1|||
150150296|NCT01586338|541686509|FG000|Overall Study|Withdrawal by participant|3|||
150150297|NCT01586338|541686509|FG000|Overall Study|Other|1|||
150150298|NCT00786474|541686514|FG000|Overall Study|Death|5|||
150150299|NCT00786474|541686515|FG001|Overall Study|Death|4|||
150150300|NCT00786474|541686514|FG000|Overall Study|Withdrawal by Subject|23|||
150150301|NCT00786474|541686515|FG001|Overall Study|Withdrawal by Subject|31|||
150150302|NCT00786474|541686514|FG000|Overall Study|Lost to Follow-up|3|||
150150303|NCT00786474|541686515|FG001|Overall Study|Lost to Follow-up|3|||
150150304|NCT00786474|541686514|FG000|Overall Study|Physician Decision|2|||
150150305|NCT00786474|541686515|FG001|Overall Study|Physician Decision|1|||
150150306|NCT00786474|541686514|FG000|Overall Study|Other|4|||
150150307|NCT00786474|541686515|FG001|Overall Study|Other|4|||
150150308|NCT01868074|541686516|FG000|Overall Study|Lost to Follow-up|3|||
150150309|NCT01868074|541686517|FG001|Overall Study|Lost to Follow-up|2|||
150150310|NCT01868074|541686516|FG000|Overall Study|Withdrawal by Subject|4|||
150150311|NCT01868074|541686517|FG001|Overall Study|Withdrawal by Subject|2|||
150150312|NCT03306043|541686518|FG000|Overall Study|Adverse Event|1|||
150150313|NCT03306043|541686518|FG000|Overall Study|Lost to Follow-up|1|||
150150314|NCT03306043|541686518|FG000|Overall Study|Withdrawal by Subject|2|||
150150315|NCT01544491|541686519|FG000|Overall Study|Withdrawal by Subject|3|||
150150316|NCT01544491|541686520|FG001|Overall Study|Withdrawal by Subject|2|||
150150317|NCT01544491|541686519|FG000|Overall Study|Lost to Follow-up|0|||
150150318|NCT01544491|541686520|FG001|Overall Study|Lost to Follow-up|1|||
150150319|NCT01544491|541686519|FG000|Overall Study|administrative problems|2|||
150150320|NCT01544491|541686520|FG001|Overall Study|administrative problems|0|||
150150321|NCT01799720|541686521|FG000|Overall Study|Withdrawal by Subject|3|||
150150322|NCT01799720|541686522|FG001|Overall Study|Withdrawal by Subject|0|||
150150323|NCT01799720|541686523|FG002|Overall Study|Withdrawal by Subject|0|||
150150324|NCT01799720|541686521|FG000|Overall Study|Protocol Violation|0|||
150150325|NCT01799720|541686522|FG001|Overall Study|Protocol Violation|1|||
150150326|NCT01799720|541686523|FG002|Overall Study|Protocol Violation|0|||
150150327|NCT01799720|541686521|FG000|Overall Study|Pregnancy|0|||
150150328|NCT01799720|541686522|FG001|Overall Study|Pregnancy|0|||
150150329|NCT01799720|541686523|FG002|Overall Study|Pregnancy|1|||
150150330|NCT01234649|541686525|FG000|Overall Study|Withdrawal by Subject|32|||
150150331|NCT01234649|541686526|FG001|Overall Study|Withdrawal by Subject|26|||
150150332|NCT01234649|541686525|FG000|Overall Study|Pregnancy|6|||
150150333|NCT01234649|541686526|FG001|Overall Study|Pregnancy|6|||
150150334|NCT01234649|541686525|FG000|Overall Study|intolerant to side effects|4|||
150150335|NCT01234649|541686526|FG001|Overall Study|intolerant to side effects|3|||
150150336|NCT01234649|541686525|FG000|Overall Study|Allergic reaction|1|||
150150337|NCT01234649|541686526|FG001|Overall Study|Allergic reaction|0|||
150150338|NCT01234649|541686525|FG000|Overall Study|Lack of Efficacy|0|||
150150339|NCT01234649|541686526|FG001|Overall Study|Lack of Efficacy|3|||
150150340|NCT00896454|541686527|FG000|Overall Study|Death|10|||
150150341|NCT00896454|541686527|FG000|Overall Study|Adverse Event|8|||
150150342|NCT00896454|541686527|FG000|Overall Study|Disease Progression|5|||
150150343|NCT00896454|541686527|FG000|Overall Study|Other|4|||
150150344|NCT00896454|541686527|FG000|Overall Study|Requirement for alternative therapy|3|||
150150345|NCT00896454|541686527|FG000|Overall Study|Ongoing in study|2|||
150150346|NCT00896454|541686527|FG000|Overall Study|Withdrawal by Subject|1|||
150150347|NCT02838628|541686532|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
150150348|NCT02838628|541686533|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
150150349|NCT02838628|541686532|FG000|Recurrence Follow-up Period|Adverse Event|1|||
150150350|NCT02838628|541686533|FG001|Recurrence Follow-up Period|Adverse Event|0|||
150150351|NCT02838628|541686532|FG000|Recurrence Follow-up Period|Non-compliance|0|||
150150352|NCT02838628|541686533|FG001|Recurrence Follow-up Period|Non-compliance|1|||
150150353|NCT02838628|541686532|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
150150354|NCT02838628|541686533|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
150150355|NCT02838628|541686532|FG000|Recurrence Follow-up Period|Other un-specified|1|||
150150356|NCT02838628|541686533|FG001|Recurrence Follow-up Period|Other un-specified|1|||
150150357|NCT03904693|541686535|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
150150358|NCT03904693|541686536|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
150150359|NCT03904693|541686537|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
150150360|NCT03904693|541686538|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
150150361|NCT03904693|541686539|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
150150362|NCT03904693|541686540|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
150150363|NCT03904693|541686535|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150150364|NCT03904693|541686536|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150150365|NCT03904693|541686537|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
150150366|NCT03904693|541686538|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150150367|NCT03904693|541686539|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150150368|NCT03904693|541686540|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150150369|NCT03904693|541686535|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150150370|NCT03904693|541686536|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
150150371|NCT03904693|541686537|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
150150372|NCT03904693|541686538|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150150373|NCT03904693|541686539|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150150374|NCT03904693|541686540|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150150375|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
150150376|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
150150377|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
150150378|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
150150379|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
150150380|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
150150381|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
150150382|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
150150383|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
150150384|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
150150385|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
150150386|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
150150387|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
150150388|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
150150389|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
150150390|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
150150391|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
150150392|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
150150393|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
150150394|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
150150395|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
150150396|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
150150397|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
150150398|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
150150399|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
150150400|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
150150401|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
150150402|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149811061|NCT02706353|540435732|FG001|Dose Level 4|Death|0|||
149811062|NCT02706353|540435733|FG002|Dose Level 4|Death|0|||
149811063|NCT02706353|540435734|FG003|Dose Level 4|Death|1|||
149811064|NCT02706353|540435735|FG004|Dose Level 4|Death|0|||
149811065|NCT02706353|540435736|FG005|Dose Level 4|Death|0|||
149811066|NCT02706353|540435731|FG000|Dose Level 5|Toxicity|0|||
149811067|NCT02706353|540435732|FG001|Dose Level 5|Toxicity|0|||
149811068|NCT02706353|540435733|FG002|Dose Level 5|Toxicity|0|||
149811069|NCT02706353|540435734|FG003|Dose Level 5|Toxicity|0|||
149811070|NCT02706353|540435735|FG004|Dose Level 5|Toxicity|1|||
149811071|NCT02706353|540435736|FG005|Dose Level 5|Toxicity|0|||
149811072|NCT02706353|540435731|FG000|Dose Level 5|Disease Progression|0|||
149811073|NCT02706353|540435732|FG001|Dose Level 5|Disease Progression|0|||
149811074|NCT02706353|540435733|FG002|Dose Level 5|Disease Progression|0|||
149811075|NCT02706353|540435734|FG003|Dose Level 5|Disease Progression|0|||
149811076|NCT02706353|540435735|FG004|Dose Level 5|Disease Progression|3|||
149811077|NCT02706353|540435736|FG005|Dose Level 5|Disease Progression|2|||
149811078|NCT02706353|540435731|FG000|Dose Level 5|Death|0|||
149811079|NCT02706353|540435732|FG001|Dose Level 5|Death|0|||
149811080|NCT02706353|540435733|FG002|Dose Level 5|Death|0|||
149811081|NCT02706353|540435734|FG003|Dose Level 5|Death|0|||
150150403|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
150150404|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
150150405|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
150150406|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
150150407|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
150150408|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
150150409|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
150150410|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
150150411|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
150150412|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
150150413|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
150150414|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149811082|NCT02706353|540435735|FG004|Dose Level 5|Death|1|||
150150415|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
150150416|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
150150417|NCT03904693|541686535|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
150150418|NCT03904693|541686536|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
150150419|NCT03904693|541686537|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
150150420|NCT03904693|541686538|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
150150421|NCT03904693|541686539|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
150150422|NCT03904693|541686540|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
150150423|NCT04654468|541686541|FG000|Overall Study|Death|1|||
150150424|NCT04654468|541686541|FG000|Overall Study|Ongoing in the Study|50|||
150150425|NCT06390826|541686542|FG000|Overall Study|Never Start Protocol Therapy|1|||
150150426|NCT06390826|541686542|FG000|Overall Study|Adverse Event|1|||
150150427|NCT06390826|541686542|FG000|Overall Study|Disease Progression|8|||
150150428|NCT01155661|541686543|FG000|Overall Study|Adverse Event|101|||
150150429|NCT01155661|541686543|FG000|Overall Study|Death|1|||
150150430|NCT01155661|541686543|FG000|Overall Study|Lack of Efficacy|32|||
150150431|NCT01155661|541686543|FG000|Overall Study|Lost to Follow-up|22|||
150150432|NCT01155661|541686543|FG000|Overall Study|Physician Decision|3|||
150150433|NCT01155661|541686543|FG000|Overall Study|Protocol Violation|35|||
150150434|NCT01155661|541686543|FG000|Overall Study|Withdrawal by Subject|73|||
150150435|NCT01155661|541686543|FG000|Overall Study|Sponsor Decision|13|||
150150436|NCT00960752|541686549|FG000|Overall Study|Adverse Event|0|||
150150437|NCT00960752|541686550|FG001|Overall Study|Adverse Event|0|||
150150438|NCT00960752|541686551|FG002|Overall Study|Adverse Event|1|||
150150439|NCT00960752|541686549|FG000|Overall Study|Progression|0|||
150150440|NCT00960752|541686550|FG001|Overall Study|Progression|0|||
150150441|NCT00960752|541686551|FG002|Overall Study|Progression|1|||
150150442|NCT05490329|541686552|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
150150443|NCT05490329|541686553|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
150150444|NCT05490329|541686552|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
150150445|NCT05490329|541686553|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
150150446|NCT05490329|541686552|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
150150447|NCT05490329|541686553|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
150150448|NCT03936777|541686554|FG000|Overall Study|Adverse Event|3|||
150150449|NCT03936777|541686554|FG000|Overall Study|Death|3|||
150150450|NCT03936777|541686554|FG000|Overall Study|Lack of Efficacy|24|||
150150451|NCT03936777|541686554|FG000|Overall Study|Lost to Follow-up|3|||
150150452|NCT03936777|541686554|FG000|Overall Study|Physician Decision|1|||
150150453|NCT03936777|541686554|FG000|Overall Study|Withdrawal by Subject|11|||
150150454|NCT03936777|541686554|FG000|Overall Study|Subjected Weaned of ZX008|1|||
150150455|NCT03936777|541686554|FG000|Overall Study|Missing|6|||
150150456|NCT02301156|541686555|FG000|Overall Study|Adverse Event|13|||
150150457|NCT02301156|541686556|FG001|Overall Study|Adverse Event|14|||
150150458|NCT02301156|541686555|FG000|Overall Study|Death|1|||
150150459|NCT02301156|541686556|FG001|Overall Study|Death|5|||
150150460|NCT02301156|541686555|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
150150461|NCT02301156|541686556|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
150150462|NCT02301156|541686555|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
150150463|NCT02301156|541686556|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
150150464|NCT02301156|541686555|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
150150465|NCT02301156|541686556|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
150150466|NCT02301156|541686555|FG000|Overall Study|Reason not Specified|6|||
150150467|NCT02301156|541686556|FG001|Overall Study|Reason not Specified|3|||
150150468|NCT03757234|541686562|FG000|Overall Study|Adverse Event|0|||
150150469|NCT03757234|541686563|FG001|Overall Study|Adverse Event|0|||
149811083|NCT02706353|540435736|FG005|Dose Level 5|Death|6|||
150150470|NCT03757234|541686564|FG002|Overall Study|Adverse Event|0|||
149811084|NCT02706353|540435731|FG000|Dose Level 5|Withdrawal by Subject|0|||
150150471|NCT03757234|541686565|FG003|Overall Study|Adverse Event|0|||
150150472|NCT03757234|541686566|FG004|Overall Study|Adverse Event|1|||
150150473|NCT03757234|541686562|FG000|Overall Study|Lost to Follow-up|1|||
150150474|NCT03757234|541686563|FG001|Overall Study|Lost to Follow-up|0|||
150150475|NCT03757234|541686564|FG002|Overall Study|Lost to Follow-up|0|||
150150476|NCT03757234|541686565|FG003|Overall Study|Lost to Follow-up|0|||
150150477|NCT03757234|541686566|FG004|Overall Study|Lost to Follow-up|1|||
150150478|NCT03757234|541686562|FG000|Overall Study|Withdrawal by Subject|1|||
150150479|NCT03757234|541686563|FG001|Overall Study|Withdrawal by Subject|1|||
150150480|NCT03757234|541686564|FG002|Overall Study|Withdrawal by Subject|0|||
150150481|NCT03757234|541686565|FG003|Overall Study|Withdrawal by Subject|1|||
150150482|NCT03757234|541686566|FG004|Overall Study|Withdrawal by Subject|2|||
150150483|NCT03757234|541686562|FG000|Overall Study|Other|1|||
150150484|NCT03757234|541686563|FG001|Overall Study|Other|1|||
150150485|NCT03757234|541686564|FG002|Overall Study|Other|0|||
150150486|NCT03757234|541686565|FG003|Overall Study|Other|0|||
150150487|NCT03757234|541686566|FG004|Overall Study|Other|0|||
150150488|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
150150489|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
150150490|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
150150491|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
150150492|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
150150493|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
150150494|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
150150495|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
150150496|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
150150497|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
150150498|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
150150499|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
150150500|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
150150501|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
150150502|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
150150503|NCT02023879|541686577|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
150150504|NCT02023879|541686578|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
150150505|NCT02023879|541686579|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
150150506|NCT02023879|541686577|FG000|Extension Open Label Treatment|Adverse Event|1|||
150150507|NCT02023879|541686578|FG001|Extension Open Label Treatment|Adverse Event|7|||
150150508|NCT02023879|541686579|FG002|Extension Open Label Treatment|Adverse Event|3|||
150150509|NCT02023879|541686577|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
150150510|NCT02023879|541686578|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
150150511|NCT02023879|541686579|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
150150512|NCT02023879|541686577|FG000|Extension Open Label Treatment|Participant moved|1|||
150150513|NCT02023879|541686578|FG001|Extension Open Label Treatment|Participant moved|2|||
150150514|NCT02023879|541686579|FG002|Extension Open Label Treatment|Participant moved|0|||
150150515|NCT02023879|541686577|FG000|Extension Open Label Treatment|Other than specified above|2|||
150150516|NCT02023879|541686578|FG001|Extension Open Label Treatment|Other than specified above|7|||
150150517|NCT02023879|541686579|FG002|Extension Open Label Treatment|Other than specified above|2|||
150150518|NCT03713021|541686580|FG000|Overall Study|Did not have CT sim scan available|6|||
150150519|NCT03713021|541686580|FG000|Overall Study|Not eligible|4|||
150150520|NCT03713021|541686580|FG000|Overall Study|Issues with TraceIT markers|5|||
150150521|NCT00874432|541686581|FG000|Overall Study|Withdrawal by Subject|1|||
150150522|NCT00874432|541686582|FG001|Overall Study|Withdrawal by Subject|0|||
150150523|NCT00874432|541686583|FG002|Overall Study|Withdrawal by Subject|0|||
150150524|NCT00874432|541686584|FG003|Overall Study|Withdrawal by Subject|0|||
150150525|NCT00874432|541686581|FG000|Overall Study|Physician Decision|1|||
150150526|NCT00874432|541686582|FG001|Overall Study|Physician Decision|0|||
150150527|NCT00874432|541686583|FG002|Overall Study|Physician Decision|0|||
150150528|NCT00874432|541686584|FG003|Overall Study|Physician Decision|0|||
150150529|NCT00874432|541686581|FG000|Overall Study|Other|1|||
150150530|NCT00874432|541686582|FG001|Overall Study|Other|2|||
150150531|NCT00874432|541686583|FG002|Overall Study|Other|8|||
150150532|NCT00874432|541686584|FG003|Overall Study|Other|3|||
150150533|NCT05256381|541686585|FG000|Overall Study|Withdrawal by Subject|4|||
150150534|NCT05256381|541686586|FG001|Overall Study|Withdrawal by Subject|0|||
150150535|NCT05256381|541686587|FG002|Overall Study|Withdrawal by Subject|2|||
150150536|NCT05256381|541686588|FG003|Overall Study|Withdrawal by Subject|2|||
150150537|NCT05256381|541686589|FG004|Overall Study|Withdrawal by Subject|8|||
150150538|NCT05256381|541686590|FG005|Overall Study|Withdrawal by Subject|6|||
150150539|NCT05256381|541686585|FG000|Overall Study|Physician Decision|0|||
150150540|NCT05256381|541686586|FG001|Overall Study|Physician Decision|0|||
150150541|NCT05256381|541686587|FG002|Overall Study|Physician Decision|1|||
149811085|NCT02706353|540435732|FG001|Dose Level 5|Withdrawal by Subject|0|||
149811086|NCT02706353|540435733|FG002|Dose Level 5|Withdrawal by Subject|0|||
149811087|NCT02706353|540435734|FG003|Dose Level 5|Withdrawal by Subject|0|||
149811088|NCT02706353|540435735|FG004|Dose Level 5|Withdrawal by Subject|0|||
149811089|NCT02706353|540435736|FG005|Dose Level 5|Withdrawal by Subject|2|||
149811090|NCT03560466|540435737|FG000|Overall Study|Adverse Event|1|||
149811091|NCT03560466|540435738|FG001|Overall Study|Adverse Event|2|||
149811092|NCT03560466|540435739|FG002|Overall Study|Adverse Event|0|||
149811093|NCT03560466|540435737|FG000|Overall Study|Poor Compliance to Protocol|0|||
149811094|NCT03560466|540435738|FG001|Overall Study|Poor Compliance to Protocol|2|||
149811095|NCT03560466|540435739|FG002|Overall Study|Poor Compliance to Protocol|0|||
149811096|NCT03560466|540435737|FG000|Overall Study|Other|6|||
149811097|NCT03560466|540435738|FG001|Overall Study|Other|8|||
149811098|NCT03560466|540435739|FG002|Overall Study|Other|1|||
149811099|NCT04071366|540437241|FG000|Part 1: Open-label (29 Days)|Death|4|||
149811100|NCT04071366|540437242|FG001|Part 1: Open-label (29 Days)|Death|2|||
149811101|NCT04071366|540437243|FG002|Part 1: Open-label (29 Days)|Death|8|||
149811102|NCT04071366|540437244|FG003|Part 1: Open-label (29 Days)|Death|0|||
149811103|NCT04071366|540437245|FG004|Part 1: Open-label (29 Days)|Death|0|||
149811104|NCT04071366|540437241|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
149811105|NCT04071366|540437242|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
149811106|NCT04071366|540437243|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
149811107|NCT04071366|540437244|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
149811108|NCT04071366|540437245|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
149811109|NCT04071366|540437241|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
149811110|NCT04071366|540437242|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
149811111|NCT04071366|540437243|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
149811112|NCT04071366|540437244|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
149811113|NCT04071366|540437245|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
149811114|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Death|0|||
149811115|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Death|0|||
149811116|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Death|0|||
149811117|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Death|2|||
149811118|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Death|2|||
149811119|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
149811120|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
149811121|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
149811122|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
149811123|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
149811124|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
149811125|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
149811126|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
149811127|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
149811128|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
149811129|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
149811130|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
149811131|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
149811132|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
149811133|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
149811134|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
149811135|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
149811136|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
149811137|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
149811138|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
149811139|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
149811140|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
149811141|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
149811142|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
149811143|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
149811144|NCT04071366|540437241|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
149811145|NCT04071366|540437242|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
149811146|NCT04071366|540437243|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
149811147|NCT04071366|540437244|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
149811148|NCT04071366|540437245|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
149811149|NCT02239692|540437246|FG000|Overall Study|Incomplete colonoscopy|1|||
149811150|NCT02239692|540437247|FG001|Overall Study|Incomplete colonoscopy|2|||
149811151|NCT02239692|540437246|FG000|Overall Study|Adverse Event|0|||
149811152|NCT02239692|540437247|FG001|Overall Study|Adverse Event|1|||
149811153|NCT02239692|540437246|FG000|Overall Study|Physician Decision|0|||
149811154|NCT02239692|540437247|FG001|Overall Study|Physician Decision|1|||
149811155|NCT02239692|540437246|FG000|Overall Study|Lost to Follow-up|1|||
150150542|NCT05256381|541686588|FG003|Overall Study|Physician Decision|0|||
150150543|NCT05256381|541686589|FG004|Overall Study|Physician Decision|2|||
150150544|NCT05256381|541686590|FG005|Overall Study|Physician Decision|0|||
150150545|NCT05256381|541686585|FG000|Overall Study|Death|17|||
150150546|NCT05256381|541686586|FG001|Overall Study|Death|3|||
150150547|NCT05256381|541686587|FG002|Overall Study|Death|4|||
150150548|NCT05256381|541686588|FG003|Overall Study|Death|5|||
150150549|NCT05256381|541686589|FG004|Overall Study|Death|24|||
150150550|NCT05256381|541686590|FG005|Overall Study|Death|21|||
150150551|NCT05256381|541686585|FG000|Overall Study|Other, not specified|0|||
150150552|NCT05256381|541686586|FG001|Overall Study|Other, not specified|0|||
150150553|NCT05256381|541686587|FG002|Overall Study|Other, not specified|0|||
150150554|NCT05256381|541686588|FG003|Overall Study|Other, not specified|0|||
150150555|NCT05256381|541686589|FG004|Overall Study|Other, not specified|2|||
150150556|NCT05256381|541686590|FG005|Overall Study|Other, not specified|1|||
150150557|NCT05256381|541686585|FG000|Overall Study|Study terminated by sponsor|18|||
150150558|NCT05256381|541686586|FG001|Overall Study|Study terminated by sponsor|5|||
150150559|NCT05256381|541686587|FG002|Overall Study|Study terminated by sponsor|5|||
150150560|NCT05256381|541686588|FG003|Overall Study|Study terminated by sponsor|5|||
150150561|NCT05256381|541686589|FG004|Overall Study|Study terminated by sponsor|18|||
150150562|NCT05256381|541686590|FG005|Overall Study|Study terminated by sponsor|11|||
150150563|NCT05256381|541686585|FG000|Overall Study|Lost to Follow-up|1|||
150150564|NCT05256381|541686586|FG001|Overall Study|Lost to Follow-up|0|||
150150565|NCT05256381|541686587|FG002|Overall Study|Lost to Follow-up|0|||
150150566|NCT05256381|541686588|FG003|Overall Study|Lost to Follow-up|0|||
150150567|NCT05256381|541686589|FG004|Overall Study|Lost to Follow-up|1|||
150150568|NCT05256381|541686590|FG005|Overall Study|Lost to Follow-up|0|||
150150569|NCT01518946|541686597|FG000|Open-label Phase|Other|4|||
150150570|NCT01518946|541686598|FG001|Open-label Phase|Other|0|||
150150571|NCT01518946|541686599|FG002|Open-label Phase|Other|0|||
150150572|NCT01518946|541686597|FG000|Randomized Phase (First Intervention)|Other|0|||
150150573|NCT01518946|541686598|FG001|Randomized Phase (First Intervention)|Other|1|||
150150574|NCT01518946|541686599|FG002|Randomized Phase (First Intervention)|Other|0|||
150150575|NCT03857841|541686600|FG000|Overall Study|Death|1|||
150150576|NCT03857841|541686601|FG001|Overall Study|Death|0|||
150150577|NCT03857841|541686602|FG002|Overall Study|Death|0|||
150150578|NCT03857841|541686603|FG003|Overall Study|Death|0|||
150150579|NCT03857841|541686600|FG000|Overall Study|Study Terminated by Sponsor|1|||
150150580|NCT03857841|541686601|FG001|Overall Study|Study Terminated by Sponsor|0|||
150150581|NCT03857841|541686602|FG002|Overall Study|Study Terminated by Sponsor|0|||
150150582|NCT03857841|541686603|FG003|Overall Study|Study Terminated by Sponsor|0|||
150150583|NCT04213989|541688663|FG000|Overall Study|Withdrawal by Subject|3|||
150150584|NCT04213989|541688664|FG001|Overall Study|Withdrawal by Subject|2|||
150150585|NCT04213989|541688663|FG000|Overall Study|Physician Decision|1|||
150150586|NCT04213989|541688664|FG001|Overall Study|Physician Decision|0|||
150150587|NCT04213989|541688663|FG000|Overall Study|Lost to Follow-up|0|||
150150588|NCT04213989|541688664|FG001|Overall Study|Lost to Follow-up|4|||
150150589|NCT03918239|541688667|FG000|Overall Study|Lost to Follow-up|3|||
150150590|NCT03918239|541688668|FG001|Overall Study|Lost to Follow-up|1|||
150150591|NCT03918239|541688667|FG000|Overall Study|Pregnancy|0|||
150150592|NCT03918239|541688668|FG001|Overall Study|Pregnancy|2|||
150150593|NCT03918239|541688667|FG000|Overall Study|Withdrawal by Subject|3|||
150150594|NCT03918239|541688668|FG001|Overall Study|Withdrawal by Subject|3|||
150150595|NCT03918239|541688667|FG000|Overall Study|positive urine drug screening results|4|||
150150596|NCT03918239|541688668|FG001|Overall Study|positive urine drug screening results|1|||
150150597|NCT03390036|541688671|FG000|Overall Study|Lost to Follow-up|1|||
150150598|NCT03390036|541688672|FG001|Overall Study|Lost to Follow-up|0|||
150150599|NCT03390036|541688673|FG002|Overall Study|Lost to Follow-up|0|||
150150600|NCT03390036|541688671|FG000|Overall Study|Lack of Efficacy|1|||
150150601|NCT03390036|541688672|FG001|Overall Study|Lack of Efficacy|0|||
150150602|NCT03390036|541688673|FG002|Overall Study|Lack of Efficacy|0|||
150150603|NCT00358215|541688674|FG000|Overall Study|Ineligibility determined|4|||
150150604|NCT00358215|541688675|FG001|Overall Study|Ineligibility determined|3|||
150150605|NCT00358215|541688674|FG000|Overall Study|Adverse Event|83|||
150150606|NCT00358215|541688675|FG001|Overall Study|Adverse Event|65|||
150150607|NCT00358215|541688674|FG000|Overall Study|Withdrawal by Subject|111|||
150150608|NCT00358215|541688675|FG001|Overall Study|Withdrawal by Subject|102|||
150150609|NCT00358215|541688674|FG000|Overall Study|Participant request|65|||
150150610|NCT00358215|541688675|FG001|Overall Study|Participant request|64|||
150150611|NCT00358215|541688674|FG000|Overall Study|Physician Decision|47|||
150150612|NCT00358215|541688675|FG001|Overall Study|Physician Decision|39|||
150150613|NCT00358215|541688674|FG000|Overall Study|Lost to Follow-up|16|||
150150614|NCT00358215|541688675|FG001|Overall Study|Lost to Follow-up|22|||
150150615|NCT00358215|541688674|FG000|Overall Study|Death|265|||
150150616|NCT00358215|541688675|FG001|Overall Study|Death|281|||
150150617|NCT00358215|541688674|FG000|Overall Study|Protocol Violation|64|||
150150618|NCT00358215|541688675|FG001|Overall Study|Protocol Violation|59|||
150150619|NCT00358215|541688674|FG000|Overall Study|Pregnancy|1|||
150150620|NCT00358215|541688675|FG001|Overall Study|Pregnancy|0|||
150150621|NCT00358215|541688674|FG000|Overall Study|Other|21|||
150150622|NCT00358215|541688675|FG001|Overall Study|Other|14|||
150150623|NCT00358215|541688674|FG000|Overall Study|Did not receive investigational product|2|||
150150624|NCT00358215|541688675|FG001|Overall Study|Did not receive investigational product|3|||
150150625|NCT00744237|541688676|FG000|Overall Study|Lack of Efficacy|1|||
150150626|NCT00744237|541688677|FG001|Overall Study|Lack of Efficacy|1|||
150150627|NCT00744237|541688678|FG002|Overall Study|Lack of Efficacy|0|||
150150628|NCT00744237|541688676|FG000|Overall Study|Withdrawal by Subject|9|||
150150629|NCT00744237|541688677|FG001|Overall Study|Withdrawal by Subject|5|||
150150630|NCT00744237|541688678|FG002|Overall Study|Withdrawal by Subject|3|||
150150631|NCT00744237|541688676|FG000|Overall Study|Lost to Follow-up|1|||
150150632|NCT00744237|541688677|FG001|Overall Study|Lost to Follow-up|1|||
150150633|NCT00744237|541688678|FG002|Overall Study|Lost to Follow-up|1|||
150150634|NCT00744237|541688676|FG000|Overall Study|Protocol Violation|3|||
150150635|NCT00744237|541688677|FG001|Overall Study|Protocol Violation|4|||
150150636|NCT00744237|541688678|FG002|Overall Study|Protocol Violation|3|||
150150637|NCT00744237|541688676|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
150150638|NCT00744237|541688677|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
150150639|NCT00744237|541688678|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
150150640|NCT00744237|541688676|FG000|Overall Study|Dosing Error|1|||
150150641|NCT00744237|541688677|FG001|Overall Study|Dosing Error|0|||
150150642|NCT00744237|541688678|FG002|Overall Study|Dosing Error|1|||
150150643|NCT00744237|541688676|FG000|Overall Study|Study Drug Error|1|||
150150644|NCT00744237|541688677|FG001|Overall Study|Study Drug Error|0|||
150150645|NCT00744237|541688678|FG002|Overall Study|Study Drug Error|0|||
150150646|NCT00744237|541688676|FG000|Overall Study|Prohibited Concomitant Medication|0|||
150150647|NCT00744237|541688677|FG001|Overall Study|Prohibited Concomitant Medication|0|||
150150648|NCT00744237|541688678|FG002|Overall Study|Prohibited Concomitant Medication|1|||
150150649|NCT00744237|541688676|FG000|Overall Study|Poor Compliance|0|||
150150650|NCT00744237|541688677|FG001|Overall Study|Poor Compliance|2|||
150150651|NCT00744237|541688678|FG002|Overall Study|Poor Compliance|0|||
150150652|NCT00744237|541688676|FG000|Overall Study|Administrative. Site Closed|1|||
150150653|NCT00744237|541688677|FG001|Overall Study|Administrative. Site Closed|1|||
150150654|NCT00744237|541688678|FG002|Overall Study|Administrative. Site Closed|1|||
150150655|NCT00744237|541688676|FG000|Overall Study|Adverse Event|9|||
150150656|NCT00744237|541688677|FG001|Overall Study|Adverse Event|13|||
150150657|NCT00744237|541688678|FG002|Overall Study|Adverse Event|5|||
150150658|NCT01984424|541688679|FG000|Overall Study|Withdrawal by Subject|3|||
150150659|NCT01984424|541688680|FG001|Overall Study|Withdrawal by Subject|5|||
150150660|NCT01984424|541688679|FG000|Overall Study|Sponsor Decision|0|||
150150661|NCT01984424|541688680|FG001|Overall Study|Sponsor Decision|1|||
150150662|NCT01984424|541688679|FG000|Overall Study|Lost to Follow-up|0|||
150150663|NCT01984424|541688680|FG001|Overall Study|Lost to Follow-up|1|||
150150664|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
150150665|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
150150666|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
150150667|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
150150668|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
150150669|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
150150670|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
150150671|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
150150672|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
150150673|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
150150674|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
150150675|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
150150676|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
150150677|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
150150678|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
150150679|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
150150680|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
150150681|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
150150682|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
150150683|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
150150684|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
150150685|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
150150686|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
150150687|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
150150688|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
150150689|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
150150690|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
150150691|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
150150692|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
150150693|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
150150694|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
150150695|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
150150696|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
150150697|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
150150698|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
150150699|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
150150700|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
150150701|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
150150702|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
150150703|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
150150704|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
150150705|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
150150706|NCT01089556|541688681|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
150150707|NCT01089556|541688682|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
150150708|NCT01089556|541688683|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
150150709|NCT01089556|541688684|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
150150710|NCT01089556|541688685|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
150150711|NCT01089556|541688686|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
150150712|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
150150713|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
150150714|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
150150715|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
150150716|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
150150717|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
150150718|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
150150719|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
150150720|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
150150721|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
150150722|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
150150723|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
150150724|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
150150725|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
150150726|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
150150727|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
150150728|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
150150729|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
150150730|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
150150731|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
150150732|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
150150733|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
150150734|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
150150735|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
150150736|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
150150737|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
150150738|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
150150739|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
150150740|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
150150741|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
150150742|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
150150743|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
150150744|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
150150745|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
150150746|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
150150747|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
150150748|NCT01089556|541688681|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
150150749|NCT01089556|541688682|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
150150750|NCT01089556|541688683|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
150150751|NCT01089556|541688684|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
150150752|NCT01089556|541688685|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
150150753|NCT01089556|541688686|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
150150754|NCT01702428|541688687|FG000|Overall Study|Adverse Event|2|||
149811156|NCT02239692|540437247|FG001|Overall Study|Lost to Follow-up|4|||
149811157|NCT02239692|540437246|FG000|Overall Study|Withdrawal by Subject|3|||
149811158|NCT02239692|540437247|FG001|Overall Study|Withdrawal by Subject|5|||
149811159|NCT02239692|540437246|FG000|Overall Study|Other reason|1|||
149811160|NCT02239692|540437247|FG001|Overall Study|Other reason|0|||
149811161|NCT01678924|540437248|FG000|Overall Study|Adverse Event|1|||
149811162|NCT01678924|540437249|FG001|Overall Study|Adverse Event|1|||
149811163|NCT01678924|540437250|FG002|Overall Study|Adverse Event|0|||
150150755|NCT01702428|541688688|FG001|Overall Study|Adverse Event|0|||
149811164|NCT01678924|540437251|FG003|Overall Study|Adverse Event|1|||
149811165|NCT01678924|540437248|FG000|Overall Study|Lack of Efficacy|7|||
150150756|NCT01702428|541688689|FG002|Overall Study|Adverse Event|0|||
150150757|NCT01702428|541688690|FG003|Overall Study|Adverse Event|0|||
150150758|NCT01702428|541688687|FG000|Overall Study|Lost to Follow-up|33|||
150150759|NCT01702428|541688688|FG001|Overall Study|Lost to Follow-up|41|||
150150760|NCT01702428|541688689|FG002|Overall Study|Lost to Follow-up|37|||
150150761|NCT01702428|541688690|FG003|Overall Study|Lost to Follow-up|44|||
150150762|NCT01702428|541688687|FG000|Overall Study|Parents cannot assist to site|1|||
150150763|NCT01702428|541688688|FG001|Overall Study|Parents cannot assist to site|0|||
150150764|NCT01702428|541688689|FG002|Overall Study|Parents cannot assist to site|1|||
150150765|NCT01702428|541688690|FG003|Overall Study|Parents cannot assist to site|0|||
150150766|NCT01702428|541688687|FG000|Overall Study|Lost Coverage|0|||
150150767|NCT01702428|541688688|FG001|Overall Study|Lost Coverage|0|||
150150768|NCT01702428|541688689|FG002|Overall Study|Lost Coverage|0|||
150150769|NCT01702428|541688690|FG003|Overall Study|Lost Coverage|1|||
150150770|NCT01702428|541688687|FG000|Overall Study|Lost Health Plan|3|||
150150771|NCT01702428|541688688|FG001|Overall Study|Lost Health Plan|5|||
150150772|NCT01702428|541688689|FG002|Overall Study|Lost Health Plan|0|||
150150773|NCT01702428|541688690|FG003|Overall Study|Lost Health Plan|2|||
150150774|NCT01702428|541688687|FG000|Overall Study|Mother transferred care|0|||
150150775|NCT01702428|541688688|FG001|Overall Study|Mother transferred care|1|||
150150776|NCT01702428|541688689|FG002|Overall Study|Mother transferred care|0|||
150150777|NCT01702428|541688690|FG003|Overall Study|Mother transferred care|0|||
150150778|NCT01702428|541688687|FG000|Overall Study|Parents too busy|1|||
150150779|NCT01702428|541688688|FG001|Overall Study|Parents too busy|0|||
150150780|NCT01702428|541688689|FG002|Overall Study|Parents too busy|0|||
150150781|NCT01702428|541688690|FG003|Overall Study|Parents too busy|0|||
150150782|NCT01702428|541688687|FG000|Overall Study|Protocol Violation|3|||
150150783|NCT01702428|541688688|FG001|Overall Study|Protocol Violation|0|||
150150784|NCT01702428|541688689|FG002|Overall Study|Protocol Violation|1|||
150150785|NCT01702428|541688690|FG003|Overall Study|Protocol Violation|0|||
150150786|NCT01702428|541688687|FG000|Overall Study|Withdrawal by Subject|21|||
150150787|NCT01702428|541688688|FG001|Overall Study|Withdrawal by Subject|23|||
150150788|NCT01702428|541688689|FG002|Overall Study|Withdrawal by Subject|14|||
150150789|NCT01702428|541688690|FG003|Overall Study|Withdrawal by Subject|10|||
150150790|NCT02091869|541688691|FG000|Overall Study|Withdrawal by Subject|0|||
150150791|NCT02091869|541688692|FG001|Overall Study|Withdrawal by Subject|3|||
150150792|NCT01533714|541688693|FG000|Overall Study|Adverse Event|0|||
150150793|NCT01533714|541688694|FG001|Overall Study|Adverse Event|1|||
150150794|NCT01533714|541688695|FG002|Overall Study|Adverse Event|2|||
150150795|NCT01533714|541688696|FG003|Overall Study|Adverse Event|2|||
150150796|NCT01533714|541688697|FG004|Overall Study|Adverse Event|2|||
150150797|NCT01533714|541688698|FG005|Overall Study|Adverse Event|1|||
150150798|NCT01533714|541688693|FG000|Overall Study|Lack of Efficacy|0|||
150150799|NCT01533714|541688694|FG001|Overall Study|Lack of Efficacy|0|||
150150800|NCT01533714|541688695|FG002|Overall Study|Lack of Efficacy|0|||
150150801|NCT01533714|541688696|FG003|Overall Study|Lack of Efficacy|0|||
150150802|NCT01533714|541688697|FG004|Overall Study|Lack of Efficacy|0|||
150150803|NCT01533714|541688698|FG005|Overall Study|Lack of Efficacy|1|||
150150804|NCT01533714|541688693|FG000|Overall Study|Withdrawal by Subject|0|||
150150805|NCT01533714|541688694|FG001|Overall Study|Withdrawal by Subject|1|||
150150806|NCT01533714|541688695|FG002|Overall Study|Withdrawal by Subject|0|||
150150807|NCT01533714|541688696|FG003|Overall Study|Withdrawal by Subject|1|||
150150808|NCT01533714|541688697|FG004|Overall Study|Withdrawal by Subject|1|||
150150809|NCT01533714|541688698|FG005|Overall Study|Withdrawal by Subject|0|||
150150810|NCT01533714|541688693|FG000|Overall Study|Exclusion criteria|0|||
150150811|NCT01533714|541688694|FG001|Overall Study|Exclusion criteria|1|||
150150812|NCT01533714|541688695|FG002|Overall Study|Exclusion criteria|0|||
150150813|NCT01533714|541688696|FG003|Overall Study|Exclusion criteria|0|||
150150814|NCT01533714|541688697|FG004|Overall Study|Exclusion criteria|0|||
150150815|NCT01533714|541688698|FG005|Overall Study|Exclusion criteria|0|||
150150816|NCT01533714|541688693|FG000|Overall Study|Positive for purified protein derivative|0|||
150150817|NCT01533714|541688694|FG001|Overall Study|Positive for purified protein derivative|0|||
150150818|NCT01533714|541688695|FG002|Overall Study|Positive for purified protein derivative|1|||
150150819|NCT01533714|541688696|FG003|Overall Study|Positive for purified protein derivative|0|||
150150820|NCT01533714|541688697|FG004|Overall Study|Positive for purified protein derivative|1|||
150150821|NCT01533714|541688698|FG005|Overall Study|Positive for purified protein derivative|0|||
150150822|NCT01533714|541688693|FG000|Overall Study|Withdrawal criteria|0|||
150150823|NCT01533714|541688694|FG001|Overall Study|Withdrawal criteria|0|||
150150824|NCT01533714|541688695|FG002|Overall Study|Withdrawal criteria|1|||
150150825|NCT01533714|541688696|FG003|Overall Study|Withdrawal criteria|0|||
150150826|NCT01533714|541688697|FG004|Overall Study|Withdrawal criteria|3|||
150150827|NCT01533714|541688698|FG005|Overall Study|Withdrawal criteria|1|||
150150828|NCT01533714|541688693|FG000|Overall Study|Ineligibility reason|0|||
150150829|NCT01533714|541688694|FG001|Overall Study|Ineligibility reason|0|||
150150830|NCT01533714|541688695|FG002|Overall Study|Ineligibility reason|0|||
150150831|NCT01533714|541688696|FG003|Overall Study|Ineligibility reason|1|||
150150832|NCT01533714|541688697|FG004|Overall Study|Ineligibility reason|0|||
150150833|NCT01533714|541688698|FG005|Overall Study|Ineligibility reason|0|||
150150834|NCT04789577|541688700|FG000|Overall Study|Withdrawal by Subject|1|||
150150835|NCT04789577|541688701|FG001|Overall Study|Withdrawal by Subject|1|||
150150836|NCT04789577|541688702|FG002|Overall Study|Withdrawal by Subject|1|||
150150837|NCT04789577|541688703|FG003|Overall Study|Withdrawal by Subject|3|||
150150838|NCT04789577|541688704|FG004|Overall Study|Withdrawal by Subject|1|||
150150839|NCT04789577|541688705|FG005|Overall Study|Withdrawal by Subject|7|||
150150840|NCT04789577|541688706|FG006|Overall Study|Withdrawal by Subject|1|||
150150841|NCT04789577|541688700|FG000|Overall Study|Lost to Follow-up|7|||
150150842|NCT04789577|541688701|FG001|Overall Study|Lost to Follow-up|12|||
150150843|NCT04789577|541688702|FG002|Overall Study|Lost to Follow-up|7|||
150150844|NCT04789577|541688703|FG003|Overall Study|Lost to Follow-up|10|||
150150845|NCT04789577|541688704|FG004|Overall Study|Lost to Follow-up|8|||
150150846|NCT04789577|541688705|FG005|Overall Study|Lost to Follow-up|6|||
150150847|NCT04789577|541688706|FG006|Overall Study|Lost to Follow-up|10|||
150150848|NCT04789577|541688700|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
150150849|NCT04789577|541688701|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
150150850|NCT04789577|541688702|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
150150851|NCT04789577|541688703|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
150150852|NCT04789577|541688704|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
150150853|NCT04789577|541688705|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
150150854|NCT04789577|541688706|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
150150855|NCT04789577|541688700|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
150150856|NCT04789577|541688701|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
150150857|NCT04789577|541688702|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
150150858|NCT04789577|541688703|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
150150859|NCT04789577|541688704|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
150150860|NCT04789577|541688705|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
150150861|NCT04789577|541688706|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
150150862|NCT01275196|541688707|FG000|Overall Study|Adverse Event|3|||
150150863|NCT01275196|541688708|FG001|Overall Study|Adverse Event|5|||
150150864|NCT01275196|541688707|FG000|Overall Study|Withdrawal by Subject|4|||
150150865|NCT01275196|541688708|FG001|Overall Study|Withdrawal by Subject|5|||
150150866|NCT01275196|541688707|FG000|Overall Study|Lost to Follow-up|1|||
150150867|NCT01275196|541688708|FG001|Overall Study|Lost to Follow-up|0|||
150150868|NCT01275196|541688707|FG000|Overall Study|Disease Progression|6|||
150150869|NCT01275196|541688708|FG001|Overall Study|Disease Progression|5|||
150150870|NCT01275196|541688707|FG000|Overall Study|Protocol Violation|1|||
150150871|NCT01275196|541688708|FG001|Overall Study|Protocol Violation|0|||
150150872|NCT01275196|541688707|FG000|Overall Study|Suboptimal response/treatment failure|5|||
150150873|NCT01275196|541688708|FG001|Overall Study|Suboptimal response/treatment failure|6|||
150150874|NCT01027364|541688709|FG000|Overall Study|Adverse Event|1|||
150150875|NCT01027364|541688710|FG001|Overall Study|Adverse Event|0|||
150150876|NCT01027364|541688711|FG002|Overall Study|Adverse Event|1|||
150150877|NCT01027364|541688712|FG003|Overall Study|Adverse Event|0|||
150150878|NCT01027364|541688709|FG000|Overall Study|Lost to Follow-up|1|||
150150879|NCT01027364|541688710|FG001|Overall Study|Lost to Follow-up|0|||
150150880|NCT01027364|541688711|FG002|Overall Study|Lost to Follow-up|0|||
150150881|NCT01027364|541688712|FG003|Overall Study|Lost to Follow-up|0|||
150150882|NCT01027364|541688709|FG000|Overall Study|Protocol Violation|1|||
150150883|NCT01027364|541688710|FG001|Overall Study|Protocol Violation|0|||
150150884|NCT01027364|541688711|FG002|Overall Study|Protocol Violation|0|||
150150885|NCT01027364|541688712|FG003|Overall Study|Protocol Violation|1|||
150150886|NCT01027364|541688709|FG000|Overall Study|Withdrawal by Subject|1|||
150150887|NCT01027364|541688710|FG001|Overall Study|Withdrawal by Subject|2|||
150150888|NCT01027364|541688711|FG002|Overall Study|Withdrawal by Subject|0|||
150150889|NCT01027364|541688712|FG003|Overall Study|Withdrawal by Subject|0|||
150150890|NCT00779584|541688713|FG000|Overall Study|Protocol Violation|0|||
150150891|NCT00779584|541688714|FG001|Overall Study|Protocol Violation|0|||
150150892|NCT00779584|541688715|FG002|Overall Study|Protocol Violation|0|||
150150893|NCT00779584|541688716|FG003|Overall Study|Protocol Violation|0|||
150150894|NCT00779584|541688717|FG004|Overall Study|Protocol Violation|0|||
150150895|NCT00779584|541688718|FG005|Overall Study|Protocol Violation|1|||
150150896|NCT00779584|541688719|FG006|Overall Study|Protocol Violation|0|||
150150897|NCT00779584|541688720|FG007|Overall Study|Protocol Violation|0|||
149811166|NCT01678924|540437249|FG001|Overall Study|Lack of Efficacy|2|||
150150898|NCT00779584|541688721|FG008|Overall Study|Protocol Violation|0|||
150150899|NCT00779584|541688713|FG000|Overall Study|Withdrawal by Subject|1|||
150150900|NCT00779584|541688714|FG001|Overall Study|Withdrawal by Subject|1|||
150150901|NCT00779584|541688715|FG002|Overall Study|Withdrawal by Subject|2|||
150150902|NCT00779584|541688716|FG003|Overall Study|Withdrawal by Subject|0|||
150150903|NCT00779584|541688717|FG004|Overall Study|Withdrawal by Subject|0|||
149811167|NCT01678924|540437250|FG002|Overall Study|Lack of Efficacy|0|||
149811168|NCT01678924|540437251|FG003|Overall Study|Lack of Efficacy|5|||
149918924|NCT01210352|540835248|FG007|Overall Study|Patient Discharged Early|0|||
150150904|NCT00779584|541688718|FG005|Overall Study|Withdrawal by Subject|2|||
150150905|NCT00779584|541688719|FG006|Overall Study|Withdrawal by Subject|1|||
150150906|NCT00779584|541688720|FG007|Overall Study|Withdrawal by Subject|0|||
150150907|NCT00779584|541688721|FG008|Overall Study|Withdrawal by Subject|0|||
150150908|NCT00779584|541688713|FG000|Overall Study|Lost to Follow-up|0|||
150150909|NCT00779584|541688714|FG001|Overall Study|Lost to Follow-up|0|||
150150910|NCT00779584|541688715|FG002|Overall Study|Lost to Follow-up|0|||
150150911|NCT00779584|541688716|FG003|Overall Study|Lost to Follow-up|0|||
150150912|NCT00779584|541688717|FG004|Overall Study|Lost to Follow-up|1|||
150150913|NCT00779584|541688718|FG005|Overall Study|Lost to Follow-up|0|||
150150914|NCT00779584|541688719|FG006|Overall Study|Lost to Follow-up|0|||
150150915|NCT00779584|541688720|FG007|Overall Study|Lost to Follow-up|0|||
150150916|NCT00779584|541688721|FG008|Overall Study|Lost to Follow-up|0|||
150150917|NCT00779584|541688713|FG000|Overall Study|Progression of Disease|0|||
150150918|NCT00779584|541688714|FG001|Overall Study|Progression of Disease|1|||
150150919|NCT00779584|541688715|FG002|Overall Study|Progression of Disease|2|||
150150920|NCT00779584|541688716|FG003|Overall Study|Progression of Disease|6|||
150150921|NCT00779584|541688717|FG004|Overall Study|Progression of Disease|5|||
150150922|NCT00779584|541688718|FG005|Overall Study|Progression of Disease|1|||
150150923|NCT00779584|541688719|FG006|Overall Study|Progression of Disease|4|||
150150924|NCT00779584|541688720|FG007|Overall Study|Progression of Disease|2|||
150150925|NCT00779584|541688721|FG008|Overall Study|Progression of Disease|1|||
150150926|NCT00779584|541688713|FG000|Overall Study|Adverse Event|1|||
150150927|NCT00779584|541688714|FG001|Overall Study|Adverse Event|0|||
150150928|NCT00779584|541688715|FG002|Overall Study|Adverse Event|2|||
150150929|NCT00779584|541688716|FG003|Overall Study|Adverse Event|0|||
150150930|NCT00779584|541688717|FG004|Overall Study|Adverse Event|0|||
150150931|NCT00779584|541688718|FG005|Overall Study|Adverse Event|0|||
150150932|NCT00779584|541688719|FG006|Overall Study|Adverse Event|2|||
150150933|NCT00779584|541688720|FG007|Overall Study|Adverse Event|1|||
150150934|NCT00779584|541688721|FG008|Overall Study|Adverse Event|1|||
150150935|NCT00779584|541688713|FG000|Overall Study|Symptomatic Deterioration|1|||
150150936|NCT00779584|541688714|FG001|Overall Study|Symptomatic Deterioration|1|||
150150937|NCT00779584|541688715|FG002|Overall Study|Symptomatic Deterioration|1|||
150150938|NCT00779584|541688716|FG003|Overall Study|Symptomatic Deterioration|0|||
150150939|NCT00779584|541688717|FG004|Overall Study|Symptomatic Deterioration|0|||
150150940|NCT00779584|541688718|FG005|Overall Study|Symptomatic Deterioration|1|||
150150941|NCT00779584|541688719|FG006|Overall Study|Symptomatic Deterioration|1|||
150150942|NCT00779584|541688720|FG007|Overall Study|Symptomatic Deterioration|0|||
150150943|NCT00779584|541688721|FG008|Overall Study|Symptomatic Deterioration|0|||
150150944|NCT00779584|541688713|FG000|Overall Study|Ongoing in Study|0|||
150150945|NCT00779584|541688714|FG001|Overall Study|Ongoing in Study|0|||
150150946|NCT00779584|541688715|FG002|Overall Study|Ongoing in Study|0|||
150150947|NCT00779584|541688716|FG003|Overall Study|Ongoing in Study|0|||
150150948|NCT00779584|541688717|FG004|Overall Study|Ongoing in Study|1|||
150150949|NCT00779584|541688718|FG005|Overall Study|Ongoing in Study|1|||
150150950|NCT00779584|541688719|FG006|Overall Study|Ongoing in Study|0|||
150150951|NCT00779584|541688720|FG007|Overall Study|Ongoing in Study|0|||
150150952|NCT00779584|541688721|FG008|Overall Study|Ongoing in Study|0|||
150150953|NCT01461993|541688722|FG000|Overall Study|Withdrawal by Subject|60|||
150150954|NCT01461993|541688723|FG001|Overall Study|Withdrawal by Subject|53|||
150150955|NCT01461993|541688724|FG002|Overall Study|Withdrawal by Subject|16|||
150150956|NCT01461993|541688722|FG000|Overall Study|Lost to Follow-up|44|||
150150957|NCT01461993|541688723|FG001|Overall Study|Lost to Follow-up|48|||
150150958|NCT01461993|541688724|FG002|Overall Study|Lost to Follow-up|22|||
150150959|NCT01461993|541688722|FG000|Overall Study|Protocol Violation|10|||
150150960|NCT01461993|541688723|FG001|Overall Study|Protocol Violation|9|||
150150961|NCT01461993|541688724|FG002|Overall Study|Protocol Violation|7|||
150150962|NCT01461993|541688722|FG000|Overall Study|Adverse Event|9|||
150150963|NCT01461993|541688723|FG001|Overall Study|Adverse Event|11|||
150150964|NCT01461993|541688724|FG002|Overall Study|Adverse Event|3|||
150150965|NCT01461993|541688722|FG000|Overall Study|No longer met eligibility criteria|13|||
150150966|NCT01461993|541688723|FG001|Overall Study|No longer met eligibility criteria|18|||
150150967|NCT01461993|541688724|FG002|Overall Study|No longer met eligibility criteria|10|||
150150968|NCT01461993|541688722|FG000|Overall Study|Did not meet entrance criteria|2|||
150150969|NCT01461993|541688723|FG001|Overall Study|Did not meet entrance criteria|3|||
150150970|NCT01461993|541688724|FG002|Overall Study|Did not meet entrance criteria|0|||
150150971|NCT01461993|541688722|FG000|Overall Study|Other|13|||
150150972|NCT01461993|541688723|FG001|Overall Study|Other|15|||
150150973|NCT01461993|541688724|FG002|Overall Study|Other|6|||
150150974|NCT00680056|541688726|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
150150975|NCT00680056|541688727|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
150150976|NCT00680056|541688726|FG000|Second Intervention|Protocol Violation|3|||
150150977|NCT00680056|541688727|FG001|Second Intervention|Protocol Violation|1|||
150150978|NCT02733042|541688733|FG000|Overall Study|Adverse Event|1|||
150150979|NCT02733042|541688734|FG001|Overall Study|Adverse Event|0|||
150150980|NCT02733042|541688735|FG002|Overall Study|Adverse Event|1|||
150150981|NCT02733042|541688736|FG003|Overall Study|Adverse Event|1|||
150150982|NCT02733042|541688737|FG004|Overall Study|Adverse Event|0|||
150150983|NCT02733042|541688738|FG005|Overall Study|Adverse Event|0|||
150150984|NCT02733042|541688739|FG006|Overall Study|Adverse Event|0|||
150150985|NCT02733042|541688740|FG007|Overall Study|Adverse Event|0|||
150150986|NCT02733042|541688741|FG008|Overall Study|Adverse Event|0|||
150150987|NCT02733042|541688742|FG009|Overall Study|Adverse Event|0|||
150150988|NCT02733042|541688743|FG010|Overall Study|Adverse Event|2|||
150150989|NCT02733042|541688744|FG011|Overall Study|Adverse Event|2|||
150150990|NCT02733042|541688745|FG012|Overall Study|Adverse Event|0|||
150150991|NCT02733042|541688746|FG013|Overall Study|Adverse Event|2|||
150150992|NCT02733042|541688747|FG014|Overall Study|Adverse Event|0|||
150150993|NCT02733042|541688748|FG015|Overall Study|Adverse Event|0|||
150150994|NCT02733042|541688749|FG016|Overall Study|Adverse Event|0|||
150150995|NCT02733042|541688750|FG017|Overall Study|Adverse Event|1|||
150150996|NCT02733042|541688751|FG018|Overall Study|Adverse Event|0|||
150150997|NCT02733042|541688733|FG000|Overall Study|Progressive Disease|2|||
150150998|NCT02733042|541688734|FG001|Overall Study|Progressive Disease|1|||
150150999|NCT02733042|541688735|FG002|Overall Study|Progressive Disease|3|||
150151000|NCT02733042|541688736|FG003|Overall Study|Progressive Disease|1|||
149811169|NCT01678924|540437248|FG000|Overall Study|Lost to Follow-up|0|||
149811170|NCT01678924|540437249|FG001|Overall Study|Lost to Follow-up|4|||
149811171|NCT01678924|540437250|FG002|Overall Study|Lost to Follow-up|0|||
150151001|NCT02733042|541688737|FG004|Overall Study|Progressive Disease|2|||
150151002|NCT02733042|541688738|FG005|Overall Study|Progressive Disease|3|||
150151003|NCT02733042|541688739|FG006|Overall Study|Progressive Disease|0|||
150151004|NCT02733042|541688740|FG007|Overall Study|Progressive Disease|3|||
150151005|NCT02733042|541688741|FG008|Overall Study|Progressive Disease|3|||
150151006|NCT02733042|541688742|FG009|Overall Study|Progressive Disease|2|||
150151007|NCT02733042|541688743|FG010|Overall Study|Progressive Disease|2|||
150151008|NCT02733042|541688744|FG011|Overall Study|Progressive Disease|2|||
150151009|NCT02733042|541688745|FG012|Overall Study|Progressive Disease|8|||
150151010|NCT02733042|541688746|FG013|Overall Study|Progressive Disease|1|||
150151011|NCT02733042|541688747|FG014|Overall Study|Progressive Disease|4|||
150151012|NCT02733042|541688748|FG015|Overall Study|Progressive Disease|7|||
150151013|NCT02733042|541688749|FG016|Overall Study|Progressive Disease|2|||
150151014|NCT02733042|541688750|FG017|Overall Study|Progressive Disease|3|||
150151015|NCT02733042|541688751|FG018|Overall Study|Progressive Disease|4|||
150151016|NCT02733042|541688733|FG000|Overall Study|Withdrawal by Subject|0|||
150151017|NCT02733042|541688734|FG001|Overall Study|Withdrawal by Subject|1|||
150151018|NCT02733042|541688735|FG002|Overall Study|Withdrawal by Subject|2|||
150151019|NCT02733042|541688736|FG003|Overall Study|Withdrawal by Subject|1|||
150151020|NCT02733042|541688737|FG004|Overall Study|Withdrawal by Subject|1|||
150151021|NCT02733042|541688738|FG005|Overall Study|Withdrawal by Subject|0|||
150151022|NCT02733042|541688739|FG006|Overall Study|Withdrawal by Subject|0|||
150151023|NCT02733042|541688740|FG007|Overall Study|Withdrawal by Subject|0|||
150151024|NCT02733042|541688741|FG008|Overall Study|Withdrawal by Subject|1|||
150151025|NCT02733042|541688742|FG009|Overall Study|Withdrawal by Subject|1|||
150151026|NCT02733042|541688743|FG010|Overall Study|Withdrawal by Subject|0|||
150151027|NCT02733042|541688744|FG011|Overall Study|Withdrawal by Subject|2|||
150151028|NCT02733042|541688745|FG012|Overall Study|Withdrawal by Subject|1|||
150151029|NCT02733042|541688746|FG013|Overall Study|Withdrawal by Subject|1|||
150151030|NCT02733042|541688747|FG014|Overall Study|Withdrawal by Subject|0|||
150151031|NCT02733042|541688748|FG015|Overall Study|Withdrawal by Subject|0|||
150151032|NCT02733042|541688749|FG016|Overall Study|Withdrawal by Subject|0|||
150151033|NCT02733042|541688750|FG017|Overall Study|Withdrawal by Subject|0|||
150151034|NCT02733042|541688751|FG018|Overall Study|Withdrawal by Subject|0|||
149811172|NCT01678924|540437251|FG003|Overall Study|Lost to Follow-up|2|||
149811173|NCT01678924|540437248|FG000|Overall Study|Personal Reasons|2|||
149811174|NCT01678924|540437249|FG001|Overall Study|Personal Reasons|2|||
149811175|NCT01678924|540437250|FG002|Overall Study|Personal Reasons|2|||
149811176|NCT01678924|540437251|FG003|Overall Study|Personal Reasons|7|||
149811177|NCT01678924|540437248|FG000|Overall Study|Withdrawal by Subject|0|||
149811178|NCT01678924|540437249|FG001|Overall Study|Withdrawal by Subject|3|||
149811179|NCT01678924|540437250|FG002|Overall Study|Withdrawal by Subject|0|||
150151035|NCT02733042|541688733|FG000|Overall Study|Other Reasons|0|||
150151036|NCT02733042|541688734|FG001|Overall Study|Other Reasons|0|||
150151037|NCT02733042|541688735|FG002|Overall Study|Other Reasons|1|||
150151038|NCT02733042|541688736|FG003|Overall Study|Other Reasons|0|||
150151039|NCT02733042|541688737|FG004|Overall Study|Other Reasons|0|||
149811180|NCT01678924|540437251|FG003|Overall Study|Withdrawal by Subject|2|||
149811181|NCT01678924|540437248|FG000|Overall Study|Unable to attend scheduled visits|0|||
149811182|NCT01678924|540437249|FG001|Overall Study|Unable to attend scheduled visits|0|||
149811183|NCT01678924|540437250|FG002|Overall Study|Unable to attend scheduled visits|0|||
149811184|NCT01678924|540437251|FG003|Overall Study|Unable to attend scheduled visits|1|||
150151040|NCT02733042|541688738|FG005|Overall Study|Other Reasons|0|||
150151041|NCT02733042|541688739|FG006|Overall Study|Other Reasons|0|||
150151042|NCT02733042|541688740|FG007|Overall Study|Other Reasons|0|||
150151043|NCT02733042|541688741|FG008|Overall Study|Other Reasons|0|||
150151044|NCT02733042|541688742|FG009|Overall Study|Other Reasons|1|||
150151045|NCT02733042|541688743|FG010|Overall Study|Other Reasons|1|||
150151046|NCT02733042|541688744|FG011|Overall Study|Other Reasons|0|||
150151047|NCT02733042|541688745|FG012|Overall Study|Other Reasons|0|||
150151048|NCT02733042|541688746|FG013|Overall Study|Other Reasons|0|||
150151049|NCT02733042|541688747|FG014|Overall Study|Other Reasons|0|||
150151050|NCT02733042|541688748|FG015|Overall Study|Other Reasons|1|||
150151051|NCT02733042|541688749|FG016|Overall Study|Other Reasons|0|||
150151052|NCT02733042|541688750|FG017|Overall Study|Other Reasons|1|||
150151053|NCT02733042|541688751|FG018|Overall Study|Other Reasons|0|||
150151054|NCT02733042|541688733|FG000|Overall Study|Death|0|||
150151055|NCT02733042|541688734|FG001|Overall Study|Death|0|||
150151056|NCT02733042|541688735|FG002|Overall Study|Death|0|||
150151057|NCT02733042|541688736|FG003|Overall Study|Death|0|||
150151058|NCT02733042|541688737|FG004|Overall Study|Death|0|||
150151059|NCT02733042|541688738|FG005|Overall Study|Death|0|||
150151060|NCT02733042|541688739|FG006|Overall Study|Death|1|||
150151061|NCT02733042|541688740|FG007|Overall Study|Death|0|||
150151062|NCT02733042|541688741|FG008|Overall Study|Death|1|||
150151063|NCT02733042|541688742|FG009|Overall Study|Death|0|||
150151064|NCT02733042|541688743|FG010|Overall Study|Death|1|||
150151065|NCT02733042|541688744|FG011|Overall Study|Death|0|||
150151066|NCT02733042|541688745|FG012|Overall Study|Death|0|||
150151067|NCT02733042|541688746|FG013|Overall Study|Death|0|||
150151068|NCT02733042|541688747|FG014|Overall Study|Death|1|||
150151069|NCT02733042|541688748|FG015|Overall Study|Death|2|||
150151070|NCT02733042|541688749|FG016|Overall Study|Death|0|||
150151071|NCT02733042|541688750|FG017|Overall Study|Death|0|||
150151072|NCT02733042|541688751|FG018|Overall Study|Death|0|||
150151073|NCT03688711|541688752|FG000|Overall Study|Withdrawal by Subject|0|||
150151074|NCT03688711|541688753|FG001|Overall Study|Withdrawal by Subject|1|||
150151075|NCT01821898|541688755|FG000|Overall Study|Withdrawal by Subject|2|||
150151076|NCT01821898|541688756|FG001|Overall Study|Withdrawal by Subject|1|||
150151077|NCT04175912|541688761|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
150151078|NCT04175912|541688762|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
150151079|NCT04175912|541688761|FG000|Overall Study|Adverse Event|0|||
150151080|NCT04175912|541688762|FG001|Overall Study|Adverse Event|3|||
150151081|NCT04175912|541688761|FG000|Overall Study|Never started treatment|3|||
150151082|NCT04175912|541688762|FG001|Overall Study|Never started treatment|3|||
149811185|NCT02156466|540437256|FG000|Overall Study|Adverse Event|0|||
149811186|NCT02156466|540437257|FG001|Overall Study|Adverse Event|0|||
149811187|NCT02156466|540437258|FG002|Overall Study|Adverse Event|1|||
149811188|NCT02156466|540437259|FG003|Overall Study|Adverse Event|1|||
149811189|NCT02156466|540437260|FG004|Overall Study|Adverse Event|0|||
149811190|NCT02156466|540437256|FG000|Overall Study|Quantiferon Positivity|0|||
149811191|NCT02156466|540437257|FG001|Overall Study|Quantiferon Positivity|0|||
150151083|NCT04175912|541688761|FG000|Overall Study|Death|0|||
150151084|NCT04175912|541688762|FG001|Overall Study|Death|1|||
150151085|NCT03169881|541688775|FG000|Overall Study|Incomplete Follow-up|10|||
150151086|NCT03169881|541688776|FG001|Overall Study|Incomplete Follow-up|15|||
150151087|NCT03169881|541688775|FG000|Overall Study|Lost to Follow-up|18|||
150151088|NCT03169881|541688776|FG001|Overall Study|Lost to Follow-up|20|||
150151089|NCT03169881|541688775|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
150151090|NCT03169881|541688776|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
150151091|NCT03734991|541688777|FG000|Overall Study|Adverse Event|4|||
150151092|NCT03734991|541688778|FG001|Overall Study|Adverse Event|0|||
150151093|NCT03734991|541688777|FG000|Overall Study|Lost to Follow-up|4|||
149811192|NCT02156466|540437258|FG002|Overall Study|Quantiferon Positivity|0|||
149811193|NCT02156466|540437259|FG003|Overall Study|Quantiferon Positivity|1|||
149811194|NCT02156466|540437260|FG004|Overall Study|Quantiferon Positivity|0|||
149811195|NCT01784419|540437261|FG000|Overall Study|Adverse Event|3|||
149811196|NCT02253654|540437262|FG000|Overall Study|Withdrawal by Subject|12|||
149811197|NCT02253654|540437263|FG001|Overall Study|Withdrawal by Subject|4|||
149811198|NCT02253654|540437262|FG000|Overall Study|Decision by Sponsor|1|||
149811199|NCT02253654|540437263|FG001|Overall Study|Decision by Sponsor|1|||
149811200|NCT02253654|540437262|FG000|Overall Study|Lost to Follow-up|2|||
149811201|NCT02253654|540437263|FG001|Overall Study|Lost to Follow-up|5|||
149811202|NCT02253654|540437262|FG000|Overall Study|Death|4|||
149811203|NCT02253654|540437263|FG001|Overall Study|Death|7|||
149811204|NCT02253654|540437262|FG000|Overall Study|Did Not Receive Study Treatment|4|||
149811205|NCT02253654|540437263|FG001|Overall Study|Did Not Receive Study Treatment|1|||
149811206|NCT03044431|540437266|FG000|Overall Study|Lost to Follow-up|59|||
149811207|NCT03456726|540437267|FG000|Overall Study|Disease Progression|6|||
150151094|NCT03734991|541688778|FG001|Overall Study|Lost to Follow-up|0|||
150151095|NCT03734991|541688777|FG000|Overall Study|Physician Decision|0|||
150151096|NCT03734991|541688778|FG001|Overall Study|Physician Decision|1|||
150151097|NCT03734991|541688777|FG000|Overall Study|Pregnancy|1|||
150151098|NCT03734991|541688778|FG001|Overall Study|Pregnancy|0|||
149811208|NCT03456726|540437268|FG001|Overall Study|Disease Progression|1|||
149811209|NCT03456726|540437267|FG000|Overall Study|Adverse Event|4|||
150151099|NCT03734991|541688777|FG000|Overall Study|Withdrawal by Subject|6|||
150151100|NCT03734991|541688778|FG001|Overall Study|Withdrawal by Subject|3|||
150151101|NCT03734991|541688777|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
150151102|NCT03734991|541688778|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
150151103|NCT03734991|541688777|FG000|Overall Study|Other|2|||
150151104|NCT03734991|541688778|FG001|Overall Study|Other|2|||
150151105|NCT03797326|541688782|FG000|Overall Study|Lost to Follow-up|1|||
150151106|NCT03797326|541688783|FG001|Overall Study|Lost to Follow-up|0|||
150151107|NCT03797326|541688784|FG002|Overall Study|Lost to Follow-up|0|||
150151108|NCT03797326|541688785|FG003|Overall Study|Lost to Follow-up|1|||
150151109|NCT03797326|541688786|FG004|Overall Study|Lost to Follow-up|0|||
150151110|NCT03797326|541688787|FG005|Overall Study|Lost to Follow-up|0|||
150151111|NCT03797326|541688788|FG006|Overall Study|Lost to Follow-up|0|||
150151112|NCT03797326|541688789|FG007|Overall Study|Lost to Follow-up|0|||
150151113|NCT03797326|541688782|FG000|Overall Study|Withdrawal by Subject|0|||
150151114|NCT03797326|541688783|FG001|Overall Study|Withdrawal by Subject|0|||
150151115|NCT03797326|541688784|FG002|Overall Study|Withdrawal by Subject|1|||
150151116|NCT03797326|541688785|FG003|Overall Study|Withdrawal by Subject|3|||
150151117|NCT03797326|541688786|FG004|Overall Study|Withdrawal by Subject|0|||
150151118|NCT03797326|541688787|FG005|Overall Study|Withdrawal by Subject|2|||
150151119|NCT03797326|541688788|FG006|Overall Study|Withdrawal by Subject|2|||
150151120|NCT03797326|541688789|FG007|Overall Study|Withdrawal by Subject|3|||
150151121|NCT03797326|541688782|FG000|Overall Study|Sponsor Decision|3|||
150151122|NCT03797326|541688783|FG001|Overall Study|Sponsor Decision|3|||
150151123|NCT03797326|541688784|FG002|Overall Study|Sponsor Decision|3|||
150151124|NCT03797326|541688785|FG003|Overall Study|Sponsor Decision|6|||
150151125|NCT03797326|541688786|FG004|Overall Study|Sponsor Decision|0|||
150151126|NCT03797326|541688787|FG005|Overall Study|Sponsor Decision|3|||
150151127|NCT03797326|541688788|FG006|Overall Study|Sponsor Decision|3|||
150151128|NCT03797326|541688789|FG007|Overall Study|Sponsor Decision|2|||
150151129|NCT03797326|541688782|FG000|Overall Study|Death|27|||
150151130|NCT03797326|541688783|FG001|Overall Study|Death|28|||
150151131|NCT03797326|541688784|FG002|Overall Study|Death|95|||
150151132|NCT03797326|541688785|FG003|Overall Study|Death|95|||
150151133|NCT03797326|541688786|FG004|Overall Study|Death|30|||
150151134|NCT03797326|541688787|FG005|Overall Study|Death|96|||
150151135|NCT03797326|541688788|FG006|Overall Study|Death|97|||
150151136|NCT03797326|541688789|FG007|Overall Study|Death|98|||
150151137|NCT03797326|541688782|FG000|Overall Study|Enrolled in error|0|||
150151138|NCT03797326|541688783|FG001|Overall Study|Enrolled in error|0|||
150151139|NCT03797326|541688784|FG002|Overall Study|Enrolled in error|3|||
150151140|NCT03797326|541688785|FG003|Overall Study|Enrolled in error|2|||
150151141|NCT03797326|541688786|FG004|Overall Study|Enrolled in error|2|||
150151142|NCT03797326|541688787|FG005|Overall Study|Enrolled in error|1|||
150151143|NCT03797326|541688788|FG006|Overall Study|Enrolled in error|1|||
150151144|NCT03797326|541688789|FG007|Overall Study|Enrolled in error|0|||
150151145|NCT03012061|541688790|FG000|Overall Study|Withdrawal by Subject|1|||
150151146|NCT03012061|541688791|FG001|Overall Study|Withdrawal by Subject|5|||
150151147|NCT03012061|541688792|FG002|Overall Study|Withdrawal by Subject|4|||
150151148|NCT03012061|541688790|FG000|Overall Study|Investigator Site Closed|1|||
150151149|NCT03012061|541688791|FG001|Overall Study|Investigator Site Closed|2|||
150151150|NCT03012061|541688792|FG002|Overall Study|Investigator Site Closed|0|||
150151151|NCT03012061|541688790|FG000|Overall Study|Lost to Follow-up|2|||
150151152|NCT03012061|541688791|FG001|Overall Study|Lost to Follow-up|1|||
150151153|NCT03012061|541688792|FG002|Overall Study|Lost to Follow-up|0|||
150151154|NCT03012061|541688790|FG000|Overall Study|Study closed/ Terminated|0|||
150151155|NCT03012061|541688791|FG001|Overall Study|Study closed/ Terminated|0|||
150151156|NCT03012061|541688792|FG002|Overall Study|Study closed/ Terminated|1|||
150151157|NCT03012061|541688790|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
150151158|NCT03012061|541688791|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
150151159|NCT03012061|541688792|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
150151160|NCT03012061|541688790|FG000|Overall Study|Protocol Violation|0|||
150151161|NCT03012061|541688791|FG001|Overall Study|Protocol Violation|0|||
150151162|NCT03012061|541688792|FG002|Overall Study|Protocol Violation|2|||
150151163|NCT03012061|541688790|FG000|Overall Study|Lack of Efficacy|0|||
150151164|NCT03012061|541688791|FG001|Overall Study|Lack of Efficacy|1|||
150151165|NCT03012061|541688792|FG002|Overall Study|Lack of Efficacy|0|||
150151166|NCT03012061|541688790|FG000|Overall Study|Adverse Event|2|||
150151167|NCT03012061|541688791|FG001|Overall Study|Adverse Event|0|||
150151168|NCT03012061|541688792|FG002|Overall Study|Adverse Event|0|||
150151169|NCT01164228|541688793|FG000|Overall Study|Progression|24|||
150151170|NCT01164228|541688794|FG001|Overall Study|Progression|25|||
150151171|NCT01164228|541688793|FG000|Overall Study|Adverse Event|13|||
150151172|NCT01164228|541688794|FG001|Overall Study|Adverse Event|7|||
150151173|NCT01164228|541688793|FG000|Overall Study|Death|1|||
150151174|NCT01164228|541688794|FG001|Overall Study|Death|1|||
150151175|NCT01164228|541688793|FG000|Overall Study|Withdrawal by Subject|2|||
150151176|NCT01164228|541688794|FG001|Overall Study|Withdrawal by Subject|0|||
150151177|NCT01164228|541688793|FG000|Overall Study|Physician Decision|1|||
150151178|NCT01164228|541688794|FG001|Overall Study|Physician Decision|2|||
150151179|NCT01164228|541688793|FG000|Overall Study|Symptomatic deterioration|1|||
150151180|NCT01164228|541688794|FG001|Overall Study|Symptomatic deterioration|0|||
150151181|NCT01164228|541688793|FG000|Overall Study|Never started treatment|1|||
150151182|NCT01164228|541688794|FG001|Overall Study|Never started treatment|3|||
150151183|NCT01164228|541688793|FG000|Overall Study|Ineligible|1|||
150151184|NCT01164228|541688794|FG001|Overall Study|Ineligible|0|||
150151185|NCT04908449|541688795|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
150151186|NCT04908449|541688796|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
150151187|NCT04908449|541688795|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
150151188|NCT04908449|541688796|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
150151189|NCT00147225|541688799|FG000|Overall Study|Withdrawal by Subject|1|||
150151190|NCT00147225|541688800|FG001|Overall Study|Withdrawal by Subject|0|||
150151191|NCT00147225|541688801|FG002|Overall Study|Withdrawal by Subject|1|||
150151192|NCT00147225|541688802|FG003|Overall Study|Withdrawal by Subject|0|||
150151193|NCT00147225|541688803|FG004|Overall Study|Withdrawal by Subject|0|||
150151194|NCT00147225|541688804|FG005|Overall Study|Withdrawal by Subject|1|||
150151195|NCT00147225|541688799|FG000|Overall Study|Adverse Event|0|||
150151196|NCT00147225|541688800|FG001|Overall Study|Adverse Event|0|||
150151197|NCT00147225|541688801|FG002|Overall Study|Adverse Event|1|||
150151198|NCT00147225|541688802|FG003|Overall Study|Adverse Event|1|||
150151199|NCT00147225|541688803|FG004|Overall Study|Adverse Event|0|||
150151200|NCT00147225|541688804|FG005|Overall Study|Adverse Event|0|||
150151201|NCT00147225|541688799|FG000|Overall Study|Screen Failure|0|||
150151202|NCT00147225|541688800|FG001|Overall Study|Screen Failure|0|||
150151203|NCT00147225|541688801|FG002|Overall Study|Screen Failure|0|||
150151204|NCT00147225|541688802|FG003|Overall Study|Screen Failure|0|||
150151205|NCT00147225|541688803|FG004|Overall Study|Screen Failure|1|||
150151206|NCT00147225|541688804|FG005|Overall Study|Screen Failure|0|||
150151207|NCT00147225|541688799|FG000|Overall Study|Chemotherapy Changed|0|||
150151208|NCT00147225|541688800|FG001|Overall Study|Chemotherapy Changed|0|||
150151209|NCT00147225|541688801|FG002|Overall Study|Chemotherapy Changed|0|||
150151210|NCT00147225|541688802|FG003|Overall Study|Chemotherapy Changed|0|||
150151211|NCT00147225|541688803|FG004|Overall Study|Chemotherapy Changed|0|||
150151212|NCT00147225|541688804|FG005|Overall Study|Chemotherapy Changed|1|||
150151213|NCT01032044|541688805|FG000|Overall Study|Protocol Violation|14|||
150151214|NCT01032044|541688806|FG001|Overall Study|Protocol Violation|8|||
150151215|NCT01032044|541688805|FG000|Overall Study|Adverse Event|0|||
150151216|NCT01032044|541688806|FG001|Overall Study|Adverse Event|1|||
150151217|NCT01032044|541688805|FG000|Overall Study|Lost to Follow-up|11|||
150151218|NCT01032044|541688806|FG001|Overall Study|Lost to Follow-up|11|||
150151219|NCT01233609|541688807|FG000|Overall Study|Death|1|||
150151220|NCT01233609|541688808|FG001|Overall Study|Death|0|||
150151221|NCT01233609|541688807|FG000|Overall Study|Lost to Follow-up|3|||
150151222|NCT01233609|541688808|FG001|Overall Study|Lost to Follow-up|1|||
150151223|NCT01233609|541688807|FG000|Overall Study|Adverse Event|2|||
150151224|NCT01233609|541688808|FG001|Overall Study|Adverse Event|1|||
150151225|NCT01233609|541688807|FG000|Overall Study|Withdrawal by Subject|3|||
150151226|NCT01233609|541688808|FG001|Overall Study|Withdrawal by Subject|0|||
150151227|NCT00735644|541688809|FG000|Overall Study|Did not receive study vaccine|0|||
150151228|NCT00735644|541688810|FG001|Overall Study|Did not receive study vaccine|1|||
150151229|NCT00735644|541688811|FG002|Overall Study|Did not receive study vaccine|0|||
150151230|NCT00735644|541688812|FG003|Overall Study|Did not receive study vaccine|0|||
150151231|NCT00735644|541688813|FG004|Overall Study|Did not receive study vaccine|0|||
150151232|NCT00735644|541688809|FG000|Overall Study|Withdrawal by Subject|0|||
150151233|NCT00735644|541688810|FG001|Overall Study|Withdrawal by Subject|1|||
150151234|NCT00735644|541688811|FG002|Overall Study|Withdrawal by Subject|1|||
150151235|NCT00735644|541688812|FG003|Overall Study|Withdrawal by Subject|1|||
150151236|NCT00735644|541688813|FG004|Overall Study|Withdrawal by Subject|0|||
150151237|NCT02961374|541688814|FG000|Overall Study|Adverse Event|4|||
150151238|NCT01567865|541688819|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
150151239|NCT01567865|541688820|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
150151240|NCT01567865|541688821|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
150151241|NCT01567865|541688822|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
150151242|NCT01567865|541688819|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
150151243|NCT01567865|541688820|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
150151244|NCT01567865|541688821|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
150151245|NCT01567865|541688822|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
150151246|NCT00309608|541688825|FG000|Overall Study|Adverse Event|1|||
150151247|NCT00309608|541688826|FG001|Overall Study|Adverse Event|5|||
150151248|NCT00309608|541688827|FG002|Overall Study|Adverse Event|3|||
150151249|NCT00309608|541688828|FG003|Overall Study|Adverse Event|2|||
150151250|NCT00309608|541688829|FG004|Overall Study|Adverse Event|3|||
150151251|NCT00309608|541688825|FG000|Overall Study|Protocol Violation|2|||
150151252|NCT00309608|541688826|FG001|Overall Study|Protocol Violation|0|||
150151253|NCT00309608|541688827|FG002|Overall Study|Protocol Violation|0|||
150151254|NCT00309608|541688828|FG003|Overall Study|Protocol Violation|0|||
150151255|NCT00309608|541688829|FG004|Overall Study|Protocol Violation|0|||
150151256|NCT00309608|541688825|FG000|Overall Study|Lost to Follow-up|0|||
150151257|NCT00309608|541688826|FG001|Overall Study|Lost to Follow-up|0|||
150151258|NCT00309608|541688827|FG002|Overall Study|Lost to Follow-up|2|||
150151259|NCT00309608|541688828|FG003|Overall Study|Lost to Follow-up|0|||
150151260|NCT00309608|541688829|FG004|Overall Study|Lost to Follow-up|1|||
150151261|NCT00309608|541688825|FG000|Overall Study|Withdrawal by Subject|1|||
150151262|NCT00309608|541688826|FG001|Overall Study|Withdrawal by Subject|4|||
150151263|NCT00309608|541688827|FG002|Overall Study|Withdrawal by Subject|2|||
150151264|NCT00309608|541688828|FG003|Overall Study|Withdrawal by Subject|0|||
150151265|NCT00309608|541688829|FG004|Overall Study|Withdrawal by Subject|0|||
150151266|NCT00309608|541688825|FG000|Overall Study|Other incl. Lack of efficacy|10|||
150151267|NCT00309608|541688826|FG001|Overall Study|Other incl. Lack of efficacy|4|||
150151268|NCT00309608|541688827|FG002|Overall Study|Other incl. Lack of efficacy|3|||
150151269|NCT00309608|541688828|FG003|Overall Study|Other incl. Lack of efficacy|4|||
150151270|NCT00309608|541688829|FG004|Overall Study|Other incl. Lack of efficacy|0|||
150151271|NCT00127413|541688830|FG000|Overall Study|Lost to Follow-up|6|||
150151272|NCT00127413|541688831|FG001|Overall Study|Lost to Follow-up|4|||
150151273|NCT00127413|541688832|FG002|Overall Study|Lost to Follow-up|8|||
150151274|NCT00127413|541688833|FG003|Overall Study|Lost to Follow-up|2|||
150151275|NCT01051063|541688834|FG000|Overall Study|Death|2|||
150151276|NCT01051063|541688835|FG001|Overall Study|Death|2|||
150151277|NCT01051063|541688834|FG000|Overall Study|Withdrawal by Subject|1|||
150151278|NCT01051063|541688835|FG001|Overall Study|Withdrawal by Subject|1|||
150151279|NCT01051063|541688834|FG000|Overall Study|Termination of the study|5|||
150151280|NCT01051063|541688835|FG001|Overall Study|Termination of the study|0|||
150151281|NCT01051063|541688834|FG000|Overall Study|Moved from the study site area|1|||
150151282|NCT01051063|541688835|FG001|Overall Study|Moved from the study site area|0|||
150151283|NCT01051063|541688834|FG000|Overall Study|Other|1|||
150151284|NCT01051063|541688835|FG001|Overall Study|Other|0|||
150151285|NCT01051063|541688834|FG000|Overall Study|Lost to Follow-up|0|||
150151286|NCT01051063|541688835|FG001|Overall Study|Lost to Follow-up|1|||
150151287|NCT01091428|541690324|FG000|Phase 1|Progressive Disease|24|||
150151288|NCT01091428|541690325|FG001|Phase 1|Progressive Disease|8|||
150151289|NCT01091428|541690326|FG002|Phase 1|Progressive Disease|0|||
150151290|NCT01091428|541690327|FG003|Phase 1|Progressive Disease|0|||
150151291|NCT01091428|541690324|FG000|Phase 1|Symptomatic Deterioration|3|||
150151292|NCT01091428|541690325|FG001|Phase 1|Symptomatic Deterioration|2|||
150151293|NCT01091428|541690326|FG002|Phase 1|Symptomatic Deterioration|0|||
150151294|NCT01091428|541690327|FG003|Phase 1|Symptomatic Deterioration|0|||
150151295|NCT01091428|541690324|FG000|Phase 1|Adverse Event|2|||
150151296|NCT01091428|541690325|FG001|Phase 1|Adverse Event|0|||
150151297|NCT01091428|541690326|FG002|Phase 1|Adverse Event|0|||
150151298|NCT01091428|541690327|FG003|Phase 1|Adverse Event|0|||
150151299|NCT01091428|541690324|FG000|Phase 1|Withdrawal by Subject|7|||
150151300|NCT01091428|541690325|FG001|Phase 1|Withdrawal by Subject|0|||
150151301|NCT01091428|541690326|FG002|Phase 1|Withdrawal by Subject|0|||
150151302|NCT01091428|541690327|FG003|Phase 1|Withdrawal by Subject|0|||
150151303|NCT01091428|541690324|FG000|Phase 1|Reason not specified|0|||
150151304|NCT01091428|541690325|FG001|Phase 1|Reason not specified|1|||
150151305|NCT01091428|541690326|FG002|Phase 1|Reason not specified|0|||
150151306|NCT01091428|541690327|FG003|Phase 1|Reason not specified|0|||
150151307|NCT01091428|541690324|FG000|Phase 1|Single-Patient IND|2|||
150151308|NCT01091428|541690325|FG001|Phase 1|Single-Patient IND|0|||
150151309|NCT01091428|541690326|FG002|Phase 1|Single-Patient IND|0|||
150151310|NCT01091428|541690327|FG003|Phase 1|Single-Patient IND|0|||
150151311|NCT01091428|541690324|FG000|Phase 2|Progressive Disease|0|||
150151312|NCT01091428|541690325|FG001|Phase 2|Progressive Disease|0|||
150151313|NCT01091428|541690326|FG002|Phase 2|Progressive Disease|44|||
150151314|NCT01091428|541690327|FG003|Phase 2|Progressive Disease|46|||
150151315|NCT01091428|541690324|FG000|Phase 2|Symptomatic Deterioration|0|||
150151316|NCT01091428|541690325|FG001|Phase 2|Symptomatic Deterioration|0|||
150151317|NCT01091428|541690326|FG002|Phase 2|Symptomatic Deterioration|1|||
150151318|NCT01091428|541690327|FG003|Phase 2|Symptomatic Deterioration|6|||
150151319|NCT01091428|541690324|FG000|Phase 2|Adverse Event|0|||
150151320|NCT01091428|541690325|FG001|Phase 2|Adverse Event|0|||
150151321|NCT01091428|541690326|FG002|Phase 2|Adverse Event|12|||
150151322|NCT01091428|541690327|FG003|Phase 2|Adverse Event|5|||
150151323|NCT01091428|541690324|FG000|Phase 2|Withdrawal by Subject|0|||
150151324|NCT01091428|541690325|FG001|Phase 2|Withdrawal by Subject|0|||
150151325|NCT01091428|541690326|FG002|Phase 2|Withdrawal by Subject|9|||
150151326|NCT01091428|541690327|FG003|Phase 2|Withdrawal by Subject|8|||
150151327|NCT01091428|541690324|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
150151328|NCT01091428|541690325|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
150151329|NCT01091428|541690326|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
150151330|NCT01091428|541690327|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
150151331|NCT01091428|541690324|FG000|Phase 2|Reason not specified|0|||
150151332|NCT01091428|541690325|FG001|Phase 2|Reason not specified|0|||
150151333|NCT01091428|541690326|FG002|Phase 2|Reason not specified|4|||
150151334|NCT01091428|541690327|FG003|Phase 2|Reason not specified|3|||
150151335|NCT01091428|541690324|FG000|Phase 2|Physician Decision|0|||
150151336|NCT01091428|541690325|FG001|Phase 2|Physician Decision|0|||
150151337|NCT01091428|541690326|FG002|Phase 2|Physician Decision|2|||
150151338|NCT01091428|541690327|FG003|Phase 2|Physician Decision|0|||
150151339|NCT00329719|541690334|FG000|Overall Study|Lost to Follow-up|0|||
150151340|NCT00329719|541690335|FG001|Overall Study|Lost to Follow-up|0|||
150151341|NCT00329719|541690336|FG002|Overall Study|Lost to Follow-up|0|||
150151342|NCT00329719|541690337|FG003|Overall Study|Lost to Follow-up|1|||
150151343|NCT01807221|541690342|FG000|Overall Study|Progressive disease|1|||
150151344|NCT01807221|541690343|FG001|Overall Study|Progressive disease|0|||
150151345|NCT01807221|541690344|FG002|Overall Study|Progressive disease|1|||
150151346|NCT01807221|541690345|FG003|Overall Study|Progressive disease|0|||
150151347|NCT01807221|541690346|FG004|Overall Study|Progressive disease|0|||
150151348|NCT01807221|541690347|FG005|Overall Study|Progressive disease|0|||
150151349|NCT01807221|541690342|FG000|Overall Study|Death|7|||
150151350|NCT01807221|541690343|FG001|Overall Study|Death|9|||
150151351|NCT01807221|541690344|FG002|Overall Study|Death|4|||
150151352|NCT01807221|541690345|FG003|Overall Study|Death|2|||
150151353|NCT01807221|541690346|FG004|Overall Study|Death|1|||
150151354|NCT01807221|541690347|FG005|Overall Study|Death|6|||
150151355|NCT01807221|541690342|FG000|Overall Study|Physician Decision|2|||
150151356|NCT01807221|541690343|FG001|Overall Study|Physician Decision|1|||
150151357|NCT01807221|541690344|FG002|Overall Study|Physician Decision|0|||
150151358|NCT01807221|541690345|FG003|Overall Study|Physician Decision|0|||
150151359|NCT01807221|541690346|FG004|Overall Study|Physician Decision|0|||
150151360|NCT01807221|541690347|FG005|Overall Study|Physician Decision|0|||
150151361|NCT01807221|541690342|FG000|Overall Study|Adverse Event|33|||
150151362|NCT01807221|541690343|FG001|Overall Study|Adverse Event|22|||
150151363|NCT01807221|541690344|FG002|Overall Study|Adverse Event|26|||
150151364|NCT01807221|541690345|FG003|Overall Study|Adverse Event|25|||
150151365|NCT01807221|541690346|FG004|Overall Study|Adverse Event|18|||
150151366|NCT01807221|541690347|FG005|Overall Study|Adverse Event|21|||
150151367|NCT01807221|541690342|FG000|Overall Study|Protocol Violation|0|||
150151368|NCT01807221|541690343|FG001|Overall Study|Protocol Violation|2|||
150151369|NCT01807221|541690344|FG002|Overall Study|Protocol Violation|1|||
150151370|NCT01807221|541690345|FG003|Overall Study|Protocol Violation|2|||
150151371|NCT01807221|541690346|FG004|Overall Study|Protocol Violation|0|||
150151372|NCT01807221|541690347|FG005|Overall Study|Protocol Violation|1|||
150151373|NCT01807221|541690342|FG000|Overall Study|Non-compliance|1|||
150151374|NCT01807221|541690343|FG001|Overall Study|Non-compliance|2|||
150151375|NCT01807221|541690344|FG002|Overall Study|Non-compliance|0|||
150151376|NCT01807221|541690345|FG003|Overall Study|Non-compliance|1|||
150151377|NCT01807221|541690346|FG004|Overall Study|Non-compliance|0|||
150151378|NCT01807221|541690347|FG005|Overall Study|Non-compliance|0|||
150151379|NCT01807221|541690342|FG000|Overall Study|Logistical difficulties|0|||
150151380|NCT01807221|541690343|FG001|Overall Study|Logistical difficulties|1|||
150151381|NCT01807221|541690344|FG002|Overall Study|Logistical difficulties|0|||
150151382|NCT01807221|541690345|FG003|Overall Study|Logistical difficulties|0|||
150151383|NCT01807221|541690346|FG004|Overall Study|Logistical difficulties|1|||
150151384|NCT01807221|541690347|FG005|Overall Study|Logistical difficulties|0|||
150151385|NCT01807221|541690342|FG000|Overall Study|Withdrawal by Subject|33|||
150151386|NCT01807221|541690343|FG001|Overall Study|Withdrawal by Subject|15|||
150151387|NCT01807221|541690344|FG002|Overall Study|Withdrawal by Subject|8|||
150151388|NCT01807221|541690345|FG003|Overall Study|Withdrawal by Subject|14|||
150151389|NCT01807221|541690346|FG004|Overall Study|Withdrawal by Subject|16|||
150151390|NCT01807221|541690347|FG005|Overall Study|Withdrawal by Subject|13|||
150151391|NCT01807221|541690342|FG000|Overall Study|Sponsor decision|2|||
150151392|NCT01807221|541690343|FG001|Overall Study|Sponsor decision|0|||
150151393|NCT01807221|541690344|FG002|Overall Study|Sponsor decision|1|||
150151394|NCT01807221|541690345|FG003|Overall Study|Sponsor decision|1|||
150151395|NCT01807221|541690346|FG004|Overall Study|Sponsor decision|0|||
150151396|NCT01807221|541690347|FG005|Overall Study|Sponsor decision|0|||
150151397|NCT01807221|541690342|FG000|Overall Study|Lost to Follow-up|1|||
150151398|NCT01807221|541690343|FG001|Overall Study|Lost to Follow-up|0|||
150151399|NCT01807221|541690344|FG002|Overall Study|Lost to Follow-up|2|||
150151400|NCT01807221|541690345|FG003|Overall Study|Lost to Follow-up|1|||
150151401|NCT01807221|541690346|FG004|Overall Study|Lost to Follow-up|0|||
150151402|NCT01807221|541690347|FG005|Overall Study|Lost to Follow-up|0|||
150151403|NCT06017999|541690348|FG000|Overall Study|Withdrawal by Subject|0|||
150151404|NCT06017999|541690349|FG001|Overall Study|Withdrawal by Subject|4|||
150151405|NCT06017999|541690350|FG002|Overall Study|Withdrawal by Subject|3|||
150151406|NCT06017999|541690348|FG000|Overall Study|Adverse Event|2|||
150151407|NCT06017999|541690349|FG001|Overall Study|Adverse Event|1|||
150151408|NCT06017999|541690350|FG002|Overall Study|Adverse Event|1|||
150151409|NCT06017999|541690348|FG000|Overall Study|Lost to Follow-up|0|||
150151410|NCT06017999|541690349|FG001|Overall Study|Lost to Follow-up|0|||
150151411|NCT06017999|541690350|FG002|Overall Study|Lost to Follow-up|1|||
150151412|NCT06017999|541690348|FG000|Overall Study|Physician Decision|1|||
150151413|NCT06017999|541690349|FG001|Overall Study|Physician Decision|1|||
150151414|NCT06017999|541690350|FG002|Overall Study|Physician Decision|0|||
150151415|NCT06017999|541690348|FG000|Overall Study|Non-Compliance|0|||
150151416|NCT06017999|541690349|FG001|Overall Study|Non-Compliance|0|||
150151417|NCT06017999|541690350|FG002|Overall Study|Non-Compliance|1|||
150151418|NCT06017999|541690348|FG000|Overall Study|Lack of Efficacy|1|||
150151419|NCT06017999|541690349|FG001|Overall Study|Lack of Efficacy|0|||
150151420|NCT06017999|541690350|FG002|Overall Study|Lack of Efficacy|7|||
150151421|NCT06017999|541690348|FG000|Overall Study|COVID Positive|0|||
150151422|NCT06017999|541690349|FG001|Overall Study|COVID Positive|1|||
150151423|NCT06017999|541690350|FG002|Overall Study|COVID Positive|0|||
150151424|NCT06017999|541690348|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
150151425|NCT06017999|541690349|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
150151426|NCT06017999|541690350|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
150151427|NCT01757665|541690358|FG000|Overall Study|Still on Study - Visit Completed|240|||
150151428|NCT01757665|541690359|FG001|Overall Study|Still on Study - Visit Completed|30|||
150151429|NCT01757665|541690358|FG000|Overall Study|Still on Study - Visit Pending|398|||
150151430|NCT01757665|541690359|FG001|Overall Study|Still on Study - Visit Pending|40|||
150151431|NCT01757665|541690358|FG000|Overall Study|Still on Study - Missed Visit|14|||
150151432|NCT01757665|541690359|FG001|Overall Study|Still on Study - Missed Visit|1|||
150151433|NCT01757665|541690358|FG000|Overall Study|Death|25|||
150151434|NCT01757665|541690359|FG001|Overall Study|Death|8|||
150151435|NCT01757665|541690358|FG000|Overall Study|Explant|1|||
150151436|NCT01757665|541690359|FG001|Overall Study|Explant|2|||
150151437|NCT01757665|541690358|FG000|Overall Study|Withdrawal by Subject|10|||
150151438|NCT01757665|541690359|FG001|Overall Study|Withdrawal by Subject|0|||
150151439|NCT01757665|541690358|FG000|Overall Study|Lost to Follow-up|1|||
150151440|NCT01757665|541690359|FG001|Overall Study|Lost to Follow-up|1|||
150151441|NCT01757665|541690358|FG000|Overall Study|Not Implanted with Device|5|||
150151442|NCT01757665|541690359|FG001|Overall Study|Not Implanted with Device|1|||
150151443|NCT00594906|541690360|FG000|Overall Study|Physician Decision|1|||
150151444|NCT00594906|541690361|FG001|Overall Study|Physician Decision|0|||
150151445|NCT00594906|541690360|FG000|Overall Study|Physician Decision|0|||
150151446|NCT00594906|541690361|FG001|Overall Study|Physician Decision|1|||
150151447|NCT00594906|541690360|FG000|Overall Study|Death|0|||
150151448|NCT00594906|541690361|FG001|Overall Study|Death|1|||
150151449|NCT02564055|541690362|FG000|Overall Study|Adverse Event|1|||
150151450|NCT02564055|541690363|FG001|Overall Study|Adverse Event|0|||
150151451|NCT02564055|541690364|FG002|Overall Study|Adverse Event|4|||
150151452|NCT02564055|541690365|FG003|Overall Study|Adverse Event|1|||
150151453|NCT02564055|541690366|FG004|Overall Study|Adverse Event|4|||
150151454|NCT02564055|541690367|FG005|Overall Study|Adverse Event|1|||
150151455|NCT02564055|541690362|FG000|Overall Study|Protocol Violation|1|||
150151456|NCT02564055|541690363|FG001|Overall Study|Protocol Violation|0|||
150151457|NCT02564055|541690364|FG002|Overall Study|Protocol Violation|0|||
150151458|NCT02564055|541690365|FG003|Overall Study|Protocol Violation|0|||
150151459|NCT02564055|541690366|FG004|Overall Study|Protocol Violation|0|||
150151460|NCT02564055|541690367|FG005|Overall Study|Protocol Violation|0|||
150151461|NCT02564055|541690362|FG000|Overall Study|Reached stopping criteria|0|||
150151462|NCT02564055|541690363|FG001|Overall Study|Reached stopping criteria|0|||
150151463|NCT02564055|541690364|FG002|Overall Study|Reached stopping criteria|0|||
150151464|NCT02564055|541690365|FG003|Overall Study|Reached stopping criteria|0|||
150151465|NCT02564055|541690366|FG004|Overall Study|Reached stopping criteria|0|||
150151466|NCT02564055|541690367|FG005|Overall Study|Reached stopping criteria|1|||
150151467|NCT02564055|541690362|FG000|Overall Study|Lost to Follow-up|0|||
150151468|NCT02564055|541690363|FG001|Overall Study|Lost to Follow-up|1|||
150151469|NCT02564055|541690364|FG002|Overall Study|Lost to Follow-up|4|||
150151470|NCT02564055|541690365|FG003|Overall Study|Lost to Follow-up|2|||
150151471|NCT02564055|541690366|FG004|Overall Study|Lost to Follow-up|1|||
150151472|NCT02564055|541690367|FG005|Overall Study|Lost to Follow-up|0|||
150151473|NCT02564055|541690362|FG000|Overall Study|Physician Decision|0|||
150151474|NCT02564055|541690363|FG001|Overall Study|Physician Decision|0|||
150151475|NCT02564055|541690364|FG002|Overall Study|Physician Decision|1|||
150151476|NCT02564055|541690365|FG003|Overall Study|Physician Decision|0|||
150151477|NCT02564055|541690366|FG004|Overall Study|Physician Decision|0|||
150151478|NCT02564055|541690367|FG005|Overall Study|Physician Decision|0|||
150151479|NCT02564055|541690362|FG000|Overall Study|Withdrawal by Subject|4|||
149811210|NCT03456726|540437268|FG001|Overall Study|Adverse Event|2|||
150151480|NCT02564055|541690363|FG001|Overall Study|Withdrawal by Subject|4|||
150151481|NCT02564055|541690364|FG002|Overall Study|Withdrawal by Subject|3|||
150151482|NCT02564055|541690365|FG003|Overall Study|Withdrawal by Subject|3|||
150151483|NCT02564055|541690366|FG004|Overall Study|Withdrawal by Subject|10|||
150151484|NCT02564055|541690367|FG005|Overall Study|Withdrawal by Subject|10|||
150151485|NCT01375959|541690368|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
150151486|NCT01375959|541690369|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
150151487|NCT01375959|541690368|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
150151488|NCT01375959|541690369|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
150151489|NCT01375959|541690368|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
150151490|NCT01375959|541690369|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
150151491|NCT02226172|541690376|FG000|Overall Study|Participant refused further follow-up|4|||
150151492|NCT02226172|541690376|FG000|Overall Study|Other|5|||
150151493|NCT02226172|541690376|FG000|Overall Study|Death|1|||
150151494|NCT02226172|541690376|FG000|Overall Study|Study terminated by sponsor|1|||
150151495|NCT02226172|541690376|FG000|Overall Study|Adverse Event|6|||
150151496|NCT02500979|541690379|FG000|Period 1|Hyperglycemia|1|||
150151497|NCT02500979|541690380|FG001|Period 1|Hyperglycemia|0|||
150151498|NCT02500979|541690379|FG000|Period 1|Severe non-compliance to protocol|0|||
150151499|NCT02500979|541690380|FG001|Period 1|Severe non-compliance to protocol|1|||
150151500|NCT02500979|541690379|FG000|Period 1|Adverse Event|1|||
150151501|NCT02500979|541690380|FG001|Period 1|Adverse Event|0|||
150151502|NCT02500979|541690379|FG000|Period 1|Subject decision|2|||
150151503|NCT02500979|541690380|FG001|Period 1|Subject decision|0|||
150151504|NCT02500979|541690379|FG000|Period 2|Change in risk|1|||
150151505|NCT02500979|541690380|FG001|Period 2|Change in risk|0|||
150151506|NCT01613027|541690381|FG000|Overall Study|Lost to Follow-up|5|||
150151507|NCT01613027|541690381|FG000|Overall Study|Switched Physician|1|||
150151508|NCT01613027|541690381|FG000|Overall Study|Lack of Efficacy|1|||
150151509|NCT01613027|541690381|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
150151510|NCT04267614|541690384|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
150151511|NCT04267614|541690384|FG000|Overall Study|Lost to Follow-up|115|||
150151512|NCT03632434|541690390|FG000|Overall Study|Withdrawal by Subject|2|||
150151513|NCT04297241|541690392|FG000|Overall Study|Withdrawal by Subject|1|||
150151514|NCT04297241|541690392|FG000|Overall Study|Adverse Event|1|||
150151515|NCT04297241|541690392|FG000|Overall Study|Physician Decision|3|||
150151516|NCT01088529|541690401|FG000|Overall Study|Did not receive study treatment|0|||
150151517|NCT01088529|541690402|FG001|Overall Study|Did not receive study treatment|1|||
150151518|NCT05832437|541690403|FG000|Overall Study|time off work|1|||
150151519|NCT05832437|541690404|FG001|Overall Study|time off work|0|||
150151520|NCT05832437|541690405|FG002|Overall Study|time off work|0|||
150151521|NCT05832437|541690406|FG003|Overall Study|time off work|0|||
150151522|NCT05376371|541690407|FG000|Overall Study|change in release date|10|||
150151523|NCT04159415|541690408|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151524|NCT04159415|541690409|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151525|NCT04159415|541690410|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151526|NCT04159415|541690411|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151527|NCT04159415|541690412|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151528|NCT04159415|541690413|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151529|NCT04159415|541690414|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
150151530|NCT04159415|541690415|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
150151531|NCT04159415|541690416|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151532|NCT04159415|541690417|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
150151533|NCT04159415|541690408|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151534|NCT04159415|541690409|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151535|NCT04159415|541690410|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151536|NCT04159415|541690411|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151537|NCT04159415|541690412|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151538|NCT04159415|541690413|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151539|NCT04159415|541690414|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151540|NCT04159415|541690415|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
150151541|NCT04159415|541690416|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151542|NCT04159415|541690417|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
150151543|NCT04159415|541690408|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151544|NCT04159415|541690409|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151545|NCT04159415|541690410|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151546|NCT04159415|541690411|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151547|NCT04159415|541690412|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151548|NCT04159415|541690413|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151549|NCT04159415|541690414|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151550|NCT04159415|541690415|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
150151551|NCT04159415|541690416|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151552|NCT04159415|541690417|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
150151553|NCT04159415|541690408|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151554|NCT04159415|541690409|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151555|NCT04159415|541690410|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151556|NCT04159415|541690411|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151557|NCT04159415|541690412|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151558|NCT04159415|541690413|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151559|NCT04159415|541690414|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151560|NCT04159415|541690415|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151561|NCT04159415|541690416|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
150151562|NCT04159415|541690417|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
150151563|NCT05407311|541690418|FG000|Overall Study|Withdrawal by Subject|5|||
150151564|NCT05407311|541690418|FG000|Overall Study|Protocol Violation|3|||
150151565|NCT05407311|541690418|FG000|Overall Study|Physician Decision|1|||
150151566|NCT05407311|541690418|FG000|Overall Study|Non-compliance|1|||
150151567|NCT00337662|541690420|FG000|Study Period II|Lost to Follow-up|0|||
150151568|NCT00337662|541690421|FG001|Study Period II|Lost to Follow-up|0|||
150151569|NCT00337662|541690422|FG002|Study Period II|Lost to Follow-up|0|||
150151570|NCT00337662|541690423|FG003|Study Period II|Lost to Follow-up|35|||
150151571|NCT00337662|541690420|FG000|Study Period II|Withdrawal by Subject|0|||
150151572|NCT00337662|541690421|FG001|Study Period II|Withdrawal by Subject|0|||
150151573|NCT00337662|541690422|FG002|Study Period II|Withdrawal by Subject|0|||
150151574|NCT00337662|541690423|FG003|Study Period II|Withdrawal by Subject|20|||
150151575|NCT00337662|541690420|FG000|Study Period II|Adverse Event|0|||
150151576|NCT00337662|541690421|FG001|Study Period II|Adverse Event|0|||
150151577|NCT00337662|541690422|FG002|Study Period II|Adverse Event|0|||
150151578|NCT00337662|541690423|FG003|Study Period II|Adverse Event|16|||
150151579|NCT00337662|541690420|FG000|Study Period II|Physician Decision|0|||
150151580|NCT00337662|541690421|FG001|Study Period II|Physician Decision|0|||
150151581|NCT00337662|541690422|FG002|Study Period II|Physician Decision|0|||
150151582|NCT00337662|541690423|FG003|Study Period II|Physician Decision|13|||
150151583|NCT00337662|541690420|FG000|Study Period II|Entry Criteria Not Met|0|||
150151584|NCT00337662|541690421|FG001|Study Period II|Entry Criteria Not Met|0|||
150151585|NCT00337662|541690422|FG002|Study Period II|Entry Criteria Not Met|0|||
150151586|NCT00337662|541690423|FG003|Study Period II|Entry Criteria Not Met|6|||
150151587|NCT00337662|541690420|FG000|Study Period II|Protocol Violation|0|||
150151588|NCT00337662|541690421|FG001|Study Period II|Protocol Violation|0|||
150151589|NCT00337662|541690422|FG002|Study Period II|Protocol Violation|0|||
150151590|NCT00337662|541690423|FG003|Study Period II|Protocol Violation|6|||
150151591|NCT00337662|541690420|FG000|Study Period II|Lack of Efficacy|0|||
150151592|NCT00337662|541690421|FG001|Study Period II|Lack of Efficacy|0|||
150151593|NCT00337662|541690422|FG002|Study Period II|Lack of Efficacy|0|||
150151594|NCT00337662|541690423|FG003|Study Period II|Lack of Efficacy|7|||
150151595|NCT00337662|541690420|FG000|Study Period II|Sponsor Decision|0|||
150151596|NCT00337662|541690421|FG001|Study Period II|Sponsor Decision|0|||
150151597|NCT00337662|541690422|FG002|Study Period II|Sponsor Decision|0|||
150151598|NCT00337662|541690423|FG003|Study Period II|Sponsor Decision|2|||
150151599|NCT00337662|541690420|FG000|Study Period II|Parent/Caregiver Decision|0|||
150151600|NCT00337662|541690421|FG001|Study Period II|Parent/Caregiver Decision|0|||
150151601|NCT00337662|541690422|FG002|Study Period II|Parent/Caregiver Decision|0|||
150151602|NCT00337662|541690423|FG003|Study Period II|Parent/Caregiver Decision|1|||
150151603|NCT00337662|541690420|FG000|Study Period III|Lost to Follow-up|14|||
150151604|NCT00337662|541690421|FG001|Study Period III|Lost to Follow-up|16|||
150151605|NCT00337662|541690422|FG002|Study Period III|Lost to Follow-up|14|||
150151606|NCT00337662|541690423|FG003|Study Period III|Lost to Follow-up|0|||
150151607|NCT00337662|541690420|FG000|Study Period III|Withdrawal by Subject|18|||
150151608|NCT00337662|541690421|FG001|Study Period III|Withdrawal by Subject|14|||
150151609|NCT00337662|541690422|FG002|Study Period III|Withdrawal by Subject|12|||
150151610|NCT00337662|541690423|FG003|Study Period III|Withdrawal by Subject|0|||
150151611|NCT00337662|541690420|FG000|Study Period III|Adverse Event|9|||
150151612|NCT00337662|541690421|FG001|Study Period III|Adverse Event|10|||
150151613|NCT00337662|541690422|FG002|Study Period III|Adverse Event|8|||
150151614|NCT00337662|541690423|FG003|Study Period III|Adverse Event|0|||
150151615|NCT00337662|541690420|FG000|Study Period III|Protocol Violation|3|||
150151616|NCT00337662|541690421|FG001|Study Period III|Protocol Violation|8|||
150151617|NCT00337662|541690422|FG002|Study Period III|Protocol Violation|2|||
150151618|NCT00337662|541690423|FG003|Study Period III|Protocol Violation|0|||
150151619|NCT00337662|541690420|FG000|Study Period III|Physician Decision|6|||
150151620|NCT00337662|541690421|FG001|Study Period III|Physician Decision|5|||
150151621|NCT00337662|541690422|FG002|Study Period III|Physician Decision|0|||
150151622|NCT00337662|541690423|FG003|Study Period III|Physician Decision|0|||
150151623|NCT00337662|541690420|FG000|Study Period III|Entry Criteria Not Met|4|||
150151624|NCT00337662|541690421|FG001|Study Period III|Entry Criteria Not Met|1|||
150151625|NCT00337662|541690422|FG002|Study Period III|Entry Criteria Not Met|3|||
150151626|NCT00337662|541690423|FG003|Study Period III|Entry Criteria Not Met|0|||
150151627|NCT00337662|541690420|FG000|Study Period III|Lack of Efficacy|4|||
150151628|NCT00337662|541690421|FG001|Study Period III|Lack of Efficacy|4|||
150151629|NCT00337662|541690422|FG002|Study Period III|Lack of Efficacy|2|||
150151630|NCT00337662|541690423|FG003|Study Period III|Lack of Efficacy|0|||
150151631|NCT00337662|541690420|FG000|Study Period III|Parent/Caregiver Decision|0|||
150151632|NCT00337662|541690421|FG001|Study Period III|Parent/Caregiver Decision|0|||
150151633|NCT00337662|541690422|FG002|Study Period III|Parent/Caregiver Decision|2|||
150151634|NCT00337662|541690423|FG003|Study Period III|Parent/Caregiver Decision|0|||
150151635|NCT00337662|541690420|FG000|Study Period III|Sponsor Decision|1|||
150151636|NCT00337662|541690421|FG001|Study Period III|Sponsor Decision|0|||
150151637|NCT00337662|541690422|FG002|Study Period III|Sponsor Decision|1|||
150151638|NCT00337662|541690423|FG003|Study Period III|Sponsor Decision|0|||
150151639|NCT00337662|541690420|FG000|Study Period III|Clinical Relapse|1|||
150151640|NCT00337662|541690421|FG001|Study Period III|Clinical Relapse|0|||
150151641|NCT00337662|541690422|FG002|Study Period III|Clinical Relapse|0|||
150151642|NCT00337662|541690423|FG003|Study Period III|Clinical Relapse|0|||
150151643|NCT01263106|541690426|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
150151644|NCT01263106|541690427|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
150151645|NCT00882921|541690428|FG000|Overall Study|Death|2|||
150151646|NCT00882921|541690428|FG000|Overall Study|Other|3|||
150151647|NCT00882921|541690428|FG000|Overall Study|Lost to Follow-up|2|||
150151648|NCT00882921|541690428|FG000|Overall Study|Termination By Investigator|3|||
150151649|NCT00882921|541690428|FG000|Overall Study|Withdrawal Of Consent|1|||
150151650|NCT05027074|541690435|FG000|Overall Study|Death|47|||
150151651|NCT05027074|541690436|FG001|Overall Study|Death|42|||
150151652|NCT05027074|541690437|FG002|Overall Study|Death|39|||
150151653|NCT05027074|541690435|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150151654|NCT05027074|541690436|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150151655|NCT05027074|541690437|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150151656|NCT05027074|541690435|FG000|Overall Study|Site Terminated By Sponsor|3|||
150151657|NCT05027074|541690436|FG001|Overall Study|Site Terminated By Sponsor|0|||
150151658|NCT05027074|541690437|FG002|Overall Study|Site Terminated By Sponsor|2|||
150151659|NCT05027074|541690435|FG000|Overall Study|Withdrawal by Subject|13|||
150151660|NCT05027074|541690436|FG001|Overall Study|Withdrawal by Subject|8|||
150151661|NCT05027074|541690437|FG002|Overall Study|Withdrawal by Subject|10|||
150151662|NCT05027074|541690435|FG000|Overall Study|Lost to Follow-up|2|||
150151663|NCT05027074|541690436|FG001|Overall Study|Lost to Follow-up|4|||
150151664|NCT05027074|541690437|FG002|Overall Study|Lost to Follow-up|3|||
150151665|NCT05027074|541690435|FG000|Overall Study|Status Not Recorded|0|||
150151666|NCT05027074|541690436|FG001|Overall Study|Status Not Recorded|0|||
150151667|NCT05027074|541690437|FG002|Overall Study|Status Not Recorded|1|||
150151668|NCT04150029|541690438|FG000|Overall Study|Disease Relapse|0|||
150151669|NCT04150029|541690439|FG001|Overall Study|Disease Relapse|18|||
150151670|NCT04150029|541690438|FG000|Overall Study|Progressive Disease|2|||
150151671|NCT04150029|541690439|FG001|Overall Study|Progressive Disease|16|||
150151672|NCT04150029|541690438|FG000|Overall Study|Adverse Event|1|||
150151673|NCT04150029|541690439|FG001|Overall Study|Adverse Event|11|||
150151674|NCT04150029|541690438|FG000|Overall Study|Physician Decision|0|||
150151675|NCT04150029|541690439|FG001|Overall Study|Physician Decision|10|||
150151676|NCT04150029|541690438|FG000|Overall Study|Study Terminated by Sponsor|1|||
150151677|NCT04150029|541690439|FG001|Overall Study|Study Terminated by Sponsor|10|||
150151678|NCT04150029|541690438|FG000|Overall Study|Death|0|||
150151679|NCT04150029|541690439|FG001|Overall Study|Death|8|||
150151680|NCT04150029|541690438|FG000|Overall Study|Participant Decision|0|||
150151681|NCT04150029|541690439|FG001|Overall Study|Participant Decision|7|||
150151682|NCT04150029|541690438|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
150151683|NCT04150029|541690439|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
150151684|NCT02322814|541690440|FG000|Overall Study|Death|7|||
150151685|NCT02322814|541690441|FG001|Overall Study|Death|29|||
150151686|NCT02322814|541690442|FG002|Overall Study|Death|32|||
150151687|NCT02322814|541690443|FG003|Overall Study|Death|23|||
150151688|NCT02322814|541690444|FG004|Overall Study|Death|14|||
150151689|NCT02322814|541690440|FG000|Overall Study|Lost to Follow-up|1|||
150151690|NCT02322814|541690441|FG001|Overall Study|Lost to Follow-up|3|||
150151691|NCT02322814|541690442|FG002|Overall Study|Lost to Follow-up|3|||
150151692|NCT02322814|541690443|FG003|Overall Study|Lost to Follow-up|1|||
150151693|NCT02322814|541690444|FG004|Overall Study|Lost to Follow-up|0|||
150151694|NCT02322814|541690440|FG000|Overall Study|Various Reasons|2|||
149811211|NCT03456726|540437267|FG000|Overall Study|Withdrawal by Subject|1|||
149811212|NCT03456726|540437268|FG001|Overall Study|Withdrawal by Subject|0|||
150151695|NCT02322814|541690441|FG001|Overall Study|Various Reasons|0|||
150151696|NCT02322814|541690442|FG002|Overall Study|Various Reasons|1|||
150151697|NCT02322814|541690443|FG003|Overall Study|Various Reasons|1|||
150151698|NCT02322814|541690444|FG004|Overall Study|Various Reasons|0|||
150151699|NCT02322814|541690440|FG000|Overall Study|Progressive Disease|0|||
150151700|NCT02322814|541690441|FG001|Overall Study|Progressive Disease|0|||
149811213|NCT03456726|540437267|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
150151701|NCT02322814|541690442|FG002|Overall Study|Progressive Disease|0|||
150151702|NCT02322814|541690443|FG003|Overall Study|Progressive Disease|1|||
150151703|NCT02322814|541690444|FG004|Overall Study|Progressive Disease|1|||
150151704|NCT02322814|541690440|FG000|Overall Study|Protocol Violation|1|||
150151705|NCT02322814|541690441|FG001|Overall Study|Protocol Violation|0|||
150151706|NCT02322814|541690442|FG002|Overall Study|Protocol Violation|0|||
150151707|NCT02322814|541690443|FG003|Overall Study|Protocol Violation|0|||
150151708|NCT02322814|541690444|FG004|Overall Study|Protocol Violation|0|||
150151709|NCT02322814|541690440|FG000|Overall Study|Study Terminated by Sponsor|0|||
150151710|NCT02322814|541690441|FG001|Overall Study|Study Terminated by Sponsor|7|||
150151711|NCT02322814|541690442|FG002|Overall Study|Study Terminated by Sponsor|9|||
150151712|NCT02322814|541690443|FG003|Overall Study|Study Terminated by Sponsor|5|||
150151713|NCT02322814|541690444|FG004|Overall Study|Study Terminated by Sponsor|13|||
150151714|NCT02322814|541690440|FG000|Overall Study|Withdrawal by Subject|5|||
150151715|NCT02322814|541690441|FG001|Overall Study|Withdrawal by Subject|4|||
150151716|NCT02322814|541690442|FG002|Overall Study|Withdrawal by Subject|2|||
150151717|NCT02322814|541690443|FG003|Overall Study|Withdrawal by Subject|1|||
150151718|NCT02322814|541690444|FG004|Overall Study|Withdrawal by Subject|3|||
150151719|NCT03864926|541691399|FG000|Overall Study|Death|0|||
150151720|NCT03864926|541691400|FG001|Overall Study|Death|2|||
150151721|NCT00445601|541691401|FG000|Overall Study|Withdrawal by Subject|11|||
150151722|NCT00445601|541691402|FG001|Overall Study|Withdrawal by Subject|11|||
150151723|NCT00445601|541691401|FG000|Overall Study|TURBT Complication|12|||
150151724|NCT00445601|541691402|FG001|Overall Study|TURBT Complication|8|||
150151725|NCT00445601|541691401|FG000|Overall Study|Incorrect Disease Status|6|||
150151726|NCT00445601|541691402|FG001|Overall Study|Incorrect Disease Status|6|||
150151727|NCT00445601|541691401|FG000|Overall Study|Drug Delivery Issue|2|||
150151728|NCT00445601|541691402|FG001|Overall Study|Drug Delivery Issue|2|||
150151729|NCT00445601|541691401|FG000|Overall Study|Adverse Event|2|||
150151730|NCT00445601|541691402|FG001|Overall Study|Adverse Event|0|||
150151731|NCT00445601|541691401|FG000|Overall Study|Death prior to TURBT|0|||
150151732|NCT00445601|541691402|FG001|Overall Study|Death prior to TURBT|1|||
150151733|NCT00373295|541691403|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
150151734|NCT00373295|541691404|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
150151735|NCT00373295|541691405|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
150151736|NCT00373295|541691406|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
150151737|NCT00373295|541691407|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
150151738|NCT00373295|541691408|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
150151739|NCT02771210|541691416|FG000|Period 1|Adverse Event|5|||
150151740|NCT02771210|541691417|FG001|Period 1|Adverse Event|3|||
150151741|NCT02771210|541691416|FG000|Period 1|Lack of Efficacy|3|||
150151742|NCT02771210|541691417|FG001|Period 1|Lack of Efficacy|6|||
150151743|NCT02771210|541691416|FG000|Period 1|Lost to Follow-up|2|||
150151744|NCT02771210|541691417|FG001|Period 1|Lost to Follow-up|0|||
150151745|NCT02771210|541691416|FG000|Period 1|Physician Decision|0|||
150151746|NCT02771210|541691417|FG001|Period 1|Physician Decision|1|||
150151747|NCT02771210|541691416|FG000|Period 1|Withdrawal by Subject|0|||
150151748|NCT02771210|541691417|FG001|Period 1|Withdrawal by Subject|3|||
150151749|NCT02771210|541691416|FG000|Period 1|Withdrawal of informed consent|1|||
150151750|NCT02771210|541691417|FG001|Period 1|Withdrawal of informed consent|5|||
150151751|NCT02771210|541691416|FG000|Period 2|Adverse Event|1|||
150151752|NCT02771210|541691417|FG001|Period 2|Adverse Event|0|||
150151753|NCT02771210|541691416|FG000|Period 2|Lack of Efficacy|0|||
150151754|NCT02771210|541691417|FG001|Period 2|Lack of Efficacy|1|||
150151755|NCT02771210|541691416|FG000|Period 2|Withdrawal by Subject|1|||
150151756|NCT02771210|541691417|FG001|Period 2|Withdrawal by Subject|0|||
150151757|NCT02771210|541691416|FG000|Period 2|Withdrawal of informed consent|0|||
150151758|NCT02771210|541691417|FG001|Period 2|Withdrawal of informed consent|2|||
150151759|NCT04012814|541691418|FG000|Overall Study|Lost to Follow-up|4|||
150151760|NCT04012814|541691418|FG000|Overall Study|Withdrawal by Subject|2|||
150151761|NCT04012814|541691418|FG000|Overall Study|Protocol Violation|1|||
150151762|NCT04012814|541691418|FG000|Overall Study|Adverse Event|1|||
150151763|NCT04397523|541691419|FG000|Overall Study|Lost to Follow-up|3|||
150151764|NCT04397523|541691419|FG000|Overall Study|Transfer from/to other hospital|8|||
150151765|NCT01394250|541691423|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
150151766|NCT01394250|541691424|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
150151767|NCT01394250|541691423|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
150151768|NCT01394250|541691424|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
150151769|NCT01865617|541691426|FG000|Overall Study|Death|27|||
150151770|NCT01865617|541691427|FG001|Overall Study|Death|3|||
150151771|NCT01865617|541691428|FG002|Overall Study|Death|1|||
150151772|NCT01865617|541691429|FG003|Overall Study|Death|1|||
150151773|NCT01865617|541691430|FG004|Overall Study|Death|5|||
150151774|NCT01865617|541691431|FG005|Overall Study|Death|1|||
150151775|NCT01865617|541691432|FG006|Overall Study|Death|11|||
150151776|NCT01865617|541691433|FG007|Overall Study|Death|1|||
150151777|NCT01865617|541691434|FG008|Overall Study|Death|11|||
150151778|NCT01865617|541691435|FG009|Overall Study|Death|3|||
150151779|NCT01865617|541691436|FG010|Overall Study|Death|32|||
150151780|NCT01865617|541691437|FG011|Overall Study|Death|6|||
150151781|NCT01865617|541691438|FG012|Overall Study|Death|13|||
150151782|NCT01865617|541691426|FG000|Overall Study|Lost to Follow-up|2|||
150151783|NCT01865617|541691427|FG001|Overall Study|Lost to Follow-up|0|||
150151784|NCT01865617|541691428|FG002|Overall Study|Lost to Follow-up|0|||
150151785|NCT01865617|541691429|FG003|Overall Study|Lost to Follow-up|0|||
150151786|NCT01865617|541691430|FG004|Overall Study|Lost to Follow-up|0|||
150151787|NCT01865617|541691431|FG005|Overall Study|Lost to Follow-up|0|||
150151788|NCT01865617|541691432|FG006|Overall Study|Lost to Follow-up|0|||
150151789|NCT01865617|541691433|FG007|Overall Study|Lost to Follow-up|0|||
150151790|NCT01865617|541691434|FG008|Overall Study|Lost to Follow-up|0|||
150151791|NCT01865617|541691435|FG009|Overall Study|Lost to Follow-up|0|||
150151792|NCT01865617|541691436|FG010|Overall Study|Lost to Follow-up|0|||
150151793|NCT01865617|541691437|FG011|Overall Study|Lost to Follow-up|0|||
150151794|NCT01865617|541691438|FG012|Overall Study|Lost to Follow-up|0|||
150151795|NCT01865617|541691426|FG000|Overall Study|Withdrawal by Subject|1|||
150151796|NCT01865617|541691427|FG001|Overall Study|Withdrawal by Subject|0|||
150151797|NCT01865617|541691428|FG002|Overall Study|Withdrawal by Subject|0|||
150151798|NCT01865617|541691429|FG003|Overall Study|Withdrawal by Subject|0|||
150151799|NCT01865617|541691430|FG004|Overall Study|Withdrawal by Subject|0|||
150151800|NCT01865617|541691431|FG005|Overall Study|Withdrawal by Subject|0|||
150151801|NCT01865617|541691432|FG006|Overall Study|Withdrawal by Subject|0|||
150151802|NCT01865617|541691433|FG007|Overall Study|Withdrawal by Subject|0|||
150151803|NCT01865617|541691434|FG008|Overall Study|Withdrawal by Subject|0|||
150151804|NCT01865617|541691435|FG009|Overall Study|Withdrawal by Subject|0|||
150151805|NCT01865617|541691436|FG010|Overall Study|Withdrawal by Subject|0|||
150151806|NCT01865617|541691437|FG011|Overall Study|Withdrawal by Subject|0|||
150151807|NCT01865617|541691438|FG012|Overall Study|Withdrawal by Subject|0|||
150151808|NCT01865617|541691426|FG000|Overall Study|Patient proceeded to new therapy|0|||
150151809|NCT01865617|541691427|FG001|Overall Study|Patient proceeded to new therapy|0|||
150151810|NCT01865617|541691428|FG002|Overall Study|Patient proceeded to new therapy|0|||
150151811|NCT01865617|541691429|FG003|Overall Study|Patient proceeded to new therapy|0|||
150151812|NCT01865617|541691430|FG004|Overall Study|Patient proceeded to new therapy|2|||
150151813|NCT01865617|541691431|FG005|Overall Study|Patient proceeded to new therapy|0|||
150151814|NCT01865617|541691432|FG006|Overall Study|Patient proceeded to new therapy|0|||
150151815|NCT01865617|541691433|FG007|Overall Study|Patient proceeded to new therapy|0|||
150151816|NCT01865617|541691434|FG008|Overall Study|Patient proceeded to new therapy|0|||
150151817|NCT01865617|541691435|FG009|Overall Study|Patient proceeded to new therapy|0|||
150151818|NCT01865617|541691436|FG010|Overall Study|Patient proceeded to new therapy|0|||
150151819|NCT01865617|541691437|FG011|Overall Study|Patient proceeded to new therapy|0|||
150151820|NCT01865617|541691438|FG012|Overall Study|Patient proceeded to new therapy|0|||
150151821|NCT01865617|541691426|FG000|Overall Study|Other|0|||
150151822|NCT01865617|541691427|FG001|Overall Study|Other|0|||
150151823|NCT01865617|541691428|FG002|Overall Study|Other|0|||
150151824|NCT01865617|541691429|FG003|Overall Study|Other|0|||
150151825|NCT01865617|541691430|FG004|Overall Study|Other|0|||
150151826|NCT01865617|541691431|FG005|Overall Study|Other|0|||
150151827|NCT01865617|541691432|FG006|Overall Study|Other|1|||
150151828|NCT01865617|541691433|FG007|Overall Study|Other|0|||
150151829|NCT01865617|541691434|FG008|Overall Study|Other|0|||
150151830|NCT01865617|541691435|FG009|Overall Study|Other|0|||
150151831|NCT01865617|541691436|FG010|Overall Study|Other|0|||
150151832|NCT01865617|541691437|FG011|Overall Study|Other|0|||
150151833|NCT01865617|541691438|FG012|Overall Study|Other|0|||
150151834|NCT00502996|541691439|FG000|Overall Study|Lost to Follow-up|9|||
150151835|NCT00502996|541691439|FG000|Overall Study|Protocol Violation|2|||
150151836|NCT00502996|541691439|FG000|Overall Study|Treatment failure|25|||
150151837|NCT00502996|541691439|FG000|Overall Study|Withdrawal Informed Consent|6|||
150151838|NCT00502996|541691439|FG000|Overall Study|Adverse Event|2|||
150151839|NCT01463293|541691446|FG000|Overall Study|Lost to Follow-up|1|||
150151840|NCT01463293|541691447|FG001|Overall Study|Lost to Follow-up|4|||
150151841|NCT01463293|541691448|FG002|Overall Study|Lost to Follow-up|5|||
150151842|NCT01463293|541691446|FG000|Overall Study|Adverse Event|1|||
150151843|NCT01463293|541691447|FG001|Overall Study|Adverse Event|2|||
149811214|NCT03456726|540437268|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
149811215|NCT01614925|540437269|FG000|Overall Study|Withdrawal by Subject|1|||
149811216|NCT01614925|540437270|FG001|Overall Study|Withdrawal by Subject|0|||
149811217|NCT01614925|540437269|FG000|Overall Study|Protocol Violation|3|||
149811218|NCT01614925|540437270|FG001|Overall Study|Protocol Violation|2|||
149811219|NCT04470622|540437271|FG000|Overall Study|Withdrawal by Subject|0|||
150151844|NCT01463293|541691448|FG002|Overall Study|Adverse Event|0|||
150151845|NCT01463293|541691446|FG000|Overall Study|Withdrawal by Subject|4|||
150151846|NCT01463293|541691447|FG001|Overall Study|Withdrawal by Subject|10|||
150151847|NCT01463293|541691448|FG002|Overall Study|Withdrawal by Subject|5|||
150151848|NCT01463293|541691446|FG000|Overall Study|Other|0|||
150151849|NCT01463293|541691447|FG001|Overall Study|Other|0|||
150151850|NCT01463293|541691448|FG002|Overall Study|Other|2|||
149811220|NCT04470622|540437272|FG001|Overall Study|Withdrawal by Subject|1|||
150151851|NCT00988351|541691450|FG000|Overall Study|Withdrawal by Subject|8|||
150151852|NCT00988351|541691451|FG001|Overall Study|Withdrawal by Subject|0|||
150151853|NCT00988351|541691450|FG000|Overall Study|Lost to Follow-up|6|||
149811221|NCT04470622|540437271|FG000|Overall Study|Screen Failure|0|||
150151854|NCT00988351|541691451|FG001|Overall Study|Lost to Follow-up|9|||
150151855|NCT00988351|541691450|FG000|Overall Study|not using CPAP|5|||
150151856|NCT00988351|541691451|FG001|Overall Study|not using CPAP|3|||
150151857|NCT01551303|541691460|FG000|Overall Study|failed awareness check on vision test|4|||
150151858|NCT01551303|541691461|FG001|Overall Study|failed awareness check on vision test|7|||
150151859|NCT04642469|541691462|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
150151860|NCT04642469|541691463|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
150151861|NCT04642469|541691462|FG000|Overall Study|Death|1|||
150151862|NCT04642469|541691463|FG001|Overall Study|Death|2|||
150151863|NCT04642469|541691462|FG000|Overall Study|Study/site closed following amendment 1|11|||
150151864|NCT04642469|541691463|FG001|Overall Study|Study/site closed following amendment 1|11|||
150151865|NCT04642469|541691462|FG000|Overall Study|Other|1|||
150151866|NCT04642469|541691463|FG001|Overall Study|Other|1|||
150151867|NCT04642469|541691462|FG000|Overall Study|Withdrawal by Subject|1|||
150151868|NCT04642469|541691463|FG001|Overall Study|Withdrawal by Subject|0|||
150151869|NCT02303626|541691465|FG000|Overall Study|Lack of Efficacy|1|||
150151870|NCT02303626|541691466|FG001|Overall Study|Lack of Efficacy|0|||
150151871|NCT02303626|541691467|FG002|Overall Study|Lack of Efficacy|1|||
150151872|NCT02303626|541691465|FG000|Overall Study|Adverse Event|0|||
150151873|NCT02303626|541691466|FG001|Overall Study|Adverse Event|2|||
150151874|NCT02303626|541691467|FG002|Overall Study|Adverse Event|0|||
150151875|NCT02303626|541691465|FG000|Overall Study|Protocol Violation|0|||
150151876|NCT02303626|541691466|FG001|Overall Study|Protocol Violation|1|||
150151877|NCT02303626|541691467|FG002|Overall Study|Protocol Violation|0|||
150151878|NCT02303626|541691465|FG000|Overall Study|Pregnancy|0|||
150151879|NCT02303626|541691466|FG001|Overall Study|Pregnancy|0|||
150151880|NCT02303626|541691467|FG002|Overall Study|Pregnancy|1|||
150151881|NCT02303626|541691465|FG000|Overall Study|Subject Non-Compliance|0|||
150151882|NCT02303626|541691466|FG001|Overall Study|Subject Non-Compliance|0|||
150151883|NCT02303626|541691467|FG002|Overall Study|Subject Non-Compliance|1|||
150151884|NCT01265823|541691468|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
150151885|NCT01265823|541691468|FG000|Overall Study|Failure to Return|4|||
150151886|NCT01265823|541691468|FG000|Overall Study|Protocol Violation|1|||
150151887|NCT01265823|541691468|FG000|Overall Study|Participant Request|1|||
150151888|NCT02302066|541691471|FG000|Overall Study|Adverse Event|1|||
150151889|NCT02302066|541691472|FG001|Overall Study|Adverse Event|1|||
150151890|NCT02302066|541691473|FG002|Overall Study|Adverse Event|3|||
150151891|NCT02302066|541691474|FG003|Overall Study|Adverse Event|0|||
150151892|NCT02302066|541691471|FG000|Overall Study|Lost to Follow-up|4|||
150151893|NCT02302066|541691472|FG001|Overall Study|Lost to Follow-up|5|||
150151894|NCT02302066|541691473|FG002|Overall Study|Lost to Follow-up|24|||
150151895|NCT02302066|541691474|FG003|Overall Study|Lost to Follow-up|7|||
150151896|NCT02302066|541691471|FG000|Overall Study|Withdrawal by Subject|25|||
150151897|NCT02302066|541691472|FG001|Overall Study|Withdrawal by Subject|58|||
150151898|NCT02302066|541691473|FG002|Overall Study|Withdrawal by Subject|124|||
150151899|NCT02302066|541691474|FG003|Overall Study|Withdrawal by Subject|33|||
150151900|NCT02302066|541691471|FG000|Overall Study|Pregnancy|2|||
150151901|NCT02302066|541691472|FG001|Overall Study|Pregnancy|10|||
150151902|NCT02302066|541691473|FG002|Overall Study|Pregnancy|12|||
150151903|NCT02302066|541691474|FG003|Overall Study|Pregnancy|0|||
150151904|NCT02302066|541691471|FG000|Overall Study|Reason Not Specified|1|||
150151905|NCT02302066|541691472|FG001|Overall Study|Reason Not Specified|1|||
150151906|NCT02302066|541691473|FG002|Overall Study|Reason Not Specified|9|||
150151907|NCT02302066|541691474|FG003|Overall Study|Reason Not Specified|1|||
150151908|NCT02180438|541691488|FG000|Overall Study|Lost to Follow-up|1|||
150151909|NCT02058290|541691489|FG000|Overall Study|Protocol Violation|2|||
150151910|NCT02058290|541691490|FG001|Overall Study|Protocol Violation|1|||
150151911|NCT02058290|541691489|FG000|Overall Study|Physician Decision|1|||
150151912|NCT02058290|541691490|FG001|Overall Study|Physician Decision|0|||
150151913|NCT02058290|541691489|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
150151914|NCT02058290|541691490|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
150151915|NCT02058290|541691489|FG000|Overall Study|Withdrawal by Subject|0|||
150151916|NCT02058290|541691490|FG001|Overall Study|Withdrawal by Subject|1|||
150151917|NCT00785707|541691492|FG000|Overall Study|Lost to Follow-up|7|||
150151918|NCT00105586|541691495|FG000|Overall Study|Adverse Event|4|||
150151919|NCT00105586|541691496|FG001|Overall Study|Adverse Event|3|||
150151920|NCT00105586|541691495|FG000|Overall Study|Physician Decision|13|||
150151921|NCT00105586|541691496|FG001|Overall Study|Physician Decision|13|||
150151922|NCT02262260|541691497|FG000|Overall Study|Adverse Event|4|||
150151923|NCT02262260|541691498|FG001|Overall Study|Adverse Event|1|||
150151924|NCT02262260|541691497|FG000|Overall Study|Withdrawal of consent|4|||
150151925|NCT02262260|541691498|FG001|Overall Study|Withdrawal of consent|2|||
150151926|NCT02262260|541691497|FG000|Overall Study|Lost to Follow-up|1|||
150151927|NCT02262260|541691498|FG001|Overall Study|Lost to Follow-up|2|||
150151928|NCT02262260|541691497|FG000|Overall Study|Protocol deviation|2|||
150151929|NCT02262260|541691498|FG001|Overall Study|Protocol deviation|5|||
150151930|NCT01794117|541691499|FG000|Overall Study|Adverse Event|1|||
150151931|NCT01794117|541691500|FG001|Overall Study|Adverse Event|0|||
150151932|NCT01794117|541691501|FG002|Overall Study|Adverse Event|0|||
150151933|NCT01794117|541691502|FG003|Overall Study|Adverse Event|0|||
150151934|NCT01794117|541691499|FG000|Overall Study|Participant noncompliance|0|||
150151935|NCT01794117|541691500|FG001|Overall Study|Participant noncompliance|1|||
150151936|NCT01794117|541691501|FG002|Overall Study|Participant noncompliance|0|||
150151937|NCT01794117|541691502|FG003|Overall Study|Participant noncompliance|0|||
150151938|NCT01794117|541691499|FG000|Overall Study|Refused further treatment|0|||
150151939|NCT01794117|541691500|FG001|Overall Study|Refused further treatment|2|||
150151940|NCT01794117|541691501|FG002|Overall Study|Refused further treatment|0|||
150151941|NCT01794117|541691502|FG003|Overall Study|Refused further treatment|0|||
150151942|NCT02696902|541691505|FG000|Overall Study|Lost to Follow-up|0|||
150151943|NCT02696902|541691506|FG001|Overall Study|Lost to Follow-up|1|||
150151944|NCT02696902|541691507|FG002|Overall Study|Lost to Follow-up|1|||
150151945|NCT02696902|541691505|FG000|Overall Study|Withdrawal by Subject|0|||
150151946|NCT02696902|541691506|FG001|Overall Study|Withdrawal by Subject|0|||
150151947|NCT02696902|541691507|FG002|Overall Study|Withdrawal by Subject|1|||
150151948|NCT02696902|541691505|FG000|Overall Study|Death|19|||
150151949|NCT02696902|541691506|FG001|Overall Study|Death|3|||
150151950|NCT02696902|541691507|FG002|Overall Study|Death|24|||
150151951|NCT02696902|541691505|FG000|Overall Study|Participant not fit post-randomization|0|||
150151952|NCT02696902|541691506|FG001|Overall Study|Participant not fit post-randomization|0|||
150151953|NCT02696902|541691507|FG002|Overall Study|Participant not fit post-randomization|1|||
150151954|NCT02696902|541691505|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
150151955|NCT02696902|541691506|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
150151956|NCT02696902|541691507|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
150151957|NCT02696902|541691505|FG000|Overall Study|Principal investigator's decision|1|||
150151958|NCT02696902|541691506|FG001|Overall Study|Principal investigator's decision|0|||
150151959|NCT02696902|541691507|FG002|Overall Study|Principal investigator's decision|0|||
150151960|NCT02696902|541691505|FG000|Overall Study|Sponsor's decision|1|||
150151961|NCT02696902|541691506|FG001|Overall Study|Sponsor's decision|0|||
150151962|NCT02696902|541691507|FG002|Overall Study|Sponsor's decision|0|||
150151963|NCT02696902|541691505|FG000|Overall Study|Transferred to other hospital|1|||
150151964|NCT02696902|541691506|FG001|Overall Study|Transferred to other hospital|0|||
150151965|NCT02696902|541691507|FG002|Overall Study|Transferred to other hospital|0|||
150151966|NCT02401308|541691513|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
150151967|NCT02401308|541691514|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
150151968|NCT02998021|541691515|FG000|Overall Study|Withdrawal by Subject|3|||
150151969|NCT02998021|541691516|FG001|Overall Study|Withdrawal by Subject|1|||
150151970|NCT02998021|541691515|FG000|Overall Study|unsafe home|0|||
150151971|NCT02998021|541691516|FG001|Overall Study|unsafe home|1|||
150151972|NCT06385483|541691517|FG000|Overall Study|Withdrawal by Subject|2|||
150151973|NCT06385483|541691517|FG000|Overall Study|Never start protocol therapy|2|||
150151974|NCT06385483|541691517|FG000|Overall Study|Disease progression|15|||
150151975|NCT05569954|541691518|FG000|Overall Study|Lost to Follow-up|3|||
150151976|NCT05569954|541691519|FG001|Overall Study|Lost to Follow-up|4|||
150151977|NCT05569954|541691518|FG000|Overall Study|Protocol Violation|1|||
150151978|NCT05569954|541691519|FG001|Overall Study|Protocol Violation|2|||
150151979|NCT05569954|541691518|FG000|Overall Study|Withdrawal by Subject|4|||
150151980|NCT05569954|541691519|FG001|Overall Study|Withdrawal by Subject|2|||
150151981|NCT00654940|541693345|FG000|Period 1|Adverse Event|0|||
150151982|NCT00654940|541693346|FG001|Period 1|Adverse Event|1|||
150151983|NCT00654940|541693345|FG000|Period 1|Intolerable Pain Level|1|||
150151984|NCT00654940|541693346|FG001|Period 1|Intolerable Pain Level|0|||
150151985|NCT00802737|541693347|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
150151986|NCT00802737|541693348|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
150151987|NCT00802737|541693349|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
150151988|NCT00802737|541693347|FG000|Overall Study|Death|6|||
150151989|NCT00802737|541693348|FG001|Overall Study|Death|5|||
150151990|NCT00802737|541693349|FG002|Overall Study|Death|1|||
150151991|NCT00802737|541693347|FG000|Overall Study|Adverse Event|1|||
150151992|NCT00802737|541693348|FG001|Overall Study|Adverse Event|0|||
150151993|NCT00802737|541693349|FG002|Overall Study|Adverse Event|0|||
150151994|NCT00802737|541693347|FG000|Overall Study|Received Prohibited Therapy|1|||
150151995|NCT00802737|541693348|FG001|Overall Study|Received Prohibited Therapy|0|||
150151996|NCT00802737|541693349|FG002|Overall Study|Received Prohibited Therapy|0|||
150151997|NCT00802737|541693347|FG000|Overall Study|Ongoing CLL-Treatment|0|||
150151998|NCT00802737|541693348|FG001|Overall Study|Ongoing CLL-Treatment|1|||
150151999|NCT00802737|541693349|FG002|Overall Study|Ongoing CLL-Treatment|0|||
150152000|NCT00802737|541693347|FG000|Overall Study|Participant too Unwell|0|||
150152001|NCT00802737|541693348|FG001|Overall Study|Participant too Unwell|2|||
150152002|NCT00802737|541693349|FG002|Overall Study|Participant too Unwell|0|||
150152003|NCT00619476|541693357|FG000|Overall Study|Adverse Event|12|||
150152004|NCT00619476|541693358|FG001|Overall Study|Adverse Event|6|||
150152005|NCT00619476|541693359|FG002|Overall Study|Adverse Event|12|||
150152006|NCT00619476|541693360|FG003|Overall Study|Adverse Event|16|||
150152007|NCT00619476|541693357|FG000|Overall Study|Lack of Efficacy|6|||
150152008|NCT00619476|541693358|FG001|Overall Study|Lack of Efficacy|1|||
150152009|NCT00619476|541693359|FG002|Overall Study|Lack of Efficacy|1|||
150152010|NCT00619476|541693360|FG003|Overall Study|Lack of Efficacy|4|||
150152011|NCT00619476|541693357|FG000|Overall Study|Protocol Violation|5|||
150152012|NCT00619476|541693358|FG001|Overall Study|Protocol Violation|4|||
150152013|NCT00619476|541693359|FG002|Overall Study|Protocol Violation|4|||
150152014|NCT00619476|541693360|FG003|Overall Study|Protocol Violation|9|||
150152015|NCT00619476|541693357|FG000|Overall Study|Lost to Follow-up|1|||
150152016|NCT00619476|541693358|FG001|Overall Study|Lost to Follow-up|2|||
150152017|NCT00619476|541693359|FG002|Overall Study|Lost to Follow-up|0|||
150152018|NCT00619476|541693360|FG003|Overall Study|Lost to Follow-up|1|||
150152019|NCT00619476|541693357|FG000|Overall Study|Investigator Discretion|2|||
150152020|NCT00619476|541693358|FG001|Overall Study|Investigator Discretion|2|||
150152021|NCT00619476|541693359|FG002|Overall Study|Investigator Discretion|2|||
150152022|NCT00619476|541693360|FG003|Overall Study|Investigator Discretion|0|||
150152023|NCT00619476|541693357|FG000|Overall Study|Withdrawal by Subject|5|||
150152024|NCT00619476|541693358|FG001|Overall Study|Withdrawal by Subject|7|||
150152025|NCT00619476|541693359|FG002|Overall Study|Withdrawal by Subject|5|||
150152026|NCT00619476|541693360|FG003|Overall Study|Withdrawal by Subject|4|||
150152027|NCT01625910|541693361|FG000|Overall Study|Lost to Follow-up|3|||
150152028|NCT01625910|541693362|FG001|Overall Study|Lost to Follow-up|4|||
150152029|NCT02391038|541693363|FG000|Overall Study|Progressive disease|3|||
150152030|NCT02391038|541693364|FG001|Overall Study|Progressive disease|3|||
150152031|NCT02391038|541693365|FG002|Overall Study|Progressive disease|6|||
150152032|NCT02959138|541693366|FG000|Overall Study|Enrolled but Never Treated|0|||
150152033|NCT02959138|541693367|FG001|Overall Study|Enrolled but Never Treated|1|||
150152034|NCT02959138|541693368|FG002|Overall Study|Enrolled but Never Treated|0|||
150152035|NCT01327547|541693374|FG000|Overall Study|Adverse Event|4|||
150152036|NCT01327547|541693375|FG001|Overall Study|Adverse Event|1|||
150152037|NCT01327547|541693374|FG000|Overall Study|Death|1|||
150152038|NCT01327547|541693375|FG001|Overall Study|Death|2|||
150152039|NCT01327547|541693374|FG000|Overall Study|Lost to Follow-up|6|||
150152040|NCT01327547|541693375|FG001|Overall Study|Lost to Follow-up|6|||
150152041|NCT01327547|541693374|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
150152042|NCT01327547|541693375|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
150152043|NCT01327547|541693374|FG000|Overall Study|Withdrawal by Subject|3|||
150152044|NCT01327547|541693375|FG001|Overall Study|Withdrawal by Subject|7|||
150152045|NCT01327547|541693374|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
150152046|NCT01327547|541693375|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
150152047|NCT01327547|541693374|FG000|Overall Study|Protocol Violation|1|||
150152048|NCT01327547|541693375|FG001|Overall Study|Protocol Violation|0|||
150152049|NCT01327547|541693374|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
150152050|NCT01327547|541693375|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
150152051|NCT01327547|541693374|FG000|Overall Study|Required prohibited medication|2|||
150152052|NCT01327547|541693375|FG001|Overall Study|Required prohibited medication|0|||
150152053|NCT01327547|541693374|FG000|Overall Study|Non-compliance with study procedures|1|||
150152054|NCT01327547|541693375|FG001|Overall Study|Non-compliance with study procedures|0|||
150152055|NCT01327547|541693374|FG000|Overall Study|By investigator in subject's interest|0|||
150152056|NCT01327547|541693375|FG001|Overall Study|By investigator in subject's interest|1|||
150152057|NCT01681368|541693378|FG000|Overall Study|Refused further treatment|1|||
150152058|NCT01681368|541693378|FG000|Overall Study|Refused further follow up|1|||
150152059|NCT00900627|541693381|FG000|Overall Study|Condition under investigation worsened|4|||
150152060|NCT00900627|541693382|FG001|Overall Study|Condition under investigation worsened|0|||
150152061|NCT00900627|541693383|FG002|Overall Study|Condition under investigation worsened|5|||
150152062|NCT00900627|541693384|FG003|Overall Study|Condition under investigation worsened|3|||
150152063|NCT00900627|541693385|FG004|Overall Study|Condition under investigation worsened|0|||
150152064|NCT00900627|541693386|FG005|Overall Study|Condition under investigation worsened|0|||
150152065|NCT00900627|541693381|FG000|Overall Study|Withdrawal by Subject|1|||
150152066|NCT00900627|541693382|FG001|Overall Study|Withdrawal by Subject|0|||
150152067|NCT00900627|541693383|FG002|Overall Study|Withdrawal by Subject|1|||
150152068|NCT00900627|541693384|FG003|Overall Study|Withdrawal by Subject|0|||
150152069|NCT00900627|541693385|FG004|Overall Study|Withdrawal by Subject|1|||
150152070|NCT00900627|541693386|FG005|Overall Study|Withdrawal by Subject|2|||
150152071|NCT00900627|541693381|FG000|Overall Study|Adverse Event|1|||
150152072|NCT00900627|541693382|FG001|Overall Study|Adverse Event|2|||
150152073|NCT00900627|541693383|FG002|Overall Study|Adverse Event|0|||
150152074|NCT00900627|541693384|FG003|Overall Study|Adverse Event|3|||
149811222|NCT04470622|540437272|FG001|Overall Study|Screen Failure|1|||
150152075|NCT00900627|541693385|FG004|Overall Study|Adverse Event|0|||
150152076|NCT00900627|541693386|FG005|Overall Study|Adverse Event|0|||
150152077|NCT00900627|541693381|FG000|Overall Study|Death|0|||
150152078|NCT00900627|541693382|FG001|Overall Study|Death|0|||
150152079|NCT00900627|541693383|FG002|Overall Study|Death|0|||
150152080|NCT00900627|541693384|FG003|Overall Study|Death|0|||
150152081|NCT00900627|541693385|FG004|Overall Study|Death|28|||
150152082|NCT00900627|541693386|FG005|Overall Study|Death|24|||
150152083|NCT03685708|541693390|FG000|Overall Study|Withdrawal by Subject|0|||
150152084|NCT03685708|541693391|FG001|Overall Study|Withdrawal by Subject|0|||
150152085|NCT03685708|541693392|FG002|Overall Study|Withdrawal by Subject|1|||
150152086|NCT03685708|541693390|FG000|Overall Study|Screen Fail|0|||
150152087|NCT03685708|541693391|FG001|Overall Study|Screen Fail|1|||
150152088|NCT03685708|541693392|FG002|Overall Study|Screen Fail|1|||
150152089|NCT03685708|541693390|FG000|Overall Study|COVID 19 Pandemic|1|||
150152090|NCT03685708|541693391|FG001|Overall Study|COVID 19 Pandemic|1|||
150152091|NCT03685708|541693392|FG002|Overall Study|COVID 19 Pandemic|6|||
150152092|NCT03685708|541693390|FG000|Overall Study|Disease Progression|0|||
150152093|NCT03685708|541693391|FG001|Overall Study|Disease Progression|0|||
150152094|NCT03685708|541693392|FG002|Overall Study|Disease Progression|1|||
150152095|NCT02222896|541693396|FG000|Abdomen|Did not qualify|34|||
150152096|NCT02222896|541693397|FG001|Abdomen|Did not qualify|10|||
150152097|NCT02222896|541693398|FG002|Abdomen|Did not qualify|32|||
150152098|NCT02222896|541693396|FG000|Groin|Did not qualify|43|||
150152099|NCT02222896|541693397|FG001|Groin|Did not qualify|9|||
150152100|NCT02222896|541693398|FG002|Groin|Did not qualify|40|||
150152101|NCT01744496|541693403|FG000|Titration Period|Adverse Event|2|||
150152102|NCT01744496|541693404|FG001|Titration Period|Adverse Event|1|||
150152103|NCT01744496|541693403|FG000|Titration Period|Personal reasons|0|||
150152104|NCT01744496|541693404|FG001|Titration Period|Personal reasons|1|||
150152105|NCT01744496|541693403|FG000|Maintenance Period|Adverse Event|1|||
150152106|NCT01744496|541693404|FG001|Maintenance Period|Adverse Event|3|||
150152107|NCT01744496|541693403|FG000|Maintenance Period|Protocol Violation|1|||
150152108|NCT01744496|541693404|FG001|Maintenance Period|Protocol Violation|0|||
150152109|NCT01744496|541693403|FG000|Maintenance Period|Withdrawal by Subject|1|||
150152110|NCT01744496|541693404|FG001|Maintenance Period|Withdrawal by Subject|1|||
150152111|NCT01744496|541693403|FG000|Maintenance Period|Subject left town|1|||
150152112|NCT01744496|541693404|FG001|Maintenance Period|Subject left town|0|||
150152113|NCT01729728|541693405|FG000|Overall Study|Adverse Event|0|||
150152114|NCT01729728|541693406|FG001|Overall Study|Adverse Event|6|||
150152115|NCT01729728|541693407|FG002|Overall Study|Adverse Event|0|||
150152116|NCT01729728|541693405|FG000|Overall Study|Protocol Violation|1|||
150152117|NCT01729728|541693406|FG001|Overall Study|Protocol Violation|0|||
150152118|NCT01729728|541693407|FG002|Overall Study|Protocol Violation|1|||
150152119|NCT03772314|541693408|FG000|Overall Study|Adverse Event|7|||
150152120|NCT03772314|541693409|FG001|Overall Study|Adverse Event|2|||
150152121|NCT00672958|541693410|FG000|Overall Study|Adverse Event|11|||
150152122|NCT00672958|541693411|FG001|Overall Study|Adverse Event|9|||
150152123|NCT00672958|541693410|FG000|Overall Study|Lack of Efficacy|6|||
150152124|NCT00672958|541693411|FG001|Overall Study|Lack of Efficacy|11|||
150152125|NCT00672958|541693410|FG000|Overall Study|Non-compliance with study drug|2|||
150152126|NCT00672958|541693411|FG001|Overall Study|Non-compliance with study drug|3|||
150152127|NCT00672958|541693410|FG000|Overall Study|Protocol deviations|11|||
150152128|NCT00672958|541693411|FG001|Overall Study|Protocol deviations|5|||
150152129|NCT00672958|541693410|FG000|Overall Study|Voluntary withdrawal|12|||
150152130|NCT00672958|541693411|FG001|Overall Study|Voluntary withdrawal|8|||
150152131|NCT00672958|541693410|FG000|Overall Study|Lost to Follow-up|22|||
150152132|NCT00672958|541693411|FG001|Overall Study|Lost to Follow-up|17|||
150152133|NCT00672958|541693410|FG000|Overall Study|Reason not specified|0|||
150152134|NCT00672958|541693411|FG001|Overall Study|Reason not specified|3|||
150152135|NCT02796963|541693412|FG000|Overall Study|Lost to Follow-up|89|||
150152136|NCT02796963|541693413|FG001|Overall Study|Lost to Follow-up|76|||
150152137|NCT02796963|541693414|FG002|Overall Study|Lost to Follow-up|69|||
150152138|NCT02796963|541693415|FG003|Overall Study|Lost to Follow-up|72|||
150152139|NCT00119262|541693416|FG000|Overall Study|Lack of Efficacy|0|||
150152140|NCT00119262|541693417|FG001|Overall Study|Lack of Efficacy|3|||
150152141|NCT00119262|541693416|FG000|Overall Study|Withdrawal by Subject|12|||
150152142|NCT00119262|541693417|FG001|Overall Study|Withdrawal by Subject|11|||
150152143|NCT00119262|541693416|FG000|Overall Study|Adverse Event|33|||
150152144|NCT00119262|541693417|FG001|Overall Study|Adverse Event|35|||
150152145|NCT00119262|541693416|FG000|Overall Study|other disease|0|||
150152146|NCT00119262|541693417|FG001|Overall Study|other disease|2|||
150152147|NCT00119262|541693416|FG000|Overall Study|ineligble|1|||
150152148|NCT00119262|541693417|FG001|Overall Study|ineligble|2|||
150152149|NCT00119262|541693416|FG000|Overall Study|others|0|||
149811223|NCT04470622|540437271|FG000|Overall Study|Death|0|||
149811224|NCT04470622|540437272|FG001|Overall Study|Death|1|||
149811225|NCT00399490|540437275|FG000|Overall Study|Adverse Event|19|||
150152150|NCT00119262|541693417|FG001|Overall Study|others|5|||
150152151|NCT01009047|541693424|FG000|Overall Study|Adverse Event|5|||
150152152|NCT01009047|541693425|FG001|Overall Study|Adverse Event|0|||
150152153|NCT01009047|541693424|FG000|Overall Study|Lost to Follow-up|0|||
150152154|NCT01009047|541693425|FG001|Overall Study|Lost to Follow-up|2|||
150152155|NCT01009047|541693424|FG000|Overall Study|Lack of Efficacy|4|||
150152156|NCT01009047|541693425|FG001|Overall Study|Lack of Efficacy|11|||
150152157|NCT01009047|541693424|FG000|Overall Study|Withdrawal by consent|16|||
150152158|NCT01009047|541693425|FG001|Overall Study|Withdrawal by consent|11|||
150152159|NCT01009047|541693424|FG000|Overall Study|Other|3|||
150152160|NCT01009047|541693425|FG001|Overall Study|Other|2|||
150152161|NCT01630590|541693430|FG000|Overall Study|Adverse Event|9|||
150152162|NCT01630590|541693430|FG000|Overall Study|Lack of Efficacy|37|||
150152163|NCT01630590|541693430|FG000|Overall Study|Withdrawal by Subject|4|||
150152164|NCT01630590|541693430|FG000|Overall Study|2nd primary tumor|2|||
150152165|NCT01630590|541693430|FG000|Overall Study|Automobile accident|1|||
150152166|NCT01630590|541693430|FG000|Overall Study|Maximum benefit|4|||
150152167|NCT02366936|541693433|FG000|Overall Study|Withdrawal by Subject|2|||
150152168|NCT02366936|541693433|FG000|Overall Study|Lost to Follow-up|4|||
150152169|NCT02366936|541693433|FG000|Overall Study|Physician Decision|2|||
150152170|NCT01751113|541693434|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
150152171|NCT01751113|541693435|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
150152172|NCT01751113|541693436|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
150152173|NCT01751113|541693437|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
150152174|NCT01751113|541693438|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
150152175|NCT01751113|541693439|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
150152176|NCT01751113|541693434|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
150152177|NCT01751113|541693435|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
150152178|NCT01751113|541693436|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
150152179|NCT01751113|541693437|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
150152180|NCT01751113|541693438|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
150152181|NCT01751113|541693439|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
150152182|NCT02878213|541693440|FG000|Overall Study|Withdrawal by Subject|2|||
150152183|NCT02878213|541693440|FG000|Overall Study|Adverse Event|1|||
150152184|NCT02141659|541693446|FG000|Overall Study|Major Protocol Deviation|0|||
150152185|NCT02141659|541693447|FG001|Overall Study|Major Protocol Deviation|1|||
150152186|NCT02141659|541693448|FG002|Overall Study|Major Protocol Deviation|0|||
150152187|NCT02141659|541693449|FG003|Overall Study|Major Protocol Deviation|0|||
150152188|NCT02141659|541693450|FG004|Overall Study|Major Protocol Deviation|0|||
150152189|NCT02141659|541693451|FG005|Overall Study|Major Protocol Deviation|0|||
150152190|NCT02141659|541693446|FG000|Overall Study|Lack of Efficacy|0|||
150152191|NCT02141659|541693447|FG001|Overall Study|Lack of Efficacy|0|||
150152192|NCT02141659|541693448|FG002|Overall Study|Lack of Efficacy|0|||
150152193|NCT02141659|541693449|FG003|Overall Study|Lack of Efficacy|0|||
150152194|NCT02141659|541693450|FG004|Overall Study|Lack of Efficacy|0|||
150152195|NCT02141659|541693451|FG005|Overall Study|Lack of Efficacy|1|||
150152196|NCT02141659|541693446|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
150152197|NCT02141659|541693447|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
150152198|NCT02141659|541693448|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
150152199|NCT02141659|541693449|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
150152200|NCT02141659|541693450|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
150152201|NCT02141659|541693451|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
150152202|NCT02471404|541693454|FG000|Overall Study|Adverse Event|7|||
150152203|NCT02471404|541693455|FG001|Overall Study|Adverse Event|1|||
150152204|NCT02471404|541693456|FG002|Overall Study|Adverse Event|2|||
150152205|NCT02471404|541693454|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
150152206|NCT02471404|541693455|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
150152207|NCT02471404|541693456|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
150152208|NCT02471404|541693454|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
150152209|NCT02471404|541693455|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
150152210|NCT02471404|541693456|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
150152211|NCT02471404|541693454|FG000|Overall Study|Lost to Follow-up|1|||
150152212|NCT02471404|541693455|FG001|Overall Study|Lost to Follow-up|1|||
150152213|NCT02471404|541693456|FG002|Overall Study|Lost to Follow-up|3|||
150152214|NCT02471404|541693454|FG000|Overall Study|Protocol Violation|1|||
150152215|NCT02471404|541693455|FG001|Overall Study|Protocol Violation|0|||
150152216|NCT02471404|541693456|FG002|Overall Study|Protocol Violation|0|||
150152217|NCT02471404|541693454|FG000|Overall Study|Withdrawal by Subject|8|||
150152218|NCT02471404|541693455|FG001|Overall Study|Withdrawal by Subject|4|||
150152219|NCT02471404|541693456|FG002|Overall Study|Withdrawal by Subject|5|||
150152220|NCT02471404|541693454|FG000|Overall Study|Other reasons not specified|10|||
150152221|NCT02471404|541693455|FG001|Overall Study|Other reasons not specified|7|||
150152222|NCT02471404|541693456|FG002|Overall Study|Other reasons not specified|12|||
150152223|NCT01927731|541693457|FG000|Overall Study|Graft Failure|1|||
150152224|NCT01927731|541693458|FG001|Overall Study|Graft Failure|2|||
150152225|NCT01927731|541693457|FG000|Overall Study|Physician Decision|2|||
150152226|NCT01927731|541693458|FG001|Overall Study|Physician Decision|3|||
150152227|NCT01927731|541693457|FG000|Overall Study|Withdrawal by Subject|0|||
150152228|NCT01927731|541693458|FG001|Overall Study|Withdrawal by Subject|2|||
150152229|NCT01927731|541693457|FG000|Overall Study|Death|0|||
150152230|NCT01927731|541693458|FG001|Overall Study|Death|3|||
150152231|NCT00305864|541693461|FG000|Overall Study|Ineligible / No protocol treatment|0|||
150152232|NCT00305864|541693462|FG001|Overall Study|Ineligible / No protocol treatment|1|||
150152233|NCT00305864|541693463|FG002|Overall Study|Ineligible / No protocol treatment|1|||
150152234|NCT00305864|541693464|FG003|Overall Study|Ineligible / No protocol treatment|13|||
150152235|NCT02836613|541693467|FG000|Overall Study|Accidental drowning|1|||
150152236|NCT02836613|541693468|FG001|Overall Study|Accidental drowning|0|||
150152237|NCT02836613|541693467|FG000|Overall Study|Lost to Follow-up|0|||
150152238|NCT02836613|541693468|FG001|Overall Study|Lost to Follow-up|1|||
150152239|NCT02836613|541693467|FG000|Overall Study|Withdrawal by Subject|0|||
150152240|NCT02836613|541693468|FG001|Overall Study|Withdrawal by Subject|2|||
150152241|NCT01464255|541693469|FG000|Overall Study|unresolve corneal staining|0|||
150152242|NCT01464255|541693470|FG001|Overall Study|unresolve corneal staining|1|||
150152243|NCT03881059|541693471|FG000|Treatment Period - Part A|Adverse Event|1|||
150152244|NCT03881059|541693472|FG001|Treatment Period - Part A|Adverse Event|3|||
150152245|NCT03881059|541693473|FG002|Treatment Period - Part A|Adverse Event|4|||
150152246|NCT03881059|541693471|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
150152247|NCT03881059|541693472|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
150152248|NCT03881059|541693473|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
150152249|NCT03881059|541693471|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
150152250|NCT03881059|541693472|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
150152251|NCT03881059|541693473|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
150152252|NCT03881059|541693471|FG000|Treatment Period - Part A|Other reasons|2|||
150152253|NCT03881059|541693472|FG001|Treatment Period - Part A|Other reasons|1|||
150152254|NCT03881059|541693473|FG002|Treatment Period - Part A|Other reasons|0|||
150152255|NCT03881059|541693471|FG000|Treatment Period - Part B|Adverse Event|0|||
150152256|NCT03881059|541693472|FG001|Treatment Period - Part B|Adverse Event|0|||
150152257|NCT03881059|541693473|FG002|Treatment Period - Part B|Adverse Event|3|||
150152258|NCT03881059|541693471|FG000|Treatment Period - Part B|Death|0|||
150152259|NCT03881059|541693472|FG001|Treatment Period - Part B|Death|1|||
150152260|NCT03881059|541693473|FG002|Treatment Period - Part B|Death|1|||
150152261|NCT03881059|541693471|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
150152262|NCT03881059|541693472|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
150152263|NCT03881059|541693473|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
150152264|NCT03881059|541693471|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
150152265|NCT03881059|541693472|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
150152266|NCT03881059|541693473|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
150152267|NCT03881059|541693471|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
150152268|NCT03881059|541693472|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
150152269|NCT03881059|541693473|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
150152270|NCT03881059|541693471|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
150152271|NCT03881059|541693472|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
150152272|NCT03881059|541693473|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
150152273|NCT03881059|541693471|FG000|Treatment Period - Part B|Other reasons|4|||
150152274|NCT03881059|541693472|FG001|Treatment Period - Part B|Other reasons|3|||
150152275|NCT03881059|541693473|FG002|Treatment Period - Part B|Other reasons|3|||
150152276|NCT02065570|541693474|FG000|Induction Study|Adverse Event|5|||
150152277|NCT02065570|541693475|FG001|Induction Study|Adverse Event|12|||
150152278|NCT02065570|541693476|FG002|Induction Study|Adverse Event|0|||
150152279|NCT02065570|541693477|FG003|Induction Study|Adverse Event|0|||
150152280|NCT02065570|541693474|FG000|Induction Study|Withdrawal by Subject|2|||
150152281|NCT02065570|541693475|FG001|Induction Study|Withdrawal by Subject|3|||
150152282|NCT02065570|541693476|FG002|Induction Study|Withdrawal by Subject|0|||
150152283|NCT02065570|541693477|FG003|Induction Study|Withdrawal by Subject|0|||
150152284|NCT02065570|541693474|FG000|Induction Study|Lost to Follow-up|1|||
150152285|NCT02065570|541693475|FG001|Induction Study|Lost to Follow-up|1|||
150152286|NCT02065570|541693476|FG002|Induction Study|Lost to Follow-up|0|||
150152287|NCT02065570|541693477|FG003|Induction Study|Lost to Follow-up|0|||
150152288|NCT02065570|541693474|FG000|Induction Study|Other, Not Specified|6|||
150152289|NCT02065570|541693475|FG001|Induction Study|Other, Not Specified|5|||
150152290|NCT02065570|541693476|FG002|Induction Study|Other, Not Specified|0|||
150152291|NCT02065570|541693477|FG003|Induction Study|Other, Not Specified|0|||
150152292|NCT02065570|541693474|FG000|Maintenance Study|Adverse Event|0|||
150152293|NCT02065570|541693475|FG001|Maintenance Study|Adverse Event|0|||
150152294|NCT02065570|541693476|FG002|Maintenance Study|Adverse Event|8|||
150152295|NCT02065570|541693477|FG003|Maintenance Study|Adverse Event|8|||
150152296|NCT02065570|541693474|FG000|Maintenance Study|Withdrawal by Subject|0|||
150152297|NCT02065570|541693475|FG001|Maintenance Study|Withdrawal by Subject|0|||
150152298|NCT02065570|541693476|FG002|Maintenance Study|Withdrawal by Subject|1|||
149811226|NCT00399490|540437275|FG000|Overall Study|Lack of Efficacy|31|||
150152299|NCT02065570|541693477|FG003|Maintenance Study|Withdrawal by Subject|4|||
150152300|NCT02065570|541693474|FG000|Maintenance Study|Lost to Follow-up|0|||
150152301|NCT02065570|541693475|FG001|Maintenance Study|Lost to Follow-up|0|||
150152302|NCT02065570|541693476|FG002|Maintenance Study|Lost to Follow-up|2|||
150152303|NCT02065570|541693477|FG003|Maintenance Study|Lost to Follow-up|2|||
149811227|NCT00399490|540437275|FG000|Overall Study|Lost to Follow-up|5|||
150152304|NCT02065570|541693474|FG000|Maintenance Study|Other, Not Specified|0|||
150152305|NCT02065570|541693475|FG001|Maintenance Study|Other, Not Specified|0|||
150152306|NCT02065570|541693476|FG002|Maintenance Study|Other, Not Specified|11|||
150152307|NCT02065570|541693477|FG003|Maintenance Study|Other, Not Specified|5|||
150152308|NCT00785538|541693481|FG000|Treatment Period|Adverse Event|1|||
150152309|NCT00785538|541693482|FG001|Treatment Period|Adverse Event|2|||
150152310|NCT00785538|541693483|FG002|Treatment Period|Adverse Event|2|||
150152311|NCT00785538|541693484|FG003|Treatment Period|Adverse Event|0|||
150152312|NCT00785538|541693481|FG000|Treatment Period|Withdrawal by Subject|0|||
150152313|NCT00785538|541693482|FG001|Treatment Period|Withdrawal by Subject|0|||
150152314|NCT00785538|541693483|FG002|Treatment Period|Withdrawal by Subject|0|||
150152315|NCT00785538|541693484|FG003|Treatment Period|Withdrawal by Subject|1|||
150152316|NCT03382600|541693485|FG000|Overall Study|Adverse Event|3|||
150152317|NCT03382600|541693486|FG001|Overall Study|Adverse Event|3|||
150152318|NCT03382600|541693485|FG000|Overall Study|Clinical Disease Progression|2|||
150152319|NCT03382600|541693486|FG001|Overall Study|Clinical Disease Progression|4|||
150152320|NCT03382600|541693485|FG000|Overall Study|Radiological Progression|40|||
150152321|NCT03382600|541693486|FG001|Overall Study|Radiological Progression|31|||
150152322|NCT03382600|541693485|FG000|Overall Study|Withdrawal by Subject|0|||
150152323|NCT03382600|541693486|FG001|Overall Study|Withdrawal by Subject|1|||
150152324|NCT03382600|541693485|FG000|Overall Study|Other|9|||
150152325|NCT03382600|541693486|FG001|Overall Study|Other|7|||
150152326|NCT02066532|541693492|FG000|Phase II|Withdrawal by Subject|1|||
150152327|NCT02066532|541693493|FG001|Phase II|Withdrawal by Subject|0|||
150152328|NCT02066532|541693494|FG002|Phase II|Withdrawal by Subject|0|||
150152329|NCT02066532|541693495|FG003|Phase II|Withdrawal by Subject|0|||
150152330|NCT05033080|541693496|FG000|Overall Study|Adverse Event|4|||
150152331|NCT05033080|541693497|FG001|Overall Study|Adverse Event|4|||
150152332|NCT05033080|541693496|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
150152333|NCT05033080|541693497|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
150152334|NCT05033080|541693496|FG000|Overall Study|Lost to Follow-up|1|||
150152335|NCT05033080|541693497|FG001|Overall Study|Lost to Follow-up|0|||
150152336|NCT05033080|541693496|FG000|Overall Study|Other non-compliance|0|||
150152337|NCT05033080|541693497|FG001|Overall Study|Other non-compliance|1|||
150152338|NCT05033080|541693496|FG000|Overall Study|Physician Decision|0|||
150152339|NCT05033080|541693497|FG001|Overall Study|Physician Decision|1|||
150152340|NCT05033080|541693496|FG000|Overall Study|Other|1|||
150152341|NCT05033080|541693497|FG001|Overall Study|Other|1|||
150152342|NCT03560245|541693499|FG000|Overall Study|Withdrawal by Subject|3|||
150152343|NCT03560245|541693500|FG001|Overall Study|Withdrawal by Subject|2|||
150152344|NCT03560245|541693499|FG000|Overall Study|Adverse Event|1|||
150152345|NCT03560245|541693500|FG001|Overall Study|Adverse Event|1|||
150152346|NCT03560245|541693499|FG000|Overall Study|Protocol Violation|1|||
150152347|NCT03560245|541693500|FG001|Overall Study|Protocol Violation|0|||
150152348|NCT03560245|541693499|FG000|Overall Study|Death|0|||
150152349|NCT03560245|541693500|FG001|Overall Study|Death|1|||
150152350|NCT03560245|541693499|FG000|Overall Study|Lost to Follow-up|0|||
150152351|NCT03560245|541693500|FG001|Overall Study|Lost to Follow-up|1|||
150152352|NCT03560245|541693499|FG000|Overall Study|Physician Decision|0|||
150152353|NCT03560245|541693500|FG001|Overall Study|Physician Decision|1|||
150152354|NCT03560245|541693499|FG000|Overall Study|Other|0|||
150152355|NCT03560245|541693500|FG001|Overall Study|Other|1|||
150152356|NCT01040780|541695175|FG000|Overall Study|Protocol Violation|1|||
150152357|NCT01040780|541695176|FG001|Overall Study|Protocol Violation|3|||
150152358|NCT03681639|541695177|FG000|Overall Study|Death|4|||
150152359|NCT03681639|541695177|FG000|Overall Study|Lost to Follow-up|2|||
150152360|NCT03681639|541695177|FG000|Overall Study|Withdrawal by Subject|1|||
150152361|NCT03681639|541695177|FG000|Overall Study|Adverse Event|2|||
150152362|NCT00581113|541695178|FG000|Overall Study|Withdrawal by Subject|0|||
150152363|NCT00581113|541695179|FG001|Overall Study|Withdrawal by Subject|1|||
150152364|NCT01818141|541695180|FG000|Overall Study|Withdrawal by Subject|2|||
150152365|NCT01818141|541695181|FG001|Overall Study|Withdrawal by Subject|0|||
150152366|NCT01818141|541695180|FG000|Overall Study|No baseline C.diff colonies|1|||
150152367|NCT01818141|541695181|FG001|Overall Study|No baseline C.diff colonies|1|||
150152368|NCT01818141|541695180|FG000|Overall Study|Lost to Follow-up|0|||
150152369|NCT01818141|541695181|FG001|Overall Study|Lost to Follow-up|2|||
150152370|NCT02169830|541695187|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
150152371|NCT02169830|541695188|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
150152372|NCT02169830|541695189|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
150152373|NCT02169830|541695187|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
150152374|NCT02169830|541695188|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
150152375|NCT02169830|541695189|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
150152376|NCT02169830|541695187|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
150152377|NCT02169830|541695188|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
150152378|NCT02169830|541695189|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
150152379|NCT02169830|541695187|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
150152380|NCT02169830|541695188|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
150152381|NCT02169830|541695189|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
150152382|NCT02169830|541695187|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
150152383|NCT02169830|541695188|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
150152384|NCT02169830|541695189|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
150152385|NCT03204695|541695190|FG000|Overall Study|Death|1|||
150152386|NCT03204695|541695190|FG000|Overall Study|Participant was treated with another device|1|||
150152387|NCT03204695|541695190|FG000|Overall Study|Physician Decision|2|||
150152388|NCT04834362|541695191|FG000|Overall Study|Death|1|||
150152389|NCT04834362|541695192|FG001|Overall Study|Death|2|||
150152390|NCT02555371|541695193|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
150152391|NCT02555371|541695194|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
150152392|NCT02555371|541695195|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
150152393|NCT02555371|541695196|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
150152394|NCT02555371|541695197|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
150152395|NCT02555371|541695193|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
150152396|NCT02555371|541695194|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
150152397|NCT02555371|541695195|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
150152398|NCT02555371|541695196|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
150152399|NCT02555371|541695197|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
150152400|NCT02555371|541695193|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
150152401|NCT02555371|541695194|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
150152402|NCT02555371|541695195|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
150152403|NCT02555371|541695196|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
150152404|NCT02555371|541695197|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
150152405|NCT02555371|541695193|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
150152406|NCT02555371|541695194|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
150152407|NCT02555371|541695195|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
150152408|NCT02555371|541695196|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
150152409|NCT02555371|541695197|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
150152410|NCT02555371|541695193|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
150152411|NCT02555371|541695194|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
150152412|NCT02555371|541695195|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
150152413|NCT02555371|541695196|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
150152414|NCT02555371|541695197|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
150152415|NCT02555371|541695193|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
150152416|NCT02555371|541695194|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
150152417|NCT02555371|541695195|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
150152418|NCT02555371|541695196|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
150152419|NCT02555371|541695197|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
150152420|NCT02555371|541695193|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
150152421|NCT02555371|541695194|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
150152422|NCT02555371|541695195|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
150152423|NCT02555371|541695196|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
150152424|NCT02555371|541695197|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
150152425|NCT02555371|541695193|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
150152426|NCT02555371|541695194|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
150152427|NCT02555371|541695195|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
150152428|NCT02555371|541695196|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
150152429|NCT02555371|541695197|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
150152430|NCT02555371|541695193|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
150152431|NCT02555371|541695194|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
150152432|NCT02555371|541695195|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
150152433|NCT02555371|541695196|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
150152434|NCT02555371|541695197|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
150152435|NCT02555371|541695193|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
150152436|NCT02555371|541695194|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
150152437|NCT02555371|541695195|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
150152438|NCT02555371|541695196|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
150152439|NCT02555371|541695197|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
150152440|NCT02555371|541695193|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
150152441|NCT02555371|541695194|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
150152442|NCT02555371|541695195|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
150152443|NCT02555371|541695196|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
150152444|NCT02555371|541695197|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
150152445|NCT02555371|541695193|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
150152446|NCT02555371|541695194|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
150152447|NCT02555371|541695195|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
150152448|NCT02555371|541695196|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
150152449|NCT02555371|541695197|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
150152450|NCT02555371|541695193|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
150152451|NCT02555371|541695194|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
150152452|NCT02555371|541695195|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
150152453|NCT02555371|541695196|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
150152454|NCT02555371|541695197|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
150152455|NCT02555371|541695193|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
150152456|NCT02555371|541695194|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
150152457|NCT02555371|541695195|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
150152458|NCT02555371|541695196|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
150152459|NCT02555371|541695197|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
150152460|NCT03095599|541695198|FG000|Overall Study|Withdrawal by Subject|1|||
150152461|NCT03095599|541695199|FG001|Overall Study|Withdrawal by Subject|0|||
150152462|NCT03095599|541695198|FG000|Overall Study|Lost to Follow-up|1|||
150152463|NCT03095599|541695199|FG001|Overall Study|Lost to Follow-up|0|||
150152464|NCT03095599|541695198|FG000|Overall Study|Withdrawal prior to vaccination|1|||
150152465|NCT03095599|541695199|FG001|Overall Study|Withdrawal prior to vaccination|0|||
150152466|NCT00742885|541695203|FG000|Overall Study|Lost to Follow-up|1|||
150152467|NCT00742885|541695204|FG001|Overall Study|Lost to Follow-up|0|||
150152468|NCT04781647|541695205|FG000|Overall Study|Study terminated by Sponsor|11|||
150152469|NCT04781647|541695206|FG001|Overall Study|Study terminated by Sponsor|9|||
150152470|NCT04781647|541695207|FG002|Overall Study|Study terminated by Sponsor|9|||
150152471|NCT04781647|541695205|FG000|Overall Study|Withdrawal by Subject|1|||
150152472|NCT04781647|541695206|FG001|Overall Study|Withdrawal by Subject|2|||
150152473|NCT04781647|541695207|FG002|Overall Study|Withdrawal by Subject|0|||
150152474|NCT04781647|541695205|FG000|Overall Study|Adverse Event|0|||
150152475|NCT04781647|541695206|FG001|Overall Study|Adverse Event|1|||
150152476|NCT04781647|541695207|FG002|Overall Study|Adverse Event|1|||
150152477|NCT04781647|541695205|FG000|Overall Study|Protocol Violation|1|||
150152478|NCT04781647|541695206|FG001|Overall Study|Protocol Violation|0|||
149811228|NCT00399490|540437275|FG000|Overall Study|Withdrawal by Subject|18|||
149811229|NCT00399490|540437275|FG000|Overall Study|Other|25|||
149811230|NCT03978117|540437276|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
149811231|NCT03978117|540437277|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
149811232|NCT03978117|540437276|FG000|Overall Study|Lost to Follow-up|4|||
149811233|NCT03978117|540437277|FG001|Overall Study|Lost to Follow-up|4|||
150152479|NCT04781647|541695207|FG002|Overall Study|Protocol Violation|0|||
150152480|NCT04781647|541695205|FG000|Overall Study|Pregnancy|0|||
150152481|NCT04781647|541695206|FG001|Overall Study|Pregnancy|0|||
150152482|NCT04781647|541695207|FG002|Overall Study|Pregnancy|1|||
150152483|NCT04781647|541695205|FG000|Overall Study|Virology rebounded|1|||
150152484|NCT04781647|541695206|FG001|Overall Study|Virology rebounded|0|||
150152485|NCT04781647|541695207|FG002|Overall Study|Virology rebounded|0|||
150152486|NCT01755689|541695208|FG000|Overall Study|Withdrawal by Subject|1|||
150152487|NCT01755689|541695209|FG001|Overall Study|Withdrawal by Subject|3|||
150152488|NCT01755689|541695210|FG002|Overall Study|Withdrawal by Subject|2|||
150152489|NCT01755689|541695211|FG003|Overall Study|Withdrawal by Subject|1|||
150152490|NCT01755689|541695212|FG004|Overall Study|Withdrawal by Subject|1|||
150152491|NCT01755689|541695208|FG000|Overall Study|Migrated/moved from study area|0|||
150152492|NCT01755689|541695209|FG001|Overall Study|Migrated/moved from study area|1|||
150152493|NCT01755689|541695210|FG002|Overall Study|Migrated/moved from study area|1|||
150152494|NCT01755689|541695211|FG003|Overall Study|Migrated/moved from study area|1|||
150152495|NCT01755689|541695212|FG004|Overall Study|Migrated/moved from study area|1|||
150152496|NCT01755689|541695208|FG000|Overall Study|Lost to Follow-up|1|||
150152497|NCT01755689|541695209|FG001|Overall Study|Lost to Follow-up|0|||
150152498|NCT01755689|541695210|FG002|Overall Study|Lost to Follow-up|1|||
150152499|NCT01755689|541695211|FG003|Overall Study|Lost to Follow-up|0|||
150152500|NCT01755689|541695212|FG004|Overall Study|Lost to Follow-up|2|||
150152501|NCT01755689|541695208|FG000|Overall Study|Pregnancy|1|||
149811234|NCT00414011|540437278|FG000|Overall Study|Physician Decision|3|||
149811235|NCT00414011|540437278|FG000|Overall Study|Withdrawal by Subject|2|||
149811236|NCT00817778|540437280|FG000|Overall Study|Adverse Event|1|||
149811237|NCT00817778|540437281|FG001|Overall Study|Adverse Event|0|||
149811238|NCT00817778|540437280|FG000|Overall Study|Withdrawal by Subject|1|||
149811239|NCT00817778|540437281|FG001|Overall Study|Withdrawal by Subject|1|||
150152502|NCT01755689|541695209|FG001|Overall Study|Pregnancy|1|||
150152503|NCT01755689|541695210|FG002|Overall Study|Pregnancy|2|||
150152504|NCT01755689|541695211|FG003|Overall Study|Pregnancy|4|||
150152505|NCT01755689|541695212|FG004|Overall Study|Pregnancy|2|||
150152506|NCT02930122|541695213|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
150152507|NCT02930122|541695214|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
150152508|NCT03943589|541695215|FG000|Overall Study|Death|1|||
149811240|NCT00817778|540437280|FG000|Overall Study|Protocol Violation|0|||
149811241|NCT00817778|540437281|FG001|Overall Study|Protocol Violation|1|||
149811242|NCT00817778|540437280|FG000|Overall Study|Study-specific discontinuation criteria|0|||
150152509|NCT03943589|541695215|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
150152510|NCT04329104|541695216|FG000|Efficacy Study|Withdrawal by Subject|0|||
150152511|NCT04329104|541695217|FG001|Efficacy Study|Withdrawal by Subject|0|||
150152512|NCT04329104|541695218|FG002|Efficacy Study|Withdrawal by Subject|0|||
150152513|NCT04329104|541695219|FG003|Efficacy Study|Withdrawal by Subject|5|||
150152514|NCT04329104|541695220|FG004|Efficacy Study|Withdrawal by Subject|6|||
150152515|NCT04329104|541695221|FG005|Efficacy Study|Withdrawal by Subject|8|||
150152516|NCT00830947|541695222|FG000|Overall Study|Lost to Follow-up|4|||
150152517|NCT00830947|541695223|FG001|Overall Study|Lost to Follow-up|4|||
150152518|NCT01238575|541695228|FG000|Overall Study|Lack of Efficacy|2|||
150152519|NCT01238575|541695229|FG001|Overall Study|Lack of Efficacy|4|||
150152520|NCT01238575|541695228|FG000|Overall Study|Adverse Event|2|||
150152521|NCT01238575|541695229|FG001|Overall Study|Adverse Event|0|||
150152522|NCT02001974|541695232|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
150152523|NCT02001974|541695233|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
150152524|NCT02001974|541695234|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
150152525|NCT02001974|541695232|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
150152526|NCT02001974|541695233|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
150152527|NCT02001974|541695234|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
150152528|NCT02001974|541695232|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
150152529|NCT02001974|541695233|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
150152530|NCT02001974|541695234|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
150152531|NCT02001974|541695232|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
150152532|NCT02001974|541695233|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
150152533|NCT02001974|541695234|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
150152534|NCT00993317|541695235|FG000|Overall Study|Adverse Event|2|||
150152535|NCT00993317|541695236|FG001|Overall Study|Adverse Event|4|||
150152536|NCT00993317|541695235|FG000|Overall Study|Lack of Efficacy|18|||
150152537|NCT00993317|541695236|FG001|Overall Study|Lack of Efficacy|18|||
150152538|NCT00993317|541695235|FG000|Overall Study|Withdrawal by Subject|0|||
150152539|NCT00993317|541695236|FG001|Overall Study|Withdrawal by Subject|2|||
150152540|NCT00993317|541695235|FG000|Overall Study|Investigator's opinion|0|||
150152541|NCT00993317|541695236|FG001|Overall Study|Investigator's opinion|1|||
150152542|NCT00993317|541695235|FG000|Overall Study|Early study termination at the site|1|||
150152543|NCT00993317|541695236|FG001|Overall Study|Early study termination at the site|0|||
150152544|NCT01380990|541695237|FG000|Overall Study|Treatment Failure|1|||
150152545|NCT01380990|541695238|FG001|Overall Study|Treatment Failure|0|||
150152546|NCT01380990|541695237|FG000|Overall Study|Death|0|||
150152547|NCT01380990|541695238|FG001|Overall Study|Death|1|||
150152548|NCT04422639|541695239|FG000|Overall Study|Death|1|||
150152549|NCT04422639|541695240|FG001|Overall Study|Death|0|||
150152550|NCT04422639|541695239|FG000|Overall Study|study closed prior to completion of FU visits|0|||
150152551|NCT04422639|541695240|FG001|Overall Study|study closed prior to completion of FU visits|2|||
150152552|NCT01964521|541695241|FG000|Overall Study|Lost to Follow-up|4|||
150152553|NCT02374593|541695242|FG000|Overall Study|non-compliant|2|||
150152554|NCT02374593|541695243|FG001|Overall Study|non-compliant|0|||
150152555|NCT00579982|541695244|FG000|Overall Study|Adverse Event|4|||
150152556|NCT00579982|541695244|FG000|Overall Study|Protocol Violation|4|||
150152557|NCT02038764|541695247|FG000|Overall Study|Adverse Event|0|||
150152558|NCT02038764|541695248|FG001|Overall Study|Adverse Event|0|||
150152559|NCT02038764|541695249|FG002|Overall Study|Adverse Event|1|||
150152560|NCT02038764|541695250|FG003|Overall Study|Adverse Event|0|||
150152561|NCT02038764|541695251|FG004|Overall Study|Adverse Event|0|||
150152562|NCT02038764|541695247|FG000|Overall Study|Lost to Follow-up|0|||
150152563|NCT02038764|541695248|FG001|Overall Study|Lost to Follow-up|1|||
150152564|NCT02038764|541695249|FG002|Overall Study|Lost to Follow-up|0|||
150152565|NCT02038764|541695250|FG003|Overall Study|Lost to Follow-up|0|||
150152566|NCT02038764|541695251|FG004|Overall Study|Lost to Follow-up|0|||
150152567|NCT02038764|541695247|FG000|Overall Study|Withdrawal by Subject|0|||
150152568|NCT02038764|541695248|FG001|Overall Study|Withdrawal by Subject|0|||
150152569|NCT02038764|541695249|FG002|Overall Study|Withdrawal by Subject|0|||
150152570|NCT02038764|541695250|FG003|Overall Study|Withdrawal by Subject|0|||
150152571|NCT02038764|541695251|FG004|Overall Study|Withdrawal by Subject|1|||
150152572|NCT02038764|541695247|FG000|Overall Study|Other|1|||
150152573|NCT02038764|541695248|FG001|Overall Study|Other|0|||
150152574|NCT02038764|541695249|FG002|Overall Study|Other|1|||
150152575|NCT02038764|541695250|FG003|Overall Study|Other|0|||
150152576|NCT02038764|541695251|FG004|Overall Study|Other|0|||
150152577|NCT03853317|541695252|FG000|Overall Study|Progressive Disease|5|||
150152578|NCT03853317|541695252|FG000|Overall Study|Adverse Event|1|||
150152579|NCT03853317|541695252|FG000|Overall Study|Death|1|||
150152580|NCT03853317|541695252|FG000|Overall Study|other event|2|||
150152581|NCT04844918|541695254|FG000|Overall Study|Adverse Event|7|||
150152582|NCT04844918|541695255|FG001|Overall Study|Adverse Event|8|||
150152583|NCT04844918|541695256|FG002|Overall Study|Adverse Event|5|||
150152584|NCT04844918|541695254|FG000|Overall Study|Physician Decision|0|||
150152585|NCT04844918|541695255|FG001|Overall Study|Physician Decision|1|||
150152586|NCT04844918|541695256|FG002|Overall Study|Physician Decision|0|||
150152587|NCT04844918|541695254|FG000|Overall Study|Withdrawal by Subject|6|||
150152588|NCT04844918|541695255|FG001|Overall Study|Withdrawal by Subject|3|||
150152589|NCT04844918|541695256|FG002|Overall Study|Withdrawal by Subject|3|||
150152590|NCT04844918|541695254|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
150152591|NCT04844918|541695255|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
150152592|NCT04844918|541695256|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
150152593|NCT01558674|541695259|FG000|Part 1|Study Terminated by Sponsor|10|||
150152594|NCT01558674|541695260|FG001|Part 1|Study Terminated by Sponsor|0|||
150152595|NCT01558674|541695259|FG000|Part 1|Withdrawal by Subject|1|||
150152596|NCT01558674|541695260|FG001|Part 1|Withdrawal by Subject|0|||
150152597|NCT02743793|541695263|FG000|Overall Study|Death|1|||
150152598|NCT02743793|541695264|FG001|Overall Study|Death|1|||
150152599|NCT02743793|541695263|FG000|Overall Study|Withdrawal by Subject|0|||
150152600|NCT02743793|541695264|FG001|Overall Study|Withdrawal by Subject|1|||
150152601|NCT02743793|541695263|FG000|Overall Study|Screen Failure|4|||
150152602|NCT02743793|541695264|FG001|Overall Study|Screen Failure|0|||
150152603|NCT02743793|541695263|FG000|Overall Study|No Primary Care Physician|0|||
150152604|NCT02743793|541695264|FG001|Overall Study|No Primary Care Physician|1|||
150152605|NCT02743793|541695263|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
150152606|NCT02743793|541695264|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
150152607|NCT02743793|541695263|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
150152608|NCT02743793|541695264|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
150152609|NCT03285113|541695265|FG000|Overall Study|Unable to implant leads|2|||
150152610|NCT00849680|541695267|FG000|Overall Study|Adverse Event|0|||
150152611|NCT00849680|541695268|FG001|Overall Study|Adverse Event|0|||
150152612|NCT00849680|541695269|FG002|Overall Study|Adverse Event|0|||
150152613|NCT00849680|541695270|FG003|Overall Study|Adverse Event|0|||
150152614|NCT00849680|541695271|FG004|Overall Study|Adverse Event|0|||
150152615|NCT00849680|541695272|FG005|Overall Study|Adverse Event|0|||
150152616|NCT00849680|541695273|FG006|Overall Study|Adverse Event|2|||
150152617|NCT00849680|541695274|FG007|Overall Study|Adverse Event|0|||
150152618|NCT00849680|541695267|FG000|Overall Study|Lost to Follow-up|7|||
150152619|NCT00849680|541695268|FG001|Overall Study|Lost to Follow-up|3|||
150152620|NCT00849680|541695269|FG002|Overall Study|Lost to Follow-up|12|||
150152621|NCT00849680|541695270|FG003|Overall Study|Lost to Follow-up|11|||
150152622|NCT00849680|541695271|FG004|Overall Study|Lost to Follow-up|8|||
150152623|NCT00849680|541695272|FG005|Overall Study|Lost to Follow-up|11|||
150152624|NCT00849680|541695273|FG006|Overall Study|Lost to Follow-up|12|||
150152625|NCT00849680|541695274|FG007|Overall Study|Lost to Follow-up|5|||
150152626|NCT00849680|541695267|FG000|Overall Study|Subject moved|1|||
150152627|NCT00849680|541695268|FG001|Overall Study|Subject moved|0|||
150152628|NCT00849680|541695269|FG002|Overall Study|Subject moved|3|||
150152629|NCT00849680|541695270|FG003|Overall Study|Subject moved|1|||
150152630|NCT00849680|541695271|FG004|Overall Study|Subject moved|0|||
150152631|NCT00849680|541695272|FG005|Overall Study|Subject moved|2|||
150152632|NCT00849680|541695273|FG006|Overall Study|Subject moved|2|||
150152633|NCT00849680|541695274|FG007|Overall Study|Subject moved|2|||
150152634|NCT00849680|541695267|FG000|Overall Study|Withdrawal by Subject|2|||
150152635|NCT00849680|541695268|FG001|Overall Study|Withdrawal by Subject|0|||
150152636|NCT00849680|541695269|FG002|Overall Study|Withdrawal by Subject|0|||
150152637|NCT00849680|541695270|FG003|Overall Study|Withdrawal by Subject|2|||
150152638|NCT00849680|541695271|FG004|Overall Study|Withdrawal by Subject|2|||
150152639|NCT00849680|541695272|FG005|Overall Study|Withdrawal by Subject|2|||
150152640|NCT00849680|541695273|FG006|Overall Study|Withdrawal by Subject|1|||
150152641|NCT00849680|541695274|FG007|Overall Study|Withdrawal by Subject|1|||
150152642|NCT00849680|541695267|FG000|Overall Study|Subject unable to comply with protocol|1|||
150152643|NCT00849680|541695268|FG001|Overall Study|Subject unable to comply with protocol|0|||
150152644|NCT00849680|541695269|FG002|Overall Study|Subject unable to comply with protocol|0|||
150152645|NCT00849680|541695270|FG003|Overall Study|Subject unable to comply with protocol|0|||
150152646|NCT00849680|541695271|FG004|Overall Study|Subject unable to comply with protocol|0|||
150152647|NCT00849680|541695272|FG005|Overall Study|Subject unable to comply with protocol|0|||
150152648|NCT00849680|541695273|FG006|Overall Study|Subject unable to comply with protocol|0|||
150152649|NCT00849680|541695274|FG007|Overall Study|Subject unable to comply with protocol|0|||
150152650|NCT02207374|541695275|FG000|Overall Study|Withdrawal by Subject|5|||
150152651|NCT02207374|541695276|FG001|Overall Study|Withdrawal by Subject|9|||
150152652|NCT02207374|541695277|FG002|Overall Study|Withdrawal by Subject|4|||
150152653|NCT02207374|541695275|FG000|Overall Study|Death|1|||
150152654|NCT02207374|541695276|FG001|Overall Study|Death|0|||
150152655|NCT02207374|541695277|FG002|Overall Study|Death|1|||
150152656|NCT02207374|541695275|FG000|Overall Study|Missing follow-up information|0|||
150152657|NCT02207374|541695276|FG001|Overall Study|Missing follow-up information|1|||
150152658|NCT02207374|541695277|FG002|Overall Study|Missing follow-up information|1|||
150152659|NCT00322374|541695278|FG000|Starting Dose|Physician Decision|2|||
150152660|NCT00322374|541695279|FG001|Starting Dose|Physician Decision|0|||
150152661|NCT00322374|541695280|FG002|Starting Dose|Physician Decision|0|||
150152662|NCT00322374|541695281|FG003|Starting Dose|Physician Decision|0|||
150152663|NCT00322374|541695278|FG000|Starting Dose|Study Drug Toxicity|4|||
150152664|NCT00322374|541695279|FG001|Starting Dose|Study Drug Toxicity|0|||
150152665|NCT00322374|541695280|FG002|Starting Dose|Study Drug Toxicity|0|||
150152666|NCT00322374|541695281|FG003|Starting Dose|Study Drug Toxicity|0|||
150152667|NCT00322374|541695278|FG000|First Escalation|Documented Disease Progression|0|||
150152668|NCT00322374|541695279|FG001|First Escalation|Documented Disease Progression|6|||
150152669|NCT00322374|541695280|FG002|First Escalation|Documented Disease Progression|0|||
150152670|NCT00322374|541695281|FG003|First Escalation|Documented Disease Progression|0|||
150152671|NCT00322374|541695278|FG000|First Escalation|Physician Decision|0|||
150152672|NCT00322374|541695279|FG001|First Escalation|Physician Decision|12|||
150152673|NCT00322374|541695280|FG002|First Escalation|Physician Decision|0|||
150152674|NCT00322374|541695281|FG003|First Escalation|Physician Decision|0|||
150152675|NCT00322374|541695278|FG000|First Escalation|Study Drug Toxicity|0|||
150152676|NCT00322374|541695279|FG001|First Escalation|Study Drug Toxicity|11|||
150152677|NCT00322374|541695280|FG002|First Escalation|Study Drug Toxicity|0|||
150152678|NCT00322374|541695281|FG003|First Escalation|Study Drug Toxicity|0|||
150152679|NCT00322374|541695278|FG000|First Escalation|Participant Request|0|||
150152680|NCT00322374|541695279|FG001|First Escalation|Participant Request|1|||
150152681|NCT00322374|541695280|FG002|First Escalation|Participant Request|0|||
150152682|NCT00322374|541695281|FG003|First Escalation|Participant Request|0|||
150152683|NCT00322374|541695278|FG000|Second Escalation|Physician Decision|0|||
150152684|NCT00322374|541695279|FG001|Second Escalation|Physician Decision|0|||
150152685|NCT00322374|541695280|FG002|Second Escalation|Physician Decision|5|||
150152686|NCT00322374|541695281|FG003|Second Escalation|Physician Decision|0|||
150152687|NCT00322374|541695278|FG000|Second Escalation|Study Drug Toxicity|0|||
150152688|NCT00322374|541695279|FG001|Second Escalation|Study Drug Toxicity|0|||
150152689|NCT00322374|541695280|FG002|Second Escalation|Study Drug Toxicity|1|||
150152690|NCT00322374|541695281|FG003|Second Escalation|Study Drug Toxicity|0|||
150152691|NCT04276090|541695284|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
150152692|NCT04276090|541695285|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
150152693|NCT01680458|541695293|FG000|Overall Study|Protocol Violation|3|||
150152694|NCT02138747|541695294|FG000|Treatment Period 1|Adverse Event|10|||
150152695|NCT02138747|541695295|FG001|Treatment Period 1|Adverse Event|14|||
150152696|NCT02138747|541695296|FG002|Treatment Period 1|Adverse Event|2|||
150152697|NCT02138747|541695297|FG003|Treatment Period 1|Adverse Event|1|||
150152698|NCT02138747|541695294|FG000|Treatment Period 1|Lost to Follow-up|0|||
150152699|NCT02138747|541695295|FG001|Treatment Period 1|Lost to Follow-up|1|||
150152700|NCT02138747|541695296|FG002|Treatment Period 1|Lost to Follow-up|1|||
150152701|NCT02138747|541695297|FG003|Treatment Period 1|Lost to Follow-up|0|||
150152702|NCT02138747|541695294|FG000|Treatment Period 1|Protocol Violation|0|||
150152703|NCT02138747|541695295|FG001|Treatment Period 1|Protocol Violation|2|||
150152704|NCT02138747|541695296|FG002|Treatment Period 1|Protocol Violation|0|||
150152705|NCT02138747|541695297|FG003|Treatment Period 1|Protocol Violation|0|||
150152706|NCT02138747|541695294|FG000|Treatment Period 1|Withdrawal by Subject|8|||
150152707|NCT02138747|541695295|FG001|Treatment Period 1|Withdrawal by Subject|4|||
150152708|NCT02138747|541695296|FG002|Treatment Period 1|Withdrawal by Subject|1|||
150152709|NCT02138747|541695297|FG003|Treatment Period 1|Withdrawal by Subject|3|||
150152710|NCT02138747|541695294|FG000|Treatment Period 1|Other - Miscellaneous|2|||
150152711|NCT02138747|541695295|FG001|Treatment Period 1|Other - Miscellaneous|4|||
150152712|NCT02138747|541695296|FG002|Treatment Period 1|Other - Miscellaneous|0|||
150152713|NCT02138747|541695297|FG003|Treatment Period 1|Other - Miscellaneous|0|||
150152714|NCT02138747|541695294|FG000|Treatment Period 2|Adverse Event|6|||
150152715|NCT02138747|541695295|FG001|Treatment Period 2|Adverse Event|3|||
150152716|NCT02138747|541695296|FG002|Treatment Period 2|Adverse Event|1|||
150152717|NCT02138747|541695297|FG003|Treatment Period 2|Adverse Event|1|||
150152718|NCT02138747|541695294|FG000|Treatment Period 2|Lost to Follow-up|2|||
150152719|NCT02138747|541695295|FG001|Treatment Period 2|Lost to Follow-up|0|||
150152720|NCT02138747|541695296|FG002|Treatment Period 2|Lost to Follow-up|0|||
150152721|NCT02138747|541695297|FG003|Treatment Period 2|Lost to Follow-up|0|||
150152722|NCT02138747|541695294|FG000|Treatment Period 2|Protocol Violation|1|||
150152723|NCT02138747|541695295|FG001|Treatment Period 2|Protocol Violation|0|||
150152724|NCT02138747|541695296|FG002|Treatment Period 2|Protocol Violation|0|||
150152725|NCT02138747|541695297|FG003|Treatment Period 2|Protocol Violation|0|||
150152726|NCT02138747|541695294|FG000|Treatment Period 2|Withdrawal by Subject|5|||
150152727|NCT02138747|541695295|FG001|Treatment Period 2|Withdrawal by Subject|4|||
150152728|NCT02138747|541695296|FG002|Treatment Period 2|Withdrawal by Subject|1|||
150152729|NCT02138747|541695297|FG003|Treatment Period 2|Withdrawal by Subject|2|||
150152730|NCT02138747|541695294|FG000|Treatment Period 2|Other - Miscellaneous|3|||
150152731|NCT02138747|541695295|FG001|Treatment Period 2|Other - Miscellaneous|0|||
150152732|NCT02138747|541695296|FG002|Treatment Period 2|Other - Miscellaneous|0|||
150152733|NCT02138747|541695297|FG003|Treatment Period 2|Other - Miscellaneous|0|||
150152734|NCT03406702|541695303|FG000|Overall Study|Missed Day 27 Dosing|1|||
150152735|NCT04318093|541695309|FG000|Overall Study|Adverse Event|2|||
150152736|NCT04318093|541695310|FG001|Overall Study|Adverse Event|2|||
150152737|NCT04318093|541695309|FG000|Overall Study|Participant withdrew consent|1|||
150152738|NCT04318093|541695310|FG001|Overall Study|Participant withdrew consent|0|||
150152739|NCT04318093|541695309|FG000|Overall Study|Other reasons|0|||
150152740|NCT04318093|541695310|FG001|Overall Study|Other reasons|1|||
150152741|NCT00514046|541695315|FG000|Overall Study|transferred to another protocol|2|||
150152742|NCT00514046|541695316|FG001|Overall Study|transferred to another protocol|1|||
150152743|NCT00514046|541695317|FG002|Overall Study|transferred to another protocol|3|||
150152744|NCT00514046|541695318|FG003|Overall Study|transferred to another protocol|0|||
150152745|NCT00514046|541695319|FG004|Overall Study|transferred to another protocol|1|||
150152746|NCT00514046|541695320|FG005|Overall Study|transferred to another protocol|0|||
150152747|NCT00514046|541695321|FG006|Overall Study|transferred to another protocol|0|||
150152748|NCT00514046|541695322|FG007|Overall Study|transferred to another protocol|0|||
150152749|NCT00514046|541695323|FG008|Overall Study|transferred to another protocol|0|||
150152750|NCT00514046|541695315|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
150152751|NCT00514046|541695316|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
150152752|NCT00514046|541695317|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
150152753|NCT00514046|541695318|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
150152754|NCT00514046|541695319|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
150152755|NCT00514046|541695320|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
150152756|NCT00514046|541695321|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
150152757|NCT00514046|541695322|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
150152758|NCT00514046|541695323|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
150152759|NCT00514046|541695315|FG000|Overall Study|Disease progression on study|0|||
150152760|NCT00514046|541695316|FG001|Overall Study|Disease progression on study|0|||
150152761|NCT00514046|541695317|FG002|Overall Study|Disease progression on study|2|||
150152762|NCT00514046|541695318|FG003|Overall Study|Disease progression on study|0|||
150152763|NCT00514046|541695319|FG004|Overall Study|Disease progression on study|0|||
150152764|NCT00514046|541695320|FG005|Overall Study|Disease progression on study|1|||
150152765|NCT00514046|541695321|FG006|Overall Study|Disease progression on study|0|||
150152766|NCT00514046|541695322|FG007|Overall Study|Disease progression on study|0|||
150152767|NCT00514046|541695323|FG008|Overall Study|Disease progression on study|0|||
150152768|NCT00655551|541695324|FG000|All Periods Combined|Adverse Event|0|||
150152769|NCT00655551|541695325|FG001|All Periods Combined|Adverse Event|3|||
150152770|NCT00655551|541695326|FG002|All Periods Combined|Adverse Event|4|||
150152771|NCT00655551|541695324|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
150152772|NCT00655551|541695325|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
150152773|NCT00655551|541695326|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
150152774|NCT00655551|541695324|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
150152775|NCT00655551|541695325|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
150152776|NCT00655551|541695326|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
150152777|NCT00655551|541695324|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
150152778|NCT00655551|541695325|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
150152779|NCT00655551|541695326|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
150152780|NCT01734434|541695327|FG000|Overall Study|Death Infant|3|||
150152781|NCT01734434|541695328|FG001|Overall Study|Death Infant|1|||
150152782|NCT01734434|541695329|FG002|Overall Study|Death Infant|17|||
150152783|NCT01734434|541695330|FG003|Overall Study|Death Infant|5|||
150152784|NCT01734434|541695327|FG000|Overall Study|Lost to Follow-up|2|||
150152785|NCT01734434|541695328|FG001|Overall Study|Lost to Follow-up|9|||
150152786|NCT01734434|541695329|FG002|Overall Study|Lost to Follow-up|67|||
150152787|NCT01734434|541695330|FG003|Overall Study|Lost to Follow-up|11|||
150152788|NCT01734434|541695327|FG000|Overall Study|No Live Birth|1|||
150152789|NCT01734434|541695328|FG001|Overall Study|No Live Birth|2|||
150152790|NCT01734434|541695329|FG002|Overall Study|No Live Birth|32|||
150152791|NCT01734434|541695330|FG003|Overall Study|No Live Birth|6|||
150152792|NCT01734434|541695327|FG000|Overall Study|Withdrawal by Subject|4|||
150152793|NCT01734434|541695328|FG001|Overall Study|Withdrawal by Subject|0|||
150152794|NCT01734434|541695329|FG002|Overall Study|Withdrawal by Subject|8|||
150152795|NCT01734434|541695330|FG003|Overall Study|Withdrawal by Subject|1|||
150152796|NCT01734434|541695327|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
150152797|NCT01734434|541695328|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
150152798|NCT01734434|541695329|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
150152799|NCT01734434|541695330|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
150152800|NCT01734434|541695327|FG000|Overall Study|Subject Not Reachable|0|||
150152801|NCT01734434|541695328|FG001|Overall Study|Subject Not Reachable|0|||
150152802|NCT01734434|541695329|FG002|Overall Study|Subject Not Reachable|1|||
150152803|NCT01734434|541695330|FG003|Overall Study|Subject Not Reachable|0|||
150152804|NCT01734434|541695327|FG000|Overall Study|Treatment Defaulter|0|||
150152805|NCT01734434|541695328|FG001|Overall Study|Treatment Defaulter|0|||
150152806|NCT01734434|541695329|FG002|Overall Study|Treatment Defaulter|1|||
150152807|NCT01734434|541695330|FG003|Overall Study|Treatment Defaulter|0|||
150152808|NCT01734434|541695327|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
150152809|NCT01734434|541695328|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
150152810|NCT01734434|541695329|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
150152811|NCT01734434|541695330|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
150152812|NCT01734434|541695327|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
150152813|NCT01734434|541695328|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
150152814|NCT01734434|541695329|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
150152815|NCT01734434|541695330|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
150152816|NCT02049710|541695335|FG000|Overall Study|Lost to Follow-up|319|||
150152817|NCT02049710|541695336|FG001|Overall Study|Lost to Follow-up|324|||
150152818|NCT03391960|541695337|FG000|Overall Study|Protocol Violation|0|||
150152819|NCT03391960|541695338|FG001|Overall Study|Protocol Violation|0|||
150152820|NCT02609659|541696912|FG000|Overall Study|Adverse Event|1|||
150152821|NCT02609659|541696912|FG000|Overall Study|Lost to Follow-up|6|||
150152822|NCT02609659|541696912|FG000|Overall Study|Other|1|||
150152823|NCT01155388|541696915|FG000|Overall Study|Adverse Event|1|||
150152824|NCT01155388|541696916|FG001|Overall Study|Adverse Event|0|||
150152825|NCT01004250|541696917|FG000|Induction Therapy Period|Adverse Event|10|||
150152826|NCT01004250|541696917|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
150152827|NCT01004250|541696917|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
150152828|NCT01004250|541696917|FG000|Induction Therapy Period|Physician Decision|2|||
150152829|NCT01004250|541696917|FG000|Maintenance Therapy Period|Adverse Event|15|||
150152830|NCT01004250|541696917|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
150152831|NCT01004250|541696917|FG000|Maintenance Therapy Period|Protocol Violation|1|||
150152832|NCT01004250|541696917|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
150152833|NCT01004250|541696917|FG000|Maintenance Therapy Period|Physician Decision|4|||
150152834|NCT01004250|541696917|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
150152835|NCT03884231|541696918|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
150152836|NCT03884231|541696918|FG000|Overall Study|Subject Withdrew Consent|1|||
150152837|NCT03884231|541696918|FG000|Overall Study|MRI Scan Not Performed|1|||
150152838|NCT01853254|541696919|FG000|Overall Study|Abnormal Laboratory Test|1|||
150152839|NCT01853254|541696919|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
150152840|NCT01853254|541696919|FG000|Overall Study|Death|1|||
150152841|NCT01853254|541696919|FG000|Overall Study|Failure to Return|43|||
150152842|NCT01853254|541696919|FG000|Overall Study|Insufficient Therapeutic Response|22|||
150152843|NCT01853254|541696919|FG000|Overall Study|Refusal of Treatment|1|||
150152844|NCT01853254|541696919|FG000|Overall Study|Other Protocol Violation|1|||
150152845|NCT01853254|541696919|FG000|Overall Study|Withdrawal of Consent|16|||
150152846|NCT01853254|541696919|FG000|Overall Study|Administrative/Other|16|||
150152847|NCT02462083|541696920|FG000|Overall Study|Sponsor request|39|||
150152848|NCT02462083|541696920|FG000|Overall Study|Withdrawal by Subject|87|||
150152849|NCT02462083|541696920|FG000|Overall Study|Lost to Follow-up|41|||
150152850|NCT02462083|541696920|FG000|Overall Study|Lack of Efficacy|151|||
150152851|NCT02462083|541696920|FG000|Overall Study|Pregnancy|1|||
150152852|NCT02462083|541696920|FG000|Overall Study|Protocol Violation|6|||
150152853|NCT02462083|541696920|FG000|Overall Study|Adverse Event|33|||
150152854|NCT02462083|541696920|FG000|Overall Study|Worsening condition|16|||
150152855|NCT02462083|541696920|FG000|Overall Study|Other than specified|45|||
150152856|NCT01642186|541696921|FG000|Overall Study|Death|0|||
150152857|NCT01642186|541696922|FG001|Overall Study|Death|2|||
150152858|NCT01642186|541696923|FG002|Overall Study|Death|2|||
150152859|NCT01642186|541696921|FG000|Overall Study|Lost to Follow-up|0|||
150152860|NCT01642186|541696922|FG001|Overall Study|Lost to Follow-up|0|||
150152861|NCT01642186|541696923|FG002|Overall Study|Lost to Follow-up|1|||
150152862|NCT00962585|541696926|FG000|Overall Study|Adverse Event|0|||
150152863|NCT00962585|541696927|FG001|Overall Study|Adverse Event|2|||
150152864|NCT00962585|541696928|FG002|Overall Study|Adverse Event|1|||
150152865|NCT00962585|541696929|FG003|Overall Study|Adverse Event|0|||
150152866|NCT00962585|541696926|FG000|Overall Study|Lost to Follow-up|3|||
150152867|NCT00962585|541696927|FG001|Overall Study|Lost to Follow-up|0|||
150152868|NCT00962585|541696928|FG002|Overall Study|Lost to Follow-up|1|||
150152869|NCT00962585|541696929|FG003|Overall Study|Lost to Follow-up|0|||
150152870|NCT00962585|541696926|FG000|Overall Study|Protocol Violation|0|||
150152871|NCT00962585|541696927|FG001|Overall Study|Protocol Violation|0|||
150152872|NCT00962585|541696928|FG002|Overall Study|Protocol Violation|1|||
150152873|NCT00962585|541696929|FG003|Overall Study|Protocol Violation|0|||
150152874|NCT00962585|541696926|FG000|Overall Study|Withdrawal by Subject|1|||
150152875|NCT00962585|541696927|FG001|Overall Study|Withdrawal by Subject|0|||
150152876|NCT00962585|541696928|FG002|Overall Study|Withdrawal by Subject|0|||
150152877|NCT00962585|541696929|FG003|Overall Study|Withdrawal by Subject|0|||
150152878|NCT00962585|541696926|FG000|Overall Study|Withdrew Consent|2|||
150152879|NCT00962585|541696927|FG001|Overall Study|Withdrew Consent|0|||
150152880|NCT00962585|541696928|FG002|Overall Study|Withdrew Consent|0|||
150152881|NCT00962585|541696929|FG003|Overall Study|Withdrew Consent|0|||
150152882|NCT02254421|541696930|FG000|Overall Study|Randomized but Not Treated|1|||
150152883|NCT02254421|541696931|FG001|Overall Study|Randomized but Not Treated|0|||
150152884|NCT02254421|541696930|FG000|Overall Study|Death|0|||
150152885|NCT02254421|541696931|FG001|Overall Study|Death|2|||
150152886|NCT02254421|541696930|FG000|Overall Study|Withdrew Consent|1|||
150152887|NCT02254421|541696931|FG001|Overall Study|Withdrew Consent|1|||
149811243|NCT00817778|540437281|FG001|Overall Study|Study-specific discontinuation criteria|1|||
149811244|NCT00817778|540437280|FG000|Overall Study|Poor venous access|1|||
149811245|NCT00817778|540437281|FG001|Overall Study|Poor venous access|0|||
149811246|NCT03343054|540437282|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
149811247|NCT03343054|540437283|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
149811248|NCT03343054|540437284|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
149811249|NCT03343054|540437282|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
149811250|NCT03343054|540437283|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
149811251|NCT03343054|540437284|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
149811252|NCT03343054|540437282|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
150152888|NCT00867490|541696932|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
149811253|NCT03343054|540437283|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
149811254|NCT03343054|540437284|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
149811255|NCT03343054|540437282|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
149811256|NCT03343054|540437283|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
149811257|NCT03343054|540437284|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
149811258|NCT01286207|540437287|FG000|Overall Study|Adverse Event|27|||
149811259|NCT01286207|540437288|FG001|Overall Study|Adverse Event|41|||
149811260|NCT01286207|540437289|FG002|Overall Study|Adverse Event|8|||
149811261|NCT01286207|540437287|FG000|Overall Study|Lost to Follow-up|49|||
149811262|NCT01286207|540437288|FG001|Overall Study|Lost to Follow-up|43|||
149811263|NCT01286207|540437289|FG002|Overall Study|Lost to Follow-up|20|||
149811264|NCT01286207|540437287|FG000|Overall Study|Withdrawal by Subject|93|||
149811265|NCT01286207|540437288|FG001|Overall Study|Withdrawal by Subject|79|||
149811266|NCT01286207|540437289|FG002|Overall Study|Withdrawal by Subject|41|||
149811267|NCT01286207|540437287|FG000|Overall Study|Lack of Response|92|||
149811268|NCT01286207|540437288|FG001|Overall Study|Lack of Response|38|||
149811269|NCT01286207|540437289|FG002|Overall Study|Lack of Response|8|||
149811270|NCT01286207|540437287|FG000|Overall Study|Other|37|||
149811271|NCT01286207|540437288|FG001|Overall Study|Other|47|||
149811272|NCT01286207|540437289|FG002|Overall Study|Other|13|||
149811273|NCT00981409|540437290|FG000|Overall Study|Adverse Event|4|||
149811274|NCT00981409|540437291|FG001|Overall Study|Adverse Event|0|||
149811275|NCT00981409|540437290|FG000|Overall Study|Protocol Violation|0|||
149811276|NCT00981409|540437291|FG001|Overall Study|Protocol Violation|1|||
149811277|NCT00981409|540437290|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
149811278|NCT00981409|540437291|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
149811279|NCT00450177|540437292|FG000|Overall Study|Adverse Event|7|||
149811280|NCT00450177|540437293|FG001|Overall Study|Adverse Event|4|||
149811281|NCT00450177|540437292|FG000|Overall Study|Withdrawal by Subject|1|||
149811282|NCT00450177|540437293|FG001|Overall Study|Withdrawal by Subject|6|||
149811283|NCT00450177|540437292|FG000|Overall Study|Withdrawal by Primary Team|1|||
149811284|NCT00450177|540437293|FG001|Overall Study|Withdrawal by Primary Team|1|||
149811285|NCT02923115|540437294|FG000|Overall Study|Lost to Follow-up|0|||
149811286|NCT02923115|540437295|FG001|Overall Study|Lost to Follow-up|0|||
149811287|NCT02923115|540437296|FG002|Overall Study|Lost to Follow-up|0|||
149811288|NCT02923115|540437297|FG003|Overall Study|Lost to Follow-up|1|||
149811289|NCT02923115|540437298|FG004|Overall Study|Lost to Follow-up|0|||
149811290|NCT02923115|540437299|FG005|Overall Study|Lost to Follow-up|0|||
149811291|NCT02923115|540437294|FG000|Overall Study|Withdrawal by Subject|0|||
149811292|NCT02923115|540437295|FG001|Overall Study|Withdrawal by Subject|1|||
149811293|NCT02923115|540437296|FG002|Overall Study|Withdrawal by Subject|0|||
149811294|NCT02923115|540437297|FG003|Overall Study|Withdrawal by Subject|0|||
149811295|NCT02923115|540437298|FG004|Overall Study|Withdrawal by Subject|0|||
149811296|NCT02923115|540437299|FG005|Overall Study|Withdrawal by Subject|0|||
150152889|NCT00867490|541696932|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
150152890|NCT00867490|541696932|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
150152891|NCT00867490|541696932|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
150152892|NCT00867490|541696932|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
150152893|NCT00358150|541696933|FG000|Overall Study|Adverse Event|3|||
150152894|NCT00358150|541696933|FG000|Overall Study|Withdrawal by Subject|1|||
150152895|NCT00358150|541696933|FG000|Overall Study|Undefined|3|||
150152896|NCT00179010|541696934|FG000|Overall Study|Muscle probe defective|1|||
150152897|NCT00179010|541696935|FG001|Overall Study|Muscle probe defective|1|||
150152898|NCT00179010|541696934|FG000|Overall Study|Failure to place arterial line|0|||
149811297|NCT02923115|540437294|FG000|Overall Study|Randomized, but not dosed|0|||
149811298|NCT02923115|540437295|FG001|Overall Study|Randomized, but not dosed|0|||
149811299|NCT02923115|540437296|FG002|Overall Study|Randomized, but not dosed|3|||
149811300|NCT02923115|540437297|FG003|Overall Study|Randomized, but not dosed|1|||
149811301|NCT02923115|540437298|FG004|Overall Study|Randomized, but not dosed|5|||
149811302|NCT02923115|540437299|FG005|Overall Study|Randomized, but not dosed|0|||
149811303|NCT03869684|540437302|FG000|Overall Study|Adverse Event|0|||
149811304|NCT03869684|540437303|FG001|Overall Study|Adverse Event|3|||
150152899|NCT00179010|541696935|FG001|Overall Study|Failure to place arterial line|1|||
150152900|NCT04747275|541696953|FG000|Overall Study|Study terminated|0|||
150152901|NCT04747275|541696954|FG001|Overall Study|Study terminated|1|||
150152902|NCT00531011|541696957|FG000|Overall Study|Withdrawal by Subject|2|||
150152903|NCT00531011|541696958|FG001|Overall Study|Withdrawal by Subject|4|||
150152904|NCT00531011|541696957|FG000|Overall Study|Death|1|||
150152905|NCT00531011|541696958|FG001|Overall Study|Death|0|||
150152906|NCT00531011|541696957|FG000|Overall Study|Lost to Follow-up|1|||
150152907|NCT00531011|541696958|FG001|Overall Study|Lost to Follow-up|0|||
150152908|NCT00531011|541696957|FG000|Overall Study|Physician Decision|0|||
150152909|NCT00531011|541696958|FG001|Overall Study|Physician Decision|3|||
150152910|NCT03268590|541696959|FG000|Overall Study|Previously unknown exclusion criteria|1|||
150152911|NCT02823964|541696982|FG000|Overall Study|Adverse Event|2|||
150152912|NCT02823964|541696982|FG000|Overall Study|Physician Decision|1|||
150152913|NCT02823964|541696982|FG000|Overall Study|Lack of Efficacy|1|||
150152914|NCT02823964|541696982|FG000|Overall Study|Withdrawal by Subject|1|||
150152915|NCT03537261|541697003|FG000|Overall Study|Lost to Follow-up|4|||
150152916|NCT03537261|541697004|FG001|Overall Study|Lost to Follow-up|5|||
150152917|NCT03537261|541697003|FG000|Overall Study|Withdrawal by Subject|4|||
150152918|NCT03537261|541697004|FG001|Overall Study|Withdrawal by Subject|6|||
150152919|NCT03537261|541697003|FG000|Overall Study|Did not return study questionnaires|0|||
150152920|NCT03537261|541697004|FG001|Overall Study|Did not return study questionnaires|1|||
150152921|NCT01177813|541697005|FG000|Overall Study|Adverse Event|8|||
150152922|NCT01177813|541697006|FG001|Overall Study|Adverse Event|2|||
150152923|NCT01177813|541697007|FG002|Overall Study|Adverse Event|4|||
150152924|NCT01177813|541697008|FG003|Overall Study|Adverse Event|6|||
150152925|NCT01177813|541697009|FG004|Overall Study|Adverse Event|3|||
150152926|NCT01177813|541697005|FG000|Overall Study|Lack of Efficacy|1|||
150152927|NCT01177813|541697006|FG001|Overall Study|Lack of Efficacy|0|||
150152928|NCT01177813|541697007|FG002|Overall Study|Lack of Efficacy|0|||
150152929|NCT01177813|541697008|FG003|Overall Study|Lack of Efficacy|0|||
150152930|NCT01177813|541697009|FG004|Overall Study|Lack of Efficacy|0|||
150152931|NCT01177813|541697005|FG000|Overall Study|Protocol Violation|3|||
150152932|NCT01177813|541697006|FG001|Overall Study|Protocol Violation|2|||
150152933|NCT01177813|541697007|FG002|Overall Study|Protocol Violation|2|||
150152934|NCT01177813|541697008|FG003|Overall Study|Protocol Violation|0|||
150152935|NCT01177813|541697009|FG004|Overall Study|Protocol Violation|1|||
150152936|NCT01177813|541697005|FG000|Overall Study|Lost to Follow-up|12|||
150152937|NCT01177813|541697006|FG001|Overall Study|Lost to Follow-up|5|||
150152938|NCT01177813|541697007|FG002|Overall Study|Lost to Follow-up|6|||
150152939|NCT01177813|541697008|FG003|Overall Study|Lost to Follow-up|3|||
150152940|NCT01177813|541697009|FG004|Overall Study|Lost to Follow-up|0|||
150152941|NCT01177813|541697005|FG000|Overall Study|Withdrawal by Subject|12|||
150152942|NCT01177813|541697006|FG001|Overall Study|Withdrawal by Subject|7|||
150152943|NCT01177813|541697007|FG002|Overall Study|Withdrawal by Subject|6|||
150152944|NCT01177813|541697008|FG003|Overall Study|Withdrawal by Subject|5|||
150152945|NCT01177813|541697009|FG004|Overall Study|Withdrawal by Subject|3|||
150152946|NCT01177813|541697005|FG000|Overall Study|Other reason not defined above|5|||
150152947|NCT01177813|541697006|FG001|Overall Study|Other reason not defined above|2|||
150152948|NCT01177813|541697007|FG002|Overall Study|Other reason not defined above|2|||
150152949|NCT01177813|541697008|FG003|Overall Study|Other reason not defined above|3|||
150152950|NCT01177813|541697009|FG004|Overall Study|Other reason not defined above|2|||
150152951|NCT04011384|541697016|FG000|Overall Study|Withdrawal by Subject|2|||
150152952|NCT04011384|541697017|FG001|Overall Study|Withdrawal by Subject|0|||
150152953|NCT03192215|541697018|FG000|Overall Study|Death|28|||
150152954|NCT03192215|541697019|FG001|Overall Study|Death|23|||
150152955|NCT03192215|541697018|FG000|Overall Study|Lost to Follow-up|10|||
150152956|NCT03192215|541697019|FG001|Overall Study|Lost to Follow-up|15|||
150152957|NCT03192215|541697018|FG000|Overall Study|Withdrawal by Subject|49|||
150152958|NCT03192215|541697019|FG001|Overall Study|Withdrawal by Subject|48|||
150152959|NCT03192215|541697018|FG000|Overall Study|Other as reported in analysis|4|||
150152960|NCT03192215|541697019|FG001|Overall Study|Other as reported in analysis|1|||
150152961|NCT04716881|541697021|FG000|Overall Study|Adverse Event|1|||
150152962|NCT04716881|541697021|FG000|Overall Study|Lost to Follow-up|1|||
150152963|NCT00363896|541697022|FG000|Overall Study|Withdrawal by Subject|29|||
150152964|NCT00363896|541697023|FG001|Overall Study|Withdrawal by Subject|16|||
150152965|NCT00363896|541697022|FG000|Overall Study|Adverse Event|24|||
150152966|NCT00363896|541697023|FG001|Overall Study|Adverse Event|13|||
150152967|NCT00363896|541697022|FG000|Overall Study|COPD exacerbation|13|||
150152968|NCT00363896|541697023|FG001|Overall Study|COPD exacerbation|7|||
150152969|NCT00363896|541697022|FG000|Overall Study|Lack of Efficacy|12|||
150152970|NCT00363896|541697023|FG001|Overall Study|Lack of Efficacy|8|||
150152971|NCT00363896|541697022|FG000|Overall Study|Protocol Violation|6|||
150152972|NCT00363896|541697023|FG001|Overall Study|Protocol Violation|1|||
150152973|NCT00363896|541697022|FG000|Overall Study|Lost to Follow-up|3|||
150152974|NCT00363896|541697023|FG001|Overall Study|Lost to Follow-up|0|||
150152975|NCT00363896|541697022|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
150152976|NCT00363896|541697023|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
150152977|NCT00363896|541697022|FG000|Overall Study|Other|1|||
150152978|NCT00363896|541697023|FG001|Overall Study|Other|2|||
150152979|NCT00924469|541697024|FG000|Overall Study|Adverse Event|2|||
150152980|NCT00924469|541697025|FG001|Overall Study|Adverse Event|0|||
150152981|NCT00924469|541697024|FG000|Overall Study|Withdrawal by Subject|0|||
150152982|NCT00924469|541697025|FG001|Overall Study|Withdrawal by Subject|1|||
150152983|NCT00924469|541697024|FG000|Overall Study|Lost to Follow-up|0|||
150152984|NCT00924469|541697025|FG001|Overall Study|Lost to Follow-up|1|||
149811305|NCT03869684|540437304|FG002|Overall Study|Adverse Event|1|||
149811306|NCT03869684|540437302|FG000|Overall Study|Withdrawal by Subject|1|||
149811307|NCT03869684|540437303|FG001|Overall Study|Withdrawal by Subject|0|||
149811308|NCT03869684|540437304|FG002|Overall Study|Withdrawal by Subject|0|||
149811309|NCT03869684|540437302|FG000|Overall Study|Lost to Follow-up|1|||
149811310|NCT03869684|540437303|FG001|Overall Study|Lost to Follow-up|0|||
149811311|NCT03869684|540437304|FG002|Overall Study|Lost to Follow-up|0|||
149811312|NCT03869684|540437302|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
149811313|NCT03869684|540437303|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
149811314|NCT03869684|540437304|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
149811315|NCT04056299|540437305|FG000|Overall Study|Sponsor discontinued study|3|||
149811316|NCT04056299|540437306|FG001|Overall Study|Sponsor discontinued study|3|||
149811317|NCT01227954|540437311|FG000|Overall Study|Protocol Violation|6|||
149811318|NCT01227954|540437311|FG000|Overall Study|No protocol treatment|7|||
149811319|NCT00078312|540437316|FG000|Overall Study|Adverse Event|43|||
149811320|NCT00078312|540437316|FG000|Overall Study|Lack of Efficacy|15|||
149811321|NCT00078312|540437316|FG000|Overall Study|Lost to Follow-up|41|||
149811322|NCT00078312|540437316|FG000|Overall Study|Physician Decision|9|||
149811323|NCT00078312|540437316|FG000|Overall Study|Protocol Violation|3|||
149811324|NCT00078312|540437316|FG000|Overall Study|Withdrawal by Subject|33|||
149811325|NCT00078312|540437316|FG000|Overall Study|Miscellaneous|33|||
149811326|NCT01296152|540437317|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
149811327|NCT04840901|540437318|FG000|Overall Study|Lost to Follow-up|3|||
149811328|NCT04840901|540437319|FG001|Overall Study|Lost to Follow-up|1|||
149811329|NCT04840901|540437318|FG000|Overall Study|Moved|1|||
149811330|NCT04840901|540437319|FG001|Overall Study|Moved|0|||
149811331|NCT04840901|540437318|FG000|Overall Study|Unable to comply with study schedule|0|||
149811332|NCT04840901|540437319|FG001|Overall Study|Unable to comply with study schedule|1|||
149811333|NCT04840901|540437318|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
149811334|NCT04840901|540437319|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
149811335|NCT01268683|540437320|FG000|Overall Study|Lost to Follow-up|1|||
149811336|NCT01268683|540437320|FG000|Overall Study|Death|1|||
149811337|NCT04256759|540437321|FG000|Overall Study|Physician Decision|1|||
149811338|NCT04256759|540437321|FG000|Overall Study|Lack of Efficacy|1|||
149811339|NCT04075292|540437326|FG000|Overall Study|Withdrawal by Subject|1|||
149811340|NCT04075292|540437327|FG001|Overall Study|Withdrawal by Subject|9|||
149811341|NCT04075292|540437326|FG000|Overall Study|Death|2|||
149811342|NCT04075292|540437327|FG001|Overall Study|Death|5|||
149811343|NCT04075292|540437326|FG000|Overall Study|Remained on study at time of DCO|74|||
149811344|NCT04075292|540437327|FG001|Overall Study|Remained on study at time of DCO|64|||
149811345|NCT01826201|540437328|FG000|Overall Study|Non compliance with protocol|4|||
149811346|NCT00103259|540437332|FG000|Overall Study|Death|3|||
149811347|NCT00103259|540437333|FG001|Overall Study|Death|2|||
150152985|NCT04147260|541697027|FG000|Overall Study|Adverse Event|1|||
150152986|NCT04147260|541697028|FG001|Overall Study|Adverse Event|0|||
150152987|NCT04147260|541697029|FG002|Overall Study|Adverse Event|1|||
150152988|NCT04147260|541697030|FG003|Overall Study|Adverse Event|2|||
150152989|NCT04147260|541697031|FG004|Overall Study|Adverse Event|0|||
150152990|NCT04147260|541697027|FG000|Overall Study|Withdrawal by Subject|0|||
149811348|NCT00103259|540437332|FG000|Overall Study|Withdrawal by Subject|2|||
149811349|NCT00103259|540437333|FG001|Overall Study|Withdrawal by Subject|3|||
149811350|NCT00103259|540437332|FG000|Overall Study|alternative therapy|1|||
149811351|NCT00103259|540437333|FG001|Overall Study|alternative therapy|0|||
149811352|NCT00103259|540437332|FG000|Overall Study|other (reasons were not specified)|2|||
149811353|NCT00103259|540437333|FG001|Overall Study|other (reasons were not specified)|1|||
149811354|NCT00103259|540437332|FG000|Overall Study|ineligible/no protocol therapy|4|||
149811355|NCT00103259|540437333|FG001|Overall Study|ineligible/no protocol therapy|6|||
149811356|NCT03224234|540437336|FG000|Main Study|Lost to Follow-up|5|||
149811357|NCT03224234|540437337|FG001|Main Study|Lost to Follow-up|5|||
149811358|NCT02610842|540437338|FG000|Overall Study|Lost to Follow-up|5|||
149811359|NCT00481871|540437341|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
149811360|NCT00481871|540437342|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
150152991|NCT04147260|541697028|FG001|Overall Study|Withdrawal by Subject|0|||
150152992|NCT04147260|541697029|FG002|Overall Study|Withdrawal by Subject|1|||
150152993|NCT04147260|541697030|FG003|Overall Study|Withdrawal by Subject|1|||
150152994|NCT04147260|541697031|FG004|Overall Study|Withdrawal by Subject|0|||
150152995|NCT00630058|541697032|FG000|Overall Study|Adverse Event|1|||
150152996|NCT00630058|541697033|FG001|Overall Study|Adverse Event|1|||
150152997|NCT00630058|541697032|FG000|Overall Study|Withdrawal by Subject|0|||
150152998|NCT00630058|541697033|FG001|Overall Study|Withdrawal by Subject|1|||
150152999|NCT00630058|541697032|FG000|Overall Study|stopping criteria|3|||
150153000|NCT00630058|541697033|FG001|Overall Study|stopping criteria|2|||
150153001|NCT01651936|541697034|FG000|Base Study|Adverse Event|3|||
150153002|NCT01651936|541697035|FG001|Base Study|Adverse Event|0|||
150153003|NCT01651936|541697036|FG002|Base Study|Adverse Event|0|||
150153004|NCT01651936|541697034|FG000|Base Study|Withdrawal by Subject|1|||
150153005|NCT01651936|541697035|FG001|Base Study|Withdrawal by Subject|1|||
150153006|NCT01651936|541697036|FG002|Base Study|Withdrawal by Subject|0|||
150153007|NCT01651936|541697034|FG000|Base Study|Early Escape|2|||
150153008|NCT01651936|541697035|FG001|Base Study|Early Escape|8|||
150153009|NCT01651936|541697036|FG002|Base Study|Early Escape|0|||
150153010|NCT01651936|541697034|FG000|Base Study|Study terminated by sponsor|21|||
150153011|NCT01651936|541697035|FG001|Base Study|Study terminated by sponsor|16|||
150153012|NCT01651936|541697036|FG002|Base Study|Study terminated by sponsor|0|||
150153013|NCT01651936|541697034|FG000|Extension Study|Lack of Efficacy|0|||
150153014|NCT01651936|541697035|FG001|Extension Study|Lack of Efficacy|0|||
150153015|NCT01651936|541697036|FG002|Extension Study|Lack of Efficacy|1|||
150153016|NCT01651936|541697034|FG000|Extension Study|Study terminated by sponsor|0|||
150153017|NCT01651936|541697035|FG001|Extension Study|Study terminated by sponsor|0|||
150153018|NCT01651936|541697036|FG002|Extension Study|Study terminated by sponsor|13|||
150153019|NCT01555021|541697039|FG000|Overall Study|Lost to Follow-up|1|||
150153020|NCT01555021|541697040|FG001|Overall Study|Lost to Follow-up|2|||
150153021|NCT02204293|541697041|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
150153022|NCT02204293|541697042|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
150153023|NCT02204293|541697043|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
150153024|NCT02204293|541697044|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
150153025|NCT02204293|541697045|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
150153026|NCT02204293|541697046|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
150153027|NCT02204293|541697041|FG000|Core Study Part I|Adverse Event|1|||
150153028|NCT02204293|541697042|FG001|Core Study Part I|Adverse Event|0|||
150153029|NCT02204293|541697043|FG002|Core Study Part I|Adverse Event|0|||
150153030|NCT02204293|541697044|FG003|Core Study Part I|Adverse Event|0|||
150153031|NCT02204293|541697045|FG004|Core Study Part I|Adverse Event|0|||
150153032|NCT02204293|541697046|FG005|Core Study Part I|Adverse Event|0|||
150153033|NCT02204293|541697041|FG000|Core Study Part I|Physician Decision|0|||
150153034|NCT02204293|541697042|FG001|Core Study Part I|Physician Decision|3|||
150153035|NCT02204293|541697043|FG002|Core Study Part I|Physician Decision|0|||
150153036|NCT02204293|541697044|FG003|Core Study Part I|Physician Decision|0|||
150153037|NCT02204293|541697045|FG004|Core Study Part I|Physician Decision|0|||
150153038|NCT02204293|541697046|FG005|Core Study Part I|Physician Decision|0|||
150153039|NCT02204293|541697041|FG000|LTE Phase|Study Suspended|0|||
150153040|NCT02204293|541697042|FG001|LTE Phase|Study Suspended|0|||
150153041|NCT02204293|541697043|FG002|LTE Phase|Study Suspended|0|||
150153042|NCT02204293|541697044|FG003|LTE Phase|Study Suspended|0|||
150153043|NCT02204293|541697045|FG004|LTE Phase|Study Suspended|0|||
150153044|NCT02204293|541697046|FG005|LTE Phase|Study Suspended|7|||
150153045|NCT03051659|541697051|FG000|Treatment Period|Withdrawal by Subject|0|||
150153046|NCT03051659|541697052|FG001|Treatment Period|Withdrawal by Subject|2|||
150153047|NCT03051659|541697051|FG000|Survival Follow-up|Lost to Follow-up|23|||
150153048|NCT03051659|541697052|FG001|Survival Follow-up|Lost to Follow-up|22|||
150153049|NCT01266993|541697053|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
150153050|NCT01266993|541697054|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
150153051|NCT01266993|541697053|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
150153052|NCT01266993|541697054|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
150153053|NCT01000376|541697055|FG000|Cycle 1 Day 1|Adverse Event|1|||
150153054|NCT01000376|541697056|FG001|Cycle 1 Day 1|Adverse Event|0|||
150153055|NCT01000376|541697055|FG000|Cycle 1 Day 1|Progressive Disease|1|||
150153056|NCT01000376|541697056|FG001|Cycle 1 Day 1|Progressive Disease|0|||
150153057|NCT02372058|541697057|FG000|Overall Study|Withdrawal by Subject|3|||
149811361|NCT00481871|540437343|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
150153058|NCT01994720|541697058|FG000|Overall Study|Withdrawal by Subject|46|||
150153059|NCT01994720|541697059|FG001|Overall Study|Withdrawal by Subject|56|||
150153060|NCT00967018|541697061|FG000|Overall Study|Adverse Event|2|||
150153061|NCT00967018|541697061|FG000|Overall Study|Physician Decision|7|||
150153062|NCT00967018|541697061|FG000|Overall Study|Lost to Follow-up|2|||
150153063|NCT00967018|541697061|FG000|Overall Study|Withdrawal by Subject|1|||
150153064|NCT00967018|541697061|FG000|Overall Study|Miscellaneous Reasons|9|||
150153065|NCT04793464|541697062|FG000|Overall Study|Lost to Follow-up|458|||
150153066|NCT04793464|541697063|FG001|Overall Study|Lost to Follow-up|168|||
150153067|NCT04793464|541697064|FG002|Overall Study|Lost to Follow-up|5|||
150153068|NCT04793464|541697062|FG000|Overall Study|Withdrawal by Subject|43|||
150153069|NCT04793464|541697063|FG001|Overall Study|Withdrawal by Subject|15|||
150153070|NCT04793464|541697064|FG002|Overall Study|Withdrawal by Subject|0|||
150153071|NCT00845871|541697068|FG000|Assessment Period|Adverse Event|2|||
150153072|NCT00845871|541697068|FG000|Assessment Period|Abnormal laboratory values|1|||
150153073|NCT00845871|541697068|FG000|Assessment Period|Abnormal test procedure results|1|||
150153074|NCT00845871|541697068|FG000|Assessment Period|Patient withdrew consent|3|||
150153075|NCT01291225|541697071|FG000|Overall Study|Lost to Follow-up|85|||
150153076|NCT01291225|541697072|FG001|Overall Study|Lost to Follow-up|39|||
150153077|NCT02855164|541697074|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
150153078|NCT02855164|541697075|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
150153079|NCT02855164|541697076|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
150153080|NCT02855164|541697077|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
150153081|NCT02855164|541697078|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
150153082|NCT02855164|541697079|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
150153083|NCT02855164|541697080|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
150153084|NCT02855164|541697081|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
150153085|NCT02855164|541697074|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
150153086|NCT02855164|541697075|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
150153087|NCT02855164|541697076|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
150153088|NCT02855164|541697077|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
150153089|NCT02855164|541697078|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
150153090|NCT02855164|541697079|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
150153091|NCT02855164|541697080|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
150153092|NCT02855164|541697081|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
150153093|NCT02855164|541697074|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
150153094|NCT02855164|541697075|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
150153095|NCT02855164|541697076|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
150153096|NCT02855164|541697077|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
150153097|NCT02855164|541697078|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
150153098|NCT02855164|541697079|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
150153099|NCT02855164|541697080|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
150153100|NCT02855164|541697081|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
150153101|NCT02855164|541697074|FG000|Part C (Randomized Set)|Adverse Event|0|||
150153102|NCT02855164|541697075|FG001|Part C (Randomized Set)|Adverse Event|0|||
150153103|NCT02855164|541697076|FG002|Part C (Randomized Set)|Adverse Event|0|||
150153104|NCT02855164|541697077|FG003|Part C (Randomized Set)|Adverse Event|0|||
150153105|NCT02855164|541697078|FG004|Part C (Randomized Set)|Adverse Event|0|||
150153106|NCT02855164|541697079|FG005|Part C (Randomized Set)|Adverse Event|5|||
150153107|NCT02855164|541697080|FG006|Part C (Randomized Set)|Adverse Event|9|||
150153108|NCT02855164|541697081|FG007|Part C (Randomized Set)|Adverse Event|2|||
150153109|NCT02855164|541697074|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
150153110|NCT02855164|541697075|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
150153111|NCT02855164|541697076|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
150153112|NCT02855164|541697077|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
150153113|NCT02855164|541697078|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
150153114|NCT02855164|541697079|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
150153115|NCT02855164|541697080|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
150153116|NCT02855164|541697081|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
150153117|NCT02855164|541697074|FG000|Part C (Randomized Set)|Physician Decision|0|||
150153118|NCT02855164|541697075|FG001|Part C (Randomized Set)|Physician Decision|0|||
150153119|NCT02855164|541697076|FG002|Part C (Randomized Set)|Physician Decision|0|||
150153120|NCT02855164|541697077|FG003|Part C (Randomized Set)|Physician Decision|0|||
150153121|NCT02855164|541697078|FG004|Part C (Randomized Set)|Physician Decision|0|||
150153122|NCT02855164|541697079|FG005|Part C (Randomized Set)|Physician Decision|1|||
150153123|NCT02855164|541697080|FG006|Part C (Randomized Set)|Physician Decision|0|||
150153124|NCT02855164|541697081|FG007|Part C (Randomized Set)|Physician Decision|1|||
150153125|NCT02855164|541697074|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
150153126|NCT02855164|541697075|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
150153127|NCT02855164|541697076|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
150153128|NCT02855164|541697077|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
150153129|NCT02855164|541697078|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
150153130|NCT02855164|541697079|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
150153131|NCT02855164|541697080|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
150153132|NCT02855164|541697081|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
150153133|NCT00876460|541697082|FG000|Combination Therapy Phase|Progressive disease|2|||
150153134|NCT00876460|541697083|FG001|Combination Therapy Phase|Progressive disease|3|||
150153135|NCT00876460|541697084|FG002|Combination Therapy Phase|Progressive disease|3|||
150153136|NCT00876460|541697085|FG003|Combination Therapy Phase|Progressive disease|3|||
150153137|NCT00876460|541697086|FG004|Combination Therapy Phase|Progressive disease|3|||
150153138|NCT00876460|541697087|FG005|Combination Therapy Phase|Progressive disease|1|||
150153139|NCT00876460|541697088|FG006|Combination Therapy Phase|Progressive disease|1|||
150153140|NCT00876460|541697089|FG007|Combination Therapy Phase|Progressive disease|1|||
150153141|NCT00876460|541697082|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
150153142|NCT00876460|541697083|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
150153143|NCT00876460|541697084|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
150153144|NCT00876460|541697085|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
150153145|NCT00876460|541697086|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
150153146|NCT00876460|541697087|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
150153147|NCT00876460|541697088|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
150153148|NCT00876460|541697089|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
150153149|NCT00876460|541697082|FG000|Combination Therapy Phase|Adverse Event|0|||
150153150|NCT00876460|541697083|FG001|Combination Therapy Phase|Adverse Event|2|||
150153151|NCT00876460|541697084|FG002|Combination Therapy Phase|Adverse Event|0|||
150153152|NCT00876460|541697085|FG003|Combination Therapy Phase|Adverse Event|2|||
150153153|NCT00876460|541697086|FG004|Combination Therapy Phase|Adverse Event|2|||
150153154|NCT00876460|541697087|FG005|Combination Therapy Phase|Adverse Event|0|||
150153155|NCT00876460|541697088|FG006|Combination Therapy Phase|Adverse Event|3|||
150153156|NCT00876460|541697089|FG007|Combination Therapy Phase|Adverse Event|2|||
150153157|NCT00876460|541697082|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
150153158|NCT00876460|541697083|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
150153159|NCT00876460|541697084|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
150153160|NCT00876460|541697085|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
150153161|NCT00876460|541697086|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
150153162|NCT00876460|541697087|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
150153163|NCT00876460|541697088|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
150153164|NCT00876460|541697089|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
150153165|NCT00876460|541697082|FG000|Combination Therapy Phase|Other reason not defined above|0|||
150153166|NCT00876460|541697083|FG001|Combination Therapy Phase|Other reason not defined above|0|||
150153167|NCT00876460|541697084|FG002|Combination Therapy Phase|Other reason not defined above|0|||
150153168|NCT00876460|541697085|FG003|Combination Therapy Phase|Other reason not defined above|0|||
150153169|NCT00876460|541697086|FG004|Combination Therapy Phase|Other reason not defined above|0|||
150153170|NCT00876460|541697087|FG005|Combination Therapy Phase|Other reason not defined above|0|||
150153171|NCT00876460|541697088|FG006|Combination Therapy Phase|Other reason not defined above|1|||
150153172|NCT00876460|541697089|FG007|Combination Therapy Phase|Other reason not defined above|2|||
150153173|NCT00876460|541697082|FG000|Combination Therapy Phase|Not treated|0|||
150153174|NCT00876460|541697083|FG001|Combination Therapy Phase|Not treated|0|||
150153175|NCT00876460|541697084|FG002|Combination Therapy Phase|Not treated|0|||
150153176|NCT00876460|541697085|FG003|Combination Therapy Phase|Not treated|0|||
150153177|NCT00876460|541697086|FG004|Combination Therapy Phase|Not treated|0|||
150153178|NCT00876460|541697087|FG005|Combination Therapy Phase|Not treated|0|||
150153179|NCT00876460|541697088|FG006|Combination Therapy Phase|Not treated|1|||
150153180|NCT00876460|541697089|FG007|Combination Therapy Phase|Not treated|0|||
150153181|NCT00876460|541697082|FG000|Mono Therapy Phase|Progressive disease|0|||
150153182|NCT00876460|541697083|FG001|Mono Therapy Phase|Progressive disease|0|||
150153183|NCT00876460|541697084|FG002|Mono Therapy Phase|Progressive disease|0|||
150153184|NCT00876460|541697085|FG003|Mono Therapy Phase|Progressive disease|0|||
150153185|NCT00876460|541697086|FG004|Mono Therapy Phase|Progressive disease|2|||
150153186|NCT00876460|541697087|FG005|Mono Therapy Phase|Progressive disease|0|||
150153187|NCT00876460|541697088|FG006|Mono Therapy Phase|Progressive disease|1|||
150153188|NCT00876460|541697089|FG007|Mono Therapy Phase|Progressive disease|3|||
150153189|NCT00876460|541697082|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
150153190|NCT00876460|541697083|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
150153191|NCT00876460|541697084|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
150153192|NCT00876460|541697085|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
150153193|NCT00876460|541697086|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
150153194|NCT00876460|541697087|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
150153195|NCT00876460|541697088|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
150153196|NCT00876460|541697089|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
150153197|NCT00876460|541697082|FG000|Mono Therapy Phase|Adverse Event|0|||
150153198|NCT00876460|541697083|FG001|Mono Therapy Phase|Adverse Event|0|||
150153199|NCT00876460|541697084|FG002|Mono Therapy Phase|Adverse Event|0|||
150153200|NCT00876460|541697085|FG003|Mono Therapy Phase|Adverse Event|1|||
150153201|NCT00876460|541697086|FG004|Mono Therapy Phase|Adverse Event|0|||
150153202|NCT00876460|541697087|FG005|Mono Therapy Phase|Adverse Event|0|||
150153203|NCT00876460|541697088|FG006|Mono Therapy Phase|Adverse Event|0|||
150153204|NCT00876460|541697089|FG007|Mono Therapy Phase|Adverse Event|0|||
150153205|NCT02468934|541697090|FG000|Overall Study|Withdrawal by Subject|4|||
150153206|NCT02468934|541697090|FG000|Overall Study|Screen Failure|3|||
150153207|NCT00383240|541697091|FG000|Overall Study|Adverse Event|4|||
150153208|NCT00383240|541697092|FG001|Overall Study|Adverse Event|6|||
150153209|NCT00383240|541697093|FG002|Overall Study|Adverse Event|9|||
150153210|NCT00383240|541697094|FG003|Overall Study|Adverse Event|7|||
150153211|NCT00383240|541697091|FG000|Overall Study|Treatment Failure|8|||
150153212|NCT00383240|541697092|FG001|Overall Study|Treatment Failure|13|||
150153213|NCT00383240|541697093|FG002|Overall Study|Treatment Failure|47|||
150153214|NCT00383240|541697094|FG003|Overall Study|Treatment Failure|46|||
150153215|NCT00383240|541697091|FG000|Overall Study|Lost to Follow-up|3|||
150153216|NCT00383240|541697092|FG001|Overall Study|Lost to Follow-up|0|||
150153217|NCT00383240|541697093|FG002|Overall Study|Lost to Follow-up|0|||
150153218|NCT00383240|541697094|FG003|Overall Study|Lost to Follow-up|2|||
150153219|NCT00383240|541697091|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
150153220|NCT00383240|541697092|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
149811362|NCT00481871|540437344|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
149811363|NCT00481871|540437345|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
149811364|NCT03332212|540437346|FG000|Overall Study|Not treated|0|||
149811365|NCT03332212|540437347|FG001|Overall Study|Not treated|1|||
149811366|NCT03332212|540437348|FG002|Overall Study|Not treated|0|||
149811367|NCT03332212|540437349|FG003|Overall Study|Not treated|0|||
149811368|NCT03332212|540437346|FG000|Overall Study|Adverse Event|0|||
149811369|NCT03332212|540437347|FG001|Overall Study|Adverse Event|0|||
149811370|NCT03332212|540437348|FG002|Overall Study|Adverse Event|0|||
149811371|NCT03332212|540437349|FG003|Overall Study|Adverse Event|1|||
149811372|NCT03332212|540437346|FG000|Overall Study|worsening of disease under study|1|||
149811373|NCT03332212|540437347|FG001|Overall Study|worsening of disease under study|1|||
149811374|NCT03332212|540437348|FG002|Overall Study|worsening of disease under study|0|||
149811375|NCT03332212|540437349|FG003|Overall Study|worsening of disease under study|0|||
149811376|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
149811377|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
149811378|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
149811379|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
149811380|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
149811381|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
149811382|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
149811383|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
149811384|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
150153221|NCT00383240|541697093|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
150153222|NCT00383240|541697094|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
150153223|NCT00383240|541697091|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
149811385|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
149811386|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
149811387|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
149811388|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
149811389|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
149811390|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
149811391|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
149811392|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
149811393|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
149811394|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
149811395|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
149811396|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
149811397|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
149811398|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
149811399|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
149811400|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
149811401|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
149811402|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
149811403|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
149811404|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
149811405|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
149811406|NCT03985293|540437355|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
149811407|NCT03985293|540437356|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
149811408|NCT03985293|540437357|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
149811409|NCT03985293|540437358|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
149811410|NCT03985293|540437359|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
149811411|NCT03985293|540437360|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
149811412|NCT03985293|540437355|FG000|FOLLOW-UP|Lost to Follow-up|0|||
149811413|NCT03985293|540437356|FG001|FOLLOW-UP|Lost to Follow-up|0|||
149811414|NCT03985293|540437357|FG002|FOLLOW-UP|Lost to Follow-up|1|||
149811415|NCT03985293|540437358|FG003|FOLLOW-UP|Lost to Follow-up|0|||
149811416|NCT03985293|540437359|FG004|FOLLOW-UP|Lost to Follow-up|0|||
149811417|NCT03985293|540437360|FG005|FOLLOW-UP|Lost to Follow-up|0|||
149811418|NCT03107715|540437361|FG000|Overall Study|did not deliver at the home hospital|4|||
149811419|NCT03107715|540437362|FG001|Overall Study|did not deliver at the home hospital|6|||
149811420|NCT03107715|540437361|FG000|Overall Study|infant stillborn|0|||
149811421|NCT03107715|540437362|FG001|Overall Study|infant stillborn|1|||
149811422|NCT01907516|540437363|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
149811423|NCT01907516|540437364|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
149811424|NCT01907516|540437363|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
149811425|NCT01907516|540437364|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
149811426|NCT01907516|540437363|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
149811427|NCT01907516|540437364|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
149811428|NCT01907516|540437363|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
150153224|NCT00383240|541697092|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
149811429|NCT01907516|540437364|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
149811430|NCT01211613|540438803|FG000|Overall Study|Lost to Follow-up|2|||
149811431|NCT01211613|540438804|FG001|Overall Study|Lost to Follow-up|2|||
149811432|NCT01211613|540438805|FG002|Overall Study|Lost to Follow-up|2|||
149811433|NCT01211613|540438803|FG000|Overall Study|Withdrawal by Subject|1|||
149811434|NCT01211613|540438804|FG001|Overall Study|Withdrawal by Subject|0|||
149811435|NCT01211613|540438805|FG002|Overall Study|Withdrawal by Subject|0|||
149811436|NCT01020773|540438806|FG000|Overall Study|Withdrawal by Subject|4|||
149811437|NCT01020773|540438807|FG001|Overall Study|Withdrawal by Subject|3|||
149811438|NCT03853213|540438808|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
149811439|NCT03853213|540438809|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
149811440|NCT03853213|540438808|FG000|Overall Study|Other (e.g., too busy)|0|||
149811441|NCT03853213|540438809|FG001|Overall Study|Other (e.g., too busy)|2|||
149811442|NCT03302299|540438810|FG000|Overall Study|Protocol Violation|1|||
149811443|NCT01458132|540438811|FG000|Overall Study|Other|15|||
149811444|NCT01458132|540438812|FG001|Overall Study|Other|3|||
149811445|NCT01788163|540438817|FG000|Overall Study|Other|53|||
149811446|NCT01788163|540438818|FG001|Overall Study|Other|0|||
149811447|NCT01788163|540438819|FG002|Overall Study|Other|0|||
149811448|NCT01788163|540438820|FG003|Overall Study|Other|0|||
149811449|NCT01788163|540438821|FG004|Overall Study|Other|0|||
149811450|NCT01788163|540438822|FG005|Overall Study|Other|7|||
149811451|NCT01788163|540438823|FG006|Overall Study|Other|1|||
149811452|NCT01788163|540438824|FG007|Overall Study|Other|48|||
149811453|NCT01788163|540438825|FG008|Overall Study|Other|15|||
149811454|NCT01788163|540438817|FG000|Overall Study|Withdrawal by Subject|2|||
149811455|NCT01788163|540438818|FG001|Overall Study|Withdrawal by Subject|0|||
149811456|NCT01788163|540438819|FG002|Overall Study|Withdrawal by Subject|0|||
149811457|NCT01788163|540438820|FG003|Overall Study|Withdrawal by Subject|0|||
149811458|NCT01788163|540438821|FG004|Overall Study|Withdrawal by Subject|0|||
149811459|NCT01788163|540438822|FG005|Overall Study|Withdrawal by Subject|0|||
149811460|NCT01788163|540438823|FG006|Overall Study|Withdrawal by Subject|0|||
149811461|NCT01788163|540438824|FG007|Overall Study|Withdrawal by Subject|0|||
149811462|NCT01788163|540438825|FG008|Overall Study|Withdrawal by Subject|1|||
149811463|NCT00545441|540438826|FG000|Overall Study|Fistula draining at 6 months|2|||
149811464|NCT00545441|540438827|FG001|Overall Study|Fistula draining at 6 months|4|||
149811465|NCT00545441|540438826|FG000|Overall Study|Lost to Follow-up|9|||
149811466|NCT00545441|540438827|FG001|Overall Study|Lost to Follow-up|5|||
149811467|NCT00545441|540438826|FG000|Overall Study|Technical failure|0|||
149811468|NCT00545441|540438827|FG001|Overall Study|Technical failure|1|||
149811469|NCT00545441|540438826|FG000|Overall Study|Withdrawal by Subject|1|||
149811470|NCT00545441|540438827|FG001|Overall Study|Withdrawal by Subject|1|||
149811471|NCT00545441|540438826|FG000|Overall Study|Persistence or recurrence of fistula|5|||
149811472|NCT00545441|540438827|FG001|Overall Study|Persistence or recurrence of fistula|2|||
149811473|NCT00545441|540438826|FG000|Overall Study|Patients were not treated|1|||
149811474|NCT00545441|540438827|FG001|Overall Study|Patients were not treated|3|||
149811475|NCT00265239|540438828|FG000|Overall Study|Adverse Event|2|||
149811476|NCT00265239|540438829|FG001|Overall Study|Adverse Event|1|||
149811477|NCT02803138|540438830|FG000|Overall Study|Failure to return|38|||
149811478|NCT02803138|540438830|FG000|Overall Study|Insufficient virological response|2|||
149811479|NCT02803138|540438830|FG000|Overall Study|Withdrawn consent|1|||
149811480|NCT02803138|540438830|FG000|Overall Study|Death|1|||
149811481|NCT02803138|540438830|FG000|Overall Study|Other, not specified|28|||
149811482|NCT04318535|540438831|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
149811483|NCT04318535|540438832|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
149811484|NCT04318535|540438833|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
149811485|NCT00021229|540438836|FG000|Overall Study|Adverse Event|10|||
149811486|NCT00021229|540438837|FG001|Overall Study|Adverse Event|5|||
149811487|NCT00021229|540438838|FG002|Overall Study|Adverse Event|2|||
149811488|NCT00021229|540438836|FG000|Overall Study|Death|0|||
149811489|NCT00021229|540438837|FG001|Overall Study|Death|1|||
149811490|NCT00021229|540438838|FG002|Overall Study|Death|0|||
149811491|NCT00021229|540438836|FG000|Overall Study|Withdrawal by Subject|7|||
149811492|NCT00021229|540438837|FG001|Overall Study|Withdrawal by Subject|7|||
149811493|NCT00021229|540438838|FG002|Overall Study|Withdrawal by Subject|1|||
149811494|NCT00021229|540438836|FG000|Overall Study|Progressive Disease|15|||
149811495|NCT00021229|540438837|FG001|Overall Study|Progressive Disease|19|||
149811496|NCT00021229|540438838|FG002|Overall Study|Progressive Disease|12|||
149811497|NCT00021229|540438836|FG000|Overall Study|Protocol Violation|1|||
149811498|NCT00021229|540438837|FG001|Overall Study|Protocol Violation|1|||
149811499|NCT00021229|540438838|FG002|Overall Study|Protocol Violation|0|||
149811500|NCT00021229|540438836|FG000|Overall Study|Physician Decision|0|||
149811501|NCT00021229|540438837|FG001|Overall Study|Physician Decision|0|||
149811502|NCT00021229|540438838|FG002|Overall Study|Physician Decision|1|||
149811503|NCT00021229|540438836|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
149811504|NCT00021229|540438837|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
149811505|NCT00021229|540438838|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
150153225|NCT00383240|541697093|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
150153226|NCT00383240|541697094|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
150153227|NCT00383240|541697091|FG000|Overall Study|Protocol Violation|4|||
150153228|NCT00383240|541697092|FG001|Overall Study|Protocol Violation|5|||
150153229|NCT00383240|541697093|FG002|Overall Study|Protocol Violation|9|||
150153230|NCT00383240|541697094|FG003|Overall Study|Protocol Violation|6|||
150153231|NCT00383240|541697091|FG000|Overall Study|Did not meet protocol eligibility|9|||
150153232|NCT00383240|541697092|FG001|Overall Study|Did not meet protocol eligibility|4|||
150153233|NCT00383240|541697093|FG002|Overall Study|Did not meet protocol eligibility|9|||
150153234|NCT00383240|541697094|FG003|Overall Study|Did not meet protocol eligibility|3|||
150153235|NCT00383240|541697091|FG000|Overall Study|Administrative|1|||
150153236|NCT00383240|541697092|FG001|Overall Study|Administrative|1|||
150153237|NCT00383240|541697093|FG002|Overall Study|Administrative|0|||
150153238|NCT00383240|541697094|FG003|Overall Study|Administrative|0|||
150153239|NCT02133924|541697095|FG000|Overall Study|Death|38|||
150153240|NCT02133924|541697095|FG000|Overall Study|Physician Decision|1|||
150153241|NCT02133924|541697095|FG000|Overall Study|Withdrawal by Subject|3|||
150153242|NCT00003458|541697096|FG000|Overall Study|Not evaluable|4|||
150153243|NCT02044458|541697097|FG000|Overall Study|Protocol Violation|3|||
150153244|NCT02044458|541697098|FG001|Overall Study|Protocol Violation|8|||
150153245|NCT02924389|541697100|FG000|Overall Study|Lost to Follow-up|1|||
150153246|NCT02924389|541697101|FG001|Overall Study|Lost to Follow-up|0|||
150153247|NCT02924389|541697100|FG000|Overall Study|Physician Decision|2|||
150153248|NCT02924389|541697101|FG001|Overall Study|Physician Decision|0|||
150153249|NCT02924389|541697100|FG000|Overall Study|Withdrawal by Subject|3|||
150153250|NCT02924389|541697101|FG001|Overall Study|Withdrawal by Subject|0|||
150153251|NCT02924389|541697100|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
150153252|NCT02924389|541697101|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
149811506|NCT01901146|540438839|FG000|Neoadjuvant Phase|Death|1|||
149811507|NCT01901146|540438840|FG001|Neoadjuvant Phase|Death|2|||
149811508|NCT01901146|540438841|FG002|Neoadjuvant Phase|Death|0|||
149811509|NCT01901146|540438842|FG003|Neoadjuvant Phase|Death|0|||
149811510|NCT01901146|540438843|FG004|Neoadjuvant Phase|Death|0|||
149811511|NCT01901146|540438839|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
149811512|NCT01901146|540438840|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
149811513|NCT01901146|540438841|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
149811514|NCT01901146|540438842|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
149811515|NCT01901146|540438843|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
149811516|NCT01901146|540438839|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
149811517|NCT01901146|540438840|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
149811518|NCT01901146|540438841|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
149811519|NCT01901146|540438842|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
149811520|NCT01901146|540438843|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
149811521|NCT01901146|540438839|FG000|Neoadjuvant Phase|Physician Decision|1|||
149811522|NCT01901146|540438840|FG001|Neoadjuvant Phase|Physician Decision|2|||
149811523|NCT01901146|540438841|FG002|Neoadjuvant Phase|Physician Decision|0|||
149811524|NCT01901146|540438842|FG003|Neoadjuvant Phase|Physician Decision|0|||
149811525|NCT01901146|540438843|FG004|Neoadjuvant Phase|Physician Decision|0|||
149811526|NCT01901146|540438839|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
149811527|NCT01901146|540438840|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
149811528|NCT01901146|540438841|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
149811529|NCT01901146|540438842|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
149811530|NCT01901146|540438843|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
149811531|NCT01901146|540438839|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
149811532|NCT01901146|540438840|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
149811533|NCT01901146|540438841|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
149811534|NCT01901146|540438842|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
149811535|NCT01901146|540438843|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
149811536|NCT01901146|540438839|FG000|Adjuvant Phase|Other|0|||
149811537|NCT01901146|540438840|FG001|Adjuvant Phase|Other|0|||
149811538|NCT01901146|540438841|FG002|Adjuvant Phase|Other|1|||
149811539|NCT01901146|540438842|FG003|Adjuvant Phase|Other|0|||
149811540|NCT01901146|540438843|FG004|Adjuvant Phase|Other|0|||
149811541|NCT01901146|540438839|FG000|Adjuvant Phase|Death|0|||
149811542|NCT01901146|540438840|FG001|Adjuvant Phase|Death|0|||
149811543|NCT01901146|540438841|FG002|Adjuvant Phase|Death|0|||
149811544|NCT01901146|540438842|FG003|Adjuvant Phase|Death|0|||
149811545|NCT01901146|540438843|FG004|Adjuvant Phase|Death|3|||
149811546|NCT01901146|540438839|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
150153253|NCT01474512|541699589|FG000|Induction Period|Adverse Event|6|||
150153254|NCT01474512|541699590|FG001|Induction Period|Adverse Event|10|||
149811547|NCT01901146|540438840|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
149811548|NCT01901146|540438841|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
149811549|NCT01901146|540438842|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
149811550|NCT01901146|540438843|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
149811551|NCT01901146|540438839|FG000|Adjuvant Phase|Physician Decision|0|||
149811552|NCT01901146|540438840|FG001|Adjuvant Phase|Physician Decision|0|||
149811553|NCT01901146|540438841|FG002|Adjuvant Phase|Physician Decision|9|||
149811554|NCT01901146|540438842|FG003|Adjuvant Phase|Physician Decision|2|||
149811555|NCT01901146|540438843|FG004|Adjuvant Phase|Physician Decision|4|||
149811556|NCT01901146|540438839|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
149811557|NCT01901146|540438840|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
149811558|NCT01901146|540438841|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
149811559|NCT01901146|540438842|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
149811560|NCT01901146|540438843|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
149811561|NCT00297492|540438847|FG000|Set Quit Date|Lost to Follow-up|7|||
149811562|NCT00297492|540438848|FG001|Set Quit Date|Lost to Follow-up|13|||
149811563|NCT00297492|540438849|FG002|Set Quit Date|Lost to Follow-up|5|||
149811564|NCT00297492|540438847|FG000|6 Month Follow-up|Lost to Follow-up|63|||
149811565|NCT00297492|540438848|FG001|6 Month Follow-up|Lost to Follow-up|49|||
149811566|NCT00297492|540438849|FG002|6 Month Follow-up|Lost to Follow-up|27|||
149811567|NCT02675426|540438850|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
149811568|NCT02675426|540438851|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
149811569|NCT02675426|540438852|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
149811570|NCT02675426|540438853|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
149811571|NCT02675426|540438850|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
149811572|NCT02675426|540438851|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
149811573|NCT02675426|540438852|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
149811574|NCT02675426|540438853|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
149811575|NCT02675426|540438850|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
149811576|NCT02675426|540438851|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
149811577|NCT02675426|540438852|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
149811578|NCT02675426|540438853|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
149811579|NCT02675426|540438850|FG000|Period 1: Week 1 to Week 12|Other|2|||
149811580|NCT02675426|540438851|FG001|Period 1: Week 1 to Week 12|Other|1|||
149811581|NCT02675426|540438852|FG002|Period 1: Week 1 to Week 12|Other|0|||
149811582|NCT02675426|540438853|FG003|Period 1: Week 1 to Week 12|Other|2|||
149811583|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
149811584|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
149811585|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
149811586|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
149811587|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
149811588|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
149811589|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
150153255|NCT01474512|541699591|FG002|Induction Period|Adverse Event|10|||
150153256|NCT01474512|541699592|FG003|Induction Period|Adverse Event|0|||
150153257|NCT01474512|541699593|FG004|Induction Period|Adverse Event|0|||
150153258|NCT01474512|541699594|FG005|Induction Period|Adverse Event|0|||
150153259|NCT01474512|541699595|FG006|Induction Period|Adverse Event|0|||
150153260|NCT01474512|541699596|FG007|Induction Period|Adverse Event|0|||
150153261|NCT01474512|541699597|FG008|Induction Period|Adverse Event|0|||
150153262|NCT01474512|541699598|FG009|Induction Period|Adverse Event|0|||
150153263|NCT01474512|541699599|FG010|Induction Period|Adverse Event|0|||
150153264|NCT01474512|541699600|FG011|Induction Period|Adverse Event|0|||
150153265|NCT01474512|541699601|FG012|Induction Period|Adverse Event|0|||
150153266|NCT01474512|541699602|FG013|Induction Period|Adverse Event|0|||
150153267|NCT01474512|541699603|FG014|Induction Period|Adverse Event|0|||
150153268|NCT01474512|541699604|FG015|Induction Period|Adverse Event|0|||
150153269|NCT01474512|541699605|FG016|Induction Period|Adverse Event|0|||
150153270|NCT01474512|541699606|FG017|Induction Period|Adverse Event|0|||
150153271|NCT01474512|541699589|FG000|Induction Period|Lack of Efficacy|7|||
150153272|NCT01474512|541699590|FG001|Induction Period|Lack of Efficacy|1|||
150153273|NCT01474512|541699591|FG002|Induction Period|Lack of Efficacy|0|||
150153274|NCT01474512|541699592|FG003|Induction Period|Lack of Efficacy|0|||
150153275|NCT01474512|541699593|FG004|Induction Period|Lack of Efficacy|0|||
150153276|NCT01474512|541699594|FG005|Induction Period|Lack of Efficacy|0|||
149811590|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
149811591|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
149811592|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
149811593|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
149811594|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
150153277|NCT01474512|541699595|FG006|Induction Period|Lack of Efficacy|0|||
150153278|NCT01474512|541699596|FG007|Induction Period|Lack of Efficacy|0|||
150153279|NCT01474512|541699597|FG008|Induction Period|Lack of Efficacy|0|||
150153280|NCT01474512|541699598|FG009|Induction Period|Lack of Efficacy|0|||
150153281|NCT01474512|541699599|FG010|Induction Period|Lack of Efficacy|0|||
150153282|NCT01474512|541699600|FG011|Induction Period|Lack of Efficacy|0|||
150153283|NCT01474512|541699601|FG012|Induction Period|Lack of Efficacy|0|||
150153284|NCT01474512|541699602|FG013|Induction Period|Lack of Efficacy|0|||
149811595|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
149811596|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
150153285|NCT01474512|541699603|FG014|Induction Period|Lack of Efficacy|0|||
149811597|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
149811598|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
149811599|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
149811600|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
149811601|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
149811602|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
149811603|NCT02675426|540438850|FG000|Period 2: Week 12 to Week 260|Other|8|||
149811604|NCT02675426|540438851|FG001|Period 2: Week 12 to Week 260|Other|12|||
149811605|NCT02675426|540438852|FG002|Period 2: Week 12 to Week 260|Other|23|||
149811606|NCT02675426|540438853|FG003|Period 2: Week 12 to Week 260|Other|15|||
149811607|NCT03724968|540438854|FG000|Overall Study|Insurance issues|0|||
149811608|NCT03724968|540438855|FG001|Overall Study|Insurance issues|1|||
149811609|NCT03724968|540438854|FG000|Overall Study|Study closed|0|||
149811610|NCT03724968|540438855|FG001|Overall Study|Study closed|1|||
149811611|NCT01858558|540438856|FG000|Overall Study|Death|1|||
149811612|NCT01858558|540438857|FG001|Overall Study|Death|1|||
149811613|NCT01858558|540438856|FG000|Overall Study|Lost to Follow-up|1|||
149811614|NCT01858558|540438857|FG001|Overall Study|Lost to Follow-up|0|||
149811615|NCT01858558|540438856|FG000|Overall Study|Disease progression|3|||
149811616|NCT01858558|540438857|FG001|Overall Study|Disease progression|1|||
149811617|NCT01858558|540438856|FG000|Overall Study|Product contamination|2|||
149811618|NCT01858558|540438857|FG001|Overall Study|Product contamination|0|||
149811619|NCT01858558|540438856|FG000|Overall Study|Failed expansion of cell product|2|||
149811620|NCT01858558|540438857|FG001|Overall Study|Failed expansion of cell product|0|||
149811621|NCT02237118|540438858|FG000|Overall Study|Protocol Violation|0|||
149811622|NCT02237118|540438859|FG001|Overall Study|Protocol Violation|1|||
149811623|NCT02237118|540438858|FG000|Overall Study|consent withdrawn|1|||
149811624|NCT02237118|540438859|FG001|Overall Study|consent withdrawn|0|||
149811625|NCT00569231|540438862|FG000|Overall Study|Study unrelated surgery|1|||
149811626|NCT00569231|540438862|FG000|Overall Study|Airfare expense|2|||
149811627|NCT00569231|540438862|FG000|Overall Study|Withdrawal by Subject|1|||
149811628|NCT00569231|540438862|FG000|Overall Study|Car accident injury|1|||
149811629|NCT00569231|540438862|FG000|Overall Study|Non-compliance|2|||
149811630|NCT02328547|540438863|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
149811631|NCT02328547|540438864|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
149811632|NCT02328547|540438863|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
149811633|NCT02328547|540438864|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
149811634|NCT01190098|540438868|FG000|Overall Study|Adverse Event|2|||
149811635|NCT01190098|540438869|FG001|Overall Study|Adverse Event|0|||
149811636|NCT01190098|540438868|FG000|Overall Study|Patient coomorbidity|0|||
149811637|NCT01190098|540438869|FG001|Overall Study|Patient coomorbidity|1|||
149811638|NCT01190098|540438868|FG000|Overall Study|Lack of transportation|1|||
149811639|NCT01190098|540438869|FG001|Overall Study|Lack of transportation|0|||
149811640|NCT01190098|540438868|FG000|Overall Study|Other|0|||
149811641|NCT01190098|540438869|FG001|Overall Study|Other|1|||
149811642|NCT00344305|540438870|FG000|Overall Study|Lost to Follow-up|2|||
149811643|NCT00344305|540438871|FG001|Overall Study|Lost to Follow-up|0|||
149811644|NCT00344305|540438870|FG000|Overall Study|Participant was not contacted in window|0|||
149811645|NCT00344305|540438871|FG001|Overall Study|Participant was not contacted in window|1|||
149811646|NCT01586624|540438877|FG000|Overall Study|Adverse Event|3|||
149811647|NCT01586624|540438878|FG001|Overall Study|Adverse Event|0|||
149811648|NCT01586624|540438879|FG002|Overall Study|Adverse Event|2|||
149811649|NCT01586624|540438880|FG003|Overall Study|Adverse Event|1|||
149811650|NCT01586624|540438881|FG004|Overall Study|Adverse Event|3|||
149811651|NCT01586624|540438882|FG005|Overall Study|Adverse Event|3|||
149811652|NCT01586624|540438883|FG006|Overall Study|Adverse Event|2|||
149811653|NCT01586624|540438884|FG007|Overall Study|Adverse Event|3|||
149811654|NCT01586624|540438877|FG000|Overall Study|Physician Decision|0|||
149811655|NCT01586624|540438878|FG001|Overall Study|Physician Decision|1|||
149811656|NCT01586624|540438879|FG002|Overall Study|Physician Decision|1|||
149811657|NCT01586624|540438880|FG003|Overall Study|Physician Decision|0|||
149811658|NCT01586624|540438881|FG004|Overall Study|Physician Decision|2|||
149811659|NCT01586624|540438882|FG005|Overall Study|Physician Decision|0|||
149811660|NCT01586624|540438883|FG006|Overall Study|Physician Decision|1|||
149811661|NCT01586624|540438884|FG007|Overall Study|Physician Decision|1|||
149811662|NCT01586624|540438877|FG000|Overall Study|Withdrawal by Subject|0|||
149811663|NCT01586624|540438878|FG001|Overall Study|Withdrawal by Subject|0|||
149811664|NCT01586624|540438879|FG002|Overall Study|Withdrawal by Subject|0|||
149811665|NCT01586624|540438880|FG003|Overall Study|Withdrawal by Subject|1|||
149811666|NCT01586624|540438881|FG004|Overall Study|Withdrawal by Subject|0|||
149811667|NCT01586624|540438882|FG005|Overall Study|Withdrawal by Subject|0|||
149811668|NCT01586624|540438883|FG006|Overall Study|Withdrawal by Subject|0|||
149811669|NCT01586624|540438884|FG007|Overall Study|Withdrawal by Subject|0|||
149811670|NCT01586624|540438877|FG000|Overall Study|Evidence of disease progression|1|||
149811671|NCT01586624|540438878|FG001|Overall Study|Evidence of disease progression|3|||
149811672|NCT01586624|540438879|FG002|Overall Study|Evidence of disease progression|2|||
149811673|NCT01586624|540438880|FG003|Overall Study|Evidence of disease progression|5|||
149811674|NCT01586624|540438881|FG004|Overall Study|Evidence of disease progression|3|||
149811675|NCT01586624|540438882|FG005|Overall Study|Evidence of disease progression|5|||
149811676|NCT01586624|540438883|FG006|Overall Study|Evidence of disease progression|4|||
149811677|NCT01586624|540438884|FG007|Overall Study|Evidence of disease progression|6|||
149811678|NCT01586624|540438877|FG000|Overall Study|Screen failure (no treatment received)|0|||
149811679|NCT01586624|540438878|FG001|Overall Study|Screen failure (no treatment received)|0|||
149811680|NCT01586624|540438879|FG002|Overall Study|Screen failure (no treatment received)|0|||
149811681|NCT01586624|540438880|FG003|Overall Study|Screen failure (no treatment received)|0|||
149811682|NCT01586624|540438881|FG004|Overall Study|Screen failure (no treatment received)|0|||
149811683|NCT01586624|540438882|FG005|Overall Study|Screen failure (no treatment received)|0|||
149811684|NCT01586624|540438883|FG006|Overall Study|Screen failure (no treatment received)|1|||
149811685|NCT01586624|540438884|FG007|Overall Study|Screen failure (no treatment received)|0|||
149811686|NCT00953927|540438887|FG000|Overall Study|Lost to Follow-up|61|||
149811687|NCT00953927|540438888|FG001|Overall Study|Lost to Follow-up|65|||
149811688|NCT00953927|540438887|FG000|Overall Study|Withdrawal by Subject|36|||
149811689|NCT00953927|540438888|FG001|Overall Study|Withdrawal by Subject|25|||
149811690|NCT00953927|540438887|FG000|Overall Study|Death|7|||
149811691|NCT00953927|540438888|FG001|Overall Study|Death|4|||
149811692|NCT00953927|540438887|FG000|Overall Study|Other study discontinuation|1|||
149811693|NCT00953927|540438888|FG001|Overall Study|Other study discontinuation|1|||
149811694|NCT01396161|540438889|FG000|Overall Study|Withdrawal by Subject|0|||
149811695|NCT01396161|540438890|FG001|Overall Study|Withdrawal by Subject|0|||
149811696|NCT01396161|540438891|FG002|Overall Study|Withdrawal by Subject|0|||
149811697|NCT01396161|540438892|FG003|Overall Study|Withdrawal by Subject|0|||
149811698|NCT01396161|540438893|FG004|Overall Study|Withdrawal by Subject|1|||
149811699|NCT01396161|540438894|FG005|Overall Study|Withdrawal by Subject|0|||
149811700|NCT01396161|540438895|FG006|Overall Study|Withdrawal by Subject|0|||
149811701|NCT01396161|540438889|FG000|Overall Study|Other|0|||
149811702|NCT01396161|540438890|FG001|Overall Study|Other|0|||
149811703|NCT01396161|540438891|FG002|Overall Study|Other|0|||
149811704|NCT01396161|540438892|FG003|Overall Study|Other|0|||
149811705|NCT01396161|540438893|FG004|Overall Study|Other|0|||
149811706|NCT01396161|540438894|FG005|Overall Study|Other|0|||
149811707|NCT01396161|540438895|FG006|Overall Study|Other|1|||
149811708|NCT02962739|540438900|FG000|Overall Study|Withdrawal by Subject|0|||
149811709|NCT02962739|540438901|FG001|Overall Study|Withdrawal by Subject|1|||
150153286|NCT01474512|541699604|FG015|Induction Period|Lack of Efficacy|0|||
150153287|NCT01474512|541699605|FG016|Induction Period|Lack of Efficacy|0|||
150153288|NCT01474512|541699606|FG017|Induction Period|Lack of Efficacy|0|||
149811710|NCT02962739|540438902|FG002|Overall Study|Withdrawal by Subject|0|||
149811711|NCT02962739|540438903|FG003|Overall Study|Withdrawal by Subject|0|||
149811712|NCT02962739|540438904|FG004|Overall Study|Withdrawal by Subject|0|||
149811713|NCT02962739|540438905|FG005|Overall Study|Withdrawal by Subject|0|||
149811714|NCT02962739|540438900|FG000|Overall Study|Protocol Violation|0|||
149811715|NCT02962739|540438901|FG001|Overall Study|Protocol Violation|0|||
149811716|NCT02962739|540438902|FG002|Overall Study|Protocol Violation|1|||
149811717|NCT02962739|540438903|FG003|Overall Study|Protocol Violation|0|||
149811718|NCT02962739|540438904|FG004|Overall Study|Protocol Violation|1|||
149811719|NCT02962739|540438905|FG005|Overall Study|Protocol Violation|0|||
149811720|NCT00306852|540438908|FG000|Overall Study|Death|14|||
149811721|NCT00306852|540438909|FG001|Overall Study|Death|14|||
149811722|NCT00306852|540438908|FG000|Overall Study|Lost to Follow-up|15|||
149811723|NCT00306852|540438909|FG001|Overall Study|Lost to Follow-up|24|||
149811724|NCT03578276|540438910|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
149811725|NCT03578276|540438911|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
149811726|NCT02360397|540438914|FG000|Overall Study|Incomplete screening|3|||
149811727|NCT02360397|540438914|FG000|Overall Study|Adverse Event|1|||
149811728|NCT01537549|540438915|FG000|Overall Study|Lost to Follow-up|1|||
149811729|NCT01537549|540438915|FG000|Overall Study|Withdrawal by Subject|2|||
149811730|NCT00883740|540438916|FG000|First Intervention|Lost to Follow-up|1|||
149811731|NCT00883740|540438917|FG001|First Intervention|Lost to Follow-up|0|||
149811732|NCT00883740|540438916|FG000|First Intervention|No longer willing to participate|2|||
149811733|NCT00883740|540438917|FG001|First Intervention|No longer willing to participate|0|||
149811734|NCT00883740|540438916|FG000|First Intervention|Protocol Violation|3|||
149811735|NCT00883740|540438917|FG001|First Intervention|Protocol Violation|6|||
149811736|NCT00883740|540438916|FG000|First Intervention|Adverse Event|1|||
149811737|NCT00883740|540438917|FG001|First Intervention|Adverse Event|2|||
149811738|NCT00883740|540438916|FG000|Second Intervention|Protocol Violation|1|||
149811739|NCT00883740|540438917|FG001|Second Intervention|Protocol Violation|0|||
149811740|NCT00883740|540438916|FG000|Second Intervention|No longer willing to participate|0|||
149811741|NCT00883740|540438917|FG001|Second Intervention|No longer willing to participate|1|||
149811742|NCT01875991|540438924|FG000|Overall Study|Withdrawal by Subject|6|||
150153289|NCT01474512|541699589|FG000|Induction Period|Withdrawal by Subject|6|||
149811743|NCT01875991|540438925|FG001|Overall Study|Withdrawal by Subject|6|||
149811744|NCT01875991|540438924|FG000|Overall Study|Sponsor Decision|1|||
149811745|NCT01875991|540438925|FG001|Overall Study|Sponsor Decision|0|||
149811746|NCT02125734|540438926|FG000|Period 2|Adverse Event|0|||
149811747|NCT02125734|540438927|FG001|Period 2|Adverse Event|1|||
149811748|NCT01308762|540438928|FG000|Overall Study|Protocol Violation|0|||
149811749|NCT01308762|540438929|FG001|Overall Study|Protocol Violation|1|||
149811750|NCT01308762|540438930|FG002|Overall Study|Protocol Violation|0|||
149811751|NCT02617446|540438931|FG000|Overall Study|Withdrawal by Subject|0|||
149811752|NCT02617446|540438932|FG001|Overall Study|Withdrawal by Subject|2|||
149811753|NCT02617446|540438933|FG002|Overall Study|Withdrawal by Subject|0|||
149811754|NCT02617446|540438931|FG000|Overall Study|Adverse Event|1|||
149811755|NCT02617446|540438932|FG001|Overall Study|Adverse Event|0|||
149811756|NCT02617446|540438933|FG002|Overall Study|Adverse Event|5|||
149811757|NCT02617446|540438931|FG000|Overall Study|Lost to Follow-up|3|||
149811758|NCT02617446|540438932|FG001|Overall Study|Lost to Follow-up|0|||
149811759|NCT02617446|540438933|FG002|Overall Study|Lost to Follow-up|0|||
149811760|NCT02617446|540438931|FG000|Overall Study|Death|0|||
149811761|NCT02617446|540438932|FG001|Overall Study|Death|0|||
149811762|NCT02617446|540438933|FG002|Overall Study|Death|2|||
149811763|NCT01556490|540438942|FG000|Randomized Patients Summary|Protocol Violation|22|||
149811764|NCT01556490|540438943|FG001|Randomized Patients Summary|Protocol Violation|23|||
149811765|NCT01556490|540438942|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
149811766|NCT01556490|540438943|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
149811767|NCT02058368|540438944|FG000|Overall Study|Adverse Event|15|||
149811768|NCT02058368|540438945|FG001|Overall Study|Adverse Event|20|||
149811769|NCT02058368|540438944|FG000|Overall Study|Lack of Efficacy|0|||
149811770|NCT02058368|540438945|FG001|Overall Study|Lack of Efficacy|1|||
149811771|NCT02058368|540438944|FG000|Overall Study|Protocol Violation|0|||
149811772|NCT02058368|540438945|FG001|Overall Study|Protocol Violation|4|||
149811773|NCT02058368|540438944|FG000|Overall Study|Lost to Follow-up|2|||
149811774|NCT02058368|540438945|FG001|Overall Study|Lost to Follow-up|0|||
149811775|NCT02058368|540438944|FG000|Overall Study|Physician Decision|2|||
149811776|NCT02058368|540438945|FG001|Overall Study|Physician Decision|3|||
149811777|NCT02058368|540438944|FG000|Overall Study|Withdrawal by Subject|22|||
149811778|NCT02058368|540438945|FG001|Overall Study|Withdrawal by Subject|26|||
149811779|NCT01652872|540438946|FG000|Overall Study|Death|36|||
149811780|NCT01652872|540438947|FG001|Overall Study|Death|39|||
149811781|NCT01652872|540438946|FG000|Overall Study|Lost to Follow-up|28|||
149811782|NCT01652872|540438947|FG001|Overall Study|Lost to Follow-up|23|||
149811783|NCT01652872|540438946|FG000|Overall Study|Decision by sponsor|5|||
149811784|NCT01652872|540438947|FG001|Overall Study|Decision by sponsor|7|||
149811785|NCT01652872|540438946|FG000|Overall Study|Withdrawal by Subject|76|||
149811786|NCT01652872|540438947|FG001|Overall Study|Withdrawal by Subject|84|||
149811787|NCT02587325|540438948|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
149811788|NCT02587325|540438949|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
149811789|NCT02587325|540438950|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
150153290|NCT01474512|541699590|FG001|Induction Period|Withdrawal by Subject|6|||
150153291|NCT01474512|541699591|FG002|Induction Period|Withdrawal by Subject|5|||
150153292|NCT01474512|541699592|FG003|Induction Period|Withdrawal by Subject|0|||
150153293|NCT01474512|541699593|FG004|Induction Period|Withdrawal by Subject|0|||
150153294|NCT01474512|541699594|FG005|Induction Period|Withdrawal by Subject|0|||
150153295|NCT01474512|541699595|FG006|Induction Period|Withdrawal by Subject|0|||
150153296|NCT01474512|541699596|FG007|Induction Period|Withdrawal by Subject|0|||
150153297|NCT01474512|541699597|FG008|Induction Period|Withdrawal by Subject|0|||
150153298|NCT01474512|541699598|FG009|Induction Period|Withdrawal by Subject|0|||
150153299|NCT01474512|541699599|FG010|Induction Period|Withdrawal by Subject|0|||
150153300|NCT01474512|541699600|FG011|Induction Period|Withdrawal by Subject|0|||
150153301|NCT01474512|541699601|FG012|Induction Period|Withdrawal by Subject|0|||
149811790|NCT02587325|540438951|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
149811791|NCT02587325|540438952|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
149811792|NCT02587325|540438948|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
149811793|NCT02587325|540438949|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
149811794|NCT02587325|540438950|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
149811795|NCT02587325|540438951|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
149811796|NCT02587325|540438952|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
149811797|NCT02587325|540438948|FG000|32-Week Optional Extension Part|Adverse Event|0|||
149811798|NCT02587325|540438949|FG001|32-Week Optional Extension Part|Adverse Event|0|||
149811799|NCT02587325|540438950|FG002|32-Week Optional Extension Part|Adverse Event|1|||
149811800|NCT02587325|540438951|FG003|32-Week Optional Extension Part|Adverse Event|0|||
149811801|NCT02587325|540438952|FG004|32-Week Optional Extension Part|Adverse Event|0|||
149811802|NCT02587325|540438948|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
150153302|NCT01474512|541699602|FG013|Induction Period|Withdrawal by Subject|0|||
150153303|NCT01474512|541699603|FG014|Induction Period|Withdrawal by Subject|0|||
150153304|NCT01474512|541699604|FG015|Induction Period|Withdrawal by Subject|0|||
149811803|NCT02587325|540438949|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
149811804|NCT02587325|540438950|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
150153305|NCT01474512|541699605|FG016|Induction Period|Withdrawal by Subject|0|||
150153306|NCT01474512|541699606|FG017|Induction Period|Withdrawal by Subject|0|||
150153307|NCT01474512|541699589|FG000|Induction Period|Protocol Violation|3|||
150153308|NCT01474512|541699590|FG001|Induction Period|Protocol Violation|6|||
150153309|NCT01474512|541699591|FG002|Induction Period|Protocol Violation|0|||
150153310|NCT01474512|541699592|FG003|Induction Period|Protocol Violation|0|||
150153311|NCT01474512|541699593|FG004|Induction Period|Protocol Violation|0|||
150153312|NCT01474512|541699594|FG005|Induction Period|Protocol Violation|0|||
150153313|NCT01474512|541699595|FG006|Induction Period|Protocol Violation|0|||
150153314|NCT01474512|541699596|FG007|Induction Period|Protocol Violation|0|||
150153315|NCT01474512|541699597|FG008|Induction Period|Protocol Violation|0|||
150153316|NCT01474512|541699598|FG009|Induction Period|Protocol Violation|0|||
150153317|NCT01474512|541699599|FG010|Induction Period|Protocol Violation|0|||
150153318|NCT01474512|541699600|FG011|Induction Period|Protocol Violation|0|||
150153319|NCT01474512|541699601|FG012|Induction Period|Protocol Violation|0|||
150153320|NCT01474512|541699602|FG013|Induction Period|Protocol Violation|0|||
150153321|NCT01474512|541699603|FG014|Induction Period|Protocol Violation|0|||
150153322|NCT01474512|541699604|FG015|Induction Period|Protocol Violation|0|||
150153323|NCT01474512|541699605|FG016|Induction Period|Protocol Violation|0|||
150153324|NCT01474512|541699606|FG017|Induction Period|Protocol Violation|0|||
150153325|NCT01474512|541699589|FG000|Induction Period|Sponsor Decision|1|||
150153326|NCT01474512|541699590|FG001|Induction Period|Sponsor Decision|1|||
150153327|NCT01474512|541699591|FG002|Induction Period|Sponsor Decision|1|||
150153328|NCT01474512|541699592|FG003|Induction Period|Sponsor Decision|0|||
150153329|NCT01474512|541699593|FG004|Induction Period|Sponsor Decision|0|||
150153330|NCT01474512|541699594|FG005|Induction Period|Sponsor Decision|0|||
150153331|NCT01474512|541699595|FG006|Induction Period|Sponsor Decision|0|||
150153332|NCT01474512|541699596|FG007|Induction Period|Sponsor Decision|0|||
150153333|NCT01474512|541699597|FG008|Induction Period|Sponsor Decision|0|||
150153334|NCT01474512|541699598|FG009|Induction Period|Sponsor Decision|0|||
150153335|NCT01474512|541699599|FG010|Induction Period|Sponsor Decision|0|||
150153336|NCT01474512|541699600|FG011|Induction Period|Sponsor Decision|0|||
150153337|NCT01474512|541699601|FG012|Induction Period|Sponsor Decision|0|||
150153338|NCT01474512|541699602|FG013|Induction Period|Sponsor Decision|0|||
150153339|NCT01474512|541699603|FG014|Induction Period|Sponsor Decision|0|||
150153340|NCT01474512|541699604|FG015|Induction Period|Sponsor Decision|0|||
150153341|NCT01474512|541699605|FG016|Induction Period|Sponsor Decision|0|||
150153342|NCT01474512|541699606|FG017|Induction Period|Sponsor Decision|0|||
150153343|NCT01474512|541699589|FG000|Induction Period|Lost to Follow-up|1|||
150153344|NCT01474512|541699590|FG001|Induction Period|Lost to Follow-up|0|||
150153345|NCT01474512|541699591|FG002|Induction Period|Lost to Follow-up|2|||
150153346|NCT01474512|541699592|FG003|Induction Period|Lost to Follow-up|0|||
150153347|NCT01474512|541699593|FG004|Induction Period|Lost to Follow-up|0|||
150153348|NCT01474512|541699594|FG005|Induction Period|Lost to Follow-up|0|||
150153349|NCT01474512|541699595|FG006|Induction Period|Lost to Follow-up|0|||
150153350|NCT01474512|541699596|FG007|Induction Period|Lost to Follow-up|0|||
150153351|NCT01474512|541699597|FG008|Induction Period|Lost to Follow-up|0|||
150153352|NCT01474512|541699598|FG009|Induction Period|Lost to Follow-up|0|||
150153353|NCT01474512|541699599|FG010|Induction Period|Lost to Follow-up|0|||
150153354|NCT01474512|541699600|FG011|Induction Period|Lost to Follow-up|0|||
150153355|NCT01474512|541699601|FG012|Induction Period|Lost to Follow-up|0|||
150153356|NCT01474512|541699602|FG013|Induction Period|Lost to Follow-up|0|||
150153357|NCT01474512|541699603|FG014|Induction Period|Lost to Follow-up|0|||
150153358|NCT01474512|541699604|FG015|Induction Period|Lost to Follow-up|0|||
150153359|NCT01474512|541699605|FG016|Induction Period|Lost to Follow-up|0|||
150153360|NCT01474512|541699606|FG017|Induction Period|Lost to Follow-up|0|||
150153361|NCT01474512|541699589|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153362|NCT01474512|541699590|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153363|NCT01474512|541699591|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153364|NCT01474512|541699592|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
150153365|NCT01474512|541699593|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
150153366|NCT01474512|541699594|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
150153367|NCT01474512|541699595|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
150153368|NCT01474512|541699596|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153369|NCT01474512|541699597|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153370|NCT01474512|541699598|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153371|NCT01474512|541699599|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153372|NCT01474512|541699600|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153373|NCT01474512|541699601|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153374|NCT01474512|541699602|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153375|NCT01474512|541699603|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153376|NCT01474512|541699604|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153377|NCT01474512|541699605|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153378|NCT01474512|541699606|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
150153379|NCT01474512|541699589|FG000|Maintenance Period|Adverse Event|0|||
150153380|NCT01474512|541699590|FG001|Maintenance Period|Adverse Event|0|||
150153381|NCT01474512|541699591|FG002|Maintenance Period|Adverse Event|0|||
150153382|NCT01474512|541699592|FG003|Maintenance Period|Adverse Event|4|||
150153383|NCT01474512|541699593|FG004|Maintenance Period|Adverse Event|2|||
150153384|NCT01474512|541699594|FG005|Maintenance Period|Adverse Event|7|||
150153385|NCT01474512|541699595|FG006|Maintenance Period|Adverse Event|0|||
150153386|NCT01474512|541699596|FG007|Maintenance Period|Adverse Event|19|||
150153387|NCT01474512|541699597|FG008|Maintenance Period|Adverse Event|1|||
150153388|NCT01474512|541699598|FG009|Maintenance Period|Adverse Event|3|||
150153389|NCT01474512|541699599|FG010|Maintenance Period|Adverse Event|0|||
150153390|NCT01474512|541699600|FG011|Maintenance Period|Adverse Event|0|||
150153391|NCT01474512|541699601|FG012|Maintenance Period|Adverse Event|0|||
150153392|NCT01474512|541699602|FG013|Maintenance Period|Adverse Event|0|||
150153393|NCT01474512|541699603|FG014|Maintenance Period|Adverse Event|0|||
150153394|NCT01474512|541699604|FG015|Maintenance Period|Adverse Event|0|||
150153395|NCT01474512|541699605|FG016|Maintenance Period|Adverse Event|0|||
150153396|NCT01474512|541699606|FG017|Maintenance Period|Adverse Event|0|||
150153397|NCT01474512|541699589|FG000|Maintenance Period|Withdrawal by Subject|0|||
150153398|NCT01474512|541699590|FG001|Maintenance Period|Withdrawal by Subject|0|||
150153399|NCT01474512|541699591|FG002|Maintenance Period|Withdrawal by Subject|0|||
150153400|NCT01474512|541699592|FG003|Maintenance Period|Withdrawal by Subject|6|||
150153401|NCT01474512|541699593|FG004|Maintenance Period|Withdrawal by Subject|2|||
150153402|NCT01474512|541699594|FG005|Maintenance Period|Withdrawal by Subject|3|||
150153403|NCT01474512|541699595|FG006|Maintenance Period|Withdrawal by Subject|1|||
150153404|NCT01474512|541699596|FG007|Maintenance Period|Withdrawal by Subject|6|||
150153405|NCT01474512|541699597|FG008|Maintenance Period|Withdrawal by Subject|3|||
150153406|NCT01474512|541699598|FG009|Maintenance Period|Withdrawal by Subject|1|||
150153407|NCT01474512|541699599|FG010|Maintenance Period|Withdrawal by Subject|0|||
150153408|NCT01474512|541699600|FG011|Maintenance Period|Withdrawal by Subject|0|||
150153409|NCT01474512|541699601|FG012|Maintenance Period|Withdrawal by Subject|0|||
150153410|NCT01474512|541699602|FG013|Maintenance Period|Withdrawal by Subject|0|||
150153411|NCT01474512|541699603|FG014|Maintenance Period|Withdrawal by Subject|0|||
150153412|NCT01474512|541699604|FG015|Maintenance Period|Withdrawal by Subject|0|||
150153413|NCT01474512|541699605|FG016|Maintenance Period|Withdrawal by Subject|0|||
150153414|NCT01474512|541699606|FG017|Maintenance Period|Withdrawal by Subject|0|||
150153415|NCT01474512|541699589|FG000|Maintenance Period|Lost to Follow-up|0|||
150153416|NCT01474512|541699590|FG001|Maintenance Period|Lost to Follow-up|0|||
150153417|NCT01474512|541699591|FG002|Maintenance Period|Lost to Follow-up|0|||
150153418|NCT01474512|541699592|FG003|Maintenance Period|Lost to Follow-up|3|||
150153419|NCT01474512|541699593|FG004|Maintenance Period|Lost to Follow-up|3|||
150153420|NCT01474512|541699594|FG005|Maintenance Period|Lost to Follow-up|0|||
150153421|NCT01474512|541699595|FG006|Maintenance Period|Lost to Follow-up|0|||
150153422|NCT01474512|541699596|FG007|Maintenance Period|Lost to Follow-up|2|||
150153423|NCT01474512|541699597|FG008|Maintenance Period|Lost to Follow-up|1|||
150153424|NCT01474512|541699598|FG009|Maintenance Period|Lost to Follow-up|1|||
150153425|NCT01474512|541699599|FG010|Maintenance Period|Lost to Follow-up|0|||
150153426|NCT01474512|541699600|FG011|Maintenance Period|Lost to Follow-up|0|||
150153427|NCT01474512|541699601|FG012|Maintenance Period|Lost to Follow-up|0|||
150153428|NCT01474512|541699602|FG013|Maintenance Period|Lost to Follow-up|0|||
150153429|NCT01474512|541699603|FG014|Maintenance Period|Lost to Follow-up|0|||
150153430|NCT01474512|541699604|FG015|Maintenance Period|Lost to Follow-up|0|||
150153431|NCT01474512|541699605|FG016|Maintenance Period|Lost to Follow-up|0|||
150153432|NCT01474512|541699606|FG017|Maintenance Period|Lost to Follow-up|0|||
150153433|NCT01474512|541699589|FG000|Maintenance Period|Death|0|||
150153434|NCT01474512|541699590|FG001|Maintenance Period|Death|0|||
150153435|NCT01474512|541699591|FG002|Maintenance Period|Death|0|||
150153436|NCT01474512|541699592|FG003|Maintenance Period|Death|0|||
150153437|NCT01474512|541699593|FG004|Maintenance Period|Death|0|||
150153438|NCT01474512|541699594|FG005|Maintenance Period|Death|2|||
150153439|NCT01474512|541699595|FG006|Maintenance Period|Death|0|||
150153440|NCT01474512|541699596|FG007|Maintenance Period|Death|0|||
150153441|NCT01474512|541699597|FG008|Maintenance Period|Death|0|||
150153442|NCT01474512|541699598|FG009|Maintenance Period|Death|0|||
150153443|NCT01474512|541699599|FG010|Maintenance Period|Death|0|||
150153444|NCT01474512|541699600|FG011|Maintenance Period|Death|0|||
150153445|NCT01474512|541699601|FG012|Maintenance Period|Death|0|||
150153446|NCT01474512|541699602|FG013|Maintenance Period|Death|0|||
150153447|NCT01474512|541699603|FG014|Maintenance Period|Death|0|||
150153448|NCT01474512|541699604|FG015|Maintenance Period|Death|0|||
150153449|NCT01474512|541699605|FG016|Maintenance Period|Death|0|||
150153450|NCT01474512|541699606|FG017|Maintenance Period|Death|0|||
150153451|NCT01474512|541699589|FG000|Maintenance Period|Physician Decision|0|||
150153452|NCT01474512|541699590|FG001|Maintenance Period|Physician Decision|0|||
150153453|NCT01474512|541699591|FG002|Maintenance Period|Physician Decision|0|||
150153454|NCT01474512|541699592|FG003|Maintenance Period|Physician Decision|0|||
150153455|NCT01474512|541699593|FG004|Maintenance Period|Physician Decision|0|||
150153456|NCT01474512|541699594|FG005|Maintenance Period|Physician Decision|1|||
150153457|NCT01474512|541699595|FG006|Maintenance Period|Physician Decision|0|||
150153458|NCT01474512|541699596|FG007|Maintenance Period|Physician Decision|2|||
150153459|NCT01474512|541699597|FG008|Maintenance Period|Physician Decision|0|||
150153460|NCT01474512|541699598|FG009|Maintenance Period|Physician Decision|0|||
150153461|NCT01474512|541699599|FG010|Maintenance Period|Physician Decision|0|||
150153462|NCT01474512|541699600|FG011|Maintenance Period|Physician Decision|0|||
150153463|NCT01474512|541699601|FG012|Maintenance Period|Physician Decision|0|||
150153464|NCT01474512|541699602|FG013|Maintenance Period|Physician Decision|0|||
150153465|NCT01474512|541699603|FG014|Maintenance Period|Physician Decision|0|||
150153466|NCT01474512|541699604|FG015|Maintenance Period|Physician Decision|0|||
150153467|NCT01474512|541699605|FG016|Maintenance Period|Physician Decision|0|||
150153468|NCT01474512|541699606|FG017|Maintenance Period|Physician Decision|0|||
150153469|NCT01474512|541699589|FG000|Maintenance Period|Clinical Relapse|0|||
150153470|NCT01474512|541699590|FG001|Maintenance Period|Clinical Relapse|0|||
150153471|NCT01474512|541699591|FG002|Maintenance Period|Clinical Relapse|0|||
150153472|NCT01474512|541699592|FG003|Maintenance Period|Clinical Relapse|1|||
150153473|NCT01474512|541699593|FG004|Maintenance Period|Clinical Relapse|0|||
150153474|NCT01474512|541699594|FG005|Maintenance Period|Clinical Relapse|0|||
150153475|NCT01474512|541699595|FG006|Maintenance Period|Clinical Relapse|0|||
150153476|NCT01474512|541699596|FG007|Maintenance Period|Clinical Relapse|0|||
150153477|NCT01474512|541699597|FG008|Maintenance Period|Clinical Relapse|0|||
150153478|NCT01474512|541699598|FG009|Maintenance Period|Clinical Relapse|0|||
150153479|NCT01474512|541699599|FG010|Maintenance Period|Clinical Relapse|0|||
150153480|NCT01474512|541699600|FG011|Maintenance Period|Clinical Relapse|0|||
150153481|NCT01474512|541699601|FG012|Maintenance Period|Clinical Relapse|0|||
150153482|NCT01474512|541699602|FG013|Maintenance Period|Clinical Relapse|0|||
150153483|NCT01474512|541699603|FG014|Maintenance Period|Clinical Relapse|0|||
150153484|NCT01474512|541699604|FG015|Maintenance Period|Clinical Relapse|0|||
150153485|NCT01474512|541699605|FG016|Maintenance Period|Clinical Relapse|0|||
150153486|NCT01474512|541699606|FG017|Maintenance Period|Clinical Relapse|0|||
150153487|NCT01474512|541699589|FG000|Maintenance Period|Lack of Efficacy|0|||
150153488|NCT01474512|541699590|FG001|Maintenance Period|Lack of Efficacy|0|||
150153489|NCT01474512|541699591|FG002|Maintenance Period|Lack of Efficacy|0|||
150153490|NCT01474512|541699592|FG003|Maintenance Period|Lack of Efficacy|1|||
150153491|NCT01474512|541699593|FG004|Maintenance Period|Lack of Efficacy|0|||
150153492|NCT01474512|541699594|FG005|Maintenance Period|Lack of Efficacy|0|||
150153493|NCT01474512|541699595|FG006|Maintenance Period|Lack of Efficacy|0|||
150153494|NCT01474512|541699596|FG007|Maintenance Period|Lack of Efficacy|11|||
150153495|NCT01474512|541699597|FG008|Maintenance Period|Lack of Efficacy|11|||
150153496|NCT01474512|541699598|FG009|Maintenance Period|Lack of Efficacy|12|||
150153497|NCT01474512|541699599|FG010|Maintenance Period|Lack of Efficacy|0|||
150153498|NCT01474512|541699600|FG011|Maintenance Period|Lack of Efficacy|0|||
150153499|NCT01474512|541699601|FG012|Maintenance Period|Lack of Efficacy|0|||
150153500|NCT01474512|541699602|FG013|Maintenance Period|Lack of Efficacy|0|||
150153501|NCT01474512|541699603|FG014|Maintenance Period|Lack of Efficacy|0|||
150153502|NCT01474512|541699604|FG015|Maintenance Period|Lack of Efficacy|0|||
150153503|NCT01474512|541699605|FG016|Maintenance Period|Lack of Efficacy|0|||
150153504|NCT01474512|541699606|FG017|Maintenance Period|Lack of Efficacy|0|||
150153505|NCT01474512|541699589|FG000|Maintenance Period|Protocol Violation|0|||
150153506|NCT01474512|541699590|FG001|Maintenance Period|Protocol Violation|0|||
150153507|NCT01474512|541699591|FG002|Maintenance Period|Protocol Violation|0|||
150153508|NCT01474512|541699592|FG003|Maintenance Period|Protocol Violation|1|||
150153509|NCT01474512|541699593|FG004|Maintenance Period|Protocol Violation|0|||
150153510|NCT01474512|541699594|FG005|Maintenance Period|Protocol Violation|0|||
150153511|NCT01474512|541699595|FG006|Maintenance Period|Protocol Violation|0|||
150153512|NCT01474512|541699596|FG007|Maintenance Period|Protocol Violation|1|||
150153513|NCT01474512|541699597|FG008|Maintenance Period|Protocol Violation|0|||
150153514|NCT01474512|541699598|FG009|Maintenance Period|Protocol Violation|1|||
150153515|NCT01474512|541699599|FG010|Maintenance Period|Protocol Violation|0|||
150153516|NCT01474512|541699600|FG011|Maintenance Period|Protocol Violation|0|||
150153517|NCT01474512|541699601|FG012|Maintenance Period|Protocol Violation|0|||
150153518|NCT01474512|541699602|FG013|Maintenance Period|Protocol Violation|0|||
150153519|NCT01474512|541699603|FG014|Maintenance Period|Protocol Violation|0|||
150153520|NCT01474512|541699604|FG015|Maintenance Period|Protocol Violation|0|||
150153521|NCT01474512|541699605|FG016|Maintenance Period|Protocol Violation|0|||
150153522|NCT01474512|541699606|FG017|Maintenance Period|Protocol Violation|0|||
150153523|NCT01474512|541699589|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
150153524|NCT01474512|541699590|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
150153525|NCT01474512|541699591|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
149811805|NCT02587325|540438951|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
149811806|NCT02587325|540438952|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
150153526|NCT01474512|541699592|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
150153527|NCT01474512|541699593|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
150153528|NCT01474512|541699594|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
150153529|NCT01474512|541699595|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
150153530|NCT01474512|541699596|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
150153531|NCT01474512|541699597|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
150153532|NCT01474512|541699598|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
149811807|NCT00390572|540438953|FG000|Overall Study|Lost to Follow-up|8|||
149811808|NCT00390572|540438954|FG001|Overall Study|Lost to Follow-up|4|||
150153533|NCT01474512|541699599|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
150153534|NCT01474512|541699600|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
150153535|NCT01474512|541699601|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
150153536|NCT01474512|541699602|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
150153537|NCT01474512|541699603|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
150153538|NCT01474512|541699604|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
150153539|NCT01474512|541699605|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
150153540|NCT01474512|541699606|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
150153541|NCT01474512|541699589|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
150153542|NCT01474512|541699590|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
150153543|NCT01474512|541699591|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
150153544|NCT01474512|541699592|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
150153545|NCT01474512|541699593|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
150153546|NCT01474512|541699594|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
150153547|NCT01474512|541699595|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
150153548|NCT01474512|541699596|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
150153549|NCT01474512|541699597|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
150153550|NCT01474512|541699598|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
150153551|NCT01474512|541699599|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
150153552|NCT01474512|541699600|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
150153553|NCT01474512|541699601|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
150153554|NCT01474512|541699602|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
150153555|NCT01474512|541699603|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
150153556|NCT01474512|541699604|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
150153557|NCT01474512|541699605|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
150153558|NCT01474512|541699606|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
150153559|NCT01474512|541699589|FG000|Long-Term Extension Period|Adverse Event|0|||
150153560|NCT01474512|541699590|FG001|Long-Term Extension Period|Adverse Event|0|||
150153561|NCT01474512|541699591|FG002|Long-Term Extension Period|Adverse Event|0|||
150153562|NCT01474512|541699592|FG003|Long-Term Extension Period|Adverse Event|0|||
150153563|NCT01474512|541699593|FG004|Long-Term Extension Period|Adverse Event|0|||
150153564|NCT01474512|541699594|FG005|Long-Term Extension Period|Adverse Event|0|||
150153565|NCT01474512|541699595|FG006|Long-Term Extension Period|Adverse Event|0|||
150153566|NCT01474512|541699596|FG007|Long-Term Extension Period|Adverse Event|0|||
150153567|NCT01474512|541699597|FG008|Long-Term Extension Period|Adverse Event|0|||
150153568|NCT01474512|541699598|FG009|Long-Term Extension Period|Adverse Event|0|||
150153569|NCT01474512|541699599|FG010|Long-Term Extension Period|Adverse Event|0|||
150153570|NCT01474512|541699600|FG011|Long-Term Extension Period|Adverse Event|1|||
150153571|NCT01474512|541699601|FG012|Long-Term Extension Period|Adverse Event|57|||
150153572|NCT01474512|541699602|FG013|Long-Term Extension Period|Adverse Event|58|||
150153573|NCT01474512|541699603|FG014|Long-Term Extension Period|Adverse Event|0|||
150153574|NCT01474512|541699604|FG015|Long-Term Extension Period|Adverse Event|0|||
150153575|NCT01474512|541699605|FG016|Long-Term Extension Period|Adverse Event|0|||
150153576|NCT01474512|541699606|FG017|Long-Term Extension Period|Adverse Event|0|||
150153577|NCT01474512|541699589|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
150153578|NCT01474512|541699590|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
150153579|NCT01474512|541699591|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
150153580|NCT01474512|541699592|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
150153581|NCT01474512|541699593|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
150153582|NCT01474512|541699594|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
150153583|NCT01474512|541699595|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
150153584|NCT01474512|541699596|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
150153585|NCT01474512|541699597|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
150153586|NCT01474512|541699598|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
150153587|NCT01474512|541699599|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
150153588|NCT01474512|541699600|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
150153589|NCT01474512|541699601|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
150153590|NCT01474512|541699602|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
150153591|NCT01474512|541699603|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
149811809|NCT00390572|540438953|FG000|Overall Study|health condition|0|||
149811810|NCT00390572|540438954|FG001|Overall Study|health condition|1|||
150153592|NCT01474512|541699604|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
150153593|NCT01474512|541699605|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
150153594|NCT01474512|541699606|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
150153595|NCT01474512|541699589|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
149811811|NCT02913261|540438961|FG000|Overall Study|Technical problems|0|||
149811812|NCT02913261|540438962|FG001|Overall Study|Technical problems|1|||
149811813|NCT02913261|540438961|FG000|Overall Study|Lack of Efficacy|32|||
149811814|NCT02913261|540438962|FG001|Overall Study|Lack of Efficacy|69|||
149811815|NCT02913261|540438961|FG000|Overall Study|Adverse Event|27|||
150153596|NCT01474512|541699590|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
150153597|NCT01474512|541699591|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
150153598|NCT01474512|541699592|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
150153599|NCT01474512|541699593|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
150153600|NCT01474512|541699594|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
150153601|NCT01474512|541699595|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
150153602|NCT01474512|541699596|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
150153603|NCT01474512|541699597|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
150153604|NCT01474512|541699598|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
150153605|NCT01474512|541699599|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
150153606|NCT01474512|541699600|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
150153607|NCT01474512|541699601|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
150153608|NCT01474512|541699602|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
150153609|NCT01474512|541699603|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
150153610|NCT01474512|541699604|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
150153611|NCT01474512|541699605|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
150153612|NCT01474512|541699606|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
150153613|NCT01474512|541699589|FG000|Long-Term Extension Period|Physician Decision|0|||
150153614|NCT01474512|541699590|FG001|Long-Term Extension Period|Physician Decision|0|||
150153615|NCT01474512|541699591|FG002|Long-Term Extension Period|Physician Decision|0|||
150153616|NCT01474512|541699592|FG003|Long-Term Extension Period|Physician Decision|0|||
150153617|NCT01474512|541699593|FG004|Long-Term Extension Period|Physician Decision|0|||
150153618|NCT01474512|541699594|FG005|Long-Term Extension Period|Physician Decision|0|||
150153619|NCT01474512|541699595|FG006|Long-Term Extension Period|Physician Decision|0|||
150153620|NCT01474512|541699596|FG007|Long-Term Extension Period|Physician Decision|0|||
150153621|NCT01474512|541699597|FG008|Long-Term Extension Period|Physician Decision|0|||
150153622|NCT01474512|541699598|FG009|Long-Term Extension Period|Physician Decision|0|||
150153623|NCT01474512|541699599|FG010|Long-Term Extension Period|Physician Decision|0|||
149811816|NCT02913261|540438962|FG001|Overall Study|Adverse Event|5|||
149811817|NCT02913261|540438961|FG000|Overall Study|Death|25|||
149811818|NCT02913261|540438962|FG001|Overall Study|Death|22|||
149811819|NCT02913261|540438961|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
149811820|NCT02913261|540438962|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
149811821|NCT02913261|540438961|FG000|Overall Study|Disease relapse|8|||
149811822|NCT02913261|540438962|FG001|Overall Study|Disease relapse|13|||
149811823|NCT02913261|540438961|FG000|Overall Study|Physician Decision|8|||
149811824|NCT02913261|540438962|FG001|Overall Study|Physician Decision|9|||
149811825|NCT02913261|540438961|FG000|Overall Study|Subject/guardian decision|4|||
149811826|NCT02913261|540438962|FG001|Overall Study|Subject/guardian decision|6|||
149811827|NCT02913261|540438961|FG000|Overall Study|Graft loss|2|||
149811828|NCT02913261|540438962|FG001|Overall Study|Graft loss|0|||
149811829|NCT03078192|540438964|FG000|Overall Study|Withdrawal by Subject|2|||
150153624|NCT01474512|541699600|FG011|Long-Term Extension Period|Physician Decision|0|||
150153625|NCT01474512|541699601|FG012|Long-Term Extension Period|Physician Decision|21|||
150153626|NCT01474512|541699602|FG013|Long-Term Extension Period|Physician Decision|21|||
150153627|NCT01474512|541699603|FG014|Long-Term Extension Period|Physician Decision|0|||
150153628|NCT01474512|541699604|FG015|Long-Term Extension Period|Physician Decision|0|||
150153629|NCT01474512|541699605|FG016|Long-Term Extension Period|Physician Decision|0|||
150153630|NCT01474512|541699606|FG017|Long-Term Extension Period|Physician Decision|0|||
150153631|NCT01474512|541699589|FG000|Long-Term Extension Period|Clinical Relapse|0|||
150153632|NCT01474512|541699590|FG001|Long-Term Extension Period|Clinical Relapse|0|||
150153633|NCT01474512|541699591|FG002|Long-Term Extension Period|Clinical Relapse|0|||
150153634|NCT01474512|541699592|FG003|Long-Term Extension Period|Clinical Relapse|0|||
150153635|NCT01474512|541699593|FG004|Long-Term Extension Period|Clinical Relapse|0|||
150153636|NCT01474512|541699594|FG005|Long-Term Extension Period|Clinical Relapse|0|||
150153637|NCT01474512|541699595|FG006|Long-Term Extension Period|Clinical Relapse|0|||
150153638|NCT01474512|541699596|FG007|Long-Term Extension Period|Clinical Relapse|0|||
150153639|NCT01474512|541699597|FG008|Long-Term Extension Period|Clinical Relapse|0|||
150153640|NCT01474512|541699598|FG009|Long-Term Extension Period|Clinical Relapse|0|||
150153641|NCT01474512|541699599|FG010|Long-Term Extension Period|Clinical Relapse|0|||
150153642|NCT01474512|541699600|FG011|Long-Term Extension Period|Clinical Relapse|0|||
150153643|NCT01474512|541699601|FG012|Long-Term Extension Period|Clinical Relapse|9|||
150153644|NCT01474512|541699602|FG013|Long-Term Extension Period|Clinical Relapse|9|||
150153645|NCT01474512|541699603|FG014|Long-Term Extension Period|Clinical Relapse|0|||
150153646|NCT01474512|541699604|FG015|Long-Term Extension Period|Clinical Relapse|0|||
150153647|NCT01474512|541699605|FG016|Long-Term Extension Period|Clinical Relapse|0|||
150153648|NCT01474512|541699606|FG017|Long-Term Extension Period|Clinical Relapse|0|||
150153649|NCT01474512|541699589|FG000|Long-Term Extension Period|Death|0|||
150153650|NCT01474512|541699590|FG001|Long-Term Extension Period|Death|0|||
150153651|NCT01474512|541699591|FG002|Long-Term Extension Period|Death|0|||
150153652|NCT01474512|541699592|FG003|Long-Term Extension Period|Death|0|||
149811830|NCT03078192|540438965|FG001|Overall Study|Withdrawal by Subject|1|||
150153653|NCT01474512|541699593|FG004|Long-Term Extension Period|Death|0|||
150153654|NCT01474512|541699594|FG005|Long-Term Extension Period|Death|0|||
150153655|NCT01474512|541699595|FG006|Long-Term Extension Period|Death|0|||
150153656|NCT01474512|541699596|FG007|Long-Term Extension Period|Death|0|||
150153657|NCT01474512|541699597|FG008|Long-Term Extension Period|Death|0|||
150153658|NCT01474512|541699598|FG009|Long-Term Extension Period|Death|0|||
150153659|NCT01474512|541699599|FG010|Long-Term Extension Period|Death|0|||
150153660|NCT01474512|541699600|FG011|Long-Term Extension Period|Death|0|||
150153661|NCT01474512|541699601|FG012|Long-Term Extension Period|Death|9|||
150153662|NCT01474512|541699602|FG013|Long-Term Extension Period|Death|9|||
150153663|NCT01474512|541699603|FG014|Long-Term Extension Period|Death|0|||
150153664|NCT01474512|541699604|FG015|Long-Term Extension Period|Death|0|||
150153665|NCT01474512|541699605|FG016|Long-Term Extension Period|Death|0|||
150153666|NCT01474512|541699606|FG017|Long-Term Extension Period|Death|0|||
150153667|NCT01474512|541699589|FG000|Long-Term Extension Period|Sponsor Decision|0|||
150153668|NCT01474512|541699590|FG001|Long-Term Extension Period|Sponsor Decision|0|||
150153669|NCT01474512|541699591|FG002|Long-Term Extension Period|Sponsor Decision|0|||
150153670|NCT01474512|541699592|FG003|Long-Term Extension Period|Sponsor Decision|0|||
150153671|NCT01474512|541699593|FG004|Long-Term Extension Period|Sponsor Decision|0|||
150153672|NCT01474512|541699594|FG005|Long-Term Extension Period|Sponsor Decision|0|||
150153673|NCT01474512|541699595|FG006|Long-Term Extension Period|Sponsor Decision|0|||
150153674|NCT01474512|541699596|FG007|Long-Term Extension Period|Sponsor Decision|0|||
150153675|NCT01474512|541699597|FG008|Long-Term Extension Period|Sponsor Decision|0|||
150153676|NCT01474512|541699598|FG009|Long-Term Extension Period|Sponsor Decision|0|||
150153677|NCT01474512|541699599|FG010|Long-Term Extension Period|Sponsor Decision|0|||
150153678|NCT01474512|541699600|FG011|Long-Term Extension Period|Sponsor Decision|0|||
150153679|NCT01474512|541699601|FG012|Long-Term Extension Period|Sponsor Decision|6|||
150153680|NCT01474512|541699602|FG013|Long-Term Extension Period|Sponsor Decision|6|||
150153681|NCT01474512|541699603|FG014|Long-Term Extension Period|Sponsor Decision|0|||
150153682|NCT01474512|541699604|FG015|Long-Term Extension Period|Sponsor Decision|0|||
150153683|NCT01474512|541699605|FG016|Long-Term Extension Period|Sponsor Decision|0|||
150153684|NCT01474512|541699606|FG017|Long-Term Extension Period|Sponsor Decision|0|||
150153685|NCT01474512|541699589|FG000|Long-Term Extension Period|Protocol Violation|0|||
150153686|NCT01474512|541699590|FG001|Long-Term Extension Period|Protocol Violation|0|||
150153687|NCT01474512|541699591|FG002|Long-Term Extension Period|Protocol Violation|0|||
150153688|NCT01474512|541699592|FG003|Long-Term Extension Period|Protocol Violation|0|||
150153689|NCT01474512|541699593|FG004|Long-Term Extension Period|Protocol Violation|0|||
150153690|NCT01474512|541699594|FG005|Long-Term Extension Period|Protocol Violation|0|||
150153691|NCT01474512|541699595|FG006|Long-Term Extension Period|Protocol Violation|0|||
150153692|NCT01474512|541699596|FG007|Long-Term Extension Period|Protocol Violation|0|||
150153693|NCT01474512|541699597|FG008|Long-Term Extension Period|Protocol Violation|0|||
150153694|NCT01474512|541699598|FG009|Long-Term Extension Period|Protocol Violation|0|||
150153695|NCT01474512|541699599|FG010|Long-Term Extension Period|Protocol Violation|0|||
150153696|NCT01474512|541699600|FG011|Long-Term Extension Period|Protocol Violation|0|||
150153697|NCT01474512|541699601|FG012|Long-Term Extension Period|Protocol Violation|5|||
150153698|NCT01474512|541699602|FG013|Long-Term Extension Period|Protocol Violation|5|||
150153699|NCT01474512|541699603|FG014|Long-Term Extension Period|Protocol Violation|0|||
150153700|NCT01474512|541699604|FG015|Long-Term Extension Period|Protocol Violation|0|||
150153701|NCT01474512|541699605|FG016|Long-Term Extension Period|Protocol Violation|0|||
150153702|NCT01474512|541699606|FG017|Long-Term Extension Period|Protocol Violation|0|||
150153703|NCT01474512|541699589|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153704|NCT01474512|541699590|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153705|NCT01474512|541699591|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153706|NCT01474512|541699592|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153707|NCT01474512|541699593|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153708|NCT01474512|541699594|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153709|NCT01474512|541699595|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153710|NCT01474512|541699596|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153711|NCT01474512|541699597|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153712|NCT01474512|541699598|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153713|NCT01474512|541699599|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153714|NCT01474512|541699600|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153715|NCT01474512|541699601|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
150153716|NCT01474512|541699602|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
150153717|NCT01474512|541699603|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153718|NCT01474512|541699604|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149811831|NCT03078192|540438964|FG000|Overall Study|screen failure|0|||
150153719|NCT01474512|541699605|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153720|NCT01474512|541699606|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
150153721|NCT01474512|541699589|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149811832|NCT03078192|540438965|FG001|Overall Study|screen failure|3|||
150153722|NCT01474512|541699590|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153723|NCT01474512|541699591|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153724|NCT01474512|541699592|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153725|NCT01474512|541699593|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153726|NCT01474512|541699594|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153727|NCT01474512|541699595|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153728|NCT01474512|541699596|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153729|NCT01474512|541699597|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153730|NCT01474512|541699598|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153731|NCT01474512|541699599|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153732|NCT01474512|541699600|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
150153733|NCT01474512|541699601|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153734|NCT01474512|541699602|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153735|NCT01474512|541699603|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153736|NCT01474512|541699604|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153737|NCT01474512|541699605|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153738|NCT01474512|541699606|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
150153739|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
150153740|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
150153741|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
150153742|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
150153743|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
150153744|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
150153745|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
150153746|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
150153747|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
150153748|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
150153749|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
150153750|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
150153751|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
150153752|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
150153753|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
150153754|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
150153755|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
150153756|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
150153757|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153758|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153759|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153760|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153761|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153762|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153763|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153764|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153765|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153766|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153767|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153768|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153769|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153770|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
150153771|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
150153772|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
150153773|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
149811833|NCT03703297|540438966|FG000|Overall Study|Death|115|||
149811834|NCT03703297|540438967|FG001|Overall Study|Death|0|||
149811835|NCT03703297|540438968|FG002|Overall Study|Death|144|||
149811836|NCT03703297|540438966|FG000|Overall Study|Withdrawal by Subject|9|||
149811837|NCT03703297|540438967|FG001|Overall Study|Withdrawal by Subject|0|||
149811838|NCT03703297|540438968|FG002|Overall Study|Withdrawal by Subject|11|||
149811839|NCT03703297|540438966|FG000|Overall Study|Ongoing at the time of DCO|140|||
149811840|NCT03703297|540438967|FG001|Overall Study|Ongoing at the time of DCO|200|||
149811841|NCT03703297|540438968|FG002|Overall Study|Ongoing at the time of DCO|111|||
149811842|NCT01336608|540441197|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
149811843|NCT01336608|540441198|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
149811844|NCT01336608|540441199|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
149811845|NCT01336608|540441200|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
149811846|NCT01336608|540441197|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
149811847|NCT01336608|540441198|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
149811848|NCT01336608|540441199|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150153774|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
149811849|NCT01336608|540441200|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
149811850|NCT01336608|540441197|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
149811851|NCT01336608|540441198|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
149811852|NCT01336608|540441199|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
149811853|NCT01336608|540441200|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
149811854|NCT01336608|540441197|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
149811855|NCT01336608|540441198|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
149811856|NCT01336608|540441199|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
149811857|NCT01336608|540441200|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
149811858|NCT01336608|540441197|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
149811859|NCT01336608|540441198|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
149811860|NCT01336608|540441199|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
149811861|NCT01336608|540441200|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
149811862|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
149811863|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
149811864|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
149811865|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
149811866|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
149811867|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
149811868|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
149811869|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
149811870|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
149811871|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
149811872|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
149811873|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
149811874|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
149811875|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
149811876|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
149811877|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
149811878|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
149811879|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
149811880|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
149811881|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
149811882|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149811883|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
149811884|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149811885|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149811886|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
149811887|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
149811888|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
149811889|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
149811890|NCT01336608|540441197|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149811891|NCT01336608|540441198|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
149811892|NCT01336608|540441199|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
149811893|NCT01336608|540441200|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
149811894|NCT02437890|540441205|FG000|Overall Study|Non-compliance to study drug|0|||
149811895|NCT02437890|540441206|FG001|Overall Study|Non-compliance to study drug|1|||
149811896|NCT02437890|540441207|FG002|Overall Study|Non-compliance to study drug|0|||
149811897|NCT02437890|540441208|FG003|Overall Study|Non-compliance to study drug|0|||
149811898|NCT02437890|540441209|FG004|Overall Study|Non-compliance to study drug|1|||
149811899|NCT02437890|540441205|FG000|Overall Study|Sponsor's decision|1|||
149811900|NCT02437890|540441206|FG001|Overall Study|Sponsor's decision|1|||
149811901|NCT02437890|540441207|FG002|Overall Study|Sponsor's decision|4|||
149811902|NCT02437890|540441208|FG003|Overall Study|Sponsor's decision|0|||
149811903|NCT02437890|540441209|FG004|Overall Study|Sponsor's decision|2|||
149811904|NCT02437890|540441205|FG000|Overall Study|Physician Decision|0|||
149811905|NCT02437890|540441206|FG001|Overall Study|Physician Decision|0|||
149811906|NCT02437890|540441207|FG002|Overall Study|Physician Decision|0|||
149811907|NCT02437890|540441208|FG003|Overall Study|Physician Decision|1|||
149811908|NCT02437890|540441209|FG004|Overall Study|Physician Decision|0|||
149811909|NCT02437890|540441205|FG000|Overall Study|Unable to attend visit(s)|1|||
149811910|NCT02437890|540441206|FG001|Overall Study|Unable to attend visit(s)|0|||
149811911|NCT02437890|540441207|FG002|Overall Study|Unable to attend visit(s)|0|||
149811912|NCT02437890|540441208|FG003|Overall Study|Unable to attend visit(s)|0|||
149811913|NCT02437890|540441209|FG004|Overall Study|Unable to attend visit(s)|0|||
149811914|NCT02437890|540441205|FG000|Overall Study|Lack of Efficacy|1|||
149811915|NCT02437890|540441206|FG001|Overall Study|Lack of Efficacy|3|||
149811916|NCT02437890|540441207|FG002|Overall Study|Lack of Efficacy|0|||
149811917|NCT02437890|540441208|FG003|Overall Study|Lack of Efficacy|3|||
149811918|NCT02437890|540441209|FG004|Overall Study|Lack of Efficacy|1|||
149811919|NCT02437890|540441205|FG000|Overall Study|Adverse Event|4|||
149811920|NCT02437890|540441206|FG001|Overall Study|Adverse Event|9|||
149811921|NCT02437890|540441207|FG002|Overall Study|Adverse Event|5|||
149811922|NCT02437890|540441208|FG003|Overall Study|Adverse Event|11|||
149811923|NCT02437890|540441209|FG004|Overall Study|Adverse Event|7|||
149811924|NCT02437890|540441205|FG000|Overall Study|Withdrawal by Subject|1|||
149811925|NCT02437890|540441206|FG001|Overall Study|Withdrawal by Subject|2|||
149811926|NCT02437890|540441207|FG002|Overall Study|Withdrawal by Subject|6|||
149811927|NCT02437890|540441208|FG003|Overall Study|Withdrawal by Subject|5|||
149811928|NCT02437890|540441209|FG004|Overall Study|Withdrawal by Subject|5|||
150153775|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153776|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153777|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153778|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153779|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153780|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153781|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153782|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153783|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153784|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153785|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153786|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153787|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153788|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
150153789|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
150153790|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
150153791|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
150153792|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
150153793|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153794|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153795|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153796|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153797|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153798|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153799|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153800|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153801|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153802|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153803|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153804|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153805|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153806|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153807|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153808|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
150153809|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
150153810|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
150153811|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
150153812|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
150153813|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
150153814|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
150153815|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
150153816|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
150153817|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
150153818|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
150153819|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
150153820|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
150153821|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
149811929|NCT02437890|540441205|FG000|Overall Study|Death|0|||
150153822|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
150153823|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
150153824|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
149811930|NCT02437890|540441206|FG001|Overall Study|Death|0|||
149811931|NCT02437890|540441207|FG002|Overall Study|Death|0|||
150153825|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
150153826|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
150153827|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
150153828|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
149811932|NCT02437890|540441208|FG003|Overall Study|Death|2|||
149811933|NCT02437890|540441209|FG004|Overall Study|Death|0|||
150153829|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153830|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
149811934|NCT04723173|540441210|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
149811935|NCT02996448|540441211|FG000|Overall Study|Study terminated due to adverse effects|3|||
149811936|NCT00902265|540441216|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
149811937|NCT00902265|540441216|FG000|Overall Study|Adverse Event|2|||
149811938|NCT00902265|540441216|FG000|Overall Study|Lack of Efficacy|2|||
149811939|NCT00902265|540441216|FG000|Overall Study|Protocol Violation|1|||
149811940|NCT02866695|540441217|FG000|Overall Study|Adverse Event|1|||
149811941|NCT02866695|540441217|FG000|Overall Study|Lost to Follow-up|1|||
149811942|NCT05016765|540441218|FG000|Overall Study|Lost to Follow-up|4|||
149811943|NCT01988493|540441219|FG000|Overall Study|Randomized but not treated|0|||
149811944|NCT01988493|540441220|FG001|Overall Study|Randomized but not treated|0|||
149811945|NCT01988493|540441221|FG002|Overall Study|Randomized but not treated|0|||
149811946|NCT01988493|540441222|FG003|Overall Study|Randomized but not treated|0|||
149811947|NCT01988493|540441223|FG004|Overall Study|Randomized but not treated|1|||
149811948|NCT01447628|540441226|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
149811949|NCT01447628|540441227|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
149811950|NCT01447628|540441228|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
149811951|NCT01447628|540441229|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
149811952|NCT00185731|540441230|FG000|Overall Study|Withdrawal by Subject|1|||
149811953|NCT00185731|540441230|FG000|Overall Study|Not Eligible|1|||
149811954|NCT03087773|540441231|FG000|Overall Study|Withdrawal by Subject|8|||
149811955|NCT03087773|540441232|FG001|Overall Study|Withdrawal by Subject|4|||
149811956|NCT03087773|540441231|FG000|Overall Study|Lost to Follow-up|12|||
149811957|NCT03087773|540441232|FG001|Overall Study|Lost to Follow-up|8|||
149811958|NCT02494583|540441235|FG000|Overall Study|Death|224|||
149811959|NCT02494583|540441236|FG001|Overall Study|Death|214|||
149811960|NCT02494583|540441237|FG002|Overall Study|Death|225|||
149811961|NCT02494583|540441235|FG000|Overall Study|Lost to Follow-up|1|||
149811962|NCT02494583|540441236|FG001|Overall Study|Lost to Follow-up|0|||
149811963|NCT02494583|540441237|FG002|Overall Study|Lost to Follow-up|0|||
149811964|NCT02494583|540441235|FG000|Overall Study|Protocol Violation|1|||
149811965|NCT02494583|540441236|FG001|Overall Study|Protocol Violation|2|||
149811966|NCT02494583|540441237|FG002|Overall Study|Protocol Violation|0|||
149811967|NCT02494583|540441235|FG000|Overall Study|Screen Failure|0|||
149811968|NCT02494583|540441236|FG001|Overall Study|Screen Failure|1|||
149811969|NCT02494583|540441237|FG002|Overall Study|Screen Failure|0|||
149811970|NCT02494583|540441235|FG000|Overall Study|Transferred to Extension Study|15|||
149811971|NCT02494583|540441236|FG001|Overall Study|Transferred to Extension Study|15|||
149811972|NCT02494583|540441237|FG002|Overall Study|Transferred to Extension Study|6|||
149811973|NCT02494583|540441235|FG000|Overall Study|Did Not Continue on Extension Study|8|||
149811974|NCT02494583|540441236|FG001|Overall Study|Did Not Continue on Extension Study|10|||
149811975|NCT02494583|540441237|FG002|Overall Study|Did Not Continue on Extension Study|4|||
149811976|NCT02494583|540441235|FG000|Overall Study|Withdrawal by Subject|7|||
149811977|NCT02494583|540441236|FG001|Overall Study|Withdrawal by Subject|15|||
149811978|NCT02494583|540441237|FG002|Overall Study|Withdrawal by Subject|15|||
149811979|NCT05144477|540441238|FG000|Overall Study|Withdrawal by Subject|1|||
149811980|NCT05144477|540441239|FG001|Overall Study|Withdrawal by Subject|1|||
149811981|NCT00627458|540441244|FG000|Overall Study|Migrated from study area|1|||
149811982|NCT00627458|540441245|FG001|Overall Study|Migrated from study area|0|||
149811983|NCT00627458|540441246|FG002|Overall Study|Migrated from study area|1|||
149811984|NCT00627458|540441244|FG000|Overall Study|Withdrawal by Subject|2|||
149811985|NCT00627458|540441245|FG001|Overall Study|Withdrawal by Subject|6|||
149811986|NCT00627458|540441246|FG002|Overall Study|Withdrawal by Subject|5|||
149811987|NCT00627458|540441244|FG000|Overall Study|Lost to Follow-up|1|||
149811988|NCT00627458|540441245|FG001|Overall Study|Lost to Follow-up|1|||
149811989|NCT00627458|540441246|FG002|Overall Study|Lost to Follow-up|0|||
149811990|NCT03891875|540441247|FG000|Overall Study|Withdrawal by Subject|20|||
149811991|NCT03891875|540441248|FG001|Overall Study|Withdrawal by Subject|3|||
149811992|NCT03891875|540441247|FG000|Overall Study|Adverse Event|10|||
149811993|NCT03891875|540441248|FG001|Overall Study|Adverse Event|4|||
149811994|NCT03891875|540441247|FG000|Overall Study|Physician Decision|1|||
149811995|NCT03891875|540441248|FG001|Overall Study|Physician Decision|1|||
149811996|NCT03891875|540441247|FG000|Overall Study|Protocol Violation|1|||
149811997|NCT03891875|540441248|FG001|Overall Study|Protocol Violation|0|||
149811998|NCT03891875|540441247|FG000|Overall Study|Lost to Follow-up|1|||
149811999|NCT03891875|540441248|FG001|Overall Study|Lost to Follow-up|0|||
149812000|NCT03891875|540441247|FG000|Overall Study|COVID-19 infection|1|||
149812001|NCT03891875|540441248|FG001|Overall Study|COVID-19 infection|0|||
149812002|NCT00854607|540441249|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
149812003|NCT00965263|540441254|FG000|Overall Study|Physician Decision|2|||
149812004|NCT00965263|540441255|FG001|Overall Study|Physician Decision|0|||
149812005|NCT00965263|540441254|FG000|Overall Study|Family emergency|0|||
149812006|NCT00965263|540441255|FG001|Overall Study|Family emergency|1|||
149812007|NCT00965263|540441254|FG000|Overall Study|Protocol Violation|0|||
149812008|NCT00965263|540441255|FG001|Overall Study|Protocol Violation|2|||
149812009|NCT02756078|540441256|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
149812010|NCT02756078|540441257|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
149812011|NCT02756078|540441256|FG000|Period 1|Lost to Follow-up|0|||
149812012|NCT02756078|540441257|FG001|Period 1|Lost to Follow-up|2|||
149812013|NCT02756078|540441256|FG000|Period 1|Protocol Violation|0|||
149812014|NCT02756078|540441257|FG001|Period 1|Protocol Violation|1|||
149812015|NCT02756078|540441256|FG000|Period 1|Adverse Event|1|||
149812016|NCT02756078|540441257|FG001|Period 1|Adverse Event|10|||
149812017|NCT02756078|540441256|FG000|Period 1|Withdrawal by Subject|6|||
149812018|NCT02756078|540441257|FG001|Period 1|Withdrawal by Subject|6|||
149812019|NCT02756078|540441256|FG000|Period 1|Lens Discomfort|2|||
149812020|NCT02756078|540441257|FG001|Period 1|Lens Discomfort|2|||
149812021|NCT02756078|540441256|FG000|Period 2|Adverse Event|3|||
149812022|NCT02756078|540441257|FG001|Period 2|Adverse Event|5|||
149812023|NCT02756078|540441256|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
149812024|NCT02756078|540441257|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
149812025|NCT02756078|540441256|FG000|Period 2|Withdrawal by Subject|3|||
149812026|NCT02756078|540441257|FG001|Period 2|Withdrawal by Subject|1|||
149812027|NCT02268045|540441258|FG000|Overall Study|Death|4|||
149812028|NCT02268045|540441259|FG001|Overall Study|Death|4|||
149812029|NCT02268045|540441258|FG000|Overall Study|Disease Progression|2|||
149812030|NCT02268045|540441259|FG001|Overall Study|Disease Progression|1|||
149812031|NCT02268045|540441258|FG000|Overall Study|Adverse Event|7|||
149812032|NCT02268045|540441259|FG001|Overall Study|Adverse Event|7|||
149812033|NCT02268045|540441258|FG000|Overall Study|Withdrawal by Subject|2|||
149812034|NCT02268045|540441259|FG001|Overall Study|Withdrawal by Subject|6|||
149812035|NCT02268045|540441258|FG000|Overall Study|Physician Decision|0|||
149812036|NCT02268045|540441259|FG001|Overall Study|Physician Decision|1|||
149812037|NCT02268045|540441258|FG000|Overall Study|Protocol Violation|1|||
149812038|NCT02268045|540441259|FG001|Overall Study|Protocol Violation|1|||
149812039|NCT03151707|540441262|FG000|Overall Study|Lost to Follow-up|6|||
149812040|NCT00646282|540441264|FG000|Overall Study|Protocol terminated|4|||
149812041|NCT00646282|540441265|FG001|Overall Study|Protocol terminated|4|||
149812042|NCT00530088|540441266|FG000|Overall Study|Disease Progression|4|||
149812043|NCT00530088|540441266|FG000|Overall Study|Physician Decision|4|||
149812044|NCT00530088|540441266|FG000|Overall Study|Other Not Specified|2|||
149812045|NCT02181842|540441271|FG000|Overall Study|Case Report Forms Uncollected|2|||
149812046|NCT00758706|540441272|FG000|Overall Study|Adverse Event|4|||
149812047|NCT00758706|540441273|FG001|Overall Study|Adverse Event|4|||
149812048|NCT02304302|540441308|FG000|Overall Study|Adverse Event|2|||
149812049|NCT02304302|540441309|FG001|Overall Study|Adverse Event|3|||
149812050|NCT02304302|540441308|FG000|Overall Study|Lost to Follow-up|1|||
149812051|NCT02304302|540441309|FG001|Overall Study|Lost to Follow-up|4|||
149812052|NCT02304302|540441308|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
149812053|NCT02304302|540441309|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
149812054|NCT00391118|540441310|FG000|Overall Study|Adverse Event|3|||
149812055|NCT00391118|540441311|FG001|Overall Study|Adverse Event|10|||
149812056|NCT00391118|540441312|FG002|Overall Study|Adverse Event|7|||
149812057|NCT00391118|540441310|FG000|Overall Study|Lost to Follow-up|0|||
149812058|NCT00391118|540441311|FG001|Overall Study|Lost to Follow-up|2|||
149812059|NCT00391118|540441312|FG002|Overall Study|Lost to Follow-up|3|||
149812060|NCT00391118|540441310|FG000|Overall Study|Withdrawal by Subject|0|||
149812061|NCT00391118|540441311|FG001|Overall Study|Withdrawal by Subject|9|||
149812062|NCT00391118|540441312|FG002|Overall Study|Withdrawal by Subject|1|||
149812063|NCT00391118|540441310|FG000|Overall Study|Death|0|||
149812064|NCT00391118|540441311|FG001|Overall Study|Death|1|||
149812065|NCT00391118|540441312|FG002|Overall Study|Death|0|||
149812066|NCT00391118|540441310|FG000|Overall Study|Physician Decision|0|||
149812067|NCT00391118|540441311|FG001|Overall Study|Physician Decision|3|||
149812068|NCT00391118|540441312|FG002|Overall Study|Physician Decision|0|||
149812069|NCT00391118|540441310|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
149812070|NCT00391118|540441311|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
149812071|NCT00391118|540441312|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
149812072|NCT00391118|540441310|FG000|Overall Study|Progressive Disease|7|||
149812073|NCT00391118|540441311|FG001|Overall Study|Progressive Disease|26|||
149812074|NCT00391118|540441312|FG002|Overall Study|Progressive Disease|43|||
149812075|NCT00391118|540441310|FG000|Overall Study|Sponsor Decision|0|||
149812076|NCT00391118|540441311|FG001|Overall Study|Sponsor Decision|1|||
149812077|NCT00391118|540441312|FG002|Overall Study|Sponsor Decision|3|||
149812078|NCT00391118|540441310|FG000|Overall Study|Protocol Violation|1|||
149812079|NCT00391118|540441311|FG001|Overall Study|Protocol Violation|0|||
149812080|NCT00391118|540441312|FG002|Overall Study|Protocol Violation|0|||
149812081|NCT01892020|540441314|FG000|Period 1|Adverse Event|1|||
149812082|NCT01892020|540441315|FG001|Period 1|Adverse Event|1|||
149812083|NCT01892020|540441314|FG000|Period 1|Protocol Violation|2|||
149812084|NCT01892020|540441315|FG001|Period 1|Protocol Violation|4|||
149812085|NCT01892020|540441314|FG000|Period 1|Unclassified|0|||
149812086|NCT01892020|540441315|FG001|Period 1|Unclassified|1|||
149812087|NCT01892020|540441314|FG000|Period 2|Protocol Violation|1|||
149812088|NCT01892020|540441315|FG001|Period 2|Protocol Violation|0|||
149812089|NCT03252756|540441321|FG000|Overall Study|Protocol Violation|2|||
149812090|NCT03252756|540441322|FG001|Overall Study|Protocol Violation|4|||
149812091|NCT03252756|540441321|FG000|Overall Study|COVID-19 Pandemic|1|||
149812092|NCT03252756|540441322|FG001|Overall Study|COVID-19 Pandemic|1|||
149812093|NCT03252756|540441321|FG000|Overall Study|Study Drug Expiration|0|||
149812094|NCT03252756|540441322|FG001|Overall Study|Study Drug Expiration|1|||
149812095|NCT03594175|540441323|FG000|Overall Study|Not treated|8|||
149812096|NCT03594175|540441324|FG001|Overall Study|Not treated|1|||
149812097|NCT03594175|540441325|FG002|Overall Study|Not treated|5|||
149812098|NCT03594175|540441323|FG000|Overall Study|Adverse Event|3|||
149812099|NCT03594175|540441324|FG001|Overall Study|Adverse Event|0|||
149812100|NCT03594175|540441325|FG002|Overall Study|Adverse Event|0|||
149812101|NCT03594175|540441323|FG000|Overall Study|Withdrawal by Subject|3|||
149812102|NCT03594175|540441324|FG001|Overall Study|Withdrawal by Subject|0|||
149812103|NCT03594175|540441325|FG002|Overall Study|Withdrawal by Subject|0|||
149812104|NCT03594175|540441323|FG000|Overall Study|Protocol Violation|2|||
149812105|NCT03594175|540441324|FG001|Overall Study|Protocol Violation|2|||
149812106|NCT03594175|540441325|FG002|Overall Study|Protocol Violation|2|||
149812107|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812108|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812109|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812110|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
149812111|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
149812112|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812113|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812114|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812115|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812116|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
149812117|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812118|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812119|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
149812120|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
149812121|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
149812122|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
149812123|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
149812124|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
149812125|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
149812126|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812127|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812128|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812129|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812130|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812131|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
149812132|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812133|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812134|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812135|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
149812136|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812137|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812138|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812139|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
149812140|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
149812141|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
149812142|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
149812143|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
149812144|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
149812145|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
149812146|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812147|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812148|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812149|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812150|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
149812151|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812152|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812153|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812154|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812155|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812156|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812157|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812158|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812159|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
149812160|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812161|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812162|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
149812163|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
149812164|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812165|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812166|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812167|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812168|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812169|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812170|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812171|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812172|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812173|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812174|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
149812175|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812176|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812177|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
149812178|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812179|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
149812180|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
149812181|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
149812182|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
150153831|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153832|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153833|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153834|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
149812183|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
149812184|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
149812185|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
150153835|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
149812186|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
149812187|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812188|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812189|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
149812190|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812191|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812192|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812193|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
149812194|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812195|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
149812196|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
149812197|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
149812198|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
149812199|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
149812200|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
149812201|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
149812202|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812203|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812204|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
149812205|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812206|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812207|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812208|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812209|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812210|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812211|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812212|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812213|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812214|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812215|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812216|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812217|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
149812218|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
149812219|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
149812220|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
149812221|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812222|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812223|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812224|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812225|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
149812226|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812227|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812228|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812229|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812230|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
149812231|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812232|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812233|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812234|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812235|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812236|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812237|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812238|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812239|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149812240|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
149812241|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812242|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812243|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812244|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812245|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
149812246|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812247|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812248|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812249|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812250|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
149812251|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812252|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812253|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
149812254|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
149812255|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
149812256|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
149812257|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
149812258|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149812259|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812260|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812261|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812262|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812263|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812264|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812265|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812266|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812267|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812268|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812269|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
149812270|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812271|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812272|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812273|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812274|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812275|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812276|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
150153836|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
149812277|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
149812278|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
149812279|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
149812280|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812281|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812282|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
149812283|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
149812284|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812285|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
149812286|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812287|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
149812288|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812289|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812290|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
149812291|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
149812292|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
149812293|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
149812294|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
149812295|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
149812296|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
149812297|NCT01915498|540441326|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
149812298|NCT01915498|540441327|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
149812299|NCT01915498|540441328|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
149812300|NCT01915498|540441329|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
149812301|NCT01915498|540441330|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
149812302|NCT01915498|540441331|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
149812303|NCT01915498|540441332|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
149812304|NCT01915498|540441333|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
149812305|NCT01915498|540441334|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
149812306|NCT01915498|540441335|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
149812307|NCT01915498|540441336|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
149812308|NCT01915498|540441337|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
149812309|NCT01915498|540441338|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
149812310|NCT01915498|540441339|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
149812311|NCT01915498|540441340|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
149812312|NCT01915498|540441341|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
149812313|NCT01915498|540441342|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
149812314|NCT01915498|540441343|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
149812315|NCT01915498|540441344|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
149812316|NCT01915498|540441326|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812317|NCT01915498|540441327|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812318|NCT01915498|540441328|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812319|NCT01915498|540441329|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812320|NCT01915498|540441330|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812321|NCT01915498|540441331|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812322|NCT01915498|540441332|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812323|NCT01915498|540441333|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812324|NCT01915498|540441334|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812325|NCT01915498|540441335|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812326|NCT01915498|540441336|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812327|NCT01915498|540441337|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812328|NCT01915498|540441338|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812329|NCT01915498|540441339|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812330|NCT01915498|540441340|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812331|NCT01915498|540441341|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812332|NCT01915498|540441342|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812333|NCT01915498|540441343|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149812334|NCT01915498|540441344|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
149812335|NCT01915498|540441326|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812336|NCT01915498|540441327|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812337|NCT01915498|540441328|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812338|NCT01915498|540441329|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812339|NCT01915498|540441330|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812340|NCT01915498|540441331|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812341|NCT01915498|540441332|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812342|NCT01915498|540441333|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812343|NCT01915498|540441334|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812344|NCT01915498|540441335|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812345|NCT01915498|540441336|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812346|NCT01915498|540441337|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812347|NCT01915498|540441338|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812348|NCT01915498|540441339|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812349|NCT01915498|540441340|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812350|NCT01915498|540441341|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812351|NCT01915498|540441342|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812352|NCT01915498|540441343|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
149812353|NCT01915498|540441344|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
149812354|NCT01915498|540441326|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812355|NCT01915498|540441327|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812356|NCT01915498|540441328|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812357|NCT01915498|540441329|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812358|NCT01915498|540441330|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812359|NCT01915498|540441331|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812360|NCT01915498|540441332|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812361|NCT01915498|540441333|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812362|NCT01915498|540441334|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812363|NCT01915498|540441335|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812364|NCT01915498|540441336|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812365|NCT01915498|540441337|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812366|NCT01915498|540441338|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812367|NCT01915498|540441339|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812368|NCT01915498|540441340|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812369|NCT01915498|540441341|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812370|NCT01915498|540441342|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812371|NCT01915498|540441343|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
149812372|NCT01915498|540441344|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
149812373|NCT01500434|540441345|FG000|Overall Study|Death|1|||
149812374|NCT01500434|540441345|FG000|Overall Study|Withdrawal by Subject|1|||
149812375|NCT01500434|540441345|FG000|Overall Study|Missed 12-month follow-up|5|||
149812376|NCT00700310|540443215|FG000|Overall Study|Adverse Event|6|||
149812377|NCT00700310|540443216|FG001|Overall Study|Adverse Event|10|||
149812378|NCT00700310|540443217|FG002|Overall Study|Adverse Event|5|||
149812379|NCT00700310|540443218|FG003|Overall Study|Adverse Event|11|||
149812380|NCT00700310|540443215|FG000|Overall Study|Lost to Follow-up|4|||
149812381|NCT00700310|540443216|FG001|Overall Study|Lost to Follow-up|1|||
149812382|NCT00700310|540443217|FG002|Overall Study|Lost to Follow-up|0|||
149812383|NCT00700310|540443218|FG003|Overall Study|Lost to Follow-up|1|||
149812384|NCT00700310|540443215|FG000|Overall Study|Withdrawal by Subject|8|||
149812385|NCT00700310|540443216|FG001|Overall Study|Withdrawal by Subject|9|||
149812386|NCT00700310|540443217|FG002|Overall Study|Withdrawal by Subject|8|||
149812387|NCT00700310|540443218|FG003|Overall Study|Withdrawal by Subject|8|||
149812388|NCT00700310|540443215|FG000|Overall Study|Lack of Efficacy|0|||
149812389|NCT00700310|540443216|FG001|Overall Study|Lack of Efficacy|3|||
149812390|NCT00700310|540443217|FG002|Overall Study|Lack of Efficacy|0|||
149812391|NCT00700310|540443218|FG003|Overall Study|Lack of Efficacy|1|||
149812392|NCT00700310|540443215|FG000|Overall Study|Administrative/Other|1|||
149812393|NCT00700310|540443216|FG001|Overall Study|Administrative/Other|3|||
149812394|NCT00700310|540443217|FG002|Overall Study|Administrative/Other|1|||
149812395|NCT00700310|540443218|FG003|Overall Study|Administrative/Other|3|||
149812396|NCT00700310|540443215|FG000|Overall Study|Randomized, Not Treated|2|||
149812397|NCT00700310|540443216|FG001|Overall Study|Randomized, Not Treated|0|||
149812398|NCT00700310|540443217|FG002|Overall Study|Randomized, Not Treated|2|||
149812399|NCT00700310|540443218|FG003|Overall Study|Randomized, Not Treated|2|||
149812400|NCT00303316|540443221|FG000|Overall Study|Protocol Violation|1|||
149812401|NCT00303316|540443222|FG001|Overall Study|Protocol Violation|0|||
149812402|NCT00303316|540443221|FG000|Overall Study|Lost to Follow-up|0|||
149812403|NCT00303316|540443222|FG001|Overall Study|Lost to Follow-up|1|||
149812404|NCT00303316|540443221|FG000|Overall Study|Withdrawal by Subject|1|||
149812405|NCT00303316|540443222|FG001|Overall Study|Withdrawal by Subject|2|||
149812406|NCT01726335|540443223|FG000|Overall Study|Lost to Follow-up|2|||
149812407|NCT01726335|540443223|FG000|Overall Study|Withdrawal by Subject|15|||
149812408|NCT01726335|540443223|FG000|Overall Study|Adverse Event|4|||
149812409|NCT01726335|540443223|FG000|Overall Study|Lost to Follow-up|2|||
149812410|NCT01726335|540443223|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
149812411|NCT01160198|540443233|FG000|Overall Study|Withdrawal by Subject|2|||
149812412|NCT01160198|540443234|FG001|Overall Study|Withdrawal by Subject|1|||
149812413|NCT01160198|540443235|FG002|Overall Study|Withdrawal by Subject|0|||
149812414|NCT01160198|540443233|FG000|Overall Study|Adverse Event|0|||
149812415|NCT01160198|540443234|FG001|Overall Study|Adverse Event|1|||
149812416|NCT01160198|540443235|FG002|Overall Study|Adverse Event|0|||
149812417|NCT01160198|540443233|FG000|Overall Study|Lost to Follow-up|0|||
149812418|NCT01160198|540443234|FG001|Overall Study|Lost to Follow-up|1|||
149812419|NCT01160198|540443235|FG002|Overall Study|Lost to Follow-up|0|||
149812420|NCT01160198|540443233|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
149812421|NCT01160198|540443234|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
149812422|NCT01160198|540443235|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
149812423|NCT01796860|540443238|FG000|Overall Study|Withdrawal by Subject|3|||
149812424|NCT01408576|540443239|FG000|Overall Study|Lack of Efficacy|17|||
149812425|NCT01408576|540443240|FG001|Overall Study|Lack of Efficacy|30|||
149812426|NCT01408576|540443241|FG002|Overall Study|Lack of Efficacy|48|||
149812427|NCT01408576|540443239|FG000|Overall Study|Protocol Violation|1|||
149812428|NCT01408576|540443240|FG001|Overall Study|Protocol Violation|2|||
149812429|NCT01408576|540443241|FG002|Overall Study|Protocol Violation|2|||
149812430|NCT01408576|540443239|FG000|Overall Study|Lost to Follow-up|10|||
149812431|NCT01408576|540443240|FG001|Overall Study|Lost to Follow-up|9|||
149812432|NCT01408576|540443241|FG002|Overall Study|Lost to Follow-up|17|||
149812433|NCT01408576|540443239|FG000|Overall Study|Withdrawal by Subject|34|||
149812434|NCT01408576|540443240|FG001|Overall Study|Withdrawal by Subject|60|||
149812435|NCT01408576|540443241|FG002|Overall Study|Withdrawal by Subject|66|||
149812436|NCT01408576|540443239|FG000|Overall Study|Sponsor terminated study|89|||
149812437|NCT01408576|540443240|FG001|Overall Study|Sponsor terminated study|333|||
149812438|NCT01408576|540443241|FG002|Overall Study|Sponsor terminated study|330|||
149812439|NCT01408576|540443239|FG000|Overall Study|AE, serious fatal|4|||
149812440|NCT01408576|540443240|FG001|Overall Study|AE, serious fatal|4|||
149812441|NCT01408576|540443241|FG002|Overall Study|AE, serious fatal|1|||
149812442|NCT01408576|540443239|FG000|Overall Study|SAE, non-fatal|11|||
149812443|NCT01408576|540443240|FG001|Overall Study|SAE, non-fatal|23|||
149812444|NCT01408576|540443241|FG002|Overall Study|SAE, non-fatal|14|||
149812445|NCT01408576|540443239|FG000|Overall Study|AE, non-serious non-fatal|12|||
149812446|NCT01408576|540443240|FG001|Overall Study|AE, non-serious non-fatal|19|||
149812447|NCT01408576|540443241|FG002|Overall Study|AE, non-serious non-fatal|11|||
149812448|NCT01408576|540443239|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
149812449|NCT01408576|540443240|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149812450|NCT01408576|540443241|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149812451|NCT01408576|540443239|FG000|Overall Study|AE, unknown type|0|||
149812452|NCT01408576|540443240|FG001|Overall Study|AE, unknown type|1|||
149812453|NCT01408576|540443241|FG002|Overall Study|AE, unknown type|0|||
149812454|NCT01408576|540443239|FG000|Overall Study|Other|10|||
149812455|NCT01408576|540443240|FG001|Overall Study|Other|16|||
149812456|NCT01408576|540443241|FG002|Overall Study|Other|18|||
149812457|NCT00802529|540443242|FG000|Overall Study|Lost to Follow-up|0|||
149812458|NCT00802529|540443243|FG001|Overall Study|Lost to Follow-up|1|||
149812459|NCT02703454|540443247|FG000|Overall Study|Not treated|1|||
149812460|NCT02703454|540443248|FG001|Overall Study|Not treated|3|||
149812461|NCT02703454|540443247|FG000|Overall Study|Withdrawal by Subject|4|||
149812462|NCT02703454|540443248|FG001|Overall Study|Withdrawal by Subject|3|||
149812463|NCT02703454|540443247|FG000|Overall Study|Lost to Follow-up|1|||
149812464|NCT02703454|540443248|FG001|Overall Study|Lost to Follow-up|2|||
149812465|NCT02703454|540443247|FG000|Overall Study|Study discontinuation|5|||
149812466|NCT02703454|540443248|FG001|Overall Study|Study discontinuation|8|||
149812467|NCT02284373|540443249|FG000|Overall Study|Withdrawal by Subject|0|||
149812468|NCT02284373|540443250|FG001|Overall Study|Withdrawal by Subject|1|||
149812469|NCT02284373|540443251|FG002|Overall Study|Withdrawal by Subject|0|||
149812470|NCT02284373|540443249|FG000|Overall Study|Other|0|||
149812471|NCT02284373|540443250|FG001|Overall Study|Other|1|||
149812472|NCT02284373|540443251|FG002|Overall Study|Other|0|||
149812473|NCT02284373|540443249|FG000|Overall Study|Lost to Follow-up|0|||
149812474|NCT02284373|540443250|FG001|Overall Study|Lost to Follow-up|1|||
149812475|NCT02284373|540443251|FG002|Overall Study|Lost to Follow-up|0|||
149812476|NCT02016755|540443252|FG000|Overall Study|Major amputation of index limb|2|||
149812477|NCT02016755|540443252|FG000|Overall Study|Adverse Event|2|||
149812478|NCT02016755|540443252|FG000|Overall Study|Physician Decision|1|||
149812479|NCT02016755|540443252|FG000|Overall Study|Death|2|||
149812480|NCT02748616|540443280|FG000|Overall Study|Lost to Follow-up|1|||
149812481|NCT02748616|540443280|FG000|Overall Study|Withdrawal by Subject|2|||
149812482|NCT02748616|540443280|FG000|Overall Study|Physician Decision|2|||
149812483|NCT02748616|540443280|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
149812484|NCT02216214|540443282|FG000|Overall Study|Randomized Never Received Study Drug|1|||
149812485|NCT02216214|540443283|FG001|Overall Study|Randomized Never Received Study Drug|0|||
149812486|NCT02216214|540443282|FG000|Overall Study|Adverse Event|10|||
149812487|NCT02216214|540443283|FG001|Overall Study|Adverse Event|8|||
149812488|NCT02216214|540443282|FG000|Overall Study|Lack of Efficacy|2|||
149812489|NCT02216214|540443283|FG001|Overall Study|Lack of Efficacy|2|||
149812490|NCT02216214|540443282|FG000|Overall Study|Lost to Follow-up|3|||
149812491|NCT02216214|540443283|FG001|Overall Study|Lost to Follow-up|2|||
149812492|NCT02216214|540443282|FG000|Overall Study|Protocol Violation|4|||
149812493|NCT02216214|540443283|FG001|Overall Study|Protocol Violation|2|||
149812494|NCT02216214|540443282|FG000|Overall Study|Withdrawal by Subject|22|||
149812495|NCT02216214|540443283|FG001|Overall Study|Withdrawal by Subject|20|||
149812496|NCT02216214|540443282|FG000|Overall Study|Study Terminated By Sponsor|0|||
149812497|NCT02216214|540443283|FG001|Overall Study|Study Terminated By Sponsor|1|||
149812498|NCT02216214|540443282|FG000|Overall Study|Miscellaneous|1|||
149812499|NCT02216214|540443283|FG001|Overall Study|Miscellaneous|1|||
149812500|NCT05354206|540443284|FG000|Overall Study|Withdrawal by Subject|1|||
149812501|NCT05354206|540443285|FG001|Overall Study|Withdrawal by Subject|0|||
149812502|NCT01414062|540443286|FG000|Overall Study|Lost to Follow-up|3|||
149812503|NCT01414062|540443287|FG001|Overall Study|Lost to Follow-up|2|||
149812504|NCT01414062|540443286|FG000|Overall Study|Left Country|1|||
149812505|NCT01414062|540443287|FG001|Overall Study|Left Country|1|||
149812506|NCT01414062|540443286|FG000|Overall Study|Family Disapproval|1|||
149812507|NCT01414062|540443287|FG001|Overall Study|Family Disapproval|0|||
149812508|NCT01414062|540443286|FG000|Overall Study|Withdrawal by Subject|0|||
149812509|NCT01414062|540443287|FG001|Overall Study|Withdrawal by Subject|1|||
149812510|NCT04285983|540443288|FG000|Overall Study|Protocol Violation|6|||
149812511|NCT04936334|540443289|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
149812512|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
149812513|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
149812514|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
149812515|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
149812516|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
149812517|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
149812518|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
149812519|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
149812520|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
149812521|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
149812522|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
149812523|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
149812524|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
149812525|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
149812526|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
149812527|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
149812528|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
149812529|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
149812530|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
149812531|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
149812532|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
149812533|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
149812534|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
149812535|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
149812536|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
149812537|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
149812538|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
149812539|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
149812540|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
149812541|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
149812542|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
149812543|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
149812544|NCT03747939|540443294|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
149812545|NCT03747939|540443295|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
149812546|NCT03747939|540443296|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
149812547|NCT03747939|540443297|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
149812548|NCT03747939|540443294|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
149812549|NCT03747939|540443295|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
149812550|NCT03747939|540443296|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
149812551|NCT03747939|540443297|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
149812552|NCT03747939|540443294|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
149812553|NCT03747939|540443295|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
149812554|NCT03747939|540443296|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
149812555|NCT03747939|540443297|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
149812556|NCT03747939|540443294|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
149812557|NCT03747939|540443295|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
149812558|NCT03747939|540443296|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
149812559|NCT03747939|540443297|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
149812560|NCT03747939|540443294|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
149812561|NCT03747939|540443295|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
149812562|NCT03747939|540443296|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
149812563|NCT03747939|540443297|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
149812564|NCT03747939|540443294|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
149812565|NCT03747939|540443295|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
149812566|NCT03747939|540443296|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
149812567|NCT03747939|540443297|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
149812568|NCT04529096|540443303|FG000|Overall Study|Adverse Event|6|||
149812569|NCT04529096|540443304|FG001|Overall Study|Adverse Event|1|||
149812570|NCT04529096|540443303|FG000|Overall Study|Lack of Efficacy|1|||
149812571|NCT04529096|540443304|FG001|Overall Study|Lack of Efficacy|0|||
149812572|NCT04529096|540443303|FG000|Overall Study|Lost to Follow-up|1|||
149812573|NCT04529096|540443304|FG001|Overall Study|Lost to Follow-up|1|||
149812574|NCT04529096|540443303|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149812575|NCT04529096|540443304|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149812576|NCT04529096|540443303|FG000|Overall Study|Physician Decision|1|||
149812577|NCT04529096|540443304|FG001|Overall Study|Physician Decision|3|||
149812578|NCT04529096|540443303|FG000|Overall Study|Withdrawal by Subject|5|||
149812579|NCT04529096|540443304|FG001|Overall Study|Withdrawal by Subject|0|||
149812580|NCT01289990|540443305|FG000|Overall Study|Death|0|||
149812581|NCT01289990|540443306|FG001|Overall Study|Death|0|||
149812582|NCT01289990|540443307|FG002|Overall Study|Death|0|||
149812583|NCT01289990|540443308|FG003|Overall Study|Death|1|||
149812584|NCT01289990|540443309|FG004|Overall Study|Death|2|||
149812585|NCT01289990|540443310|FG005|Overall Study|Death|1|||
149812586|NCT01289990|540443311|FG006|Overall Study|Death|0|||
149812587|NCT01289990|540443312|FG007|Overall Study|Death|0|||
149812588|NCT01289990|540443313|FG008|Overall Study|Death|0|||
149812589|NCT01289990|540443314|FG009|Overall Study|Death|0|||
149812590|NCT01289990|540443315|FG010|Overall Study|Death|0|||
149812591|NCT01289990|540443316|FG011|Overall Study|Death|1|||
149812592|NCT01289990|540443317|FG012|Overall Study|Death|0|||
149812593|NCT01289990|540443305|FG000|Overall Study|Lost to Follow-up|3|||
149812594|NCT01289990|540443306|FG001|Overall Study|Lost to Follow-up|2|||
149812595|NCT01289990|540443307|FG002|Overall Study|Lost to Follow-up|5|||
149812596|NCT01289990|540443308|FG003|Overall Study|Lost to Follow-up|5|||
149812597|NCT01289990|540443309|FG004|Overall Study|Lost to Follow-up|3|||
149812598|NCT01289990|540443310|FG005|Overall Study|Lost to Follow-up|4|||
149812599|NCT01289990|540443311|FG006|Overall Study|Lost to Follow-up|2|||
149812600|NCT01289990|540443312|FG007|Overall Study|Lost to Follow-up|2|||
149812601|NCT01289990|540443313|FG008|Overall Study|Lost to Follow-up|1|||
149812602|NCT01289990|540443314|FG009|Overall Study|Lost to Follow-up|4|||
149812603|NCT01289990|540443315|FG010|Overall Study|Lost to Follow-up|2|||
149812604|NCT01289990|540443316|FG011|Overall Study|Lost to Follow-up|1|||
149812605|NCT01289990|540443317|FG012|Overall Study|Lost to Follow-up|2|||
149812606|NCT01289990|540443305|FG000|Overall Study|Withdrawal by Subject|15|||
149812607|NCT01289990|540443306|FG001|Overall Study|Withdrawal by Subject|14|||
149812608|NCT01289990|540443307|FG002|Overall Study|Withdrawal by Subject|12|||
149812609|NCT01289990|540443308|FG003|Overall Study|Withdrawal by Subject|13|||
149812610|NCT01289990|540443309|FG004|Overall Study|Withdrawal by Subject|8|||
149812611|NCT01289990|540443310|FG005|Overall Study|Withdrawal by Subject|7|||
149812612|NCT01289990|540443311|FG006|Overall Study|Withdrawal by Subject|13|||
149812613|NCT01289990|540443312|FG007|Overall Study|Withdrawal by Subject|9|||
149812614|NCT01289990|540443313|FG008|Overall Study|Withdrawal by Subject|12|||
149812615|NCT01289990|540443314|FG009|Overall Study|Withdrawal by Subject|13|||
149812616|NCT01289990|540443315|FG010|Overall Study|Withdrawal by Subject|11|||
149812617|NCT01289990|540443316|FG011|Overall Study|Withdrawal by Subject|13|||
149812618|NCT01289990|540443317|FG012|Overall Study|Withdrawal by Subject|16|||
149812619|NCT01289990|540443305|FG000|Overall Study|discontinued in preceding trial|18|||
149812620|NCT01289990|540443306|FG001|Overall Study|discontinued in preceding trial|20|||
149812621|NCT01289990|540443307|FG002|Overall Study|discontinued in preceding trial|41|||
149812622|NCT01289990|540443308|FG003|Overall Study|discontinued in preceding trial|17|||
149812623|NCT01289990|540443309|FG004|Overall Study|discontinued in preceding trial|11|||
149812624|NCT01289990|540443310|FG005|Overall Study|discontinued in preceding trial|12|||
149812625|NCT01289990|540443311|FG006|Overall Study|discontinued in preceding trial|18|||
149812626|NCT01289990|540443312|FG007|Overall Study|discontinued in preceding trial|8|||
149812627|NCT01289990|540443313|FG008|Overall Study|discontinued in preceding trial|17|||
149812628|NCT01289990|540443314|FG009|Overall Study|discontinued in preceding trial|21|||
149812629|NCT01289990|540443315|FG010|Overall Study|discontinued in preceding trial|17|||
149812630|NCT01289990|540443316|FG011|Overall Study|discontinued in preceding trial|17|||
149812631|NCT01289990|540443317|FG012|Overall Study|discontinued in preceding trial|24|||
149812632|NCT01289990|540443305|FG000|Overall Study|did not continue in extension|41|||
149812633|NCT01289990|540443306|FG001|Overall Study|did not continue in extension|45|||
149812634|NCT01289990|540443307|FG002|Overall Study|did not continue in extension|51|||
149812635|NCT01289990|540443308|FG003|Overall Study|did not continue in extension|51|||
149812636|NCT01289990|540443309|FG004|Overall Study|did not continue in extension|48|||
149812637|NCT01289990|540443310|FG005|Overall Study|did not continue in extension|50|||
149812638|NCT01289990|540443311|FG006|Overall Study|did not continue in extension|54|||
149812639|NCT01289990|540443312|FG007|Overall Study|did not continue in extension|36|||
149812640|NCT01289990|540443313|FG008|Overall Study|did not continue in extension|44|||
149812641|NCT01289990|540443314|FG009|Overall Study|did not continue in extension|48|||
149812642|NCT01289990|540443315|FG010|Overall Study|did not continue in extension|45|||
149812643|NCT01289990|540443316|FG011|Overall Study|did not continue in extension|34|||
149812644|NCT01289990|540443317|FG012|Overall Study|did not continue in extension|56|||
149812645|NCT01289990|540443305|FG000|Overall Study|Not treated|0|||
149812646|NCT01289990|540443306|FG001|Overall Study|Not treated|0|||
149812647|NCT01289990|540443307|FG002|Overall Study|Not treated|0|||
149812648|NCT01289990|540443308|FG003|Overall Study|Not treated|0|||
149812649|NCT01289990|540443309|FG004|Overall Study|Not treated|0|||
149812650|NCT01289990|540443310|FG005|Overall Study|Not treated|0|||
149812651|NCT01289990|540443311|FG006|Overall Study|Not treated|1|||
149812652|NCT01289990|540443312|FG007|Overall Study|Not treated|0|||
149812653|NCT01289990|540443313|FG008|Overall Study|Not treated|1|||
149812654|NCT01289990|540443314|FG009|Overall Study|Not treated|0|||
149812655|NCT01289990|540443315|FG010|Overall Study|Not treated|1|||
149812656|NCT01289990|540443316|FG011|Overall Study|Not treated|2|||
149812657|NCT01289990|540443317|FG012|Overall Study|Not treated|0|||
149812658|NCT03454672|540443318|FG000|Overall Study|Adverse Event|1|||
149812659|NCT03454672|540443319|FG001|Overall Study|Adverse Event|1|||
149812660|NCT03454672|540443318|FG000|Overall Study|Lost to Follow-up|1|||
149812661|NCT03454672|540443319|FG001|Overall Study|Lost to Follow-up|3|||
149812662|NCT03454672|540443318|FG000|Overall Study|painful|1|||
149812663|NCT03454672|540443319|FG001|Overall Study|painful|2|||
149812664|NCT03454672|540443318|FG000|Overall Study|Non-compliance|2|||
149812665|NCT03454672|540443319|FG001|Overall Study|Non-compliance|4|||
149812666|NCT03454672|540443318|FG000|Overall Study|personal reasons|3|||
149812667|NCT03454672|540443319|FG001|Overall Study|personal reasons|2|||
149812668|NCT03454672|540443318|FG000|Overall Study|Withdrawal by Subject|1|||
149812669|NCT03454672|540443319|FG001|Overall Study|Withdrawal by Subject|0|||
149812670|NCT01488071|540443320|FG000|Overall Study|Adverse Event|15|||
149812671|NCT01488071|540443321|FG001|Overall Study|Adverse Event|23|||
149812672|NCT01488071|540443320|FG000|Overall Study|Lack of Efficacy|11|||
149812673|NCT01488071|540443321|FG001|Overall Study|Lack of Efficacy|17|||
149812674|NCT01488071|540443320|FG000|Overall Study|Non-compliance with study drug|2|||
149812675|NCT01488071|540443321|FG001|Overall Study|Non-compliance with study drug|0|||
149812676|NCT01488071|540443320|FG000|Overall Study|Protocol Violation|5|||
149812677|NCT01488071|540443321|FG001|Overall Study|Protocol Violation|7|||
149812678|NCT01488071|540443320|FG000|Overall Study|Withdrawal of Consent|14|||
149812679|NCT01488071|540443321|FG001|Overall Study|Withdrawal of Consent|12|||
149812680|NCT01488071|540443320|FG000|Overall Study|Lost to Follow-up|1|||
149812681|NCT01488071|540443321|FG001|Overall Study|Lost to Follow-up|0|||
149812682|NCT01488071|540443320|FG000|Overall Study|Administrative or Other Reason(s)|5|||
149812683|NCT01488071|540443321|FG001|Overall Study|Administrative or Other Reason(s)|4|||
149812684|NCT02139306|540443322|FG000|Overall Study|Withdrawal by Subject|4|||
149812685|NCT02139306|540443323|FG001|Overall Study|Withdrawal by Subject|6|||
149812686|NCT02139306|540443322|FG000|Overall Study|Adverse Event|3|||
149812687|NCT02139306|540443323|FG001|Overall Study|Adverse Event|4|||
149812688|NCT02139306|540443322|FG000|Overall Study|Physician Decision|0|||
149812689|NCT02139306|540443323|FG001|Overall Study|Physician Decision|1|||
149812690|NCT02139306|540443322|FG000|Overall Study|Other Unspecified|2|||
149812691|NCT02139306|540443323|FG001|Overall Study|Other Unspecified|3|||
149812692|NCT02139306|540443322|FG000|Overall Study|Protocol Violation|4|||
149812693|NCT02139306|540443323|FG001|Overall Study|Protocol Violation|0|||
149812694|NCT04449354|540443324|FG000|Overall Study|Withdrawal by Subject|1|||
149812695|NCT05899218|540443325|FG000|Overall Study|Lost to Follow-up|2|||
149812696|NCT05899218|540443326|FG001|Overall Study|Lost to Follow-up|2|||
149812697|NCT05899218|540443325|FG000|Overall Study|deemed ineligible out of country|1|||
149812698|NCT05899218|540443326|FG001|Overall Study|deemed ineligible out of country|0|||
149812699|NCT01220128|540443327|FG000|Overall Study|Progressive disease|0|||
149812700|NCT01220128|540443328|FG001|Overall Study|Progressive disease|0|||
149812701|NCT01220128|540443329|FG002|Overall Study|Progressive disease|2|||
149812702|NCT01220128|540443330|FG003|Overall Study|Progressive disease|0|||
149812703|NCT01220128|540443331|FG004|Overall Study|Progressive disease|0|||
149812704|NCT01220128|540443332|FG005|Overall Study|Progressive disease|0|||
149812705|NCT01220128|540443333|FG006|Overall Study|Progressive disease|0|||
149812706|NCT01220128|540443327|FG000|Overall Study|Sponsor study termination|0|||
149812707|NCT01220128|540443328|FG001|Overall Study|Sponsor study termination|1|||
149812708|NCT01220128|540443329|FG002|Overall Study|Sponsor study termination|0|||
149812709|NCT01220128|540443330|FG003|Overall Study|Sponsor study termination|0|||
149812710|NCT01220128|540443331|FG004|Overall Study|Sponsor study termination|0|||
149812711|NCT01220128|540443332|FG005|Overall Study|Sponsor study termination|0|||
149812712|NCT01220128|540443333|FG006|Overall Study|Sponsor study termination|1|||
149812713|NCT01220128|540443327|FG000|Overall Study|Adverse event, serious fatal|2|||
149812714|NCT01220128|540443328|FG001|Overall Study|Adverse event, serious fatal|0|||
149812715|NCT01220128|540443329|FG002|Overall Study|Adverse event, serious fatal|0|||
149812716|NCT01220128|540443330|FG003|Overall Study|Adverse event, serious fatal|0|||
149812717|NCT01220128|540443331|FG004|Overall Study|Adverse event, serious fatal|0|||
149812718|NCT01220128|540443332|FG005|Overall Study|Adverse event, serious fatal|0|||
149812719|NCT01220128|540443333|FG006|Overall Study|Adverse event, serious fatal|1|||
149812720|NCT01220128|540443327|FG000|Overall Study|Adverse event, non-fatal|1|||
149812721|NCT01220128|540443328|FG001|Overall Study|Adverse event, non-fatal|0|||
149812722|NCT01220128|540443329|FG002|Overall Study|Adverse event, non-fatal|0|||
149812723|NCT01220128|540443330|FG003|Overall Study|Adverse event, non-fatal|0|||
149812724|NCT01220128|540443331|FG004|Overall Study|Adverse event, non-fatal|0|||
149812725|NCT01220128|540443332|FG005|Overall Study|Adverse event, non-fatal|0|||
149812726|NCT01220128|540443333|FG006|Overall Study|Adverse event, non-fatal|3|||
149812727|NCT01220128|540443327|FG000|Overall Study|Other|0|||
149812728|NCT01220128|540443328|FG001|Overall Study|Other|0|||
149812729|NCT01220128|540443329|FG002|Overall Study|Other|1|||
149812730|NCT01220128|540443330|FG003|Overall Study|Other|0|||
149812731|NCT01220128|540443331|FG004|Overall Study|Other|0|||
149812732|NCT01220128|540443332|FG005|Overall Study|Other|0|||
149812733|NCT01220128|540443333|FG006|Overall Study|Other|0|||
149812734|NCT01220128|540443327|FG000|Overall Study|Consent withdrawn by subject|1|||
149812735|NCT01220128|540443328|FG001|Overall Study|Consent withdrawn by subject|0|||
149812736|NCT01220128|540443329|FG002|Overall Study|Consent withdrawn by subject|0|||
149812737|NCT01220128|540443330|FG003|Overall Study|Consent withdrawn by subject|0|||
149812738|NCT01220128|540443331|FG004|Overall Study|Consent withdrawn by subject|0|||
149812739|NCT01220128|540443332|FG005|Overall Study|Consent withdrawn by subject|0|||
149812740|NCT01220128|540443333|FG006|Overall Study|Consent withdrawn by subject|0|||
149812741|NCT02873195|540443336|FG000|Overall Study|Ineligible|5|||
149812742|NCT02873195|540443337|FG001|Overall Study|Ineligible|0|||
149812743|NCT02508649|540443338|FG000|Overall Study|Withdrawal by Subject|4|||
149812744|NCT02508649|540443339|FG001|Overall Study|Withdrawal by Subject|6|||
149812745|NCT02508649|540443340|FG002|Overall Study|Withdrawal by Subject|5|||
149812746|NCT02508649|540443341|FG003|Overall Study|Withdrawal by Subject|6|||
149812747|NCT02508649|540443338|FG000|Overall Study|Investigator withdrew the subject|1|||
149812748|NCT02508649|540443339|FG001|Overall Study|Investigator withdrew the subject|2|||
149812749|NCT02508649|540443340|FG002|Overall Study|Investigator withdrew the subject|1|||
149812750|NCT02508649|540443341|FG003|Overall Study|Investigator withdrew the subject|0|||
149812751|NCT02508649|540443338|FG000|Overall Study|Post randomization screening failure|12|||
149812752|NCT02508649|540443339|FG001|Overall Study|Post randomization screening failure|4|||
149812753|NCT02508649|540443340|FG002|Overall Study|Post randomization screening failure|9|||
149812754|NCT02508649|540443341|FG003|Overall Study|Post randomization screening failure|3|||
149812755|NCT02508649|540443338|FG000|Overall Study|Lost to Follow-up|1|||
149812756|NCT02508649|540443339|FG001|Overall Study|Lost to Follow-up|1|||
149812757|NCT02508649|540443340|FG002|Overall Study|Lost to Follow-up|0|||
149812758|NCT02508649|540443341|FG003|Overall Study|Lost to Follow-up|1|||
149812759|NCT02149199|540443346|FG000|Overall Study|Study specific withdrawal criteria|4|||
149812760|NCT02149199|540443347|FG001|Overall Study|Study specific withdrawal criteria|21|||
149812761|NCT02149199|540443348|FG002|Overall Study|Study specific withdrawal criteria|6|||
149812762|NCT02149199|540443346|FG000|Overall Study|Other|20|||
149812763|NCT02149199|540443347|FG001|Overall Study|Other|25|||
149812764|NCT02149199|540443348|FG002|Overall Study|Other|20|||
149812765|NCT02149199|540443346|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
149812766|NCT02149199|540443347|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
149812767|NCT02149199|540443348|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
149812768|NCT02149199|540443346|FG000|Overall Study|Withdrawal by Subject|75|||
149812769|NCT02149199|540443347|FG001|Overall Study|Withdrawal by Subject|93|||
149812770|NCT02149199|540443348|FG002|Overall Study|Withdrawal by Subject|77|||
149812771|NCT02149199|540443346|FG000|Overall Study|Protocol Violation|16|||
149812772|NCT02149199|540443347|FG001|Overall Study|Protocol Violation|13|||
149812773|NCT02149199|540443348|FG002|Overall Study|Protocol Violation|15|||
149812774|NCT02149199|540443346|FG000|Overall Study|Lost to Follow-up|3|||
149812775|NCT02149199|540443347|FG001|Overall Study|Lost to Follow-up|12|||
149812776|NCT02149199|540443348|FG002|Overall Study|Lost to Follow-up|11|||
149812777|NCT02149199|540443346|FG000|Overall Study|Death|0|||
149812778|NCT02149199|540443347|FG001|Overall Study|Death|0|||
149812779|NCT02149199|540443348|FG002|Overall Study|Death|1|||
149812780|NCT02149199|540443346|FG000|Overall Study|Adverse Event|6|||
149812781|NCT02149199|540443347|FG001|Overall Study|Adverse Event|15|||
149812782|NCT02149199|540443348|FG002|Overall Study|Adverse Event|9|||
149812783|NCT00752895|540443351|FG000|Overall Study|Withdrawal by Subject|8|||
149812784|NCT00752895|540443352|FG001|Overall Study|Withdrawal by Subject|3|||
149812785|NCT00633217|540443353|FG000|Overall Study|Adverse Event|5|||
149812786|NCT00633217|540443354|FG001|Overall Study|Adverse Event|9|||
149812787|NCT00633217|540443353|FG000|Overall Study|Lack of Efficacy|0|||
149812788|NCT00633217|540443354|FG001|Overall Study|Lack of Efficacy|2|||
149812789|NCT00633217|540443353|FG000|Overall Study|Protocol Violation|3|||
149812790|NCT00633217|540443354|FG001|Overall Study|Protocol Violation|7|||
149812791|NCT00633217|540443353|FG000|Overall Study|Lost to Follow-up|2|||
149812792|NCT00633217|540443354|FG001|Overall Study|Lost to Follow-up|2|||
149812793|NCT00633217|540443353|FG000|Overall Study|Investigator Discretion|2|||
149812794|NCT00633217|540443354|FG001|Overall Study|Investigator Discretion|0|||
149812795|NCT00633217|540443353|FG000|Overall Study|Withdrew Consent|3|||
149812796|NCT00633217|540443354|FG001|Overall Study|Withdrew Consent|3|||
149812797|NCT00314262|540443355|FG000|Overall Study|Adverse Event|2|||
149812798|NCT00314262|540443355|FG000|Overall Study|Withdrawal by Subject|2|||
149812799|NCT00314262|540443355|FG000|Overall Study|Physician Decision|1|||
149812800|NCT04881448|540443356|FG000|Overall Study|Study cancelled by sponsor|220|||
149812801|NCT04881448|540443356|FG000|Overall Study|Withdrawal by Subject|2|||
149812802|NCT04881448|540443356|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
149812803|NCT01966107|540443357|FG000|Overall Study|excluded from FAS|21|||
149812804|NCT01966107|540443358|FG001|Overall Study|excluded from FAS|20|||
149812805|NCT01966107|540443357|FG000|Overall Study|discontinued treatment|345|||
149812806|NCT01966107|540443358|FG001|Overall Study|discontinued treatment|372|||
149812807|NCT01966107|540443357|FG000|Overall Study|due to study closure|164|||
149812808|NCT01966107|540443358|FG001|Overall Study|due to study closure|186|||
149812809|NCT01966107|540443357|FG000|Overall Study|withdrew from the study|272|||
149812810|NCT01966107|540443358|FG001|Overall Study|withdrew from the study|303|||
149812811|NCT00532779|540443359|FG000|Overall Study|Adverse Event|122|||
149812812|NCT00532779|540443360|FG001|Overall Study|Adverse Event|112|||
149812813|NCT00532779|540443361|FG002|Overall Study|Adverse Event|56|||
149812814|NCT00532779|540443359|FG000|Overall Study|Lost to Follow-up|76|||
149812815|NCT00532779|540443360|FG001|Overall Study|Lost to Follow-up|65|||
149812816|NCT00532779|540443361|FG002|Overall Study|Lost to Follow-up|66|||
149812817|NCT00532779|540443359|FG000|Overall Study|Withdrawal by Subject|63|||
149812818|NCT00532779|540443360|FG001|Overall Study|Withdrawal by Subject|60|||
149812819|NCT00532779|540443361|FG002|Overall Study|Withdrawal by Subject|90|||
149812820|NCT00532779|540443359|FG000|Overall Study|Lack of Efficacy|12|||
149812821|NCT00532779|540443360|FG001|Overall Study|Lack of Efficacy|12|||
149812822|NCT00532779|540443361|FG002|Overall Study|Lack of Efficacy|40|||
149812823|NCT00532779|540443359|FG000|Overall Study|Protocol Violation|5|||
149812824|NCT00532779|540443360|FG001|Overall Study|Protocol Violation|9|||
149812825|NCT00532779|540443361|FG002|Overall Study|Protocol Violation|7|||
149812826|NCT00532779|540443359|FG000|Overall Study|Pregnancy|2|||
149812827|NCT00532779|540443360|FG001|Overall Study|Pregnancy|5|||
149812828|NCT00532779|540443361|FG002|Overall Study|Pregnancy|3|||
149812829|NCT00532779|540443359|FG000|Overall Study|Death|0|||
149812830|NCT00532779|540443360|FG001|Overall Study|Death|1|||
149812831|NCT00532779|540443361|FG002|Overall Study|Death|0|||
149812832|NCT00532779|540443359|FG000|Overall Study|Drug noncompliance, moved, other|14|||
149812833|NCT00532779|540443360|FG001|Overall Study|Drug noncompliance, moved, other|23|||
149812834|NCT00532779|540443361|FG002|Overall Study|Drug noncompliance, moved, other|29|||
149812835|NCT02662556|540443362|FG000|Overall Study|Adverse Event|4|||
149812836|NCT02662556|540443362|FG000|Overall Study|Lack of Efficacy|4|||
149812837|NCT00828516|540443373|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
149812838|NCT00689273|540443374|FG000|Overall Study|Adverse Event|3|||
149812839|NCT00689273|540443375|FG001|Overall Study|Adverse Event|1|||
149812840|NCT00689273|540443374|FG000|Overall Study|Lack of Efficacy|3|||
149812841|NCT00689273|540443375|FG001|Overall Study|Lack of Efficacy|0|||
149812842|NCT00689273|540443374|FG000|Overall Study|Lost to Follow-up|0|||
149812843|NCT00689273|540443375|FG001|Overall Study|Lost to Follow-up|2|||
149812844|NCT00689273|540443374|FG000|Overall Study|Other|6|||
149812845|NCT00689273|540443375|FG001|Overall Study|Other|2|||
149812846|NCT00689273|540443374|FG000|Overall Study|Randomized but not Treated|1|||
149812847|NCT00689273|540443375|FG001|Overall Study|Randomized but not Treated|0|||
149812848|NCT02082262|540445715|FG000|Overall Study|Withdrawal by Subject|3|||
149812849|NCT02082262|540445715|FG000|Overall Study|Adverse Event|48|||
149812850|NCT01074307|540445716|FG000|Overall Study|No primary endpoint evaluation|14|||
149812851|NCT01074307|540445717|FG001|Overall Study|No primary endpoint evaluation|6|||
149812852|NCT01074307|540445716|FG000|Overall Study|Exclusion criterion|0|||
149812853|NCT01074307|540445717|FG001|Overall Study|Exclusion criterion|1|||
149812854|NCT01074307|540445716|FG000|Overall Study|Protocol Violation|8|||
149812855|NCT01074307|540445717|FG001|Overall Study|Protocol Violation|5|||
149812856|NCT02162511|540445718|FG000|Overall Study|Lack of Efficacy|0|||
149812857|NCT02162511|540445719|FG001|Overall Study|Lack of Efficacy|0|||
149812858|NCT02162511|540445720|FG002|Overall Study|Lack of Efficacy|2|||
149812859|NCT02476851|540445722|FG000|Overall Study|Protocol Violation|1|||
149812860|NCT02476851|540445723|FG001|Overall Study|Protocol Violation|1|||
149812861|NCT01399125|540445724|FG000|Overall Study|Adverse Event|32|||
149812862|NCT01399125|540445725|FG001|Overall Study|Adverse Event|30|||
149812863|NCT01399125|540445724|FG000|Overall Study|Abnormal Lab values|0|||
149812864|NCT01399125|540445725|FG001|Overall Study|Abnormal Lab values|1|||
149812865|NCT01399125|540445724|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149812866|NCT01399125|540445725|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
149812867|NCT01399125|540445724|FG000|Overall Study|Withdrawal by Subject|5|||
149812868|NCT01399125|540445725|FG001|Overall Study|Withdrawal by Subject|8|||
149812869|NCT01399125|540445724|FG000|Overall Study|Lost to Follow-up|2|||
149812870|NCT01399125|540445725|FG001|Overall Study|Lost to Follow-up|3|||
149812871|NCT01399125|540445724|FG000|Overall Study|Administrative Problems|7|||
149812872|NCT01399125|540445725|FG001|Overall Study|Administrative Problems|11|||
149812873|NCT01399125|540445724|FG000|Overall Study|Death|0|||
149812874|NCT01399125|540445725|FG001|Overall Study|Death|1|||
149812875|NCT01399125|540445724|FG000|Overall Study|Protocol Deviation|5|||
149812876|NCT01399125|540445725|FG001|Overall Study|Protocol Deviation|2|||
149812877|NCT00337129|540445726|FG000|Overall Study|Adverse Event|4|||
149812878|NCT00337129|540445726|FG000|Overall Study|Withdrawal by Subject|1|||
149812879|NCT00337129|540445726|FG000|Overall Study|Lack of Efficacy|32|||
149812880|NCT00337129|540445726|FG000|Overall Study|Death|2|||
149812881|NCT00337129|540445726|FG000|Overall Study|not protocol specified|1|||
149812882|NCT00647426|540445727|FG000|Overall Study|Withdrawal by Subject|2|||
149812883|NCT00563524|540445730|FG000|Overall Study|Adverse Event|0|||
149812884|NCT00563524|540445731|FG001|Overall Study|Adverse Event|1|||
149812885|NCT00563524|540445732|FG002|Overall Study|Adverse Event|0|||
149812886|NCT00563524|540445733|FG003|Overall Study|Adverse Event|0|||
149812887|NCT00563524|540445734|FG004|Overall Study|Adverse Event|2|||
149812888|NCT00563524|540445735|FG005|Overall Study|Adverse Event|0|||
149812889|NCT00563524|540445730|FG000|Overall Study|Lost to Follow-up|1|||
149812890|NCT00563524|540445731|FG001|Overall Study|Lost to Follow-up|0|||
149812891|NCT00563524|540445732|FG002|Overall Study|Lost to Follow-up|0|||
149812892|NCT00563524|540445733|FG003|Overall Study|Lost to Follow-up|0|||
149812893|NCT00563524|540445734|FG004|Overall Study|Lost to Follow-up|0|||
149812894|NCT00563524|540445735|FG005|Overall Study|Lost to Follow-up|0|||
149812895|NCT00563524|540445730|FG000|Overall Study|Protocol Violation|0|||
149812896|NCT00563524|540445731|FG001|Overall Study|Protocol Violation|1|||
149812897|NCT00563524|540445732|FG002|Overall Study|Protocol Violation|0|||
149812898|NCT00563524|540445733|FG003|Overall Study|Protocol Violation|0|||
149812899|NCT00563524|540445734|FG004|Overall Study|Protocol Violation|0|||
149812900|NCT00563524|540445735|FG005|Overall Study|Protocol Violation|0|||
149812901|NCT00563524|540445730|FG000|Overall Study|Withdrawal by Subject|1|||
149812902|NCT00563524|540445731|FG001|Overall Study|Withdrawal by Subject|1|||
149812903|NCT00563524|540445732|FG002|Overall Study|Withdrawal by Subject|3|||
149812904|NCT00563524|540445733|FG003|Overall Study|Withdrawal by Subject|0|||
149812905|NCT00563524|540445734|FG004|Overall Study|Withdrawal by Subject|0|||
149812906|NCT00563524|540445735|FG005|Overall Study|Withdrawal by Subject|1|||
149812907|NCT02626182|540445739|FG000|Overall Study|Adverse Event|2|||
149812908|NCT02626182|540445740|FG001|Overall Study|Adverse Event|0|||
149812909|NCT01084603|540445743|FG000|Baseline|Withdrawal by Subject|2|||
149812910|NCT01084603|540445743|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
149812911|NCT01084603|540445743|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
149812912|NCT01084603|540445743|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
149812913|NCT01084603|540445743|FG000|Washout Period 4|Adverse Event|1|||
149812914|NCT03836729|540445747|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
149812915|NCT00948025|540445748|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
149812916|NCT00948025|540445749|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
149812917|NCT00948025|540445748|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
149812918|NCT00948025|540445749|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
149812919|NCT00948025|540445748|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
149812920|NCT00948025|540445749|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
149812921|NCT01508325|540445750|FG000|Overall Study|Withdrawal by Subject|8|||
149812922|NCT01508325|540445751|FG001|Overall Study|Withdrawal by Subject|9|||
149812923|NCT01508325|540445750|FG000|Overall Study|Protocol Violation|0|||
149812924|NCT01508325|540445751|FG001|Overall Study|Protocol Violation|3|||
149812925|NCT01508325|540445750|FG000|Overall Study|Physician Decision|2|||
149812926|NCT01508325|540445751|FG001|Overall Study|Physician Decision|1|||
149812927|NCT01508325|540445750|FG000|Overall Study|Adverse Event|1|||
149812928|NCT01508325|540445751|FG001|Overall Study|Adverse Event|0|||
149812929|NCT01508325|540445750|FG000|Overall Study|Lost to Follow-up|5|||
149812930|NCT01508325|540445751|FG001|Overall Study|Lost to Follow-up|6|||
149812931|NCT01508325|540445750|FG000|Overall Study|Other|2|||
149812932|NCT01508325|540445751|FG001|Overall Study|Other|2|||
149812933|NCT01392170|540445752|FG000|Overall Study|Withdrawal by Subject|1|||
149812934|NCT01392170|540445752|FG000|Overall Study|Ineligible|1|||
149812935|NCT03543046|540445759|FG000|Overall Study|Adverse Event|1|||
149812936|NCT03543046|540445760|FG001|Overall Study|Adverse Event|1|||
149812937|NCT03543046|540445759|FG000|Overall Study|Physician Decision|1|||
149812938|NCT03543046|540445760|FG001|Overall Study|Physician Decision|1|||
149812939|NCT03543046|540445759|FG000|Overall Study|Protocol Violation|1|||
149812940|NCT03543046|540445760|FG001|Overall Study|Protocol Violation|0|||
149812941|NCT03174925|540445763|FG000|Overall Study|Elastographic images not retrievable|2|||
149812942|NCT03174925|540445763|FG000|Overall Study|Elastography image not interpretable|1|||
149812943|NCT01791127|540445764|FG000|Overall Study|Death|356|||
149812944|NCT01791127|540445764|FG000|Overall Study|Patient has withdrawn from study|293|||
149812945|NCT01791127|540445764|FG000|Overall Study|Lost to Follow-up|42|||
149812946|NCT01791127|540445764|FG000|Overall Study|All Siello leads are explanted|31|||
149812947|NCT01791127|540445764|FG000|Overall Study|Completion of 30 day safety registry|1|||
149812948|NCT01791127|540445764|FG000|Overall Study|Study terminated for EP Passion|749|||
149812949|NCT00520494|540445765|FG000|Overall Study|Withdrawal by Subject|1|||
149812950|NCT04247594|540445766|FG000|Overall Study|Withdrawal by Subject|4|||
149812951|NCT02018042|540445769|FG000|Overall Study|Withdrawal by Subject|1|||
149812952|NCT00589693|540445774|FG000|Overall Study|randomized in error|12|||
149812953|NCT00589693|540445775|FG001|Overall Study|randomized in error|6|||
149812954|NCT00589693|540445774|FG000|Overall Study|Adverse Event|4|||
149812955|NCT00589693|540445775|FG001|Overall Study|Adverse Event|4|||
149812956|NCT00589693|540445774|FG000|Overall Study|Death|26|||
149812957|NCT00589693|540445775|FG001|Overall Study|Death|16|||
149812958|NCT00589693|540445774|FG000|Overall Study|Lack of Efficacy|0|||
149812959|NCT00589693|540445775|FG001|Overall Study|Lack of Efficacy|1|||
149812960|NCT00589693|540445774|FG000|Overall Study|Lost to Follow-up|1|||
149812961|NCT00589693|540445775|FG001|Overall Study|Lost to Follow-up|0|||
149812962|NCT00589693|540445774|FG000|Overall Study|Physician Decision|0|||
149812963|NCT00589693|540445775|FG001|Overall Study|Physician Decision|1|||
149812964|NCT00589693|540445774|FG000|Overall Study|Protocol Violation|1|||
149812965|NCT00589693|540445775|FG001|Overall Study|Protocol Violation|1|||
149812966|NCT03231709|540445776|FG000|Treatment Period 1|Reason not Specified|0|||
149812967|NCT03231709|540445777|FG001|Treatment Period 1|Reason not Specified|1|||
149812968|NCT03231709|540445776|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
149812969|NCT03231709|540445777|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
149812970|NCT02609178|540445778|FG000|First Crown|Withdrawal by Subject|0|||
149812971|NCT02609178|540445779|FG001|First Crown|Withdrawal by Subject|0|||
149812972|NCT02609178|540445780|FG002|First Crown|Withdrawal by Subject|1|||
149812973|NCT02609178|540445781|FG003|First Crown|Withdrawal by Subject|1|||
149812974|NCT02609178|540445782|FG004|First Crown|Withdrawal by Subject|0|||
149812975|NCT02609178|540445783|FG005|First Crown|Withdrawal by Subject|0|||
149812976|NCT01128153|540445784|FG000|Overall Study|Adverse Event|1|||
149812977|NCT01128153|540445785|FG001|Overall Study|Adverse Event|3|||
149812978|NCT01128153|540445784|FG000|Overall Study|Condition under investigation worsened|8|||
149812979|NCT01128153|540445785|FG001|Overall Study|Condition under investigation worsened|7|||
149812980|NCT01128153|540445784|FG000|Overall Study|Withdrawal by Subject|2|||
149812981|NCT01128153|540445785|FG001|Overall Study|Withdrawal by Subject|3|||
149812982|NCT01128153|540445784|FG000|Overall Study|Incorrect enrolment to study|2|||
149812983|NCT01128153|540445785|FG001|Overall Study|Incorrect enrolment to study|1|||
149812984|NCT01128153|540445784|FG000|Overall Study|Protocol Violation|2|||
149812985|NCT01128153|540445785|FG001|Overall Study|Protocol Violation|0|||
149812986|NCT01128153|540445784|FG000|Overall Study|Developed discontinuation criteria|1|||
149812987|NCT01128153|540445785|FG001|Overall Study|Developed discontinuation criteria|1|||
149812988|NCT02419469|540445786|FG000|Overall Study|Withdrawal by Subject|1|||
149812989|NCT01682512|540445787|FG000|Overall Study|Adverse Event|6|||
149812990|NCT01682512|540445788|FG001|Overall Study|Adverse Event|5|||
149812991|NCT01682512|540445789|FG002|Overall Study|Adverse Event|2|||
149812992|NCT01682512|540445787|FG000|Overall Study|Withdrawal by Subject|2|||
149812993|NCT01682512|540445788|FG001|Overall Study|Withdrawal by Subject|6|||
149812994|NCT01682512|540445789|FG002|Overall Study|Withdrawal by Subject|3|||
149812995|NCT01682512|540445787|FG000|Overall Study|Physician Decision|0|||
149812996|NCT01682512|540445788|FG001|Overall Study|Physician Decision|2|||
149812997|NCT01682512|540445789|FG002|Overall Study|Physician Decision|0|||
149812998|NCT01682512|540445787|FG000|Overall Study|Study terminated by sponsor|46|||
149812999|NCT01682512|540445788|FG001|Overall Study|Study terminated by sponsor|43|||
149813000|NCT01682512|540445789|FG002|Overall Study|Study terminated by sponsor|0|||
149813001|NCT01682512|540445787|FG000|Overall Study|Lost to Follow-up|3|||
149813002|NCT01682512|540445788|FG001|Overall Study|Lost to Follow-up|0|||
149813003|NCT01682512|540445789|FG002|Overall Study|Lost to Follow-up|2|||
149813004|NCT01682512|540445787|FG000|Overall Study|Protocol Violation|2|||
149813005|NCT01682512|540445788|FG001|Overall Study|Protocol Violation|3|||
149813006|NCT01682512|540445789|FG002|Overall Study|Protocol Violation|2|||
149813007|NCT01682512|540445787|FG000|Overall Study|Primary lack of efficacy|10|||
149813008|NCT01682512|540445788|FG001|Overall Study|Primary lack of efficacy|7|||
149813009|NCT01682512|540445789|FG002|Overall Study|Primary lack of efficacy|7|||
149813010|NCT01682512|540445787|FG000|Overall Study|Secondary lack of efficacy|1|||
149813011|NCT01682512|540445788|FG001|Overall Study|Secondary lack of efficacy|1|||
149813012|NCT01682512|540445789|FG002|Overall Study|Secondary lack of efficacy|0|||
149813013|NCT01682512|540445787|FG000|Overall Study|Other than stated above|2|||
149813014|NCT01682512|540445788|FG001|Overall Study|Other than stated above|4|||
149813015|NCT01682512|540445789|FG002|Overall Study|Other than stated above|2|||
149813016|NCT00713830|540445790|FG000|Overall Study|Adverse Event|23|||
149813017|NCT00713830|540445791|FG001|Overall Study|Adverse Event|71|||
149813018|NCT00713830|540445790|FG000|Overall Study|Lack of Efficacy|24|||
149813019|NCT00713830|540445791|FG001|Overall Study|Lack of Efficacy|16|||
149813020|NCT00713830|540445790|FG000|Overall Study|Lost to Follow-up|2|||
149813021|NCT00713830|540445791|FG001|Overall Study|Lost to Follow-up|9|||
149813022|NCT00713830|540445790|FG000|Overall Study|Withdrawal by Subject|13|||
149813023|NCT00713830|540445791|FG001|Overall Study|Withdrawal by Subject|23|||
149813024|NCT00713830|540445790|FG000|Overall Study|Poor Compliance to Protocol|7|||
149813025|NCT00713830|540445791|FG001|Overall Study|Poor Compliance to Protocol|14|||
149813026|NCT00713830|540445790|FG000|Overall Study|Familial and Personal Reasons|9|||
149813027|NCT00713830|540445791|FG001|Overall Study|Familial and Personal Reasons|34|||
149813028|NCT00713830|540445790|FG000|Overall Study|Sponsor Decision|4|||
149813029|NCT00713830|540445791|FG001|Overall Study|Sponsor Decision|10|||
149813030|NCT00422058|540445792|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
149813031|NCT00422058|540445793|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
149813032|NCT00422058|540445794|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
149813033|NCT00422058|540445795|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
149813034|NCT00422058|540445796|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
149813035|NCT00422058|540445797|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
149813036|NCT00422058|540445792|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
149813037|NCT00422058|540445793|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
149813038|NCT00422058|540445794|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
149813039|NCT00422058|540445795|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
149813040|NCT00422058|540445796|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
149813041|NCT00422058|540445797|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
149813042|NCT00422058|540445792|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
149813043|NCT00422058|540445793|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
149813044|NCT00422058|540445794|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
149813045|NCT00422058|540445795|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
149813046|NCT00422058|540445796|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
149813047|NCT00422058|540445797|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
149813048|NCT00422058|540445792|FG000|Double-Blind, Week 0-20|Other|11|||
149813049|NCT00422058|540445793|FG001|Double-Blind, Week 0-20|Other|3|||
149813050|NCT00422058|540445794|FG002|Double-Blind, Week 0-20|Other|8|||
149813051|NCT00422058|540445795|FG003|Double-Blind, Week 0-20|Other|8|||
149813052|NCT00422058|540445796|FG004|Double-Blind, Week 0-20|Other|4|||
149813053|NCT00422058|540445797|FG005|Double-Blind, Week 0-20|Other|10|||
149813054|NCT00422058|540445792|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
149813055|NCT00422058|540445793|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
149813056|NCT00422058|540445794|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
149813057|NCT00422058|540445795|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
149813058|NCT00422058|540445796|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
149813059|NCT00422058|540445797|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
149813060|NCT00422058|540445792|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
149813061|NCT00422058|540445793|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
149813062|NCT00422058|540445794|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
149813063|NCT00422058|540445795|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
149813064|NCT00422058|540445796|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
149813065|NCT00422058|540445797|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
149813066|NCT00422058|540445792|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
149813067|NCT00422058|540445793|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
149813068|NCT00422058|540445794|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
149813069|NCT00422058|540445795|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
149813070|NCT00422058|540445796|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
149813071|NCT00422058|540445797|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
149813072|NCT00422058|540445792|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
149813073|NCT00422058|540445793|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
149813074|NCT00422058|540445794|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
149813075|NCT00422058|540445795|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
149813076|NCT00422058|540445796|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
149813077|NCT00422058|540445797|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
149813078|NCT00422058|540445792|FG000|Open-Label Extension, Week 20-104|Other|13|||
149813079|NCT00422058|540445793|FG001|Open-Label Extension, Week 20-104|Other|14|||
149813080|NCT00422058|540445794|FG002|Open-Label Extension, Week 20-104|Other|6|||
149813081|NCT00422058|540445795|FG003|Open-Label Extension, Week 20-104|Other|13|||
149813082|NCT00422058|540445796|FG004|Open-Label Extension, Week 20-104|Other|16|||
149813083|NCT00422058|540445797|FG005|Open-Label Extension, Week 20-104|Other|18|||
149813084|NCT02787785|540445798|FG000|Overall Study|Death|3|||
150153837|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153838|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153839|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
149813085|NCT02787785|540445799|FG001|Overall Study|Death|4|||
149813086|NCT02787785|540445798|FG000|Overall Study|Lost to Follow-up|1|||
149813087|NCT02787785|540445799|FG001|Overall Study|Lost to Follow-up|1|||
149813088|NCT02787785|540445798|FG000|Overall Study|Withdrawal by Subject|0|||
149813089|NCT02787785|540445799|FG001|Overall Study|Withdrawal by Subject|5|||
149813090|NCT02030834|540445800|FG000|Overall Study|Death|4|||
149813091|NCT02030834|540445801|FG001|Overall Study|Death|0|||
149813092|NCT02030834|540445802|FG002|Overall Study|Death|0|||
149813093|NCT02030834|540445800|FG000|Overall Study|Manufacturing failure|2|||
149813094|NCT02030834|540445801|FG001|Overall Study|Manufacturing failure|0|||
149813095|NCT02030834|540445802|FG002|Overall Study|Manufacturing failure|1|||
149813096|NCT02030834|540445800|FG000|Overall Study|Disease progression|2|||
149813097|NCT02030834|540445801|FG001|Overall Study|Disease progression|0|||
149813098|NCT02030834|540445802|FG002|Overall Study|Disease progression|2|||
149813099|NCT02030834|540445800|FG000|Overall Study|Lost to Follow-up|1|||
149813100|NCT02030834|540445801|FG001|Overall Study|Lost to Follow-up|0|||
149813101|NCT02030834|540445802|FG002|Overall Study|Lost to Follow-up|0|||
149813102|NCT02030834|540445800|FG000|Overall Study|Withdrawal by Subject|1|||
149813103|NCT02030834|540445801|FG001|Overall Study|Withdrawal by Subject|0|||
149813104|NCT02030834|540445802|FG002|Overall Study|Withdrawal by Subject|0|||
149813105|NCT02030834|540445800|FG000|Overall Study|Lack of funding|1|||
149813106|NCT02030834|540445801|FG001|Overall Study|Lack of funding|0|||
149813107|NCT02030834|540445802|FG002|Overall Study|Lack of funding|0|||
149813108|NCT01766310|540445807|FG000|Overall Study|Lost to Follow-up|1|||
149813109|NCT01766310|540445808|FG001|Overall Study|Lost to Follow-up|3|||
149813110|NCT01591499|540445809|FG000|Baseline Visit|Withdrawal by Subject|0|||
149813111|NCT01591499|540445810|FG001|Baseline Visit|Withdrawal by Subject|2|||
149813112|NCT01591499|540445811|FG002|Baseline Visit|Withdrawal by Subject|0|||
149813113|NCT01591499|540445812|FG003|Baseline Visit|Withdrawal by Subject|2|||
149813114|NCT01591499|540445809|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
149813115|NCT01591499|540445810|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
149813116|NCT01591499|540445811|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
149813117|NCT01591499|540445812|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
149813118|NCT01591499|540445809|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
149813119|NCT01591499|540445810|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
149813120|NCT01591499|540445811|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
149813121|NCT01591499|540445812|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
149813122|NCT00902278|540445813|FG000|Overall Study|Physician Decision|1|||
149813123|NCT00902278|540445814|FG001|Overall Study|Physician Decision|0|||
149813124|NCT00902278|540445815|FG002|Overall Study|Physician Decision|2|||
149813125|NCT00902278|540445816|FG003|Overall Study|Physician Decision|0|||
149813126|NCT00902278|540445817|FG004|Overall Study|Physician Decision|1|||
149813127|NCT00902278|540445813|FG000|Overall Study|Lost to Follow-up|3|||
149813128|NCT00902278|540445814|FG001|Overall Study|Lost to Follow-up|2|||
149813129|NCT00902278|540445815|FG002|Overall Study|Lost to Follow-up|3|||
149813130|NCT00902278|540445816|FG003|Overall Study|Lost to Follow-up|0|||
149813131|NCT00902278|540445817|FG004|Overall Study|Lost to Follow-up|1|||
149813132|NCT00446134|540445820|FG000|Overall Study|Adverse Event|7|||
149813133|NCT00446134|540445821|FG001|Overall Study|Adverse Event|17|||
149813134|NCT00446134|540445822|FG002|Overall Study|Adverse Event|13|||
149813135|NCT00446134|540445823|FG003|Overall Study|Adverse Event|18|||
149813136|NCT00446134|540445820|FG000|Overall Study|Lack of Efficacy|19|||
149813137|NCT00446134|540445821|FG001|Overall Study|Lack of Efficacy|19|||
149813138|NCT00446134|540445822|FG002|Overall Study|Lack of Efficacy|24|||
149813139|NCT00446134|540445823|FG003|Overall Study|Lack of Efficacy|19|||
149813140|NCT00446134|540445820|FG000|Overall Study|Protocol Violation|0|||
149813141|NCT00446134|540445821|FG001|Overall Study|Protocol Violation|2|||
149813142|NCT00446134|540445822|FG002|Overall Study|Protocol Violation|1|||
149813143|NCT00446134|540445823|FG003|Overall Study|Protocol Violation|0|||
149813144|NCT00446134|540445820|FG000|Overall Study|Lost to Follow-up|1|||
149813145|NCT00446134|540445821|FG001|Overall Study|Lost to Follow-up|3|||
149813146|NCT00446134|540445822|FG002|Overall Study|Lost to Follow-up|1|||
149813147|NCT00446134|540445823|FG003|Overall Study|Lost to Follow-up|1|||
149813148|NCT00446134|540445820|FG000|Overall Study|Withdrawal by Subject|3|||
149813149|NCT00446134|540445821|FG001|Overall Study|Withdrawal by Subject|3|||
149813150|NCT00446134|540445822|FG002|Overall Study|Withdrawal by Subject|1|||
149813151|NCT00446134|540445823|FG003|Overall Study|Withdrawal by Subject|3|||
149813152|NCT00446134|540445820|FG000|Overall Study|Physician Decision|0|||
149813153|NCT00446134|540445821|FG001|Overall Study|Physician Decision|0|||
149813154|NCT00446134|540445822|FG002|Overall Study|Physician Decision|0|||
149813155|NCT00446134|540445823|FG003|Overall Study|Physician Decision|2|||
149813156|NCT00446134|540445820|FG000|Overall Study|Adverse Event-Diarrhea|1|||
149813157|NCT00446134|540445821|FG001|Overall Study|Adverse Event-Diarrhea|1|||
149813158|NCT00446134|540445822|FG002|Overall Study|Adverse Event-Diarrhea|2|||
149813159|NCT00446134|540445823|FG003|Overall Study|Adverse Event-Diarrhea|0|||
149813160|NCT00446134|540445820|FG000|Overall Study|Reason Not Completed|3|||
149813161|NCT00446134|540445821|FG001|Overall Study|Reason Not Completed|0|||
149813162|NCT00446134|540445822|FG002|Overall Study|Reason Not Completed|1|||
149813163|NCT00446134|540445823|FG003|Overall Study|Reason Not Completed|2|||
149813164|NCT01311505|540445824|FG000|First Intervention Period|Protocol Violation|0|||
149813165|NCT01311505|540445825|FG001|First Intervention Period|Protocol Violation|1|||
149813166|NCT00567996|540445829|FG000|Overall Study|Adverse Event|18|||
149813167|NCT00567996|540445830|FG001|Overall Study|Adverse Event|16|||
149813168|NCT00567996|540445831|FG002|Overall Study|Adverse Event|13|||
149813169|NCT00567996|540445829|FG000|Overall Study|Protocol Deviation|9|||
149813170|NCT00567996|540445830|FG001|Overall Study|Protocol Deviation|11|||
149813171|NCT00567996|540445831|FG002|Overall Study|Protocol Deviation|13|||
149813172|NCT00567996|540445829|FG000|Overall Study|Withdrawal by Subject|8|||
149813173|NCT00567996|540445830|FG001|Overall Study|Withdrawal by Subject|12|||
149813174|NCT00567996|540445831|FG002|Overall Study|Withdrawal by Subject|22|||
149813175|NCT00567996|540445829|FG000|Overall Study|Abnormal Lab value(s)|2|||
149813176|NCT00567996|540445830|FG001|Overall Study|Abnormal Lab value(s)|1|||
149813177|NCT00567996|540445831|FG002|Overall Study|Abnormal Lab value(s)|2|||
149813178|NCT00567996|540445829|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149813179|NCT00567996|540445830|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149813180|NCT00567996|540445831|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149813181|NCT00567996|540445829|FG000|Overall Study|Lost to Follow-up|2|||
149813182|NCT00567996|540445830|FG001|Overall Study|Lost to Follow-up|5|||
149813183|NCT00567996|540445831|FG002|Overall Study|Lost to Follow-up|2|||
149813184|NCT00567996|540445829|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149813185|NCT00567996|540445830|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149813186|NCT00567996|540445831|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
149813187|NCT00567996|540445829|FG000|Overall Study|Administrative problems|1|||
149813188|NCT00567996|540445830|FG001|Overall Study|Administrative problems|1|||
149813189|NCT00567996|540445831|FG002|Overall Study|Administrative problems|0|||
149813190|NCT00567996|540445829|FG000|Overall Study|Death|1|||
149813191|NCT00567996|540445830|FG001|Overall Study|Death|0|||
149813192|NCT00567996|540445831|FG002|Overall Study|Death|2|||
149813193|NCT00567996|540445829|FG000|Overall Study|Patient's inability to use the device|0|||
149813194|NCT00567996|540445830|FG001|Overall Study|Patient's inability to use the device|1|||
149813195|NCT00567996|540445831|FG002|Overall Study|Patient's inability to use the device|0|||
149813196|NCT02956005|540445832|FG000|Overall Study|Not eligible|1|||
149813197|NCT02956005|540445832|FG000|Overall Study|Withdrawal by Subject|3|||
149813198|NCT02956005|540445832|FG000|Overall Study|Physician Decision|12|||
149813199|NCT02524665|540445835|FG000|Overall Study|Lost to Follow-up|1|||
149813200|NCT02602080|540445838|FG000|Overall Study|Protocol Violation|6|||
149813201|NCT02602080|540445839|FG001|Overall Study|Protocol Violation|1|||
149813202|NCT02602080|540445840|FG002|Overall Study|Protocol Violation|3|||
149813203|NCT02574260|540445846|FG000|Overall Study|Disease Progression|1|||
149813204|NCT01066039|540445847|FG000|Overall Study|Adverse Event|6|||
149813205|NCT01066039|540445847|FG000|Overall Study|Withdrawal by Subject|17|||
149813206|NCT01066039|540445847|FG000|Overall Study|Protocol Violation|2|||
149813207|NCT01066039|540445847|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
149813208|NCT01066039|540445847|FG000|Overall Study|Investigator's Request|1|||
149813209|NCT01066039|540445847|FG000|Overall Study|Dropout due to Insulin Administration|1|||
149813210|NCT01066039|540445847|FG000|Overall Study|Additional Antihypertensive Required|4|||
149813211|NCT01066039|540445847|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
149813212|NCT01066039|540445847|FG000|Overall Study|Failure to Control Blood Pressure|1|||
149813213|NCT01066039|540445847|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
149813214|NCT03022799|540445854|FG000|Overall Study|Adverse Event|0|||
149813215|NCT03022799|540445855|FG001|Overall Study|Adverse Event|0|||
149813216|NCT03022799|540445856|FG002|Overall Study|Adverse Event|0|||
149813217|NCT03022799|540445857|FG003|Overall Study|Adverse Event|0|||
149813218|NCT03022799|540445858|FG004|Overall Study|Adverse Event|0|||
149813219|NCT03022799|540445859|FG005|Overall Study|Adverse Event|0|||
149813220|NCT03022799|540445860|FG006|Overall Study|Adverse Event|0|||
149813221|NCT03022799|540445861|FG007|Overall Study|Adverse Event|0|||
149813222|NCT03022799|540445862|FG008|Overall Study|Adverse Event|0|||
149813223|NCT03022799|540445863|FG009|Overall Study|Adverse Event|1|||
149813224|NCT03022799|540445864|FG010|Overall Study|Adverse Event|1|||
149813225|NCT03022799|540445865|FG011|Overall Study|Adverse Event|0|||
149813226|NCT03022799|540445866|FG012|Overall Study|Adverse Event|0|||
149813227|NCT00883129|540445870|FG000|Overall Study|Adverse Event|7|||
149813228|NCT00883129|540445871|FG001|Overall Study|Adverse Event|15|||
149813229|NCT00883129|540445870|FG000|Overall Study|Withdrawal by Subject|8|||
149813230|NCT00883129|540445871|FG001|Overall Study|Withdrawal by Subject|9|||
149813231|NCT00883129|540445870|FG000|Overall Study|Non-compliance|3|||
149813232|NCT00883129|540445871|FG001|Overall Study|Non-compliance|6|||
149813233|NCT00883129|540445870|FG000|Overall Study|Lost to Follow-up|1|||
149813234|NCT00883129|540445871|FG001|Overall Study|Lost to Follow-up|2|||
149813235|NCT00883129|540445870|FG000|Overall Study|Death|1|||
149813236|NCT00883129|540445871|FG001|Overall Study|Death|2|||
149813237|NCT00883129|540445870|FG000|Overall Study|Defined Treatment Failure|0|||
149813238|NCT00883129|540445871|FG001|Overall Study|Defined Treatment Failure|2|||
149813239|NCT03273257|540445872|FG000|Overall Study|Death|0|||
149813240|NCT03273257|540445873|FG001|Overall Study|Death|1|||
149813241|NCT03273257|540445872|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
149813242|NCT03273257|540445873|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
149813243|NCT03273257|540445872|FG000|Overall Study|Study terminated|3|||
149813244|NCT03273257|540445873|FG001|Overall Study|Study terminated|2|||
149813245|NCT01185639|540445875|FG000|Overall Study|Progressed and didn't receive therapy|2|||
149813246|NCT02200614|540445876|FG000|Double Blind Treatment|Adverse Event|86|||
149813247|NCT02200614|540445877|FG001|Double Blind Treatment|Adverse Event|48|||
149813248|NCT02200614|540445876|FG000|Double Blind Treatment|Confirmed metastasis|120|||
149813249|NCT02200614|540445877|FG001|Double Blind Treatment|Confirmed metastasis|140|||
149813250|NCT02200614|540445876|FG000|Double Blind Treatment|Judgment of the investigator|59|||
149813251|NCT02200614|540445877|FG001|Double Blind Treatment|Judgment of the investigator|99|||
149813252|NCT02200614|540445876|FG000|Double Blind Treatment|Metastasis by local reading|1|||
149813253|NCT02200614|540445877|FG001|Double Blind Treatment|Metastasis by local reading|3|||
149813254|NCT02200614|540445876|FG000|Double Blind Treatment|Other reason|6|||
149813255|NCT02200614|540445877|FG001|Double Blind Treatment|Other reason|2|||
149813256|NCT02200614|540445876|FG000|Double Blind Treatment|Personal reason|77|||
149813257|NCT02200614|540445877|FG001|Double Blind Treatment|Personal reason|85|||
149813258|NCT02200614|540445876|FG000|Double Blind Treatment|Protocol deviation|14|||
149813259|NCT02200614|540445877|FG001|Double Blind Treatment|Protocol deviation|7|||
149813260|NCT02200614|540445876|FG000|Double Blind Treatment|Not treated|1|||
149813261|NCT02200614|540445877|FG001|Double Blind Treatment|Not treated|0|||
149813262|NCT02200614|540445876|FG000|Open Label|Adverse Event|41|||
149813263|NCT02200614|540445877|FG001|Open Label|Adverse Event|11|||
149813264|NCT02200614|540445876|FG000|Open Label|Confirmed metastasis|1|||
149813265|NCT02200614|540445877|FG001|Open Label|Confirmed metastasis|0|||
149813266|NCT02200614|540445876|FG000|Open Label|Judgment of the investigator|29|||
149813267|NCT02200614|540445877|FG001|Open Label|Judgment of the investigator|2|||
149813268|NCT02200614|540445876|FG000|Open Label|Metastasis by local reading|138|||
149813269|NCT02200614|540445877|FG001|Open Label|Metastasis by local reading|27|||
149813270|NCT02200614|540445876|FG000|Open Label|Other reason|22|||
149813271|NCT02200614|540445877|FG001|Open Label|Other reason|4|||
149813272|NCT02200614|540445876|FG000|Open Label|Personal reason|60|||
149813273|NCT02200614|540445877|FG001|Open Label|Personal reason|8|||
149813274|NCT02200614|540445876|FG000|Open Label|Protocol deviation|3|||
149813275|NCT02200614|540445877|FG001|Open Label|Protocol deviation|2|||
149813276|NCT02200614|540445876|FG000|Open Label|Missing|2|||
149813277|NCT02200614|540445877|FG001|Open Label|Missing|2|||
149813278|NCT01898884|540445878|FG000|Multiple Dose Period|Adverse Event|0|||
149813279|NCT01898884|540445879|FG001|Multiple Dose Period|Adverse Event|0|||
149813280|NCT01898884|540445880|FG002|Multiple Dose Period|Adverse Event|0|||
149813281|NCT01898884|540445881|FG003|Multiple Dose Period|Adverse Event|0|||
149813282|NCT01898884|540445882|FG004|Multiple Dose Period|Adverse Event|0|||
149813283|NCT01898884|540445883|FG005|Multiple Dose Period|Adverse Event|0|||
149813284|NCT01898884|540445884|FG006|Multiple Dose Period|Adverse Event|1|||
149813285|NCT01898884|540445885|FG007|Multiple Dose Period|Adverse Event|0|||
149813286|NCT01898884|540445886|FG008|Multiple Dose Period|Adverse Event|0|||
149813287|NCT01898884|540445878|FG000|Multiple Dose Period|Randomized Not Treated|0|||
149813288|NCT01898884|540445879|FG001|Multiple Dose Period|Randomized Not Treated|0|||
149813289|NCT01898884|540445880|FG002|Multiple Dose Period|Randomized Not Treated|0|||
149813290|NCT01898884|540445881|FG003|Multiple Dose Period|Randomized Not Treated|0|||
149813291|NCT01898884|540445882|FG004|Multiple Dose Period|Randomized Not Treated|0|||
149813292|NCT01898884|540445883|FG005|Multiple Dose Period|Randomized Not Treated|0|||
149813293|NCT01898884|540445884|FG006|Multiple Dose Period|Randomized Not Treated|0|||
149813294|NCT01898884|540445885|FG007|Multiple Dose Period|Randomized Not Treated|0|||
149813295|NCT01898884|540445886|FG008|Multiple Dose Period|Randomized Not Treated|1|||
149813296|NCT00434148|540445887|FG000|Overall Study|Adverse Event|18|||
149813297|NCT00434148|540445888|FG001|Overall Study|Adverse Event|18|||
149813298|NCT00434148|540445887|FG000|Overall Study|Lack of Efficacy|25|||
149813299|NCT00434148|540445888|FG001|Overall Study|Lack of Efficacy|28|||
149813300|NCT00434148|540445887|FG000|Overall Study|Withdrawal by Subject|15|||
149813301|NCT00434148|540445888|FG001|Overall Study|Withdrawal by Subject|15|||
149813302|NCT00434148|540445887|FG000|Overall Study|Protocol Violation|4|||
149813303|NCT00434148|540445888|FG001|Overall Study|Protocol Violation|0|||
149813304|NCT00434148|540445887|FG000|Overall Study|Administrative problems|6|||
149813305|NCT00434148|540445888|FG001|Overall Study|Administrative problems|10|||
149813306|NCT00434148|540445887|FG000|Overall Study|Lost to Follow-up|0|||
149813307|NCT00434148|540445888|FG001|Overall Study|Lost to Follow-up|1|||
149813308|NCT00434148|540445887|FG000|Overall Study|Condition no longer requires study drug|1|||
149813309|NCT00434148|540445888|FG001|Overall Study|Condition no longer requires study drug|0|||
149813310|NCT00434148|540445887|FG000|Overall Study|Abnormal test procedure result|0|||
149813311|NCT00434148|540445888|FG001|Overall Study|Abnormal test procedure result|1|||
149813312|NCT01556165|540445889|FG000|Overall Study|Adverse Event|5|||
149813313|NCT01556165|540445890|FG001|Overall Study|Adverse Event|3|||
149813314|NCT01556165|540445889|FG000|Overall Study|Protocol Violation|0|||
149813315|NCT01556165|540445890|FG001|Overall Study|Protocol Violation|3|||
149813316|NCT01556165|540445889|FG000|Overall Study|Withdrawal of Consent|7|||
149813317|NCT01556165|540445890|FG001|Overall Study|Withdrawal of Consent|1|||
149813318|NCT02531698|540445893|FG000|Overall Study|Adverse Event|2|||
149813319|NCT02531698|540445894|FG001|Overall Study|Adverse Event|1|||
149813320|NCT02531698|540445893|FG000|Overall Study|Withdrawal by Subject|6|||
149813321|NCT02531698|540445894|FG001|Overall Study|Withdrawal by Subject|1|||
149813322|NCT02531698|540445893|FG000|Overall Study|Protocol Violation|2|||
149813323|NCT02531698|540445894|FG001|Overall Study|Protocol Violation|0|||
149813324|NCT02531698|540445893|FG000|Overall Study|Lost to Follow-up|1|||
149813325|NCT02531698|540445894|FG001|Overall Study|Lost to Follow-up|0|||
149813326|NCT02395536|540445900|FG000|Overall Study|Lost to Follow-up|4|||
149813327|NCT02395536|540445901|FG001|Overall Study|Lost to Follow-up|4|||
149813328|NCT02395536|540445900|FG000|Overall Study|Death|2|||
149813329|NCT02395536|540445901|FG001|Overall Study|Death|0|||
149813330|NCT02395536|540445900|FG000|Overall Study|Physician Decision|4|||
149813331|NCT02395536|540445901|FG001|Overall Study|Physician Decision|6|||
149813332|NCT02395536|540445900|FG000|Overall Study|Withdrawal by Subject|9|||
149813333|NCT02395536|540445901|FG001|Overall Study|Withdrawal by Subject|17|||
149813334|NCT02395536|540445900|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
149813335|NCT02395536|540445901|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
149813336|NCT02395536|540445900|FG000|Overall Study|Insurance issue|0|||
149813337|NCT02395536|540445901|FG001|Overall Study|Insurance issue|1|||
149813338|NCT00701558|540445902|FG000|Overall Study|Death|7|||
149813339|NCT00701558|540445902|FG000|Overall Study|Lost to Follow-up|8|||
149813340|NCT01640964|540445903|FG000|Overall Study|Lost to Follow-up|0|||
149813341|NCT01640964|540445904|FG001|Overall Study|Lost to Follow-up|0|||
149813342|NCT01640964|540445905|FG002|Overall Study|Lost to Follow-up|1|||
149813343|NCT01640964|540445903|FG000|Overall Study|Protocol Deviation|1|||
149813344|NCT01640964|540445904|FG001|Overall Study|Protocol Deviation|1|||
149813345|NCT01640964|540445905|FG002|Overall Study|Protocol Deviation|2|||
149813346|NCT02787746|540445906|FG000|Overall Study|Adverse Event|42|||
149813347|NCT02787746|540445906|FG000|Overall Study|Withdrawal by Subject|65|||
149813348|NCT02787746|540445906|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
149813349|NCT04822701|540445909|FG000|Overall Study|Not treated|2|||
149813350|NCT04822701|540445910|FG001|Overall Study|Not treated|0|||
149813351|NCT04822701|540445909|FG000|Overall Study|Lost to Follow-up|1|||
149813352|NCT04822701|540445910|FG001|Overall Study|Lost to Follow-up|0|||
149813353|NCT04822701|540445909|FG000|Overall Study|Withdrawal by Subject|1|||
149813354|NCT04822701|540445910|FG001|Overall Study|Withdrawal by Subject|0|||
149813355|NCT01142466|540447531|FG000|Overall Study|Adverse Event|2|||
149813356|NCT01142466|540447532|FG001|Overall Study|Adverse Event|1|||
149813357|NCT01142466|540447531|FG000|Overall Study|Withdrawal by Subject|1|||
149813358|NCT01142466|540447532|FG001|Overall Study|Withdrawal by Subject|1|||
149813359|NCT01422720|540447537|FG000|Overall Study|Adverse Event|16|||
149813360|NCT01422720|540447537|FG000|Overall Study|Lack of Efficacy|1|||
149813361|NCT01422720|540447537|FG000|Overall Study|Withdrawal by Subject|4|||
149813362|NCT01422720|540447537|FG000|Overall Study|Ineligibility|1|||
149813363|NCT00606801|540447538|FG000|Intervention|Protocol Violation|3|||
149813364|NCT00606801|540447539|FG001|Intervention|Protocol Violation|3|||
149813365|NCT02499406|540447541|FG000|Overall Study|missed 3 treatment sessions|4|||
149813366|NCT00552617|540447545|FG000|Overall Study|Not Treated|0|||
149813367|NCT00552617|540447546|FG001|Overall Study|Not Treated|0|||
149813368|NCT00552617|540447547|FG002|Overall Study|Not Treated|1|||
149813369|NCT00552617|540447548|FG003|Overall Study|Not Treated|0|||
149813370|NCT00552617|540447549|FG004|Overall Study|Not Treated|0|||
149813371|NCT00552617|540447550|FG005|Overall Study|Not Treated|0|||
149813372|NCT00552617|540447551|FG006|Overall Study|Not Treated|0|||
149813373|NCT00552617|540447552|FG007|Overall Study|Not Treated|0|||
149813374|NCT00552617|540447553|FG008|Overall Study|Not Treated|0|||
149813375|NCT00552617|540447554|FG009|Overall Study|Not Treated|1|||
149813376|NCT00552617|540447545|FG000|Overall Study|Lost to Follow-up|0|||
149813377|NCT00552617|540447546|FG001|Overall Study|Lost to Follow-up|0|||
149813378|NCT00552617|540447547|FG002|Overall Study|Lost to Follow-up|0|||
149813379|NCT00552617|540447548|FG003|Overall Study|Lost to Follow-up|1|||
149813380|NCT00552617|540447549|FG004|Overall Study|Lost to Follow-up|0|||
149813381|NCT00552617|540447550|FG005|Overall Study|Lost to Follow-up|2|||
149813382|NCT00552617|540447551|FG006|Overall Study|Lost to Follow-up|0|||
149813383|NCT00552617|540447552|FG007|Overall Study|Lost to Follow-up|0|||
149813384|NCT00552617|540447553|FG008|Overall Study|Lost to Follow-up|2|||
149813385|NCT00552617|540447554|FG009|Overall Study|Lost to Follow-up|0|||
149813386|NCT04651218|540447555|FG000|Overall Study|Withdrawal by Subject|0|||
149813387|NCT04651218|540447556|FG001|Overall Study|Withdrawal by Subject|2|||
149813388|NCT01467570|540447559|FG000|Overall Study|Lost to Follow-up|8|||
149813389|NCT01467570|540447560|FG001|Overall Study|Lost to Follow-up|9|||
149813390|NCT02239601|540447570|FG000|Overall Study|Withdrawal by Subject|3|||
149813391|NCT02239601|540447571|FG001|Overall Study|Withdrawal by Subject|4|||
149813392|NCT02239601|540447570|FG000|Overall Study|Protocol Violation|4|||
149813393|NCT02239601|540447571|FG001|Overall Study|Protocol Violation|2|||
149813394|NCT00068406|540447576|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
149813395|NCT00068406|540447576|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
149813396|NCT01954082|540447577|FG000|Overall Study|Study Suspension|42|||
149813397|NCT01954082|540447578|FG001|Overall Study|Study Suspension|36|||
149813398|NCT01954082|540447577|FG000|Overall Study|Adverse Event|10|||
149813399|NCT01954082|540447578|FG001|Overall Study|Adverse Event|4|||
149813400|NCT01954082|540447577|FG000|Overall Study|Intolerance|0|||
149813401|NCT01954082|540447578|FG001|Overall Study|Intolerance|1|||
149813402|NCT01954082|540447577|FG000|Overall Study|Non-compliance|6|||
149813403|NCT01954082|540447578|FG001|Overall Study|Non-compliance|4|||
149813404|NCT01954082|540447577|FG000|Overall Study|Physician Decision|2|||
149813405|NCT01954082|540447578|FG001|Overall Study|Physician Decision|0|||
149813406|NCT01954082|540447577|FG000|Overall Study|Parent Decision|1|||
149813407|NCT01954082|540447578|FG001|Overall Study|Parent Decision|0|||
149813408|NCT01954082|540447577|FG000|Overall Study|Withdrawal by Subject|0|||
149813409|NCT01954082|540447578|FG001|Overall Study|Withdrawal by Subject|1|||
149813410|NCT01954082|540447577|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
149813411|NCT01954082|540447578|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
149813412|NCT01954082|540447577|FG000|Overall Study|Redirection of Care|0|||
149813413|NCT01954082|540447578|FG001|Overall Study|Redirection of Care|2|||
149813414|NCT01954082|540447577|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
149813415|NCT01954082|540447578|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
149813416|NCT01954082|540447577|FG000|Overall Study|Comfort Care|0|||
149813417|NCT01954082|540447578|FG001|Overall Study|Comfort Care|1|||
149813418|NCT01954082|540447577|FG000|Overall Study|Infant Moved|0|||
149813419|NCT01954082|540447578|FG001|Overall Study|Infant Moved|1|||
149813420|NCT01954082|540447577|FG000|Overall Study|Randomized not Treated|4|||
149813421|NCT01954082|540447578|FG001|Overall Study|Randomized not Treated|2|||
149813422|NCT01377233|540447579|FG000|Open-label|Adverse Event|1|||
149813423|NCT01377233|540447580|FG001|Open-label|Adverse Event|0|||
149813424|NCT01377233|540447581|FG002|Open-label|Adverse Event|0|||
149813425|NCT01377233|540447582|FG003|Open-label|Adverse Event|0|||
149813426|NCT01377233|540447583|FG004|Open-label|Adverse Event|0|||
149813427|NCT01377233|540447579|FG000|Open-label|Withdrawal by Subject|3|||
149813428|NCT01377233|540447580|FG001|Open-label|Withdrawal by Subject|0|||
149813429|NCT01377233|540447581|FG002|Open-label|Withdrawal by Subject|0|||
149813430|NCT01377233|540447582|FG003|Open-label|Withdrawal by Subject|0|||
149813431|NCT01377233|540447583|FG004|Open-label|Withdrawal by Subject|0|||
149813432|NCT01377233|540447579|FG000|Double-blind|Adverse Event|0|||
149813433|NCT01377233|540447580|FG001|Double-blind|Adverse Event|1|||
149813434|NCT01377233|540447581|FG002|Double-blind|Adverse Event|2|||
149813435|NCT01377233|540447582|FG003|Double-blind|Adverse Event|2|||
149813436|NCT01377233|540447583|FG004|Double-blind|Adverse Event|0|||
149813437|NCT01377233|540447579|FG000|Double-blind|Protocol Violation|0|||
149813438|NCT01377233|540447580|FG001|Double-blind|Protocol Violation|0|||
149813439|NCT01377233|540447581|FG002|Double-blind|Protocol Violation|0|||
149813440|NCT01377233|540447582|FG003|Double-blind|Protocol Violation|0|||
149813441|NCT01377233|540447583|FG004|Double-blind|Protocol Violation|1|||
149813442|NCT01377233|540447579|FG000|Double-blind|Withdrawal by Subject|0|||
149813443|NCT01377233|540447580|FG001|Double-blind|Withdrawal by Subject|0|||
149813444|NCT01377233|540447581|FG002|Double-blind|Withdrawal by Subject|0|||
149813445|NCT01377233|540447582|FG003|Double-blind|Withdrawal by Subject|1|||
149813446|NCT01377233|540447583|FG004|Double-blind|Withdrawal by Subject|0|||
149813447|NCT01377233|540447579|FG000|Double-blind|Administrative or other|0|||
149813448|NCT01377233|540447580|FG001|Double-blind|Administrative or other|0|||
149813449|NCT01377233|540447581|FG002|Double-blind|Administrative or other|0|||
149813450|NCT01377233|540447582|FG003|Double-blind|Administrative or other|1|||
149813451|NCT01377233|540447583|FG004|Double-blind|Administrative or other|1|||
149813452|NCT01785875|540447584|FG000|Overall Study|Withdrawal by Subject|41|||
149813453|NCT01785875|540447585|FG001|Overall Study|Withdrawal by Subject|34|||
149813454|NCT01785875|540447586|FG002|Overall Study|Withdrawal by Subject|36|||
149813455|NCT01785875|540447584|FG000|Overall Study|Lost to Follow-up|19|||
149813456|NCT01785875|540447585|FG001|Overall Study|Lost to Follow-up|22|||
149813457|NCT01785875|540447586|FG002|Overall Study|Lost to Follow-up|6|||
149813458|NCT01785875|540447584|FG000|Overall Study|Death|27|||
149813459|NCT01785875|540447585|FG001|Overall Study|Death|16|||
149813460|NCT01785875|540447586|FG002|Overall Study|Death|7|||
149813461|NCT01785875|540447584|FG000|Overall Study|Sponsor Decision|0|||
149813462|NCT01785875|540447585|FG001|Overall Study|Sponsor Decision|2|||
149813463|NCT01785875|540447586|FG002|Overall Study|Sponsor Decision|0|||
149813464|NCT01785875|540447584|FG000|Overall Study|Protocol Specified Criteria|207|||
149813465|NCT01785875|540447585|FG001|Overall Study|Protocol Specified Criteria|214|||
149813466|NCT01785875|540447586|FG002|Overall Study|Protocol Specified Criteria|55|||
149813467|NCT01785875|540447584|FG000|Overall Study|Missing|0|||
149813468|NCT01785875|540447585|FG001|Overall Study|Missing|1|||
149813469|NCT01785875|540447586|FG002|Overall Study|Missing|3|||
149813470|NCT03137082|540447589|FG000|Overall Study|Withdrawal by Subject|1|||
149813471|NCT03137082|540447590|FG001|Overall Study|Withdrawal by Subject|1|||
149813472|NCT03137082|540447589|FG000|Overall Study|Lost to Follow-up|1|||
149813473|NCT03137082|540447590|FG001|Overall Study|Lost to Follow-up|0|||
149813474|NCT00417027|540447591|FG000|Overall Study|Protocol Violation|0|||
149813475|NCT00417027|540447592|FG001|Overall Study|Protocol Violation|5|||
149813476|NCT00417027|540447593|FG002|Overall Study|Protocol Violation|5|||
149813477|NCT00707174|540447594|FG000|Overall Study|Adverse Event|1|||
149813478|NCT00707174|540447595|FG001|Overall Study|Adverse Event|6|||
149813479|NCT00707174|540447594|FG000|Overall Study|Withdrawal by Subject|4|||
149813480|NCT00707174|540447595|FG001|Overall Study|Withdrawal by Subject|1|||
149813481|NCT00544557|540447596|FG000|Overall Study|Adverse Event|140|||
149813482|NCT00544557|540447596|FG000|Overall Study|Lack of Efficacy|196|||
149813483|NCT00544557|540447596|FG000|Overall Study|Other|98|||
149813484|NCT04057118|540447600|FG000|Overall Study|Adverse Event|1|||
149813485|NCT04057118|540447601|FG001|Overall Study|Adverse Event|0|||
149813486|NCT04057118|540447602|FG002|Overall Study|Adverse Event|1|||
149813487|NCT04057118|540447603|FG003|Overall Study|Adverse Event|1|||
149813488|NCT04057118|540447600|FG000|Overall Study|Physician Decision|0|||
149813489|NCT04057118|540447601|FG001|Overall Study|Physician Decision|0|||
149813490|NCT04057118|540447602|FG002|Overall Study|Physician Decision|1|||
149813491|NCT04057118|540447603|FG003|Overall Study|Physician Decision|1|||
149813492|NCT04057118|540447600|FG000|Overall Study|Withdrawal by Subject|2|||
149813493|NCT04057118|540447601|FG001|Overall Study|Withdrawal by Subject|2|||
149813494|NCT04057118|540447602|FG002|Overall Study|Withdrawal by Subject|0|||
149813495|NCT04057118|540447603|FG003|Overall Study|Withdrawal by Subject|2|||
149813496|NCT04057118|540447600|FG000|Overall Study|Not Specific|0|||
149813497|NCT04057118|540447601|FG001|Overall Study|Not Specific|0|||
149813498|NCT04057118|540447602|FG002|Overall Study|Not Specific|1|||
149813499|NCT04057118|540447603|FG003|Overall Study|Not Specific|1|||
149813500|NCT01850108|540447609|FG000|Overall Study|Lost to Follow-up|4|||
149813501|NCT01850108|540447609|FG000|Overall Study|Not eligible|1|||
149813502|NCT01850108|540447609|FG000|Overall Study|Failed engraftment|2|||
149813503|NCT01850108|540447609|FG000|Overall Study|Physician Decision|1|||
149813504|NCT03273712|540447617|FG000|Overall Study|Death|5|||
149813505|NCT03273712|540447617|FG000|Overall Study|Adverse Event|1|||
149813506|NCT03273712|540447617|FG000|Overall Study|Disease Progression|1|||
149813507|NCT04333199|540447618|FG000|Evaluated Patients|Lost to Follow-up|0|||
149813508|NCT04333199|540447619|FG001|Evaluated Patients|Lost to Follow-up|1|||
149813509|NCT04333199|540447620|FG002|Evaluated Patients|Lost to Follow-up|2|||
149813510|NCT00666718|540447622|FG000|Overall Study|Adverse Event|0|||
149813511|NCT00666718|540447623|FG001|Overall Study|Adverse Event|1|||
149813512|NCT00666718|540447622|FG000|Overall Study|Death|1|||
149813513|NCT00666718|540447623|FG001|Overall Study|Death|0|||
149813514|NCT00666718|540447622|FG000|Overall Study|Lost to Follow-up|1|||
149813515|NCT00666718|540447623|FG001|Overall Study|Lost to Follow-up|0|||
149813516|NCT00666718|540447622|FG000|Overall Study|Entry Criteria Not Met|2|||
149813517|NCT00666718|540447623|FG001|Overall Study|Entry Criteria Not Met|0|||
149813518|NCT00666718|540447622|FG000|Overall Study|Protocol Violation|1|||
149813519|NCT00666718|540447623|FG001|Overall Study|Protocol Violation|3|||
149813520|NCT00666718|540447622|FG000|Overall Study|Withdrawal by Subject|7|||
149813521|NCT00666718|540447623|FG001|Overall Study|Withdrawal by Subject|12|||
149813522|NCT00666718|540447622|FG000|Overall Study|Physician Decision|0|||
149813523|NCT00666718|540447623|FG001|Overall Study|Physician Decision|2|||
149813524|NCT00963599|540447624|FG000|Overall Study|Adverse Event|2|||
149813525|NCT00963599|540447625|FG001|Overall Study|Adverse Event|0|||
149813526|NCT00963599|540447626|FG002|Overall Study|Adverse Event|1|||
149813527|NCT00963599|540447627|FG003|Overall Study|Adverse Event|2|||
149813528|NCT00963599|540447624|FG000|Overall Study|Lack of Efficacy|0|||
149813529|NCT00963599|540447625|FG001|Overall Study|Lack of Efficacy|2|||
149813530|NCT00963599|540447626|FG002|Overall Study|Lack of Efficacy|1|||
149813531|NCT00963599|540447627|FG003|Overall Study|Lack of Efficacy|4|||
149813532|NCT00963599|540447624|FG000|Overall Study|Lost to Follow-up|0|||
149813533|NCT00963599|540447625|FG001|Overall Study|Lost to Follow-up|1|||
149813534|NCT00963599|540447626|FG002|Overall Study|Lost to Follow-up|1|||
149813535|NCT00963599|540447627|FG003|Overall Study|Lost to Follow-up|1|||
149813536|NCT00963599|540447624|FG000|Overall Study|Protocol Violation|2|||
149813537|NCT00963599|540447625|FG001|Overall Study|Protocol Violation|2|||
149813538|NCT00963599|540447626|FG002|Overall Study|Protocol Violation|3|||
149813539|NCT00963599|540447627|FG003|Overall Study|Protocol Violation|4|||
149813540|NCT00963599|540447624|FG000|Overall Study|Withdrawal by Subject|2|||
149813541|NCT00963599|540447625|FG001|Overall Study|Withdrawal by Subject|1|||
149813542|NCT00963599|540447626|FG002|Overall Study|Withdrawal by Subject|3|||
149813543|NCT00963599|540447627|FG003|Overall Study|Withdrawal by Subject|3|||
149813544|NCT03959137|540447628|FG000|Overall Study|Protocol Violation|6|||
149813545|NCT00190684|540447635|FG000|Overall Study|Adverse Event|86|||
149813546|NCT00190684|540447635|FG000|Overall Study|Satisfactory response|80|||
149813547|NCT00190684|540447635|FG000|Overall Study|Lack of efficacy|204|||
149813548|NCT00190684|540447635|FG000|Overall Study|Lost to Follow-up|232|||
149813549|NCT00190684|540447635|FG000|Overall Study|Patient moved|60|||
149813550|NCT00190684|540447635|FG000|Overall Study|Patient Decision|432|||
149813551|NCT00190684|540447635|FG000|Overall Study|Clinical relapse|67|||
149813552|NCT00190684|540447635|FG000|Overall Study|Sponsor's decision|17|||
149813553|NCT00190684|540447635|FG000|Overall Study|Physician Decision|84|||
149813554|NCT00190684|540447635|FG000|Overall Study|Protocol Violation|123|||
149813555|NCT00190684|540447635|FG000|Overall Study|Study Period III Completed|103|||
149813556|NCT00190684|540447635|FG000|Overall Study|Study Period V Completed|1|||
149813557|NCT03496207|540447636|FG000|Base Study|Adverse Event|0|||
149813558|NCT03496207|540447637|FG001|Base Study|Adverse Event|0|||
149813559|NCT03496207|540447638|FG002|Base Study|Adverse Event|1|||
149813560|NCT03496207|540447639|FG003|Base Study|Adverse Event|1|||
149813561|NCT03496207|540447640|FG004|Base Study|Adverse Event|4|||
149813562|NCT03496207|540447636|FG000|Base Study|Death|0|||
149813563|NCT03496207|540447637|FG001|Base Study|Death|0|||
149813564|NCT03496207|540447638|FG002|Base Study|Death|0|||
149813565|NCT03496207|540447639|FG003|Base Study|Death|0|||
149813566|NCT03496207|540447640|FG004|Base Study|Death|1|||
149813567|NCT03496207|540447636|FG000|Base Study|Withdrawal by Subject|0|||
149813568|NCT03496207|540447637|FG001|Base Study|Withdrawal by Subject|0|||
149813569|NCT03496207|540447638|FG002|Base Study|Withdrawal by Subject|1|||
149813570|NCT03496207|540447639|FG003|Base Study|Withdrawal by Subject|0|||
149813571|NCT03496207|540447640|FG004|Base Study|Withdrawal by Subject|1|||
149813572|NCT03496207|540447636|FG000|Extension Period|Adverse Event|0|||
149813573|NCT03496207|540447637|FG001|Extension Period|Adverse Event|0|||
149813574|NCT03496207|540447638|FG002|Extension Period|Adverse Event|0|||
149813575|NCT03496207|540447639|FG003|Extension Period|Adverse Event|1|||
149813576|NCT03496207|540447640|FG004|Extension Period|Adverse Event|1|||
149813577|NCT03496207|540447636|FG000|Extension Period|Death|1|||
149813578|NCT03496207|540447637|FG001|Extension Period|Death|0|||
149813579|NCT03496207|540447638|FG002|Extension Period|Death|0|||
149813580|NCT03496207|540447639|FG003|Extension Period|Death|1|||
149813581|NCT03496207|540447640|FG004|Extension Period|Death|2|||
149813582|NCT03496207|540447636|FG000|Extension Period|Withdrawal by Subject|1|||
149813583|NCT03496207|540447637|FG001|Extension Period|Withdrawal by Subject|0|||
149813584|NCT03496207|540447638|FG002|Extension Period|Withdrawal by Subject|0|||
149813585|NCT03496207|540447639|FG003|Extension Period|Withdrawal by Subject|1|||
149813586|NCT03496207|540447640|FG004|Extension Period|Withdrawal by Subject|1|||
149813587|NCT03496207|540447636|FG000|Extension Period|Elevated hemoglobin levels|0|||
149813588|NCT03496207|540447637|FG001|Extension Period|Elevated hemoglobin levels|0|||
149813589|NCT03496207|540447638|FG002|Extension Period|Elevated hemoglobin levels|0|||
149813590|NCT03496207|540447639|FG003|Extension Period|Elevated hemoglobin levels|0|||
149813591|NCT03496207|540447640|FG004|Extension Period|Elevated hemoglobin levels|1|||
149813592|NCT00810615|540447646|FG000|Overall Study|Withdrawal by Subject|1|||
149813593|NCT00810615|540447647|FG001|Overall Study|Withdrawal by Subject|1|||
149813594|NCT02567266|540447648|FG000|Overall Study|Withdrawal by Subject|10|||
149813595|NCT02567266|540447649|FG001|Overall Study|Withdrawal by Subject|7|||
149813596|NCT02567266|540447650|FG002|Overall Study|Withdrawal by Subject|6|||
149813597|NCT02567266|540447648|FG000|Overall Study|Lost to Follow-up|13|||
149813598|NCT02567266|540447649|FG001|Overall Study|Lost to Follow-up|8|||
149813599|NCT02567266|540447650|FG002|Overall Study|Lost to Follow-up|10|||
149813600|NCT00995488|540447655|FG000|Overall Study|Withdrawal by Subject|1|||
149813601|NCT04529499|540447656|FG000|Overall Study|Withdrawal by Subject|9|||
149813602|NCT04529499|540447657|FG001|Overall Study|Withdrawal by Subject|11|||
149813603|NCT04529499|540447656|FG000|Overall Study|Physician Decision|1|||
149813604|NCT04529499|540447657|FG001|Overall Study|Physician Decision|2|||
149813605|NCT04529499|540447656|FG000|Overall Study|Adverse Event|4|||
149813606|NCT04529499|540447657|FG001|Overall Study|Adverse Event|4|||
149813607|NCT04529499|540447656|FG000|Overall Study|Death|14|||
149813608|NCT04529499|540447657|FG001|Overall Study|Death|11|||
149813609|NCT04529499|540447656|FG000|Overall Study|Lost to Follow-up|1|||
149813610|NCT04529499|540447657|FG001|Overall Study|Lost to Follow-up|1|||
149813611|NCT04529499|540447656|FG000|Overall Study|Others|7|||
149813612|NCT04529499|540447657|FG001|Overall Study|Others|11|||
149813613|NCT00683904|540447658|FG000|Dose Level 1|Disease progression|2|||
149813614|NCT00683904|540447659|FG001|Dose Level 1|Disease progression|0|||
149813615|NCT00683904|540447658|FG000|Dose Level 1|Adverse Event|1|||
149813616|NCT00683904|540447659|FG001|Dose Level 1|Adverse Event|0|||
149813617|NCT00683904|540447658|FG000|Dose Level 2|Adverse Event|0|||
149813618|NCT00683904|540447659|FG001|Dose Level 2|Adverse Event|2|||
149813619|NCT02441179|540447661|FG000|Overall Study|Withdrawal by Subject|1|||
149813620|NCT02441179|540447662|FG001|Overall Study|Withdrawal by Subject|1|||
149813621|NCT01494649|540447663|FG000|Overall Study|Lost to Follow-up|0|||
149813622|NCT01494649|540447664|FG001|Overall Study|Lost to Follow-up|1|||
149813623|NCT03091400|540447665|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
149813624|NCT03091400|540447666|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
149813625|NCT01656967|540447667|FG000|Overall Study|faulty monitor|1|||
149813626|NCT01656967|540447668|FG001|Overall Study|faulty monitor|0|||
149813627|NCT01656967|540447667|FG000|Overall Study|unsuccessful ETT insertion|3|||
149813628|NCT01656967|540447668|FG001|Overall Study|unsuccessful ETT insertion|2|||
149813629|NCT00975884|540447669|FG000|Overall Study|Adverse Event|1|||
149813630|NCT00975884|540447670|FG001|Overall Study|Adverse Event|0|||
149813631|NCT00975884|540447669|FG000|Overall Study|Lost to Follow-up|5|||
149813632|NCT00975884|540447670|FG001|Overall Study|Lost to Follow-up|3|||
149813633|NCT00975884|540447669|FG000|Overall Study|Withdrawal by Subject|9|||
149813634|NCT00975884|540447670|FG001|Overall Study|Withdrawal by Subject|9|||
149813635|NCT00975884|540447669|FG000|Overall Study|Other|1|||
149813636|NCT00975884|540447670|FG001|Overall Study|Other|3|||
149813637|NCT00051636|540447671|FG000|Period 1 - Core|Adverse Event|2|||
149813638|NCT00051636|540447672|FG001|Period 1 - Core|Adverse Event|2|||
149813639|NCT00051636|540447671|FG000|Period 1 - Core|Protocol Violation|1|||
149813640|NCT00051636|540447672|FG001|Period 1 - Core|Protocol Violation|0|||
149813641|NCT00051636|540447671|FG000|Period 1 - Core|Withdrawal by Subject|1|||
149813642|NCT00051636|540447672|FG001|Period 1 - Core|Withdrawal by Subject|2|||
149813643|NCT00051636|540447671|FG000|Period 1 - Core|Lost to Follow-up|0|||
149813644|NCT00051636|540447672|FG001|Period 1 - Core|Lost to Follow-up|2|||
149813645|NCT00051636|540447671|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
149813646|NCT00051636|540447672|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
149813647|NCT00051636|540447671|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
149813648|NCT00051636|540447672|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
149813649|NCT00051636|540447671|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
149813650|NCT00051636|540447672|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
149813651|NCT00051636|540447671|FG000|Period 2- Extended Observation Period|Death|4|||
149813652|NCT00051636|540447672|FG001|Period 2- Extended Observation Period|Death|5|||
149813653|NCT00051636|540447671|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
149813654|NCT00051636|540447672|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
149813655|NCT02340078|540447673|FG000|Overall Study|Protocol Violation|1|||
149813656|NCT01831596|540447674|FG000|Overall Study|Other|8|||
149813657|NCT02414854|540449393|FG000|Overall Study|Adverse Event|9|||
149813658|NCT02414854|540449394|FG001|Overall Study|Adverse Event|7|||
149813659|NCT02414854|540449395|FG002|Overall Study|Adverse Event|1|||
149813660|NCT02414854|540449396|FG003|Overall Study|Adverse Event|12|||
149813661|NCT02414854|540449393|FG000|Overall Study|Poor compliance to protocol|1|||
149813662|NCT02414854|540449394|FG001|Overall Study|Poor compliance to protocol|1|||
149813663|NCT02414854|540449395|FG002|Overall Study|Poor compliance to protocol|2|||
149813664|NCT02414854|540449396|FG003|Overall Study|Poor compliance to protocol|2|||
149813665|NCT02414854|540449393|FG000|Overall Study|Other than specified above|12|||
149813666|NCT02414854|540449394|FG001|Overall Study|Other than specified above|37|||
149813667|NCT02414854|540449395|FG002|Overall Study|Other than specified above|17|||
149813668|NCT02414854|540449396|FG003|Overall Study|Other than specified above|37|||
149813669|NCT01355523|540449397|FG000|Overall Study|Withdrawal by Subject|1|||
149813670|NCT01355523|540449398|FG001|Overall Study|Withdrawal by Subject|4|||
149813671|NCT01355523|540449397|FG000|Overall Study|Lost to Follow-up|0|||
149813672|NCT01355523|540449398|FG001|Overall Study|Lost to Follow-up|2|||
149813673|NCT01355523|540449397|FG000|Overall Study|Protocol Violation|0|||
149813674|NCT01355523|540449398|FG001|Overall Study|Protocol Violation|2|||
149813675|NCT01355523|540449397|FG000|Overall Study|Adverse Event|0|||
149813676|NCT01355523|540449398|FG001|Overall Study|Adverse Event|2|||
149813677|NCT02766088|540449399|FG000|Overall Study|Sponsor study termination|498|||
149813678|NCT02766088|540449399|FG000|Overall Study|Migrated/moved from the study area|1|||
149813679|NCT02766088|540449399|FG000|Overall Study|Lost to Follow-up|5|||
149813680|NCT02766088|540449399|FG000|Overall Study|Other|1|||
149813681|NCT02766088|540449399|FG000|Overall Study|Death|1|||
149813682|NCT01222715|540449400|FG000|Overall Study|Adverse Event|0|||
149813683|NCT01222715|540449401|FG001|Overall Study|Adverse Event|4|||
149813684|NCT01222715|540449400|FG000|Overall Study|Death|0|||
149813685|NCT01222715|540449401|FG001|Overall Study|Death|1|||
149813686|NCT01222715|540449400|FG000|Overall Study|Lack of Efficacy|22|||
149813687|NCT01222715|540449401|FG001|Overall Study|Lack of Efficacy|14|||
149813688|NCT01222715|540449400|FG000|Overall Study|Physician Decision|12|||
149813689|NCT01222715|540449401|FG001|Overall Study|Physician Decision|2|||
149813690|NCT01222715|540449400|FG000|Overall Study|Refusal of further protocol therapy|0|||
149813691|NCT01222715|540449401|FG001|Overall Study|Refusal of further protocol therapy|4|||
149813692|NCT01222715|540449400|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
149813693|NCT01222715|540449401|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
149813694|NCT01222715|540449400|FG000|Overall Study|Ineligible|0|||
149813695|NCT01222715|540449401|FG001|Overall Study|Ineligible|1|||
149813696|NCT01222715|540449400|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
149813697|NCT01222715|540449401|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
149813698|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
149813699|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
149813700|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
149813701|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
149813702|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
149813703|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
149813704|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
149813705|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
149813706|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813707|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813708|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813709|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
149813710|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
149813711|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813712|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813713|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
149813714|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
149813715|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
149813716|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
149813717|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
149813718|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
149813719|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
149813720|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
149813721|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
149813722|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
149813723|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
149813724|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
149813725|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
149813726|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
149813727|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
149813728|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
149813729|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
149813730|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
149813731|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
149813732|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
149813733|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
149813734|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
149813735|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
149813736|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
149813737|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
149813738|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
149813739|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
149813740|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
149813741|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
149813742|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
149813743|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
149813744|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
149813745|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
149813746|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
149813747|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
149813748|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
149813749|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
149813750|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
149813751|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
149813752|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
149813753|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
149813754|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
149813755|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
149813756|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
149813757|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
149813758|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
150153840|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153841|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153842|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153843|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153844|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
150153845|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
150153846|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
150153847|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
150153848|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
150153849|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
150153850|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
149813759|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
150153851|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
150153852|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
149813760|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
149813761|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
149813762|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
149813763|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
149813764|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
149813765|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
149813766|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
149813767|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
149813768|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
149813769|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
149813770|NCT04440163|540449402|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
149813771|NCT04440163|540449403|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
149813772|NCT04440163|540449404|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
149813773|NCT04440163|540449405|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
149813774|NCT04440163|540449406|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
149813775|NCT04440163|540449407|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
149813776|NCT04440163|540449408|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
149813777|NCT04440163|540449409|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
149813778|NCT04440163|540449402|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
149813779|NCT04440163|540449403|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
149813780|NCT04440163|540449404|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
149813781|NCT04440163|540449405|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
149813782|NCT04440163|540449406|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
149813783|NCT04440163|540449407|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
149813784|NCT04440163|540449408|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
149813785|NCT04440163|540449409|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
149813786|NCT04440163|540449402|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813787|NCT04440163|540449403|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813788|NCT04440163|540449404|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813789|NCT04440163|540449405|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
149813790|NCT04440163|540449406|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813791|NCT04440163|540449407|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813792|NCT04440163|540449408|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813793|NCT04440163|540449409|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149813794|NCT01440595|540449414|FG000|Overall Study|Lost to Follow-up|0|||
149813795|NCT01440595|540449415|FG001|Overall Study|Lost to Follow-up|1|||
149813796|NCT01440595|540449416|FG002|Overall Study|Lost to Follow-up|0|||
149813797|NCT01440595|540449414|FG000|Overall Study|Study terminated by sponsor.|1|||
149813798|NCT01440595|540449415|FG001|Overall Study|Study terminated by sponsor.|2|||
149813799|NCT01440595|540449416|FG002|Overall Study|Study terminated by sponsor.|1|||
149813800|NCT01347879|540449417|FG000|Overall Study|Adverse Event|0|||
149813801|NCT01347879|540449418|FG001|Overall Study|Adverse Event|12|||
149813802|NCT01347879|540449417|FG000|Overall Study|Lost to Follow-up|2|||
149813803|NCT01347879|540449418|FG001|Overall Study|Lost to Follow-up|0|||
149813804|NCT01347879|540449417|FG000|Overall Study|Withdrawal by Subject|3|||
149813805|NCT01347879|540449418|FG001|Overall Study|Withdrawal by Subject|2|||
149813806|NCT01347879|540449417|FG000|Overall Study|Other|2|||
149813807|NCT01347879|540449418|FG001|Overall Study|Other|3|||
149813808|NCT01466673|540449423|FG000|Overall Study|Non-compliance with study treatment|2|||
149813809|NCT01466673|540449424|FG001|Overall Study|Non-compliance with study treatment|0|||
149813810|NCT01466673|540449423|FG000|Overall Study|Lost to Follow-up|3|||
149813811|NCT01466673|540449424|FG001|Overall Study|Lost to Follow-up|5|||
149813812|NCT01466673|540449423|FG000|Overall Study|Adverse Event|2|||
149813813|NCT01466673|540449424|FG001|Overall Study|Adverse Event|1|||
149813814|NCT02725671|540449425|FG000|Overall Study|Lost to Follow-up|1|||
149813815|NCT02981602|540449426|FG000|Overall Study|Adverse Event|0|||
149813816|NCT02981602|540449427|FG001|Overall Study|Adverse Event|0|||
149813817|NCT02981602|540449428|FG002|Overall Study|Adverse Event|0|||
149813818|NCT02981602|540449429|FG003|Overall Study|Adverse Event|1|||
149813819|NCT02981602|540449430|FG004|Overall Study|Adverse Event|0|||
149813820|NCT02983227|540449433|FG000|Overall Study|Adverse Event|21|||
149813821|NCT02983227|540449434|FG001|Overall Study|Adverse Event|3|||
149813822|NCT02983227|540449433|FG000|Overall Study|Death|3|||
149813823|NCT02983227|540449434|FG001|Overall Study|Death|0|||
149813824|NCT02983227|540449433|FG000|Overall Study|Lack of Efficacy|8|||
149813825|NCT02983227|540449434|FG001|Overall Study|Lack of Efficacy|1|||
149813826|NCT02983227|540449433|FG000|Overall Study|Lost to Follow-up|3|||
149813827|NCT02983227|540449434|FG001|Overall Study|Lost to Follow-up|0|||
149813828|NCT02983227|540449433|FG000|Overall Study|Multiple Reasons|2|||
149813829|NCT02983227|540449434|FG001|Overall Study|Multiple Reasons|1|||
149813830|NCT02983227|540449433|FG000|Overall Study|Physician Decision|3|||
149813831|NCT02983227|540449434|FG001|Overall Study|Physician Decision|1|||
149813832|NCT02983227|540449433|FG000|Overall Study|Withdrawal by Subject|19|||
149813833|NCT02983227|540449434|FG001|Overall Study|Withdrawal by Subject|8|||
149813834|NCT01706770|540449435|FG000|Overall Study|Lost to Follow-up|1|||
149813835|NCT01706770|540449436|FG001|Overall Study|Lost to Follow-up|0|||
149813836|NCT01706770|540449435|FG000|Overall Study|Physician Decision|1|||
149813837|NCT01706770|540449436|FG001|Overall Study|Physician Decision|0|||
149813838|NCT00068445|540449437|FG000|Randomization|Cancel|1|||
149813839|NCT00068445|540449438|FG001|Randomization|Cancel|3|||
149813840|NCT00068445|540449437|FG000|Randomization|Ineligible|1|||
149813841|NCT00068445|540449438|FG001|Randomization|Ineligible|1|||
149813842|NCT00068445|540449437|FG000|Treatment|Refused Further Treatment|13|||
149813843|NCT00068445|540449438|FG001|Treatment|Refused Further Treatment|10|||
149813844|NCT00068445|540449437|FG000|Treatment|Adverse Event|7|||
149813845|NCT00068445|540449438|FG001|Treatment|Adverse Event|1|||
149813846|NCT00068445|540449437|FG000|Treatment|Other (Specifics not available)|9|||
149813847|NCT00068445|540449438|FG001|Treatment|Other (Specifics not available)|5|||
149813848|NCT01155284|540449439|FG000|Overall Study|Withdrawal by Subject|4|||
149813849|NCT01155284|540449440|FG001|Overall Study|Withdrawal by Subject|3|||
149813850|NCT01155284|540449439|FG000|Overall Study|Lost to Follow-up|1|||
149813851|NCT01155284|540449440|FG001|Overall Study|Lost to Follow-up|2|||
149813852|NCT01155284|540449439|FG000|Overall Study|Physician Decision|1|||
149813853|NCT01155284|540449440|FG001|Overall Study|Physician Decision|0|||
149813854|NCT01155284|540449439|FG000|Overall Study|Adverse Event|1|||
149813855|NCT01155284|540449440|FG001|Overall Study|Adverse Event|0|||
149813856|NCT01896700|540449441|FG000|Overall Study|Adverse Event|4|||
149813857|NCT01896700|540449442|FG001|Overall Study|Adverse Event|5|||
149813858|NCT01896700|540449441|FG000|Overall Study|Withdrawal by Subject|0|||
149813859|NCT01896700|540449442|FG001|Overall Study|Withdrawal by Subject|1|||
149813860|NCT00123487|540449443|FG000|Randomized|Death prior to starting treatment|0|||
149813861|NCT00123487|540449444|FG001|Randomized|Death prior to starting treatment|1|||
149813862|NCT00123487|540449443|FG000|Randomized|SAE prior to starting treatment|1|||
149813863|NCT00123487|540449444|FG001|Randomized|SAE prior to starting treatment|0|||
149813864|NCT00123487|540449443|FG000|Treated With Study Drug|Adverse Event|23|||
149813865|NCT00123487|540449444|FG001|Treated With Study Drug|Adverse Event|22|||
149813866|NCT00123487|540449443|FG000|Treated With Study Drug|Disease Progression|141|||
149813867|NCT00123487|540449444|FG001|Treated With Study Drug|Disease Progression|122|||
149813868|NCT00123487|540449443|FG000|Treated With Study Drug|Physician Decision|8|||
149813869|NCT00123487|540449444|FG001|Treated With Study Drug|Physician Decision|9|||
149813870|NCT00123487|540449443|FG000|Treated With Study Drug|Other|59|||
149813871|NCT00123487|540449444|FG001|Treated With Study Drug|Other|58|||
149813872|NCT00123487|540449443|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
149813873|NCT00123487|540449444|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
149813874|NCT00123487|540449443|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
149813875|NCT00123487|540449444|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
149813876|NCT00123487|540449443|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
149813877|NCT00123487|540449444|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
149813878|NCT00423488|540449445|FG000|Overall Study|No evidence of study drug intake|2|||
149813879|NCT00423488|540449446|FG001|Overall Study|No evidence of study drug intake|1|||
149813880|NCT00423488|540449445|FG000|Overall Study|No post baseline data|3|||
149813881|NCT00423488|540449446|FG001|Overall Study|No post baseline data|0|||
149813882|NCT00886782|540449447|FG000|Overall Study|Disease progression|3|||
149813883|NCT00886782|540449448|FG001|Overall Study|Disease progression|3|||
149813884|NCT00886782|540449449|FG002|Overall Study|Disease progression|3|||
149813885|NCT00886782|540449447|FG000|Overall Study|Study drug toxicity|0|||
149813886|NCT00886782|540449448|FG001|Overall Study|Study drug toxicity|0|||
149813887|NCT00886782|540449449|FG002|Overall Study|Study drug toxicity|1|||
149813888|NCT00886782|540449447|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
149813889|NCT00886782|540449448|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
149813890|NCT00886782|540449449|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
149813891|NCT01255722|540449450|FG000|Overall Study|Adverse Event|0|||
149813892|NCT01255722|540449451|FG001|Overall Study|Adverse Event|1|||
149813893|NCT01255722|540449452|FG002|Overall Study|Adverse Event|1|||
150153853|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
150153854|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
149813894|NCT01255722|540449450|FG000|Overall Study|asymptomatic patient|1|||
149813895|NCT01255722|540449451|FG001|Overall Study|asymptomatic patient|0|||
149813896|NCT01255722|540449452|FG002|Overall Study|asymptomatic patient|0|||
149813897|NCT01255722|540449450|FG000|Overall Study|beta-blocker contraindicated|2|||
149813898|NCT01255722|540449451|FG001|Overall Study|beta-blocker contraindicated|0|||
149813899|NCT01255722|540449452|FG002|Overall Study|beta-blocker contraindicated|0|||
149813900|NCT02643966|540449453|FG000|First Screening Round|ineligible|1|||
149813901|NCT02643966|540449453|FG000|First Screening Round|excluded from analysis|2|||
149813902|NCT02643966|540449453|FG000|First Screening Round|Lost to Follow-up|56|||
149813903|NCT02643966|540449453|FG000|First Screening Round|Withdrawal by Subject|28|||
149813904|NCT02643966|540449453|FG000|First Screening Round|Death|1|||
149813905|NCT02643966|540449453|FG000|Between First and Second Screening|Lost to Follow-up|65|||
149813906|NCT02643966|540449453|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
149813907|NCT02643966|540449453|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
149813908|NCT02643966|540449453|FG000|Second Screening Round|Withdrawal by Subject|20|||
149813909|NCT02643966|540449453|FG000|Second Screening Round|Lost to Follow-up|57|||
149813910|NCT02643966|540449453|FG000|Second Screening Round|Physician Decision|2|||
149813911|NCT02643966|540449453|FG000|Second Screening Round|Death|4|||
149813912|NCT02643966|540449453|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
149813913|NCT02643966|540449453|FG000|Between Second and Third Screening|Death|1|||
149813914|NCT02643966|540449453|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
149813915|NCT02643966|540449453|FG000|Third Screening Round|PI excluded|2|||
149813916|NCT02643966|540449453|FG000|Third Screening Round|Lost to Follow-up|241|||
149813917|NCT03835975|540449456|FG000|Overall Study|Lost to Follow-up|1|||
149813918|NCT03835975|540449457|FG001|Overall Study|Lost to Follow-up|1|||
149813919|NCT03835975|540449458|FG002|Overall Study|Lost to Follow-up|0|||
149813920|NCT03835975|540449459|FG003|Overall Study|Lost to Follow-up|0|||
149813921|NCT03835975|540449460|FG004|Overall Study|Lost to Follow-up|0|||
149813922|NCT03835975|540449456|FG000|Overall Study|No longer met eligibility criteria|0|||
149813923|NCT03835975|540449457|FG001|Overall Study|No longer met eligibility criteria|1|||
149813924|NCT03835975|540449458|FG002|Overall Study|No longer met eligibility criteria|0|||
149813925|NCT03835975|540449459|FG003|Overall Study|No longer met eligibility criteria|0|||
149813926|NCT03835975|540449460|FG004|Overall Study|No longer met eligibility criteria|0|||
149813927|NCT03835975|540449456|FG000|Overall Study|Protocol Violation|1|||
149813928|NCT03835975|540449457|FG001|Overall Study|Protocol Violation|1|||
149813929|NCT03835975|540449458|FG002|Overall Study|Protocol Violation|2|||
149813930|NCT03835975|540449459|FG003|Overall Study|Protocol Violation|0|||
149813931|NCT03835975|540449460|FG004|Overall Study|Protocol Violation|0|||
149813932|NCT03835975|540449456|FG000|Overall Study|Withdrawal by Subject|1|||
149813933|NCT03835975|540449457|FG001|Overall Study|Withdrawal by Subject|0|||
149813934|NCT03835975|540449458|FG002|Overall Study|Withdrawal by Subject|1|||
149813935|NCT03835975|540449459|FG003|Overall Study|Withdrawal by Subject|1|||
149813936|NCT03835975|540449460|FG004|Overall Study|Withdrawal by Subject|0|||
149813937|NCT03070431|540449463|FG000|Overall Study|Withdrawal by Subject|2|||
149813938|NCT03070431|540449463|FG000|Overall Study|Lost to Follow-up|2|||
149813939|NCT01542736|540449466|FG000|Overall Study|Death|1|||
149813940|NCT01783483|540449467|FG000|Overall Study|Death|3|||
149813941|NCT01783483|540449468|FG001|Overall Study|Death|3|||
149813942|NCT01783483|540449467|FG000|Overall Study|Lost to Follow-up|14|||
149813943|NCT01783483|540449468|FG001|Overall Study|Lost to Follow-up|10|||
149813944|NCT01783483|540449467|FG000|Overall Study|Withdrawal by Subject|2|||
149813945|NCT01783483|540449468|FG001|Overall Study|Withdrawal by Subject|1|||
149813946|NCT01783483|540449467|FG000|Overall Study|Physician Decision|1|||
149813947|NCT01783483|540449468|FG001|Overall Study|Physician Decision|1|||
149813948|NCT00370396|540449474|FG000|Overall Study|Withdrawal by Subject|0|||
149813949|NCT00370396|540449475|FG001|Overall Study|Withdrawal by Subject|0|||
149813950|NCT00370396|540449476|FG002|Overall Study|Withdrawal by Subject|1|||
149813951|NCT00370396|540449474|FG000|Overall Study|Lost to Follow-up|11|||
149813952|NCT00370396|540449475|FG001|Overall Study|Lost to Follow-up|1|||
149813953|NCT00370396|540449476|FG002|Overall Study|Lost to Follow-up|0|||
149813954|NCT02065791|540449477|FG000|Overall Study|Closed Site|1|||
149813955|NCT02065791|540449478|FG001|Overall Study|Closed Site|1|||
149813956|NCT02065791|540449477|FG000|Overall Study|Withdrawal by Subject|11|||
149813957|NCT02065791|540449478|FG001|Overall Study|Withdrawal by Subject|5|||
149813958|NCT02065791|540449477|FG000|Overall Study|Lost to Follow-up|13|||
149813959|NCT02065791|540449478|FG001|Overall Study|Lost to Follow-up|9|||
149813960|NCT02702271|540449481|FG000|Overall Study|Death|36|||
149813961|NCT02702271|540449482|FG001|Overall Study|Death|7|||
149813962|NCT02702271|540449481|FG000|Overall Study|Lost to Follow-up|12|||
149813963|NCT02702271|540449482|FG001|Overall Study|Lost to Follow-up|0|||
149813964|NCT02702271|540449481|FG000|Overall Study|Withdrawal by Subject|8|||
149813965|NCT02702271|540449482|FG001|Overall Study|Withdrawal by Subject|1|||
149813966|NCT02702271|540449481|FG000|Overall Study|Physician Decision|2|||
149813967|NCT02702271|540449482|FG001|Overall Study|Physician Decision|0|||
149813968|NCT02702271|540449481|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
149813969|NCT02702271|540449482|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
149813970|NCT03467971|540449483|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149813971|NCT03467971|540449484|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149813972|NCT01174368|540449485|FG000|Overall Study|Withdrawal by Subject|1|||
149813973|NCT00479765|540449486|FG000|Overall Study|study terminated|4|||
149813974|NCT00363129|540449489|FG000|Overall Study|Withdrawal by Subject|11|||
149813975|NCT00363129|540449490|FG001|Overall Study|Withdrawal by Subject|18|||
149813976|NCT00363129|540449489|FG000|Overall Study|Adverse Event|8|||
149813977|NCT00363129|540449490|FG001|Overall Study|Adverse Event|3|||
149813978|NCT00363129|540449489|FG000|Overall Study|Alternate Treatment|2|||
149813979|NCT00363129|540449490|FG001|Overall Study|Alternate Treatment|4|||
149813980|NCT00363129|540449489|FG000|Overall Study|Other Medical Problems|2|||
149813981|NCT00363129|540449490|FG001|Overall Study|Other Medical Problems|4|||
149813982|NCT00363129|540449489|FG000|Overall Study|Death|0|||
149813983|NCT00363129|540449490|FG001|Overall Study|Death|1|||
149813984|NCT00363129|540449489|FG000|Overall Study|Other Reasons|6|||
149813985|NCT00363129|540449490|FG001|Overall Study|Other Reasons|3|||
149813986|NCT03707522|540449491|FG000|Overall Study|Lost to Follow-up|24|||
149813987|NCT03707522|540449492|FG001|Overall Study|Lost to Follow-up|27|||
149813988|NCT03707522|540449493|FG002|Overall Study|Lost to Follow-up|41|||
149813989|NCT03707522|540449494|FG003|Overall Study|Lost to Follow-up|36|||
149813990|NCT05166512|540449495|FG000|Randomized|Lost to Follow-up|2|||
149813991|NCT05166512|540449496|FG001|Randomized|Lost to Follow-up|0|||
149813992|NCT05166512|540449495|FG000|Randomized|Withdrawal by Subject|1|||
149813993|NCT05166512|540449496|FG001|Randomized|Withdrawal by Subject|0|||
149813994|NCT05166512|540449495|FG000|Baseline Data Collection|Lost to Follow-up|0|||
149813995|NCT05166512|540449496|FG001|Baseline Data Collection|Lost to Follow-up|3|||
149813996|NCT05166512|540449495|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
149813997|NCT05166512|540449496|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
149813998|NCT05166512|540449495|FG000|Baseline Data Collection|Protocol Violation|2|||
149813999|NCT05166512|540449496|FG001|Baseline Data Collection|Protocol Violation|0|||
149814000|NCT05166512|540449495|FG000|4 Month Data Collection|Lost to Follow-up|1|||
149814001|NCT05166512|540449496|FG001|4 Month Data Collection|Lost to Follow-up|0|||
149814002|NCT05166512|540449495|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
149814003|NCT05166512|540449496|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
149814004|NCT05166512|540449495|FG000|12 Month Data Collection|Lost to Follow-up|3|||
149814005|NCT05166512|540449496|FG001|12 Month Data Collection|Lost to Follow-up|1|||
149814006|NCT05166512|540449495|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
149814007|NCT05166512|540449496|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
149814008|NCT00420849|540449497|FG000|Overall Study|Lack of Efficacy|154|||
149814009|NCT00420849|540449497|FG000|Overall Study|Adverse Event|107|||
149814010|NCT00420849|540449497|FG000|Overall Study|Withdrawal by Subject|28|||
149814011|NCT00420849|540449497|FG000|Overall Study|Death|18|||
149814012|NCT00420849|540449497|FG000|Overall Study|Other|14|||
149814013|NCT00420849|540449497|FG000|Overall Study|Transplant|8|||
149814014|NCT00420849|540449497|FG000|Overall Study|Protocol Violation|1|||
149814015|NCT00420849|540449497|FG000|Overall Study|Lost to Follow-up|1|||
149814016|NCT00383019|540449498|FG000|Overall Study|Adverse Event|5|||
149814017|NCT00383019|540449499|FG001|Overall Study|Adverse Event|1|||
149814018|NCT00383019|540449498|FG000|Overall Study|Withdrawal by Subject|0|||
149814019|NCT00383019|540449499|FG001|Overall Study|Withdrawal by Subject|1|||
149814020|NCT05789420|540449500|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
149814021|NCT05789420|540449500|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
149814022|NCT02278952|540449501|FG000|Overall Study|Insufficient Sample|6|||
149814023|NCT00659581|540449502|FG000|Overall Study|Adverse Event|1006|||
149814024|NCT00659581|540449502|FG000|Overall Study|Lack of Efficacy|1183|||
149814025|NCT00659581|540449502|FG000|Overall Study|Other|6393|||
149814026|NCT00725725|540449503|FG000|Overall Study|Adverse Event|1|||
149814027|NCT00725725|540449504|FG001|Overall Study|Adverse Event|3|||
149814028|NCT00725725|540449505|FG002|Overall Study|Adverse Event|2|||
149814029|NCT00725725|540449503|FG000|Overall Study|Lost to Follow-up|2|||
149814030|NCT00725725|540449504|FG001|Overall Study|Lost to Follow-up|0|||
149814031|NCT00725725|540449505|FG002|Overall Study|Lost to Follow-up|2|||
149814032|NCT00725725|540449503|FG000|Overall Study|Withdrawal by Subject|1|||
149814033|NCT00725725|540449504|FG001|Overall Study|Withdrawal by Subject|0|||
149814034|NCT00725725|540449505|FG002|Overall Study|Withdrawal by Subject|1|||
149814035|NCT00725725|540449503|FG000|Overall Study|Protocol Violation|0|||
149814036|NCT00725725|540449504|FG001|Overall Study|Protocol Violation|1|||
149814037|NCT00725725|540449505|FG002|Overall Study|Protocol Violation|0|||
149814038|NCT01619085|540449509|FG000|Overall Study|Adverse Event|231|||
149814039|NCT01619085|540449509|FG000|Overall Study|Protocol Violation|4|||
149814040|NCT01619085|540449509|FG000|Overall Study|Lost to Follow-up|3|||
149814041|NCT01619085|540449509|FG000|Overall Study|Withdrawal by Subject|45|||
149814042|NCT01619085|540449509|FG000|Overall Study|Other than specified|96|||
149814043|NCT01619085|540449509|FG000|Overall Study|Not treated|1|||
149814044|NCT01619085|540449509|FG000|Overall Study|Death|145|||
149814045|NCT05473247|540449510|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
149814046|NCT02392559|540449511|FG000|Overall Study|Withdrawal by Subject|0|||
149814047|NCT02392559|540449512|FG001|Overall Study|Withdrawal by Subject|1|||
149814048|NCT01345058|540449513|FG000|Overall Study|Withdrawal by Subject|1|||
149814049|NCT01345058|540449514|FG001|Overall Study|Withdrawal by Subject|0|||
149814050|NCT01345058|540449513|FG000|Overall Study|Participant Reported Increase in Events|1|||
149814051|NCT01345058|540449514|FG001|Overall Study|Participant Reported Increase in Events|0|||
149814052|NCT01345058|540449513|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
149814053|NCT01345058|540449514|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
149814054|NCT01345058|540449513|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
149814055|NCT01345058|540449514|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
149814056|NCT01345058|540449513|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
149814057|NCT01345058|540449514|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
149814058|NCT00000135|540449520|FG000|Overall Study|Death|27|||
149814059|NCT00000135|540449521|FG001|Overall Study|Death|14|||
149814060|NCT00944125|540449524|FG000|3 to 6 Months|Withdrawal by Subject|0|||
149814061|NCT00944125|540449525|FG001|3 to 6 Months|Withdrawal by Subject|2|||
149814062|NCT00944125|540449524|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
150153855|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
150153856|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
150153857|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
150153858|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
150153859|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
150153860|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
150153861|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
150153862|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
150153863|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
150153864|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
150153865|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153866|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153867|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153868|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153869|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153870|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153871|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153872|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153873|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153874|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153875|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153876|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153877|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153878|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153879|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
150153880|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153881|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
150153882|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
150153883|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153884|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153885|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153886|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153887|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153888|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153889|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153890|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153891|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153892|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153893|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153894|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153895|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153896|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153897|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
150153898|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153899|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
150153900|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
150153901|NCT01474512|541699589|FG000|Post-Treatment Follow-Up|Death|0|||
150153902|NCT01474512|541699590|FG001|Post-Treatment Follow-Up|Death|0|||
150153903|NCT01474512|541699591|FG002|Post-Treatment Follow-Up|Death|0|||
150153904|NCT01474512|541699592|FG003|Post-Treatment Follow-Up|Death|0|||
150153905|NCT01474512|541699593|FG004|Post-Treatment Follow-Up|Death|0|||
150153906|NCT01474512|541699594|FG005|Post-Treatment Follow-Up|Death|0|||
150153907|NCT01474512|541699595|FG006|Post-Treatment Follow-Up|Death|0|||
150153908|NCT01474512|541699596|FG007|Post-Treatment Follow-Up|Death|0|||
150153909|NCT01474512|541699597|FG008|Post-Treatment Follow-Up|Death|0|||
150153910|NCT01474512|541699598|FG009|Post-Treatment Follow-Up|Death|0|||
150153911|NCT01474512|541699599|FG010|Post-Treatment Follow-Up|Death|0|||
150153912|NCT01474512|541699600|FG011|Post-Treatment Follow-Up|Death|0|||
150153913|NCT01474512|541699601|FG012|Post-Treatment Follow-Up|Death|0|||
150153914|NCT01474512|541699602|FG013|Post-Treatment Follow-Up|Death|0|||
150153915|NCT01474512|541699603|FG014|Post-Treatment Follow-Up|Death|0|||
149814063|NCT00944125|540449525|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
149814064|NCT03125629|540449526|FG000|Overall Study|Withdrawal by Subject|2|||
149814065|NCT03125629|540449526|FG000|Overall Study|Equipment malfunction|1|||
149814066|NCT00743119|540449527|FG000|Overall Study|unreliable|3|||
149814067|NCT00743119|540449527|FG000|Overall Study|Withdrawal by Subject|1|||
149814068|NCT02989610|540449528|FG000|Overall Study|Withdrawal by Subject|20|||
149814069|NCT02989610|540449528|FG000|Overall Study|Departure of PI from Site|8|||
149814070|NCT02989610|540449528|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
149814071|NCT02989610|540449528|FG000|Overall Study|Lost to Follow-up|3|||
149814072|NCT02989610|540449528|FG000|Overall Study|Death|3|||
149814073|NCT02989610|540449528|FG000|Overall Study|System Explant|3|||
149814074|NCT02989610|540449528|FG000|Overall Study|Subject Non-Compliance|2|||
149814075|NCT02989610|540449528|FG000|Overall Study|System Revision|2|||
149814076|NCT02989610|540449528|FG000|Overall Study|PI Left, Study Closing|1|||
149814077|NCT02989610|540449528|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
149814078|NCT02989610|540449528|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
149814079|NCT04508621|540449529|FG000|Overall Study|Adverse Event|39|||
149814080|NCT04508621|540449530|FG001|Overall Study|Adverse Event|16|||
149814081|NCT04508621|540449529|FG000|Overall Study|Lack of Efficacy|2|||
149814082|NCT04508621|540449530|FG001|Overall Study|Lack of Efficacy|8|||
149814083|NCT04508621|540449529|FG000|Overall Study|Physician Decision|0|||
149814084|NCT04508621|540449530|FG001|Overall Study|Physician Decision|1|||
149814085|NCT04508621|540449529|FG000|Overall Study|Withdrawal by Subject|10|||
149814086|NCT04508621|540449530|FG001|Overall Study|Withdrawal by Subject|14|||
149814087|NCT04508621|540449529|FG000|Overall Study|Lost to Follow-up|12|||
149814088|NCT04508621|540449530|FG001|Overall Study|Lost to Follow-up|9|||
149814089|NCT04508621|540449529|FG000|Overall Study|COVID-19 related crisis|3|||
149814090|NCT04508621|540449530|FG001|Overall Study|COVID-19 related crisis|0|||
149814091|NCT04508621|540449529|FG000|Overall Study|Subject non-compliance|1|||
149814092|NCT04508621|540449530|FG001|Overall Study|Subject non-compliance|0|||
149814093|NCT00833976|540451180|FG000|Overall Study|Withdrawal by Subject|5|||
149814094|NCT00833976|540451180|FG000|Overall Study|Lost to Follow-up|4|||
149814095|NCT00833976|540451180|FG000|Overall Study|Did not meet eligibility criteria|41|||
149814096|NCT00833976|540451180|FG000|Overall Study|Physician Decision|1|||
149814097|NCT04575038|540451181|FG000|Overall Study|Withdrawal by Subject|1|||
149814098|NCT04575038|540451182|FG001|Overall Study|Withdrawal by Subject|1|||
149814099|NCT02464059|540451185|FG000|Overall Study|Lost to Follow-up|6|||
149814100|NCT03591107|540451187|FG000|Overall Study|Same patient in both arms|1|||
149814101|NCT03591107|540451188|FG001|Overall Study|Same patient in both arms|1|||
149814102|NCT03591107|540451187|FG000|Overall Study|Sought care at other clinics|0|||
149814103|NCT03591107|540451188|FG001|Overall Study|Sought care at other clinics|2|||
149814104|NCT03591107|540451187|FG000|Overall Study|Discharged from clinic|0|||
149814105|NCT03591107|540451188|FG001|Overall Study|Discharged from clinic|1|||
149814106|NCT03591107|540451187|FG000|Overall Study|Withdrawal by Subject|0|||
149814107|NCT03591107|540451188|FG001|Overall Study|Withdrawal by Subject|1|||
149814108|NCT01902134|540451189|FG000|Overall Study|Adverse Event|3|||
149814109|NCT01902134|540451190|FG001|Overall Study|Adverse Event|1|||
149814110|NCT01902134|540451191|FG002|Overall Study|Adverse Event|2|||
149814111|NCT01902134|540451192|FG003|Overall Study|Adverse Event|1|||
149814112|NCT01902134|540451193|FG004|Overall Study|Adverse Event|1|||
149814113|NCT01902134|540451194|FG005|Overall Study|Adverse Event|3|||
149814114|NCT01902134|540451189|FG000|Overall Study|Lack of Efficacy|0|||
149814115|NCT01902134|540451190|FG001|Overall Study|Lack of Efficacy|0|||
149814116|NCT01902134|540451191|FG002|Overall Study|Lack of Efficacy|2|||
149814117|NCT01902134|540451192|FG003|Overall Study|Lack of Efficacy|0|||
149814118|NCT01902134|540451193|FG004|Overall Study|Lack of Efficacy|0|||
149814119|NCT01902134|540451194|FG005|Overall Study|Lack of Efficacy|1|||
149814120|NCT01902134|540451189|FG000|Overall Study|Physician Decision|0|||
149814121|NCT01902134|540451190|FG001|Overall Study|Physician Decision|1|||
149814122|NCT01902134|540451191|FG002|Overall Study|Physician Decision|0|||
149814123|NCT01902134|540451192|FG003|Overall Study|Physician Decision|0|||
149814124|NCT01902134|540451193|FG004|Overall Study|Physician Decision|0|||
149814125|NCT01902134|540451194|FG005|Overall Study|Physician Decision|0|||
149814126|NCT01902134|540451189|FG000|Overall Study|Protocol Violation|0|||
149814127|NCT01902134|540451190|FG001|Overall Study|Protocol Violation|0|||
149814128|NCT01902134|540451191|FG002|Overall Study|Protocol Violation|0|||
149814129|NCT01902134|540451192|FG003|Overall Study|Protocol Violation|0|||
149814130|NCT01902134|540451193|FG004|Overall Study|Protocol Violation|0|||
149814131|NCT01902134|540451194|FG005|Overall Study|Protocol Violation|1|||
149814132|NCT01902134|540451189|FG000|Overall Study|Withdrawal by Subject|4|||
149814133|NCT01902134|540451190|FG001|Overall Study|Withdrawal by Subject|8|||
149814134|NCT01902134|540451191|FG002|Overall Study|Withdrawal by Subject|9|||
149814135|NCT01902134|540451192|FG003|Overall Study|Withdrawal by Subject|1|||
150153916|NCT01474512|541699604|FG015|Post-Treatment Follow-Up|Death|0|||
149814136|NCT01902134|540451193|FG004|Overall Study|Withdrawal by Subject|5|||
149814137|NCT01902134|540451194|FG005|Overall Study|Withdrawal by Subject|4|||
149814138|NCT01902134|540451189|FG000|Overall Study|no compliance|1|||
149814139|NCT01902134|540451190|FG001|Overall Study|no compliance|0|||
149814140|NCT01902134|540451191|FG002|Overall Study|no compliance|0|||
149814141|NCT01902134|540451192|FG003|Overall Study|no compliance|0|||
149814142|NCT01902134|540451193|FG004|Overall Study|no compliance|0|||
149814143|NCT01902134|540451194|FG005|Overall Study|no compliance|0|||
149814144|NCT01902134|540451189|FG000|Overall Study|Other|0|||
149814145|NCT01902134|540451190|FG001|Overall Study|Other|1|||
149814146|NCT01902134|540451191|FG002|Overall Study|Other|2|||
149814147|NCT01902134|540451192|FG003|Overall Study|Other|0|||
149814148|NCT01902134|540451193|FG004|Overall Study|Other|1|||
149814149|NCT01902134|540451194|FG005|Overall Study|Other|0|||
149814150|NCT00305110|540451195|FG000|Overall Study|Missing data|29|||
149814151|NCT01272193|540451198|FG000|Overall Study|Adverse Event|1|||
149814152|NCT01272193|540451199|FG001|Overall Study|Adverse Event|1|||
149814153|NCT01272193|540451198|FG000|Overall Study|Lack of Efficacy|0|||
149814154|NCT01272193|540451199|FG001|Overall Study|Lack of Efficacy|3|||
149814155|NCT01272193|540451198|FG000|Overall Study|Withdrawal Criteria|1|||
149814156|NCT01272193|540451199|FG001|Overall Study|Withdrawal Criteria|1|||
149814157|NCT01272193|540451198|FG000|Overall Study|Unclassified|8|||
149814158|NCT01272193|540451199|FG001|Overall Study|Unclassified|7|||
149814159|NCT00350519|540451210|FG000|Overall Study|Death|0|||
149814160|NCT00350519|540451211|FG001|Overall Study|Death|1|||
149814161|NCT00350519|540451210|FG000|Overall Study|Physician Decision|0|||
149814162|NCT00350519|540451211|FG001|Overall Study|Physician Decision|1|||
149814163|NCT00350519|540451210|FG000|Overall Study|Protocol Violation|1|||
149814164|NCT00350519|540451211|FG001|Overall Study|Protocol Violation|2|||
149814165|NCT00350519|540451210|FG000|Overall Study|Withdrawal by Subject|3|||
149814166|NCT00350519|540451211|FG001|Overall Study|Withdrawal by Subject|2|||
149814167|NCT00736099|540451213|FG000|Overall Study|Adverse Event|61|||
149814168|NCT00736099|540451214|FG001|Overall Study|Adverse Event|18|||
149814169|NCT00736099|540451213|FG000|Overall Study|Protocol Violation|10|||
149814170|NCT00736099|540451214|FG001|Overall Study|Protocol Violation|4|||
149814171|NCT00736099|540451213|FG000|Overall Study|Lost to Follow-up|12|||
149814172|NCT00736099|540451214|FG001|Overall Study|Lost to Follow-up|5|||
149814173|NCT00736099|540451213|FG000|Overall Study|Withdrawal by Subject|42|||
149814174|NCT00736099|540451214|FG001|Overall Study|Withdrawal by Subject|13|||
149814175|NCT00736099|540451213|FG000|Overall Study|Lack of Efficacy|15|||
149814176|NCT00736099|540451214|FG001|Overall Study|Lack of Efficacy|8|||
149814177|NCT00736099|540451213|FG000|Overall Study|Other reason|43|||
149814178|NCT00736099|540451214|FG001|Overall Study|Other reason|10|||
149814179|NCT01637961|540451217|FG000|Overall Study|Ineligible: wrong primary|1|||
149814180|NCT01637961|540451217|FG000|Overall Study|Ineligible: inadequate pathology|1|||
149814181|NCT03101293|540451218|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
149814182|NCT03101293|540451219|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
149814183|NCT03555890|540451227|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149814184|NCT03555890|540451228|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149814185|NCT03555890|540451229|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149814186|NCT03555890|540451230|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
149814187|NCT03372369|540451231|FG000|Qualification Period|Withdrawal by Subject|16|||
149814188|NCT03372369|540451232|FG001|Qualification Period|Withdrawal by Subject|13|||
149814189|NCT03372369|540451231|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
149814190|NCT03372369|540451232|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
149814191|NCT03372369|540451231|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
149814192|NCT03372369|540451232|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
149814193|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
149814194|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
149814195|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
149814196|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
149814197|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
149814198|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
149814199|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
149814200|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149814201|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149814202|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149814203|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
149814204|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149814205|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149814206|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149814207|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149814208|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
149814209|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
149814210|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
149814211|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
149814212|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
149814213|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
149814214|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
149814215|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
149814216|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
149814217|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
149814218|NCT04682639|540451233|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
149814219|NCT04682639|540451234|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
149814220|NCT04682639|540451235|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
149814221|NCT04682639|540451236|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149814222|NCT04682639|540451237|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149814223|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
149814224|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
149814225|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
149814226|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
149814227|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
149814228|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Other|1|||
149814229|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Other|2|||
149814230|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Other|0|||
149814231|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Other|0|||
149814232|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Other|1|||
149814233|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
149814234|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
149814235|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
149814236|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
149814237|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
149814238|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
149814239|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
149814240|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149814241|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149814242|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149814243|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
149814244|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
149814245|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149814246|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149814247|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149814248|NCT04682639|540451233|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
149814249|NCT04682639|540451234|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
149814250|NCT04682639|540451235|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
149814251|NCT04682639|540451236|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
149814252|NCT04682639|540451237|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
149814253|NCT01383954|540451238|FG000|Overall Study|Lack of Efficacy|2|||
149814254|NCT01383954|540451238|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
149814255|NCT01383954|540451238|FG000|Overall Study|Adverse Event|1|||
149814256|NCT01383954|540451238|FG000|Overall Study|Reason Not Specified|9|||
149814257|NCT00763269|540451239|FG000|Overall Study|Lost to Follow-up|12|||
149814258|NCT00763269|540451240|FG001|Overall Study|Lost to Follow-up|13|||
149814259|NCT04388527|540451241|FG000|Overall Study|Death|14|||
149814260|NCT04388527|540451241|FG000|Overall Study|Withdrawal by Subject|2|||
149814261|NCT04388527|540451241|FG000|Overall Study|Lost to Follow-up|1|||
149814262|NCT03471182|540451242|FG000|Overall Study|Withdrawal by Subject|1|||
149814263|NCT03471182|540451243|FG001|Overall Study|Withdrawal by Subject|1|||
149814264|NCT03471182|540451244|FG002|Overall Study|Withdrawal by Subject|0|||
149814265|NCT03471182|540451242|FG000|Overall Study|Technical failure|2|||
149814266|NCT03471182|540451243|FG001|Overall Study|Technical failure|0|||
149814267|NCT03471182|540451244|FG002|Overall Study|Technical failure|0|||
149814268|NCT03451331|540451247|FG000|Overall Study|Withdrawal by Subject|1|||
149814269|NCT03451331|540451248|FG001|Overall Study|Withdrawal by Subject|0|||
149814270|NCT03451331|540451247|FG000|Overall Study|Unable to start treatment.|1|||
149814271|NCT03451331|540451248|FG001|Overall Study|Unable to start treatment.|1|||
149814272|NCT00289731|540451249|FG000|Overall Study|Adverse Event|1|||
149814273|NCT00289731|540451250|FG001|Overall Study|Adverse Event|2|||
149814274|NCT00289731|540451251|FG002|Overall Study|Adverse Event|2|||
149814275|NCT00289731|540451249|FG000|Overall Study|Other|1|||
149814276|NCT00289731|540451250|FG001|Overall Study|Other|0|||
149814277|NCT00289731|540451251|FG002|Overall Study|Other|0|||
149814278|NCT01017029|540451252|FG000|Overall Study|Lost to Follow-up|1|||
149814279|NCT01017029|540451253|FG001|Overall Study|Lost to Follow-up|0|||
149814280|NCT01017029|540451252|FG000|Overall Study|Administrative problem|0|||
149814281|NCT01017029|540451253|FG001|Overall Study|Administrative problem|1|||
149814282|NCT01017029|540451252|FG000|Overall Study|Death|3|||
149814283|NCT01017029|540451253|FG001|Overall Study|Death|1|||
149814284|NCT00618774|540451256|FG000|Overall Study|Adverse Event|5|||
149814285|NCT00618774|540451257|FG001|Overall Study|Adverse Event|3|||
149814286|NCT00618774|540451256|FG000|Overall Study|Withdrawal by Subject|1|||
149814287|NCT00618774|540451257|FG001|Overall Study|Withdrawal by Subject|0|||
149814288|NCT02770716|540451258|FG000|Overall Study|Death|101|||
149814289|NCT02770716|540451259|FG001|Overall Study|Death|45|||
149814290|NCT02770716|540451258|FG000|Overall Study|Withdrawal by Subject|4|||
149814291|NCT02770716|540451259|FG001|Overall Study|Withdrawal by Subject|2|||
149814292|NCT02770716|540451258|FG000|Overall Study|Lost to Follow-up|1|||
149814293|NCT02770716|540451259|FG001|Overall Study|Lost to Follow-up|0|||
149814294|NCT02770716|540451258|FG000|Overall Study|Various reasons|6|||
149814295|NCT02770716|540451259|FG001|Overall Study|Various reasons|2|||
149814296|NCT01725113|540451260|FG000|Overall Study|Kidney Transplant|1|||
149814297|NCT01725113|540451261|FG001|Overall Study|Kidney Transplant|1|||
149814298|NCT01725113|540451260|FG000|Overall Study|Withdrawal by Subject|0|||
149814299|NCT01725113|540451261|FG001|Overall Study|Withdrawal by Subject|1|||
149814300|NCT02753400|540451263|FG000|Overall Study|Adverse Event|3|||
149814301|NCT02753400|540451264|FG001|Overall Study|Adverse Event|0|||
149814302|NCT02753400|540451263|FG000|Overall Study|Withdrawal by Subject|2|||
149814303|NCT02753400|540451264|FG001|Overall Study|Withdrawal by Subject|1|||
149814304|NCT03989115|540451265|FG000|Overall Study|Withdrawal by Subject|2|||
149814305|NCT03989115|540451266|FG001|Overall Study|Withdrawal by Subject|1|||
149814306|NCT03989115|540451267|FG002|Overall Study|Withdrawal by Subject|3|||
149814307|NCT03989115|540451268|FG003|Overall Study|Withdrawal by Subject|0|||
149814308|NCT03989115|540451269|FG004|Overall Study|Withdrawal by Subject|17|||
149814309|NCT03989115|540451270|FG005|Overall Study|Withdrawal by Subject|1|||
149814310|NCT03989115|540451271|FG006|Overall Study|Withdrawal by Subject|0|||
149814311|NCT03989115|540451272|FG007|Overall Study|Withdrawal by Subject|0|||
149814312|NCT03989115|540451265|FG000|Overall Study|Sponsor decision to terminate the study|1|||
149814313|NCT03989115|540451266|FG001|Overall Study|Sponsor decision to terminate the study|1|||
149814314|NCT03989115|540451267|FG002|Overall Study|Sponsor decision to terminate the study|0|||
149814315|NCT03989115|540451268|FG003|Overall Study|Sponsor decision to terminate the study|1|||
149814316|NCT03989115|540451269|FG004|Overall Study|Sponsor decision to terminate the study|11|||
149814317|NCT03989115|540451270|FG005|Overall Study|Sponsor decision to terminate the study|0|||
149814318|NCT03989115|540451271|FG006|Overall Study|Sponsor decision to terminate the study|2|||
149814319|NCT03989115|540451272|FG007|Overall Study|Sponsor decision to terminate the study|1|||
149814320|NCT03989115|540451265|FG000|Overall Study|Lost to Follow-up|2|||
149814321|NCT03989115|540451266|FG001|Overall Study|Lost to Follow-up|0|||
149814322|NCT03989115|540451267|FG002|Overall Study|Lost to Follow-up|0|||
149814323|NCT03989115|540451268|FG003|Overall Study|Lost to Follow-up|0|||
149814324|NCT03989115|540451269|FG004|Overall Study|Lost to Follow-up|1|||
149814325|NCT03989115|540451270|FG005|Overall Study|Lost to Follow-up|0|||
149814326|NCT03989115|540451271|FG006|Overall Study|Lost to Follow-up|0|||
149814327|NCT03989115|540451272|FG007|Overall Study|Lost to Follow-up|0|||
149814328|NCT03989115|540451265|FG000|Overall Study|Death|2|||
149814329|NCT03989115|540451266|FG001|Overall Study|Death|2|||
149814330|NCT03989115|540451267|FG002|Overall Study|Death|9|||
149814331|NCT03989115|540451268|FG003|Overall Study|Death|6|||
149814332|NCT03989115|540451269|FG004|Overall Study|Death|31|||
149814333|NCT03989115|540451270|FG005|Overall Study|Death|6|||
149814334|NCT03989115|540451271|FG006|Overall Study|Death|2|||
149814335|NCT03989115|540451272|FG007|Overall Study|Death|3|||
149814336|NCT03989115|540451265|FG000|Overall Study|Other|1|||
149814337|NCT03989115|540451266|FG001|Overall Study|Other|2|||
149814338|NCT03989115|540451267|FG002|Overall Study|Other|0|||
149814339|NCT03989115|540451268|FG003|Overall Study|Other|0|||
149814340|NCT03989115|540451269|FG004|Overall Study|Other|5|||
149814341|NCT03989115|540451270|FG005|Overall Study|Other|0|||
149814342|NCT03989115|540451271|FG006|Overall Study|Other|0|||
149814343|NCT03989115|540451272|FG007|Overall Study|Other|0|||
149814344|NCT01415921|540451274|FG000|Overall Study|Adverse Event|0|||
149814345|NCT01415921|540451275|FG001|Overall Study|Adverse Event|1|||
149814346|NCT01415921|540451274|FG000|Overall Study|Physician Decision|1|||
149814347|NCT01415921|540451275|FG001|Overall Study|Physician Decision|1|||
149814348|NCT01415921|540451274|FG000|Overall Study|Withdrawal by Subject|0|||
149814349|NCT01415921|540451275|FG001|Overall Study|Withdrawal by Subject|1|||
149814350|NCT01415921|540451274|FG000|Overall Study|Other|2|||
149814351|NCT01415921|540451275|FG001|Overall Study|Other|0|||
149814352|NCT01830920|540451278|FG000|Overall Study|Adverse Event|1|||
149814353|NCT01830920|540451279|FG001|Overall Study|Adverse Event|0|||
149814354|NCT01830920|540451280|FG002|Overall Study|Adverse Event|1|||
149814355|NCT01830920|540451281|FG003|Overall Study|Adverse Event|0|||
149814356|NCT01830920|540451282|FG004|Overall Study|Adverse Event|0|||
149814357|NCT01830920|540451278|FG000|Overall Study|Withdrawal by Subject|2|||
149814358|NCT01830920|540451279|FG001|Overall Study|Withdrawal by Subject|2|||
149814359|NCT01830920|540451280|FG002|Overall Study|Withdrawal by Subject|1|||
149814360|NCT01830920|540451281|FG003|Overall Study|Withdrawal by Subject|7|||
149814361|NCT01830920|540451282|FG004|Overall Study|Withdrawal by Subject|1|||
149814362|NCT01830920|540451278|FG000|Overall Study|Death|3|||
149814363|NCT01830920|540451279|FG001|Overall Study|Death|3|||
149814364|NCT01830920|540451280|FG002|Overall Study|Death|5|||
149814365|NCT01830920|540451281|FG003|Overall Study|Death|4|||
149814366|NCT01830920|540451282|FG004|Overall Study|Death|4|||
149814367|NCT01830920|540451278|FG000|Overall Study|Other|15|||
149814368|NCT01830920|540451279|FG001|Overall Study|Other|1|||
149814369|NCT01830920|540451280|FG002|Overall Study|Other|1|||
149814370|NCT01830920|540451281|FG003|Overall Study|Other|5|||
149814371|NCT01830920|540451282|FG004|Overall Study|Other|3|||
149814372|NCT01313728|540451283|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
149814373|NCT00572156|540451291|FG000|Overall Study|Adverse Event|3|||
149814374|NCT00572156|540451292|FG001|Overall Study|Adverse Event|1|||
149814375|NCT00572156|540451293|FG002|Overall Study|Adverse Event|5|||
149814376|NCT00572156|540451294|FG003|Overall Study|Adverse Event|1|||
149814377|NCT00572156|540451291|FG000|Overall Study|Lost to Follow-up|1|||
149814378|NCT00572156|540451292|FG001|Overall Study|Lost to Follow-up|1|||
149814379|NCT00572156|540451293|FG002|Overall Study|Lost to Follow-up|1|||
149814380|NCT00572156|540451294|FG003|Overall Study|Lost to Follow-up|0|||
149814381|NCT00572156|540451291|FG000|Overall Study|Protocol Violation|1|||
149814382|NCT00572156|540451292|FG001|Overall Study|Protocol Violation|2|||
149814383|NCT00572156|540451293|FG002|Overall Study|Protocol Violation|0|||
149814384|NCT00572156|540451294|FG003|Overall Study|Protocol Violation|2|||
149814385|NCT00572156|540451291|FG000|Overall Study|Patient/Parent Decision|1|||
149814386|NCT00572156|540451292|FG001|Overall Study|Patient/Parent Decision|6|||
149814387|NCT00572156|540451293|FG002|Overall Study|Patient/Parent Decision|4|||
149814388|NCT00572156|540451294|FG003|Overall Study|Patient/Parent Decision|3|||
149814389|NCT00572156|540451291|FG000|Overall Study|Sponsor Decision|20|||
149814390|NCT00572156|540451292|FG001|Overall Study|Sponsor Decision|16|||
149814391|NCT00572156|540451293|FG002|Overall Study|Sponsor Decision|17|||
149814392|NCT00572156|540451294|FG003|Overall Study|Sponsor Decision|19|||
149814393|NCT00720304|540451295|FG000|Overall Study|Withdrawal by Subject|14|||
149814394|NCT00720304|540451296|FG001|Overall Study|Withdrawal by Subject|1|||
149814395|NCT00720304|540451295|FG000|Overall Study|Death|1|||
149814396|NCT00720304|540451296|FG001|Overall Study|Death|0|||
149814397|NCT00720304|540451295|FG000|Overall Study|Physician Decision|5|||
149814398|NCT00720304|540451296|FG001|Overall Study|Physician Decision|2|||
149814399|NCT00720304|540451295|FG000|Overall Study|Adverse Event|3|||
149814400|NCT00720304|540451296|FG001|Overall Study|Adverse Event|1|||
149814401|NCT00720304|540451295|FG000|Overall Study|Disease progression|6|||
149814402|NCT00720304|540451296|FG001|Overall Study|Disease progression|1|||
149814403|NCT04330482|540451299|FG000|Overall Study|Lost to Follow-up|2|||
149814404|NCT04330482|540451300|FG001|Overall Study|Lost to Follow-up|1|||
149814405|NCT04330482|540451299|FG000|Overall Study|Withdrawal by Subject|0|||
149814406|NCT04330482|540451300|FG001|Overall Study|Withdrawal by Subject|3|||
149814407|NCT00996918|540451301|FG000|Overall Study|Lack of Efficacy|1|||
149814408|NCT00996918|540451302|FG001|Overall Study|Lack of Efficacy|1|||
149814409|NCT00996918|540451303|FG002|Overall Study|Lack of Efficacy|2|||
149814410|NCT00996918|540451304|FG003|Overall Study|Lack of Efficacy|2|||
149814411|NCT00996918|540451305|FG004|Overall Study|Lack of Efficacy|0|||
149814412|NCT00996918|540451301|FG000|Overall Study|Adverse Event|2|||
149814413|NCT00996918|540451302|FG001|Overall Study|Adverse Event|5|||
149814414|NCT00996918|540451303|FG002|Overall Study|Adverse Event|2|||
149814415|NCT00996918|540451304|FG003|Overall Study|Adverse Event|6|||
149814416|NCT00996918|540451305|FG004|Overall Study|Adverse Event|0|||
149814417|NCT00996918|540451301|FG000|Overall Study|Withdrawal by Subject|1|||
149814418|NCT00996918|540451302|FG001|Overall Study|Withdrawal by Subject|4|||
149814419|NCT00996918|540451303|FG002|Overall Study|Withdrawal by Subject|3|||
149814420|NCT00996918|540451304|FG003|Overall Study|Withdrawal by Subject|3|||
149814421|NCT00996918|540451305|FG004|Overall Study|Withdrawal by Subject|2|||
149814422|NCT00996918|540451301|FG000|Overall Study|Physician Decision|1|||
149814423|NCT00996918|540451302|FG001|Overall Study|Physician Decision|0|||
149814424|NCT00996918|540451303|FG002|Overall Study|Physician Decision|0|||
149814425|NCT00996918|540451304|FG003|Overall Study|Physician Decision|0|||
149814426|NCT00996918|540451305|FG004|Overall Study|Physician Decision|0|||
149814427|NCT00996918|540451301|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
149814428|NCT00996918|540451302|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
149814429|NCT00996918|540451303|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
149814430|NCT00996918|540451304|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
149814431|NCT00996918|540451305|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
149814432|NCT00996918|540451301|FG000|Overall Study|Loss of Caregiver|0|||
149814433|NCT00996918|540451302|FG001|Overall Study|Loss of Caregiver|1|||
149814434|NCT00996918|540451303|FG002|Overall Study|Loss of Caregiver|0|||
149814435|NCT00996918|540451304|FG003|Overall Study|Loss of Caregiver|0|||
149814436|NCT00996918|540451305|FG004|Overall Study|Loss of Caregiver|0|||
149814437|NCT00996918|540451301|FG000|Overall Study|Other|3|||
149814438|NCT00996918|540451302|FG001|Overall Study|Other|1|||
149814439|NCT00996918|540451303|FG002|Overall Study|Other|0|||
149814440|NCT00996918|540451304|FG003|Overall Study|Other|0|||
149814441|NCT00996918|540451305|FG004|Overall Study|Other|0|||
149814442|NCT01333475|540451308|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
149814443|NCT01333475|540451309|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
149814444|NCT01333475|540451308|FG000|Overall Study|Toxicity|1|||
149814445|NCT01333475|540451309|FG001|Overall Study|Toxicity|3|||
149814446|NCT04440007|540451310|FG000|Overall Study|Adverse Event|0|||
149814447|NCT04440007|540451311|FG001|Overall Study|Adverse Event|1|||
149814448|NCT04440007|540451310|FG000|Overall Study|Lost to Follow-up|1|||
149814449|NCT04440007|540451311|FG001|Overall Study|Lost to Follow-up|3|||
149814450|NCT04440007|540451310|FG000|Overall Study|Death|7|||
149814451|NCT04440007|540451311|FG001|Overall Study|Death|2|||
149814452|NCT04440007|540451310|FG000|Overall Study|Physician Decision|1|||
149814453|NCT04440007|540451311|FG001|Overall Study|Physician Decision|1|||
149814454|NCT04440007|540451310|FG000|Overall Study|Withdrawal by Subject|2|||
149814455|NCT04440007|540451311|FG001|Overall Study|Withdrawal by Subject|1|||
149814456|NCT04440007|540451310|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
149814457|NCT04440007|540451311|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
149814458|NCT04440007|540451310|FG000|Overall Study|Discontinued prior to dosing|0|||
149814459|NCT04440007|540451311|FG001|Overall Study|Discontinued prior to dosing|2|||
149814460|NCT03118765|540451312|FG000|Overall Study|Withdrawal by Subject|0|||
149814461|NCT03118765|540451313|FG001|Overall Study|Withdrawal by Subject|0|||
149814462|NCT03118765|540451314|FG002|Overall Study|Withdrawal by Subject|1|||
149814463|NCT03118765|540451315|FG003|Overall Study|Withdrawal by Subject|0|||
149814464|NCT03118765|540451316|FG004|Overall Study|Withdrawal by Subject|0|||
149814465|NCT03118765|540451312|FG000|Overall Study|Adverse Event|1|||
149814466|NCT03118765|540451313|FG001|Overall Study|Adverse Event|1|||
149814467|NCT03118765|540451314|FG002|Overall Study|Adverse Event|1|||
149814468|NCT03118765|540451315|FG003|Overall Study|Adverse Event|1|||
149814469|NCT03118765|540451316|FG004|Overall Study|Adverse Event|1|||
149814470|NCT03118765|540451312|FG000|Overall Study|Non compliance with Study Procedures|0|||
149814471|NCT03118765|540451313|FG001|Overall Study|Non compliance with Study Procedures|0|||
149814472|NCT03118765|540451314|FG002|Overall Study|Non compliance with Study Procedures|0|||
149814473|NCT03118765|540451315|FG003|Overall Study|Non compliance with Study Procedures|1|||
149814474|NCT03118765|540451316|FG004|Overall Study|Non compliance with Study Procedures|0|||
149814475|NCT03118765|540451312|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
149814476|NCT03118765|540451313|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
149814477|NCT03118765|540451314|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
149814478|NCT03118765|540451315|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
149814479|NCT03118765|540451316|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
149814480|NCT03118765|540451312|FG000|Overall Study|COPD Exacerbation|1|||
149814481|NCT03118765|540451313|FG001|Overall Study|COPD Exacerbation|0|||
149814482|NCT03118765|540451314|FG002|Overall Study|COPD Exacerbation|0|||
149814483|NCT03118765|540451315|FG003|Overall Study|COPD Exacerbation|1|||
149814484|NCT03118765|540451316|FG004|Overall Study|COPD Exacerbation|0|||
149814485|NCT03118765|540451312|FG000|Overall Study|Lost to Follow-up|1|||
149814486|NCT03118765|540451313|FG001|Overall Study|Lost to Follow-up|0|||
149814487|NCT03118765|540451314|FG002|Overall Study|Lost to Follow-up|1|||
149814488|NCT03118765|540451315|FG003|Overall Study|Lost to Follow-up|0|||
149814489|NCT03118765|540451316|FG004|Overall Study|Lost to Follow-up|0|||
149814490|NCT03118765|540451312|FG000|Overall Study|Sponsor Decision|1|||
149814491|NCT03118765|540451313|FG001|Overall Study|Sponsor Decision|0|||
149814492|NCT03118765|540451314|FG002|Overall Study|Sponsor Decision|1|||
149814493|NCT03118765|540451315|FG003|Overall Study|Sponsor Decision|0|||
149814494|NCT03118765|540451316|FG004|Overall Study|Sponsor Decision|1|||
149814495|NCT03674827|540451317|FG000|Treatment Phase|Adverse Event|0|||
149814496|NCT03674827|540451318|FG001|Treatment Phase|Adverse Event|0|||
149814497|NCT03674827|540451319|FG002|Treatment Phase|Adverse Event|0|||
149814498|NCT03674827|540451320|FG003|Treatment Phase|Adverse Event|0|||
149814499|NCT03674827|540451321|FG004|Treatment Phase|Adverse Event|0|||
149814500|NCT03674827|540451322|FG005|Treatment Phase|Adverse Event|2|||
149814501|NCT03674827|540451317|FG000|Treatment Phase|Death|2|||
149814502|NCT03674827|540451318|FG001|Treatment Phase|Death|0|||
149814503|NCT03674827|540451319|FG002|Treatment Phase|Death|0|||
149814504|NCT03674827|540451320|FG003|Treatment Phase|Death|0|||
149814505|NCT03674827|540451321|FG004|Treatment Phase|Death|1|||
149814506|NCT03674827|540451322|FG005|Treatment Phase|Death|0|||
149814507|NCT03674827|540451317|FG000|Treatment Phase|Progressive Disease|0|||
149814508|NCT03674827|540451318|FG001|Treatment Phase|Progressive Disease|4|||
149814509|NCT03674827|540451319|FG002|Treatment Phase|Progressive Disease|3|||
149814510|NCT03674827|540451320|FG003|Treatment Phase|Progressive Disease|4|||
149814511|NCT03674827|540451321|FG004|Treatment Phase|Progressive Disease|4|||
149814512|NCT03674827|540451322|FG005|Treatment Phase|Progressive Disease|9|||
149814513|NCT03674827|540451317|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
149814514|NCT03674827|540451318|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
149814515|NCT03674827|540451319|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
149814516|NCT03674827|540451320|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
149814517|NCT03674827|540451321|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
149814518|NCT03674827|540451322|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
149814519|NCT03674827|540451317|FG000|Treatment Phase|Withdrawal by Subject|0|||
149814520|NCT03674827|540451318|FG001|Treatment Phase|Withdrawal by Subject|0|||
149814521|NCT03674827|540451319|FG002|Treatment Phase|Withdrawal by Subject|0|||
149814522|NCT03674827|540451320|FG003|Treatment Phase|Withdrawal by Subject|0|||
149814523|NCT03674827|540451321|FG004|Treatment Phase|Withdrawal by Subject|0|||
149814524|NCT03674827|540451322|FG005|Treatment Phase|Withdrawal by Subject|1|||
149814525|NCT03674827|540451317|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
150153917|NCT01474512|541699605|FG016|Post-Treatment Follow-Up|Death|1|||
149814526|NCT03674827|540451318|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
149814527|NCT03674827|540451319|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
149814528|NCT03674827|540451320|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
149814529|NCT03674827|540451321|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
149814530|NCT03674827|540451322|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
149814531|NCT03674827|540451317|FG000|Treatment Phase|Other|0|||
149814532|NCT03674827|540451318|FG001|Treatment Phase|Other|1|||
149814533|NCT03674827|540451319|FG002|Treatment Phase|Other|0|||
149814534|NCT03674827|540451320|FG003|Treatment Phase|Other|0|||
149814535|NCT03674827|540451321|FG004|Treatment Phase|Other|0|||
149814536|NCT03674827|540451322|FG005|Treatment Phase|Other|1|||
149814537|NCT03674827|540451317|FG000|Long-Term Follow-up Phase|Death|2|||
149814538|NCT03674827|540451318|FG001|Long-Term Follow-up Phase|Death|4|||
149814539|NCT03674827|540451319|FG002|Long-Term Follow-up Phase|Death|2|||
149814540|NCT03674827|540451320|FG003|Long-Term Follow-up Phase|Death|3|||
149814541|NCT03674827|540451321|FG004|Long-Term Follow-up Phase|Death|2|||
149814542|NCT03674827|540451322|FG005|Long-Term Follow-up Phase|Death|6|||
149814543|NCT03674827|540451317|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
149814544|NCT03674827|540451318|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
149814545|NCT03674827|540451319|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
149814546|NCT03674827|540451320|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
149814547|NCT03674827|540451321|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
149814548|NCT03674827|540451322|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
149814549|NCT03674827|540451317|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
149814550|NCT03674827|540451318|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
149814551|NCT03674827|540451319|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
149814552|NCT03674827|540451320|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
149814553|NCT03674827|540451321|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
149814554|NCT03674827|540451322|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
149814555|NCT04816877|540451327|FG000|Overall Study|Withdrawal by Subject|1|||
149814556|NCT04816877|540451328|FG001|Overall Study|Withdrawal by Subject|0|||
149814557|NCT00759759|540451331|FG000|Overall Study|didn't return for period 2|1|||
149814558|NCT00759759|540451332|FG001|Overall Study|didn't return for period 2|0|||
149814559|NCT00759759|540451331|FG000|Overall Study|Didn't receive drug in period 2|1|||
149814560|NCT00759759|540451332|FG001|Overall Study|Didn't receive drug in period 2|0|||
149814561|NCT00759759|540451331|FG000|Overall Study|Withdrawal by Subject|2|||
149814562|NCT00759759|540451332|FG001|Overall Study|Withdrawal by Subject|1|||
149814563|NCT01861717|540451336|FG000|Overall Study|Lost to Follow-up|1|||
149814564|NCT01861717|540451336|FG000|Overall Study|Withdrawal by Subject|1|||
149814565|NCT00681824|540452775|FG000|Overall Study|withdrawn by investigator|0|||
149814566|NCT00681824|540452776|FG001|Overall Study|withdrawn by investigator|0|||
149814567|NCT00681824|540452777|FG002|Overall Study|withdrawn by investigator|1|||
149814568|NCT00681824|540452775|FG000|Overall Study|scheduling conflict|1|||
149814569|NCT00681824|540452776|FG001|Overall Study|scheduling conflict|0|||
149814570|NCT00681824|540452777|FG002|Overall Study|scheduling conflict|0|||
149814571|NCT00681824|540452775|FG000|Overall Study|Death|0|||
149814572|NCT00681824|540452776|FG001|Overall Study|Death|1|||
149814573|NCT00681824|540452777|FG002|Overall Study|Death|0|||
149814574|NCT03724916|540452778|FG000|Overall Study|Withdrawal by Subject|0|||
149814575|NCT03724916|540452779|FG001|Overall Study|Withdrawal by Subject|1|||
149814576|NCT03724916|540452780|FG002|Overall Study|Withdrawal by Subject|1|||
149814577|NCT03724916|540452781|FG003|Overall Study|Withdrawal by Subject|2|||
149814578|NCT03724916|540452778|FG000|Overall Study|Randomized but not Treated|1|||
149814579|NCT03724916|540452779|FG001|Overall Study|Randomized but not Treated|0|||
149814580|NCT03724916|540452780|FG002|Overall Study|Randomized but not Treated|0|||
149814581|NCT03724916|540452781|FG003|Overall Study|Randomized but not Treated|0|||
149814582|NCT02773446|540452792|FG000|First Admission|Withdrawal by Subject|0|||
149814583|NCT02773446|540452793|FG001|First Admission|Withdrawal by Subject|0|||
149814584|NCT02773446|540452794|FG002|First Admission|Withdrawal by Subject|0|||
149814585|NCT02773446|540452795|FG003|First Admission|Withdrawal by Subject|1|||
149814586|NCT02773446|540452796|FG004|First Admission|Withdrawal by Subject|0|||
149814587|NCT02773446|540452797|FG005|First Admission|Withdrawal by Subject|0|||
149918925|NCT01210352|540835249|FG008|Overall Study|Patient Discharged Early|0|||
149814588|NCT02773446|540452792|FG000|First Admission|Lost to Follow-up|1|||
149814589|NCT02773446|540452793|FG001|First Admission|Lost to Follow-up|0|||
149814590|NCT02773446|540452794|FG002|First Admission|Lost to Follow-up|0|||
149814591|NCT02773446|540452795|FG003|First Admission|Lost to Follow-up|0|||
149814592|NCT02773446|540452796|FG004|First Admission|Lost to Follow-up|0|||
149814593|NCT02773446|540452797|FG005|First Admission|Lost to Follow-up|0|||
149814594|NCT04023994|540452798|FG000|Overall Study|Lost to Follow-up|0|||
149814595|NCT04023994|540452799|FG001|Overall Study|Lost to Follow-up|1|||
149814596|NCT04023994|540452800|FG002|Overall Study|Lost to Follow-up|2|||
149814597|NCT04023994|540452801|FG003|Overall Study|Lost to Follow-up|0|||
149814598|NCT04023994|540452802|FG004|Overall Study|Lost to Follow-up|0|||
149814599|NCT04023994|540452803|FG005|Overall Study|Lost to Follow-up|0|||
149814600|NCT04023994|540452798|FG000|Overall Study|Withdrawal by Subject|0|||
149814601|NCT04023994|540452799|FG001|Overall Study|Withdrawal by Subject|0|||
149814602|NCT04023994|540452800|FG002|Overall Study|Withdrawal by Subject|0|||
149814603|NCT04023994|540452801|FG003|Overall Study|Withdrawal by Subject|1|||
149814604|NCT04023994|540452802|FG004|Overall Study|Withdrawal by Subject|0|||
149814605|NCT04023994|540452803|FG005|Overall Study|Withdrawal by Subject|0|||
149814606|NCT01613131|540452804|FG000|Overall Study|Withdrawal by Subject|3|||
149814607|NCT01613131|540452805|FG001|Overall Study|Withdrawal by Subject|5|||
149814608|NCT02454972|540452806|FG000|Overall Study|Progressive disease|17|||
149814609|NCT02454972|540452807|FG001|Overall Study|Progressive disease|16|||
149814610|NCT02454972|540452808|FG002|Overall Study|Progressive disease|59|||
149814611|NCT02454972|540452809|FG003|Overall Study|Progressive disease|23|||
149814612|NCT02454972|540452810|FG004|Overall Study|Progressive disease|16|||
149814613|NCT02454972|540452811|FG005|Overall Study|Progressive disease|12|||
149814614|NCT02454972|540452812|FG006|Overall Study|Progressive disease|19|||
149814615|NCT02454972|540452813|FG007|Overall Study|Progressive disease|27|||
149814616|NCT02454972|540452814|FG008|Overall Study|Progressive disease|0|||
149814617|NCT02454972|540452806|FG000|Overall Study|Death|0|||
149814618|NCT02454972|540452807|FG001|Overall Study|Death|0|||
149814619|NCT02454972|540452808|FG002|Overall Study|Death|5|||
149814620|NCT02454972|540452809|FG003|Overall Study|Death|1|||
149814621|NCT02454972|540452810|FG004|Overall Study|Death|0|||
149814622|NCT02454972|540452811|FG005|Overall Study|Death|0|||
149814623|NCT02454972|540452812|FG006|Overall Study|Death|0|||
149814624|NCT02454972|540452813|FG007|Overall Study|Death|0|||
149814625|NCT02454972|540452814|FG008|Overall Study|Death|95|||
149814626|NCT02454972|540452806|FG000|Overall Study|Physician Decision|0|||
149814627|NCT02454972|540452807|FG001|Overall Study|Physician Decision|1|||
149814628|NCT02454972|540452808|FG002|Overall Study|Physician Decision|2|||
149814629|NCT02454972|540452809|FG003|Overall Study|Physician Decision|1|||
149814630|NCT02454972|540452810|FG004|Overall Study|Physician Decision|2|||
149814631|NCT02454972|540452811|FG005|Overall Study|Physician Decision|0|||
149814632|NCT02454972|540452812|FG006|Overall Study|Physician Decision|0|||
149814633|NCT02454972|540452813|FG007|Overall Study|Physician Decision|1|||
149814634|NCT02454972|540452814|FG008|Overall Study|Physician Decision|0|||
149814635|NCT02454972|540452806|FG000|Overall Study|Non treatment-related adverse event|2|||
149814636|NCT02454972|540452807|FG001|Overall Study|Non treatment-related adverse event|0|||
149814637|NCT02454972|540452808|FG002|Overall Study|Non treatment-related adverse event|1|||
149814638|NCT02454972|540452809|FG003|Overall Study|Non treatment-related adverse event|0|||
149814639|NCT02454972|540452810|FG004|Overall Study|Non treatment-related adverse event|0|||
149814640|NCT02454972|540452811|FG005|Overall Study|Non treatment-related adverse event|1|||
149814641|NCT02454972|540452812|FG006|Overall Study|Non treatment-related adverse event|0|||
149814642|NCT02454972|540452813|FG007|Overall Study|Non treatment-related adverse event|1|||
149814643|NCT02454972|540452814|FG008|Overall Study|Non treatment-related adverse event|0|||
149814644|NCT02454972|540452806|FG000|Overall Study|Treatment-related adverse events|0|||
149814645|NCT02454972|540452807|FG001|Overall Study|Treatment-related adverse events|1|||
149814646|NCT02454972|540452808|FG002|Overall Study|Treatment-related adverse events|1|||
149814647|NCT02454972|540452809|FG003|Overall Study|Treatment-related adverse events|0|||
149814648|NCT02454972|540452810|FG004|Overall Study|Treatment-related adverse events|2|||
149814649|NCT02454972|540452811|FG005|Overall Study|Treatment-related adverse events|0|||
149814650|NCT02454972|540452812|FG006|Overall Study|Treatment-related adverse events|0|||
149814651|NCT02454972|540452813|FG007|Overall Study|Treatment-related adverse events|2|||
149814652|NCT02454972|540452814|FG008|Overall Study|Treatment-related adverse events|0|||
149814653|NCT02454972|540452806|FG000|Overall Study|Patient moves to compassionate use|0|||
149814654|NCT02454972|540452807|FG001|Overall Study|Patient moves to compassionate use|0|||
149814655|NCT02454972|540452808|FG002|Overall Study|Patient moves to compassionate use|0|||
149814656|NCT02454972|540452809|FG003|Overall Study|Patient moves to compassionate use|0|||
149814657|NCT02454972|540452810|FG004|Overall Study|Patient moves to compassionate use|0|||
149814658|NCT02454972|540452811|FG005|Overall Study|Patient moves to compassionate use|0|||
149814659|NCT02454972|540452812|FG006|Overall Study|Patient moves to compassionate use|2|||
149814660|NCT02454972|540452813|FG007|Overall Study|Patient moves to compassionate use|0|||
149814661|NCT02454972|540452814|FG008|Overall Study|Patient moves to compassionate use|0|||
149814662|NCT02454972|540452806|FG000|Overall Study|Withdrawal by Subject|0|||
149814663|NCT02454972|540452807|FG001|Overall Study|Withdrawal by Subject|1|||
149814664|NCT02454972|540452808|FG002|Overall Study|Withdrawal by Subject|5|||
149814665|NCT02454972|540452809|FG003|Overall Study|Withdrawal by Subject|2|||
149814666|NCT02454972|540452810|FG004|Overall Study|Withdrawal by Subject|3|||
149814667|NCT02454972|540452811|FG005|Overall Study|Withdrawal by Subject|2|||
149814668|NCT02454972|540452812|FG006|Overall Study|Withdrawal by Subject|0|||
149814669|NCT02454972|540452813|FG007|Overall Study|Withdrawal by Subject|1|||
149814670|NCT02454972|540452814|FG008|Overall Study|Withdrawal by Subject|2|||
150153918|NCT01474512|541699606|FG017|Post-Treatment Follow-Up|Death|0|||
149814671|NCT02454972|540452806|FG000|Overall Study|Multiple delay/holds on treatment|0|||
149814672|NCT02454972|540452807|FG001|Overall Study|Multiple delay/holds on treatment|0|||
149814673|NCT02454972|540452808|FG002|Overall Study|Multiple delay/holds on treatment|0|||
150153919|NCT01154036|541699610|FG000|Phase I|Physician Decision|0|||
150153920|NCT01154036|541699611|FG001|Phase I|Physician Decision|1|||
149814674|NCT02454972|540452809|FG003|Overall Study|Multiple delay/holds on treatment|1|||
149814675|NCT02454972|540452810|FG004|Overall Study|Multiple delay/holds on treatment|0|||
149814676|NCT02454972|540452811|FG005|Overall Study|Multiple delay/holds on treatment|0|||
149814677|NCT02454972|540452812|FG006|Overall Study|Multiple delay/holds on treatment|0|||
149814678|NCT02454972|540452813|FG007|Overall Study|Multiple delay/holds on treatment|0|||
149814679|NCT02454972|540452814|FG008|Overall Study|Multiple delay/holds on treatment|0|||
149814680|NCT02454972|540452806|FG000|Overall Study|Never treated|0|||
149814681|NCT02454972|540452807|FG001|Overall Study|Never treated|0|||
149814682|NCT02454972|540452808|FG002|Overall Study|Never treated|3|||
149814683|NCT02454972|540452809|FG003|Overall Study|Never treated|1|||
149814684|NCT02454972|540452810|FG004|Overall Study|Never treated|1|||
149814685|NCT02454972|540452811|FG005|Overall Study|Never treated|0|||
149814686|NCT02454972|540452812|FG006|Overall Study|Never treated|0|||
149814687|NCT02454972|540452813|FG007|Overall Study|Never treated|0|||
149814688|NCT02454972|540452814|FG008|Overall Study|Never treated|5|||
149814689|NCT02454972|540452806|FG000|Overall Study|Lost to Follow-up|0|||
149814690|NCT02454972|540452807|FG001|Overall Study|Lost to Follow-up|0|||
149814691|NCT02454972|540452808|FG002|Overall Study|Lost to Follow-up|0|||
149814692|NCT02454972|540452809|FG003|Overall Study|Lost to Follow-up|0|||
149814693|NCT02454972|540452810|FG004|Overall Study|Lost to Follow-up|0|||
149814694|NCT02454972|540452811|FG005|Overall Study|Lost to Follow-up|0|||
149814695|NCT02454972|540452812|FG006|Overall Study|Lost to Follow-up|0|||
149814696|NCT02454972|540452813|FG007|Overall Study|Lost to Follow-up|0|||
149814697|NCT02454972|540452814|FG008|Overall Study|Lost to Follow-up|2|||
149814698|NCT02454972|540452806|FG000|Overall Study|Study termination|0|||
149814699|NCT02454972|540452807|FG001|Overall Study|Study termination|0|||
149814700|NCT02454972|540452808|FG002|Overall Study|Study termination|0|||
149814701|NCT02454972|540452809|FG003|Overall Study|Study termination|0|||
149814702|NCT02454972|540452810|FG004|Overall Study|Study termination|0|||
149814703|NCT02454972|540452811|FG005|Overall Study|Study termination|0|||
149814704|NCT02454972|540452812|FG006|Overall Study|Study termination|0|||
149814705|NCT02454972|540452813|FG007|Overall Study|Study termination|0|||
149814706|NCT02454972|540452814|FG008|Overall Study|Study termination|6|||
149814707|NCT01020305|540452819|FG000|Overall Study|Adverse Event|2|||
149814708|NCT00467818|540452820|FG000|Overall Study|Adverse Event|1|||
149814709|NCT00467818|540452821|FG001|Overall Study|Adverse Event|0|||
149814710|NCT00467818|540452820|FG000|Overall Study|Lost to Follow-up|2|||
149814711|NCT00467818|540452821|FG001|Overall Study|Lost to Follow-up|2|||
149814712|NCT01070966|540452825|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
149814713|NCT01070966|540452825|FG000|Participants for Safety Evaluation|Off-label use|9|||
149814714|NCT01070966|540452825|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
149814715|NCT01070966|540452825|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
149814716|NCT01070966|540452825|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
149814717|NCT01070966|540452825|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
149814718|NCT01070966|540452825|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
149814719|NCT01070966|540452825|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
149814720|NCT00736333|540452826|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
149814721|NCT00736333|540452826|FG000|Overall Study|Data Missing|2|||
149814722|NCT00736333|540452826|FG000|Overall Study|Tumor Progression|75|||
149814723|NCT00736333|540452826|FG000|Overall Study|Toxicity|6|||
149814724|NCT00736333|540452826|FG000|Overall Study|Withdrawal by Subject|10|||
149814725|NCT00736333|540452826|FG000|Overall Study|Death|7|||
149814726|NCT00736333|540452826|FG000|Overall Study|Other|4|||
149814727|NCT02117479|540452830|FG000|Overall Study|Death|13|||
149814728|NCT02117479|540452831|FG001|Overall Study|Death|8|||
149814729|NCT02117479|540452830|FG000|Overall Study|Adverse Event|8|||
149814730|NCT02117479|540452831|FG001|Overall Study|Adverse Event|16|||
149814731|NCT02117479|540452830|FG000|Overall Study|Subject decision|8|||
149814732|NCT02117479|540452831|FG001|Overall Study|Subject decision|9|||
149814733|NCT02117479|540452830|FG000|Overall Study|Disease progression|104|||
149814734|NCT02117479|540452831|FG001|Overall Study|Disease progression|108|||
149814735|NCT02117479|540452830|FG000|Overall Study|Noncompliance with study treatment|1|||
149814736|NCT02117479|540452831|FG001|Overall Study|Noncompliance with study treatment|0|||
149814737|NCT02117479|540452830|FG000|Overall Study|Study terminated by the sponsor|4|||
149814738|NCT02117479|540452831|FG001|Overall Study|Study terminated by the sponsor|6|||
149814739|NCT02117479|540452830|FG000|Overall Study|Physician Decision|7|||
149814740|NCT02117479|540452831|FG001|Overall Study|Physician Decision|2|||
149814741|NCT02117479|540452830|FG000|Overall Study|Other unspecified|11|||
149814742|NCT02117479|540452831|FG001|Overall Study|Other unspecified|7|||
149814743|NCT02261974|540452832|FG000|Overall Study|Withdrawal by Subject|3|||
149814744|NCT02261974|540452833|FG001|Overall Study|Withdrawal by Subject|2|||
149814745|NCT02261974|540452832|FG000|Overall Study|Pregnancy|0|||
149814746|NCT02261974|540452833|FG001|Overall Study|Pregnancy|1|||
149814747|NCT02261974|540452832|FG000|Overall Study|Missed treatment cut-off date|6|||
149814748|NCT02261974|540452833|FG001|Overall Study|Missed treatment cut-off date|3|||
149814749|NCT02261974|540452832|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
149814750|NCT02261974|540452833|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
149814751|NCT02261974|540452832|FG000|Overall Study|Lost to Follow-up|2|||
149814752|NCT02261974|540452833|FG001|Overall Study|Lost to Follow-up|0|||
149814753|NCT02261974|540452832|FG000|Overall Study|Adverse Event|1|||
149814754|NCT02261974|540452833|FG001|Overall Study|Adverse Event|0|||
149814755|NCT03216954|540452834|FG000|Overall Study|Adverse Event|0|||
149814756|NCT03216954|540452835|FG001|Overall Study|Adverse Event|0|||
149814757|NCT03216954|540452836|FG002|Overall Study|Adverse Event|1|||
149814758|NCT03216954|540452837|FG003|Overall Study|Adverse Event|0|||
149814759|NCT03216954|540452838|FG004|Overall Study|Adverse Event|1|||
149814760|NCT03216954|540452834|FG000|Overall Study|Withdrawal by Subject|2|||
149814761|NCT03216954|540452835|FG001|Overall Study|Withdrawal by Subject|0|||
149814762|NCT03216954|540452836|FG002|Overall Study|Withdrawal by Subject|0|||
149814763|NCT03216954|540452837|FG003|Overall Study|Withdrawal by Subject|0|||
149814764|NCT03216954|540452838|FG004|Overall Study|Withdrawal by Subject|0|||
149814765|NCT03216954|540452834|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149814766|NCT03216954|540452835|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
149814767|NCT03216954|540452836|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149814768|NCT03216954|540452837|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149814769|NCT03216954|540452838|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149814770|NCT04736576|540452843|FG000|Overall Study|Progressive disease|3|||
149814771|NCT04736576|540452844|FG001|Overall Study|Progressive disease|1|||
149814772|NCT04736576|540452843|FG000|Overall Study|Death|1|||
149814773|NCT04736576|540452844|FG001|Overall Study|Death|0|||
149814774|NCT02525562|540452851|FG000|Overall Study|Death|9|||
149814775|NCT02525562|540452852|FG001|Overall Study|Death|0|||
149814776|NCT02525562|540452853|FG002|Overall Study|Death|0|||
149814777|NCT02525562|540452851|FG000|Overall Study|Lost to Follow-up|19|||
149814778|NCT02525562|540452852|FG001|Overall Study|Lost to Follow-up|0|||
149814779|NCT02525562|540452853|FG002|Overall Study|Lost to Follow-up|0|||
149814780|NCT02525562|540452851|FG000|Overall Study|Withdrawal by Subject|37|||
149814781|NCT02525562|540452852|FG001|Overall Study|Withdrawal by Subject|0|||
149814782|NCT02525562|540452853|FG002|Overall Study|Withdrawal by Subject|0|||
149814783|NCT02525562|540452851|FG000|Overall Study|Revision/Removal of Study Device|4|||
149814784|NCT02525562|540452852|FG001|Overall Study|Revision/Removal of Study Device|0|||
149814785|NCT02525562|540452853|FG002|Overall Study|Revision/Removal of Study Device|0|||
149814786|NCT02525562|540452851|FG000|Overall Study|Study Closed by Sponsor|154|||
149814787|NCT02525562|540452852|FG001|Overall Study|Study Closed by Sponsor|0|||
149814788|NCT02525562|540452853|FG002|Overall Study|Study Closed by Sponsor|0|||
149814789|NCT02354976|540452854|FG000|Overall Study|Other - reason not specified|1|||
149814790|NCT02354976|540452855|FG001|Overall Study|Other - reason not specified|0|||
149814791|NCT02354976|540452856|FG002|Overall Study|Other - reason not specified|1|||
149814792|NCT02354976|540452854|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
149814793|NCT02354976|540452855|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
149814794|NCT02354976|540452856|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
149814795|NCT02354976|540452854|FG000|Overall Study|Adverse Event|1|||
149814796|NCT02354976|540452855|FG001|Overall Study|Adverse Event|0|||
149814797|NCT02354976|540452856|FG002|Overall Study|Adverse Event|2|||
149814798|NCT02164539|540452859|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
149814799|NCT02164539|540452860|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
149814800|NCT02164539|540452861|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
149814801|NCT02164539|540452862|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
149814802|NCT02164539|540452863|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
150153921|NCT01154036|541699612|FG002|Phase I|Physician Decision|0|||
150153922|NCT01154036|541699613|FG003|Phase I|Physician Decision|0|||
150153923|NCT01154036|541699614|FG004|Phase I|Physician Decision|0|||
150153924|NCT01154036|541699615|FG005|Phase I|Physician Decision|0|||
150153925|NCT01154036|541699616|FG006|Phase I|Physician Decision|0|||
150153926|NCT01154036|541699617|FG007|Phase I|Physician Decision|0|||
150153927|NCT01154036|541699610|FG000|Phase I|Lost to Follow-up|0|||
150153928|NCT01154036|541699611|FG001|Phase I|Lost to Follow-up|3|||
150153929|NCT01154036|541699612|FG002|Phase I|Lost to Follow-up|6|||
150153930|NCT01154036|541699613|FG003|Phase I|Lost to Follow-up|0|||
150153931|NCT01154036|541699614|FG004|Phase I|Lost to Follow-up|0|||
150153932|NCT01154036|541699615|FG005|Phase I|Lost to Follow-up|0|||
149814803|NCT02164539|540452864|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
149814804|NCT02164539|540452865|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
150153933|NCT01154036|541699616|FG006|Phase I|Lost to Follow-up|0|||
150153934|NCT01154036|541699617|FG007|Phase I|Lost to Follow-up|0|||
150153935|NCT01154036|541699610|FG000|Phase I|Protocol Violation|0|||
150153936|NCT01154036|541699611|FG001|Phase I|Protocol Violation|3|||
150153937|NCT01154036|541699612|FG002|Phase I|Protocol Violation|9|||
150153938|NCT01154036|541699613|FG003|Phase I|Protocol Violation|0|||
150153939|NCT01154036|541699614|FG004|Phase I|Protocol Violation|0|||
149814805|NCT02164539|540452859|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
150153940|NCT01154036|541699615|FG005|Phase I|Protocol Violation|0|||
149814806|NCT02164539|540452860|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
149814807|NCT02164539|540452861|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
149814808|NCT02164539|540452862|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
149814809|NCT02164539|540452863|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
149814810|NCT02164539|540452864|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
149814811|NCT02164539|540452865|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
149814812|NCT02164539|540452859|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
149814813|NCT02164539|540452860|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
149814814|NCT02164539|540452861|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
149814815|NCT02164539|540452862|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
149814816|NCT02164539|540452863|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
149814817|NCT02164539|540452864|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
149814818|NCT02164539|540452865|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
149814819|NCT02164539|540452859|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
149814820|NCT02164539|540452860|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814821|NCT02164539|540452861|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814822|NCT02164539|540452862|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814823|NCT02164539|540452863|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814824|NCT02164539|540452864|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814825|NCT02164539|540452865|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
149814826|NCT02164539|540452859|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
149814827|NCT02164539|540452860|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
149814828|NCT02164539|540452861|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
149814829|NCT02164539|540452862|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
149814830|NCT02164539|540452863|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
149814831|NCT02164539|540452864|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
149814832|NCT02164539|540452865|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
149814833|NCT02164539|540452859|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
149814834|NCT02164539|540452860|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
149814835|NCT02164539|540452861|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
149814836|NCT02164539|540452862|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
149814837|NCT02164539|540452863|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
149814838|NCT02164539|540452864|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
149814839|NCT02164539|540452865|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
149814840|NCT01493531|540452866|FG000|Overall Study|Adverse Event|4|||
149814841|NCT01493531|540452867|FG001|Overall Study|Adverse Event|12|||
149814842|NCT01493531|540452868|FG002|Overall Study|Adverse Event|9|||
149814843|NCT01493531|540452866|FG000|Overall Study|Gout flare|3|||
149814844|NCT01493531|540452867|FG001|Overall Study|Gout flare|0|||
149814845|NCT01493531|540452868|FG002|Overall Study|Gout flare|2|||
149814846|NCT01493531|540452866|FG000|Overall Study|Protocol Violation|8|||
149814847|NCT01493531|540452867|FG001|Overall Study|Protocol Violation|15|||
149814848|NCT01493531|540452868|FG002|Overall Study|Protocol Violation|12|||
149814849|NCT01493531|540452866|FG000|Overall Study|Sponsor terminated study|5|||
149814850|NCT01493531|540452867|FG001|Overall Study|Sponsor terminated study|2|||
149814851|NCT01493531|540452868|FG002|Overall Study|Sponsor terminated study|3|||
149814852|NCT01493531|540452866|FG000|Overall Study|Lost to Follow-up|5|||
149814853|NCT01493531|540452867|FG001|Overall Study|Lost to Follow-up|7|||
149814854|NCT01493531|540452868|FG002|Overall Study|Lost to Follow-up|11|||
149814855|NCT01493531|540452866|FG000|Overall Study|Withdrawal by Subject|16|||
149814856|NCT01493531|540452867|FG001|Overall Study|Withdrawal by Subject|13|||
149814857|NCT01493531|540452868|FG002|Overall Study|Withdrawal by Subject|11|||
149814858|NCT01493531|540452866|FG000|Overall Study|Death|0|||
149814859|NCT01493531|540452867|FG001|Overall Study|Death|1|||
149814860|NCT01493531|540452868|FG002|Overall Study|Death|0|||
149814861|NCT01946282|540452869|FG000|Year 1|Did not return FIT kit|4186|||
149814862|NCT01946282|540452870|FG001|Year 1|Did not return FIT kit|608|||
149814863|NCT01946282|540452871|FG002|Year 1|Did not return FIT kit|654|||
149814864|NCT01946282|540452869|FG000|Year 2|Did not return FIT kit|803|||
149814865|NCT01946282|540452870|FG001|Year 2|Did not return FIT kit|131|||
149814866|NCT01946282|540452871|FG002|Year 2|Did not return FIT kit|115|||
150153941|NCT01154036|541699616|FG006|Phase I|Protocol Violation|0|||
149814867|NCT01946282|540452869|FG000|Year 3|Did not return FIT kit|288|||
149814868|NCT01946282|540452870|FG001|Year 3|Did not return FIT kit|43|||
149814869|NCT01946282|540452871|FG002|Year 3|Did not return FIT kit|30|||
149814870|NCT03031431|540452872|FG000|Overall Study|Infant removed by maternal request|1|||
149814871|NCT01612702|540452873|FG000|Overall Study|Protocol Violation|11|||
149814872|NCT01612702|540452874|FG001|Overall Study|Protocol Violation|11|||
149814873|NCT00527397|540452875|FG000|Overall Study|Adverse Event|3|||
149814874|NCT00527397|540452875|FG000|Overall Study|Lack of Efficacy|1|||
149814875|NCT00527397|540452875|FG000|Overall Study|Protocol Violation|1|||
149814876|NCT00527397|540452875|FG000|Overall Study|Withdrawal by Subject|6|||
149814877|NCT00527397|540452875|FG000|Overall Study|Study terminated by sponsor|13|||
149814878|NCT03012815|540452876|FG000|Overall Study|Lost to Follow-up|1|||
149814879|NCT03012815|540452877|FG001|Overall Study|Lost to Follow-up|0|||
149814880|NCT03012815|540452876|FG000|Overall Study|Physician Decision|3|||
149814881|NCT03012815|540452877|FG001|Overall Study|Physician Decision|2|||
149814882|NCT03012815|540452876|FG000|Overall Study|Adverse Event|1|||
149814883|NCT03012815|540452877|FG001|Overall Study|Adverse Event|0|||
149814884|NCT01462695|540452878|FG000|Overall Study|Adverse Event|1|||
149814885|NCT01462695|540452879|FG001|Overall Study|Adverse Event|1|||
149814886|NCT01462695|540452878|FG000|Overall Study|Death|2|||
149814887|NCT01462695|540452879|FG001|Overall Study|Death|0|||
149814888|NCT01462695|540452878|FG000|Overall Study|Lack of Efficacy|6|||
149814889|NCT01462695|540452879|FG001|Overall Study|Lack of Efficacy|12|||
149814890|NCT01462695|540452878|FG000|Overall Study|Physician Decision|5|||
149814891|NCT01462695|540452879|FG001|Overall Study|Physician Decision|0|||
149814892|NCT01462695|540452878|FG000|Overall Study|Withdrawal by Subject|2|||
149814893|NCT01462695|540452879|FG001|Overall Study|Withdrawal by Subject|0|||
149814894|NCT01462695|540452878|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
149814895|NCT01462695|540452879|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
149814896|NCT02400905|540452880|FG000|Overall Study|Death|24|||
149814897|NCT02400905|540452880|FG000|Overall Study|Lost to Follow-up|18|||
149814898|NCT02400905|540452880|FG000|Overall Study|Withdrawal by Subject|16|||
149814899|NCT02400905|540452880|FG000|Overall Study|Physician Decision|4|||
149814900|NCT02400905|540452880|FG000|Overall Study|Other|1|||
149814901|NCT00879970|540452881|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
149814902|NCT00879970|540452882|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
149814903|NCT00879970|540452883|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
149814904|NCT00879970|540452884|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
149814905|NCT00879970|540452885|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
149814906|NCT00879970|540452881|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
149814907|NCT00879970|540452882|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
149814908|NCT00879970|540452883|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
149814909|NCT00879970|540452884|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
149814910|NCT00879970|540452885|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
149814911|NCT00879970|540452881|FG000|Period 1 TZD Randomization|Death|2|||
149814912|NCT00879970|540452882|FG001|Period 1 TZD Randomization|Death|1|||
149814913|NCT00879970|540452883|FG002|Period 1 TZD Randomization|Death|0|||
149814914|NCT00879970|540452884|FG003|Period 1 TZD Randomization|Death|0|||
149814915|NCT00879970|540452885|FG004|Period 1 TZD Randomization|Death|0|||
149814916|NCT00879970|540452881|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
149814917|NCT00879970|540452882|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
149814918|NCT00879970|540452883|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
149814919|NCT00879970|540452884|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
149814920|NCT00879970|540452885|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
149814921|NCT00879970|540452881|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
149814922|NCT00879970|540452882|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
149814923|NCT00879970|540452883|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
149814924|NCT00879970|540452884|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
149814925|NCT00879970|540452885|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
149814926|NCT00879970|540452881|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
149814927|NCT00879970|540452882|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
149814928|NCT00879970|540452883|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
149814929|NCT00879970|540452884|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
149814930|NCT00879970|540452885|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
149814931|NCT00879970|540452881|FG000|Period 2 Vitamin D Randomization|Death|0|||
149814932|NCT00879970|540452882|FG001|Period 2 Vitamin D Randomization|Death|0|||
149814933|NCT00879970|540452883|FG002|Period 2 Vitamin D Randomization|Death|0|||
149814934|NCT00879970|540452884|FG003|Period 2 Vitamin D Randomization|Death|2|||
149814935|NCT00879970|540452885|FG004|Period 2 Vitamin D Randomization|Death|0|||
149814936|NCT00061945|540452888|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
149814937|NCT00061945|540452889|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
149814938|NCT00061945|540452888|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
149814939|NCT00061945|540452889|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
149814940|NCT00061945|540452888|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
149814941|NCT00061945|540452889|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
149814942|NCT00061945|540452888|FG000|Course IV: Alemtuzumab|Early exits|6|||
149814943|NCT00061945|540452889|FG001|Course IV: Alemtuzumab|Early exits|15|||
149814944|NCT01039584|540452890|FG000|Overall Study|Withdrawal by Subject|4|||
149814945|NCT01039584|540452891|FG001|Overall Study|Withdrawal by Subject|2|||
149814946|NCT01039584|540452892|FG002|Overall Study|Withdrawal by Subject|1|||
149814947|NCT01039584|540452890|FG000|Overall Study|Protocol Violation|10|||
149814948|NCT01039584|540452891|FG001|Overall Study|Protocol Violation|4|||
149814949|NCT01039584|540452892|FG002|Overall Study|Protocol Violation|6|||
149814950|NCT01039584|540452890|FG000|Overall Study|Lost to Follow-up|5|||
149814951|NCT01039584|540452891|FG001|Overall Study|Lost to Follow-up|3|||
149814952|NCT01039584|540452892|FG002|Overall Study|Lost to Follow-up|4|||
149814953|NCT01039584|540452890|FG000|Overall Study|Negative Baseline culture for Candida|59|||
149814954|NCT01039584|540452891|FG001|Overall Study|Negative Baseline culture for Candida|59|||
149814955|NCT01039584|540452892|FG002|Overall Study|Negative Baseline culture for Candida|24|||
149814956|NCT01039584|540452890|FG000|Overall Study|Lack of Efficacy|7|||
149814957|NCT01039584|540452891|FG001|Overall Study|Lack of Efficacy|6|||
149814958|NCT01039584|540452892|FG002|Overall Study|Lack of Efficacy|10|||
149814959|NCT01039584|540452890|FG000|Overall Study|other|1|||
149814960|NCT01039584|540452891|FG001|Overall Study|other|3|||
149814961|NCT01039584|540452892|FG002|Overall Study|other|1|||
149814962|NCT01039584|540452890|FG000|Overall Study|Pap smear with significant pathology|10|||
149814963|NCT01039584|540452891|FG001|Overall Study|Pap smear with significant pathology|10|||
149814964|NCT01039584|540452892|FG002|Overall Study|Pap smear with significant pathology|3|||
149814965|NCT01039584|540452890|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
149814966|NCT01039584|540452891|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
149814967|NCT01039584|540452892|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
149814968|NCT03672396|540452895|FG000|Overall Study|Withdrawal by Subject|4|||
149814969|NCT03672396|540452895|FG000|Overall Study|Physician Decision|1|||
149814970|NCT03672396|540452895|FG000|Overall Study|Adverse Event|1|||
149814971|NCT00558519|540452898|FG000|Overall Study|Ph+|20|||
149814972|NCT00558519|540452898|FG000|Overall Study|Ineligible|1|||
149814973|NCT00558519|540452898|FG000|Overall Study|Insufficient data|1|||
149814974|NCT00558519|540452898|FG000|Overall Study|Never received treatment|1|||
149814975|NCT03001011|540452899|FG000|Overall Study|Adverse Event|9|||
149814976|NCT03001011|540452900|FG001|Overall Study|Adverse Event|3|||
149814977|NCT03001011|540452899|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
149814978|NCT03001011|540452900|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
149814979|NCT03001011|540452899|FG000|Overall Study|Other than specified above|3|||
149814980|NCT03001011|540452900|FG001|Overall Study|Other than specified above|8|||
149814981|NCT04355767|540452901|FG000|Overall Study|Withdrawal by Subject|2|||
149814982|NCT04355767|540452902|FG001|Overall Study|Withdrawal by Subject|2|||
149814983|NCT04355767|540452901|FG000|Overall Study|Death|5|||
149814984|NCT04355767|540452902|FG001|Overall Study|Death|1|||
149814985|NCT01999322|540452903|FG000|Overall Study|Adverse Event|1|||
149814986|NCT01999322|540452904|FG001|Overall Study|Adverse Event|0|||
149814987|NCT03338673|540452907|FG000|Overall Study|Lost to Follow-up|1|||
149814988|NCT03338673|540452908|FG001|Overall Study|Lost to Follow-up|1|||
149814989|NCT04523831|540452918|FG000|Overall Study|Lost to Follow-up|15|||
149814990|NCT04523831|540452919|FG001|Overall Study|Lost to Follow-up|17|||
149814991|NCT04523831|540452918|FG000|Overall Study|Death|0|||
149814992|NCT04523831|540452919|FG001|Overall Study|Death|3|||
149814993|NCT04523831|540452918|FG000|Overall Study|Adverse Event|2|||
149814994|NCT04523831|540452919|FG001|Overall Study|Adverse Event|0|||
149814995|NCT04556838|540452920|FG000|Overall Study|Withdrawal by Subject|3|||
149814996|NCT04556838|540452921|FG001|Overall Study|Withdrawal by Subject|1|||
149814997|NCT04556838|540452922|FG002|Overall Study|Withdrawal by Subject|2|||
149814998|NCT04556838|540452920|FG000|Overall Study|Adverse Event|0|||
149814999|NCT04556838|540452921|FG001|Overall Study|Adverse Event|1|||
149815000|NCT04556838|540452922|FG002|Overall Study|Adverse Event|1|||
149815001|NCT04556838|540452920|FG000|Overall Study|Lost to Follow-up|0|||
149815002|NCT04556838|540452921|FG001|Overall Study|Lost to Follow-up|0|||
149815003|NCT04556838|540452922|FG002|Overall Study|Lost to Follow-up|2|||
149815004|NCT04556838|540452920|FG000|Overall Study|Subject travel|0|||
149815005|NCT04556838|540452921|FG001|Overall Study|Subject travel|1|||
149815006|NCT04556838|540452922|FG002|Overall Study|Subject travel|0|||
149815007|NCT04556838|540452920|FG000|Overall Study|Physician Decision|1|||
149815008|NCT04556838|540452921|FG001|Overall Study|Physician Decision|0|||
149815009|NCT04556838|540452922|FG002|Overall Study|Physician Decision|0|||
149815010|NCT00995930|540452923|FG000|Overall Study|Protocol deviation|2|||
149815011|NCT00995930|540452924|FG001|Overall Study|Protocol deviation|5|||
149815012|NCT00995930|540452923|FG000|Overall Study|Death|0|||
149815013|NCT00995930|540452924|FG001|Overall Study|Death|1|||
149815014|NCT00995930|540452923|FG000|Overall Study|Administrative problems|4|||
149815015|NCT00995930|540452924|FG001|Overall Study|Administrative problems|2|||
149815016|NCT00995930|540452923|FG000|Overall Study|Lost to Follow-up|1|||
149815017|NCT00995930|540452924|FG001|Overall Study|Lost to Follow-up|2|||
149815018|NCT00995930|540452923|FG000|Overall Study|Withdrawal by Subject|3|||
149815019|NCT00995930|540452924|FG001|Overall Study|Withdrawal by Subject|4|||
149815020|NCT00995930|540452923|FG000|Overall Study|Adverse Event|11|||
149815021|NCT00995930|540452924|FG001|Overall Study|Adverse Event|14|||
149815022|NCT05788237|540452929|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
149815023|NCT05788237|540452930|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
149815024|NCT05788237|540452931|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
149815025|NCT05788237|540452932|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
149815026|NCT05788237|540452929|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
149815027|NCT05788237|540452930|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
149815028|NCT05788237|540452931|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
149815029|NCT05788237|540452932|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
149815030|NCT05788237|540452929|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
149815031|NCT05788237|540452930|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
149815032|NCT05788237|540452931|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
149815033|NCT05788237|540452932|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
149815034|NCT05788237|540452929|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
149815035|NCT05788237|540452930|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
149815036|NCT05788237|540452931|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
149815037|NCT05788237|540452932|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
149815038|NCT05788237|540452929|FG000|SSA (Approximately 2 Months)|Death|0|||
149815039|NCT05788237|540452930|FG001|SSA (Approximately 2 Months)|Death|1|||
149815040|NCT05788237|540452931|FG002|SSA (Approximately 2 Months)|Death|0|||
149815041|NCT05788237|540452932|FG003|SSA (Approximately 2 Months)|Death|0|||
149815042|NCT05788237|540452929|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
149815043|NCT05788237|540452930|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
149815044|NCT05788237|540452931|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
149815045|NCT05788237|540452932|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
149815046|NCT05788237|540452929|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
149815047|NCT05788237|540452930|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
149815048|NCT05788237|540452931|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
150153942|NCT01154036|541699617|FG007|Phase I|Protocol Violation|0|||
149815049|NCT05788237|540452932|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
149815050|NCT05788237|540452929|FG000|SSB (Approximately 1 Month)|Other|0|||
149815051|NCT05788237|540452930|FG001|SSB (Approximately 1 Month)|Other|0|||
149815052|NCT05788237|540452931|FG002|SSB (Approximately 1 Month)|Other|0|||
149815053|NCT05788237|540452932|FG003|SSB (Approximately 1 Month)|Other|1|||
149815054|NCT01246973|540454526|FG000|Overall Study|Other|38|||
149815055|NCT01246973|540454527|FG001|Overall Study|Other|25|||
149815056|NCT01246973|540454526|FG000|Overall Study|Adverse Event|16|||
149815057|NCT01246973|540454527|FG001|Overall Study|Adverse Event|9|||
149815058|NCT01246973|540454526|FG000|Overall Study|Withdrawal by Subject|7|||
149815059|NCT01246973|540454527|FG001|Overall Study|Withdrawal by Subject|13|||
149815060|NCT03053622|540454529|FG000|Overall Study|Lost to Follow-up|0|||
149815061|NCT03053622|540454530|FG001|Overall Study|Lost to Follow-up|0|||
149815062|NCT03053622|540454531|FG002|Overall Study|Lost to Follow-up|0|||
149815063|NCT03053622|540454532|FG003|Overall Study|Lost to Follow-up|1|||
149815064|NCT02598622|540454533|FG000|Overall Study|Withdrawal by Subject|3|||
149815065|NCT02598622|540454534|FG001|Overall Study|Withdrawal by Subject|0|||
149815066|NCT02598622|540454533|FG000|Overall Study|Physician Decision|3|||
149815067|NCT02598622|540454534|FG001|Overall Study|Physician Decision|0|||
149815068|NCT01416142|540454538|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
149815069|NCT01416142|540454539|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
149815070|NCT01416142|540454540|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
149815071|NCT00678379|540454541|FG000|Overall Study|Injection performed after tonsillectomy|2|||
149815072|NCT00678379|540454542|FG001|Overall Study|Injection performed after tonsillectomy|0|||
149815073|NCT00678379|540454543|FG002|Overall Study|Injection performed after tonsillectomy|1|||
149815074|NCT00678379|540454541|FG000|Overall Study|Incomplete Data|4|||
149815075|NCT00678379|540454542|FG001|Overall Study|Incomplete Data|3|||
149815076|NCT00678379|540454543|FG002|Overall Study|Incomplete Data|3|||
149815077|NCT04335110|540454544|FG000|Overall Study|Withdrawal by Subject|1|||
149815078|NCT04335110|540454545|FG001|Overall Study|Withdrawal by Subject|1|||
149815079|NCT04335110|540454544|FG000|Overall Study|Death|0|||
149815080|NCT04335110|540454545|FG001|Overall Study|Death|1|||
149815081|NCT04006847|540454547|FG000|Overall Study|Product issue|1|||
149815082|NCT03333382|540454552|FG000|Overall Study|Lost to Follow-up|1|||
149815083|NCT03333382|540454553|FG001|Overall Study|Lost to Follow-up|0|||
149815084|NCT02513459|540454554|FG000|Overall Study|Adverse Event|7|||
149815085|NCT02513459|540454554|FG000|Overall Study|Withdrew consent|5|||
149815086|NCT02513459|540454554|FG000|Overall Study|Loss of efficacy|2|||
149815087|NCT02513459|540454554|FG000|Overall Study|Pregnancy|2|||
149815088|NCT02513459|540454554|FG000|Overall Study|Subject decision|2|||
149815089|NCT02513459|540454554|FG000|Overall Study|Lack of response|1|||
149815090|NCT02513459|540454554|FG000|Overall Study|Reproductive plans|1|||
149815091|NCT02513459|540454554|FG000|Overall Study|Surgery planned-- not done|1|||
149815092|NCT00830063|540454559|FG000|Overall Study|Adverse Event|7|||
149815093|NCT00830063|540454560|FG001|Overall Study|Adverse Event|13|||
149815094|NCT00830063|540454561|FG002|Overall Study|Adverse Event|16|||
149815095|NCT00830063|540454562|FG003|Overall Study|Adverse Event|13|||
149815096|NCT00830063|540454559|FG000|Overall Study|Death|1|||
149815097|NCT00830063|540454560|FG001|Overall Study|Death|0|||
149815098|NCT00830063|540454561|FG002|Overall Study|Death|0|||
149815099|NCT00830063|540454562|FG003|Overall Study|Death|0|||
149815100|NCT00830063|540454559|FG000|Overall Study|Lost to Follow-up|0|||
150153943|NCT01154036|541699610|FG000|Phase I|Withdrawal by Subject|2|||
149815101|NCT00830063|540454560|FG001|Overall Study|Lost to Follow-up|0|||
149815102|NCT00830063|540454561|FG002|Overall Study|Lost to Follow-up|3|||
149815103|NCT00830063|540454562|FG003|Overall Study|Lost to Follow-up|1|||
149815104|NCT00830063|540454559|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
149815105|NCT00830063|540454560|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
149815106|NCT00830063|540454561|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
149815107|NCT00830063|540454562|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
149815108|NCT00830063|540454559|FG000|Overall Study|Lack of Efficacy|51|||
149815109|NCT00830063|540454560|FG001|Overall Study|Lack of Efficacy|23|||
149815110|NCT00830063|540454561|FG002|Overall Study|Lack of Efficacy|25|||
149815111|NCT00830063|540454562|FG003|Overall Study|Lack of Efficacy|32|||
149815112|NCT00830063|540454559|FG000|Overall Study|Other|5|||
149815113|NCT00830063|540454560|FG001|Overall Study|Other|5|||
149815114|NCT00830063|540454561|FG002|Overall Study|Other|8|||
149815115|NCT00830063|540454562|FG003|Overall Study|Other|6|||
149815116|NCT00830063|540454559|FG000|Overall Study|Withdrawal by Subject|16|||
149815117|NCT00830063|540454560|FG001|Overall Study|Withdrawal by Subject|10|||
149815118|NCT00830063|540454561|FG002|Overall Study|Withdrawal by Subject|16|||
149815119|NCT00830063|540454562|FG003|Overall Study|Withdrawal by Subject|13|||
149815120|NCT00830063|540454559|FG000|Overall Study|Protocol Violation|1|||
149815121|NCT00830063|540454560|FG001|Overall Study|Protocol Violation|0|||
149815122|NCT00830063|540454561|FG002|Overall Study|Protocol Violation|3|||
149815123|NCT00830063|540454562|FG003|Overall Study|Protocol Violation|2|||
149815124|NCT00830063|540454559|FG000|Overall Study|Randomized But Not Treated|0|||
149815125|NCT00830063|540454560|FG001|Overall Study|Randomized But Not Treated|2|||
149815126|NCT00830063|540454561|FG002|Overall Study|Randomized But Not Treated|0|||
149815127|NCT00830063|540454562|FG003|Overall Study|Randomized But Not Treated|2|||
149815128|NCT00787566|540454563|FG000|Overall Study|AE related to chemotherapy|0|||
149815129|NCT00787566|540454564|FG001|Overall Study|AE related to chemotherapy|1|||
149815130|NCT00787566|540454565|FG002|Overall Study|AE related to chemotherapy|0|||
149815131|NCT00660790|540454574|FG000|Baseline to 3 Months|Death|1|||
149815132|NCT00660790|540454574|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
149815133|NCT00660790|540454574|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
149815134|NCT00686374|540454579|FG000|Overall Study|Lack of Efficacy|10|||
149815135|NCT00686374|540454579|FG000|Overall Study|Adverse Event|8|||
149815136|NCT00686374|540454579|FG000|Overall Study|Withdrew consent|5|||
149815137|NCT00686374|540454579|FG000|Overall Study|Lost to Follow-up|1|||
149815138|NCT00686374|540454579|FG000|Overall Study|Missing reason|33|||
149815139|NCT00686374|540454579|FG000|Overall Study|Other, not specified|4|||
149815140|NCT01808209|540454581|FG000|Overall Study|Lost to Follow-up|0|||
149815141|NCT01808209|540454582|FG001|Overall Study|Lost to Follow-up|1|||
149815142|NCT02629133|540454588|FG000|Overall Study|Lost to Follow-up|3|||
149815143|NCT02629133|540454589|FG001|Overall Study|Lost to Follow-up|1|||
149815144|NCT02629133|540454588|FG000|Overall Study|Withdrawal by Subject|1|||
149815145|NCT02629133|540454589|FG001|Overall Study|Withdrawal by Subject|1|||
149815146|NCT05180630|540454590|FG000|First Intervention|Physician Decision|0|||
149815147|NCT05180630|540454591|FG001|First Intervention|Physician Decision|0|||
149815148|NCT05180630|540454592|FG002|First Intervention|Physician Decision|3|||
149815149|NCT00709735|540454595|FG000|Overall Study|Lost to Follow-up|1|||
149815150|NCT00709735|540454596|FG001|Overall Study|Lost to Follow-up|1|||
149815151|NCT00709735|540454595|FG000|Overall Study|Relapse into Opioid Abuse|0|||
149815152|NCT00709735|540454596|FG001|Overall Study|Relapse into Opioid Abuse|1|||
149815153|NCT00709735|540454595|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
149815154|NCT00709735|540454596|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
149815155|NCT00386100|540454597|FG000|Overall Study|Did not receive study medication|6|||
149815156|NCT00386100|540454598|FG001|Overall Study|Did not receive study medication|4|||
149815157|NCT00386100|540454597|FG000|Overall Study|Adverse Event|15|||
149815158|NCT00386100|540454598|FG001|Overall Study|Adverse Event|25|||
149815159|NCT00386100|540454597|FG000|Overall Study|Death|0|||
149815160|NCT00386100|540454598|FG001|Overall Study|Death|1|||
149815161|NCT00386100|540454597|FG000|Overall Study|Insufficient therapeutic effect|30|||
150153944|NCT01154036|541699611|FG001|Phase I|Withdrawal by Subject|10|||
150153945|NCT01154036|541699612|FG002|Phase I|Withdrawal by Subject|29|||
150153946|NCT01154036|541699613|FG003|Phase I|Withdrawal by Subject|0|||
150153947|NCT01154036|541699614|FG004|Phase I|Withdrawal by Subject|0|||
150153948|NCT01154036|541699615|FG005|Phase I|Withdrawal by Subject|0|||
150153949|NCT01154036|541699616|FG006|Phase I|Withdrawal by Subject|0|||
150153950|NCT01154036|541699617|FG007|Phase I|Withdrawal by Subject|0|||
150153951|NCT01154036|541699610|FG000|Phase I|Adverse Event|1|||
150153952|NCT01154036|541699611|FG001|Phase I|Adverse Event|11|||
149815162|NCT00386100|540454598|FG001|Overall Study|Insufficient therapeutic effect|6|||
149815163|NCT00386100|540454597|FG000|Overall Study|Lost to Follow-up|29|||
149815164|NCT00386100|540454598|FG001|Overall Study|Lost to Follow-up|29|||
150153953|NCT01154036|541699612|FG002|Phase I|Adverse Event|12|||
150153954|NCT01154036|541699613|FG003|Phase I|Adverse Event|0|||
150153955|NCT01154036|541699614|FG004|Phase I|Adverse Event|0|||
149815165|NCT00386100|540454597|FG000|Overall Study|Non-compliance|18|||
149815166|NCT00386100|540454598|FG001|Overall Study|Non-compliance|19|||
149815167|NCT00386100|540454597|FG000|Overall Study|Protocol Violation|5|||
149815168|NCT00386100|540454598|FG001|Overall Study|Protocol Violation|3|||
149815169|NCT00386100|540454597|FG000|Overall Study|Withdrawal by Subject|32|||
150153956|NCT01154036|541699615|FG005|Phase I|Adverse Event|0|||
150153957|NCT01154036|541699616|FG006|Phase I|Adverse Event|0|||
150153958|NCT01154036|541699617|FG007|Phase I|Adverse Event|0|||
150153959|NCT01154036|541699610|FG000|Phase II|Adverse Event|0|||
150153960|NCT01154036|541699611|FG001|Phase II|Adverse Event|0|||
150153961|NCT01154036|541699612|FG002|Phase II|Adverse Event|0|||
150153962|NCT01154036|541699613|FG003|Phase II|Adverse Event|0|||
150153963|NCT01154036|541699614|FG004|Phase II|Adverse Event|1|||
150153964|NCT01154036|541699615|FG005|Phase II|Adverse Event|1|||
150153965|NCT01154036|541699616|FG006|Phase II|Adverse Event|1|||
150153966|NCT01154036|541699617|FG007|Phase II|Adverse Event|1|||
150153967|NCT01154036|541699610|FG000|Phase II|Physician Decision|0|||
150153968|NCT01154036|541699611|FG001|Phase II|Physician Decision|0|||
150153969|NCT01154036|541699612|FG002|Phase II|Physician Decision|0|||
150153970|NCT01154036|541699613|FG003|Phase II|Physician Decision|0|||
150153971|NCT01154036|541699614|FG004|Phase II|Physician Decision|0|||
150153972|NCT01154036|541699615|FG005|Phase II|Physician Decision|0|||
150153973|NCT01154036|541699616|FG006|Phase II|Physician Decision|1|||
150153974|NCT01154036|541699617|FG007|Phase II|Physician Decision|0|||
150153975|NCT01154036|541699610|FG000|Phase II|Lost to Follow-up|0|||
150153976|NCT01154036|541699611|FG001|Phase II|Lost to Follow-up|0|||
150153977|NCT01154036|541699612|FG002|Phase II|Lost to Follow-up|0|||
150153978|NCT01154036|541699613|FG003|Phase II|Lost to Follow-up|1|||
150153979|NCT01154036|541699614|FG004|Phase II|Lost to Follow-up|2|||
150153980|NCT01154036|541699615|FG005|Phase II|Lost to Follow-up|0|||
150153981|NCT01154036|541699616|FG006|Phase II|Lost to Follow-up|2|||
150153982|NCT01154036|541699617|FG007|Phase II|Lost to Follow-up|1|||
150153983|NCT01154036|541699610|FG000|Phase II|Protocol Violation|0|||
150153984|NCT01154036|541699611|FG001|Phase II|Protocol Violation|0|||
150153985|NCT01154036|541699612|FG002|Phase II|Protocol Violation|0|||
150153986|NCT01154036|541699613|FG003|Phase II|Protocol Violation|0|||
150153987|NCT01154036|541699614|FG004|Phase II|Protocol Violation|1|||
150153988|NCT01154036|541699615|FG005|Phase II|Protocol Violation|2|||
150153989|NCT01154036|541699616|FG006|Phase II|Protocol Violation|0|||
150153990|NCT01154036|541699617|FG007|Phase II|Protocol Violation|0|||
149815170|NCT00386100|540454598|FG001|Overall Study|Withdrawal by Subject|31|||
149815171|NCT00386100|540454597|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
149815172|NCT00386100|540454598|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
149815173|NCT00386100|540454597|FG000|Overall Study|BMD <2.5|1|||
149815174|NCT00386100|540454598|FG001|Overall Study|BMD <2.5|0|||
149815175|NCT00386100|540454597|FG000|Overall Study|Consecutive elevated Hba1C|1|||
150153991|NCT01154036|541699610|FG000|Phase II|Withdrawal by Subject|0|||
150153992|NCT01154036|541699611|FG001|Phase II|Withdrawal by Subject|0|||
150153993|NCT01154036|541699612|FG002|Phase II|Withdrawal by Subject|0|||
150153994|NCT01154036|541699613|FG003|Phase II|Withdrawal by Subject|0|||
150153995|NCT01154036|541699614|FG004|Phase II|Withdrawal by Subject|4|||
150153996|NCT01154036|541699615|FG005|Phase II|Withdrawal by Subject|2|||
150153997|NCT01154036|541699616|FG006|Phase II|Withdrawal by Subject|5|||
150153998|NCT01154036|541699617|FG007|Phase II|Withdrawal by Subject|4|||
150153999|NCT04076020|541699618|FG000|Overall Study|Death|4|||
150154000|NCT04076020|541699619|FG001|Overall Study|Death|6|||
150154001|NCT04076020|541699618|FG000|Overall Study|Withdrawal by Subject|12|||
150154002|NCT04076020|541699619|FG001|Overall Study|Withdrawal by Subject|8|||
150154003|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
150154004|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
150154005|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
150154006|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
150154007|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
150154008|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
150154009|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
150154010|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
150154011|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
150154012|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
150154013|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
150154014|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
150154015|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
150154016|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
150154017|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
150154018|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
150154019|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
150154020|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
150154021|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
150154022|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
150154023|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
149815176|NCT00386100|540454598|FG001|Overall Study|Consecutive elevated Hba1C|0|||
150154024|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
150154025|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
150154026|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
150154027|NCT03230864|541699621|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
150154028|NCT03230864|541699622|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
149815177|NCT00386100|540454597|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
149815178|NCT00386100|540454598|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
149815179|NCT00386100|540454597|FG000|Overall Study|Laboratory findings|1|||
149815180|NCT00386100|540454598|FG001|Overall Study|Laboratory findings|0|||
149815181|NCT00386100|540454597|FG000|Overall Study|Participant's concern due to CPK levels|1|||
149815182|NCT00386100|540454598|FG001|Overall Study|Participant's concern due to CPK levels|0|||
149815183|NCT00386100|540454597|FG000|Overall Study|Participant moving out of state|2|||
149815184|NCT00386100|540454598|FG001|Overall Study|Participant moving out of state|0|||
149815185|NCT00386100|540454597|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
149815186|NCT00386100|540454598|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
149815187|NCT00386100|540454597|FG000|Overall Study|Didn't meet entry criteria|1|||
149815188|NCT00386100|540454598|FG001|Overall Study|Didn't meet entry criteria|1|||
149815189|NCT00386100|540454597|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
149815190|NCT00386100|540454598|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
149815191|NCT00386100|540454597|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
149815192|NCT00386100|540454598|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
149815193|NCT00386100|540454597|FG000|Overall Study|Bad metabolic control & patient security|1|||
149815194|NCT00386100|540454598|FG001|Overall Study|Bad metabolic control & patient security|0|||
149815195|NCT00386100|540454597|FG000|Overall Study|Bone loss by DXA bone scan|1|||
149815196|NCT00386100|540454598|FG001|Overall Study|Bone loss by DXA bone scan|0|||
149815197|NCT00386100|540454597|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
149815198|NCT00386100|540454598|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
149815199|NCT00386100|540454597|FG000|Overall Study|7.6% bone loss|1|||
149815200|NCT00386100|540454598|FG001|Overall Study|7.6% bone loss|0|||
149815201|NCT00386100|540454597|FG000|Overall Study|Osteoporosis|0|||
149815202|NCT00386100|540454598|FG001|Overall Study|Osteoporosis|1|||
149815203|NCT00386100|540454597|FG000|Overall Study|Positive pregnancy test|1|||
149815204|NCT00386100|540454598|FG001|Overall Study|Positive pregnancy test|3|||
149815205|NCT00386100|540454597|FG000|Overall Study|Out of country for 5 months|1|||
149815206|NCT00386100|540454598|FG001|Overall Study|Out of country for 5 months|0|||
150154029|NCT03230864|541699623|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
150154030|NCT03230864|541699624|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
149815207|NCT00386100|540454597|FG000|Overall Study|Hb1Ac >8%|0|||
149815208|NCT00386100|540454598|FG001|Overall Study|Hb1Ac >8%|1|||
149815209|NCT00386100|540454597|FG000|Overall Study|Participant randomized in error|1|||
149815210|NCT00386100|540454598|FG001|Overall Study|Participant randomized in error|0|||
149815211|NCT00849524|540454608|FG000|Overall Study|Lack of Efficacy|3|||
149815212|NCT01027884|540454614|FG000|Overall Study|Adverse Event|2|||
149815213|NCT01027884|540454615|FG001|Overall Study|Adverse Event|1|||
149815214|NCT01027884|540454614|FG000|Overall Study|Protocol Violation|1|||
149815215|NCT01027884|540454615|FG001|Overall Study|Protocol Violation|0|||
149815216|NCT01027884|540454614|FG000|Overall Study|Non-compliance|1|||
149815217|NCT01027884|540454615|FG001|Overall Study|Non-compliance|1|||
149815218|NCT01027884|540454614|FG000|Overall Study|Withdrawal by Subject|0|||
149815219|NCT01027884|540454615|FG001|Overall Study|Withdrawal by Subject|1|||
149815220|NCT01027884|540454614|FG000|Overall Study|Lost to Follow-up|0|||
149815221|NCT01027884|540454615|FG001|Overall Study|Lost to Follow-up|1|||
149815222|NCT01027884|540454614|FG000|Overall Study|Spinal fixation surgery|0|||
149815223|NCT01027884|540454615|FG001|Overall Study|Spinal fixation surgery|3|||
150154031|NCT03230864|541699621|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
150154032|NCT03230864|541699622|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
150154033|NCT03230864|541699623|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
150154034|NCT03230864|541699624|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
150154035|NCT03230864|541699621|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149815224|NCT03670537|540454617|FG000|Overall Study|Protocol Violation|1|||
149815225|NCT02624518|540454618|FG000|Overall Study|Physician Decision|1|||
149815226|NCT02729194|540454619|FG000|Overall Study|Withdrawal by Subject|3|||
149815227|NCT01256398|540454620|FG000|Overall Study|Withdrawal by Subject|1|||
149815228|NCT04380701|540454621|FG000|Overall Study|Pregnancy|0|||
150154036|NCT03230864|541699622|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149815229|NCT04380701|540454622|FG001|Overall Study|Pregnancy|0|||
149815230|NCT04380701|540454623|FG002|Overall Study|Pregnancy|0|||
149815231|NCT04380701|540454624|FG003|Overall Study|Pregnancy|0|||
149815232|NCT04380701|540454625|FG004|Overall Study|Pregnancy|0|||
149815233|NCT04380701|540454626|FG005|Overall Study|Pregnancy|0|||
149815234|NCT04380701|540454627|FG006|Overall Study|Pregnancy|0|||
149815235|NCT04380701|540454628|FG007|Overall Study|Pregnancy|0|||
149918926|NCT00422292|540835250|FG000|Overall Study|Serious adverse events|1|||
150154037|NCT03230864|541699623|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
150154038|NCT03230864|541699624|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
150154039|NCT03230864|541699621|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
150154040|NCT03230864|541699622|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
150154041|NCT03230864|541699623|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
150154042|NCT03230864|541699624|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
150154043|NCT00432679|541699625|FG000|Overall Study|Adverse Event|2|||
150154044|NCT00432679|541699626|FG001|Overall Study|Adverse Event|1|||
150154045|NCT00432679|541699625|FG000|Overall Study|Withdrawal by Subject|3|||
150154046|NCT00432679|541699626|FG001|Overall Study|Withdrawal by Subject|2|||
150154047|NCT02056119|541699627|FG000|Overall Study|Death|1|||
150154048|NCT02056119|541699628|FG001|Overall Study|Death|2|||
150154049|NCT02056119|541699627|FG000|Overall Study|Intubated for less than 24 hrs|2|||
150154050|NCT02056119|541699628|FG001|Overall Study|Intubated for less than 24 hrs|7|||
150154051|NCT02056119|541699627|FG000|Overall Study|No aerosol treatments were given.|3|||
150154052|NCT02056119|541699628|FG001|Overall Study|No aerosol treatments were given.|2|||
150154053|NCT02056119|541699627|FG000|Overall Study|Received Metaneb treatment|0|||
150154054|NCT02056119|541699628|FG001|Overall Study|Received Metaneb treatment|2|||
150154055|NCT02056119|541699627|FG000|Overall Study|Protocol Violation|4|||
150154056|NCT02056119|541699628|FG001|Overall Study|Protocol Violation|7|||
150154057|NCT03220737|541699629|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
150154058|NCT03220737|541699630|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
150154059|NCT03220737|541699631|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
150154060|NCT03220737|541699632|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
150154061|NCT03220737|541699633|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
150154062|NCT03220737|541699634|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
150154063|NCT03220737|541699635|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
150154064|NCT03220737|541699629|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
150154065|NCT03220737|541699630|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
150154066|NCT03220737|541699631|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
150154067|NCT03220737|541699632|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
149815236|NCT04380701|540454629|FG008|Overall Study|Pregnancy|0|||
149815237|NCT04380701|540454630|FG009|Overall Study|Pregnancy|0|||
149815238|NCT04380701|540454631|FG010|Overall Study|Pregnancy|0|||
149815239|NCT04380701|540454632|FG011|Overall Study|Pregnancy|0|||
149815240|NCT04380701|540454633|FG012|Overall Study|Pregnancy|0|||
149815241|NCT04380701|540454634|FG013|Overall Study|Pregnancy|0|||
149815242|NCT04380701|540454635|FG014|Overall Study|Pregnancy|0|||
149815243|NCT04380701|540454636|FG015|Overall Study|Pregnancy|0|||
149815244|NCT04380701|540454637|FG016|Overall Study|Pregnancy|0|||
149815245|NCT04380701|540454638|FG017|Overall Study|Pregnancy|0|||
149815246|NCT04380701|540454639|FG018|Overall Study|Pregnancy|0|||
149815247|NCT04380701|540454640|FG019|Overall Study|Pregnancy|0|||
149815248|NCT04380701|540454641|FG020|Overall Study|Pregnancy|0|||
149815249|NCT04380701|540454642|FG021|Overall Study|Pregnancy|0|||
149815250|NCT04380701|540454643|FG022|Overall Study|Pregnancy|0|||
149815251|NCT04380701|540454644|FG023|Overall Study|Pregnancy|0|||
149815252|NCT04380701|540454645|FG024|Overall Study|Pregnancy|0|||
149815253|NCT04380701|540454646|FG025|Overall Study|Pregnancy|0|||
149815254|NCT04380701|540454647|FG026|Overall Study|Pregnancy|0|||
149815255|NCT04380701|540454648|FG027|Overall Study|Pregnancy|0|||
149815256|NCT04380701|540454649|FG028|Overall Study|Pregnancy|0|||
149815257|NCT04380701|540454650|FG029|Overall Study|Pregnancy|0|||
149815258|NCT04380701|540454651|FG030|Overall Study|Pregnancy|0|||
149815259|NCT04380701|540454652|FG031|Overall Study|Pregnancy|0|||
149815260|NCT04380701|540454653|FG032|Overall Study|Pregnancy|1|||
149815261|NCT04380701|540454654|FG033|Overall Study|Pregnancy|0|||
149815262|NCT04380701|540454621|FG000|Overall Study|Lost to Follow-up|0|||
149815263|NCT04380701|540454622|FG001|Overall Study|Lost to Follow-up|0|||
149815264|NCT04380701|540454623|FG002|Overall Study|Lost to Follow-up|0|||
150154068|NCT03220737|541699633|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
150154069|NCT03220737|541699634|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
150154070|NCT03220737|541699635|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
150154071|NCT03220737|541699629|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
150154072|NCT03220737|541699630|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
150154073|NCT03220737|541699631|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
150154074|NCT03220737|541699632|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
150154075|NCT03220737|541699633|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
149815265|NCT04380701|540454624|FG003|Overall Study|Lost to Follow-up|0|||
149815266|NCT04380701|540454625|FG004|Overall Study|Lost to Follow-up|0|||
149815267|NCT04380701|540454626|FG005|Overall Study|Lost to Follow-up|0|||
149815268|NCT04380701|540454627|FG006|Overall Study|Lost to Follow-up|0|||
149815269|NCT04380701|540454628|FG007|Overall Study|Lost to Follow-up|0|||
149815270|NCT04380701|540454629|FG008|Overall Study|Lost to Follow-up|0|||
149815271|NCT04380701|540454630|FG009|Overall Study|Lost to Follow-up|0|||
149815272|NCT04380701|540454631|FG010|Overall Study|Lost to Follow-up|0|||
150154076|NCT03220737|541699634|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
150154077|NCT03220737|541699635|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
150154078|NCT03220737|541699629|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154079|NCT03220737|541699630|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154080|NCT03220737|541699631|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
150154081|NCT03220737|541699632|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154082|NCT03220737|541699633|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154083|NCT03220737|541699634|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154084|NCT03220737|541699635|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
150154085|NCT03220737|541699629|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154086|NCT03220737|541699630|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154087|NCT03220737|541699631|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154088|NCT03220737|541699632|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154089|NCT03220737|541699633|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
150154090|NCT03220737|541699634|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154091|NCT03220737|541699635|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
150154092|NCT03220737|541699629|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
150154093|NCT03220737|541699630|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
150154094|NCT03220737|541699631|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
150154095|NCT03220737|541699632|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
150154096|NCT03220737|541699633|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
150154097|NCT03220737|541699634|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
150154098|NCT03220737|541699635|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149815273|NCT04380701|540454632|FG011|Overall Study|Lost to Follow-up|0|||
149815274|NCT04380701|540454633|FG012|Overall Study|Lost to Follow-up|0|||
149815275|NCT04380701|540454634|FG013|Overall Study|Lost to Follow-up|0|||
149815276|NCT04380701|540454635|FG014|Overall Study|Lost to Follow-up|0|||
149815277|NCT04380701|540454636|FG015|Overall Study|Lost to Follow-up|0|||
149815278|NCT04380701|540454637|FG016|Overall Study|Lost to Follow-up|0|||
149815279|NCT04380701|540454638|FG017|Overall Study|Lost to Follow-up|0|||
149815280|NCT04380701|540454639|FG018|Overall Study|Lost to Follow-up|0|||
149815281|NCT04380701|540454640|FG019|Overall Study|Lost to Follow-up|0|||
149815282|NCT04380701|540454641|FG020|Overall Study|Lost to Follow-up|1|||
149815283|NCT04380701|540454642|FG021|Overall Study|Lost to Follow-up|0|||
149815284|NCT04380701|540454643|FG022|Overall Study|Lost to Follow-up|0|||
149815285|NCT04380701|540454644|FG023|Overall Study|Lost to Follow-up|1|||
149815286|NCT04380701|540454645|FG024|Overall Study|Lost to Follow-up|0|||
149815287|NCT04380701|540454646|FG025|Overall Study|Lost to Follow-up|0|||
149815288|NCT04380701|540454647|FG026|Overall Study|Lost to Follow-up|0|||
149815289|NCT04380701|540454648|FG027|Overall Study|Lost to Follow-up|0|||
149815290|NCT04380701|540454649|FG028|Overall Study|Lost to Follow-up|0|||
149815291|NCT04380701|540454650|FG029|Overall Study|Lost to Follow-up|1|||
149815292|NCT04380701|540454651|FG030|Overall Study|Lost to Follow-up|0|||
149815293|NCT04380701|540454652|FG031|Overall Study|Lost to Follow-up|0|||
149815294|NCT04380701|540454653|FG032|Overall Study|Lost to Follow-up|0|||
149815295|NCT04380701|540454654|FG033|Overall Study|Lost to Follow-up|1|||
149815296|NCT04380701|540454621|FG000|Overall Study|Private reason(s)|0|||
149815297|NCT04380701|540454622|FG001|Overall Study|Private reason(s)|0|||
149815298|NCT04380701|540454623|FG002|Overall Study|Private reason(s)|0|||
149815299|NCT04380701|540454624|FG003|Overall Study|Private reason(s)|0|||
149815300|NCT04380701|540454625|FG004|Overall Study|Private reason(s)|0|||
149815301|NCT04380701|540454626|FG005|Overall Study|Private reason(s)|0|||
149815302|NCT04380701|540454627|FG006|Overall Study|Private reason(s)|1|||
149815303|NCT04380701|540454628|FG007|Overall Study|Private reason(s)|0|||
149815304|NCT04380701|540454629|FG008|Overall Study|Private reason(s)|1|||
149815305|NCT04380701|540454630|FG009|Overall Study|Private reason(s)|1|||
149815306|NCT04380701|540454631|FG010|Overall Study|Private reason(s)|0|||
149815307|NCT04380701|540454632|FG011|Overall Study|Private reason(s)|0|||
150154099|NCT03220737|541699629|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
150154100|NCT03220737|541699630|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
150154101|NCT03220737|541699631|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
150154102|NCT03220737|541699632|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149815308|NCT04380701|540454633|FG012|Overall Study|Private reason(s)|0|||
149815309|NCT04380701|540454634|FG013|Overall Study|Private reason(s)|0|||
149815310|NCT04380701|540454635|FG014|Overall Study|Private reason(s)|0|||
149815311|NCT04380701|540454636|FG015|Overall Study|Private reason(s)|0|||
149815312|NCT04380701|540454637|FG016|Overall Study|Private reason(s)|0|||
149815313|NCT04380701|540454638|FG017|Overall Study|Private reason(s)|0|||
149815314|NCT04380701|540454639|FG018|Overall Study|Private reason(s)|0|||
149815315|NCT04380701|540454640|FG019|Overall Study|Private reason(s)|0|||
149815316|NCT04380701|540454641|FG020|Overall Study|Private reason(s)|0|||
149815317|NCT04380701|540454642|FG021|Overall Study|Private reason(s)|0|||
149815318|NCT04380701|540454643|FG022|Overall Study|Private reason(s)|0|||
149815319|NCT04380701|540454644|FG023|Overall Study|Private reason(s)|1|||
149815320|NCT04380701|540454645|FG024|Overall Study|Private reason(s)|0|||
149815321|NCT04380701|540454646|FG025|Overall Study|Private reason(s)|0|||
149815322|NCT04380701|540454647|FG026|Overall Study|Private reason(s)|0|||
150154103|NCT03220737|541699633|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
150154104|NCT03220737|541699634|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
150154105|NCT03220737|541699635|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
150154106|NCT03220737|541699629|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
150154107|NCT03220737|541699630|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154108|NCT03220737|541699631|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154109|NCT03220737|541699632|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154110|NCT03220737|541699633|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154111|NCT03220737|541699634|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154112|NCT03220737|541699635|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
150154113|NCT01316692|541699636|FG000|Overall Study|Adverse Event|5|||
150154114|NCT01316692|541699636|FG000|Overall Study|Disease Progression|7|||
150154115|NCT01686932|541699641|FG000|Period 1|Adverse Event|1|||
150154116|NCT01686932|541699642|FG001|Period 1|Adverse Event|1|||
150154117|NCT01284140|541699644|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
150154118|NCT01284140|541699645|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
150154119|NCT01284140|541699644|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
150154120|NCT01284140|541699645|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
150154121|NCT03044353|541699646|FG000|Overall Study|Adverse Event|0|||
150154122|NCT03044353|541699647|FG001|Overall Study|Adverse Event|1|||
150154123|NCT03044353|541699648|FG002|Overall Study|Adverse Event|0|||
150154124|NCT01313923|541699656|FG000|Overall Study|Physician Decision|3|||
150154125|NCT01388530|541699657|FG000|Overall Study|Lost to Follow-up|5|||
150154126|NCT05284019|541699658|FG000|Overall Study|Study terminated|2|||
150154127|NCT05284019|541699659|FG001|Overall Study|Study terminated|2|||
150154128|NCT05284019|541699660|FG002|Overall Study|Study terminated|2|||
150154129|NCT05284019|541699661|FG003|Overall Study|Study terminated|5|||
150154130|NCT05284019|541699662|FG004|Overall Study|Study terminated|15|||
150154131|NCT05284019|541699658|FG000|Overall Study|Withdrawal by Subject|0|||
150154132|NCT05284019|541699659|FG001|Overall Study|Withdrawal by Subject|0|||
150154133|NCT05284019|541699660|FG002|Overall Study|Withdrawal by Subject|0|||
150154134|NCT05284019|541699661|FG003|Overall Study|Withdrawal by Subject|1|||
150154135|NCT05284019|541699662|FG004|Overall Study|Withdrawal by Subject|1|||
150154136|NCT05284019|541699658|FG000|Overall Study|Lost to Follow-up|1|||
150154137|NCT05284019|541699659|FG001|Overall Study|Lost to Follow-up|0|||
150154138|NCT05284019|541699660|FG002|Overall Study|Lost to Follow-up|0|||
150154139|NCT05284019|541699661|FG003|Overall Study|Lost to Follow-up|2|||
150154140|NCT05284019|541699662|FG004|Overall Study|Lost to Follow-up|1|||
150154141|NCT02420327|541699663|FG000|Overall Study|Adverse Event|7|||
150154142|NCT02420327|541699663|FG000|Overall Study|Pregnancy|1|||
150154143|NCT02420327|541699663|FG000|Overall Study|Withdrawal by Subject|6|||
150154144|NCT02420327|541699663|FG000|Overall Study|Lost to Follow-up|1|||
150154145|NCT02420327|541699663|FG000|Overall Study|Protocol Violation|1|||
150154146|NCT01990300|541699664|FG000|Overall Study|Case Report Forms Uncollected|89|||
150154147|NCT01990300|541699664|FG000|Overall Study|Protocol Deviation|53|||
150154148|NCT01231503|541699665|FG000|Overall Study|Adverse Event|0|||
150154149|NCT01231503|541699666|FG001|Overall Study|Adverse Event|0|||
150154150|NCT01231503|541699667|FG002|Overall Study|Adverse Event|0|||
150154151|NCT01231503|541699668|FG003|Overall Study|Adverse Event|0|||
150154152|NCT01231503|541699669|FG004|Overall Study|Adverse Event|0|||
150154153|NCT01231503|541699670|FG005|Overall Study|Adverse Event|1|||
150154154|NCT01231503|541699671|FG006|Overall Study|Adverse Event|0|||
150154155|NCT01231503|541699672|FG007|Overall Study|Adverse Event|0|||
150154156|NCT01231503|541699665|FG000|Overall Study|Adverse event, serious fatal|0|||
150154157|NCT01231503|541699666|FG001|Overall Study|Adverse event, serious fatal|0|||
150154158|NCT01231503|541699667|FG002|Overall Study|Adverse event, serious fatal|1|||
150154159|NCT01231503|541699668|FG003|Overall Study|Adverse event, serious fatal|1|||
150154160|NCT01231503|541699669|FG004|Overall Study|Adverse event, serious fatal|0|||
150154161|NCT01231503|541699670|FG005|Overall Study|Adverse event, serious fatal|1|||
150154162|NCT01231503|541699671|FG006|Overall Study|Adverse event, serious fatal|0|||
150154163|NCT01231503|541699672|FG007|Overall Study|Adverse event, serious fatal|0|||
150154164|NCT01231503|541699665|FG000|Overall Study|Withdrawal by Subject|6|||
150154165|NCT01231503|541699666|FG001|Overall Study|Withdrawal by Subject|3|||
150154166|NCT01231503|541699667|FG002|Overall Study|Withdrawal by Subject|3|||
150154167|NCT01231503|541699668|FG003|Overall Study|Withdrawal by Subject|1|||
150154168|NCT01231503|541699669|FG004|Overall Study|Withdrawal by Subject|3|||
150154169|NCT01231503|541699670|FG005|Overall Study|Withdrawal by Subject|5|||
150154170|NCT01231503|541699671|FG006|Overall Study|Withdrawal by Subject|1|||
150154171|NCT01231503|541699672|FG007|Overall Study|Withdrawal by Subject|2|||
150154172|NCT01231503|541699665|FG000|Overall Study|Lost to Follow-up|8|||
150154173|NCT01231503|541699666|FG001|Overall Study|Lost to Follow-up|10|||
150154174|NCT01231503|541699667|FG002|Overall Study|Lost to Follow-up|8|||
150154175|NCT01231503|541699668|FG003|Overall Study|Lost to Follow-up|5|||
150154176|NCT01231503|541699669|FG004|Overall Study|Lost to Follow-up|7|||
150154177|NCT01231503|541699670|FG005|Overall Study|Lost to Follow-up|9|||
150154178|NCT01231503|541699671|FG006|Overall Study|Lost to Follow-up|6|||
150154179|NCT01231503|541699672|FG007|Overall Study|Lost to Follow-up|6|||
150154180|NCT01231503|541699665|FG000|Overall Study|Protocol Violation|0|||
150154181|NCT01231503|541699666|FG001|Overall Study|Protocol Violation|0|||
150154182|NCT01231503|541699667|FG002|Overall Study|Protocol Violation|0|||
150154183|NCT01231503|541699668|FG003|Overall Study|Protocol Violation|1|||
150154184|NCT01231503|541699669|FG004|Overall Study|Protocol Violation|0|||
150154185|NCT01231503|541699670|FG005|Overall Study|Protocol Violation|0|||
150154186|NCT01231503|541699671|FG006|Overall Study|Protocol Violation|0|||
150154187|NCT01231503|541699672|FG007|Overall Study|Protocol Violation|0|||
150154188|NCT01225835|541699673|FG000|Overall Study|Completed protocol|2|||
150154189|NCT01225835|541699674|FG001|Overall Study|Completed protocol|1|||
150154190|NCT01225835|541699673|FG000|Overall Study|Did not meet hCG criterion|2|||
150154191|NCT01225835|541699674|FG001|Overall Study|Did not meet hCG criterion|0|||
150154192|NCT01225835|541699673|FG000|Overall Study|Adverse Event|2|||
150154193|NCT01225835|541699674|FG001|Overall Study|Adverse Event|1|||
150154194|NCT01225835|541699673|FG000|Overall Study|Other|1|||
150154195|NCT01225835|541699674|FG001|Overall Study|Other|1|||
150154196|NCT01146574|541699677|FG000|Overall Study|Death|0|||
150154197|NCT01146574|541699678|FG001|Overall Study|Death|1|||
150154198|NCT01146574|541699679|FG002|Overall Study|Death|1|||
150154199|NCT01146574|541699680|FG003|Overall Study|Death|0|||
150154200|NCT01146574|541699681|FG004|Overall Study|Death|0|||
150154201|NCT01146574|541699682|FG005|Overall Study|Death|0|||
150154202|NCT01146574|541699683|FG006|Overall Study|Death|0|||
150154203|NCT01146574|541699677|FG000|Overall Study|Other reasons|0|||
150154204|NCT01146574|541699678|FG001|Overall Study|Other reasons|0|||
150154205|NCT01146574|541699679|FG002|Overall Study|Other reasons|3|||
150154206|NCT01146574|541699680|FG003|Overall Study|Other reasons|0|||
150154207|NCT01146574|541699681|FG004|Overall Study|Other reasons|0|||
150154208|NCT01146574|541699682|FG005|Overall Study|Other reasons|0|||
150154209|NCT01146574|541699683|FG006|Overall Study|Other reasons|0|||
150154210|NCT01146574|541699677|FG000|Overall Study|Kidney transplant|0|||
150154211|NCT01146574|541699678|FG001|Overall Study|Kidney transplant|0|||
150154212|NCT01146574|541699679|FG002|Overall Study|Kidney transplant|1|||
150154213|NCT01146574|541699680|FG003|Overall Study|Kidney transplant|1|||
150154214|NCT01146574|541699681|FG004|Overall Study|Kidney transplant|0|||
150154215|NCT01146574|541699682|FG005|Overall Study|Kidney transplant|0|||
150154216|NCT01146574|541699683|FG006|Overall Study|Kidney transplant|0|||
150154217|NCT01146574|541699677|FG000|Overall Study|Withdrew consent|0|||
150154218|NCT01146574|541699678|FG001|Overall Study|Withdrew consent|0|||
150154219|NCT01146574|541699679|FG002|Overall Study|Withdrew consent|1|||
150154220|NCT01146574|541699680|FG003|Overall Study|Withdrew consent|1|||
150154221|NCT01146574|541699681|FG004|Overall Study|Withdrew consent|2|||
150154222|NCT01146574|541699682|FG005|Overall Study|Withdrew consent|1|||
150154223|NCT01146574|541699683|FG006|Overall Study|Withdrew consent|1|||
150154224|NCT02589392|541699684|FG000|Overall Study|Adverse Event|1|||
150154225|NCT02589392|541699685|FG001|Overall Study|Adverse Event|1|||
150154226|NCT02589392|541699684|FG000|Overall Study|Withdrawal by Subject|1|||
150154227|NCT02589392|541699685|FG001|Overall Study|Withdrawal by Subject|2|||
150154228|NCT02589392|541699684|FG000|Overall Study|Protocol Violation|1|||
150154229|NCT02589392|541699685|FG001|Overall Study|Protocol Violation|1|||
150154230|NCT02589392|541699684|FG000|Overall Study|Lost to Follow-up|2|||
150154231|NCT02589392|541699685|FG001|Overall Study|Lost to Follow-up|2|||
150154232|NCT02589392|541699684|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
150154233|NCT02589392|541699685|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
150154234|NCT02293837|541699686|FG000|Overall Study|Lost to Follow-up|0|||
150154235|NCT02293837|541699687|FG001|Overall Study|Lost to Follow-up|2|||
150154236|NCT02293837|541699688|FG002|Overall Study|Lost to Follow-up|1|||
150154237|NCT02293837|541699689|FG003|Overall Study|Lost to Follow-up|0|||
150154238|NCT02293837|541699686|FG000|Overall Study|Withdrawal by Subject|2|||
150154239|NCT02293837|541699687|FG001|Overall Study|Withdrawal by Subject|1|||
150154240|NCT02293837|541699688|FG002|Overall Study|Withdrawal by Subject|2|||
150154241|NCT02293837|541699689|FG003|Overall Study|Withdrawal by Subject|1|||
150154242|NCT02293837|541699686|FG000|Overall Study|COVID-19 Related|1|||
150154243|NCT02293837|541699687|FG001|Overall Study|COVID-19 Related|1|||
150154244|NCT02293837|541699688|FG002|Overall Study|COVID-19 Related|0|||
150154245|NCT02293837|541699689|FG003|Overall Study|COVID-19 Related|0|||
150154246|NCT02293837|541699686|FG000|Overall Study|Participant ill and could not be infused|0|||
150154247|NCT02293837|541699687|FG001|Overall Study|Participant ill and could not be infused|0|||
150154248|NCT02293837|541699688|FG002|Overall Study|Participant ill and could not be infused|1|||
150154249|NCT02293837|541699689|FG003|Overall Study|Participant ill and could not be infused|0|||
150154250|NCT04779242|541699690|FG000|Overall Study|Adverse Event|1|||
150154251|NCT04779242|541699691|FG001|Overall Study|Adverse Event|1|||
150154252|NCT04779242|541699690|FG000|Overall Study|Lost to Follow-up|2|||
150154253|NCT04779242|541699691|FG001|Overall Study|Lost to Follow-up|4|||
150154254|NCT04779242|541699690|FG000|Overall Study|Withdrawal by Subject|7|||
150154255|NCT04779242|541699691|FG001|Overall Study|Withdrawal by Subject|9|||
150154256|NCT04779242|541699690|FG000|Overall Study|Death|6|||
150154257|NCT04779242|541699691|FG001|Overall Study|Death|6|||
150154258|NCT04779242|541699690|FG000|Overall Study|COVID-19 related reasons|2|||
150154259|NCT04779242|541699691|FG001|Overall Study|COVID-19 related reasons|1|||
150154260|NCT04779242|541699690|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
150154261|NCT04779242|541699691|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
150154262|NCT04779242|541699690|FG000|Overall Study|Martial Law in Ukraine|2|||
150154263|NCT04779242|541699691|FG001|Overall Study|Martial Law in Ukraine|3|||
150154264|NCT01076088|541699694|FG000|Overall Study|Adverse Event|1|||
150154265|NCT01076088|541699695|FG001|Overall Study|Adverse Event|6|||
150154266|NCT01076088|541699696|FG002|Overall Study|Adverse Event|3|||
150154267|NCT01076088|541699697|FG003|Overall Study|Adverse Event|2|||
150154268|NCT01076088|541699698|FG004|Overall Study|Adverse Event|3|||
150154269|NCT01076088|541699699|FG005|Overall Study|Adverse Event|3|||
150154270|NCT01076088|541699694|FG000|Overall Study|Lost to Follow-up|1|||
150154271|NCT01076088|541699695|FG001|Overall Study|Lost to Follow-up|1|||
150154272|NCT01076088|541699696|FG002|Overall Study|Lost to Follow-up|0|||
150154273|NCT01076088|541699697|FG003|Overall Study|Lost to Follow-up|1|||
150154274|NCT01076088|541699698|FG004|Overall Study|Lost to Follow-up|1|||
150154275|NCT01076088|541699699|FG005|Overall Study|Lost to Follow-up|2|||
150154276|NCT01076088|541699694|FG000|Overall Study|Non-compliance with study drug|0|||
150154277|NCT01076088|541699695|FG001|Overall Study|Non-compliance with study drug|0|||
150154278|NCT01076088|541699696|FG002|Overall Study|Non-compliance with study drug|0|||
150154279|NCT01076088|541699697|FG003|Overall Study|Non-compliance with study drug|1|||
150154280|NCT01076088|541699698|FG004|Overall Study|Non-compliance with study drug|0|||
150154281|NCT01076088|541699699|FG005|Overall Study|Non-compliance with study drug|0|||
150154282|NCT01076088|541699694|FG000|Overall Study|Physician Decision|1|||
150154283|NCT01076088|541699695|FG001|Overall Study|Physician Decision|3|||
150154284|NCT01076088|541699696|FG002|Overall Study|Physician Decision|0|||
150154285|NCT01076088|541699697|FG003|Overall Study|Physician Decision|1|||
150154286|NCT01076088|541699698|FG004|Overall Study|Physician Decision|1|||
150154287|NCT01076088|541699699|FG005|Overall Study|Physician Decision|0|||
150154288|NCT01076088|541699694|FG000|Overall Study|Withdrawal by Subject|8|||
149815323|NCT04380701|540454648|FG027|Overall Study|Private reason(s)|0|||
149815324|NCT04380701|540454649|FG028|Overall Study|Private reason(s)|0|||
149815325|NCT04380701|540454650|FG029|Overall Study|Private reason(s)|1|||
149815326|NCT04380701|540454651|FG030|Overall Study|Private reason(s)|0|||
149815327|NCT04380701|540454652|FG031|Overall Study|Private reason(s)|0|||
149815328|NCT04380701|540454653|FG032|Overall Study|Private reason(s)|0|||
149815329|NCT04380701|540454654|FG033|Overall Study|Private reason(s)|0|||
150154289|NCT01076088|541699695|FG001|Overall Study|Withdrawal by Subject|8|||
150154290|NCT01076088|541699696|FG002|Overall Study|Withdrawal by Subject|14|||
150154291|NCT01076088|541699697|FG003|Overall Study|Withdrawal by Subject|10|||
150154292|NCT01076088|541699698|FG004|Overall Study|Withdrawal by Subject|11|||
150154293|NCT01076088|541699699|FG005|Overall Study|Withdrawal by Subject|17|||
150154294|NCT01076088|541699694|FG000|Overall Study|Other protocol specified criteria|0|||
150154295|NCT01076088|541699695|FG001|Overall Study|Other protocol specified criteria|0|||
150154296|NCT01076088|541699696|FG002|Overall Study|Other protocol specified criteria|0|||
150154297|NCT01076088|541699697|FG003|Overall Study|Other protocol specified criteria|0|||
150154298|NCT01076088|541699698|FG004|Overall Study|Other protocol specified criteria|0|||
150154299|NCT01076088|541699699|FG005|Overall Study|Other protocol specified criteria|1|||
150154300|NCT03053492|541699702|FG000|Overall Study|Adverse Event|1|||
150154301|NCT03053492|541699703|FG001|Overall Study|Adverse Event|1|||
150154302|NCT03053492|541699702|FG000|Overall Study|Withdrawal by Subject|7|||
150154303|NCT03053492|541699703|FG001|Overall Study|Withdrawal by Subject|5|||
150154304|NCT02087150|541699704|FG000|Overall Study|Death|0|||
150154305|NCT02087150|541699705|FG001|Overall Study|Death|1|||
149815330|NCT04380701|540454621|FG000|Overall Study|Withdrawal by Subject|0|||
150154306|NCT02087150|541699706|FG002|Overall Study|Death|0|||
150154307|NCT02087150|541699704|FG000|Overall Study|Lost to Follow-up|6|||
150154308|NCT02087150|541699705|FG001|Overall Study|Lost to Follow-up|13|||
150154309|NCT02087150|541699706|FG002|Overall Study|Lost to Follow-up|7|||
150154310|NCT02087150|541699704|FG000|Overall Study|Withdrawal by Subject|2|||
150154311|NCT02087150|541699705|FG001|Overall Study|Withdrawal by Subject|5|||
150154312|NCT02087150|541699706|FG002|Overall Study|Withdrawal by Subject|3|||
150154313|NCT02087150|541699704|FG000|Overall Study|Physician Decision|0|||
150154314|NCT02087150|541699705|FG001|Overall Study|Physician Decision|1|||
150154315|NCT02087150|541699706|FG002|Overall Study|Physician Decision|0|||
150154316|NCT02087150|541699704|FG000|Overall Study|Procedure not done|1|||
150154317|NCT02087150|541699705|FG001|Overall Study|Procedure not done|13|||
150154318|NCT02087150|541699706|FG002|Overall Study|Procedure not done|0|||
150154319|NCT02087150|541699704|FG000|Overall Study|F/U not completed w/in study window|0|||
150154320|NCT02087150|541699705|FG001|Overall Study|F/U not completed w/in study window|0|||
150154321|NCT02087150|541699706|FG002|Overall Study|F/U not completed w/in study window|1|||
150154322|NCT02087150|541699704|FG000|Overall Study|Other|1|||
150154323|NCT02087150|541699705|FG001|Overall Study|Other|0|||
149815331|NCT04380701|540454622|FG001|Overall Study|Withdrawal by Subject|0|||
149815332|NCT04380701|540454623|FG002|Overall Study|Withdrawal by Subject|0|||
149815333|NCT04380701|540454624|FG003|Overall Study|Withdrawal by Subject|0|||
149815334|NCT04380701|540454625|FG004|Overall Study|Withdrawal by Subject|0|||
149815335|NCT04380701|540454626|FG005|Overall Study|Withdrawal by Subject|0|||
149815336|NCT04380701|540454627|FG006|Overall Study|Withdrawal by Subject|1|||
149815337|NCT04380701|540454628|FG007|Overall Study|Withdrawal by Subject|1|||
149815338|NCT04380701|540454629|FG008|Overall Study|Withdrawal by Subject|0|||
149815339|NCT04380701|540454630|FG009|Overall Study|Withdrawal by Subject|0|||
149815340|NCT04380701|540454631|FG010|Overall Study|Withdrawal by Subject|0|||
149815341|NCT04380701|540454632|FG011|Overall Study|Withdrawal by Subject|1|||
149815342|NCT04380701|540454633|FG012|Overall Study|Withdrawal by Subject|0|||
149815343|NCT04380701|540454634|FG013|Overall Study|Withdrawal by Subject|1|||
149815344|NCT04380701|540454635|FG014|Overall Study|Withdrawal by Subject|0|||
149815345|NCT04380701|540454636|FG015|Overall Study|Withdrawal by Subject|0|||
149815346|NCT04380701|540454637|FG016|Overall Study|Withdrawal by Subject|1|||
149815347|NCT04380701|540454638|FG017|Overall Study|Withdrawal by Subject|0|||
149815348|NCT04380701|540454639|FG018|Overall Study|Withdrawal by Subject|0|||
149815349|NCT04380701|540454640|FG019|Overall Study|Withdrawal by Subject|0|||
149815350|NCT04380701|540454641|FG020|Overall Study|Withdrawal by Subject|0|||
149815351|NCT04380701|540454642|FG021|Overall Study|Withdrawal by Subject|0|||
149815352|NCT04380701|540454643|FG022|Overall Study|Withdrawal by Subject|2|||
149815353|NCT04380701|540454644|FG023|Overall Study|Withdrawal by Subject|2|||
149815354|NCT04380701|540454645|FG024|Overall Study|Withdrawal by Subject|1|||
149815355|NCT04380701|540454646|FG025|Overall Study|Withdrawal by Subject|1|||
149815356|NCT04380701|540454647|FG026|Overall Study|Withdrawal by Subject|0|||
149815357|NCT04380701|540454648|FG027|Overall Study|Withdrawal by Subject|0|||
149815358|NCT04380701|540454649|FG028|Overall Study|Withdrawal by Subject|0|||
149815359|NCT04380701|540454650|FG029|Overall Study|Withdrawal by Subject|0|||
149815360|NCT04380701|540454651|FG030|Overall Study|Withdrawal by Subject|0|||
149815361|NCT04380701|540454652|FG031|Overall Study|Withdrawal by Subject|0|||
149815362|NCT04380701|540454653|FG032|Overall Study|Withdrawal by Subject|0|||
149815363|NCT04380701|540454654|FG033|Overall Study|Withdrawal by Subject|0|||
149815364|NCT04380701|540454621|FG000|Overall Study|Adverse Event|0|||
149815365|NCT04380701|540454622|FG001|Overall Study|Adverse Event|0|||
149815366|NCT04380701|540454623|FG002|Overall Study|Adverse Event|0|||
149815367|NCT04380701|540454624|FG003|Overall Study|Adverse Event|0|||
149815368|NCT04380701|540454625|FG004|Overall Study|Adverse Event|0|||
149815369|NCT04380701|540454626|FG005|Overall Study|Adverse Event|1|||
149815370|NCT04380701|540454627|FG006|Overall Study|Adverse Event|0|||
149815371|NCT04380701|540454628|FG007|Overall Study|Adverse Event|0|||
149815372|NCT04380701|540454629|FG008|Overall Study|Adverse Event|0|||
149815373|NCT04380701|540454630|FG009|Overall Study|Adverse Event|0|||
149815374|NCT04380701|540454631|FG010|Overall Study|Adverse Event|0|||
149815375|NCT04380701|540454632|FG011|Overall Study|Adverse Event|0|||
149815376|NCT04380701|540454633|FG012|Overall Study|Adverse Event|0|||
149815377|NCT04380701|540454634|FG013|Overall Study|Adverse Event|0|||
149815378|NCT04380701|540454635|FG014|Overall Study|Adverse Event|0|||
149815379|NCT04380701|540454636|FG015|Overall Study|Adverse Event|1|||
149815380|NCT04380701|540454637|FG016|Overall Study|Adverse Event|0|||
149815381|NCT04380701|540454638|FG017|Overall Study|Adverse Event|0|||
149815382|NCT04380701|540454639|FG018|Overall Study|Adverse Event|0|||
149815383|NCT04380701|540454640|FG019|Overall Study|Adverse Event|1|||
149815384|NCT04380701|540454641|FG020|Overall Study|Adverse Event|0|||
149815385|NCT04380701|540454642|FG021|Overall Study|Adverse Event|0|||
149815386|NCT04380701|540454643|FG022|Overall Study|Adverse Event|0|||
149815387|NCT04380701|540454644|FG023|Overall Study|Adverse Event|0|||
149815388|NCT04380701|540454645|FG024|Overall Study|Adverse Event|0|||
150154324|NCT02087150|541699706|FG002|Overall Study|Other|0|||
150154325|NCT02087150|541699704|FG000|Overall Study|Pt moved out of town|0|||
150154326|NCT02087150|541699705|FG001|Overall Study|Pt moved out of town|1|||
149815389|NCT04380701|540454646|FG025|Overall Study|Adverse Event|0|||
149815390|NCT04380701|540454647|FG026|Overall Study|Adverse Event|0|||
149815391|NCT04380701|540454648|FG027|Overall Study|Adverse Event|0|||
149815392|NCT04380701|540454649|FG028|Overall Study|Adverse Event|0|||
149815393|NCT04380701|540454650|FG029|Overall Study|Adverse Event|0|||
149815394|NCT04380701|540454651|FG030|Overall Study|Adverse Event|0|||
149815395|NCT04380701|540454652|FG031|Overall Study|Adverse Event|0|||
150154327|NCT02087150|541699706|FG002|Overall Study|Pt moved out of town|0|||
150154328|NCT00683449|541699709|FG000|Overall Study|Lost to Follow-up|0|||
149815396|NCT04380701|540454653|FG032|Overall Study|Adverse Event|0|||
149815397|NCT04380701|540454654|FG033|Overall Study|Adverse Event|0|||
149815398|NCT04380701|540454621|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
149815399|NCT04380701|540454622|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
149815400|NCT04380701|540454623|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
149815401|NCT04380701|540454624|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
149815402|NCT04380701|540454625|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
149815403|NCT04380701|540454626|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
149815404|NCT04380701|540454627|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
150154329|NCT00683449|541699710|FG001|Overall Study|Lost to Follow-up|1|||
150154330|NCT00683449|541699711|FG002|Overall Study|Lost to Follow-up|0|||
150154331|NCT00683449|541699712|FG003|Overall Study|Lost to Follow-up|0|||
150154332|NCT00683449|541699713|FG004|Overall Study|Lost to Follow-up|0|||
150154333|NCT01448044|541699716|FG000|Treatment Period|Adverse Event|4|||
150154334|NCT01448044|541699717|FG001|Treatment Period|Adverse Event|3|||
150154335|NCT01448044|541699716|FG000|Treatment Period|Lack of Efficacy|5|||
150154336|NCT01448044|541699717|FG001|Treatment Period|Lack of Efficacy|12|||
150154337|NCT01448044|541699716|FG000|Treatment Period|Subject requested discontinue study drug|1|||
150154338|NCT01448044|541699717|FG001|Treatment Period|Subject requested discontinue study drug|0|||
150154339|NCT01448044|541699716|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
150154340|NCT01448044|541699717|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
150154341|NCT01448044|541699716|FG000|Treatment Period|Participant does not meet study criteria|1|||
150154342|NCT01448044|541699717|FG001|Treatment Period|Participant does not meet study criteria|0|||
150154343|NCT01448044|541699716|FG000|Treatment Period|Lost to Follow-up|2|||
150154344|NCT01448044|541699717|FG001|Treatment Period|Lost to Follow-up|1|||
150154345|NCT01448044|541699716|FG000|Treatment Period|Other reason|2|||
150154346|NCT01448044|541699717|FG001|Treatment Period|Other reason|0|||
150154347|NCT01448044|541699716|FG000|Follow Up Period|Withdrawal by Subject|1|||
150154348|NCT01448044|541699717|FG001|Follow Up Period|Withdrawal by Subject|1|||
150154349|NCT01448044|541699716|FG000|Follow Up Period|Lost to Follow-up|6|||
150154350|NCT01448044|541699717|FG001|Follow Up Period|Lost to Follow-up|2|||
150154351|NCT01448044|541699716|FG000|Follow Up Period|Other|5|||
150154352|NCT01448044|541699717|FG001|Follow Up Period|Other|11|||
150154353|NCT00507026|541699721|FG000|Overall Study|Lack of Efficacy|6|||
150154354|NCT00507026|541699722|FG001|Overall Study|Lack of Efficacy|4|||
150154355|NCT00507026|541699723|FG002|Overall Study|Lack of Efficacy|21|||
150154356|NCT00507026|541699721|FG000|Overall Study|Withdrawal by Subject|2|||
150154357|NCT00507026|541699722|FG001|Overall Study|Withdrawal by Subject|0|||
150154358|NCT00507026|541699723|FG002|Overall Study|Withdrawal by Subject|0|||
150154359|NCT00507026|541699721|FG000|Overall Study|Investigator Decision|1|||
150154360|NCT00507026|541699722|FG001|Overall Study|Investigator Decision|0|||
150154361|NCT00507026|541699723|FG002|Overall Study|Investigator Decision|0|||
150154362|NCT00507026|541699721|FG000|Overall Study|Adverse Event|2|||
150154363|NCT00507026|541699722|FG001|Overall Study|Adverse Event|0|||
150154364|NCT00507026|541699723|FG002|Overall Study|Adverse Event|0|||
150154365|NCT00507026|541699721|FG000|Overall Study|Protocol Violation|1|||
150154366|NCT00507026|541699722|FG001|Overall Study|Protocol Violation|0|||
150154367|NCT00507026|541699723|FG002|Overall Study|Protocol Violation|0|||
150154368|NCT00507026|541699721|FG000|Overall Study|Other|1|||
150154369|NCT00507026|541699722|FG001|Overall Study|Other|0|||
150154370|NCT00507026|541699723|FG002|Overall Study|Other|0|||
150154371|NCT00681187|541699724|FG000|Overall Study|Withdrawal by Subject|1|||
150154372|NCT00681187|541699725|FG001|Overall Study|Withdrawal by Subject|0|||
150154373|NCT00681187|541699724|FG000|Overall Study|Death|0|||
150154374|NCT00681187|541699725|FG001|Overall Study|Death|1|||
150154375|NCT00681187|541699724|FG000|Overall Study|Adverse Event|0|||
150154376|NCT00681187|541699725|FG001|Overall Study|Adverse Event|1|||
150154377|NCT04230980|541699726|FG000|Overall Study|Lost to Follow-up|1|||
150154378|NCT04230980|541699727|FG001|Overall Study|Lost to Follow-up|2|||
150154379|NCT04230980|541699726|FG000|Overall Study|Adverse Event|0|||
150154380|NCT04230980|541699727|FG001|Overall Study|Adverse Event|1|||
150154381|NCT02788006|541699732|FG000|Overall Study|Patient not treated|1|||
150154382|NCT00318149|541699733|FG000|Overall Study|Adverse Event|0|||
150154383|NCT00318149|541699734|FG001|Overall Study|Adverse Event|0|||
150154384|NCT00318149|541699735|FG002|Overall Study|Adverse Event|0|||
150154385|NCT00318149|541699736|FG003|Overall Study|Adverse Event|0|||
150154386|NCT00318149|541699737|FG004|Overall Study|Adverse Event|0|||
150154387|NCT00318149|541699738|FG005|Overall Study|Adverse Event|2|||
150154388|NCT02269943|541699739|FG000|Treatment Period|Death|0|||
150154389|NCT02269943|541699740|FG001|Treatment Period|Death|1|||
150154390|NCT02269943|541699739|FG000|Treatment Period|Adverse Event|1|||
150154391|NCT02269943|541699740|FG001|Treatment Period|Adverse Event|10|||
150154392|NCT02269943|541699739|FG000|Treatment Period|Progressive Disease|5|||
150154393|NCT02269943|541699740|FG001|Treatment Period|Progressive Disease|17|||
150154394|NCT02269943|541699739|FG000|Treatment Period|Symptomatic Deterioration|0|||
150154395|NCT02269943|541699740|FG001|Treatment Period|Symptomatic Deterioration|2|||
150154396|NCT02269943|541699739|FG000|Follow-Up Survival Period|Death|3|||
150154397|NCT02269943|541699740|FG001|Follow-Up Survival Period|Death|16|||
150154398|NCT02269943|541699739|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
150154399|NCT02269943|541699740|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
150154400|NCT02269943|541699739|FG000|Follow-Up Survival Period|Alive|2|||
150154401|NCT02269943|541699740|FG001|Follow-Up Survival Period|Alive|8|||
150154402|NCT03541642|541699741|FG000|Overall Study|Withdrawal by Subject|1|||
150154403|NCT03541642|541699742|FG001|Overall Study|Withdrawal by Subject|2|||
150154404|NCT03541642|541699741|FG000|Overall Study|Lost to Follow-up|16|||
150154405|NCT03541642|541699742|FG001|Overall Study|Lost to Follow-up|12|||
150154406|NCT03541642|541699741|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
150154407|NCT03541642|541699742|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
150154408|NCT03523871|541699743|FG000|Overall Study|Death|1|||
150154409|NCT00219141|541699745|FG000|Overall Study|Adverse Event|4|||
150154410|NCT00219141|541699746|FG001|Overall Study|Adverse Event|10|||
150154411|NCT00219141|541699747|FG002|Overall Study|Adverse Event|5|||
150154412|NCT00219141|541699745|FG000|Overall Study|Lack of Efficacy|3|||
150154413|NCT00219141|541699746|FG001|Overall Study|Lack of Efficacy|2|||
150154414|NCT00219141|541699747|FG002|Overall Study|Lack of Efficacy|0|||
150154415|NCT00219141|541699745|FG000|Overall Study|Administrative problems|0|||
150154416|NCT00219141|541699746|FG001|Overall Study|Administrative problems|1|||
150154417|NCT00219141|541699747|FG002|Overall Study|Administrative problems|0|||
150154418|NCT00219141|541699745|FG000|Overall Study|Lost to Follow-up|2|||
150154419|NCT00219141|541699746|FG001|Overall Study|Lost to Follow-up|4|||
150154420|NCT00219141|541699747|FG002|Overall Study|Lost to Follow-up|1|||
150154421|NCT00219141|541699745|FG000|Overall Study|Protocol Violation|3|||
150154422|NCT00219141|541699746|FG001|Overall Study|Protocol Violation|1|||
150154423|NCT00219141|541699747|FG002|Overall Study|Protocol Violation|1|||
150154424|NCT00219141|541699745|FG000|Overall Study|Withdrawal by Subject|1|||
150154425|NCT00219141|541699746|FG001|Overall Study|Withdrawal by Subject|3|||
150154426|NCT00219141|541699747|FG002|Overall Study|Withdrawal by Subject|5|||
150154427|NCT00219141|541699745|FG000|Overall Study|Condition no longer requires study drug|1|||
150154428|NCT00219141|541699746|FG001|Overall Study|Condition no longer requires study drug|0|||
150154429|NCT00219141|541699747|FG002|Overall Study|Condition no longer requires study drug|0|||
150154430|NCT00972179|541699748|FG000|Overall Study|Noncompliance|1|||
150154431|NCT00972179|541699749|FG001|Overall Study|Noncompliance|0|||
150154432|NCT00972179|541699750|FG002|Overall Study|Noncompliance|0|||
150154433|NCT00972179|541699751|FG003|Overall Study|Noncompliance|0|||
150154434|NCT00972179|541699752|FG004|Overall Study|Noncompliance|1|||
150154435|NCT00972179|541699753|FG005|Overall Study|Noncompliance|0|||
150154436|NCT00972179|541699754|FG006|Overall Study|Noncompliance|1|||
150154437|NCT00972179|541699748|FG000|Overall Study|Withdrawal by Subject|0|||
150154438|NCT00972179|541699749|FG001|Overall Study|Withdrawal by Subject|3|||
150154439|NCT00972179|541699750|FG002|Overall Study|Withdrawal by Subject|0|||
150154440|NCT00972179|541699751|FG003|Overall Study|Withdrawal by Subject|1|||
150154441|NCT00972179|541699752|FG004|Overall Study|Withdrawal by Subject|0|||
150154442|NCT00972179|541699753|FG005|Overall Study|Withdrawal by Subject|0|||
150154443|NCT00972179|541699754|FG006|Overall Study|Withdrawal by Subject|2|||
150154444|NCT00972179|541699748|FG000|Overall Study|Administrative Decision|0|||
150154445|NCT00972179|541699749|FG001|Overall Study|Administrative Decision|0|||
150154446|NCT00972179|541699750|FG002|Overall Study|Administrative Decision|0|||
150154447|NCT00972179|541699751|FG003|Overall Study|Administrative Decision|0|||
150154448|NCT00972179|541699752|FG004|Overall Study|Administrative Decision|1|||
150154449|NCT00972179|541699753|FG005|Overall Study|Administrative Decision|0|||
150154450|NCT00972179|541699754|FG006|Overall Study|Administrative Decision|0|||
150154451|NCT00972179|541699748|FG000|Overall Study|Lost to Follow-up|0|||
150154452|NCT00972179|541699749|FG001|Overall Study|Lost to Follow-up|0|||
150154453|NCT00972179|541699750|FG002|Overall Study|Lost to Follow-up|1|||
150154454|NCT00972179|541699751|FG003|Overall Study|Lost to Follow-up|0|||
150154455|NCT00972179|541699752|FG004|Overall Study|Lost to Follow-up|0|||
150154456|NCT00972179|541699753|FG005|Overall Study|Lost to Follow-up|3|||
150154457|NCT00972179|541699754|FG006|Overall Study|Lost to Follow-up|1|||
150154458|NCT03055832|541699755|FG000|Week 2|Withdrawal by Subject|1|||
150154459|NCT03055832|541699756|FG001|Week 2|Withdrawal by Subject|0|||
150154460|NCT03619174|541699757|FG000|Overall Study|Lost to Follow-up|3|||
150154461|NCT03619174|541699758|FG001|Overall Study|Lost to Follow-up|0|||
150154462|NCT03619174|541699757|FG000|Overall Study|Withdrawal by Subject|4|||
150154463|NCT03619174|541699758|FG001|Overall Study|Withdrawal by Subject|3|||
150154464|NCT03619174|541699757|FG000|Overall Study|Pregnancy|1|||
150154465|NCT03619174|541699758|FG001|Overall Study|Pregnancy|1|||
150154466|NCT03619174|541699757|FG000|Overall Study|Discomfort during treatment|1|||
150154467|NCT03619174|541699758|FG001|Overall Study|Discomfort during treatment|0|||
150154468|NCT04285229|541699761|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
150154469|NCT04285229|541699762|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150154470|NCT04285229|541699763|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150154471|NCT04285229|541699764|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150154472|NCT04285229|541699765|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150154473|NCT04285229|541699766|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150154474|NCT04285229|541699761|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
150154475|NCT04285229|541699762|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
150154476|NCT04285229|541699763|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
150154477|NCT04285229|541699764|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
150154478|NCT04285229|541699765|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
150154479|NCT04285229|541699766|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
150154480|NCT04285229|541699761|FG000|Extended Treatment Period|Adverse Event|0|||
150154481|NCT04285229|541699762|FG001|Extended Treatment Period|Adverse Event|0|||
150154482|NCT04285229|541699763|FG002|Extended Treatment Period|Adverse Event|0|||
150154483|NCT04285229|541699764|FG003|Extended Treatment Period|Adverse Event|1|||
149815405|NCT04380701|540454628|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
150154484|NCT04285229|541699765|FG004|Extended Treatment Period|Adverse Event|0|||
150154485|NCT04285229|541699766|FG005|Extended Treatment Period|Adverse Event|0|||
150154486|NCT04285229|541699761|FG000|Extended Treatment Period|Physician Decision|0|||
150154487|NCT04285229|541699762|FG001|Extended Treatment Period|Physician Decision|0|||
150154488|NCT04285229|541699763|FG002|Extended Treatment Period|Physician Decision|1|||
150154489|NCT04285229|541699764|FG003|Extended Treatment Period|Physician Decision|0|||
150154490|NCT04285229|541699765|FG004|Extended Treatment Period|Physician Decision|0|||
150154491|NCT04285229|541699766|FG005|Extended Treatment Period|Physician Decision|0|||
150154492|NCT04285229|541699761|FG000|Follow-up Period|Adverse Event|0|||
149815406|NCT04380701|540454629|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
149815407|NCT04380701|540454630|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
149815408|NCT04380701|540454631|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
149815409|NCT04380701|540454632|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
149815410|NCT04380701|540454633|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
149815411|NCT04380701|540454634|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
149815412|NCT04380701|540454635|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
149815413|NCT04380701|540454636|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
149815414|NCT04380701|540454637|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
149815415|NCT04380701|540454638|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
149815416|NCT04380701|540454639|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
149815417|NCT04380701|540454640|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
149815418|NCT04380701|540454641|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
149815419|NCT04380701|540454642|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
149815420|NCT04380701|540454643|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
149815421|NCT04380701|540454644|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
149815422|NCT04380701|540454645|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
149815423|NCT04380701|540454646|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
149815424|NCT04380701|540454647|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
149815425|NCT04380701|540454648|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
149815426|NCT04380701|540454649|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
150154493|NCT04285229|541699762|FG001|Follow-up Period|Adverse Event|0|||
150154494|NCT04285229|541699763|FG002|Follow-up Period|Adverse Event|0|||
150154495|NCT04285229|541699764|FG003|Follow-up Period|Adverse Event|0|||
150154496|NCT04285229|541699765|FG004|Follow-up Period|Adverse Event|1|||
150154497|NCT04285229|541699766|FG005|Follow-up Period|Adverse Event|4|||
150154498|NCT04285229|541699761|FG000|Follow-up Period|Withdrawal by Subject|0|||
150154499|NCT04285229|541699762|FG001|Follow-up Period|Withdrawal by Subject|0|||
150154500|NCT04285229|541699763|FG002|Follow-up Period|Withdrawal by Subject|0|||
150154501|NCT04285229|541699764|FG003|Follow-up Period|Withdrawal by Subject|0|||
150154502|NCT04285229|541699765|FG004|Follow-up Period|Withdrawal by Subject|0|||
150154503|NCT04285229|541699766|FG005|Follow-up Period|Withdrawal by Subject|5|||
150154504|NCT04285229|541699761|FG000|Follow-up Period|Covid-19|0|||
150154505|NCT04285229|541699762|FG001|Follow-up Period|Covid-19|0|||
149815427|NCT04380701|540454650|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
149815428|NCT04380701|540454651|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
149815429|NCT04380701|540454652|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
149815430|NCT04380701|540454653|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
149815431|NCT04380701|540454654|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
149815432|NCT04380701|540454621|FG000|Overall Study|Physician Decision|0|||
149815433|NCT04380701|540454622|FG001|Overall Study|Physician Decision|0|||
149815434|NCT04380701|540454623|FG002|Overall Study|Physician Decision|0|||
149815435|NCT04380701|540454624|FG003|Overall Study|Physician Decision|0|||
149815436|NCT04380701|540454625|FG004|Overall Study|Physician Decision|0|||
149815437|NCT04380701|540454626|FG005|Overall Study|Physician Decision|0|||
149815438|NCT04380701|540454627|FG006|Overall Study|Physician Decision|0|||
149815439|NCT04380701|540454628|FG007|Overall Study|Physician Decision|0|||
149815440|NCT04380701|540454629|FG008|Overall Study|Physician Decision|0|||
149815441|NCT04380701|540454630|FG009|Overall Study|Physician Decision|0|||
149815442|NCT04380701|540454631|FG010|Overall Study|Physician Decision|0|||
149815443|NCT04380701|540454632|FG011|Overall Study|Physician Decision|0|||
149815444|NCT04380701|540454633|FG012|Overall Study|Physician Decision|0|||
149815445|NCT04380701|540454634|FG013|Overall Study|Physician Decision|0|||
149815446|NCT04380701|540454635|FG014|Overall Study|Physician Decision|0|||
150154506|NCT04285229|541699763|FG002|Follow-up Period|Covid-19|0|||
149815447|NCT04380701|540454636|FG015|Overall Study|Physician Decision|0|||
149815448|NCT04380701|540454637|FG016|Overall Study|Physician Decision|0|||
149815449|NCT04380701|540454638|FG017|Overall Study|Physician Decision|0|||
149815450|NCT04380701|540454639|FG018|Overall Study|Physician Decision|0|||
149815451|NCT04380701|540454640|FG019|Overall Study|Physician Decision|0|||
150154507|NCT04285229|541699764|FG003|Follow-up Period|Covid-19|0|||
150154508|NCT04285229|541699765|FG004|Follow-up Period|Covid-19|0|||
150154509|NCT04285229|541699766|FG005|Follow-up Period|Covid-19|2|||
150154510|NCT04285229|541699761|FG000|Follow-up Period|Physician Decision|0|||
150154511|NCT04285229|541699762|FG001|Follow-up Period|Physician Decision|0|||
150154512|NCT04285229|541699763|FG002|Follow-up Period|Physician Decision|0|||
150154513|NCT04285229|541699764|FG003|Follow-up Period|Physician Decision|0|||
150154514|NCT04285229|541699765|FG004|Follow-up Period|Physician Decision|0|||
150154515|NCT04285229|541699766|FG005|Follow-up Period|Physician Decision|1|||
150154516|NCT01012973|541699767|FG000|Overall Study|Adverse Event|5|||
150154517|NCT01012973|541699768|FG001|Overall Study|Adverse Event|5|||
150154518|NCT01012973|541699767|FG000|Overall Study|Lack of Efficacy|0|||
150154519|NCT01012973|541699768|FG001|Overall Study|Lack of Efficacy|5|||
150154520|NCT01012973|541699767|FG000|Overall Study|Lost to Follow-up|1|||
150154521|NCT01012973|541699768|FG001|Overall Study|Lost to Follow-up|0|||
150154522|NCT01012973|541699767|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
150154523|NCT01012973|541699768|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
150154524|NCT01012973|541699767|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
150154525|NCT01012973|541699768|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
150154526|NCT01012973|541699767|FG000|Overall Study|Protocol Violation|5|||
150154527|NCT01012973|541699768|FG001|Overall Study|Protocol Violation|2|||
150154528|NCT01012973|541699767|FG000|Overall Study|Withdrawal by Subject|4|||
150154529|NCT01012973|541699768|FG001|Overall Study|Withdrawal by Subject|6|||
150154530|NCT02061761|541699769|FG000|Overall Study|Disease progression|2|||
150154531|NCT02061761|541699770|FG001|Overall Study|Disease progression|8|||
150154532|NCT02061761|541699771|FG002|Overall Study|Disease progression|4|||
150154533|NCT02061761|541699772|FG003|Overall Study|Disease progression|5|||
150154534|NCT02061761|541699773|FG004|Overall Study|Disease progression|9|||
150154535|NCT02061761|541699774|FG005|Overall Study|Disease progression|3|||
150154536|NCT02061761|541699775|FG006|Overall Study|Disease progression|1|||
150154537|NCT02061761|541699776|FG007|Overall Study|Disease progression|2|||
150154538|NCT02061761|541699777|FG008|Overall Study|Disease progression|28|||
150154539|NCT02061761|541699769|FG000|Overall Study|Study Drug toxicity|0|||
150154540|NCT02061761|541699770|FG001|Overall Study|Study Drug toxicity|0|||
150154541|NCT02061761|541699771|FG002|Overall Study|Study Drug toxicity|0|||
150154542|NCT02061761|541699772|FG003|Overall Study|Study Drug toxicity|0|||
150154543|NCT02061761|541699773|FG004|Overall Study|Study Drug toxicity|0|||
150154544|NCT02061761|541699774|FG005|Overall Study|Study Drug toxicity|1|||
150154545|NCT02061761|541699775|FG006|Overall Study|Study Drug toxicity|0|||
150154546|NCT02061761|541699776|FG007|Overall Study|Study Drug toxicity|2|||
150154547|NCT02061761|541699777|FG008|Overall Study|Study Drug toxicity|6|||
150154548|NCT02061761|541699769|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
150154549|NCT02061761|541699770|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
150154550|NCT02061761|541699771|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
150154551|NCT02061761|541699772|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
150154552|NCT02061761|541699773|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
150154553|NCT02061761|541699774|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
150154554|NCT02061761|541699775|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
150154555|NCT02061761|541699776|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
150154556|NCT02061761|541699777|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
150154557|NCT02061761|541699769|FG000|Overall Study|Participant request to discontinue study treatment|0|||
150154558|NCT02061761|541699770|FG001|Overall Study|Participant request to discontinue study treatment|0|||
150154559|NCT02061761|541699771|FG002|Overall Study|Participant request to discontinue study treatment|2|||
150154560|NCT02061761|541699772|FG003|Overall Study|Participant request to discontinue study treatment|2|||
150154561|NCT02061761|541699773|FG004|Overall Study|Participant request to discontinue study treatment|0|||
150154562|NCT02061761|541699774|FG005|Overall Study|Participant request to discontinue study treatment|1|||
150154563|NCT02061761|541699775|FG006|Overall Study|Participant request to discontinue study treatment|0|||
150154564|NCT02061761|541699776|FG007|Overall Study|Participant request to discontinue study treatment|0|||
150154565|NCT02061761|541699777|FG008|Overall Study|Participant request to discontinue study treatment|2|||
150154566|NCT02061761|541699769|FG000|Overall Study|Withdrawal by Subject|0|||
150154567|NCT02061761|541699770|FG001|Overall Study|Withdrawal by Subject|0|||
150154568|NCT02061761|541699771|FG002|Overall Study|Withdrawal by Subject|0|||
150154569|NCT02061761|541699772|FG003|Overall Study|Withdrawal by Subject|0|||
150154570|NCT02061761|541699773|FG004|Overall Study|Withdrawal by Subject|0|||
150154571|NCT02061761|541699774|FG005|Overall Study|Withdrawal by Subject|0|||
150154572|NCT02061761|541699775|FG006|Overall Study|Withdrawal by Subject|0|||
150154573|NCT02061761|541699776|FG007|Overall Study|Withdrawal by Subject|0|||
149815452|NCT04380701|540454641|FG020|Overall Study|Physician Decision|0|||
149815453|NCT04380701|540454642|FG021|Overall Study|Physician Decision|0|||
150154574|NCT02061761|541699777|FG008|Overall Study|Withdrawal by Subject|2|||
150154575|NCT02061761|541699769|FG000|Overall Study|Maximum clinical benefit|0|||
150154576|NCT02061761|541699770|FG001|Overall Study|Maximum clinical benefit|0|||
150154577|NCT02061761|541699771|FG002|Overall Study|Maximum clinical benefit|0|||
150154578|NCT02061761|541699772|FG003|Overall Study|Maximum clinical benefit|1|||
150154579|NCT02061761|541699773|FG004|Overall Study|Maximum clinical benefit|0|||
149815454|NCT04380701|540454643|FG022|Overall Study|Physician Decision|0|||
150154580|NCT02061761|541699774|FG005|Overall Study|Maximum clinical benefit|0|||
150154581|NCT02061761|541699775|FG006|Overall Study|Maximum clinical benefit|0|||
150154582|NCT02061761|541699776|FG007|Overall Study|Maximum clinical benefit|0|||
150154583|NCT02061761|541699777|FG008|Overall Study|Maximum clinical benefit|6|||
150154584|NCT02061761|541699769|FG000|Overall Study|Participant no longer meets study criteria|0|||
150154585|NCT02061761|541699770|FG001|Overall Study|Participant no longer meets study criteria|0|||
150154586|NCT02061761|541699771|FG002|Overall Study|Participant no longer meets study criteria|0|||
150154587|NCT02061761|541699772|FG003|Overall Study|Participant no longer meets study criteria|0|||
150154588|NCT02061761|541699773|FG004|Overall Study|Participant no longer meets study criteria|0|||
150154589|NCT02061761|541699774|FG005|Overall Study|Participant no longer meets study criteria|0|||
150154590|NCT02061761|541699775|FG006|Overall Study|Participant no longer meets study criteria|0|||
150154591|NCT02061761|541699776|FG007|Overall Study|Participant no longer meets study criteria|0|||
150154592|NCT02061761|541699777|FG008|Overall Study|Participant no longer meets study criteria|1|||
150154593|NCT02061761|541699769|FG000|Overall Study|Other reasons|0|||
150154594|NCT02061761|541699770|FG001|Overall Study|Other reasons|0|||
150154595|NCT02061761|541699771|FG002|Overall Study|Other reasons|0|||
150154596|NCT02061761|541699772|FG003|Overall Study|Other reasons|0|||
150154597|NCT02061761|541699773|FG004|Overall Study|Other reasons|2|||
150154598|NCT02061761|541699774|FG005|Overall Study|Other reasons|0|||
150154599|NCT02061761|541699775|FG006|Overall Study|Other reasons|0|||
150154600|NCT02061761|541699776|FG007|Overall Study|Other reasons|0|||
150154601|NCT02061761|541699777|FG008|Overall Study|Other reasons|6|||
150154602|NCT00903786|541699786|FG000|Overall Study|Physician Decision|6|||
150154603|NCT00903786|541699786|FG000|Overall Study|Lack of Efficacy|5|||
150154604|NCT00903786|541699786|FG000|Overall Study|Reason other than lack of efficacy|4|||
150154605|NCT01857622|541699790|FG000|Overall Study|Adverse Event|5|||
150154606|NCT01857622|541699791|FG001|Overall Study|Adverse Event|0|||
150154607|NCT01857622|541699792|FG002|Overall Study|Adverse Event|2|||
150154608|NCT01857622|541699790|FG000|Overall Study|Physician Decision|1|||
150154609|NCT01857622|541699791|FG001|Overall Study|Physician Decision|0|||
150154610|NCT01857622|541699792|FG002|Overall Study|Physician Decision|0|||
150154611|NCT01857622|541699790|FG000|Overall Study|Protocol Violation|4|||
150154612|NCT01857622|541699791|FG001|Overall Study|Protocol Violation|1|||
150154613|NCT01857622|541699792|FG002|Overall Study|Protocol Violation|0|||
150154614|NCT01857622|541699790|FG000|Overall Study|Withdrawal by Subject|1|||
150154615|NCT01857622|541699791|FG001|Overall Study|Withdrawal by Subject|0|||
150154616|NCT01857622|541699792|FG002|Overall Study|Withdrawal by Subject|0|||
150154617|NCT01267253|541699794|FG000|Overall Study|Ineligible - required test not done|1|||
150154618|NCT01267253|541699794|FG000|Overall Study|Inevaluable-never received study treatme|2|||
150154619|NCT00064025|541699795|FG000|Overall Study|Ineligible|4|||
150154620|NCT00064025|541699795|FG000|Overall Study|Inevaluable|3|||
150154621|NCT01370603|541699796|FG000|Period 1|Adverse Event|5|||
150154622|NCT01370603|541699797|FG001|Period 1|Adverse Event|3|||
150154623|NCT01370603|541699796|FG000|Period 1|Lost to Follow-up|2|||
150154624|NCT01370603|541699797|FG001|Period 1|Lost to Follow-up|0|||
150154625|NCT01370603|541699796|FG000|Period 1|Protocol Violation|2|||
150154626|NCT01370603|541699797|FG001|Period 1|Protocol Violation|2|||
150154627|NCT01370603|541699796|FG000|Period 1|Withdrawal by Subject|5|||
150154628|NCT01370603|541699797|FG001|Period 1|Withdrawal by Subject|5|||
150154629|NCT01370603|541699796|FG000|Crossover Washout|Adverse Event|2|||
150154630|NCT01370603|541699797|FG001|Crossover Washout|Adverse Event|1|||
150154631|NCT01370603|541699796|FG000|Crossover Washout|Lost to Follow-up|2|||
150154632|NCT01370603|541699797|FG001|Crossover Washout|Lost to Follow-up|0|||
150154633|NCT01370603|541699796|FG000|Crossover Washout|Protocol Violation|1|||
149815455|NCT04380701|540454644|FG023|Overall Study|Physician Decision|0|||
149815456|NCT04380701|540454645|FG024|Overall Study|Physician Decision|2|||
149815457|NCT04380701|540454646|FG025|Overall Study|Physician Decision|0|||
149815458|NCT04380701|540454647|FG026|Overall Study|Physician Decision|0|||
149815459|NCT04380701|540454648|FG027|Overall Study|Physician Decision|0|||
149815460|NCT04380701|540454649|FG028|Overall Study|Physician Decision|0|||
149815461|NCT04380701|540454650|FG029|Overall Study|Physician Decision|0|||
149815462|NCT04380701|540454651|FG030|Overall Study|Physician Decision|0|||
149815463|NCT04380701|540454652|FG031|Overall Study|Physician Decision|0|||
149815464|NCT04380701|540454653|FG032|Overall Study|Physician Decision|0|||
149815465|NCT04380701|540454654|FG033|Overall Study|Physician Decision|0|||
149815466|NCT04380701|540454621|FG000|Overall Study|Death|0|||
149815467|NCT04380701|540454622|FG001|Overall Study|Death|0|||
150154634|NCT01370603|541699797|FG001|Crossover Washout|Protocol Violation|0|||
150154635|NCT01370603|541699796|FG000|Crossover Washout|Withdrawal by Subject|4|||
150154636|NCT01370603|541699797|FG001|Crossover Washout|Withdrawal by Subject|1|||
150154637|NCT01370603|541699796|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
150154638|NCT01370603|541699797|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
150154639|NCT01370603|541699796|FG000|Period 2|Adverse Event|1|||
150154640|NCT01370603|541699797|FG001|Period 2|Adverse Event|4|||
150154641|NCT01370603|541699796|FG000|Period 2|Lost to Follow-up|1|||
150154642|NCT01370603|541699797|FG001|Period 2|Lost to Follow-up|0|||
149815468|NCT04380701|540454623|FG002|Overall Study|Death|0|||
150154643|NCT01370603|541699796|FG000|Period 2|Withdrawal by Subject|1|||
150154644|NCT01370603|541699797|FG001|Period 2|Withdrawal by Subject|0|||
150154645|NCT00547911|541699805|FG000|Overall Study|Adverse Event|0|||
150154646|NCT00547911|541699806|FG001|Overall Study|Adverse Event|0|||
150154647|NCT00547911|541699807|FG002|Overall Study|Adverse Event|0|||
150154648|NCT00547911|541699808|FG003|Overall Study|Adverse Event|1|||
150154649|NCT00547911|541699809|FG004|Overall Study|Adverse Event|0|||
150154650|NCT00547911|541699810|FG005|Overall Study|Adverse Event|0|||
150154651|NCT01644474|541699812|FG000|Overall Study|Poor compliance to protocol|1|||
150154652|NCT01644474|541699813|FG001|Overall Study|Poor compliance to protocol|0|||
150154653|NCT01644474|541699812|FG000|Overall Study|Consent withdrawn by participant|0|||
150154654|NCT01644474|541699813|FG001|Overall Study|Consent withdrawn by participant|1|||
150154655|NCT01644474|541699812|FG000|Overall Study|Participant moved|0|||
150154656|NCT01644474|541699813|FG001|Overall Study|Participant moved|1|||
150154657|NCT01644474|541699812|FG000|Overall Study|Adverse Event|4|||
150154658|NCT01644474|541699813|FG001|Overall Study|Adverse Event|5|||
150154659|NCT01644474|541699812|FG000|Overall Study|Site scheduling error|1|||
150154660|NCT01644474|541699813|FG001|Overall Study|Site scheduling error|1|||
150154661|NCT01644474|541699812|FG000|Overall Study|Protocol Violation|1|||
150154662|NCT01644474|541699813|FG001|Overall Study|Protocol Violation|0|||
150154663|NCT01163747|541699819|FG000|Overall Study|Adverse Event|0|||
150154664|NCT01163747|541699820|FG001|Overall Study|Adverse Event|5|||
150154665|NCT01163747|541699819|FG000|Overall Study|Insufficient Therapeutic Response|0|||
150154666|NCT01163747|541699820|FG001|Overall Study|Insufficient Therapeutic Response|1|||
150154667|NCT01163747|541699819|FG000|Overall Study|Protocol Violation|0|||
150154668|NCT01163747|541699820|FG001|Overall Study|Protocol Violation|1|||
150154669|NCT01163747|541699819|FG000|Overall Study|Refused Treatment|6|||
150154670|NCT01163747|541699820|FG001|Overall Study|Refused Treatment|4|||
150154671|NCT01216293|541699824|FG000|Main Study|Adverse Event|1|||
150154672|NCT01216293|541699825|FG001|Main Study|Adverse Event|4|||
150154673|NCT01216293|541699826|FG002|Main Study|Adverse Event|2|||
150154674|NCT01216293|541699824|FG000|Main Study|Major Protocol Deviation|1|||
150154675|NCT01216293|541699825|FG001|Main Study|Major Protocol Deviation|0|||
150154676|NCT01216293|541699826|FG002|Main Study|Major Protocol Deviation|1|||
150154677|NCT01216293|541699824|FG000|Main Study|Lost to Follow-up|3|||
150154678|NCT01216293|541699825|FG001|Main Study|Lost to Follow-up|1|||
150154679|NCT01216293|541699826|FG002|Main Study|Lost to Follow-up|0|||
150154680|NCT01216293|541699824|FG000|Main Study|Voluntary Withdrawal|2|||
150154681|NCT01216293|541699825|FG001|Main Study|Voluntary Withdrawal|2|||
150154682|NCT01216293|541699826|FG002|Main Study|Voluntary Withdrawal|2|||
150154683|NCT01216293|541699824|FG000|Main Study|Other Reason Not Specified|0|||
150154684|NCT01216293|541699825|FG001|Main Study|Other Reason Not Specified|1|||
150154685|NCT01216293|541699826|FG002|Main Study|Other Reason Not Specified|1|||
150154686|NCT01216293|541699824|FG000|Main Study|Randomized, Not Treated|1|||
150154687|NCT01216293|541699825|FG001|Main Study|Randomized, Not Treated|0|||
150154688|NCT01216293|541699826|FG002|Main Study|Randomized, Not Treated|0|||
150154689|NCT01216293|541699824|FG000|Calcium Absorption Substudy|Adverse Event|0|||
150154690|NCT01216293|541699825|FG001|Calcium Absorption Substudy|Adverse Event|2|||
150154691|NCT01216293|541699826|FG002|Calcium Absorption Substudy|Adverse Event|0|||
150154692|NCT01216293|541699824|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
150154693|NCT01216293|541699825|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
150154694|NCT01216293|541699826|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
150154695|NCT01216293|541699824|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
150154696|NCT01216293|541699825|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
150154697|NCT01216293|541699826|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
150154698|NCT04714216|541701381|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
150154699|NCT04714216|541701381|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
150154700|NCT01349829|541701385|FG000|Overall Study|Lost to Follow-up|4|||
150154701|NCT01349829|541701386|FG001|Overall Study|Lost to Follow-up|8|||
150154702|NCT01349829|541701385|FG000|Overall Study|Consent withdrawal|3|||
150154703|NCT01349829|541701386|FG001|Overall Study|Consent withdrawal|8|||
150154704|NCT01349829|541701385|FG000|Overall Study|Migrated/moved|2|||
150154705|NCT01349829|541701386|FG001|Overall Study|Migrated/moved|7|||
150154706|NCT00513019|541701387|FG000|Overall Study|Adverse Event|1|||
150154707|NCT00513019|541701388|FG001|Overall Study|Adverse Event|0|||
150154708|NCT00513019|541701387|FG000|Overall Study|Withdrawal by Subject|4|||
150154709|NCT00513019|541701388|FG001|Overall Study|Withdrawal by Subject|5|||
150154710|NCT00777803|541701389|FG000|Overall Study|Lost to Follow-up|12|||
150154711|NCT00777803|541701390|FG001|Overall Study|Lost to Follow-up|5|||
150154712|NCT00777803|541701389|FG000|Overall Study|Adverse Event|1|||
150154713|NCT00777803|541701390|FG001|Overall Study|Adverse Event|0|||
150154714|NCT00777803|541701389|FG000|Overall Study|Non-compliance|2|||
150154715|NCT00777803|541701390|FG001|Overall Study|Non-compliance|2|||
150154716|NCT01995357|541701393|FG000|Period 5|Lack of Efficacy|1|||
150154717|NCT01995357|541701394|FG001|Period 5|Lack of Efficacy|0|||
150154718|NCT01995357|541701395|FG002|Period 5|Lack of Efficacy|0|||
150154719|NCT01995357|541701396|FG003|Period 5|Lack of Efficacy|0|||
150154720|NCT01995357|541701397|FG004|Period 5|Lack of Efficacy|0|||
150154721|NCT01995357|541701398|FG005|Period 5|Lack of Efficacy|0|||
150154722|NCT01995357|541701393|FG000|Period 5|Adverse Event|1|||
150154723|NCT01995357|541701394|FG001|Period 5|Adverse Event|0|||
150154724|NCT01995357|541701395|FG002|Period 5|Adverse Event|1|||
150154725|NCT01995357|541701396|FG003|Period 5|Adverse Event|0|||
150154726|NCT01995357|541701397|FG004|Period 5|Adverse Event|0|||
150154727|NCT01995357|541701398|FG005|Period 5|Adverse Event|0|||
150154728|NCT01852162|541701401|FG000|Overall Study|Adverse Event|1|||
150154729|NCT01852162|541701402|FG001|Overall Study|Adverse Event|0|||
150154730|NCT01852162|541701401|FG000|Overall Study|Withdrawal by Subject|3|||
150154731|NCT01852162|541701402|FG001|Overall Study|Withdrawal by Subject|1|||
150154732|NCT01500226|541701403|FG000|Overall Study|Adverse Event|31|||
150154733|NCT01500226|541701404|FG001|Overall Study|Adverse Event|38|||
150154734|NCT01500226|541701403|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
150154735|NCT01500226|541701404|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
150154736|NCT01500226|541701403|FG000|Overall Study|Withdrawal by Subject|93|||
150154737|NCT01500226|541701404|FG001|Overall Study|Withdrawal by Subject|96|||
150154738|NCT01500226|541701403|FG000|Overall Study|Death|12|||
150154739|NCT01500226|541701404|FG001|Overall Study|Death|4|||
150154740|NCT01500226|541701403|FG000|Overall Study|Disease Progression|16|||
150154741|NCT01500226|541701404|FG001|Overall Study|Disease Progression|14|||
150154742|NCT01500226|541701403|FG000|Overall Study|Protocol Violation|53|||
150154743|NCT01500226|541701404|FG001|Overall Study|Protocol Violation|39|||
150154744|NCT01500226|541701403|FG000|Overall Study|Physician Decision|17|||
150154745|NCT01500226|541701404|FG001|Overall Study|Physician Decision|15|||
150154746|NCT01500226|541701403|FG000|Overall Study|Lack of Efficacy|14|||
150154747|NCT01500226|541701404|FG001|Overall Study|Lack of Efficacy|30|||
150154748|NCT01500226|541701403|FG000|Overall Study|Lost to Follow-up|9|||
150154749|NCT01500226|541701404|FG001|Overall Study|Lost to Follow-up|5|||
150154750|NCT01500226|541701403|FG000|Overall Study|Other Reasons|19|||
150154751|NCT01500226|541701404|FG001|Overall Study|Other Reasons|16|||
150154752|NCT02955277|541701405|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
150154753|NCT02955277|541701406|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
150154754|NCT02955277|541701405|FG000|Post to Follow-up|Lost to Follow-up|8|||
150154755|NCT02955277|541701406|FG001|Post to Follow-up|Lost to Follow-up|11|||
150154756|NCT04212169|541701407|FG000|Overall Study|Adverse Event|0|||
150154757|NCT04212169|541701408|FG001|Overall Study|Adverse Event|0|||
150154758|NCT04212169|541701409|FG002|Overall Study|Adverse Event|0|||
150154759|NCT04212169|541701410|FG003|Overall Study|Adverse Event|2|||
150154760|NCT04212169|541701407|FG000|Overall Study|Lost to Follow-up|1|||
150154761|NCT04212169|541701408|FG001|Overall Study|Lost to Follow-up|0|||
150154762|NCT04212169|541701409|FG002|Overall Study|Lost to Follow-up|0|||
150154763|NCT04212169|541701410|FG003|Overall Study|Lost to Follow-up|2|||
150154764|NCT04212169|541701407|FG000|Overall Study|Withdrawal by Subject|10|||
150154765|NCT04212169|541701408|FG001|Overall Study|Withdrawal by Subject|2|||
150154766|NCT04212169|541701409|FG002|Overall Study|Withdrawal by Subject|5|||
150154767|NCT04212169|541701410|FG003|Overall Study|Withdrawal by Subject|7|||
150154768|NCT04212169|541701407|FG000|Overall Study|Other reason, unspecified|3|||
150154769|NCT04212169|541701408|FG001|Overall Study|Other reason, unspecified|1|||
150154770|NCT04212169|541701409|FG002|Overall Study|Other reason, unspecified|0|||
150154771|NCT04212169|541701410|FG003|Overall Study|Other reason, unspecified|2|||
150154772|NCT00504348|541701414|FG000|Overall Study|Adverse Event|3|||
150154773|NCT00504348|541701414|FG000|Overall Study|Lack of Efficacy|4|||
150154774|NCT00504348|541701414|FG000|Overall Study|Physician Decision|1|||
150154775|NCT02819479|541701415|FG000|Overall Study|Adverse Event|2|||
150154776|NCT01118962|541701416|FG000|Overall Study|Adverse Event|2|||
150154777|NCT01118962|541701416|FG000|Overall Study|Lack of Efficacy|1|||
150154778|NCT01118962|541701416|FG000|Overall Study|Protocol Violation|1|||
150154779|NCT01118962|541701416|FG000|Overall Study|Withdrawal by Subject|4|||
150154780|NCT01118962|541701416|FG000|Overall Study|Pregnancy|1|||
150154781|NCT01118962|541701416|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
150154782|NCT00593554|541701420|FG000|Overall Study|Death|1|||
150154783|NCT00593554|541701421|FG001|Overall Study|Death|2|||
150154784|NCT00593554|541701420|FG000|Overall Study|Physician Decision|0|||
150154785|NCT00593554|541701421|FG001|Overall Study|Physician Decision|1|||
150154786|NCT00593554|541701420|FG000|Overall Study|Withdrawal by Subject|1|||
150154787|NCT00593554|541701421|FG001|Overall Study|Withdrawal by Subject|0|||
150154788|NCT00593554|541701420|FG000|Overall Study|Disease Progression|1|||
150154789|NCT00593554|541701421|FG001|Overall Study|Disease Progression|2|||
150154790|NCT00795132|541701423|FG000|Overall Study|Death|1|||
150154791|NCT00795132|541701423|FG000|Overall Study|Relapse|2|||
150154792|NCT02561455|541701424|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
150154793|NCT02561455|541701425|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
150154794|NCT02561455|541701426|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
150154795|NCT02561455|541701427|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
150154796|NCT02561455|541701424|FG000|Overall Study|Withdrawal by Subject|1|||
150154797|NCT02561455|541701425|FG001|Overall Study|Withdrawal by Subject|0|||
150154798|NCT02561455|541701426|FG002|Overall Study|Withdrawal by Subject|1|||
150154799|NCT02561455|541701427|FG003|Overall Study|Withdrawal by Subject|0|||
150154800|NCT02561455|541701424|FG000|Overall Study|Disease Progression|0|||
150154801|NCT02561455|541701425|FG001|Overall Study|Disease Progression|1|||
150154802|NCT02561455|541701426|FG002|Overall Study|Disease Progression|0|||
150154803|NCT02561455|541701427|FG003|Overall Study|Disease Progression|0|||
150154804|NCT00262743|541701432|FG000|Overall Study|Adverse Event|0|||
150154805|NCT00262743|541701433|FG001|Overall Study|Adverse Event|9|||
150154806|NCT00262743|541701432|FG000|Overall Study|Disease progression|0|||
150154807|NCT00262743|541701433|FG001|Overall Study|Disease progression|3|||
150154808|NCT01950273|541701447|FG000|Overall Study|Protocol Violation|1|||
150154809|NCT01950273|541701448|FG001|Overall Study|Protocol Violation|0|||
150154810|NCT01950273|541701447|FG000|Overall Study|Withdrawal by Subject|2|||
150154811|NCT01950273|541701448|FG001|Overall Study|Withdrawal by Subject|0|||
150154812|NCT01950273|541701447|FG000|Overall Study|Other not defined above|1|||
150154813|NCT01950273|541701448|FG001|Overall Study|Other not defined above|0|||
150154814|NCT01254565|541701449|FG000|Overall Study|Non-compliance to Study Procedures|0|||
150154815|NCT01254565|541701450|FG001|Overall Study|Non-compliance to Study Procedures|0|||
150154816|NCT01254565|541701451|FG002|Overall Study|Non-compliance to Study Procedures|0|||
150154817|NCT01254565|541701452|FG003|Overall Study|Non-compliance to Study Procedures|0|||
150154818|NCT01254565|541701453|FG004|Overall Study|Non-compliance to Study Procedures|1|||
150154819|NCT01254565|541701454|FG005|Overall Study|Non-compliance to Study Procedures|0|||
150154820|NCT01254565|541701449|FG000|Overall Study|Did not Receive Treatment|1|||
150154821|NCT01254565|541701450|FG001|Overall Study|Did not Receive Treatment|1|||
150154822|NCT01254565|541701451|FG002|Overall Study|Did not Receive Treatment|0|||
150154823|NCT01254565|541701452|FG003|Overall Study|Did not Receive Treatment|0|||
150154824|NCT01254565|541701453|FG004|Overall Study|Did not Receive Treatment|3|||
150154825|NCT01254565|541701454|FG005|Overall Study|Did not Receive Treatment|4|||
150154826|NCT01254565|541701449|FG000|Overall Study|Other|0|||
150154827|NCT01254565|541701450|FG001|Overall Study|Other|0|||
150154828|NCT01254565|541701451|FG002|Overall Study|Other|0|||
150154829|NCT01254565|541701452|FG003|Overall Study|Other|1|||
150154830|NCT01254565|541701453|FG004|Overall Study|Other|0|||
150154831|NCT01254565|541701454|FG005|Overall Study|Other|0|||
150154832|NCT00472186|541701455|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
150154833|NCT00472186|541701456|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
150154834|NCT02726399|541701461|FG000|Overall Study|Participant Non-Compliance|1|||
150154835|NCT02726399|541701461|FG000|Overall Study|Adverse Event|2|||
150154836|NCT02726399|541701461|FG000|Overall Study|Progression of disease|4|||
150154837|NCT04006366|541701464|FG000|Overall Study|Withdrawal by Subject|1|||
150154838|NCT04430335|541701465|FG000|Overall Study|Withdrawal by Subject|1|||
150154839|NCT03249376|541701472|FG000|Overall Study|Adverse Event|11|||
150154840|NCT03249376|541701473|FG001|Overall Study|Adverse Event|5|||
150154841|NCT03249376|541701472|FG000|Overall Study|Lack of Efficacy|2|||
150154842|NCT03249376|541701473|FG001|Overall Study|Lack of Efficacy|4|||
150154843|NCT03249376|541701472|FG000|Overall Study|Protocol Violation|3|||
150154844|NCT03249376|541701473|FG001|Overall Study|Protocol Violation|2|||
150154845|NCT03249376|541701472|FG000|Overall Study|Physician Decision|0|||
150154846|NCT03249376|541701473|FG001|Overall Study|Physician Decision|2|||
150154847|NCT03249376|541701472|FG000|Overall Study|Withdrawal by Subject|3|||
150154848|NCT03249376|541701473|FG001|Overall Study|Withdrawal by Subject|9|||
150154849|NCT03249376|541701472|FG000|Overall Study|LTFU|2|||
150154850|NCT03249376|541701473|FG001|Overall Study|LTFU|1|||
150154851|NCT00627042|541701477|FG000|Overall Study|Withdrawal by Subject|2|||
150154852|NCT02264574|541701480|FG000|Overall Study|Death|21|||
150154853|NCT02264574|541701481|FG001|Overall Study|Death|21|||
150154854|NCT02264574|541701480|FG000|Overall Study|Withdrawal by Subject|8|||
150154855|NCT02264574|541701481|FG001|Overall Study|Withdrawal by Subject|6|||
150154856|NCT02264574|541701480|FG000|Overall Study|Other, Not Specified|0|||
150154857|NCT02264574|541701481|FG001|Overall Study|Other, Not Specified|3|||
150154858|NCT04254679|541701484|FG000|Overall Study|Protocol Violation|1|||
150154859|NCT04254679|541701485|FG001|Overall Study|Protocol Violation|1|||
150154860|NCT04254679|541701484|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
150154861|NCT04254679|541701485|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
150154862|NCT02206152|541701490|FG000|Pre-Randomization|Withdrawal by Subject|2|||
150154863|NCT00478608|541701491|FG000|Overall Study|Adverse Event|1|||
150154864|NCT00478608|541701491|FG000|Overall Study|Serious Adverse Event|14|||
150154865|NCT00478608|541701491|FG000|Overall Study|Withdrawal by Subject|2|||
150154866|NCT00478608|541701491|FG000|Overall Study|Protocol Violation|3|||
150154867|NCT02080520|541701492|FG000|Overall Study|Self-reported symptoms|5|||
150154868|NCT02080520|541701493|FG001|Overall Study|Self-reported symptoms|6|||
150154869|NCT02080520|541701492|FG000|Overall Study|Unable to contact|2|||
150154870|NCT02080520|541701493|FG001|Overall Study|Unable to contact|1|||
150154871|NCT02080520|541701492|FG000|Overall Study|Initiated aspirin|2|||
150154872|NCT02080520|541701493|FG001|Overall Study|Initiated aspirin|0|||
150154873|NCT02080520|541701492|FG000|Overall Study|Atrial fibrillation|1|||
149815469|NCT04380701|540454624|FG003|Overall Study|Death|0|||
149815470|NCT04380701|540454625|FG004|Overall Study|Death|0|||
149815471|NCT04380701|540454626|FG005|Overall Study|Death|0|||
150154874|NCT02080520|541701493|FG001|Overall Study|Atrial fibrillation|1|||
150154875|NCT02080520|541701492|FG000|Overall Study|Cancer|1|||
150154876|NCT02080520|541701493|FG001|Overall Study|Cancer|2|||
150154877|NCT02080520|541701492|FG000|Overall Study|Not interested in study|1|||
150154878|NCT02080520|541701493|FG001|Overall Study|Not interested in study|3|||
150154879|NCT02080520|541701492|FG000|Overall Study|Too busy|1|||
150154880|NCT02080520|541701493|FG001|Overall Study|Too busy|1|||
150154881|NCT02080520|541701492|FG000|Overall Study|Work-related injury|1|||
150154882|NCT02080520|541701493|FG001|Overall Study|Work-related injury|0|||
150154883|NCT02080520|541701492|FG000|Overall Study|Personal reasons|0|||
150154884|NCT02080520|541701493|FG001|Overall Study|Personal reasons|3|||
150154885|NCT00390455|541701494|FG000|Overall Study|Adverse Event|17|||
150154886|NCT00390455|541701495|FG001|Overall Study|Adverse Event|3|||
150154887|NCT00390455|541701494|FG000|Overall Study|Withdrawal by Subject|8|||
150154888|NCT00390455|541701495|FG001|Overall Study|Withdrawal by Subject|8|||
150154889|NCT00390455|541701494|FG000|Overall Study|Alternate Treatment|0|||
150154890|NCT00390455|541701495|FG001|Overall Study|Alternate Treatment|1|||
150154891|NCT00390455|541701494|FG000|Overall Study|Other Medical Reasons|7|||
150154892|NCT00390455|541701495|FG001|Overall Study|Other Medical Reasons|11|||
150154893|NCT00794820|541701498|FG000|Overall Study|Adverse Event|11|||
150154894|NCT00794820|541701498|FG000|Overall Study|Secondary Malignancies|2|||
150154895|NCT00794820|541701498|FG000|Overall Study|Resistant Disease|2|||
150154896|NCT00794820|541701498|FG000|Overall Study|Ineligible/Screen Failure|1|||
150154897|NCT02406261|541701500|FG000|Period 1|Lost to Follow-up|2|||
150154898|NCT02406261|541701501|FG001|Period 1|Lost to Follow-up|0|||
150154899|NCT02406261|541701500|FG000|Period 1|Adverse Event|1|||
150154900|NCT02406261|541701501|FG001|Period 1|Adverse Event|0|||
150154901|NCT02406261|541701500|FG000|Period 2|Physician Decision|0|||
150154902|NCT02406261|541701501|FG001|Period 2|Physician Decision|1|||
150154903|NCT02406261|541701500|FG000|Period 2|Protocol Violation|0|||
150154904|NCT02406261|541701501|FG001|Period 2|Protocol Violation|1|||
150154905|NCT02406261|541701500|FG000|Period 2|Withdrawal by Subject|0|||
150154906|NCT02406261|541701501|FG001|Period 2|Withdrawal by Subject|1|||
150154907|NCT01591460|541701504|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
150154908|NCT01591460|541701504|FG000|Overall Study|Futility Rule (Week 12)|7|||
150154909|NCT01591460|541701504|FG000|Overall Study|Futility Rule (Week 24)|3|||
150154910|NCT01591460|541701504|FG000|Overall Study|Rebound or Breakthrough|3|||
150154911|NCT01591460|541701504|FG000|Overall Study|Treatment Discontinued by Error|1|||
150154912|NCT01591460|541701504|FG000|Overall Study|Lost to Follow-up|1|||
150154913|NCT01591460|541701504|FG000|Overall Study|Noncompliance|1|||
150154914|NCT01591460|541701504|FG000|Overall Study|Participant Refusal|3|||
150154915|NCT01591460|541701504|FG000|Overall Study|Withdrawal by Subject|1|||
150154916|NCT01591460|541701504|FG000|Overall Study|Protocol Violation|1|||
150154917|NCT00610675|541701511|FG000|Overall Study|Untreated|4|||
150154918|NCT00610675|541701511|FG000|Overall Study|Adverse Event|67|||
150154919|NCT00610675|541701511|FG000|Overall Study|Insufficient Effect|31|||
150154920|NCT00610675|541701511|FG000|Overall Study|Withdrawal by Subject|28|||
150154921|NCT00610675|541701511|FG000|Overall Study|Reasons unrelated to trial|27|||
150154922|NCT00610675|541701511|FG000|Overall Study|Lack of Compliance|7|||
150154923|NCT00610675|541701511|FG000|Overall Study|Lost to Follow-up|31|||
150154924|NCT00610675|541701511|FG000|Overall Study|Other reason (not specified)|25|||
150154925|NCT01458249|541701512|FG000|Overall Study|Not treated|1|||
150154926|NCT01458249|541701512|FG000|Overall Study|Adverse Event|4|||
150154927|NCT01458249|541701512|FG000|Overall Study|Other|2|||
150154928|NCT01458249|541701512|FG000|Overall Study|Ongoing|1|||
150154929|NCT02176928|541703338|FG000|Overall Study|Lost to Follow-up|2|||
150154930|NCT02176928|541703339|FG001|Overall Study|Lost to Follow-up|4|||
150154931|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
150154932|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
150154933|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
150154934|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
150154935|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
150154936|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
150154937|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149815472|NCT04380701|540454627|FG006|Overall Study|Death|0|||
150154938|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
150154939|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
150154940|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
150154941|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154942|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154943|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154944|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
150154945|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
150154946|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154947|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154948|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154949|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154950|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
150154951|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
150154952|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
150154953|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
150154954|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
150154955|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
150154956|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
150154957|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
150154958|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
150154959|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
150154960|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
150154961|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
150154962|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154963|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154964|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
150154965|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
150154966|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154967|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154968|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154969|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154970|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
150154971|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154972|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154973|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
150154974|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
150154975|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154976|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154977|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154978|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154979|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154980|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
150154981|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154982|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154983|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154984|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154985|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
150154986|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154987|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154988|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154989|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154990|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
150154991|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150154992|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150154993|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150154994|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
150154995|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
150154996|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
150154997|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150154998|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150154999|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150155000|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
150155001|NCT02018861|541703346|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155002|NCT02018861|541703347|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155003|NCT02018861|541703348|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155004|NCT02018861|541703349|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
150155005|NCT02018861|541703350|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
150155006|NCT02018861|541703351|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155007|NCT02018861|541703352|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155008|NCT02018861|541703353|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155009|NCT02018861|541703354|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155010|NCT02018861|541703355|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
150155011|NCT02018861|541703346|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155012|NCT02018861|541703347|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155013|NCT02018861|541703348|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155014|NCT02018861|541703349|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155015|NCT02018861|541703350|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155016|NCT02018861|541703351|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155017|NCT02018861|541703352|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
150155018|NCT02018861|541703353|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
150155019|NCT02018861|541703354|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155020|NCT02018861|541703355|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
150155021|NCT02018861|541703346|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155022|NCT02018861|541703347|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155023|NCT02018861|541703348|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155024|NCT02018861|541703349|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155025|NCT02018861|541703350|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155026|NCT02018861|541703351|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155027|NCT02018861|541703352|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
150155028|NCT02018861|541703353|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
150155029|NCT02018861|541703354|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155030|NCT02018861|541703355|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
150155031|NCT02018861|541703346|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155032|NCT02018861|541703347|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155033|NCT02018861|541703348|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155034|NCT02018861|541703349|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155035|NCT02018861|541703350|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155036|NCT02018861|541703351|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155037|NCT02018861|541703352|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155038|NCT02018861|541703353|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155039|NCT02018861|541703354|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
150155040|NCT02018861|541703355|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
150155041|NCT02018861|541703346|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155042|NCT02018861|541703347|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155043|NCT02018861|541703348|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155044|NCT02018861|541703349|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155045|NCT02018861|541703350|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155046|NCT02018861|541703351|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155047|NCT02018861|541703352|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155048|NCT02018861|541703353|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155049|NCT02018861|541703354|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
150155050|NCT02018861|541703355|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
150155051|NCT02018861|541703346|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155052|NCT02018861|541703347|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155053|NCT02018861|541703348|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155054|NCT02018861|541703349|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155055|NCT02018861|541703350|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155056|NCT02018861|541703351|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155057|NCT02018861|541703352|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155058|NCT02018861|541703353|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155059|NCT02018861|541703354|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
150155060|NCT02018861|541703355|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
150155061|NCT00163215|541703359|FG000|Overall Study|Lack of Efficacy|3|||
150155062|NCT00163215|541703359|FG000|Overall Study|Withdrawal by Subject|5|||
150155063|NCT00163215|541703359|FG000|Overall Study|Other|7|||
150155064|NCT01668147|541703362|FG000|Overall Study|Withdrawal by Subject|6|||
150155065|NCT01809210|541703363|FG000|Overall Study|Withdrawal by Subject|0|||
150155066|NCT01809210|541703364|FG001|Overall Study|Withdrawal by Subject|0|||
150155067|NCT01809210|541703365|FG002|Overall Study|Withdrawal by Subject|1|||
150155068|NCT01809210|541703366|FG003|Overall Study|Withdrawal by Subject|1|||
150155069|NCT01809210|541703367|FG004|Overall Study|Withdrawal by Subject|1|||
150155070|NCT01809210|541703368|FG005|Overall Study|Withdrawal by Subject|0|||
150155071|NCT01809210|541703369|FG006|Overall Study|Withdrawal by Subject|4|||
150155072|NCT01809210|541703363|FG000|Overall Study|Death|1|||
150155073|NCT01809210|541703364|FG001|Overall Study|Death|1|||
150155074|NCT01809210|541703365|FG002|Overall Study|Death|2|||
150155075|NCT01809210|541703366|FG003|Overall Study|Death|0|||
150155076|NCT01809210|541703367|FG004|Overall Study|Death|1|||
150155077|NCT01809210|541703368|FG005|Overall Study|Death|3|||
150155078|NCT01809210|541703369|FG006|Overall Study|Death|1|||
150155079|NCT01115998|541703372|FG000|Overall Study|Lost to Follow-up|6|||
150155080|NCT01115998|541703373|FG001|Overall Study|Lost to Follow-up|6|||
150155081|NCT00224133|541703374|FG000|Overall Study|Adverse Event|93|||
150155082|NCT00224133|541703374|FG000|Overall Study|Protocol Violation|6|||
150155083|NCT00224133|541703374|FG000|Overall Study|Withdrawal by Subject|33|||
150155084|NCT00224133|541703374|FG000|Overall Study|Lack of Efficacy|58|||
150155085|NCT00224133|541703374|FG000|Overall Study|Lost to Follow-up|21|||
150155086|NCT00224133|541703374|FG000|Overall Study|Physician Decision|1|||
150155087|NCT00224133|541703374|FG000|Overall Study|Other|14|||
150155088|NCT03699124|541703378|FG000|Overall Study|Adverse Event|6|||
150155089|NCT03699124|541703379|FG001|Overall Study|Adverse Event|5|||
150155090|NCT03699124|541703380|FG002|Overall Study|Adverse Event|2|||
150155091|NCT03699124|541703378|FG000|Overall Study|Death|0|||
150155092|NCT03699124|541703379|FG001|Overall Study|Death|2|||
150155093|NCT03699124|541703380|FG002|Overall Study|Death|0|||
150155094|NCT03699124|541703378|FG000|Overall Study|Lost to Follow-up|20|||
150155095|NCT03699124|541703379|FG001|Overall Study|Lost to Follow-up|16|||
150155096|NCT03699124|541703380|FG002|Overall Study|Lost to Follow-up|15|||
150155097|NCT03699124|541703378|FG000|Overall Study|Protocol Violation|1|||
150155098|NCT03699124|541703379|FG001|Overall Study|Protocol Violation|0|||
150155099|NCT03699124|541703380|FG002|Overall Study|Protocol Violation|0|||
150155100|NCT03699124|541703378|FG000|Overall Study|Withdrawal by Subject|13|||
150155101|NCT03699124|541703379|FG001|Overall Study|Withdrawal by Subject|14|||
150155102|NCT03699124|541703380|FG002|Overall Study|Withdrawal by Subject|13|||
150155103|NCT03699124|541703378|FG000|Overall Study|Other reasons|5|||
150155104|NCT03699124|541703379|FG001|Overall Study|Other reasons|3|||
150155105|NCT03699124|541703380|FG002|Overall Study|Other reasons|10|||
150155106|NCT00506285|541703382|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
150155107|NCT00506285|541703383|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
150155108|NCT00506285|541703382|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
150155109|NCT00506285|541703383|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
150155110|NCT00506285|541703382|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
150155111|NCT00506285|541703383|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
150155112|NCT00506285|541703382|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
150155113|NCT00506285|541703383|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
150155114|NCT00506285|541703382|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
150155115|NCT00506285|541703383|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
150155116|NCT00551213|541703386|FG000|Overall Study|Adverse Event|6|||
150155117|NCT00551213|541703387|FG001|Overall Study|Adverse Event|3|||
150155118|NCT00551213|541703386|FG000|Overall Study|Progressive Disease|41|||
150155119|NCT00551213|541703387|FG001|Overall Study|Progressive Disease|12|||
150155120|NCT00551213|541703386|FG000|Overall Study|Withdrawal by Subject|2|||
150155121|NCT00551213|541703387|FG001|Overall Study|Withdrawal by Subject|0|||
150155122|NCT00551213|541703386|FG000|Overall Study|Not Treated|1|||
150155123|NCT00551213|541703387|FG001|Overall Study|Not Treated|2|||
150155124|NCT01890967|541703388|FG000|Overall Study|Adverse Event|3|||
150155125|NCT01890967|541703389|FG001|Overall Study|Adverse Event|3|||
150155126|NCT01890967|541703390|FG002|Overall Study|Adverse Event|3|||
150155127|NCT01890967|541703391|FG003|Overall Study|Adverse Event|2|||
150155128|NCT01890967|541703392|FG004|Overall Study|Adverse Event|1|||
150155129|NCT01890967|541703393|FG005|Overall Study|Adverse Event|7|||
150155130|NCT01890967|541703388|FG000|Overall Study|Death|1|||
150155131|NCT01890967|541703389|FG001|Overall Study|Death|0|||
149815473|NCT04380701|540454628|FG007|Overall Study|Death|0|||
149815474|NCT04380701|540454629|FG008|Overall Study|Death|0|||
149815475|NCT04380701|540454630|FG009|Overall Study|Death|0|||
149815476|NCT04380701|540454631|FG010|Overall Study|Death|0|||
149815477|NCT04380701|540454632|FG011|Overall Study|Death|0|||
149815478|NCT04380701|540454633|FG012|Overall Study|Death|0|||
149815479|NCT04380701|540454634|FG013|Overall Study|Death|0|||
149815480|NCT04380701|540454635|FG014|Overall Study|Death|0|||
149815481|NCT04380701|540454636|FG015|Overall Study|Death|0|||
150155132|NCT01890967|541703390|FG002|Overall Study|Death|0|||
150155133|NCT01890967|541703391|FG003|Overall Study|Death|0|||
150155134|NCT01890967|541703392|FG004|Overall Study|Death|0|||
150155135|NCT01890967|541703393|FG005|Overall Study|Death|0|||
149815482|NCT04380701|540454637|FG016|Overall Study|Death|0|||
150155136|NCT01890967|541703388|FG000|Overall Study|Lost to Follow-up|1|||
150155137|NCT01890967|541703389|FG001|Overall Study|Lost to Follow-up|1|||
150155138|NCT01890967|541703390|FG002|Overall Study|Lost to Follow-up|1|||
150155139|NCT01890967|541703391|FG003|Overall Study|Lost to Follow-up|1|||
150155140|NCT01890967|541703392|FG004|Overall Study|Lost to Follow-up|0|||
149815483|NCT04380701|540454638|FG017|Overall Study|Death|0|||
149815484|NCT04380701|540454639|FG018|Overall Study|Death|0|||
150155141|NCT01890967|541703393|FG005|Overall Study|Lost to Follow-up|1|||
150155142|NCT01890967|541703388|FG000|Overall Study|Protocol Violation|0|||
150155143|NCT01890967|541703389|FG001|Overall Study|Protocol Violation|3|||
150155144|NCT01890967|541703390|FG002|Overall Study|Protocol Violation|3|||
150155145|NCT01890967|541703391|FG003|Overall Study|Protocol Violation|2|||
150155146|NCT01890967|541703392|FG004|Overall Study|Protocol Violation|4|||
149815485|NCT04380701|540454640|FG019|Overall Study|Death|0|||
149815486|NCT04380701|540454641|FG020|Overall Study|Death|0|||
149815487|NCT04380701|540454642|FG021|Overall Study|Death|0|||
149815488|NCT04380701|540454643|FG022|Overall Study|Death|0|||
149815489|NCT04380701|540454644|FG023|Overall Study|Death|0|||
149815490|NCT04380701|540454645|FG024|Overall Study|Death|1|||
149815491|NCT04380701|540454646|FG025|Overall Study|Death|0|||
149815492|NCT04380701|540454647|FG026|Overall Study|Death|0|||
149815493|NCT04380701|540454648|FG027|Overall Study|Death|0|||
149815494|NCT04380701|540454649|FG028|Overall Study|Death|0|||
149815495|NCT04380701|540454650|FG029|Overall Study|Death|0|||
149815496|NCT04380701|540454651|FG030|Overall Study|Death|0|||
149815497|NCT04380701|540454652|FG031|Overall Study|Death|0|||
149815498|NCT04380701|540454653|FG032|Overall Study|Death|0|||
149815499|NCT04380701|540454654|FG033|Overall Study|Death|0|||
149815500|NCT04380701|540454621|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815501|NCT04380701|540454622|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815502|NCT04380701|540454623|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815503|NCT04380701|540454624|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815504|NCT04380701|540454625|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815505|NCT04380701|540454626|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815506|NCT04380701|540454627|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815507|NCT04380701|540454628|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815508|NCT04380701|540454629|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815509|NCT04380701|540454630|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815510|NCT04380701|540454631|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815511|NCT04380701|540454632|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815512|NCT04380701|540454633|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815513|NCT04380701|540454634|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815514|NCT04380701|540454635|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815515|NCT04380701|540454636|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815516|NCT04380701|540454637|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815517|NCT04380701|540454638|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815518|NCT04380701|540454639|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815519|NCT04380701|540454640|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815520|NCT04380701|540454641|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815521|NCT04380701|540454642|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
149815522|NCT04380701|540454643|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
149815523|NCT04380701|540454644|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
149815524|NCT04380701|540454645|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
149815525|NCT04380701|540454646|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815526|NCT04380701|540454647|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815527|NCT04380701|540454648|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815528|NCT04380701|540454649|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815529|NCT04380701|540454650|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815530|NCT04380701|540454651|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815531|NCT04380701|540454652|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815532|NCT04380701|540454653|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815533|NCT04380701|540454654|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149815534|NCT01021137|540454656|FG000|Overall Study|Lost to Follow-up|9|||
149815535|NCT01021137|540454657|FG001|Overall Study|Lost to Follow-up|4|||
149815536|NCT01021137|540454658|FG002|Overall Study|Lost to Follow-up|2|||
149815537|NCT01021137|540454659|FG003|Overall Study|Lost to Follow-up|6|||
149815538|NCT01021137|540454656|FG000|Overall Study|Withdrawal by Subject|1|||
149815539|NCT01021137|540454657|FG001|Overall Study|Withdrawal by Subject|0|||
150155147|NCT01890967|541703393|FG005|Overall Study|Protocol Violation|1|||
150155148|NCT01890967|541703388|FG000|Overall Study|Sponsor Decision|2|||
150155149|NCT01890967|541703389|FG001|Overall Study|Sponsor Decision|0|||
150155150|NCT01890967|541703390|FG002|Overall Study|Sponsor Decision|1|||
150155151|NCT01890967|541703391|FG003|Overall Study|Sponsor Decision|3|||
150155152|NCT01890967|541703392|FG004|Overall Study|Sponsor Decision|2|||
150155153|NCT01890967|541703393|FG005|Overall Study|Sponsor Decision|3|||
150155154|NCT01890967|541703388|FG000|Overall Study|Withdrawal by Subject|3|||
150155155|NCT01890967|541703389|FG001|Overall Study|Withdrawal by Subject|4|||
150155156|NCT01890967|541703390|FG002|Overall Study|Withdrawal by Subject|2|||
150155157|NCT01890967|541703391|FG003|Overall Study|Withdrawal by Subject|3|||
150155158|NCT01890967|541703392|FG004|Overall Study|Withdrawal by Subject|3|||
150155159|NCT01890967|541703393|FG005|Overall Study|Withdrawal by Subject|1|||
150155160|NCT01383993|541703396|FG000|Overall Study|Adverse Event|1|||
150155161|NCT01383993|541703397|FG001|Overall Study|Adverse Event|1|||
150155162|NCT01383993|541703398|FG002|Overall Study|Adverse Event|0|||
150155163|NCT01383993|541703396|FG000|Overall Study|Withdrawal by Subject|0|||
150155164|NCT01383993|541703397|FG001|Overall Study|Withdrawal by Subject|0|||
150155165|NCT01383993|541703398|FG002|Overall Study|Withdrawal by Subject|1|||
150155166|NCT01383993|541703396|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
150155167|NCT01383993|541703397|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
150155168|NCT01383993|541703398|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
150155169|NCT01489020|541703403|FG000|Overall Study|Withdrawal by Subject|1|||
150155170|NCT01489020|541703404|FG001|Overall Study|Withdrawal by Subject|0|||
150155171|NCT01489020|541703405|FG002|Overall Study|Withdrawal by Subject|0|||
150155172|NCT01489020|541703406|FG003|Overall Study|Withdrawal by Subject|0|||
150155173|NCT01489020|541703407|FG004|Overall Study|Withdrawal by Subject|0|||
150155174|NCT01489020|541703408|FG005|Overall Study|Withdrawal by Subject|0|||
150155175|NCT01489020|541703403|FG000|Overall Study|Adverse Event|0|||
150155176|NCT01489020|541703404|FG001|Overall Study|Adverse Event|0|||
150155177|NCT01489020|541703405|FG002|Overall Study|Adverse Event|3|||
150155178|NCT01489020|541703406|FG003|Overall Study|Adverse Event|0|||
150155179|NCT01489020|541703407|FG004|Overall Study|Adverse Event|3|||
150155180|NCT01489020|541703408|FG005|Overall Study|Adverse Event|0|||
150155181|NCT01489020|541703403|FG000|Overall Study|Concomitant disease|0|||
150155182|NCT01489020|541703404|FG001|Overall Study|Concomitant disease|0|||
150155183|NCT01489020|541703405|FG002|Overall Study|Concomitant disease|0|||
150155184|NCT01489020|541703406|FG003|Overall Study|Concomitant disease|0|||
150155185|NCT01489020|541703407|FG004|Overall Study|Concomitant disease|3|||
150155186|NCT01489020|541703408|FG005|Overall Study|Concomitant disease|0|||
150155187|NCT02451930|541703412|FG000|Overall Study|Death|0|||
150155188|NCT02451930|541703413|FG001|Overall Study|Death|15|||
150155189|NCT02451930|541703412|FG000|Overall Study|Lost to Follow-up|0|||
150155190|NCT02451930|541703413|FG001|Overall Study|Lost to Follow-up|3|||
150155191|NCT02451930|541703412|FG000|Overall Study|Sponsor Decision|2|||
150155192|NCT02451930|541703413|FG001|Overall Study|Sponsor Decision|10|||
150155193|NCT02451930|541703412|FG000|Overall Study|Withdrawal by Subject|0|||
150155194|NCT02451930|541703413|FG001|Overall Study|Withdrawal by Subject|1|||
150155195|NCT02451930|541703412|FG000|Overall Study|Other|0|||
150155196|NCT02451930|541703413|FG001|Overall Study|Other|1|||
150155197|NCT02485353|541703416|FG000|Overall Study|Death|1|||
150155198|NCT02485353|541703416|FG000|Overall Study|Disease Progression|1|||
150155199|NCT03354637|541703421|FG000|Double-blind Period|Protocol Violation|2|||
150155200|NCT03354637|541703422|FG001|Double-blind Period|Protocol Violation|0|||
150155201|NCT03354637|541703423|FG002|Double-blind Period|Protocol Violation|0|||
150155202|NCT03354637|541703421|FG000|Double-blind Period|Adverse Event|1|||
150155203|NCT03354637|541703422|FG001|Double-blind Period|Adverse Event|2|||
150155204|NCT03354637|541703423|FG002|Double-blind Period|Adverse Event|0|||
150155205|NCT03354637|541703421|FG000|Double-blind Period|Lost to Follow-up|3|||
150155206|NCT03354637|541703422|FG001|Double-blind Period|Lost to Follow-up|4|||
150155207|NCT03354637|541703423|FG002|Double-blind Period|Lost to Follow-up|3|||
150155208|NCT03354637|541703421|FG000|Double-blind Period|Withdrawal by Subject|10|||
150155209|NCT03354637|541703422|FG001|Double-blind Period|Withdrawal by Subject|6|||
150155210|NCT03354637|541703423|FG002|Double-blind Period|Withdrawal by Subject|4|||
150155211|NCT03354637|541703421|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
150155212|NCT03354637|541703422|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
150155213|NCT03354637|541703423|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
150155214|NCT03354637|541703421|FG000|Open Label Extension|Adverse Event|0|||
150155215|NCT03354637|541703422|FG001|Open Label Extension|Adverse Event|0|||
150155216|NCT03354637|541703423|FG002|Open Label Extension|Adverse Event|1|||
150155217|NCT03354637|541703421|FG000|Open Label Extension|Lost to Follow-up|0|||
150155218|NCT03354637|541703422|FG001|Open Label Extension|Lost to Follow-up|0|||
150155219|NCT03354637|541703423|FG002|Open Label Extension|Lost to Follow-up|2|||
150155220|NCT03354637|541703421|FG000|Open Label Extension|Withdrawal by Subject|0|||
150155221|NCT03354637|541703422|FG001|Open Label Extension|Withdrawal by Subject|0|||
150155222|NCT03354637|541703423|FG002|Open Label Extension|Withdrawal by Subject|5|||
150155223|NCT03354637|541703421|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
150155224|NCT03354637|541703422|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
150155225|NCT03354637|541703423|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
150155226|NCT03354637|541703421|FG000|Open Label Extension|Subject Noncompliance|0|||
150155227|NCT03354637|541703422|FG001|Open Label Extension|Subject Noncompliance|0|||
150155228|NCT03354637|541703423|FG002|Open Label Extension|Subject Noncompliance|1|||
150155229|NCT03354637|541703421|FG000|Open Label Extension|Lack of Efficacy|0|||
150155230|NCT03354637|541703422|FG001|Open Label Extension|Lack of Efficacy|0|||
150155231|NCT03354637|541703423|FG002|Open Label Extension|Lack of Efficacy|1|||
150155232|NCT03354637|541703421|FG000|Open Label Extension|Physician Decision|0|||
150155233|NCT03354637|541703422|FG001|Open Label Extension|Physician Decision|0|||
150155234|NCT03354637|541703423|FG002|Open Label Extension|Physician Decision|1|||
150155235|NCT02086552|541703426|FG000|Overall Study|Withdrawal by Subject|1|||
150155236|NCT04102540|541703430|FG000|Overall Study|Withdrawn by PI|2|||
150155237|NCT04102540|541703430|FG000|Overall Study|Lost to Follow-up|6|||
150155238|NCT01567163|541703433|FG000|Overall Study|Progressive Disease|2|||
150155239|NCT01567163|541703433|FG000|Overall Study|Lost to Follow-up|2|||
150155240|NCT03405662|541703434|FG000|Overall Study|COVID-19 restriction|1|||
150155241|NCT03405662|541703435|FG001|Overall Study|COVID-19 restriction|0|||
150155242|NCT03405662|541703434|FG000|Overall Study|unblinding|0|||
150155243|NCT03405662|541703435|FG001|Overall Study|unblinding|1|||
150155244|NCT03405662|541703434|FG000|Overall Study|placement in memory care facility|0|||
150155245|NCT03405662|541703435|FG001|Overall Study|placement in memory care facility|2|||
150155246|NCT00280293|541703436|FG000|Overall Study|Protocol Violation|3|||
150155247|NCT00280293|541703437|FG001|Overall Study|Protocol Violation|0|||
150155248|NCT00280293|541703436|FG000|Overall Study|Physician Decision|5|||
150155249|NCT00280293|541703437|FG001|Overall Study|Physician Decision|4|||
150155250|NCT00280293|541703436|FG000|Overall Study|Lost to Follow-up|14|||
150155251|NCT00280293|541703437|FG001|Overall Study|Lost to Follow-up|12|||
150155252|NCT00280293|541703436|FG000|Overall Study|Withdrawal by Subject|3|||
150155253|NCT00280293|541703437|FG001|Overall Study|Withdrawal by Subject|5|||
150155254|NCT00280293|541703436|FG000|Overall Study|Incarceration/Legal Reasons|1|||
150155255|NCT00280293|541703437|FG001|Overall Study|Incarceration/Legal Reasons|1|||
150155256|NCT00280293|541703436|FG000|Overall Study|Adverse Event|0|||
150155257|NCT00280293|541703437|FG001|Overall Study|Adverse Event|1|||
150155258|NCT01348854|541703440|FG000|Overall Study|Lost to Follow-up|2|||
150155259|NCT01348854|541703441|FG001|Overall Study|Lost to Follow-up|1|||
150155260|NCT01348854|541703440|FG000|Overall Study|Withdrawal by Subject|1|||
150155261|NCT01348854|541703441|FG001|Overall Study|Withdrawal by Subject|0|||
150155262|NCT01720797|541703442|FG000|Overall Study|Withdrawal by Subject|3|||
150155263|NCT01720797|541703443|FG001|Overall Study|Withdrawal by Subject|0|||
150155264|NCT00983619|541703446|FG000|Overall Study|Lost to Follow-up|0|||
150155265|NCT00983619|541703447|FG001|Overall Study|Lost to Follow-up|1|||
150155266|NCT00983619|541703448|FG002|Overall Study|Lost to Follow-up|0|||
150155267|NCT00983619|541703449|FG003|Overall Study|Lost to Follow-up|0|||
150155268|NCT00983619|541703450|FG004|Overall Study|Lost to Follow-up|0|||
150155269|NCT00983619|541703451|FG005|Overall Study|Lost to Follow-up|2|||
150155270|NCT00983619|541703452|FG006|Overall Study|Lost to Follow-up|0|||
150155271|NCT00983619|541703453|FG007|Overall Study|Lost to Follow-up|0|||
150155272|NCT00983619|541703454|FG008|Overall Study|Lost to Follow-up|0|||
150155273|NCT00983619|541703455|FG009|Overall Study|Lost to Follow-up|0|||
150155274|NCT00983619|541703456|FG010|Overall Study|Lost to Follow-up|0|||
150155275|NCT00983619|541703457|FG011|Overall Study|Lost to Follow-up|2|||
150155276|NCT00983619|541703446|FG000|Overall Study|Withdrawal by Subject|2|||
150155277|NCT00983619|541703447|FG001|Overall Study|Withdrawal by Subject|1|||
150155278|NCT00983619|541703448|FG002|Overall Study|Withdrawal by Subject|1|||
150155279|NCT00983619|541703449|FG003|Overall Study|Withdrawal by Subject|3|||
150155280|NCT00983619|541703450|FG004|Overall Study|Withdrawal by Subject|1|||
150155281|NCT00983619|541703451|FG005|Overall Study|Withdrawal by Subject|23|||
150155282|NCT00983619|541703452|FG006|Overall Study|Withdrawal by Subject|0|||
150155283|NCT00983619|541703453|FG007|Overall Study|Withdrawal by Subject|0|||
150155284|NCT00983619|541703454|FG008|Overall Study|Withdrawal by Subject|0|||
150155285|NCT00983619|541703455|FG009|Overall Study|Withdrawal by Subject|0|||
150155286|NCT00983619|541703456|FG010|Overall Study|Withdrawal by Subject|1|||
150155287|NCT00983619|541703457|FG011|Overall Study|Withdrawal by Subject|1|||
150155288|NCT00983619|541703446|FG000|Overall Study|Death|0|||
150155289|NCT00983619|541703447|FG001|Overall Study|Death|2|||
150155290|NCT00983619|541703448|FG002|Overall Study|Death|2|||
150155291|NCT00983619|541703449|FG003|Overall Study|Death|1|||
150155292|NCT00983619|541703450|FG004|Overall Study|Death|2|||
150155293|NCT00983619|541703451|FG005|Overall Study|Death|30|||
150155294|NCT00983619|541703452|FG006|Overall Study|Death|1|||
150155295|NCT00983619|541703453|FG007|Overall Study|Death|0|||
150155296|NCT00983619|541703454|FG008|Overall Study|Death|1|||
150155297|NCT00983619|541703455|FG009|Overall Study|Death|2|||
150155298|NCT00983619|541703456|FG010|Overall Study|Death|9|||
150155299|NCT00983619|541703457|FG011|Overall Study|Death|8|||
150155300|NCT00983619|541703446|FG000|Overall Study|Other|1|||
150155301|NCT00983619|541703447|FG001|Overall Study|Other|0|||
150155302|NCT00983619|541703448|FG002|Overall Study|Other|0|||
150155303|NCT00983619|541703449|FG003|Overall Study|Other|1|||
150155304|NCT00983619|541703450|FG004|Overall Study|Other|0|||
150155305|NCT00983619|541703451|FG005|Overall Study|Other|12|||
150155306|NCT00983619|541703452|FG006|Overall Study|Other|2|||
150155307|NCT00983619|541703453|FG007|Overall Study|Other|2|||
150155308|NCT00983619|541703454|FG008|Overall Study|Other|0|||
150155309|NCT00983619|541703455|FG009|Overall Study|Other|1|||
150155310|NCT00983619|541703456|FG010|Overall Study|Other|1|||
150155311|NCT00983619|541703457|FG011|Overall Study|Other|0|||
150155312|NCT00724061|541703458|FG000|Dose Escalation Phase|Adverse Event|2|||
150155313|NCT00724061|541703458|FG000|Dose Escalation Phase|Disease Progression|3|||
150155314|NCT04827134|541703459|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
150155315|NCT04827134|541703460|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
150155316|NCT04827134|541703461|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
150155317|NCT04827134|541703462|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
150155318|NCT02443103|541703467|FG000|Overall Study|Adverse Event|2|||
150155319|NCT02443103|541703467|FG000|Overall Study|Noncompliance|1|||
150155320|NCT03358329|541703468|FG000|Overall Study|Lost to Follow-up|2|||
150155321|NCT03358329|541703468|FG000|Overall Study|Withdrawal by Subject|2|||
150155322|NCT02982720|541703469|FG000|Overall Study|Adverse Event|3|||
150155323|NCT02982720|541703469|FG000|Overall Study|Death|1|||
150155324|NCT03875911|541703472|FG000|Overall Study|Lost to Follow-up|3|||
150155325|NCT03875911|541703473|FG001|Overall Study|Lost to Follow-up|6|||
150155326|NCT03875911|541703474|FG002|Overall Study|Lost to Follow-up|2|||
150155327|NCT03875911|541703472|FG000|Overall Study|Surgery cancelled|1|||
150155328|NCT03875911|541703473|FG001|Overall Study|Surgery cancelled|0|||
150155329|NCT03875911|541703474|FG002|Overall Study|Surgery cancelled|1|||
150155330|NCT03875911|541703472|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
150155331|NCT03875911|541703473|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
150155332|NCT03875911|541703474|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
150155333|NCT03824938|541703479|FG000|Overall Study|Withdrawal by Subject|2|||
150155334|NCT03824938|541703480|FG001|Overall Study|Withdrawal by Subject|1|||
150155335|NCT03824938|541703481|FG002|Overall Study|Withdrawal by Subject|0|||
150155336|NCT03824938|541703482|FG003|Overall Study|Withdrawal by Subject|2|||
150155337|NCT03824938|541703483|FG004|Overall Study|Withdrawal by Subject|0|||
150155338|NCT03824938|541703484|FG005|Overall Study|Withdrawal by Subject|1|||
150155339|NCT03824938|541703479|FG000|Overall Study|Lost to Follow-up|0|||
150155340|NCT03824938|541703480|FG001|Overall Study|Lost to Follow-up|1|||
150155341|NCT03824938|541703481|FG002|Overall Study|Lost to Follow-up|0|||
150155342|NCT03824938|541703482|FG003|Overall Study|Lost to Follow-up|0|||
150155343|NCT03824938|541703483|FG004|Overall Study|Lost to Follow-up|1|||
150155344|NCT03824938|541703484|FG005|Overall Study|Lost to Follow-up|0|||
150155345|NCT00287469|541703485|FG000|Overall Study|serious adverse event|1|||
150155346|NCT00287469|541703486|FG001|Overall Study|serious adverse event|6|||
150155347|NCT00287469|541703485|FG000|Overall Study|Adverse Event|1|||
150155348|NCT00287469|541703486|FG001|Overall Study|Adverse Event|1|||
150155349|NCT00287469|541703485|FG000|Overall Study|moved from area|144|||
150155350|NCT00287469|541703486|FG001|Overall Study|moved from area|138|||
150155351|NCT00287469|541703485|FG000|Overall Study|Lost to Follow-up|74|||
150155352|NCT00287469|541703486|FG001|Overall Study|Lost to Follow-up|69|||
150155353|NCT00393094|541703490|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
150155354|NCT00393094|541703490|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
150155355|NCT02019602|541703491|FG000|Screening Period|Ineligibility|4|||
150155356|NCT02019602|541703492|FG001|Screening Period|Ineligibility|0|||
150155357|NCT02019602|541703491|FG000|Screening Period|Adverse Event|1|||
150155358|NCT02019602|541703492|FG001|Screening Period|Adverse Event|0|||
150155359|NCT01556763|541703498|FG000|Overall Study|Withdrawal by Subject|0|||
150155360|NCT01556763|541703499|FG001|Overall Study|Withdrawal by Subject|1|||
150155361|NCT01556763|541703500|FG002|Overall Study|Withdrawal by Subject|0|||
150155362|NCT02258464|541703501|FG000|Overall Study|Progressive disease (PD)|9|||
150155363|NCT02258464|541703502|FG001|Overall Study|Progressive disease (PD)|17|||
150155364|NCT02258464|541703501|FG000|Overall Study|Study drug never administered|1|||
150155365|NCT02258464|541703502|FG001|Overall Study|Study drug never administered|1|||
150155366|NCT02258464|541703501|FG000|Overall Study|AE not related to clinical PD|1|||
150155367|NCT02258464|541703502|FG001|Overall Study|AE not related to clinical PD|3|||
150155368|NCT02258464|541703501|FG000|Overall Study|Withdrawal by Subject|5|||
150155369|NCT02258464|541703502|FG001|Overall Study|Withdrawal by Subject|4|||
150155370|NCT02258464|541703501|FG000|Overall Study|AE related to clinical PD|1|||
150155371|NCT02258464|541703502|FG001|Overall Study|AE related to clinical PD|0|||
149815540|NCT01021137|540454658|FG002|Overall Study|Withdrawal by Subject|0|||
149815541|NCT01021137|540454659|FG003|Overall Study|Withdrawal by Subject|3|||
149815542|NCT03125915|540454669|FG000|1 Month Follow up|Lost to Follow-up|3|||
149815543|NCT03125915|540454670|FG001|1 Month Follow up|Lost to Follow-up|3|||
149815544|NCT03125915|540454671|FG002|1 Month Follow up|Lost to Follow-up|2|||
149815545|NCT03125915|540454672|FG003|1 Month Follow up|Lost to Follow-up|3|||
149815546|NCT03125915|540454669|FG000|3 Month Follow-up|Lost to Follow-up|6|||
149815547|NCT03125915|540454670|FG001|3 Month Follow-up|Lost to Follow-up|4|||
149815548|NCT03125915|540454671|FG002|3 Month Follow-up|Lost to Follow-up|4|||
149815549|NCT03125915|540454672|FG003|3 Month Follow-up|Lost to Follow-up|2|||
149815550|NCT03125915|540454669|FG000|6 Month Follow-up|Lost to Follow-up|7|||
149815551|NCT03125915|540454670|FG001|6 Month Follow-up|Lost to Follow-up|3|||
149815552|NCT03125915|540454671|FG002|6 Month Follow-up|Lost to Follow-up|6|||
149815553|NCT03125915|540454672|FG003|6 Month Follow-up|Lost to Follow-up|3|||
150155372|NCT04170296|541703503|FG000|Overall Study|Adverse Event|1|||
150155373|NCT04170296|541703504|FG001|Overall Study|Adverse Event|0|||
150155374|NCT04170296|541703503|FG000|Overall Study|Withdrawal by Subject|3|||
150155375|NCT04170296|541703504|FG001|Overall Study|Withdrawal by Subject|2|||
150155376|NCT04170296|541703503|FG000|Overall Study|Lost to Follow-up|4|||
149815554|NCT02176642|540454677|FG000|Overall Study|Withdrawal by Subject|0|||
149815555|NCT02176642|540454678|FG001|Overall Study|Withdrawal by Subject|1|||
149815556|NCT00295620|540454680|FG000|Overall Study|Lost to Follow-up|9|||
150155377|NCT04170296|541703504|FG001|Overall Study|Lost to Follow-up|2|||
150155378|NCT00932646|541703505|FG000|Overall Study|Adverse Event|2|||
150155379|NCT00932646|541703506|FG001|Overall Study|Adverse Event|1|||
150155380|NCT00932646|541703507|FG002|Overall Study|Adverse Event|1|||
150155381|NCT00932646|541703508|FG003|Overall Study|Adverse Event|1|||
150155382|NCT00932646|541703505|FG000|Overall Study|Lost to Follow-up|2|||
150155383|NCT00932646|541703506|FG001|Overall Study|Lost to Follow-up|1|||
150155384|NCT00932646|541703507|FG002|Overall Study|Lost to Follow-up|0|||
150155385|NCT00932646|541703508|FG003|Overall Study|Lost to Follow-up|0|||
150155386|NCT00932646|541703505|FG000|Overall Study|Withdrawal by Subject|1|||
150155387|NCT00932646|541703506|FG001|Overall Study|Withdrawal by Subject|1|||
150155388|NCT00932646|541703507|FG002|Overall Study|Withdrawal by Subject|3|||
150155389|NCT00932646|541703508|FG003|Overall Study|Withdrawal by Subject|0|||
150155390|NCT00653263|541703509|FG000|Overall Study|Withdrawal by Subject|1|||
150155391|NCT00653263|541703509|FG000|Overall Study|Physician Decision|1|||
150155392|NCT00776100|541703510|FG000|Overall Study|Disease Progression|1|||
150155393|NCT00776100|541703511|FG001|Overall Study|Disease Progression|0|||
150155394|NCT03567993|541703514|FG000|Overall Study|Lost to Follow-up|4|||
150155395|NCT03567993|541703515|FG001|Overall Study|Lost to Follow-up|2|||
150155396|NCT03567993|541703514|FG000|Overall Study|Death|1|||
150155397|NCT03567993|541703515|FG001|Overall Study|Death|1|||
150155398|NCT03567993|541703514|FG000|Overall Study|Withdrawal by Subject|1|||
150155399|NCT03567993|541703515|FG001|Overall Study|Withdrawal by Subject|0|||
150155400|NCT02285595|541703516|FG000|Overall Study|Lost to Follow-up|14|||
150155401|NCT02285595|541703516|FG000|Overall Study|Withdrawal by Subject|1|||
150155402|NCT01960790|541703517|FG000|Overall Study|Survey forms could not be recovered|3|||
150155403|NCT01960790|541703517|FG000|Overall Study|Treat with Humira outside survey period|3|||
150155404|NCT01960790|541703517|FG000|Overall Study|Transferred to another hospital|4|||
150155405|NCT01960790|541703517|FG000|Overall Study|Unevaluable for safety|1|||
150155406|NCT04129580|541705077|FG000|Overall Study|Lost to Follow-up|14|||
150155407|NCT04129580|541705078|FG001|Overall Study|Lost to Follow-up|25|||
150155408|NCT02711995|541705081|FG000|Washout (90 Days)|Conflicting medication|1|||
150155409|NCT00322868|541705082|FG000|Overall Study|disease progression|1|||
150155410|NCT03615482|541705083|FG000|Overall Study|Death|1|||
150155411|NCT03615482|541705084|FG001|Overall Study|Death|0|||
150155412|NCT03615482|541705083|FG000|Overall Study|Lost to Follow-up|7|||
150155413|NCT03615482|541705084|FG001|Overall Study|Lost to Follow-up|7|||
150155414|NCT03615482|541705083|FG000|Overall Study|Physician Decision|2|||
150155415|NCT03615482|541705084|FG001|Overall Study|Physician Decision|3|||
150155416|NCT03615482|541705083|FG000|Overall Study|Withdrawal by Subject|7|||
150155417|NCT03615482|541705084|FG001|Overall Study|Withdrawal by Subject|7|||
150155418|NCT00590980|541705097|FG000|Overall Study|Did not meet all inclusion criteria|10|||
150155419|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
150155420|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
150155421|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
150155422|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
150155423|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
150155424|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
150155425|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
150155426|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
150155427|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
150155428|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
150155429|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
150155430|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
150155431|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
150155432|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
150155433|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
150155434|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
150155435|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
150155436|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
150155437|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
150155438|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
150155439|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
150155440|NCT02718417|541705098|FG000|Chemotherapy Phase (CP)|Other|2|||
150155441|NCT02718417|541705099|FG001|Chemotherapy Phase (CP)|Other|0|||
150155442|NCT02718417|541705100|FG002|Chemotherapy Phase (CP)|Other|1|||
150155443|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Adverse Event|21|||
150155444|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Adverse Event|26|||
150155445|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Adverse Event|0|||
150155446|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
150155447|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
150155448|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
150155449|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
149815557|NCT00295620|540454681|FG001|Overall Study|Lost to Follow-up|5|||
150155450|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
150155451|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
150155452|NCT02718417|541705098|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
150155453|NCT02718417|541705099|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
150155454|NCT02718417|541705100|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
150155455|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Physician's decision|6|||
150155456|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Physician's decision|7|||
150155457|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Physician's decision|0|||
150155458|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Progressive disease|100|||
150155459|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Progressive disease|88|||
150155460|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Progressive disease|0|||
150155461|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Other|2|||
150155462|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Other|1|||
150155463|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Other|0|||
150155464|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
150155465|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
150155466|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
150155467|NCT02718417|541705098|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
150155468|NCT02718417|541705099|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
150155469|NCT02718417|541705100|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
150155470|NCT02718417|541705098|FG000|Observation Phase (OP)|Adverse Event|0|||
150155471|NCT02718417|541705099|FG001|Observation Phase (OP)|Adverse Event|0|||
150155472|NCT02718417|541705100|FG002|Observation Phase (OP)|Adverse Event|1|||
150155473|NCT02718417|541705098|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
150155474|NCT02718417|541705099|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
150155475|NCT02718417|541705100|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
150155476|NCT02718417|541705098|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
150155477|NCT02718417|541705099|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
150155478|NCT02718417|541705100|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
150155479|NCT02718417|541705098|FG000|Observation Phase (OP)|Physician Decision|0|||
150155480|NCT02718417|541705099|FG001|Observation Phase (OP)|Physician Decision|0|||
150155481|NCT02718417|541705100|FG002|Observation Phase (OP)|Physician Decision|9|||
150155482|NCT02718417|541705098|FG000|Observation Phase (OP)|Progressive disease|0|||
150155483|NCT02718417|541705099|FG001|Observation Phase (OP)|Progressive disease|0|||
150155484|NCT02718417|541705100|FG002|Observation Phase (OP)|Progressive disease|92|||
150155485|NCT02718417|541705098|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
150155486|NCT02718417|541705099|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
150155487|NCT02718417|541705100|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
150155488|NCT02718417|541705098|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
150155489|NCT02718417|541705099|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
150155490|NCT02718417|541705100|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
150155491|NCT02718417|541705098|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
150155492|NCT02718417|541705099|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
150155493|NCT02718417|541705100|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
150155494|NCT02718417|541705098|FG000|Observation Phase (OP)|Other|0|||
150155495|NCT02718417|541705099|FG001|Observation Phase (OP)|Other|0|||
150155496|NCT02718417|541705100|FG002|Observation Phase (OP)|Other|7|||
150155497|NCT02718417|541705098|FG000|Follow-up Phase|Adverse Event|3|||
150155498|NCT02718417|541705099|FG001|Follow-up Phase|Adverse Event|1|||
150155499|NCT02718417|541705100|FG002|Follow-up Phase|Adverse Event|1|||
150155500|NCT02718417|541705098|FG000|Follow-up Phase|Other|4|||
150155501|NCT02718417|541705099|FG001|Follow-up Phase|Other|6|||
150155502|NCT02718417|541705100|FG002|Follow-up Phase|Other|4|||
150155503|NCT02718417|541705098|FG000|Follow-up Phase|Withdrawal by Subject|19|||
150155504|NCT02718417|541705099|FG001|Follow-up Phase|Withdrawal by Subject|17|||
150155505|NCT02718417|541705100|FG002|Follow-up Phase|Withdrawal by Subject|5|||
150155506|NCT02718417|541705098|FG000|Follow-up Phase|Study terminated by sponsor|100|||
150155507|NCT02718417|541705099|FG001|Follow-up Phase|Study terminated by sponsor|138|||
150155508|NCT02718417|541705100|FG002|Follow-up Phase|Study terminated by sponsor|6|||
150155509|NCT02718417|541705098|FG000|Follow-up Phase|Lost to Follow-up|2|||
150155510|NCT02718417|541705099|FG001|Follow-up Phase|Lost to Follow-up|3|||
150155511|NCT02718417|541705100|FG002|Follow-up Phase|Lost to Follow-up|0|||
150155512|NCT02718417|541705098|FG000|Follow-up Phase|Death leading to discontinuation|7|||
150155513|NCT02718417|541705099|FG001|Follow-up Phase|Death leading to discontinuation|7|||
150155514|NCT02718417|541705100|FG002|Follow-up Phase|Death leading to discontinuation|3|||
150155515|NCT02718417|541705098|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
150155516|NCT02718417|541705099|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
150155517|NCT02718417|541705100|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
150155518|NCT02718417|541705098|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
150155519|NCT02718417|541705099|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
150155520|NCT02718417|541705100|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
150155521|NCT02718417|541705098|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
150155522|NCT02718417|541705099|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
150155523|NCT02718417|541705100|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
150155524|NCT02718417|541705098|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
150155525|NCT02718417|541705099|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
150155526|NCT02718417|541705100|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
150155527|NCT02718417|541705098|FG000|Long-term Follow-up Phase|Other|0|||
150155528|NCT02718417|541705099|FG001|Long-term Follow-up Phase|Other|2|||
150155529|NCT02718417|541705100|FG002|Long-term Follow-up Phase|Other|0|||
150155530|NCT01023308|541705101|FG000|Overall Study|Abnormal test proceedure results|3|||
150155531|NCT01023308|541705102|FG001|Overall Study|Abnormal test proceedure results|8|||
150155532|NCT01023308|541705101|FG000|Overall Study|Administrative problems|2|||
150155533|NCT01023308|541705102|FG001|Overall Study|Administrative problems|1|||
150155534|NCT01023308|541705101|FG000|Overall Study|Adverse Event|130|||
149815558|NCT00295620|540454680|FG000|Overall Study|Withdrawal by Subject|37|||
149815559|NCT00295620|540454681|FG001|Overall Study|Withdrawal by Subject|50|||
149815560|NCT00295620|540454680|FG000|Overall Study|Death|206|||
149815561|NCT00295620|540454681|FG001|Overall Study|Death|207|||
149815562|NCT00295620|540454680|FG000|Overall Study|Other reasons|10|||
149815563|NCT00295620|540454681|FG001|Overall Study|Other reasons|9|||
149815564|NCT00295620|540454680|FG000|Overall Study|Discontinuation by sponsor|580|||
149815565|NCT00295620|540454681|FG001|Overall Study|Discontinuation by sponsor|593|||
149815566|NCT00295620|540454680|FG000|Overall Study|Protocol Violation|30|||
149815567|NCT00295620|540454681|FG001|Overall Study|Protocol Violation|32|||
149815568|NCT01309828|540454682|FG000|Overall Study|Adverse Event|10|||
149815569|NCT01309828|540454683|FG001|Overall Study|Adverse Event|11|||
149815570|NCT01309828|540454682|FG000|Overall Study|Voluntary Withdrawal|5|||
149815571|NCT01309828|540454683|FG001|Overall Study|Voluntary Withdrawal|4|||
149815572|NCT01309828|540454682|FG000|Overall Study|Major Protocol Deviation|0|||
149815573|NCT01309828|540454683|FG001|Overall Study|Major Protocol Deviation|1|||
149815574|NCT01309828|540454682|FG000|Overall Study|Other|1|||
149815575|NCT01309828|540454683|FG001|Overall Study|Other|0|||
149815576|NCT00217971|540454684|FG000|Overall Study|Adverse Event|1|||
149815577|NCT00217971|540454685|FG001|Overall Study|Adverse Event|1|||
149815578|NCT00217971|540454684|FG000|Overall Study|Lost to Follow-up|15|||
149815579|NCT00217971|540454685|FG001|Overall Study|Lost to Follow-up|19|||
149815580|NCT00217971|540454684|FG000|Overall Study|Physician Decision|0|||
149815581|NCT00217971|540454685|FG001|Overall Study|Physician Decision|1|||
149815582|NCT00217971|540454684|FG000|Overall Study|Withdrawal by Subject|7|||
149815583|NCT00217971|540454685|FG001|Overall Study|Withdrawal by Subject|12|||
149815584|NCT00217971|540454684|FG000|Overall Study|non compliant|1|||
149815585|NCT00217971|540454685|FG001|Overall Study|non compliant|0|||
149815586|NCT02556632|540454686|FG000|Overall Study|Lost to Follow-up|1|||
149815587|NCT02556632|540454687|FG001|Overall Study|Lost to Follow-up|0|||
149815588|NCT02556632|540454688|FG002|Overall Study|Lost to Follow-up|0|||
149815589|NCT02556632|540454686|FG000|Overall Study|Disliked Intervention|1|||
149815590|NCT02556632|540454687|FG001|Overall Study|Disliked Intervention|1|||
149815591|NCT02556632|540454688|FG002|Overall Study|Disliked Intervention|1|||
149815592|NCT02556632|540454686|FG000|Overall Study|No Reason|1|||
149815593|NCT02556632|540454687|FG001|Overall Study|No Reason|0|||
149815594|NCT02556632|540454688|FG002|Overall Study|No Reason|1|||
149815595|NCT02556632|540454686|FG000|Overall Study|Personal Issues|0|||
149815596|NCT02556632|540454687|FG001|Overall Study|Personal Issues|1|||
149815597|NCT02556632|540454688|FG002|Overall Study|Personal Issues|1|||
149815598|NCT02556632|540454686|FG000|Overall Study|Changed Mind|0|||
149815599|NCT02556632|540454687|FG001|Overall Study|Changed Mind|1|||
149815600|NCT02556632|540454688|FG002|Overall Study|Changed Mind|0|||
149815601|NCT02556632|540454686|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
149815602|NCT02556632|540454687|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
149815603|NCT02556632|540454688|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
149815604|NCT02556632|540454686|FG000|Overall Study|Unrelated Adverse Event|1|||
149815605|NCT02556632|540454687|FG001|Overall Study|Unrelated Adverse Event|0|||
149815606|NCT02556632|540454688|FG002|Overall Study|Unrelated Adverse Event|3|||
149815607|NCT02556632|540454686|FG000|Overall Study|Related Adverse Event|0|||
149815608|NCT02556632|540454687|FG001|Overall Study|Related Adverse Event|1|||
149815609|NCT02556632|540454688|FG002|Overall Study|Related Adverse Event|0|||
149815610|NCT02556632|540454686|FG000|Overall Study|Possibly Related Adverse Event|0|||
149815611|NCT02556632|540454687|FG001|Overall Study|Possibly Related Adverse Event|0|||
149815612|NCT02556632|540454688|FG002|Overall Study|Possibly Related Adverse Event|1|||
149815613|NCT02556632|540454686|FG000|Overall Study|Did Not Start RT|0|||
149815614|NCT02556632|540454687|FG001|Overall Study|Did Not Start RT|1|||
150155535|NCT01023308|541705102|FG001|Overall Study|Adverse Event|66|||
150155536|NCT01023308|541705101|FG000|Overall Study|Death|21|||
150155537|NCT01023308|541705102|FG001|Overall Study|Death|17|||
149815615|NCT02556632|540454688|FG002|Overall Study|Did Not Start RT|0|||
149815616|NCT02556632|540454686|FG000|Overall Study|Ineligible|0|||
149815617|NCT02556632|540454687|FG001|Overall Study|Ineligible|1|||
149815618|NCT02556632|540454688|FG002|Overall Study|Ineligible|0|||
150155538|NCT01023308|541705101|FG000|Overall Study|Disease progression|82|||
150155539|NCT01023308|541705102|FG001|Overall Study|Disease progression|153|||
150155540|NCT01023308|541705101|FG000|Overall Study|New Cancer therapy|4|||
150155541|NCT01023308|541705102|FG001|Overall Study|New Cancer therapy|7|||
150155542|NCT01023308|541705101|FG000|Overall Study|Protocol Violation|3|||
150155543|NCT01023308|541705102|FG001|Overall Study|Protocol Violation|4|||
150155544|NCT01023308|541705101|FG000|Overall Study|Untreated|5|||
150155545|NCT01023308|541705102|FG001|Overall Study|Untreated|5|||
150155546|NCT01023308|541705101|FG000|Overall Study|Lost to Follow-up|1|||
150155547|NCT01023308|541705102|FG001|Overall Study|Lost to Follow-up|0|||
150155548|NCT01023308|541705101|FG000|Overall Study|Withdrawal by Subject|34|||
150155549|NCT01023308|541705102|FG001|Overall Study|Withdrawal by Subject|18|||
150155550|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
150155551|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
150155552|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
150155553|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
150155554|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
150155555|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
150155556|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
150155557|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
150155558|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
150155559|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
150155560|NCT01646320|541705103|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
150155561|NCT01646320|541705104|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
150155562|NCT01646320|541705103|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
150155563|NCT01646320|541705104|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
150155564|NCT01646320|541705103|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
150155565|NCT01646320|541705104|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
150155566|NCT01646320|541705103|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
150155567|NCT01646320|541705104|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
150155568|NCT01646320|541705103|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
150155569|NCT01646320|541705104|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
150155570|NCT01646320|541705103|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
150155571|NCT01646320|541705104|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
150155572|NCT02892409|541705105|FG000|Overall Study|Adverse Event|1|||
150155573|NCT02892409|541705106|FG001|Overall Study|Adverse Event|0|||
150155574|NCT02892409|541705105|FG000|Overall Study|Withdrawal by Subject|2|||
150155575|NCT02892409|541705106|FG001|Overall Study|Withdrawal by Subject|1|||
150155576|NCT01440049|541705109|FG000|Overall Study|Adverse Event|5|||
150155577|NCT02268552|541705110|FG000|Part 1|Death|1|||
150155578|NCT02268552|541705111|FG001|Part 1|Death|1|||
150155579|NCT02268552|541705112|FG002|Part 1|Death|1|||
150155580|NCT02268552|541705113|FG003|Part 1|Death|2|||
150155581|NCT02268552|541705114|FG004|Part 1|Death|0|||
150155582|NCT02268552|541705115|FG005|Part 1|Death|0|||
150155583|NCT02268552|541705116|FG006|Part 1|Death|0|||
150155584|NCT02268552|541705110|FG000|Part 1|Subject/guardian decision|0|||
150155585|NCT02268552|541705111|FG001|Part 1|Subject/guardian decision|0|||
150155586|NCT02268552|541705112|FG002|Part 1|Subject/guardian decision|0|||
150155587|NCT02268552|541705113|FG003|Part 1|Subject/guardian decision|1|||
150155588|NCT02268552|541705114|FG004|Part 1|Subject/guardian decision|0|||
150155589|NCT02268552|541705115|FG005|Part 1|Subject/guardian decision|0|||
150155590|NCT02268552|541705116|FG006|Part 1|Subject/guardian decision|0|||
150155591|NCT02268552|541705110|FG000|Part 2|Death|0|||
150155592|NCT02268552|541705111|FG001|Part 2|Death|0|||
150155593|NCT02268552|541705112|FG002|Part 2|Death|0|||
150155594|NCT02268552|541705113|FG003|Part 2|Death|0|||
150155595|NCT02268552|541705114|FG004|Part 2|Death|0|||
150155596|NCT02268552|541705115|FG005|Part 2|Death|0|||
150155597|NCT02268552|541705116|FG006|Part 2|Death|2|||
150155598|NCT02268552|541705110|FG000|Part 2|Subject/guardian decision|0|||
150155599|NCT02268552|541705111|FG001|Part 2|Subject/guardian decision|0|||
150155600|NCT02268552|541705112|FG002|Part 2|Subject/guardian decision|0|||
150155601|NCT02268552|541705113|FG003|Part 2|Subject/guardian decision|0|||
150155602|NCT02268552|541705114|FG004|Part 2|Subject/guardian decision|0|||
150155603|NCT02268552|541705115|FG005|Part 2|Subject/guardian decision|0|||
150155604|NCT02268552|541705116|FG006|Part 2|Subject/guardian decision|1|||
150155605|NCT02268552|541705110|FG000|Part 3 Extension|Death|0|||
150155606|NCT02268552|541705111|FG001|Part 3 Extension|Death|1|||
150155607|NCT02268552|541705112|FG002|Part 3 Extension|Death|1|||
150155608|NCT02268552|541705113|FG003|Part 3 Extension|Death|1|||
150155609|NCT02268552|541705114|FG004|Part 3 Extension|Death|1|||
150155610|NCT02268552|541705115|FG005|Part 3 Extension|Death|1|||
150155611|NCT02268552|541705116|FG006|Part 3 Extension|Death|0|||
150155612|NCT02268552|541705110|FG000|Part 3 Extension|Early termination of trial|1|||
150155613|NCT02268552|541705111|FG001|Part 3 Extension|Early termination of trial|0|||
150155614|NCT02268552|541705112|FG002|Part 3 Extension|Early termination of trial|0|||
150155615|NCT02268552|541705113|FG003|Part 3 Extension|Early termination of trial|0|||
150155616|NCT02268552|541705114|FG004|Part 3 Extension|Early termination of trial|2|||
150155617|NCT02268552|541705115|FG005|Part 3 Extension|Early termination of trial|9|||
150155618|NCT02268552|541705116|FG006|Part 3 Extension|Early termination of trial|11|||
150155619|NCT02268552|541705110|FG000|Part 3 Extension|Subject/guardian decision|0|||
150155620|NCT02268552|541705111|FG001|Part 3 Extension|Subject/guardian decision|0|||
150155621|NCT02268552|541705112|FG002|Part 3 Extension|Subject/guardian decision|0|||
150155622|NCT02268552|541705113|FG003|Part 3 Extension|Subject/guardian decision|0|||
150155623|NCT02268552|541705114|FG004|Part 3 Extension|Subject/guardian decision|0|||
150155624|NCT02268552|541705115|FG005|Part 3 Extension|Subject/guardian decision|0|||
150155625|NCT02268552|541705116|FG006|Part 3 Extension|Subject/guardian decision|1|||
150155626|NCT02748512|541705120|FG000|Overall Study|Lost to Follow-up|1|||
150155627|NCT02748512|541705121|FG001|Overall Study|Lost to Follow-up|1|||
150155628|NCT00997243|541705122|FG000|Overall Study|Early termination of study by sponsor|7|||
150155629|NCT03415022|541705129|FG000|Overall Study|Withdrawal by Subject|1|||
150155630|NCT03415022|541705130|FG001|Overall Study|Withdrawal by Subject|2|||
150155631|NCT03415022|541705129|FG000|Overall Study|COVID-19 Suspension|2|||
150155632|NCT03415022|541705130|FG001|Overall Study|COVID-19 Suspension|3|||
150155633|NCT03415022|541705129|FG000|Overall Study|Lost to Follow-up|2|||
150155634|NCT03415022|541705130|FG001|Overall Study|Lost to Follow-up|0|||
150155635|NCT03583541|541705136|FG000|Overall Study|Lost to Follow-up|31|||
150155636|NCT03583541|541705137|FG001|Overall Study|Lost to Follow-up|65|||
150155637|NCT00884286|541705138|FG000|Overall Study|Progressive disease|21|||
150155638|NCT00884286|541705139|FG001|Overall Study|Progressive disease|28|||
150155639|NCT00884286|541705138|FG000|Overall Study|Toxicity|4|||
150155640|NCT00884286|541705139|FG001|Overall Study|Toxicity|1|||
150155641|NCT00884286|541705138|FG000|Overall Study|Death|2|||
150155642|NCT00884286|541705139|FG001|Overall Study|Death|2|||
150155643|NCT00884286|541705138|FG000|Overall Study|Physician Decision|1|||
150155644|NCT00884286|541705139|FG001|Overall Study|Physician Decision|0|||
150155645|NCT00884286|541705138|FG000|Overall Study|Septic shock|1|||
150155646|NCT00884286|541705139|FG001|Overall Study|Septic shock|0|||
150155647|NCT00884286|541705138|FG000|Overall Study|Thrombus in right auricle|1|||
150155648|NCT00884286|541705139|FG001|Overall Study|Thrombus in right auricle|0|||
150155649|NCT00884286|541705138|FG000|Overall Study|Not treated|2|||
150155650|NCT00884286|541705139|FG001|Overall Study|Not treated|1|||
150155651|NCT00884286|541705138|FG000|Overall Study|Comprised lung carcinoma|0|||
150155652|NCT00884286|541705139|FG001|Overall Study|Comprised lung carcinoma|1|||
150155653|NCT01196104|541705140|FG000|Overall Study|Lost to Follow-up|1|||
150155654|NCT01196104|541705141|FG001|Overall Study|Lost to Follow-up|0|||
150155655|NCT01196104|541705140|FG000|Overall Study|Physician Decision|0|||
150155656|NCT01196104|541705141|FG001|Overall Study|Physician Decision|1|||
150155657|NCT01196104|541705140|FG000|Overall Study|Withdrawal by Subject|3|||
150155658|NCT01196104|541705141|FG001|Overall Study|Withdrawal by Subject|3|||
150155659|NCT01196104|541705140|FG000|Overall Study|Various|0|||
150155660|NCT01196104|541705141|FG001|Overall Study|Various|1|||
150155661|NCT01094171|541705146|FG000|Overall Study|Lost to Follow-up|2|||
150155662|NCT01094171|541705146|FG000|Overall Study|Informed consent withdrawal|4|||
150155663|NCT01094171|541705146|FG000|Overall Study|Migration from the study area|3|||
150155664|NCT01094171|541705146|FG000|Overall Study|Other|1|||
150155665|NCT00594932|541705147|FG000|First 3 Months|Withdrawal by Subject|1|||
150155666|NCT00594932|541705148|FG001|First 3 Months|Withdrawal by Subject|3|||
150155667|NCT00594932|541705147|FG000|Final 3 Months|Withdrawal by Subject|4|||
150155668|NCT00594932|541705148|FG001|Final 3 Months|Withdrawal by Subject|3|||
150155669|NCT01536145|541705149|FG000|Overall Study|Progressive disease|3|||
150155670|NCT01536145|541705150|FG001|Overall Study|Progressive disease|4|||
150155671|NCT01536145|541705151|FG002|Overall Study|Progressive disease|1|||
150155672|NCT01536145|541705152|FG003|Overall Study|Progressive disease|2|||
150155673|NCT01536145|541705153|FG004|Overall Study|Progressive disease|1|||
150155674|NCT01536145|541705154|FG005|Overall Study|Progressive disease|2|||
150155675|NCT01536145|541705155|FG006|Overall Study|Progressive disease|1|||
150155676|NCT01536145|541705156|FG007|Overall Study|Progressive disease|2|||
150155677|NCT01536145|541705157|FG008|Overall Study|Progressive disease|1|||
150155678|NCT01536145|541705158|FG009|Overall Study|Progressive disease|3|||
150155679|NCT01536145|541705159|FG010|Overall Study|Progressive disease|3|||
150155680|NCT01536145|541705149|FG000|Overall Study|Withdrawal by Subject|0|||
150155681|NCT01536145|541705150|FG001|Overall Study|Withdrawal by Subject|0|||
150155682|NCT01536145|541705151|FG002|Overall Study|Withdrawal by Subject|1|||
150155683|NCT01536145|541705152|FG003|Overall Study|Withdrawal by Subject|0|||
150155684|NCT01536145|541705153|FG004|Overall Study|Withdrawal by Subject|0|||
150155685|NCT01536145|541705154|FG005|Overall Study|Withdrawal by Subject|1|||
150155686|NCT01536145|541705155|FG006|Overall Study|Withdrawal by Subject|0|||
150155687|NCT01536145|541705156|FG007|Overall Study|Withdrawal by Subject|0|||
150155688|NCT01536145|541705157|FG008|Overall Study|Withdrawal by Subject|2|||
150155689|NCT01536145|541705158|FG009|Overall Study|Withdrawal by Subject|0|||
150155690|NCT01536145|541705159|FG010|Overall Study|Withdrawal by Subject|2|||
150155691|NCT01536145|541705149|FG000|Overall Study|Other|0|||
150155692|NCT01536145|541705150|FG001|Overall Study|Other|0|||
150155693|NCT01536145|541705151|FG002|Overall Study|Other|0|||
150155694|NCT01536145|541705152|FG003|Overall Study|Other|0|||
150155695|NCT01536145|541705153|FG004|Overall Study|Other|1|||
150155696|NCT01536145|541705154|FG005|Overall Study|Other|0|||
150155697|NCT01536145|541705155|FG006|Overall Study|Other|0|||
150155698|NCT01536145|541705156|FG007|Overall Study|Other|0|||
150155699|NCT01536145|541705157|FG008|Overall Study|Other|0|||
150155700|NCT01536145|541705158|FG009|Overall Study|Other|3|||
150155701|NCT01536145|541705159|FG010|Overall Study|Other|2|||
150155702|NCT01536145|541705149|FG000|Overall Study|Death|0|||
150155703|NCT01536145|541705150|FG001|Overall Study|Death|0|||
150155704|NCT01536145|541705151|FG002|Overall Study|Death|0|||
150155705|NCT01536145|541705152|FG003|Overall Study|Death|0|||
150155706|NCT01536145|541705153|FG004|Overall Study|Death|0|||
150155707|NCT01536145|541705154|FG005|Overall Study|Death|0|||
150155708|NCT01536145|541705155|FG006|Overall Study|Death|1|||
150155709|NCT01536145|541705156|FG007|Overall Study|Death|0|||
150155710|NCT01536145|541705157|FG008|Overall Study|Death|0|||
150155711|NCT01536145|541705158|FG009|Overall Study|Death|0|||
150155712|NCT01536145|541705159|FG010|Overall Study|Death|0|||
150155713|NCT01536145|541705149|FG000|Overall Study|Adverse Event|0|||
150155714|NCT01536145|541705150|FG001|Overall Study|Adverse Event|0|||
150155715|NCT01536145|541705151|FG002|Overall Study|Adverse Event|0|||
150155716|NCT01536145|541705152|FG003|Overall Study|Adverse Event|0|||
150155717|NCT01536145|541705153|FG004|Overall Study|Adverse Event|0|||
150155718|NCT01536145|541705154|FG005|Overall Study|Adverse Event|0|||
150155719|NCT01536145|541705155|FG006|Overall Study|Adverse Event|0|||
150155720|NCT01536145|541705156|FG007|Overall Study|Adverse Event|2|||
150155721|NCT01536145|541705157|FG008|Overall Study|Adverse Event|0|||
150155722|NCT01536145|541705158|FG009|Overall Study|Adverse Event|0|||
150155723|NCT01536145|541705159|FG010|Overall Study|Adverse Event|3|||
150155724|NCT00088205|541705164|FG000|Overall Study|Adverse Event|4|||
150155725|NCT00088205|541705164|FG000|Overall Study|Progressive Disease|51|||
150155726|NCT00088205|541705164|FG000|Overall Study|Physician Decision|1|||
150155727|NCT00088205|541705164|FG000|Overall Study|Death Due to Study Disease|4|||
150155728|NCT05199233|541705165|FG000|Overall Study|Lack of Efficacy|1|||
150155729|NCT00688259|541705170|FG000|Overall Study|Lost to Follow-up|2|||
150155730|NCT00688259|541705171|FG001|Overall Study|Lost to Follow-up|4|||
150155731|NCT00688259|541705170|FG000|Overall Study|Physician Decision|1|||
150155732|NCT00688259|541705171|FG001|Overall Study|Physician Decision|0|||
150155733|NCT00688259|541705170|FG000|Overall Study|Withdrawal by Subject|2|||
150155734|NCT00688259|541705171|FG001|Overall Study|Withdrawal by Subject|0|||
150155735|NCT00688259|541705170|FG000|Overall Study|Declined Interview|2|||
150155736|NCT00688259|541705171|FG001|Overall Study|Declined Interview|3|||
150155737|NCT00688259|541705170|FG000|Overall Study|Hospitalized at Follow-up|0|||
150155738|NCT00688259|541705171|FG001|Overall Study|Hospitalized at Follow-up|1|||
150155739|NCT00065468|541705179|FG000|Overall Study|Death|172|||
150155740|NCT00065468|541705180|FG001|Overall Study|Death|169|||
150155741|NCT00065468|541705181|FG002|Overall Study|Death|171|||
150155742|NCT00065468|541705179|FG000|Overall Study|Withdrawal by Subject|3|||
150155743|NCT00065468|541705180|FG001|Overall Study|Withdrawal by Subject|4|||
150155744|NCT00065468|541705181|FG002|Overall Study|Withdrawal by Subject|5|||
150155745|NCT00065468|541705179|FG000|Overall Study|Lost to Follow-up|5|||
150155746|NCT00065468|541705180|FG001|Overall Study|Lost to Follow-up|3|||
150155747|NCT00065468|541705181|FG002|Overall Study|Lost to Follow-up|2|||
150155748|NCT00065468|541705179|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
150155749|NCT00065468|541705180|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
150155750|NCT00065468|541705181|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
150155751|NCT00065468|541705179|FG000|Overall Study|Disease progression|0|||
150155752|NCT00065468|541705180|FG001|Overall Study|Disease progression|0|||
150155753|NCT00065468|541705181|FG002|Overall Study|Disease progression|1|||
150155754|NCT00065468|541705179|FG000|Overall Study|Other|14|||
150155755|NCT00065468|541705180|FG001|Overall Study|Other|24|||
150155756|NCT00065468|541705181|FG002|Overall Study|Other|18|||
150155757|NCT01058863|541705182|FG000|Overall Study|Lost to Follow-up|1|||
150155758|NCT01058863|541705182|FG000|Overall Study|Withdrawal by Subject|1|||
150155759|NCT01058863|541705182|FG000|Overall Study|Sponsor requested withdrawal|1|||
150155760|NCT01058863|541705182|FG000|Overall Study|Randomized in error|1|||
150155761|NCT03653416|541705183|FG000|Overall Study|Protocol Violation|6|||
150155762|NCT03653416|541705184|FG001|Overall Study|Protocol Violation|1|||
150155763|NCT03050398|541705190|FG000|Overall Study|Study terminated by sponsor|8|||
150155764|NCT01083160|541705191|FG000|Overall Study|Adverse Event|1|||
150155765|NCT01951092|541705192|FG000|Overall Study|Lost to Follow-up|10|||
150155766|NCT01951092|541705192|FG000|Overall Study|Incarceration|1|||
150155767|NCT01951092|541705192|FG000|Overall Study|Transfer of Care|1|||
150155768|NCT00918749|541705193|FG000|Overall Study|Adverse Event|1|||
150155769|NCT00918749|541705194|FG001|Overall Study|Adverse Event|0|||
150155770|NCT00918749|541705195|FG002|Overall Study|Adverse Event|1|||
150155771|NCT00918749|541705193|FG000|Overall Study|Lost to Follow-up|0|||
150155772|NCT00918749|541705194|FG001|Overall Study|Lost to Follow-up|0|||
150155773|NCT00918749|541705195|FG002|Overall Study|Lost to Follow-up|1|||
150155774|NCT00918749|541705193|FG000|Overall Study|Withdrawal by Subject|5|||
150155775|NCT00918749|541705194|FG001|Overall Study|Withdrawal by Subject|3|||
150155776|NCT00918749|541705195|FG002|Overall Study|Withdrawal by Subject|5|||
150155777|NCT00918749|541705193|FG000|Overall Study|No Study Medication Taken|1|||
150155778|NCT00918749|541705194|FG001|Overall Study|No Study Medication Taken|0|||
150155779|NCT00918749|541705195|FG002|Overall Study|No Study Medication Taken|0|||
150155780|NCT01708187|541705196|FG000|Overall Study|Lost to Follow-up|0|||
150155781|NCT01708187|541705197|FG001|Overall Study|Lost to Follow-up|1|||
150155782|NCT03018106|541705198|FG000|Overall Study|Lost to Follow-up|0|||
150155783|NCT03018106|541705199|FG001|Overall Study|Lost to Follow-up|1|||
150155784|NCT00136916|541705200|FG000|Overall Study|Never received study treatment|3|||
150155785|NCT00136916|541705201|FG001|Overall Study|Never received study treatment|5|||
150155786|NCT00136916|541705200|FG000|Overall Study|Death|1|||
150155787|NCT00136916|541705201|FG001|Overall Study|Death|3|||
150155788|NCT00136916|541705200|FG000|Overall Study|Adverse Event|27|||
150155789|NCT00136916|541705201|FG001|Overall Study|Adverse Event|8|||
150155790|NCT00136916|541705200|FG000|Overall Study|Laboratory abnormality|0|||
150155791|NCT00136916|541705201|FG001|Overall Study|Laboratory abnormality|1|||
150155792|NCT00136916|541705200|FG000|Overall Study|Lack of Efficacy|13|||
150155793|NCT00136916|541705201|FG001|Overall Study|Lack of Efficacy|3|||
150155794|NCT00136916|541705200|FG000|Overall Study|Lost to Follow-up|12|||
150155795|NCT00136916|541705201|FG001|Overall Study|Lost to Follow-up|14|||
150155796|NCT00136916|541705200|FG000|Overall Study|Withdrawal by Subject|44|||
150155797|NCT00136916|541705201|FG001|Overall Study|Withdrawal by Subject|46|||
150155798|NCT00136916|541705200|FG000|Overall Study|Other|22|||
150155799|NCT00136916|541705201|FG001|Overall Study|Other|24|||
150155800|NCT00136916|541705200|FG000|Overall Study|Discontinued in follow up period|3|||
150155801|NCT00136916|541705201|FG001|Overall Study|Discontinued in follow up period|0|||
150155802|NCT01991197|541705202|FG000|Overall Study|Lost to Follow-up|1|||
150155803|NCT01991197|541705203|FG001|Overall Study|Lost to Follow-up|1|||
150155804|NCT01991197|541705202|FG000|Overall Study|Physician Decision|0|||
150155805|NCT01991197|541705203|FG001|Overall Study|Physician Decision|2|||
150155806|NCT01991197|541705202|FG000|Overall Study|Withdrawal by Subject|2|||
150155807|NCT01991197|541705203|FG001|Overall Study|Withdrawal by Subject|0|||
150155808|NCT00195715|541705204|FG000|Overall Study|Adverse Event|122|||
150155809|NCT00195715|541705204|FG000|Overall Study|Withdrawal by Subject|58|||
150155810|NCT00195715|541705204|FG000|Overall Study|Lost to Follow-up|27|||
150155811|NCT00195715|541705204|FG000|Overall Study|Protocol Violation|13|||
150155812|NCT00195715|541705204|FG000|Overall Study|Lack of Efficacy|93|||
150155813|NCT00195715|541705204|FG000|Overall Study|Pregnancy|14|||
150155814|NCT00195715|541705204|FG000|Overall Study|Investigative site closure|8|||
150155815|NCT00195715|541705204|FG000|Overall Study|Subject moved/relocated|7|||
150155816|NCT00195715|541705204|FG000|Overall Study|Subject non-compliance|6|||
150155817|NCT00195715|541705204|FG000|Overall Study|Subject started commercial Humira|5|||
150155818|NCT00195715|541705204|FG000|Overall Study|Subject choice|3|||
150155819|NCT00195715|541705204|FG000|Overall Study|Loss of response/no improvement|3|||
150155820|NCT00195715|541705204|FG000|Overall Study|Sponsor stopped study|1|||
150155821|NCT00195715|541705204|FG000|Overall Study|Administrative reasons|2|||
150155822|NCT00195715|541705204|FG000|Overall Study|Investigator's decision|2|||
150155823|NCT00195715|541705204|FG000|Overall Study|Subject wants to get pregnant|4|||
150155824|NCT00195715|541705204|FG000|Overall Study|Use of prohibited medication|2|||
150155825|NCT00195715|541705204|FG000|Overall Study|Planned surgery|2|||
150155826|NCT00195715|541705204|FG000|Overall Study|Increased infection rate|1|||
150155827|NCT00195715|541705204|FG000|Overall Study|Ineligible|1|||
150155828|NCT00195715|541705204|FG000|Overall Study|Colonic stricture|1|||
150155829|NCT00195715|541705204|FG000|Overall Study|Sponsor discontinued trial|1|||
150155830|NCT00195715|541705204|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
150155831|NCT05822921|541705209|FG000|Overall Study|Lost to Follow-up|1|||
150155832|NCT05822921|541705210|FG001|Overall Study|Lost to Follow-up|1|||
150155833|NCT00544544|541705211|FG000|Overall Study|Withdrawal by Subject|1|||
150155834|NCT00544544|541705211|FG000|Overall Study|Adverse Event|1|||
150155835|NCT00544544|541705211|FG000|Overall Study|Lost to Follow-up|1|||
150155836|NCT02036515|541705217|FG000|Overall Study|Adverse Event|1|||
150155837|NCT02036515|541705218|FG001|Overall Study|Adverse Event|1|||
150155838|NCT02036515|541705219|FG002|Overall Study|Adverse Event|2|||
150155839|NCT02036515|541705217|FG000|Overall Study|Lost to Follow-up|0|||
150155840|NCT02036515|541705218|FG001|Overall Study|Lost to Follow-up|2|||
150155841|NCT02036515|541705219|FG002|Overall Study|Lost to Follow-up|0|||
150155842|NCT02036515|541705217|FG000|Overall Study|Non-compliance with study drug|0|||
150155843|NCT02036515|541705218|FG001|Overall Study|Non-compliance with study drug|0|||
150155844|NCT02036515|541705219|FG002|Overall Study|Non-compliance with study drug|2|||
150155845|NCT02036515|541705217|FG000|Overall Study|Screen failure|0|||
150155846|NCT02036515|541705218|FG001|Overall Study|Screen failure|2|||
150155847|NCT02036515|541705219|FG002|Overall Study|Screen failure|0|||
150155848|NCT02036515|541705217|FG000|Overall Study|Withdrawal by Subject|4|||
150155849|NCT02036515|541705218|FG001|Overall Study|Withdrawal by Subject|7|||
150155850|NCT02036515|541705219|FG002|Overall Study|Withdrawal by Subject|9|||
150155851|NCT02036515|541705217|FG000|Overall Study|Hyperglycemia|0|||
150155852|NCT02036515|541705218|FG001|Overall Study|Hyperglycemia|0|||
150155853|NCT02036515|541705219|FG002|Overall Study|Hyperglycemia|1|||
150155854|NCT01671748|541705226|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
150155855|NCT01671748|541705227|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
150155856|NCT01671748|541705226|FG000|4 Week run-in Phase|Adverse Event|1|||
150155857|NCT01671748|541705227|FG001|4 Week run-in Phase|Adverse Event|0|||
150155858|NCT01671748|541705226|FG000|4 Week run-in Phase|Not eligible|9|||
150155859|NCT01671748|541705227|FG001|4 Week run-in Phase|Not eligible|0|||
150155860|NCT02601937|541705228|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155861|NCT02601937|541705229|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155862|NCT02601937|541705230|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155863|NCT02601937|541705231|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155864|NCT02601937|541705232|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155865|NCT02601937|541705233|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
150155866|NCT02601937|541705234|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155867|NCT02601937|541705235|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155868|NCT02601937|541705236|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155869|NCT02601937|541705237|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155870|NCT02601937|541705238|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
150155871|NCT02601937|541705228|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
150155872|NCT02601937|541705229|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155873|NCT02601937|541705230|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155874|NCT02601937|541705231|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155875|NCT02601937|541705232|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155876|NCT02601937|541705233|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155877|NCT02601937|541705234|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
150155878|NCT02601937|541705235|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155879|NCT02601937|541705236|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155880|NCT02601937|541705237|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155881|NCT02601937|541705238|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
150155882|NCT02601937|541705228|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155883|NCT02601937|541705229|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155884|NCT02601937|541705230|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
150155885|NCT02601937|541705231|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155886|NCT02601937|541705232|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155887|NCT02601937|541705233|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155888|NCT02601937|541705234|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155889|NCT02601937|541705235|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155890|NCT02601937|541705236|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155891|NCT02601937|541705237|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155892|NCT02601937|541705238|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
150155893|NCT02601937|541705228|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
150155894|NCT02601937|541705229|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
150155895|NCT02601937|541705230|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
150155896|NCT02601937|541705231|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
150155897|NCT02601937|541705232|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
150155898|NCT02601937|541705233|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
150155899|NCT02601937|541705234|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
150155900|NCT02601937|541705235|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
150155901|NCT02601937|541705236|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
150155902|NCT02601937|541705237|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
150155903|NCT02601937|541705238|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
150155904|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155905|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155906|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155907|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155908|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155909|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155910|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155911|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155912|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155913|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
150155914|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
150155915|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155916|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149815619|NCT02556632|540454686|FG000|Overall Study|Disliked Study Procedures|0|||
149815620|NCT02556632|540454687|FG001|Overall Study|Disliked Study Procedures|0|||
149815621|NCT02556632|540454688|FG002|Overall Study|Disliked Study Procedures|1|||
150155917|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155918|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155919|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155920|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155921|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155922|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
150155923|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155924|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155925|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
150155926|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155927|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155928|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155929|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155930|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155931|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155932|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155933|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155934|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
150155935|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
150155936|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
150155937|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155938|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155939|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155940|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155941|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155942|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155943|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
150155944|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
150155945|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
150155946|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
150155947|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
150155948|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Other|0|||
150155949|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Other|0|||
150155950|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Other|0|||
150155951|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Other|0|||
150155952|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Other|0|||
150155953|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Other|0|||
150155954|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Other|0|||
150155955|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Other|0|||
150155956|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Other|2|||
150155957|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Other|2|||
150155958|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Other|0|||
150155959|NCT02601937|541705228|FG000|Period 2: Dose Expansion Cohort|Death|0|||
150155960|NCT02601937|541705229|FG001|Period 2: Dose Expansion Cohort|Death|0|||
150155961|NCT02601937|541705230|FG002|Period 2: Dose Expansion Cohort|Death|0|||
150155962|NCT02601937|541705231|FG003|Period 2: Dose Expansion Cohort|Death|0|||
150155963|NCT02601937|541705232|FG004|Period 2: Dose Expansion Cohort|Death|0|||
150155964|NCT02601937|541705233|FG005|Period 2: Dose Expansion Cohort|Death|0|||
150155965|NCT02601937|541705234|FG006|Period 2: Dose Expansion Cohort|Death|0|||
150155966|NCT02601937|541705235|FG007|Period 2: Dose Expansion Cohort|Death|0|||
150155967|NCT02601937|541705236|FG008|Period 2: Dose Expansion Cohort|Death|1|||
150155968|NCT02601937|541705237|FG009|Period 2: Dose Expansion Cohort|Death|0|||
150155969|NCT02601937|541705238|FG010|Period 2: Dose Expansion Cohort|Death|0|||
150155970|NCT04145349|541706105|FG000|Overall Study|Withdrawal by Subject|3|||
150155971|NCT04145349|541706106|FG001|Overall Study|Withdrawal by Subject|0|||
150155972|NCT04145349|541706105|FG000|Overall Study|Lost to Follow-up|0|||
150155973|NCT04145349|541706106|FG001|Overall Study|Lost to Follow-up|1|||
150155974|NCT04145349|541706105|FG000|Overall Study|On study treatment (Ongoing)|0|||
150155975|NCT04145349|541706106|FG001|Overall Study|On study treatment (Ongoing)|1|||
150155976|NCT03595683|541706112|FG000|Overall Study|Adverse Event|1|||
150155977|NCT03595683|541706113|FG001|Overall Study|Adverse Event|0|||
150155978|NCT03595683|541706112|FG000|Overall Study|Pursue alternative therapy|1|||
150155979|NCT03595683|541706113|FG001|Overall Study|Pursue alternative therapy|1|||
150155980|NCT03595683|541706112|FG000|Overall Study|Progressive disease|1|||
150155981|NCT03595683|541706113|FG001|Overall Study|Progressive disease|3|||
150155982|NCT05675709|541706115|FG000|Overall Study|incomplete outcome data|2|||
150155983|NCT05675709|541706116|FG001|Overall Study|incomplete outcome data|8|||
150155984|NCT05876351|541706119|FG000|Overall Study|Other than specified|2|||
150155985|NCT05876351|541706119|FG000|Overall Study|Study specific discontinuation criteria|1|||
150155986|NCT04168385|541706120|FG000|Overall Study|Withdrawal by Subject|1|||
150155987|NCT04168385|541706121|FG001|Overall Study|Withdrawal by Subject|0|||
150155988|NCT04168385|541706120|FG000|Overall Study|Adverse Event|2|||
150155989|NCT04168385|541706121|FG001|Overall Study|Adverse Event|1|||
150155990|NCT04168385|541706120|FG000|Overall Study|Liver transplant|3|||
150155991|NCT04168385|541706121|FG001|Overall Study|Liver transplant|1|||
150155992|NCT04168385|541706120|FG000|Overall Study|Listed for liver transplant|1|||
150155993|NCT04168385|541706121|FG001|Overall Study|Listed for liver transplant|0|||
150155994|NCT03207711|541706122|FG000|Overall Study|Withdrawal by Subject|1|||
150155995|NCT03207711|541706123|FG001|Overall Study|Withdrawal by Subject|2|||
150155996|NCT05108649|541706124|FG000|Overall Study|Lost to Follow-up|0|||
150155997|NCT05108649|541706125|FG001|Overall Study|Lost to Follow-up|4|||
150155998|NCT05108649|541706126|FG002|Overall Study|Lost to Follow-up|3|||
150155999|NCT05108649|541706127|FG003|Overall Study|Lost to Follow-up|6|||
150156000|NCT05108649|541706124|FG000|Overall Study|Not Interested|1|||
150156001|NCT05108649|541706125|FG001|Overall Study|Not Interested|1|||
150156002|NCT05108649|541706126|FG002|Overall Study|Not Interested|0|||
150156003|NCT05108649|541706127|FG003|Overall Study|Not Interested|1|||
150156004|NCT05108649|541706124|FG000|Overall Study|Out of area|0|||
150156005|NCT05108649|541706125|FG001|Overall Study|Out of area|0|||
150156006|NCT05108649|541706126|FG002|Overall Study|Out of area|0|||
150156007|NCT05108649|541706127|FG003|Overall Study|Out of area|1|||
150156008|NCT05108649|541706124|FG000|Overall Study|PI decision|1|||
150156009|NCT05108649|541706125|FG001|Overall Study|PI decision|0|||
150156010|NCT05108649|541706126|FG002|Overall Study|PI decision|0|||
150156011|NCT05108649|541706127|FG003|Overall Study|PI decision|0|||
150156012|NCT05108649|541706124|FG000|Overall Study|Significant Non-Compliance|0|||
150156013|NCT05108649|541706125|FG001|Overall Study|Significant Non-Compliance|1|||
150156014|NCT05108649|541706126|FG002|Overall Study|Significant Non-Compliance|0|||
150156015|NCT05108649|541706127|FG003|Overall Study|Significant Non-Compliance|0|||
150156016|NCT05108649|541706124|FG000|Overall Study|Unable to adhere to study protocol|0|||
150156017|NCT05108649|541706125|FG001|Overall Study|Unable to adhere to study protocol|2|||
150156018|NCT05108649|541706126|FG002|Overall Study|Unable to adhere to study protocol|0|||
150156019|NCT05108649|541706127|FG003|Overall Study|Unable to adhere to study protocol|0|||
150156020|NCT01010217|541706130|FG000|Overall Study|Lost to Follow-up|4|||
150156021|NCT01010217|541706131|FG001|Overall Study|Lost to Follow-up|5|||
150156022|NCT01010217|541706132|FG002|Overall Study|Lost to Follow-up|1|||
150156023|NCT01010217|541706133|FG003|Overall Study|Lost to Follow-up|0|||
150156024|NCT01010217|541706134|FG004|Overall Study|Lost to Follow-up|0|||
150156025|NCT01010217|541706130|FG000|Overall Study|Withdrawal by Subject|1|||
150156026|NCT01010217|541706131|FG001|Overall Study|Withdrawal by Subject|0|||
150156027|NCT01010217|541706132|FG002|Overall Study|Withdrawal by Subject|0|||
150156028|NCT01010217|541706133|FG003|Overall Study|Withdrawal by Subject|0|||
150156029|NCT01010217|541706134|FG004|Overall Study|Withdrawal by Subject|0|||
150156030|NCT01010217|541706130|FG000|Overall Study|Physician Decision|0|||
150156031|NCT01010217|541706131|FG001|Overall Study|Physician Decision|0|||
150156032|NCT01010217|541706132|FG002|Overall Study|Physician Decision|0|||
150156033|NCT01010217|541706133|FG003|Overall Study|Physician Decision|6|||
150156034|NCT01010217|541706134|FG004|Overall Study|Physician Decision|3|||
150156035|NCT04242875|541706135|FG000|Overall Study|Adverse Event|2|||
150156036|NCT02213055|541706137|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
150156037|NCT02213055|541706138|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
150156038|NCT02213055|541706137|FG000|Overall Study|Protocol was not Followed during Study|1|||
150156039|NCT02213055|541706138|FG001|Overall Study|Protocol was not Followed during Study|0|||
150156040|NCT02213055|541706137|FG000|Overall Study|Documentation Issue at Enrollment|1|||
150156041|NCT02213055|541706138|FG001|Overall Study|Documentation Issue at Enrollment|0|||
150156042|NCT02213055|541706137|FG000|Overall Study|Documentation Issue during Study|10|||
150156043|NCT02213055|541706138|FG001|Overall Study|Documentation Issue during Study|0|||
150156044|NCT02213055|541706137|FG000|Overall Study|Did not have Live Lice|8|||
150156045|NCT02213055|541706138|FG001|Overall Study|Did not have Live Lice|0|||
150156046|NCT02213055|541706137|FG000|Overall Study|Had another Treatment during the Study|3|||
150156047|NCT02213055|541706138|FG001|Overall Study|Had another Treatment during the Study|0|||
150156048|NCT02213055|541706137|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
150156049|NCT02213055|541706138|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
150156050|NCT02213055|541706137|FG000|Overall Study|Did not Return to School|5|||
150156051|NCT02213055|541706138|FG001|Overall Study|Did not Return to School|0|||
150156052|NCT00231894|541706139|FG000|Overall Study|Withdrawal by Subject|1|||
150156053|NCT00231894|541706140|FG001|Overall Study|Withdrawal by Subject|1|||
150156054|NCT02025205|541706142|FG000|Overall Study|Withdrawal by Subject|1|||
150156055|NCT02025205|541706143|FG001|Overall Study|Withdrawal by Subject|1|||
150156056|NCT02025205|541706142|FG000|Overall Study|Protocol Violation|2|||
150156057|NCT02025205|541706143|FG001|Overall Study|Protocol Violation|1|||
150156058|NCT02025205|541706142|FG000|Overall Study|Death|0|||
150156059|NCT02025205|541706143|FG001|Overall Study|Death|1|||
150156060|NCT03260504|541706146|FG000|Overall Study|Adverse Event|0|||
150156061|NCT03260504|541706147|FG001|Overall Study|Adverse Event|1|||
150156062|NCT00846742|541706148|FG000|Overall Study|Withdrawal by Subject|1|||
150156063|NCT05868954|541706154|FG000|Overall Study|Lost to Follow-up|0|||
150156064|NCT05868954|541706155|FG001|Overall Study|Lost to Follow-up|1|||
150156065|NCT05868954|541706154|FG000|Overall Study|Withdrawal by Subject|2|||
150156066|NCT05868954|541706155|FG001|Overall Study|Withdrawal by Subject|2|||
150156067|NCT05868954|541706154|FG000|Overall Study|Participant delivered|1|||
150156068|NCT05868954|541706155|FG001|Overall Study|Participant delivered|1|||
149815622|NCT02556632|540454686|FG000|Overall Study|Treatment or Change Delay|0|||
149815623|NCT02556632|540454687|FG001|Overall Study|Treatment or Change Delay|0|||
149815624|NCT02556632|540454688|FG002|Overall Study|Treatment or Change Delay|1|||
149815625|NCT00808015|540454689|FG000|Overall Study|Death|1|||
149815626|NCT00808015|540454689|FG000|Overall Study|Lack of Efficacy|58|||
149815627|NCT00808015|540454689|FG000|Overall Study|Lost to Follow-up|76|||
149815628|NCT00808015|540454689|FG000|Overall Study|Participants not willing to participate|158|||
149815629|NCT00808015|540454689|FG000|Overall Study|Adverse Event|22|||
149815630|NCT00808015|540454689|FG000|Overall Study|Other|25|||
149815631|NCT00808015|540454689|FG000|Overall Study|Enrolled but not treated|4|||
149815632|NCT00084617|540454701|FG000|Overall Study|Withdrawal by Subject|7|||
149815633|NCT00084617|540454701|FG000|Overall Study|Lack of Efficacy|1|||
149815634|NCT00084617|540454701|FG000|Overall Study|Protocol Violation|1|||
149815635|NCT01625286|540454702|FG000|Overall Study|Adverse Event|0|||
149815636|NCT01625286|540454703|FG001|Overall Study|Adverse Event|0|||
149815637|NCT01625286|540454704|FG002|Overall Study|Adverse Event|0|||
149815638|NCT01625286|540454705|FG003|Overall Study|Adverse Event|0|||
149815639|NCT01625286|540454706|FG004|Overall Study|Adverse Event|1|||
149815640|NCT01625286|540454707|FG005|Overall Study|Adverse Event|2|||
149815641|NCT01625286|540454708|FG006|Overall Study|Adverse Event|1|||
149815642|NCT01625286|540454702|FG000|Overall Study|Death|0|||
149815643|NCT01625286|540454703|FG001|Overall Study|Death|0|||
149815644|NCT01625286|540454704|FG002|Overall Study|Death|1|||
149815645|NCT01625286|540454705|FG003|Overall Study|Death|1|||
149815646|NCT01625286|540454706|FG004|Overall Study|Death|0|||
149815647|NCT01625286|540454707|FG005|Overall Study|Death|11|||
149815648|NCT01625286|540454708|FG006|Overall Study|Death|16|||
149815649|NCT01625286|540454702|FG000|Overall Study|Withdrawal by Subject|0|||
149815650|NCT01625286|540454703|FG001|Overall Study|Withdrawal by Subject|1|||
149815651|NCT01625286|540454704|FG002|Overall Study|Withdrawal by Subject|0|||
149815652|NCT01625286|540454705|FG003|Overall Study|Withdrawal by Subject|1|||
149815653|NCT01625286|540454706|FG004|Overall Study|Withdrawal by Subject|0|||
149815654|NCT01625286|540454707|FG005|Overall Study|Withdrawal by Subject|0|||
149815655|NCT01625286|540454708|FG006|Overall Study|Withdrawal by Subject|1|||
149815656|NCT01625286|540454702|FG000|Overall Study|Any reason not specifically recorded|0|||
149815657|NCT01625286|540454703|FG001|Overall Study|Any reason not specifically recorded|0|||
149815658|NCT01625286|540454704|FG002|Overall Study|Any reason not specifically recorded|0|||
149815659|NCT01625286|540454705|FG003|Overall Study|Any reason not specifically recorded|0|||
149815660|NCT01625286|540454706|FG004|Overall Study|Any reason not specifically recorded|0|||
149815661|NCT01625286|540454707|FG005|Overall Study|Any reason not specifically recorded|1|||
149815662|NCT01625286|540454708|FG006|Overall Study|Any reason not specifically recorded|0|||
149815663|NCT01625286|540454702|FG000|Overall Study|Progressive disease|6|||
149815664|NCT01625286|540454703|FG001|Overall Study|Progressive disease|3|||
149815665|NCT01625286|540454704|FG002|Overall Study|Progressive disease|4|||
149815666|NCT01625286|540454705|FG003|Overall Study|Progressive disease|5|||
149815667|NCT01625286|540454706|FG004|Overall Study|Progressive disease|5|||
149815668|NCT01625286|540454707|FG005|Overall Study|Progressive disease|0|||
149815669|NCT01625286|540454708|FG006|Overall Study|Progressive disease|0|||
149815670|NCT01625286|540454702|FG000|Overall Study|Lost to Follow-up|0|||
149815671|NCT01625286|540454703|FG001|Overall Study|Lost to Follow-up|0|||
149815672|NCT01625286|540454704|FG002|Overall Study|Lost to Follow-up|0|||
149815673|NCT01625286|540454705|FG003|Overall Study|Lost to Follow-up|0|||
149815674|NCT01625286|540454706|FG004|Overall Study|Lost to Follow-up|0|||
149815675|NCT01625286|540454707|FG005|Overall Study|Lost to Follow-up|0|||
149815676|NCT01625286|540454708|FG006|Overall Study|Lost to Follow-up|1|||
149815677|NCT00928135|540454709|FG000|Overall Study|Withdrawal by Subject|1|||
149815678|NCT00928135|540454710|FG001|Overall Study|Withdrawal by Subject|0|||
149815679|NCT00304954|540456726|FG000|Overall Study|Withdrawal by Subject|0|||
149815680|NCT00304954|540456727|FG001|Overall Study|Withdrawal by Subject|0|||
149815681|NCT00304954|540456728|FG002|Overall Study|Withdrawal by Subject|1|||
149815682|NCT00304954|540456729|FG003|Overall Study|Withdrawal by Subject|0|||
149815683|NCT00304954|540456726|FG000|Overall Study|Adverse Event|1|||
149815684|NCT00304954|540456727|FG001|Overall Study|Adverse Event|0|||
149815685|NCT00304954|540456728|FG002|Overall Study|Adverse Event|0|||
149815686|NCT00304954|540456729|FG003|Overall Study|Adverse Event|0|||
149815687|NCT01440647|540456730|FG000|Overall Study|Death|2|||
149815688|NCT01440647|540456731|FG001|Overall Study|Death|3|||
150156069|NCT05868954|541706154|FG000|Overall Study|Miscarriage|0|||
150156070|NCT05868954|541706155|FG001|Overall Study|Miscarriage|1|||
149815689|NCT01326702|540456748|FG000|Overall Study|Other|1|||
150156071|NCT01435798|541706158|FG000|Overall Study|Withdrawal by Subject|1|||
150156072|NCT01570868|541706162|FG000|Overall Study|Adverse Event|8|||
150156073|NCT01570868|541706163|FG001|Overall Study|Adverse Event|1|||
150156074|NCT01570868|541706162|FG000|Overall Study|FDA Recommendation|23|||
150156075|NCT01570868|541706163|FG001|Overall Study|FDA Recommendation|3|||
150156076|NCT01570868|541706162|FG000|Overall Study|Physician Decision|10|||
150156077|NCT01570868|541706163|FG001|Overall Study|Physician Decision|4|||
150156078|NCT01570868|541706162|FG000|Overall Study|Lost to Follow-up|1|||
150156079|NCT01570868|541706163|FG001|Overall Study|Lost to Follow-up|0|||
150156080|NCT01570868|541706162|FG000|Overall Study|Withdrawal by Subject|1|||
150156081|NCT01570868|541706163|FG001|Overall Study|Withdrawal by Subject|0|||
150156082|NCT04936308|541706164|FG000|Overall Study|Death|0|||
150156083|NCT04936308|541706165|FG001|Overall Study|Death|0|||
150156084|NCT04936308|541706166|FG002|Overall Study|Death|1|||
150156085|NCT04936308|541706164|FG000|Overall Study|Withdrawal by Subject|6|||
150156086|NCT04936308|541706165|FG001|Overall Study|Withdrawal by Subject|3|||
150156087|NCT04936308|541706166|FG002|Overall Study|Withdrawal by Subject|0|||
150156088|NCT04936308|541706164|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
150156089|NCT04936308|541706165|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
150156090|NCT04936308|541706166|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
150156091|NCT04936308|541706164|FG000|Overall Study|Completed protocol-required follow-up|1|||
150156092|NCT04936308|541706165|FG001|Overall Study|Completed protocol-required follow-up|2|||
150156093|NCT04936308|541706166|FG002|Overall Study|Completed protocol-required follow-up|2|||
150156094|NCT04936308|541706164|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
150156095|NCT04936308|541706165|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
150156096|NCT04936308|541706166|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
150156097|NCT04936308|541706164|FG000|Overall Study|Other|3|||
150156098|NCT04936308|541706165|FG001|Overall Study|Other|0|||
150156099|NCT04936308|541706166|FG002|Overall Study|Other|2|||
150156100|NCT02611830|541706167|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
150156101|NCT02611830|541706168|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
150156102|NCT02611830|541706169|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
150156103|NCT02611830|541706170|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
150156104|NCT02611830|541706167|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
150156105|NCT02611830|541706168|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
150156106|NCT02611830|541706169|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
150156107|NCT02611830|541706170|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
150156108|NCT02611830|541706167|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
150156109|NCT02611830|541706168|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
150156110|NCT02611830|541706169|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
150156111|NCT02611830|541706170|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
150156112|NCT02611830|541706167|FG000|OL Induction Phase|Lack of Efficacy|9|||
150156113|NCT02611830|541706168|FG001|OL Induction Phase|Lack of Efficacy|0|||
150156114|NCT02611830|541706169|FG002|OL Induction Phase|Lack of Efficacy|0|||
150156115|NCT02611830|541706170|FG003|OL Induction Phase|Lack of Efficacy|0|||
150156116|NCT02611830|541706167|FG000|OL Induction Phase|Reason not specified|3|||
150156117|NCT02611830|541706168|FG001|OL Induction Phase|Reason not specified|0|||
150156118|NCT02611830|541706169|FG002|OL Induction Phase|Reason not specified|0|||
150156119|NCT02611830|541706170|FG003|OL Induction Phase|Reason not specified|0|||
150156120|NCT02611830|541706167|FG000|Maintenance Phase|Lack of Efficacy|0|||
150156121|NCT02611830|541706168|FG001|Maintenance Phase|Lack of Efficacy|29|||
150156122|NCT02611830|541706169|FG002|Maintenance Phase|Lack of Efficacy|18|||
150156123|NCT02611830|541706170|FG003|Maintenance Phase|Lack of Efficacy|6|||
150156124|NCT02611830|541706167|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
150156125|NCT02611830|541706168|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
150156126|NCT02611830|541706169|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
150156127|NCT02611830|541706170|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
150156128|NCT02611830|541706167|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
150156129|NCT02611830|541706168|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
150156130|NCT02611830|541706169|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
150156131|NCT02611830|541706170|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
150156132|NCT02611830|541706167|FG000|Maintenance Phase|Lost to Follow-up|0|||
150156133|NCT02611830|541706168|FG001|Maintenance Phase|Lost to Follow-up|0|||
150156134|NCT02611830|541706169|FG002|Maintenance Phase|Lost to Follow-up|0|||
150156135|NCT02611830|541706170|FG003|Maintenance Phase|Lost to Follow-up|1|||
150156136|NCT02611830|541706167|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
149815690|NCT01326702|540456749|FG001|Overall Study|Other|0|||
150156137|NCT02611830|541706168|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
150156138|NCT02611830|541706169|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
150156139|NCT02611830|541706170|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
150156140|NCT02611830|541706167|FG000|Maintenance Phase|Pregnancy|0|||
150156141|NCT02611830|541706168|FG001|Maintenance Phase|Pregnancy|0|||
150156142|NCT02611830|541706169|FG002|Maintenance Phase|Pregnancy|1|||
150156143|NCT02611830|541706170|FG003|Maintenance Phase|Pregnancy|0|||
150156144|NCT02611830|541706167|FG000|Maintenance Phase|Reason not specified|0|||
150156145|NCT02611830|541706168|FG001|Maintenance Phase|Reason not specified|1|||
150156146|NCT02611830|541706169|FG002|Maintenance Phase|Reason not specified|4|||
150156147|NCT02611830|541706170|FG003|Maintenance Phase|Reason not specified|0|||
150156148|NCT02275533|541706591|FG000|Overall Study|Protocol Violation|2|||
150156149|NCT02275533|541706592|FG001|Overall Study|Protocol Violation|0|||
150156150|NCT02275533|541706591|FG000|Overall Study|Never received study treatment|1|||
150156151|NCT02275533|541706592|FG001|Overall Study|Never received study treatment|0|||
150156152|NCT03370276|541706593|FG000|Overall Study|Death|0|||
150156153|NCT03370276|541706594|FG001|Overall Study|Death|2|||
150156154|NCT03370276|541706595|FG002|Overall Study|Death|5|||
150156155|NCT03500172|541706596|FG000|Period 1: Baseline Randomization|Death|0|||
150156156|NCT03500172|541706597|FG001|Period 1: Baseline Randomization|Death|0|||
150156157|NCT03500172|541706598|FG002|Period 1: Baseline Randomization|Death|0|||
150156158|NCT03500172|541706599|FG003|Period 1: Baseline Randomization|Death|0|||
150156159|NCT03500172|541706600|FG004|Period 1: Baseline Randomization|Death|0|||
150156160|NCT03500172|541706601|FG005|Period 1: Baseline Randomization|Death|0|||
150156161|NCT03500172|541706602|FG006|Period 1: Baseline Randomization|Death|0|||
150156162|NCT03500172|541706603|FG007|Period 1: Baseline Randomization|Death|0|||
150156163|NCT03500172|541706604|FG008|Period 1: Baseline Randomization|Death|0|||
150156164|NCT03500172|541706605|FG009|Period 1: Baseline Randomization|Death|2|||
150156165|NCT03500172|541706606|FG010|Period 1: Baseline Randomization|Death|0|||
150156166|NCT03500172|541706596|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
150156167|NCT03500172|541706597|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
150156168|NCT03500172|541706598|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
150156169|NCT03500172|541706599|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
150156170|NCT03500172|541706600|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
150156171|NCT03500172|541706601|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
150156172|NCT03500172|541706602|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
150156173|NCT03500172|541706603|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
150156174|NCT03500172|541706604|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
150156175|NCT03500172|541706605|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
150156176|NCT03500172|541706606|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
149815691|NCT01326702|540456750|FG002|Overall Study|Other|0|||
149815692|NCT01326702|540456751|FG003|Overall Study|Other|0|||
149815693|NCT01326702|540456752|FG004|Overall Study|Other|0|||
149815694|NCT01326702|540456753|FG005|Overall Study|Other|1|||
149815695|NCT01326702|540456754|FG006|Overall Study|Other|0|||
149815696|NCT01326702|540456748|FG000|Overall Study|progressive disease|1|||
149815697|NCT01326702|540456749|FG001|Overall Study|progressive disease|1|||
149815698|NCT01326702|540456750|FG002|Overall Study|progressive disease|3|||
149815699|NCT01326702|540456751|FG003|Overall Study|progressive disease|1|||
149815700|NCT01326702|540456752|FG004|Overall Study|progressive disease|3|||
149815701|NCT01326702|540456753|FG005|Overall Study|progressive disease|2|||
149815702|NCT01326702|540456754|FG006|Overall Study|progressive disease|3|||
149815703|NCT01326702|540456748|FG000|Overall Study|Death|0|||
149815704|NCT01326702|540456749|FG001|Overall Study|Death|1|||
149815705|NCT01326702|540456750|FG002|Overall Study|Death|0|||
149815706|NCT01326702|540456751|FG003|Overall Study|Death|0|||
149815707|NCT01326702|540456752|FG004|Overall Study|Death|0|||
149815708|NCT01326702|540456753|FG005|Overall Study|Death|0|||
149815709|NCT01326702|540456754|FG006|Overall Study|Death|0|||
149815710|NCT01326702|540456748|FG000|Overall Study|Adverse Event|0|||
149815711|NCT01326702|540456749|FG001|Overall Study|Adverse Event|0|||
149815712|NCT01326702|540456750|FG002|Overall Study|Adverse Event|1|||
149815713|NCT01326702|540456751|FG003|Overall Study|Adverse Event|1|||
149815714|NCT01326702|540456752|FG004|Overall Study|Adverse Event|0|||
149815715|NCT01326702|540456753|FG005|Overall Study|Adverse Event|3|||
149815716|NCT01326702|540456754|FG006|Overall Study|Adverse Event|1|||
149815717|NCT01326702|540456748|FG000|Overall Study|Withdrawal by Subject|0|||
149815718|NCT01326702|540456749|FG001|Overall Study|Withdrawal by Subject|0|||
149815719|NCT01326702|540456750|FG002|Overall Study|Withdrawal by Subject|1|||
149815720|NCT01326702|540456751|FG003|Overall Study|Withdrawal by Subject|0|||
149815721|NCT01326702|540456752|FG004|Overall Study|Withdrawal by Subject|1|||
150156177|NCT03500172|541706596|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
149815722|NCT01326702|540456753|FG005|Overall Study|Withdrawal by Subject|1|||
149815723|NCT01326702|540456754|FG006|Overall Study|Withdrawal by Subject|3|||
150156178|NCT03500172|541706597|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
150156179|NCT03500172|541706598|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
150156180|NCT03500172|541706599|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
149815724|NCT01326702|540456748|FG000|Overall Study|Not Treated|0|||
149815725|NCT01326702|540456749|FG001|Overall Study|Not Treated|0|||
149815726|NCT01326702|540456750|FG002|Overall Study|Not Treated|0|||
149815727|NCT01326702|540456751|FG003|Overall Study|Not Treated|1|||
149815728|NCT01326702|540456752|FG004|Overall Study|Not Treated|0|||
149815729|NCT01326702|540456753|FG005|Overall Study|Not Treated|1|||
150156181|NCT03500172|541706600|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
150156182|NCT03500172|541706601|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
150156183|NCT03500172|541706602|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
150156184|NCT03500172|541706603|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
150156185|NCT03500172|541706604|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
150156186|NCT03500172|541706605|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
150156187|NCT03500172|541706606|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
150156188|NCT03500172|541706596|FG000|Period 2: Re-Randomization|Death|0|||
150156189|NCT03500172|541706597|FG001|Period 2: Re-Randomization|Death|0|||
150156190|NCT03500172|541706598|FG002|Period 2: Re-Randomization|Death|0|||
150156191|NCT03500172|541706599|FG003|Period 2: Re-Randomization|Death|4|||
150156192|NCT03500172|541706600|FG004|Period 2: Re-Randomization|Death|2|||
150156193|NCT03500172|541706601|FG005|Period 2: Re-Randomization|Death|0|||
150156194|NCT03500172|541706602|FG006|Period 2: Re-Randomization|Death|5|||
150156195|NCT03500172|541706603|FG007|Period 2: Re-Randomization|Death|2|||
150156196|NCT03500172|541706604|FG008|Period 2: Re-Randomization|Death|0|||
150156197|NCT03500172|541706605|FG009|Period 2: Re-Randomization|Death|0|||
150156198|NCT03500172|541706606|FG010|Period 2: Re-Randomization|Death|0|||
150156199|NCT04759885|541706609|FG000|Overall Study|Other|1|||
150156200|NCT04759885|541706610|FG001|Overall Study|Other|0|||
150156201|NCT04759885|541706611|FG002|Overall Study|Other|2|||
150156202|NCT04759885|541706612|FG003|Overall Study|Other|0|||
150156203|NCT04759885|541706613|FG004|Overall Study|Other|0|||
150156204|NCT04759885|541706609|FG000|Overall Study|Withdrawal by Subject|0|||
150156205|NCT04759885|541706610|FG001|Overall Study|Withdrawal by Subject|0|||
150156206|NCT04759885|541706611|FG002|Overall Study|Withdrawal by Subject|1|||
150156207|NCT04759885|541706612|FG003|Overall Study|Withdrawal by Subject|9|||
150156208|NCT04759885|541706613|FG004|Overall Study|Withdrawal by Subject|6|||
150156209|NCT04759885|541706609|FG000|Overall Study|Adverse Event|0|||
150156210|NCT04759885|541706610|FG001|Overall Study|Adverse Event|0|||
150156211|NCT04759885|541706611|FG002|Overall Study|Adverse Event|0|||
150156212|NCT04759885|541706612|FG003|Overall Study|Adverse Event|3|||
150156213|NCT04759885|541706613|FG004|Overall Study|Adverse Event|0|||
150156214|NCT04759885|541706609|FG000|Overall Study|Physician Decision|0|||
150156215|NCT04759885|541706610|FG001|Overall Study|Physician Decision|0|||
150156216|NCT04759885|541706611|FG002|Overall Study|Physician Decision|0|||
150156217|NCT04759885|541706612|FG003|Overall Study|Physician Decision|2|||
150156218|NCT04759885|541706613|FG004|Overall Study|Physician Decision|0|||
150156219|NCT05294419|541706614|FG000|Overall Study|Protocol Violation|4|||
150156220|NCT05294419|541706615|FG001|Overall Study|Protocol Violation|0|||
150156221|NCT05294419|541706616|FG002|Overall Study|Protocol Violation|0|||
150156222|NCT05294419|541706614|FG000|Overall Study|Lost to Follow-up|6|||
150156223|NCT05294419|541706615|FG001|Overall Study|Lost to Follow-up|0|||
150156224|NCT05294419|541706616|FG002|Overall Study|Lost to Follow-up|0|||
150156225|NCT05294419|541706614|FG000|Overall Study|Results voided after publishing|2|||
150156226|NCT05294419|541706615|FG001|Overall Study|Results voided after publishing|0|||
150156227|NCT05294419|541706616|FG002|Overall Study|Results voided after publishing|0|||
150156228|NCT04684914|541706617|FG000|Overall Study|Withdrawal by Subject|1|||
150156229|NCT04684914|541706618|FG001|Overall Study|Withdrawal by Subject|0|||
150156230|NCT04684914|541706617|FG000|Overall Study|Discontinued before receiving study treatment|1|||
150156231|NCT04684914|541706618|FG001|Overall Study|Discontinued before receiving study treatment|2|||
150156232|NCT07083843|541706623|FG000|Intervention period.|Withdrawal by Subject|1|||
150156233|NCT07083843|541706624|FG001|Intervention period.|Withdrawal by Subject|0|||
150156234|NCT07083843|541706623|FG000|Intervention period.|Death|0|||
150156235|NCT07083843|541706624|FG001|Intervention period.|Death|1|||
150156236|NCT04988477|541706627|FG000|Overall Study|Death|1|||
150156237|NCT04988477|541706628|FG001|Overall Study|Death|0|||
150156238|NCT04988477|541706629|FG002|Overall Study|Death|0|||
150156239|NCT04988477|541706627|FG000|Overall Study|Lost to Follow-up|5|||
150156240|NCT04988477|541706628|FG001|Overall Study|Lost to Follow-up|2|||
150156241|NCT04988477|541706629|FG002|Overall Study|Lost to Follow-up|0|||
150156242|NCT04988477|541706627|FG000|Overall Study|Withdrawal by Subject|2|||
150156243|NCT04988477|541706628|FG001|Overall Study|Withdrawal by Subject|0|||
150156244|NCT04988477|541706629|FG002|Overall Study|Withdrawal by Subject|0|||
150156245|NCT05089656|541706630|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
150156246|NCT05089656|541706631|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
150156247|NCT05089656|541706630|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
150156248|NCT05089656|541706631|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
150156249|NCT05089656|541706630|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
150156250|NCT05089656|541706631|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
150156251|NCT05089656|541706630|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
150156252|NCT05089656|541706631|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
150156253|NCT04191135|541706632|FG000|Induction Treatment|Not Treated|2|||
150156254|NCT04191135|541706633|FG001|Induction Treatment|Not Treated|0|||
150156255|NCT04191135|541706634|FG002|Induction Treatment|Not Treated|0|||
150156256|NCT04191135|541706632|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
150156257|NCT04191135|541706633|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
150156258|NCT04191135|541706634|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
150156259|NCT04191135|541706632|FG000|Induction Treatment|Adverse Event|25|||
150156260|NCT04191135|541706633|FG001|Induction Treatment|Adverse Event|0|||
150156261|NCT04191135|541706634|FG002|Induction Treatment|Adverse Event|0|||
150156262|NCT04191135|541706632|FG000|Induction Treatment|Clinical Progression|8|||
150156263|NCT04191135|541706633|FG001|Induction Treatment|Clinical Progression|0|||
150156264|NCT04191135|541706634|FG002|Induction Treatment|Clinical Progression|0|||
150156265|NCT04191135|541706632|FG000|Induction Treatment|Excluded Medication|1|||
150156266|NCT04191135|541706633|FG001|Induction Treatment|Excluded Medication|0|||
150156267|NCT04191135|541706634|FG002|Induction Treatment|Excluded Medication|0|||
150156268|NCT04191135|541706632|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
150156269|NCT04191135|541706633|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
150156270|NCT04191135|541706634|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
150156271|NCT04191135|541706632|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
150156272|NCT04191135|541706633|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
150156273|NCT04191135|541706634|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
150156274|NCT04191135|541706632|FG000|Induction Treatment|Physician Decision|2|||
150156275|NCT04191135|541706633|FG001|Induction Treatment|Physician Decision|0|||
150156276|NCT04191135|541706634|FG002|Induction Treatment|Physician Decision|0|||
150156277|NCT04191135|541706632|FG000|Induction Treatment|Progressive Disease|135|||
150156278|NCT04191135|541706633|FG001|Induction Treatment|Progressive Disease|0|||
150156279|NCT04191135|541706634|FG002|Induction Treatment|Progressive Disease|0|||
150156280|NCT04191135|541706632|FG000|Induction Treatment|Protocol Violation|10|||
150156281|NCT04191135|541706633|FG001|Induction Treatment|Protocol Violation|0|||
150156282|NCT04191135|541706634|FG002|Induction Treatment|Protocol Violation|0|||
150156283|NCT04191135|541706632|FG000|Induction Treatment|Withdrawal by Subject|4|||
150156284|NCT04191135|541706633|FG001|Induction Treatment|Withdrawal by Subject|0|||
150156285|NCT04191135|541706634|FG002|Induction Treatment|Withdrawal by Subject|0|||
150156286|NCT04191135|541706632|FG000|Randomized Treatment|Death|0|||
150156287|NCT04191135|541706633|FG001|Randomized Treatment|Death|50|||
150156288|NCT04191135|541706634|FG002|Randomized Treatment|Death|54|||
150156289|NCT04191135|541706632|FG000|Randomized Treatment|Lost to Follow-up|0|||
150156290|NCT04191135|541706633|FG001|Randomized Treatment|Lost to Follow-up|0|||
150156291|NCT04191135|541706634|FG002|Randomized Treatment|Lost to Follow-up|1|||
150156292|NCT04191135|541706632|FG000|Randomized Treatment|Withdrawal by Subject|0|||
150156293|NCT04191135|541706633|FG001|Randomized Treatment|Withdrawal by Subject|2|||
150156294|NCT04191135|541706634|FG002|Randomized Treatment|Withdrawal by Subject|0|||
150156295|NCT04191135|541706632|FG000|Randomized Treatment|Ongoing in Trial|0|||
150156296|NCT04191135|541706633|FG001|Randomized Treatment|Ongoing in Trial|83|||
150156297|NCT04191135|541706634|FG002|Randomized Treatment|Ongoing in Trial|81|||
150156298|NCT03038672|541708516|FG000|Initial Treatment|Unacceptable chemistry|0|||
150156299|NCT03038672|541708517|FG001|Initial Treatment|Unacceptable chemistry|1|||
150156300|NCT03038672|541708516|FG000|Initial Treatment|Progression prior to treatment|1|||
150156301|NCT03038672|541708517|FG001|Initial Treatment|Progression prior to treatment|0|||
150156302|NCT03038672|541708516|FG000|Initial Treatment|No treatment per protocol|1|||
150156303|NCT03038672|541708517|FG001|Initial Treatment|No treatment per protocol|0|||
150156304|NCT04423393|541708518|FG000|Overall Study|Withdrawal by Subject|0|||
150156305|NCT04423393|541708519|FG001|Overall Study|Withdrawal by Subject|0|||
150156306|NCT04423393|541708520|FG002|Overall Study|Withdrawal by Subject|0|||
150156307|NCT04423393|541708521|FG003|Overall Study|Withdrawal by Subject|0|||
150156308|NCT04423393|541708522|FG004|Overall Study|Withdrawal by Subject|0|||
150156309|NCT04423393|541708523|FG005|Overall Study|Withdrawal by Subject|1|||
150156310|NCT04423393|541708524|FG006|Overall Study|Withdrawal by Subject|0|||
150156311|NCT04423393|541708525|FG007|Overall Study|Withdrawal by Subject|0|||
150156312|NCT04423393|541708526|FG008|Overall Study|Withdrawal by Subject|0|||
150156313|NCT04423393|541708527|FG009|Overall Study|Withdrawal by Subject|0|||
150156314|NCT04423393|541708528|FG010|Overall Study|Withdrawal by Subject|0|||
150156315|NCT04423393|541708529|FG011|Overall Study|Withdrawal by Subject|0|||
150156316|NCT04423393|541708530|FG012|Overall Study|Withdrawal by Subject|0|||
150156317|NCT04423393|541708531|FG013|Overall Study|Withdrawal by Subject|1|||
150156318|NCT04423393|541708532|FG014|Overall Study|Withdrawal by Subject|0|||
150156319|NCT04423393|541708533|FG015|Overall Study|Withdrawal by Subject|0|||
150156320|NCT04423393|541708534|FG016|Overall Study|Withdrawal by Subject|0|||
150156321|NCT04423393|541708535|FG017|Overall Study|Withdrawal by Subject|0|||
150156322|NCT04423393|541708518|FG000|Overall Study|Sponsor Decision|0|||
150156323|NCT04423393|541708519|FG001|Overall Study|Sponsor Decision|0|||
150156324|NCT04423393|541708520|FG002|Overall Study|Sponsor Decision|0|||
150156325|NCT04423393|541708521|FG003|Overall Study|Sponsor Decision|0|||
150156326|NCT04423393|541708522|FG004|Overall Study|Sponsor Decision|0|||
150156327|NCT04423393|541708523|FG005|Overall Study|Sponsor Decision|0|||
150156328|NCT04423393|541708524|FG006|Overall Study|Sponsor Decision|0|||
150156329|NCT04423393|541708525|FG007|Overall Study|Sponsor Decision|0|||
150156330|NCT04423393|541708526|FG008|Overall Study|Sponsor Decision|0|||
150156331|NCT04423393|541708527|FG009|Overall Study|Sponsor Decision|0|||
150156332|NCT04423393|541708528|FG010|Overall Study|Sponsor Decision|0|||
150156333|NCT04423393|541708529|FG011|Overall Study|Sponsor Decision|0|||
150156334|NCT04423393|541708530|FG012|Overall Study|Sponsor Decision|0|||
150156335|NCT04423393|541708531|FG013|Overall Study|Sponsor Decision|1|||
150156336|NCT04423393|541708532|FG014|Overall Study|Sponsor Decision|0|||
150156337|NCT04423393|541708533|FG015|Overall Study|Sponsor Decision|0|||
150156338|NCT04423393|541708534|FG016|Overall Study|Sponsor Decision|0|||
150156339|NCT04423393|541708535|FG017|Overall Study|Sponsor Decision|0|||
150156340|NCT05220501|541708536|FG000|Overall Study|Withdrawal by Subject|11|||
150156341|NCT05220501|541708537|FG001|Overall Study|Withdrawal by Subject|21|||
150156342|NCT05220501|541708538|FG002|Overall Study|Withdrawal by Subject|32|||
150156343|NCT05220501|541708536|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
150156344|NCT05220501|541708537|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
150156345|NCT05220501|541708538|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
150156346|NCT02692235|541708539|FG000|Overall Study|Withdrawal by Subject|2|||
150156347|NCT02692235|541708540|FG001|Overall Study|Withdrawal by Subject|1|||
150156348|NCT02692235|541708539|FG000|Overall Study|Adverse Event|1|||
150156349|NCT02692235|541708540|FG001|Overall Study|Adverse Event|2|||
150156350|NCT01929993|541708542|FG000|Overall Study|Protocol Violation|4|||
150156351|NCT01929993|541708543|FG001|Overall Study|Protocol Violation|6|||
150156352|NCT01929993|541708542|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
150156353|NCT01929993|541708543|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
150156354|NCT00107380|541708544|FG000|Overall Study|Adverse Event|7|||
150156355|NCT00107380|541708544|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
150156356|NCT00107380|541708544|FG000|Overall Study|Progression/relapse|4|||
150156357|NCT00107380|541708544|FG000|Overall Study|Death|3|||
150156358|NCT00107380|541708544|FG000|Overall Study|Other - not protocol specified|7|||
150156359|NCT00107380|541708544|FG000|Overall Study|Ineligible|2|||
150156360|NCT03673098|541708545|FG000|Overall Study|Lost to Follow-up|2|||
150156361|NCT03673098|541708546|FG001|Overall Study|Lost to Follow-up|3|||
150156362|NCT03673098|541708545|FG000|Overall Study|Withdrawal by Subject|6|||
150156363|NCT03673098|541708546|FG001|Overall Study|Withdrawal by Subject|1|||
150156364|NCT03673098|541708545|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
150156365|NCT03673098|541708546|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
150156366|NCT01268059|541708547|FG000|Overall Study|Lost to Follow-up|0|||
150156367|NCT01268059|541708548|FG001|Overall Study|Lost to Follow-up|1|||
150156368|NCT01268059|541708549|FG002|Overall Study|Lost to Follow-up|0|||
150156369|NCT01268059|541708550|FG003|Overall Study|Lost to Follow-up|0|||
150156370|NCT01268059|541708547|FG000|Overall Study|Withdrawal by Subject|7|||
150156371|NCT01268059|541708548|FG001|Overall Study|Withdrawal by Subject|4|||
150156372|NCT01268059|541708549|FG002|Overall Study|Withdrawal by Subject|0|||
150156373|NCT01268059|541708550|FG003|Overall Study|Withdrawal by Subject|0|||
150156374|NCT01268059|541708547|FG000|Overall Study|Death|20|||
150156375|NCT01268059|541708548|FG001|Overall Study|Death|30|||
150156376|NCT01268059|541708549|FG002|Overall Study|Death|3|||
150156377|NCT01268059|541708550|FG003|Overall Study|Death|5|||
150156378|NCT01268059|541708547|FG000|Overall Study|Progression of disease|1|||
150156379|NCT01268059|541708548|FG001|Overall Study|Progression of disease|0|||
150156380|NCT01268059|541708549|FG002|Overall Study|Progression of disease|0|||
150156381|NCT01268059|541708550|FG003|Overall Study|Progression of disease|0|||
150156382|NCT03660943|541708551|FG000|Overall Study|Adverse Event|5|||
150156383|NCT03660943|541708552|FG001|Overall Study|Adverse Event|3|||
150156384|NCT03660943|541708551|FG000|Overall Study|Death|0|||
150156385|NCT03660943|541708552|FG001|Overall Study|Death|2|||
150156386|NCT03660943|541708551|FG000|Overall Study|Lost to Follow-up|7|||
150156387|NCT03660943|541708552|FG001|Overall Study|Lost to Follow-up|3|||
150156388|NCT03660943|541708551|FG000|Overall Study|Protocol Violation|3|||
150156389|NCT03660943|541708552|FG001|Overall Study|Protocol Violation|5|||
150156390|NCT03660943|541708551|FG000|Overall Study|Withdrawal by Subject|8|||
150156391|NCT03660943|541708552|FG001|Overall Study|Withdrawal by Subject|15|||
150156392|NCT03660943|541708551|FG000|Overall Study|Lack of Efficacy|9|||
150156393|NCT03660943|541708552|FG001|Overall Study|Lack of Efficacy|12|||
150156394|NCT03660943|541708551|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
150156395|NCT03660943|541708552|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
150156396|NCT03850444|541708553|FG000|Overall Study|Adverse Event|16|||
150156397|NCT03850444|541708554|FG001|Overall Study|Adverse Event|10|||
150156398|NCT03850444|541708553|FG000|Overall Study|Death|87|||
150156399|NCT03850444|541708554|FG001|Overall Study|Death|107|||
150156400|NCT03850444|541708553|FG000|Overall Study|Lost to Follow-up|1|||
150156401|NCT03850444|541708554|FG001|Overall Study|Lost to Follow-up|1|||
150156402|NCT03850444|541708553|FG000|Overall Study|Withdrawal by Subject|1|||
150156403|NCT03850444|541708554|FG001|Overall Study|Withdrawal by Subject|5|||
150156404|NCT03850444|541708553|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
150156405|NCT03850444|541708554|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
150156406|NCT00839917|541708557|FG000|Overall Study|Lost to Follow-up|1|||
150156407|NCT00839917|541708558|FG001|Overall Study|Lost to Follow-up|0|||
150156408|NCT00839917|541708557|FG000|Overall Study|Did not receive vaccine|0|||
150156409|NCT00839917|541708558|FG001|Overall Study|Did not receive vaccine|1|||
150156410|NCT00109928|541708566|FG000|Overall Study|Adverse Event|2|||
150156411|NCT00109928|541708566|FG000|Overall Study|Progression|6|||
150156412|NCT00109928|541708566|FG000|Overall Study|Death|2|||
150156413|NCT00109928|541708566|FG000|Overall Study|not protocol specified|2|||
150156414|NCT00109928|541708566|FG000|Overall Study|not eligible|1|||
150156415|NCT02491892|541708572|FG000|Overall Study|Adverse Event|1|||
150156416|NCT02491892|541708573|FG001|Overall Study|Adverse Event|1|||
150156417|NCT02491892|541708572|FG000|Overall Study|Death|1|||
150156418|NCT02491892|541708573|FG001|Overall Study|Death|1|||
150156419|NCT02491892|541708572|FG000|Overall Study|Lack of Efficacy|37|||
150156420|NCT02491892|541708573|FG001|Overall Study|Lack of Efficacy|36|||
150156421|NCT02491892|541708572|FG000|Overall Study|Refused Treatment|1|||
150156422|NCT02491892|541708573|FG001|Overall Study|Refused Treatment|0|||
150156423|NCT02491892|541708572|FG000|Overall Study|Lost to Follow-up|1|||
150156424|NCT02491892|541708573|FG001|Overall Study|Lost to Follow-up|0|||
150156425|NCT01734850|541708574|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
150156426|NCT01734850|541708575|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
150156427|NCT01734850|541708576|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
150156428|NCT01734850|541708574|FG000|Overall Study|Not infused due to manufacturing failure|0|||
150156429|NCT01734850|541708575|FG001|Overall Study|Not infused due to manufacturing failure|0|||
150156430|NCT01734850|541708576|FG002|Overall Study|Not infused due to manufacturing failure|1|||
150156431|NCT00661258|541708578|FG000|Overall Study|Death|1|||
150156432|NCT00661258|541708579|FG001|Overall Study|Death|0|||
150156433|NCT00661258|541708578|FG000|Overall Study|caught by police and in detox center|2|||
150156434|NCT00661258|541708579|FG001|Overall Study|caught by police and in detox center|1|||
150156435|NCT04496167|541708580|FG000|Overall Study|Adverse Event|6|||
150156436|NCT04496167|541708581|FG001|Overall Study|Adverse Event|2|||
150156437|NCT04496167|541708580|FG000|Overall Study|Withdrawal by Subject|7|||
150156438|NCT04496167|541708581|FG001|Overall Study|Withdrawal by Subject|6|||
150156439|NCT04496167|541708580|FG000|Overall Study|Lost to Follow-up|3|||
150156440|NCT04496167|541708581|FG001|Overall Study|Lost to Follow-up|5|||
150156441|NCT04496167|541708580|FG000|Overall Study|Not Treated|1|||
150156442|NCT04496167|541708581|FG001|Overall Study|Not Treated|2|||
150156443|NCT04496167|541708580|FG000|Overall Study|Other Than Specified|1|||
150156444|NCT04496167|541708581|FG001|Overall Study|Other Than Specified|1|||
150156445|NCT00598481|541708584|FG000|Treatment|Physician Decision|1|||
150156446|NCT01712789|541708587|FG000|Overall Study|Lack of Efficacy|2|||
150156447|NCT01712789|541708587|FG000|Overall Study|Lost to Follow-up|1|||
150156448|NCT01712789|541708587|FG000|Overall Study|Progressive Disease|504|||
150156449|NCT01712789|541708587|FG000|Overall Study|Death|57|||
150156450|NCT01712789|541708587|FG000|Overall Study|Adverse Event|52|||
150156451|NCT01712789|541708587|FG000|Overall Study|Miscellaneous|31|||
150156452|NCT01712789|541708587|FG000|Overall Study|Withdrawal by Subject|21|||
150156453|NCT01712789|541708587|FG000|Overall Study|Transition to Commercial Treatment|8|||
150156454|NCT01712789|541708587|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
150156455|NCT02408549|541708588|FG000|Overall Study|Adverse Event|15|||
150156456|NCT02408549|541708588|FG000|Overall Study|Death|4|||
150156457|NCT02408549|541708588|FG000|Overall Study|Lack of Efficacy|17|||
150156458|NCT02408549|541708588|FG000|Overall Study|Protocol Violation|4|||
150156459|NCT02408549|541708588|FG000|Overall Study|Lost to Follow-up|6|||
150156460|NCT02408549|541708588|FG000|Overall Study|Consent withdrawn|30|||
150156461|NCT02408549|541708588|FG000|Overall Study|Neurology research program closing at site|1|||
150156462|NCT02408549|541708588|FG000|Overall Study|Site closure|1|||
150156463|NCT02408549|541708588|FG000|Overall Study|Pregnancy|1|||
150156464|NCT02408549|541708588|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
150156465|NCT02408549|541708588|FG000|Overall Study|Subject moved to another place, far from site|1|||
150156466|NCT02408549|541708588|FG000|Overall Study|Study terminated at site|1|||
150156467|NCT01024751|541708591|FG000|Enrolled Participants|Ineligible at baseline|3|||
150156468|NCT01024751|541708592|FG001|Enrolled Participants|Ineligible at baseline|4|||
150156469|NCT01024751|541708591|FG000|Eligible Participants|Withdrawal by Subject|0|||
150156470|NCT01024751|541708592|FG001|Eligible Participants|Withdrawal by Subject|1|||
150156471|NCT01024751|541708591|FG000|Eligible Participants|Lost to Follow-up|0|||
149918927|NCT00422292|540835251|FG001|Overall Study|Serious adverse events|4|||
150156472|NCT01024751|541708592|FG001|Eligible Participants|Lost to Follow-up|1|||
149815730|NCT01326702|540456754|FG006|Overall Study|Not Treated|0|||
150156473|NCT01024751|541708591|FG000|Eligible Participants|Ineligible|0|||
150156474|NCT01024751|541708592|FG001|Eligible Participants|Ineligible|1|||
150156475|NCT02448719|541708593|FG000|Overall Study|Withdrawal by Subject|0|||
150156476|NCT02448719|541708594|FG001|Overall Study|Withdrawal by Subject|0|||
150156477|NCT02448719|541708595|FG002|Overall Study|Withdrawal by Subject|0|||
150156478|NCT02448719|541708596|FG003|Overall Study|Withdrawal by Subject|0|||
150156479|NCT02448719|541708597|FG004|Overall Study|Withdrawal by Subject|1|||
150156480|NCT02448719|541708598|FG005|Overall Study|Withdrawal by Subject|0|||
149815731|NCT02082912|540456755|FG000|Overall Study|Physician Decision|0|||
149815732|NCT02082912|540456756|FG001|Overall Study|Physician Decision|1|||
149815733|NCT01835132|540456762|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
149815734|NCT00782275|540456768|FG000|Overall Study|Adverse Event|11|||
149815735|NCT00782275|540456768|FG000|Overall Study|Withdrawal by Subject|1|||
149815736|NCT00782275|540456768|FG000|Overall Study|Progressive Disease|21|||
149815737|NCT00782275|540456768|FG000|Overall Study|Physician Decision|4|||
149815738|NCT00782275|540456768|FG000|Overall Study|Not started treatment|1|||
149815739|NCT00782275|540456768|FG000|Overall Study|Other|3|||
149815740|NCT00331773|540456769|FG000|Overall Study|Withdrawal by Subject|6|||
149815741|NCT00331773|540456770|FG001|Overall Study|Withdrawal by Subject|4|||
149815742|NCT00331773|540456769|FG000|Overall Study|Protocol Violation|10|||
149815743|NCT00331773|540456770|FG001|Overall Study|Protocol Violation|3|||
149815744|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
149815745|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
149815746|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
149815747|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
149815748|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
149815749|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
149815750|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
149815751|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
149815752|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
149815753|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
149815754|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
149815755|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
149815756|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
149815757|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
149815758|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
149815759|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
149815760|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
149815761|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
149815762|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
149815763|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
149815764|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
149815765|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
149815766|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
149815767|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
149815768|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
149815769|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
149815770|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
149815771|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
149815772|NCT01872689|540456782|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
149815773|NCT01872689|540456783|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
149815774|NCT01872689|540456784|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
149815775|NCT01872689|540456785|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
149815776|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
149815777|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
149815778|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
149815779|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
149815780|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
149815781|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
149815782|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
149815783|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
149815784|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
149815785|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
149815786|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
149815787|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
149815788|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
149815789|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
149815790|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
149815791|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
149815792|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
149815793|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
149815794|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
149815795|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
149815796|NCT01872689|540456782|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
150156481|NCT02448719|541708599|FG006|Overall Study|Withdrawal by Subject|0|||
150156482|NCT02448719|541708600|FG007|Overall Study|Withdrawal by Subject|0|||
150156483|NCT02448719|541708601|FG008|Overall Study|Withdrawal by Subject|0|||
150156484|NCT02448719|541708602|FG009|Overall Study|Withdrawal by Subject|0|||
150156485|NCT02448719|541708603|FG010|Overall Study|Withdrawal by Subject|0|||
150156486|NCT01232556|541708604|FG000|Overall Study|Withdrawal by Subject|21|||
150156487|NCT01232556|541708605|FG001|Overall Study|Withdrawal by Subject|17|||
150156488|NCT01232556|541708604|FG000|Overall Study|Death|97|||
150156489|NCT01232556|541708605|FG001|Overall Study|Death|97|||
150156490|NCT01232556|541708604|FG000|Overall Study|Lost to Follow-up|0|||
150156491|NCT01232556|541708605|FG001|Overall Study|Lost to Follow-up|2|||
150156492|NCT01232556|541708604|FG000|Overall Study|Terminated by Sponsor|35|||
150156493|NCT01232556|541708605|FG001|Overall Study|Terminated by Sponsor|51|||
150156494|NCT01232556|541708604|FG000|Overall Study|Other|6|||
150156495|NCT01232556|541708605|FG001|Overall Study|Other|4|||
150156496|NCT01603121|541708611|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
149815797|NCT01872689|540456783|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
149815798|NCT01872689|540456784|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
149815799|NCT01872689|540456785|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
149815800|NCT02143947|540456786|FG000|Overall Study|Lost to Follow-up|4|||
149815801|NCT02143947|540456787|FG001|Overall Study|Lost to Follow-up|2|||
149815802|NCT01244815|540456790|FG000|Overall Study|Not Treated|0|||
149815803|NCT01244815|540456791|FG001|Overall Study|Not Treated|1|||
149815804|NCT01244815|540456792|FG002|Overall Study|Not Treated|0|||
149815805|NCT01244815|540456793|FG003|Overall Study|Not Treated|0|||
149815806|NCT01244815|540456790|FG000|Overall Study|Adverse Event|4|||
149815807|NCT01244815|540456791|FG001|Overall Study|Adverse Event|7|||
149815808|NCT01244815|540456792|FG002|Overall Study|Adverse Event|5|||
149815809|NCT01244815|540456793|FG003|Overall Study|Adverse Event|5|||
149815810|NCT01244815|540456790|FG000|Overall Study|Treatment Failure|0|||
149815811|NCT01244815|540456791|FG001|Overall Study|Treatment Failure|0|||
149815812|NCT01244815|540456792|FG002|Overall Study|Treatment Failure|0|||
149815813|NCT01244815|540456793|FG003|Overall Study|Treatment Failure|1|||
149815814|NCT01244815|540456790|FG000|Overall Study|Lost to Follow-up|3|||
149815815|NCT01244815|540456791|FG001|Overall Study|Lost to Follow-up|2|||
149815816|NCT01244815|540456792|FG002|Overall Study|Lost to Follow-up|3|||
149815817|NCT01244815|540456793|FG003|Overall Study|Lost to Follow-up|2|||
149815818|NCT01244815|540456790|FG000|Overall Study|Withdrawal by Subject|0|||
149815819|NCT01244815|540456791|FG001|Overall Study|Withdrawal by Subject|2|||
149815820|NCT01244815|540456792|FG002|Overall Study|Withdrawal by Subject|0|||
149815821|NCT01244815|540456793|FG003|Overall Study|Withdrawal by Subject|3|||
149815822|NCT01244815|540456790|FG000|Overall Study|Protocol Violation|7|||
149815823|NCT01244815|540456791|FG001|Overall Study|Protocol Violation|4|||
149815824|NCT01244815|540456792|FG002|Overall Study|Protocol Violation|3|||
149815825|NCT01244815|540456793|FG003|Overall Study|Protocol Violation|1|||
149815826|NCT01244815|540456790|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
149815827|NCT01244815|540456791|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
149815828|NCT01244815|540456792|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
149815829|NCT01244815|540456793|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
149815830|NCT00697112|540456795|FG000|Overall Study|Adverse Event|8|||
149815831|NCT00697112|540456795|FG000|Overall Study|Lost to Follow-up|1|||
149815832|NCT00697112|540456795|FG000|Overall Study|Did not meet inclusion criteria|1|||
149815833|NCT01427920|540456800|FG000|Overall Study|Adverse Event|1|||
149815834|NCT01427920|540456801|FG001|Overall Study|Adverse Event|2|||
149815835|NCT01427920|540456800|FG000|Overall Study|Lack of Efficacy|1|||
149815836|NCT01427920|540456801|FG001|Overall Study|Lack of Efficacy|0|||
149815837|NCT01427920|540456800|FG000|Overall Study|Protocol Violation|1|||
149815838|NCT01427920|540456801|FG001|Overall Study|Protocol Violation|3|||
149815839|NCT01427920|540456800|FG000|Overall Study|Withdrawal Criteria|4|||
149815840|NCT01427920|540456801|FG001|Overall Study|Withdrawal Criteria|4|||
149815841|NCT01427920|540456800|FG000|Overall Study|Unclassified|2|||
149815842|NCT01427920|540456801|FG001|Overall Study|Unclassified|8|||
149815843|NCT04228302|540456802|FG000|Overall Study|Adverse Event|0|||
150156497|NCT01603121|541708612|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
150156498|NCT00577720|541708613|FG000|Overall Study|Adverse Event|2|||
150156499|NCT00577720|541708614|FG001|Overall Study|Adverse Event|1|||
150156500|NCT00577720|541708615|FG002|Overall Study|Adverse Event|0|||
150156501|NCT00577720|541708616|FG003|Overall Study|Adverse Event|4|||
150156502|NCT00577720|541708613|FG000|Overall Study|Lost to Follow-up|0|||
150156503|NCT00577720|541708614|FG001|Overall Study|Lost to Follow-up|0|||
149815844|NCT04228302|540456803|FG001|Overall Study|Adverse Event|0|||
149815845|NCT04228302|540456804|FG002|Overall Study|Adverse Event|0|||
149815846|NCT04228302|540456805|FG003|Overall Study|Adverse Event|0|||
149815847|NCT04228302|540456806|FG004|Overall Study|Adverse Event|1|||
149815848|NCT04228302|540456807|FG005|Overall Study|Adverse Event|0|||
149815849|NCT00054275|540456808|FG000|Overall Study|Withdrawal by Subject|4|||
149815850|NCT00054275|540456808|FG000|Overall Study|Adverse Event|5|||
149815851|NCT00054275|540456808|FG000|Overall Study|Progressive disease in cycle 1|1|||
149815852|NCT00054275|540456808|FG000|Overall Study|Physician Decision|1|||
149815853|NCT03402126|540456809|FG000|Overall Study|Lost to Follow-up|6|||
150156504|NCT00577720|541708615|FG002|Overall Study|Lost to Follow-up|1|||
150156505|NCT00577720|541708616|FG003|Overall Study|Lost to Follow-up|0|||
150156506|NCT00577720|541708613|FG000|Overall Study|Protocol Violation|0|||
150156507|NCT00577720|541708614|FG001|Overall Study|Protocol Violation|0|||
150156508|NCT00577720|541708615|FG002|Overall Study|Protocol Violation|0|||
150156509|NCT00577720|541708616|FG003|Overall Study|Protocol Violation|1|||
150156510|NCT00577720|541708613|FG000|Overall Study|Withdrawal by Subject|2|||
150156511|NCT00577720|541708614|FG001|Overall Study|Withdrawal by Subject|0|||
150156512|NCT00577720|541708615|FG002|Overall Study|Withdrawal by Subject|0|||
150156513|NCT00577720|541708616|FG003|Overall Study|Withdrawal by Subject|2|||
150156514|NCT01628510|541708619|FG000|Overall Study|Withdrawal by Subject|0|||
150156515|NCT01628510|541708620|FG001|Overall Study|Withdrawal by Subject|4|||
150156516|NCT01628510|541708619|FG000|Overall Study|Death|3|||
150156517|NCT01628510|541708620|FG001|Overall Study|Death|1|||
150156518|NCT04707391|541708621|FG000|Overall Study|Adverse Event|5|||
150156519|NCT04707391|541708622|FG001|Overall Study|Adverse Event|8|||
150156520|NCT04707391|541708621|FG000|Overall Study|Lost to Follow-up|44|||
150156521|NCT04707391|541708622|FG001|Overall Study|Lost to Follow-up|31|||
150156522|NCT04707391|541708621|FG000|Overall Study|Protocol Violation|1|||
150156523|NCT04707391|541708622|FG001|Overall Study|Protocol Violation|5|||
150156524|NCT04707391|541708621|FG000|Overall Study|Withdrawal by Subject|27|||
150156525|NCT04707391|541708622|FG001|Overall Study|Withdrawal by Subject|25|||
150156526|NCT04707391|541708621|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
150156527|NCT04707391|541708622|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
150156528|NCT04707391|541708621|FG000|Overall Study|Other|0|||
150156529|NCT04707391|541708622|FG001|Overall Study|Other|2|||
150156530|NCT03246672|541708624|FG000|Overall Study|Lost to Follow-up|2|||
150156531|NCT01932996|541708625|FG000|Overall Study|Protocol Violation|2|||
150156532|NCT01932996|541708626|FG001|Overall Study|Protocol Violation|0|||
150156533|NCT02500316|541708630|FG000|Overall Study|Adverse Event|3|||
150156534|NCT02500316|541708630|FG000|Overall Study|Lost to Follow-up|2|||
150156535|NCT02500316|541708630|FG000|Overall Study|Protocol Violation|1|||
150156536|NCT02500316|541708630|FG000|Overall Study|Withdrawal by Subject|15|||
150156537|NCT02500316|541708630|FG000|Overall Study|Final height achieved|5|||
150156538|NCT02500316|541708630|FG000|Overall Study|Due to war activity|1|||
150156539|NCT01406717|541708631|FG000|Overall Study|Subject non-compliance|4|||
150156540|NCT01406717|541708632|FG001|Overall Study|Subject non-compliance|3|||
150156541|NCT01406717|541708631|FG000|Overall Study|Protocol Violation|5|||
150156542|NCT01406717|541708632|FG001|Overall Study|Protocol Violation|1|||
150156543|NCT01406717|541708631|FG000|Overall Study|Lost to Follow-up|14|||
150156544|NCT01406717|541708632|FG001|Overall Study|Lost to Follow-up|8|||
150156545|NCT01406717|541708631|FG000|Overall Study|Withdrawal by Subject|19|||
150156546|NCT01406717|541708632|FG001|Overall Study|Withdrawal by Subject|15|||
150156547|NCT01406717|541708631|FG000|Overall Study|Adverse Event|1|||
150156548|NCT01406717|541708632|FG001|Overall Study|Adverse Event|2|||
150156549|NCT01406717|541708631|FG000|Overall Study|Lack of Efficacy|0|||
150156550|NCT01406717|541708632|FG001|Overall Study|Lack of Efficacy|1|||
150156551|NCT01406717|541708631|FG000|Overall Study|Non-completion of visit activity|0|||
150156552|NCT01406717|541708632|FG001|Overall Study|Non-completion of visit activity|1|||
150156553|NCT02040090|541708633|FG000|Overall Study|Adverse Event|2|||
150156554|NCT02040090|541708634|FG001|Overall Study|Adverse Event|0|||
149815854|NCT03402126|540456809|FG000|Overall Study|Protocol Violation|10|||
149815855|NCT03402126|540456809|FG000|Overall Study|Sponsor request/Study termination|29|||
150156555|NCT02040090|541708633|FG000|Overall Study|Physician Decision|1|||
150156556|NCT02040090|541708634|FG001|Overall Study|Physician Decision|0|||
150156557|NCT02040090|541708633|FG000|Overall Study|Withdrawal by Subject|0|||
150156558|NCT02040090|541708634|FG001|Overall Study|Withdrawal by Subject|1|||
150156559|NCT02040090|541708633|FG000|Overall Study|Lost to Follow-up|0|||
150156560|NCT02040090|541708634|FG001|Overall Study|Lost to Follow-up|1|||
150156561|NCT03257995|541708635|FG000|Overall Study|Adverse Event|0|||
149815856|NCT03402126|540456809|FG000|Overall Study|Study product no longer in use|1|||
149815857|NCT03402126|540456809|FG000|Overall Study|Technical problems|1|||
150156562|NCT03257995|541708636|FG001|Overall Study|Adverse Event|1|||
149815858|NCT03402126|540456809|FG000|Overall Study|Withdrawal by Subject|6|||
149815859|NCT03402126|540456809|FG000|Overall Study|Physician Decision|2|||
149815860|NCT03402126|540456809|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
149815861|NCT03402126|540456809|FG000|Overall Study|Death|4|||
150156563|NCT03257995|541708637|FG002|Overall Study|Adverse Event|0|||
150156564|NCT03257995|541708638|FG003|Overall Study|Adverse Event|0|||
150156565|NCT03257995|541708639|FG004|Overall Study|Adverse Event|0|||
150156566|NCT03257995|541708640|FG005|Overall Study|Adverse Event|0|||
150156567|NCT03257995|541708635|FG000|Overall Study|Protocol deviation|0|||
149815862|NCT02444182|540456810|FG000|Overall Study|non-compliance|2|||
149815863|NCT02444182|540456811|FG001|Overall Study|non-compliance|1|||
150156568|NCT03257995|541708636|FG001|Overall Study|Protocol deviation|0|||
150156569|NCT03257995|541708637|FG002|Overall Study|Protocol deviation|0|||
150156570|NCT03257995|541708638|FG003|Overall Study|Protocol deviation|0|||
150156571|NCT03257995|541708639|FG004|Overall Study|Protocol deviation|0|||
150156572|NCT03257995|541708640|FG005|Overall Study|Protocol deviation|2|||
149815864|NCT02444182|540456810|FG000|Overall Study|Lost to Follow-up|0|||
149815865|NCT02444182|540456811|FG001|Overall Study|Lost to Follow-up|4|||
149815866|NCT01959230|540456814|FG000|Overall Study|Failure to follow study procedures|0|||
149815867|NCT01959230|540456815|FG001|Overall Study|Failure to follow study procedures|1|||
149815868|NCT01959230|540456814|FG000|Overall Study|Administrative reasons|2|||
149815869|NCT01959230|540456815|FG001|Overall Study|Administrative reasons|0|||
149815870|NCT01959230|540456814|FG000|Overall Study|Withdrawal by Subject|2|||
149815871|NCT01959230|540456815|FG001|Overall Study|Withdrawal by Subject|0|||
149815872|NCT01453374|540456816|FG000|Overall Study|Adverse Event|7|||
149815873|NCT01453374|540456816|FG000|Overall Study|Lack of Efficacy|1|||
149815874|NCT01453374|540456816|FG000|Overall Study|Lost to Follow-up|3|||
149815875|NCT01453374|540456816|FG000|Overall Study|Withdrawal by Subject|5|||
149815876|NCT01453374|540456816|FG000|Overall Study|Incarcerated|2|||
149815877|NCT01223196|540456817|FG000|Overall Study|Lost to Follow-up|2|||
149815878|NCT01223196|540456818|FG001|Overall Study|Lost to Follow-up|0|||
149815879|NCT01223196|540456817|FG000|Overall Study|Physician Decision|1|||
149815880|NCT01223196|540456818|FG001|Overall Study|Physician Decision|0|||
149815881|NCT01223196|540456817|FG000|Overall Study|Withdrawal by Subject|1|||
149815882|NCT01223196|540456818|FG001|Overall Study|Withdrawal by Subject|0|||
149815883|NCT01238822|540456819|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
149815884|NCT02487979|540456820|FG000|Overall Study|Physician Decision|2|||
149815885|NCT02487979|540456820|FG000|Overall Study|Withdrawal by Subject|2|||
149815886|NCT02487979|540456820|FG000|Overall Study|Progressive Disease|17|||
149815887|NCT00447694|540456821|FG000|Overall Study|Adverse Event|2|||
149815888|NCT00447694|540456821|FG000|Overall Study|Abnormal laboratory value|1|||
149815889|NCT00447694|540456821|FG000|Overall Study|Abnormal test procedure result|1|||
149815890|NCT00447694|540456821|FG000|Overall Study|Withdrawal by Subject|2|||
149815891|NCT01965535|540456822|FG000|Overall Study|Lack of Efficacy|2|||
149815892|NCT01965535|540456823|FG001|Overall Study|Lack of Efficacy|1|||
149815893|NCT01169987|540456824|FG000|Overall Study|Withdrawal by Subject|3|||
149815894|NCT01169987|540456824|FG000|Overall Study|Lost to Follow-up|24|||
149815895|NCT01169987|540456824|FG000|Overall Study|Other|4|||
149815896|NCT00829439|540456825|FG000|Overall Study|Adverse Event|0|||
149815897|NCT00829439|540456826|FG001|Overall Study|Adverse Event|0|||
149815898|NCT00829439|540456827|FG002|Overall Study|Adverse Event|1|||
149815899|NCT00829439|540456828|FG003|Overall Study|Adverse Event|0|||
149815900|NCT01825876|540456831|FG000|Period 2|Withdrawal by Subject|0|||
149815901|NCT01825876|540456832|FG001|Period 2|Withdrawal by Subject|1|||
149815902|NCT03636542|540456833|FG000|Overall Study|Lost to Follow-up|1|||
149815903|NCT03636542|540456834|FG001|Overall Study|Lost to Follow-up|1|||
150156573|NCT02584855|541708648|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
150156574|NCT02584855|541708649|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
150156575|NCT02584855|541708650|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
150156576|NCT02584855|541708651|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
150156577|NCT02584855|541708652|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
150156578|NCT02584855|541708653|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
150156579|NCT02584855|541708648|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
150156580|NCT02584855|541708649|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
150156581|NCT02584855|541708650|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
150156582|NCT02584855|541708651|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
150156583|NCT02584855|541708652|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
150156584|NCT02584855|541708653|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
150156585|NCT02584855|541708648|FG000|Open-Label Treatment Period|Adverse Event|14|||
150156586|NCT02584855|541708649|FG001|Open-Label Treatment Period|Adverse Event|0|||
150156587|NCT02584855|541708650|FG002|Open-Label Treatment Period|Adverse Event|0|||
150156588|NCT02584855|541708651|FG003|Open-Label Treatment Period|Adverse Event|0|||
150156589|NCT02584855|541708652|FG004|Open-Label Treatment Period|Adverse Event|0|||
150156590|NCT02584855|541708653|FG005|Open-Label Treatment Period|Adverse Event|0|||
150156591|NCT02584855|541708648|FG000|Open-Label Treatment Period|Death|2|||
150156592|NCT02584855|541708649|FG001|Open-Label Treatment Period|Death|0|||
150156593|NCT02584855|541708650|FG002|Open-Label Treatment Period|Death|0|||
150156594|NCT02584855|541708651|FG003|Open-Label Treatment Period|Death|0|||
149815904|NCT03636542|540456833|FG000|Overall Study|Physician Decision|0|||
149815905|NCT03636542|540456834|FG001|Overall Study|Physician Decision|1|||
149815906|NCT03636542|540456833|FG000|Overall Study|Withdrawal by Subject|1|||
149815907|NCT03636542|540456834|FG001|Overall Study|Withdrawal by Subject|0|||
149815908|NCT02059187|540456837|FG000|Overall Study|Adverse Event|0|||
149815909|NCT02059187|540456838|FG001|Overall Study|Adverse Event|3|||
150156595|NCT02584855|541708652|FG004|Open-Label Treatment Period|Death|0|||
150156596|NCT02584855|541708653|FG005|Open-Label Treatment Period|Death|0|||
150156597|NCT02584855|541708648|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
149815910|NCT02059187|540456837|FG000|Overall Study|Death|1|||
149815911|NCT02059187|540456838|FG001|Overall Study|Death|1|||
149815912|NCT02059187|540456837|FG000|Overall Study|Lost to Follow-up|9|||
149815913|NCT02059187|540456838|FG001|Overall Study|Lost to Follow-up|8|||
149815914|NCT02059187|540456837|FG000|Overall Study|Non-compliance with study drug|1|||
149815915|NCT02059187|540456838|FG001|Overall Study|Non-compliance with study drug|0|||
150156598|NCT02584855|541708649|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
150156599|NCT02584855|541708650|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
150156600|NCT02584855|541708651|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
150156601|NCT02584855|541708652|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
150156602|NCT02584855|541708653|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
150156603|NCT02584855|541708648|FG000|Open-Label Treatment Period|Protocol Violation|1|||
150156604|NCT02584855|541708649|FG001|Open-Label Treatment Period|Protocol Violation|0|||
150156605|NCT02584855|541708650|FG002|Open-Label Treatment Period|Protocol Violation|0|||
150156606|NCT02584855|541708651|FG003|Open-Label Treatment Period|Protocol Violation|0|||
150156607|NCT02584855|541708652|FG004|Open-Label Treatment Period|Protocol Violation|0|||
150156608|NCT02584855|541708653|FG005|Open-Label Treatment Period|Protocol Violation|0|||
150156609|NCT02584855|541708648|FG000|Open-Label Treatment Period|No PI Available|2|||
150156610|NCT02584855|541708649|FG001|Open-Label Treatment Period|No PI Available|0|||
150156611|NCT02584855|541708650|FG002|Open-Label Treatment Period|No PI Available|0|||
150156612|NCT02584855|541708651|FG003|Open-Label Treatment Period|No PI Available|0|||
150156613|NCT02584855|541708652|FG004|Open-Label Treatment Period|No PI Available|0|||
150156614|NCT02584855|541708653|FG005|Open-Label Treatment Period|No PI Available|0|||
150156615|NCT02584855|541708648|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
150156616|NCT02584855|541708649|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
150156617|NCT02584855|541708650|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
150156618|NCT02584855|541708651|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
150156619|NCT02584855|541708652|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
150156620|NCT02584855|541708653|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
150156621|NCT02584855|541708648|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
150156622|NCT02584855|541708649|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
150156623|NCT02584855|541708650|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
150156624|NCT02584855|541708651|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
150156625|NCT02584855|541708652|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
150156626|NCT02584855|541708653|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
150156627|NCT02584855|541708648|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
150156628|NCT02584855|541708649|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
150156629|NCT02584855|541708650|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
150156630|NCT02584855|541708651|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
150156631|NCT02584855|541708652|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
150156632|NCT02584855|541708653|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
150156633|NCT02584855|541708648|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
150156634|NCT02584855|541708649|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
150156635|NCT02584855|541708650|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
150156636|NCT02584855|541708651|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
150156637|NCT02584855|541708652|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
150156638|NCT02584855|541708653|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
150156639|NCT02584855|541708648|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
150156640|NCT02584855|541708649|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
150156641|NCT02584855|541708650|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
150156642|NCT02584855|541708651|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
150156643|NCT02584855|541708652|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
150156644|NCT02584855|541708653|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
150156645|NCT02584855|541708648|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150156646|NCT02584855|541708649|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150156647|NCT02584855|541708650|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150156648|NCT02584855|541708651|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150156649|NCT02584855|541708652|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
150156650|NCT02584855|541708653|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150156651|NCT02584855|541708648|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
150156652|NCT02584855|541708649|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
150156653|NCT02584855|541708650|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
150156654|NCT02584855|541708651|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
150156655|NCT02584855|541708652|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
150156656|NCT02584855|541708653|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
150156657|NCT02337478|541708654|FG000|Overall Study|Lack of Efficacy|5|||
150156658|NCT00895843|541708655|FG000|Overall Study|Protocol Violation|12|||
150156659|NCT00895843|541708656|FG001|Overall Study|Protocol Violation|12|||
150156660|NCT02906202|541708661|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
150156661|NCT04131907|541708663|FG000|Overall Study|Adverse Event|2|||
150156662|NCT04131907|541708664|FG001|Overall Study|Adverse Event|0|||
150156663|NCT04131907|541708665|FG002|Overall Study|Adverse Event|0|||
150156664|NCT04131907|541708663|FG000|Overall Study|Physician Decision|4|||
150156665|NCT04131907|541708664|FG001|Overall Study|Physician Decision|22|||
150156666|NCT04131907|541708665|FG002|Overall Study|Physician Decision|0|||
150156667|NCT04131907|541708663|FG000|Overall Study|Withdrawal by Subject|2|||
150156668|NCT04131907|541708664|FG001|Overall Study|Withdrawal by Subject|0|||
150156669|NCT04131907|541708665|FG002|Overall Study|Withdrawal by Subject|1|||
150156670|NCT04131907|541708663|FG000|Overall Study|Treatment failure|2|||
150156671|NCT04131907|541708664|FG001|Overall Study|Treatment failure|0|||
150156672|NCT04131907|541708665|FG002|Overall Study|Treatment failure|1|||
150156673|NCT03428815|541708668|FG000|Overall Study|Lost to Follow-up|2|||
150156674|NCT03428815|541708669|FG001|Overall Study|Lost to Follow-up|2|||
150156675|NCT03428815|541708668|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
150156676|NCT03428815|541708669|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
150156677|NCT03428815|541708668|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
150156678|NCT03428815|541708669|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
150156679|NCT02404493|541708670|FG000|Overall Study|Adverse Event|1|||
150156680|NCT02404493|541708671|FG001|Overall Study|Adverse Event|1|||
150156681|NCT01700348|541708672|FG000|Overall Study|Withdrawal by Subject|22|||
150156682|NCT01700348|541708672|FG000|Overall Study|Lost to Follow-up|1|||
150156683|NCT03958630|541708673|FG000|Overall Study|Withdrawal by Subject|0|||
150156684|NCT03958630|541708674|FG001|Overall Study|Withdrawal by Subject|0|||
150156685|NCT03958630|541708675|FG002|Overall Study|Withdrawal by Subject|1|||
150156686|NCT03958630|541708673|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
150156687|NCT03958630|541708674|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
150156688|NCT03958630|541708675|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
150156689|NCT04157686|541708680|FG000|Overall Study|Adverse Event|1|||
150156690|NCT04157686|541708681|FG001|Overall Study|Adverse Event|0|||
150156691|NCT04157686|541708682|FG002|Overall Study|Adverse Event|1|||
150156692|NCT04157686|541708683|FG003|Overall Study|Adverse Event|0|||
150156693|NCT04157686|541708684|FG004|Overall Study|Adverse Event|1|||
150156694|NCT04157686|541708685|FG005|Overall Study|Adverse Event|0|||
150156695|NCT04157686|541708686|FG006|Overall Study|Adverse Event|0|||
150156696|NCT04157686|541708687|FG007|Overall Study|Adverse Event|0|||
150156697|NCT04157686|541708680|FG000|Overall Study|Pregnancy|0|||
150156698|NCT04157686|541708681|FG001|Overall Study|Pregnancy|1|||
150156699|NCT04157686|541708682|FG002|Overall Study|Pregnancy|3|||
150156700|NCT04157686|541708683|FG003|Overall Study|Pregnancy|0|||
150156701|NCT04157686|541708684|FG004|Overall Study|Pregnancy|0|||
150156702|NCT04157686|541708685|FG005|Overall Study|Pregnancy|0|||
150156703|NCT04157686|541708686|FG006|Overall Study|Pregnancy|3|||
150156704|NCT04157686|541708687|FG007|Overall Study|Pregnancy|0|||
150156705|NCT04157686|541708680|FG000|Overall Study|Lost to Follow-up|1|||
150156706|NCT04157686|541708681|FG001|Overall Study|Lost to Follow-up|2|||
150156707|NCT04157686|541708682|FG002|Overall Study|Lost to Follow-up|8|||
150156708|NCT04157686|541708683|FG003|Overall Study|Lost to Follow-up|6|||
150156709|NCT04157686|541708684|FG004|Overall Study|Lost to Follow-up|6|||
150156710|NCT04157686|541708685|FG005|Overall Study|Lost to Follow-up|3|||
150156711|NCT04157686|541708686|FG006|Overall Study|Lost to Follow-up|7|||
150156712|NCT04157686|541708687|FG007|Overall Study|Lost to Follow-up|9|||
150156713|NCT04157686|541708680|FG000|Overall Study|Lack of Efficacy|0|||
150156714|NCT04157686|541708681|FG001|Overall Study|Lack of Efficacy|0|||
150156715|NCT04157686|541708682|FG002|Overall Study|Lack of Efficacy|0|||
150156716|NCT04157686|541708683|FG003|Overall Study|Lack of Efficacy|0|||
150156717|NCT04157686|541708684|FG004|Overall Study|Lack of Efficacy|0|||
150156718|NCT04157686|541708685|FG005|Overall Study|Lack of Efficacy|2|||
150156719|NCT04157686|541708686|FG006|Overall Study|Lack of Efficacy|0|||
150156720|NCT04157686|541708687|FG007|Overall Study|Lack of Efficacy|1|||
150156721|NCT04157686|541708680|FG000|Overall Study|Withdrawal by Subject|10|||
150156722|NCT04157686|541708681|FG001|Overall Study|Withdrawal by Subject|10|||
150156723|NCT04157686|541708682|FG002|Overall Study|Withdrawal by Subject|12|||
150156724|NCT04157686|541708683|FG003|Overall Study|Withdrawal by Subject|20|||
150156725|NCT04157686|541708684|FG004|Overall Study|Withdrawal by Subject|12|||
150156726|NCT04157686|541708685|FG005|Overall Study|Withdrawal by Subject|11|||
150156727|NCT04157686|541708686|FG006|Overall Study|Withdrawal by Subject|18|||
150156728|NCT04157686|541708687|FG007|Overall Study|Withdrawal by Subject|24|||
150156729|NCT04157686|541708680|FG000|Overall Study|Physician Decision|0|||
150156730|NCT04157686|541708681|FG001|Overall Study|Physician Decision|0|||
150156731|NCT04157686|541708682|FG002|Overall Study|Physician Decision|1|||
150156732|NCT04157686|541708683|FG003|Overall Study|Physician Decision|0|||
150156733|NCT04157686|541708684|FG004|Overall Study|Physician Decision|1|||
150156734|NCT04157686|541708685|FG005|Overall Study|Physician Decision|0|||
150156735|NCT04157686|541708686|FG006|Overall Study|Physician Decision|3|||
150156736|NCT04157686|541708687|FG007|Overall Study|Physician Decision|0|||
150156737|NCT04157686|541708680|FG000|Overall Study|Death|0|||
150156738|NCT04157686|541708681|FG001|Overall Study|Death|0|||
150156739|NCT04157686|541708682|FG002|Overall Study|Death|0|||
150156740|NCT04157686|541708683|FG003|Overall Study|Death|2|||
150156741|NCT04157686|541708684|FG004|Overall Study|Death|0|||
150156742|NCT04157686|541708685|FG005|Overall Study|Death|0|||
150156743|NCT04157686|541708686|FG006|Overall Study|Death|0|||
150156744|NCT04157686|541708687|FG007|Overall Study|Death|0|||
150156745|NCT04157686|541708680|FG000|Overall Study|Protocol Violation|0|||
150156746|NCT04157686|541708681|FG001|Overall Study|Protocol Violation|0|||
150156747|NCT04157686|541708682|FG002|Overall Study|Protocol Violation|0|||
150156748|NCT04157686|541708683|FG003|Overall Study|Protocol Violation|0|||
150156749|NCT04157686|541708684|FG004|Overall Study|Protocol Violation|1|||
150156750|NCT04157686|541708685|FG005|Overall Study|Protocol Violation|0|||
150156751|NCT04157686|541708686|FG006|Overall Study|Protocol Violation|0|||
150156752|NCT04157686|541708687|FG007|Overall Study|Protocol Violation|0|||
150156753|NCT04157686|541708680|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
150156754|NCT04157686|541708681|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
150156755|NCT04157686|541708682|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
150156756|NCT04157686|541708683|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
150156757|NCT04157686|541708684|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
150156758|NCT04157686|541708685|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
150156759|NCT04157686|541708686|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
150156760|NCT04157686|541708687|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
150156761|NCT01021878|541710900|FG000|Overall Study|Lost to Follow-up|4|||
150156762|NCT01021878|541710901|FG001|Overall Study|Lost to Follow-up|3|||
150156763|NCT01021878|541710900|FG000|Overall Study|Death|0|||
150156764|NCT01021878|541710901|FG001|Overall Study|Death|1|||
150156765|NCT01021878|541710900|FG000|Overall Study|Adverse Event|6|||
150156766|NCT01021878|541710901|FG001|Overall Study|Adverse Event|5|||
150156767|NCT01021878|541710900|FG000|Overall Study|Transplantation|6|||
150156768|NCT01021878|541710901|FG001|Overall Study|Transplantation|1|||
150156769|NCT01155726|541710902|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
150156770|NCT01155726|541710903|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
150156771|NCT01155726|541710904|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
150156772|NCT01155726|541710905|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
150156773|NCT05305040|541710906|FG000|Overall Study|Not Dosed|37|||
150156774|NCT05305040|541710907|FG001|Overall Study|Not Dosed|37|||
150156775|NCT05305040|541710906|FG000|Overall Study|Study Closure|34|||
150156776|NCT05305040|541710907|FG001|Overall Study|Study Closure|46|||
150156777|NCT05305040|541710906|FG000|Overall Study|Death|14|||
150156778|NCT05305040|541710907|FG001|Overall Study|Death|13|||
150156779|NCT05305040|541710906|FG000|Overall Study|Withdrawal by Subject|15|||
150156780|NCT05305040|541710907|FG001|Overall Study|Withdrawal by Subject|10|||
150156781|NCT05305040|541710906|FG000|Overall Study|Other|13|||
150156782|NCT05305040|541710907|FG001|Overall Study|Other|10|||
150156783|NCT05305040|541710906|FG000|Overall Study|Primary Malignancy Relapse|3|||
150156784|NCT05305040|541710907|FG001|Overall Study|Primary Malignancy Relapse|4|||
150156785|NCT05305040|541710906|FG000|Overall Study|Adverse Event|3|||
150156786|NCT05305040|541710907|FG001|Overall Study|Adverse Event|3|||
150156787|NCT05305040|541710906|FG000|Overall Study|Lost to Follow-up|2|||
150156788|NCT05305040|541710907|FG001|Overall Study|Lost to Follow-up|1|||
150156789|NCT05305040|541710906|FG000|Overall Study|Graft versus host disease|2|||
150156790|NCT05305040|541710907|FG001|Overall Study|Graft versus host disease|0|||
150156791|NCT05305040|541710906|FG000|Overall Study|Investigator's Decision|1|||
150156792|NCT05305040|541710907|FG001|Overall Study|Investigator's Decision|1|||
150156793|NCT05305040|541710906|FG000|Overall Study|COVID-19 Reasons|1|||
150156794|NCT05305040|541710907|FG001|Overall Study|COVID-19 Reasons|0|||
150156795|NCT01195675|541710911|FG000|Overall Study|Adverse Event|1|||
150156796|NCT01195675|541710911|FG000|Overall Study|Withdrawal by Subject|2|||
150156797|NCT02424344|541710912|FG000|Overall Study|Lack of Efficacy|0|||
150156798|NCT02424344|541710913|FG001|Overall Study|Lack of Efficacy|1|||
150156799|NCT02424344|541710912|FG000|Overall Study|Withdrawal by Subject|2|||
150156800|NCT02424344|541710913|FG001|Overall Study|Withdrawal by Subject|1|||
150156801|NCT02424344|541710912|FG000|Overall Study|Lost to Follow-up|1|||
150156802|NCT02424344|541710913|FG001|Overall Study|Lost to Follow-up|0|||
150156803|NCT02424344|541710912|FG000|Overall Study|Adverse Event|4|||
150156804|NCT02424344|541710913|FG001|Overall Study|Adverse Event|8|||
150156805|NCT01174550|541710914|FG000|Overall Study|Death|75|||
150156806|NCT01174550|541710915|FG001|Overall Study|Death|74|||
150156807|NCT01174550|541710914|FG000|Overall Study|Lost to Follow-up|652|||
150156808|NCT01174550|541710915|FG001|Overall Study|Lost to Follow-up|510|||
150156809|NCT01174550|541710914|FG000|Overall Study|Withdrawal by Subject|543|||
150156810|NCT01174550|541710915|FG001|Overall Study|Withdrawal by Subject|289|||
150156811|NCT01536262|541710916|FG000|Overall Study|Adverse Event|6|||
150156812|NCT01536262|541710917|FG001|Overall Study|Adverse Event|1|||
150156813|NCT01536262|541710918|FG002|Overall Study|Adverse Event|2|||
150156814|NCT01536262|541710916|FG000|Overall Study|Withdrawal by Subject|1|||
150156815|NCT01536262|541710917|FG001|Overall Study|Withdrawal by Subject|1|||
150156816|NCT01536262|541710918|FG002|Overall Study|Withdrawal by Subject|0|||
150156817|NCT01536262|541710916|FG000|Overall Study|Other than stated above|1|||
150156818|NCT01536262|541710917|FG001|Overall Study|Other than stated above|0|||
150156819|NCT01536262|541710918|FG002|Overall Study|Other than stated above|0|||
150156820|NCT05257837|541710922|FG000|Overall Study|Excluded (did not find the guns)|4|||
150156821|NCT05257837|541710923|FG001|Overall Study|Excluded (did not find the guns)|2|||
150156822|NCT05257837|541710924|FG002|Overall Study|Excluded (did not find the guns)|4|||
150156823|NCT05257837|541710925|FG003|Overall Study|Excluded (did not find the guns)|0|||
150156824|NCT03639675|541710926|FG000|Overall Study|Withdrawal by Subject|1|||
150156825|NCT02459587|541710927|FG000|3-Month Follow-up Assessment|Death|0|||
150156826|NCT02459587|541710928|FG001|3-Month Follow-up Assessment|Death|2|||
150156827|NCT02459587|541710927|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
150156828|NCT02459587|541710928|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
150156829|NCT02459587|541710927|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
150156830|NCT02459587|541710928|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
150156831|NCT02459587|541710927|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
150156832|NCT02459587|541710928|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
150156833|NCT02459587|541710927|FG000|6-month Follow-up Assessment|Death|2|||
150156834|NCT02459587|541710928|FG001|6-month Follow-up Assessment|Death|1|||
150156835|NCT02459587|541710927|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
150156836|NCT02459587|541710928|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
150259439|NCT04617275|542085210|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
150259440|NCT04617275|542085211|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
150259441|NCT04617275|542085212|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
150259442|NCT04617275|542085213|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
150259443|NCT04617275|542085214|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
150259444|NCT04617275|542085215|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
150259445|NCT04617275|542085208|FG000|Follow-up Period|Other|0|||
150259446|NCT04617275|542085209|FG001|Follow-up Period|Other|1|||
150259447|NCT04617275|542085210|FG002|Follow-up Period|Other|0|||
150259448|NCT04617275|542085211|FG003|Follow-up Period|Other|0|||
150259449|NCT04617275|542085212|FG004|Follow-up Period|Other|0|||
150259450|NCT04617275|542085213|FG005|Follow-up Period|Other|0|||
150259451|NCT04617275|542085214|FG006|Follow-up Period|Other|0|||
150259452|NCT04617275|542085215|FG007|Follow-up Period|Other|0|||
150259453|NCT04617275|542085208|FG000|Follow-up Period|Withdrawal by Subject|2|||
150259454|NCT04617275|542085209|FG001|Follow-up Period|Withdrawal by Subject|0|||
150259455|NCT04617275|542085210|FG002|Follow-up Period|Withdrawal by Subject|0|||
150259456|NCT04617275|542085211|FG003|Follow-up Period|Withdrawal by Subject|2|||
150259457|NCT04617275|542085212|FG004|Follow-up Period|Withdrawal by Subject|2|||
150259458|NCT04617275|542085213|FG005|Follow-up Period|Withdrawal by Subject|0|||
150259459|NCT04617275|542085214|FG006|Follow-up Period|Withdrawal by Subject|1|||
150259460|NCT04617275|542085215|FG007|Follow-up Period|Withdrawal by Subject|2|||
150259461|NCT04227704|542085216|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
150259462|NCT04227704|542085217|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
150259463|NCT04227704|542085218|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
150259464|NCT04227704|542085216|FG000|Overall Study|due to C/S being cancelled|1|||
150259465|NCT04227704|542085217|FG001|Overall Study|due to C/S being cancelled|0|||
150259466|NCT04227704|542085218|FG002|Overall Study|due to C/S being cancelled|0|||
150259467|NCT02317432|542085222|FG000|Overall Study|Death|4|||
150259468|NCT02317432|542085223|FG001|Overall Study|Death|1|||
150259469|NCT02317432|542085222|FG000|Overall Study|Lost to Follow-up|0|||
150259470|NCT02317432|542085223|FG001|Overall Study|Lost to Follow-up|5|||
150259471|NCT02317432|542085222|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
150259472|NCT02317432|542085223|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
150259473|NCT01111474|542087124|FG000|Overall Study|Lost to Follow-up|12|||
150259474|NCT04101318|542087127|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
150259475|NCT04101318|542087128|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
150259476|NCT04101318|542087127|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
150259477|NCT04101318|542087128|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
150259478|NCT04101318|542087127|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
150259479|NCT04101318|542087128|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
150259480|NCT00558259|542087129|FG000|Overall Study|Adverse Event|50|||
150259481|NCT00558259|542087130|FG001|Overall Study|Adverse Event|81|||
150259482|NCT00558259|542087129|FG000|Overall Study|Protocol Violation|9|||
150259483|NCT00558259|542087130|FG001|Overall Study|Protocol Violation|5|||
150259484|NCT00558259|542087129|FG000|Overall Study|Withdrawal by Subject|12|||
150259485|NCT00558259|542087130|FG001|Overall Study|Withdrawal by Subject|13|||
150259486|NCT00156819|542087133|FG000|Overall Study|Lost to Follow-up|1|||
150259487|NCT00156819|542087134|FG001|Overall Study|Lost to Follow-up|1|||
150259488|NCT00156819|542087135|FG002|Overall Study|Lost to Follow-up|3|||
150259489|NCT03718533|542087136|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
150259490|NCT03718533|542087136|FG000|Overall Study|Protocol deviation|1|||
150259491|NCT03718533|542087136|FG000|Overall Study|Disease progression|1|||
150259492|NCT03718533|542087136|FG000|Overall Study|Relapse|1|||
150259493|NCT03718533|542087136|FG000|Overall Study|Physician Decision|2|||
150259494|NCT03718533|542087136|FG000|Overall Study|Physician Decision and Adverse Event|1|||
150259495|NCT00321373|542087147|FG000|Overall Study|Adverse Event|0|||
149815916|NCT02059187|540456837|FG000|Overall Study|Physician Decision|1|||
150156837|NCT02459587|541710927|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
150156838|NCT02459587|541710928|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
150156839|NCT02459587|541710927|FG000|12-month Follow-up Assessment|Death|2|||
150156840|NCT02459587|541710928|FG001|12-month Follow-up Assessment|Death|0|||
150156841|NCT02459587|541710927|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
150156842|NCT02459587|541710928|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
150156843|NCT02459587|541710927|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
150156844|NCT02459587|541710928|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
150156845|NCT02459587|541710927|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
150156846|NCT02459587|541710928|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
150156847|NCT05343455|541710931|FG000|Overall Study|Withdrawal by Subject|4|||
150156848|NCT05343455|541710932|FG001|Overall Study|Withdrawal by Subject|9|||
150156849|NCT05343455|541710933|FG002|Overall Study|Withdrawal by Subject|7|||
150156850|NCT05343455|541710931|FG000|Overall Study|Adverse Event|2|||
150156851|NCT05343455|541710932|FG001|Overall Study|Adverse Event|1|||
150156852|NCT05343455|541710933|FG002|Overall Study|Adverse Event|2|||
150156853|NCT05343455|541710931|FG000|Overall Study|Lost to Follow-up|1|||
150156854|NCT05343455|541710932|FG001|Overall Study|Lost to Follow-up|1|||
150156855|NCT05343455|541710933|FG002|Overall Study|Lost to Follow-up|3|||
150156856|NCT05343455|541710931|FG000|Overall Study|Pregnancy|1|||
150156857|NCT05343455|541710932|FG001|Overall Study|Pregnancy|0|||
150156858|NCT05343455|541710933|FG002|Overall Study|Pregnancy|0|||
150156859|NCT05343455|541710931|FG000|Overall Study|Physician Decision|0|||
150156860|NCT05343455|541710932|FG001|Overall Study|Physician Decision|0|||
150156861|NCT05343455|541710933|FG002|Overall Study|Physician Decision|1|||
150156862|NCT05343455|541710931|FG000|Overall Study|Protocol Violation|0|||
150156863|NCT05343455|541710932|FG001|Overall Study|Protocol Violation|1|||
150156864|NCT05343455|541710933|FG002|Overall Study|Protocol Violation|1|||
150156865|NCT03468426|541710934|FG000|Overall Study|Progressive disease|3|||
150156866|NCT03468426|541710935|FG001|Overall Study|Progressive disease|0|||
150156867|NCT03468426|541710936|FG002|Overall Study|Progressive disease|4|||
150156868|NCT03468426|541710937|FG003|Overall Study|Progressive disease|20|||
150156869|NCT03468426|541710938|FG004|Overall Study|Progressive disease|23|||
150156870|NCT03468426|541710939|FG005|Overall Study|Progressive disease|15|||
150156871|NCT03468426|541710940|FG006|Overall Study|Progressive disease|24|||
150156872|NCT03468426|541710941|FG007|Overall Study|Progressive disease|27|||
150156873|NCT03468426|541710942|FG008|Overall Study|Progressive disease|13|||
150156874|NCT03468426|541710943|FG009|Overall Study|Progressive disease|13|||
150156875|NCT03468426|541710944|FG010|Overall Study|Progressive disease|0|||
150156876|NCT03468426|541710934|FG000|Overall Study|Other adverse event or clinical progression|0|||
150156877|NCT03468426|541710935|FG001|Overall Study|Other adverse event or clinical progression|1|||
150156878|NCT03468426|541710936|FG002|Overall Study|Other adverse event or clinical progression|3|||
150156879|NCT03468426|541710937|FG003|Overall Study|Other adverse event or clinical progression|14|||
150156880|NCT03468426|541710938|FG004|Overall Study|Other adverse event or clinical progression|10|||
150156881|NCT03468426|541710939|FG005|Overall Study|Other adverse event or clinical progression|8|||
150156882|NCT03468426|541710940|FG006|Overall Study|Other adverse event or clinical progression|5|||
150156883|NCT03468426|541710941|FG007|Overall Study|Other adverse event or clinical progression|4|||
150156884|NCT03468426|541710942|FG008|Overall Study|Other adverse event or clinical progression|6|||
150156885|NCT03468426|541710943|FG009|Overall Study|Other adverse event or clinical progression|11|||
150156886|NCT03468426|541710944|FG010|Overall Study|Other adverse event or clinical progression|0|||
150156887|NCT03468426|541710934|FG000|Overall Study|Refused to continue taking trial medication|0|||
150156888|NCT03468426|541710935|FG001|Overall Study|Refused to continue taking trial medication|0|||
150156889|NCT03468426|541710936|FG002|Overall Study|Refused to continue taking trial medication|0|||
150156890|NCT03468426|541710937|FG003|Overall Study|Refused to continue taking trial medication|2|||
150156891|NCT03468426|541710938|FG004|Overall Study|Refused to continue taking trial medication|0|||
150156892|NCT03468426|541710939|FG005|Overall Study|Refused to continue taking trial medication|3|||
150156893|NCT03468426|541710940|FG006|Overall Study|Refused to continue taking trial medication|0|||
150156894|NCT03468426|541710941|FG007|Overall Study|Refused to continue taking trial medication|0|||
150156895|NCT03468426|541710942|FG008|Overall Study|Refused to continue taking trial medication|1|||
150156896|NCT03468426|541710943|FG009|Overall Study|Refused to continue taking trial medication|0|||
150156897|NCT03468426|541710944|FG010|Overall Study|Refused to continue taking trial medication|0|||
150156898|NCT03468426|541710934|FG000|Overall Study|Other than listed|0|||
150156899|NCT03468426|541710935|FG001|Overall Study|Other than listed|1|||
150156900|NCT03468426|541710936|FG002|Overall Study|Other than listed|0|||
150156901|NCT03468426|541710937|FG003|Overall Study|Other than listed|0|||
150156902|NCT03468426|541710938|FG004|Overall Study|Other than listed|2|||
150156903|NCT03468426|541710939|FG005|Overall Study|Other than listed|2|||
150156904|NCT03468426|541710940|FG006|Overall Study|Other than listed|0|||
150156905|NCT03468426|541710941|FG007|Overall Study|Other than listed|0|||
150156906|NCT03468426|541710942|FG008|Overall Study|Other than listed|4|||
150156907|NCT03468426|541710943|FG009|Overall Study|Other than listed|4|||
150156908|NCT03468426|541710944|FG010|Overall Study|Other than listed|1|||
150156909|NCT03468426|541710934|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156910|NCT03468426|541710935|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156911|NCT03468426|541710936|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
150156912|NCT03468426|541710937|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156913|NCT03468426|541710938|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156914|NCT03468426|541710939|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156915|NCT03468426|541710940|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156916|NCT03468426|541710941|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156917|NCT03468426|541710942|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156918|NCT03468426|541710943|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156919|NCT03468426|541710944|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150156920|NCT03468426|541710934|FG000|Overall Study|missing reason|0|||
150156921|NCT03468426|541710935|FG001|Overall Study|missing reason|0|||
150156922|NCT03468426|541710936|FG002|Overall Study|missing reason|0|||
150156923|NCT03468426|541710937|FG003|Overall Study|missing reason|0|||
150156924|NCT03468426|541710938|FG004|Overall Study|missing reason|0|||
150156925|NCT03468426|541710939|FG005|Overall Study|missing reason|0|||
150156926|NCT03468426|541710940|FG006|Overall Study|missing reason|0|||
150156927|NCT03468426|541710941|FG007|Overall Study|missing reason|0|||
150156928|NCT03468426|541710942|FG008|Overall Study|missing reason|0|||
150156929|NCT03468426|541710943|FG009|Overall Study|missing reason|1|||
150156930|NCT03468426|541710944|FG010|Overall Study|missing reason|0|||
150156931|NCT02139982|541710945|FG000|Overall Study|Lack of Efficacy|0|||
150156932|NCT02139982|541710946|FG001|Overall Study|Lack of Efficacy|1|||
150156933|NCT02139982|541710947|FG002|Overall Study|Lack of Efficacy|0|||
150156934|NCT02139982|541710948|FG003|Overall Study|Lack of Efficacy|1|||
150156935|NCT02139982|541710949|FG004|Overall Study|Lack of Efficacy|0|||
150156936|NCT02139982|541710950|FG005|Overall Study|Lack of Efficacy|0|||
150156937|NCT02139982|541710951|FG006|Overall Study|Lack of Efficacy|0|||
150156938|NCT02139982|541710952|FG007|Overall Study|Lack of Efficacy|0|||
150156939|NCT02139982|541710953|FG008|Overall Study|Lack of Efficacy|0|||
150156940|NCT02139982|541710954|FG009|Overall Study|Lack of Efficacy|0|||
150156941|NCT04466618|541710955|FG000|Overall Study|Withdrawal by Subject|0|||
150156942|NCT04466618|541710956|FG001|Overall Study|Withdrawal by Subject|1|||
150156943|NCT04004208|541710957|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150156944|NCT04004208|541710958|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150156945|NCT04004208|541710957|FG000|Overall Study|Death|3|||
150156946|NCT04004208|541710958|FG001|Overall Study|Death|0|||
150156947|NCT04004208|541710957|FG000|Overall Study|COVID-19 pandemic|1|||
150156948|NCT04004208|541710958|FG001|Overall Study|COVID-19 pandemic|0|||
150156949|NCT04004208|541710957|FG000|Overall Study|Physician Decision|1|||
150156950|NCT04004208|541710958|FG001|Overall Study|Physician Decision|0|||
150156951|NCT04004208|541710957|FG000|Overall Study|Adverse Event|1|||
150156952|NCT04004208|541710958|FG001|Overall Study|Adverse Event|1|||
150156953|NCT01364727|541710963|FG000|Overall Study|Not Eligible|2|||
150156954|NCT01676220|541710965|FG000|Overall Study|Randomized But Not Treated|4|||
150156955|NCT01676220|541710966|FG001|Overall Study|Randomized But Not Treated|1|||
150156956|NCT01676220|541710965|FG000|Overall Study|Adverse Event|10|||
150156957|NCT01676220|541710966|FG001|Overall Study|Adverse Event|8|||
150156958|NCT01676220|541710965|FG000|Overall Study|Lack of Efficacy|2|||
150156959|NCT01676220|541710966|FG001|Overall Study|Lack of Efficacy|5|||
150156960|NCT01676220|541710965|FG000|Overall Study|Protocol Violation|11|||
150156961|NCT01676220|541710966|FG001|Overall Study|Protocol Violation|12|||
150156962|NCT01676220|541710965|FG000|Overall Study|Received Rescue Therapy|14|||
150156963|NCT01676220|541710966|FG001|Overall Study|Received Rescue Therapy|22|||
150156964|NCT01676220|541710965|FG000|Overall Study|Personal Reason|34|||
150156965|NCT01676220|541710966|FG001|Overall Study|Personal Reason|45|||
150156966|NCT01676220|541710965|FG000|Overall Study|Lost to Follow-up|11|||
150156967|NCT01676220|541710966|FG001|Overall Study|Lost to Follow-up|18|||
150156968|NCT01676220|541710965|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
150156969|NCT01676220|541710966|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
150156970|NCT01676220|541710965|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
150156971|NCT01676220|541710966|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
150156972|NCT01676220|541710965|FG000|Overall Study|Perceived Lack of Efficacy|3|||
150156973|NCT01676220|541710966|FG001|Overall Study|Perceived Lack of Efficacy|1|||
150156974|NCT01676220|541710965|FG000|Overall Study|Non Serious Hypoglycemia|2|||
150156975|NCT01676220|541710966|FG001|Overall Study|Non Serious Hypoglycemia|0|||
150156976|NCT01676220|541710965|FG000|Overall Study|No More Need of Insulin|1|||
149815917|NCT02059187|540456838|FG001|Overall Study|Physician Decision|2|||
149815918|NCT02059187|540456837|FG000|Overall Study|Protocol Violation|1|||
150156977|NCT01676220|541710966|FG001|Overall Study|No More Need of Insulin|0|||
150156978|NCT02411591|541710967|FG000|Overall Study|Adverse Event|0|||
150156979|NCT02411591|541710968|FG001|Overall Study|Adverse Event|4|||
150156980|NCT02411591|541710969|FG002|Overall Study|Adverse Event|2|||
150156981|NCT02411591|541710967|FG000|Overall Study|Withdrawal by Subject|0|||
150156982|NCT02411591|541710968|FG001|Overall Study|Withdrawal by Subject|3|||
150156983|NCT02411591|541710969|FG002|Overall Study|Withdrawal by Subject|0|||
150156984|NCT02411591|541710967|FG000|Overall Study|Physician Decision|0|||
150156985|NCT02411591|541710968|FG001|Overall Study|Physician Decision|3|||
150156986|NCT02411591|541710969|FG002|Overall Study|Physician Decision|1|||
150156987|NCT04227340|541710970|FG000|Overall Study|Withdrawal by Subject|3|||
150156988|NCT00750893|541710973|FG000|Overall Study|Adverse Event|5|||
150156989|NCT00750893|541710973|FG000|Overall Study|Withdrawal by Subject|10|||
150156990|NCT00750893|541710973|FG000|Overall Study|Lost to Follow-up|510|||
150156991|NCT00750893|541710973|FG000|Overall Study|Other|17|||
150156992|NCT01152554|541710975|FG000|Overall Study|Withdrawal by Subject|73|||
150156993|NCT01152554|541710976|FG001|Overall Study|Withdrawal by Subject|28|||
150156994|NCT01152554|541710975|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
150156995|NCT01152554|541710976|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
150156996|NCT01152554|541710975|FG000|Overall Study|Adverse Event|67|||
150156997|NCT01152554|541710976|FG001|Overall Study|Adverse Event|14|||
150156998|NCT01152554|541710975|FG000|Overall Study|Severe non-compliance to protocol|36|||
150156999|NCT01152554|541710976|FG001|Overall Study|Severe non-compliance to protocol|14|||
150157000|NCT01152554|541710975|FG000|Overall Study|Condition under investigation worsened|5|||
150157001|NCT01152554|541710976|FG001|Overall Study|Condition under investigation worsened|2|||
150157002|NCT01152554|541710975|FG000|Overall Study|Lack of Efficacy|20|||
150157003|NCT01152554|541710976|FG001|Overall Study|Lack of Efficacy|3|||
150157004|NCT01152554|541710975|FG000|Overall Study|Study-specific withdrawal criteria|17|||
150157005|NCT01152554|541710976|FG001|Overall Study|Study-specific withdrawal criteria|8|||
150157006|NCT01152554|541710975|FG000|Overall Study|Lost to Follow-up|87|||
150157007|NCT01152554|541710976|FG001|Overall Study|Lost to Follow-up|32|||
150157008|NCT01152554|541710975|FG000|Overall Study|Other|28|||
150157009|NCT01152554|541710976|FG001|Overall Study|Other|8|||
150157010|NCT01152554|541710975|FG000|Overall Study|Death|1|||
150157011|NCT01152554|541710976|FG001|Overall Study|Death|1|||
150157012|NCT02117544|541710977|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
150157013|NCT02117544|541710978|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
150157014|NCT03486899|541710979|FG000|Overall Study|Lost to Follow-up|4|||
150157015|NCT03486899|541710980|FG001|Overall Study|Lost to Follow-up|1|||
150157016|NCT03486899|541710981|FG002|Overall Study|Lost to Follow-up|4|||
150157017|NCT03486899|541710982|FG003|Overall Study|Lost to Follow-up|3|||
150157018|NCT03486899|541710979|FG000|Overall Study|Death|1|||
150157019|NCT03486899|541710980|FG001|Overall Study|Death|0|||
150157020|NCT03486899|541710981|FG002|Overall Study|Death|0|||
150157021|NCT03486899|541710982|FG003|Overall Study|Death|1|||
150157022|NCT03486899|541710979|FG000|Overall Study|Adverse Event|0|||
150157023|NCT03486899|541710980|FG001|Overall Study|Adverse Event|2|||
150157024|NCT03486899|541710981|FG002|Overall Study|Adverse Event|0|||
150157025|NCT03486899|541710982|FG003|Overall Study|Adverse Event|2|||
150157026|NCT03486899|541710979|FG000|Overall Study|Withdrawal by Subject|3|||
150157027|NCT03486899|541710980|FG001|Overall Study|Withdrawal by Subject|7|||
150157028|NCT03486899|541710981|FG002|Overall Study|Withdrawal by Subject|4|||
150157029|NCT03486899|541710982|FG003|Overall Study|Withdrawal by Subject|3|||
150157030|NCT03486899|541710979|FG000|Overall Study|Other Reasons|0|||
150157031|NCT03486899|541710980|FG001|Overall Study|Other Reasons|1|||
150157032|NCT03486899|541710981|FG002|Overall Study|Other Reasons|0|||
150157033|NCT03486899|541710982|FG003|Overall Study|Other Reasons|1|||
150157034|NCT01439711|541710983|FG000|Overall Study|Ineligible|13|||
150157035|NCT01439711|541710983|FG000|Overall Study|Cancel|3|||
150157036|NCT01439711|541710983|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
150157037|NCT01439711|541710983|FG000|Overall Study|Adverse Event|5|||
149815919|NCT02059187|540456838|FG001|Overall Study|Protocol Violation|0|||
149815920|NCT02059187|540456837|FG000|Overall Study|Withdrawal by Subject|12|||
149815921|NCT02059187|540456838|FG001|Overall Study|Withdrawal by Subject|8|||
149815922|NCT03751020|540456839|FG000|Overall Study|Withdrawal by Subject|2|||
149815923|NCT03751020|540456840|FG001|Overall Study|Withdrawal by Subject|0|||
149815924|NCT03751020|540456841|FG002|Overall Study|Withdrawal by Subject|0|||
150157038|NCT01439711|541710983|FG000|Overall Study|Withdrawal by Subject|3|||
150157039|NCT01439711|541710983|FG000|Overall Study|Progression During Active Tx|3|||
150157040|NCT01439711|541710983|FG000|Overall Study|Noncompliance|3|||
150157041|NCT01439711|541710983|FG000|Overall Study|No MRI|9|||
150157042|NCT02397460|541710984|FG000|Treatment Period 2|Adverse Event|0|||
150157043|NCT02397460|541710985|FG001|Treatment Period 2|Adverse Event|0|||
149815925|NCT03751020|540456839|FG000|Overall Study|Lost to Follow-up|7|||
149815926|NCT03751020|540456840|FG001|Overall Study|Lost to Follow-up|4|||
149815927|NCT03751020|540456841|FG002|Overall Study|Lost to Follow-up|10|||
150157044|NCT02397460|541710986|FG002|Treatment Period 2|Adverse Event|0|||
150157045|NCT02397460|541710987|FG003|Treatment Period 2|Adverse Event|0|||
150157046|NCT02397460|541710988|FG004|Treatment Period 2|Adverse Event|0|||
150157047|NCT02397460|541710989|FG005|Treatment Period 2|Adverse Event|0|||
150157048|NCT02397460|541710990|FG006|Treatment Period 2|Adverse Event|0|||
150157049|NCT02397460|541710991|FG007|Treatment Period 2|Adverse Event|1|||
149815928|NCT01889862|540456842|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
150157050|NCT02397460|541710984|FG000|Treatment Period 4|Adverse Event|0|||
150157051|NCT02397460|541710985|FG001|Treatment Period 4|Adverse Event|1|||
150157052|NCT02397460|541710986|FG002|Treatment Period 4|Adverse Event|0|||
150157053|NCT02397460|541710987|FG003|Treatment Period 4|Adverse Event|0|||
150157054|NCT02397460|541710988|FG004|Treatment Period 4|Adverse Event|0|||
150157055|NCT02397460|541710989|FG005|Treatment Period 4|Adverse Event|0|||
150157056|NCT02397460|541710990|FG006|Treatment Period 4|Adverse Event|0|||
150157057|NCT02397460|541710991|FG007|Treatment Period 4|Adverse Event|0|||
150157058|NCT02397460|541710984|FG000|Treatment Period 4|Physician Decision|0|||
150157059|NCT02397460|541710985|FG001|Treatment Period 4|Physician Decision|0|||
150157060|NCT02397460|541710986|FG002|Treatment Period 4|Physician Decision|0|||
150157061|NCT02397460|541710987|FG003|Treatment Period 4|Physician Decision|0|||
150157062|NCT02397460|541710988|FG004|Treatment Period 4|Physician Decision|1|||
150157063|NCT02397460|541710989|FG005|Treatment Period 4|Physician Decision|0|||
150157064|NCT02397460|541710990|FG006|Treatment Period 4|Physician Decision|0|||
150157065|NCT02397460|541710991|FG007|Treatment Period 4|Physician Decision|0|||
150157066|NCT01767129|541710992|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
150157067|NCT01767129|541710993|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
150157068|NCT01473420|541710997|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
150157069|NCT01473420|541710998|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
150157070|NCT01473420|541710997|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
150157071|NCT01473420|541710998|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
150157072|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
150157073|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
150157074|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
150157075|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
150157076|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
150157077|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
150157078|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
150157079|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
150157080|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
150157081|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
150157082|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
150157083|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
150157084|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
150157085|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
150157086|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
150157087|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
150157088|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
150157089|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
150157090|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
150157091|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
150157092|NCT01473420|541710997|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
150157093|NCT01473420|541710998|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
150157094|NCT00738530|541710999|FG000|Overall Study|Death|220|||
150157095|NCT00738530|541711000|FG001|Overall Study|Death|224|||
150157096|NCT00738530|541710999|FG000|Overall Study|Lost to Follow-up|8|||
150157097|NCT00738530|541711000|FG001|Overall Study|Lost to Follow-up|6|||
150157098|NCT00738530|541710999|FG000|Overall Study|Withdrawal by Subject|6|||
150157099|NCT00738530|541711000|FG001|Overall Study|Withdrawal by Subject|8|||
150157100|NCT01656759|541711001|FG000|Overall Study|Protocol Violation|2|||
150157101|NCT01656759|541711002|FG001|Overall Study|Protocol Violation|3|||
150157102|NCT04963062|541711009|FG000|Overall Study|withdrew by the study team|4|||
150157103|NCT04963062|541711010|FG001|Overall Study|withdrew by the study team|2|||
150157104|NCT01513967|541711021|FG000|Overall Study|Pregnancy|0|||
150157105|NCT01513967|541711022|FG001|Overall Study|Pregnancy|0|||
150157106|NCT01513967|541711023|FG002|Overall Study|Pregnancy|0|||
150157107|NCT01513967|541711024|FG003|Overall Study|Pregnancy|0|||
150157108|NCT01513967|541711025|FG004|Overall Study|Pregnancy|0|||
150157109|NCT01513967|541711026|FG005|Overall Study|Pregnancy|0|||
150157110|NCT01513967|541711027|FG006|Overall Study|Pregnancy|1|||
150157111|NCT01513967|541711028|FG007|Overall Study|Pregnancy|0|||
150157112|NCT01513967|541711021|FG000|Overall Study|missed a study visit|0|||
150157113|NCT01513967|541711022|FG001|Overall Study|missed a study visit|0|||
150157114|NCT01513967|541711023|FG002|Overall Study|missed a study visit|0|||
150157115|NCT01513967|541711024|FG003|Overall Study|missed a study visit|0|||
150157116|NCT01513967|541711025|FG004|Overall Study|missed a study visit|0|||
150157117|NCT01513967|541711026|FG005|Overall Study|missed a study visit|0|||
150157118|NCT01513967|541711027|FG006|Overall Study|missed a study visit|1|||
150157119|NCT01513967|541711028|FG007|Overall Study|missed a study visit|0|||
150157120|NCT01513967|541711021|FG000|Overall Study|excluded due to positive drug screen|0|||
150157121|NCT01513967|541711022|FG001|Overall Study|excluded due to positive drug screen|0|||
150157122|NCT01513967|541711023|FG002|Overall Study|excluded due to positive drug screen|0|||
150157123|NCT01513967|541711024|FG003|Overall Study|excluded due to positive drug screen|0|||
150157124|NCT01513967|541711025|FG004|Overall Study|excluded due to positive drug screen|0|||
150157125|NCT01513967|541711026|FG005|Overall Study|excluded due to positive drug screen|0|||
150157126|NCT01513967|541711027|FG006|Overall Study|excluded due to positive drug screen|0|||
150157127|NCT01513967|541711028|FG007|Overall Study|excluded due to positive drug screen|2|||
150157128|NCT01513967|541711021|FG000|Overall Study|Physician Decision|0|||
150157129|NCT01513967|541711022|FG001|Overall Study|Physician Decision|0|||
150157130|NCT01513967|541711023|FG002|Overall Study|Physician Decision|0|||
150157131|NCT01513967|541711024|FG003|Overall Study|Physician Decision|0|||
150157132|NCT01513967|541711025|FG004|Overall Study|Physician Decision|0|||
150157133|NCT01513967|541711026|FG005|Overall Study|Physician Decision|1|||
150157134|NCT01513967|541711027|FG006|Overall Study|Physician Decision|0|||
150157135|NCT01513967|541711028|FG007|Overall Study|Physician Decision|0|||
150157136|NCT01987830|541711029|FG000|Overall Study|Never received baseline scan|1|||
150157137|NCT03990363|541711030|FG000|Overall Study|Withdrawal by Subject|10|||
150157138|NCT03990363|541711031|FG001|Overall Study|Withdrawal by Subject|9|||
150157139|NCT03990363|541711032|FG002|Overall Study|Withdrawal by Subject|18|||
150157140|NCT03990363|541711033|FG003|Overall Study|Withdrawal by Subject|11|||
150157141|NCT03990363|541711034|FG004|Overall Study|Withdrawal by Subject|9|||
150157142|NCT03990363|541711030|FG000|Overall Study|Physician Decision|1|||
150157143|NCT03990363|541711031|FG001|Overall Study|Physician Decision|0|||
150157144|NCT03990363|541711032|FG002|Overall Study|Physician Decision|0|||
150157145|NCT03990363|541711033|FG003|Overall Study|Physician Decision|0|||
150157146|NCT03990363|541711034|FG004|Overall Study|Physician Decision|0|||
150157147|NCT03990363|541711030|FG000|Overall Study|Adverse Event|1|||
150157148|NCT03990363|541711031|FG001|Overall Study|Adverse Event|3|||
150157149|NCT03990363|541711032|FG002|Overall Study|Adverse Event|2|||
150157150|NCT03990363|541711033|FG003|Overall Study|Adverse Event|2|||
150157151|NCT03990363|541711034|FG004|Overall Study|Adverse Event|0|||
150157152|NCT03990363|541711030|FG000|Overall Study|Death|14|||
150157153|NCT03990363|541711031|FG001|Overall Study|Death|8|||
150157154|NCT03990363|541711032|FG002|Overall Study|Death|14|||
150157155|NCT03990363|541711033|FG003|Overall Study|Death|10|||
150157156|NCT03990363|541711034|FG004|Overall Study|Death|11|||
150157157|NCT03990363|541711030|FG000|Overall Study|Failure to meet randomization criteria|0|||
150157158|NCT03990363|541711031|FG001|Overall Study|Failure to meet randomization criteria|1|||
150157159|NCT03990363|541711032|FG002|Overall Study|Failure to meet randomization criteria|1|||
150157160|NCT03990363|541711033|FG003|Overall Study|Failure to meet randomization criteria|0|||
150157161|NCT03990363|541711034|FG004|Overall Study|Failure to meet randomization criteria|0|||
150157162|NCT03990363|541711030|FG000|Overall Study|Lost to Follow-up|0|||
150157163|NCT03990363|541711031|FG001|Overall Study|Lost to Follow-up|0|||
150157164|NCT03990363|541711032|FG002|Overall Study|Lost to Follow-up|0|||
150157165|NCT03990363|541711033|FG003|Overall Study|Lost to Follow-up|1|||
150157166|NCT03990363|541711034|FG004|Overall Study|Lost to Follow-up|2|||
150157167|NCT03990363|541711030|FG000|Overall Study|Non-compliance with study drug|2|||
150157168|NCT03990363|541711031|FG001|Overall Study|Non-compliance with study drug|1|||
150157169|NCT03990363|541711032|FG002|Overall Study|Non-compliance with study drug|2|||
150157170|NCT03990363|541711033|FG003|Overall Study|Non-compliance with study drug|0|||
150157171|NCT03990363|541711034|FG004|Overall Study|Non-compliance with study drug|0|||
150157172|NCT03990363|541711030|FG000|Overall Study|Study terminated by sponsor|0|||
150157173|NCT03990363|541711031|FG001|Overall Study|Study terminated by sponsor|1|||
150157174|NCT03990363|541711032|FG002|Overall Study|Study terminated by sponsor|0|||
150157175|NCT03990363|541711033|FG003|Overall Study|Study terminated by sponsor|0|||
150157176|NCT03990363|541711034|FG004|Overall Study|Study terminated by sponsor|0|||
150157177|NCT03990363|541711030|FG000|Overall Study|Site terminated by sponsor|2|||
150157178|NCT03990363|541711031|FG001|Overall Study|Site terminated by sponsor|1|||
150157179|NCT03990363|541711032|FG002|Overall Study|Site terminated by sponsor|2|||
150157180|NCT03990363|541711033|FG003|Overall Study|Site terminated by sponsor|0|||
150157181|NCT03990363|541711034|FG004|Overall Study|Site terminated by sponsor|2|||
150157182|NCT03990363|541711030|FG000|Overall Study|Not categorized|5|||
150157183|NCT03990363|541711031|FG001|Overall Study|Not categorized|5|||
150157184|NCT03990363|541711032|FG002|Overall Study|Not categorized|3|||
150157185|NCT03990363|541711033|FG003|Overall Study|Not categorized|2|||
150157186|NCT03990363|541711034|FG004|Overall Study|Not categorized|2|||
150157187|NCT01349660|541711035|FG000|Overall Study|Still Receiving Study Treatment|0|||
150157188|NCT01349660|541711036|FG001|Overall Study|Still Receiving Study Treatment|0|||
150157189|NCT01349660|541711037|FG002|Overall Study|Still Receiving Study Treatment|1|||
150157190|NCT01349660|541711035|FG000|Overall Study|Disease Progression|2|||
150157191|NCT01349660|541711036|FG001|Overall Study|Disease Progression|4|||
150157192|NCT01349660|541711037|FG002|Overall Study|Disease Progression|50|||
150157193|NCT01349660|541711035|FG000|Overall Study|Adverse Event|1|||
150157194|NCT01349660|541711036|FG001|Overall Study|Adverse Event|1|||
150157195|NCT01349660|541711037|FG002|Overall Study|Adverse Event|12|||
150157196|NCT01349660|541711035|FG000|Overall Study|Withdrawal by Subject|2|||
150157197|NCT01349660|541711036|FG001|Overall Study|Withdrawal by Subject|0|||
150157198|NCT01349660|541711037|FG002|Overall Study|Withdrawal by Subject|9|||
150157199|NCT01349660|541711035|FG000|Overall Study|Death|1|||
150157200|NCT01349660|541711036|FG001|Overall Study|Death|1|||
150157201|NCT01349660|541711037|FG002|Overall Study|Death|0|||
150157202|NCT01349660|541711035|FG000|Overall Study|Non-Permitted Interventions|0|||
150157203|NCT01349660|541711036|FG001|Overall Study|Non-Permitted Interventions|0|||
150157204|NCT01349660|541711037|FG002|Overall Study|Non-Permitted Interventions|2|||
150157205|NCT01349660|541711035|FG000|Overall Study|Study Compliance|0|||
150157206|NCT01349660|541711036|FG001|Overall Study|Study Compliance|0|||
150157207|NCT01349660|541711037|FG002|Overall Study|Study Compliance|1|||
150157208|NCT01349660|541711035|FG000|Overall Study|Declining Performance Status|0|||
150157209|NCT01349660|541711036|FG001|Overall Study|Declining Performance Status|0|||
150157210|NCT01349660|541711037|FG002|Overall Study|Declining Performance Status|1|||
150157211|NCT01563978|541711040|FG000|Overall Study|Physician Decision|1|||
150157212|NCT01563978|541711041|FG001|Overall Study|Physician Decision|0|||
150157213|NCT01563978|541711040|FG000|Overall Study|Lost to Follow-up|1|||
150157214|NCT01563978|541711041|FG001|Overall Study|Lost to Follow-up|0|||
150157215|NCT01563978|541711040|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
150157216|NCT01563978|541711041|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
150157217|NCT01563978|541711040|FG000|Overall Study|Adverse Event|1|||
150157218|NCT01563978|541711041|FG001|Overall Study|Adverse Event|2|||
150157219|NCT05764239|541711042|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
150157220|NCT05764239|541711042|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
150157221|NCT05764239|541711042|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
150157222|NCT05764239|541711042|FG000|DEP (Part 1)|Adverse Event|1|||
150157223|NCT05764239|541711042|FG000|DEP (Part 1)|Lost to Follow-up|1|||
150157224|NCT05764239|541711042|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
150157225|NCT05764239|541711042|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
150157226|NCT05764239|541711042|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
150157227|NCT05764239|541711042|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
150157228|NCT00057811|541711043|FG000|Overall Study|Lack of Efficacy|1|||
150157229|NCT00057811|541711044|FG001|Overall Study|Lack of Efficacy|4|||
150157230|NCT00057811|541711043|FG000|Overall Study|Physician Decision|1|||
150157231|NCT00057811|541711044|FG001|Overall Study|Physician Decision|0|||
150157232|NCT00057811|541711043|FG000|Overall Study|Withdrawal by Subject|3|||
150157233|NCT00057811|541711044|FG001|Overall Study|Withdrawal by Subject|4|||
150157234|NCT00057811|541711043|FG000|Overall Study|Ineligible|4|||
150157235|NCT00057811|541711044|FG001|Overall Study|Ineligible|2|||
150157236|NCT00057811|541711043|FG000|Overall Study|Inevaluable|1|||
150157237|NCT00057811|541711044|FG001|Overall Study|Inevaluable|2|||
150157238|NCT00556374|541711045|FG000|Overall Study|Withdrawal by Subject|235|||
150157239|NCT00556374|541711046|FG001|Overall Study|Withdrawal by Subject|205|||
150157240|NCT00556374|541711045|FG000|Overall Study|Death|158|||
150157241|NCT00556374|541711046|FG001|Overall Study|Death|127|||
150157242|NCT00556374|541711045|FG000|Overall Study|Lost to Follow-up|24|||
150157243|NCT00556374|541711046|FG001|Overall Study|Lost to Follow-up|17|||
150157244|NCT00556374|541711045|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
150157245|NCT00556374|541711046|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
150157246|NCT00847301|541711047|FG000|Overall Study|Adverse Event|35|||
150157247|NCT00847301|541711047|FG000|Overall Study|Switch to other anticoagulants|16|||
150157248|NCT00847301|541711047|FG000|Overall Study|Lost to Follow-up|1|||
150157249|NCT00847301|541711047|FG000|Overall Study|No prescription after hospital discharge|1|||
150157250|NCT00847301|541711047|FG000|Overall Study|Other reason not defined above|1|||
150157251|NCT00996580|541711048|FG000|Overall Study|Adverse Event|466|||
150157252|NCT00996580|541711048|FG000|Overall Study|Lost to Follow-up|480|||
150157253|NCT00996580|541711048|FG000|Overall Study|Noncompliance with the protocol|137|||
150157254|NCT00996580|541711048|FG000|Overall Study|Physician Decision|5|||
150157255|NCT00996580|541711048|FG000|Overall Study|Pregnancy|68|||
150157256|NCT00996580|541711048|FG000|Overall Study|Protocol Violation|16|||
150157257|NCT00996580|541711048|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
150157258|NCT00996580|541711048|FG000|Overall Study|Withdrawal by Subject|217|||
150157259|NCT00996580|541711048|FG000|Overall Study|Other|29|||
150157260|NCT05708846|541711049|FG000|Overall Study|Death|5|||
150157261|NCT05708846|541711049|FG000|Overall Study|Withdrawal by Subject|20|||
150157262|NCT03621982|541711050|FG000|Overall Study|Withdrawal by Subject|1|||
150157263|NCT03621982|541711051|FG001|Overall Study|Withdrawal by Subject|0|||
150157264|NCT03621982|541711052|FG002|Overall Study|Withdrawal by Subject|0|||
150157265|NCT03621982|541711053|FG003|Overall Study|Withdrawal by Subject|1|||
150157266|NCT03621982|541711054|FG004|Overall Study|Withdrawal by Subject|0|||
150157267|NCT03621982|541711055|FG005|Overall Study|Withdrawal by Subject|1|||
150157268|NCT03621982|541711056|FG006|Overall Study|Withdrawal by Subject|1|||
150157269|NCT03621982|541711057|FG007|Overall Study|Withdrawal by Subject|0|||
150157270|NCT03621982|541711058|FG008|Overall Study|Withdrawal by Subject|1|||
150157271|NCT03621982|541711059|FG009|Overall Study|Withdrawal by Subject|0|||
150157272|NCT03621982|541711060|FG010|Overall Study|Withdrawal by Subject|2|||
150157273|NCT03621982|541711061|FG011|Overall Study|Withdrawal by Subject|1|||
150157274|NCT03621982|541711062|FG012|Overall Study|Withdrawal by Subject|2|||
150157275|NCT03621982|541711063|FG013|Overall Study|Withdrawal by Subject|2|||
150157276|NCT03621982|541711050|FG000|Overall Study|Investigator/Sponsor decision|0|||
150157277|NCT03621982|541711051|FG001|Overall Study|Investigator/Sponsor decision|0|||
150157278|NCT03621982|541711052|FG002|Overall Study|Investigator/Sponsor decision|0|||
150157279|NCT03621982|541711053|FG003|Overall Study|Investigator/Sponsor decision|0|||
150157280|NCT03621982|541711054|FG004|Overall Study|Investigator/Sponsor decision|0|||
150157281|NCT03621982|541711055|FG005|Overall Study|Investigator/Sponsor decision|0|||
150157282|NCT03621982|541711056|FG006|Overall Study|Investigator/Sponsor decision|0|||
150157283|NCT03621982|541711057|FG007|Overall Study|Investigator/Sponsor decision|0|||
150157284|NCT03621982|541711058|FG008|Overall Study|Investigator/Sponsor decision|0|||
150157285|NCT03621982|541711059|FG009|Overall Study|Investigator/Sponsor decision|0|||
150157286|NCT03621982|541711060|FG010|Overall Study|Investigator/Sponsor decision|0|||
150157287|NCT03621982|541711061|FG011|Overall Study|Investigator/Sponsor decision|4|||
150157288|NCT03621982|541711062|FG012|Overall Study|Investigator/Sponsor decision|0|||
150157289|NCT03621982|541711063|FG013|Overall Study|Investigator/Sponsor decision|2|||
150157290|NCT03621982|541711050|FG000|Overall Study|Death|2|||
150157291|NCT03621982|541711051|FG001|Overall Study|Death|4|||
150157292|NCT03621982|541711052|FG002|Overall Study|Death|4|||
150157293|NCT03621982|541711053|FG003|Overall Study|Death|3|||
150157294|NCT03621982|541711054|FG004|Overall Study|Death|8|||
150157295|NCT03621982|541711055|FG005|Overall Study|Death|4|||
150157296|NCT03621982|541711056|FG006|Overall Study|Death|6|||
150157297|NCT03621982|541711057|FG007|Overall Study|Death|3|||
150157298|NCT03621982|541711058|FG008|Overall Study|Death|0|||
150157299|NCT03621982|541711059|FG009|Overall Study|Death|3|||
150157300|NCT03621982|541711060|FG010|Overall Study|Death|8|||
150157301|NCT03621982|541711061|FG011|Overall Study|Death|4|||
150157302|NCT03621982|541711062|FG012|Overall Study|Death|2|||
150157303|NCT03621982|541711063|FG013|Overall Study|Death|2|||
150157304|NCT03621982|541711050|FG000|Overall Study|Lost to Follow-up|0|||
150157305|NCT03621982|541711051|FG001|Overall Study|Lost to Follow-up|0|||
150157306|NCT03621982|541711052|FG002|Overall Study|Lost to Follow-up|1|||
150157307|NCT03621982|541711053|FG003|Overall Study|Lost to Follow-up|0|||
150157308|NCT03621982|541711054|FG004|Overall Study|Lost to Follow-up|0|||
150157309|NCT03621982|541711055|FG005|Overall Study|Lost to Follow-up|0|||
150157310|NCT03621982|541711056|FG006|Overall Study|Lost to Follow-up|1|||
150157311|NCT03621982|541711057|FG007|Overall Study|Lost to Follow-up|0|||
150157312|NCT03621982|541711058|FG008|Overall Study|Lost to Follow-up|0|||
150157313|NCT03621982|541711059|FG009|Overall Study|Lost to Follow-up|1|||
150157314|NCT03621982|541711060|FG010|Overall Study|Lost to Follow-up|0|||
150157315|NCT03621982|541711061|FG011|Overall Study|Lost to Follow-up|0|||
150157316|NCT03621982|541711062|FG012|Overall Study|Lost to Follow-up|0|||
150157317|NCT03621982|541711063|FG013|Overall Study|Lost to Follow-up|0|||
150157318|NCT00238420|541711064|FG000|Overall Study|Protocol Violation|1|||
150157319|NCT00238420|541711065|FG001|Overall Study|Protocol Violation|1|||
150157320|NCT00442286|541711066|FG000|Overall Study|Death|2|||
150157321|NCT00442286|541711067|FG001|Overall Study|Death|2|||
150157322|NCT00442286|541711066|FG000|Overall Study|Lost to Follow-up|1|||
150157323|NCT00442286|541711067|FG001|Overall Study|Lost to Follow-up|0|||
150157324|NCT00442286|541711066|FG000|Overall Study|Withdrawal by Subject|2|||
150157325|NCT00442286|541711067|FG001|Overall Study|Withdrawal by Subject|0|||
150157326|NCT00442286|541711066|FG000|Overall Study|System explanted|1|||
150157327|NCT00442286|541711067|FG001|Overall Study|System explanted|0|||
150157328|NCT00442286|541711066|FG000|Overall Study|Patient Injury|1|||
150157329|NCT00442286|541711067|FG001|Overall Study|Patient Injury|0|||
150157330|NCT00641186|541711068|FG000|Overall Study|Adverse Event|3|||
150157331|NCT05221749|541711071|FG000|Overall Study|Lost to Follow-up|2|||
150157332|NCT05221749|541711072|FG001|Overall Study|Lost to Follow-up|3|||
150157333|NCT02218489|541711073|FG000|Overall Study|Withdrawal by Subject|4|||
150157334|NCT02218489|541711074|FG001|Overall Study|Withdrawal by Subject|3|||
150157335|NCT02218489|541711073|FG000|Overall Study|Lost to Follow-up|1|||
150157336|NCT02218489|541711074|FG001|Overall Study|Lost to Follow-up|0|||
150157337|NCT04140890|541711075|FG000|Overall Study|Withdrawal by Subject|0|||
150157338|NCT04140890|541711076|FG001|Overall Study|Withdrawal by Subject|1|||
150157339|NCT02102464|541711079|FG000|Randomized Study|Withdrawal by Subject|0|||
150157340|NCT02102464|541711080|FG001|Randomized Study|Withdrawal by Subject|1|||
150157341|NCT02102464|541711081|FG002|Randomized Study|Withdrawal by Subject|0|||
150157342|NCT02388074|541711082|FG000|Overall Study|Lost in Transit|2|||
150157343|NCT02388074|541711082|FG000|Overall Study|Sample Not Returned|1|||
150157344|NCT01778062|541711085|FG000|Overall Study|Adverse Event|1|||
150157345|NCT01778062|541711086|FG001|Overall Study|Adverse Event|3|||
150157346|NCT01778062|541711085|FG000|Overall Study|Consent Withdrawal|1|||
150157347|NCT01778062|541711086|FG001|Overall Study|Consent Withdrawal|5|||
150157348|NCT01778062|541711085|FG000|Overall Study|major protocol deviation|4|||
150157349|NCT01778062|541711086|FG001|Overall Study|major protocol deviation|3|||
150157350|NCT01824472|541711089|FG000|Overall Study|Lost to Follow-up|0|||
150157351|NCT01824472|541711090|FG001|Overall Study|Lost to Follow-up|0|||
150157352|NCT01824472|541711091|FG002|Overall Study|Lost to Follow-up|1|||
150157353|NCT01824472|541711089|FG000|Overall Study|Withdrawal by Subject|1|||
150157354|NCT01824472|541711090|FG001|Overall Study|Withdrawal by Subject|5|||
150157355|NCT01824472|541711091|FG002|Overall Study|Withdrawal by Subject|3|||
150157356|NCT01824472|541711089|FG000|Overall Study|Ineligible post randomization&screening|0|||
150157357|NCT01824472|541711090|FG001|Overall Study|Ineligible post randomization&screening|2|||
150157358|NCT01824472|541711091|FG002|Overall Study|Ineligible post randomization&screening|0|||
150157359|NCT04039503|541711092|FG000|Overall Study|Adverse Event|3|||
150157360|NCT04039503|541711093|FG001|Overall Study|Adverse Event|0|||
150157361|NCT04039503|541711094|FG002|Overall Study|Adverse Event|2|||
150157362|NCT04039503|541711095|FG003|Overall Study|Adverse Event|0|||
150157363|NCT04039503|541711092|FG000|Overall Study|Lost to Follow-up|0|||
150157364|NCT04039503|541711093|FG001|Overall Study|Lost to Follow-up|0|||
150157365|NCT04039503|541711094|FG002|Overall Study|Lost to Follow-up|1|||
150157366|NCT04039503|541711095|FG003|Overall Study|Lost to Follow-up|0|||
150157367|NCT04039503|541711092|FG000|Overall Study|Protocol Violation|0|||
150157368|NCT04039503|541711093|FG001|Overall Study|Protocol Violation|1|||
150157369|NCT04039503|541711094|FG002|Overall Study|Protocol Violation|2|||
150157370|NCT04039503|541711095|FG003|Overall Study|Protocol Violation|1|||
150157371|NCT04039503|541711092|FG000|Overall Study|Withdrawal by Subject|4|||
150157372|NCT04039503|541711093|FG001|Overall Study|Withdrawal by Subject|3|||
150157373|NCT04039503|541711094|FG002|Overall Study|Withdrawal by Subject|5|||
150157374|NCT04039503|541711095|FG003|Overall Study|Withdrawal by Subject|2|||
150157375|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
150157376|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
150157377|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
150157378|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
150157379|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
150157380|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
150157381|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
150157382|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
150157383|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
150157384|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
150157385|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
150157386|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
150157387|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
150157388|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
150157389|NCT01815736|541711096|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
150157390|NCT01815736|541711097|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
150157391|NCT01815736|541711096|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
150157392|NCT01815736|541711097|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
150157393|NCT01815736|541711096|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
150157394|NCT01815736|541711097|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
150157395|NCT01815736|541711096|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
150157396|NCT01815736|541711097|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
150157397|NCT01815736|541711096|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
150157398|NCT01815736|541711097|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
150157399|NCT01815736|541711096|FG000|Extension Treatment Phase- After Week 96|Death|1|||
150157400|NCT01815736|541711097|FG001|Extension Treatment Phase- After Week 96|Death|0|||
150157401|NCT03387514|541711101|FG000|Overall Study|Withdrawal by Subject|2|||
150157402|NCT03387514|541711101|FG000|Overall Study|Physician Decision|1|||
150157403|NCT03387514|541711101|FG000|Overall Study|Lost to Follow-up|2|||
150157404|NCT03040687|541711106|FG000|Overall Study|Withdrawal by Subject|1|||
150157405|NCT03040687|541711107|FG001|Overall Study|Withdrawal by Subject|0|||
150157406|NCT03040687|541711108|FG002|Overall Study|Withdrawal by Subject|0|||
150157407|NCT03317379|541711109|FG000|Overall Study|Lost to Follow-up|0|||
150157408|NCT03317379|541711110|FG001|Overall Study|Lost to Follow-up|3|||
150157409|NCT03317379|541711111|FG002|Overall Study|Lost to Follow-up|2|||
150157410|NCT02846558|541711112|FG000|Overall Study|Adverse Event|1|||
150157411|NCT02846558|541711113|FG001|Overall Study|Adverse Event|0|||
150157412|NCT02846558|541711114|FG002|Overall Study|Adverse Event|0|||
150157413|NCT02846558|541711115|FG003|Overall Study|Adverse Event|0|||
150157414|NCT02846558|541711112|FG000|Overall Study|Withdrawal by Subject|5|||
150157415|NCT02846558|541711113|FG001|Overall Study|Withdrawal by Subject|4|||
150157416|NCT02846558|541711114|FG002|Overall Study|Withdrawal by Subject|2|||
150157417|NCT02846558|541711115|FG003|Overall Study|Withdrawal by Subject|2|||
150157418|NCT02846558|541711112|FG000|Overall Study|Lost to Follow-up|2|||
150157419|NCT02846558|541711113|FG001|Overall Study|Lost to Follow-up|0|||
150157420|NCT02846558|541711114|FG002|Overall Study|Lost to Follow-up|0|||
150157421|NCT02846558|541711115|FG003|Overall Study|Lost to Follow-up|0|||
150157422|NCT04445155|541711116|FG000|Overall Study|Lost to Follow-up|11|||
150157423|NCT04445155|541711117|FG001|Overall Study|Lost to Follow-up|2|||
150157424|NCT04445155|541711118|FG002|Overall Study|Lost to Follow-up|3|||
150157425|NCT04445155|541711119|FG003|Overall Study|Lost to Follow-up|0|||
150157426|NCT04445155|541711116|FG000|Overall Study|Withdrawal by Subject|8|||
150157427|NCT04445155|541711117|FG001|Overall Study|Withdrawal by Subject|0|||
150157428|NCT04445155|541711118|FG002|Overall Study|Withdrawal by Subject|0|||
150157429|NCT04445155|541711119|FG003|Overall Study|Withdrawal by Subject|0|||
150157430|NCT04445155|541711116|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
150157431|NCT04445155|541711117|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
150157432|NCT04445155|541711118|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
150157433|NCT04445155|541711119|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
150157434|NCT04445155|541711116|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
150157435|NCT04445155|541711117|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
150157436|NCT04445155|541711118|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
150157437|NCT04445155|541711119|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
150157438|NCT03363659|541711122|FG000|Overall Study|Adverse Event|1|||
150157439|NCT03363659|541711122|FG000|Overall Study|Screen fail|1|||
150157440|NCT03363659|541711122|FG000|Overall Study|Withdrawal by Subject|1|||
150157441|NCT03872388|541711123|FG000|Overall Study|Disease Progression|0|||
150157442|NCT03872388|541711124|FG001|Overall Study|Disease Progression|0|||
150157443|NCT03872388|541711125|FG002|Overall Study|Disease Progression|0|||
150157444|NCT03872388|541711126|FG003|Overall Study|Disease Progression|0|||
150157445|NCT03872388|541711127|FG004|Overall Study|Disease Progression|0|||
150157446|NCT03872388|541711128|FG005|Overall Study|Disease Progression|0|||
150157447|NCT03872388|541711129|FG006|Overall Study|Disease Progression|1|||
150157448|NCT03872388|541711130|FG007|Overall Study|Disease Progression|1|||
150157449|NCT01781611|541712369|FG000|Overall Study|Adverse Event|4|||
150157450|NCT01781611|541712370|FG001|Overall Study|Adverse Event|0|||
150157451|NCT01477749|541712373|FG000|Overall Study|Physician Decision|4|||
150157452|NCT04172987|541712376|FG000|Lead In Period|Adverse Event|1|||
150157453|NCT04172987|541712376|FG000|Lead In Period|Protocol Violation|1|||
150157454|NCT04172987|541712376|FG000|Period 1|Physician Decision|1|||
150157455|NCT04172987|541712376|FG000|Period 2|Adverse Event|5|||
150157456|NCT04172987|541712376|FG000|Period 2|Dosing Termination by Sponsor|4|||
150157457|NCT04179461|541712382|FG000|Overall Study|Lost to Follow-up|4|||
150157458|NCT03100838|541712383|FG000|Overall Study|Adverse Event|1|||
150157459|NCT03100838|541712384|FG001|Overall Study|Adverse Event|0|||
150157460|NCT03100838|541712385|FG002|Overall Study|Adverse Event|0|||
150157461|NCT03100838|541712386|FG003|Overall Study|Adverse Event|0|||
150157462|NCT03100838|541712383|FG000|Overall Study|Physician Decision|1|||
150157463|NCT03100838|541712384|FG001|Overall Study|Physician Decision|1|||
150157464|NCT03100838|541712385|FG002|Overall Study|Physician Decision|1|||
150157465|NCT03100838|541712386|FG003|Overall Study|Physician Decision|1|||
150157466|NCT03100838|541712383|FG000|Overall Study|Pregnancy|0|||
150157467|NCT03100838|541712384|FG001|Overall Study|Pregnancy|1|||
150157468|NCT03100838|541712385|FG002|Overall Study|Pregnancy|0|||
150157469|NCT03100838|541712386|FG003|Overall Study|Pregnancy|0|||
150157470|NCT03100838|541712383|FG000|Overall Study|Lost to Follow-up|0|||
150157471|NCT03100838|541712384|FG001|Overall Study|Lost to Follow-up|0|||
150157472|NCT03100838|541712385|FG002|Overall Study|Lost to Follow-up|1|||
150157473|NCT03100838|541712386|FG003|Overall Study|Lost to Follow-up|0|||
150157474|NCT00184028|541712387|FG000|Overall Study|Death|1|||
150157475|NCT00184028|541712387|FG000|Overall Study|Lack of Efficacy|4|||
150157476|NCT00184028|541712387|FG000|Overall Study|Adverse Event|2|||
150157477|NCT00184028|541712387|FG000|Overall Study|Withdrawal by Subject|1|||
150157478|NCT00184028|541712387|FG000|Overall Study|Non-compliance|2|||
150157479|NCT01347645|541712388|FG000|Overall Study|Death|1|||
150157480|NCT01347645|541712389|FG001|Overall Study|Death|5|||
150157481|NCT01347645|541712390|FG002|Overall Study|Death|2|||
150157482|NCT01347645|541712391|FG003|Overall Study|Death|7|||
150157483|NCT01347645|541712392|FG004|Overall Study|Death|7|||
150157484|NCT01347645|541712388|FG000|Overall Study|Lost to Follow-up|1|||
150157485|NCT01347645|541712389|FG001|Overall Study|Lost to Follow-up|1|||
150157486|NCT01347645|541712390|FG002|Overall Study|Lost to Follow-up|0|||
150157487|NCT01347645|541712391|FG003|Overall Study|Lost to Follow-up|1|||
150157488|NCT01347645|541712392|FG004|Overall Study|Lost to Follow-up|1|||
150157489|NCT01347645|541712388|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
150157490|NCT01347645|541712389|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
150157491|NCT01347645|541712390|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
150157492|NCT01347645|541712391|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
150157493|NCT01347645|541712392|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
150157494|NCT01347645|541712388|FG000|Overall Study|Other|1|||
150157495|NCT01347645|541712389|FG001|Overall Study|Other|0|||
150157496|NCT01347645|541712390|FG002|Overall Study|Other|0|||
150157497|NCT01347645|541712391|FG003|Overall Study|Other|0|||
150157498|NCT01347645|541712392|FG004|Overall Study|Other|1|||
150157499|NCT01347645|541712388|FG000|Overall Study|Withdrawal by Subject|0|||
150157500|NCT01347645|541712389|FG001|Overall Study|Withdrawal by Subject|0|||
150157501|NCT01347645|541712390|FG002|Overall Study|Withdrawal by Subject|0|||
150157502|NCT01347645|541712391|FG003|Overall Study|Withdrawal by Subject|3|||
150157503|NCT01347645|541712392|FG004|Overall Study|Withdrawal by Subject|3|||
150157504|NCT01347645|541712388|FG000|Overall Study|Physician Decision|0|||
150157505|NCT01347645|541712389|FG001|Overall Study|Physician Decision|0|||
150157506|NCT01347645|541712390|FG002|Overall Study|Physician Decision|0|||
150157507|NCT01347645|541712391|FG003|Overall Study|Physician Decision|0|||
150157508|NCT01347645|541712392|FG004|Overall Study|Physician Decision|1|||
150157509|NCT01347645|541712388|FG000|Overall Study|Adverse Event|0|||
150157510|NCT01347645|541712389|FG001|Overall Study|Adverse Event|0|||
150157511|NCT01347645|541712390|FG002|Overall Study|Adverse Event|0|||
150157512|NCT01347645|541712391|FG003|Overall Study|Adverse Event|1|||
150157513|NCT01347645|541712392|FG004|Overall Study|Adverse Event|1|||
150157514|NCT01141660|541712393|FG000|Overall Study|Physician Decision|0|||
150157515|NCT01141660|541712394|FG001|Overall Study|Physician Decision|12|||
150157516|NCT00209027|541712396|FG000|Overall Study|study terminated|10|||
150157517|NCT00209027|541712397|FG001|Overall Study|study terminated|0|||
150157518|NCT03785340|541712398|FG000|Overall Study|Lost to Follow-up|2|||
150157519|NCT03785340|541712399|FG001|Overall Study|Lost to Follow-up|0|||
150157520|NCT03785340|541712398|FG000|Overall Study|Adverse Event|1|||
150157521|NCT03785340|541712399|FG001|Overall Study|Adverse Event|0|||
150157522|NCT01848834|541712400|FG000|Overall Study|Adverse Event|3|||
150157523|NCT01848834|541712401|FG001|Overall Study|Adverse Event|11|||
150157524|NCT01848834|541712402|FG002|Overall Study|Adverse Event|3|||
150157525|NCT01848834|541712403|FG003|Overall Study|Adverse Event|5|||
150157526|NCT01848834|541712404|FG004|Overall Study|Adverse Event|9|||
150157527|NCT01848834|541712400|FG000|Overall Study|Death|2|||
150157528|NCT01848834|541712401|FG001|Overall Study|Death|11|||
150157529|NCT01848834|541712402|FG002|Overall Study|Death|1|||
150157530|NCT01848834|541712403|FG003|Overall Study|Death|8|||
150157531|NCT01848834|541712404|FG004|Overall Study|Death|27|||
150157532|NCT01848834|541712400|FG000|Overall Study|Excluded Medication|5|||
150157533|NCT01848834|541712401|FG001|Overall Study|Excluded Medication|4|||
150157534|NCT01848834|541712402|FG002|Overall Study|Excluded Medication|3|||
150157535|NCT01848834|541712403|FG003|Overall Study|Excluded Medication|6|||
150157536|NCT01848834|541712404|FG004|Overall Study|Excluded Medication|6|||
150157537|NCT01848834|541712400|FG000|Overall Study|Lost to Follow-up|5|||
150157538|NCT01848834|541712401|FG001|Overall Study|Lost to Follow-up|5|||
150157539|NCT01848834|541712402|FG002|Overall Study|Lost to Follow-up|3|||
150157540|NCT01848834|541712403|FG003|Overall Study|Lost to Follow-up|0|||
150157541|NCT01848834|541712404|FG004|Overall Study|Lost to Follow-up|3|||
150157542|NCT01848834|541712400|FG000|Overall Study|Physician Decision|1|||
150157543|NCT01848834|541712401|FG001|Overall Study|Physician Decision|3|||
150157544|NCT01848834|541712402|FG002|Overall Study|Physician Decision|4|||
150157545|NCT01848834|541712403|FG003|Overall Study|Physician Decision|0|||
150157546|NCT01848834|541712404|FG004|Overall Study|Physician Decision|11|||
150157547|NCT01848834|541712400|FG000|Overall Study|Protocol Violation|0|||
150157548|NCT01848834|541712401|FG001|Overall Study|Protocol Violation|0|||
150157549|NCT01848834|541712402|FG002|Overall Study|Protocol Violation|0|||
150157550|NCT01848834|541712403|FG003|Overall Study|Protocol Violation|0|||
150157551|NCT01848834|541712404|FG004|Overall Study|Protocol Violation|1|||
150157552|NCT01848834|541712400|FG000|Overall Study|Sponsor Decision|1|||
150157553|NCT01848834|541712401|FG001|Overall Study|Sponsor Decision|1|||
150157554|NCT01848834|541712402|FG002|Overall Study|Sponsor Decision|0|||
150157555|NCT01848834|541712403|FG003|Overall Study|Sponsor Decision|1|||
150157556|NCT01848834|541712404|FG004|Overall Study|Sponsor Decision|1|||
150157557|NCT01848834|541712400|FG000|Overall Study|Withdrawal by Subject|2|||
150157558|NCT01848834|541712401|FG001|Overall Study|Withdrawal by Subject|13|||
150157559|NCT01848834|541712402|FG002|Overall Study|Withdrawal by Subject|10|||
150157560|NCT01848834|541712403|FG003|Overall Study|Withdrawal by Subject|6|||
150157561|NCT01848834|541712404|FG004|Overall Study|Withdrawal by Subject|36|||
150157562|NCT03259373|541712415|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
150157563|NCT03259373|541712416|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
150157564|NCT03259373|541712415|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
150157565|NCT03259373|541712416|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
150157566|NCT03259373|541712415|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
150157567|NCT03259373|541712416|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
150157568|NCT03259373|541712415|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
150157569|NCT03259373|541712416|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
150157570|NCT03259373|541712415|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
150157571|NCT03259373|541712416|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
150157572|NCT03259373|541712415|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
150157573|NCT03259373|541712416|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
150157574|NCT01923428|541712418|FG000|Overall Study|Adverse Event|8|||
150157575|NCT01923428|541712419|FG001|Overall Study|Adverse Event|6|||
150157576|NCT01923428|541712420|FG002|Overall Study|Adverse Event|3|||
150157577|NCT01923428|541712421|FG003|Overall Study|Adverse Event|3|||
150157578|NCT01923428|541712418|FG000|Overall Study|Withdrawal by Subject|5|||
150157579|NCT01923428|541712419|FG001|Overall Study|Withdrawal by Subject|3|||
150157580|NCT01923428|541712420|FG002|Overall Study|Withdrawal by Subject|0|||
150157581|NCT01923428|541712421|FG003|Overall Study|Withdrawal by Subject|4|||
150157582|NCT01923428|541712418|FG000|Overall Study|Lost to Follow-up|2|||
150157583|NCT01923428|541712419|FG001|Overall Study|Lost to Follow-up|1|||
150157584|NCT01923428|541712420|FG002|Overall Study|Lost to Follow-up|5|||
150157585|NCT01923428|541712421|FG003|Overall Study|Lost to Follow-up|0|||
150157586|NCT01923428|541712418|FG000|Overall Study|Protocol Violation|3|||
150157587|NCT01923428|541712419|FG001|Overall Study|Protocol Violation|0|||
150157588|NCT01923428|541712420|FG002|Overall Study|Protocol Violation|2|||
150157589|NCT01923428|541712421|FG003|Overall Study|Protocol Violation|1|||
150157590|NCT01923428|541712418|FG000|Overall Study|Non Compliance to treatment|1|||
150157591|NCT01923428|541712419|FG001|Overall Study|Non Compliance to treatment|2|||
150157592|NCT01923428|541712420|FG002|Overall Study|Non Compliance to treatment|0|||
150157593|NCT01923428|541712421|FG003|Overall Study|Non Compliance to treatment|1|||
150157594|NCT01923428|541712418|FG000|Overall Study|Lack of Efficacy|0|||
150157595|NCT01923428|541712419|FG001|Overall Study|Lack of Efficacy|0|||
150157596|NCT01923428|541712420|FG002|Overall Study|Lack of Efficacy|1|||
150157597|NCT01923428|541712421|FG003|Overall Study|Lack of Efficacy|1|||
150157598|NCT00885495|541712423|FG000|Overall Study|Adverse Event|1|||
150157599|NCT00885495|541712424|FG001|Overall Study|Adverse Event|2|||
150157600|NCT00885495|541712423|FG000|Overall Study|Protocol Violation|0|||
150157601|NCT00885495|541712424|FG001|Overall Study|Protocol Violation|1|||
150157602|NCT00885495|541712423|FG000|Overall Study|Withdrawal by Subject|1|||
149815929|NCT01889862|540456843|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
149815930|NCT01889862|540456844|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
150157603|NCT00885495|541712424|FG001|Overall Study|Withdrawal by Subject|0|||
150157604|NCT02107443|541712425|FG000|Overall Study|Death|42|||
150157605|NCT02107443|541712426|FG001|Overall Study|Death|30|||
150157606|NCT02107443|541712425|FG000|Overall Study|Study Protocol Violation|3|||
150157607|NCT02107443|541712426|FG001|Overall Study|Study Protocol Violation|1|||
150157608|NCT02107443|541712425|FG000|Overall Study|Registered but Not Eligible|0|||
150157609|NCT02107443|541712426|FG001|Overall Study|Registered but Not Eligible|1|||
150157610|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
150157611|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
150157612|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
150157613|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
150157614|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Changed Mind|2|||
150157615|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Changed Mind|0|||
150157616|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
150157617|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
150157618|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
150157619|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
150157620|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
149815931|NCT01889862|540456845|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
149815932|NCT01889862|540456846|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
149815933|NCT01889862|540456842|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
150157621|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
150157622|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
150157623|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
150157624|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Other Medical|9|||
150157625|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Other Medical|5|||
150157626|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Disease Progression|4|||
150157627|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Disease Progression|2|||
150157628|NCT02107443|541712425|FG000|Overall Study|Withdrawal: Personal Issues|0|||
150157629|NCT02107443|541712426|FG001|Overall Study|Withdrawal: Personal Issues|3|||
150157630|NCT01400893|541712427|FG000|Overall Study|Death|27|||
150157631|NCT01400893|541712428|FG001|Overall Study|Death|21|||
150157632|NCT01400893|541712427|FG000|Overall Study|Lost to Follow-up|0|||
150157633|NCT01400893|541712428|FG001|Overall Study|Lost to Follow-up|6|||
150157634|NCT00946647|541712429|FG000|Phase 1 Part|Adverse Event|2|||
150157635|NCT00946647|541712430|FG001|Phase 1 Part|Adverse Event|5|||
150157636|NCT00946647|541712431|FG002|Phase 1 Part|Adverse Event|3|||
150157637|NCT00946647|541712432|FG003|Phase 1 Part|Adverse Event|0|||
150157638|NCT00946647|541712433|FG004|Phase 1 Part|Adverse Event|0|||
150157639|NCT00946647|541712429|FG000|Phase 1 Part|Disease progression|3|||
150157640|NCT00946647|541712430|FG001|Phase 1 Part|Disease progression|6|||
150157641|NCT00946647|541712431|FG002|Phase 1 Part|Disease progression|1|||
150157642|NCT00946647|541712432|FG003|Phase 1 Part|Disease progression|0|||
150157643|NCT00946647|541712433|FG004|Phase 1 Part|Disease progression|0|||
150157644|NCT00946647|541712429|FG000|Phase 1 Part|Withdrawal by Subject|1|||
150157645|NCT00946647|541712430|FG001|Phase 1 Part|Withdrawal by Subject|4|||
150157646|NCT00946647|541712431|FG002|Phase 1 Part|Withdrawal by Subject|3|||
150157647|NCT00946647|541712432|FG003|Phase 1 Part|Withdrawal by Subject|0|||
150157648|NCT00946647|541712433|FG004|Phase 1 Part|Withdrawal by Subject|0|||
150157649|NCT00946647|541712429|FG000|Phase 1 Part|Abnormal values|0|||
150157650|NCT00946647|541712430|FG001|Phase 1 Part|Abnormal values|2|||
150157651|NCT00946647|541712431|FG002|Phase 1 Part|Abnormal values|0|||
150157652|NCT00946647|541712432|FG003|Phase 1 Part|Abnormal values|0|||
150157653|NCT00946647|541712433|FG004|Phase 1 Part|Abnormal values|0|||
150157654|NCT00946647|541712429|FG000|Phase 1 Part|Reason missing|0|||
150157655|NCT00946647|541712430|FG001|Phase 1 Part|Reason missing|1|||
150157656|NCT00946647|541712431|FG002|Phase 1 Part|Reason missing|0|||
150157657|NCT00946647|541712432|FG003|Phase 1 Part|Reason missing|0|||
150157658|NCT00946647|541712433|FG004|Phase 1 Part|Reason missing|0|||
150157659|NCT00946647|541712429|FG000|Phase ll Part|Untreated|0|||
150157660|NCT00946647|541712430|FG001|Phase ll Part|Untreated|0|||
150157661|NCT00946647|541712431|FG002|Phase ll Part|Untreated|0|||
150157662|NCT00946647|541712432|FG003|Phase ll Part|Untreated|0|||
150157663|NCT00946647|541712433|FG004|Phase ll Part|Untreated|2|||
150157664|NCT00946647|541712429|FG000|Phase ll Part|Adverse Event|0|||
150157665|NCT00946647|541712430|FG001|Phase ll Part|Adverse Event|0|||
150157666|NCT00946647|541712431|FG002|Phase ll Part|Adverse Event|0|||
150157667|NCT00946647|541712432|FG003|Phase ll Part|Adverse Event|10|||
150157668|NCT00946647|541712433|FG004|Phase ll Part|Adverse Event|6|||
150157669|NCT00946647|541712429|FG000|Phase ll Part|Withdrawal by Subject|0|||
150157670|NCT00946647|541712430|FG001|Phase ll Part|Withdrawal by Subject|0|||
150157671|NCT00946647|541712431|FG002|Phase ll Part|Withdrawal by Subject|0|||
150157672|NCT00946647|541712432|FG003|Phase ll Part|Withdrawal by Subject|8|||
150157673|NCT00946647|541712433|FG004|Phase ll Part|Withdrawal by Subject|6|||
150157674|NCT00946647|541712429|FG000|Phase ll Part|Administrative problems|0|||
150157675|NCT00946647|541712430|FG001|Phase ll Part|Administrative problems|0|||
150157676|NCT00946647|541712431|FG002|Phase ll Part|Administrative problems|0|||
150157677|NCT00946647|541712432|FG003|Phase ll Part|Administrative problems|3|||
150157678|NCT00946647|541712433|FG004|Phase ll Part|Administrative problems|8|||
150157679|NCT00946647|541712429|FG000|Phase ll Part|Death|0|||
150157680|NCT00946647|541712430|FG001|Phase ll Part|Death|0|||
149815934|NCT01889862|540456843|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
150157681|NCT00946647|541712431|FG002|Phase ll Part|Death|0|||
150157682|NCT00946647|541712432|FG003|Phase ll Part|Death|7|||
150157683|NCT00946647|541712433|FG004|Phase ll Part|Death|4|||
150157684|NCT00946647|541712429|FG000|Phase ll Part|Disease progression|0|||
150157685|NCT00946647|541712430|FG001|Phase ll Part|Disease progression|0|||
150157686|NCT00946647|541712431|FG002|Phase ll Part|Disease progression|0|||
150157687|NCT00946647|541712432|FG003|Phase ll Part|Disease progression|6|||
150157688|NCT00946647|541712433|FG004|Phase ll Part|Disease progression|14|||
150157689|NCT00946647|541712429|FG000|Phase ll Part|Protocol Violation|0|||
150157690|NCT00946647|541712430|FG001|Phase ll Part|Protocol Violation|0|||
150157691|NCT00946647|541712431|FG002|Phase ll Part|Protocol Violation|0|||
150157692|NCT00946647|541712432|FG003|Phase ll Part|Protocol Violation|4|||
150157693|NCT00946647|541712433|FG004|Phase ll Part|Protocol Violation|2|||
150157694|NCT00946647|541712429|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
150157695|NCT00946647|541712430|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
150157696|NCT00946647|541712431|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
150157697|NCT00946647|541712432|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
150259496|NCT00321373|542087148|FG001|Overall Study|Adverse Event|0|||
150157698|NCT00946647|541712433|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
150157699|NCT00519636|541712434|FG000|Treatment Period 1|Adverse Event|1|||
150157700|NCT00519636|541712435|FG001|Treatment Period 1|Adverse Event|0|||
150157701|NCT00519636|541712436|FG002|Treatment Period 1|Adverse Event|1|||
150157702|NCT00519636|541712437|FG003|Treatment Period 1|Adverse Event|0|||
150157703|NCT00519636|541712434|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
150157704|NCT00519636|541712435|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
150157705|NCT00519636|541712436|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
150157706|NCT00519636|541712437|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
150157707|NCT00519636|541712434|FG000|Washout Period|Adverse Event|2|||
150157708|NCT00519636|541712435|FG001|Washout Period|Adverse Event|1|||
150157709|NCT00519636|541712436|FG002|Washout Period|Adverse Event|1|||
150157710|NCT00519636|541712437|FG003|Washout Period|Adverse Event|0|||
150157711|NCT00519636|541712434|FG000|Washout Period|Lost to Follow-up|1|||
150157712|NCT00519636|541712435|FG001|Washout Period|Lost to Follow-up|0|||
150157713|NCT00519636|541712436|FG002|Washout Period|Lost to Follow-up|0|||
150157714|NCT00519636|541712437|FG003|Washout Period|Lost to Follow-up|0|||
150157715|NCT00519636|541712434|FG000|Washout Period|Protocol Violation|0|||
150157716|NCT00519636|541712435|FG001|Washout Period|Protocol Violation|0|||
150157717|NCT00519636|541712436|FG002|Washout Period|Protocol Violation|1|||
150157718|NCT00519636|541712437|FG003|Washout Period|Protocol Violation|2|||
150157719|NCT00519636|541712434|FG000|Washout Period|Withdrawal by Subject|1|||
150157720|NCT00519636|541712435|FG001|Washout Period|Withdrawal by Subject|0|||
150157721|NCT00519636|541712436|FG002|Washout Period|Withdrawal by Subject|1|||
150157722|NCT00519636|541712437|FG003|Washout Period|Withdrawal by Subject|0|||
150157723|NCT00519636|541712434|FG000|Washout Period|Failed to meet continuation criteria|14|||
150157724|NCT00519636|541712435|FG001|Washout Period|Failed to meet continuation criteria|11|||
150157725|NCT00519636|541712436|FG002|Washout Period|Failed to meet continuation criteria|9|||
150157726|NCT00519636|541712437|FG003|Washout Period|Failed to meet continuation criteria|3|||
150157727|NCT00519636|541712434|FG000|Washout Period|Out of pollen area > 48 hours|1|||
150157728|NCT00519636|541712435|FG001|Washout Period|Out of pollen area > 48 hours|0|||
150157729|NCT00519636|541712436|FG002|Washout Period|Out of pollen area > 48 hours|0|||
150157730|NCT00519636|541712437|FG003|Washout Period|Out of pollen area > 48 hours|0|||
150157731|NCT00519636|541712434|FG000|Washout Period|Participating in study at another site|1|||
150157732|NCT00519636|541712435|FG001|Washout Period|Participating in study at another site|0|||
150157733|NCT00519636|541712436|FG002|Washout Period|Participating in study at another site|0|||
150157734|NCT00519636|541712437|FG003|Washout Period|Participating in study at another site|0|||
150157735|NCT00519636|541712434|FG000|Washout Period|Non-compliant|0|||
150157736|NCT00519636|541712435|FG001|Washout Period|Non-compliant|1|||
150157737|NCT00519636|541712436|FG002|Washout Period|Non-compliant|0|||
150157738|NCT00519636|541712437|FG003|Washout Period|Non-compliant|0|||
150157739|NCT00519636|541712434|FG000|Washout Period|Per doctors request|0|||
150157740|NCT00519636|541712435|FG001|Washout Period|Per doctors request|1|||
150157741|NCT00519636|541712436|FG002|Washout Period|Per doctors request|0|||
150157742|NCT00519636|541712437|FG003|Washout Period|Per doctors request|0|||
150157743|NCT00519636|541712434|FG000|Washout Period|Subject randomized in error|0|||
150157744|NCT00519636|541712435|FG001|Washout Period|Subject randomized in error|0|||
150157745|NCT00519636|541712436|FG002|Washout Period|Subject randomized in error|1|||
150157746|NCT00519636|541712437|FG003|Washout Period|Subject randomized in error|0|||
150157747|NCT00519636|541712434|FG000|Washout Period|Prohibited medications|0|||
150157748|NCT00519636|541712435|FG001|Washout Period|Prohibited medications|0|||
150157749|NCT00519636|541712436|FG002|Washout Period|Prohibited medications|1|||
150157750|NCT00519636|541712437|FG003|Washout Period|Prohibited medications|0|||
150157751|NCT00519636|541712434|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
150157752|NCT00519636|541712435|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
150157753|NCT00519636|541712436|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
150157754|NCT00519636|541712437|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
150157755|NCT00519636|541712434|FG000|Treatment Period 2|Subject randomized in error|0|||
150157756|NCT00519636|541712435|FG001|Treatment Period 2|Subject randomized in error|1|||
150157757|NCT00519636|541712436|FG002|Treatment Period 2|Subject randomized in error|0|||
150157758|NCT00519636|541712437|FG003|Treatment Period 2|Subject randomized in error|0|||
150157759|NCT00519636|541712434|FG000|Treatment Period 2|Per doctors request|0|||
150157760|NCT00519636|541712435|FG001|Treatment Period 2|Per doctors request|0|||
150157761|NCT00519636|541712436|FG002|Treatment Period 2|Per doctors request|1|||
150157762|NCT00519636|541712437|FG003|Treatment Period 2|Per doctors request|0|||
150157763|NCT00519636|541712434|FG000|Treatment Period 2|Subject misrandomized|0|||
150157764|NCT00519636|541712435|FG001|Treatment Period 2|Subject misrandomized|0|||
150157765|NCT00519636|541712436|FG002|Treatment Period 2|Subject misrandomized|0|||
150157766|NCT00519636|541712437|FG003|Treatment Period 2|Subject misrandomized|1|||
150157767|NCT00519636|541712434|FG000|Post Study Period|Subject randomized in error|0|||
150157768|NCT00519636|541712435|FG001|Post Study Period|Subject randomized in error|0|||
150157769|NCT00519636|541712436|FG002|Post Study Period|Subject randomized in error|0|||
150259497|NCT00321373|542087149|FG002|Overall Study|Adverse Event|1|||
150259498|NCT00321373|542087147|FG000|Overall Study|Lost to Follow-up|1|||
149815935|NCT01889862|540456844|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
149815936|NCT01889862|540456845|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
149815937|NCT01889862|540456846|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
149815938|NCT01889862|540456842|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
149815939|NCT01889862|540456843|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
149815940|NCT01889862|540456844|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
149815941|NCT01889862|540456845|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
149815942|NCT01889862|540456846|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
149815943|NCT01889862|540456842|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
149815944|NCT01889862|540456843|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
149815945|NCT01889862|540456844|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
149815946|NCT01889862|540456845|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
149815947|NCT01889862|540456846|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
149815948|NCT01889862|540456842|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
149815949|NCT01889862|540456843|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
149815950|NCT01889862|540456844|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
149815951|NCT01889862|540456845|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
149815952|NCT01889862|540456846|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
149815953|NCT01889862|540456842|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
149815954|NCT01889862|540456843|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
149815955|NCT01889862|540456844|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
149815956|NCT01889862|540456845|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
149815957|NCT01889862|540456846|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
149815958|NCT01889862|540456842|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
149815959|NCT01889862|540456843|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
149815960|NCT01889862|540456844|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
149815961|NCT01889862|540456845|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
149815962|NCT01889862|540456846|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
149815963|NCT01889862|540456842|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
149918928|NCT00422292|540835252|FG002|Overall Study|Serious adverse events|0|||
149918929|NCT00422292|540835253|FG003|Overall Study|Serious adverse events|0|||
149918930|NCT00422292|540835250|FG000|Overall Study|Adverse Event|1|||
149918931|NCT00422292|540835251|FG001|Overall Study|Adverse Event|0|||
149918932|NCT00422292|540835252|FG002|Overall Study|Adverse Event|1|||
149918933|NCT00422292|540835253|FG003|Overall Study|Adverse Event|0|||
149918934|NCT00422292|540835250|FG000|Overall Study|Protocol Violation|4|||
149918935|NCT00422292|540835251|FG001|Overall Study|Protocol Violation|25|||
149918936|NCT00422292|540835252|FG002|Overall Study|Protocol Violation|8|||
149918937|NCT00422292|540835253|FG003|Overall Study|Protocol Violation|5|||
149918938|NCT00422292|540835250|FG000|Overall Study|Lost to Follow-up|6|||
149918939|NCT00422292|540835251|FG001|Overall Study|Lost to Follow-up|12|||
149918940|NCT00422292|540835252|FG002|Overall Study|Lost to Follow-up|6|||
149918941|NCT00422292|540835253|FG003|Overall Study|Lost to Follow-up|6|||
149918942|NCT00422292|540835250|FG000|Overall Study|Withdrawal by Subject|6|||
149918943|NCT00422292|540835251|FG001|Overall Study|Withdrawal by Subject|25|||
149918944|NCT00422292|540835252|FG002|Overall Study|Withdrawal by Subject|7|||
149918945|NCT00422292|540835253|FG003|Overall Study|Withdrawal by Subject|13|||
149918946|NCT02440854|540835254|FG000|Overall Study|Relocation of patient|1|||
149918947|NCT02440854|540835254|FG000|Overall Study|Death|6|||
149918948|NCT02440854|540835254|FG000|Overall Study|Lost to Follow-up|10|||
149918949|NCT02440854|540835254|FG000|Overall Study|Afatinib discontinuation|46|||
149918950|NCT02440854|540835254|FG000|Overall Study|stopped study at earlier timepoint|14|||
149918951|NCT02440854|540835254|FG000|Overall Study|Study medication not received|1|||
149918952|NCT02440854|540835254|FG000|Overall Study|Violation of inclusion criteria|2|||
149918953|NCT02243046|540835255|FG000|Overall Study|Lost to Follow-up|1|||
149918954|NCT02243046|540835256|FG001|Overall Study|Lost to Follow-up|1|||
149918955|NCT02243046|540835257|FG002|Overall Study|Lost to Follow-up|4|||
149918956|NCT01908582|540837215|FG000|Period 2|Physician Decision|1|||
149918957|NCT01908582|540837215|FG000|Period 2|Withdrawal by Subject|1|||
149918958|NCT03594955|540837216|FG000|Overall Study|Adverse Event|1|||
149918959|NCT03594955|540837216|FG000|Overall Study|Progressive disease|5|||
149918960|NCT03594955|540837216|FG000|Overall Study|Sponsor's decision|1|||
149918961|NCT02065518|540837218|FG000|Overall Study|Lost to Follow-up|3|||
149918962|NCT02065518|540837219|FG001|Overall Study|Lost to Follow-up|4|||
149918963|NCT02065518|540837220|FG002|Overall Study|Lost to Follow-up|0|||
149918964|NCT02065518|540837221|FG003|Overall Study|Lost to Follow-up|3|||
149918965|NCT02065518|540837218|FG000|Overall Study|Withdrawal by Subject|3|||
149918966|NCT02065518|540837219|FG001|Overall Study|Withdrawal by Subject|4|||
149918967|NCT02065518|540837220|FG002|Overall Study|Withdrawal by Subject|9|||
149918968|NCT02065518|540837221|FG003|Overall Study|Withdrawal by Subject|2|||
149918969|NCT01066663|540837223|FG000|Overall Study|Adverse Event|0|||
149918970|NCT01066663|540837224|FG001|Overall Study|Adverse Event|0|||
149918971|NCT01066663|540837225|FG002|Overall Study|Adverse Event|1|||
149918972|NCT01090050|540837226|FG000|Overall Study|Lost to Follow-up|0|||
149918973|NCT01090050|540837227|FG001|Overall Study|Lost to Follow-up|1|||
150157770|NCT00519636|541712437|FG003|Post Study Period|Subject randomized in error|1|||
150157771|NCT01368211|541712438|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
150157772|NCT01368211|541712439|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
150157773|NCT03057834|541712440|FG000|Overall Study|Withdrawal by Subject|25|||
150157774|NCT03057834|541712441|FG001|Overall Study|Withdrawal by Subject|29|||
150157775|NCT04630756|541712454|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
150157776|NCT04630756|541712455|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
150157777|NCT04630756|541712456|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
150157778|NCT05593211|541712458|FG000|Overall Study|Withdrawal by Subject|1|||
150157779|NCT03077620|541712462|FG000|Overall Study|Unable to place lumbar catheter|1|||
150157780|NCT03077620|541712463|FG001|Overall Study|Unable to place lumbar catheter|0|||
150157781|NCT03077620|541712464|FG002|Overall Study|Unable to place lumbar catheter|1|||
150157782|NCT03077620|541712465|FG003|Overall Study|Unable to place lumbar catheter|0|||
150157783|NCT03077620|541712462|FG000|Overall Study|Withdrawal by Subject|0|||
150157784|NCT03077620|541712463|FG001|Overall Study|Withdrawal by Subject|1|||
150157785|NCT03077620|541712464|FG002|Overall Study|Withdrawal by Subject|0|||
150157786|NCT03077620|541712465|FG003|Overall Study|Withdrawal by Subject|0|||
150157787|NCT03077620|541712462|FG000|Overall Study|Physician Decision|0|||
150157788|NCT03077620|541712463|FG001|Overall Study|Physician Decision|0|||
150157789|NCT03077620|541712464|FG002|Overall Study|Physician Decision|1|||
150157790|NCT03077620|541712465|FG003|Overall Study|Physician Decision|0|||
150157791|NCT03225846|541712466|FG000|Overall Study|Adverse Event|0|||
150157792|NCT03225846|541712467|FG001|Overall Study|Adverse Event|0|||
150157793|NCT03225846|541712468|FG002|Overall Study|Adverse Event|0|||
150157794|NCT03225846|541712469|FG003|Overall Study|Adverse Event|0|||
150157795|NCT03225846|541712470|FG004|Overall Study|Adverse Event|0|||
150157796|NCT03225846|541712471|FG005|Overall Study|Adverse Event|0|||
150157797|NCT03225846|541712472|FG006|Overall Study|Adverse Event|6|||
150157798|NCT03225846|541712466|FG000|Overall Study|Withdrawal by Subject|0|||
150157799|NCT03225846|541712467|FG001|Overall Study|Withdrawal by Subject|1|||
150157800|NCT03225846|541712468|FG002|Overall Study|Withdrawal by Subject|0|||
150157801|NCT03225846|541712469|FG003|Overall Study|Withdrawal by Subject|0|||
150157802|NCT03225846|541712470|FG004|Overall Study|Withdrawal by Subject|0|||
150157803|NCT03225846|541712471|FG005|Overall Study|Withdrawal by Subject|0|||
150157804|NCT03225846|541712472|FG006|Overall Study|Withdrawal by Subject|0|||
150157805|NCT03225846|541712466|FG000|Overall Study|Death|0|||
150157806|NCT03225846|541712467|FG001|Overall Study|Death|1|||
150157807|NCT03225846|541712468|FG002|Overall Study|Death|0|||
150157808|NCT03225846|541712469|FG003|Overall Study|Death|0|||
150157809|NCT03225846|541712470|FG004|Overall Study|Death|0|||
150157810|NCT03225846|541712471|FG005|Overall Study|Death|0|||
150157811|NCT03225846|541712472|FG006|Overall Study|Death|0|||
150157812|NCT03225846|541712466|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157813|NCT03225846|541712467|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157814|NCT03225846|541712468|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
150157815|NCT03225846|541712469|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157816|NCT03225846|541712470|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157817|NCT03225846|541712471|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157818|NCT03225846|541712472|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
150157819|NCT03225846|541712466|FG000|Overall Study|Patient decision|0|||
150157820|NCT03225846|541712467|FG001|Overall Study|Patient decision|0|||
150157821|NCT03225846|541712468|FG002|Overall Study|Patient decision|0|||
150157822|NCT03225846|541712469|FG003|Overall Study|Patient decision|0|||
150157823|NCT03225846|541712470|FG004|Overall Study|Patient decision|0|||
150157824|NCT03225846|541712471|FG005|Overall Study|Patient decision|0|||
150157825|NCT03225846|541712472|FG006|Overall Study|Patient decision|1|||
150157826|NCT04248465|541712473|FG000|Randomized-Controlled Period|Death|12|||
150157827|NCT04248465|541712474|FG001|Randomized-Controlled Period|Death|5|||
150157828|NCT04248465|541712473|FG000|Randomized-Controlled Period|Adverse Event|2|||
150157829|NCT04248465|541712474|FG001|Randomized-Controlled Period|Adverse Event|0|||
150157830|NCT04248465|541712473|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
150157831|NCT04248465|541712474|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
150157832|NCT04248465|541712473|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
150157833|NCT04248465|541712474|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
150157834|NCT04248465|541712473|FG000|Randomized-Controlled Period|Physician Decision|1|||
150157835|NCT04248465|541712474|FG001|Randomized-Controlled Period|Physician Decision|1|||
150157836|NCT04248465|541712473|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
150157837|NCT04248465|541712474|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
150157838|NCT04248465|541712473|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
150157839|NCT04248465|541712474|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
150157840|NCT04248465|541712473|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
150157841|NCT04248465|541712474|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
150157842|NCT01254890|541712475|FG000|Overall Study|Ineligible|0|||
150157843|NCT01254890|541712476|FG001|Overall Study|Ineligible|3|||
150157844|NCT01254890|541712475|FG000|Overall Study|Withdrawal by Subject|1|||
150157845|NCT01254890|541712476|FG001|Overall Study|Withdrawal by Subject|2|||
150157846|NCT01254890|541712475|FG000|Overall Study|Disease Progression|0|||
150157847|NCT01254890|541712476|FG001|Overall Study|Disease Progression|5|||
150157848|NCT00245011|541712485|FG000|Overall Study|Lack of Efficacy|1|||
150157849|NCT00550173|541712486|FG000|Overall Study|Death|45|||
149815964|NCT01889862|540456843|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
149815965|NCT01889862|540456844|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
149815966|NCT01889862|540456845|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
149815967|NCT01889862|540456846|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
149815968|NCT01889862|540456842|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
149815969|NCT01889862|540456843|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
149815970|NCT01889862|540456844|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
149815971|NCT01889862|540456845|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
149815972|NCT01889862|540456846|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
149815973|NCT01889862|540456842|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
149815974|NCT01889862|540456843|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
149815975|NCT01889862|540456844|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
149815976|NCT01889862|540456845|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
149815977|NCT01889862|540456846|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
149815978|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
149815979|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
149815980|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
149815981|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
149815982|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
149815983|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
149815984|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
149815985|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
149815986|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
149815987|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
149815988|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
149815989|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
149815990|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
149815991|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
149815992|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
149815993|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
149815994|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
149815995|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
149815996|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
149815997|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
149815998|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
149815999|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
149816000|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
149816001|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
149816002|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
149816003|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
149816004|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
149816005|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
149816006|NCT00528879|540456847|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
149816007|NCT00528879|540456848|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
149816008|NCT00528879|540456849|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
149816009|NCT00528879|540456850|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
149816010|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
149816011|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
149816012|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
149816013|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
149816014|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
149816015|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
149816016|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
149816017|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
149816018|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
149816019|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
149816020|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
149816021|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
150157850|NCT00550173|541712487|FG001|Overall Study|Death|38|||
150157851|NCT00550173|541712488|FG002|Overall Study|Death|50|||
150157852|NCT00550173|541712486|FG000|Overall Study|Physician Decision|1|||
150157853|NCT00550173|541712487|FG001|Overall Study|Physician Decision|2|||
150157854|NCT00550173|541712488|FG002|Overall Study|Physician Decision|2|||
150157855|NCT00550173|541712486|FG000|Overall Study|Withdrawal by Subject|9|||
150157856|NCT00550173|541712487|FG001|Overall Study|Withdrawal by Subject|12|||
150157857|NCT00550173|541712488|FG002|Overall Study|Withdrawal by Subject|17|||
150157858|NCT00550173|541712486|FG000|Overall Study|Sponsor Decision|13|||
150157859|NCT00550173|541712487|FG001|Overall Study|Sponsor Decision|7|||
150157860|NCT00550173|541712488|FG002|Overall Study|Sponsor Decision|1|||
150157861|NCT00550173|541712486|FG000|Overall Study|Lost to Follow-up|4|||
150157862|NCT00550173|541712487|FG001|Overall Study|Lost to Follow-up|4|||
150157863|NCT00550173|541712488|FG002|Overall Study|Lost to Follow-up|3|||
150157864|NCT00810641|541712496|FG000|Overall Study|Withdrawal by Subject|0|||
150157865|NCT00810641|541712497|FG001|Overall Study|Withdrawal by Subject|1|||
150157866|NCT00810641|541712498|FG002|Overall Study|Withdrawal by Subject|2|||
150157867|NCT01556243|541712499|FG000|Overall Study|Ineligible|34|||
150157868|NCT01556243|541712499|FG000|Overall Study|Converted to mastectomy|14|||
150157869|NCT01556243|541712499|FG000|Overall Study|Unable to achieve negative margins|2|||
150157870|NCT01556243|541712499|FG000|Overall Study|Withdrawal by Subject|16|||
150157871|NCT01388543|541712500|FG000|Day 14|Adverse Event|1|||
150157872|NCT01388543|541712501|FG001|Day 14|Adverse Event|4|||
150157873|NCT02325713|541712504|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157874|NCT02325713|541712505|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157875|NCT02325713|541712506|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157876|NCT02325713|541712507|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157877|NCT02325713|541712508|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157878|NCT02325713|541712509|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157879|NCT02325713|541712510|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157880|NCT02325713|541712511|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157881|NCT02325713|541712512|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157882|NCT02325713|541712513|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157883|NCT02325713|541712514|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
150157884|NCT02325713|541712515|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157885|NCT02325713|541712516|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157886|NCT02325713|541712517|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157887|NCT02325713|541712518|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157888|NCT02325713|541712519|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
150157889|NCT02325713|541712504|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
150157890|NCT02325713|541712505|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157891|NCT02325713|541712506|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157892|NCT02325713|541712507|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157893|NCT02325713|541712508|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157894|NCT02325713|541712509|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157895|NCT02325713|541712510|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157896|NCT02325713|541712511|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157897|NCT02325713|541712512|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157898|NCT02325713|541712513|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157899|NCT02325713|541712514|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157900|NCT02325713|541712515|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157901|NCT02325713|541712516|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157902|NCT02325713|541712517|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157903|NCT02325713|541712518|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157904|NCT02325713|541712519|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
150157905|NCT02325713|541712504|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157906|NCT02325713|541712505|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157907|NCT02325713|541712506|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157908|NCT02325713|541712507|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157909|NCT02325713|541712508|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157910|NCT02325713|541712509|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157911|NCT02325713|541712510|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157912|NCT02325713|541712511|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157913|NCT02325713|541712512|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157914|NCT02325713|541712513|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
150157915|NCT02325713|541712514|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157916|NCT02325713|541712515|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157917|NCT02325713|541712516|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157918|NCT02325713|541712517|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157919|NCT02325713|541712518|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157920|NCT02325713|541712519|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
150157921|NCT01213173|541712521|FG000|Overall Study|Protocol Violation|2|||
150157922|NCT01213173|541712522|FG001|Overall Study|Protocol Violation|0|||
150157923|NCT01213173|541712521|FG000|Overall Study|Adverse Event|4|||
150157924|NCT01213173|541712522|FG001|Overall Study|Adverse Event|8|||
150157925|NCT01213173|541712521|FG000|Overall Study|Withdrawal by Subject|5|||
150157926|NCT01213173|541712522|FG001|Overall Study|Withdrawal by Subject|5|||
150157927|NCT01213173|541712521|FG000|Overall Study|Incorrect Enrollment|1|||
150157928|NCT01213173|541712522|FG001|Overall Study|Incorrect Enrollment|3|||
150157929|NCT02253316|541712523|FG000|Consolidation|Progression|4|||
150157930|NCT02253316|541712524|FG001|Consolidation|Progression|0|||
150157931|NCT02253316|541712525|FG002|Consolidation|Progression|0|||
150157932|NCT02253316|541712523|FG000|Consolidation|Non-Compliance|1|||
150157933|NCT02253316|541712524|FG001|Consolidation|Non-Compliance|0|||
150157934|NCT02253316|541712525|FG002|Consolidation|Non-Compliance|0|||
150157935|NCT02253316|541712523|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
150157936|NCT02253316|541712524|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
150157937|NCT02253316|541712525|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
149816022|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
149816023|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
149816024|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
149816025|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
149816026|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
149816027|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
149816028|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
149816029|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
149816030|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
149816031|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
149816032|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
150157938|NCT02253316|541712523|FG000|Consolidation|Secondary Malignancy|2|||
150157939|NCT02253316|541712524|FG001|Consolidation|Secondary Malignancy|0|||
150157940|NCT02253316|541712525|FG002|Consolidation|Secondary Malignancy|0|||
150157941|NCT02253316|541712523|FG000|Consolidation|Adverse Event|7|||
150157942|NCT02253316|541712524|FG001|Consolidation|Adverse Event|0|||
150157943|NCT02253316|541712525|FG002|Consolidation|Adverse Event|0|||
150157944|NCT02253316|541712523|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
150157945|NCT02253316|541712524|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
150157946|NCT02253316|541712525|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
150157947|NCT02253316|541712523|FG000|Maintenance|Physician Decision|0|||
150157948|NCT02253316|541712524|FG001|Maintenance|Physician Decision|7|||
150157949|NCT02253316|541712525|FG002|Maintenance|Physician Decision|16|||
150157950|NCT02253316|541712523|FG000|Maintenance|Non-Compliance|0|||
150157951|NCT02253316|541712524|FG001|Maintenance|Non-Compliance|1|||
150157952|NCT02253316|541712525|FG002|Maintenance|Non-Compliance|1|||
150157953|NCT02253316|541712523|FG000|Maintenance|Secondary Malignancy|0|||
150157954|NCT02253316|541712524|FG001|Maintenance|Secondary Malignancy|2|||
150157955|NCT02253316|541712525|FG002|Maintenance|Secondary Malignancy|6|||
150157956|NCT02253316|541712523|FG000|Maintenance|Adverse Event|0|||
150157957|NCT02253316|541712524|FG001|Maintenance|Adverse Event|8|||
150157958|NCT02253316|541712525|FG002|Maintenance|Adverse Event|12|||
150157959|NCT02253316|541712523|FG000|Maintenance|Still receiving active treatment|0|||
150157960|NCT02253316|541712524|FG001|Maintenance|Still receiving active treatment|4|||
150157961|NCT02253316|541712525|FG002|Maintenance|Still receiving active treatment|0|||
150157962|NCT02353832|541712526|FG000|Overall Study|Ineligible after enrollment|1|||
150157963|NCT02353832|541712526|FG000|Overall Study|Lost to Follow-up|1|||
150157964|NCT00904150|541712527|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
150157965|NCT00904150|541712528|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
150157966|NCT00904150|541712527|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
150157967|NCT00904150|541712528|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
150157968|NCT05567952|541714015|FG000|Overall Study|Lost to Follow-up|3|||
150157969|NCT05567952|541714016|FG001|Overall Study|Lost to Follow-up|2|||
150157970|NCT05567952|541714015|FG000|Overall Study|Withdrawal by Subject|6|||
150157971|NCT05567952|541714016|FG001|Overall Study|Withdrawal by Subject|3|||
150157972|NCT05567952|541714015|FG000|Overall Study|Other|3|||
150157973|NCT05567952|541714016|FG001|Overall Study|Other|1|||
150157974|NCT03280563|541714018|FG000|Stage 1|Death|2|||
149816033|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
149816034|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
150157975|NCT03280563|541714019|FG001|Stage 1|Death|1|||
150157976|NCT03280563|541714020|FG002|Stage 1|Death|0|||
150157977|NCT03280563|541714021|FG003|Stage 1|Death|0|||
150157978|NCT03280563|541714022|FG004|Stage 1|Death|0|||
150157979|NCT03280563|541714023|FG005|Stage 1|Death|3|||
150157980|NCT03280563|541714024|FG006|Stage 1|Death|0|||
150157981|NCT03280563|541714025|FG007|Stage 1|Death|0|||
150157982|NCT03280563|541714026|FG008|Stage 1|Death|0|||
150157983|NCT03280563|541714018|FG000|Stage 1|Study Ended by Sponsor|0|||
150157984|NCT03280563|541714019|FG001|Stage 1|Study Ended by Sponsor|0|||
150157985|NCT03280563|541714020|FG002|Stage 1|Study Ended by Sponsor|1|||
150157986|NCT03280563|541714021|FG003|Stage 1|Study Ended by Sponsor|0|||
150157987|NCT03280563|541714022|FG004|Stage 1|Study Ended by Sponsor|0|||
150157988|NCT03280563|541714023|FG005|Stage 1|Study Ended by Sponsor|1|||
150157989|NCT03280563|541714024|FG006|Stage 1|Study Ended by Sponsor|0|||
150157990|NCT03280563|541714025|FG007|Stage 1|Study Ended by Sponsor|0|||
150157991|NCT03280563|541714026|FG008|Stage 1|Study Ended by Sponsor|0|||
150157992|NCT03280563|541714018|FG000|Stage 1|Withdrawal by Subject|5|||
150157993|NCT03280563|541714019|FG001|Stage 1|Withdrawal by Subject|1|||
150157994|NCT03280563|541714020|FG002|Stage 1|Withdrawal by Subject|2|||
150157995|NCT03280563|541714021|FG003|Stage 1|Withdrawal by Subject|0|||
150157996|NCT03280563|541714022|FG004|Stage 1|Withdrawal by Subject|0|||
150157997|NCT03280563|541714023|FG005|Stage 1|Withdrawal by Subject|2|||
150157998|NCT03280563|541714024|FG006|Stage 1|Withdrawal by Subject|0|||
150157999|NCT03280563|541714025|FG007|Stage 1|Withdrawal by Subject|0|||
150158000|NCT03280563|541714026|FG008|Stage 1|Withdrawal by Subject|0|||
150158001|NCT03280563|541714018|FG000|Stage 1|Reason Not Specified|0|||
150158002|NCT03280563|541714019|FG001|Stage 1|Reason Not Specified|0|||
150158003|NCT03280563|541714020|FG002|Stage 1|Reason Not Specified|0|||
150158004|NCT03280563|541714021|FG003|Stage 1|Reason Not Specified|0|||
150158005|NCT03280563|541714022|FG004|Stage 1|Reason Not Specified|0|||
150158006|NCT03280563|541714023|FG005|Stage 1|Reason Not Specified|1|||
150158007|NCT03280563|541714024|FG006|Stage 1|Reason Not Specified|0|||
150158008|NCT03280563|541714025|FG007|Stage 1|Reason Not Specified|0|||
150158009|NCT03280563|541714026|FG008|Stage 1|Reason Not Specified|0|||
150158010|NCT03280563|541714018|FG000|Stage 1|Physician Decision|0|||
150158011|NCT03280563|541714019|FG001|Stage 1|Physician Decision|1|||
150158012|NCT03280563|541714020|FG002|Stage 1|Physician Decision|0|||
150158013|NCT03280563|541714021|FG003|Stage 1|Physician Decision|0|||
150158014|NCT03280563|541714022|FG004|Stage 1|Physician Decision|0|||
150158015|NCT03280563|541714023|FG005|Stage 1|Physician Decision|0|||
150158016|NCT03280563|541714024|FG006|Stage 1|Physician Decision|0|||
150158017|NCT03280563|541714025|FG007|Stage 1|Physician Decision|0|||
150158018|NCT03280563|541714026|FG008|Stage 1|Physician Decision|0|||
150158019|NCT03280563|541714018|FG000|Stage 2|Death|0|||
150158020|NCT03280563|541714019|FG001|Stage 2|Death|0|||
150158021|NCT03280563|541714020|FG002|Stage 2|Death|0|||
150158022|NCT03280563|541714021|FG003|Stage 2|Death|0|||
150158023|NCT03280563|541714022|FG004|Stage 2|Death|0|||
150158024|NCT03280563|541714023|FG005|Stage 2|Death|0|||
150158025|NCT03280563|541714024|FG006|Stage 2|Death|0|||
150158026|NCT03280563|541714025|FG007|Stage 2|Death|1|||
150158027|NCT03280563|541714026|FG008|Stage 2|Death|0|||
150158028|NCT03280563|541714018|FG000|Stage 2|Progressive Disease|0|||
150158029|NCT03280563|541714019|FG001|Stage 2|Progressive Disease|0|||
150158030|NCT03280563|541714020|FG002|Stage 2|Progressive Disease|0|||
150158031|NCT03280563|541714021|FG003|Stage 2|Progressive Disease|0|||
150158032|NCT03280563|541714022|FG004|Stage 2|Progressive Disease|0|||
150158033|NCT03280563|541714023|FG005|Stage 2|Progressive Disease|0|||
150158034|NCT03280563|541714024|FG006|Stage 2|Progressive Disease|2|||
150158035|NCT03280563|541714025|FG007|Stage 2|Progressive Disease|0|||
150158036|NCT03280563|541714026|FG008|Stage 2|Progressive Disease|0|||
150158037|NCT03280563|541714018|FG000|Long-term Survival Follow-up|Death|10|||
149816035|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
149816036|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
149816037|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
149816038|NCT00528879|540456847|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
149816039|NCT00528879|540456848|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
149816040|NCT00528879|540456849|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
149816041|NCT00528879|540456850|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
149816042|NCT00078819|540456851|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
149816043|NCT00078819|540456852|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
149816044|NCT00078819|540456853|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
149816045|NCT00078819|540456854|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
149816046|NCT00078819|540456851|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
149816047|NCT00078819|540456852|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
149816048|NCT00078819|540456853|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
149816049|NCT00078819|540456854|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
150158038|NCT03280563|541714019|FG001|Long-term Survival Follow-up|Death|14|||
150158039|NCT03280563|541714020|FG002|Long-term Survival Follow-up|Death|15|||
150158040|NCT03280563|541714021|FG003|Long-term Survival Follow-up|Death|3|||
150158041|NCT03280563|541714022|FG004|Long-term Survival Follow-up|Death|6|||
150158042|NCT03280563|541714023|FG005|Long-term Survival Follow-up|Death|18|||
150158043|NCT03280563|541714024|FG006|Long-term Survival Follow-up|Death|11|||
150158044|NCT03280563|541714025|FG007|Long-term Survival Follow-up|Death|1|||
150158045|NCT03280563|541714026|FG008|Long-term Survival Follow-up|Death|3|||
150158046|NCT03280563|541714018|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
150259499|NCT00321373|542087148|FG001|Overall Study|Lost to Follow-up|0|||
150158047|NCT03280563|541714019|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
149816050|NCT00078819|540456851|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
149816051|NCT00078819|540456852|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
150158048|NCT03280563|541714020|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
150158049|NCT03280563|541714021|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
150158050|NCT03280563|541714022|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
150158051|NCT03280563|541714023|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
150158052|NCT03280563|541714024|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
150158053|NCT03280563|541714025|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
150158054|NCT03280563|541714026|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
150158055|NCT03280563|541714018|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
150158056|NCT03280563|541714019|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
150158057|NCT03280563|541714020|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
150158058|NCT03280563|541714021|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
150158059|NCT03280563|541714022|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
150158060|NCT03280563|541714023|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
150158061|NCT03280563|541714024|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
150158062|NCT03280563|541714025|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
150158063|NCT03280563|541714026|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
150158064|NCT03280563|541714018|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
150158065|NCT03280563|541714019|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
150158066|NCT03280563|541714020|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
150158067|NCT03280563|541714021|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
150158068|NCT03280563|541714022|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
150158069|NCT03280563|541714023|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
150158070|NCT03280563|541714024|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
150158071|NCT03280563|541714025|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
150158072|NCT03280563|541714026|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
150158073|NCT04096365|541714027|FG000|Overall Study|Adverse Event|1|||
150158074|NCT02065245|541714031|FG000|Infusion 1|Lost to Follow-up|0|||
150158075|NCT02065245|541714032|FG001|Infusion 1|Lost to Follow-up|0|||
150158076|NCT02065245|541714033|FG002|Infusion 1|Lost to Follow-up|0|||
150158077|NCT02065245|541714034|FG003|Infusion 1|Lost to Follow-up|0|||
150158078|NCT02065245|541714035|FG004|Infusion 1|Lost to Follow-up|0|||
150158079|NCT02065245|541714036|FG005|Infusion 1|Lost to Follow-up|0|||
150158080|NCT02065245|541714037|FG006|Infusion 1|Lost to Follow-up|1|||
150158081|NCT02065245|541714031|FG000|Infusion 1|Death|0|||
150158082|NCT02065245|541714032|FG001|Infusion 1|Death|0|||
150158083|NCT02065245|541714033|FG002|Infusion 1|Death|1|||
150158084|NCT02065245|541714034|FG003|Infusion 1|Death|0|||
150158085|NCT02065245|541714035|FG004|Infusion 1|Death|1|||
150158086|NCT02065245|541714036|FG005|Infusion 1|Death|0|||
150158087|NCT02065245|541714037|FG006|Infusion 1|Death|0|||
150158088|NCT02065245|541714031|FG000|Infusion 2|Death|0|||
150158089|NCT02065245|541714032|FG001|Infusion 2|Death|0|||
150158090|NCT02065245|541714033|FG002|Infusion 2|Death|0|||
150158091|NCT02065245|541714034|FG003|Infusion 2|Death|0|||
150158092|NCT02065245|541714035|FG004|Infusion 2|Death|0|||
150158093|NCT02065245|541714036|FG005|Infusion 2|Death|0|||
150158094|NCT02065245|541714037|FG006|Infusion 2|Death|1|||
150158095|NCT02065245|541714031|FG000|Infusion 3|Lost to Follow-up|1|||
150158096|NCT02065245|541714032|FG001|Infusion 3|Lost to Follow-up|1|||
150158097|NCT02065245|541714033|FG002|Infusion 3|Lost to Follow-up|0|||
150158098|NCT02065245|541714034|FG003|Infusion 3|Lost to Follow-up|0|||
150158099|NCT02065245|541714035|FG004|Infusion 3|Lost to Follow-up|0|||
150158100|NCT02065245|541714036|FG005|Infusion 3|Lost to Follow-up|0|||
150158101|NCT02065245|541714037|FG006|Infusion 3|Lost to Follow-up|0|||
150158102|NCT01518257|541714038|FG000|Overall Study|Lost to Follow-up|1|||
150158103|NCT01518257|541714039|FG001|Overall Study|Lost to Follow-up|0|||
150158104|NCT01518257|541714038|FG000|Overall Study|Other Miscellaneous Reason|1|||
150158105|NCT01518257|541714039|FG001|Overall Study|Other Miscellaneous Reason|0|||
150158106|NCT02107274|541714040|FG000|Treatment vs. Placebo|Adverse Event|3|||
150158107|NCT02107274|541714041|FG001|Treatment vs. Placebo|Adverse Event|0|||
150158108|NCT02107274|541714040|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
150158109|NCT02107274|541714041|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
150158110|NCT02107274|541714040|FG000|Control Phase|Lost to Follow-up|1|||
150158111|NCT02107274|541714041|FG001|Control Phase|Lost to Follow-up|1|||
150158112|NCT02107274|541714040|FG000|Control Phase|Death|2|||
150158113|NCT02107274|541714041|FG001|Control Phase|Death|0|||
149816052|NCT00078819|540456853|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
150158114|NCT02107274|541714040|FG000|Control Phase|Adverse Event|0|||
150158115|NCT02107274|541714041|FG001|Control Phase|Adverse Event|1|||
150158116|NCT03531905|541714042|FG000|Overall Study|Withdrawal by Subject|3|||
150158117|NCT03531905|541714043|FG001|Overall Study|Withdrawal by Subject|3|||
150158118|NCT03531905|541714044|FG002|Overall Study|Withdrawal by Subject|2|||
150158119|NCT03531905|541714042|FG000|Overall Study|Lost to Follow-up|2|||
149816053|NCT00078819|540456854|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
149816054|NCT00078819|540456851|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
149816055|NCT00078819|540456852|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
149816056|NCT00078819|540456853|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
149816057|NCT00078819|540456854|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
149816058|NCT00078819|540456851|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
149816059|NCT00078819|540456852|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
149816060|NCT00078819|540456853|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
149816061|NCT00078819|540456854|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
149816062|NCT00078819|540456851|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
149816063|NCT00078819|540456852|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
149816064|NCT00078819|540456853|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
149816065|NCT00078819|540456854|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
149816066|NCT00078819|540456851|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
149816067|NCT00078819|540456852|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
149816068|NCT00078819|540456853|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
149816069|NCT00078819|540456854|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
149816070|NCT00078819|540456851|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
149816071|NCT00078819|540456852|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
149816072|NCT00078819|540456853|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
149816073|NCT00078819|540456854|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
149816074|NCT04133519|540456855|FG000|Overall Study|Withdrawal by Subject|5|||
149816075|NCT04133519|540456856|FG001|Overall Study|Withdrawal by Subject|4|||
149816076|NCT04133519|540456855|FG000|Overall Study|Protocol Violation|0|||
149816077|NCT04133519|540456856|FG001|Overall Study|Protocol Violation|1|||
149816078|NCT04133519|540456855|FG000|Overall Study|Never started treatment|1|||
149816079|NCT04133519|540456856|FG001|Overall Study|Never started treatment|1|||
149816080|NCT02217345|540456857|FG000|Overall Study|Lost to Follow-up|2|||
149816081|NCT02217345|540456858|FG001|Overall Study|Lost to Follow-up|1|||
149816082|NCT02217345|540456857|FG000|Overall Study|Withdrawal by Subject|3|||
149816083|NCT02217345|540456858|FG001|Overall Study|Withdrawal by Subject|2|||
149816084|NCT02217345|540456857|FG000|Overall Study|Adverse Event|2|||
149816085|NCT02217345|540456858|FG001|Overall Study|Adverse Event|1|||
149816086|NCT02217345|540456857|FG000|Overall Study|Physician Decision|0|||
149816087|NCT02217345|540456858|FG001|Overall Study|Physician Decision|1|||
149816088|NCT00971204|540456859|FG000|Overall Study|Did not meet all criteria-not treated|14|||
149816089|NCT00971204|540456859|FG000|Overall Study|Lost to Follow-up|10|||
149816090|NCT04130919|540456860|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
149816091|NCT04130919|540456861|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
149816092|NCT04130919|540456862|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
149816093|NCT04130919|540456863|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
149816094|NCT04130919|540456864|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
149816095|NCT04130919|540456865|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
149816096|NCT04130919|540456860|FG000|Blinded Treatment Phase|Adverse Event|0|||
149816097|NCT04130919|540456861|FG001|Blinded Treatment Phase|Adverse Event|0|||
149816098|NCT04130919|540456862|FG002|Blinded Treatment Phase|Adverse Event|1|||
149918974|NCT01090050|540837226|FG000|Overall Study|Lack of Efficacy|1|||
149918975|NCT01090050|540837227|FG001|Overall Study|Lack of Efficacy|5|||
149918976|NCT01090050|540837226|FG000|Overall Study|Physician Decision|0|||
149918977|NCT01090050|540837227|FG001|Overall Study|Physician Decision|1|||
149918978|NCT03539484|540837228|FG000|Overall Study|Death|1|||
149918979|NCT03539484|540837229|FG001|Overall Study|Death|0|||
149918980|NCT03539484|540837230|FG002|Overall Study|Death|0|||
149918981|NCT03539484|540837231|FG003|Overall Study|Death|2|||
149918982|NCT03539484|540837232|FG004|Overall Study|Death|8|||
149918983|NCT03539484|540837233|FG005|Overall Study|Death|3|||
149918984|NCT03539484|540837234|FG006|Overall Study|Death|0|||
149918985|NCT03539484|540837228|FG000|Overall Study|Lost to Follow-up|0|||
150158120|NCT03531905|541714043|FG001|Overall Study|Lost to Follow-up|2|||
150158121|NCT03531905|541714044|FG002|Overall Study|Lost to Follow-up|1|||
150158122|NCT03531905|541714042|FG000|Overall Study|Participant was out of town|1|||
150158123|NCT03531905|541714043|FG001|Overall Study|Participant was out of town|0|||
150158124|NCT03531905|541714044|FG002|Overall Study|Participant was out of town|0|||
150158125|NCT03531905|541714042|FG000|Overall Study|Could not speak with the participant|1|||
150158126|NCT03531905|541714043|FG001|Overall Study|Could not speak with the participant|0|||
150158127|NCT03531905|541714044|FG002|Overall Study|Could not speak with the participant|0|||
149816099|NCT04130919|540456863|FG003|Blinded Treatment Phase|Adverse Event|0|||
149816100|NCT04130919|540456864|FG004|Blinded Treatment Phase|Adverse Event|0|||
149816101|NCT04130919|540456865|FG005|Blinded Treatment Phase|Adverse Event|0|||
149816102|NCT04130919|540456860|FG000|Blinded Treatment Phase|Disease worsening|0|||
149918986|NCT03539484|540837229|FG001|Overall Study|Lost to Follow-up|1|||
149918987|NCT03539484|540837230|FG002|Overall Study|Lost to Follow-up|0|||
149918988|NCT03539484|540837231|FG003|Overall Study|Lost to Follow-up|0|||
150158128|NCT01036087|541714045|FG000|Overall Study|Adverse Event|2|||
150158129|NCT01036087|541714045|FG000|Overall Study|Lack of Efficacy|1|||
150158130|NCT03158948|541714051|FG000|Overall Study|Death|1|||
150158131|NCT03158948|541714052|FG001|Overall Study|Death|1|||
150158132|NCT03158948|541714053|FG002|Overall Study|Death|3|||
150158133|NCT03158948|541714054|FG003|Overall Study|Death|2|||
150158134|NCT03158948|541714051|FG000|Overall Study|Physician Decision|0|||
149816103|NCT04130919|540456861|FG001|Blinded Treatment Phase|Disease worsening|0|||
149816104|NCT04130919|540456862|FG002|Blinded Treatment Phase|Disease worsening|1|||
149816105|NCT04130919|540456863|FG003|Blinded Treatment Phase|Disease worsening|0|||
149816106|NCT04130919|540456864|FG004|Blinded Treatment Phase|Disease worsening|0|||
149816107|NCT04130919|540456865|FG005|Blinded Treatment Phase|Disease worsening|0|||
149816108|NCT04130919|540456860|FG000|Blinded Treatment Phase|Investigator's decision|0|||
149816109|NCT04130919|540456861|FG001|Blinded Treatment Phase|Investigator's decision|1|||
149816110|NCT04130919|540456862|FG002|Blinded Treatment Phase|Investigator's decision|0|||
149816111|NCT04130919|540456863|FG003|Blinded Treatment Phase|Investigator's decision|0|||
149816112|NCT04130919|540456864|FG004|Blinded Treatment Phase|Investigator's decision|0|||
149816113|NCT04130919|540456865|FG005|Blinded Treatment Phase|Investigator's decision|0|||
149816114|NCT04130919|540456860|FG000|Blinded Treatment Phase|Withdrew consent|1|||
149816115|NCT04130919|540456861|FG001|Blinded Treatment Phase|Withdrew consent|0|||
149816116|NCT04130919|540456862|FG002|Blinded Treatment Phase|Withdrew consent|0|||
149816117|NCT04130919|540456863|FG003|Blinded Treatment Phase|Withdrew consent|0|||
149816118|NCT04130919|540456864|FG004|Blinded Treatment Phase|Withdrew consent|0|||
149816119|NCT04130919|540456865|FG005|Blinded Treatment Phase|Withdrew consent|0|||
149816120|NCT04130919|540456860|FG000|Open-label Treatment Phase|Withdrew consent|0|||
149816121|NCT04130919|540456861|FG001|Open-label Treatment Phase|Withdrew consent|0|||
149816122|NCT04130919|540456862|FG002|Open-label Treatment Phase|Withdrew consent|0|||
149816123|NCT04130919|540456863|FG003|Open-label Treatment Phase|Withdrew consent|1|||
149816124|NCT04130919|540456864|FG004|Open-label Treatment Phase|Withdrew consent|1|||
149816125|NCT04130919|540456865|FG005|Open-label Treatment Phase|Withdrew consent|1|||
149816126|NCT04130919|540456860|FG000|Open-label Treatment Phase|Disease worsening|0|||
149816127|NCT04130919|540456861|FG001|Open-label Treatment Phase|Disease worsening|0|||
149816128|NCT04130919|540456862|FG002|Open-label Treatment Phase|Disease worsening|0|||
149816129|NCT04130919|540456863|FG003|Open-label Treatment Phase|Disease worsening|1|||
149816130|NCT04130919|540456864|FG004|Open-label Treatment Phase|Disease worsening|0|||
149816131|NCT04130919|540456865|FG005|Open-label Treatment Phase|Disease worsening|1|||
149816132|NCT04130919|540456860|FG000|Open-label Treatment Phase|Investigator's decision|0|||
149816133|NCT04130919|540456861|FG001|Open-label Treatment Phase|Investigator's decision|0|||
149816134|NCT04130919|540456862|FG002|Open-label Treatment Phase|Investigator's decision|0|||
149816135|NCT04130919|540456863|FG003|Open-label Treatment Phase|Investigator's decision|1|||
149816136|NCT04130919|540456864|FG004|Open-label Treatment Phase|Investigator's decision|0|||
149816137|NCT04130919|540456865|FG005|Open-label Treatment Phase|Investigator's decision|0|||
149816138|NCT04130919|540456860|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
149816139|NCT04130919|540456861|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
149816140|NCT04130919|540456862|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
149816141|NCT04130919|540456863|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
149816142|NCT04130919|540456864|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
149816143|NCT04130919|540456865|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
149816144|NCT04130919|540456860|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
149816145|NCT04130919|540456861|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
149816146|NCT04130919|540456862|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
149816147|NCT04130919|540456863|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
149816148|NCT04130919|540456864|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
149816149|NCT04130919|540456865|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
149816150|NCT00845026|540456866|FG000|Study Period III|Adverse Event|23|||
149816151|NCT00845026|540456867|FG001|Study Period III|Adverse Event|19|||
149816152|NCT00845026|540456866|FG000|Study Period III|Perceived lack of efficacy|27|||
149816153|NCT00845026|540456867|FG001|Study Period III|Perceived lack of efficacy|15|||
149816154|NCT00845026|540456866|FG000|Study Period III|Withdrawal by Subject|19|||
149816155|NCT00845026|540456867|FG001|Study Period III|Withdrawal by Subject|15|||
149816156|NCT00845026|540456866|FG000|Study Period III|Entry Criteria not met|8|||
149816157|NCT00845026|540456867|FG001|Study Period III|Entry Criteria not met|11|||
149816158|NCT00845026|540456866|FG000|Study Period III|Lost to Follow-up|4|||
149816159|NCT00845026|540456867|FG001|Study Period III|Lost to Follow-up|5|||
149816160|NCT00845026|540456866|FG000|Study Period III|Protocol Violation|8|||
149816161|NCT00845026|540456867|FG001|Study Period III|Protocol Violation|1|||
149816162|NCT00845026|540456866|FG000|Study Period III|Scheduled conflict|3|||
149816163|NCT00845026|540456867|FG001|Study Period III|Scheduled conflict|1|||
149816164|NCT00845026|540456866|FG000|Study Period III|Subject is moving or has moved|2|||
149816165|NCT00845026|540456867|FG001|Study Period III|Subject is moving or has moved|4|||
149816166|NCT00845026|540456866|FG000|Study Period III|Transportation issues|1|||
149816167|NCT00845026|540456867|FG001|Study Period III|Transportation issues|1|||
149816168|NCT00845026|540456866|FG000|Study Period IV|Adverse Event|4|||
149816169|NCT00845026|540456867|FG001|Study Period IV|Adverse Event|0|||
149816170|NCT00845026|540456866|FG000|Study Period IV|Perceived lack of efficacy|2|||
149816171|NCT00845026|540456867|FG001|Study Period IV|Perceived lack of efficacy|1|||
149816172|NCT00845026|540456866|FG000|Study Period IV|Protocol Violation|3|||
149816173|NCT00845026|540456867|FG001|Study Period IV|Protocol Violation|1|||
149816174|NCT00845026|540456866|FG000|Study Period IV|Lost to Follow-up|1|||
149816175|NCT00845026|540456867|FG001|Study Period IV|Lost to Follow-up|0|||
149816176|NCT00845026|540456866|FG000|Study Period IV|Withdrawal by Subject|4|||
149816177|NCT00845026|540456867|FG001|Study Period IV|Withdrawal by Subject|1|||
149816178|NCT00845026|540456866|FG000|Study Period IV|Entry Criteria Not Met|1|||
149816179|NCT00845026|540456867|FG001|Study Period IV|Entry Criteria Not Met|0|||
149816180|NCT00845026|540456866|FG000|Study Period IV|Subject is moving or has moved|0|||
149816181|NCT00845026|540456867|FG001|Study Period IV|Subject is moving or has moved|1|||
149816182|NCT00845026|540456866|FG000|Study Period IV|Scheduling conflict|1|||
149816183|NCT00845026|540456867|FG001|Study Period IV|Scheduling conflict|0|||
149816184|NCT01749033|540456872|FG000|Overall Study|Did not receive allocated intervention|3|||
149816185|NCT01749033|540456873|FG001|Overall Study|Did not receive allocated intervention|3|||
149816186|NCT01749033|540456874|FG002|Overall Study|Did not receive allocated intervention|0|||
149816187|NCT01749033|540456872|FG000|Overall Study|Lost to Follow-up|0|||
149816188|NCT01749033|540456873|FG001|Overall Study|Lost to Follow-up|2|||
149816189|NCT01749033|540456874|FG002|Overall Study|Lost to Follow-up|1|||
149816190|NCT01364298|540456877|FG000|Overall Study|Adverse Event|3|||
149816191|NCT01364298|540456878|FG001|Overall Study|Adverse Event|4|||
149816192|NCT01364298|540456877|FG000|Overall Study|Lack of adherence to treatment|1|||
149816193|NCT01364298|540456878|FG001|Overall Study|Lack of adherence to treatment|3|||
149816194|NCT01364298|540456877|FG000|Overall Study|Lack of Efficacy|1|||
149816195|NCT01364298|540456878|FG001|Overall Study|Lack of Efficacy|0|||
149816196|NCT01364298|540456877|FG000|Overall Study|Lost to Follow-up|5|||
149816197|NCT01364298|540456878|FG001|Overall Study|Lost to Follow-up|10|||
149816198|NCT01364298|540456877|FG000|Overall Study|Withdrawal by Subject|3|||
149816199|NCT01364298|540456878|FG001|Overall Study|Withdrawal by Subject|3|||
149816200|NCT01364298|540456877|FG000|Overall Study|Other|1|||
149816201|NCT01364298|540456878|FG001|Overall Study|Other|3|||
149816202|NCT03550794|540456881|FG000|Overall Study|No longer met inclusion criteria|1|||
149816203|NCT03550794|540456882|FG001|Overall Study|No longer met inclusion criteria|2|||
149816204|NCT03550794|540456881|FG000|Overall Study|Goals of care changed|1|||
149816205|NCT03550794|540456882|FG001|Overall Study|Goals of care changed|0|||
149816206|NCT03550794|540456881|FG000|Overall Study|Withdrawal by Subject|2|||
149816207|NCT03550794|540456882|FG001|Overall Study|Withdrawal by Subject|0|||
149816208|NCT03550794|540456881|FG000|Overall Study|Death|0|||
149816209|NCT03550794|540456882|FG001|Overall Study|Death|1|||
149816210|NCT01864525|540456883|FG000|Overall Study|Adverse Event|1|||
149816211|NCT01864525|540456884|FG001|Overall Study|Adverse Event|0|||
149816212|NCT01890785|540456885|FG000|Third Intervention|Withdrawal by Subject|0|||
149816213|NCT01890785|540456886|FG001|Third Intervention|Withdrawal by Subject|1|||
149816214|NCT01890785|540456887|FG002|Third Intervention|Withdrawal by Subject|0|||
149816215|NCT01890785|540456888|FG003|Third Intervention|Withdrawal by Subject|0|||
149816216|NCT01890785|540456889|FG004|Third Intervention|Withdrawal by Subject|0|||
149816217|NCT01890785|540456890|FG005|Third Intervention|Withdrawal by Subject|0|||
149816218|NCT03296553|540456891|FG000|Overall Study|Withdrawal by Subject|1|||
149816219|NCT03296553|540456892|FG001|Overall Study|Withdrawal by Subject|1|||
149816220|NCT03296553|540456891|FG000|Overall Study|Death|1|||
149816221|NCT03296553|540456892|FG001|Overall Study|Death|0|||
149816222|NCT00065065|540456893|FG000|Overall Study|Adverse Event|3|||
149816223|NCT00065065|540456894|FG001|Overall Study|Adverse Event|2|||
149816224|NCT00065065|540456893|FG000|Overall Study|Withdrawal by Subject|1|||
149816225|NCT00065065|540456894|FG001|Overall Study|Withdrawal by Subject|5|||
149816226|NCT00065065|540456893|FG000|Overall Study|Lack of Efficacy|4|||
149816227|NCT00065065|540456894|FG001|Overall Study|Lack of Efficacy|11|||
149816228|NCT00065065|540456893|FG000|Overall Study|Other|2|||
149816229|NCT00065065|540456894|FG001|Overall Study|Other|2|||
150158135|NCT03158948|541714052|FG001|Overall Study|Physician Decision|0|||
149816230|NCT04363736|540456895|FG000|Overall Study|Withdrawal by Subject|1|||
149816231|NCT04363736|540456896|FG001|Overall Study|Withdrawal by Subject|0|||
149816232|NCT04363736|540456895|FG000|Overall Study|Lost to Follow-up|10|||
149816233|NCT04363736|540456896|FG001|Overall Study|Lost to Follow-up|7|||
149816234|NCT04363736|540456895|FG000|Overall Study|Death|8|||
149816235|NCT04363736|540456896|FG001|Overall Study|Death|6|||
149816236|NCT01050673|540456897|FG000|Overall Study|Physician Decision|4|||
149816237|NCT01050673|540456898|FG001|Overall Study|Physician Decision|5|||
149816238|NCT01458119|540456899|FG000|Overall Study|Physician Decision|4|||
149816239|NCT01458119|540456899|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
149816240|NCT01458119|540456899|FG000|Overall Study|Pregnancy|1|||
149816241|NCT01458119|540456899|FG000|Overall Study|Death|2|||
149816242|NCT01458119|540456899|FG000|Overall Study|Adverse Event|1|||
149816243|NCT01458119|540456899|FG000|Overall Study|Consent Withdrawn by Participant|8|||
149816244|NCT01458119|540456899|FG000|Overall Study|Non-compliance With Study Drug|3|||
149816245|NCT03033069|540456900|FG000|Overall Study|Adverse Event|6|||
149816246|NCT03033069|540456901|FG001|Overall Study|Adverse Event|7|||
149816247|NCT03033069|540456902|FG002|Overall Study|Adverse Event|4|||
149816248|NCT03033069|540456903|FG003|Overall Study|Adverse Event|6|||
149816249|NCT03033069|540456900|FG000|Overall Study|Lack of Efficacy|0|||
149816250|NCT03033069|540456901|FG001|Overall Study|Lack of Efficacy|0|||
149816251|NCT03033069|540456902|FG002|Overall Study|Lack of Efficacy|1|||
149816252|NCT03033069|540456903|FG003|Overall Study|Lack of Efficacy|0|||
149816253|NCT03033069|540456900|FG000|Overall Study|Lost to Follow-up|6|||
149816254|NCT03033069|540456901|FG001|Overall Study|Lost to Follow-up|5|||
149816255|NCT03033069|540456902|FG002|Overall Study|Lost to Follow-up|5|||
149816256|NCT03033069|540456903|FG003|Overall Study|Lost to Follow-up|6|||
149816257|NCT03033069|540456900|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149816258|NCT03033069|540456901|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149816259|NCT03033069|540456902|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149816260|NCT03033069|540456903|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149816261|NCT03033069|540456900|FG000|Overall Study|Protocol Deviation|0|||
149816262|NCT03033069|540456901|FG001|Overall Study|Protocol Deviation|1|||
149816263|NCT03033069|540456902|FG002|Overall Study|Protocol Deviation|0|||
149816264|NCT03033069|540456903|FG003|Overall Study|Protocol Deviation|0|||
149816265|NCT03033069|540456900|FG000|Overall Study|Withdrawal by Subject|10|||
149816266|NCT03033069|540456901|FG001|Overall Study|Withdrawal by Subject|10|||
149816267|NCT03033069|540456902|FG002|Overall Study|Withdrawal by Subject|11|||
149816268|NCT03033069|540456903|FG003|Overall Study|Withdrawal by Subject|6|||
149816269|NCT03033069|540456900|FG000|Overall Study|Withdrawal By Caregiver|1|||
149816270|NCT03033069|540456901|FG001|Overall Study|Withdrawal By Caregiver|0|||
149816271|NCT03033069|540456902|FG002|Overall Study|Withdrawal By Caregiver|0|||
149816272|NCT03033069|540456903|FG003|Overall Study|Withdrawal By Caregiver|0|||
149816273|NCT03033069|540456900|FG000|Overall Study|Reason not Specified|0|||
149816274|NCT03033069|540456901|FG001|Overall Study|Reason not Specified|1|||
149816275|NCT03033069|540456902|FG002|Overall Study|Reason not Specified|0|||
149816276|NCT03033069|540456903|FG003|Overall Study|Reason not Specified|1|||
149816277|NCT00789828|540456906|FG000|Core Period (48 Weeks)|Administrative problems|0|||
149816278|NCT00789828|540456907|FG001|Core Period (48 Weeks)|Administrative problems|1|||
149816279|NCT00789828|540456906|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
149918989|NCT03539484|540837232|FG004|Overall Study|Lost to Follow-up|1|||
149918990|NCT03539484|540837233|FG005|Overall Study|Lost to Follow-up|0|||
149918991|NCT03539484|540837234|FG006|Overall Study|Lost to Follow-up|0|||
150158136|NCT03158948|541714053|FG002|Overall Study|Physician Decision|0|||
150158137|NCT03158948|541714054|FG003|Overall Study|Physician Decision|1|||
150158138|NCT04730947|541714055|FG000|Overall Study|Withdrawal by Subject|0|||
150158139|NCT04730947|541714056|FG001|Overall Study|Withdrawal by Subject|1|||
150158140|NCT01033643|541714057|FG000|Overall Study|Withdrew Consent|0|||
150158141|NCT01033643|541714058|FG001|Overall Study|Withdrew Consent|3|||
150158142|NCT01033643|541714059|FG002|Overall Study|Withdrew Consent|0|||
150158143|NCT01033643|541714060|FG003|Overall Study|Withdrew Consent|0|||
150158144|NCT01033643|541714061|FG004|Overall Study|Withdrew Consent|0|||
150158145|NCT01033643|541714062|FG005|Overall Study|Withdrew Consent|1|||
150158146|NCT01625338|541714063|FG000|Overall Study|Enrolled but not Treated|0|||
150158147|NCT01625338|541714064|FG001|Overall Study|Enrolled but not Treated|0|||
150158148|NCT01625338|541714065|FG002|Overall Study|Enrolled but not Treated|1|||
150158149|NCT01625338|541714063|FG000|Overall Study|Efficacy Failure|27|||
150158150|NCT01625338|541714064|FG001|Overall Study|Efficacy Failure|39|||
150158151|NCT01625338|541714065|FG002|Overall Study|Efficacy Failure|31|||
150158152|NCT01625338|541714063|FG000|Overall Study|Lost to Follow-up|3|||
150158153|NCT01625338|541714064|FG001|Overall Study|Lost to Follow-up|3|||
150158154|NCT01625338|541714065|FG002|Overall Study|Lost to Follow-up|2|||
150158155|NCT01625338|541714063|FG000|Overall Study|Investigator Decision|0|||
150158156|NCT01625338|541714064|FG001|Overall Study|Investigator Decision|2|||
150158157|NCT01625338|541714065|FG002|Overall Study|Investigator Decision|1|||
150158158|NCT01625338|541714063|FG000|Overall Study|Subject Withdrew Consent|1|||
150158159|NCT01625338|541714064|FG001|Overall Study|Subject Withdrew Consent|0|||
150158160|NCT01625338|541714065|FG002|Overall Study|Subject Withdrew Consent|2|||
150158161|NCT01625338|541714063|FG000|Overall Study|Adverse Event|1|||
150158162|NCT01625338|541714064|FG001|Overall Study|Adverse Event|0|||
150158163|NCT01625338|541714065|FG002|Overall Study|Adverse Event|1|||
149816280|NCT00789828|540456907|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
149816281|NCT00789828|540456906|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
149816282|NCT00789828|540456907|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
149816283|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
150158164|NCT01625338|541714063|FG000|Overall Study|Study Discontinued by Sponsor|0|||
150158165|NCT01625338|541714064|FG001|Overall Study|Study Discontinued by Sponsor|0|||
150259500|NCT00321373|542087149|FG002|Overall Study|Lost to Follow-up|1|||
149816284|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
149816285|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
149918992|NCT03539484|540837228|FG000|Overall Study|Withdrawal by Subject|0|||
149918993|NCT03539484|540837229|FG001|Overall Study|Withdrawal by Subject|0|||
149918994|NCT03539484|540837230|FG002|Overall Study|Withdrawal by Subject|0|||
149918995|NCT03539484|540837231|FG003|Overall Study|Withdrawal by Subject|0|||
149918996|NCT03539484|540837232|FG004|Overall Study|Withdrawal by Subject|2|||
149918997|NCT03539484|540837233|FG005|Overall Study|Withdrawal by Subject|0|||
149918998|NCT03539484|540837234|FG006|Overall Study|Withdrawal by Subject|1|||
149918999|NCT03539484|540837228|FG000|Overall Study|Study Terminated by Sponsor|0|||
149919000|NCT03539484|540837229|FG001|Overall Study|Study Terminated by Sponsor|0|||
149919001|NCT03539484|540837230|FG002|Overall Study|Study Terminated by Sponsor|1|||
149919002|NCT03539484|540837231|FG003|Overall Study|Study Terminated by Sponsor|1|||
149919003|NCT03539484|540837232|FG004|Overall Study|Study Terminated by Sponsor|2|||
149919004|NCT03539484|540837233|FG005|Overall Study|Study Terminated by Sponsor|2|||
149919005|NCT03539484|540837234|FG006|Overall Study|Study Terminated by Sponsor|1|||
149919006|NCT02232061|540837235|FG000|Overall Study|Administrative problems|1|||
149919007|NCT02232061|540837235|FG000|Overall Study|Withdrawal by Subject|1|||
149919008|NCT00571103|540837236|FG000|Overall Study|Withdrawal by Subject|1|||
149919009|NCT00571103|540837236|FG000|Overall Study|Lost to Follow-up|1|||
149919010|NCT00564278|540837238|FG000|Overall Study|Lost to Follow-up|35|||
149919011|NCT00564278|540837239|FG001|Overall Study|Lost to Follow-up|33|||
149919012|NCT00564278|540837238|FG000|Overall Study|Physician Decision|1|||
149919013|NCT00564278|540837239|FG001|Overall Study|Physician Decision|2|||
149919014|NCT00564278|540837238|FG000|Overall Study|Withdrawal by Subject|11|||
149919015|NCT00564278|540837239|FG001|Overall Study|Withdrawal by Subject|7|||
150158166|NCT01625338|541714065|FG002|Overall Study|Study Discontinued by Sponsor|1|||
150158167|NCT00354029|541714068|FG000|Overall Study|Protocol Violation|4|||
150158168|NCT00354029|541714069|FG001|Overall Study|Protocol Violation|2|||
150158169|NCT01021332|541714070|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
150158170|NCT01021332|541714070|FG000|Overall Study|Adverse Event|43|||
150158171|NCT01021332|541714070|FG000|Overall Study|Lack of Efficacy|19|||
150158172|NCT01021332|541714070|FG000|Overall Study|Withdrawal of Consent|23|||
150158173|NCT01021332|541714070|FG000|Overall Study|Lost to Follow-up|4|||
150158174|NCT01021332|541714070|FG000|Overall Study|Protocol Violation|9|||
150158175|NCT01021332|541714070|FG000|Overall Study|Miscellaneous|3|||
150158176|NCT01349907|541714083|FG000|Overall Study|Adverse Event|37|||
150158177|NCT01349907|541714084|FG001|Overall Study|Adverse Event|11|||
150158178|NCT01349907|541714083|FG000|Overall Study|Treatment failure|13|||
149816286|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
149816287|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
149816288|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
149816289|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
149816290|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
149816291|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Death|1|||
149816292|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Death|0|||
149816293|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
149816294|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
149816295|NCT00789828|540456906|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
149816296|NCT00789828|540456907|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
149816297|NCT02623426|540456908|FG000|Overall Study|Lost to Follow-up|0|||
149816298|NCT02623426|540456909|FG001|Overall Study|Lost to Follow-up|0|||
149816299|NCT02623426|540456910|FG002|Overall Study|Lost to Follow-up|1|||
149816300|NCT02623426|540456908|FG000|Overall Study|Withdrawal by Subject|1|||
149816301|NCT02623426|540456909|FG001|Overall Study|Withdrawal by Subject|2|||
149816302|NCT02623426|540456910|FG002|Overall Study|Withdrawal by Subject|2|||
149816303|NCT02094937|540456911|FG000|8 Weeks in Period 1|Adverse Event|9|||
149816304|NCT02094937|540456912|FG001|8 Weeks in Period 1|Adverse Event|0|||
149816305|NCT02094937|540456913|FG002|8 Weeks in Period 1|Adverse Event|0|||
149816306|NCT02094937|540456914|FG003|8 Weeks in Period 1|Adverse Event|0|||
149816307|NCT02094937|540456911|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
149816308|NCT02094937|540456912|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
149816309|NCT02094937|540456913|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
149816310|NCT02094937|540456914|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
149816311|NCT02094937|540456911|FG000|8 Weeks in Period 1|Protocol Violation|2|||
149816312|NCT02094937|540456912|FG001|8 Weeks in Period 1|Protocol Violation|0|||
149816313|NCT02094937|540456913|FG002|8 Weeks in Period 1|Protocol Violation|0|||
149816314|NCT02094937|540456914|FG003|8 Weeks in Period 1|Protocol Violation|0|||
149919016|NCT00560703|540837240|FG000|Overall Study|Adverse Event|0|||
149919017|NCT00560703|540837241|FG001|Overall Study|Adverse Event|2|||
149919018|NCT00560703|540837240|FG000|Overall Study|Protocol Violation|0|||
149919019|NCT00560703|540837241|FG001|Overall Study|Protocol Violation|2|||
149919020|NCT00560703|540837240|FG000|Overall Study|Withdrawal by Subject|0|||
149919021|NCT00560703|540837241|FG001|Overall Study|Withdrawal by Subject|1|||
149919022|NCT00560703|540837240|FG000|Overall Study|non-compliance|0|||
150158179|NCT01349907|541714084|FG001|Overall Study|Treatment failure|4|||
150158180|NCT01349907|541714083|FG000|Overall Study|Lost to Follow-up|25|||
150158181|NCT01349907|541714084|FG001|Overall Study|Lost to Follow-up|6|||
150158182|NCT01349907|541714083|FG000|Overall Study|Withdrawal by Subject|30|||
150158183|NCT01349907|541714084|FG001|Overall Study|Withdrawal by Subject|8|||
150158184|NCT01349907|541714083|FG000|Overall Study|Protocol Violation|33|||
150158185|NCT01349907|541714084|FG001|Overall Study|Protocol Violation|13|||
150158186|NCT01349907|541714083|FG000|Overall Study|Administrative|1|||
150158187|NCT01349907|541714084|FG001|Overall Study|Administrative|1|||
150158188|NCT01310868|541714087|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
150158189|NCT01628874|541714094|FG000|Overall Study|Physician Decision|1|||
150158190|NCT01628874|541714095|FG001|Overall Study|Physician Decision|1|||
150158191|NCT01628874|541714094|FG000|Overall Study|Age >4 months|4|||
150259501|NCT00321373|542087147|FG000|Overall Study|Withdrawal by Subject|1|||
149816315|NCT02094937|540456911|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
149816316|NCT02094937|540456912|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
149816317|NCT02094937|540456913|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
149816318|NCT02094937|540456914|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
149816319|NCT02094937|540456911|FG000|8 Weeks in Period 1|Physician Decision|1|||
149816320|NCT02094937|540456912|FG001|8 Weeks in Period 1|Physician Decision|0|||
149816321|NCT02094937|540456913|FG002|8 Weeks in Period 1|Physician Decision|0|||
149816322|NCT02094937|540456914|FG003|8 Weeks in Period 1|Physician Decision|0|||
149816323|NCT02094937|540456911|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
149816324|NCT02094937|540456912|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
149816325|NCT02094937|540456913|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
149816326|NCT02094937|540456914|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
149816327|NCT02094937|540456911|FG000|12 Weeks in Period 2|Adverse Event|0|||
149816328|NCT02094937|540456912|FG001|12 Weeks in Period 2|Adverse Event|2|||
149816329|NCT02094937|540456913|FG002|12 Weeks in Period 2|Adverse Event|4|||
149816330|NCT02094937|540456914|FG003|12 Weeks in Period 2|Adverse Event|1|||
149816331|NCT02094937|540456911|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
149816332|NCT02094937|540456912|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
149816333|NCT02094937|540456913|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
149816334|NCT02094937|540456914|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
149816335|NCT02094937|540456911|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
149816336|NCT02094937|540456912|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
149816337|NCT02094937|540456913|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
149816338|NCT02094937|540456914|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
149816339|NCT02094937|540456911|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
149816340|NCT02094937|540456912|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
149816341|NCT02094937|540456913|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
149816342|NCT02094937|540456914|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
149816343|NCT02094937|540456911|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
149816344|NCT02094937|540456912|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
149816345|NCT02094937|540456913|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
149816346|NCT02094937|540456914|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
149816347|NCT00555399|540456915|FG000|Overall Study|Withdrawal by Subject|0|||
149816348|NCT00555399|540456916|FG001|Overall Study|Withdrawal by Subject|0|||
149816349|NCT00555399|540456917|FG002|Overall Study|Withdrawal by Subject|1|||
149816350|NCT00555399|540456918|FG003|Overall Study|Withdrawal by Subject|0|||
149816351|NCT00555399|540456919|FG004|Overall Study|Withdrawal by Subject|0|||
149816352|NCT00555399|540456920|FG005|Overall Study|Withdrawal by Subject|0|||
149816353|NCT00555399|540456921|FG006|Overall Study|Withdrawal by Subject|0|||
149816354|NCT00555399|540456922|FG007|Overall Study|Withdrawal by Subject|0|||
149816355|NCT00555399|540456923|FG008|Overall Study|Withdrawal by Subject|0|||
149816356|NCT00555399|540456924|FG009|Overall Study|Withdrawal by Subject|0|||
149816357|NCT00555399|540456925|FG010|Overall Study|Withdrawal by Subject|0|||
149816358|NCT00555399|540456926|FG011|Overall Study|Withdrawal by Subject|1|||
149816359|NCT00555399|540456915|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
149816360|NCT00555399|540456916|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
149816361|NCT00555399|540456917|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
149816362|NCT00555399|540456918|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
149816363|NCT00555399|540456919|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
149816364|NCT00555399|540456920|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
149816365|NCT00555399|540456921|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
149816366|NCT00555399|540456922|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
149816367|NCT00555399|540456923|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
149816368|NCT00555399|540456924|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
149816369|NCT00555399|540456925|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
149816370|NCT00555399|540456926|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
149816371|NCT05458895|540456927|FG000|Overall Study|Withdrawal by Subject|8|||
150158192|NCT01628874|541714095|FG001|Overall Study|Age >4 months|2|||
150158193|NCT00873093|541714096|FG000|Overall Study|Adverse Event|0|||
150259502|NCT00321373|542087148|FG001|Overall Study|Withdrawal by Subject|0|||
149919023|NCT00560703|540837241|FG001|Overall Study|non-compliance|1|||
149919024|NCT06439095|540837242|FG000|Overall Study|Lost to Follow-up|2|||
149919025|NCT03484403|540837244|FG000|Overall Study|Withdrawal by Subject|6|||
149919026|NCT03484403|540837245|FG001|Overall Study|Withdrawal by Subject|4|||
149919027|NCT04278924|540837246|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
149919028|NCT04278924|540837247|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
149919029|NCT04278924|540837248|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
149919030|NCT04278924|540837249|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
149919031|NCT04278924|540837250|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
149919032|NCT04278924|540837251|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
149919033|NCT04278924|540837252|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
149919034|NCT04278924|540837246|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919035|NCT04278924|540837247|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
149919036|NCT04278924|540837248|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919037|NCT04278924|540837249|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919038|NCT04278924|540837250|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919039|NCT04278924|540837251|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919040|NCT04278924|540837252|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
149919041|NCT04847232|540837253|FG000|Overall Study|Death|123|||
149919042|NCT04847232|540837254|FG001|Overall Study|Death|115|||
149919043|NCT04847232|540837253|FG000|Overall Study|Lost to Follow-up|3|||
149919044|NCT04847232|540837254|FG001|Overall Study|Lost to Follow-up|10|||
149919045|NCT04847232|540837253|FG000|Overall Study|Withdrawal by Subject|73|||
149919046|NCT04847232|540837254|FG001|Overall Study|Withdrawal by Subject|101|||
150158194|NCT00873093|541714097|FG001|Overall Study|Adverse Event|2|||
150158195|NCT00873093|541714098|FG002|Overall Study|Adverse Event|0|||
150158196|NCT00873093|541714099|FG003|Overall Study|Adverse Event|0|||
150158197|NCT00873093|541714100|FG004|Overall Study|Adverse Event|0|||
150158198|NCT00873093|541714096|FG000|Overall Study|Death|0|||
149919047|NCT04847232|540837253|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
150158199|NCT00873093|541714097|FG001|Overall Study|Death|3|||
150158200|NCT00873093|541714098|FG002|Overall Study|Death|2|||
150158201|NCT00873093|541714099|FG003|Overall Study|Death|0|||
150158202|NCT00873093|541714100|FG004|Overall Study|Death|0|||
150158203|NCT00873093|541714096|FG000|Overall Study|Physician Decision|0|||
150158204|NCT00873093|541714097|FG001|Overall Study|Physician Decision|17|||
150158205|NCT00873093|541714098|FG002|Overall Study|Physician Decision|10|||
150158206|NCT00873093|541714099|FG003|Overall Study|Physician Decision|10|||
150158207|NCT00873093|541714100|FG004|Overall Study|Physician Decision|2|||
150158208|NCT00873093|541714096|FG000|Overall Study|Withdrawal by Subject|1|||
150158209|NCT00873093|541714097|FG001|Overall Study|Withdrawal by Subject|4|||
150158210|NCT00873093|541714098|FG002|Overall Study|Withdrawal by Subject|4|||
150158211|NCT00873093|541714099|FG003|Overall Study|Withdrawal by Subject|0|||
150158212|NCT00873093|541714100|FG004|Overall Study|Withdrawal by Subject|0|||
150158213|NCT00873093|541714096|FG000|Overall Study|Ineligible|0|||
150158214|NCT00873093|541714097|FG001|Overall Study|Ineligible|1|||
150158215|NCT00873093|541714098|FG002|Overall Study|Ineligible|0|||
150158216|NCT00873093|541714099|FG003|Overall Study|Ineligible|1|||
150158217|NCT00873093|541714100|FG004|Overall Study|Ineligible|0|||
150158218|NCT00146640|541714103|FG000|Overall Study|Adverse Event|12|||
150158219|NCT00146640|541714104|FG001|Overall Study|Adverse Event|10|||
150158220|NCT00146640|541714103|FG000|Overall Study|Medical Reasons|3|||
150158221|NCT00146640|541714104|FG001|Overall Study|Medical Reasons|0|||
150158222|NCT00146640|541714103|FG000|Overall Study|Non-Medical Reasons|8|||
150158223|NCT00146640|541714104|FG001|Overall Study|Non-Medical Reasons|4|||
150158224|NCT02059161|541714105|FG000|Overall Study|Pregnancy|0|||
150158225|NCT02059161|541714106|FG001|Overall Study|Pregnancy|2|||
150158226|NCT02059161|541714105|FG000|Overall Study|Adverse Event|2|||
150158227|NCT02059161|541714106|FG001|Overall Study|Adverse Event|6|||
150158228|NCT02059161|541714105|FG000|Overall Study|Lost to Follow-up|20|||
150158229|NCT02059161|541714106|FG001|Overall Study|Lost to Follow-up|12|||
150158230|NCT02059161|541714105|FG000|Overall Study|Physician Decision|4|||
150158231|NCT02059161|541714106|FG001|Overall Study|Physician Decision|4|||
150158232|NCT02059161|541714105|FG000|Overall Study|Protocol Violation|1|||
149919048|NCT04847232|540837254|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
149919049|NCT02476916|540837255|FG000|Core Period|Adverse Event|2|||
150158233|NCT02059161|541714106|FG001|Overall Study|Protocol Violation|1|||
150158234|NCT02059161|541714105|FG000|Overall Study|Withdrawal by Subject|16|||
150158235|NCT02059161|541714106|FG001|Overall Study|Withdrawal by Subject|13|||
150158236|NCT02059161|541714105|FG000|Overall Study|Randomized in error, no study drug|0|||
150158237|NCT02059161|541714106|FG001|Overall Study|Randomized in error, no study drug|1|||
150158238|NCT02059161|541714105|FG000|Overall Study|Non-compliance with study drug|6|||
150158239|NCT02059161|541714106|FG001|Overall Study|Non-compliance with study drug|2|||
150158240|NCT01723826|541714110|FG000|Overall Study|Adverse Event|4|||
150158241|NCT01723826|541714111|FG001|Overall Study|Adverse Event|1|||
150158242|NCT01723826|541714112|FG002|Overall Study|Adverse Event|4|||
150158243|NCT01723826|541714113|FG003|Overall Study|Adverse Event|5|||
149919050|NCT02476916|540837256|FG001|Core Period|Adverse Event|2|||
149919051|NCT02476916|540837255|FG000|Core Period|Investigator decision|1|||
149919052|NCT02476916|540837256|FG001|Core Period|Investigator decision|1|||
149919053|NCT02476916|540837255|FG000|Core Period|Withdrawal by Subject|3|||
149919054|NCT02476916|540837256|FG001|Core Period|Withdrawal by Subject|0|||
149919055|NCT02476916|540837255|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
149919056|NCT02476916|540837256|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
149919057|NCT02476916|540837255|FG000|Extension Period|On Treatment|12|||
149919058|NCT02476916|540837256|FG001|Extension Period|On Treatment|17|||
149919059|NCT05600036|540837258|FG000|Overall Study|Adverse Event|0|||
149919060|NCT05600036|540837259|FG001|Overall Study|Adverse Event|2|||
149919061|NCT05600036|540837260|FG002|Overall Study|Adverse Event|1|||
149919062|NCT05600036|540837261|FG003|Overall Study|Adverse Event|0|||
149919063|NCT05600036|540837262|FG004|Overall Study|Adverse Event|1|||
149919064|NCT05600036|540837263|FG005|Overall Study|Adverse Event|0|||
149919065|NCT05600036|540837258|FG000|Overall Study|Lost to Follow-up|0|||
149919066|NCT05600036|540837259|FG001|Overall Study|Lost to Follow-up|2|||
149919067|NCT05600036|540837260|FG002|Overall Study|Lost to Follow-up|1|||
149919068|NCT05600036|540837261|FG003|Overall Study|Lost to Follow-up|1|||
149919069|NCT05600036|540837262|FG004|Overall Study|Lost to Follow-up|0|||
149919070|NCT05600036|540837263|FG005|Overall Study|Lost to Follow-up|0|||
149919071|NCT05600036|540837258|FG000|Overall Study|Protocol Violation|0|||
149919072|NCT05600036|540837259|FG001|Overall Study|Protocol Violation|0|||
149919073|NCT05600036|540837260|FG002|Overall Study|Protocol Violation|2|||
149919074|NCT05600036|540837261|FG003|Overall Study|Protocol Violation|0|||
149919075|NCT05600036|540837262|FG004|Overall Study|Protocol Violation|0|||
149919076|NCT05600036|540837263|FG005|Overall Study|Protocol Violation|0|||
149919077|NCT05600036|540837258|FG000|Overall Study|Withdrawal by Subject|0|||
149919078|NCT05600036|540837259|FG001|Overall Study|Withdrawal by Subject|1|||
149919079|NCT05600036|540837260|FG002|Overall Study|Withdrawal by Subject|2|||
149919080|NCT05600036|540837261|FG003|Overall Study|Withdrawal by Subject|0|||
149919081|NCT05600036|540837262|FG004|Overall Study|Withdrawal by Subject|3|||
149919082|NCT05600036|540837263|FG005|Overall Study|Withdrawal by Subject|5|||
149919083|NCT05600036|540837258|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
149919084|NCT05600036|540837259|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
149919085|NCT05600036|540837260|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
149919086|NCT05600036|540837261|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
149919087|NCT05600036|540837262|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
149919088|NCT05600036|540837263|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
149919089|NCT05600036|540837258|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
150158244|NCT01723826|541714110|FG000|Overall Study|Death according to AE eCRF|2|||
150158245|NCT01723826|541714111|FG001|Overall Study|Death according to AE eCRF|3|||
150158246|NCT01723826|541714112|FG002|Overall Study|Death according to AE eCRF|3|||
150158247|NCT01723826|541714113|FG003|Overall Study|Death according to AE eCRF|7|||
150158248|NCT01723826|541714110|FG000|Overall Study|Lost to Follow-up|1|||
150158249|NCT01723826|541714111|FG001|Overall Study|Lost to Follow-up|3|||
150158250|NCT01723826|541714112|FG002|Overall Study|Lost to Follow-up|1|||
150158251|NCT01723826|541714113|FG003|Overall Study|Lost to Follow-up|1|||
150158252|NCT01723826|541714110|FG000|Overall Study|Non-compliance|0|||
150158253|NCT01723826|541714111|FG001|Overall Study|Non-compliance|1|||
150158254|NCT01723826|541714112|FG002|Overall Study|Non-compliance|3|||
150158255|NCT01723826|541714113|FG003|Overall Study|Non-compliance|3|||
150158256|NCT01723826|541714110|FG000|Overall Study|Non-compliance With Study Drug|0|||
150158257|NCT01723826|541714111|FG001|Overall Study|Non-compliance With Study Drug|1|||
150158258|NCT01723826|541714112|FG002|Overall Study|Non-compliance With Study Drug|0|||
150158259|NCT01723826|541714113|FG003|Overall Study|Non-compliance With Study Drug|0|||
150158260|NCT01723826|541714110|FG000|Overall Study|Other Reason|8|||
150158261|NCT01723826|541714111|FG001|Overall Study|Other Reason|6|||
150158262|NCT01723826|541714112|FG002|Overall Study|Other Reason|12|||
150158263|NCT01723826|541714113|FG003|Overall Study|Other Reason|14|||
150259503|NCT00321373|542087149|FG002|Overall Study|Withdrawal by Subject|0|||
149919090|NCT05600036|540837259|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
149919091|NCT05600036|540837260|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
149919092|NCT05600036|540837261|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
149919093|NCT05600036|540837262|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
149919094|NCT05600036|540837263|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
149919095|NCT05600036|540837258|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
149919096|NCT05600036|540837259|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
149919097|NCT05600036|540837260|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
150158264|NCT01723826|541714110|FG000|Overall Study|Physician Decision|1|||
150158265|NCT01723826|541714111|FG001|Overall Study|Physician Decision|3|||
150158266|NCT01723826|541714112|FG002|Overall Study|Physician Decision|4|||
150158267|NCT01723826|541714113|FG003|Overall Study|Physician Decision|11|||
149919098|NCT05600036|540837261|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
149919099|NCT05600036|540837262|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
149919100|NCT05600036|540837263|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
149919101|NCT06010732|540837264|FG000|Crossover Period 1|Protocol Violation|0|||
150158268|NCT01723826|541714110|FG000|Overall Study|Protocol Violation|1|||
150158269|NCT01723826|541714111|FG001|Overall Study|Protocol Violation|1|||
150158270|NCT01723826|541714112|FG002|Overall Study|Protocol Violation|3|||
150158271|NCT01723826|541714113|FG003|Overall Study|Protocol Violation|1|||
150158272|NCT01723826|541714110|FG000|Overall Study|Withdrawal by Subject|10|||
150158273|NCT01723826|541714111|FG001|Overall Study|Withdrawal by Subject|17|||
150158274|NCT01723826|541714112|FG002|Overall Study|Withdrawal by Subject|27|||
150158275|NCT01723826|541714113|FG003|Overall Study|Withdrawal by Subject|48|||
150158276|NCT02013687|541714114|FG000|Overall Study|Lost to Follow-up|0|||
150158277|NCT02013687|541714115|FG001|Overall Study|Lost to Follow-up|0|||
150158278|NCT02013687|541714116|FG002|Overall Study|Lost to Follow-up|1|||
150158279|NCT02013687|541714117|FG003|Overall Study|Lost to Follow-up|0|||
150158280|NCT02013687|541714114|FG000|Overall Study|Protocol Violation|0|||
150158281|NCT02013687|541714115|FG001|Overall Study|Protocol Violation|0|||
150158282|NCT02013687|541714116|FG002|Overall Study|Protocol Violation|0|||
150158283|NCT02013687|541714117|FG003|Overall Study|Protocol Violation|1|||
150158284|NCT02013687|541714114|FG000|Overall Study|Withdrawal by Subject|0|||
150158285|NCT02013687|541714115|FG001|Overall Study|Withdrawal by Subject|0|||
150158286|NCT02013687|541714116|FG002|Overall Study|Withdrawal by Subject|0|||
150158287|NCT02013687|541714117|FG003|Overall Study|Withdrawal by Subject|1|||
150158288|NCT02013687|541714114|FG000|Overall Study|Missed visits due to patient travel|0|||
150158289|NCT02013687|541714115|FG001|Overall Study|Missed visits due to patient travel|0|||
150158290|NCT02013687|541714116|FG002|Overall Study|Missed visits due to patient travel|1|||
150158291|NCT02013687|541714117|FG003|Overall Study|Missed visits due to patient travel|0|||
150158292|NCT01782326|541714118|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
150158293|NCT01782326|541714119|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
150158294|NCT01782326|541714118|FG000|Planned Treatment Epoch|Death|29|||
150158295|NCT01782326|541714119|FG001|Planned Treatment Epoch|Death|30|||
150158296|NCT01782326|541714118|FG000|Planned Treatment Epoch|Physician Decision|18|||
150158297|NCT01782326|541714119|FG001|Planned Treatment Epoch|Physician Decision|16|||
150158298|NCT01782326|541714118|FG000|Planned Treatment Epoch|Protocol deviation|2|||
150158299|NCT01782326|541714119|FG001|Planned Treatment Epoch|Protocol deviation|3|||
150158300|NCT01782326|541714118|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
150158301|NCT01782326|541714119|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
150158302|NCT01782326|541714118|FG000|Planned Treatment Epoch|Technical problems|0|||
150158303|NCT01782326|541714119|FG001|Planned Treatment Epoch|Technical problems|4|||
150158304|NCT01782326|541714118|FG000|Double-blind Treatment|Adverse Event|129|||
150158305|NCT01782326|541714119|FG001|Double-blind Treatment|Adverse Event|145|||
150158306|NCT01782326|541714118|FG000|Double-blind Treatment|Subject/guardian decision|111|||
150158307|NCT01782326|541714119|FG001|Double-blind Treatment|Subject/guardian decision|125|||
150158308|NCT01782326|541714118|FG000|Double-blind Treatment|Lack of Efficacy|17|||
150158309|NCT01782326|541714119|FG001|Double-blind Treatment|Lack of Efficacy|22|||
150158310|NCT01782326|541714118|FG000|Double-blind Treatment|Physician Decision|13|||
150158311|NCT01782326|541714119|FG001|Double-blind Treatment|Physician Decision|16|||
150158312|NCT01782326|541714118|FG000|Double-blind Treatment|Protocol deviation|8|||
150158313|NCT01782326|541714119|FG001|Double-blind Treatment|Protocol deviation|7|||
150158314|NCT01782326|541714118|FG000|Double-blind Treatment|Technical problems|0|||
150158315|NCT01782326|541714119|FG001|Double-blind Treatment|Technical problems|5|||
150158316|NCT04894903|541714122|FG000|Overall Study|Death|1|||
150158317|NCT04894903|541714123|FG001|Overall Study|Death|0|||
150158318|NCT04894903|541714122|FG000|Overall Study|Pregnancy|1|||
150158319|NCT04894903|541714123|FG001|Overall Study|Pregnancy|0|||
150158320|NCT04894903|541714122|FG000|Overall Study|Withdrawal by Subject|1|||
150158321|NCT04894903|541714123|FG001|Overall Study|Withdrawal by Subject|1|||
150158322|NCT04894903|541714122|FG000|Overall Study|moved or exited health system|1|||
150158323|NCT04894903|541714123|FG001|Overall Study|moved or exited health system|3|||
150158324|NCT01822353|541714125|FG000|Overall Study|Adverse Event|1|||
150158325|NCT01822353|541714126|FG001|Overall Study|Adverse Event|3|||
150158326|NCT01822353|541714127|FG002|Overall Study|Adverse Event|1|||
150259504|NCT00321373|542087147|FG000|Overall Study|Other|0|||
150158327|NCT01822353|541714125|FG000|Overall Study|Pregnancy|0|||
149919102|NCT06010732|540837265|FG001|Crossover Period 1|Protocol Violation|0|||
150158328|NCT01822353|541714126|FG001|Overall Study|Pregnancy|1|||
150158329|NCT01822353|541714127|FG002|Overall Study|Pregnancy|0|||
150158330|NCT01822353|541714125|FG000|Overall Study|Withdrawal by Subject|3|||
150259505|NCT00321373|542087148|FG001|Overall Study|Other|0|||
150158331|NCT01822353|541714126|FG001|Overall Study|Withdrawal by Subject|1|||
150158332|NCT01822353|541714127|FG002|Overall Study|Withdrawal by Subject|0|||
150158333|NCT02550873|541714128|FG000|Randomized Double Blind|Adverse Event|3|||
150158334|NCT02550873|541714129|FG001|Randomized Double Blind|Adverse Event|1|||
150158335|NCT02550873|541714130|FG002|Randomized Double Blind|Adverse Event|0|||
149816372|NCT05458895|540456927|FG000|Overall Study|Lost to Follow-up|17|||
149816373|NCT05458895|540456927|FG000|Overall Study|Pregnancy|2|||
149816374|NCT05458895|540456927|FG000|Overall Study|Withdrawal by Study Team|1|||
149816375|NCT04639310|540456928|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
149816376|NCT04639310|540456929|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
149816377|NCT01835470|540458512|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
149816378|NCT01835470|540458512|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
149816379|NCT01011907|540458513|FG000|Overall Study|Withdrawal by Subject|13|||
149816380|NCT01011907|540458514|FG001|Overall Study|Withdrawal by Subject|11|||
149816381|NCT01011907|540458513|FG000|Overall Study|Adverse Event|1|||
149816382|NCT01011907|540458514|FG001|Overall Study|Adverse Event|4|||
150158336|NCT02550873|541714128|FG000|Randomized Double Blind|Disease progression|1|||
150158337|NCT02550873|541714129|FG001|Randomized Double Blind|Disease progression|1|||
150158338|NCT02550873|541714130|FG002|Randomized Double Blind|Disease progression|0|||
150158339|NCT02550873|541714128|FG000|Open Label Extension|Study ongoing|0|||
150158340|NCT02550873|541714129|FG001|Open Label Extension|Study ongoing|0|||
150158341|NCT02550873|541714130|FG002|Open Label Extension|Study ongoing|111|||
149816383|NCT00207714|540458517|FG000|Overall Study|Adverse Event|6|||
149816384|NCT00207714|540458518|FG001|Overall Study|Adverse Event|2|||
149816385|NCT00207714|540458519|FG002|Overall Study|Adverse Event|4|||
149816386|NCT00207714|540458520|FG003|Overall Study|Adverse Event|3|||
149816387|NCT00207714|540458521|FG004|Overall Study|Adverse Event|1|||
149816388|NCT00207714|540458517|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
149816389|NCT00207714|540458518|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149816390|NCT00207714|540458519|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
149816391|NCT00207714|540458520|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
149816392|NCT00207714|540458521|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
149816393|NCT00207714|540458517|FG000|Overall Study|Other|3|||
149816394|NCT00207714|540458518|FG001|Overall Study|Other|2|||
149816395|NCT00207714|540458519|FG002|Overall Study|Other|5|||
149816396|NCT00207714|540458520|FG003|Overall Study|Other|1|||
149816397|NCT00207714|540458521|FG004|Overall Study|Other|0|||
149816398|NCT03627195|540458522|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
149816399|NCT03627195|540458523|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
149816400|NCT03627195|540458524|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
149816401|NCT03627195|540458525|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
149816402|NCT03627195|540458526|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
149816403|NCT03627195|540458527|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
149816404|NCT02290028|540458530|FG000|Overall Study|Death|217|||
149816405|NCT02290028|540458530|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
149816406|NCT02290028|540458530|FG000|Overall Study|No longer under care of study physician|76|||
149816407|NCT02290028|540458530|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
149816408|NCT02290028|540458530|FG000|Overall Study|Withdrawal by Subject|52|||
149816409|NCT02290028|540458530|FG000|Overall Study|Study site closure|44|||
149816410|NCT02290028|540458530|FG000|Overall Study|Lost to Follow-up|34|||
149816411|NCT02290028|540458530|FG000|Overall Study|Miscellaneous|10|||
149816412|NCT02290028|540458530|FG000|Overall Study|Transition to EP PASSION|1295|||
149816413|NCT02290028|540458530|FG000|Overall Study|Planned study completion at 12 months|257|||
149816414|NCT03862625|540458531|FG000|Overall Study|Lost to Follow-up|0|||
149816415|NCT03862625|540458532|FG001|Overall Study|Lost to Follow-up|1|||
149816416|NCT02614703|540458534|FG000|Overall Study|Withdrawal by Subject|7|||
149816417|NCT02614703|540458535|FG001|Overall Study|Withdrawal by Subject|1|||
149816418|NCT02402933|540458536|FG000|Overall Study|Withdrawal by Subject|4|||
149816419|NCT02402933|540458536|FG000|Overall Study|Discontinued; Site Termination|10|||
149816420|NCT00856778|540458545|FG000|Overall Study|Adverse Event|7|||
150158342|NCT04320615|541714131|FG000|Overall Study|Withdrawal by Subject|4|||
150158343|NCT04320615|541714132|FG001|Overall Study|Withdrawal by Subject|10|||
150158344|NCT04320615|541714131|FG000|Overall Study|Physician Decision|2|||
150158345|NCT04320615|541714132|FG001|Overall Study|Physician Decision|0|||
150158346|NCT04320615|541714131|FG000|Overall Study|Other|2|||
150158347|NCT04320615|541714132|FG001|Overall Study|Other|0|||
150158348|NCT04320615|541714131|FG000|Overall Study|Lost to Follow-up|5|||
150158349|NCT04320615|541714132|FG001|Overall Study|Lost to Follow-up|23|||
150158350|NCT04320615|541714131|FG000|Overall Study|Death|35|||
150158351|NCT04320615|541714132|FG001|Overall Study|Death|71|||
150158352|NCT04504916|541714133|FG000|Overall Study|Study terminated|7|||
150158353|NCT04504916|541714134|FG001|Overall Study|Study terminated|8|||
150158354|NCT04504916|541714133|FG000|Overall Study|Death|54|||
150158355|NCT04504916|541714134|FG001|Overall Study|Death|18|||
149816421|NCT00856778|540458545|FG000|Overall Study|Withdrawal by Subject|10|||
149816422|NCT00856778|540458545|FG000|Overall Study|Study deviation|2|||
149816423|NCT00856778|540458545|FG000|Overall Study|Lost to Follow-up|5|||
149816424|NCT01681771|540458546|FG000|Overall Study|Lost to Follow-up|4|||
149816425|NCT01681771|540458547|FG001|Overall Study|Lost to Follow-up|2|||
149816426|NCT00265083|540458548|FG000|Overall Study|Adverse Event|5|||
149816427|NCT00265083|540458549|FG001|Overall Study|Adverse Event|13|||
150158356|NCT04504916|541714133|FG000|Overall Study|Lost to Follow-up|1|||
150158357|NCT04504916|541714134|FG001|Overall Study|Lost to Follow-up|1|||
150158358|NCT04504916|541714133|FG000|Overall Study|Withdrawal by Subject|8|||
150158359|NCT04504916|541714134|FG001|Overall Study|Withdrawal by Subject|4|||
150158360|NCT04504916|541714133|FG000|Overall Study|Did not agree to follow-up|0|||
150158361|NCT04504916|541714134|FG001|Overall Study|Did not agree to follow-up|1|||
150158362|NCT00003509|541714135|FG000|Overall Study|Not evaluable|5|||
150158363|NCT02684903|541714138|FG000|Overall Study|COVID-19 shutdown of lab|4|||
150158364|NCT02684903|541714139|FG001|Overall Study|COVID-19 shutdown of lab|6|||
150158365|NCT02684903|541714138|FG000|Overall Study|Lost to Follow-up|31|||
150158366|NCT02684903|541714139|FG001|Overall Study|Lost to Follow-up|41|||
150158367|NCT04213846|541716266|FG000|Overall Study|Withdrawal by Subject|7|||
150158368|NCT04213846|541716267|FG001|Overall Study|Withdrawal by Subject|6|||
150158369|NCT04213846|541716266|FG000|Overall Study|Lost to Follow-up|15|||
150158370|NCT04213846|541716267|FG001|Overall Study|Lost to Follow-up|21|||
150158371|NCT00802841|541716276|FG000|Overall Study|Administrative problems|1|||
150158372|NCT00802841|541716277|FG001|Overall Study|Administrative problems|0|||
150158373|NCT00802841|541716276|FG000|Overall Study|Lost to Follow-up|2|||
150158374|NCT00802841|541716277|FG001|Overall Study|Lost to Follow-up|1|||
149919103|NCT06010732|540837266|FG002|Crossover Period 1|Protocol Violation|1|||
149919104|NCT06010732|540837267|FG003|Crossover Period 1|Protocol Violation|0|||
149919105|NCT06010732|540837268|FG004|Crossover Period 1|Protocol Violation|1|||
149919106|NCT06010732|540837269|FG005|Crossover Period 1|Protocol Violation|0|||
149919107|NCT06010732|540837264|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
149919108|NCT06010732|540837265|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
149919109|NCT06010732|540837266|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
150158375|NCT00802841|541716276|FG000|Overall Study|Death|1|||
150158376|NCT00802841|541716277|FG001|Overall Study|Death|2|||
149919110|NCT06010732|540837267|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
150158377|NCT00802841|541716276|FG000|Overall Study|Adverse Event|8|||
150158378|NCT00802841|541716277|FG001|Overall Study|Adverse Event|2|||
150158379|NCT00802841|541716276|FG000|Overall Study|Disease progression|7|||
150158380|NCT00802841|541716277|FG001|Overall Study|Disease progression|3|||
149919111|NCT06010732|540837268|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
149919112|NCT06010732|540837269|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
150158381|NCT00802841|541716276|FG000|Overall Study|Withdrawal by Subject|9|||
150158382|NCT00802841|541716277|FG001|Overall Study|Withdrawal by Subject|5|||
150158383|NCT00802841|541716276|FG000|Overall Study|Protocol deviation|2|||
150158384|NCT00802841|541716277|FG001|Overall Study|Protocol deviation|6|||
150158385|NCT00802841|541716276|FG000|Overall Study|Treatment duration completed|66|||
150158386|NCT00802841|541716277|FG001|Overall Study|Treatment duration completed|76|||
150158387|NCT00432159|541716280|FG000|Overall Study|Death|0|||
150158388|NCT00432159|541716281|FG001|Overall Study|Death|1|||
149919113|NCT06010732|540837264|FG000|Crossover Period 2|Adverse Event|0|||
149919114|NCT06010732|540837265|FG001|Crossover Period 2|Adverse Event|1|||
149919115|NCT06010732|540837266|FG002|Crossover Period 2|Adverse Event|0|||
149919116|NCT06010732|540837267|FG003|Crossover Period 2|Adverse Event|0|||
149919117|NCT06010732|540837268|FG004|Crossover Period 2|Adverse Event|0|||
149919118|NCT06010732|540837269|FG005|Crossover Period 2|Adverse Event|0|||
149919119|NCT06010732|540837264|FG000|Crossover Period 2|broken denture|0|||
149919120|NCT06010732|540837265|FG001|Crossover Period 2|broken denture|0|||
149919121|NCT06010732|540837266|FG002|Crossover Period 2|broken denture|1|||
149919122|NCT06010732|540837267|FG003|Crossover Period 2|broken denture|0|||
149919123|NCT06010732|540837268|FG004|Crossover Period 2|broken denture|0|||
149919124|NCT06010732|540837269|FG005|Crossover Period 2|broken denture|0|||
149919125|NCT03699540|540837270|FG000|Overall Study|Lost to Follow-up|1|||
149919126|NCT02697591|540837275|FG000|Overall Study|Lost to Follow-up|0|||
149919127|NCT02697591|540837276|FG001|Overall Study|Lost to Follow-up|0|||
150158389|NCT00432159|541716282|FG002|Overall Study|Death|0|||
150158390|NCT00432159|541716283|FG003|Overall Study|Death|0|||
150158391|NCT00432159|541716284|FG004|Overall Study|Death|0|||
150158392|NCT00432159|541716280|FG000|Overall Study|Failure|9|||
150158393|NCT00432159|541716281|FG001|Overall Study|Failure|5|||
150158394|NCT00432159|541716282|FG002|Overall Study|Failure|3|||
150158395|NCT00432159|541716283|FG003|Overall Study|Failure|2|||
150259506|NCT00321373|542087149|FG002|Overall Study|Other|1|||
150158396|NCT00432159|541716284|FG004|Overall Study|Failure|3|||
150158397|NCT00432159|541716280|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
150158398|NCT00432159|541716281|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
150158399|NCT00432159|541716282|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
150158400|NCT00432159|541716283|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
149919128|NCT02697591|540837277|FG002|Overall Study|Lost to Follow-up|0|||
149919129|NCT02697591|540837278|FG003|Overall Study|Lost to Follow-up|0|||
149919130|NCT02697591|540837279|FG004|Overall Study|Lost to Follow-up|0|||
149919131|NCT02697591|540837280|FG005|Overall Study|Lost to Follow-up|1|||
149919132|NCT02697591|540837281|FG006|Overall Study|Lost to Follow-up|1|||
149919133|NCT02697591|540837282|FG007|Overall Study|Lost to Follow-up|0|||
149919134|NCT02697591|540837283|FG008|Overall Study|Lost to Follow-up|0|||
149919135|NCT02697591|540837284|FG009|Overall Study|Lost to Follow-up|1|||
149919136|NCT02697591|540837275|FG000|Overall Study|Withdrawal by Subject|1|||
149919137|NCT02697591|540837276|FG001|Overall Study|Withdrawal by Subject|1|||
149919138|NCT02697591|540837277|FG002|Overall Study|Withdrawal by Subject|2|||
149919139|NCT02697591|540837278|FG003|Overall Study|Withdrawal by Subject|1|||
149919140|NCT02697591|540837279|FG004|Overall Study|Withdrawal by Subject|7|||
149919141|NCT02697591|540837280|FG005|Overall Study|Withdrawal by Subject|6|||
149919142|NCT02697591|540837281|FG006|Overall Study|Withdrawal by Subject|9|||
149919143|NCT02697591|540837282|FG007|Overall Study|Withdrawal by Subject|1|||
149919144|NCT02697591|540837283|FG008|Overall Study|Withdrawal by Subject|6|||
149919145|NCT02697591|540837284|FG009|Overall Study|Withdrawal by Subject|10|||
149919146|NCT02697591|540837275|FG000|Overall Study|Physician Decision|1|||
149919147|NCT02697591|540837276|FG001|Overall Study|Physician Decision|0|||
149919148|NCT02697591|540837277|FG002|Overall Study|Physician Decision|0|||
149919149|NCT02697591|540837278|FG003|Overall Study|Physician Decision|0|||
149919150|NCT02697591|540837279|FG004|Overall Study|Physician Decision|1|||
149919151|NCT02697591|540837280|FG005|Overall Study|Physician Decision|2|||
149919152|NCT02697591|540837281|FG006|Overall Study|Physician Decision|0|||
149919153|NCT02697591|540837282|FG007|Overall Study|Physician Decision|0|||
149919154|NCT02697591|540837283|FG008|Overall Study|Physician Decision|1|||
149919155|NCT02697591|540837284|FG009|Overall Study|Physician Decision|1|||
149919156|NCT02697591|540837275|FG000|Overall Study|Death|2|||
149919157|NCT02697591|540837276|FG001|Overall Study|Death|3|||
149919158|NCT02697591|540837277|FG002|Overall Study|Death|1|||
149919159|NCT02697591|540837278|FG003|Overall Study|Death|1|||
149919160|NCT02697591|540837279|FG004|Overall Study|Death|4|||
149919161|NCT02697591|540837280|FG005|Overall Study|Death|5|||
149919162|NCT02697591|540837281|FG006|Overall Study|Death|3|||
149919163|NCT02697591|540837282|FG007|Overall Study|Death|1|||
149919164|NCT02697591|540837283|FG008|Overall Study|Death|1|||
149919165|NCT02697591|540837284|FG009|Overall Study|Death|5|||
149919166|NCT02697591|540837275|FG000|Overall Study|Reason not Specified|0|||
149919167|NCT02697591|540837276|FG001|Overall Study|Reason not Specified|0|||
149919168|NCT02697591|540837277|FG002|Overall Study|Reason not Specified|0|||
149919169|NCT02697591|540837278|FG003|Overall Study|Reason not Specified|1|||
149919170|NCT02697591|540837279|FG004|Overall Study|Reason not Specified|1|||
149919171|NCT02697591|540837280|FG005|Overall Study|Reason not Specified|2|||
149919172|NCT02697591|540837281|FG006|Overall Study|Reason not Specified|3|||
149919173|NCT02697591|540837282|FG007|Overall Study|Reason not Specified|1|||
149919174|NCT02697591|540837283|FG008|Overall Study|Reason not Specified|1|||
149919175|NCT02697591|540837284|FG009|Overall Study|Reason not Specified|3|||
150158401|NCT00432159|541716284|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
150158402|NCT01939158|541716286|FG000|Overall Study|Adverse Event|1|||
150158403|NCT01939158|541716287|FG001|Overall Study|Adverse Event|0|||
150158404|NCT01939158|541716288|FG002|Overall Study|Adverse Event|0|||
150158405|NCT01939158|541716289|FG003|Overall Study|Adverse Event|0|||
150158406|NCT01939158|541716286|FG000|Overall Study|Withdrawal by Subject|22|||
150158407|NCT01939158|541716287|FG001|Overall Study|Withdrawal by Subject|25|||
150158408|NCT01939158|541716288|FG002|Overall Study|Withdrawal by Subject|15|||
150158409|NCT01939158|541716289|FG003|Overall Study|Withdrawal by Subject|17|||
150158410|NCT01939158|541716286|FG000|Overall Study|Migrated/moved from study area|5|||
150158411|NCT01939158|541716287|FG001|Overall Study|Migrated/moved from study area|7|||
149919176|NCT02722746|540837285|FG000|Overall Study|Withdrawal by Subject|0|||
149919177|NCT02722746|540837286|FG001|Overall Study|Withdrawal by Subject|1|||
149919178|NCT02722746|540837287|FG002|Overall Study|Withdrawal by Subject|0|||
149919179|NCT02722746|540837285|FG000|Overall Study|Protocol Violation|8|||
149919180|NCT02722746|540837286|FG001|Overall Study|Protocol Violation|4|||
149919181|NCT02722746|540837287|FG002|Overall Study|Protocol Violation|6|||
149919182|NCT01939223|540837288|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
149919183|NCT01939223|540837289|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
149919184|NCT01939223|540837288|FG000|Overall Study|Disease recurrence (radiological)|1|||
149919185|NCT01939223|540837289|FG001|Overall Study|Disease recurrence (radiological)|3|||
149919186|NCT01939223|540837288|FG000|Overall Study|Study stopped by Sponsor|5|||
149919187|NCT01939223|540837289|FG001|Overall Study|Study stopped by Sponsor|7|||
149919188|NCT01939223|540837288|FG000|Overall Study|Withdrawal by Subject|6|||
150158412|NCT01939158|541716288|FG002|Overall Study|Migrated/moved from study area|3|||
150158413|NCT01939158|541716289|FG003|Overall Study|Migrated/moved from study area|6|||
150158414|NCT01939158|541716286|FG000|Overall Study|Lost to Follow-up|18|||
150158415|NCT01939158|541716287|FG001|Overall Study|Lost to Follow-up|17|||
150158416|NCT01939158|541716288|FG002|Overall Study|Lost to Follow-up|17|||
150158417|NCT01939158|541716289|FG003|Overall Study|Lost to Follow-up|17|||
150158418|NCT01939158|541716286|FG000|Overall Study|Death|0|||
150158419|NCT01939158|541716287|FG001|Overall Study|Death|0|||
150158420|NCT01939158|541716288|FG002|Overall Study|Death|1|||
150158421|NCT01939158|541716289|FG003|Overall Study|Death|1|||
150158422|NCT01939158|541716286|FG000|Overall Study|No longer meets eligibility criteria|0|||
150158423|NCT01939158|541716287|FG001|Overall Study|No longer meets eligibility criteria|0|||
150158424|NCT01939158|541716288|FG002|Overall Study|No longer meets eligibility criteria|1|||
150158425|NCT01939158|541716289|FG003|Overall Study|No longer meets eligibility criteria|0|||
150158426|NCT01939158|541716286|FG000|Overall Study|Other|1|||
150158427|NCT01939158|541716287|FG001|Overall Study|Other|3|||
150158428|NCT01939158|541716288|FG002|Overall Study|Other|4|||
150158429|NCT01939158|541716289|FG003|Overall Study|Other|3|||
150158430|NCT05310084|541716290|FG000|Overall Study|Withdrawal by Subject|2|||
150158431|NCT05310084|541716291|FG001|Overall Study|Withdrawal by Subject|3|||
150158432|NCT05310084|541716290|FG000|Overall Study|Participant availability|0|||
150158433|NCT05310084|541716291|FG001|Overall Study|Participant availability|4|||
150158434|NCT05310084|541716290|FG000|Overall Study|Lost to Follow-up|1|||
150158435|NCT05310084|541716291|FG001|Overall Study|Lost to Follow-up|1|||
149816428|NCT00265083|540458550|FG002|Overall Study|Adverse Event|15|||
149816429|NCT00265083|540458548|FG000|Overall Study|Lost to Follow-up|3|||
149816430|NCT00265083|540458549|FG001|Overall Study|Lost to Follow-up|4|||
149816431|NCT00265083|540458550|FG002|Overall Study|Lost to Follow-up|4|||
149816432|NCT00265083|540458548|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
149816433|NCT00265083|540458549|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
149816434|NCT00265083|540458550|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
150158436|NCT05310084|541716290|FG000|Overall Study|Adverse Event|1|||
150158437|NCT05310084|541716291|FG001|Overall Study|Adverse Event|1|||
150158438|NCT05310084|541716290|FG000|Overall Study|Randomized but not vaccinated|4|||
150158439|NCT05310084|541716291|FG001|Overall Study|Randomized but not vaccinated|2|||
150158440|NCT02123966|541716292|FG000|Overall Study|Intercurrent Illness|1|||
150158441|NCT01460381|541716293|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
150158442|NCT01460381|541716294|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
150158443|NCT01097655|541716295|FG000|Overall Study|Withdrawal by Subject|1|||
150158444|NCT01097655|541716295|FG000|Overall Study|Subject Documented Twice|1|||
150158445|NCT01097655|541716295|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
150158446|NCT03303105|541716296|FG000|Overall Study|Adverse Event|0|||
150158447|NCT03303105|541716297|FG001|Overall Study|Adverse Event|2|||
150158448|NCT03303105|541716296|FG000|Overall Study|Lack of Efficacy|1|||
150158449|NCT03303105|541716297|FG001|Overall Study|Lack of Efficacy|0|||
150259507|NCT01774487|542087150|FG000|Overall Study|Did not tolerate taste|4|||
150259508|NCT01774487|542087151|FG001|Overall Study|Did not tolerate taste|4|||
150158450|NCT03303105|541716296|FG000|Overall Study|Protocol Violation|1|||
150158451|NCT03303105|541716297|FG001|Overall Study|Protocol Violation|0|||
150259509|NCT00477334|542087152|FG000|Overall Study|Discontinued prior to taking study drug|106|||
150259510|NCT00477334|542087153|FG001|Overall Study|Discontinued prior to taking study drug|53|||
150259511|NCT00477334|542087152|FG000|Overall Study|Adverse Event|1|||
149816435|NCT00265083|540458548|FG000|Overall Study|Other|1|||
150158452|NCT03303105|541716296|FG000|Overall Study|Withdrawal by Subject|0|||
150158453|NCT03303105|541716297|FG001|Overall Study|Withdrawal by Subject|2|||
150158454|NCT03527277|541716299|FG000|Overall Study|Withdrawal by Subject|5|||
150158455|NCT03527277|541716300|FG001|Overall Study|Withdrawal by Subject|0|||
150158456|NCT03527277|541716299|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
150158457|NCT03527277|541716300|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
150158458|NCT03527277|541716299|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
150158459|NCT03527277|541716300|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
149816436|NCT00265083|540458549|FG001|Overall Study|Other|12|||
149816437|NCT00265083|540458550|FG002|Overall Study|Other|9|||
149816438|NCT03208933|540458551|FG000|Overall Study|Death|3|||
150158460|NCT01333943|541716301|FG000|Overall Study|Known neuropathy|1|||
150158461|NCT01333943|541716302|FG001|Overall Study|Known neuropathy|0|||
150158462|NCT02652130|541716307|FG000|Overall Study|Death|1|||
149816439|NCT03208933|540458551|FG000|Overall Study|Withdrawal by Subject|3|||
149816440|NCT03208933|540458551|FG000|Overall Study|Adverse Event|1|||
150158463|NCT02028884|541716308|FG000|Double-blind Period|Adverse Event|5|||
150158464|NCT02028884|541716309|FG001|Double-blind Period|Adverse Event|3|||
149816441|NCT03208933|540458551|FG000|Overall Study|Lost to Follow-up|2|||
150158465|NCT02028884|541716310|FG002|Double-blind Period|Adverse Event|0|||
150158466|NCT02028884|541716308|FG000|Double-blind Period|Eligibility Violation|1|||
150158467|NCT02028884|541716309|FG001|Double-blind Period|Eligibility Violation|0|||
150259512|NCT00477334|542087153|FG001|Overall Study|Adverse Event|2|||
150158468|NCT02028884|541716310|FG002|Double-blind Period|Eligibility Violation|0|||
150158469|NCT02028884|541716308|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
150158470|NCT02028884|541716309|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
150158471|NCT02028884|541716310|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
150158472|NCT02028884|541716308|FG000|Double-blind Period|Withdrawal by Subject|2|||
150158473|NCT02028884|541716309|FG001|Double-blind Period|Withdrawal by Subject|0|||
150158474|NCT02028884|541716310|FG002|Double-blind Period|Withdrawal by Subject|0|||
150259513|NCT00477334|542087152|FG000|Overall Study|Withdrawal by Subject|2|||
150259514|NCT00477334|542087153|FG001|Overall Study|Withdrawal by Subject|1|||
150259515|NCT00477334|542087152|FG000|Overall Study|Lost to Follow-up|15|||
150259516|NCT00477334|542087153|FG001|Overall Study|Lost to Follow-up|4|||
150259517|NCT00477334|542087152|FG000|Overall Study|Administrative Problems|39|||
150259518|NCT00477334|542087153|FG001|Overall Study|Administrative Problems|15|||
150259519|NCT00477334|542087152|FG000|Overall Study|Protocol Violation|7|||
150259520|NCT00477334|542087153|FG001|Overall Study|Protocol Violation|1|||
150259521|NCT02354508|542087158|FG000|Period 1: Core Phase|Adverse Event|1|||
150158475|NCT02028884|541716308|FG000|Open-label Extension Period|Adverse Event|3|||
150158476|NCT02028884|541716309|FG001|Open-label Extension Period|Adverse Event|1|||
150158477|NCT02028884|541716310|FG002|Open-label Extension Period|Adverse Event|0|||
150158478|NCT02028884|541716308|FG000|Open-label Extension Period|Lack of Efficacy|3|||
150158479|NCT02028884|541716309|FG001|Open-label Extension Period|Lack of Efficacy|0|||
150158480|NCT02028884|541716310|FG002|Open-label Extension Period|Lack of Efficacy|0|||
150158481|NCT02028884|541716308|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
150158482|NCT02028884|541716309|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
150158483|NCT02028884|541716310|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
150158484|NCT02028884|541716308|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
150158485|NCT02028884|541716309|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
150158486|NCT02028884|541716310|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
150158487|NCT02028884|541716308|FG000|Open-label Extension Period|Switched to another treatment option|3|||
150158488|NCT02028884|541716309|FG001|Open-label Extension Period|Switched to another treatment option|0|||
150158489|NCT02028884|541716310|FG002|Open-label Extension Period|Switched to another treatment option|0|||
150158490|NCT02403674|541716311|FG000|Base Study|Death|1|||
150158491|NCT02403674|541716312|FG001|Base Study|Death|4|||
150158492|NCT02403674|541716311|FG000|Base Study|Adverse Event|11|||
150158493|NCT02403674|541716312|FG001|Base Study|Adverse Event|26|||
150158494|NCT02403674|541716311|FG000|Base Study|Lack of Efficacy|31|||
150158495|NCT02403674|541716312|FG001|Base Study|Lack of Efficacy|23|||
150158496|NCT02403674|541716311|FG000|Base Study|Lost to Follow-up|6|||
150158497|NCT02403674|541716312|FG001|Base Study|Lost to Follow-up|8|||
150158498|NCT02403674|541716311|FG000|Base Study|Withdrawal by Subject|10|||
150158499|NCT02403674|541716312|FG001|Base Study|Withdrawal by Subject|17|||
150158500|NCT02403674|541716311|FG000|Base Study|Physician Decision|2|||
150158501|NCT02403674|541716312|FG001|Base Study|Physician Decision|2|||
150158502|NCT02403674|541716311|FG000|Base Study|Pregnancy|2|||
150158503|NCT02403674|541716312|FG001|Base Study|Pregnancy|2|||
150158504|NCT02403674|541716311|FG000|Base Study|Protocol Violation|8|||
150158505|NCT02403674|541716312|FG001|Base Study|Protocol Violation|4|||
150158506|NCT02403674|541716311|FG000|Base Study|Non-Compliance with study drug|1|||
150158507|NCT02403674|541716312|FG001|Base Study|Non-Compliance with study drug|4|||
150158508|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
150158509|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
150259522|NCT02354508|542087159|FG001|Period 1: Core Phase|Adverse Event|1|||
150259523|NCT02354508|542087160|FG002|Period 1: Core Phase|Adverse Event|2|||
150259524|NCT02354508|542087158|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
150158510|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
150158511|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
150158512|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
150158513|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
150158514|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
150158515|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
150158516|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
150259525|NCT02354508|542087159|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
150259526|NCT02354508|542087160|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
150259527|NCT02354508|542087158|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
150259528|NCT02354508|542087159|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
150259529|NCT02354508|542087160|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
150259530|NCT02354508|542087158|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
150259531|NCT02354508|542087159|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
150259532|NCT02354508|542087160|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
150259533|NCT02354508|542087158|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
150259534|NCT02354508|542087159|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
150259535|NCT02354508|542087160|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
150259536|NCT02354508|542087158|FG000|Period 2: Extension Phase|Physician Decision|5|||
150259537|NCT02354508|542087159|FG001|Period 2: Extension Phase|Physician Decision|0|||
150259538|NCT02354508|542087160|FG002|Period 2: Extension Phase|Physician Decision|1|||
150259539|NCT02354508|542087158|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
150259540|NCT02354508|542087159|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
150259541|NCT02354508|542087160|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
150259542|NCT02354508|542087158|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
150259543|NCT02354508|542087159|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
150259544|NCT02354508|542087160|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
150259545|NCT02354508|542087158|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
149816442|NCT03208933|540458551|FG000|Overall Study|Physician Decision|3|||
149816443|NCT03208933|540458551|FG000|Overall Study|Protocol Violation|1|||
149816444|NCT04242186|540458557|FG000|Overall Study|Death|5|||
150158517|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
150158518|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
150158519|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
150158520|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Death|1|||
150158521|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Death|0|||
150158522|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
150158523|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
150158524|NCT02403674|541716311|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
150158525|NCT02403674|541716312|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
150158526|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
150158527|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
150158528|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
150158529|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
150158530|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
150158531|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
150158532|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
150158533|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
150158534|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
150158535|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
150158536|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Death|2|||
150158537|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Death|2|||
150158538|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
150158539|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
150158540|NCT02403674|541716311|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
150158541|NCT02403674|541716312|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
150158542|NCT02403674|541716311|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
150158543|NCT02403674|541716312|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
150158544|NCT02403674|541716311|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
150158545|NCT02403674|541716312|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
150158546|NCT02403674|541716311|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
150158547|NCT02403674|541716312|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
150158548|NCT02403674|541716311|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
150158549|NCT02403674|541716312|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
150158550|NCT02403674|541716311|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
150158551|NCT02403674|541716312|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
150158552|NCT00826280|541716313|FG000|Overall Study|Randomized but drug not received|1|||
150158553|NCT00826280|541716314|FG001|Overall Study|Randomized but drug not received|0|||
150158554|NCT00826280|541716315|FG002|Overall Study|Randomized but drug not received|1|||
150158555|NCT00826280|541716313|FG000|Overall Study|Adverse Event|1|||
150158556|NCT00826280|541716314|FG001|Overall Study|Adverse Event|3|||
150158557|NCT00826280|541716315|FG002|Overall Study|Adverse Event|0|||
150158558|NCT00826280|541716313|FG000|Overall Study|Lost to Follow-up|0|||
150158559|NCT00826280|541716314|FG001|Overall Study|Lost to Follow-up|1|||
149816445|NCT00550420|540458558|FG000|Overall Study|Adverse Event|28|||
150158560|NCT00826280|541716315|FG002|Overall Study|Lost to Follow-up|0|||
150158561|NCT00826280|541716313|FG000|Overall Study|Sponsor discontinued subject or study|1|||
150158562|NCT00826280|541716314|FG001|Overall Study|Sponsor discontinued subject or study|0|||
150158563|NCT00826280|541716315|FG002|Overall Study|Sponsor discontinued subject or study|0|||
150158564|NCT00826280|541716313|FG000|Overall Study|Reversible ischemic defect not present|43|||
150158565|NCT00826280|541716314|FG001|Overall Study|Reversible ischemic defect not present|40|||
150158566|NCT00826280|541716315|FG002|Overall Study|Reversible ischemic defect not present|44|||
150158567|NCT00826280|541716313|FG000|Overall Study|Interpretation Failure|1|||
150158568|NCT00826280|541716314|FG001|Overall Study|Interpretation Failure|0|||
150158569|NCT00826280|541716315|FG002|Overall Study|Interpretation Failure|0|||
150158570|NCT00826280|541716313|FG000|Overall Study|Machine Failure|1|||
150158571|NCT00826280|541716314|FG001|Overall Study|Machine Failure|1|||
150158572|NCT00826280|541716315|FG002|Overall Study|Machine Failure|0|||
150158573|NCT00826280|541716313|FG000|Overall Study|One or more non-interpretable scan|0|||
150158574|NCT00826280|541716314|FG001|Overall Study|One or more non-interpretable scan|1|||
150158575|NCT00826280|541716315|FG002|Overall Study|One or more non-interpretable scan|1|||
149816446|NCT00550420|540458558|FG000|Overall Study|Lost to Follow-up|8|||
149816447|NCT00550420|540458558|FG000|Overall Study|Protocol Violation|11|||
149816448|NCT00550420|540458558|FG000|Overall Study|Withdrawal by Subject|30|||
149816449|NCT00550420|540458558|FG000|Overall Study|Still in study at termination|206|||
149816450|NCT00550420|540458558|FG000|Overall Study|Missing|2|||
149816451|NCT00550420|540458558|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
149816452|NCT00550420|540458558|FG000|Overall Study|Investigators opinion|1|||
149816453|NCT00550420|540458558|FG000|Overall Study|Lack of curative effect|1|||
149816454|NCT00550420|540458558|FG000|Overall Study|Unethical stop of enrollment|2|||
149816455|NCT00550420|540458558|FG000|Overall Study|Caregiver's decision to withdraw|1|||
149816456|NCT00550420|540458558|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
149816457|NCT00550420|540458558|FG000|Overall Study|Exclusion criteria|1|||
149816458|NCT00550420|540458558|FG000|Overall Study|Prohibited medicine|1|||
149816459|NCT04378010|540458559|FG000|Overall Study|Adverse Event|8|||
149816460|NCT04378010|540458560|FG001|Overall Study|Adverse Event|14|||
149816461|NCT04378010|540458561|FG002|Overall Study|Adverse Event|4|||
149816462|NCT04378010|540458559|FG000|Overall Study|Withdrawal by Subject|0|||
149816463|NCT04378010|540458560|FG001|Overall Study|Withdrawal by Subject|2|||
149816464|NCT04378010|540458561|FG002|Overall Study|Withdrawal by Subject|1|||
149816465|NCT04378010|540458559|FG000|Overall Study|Protocol Violation|2|||
149816466|NCT04378010|540458560|FG001|Overall Study|Protocol Violation|1|||
149816467|NCT04378010|540458561|FG002|Overall Study|Protocol Violation|4|||
149816468|NCT04378010|540458559|FG000|Overall Study|Study terminated by Sponsor|22|||
149816469|NCT04378010|540458560|FG001|Overall Study|Study terminated by Sponsor|16|||
149816470|NCT04378010|540458561|FG002|Overall Study|Study terminated by Sponsor|22|||
149816471|NCT04378010|540458559|FG000|Overall Study|Subject inability to complete study visit|0|||
149816472|NCT04378010|540458560|FG001|Overall Study|Subject inability to complete study visit|0|||
149816473|NCT04378010|540458561|FG002|Overall Study|Subject inability to complete study visit|1|||
149816474|NCT04378010|540458559|FG000|Overall Study|Subject never dosed|0|||
149816475|NCT04378010|540458560|FG001|Overall Study|Subject never dosed|1|||
149816476|NCT04378010|540458561|FG002|Overall Study|Subject never dosed|0|||
149816477|NCT01792284|540458562|FG000|Lead-in Period|Adverse Event|15|||
149816478|NCT01792284|540458563|FG001|Lead-in Period|Adverse Event|0|||
149816479|NCT01792284|540458564|FG002|Lead-in Period|Adverse Event|0|||
149816480|NCT01792284|540458562|FG000|Lead-in Period|Lost to Follow-up|2|||
149816481|NCT01792284|540458563|FG001|Lead-in Period|Lost to Follow-up|0|||
149816482|NCT01792284|540458564|FG002|Lead-in Period|Lost to Follow-up|0|||
149816483|NCT01792284|540458562|FG000|Lead-in Period|Protocol Violation|1|||
149816484|NCT01792284|540458563|FG001|Lead-in Period|Protocol Violation|0|||
149816485|NCT01792284|540458564|FG002|Lead-in Period|Protocol Violation|0|||
149816486|NCT01792284|540458562|FG000|Lead-in Period|Withdrawal by Subject|10|||
149816487|NCT01792284|540458563|FG001|Lead-in Period|Withdrawal by Subject|0|||
149816488|NCT01792284|540458564|FG002|Lead-in Period|Withdrawal by Subject|0|||
149816489|NCT01792284|540458562|FG000|Lead-in Period|Physician Decision|1|||
149816490|NCT01792284|540458563|FG001|Lead-in Period|Physician Decision|0|||
149816491|NCT01792284|540458564|FG002|Lead-in Period|Physician Decision|0|||
149816492|NCT01792284|540458562|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
150158576|NCT03487666|541716316|FG000|Overall Study|Disease progression|4|||
150158577|NCT03487666|541716317|FG001|Overall Study|Disease progression|2|||
150158578|NCT03487666|541716318|FG002|Overall Study|Disease progression|0|||
150158579|NCT03487666|541716316|FG000|Overall Study|Adverse Event|0|||
149816493|NCT01792284|540458563|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
149816494|NCT01792284|540458564|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
149816495|NCT01792284|540458562|FG000|Randomization Period 1|Withdrawal by Subject|0|||
149816496|NCT01792284|540458563|FG001|Randomization Period 1|Withdrawal by Subject|1|||
149816497|NCT01792284|540458564|FG002|Randomization Period 1|Withdrawal by Subject|1|||
149816498|NCT01792284|540458562|FG000|Randomization Period 1|Physician Decision|0|||
149816499|NCT01792284|540458563|FG001|Randomization Period 1|Physician Decision|1|||
149816500|NCT01792284|540458564|FG002|Randomization Period 1|Physician Decision|1|||
149816501|NCT01792284|540458562|FG000|Randomization Period 1|Adverse Event|0|||
150158580|NCT03487666|541716317|FG001|Overall Study|Adverse Event|0|||
150158581|NCT03487666|541716318|FG002|Overall Study|Adverse Event|1|||
150158582|NCT03930186|541716320|FG000|Weeks 0 to 16|Adverse Event|6|||
150158583|NCT03930186|541716320|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
150158584|NCT03930186|541716320|FG000|Weeks 16 to 32|Adverse Event|1|||
150158585|NCT03930186|541716320|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
150158586|NCT02800928|541716326|FG000|Overall Study|Withdrawal by Subject|1|||
150158587|NCT02800928|541716327|FG001|Overall Study|Withdrawal by Subject|1|||
150158588|NCT02800928|541716326|FG000|Overall Study|Protocol Violation|1|||
150158589|NCT02800928|541716327|FG001|Overall Study|Protocol Violation|1|||
150158590|NCT05968482|541716332|FG000|First Crossover Period|Withdrawal by Subject|0|||
150158591|NCT05968482|541716333|FG001|First Crossover Period|Withdrawal by Subject|0|||
150158592|NCT05968482|541716334|FG002|First Crossover Period|Withdrawal by Subject|1|||
150158593|NCT05968482|541716335|FG003|First Crossover Period|Withdrawal by Subject|0|||
150158594|NCT05968482|541716336|FG004|First Crossover Period|Withdrawal by Subject|0|||
150158595|NCT05968482|541716337|FG005|First Crossover Period|Withdrawal by Subject|0|||
150158596|NCT05968482|541716332|FG000|First Crossover Period|Adverse Event|0|||
150158597|NCT05968482|541716333|FG001|First Crossover Period|Adverse Event|0|||
150158598|NCT05968482|541716334|FG002|First Crossover Period|Adverse Event|0|||
150158599|NCT05968482|541716335|FG003|First Crossover Period|Adverse Event|0|||
150158600|NCT05968482|541716336|FG004|First Crossover Period|Adverse Event|0|||
150158601|NCT05968482|541716337|FG005|First Crossover Period|Adverse Event|1|||
150158602|NCT05968482|541716332|FG000|Second Crossover Period|Withdrawal by Subject|0|||
150158603|NCT05968482|541716333|FG001|Second Crossover Period|Withdrawal by Subject|0|||
150158604|NCT05968482|541716334|FG002|Second Crossover Period|Withdrawal by Subject|0|||
150158605|NCT05968482|541716335|FG003|Second Crossover Period|Withdrawal by Subject|0|||
150158606|NCT05968482|541716336|FG004|Second Crossover Period|Withdrawal by Subject|1|||
150158607|NCT05968482|541716337|FG005|Second Crossover Period|Withdrawal by Subject|0|||
150158608|NCT05968482|541716332|FG000|Third Crossover Period|Adverse Event|0|||
150158609|NCT05968482|541716333|FG001|Third Crossover Period|Adverse Event|0|||
150158610|NCT05968482|541716334|FG002|Third Crossover Period|Adverse Event|0|||
150158611|NCT05968482|541716335|FG003|Third Crossover Period|Adverse Event|0|||
150158612|NCT05968482|541716336|FG004|Third Crossover Period|Adverse Event|1|||
150158613|NCT05968482|541716337|FG005|Third Crossover Period|Adverse Event|0|||
150158614|NCT05968482|541716332|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
150158615|NCT05968482|541716333|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
150158616|NCT05968482|541716334|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
150158617|NCT05968482|541716335|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
150158618|NCT05968482|541716336|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
150158619|NCT05968482|541716337|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
150158620|NCT02559817|541716338|FG000|Treatment Period|Adverse Event|1|||
150158621|NCT02559817|541716339|FG001|Treatment Period|Adverse Event|0|||
150158622|NCT02559817|541716340|FG002|Treatment Period|Adverse Event|1|||
150158623|NCT02559817|541716341|FG003|Treatment Period|Adverse Event|0|||
150158624|NCT02559817|541716342|FG004|Treatment Period|Adverse Event|0|||
150158625|NCT02559817|541716338|FG000|Treatment Period|Lack of Efficacy|0|||
150158626|NCT02559817|541716339|FG001|Treatment Period|Lack of Efficacy|1|||
150158627|NCT02559817|541716340|FG002|Treatment Period|Lack of Efficacy|0|||
150158628|NCT02559817|541716341|FG003|Treatment Period|Lack of Efficacy|0|||
150158629|NCT02559817|541716342|FG004|Treatment Period|Lack of Efficacy|0|||
150158630|NCT02559817|541716338|FG000|Treatment Period|Lost to Follow-up|0|||
150158631|NCT02559817|541716339|FG001|Treatment Period|Lost to Follow-up|1|||
150158632|NCT02559817|541716340|FG002|Treatment Period|Lost to Follow-up|0|||
150158633|NCT02559817|541716341|FG003|Treatment Period|Lost to Follow-up|1|||
150158634|NCT02559817|541716342|FG004|Treatment Period|Lost to Follow-up|0|||
150158635|NCT02559817|541716338|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
150158636|NCT02559817|541716339|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
150158637|NCT02559817|541716340|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
150158638|NCT02559817|541716341|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
150158639|NCT02559817|541716342|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
150158640|NCT02559817|541716338|FG000|Treatment Period|Protocol Violation|0|||
150158641|NCT02559817|541716339|FG001|Treatment Period|Protocol Violation|0|||
150158642|NCT02559817|541716340|FG002|Treatment Period|Protocol Violation|0|||
150158643|NCT02559817|541716341|FG003|Treatment Period|Protocol Violation|1|||
150158644|NCT02559817|541716342|FG004|Treatment Period|Protocol Violation|0|||
150158645|NCT03389893|541716343|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
150158646|NCT03389893|541716344|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
150158647|NCT03389893|541716345|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
150158648|NCT03389893|541716346|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
150158649|NCT03389893|541716343|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
150158650|NCT03389893|541716344|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
150158651|NCT03389893|541716345|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
150158652|NCT03389893|541716346|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
150158653|NCT03389893|541716343|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
150158654|NCT03389893|541716344|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
150158655|NCT03389893|541716345|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
150158656|NCT03389893|541716346|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
150158657|NCT03389893|541716343|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
150158658|NCT03389893|541716344|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
150158659|NCT03389893|541716345|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
150158660|NCT03389893|541716346|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
150158661|NCT01925170|541716348|FG000|Overall Study|Unverified cancer status|53|||
150158662|NCT02034435|541716349|FG000|Overall Study|Withdrawal by Subject|1|||
150158663|NCT02034435|541716350|FG001|Overall Study|Withdrawal by Subject|0|||
150158664|NCT02034435|541716351|FG002|Overall Study|Withdrawal by Subject|0|||
150158665|NCT02034435|541716352|FG003|Overall Study|Withdrawal by Subject|0|||
149816502|NCT01792284|540458563|FG001|Randomization Period 1|Adverse Event|0|||
149816503|NCT01792284|540458564|FG002|Randomization Period 1|Adverse Event|2|||
149816504|NCT01792284|540458562|FG000|Randomization Period 1|Lost to Follow-up|0|||
149816505|NCT01792284|540458563|FG001|Randomization Period 1|Lost to Follow-up|0|||
149816506|NCT01792284|540458564|FG002|Randomization Period 1|Lost to Follow-up|1|||
149816507|NCT01792284|540458562|FG000|Randomization Period 2|Protocol Violation|0|||
149816508|NCT01792284|540458563|FG001|Randomization Period 2|Protocol Violation|1|||
149816509|NCT01792284|540458564|FG002|Randomization Period 2|Protocol Violation|0|||
149816510|NCT01792284|540458562|FG000|Randomization Period 2|Withdrawal by Subject|0|||
149816511|NCT01792284|540458563|FG001|Randomization Period 2|Withdrawal by Subject|2|||
149816512|NCT01792284|540458564|FG002|Randomization Period 2|Withdrawal by Subject|0|||
149816513|NCT02019979|540458565|FG000|Overall Study|study terminated|14|||
149816514|NCT00379587|540458571|FG000|Overall Study|Lost to Follow-up|2|||
149816515|NCT03237611|540458572|FG000|Overall Study|Withdrawal by Subject|1|||
149816516|NCT03237611|540458572|FG000|Overall Study|Ineligible|1|||
150158666|NCT02034435|541716349|FG000|Overall Study|Illness|0|||
150158667|NCT02034435|541716350|FG001|Overall Study|Illness|2|||
150158668|NCT02034435|541716351|FG002|Overall Study|Illness|0|||
150158669|NCT02034435|541716352|FG003|Overall Study|Illness|0|||
150158670|NCT02034435|541716349|FG000|Overall Study|Inadequate IV access|1|||
150158671|NCT02034435|541716350|FG001|Overall Study|Inadequate IV access|0|||
150158672|NCT02034435|541716351|FG002|Overall Study|Inadequate IV access|0|||
150158673|NCT02034435|541716352|FG003|Overall Study|Inadequate IV access|1|||
150158674|NCT00801242|541716355|FG000|Overall Study|Adverse Event|10|||
150158675|NCT00801242|541716355|FG000|Overall Study|Withdrawal by Subject|13|||
150158676|NCT00801242|541716355|FG000|Overall Study|Protocol Violation|5|||
150158677|NCT00801242|541716355|FG000|Overall Study|Physician Decision|3|||
150158678|NCT00801242|541716355|FG000|Overall Study|Lost to Follow-up|1|||
150158679|NCT00801242|541716355|FG000|Overall Study|Miscellaneous reasons|20|||
150158680|NCT02554513|541716356|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
150158681|NCT02554513|541716357|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
150158682|NCT00388362|541716358|FG000|Enrolled|Ineligible|1|||
150158683|NCT00388362|541716358|FG000|Enrolled|Adverse Event|9|||
150158684|NCT00388362|541716358|FG000|Enrolled|Death|1|||
150158685|NCT00388362|541716358|FG000|Enrolled|Loss insurance|1|||
150158686|NCT00388362|541716358|FG000|Enrolled|Withdrawal by Subject|1|||
150158687|NCT00388362|541716358|FG000|Remained on Study Median of 514 Days|Death|2|||
150158688|NCT02335268|541716363|FG000|Overall Study|Physician Decision|5|||
150158689|NCT02335268|541716364|FG001|Overall Study|Physician Decision|1|||
150158690|NCT02335268|541716363|FG000|Overall Study|Lack of Efficacy|2|||
150158691|NCT02335268|541716364|FG001|Overall Study|Lack of Efficacy|1|||
150158692|NCT02335268|541716363|FG000|Overall Study|Adverse Event|5|||
150158693|NCT02335268|541716364|FG001|Overall Study|Adverse Event|2|||
150158694|NCT02335268|541716363|FG000|Overall Study|increase blasts|2|||
150158695|NCT02335268|541716364|FG001|Overall Study|increase blasts|0|||
150158696|NCT02335268|541716363|FG000|Overall Study|Withdrawal by Subject|3|||
150158697|NCT02335268|541716364|FG001|Overall Study|Withdrawal by Subject|2|||
150158698|NCT03160079|541716371|FG000|Overall Study|Adverse Event|2|||
150158699|NCT03160079|541716372|FG001|Overall Study|Adverse Event|0|||
150158700|NCT03160079|541716371|FG000|Overall Study|Disease Progression|1|||
150158701|NCT03160079|541716372|FG001|Overall Study|Disease Progression|0|||
150158702|NCT03160079|541716371|FG000|Overall Study|Physician Decision|1|||
149816517|NCT00923195|540458580|FG000|Overall Study|Death|0|||
149816518|NCT00923195|540458581|FG001|Overall Study|Death|1|||
149816519|NCT00525031|540458582|FG000|Overall Study|Disease Progression|1|||
150158703|NCT03160079|541716372|FG001|Overall Study|Physician Decision|0|||
150158704|NCT05893797|541716376|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
150158705|NCT05893797|541716376|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
150158706|NCT05893797|541716376|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
149919189|NCT01939223|540837289|FG001|Overall Study|Withdrawal by Subject|0|||
149816520|NCT00525031|540458583|FG001|Overall Study|Disease Progression|1|||
149919190|NCT05053035|540837290|FG000|Overall Study|Withdrawal by Subject|1|||
150158707|NCT05893797|541716376|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
150158708|NCT04770220|541716377|FG000|Overall Study|Adverse Event|2|||
150158709|NCT04770220|541716378|FG001|Overall Study|Adverse Event|11|||
150158710|NCT04770220|541716377|FG000|Overall Study|Withdrawal by Subject|5|||
149816521|NCT02370784|540458586|FG000|Overall Study|Patient started prohibited medication|0|||
149816522|NCT02370784|540458587|FG001|Overall Study|Patient started prohibited medication|1|||
149816523|NCT02140164|540458588|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
149816524|NCT01814761|540458590|FG000|Overall Study|Other Reasons|1|||
149816525|NCT01814761|540458591|FG001|Overall Study|Other Reasons|10|||
149816526|NCT01814761|540458590|FG000|Overall Study|Ocular Adverse Event|6|||
149816527|NCT01814761|540458591|FG001|Overall Study|Ocular Adverse Event|15|||
149816528|NCT01814761|540458590|FG000|Overall Study|Lost to Follow-up|1|||
149816529|NCT01814761|540458591|FG001|Overall Study|Lost to Follow-up|5|||
150158711|NCT04770220|541716378|FG001|Overall Study|Withdrawal by Subject|11|||
150158712|NCT04770220|541716377|FG000|Overall Study|Lost to Follow-up|4|||
150158713|NCT04770220|541716378|FG001|Overall Study|Lost to Follow-up|3|||
150158714|NCT04770220|541716377|FG000|Overall Study|not otherwise specified|2|||
150158715|NCT04770220|541716378|FG001|Overall Study|not otherwise specified|3|||
150158716|NCT04770220|541716377|FG000|Overall Study|Physician Decision|1|||
150158717|NCT04770220|541716378|FG001|Overall Study|Physician Decision|3|||
149816530|NCT02962882|540458592|FG000|Overall Study|Adverse Event|2|||
149816531|NCT02962882|540458592|FG000|Overall Study|Withdrawal by Subject|2|||
149816532|NCT02962882|540458592|FG000|Overall Study|Transfer from ICU|32|||
149816533|NCT03763331|540458597|FG000|Overall Study|Lost to Follow-up|1|||
149816534|NCT03763331|540458598|FG001|Overall Study|Lost to Follow-up|0|||
149816535|NCT03763331|540458597|FG000|Overall Study|Withdrawal by Subject|1|||
149816536|NCT03763331|540458598|FG001|Overall Study|Withdrawal by Subject|0|||
149816537|NCT03763331|540458597|FG000|Overall Study|Non-compliance|0|||
149816538|NCT03763331|540458598|FG001|Overall Study|Non-compliance|3|||
149816539|NCT01155063|540458599|FG000|Overall Study|Adverse Event|1|||
149816540|NCT01155063|540458599|FG000|Overall Study|Withdrawal by Subject|1|||
149816541|NCT01155063|540458599|FG000|Overall Study|Study terminated by sponsor|87|||
149816542|NCT04741503|540458600|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
149816543|NCT04741503|540458601|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
149816544|NCT04741503|540458602|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
149816545|NCT04741503|540458600|FG000|Initial Enrollment|Overquotas removed|0|||
149816546|NCT04741503|540458601|FG001|Initial Enrollment|Overquotas removed|0|||
149816547|NCT04741503|540458602|FG002|Initial Enrollment|Overquotas removed|186|||
149816548|NCT04741503|540458600|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
149816549|NCT04741503|540458601|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
149816550|NCT04741503|540458602|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
149816551|NCT01663714|540458603|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
149816552|NCT01663714|540458603|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
149816553|NCT01663714|540458603|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
149816554|NCT01663714|540458603|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
149816555|NCT01663714|540458603|FG000|Long-Term Follow-Up|Death|4|||
149816556|NCT01663714|540458603|FG000|Long-Term Follow-Up|Non-compliance|1|||
149816557|NCT00597584|540458604|FG000|Overall Study|Adverse Event|4|||
149816558|NCT00597584|540458605|FG001|Overall Study|Adverse Event|2|||
149816559|NCT00597584|540458604|FG000|Overall Study|Death|53|||
149816560|NCT00597584|540458605|FG001|Overall Study|Death|30|||
149816561|NCT00597584|540458604|FG000|Overall Study|Lack of Efficacy|1|||
149816562|NCT00597584|540458605|FG001|Overall Study|Lack of Efficacy|0|||
149816563|NCT00597584|540458604|FG000|Overall Study|Lost to Follow-up|2|||
149816564|NCT00597584|540458605|FG001|Overall Study|Lost to Follow-up|4|||
149816565|NCT00597584|540458604|FG000|Overall Study|Physician Decision|3|||
149816566|NCT00597584|540458605|FG001|Overall Study|Physician Decision|0|||
149816567|NCT00597584|540458604|FG000|Overall Study|Pregnancy|2|||
149816568|NCT00597584|540458605|FG001|Overall Study|Pregnancy|0|||
149816569|NCT00597584|540458604|FG000|Overall Study|Withdrawal by Subject|44|||
149816570|NCT00597584|540458605|FG001|Overall Study|Withdrawal by Subject|12|||
149816571|NCT00597584|540458604|FG000|Overall Study|Discontinued Dialysis|0|||
149816572|NCT00597584|540458605|FG001|Overall Study|Discontinued Dialysis|1|||
149816573|NCT00597584|540458604|FG000|Overall Study|Lost ability to consent|1|||
149816574|NCT00597584|540458605|FG001|Overall Study|Lost ability to consent|1|||
149816575|NCT00597584|540458604|FG000|Overall Study|Never dosed|1|||
149816576|NCT00597584|540458605|FG001|Overall Study|Never dosed|0|||
149816577|NCT00597584|540458604|FG000|Overall Study|Relocation|8|||
149816578|NCT00597584|540458605|FG001|Overall Study|Relocation|6|||
149816579|NCT00597584|540458604|FG000|Overall Study|Renal transplant|9|||
149816580|NCT00597584|540458605|FG001|Overall Study|Renal transplant|7|||
149816581|NCT01456052|540458612|FG000|Overall Study|Adverse Event|1|||
149816582|NCT01456052|540458613|FG001|Overall Study|Adverse Event|1|||
149816583|NCT01456052|540458614|FG002|Overall Study|Adverse Event|2|||
150158718|NCT04955626|541716379|FG000|Blinded Period|Lost to Follow-up|28|||
149919191|NCT05053035|540837291|FG001|Overall Study|Withdrawal by Subject|0|||
150158719|NCT04955626|541716380|FG001|Blinded Period|Lost to Follow-up|28|||
150158720|NCT04955626|541716381|FG002|Blinded Period|Lost to Follow-up|7|||
150158721|NCT04955626|541716382|FG003|Blinded Period|Lost to Follow-up|14|||
150158722|NCT04955626|541716383|FG004|Blinded Period|Lost to Follow-up|3|||
150158723|NCT04955626|541716384|FG005|Blinded Period|Lost to Follow-up|2|||
150158724|NCT04955626|541716385|FG006|Blinded Period|Lost to Follow-up|6|||
149919192|NCT01618916|540837294|FG000|Overall Study|Adverse Event|1|||
149919193|NCT01618916|540837295|FG001|Overall Study|Adverse Event|0|||
149919194|NCT01618916|540837296|FG002|Overall Study|Adverse Event|0|||
150158725|NCT04955626|541716386|FG007|Blinded Period|Lost to Follow-up|4|||
150158726|NCT04955626|541716387|FG008|Blinded Period|Lost to Follow-up|5|||
150158727|NCT04955626|541716388|FG009|Blinded Period|Lost to Follow-up|8|||
149919195|NCT01618916|540837297|FG003|Overall Study|Adverse Event|0|||
150158728|NCT04955626|541716389|FG010|Blinded Period|Lost to Follow-up|10|||
150158729|NCT04955626|541716390|FG011|Blinded Period|Lost to Follow-up|32|||
150158730|NCT04955626|541716391|FG012|Blinded Period|Lost to Follow-up|0|||
150158731|NCT04955626|541716392|FG013|Blinded Period|Lost to Follow-up|0|||
149816584|NCT01456052|540458612|FG000|Overall Study|Consent withdrawn|0|||
149816585|NCT01456052|540458613|FG001|Overall Study|Consent withdrawn|2|||
149816586|NCT01456052|540458614|FG002|Overall Study|Consent withdrawn|1|||
149816587|NCT01456052|540458612|FG000|Overall Study|Protocol Violation|0|||
149816588|NCT01456052|540458613|FG001|Overall Study|Protocol Violation|1|||
149816589|NCT01456052|540458614|FG002|Overall Study|Protocol Violation|0|||
149816590|NCT01456052|540458612|FG000|Overall Study|Physician Decision|1|||
149816591|NCT01456052|540458613|FG001|Overall Study|Physician Decision|0|||
149816592|NCT01456052|540458614|FG002|Overall Study|Physician Decision|1|||
149816593|NCT01456052|540458612|FG000|Overall Study|Treatment Failure|0|||
149816594|NCT01456052|540458613|FG001|Overall Study|Treatment Failure|1|||
149816595|NCT01456052|540458614|FG002|Overall Study|Treatment Failure|1|||
149816596|NCT02424565|540458615|FG000|Period 1 (D0)|Protocol Violation|0|||
149816597|NCT02424565|540458616|FG001|Period 1 (D0)|Protocol Violation|1|||
149816598|NCT01677910|540458617|FG000|Double-Blind Treatment Period|Adverse Event|6|||
149816599|NCT01677910|540458618|FG001|Double-Blind Treatment Period|Adverse Event|2|||
149816600|NCT01677910|540458619|FG002|Double-Blind Treatment Period|Adverse Event|3|||
149816601|NCT01677910|540458620|FG003|Double-Blind Treatment Period|Adverse Event|0|||
149816602|NCT01677910|540458617|FG000|Double-Blind Treatment Period|Physician Decision|0|||
149816603|NCT01677910|540458618|FG001|Double-Blind Treatment Period|Physician Decision|0|||
149816604|NCT01677910|540458619|FG002|Double-Blind Treatment Period|Physician Decision|1|||
149816605|NCT01677910|540458620|FG003|Double-Blind Treatment Period|Physician Decision|0|||
149816606|NCT01677910|540458617|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
149816607|NCT01677910|540458618|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
149816608|NCT01677910|540458619|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
149816609|NCT01677910|540458620|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
149816610|NCT01677910|540458617|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
149816611|NCT01677910|540458618|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
149816612|NCT01677910|540458619|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
149816613|NCT01677910|540458620|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
149816614|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
149816615|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
149816616|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
149816617|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
149816618|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149816619|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149816620|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149816621|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
149816622|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149816623|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149816624|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149816625|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
149816626|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149816627|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149816628|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149816629|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
149816630|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
149816631|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
149816632|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
149816633|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
149816634|NCT01677910|540458617|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
149816635|NCT01677910|540458618|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
149816636|NCT01677910|540458619|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
149816637|NCT01677910|540458620|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
149816638|NCT03650400|540458621|FG000|Overall Study|Study terminated by sponsor|0|||
149816639|NCT03650400|540458622|FG001|Overall Study|Study terminated by sponsor|5|||
149816640|NCT01703741|540458623|FG000|Overall Study|Withdrawal by Subject|6|||
149816641|NCT01703741|540458623|FG000|Overall Study|Adverse Event|2|||
149816642|NCT01703741|540458623|FG000|Overall Study|Physician Decision|2|||
149816643|NCT01703741|540458623|FG000|Overall Study|Protocol Violation|1|||
149816644|NCT01703741|540458623|FG000|Overall Study|Lost to Follow-up|3|||
149816645|NCT01703741|540458623|FG000|Overall Study|Subject did not want to continue|2|||
149816646|NCT01703741|540458623|FG000|Overall Study|Subject cannot comply with study visits|1|||
149816647|NCT01703741|540458623|FG000|Overall Study|Subject started testosterone injections|1|||
149816648|NCT03066440|540458626|FG000|Overall Study|Physician Decision|1|||
149816649|NCT03066440|540458627|FG001|Overall Study|Physician Decision|1|||
149816650|NCT03066440|540458626|FG000|Overall Study|Protocol Violation|0|||
149816651|NCT03066440|540458627|FG001|Overall Study|Protocol Violation|2|||
149816652|NCT04991311|540458629|FG000|Overall Study|Adverse Event|1|||
149816653|NCT00755937|540458631|FG000|Recruitment|Unknown if infliximab received|164|||
149816654|NCT00755937|540458631|FG000|Observational Follow-up|Lost to Follow-up|148|||
149816655|NCT01106352|540458632|FG000|Overall Study|Subjects untreated|0|||
149816656|NCT01106352|540458633|FG001|Overall Study|Subjects untreated|0|||
149816657|NCT01106352|540458634|FG002|Overall Study|Subjects untreated|0|||
149816658|NCT01106352|540458635|FG003|Overall Study|Subjects untreated|3|||
149816659|NCT01106352|540458636|FG004|Overall Study|Subjects untreated|4|||
149816660|NCT01106352|540458632|FG000|Overall Study|Sponsor Decision|1|||
149816661|NCT01106352|540458633|FG001|Overall Study|Sponsor Decision|0|||
149816662|NCT01106352|540458634|FG002|Overall Study|Sponsor Decision|0|||
149816663|NCT01106352|540458635|FG003|Overall Study|Sponsor Decision|0|||
149816664|NCT01106352|540458636|FG004|Overall Study|Sponsor Decision|0|||
149816665|NCT01106352|540458632|FG000|Overall Study|Too ill to come in for the visit|0|||
149816666|NCT01106352|540458633|FG001|Overall Study|Too ill to come in for the visit|0|||
149816667|NCT01106352|540458634|FG002|Overall Study|Too ill to come in for the visit|1|||
149816668|NCT01106352|540458635|FG003|Overall Study|Too ill to come in for the visit|0|||
149816669|NCT01106352|540458636|FG004|Overall Study|Too ill to come in for the visit|0|||
149816670|NCT01106352|540458632|FG000|Overall Study|Lost to Follow-up|0|||
149816671|NCT01106352|540458633|FG001|Overall Study|Lost to Follow-up|0|||
149816672|NCT01106352|540458634|FG002|Overall Study|Lost to Follow-up|0|||
149816673|NCT01106352|540458635|FG003|Overall Study|Lost to Follow-up|0|||
149816674|NCT01106352|540458636|FG004|Overall Study|Lost to Follow-up|1|||
149816675|NCT01106352|540458632|FG000|Overall Study|Death|0|||
149816676|NCT01106352|540458633|FG001|Overall Study|Death|0|||
149816677|NCT01106352|540458634|FG002|Overall Study|Death|1|||
149816678|NCT01106352|540458635|FG003|Overall Study|Death|3|||
149816679|NCT01106352|540458636|FG004|Overall Study|Death|1|||
149816680|NCT01106352|540458632|FG000|Overall Study|Disease progression|0|||
149816681|NCT01106352|540458633|FG001|Overall Study|Disease progression|0|||
149816682|NCT01106352|540458634|FG002|Overall Study|Disease progression|0|||
149816683|NCT01106352|540458635|FG003|Overall Study|Disease progression|1|||
150158732|NCT04955626|541716393|FG014|Blinded Period|Lost to Follow-up|0|||
150158733|NCT04955626|541716394|FG015|Blinded Period|Lost to Follow-up|12|||
150158734|NCT04955626|541716395|FG016|Blinded Period|Lost to Follow-up|2|||
150158735|NCT04955626|541716396|FG017|Blinded Period|Lost to Follow-up|5|||
150158736|NCT04955626|541716397|FG018|Blinded Period|Lost to Follow-up|0|||
150158737|NCT04955626|541716398|FG019|Blinded Period|Lost to Follow-up|0|||
150158738|NCT04955626|541716399|FG020|Blinded Period|Lost to Follow-up|0|||
150158739|NCT04955626|541716400|FG021|Blinded Period|Lost to Follow-up|0|||
150158740|NCT04955626|541716401|FG022|Blinded Period|Lost to Follow-up|0|||
150158741|NCT04955626|541716402|FG023|Blinded Period|Lost to Follow-up|0|||
150158742|NCT04955626|541716403|FG024|Blinded Period|Lost to Follow-up|3|||
150158743|NCT04955626|541716404|FG025|Blinded Period|Lost to Follow-up|1|||
150158744|NCT04955626|541716405|FG026|Blinded Period|Lost to Follow-up|2|||
150158745|NCT04955626|541716406|FG027|Blinded Period|Lost to Follow-up|2|||
150158746|NCT04955626|541716407|FG028|Blinded Period|Lost to Follow-up|2|||
150158747|NCT04955626|541716408|FG029|Blinded Period|Lost to Follow-up|0|||
150158748|NCT04955626|541716409|FG030|Blinded Period|Lost to Follow-up|0|||
150158749|NCT04955626|541716410|FG031|Blinded Period|Lost to Follow-up|0|||
150158750|NCT04955626|541716411|FG032|Blinded Period|Lost to Follow-up|0|||
150158751|NCT04955626|541716412|FG033|Blinded Period|Lost to Follow-up|0|||
150158752|NCT04955626|541716413|FG034|Blinded Period|Lost to Follow-up|0|||
150158753|NCT04955626|541716414|FG035|Blinded Period|Lost to Follow-up|0|||
150158754|NCT04955626|541716379|FG000|Blinded Period|Protocol Violation|5|||
150158755|NCT04955626|541716380|FG001|Blinded Period|Protocol Violation|14|||
150158756|NCT04955626|541716381|FG002|Blinded Period|Protocol Violation|0|||
150158757|NCT04955626|541716382|FG003|Blinded Period|Protocol Violation|1|||
150158758|NCT04955626|541716383|FG004|Blinded Period|Protocol Violation|2|||
150158759|NCT04955626|541716384|FG005|Blinded Period|Protocol Violation|2|||
150158760|NCT04955626|541716385|FG006|Blinded Period|Protocol Violation|0|||
150158761|NCT04955626|541716386|FG007|Blinded Period|Protocol Violation|0|||
150158762|NCT04955626|541716387|FG008|Blinded Period|Protocol Violation|0|||
150158763|NCT04955626|541716388|FG009|Blinded Period|Protocol Violation|4|||
150158764|NCT04955626|541716389|FG010|Blinded Period|Protocol Violation|6|||
150158765|NCT04955626|541716390|FG011|Blinded Period|Protocol Violation|1|||
150158766|NCT04955626|541716391|FG012|Blinded Period|Protocol Violation|0|||
150158767|NCT04955626|541716392|FG013|Blinded Period|Protocol Violation|0|||
150158768|NCT04955626|541716393|FG014|Blinded Period|Protocol Violation|2|||
150158769|NCT04955626|541716394|FG015|Blinded Period|Protocol Violation|6|||
150158770|NCT04955626|541716395|FG016|Blinded Period|Protocol Violation|4|||
150158771|NCT04955626|541716396|FG017|Blinded Period|Protocol Violation|6|||
150158772|NCT04955626|541716397|FG018|Blinded Period|Protocol Violation|0|||
150158773|NCT04955626|541716398|FG019|Blinded Period|Protocol Violation|1|||
150158774|NCT04955626|541716399|FG020|Blinded Period|Protocol Violation|0|||
150158775|NCT04955626|541716400|FG021|Blinded Period|Protocol Violation|1|||
150158776|NCT04955626|541716401|FG022|Blinded Period|Protocol Violation|0|||
150158777|NCT04955626|541716402|FG023|Blinded Period|Protocol Violation|0|||
150158778|NCT04955626|541716403|FG024|Blinded Period|Protocol Violation|4|||
150158779|NCT04955626|541716404|FG025|Blinded Period|Protocol Violation|6|||
149816684|NCT01106352|540458636|FG004|Overall Study|Disease progression|0|||
149816685|NCT01106352|540458632|FG000|Overall Study|Withdrawal by Subject|0|||
149816686|NCT01106352|540458633|FG001|Overall Study|Withdrawal by Subject|0|||
149816687|NCT01106352|540458634|FG002|Overall Study|Withdrawal by Subject|0|||
149816688|NCT01106352|540458635|FG003|Overall Study|Withdrawal by Subject|3|||
149816689|NCT01106352|540458636|FG004|Overall Study|Withdrawal by Subject|2|||
149816690|NCT01106352|540458632|FG000|Overall Study|Went on hospice|0|||
149816691|NCT01106352|540458633|FG001|Overall Study|Went on hospice|0|||
149816692|NCT01106352|540458634|FG002|Overall Study|Went on hospice|0|||
149816693|NCT01106352|540458635|FG003|Overall Study|Went on hospice|1|||
149816694|NCT01106352|540458636|FG004|Overall Study|Went on hospice|0|||
150158780|NCT04955626|541716405|FG026|Blinded Period|Protocol Violation|5|||
150158781|NCT04955626|541716406|FG027|Blinded Period|Protocol Violation|3|||
150158782|NCT04955626|541716407|FG028|Blinded Period|Protocol Violation|4|||
150158783|NCT04955626|541716408|FG029|Blinded Period|Protocol Violation|3|||
150158784|NCT04955626|541716409|FG030|Blinded Period|Protocol Violation|0|||
150158785|NCT04955626|541716410|FG031|Blinded Period|Protocol Violation|0|||
150158786|NCT04955626|541716411|FG032|Blinded Period|Protocol Violation|0|||
150158787|NCT04955626|541716412|FG033|Blinded Period|Protocol Violation|0|||
150158788|NCT04955626|541716413|FG034|Blinded Period|Protocol Violation|0|||
150158789|NCT04955626|541716414|FG035|Blinded Period|Protocol Violation|0|||
150158790|NCT04955626|541716379|FG000|Blinded Period|Death|0|||
150158791|NCT04955626|541716380|FG001|Blinded Period|Death|2|||
150158792|NCT04955626|541716381|FG002|Blinded Period|Death|0|||
150158793|NCT04955626|541716382|FG003|Blinded Period|Death|0|||
150158794|NCT04955626|541716383|FG004|Blinded Period|Death|0|||
150158795|NCT04955626|541716384|FG005|Blinded Period|Death|0|||
149816695|NCT01106352|540458632|FG000|Overall Study|Subject entered hospice|0|||
150158796|NCT04955626|541716385|FG006|Blinded Period|Death|0|||
150158797|NCT04955626|541716386|FG007|Blinded Period|Death|2|||
150158798|NCT04955626|541716387|FG008|Blinded Period|Death|1|||
150158799|NCT04955626|541716388|FG009|Blinded Period|Death|1|||
150158800|NCT04955626|541716389|FG010|Blinded Period|Death|0|||
149816696|NCT01106352|540458633|FG001|Overall Study|Subject entered hospice|0|||
149816697|NCT01106352|540458634|FG002|Overall Study|Subject entered hospice|0|||
149816698|NCT01106352|540458635|FG003|Overall Study|Subject entered hospice|1|||
149816699|NCT01106352|540458636|FG004|Overall Study|Subject entered hospice|0|||
150158801|NCT04955626|541716390|FG011|Blinded Period|Death|2|||
150158802|NCT04955626|541716391|FG012|Blinded Period|Death|0|||
150158803|NCT04955626|541716392|FG013|Blinded Period|Death|0|||
150158804|NCT04955626|541716393|FG014|Blinded Period|Death|0|||
150158805|NCT04955626|541716394|FG015|Blinded Period|Death|0|||
149816700|NCT01106352|540458632|FG000|Overall Study|Home hospice since July 2013|0|||
149816701|NCT01106352|540458633|FG001|Overall Study|Home hospice since July 2013|0|||
149816702|NCT01106352|540458634|FG002|Overall Study|Home hospice since July 2013|0|||
149816703|NCT01106352|540458635|FG003|Overall Study|Home hospice since July 2013|1|||
149816704|NCT01106352|540458636|FG004|Overall Study|Home hospice since July 2013|0|||
149816705|NCT03876873|540458637|FG000|Overall Study|Physician Decision|0|||
149816706|NCT03876873|540458638|FG001|Overall Study|Physician Decision|1|||
149816707|NCT03547531|540458639|FG000|Overall Study|not coming in data collection : sick|2|||
149816708|NCT03547531|540458640|FG001|Overall Study|not coming in data collection : sick|2|||
149816709|NCT03547531|540458639|FG000|Overall Study|having family occasion|0|||
149816710|NCT03547531|540458640|FG001|Overall Study|having family occasion|2|||
149816711|NCT03944707|540458641|FG000|Overall Study|Adverse Event|0|||
149816712|NCT03944707|540458642|FG001|Overall Study|Adverse Event|2|||
149816713|NCT03944707|540458641|FG000|Overall Study|Study terminated by sponsor|12|||
149816714|NCT03944707|540458642|FG001|Overall Study|Study terminated by sponsor|7|||
149816715|NCT03944707|540458641|FG000|Overall Study|Subject decision|0|||
149816716|NCT03944707|540458642|FG001|Overall Study|Subject decision|1|||
149816717|NCT00751998|540458656|FG000|Overall Study|Lost to Follow-up|7|||
149816718|NCT00751998|540458656|FG000|Overall Study|Death|11|||
150158806|NCT04955626|541716395|FG016|Blinded Period|Death|0|||
150158807|NCT04955626|541716396|FG017|Blinded Period|Death|0|||
150158808|NCT04955626|541716397|FG018|Blinded Period|Death|0|||
150158809|NCT04955626|541716398|FG019|Blinded Period|Death|0|||
150158810|NCT04955626|541716399|FG020|Blinded Period|Death|0|||
150158811|NCT04955626|541716400|FG021|Blinded Period|Death|0|||
150158812|NCT04955626|541716401|FG022|Blinded Period|Death|0|||
149816719|NCT00751998|540458656|FG000|Overall Study|Withdrawal by Subject|2|||
149816720|NCT04126733|540458657|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
149816721|NCT04126733|540458657|FG000|Treatment Period|Adverse Event|8|||
149816722|NCT04126733|540458657|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
149816723|NCT04126733|540458657|FG000|Treatment Period|Physician Decision|5|||
149816724|NCT04126733|540458657|FG000|Treatment Period|Death|1|||
149816725|NCT04126733|540458657|FG000|Treatment Period|Other Reasons|2|||
149816726|NCT04126733|540458657|FG000|Active Follow-up Period|Death|13|||
149816727|NCT04126733|540458657|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
149816728|NCT04126733|540458657|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
149816729|NCT04126733|540458657|FG000|Active Follow-up Period|Other Reasons|1|||
149816730|NCT04126733|540458657|FG000|Long-term Follow-up Period|Death|22|||
149816731|NCT04126733|540458657|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
149816732|NCT04126733|540458657|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
149816733|NCT02598193|540458658|FG000|Overall Study|Adverse Event|13|||
149816734|NCT02598193|540458658|FG000|Overall Study|Withdrawal by Subject|1|||
149816735|NCT02598193|540458658|FG000|Overall Study|Listed in active lung transplant list|1|||
149816736|NCT02598193|540458658|FG000|Overall Study|Does not want to take Nintedanib|1|||
149816737|NCT02555618|540458659|FG000|Overall Study|Sponsor's Circumstances|1|||
149816738|NCT02555618|540458660|FG001|Overall Study|Sponsor's Circumstances|0|||
149816739|NCT01280981|540458667|FG000|Overall Study|Withdrawal by Subject|11|||
149816740|NCT01280981|540458667|FG000|Overall Study|Protocol Violation|2|||
149816741|NCT01280981|540458667|FG000|Overall Study|Lack of Efficacy|13|||
149816742|NCT01280981|540458667|FG000|Overall Study|Lost to Follow-up|3|||
149816743|NCT01280981|540458667|FG000|Overall Study|Adverse Event|6|||
149816744|NCT01280981|540458667|FG000|Overall Study|Irregular or discontinued menses|3|||
149816745|NCT01280981|540458667|FG000|Overall Study|Failed to return|45|||
149816746|NCT01280981|540458667|FG000|Overall Study|Non-compliance with protocol|3|||
149816747|NCT01280981|540458667|FG000|Overall Study|Withdrawal of consent|3|||
149816748|NCT01280981|540458667|FG000|Overall Study|Elective surgery|2|||
149816749|NCT01280981|540458667|FG000|Overall Study|Study site closure|1|||
149816750|NCT01254045|540458669|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
149816751|NCT01254045|540458670|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
149816752|NCT01254045|540458671|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
149816753|NCT01254045|540458672|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
149816754|NCT01254045|540458673|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
149816755|NCT01254045|540458674|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
149816756|NCT00520351|540458675|FG000|First Intervention|Withdrawal by Subject|1|||
149816757|NCT00520351|540458676|FG001|First Intervention|Withdrawal by Subject|1|||
149816758|NCT03797222|540458678|FG000|Overall Study|Withdrawal by Subject|1|||
149816759|NCT04288115|540458683|FG000|Overall Study|Withdrawal by Subject|0|||
149816760|NCT04288115|540458684|FG001|Overall Study|Withdrawal by Subject|1|||
149816761|NCT04288115|540458683|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
149816762|NCT04288115|540458684|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
149816763|NCT00729365|540458685|FG000|Overall Study|Physician Decision|33|||
149816764|NCT00729365|540458686|FG001|Overall Study|Physician Decision|6|||
149816765|NCT00729365|540458687|FG002|Overall Study|Physician Decision|7|||
149816766|NCT02766400|540458691|FG000|Overall Study|Death|1|||
149816767|NCT02766400|540458692|FG001|Overall Study|Death|2|||
149816768|NCT02766400|540458691|FG000|Overall Study|Withdrawal by Subject|1|||
149816769|NCT02766400|540458692|FG001|Overall Study|Withdrawal by Subject|0|||
149816770|NCT01133392|540458693|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
149816771|NCT01133392|540458694|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
149816772|NCT01133392|540458693|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
149816773|NCT01133392|540458694|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
149816774|NCT03185949|540458695|FG000|ITT Analysis|Withdrawal by Subject|4|||
149816775|NCT03185949|540458696|FG001|ITT Analysis|Withdrawal by Subject|3|||
149816776|NCT03185949|540458695|FG000|PP Analysis|Protocol Violation|2|||
149816777|NCT03185949|540458696|FG001|PP Analysis|Protocol Violation|2|||
149816778|NCT03185949|540458695|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
149816779|NCT03185949|540458696|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
149816780|NCT03751124|540458702|FG000|Overall Study|Adverse Event|4|||
149816781|NCT03751124|540458703|FG001|Overall Study|Adverse Event|3|||
149816782|NCT03751124|540458702|FG000|Overall Study|Protocol Deviation|0|||
149816783|NCT03751124|540458703|FG001|Overall Study|Protocol Deviation|1|||
149816784|NCT03751124|540458702|FG000|Overall Study|Lost to Follow-up|6|||
150158813|NCT04955626|541716402|FG023|Blinded Period|Death|1|||
150158814|NCT04955626|541716403|FG024|Blinded Period|Death|0|||
149816785|NCT03751124|540458703|FG001|Overall Study|Lost to Follow-up|4|||
149816786|NCT03751124|540458702|FG000|Overall Study|Withdrawal by Subject|6|||
149816787|NCT03751124|540458703|FG001|Overall Study|Withdrawal by Subject|8|||
149816788|NCT03751124|540458702|FG000|Overall Study|Lack of Efficacy|1|||
149816789|NCT03751124|540458703|FG001|Overall Study|Lack of Efficacy|1|||
149816790|NCT03751124|540458702|FG000|Overall Study|Pregnancy|0|||
149816791|NCT03751124|540458703|FG001|Overall Study|Pregnancy|1|||
149816792|NCT03751124|540458702|FG000|Overall Study|Other|9|||
149816793|NCT03751124|540458703|FG001|Overall Study|Other|9|||
149816794|NCT03751124|540458702|FG000|Overall Study|Participants who did not receive any study drug|0|||
149816795|NCT03751124|540458703|FG001|Overall Study|Participants who did not receive any study drug|1|||
149816796|NCT01406873|540459902|FG000|Overall Study|Withdrawal by Subject|1|||
149816797|NCT01406873|540459903|FG001|Overall Study|Withdrawal by Subject|1|||
149816798|NCT00854620|540459904|FG000|Overall Study|Adverse Event|1|||
149816799|NCT01169649|540459908|FG000|Overall Study|Patient Not Treated|3|||
149816800|NCT00534092|540459909|FG000|Overall Study|Lost to Follow-up|1|||
149816801|NCT00534092|540459910|FG001|Overall Study|Lost to Follow-up|0|||
149816802|NCT00534092|540459909|FG000|Overall Study|personal reasons/family concerns|1|||
149816803|NCT00534092|540459910|FG001|Overall Study|personal reasons/family concerns|0|||
149816804|NCT02919475|540459911|FG000|Overall Study|Adverse Event|3|||
149816805|NCT02919475|540459912|FG001|Overall Study|Adverse Event|3|||
149816806|NCT02919475|540459913|FG002|Overall Study|Adverse Event|3|||
149816807|NCT02919475|540459914|FG003|Overall Study|Adverse Event|9|||
149816808|NCT02919475|540459915|FG004|Overall Study|Adverse Event|2|||
149816809|NCT02919475|540459911|FG000|Overall Study|Death|0|||
149816810|NCT02919475|540459912|FG001|Overall Study|Death|1|||
149816811|NCT02919475|540459913|FG002|Overall Study|Death|0|||
149816812|NCT02919475|540459914|FG003|Overall Study|Death|0|||
149816813|NCT02919475|540459915|FG004|Overall Study|Death|0|||
149816814|NCT02919475|540459911|FG000|Overall Study|Lost to Follow-up|0|||
149816815|NCT02919475|540459912|FG001|Overall Study|Lost to Follow-up|0|||
149816816|NCT02919475|540459913|FG002|Overall Study|Lost to Follow-up|0|||
149816817|NCT02919475|540459914|FG003|Overall Study|Lost to Follow-up|1|||
149816818|NCT02919475|540459915|FG004|Overall Study|Lost to Follow-up|0|||
149816819|NCT02919475|540459911|FG000|Overall Study|Withdrawal by Subject|2|||
149816820|NCT02919475|540459912|FG001|Overall Study|Withdrawal by Subject|3|||
149816821|NCT02919475|540459913|FG002|Overall Study|Withdrawal by Subject|1|||
149816822|NCT02919475|540459914|FG003|Overall Study|Withdrawal by Subject|2|||
150158815|NCT04955626|541716404|FG025|Blinded Period|Death|0|||
150158816|NCT04955626|541716405|FG026|Blinded Period|Death|1|||
150158817|NCT04955626|541716406|FG027|Blinded Period|Death|1|||
150158818|NCT04955626|541716407|FG028|Blinded Period|Death|0|||
150158819|NCT04955626|541716408|FG029|Blinded Period|Death|1|||
150158820|NCT04955626|541716409|FG030|Blinded Period|Death|0|||
150158821|NCT04955626|541716410|FG031|Blinded Period|Death|0|||
150158822|NCT04955626|541716411|FG032|Blinded Period|Death|0|||
150158823|NCT04955626|541716412|FG033|Blinded Period|Death|0|||
150158824|NCT04955626|541716413|FG034|Blinded Period|Death|0|||
150158825|NCT04955626|541716414|FG035|Blinded Period|Death|0|||
150158826|NCT04955626|541716379|FG000|Blinded Period|Adverse Event|0|||
150158827|NCT04955626|541716380|FG001|Blinded Period|Adverse Event|1|||
150158828|NCT04955626|541716381|FG002|Blinded Period|Adverse Event|1|||
150158829|NCT04955626|541716382|FG003|Blinded Period|Adverse Event|1|||
150158830|NCT04955626|541716383|FG004|Blinded Period|Adverse Event|0|||
150158831|NCT04955626|541716384|FG005|Blinded Period|Adverse Event|0|||
150158832|NCT04955626|541716385|FG006|Blinded Period|Adverse Event|0|||
150158833|NCT04955626|541716386|FG007|Blinded Period|Adverse Event|0|||
150158834|NCT04955626|541716387|FG008|Blinded Period|Adverse Event|0|||
150158835|NCT04955626|541716388|FG009|Blinded Period|Adverse Event|1|||
150158836|NCT04955626|541716389|FG010|Blinded Period|Adverse Event|1|||
150158837|NCT04955626|541716390|FG011|Blinded Period|Adverse Event|0|||
150158838|NCT04955626|541716391|FG012|Blinded Period|Adverse Event|0|||
150158839|NCT04955626|541716392|FG013|Blinded Period|Adverse Event|0|||
150158840|NCT04955626|541716393|FG014|Blinded Period|Adverse Event|0|||
150158841|NCT04955626|541716394|FG015|Blinded Period|Adverse Event|0|||
150158842|NCT04955626|541716395|FG016|Blinded Period|Adverse Event|0|||
150158843|NCT04955626|541716396|FG017|Blinded Period|Adverse Event|0|||
150158844|NCT04955626|541716397|FG018|Blinded Period|Adverse Event|1|||
150158845|NCT04955626|541716398|FG019|Blinded Period|Adverse Event|0|||
150158846|NCT04955626|541716399|FG020|Blinded Period|Adverse Event|0|||
150158847|NCT04955626|541716400|FG021|Blinded Period|Adverse Event|0|||
150158848|NCT04955626|541716401|FG022|Blinded Period|Adverse Event|0|||
150158849|NCT04955626|541716402|FG023|Blinded Period|Adverse Event|0|||
150158850|NCT04955626|541716403|FG024|Blinded Period|Adverse Event|0|||
150158851|NCT04955626|541716404|FG025|Blinded Period|Adverse Event|0|||
150158852|NCT04955626|541716405|FG026|Blinded Period|Adverse Event|1|||
150158853|NCT04955626|541716406|FG027|Blinded Period|Adverse Event|0|||
150158854|NCT04955626|541716407|FG028|Blinded Period|Adverse Event|0|||
150158855|NCT04955626|541716408|FG029|Blinded Period|Adverse Event|0|||
150158856|NCT04955626|541716409|FG030|Blinded Period|Adverse Event|0|||
150158857|NCT04955626|541716410|FG031|Blinded Period|Adverse Event|0|||
150158858|NCT04955626|541716411|FG032|Blinded Period|Adverse Event|0|||
150158859|NCT04955626|541716412|FG033|Blinded Period|Adverse Event|0|||
150158860|NCT04955626|541716413|FG034|Blinded Period|Adverse Event|0|||
150158861|NCT04955626|541716414|FG035|Blinded Period|Adverse Event|0|||
150158862|NCT04955626|541716379|FG000|Blinded Period|No longer meets eligibility criteria|1|||
150158863|NCT04955626|541716380|FG001|Blinded Period|No longer meets eligibility criteria|2|||
150158864|NCT04955626|541716381|FG002|Blinded Period|No longer meets eligibility criteria|0|||
150158865|NCT04955626|541716382|FG003|Blinded Period|No longer meets eligibility criteria|1|||
150158866|NCT04955626|541716383|FG004|Blinded Period|No longer meets eligibility criteria|0|||
150158867|NCT04955626|541716384|FG005|Blinded Period|No longer meets eligibility criteria|0|||
150158868|NCT04955626|541716385|FG006|Blinded Period|No longer meets eligibility criteria|0|||
150158869|NCT04955626|541716386|FG007|Blinded Period|No longer meets eligibility criteria|0|||
150158870|NCT04955626|541716387|FG008|Blinded Period|No longer meets eligibility criteria|1|||
150158871|NCT04955626|541716388|FG009|Blinded Period|No longer meets eligibility criteria|0|||
150158872|NCT04955626|541716389|FG010|Blinded Period|No longer meets eligibility criteria|1|||
150158873|NCT04955626|541716390|FG011|Blinded Period|No longer meets eligibility criteria|1|||
150158874|NCT04955626|541716391|FG012|Blinded Period|No longer meets eligibility criteria|0|||
150158875|NCT04955626|541716392|FG013|Blinded Period|No longer meets eligibility criteria|0|||
150158876|NCT04955626|541716393|FG014|Blinded Period|No longer meets eligibility criteria|0|||
150158877|NCT04955626|541716394|FG015|Blinded Period|No longer meets eligibility criteria|3|||
150158878|NCT04955626|541716395|FG016|Blinded Period|No longer meets eligibility criteria|0|||
150158879|NCT04955626|541716396|FG017|Blinded Period|No longer meets eligibility criteria|2|||
150158880|NCT04955626|541716397|FG018|Blinded Period|No longer meets eligibility criteria|0|||
150158881|NCT04955626|541716398|FG019|Blinded Period|No longer meets eligibility criteria|0|||
150158882|NCT04955626|541716399|FG020|Blinded Period|No longer meets eligibility criteria|0|||
150158883|NCT04955626|541716400|FG021|Blinded Period|No longer meets eligibility criteria|0|||
150158884|NCT04955626|541716401|FG022|Blinded Period|No longer meets eligibility criteria|0|||
150158885|NCT04955626|541716402|FG023|Blinded Period|No longer meets eligibility criteria|0|||
150158886|NCT04955626|541716403|FG024|Blinded Period|No longer meets eligibility criteria|1|||
150158887|NCT04955626|541716404|FG025|Blinded Period|No longer meets eligibility criteria|0|||
150158888|NCT04955626|541716405|FG026|Blinded Period|No longer meets eligibility criteria|0|||
150158889|NCT04955626|541716406|FG027|Blinded Period|No longer meets eligibility criteria|1|||
150158890|NCT04955626|541716407|FG028|Blinded Period|No longer meets eligibility criteria|0|||
150158891|NCT04955626|541716408|FG029|Blinded Period|No longer meets eligibility criteria|0|||
150158892|NCT04955626|541716409|FG030|Blinded Period|No longer meets eligibility criteria|0|||
150158893|NCT04955626|541716410|FG031|Blinded Period|No longer meets eligibility criteria|0|||
150158894|NCT04955626|541716411|FG032|Blinded Period|No longer meets eligibility criteria|0|||
150158895|NCT04955626|541716412|FG033|Blinded Period|No longer meets eligibility criteria|0|||
150158896|NCT04955626|541716413|FG034|Blinded Period|No longer meets eligibility criteria|0|||
150158897|NCT04955626|541716414|FG035|Blinded Period|No longer meets eligibility criteria|0|||
150158898|NCT04955626|541716379|FG000|Blinded Period|Other|54|||
150158899|NCT04955626|541716380|FG001|Blinded Period|Other|3|||
150158900|NCT04955626|541716381|FG002|Blinded Period|Other|4|||
150158901|NCT04955626|541716382|FG003|Blinded Period|Other|2|||
150158902|NCT04955626|541716383|FG004|Blinded Period|Other|0|||
150158903|NCT04955626|541716384|FG005|Blinded Period|Other|0|||
150158904|NCT04955626|541716385|FG006|Blinded Period|Other|2|||
150158905|NCT04955626|541716386|FG007|Blinded Period|Other|2|||
150158906|NCT04955626|541716387|FG008|Blinded Period|Other|1|||
150158907|NCT04955626|541716388|FG009|Blinded Period|Other|0|||
150158908|NCT04955626|541716389|FG010|Blinded Period|Other|1|||
150158909|NCT04955626|541716390|FG011|Blinded Period|Other|1|||
150158910|NCT04955626|541716391|FG012|Blinded Period|Other|0|||
150158911|NCT04955626|541716392|FG013|Blinded Period|Other|0|||
150158912|NCT04955626|541716393|FG014|Blinded Period|Other|0|||
150158913|NCT04955626|541716394|FG015|Blinded Period|Other|0|||
150158914|NCT04955626|541716395|FG016|Blinded Period|Other|0|||
150158915|NCT04955626|541716396|FG017|Blinded Period|Other|1|||
150158916|NCT04955626|541716397|FG018|Blinded Period|Other|0|||
150158917|NCT04955626|541716398|FG019|Blinded Period|Other|0|||
150158918|NCT04955626|541716399|FG020|Blinded Period|Other|0|||
150158919|NCT04955626|541716400|FG021|Blinded Period|Other|0|||
150158920|NCT04955626|541716401|FG022|Blinded Period|Other|0|||
150158921|NCT04955626|541716402|FG023|Blinded Period|Other|0|||
150158922|NCT04955626|541716403|FG024|Blinded Period|Other|0|||
150158923|NCT04955626|541716404|FG025|Blinded Period|Other|0|||
150158924|NCT04955626|541716405|FG026|Blinded Period|Other|2|||
150158925|NCT04955626|541716406|FG027|Blinded Period|Other|0|||
150158926|NCT04955626|541716407|FG028|Blinded Period|Other|0|||
150158927|NCT04955626|541716408|FG029|Blinded Period|Other|0|||
150158928|NCT04955626|541716409|FG030|Blinded Period|Other|0|||
150158929|NCT04955626|541716410|FG031|Blinded Period|Other|0|||
150158930|NCT04955626|541716411|FG032|Blinded Period|Other|0|||
150158931|NCT04955626|541716412|FG033|Blinded Period|Other|0|||
150158932|NCT04955626|541716413|FG034|Blinded Period|Other|0|||
150158933|NCT04955626|541716414|FG035|Blinded Period|Other|0|||
150158934|NCT04955626|541716379|FG000|Blinded Period|Physician Decision|1|||
150158935|NCT04955626|541716380|FG001|Blinded Period|Physician Decision|1|||
150158936|NCT04955626|541716381|FG002|Blinded Period|Physician Decision|0|||
150158937|NCT04955626|541716382|FG003|Blinded Period|Physician Decision|3|||
150158938|NCT04955626|541716383|FG004|Blinded Period|Physician Decision|0|||
150158939|NCT04955626|541716384|FG005|Blinded Period|Physician Decision|0|||
150158940|NCT04955626|541716385|FG006|Blinded Period|Physician Decision|1|||
150158941|NCT04955626|541716386|FG007|Blinded Period|Physician Decision|1|||
150158942|NCT04955626|541716387|FG008|Blinded Period|Physician Decision|0|||
150158943|NCT04955626|541716388|FG009|Blinded Period|Physician Decision|0|||
150158944|NCT04955626|541716389|FG010|Blinded Period|Physician Decision|0|||
150158945|NCT04955626|541716390|FG011|Blinded Period|Physician Decision|5|||
150158946|NCT04955626|541716391|FG012|Blinded Period|Physician Decision|0|||
150158947|NCT04955626|541716392|FG013|Blinded Period|Physician Decision|0|||
150158948|NCT04955626|541716393|FG014|Blinded Period|Physician Decision|0|||
150158949|NCT04955626|541716394|FG015|Blinded Period|Physician Decision|0|||
150158950|NCT04955626|541716395|FG016|Blinded Period|Physician Decision|0|||
150158951|NCT04955626|541716396|FG017|Blinded Period|Physician Decision|0|||
149816823|NCT02919475|540459915|FG004|Overall Study|Withdrawal by Subject|2|||
150158952|NCT04955626|541716397|FG018|Blinded Period|Physician Decision|0|||
150158953|NCT04955626|541716398|FG019|Blinded Period|Physician Decision|0|||
150158954|NCT04955626|541716399|FG020|Blinded Period|Physician Decision|0|||
150158955|NCT04955626|541716400|FG021|Blinded Period|Physician Decision|0|||
150158956|NCT04955626|541716401|FG022|Blinded Period|Physician Decision|0|||
149816824|NCT02919475|540459911|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
149816825|NCT02919475|540459912|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
149816826|NCT02919475|540459913|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
149816827|NCT02919475|540459914|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
149816828|NCT02919475|540459915|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149816829|NCT02323295|540459916|FG000|Overall Study|Adverse Event|0|||
149816830|NCT02323295|540459917|FG001|Overall Study|Adverse Event|1|||
149816831|NCT02323295|540459916|FG000|Overall Study|Withdrawal by Subject|0|||
149816832|NCT02323295|540459917|FG001|Overall Study|Withdrawal by Subject|1|||
149816833|NCT02323295|540459916|FG000|Overall Study|Patient did not have surgery as planned.|0|||
149816834|NCT02323295|540459917|FG001|Overall Study|Patient did not have surgery as planned.|1|||
149816835|NCT00775983|540459918|FG000|Overall Study|Protocol Violation|1|||
149816836|NCT00775983|540459919|FG001|Overall Study|Protocol Violation|2|||
149816837|NCT01059071|540459920|FG000|Overall Study|Lack of Efficacy|1|||
149816838|NCT01059071|540459921|FG001|Overall Study|Lack of Efficacy|4|||
149816839|NCT01059071|540459922|FG002|Overall Study|Lack of Efficacy|2|||
149816840|NCT01059071|540459923|FG003|Overall Study|Lack of Efficacy|3|||
149816841|NCT01059071|540459920|FG000|Overall Study|Withdrawal by Subject|1|||
149816842|NCT01059071|540459921|FG001|Overall Study|Withdrawal by Subject|0|||
149816843|NCT01059071|540459922|FG002|Overall Study|Withdrawal by Subject|0|||
149816844|NCT01059071|540459923|FG003|Overall Study|Withdrawal by Subject|2|||
149816845|NCT01059071|540459920|FG000|Overall Study|Physician Decision|0|||
149816846|NCT01059071|540459921|FG001|Overall Study|Physician Decision|0|||
149816847|NCT01059071|540459922|FG002|Overall Study|Physician Decision|0|||
149816848|NCT01059071|540459923|FG003|Overall Study|Physician Decision|1|||
149816849|NCT00936884|540459924|FG000|Double-blind|Withdrawal by Subject|6|||
149816850|NCT00936884|540459925|FG001|Double-blind|Withdrawal by Subject|4|||
149816851|NCT00936884|540459926|FG002|Double-blind|Withdrawal by Subject|0|||
149816852|NCT00936884|540459924|FG000|Double-blind|Death|2|||
149816853|NCT00936884|540459925|FG001|Double-blind|Death|1|||
149816854|NCT00936884|540459926|FG002|Double-blind|Death|0|||
149816855|NCT00936884|540459924|FG000|Double-blind|Lack of Efficacy|1|||
149816856|NCT00936884|540459925|FG001|Double-blind|Lack of Efficacy|1|||
149816857|NCT00936884|540459926|FG002|Double-blind|Lack of Efficacy|0|||
149816858|NCT00936884|540459924|FG000|Double-blind|Adverse Event|1|||
149816859|NCT00936884|540459925|FG001|Double-blind|Adverse Event|0|||
149816860|NCT00936884|540459926|FG002|Double-blind|Adverse Event|0|||
150158957|NCT04955626|541716402|FG023|Blinded Period|Physician Decision|0|||
150158958|NCT04955626|541716403|FG024|Blinded Period|Physician Decision|0|||
149816861|NCT00936884|540459924|FG000|Double-blind|Physician Decision|1|||
149816862|NCT00936884|540459925|FG001|Double-blind|Physician Decision|0|||
149816863|NCT00936884|540459926|FG002|Double-blind|Physician Decision|0|||
149816864|NCT00936884|540459924|FG000|Double-blind|No post baseline diary entry|1|||
149816865|NCT00936884|540459925|FG001|Double-blind|No post baseline diary entry|0|||
149816866|NCT00936884|540459926|FG002|Double-blind|No post baseline diary entry|0|||
149816867|NCT00936884|540459924|FG000|Double-blind|Did not receive study drug|0|||
149816868|NCT00936884|540459925|FG001|Double-blind|Did not receive study drug|1|||
150158959|NCT04955626|541716404|FG025|Blinded Period|Physician Decision|0|||
150158960|NCT04955626|541716405|FG026|Blinded Period|Physician Decision|0|||
150158961|NCT04955626|541716406|FG027|Blinded Period|Physician Decision|0|||
150158962|NCT04955626|541716407|FG028|Blinded Period|Physician Decision|0|||
150158963|NCT04955626|541716408|FG029|Blinded Period|Physician Decision|0|||
150158964|NCT04955626|541716409|FG030|Blinded Period|Physician Decision|0|||
150158965|NCT04955626|541716410|FG031|Blinded Period|Physician Decision|0|||
150158966|NCT04955626|541716411|FG032|Blinded Period|Physician Decision|0|||
150158967|NCT04955626|541716412|FG033|Blinded Period|Physician Decision|0|||
150158968|NCT04955626|541716413|FG034|Blinded Period|Physician Decision|0|||
150158969|NCT04955626|541716414|FG035|Blinded Period|Physician Decision|0|||
150158970|NCT04955626|541716379|FG000|Blinded Period|Withdrawal by Subject|26|||
150158971|NCT04955626|541716380|FG001|Blinded Period|Withdrawal by Subject|62|||
150158972|NCT04955626|541716381|FG002|Blinded Period|Withdrawal by Subject|14|||
150158973|NCT04955626|541716382|FG003|Blinded Period|Withdrawal by Subject|16|||
150158974|NCT04955626|541716383|FG004|Blinded Period|Withdrawal by Subject|1|||
150158975|NCT04955626|541716384|FG005|Blinded Period|Withdrawal by Subject|2|||
150158976|NCT04955626|541716385|FG006|Blinded Period|Withdrawal by Subject|9|||
150158977|NCT04955626|541716386|FG007|Blinded Period|Withdrawal by Subject|5|||
150158978|NCT04955626|541716387|FG008|Blinded Period|Withdrawal by Subject|3|||
150158979|NCT04955626|541716388|FG009|Blinded Period|Withdrawal by Subject|15|||
150158980|NCT04955626|541716389|FG010|Blinded Period|Withdrawal by Subject|11|||
150158981|NCT04955626|541716390|FG011|Blinded Period|Withdrawal by Subject|7|||
150158982|NCT04955626|541716391|FG012|Blinded Period|Withdrawal by Subject|2|||
150158983|NCT04955626|541716392|FG013|Blinded Period|Withdrawal by Subject|0|||
150158984|NCT04955626|541716393|FG014|Blinded Period|Withdrawal by Subject|1|||
150158985|NCT04955626|541716394|FG015|Blinded Period|Withdrawal by Subject|11|||
150158986|NCT04955626|541716395|FG016|Blinded Period|Withdrawal by Subject|2|||
150158987|NCT04955626|541716396|FG017|Blinded Period|Withdrawal by Subject|5|||
150158988|NCT04955626|541716397|FG018|Blinded Period|Withdrawal by Subject|0|||
150158989|NCT04955626|541716398|FG019|Blinded Period|Withdrawal by Subject|0|||
150158990|NCT04955626|541716399|FG020|Blinded Period|Withdrawal by Subject|1|||
150158991|NCT04955626|541716400|FG021|Blinded Period|Withdrawal by Subject|0|||
150158992|NCT04955626|541716401|FG022|Blinded Period|Withdrawal by Subject|0|||
150158993|NCT04955626|541716402|FG023|Blinded Period|Withdrawal by Subject|0|||
150158994|NCT04955626|541716403|FG024|Blinded Period|Withdrawal by Subject|5|||
150158995|NCT04955626|541716404|FG025|Blinded Period|Withdrawal by Subject|1|||
150158996|NCT04955626|541716405|FG026|Blinded Period|Withdrawal by Subject|5|||
150158997|NCT04955626|541716406|FG027|Blinded Period|Withdrawal by Subject|1|||
150158998|NCT04955626|541716407|FG028|Blinded Period|Withdrawal by Subject|4|||
149816869|NCT00936884|540459926|FG002|Double-blind|Did not receive study drug|0|||
149816870|NCT02280421|540459929|FG000|Washout (2 Weeks)|Adverse Event|0|||
149816871|NCT02280421|540459930|FG001|Washout (2 Weeks)|Adverse Event|1|||
149816872|NCT02280421|540459929|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
150158999|NCT04955626|541716408|FG029|Blinded Period|Withdrawal by Subject|2|||
150159000|NCT04955626|541716409|FG030|Blinded Period|Withdrawal by Subject|0|||
150159001|NCT04955626|541716410|FG031|Blinded Period|Withdrawal by Subject|0|||
150159002|NCT04955626|541716411|FG032|Blinded Period|Withdrawal by Subject|0|||
150159003|NCT04955626|541716412|FG033|Blinded Period|Withdrawal by Subject|0|||
150159004|NCT04955626|541716413|FG034|Blinded Period|Withdrawal by Subject|0|||
150159005|NCT04955626|541716414|FG035|Blinded Period|Withdrawal by Subject|0|||
150159006|NCT04955626|541716379|FG000|Blinded Period|Refused further study procedures|0|||
150159007|NCT04955626|541716380|FG001|Blinded Period|Refused further study procedures|0|||
150159008|NCT04955626|541716381|FG002|Blinded Period|Refused further study procedures|0|||
150159009|NCT04955626|541716382|FG003|Blinded Period|Refused further study procedures|0|||
150159010|NCT04955626|541716383|FG004|Blinded Period|Refused further study procedures|0|||
150159011|NCT04955626|541716384|FG005|Blinded Period|Refused further study procedures|0|||
150159012|NCT04955626|541716385|FG006|Blinded Period|Refused further study procedures|1|||
150159013|NCT04955626|541716386|FG007|Blinded Period|Refused further study procedures|0|||
150159014|NCT04955626|541716387|FG008|Blinded Period|Refused further study procedures|0|||
150159015|NCT04955626|541716388|FG009|Blinded Period|Refused further study procedures|0|||
150159016|NCT04955626|541716389|FG010|Blinded Period|Refused further study procedures|0|||
150159017|NCT04955626|541716390|FG011|Blinded Period|Refused further study procedures|2|||
150159018|NCT04955626|541716391|FG012|Blinded Period|Refused further study procedures|0|||
150159019|NCT04955626|541716392|FG013|Blinded Period|Refused further study procedures|0|||
150159020|NCT04955626|541716393|FG014|Blinded Period|Refused further study procedures|0|||
150159021|NCT04955626|541716394|FG015|Blinded Period|Refused further study procedures|0|||
150159022|NCT04955626|541716395|FG016|Blinded Period|Refused further study procedures|0|||
150159023|NCT04955626|541716396|FG017|Blinded Period|Refused further study procedures|0|||
150159024|NCT04955626|541716397|FG018|Blinded Period|Refused further study procedures|0|||
150159025|NCT04955626|541716398|FG019|Blinded Period|Refused further study procedures|0|||
149816873|NCT02280421|540459930|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
149816874|NCT02410837|540459931|FG000|Overall Study|Death|387|||
149816875|NCT02410837|540459931|FG000|Overall Study|Lost to Follow-up|50|||
149816876|NCT02410837|540459931|FG000|Overall Study|Withdrawal by Subject|44|||
149816877|NCT02410837|540459931|FG000|Overall Study|Physician Decision|6|||
149816878|NCT02410837|540459931|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
150159026|NCT04955626|541716399|FG020|Blinded Period|Refused further study procedures|0|||
150159027|NCT04955626|541716400|FG021|Blinded Period|Refused further study procedures|0|||
150159028|NCT04955626|541716401|FG022|Blinded Period|Refused further study procedures|0|||
149816879|NCT00837577|540459932|FG000|Double-blind Period|Clinical Adverse Event|1|||
149816880|NCT00837577|540459933|FG001|Double-blind Period|Clinical Adverse Event|0|||
150159029|NCT04955626|541716402|FG023|Blinded Period|Refused further study procedures|0|||
150159030|NCT04955626|541716403|FG024|Blinded Period|Refused further study procedures|0|||
150159031|NCT04955626|541716404|FG025|Blinded Period|Refused further study procedures|0|||
150159032|NCT04955626|541716405|FG026|Blinded Period|Refused further study procedures|0|||
150159033|NCT04955626|541716406|FG027|Blinded Period|Refused further study procedures|0|||
150159034|NCT04955626|541716407|FG028|Blinded Period|Refused further study procedures|0|||
150159035|NCT04955626|541716408|FG029|Blinded Period|Refused further study procedures|0|||
150159036|NCT04955626|541716409|FG030|Blinded Period|Refused further study procedures|0|||
150159037|NCT04955626|541716410|FG031|Blinded Period|Refused further study procedures|0|||
150159038|NCT04955626|541716411|FG032|Blinded Period|Refused further study procedures|0|||
150159039|NCT04955626|541716412|FG033|Blinded Period|Refused further study procedures|0|||
150159040|NCT04955626|541716413|FG034|Blinded Period|Refused further study procedures|0|||
150159041|NCT04955626|541716414|FG035|Blinded Period|Refused further study procedures|0|||
150159042|NCT04955626|541716379|FG000|Blinded Period|Participants entered open label period|4544|||
150159043|NCT04955626|541716380|FG001|Blinded Period|Participants entered open label period|4906|||
150159044|NCT04955626|541716381|FG002|Blinded Period|Participants entered open label period|0|||
150159045|NCT04955626|541716382|FG003|Blinded Period|Participants entered open label period|0|||
150159046|NCT04955626|541716383|FG004|Blinded Period|Participants entered open label period|0|||
150159047|NCT04955626|541716384|FG005|Blinded Period|Participants entered open label period|0|||
150159048|NCT04955626|541716385|FG006|Blinded Period|Participants entered open label period|0|||
150159049|NCT04955626|541716386|FG007|Blinded Period|Participants entered open label period|0|||
150159050|NCT04955626|541716387|FG008|Blinded Period|Participants entered open label period|0|||
150159051|NCT04955626|541716388|FG009|Blinded Period|Participants entered open label period|0|||
150159052|NCT04955626|541716389|FG010|Blinded Period|Participants entered open label period|0|||
150159053|NCT04955626|541716390|FG011|Blinded Period|Participants entered open label period|0|||
150159054|NCT04955626|541716391|FG012|Blinded Period|Participants entered open label period|0|||
150159055|NCT04955626|541716392|FG013|Blinded Period|Participants entered open label period|0|||
150159056|NCT04955626|541716393|FG014|Blinded Period|Participants entered open label period|0|||
150159057|NCT04955626|541716394|FG015|Blinded Period|Participants entered open label period|0|||
150159058|NCT04955626|541716395|FG016|Blinded Period|Participants entered open label period|0|||
150159059|NCT04955626|541716396|FG017|Blinded Period|Participants entered open label period|0|||
150159060|NCT04955626|541716397|FG018|Blinded Period|Participants entered open label period|0|||
150159061|NCT04955626|541716398|FG019|Blinded Period|Participants entered open label period|0|||
150159062|NCT04955626|541716399|FG020|Blinded Period|Participants entered open label period|0|||
150159063|NCT04955626|541716400|FG021|Blinded Period|Participants entered open label period|0|||
150159064|NCT04955626|541716401|FG022|Blinded Period|Participants entered open label period|0|||
150159065|NCT04955626|541716402|FG023|Blinded Period|Participants entered open label period|0|||
149816881|NCT00837577|540459932|FG000|Double-blind Period|Withdrawal by Subject|1|||
149816882|NCT00837577|540459933|FG001|Double-blind Period|Withdrawal by Subject|0|||
149816883|NCT00837577|540459932|FG000|Open-label Period|Clinical Adverse Event|2|||
149816884|NCT00837577|540459933|FG001|Open-label Period|Clinical Adverse Event|2|||
149816885|NCT00837577|540459932|FG000|Open-label Period|Laboratory Adverse Event|0|||
149816886|NCT00837577|540459933|FG001|Open-label Period|Laboratory Adverse Event|1|||
149816887|NCT00837577|540459932|FG000|Open-label Period|Lack of Efficacy|4|||
149816888|NCT00837577|540459933|FG001|Open-label Period|Lack of Efficacy|3|||
149816889|NCT00837577|540459932|FG000|Open-label Period|Withdrawal by Subject|1|||
149816890|NCT00837577|540459933|FG001|Open-label Period|Withdrawal by Subject|2|||
149816891|NCT00837577|540459932|FG000|Open-label Period|Other Reason|1|||
149816892|NCT00837577|540459933|FG001|Open-label Period|Other Reason|1|||
149816893|NCT00033631|540459934|FG000|Overall Study|Protocol Violation|14|||
149816894|NCT00033631|540459935|FG001|Overall Study|Protocol Violation|11|||
149816895|NCT00033631|540459934|FG000|Overall Study|Withdrawal by Subject|4|||
149816896|NCT00033631|540459935|FG001|Overall Study|Withdrawal by Subject|4|||
149816897|NCT01159769|540459938|FG000|Overall Study|Adverse Event|1|||
149816898|NCT01325532|540459941|FG000|Overall Study|Withdrawal by Subject|2|||
149816899|NCT01325532|540459942|FG001|Overall Study|Withdrawal by Subject|0|||
150159066|NCT04955626|541716403|FG024|Blinded Period|Participants entered open label period|0|||
150159067|NCT04955626|541716404|FG025|Blinded Period|Participants entered open label period|0|||
150159068|NCT04955626|541716405|FG026|Blinded Period|Participants entered open label period|0|||
150159069|NCT04955626|541716406|FG027|Blinded Period|Participants entered open label period|0|||
150159070|NCT04955626|541716407|FG028|Blinded Period|Participants entered open label period|0|||
150159071|NCT04955626|541716408|FG029|Blinded Period|Participants entered open label period|0|||
150159072|NCT04955626|541716409|FG030|Blinded Period|Participants entered open label period|0|||
150159073|NCT04955626|541716410|FG031|Blinded Period|Participants entered open label period|0|||
150159074|NCT04955626|541716411|FG032|Blinded Period|Participants entered open label period|0|||
150159075|NCT04955626|541716412|FG033|Blinded Period|Participants entered open label period|0|||
150159076|NCT04955626|541716413|FG034|Blinded Period|Participants entered open label period|0|||
150159077|NCT04955626|541716414|FG035|Blinded Period|Participants entered open label period|0|||
150159078|NCT04955626|541716379|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
150159079|NCT04955626|541716380|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
150159080|NCT04955626|541716381|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
150159081|NCT04955626|541716382|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
150159082|NCT04955626|541716383|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
150159083|NCT04955626|541716384|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
150159084|NCT04955626|541716385|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
150159085|NCT04955626|541716386|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
150159086|NCT04955626|541716387|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
150159087|NCT04955626|541716388|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
150159088|NCT04955626|541716389|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
150159089|NCT04955626|541716390|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
150159090|NCT04955626|541716391|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
150159091|NCT04955626|541716392|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
150159092|NCT04955626|541716393|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
150159093|NCT04955626|541716394|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
150159094|NCT04955626|541716395|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
150159095|NCT04955626|541716396|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
150159096|NCT04955626|541716397|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
150159097|NCT04955626|541716398|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
150159098|NCT04955626|541716399|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
150159099|NCT04955626|541716400|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
150159100|NCT04955626|541716401|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
150159101|NCT04955626|541716402|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
150159102|NCT04955626|541716403|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
150159103|NCT04955626|541716404|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
149816900|NCT00272961|540459943|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
150159104|NCT04955626|541716405|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
150159105|NCT04955626|541716406|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
150159106|NCT04955626|541716407|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
150159107|NCT04955626|541716408|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
150159108|NCT04955626|541716409|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
150159109|NCT04955626|541716410|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
150159110|NCT04955626|541716411|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
150159111|NCT04955626|541716412|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
150159112|NCT04955626|541716413|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
150159113|NCT04955626|541716414|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
150159114|NCT04955626|541716379|FG000|Blinded Period|Medication error|0|||
150159115|NCT04955626|541716380|FG001|Blinded Period|Medication error|0|||
150159116|NCT04955626|541716381|FG002|Blinded Period|Medication error|0|||
150159117|NCT04955626|541716382|FG003|Blinded Period|Medication error|0|||
150159118|NCT04955626|541716383|FG004|Blinded Period|Medication error|0|||
150159119|NCT04955626|541716384|FG005|Blinded Period|Medication error|0|||
150159120|NCT04955626|541716385|FG006|Blinded Period|Medication error|0|||
150159121|NCT04955626|541716386|FG007|Blinded Period|Medication error|0|||
149816901|NCT00272961|540459944|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
149816902|NCT00272961|540459945|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
149816903|NCT00272961|540459946|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
149816904|NCT00272961|540459947|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
149816905|NCT00272961|540459943|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
149816906|NCT00272961|540459944|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
149816907|NCT00272961|540459945|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
149816908|NCT00272961|540459946|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
149816909|NCT00272961|540459947|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
149816910|NCT00272961|540459943|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
149816911|NCT00272961|540459944|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
149816912|NCT00272961|540459945|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
149816913|NCT00272961|540459946|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
149816914|NCT00272961|540459947|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
149816915|NCT00272961|540459943|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
149816916|NCT00272961|540459944|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
149816917|NCT00272961|540459945|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
149816918|NCT00272961|540459946|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
149816919|NCT00272961|540459947|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
149816920|NCT00272961|540459943|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
149816921|NCT00272961|540459944|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
149816922|NCT00272961|540459945|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
149816923|NCT00272961|540459946|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
149816924|NCT00272961|540459947|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
149816925|NCT00272961|540459943|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
149816926|NCT00272961|540459944|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
149816927|NCT00272961|540459945|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
149816928|NCT00272961|540459946|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
150159122|NCT04955626|541716387|FG008|Blinded Period|Medication error|0|||
150159123|NCT04955626|541716388|FG009|Blinded Period|Medication error|0|||
150159124|NCT04955626|541716389|FG010|Blinded Period|Medication error|2|||
150159125|NCT04955626|541716390|FG011|Blinded Period|Medication error|0|||
150159126|NCT04955626|541716391|FG012|Blinded Period|Medication error|0|||
150159127|NCT04955626|541716392|FG013|Blinded Period|Medication error|0|||
150159128|NCT04955626|541716393|FG014|Blinded Period|Medication error|0|||
150159129|NCT04955626|541716394|FG015|Blinded Period|Medication error|0|||
150159130|NCT04955626|541716395|FG016|Blinded Period|Medication error|0|||
150159131|NCT04955626|541716396|FG017|Blinded Period|Medication error|0|||
150159132|NCT04955626|541716397|FG018|Blinded Period|Medication error|0|||
150159133|NCT04955626|541716398|FG019|Blinded Period|Medication error|0|||
150159134|NCT04955626|541716399|FG020|Blinded Period|Medication error|0|||
150159135|NCT04955626|541716400|FG021|Blinded Period|Medication error|0|||
150159136|NCT04955626|541716401|FG022|Blinded Period|Medication error|0|||
150159137|NCT04955626|541716402|FG023|Blinded Period|Medication error|0|||
150159138|NCT04955626|541716403|FG024|Blinded Period|Medication error|0|||
150159139|NCT04955626|541716404|FG025|Blinded Period|Medication error|0|||
150159140|NCT04955626|541716405|FG026|Blinded Period|Medication error|0|||
150159141|NCT04955626|541716406|FG027|Blinded Period|Medication error|0|||
150159142|NCT04955626|541716407|FG028|Blinded Period|Medication error|4|||
150159143|NCT04955626|541716408|FG029|Blinded Period|Medication error|0|||
150159144|NCT04955626|541716409|FG030|Blinded Period|Medication error|0|||
150159145|NCT04955626|541716410|FG031|Blinded Period|Medication error|0|||
150159146|NCT04955626|541716411|FG032|Blinded Period|Medication error|0|||
149816929|NCT00272961|540459947|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
149816930|NCT00272961|540459943|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
149816931|NCT00272961|540459944|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
149816932|NCT00272961|540459945|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
149816933|NCT00272961|540459946|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
149816934|NCT00272961|540459947|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
149816935|NCT00272961|540459943|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
149816936|NCT00272961|540459944|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
149816937|NCT00272961|540459945|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
149816938|NCT00272961|540459946|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
150159147|NCT04955626|541716412|FG033|Blinded Period|Medication error|0|||
150159148|NCT04955626|541716413|FG034|Blinded Period|Medication error|0|||
150159149|NCT04955626|541716414|FG035|Blinded Period|Medication error|0|||
150159150|NCT04955626|541716379|FG000|Open-Label Period|Lost to Follow-up|109|||
150159151|NCT04955626|541716380|FG001|Open-Label Period|Lost to Follow-up|41|||
150159152|NCT04955626|541716381|FG002|Open-Label Period|Lost to Follow-up|0|||
150159153|NCT04955626|541716382|FG003|Open-Label Period|Lost to Follow-up|0|||
150159154|NCT04955626|541716383|FG004|Open-Label Period|Lost to Follow-up|0|||
150159155|NCT04955626|541716384|FG005|Open-Label Period|Lost to Follow-up|0|||
150159156|NCT04955626|541716385|FG006|Open-Label Period|Lost to Follow-up|0|||
150159157|NCT04955626|541716386|FG007|Open-Label Period|Lost to Follow-up|0|||
150159158|NCT04955626|541716387|FG008|Open-Label Period|Lost to Follow-up|0|||
150159159|NCT04955626|541716388|FG009|Open-Label Period|Lost to Follow-up|0|||
150159160|NCT04955626|541716389|FG010|Open-Label Period|Lost to Follow-up|0|||
150159161|NCT04955626|541716390|FG011|Open-Label Period|Lost to Follow-up|0|||
150159162|NCT04955626|541716391|FG012|Open-Label Period|Lost to Follow-up|0|||
150159163|NCT04955626|541716392|FG013|Open-Label Period|Lost to Follow-up|0|||
150159164|NCT04955626|541716393|FG014|Open-Label Period|Lost to Follow-up|0|||
150159165|NCT04955626|541716394|FG015|Open-Label Period|Lost to Follow-up|0|||
150159166|NCT04955626|541716395|FG016|Open-Label Period|Lost to Follow-up|0|||
150159167|NCT04955626|541716396|FG017|Open-Label Period|Lost to Follow-up|0|||
150159168|NCT04955626|541716397|FG018|Open-Label Period|Lost to Follow-up|0|||
150159169|NCT04955626|541716398|FG019|Open-Label Period|Lost to Follow-up|0|||
150159170|NCT04955626|541716399|FG020|Open-Label Period|Lost to Follow-up|0|||
150159171|NCT04955626|541716400|FG021|Open-Label Period|Lost to Follow-up|0|||
150159172|NCT04955626|541716401|FG022|Open-Label Period|Lost to Follow-up|0|||
150159173|NCT04955626|541716402|FG023|Open-Label Period|Lost to Follow-up|0|||
150159174|NCT04955626|541716403|FG024|Open-Label Period|Lost to Follow-up|0|||
150159175|NCT04955626|541716404|FG025|Open-Label Period|Lost to Follow-up|0|||
150159176|NCT04955626|541716405|FG026|Open-Label Period|Lost to Follow-up|0|||
150159177|NCT04955626|541716406|FG027|Open-Label Period|Lost to Follow-up|0|||
150159178|NCT04955626|541716407|FG028|Open-Label Period|Lost to Follow-up|0|||
150159179|NCT04955626|541716408|FG029|Open-Label Period|Lost to Follow-up|0|||
150159180|NCT04955626|541716409|FG030|Open-Label Period|Lost to Follow-up|0|||
150159181|NCT04955626|541716410|FG031|Open-Label Period|Lost to Follow-up|0|||
150159182|NCT04955626|541716411|FG032|Open-Label Period|Lost to Follow-up|0|||
150159183|NCT04955626|541716412|FG033|Open-Label Period|Lost to Follow-up|0|||
150159184|NCT04955626|541716413|FG034|Open-Label Period|Lost to Follow-up|0|||
150159185|NCT04955626|541716414|FG035|Open-Label Period|Lost to Follow-up|0|||
150159186|NCT04955626|541716379|FG000|Open-Label Period|Protocol Violation|377|||
150159187|NCT04955626|541716380|FG001|Open-Label Period|Protocol Violation|48|||
150159188|NCT04955626|541716381|FG002|Open-Label Period|Protocol Violation|0|||
150159189|NCT04955626|541716382|FG003|Open-Label Period|Protocol Violation|0|||
150159190|NCT04955626|541716383|FG004|Open-Label Period|Protocol Violation|0|||
150159191|NCT04955626|541716384|FG005|Open-Label Period|Protocol Violation|0|||
150159192|NCT04955626|541716385|FG006|Open-Label Period|Protocol Violation|0|||
150159193|NCT04955626|541716386|FG007|Open-Label Period|Protocol Violation|0|||
150159194|NCT04955626|541716387|FG008|Open-Label Period|Protocol Violation|0|||
150159195|NCT04955626|541716388|FG009|Open-Label Period|Protocol Violation|0|||
150159196|NCT04955626|541716389|FG010|Open-Label Period|Protocol Violation|0|||
150159197|NCT04955626|541716390|FG011|Open-Label Period|Protocol Violation|0|||
150159198|NCT04955626|541716391|FG012|Open-Label Period|Protocol Violation|0|||
150159199|NCT04955626|541716392|FG013|Open-Label Period|Protocol Violation|0|||
150159200|NCT04955626|541716393|FG014|Open-Label Period|Protocol Violation|0|||
150159201|NCT04955626|541716394|FG015|Open-Label Period|Protocol Violation|0|||
149816939|NCT00272961|540459947|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
150159202|NCT04955626|541716395|FG016|Open-Label Period|Protocol Violation|0|||
150159203|NCT04955626|541716396|FG017|Open-Label Period|Protocol Violation|0|||
150159204|NCT04955626|541716397|FG018|Open-Label Period|Protocol Violation|0|||
150159205|NCT04955626|541716398|FG019|Open-Label Period|Protocol Violation|0|||
150159206|NCT04955626|541716399|FG020|Open-Label Period|Protocol Violation|0|||
150159207|NCT04955626|541716400|FG021|Open-Label Period|Protocol Violation|0|||
150159208|NCT04955626|541716401|FG022|Open-Label Period|Protocol Violation|0|||
150159209|NCT04955626|541716402|FG023|Open-Label Period|Protocol Violation|0|||
150159210|NCT04955626|541716403|FG024|Open-Label Period|Protocol Violation|0|||
150159211|NCT04955626|541716404|FG025|Open-Label Period|Protocol Violation|0|||
150159212|NCT04955626|541716405|FG026|Open-Label Period|Protocol Violation|0|||
150159213|NCT04955626|541716406|FG027|Open-Label Period|Protocol Violation|0|||
150159214|NCT04955626|541716407|FG028|Open-Label Period|Protocol Violation|0|||
150159215|NCT04955626|541716408|FG029|Open-Label Period|Protocol Violation|0|||
150159216|NCT04955626|541716409|FG030|Open-Label Period|Protocol Violation|0|||
150159217|NCT04955626|541716410|FG031|Open-Label Period|Protocol Violation|0|||
150159218|NCT04955626|541716411|FG032|Open-Label Period|Protocol Violation|0|||
150159219|NCT04955626|541716412|FG033|Open-Label Period|Protocol Violation|0|||
150159220|NCT04955626|541716413|FG034|Open-Label Period|Protocol Violation|0|||
150159221|NCT04955626|541716414|FG035|Open-Label Period|Protocol Violation|0|||
150159222|NCT04955626|541716379|FG000|Open-Label Period|Death|5|||
150159223|NCT04955626|541716380|FG001|Open-Label Period|Death|5|||
150159224|NCT04955626|541716381|FG002|Open-Label Period|Death|0|||
150159225|NCT04955626|541716382|FG003|Open-Label Period|Death|0|||
150159226|NCT04955626|541716383|FG004|Open-Label Period|Death|0|||
150159227|NCT04955626|541716384|FG005|Open-Label Period|Death|0|||
150159228|NCT04955626|541716385|FG006|Open-Label Period|Death|0|||
150159229|NCT04955626|541716386|FG007|Open-Label Period|Death|0|||
150159230|NCT04955626|541716387|FG008|Open-Label Period|Death|0|||
150159231|NCT04955626|541716388|FG009|Open-Label Period|Death|0|||
150159232|NCT04955626|541716389|FG010|Open-Label Period|Death|0|||
150159233|NCT04955626|541716390|FG011|Open-Label Period|Death|0|||
150159234|NCT04955626|541716391|FG012|Open-Label Period|Death|0|||
150159235|NCT04955626|541716392|FG013|Open-Label Period|Death|0|||
150159236|NCT04955626|541716393|FG014|Open-Label Period|Death|0|||
150159237|NCT04955626|541716394|FG015|Open-Label Period|Death|0|||
150159238|NCT04955626|541716395|FG016|Open-Label Period|Death|0|||
150159239|NCT04955626|541716396|FG017|Open-Label Period|Death|0|||
150159240|NCT04955626|541716397|FG018|Open-Label Period|Death|0|||
150159241|NCT04955626|541716398|FG019|Open-Label Period|Death|0|||
150159242|NCT04955626|541716399|FG020|Open-Label Period|Death|0|||
150159243|NCT04955626|541716400|FG021|Open-Label Period|Death|0|||
150159244|NCT04955626|541716401|FG022|Open-Label Period|Death|0|||
150159245|NCT04955626|541716402|FG023|Open-Label Period|Death|0|||
150159246|NCT04955626|541716403|FG024|Open-Label Period|Death|0|||
150159247|NCT04955626|541716404|FG025|Open-Label Period|Death|0|||
150159248|NCT04955626|541716405|FG026|Open-Label Period|Death|0|||
150159249|NCT04955626|541716406|FG027|Open-Label Period|Death|0|||
150159250|NCT04955626|541716407|FG028|Open-Label Period|Death|0|||
150159251|NCT04955626|541716408|FG029|Open-Label Period|Death|0|||
150159252|NCT04955626|541716409|FG030|Open-Label Period|Death|0|||
150159253|NCT04955626|541716410|FG031|Open-Label Period|Death|0|||
150159254|NCT04955626|541716411|FG032|Open-Label Period|Death|0|||
150159255|NCT04955626|541716412|FG033|Open-Label Period|Death|0|||
149816940|NCT01507831|540459949|FG000|Overall Study|Randomized but not treated|0|||
149816941|NCT01507831|540459950|FG001|Overall Study|Randomized but not treated|3|||
149816942|NCT01507831|540459949|FG000|Overall Study|Adverse Event|48|||
149816943|NCT01507831|540459950|FG001|Overall Study|Adverse Event|113|||
149816944|NCT01507831|540459949|FG000|Overall Study|Death|6|||
149816945|NCT01507831|540459950|FG001|Overall Study|Death|2|||
149816946|NCT01507831|540459949|FG000|Overall Study|Poor compliance to protocol|38|||
149816947|NCT01507831|540459950|FG001|Overall Study|Poor compliance to protocol|60|||
149816948|NCT01507831|540459949|FG000|Overall Study|Physician Decision|0|||
149816949|NCT01507831|540459950|FG001|Overall Study|Physician Decision|4|||
149816950|NCT01507831|540459949|FG000|Overall Study|Participant moved|5|||
149816951|NCT01507831|540459950|FG001|Overall Study|Participant moved|19|||
149816952|NCT01507831|540459949|FG000|Overall Study|Consent withdrawn by participant|34|||
149816953|NCT01507831|540459950|FG001|Overall Study|Consent withdrawn by participant|72|||
149816954|NCT01507831|540459949|FG000|Overall Study|Related to study drug administration|5|||
149816955|NCT01507831|540459950|FG001|Overall Study|Related to study drug administration|14|||
149816956|NCT01507831|540459949|FG000|Overall Study|Last visit outside protocol visit window|51|||
149816957|NCT01507831|540459950|FG001|Overall Study|Last visit outside protocol visit window|143|||
149816958|NCT01507831|540459949|FG000|Overall Study|Selection criteria finally not met|0|||
149816959|NCT01507831|540459950|FG001|Overall Study|Selection criteria finally not met|1|||
150159256|NCT04955626|541716413|FG034|Open-Label Period|Death|0|||
150159257|NCT04955626|541716414|FG035|Open-Label Period|Death|0|||
150159258|NCT04955626|541716379|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
150159259|NCT04955626|541716380|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
150159260|NCT04955626|541716381|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
150159261|NCT04955626|541716382|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
149816960|NCT01507831|540459949|FG000|Overall Study|Site closure|0|||
150159262|NCT04955626|541716383|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
150159263|NCT04955626|541716384|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
150159264|NCT04955626|541716385|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
150159265|NCT04955626|541716386|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
150159266|NCT04955626|541716387|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
150159267|NCT04955626|541716388|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
150159268|NCT04955626|541716389|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
150159269|NCT04955626|541716390|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
150159270|NCT04955626|541716391|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
150159271|NCT04955626|541716392|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
150159272|NCT04955626|541716393|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
150159273|NCT04955626|541716394|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
150159274|NCT04955626|541716395|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
150159275|NCT04955626|541716396|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
150159276|NCT04955626|541716397|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
150159277|NCT04955626|541716398|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
150159278|NCT04955626|541716399|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
150159279|NCT04955626|541716400|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
150159280|NCT04955626|541716401|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
150159281|NCT04955626|541716402|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
150159282|NCT04955626|541716403|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
150159283|NCT04955626|541716404|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
150159284|NCT04955626|541716405|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
150159285|NCT04955626|541716406|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
150159286|NCT04955626|541716407|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
150159287|NCT04955626|541716408|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
150159288|NCT04955626|541716409|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
150159289|NCT04955626|541716410|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
150159290|NCT04955626|541716411|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
150159291|NCT04955626|541716412|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
150159292|NCT04955626|541716413|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
150159293|NCT04955626|541716414|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
150159294|NCT04955626|541716379|FG000|Open-Label Period|Other|621|||
150159295|NCT04955626|541716380|FG001|Open-Label Period|Other|429|||
150159296|NCT04955626|541716381|FG002|Open-Label Period|Other|0|||
150159297|NCT04955626|541716382|FG003|Open-Label Period|Other|0|||
150159298|NCT04955626|541716383|FG004|Open-Label Period|Other|0|||
150159299|NCT04955626|541716384|FG005|Open-Label Period|Other|0|||
150159300|NCT04955626|541716385|FG006|Open-Label Period|Other|0|||
150159301|NCT04955626|541716386|FG007|Open-Label Period|Other|0|||
150159302|NCT04955626|541716387|FG008|Open-Label Period|Other|0|||
150159303|NCT04955626|541716388|FG009|Open-Label Period|Other|0|||
150159304|NCT04955626|541716389|FG010|Open-Label Period|Other|0|||
150159305|NCT04955626|541716390|FG011|Open-Label Period|Other|0|||
150159306|NCT04955626|541716391|FG012|Open-Label Period|Other|0|||
150159307|NCT04955626|541716392|FG013|Open-Label Period|Other|0|||
150159308|NCT04955626|541716393|FG014|Open-Label Period|Other|0|||
150159309|NCT04955626|541716394|FG015|Open-Label Period|Other|0|||
150159310|NCT04955626|541716395|FG016|Open-Label Period|Other|0|||
150159311|NCT04955626|541716396|FG017|Open-Label Period|Other|0|||
150159312|NCT04955626|541716397|FG018|Open-Label Period|Other|0|||
150159313|NCT04955626|541716398|FG019|Open-Label Period|Other|0|||
150159314|NCT04955626|541716399|FG020|Open-Label Period|Other|0|||
150159315|NCT04955626|541716400|FG021|Open-Label Period|Other|0|||
150159316|NCT04955626|541716401|FG022|Open-Label Period|Other|0|||
150159317|NCT04955626|541716402|FG023|Open-Label Period|Other|0|||
150159318|NCT04955626|541716403|FG024|Open-Label Period|Other|0|||
150159319|NCT04955626|541716404|FG025|Open-Label Period|Other|0|||
150159320|NCT04955626|541716405|FG026|Open-Label Period|Other|0|||
150159321|NCT04955626|541716406|FG027|Open-Label Period|Other|0|||
150159322|NCT04955626|541716407|FG028|Open-Label Period|Other|0|||
150159323|NCT04955626|541716408|FG029|Open-Label Period|Other|0|||
150159324|NCT04955626|541716409|FG030|Open-Label Period|Other|0|||
150159325|NCT04955626|541716410|FG031|Open-Label Period|Other|0|||
150159326|NCT04955626|541716411|FG032|Open-Label Period|Other|0|||
150159327|NCT04955626|541716412|FG033|Open-Label Period|Other|0|||
150159328|NCT04955626|541716413|FG034|Open-Label Period|Other|0|||
150159329|NCT04955626|541716414|FG035|Open-Label Period|Other|0|||
150159330|NCT04955626|541716379|FG000|Open-Label Period|Physician Decision|2|||
150159331|NCT04955626|541716380|FG001|Open-Label Period|Physician Decision|0|||
150159332|NCT04955626|541716381|FG002|Open-Label Period|Physician Decision|0|||
150159333|NCT04955626|541716382|FG003|Open-Label Period|Physician Decision|0|||
150159334|NCT04955626|541716383|FG004|Open-Label Period|Physician Decision|0|||
150159335|NCT04955626|541716384|FG005|Open-Label Period|Physician Decision|0|||
150159336|NCT04955626|541716385|FG006|Open-Label Period|Physician Decision|0|||
150159337|NCT04955626|541716386|FG007|Open-Label Period|Physician Decision|0|||
150159338|NCT04955626|541716387|FG008|Open-Label Period|Physician Decision|0|||
150159339|NCT04955626|541716388|FG009|Open-Label Period|Physician Decision|0|||
150159340|NCT04955626|541716389|FG010|Open-Label Period|Physician Decision|0|||
150159341|NCT04955626|541716390|FG011|Open-Label Period|Physician Decision|0|||
150159342|NCT04955626|541716391|FG012|Open-Label Period|Physician Decision|0|||
150159343|NCT04955626|541716392|FG013|Open-Label Period|Physician Decision|0|||
150159344|NCT04955626|541716393|FG014|Open-Label Period|Physician Decision|0|||
150159345|NCT04955626|541716394|FG015|Open-Label Period|Physician Decision|0|||
150159346|NCT04955626|541716395|FG016|Open-Label Period|Physician Decision|0|||
150159347|NCT04955626|541716396|FG017|Open-Label Period|Physician Decision|0|||
150159348|NCT04955626|541716397|FG018|Open-Label Period|Physician Decision|0|||
150159349|NCT04955626|541716398|FG019|Open-Label Period|Physician Decision|0|||
150159350|NCT04955626|541716399|FG020|Open-Label Period|Physician Decision|0|||
150159351|NCT04955626|541716400|FG021|Open-Label Period|Physician Decision|0|||
150159352|NCT04955626|541716401|FG022|Open-Label Period|Physician Decision|0|||
150159353|NCT04955626|541716402|FG023|Open-Label Period|Physician Decision|0|||
150159354|NCT04955626|541716403|FG024|Open-Label Period|Physician Decision|0|||
150159355|NCT04955626|541716404|FG025|Open-Label Period|Physician Decision|0|||
150159356|NCT04955626|541716405|FG026|Open-Label Period|Physician Decision|0|||
150159357|NCT04955626|541716406|FG027|Open-Label Period|Physician Decision|0|||
150159358|NCT04955626|541716407|FG028|Open-Label Period|Physician Decision|0|||
150159359|NCT04955626|541716408|FG029|Open-Label Period|Physician Decision|0|||
150159360|NCT04955626|541716409|FG030|Open-Label Period|Physician Decision|0|||
150159361|NCT04955626|541716410|FG031|Open-Label Period|Physician Decision|0|||
150159362|NCT04955626|541716411|FG032|Open-Label Period|Physician Decision|0|||
150159363|NCT04955626|541716412|FG033|Open-Label Period|Physician Decision|0|||
150159364|NCT04955626|541716413|FG034|Open-Label Period|Physician Decision|0|||
150159365|NCT04955626|541716414|FG035|Open-Label Period|Physician Decision|0|||
150159366|NCT04955626|541716379|FG000|Open-Label Period|Withdrawal by Subject|135|||
150159367|NCT04955626|541716380|FG001|Open-Label Period|Withdrawal by Subject|25|||
150159368|NCT04955626|541716381|FG002|Open-Label Period|Withdrawal by Subject|0|||
150159369|NCT04955626|541716382|FG003|Open-Label Period|Withdrawal by Subject|0|||
150159370|NCT04955626|541716383|FG004|Open-Label Period|Withdrawal by Subject|0|||
150159371|NCT04955626|541716384|FG005|Open-Label Period|Withdrawal by Subject|0|||
150159372|NCT04955626|541716385|FG006|Open-Label Period|Withdrawal by Subject|0|||
150159373|NCT04955626|541716386|FG007|Open-Label Period|Withdrawal by Subject|0|||
150159374|NCT04955626|541716387|FG008|Open-Label Period|Withdrawal by Subject|0|||
150159375|NCT04955626|541716388|FG009|Open-Label Period|Withdrawal by Subject|0|||
150159376|NCT04955626|541716389|FG010|Open-Label Period|Withdrawal by Subject|0|||
150159377|NCT04955626|541716390|FG011|Open-Label Period|Withdrawal by Subject|0|||
150159378|NCT04955626|541716391|FG012|Open-Label Period|Withdrawal by Subject|0|||
150159379|NCT04955626|541716392|FG013|Open-Label Period|Withdrawal by Subject|0|||
150159380|NCT04955626|541716393|FG014|Open-Label Period|Withdrawal by Subject|0|||
150159381|NCT04955626|541716394|FG015|Open-Label Period|Withdrawal by Subject|0|||
150159382|NCT04955626|541716395|FG016|Open-Label Period|Withdrawal by Subject|0|||
150159383|NCT04955626|541716396|FG017|Open-Label Period|Withdrawal by Subject|0|||
149919196|NCT01618916|540837298|FG004|Overall Study|Adverse Event|0|||
150159384|NCT04955626|541716397|FG018|Open-Label Period|Withdrawal by Subject|0|||
149919197|NCT01618916|540837299|FG005|Overall Study|Adverse Event|0|||
150159385|NCT04955626|541716398|FG019|Open-Label Period|Withdrawal by Subject|0|||
150159386|NCT04955626|541716399|FG020|Open-Label Period|Withdrawal by Subject|0|||
150159387|NCT04955626|541716400|FG021|Open-Label Period|Withdrawal by Subject|0|||
150159388|NCT04955626|541716401|FG022|Open-Label Period|Withdrawal by Subject|0|||
150159389|NCT04955626|541716402|FG023|Open-Label Period|Withdrawal by Subject|0|||
150159390|NCT04955626|541716403|FG024|Open-Label Period|Withdrawal by Subject|0|||
150159391|NCT04955626|541716404|FG025|Open-Label Period|Withdrawal by Subject|0|||
150159392|NCT04955626|541716405|FG026|Open-Label Period|Withdrawal by Subject|0|||
150159393|NCT04955626|541716406|FG027|Open-Label Period|Withdrawal by Subject|0|||
150159394|NCT04955626|541716407|FG028|Open-Label Period|Withdrawal by Subject|0|||
150159395|NCT04955626|541716408|FG029|Open-Label Period|Withdrawal by Subject|0|||
150159396|NCT04955626|541716409|FG030|Open-Label Period|Withdrawal by Subject|0|||
150159397|NCT04955626|541716410|FG031|Open-Label Period|Withdrawal by Subject|0|||
150159398|NCT04955626|541716411|FG032|Open-Label Period|Withdrawal by Subject|0|||
150159399|NCT04955626|541716412|FG033|Open-Label Period|Withdrawal by Subject|0|||
150159400|NCT04955626|541716413|FG034|Open-Label Period|Withdrawal by Subject|0|||
150159401|NCT04955626|541716414|FG035|Open-Label Period|Withdrawal by Subject|0|||
150159402|NCT04955626|541716379|FG000|Open-Label Period|Refused further study procedures|1|||
150159403|NCT04955626|541716380|FG001|Open-Label Period|Refused further study procedures|0|||
150159404|NCT04955626|541716381|FG002|Open-Label Period|Refused further study procedures|0|||
150159405|NCT04955626|541716382|FG003|Open-Label Period|Refused further study procedures|0|||
150159406|NCT04955626|541716383|FG004|Open-Label Period|Refused further study procedures|0|||
150159407|NCT04955626|541716384|FG005|Open-Label Period|Refused further study procedures|0|||
150159408|NCT04955626|541716385|FG006|Open-Label Period|Refused further study procedures|0|||
150159409|NCT04955626|541716386|FG007|Open-Label Period|Refused further study procedures|0|||
150159410|NCT04955626|541716387|FG008|Open-Label Period|Refused further study procedures|0|||
150159411|NCT04955626|541716388|FG009|Open-Label Period|Refused further study procedures|0|||
150159412|NCT04955626|541716389|FG010|Open-Label Period|Refused further study procedures|0|||
150159413|NCT04955626|541716390|FG011|Open-Label Period|Refused further study procedures|0|||
150159414|NCT04955626|541716391|FG012|Open-Label Period|Refused further study procedures|0|||
150159415|NCT04955626|541716392|FG013|Open-Label Period|Refused further study procedures|0|||
150159416|NCT04955626|541716393|FG014|Open-Label Period|Refused further study procedures|0|||
150159417|NCT04955626|541716394|FG015|Open-Label Period|Refused further study procedures|0|||
149816961|NCT01507831|540459950|FG001|Overall Study|Site closure|3|||
149816962|NCT01507831|540459949|FG000|Overall Study|Potential lost to follow-up|3|||
149816963|NCT01507831|540459950|FG001|Overall Study|Potential lost to follow-up|0|||
149816964|NCT01507831|540459949|FG000|Overall Study|Other|3|||
149816965|NCT01507831|540459950|FG001|Overall Study|Other|6|||
149816966|NCT03196791|540459951|FG000|Overall Study|Protocol Violation|7|||
149816967|NCT03196791|540459952|FG001|Overall Study|Protocol Violation|3|||
149816968|NCT03196791|540459951|FG000|Overall Study|Withdrawal by Subject|3|||
149816969|NCT03196791|540459952|FG001|Overall Study|Withdrawal by Subject|2|||
149816970|NCT03056001|540459955|FG000|Overall Study|Death|24|||
149816971|NCT02295280|540459957|FG000|Overall Study|Adverse Event|0|||
149816972|NCT02295280|540459958|FG001|Overall Study|Adverse Event|1|||
149816973|NCT02875067|540459959|FG000|Overall Study|Withdrawal by Subject|1|||
149816974|NCT02875067|540459959|FG000|Overall Study|Withdrawal by Termination of Study|5|||
149816975|NCT02713243|540459961|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
149816976|NCT02713243|540459962|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
149816977|NCT02713243|540459961|FG000|Overall Study|Administrative problems|0|||
149816978|NCT02713243|540459962|FG001|Overall Study|Administrative problems|1|||
149816979|NCT02713243|540459961|FG000|Overall Study|Protocol deviation|0|||
149816980|NCT02713243|540459962|FG001|Overall Study|Protocol deviation|1|||
149816981|NCT03056352|540459963|FG000|Overall Study|Lost to Follow-up|1|||
149816982|NCT02971605|540459964|FG000|Overall Study|Withdrawal by Subject|1|||
149816983|NCT00597207|540459965|FG000|Overall Study|Lost to Follow-up|5|||
149816984|NCT00597207|540459966|FG001|Overall Study|Lost to Follow-up|7|||
149816985|NCT03439293|540459969|FG000|Overall Study|Death|22|||
149816986|NCT03439293|540459969|FG000|Overall Study|Withdrawal by Subject|8|||
150159418|NCT04955626|541716395|FG016|Open-Label Period|Refused further study procedures|0|||
150159419|NCT04955626|541716396|FG017|Open-Label Period|Refused further study procedures|0|||
150159420|NCT04955626|541716397|FG018|Open-Label Period|Refused further study procedures|0|||
150159421|NCT04955626|541716398|FG019|Open-Label Period|Refused further study procedures|0|||
149816987|NCT03439293|540459969|FG000|Overall Study|Lost to Follow-up|2|||
149816988|NCT03439293|540459969|FG000|Overall Study|Reason Not Specified|28|||
149816989|NCT03439293|540459969|FG000|Overall Study|Missing|1|||
150159422|NCT04955626|541716399|FG020|Open-Label Period|Refused further study procedures|0|||
150159423|NCT04955626|541716400|FG021|Open-Label Period|Refused further study procedures|0|||
150159424|NCT04955626|541716401|FG022|Open-Label Period|Refused further study procedures|0|||
150159425|NCT04955626|541716402|FG023|Open-Label Period|Refused further study procedures|0|||
150159426|NCT04955626|541716403|FG024|Open-Label Period|Refused further study procedures|0|||
150159427|NCT04955626|541716404|FG025|Open-Label Period|Refused further study procedures|0|||
150159428|NCT04955626|541716405|FG026|Open-Label Period|Refused further study procedures|0|||
150159429|NCT04955626|541716406|FG027|Open-Label Period|Refused further study procedures|0|||
150159430|NCT04955626|541716407|FG028|Open-Label Period|Refused further study procedures|0|||
150159431|NCT04955626|541716408|FG029|Open-Label Period|Refused further study procedures|0|||
150159432|NCT04955626|541716409|FG030|Open-Label Period|Refused further study procedures|0|||
150159433|NCT04955626|541716410|FG031|Open-Label Period|Refused further study procedures|0|||
150159434|NCT04955626|541716411|FG032|Open-Label Period|Refused further study procedures|0|||
150159435|NCT04955626|541716412|FG033|Open-Label Period|Refused further study procedures|0|||
150159436|NCT04955626|541716413|FG034|Open-Label Period|Refused further study procedures|0|||
150159437|NCT04955626|541716414|FG035|Open-Label Period|Refused further study procedures|0|||
150159438|NCT04955626|541716379|FG000|Open-Label Period|Adverse Event|1|||
150159439|NCT04955626|541716380|FG001|Open-Label Period|Adverse Event|0|||
150159440|NCT04955626|541716381|FG002|Open-Label Period|Adverse Event|0|||
150159441|NCT04955626|541716382|FG003|Open-Label Period|Adverse Event|0|||
150159442|NCT04955626|541716383|FG004|Open-Label Period|Adverse Event|0|||
150159443|NCT04955626|541716384|FG005|Open-Label Period|Adverse Event|0|||
150159444|NCT04955626|541716385|FG006|Open-Label Period|Adverse Event|0|||
150159445|NCT04955626|541716386|FG007|Open-Label Period|Adverse Event|0|||
150159446|NCT04955626|541716387|FG008|Open-Label Period|Adverse Event|0|||
150159447|NCT04955626|541716388|FG009|Open-Label Period|Adverse Event|0|||
150159448|NCT04955626|541716389|FG010|Open-Label Period|Adverse Event|0|||
150159449|NCT04955626|541716390|FG011|Open-Label Period|Adverse Event|0|||
150159450|NCT04955626|541716391|FG012|Open-Label Period|Adverse Event|0|||
150159451|NCT04955626|541716392|FG013|Open-Label Period|Adverse Event|0|||
150159452|NCT04955626|541716393|FG014|Open-Label Period|Adverse Event|0|||
150159453|NCT04955626|541716394|FG015|Open-Label Period|Adverse Event|0|||
150159454|NCT04955626|541716395|FG016|Open-Label Period|Adverse Event|0|||
150159455|NCT04955626|541716396|FG017|Open-Label Period|Adverse Event|0|||
150159456|NCT04955626|541716397|FG018|Open-Label Period|Adverse Event|0|||
150159457|NCT04955626|541716398|FG019|Open-Label Period|Adverse Event|0|||
150159458|NCT04955626|541716399|FG020|Open-Label Period|Adverse Event|0|||
150159459|NCT04955626|541716400|FG021|Open-Label Period|Adverse Event|0|||
150159460|NCT04955626|541716401|FG022|Open-Label Period|Adverse Event|0|||
150159461|NCT04955626|541716402|FG023|Open-Label Period|Adverse Event|0|||
150159462|NCT04955626|541716403|FG024|Open-Label Period|Adverse Event|0|||
150159463|NCT04955626|541716404|FG025|Open-Label Period|Adverse Event|0|||
150159464|NCT04955626|541716405|FG026|Open-Label Period|Adverse Event|0|||
150159465|NCT04955626|541716406|FG027|Open-Label Period|Adverse Event|0|||
150159466|NCT04955626|541716407|FG028|Open-Label Period|Adverse Event|0|||
150159467|NCT04955626|541716408|FG029|Open-Label Period|Adverse Event|0|||
150159468|NCT04955626|541716409|FG030|Open-Label Period|Adverse Event|0|||
150159469|NCT04955626|541716410|FG031|Open-Label Period|Adverse Event|0|||
150159470|NCT04955626|541716411|FG032|Open-Label Period|Adverse Event|0|||
150159471|NCT04955626|541716412|FG033|Open-Label Period|Adverse Event|0|||
150159472|NCT04955626|541716413|FG034|Open-Label Period|Adverse Event|0|||
150159473|NCT04955626|541716414|FG035|Open-Label Period|Adverse Event|0|||
150159474|NCT04955626|541716379|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
150159475|NCT04955626|541716380|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
150159476|NCT04955626|541716381|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
150159477|NCT04955626|541716382|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
150159478|NCT04955626|541716383|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
150159479|NCT04955626|541716384|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
150159480|NCT04955626|541716385|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
150159481|NCT04955626|541716386|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
150159482|NCT04955626|541716387|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
150159483|NCT04955626|541716388|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
150159484|NCT04955626|541716389|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
150159485|NCT04955626|541716390|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
150159486|NCT04955626|541716391|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
150159487|NCT04955626|541716392|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
150159488|NCT04955626|541716393|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
150159489|NCT04955626|541716394|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
150159490|NCT04955626|541716395|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
150159491|NCT04955626|541716396|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
150159492|NCT04955626|541716397|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
150159493|NCT04955626|541716398|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
150159494|NCT04955626|541716399|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
150159495|NCT04955626|541716400|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
149816990|NCT03077828|540459972|FG000|Treatment Cycles|Death|1|||
149816991|NCT03077828|540459972|FG000|Treatment Cycles|Withdrawal by Subject|1|||
149816992|NCT03077828|540459972|FG000|Treatment Cycles|Screen Fail|2|||
149816993|NCT03077828|540459972|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
149816994|NCT03077828|540459972|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
149816995|NCT03077828|540459972|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
150159496|NCT04955626|541716401|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
150159497|NCT04955626|541716402|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
150159498|NCT04955626|541716403|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
149816996|NCT03077828|540459972|FG000|Follow-up|Patients still in follow-up|15|||
149816997|NCT00869089|540459974|FG000|Overall Study|Lost to Follow-up|1|||
149816998|NCT00869089|540459974|FG000|Overall Study|Withdrawal by Subject|1|||
149816999|NCT00869089|540459974|FG000|Overall Study|Screen Fail|1|||
149817000|NCT05037409|540459976|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
149817001|NCT05037409|540459977|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
149817002|NCT05037409|540459978|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
149817003|NCT03499249|540459979|FG000|Overall Study|Physician Decision|1|||
149817004|NCT01374906|540459982|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149817005|NCT01374906|540459983|FG001|Overall Study|Abnormal laboratory value(s)|3|||
149817006|NCT01374906|540459982|FG000|Overall Study|Administrative problems|2|||
149817007|NCT01374906|540459983|FG001|Overall Study|Administrative problems|2|||
149817008|NCT01374906|540459982|FG000|Overall Study|Adverse Event|10|||
149817009|NCT01374906|540459983|FG001|Overall Study|Adverse Event|11|||
149817010|NCT01374906|540459982|FG000|Overall Study|Death|0|||
149817011|NCT01374906|540459983|FG001|Overall Study|Death|2|||
149817012|NCT01374906|540459982|FG000|Overall Study|Protocol Violation|2|||
149817013|NCT01374906|540459983|FG001|Overall Study|Protocol Violation|2|||
149817014|NCT01374906|540459982|FG000|Overall Study|Withdrawal by Subject|15|||
149817015|NCT01374906|540459983|FG001|Overall Study|Withdrawal by Subject|9|||
149817016|NCT01374906|540459982|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
149817017|NCT01374906|540459983|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
149817018|NCT02475980|540459986|FG000|Overall Study|Lost to Follow-up|4|||
149817019|NCT02475980|540459986|FG000|Overall Study|Withdrawal by Subject|1|||
149817020|NCT00435825|540459989|FG000|Overall Study|Abnormality of Laboratory Test|0|||
149817021|NCT00435825|540459990|FG001|Overall Study|Abnormality of Laboratory Test|1|||
149817022|NCT00435825|540459991|FG002|Overall Study|Abnormality of Laboratory Test|0|||
149817023|NCT00435825|540459992|FG003|Overall Study|Abnormality of Laboratory Test|0|||
149817024|NCT00435825|540459989|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149817025|NCT00435825|540459990|FG001|Overall Study|Insufficient Therapeutic Response|1|||
149817026|NCT00435825|540459991|FG002|Overall Study|Insufficient Therapeutic Response|0|||
149817027|NCT00435825|540459992|FG003|Overall Study|Insufficient Therapeutic Response|3|||
149817028|NCT00435825|540459989|FG000|Overall Study|Other Protocol Violation|1|||
149817029|NCT00435825|540459990|FG001|Overall Study|Other Protocol Violation|0|||
149817030|NCT00435825|540459991|FG002|Overall Study|Other Protocol Violation|0|||
149817031|NCT00435825|540459992|FG003|Overall Study|Other Protocol Violation|0|||
149817032|NCT00435825|540459989|FG000|Overall Study|Refused treatment|2|||
149817033|NCT00435825|540459990|FG001|Overall Study|Refused treatment|0|||
149817034|NCT00435825|540459991|FG002|Overall Study|Refused treatment|0|||
150159499|NCT04955626|541716404|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
150159500|NCT04955626|541716405|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
150159501|NCT04955626|541716406|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
149817035|NCT00435825|540459992|FG003|Overall Study|Refused treatment|5|||
149817036|NCT00435825|540459989|FG000|Overall Study|Failure to return|5|||
150159502|NCT04955626|541716407|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
150159503|NCT04955626|541716408|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
150159504|NCT04955626|541716409|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
150159505|NCT04955626|541716410|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
150159506|NCT04955626|541716411|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
150159507|NCT04955626|541716412|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
150159508|NCT04955626|541716413|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
150159509|NCT04955626|541716414|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
150159510|NCT04955626|541716379|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159511|NCT04955626|541716380|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
150159512|NCT04955626|541716381|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159513|NCT04955626|541716382|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159514|NCT04955626|541716383|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159515|NCT04955626|541716384|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159516|NCT04955626|541716385|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159517|NCT04955626|541716386|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159518|NCT04955626|541716387|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159519|NCT04955626|541716388|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159520|NCT04955626|541716389|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159521|NCT04955626|541716390|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159522|NCT04955626|541716391|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159523|NCT04955626|541716392|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159524|NCT04955626|541716393|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159525|NCT04955626|541716394|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159526|NCT04955626|541716395|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159527|NCT04955626|541716396|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159528|NCT04955626|541716397|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159529|NCT04955626|541716398|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159530|NCT04955626|541716399|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159531|NCT04955626|541716400|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159532|NCT04955626|541716401|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159533|NCT04955626|541716402|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159534|NCT04955626|541716403|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159535|NCT04955626|541716404|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159536|NCT04955626|541716405|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159537|NCT04955626|541716406|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159538|NCT04955626|541716407|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159539|NCT04955626|541716408|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159540|NCT04955626|541716409|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159541|NCT04955626|541716410|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159542|NCT04955626|541716411|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159543|NCT04955626|541716412|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159544|NCT04955626|541716413|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159545|NCT04955626|541716414|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
150159546|NCT03873246|541716415|FG000|Overall Study|Adverse Event|1|||
150159547|NCT03873246|541716416|FG001|Overall Study|Adverse Event|3|||
150159548|NCT03873246|541716417|FG002|Overall Study|Adverse Event|3|||
150159549|NCT03873246|541716415|FG000|Overall Study|Lost to Follow-up|4|||
150159550|NCT03873246|541716416|FG001|Overall Study|Lost to Follow-up|4|||
150159551|NCT03873246|541716417|FG002|Overall Study|Lost to Follow-up|5|||
150159552|NCT03873246|541716415|FG000|Overall Study|Protocol Violation|0|||
150159553|NCT03873246|541716416|FG001|Overall Study|Protocol Violation|1|||
150159554|NCT03873246|541716417|FG002|Overall Study|Protocol Violation|0|||
150159555|NCT03873246|541716415|FG000|Overall Study|Withdrawal by Subject|0|||
150159556|NCT03873246|541716416|FG001|Overall Study|Withdrawal by Subject|4|||
150159557|NCT03873246|541716417|FG002|Overall Study|Withdrawal by Subject|1|||
150159558|NCT01857323|541716418|FG000|Overall Study|Adverse Event|1|||
150159559|NCT01857323|541716418|FG000|Overall Study|Withdrawal by Subject|3|||
150159560|NCT01857323|541716418|FG000|Overall Study|Non-compliance|1|||
150159561|NCT01857323|541716418|FG000|Overall Study|Protocol Violation|6|||
150159562|NCT01857323|541716418|FG000|Overall Study|Lost to Follow-up|1|||
150159563|NCT01857323|541716418|FG000|Overall Study|Other|4|||
150159564|NCT01857323|541716418|FG000|Overall Study|Did not complete 180 doses|48|||
150159565|NCT04209790|541716419|FG000|Overall Study|Physician Decision|1|||
150159566|NCT04060680|541716421|FG000|Overall Study|Unsuccessful implant|17|||
150159567|NCT04060680|541716422|FG001|Overall Study|Unsuccessful implant|2|||
150159568|NCT04060680|541716421|FG000|Overall Study|Adverse Event|3|||
150159569|NCT04060680|541716422|FG001|Overall Study|Adverse Event|0|||
150159570|NCT04060680|541716421|FG000|Overall Study|Death|2|||
150159571|NCT04060680|541716422|FG001|Overall Study|Death|0|||
150159572|NCT04060680|541716421|FG000|Overall Study|Study product no longer in use|1|||
150159573|NCT04060680|541716422|FG001|Overall Study|Study product no longer in use|0|||
150159574|NCT04060680|541716421|FG000|Overall Study|Withdrawal by Subject|1|||
150159575|NCT04060680|541716422|FG001|Overall Study|Withdrawal by Subject|0|||
150159576|NCT05617040|541716423|FG000|Overall Study|Adverse Event|0|||
150159577|NCT05617040|541716424|FG001|Overall Study|Adverse Event|1|||
150159578|NCT05617040|541716425|FG002|Overall Study|Adverse Event|0|||
150159579|NCT05617040|541716423|FG000|Overall Study|Death|0|||
150159580|NCT05617040|541716424|FG001|Overall Study|Death|0|||
150159581|NCT05617040|541716425|FG002|Overall Study|Death|1|||
150159582|NCT02711826|541716426|FG000|Overall Study|Physician Decision|0|||
150159583|NCT02711826|541716427|FG001|Overall Study|Physician Decision|0|||
150159584|NCT02711826|541716428|FG002|Overall Study|Physician Decision|0|||
150159585|NCT02711826|541716429|FG003|Overall Study|Physician Decision|1|||
150159586|NCT02711826|541716430|FG004|Overall Study|Physician Decision|0|||
150159587|NCT02711826|541716426|FG000|Overall Study|Withdrawal by Subject|0|||
150159588|NCT02711826|541716427|FG001|Overall Study|Withdrawal by Subject|1|||
150159589|NCT02711826|541716428|FG002|Overall Study|Withdrawal by Subject|0|||
149817037|NCT00435825|540459990|FG001|Overall Study|Failure to return|0|||
149817038|NCT00435825|540459991|FG002|Overall Study|Failure to return|4|||
149817039|NCT00435825|540459992|FG003|Overall Study|Failure to return|0|||
149817040|NCT00435825|540459989|FG000|Overall Study|Did not receive study drug|1|||
150159590|NCT02711826|541716429|FG003|Overall Study|Withdrawal by Subject|4|||
149817041|NCT00435825|540459990|FG001|Overall Study|Did not receive study drug|0|||
149817042|NCT00435825|540459991|FG002|Overall Study|Did not receive study drug|2|||
149817043|NCT00435825|540459992|FG003|Overall Study|Did not receive study drug|0|||
149817044|NCT00435825|540459989|FG000|Overall Study|Did not enter follow-up|0|||
149817045|NCT00435825|540459990|FG001|Overall Study|Did not enter follow-up|4|||
149817046|NCT00435825|540459991|FG002|Overall Study|Did not enter follow-up|1|||
150159591|NCT02711826|541716430|FG004|Overall Study|Withdrawal by Subject|0|||
150159592|NCT02711826|541716426|FG000|Overall Study|Failure to manufacture cellular product|0|||
150159593|NCT02711826|541716427|FG001|Overall Study|Failure to manufacture cellular product|0|||
150159594|NCT02711826|541716428|FG002|Overall Study|Failure to manufacture cellular product|5|||
150159595|NCT02711826|541716429|FG003|Overall Study|Failure to manufacture cellular product|0|||
150159596|NCT02711826|541716430|FG004|Overall Study|Failure to manufacture cellular product|0|||
150159597|NCT02711826|541716426|FG000|Overall Study|Infusion canceled for active infection|0|||
150159598|NCT02711826|541716427|FG001|Overall Study|Infusion canceled for active infection|1|||
150159599|NCT02711826|541716428|FG002|Overall Study|Infusion canceled for active infection|0|||
150159600|NCT02711826|541716429|FG003|Overall Study|Infusion canceled for active infection|0|||
150159601|NCT02711826|541716430|FG004|Overall Study|Infusion canceled for active infection|0|||
150159602|NCT02711826|541716426|FG000|Overall Study|Screen failures|0|||
150159603|NCT02711826|541716427|FG001|Overall Study|Screen failures|0|||
150159604|NCT02711826|541716428|FG002|Overall Study|Screen failures|0|||
150159605|NCT02711826|541716429|FG003|Overall Study|Screen failures|4|||
150159606|NCT02711826|541716430|FG004|Overall Study|Screen failures|0|||
150159607|NCT00729690|541716432|FG000|Overall Study|IT Catheter Malfunction|0|||
150159608|NCT00729690|541716433|FG001|Overall Study|IT Catheter Malfunction|2|||
150159609|NCT00729690|541716434|FG002|Overall Study|IT Catheter Malfunction|2|||
150159610|NCT02169219|541716435|FG000|Overall Study|Lack of Efficacy|6|||
150159611|NCT02886936|541716436|FG000|Overall Study|Lost to Follow-up|4|||
150159612|NCT02886936|541716437|FG001|Overall Study|Lost to Follow-up|3|||
150159613|NCT02886936|541716438|FG002|Overall Study|Lost to Follow-up|0|||
150159614|NCT04562779|541716439|FG000|Overall Study|Lost to Follow-up|7|||
150159615|NCT04562779|541716440|FG001|Overall Study|Lost to Follow-up|5|||
150159616|NCT04562779|541716441|FG002|Overall Study|Lost to Follow-up|10|||
150159617|NCT04562779|541716439|FG000|Overall Study|Protocol Violation|2|||
150159618|NCT04562779|541716440|FG001|Overall Study|Protocol Violation|2|||
150159619|NCT04562779|541716441|FG002|Overall Study|Protocol Violation|0|||
150159620|NCT02320721|541716442|FG000|Overall Study|Adverse Event|6|||
150159621|NCT02320721|541716443|FG001|Overall Study|Adverse Event|6|||
150159622|NCT02320721|541716442|FG000|Overall Study|Lack of Efficacy|2|||
150159623|NCT02320721|541716443|FG001|Overall Study|Lack of Efficacy|0|||
150159624|NCT02320721|541716442|FG000|Overall Study|Poor compliance to protocol|3|||
150159625|NCT02320721|541716443|FG001|Overall Study|Poor compliance to protocol|7|||
150159626|NCT02320721|541716442|FG000|Overall Study|Randomized but not treated|0|||
150159627|NCT02320721|541716443|FG001|Overall Study|Randomized but not treated|1|||
150159628|NCT02320721|541716442|FG000|Overall Study|Hypoglycemia|1|||
150159629|NCT02320721|541716443|FG001|Overall Study|Hypoglycemia|0|||
150159630|NCT02320721|541716442|FG000|Overall Study|Other than specified above|15|||
150159631|NCT02320721|541716443|FG001|Overall Study|Other than specified above|20|||
150159632|NCT03173248|541716444|FG000|Overall Study|Death|28|||
150159633|NCT03173248|541716445|FG001|Overall Study|Death|46|||
150159634|NCT03173248|541716444|FG000|Overall Study|Lost to Follow-up|0|||
150159635|NCT03173248|541716445|FG001|Overall Study|Lost to Follow-up|1|||
150159636|NCT03173248|541716444|FG000|Overall Study|Withdrawal by Subject|6|||
150159637|NCT03173248|541716445|FG001|Overall Study|Withdrawal by Subject|4|||
150159638|NCT03173248|541716444|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
150159639|NCT03173248|541716445|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
150159640|NCT01544582|541716446|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
150159641|NCT01544582|541716447|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
150159642|NCT01544582|541716448|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
150159643|NCT01544582|541716449|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
150159644|NCT01544582|541716446|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
150159645|NCT01544582|541716447|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
150159646|NCT01544582|541716448|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
150159647|NCT01544582|541716449|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
150159648|NCT01544582|541716446|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
150159649|NCT01544582|541716447|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
150159650|NCT01544582|541716448|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
150159651|NCT01544582|541716449|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
150159652|NCT01544582|541716446|FG000|Analysis Population|Physician Decision|0|||
150159653|NCT01544582|541716447|FG001|Analysis Population|Physician Decision|13|||
150159654|NCT01544582|541716448|FG002|Analysis Population|Physician Decision|10|||
150159655|NCT01544582|541716449|FG003|Analysis Population|Physician Decision|9|||
150159656|NCT01544582|541716446|FG000|Analysis Population|Safety Reason|0|||
150159657|NCT01544582|541716447|FG001|Analysis Population|Safety Reason|33|||
149817047|NCT00435825|540459992|FG003|Overall Study|Did not enter follow-up|3|||
150159658|NCT01544582|541716448|FG002|Analysis Population|Safety Reason|31|||
150159659|NCT01544582|541716449|FG003|Analysis Population|Safety Reason|8|||
150159660|NCT01544582|541716446|FG000|Analysis Population|Effectiveness Reason|0|||
150159661|NCT01544582|541716447|FG001|Analysis Population|Effectiveness Reason|48|||
150159662|NCT01544582|541716448|FG002|Analysis Population|Effectiveness Reason|29|||
150159663|NCT01544582|541716449|FG003|Analysis Population|Effectiveness Reason|12|||
150159664|NCT01544582|541716446|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
150159665|NCT01544582|541716447|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
150159666|NCT01544582|541716448|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
150159667|NCT01544582|541716449|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
150159668|NCT01544582|541716446|FG000|Analysis Population|Lost to Follow-up|0|||
150159669|NCT01544582|541716447|FG001|Analysis Population|Lost to Follow-up|6|||
150159670|NCT01544582|541716448|FG002|Analysis Population|Lost to Follow-up|6|||
150159671|NCT01544582|541716449|FG003|Analysis Population|Lost to Follow-up|5|||
150159672|NCT01544582|541716446|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
150159673|NCT01544582|541716447|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
150159674|NCT01544582|541716448|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
150159675|NCT01544582|541716449|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
150159676|NCT01544582|541716446|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
150159677|NCT01544582|541716447|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
150159678|NCT01544582|541716448|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
150159679|NCT01544582|541716449|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
150159680|NCT01544582|541716446|FG000|Analysis Population|Intolerance|0|||
150159681|NCT01544582|541716447|FG001|Analysis Population|Intolerance|1|||
150159682|NCT01544582|541716448|FG002|Analysis Population|Intolerance|0|||
150159683|NCT01544582|541716449|FG003|Analysis Population|Intolerance|0|||
150159684|NCT01544582|541716446|FG000|Analysis Population|Liver Transplantation|0|||
150159685|NCT01544582|541716447|FG001|Analysis Population|Liver Transplantation|0|||
150159686|NCT01544582|541716448|FG002|Analysis Population|Liver Transplantation|1|||
150159687|NCT01544582|541716449|FG003|Analysis Population|Liver Transplantation|0|||
150159688|NCT01544582|541716446|FG000|Analysis Population|No Social Insurance|0|||
150159689|NCT01544582|541716447|FG001|Analysis Population|No Social Insurance|0|||
150159690|NCT01544582|541716448|FG002|Analysis Population|No Social Insurance|1|||
150159691|NCT01544582|541716449|FG003|Analysis Population|No Social Insurance|0|||
150159692|NCT01544582|541716446|FG000|Analysis Population|Poor Adherence|0|||
150159693|NCT01544582|541716447|FG001|Analysis Population|Poor Adherence|0|||
150159694|NCT01544582|541716448|FG002|Analysis Population|Poor Adherence|1|||
150159695|NCT01544582|541716449|FG003|Analysis Population|Poor Adherence|0|||
150159696|NCT01544582|541716446|FG000|Analysis Population|Poor Participant Compliance|0|||
150159697|NCT01544582|541716447|FG001|Analysis Population|Poor Participant Compliance|1|||
150159698|NCT01544582|541716448|FG002|Analysis Population|Poor Participant Compliance|0|||
150159699|NCT01544582|541716449|FG003|Analysis Population|Poor Participant Compliance|0|||
150159700|NCT01544582|541716446|FG000|Analysis Population|Programmed Surgery|0|||
150159701|NCT01544582|541716447|FG001|Analysis Population|Programmed Surgery|1|||
150159702|NCT01544582|541716448|FG002|Analysis Population|Programmed Surgery|0|||
150159703|NCT01544582|541716449|FG003|Analysis Population|Programmed Surgery|0|||
150159704|NCT01544582|541716446|FG000|Analysis Population|Participant in Jail|0|||
150159705|NCT01544582|541716447|FG001|Analysis Population|Participant in Jail|0|||
150159706|NCT01544582|541716448|FG002|Analysis Population|Participant in Jail|1|||
150159707|NCT01544582|541716449|FG003|Analysis Population|Participant in Jail|0|||
150159708|NCT02419755|541716450|FG000|Overall Study|Death|1|||
150159709|NCT02419755|541716451|FG001|Overall Study|Death|3|||
150159710|NCT02419755|541716450|FG000|Overall Study|Relapse|0|||
150159711|NCT02419755|541716451|FG001|Overall Study|Relapse|1|||
150159712|NCT02419755|541716450|FG000|Overall Study|Ineligible|1|||
150159713|NCT02419755|541716451|FG001|Overall Study|Ineligible|0|||
150159714|NCT02419755|541716450|FG000|Overall Study|Withdrawal by Subject|1|||
150159715|NCT02419755|541716451|FG001|Overall Study|Withdrawal by Subject|0|||
150159716|NCT06403605|541716458|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
150159717|NCT06403605|541716459|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
150159718|NCT06403605|541716458|FG000|Follow-up|Adverse Event|4|||
150159719|NCT06403605|541716459|FG001|Follow-up|Adverse Event|2|||
150159720|NCT06403605|541716458|FG000|Follow-up|Withdrawal by Subject|2|||
150159721|NCT06403605|541716459|FG001|Follow-up|Withdrawal by Subject|3|||
150159722|NCT06403605|541716458|FG000|Follow-up|Lost to Follow-up|1|||
150159723|NCT06403605|541716459|FG001|Follow-up|Lost to Follow-up|0|||
150159724|NCT06403605|541716458|FG000|Follow-up|Death|1|||
150159725|NCT06403605|541716459|FG001|Follow-up|Death|0|||
150159726|NCT06403605|541716458|FG000|Follow-up|Other reasons|0|||
150159727|NCT06403605|541716459|FG001|Follow-up|Other reasons|4|||
150159728|NCT05194735|541717705|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
150159729|NCT05194735|541717706|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
150159730|NCT05194735|541717707|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
150159731|NCT05194735|541717705|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
150159732|NCT05194735|541717706|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
150159733|NCT05194735|541717707|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
150159734|NCT05194735|541717705|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
150159735|NCT05194735|541717706|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
150159736|NCT05194735|541717707|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
150159737|NCT05194735|541717705|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
149817048|NCT00435825|540459989|FG000|Overall Study|Did not complete full follow-up period|6|||
149817049|NCT00435825|540459990|FG001|Overall Study|Did not complete full follow-up period|6|||
149817050|NCT00435825|540459991|FG002|Overall Study|Did not complete full follow-up period|4|||
150159738|NCT05194735|541717706|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
150159739|NCT05194735|541717707|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
150159740|NCT00731042|541717708|FG000|Second Intervention|Did not meet inclusion criteria|0|||
150159741|NCT00731042|541717709|FG001|Second Intervention|Did not meet inclusion criteria|2|||
150159742|NCT02491411|541717715|FG000|Overall Study|Physician Decision|4|||
150159743|NCT00924664|541717716|FG000|Overall Study|Adverse Event|23|||
150159744|NCT00924664|541717717|FG001|Overall Study|Adverse Event|39|||
150159745|NCT00924664|541717716|FG000|Overall Study|Lack of Efficacy|10|||
150159746|NCT00924664|541717717|FG001|Overall Study|Lack of Efficacy|15|||
150159747|NCT00924664|541717716|FG000|Overall Study|Lost to Follow-up|10|||
149817051|NCT00435825|540459992|FG003|Overall Study|Did not complete full follow-up period|5|||
149817052|NCT00430638|540459993|FG000|Overall Study|Adverse Event|15|||
149817053|NCT00430638|540459994|FG001|Overall Study|Adverse Event|15|||
149817054|NCT00430638|540459993|FG000|Overall Study|Uncontrolled blood pressure|48|||
149817055|NCT00430638|540459994|FG001|Overall Study|Uncontrolled blood pressure|13|||
149817056|NCT00430638|540459993|FG000|Overall Study|Lost to Follow-up|1|||
149817057|NCT00430638|540459994|FG001|Overall Study|Lost to Follow-up|7|||
149817058|NCT00430638|540459993|FG000|Overall Study|Protocol Violation|6|||
149817059|NCT00430638|540459994|FG001|Overall Study|Protocol Violation|4|||
149817060|NCT00430638|540459993|FG000|Overall Study|Withdrawal by Subject|4|||
149817061|NCT00430638|540459994|FG001|Overall Study|Withdrawal by Subject|6|||
150259546|NCT02354508|542087159|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
150259547|NCT02354508|542087160|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
150259548|NCT03587974|542087161|FG000|Overall Study|caregiver demented, care recipient died|3|||
150259549|NCT03587974|542087162|FG001|Overall Study|caregiver demented, care recipient died|3|||
150259550|NCT03587974|542087161|FG000|Overall Study|Withdrawal by Subject|2|||
150259551|NCT03587974|542087162|FG001|Overall Study|Withdrawal by Subject|1|||
150259552|NCT02585232|542087163|FG000|Overall Study|Lost to Follow-up|8|||
150259553|NCT02585232|542087164|FG001|Overall Study|Lost to Follow-up|8|||
150259554|NCT02585232|542087163|FG000|Overall Study|Withdrawal by Subject|4|||
149817062|NCT00430638|540459993|FG000|Overall Study|Non-compliant|2|||
149817063|NCT00430638|540459994|FG001|Overall Study|Non-compliant|1|||
149817064|NCT00430638|540459993|FG000|Overall Study|Other|2|||
149817065|NCT00430638|540459994|FG001|Overall Study|Other|2|||
149817066|NCT02367781|540459995|FG000|Overall Study|Withdrawal by Subject|20|||
149817067|NCT02367781|540459996|FG001|Overall Study|Withdrawal by Subject|13|||
149817068|NCT02367781|540459995|FG000|Overall Study|Protocol Violation|0|||
149817069|NCT02367781|540459996|FG001|Overall Study|Protocol Violation|1|||
149817070|NCT02367781|540459995|FG000|Overall Study|Physician Decision|7|||
149817071|NCT02367781|540459996|FG001|Overall Study|Physician Decision|0|||
149817072|NCT02367781|540459995|FG000|Overall Study|Randomized in Error|5|||
149817073|NCT02367781|540459996|FG001|Overall Study|Randomized in Error|4|||
149817074|NCT02367781|540459995|FG000|Overall Study|Non-Compliance|1|||
149817075|NCT02367781|540459996|FG001|Overall Study|Non-Compliance|0|||
149817076|NCT02367781|540459995|FG000|Overall Study|Lost to Follow-up|1|||
149817077|NCT02367781|540459996|FG001|Overall Study|Lost to Follow-up|2|||
149817078|NCT02367781|540459995|FG000|Overall Study|Death|330|||
149817079|NCT02367781|540459996|FG001|Overall Study|Death|176|||
149817080|NCT02367781|540459995|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
149817081|NCT02367781|540459996|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
149817082|NCT02367781|540459995|FG000|Overall Study|Prolonged Hospitalization|1|||
149817083|NCT02367781|540459996|FG001|Overall Study|Prolonged Hospitalization|0|||
149817084|NCT02367781|540459995|FG000|Overall Study|Death Prior First Dose|1|||
149817085|NCT02367781|540459996|FG001|Overall Study|Death Prior First Dose|0|||
149817086|NCT02367781|540459995|FG000|Overall Study|Administrative-Change Facility|1|||
149817087|NCT02367781|540459996|FG001|Overall Study|Administrative-Change Facility|0|||
149817088|NCT02367781|540459995|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
149817089|NCT02367781|540459996|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
149817090|NCT02367781|540459995|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
149817091|NCT02367781|540459996|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
149817092|NCT02367781|540459995|FG000|Overall Study|Study Terminated by Sponsor|3|||
149817093|NCT02367781|540459996|FG001|Overall Study|Study Terminated by Sponsor|1|||
149817094|NCT02367781|540459995|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
149817095|NCT02367781|540459996|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
149817096|NCT02367781|540459995|FG000|Overall Study|Sponsor Decision|2|||
149817097|NCT02367781|540459996|FG001|Overall Study|Sponsor Decision|0|||
149817098|NCT02367781|540459995|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
149817099|NCT02367781|540459996|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
149817100|NCT01529749|540459997|FG000|Overall Study|Lost to Follow-up|0|||
149817101|NCT01529749|540459998|FG001|Overall Study|Lost to Follow-up|1|||
149817102|NCT01529749|540459999|FG002|Overall Study|Lost to Follow-up|1|||
149817103|NCT01529749|540460000|FG003|Overall Study|Lost to Follow-up|0|||
149817104|NCT01529749|540459997|FG000|Overall Study|Physician Decision|0|||
149817105|NCT01529749|540459998|FG001|Overall Study|Physician Decision|0|||
149817106|NCT01529749|540459999|FG002|Overall Study|Physician Decision|0|||
149817107|NCT01529749|540460000|FG003|Overall Study|Physician Decision|1|||
149817108|NCT01529749|540459997|FG000|Overall Study|Withdrawal by Subject|0|||
149817109|NCT01529749|540459998|FG001|Overall Study|Withdrawal by Subject|1|||
149817110|NCT01529749|540459999|FG002|Overall Study|Withdrawal by Subject|1|||
149817111|NCT01529749|540460000|FG003|Overall Study|Withdrawal by Subject|0|||
150159748|NCT00924664|541717717|FG001|Overall Study|Lost to Follow-up|12|||
150159749|NCT00924664|541717716|FG000|Overall Study|Withdrawal by Subject|47|||
150159750|NCT00924664|541717717|FG001|Overall Study|Withdrawal by Subject|71|||
150159751|NCT00924664|541717716|FG000|Overall Study|Protocol Violation|2|||
150159752|NCT00924664|541717717|FG001|Overall Study|Protocol Violation|5|||
150159753|NCT00924664|541717716|FG000|Overall Study|Pregnancy|1|||
150159754|NCT00924664|541717717|FG001|Overall Study|Pregnancy|1|||
150159755|NCT00924664|541717716|FG000|Overall Study|Death|0|||
150159756|NCT00924664|541717717|FG001|Overall Study|Death|2|||
150159757|NCT00924664|541717716|FG000|Overall Study|Study terminated by sponsor|199|||
150159758|NCT00924664|541717717|FG001|Overall Study|Study terminated by sponsor|330|||
150159759|NCT00924664|541717716|FG000|Overall Study|Other|29|||
150159760|NCT00924664|541717717|FG001|Overall Study|Other|52|||
150159761|NCT00924664|541717716|FG000|Overall Study|Randomized but not Treated|1|||
149919198|NCT01618916|540837294|FG000|Overall Study|Withdrawal by Subject|0|||
149919199|NCT01618916|540837295|FG001|Overall Study|Withdrawal by Subject|1|||
149919200|NCT01618916|540837296|FG002|Overall Study|Withdrawal by Subject|1|||
149919201|NCT01618916|540837297|FG003|Overall Study|Withdrawal by Subject|0|||
149919202|NCT01618916|540837298|FG004|Overall Study|Withdrawal by Subject|1|||
149919203|NCT01618916|540837299|FG005|Overall Study|Withdrawal by Subject|0|||
149919204|NCT01618916|540837294|FG000|Overall Study|Lost to Follow-up|1|||
149919205|NCT01618916|540837295|FG001|Overall Study|Lost to Follow-up|0|||
149919206|NCT01618916|540837296|FG002|Overall Study|Lost to Follow-up|0|||
149919207|NCT01618916|540837297|FG003|Overall Study|Lost to Follow-up|2|||
149919208|NCT01618916|540837298|FG004|Overall Study|Lost to Follow-up|0|||
149919209|NCT01618916|540837299|FG005|Overall Study|Lost to Follow-up|0|||
149919210|NCT03004924|540837300|FG000|Overall Study|Adverse Event|6|||
149919211|NCT03004924|540837301|FG001|Overall Study|Adverse Event|5|||
149919212|NCT03004924|540837302|FG002|Overall Study|Adverse Event|10|||
149919213|NCT03004924|540837300|FG000|Overall Study|Protocol Violation|4|||
149817112|NCT01529749|540459997|FG000|Overall Study|Protocol Violation|0|||
149817113|NCT01529749|540459998|FG001|Overall Study|Protocol Violation|0|||
149817114|NCT01529749|540459999|FG002|Overall Study|Protocol Violation|0|||
149817115|NCT01529749|540460000|FG003|Overall Study|Protocol Violation|1|||
149817116|NCT00378482|540460001|FG000|Overall Study|Lost to Follow-up|1|||
149817117|NCT00378482|540460001|FG000|Overall Study|Lack of Efficacy|8|||
149817118|NCT00378482|540460001|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
149817119|NCT00378482|540460001|FG000|Overall Study|Withdrawal by Subject|4|||
149817120|NCT00378482|540460001|FG000|Overall Study|Adverse Event|9|||
149817121|NCT05166421|540460002|FG000|Overall Study|Other|3|||
149817122|NCT05166421|540460003|FG001|Overall Study|Other|1|||
149817123|NCT05166421|540460004|FG002|Overall Study|Other|1|||
149817124|NCT05166421|540460002|FG000|Overall Study|Withdrawal by Subject|5|||
149817125|NCT05166421|540460003|FG001|Overall Study|Withdrawal by Subject|3|||
149817126|NCT05166421|540460004|FG002|Overall Study|Withdrawal by Subject|6|||
149817127|NCT05166421|540460002|FG000|Overall Study|Lost to Follow-up|4|||
149817128|NCT05166421|540460003|FG001|Overall Study|Lost to Follow-up|1|||
149817129|NCT05166421|540460004|FG002|Overall Study|Lost to Follow-up|7|||
149817130|NCT01246986|540461453|FG000|Overall Study|Lost to Follow-up|0|||
149817131|NCT01246986|540461454|FG001|Overall Study|Lost to Follow-up|1|||
149817132|NCT01246986|540461455|FG002|Overall Study|Lost to Follow-up|3|||
149817133|NCT01246986|540461456|FG003|Overall Study|Lost to Follow-up|0|||
149817134|NCT01246986|540461457|FG004|Overall Study|Lost to Follow-up|0|||
149817135|NCT01246986|540461458|FG005|Overall Study|Lost to Follow-up|1|||
149817136|NCT01246986|540461459|FG006|Overall Study|Lost to Follow-up|0|||
149817137|NCT01246986|540461453|FG000|Overall Study|Withdrawal by Subject|3|||
149817138|NCT01246986|540461454|FG001|Overall Study|Withdrawal by Subject|4|||
149817139|NCT01246986|540461455|FG002|Overall Study|Withdrawal by Subject|3|||
149817140|NCT01246986|540461456|FG003|Overall Study|Withdrawal by Subject|0|||
149817141|NCT01246986|540461457|FG004|Overall Study|Withdrawal by Subject|4|||
149817142|NCT01246986|540461458|FG005|Overall Study|Withdrawal by Subject|0|||
149817143|NCT01246986|540461459|FG006|Overall Study|Withdrawal by Subject|0|||
149817144|NCT01335399|540461460|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
149817145|NCT01335399|540461461|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
149817146|NCT01335399|540461460|FG000|Pre-treatment Period|Participant request to discontinue|0|||
149817147|NCT01335399|540461461|FG001|Pre-treatment Period|Participant request to discontinue|1|||
149817148|NCT01335399|540461460|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
149817149|NCT01335399|540461461|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
149817150|NCT01335399|540461460|FG000|Pre-treatment Period|Consent withdrawal|3|||
149817151|NCT01335399|540461461|FG001|Pre-treatment Period|Consent withdrawal|0|||
149817152|NCT01335399|540461460|FG000|Treatment Period|Disease progression|117|||
149817153|NCT01335399|540461461|FG001|Treatment Period|Disease progression|145|||
149817154|NCT01335399|540461460|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
149817155|NCT01335399|540461461|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
149817156|NCT01335399|540461460|FG000|Treatment Period|Study drug toxicity|52|||
149817157|NCT01335399|540461461|FG001|Treatment Period|Study drug toxicity|64|||
149817158|NCT01335399|540461460|FG000|Treatment Period|Participant request to discontinue|30|||
149817159|NCT01335399|540461461|FG001|Treatment Period|Participant request to discontinue|22|||
149817160|NCT01335399|540461460|FG000|Treatment Period|Other reasons|30|||
149817161|NCT01335399|540461461|FG001|Treatment Period|Other reasons|30|||
149817162|NCT01335399|540461460|FG000|Treatment Period|Consent withdrawal|10|||
149817163|NCT01335399|540461461|FG001|Treatment Period|Consent withdrawal|7|||
149817164|NCT01335399|540461460|FG000|Treatment Period|Death|7|||
149817165|NCT01335399|540461461|FG001|Treatment Period|Death|6|||
149817166|NCT01335399|540461460|FG000|Treatment Period|Poor/Non-compliance|3|||
149817167|NCT01335399|540461461|FG001|Treatment Period|Poor/Non-compliance|4|||
149817168|NCT01335399|540461460|FG000|Treatment Period|Lost to Follow-up|2|||
149817169|NCT01335399|540461461|FG001|Treatment Period|Lost to Follow-up|2|||
149817170|NCT01335399|540461460|FG000|Treatment Period|Maximum clinical benefit|1|||
149817171|NCT01335399|540461461|FG001|Treatment Period|Maximum clinical benefit|1|||
149919214|NCT03004924|540837301|FG001|Overall Study|Protocol Violation|0|||
149919215|NCT03004924|540837302|FG002|Overall Study|Protocol Violation|1|||
149817172|NCT01335399|540461460|FG000|Treatment Period|No longer meet study criteria|1|||
149919216|NCT03004924|540837300|FG000|Overall Study|Withdrawal by Subject|5|||
149919217|NCT03004924|540837301|FG001|Overall Study|Withdrawal by Subject|3|||
149919218|NCT03004924|540837302|FG002|Overall Study|Withdrawal by Subject|5|||
149919219|NCT03004924|540837300|FG000|Overall Study|Lost to Follow-up|6|||
149919220|NCT03004924|540837301|FG001|Overall Study|Lost to Follow-up|1|||
149919221|NCT03004924|540837302|FG002|Overall Study|Lost to Follow-up|4|||
149919222|NCT03004924|540837300|FG000|Overall Study|Lack of Efficacy|2|||
149919223|NCT03004924|540837301|FG001|Overall Study|Lack of Efficacy|4|||
149919224|NCT03004924|540837302|FG002|Overall Study|Lack of Efficacy|2|||
149919225|NCT03004924|540837300|FG000|Overall Study|Physician Decision|1|||
149919226|NCT03004924|540837301|FG001|Overall Study|Physician Decision|0|||
149919227|NCT03004924|540837302|FG002|Overall Study|Physician Decision|1|||
149919228|NCT03004924|540837300|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149919229|NCT03004924|540837301|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149919230|NCT03004924|540837302|FG002|Overall Study|Withdrawal by parent/guardian|2|||
149919231|NCT03004924|540837300|FG000|Overall Study|Screen Failure|1|||
149919232|NCT03004924|540837301|FG001|Overall Study|Screen Failure|0|||
149919233|NCT03004924|540837302|FG002|Overall Study|Screen Failure|0|||
149919234|NCT03004924|540837300|FG000|Overall Study|Pregnancy|0|||
149919235|NCT03004924|540837301|FG001|Overall Study|Pregnancy|1|||
149919236|NCT03004924|540837302|FG002|Overall Study|Pregnancy|0|||
149919237|NCT03004924|540837300|FG000|Overall Study|Terminated by Sponsor|0|||
149919238|NCT03004924|540837301|FG001|Overall Study|Terminated by Sponsor|0|||
149919239|NCT03004924|540837302|FG002|Overall Study|Terminated by Sponsor|1|||
149919240|NCT03004924|540837300|FG000|Overall Study|Missed Study Visit|0|||
149919241|NCT03004924|540837301|FG001|Overall Study|Missed Study Visit|0|||
149919242|NCT03004924|540837302|FG002|Overall Study|Missed Study Visit|2|||
149919243|NCT03004924|540837300|FG000|Overall Study|HSV1 Positive|1|||
149919244|NCT03004924|540837301|FG001|Overall Study|HSV1 Positive|0|||
149919245|NCT03004924|540837302|FG002|Overall Study|HSV1 Positive|0|||
149919246|NCT00438256|540837305|FG000|Overall Study|Ineligible for Resection|2|||
149919247|NCT00438256|540837306|FG001|Overall Study|Ineligible for Resection|1|||
149919248|NCT00438256|540837307|FG002|Overall Study|Ineligible for Resection|1|||
149919249|NCT00438256|540837308|FG003|Overall Study|Ineligible for Resection|7|||
149919250|NCT00438256|540837305|FG000|Overall Study|Excluded final Diagnosis|0|||
149919251|NCT00438256|540837306|FG001|Overall Study|Excluded final Diagnosis|0|||
149919252|NCT00438256|540837307|FG002|Overall Study|Excluded final Diagnosis|0|||
149919253|NCT00438256|540837308|FG003|Overall Study|Excluded final Diagnosis|2|||
149919254|NCT02005627|540837309|FG000|Overall Study|Lost to Follow-up|1|||
149919255|NCT02005627|540837310|FG001|Overall Study|Lost to Follow-up|2|||
149919256|NCT02005627|540837309|FG000|Overall Study|Withdrawal by Subject|1|||
149919257|NCT02005627|540837310|FG001|Overall Study|Withdrawal by Subject|2|||
149919258|NCT03913104|540837323|FG000|Overall Study|Lost to Follow-up|20|||
149919259|NCT03913104|540837323|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
149919260|NCT03913104|540837323|FG000|Overall Study|Withdrawal by Subject|2|||
149919261|NCT01370616|540837324|FG000|Overall Study|Adverse Event|11|||
149919262|NCT01370616|540837325|FG001|Overall Study|Adverse Event|16|||
149919263|NCT01370616|540837324|FG000|Overall Study|Death|1|||
149919264|NCT01370616|540837325|FG001|Overall Study|Death|0|||
149919265|NCT01370616|540837324|FG000|Overall Study|Lack of Efficacy|6|||
149919266|NCT01370616|540837325|FG001|Overall Study|Lack of Efficacy|2|||
149919267|NCT01370616|540837324|FG000|Overall Study|Lost to Follow-up|0|||
149919268|NCT01370616|540837325|FG001|Overall Study|Lost to Follow-up|3|||
149919269|NCT01370616|540837324|FG000|Overall Study|Physician Decision|6|||
149919270|NCT01370616|540837325|FG001|Overall Study|Physician Decision|6|||
149919271|NCT01370616|540837324|FG000|Overall Study|Progressive Disease|0|||
149919272|NCT01370616|540837325|FG001|Overall Study|Progressive Disease|1|||
149919273|NCT01370616|540837324|FG000|Overall Study|Recovery|1|||
149919274|NCT01370616|540837325|FG001|Overall Study|Recovery|0|||
149919275|NCT01370616|540837324|FG000|Overall Study|Technical Problems|3|||
149919276|NCT01370616|540837325|FG001|Overall Study|Technical Problems|5|||
149919277|NCT01370616|540837324|FG000|Overall Study|Withdrawal by Subject|34|||
149919278|NCT01370616|540837325|FG001|Overall Study|Withdrawal by Subject|34|||
149919279|NCT01084538|540837326|FG000|Overall Study|Drug not available|30|||
149919280|NCT01084538|540837326|FG000|Overall Study|Adverse Event|9|||
149919281|NCT01084538|540837326|FG000|Overall Study|Kidney transplant|6|||
149919282|NCT01084538|540837326|FG000|Overall Study|Serious Adverse Event|3|||
149919283|NCT01084538|540837326|FG000|Overall Study|Lack of effectiveness|2|||
149919284|NCT01084538|540837326|FG000|Overall Study|Patient noncompliance|2|||
149919285|NCT01084538|540837326|FG000|Overall Study|Hyperphosphatemia|2|||
149919286|NCT01084538|540837326|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
149919287|NCT01084538|540837326|FG000|Overall Study|Change of residence|2|||
149919288|NCT01084538|540837326|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
149919289|NCT01084538|540837326|FG000|Overall Study|Reason unknown|8|||
149919290|NCT00803205|540837331|FG000|Overall Study|Adverse Event|7|||
149919291|NCT00803205|540837332|FG001|Overall Study|Adverse Event|2|||
149919292|NCT00803205|540837331|FG000|Overall Study|Lost to Follow-up|1|||
149919293|NCT00803205|540837332|FG001|Overall Study|Lost to Follow-up|0|||
149919294|NCT00803205|540837331|FG000|Overall Study|Withdrawal by Subject|9|||
149919295|NCT00803205|540837332|FG001|Overall Study|Withdrawal by Subject|9|||
149919296|NCT00803205|540837331|FG000|Overall Study|Physician Decision|1|||
149919297|NCT00803205|540837332|FG001|Overall Study|Physician Decision|0|||
149919298|NCT00803205|540837331|FG000|Overall Study|Protocol Violation|1|||
149919299|NCT00803205|540837332|FG001|Overall Study|Protocol Violation|1|||
149919300|NCT00803205|540837331|FG000|Overall Study|Medical Monitor Decision|1|||
149919301|NCT00803205|540837332|FG001|Overall Study|Medical Monitor Decision|0|||
149919302|NCT00803205|540837331|FG000|Overall Study|Acquired a Lung Infection|0|||
149919303|NCT00803205|540837332|FG001|Overall Study|Acquired a Lung Infection|1|||
149919304|NCT00803205|540837331|FG000|Overall Study|Sponsor Decision|0|||
149919305|NCT00803205|540837332|FG001|Overall Study|Sponsor Decision|1|||
149919306|NCT01490697|540837335|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
149919307|NCT01490697|540837336|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
149919308|NCT00379808|540837337|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
149919309|NCT00379808|540837338|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
149919310|NCT02906033|540837345|FG000|Baseline|Protocol Violation|37|||
149919311|NCT02906033|540837346|FG001|Baseline|Protocol Violation|33|||
149919312|NCT02906033|540837345|FG000|Follow-up|Lost to Follow-up|46|||
149919313|NCT02906033|540837346|FG001|Follow-up|Lost to Follow-up|62|||
149919314|NCT01625689|540837351|FG000|Overall Study|Migration|2|||
149919315|NCT01625689|540837352|FG001|Overall Study|Migration|1|||
149919316|NCT01333956|540837367|FG000|Overall Study|Lost to Follow-up|1|||
149919317|NCT01333956|540837368|FG001|Overall Study|Lost to Follow-up|2|||
149919318|NCT01333956|540837369|FG002|Overall Study|Lost to Follow-up|0|||
149919319|NCT01333956|540837370|FG003|Overall Study|Lost to Follow-up|1|||
149919320|NCT01333956|540837367|FG000|Overall Study|Unable to complete study procedure|1|||
149919321|NCT01333956|540837368|FG001|Overall Study|Unable to complete study procedure|0|||
149919322|NCT01333956|540837369|FG002|Overall Study|Unable to complete study procedure|0|||
149919323|NCT01333956|540837370|FG003|Overall Study|Unable to complete study procedure|1|||
149919324|NCT01333956|540837367|FG000|Overall Study|Withdrawal by Subject|0|||
149919325|NCT01333956|540837368|FG001|Overall Study|Withdrawal by Subject|2|||
149919326|NCT01333956|540837369|FG002|Overall Study|Withdrawal by Subject|1|||
149919327|NCT01333956|540837370|FG003|Overall Study|Withdrawal by Subject|0|||
149919328|NCT02134353|540837371|FG000|Overall Study|Adverse Event|10|||
149919329|NCT02134353|540837372|FG001|Overall Study|Adverse Event|6|||
149919330|NCT02134353|540837371|FG000|Overall Study|Lost to Follow-up|1|||
149919331|NCT02134353|540837372|FG001|Overall Study|Lost to Follow-up|1|||
149919332|NCT02134353|540837371|FG000|Overall Study|Lack of Efficacy|2|||
149919333|NCT02134353|540837372|FG001|Overall Study|Lack of Efficacy|1|||
149919334|NCT02134353|540837371|FG000|Overall Study|Withdrawal by Subject|12|||
149919335|NCT02134353|540837372|FG001|Overall Study|Withdrawal by Subject|13|||
149919336|NCT02134353|540837371|FG000|Overall Study|Death|0|||
149919337|NCT02134353|540837372|FG001|Overall Study|Death|1|||
149919338|NCT02134353|540837371|FG000|Overall Study|Pregnancy|0|||
149919339|NCT02134353|540837372|FG001|Overall Study|Pregnancy|1|||
149919340|NCT02134353|540837371|FG000|Overall Study|Relocation|1|||
149919341|NCT02134353|540837372|FG001|Overall Study|Relocation|0|||
149919342|NCT02134353|540837371|FG000|Overall Study|Other - Patient's Choice|0|||
149919343|NCT02134353|540837372|FG001|Overall Study|Other - Patient's Choice|1|||
149919344|NCT01732471|540837375|FG000|Overall Study|Withdrawal by Subject|1|||
149919345|NCT00474786|540837376|FG000|Overall Study|Not Meeting Study Criteria|0|||
149919346|NCT00474786|540837377|FG001|Overall Study|Not Meeting Study Criteria|1|||
149919347|NCT00474786|540837376|FG000|Overall Study|Investigator Request|2|||
149919348|NCT00474786|540837377|FG001|Overall Study|Investigator Request|1|||
149919349|NCT00474786|540837376|FG000|Overall Study|Death|189|||
149919350|NCT00474786|540837377|FG001|Overall Study|Death|170|||
149919351|NCT00474786|540837376|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
149919352|NCT00474786|540837377|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
149919353|NCT00474786|540837376|FG000|Overall Study|Lost to Follow-up|4|||
149919354|NCT00474786|540837377|FG001|Overall Study|Lost to Follow-up|7|||
149919355|NCT00474786|540837376|FG000|Overall Study|Protocol Violation|2|||
149919356|NCT00474786|540837377|FG001|Overall Study|Protocol Violation|0|||
149919357|NCT00474786|540837376|FG000|Overall Study|Withdrawal by Subject|15|||
149919358|NCT00474786|540837377|FG001|Overall Study|Withdrawal by Subject|15|||
149919359|NCT00474786|540837376|FG000|Overall Study|Other|5|||
149919360|NCT00474786|540837377|FG001|Overall Study|Other|0|||
149919361|NCT03426436|540837378|FG000|Overall Study|Incorrect lead placement|12|||
149919362|NCT03426436|540837378|FG000|Overall Study|Withdrawal by Subject|2|||
149919363|NCT03426436|540837378|FG000|Overall Study|Consent issue|1|||
149919364|NCT03426436|540837378|FG000|Overall Study|ECGs not saved|4|||
149919365|NCT02892513|540837379|FG000|Overall Study|Withdrawal by Subject|0|||
149919366|NCT02892513|540837380|FG001|Overall Study|Withdrawal by Subject|1|||
149919367|NCT00358956|540837381|FG000|Overall Study|Adverse Event|3|||
149919368|NCT00358956|540837381|FG000|Overall Study|condition under investigation worsened|4|||
149919369|NCT00358956|540837381|FG000|Overall Study|Withdrawal by Subject|1|||
149919370|NCT00655681|540837382|FG000|Overall Study|Lost to Follow-up|1|||
149919371|NCT00655681|540837383|FG001|Overall Study|Lost to Follow-up|1|||
149919372|NCT04776018|540837385|FG000|Overall Study|Death|0|||
149919373|NCT04776018|540837386|FG001|Overall Study|Death|1|||
149919374|NCT04776018|540837387|FG002|Overall Study|Death|4|||
149919375|NCT04776018|540837388|FG003|Overall Study|Death|1|||
149919376|NCT04776018|540837389|FG004|Overall Study|Death|4|||
149919377|NCT04776018|540837390|FG005|Overall Study|Death|0|||
149919378|NCT04776018|540837391|FG006|Overall Study|Death|0|||
149919379|NCT04776018|540837385|FG000|Overall Study|Study terminated by sponsor|2|||
149919380|NCT04776018|540837386|FG001|Overall Study|Study terminated by sponsor|1|||
149919381|NCT04776018|540837387|FG002|Overall Study|Study terminated by sponsor|4|||
149919382|NCT04776018|540837388|FG003|Overall Study|Study terminated by sponsor|0|||
149919383|NCT04776018|540837389|FG004|Overall Study|Study terminated by sponsor|3|||
149919384|NCT04776018|540837390|FG005|Overall Study|Study terminated by sponsor|0|||
149919385|NCT04776018|540837391|FG006|Overall Study|Study terminated by sponsor|0|||
149919386|NCT04776018|540837385|FG000|Overall Study|Withdrawal by Subject|1|||
149919387|NCT04776018|540837386|FG001|Overall Study|Withdrawal by Subject|0|||
149919388|NCT04776018|540837387|FG002|Overall Study|Withdrawal by Subject|0|||
149919389|NCT04776018|540837388|FG003|Overall Study|Withdrawal by Subject|2|||
149919390|NCT04776018|540837389|FG004|Overall Study|Withdrawal by Subject|1|||
149919391|NCT04776018|540837390|FG005|Overall Study|Withdrawal by Subject|0|||
149919392|NCT04776018|540837391|FG006|Overall Study|Withdrawal by Subject|0|||
149919393|NCT04776018|540837385|FG000|Overall Study|Other|0|||
149919394|NCT04776018|540837386|FG001|Overall Study|Other|1|||
149919395|NCT04776018|540837387|FG002|Overall Study|Other|1|||
149919396|NCT04776018|540837388|FG003|Overall Study|Other|0|||
149919397|NCT04776018|540837389|FG004|Overall Study|Other|0|||
149919398|NCT04776018|540837390|FG005|Overall Study|Other|0|||
149919399|NCT04776018|540837391|FG006|Overall Study|Other|0|||
149919400|NCT04776018|540837385|FG000|Overall Study|Lost to Follow-up|0|||
149919401|NCT04776018|540837386|FG001|Overall Study|Lost to Follow-up|0|||
149919402|NCT04776018|540837387|FG002|Overall Study|Lost to Follow-up|1|||
149919403|NCT04776018|540837388|FG003|Overall Study|Lost to Follow-up|0|||
149919404|NCT04776018|540837389|FG004|Overall Study|Lost to Follow-up|0|||
149919405|NCT04776018|540837390|FG005|Overall Study|Lost to Follow-up|0|||
149919406|NCT04776018|540837391|FG006|Overall Study|Lost to Follow-up|0|||
149919407|NCT03168919|540837392|FG000|Overall Study|Withdrawal by Subject|2|||
149919408|NCT01085136|540837393|FG000|Part A|Other Adverse event|223|||
149919409|NCT01085136|540837394|FG001|Part A|Other Adverse event|0|||
149919410|NCT01085136|540837395|FG002|Part A|Other Adverse event|0|||
149919411|NCT01085136|540837393|FG000|Part A|Protocol Violation|3|||
149919412|NCT01085136|540837394|FG001|Part A|Protocol Violation|0|||
149919413|NCT01085136|540837395|FG002|Part A|Protocol Violation|0|||
149919414|NCT01085136|540837393|FG000|Part A|Lost to Follow-up|3|||
149919415|NCT01085136|540837394|FG001|Part A|Lost to Follow-up|0|||
149919416|NCT01085136|540837395|FG002|Part A|Lost to Follow-up|0|||
149919417|NCT01085136|540837393|FG000|Part A|Refusal to continue trial medication|64|||
149919418|NCT01085136|540837394|FG001|Part A|Refusal to continue trial medication|0|||
149919419|NCT01085136|540837395|FG002|Part A|Refusal to continue trial medication|0|||
149919420|NCT01085136|540837393|FG000|Part A|Other reason not defined above|30|||
149919421|NCT01085136|540837394|FG001|Part A|Other reason not defined above|0|||
149919422|NCT01085136|540837395|FG002|Part A|Other reason not defined above|0|||
149919423|NCT01085136|540837393|FG000|Part B|Other AE|0|||
149919424|NCT01085136|540837394|FG001|Part B|Other AE|29|||
149919425|NCT01085136|540837395|FG002|Part B|Other AE|8|||
149919426|NCT01085136|540837393|FG000|Part B|Refusal to continue trial medication|0|||
149919427|NCT01085136|540837394|FG001|Part B|Refusal to continue trial medication|12|||
149919428|NCT01085136|540837395|FG002|Part B|Refusal to continue trial medication|7|||
149919429|NCT01085136|540837393|FG000|Part B|Not treated|0|||
149919430|NCT01085136|540837394|FG001|Part B|Not treated|4|||
149919431|NCT01085136|540837395|FG002|Part B|Not treated|8|||
149919432|NCT01085136|540837393|FG000|Part B|Other reason not defined above|0|||
149919433|NCT01085136|540837394|FG001|Part B|Other reason not defined above|6|||
149919434|NCT01085136|540837395|FG002|Part B|Other reason not defined above|3|||
149919435|NCT02195427|540837396|FG000|Overall Study|Did not consent to study extension|13|||
149919436|NCT02195427|540837397|FG001|Overall Study|Did not consent to study extension|9|||
149919437|NCT02195427|540837396|FG000|Overall Study|Withdrawal by Subject|4|||
149919438|NCT02195427|540837397|FG001|Overall Study|Withdrawal by Subject|2|||
149919439|NCT02195427|540837396|FG000|Overall Study|Lost to Follow-up|0|||
149919440|NCT02195427|540837397|FG001|Overall Study|Lost to Follow-up|1|||
149919441|NCT02195427|540837396|FG000|Overall Study|Protocol Violation|7|||
149919442|NCT02195427|540837397|FG001|Overall Study|Protocol Violation|14|||
149919443|NCT02195427|540837396|FG000|Overall Study|Conditional re-treatment at W52|2|||
149919444|NCT02195427|540837397|FG001|Overall Study|Conditional re-treatment at W52|1|||
149919445|NCT01210144|540837401|FG000|Overall Study|Lack of ovarian response|1|||
149919446|NCT01210144|540837402|FG001|Overall Study|Lack of ovarian response|0|||
149919447|NCT01210144|540837401|FG000|Overall Study|No fertilization|1|||
149919448|NCT01210144|540837402|FG001|Overall Study|No fertilization|0|||
149919449|NCT01210144|540837401|FG000|Overall Study|No transfer|1|||
149919450|NCT01210144|540837402|FG001|Overall Study|No transfer|0|||
149919451|NCT00386425|540837403|FG000|Overall Study|Physician Decision|3|||
149919452|NCT00386425|540837404|FG001|Overall Study|Physician Decision|0|||
149919453|NCT00386425|540837405|FG002|Overall Study|Physician Decision|0|||
149919454|NCT00386425|540837403|FG000|Overall Study|Withdrawal by Subject|0|||
149919455|NCT00386425|540837404|FG001|Overall Study|Withdrawal by Subject|1|||
149919456|NCT00386425|540837405|FG002|Overall Study|Withdrawal by Subject|0|||
149919457|NCT02655419|540837406|FG000|Overall Study|Enrolled but not treated|1|||
149919458|NCT02655419|540837407|FG001|Overall Study|Enrolled but not treated|5|||
149919459|NCT02655419|540837406|FG000|Overall Study|Withdrawal by Subject|4|||
149919460|NCT02655419|540837407|FG001|Overall Study|Withdrawal by Subject|1|||
149919461|NCT02655419|540837406|FG000|Overall Study|Other|0|||
149919462|NCT02655419|540837407|FG001|Overall Study|Other|1|||
149919463|NCT04226495|540837408|FG000|Overall Study|Withdrawal by Subject|3|||
149919464|NCT04226495|540837409|FG001|Overall Study|Withdrawal by Subject|3|||
149919465|NCT04226495|540837408|FG000|Overall Study|PI discretion|3|||
149919466|NCT04226495|540837409|FG001|Overall Study|PI discretion|4|||
149919467|NCT00435019|540837410|FG000|Overall Study|Adverse Event|1|||
149919468|NCT00435019|540837411|FG001|Overall Study|Adverse Event|0|||
149919469|NCT00435019|540837410|FG000|Overall Study|Lack of Efficacy|1|||
149919470|NCT00435019|540837411|FG001|Overall Study|Lack of Efficacy|2|||
149919471|NCT00435019|540837410|FG000|Overall Study|Protocol Violation|3|||
149919472|NCT00435019|540837411|FG001|Overall Study|Protocol Violation|1|||
149919473|NCT00435019|540837410|FG000|Overall Study|Personal reasons for withdrawal|8|||
149919474|NCT00435019|540837411|FG001|Overall Study|Personal reasons for withdrawal|7|||
149919475|NCT03338569|540837412|FG000|Overall Study|Physician Decision|8|||
149919476|NCT03338569|540837413|FG001|Overall Study|Physician Decision|3|||
149919477|NCT03338569|540837412|FG000|Overall Study|Withdrawal by Subject|0|||
149919478|NCT03338569|540837413|FG001|Overall Study|Withdrawal by Subject|1|||
149919479|NCT03338569|540837412|FG000|Overall Study|Lost to Follow-up|0|||
149919480|NCT03338569|540837413|FG001|Overall Study|Lost to Follow-up|1|||
149919481|NCT04607980|540837414|FG000|Overall Study|Adverse Event|3|||
149919482|NCT04607980|540837415|FG001|Overall Study|Adverse Event|4|||
149919483|NCT04607980|540837414|FG000|Overall Study|Death|0|||
149919484|NCT04607980|540837415|FG001|Overall Study|Death|1|||
149919485|NCT04607980|540837414|FG000|Overall Study|Withdrawal by Subject|2|||
149919486|NCT04607980|540837415|FG001|Overall Study|Withdrawal by Subject|5|||
149919487|NCT04607980|540837414|FG000|Overall Study|Lost to Follow-up|4|||
149919488|NCT04607980|540837415|FG001|Overall Study|Lost to Follow-up|8|||
149919489|NCT04607980|540837414|FG000|Overall Study|Protocol Violation|0|||
149919490|NCT04607980|540837415|FG001|Overall Study|Protocol Violation|3|||
149919491|NCT04607980|540837414|FG000|Overall Study|Other|3|||
149919492|NCT04607980|540837415|FG001|Overall Study|Other|0|||
149919493|NCT01854879|540837416|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
149919494|NCT01854879|540837416|FG000|Overall Study|screen fail|3|||
149919495|NCT01854879|540837416|FG000|Overall Study|incomplete data set|1|||
149919496|NCT02012959|540837417|FG000|Treatment Phase A|Adverse Event|2|||
149919497|NCT02012959|540837418|FG001|Treatment Phase A|Adverse Event|0|||
149919498|NCT02012959|540837419|FG002|Treatment Phase A|Adverse Event|0|||
149919499|NCT02012959|540837420|FG003|Treatment Phase A|Adverse Event|0|||
149919500|NCT02012959|540837421|FG004|Treatment Phase A|Adverse Event|0|||
149919501|NCT04494425|540839775|FG000|Overall Study|Death|160|||
149919502|NCT04494425|540839776|FG001|Overall Study|Death|166|||
149919503|NCT04494425|540839775|FG000|Overall Study|Withdrawal by Subject|10|||
149919504|NCT04494425|540839776|FG001|Overall Study|Withdrawal by Subject|40|||
149919505|NCT04494425|540839775|FG000|Overall Study|Other|1|||
149919506|NCT04494425|540839776|FG001|Overall Study|Other|1|||
149919507|NCT04494425|540839775|FG000|Overall Study|Ongoing at the time of PCD|265|||
149919508|NCT04494425|540839776|FG001|Overall Study|Ongoing at the time of PCD|223|||
149919509|NCT01270321|540839777|FG000|Overall Study|Death|3|||
149919510|NCT01270321|540839778|FG001|Overall Study|Death|1|||
149919511|NCT01270321|540839779|FG002|Overall Study|Death|4|||
149919512|NCT01270321|540839777|FG000|Overall Study|Adverse Event|7|||
149919513|NCT01270321|540839778|FG001|Overall Study|Adverse Event|9|||
149919514|NCT01270321|540839779|FG002|Overall Study|Adverse Event|5|||
149919515|NCT04003623|540839783|FG000|Overall Study|Withdrawal by Subject|1|||
149919516|NCT04003623|540839784|FG001|Overall Study|Withdrawal by Subject|0|||
149919517|NCT01744483|540839790|FG000|Overall Study|Death|9|||
149919518|NCT01744483|540839791|FG001|Overall Study|Death|4|||
149919519|NCT01744483|540839792|FG002|Overall Study|Death|11|||
149919520|NCT01744483|540839790|FG000|Overall Study|Lost to Follow-up|8|||
149919521|NCT01744483|540839791|FG001|Overall Study|Lost to Follow-up|9|||
149919522|NCT01744483|540839792|FG002|Overall Study|Lost to Follow-up|11|||
149919523|NCT01744483|540839790|FG000|Overall Study|Protocol Violation|1|||
149919524|NCT01744483|540839791|FG001|Overall Study|Protocol Violation|2|||
149919525|NCT01744483|540839792|FG002|Overall Study|Protocol Violation|1|||
149919526|NCT01744483|540839790|FG000|Overall Study|Withdrawal by Subject|4|||
149919527|NCT01744483|540839791|FG001|Overall Study|Withdrawal by Subject|6|||
149919528|NCT01744483|540839792|FG002|Overall Study|Withdrawal by Subject|2|||
149919529|NCT01744483|540839790|FG000|Overall Study|No ICU Admit|5|||
149919530|NCT01744483|540839791|FG001|Overall Study|No ICU Admit|1|||
149919531|NCT01744483|540839792|FG002|Overall Study|No ICU Admit|2|||
149919532|NCT01744483|540839790|FG000|Overall Study|Routed to OSH|2|||
149919533|NCT01744483|540839791|FG001|Overall Study|Routed to OSH|0|||
149919534|NCT01744483|540839792|FG002|Overall Study|Routed to OSH|1|||
149919535|NCT01190189|540839793|FG000|Overall Study|Lost to Follow-up|4|||
149919536|NCT01190189|540839793|FG000|Overall Study|Withdrawal by Subject|1|||
149919537|NCT01190189|540839793|FG000|Overall Study|Migrated/moved from study area|1|||
149919538|NCT03915626|540839794|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
149919539|NCT05025332|540839795|FG000|Screening|Screen failure|12|||
149919540|NCT05025332|540839795|FG000|Treatment & Follow Up|Protocol Violation|1|||
149919541|NCT05025332|540839795|FG000|Treatment & Follow Up|Adverse Event|4|||
149919542|NCT01026818|540839802|FG000|Screening Period|Entry Criteria Not Met|105|||
149919543|NCT01026818|540839803|FG001|Screening Period|Entry Criteria Not Met|0|||
149919544|NCT01026818|540839804|FG002|Screening Period|Entry Criteria Not Met|0|||
149919545|NCT01026818|540839805|FG003|Screening Period|Entry Criteria Not Met|0|||
149919546|NCT01026818|540839802|FG000|Screening Period|Withdrawal by Subject|49|||
149919547|NCT01026818|540839803|FG001|Screening Period|Withdrawal by Subject|0|||
149919548|NCT01026818|540839804|FG002|Screening Period|Withdrawal by Subject|0|||
149919549|NCT01026818|540839805|FG003|Screening Period|Withdrawal by Subject|0|||
149919550|NCT01026818|540839802|FG000|Screening Period|Protocol Deviation|3|||
149919551|NCT01026818|540839803|FG001|Screening Period|Protocol Deviation|0|||
149919552|NCT01026818|540839804|FG002|Screening Period|Protocol Deviation|0|||
149919553|NCT01026818|540839805|FG003|Screening Period|Protocol Deviation|0|||
149919554|NCT01026818|540839802|FG000|Screening Period|Adverse Event|2|||
149919555|NCT01026818|540839803|FG001|Screening Period|Adverse Event|0|||
149919556|NCT01026818|540839804|FG002|Screening Period|Adverse Event|0|||
149919557|NCT01026818|540839805|FG003|Screening Period|Adverse Event|0|||
149919558|NCT01026818|540839802|FG000|Screening Period|Physician Decision|1|||
149919559|NCT01026818|540839803|FG001|Screening Period|Physician Decision|0|||
149919560|NCT01026818|540839804|FG002|Screening Period|Physician Decision|0|||
149919561|NCT01026818|540839805|FG003|Screening Period|Physician Decision|0|||
149919562|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
149919563|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
149919564|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
149919565|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
149919566|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
149919567|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
149919568|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
149919569|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
149919570|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
149919571|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
149919572|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
149919573|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
150159762|NCT00924664|541717717|FG001|Overall Study|Randomized but not Treated|0|||
150159763|NCT01598987|541717718|FG000|Baseline to Month 12|Administrative problems|2|||
150159764|NCT01598987|541717718|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
150159765|NCT01598987|541717718|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
150159766|NCT01598987|541717718|FG000|Baseline to 24 Month|Administrative problems|2|||
150159767|NCT01598987|541717718|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
150159768|NCT01616563|541717720|FG000|Overall Study|Lost to Follow-up|40|||
150159769|NCT00072475|541717721|FG000|Overall Study|Adverse Event|44|||
150159770|NCT00072475|541717721|FG000|Overall Study|Death|3|||
150159771|NCT00072475|541717721|FG000|Overall Study|Withdrawal by Subject|46|||
150159772|NCT00072475|541717721|FG000|Overall Study|Patient/Investigator Decision|4|||
149817173|NCT01335399|540461461|FG001|Treatment Period|No longer meet study criteria|1|||
149817174|NCT01335399|540461460|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
149817175|NCT01335399|540461461|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
149817176|NCT03990389|540461462|FG000|Overall Study|Lost to Follow-up|3|||
149817177|NCT03990389|540461463|FG001|Overall Study|Lost to Follow-up|0|||
149817178|NCT03770000|540461465|FG000|Overall Study|Premature discontinuation due to PD|0|||
149817179|NCT03770000|540461466|FG001|Overall Study|Premature discontinuation due to PD|0|||
149817180|NCT03770000|540461467|FG002|Overall Study|Premature discontinuation due to PD|1|||
149817181|NCT03770000|540461468|FG003|Overall Study|Premature discontinuation due to PD|3|||
149817182|NCT03770000|540461469|FG004|Overall Study|Premature discontinuation due to PD|2|||
149817183|NCT02595528|540461470|FG000|Overall Study|Withdrawal by Subject|1|||
149817184|NCT02595528|540461471|FG001|Overall Study|Withdrawal by Subject|2|||
149817185|NCT02595528|540461472|FG002|Overall Study|Withdrawal by Subject|1|||
149817186|NCT02595528|540461473|FG003|Overall Study|Withdrawal by Subject|3|||
149817187|NCT02595528|540461470|FG000|Overall Study|Lost to Follow-up|1|||
149817188|NCT02595528|540461471|FG001|Overall Study|Lost to Follow-up|1|||
149817189|NCT02595528|540461472|FG002|Overall Study|Lost to Follow-up|0|||
149817190|NCT02595528|540461473|FG003|Overall Study|Lost to Follow-up|1|||
149817191|NCT03202511|540461474|FG000|Overall Study|Withdrawal by Subject|1|||
149817192|NCT03202511|540461475|FG001|Overall Study|Withdrawal by Subject|0|||
149817193|NCT00686790|540461476|FG000|Overall Study|Adverse Event|2|||
149817194|NCT00686790|540461476|FG000|Overall Study|Withdrawal by Subject|1|||
149919574|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
149919575|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
149919576|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
149919577|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
149919578|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
149919579|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
149919580|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
149919581|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
149919582|NCT01026818|540839802|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
149919583|NCT01026818|540839803|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
149919584|NCT01026818|540839804|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
149919585|NCT01026818|540839805|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
149919586|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
149919587|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
150259555|NCT02585232|542087164|FG001|Overall Study|Withdrawal by Subject|8|||
150259556|NCT00461032|542087167|FG000|Overall Study|Adverse Event|5|||
150259557|NCT00461032|542087168|FG001|Overall Study|Adverse Event|6|||
150259558|NCT00461032|542087167|FG000|Overall Study|Lack of Efficacy|5|||
150259559|NCT00461032|542087168|FG001|Overall Study|Lack of Efficacy|1|||
150259560|NCT00461032|542087167|FG000|Overall Study|Lost to Follow-up|7|||
150259561|NCT00461032|542087168|FG001|Overall Study|Lost to Follow-up|12|||
150259562|NCT00461032|542087167|FG000|Overall Study|Protocol Violation|4|||
150259563|NCT00461032|542087168|FG001|Overall Study|Protocol Violation|4|||
150259564|NCT00461032|542087167|FG000|Overall Study|Withdrawal by Subject|7|||
150259565|NCT00461032|542087168|FG001|Overall Study|Withdrawal by Subject|15|||
150259566|NCT00461032|542087167|FG000|Overall Study|Patient Moved or Relocated|2|||
150259567|NCT00461032|542087168|FG001|Overall Study|Patient Moved or Relocated|1|||
150259568|NCT00461032|542087167|FG000|Overall Study|Other|7|||
150259569|NCT00461032|542087168|FG001|Overall Study|Other|5|||
150259570|NCT00297232|542087169|FG000|Overall Study|Lack of Efficacy|7|||
150259571|NCT00297232|542087169|FG000|Overall Study|Lost to Follow-up|10|||
150259572|NCT00297232|542087169|FG000|Overall Study|Adverse Event|63|||
150259573|NCT00297232|542087169|FG000|Overall Study|Voluntary Withdrawal|120|||
150259574|NCT00297232|542087169|FG000|Overall Study|Subject was Noncompliant|9|||
150259575|NCT00297232|542087169|FG000|Overall Study|Death|9|||
150259576|NCT00297232|542087169|FG000|Overall Study|Anti-natalizumab Positive|8|||
150259577|NCT00297232|542087169|FG000|Overall Study|Switched to Commercial Tysabri|22|||
149919588|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
149919589|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
149919590|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
149919591|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
149919592|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
149919593|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
149919594|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
149919595|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
149919596|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
149919597|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
149919598|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
149919599|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
149919600|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
149919601|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
149919602|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
149919603|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
149919604|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
149919605|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
149919606|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
149919607|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
149919608|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
149919609|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
149919610|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
149919611|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
149919612|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
149919613|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
149919614|NCT01026818|540839802|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
150259578|NCT00297232|542087169|FG000|Overall Study|Disease Progression|8|||
150259579|NCT00297232|542087169|FG000|Overall Study|Fear of PML|10|||
150259580|NCT00297232|542087169|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
150259581|NCT00297232|542087169|FG000|Overall Study|Miscellaneous|5|||
150259582|NCT00297232|542087169|FG000|Overall Study|Sponsor Decision|34|||
150259583|NCT00297232|542087169|FG000|Overall Study|Subject Relocated|7|||
150259584|NCT00297232|542087169|FG000|Overall Study|Subject Withdrew Consent|37|||
150259585|NCT00297232|542087169|FG000|Overall Study|Persistently Positive Antibodies|11|||
150259586|NCT00297232|542087169|FG000|Overall Study|Investigator Withdrew From Program|19|||
150259587|NCT00297232|542087169|FG000|Overall Study|Did Not Enroll to Week 264|34|||
150259588|NCT00297232|542087169|FG000|Overall Study|Did Not Enroll to Week 480|17|||
150259589|NCT00297232|542087169|FG000|Overall Study|No data available after Week 264|161|||
149919615|NCT01026818|540839803|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
149919616|NCT01026818|540839804|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
149919617|NCT01026818|540839805|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
149919618|NCT01026818|540839802|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
149919619|NCT01026818|540839803|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
149919620|NCT01026818|540839804|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
149919621|NCT01026818|540839805|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
149919622|NCT01026818|540839802|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
149919623|NCT01026818|540839803|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
149919624|NCT01026818|540839804|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
149919625|NCT01026818|540839805|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
149919626|NCT01026818|540839802|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
149919627|NCT01026818|540839803|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
149919628|NCT01026818|540839804|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
149919629|NCT01026818|540839805|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
149919630|NCT01026818|540839802|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
149919631|NCT01026818|540839803|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
149919632|NCT01026818|540839804|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
149919633|NCT01026818|540839805|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
149919634|NCT01026818|540839802|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
149919635|NCT01026818|540839803|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
149919636|NCT01026818|540839804|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
149919637|NCT01026818|540839805|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
149919638|NCT04575584|540839806|FG000|Overall Study|Death|6|||
149919639|NCT04575584|540839807|FG001|Overall Study|Death|4|||
149919640|NCT04575584|540839808|FG002|Overall Study|Death|6|||
149919641|NCT04575584|540839809|FG003|Overall Study|Death|2|||
149919642|NCT04575584|540839810|FG004|Overall Study|Death|0|||
149919643|NCT04575584|540839811|FG005|Overall Study|Death|0|||
149919644|NCT04575584|540839806|FG000|Overall Study|Lost to Follow-up|1|||
149919645|NCT04575584|540839807|FG001|Overall Study|Lost to Follow-up|1|||
149919646|NCT04575584|540839808|FG002|Overall Study|Lost to Follow-up|1|||
149919647|NCT04575584|540839809|FG003|Overall Study|Lost to Follow-up|1|||
149919648|NCT04575584|540839810|FG004|Overall Study|Lost to Follow-up|0|||
149919649|NCT04575584|540839811|FG005|Overall Study|Lost to Follow-up|0|||
149919650|NCT04575584|540839806|FG000|Overall Study|Physician Decision|0|||
149919651|NCT04575584|540839807|FG001|Overall Study|Physician Decision|1|||
149919652|NCT04575584|540839808|FG002|Overall Study|Physician Decision|1|||
149919653|NCT04575584|540839809|FG003|Overall Study|Physician Decision|1|||
149919654|NCT04575584|540839810|FG004|Overall Study|Physician Decision|0|||
149919655|NCT04575584|540839811|FG005|Overall Study|Physician Decision|0|||
149919656|NCT04575584|540839806|FG000|Overall Study|Withdrawal by Subject|7|||
149919657|NCT04575584|540839807|FG001|Overall Study|Withdrawal by Subject|9|||
149919658|NCT04575584|540839808|FG002|Overall Study|Withdrawal by Subject|5|||
149919659|NCT04575584|540839809|FG003|Overall Study|Withdrawal by Subject|3|||
149919660|NCT04575584|540839810|FG004|Overall Study|Withdrawal by Subject|0|||
149919661|NCT04575584|540839811|FG005|Overall Study|Withdrawal by Subject|0|||
149919662|NCT04575584|540839806|FG000|Overall Study|Not recorded|0|||
149919663|NCT04575584|540839807|FG001|Overall Study|Not recorded|0|||
149919664|NCT04575584|540839808|FG002|Overall Study|Not recorded|0|||
149919665|NCT04575584|540839809|FG003|Overall Study|Not recorded|1|||
149919666|NCT04575584|540839810|FG004|Overall Study|Not recorded|0|||
149919667|NCT04575584|540839811|FG005|Overall Study|Not recorded|0|||
149919668|NCT02634801|540839812|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
150259590|NCT00297232|542087169|FG000|Overall Study|Other|1|||
150259591|NCT02257567|542087170|FG000|Overall Study|Adverse Event|0|||
150259592|NCT02257567|542087171|FG001|Overall Study|Adverse Event|0|||
149919669|NCT02634801|540839813|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
149919670|NCT02634801|540839814|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
149919671|NCT02634801|540839812|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
149919672|NCT02634801|540839813|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
150259593|NCT02257567|542087172|FG002|Overall Study|Adverse Event|0|||
150259594|NCT02257567|542087173|FG003|Overall Study|Adverse Event|1|||
149919673|NCT02634801|540839814|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
149919674|NCT02634801|540839812|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
149919675|NCT02634801|540839813|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
150259595|NCT02257567|542087174|FG004|Overall Study|Adverse Event|1|||
149919676|NCT02634801|540839814|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
150259596|NCT02257567|542087175|FG005|Overall Study|Adverse Event|0|||
150259597|NCT02257567|542087176|FG006|Overall Study|Adverse Event|0|||
150259598|NCT02257567|542087177|FG007|Overall Study|Adverse Event|0|||
150259599|NCT02257567|542087178|FG008|Overall Study|Adverse Event|1|||
150259600|NCT02257567|542087179|FG009|Overall Study|Adverse Event|0|||
150259601|NCT02257567|542087180|FG010|Overall Study|Adverse Event|0|||
150259602|NCT02257567|542087170|FG000|Overall Study|Death|2|||
150259603|NCT02257567|542087171|FG001|Overall Study|Death|2|||
150259604|NCT02257567|542087172|FG002|Overall Study|Death|2|||
150259605|NCT02257567|542087173|FG003|Overall Study|Death|4|||
150259606|NCT02257567|542087174|FG004|Overall Study|Death|15|||
150259607|NCT02257567|542087175|FG005|Overall Study|Death|11|||
150259608|NCT02257567|542087176|FG006|Overall Study|Death|26|||
150259609|NCT02257567|542087177|FG007|Overall Study|Death|30|||
150259610|NCT02257567|542087178|FG008|Overall Study|Death|2|||
150259611|NCT02257567|542087179|FG009|Overall Study|Death|18|||
150259612|NCT02257567|542087180|FG010|Overall Study|Death|65|||
150259613|NCT02257567|542087170|FG000|Overall Study|Lost to Follow-up|0|||
150259614|NCT02257567|542087171|FG001|Overall Study|Lost to Follow-up|0|||
150259615|NCT02257567|542087172|FG002|Overall Study|Lost to Follow-up|0|||
150259616|NCT02257567|542087173|FG003|Overall Study|Lost to Follow-up|0|||
150259617|NCT02257567|542087174|FG004|Overall Study|Lost to Follow-up|2|||
150259618|NCT02257567|542087175|FG005|Overall Study|Lost to Follow-up|2|||
150259619|NCT02257567|542087176|FG006|Overall Study|Lost to Follow-up|0|||
150259620|NCT02257567|542087177|FG007|Overall Study|Lost to Follow-up|0|||
150259621|NCT02257567|542087178|FG008|Overall Study|Lost to Follow-up|0|||
150259622|NCT02257567|542087179|FG009|Overall Study|Lost to Follow-up|1|||
150259623|NCT02257567|542087180|FG010|Overall Study|Lost to Follow-up|1|||
150259624|NCT02257567|542087170|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259625|NCT02257567|542087171|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259626|NCT02257567|542087172|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259627|NCT02257567|542087173|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259628|NCT02257567|542087174|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
150259629|NCT02257567|542087175|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259630|NCT02257567|542087176|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
150259631|NCT02257567|542087177|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259632|NCT02257567|542087178|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259633|NCT02257567|542087179|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259634|NCT02257567|542087180|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
150259635|NCT02257567|542087170|FG000|Overall Study|Physician Decision|0|||
150259636|NCT02257567|542087171|FG001|Overall Study|Physician Decision|0|||
150259637|NCT02257567|542087172|FG002|Overall Study|Physician Decision|0|||
150259638|NCT02257567|542087173|FG003|Overall Study|Physician Decision|0|||
150259639|NCT02257567|542087174|FG004|Overall Study|Physician Decision|0|||
150259640|NCT02257567|542087175|FG005|Overall Study|Physician Decision|0|||
150259641|NCT02257567|542087176|FG006|Overall Study|Physician Decision|0|||
150259642|NCT02257567|542087177|FG007|Overall Study|Physician Decision|2|||
150259643|NCT02257567|542087178|FG008|Overall Study|Physician Decision|0|||
150259644|NCT02257567|542087179|FG009|Overall Study|Physician Decision|1|||
150259645|NCT02257567|542087180|FG010|Overall Study|Physician Decision|0|||
150259646|NCT02257567|542087170|FG000|Overall Study|Withdrawal by Subject|0|||
150259647|NCT02257567|542087171|FG001|Overall Study|Withdrawal by Subject|0|||
150259648|NCT02257567|542087172|FG002|Overall Study|Withdrawal by Subject|2|||
150259649|NCT02257567|542087173|FG003|Overall Study|Withdrawal by Subject|0|||
150259650|NCT02257567|542087174|FG004|Overall Study|Withdrawal by Subject|0|||
150259651|NCT02257567|542087175|FG005|Overall Study|Withdrawal by Subject|6|||
150259652|NCT02257567|542087176|FG006|Overall Study|Withdrawal by Subject|6|||
150259653|NCT02257567|542087177|FG007|Overall Study|Withdrawal by Subject|6|||
150259654|NCT02257567|542087178|FG008|Overall Study|Withdrawal by Subject|1|||
150259655|NCT02257567|542087179|FG009|Overall Study|Withdrawal by Subject|1|||
150259656|NCT02257567|542087180|FG010|Overall Study|Withdrawal by Subject|10|||
150259657|NCT01878214|542087183|FG000|Overall Study|Withdrawal by Subject|18|||
150259658|NCT01878214|542087184|FG001|Overall Study|Withdrawal by Subject|7|||
150259659|NCT01878214|542087183|FG000|Overall Study|Death|0|||
149817195|NCT00686790|540461476|FG000|Overall Study|Death|1|||
149817196|NCT00686790|540461476|FG000|Overall Study|Lost to Follow-up|12|||
149817197|NCT00096382|540461477|FG000|Overall Study|Not treated|1|||
149817198|NCT00096382|540461478|FG001|Overall Study|Not treated|0|||
149817199|NCT00096382|540461477|FG000|Overall Study|Death during treatment|1|||
149817200|NCT00096382|540461478|FG001|Overall Study|Death during treatment|0|||
149817201|NCT00382291|540461479|FG000|Overall Study|Adverse Event|1|||
149817202|NCT00382291|540461480|FG001|Overall Study|Adverse Event|2|||
149817203|NCT00382291|540461481|FG002|Overall Study|Adverse Event|2|||
149817204|NCT00382291|540461479|FG000|Overall Study|Protocol Violation|1|||
149817205|NCT00382291|540461480|FG001|Overall Study|Protocol Violation|0|||
149817206|NCT00382291|540461481|FG002|Overall Study|Protocol Violation|0|||
149817207|NCT00382291|540461479|FG000|Overall Study|Temporary study suspension|2|||
149817208|NCT00382291|540461480|FG001|Overall Study|Temporary study suspension|2|||
149817209|NCT00382291|540461481|FG002|Overall Study|Temporary study suspension|5|||
149817210|NCT00382291|540461479|FG000|Overall Study|Withdrawal by Subject|0|||
149817211|NCT00382291|540461480|FG001|Overall Study|Withdrawal by Subject|2|||
149817212|NCT00382291|540461481|FG002|Overall Study|Withdrawal by Subject|0|||
149817213|NCT00382291|540461479|FG000|Overall Study|Physician Decision|0|||
149817214|NCT00382291|540461480|FG001|Overall Study|Physician Decision|1|||
149817215|NCT00382291|540461481|FG002|Overall Study|Physician Decision|0|||
149817216|NCT00382291|540461479|FG000|Overall Study|Lack of Efficacy|0|||
149817217|NCT00382291|540461480|FG001|Overall Study|Lack of Efficacy|0|||
149817218|NCT00382291|540461481|FG002|Overall Study|Lack of Efficacy|1|||
149817219|NCT01270841|540461482|FG000|Overall Study|Adverse Event|0|||
149817220|NCT01270841|540461483|FG001|Overall Study|Adverse Event|1|||
149817221|NCT01270841|540461484|FG002|Overall Study|Adverse Event|0|||
149817222|NCT01270841|540461485|FG003|Overall Study|Adverse Event|3|||
149817223|NCT01270841|540461482|FG000|Overall Study|Withdrawal by Subject|3|||
149817224|NCT01270841|540461483|FG001|Overall Study|Withdrawal by Subject|2|||
149817225|NCT01270841|540461484|FG002|Overall Study|Withdrawal by Subject|3|||
149817226|NCT01270841|540461485|FG003|Overall Study|Withdrawal by Subject|3|||
149817227|NCT01270841|540461482|FG000|Overall Study|Lost to Follow-up|3|||
149817228|NCT01270841|540461483|FG001|Overall Study|Lost to Follow-up|1|||
149817229|NCT01270841|540461484|FG002|Overall Study|Lost to Follow-up|4|||
149817230|NCT01270841|540461485|FG003|Overall Study|Lost to Follow-up|2|||
149817231|NCT01270841|540461482|FG000|Overall Study|Physician Decision|0|||
149817232|NCT01270841|540461483|FG001|Overall Study|Physician Decision|1|||
149817233|NCT01270841|540461484|FG002|Overall Study|Physician Decision|0|||
149817234|NCT01270841|540461485|FG003|Overall Study|Physician Decision|0|||
149817235|NCT01270841|540461482|FG000|Overall Study|Did not qualify|6|||
149817236|NCT01270841|540461483|FG001|Overall Study|Did not qualify|3|||
149817237|NCT01270841|540461484|FG002|Overall Study|Did not qualify|4|||
149817238|NCT01270841|540461485|FG003|Overall Study|Did not qualify|5|||
149817239|NCT01270841|540461482|FG000|Overall Study|Protocol Violation|1|||
149817240|NCT01270841|540461483|FG001|Overall Study|Protocol Violation|5|||
149817241|NCT01270841|540461484|FG002|Overall Study|Protocol Violation|0|||
149817242|NCT01270841|540461485|FG003|Overall Study|Protocol Violation|0|||
149817243|NCT01270841|540461482|FG000|Overall Study|Enrolled in error|0|||
149817244|NCT01270841|540461483|FG001|Overall Study|Enrolled in error|1|||
149817245|NCT01270841|540461484|FG002|Overall Study|Enrolled in error|0|||
149817246|NCT01270841|540461485|FG003|Overall Study|Enrolled in error|0|||
149817247|NCT01375010|540461486|FG000|Overall Study|Lost to Follow-up|8|||
149817248|NCT01375010|540461487|FG001|Overall Study|Lost to Follow-up|2|||
149817249|NCT01375010|540461486|FG000|Overall Study|Withdrawal by Subject|4|||
149817250|NCT01375010|540461487|FG001|Overall Study|Withdrawal by Subject|2|||
149817251|NCT02266706|540461488|FG000|Overall Study|Withdrawal by Subject|0|||
149817252|NCT02266706|540461489|FG001|Overall Study|Withdrawal by Subject|1|||
149817253|NCT02266706|540461490|FG002|Overall Study|Withdrawal by Subject|1|||
149817254|NCT02266706|540461491|FG003|Overall Study|Withdrawal by Subject|0|||
149817255|NCT02266706|540461492|FG004|Overall Study|Withdrawal by Subject|0|||
149817256|NCT02266706|540461493|FG005|Overall Study|Withdrawal by Subject|1|||
149817257|NCT02266706|540461494|FG006|Overall Study|Withdrawal by Subject|0|||
149817258|NCT02266706|540461495|FG007|Overall Study|Withdrawal by Subject|0|||
149817259|NCT02266706|540461496|FG008|Overall Study|Withdrawal by Subject|0|||
149817260|NCT02266706|540461488|FG000|Overall Study|Screen failure|0|||
149817261|NCT02266706|540461489|FG001|Overall Study|Screen failure|0|||
149817262|NCT02266706|540461490|FG002|Overall Study|Screen failure|0|||
149817263|NCT02266706|540461491|FG003|Overall Study|Screen failure|0|||
149817264|NCT02266706|540461492|FG004|Overall Study|Screen failure|0|||
149817265|NCT02266706|540461493|FG005|Overall Study|Screen failure|1|||
149817266|NCT02266706|540461494|FG006|Overall Study|Screen failure|1|||
149817267|NCT02266706|540461495|FG007|Overall Study|Screen failure|0|||
149817268|NCT02266706|540461496|FG008|Overall Study|Screen failure|0|||
149817269|NCT02266706|540461488|FG000|Overall Study|Enrollment in another study|0|||
149817270|NCT02266706|540461489|FG001|Overall Study|Enrollment in another study|0|||
149817271|NCT02266706|540461490|FG002|Overall Study|Enrollment in another study|0|||
149817272|NCT02266706|540461491|FG003|Overall Study|Enrollment in another study|1|||
149817273|NCT02266706|540461492|FG004|Overall Study|Enrollment in another study|0|||
149817274|NCT02266706|540461493|FG005|Overall Study|Enrollment in another study|0|||
149817275|NCT02266706|540461494|FG006|Overall Study|Enrollment in another study|0|||
149817276|NCT02266706|540461495|FG007|Overall Study|Enrollment in another study|0|||
149817277|NCT02266706|540461496|FG008|Overall Study|Enrollment in another study|0|||
149817278|NCT01977352|540461497|FG000|Overall Study|Lost to Follow-up|1|||
150259660|NCT01878214|542087184|FG001|Overall Study|Death|1|||
150259661|NCT01878214|542087183|FG000|Overall Study|Lost to Follow-up|35|||
150259662|NCT01878214|542087184|FG001|Overall Study|Lost to Follow-up|36|||
149919677|NCT02634801|540839812|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
149919678|NCT02634801|540839813|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
149919679|NCT02634801|540839814|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
149919680|NCT02634801|540839812|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
149919681|NCT02634801|540839813|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
149919682|NCT02634801|540839814|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
149919683|NCT02634801|540839812|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
149919684|NCT02634801|540839813|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
149919685|NCT02634801|540839814|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
149919686|NCT02634801|540839812|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
149919687|NCT02634801|540839813|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
149919688|NCT02634801|540839814|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
149919689|NCT02634801|540839812|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
149919690|NCT02634801|540839813|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
149919691|NCT02634801|540839814|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
149919692|NCT02634801|540839812|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
149919693|NCT02634801|540839813|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
149919694|NCT02634801|540839814|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
149919695|NCT02634801|540839812|FG000|Follow-up Period|Lost to Follow-up|3|||
149919696|NCT02634801|540839813|FG001|Follow-up Period|Lost to Follow-up|1|||
149919697|NCT02634801|540839814|FG002|Follow-up Period|Lost to Follow-up|2|||
149919698|NCT02634801|540839812|FG000|Follow-up Period|Physician Decision|0|||
149919699|NCT02634801|540839813|FG001|Follow-up Period|Physician Decision|0|||
149919700|NCT02634801|540839814|FG002|Follow-up Period|Physician Decision|1|||
149919701|NCT02634801|540839812|FG000|Follow-up Period|Withdrawal by Subject|1|||
149919702|NCT02634801|540839813|FG001|Follow-up Period|Withdrawal by Subject|2|||
149919703|NCT02634801|540839814|FG002|Follow-up Period|Withdrawal by Subject|5|||
149919704|NCT02634801|540839812|FG000|Follow-up Period|Adverse Event|1|||
149919705|NCT02634801|540839813|FG001|Follow-up Period|Adverse Event|5|||
149919706|NCT02634801|540839814|FG002|Follow-up Period|Adverse Event|0|||
149919707|NCT02335346|540839837|FG000|Overall Study|Adverse Event|11|||
149919708|NCT02335346|540839837|FG000|Overall Study|Withdrawal by Subject|1|||
149919709|NCT01548768|540839838|FG000|Overall Study|Withdrawal by Subject|0|||
149919710|NCT01548768|540839839|FG001|Overall Study|Withdrawal by Subject|2|||
149919711|NCT01548768|540839840|FG002|Overall Study|Withdrawal by Subject|1|||
149919712|NCT01548768|540839841|FG003|Overall Study|Withdrawal by Subject|0|||
149919713|NCT01548768|540839838|FG000|Overall Study|Physician Decision|1|||
149919714|NCT01548768|540839839|FG001|Overall Study|Physician Decision|0|||
149919715|NCT01548768|540839840|FG002|Overall Study|Physician Decision|0|||
149919716|NCT01548768|540839841|FG003|Overall Study|Physician Decision|0|||
149919717|NCT01548768|540839838|FG000|Overall Study|Adverse Event|0|||
149919718|NCT01548768|540839839|FG001|Overall Study|Adverse Event|0|||
149919719|NCT01548768|540839840|FG002|Overall Study|Adverse Event|0|||
149919720|NCT01548768|540839841|FG003|Overall Study|Adverse Event|1|||
149919721|NCT01548768|540839838|FG000|Overall Study|Non-Compliance|0|||
149919722|NCT01548768|540839839|FG001|Overall Study|Non-Compliance|0|||
149919723|NCT01548768|540839840|FG002|Overall Study|Non-Compliance|0|||
149919724|NCT01548768|540839841|FG003|Overall Study|Non-Compliance|3|||
149919725|NCT03300050|540839842|FG000|Overall Study|Lost to Follow-up|2|||
149919726|NCT03300050|540839843|FG001|Overall Study|Lost to Follow-up|1|||
149919727|NCT03300050|540839844|FG002|Overall Study|Lost to Follow-up|0|||
149919728|NCT03300050|540839845|FG003|Overall Study|Lost to Follow-up|0|||
149919729|NCT03300050|540839846|FG004|Overall Study|Lost to Follow-up|1|||
149919730|NCT03300050|540839842|FG000|Overall Study|Withdrawal by Subject|1|||
149919731|NCT03300050|540839843|FG001|Overall Study|Withdrawal by Subject|1|||
149919732|NCT03300050|540839844|FG002|Overall Study|Withdrawal by Subject|1|||
149919733|NCT03300050|540839845|FG003|Overall Study|Withdrawal by Subject|0|||
149919734|NCT03300050|540839846|FG004|Overall Study|Withdrawal by Subject|0|||
149919735|NCT03300050|540839842|FG000|Overall Study|Death|0|||
150259663|NCT00946101|542087185|FG000|Overall Study|Lost to Follow-up|2|||
150259664|NCT00946101|542087186|FG001|Overall Study|Lost to Follow-up|1|||
150259665|NCT00946101|542087185|FG000|Overall Study|Withdrawal of consent|2|||
150259666|NCT00946101|542087186|FG001|Overall Study|Withdrawal of consent|0|||
149919736|NCT03300050|540839843|FG001|Overall Study|Death|0|||
149919737|NCT03300050|540839844|FG002|Overall Study|Death|1|||
149919738|NCT03300050|540839845|FG003|Overall Study|Death|0|||
149919739|NCT03300050|540839846|FG004|Overall Study|Death|0|||
149919740|NCT03300050|540839842|FG000|Overall Study|Not Eligible at Randomization|0|||
149919741|NCT03300050|540839843|FG001|Overall Study|Not Eligible at Randomization|0|||
149919742|NCT03300050|540839844|FG002|Overall Study|Not Eligible at Randomization|1|||
149919743|NCT03300050|540839845|FG003|Overall Study|Not Eligible at Randomization|1|||
149919744|NCT03300050|540839846|FG004|Overall Study|Not Eligible at Randomization|0|||
150259667|NCT00946101|542087185|FG000|Overall Study|Physician Decision|0|||
149919745|NCT02907619|540839847|FG000|Overall Study|Study terminated by sponsor|18|||
149919746|NCT02907619|540839848|FG001|Overall Study|Study terminated by sponsor|18|||
149919747|NCT02907619|540839849|FG002|Overall Study|Study terminated by sponsor|19|||
149919748|NCT02907619|540839847|FG000|Overall Study|Death|0|||
149919749|NCT02907619|540839848|FG001|Overall Study|Death|0|||
149919750|NCT02907619|540839849|FG002|Overall Study|Death|1|||
149919751|NCT02907619|540839847|FG000|Overall Study|Withdrawal by Subject|1|||
149919752|NCT02907619|540839848|FG001|Overall Study|Withdrawal by Subject|1|||
149919753|NCT02907619|540839849|FG002|Overall Study|Withdrawal by Subject|0|||
149919754|NCT02907619|540839847|FG000|Overall Study|Other|0|||
149919755|NCT02907619|540839848|FG001|Overall Study|Other|1|||
149919756|NCT02907619|540839849|FG002|Overall Study|Other|0|||
149919757|NCT03326518|540839850|FG000|Overall Study|Protocol Violation|1|||
149919758|NCT03326518|540839851|FG001|Overall Study|Protocol Violation|0|||
149919759|NCT03326518|540839852|FG002|Overall Study|Protocol Violation|0|||
149919760|NCT03326518|540839850|FG000|Overall Study|Withdrawal by Subject|1|||
149919761|NCT03326518|540839851|FG001|Overall Study|Withdrawal by Subject|0|||
149919762|NCT03326518|540839852|FG002|Overall Study|Withdrawal by Subject|0|||
149919763|NCT03326518|540839850|FG000|Overall Study|Lost to Follow-up|1|||
149919764|NCT03326518|540839851|FG001|Overall Study|Lost to Follow-up|0|||
149919765|NCT03326518|540839852|FG002|Overall Study|Lost to Follow-up|1|||
149919766|NCT01375374|540839853|FG000|Overall Study|Adverse Event|1|||
149919767|NCT04401202|540839859|FG000|Overall Study|Lost to Follow-up|2|||
149919768|NCT04401202|540839860|FG001|Overall Study|Lost to Follow-up|2|||
149919769|NCT04401202|540839859|FG000|Overall Study|Adverse Event|0|||
149919770|NCT04401202|540839860|FG001|Overall Study|Adverse Event|1|||
149919771|NCT04401202|540839859|FG000|Overall Study|Hospitalized|4|||
149919772|NCT04401202|540839860|FG001|Overall Study|Hospitalized|1|||
149919773|NCT02714036|540839862|FG000|Overall Study|Adverse Event|9|||
149919774|NCT02714036|540839863|FG001|Overall Study|Adverse Event|2|||
149919775|NCT02714036|540839862|FG000|Overall Study|Withdrawal by Subject|3|||
150159773|NCT01450943|541717724|FG000|Overall Study|Screen failure, loss to follow-up|2|||
150159774|NCT01450943|541717725|FG001|Overall Study|Screen failure, loss to follow-up|7|||
150159775|NCT01450943|541717726|FG002|Overall Study|Screen failure, loss to follow-up|6|||
150159776|NCT04822298|541717731|FG000|Overall Study|Death|3|||
150159777|NCT03201757|541717737|FG000|Overall Study|Withdrawal by Subject|133|||
150159778|NCT03201757|541717737|FG000|Overall Study|Adverse Event|44|||
150159779|NCT03201757|541717737|FG000|Overall Study|Lost to Follow-up|37|||
150159780|NCT03201757|541717737|FG000|Overall Study|Pregnancy|2|||
150159781|NCT03201757|541717737|FG000|Overall Study|Lack of Efficacy|1|||
150159782|NCT03201757|541717737|FG000|Overall Study|Protocol Violation|20|||
150159783|NCT03201757|541717737|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
150159784|NCT03201757|541717737|FG000|Overall Study|Not Yet Determined|5|||
150159785|NCT03201757|541717737|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
150159786|NCT03201757|541717737|FG000|Overall Study|Other|20|||
150159787|NCT02886728|541717741|FG000|Overall Study|Withdrew Consent|31|||
150159788|NCT02886728|541717742|FG001|Overall Study|Withdrew Consent|13|||
150159789|NCT02886728|541717743|FG002|Overall Study|Withdrew Consent|11|||
150159790|NCT02886728|541717744|FG003|Overall Study|Withdrew Consent|47|||
150159791|NCT02886728|541717741|FG000|Overall Study|Lost to Follow-up|12|||
150159792|NCT02886728|541717742|FG001|Overall Study|Lost to Follow-up|6|||
150159793|NCT02886728|541717743|FG002|Overall Study|Lost to Follow-up|13|||
150159794|NCT02886728|541717744|FG003|Overall Study|Lost to Follow-up|12|||
150159795|NCT02886728|541717741|FG000|Overall Study|Adverse Event|13|||
150159796|NCT02886728|541717742|FG001|Overall Study|Adverse Event|5|||
150159797|NCT02886728|541717743|FG002|Overall Study|Adverse Event|5|||
150159798|NCT02886728|541717744|FG003|Overall Study|Adverse Event|11|||
150159799|NCT02886728|541717741|FG000|Overall Study|Investigator's Discretion|11|||
150159800|NCT02886728|541717742|FG001|Overall Study|Investigator's Discretion|7|||
150159801|NCT02886728|541717743|FG002|Overall Study|Investigator's Discretion|5|||
150159802|NCT02886728|541717744|FG003|Overall Study|Investigator's Discretion|11|||
150159803|NCT02886728|541717741|FG000|Overall Study|Death|3|||
150159804|NCT02886728|541717742|FG001|Overall Study|Death|1|||
150159805|NCT02886728|541717743|FG002|Overall Study|Death|0|||
150159806|NCT02886728|541717744|FG003|Overall Study|Death|0|||
150159807|NCT02886728|541717741|FG000|Overall Study|Protocol Violation|0|||
150159808|NCT02886728|541717742|FG001|Overall Study|Protocol Violation|0|||
150159809|NCT02886728|541717743|FG002|Overall Study|Protocol Violation|0|||
150159810|NCT02886728|541717744|FG003|Overall Study|Protocol Violation|4|||
150159811|NCT02886728|541717741|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150159812|NCT02886728|541717742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150159813|NCT02886728|541717743|FG002|Overall Study|Non-Compliance with Study Drug|1|||
150159814|NCT02886728|541717744|FG003|Overall Study|Non-Compliance with Study Drug|0|||
150159815|NCT02886728|541717741|FG000|Overall Study|Pregnancy|0|||
150159816|NCT02886728|541717742|FG001|Overall Study|Pregnancy|0|||
150159817|NCT02886728|541717743|FG002|Overall Study|Pregnancy|1|||
149919776|NCT02714036|540839863|FG001|Overall Study|Withdrawal by Subject|2|||
149919777|NCT00715520|540839865|FG000|Overall Study|Screen failure|8|||
149919778|NCT00715520|540839866|FG001|Overall Study|Screen failure|1|||
149919779|NCT00715520|540839867|FG002|Overall Study|Screen failure|1|||
149919780|NCT00715520|540839865|FG000|Overall Study|Withdrawal by Subject|2|||
149919781|NCT00715520|540839866|FG001|Overall Study|Withdrawal by Subject|0|||
149919782|NCT00715520|540839867|FG002|Overall Study|Withdrawal by Subject|1|||
149919783|NCT01006590|540839868|FG000|Overall Study|Adverse Event|2|||
149919784|NCT01006590|540839869|FG001|Overall Study|Adverse Event|3|||
149919785|NCT01006590|540839868|FG000|Overall Study|Death|1|||
149919786|NCT01006590|540839869|FG001|Overall Study|Death|1|||
149919787|NCT01006590|540839868|FG000|Overall Study|Lost to Follow-up|1|||
149919788|NCT01006590|540839869|FG001|Overall Study|Lost to Follow-up|1|||
149919789|NCT01006590|540839868|FG000|Overall Study|Protocol Violation|1|||
149919790|NCT01006590|540839869|FG001|Overall Study|Protocol Violation|0|||
149919791|NCT01006590|540839868|FG000|Overall Study|Withdrawal by Subject|4|||
149919792|NCT01006590|540839869|FG001|Overall Study|Withdrawal by Subject|2|||
149919793|NCT01006590|540839868|FG000|Overall Study|Study specific discontinuation criteria|16|||
149919794|NCT01006590|540839869|FG001|Overall Study|Study specific discontinuation criteria|23|||
149919795|NCT01006590|540839868|FG000|Overall Study|Other|3|||
149919796|NCT01006590|540839869|FG001|Overall Study|Other|2|||
149919797|NCT03332095|540839870|FG000|Overall Study|Lost to Follow-up|1|||
149919798|NCT03332095|540839871|FG001|Overall Study|Lost to Follow-up|0|||
149919799|NCT03332095|540839870|FG000|Overall Study|Pregnancy|0|||
149919800|NCT03332095|540839871|FG001|Overall Study|Pregnancy|1|||
149919801|NCT04942210|540839875|FG000|Overall Study|Adverse Event|0|||
149919802|NCT04942210|540839876|FG001|Overall Study|Adverse Event|1|||
149919803|NCT04942210|540839875|FG000|Overall Study|Protocol Deviation|4|||
149919804|NCT04942210|540839876|FG001|Overall Study|Protocol Deviation|1|||
149919805|NCT04942210|540839875|FG000|Overall Study|Withdrawal by Subject|5|||
149919806|NCT04942210|540839876|FG001|Overall Study|Withdrawal by Subject|2|||
149919807|NCT04942210|540839875|FG000|Overall Study|Lost to Follow-up|16|||
149919808|NCT04942210|540839876|FG001|Overall Study|Lost to Follow-up|7|||
149919809|NCT04942210|540839875|FG000|Overall Study|Ongoing at the time of DBL date|60|||
149919810|NCT04942210|540839876|FG001|Overall Study|Ongoing at the time of DBL date|25|||
149919811|NCT04942210|540839875|FG000|Overall Study|Randomized but did not receive vaccination|3|||
149919812|NCT04942210|540839876|FG001|Overall Study|Randomized but did not receive vaccination|0|||
149919813|NCT05697627|540839879|FG000|Overall Study|Adverse Event|1|||
149919814|NCT02570750|540839880|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
149919815|NCT02570750|540839881|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
149919816|NCT02570750|540839880|FG000|Overall Study|Protocol deviation|4|||
149919817|NCT02570750|540839881|FG001|Overall Study|Protocol deviation|2|||
149919818|NCT02570750|540839880|FG000|Overall Study|Withdrawal by Subject|5|||
149919819|NCT02570750|540839881|FG001|Overall Study|Withdrawal by Subject|0|||
149919820|NCT02570750|540839880|FG000|Overall Study|Lost to Follow-up|2|||
149919821|NCT02570750|540839881|FG001|Overall Study|Lost to Follow-up|2|||
149919822|NCT02570750|540839880|FG000|Overall Study|Adverse Event|2|||
149919823|NCT02570750|540839881|FG001|Overall Study|Adverse Event|1|||
149919824|NCT04122625|540839882|FG000|Part A (up to 2.92 Years)|Death|2|||
149919825|NCT04122625|540839883|FG001|Part A (up to 2.92 Years)|Death|4|||
149919826|NCT04122625|540839884|FG002|Part A (up to 2.92 Years)|Death|0|||
149919827|NCT04122625|540839885|FG003|Part A (up to 2.92 Years)|Death|0|||
149919828|NCT04122625|540839886|FG004|Part A (up to 2.92 Years)|Death|0|||
149919829|NCT04122625|540839887|FG005|Part A (up to 2.92 Years)|Death|0|||
149919830|NCT04122625|540839882|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
149919831|NCT04122625|540839883|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
149919832|NCT04122625|540839884|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
149919833|NCT04122625|540839885|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
149919834|NCT04122625|540839886|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
149919835|NCT04122625|540839887|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
149919836|NCT04122625|540839882|FG000|Part B (up to 2.33 Years)|Death|0|||
149919837|NCT04122625|540839883|FG001|Part B (up to 2.33 Years)|Death|0|||
149919838|NCT04122625|540839884|FG002|Part B (up to 2.33 Years)|Death|5|||
149919839|NCT04122625|540839885|FG003|Part B (up to 2.33 Years)|Death|7|||
149919840|NCT04122625|540839886|FG004|Part B (up to 2.33 Years)|Death|6|||
149919841|NCT04122625|540839887|FG005|Part B (up to 2.33 Years)|Death|7|||
149919842|NCT01410240|540839888|FG000|Overall Study|Physician Decision|0|||
149919843|NCT01410240|540839889|FG001|Overall Study|Physician Decision|0|||
149919844|NCT01410240|540839890|FG002|Overall Study|Physician Decision|1|||
149919845|NCT01410240|540839888|FG000|Overall Study|Missed week 6 assessments|1|||
149919846|NCT01410240|540839889|FG001|Overall Study|Missed week 6 assessments|1|||
149919847|NCT01410240|540839890|FG002|Overall Study|Missed week 6 assessments|1|||
149919848|NCT04348500|540839891|FG000|Overall Study|Death|2|||
149919849|NCT04348500|540839892|FG001|Overall Study|Death|2|||
149919850|NCT04348500|540839891|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
149919851|NCT04348500|540839892|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
149919852|NCT02776670|540839893|FG000|Overall Study|Adverse Event|0|||
149919853|NCT02776670|540839894|FG001|Overall Study|Adverse Event|2|||
149919854|NCT02776670|540839893|FG000|Overall Study|Protocol Violation|0|||
149919855|NCT02776670|540839894|FG001|Overall Study|Protocol Violation|2|||
149919856|NCT02776670|540839893|FG000|Overall Study|Withdrawal by Subject|0|||
149919857|NCT02776670|540839894|FG001|Overall Study|Withdrawal by Subject|1|||
149919858|NCT02776670|540839893|FG000|Overall Study|Other - Reason not given|0|||
149919859|NCT02776670|540839894|FG001|Overall Study|Other - Reason not given|1|||
149919860|NCT02636699|540839899|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
149919861|NCT02636699|540839900|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
149919862|NCT02636699|540839901|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
149919863|NCT02636699|540839899|FG000|Screening Period|Withdrawal by Subject|0|||
149919864|NCT02636699|540839900|FG001|Screening Period|Withdrawal by Subject|0|||
149919865|NCT02636699|540839901|FG002|Screening Period|Withdrawal by Subject|23|||
149919866|NCT02636699|540839899|FG000|Screening Period|Adverse Event|0|||
149919867|NCT02636699|540839900|FG001|Screening Period|Adverse Event|0|||
149919868|NCT02636699|540839901|FG002|Screening Period|Adverse Event|1|||
150159818|NCT02886728|541717744|FG003|Overall Study|Pregnancy|0|||
150159819|NCT02886728|541717741|FG000|Overall Study|Randomized but Not Dosed|1|||
150159820|NCT02886728|541717742|FG001|Overall Study|Randomized but Not Dosed|0|||
150159821|NCT02886728|541717743|FG002|Overall Study|Randomized but Not Dosed|0|||
150159822|NCT02886728|541717744|FG003|Overall Study|Randomized but Not Dosed|2|||
150159823|NCT04990440|541717753|FG000|Overall Study|Sponsor's Decision|0|||
150159824|NCT04990440|541717754|FG001|Overall Study|Sponsor's Decision|0|||
150159825|NCT04990440|541717755|FG002|Overall Study|Sponsor's Decision|1|||
150159826|NCT03712098|541717756|FG000|Overall Study|Lost to Follow-up|3|||
150159827|NCT03712098|541717757|FG001|Overall Study|Lost to Follow-up|7|||
150159828|NCT03712098|541717756|FG000|Overall Study|Withdrawal by Subject|9|||
150159829|NCT03712098|541717757|FG001|Overall Study|Withdrawal by Subject|4|||
150159830|NCT03712098|541717756|FG000|Overall Study|Protocol Violation|2|||
150159831|NCT03712098|541717757|FG001|Overall Study|Protocol Violation|1|||
150159832|NCT01066156|541717766|FG000|Overall Study|ineligible|2|||
150159833|NCT01066156|541717766|FG000|Overall Study|Lost to Follow-up|7|||
150159834|NCT01066156|541717766|FG000|Overall Study|Withdrawal by Subject|1|||
150159835|NCT01052662|541717770|FG000|Overall Study|Lost to Follow-up|15|||
150159836|NCT01052662|541717771|FG001|Overall Study|Lost to Follow-up|13|||
150159837|NCT01052662|541717772|FG002|Overall Study|Lost to Follow-up|18|||
150159838|NCT01052662|541717770|FG000|Overall Study|Withdrawal by Subject|3|||
150159839|NCT01052662|541717771|FG001|Overall Study|Withdrawal by Subject|2|||
150159840|NCT01052662|541717772|FG002|Overall Study|Withdrawal by Subject|1|||
150159841|NCT01052662|541717770|FG000|Overall Study|Pharmacy issue|1|||
150159842|NCT01052662|541717771|FG001|Overall Study|Pharmacy issue|3|||
150159843|NCT01052662|541717772|FG002|Overall Study|Pharmacy issue|3|||
150159844|NCT01052662|541717770|FG000|Overall Study|Adverse Event|1|||
150159845|NCT01052662|541717771|FG001|Overall Study|Adverse Event|1|||
150159846|NCT01052662|541717772|FG002|Overall Study|Adverse Event|0|||
150159847|NCT01052662|541717770|FG000|Overall Study|Legal Problem|2|||
150159848|NCT01052662|541717771|FG001|Overall Study|Legal Problem|0|||
150159849|NCT01052662|541717772|FG002|Overall Study|Legal Problem|0|||
150159850|NCT01052662|541717770|FG000|Overall Study|Administrative|0|||
150159851|NCT01052662|541717771|FG001|Overall Study|Administrative|3|||
150159852|NCT01052662|541717772|FG002|Overall Study|Administrative|0|||
150159853|NCT03023332|541717776|FG000|Overall Study|Withdrawal by Subject|10|||
150159854|NCT03023332|541717777|FG001|Overall Study|Withdrawal by Subject|5|||
150159855|NCT03023332|541717778|FG002|Overall Study|Withdrawal by Subject|4|||
150159856|NCT03023332|541717779|FG003|Overall Study|Withdrawal by Subject|7|||
150159857|NCT03023332|541717776|FG000|Overall Study|Lost to Follow-up|13|||
150159858|NCT03023332|541717777|FG001|Overall Study|Lost to Follow-up|16|||
150159859|NCT03023332|541717778|FG002|Overall Study|Lost to Follow-up|8|||
150159860|NCT03023332|541717779|FG003|Overall Study|Lost to Follow-up|13|||
150159861|NCT03023332|541717776|FG000|Overall Study|Death|1|||
150159862|NCT03023332|541717777|FG001|Overall Study|Death|0|||
150159863|NCT03023332|541717778|FG002|Overall Study|Death|0|||
150159864|NCT03023332|541717779|FG003|Overall Study|Death|0|||
150159865|NCT01627340|541717782|FG000|Overall Study|Adverse Event|1|||
150159866|NCT01627340|541717783|FG001|Overall Study|Adverse Event|0|||
150159867|NCT01627340|541717782|FG000|Overall Study|Lost to Follow-up|8|||
149919869|NCT02636699|540839899|FG000|Screening Period|Other not specified|0|||
149919870|NCT02636699|540839900|FG001|Screening Period|Other not specified|0|||
149919871|NCT02636699|540839901|FG002|Screening Period|Other not specified|3|||
150159868|NCT01627340|541717783|FG001|Overall Study|Lost to Follow-up|4|||
150159869|NCT01627340|541717782|FG000|Overall Study|Pregnancy|1|||
150159870|NCT01627340|541717783|FG001|Overall Study|Pregnancy|0|||
150159871|NCT01627340|541717782|FG000|Overall Study|Withdrawal by Subject|2|||
150159872|NCT01627340|541717783|FG001|Overall Study|Withdrawal by Subject|0|||
150159873|NCT01272011|541717784|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
150159874|NCT01272011|541717785|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
150159875|NCT01272011|541717786|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
150159876|NCT02240680|541717789|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
150159877|NCT02240680|541717790|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
150159878|NCT02240680|541717791|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
149919872|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
149919873|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
149919874|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
149919875|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
149919876|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
149919877|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
149919878|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
149919879|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
149919880|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
149919881|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
149919882|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
150159879|NCT02240680|541717792|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
150159880|NCT02240680|541717789|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
150159881|NCT02240680|541717790|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
150159882|NCT02240680|541717791|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
150159883|NCT02240680|541717792|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
150159884|NCT02240680|541717789|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
150159885|NCT02240680|541717790|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
150159886|NCT02240680|541717791|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
150159887|NCT02240680|541717792|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
150159888|NCT02240680|541717789|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
150159889|NCT02240680|541717790|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
150159890|NCT02240680|541717791|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
150159891|NCT02240680|541717792|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
150159892|NCT02240680|541717789|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
150159893|NCT02240680|541717790|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
150159894|NCT02240680|541717791|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
150159895|NCT02240680|541717792|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
150159896|NCT02240680|541717789|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
150159897|NCT02240680|541717790|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
150159898|NCT02240680|541717791|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
150159899|NCT02240680|541717792|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
150159900|NCT02240680|541717789|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
150159901|NCT02240680|541717790|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
150159902|NCT02240680|541717791|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
150159903|NCT02240680|541717792|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
150159904|NCT02240680|541717789|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
150159905|NCT02240680|541717790|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
150159906|NCT02240680|541717791|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
150159907|NCT02240680|541717792|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
150159908|NCT01657032|541717793|FG000|Overall Study|Lost to Follow-up|0|||
150159909|NCT01657032|541717794|FG001|Overall Study|Lost to Follow-up|7|||
150159910|NCT03633903|541717795|FG000|Overall Study|Withdrawal by Subject|1|||
150159911|NCT03633903|541717796|FG001|Overall Study|Withdrawal by Subject|2|||
150159912|NCT03633903|541717795|FG000|Overall Study|Lost to Follow-up|5|||
150159913|NCT03633903|541717796|FG001|Overall Study|Lost to Follow-up|5|||
150159914|NCT01657682|541717797|FG000|Overall Study|Lost to Follow-up|1|||
150159915|NCT01657682|541717798|FG001|Overall Study|Lost to Follow-up|0|||
150159916|NCT01657682|541717799|FG002|Overall Study|Lost to Follow-up|0|||
150159917|NCT01657682|541717797|FG000|Overall Study|Withdrawal by Subject|0|||
150159918|NCT01657682|541717798|FG001|Overall Study|Withdrawal by Subject|1|||
150159919|NCT01657682|541717799|FG002|Overall Study|Withdrawal by Subject|1|||
150159920|NCT01657682|541717797|FG000|Overall Study|Adverse Event|0|||
150159921|NCT01657682|541717798|FG001|Overall Study|Adverse Event|1|||
150159922|NCT01657682|541717799|FG002|Overall Study|Adverse Event|0|||
150159923|NCT01719861|541717803|FG000|Cycle 1|Death|4|||
150159924|NCT01719861|541717803|FG000|Cycle 2|Death|1|||
150159925|NCT02839681|541717815|FG000|Overall Study|Death|2|||
150159926|NCT01653847|541717816|FG000|Overall Study|Withdrawal by Subject|1|||
150159927|NCT01653847|541717817|FG001|Overall Study|Withdrawal by Subject|0|||
150159928|NCT02015195|541717823|FG000|Overall Study|Adverse Event|0|||
150159929|NCT02015195|541717824|FG001|Overall Study|Adverse Event|0|||
150159930|NCT02015195|541717825|FG002|Overall Study|Adverse Event|0|||
150159931|NCT02015195|541717826|FG003|Overall Study|Adverse Event|1|||
150159932|NCT02015195|541717827|FG004|Overall Study|Adverse Event|0|||
150159933|NCT02015195|541717828|FG005|Overall Study|Adverse Event|0|||
150159934|NCT02015195|541717829|FG006|Overall Study|Adverse Event|0|||
150159935|NCT01318811|541717830|FG000|Overall Study|Physician Decision|1|||
150159936|NCT01318811|541717831|FG001|Overall Study|Physician Decision|1|||
150159937|NCT01318811|541717830|FG000|Overall Study|CRRT stopped for head CT|0|||
149919883|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
149919884|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
149919885|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
149919886|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
149919887|NCT02636699|540839899|FG000|Treatment and Follow-up Periods|Other|3|||
149919888|NCT02636699|540839900|FG001|Treatment and Follow-up Periods|Other|1|||
149919889|NCT02636699|540839901|FG002|Treatment and Follow-up Periods|Other|0|||
149919890|NCT00624832|540839902|FG000|Overall Study|Adverse Event|0|||
149919891|NCT00624832|540839903|FG001|Overall Study|Adverse Event|1|||
149919892|NCT00624832|540839904|FG002|Overall Study|Adverse Event|0|||
149919893|NCT00624832|540839905|FG003|Overall Study|Adverse Event|1|||
149919894|NCT00624832|540839902|FG000|Overall Study|Abnormal Laboratory Value|2|||
149919895|NCT00624832|540839903|FG001|Overall Study|Abnormal Laboratory Value|0|||
149919896|NCT00624832|540839904|FG002|Overall Study|Abnormal Laboratory Value|0|||
149919897|NCT00624832|540839905|FG003|Overall Study|Abnormal Laboratory Value|0|||
149919898|NCT04379700|540839906|FG000|Overall Study|Withdrawal by Subject|10|||
149919899|NCT04379700|540839906|FG000|Overall Study|Screen Fail|4|||
149919900|NCT04379700|540839906|FG000|Overall Study|Lost to Follow-up|3|||
149919901|NCT03624569|540839908|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149919902|NCT03624569|540839909|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
149919903|NCT03624569|540839908|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
149919904|NCT03624569|540839909|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
149919905|NCT00957424|540839910|FG000|Overall Study|Lost to Follow-up|19|||
149919906|NCT00957424|540839910|FG000|Overall Study|Protocol Violation|3|||
149919907|NCT00957424|540839910|FG000|Overall Study|Withdrawal by Subject|1|||
149919908|NCT01038752|540839911|FG000|Overall Study|Tumor Progression|2|||
149919909|NCT01038752|540839912|FG001|Overall Study|Tumor Progression|2|||
149919910|NCT01038752|540839911|FG000|Overall Study|Lost to Follow-up|3|||
149919911|NCT01038752|540839912|FG001|Overall Study|Lost to Follow-up|3|||
149919912|NCT00703118|540839917|FG000|Overall Study|Adverse Event|1|||
149919913|NCT00703118|540839918|FG001|Overall Study|Adverse Event|2|||
149919914|NCT00703118|540839919|FG002|Overall Study|Adverse Event|2|||
149919915|NCT00703118|540839917|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
149919916|NCT00703118|540839918|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
149919917|NCT00703118|540839919|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
149919918|NCT00703118|540839917|FG000|Overall Study|Lost to Follow-up|6|||
149919919|NCT00703118|540839918|FG001|Overall Study|Lost to Follow-up|4|||
149919920|NCT00703118|540839919|FG002|Overall Study|Lost to Follow-up|4|||
149919921|NCT00703118|540839917|FG000|Overall Study|Withdrawal by Subject|8|||
149919922|NCT00703118|540839918|FG001|Overall Study|Withdrawal by Subject|7|||
149919923|NCT00703118|540839919|FG002|Overall Study|Withdrawal by Subject|13|||
149919924|NCT00703118|540839917|FG000|Overall Study|Other|0|||
149919925|NCT00703118|540839918|FG001|Overall Study|Other|0|||
149919926|NCT00703118|540839919|FG002|Overall Study|Other|1|||
149919927|NCT01578499|540839935|FG000|Overall Study|Reason not Specified|0|||
149919928|NCT01578499|540839936|FG001|Overall Study|Reason not Specified|1|||
149919929|NCT01578499|540839935|FG000|Overall Study|Lost to Follow-up|2|||
149919930|NCT01578499|540839936|FG001|Overall Study|Lost to Follow-up|1|||
149919931|NCT01578499|540839935|FG000|Overall Study|Withdrawal by Subject|10|||
149919932|NCT01578499|540839936|FG001|Overall Study|Withdrawal by Subject|16|||
149919933|NCT01578499|540839935|FG000|Overall Study|Death|20|||
149919934|NCT01578499|540839936|FG001|Overall Study|Death|25|||
149919935|NCT01578499|540839935|FG000|Overall Study|Died and End of Study Page not Completed|2|||
150159938|NCT01318811|541717831|FG001|Overall Study|CRRT stopped for head CT|1|||
150159939|NCT01318811|541717830|FG000|Overall Study|Death|0|||
150159940|NCT01318811|541717831|FG001|Overall Study|Death|1|||
150159941|NCT01318811|541717830|FG000|Overall Study|CRRT stopped for head MRI|0|||
150159942|NCT01318811|541717831|FG001|Overall Study|CRRT stopped for head MRI|1|||
150159943|NCT00131911|541717832|FG000|Overall Study|Withdrawal by Subject|1|||
150159944|NCT00131911|541717833|FG001|Overall Study|Withdrawal by Subject|0|||
150159945|NCT01670500|541717837|FG000|Overall Study|Withdrawal by Subject|1|||
150159946|NCT01670500|541717838|FG001|Overall Study|Withdrawal by Subject|0|||
150159947|NCT03658811|541717839|FG000|Overall Study|Lost to Follow-up|3|||
150159948|NCT04951479|541717840|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
150159949|NCT02507219|541717841|FG000|Overall Study|Physician Decision|1|||
150159950|NCT02507219|541717842|FG001|Overall Study|Physician Decision|0|||
150159951|NCT02507219|541717843|FG002|Overall Study|Physician Decision|0|||
150159952|NCT02507219|541717844|FG003|Overall Study|Physician Decision|0|||
149919936|NCT01578499|540839936|FG001|Overall Study|Died and End of Study Page not Completed|0|||
149919937|NCT00094536|540839943|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
149919938|NCT00094536|540839943|FG000|Treatment and Follow-up|Adverse Event|4|||
149919939|NCT00094536|540839943|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
149919940|NCT00094536|540839943|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
149919941|NCT00094536|540839943|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
150159953|NCT02507219|541717845|FG004|Overall Study|Physician Decision|0|||
150159954|NCT02507219|541717846|FG005|Overall Study|Physician Decision|0|||
149919942|NCT00094536|540839943|FG000|Treatment and Follow-up|Subject non-compliance|9|||
149919943|NCT00094536|540839943|FG000|Treatment and Follow-up|Unable to attend visits|1|||
149919944|NCT01900431|540839944|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
149919945|NCT01900431|540839945|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
149919946|NCT01900431|540839946|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
149919947|NCT01900431|540839944|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
149919948|NCT01900431|540839945|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
149919949|NCT01900431|540839946|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
149919950|NCT01900431|540839944|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
149919951|NCT01900431|540839945|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
149919952|NCT01900431|540839946|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
149919953|NCT01900431|540839944|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
149919954|NCT01900431|540839945|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
149919955|NCT01900431|540839946|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
149919956|NCT01900431|540839944|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
149919957|NCT01900431|540839945|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
149919958|NCT01900431|540839946|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
149919959|NCT01900431|540839944|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
149919960|NCT01900431|540839945|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
149919961|NCT01900431|540839946|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
149919962|NCT01900431|540839944|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
149919963|NCT01900431|540839945|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
149919964|NCT01900431|540839946|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
149919965|NCT01900431|540839944|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
149919966|NCT01900431|540839945|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
149919967|NCT01900431|540839946|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
149919968|NCT01900431|540839944|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
149919969|NCT01900431|540839945|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
149919970|NCT01900431|540839946|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
149919971|NCT03782974|540839949|FG000|Overall Study|Withdrawal by Subject|7|||
149919972|NCT03782974|540839950|FG001|Overall Study|Withdrawal by Subject|7|||
149919973|NCT03782974|540839949|FG000|Overall Study|Pregnancy|1|||
149919974|NCT03782974|540839950|FG001|Overall Study|Pregnancy|0|||
149919975|NCT00448812|540839957|FG000|Year 2|Missed visit but remained in study|4|||
149919976|NCT00448812|540839958|FG001|Year 2|Missed visit but remained in study|1|||
149919977|NCT00448812|540839957|FG000|Year 3|Withdrawal by Subject|1|||
149919978|NCT00448812|540839958|FG001|Year 3|Withdrawal by Subject|3|||
149919979|NCT00448812|540839957|FG000|Year 3|Lost to Follow-up|1|||
149919980|NCT00448812|540839958|FG001|Year 3|Lost to Follow-up|0|||
149919981|NCT00448812|540839957|FG000|Year 3|Missed visit but remained in study|2|||
149919982|NCT00448812|540839958|FG001|Year 3|Missed visit but remained in study|0|||
149919983|NCT00448812|540839957|FG000|Year 5|Missed visit but remained in study|1|||
149919984|NCT00448812|540839958|FG001|Year 5|Missed visit but remained in study|0|||
149919985|NCT01687283|540841902|FG000|Overall Study|Adverse Event|11|||
149919986|NCT01687283|540841903|FG001|Overall Study|Adverse Event|4|||
149919987|NCT01687283|540841902|FG000|Overall Study|Lack of Efficacy|3|||
149919988|NCT01687283|540841903|FG001|Overall Study|Lack of Efficacy|1|||
149919989|NCT01687283|540841902|FG000|Overall Study|Protocol Violation|1|||
149919990|NCT01687283|540841903|FG001|Overall Study|Protocol Violation|3|||
149919991|NCT01687283|540841902|FG000|Overall Study|protocol defined stopping criteria|8|||
149919992|NCT01687283|540841903|FG001|Overall Study|protocol defined stopping criteria|10|||
149919993|NCT01687283|540841902|FG000|Overall Study|Lost to Follow-up|1|||
149919994|NCT01687283|540841903|FG001|Overall Study|Lost to Follow-up|1|||
149919995|NCT01687283|540841902|FG000|Overall Study|Investigator discretion|2|||
149919996|NCT01687283|540841903|FG001|Overall Study|Investigator discretion|0|||
149919997|NCT01687283|540841902|FG000|Overall Study|Withdrawal by Subject|9|||
149919998|NCT01687283|540841903|FG001|Overall Study|Withdrawal by Subject|8|||
149919999|NCT03307837|540841907|FG000|Overall Study|Withdrawal by Subject|0|||
149920000|NCT03307837|540841908|FG001|Overall Study|Withdrawal by Subject|0|||
149920001|NCT03307837|540841909|FG002|Overall Study|Withdrawal by Subject|1|||
149920002|NCT03307837|540841910|FG003|Overall Study|Withdrawal by Subject|0|||
149920003|NCT03307837|540841911|FG004|Overall Study|Withdrawal by Subject|0|||
149920004|NCT03307837|540841912|FG005|Overall Study|Withdrawal by Subject|1|||
149920005|NCT03307837|540841907|FG000|Overall Study|Lost to Follow-up|1|||
149920006|NCT03307837|540841908|FG001|Overall Study|Lost to Follow-up|1|||
149920007|NCT03307837|540841909|FG002|Overall Study|Lost to Follow-up|0|||
149920008|NCT03307837|540841910|FG003|Overall Study|Lost to Follow-up|0|||
149920009|NCT03307837|540841911|FG004|Overall Study|Lost to Follow-up|0|||
149920010|NCT03307837|540841912|FG005|Overall Study|Lost to Follow-up|1|||
149920011|NCT00904917|540841914|FG000|Overall Study|Lost to Follow-up|2|||
149920012|NCT00904917|540841915|FG001|Overall Study|Lost to Follow-up|2|||
149920013|NCT00904917|540841916|FG002|Overall Study|Lost to Follow-up|2|||
149920014|NCT00904917|540841917|FG003|Overall Study|Lost to Follow-up|2|||
149920015|NCT00762034|540841918|FG000|Induction Period|Protocol Violation|1|||
149920016|NCT00762034|540841919|FG001|Induction Period|Protocol Violation|2|||
149920017|NCT00762034|540841918|FG000|Induction Period|Entry Criterion Not Met|12|||
149920018|NCT00762034|540841919|FG001|Induction Period|Entry Criterion Not Met|11|||
149920019|NCT00762034|540841918|FG000|Induction Period|Adverse Event|27|||
149920020|NCT00762034|540841919|FG001|Induction Period|Adverse Event|38|||
149920021|NCT00762034|540841918|FG000|Induction Period|Lost to Follow-up|1|||
149920022|NCT00762034|540841919|FG001|Induction Period|Lost to Follow-up|1|||
149920023|NCT00762034|540841918|FG000|Induction Period|Progressive Disease|73|||
149920024|NCT00762034|540841919|FG001|Induction Period|Progressive Disease|55|||
149920025|NCT00762034|540841918|FG000|Induction Period|Physician Decision|21|||
149920026|NCT00762034|540841919|FG001|Induction Period|Physician Decision|20|||
149920027|NCT00762034|540841918|FG000|Induction Period|Withdrawal by Subject|15|||
149920028|NCT00762034|540841919|FG001|Induction Period|Withdrawal by Subject|19|||
149920029|NCT00762034|540841918|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
149920030|NCT00762034|540841919|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
149920031|NCT00762034|540841918|FG000|Induction Period|Deaths Due to Study Disease|9|||
149920032|NCT00762034|540841919|FG001|Induction Period|Deaths Due to Study Disease|9|||
149920033|NCT00762034|540841918|FG000|Maintenance Period|Protocol Violation|1|||
149920034|NCT00762034|540841919|FG001|Maintenance Period|Protocol Violation|3|||
149920035|NCT00762034|540841918|FG000|Maintenance Period|Entry Criterion Not Met|0|||
149920036|NCT00762034|540841919|FG001|Maintenance Period|Entry Criterion Not Met|2|||
149920037|NCT00762034|540841918|FG000|Maintenance Period|Adverse Event|42|||
149920038|NCT00762034|540841919|FG001|Maintenance Period|Adverse Event|26|||
149920039|NCT00762034|540841918|FG000|Maintenance Period|Progressive Disease|186|||
149920040|NCT00762034|540841919|FG001|Maintenance Period|Progressive Disease|224|||
149920041|NCT00762034|540841918|FG000|Maintenance Period|Physician Decision|25|||
149920042|NCT00762034|540841919|FG001|Maintenance Period|Physician Decision|20|||
149920043|NCT00762034|540841918|FG000|Maintenance Period|Withdrawal by Subject|34|||
149920044|NCT00762034|540841919|FG001|Maintenance Period|Withdrawal by Subject|14|||
149920045|NCT00762034|540841918|FG000|Maintenance Period|Death not due to study disease|2|||
149920046|NCT00762034|540841919|FG001|Maintenance Period|Death not due to study disease|5|||
149920047|NCT00762034|540841918|FG000|Maintenance Period|Death due to study disease|3|||
149920048|NCT00762034|540841919|FG001|Maintenance Period|Death due to study disease|3|||
149920049|NCT00762034|540841918|FG000|Maintenance Period|Other|1|||
149920050|NCT00762034|540841919|FG001|Maintenance Period|Other|1|||
149920051|NCT02442206|540841920|FG000|Period 1|Adverse Event|1|||
149920052|NCT02442206|540841921|FG001|Period 1|Adverse Event|1|||
149920053|NCT02442206|540841920|FG000|Period 1|withdrew consent|0|||
149920054|NCT02442206|540841921|FG001|Period 1|withdrew consent|1|||
149920055|NCT02442206|540841920|FG000|Period 1|COPD exacerbation|0|||
149920056|NCT02442206|540841921|FG001|Period 1|COPD exacerbation|1|||
149920057|NCT02442206|540841920|FG000|Period 2|Adverse Event|1|||
149920058|NCT02442206|540841921|FG001|Period 2|Adverse Event|0|||
149920059|NCT00497146|540841922|FG000|Treatment Period|Adverse Event|6|||
149920060|NCT00497146|540841923|FG001|Treatment Period|Adverse Event|2|||
149920061|NCT00497146|540841922|FG000|Treatment Period|Withdrawal by Subject|5|||
149920062|NCT00497146|540841923|FG001|Treatment Period|Withdrawal by Subject|9|||
149920063|NCT00497146|540841922|FG000|Treatment Period|Lost to Follow-up|1|||
149920064|NCT00497146|540841923|FG001|Treatment Period|Lost to Follow-up|3|||
149920065|NCT00497146|540841922|FG000|Treatment Period|Required dialysis|4|||
149920066|NCT00497146|540841923|FG001|Treatment Period|Required dialysis|1|||
149920067|NCT00497146|540841922|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
149920068|NCT00497146|540841923|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
149920069|NCT00497146|540841922|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
149920070|NCT00497146|540841923|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
149920071|NCT00497146|540841922|FG000|Treatment Period|Other Reason|2|||
149920072|NCT00497146|540841923|FG001|Treatment Period|Other Reason|3|||
149920073|NCT00497146|540841922|FG000|Long-term Follow-up Period|Adverse Event|2|||
149920074|NCT00497146|540841923|FG001|Long-term Follow-up Period|Adverse Event|2|||
149920075|NCT00497146|540841922|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
150159955|NCT02507219|541717841|FG000|Overall Study|Withdrawal by Subject|0|||
150159956|NCT02507219|541717842|FG001|Overall Study|Withdrawal by Subject|0|||
150159957|NCT02507219|541717843|FG002|Overall Study|Withdrawal by Subject|0|||
150159958|NCT02507219|541717844|FG003|Overall Study|Withdrawal by Subject|0|||
150159959|NCT02507219|541717845|FG004|Overall Study|Withdrawal by Subject|1|||
150159960|NCT02507219|541717846|FG005|Overall Study|Withdrawal by Subject|0|||
150159961|NCT05397470|541717847|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
150159962|NCT05397470|541717848|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
150159963|NCT05397470|541717849|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
150159964|NCT05397470|541717847|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
150159965|NCT05397470|541717848|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
150159966|NCT05397470|541717849|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
150159967|NCT05397470|541717847|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
150159968|NCT05397470|541717848|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
150259668|NCT00946101|542087186|FG001|Overall Study|Physician Decision|1|||
150259669|NCT01174160|542087187|FG000|Overall Study|Adverse Event|1|||
150259670|NCT01174160|542087188|FG001|Overall Study|Adverse Event|0|||
150259671|NCT01174160|542087187|FG000|Overall Study|Lost to Follow-up|1|||
150259672|NCT01174160|542087188|FG001|Overall Study|Lost to Follow-up|0|||
150259673|NCT01174160|542087187|FG000|Overall Study|Physician Decision|1|||
150259674|NCT01174160|542087188|FG001|Overall Study|Physician Decision|0|||
150259675|NCT01174160|542087187|FG000|Overall Study|Protocol Violation|4|||
150259676|NCT01174160|542087188|FG001|Overall Study|Protocol Violation|6|||
150259677|NCT01174160|542087187|FG000|Overall Study|Withdrawal by Subject|1|||
150259678|NCT01174160|542087188|FG001|Overall Study|Withdrawal by Subject|0|||
150259679|NCT06377488|542087189|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
150259680|NCT06377488|542087189|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
150259681|NCT06377488|542087189|FG000|Overall Study|Protocol Violation|1|||
150259682|NCT06377488|542087189|FG000|Overall Study|Lost to Follow-up|1|||
150259683|NCT06377488|542087189|FG000|Overall Study|Incorrect Lens Dispensed|2|||
150259684|NCT03625895|542087190|FG000|Overall Study|Protocol Violation|585|||
150259685|NCT00552240|542087193|FG000|Overall Study|Adverse Event|9|||
150259686|NCT00552240|542087194|FG001|Overall Study|Adverse Event|9|||
150259687|NCT00552240|542087193|FG000|Overall Study|Protocol Violation|1|||
150259688|NCT00552240|542087194|FG001|Overall Study|Protocol Violation|1|||
150259689|NCT00552240|542087193|FG000|Overall Study|Lost to Follow-up|5|||
150259690|NCT00552240|542087194|FG001|Overall Study|Lost to Follow-up|6|||
150259691|NCT00552240|542087193|FG000|Overall Study|Withdrawal by Subject|2|||
150259692|NCT00552240|542087194|FG001|Overall Study|Withdrawal by Subject|2|||
150259693|NCT00552240|542087193|FG000|Overall Study|Lack of Efficacy|6|||
150259694|NCT00552240|542087194|FG001|Overall Study|Lack of Efficacy|0|||
150259695|NCT00552240|542087193|FG000|Overall Study|Other|1|||
150259696|NCT00552240|542087194|FG001|Overall Study|Other|0|||
150259697|NCT02679573|542087195|FG000|Overall Study|Adverse Event|13|||
150259698|NCT02679573|542087196|FG001|Overall Study|Adverse Event|6|||
150259699|NCT02679573|542087195|FG000|Overall Study|Lack of Efficacy|12|||
150259700|NCT02679573|542087196|FG001|Overall Study|Lack of Efficacy|15|||
149817279|NCT01977352|540461498|FG001|Overall Study|Lost to Follow-up|2|||
149817280|NCT00409188|540461499|FG000|Overall Study|Ongoing at data cut-off|383|||
149817281|NCT00409188|540461500|FG001|Overall Study|Ongoing at data cut-off|175|||
149817282|NCT00275028|540461504|FG000|Overall Study|Withdrew consent before treatment began|1|||
149817283|NCT00275028|540461504|FG000|Overall Study|Withdrawal by Subject|5|||
149817284|NCT00275028|540461504|FG000|Overall Study|Adverse Event|9|||
149817285|NCT00275028|540461504|FG000|Overall Study|Progressive Disease|30|||
149817286|NCT00275028|540461504|FG000|Overall Study|Physician Decision|2|||
149817287|NCT01847313|540461505|FG000|Overall Study|Death|0|||
149817288|NCT01847313|540461506|FG001|Overall Study|Death|1|||
149817289|NCT01847313|540461505|FG000|Overall Study|Withdrawal by Subject|0|||
149817290|NCT01847313|540461506|FG001|Overall Study|Withdrawal by Subject|1|||
149817291|NCT00598559|540461507|FG000|Overall Study|Adverse Event|11|||
149817292|NCT00598559|540461508|FG001|Overall Study|Adverse Event|7|||
149817293|NCT00598559|540461509|FG002|Overall Study|Adverse Event|0|||
149817294|NCT00598559|540461507|FG000|Overall Study|Withdrawal by Subject|2|||
149817295|NCT00598559|540461508|FG001|Overall Study|Withdrawal by Subject|2|||
149817296|NCT00598559|540461509|FG002|Overall Study|Withdrawal by Subject|0|||
149817297|NCT00598559|540461507|FG000|Overall Study|Protocol Non-compliance|1|||
149817298|NCT00598559|540461508|FG001|Overall Study|Protocol Non-compliance|0|||
149817299|NCT00598559|540461509|FG002|Overall Study|Protocol Non-compliance|0|||
149817300|NCT00598559|540461507|FG000|Overall Study|Early discharge from hospital|9|||
149817301|NCT00598559|540461508|FG001|Overall Study|Early discharge from hospital|12|||
149817302|NCT00598559|540461509|FG002|Overall Study|Early discharge from hospital|3|||
149817303|NCT00598559|540461507|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
149817304|NCT00598559|540461508|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
149817305|NCT00598559|540461509|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
149817306|NCT00515073|540461510|FG000|Overall Study|Withdrawal by Subject|1|||
149817307|NCT00515073|540461510|FG000|Overall Study|Physician Decision|1|||
149817308|NCT02764489|540461511|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
149817309|NCT02764489|540461512|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
149817310|NCT02764489|540461511|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
149817311|NCT02764489|540461512|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
149817312|NCT02764489|540461511|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
149817313|NCT02764489|540461512|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
149817314|NCT02764489|540461511|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
150259701|NCT02679573|542087195|FG000|Overall Study|Could not complete required study visits|6|||
150259702|NCT02679573|542087196|FG001|Overall Study|Could not complete required study visits|2|||
150259703|NCT02679573|542087195|FG000|Overall Study|Withdrawal by Subject|2|||
150259704|NCT02679573|542087196|FG001|Overall Study|Withdrawal by Subject|9|||
150259705|NCT02679573|542087195|FG000|Overall Study|Death|2|||
150259706|NCT02679573|542087196|FG001|Overall Study|Death|0|||
150259707|NCT02679573|542087195|FG000|Overall Study|Physician Decision|2|||
150259708|NCT02679573|542087196|FG001|Overall Study|Physician Decision|4|||
149920076|NCT00497146|540841923|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
149920077|NCT00497146|540841922|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
149920078|NCT00497146|540841923|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
149920079|NCT00497146|540841922|FG000|Long-term Follow-up Period|Other|0|||
149920080|NCT00497146|540841923|FG001|Long-term Follow-up Period|Other|1|||
149920081|NCT01471444|540841924|FG000|Overall Study|Physician Decision|3|||
149920082|NCT01471444|540841925|FG001|Overall Study|Physician Decision|2|||
149920083|NCT01471444|540841924|FG000|Overall Study|Withdrawal by Subject|0|||
149920084|NCT01471444|540841925|FG001|Overall Study|Withdrawal by Subject|1|||
149920085|NCT01709409|540841930|FG000|Overall Study|Protocol Violation|1|||
149920086|NCT01709409|540841931|FG001|Overall Study|Protocol Violation|0|||
149920087|NCT02412878|540841934|FG000|Overall Study|Withdrawal by Subject|19|||
149920088|NCT02412878|540841935|FG001|Overall Study|Withdrawal by Subject|10|||
149920089|NCT02412878|540841934|FG000|Overall Study|Lost to Follow-up|2|||
149920090|NCT02412878|540841935|FG001|Overall Study|Lost to Follow-up|3|||
149920091|NCT02190721|540841936|FG000|Overall Study|Patient was out of the city|0|||
149920092|NCT02190721|540841937|FG001|Overall Study|Patient was out of the city|1|||
149920093|NCT02190721|540841938|FG002|Overall Study|Patient was out of the city|0|||
149920094|NCT04571385|540841939|FG000|Overall Study|Participant non-compliance|1|||
149920095|NCT04571385|540841940|FG001|Overall Study|Participant non-compliance|0|||
149920096|NCT04571385|540841941|FG002|Overall Study|Participant non-compliance|0|||
149920097|NCT04571385|540841939|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
149920098|NCT04571385|540841940|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
149920099|NCT04571385|540841941|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
149920100|NCT04571385|540841939|FG000|Overall Study|Screen failure|0|||
149920101|NCT04571385|540841940|FG001|Overall Study|Screen failure|0|||
149920102|NCT04571385|540841941|FG002|Overall Study|Screen failure|1|||
149920103|NCT04676152|540841943|FG000|Overall Study|screen fail|9|||
149920104|NCT01928199|540841944|FG000|Overall Study|Lost to Follow-up|2|||
149920105|NCT01928199|540841945|FG001|Overall Study|Lost to Follow-up|1|||
149920106|NCT01928199|540841944|FG000|Overall Study|Withdrawal by Subject|3|||
149920107|NCT01928199|540841945|FG001|Overall Study|Withdrawal by Subject|5|||
149920108|NCT02107313|540841947|FG000|Overall Study|One participant did not do the FED cohor|0|||
149920109|NCT02107313|540841948|FG001|Overall Study|One participant did not do the FED cohor|1|||
150159969|NCT05397470|541717849|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
150159970|NCT05397470|541717847|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
150159971|NCT05397470|541717848|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
150159972|NCT05397470|541717849|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
150159973|NCT05397470|541717847|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
150159974|NCT05397470|541717848|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
150159975|NCT05397470|541717849|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
150159976|NCT05397470|541717847|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
150159977|NCT05397470|541717848|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
150159978|NCT05397470|541717849|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
150159979|NCT05397470|541717847|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
150159980|NCT05397470|541717848|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
150159981|NCT05397470|541717849|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
150159982|NCT00394095|541719605|FG000|Screening|Withdrawal by Subject|1|||
150159983|NCT00394095|541719606|FG001|Screening|Withdrawal by Subject|0|||
150159984|NCT00394095|541719605|FG000|Randomized|Withdrawal by Subject|5|||
150159985|NCT00394095|541719606|FG001|Randomized|Withdrawal by Subject|1|||
150159986|NCT00394095|541719605|FG000|Randomized|Adverse Event|1|||
150159987|NCT00394095|541719606|FG001|Randomized|Adverse Event|1|||
150159988|NCT00394095|541719605|FG000|Randomized|Overdose|1|||
150159989|NCT00394095|541719606|FG001|Randomized|Overdose|0|||
150159990|NCT00394095|541719605|FG000|Randomized|Lost to Follow-up|1|||
150159991|NCT00394095|541719606|FG001|Randomized|Lost to Follow-up|2|||
150159992|NCT01256476|541719607|FG000|Overall Study|Adverse Event|2|||
150159993|NCT01256476|541719608|FG001|Overall Study|Adverse Event|1|||
150159994|NCT01256476|541719607|FG000|Overall Study|Withdrawal by Subject|2|||
150159995|NCT01256476|541719608|FG001|Overall Study|Withdrawal by Subject|1|||
150159996|NCT01256476|541719607|FG000|Overall Study|Lost to Follow-up|1|||
150159997|NCT01256476|541719608|FG001|Overall Study|Lost to Follow-up|2|||
150159998|NCT01256476|541719607|FG000|Overall Study|Persistent ALT or AST elevation|1|||
150159999|NCT01256476|541719608|FG001|Overall Study|Persistent ALT or AST elevation|0|||
150160000|NCT01256476|541719607|FG000|Overall Study|Physician Decision|0|||
150160001|NCT01256476|541719608|FG001|Overall Study|Physician Decision|1|||
150160002|NCT01256476|541719607|FG000|Overall Study|Subject non-compliance|0|||
149920110|NCT01031004|540841951|FG000|Overall Study|Protocol Violation|0|||
149920111|NCT01031004|540841952|FG001|Overall Study|Protocol Violation|1|||
149920112|NCT01031004|540841951|FG000|Overall Study|Lost to Follow-up|1|||
149920113|NCT01031004|540841952|FG001|Overall Study|Lost to Follow-up|0|||
149920114|NCT01214668|540841960|FG000|Overall Study|Adverse Event|0|||
149920115|NCT01214668|540841961|FG001|Overall Study|Adverse Event|1|||
150160003|NCT01256476|541719608|FG001|Overall Study|Subject non-compliance|1|||
150160004|NCT01256476|541719607|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
150160005|NCT01256476|541719608|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
150160006|NCT02401529|541719609|FG000|Overall Study|Lost to Follow-up|2|||
150160007|NCT02401529|541719610|FG001|Overall Study|Lost to Follow-up|1|||
150160008|NCT02401529|541719609|FG000|Overall Study|Physician Decision|2|||
150160009|NCT02401529|541719610|FG001|Overall Study|Physician Decision|6|||
150160010|NCT02401529|541719609|FG000|Overall Study|Protocol Violation|5|||
150160011|NCT02401529|541719610|FG001|Overall Study|Protocol Violation|0|||
150160012|NCT04034238|541719611|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
150160013|NCT04034238|541719612|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
150160014|NCT04034238|541719613|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
150160015|NCT04034238|541719614|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
150160016|NCT04034238|541719611|FG000|Dose Escalation Phase|Screen failures|0|||
150160017|NCT04034238|541719612|FG001|Dose Escalation Phase|Screen failures|0|||
150160018|NCT04034238|541719613|FG002|Dose Escalation Phase|Screen failures|0|||
150160019|NCT04034238|541719614|FG003|Dose Escalation Phase|Screen failures|2|||
150160020|NCT04034238|541719611|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
150160021|NCT04034238|541719612|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
150160022|NCT04034238|541719613|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
150160023|NCT04034238|541719614|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
150160024|NCT04034238|541719611|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
150160025|NCT04034238|541719612|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
150160026|NCT04034238|541719613|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
150160027|NCT04034238|541719614|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
150160028|NCT01106287|541719616|FG000|Overall Study|Adverse Event|1|||
150160029|NCT01106287|541719617|FG001|Overall Study|Adverse Event|0|||
150160030|NCT01106287|541719618|FG002|Overall Study|Adverse Event|0|||
150160031|NCT01106287|541719619|FG003|Overall Study|Adverse Event|0|||
150160032|NCT01789203|541719620|FG000|Overall Study|Adverse Event|2|||
150160033|NCT01789203|541719621|FG001|Overall Study|Adverse Event|2|||
150160034|NCT01789203|541719620|FG000|Overall Study|Withdrawal by Subject|1|||
150160035|NCT01789203|541719621|FG001|Overall Study|Withdrawal by Subject|0|||
150160036|NCT01789203|541719620|FG000|Overall Study|Death|1|||
150160037|NCT01789203|541719621|FG001|Overall Study|Death|0|||
150160038|NCT01789203|541719620|FG000|Overall Study|Protocol Violation|2|||
150160039|NCT01789203|541719621|FG001|Overall Study|Protocol Violation|1|||
150160040|NCT01789203|541719620|FG000|Overall Study|Other|1|||
150160041|NCT01789203|541719621|FG001|Overall Study|Other|1|||
150160042|NCT01789203|541719620|FG000|Overall Study|patient non-adherent|2|||
150160043|NCT01789203|541719621|FG001|Overall Study|patient non-adherent|0|||
150160044|NCT01254305|541719628|FG000|Overall Study|Adverse Event|6|||
150160045|NCT01254305|541719629|FG001|Overall Study|Adverse Event|3|||
150160046|NCT01254305|541719630|FG002|Overall Study|Adverse Event|2|||
150160047|NCT01254305|541719628|FG000|Overall Study|Lack of Efficacy|1|||
149817315|NCT02764489|540461512|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
149817316|NCT00881959|540461513|FG000|Overall Study|Lost to Follow-up|2|||
149817317|NCT00881959|540461514|FG001|Overall Study|Lost to Follow-up|4|||
149817318|NCT02791659|540461515|FG000|Overall Study|Protocol Violation|0|||
149817319|NCT02791659|540461516|FG001|Overall Study|Protocol Violation|1|||
149817320|NCT03840811|540461517|FG000|Overall Study|Lost to Follow-up|0|||
149817321|NCT03840811|540461518|FG001|Overall Study|Lost to Follow-up|0|||
149817322|NCT03840811|540461519|FG002|Overall Study|Lost to Follow-up|1|||
149817323|NCT01904383|540461520|FG000|Overall Study|CRF not collected|117|||
149817324|NCT01904383|540461520|FG000|Overall Study|Reason not listed|147|||
149817325|NCT01904383|540461520|FG000|Overall Study|Lost to Follow-up|674|||
149817326|NCT01904383|540461520|FG000|Overall Study|Lack of Efficacy|370|||
149817327|NCT01904383|540461520|FG000|Overall Study|Improvement|141|||
149817328|NCT01904383|540461520|FG000|Overall Study|Adverse Event|271|||
149817329|NCT01904383|540461520|FG000|Overall Study|No patient visit after entry|54|||
149817330|NCT01625845|540461521|FG000|Overall Study|Adverse Event|1|||
149817331|NCT01625845|540461522|FG001|Overall Study|Adverse Event|2|||
149817332|NCT01625845|540461521|FG000|Overall Study|Lost to Follow-up|2|||
149817333|NCT01625845|540461522|FG001|Overall Study|Lost to Follow-up|1|||
149817334|NCT01625845|540461521|FG000|Overall Study|Withdrawal by Subject|2|||
149817335|NCT01625845|540461522|FG001|Overall Study|Withdrawal by Subject|0|||
149817336|NCT02853929|540461523|FG000|Overall Study|Lost to Follow-up|3|||
149817337|NCT02853929|540461524|FG001|Overall Study|Lost to Follow-up|0|||
149817338|NCT02853929|540461523|FG000|Overall Study|Withdrawal by Subject|1|||
149817339|NCT02853929|540461524|FG001|Overall Study|Withdrawal by Subject|0|||
149817340|NCT02853929|540461523|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
149817341|NCT02853929|540461524|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
149817342|NCT01294592|540461525|FG000|Overall Study|Adverse Event|28|||
149817343|NCT01294592|540461526|FG001|Overall Study|Adverse Event|13|||
149817344|NCT01294592|540461525|FG000|Overall Study|Lack of Efficacy|7|||
150259709|NCT02679573|542087195|FG000|Overall Study|Lost to Follow-up|0|||
150259710|NCT02679573|542087196|FG001|Overall Study|Lost to Follow-up|3|||
150259711|NCT01415531|542087197|FG000|Overall Study|Adverse Event|7|||
150259712|NCT01415531|542087198|FG001|Overall Study|Adverse Event|10|||
150259713|NCT01415531|542087197|FG000|Overall Study|Lack of Efficacy|3|||
150259714|NCT01415531|542087198|FG001|Overall Study|Lack of Efficacy|2|||
150259715|NCT01415531|542087197|FG000|Overall Study|Protocol Violation|0|||
150259716|NCT01415531|542087198|FG001|Overall Study|Protocol Violation|1|||
150259717|NCT01415531|542087197|FG000|Overall Study|Withdrawal by Subject|5|||
150259718|NCT01415531|542087198|FG001|Overall Study|Withdrawal by Subject|4|||
150259719|NCT01415531|542087197|FG000|Overall Study|Lost to Follow-up|6|||
150259720|NCT01415531|542087198|FG001|Overall Study|Lost to Follow-up|14|||
150259721|NCT01415531|542087197|FG000|Overall Study|Lack of Compliance|1|||
150259722|NCT01415531|542087198|FG001|Overall Study|Lack of Compliance|4|||
150259723|NCT01415531|542087197|FG000|Overall Study|Other Reasons|3|||
150259724|NCT01415531|542087198|FG001|Overall Study|Other Reasons|2|||
150259725|NCT05753670|542087199|FG000|Overall Study|Withdrawal by Subject|6|||
150259726|NCT05753670|542087200|FG001|Overall Study|Withdrawal by Subject|8|||
150259727|NCT05753670|542087199|FG000|Overall Study|Protocol Violation|3|||
150259728|NCT05753670|542087200|FG001|Overall Study|Protocol Violation|1|||
150259729|NCT00122460|542087201|FG000|Overall Study|investigational study phase ongoing|7|||
150259730|NCT00122460|542087202|FG001|Overall Study|investigational study phase ongoing|1|||
149817345|NCT01294592|540461526|FG001|Overall Study|Lack of Efficacy|5|||
149817346|NCT01294592|540461525|FG000|Overall Study|Protocol Violation|1|||
149817347|NCT01294592|540461526|FG001|Overall Study|Protocol Violation|7|||
149817348|NCT01294592|540461525|FG000|Overall Study|Lost to Follow-up|7|||
149817349|NCT01294592|540461526|FG001|Overall Study|Lost to Follow-up|9|||
149817350|NCT01294592|540461525|FG000|Overall Study|Physician Decision|6|||
149817351|NCT01294592|540461526|FG001|Overall Study|Physician Decision|11|||
149817352|NCT01294592|540461525|FG000|Overall Study|Withdrawal by Subject|28|||
149817353|NCT01294592|540461526|FG001|Overall Study|Withdrawal by Subject|28|||
149817354|NCT02762565|540461527|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
149817355|NCT01113710|540461528|FG000|Overall Study|Adverse Event|64|||
149817356|NCT01113710|540461528|FG000|Overall Study|Lack of Efficacy|41|||
149817357|NCT01113710|540461528|FG000|Overall Study|No Information Available|40|||
149817358|NCT01113710|540461528|FG000|Overall Study|Withdrawal by Subject|28|||
149817359|NCT01113710|540461528|FG000|Overall Study|Lost to Follow-up|20|||
149817360|NCT01113710|540461528|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
149817361|NCT01113710|540461528|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
149817362|NCT01113710|540461528|FG000|Overall Study|Lack of Patient's Compliance|8|||
149817363|NCT01113710|540461528|FG000|Overall Study|Other|7|||
149817364|NCT01113710|540461528|FG000|Overall Study|Adverse Event/Other|5|||
149817365|NCT01113710|540461528|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
149817366|NCT01113710|540461528|FG000|Overall Study|Lack of Efficacy/Other|4|||
149817367|NCT01113710|540461528|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
149817368|NCT01113710|540461528|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
149817369|NCT01113710|540461528|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
149817370|NCT01113710|540461528|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
149817371|NCT01113710|540461528|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
149817372|NCT01113710|540461528|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
149817373|NCT01113710|540461528|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
149817374|NCT01113710|540461528|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
149817375|NCT01113710|540461528|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
149817376|NCT01113710|540461528|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
149817377|NCT01113710|540461528|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
149817378|NCT01113710|540461528|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
149817379|NCT01113710|540461528|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
149817380|NCT00623623|540461530|FG000|Overall Study|Previous enrolment into this study|1|||
149817381|NCT00623623|540461531|FG001|Overall Study|Previous enrolment into this study|1|||
149817382|NCT00693784|540461533|FG000|Overall Study|Lost to Follow-up|2|||
149817383|NCT00693784|540461533|FG000|Overall Study|Withdrawal by Subject|2|||
149817384|NCT02265952|540461534|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
149817385|NCT02265952|540461535|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
149817386|NCT02265952|540461534|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
149817387|NCT02265952|540461535|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
150259731|NCT02483585|542087203|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
150259732|NCT02483585|542087204|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
150259733|NCT02483585|542087203|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
150259734|NCT02483585|542087204|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
150259735|NCT02483585|542087203|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
150259736|NCT02483585|542087204|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
150259737|NCT02483585|542087203|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
149920116|NCT01214668|540841962|FG002|Overall Study|Adverse Event|0|||
150259738|NCT02483585|542087204|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
150259739|NCT02483585|542087203|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
150259740|NCT02483585|542087204|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
150259741|NCT02483585|542087203|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
149920117|NCT01214668|540841963|FG003|Overall Study|Adverse Event|2|||
149920118|NCT01214668|540841964|FG004|Overall Study|Adverse Event|1|||
149920119|NCT01214668|540841965|FG005|Overall Study|Adverse Event|1|||
149920120|NCT01214668|540841960|FG000|Overall Study|Death|0|||
149920121|NCT01214668|540841961|FG001|Overall Study|Death|0|||
149920122|NCT01214668|540841962|FG002|Overall Study|Death|1|||
149920123|NCT01214668|540841963|FG003|Overall Study|Death|0|||
149920124|NCT01214668|540841964|FG004|Overall Study|Death|0|||
149920125|NCT01214668|540841965|FG005|Overall Study|Death|0|||
149920126|NCT01214668|540841960|FG000|Overall Study|Progressive Disease|4|||
149920127|NCT01214668|540841961|FG001|Overall Study|Progressive Disease|2|||
150259742|NCT02483585|542087204|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
150259743|NCT02483585|542087203|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
150259744|NCT02483585|542087204|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
149920128|NCT01214668|540841962|FG002|Overall Study|Progressive Disease|5|||
149920129|NCT01214668|540841963|FG003|Overall Study|Progressive Disease|4|||
149920130|NCT01214668|540841964|FG004|Overall Study|Progressive Disease|4|||
149920131|NCT01214668|540841965|FG005|Overall Study|Progressive Disease|5|||
149920132|NCT01214668|540841960|FG000|Overall Study|Withdrawal by Subject|0|||
149920133|NCT01214668|540841961|FG001|Overall Study|Withdrawal by Subject|0|||
149920134|NCT01214668|540841962|FG002|Overall Study|Withdrawal by Subject|0|||
149920135|NCT01214668|540841963|FG003|Overall Study|Withdrawal by Subject|0|||
149920136|NCT01214668|540841964|FG004|Overall Study|Withdrawal by Subject|1|||
149920137|NCT01214668|540841965|FG005|Overall Study|Withdrawal by Subject|0|||
149920138|NCT02815267|540841966|FG000|Double-Blind Phase|Adverse Event|0|||
149920139|NCT02815267|540841967|FG001|Double-Blind Phase|Adverse Event|3|||
149920140|NCT02815267|540841966|FG000|Double-Blind Phase|Lost to Follow-up|17|||
149920141|NCT02815267|540841967|FG001|Double-Blind Phase|Lost to Follow-up|9|||
149920142|NCT02815267|540841966|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
149920143|NCT02815267|540841967|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
149920144|NCT02815267|540841966|FG000|Double-Blind Phase|Protocol Violation|3|||
149920145|NCT02815267|540841967|FG001|Double-Blind Phase|Protocol Violation|2|||
149920146|NCT02815267|540841966|FG000|Double-Blind Phase|Site withdrawal|1|||
149920147|NCT02815267|540841967|FG001|Double-Blind Phase|Site withdrawal|6|||
149920148|NCT02815267|540841966|FG000|Double-Blind Phase|Received a disallowed medication|1|||
149920149|NCT02815267|540841967|FG001|Double-Blind Phase|Received a disallowed medication|1|||
149920150|NCT02815267|540841966|FG000|Open-Label Phase|Adverse Event|1|||
149920151|NCT02815267|540841967|FG001|Open-Label Phase|Adverse Event|1|||
149920152|NCT02815267|540841966|FG000|Open-Label Phase|Lost to Follow-up|23|||
149920153|NCT02815267|540841967|FG001|Open-Label Phase|Lost to Follow-up|9|||
149920154|NCT02815267|540841966|FG000|Open-Label Phase|Withdrawal by Subject|24|||
149920155|NCT02815267|540841967|FG001|Open-Label Phase|Withdrawal by Subject|13|||
149920156|NCT02815267|540841966|FG000|Open-Label Phase|Protocol Violation|0|||
149920157|NCT02815267|540841967|FG001|Open-Label Phase|Protocol Violation|1|||
149920158|NCT02815267|540841966|FG000|Open-Label Phase|Administrative|21|||
149920159|NCT02815267|540841967|FG001|Open-Label Phase|Administrative|12|||
149920160|NCT02815267|540841966|FG000|Open-Label Phase|Other|2|||
149920161|NCT02815267|540841967|FG001|Open-Label Phase|Other|5|||
149920162|NCT01108237|540841968|FG000|Overall Study|No alignment data|2|||
149920163|NCT01108237|540841969|FG001|Overall Study|No alignment data|15|||
149920164|NCT01108237|540841968|FG000|Overall Study|Did not meet criteria for analysis|7|||
149920165|NCT01108237|540841969|FG001|Overall Study|Did not meet criteria for analysis|0|||
149920166|NCT02178358|540841972|FG000|Overall Study|Withdrawal by Subject|0|||
149920167|NCT02178358|540841973|FG001|Overall Study|Withdrawal by Subject|2|||
149920168|NCT02178358|540841974|FG002|Overall Study|Withdrawal by Subject|2|||
149920169|NCT02178358|540841972|FG000|Overall Study|Lost to Follow-up|1|||
149920170|NCT02178358|540841973|FG001|Overall Study|Lost to Follow-up|0|||
149920171|NCT02178358|540841974|FG002|Overall Study|Lost to Follow-up|0|||
149920172|NCT03297021|540841975|FG000|Overall Study|Incomplete/illegible data sheet|4|||
149920173|NCT03297021|540841976|FG001|Overall Study|Incomplete/illegible data sheet|2|||
149920174|NCT03297021|540841977|FG002|Overall Study|Incomplete/illegible data sheet|3|||
150259745|NCT02325557|542087212|FG000|Overall Study|Progressive disease|1|||
150259746|NCT02325557|542087213|FG001|Overall Study|Progressive disease|0|||
150259747|NCT02325557|542087214|FG002|Overall Study|Progressive disease|0|||
149920175|NCT03297021|540841975|FG000|Overall Study|Missing Post-Op Data|1|||
149920176|NCT03297021|540841976|FG001|Overall Study|Missing Post-Op Data|2|||
149920177|NCT03297021|540841977|FG002|Overall Study|Missing Post-Op Data|1|||
149920178|NCT00948922|540841978|FG000|Overall Study|Did not start study treatment|2|||
149920179|NCT00948922|540841979|FG001|Overall Study|Did not start study treatment|5|||
149920180|NCT00948922|540841980|FG002|Overall Study|Did not start study treatment|0|||
149920181|NCT00948922|540841978|FG000|Overall Study|Withdrawal by Subject|0|||
149920182|NCT00948922|540841979|FG001|Overall Study|Withdrawal by Subject|2|||
149920183|NCT00948922|540841980|FG002|Overall Study|Withdrawal by Subject|1|||
150259748|NCT02325557|542087215|FG003|Overall Study|Progressive disease|0|||
150259749|NCT02325557|542087212|FG000|Overall Study|Withdrawal by Subject|4|||
150160048|NCT01254305|541719629|FG001|Overall Study|Lack of Efficacy|0|||
150160049|NCT01254305|541719630|FG002|Overall Study|Lack of Efficacy|1|||
150160050|NCT01254305|541719628|FG000|Overall Study|Protocol Violation|1|||
150160051|NCT01254305|541719629|FG001|Overall Study|Protocol Violation|7|||
150160052|NCT01254305|541719630|FG002|Overall Study|Protocol Violation|3|||
150160053|NCT01254305|541719628|FG000|Overall Study|Withdrawal by Subject|4|||
150160054|NCT01254305|541719629|FG001|Overall Study|Withdrawal by Subject|2|||
150160055|NCT01254305|541719630|FG002|Overall Study|Withdrawal by Subject|4|||
150160056|NCT01254305|541719628|FG000|Overall Study|Lost to Follow-up|10|||
150160057|NCT01254305|541719629|FG001|Overall Study|Lost to Follow-up|6|||
150160058|NCT01254305|541719630|FG002|Overall Study|Lost to Follow-up|5|||
150160059|NCT01254305|541719628|FG000|Overall Study|Other Reasons|0|||
150160060|NCT01254305|541719629|FG001|Overall Study|Other Reasons|0|||
150160061|NCT01254305|541719630|FG002|Overall Study|Other Reasons|2|||
150160062|NCT00765362|541719631|FG000|Overall Study|Death|9|||
150160063|NCT00765362|541719631|FG000|Overall Study|Adverse Event|2|||
150160064|NCT00765362|541719631|FG000|Overall Study|Protocol Violation|18|||
150160065|NCT00765362|541719631|FG000|Overall Study|Withdrawal by Subject|13|||
150160066|NCT00765362|541719631|FG000|Overall Study|Lost to Follow-up|95|||
150160067|NCT03019458|541719635|FG000|Overall Study|Death|0|||
150160068|NCT03019458|541719636|FG001|Overall Study|Death|1|||
150160069|NCT00557505|541719637|FG000|Overall Study|Death|0|||
150160070|NCT00557505|541719638|FG001|Overall Study|Death|0|||
150160071|NCT00557505|541719639|FG002|Overall Study|Death|0|||
150160072|NCT00557505|541719640|FG003|Overall Study|Death|0|||
150160073|NCT00557505|541719641|FG004|Overall Study|Death|0|||
150160074|NCT00557505|541719642|FG005|Overall Study|Death|0|||
150160075|NCT00557505|541719643|FG006|Overall Study|Death|0|||
150160076|NCT00557505|541719644|FG007|Overall Study|Death|0|||
150160077|NCT00557505|541719645|FG008|Overall Study|Death|1|||
150160078|NCT00557505|541719637|FG000|Overall Study|Adverse Event|0|||
150160079|NCT00557505|541719638|FG001|Overall Study|Adverse Event|0|||
150160080|NCT00557505|541719639|FG002|Overall Study|Adverse Event|1|||
150160081|NCT00557505|541719640|FG003|Overall Study|Adverse Event|0|||
150160082|NCT00557505|541719641|FG004|Overall Study|Adverse Event|0|||
150160083|NCT00557505|541719642|FG005|Overall Study|Adverse Event|0|||
150160084|NCT00557505|541719643|FG006|Overall Study|Adverse Event|1|||
150160085|NCT00557505|541719644|FG007|Overall Study|Adverse Event|0|||
150160086|NCT00557505|541719645|FG008|Overall Study|Adverse Event|0|||
150160087|NCT00557505|541719637|FG000|Overall Study|Global deterioration of health|1|||
150160088|NCT00557505|541719638|FG001|Overall Study|Global deterioration of health|0|||
150160089|NCT00557505|541719639|FG002|Overall Study|Global deterioration of health|0|||
149817388|NCT00326885|540461539|FG000|Overall Study|Adverse Event|1|||
149817389|NCT00326885|540461539|FG000|Overall Study|Withdrawal by Subject|3|||
149817390|NCT00326885|540461539|FG000|Overall Study|Physician Decision|1|||
149817391|NCT00326885|540461539|FG000|Overall Study|Hospice withdrew consent|2|||
149817392|NCT01042977|540461540|FG000|Overall Study|Adverse Event|4|||
149817393|NCT01042977|540461541|FG001|Overall Study|Adverse Event|12|||
149817394|NCT01042977|540461540|FG000|Overall Study|Death|2|||
149817395|NCT01042977|540461541|FG001|Overall Study|Death|1|||
149817396|NCT01042977|540461540|FG000|Overall Study|Withdrawal by Subject|8|||
149817397|NCT01042977|540461541|FG001|Overall Study|Withdrawal by Subject|16|||
149817398|NCT01042977|540461540|FG000|Overall Study|Lost to Follow-up|0|||
149817399|NCT01042977|540461541|FG001|Overall Study|Lost to Follow-up|2|||
149817400|NCT01042977|540461540|FG000|Overall Study|Poor/non-compliance|3|||
149817401|NCT01042977|540461541|FG001|Overall Study|Poor/non-compliance|4|||
149817402|NCT01042977|540461540|FG000|Overall Study|Subject no longer meets study criteria|15|||
149817403|NCT01042977|540461541|FG001|Overall Study|Subject no longer meets study criteria|13|||
149817404|NCT01042977|540461540|FG000|Overall Study|Incorrect enrollment|6|||
149817405|NCT01042977|540461541|FG001|Overall Study|Incorrect enrollment|4|||
149817406|NCT01042977|540461540|FG000|Overall Study|Safety|0|||
149817407|NCT01042977|540461541|FG001|Overall Study|Safety|2|||
149817408|NCT01042977|540461540|FG000|Overall Study|Administrative reason by sponsor|0|||
149817409|NCT01042977|540461541|FG001|Overall Study|Administrative reason by sponsor|1|||
149817410|NCT01042977|540461540|FG000|Overall Study|Various|3|||
149817411|NCT01042977|540461541|FG001|Overall Study|Various|0|||
150160090|NCT00557505|541719640|FG003|Overall Study|Global deterioration of health|0|||
150160091|NCT00557505|541719641|FG004|Overall Study|Global deterioration of health|0|||
150160092|NCT00557505|541719642|FG005|Overall Study|Global deterioration of health|0|||
150160093|NCT00557505|541719643|FG006|Overall Study|Global deterioration of health|0|||
150160094|NCT00557505|541719644|FG007|Overall Study|Global deterioration of health|0|||
149817412|NCT02499354|540461542|FG000|Overall Study|Withdrawal by Subject|1|||
149817413|NCT02499354|540461543|FG001|Overall Study|Withdrawal by Subject|0|||
150160095|NCT00557505|541719645|FG008|Overall Study|Global deterioration of health|0|||
149817414|NCT04356573|540461545|FG000|Overall Study|Didn't Qualify|1|||
150160096|NCT00557505|541719637|FG000|Overall Study|Objective progression or relapse|2|||
149920184|NCT00948922|540841978|FG000|Overall Study|Death|3|||
149920185|NCT00948922|540841979|FG001|Overall Study|Death|0|||
149920186|NCT00948922|540841980|FG002|Overall Study|Death|0|||
149920187|NCT00948922|540841978|FG000|Overall Study|Disease progression|0|||
149920188|NCT00948922|540841979|FG001|Overall Study|Disease progression|1|||
149920189|NCT00948922|540841980|FG002|Overall Study|Disease progression|0|||
149920190|NCT00948922|540841978|FG000|Overall Study|Insurance issues|1|||
149920191|NCT00948922|540841979|FG001|Overall Study|Insurance issues|0|||
149920192|NCT00948922|540841980|FG002|Overall Study|Insurance issues|0|||
150160097|NCT00557505|541719638|FG001|Overall Study|Objective progression or relapse|3|||
150160098|NCT00557505|541719639|FG002|Overall Study|Objective progression or relapse|3|||
150160099|NCT00557505|541719640|FG003|Overall Study|Objective progression or relapse|2|||
150160100|NCT00557505|541719641|FG004|Overall Study|Objective progression or relapse|2|||
150160101|NCT00557505|541719642|FG005|Overall Study|Objective progression or relapse|3|||
150160102|NCT00557505|541719643|FG006|Overall Study|Objective progression or relapse|2|||
150160103|NCT00557505|541719644|FG007|Overall Study|Objective progression or relapse|5|||
150160104|NCT00557505|541719645|FG008|Overall Study|Objective progression or relapse|15|||
150160105|NCT00557505|541719637|FG000|Overall Study|Withdrawal by Subject|0|||
150160106|NCT00557505|541719638|FG001|Overall Study|Withdrawal by Subject|0|||
150160107|NCT00557505|541719639|FG002|Overall Study|Withdrawal by Subject|0|||
150160108|NCT00557505|541719640|FG003|Overall Study|Withdrawal by Subject|1|||
150160109|NCT00557505|541719641|FG004|Overall Study|Withdrawal by Subject|0|||
150160110|NCT00557505|541719642|FG005|Overall Study|Withdrawal by Subject|0|||
150160111|NCT00557505|541719643|FG006|Overall Study|Withdrawal by Subject|0|||
150160112|NCT00557505|541719644|FG007|Overall Study|Withdrawal by Subject|0|||
150160113|NCT00557505|541719645|FG008|Overall Study|Withdrawal by Subject|1|||
150160114|NCT00031447|541719646|FG000|Overall Study|Lost to Follow-up|0|||
150160115|NCT00031447|541719647|FG001|Overall Study|Lost to Follow-up|1|||
150160116|NCT00031447|541719646|FG000|Overall Study|Non-compliant|1|||
150160117|NCT00031447|541719647|FG001|Overall Study|Non-compliant|1|||
150160118|NCT00031447|541719646|FG000|Overall Study|Re-activation of Disease|2|||
150160119|NCT00031447|541719647|FG001|Overall Study|Re-activation of Disease|1|||
150160120|NCT00031447|541719646|FG000|Overall Study|Disruption of blinded study drug supply|7|||
150160121|NCT00031447|541719647|FG001|Overall Study|Disruption of blinded study drug supply|4|||
150160122|NCT01636362|541719648|FG000|Overall Study|Physician Decision|6|||
150160123|NCT01636362|541719648|FG000|Overall Study|Subject healed, not returning|1|||
150160124|NCT01636362|541719648|FG000|Overall Study|Withdrawal by Subject|1|||
150160125|NCT00519779|541719649|FG000|Overall Study|Withdrawal by Subject|0|||
150160126|NCT00519779|541719650|FG001|Overall Study|Withdrawal by Subject|1|||
150160127|NCT03330119|541719651|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
150160128|NCT03330119|541719652|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
150160129|NCT01561079|541719653|FG000|Overall Study|Physician Decision|17|||
150160130|NCT01561079|541719653|FG000|Overall Study|Withdrawal by Subject|59|||
150160131|NCT01561079|541719653|FG000|Overall Study|Protocol Violation|2|||
150160132|NCT00664521|541719656|FG000|Overall Study|Adverse Event|4|||
150160133|NCT00664521|541719657|FG001|Overall Study|Adverse Event|1|||
150160134|NCT00664521|541719656|FG000|Overall Study|Lost to Follow-up|1|||
150160135|NCT00664521|541719657|FG001|Overall Study|Lost to Follow-up|0|||
150160136|NCT00664521|541719656|FG000|Overall Study|Other|1|||
150160137|NCT00664521|541719657|FG001|Overall Study|Other|0|||
150160138|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
150160139|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
150160140|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
150160141|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
150160142|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
150160143|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
150160144|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
150160145|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
150160146|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
150160147|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
150160148|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
150160149|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
150160150|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
150160151|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
150160152|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
150160153|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
150160154|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
150160155|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
150160156|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
150160157|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149920193|NCT00948922|540841978|FG000|Overall Study|Transplant eligibility issues|2|||
149920194|NCT00948922|540841979|FG001|Overall Study|Transplant eligibility issues|3|||
150160158|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
150259750|NCT02325557|542087213|FG001|Overall Study|Withdrawal by Subject|0|||
150259751|NCT02325557|542087214|FG002|Overall Study|Withdrawal by Subject|0|||
150259752|NCT02325557|542087215|FG003|Overall Study|Withdrawal by Subject|15|||
150259753|NCT02325557|542087212|FG000|Overall Study|Death|5|||
150259754|NCT02325557|542087213|FG001|Overall Study|Death|1|||
150259755|NCT02325557|542087214|FG002|Overall Study|Death|1|||
150259756|NCT02325557|542087215|FG003|Overall Study|Death|16|||
150259757|NCT02325557|542087212|FG000|Overall Study|Lost to Follow-up|0|||
150259758|NCT02325557|542087213|FG001|Overall Study|Lost to Follow-up|0|||
150259759|NCT02325557|542087214|FG002|Overall Study|Lost to Follow-up|1|||
150259760|NCT02325557|542087215|FG003|Overall Study|Lost to Follow-up|1|||
150259761|NCT02325557|542087212|FG000|Overall Study|Other|0|||
150259762|NCT02325557|542087213|FG001|Overall Study|Other|0|||
150259763|NCT02325557|542087214|FG002|Overall Study|Other|0|||
150259764|NCT02325557|542087215|FG003|Overall Study|Other|5|||
150259765|NCT01502631|542087216|FG000|Overall Study|Adverse Event|5|||
150259766|NCT01502631|542087217|FG001|Overall Study|Adverse Event|8|||
150259767|NCT01502631|542087216|FG000|Overall Study|Lost to Follow-up|2|||
150259768|NCT01502631|542087217|FG001|Overall Study|Lost to Follow-up|2|||
150259769|NCT01502631|542087216|FG000|Overall Study|Participant withdrew consent|2|||
150259770|NCT01502631|542087217|FG001|Overall Study|Participant withdrew consent|4|||
150259771|NCT01502631|542087216|FG000|Overall Study|Participant non-compliant|1|||
150259772|NCT01502631|542087217|FG001|Overall Study|Participant non-compliant|0|||
150259773|NCT01502631|542087216|FG000|Overall Study|Investigator's decision|0|||
150259774|NCT01502631|542087217|FG001|Overall Study|Investigator's decision|1|||
150259775|NCT01502631|542087216|FG000|Overall Study|Other|10|||
150259776|NCT01502631|542087217|FG001|Overall Study|Other|5|||
150259777|NCT01488487|542087220|FG000|Overall Study|Adverse Event|6|||
150259778|NCT01488487|542087220|FG000|Overall Study|Death|1|||
149817415|NCT04356573|540461546|FG001|Overall Study|Didn't Qualify|0|||
149817416|NCT01170364|540461550|FG000|Overall Study|Protocol Violation|4|||
149817417|NCT01170364|540461551|FG001|Overall Study|Protocol Violation|1|||
149817418|NCT04132232|540461552|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
149817419|NCT04132232|540461553|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
149817420|NCT04132232|540461552|FG000|Overall Study|Lost to Follow-up|6|||
149817421|NCT04132232|540461553|FG001|Overall Study|Lost to Follow-up|7|||
149817422|NCT01717456|540461554|FG000|End of Treatment|Physician Decision|0|||
149817423|NCT01717456|540461555|FG001|End of Treatment|Physician Decision|1|||
149817424|NCT01717456|540461554|FG000|End of Treatment|Lost to Follow-up|0|||
149817425|NCT01717456|540461555|FG001|End of Treatment|Lost to Follow-up|1|||
149817426|NCT01717456|540461554|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
149817427|NCT01717456|540461555|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
149817428|NCT00986154|540461556|FG000|Overall Study|Death|136|||
149817429|NCT00986154|540461557|FG001|Overall Study|Death|127|||
149817430|NCT00986154|540461556|FG000|Overall Study|Lost to Follow-up|7|||
149817431|NCT00986154|540461557|FG001|Overall Study|Lost to Follow-up|4|||
149817432|NCT00986154|540461556|FG000|Overall Study|Withdrawal by Subject|32|||
149817433|NCT00986154|540461557|FG001|Overall Study|Withdrawal by Subject|33|||
149817434|NCT00986154|540461556|FG000|Overall Study|investigator/subject decide not continue|6|||
149817435|NCT00986154|540461557|FG001|Overall Study|investigator/subject decide not continue|3|||
149817436|NCT00986154|540461556|FG000|Overall Study|never received study drug|25|||
149817437|NCT00986154|540461557|FG001|Overall Study|never received study drug|27|||
149817438|NCT03726437|540461558|FG000|Overall Study|Lost to Follow-up|85|||
149817439|NCT03726437|540461559|FG001|Overall Study|Lost to Follow-up|76|||
149817440|NCT00267007|540461561|FG000|Overall Study|Withdrawal by Subject|6|||
149817441|NCT00267007|540461562|FG001|Overall Study|Withdrawal by Subject|0|||
149817442|NCT00267007|540461561|FG000|Overall Study|Lost to Follow-up|1|||
149817443|NCT00267007|540461562|FG001|Overall Study|Lost to Follow-up|0|||
149817444|NCT00267007|540461561|FG000|Overall Study|Non-compliance|0|||
149817445|NCT00267007|540461562|FG001|Overall Study|Non-compliance|1|||
149817446|NCT00267007|540461561|FG000|Overall Study|Adverse Event|1|||
150259779|NCT01488487|542087220|FG000|Overall Study|Withdrawal by Subject|2|||
150259780|NCT00395460|542087221|FG000|Overall Study|Withdrawal by Subject|1|||
150259781|NCT00395460|542087222|FG001|Overall Study|Withdrawal by Subject|0|||
150259782|NCT02319525|542087227|FG000|Overall Study|Withdrawal by Subject|2|||
150259783|NCT02319525|542087228|FG001|Overall Study|Withdrawal by Subject|1|||
150259784|NCT01200589|542087230|FG000|Overall Study|Withdrawal by Subject|13|||
150259785|NCT01200589|542087231|FG001|Overall Study|Withdrawal by Subject|11|||
150259786|NCT01200589|542087230|FG000|Overall Study|Physician Decision|2|||
150259787|NCT01200589|542087231|FG001|Overall Study|Physician Decision|2|||
149817447|NCT00267007|540461562|FG001|Overall Study|Adverse Event|0|||
149817448|NCT01252238|540461567|FG000|Overall Study|Sponsor terminated study|4|||
149817449|NCT01252238|540461568|FG001|Overall Study|Sponsor terminated study|4|||
149817450|NCT01252238|540461569|FG002|Overall Study|Sponsor terminated study|4|||
149817451|NCT00068237|540461570|FG000|Overall Study|Ineligible|3|||
149817452|NCT00068237|540461570|FG000|Overall Study|No protocol treatment received|2|||
150259788|NCT01200589|542087230|FG000|Overall Study|Lost to Follow-up|5|||
150259789|NCT01200589|542087231|FG001|Overall Study|Lost to Follow-up|4|||
149920195|NCT00948922|540841980|FG002|Overall Study|Transplant eligibility issues|0|||
149920196|NCT00948922|540841978|FG000|Overall Study|Not evaluable at time of analysis|0|||
149920197|NCT00948922|540841979|FG001|Overall Study|Not evaluable at time of analysis|3|||
149920198|NCT00948922|540841980|FG002|Overall Study|Not evaluable at time of analysis|0|||
149920199|NCT02734862|540841981|FG000|Part A|Death|3|||
149920200|NCT02734862|540841982|FG001|Part A|Death|4|||
149920201|NCT02734862|540841983|FG002|Part A|Death|6|||
149920202|NCT02734862|540841981|FG000|Part A|Lost to Follow-up|2|||
149920203|NCT02734862|540841982|FG001|Part A|Lost to Follow-up|1|||
149920204|NCT02734862|540841983|FG002|Part A|Lost to Follow-up|1|||
149920205|NCT02734862|540841981|FG000|Part A|Withdrawal by Subject|1|||
149920206|NCT02734862|540841982|FG001|Part A|Withdrawal by Subject|1|||
149920207|NCT02734862|540841983|FG002|Part A|Withdrawal by Subject|2|||
149920208|NCT02734862|540841981|FG000|Part A|Physician Decision|2|||
149920209|NCT02734862|540841982|FG001|Part A|Physician Decision|0|||
149920210|NCT02734862|540841983|FG002|Part A|Physician Decision|1|||
149920211|NCT02734862|540841981|FG000|Part A|Adverse Event|2|||
149920212|NCT02734862|540841982|FG001|Part A|Adverse Event|0|||
149920213|NCT02734862|540841983|FG002|Part A|Adverse Event|1|||
149920214|NCT02734862|540841981|FG000|Part A|Noncompliance|1|||
149920215|NCT02734862|540841982|FG001|Part A|Noncompliance|1|||
149920216|NCT02734862|540841983|FG002|Part A|Noncompliance|0|||
149920217|NCT02734862|540841981|FG000|Part A|Other|1|||
149920218|NCT02734862|540841982|FG001|Part A|Other|1|||
149920219|NCT02734862|540841983|FG002|Part A|Other|3|||
149920220|NCT02734862|540841981|FG000|Part B|Death|8|||
149920221|NCT02734862|540841982|FG001|Part B|Death|3|||
149920222|NCT02734862|540841983|FG002|Part B|Death|5|||
149920223|NCT02734862|540841981|FG000|Part B|Lost to Follow-up|2|||
149920224|NCT02734862|540841982|FG001|Part B|Lost to Follow-up|2|||
149920225|NCT02734862|540841983|FG002|Part B|Lost to Follow-up|0|||
149920226|NCT02734862|540841981|FG000|Part B|Withdrawal by Subject|3|||
149920227|NCT02734862|540841982|FG001|Part B|Withdrawal by Subject|1|||
149920228|NCT02734862|540841983|FG002|Part B|Withdrawal by Subject|0|||
149920229|NCT02734862|540841981|FG000|Part B|Other|0|||
149920230|NCT02734862|540841982|FG001|Part B|Other|1|||
149920231|NCT02734862|540841983|FG002|Part B|Other|0|||
149920232|NCT02700698|540841986|FG000|Overall Study|Withdrawal by Subject|1|||
149920233|NCT02700698|540841987|FG001|Overall Study|Withdrawal by Subject|0|||
149920234|NCT04165135|540841988|FG000|Overall Study|Protocol Violation|10|||
149920235|NCT04165135|540841988|FG000|Overall Study|Participants withdrawal of consent|5|||
149920236|NCT00530790|540841989|FG000|Overall Study|Adverse Event|2|||
149920237|NCT00530790|540841989|FG000|Overall Study|Withdrawal by Subject|2|||
149920238|NCT00530790|540841989|FG000|Overall Study|Physician Decision|1|||
149920239|NCT03760458|540842003|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
149920240|NCT03760458|540842004|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
149920241|NCT03760458|540842005|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
149920242|NCT03760458|540842006|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
149920243|NCT03760458|540842007|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
149920244|NCT01119846|540842010|FG000|Overall Study|Adverse Event|1|||
149920245|NCT01119846|540842011|FG001|Overall Study|Adverse Event|0|||
149920246|NCT01119846|540842012|FG002|Overall Study|Adverse Event|6|||
149920247|NCT01119846|540842010|FG000|Overall Study|Physician Decision|1|||
149920248|NCT01119846|540842011|FG001|Overall Study|Physician Decision|0|||
149920249|NCT01119846|540842012|FG002|Overall Study|Physician Decision|0|||
149920250|NCT01119846|540842010|FG000|Overall Study|Protocol Violation|0|||
149920251|NCT01119846|540842011|FG001|Overall Study|Protocol Violation|0|||
149920252|NCT01119846|540842012|FG002|Overall Study|Protocol Violation|1|||
149920253|NCT01119846|540842010|FG000|Overall Study|Withdrawal by Subject|0|||
149920254|NCT01119846|540842011|FG001|Overall Study|Withdrawal by Subject|0|||
149920255|NCT01119846|540842012|FG002|Overall Study|Withdrawal by Subject|4|||
149920256|NCT00048997|540842015|FG000|Overall Study|Protocol Violation|7|||
149920257|NCT00048997|540842016|FG001|Overall Study|Protocol Violation|2|||
149920258|NCT00048997|540842015|FG000|Overall Study|Withdrawal by Subject|6|||
149920259|NCT00048997|540842016|FG001|Overall Study|Withdrawal by Subject|1|||
149920260|NCT01404949|540842021|FG000|Overall Study|Not Treated|1|||
150259790|NCT01200589|542087230|FG000|Overall Study|Study terminated|170|||
149920261|NCT04527978|540842025|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
149920262|NCT04527978|540842026|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
149920263|NCT00055497|540842027|FG000|Overall Study|Adverse Event|1|||
149920264|NCT00055497|540842028|FG001|Overall Study|Adverse Event|1|||
149920265|NCT00055497|540842029|FG002|Overall Study|Adverse Event|1|||
149920266|NCT00055497|540842030|FG003|Overall Study|Adverse Event|28|||
149920267|NCT00055497|540842027|FG000|Overall Study|Withdrawal by Subject|3|||
149920268|NCT00055497|540842028|FG001|Overall Study|Withdrawal by Subject|1|||
149920269|NCT00055497|540842029|FG002|Overall Study|Withdrawal by Subject|1|||
149920270|NCT00055497|540842030|FG003|Overall Study|Withdrawal by Subject|15|||
149920271|NCT00055497|540842027|FG000|Overall Study|Lost to Follow-up|0|||
149920272|NCT00055497|540842028|FG001|Overall Study|Lost to Follow-up|1|||
149920273|NCT00055497|540842029|FG002|Overall Study|Lost to Follow-up|0|||
149920274|NCT00055497|540842030|FG003|Overall Study|Lost to Follow-up|5|||
150160159|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
150160160|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
150160161|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
150160162|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150160163|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150160164|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150160165|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150160166|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
150160167|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150160168|NCT01323660|541719658|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
150160169|NCT01323660|541719659|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
150160170|NCT01323660|541719660|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
150160171|NCT01323660|541719661|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
150160172|NCT01323660|541719662|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
150160173|NCT01323660|541719663|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
150160174|NCT01323660|541719658|FG000|Washout Period (14 Days)|Adverse Event|0|||
150160175|NCT01323660|541719659|FG001|Washout Period (14 Days)|Adverse Event|0|||
150160176|NCT01323660|541719660|FG002|Washout Period (14 Days)|Adverse Event|0|||
150160177|NCT01323660|541719661|FG003|Washout Period (14 Days)|Adverse Event|0|||
150160178|NCT01323660|541719662|FG004|Washout Period (14 Days)|Adverse Event|1|||
150160179|NCT01323660|541719663|FG005|Washout Period (14 Days)|Adverse Event|0|||
150160180|NCT01323660|541719658|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
150160181|NCT01323660|541719659|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
150160182|NCT01323660|541719660|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
150160183|NCT01323660|541719661|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
150160184|NCT01323660|541719662|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
150160185|NCT01323660|541719663|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
150160186|NCT01323660|541719658|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150160187|NCT01323660|541719659|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
150160188|NCT01323660|541719660|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
150160189|NCT01323660|541719661|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150160190|NCT01323660|541719662|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150160191|NCT01323660|541719663|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
150160192|NCT01323660|541719658|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
150160193|NCT01323660|541719659|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
150160194|NCT01323660|541719660|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
150160195|NCT01323660|541719661|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
150160196|NCT01323660|541719662|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
150160197|NCT01323660|541719663|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
150160198|NCT01323660|541719658|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
150160199|NCT01323660|541719659|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
150160200|NCT01323660|541719660|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
150160201|NCT01323660|541719661|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
150160202|NCT01323660|541719662|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
150160203|NCT01323660|541719663|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
150160204|NCT01323660|541719658|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
150160205|NCT01323660|541719659|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150160206|NCT01323660|541719660|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150160207|NCT01323660|541719661|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150160208|NCT01323660|541719662|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150160209|NCT01323660|541719663|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
150160210|NCT01323660|541719658|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150160211|NCT01323660|541719659|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150160212|NCT01323660|541719660|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149817453|NCT00990093|540461580|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
149817454|NCT00990093|540461581|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
149817455|NCT00990093|540461580|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
149817456|NCT00990093|540461581|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
149817457|NCT00990093|540461580|FG000|Test Period 1 (1-14 Days)|Other|1|||
149817458|NCT00990093|540461581|FG001|Test Period 1 (1-14 Days)|Other|0|||
149817459|NCT00990093|540461580|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
149817460|NCT00990093|540461581|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
149817461|NCT00990093|540461580|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
150160213|NCT01323660|541719661|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150160214|NCT01323660|541719662|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
150160215|NCT01323660|541719663|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150160216|NCT00751790|541719664|FG000|Overall Study|Lost to Follow-up|1|||
150160217|NCT00751790|541719664|FG000|Overall Study|Death|3|||
150160218|NCT00751790|541719664|FG000|Overall Study|Withdrawal by Subject|1|||
149817462|NCT00990093|540461581|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
150259791|NCT01200589|542087231|FG001|Overall Study|Study terminated|172|||
150259792|NCT01590082|542087232|FG000|Overall Study|Withdrawal by Subject|1|||
149920275|NCT00055497|540842027|FG000|Overall Study|Protocol Violation|0|||
149920276|NCT00055497|540842028|FG001|Overall Study|Protocol Violation|0|||
149920277|NCT00055497|540842029|FG002|Overall Study|Protocol Violation|0|||
150259793|NCT01590082|542087233|FG001|Overall Study|Withdrawal by Subject|0|||
150259794|NCT01590082|542087232|FG000|Overall Study|Ineligible|1|||
149920278|NCT00055497|540842030|FG003|Overall Study|Protocol Violation|3|||
149920279|NCT00055497|540842027|FG000|Overall Study|Lack of Efficacy|1|||
149920280|NCT00055497|540842028|FG001|Overall Study|Lack of Efficacy|0|||
149920281|NCT00055497|540842029|FG002|Overall Study|Lack of Efficacy|0|||
149920282|NCT00055497|540842030|FG003|Overall Study|Lack of Efficacy|27|||
149920283|NCT00055497|540842027|FG000|Overall Study|Administrative Reasons|0|||
149920284|NCT00055497|540842028|FG001|Overall Study|Administrative Reasons|0|||
149920285|NCT00055497|540842029|FG002|Overall Study|Administrative Reasons|0|||
149920286|NCT00055497|540842030|FG003|Overall Study|Administrative Reasons|1|||
149920287|NCT00055497|540842027|FG000|Overall Study|Other|0|||
149920288|NCT00055497|540842028|FG001|Overall Study|Other|0|||
149920289|NCT00055497|540842029|FG002|Overall Study|Other|0|||
149920290|NCT00055497|540842030|FG003|Overall Study|Other|11|||
149920291|NCT00048165|540842032|FG000|Completed 6 Months Study|Administration/Other|8|||
149920292|NCT00048165|540842033|FG001|Completed 6 Months Study|Administration/Other|8|||
149920293|NCT00048165|540842032|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
149920294|NCT00048165|540842033|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
149920295|NCT00048165|540842032|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
149920296|NCT00048165|540842033|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
149920297|NCT00048165|540842032|FG000|Completed 6 Months Study|Death|12|||
149920298|NCT00048165|540842033|FG001|Completed 6 Months Study|Death|6|||
149920299|NCT00048165|540842032|FG000|Completed 6 Months Study|Insufficient therapy|1|||
149920300|NCT00048165|540842033|FG001|Completed 6 Months Study|Insufficient therapy|4|||
149920301|NCT00048165|540842032|FG000|Completed 6 Months Study|Other violation|4|||
149920302|NCT00048165|540842033|FG001|Completed 6 Months Study|Other violation|6|||
149920303|NCT00048165|540842032|FG000|Completed 6 Months Study|Refused treatment|5|||
149920304|NCT00048165|540842033|FG001|Completed 6 Months Study|Refused treatment|5|||
149920305|NCT00048165|540842032|FG000|Completed 6 Months Study|Violation criteria|0|||
149920306|NCT00048165|540842033|FG001|Completed 6 Months Study|Violation criteria|2|||
149920307|NCT00048165|540842032|FG000|Completed 6 Months Study|Did not receive study drug|6|||
149920308|NCT00048165|540842033|FG001|Completed 6 Months Study|Did not receive study drug|6|||
149920309|NCT00048165|540842032|FG000|Completed 12 Months Study|Administration/Other|0|||
149920310|NCT00048165|540842033|FG001|Completed 12 Months Study|Administration/Other|2|||
149920311|NCT00048165|540842032|FG000|Completed 12 Months Study|Death|2|||
149920312|NCT00048165|540842033|FG001|Completed 12 Months Study|Death|1|||
149920313|NCT00048165|540842032|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
149920314|NCT00048165|540842033|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
149920315|NCT00731731|540842034|FG000|Overall Study|Protocol Violation|0|||
149920316|NCT00731731|540842035|FG001|Overall Study|Protocol Violation|0|||
149920317|NCT00731731|540842036|FG002|Overall Study|Protocol Violation|1|||
149920318|NCT00731731|540842034|FG000|Overall Study|Cancel prior to treatment|0|||
149920319|NCT00731731|540842035|FG001|Overall Study|Cancel prior to treatment|0|||
149920320|NCT00731731|540842036|FG002|Overall Study|Cancel prior to treatment|2|||
149920321|NCT02112877|540842037|FG000|Overall Study|Withdrawal by Subject|1|||
149920322|NCT02112877|540842038|FG001|Overall Study|Withdrawal by Subject|7|||
149920323|NCT02112877|540842037|FG000|Overall Study|Visit Missed|1|||
149920324|NCT02112877|540842038|FG001|Overall Study|Visit Missed|6|||
149920325|NCT01153009|540843337|FG000|Overall Study|Adverse Event|4|||
149920326|NCT01153009|540843338|FG001|Overall Study|Adverse Event|14|||
149920327|NCT01153009|540843339|FG002|Overall Study|Adverse Event|14|||
149920328|NCT01153009|540843340|FG003|Overall Study|Adverse Event|10|||
149920329|NCT01153009|540843337|FG000|Overall Study|Lack of Efficacy|9|||
149920330|NCT01153009|540843338|FG001|Overall Study|Lack of Efficacy|0|||
149920331|NCT01153009|540843339|FG002|Overall Study|Lack of Efficacy|2|||
150259795|NCT01590082|542087233|FG001|Overall Study|Ineligible|0|||
149920332|NCT01153009|540843340|FG003|Overall Study|Lack of Efficacy|1|||
149920333|NCT01153009|540843337|FG000|Overall Study|Noncompliance with Study Medication|1|||
150259796|NCT01853644|542087234|FG000|Registration and Treatment Start|Did not start treatment|1|||
150259797|NCT01853644|542087234|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
150259798|NCT01853644|542087234|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
149920334|NCT01153009|540843338|FG001|Overall Study|Noncompliance with Study Medication|3|||
149920335|NCT01153009|540843339|FG002|Overall Study|Noncompliance with Study Medication|4|||
149920336|NCT01153009|540843340|FG003|Overall Study|Noncompliance with Study Medication|1|||
149920337|NCT01153009|540843337|FG000|Overall Study|Protocol Deviations|4|||
149920338|NCT01153009|540843338|FG001|Overall Study|Protocol Deviations|3|||
149920339|NCT01153009|540843339|FG002|Overall Study|Protocol Deviations|3|||
149920340|NCT01153009|540843340|FG003|Overall Study|Protocol Deviations|2|||
149920341|NCT01153009|540843337|FG000|Overall Study|Withdrawal of Consent|5|||
149920342|NCT01153009|540843338|FG001|Overall Study|Withdrawal of Consent|5|||
150259799|NCT01853644|542087234|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
150259800|NCT01853644|542087234|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
150259801|NCT01853644|542087234|FG000|Continued Treatment After First Response|Adverse Event|2|||
150259802|NCT01853644|542087234|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
150259803|NCT02891408|542087235|FG000|Overall Study|Lost to Follow-up|0|||
150259804|NCT02891408|542087236|FG001|Overall Study|Lost to Follow-up|0|||
150259805|NCT02891408|542087237|FG002|Overall Study|Lost to Follow-up|1|||
150259806|NCT02891408|542087238|FG003|Overall Study|Lost to Follow-up|0|||
149920343|NCT01153009|540843339|FG002|Overall Study|Withdrawal of Consent|4|||
149920344|NCT01153009|540843340|FG003|Overall Study|Withdrawal of Consent|6|||
149920345|NCT01153009|540843337|FG000|Overall Study|Lost to Follow-up|8|||
149920346|NCT01153009|540843338|FG001|Overall Study|Lost to Follow-up|8|||
149920347|NCT01153009|540843339|FG002|Overall Study|Lost to Follow-up|11|||
149920348|NCT01153009|540843340|FG003|Overall Study|Lost to Follow-up|15|||
149920349|NCT01153009|540843337|FG000|Overall Study|Other|1|||
149920350|NCT01153009|540843338|FG001|Overall Study|Other|1|||
149920351|NCT01153009|540843339|FG002|Overall Study|Other|3|||
149920352|NCT01153009|540843340|FG003|Overall Study|Other|2|||
149920353|NCT00410072|540843341|FG000|Day 1 to Week 48|Adverse Event|1|||
149920354|NCT00410072|540843342|FG001|Day 1 to Week 48|Adverse Event|2|||
149920355|NCT00410072|540843341|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
149920356|NCT00410072|540843342|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
149920357|NCT00410072|540843341|FG000|Day 1 to Week 48|Other|0|||
149920358|NCT00410072|540843342|FG001|Day 1 to Week 48|Other|1|||
149920359|NCT00410072|540843341|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
149920360|NCT00410072|540843342|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
149920361|NCT00410072|540843341|FG000|Day 1 to Week 48|Pregnancy|0|||
149920362|NCT00410072|540843342|FG001|Day 1 to Week 48|Pregnancy|2|||
149920363|NCT00410072|540843341|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
149920364|NCT00410072|540843342|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
149920365|NCT00410072|540843341|FG000|After Week 48 to Week 96|Adverse Event|1|||
149920366|NCT00410072|540843342|FG001|After Week 48 to Week 96|Adverse Event|2|||
149920367|NCT00410072|540843341|FG000|After Week 48 to Week 96|Death|0|||
149920368|NCT00410072|540843342|FG001|After Week 48 to Week 96|Death|1|||
149920369|NCT00410072|540843341|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
149920370|NCT00410072|540843342|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
149920371|NCT00410072|540843341|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
149920372|NCT00410072|540843342|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
149920373|NCT00410072|540843341|FG000|After Week 48 to Week 96|Other|2|||
149920374|NCT00410072|540843342|FG001|After Week 48 to Week 96|Other|0|||
149920375|NCT00410072|540843341|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
149920376|NCT00410072|540843342|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
149920377|NCT00410072|540843341|FG000|After Week 48 to Week 96|Pregnancy|0|||
149920378|NCT00410072|540843342|FG001|After Week 48 to Week 96|Pregnancy|2|||
149920379|NCT00410072|540843341|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
149920380|NCT00410072|540843342|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
149920381|NCT01212159|540843345|FG000|Overall Study|Withdrawal by Subject|12|||
149920382|NCT01212159|540843346|FG001|Overall Study|Withdrawal by Subject|12|||
149920383|NCT01641471|540843347|FG000|Overall Study|Withdrawal by Subject|19|||
149920384|NCT01641471|540843348|FG001|Overall Study|Withdrawal by Subject|19|||
149920385|NCT01641471|540843347|FG000|Overall Study|Lost to Follow-up|2|||
149920386|NCT01641471|540843348|FG001|Overall Study|Lost to Follow-up|4|||
149920387|NCT01641471|540843347|FG000|Overall Study|Protocol Violation|2|||
149920388|NCT01641471|540843348|FG001|Overall Study|Protocol Violation|4|||
149920389|NCT02784288|540843349|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
149920390|NCT02757625|540843350|FG000|Overall Study|Investigator's discretion|0|||
149920391|NCT02757625|540843351|FG001|Overall Study|Investigator's discretion|0|||
149920392|NCT02757625|540843352|FG002|Overall Study|Investigator's discretion|1|||
149920393|NCT02757625|540843353|FG003|Overall Study|Investigator's discretion|0|||
149920394|NCT02757625|540843350|FG000|Overall Study|Adverse Event|0|||
149920395|NCT02757625|540843351|FG001|Overall Study|Adverse Event|0|||
149920396|NCT02757625|540843352|FG002|Overall Study|Adverse Event|1|||
149920397|NCT02757625|540843353|FG003|Overall Study|Adverse Event|0|||
149920398|NCT02131233|540843354|FG000|Overall Study|Not Treated|2|||
149920399|NCT02131233|540843355|FG001|Overall Study|Not Treated|3|||
149920400|NCT02131233|540843354|FG000|Overall Study|Adverse Event|7|||
150259807|NCT02891408|542087239|FG004|Overall Study|Lost to Follow-up|0|||
150259808|NCT02891408|542087240|FG005|Overall Study|Lost to Follow-up|0|||
150259809|NCT02891408|542087241|FG006|Overall Study|Lost to Follow-up|0|||
150259810|NCT00185965|542087242|FG000|Overall Study|Adverse Event|0|||
149920401|NCT02131233|540843355|FG001|Overall Study|Adverse Event|6|||
149920402|NCT02131233|540843354|FG000|Overall Study|Death|0|||
149920403|NCT02131233|540843355|FG001|Overall Study|Death|1|||
149920404|NCT02131233|540843354|FG000|Overall Study|Lack of Efficacy|6|||
149920405|NCT02131233|540843355|FG001|Overall Study|Lack of Efficacy|3|||
149920406|NCT02131233|540843354|FG000|Overall Study|Lost to Follow-up|14|||
149920407|NCT02131233|540843355|FG001|Overall Study|Lost to Follow-up|13|||
149920408|NCT02131233|540843354|FG000|Overall Study|Non-Compliance With Study Drug|8|||
149920409|NCT02131233|540843355|FG001|Overall Study|Non-Compliance With Study Drug|5|||
149920410|NCT02131233|540843354|FG000|Overall Study|Physician Decision|7|||
149920411|NCT02131233|540843355|FG001|Overall Study|Physician Decision|0|||
149920412|NCT02131233|540843354|FG000|Overall Study|Pregnancy|4|||
149920413|NCT02131233|540843355|FG001|Overall Study|Pregnancy|0|||
149920414|NCT02131233|540843354|FG000|Overall Study|Withdrawal by Subject|18|||
149920415|NCT02131233|540843355|FG001|Overall Study|Withdrawal by Subject|11|||
149920416|NCT00645671|540843356|FG000|Overall Study|Protocol Violation|1|||
149920417|NCT00645671|540843357|FG001|Overall Study|Protocol Violation|0|||
149920418|NCT00645671|540843356|FG000|Overall Study|Withdrawal by Subject|0|||
149920419|NCT00645671|540843357|FG001|Overall Study|Withdrawal by Subject|4|||
149920420|NCT00645671|540843356|FG000|Overall Study|Adverse Event|0|||
149920421|NCT00645671|540843357|FG001|Overall Study|Adverse Event|1|||
149920422|NCT00645671|540843356|FG000|Overall Study|Physician Decision|0|||
149920423|NCT00645671|540843357|FG001|Overall Study|Physician Decision|1|||
149920424|NCT02095197|540843358|FG000|Overall Study|Lost to Follow-up|0|||
149920425|NCT02095197|540843359|FG001|Overall Study|Lost to Follow-up|3|||
149920426|NCT05114564|540843360|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
149920427|NCT05114564|540843361|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
149920428|NCT05114564|540843360|FG000|First Intervention|Adverse Event|0|||
149920429|NCT05114564|540843361|FG001|First Intervention|Adverse Event|1|||
149920430|NCT00493311|540843362|FG000|Overall Study|Need for rescue medication|2|||
149920431|NCT00493311|540843363|FG001|Overall Study|Need for rescue medication|2|||
149920432|NCT02779075|540843364|FG000|Overall Study|Withdrawal by Subject|1|||
149920433|NCT02779075|540843365|FG001|Overall Study|Withdrawal by Subject|3|||
149920434|NCT02779075|540843364|FG000|Overall Study|IV lost during 2nd study|1|||
149920435|NCT02779075|540843365|FG001|Overall Study|IV lost during 2nd study|0|||
149920436|NCT00790556|540843366|FG000|Treatment Period 1|Physician Decision|1|||
149920437|NCT00790556|540843367|FG001|Treatment Period 1|Physician Decision|0|||
149920438|NCT00790556|540843366|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149920439|NCT00790556|540843367|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149920440|NCT00255840|540843368|FG000|Overall Study|Lost to Follow-up|10|||
149920441|NCT00255840|540843369|FG001|Overall Study|Lost to Follow-up|14|||
149920442|NCT00255840|540843368|FG000|Overall Study|Discontinued intervention|53|||
149920443|NCT00255840|540843369|FG001|Overall Study|Discontinued intervention|56|||
149920444|NCT00339833|540843372|FG000|Overall Study|Withdrawal by Subject|1|||
149920445|NCT00339833|540843373|FG001|Overall Study|Withdrawal by Subject|2|||
150160219|NCT01106976|541719668|FG000|Overall Study|Lost to Follow-up|8|||
150160220|NCT03836664|541719679|FG000|Overall Study|Didn't complete forms and lost drug|3|||
150160221|NCT03836664|541719680|FG001|Overall Study|Didn't complete forms and lost drug|3|||
150160222|NCT03566680|541719681|FG000|Overall Study|Pregnancy|1|||
150160223|NCT03566680|541719681|FG000|Overall Study|Lost to Follow-up|13|||
150160224|NCT03566680|541719681|FG000|Overall Study|Withdrawal by Subject|3|||
150160225|NCT02724020|541719682|FG000|Overall Study|Death|16|||
150160226|NCT02724020|541719683|FG001|Overall Study|Death|18|||
150160227|NCT02724020|541719684|FG002|Overall Study|Death|19|||
150160228|NCT02724020|541719682|FG000|Overall Study|Lost to Follow-up|0|||
150160229|NCT02724020|541719683|FG001|Overall Study|Lost to Follow-up|3|||
150160230|NCT02724020|541719684|FG002|Overall Study|Lost to Follow-up|0|||
150160231|NCT02724020|541719682|FG000|Overall Study|Site Terminated by Sponsor|15|||
150160232|NCT02724020|541719683|FG001|Overall Study|Site Terminated by Sponsor|8|||
150160233|NCT02724020|541719684|FG002|Overall Study|Site Terminated by Sponsor|8|||
150160234|NCT02724020|541719682|FG000|Overall Study|Withdrawal by Subject|1|||
150160235|NCT02724020|541719683|FG001|Overall Study|Withdrawal by Subject|3|||
150160236|NCT02724020|541719684|FG002|Overall Study|Withdrawal by Subject|5|||
150160237|NCT00425503|541719685|FG000|Overall Study|Adverse Event|2|||
150259811|NCT00185965|542087243|FG001|Overall Study|Adverse Event|1|||
149920446|NCT00339833|540843372|FG000|Overall Study|toothache|0|||
149920447|NCT00339833|540843373|FG001|Overall Study|toothache|1|||
149920448|NCT00339833|540843372|FG000|Overall Study|indigestion|0|||
149920449|NCT00339833|540843373|FG001|Overall Study|indigestion|1|||
149920450|NCT00339833|540843372|FG000|Overall Study|Chest pain|0|||
149920451|NCT00339833|540843373|FG001|Overall Study|Chest pain|1|||
149920452|NCT00339833|540843372|FG000|Overall Study|minor infection|0|||
149920453|NCT00339833|540843373|FG001|Overall Study|minor infection|1|||
149920454|NCT00339833|540843372|FG000|Overall Study|Poor venous access|2|||
149920455|NCT00339833|540843373|FG001|Overall Study|Poor venous access|2|||
150160238|NCT00425503|541719685|FG000|Overall Study|Protocol Violation|1|||
150160239|NCT02179918|541719686|FG000|Overall Study|Death|0|||
150160240|NCT02179918|541719687|FG001|Overall Study|Death|0|||
150160241|NCT02179918|541719688|FG002|Overall Study|Death|0|||
150160242|NCT02179918|541719689|FG003|Overall Study|Death|1|||
150160243|NCT02179918|541719690|FG004|Overall Study|Death|0|||
150160244|NCT02179918|541719686|FG000|Overall Study|Lost to Follow-up|0|||
150160245|NCT02179918|541719687|FG001|Overall Study|Lost to Follow-up|0|||
150160246|NCT02179918|541719688|FG002|Overall Study|Lost to Follow-up|1|||
150160247|NCT02179918|541719689|FG003|Overall Study|Lost to Follow-up|0|||
149920456|NCT00339833|540843372|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
149920457|NCT00339833|540843373|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
149920458|NCT00339833|540843372|FG000|Overall Study|Error in data records|1|||
149920459|NCT00339833|540843373|FG001|Overall Study|Error in data records|0|||
149920460|NCT02829047|540843374|FG000|Overall Study|Withdrawal by Subject|1|||
149920461|NCT01005901|540843376|FG000|Overall Study|Withdrawal by Subject|38|||
149920462|NCT01005901|540843377|FG001|Overall Study|Withdrawal by Subject|14|||
149920463|NCT01005901|540843376|FG000|Overall Study|Adverse Event|30|||
149920464|NCT01005901|540843377|FG001|Overall Study|Adverse Event|16|||
149920465|NCT01005901|540843376|FG000|Overall Study|Administrative problems|21|||
149920466|NCT01005901|540843377|FG001|Overall Study|Administrative problems|13|||
149920467|NCT01005901|540843376|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
149920468|NCT01005901|540843377|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
149920469|NCT01005901|540843376|FG000|Overall Study|Protocol Violation|4|||
149920470|NCT01005901|540843377|FG001|Overall Study|Protocol Violation|3|||
149920471|NCT01005901|540843376|FG000|Overall Study|Death|2|||
149920472|NCT01005901|540843377|FG001|Overall Study|Death|3|||
149920473|NCT01005901|540843376|FG000|Overall Study|Lost to Follow-up|1|||
149920474|NCT01005901|540843377|FG001|Overall Study|Lost to Follow-up|2|||
149920475|NCT01005901|540843376|FG000|Overall Study|Patient's inability to use the device|1|||
149920476|NCT01005901|540843377|FG001|Overall Study|Patient's inability to use the device|1|||
149920477|NCT01005901|540843376|FG000|Overall Study|No longer requires study drug|0|||
149920478|NCT01005901|540843377|FG001|Overall Study|No longer requires study drug|1|||
149920479|NCT01597492|540843378|FG000|Overall Study|Withdrawal by Subject|1|||
149920480|NCT01597492|540843379|FG001|Overall Study|Withdrawal by Subject|2|||
149920481|NCT01597492|540843378|FG000|Overall Study|Adverse Event|3|||
149920482|NCT01597492|540843379|FG001|Overall Study|Adverse Event|0|||
149920483|NCT01597492|540843378|FG000|Overall Study|Lost to Follow-up|0|||
149920484|NCT01597492|540843379|FG001|Overall Study|Lost to Follow-up|2|||
149920485|NCT01597492|540843378|FG000|Overall Study|Other Reason|2|||
149920486|NCT01597492|540843379|FG001|Overall Study|Other Reason|0|||
149920487|NCT00162097|540843380|FG000|Overall Study|Participant no longer met study criteria|0|||
149920488|NCT00162097|540843381|FG001|Overall Study|Participant no longer met study criteria|0|||
149920489|NCT00162097|540843382|FG002|Overall Study|Participant no longer met study criteria|0|||
149920490|NCT00162097|540843383|FG003|Overall Study|Participant no longer met study criteria|1|||
149920491|NCT01204918|540843384|FG000|Overall Study|Withdrawal by Subject|4|||
149920492|NCT01204918|540843385|FG001|Overall Study|Withdrawal by Subject|10|||
149920493|NCT01204918|540843386|FG002|Overall Study|Withdrawal by Subject|5|||
149920494|NCT03517449|540843391|FG000|Overall Study|Death|184|||
149920495|NCT03517449|540843392|FG001|Overall Study|Death|236|||
149920496|NCT03517449|540843391|FG000|Overall Study|Lost to Follow-up|0|||
149920497|NCT03517449|540843392|FG001|Overall Study|Lost to Follow-up|2|||
149920498|NCT03517449|540843391|FG000|Overall Study|Withdrawal by Subject|7|||
149920499|NCT03517449|540843392|FG001|Overall Study|Withdrawal by Subject|26|||
150160248|NCT02179918|541719690|FG004|Overall Study|Lost to Follow-up|0|||
150160249|NCT02179918|541719686|FG000|Overall Study|Progressive Disease|4|||
150160250|NCT02179918|541719687|FG001|Overall Study|Progressive Disease|1|||
150160251|NCT02179918|541719688|FG002|Overall Study|Progressive Disease|1|||
150160252|NCT02179918|541719689|FG003|Overall Study|Progressive Disease|2|||
150160253|NCT02179918|541719690|FG004|Overall Study|Progressive Disease|6|||
150160254|NCT02179918|541719686|FG000|Overall Study|Other|0|||
150160255|NCT02179918|541719687|FG001|Overall Study|Other|1|||
150160256|NCT02179918|541719688|FG002|Overall Study|Other|0|||
150160257|NCT02179918|541719689|FG003|Overall Study|Other|0|||
150160258|NCT02179918|541719690|FG004|Overall Study|Other|1|||
150160259|NCT02179918|541719686|FG000|Overall Study|Subject refused further follow-up|0|||
150160260|NCT02179918|541719687|FG001|Overall Study|Subject refused further follow-up|1|||
150160261|NCT02179918|541719688|FG002|Overall Study|Subject refused further follow-up|0|||
150160262|NCT02179918|541719689|FG003|Overall Study|Subject refused further follow-up|0|||
150160263|NCT02179918|541719690|FG004|Overall Study|Subject refused further follow-up|1|||
150160264|NCT02118714|541719695|FG000|Overall Study|Lost to Follow-up|2|||
150160265|NCT02118714|541719695|FG000|Overall Study|Protocol Violation|1|||
149920500|NCT03517449|540843391|FG000|Overall Study|Participants Ongoing|220|||
149920501|NCT03517449|540843392|FG001|Overall Study|Participants Ongoing|152|||
149920502|NCT01280682|540843397|FG000|Overall Study|Lost to Follow-up|0|||
149920503|NCT01280682|540843398|FG001|Overall Study|Lost to Follow-up|6|||
149920504|NCT01280682|540843397|FG000|Overall Study|Withdrawal by Subject|0|||
149920505|NCT01280682|540843398|FG001|Overall Study|Withdrawal by Subject|7|||
149920506|NCT00269477|540843407|FG000|Overall Study|Protocol Violation|5|||
149920507|NCT00269477|540843408|FG001|Overall Study|Protocol Violation|5|||
149920508|NCT00269477|540843409|FG002|Overall Study|Protocol Violation|1|||
149920509|NCT00269477|540843410|FG003|Overall Study|Protocol Violation|0|||
150160266|NCT02954575|541719696|FG000|Overall Study|Withdrawal by Subject|2|||
150160267|NCT02954575|541719696|FG000|Overall Study|Adverse Event|1|||
150160268|NCT00570661|541719698|FG000|Overall Study|Disease worsening|5|||
150160269|NCT00570661|541719698|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
150160270|NCT00570661|541719698|FG000|Overall Study|Adverse Event|1|||
149920510|NCT00269477|540843407|FG000|Overall Study|Missed post-vaccination blood draw|0|||
149920511|NCT00269477|540843408|FG001|Overall Study|Missed post-vaccination blood draw|1|||
149920512|NCT00269477|540843409|FG002|Overall Study|Missed post-vaccination blood draw|0|||
149920513|NCT00269477|540843410|FG003|Overall Study|Missed post-vaccination blood draw|0|||
149920514|NCT00431067|540843411|FG000|Overall Study|Other Adverse Event|9|||
149920515|NCT00431067|540843411|FG000|Overall Study|Progressive disease|30|||
149920516|NCT00431067|540843411|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
149920517|NCT00938587|540843412|FG000|Overall Study|Adverse Event|2|||
149920518|NCT00938587|540843413|FG001|Overall Study|Adverse Event|0|||
149920519|NCT00938587|540843414|FG002|Overall Study|Adverse Event|0|||
149920520|NCT00938587|540843415|FG003|Overall Study|Adverse Event|2|||
149920521|NCT00938587|540843412|FG000|Overall Study|Did not meet entrance criteria|0|||
149920522|NCT00938587|540843413|FG001|Overall Study|Did not meet entrance criteria|0|||
149920523|NCT00938587|540843414|FG002|Overall Study|Did not meet entrance criteria|1|||
149920524|NCT00938587|540843415|FG003|Overall Study|Did not meet entrance criteria|0|||
149920525|NCT00938587|540843412|FG000|Overall Study|Withdrawal by Subject|1|||
149920526|NCT00938587|540843413|FG001|Overall Study|Withdrawal by Subject|1|||
149920527|NCT00938587|540843414|FG002|Overall Study|Withdrawal by Subject|0|||
149920528|NCT00938587|540843415|FG003|Overall Study|Withdrawal by Subject|0|||
149920529|NCT00849290|540843416|FG000|Overall Study|Adverse Event|3|||
149920530|NCT00849290|540843416|FG000|Overall Study|Death|14|||
149920531|NCT00849290|540843416|FG000|Overall Study|Withdrawal by Subject|11|||
149920532|NCT00849290|540843416|FG000|Overall Study|Lost to Follow-up|2|||
149920533|NCT00849290|540843416|FG000|Overall Study|Protocol Violation|5|||
149920534|NCT00849290|540843416|FG000|Overall Study|Disease Progression|20|||
149920535|NCT00548249|540843417|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
149920536|NCT00548249|540843418|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
149920537|NCT00548249|540843419|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
149920538|NCT00548249|540843420|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
149920539|NCT00548249|540843421|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
149920540|NCT00548249|540843417|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
149920541|NCT00548249|540843418|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
149920542|NCT00548249|540843419|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
149920543|NCT00548249|540843420|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
149920544|NCT00548249|540843421|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
149920545|NCT00548249|540843417|FG000|Overall Study|Protocol Violation|1|||
149920546|NCT00548249|540843418|FG001|Overall Study|Protocol Violation|1|||
149920547|NCT00548249|540843419|FG002|Overall Study|Protocol Violation|4|||
149920548|NCT00548249|540843420|FG003|Overall Study|Protocol Violation|0|||
149920549|NCT00548249|540843421|FG004|Overall Study|Protocol Violation|3|||
149920550|NCT00548249|540843417|FG000|Overall Study|Miscellaneous|2|||
149920551|NCT00548249|540843418|FG001|Overall Study|Miscellaneous|3|||
149920552|NCT00548249|540843419|FG002|Overall Study|Miscellaneous|2|||
149920553|NCT00548249|540843420|FG003|Overall Study|Miscellaneous|0|||
149920554|NCT00548249|540843421|FG004|Overall Study|Miscellaneous|2|||
149920555|NCT00548249|540843417|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
149920556|NCT00548249|540843418|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
149920557|NCT00548249|540843419|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
149920558|NCT00548249|540843420|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
149920559|NCT00548249|540843421|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
149920560|NCT00548249|540843417|FG000|Overall Study|Adverse Event|2|||
149920561|NCT00548249|540843418|FG001|Overall Study|Adverse Event|2|||
149920562|NCT00548249|540843419|FG002|Overall Study|Adverse Event|0|||
149920563|NCT00548249|540843420|FG003|Overall Study|Adverse Event|1|||
149920564|NCT00548249|540843421|FG004|Overall Study|Adverse Event|1|||
149920565|NCT00548249|540843417|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
149920566|NCT00548249|540843418|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
150160271|NCT01734382|541719699|FG000|Part 1|Adverse Event|2|||
150160272|NCT01734382|541719700|FG001|Part 1|Adverse Event|0|||
150160273|NCT01734382|541719701|FG002|Part 1|Adverse Event|0|||
150160274|NCT01734382|541719699|FG000|Part 2|Adverse Event|0|||
150160275|NCT01734382|541719700|FG001|Part 2|Adverse Event|0|||
150160276|NCT01734382|541719701|FG002|Part 2|Adverse Event|1|||
150160277|NCT01734382|541719699|FG000|Part 2|Lack of Efficacy|0|||
150160278|NCT01734382|541719700|FG001|Part 2|Lack of Efficacy|1|||
150160279|NCT01734382|541719701|FG002|Part 2|Lack of Efficacy|1|||
150160280|NCT01734382|541719699|FG000|Part 2|Other|0|||
150160281|NCT01734382|541719700|FG001|Part 2|Other|0|||
150160282|NCT01734382|541719701|FG002|Part 2|Other|1|||
150160283|NCT01734382|541719699|FG000|Part 2|Physician Decision|0|||
149920567|NCT00548249|540843419|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
150160284|NCT01734382|541719700|FG001|Part 2|Physician Decision|0|||
150160285|NCT01734382|541719701|FG002|Part 2|Physician Decision|3|||
150160286|NCT01734382|541719699|FG000|Part 2|Protocol Violation|0|||
150160287|NCT01734382|541719700|FG001|Part 2|Protocol Violation|1|||
150160288|NCT01734382|541719701|FG002|Part 2|Protocol Violation|0|||
150160289|NCT01734382|541719699|FG000|Part 2|Withdrawal by Subject|0|||
149920568|NCT00548249|540843420|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
149920569|NCT00548249|540843421|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
149920570|NCT00548249|540843417|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
149920571|NCT00548249|540843418|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
149920572|NCT00548249|540843419|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
149920573|NCT00548249|540843420|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
149920574|NCT00548249|540843421|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
149920575|NCT00548249|540843417|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
149920576|NCT00548249|540843418|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
149920577|NCT00548249|540843419|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
149920578|NCT00548249|540843420|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
149920579|NCT00548249|540843421|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
149920580|NCT00548249|540843417|FG000|Overall Study|Prolonged hospitalization|0|||
149920581|NCT00548249|540843418|FG001|Overall Study|Prolonged hospitalization|0|||
149920582|NCT00548249|540843419|FG002|Overall Study|Prolonged hospitalization|2|||
149920583|NCT00548249|540843420|FG003|Overall Study|Prolonged hospitalization|1|||
149920584|NCT00548249|540843421|FG004|Overall Study|Prolonged hospitalization|0|||
149920585|NCT00548249|540843417|FG000|Overall Study|Withdrawal by Subject|2|||
149920586|NCT00548249|540843418|FG001|Overall Study|Withdrawal by Subject|0|||
149920587|NCT00548249|540843419|FG002|Overall Study|Withdrawal by Subject|0|||
149920588|NCT00548249|540843420|FG003|Overall Study|Withdrawal by Subject|0|||
150160290|NCT01734382|541719700|FG001|Part 2|Withdrawal by Subject|0|||
150160291|NCT01734382|541719701|FG002|Part 2|Withdrawal by Subject|1|||
150259812|NCT01920854|542087246|FG000|Overall Study|Withdrawal by Subject|1|||
150259813|NCT01920854|542087247|FG001|Overall Study|Withdrawal by Subject|0|||
150259814|NCT01920854|542087248|FG002|Overall Study|Withdrawal by Subject|0|||
150259815|NCT01920854|542087249|FG003|Overall Study|Withdrawal by Subject|0|||
150259816|NCT01920854|542087250|FG004|Overall Study|Withdrawal by Subject|1|||
150259817|NCT01920854|542087251|FG005|Overall Study|Withdrawal by Subject|0|||
150259818|NCT01920854|542087252|FG006|Overall Study|Withdrawal by Subject|1|||
150259819|NCT03265938|542087256|FG000|Overall Study|Withdrawal by Subject|1|||
150259820|NCT03265938|542087256|FG000|Overall Study|Physician Decision|1|||
150259821|NCT03265938|542087256|FG000|Overall Study|friable mass|6|||
150259822|NCT03143166|542087257|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
150259823|NCT02673515|542087258|FG000|Overall Study|Lack of motivation|2|||
150259824|NCT02673515|542087259|FG001|Overall Study|Lack of motivation|1|||
150259825|NCT03683823|542087260|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
150259826|NCT03683823|542087261|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
150259827|NCT03683823|542087260|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
150259828|NCT03683823|542087261|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
150259829|NCT03683823|542087260|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
150259830|NCT03683823|542087261|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
149920589|NCT00548249|540843421|FG004|Overall Study|Withdrawal by Subject|0|||
150160292|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
150160293|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
150160294|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
150160295|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
150160296|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
150160297|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
150160298|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
150160299|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
150160300|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
150160301|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
150160302|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
150160303|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
150160304|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
150160305|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
150160306|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
150160307|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
150160308|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
149920590|NCT00548249|540843417|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
149920591|NCT00548249|540843418|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
149920592|NCT00548249|540843419|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
149920593|NCT00548249|540843420|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
149920594|NCT00548249|540843421|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
150259831|NCT00994682|542087262|FG000|Double Bilnd|Withdrawal by Subject|5|||
150259832|NCT00994682|542087263|FG001|Double Bilnd|Withdrawal by Subject|6|||
150259833|NCT00994682|542087262|FG000|Double Bilnd|Lost to Follow-up|3|||
150259834|NCT00994682|542087263|FG001|Double Bilnd|Lost to Follow-up|3|||
150259835|NCT00994682|542087262|FG000|Double Bilnd|Adverse Event|1|||
150259836|NCT00994682|542087263|FG001|Double Bilnd|Adverse Event|0|||
150259837|NCT00994682|542087262|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
150259838|NCT00994682|542087263|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
150259839|NCT00994682|542087262|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
150259840|NCT00994682|542087263|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
150259841|NCT00994682|542087262|FG000|Pioglitazone Open Label|Physician Decision|6|||
150259842|NCT00994682|542087263|FG001|Pioglitazone Open Label|Physician Decision|1|||
150259843|NCT01323972|542087264|FG000|Overall Study|Withdrawal by Subject|1|||
150259844|NCT01323972|542087265|FG001|Overall Study|Withdrawal by Subject|0|||
150259845|NCT01323972|542087266|FG002|Overall Study|Withdrawal by Subject|1|||
150259846|NCT01323972|542087267|FG003|Overall Study|Withdrawal by Subject|0|||
150259847|NCT01323972|542087264|FG000|Overall Study|Migrated/moved from study area|1|||
150259848|NCT01323972|542087265|FG001|Overall Study|Migrated/moved from study area|2|||
150259849|NCT01323972|542087266|FG002|Overall Study|Migrated/moved from study area|0|||
149920595|NCT00548249|540843417|FG000|Overall Study|Sponsor's request|0|||
149920596|NCT00548249|540843418|FG001|Overall Study|Sponsor's request|0|||
149920597|NCT00548249|540843419|FG002|Overall Study|Sponsor's request|0|||
149920598|NCT00548249|540843420|FG003|Overall Study|Sponsor's request|1|||
149920599|NCT00548249|540843421|FG004|Overall Study|Sponsor's request|0|||
150259850|NCT01323972|542087267|FG003|Overall Study|Migrated/moved from study area|0|||
150259851|NCT01323972|542087264|FG000|Overall Study|Lost to Follow-up|0|||
150259852|NCT01323972|542087265|FG001|Overall Study|Lost to Follow-up|1|||
150259853|NCT01323972|542087266|FG002|Overall Study|Lost to Follow-up|1|||
150259854|NCT01323972|542087267|FG003|Overall Study|Lost to Follow-up|1|||
149920600|NCT01464619|540843424|FG000|Overall Study|Lost to Follow-up|3|||
149920601|NCT01464619|540843425|FG001|Overall Study|Lost to Follow-up|4|||
149920602|NCT00750919|540843426|FG000|Overall Study|Adverse Event|9|||
149920603|NCT00750919|540843426|FG000|Overall Study|Withdrawal by Subject|1|||
149920604|NCT00750919|540843426|FG000|Overall Study|Lack of Efficacy|8|||
149920605|NCT00750919|540843426|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
149920606|NCT00750919|540843426|FG000|Overall Study|Other|36|||
149920607|NCT00080483|540843431|FG000|Overall Study|Lost to Follow-up|1|||
149920608|NCT00080483|540843432|FG001|Overall Study|Lost to Follow-up|1|||
149920609|NCT00080483|540843431|FG000|Overall Study|Physician Decision|1|||
149920610|NCT00080483|540843432|FG001|Overall Study|Physician Decision|1|||
149920611|NCT02819440|540843433|FG000|Overall Study|Adverse Event|3|||
149920612|NCT02819440|540843434|FG001|Overall Study|Adverse Event|1|||
149920613|NCT02819440|540843433|FG000|Overall Study|Lost to Follow-up|1|||
149920614|NCT02819440|540843434|FG001|Overall Study|Lost to Follow-up|3|||
149920615|NCT02819440|540843433|FG000|Overall Study|Withdrawal by Subject|9|||
149920616|NCT02819440|540843434|FG001|Overall Study|Withdrawal by Subject|8|||
149920617|NCT00002525|540843442|FG000|Overall Study|Adverse Event|36|||
149920618|NCT00002525|540843443|FG001|Overall Study|Adverse Event|0|||
149920619|NCT00002525|540843442|FG000|Overall Study|Death|5|||
149920620|NCT00002525|540843443|FG001|Overall Study|Death|0|||
149920621|NCT00002525|540843442|FG000|Overall Study|Withdrawal by Subject|11|||
149920622|NCT00002525|540843443|FG001|Overall Study|Withdrawal by Subject|0|||
149920623|NCT00002525|540843442|FG000|Overall Study|Start non-protocol therapy|1|||
149920624|NCT00002525|540843443|FG001|Overall Study|Start non-protocol therapy|0|||
149920625|NCT00002525|540843442|FG000|Overall Study|Other complicating disease|1|||
149920626|NCT00002525|540843443|FG001|Overall Study|Other complicating disease|0|||
149920627|NCT00002525|540843442|FG000|Overall Study|Duke's A, B1, D disease|92|||
149920628|NCT00002525|540843443|FG001|Overall Study|Duke's A, B1, D disease|0|||
149920629|NCT00002525|540843442|FG000|Overall Study|Error|6|||
149920630|NCT00002525|540843443|FG001|Overall Study|Error|0|||
149920631|NCT00002525|540843442|FG000|Overall Study|Other|26|||
149920632|NCT00002525|540843443|FG001|Overall Study|Other|0|||
149920633|NCT00002525|540843442|FG000|Overall Study|Never start protocol therapy|8|||
149920634|NCT00002525|540843443|FG001|Overall Study|Never start protocol therapy|0|||
149920635|NCT03304184|540843444|FG000|Overall Study|Withdrawal by Subject|1|||
149920636|NCT03304184|540843445|FG001|Overall Study|Withdrawal by Subject|2|||
149920637|NCT03420222|540843448|FG000|Overall Study|Withdrawal by Subject|5|||
149920638|NCT03420222|540843449|FG001|Overall Study|Withdrawal by Subject|0|||
150259855|NCT01946438|542087272|FG000|Overall Study|Adverse Event|0|||
150259856|NCT01946438|542087273|FG001|Overall Study|Adverse Event|0|||
149920639|NCT03420222|540843448|FG000|Overall Study|Physician Decision|0|||
149920640|NCT03420222|540843449|FG001|Overall Study|Physician Decision|1|||
150259857|NCT01946438|542087274|FG002|Overall Study|Adverse Event|0|||
149920641|NCT02334384|540843452|FG000|Overall Study|Lost to Follow-up|1|||
149920642|NCT02334384|540843453|FG001|Overall Study|Lost to Follow-up|1|||
149920643|NCT02651688|540843454|FG000|Overall Study|Non-compliance|0|||
149920644|NCT02651688|540843455|FG001|Overall Study|Non-compliance|0|||
149920645|NCT02651688|540843456|FG002|Overall Study|Non-compliance|1|||
149920646|NCT02651688|540843454|FG000|Overall Study|Principal Investigator (PI) decision|0|||
149920647|NCT02651688|540843455|FG001|Overall Study|Principal Investigator (PI) decision|2|||
149920648|NCT02651688|540843456|FG002|Overall Study|Principal Investigator (PI) decision|0|||
149920649|NCT02651688|540843454|FG000|Overall Study|Lost to Follow-up|1|||
149920650|NCT02651688|540843455|FG001|Overall Study|Lost to Follow-up|3|||
149920651|NCT02651688|540843456|FG002|Overall Study|Lost to Follow-up|0|||
149920652|NCT02651688|540843454|FG000|Overall Study|Withdrawal by Subject|1|||
149920653|NCT02651688|540843455|FG001|Overall Study|Withdrawal by Subject|0|||
149920654|NCT02651688|540843456|FG002|Overall Study|Withdrawal by Subject|2|||
149920655|NCT00625183|540843457|FG000|Overall Study|Disease Progression|1|||
149920656|NCT01429441|540843458|FG000|Overall Study|Adverse Event|5|||
149920657|NCT01429441|540843459|FG001|Overall Study|Adverse Event|1|||
149920658|NCT01429441|540843458|FG000|Overall Study|Death|0|||
149920659|NCT01429441|540843459|FG001|Overall Study|Death|2|||
149920660|NCT01429441|540843458|FG000|Overall Study|Lost to Follow-up|5|||
149920661|NCT01429441|540843459|FG001|Overall Study|Lost to Follow-up|2|||
149920662|NCT01429441|540843458|FG000|Overall Study|Physician Decision|1|||
149920663|NCT01429441|540843459|FG001|Overall Study|Physician Decision|0|||
149920664|NCT01429441|540843458|FG000|Overall Study|Withdrawal by Subject|27|||
149920665|NCT01429441|540843459|FG001|Overall Study|Withdrawal by Subject|18|||
149920666|NCT01606748|540843460|FG000|Overall Study|Adverse Event|1|||
149920667|NCT01606748|540843461|FG001|Overall Study|Adverse Event|0|||
149920668|NCT01606748|540843460|FG000|Overall Study|Progressive Disease|1|||
149920669|NCT01606748|540843461|FG001|Overall Study|Progressive Disease|0|||
149920670|NCT01606748|540843460|FG000|Overall Study|Withdrawal by Subject|1|||
149920671|NCT01606748|540843461|FG001|Overall Study|Withdrawal by Subject|0|||
149920672|NCT00621517|540843464|FG000|Overall Study|Lost to Follow-up|3|||
149920673|NCT00621517|540843465|FG001|Overall Study|Lost to Follow-up|3|||
149920674|NCT00621517|540843464|FG000|Overall Study|Withdrawal by Subject|3|||
149920675|NCT00621517|540843465|FG001|Overall Study|Withdrawal by Subject|4|||
149920676|NCT00621517|540843464|FG000|Overall Study|Adverse Event|1|||
149920677|NCT00621517|540843465|FG001|Overall Study|Adverse Event|0|||
149920678|NCT01863732|540843466|FG000|Overall Study|Adverse Event|2|||
149920679|NCT01863732|540843467|FG001|Overall Study|Adverse Event|0|||
149920680|NCT01863732|540843468|FG002|Overall Study|Adverse Event|3|||
149920681|NCT01863732|540843469|FG003|Overall Study|Adverse Event|3|||
149920682|NCT01863732|540843466|FG000|Overall Study|Lack of Efficacy|1|||
149920683|NCT01863732|540843467|FG001|Overall Study|Lack of Efficacy|0|||
149920684|NCT01863732|540843468|FG002|Overall Study|Lack of Efficacy|2|||
149920685|NCT01863732|540843469|FG003|Overall Study|Lack of Efficacy|1|||
149920686|NCT01863732|540843466|FG000|Overall Study|Lost to Follow-up|2|||
149920687|NCT01863732|540843467|FG001|Overall Study|Lost to Follow-up|2|||
149920688|NCT01863732|540843468|FG002|Overall Study|Lost to Follow-up|1|||
149920689|NCT01863732|540843469|FG003|Overall Study|Lost to Follow-up|1|||
149920690|NCT01863732|540843466|FG000|Overall Study|Physician Decision|1|||
149920691|NCT01863732|540843467|FG001|Overall Study|Physician Decision|0|||
149920692|NCT01863732|540843468|FG002|Overall Study|Physician Decision|1|||
149920693|NCT01863732|540843469|FG003|Overall Study|Physician Decision|0|||
149920694|NCT01863732|540843466|FG000|Overall Study|Pregnancy|0|||
149920695|NCT01863732|540843467|FG001|Overall Study|Pregnancy|0|||
149920696|NCT01863732|540843468|FG002|Overall Study|Pregnancy|0|||
149920697|NCT01863732|540843469|FG003|Overall Study|Pregnancy|1|||
149920698|NCT01863732|540843466|FG000|Overall Study|Technical problems|0|||
150160309|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
150160310|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
150160311|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
150160312|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
150160313|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
150160314|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
150160315|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
150160316|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
150160317|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
150160318|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
150160319|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
150160320|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
150160321|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
150160322|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
150160323|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
149920699|NCT01863732|540843467|FG001|Overall Study|Technical problems|1|||
149920700|NCT01863732|540843468|FG002|Overall Study|Technical problems|1|||
149920701|NCT01863732|540843469|FG003|Overall Study|Technical problems|0|||
149920702|NCT01863732|540843466|FG000|Overall Study|Subject/guardian decision|6|||
149920703|NCT01863732|540843467|FG001|Overall Study|Subject/guardian decision|9|||
149920704|NCT01863732|540843468|FG002|Overall Study|Subject/guardian decision|3|||
149920705|NCT01863732|540843469|FG003|Overall Study|Subject/guardian decision|1|||
149920706|NCT01863732|540843466|FG000|Overall Study|Death|1|||
149920707|NCT01863732|540843467|FG001|Overall Study|Death|0|||
149920708|NCT01863732|540843468|FG002|Overall Study|Death|0|||
149920709|NCT01863732|540843469|FG003|Overall Study|Death|1|||
149920710|NCT03084315|540843470|FG000|Overall Study|Lost to Follow-up|8|||
149920711|NCT03084315|540843471|FG001|Overall Study|Lost to Follow-up|7|||
149920712|NCT03084315|540843470|FG000|Overall Study|Withdrawal by Subject|2|||
149920713|NCT03084315|540843471|FG001|Overall Study|Withdrawal by Subject|2|||
149920714|NCT00395642|540843472|FG000|Overall Study|Death|4|||
149920715|NCT00395642|540843472|FG000|Overall Study|Lost to Follow-up|1|||
149920716|NCT00395642|540843472|FG000|Overall Study|Physician Decision|7|||
149920717|NCT00395642|540843472|FG000|Overall Study|Withdrawal by Subject|1|||
149920718|NCT01421147|540844892|FG000|Treatment Period|Adverse Event|2|||
149920719|NCT01421147|540844893|FG001|Treatment Period|Adverse Event|3|||
149920720|NCT01421147|540844892|FG000|Treatment Period|Lost to Follow-up|2|||
149920721|NCT01421147|540844893|FG001|Treatment Period|Lost to Follow-up|1|||
149920722|NCT01421147|540844892|FG000|Treatment Period|Physician Decision|2|||
149920723|NCT01421147|540844893|FG001|Treatment Period|Physician Decision|2|||
149920724|NCT01421147|540844892|FG000|Treatment Period|Withdrawal by Subject|10|||
149920725|NCT01421147|540844893|FG001|Treatment Period|Withdrawal by Subject|5|||
149920726|NCT01421147|540844892|FG000|Extension Period|Adverse Event|0|||
149920727|NCT01421147|540844893|FG001|Extension Period|Adverse Event|2|||
149920728|NCT01421147|540844892|FG000|Extension Period|Death|0|||
149920729|NCT01421147|540844893|FG001|Extension Period|Death|1|||
149920730|NCT01421147|540844892|FG000|Extension Period|Lost to Follow-up|2|||
149920731|NCT01421147|540844893|FG001|Extension Period|Lost to Follow-up|5|||
149920732|NCT01421147|540844892|FG000|Extension Period|Physician Decision|1|||
149920733|NCT01421147|540844893|FG001|Extension Period|Physician Decision|0|||
149920734|NCT01421147|540844892|FG000|Extension Period|Withdrawal by Subject|5|||
149920735|NCT01421147|540844893|FG001|Extension Period|Withdrawal by Subject|3|||
149920736|NCT00171158|540844896|FG000|Core Study|Death|27|||
149920737|NCT00171158|540844896|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
149920738|NCT00171158|540844896|FG000|Core Study|Protocol Violation|4|||
149920739|NCT00171158|540844896|FG000|Core Study|Administrative problems|1|||
149920740|NCT00171158|540844896|FG000|Core Study|Adverse event, non-fatal|21|||
149920741|NCT00171158|540844896|FG000|Core Study|Consent withdrawn by subject|6|||
149920742|NCT00171158|540844896|FG000|Core Study|No longer required drug (BMT)|14|||
149920743|NCT00171158|540844896|FG000|Core Study|Abnormal Laboratory Values|2|||
149920744|NCT00171158|540844896|FG000|Core Study|Lost to Follow-up|1|||
149920745|NCT00171158|540844896|FG000|E2 Extension|Other|7|||
149920746|NCT02757352|540844897|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
149920747|NCT02757352|540844898|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920748|NCT02757352|540844899|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
149920749|NCT02757352|540844900|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920750|NCT02757352|540844901|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920751|NCT02757352|540844902|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920752|NCT02757352|540844903|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920753|NCT02757352|540844904|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920754|NCT02757352|540844905|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920755|NCT02757352|540844906|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149920756|NCT02757352|540844897|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920757|NCT02757352|540844898|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920758|NCT02757352|540844899|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
149920759|NCT02757352|540844900|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920760|NCT02757352|540844901|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920761|NCT02757352|540844902|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920762|NCT02757352|540844903|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920763|NCT02757352|540844904|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920764|NCT02757352|540844905|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920765|NCT02757352|540844906|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
149920766|NCT02757352|540844897|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
149920767|NCT02757352|540844898|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
149920768|NCT02757352|540844899|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
149920769|NCT02757352|540844900|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920770|NCT02757352|540844901|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
150160324|NCT03890120|541719702|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
150160325|NCT03890120|541719703|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
149920771|NCT02757352|540844902|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920772|NCT02757352|540844903|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920773|NCT02757352|540844904|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920774|NCT02757352|540844905|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920775|NCT02757352|540844906|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
149920776|NCT02757352|540844897|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920777|NCT02757352|540844898|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
149920778|NCT02757352|540844899|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920779|NCT02757352|540844900|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920780|NCT02757352|540844901|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920781|NCT02757352|540844902|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920782|NCT02757352|540844903|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920783|NCT02757352|540844904|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920784|NCT02757352|540844905|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920785|NCT02757352|540844906|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
149920786|NCT02757352|540844897|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920787|NCT02757352|540844898|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
149920788|NCT02757352|540844899|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920789|NCT02757352|540844900|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920790|NCT02757352|540844901|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920791|NCT02757352|540844902|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920792|NCT02757352|540844903|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920793|NCT02757352|540844904|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920794|NCT02757352|540844905|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920795|NCT02757352|540844906|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920796|NCT02757352|540844897|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
149920797|NCT02757352|540844898|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
149920798|NCT02757352|540844899|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
149920799|NCT02757352|540844900|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920800|NCT02757352|540844901|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920801|NCT02757352|540844902|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920802|NCT02757352|540844903|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920803|NCT02757352|540844904|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920804|NCT02757352|540844905|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920805|NCT02757352|540844906|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920806|NCT02757352|540844897|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
149920807|NCT02757352|540844898|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
149920808|NCT02757352|540844899|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
149920809|NCT02757352|540844900|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920810|NCT02757352|540844901|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920811|NCT02757352|540844902|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920812|NCT02757352|540844903|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920813|NCT02757352|540844904|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920814|NCT02757352|540844905|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920815|NCT02757352|540844906|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
149920816|NCT02757352|540844897|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920817|NCT02757352|540844898|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920818|NCT02757352|540844899|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
150160326|NCT03890120|541719704|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
150160327|NCT03890120|541719705|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
150160328|NCT03890120|541719702|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
150160329|NCT03890120|541719703|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
150160330|NCT03890120|541719704|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
150160331|NCT03890120|541719705|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
150160332|NCT03890120|541719702|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
150160333|NCT03890120|541719703|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
150160334|NCT03890120|541719704|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
150160335|NCT03890120|541719705|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
150160336|NCT03890120|541719702|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
150160337|NCT03890120|541719703|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
150160338|NCT03890120|541719704|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
150160339|NCT03890120|541719705|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
150160340|NCT03890120|541719702|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
150160341|NCT03890120|541719703|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
150160342|NCT03890120|541719704|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
150160343|NCT03890120|541719705|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
150160344|NCT04537949|541719706|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
150160345|NCT04537949|541719707|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
150160346|NCT04537949|541719708|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
150160347|NCT04537949|541719709|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
150160348|NCT04537949|541719710|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
149920819|NCT02757352|540844900|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
149920820|NCT02757352|540844901|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920821|NCT02757352|540844902|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
149920822|NCT02757352|540844903|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920823|NCT02757352|540844904|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920824|NCT02757352|540844905|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920825|NCT02757352|540844906|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
149920826|NCT02757352|540844897|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920827|NCT02757352|540844898|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920828|NCT02757352|540844899|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920829|NCT02757352|540844900|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
149920830|NCT02757352|540844901|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
149920831|NCT02757352|540844902|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
149920832|NCT02757352|540844903|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920833|NCT02757352|540844904|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920834|NCT02757352|540844905|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920835|NCT02757352|540844906|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149920836|NCT02757352|540844897|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920837|NCT02757352|540844898|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920838|NCT02757352|540844899|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920839|NCT02757352|540844900|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920840|NCT02757352|540844901|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
149920841|NCT02757352|540844902|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920842|NCT02757352|540844903|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920843|NCT02757352|540844904|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920844|NCT02757352|540844905|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920845|NCT02757352|540844906|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
149920846|NCT02757352|540844897|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920847|NCT02757352|540844898|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920848|NCT02757352|540844899|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920849|NCT02757352|540844900|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920850|NCT02757352|540844901|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920851|NCT02757352|540844902|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
149920852|NCT02757352|540844903|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920853|NCT02757352|540844904|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920854|NCT02757352|540844905|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920855|NCT02757352|540844906|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
149920856|NCT02757352|540844897|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920857|NCT02757352|540844898|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920858|NCT02757352|540844899|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920859|NCT02757352|540844900|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
149920860|NCT02757352|540844901|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
149920861|NCT02757352|540844902|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
149920862|NCT02757352|540844903|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920863|NCT02757352|540844904|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149920864|NCT02757352|540844905|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
150259858|NCT01946438|542087275|FG003|Overall Study|Adverse Event|1|||
150259859|NCT01946438|542087272|FG000|Overall Study|Serious Adverse event|1|||
150259860|NCT01946438|542087273|FG001|Overall Study|Serious Adverse event|0|||
150259861|NCT01946438|542087274|FG002|Overall Study|Serious Adverse event|0|||
150259862|NCT01946438|542087275|FG003|Overall Study|Serious Adverse event|0|||
150259863|NCT01946438|542087272|FG000|Overall Study|Protocol Violation|0|||
150259864|NCT01946438|542087273|FG001|Overall Study|Protocol Violation|0|||
150259865|NCT01946438|542087274|FG002|Overall Study|Protocol Violation|1|||
150259866|NCT01946438|542087275|FG003|Overall Study|Protocol Violation|0|||
150259867|NCT01946438|542087272|FG000|Overall Study|Withdrawal by Subject|1|||
150259868|NCT01946438|542087273|FG001|Overall Study|Withdrawal by Subject|0|||
150259869|NCT01946438|542087274|FG002|Overall Study|Withdrawal by Subject|0|||
150259870|NCT01946438|542087275|FG003|Overall Study|Withdrawal by Subject|0|||
150259871|NCT00589121|542087276|FG000|Overall Study|Protocol Violation|2|||
150259872|NCT00589121|542087277|FG001|Overall Study|Protocol Violation|6|||
150259873|NCT00589121|542087276|FG000|Overall Study|No protocol treatment received|0|||
150259874|NCT00589121|542087277|FG001|Overall Study|No protocol treatment received|1|||
150259875|NCT02412371|542087278|FG000|Overall Study|Withdrawal by Subject|0|||
149920865|NCT02757352|540844906|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
150259876|NCT02412371|542087279|FG001|Overall Study|Withdrawal by Subject|2|||
150259877|NCT02412371|542087280|FG002|Overall Study|Withdrawal by Subject|0|||
149920866|NCT02757352|540844897|FG000|Follow-Up Period|Adverse Event|0|||
149920867|NCT02757352|540844898|FG001|Follow-Up Period|Adverse Event|0|||
149920868|NCT02757352|540844899|FG002|Follow-Up Period|Adverse Event|0|||
149920869|NCT02757352|540844900|FG003|Follow-Up Period|Adverse Event|0|||
149920870|NCT02757352|540844901|FG004|Follow-Up Period|Adverse Event|0|||
149920871|NCT02757352|540844902|FG005|Follow-Up Period|Adverse Event|0|||
149920872|NCT02757352|540844903|FG006|Follow-Up Period|Adverse Event|1|||
149920873|NCT02757352|540844904|FG007|Follow-Up Period|Adverse Event|0|||
149920874|NCT02757352|540844905|FG008|Follow-Up Period|Adverse Event|2|||
149920875|NCT02757352|540844906|FG009|Follow-Up Period|Adverse Event|0|||
149920876|NCT02757352|540844897|FG000|Follow-Up Period|Lost to Follow-up|0|||
149920877|NCT02757352|540844898|FG001|Follow-Up Period|Lost to Follow-up|0|||
149920878|NCT02757352|540844899|FG002|Follow-Up Period|Lost to Follow-up|0|||
149920879|NCT02757352|540844900|FG003|Follow-Up Period|Lost to Follow-up|0|||
149920880|NCT02757352|540844901|FG004|Follow-Up Period|Lost to Follow-up|0|||
149920881|NCT02757352|540844902|FG005|Follow-Up Period|Lost to Follow-up|0|||
149920882|NCT02757352|540844903|FG006|Follow-Up Period|Lost to Follow-up|0|||
149920883|NCT02757352|540844904|FG007|Follow-Up Period|Lost to Follow-up|0|||
149920884|NCT02757352|540844905|FG008|Follow-Up Period|Lost to Follow-up|1|||
149920885|NCT02757352|540844906|FG009|Follow-Up Period|Lost to Follow-up|0|||
149920886|NCT02757352|540844897|FG000|Follow-Up Period|Lack of Efficacy|0|||
149920887|NCT02757352|540844898|FG001|Follow-Up Period|Lack of Efficacy|0|||
149920888|NCT02757352|540844899|FG002|Follow-Up Period|Lack of Efficacy|0|||
149920889|NCT02757352|540844900|FG003|Follow-Up Period|Lack of Efficacy|0|||
149920890|NCT02757352|540844901|FG004|Follow-Up Period|Lack of Efficacy|0|||
149920891|NCT02757352|540844902|FG005|Follow-Up Period|Lack of Efficacy|0|||
149920892|NCT02757352|540844903|FG006|Follow-Up Period|Lack of Efficacy|0|||
149920893|NCT02757352|540844904|FG007|Follow-Up Period|Lack of Efficacy|0|||
149920894|NCT02757352|540844905|FG008|Follow-Up Period|Lack of Efficacy|1|||
149920895|NCT02757352|540844906|FG009|Follow-Up Period|Lack of Efficacy|1|||
149920896|NCT02757352|540844897|FG000|Follow-Up Period|Withdrawal by Subject|0|||
149920897|NCT02757352|540844898|FG001|Follow-Up Period|Withdrawal by Subject|0|||
149920898|NCT02757352|540844899|FG002|Follow-Up Period|Withdrawal by Subject|0|||
150160349|NCT04537949|541719711|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
150160350|NCT04537949|541719712|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
149920899|NCT02757352|540844900|FG003|Follow-Up Period|Withdrawal by Subject|0|||
149920900|NCT02757352|540844901|FG004|Follow-Up Period|Withdrawal by Subject|0|||
150160351|NCT04537949|541719713|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
149920901|NCT02757352|540844902|FG005|Follow-Up Period|Withdrawal by Subject|0|||
150160352|NCT04537949|541719706|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
150160353|NCT04537949|541719707|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
150160354|NCT04537949|541719708|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
150160355|NCT04537949|541719709|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
150160356|NCT04537949|541719710|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
150160357|NCT04537949|541719711|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
150160358|NCT04537949|541719712|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
150160359|NCT04537949|541719713|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
150160360|NCT04537949|541719706|FG000|Follow-up Phase|Lost to Follow-up|0|||
150160361|NCT04537949|541719707|FG001|Follow-up Phase|Lost to Follow-up|3|||
150160362|NCT04537949|541719708|FG002|Follow-up Phase|Lost to Follow-up|0|||
150160363|NCT04537949|541719709|FG003|Follow-up Phase|Lost to Follow-up|0|||
150160364|NCT04537949|541719710|FG004|Follow-up Phase|Lost to Follow-up|0|||
150160365|NCT04537949|541719711|FG005|Follow-up Phase|Lost to Follow-up|0|||
150160366|NCT04537949|541719712|FG006|Follow-up Phase|Lost to Follow-up|0|||
150160367|NCT04537949|541719713|FG007|Follow-up Phase|Lost to Follow-up|0|||
150160368|NCT04537949|541719706|FG000|Follow-up Phase|personal reasons|0|||
150160369|NCT04537949|541719707|FG001|Follow-up Phase|personal reasons|0|||
150160370|NCT04537949|541719708|FG002|Follow-up Phase|personal reasons|0|||
150160371|NCT04537949|541719709|FG003|Follow-up Phase|personal reasons|1|||
150160372|NCT04537949|541719710|FG004|Follow-up Phase|personal reasons|1|||
150160373|NCT04537949|541719711|FG005|Follow-up Phase|personal reasons|0|||
150160374|NCT04537949|541719712|FG006|Follow-up Phase|personal reasons|0|||
150160375|NCT04537949|541719713|FG007|Follow-up Phase|personal reasons|0|||
150160376|NCT04537949|541719706|FG000|Follow-up Phase|Withdrawal by Subject|0|||
150160377|NCT04537949|541719707|FG001|Follow-up Phase|Withdrawal by Subject|0|||
150160378|NCT04537949|541719708|FG002|Follow-up Phase|Withdrawal by Subject|0|||
150160379|NCT04537949|541719709|FG003|Follow-up Phase|Withdrawal by Subject|0|||
150160380|NCT04537949|541719710|FG004|Follow-up Phase|Withdrawal by Subject|1|||
150160381|NCT04537949|541719711|FG005|Follow-up Phase|Withdrawal by Subject|0|||
150160382|NCT04537949|541719712|FG006|Follow-up Phase|Withdrawal by Subject|0|||
150160383|NCT04537949|541719713|FG007|Follow-up Phase|Withdrawal by Subject|0|||
150160384|NCT00479674|541719715|FG000|Overall Study|Adverse Event|18|||
149920902|NCT02757352|540844903|FG006|Follow-Up Period|Withdrawal by Subject|0|||
149920903|NCT02757352|540844904|FG007|Follow-Up Period|Withdrawal by Subject|1|||
149920904|NCT02757352|540844905|FG008|Follow-Up Period|Withdrawal by Subject|6|||
149920905|NCT02757352|540844906|FG009|Follow-Up Period|Withdrawal by Subject|2|||
150160385|NCT00479674|541719715|FG000|Overall Study|Withdrawal by Subject|6|||
149920906|NCT03488563|540844911|FG000|Overall Study|Lost to Follow-up|7|||
149920907|NCT03488563|540844912|FG001|Overall Study|Lost to Follow-up|6|||
149920908|NCT03488563|540844913|FG002|Overall Study|Lost to Follow-up|7|||
149920909|NCT03488563|540844911|FG000|Overall Study|Withdrawal by Subject|8|||
149920910|NCT03488563|540844912|FG001|Overall Study|Withdrawal by Subject|7|||
149920911|NCT03488563|540844913|FG002|Overall Study|Withdrawal by Subject|7|||
150160386|NCT00479674|541719715|FG000|Overall Study|Physician Decision|14|||
150160387|NCT00479674|541719715|FG000|Overall Study|none provided|3|||
150160388|NCT03293485|541719718|FG000|Overall Study|Death|1|||
150160389|NCT03293485|541719718|FG000|Overall Study|Screen Failure|2|||
150160390|NCT03293485|541719718|FG000|Overall Study|Withdrawal by Subject|2|||
150160391|NCT00087490|541719719|FG000|Overall Study|Death|6|||
150160392|NCT00087490|541719720|FG001|Overall Study|Death|4|||
150160393|NCT00087490|541719719|FG000|Overall Study|Adverse Event|3|||
150160394|NCT00087490|541719720|FG001|Overall Study|Adverse Event|8|||
150160395|NCT00087490|541719719|FG000|Overall Study|Lack of Efficacy|0|||
150160396|NCT00087490|541719720|FG001|Overall Study|Lack of Efficacy|2|||
150160397|NCT00087490|541719719|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
150160398|NCT00087490|541719720|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
150160399|NCT00087490|541719719|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
150160400|NCT00087490|541719720|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
150160401|NCT00087490|541719719|FG000|Overall Study|Randomized but not treated|7|||
150160402|NCT00087490|541719720|FG001|Overall Study|Randomized but not treated|18|||
150160403|NCT00761774|541719721|FG000|Overall Study|Adverse Event|17|||
150160404|NCT00761774|541719721|FG000|Overall Study|Lack of Efficacy|37|||
150160405|NCT00761774|541719721|FG000|Overall Study|Lost to Follow-up|2|||
150160406|NCT00761774|541719721|FG000|Overall Study|Withdrawal by Subject|9|||
150160407|NCT00761774|541719721|FG000|Overall Study|Non-compliance|4|||
150160408|NCT00761774|541719721|FG000|Overall Study|End of study|2|||
150160409|NCT00761774|541719721|FG000|Overall Study|Reclassification of seizures|1|||
150160410|NCT00761774|541719721|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
150160411|NCT00761774|541719721|FG000|Overall Study|Sponsor decision|1|||
150160412|NCT00761774|541719721|FG000|Overall Study|Investigator clinical judgement|1|||
150160413|NCT00761774|541719721|FG000|Overall Study|Patient moved out of study area|1|||
150160414|NCT00761774|541719721|FG000|Overall Study|Coordinator leaving site|1|||
150160415|NCT00761774|541719721|FG000|Overall Study|Subject IP non-compliance|1|||
150160416|NCT00761774|541719721|FG000|Overall Study|IP stopped by hospital physician|1|||
150160417|NCT01077024|541719722|FG000|Overall Study|Lost to Follow-up|20|||
150160418|NCT01077024|541719723|FG001|Overall Study|Lost to Follow-up|14|||
150160419|NCT01077024|541719722|FG000|Overall Study|Withdrawal by Subject|0|||
150160420|NCT01077024|541719723|FG001|Overall Study|Withdrawal by Subject|2|||
150160421|NCT01077024|541719722|FG000|Overall Study|Incarcerated|7|||
150160422|NCT01077024|541719723|FG001|Overall Study|Incarcerated|8|||
150160423|NCT01077024|541719722|FG000|Overall Study|Other|4|||
150160424|NCT01077024|541719723|FG001|Overall Study|Other|4|||
150160425|NCT02300311|541719727|FG000|Overall Study|Other than the reason specified|1|||
150160426|NCT02300311|541719728|FG001|Overall Study|Other than the reason specified|0|||
150160427|NCT02300311|541719727|FG000|Overall Study|Refused to continue taking medication|18|||
150160428|NCT02300311|541719728|FG001|Overall Study|Refused to continue taking medication|0|||
150160429|NCT02687919|541719729|FG000|Overall Study|Withdrawal by Subject|6|||
150160430|NCT02687919|541719730|FG001|Overall Study|Withdrawal by Subject|6|||
150160431|NCT02687919|541719729|FG000|Overall Study|Protocol Violation|2|||
150160432|NCT02687919|541719730|FG001|Overall Study|Protocol Violation|0|||
150160433|NCT00419003|541719731|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
150160434|NCT00419003|541719732|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
150160435|NCT00419003|541719731|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
150160436|NCT00419003|541719732|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
150160437|NCT00772928|541719733|FG000|Overall Study|Lost to Follow-up|9|||
150160438|NCT00772928|541719734|FG001|Overall Study|Lost to Follow-up|6|||
150160439|NCT00772928|541719733|FG000|Overall Study|Protocol Violation|10|||
149920912|NCT03488563|540844911|FG000|Overall Study|Physician Decision|0|||
150160440|NCT00772928|541719734|FG001|Overall Study|Protocol Violation|12|||
150160441|NCT00772928|541719733|FG000|Overall Study|Withdrawal by Subject|25|||
150160442|NCT00772928|541719734|FG001|Overall Study|Withdrawal by Subject|22|||
150160443|NCT00772928|541719733|FG000|Overall Study|Did not receive vaccine|0|||
150160444|NCT00772928|541719734|FG001|Overall Study|Did not receive vaccine|1|||
150160445|NCT01653743|541719735|FG000|Overall Study|Withdrawal by Subject|1|||
150160446|NCT01653743|541719736|FG001|Overall Study|Withdrawal by Subject|0|||
150160447|NCT01653743|541719735|FG000|Overall Study|Investigator discretion|3|||
150160448|NCT01653743|541719736|FG001|Overall Study|Investigator discretion|0|||
150160449|NCT02303574|541719744|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160450|NCT02303574|541719745|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160451|NCT02303574|541719746|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
150160452|NCT02303574|541719747|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160453|NCT02303574|541719748|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160454|NCT02303574|541719749|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149920913|NCT03488563|540844912|FG001|Overall Study|Physician Decision|0|||
149920914|NCT03488563|540844913|FG002|Overall Study|Physician Decision|1|||
149920915|NCT03488563|540844911|FG000|Overall Study|Protocol Violation|3|||
149920916|NCT03488563|540844912|FG001|Overall Study|Protocol Violation|2|||
149920917|NCT03488563|540844913|FG002|Overall Study|Protocol Violation|6|||
149920918|NCT03488563|540844911|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
149920919|NCT03488563|540844912|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
149920920|NCT03488563|540844913|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
149920921|NCT03488563|540844911|FG000|Overall Study|Use of prohibited medication|2|||
149920922|NCT03488563|540844912|FG001|Overall Study|Use of prohibited medication|0|||
149920923|NCT03488563|540844913|FG002|Overall Study|Use of prohibited medication|0|||
149920924|NCT03488563|540844911|FG000|Overall Study|Adverse Event|1|||
149920925|NCT03488563|540844912|FG001|Overall Study|Adverse Event|0|||
149920926|NCT03488563|540844913|FG002|Overall Study|Adverse Event|1|||
149920927|NCT03488563|540844911|FG000|Overall Study|Subject returned for ET visit|0|||
149920928|NCT03488563|540844912|FG001|Overall Study|Subject returned for ET visit|1|||
149920929|NCT03488563|540844913|FG002|Overall Study|Subject returned for ET visit|0|||
149920930|NCT03488563|540844911|FG000|Overall Study|Sponsor's decision|0|||
149920931|NCT03488563|540844912|FG001|Overall Study|Sponsor's decision|0|||
149920932|NCT03488563|540844913|FG002|Overall Study|Sponsor's decision|1|||
149920933|NCT00582426|540844922|FG000|Overall Study|Lost to Follow-up|0|||
149920934|NCT00582426|540844923|FG001|Overall Study|Lost to Follow-up|2|||
149920935|NCT00582426|540844922|FG000|Overall Study|Adverse Event|4|||
149920936|NCT00582426|540844923|FG001|Overall Study|Adverse Event|2|||
149920937|NCT00582426|540844922|FG000|Overall Study|Protocol Violation|6|||
149920938|NCT00582426|540844923|FG001|Overall Study|Protocol Violation|2|||
149920939|NCT00582426|540844922|FG000|Overall Study|Death|4|||
149920940|NCT00582426|540844923|FG001|Overall Study|Death|3|||
149920941|NCT00582426|540844922|FG000|Overall Study|Withdrawal by Subject|3|||
149920942|NCT00582426|540844923|FG001|Overall Study|Withdrawal by Subject|2|||
149920943|NCT00582426|540844922|FG000|Overall Study|Disease Progression|2|||
149920944|NCT00582426|540844923|FG001|Overall Study|Disease Progression|2|||
149920945|NCT00582426|540844922|FG000|Overall Study|Use of illicit drugs|1|||
149920946|NCT00582426|540844923|FG001|Overall Study|Use of illicit drugs|0|||
149920947|NCT00662311|540844926|FG000|Overall Study|Respiratory Infection|1|||
149920948|NCT00662311|540844927|FG001|Overall Study|Respiratory Infection|0|||
149920949|NCT00662311|540844928|FG002|Overall Study|Respiratory Infection|0|||
149920950|NCT01964989|540844932|FG000|Overall Study|Protocol Violation|3|||
149920951|NCT01964989|540844933|FG001|Overall Study|Protocol Violation|4|||
149920952|NCT01964989|540844932|FG000|Overall Study|Administrative Reason|103|||
149920953|NCT01964989|540844933|FG001|Overall Study|Administrative Reason|95|||
150160455|NCT02303574|541719750|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160456|NCT02303574|541719751|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160457|NCT02303574|541719752|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160458|NCT02303574|541719753|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
150160459|NCT02303574|541719744|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160460|NCT02303574|541719745|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160461|NCT02303574|541719746|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160462|NCT02303574|541719747|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160463|NCT02303574|541719748|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160464|NCT02303574|541719749|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160465|NCT02303574|541719750|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160466|NCT02303574|541719751|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
150160467|NCT02303574|541719752|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160468|NCT02303574|541719753|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
150160469|NCT00994279|541719758|FG000|Overall Study|Withdrawal by Subject|2|||
150160470|NCT00994279|541719759|FG001|Overall Study|Withdrawal by Subject|2|||
150160471|NCT00994279|541719758|FG000|Overall Study|Toxicity|1|||
150160472|NCT00994279|541719759|FG001|Overall Study|Toxicity|0|||
150160473|NCT00994279|541719758|FG000|Overall Study|Multiple reasons|1|||
150160474|NCT00994279|541719759|FG001|Overall Study|Multiple reasons|3|||
150160475|NCT01606189|541719760|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
150160476|NCT01606189|541719761|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
150160477|NCT01606189|541719762|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
150160478|NCT01606189|541719763|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
150160479|NCT01606189|541719764|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
150160480|NCT01606189|541719765|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
149920954|NCT01964989|540844932|FG000|Overall Study|Adverse Event|0|||
150160481|NCT01606189|541719760|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
150160482|NCT01606189|541719761|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
150160483|NCT01606189|541719762|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149920955|NCT01964989|540844933|FG001|Overall Study|Adverse Event|1|||
149920956|NCT01964989|540844932|FG000|Overall Study|Death|1|||
149920957|NCT01964989|540844933|FG001|Overall Study|Death|3|||
149920958|NCT01964989|540844932|FG000|Overall Study|Withdrawal by Subject|156|||
149920959|NCT01964989|540844933|FG001|Overall Study|Withdrawal by Subject|160|||
149920960|NCT01964989|540844932|FG000|Overall Study|Lost to Follow-up|254|||
149920961|NCT01964989|540844933|FG001|Overall Study|Lost to Follow-up|232|||
150259878|NCT02412371|542087281|FG003|Overall Study|Withdrawal by Subject|1|||
150259879|NCT02412371|542087282|FG004|Overall Study|Withdrawal by Subject|1|||
150259880|NCT02412371|542087283|FG005|Overall Study|Withdrawal by Subject|0|||
150259881|NCT02412371|542087278|FG000|Overall Study|Sponsor Discontinued Study|1|||
150259882|NCT02412371|542087279|FG001|Overall Study|Sponsor Discontinued Study|4|||
150259883|NCT02412371|542087280|FG002|Overall Study|Sponsor Discontinued Study|6|||
150259884|NCT02412371|542087281|FG003|Overall Study|Sponsor Discontinued Study|4|||
150259885|NCT02412371|542087282|FG004|Overall Study|Sponsor Discontinued Study|5|||
150259886|NCT02412371|542087283|FG005|Overall Study|Sponsor Discontinued Study|0|||
150259887|NCT02412371|542087278|FG000|Overall Study|Death|4|||
150259888|NCT02412371|542087279|FG001|Overall Study|Death|2|||
149817463|NCT00990093|540461580|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
149817464|NCT00990093|540461581|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
149817465|NCT00990093|540461580|FG000|Test Period 2 (15-28 Days)|Other|0|||
149817466|NCT00990093|540461581|FG001|Test Period 2 (15-28 Days)|Other|1|||
149817467|NCT04147611|540461587|FG000|Overall Study|Physician Decision|0|||
149817468|NCT04147611|540461588|FG001|Overall Study|Physician Decision|1|||
149817469|NCT05003167|540461589|FG000|Overall Study|Withdrawal by Subject|1|||
149817470|NCT01010230|540461590|FG000|Overall Study|Withdrawal by Subject|6|||
149817471|NCT01010230|540461591|FG001|Overall Study|Withdrawal by Subject|5|||
149817472|NCT01010230|540461590|FG000|Overall Study|Lost to Follow-up|4|||
149817473|NCT01010230|540461591|FG001|Overall Study|Lost to Follow-up|2|||
149817474|NCT01585831|540461592|FG000|Overall Study|Physician Decision|0|||
149817475|NCT01585831|540461593|FG001|Overall Study|Physician Decision|1|||
149817476|NCT01585831|540461592|FG000|Overall Study|Withdrawal by Subject|2|||
149817477|NCT01585831|540461593|FG001|Overall Study|Withdrawal by Subject|1|||
149817478|NCT01123980|540461594|FG000|Overall Study|Adverse Event|1|||
149817479|NCT01123980|540461595|FG001|Overall Study|Adverse Event|1|||
149817480|NCT01123980|540461594|FG000|Overall Study|Lack of Efficacy|1|||
149817481|NCT01123980|540461595|FG001|Overall Study|Lack of Efficacy|0|||
149817482|NCT01123980|540461594|FG000|Overall Study|Physician Decision|0|||
149817483|NCT01123980|540461595|FG001|Overall Study|Physician Decision|1|||
149817484|NCT01123980|540461594|FG000|Overall Study|Lost to Follow-up|0|||
149817485|NCT01123980|540461595|FG001|Overall Study|Lost to Follow-up|6|||
149817486|NCT01123980|540461594|FG000|Overall Study|Protocol Violation|6|||
149817487|NCT01123980|540461595|FG001|Overall Study|Protocol Violation|6|||
149817488|NCT01123980|540461594|FG000|Overall Study|Withdrawal by Subject|5|||
149817489|NCT01123980|540461595|FG001|Overall Study|Withdrawal by Subject|3|||
149817490|NCT01123980|540461594|FG000|Overall Study|Unclassified|6|||
149817491|NCT01123980|540461595|FG001|Overall Study|Unclassified|7|||
149817492|NCT01225991|540461596|FG000|Overall Study|Withdrawal by Subject|6|||
149817493|NCT04444752|540461597|FG000|Overall Study|Adverse Event|1|||
149817494|NCT04444752|540461598|FG001|Overall Study|Adverse Event|0|||
149817495|NCT04444752|540461599|FG002|Overall Study|Adverse Event|0|||
149817496|NCT04444752|540461600|FG003|Overall Study|Adverse Event|2|||
149817497|NCT04444752|540461597|FG000|Overall Study|Lost to Follow-up|2|||
149817498|NCT04444752|540461598|FG001|Overall Study|Lost to Follow-up|6|||
149817499|NCT04444752|540461599|FG002|Overall Study|Lost to Follow-up|2|||
149817500|NCT04444752|540461600|FG003|Overall Study|Lost to Follow-up|5|||
149817501|NCT04444752|540461597|FG000|Overall Study|Physician Decision|0|||
149817502|NCT04444752|540461598|FG001|Overall Study|Physician Decision|0|||
149817503|NCT04444752|540461599|FG002|Overall Study|Physician Decision|0|||
149817504|NCT04444752|540461600|FG003|Overall Study|Physician Decision|2|||
149817505|NCT04444752|540461597|FG000|Overall Study|Pregnancy|0|||
149817506|NCT04444752|540461598|FG001|Overall Study|Pregnancy|0|||
149817507|NCT04444752|540461599|FG002|Overall Study|Pregnancy|0|||
149817508|NCT04444752|540461600|FG003|Overall Study|Pregnancy|1|||
149817509|NCT04444752|540461597|FG000|Overall Study|Withdrawal by Subject|6|||
149817510|NCT04444752|540461598|FG001|Overall Study|Withdrawal by Subject|5|||
149817511|NCT04444752|540461599|FG002|Overall Study|Withdrawal by Subject|3|||
149817512|NCT04444752|540461600|FG003|Overall Study|Withdrawal by Subject|4|||
149817513|NCT04444752|540461597|FG000|Overall Study|Protocol Violation|1|||
150259889|NCT02412371|542087280|FG002|Overall Study|Death|1|||
150259890|NCT02412371|542087281|FG003|Overall Study|Death|3|||
150259891|NCT02412371|542087282|FG004|Overall Study|Death|5|||
149817514|NCT04444752|540461598|FG001|Overall Study|Protocol Violation|1|||
149817515|NCT04444752|540461599|FG002|Overall Study|Protocol Violation|0|||
149817516|NCT04444752|540461600|FG003|Overall Study|Protocol Violation|0|||
149817517|NCT04444752|540461597|FG000|Overall Study|Patient moving out of town|1|||
149817518|NCT04444752|540461598|FG001|Overall Study|Patient moving out of town|0|||
149817519|NCT04444752|540461599|FG002|Overall Study|Patient moving out of town|0|||
149817520|NCT04444752|540461600|FG003|Overall Study|Patient moving out of town|1|||
149817521|NCT04444752|540461597|FG000|Overall Study|Lack of Efficacy|0|||
149817522|NCT04444752|540461598|FG001|Overall Study|Lack of Efficacy|0|||
149920962|NCT01964989|540844932|FG000|Overall Study|Other|267|||
150259892|NCT02412371|542087283|FG005|Overall Study|Death|2|||
149920963|NCT01964989|540844933|FG001|Overall Study|Other|252|||
149920964|NCT02499263|540844934|FG000|Overall Study|Lost to Follow-up|9|||
149920965|NCT02499263|540844934|FG000|Overall Study|Participant's withdrawal of consent|4|||
149920966|NCT02499263|540844934|FG000|Overall Study|Lack of Efficacy|22|||
149920967|NCT02499263|540844934|FG000|Overall Study|investigator's judgment|12|||
149920968|NCT02499263|540844934|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
149920969|NCT02499263|540844934|FG000|Overall Study|Participant's decision|3|||
149920970|NCT02499263|540844934|FG000|Overall Study|Pregnancy|1|||
149920971|NCT02769312|540844935|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
149920972|NCT02769312|540844936|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
149920973|NCT02769312|540844935|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
149920974|NCT02769312|540844936|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
149920975|NCT02769312|540844935|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
149920976|NCT02769312|540844936|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
149920977|NCT02769312|540844935|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
149920978|NCT02769312|540844936|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
149920979|NCT02769312|540844935|FG000|Follow-up|Lost to Follow-up|1|||
149920980|NCT02769312|540844936|FG001|Follow-up|Lost to Follow-up|1|||
149920981|NCT04126317|540844937|FG000|Overall Study|Adverse Event|0|||
149920982|NCT04126317|540844938|FG001|Overall Study|Adverse Event|1|||
149920983|NCT04126317|540844937|FG000|Overall Study|Withdrawal by Subject|4|||
149920984|NCT04126317|540844938|FG001|Overall Study|Withdrawal by Subject|1|||
149920985|NCT00424593|540844939|FG000|Acute Double-Blind Period|Adverse Event|16|||
149920986|NCT00424593|540844940|FG001|Acute Double-Blind Period|Adverse Event|7|||
149920987|NCT00424593|540844939|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
149920988|NCT00424593|540844940|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
149920989|NCT00424593|540844939|FG000|Acute Double-Blind Period|Protocol Violation|2|||
149920990|NCT00424593|540844940|FG001|Acute Double-Blind Period|Protocol Violation|2|||
149920991|NCT00424593|540844939|FG000|Acute Double-Blind Period|Physician Decision|1|||
149920992|NCT00424593|540844940|FG001|Acute Double-Blind Period|Physician Decision|2|||
149920993|NCT00424593|540844939|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
149920994|NCT00424593|540844940|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
149920995|NCT00424593|540844939|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
149920996|NCT00424593|540844940|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
149920997|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
149920998|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
149920999|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Adverse Event|18|||
149921000|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Adverse Event|0|||
149921001|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
149921002|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
149921003|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
149921004|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
149921005|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
149921006|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
149921007|NCT00424593|540844939|FG000|Dose-Blind Extension Period|Physician Decision|3|||
149921008|NCT00424593|540844940|FG001|Dose-Blind Extension Period|Physician Decision|0|||
149921009|NCT02496039|540844943|FG000|Overall Study|Adverse Event|3|||
149921010|NCT02496039|540844943|FG000|Overall Study|Protocol Violation|1|||
149921011|NCT00217581|540844946|FG000|Overall Study|Withdrawal by Subject|1|||
149921012|NCT00496587|540844947|FG000|Overall Study|Adverse Event|2|||
149921013|NCT00496587|540844947|FG000|Overall Study|Progressive Disease|24|||
149921014|NCT00496587|540844947|FG000|Overall Study|Withdrawal by Subject|2|||
149921015|NCT00496587|540844947|FG000|Overall Study|Death|1|||
149921016|NCT00496587|540844947|FG000|Overall Study|Complications unrelated|2|||
149921017|NCT00482170|540844948|FG000|Overall Study|Adverse Event|5|||
149921018|NCT00482170|540844949|FG001|Overall Study|Adverse Event|14|||
149921019|NCT00482170|540844948|FG000|Overall Study|Withdrawal by Subject|6|||
150160484|NCT01606189|541719763|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
150160485|NCT01606189|541719764|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
150160486|NCT01606189|541719765|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
150160487|NCT01354938|541719766|FG000|Overall Study|Lost to Follow-up|1|||
150160488|NCT01167023|541719767|FG000|Overall Study|Lost to Follow-up|0|||
150160489|NCT01167023|541719768|FG001|Overall Study|Lost to Follow-up|1|||
150160490|NCT01167023|541719769|FG002|Overall Study|Lost to Follow-up|1|||
150160491|NCT01167023|541719767|FG000|Overall Study|Screen Failure|0|||
150160492|NCT01167023|541719768|FG001|Overall Study|Screen Failure|1|||
150160493|NCT01167023|541719769|FG002|Overall Study|Screen Failure|0|||
149921020|NCT00482170|540844949|FG001|Overall Study|Withdrawal by Subject|1|||
149921021|NCT00482170|540844948|FG000|Overall Study|Protocol Violation|2|||
149921022|NCT00482170|540844949|FG001|Overall Study|Protocol Violation|3|||
149921023|NCT00482170|540844948|FG000|Overall Study|Lost to Follow-up|2|||
150160494|NCT01167023|541719767|FG000|Overall Study|Sponsor Decision|0|||
150160495|NCT01167023|541719768|FG001|Overall Study|Sponsor Decision|1|||
150160496|NCT01167023|541719769|FG002|Overall Study|Sponsor Decision|0|||
149921024|NCT00482170|540844949|FG001|Overall Study|Lost to Follow-up|0|||
149921025|NCT00482170|540844948|FG000|Overall Study|Unspecified reason|0|||
149921026|NCT00482170|540844949|FG001|Overall Study|Unspecified reason|2|||
150259893|NCT02412371|542087278|FG000|Overall Study|Other|2|||
150259894|NCT02412371|542087279|FG001|Overall Study|Other|1|||
150259895|NCT02412371|542087280|FG002|Overall Study|Other|0|||
150259896|NCT02412371|542087281|FG003|Overall Study|Other|0|||
150259897|NCT02412371|542087282|FG004|Overall Study|Other|1|||
150259898|NCT02412371|542087283|FG005|Overall Study|Other|3|||
150259899|NCT00847808|542087284|FG000|Overall Study|Adverse Event|7|||
150259900|NCT00847808|542087284|FG000|Overall Study|Protocol Violation|1|||
150259901|NCT00847808|542087284|FG000|Overall Study|Lost to Follow-up|1|||
150259902|NCT00847808|542087284|FG000|Overall Study|Withdrawal by Subject|4|||
150259903|NCT00847808|542087284|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
150259904|NCT00847808|542087284|FG000|Overall Study|Participant Took Excluded Medication|1|||
150259905|NCT05000931|542087293|FG000|Overall Study|Lost to Follow-up|1|||
150259906|NCT00925132|542087294|FG000|Overall Study|Withdrawal by Subject|2|||
150259907|NCT00925132|542087295|FG001|Overall Study|Withdrawal by Subject|0|||
150259908|NCT00925132|542087296|FG002|Overall Study|Withdrawal by Subject|0|||
150259909|NCT00925132|542087297|FG003|Overall Study|Withdrawal by Subject|0|||
150259910|NCT00925132|542087298|FG004|Overall Study|Withdrawal by Subject|1|||
150259911|NCT00925132|542087294|FG000|Overall Study|Removed due to disease progression|0|||
150259912|NCT00925132|542087295|FG001|Overall Study|Removed due to disease progression|0|||
150259913|NCT00925132|542087296|FG002|Overall Study|Removed due to disease progression|0|||
150259914|NCT00925132|542087297|FG003|Overall Study|Removed due to disease progression|0|||
150259915|NCT00925132|542087298|FG004|Overall Study|Removed due to disease progression|4|||
150259916|NCT02545933|542087299|FG000|Overall Study|Adverse Event|3|||
150259917|NCT02545933|542087300|FG001|Overall Study|Adverse Event|0|||
150259918|NCT02545933|542087301|FG002|Overall Study|Adverse Event|0|||
150259919|NCT02545933|542087299|FG000|Overall Study|Withdrawal by Subject|2|||
150259920|NCT02545933|542087300|FG001|Overall Study|Withdrawal by Subject|3|||
150259921|NCT02545933|542087301|FG002|Overall Study|Withdrawal by Subject|3|||
149921027|NCT01134263|540844950|FG000|Overall Study|Serious adverse event|2|||
149921028|NCT01134263|540844951|FG001|Overall Study|Serious adverse event|1|||
149921029|NCT01134263|540844952|FG002|Overall Study|Serious adverse event|1|||
149921030|NCT01134263|540844953|FG003|Overall Study|Serious adverse event|1|||
149921031|NCT01134263|540844954|FG004|Overall Study|Serious adverse event|1|||
149921032|NCT01134263|540844950|FG000|Overall Study|Other adverse event|1|||
149921033|NCT01134263|540844951|FG001|Overall Study|Other adverse event|2|||
149921034|NCT01134263|540844952|FG002|Overall Study|Other adverse event|5|||
149921035|NCT01134263|540844953|FG003|Overall Study|Other adverse event|3|||
149921036|NCT01134263|540844954|FG004|Overall Study|Other adverse event|0|||
149921037|NCT01134263|540844950|FG000|Overall Study|Protocol Violation|8|||
149921038|NCT01134263|540844951|FG001|Overall Study|Protocol Violation|7|||
149921039|NCT01134263|540844952|FG002|Overall Study|Protocol Violation|2|||
149921040|NCT01134263|540844953|FG003|Overall Study|Protocol Violation|4|||
149921041|NCT01134263|540844954|FG004|Overall Study|Protocol Violation|2|||
149921042|NCT01134263|540844950|FG000|Overall Study|Lost to Follow-up|4|||
149921043|NCT01134263|540844951|FG001|Overall Study|Lost to Follow-up|3|||
149921044|NCT01134263|540844952|FG002|Overall Study|Lost to Follow-up|5|||
149921045|NCT01134263|540844953|FG003|Overall Study|Lost to Follow-up|3|||
149921046|NCT01134263|540844954|FG004|Overall Study|Lost to Follow-up|1|||
149921047|NCT01134263|540844950|FG000|Overall Study|Withdrawal by Subject|8|||
149921048|NCT01134263|540844951|FG001|Overall Study|Withdrawal by Subject|6|||
149921049|NCT01134263|540844952|FG002|Overall Study|Withdrawal by Subject|16|||
149921050|NCT01134263|540844953|FG003|Overall Study|Withdrawal by Subject|7|||
149921051|NCT01134263|540844954|FG004|Overall Study|Withdrawal by Subject|5|||
149921052|NCT01134263|540844950|FG000|Overall Study|Enrolled, but not treated|1|||
149921053|NCT01134263|540844951|FG001|Overall Study|Enrolled, but not treated|1|||
149921054|NCT01134263|540844952|FG002|Overall Study|Enrolled, but not treated|0|||
149921055|NCT01134263|540844953|FG003|Overall Study|Enrolled, but not treated|1|||
149921056|NCT01134263|540844954|FG004|Overall Study|Enrolled, but not treated|0|||
149921057|NCT01557517|540844955|FG000|Overall Study|Death|1|||
149921058|NCT01557517|540844956|FG001|Overall Study|Death|0|||
150259922|NCT02545933|542087299|FG000|Overall Study|Protocol Violation|1|||
150259923|NCT02545933|542087300|FG001|Overall Study|Protocol Violation|0|||
150259924|NCT02545933|542087301|FG002|Overall Study|Protocol Violation|1|||
149921059|NCT01557517|540844955|FG000|Overall Study|Refused further treatment|0|||
149921060|NCT01557517|540844956|FG001|Overall Study|Refused further treatment|2|||
149921061|NCT01557517|540844955|FG000|Overall Study|Adverse Event|0|||
149921062|NCT01557517|540844956|FG001|Overall Study|Adverse Event|2|||
149921063|NCT01557517|540844955|FG000|Overall Study|Pt declined before treatment started|1|||
150259925|NCT03141905|542087302|FG000|Overall Study|Death|3|||
150259926|NCT03141905|542087303|FG001|Overall Study|Death|2|||
149921064|NCT01557517|540844956|FG001|Overall Study|Pt declined before treatment started|0|||
150259927|NCT03141905|542087302|FG000|Overall Study|Withdrawal by Subject|1|||
150259928|NCT03141905|542087303|FG001|Overall Study|Withdrawal by Subject|0|||
150259929|NCT03141905|542087302|FG000|Overall Study|Lost to Follow-up|3|||
149921065|NCT02007278|540844959|FG000|Overall Study|Failure to comply with an eligibility|0|||
149921066|NCT02007278|540844960|FG001|Overall Study|Failure to comply with an eligibility|1|||
149921067|NCT02007278|540844959|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
149921068|NCT02007278|540844960|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
149921069|NCT02007278|540844959|FG000|Overall Study|Incorrect medication administration|1|||
149921070|NCT02007278|540844960|FG001|Overall Study|Incorrect medication administration|0|||
149921071|NCT02007278|540844959|FG000|Overall Study|Mis-randomization|1|||
149921072|NCT02007278|540844960|FG001|Overall Study|Mis-randomization|1|||
149921073|NCT02279745|540844965|FG000|Overall Study|Adverse Event|7|||
149921074|NCT02279745|540844965|FG000|Overall Study|Death|6|||
149921075|NCT02279745|540844965|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
149921076|NCT02279745|540844965|FG000|Overall Study|Withdrawal by Subject|2|||
149921077|NCT02279745|540844965|FG000|Overall Study|Pregnancy|1|||
149921078|NCT02279745|540844965|FG000|Overall Study|Study Non-compliance|1|||
149921079|NCT02279745|540844965|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
149921080|NCT00380718|540844966|FG000|Overall Study|Adverse Event|1|||
149921081|NCT00380718|540844966|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
149921082|NCT01706575|540844970|FG000|Overall Study|Participant Withdrew Consent|4|||
149921083|NCT01706575|540844970|FG000|Overall Study|Lost to Follow-up|2|||
149921084|NCT01706575|540844970|FG000|Overall Study|Started but not Treated|6|||
149921085|NCT02912455|540844971|FG000|Overall Study|Withdrawal by Subject|0|||
149921086|NCT02912455|540844972|FG001|Overall Study|Withdrawal by Subject|1|||
149921087|NCT02912455|540844971|FG000|Overall Study|Lack of Efficacy|0|||
149921088|NCT02912455|540844972|FG001|Overall Study|Lack of Efficacy|1|||
149921089|NCT02912455|540844971|FG000|Overall Study|Lost to Follow-up|2|||
149921090|NCT02912455|540844972|FG001|Overall Study|Lost to Follow-up|1|||
149921091|NCT02670382|540844973|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
149921092|NCT02670382|540844974|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
149921093|NCT03244618|540844977|FG000|Overall Study|Lost to Follow-up|3|||
149921094|NCT03244618|540844978|FG001|Overall Study|Lost to Follow-up|4|||
149921095|NCT03244618|540844977|FG000|Overall Study|Protocol Violation|4|||
149921096|NCT03244618|540844978|FG001|Overall Study|Protocol Violation|3|||
149921097|NCT03244618|540844977|FG000|Overall Study|Withdrawal by Subject|0|||
149921098|NCT03244618|540844978|FG001|Overall Study|Withdrawal by Subject|2|||
149921099|NCT03469999|540844979|FG000|Overall Study|Lost to Follow-up|2|||
149921100|NCT04424914|540844983|FG000|Overall Study|Other|0|||
149921101|NCT04424914|540844984|FG001|Overall Study|Other|0|||
149921102|NCT04424914|540844985|FG002|Overall Study|Other|28|||
149921103|NCT04424914|540844983|FG000|Overall Study|Withdrawal by Subject|3|||
149921104|NCT04424914|540844984|FG001|Overall Study|Withdrawal by Subject|0|||
149921105|NCT04424914|540844985|FG002|Overall Study|Withdrawal by Subject|0|||
149921106|NCT04424914|540844983|FG000|Overall Study|Study terminated by sponsor|23|||
149921107|NCT04424914|540844984|FG001|Overall Study|Study terminated by sponsor|7|||
149921108|NCT04424914|540844985|FG002|Overall Study|Study terminated by sponsor|0|||
149921109|NCT04424914|540844983|FG000|Overall Study|Lost to Follow-up|0|||
149921110|NCT04424914|540844984|FG001|Overall Study|Lost to Follow-up|0|||
149921111|NCT04424914|540844985|FG002|Overall Study|Lost to Follow-up|1|||
149921112|NCT04424914|540844983|FG000|Overall Study|Death|3|||
149921113|NCT04424914|540844984|FG001|Overall Study|Death|1|||
149921114|NCT04424914|540844985|FG002|Overall Study|Death|0|||
149921115|NCT00460746|540844986|FG000|Overall Study|Adverse Event|1|||
149921116|NCT00460746|540844986|FG000|Overall Study|Lost to Follow-up|1|||
149921117|NCT02791438|540844990|FG000|Treatment Period|Adverse Event|1|||
149921118|NCT02791438|540844991|FG001|Treatment Period|Adverse Event|0|||
149921119|NCT02791438|540844990|FG000|Treatment Period|Withdrawal by Subject|0|||
149921120|NCT02791438|540844991|FG001|Treatment Period|Withdrawal by Subject|1|||
149921121|NCT02791438|540844990|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
149921122|NCT02791438|540844991|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
149921123|NCT01428115|540844992|FG000|Overall Study|Lack of Efficacy|3|||
149921124|NCT01428115|540844992|FG000|Overall Study|Lost to Follow-up|10|||
149921125|NCT01428115|540844992|FG000|Overall Study|Pregnancy|1|||
149921126|NCT01428115|540844992|FG000|Overall Study|Protocol Violation|3|||
149921127|NCT01428115|540844992|FG000|Overall Study|Withdrawal by Subject|4|||
150160497|NCT01167023|541719767|FG000|Overall Study|Withdrawal by Subject|0|||
150160498|NCT01167023|541719768|FG001|Overall Study|Withdrawal by Subject|0|||
150160499|NCT01167023|541719769|FG002|Overall Study|Withdrawal by Subject|1|||
150160500|NCT00410384|541719770|FG000|Overall Study|Withdrawal by Subject|28|||
150160501|NCT00410384|541719771|FG001|Overall Study|Withdrawal by Subject|17|||
150160502|NCT00410384|541719772|FG002|Overall Study|Withdrawal by Subject|20|||
150160503|NCT00410384|541719770|FG000|Overall Study|Adverse Event|23|||
149921128|NCT01810783|540844993|FG000|Overall Study|Adverse Event|32|||
149921129|NCT01810783|540844993|FG000|Overall Study|Withdrawal by Subject|22|||
149921130|NCT01810783|540844993|FG000|Overall Study|Lack of Efficacy|12|||
149921131|NCT01810783|540844993|FG000|Overall Study|Lost to Follow-up|10|||
149921132|NCT01810783|540844993|FG000|Overall Study|Protocol Violation|5|||
149921133|NCT01810783|540844993|FG000|Overall Study|Non-compliance with IMP|4|||
150160504|NCT00410384|541719771|FG001|Overall Study|Adverse Event|18|||
149921134|NCT01810783|540844993|FG000|Overall Study|Adminstrative or other reason(s)|23|||
150160505|NCT00410384|541719772|FG002|Overall Study|Adverse Event|23|||
150160506|NCT00410384|541719770|FG000|Overall Study|Lack of Efficacy|20|||
150160507|NCT00410384|541719771|FG001|Overall Study|Lack of Efficacy|12|||
150160508|NCT00410384|541719772|FG002|Overall Study|Lack of Efficacy|17|||
150160509|NCT00410384|541719770|FG000|Overall Study|Lack of Compliance|2|||
150160510|NCT00410384|541719771|FG001|Overall Study|Lack of Compliance|2|||
150160511|NCT00410384|541719772|FG002|Overall Study|Lack of Compliance|2|||
150160512|NCT00410384|541719770|FG000|Overall Study|Lost to Follow-up|4|||
150160513|NCT00410384|541719771|FG001|Overall Study|Lost to Follow-up|6|||
150160514|NCT00410384|541719772|FG002|Overall Study|Lost to Follow-up|6|||
150160515|NCT00410384|541719770|FG000|Overall Study|Protocol Violation|6|||
150160516|NCT00410384|541719771|FG001|Overall Study|Protocol Violation|6|||
150160517|NCT00410384|541719772|FG002|Overall Study|Protocol Violation|6|||
150160518|NCT00410384|541719770|FG000|Overall Study|Physician Decision|3|||
149817523|NCT04444752|540461599|FG002|Overall Study|Lack of Efficacy|0|||
149817524|NCT04444752|540461600|FG003|Overall Study|Lack of Efficacy|1|||
149817525|NCT04444752|540461597|FG000|Overall Study|Death|0|||
149817526|NCT04444752|540461598|FG001|Overall Study|Death|0|||
149817527|NCT04444752|540461599|FG002|Overall Study|Death|1|||
149817528|NCT04444752|540461600|FG003|Overall Study|Death|0|||
149817529|NCT01963676|540463422|FG000|Overall Study|Withdrawal by Subject|1|||
149817530|NCT01963676|540463423|FG001|Overall Study|Withdrawal by Subject|0|||
149817531|NCT02496221|540463424|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
149817532|NCT02496221|540463425|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
149817533|NCT02496221|540463424|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
149817534|NCT02496221|540463425|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
149817535|NCT02496221|540463424|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
149817536|NCT02496221|540463425|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
149817537|NCT01120600|540463428|FG000|Overall Study|Adverse Event|7|||
149817538|NCT01120600|540463429|FG001|Overall Study|Adverse Event|7|||
149817539|NCT01120600|540463428|FG000|Overall Study|Excessive Bone Loss|0|||
149817540|NCT01120600|540463429|FG001|Overall Study|Excessive Bone Loss|4|||
149817541|NCT01120600|540463428|FG000|Overall Study|Lost to Follow-up|1|||
149817542|NCT01120600|540463429|FG001|Overall Study|Lost to Follow-up|3|||
149817543|NCT01120600|540463428|FG000|Overall Study|Physician Decision|1|||
149817544|NCT01120600|540463429|FG001|Overall Study|Physician Decision|3|||
149817545|NCT01120600|540463428|FG000|Overall Study|Protocol Violation|0|||
149817546|NCT01120600|540463429|FG001|Overall Study|Protocol Violation|4|||
149817547|NCT01120600|540463428|FG000|Overall Study|Withdrawal by Subject|10|||
149817548|NCT01120600|540463429|FG001|Overall Study|Withdrawal by Subject|11|||
149817549|NCT00833547|540463431|FG000|Overall Study|Withdrawal by Subject|2|||
149817550|NCT00833547|540463432|FG001|Overall Study|Withdrawal by Subject|2|||
149817551|NCT00566098|540463434|FG000|Collection of MILs|Withdrawal by Subject|1|||
149817552|NCT00566098|540463434|FG000|Collection of MILs|Relapsed|1|||
149817553|NCT00566098|540463434|FG000|Generation of MILs Product|Relapsed|1|||
149817554|NCT00566098|540463434|FG000|Administration of ASCT+MILs|Death|10|||
149817555|NCT00566098|540463434|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
149817556|NCT01690520|540463437|FG000|Overall Study|Death|25|||
149817557|NCT01690520|540463438|FG001|Overall Study|Death|21|||
149817558|NCT01690520|540463437|FG000|Overall Study|Lost to Follow-up|2|||
149817559|NCT01690520|540463438|FG001|Overall Study|Lost to Follow-up|3|||
149817560|NCT01690520|540463437|FG000|Overall Study|Withdrawal by Subject|2|||
149817561|NCT01690520|540463438|FG001|Overall Study|Withdrawal by Subject|0|||
149817562|NCT01690520|540463437|FG000|Overall Study|Relapse|0|||
149817563|NCT01690520|540463438|FG001|Overall Study|Relapse|1|||
149817564|NCT01690520|540463437|FG000|Overall Study|Other|0|||
149817565|NCT01690520|540463438|FG001|Overall Study|Other|1|||
149817566|NCT01690520|540463437|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
149817567|NCT01690520|540463438|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
149817568|NCT02236754|540463439|FG000|Overall Study|Withdrawal by Subject|1|||
149817569|NCT02236754|540463440|FG001|Overall Study|Withdrawal by Subject|0|||
149817570|NCT04313283|540463444|FG000|Overall Study|did not complete intervention|4|||
149817571|NCT00368537|540463446|FG000|Randomization|No study drug dosed|13|||
149817572|NCT00368537|540463447|FG001|Randomization|No study drug dosed|6|||
149817573|NCT00368537|540463446|FG000|Baseline Participants|Lost to Follow-up|16|||
149921135|NCT01810783|540844993|FG000|Overall Study|Enrolled, not treated|1|||
149817574|NCT00368537|540463447|FG001|Baseline Participants|Lost to Follow-up|17|||
149817575|NCT00368537|540463446|FG000|Baseline Participants|Withdrawal by Subject|6|||
149921136|NCT02620384|540844994|FG000|Overall Study|Adverse Event|2|||
150160519|NCT00410384|541719771|FG001|Overall Study|Physician Decision|3|||
150160520|NCT00410384|541719772|FG002|Overall Study|Physician Decision|4|||
150160521|NCT00410384|541719770|FG000|Overall Study|Other|3|||
150160522|NCT00410384|541719771|FG001|Overall Study|Other|8|||
149817576|NCT00368537|540463447|FG001|Baseline Participants|Withdrawal by Subject|4|||
149817577|NCT00368537|540463446|FG000|Baseline Participants|Death|1|||
149817578|NCT00368537|540463447|FG001|Baseline Participants|Death|2|||
149817579|NCT00368537|540463446|FG000|Baseline Participants|No susceptibility|1|||
150160523|NCT00410384|541719772|FG002|Overall Study|Other|4|||
149921137|NCT02620384|540844995|FG001|Overall Study|Adverse Event|1|||
149921138|NCT02620384|540844994|FG000|Overall Study|Discharged prior to 2nd dose|2|||
149921139|NCT02620384|540844995|FG001|Overall Study|Discharged prior to 2nd dose|5|||
149921140|NCT02620384|540844994|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
149921141|NCT02620384|540844995|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
149921142|NCT02071082|540844996|FG000|Overall Study|Enrolled and Never Treated|1|||
149921143|NCT02071082|540844997|FG001|Overall Study|Enrolled and Never Treated|1|||
149921144|NCT02071082|540844996|FG000|Overall Study|Adverse Event|0|||
149921145|NCT02071082|540844997|FG001|Overall Study|Adverse Event|1|||
149921146|NCT02071082|540844996|FG000|Overall Study|Withdrew Consent|0|||
149921147|NCT02071082|540844997|FG001|Overall Study|Withdrew Consent|4|||
149921148|NCT02071082|540844996|FG000|Overall Study|Lost to Follow-up|1|||
149921149|NCT02071082|540844997|FG001|Overall Study|Lost to Follow-up|1|||
149921150|NCT00630747|540844998|FG000|Overall Study|Death|1|||
149921151|NCT00630747|540844998|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
149921152|NCT00630747|540844998|FG000|Overall Study|Returned to country of origin|1|||
149921153|NCT04503668|540845001|FG000|Overall Study|Incomplete data|4|||
149921154|NCT04503668|540845002|FG001|Overall Study|Incomplete data|3|||
149921155|NCT04503668|540845001|FG000|Overall Study|Withdrawal by Subject|1|||
149921156|NCT04503668|540845002|FG001|Overall Study|Withdrawal by Subject|1|||
149921157|NCT04503668|540845001|FG000|Overall Study|Adverse Event|2|||
149921158|NCT04503668|540845002|FG001|Overall Study|Adverse Event|0|||
149921159|NCT03403621|540845003|FG000|Overall Study|Withdrawal by Subject|2|||
149921160|NCT03403621|540845004|FG001|Overall Study|Withdrawal by Subject|2|||
149921161|NCT01078298|540845005|FG000|Overall Study|Lost to Follow-up|12|||
149921162|NCT01078298|540845006|FG001|Overall Study|Lost to Follow-up|13|||
149921163|NCT01078298|540845005|FG000|Overall Study|Withdrawal by Subject|31|||
149921164|NCT01078298|540845006|FG001|Overall Study|Withdrawal by Subject|33|||
149921165|NCT01078298|540845005|FG000|Overall Study|Protocol Violation|6|||
149921166|NCT01078298|540845006|FG001|Overall Study|Protocol Violation|6|||
149921167|NCT01078298|540845005|FG000|Overall Study|Adverse Event|6|||
149921168|NCT01078298|540845006|FG001|Overall Study|Adverse Event|5|||
149921169|NCT01078298|540845005|FG000|Overall Study|Death|2|||
149921170|NCT01078298|540845006|FG001|Overall Study|Death|0|||
149921171|NCT01078298|540845005|FG000|Overall Study|Did not meet entrance criteria|0|||
149921172|NCT01078298|540845006|FG001|Overall Study|Did not meet entrance criteria|1|||
149921173|NCT01078298|540845005|FG000|Overall Study|Other|24|||
149921174|NCT01078298|540845006|FG001|Overall Study|Other|32|||
149921175|NCT00659776|540845007|FG000|Overall Study|Withdrawal by Subject|12|||
149921176|NCT00659776|540845008|FG001|Overall Study|Withdrawal by Subject|2|||
149921177|NCT00659776|540845009|FG002|Overall Study|Withdrawal by Subject|0|||
149921178|NCT00742027|540845010|FG000|Overall Study|Disease Progression|76|||
149921179|NCT00742027|540845010|FG000|Overall Study|New Cancer Therapy|19|||
149921180|NCT00742027|540845010|FG000|Overall Study|Withdrawal by Subject|18|||
149921181|NCT00742027|540845010|FG000|Overall Study|Death|7|||
149921182|NCT00742027|540845010|FG000|Overall Study|Lost to Follow-up|4|||
149921183|NCT00742027|540845010|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
149921184|NCT00742027|540845010|FG000|Overall Study|Missing|2|||
149921185|NCT00742027|540845010|FG000|Overall Study|Administrative Problems|1|||
149921186|NCT00628927|540845011|FG000|Overall Study|Problems performing blood draw|6|||
149921187|NCT00628927|540845012|FG001|Overall Study|Problems performing blood draw|0|||
149921188|NCT00628927|540845011|FG000|Overall Study|Lost to Follow-up|1|||
149921189|NCT00628927|540845012|FG001|Overall Study|Lost to Follow-up|0|||
149921190|NCT00628927|540845011|FG000|Overall Study|Equipment failure|1|||
149921191|NCT00628927|540845012|FG001|Overall Study|Equipment failure|0|||
149921192|NCT01298141|540845016|FG000|Overall Study|Adverse Event|3|||
149921193|NCT01298141|540845016|FG000|Overall Study|Refusal of Required Study Procedures|1|||
149921194|NCT01298141|540845016|FG000|Overall Study|Withdrawal by Subject|6|||
149921195|NCT01298141|540845016|FG000|Overall Study|Termination of Study by the Investigator|5|||
149921196|NCT01298141|540845016|FG000|Overall Study|Other|5|||
149921197|NCT01298141|540845016|FG000|Overall Study|Lost to Follow-up|1|||
149921198|NCT01298141|540845016|FG000|Overall Study|Death|6|||
149921199|NCT01298141|540845016|FG000|Overall Study|Not treated|4|||
149921200|NCT02164318|540846696|FG000|Overall Study|Withdrawal by Subject|0|||
149921201|NCT02164318|540846697|FG001|Overall Study|Withdrawal by Subject|1|||
149921202|NCT02164318|540846698|FG002|Overall Study|Withdrawal by Subject|0|||
149921203|NCT02164318|540846699|FG003|Overall Study|Withdrawal by Subject|1|||
149921204|NCT01467271|540846702|FG000|Overall Study|Death|84|||
149921205|NCT01467271|540846702|FG000|Overall Study|Lost to Follow-up|83|||
149921206|NCT01467271|540846702|FG000|Overall Study|Retraction of patient's consent|21|||
149921207|NCT01467271|540846702|FG000|Overall Study|Other reason|14|||
149921208|NCT01411319|540846703|FG000|Overall Study|Lost to Follow-up|1|||
149921209|NCT00660595|540846724|FG000|Overall Study|Lost to Follow-up|0|||
149921210|NCT00660595|540846725|FG001|Overall Study|Lost to Follow-up|1|||
149921211|NCT00660595|540846724|FG000|Overall Study|Did not consent to participate in study|12|||
149921212|NCT00660595|540846725|FG001|Overall Study|Did not consent to participate in study|8|||
149921213|NCT00660595|540846724|FG000|Overall Study|Participant left hospital|1|||
149921214|NCT00660595|540846725|FG001|Overall Study|Participant left hospital|0|||
149921215|NCT00660595|540846724|FG000|Overall Study|Non Specified reasons|5|||
149921216|NCT00660595|540846725|FG001|Overall Study|Non Specified reasons|0|||
149921217|NCT01148459|540846726|FG000|Overall Study|Serious Adverse Event|5|||
149921218|NCT01148459|540846727|FG001|Overall Study|Serious Adverse Event|4|||
149921219|NCT01148459|540846726|FG000|Overall Study|Withdrawal by Subject|1|||
149921220|NCT01148459|540846727|FG001|Overall Study|Withdrawal by Subject|0|||
149921221|NCT01148459|540846726|FG000|Overall Study|Migrated/moved from study area|3|||
149921222|NCT01148459|540846727|FG001|Overall Study|Migrated/moved from study area|6|||
149921223|NCT01148459|540846726|FG000|Overall Study|Lost to Follow-up|2|||
149921224|NCT01148459|540846727|FG001|Overall Study|Lost to Follow-up|0|||
149921225|NCT01148459|540846726|FG000|Overall Study|Refusal|1|||
149921226|NCT01148459|540846727|FG001|Overall Study|Refusal|0|||
149921227|NCT01148459|540846726|FG000|Overall Study|Failure to comply with study procedures|0|||
149921228|NCT01148459|540846727|FG001|Overall Study|Failure to comply with study procedures|1|||
149921229|NCT04854057|540846728|FG000|Overall Study|Adverse Event|0|||
149921230|NCT04854057|540846729|FG001|Overall Study|Adverse Event|1|||
149921231|NCT03230838|540846740|FG000|Overall Study|Withdrawal by Subject|3|||
149921232|NCT03230838|540846741|FG001|Overall Study|Withdrawal by Subject|0|||
149921233|NCT03230838|540846740|FG000|Overall Study|Temperature excursion|1|||
149921234|NCT03230838|540846741|FG001|Overall Study|Temperature excursion|0|||
149921235|NCT00435188|540846742|FG000|Overall Study|Death|1|||
149921236|NCT00435188|540846743|FG001|Overall Study|Death|6|||
149921237|NCT00435188|540846742|FG000|Overall Study|Withdrawal by Subject|16|||
149921238|NCT00435188|540846743|FG001|Overall Study|Withdrawal by Subject|11|||
149921239|NCT00435188|540846742|FG000|Overall Study|Lost to Follow-up|5|||
149921240|NCT00435188|540846743|FG001|Overall Study|Lost to Follow-up|6|||
149921241|NCT01915771|540846746|FG000|Day 1|Withdrawal by Subject|1|||
149921242|NCT01915771|540846746|FG000|Day 15|Withdrawal by Subject|1|||
149921243|NCT00575510|540846749|FG000|Overall Study|Lost to Follow-up|4|||
149921244|NCT00575510|540846750|FG001|Overall Study|Lost to Follow-up|6|||
149921245|NCT00575510|540846751|FG002|Overall Study|Lost to Follow-up|9|||
149921246|NCT00575510|540846749|FG000|Overall Study|Withdrawal by Subject|1|||
150160524|NCT02206685|541721408|FG000|Overall Study|Surgery cancelled/changed|2|||
150160525|NCT02206685|541721409|FG001|Overall Study|Surgery cancelled/changed|3|||
150160526|NCT02206685|541721408|FG000|Overall Study|Withdrawal by Subject|1|||
150160527|NCT02206685|541721409|FG001|Overall Study|Withdrawal by Subject|2|||
150160528|NCT02206685|541721408|FG000|Overall Study|Protocol Violation|2|||
150160529|NCT02206685|541721409|FG001|Overall Study|Protocol Violation|2|||
150160530|NCT01345292|541721410|FG000|Overall Study|Withdrawal by Subject|2|||
150160531|NCT01345292|541721411|FG001|Overall Study|Withdrawal by Subject|0|||
150160532|NCT01345292|541721412|FG002|Overall Study|Withdrawal by Subject|1|||
150160533|NCT00465361|541721416|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
150160534|NCT05406791|541721417|FG000|Overall Study|Lost to Follow-up|13|||
150160535|NCT05406791|541721418|FG001|Overall Study|Lost to Follow-up|10|||
150160536|NCT00515086|541721419|FG000|Overall Study|Adverse Event|1|||
150160537|NCT00515086|541721420|FG001|Overall Study|Adverse Event|1|||
150160538|NCT00515086|541721421|FG002|Overall Study|Adverse Event|2|||
150160539|NCT00515086|541721422|FG003|Overall Study|Adverse Event|3|||
150160540|NCT00515086|541721419|FG000|Overall Study|Administrative|1|||
150160541|NCT00515086|541721420|FG001|Overall Study|Administrative|1|||
150160542|NCT00515086|541721421|FG002|Overall Study|Administrative|0|||
150160543|NCT00515086|541721422|FG003|Overall Study|Administrative|0|||
150160544|NCT00515086|541721419|FG000|Overall Study|Withdrawal by Subject|1|||
150160545|NCT00515086|541721420|FG001|Overall Study|Withdrawal by Subject|0|||
150160546|NCT00515086|541721421|FG002|Overall Study|Withdrawal by Subject|0|||
150160547|NCT00515086|541721422|FG003|Overall Study|Withdrawal by Subject|1|||
150160548|NCT00515086|541721419|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
150160549|NCT00515086|541721420|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
150160550|NCT00515086|541721421|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
150160551|NCT00515086|541721422|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
150160552|NCT00515086|541721419|FG000|Overall Study|Lost to Follow-up|1|||
150160553|NCT00515086|541721420|FG001|Overall Study|Lost to Follow-up|0|||
150160554|NCT00515086|541721421|FG002|Overall Study|Lost to Follow-up|0|||
150160555|NCT00515086|541721422|FG003|Overall Study|Lost to Follow-up|0|||
150160556|NCT00515086|541721419|FG000|Overall Study|Study drug no longer required|0|||
149921247|NCT00575510|540846750|FG001|Overall Study|Withdrawal by Subject|0|||
149921248|NCT00575510|540846751|FG002|Overall Study|Withdrawal by Subject|0|||
149921249|NCT00575510|540846749|FG000|Overall Study|Clinic Called Patient|7|||
149921250|NCT00575510|540846750|FG001|Overall Study|Clinic Called Patient|7|||
149921251|NCT00575510|540846751|FG002|Overall Study|Clinic Called Patient|7|||
150160557|NCT00515086|541721420|FG001|Overall Study|Study drug no longer required|1|||
150160558|NCT00515086|541721421|FG002|Overall Study|Study drug no longer required|0|||
150160559|NCT00515086|541721422|FG003|Overall Study|Study drug no longer required|0|||
150160560|NCT00515086|541721419|FG000|Overall Study|Death|2|||
150160561|NCT00515086|541721420|FG001|Overall Study|Death|0|||
150160562|NCT00515086|541721421|FG002|Overall Study|Death|0|||
150160563|NCT00515086|541721422|FG003|Overall Study|Death|0|||
150259930|NCT03141905|542087303|FG001|Overall Study|Lost to Follow-up|7|||
150259931|NCT03141905|542087302|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
149921252|NCT00575510|540846749|FG000|Overall Study|Pregnancy|0|||
149921253|NCT00575510|540846750|FG001|Overall Study|Pregnancy|0|||
150259932|NCT03141905|542087303|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
150259933|NCT05180500|542087305|FG000|Overall Study|Adverse Event|1|||
150259934|NCT05180500|542087306|FG001|Overall Study|Adverse Event|0|||
149921254|NCT00575510|540846751|FG002|Overall Study|Pregnancy|1|||
149921255|NCT01778751|540846756|FG000|Overall Study|Lost to Follow-up|1|||
149921256|NCT01778751|540846757|FG001|Overall Study|Lost to Follow-up|0|||
149921257|NCT01778751|540846756|FG000|Overall Study|Withdrawal by Subject|0|||
150259935|NCT05180500|542087305|FG000|Overall Study|Withdrawal by Subject|2|||
150259936|NCT05180500|542087306|FG001|Overall Study|Withdrawal by Subject|0|||
150259937|NCT04927884|542087307|FG000|Overall Study|Progressive Disease|2|||
150259938|NCT00727311|542087308|FG000|Overall Study|Did not receive drug|316|||
150259939|NCT00727311|542087308|FG000|Overall Study|Missing end of therapy data|205|||
150259940|NCT00727311|542087308|FG000|Overall Study|Adverse Event|58|||
150259941|NCT00727311|542087308|FG000|Overall Study|Lack of Efficacy|242|||
149921258|NCT01778751|540846757|FG001|Overall Study|Withdrawal by Subject|2|||
149921259|NCT01778751|540846756|FG000|Overall Study|Transfered care|1|||
149921260|NCT01778751|540846757|FG001|Overall Study|Transfered care|0|||
149921261|NCT02669667|540846761|FG000|Overall Study|Lost to Follow-up|0|||
149921262|NCT02669667|540846762|FG001|Overall Study|Lost to Follow-up|0|||
149921263|NCT02669667|540846763|FG002|Overall Study|Lost to Follow-up|0|||
149921264|NCT02669667|540846764|FG003|Overall Study|Lost to Follow-up|0|||
149921265|NCT02669667|540846765|FG004|Overall Study|Lost to Follow-up|0|||
150259942|NCT00727311|542087308|FG000|Overall Study|Lost to Follow-up|73|||
150259943|NCT00727311|542087308|FG000|Overall Study|Withdrawal by Subject|77|||
150259944|NCT00727311|542087308|FG000|Overall Study|Other|97|||
149921266|NCT02669667|540846766|FG005|Overall Study|Lost to Follow-up|1|||
150259945|NCT00727311|542087308|FG000|Overall Study|Multiple reasons|39|||
150259946|NCT03992846|542087309|FG000|Overall Study|Adverse Event|8|||
149921267|NCT02669667|540846767|FG006|Overall Study|Lost to Follow-up|0|||
149921268|NCT01603394|540846768|FG000|Overall Study|Adverse Event|1|||
149921269|NCT00840034|540846769|FG000|Acute Treatment Phase|Adverse Event|6|||
149921270|NCT00840034|540846770|FG001|Acute Treatment Phase|Adverse Event|8|||
149921271|NCT00840034|540846769|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
149921272|NCT00840034|540846770|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
149921273|NCT00840034|540846769|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
149921274|NCT00840034|540846770|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
149921275|NCT00840034|540846769|FG000|Acute Treatment Phase|Physician Decision|0|||
149921276|NCT00840034|540846770|FG001|Acute Treatment Phase|Physician Decision|1|||
149921277|NCT00840034|540846769|FG000|Acute Treatment Phase|Protocol Violation|2|||
149921278|NCT00840034|540846770|FG001|Acute Treatment Phase|Protocol Violation|4|||
149921279|NCT00840034|540846769|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
149921280|NCT00840034|540846770|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
149921281|NCT00840034|540846769|FG000|Taper Phase|Adverse Event|1|||
149921282|NCT00840034|540846770|FG001|Taper Phase|Adverse Event|0|||
149921283|NCT00840034|540846769|FG000|Taper Phase|Lost to Follow-up|1|||
149921284|NCT00840034|540846770|FG001|Taper Phase|Lost to Follow-up|1|||
149921285|NCT00840034|540846769|FG000|Taper Phase|Withdrawal by Subject|1|||
149921286|NCT00840034|540846770|FG001|Taper Phase|Withdrawal by Subject|1|||
149921287|NCT01215435|540846771|FG000|Overall Study|Adverse Event|1|||
149921288|NCT01215435|540846772|FG001|Overall Study|Adverse Event|0|||
149921289|NCT01215435|540846771|FG000|Overall Study|Protocol Violation|2|||
149921290|NCT01215435|540846772|FG001|Overall Study|Protocol Violation|0|||
149921291|NCT01215435|540846771|FG000|Overall Study|Withdrawal Criteria|8|||
149921292|NCT01215435|540846772|FG001|Overall Study|Withdrawal Criteria|11|||
149921293|NCT01215435|540846771|FG000|Overall Study|Lost to Follow-up|3|||
149921294|NCT01215435|540846772|FG001|Overall Study|Lost to Follow-up|0|||
149921295|NCT01215435|540846771|FG000|Overall Study|Unclassified|5|||
149921296|NCT01215435|540846772|FG001|Overall Study|Unclassified|5|||
149921297|NCT00394771|540846779|FG000|Overall Study|Did not meet protocol requirements|1|||
149921298|NCT00394771|540846780|FG001|Overall Study|Did not meet protocol requirements|0|||
149921299|NCT00394771|540846781|FG002|Overall Study|Did not meet protocol requirements|2|||
149921300|NCT00394771|540846782|FG003|Overall Study|Did not meet protocol requirements|0|||
149921301|NCT00394771|540846779|FG000|Overall Study|Protocol Violation|2|||
149921302|NCT00394771|540846780|FG001|Overall Study|Protocol Violation|4|||
149921303|NCT00394771|540846781|FG002|Overall Study|Protocol Violation|9|||
149921304|NCT00394771|540846782|FG003|Overall Study|Protocol Violation|7|||
149921305|NCT00394771|540846779|FG000|Overall Study|Withdrawal by Subject|10|||
149921306|NCT00394771|540846780|FG001|Overall Study|Withdrawal by Subject|6|||
149921307|NCT00394771|540846781|FG002|Overall Study|Withdrawal by Subject|8|||
149921308|NCT00394771|540846782|FG003|Overall Study|Withdrawal by Subject|12|||
149921309|NCT00394771|540846779|FG000|Overall Study|Adverse Event|10|||
149921310|NCT00394771|540846780|FG001|Overall Study|Adverse Event|5|||
150259947|NCT03992846|542087310|FG001|Overall Study|Adverse Event|6|||
150259948|NCT03992846|542087311|FG002|Overall Study|Adverse Event|3|||
149921311|NCT00394771|540846781|FG002|Overall Study|Adverse Event|12|||
149921312|NCT00394771|540846782|FG003|Overall Study|Adverse Event|8|||
149921313|NCT00394771|540846779|FG000|Overall Study|Participant pregnant|0|||
149921314|NCT00394771|540846780|FG001|Overall Study|Participant pregnant|1|||
149921315|NCT00394771|540846781|FG002|Overall Study|Participant pregnant|2|||
149921316|NCT00394771|540846782|FG003|Overall Study|Participant pregnant|2|||
149921317|NCT00394771|540846779|FG000|Overall Study|Lost to Follow-up|15|||
149921318|NCT00394771|540846780|FG001|Overall Study|Lost to Follow-up|15|||
149921319|NCT00394771|540846781|FG002|Overall Study|Lost to Follow-up|13|||
149921320|NCT00394771|540846782|FG003|Overall Study|Lost to Follow-up|10|||
149921321|NCT00394771|540846779|FG000|Overall Study|Other|3|||
149921322|NCT00394771|540846780|FG001|Overall Study|Other|3|||
149921323|NCT00394771|540846781|FG002|Overall Study|Other|1|||
149921324|NCT00394771|540846782|FG003|Overall Study|Other|0|||
149921325|NCT03383692|540846783|FG000|Overall Study|Progressive disease as per RECIST|3|||
149921326|NCT03383692|540846784|FG001|Overall Study|Progressive disease as per RECIST|3|||
149921327|NCT03383692|540846783|FG000|Overall Study|Clinical progression|0|||
149921328|NCT03383692|540846784|FG001|Overall Study|Clinical progression|1|||
149921329|NCT03383692|540846783|FG000|Overall Study|Adverse Event|3|||
149921330|NCT03383692|540846784|FG001|Overall Study|Adverse Event|0|||
149921331|NCT02839876|540846791|FG000|Overall Study|Protocol Violation|10|||
149921332|NCT02839876|540846792|FG001|Overall Study|Protocol Violation|11|||
149921333|NCT01156051|540846799|FG000|Overall Study|Lost to Follow-up|1|||
149921334|NCT01156051|540846800|FG001|Overall Study|Lost to Follow-up|0|||
149921335|NCT01156051|540846799|FG000|Overall Study|patient not compliant with protocol|0|||
149921336|NCT01156051|540846800|FG001|Overall Study|patient not compliant with protocol|1|||
149921337|NCT03816007|540846801|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
149921338|NCT03816007|540846802|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
149921339|NCT03816007|540846801|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
149921340|NCT03816007|540846802|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
149921341|NCT03816007|540846801|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
149921342|NCT03816007|540846802|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
149921343|NCT02179749|540846806|FG000|Overall Study|Adverse Event|0|||
149921344|NCT02179749|540846807|FG001|Overall Study|Adverse Event|0|||
149921345|NCT02179749|540846808|FG002|Overall Study|Adverse Event|1|||
149921346|NCT02179749|540846806|FG000|Overall Study|Withdrawal by Subject|0|||
149921347|NCT02179749|540846807|FG001|Overall Study|Withdrawal by Subject|0|||
149921348|NCT02179749|540846808|FG002|Overall Study|Withdrawal by Subject|1|||
149921349|NCT00793546|540846809|FG000|Overall Study|Death|3|||
149921350|NCT00793546|540846810|FG001|Overall Study|Death|0|||
149921351|NCT00793546|540846809|FG000|Overall Study|Lost to Follow-up|1|||
149921352|NCT00793546|540846810|FG001|Overall Study|Lost to Follow-up|0|||
149921353|NCT00793546|540846809|FG000|Overall Study|Withdrawal by Subject|1|||
149921354|NCT00793546|540846810|FG001|Overall Study|Withdrawal by Subject|1|||
149921355|NCT00793546|540846809|FG000|Overall Study|Study Terminated by Sponsor|8|||
149921356|NCT00793546|540846810|FG001|Overall Study|Study Terminated by Sponsor|27|||
149921357|NCT00793546|540846809|FG000|Overall Study|Other|1|||
149921358|NCT00793546|540846810|FG001|Overall Study|Other|0|||
149921359|NCT02101359|540846811|FG000|Overall Study|Not included|23|||
149921360|NCT02101359|540846812|FG001|Overall Study|Not included|13|||
149921361|NCT02101359|540846811|FG000|Overall Study|Withdrawal by Subject|5|||
149921362|NCT02101359|540846812|FG001|Overall Study|Withdrawal by Subject|4|||
149921363|NCT02101359|540846811|FG000|Overall Study|Lost to Follow-up|1|||
149921364|NCT02101359|540846812|FG001|Overall Study|Lost to Follow-up|0|||
149921365|NCT02101359|540846811|FG000|Overall Study|Protocol Violation|0|||
149921366|NCT02101359|540846812|FG001|Overall Study|Protocol Violation|2|||
149921367|NCT01841567|540846817|FG000|Overall Study|Adverse Event|3|||
149921368|NCT03755518|540846818|FG000|Overall Study|Lack of Efficacy|10|||
149921369|NCT03755518|540846818|FG000|Overall Study|Adverse Event|7|||
149921370|NCT03755518|540846818|FG000|Overall Study|Study Terminated by Sponsor|5|||
149921371|NCT03755518|540846818|FG000|Overall Study|Death|1|||
150160564|NCT02373813|541721423|FG000|Run-In Period|Other, Not Specified|5|||
149921372|NCT03755518|540846818|FG000|Overall Study|Withdrawal by Subject|3|||
149921373|NCT03755518|540846818|FG000|Overall Study|Progressive Disease|4|||
149921374|NCT03755518|540846818|FG000|Overall Study|Bone Marrow Transplant|4|||
150160565|NCT02373813|541721424|FG001|Run-In Period|Other, Not Specified|0|||
150160566|NCT02373813|541721425|FG002|Run-In Period|Other, Not Specified|0|||
149921375|NCT03755518|540846818|FG000|Overall Study|Physicians Decision|1|||
149921376|NCT03755518|540846818|FG000|Overall Study|Relapse|1|||
149921377|NCT03755518|540846818|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
149921378|NCT03755518|540846818|FG000|Overall Study|Withdrawal by PI|1|||
149921379|NCT03172364|540846819|FG000|Overall Study|Adverse Event|1|||
149921380|NCT03172364|540846820|FG001|Overall Study|Adverse Event|1|||
149921381|NCT03172364|540846819|FG000|Overall Study|Protocol Violation|1|||
149921382|NCT03172364|540846820|FG001|Overall Study|Protocol Violation|0|||
149921383|NCT01714609|540846821|FG000|Overall Study|Protocol Violation|1|||
149921384|NCT01714609|540846822|FG001|Overall Study|Protocol Violation|0|||
149921385|NCT02732327|540846823|FG000|Overall Study|Protocol Violation|0|||
149921386|NCT02732327|540846824|FG001|Overall Study|Protocol Violation|1|||
149921387|NCT02306694|540846825|FG000|Overall Study|Withdrawal by Subject|3|||
149921388|NCT02306694|540846825|FG000|Overall Study|Lost to Follow-up|1|||
149921389|NCT00603382|540846826|FG000|Overall Study|Adverse Event|0|||
149921390|NCT00603382|540846827|FG001|Overall Study|Adverse Event|1|||
149921391|NCT00603382|540846828|FG002|Overall Study|Adverse Event|1|||
149921392|NCT00603382|540846829|FG003|Overall Study|Adverse Event|2|||
149921393|NCT00603382|540846830|FG004|Overall Study|Adverse Event|1|||
149921394|NCT00603382|540846831|FG005|Overall Study|Adverse Event|2|||
149921395|NCT00603382|540846826|FG000|Overall Study|Lack of Efficacy|14|||
149921396|NCT00603382|540846827|FG001|Overall Study|Lack of Efficacy|9|||
149921397|NCT00603382|540846828|FG002|Overall Study|Lack of Efficacy|3|||
149921398|NCT00603382|540846829|FG003|Overall Study|Lack of Efficacy|6|||
149921399|NCT00603382|540846830|FG004|Overall Study|Lack of Efficacy|6|||
149921400|NCT00603382|540846831|FG005|Overall Study|Lack of Efficacy|11|||
149921401|NCT00603382|540846826|FG000|Overall Study|Protocol Violation|1|||
149921402|NCT00603382|540846827|FG001|Overall Study|Protocol Violation|0|||
149921403|NCT00603382|540846828|FG002|Overall Study|Protocol Violation|1|||
149921404|NCT00603382|540846829|FG003|Overall Study|Protocol Violation|2|||
149921405|NCT00603382|540846830|FG004|Overall Study|Protocol Violation|1|||
149921406|NCT00603382|540846831|FG005|Overall Study|Protocol Violation|0|||
149921407|NCT00603382|540846826|FG000|Overall Study|Lost to Follow-up|0|||
149921408|NCT00603382|540846827|FG001|Overall Study|Lost to Follow-up|1|||
149921409|NCT00603382|540846828|FG002|Overall Study|Lost to Follow-up|1|||
149921410|NCT00603382|540846829|FG003|Overall Study|Lost to Follow-up|1|||
149921411|NCT00603382|540846830|FG004|Overall Study|Lost to Follow-up|0|||
149921412|NCT00603382|540846831|FG005|Overall Study|Lost to Follow-up|1|||
149921413|NCT00603382|540846826|FG000|Overall Study|Physician Decision|0|||
149921414|NCT00603382|540846827|FG001|Overall Study|Physician Decision|0|||
149921415|NCT00603382|540846828|FG002|Overall Study|Physician Decision|2|||
149921416|NCT00603382|540846829|FG003|Overall Study|Physician Decision|0|||
149921417|NCT00603382|540846830|FG004|Overall Study|Physician Decision|1|||
149921418|NCT00603382|540846831|FG005|Overall Study|Physician Decision|3|||
149921419|NCT00603382|540846826|FG000|Overall Study|Withdrawal by Subject|3|||
149921420|NCT00603382|540846827|FG001|Overall Study|Withdrawal by Subject|3|||
149921421|NCT00603382|540846828|FG002|Overall Study|Withdrawal by Subject|1|||
149921422|NCT00603382|540846829|FG003|Overall Study|Withdrawal by Subject|1|||
149921423|NCT00603382|540846830|FG004|Overall Study|Withdrawal by Subject|0|||
149921424|NCT00603382|540846831|FG005|Overall Study|Withdrawal by Subject|1|||
149921425|NCT01573754|540846838|FG000|Overall Study|Noncompliance or remission not achieved|3|||
149921426|NCT01573754|540846839|FG001|Overall Study|Noncompliance or remission not achieved|15|||
149921427|NCT01180049|540846842|FG000|Overall Study|Other|9|||
149921428|NCT01180049|540846843|FG001|Overall Study|Other|7|||
149921429|NCT01180049|540846842|FG000|Overall Study|Lost to Follow-up|8|||
149921430|NCT01180049|540846843|FG001|Overall Study|Lost to Follow-up|6|||
149921431|NCT01180049|540846842|FG000|Overall Study|Death|36|||
149921432|NCT01180049|540846843|FG001|Overall Study|Death|35|||
149921433|NCT01738191|540846844|FG000|Overall Study|Withdrawal by Subject|4|||
149921434|NCT01738191|540846845|FG001|Overall Study|Withdrawal by Subject|1|||
149921435|NCT02483572|540846846|FG000|Overall Study|Withdrawal by Subject|1|||
149921436|NCT02483572|540846847|FG001|Overall Study|Withdrawal by Subject|0|||
149921437|NCT02483572|540846846|FG000|Overall Study|Lost to Follow-up|1|||
149921438|NCT02483572|540846847|FG001|Overall Study|Lost to Follow-up|0|||
149921439|NCT02483572|540846846|FG000|Overall Study|Physician Decision|0|||
149921440|NCT02483572|540846847|FG001|Overall Study|Physician Decision|1|||
149921441|NCT00350779|540846848|FG000|Overall Study|Adverse Event|4|||
149921442|NCT00350779|540846849|FG001|Overall Study|Adverse Event|2|||
149921443|NCT00350779|540846848|FG000|Overall Study|Lack of Efficacy|0|||
149921444|NCT00350779|540846849|FG001|Overall Study|Lack of Efficacy|4|||
149921445|NCT00350779|540846848|FG000|Overall Study|Lost to Follow-up|2|||
149921446|NCT00350779|540846849|FG001|Overall Study|Lost to Follow-up|0|||
149921447|NCT00350779|540846848|FG000|Overall Study|Physician Decision|2|||
149921448|NCT00350779|540846849|FG001|Overall Study|Physician Decision|4|||
149921449|NCT00350779|540846848|FG000|Overall Study|Protocol Violation|3|||
149921450|NCT00350779|540846849|FG001|Overall Study|Protocol Violation|1|||
149921451|NCT00350779|540846848|FG000|Overall Study|Withdrawal by Subject|9|||
149921452|NCT00350779|540846849|FG001|Overall Study|Withdrawal by Subject|8|||
149921453|NCT00350779|540846848|FG000|Overall Study|Patient Moved|2|||
149921454|NCT00350779|540846849|FG001|Overall Study|Patient Moved|1|||
149921455|NCT00350779|540846848|FG000|Overall Study|Non-compliance with study procedures|0|||
149921456|NCT00350779|540846849|FG001|Overall Study|Non-compliance with study procedures|1|||
149921457|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
149921458|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921459|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921460|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921461|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921462|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921463|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921464|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921465|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
149921466|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
149921467|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
149921468|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
149921469|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
149921470|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
149921471|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
149921472|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
149921473|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
149921474|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
149921475|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
149921476|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
149921477|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
149921478|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
149921479|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
149921480|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
149921481|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
149921482|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
149921483|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
149921484|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
149921485|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
149921486|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
149921487|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
150259949|NCT03992846|542087309|FG000|Overall Study|Lost to Follow-up|0|||
150259950|NCT03992846|542087310|FG001|Overall Study|Lost to Follow-up|1|||
150259951|NCT03992846|542087311|FG002|Overall Study|Lost to Follow-up|1|||
150259952|NCT03992846|542087309|FG000|Overall Study|Pregnancy|2|||
150259953|NCT03992846|542087310|FG001|Overall Study|Pregnancy|0|||
150259954|NCT03992846|542087311|FG002|Overall Study|Pregnancy|1|||
150259955|NCT03992846|542087309|FG000|Overall Study|Protocol Violation|1|||
150259956|NCT03992846|542087310|FG001|Overall Study|Protocol Violation|2|||
150259957|NCT03992846|542087311|FG002|Overall Study|Protocol Violation|0|||
150259958|NCT03992846|542087309|FG000|Overall Study|Withdrawal by Subject|8|||
150259959|NCT03992846|542087310|FG001|Overall Study|Withdrawal by Subject|10|||
150259960|NCT03992846|542087311|FG002|Overall Study|Withdrawal by Subject|20|||
150259961|NCT03992846|542087309|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
150259962|NCT03992846|542087310|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
150259963|NCT03992846|542087311|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
150259964|NCT00729378|542089232|FG000|Baseline|Did not complete study measurements|72|||
149921488|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
149921489|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
149921490|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
149921491|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
149921492|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
149921493|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921494|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921495|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
150259965|NCT00729378|542089233|FG001|Baseline|Did not complete study measurements|33|||
150259966|NCT00729378|542089232|FG000|Baseline|Withdrawal by Subject|66|||
149921496|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
149921497|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921498|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
149921499|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921500|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921501|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149921502|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
149921503|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921504|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
149921505|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921506|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921507|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
149921508|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921509|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921510|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149921511|NCT00528372|540846850|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
149921512|NCT00528372|540846851|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921513|NCT00528372|540846852|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921514|NCT00528372|540846853|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
149921515|NCT00528372|540846854|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921516|NCT00528372|540846855|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921517|NCT00528372|540846856|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921518|NCT00528372|540846857|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
149921519|NCT00528372|540846858|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
149921520|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
149921521|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
149921522|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
149921523|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
149921524|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
149921525|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
149921526|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
149921527|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
149921528|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
149921529|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
149921530|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
149921531|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
149921532|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
149921533|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
149921534|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
149921535|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
149921536|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
149921537|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
149921538|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
149921539|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
149921540|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
149921541|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
149921542|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
149921543|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
149921544|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
149921545|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
149921546|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
149921547|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
149921548|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
149921549|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
149921550|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
149921551|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
149921552|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
149921553|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
149921554|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
149921555|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
150160567|NCT02373813|541721426|FG003|Run-In Period|Other, Not Specified|0|||
150160568|NCT02373813|541721423|FG000|Run-In Period|Withdrawal by Subject|16|||
150160569|NCT02373813|541721424|FG001|Run-In Period|Withdrawal by Subject|0|||
150160570|NCT02373813|541721425|FG002|Run-In Period|Withdrawal by Subject|0|||
150160571|NCT02373813|541721426|FG003|Run-In Period|Withdrawal by Subject|0|||
150160572|NCT02373813|541721423|FG000|Run-In Period|Decision by Sponsor|11|||
150160573|NCT02373813|541721424|FG001|Run-In Period|Decision by Sponsor|0|||
150160574|NCT02373813|541721425|FG002|Run-In Period|Decision by Sponsor|0|||
150160575|NCT02373813|541721426|FG003|Run-In Period|Decision by Sponsor|0|||
150160576|NCT02373813|541721423|FG000|Run-In Period|Protocol Violation|75|||
150160577|NCT02373813|541721424|FG001|Run-In Period|Protocol Violation|0|||
150160578|NCT02373813|541721425|FG002|Run-In Period|Protocol Violation|0|||
150160579|NCT02373813|541721426|FG003|Run-In Period|Protocol Violation|0|||
150160580|NCT02373813|541721423|FG000|Run-In Period|Lost to Follow-up|2|||
150160581|NCT02373813|541721424|FG001|Run-In Period|Lost to Follow-up|0|||
150160582|NCT02373813|541721425|FG002|Run-In Period|Lost to Follow-up|0|||
150160583|NCT02373813|541721426|FG003|Run-In Period|Lost to Follow-up|0|||
150160584|NCT02373813|541721423|FG000|Run-In Period|Adverse Event|3|||
150160585|NCT02373813|541721424|FG001|Run-In Period|Adverse Event|0|||
150160586|NCT02373813|541721425|FG002|Run-In Period|Adverse Event|0|||
150160587|NCT02373813|541721426|FG003|Run-In Period|Adverse Event|0|||
150160588|NCT02373813|541721423|FG000|Run-In Period|Noncompliance|1|||
150160589|NCT02373813|541721424|FG001|Run-In Period|Noncompliance|0|||
150160590|NCT02373813|541721425|FG002|Run-In Period|Noncompliance|0|||
150160591|NCT02373813|541721426|FG003|Run-In Period|Noncompliance|0|||
150160592|NCT02373813|541721423|FG000|Run-In Period|Ineligibility Determined|3|||
149921556|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
149921557|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
149921558|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
149921559|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
149921560|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
149921561|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
149921562|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
149921563|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
149921564|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
149921565|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921566|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921567|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921568|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921569|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
149921570|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
149921571|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921572|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921573|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149921574|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921575|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
149921576|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921577|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921578|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921579|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921580|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
149921581|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
149921582|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
149921583|NCT00528372|540846850|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
149921584|NCT00528372|540846851|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
149921585|NCT00528372|540846852|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
149921586|NCT00528372|540846853|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
149921587|NCT00528372|540846854|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
149921588|NCT00528372|540846855|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
149921589|NCT00528372|540846856|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
149921590|NCT00528372|540846857|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
149921591|NCT00528372|540846858|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
149921592|NCT02432144|540846863|FG000|Overall Study|Participant Non-Compliance|1|||
149921593|NCT02109445|540846865|FG000|Overall Study|Symptomatic deterioration|2|||
149921594|NCT02109445|540846865|FG000|Overall Study|Adverse Event|1|||
149921595|NCT00966355|540846870|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
149921596|NCT00966355|540846871|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
149921597|NCT00966355|540846872|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
149921598|NCT00966355|540846870|FG000|Overall Study|newly diagnosed advanced HCC|11|||
149921599|NCT00966355|540846871|FG001|Overall Study|newly diagnosed advanced HCC|12|||
149921600|NCT00966355|540846872|FG002|Overall Study|newly diagnosed advanced HCC|10|||
149921601|NCT00966355|540846870|FG000|Overall Study|Lost to Follow-up|5|||
149921602|NCT00966355|540846871|FG001|Overall Study|Lost to Follow-up|4|||
149921603|NCT00966355|540846872|FG002|Overall Study|Lost to Follow-up|3|||
149921604|NCT00958412|540846873|FG000|Overall Study|Study prematurely terminated|18|||
149921605|NCT02552888|540846874|FG000|Overall Study|Lost to Follow-up|1|||
149921606|NCT02552888|540846875|FG001|Overall Study|Lost to Follow-up|1|||
149921607|NCT00385827|540848686|FG000|Part 1|Adverse Event|1|||
149921608|NCT00385827|540848687|FG001|Part 1|Adverse Event|0|||
149921609|NCT00385827|540848688|FG002|Part 1|Adverse Event|0|||
149921610|NCT00385827|540848686|FG000|Part 1|Death|2|||
149921611|NCT00385827|540848687|FG001|Part 1|Death|0|||
149921612|NCT00385827|540848688|FG002|Part 1|Death|0|||
149921613|NCT00385827|540848686|FG000|Part 1|Lack of Efficacy|5|||
149921614|NCT00385827|540848687|FG001|Part 1|Lack of Efficacy|0|||
149921615|NCT00385827|540848688|FG002|Part 1|Lack of Efficacy|0|||
149921616|NCT00385827|540848686|FG000|Part 1|Other|1|||
149921617|NCT00385827|540848687|FG001|Part 1|Other|0|||
149921618|NCT00385827|540848688|FG002|Part 1|Other|0|||
149921619|NCT00385827|540848686|FG000|Part 2|Adverse Event|0|||
149921620|NCT00385827|540848687|FG001|Part 2|Adverse Event|6|||
149921621|NCT00385827|540848688|FG002|Part 2|Adverse Event|10|||
149921622|NCT00385827|540848686|FG000|Part 2|Death|0|||
149921623|NCT00385827|540848687|FG001|Part 2|Death|0|||
149921624|NCT00385827|540848688|FG002|Part 2|Death|2|||
149921625|NCT00385827|540848686|FG000|Part 2|Lack of Efficacy|0|||
149921626|NCT00385827|540848687|FG001|Part 2|Lack of Efficacy|14|||
149921627|NCT00385827|540848688|FG002|Part 2|Lack of Efficacy|13|||
150160593|NCT02373813|541721424|FG001|Run-In Period|Ineligibility Determined|0|||
150160594|NCT02373813|541721425|FG002|Run-In Period|Ineligibility Determined|0|||
150160595|NCT02373813|541721426|FG003|Run-In Period|Ineligibility Determined|0|||
150160596|NCT02373813|541721423|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
150160597|NCT02373813|541721424|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
150160598|NCT02373813|541721425|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
150160599|NCT02373813|541721426|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
150160600|NCT02373813|541721423|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
150160601|NCT02373813|541721424|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
150160602|NCT02373813|541721425|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
150160603|NCT02373813|541721426|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
150160604|NCT02373813|541721423|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150160605|NCT02373813|541721424|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
150160606|NCT02373813|541721425|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
150160607|NCT02373813|541721426|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
150160608|NCT02373813|541721423|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150160609|NCT02373813|541721424|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
150160610|NCT02373813|541721425|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
150160611|NCT02373813|541721426|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
150160612|NCT01511536|541721433|FG000|Phase 1|Other|0|||
150160613|NCT01511536|541721434|FG001|Phase 1|Other|1|||
150160614|NCT01511536|541721435|FG002|Phase 1|Other|0|||
150160615|NCT01511536|541721433|FG000|Phase 2|Other|0|||
150160616|NCT01511536|541721434|FG001|Phase 2|Other|0|||
150160617|NCT01511536|541721435|FG002|Phase 2|Other|9|||
150160618|NCT02297503|541721439|FG000|Overall Study|Withdrawal by Subject|1|||
150160619|NCT02297503|541721440|FG001|Overall Study|Withdrawal by Subject|1|||
150160620|NCT02297503|541721439|FG000|Overall Study|Protocol Violation|1|||
150160621|NCT02297503|541721440|FG001|Overall Study|Protocol Violation|0|||
150160622|NCT02297503|541721439|FG000|Overall Study|Pregnancy|0|||
150160623|NCT02297503|541721440|FG001|Overall Study|Pregnancy|1|||
150160624|NCT02297503|541721439|FG000|Overall Study|Lost to Follow-up|0|||
150160625|NCT02297503|541721440|FG001|Overall Study|Lost to Follow-up|1|||
150160626|NCT02297503|541721439|FG000|Overall Study|Medical reason|0|||
150160627|NCT02297503|541721440|FG001|Overall Study|Medical reason|1|||
150160628|NCT02703532|541721442|FG000|Overall Study|Withdrawal by Subject|0|||
150160629|NCT02703532|541721443|FG001|Overall Study|Withdrawal by Subject|1|||
150160630|NCT02703532|541721444|FG002|Overall Study|Withdrawal by Subject|0|||
150160631|NCT02703532|541721445|FG003|Overall Study|Withdrawal by Subject|1|||
150160632|NCT02703532|541721442|FG000|Overall Study|Lost to Follow-up|2|||
150160633|NCT02703532|541721443|FG001|Overall Study|Lost to Follow-up|0|||
150160634|NCT02703532|541721444|FG002|Overall Study|Lost to Follow-up|2|||
150160635|NCT02703532|541721445|FG003|Overall Study|Lost to Follow-up|0|||
150160636|NCT03738241|541721449|FG000|Overall Study|Withdrawal by Subject|0|||
150160637|NCT03738241|541721450|FG001|Overall Study|Withdrawal by Subject|0|||
150160638|NCT03738241|541721451|FG002|Overall Study|Withdrawal by Subject|0|||
150160639|NCT03738241|541721452|FG003|Overall Study|Withdrawal by Subject|0|||
150160640|NCT03738241|541721453|FG004|Overall Study|Withdrawal by Subject|0|||
150160641|NCT03738241|541721454|FG005|Overall Study|Withdrawal by Subject|0|||
150160642|NCT03738241|541721455|FG006|Overall Study|Withdrawal by Subject|0|||
150160643|NCT03738241|541721456|FG007|Overall Study|Withdrawal by Subject|0|||
150160644|NCT03738241|541721457|FG008|Overall Study|Withdrawal by Subject|0|||
150160645|NCT03738241|541721458|FG009|Overall Study|Withdrawal by Subject|1|||
150160646|NCT03738241|541721449|FG000|Overall Study|Physician Decision|0|||
150160647|NCT03738241|541721450|FG001|Overall Study|Physician Decision|0|||
150160648|NCT03738241|541721451|FG002|Overall Study|Physician Decision|0|||
150160649|NCT03738241|541721452|FG003|Overall Study|Physician Decision|0|||
150160650|NCT03738241|541721453|FG004|Overall Study|Physician Decision|0|||
150160651|NCT03738241|541721454|FG005|Overall Study|Physician Decision|0|||
150160652|NCT03738241|541721455|FG006|Overall Study|Physician Decision|0|||
150160653|NCT03738241|541721456|FG007|Overall Study|Physician Decision|0|||
150160654|NCT03738241|541721457|FG008|Overall Study|Physician Decision|1|||
150160655|NCT03738241|541721458|FG009|Overall Study|Physician Decision|0|||
150160656|NCT03738241|541721449|FG000|Overall Study|Adverse Event|1|||
150160657|NCT03738241|541721450|FG001|Overall Study|Adverse Event|0|||
150160658|NCT03738241|541721451|FG002|Overall Study|Adverse Event|0|||
150160659|NCT03738241|541721452|FG003|Overall Study|Adverse Event|0|||
150160660|NCT03738241|541721453|FG004|Overall Study|Adverse Event|0|||
150160661|NCT03738241|541721454|FG005|Overall Study|Adverse Event|0|||
150160662|NCT03738241|541721455|FG006|Overall Study|Adverse Event|0|||
150160663|NCT03738241|541721456|FG007|Overall Study|Adverse Event|0|||
150160664|NCT03738241|541721457|FG008|Overall Study|Adverse Event|0|||
150160665|NCT03738241|541721458|FG009|Overall Study|Adverse Event|0|||
150160666|NCT01244763|541721459|FG000|Overall Study|Adverse Event|1|||
150160667|NCT01244763|541721460|FG001|Overall Study|Adverse Event|0|||
150160668|NCT01244763|541721461|FG002|Overall Study|Adverse Event|0|||
150160669|NCT01244763|541721462|FG003|Overall Study|Adverse Event|0|||
149921628|NCT00385827|540848686|FG000|Part 2|Randomized but not treated|0|||
149921629|NCT00385827|540848687|FG001|Part 2|Randomized but not treated|2|||
149921630|NCT00385827|540848688|FG002|Part 2|Randomized but not treated|2|||
149921631|NCT00385827|540848686|FG000|Part 2|Other|0|||
149921632|NCT00385827|540848687|FG001|Part 2|Other|11|||
149921633|NCT00385827|540848688|FG002|Part 2|Other|21|||
149921634|NCT04378569|540848689|FG000|Overall Study|Adverse Event|0|||
149921635|NCT04378569|540848690|FG001|Overall Study|Adverse Event|0|||
149921636|NCT04378569|540848691|FG002|Overall Study|Adverse Event|2|||
149921637|NCT04378569|540848692|FG003|Overall Study|Adverse Event|0|||
149921638|NCT04378569|540848693|FG004|Overall Study|Adverse Event|3|||
149921639|NCT04378569|540848694|FG005|Overall Study|Adverse Event|3|||
149921640|NCT04378569|540848689|FG000|Overall Study|Lost to Follow-up|0|||
149921641|NCT04378569|540848690|FG001|Overall Study|Lost to Follow-up|3|||
149921642|NCT04378569|540848691|FG002|Overall Study|Lost to Follow-up|1|||
149921643|NCT04378569|540848692|FG003|Overall Study|Lost to Follow-up|0|||
149921644|NCT04378569|540848693|FG004|Overall Study|Lost to Follow-up|1|||
149921645|NCT04378569|540848694|FG005|Overall Study|Lost to Follow-up|1|||
149921646|NCT04378569|540848689|FG000|Overall Study|Protocol Violation|0|||
149921647|NCT04378569|540848690|FG001|Overall Study|Protocol Violation|0|||
149921648|NCT04378569|540848691|FG002|Overall Study|Protocol Violation|0|||
149921649|NCT04378569|540848692|FG003|Overall Study|Protocol Violation|0|||
149921650|NCT04378569|540848693|FG004|Overall Study|Protocol Violation|0|||
149921651|NCT04378569|540848694|FG005|Overall Study|Protocol Violation|1|||
149921652|NCT04378569|540848689|FG000|Overall Study|Withdrawal by Subject|0|||
149921653|NCT04378569|540848690|FG001|Overall Study|Withdrawal by Subject|6|||
149921654|NCT04378569|540848691|FG002|Overall Study|Withdrawal by Subject|7|||
149921655|NCT04378569|540848692|FG003|Overall Study|Withdrawal by Subject|4|||
149921656|NCT04378569|540848693|FG004|Overall Study|Withdrawal by Subject|5|||
149921657|NCT04378569|540848694|FG005|Overall Study|Withdrawal by Subject|4|||
149921658|NCT04378569|540848689|FG000|Overall Study|Lack of response|0|||
149921659|NCT04378569|540848690|FG001|Overall Study|Lack of response|0|||
149921660|NCT04378569|540848691|FG002|Overall Study|Lack of response|1|||
149921661|NCT04378569|540848692|FG003|Overall Study|Lack of response|0|||
149921662|NCT04378569|540848693|FG004|Overall Study|Lack of response|1|||
149921663|NCT04378569|540848694|FG005|Overall Study|Lack of response|1|||
149921664|NCT01048944|540848695|FG000|Overall Study|Protocol Violation|8|||
149921665|NCT01048944|540848696|FG001|Overall Study|Protocol Violation|10|||
149921666|NCT01048944|540848697|FG002|Overall Study|Protocol Violation|10|||
149921667|NCT01048944|540848698|FG003|Overall Study|Protocol Violation|2|||
149921668|NCT01844817|540848699|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
149921669|NCT01844817|540848700|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
149921670|NCT01844817|540848699|FG000|Treatment|Progressive Disease|27|||
149921671|NCT01844817|540848700|FG001|Treatment|Progressive Disease|36|||
149921672|NCT01844817|540848699|FG000|Treatment|Adverse Event|17|||
149921673|NCT01844817|540848700|FG001|Treatment|Adverse Event|9|||
149921674|NCT01844817|540848699|FG000|Treatment|Withdrawal by Subject|10|||
149921675|NCT01844817|540848700|FG001|Treatment|Withdrawal by Subject|6|||
149921676|NCT01844817|540848699|FG000|Treatment|Death|10|||
149921677|NCT01844817|540848700|FG001|Treatment|Death|8|||
149921678|NCT01844817|540848699|FG000|Treatment|Lost to Follow-up|0|||
149921679|NCT01844817|540848700|FG001|Treatment|Lost to Follow-up|1|||
149921680|NCT01844817|540848699|FG000|Treatment|Other|0|||
149921681|NCT01844817|540848700|FG001|Treatment|Other|3|||
149921682|NCT04227405|540848701|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
149921683|NCT04227405|540848702|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
149921684|NCT04227405|540848701|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
149921685|NCT04227405|540848702|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
149921686|NCT04227405|540848701|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
149921687|NCT04227405|540848702|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
149921688|NCT04985942|540848703|FG000|Overall Study|Adverse Event|14|||
149921689|NCT04985942|540848704|FG001|Overall Study|Adverse Event|2|||
149921690|NCT04985942|540848703|FG000|Overall Study|Lack of Efficacy|0|||
149921691|NCT04985942|540848704|FG001|Overall Study|Lack of Efficacy|3|||
149921692|NCT04985942|540848703|FG000|Overall Study|Lost to Follow-up|1|||
149921693|NCT04985942|540848704|FG001|Overall Study|Lost to Follow-up|1|||
149921694|NCT04985942|540848703|FG000|Overall Study|Protocol Violation|1|||
149921695|NCT04985942|540848704|FG001|Overall Study|Protocol Violation|1|||
149921696|NCT04985942|540848703|FG000|Overall Study|Withdrawal by Subject|5|||
149921697|NCT04985942|540848704|FG001|Overall Study|Withdrawal by Subject|4|||
149921698|NCT03536663|540848709|FG000|Endexo|Protocol Violation|1|||
149921699|NCT00885378|540848710|FG000|Overall Study|Lack of Efficacy|2|||
149921700|NCT00885378|540848711|FG001|Overall Study|Lack of Efficacy|2|||
149921701|NCT00885378|540848710|FG000|Overall Study|Withdrawal by Subject|1|||
149921702|NCT00885378|540848711|FG001|Overall Study|Withdrawal by Subject|2|||
149921703|NCT00885378|540848710|FG000|Overall Study|Lost to Follow-up|1|||
149921704|NCT00885378|540848711|FG001|Overall Study|Lost to Follow-up|2|||
149921705|NCT00885378|540848710|FG000|Overall Study|Poor/Noncompliance|2|||
149921706|NCT00885378|540848711|FG001|Overall Study|Poor/Noncompliance|2|||
149921707|NCT00885378|540848710|FG000|Overall Study|Protocol Violation|2|||
149921708|NCT00885378|540848711|FG001|Overall Study|Protocol Violation|0|||
149921709|NCT04750278|540848712|FG000|Overall Study|Death|9|||
149921710|NCT04750278|540848713|FG001|Overall Study|Death|10|||
149921711|NCT04750278|540848714|FG002|Overall Study|Death|10|||
149921712|NCT04750278|540848712|FG000|Overall Study|Withdrawal by Subject|4|||
149921713|NCT04750278|540848713|FG001|Overall Study|Withdrawal by Subject|1|||
149921714|NCT04750278|540848714|FG002|Overall Study|Withdrawal by Subject|2|||
149921715|NCT04750278|540848712|FG000|Overall Study|Lost to Follow-up|1|||
149921716|NCT04750278|540848713|FG001|Overall Study|Lost to Follow-up|1|||
149921717|NCT04750278|540848714|FG002|Overall Study|Lost to Follow-up|1|||
149921718|NCT04750278|540848712|FG000|Overall Study|Pregnancy|1|||
149921719|NCT04750278|540848713|FG001|Overall Study|Pregnancy|0|||
149921720|NCT04750278|540848714|FG002|Overall Study|Pregnancy|0|||
149921721|NCT04750278|540848712|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
149921722|NCT04750278|540848713|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
149921723|NCT04750278|540848714|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
149921724|NCT04750278|540848712|FG000|Overall Study|Non-compliance|0|||
149921725|NCT04750278|540848713|FG001|Overall Study|Non-compliance|0|||
149921726|NCT04750278|540848714|FG002|Overall Study|Non-compliance|1|||
149921727|NCT04750278|540848712|FG000|Overall Study|Transfer to Outside Facility|0|||
149921728|NCT04750278|540848713|FG001|Overall Study|Transfer to Outside Facility|2|||
149921729|NCT04750278|540848714|FG002|Overall Study|Transfer to Outside Facility|1|||
149921730|NCT04750278|540848712|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
149921731|NCT04750278|540848713|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
149921732|NCT04750278|540848714|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
149921733|NCT04750278|540848712|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
149921734|NCT04750278|540848713|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
149921735|NCT04750278|540848714|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
149921736|NCT04076319|540848720|FG000|Overall Study|Withdrawal by Subject|2|||
149921737|NCT04076319|540848721|FG001|Overall Study|Withdrawal by Subject|0|||
149921738|NCT04076319|540848720|FG000|Overall Study|Death|1|||
149921739|NCT04076319|540848721|FG001|Overall Study|Death|0|||
149921740|NCT03252145|540848722|FG000|Overall Study|Withdrawal by Subject|1|||
149921741|NCT03252145|540848723|FG001|Overall Study|Withdrawal by Subject|0|||
149921742|NCT03252145|540848722|FG000|Overall Study|Complicating Disease|1|||
149921743|NCT03252145|540848723|FG001|Overall Study|Complicating Disease|2|||
149921744|NCT03504189|540848724|FG000|Overall Study|Withdrawal by Subject|1|||
149921745|NCT03504189|540848724|FG000|Overall Study|Screening Failure|1|||
149921746|NCT03504189|540848724|FG000|Overall Study|Device Failure|2|||
149921747|NCT02626000|540848733|FG000|Overall Study|Decision by Sponsor|1|||
149921748|NCT02626000|540848733|FG000|Overall Study|Death|29|||
149921749|NCT04727528|540848734|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
149921750|NCT04727528|540848735|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
149921751|NCT04727528|540848734|FG000|Open-label Period|Randomized who did not receive treatment|1|||
149921752|NCT04727528|540848735|FG001|Open-label Period|Randomized who did not receive treatment|0|||
149921753|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Adverse Event|0|||
149921754|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Adverse Event|1|||
149921755|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Death|0|||
149921756|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Death|1|||
149921757|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
149921758|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
149921759|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
149921760|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
149921761|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Physician Decision|0|||
149921762|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Physician Decision|1|||
149921763|NCT04727528|540848734|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
149921764|NCT04727528|540848735|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149921765|NCT01796301|540848746|FG000|Overall Study|Withdrawal by Subject|15|||
149921766|NCT01796301|540848747|FG001|Overall Study|Withdrawal by Subject|15|||
149921767|NCT01796301|540848746|FG000|Overall Study|Lost to Follow-up|3|||
149921768|NCT01796301|540848747|FG001|Overall Study|Lost to Follow-up|3|||
149921769|NCT01796301|540848746|FG000|Overall Study|Death|0|||
149921770|NCT01796301|540848747|FG001|Overall Study|Death|1|||
149921771|NCT01796301|540848746|FG000|Overall Study|Decision by Sponsor|0|||
149921772|NCT01796301|540848747|FG001|Overall Study|Decision by Sponsor|1|||
149921773|NCT00667563|540848748|FG000|Overall Study|Protocol Violation|24|||
149921774|NCT02985021|540848751|FG000|Overall Study|Inability to comply with study procedures|1|||
149921775|NCT01951573|540848752|FG000|Washout Period|Adverse Event|0|||
149921776|NCT01951573|540848753|FG001|Washout Period|Adverse Event|1|||
149921777|NCT04399889|540848754|FG000|Overall Study|Death|5|||
149921778|NCT04399889|540848755|FG001|Overall Study|Death|1|||
150160670|NCT01244763|541721463|FG004|Overall Study|Adverse Event|0|||
150160671|NCT01244763|541721464|FG005|Overall Study|Adverse Event|1|||
150160672|NCT01244763|541721459|FG000|Overall Study|Death|1|||
150160673|NCT01244763|541721460|FG001|Overall Study|Death|0|||
150160674|NCT01244763|541721461|FG002|Overall Study|Death|1|||
150160675|NCT01244763|541721462|FG003|Overall Study|Death|0|||
150160676|NCT01244763|541721463|FG004|Overall Study|Death|2|||
150160677|NCT01244763|541721464|FG005|Overall Study|Death|0|||
150160678|NCT01244763|541721459|FG000|Overall Study|Physician Decision|0|||
150160679|NCT01244763|541721460|FG001|Overall Study|Physician Decision|0|||
150160680|NCT01244763|541721461|FG002|Overall Study|Physician Decision|1|||
150160681|NCT01244763|541721462|FG003|Overall Study|Physician Decision|0|||
150160682|NCT01244763|541721463|FG004|Overall Study|Physician Decision|0|||
150160683|NCT01244763|541721464|FG005|Overall Study|Physician Decision|0|||
150160684|NCT01244763|541721459|FG000|Overall Study|Withdrawal by Subject|1|||
150160685|NCT01244763|541721460|FG001|Overall Study|Withdrawal by Subject|2|||
150160686|NCT01244763|541721461|FG002|Overall Study|Withdrawal by Subject|0|||
150160687|NCT01244763|541721462|FG003|Overall Study|Withdrawal by Subject|1|||
150160688|NCT01244763|541721463|FG004|Overall Study|Withdrawal by Subject|1|||
150160689|NCT01244763|541721464|FG005|Overall Study|Withdrawal by Subject|2|||
150160690|NCT01244763|541721459|FG000|Overall Study|Lost to Follow-up|0|||
150160691|NCT01244763|541721460|FG001|Overall Study|Lost to Follow-up|1|||
150160692|NCT01244763|541721461|FG002|Overall Study|Lost to Follow-up|0|||
150160693|NCT01244763|541721462|FG003|Overall Study|Lost to Follow-up|0|||
150160694|NCT01244763|541721463|FG004|Overall Study|Lost to Follow-up|0|||
150160695|NCT01244763|541721464|FG005|Overall Study|Lost to Follow-up|0|||
150160696|NCT01244763|541721459|FG000|Overall Study|Enrolled into the Extension Study|0|||
150160697|NCT01244763|541721460|FG001|Overall Study|Enrolled into the Extension Study|0|||
150160698|NCT01244763|541721461|FG002|Overall Study|Enrolled into the Extension Study|0|||
150160699|NCT01244763|541721462|FG003|Overall Study|Enrolled into the Extension Study|0|||
150160700|NCT01244763|541721463|FG004|Overall Study|Enrolled into the Extension Study|0|||
150160701|NCT01244763|541721464|FG005|Overall Study|Enrolled into the Extension Study|1|||
150160702|NCT04170023|541721465|FG000|LTE Period|Withdrawal by Subject|1|||
150160703|NCT04170023|541721466|FG001|LTE Period|Withdrawal by Subject|0|||
150160704|NCT04170023|541721467|FG002|LTE Period|Withdrawal by Subject|0|||
150160705|NCT04170023|541721465|FG000|LTE Period|Study Termination|11|||
150160706|NCT04170023|541721466|FG001|LTE Period|Study Termination|11|||
150160707|NCT04170023|541721467|FG002|LTE Period|Study Termination|5|||
150160708|NCT04003974|541721468|FG000|Overall Study|Missing|1|||
150160709|NCT04003974|541721469|FG001|Overall Study|Missing|0|||
150160710|NCT04003974|541721468|FG000|Overall Study|Withdrawal by Subject|0|||
150160711|NCT04003974|541721469|FG001|Overall Study|Withdrawal by Subject|2|||
150160712|NCT02400307|541721470|FG000|Overall Study|Enrolled and Never Dosed|1|||
150160713|NCT02400307|541721471|FG001|Overall Study|Enrolled and Never Dosed|0|||
150160714|NCT02015663|541721474|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
150160715|NCT02015663|541721475|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
150160716|NCT02015663|541721474|FG000|Overall Study|Withdrawal by Subject|1|||
150160717|NCT02015663|541721475|FG001|Overall Study|Withdrawal by Subject|0|||
150160718|NCT02015663|541721474|FG000|Overall Study|Protocol Violation|0|||
150160719|NCT02015663|541721475|FG001|Overall Study|Protocol Violation|1|||
150160720|NCT02015663|541721474|FG000|Overall Study|Adverse Event|3|||
150160721|NCT02015663|541721475|FG001|Overall Study|Adverse Event|0|||
150160722|NCT02015663|541721474|FG000|Overall Study|Administrative problems|10|||
150160723|NCT02015663|541721475|FG001|Overall Study|Administrative problems|11|||
150160724|NCT02531438|541721483|FG000|Overall Study|Adverse Event|7|||
150160725|NCT02531438|541721484|FG001|Overall Study|Adverse Event|9|||
150160726|NCT02531438|541721483|FG000|Overall Study|Lost to Follow-up|0|||
150160727|NCT02531438|541721484|FG001|Overall Study|Lost to Follow-up|3|||
150160728|NCT02531438|541721483|FG000|Overall Study|Withdrawal by Subject|7|||
150160729|NCT02531438|541721484|FG001|Overall Study|Withdrawal by Subject|8|||
150160730|NCT02531438|541721483|FG000|Overall Study|Physician Decision|0|||
150160731|NCT02531438|541721484|FG001|Overall Study|Physician Decision|1|||
150160732|NCT02531438|541721483|FG000|Overall Study|Death|6|||
150160733|NCT02531438|541721484|FG001|Overall Study|Death|3|||
150160734|NCT02531438|541721483|FG000|Overall Study|Randomized, but Not Treated|4|||
150160735|NCT02531438|541721484|FG001|Overall Study|Randomized, but Not Treated|0|||
150160736|NCT02531438|541721483|FG000|Overall Study|Missed EOT/PTE Visit|5|||
150160737|NCT02531438|541721484|FG001|Overall Study|Missed EOT/PTE Visit|2|||
150259967|NCT00729378|542089233|FG001|Baseline|Withdrawal by Subject|59|||
150259968|NCT00729378|542089232|FG000|12-months|Lost to Follow-up|100|||
150160738|NCT02531438|541721483|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
150160739|NCT02531438|541721484|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
150160740|NCT01813422|541721486|FG000|Overall Study|Withdrawal by Subject|14|||
150160741|NCT01813422|541721487|FG001|Overall Study|Withdrawal by Subject|8|||
150160742|NCT01813422|541721486|FG000|Overall Study|Death|2|||
150160743|NCT01813422|541721487|FG001|Overall Study|Death|3|||
150160744|NCT01813422|541721486|FG000|Overall Study|Sponsor Decision|2|||
150160745|NCT01813422|541721487|FG001|Overall Study|Sponsor Decision|1|||
150259969|NCT00729378|542089233|FG001|12-months|Lost to Follow-up|65|||
149921779|NCT04399889|540848756|FG002|Overall Study|Death|1|||
149921780|NCT00707980|540848757|FG000|Overall Study|Adverse Event|49|||
149921781|NCT00707980|540848757|FG000|Overall Study|Lack of Efficacy|35|||
149921782|NCT00707980|540848757|FG000|Overall Study|Non-Compliance with Study Drug|28|||
149921783|NCT00707980|540848757|FG000|Overall Study|Protocol Deviations|19|||
149921784|NCT00707980|540848757|FG000|Overall Study|Withdrawal of Consent|81|||
149921785|NCT00707980|540848757|FG000|Overall Study|Lost to Follow-up|59|||
149921786|NCT00707980|540848757|FG000|Overall Study|Other|39|||
149921787|NCT01152996|540848761|FG000|Overall Study|Withdrawal by Subject|142|||
149921788|NCT01152996|540848761|FG000|Overall Study|Adverse Event|115|||
149921789|NCT01152996|540848761|FG000|Overall Study|Lost to Follow-up|112|||
149921790|NCT01152996|540848761|FG000|Overall Study|Lack of Efficacy|68|||
149921791|NCT01152996|540848761|FG000|Overall Study|Noncompliance|41|||
149921792|NCT01152996|540848761|FG000|Overall Study|Other|36|||
149921793|NCT01152996|540848761|FG000|Overall Study|Protocol Violation|22|||
149921794|NCT01152996|540848761|FG000|Overall Study|Elevated liver enzymes|1|||
149921795|NCT03077607|540848763|FG000|Period 1 (15 Days)|Adverse Event|1|||
149921796|NCT03077607|540848764|FG001|Period 1 (15 Days)|Adverse Event|0|||
149921797|NCT03077607|540848763|FG000|Period 1 (15 Days)|Death|1|||
149921798|NCT03077607|540848764|FG001|Period 1 (15 Days)|Death|0|||
149921799|NCT03077607|540848763|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
149921800|NCT03077607|540848764|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
149921801|NCT03077607|540848763|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
149921802|NCT03077607|540848764|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
149921803|NCT00460239|540848765|FG000|Overall Study|Physician Decision|0|||
149921804|NCT00460239|540848766|FG001|Overall Study|Physician Decision|1|||
149921805|NCT00460239|540848767|FG002|Overall Study|Physician Decision|0|||
149921806|NCT00460239|540848768|FG003|Overall Study|Physician Decision|0|||
149921807|NCT00460239|540848769|FG004|Overall Study|Physician Decision|0|||
149921808|NCT00460239|540848770|FG005|Overall Study|Physician Decision|2|||
149921809|NCT00460239|540848771|FG006|Overall Study|Physician Decision|0|||
149921810|NCT00460239|540848772|FG007|Overall Study|Physician Decision|0|||
149921811|NCT00460239|540848773|FG008|Overall Study|Physician Decision|0|||
149921812|NCT00460239|540848765|FG000|Overall Study|Withdrawal by Subject|0|||
149921813|NCT00460239|540848766|FG001|Overall Study|Withdrawal by Subject|0|||
149921814|NCT00460239|540848767|FG002|Overall Study|Withdrawal by Subject|0|||
149921815|NCT00460239|540848768|FG003|Overall Study|Withdrawal by Subject|0|||
149921816|NCT00460239|540848769|FG004|Overall Study|Withdrawal by Subject|0|||
149921817|NCT00460239|540848770|FG005|Overall Study|Withdrawal by Subject|1|||
149921818|NCT00460239|540848771|FG006|Overall Study|Withdrawal by Subject|0|||
149921819|NCT00460239|540848772|FG007|Overall Study|Withdrawal by Subject|0|||
149921820|NCT00460239|540848773|FG008|Overall Study|Withdrawal by Subject|0|||
149921821|NCT00760487|540848793|FG000|Overall Study|Unilateral implantation|3|||
149921822|NCT05259917|540848803|FG000|Overall Study|Protocol Violation|0|||
149921823|NCT05259917|540848804|FG001|Overall Study|Protocol Violation|0|||
149921824|NCT05259917|540848805|FG002|Overall Study|Protocol Violation|1|||
149921825|NCT05259917|540848806|FG003|Overall Study|Protocol Violation|0|||
149921826|NCT05259917|540848807|FG004|Overall Study|Protocol Violation|0|||
149921827|NCT05259917|540848808|FG005|Overall Study|Protocol Violation|0|||
149921828|NCT05259917|540848803|FG000|Overall Study|Lost to Follow-up|0|||
149921829|NCT05259917|540848804|FG001|Overall Study|Lost to Follow-up|0|||
149921830|NCT05259917|540848805|FG002|Overall Study|Lost to Follow-up|1|||
149921831|NCT05259917|540848806|FG003|Overall Study|Lost to Follow-up|0|||
149921832|NCT05259917|540848807|FG004|Overall Study|Lost to Follow-up|0|||
149921833|NCT05259917|540848808|FG005|Overall Study|Lost to Follow-up|1|||
149921834|NCT05259917|540848803|FG000|Overall Study|Physician Decision|0|||
149921835|NCT05259917|540848804|FG001|Overall Study|Physician Decision|1|||
149921836|NCT05259917|540848805|FG002|Overall Study|Physician Decision|0|||
149921837|NCT05259917|540848806|FG003|Overall Study|Physician Decision|0|||
149921838|NCT05259917|540848807|FG004|Overall Study|Physician Decision|0|||
149921839|NCT05259917|540848808|FG005|Overall Study|Physician Decision|0|||
149921840|NCT05259917|540848803|FG000|Overall Study|Withdrawal by Subject|0|||
149921841|NCT05259917|540848804|FG001|Overall Study|Withdrawal by Subject|1|||
149921842|NCT05259917|540848805|FG002|Overall Study|Withdrawal by Subject|0|||
149921843|NCT05259917|540848806|FG003|Overall Study|Withdrawal by Subject|0|||
149921844|NCT05259917|540848807|FG004|Overall Study|Withdrawal by Subject|1|||
149921845|NCT05259917|540848808|FG005|Overall Study|Withdrawal by Subject|1|||
149921846|NCT05259917|540848803|FG000|Overall Study|Trial Termination by Sponsor|7|||
149921847|NCT05259917|540848804|FG001|Overall Study|Trial Termination by Sponsor|2|||
149921848|NCT05259917|540848805|FG002|Overall Study|Trial Termination by Sponsor|3|||
149921849|NCT05259917|540848806|FG003|Overall Study|Trial Termination by Sponsor|5|||
149921850|NCT05259917|540848807|FG004|Overall Study|Trial Termination by Sponsor|11|||
149921851|NCT05259917|540848808|FG005|Overall Study|Trial Termination by Sponsor|4|||
149921852|NCT05259917|540848803|FG000|Overall Study|Other|1|||
149921853|NCT05259917|540848804|FG001|Overall Study|Other|0|||
149921854|NCT05259917|540848805|FG002|Overall Study|Other|2|||
149921855|NCT05259917|540848806|FG003|Overall Study|Other|0|||
149921856|NCT05259917|540848807|FG004|Overall Study|Other|0|||
149921857|NCT05259917|540848808|FG005|Overall Study|Other|0|||
149921858|NCT00592592|540848809|FG000|Overall Study|Patient found ineligible upon chart review|1|||
149921859|NCT03585712|540848810|FG000|Treatment Period 1|Protocol Violation|1|||
149921860|NCT03585712|540848811|FG001|Treatment Period 1|Protocol Violation|0|||
149921861|NCT03585712|540848812|FG002|Treatment Period 1|Protocol Violation|0|||
149921862|NCT03585712|540848810|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
149921863|NCT03585712|540848811|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
149921864|NCT03585712|540848812|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
149921865|NCT03585712|540848810|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
149921866|NCT03585712|540848811|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
149921867|NCT03585712|540848812|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
149921868|NCT03585712|540848810|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
149921869|NCT03585712|540848811|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
150160746|NCT01813422|541721486|FG000|Overall Study|Lost to Follow-up|2|||
150160747|NCT01813422|541721487|FG001|Overall Study|Lost to Follow-up|4|||
150160748|NCT00811187|541721488|FG000|Overall Study|Unable to place device / procedure abort|3|||
150160749|NCT00811187|541721489|FG001|Overall Study|Unable to place device / procedure abort|3|||
150160750|NCT00329303|541721490|FG000|Overall Study|Lack of Efficacy|1|||
150160751|NCT00329303|541721491|FG001|Overall Study|Lack of Efficacy|0|||
150160752|NCT00329303|541721490|FG000|Overall Study|Decision of the sponsor|0|||
150160753|NCT00329303|541721491|FG001|Overall Study|Decision of the sponsor|1|||
150160754|NCT00329303|541721490|FG000|Overall Study|Patient no longer available|1|||
150160755|NCT00329303|541721491|FG001|Overall Study|Patient no longer available|0|||
150160756|NCT00329303|541721490|FG000|Overall Study|Patient relocated|0|||
150160757|NCT00329303|541721491|FG001|Overall Study|Patient relocated|1|||
150160758|NCT03704298|541721492|FG000|Overall Study|Death|3|||
150160759|NCT03704298|541721493|FG001|Overall Study|Death|1|||
150160760|NCT03704298|541721494|FG002|Overall Study|Death|1|||
150160761|NCT03704298|541721495|FG003|Overall Study|Death|0|||
150160762|NCT03704298|541721492|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
150160763|NCT03704298|541721493|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
150160764|NCT03704298|541721494|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
150160765|NCT03704298|541721495|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
150160766|NCT03704298|541721492|FG000|Overall Study|Withdrawal by Subject|1|||
150160767|NCT03704298|541721493|FG001|Overall Study|Withdrawal by Subject|0|||
150160768|NCT03704298|541721494|FG002|Overall Study|Withdrawal by Subject|0|||
150160769|NCT03704298|541721495|FG003|Overall Study|Withdrawal by Subject|0|||
150160770|NCT03704298|541721492|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
150160771|NCT03704298|541721493|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
150160772|NCT03704298|541721494|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
150160773|NCT03704298|541721495|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
150160774|NCT00558753|541721496|FG000|Overall Study|Lost to Follow-up|5|||
150160775|NCT00558753|541721497|FG001|Overall Study|Lost to Follow-up|7|||
150160776|NCT00577629|541721505|FG000|Treatment Period|Death|1|||
150160777|NCT00577629|541721505|FG000|Long Term Follow-Up|Death|15|||
150160778|NCT00577629|541721505|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
150160779|NCT00577629|541721505|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
150160780|NCT00577629|541721505|FG000|Long Term Follow-Up|Physician Decision|1|||
150160781|NCT04159896|541721506|FG000|Overall Study|Lack of Efficacy|7|||
150160782|NCT04159896|541721506|FG000|Overall Study|Withdrawal by Subject|1|||
150160783|NCT04159896|541721506|FG000|Overall Study|Adverse Event|1|||
150160784|NCT04159896|541721506|FG000|Overall Study|A transient ischaemic attack|1|||
150160785|NCT01449721|541721507|FG000|Overall Study|Physician Decision|0|||
150160786|NCT01449721|541721508|FG001|Overall Study|Physician Decision|1|||
150160787|NCT01449721|541721507|FG000|Overall Study|Physician Decision|0|||
150160788|NCT01449721|541721508|FG001|Overall Study|Physician Decision|1|||
150160789|NCT03706690|541721513|FG000|Overall Study|Withdrawal by Subject|8|||
150160790|NCT03706690|541721514|FG001|Overall Study|Withdrawal by Subject|8|||
150160791|NCT03706690|541721513|FG000|Overall Study|Death|143|||
150160792|NCT03706690|541721514|FG001|Overall Study|Death|75|||
150160793|NCT03706690|541721513|FG000|Overall Study|Ongoing at DCO|121|||
150160794|NCT03706690|541721514|FG001|Overall Study|Ongoing at DCO|52|||
150160795|NCT03803774|541721515|FG000|Dose Escalation|Withdrawal by Subject|0|||
150160796|NCT03803774|541721516|FG001|Dose Escalation|Withdrawal by Subject|0|||
149921870|NCT03585712|540848812|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
149921871|NCT02886884|540848815|FG000|Follow-up|Withdrawal by Subject|0|||
149921872|NCT02886884|540848816|FG001|Follow-up|Withdrawal by Subject|0|||
149921873|NCT02886884|540848817|FG002|Follow-up|Withdrawal by Subject|0|||
150160797|NCT03803774|541721517|FG002|Dose Escalation|Withdrawal by Subject|0|||
150259970|NCT00729378|542089232|FG000|24-months|Lost to Follow-up|72|||
150160798|NCT03803774|541721518|FG003|Dose Escalation|Withdrawal by Subject|1|||
150160799|NCT03803774|541721519|FG004|Dose Escalation|Withdrawal by Subject|0|||
150160800|NCT03212365|541721527|FG000|Overall Study|Discharged prior to Xa level|12|||
150160801|NCT03212365|541721528|FG001|Overall Study|Discharged prior to Xa level|8|||
150160802|NCT03212365|541721527|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
149921874|NCT02886884|540848818|FG003|Follow-up|Withdrawal by Subject|1|||
149921875|NCT02697734|540848824|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
149921876|NCT02697734|540848825|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
149921877|NCT02697734|540848824|FG000|Core Phase - up to Week 48|Adverse Event|1|||
149921878|NCT02697734|540848825|FG001|Core Phase - up to Week 48|Adverse Event|2|||
149921879|NCT02697734|540848824|FG000|Core Phase - up to Week 48|Physician Decision|1|||
149921880|NCT02697734|540848825|FG001|Core Phase - up to Week 48|Physician Decision|0|||
149921881|NCT02697734|540848824|FG000|Optional Extension Phase|Adverse Event|5|||
149921882|NCT02697734|540848825|FG001|Optional Extension Phase|Adverse Event|1|||
149921883|NCT02697734|540848824|FG000|Optional Extension Phase|Physician Decision|0|||
149921884|NCT02697734|540848825|FG001|Optional Extension Phase|Physician Decision|1|||
149921885|NCT02324699|540848826|FG000|Overall Study|study terminated|1|||
149921886|NCT03970200|540848827|FG000|Overall Study|Death|2|||
149921887|NCT03970200|540848828|FG001|Overall Study|Death|2|||
149921888|NCT03970200|540848829|FG002|Overall Study|Death|1|||
149921889|NCT03970200|540848827|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
149921890|NCT03970200|540848828|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
149921891|NCT03970200|540848829|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
149921892|NCT01607346|540848830|FG000|Overall Study|Adverse Event|3|||
149921893|NCT01098162|540848831|FG000|Overall Study|Adverse Event|37|||
149921894|NCT01098162|540848831|FG000|Overall Study|Lack of Efficacy|4|||
149921895|NCT01098162|540848831|FG000|Overall Study|Wish of Patient|7|||
149921896|NCT01098162|540848831|FG000|Overall Study|Lost to Follow-up|9|||
149921897|NCT01098162|540848831|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
149921898|NCT01098162|540848831|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
149921899|NCT01098162|540848831|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
149921900|NCT01098162|540848831|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
149921901|NCT01098162|540848831|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
149921902|NCT01098162|540848831|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
149921903|NCT01098162|540848831|FG000|Overall Study|Other Reason|1|||
149921904|NCT01098162|540848831|FG000|Overall Study|Reason Unknown|26|||
149921905|NCT01605825|540848832|FG000|Overall Study|Adverse Event|4|||
149921906|NCT01605825|540848833|FG001|Overall Study|Adverse Event|2|||
149921907|NCT01605825|540848832|FG000|Overall Study|Withdrawal by Subject|0|||
149921908|NCT01605825|540848833|FG001|Overall Study|Withdrawal by Subject|1|||
149921909|NCT01605825|540848832|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
149921910|NCT01605825|540848833|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
149921911|NCT01605825|540848832|FG000|Overall Study|Non-Compliance with Protocol|3|||
149921912|NCT01605825|540848833|FG001|Overall Study|Non-Compliance with Protocol|0|||
149921913|NCT00830518|540848834|FG000|Overall Study|Progressive Disease|18|||
149921914|NCT00830518|540848835|FG001|Overall Study|Progressive Disease|8|||
149921915|NCT00830518|540848834|FG000|Overall Study|Symptomatic Deterioration|4|||
149921916|NCT00830518|540848835|FG001|Overall Study|Symptomatic Deterioration|1|||
149921917|NCT00830518|540848834|FG000|Overall Study|Adverse Event|14|||
149921918|NCT00830518|540848835|FG001|Overall Study|Adverse Event|1|||
149921919|NCT00830518|540848834|FG000|Overall Study|Withdrawal by Patient|2|||
149921920|NCT00830518|540848835|FG001|Overall Study|Withdrawal by Patient|0|||
149921921|NCT00830518|540848834|FG000|Overall Study|Reason not Specified|8|||
149921922|NCT00830518|540848835|FG001|Overall Study|Reason not Specified|1|||
149921923|NCT00494221|540848838|FG000|Overall Study|Death|15|||
149921924|NCT00494221|540848839|FG001|Overall Study|Death|9|||
149921925|NCT00494221|540848840|FG002|Overall Study|Death|14|||
149921926|NCT00494221|540848838|FG000|Overall Study|Withdrawal by Subject|1|||
149921927|NCT00494221|540848839|FG001|Overall Study|Withdrawal by Subject|2|||
149921928|NCT00494221|540848840|FG002|Overall Study|Withdrawal by Subject|0|||
149921929|NCT00583102|540848841|FG000|Overall Study|Adverse Event|3|||
149921930|NCT01994902|540848842|FG000|Test Period 1|Withdrawal by Subject|3|||
149921931|NCT01994902|540848843|FG001|Test Period 1|Withdrawal by Subject|0|||
149921932|NCT01994902|540848842|FG000|Test Period 1|device deficiency with adverse event|0|||
149921933|NCT01994902|540848843|FG001|Test Period 1|device deficiency with adverse event|1|||
149921934|NCT01994902|540848842|FG000|Test Period 1|Adverse Event|2|||
149921935|NCT01994902|540848843|FG001|Test Period 1|Adverse Event|1|||
149921936|NCT01994902|540848842|FG000|Test Period 1|Lack of Efficacy|0|||
149921937|NCT01994902|540848843|FG001|Test Period 1|Lack of Efficacy|1|||
149921938|NCT01994902|540848842|FG000|Test Period 1|bag too small|1|||
149921939|NCT01994902|540848843|FG001|Test Period 1|bag too small|0|||
149921940|NCT01994902|540848842|FG000|Test Period 2|Withdrawal by Subject|0|||
149921941|NCT01994902|540848843|FG001|Test Period 2|Withdrawal by Subject|2|||
149921942|NCT01994902|540848842|FG000|Test Period 2|Lack of Efficacy|0|||
149921943|NCT01994902|540848843|FG001|Test Period 2|Lack of Efficacy|1|||
149921944|NCT01994902|540848842|FG000|Test Period 2|Other|0|||
149921945|NCT01994902|540848843|FG001|Test Period 2|Other|3|||
149921946|NCT03951753|540848846|FG000|Overall Study|Adverse Event|1|||
149921947|NCT03951753|540848847|FG001|Overall Study|Adverse Event|0|||
149921948|NCT03951753|540848848|FG002|Overall Study|Adverse Event|3|||
149921949|NCT03951753|540848846|FG000|Overall Study|Withdrawal by Subject|3|||
149921950|NCT03951753|540848847|FG001|Overall Study|Withdrawal by Subject|1|||
149921951|NCT03951753|540848848|FG002|Overall Study|Withdrawal by Subject|0|||
149921952|NCT03951753|540848846|FG000|Overall Study|Lost to Follow-up|0|||
149921953|NCT03951753|540848847|FG001|Overall Study|Lost to Follow-up|0|||
149921954|NCT03951753|540848848|FG002|Overall Study|Lost to Follow-up|1|||
149921955|NCT01905592|540848851|FG000|Overall Study|Disease Progression|51|||
149921956|NCT01905592|540848852|FG001|Overall Study|Disease Progression|110|||
149921957|NCT01905592|540848851|FG000|Overall Study|Toxicity|1|||
149921958|NCT01905592|540848852|FG001|Overall Study|Toxicity|16|||
149921959|NCT01905592|540848851|FG000|Overall Study|Physician Decision|0|||
149921960|NCT01905592|540848852|FG001|Overall Study|Physician Decision|2|||
149921961|NCT01905592|540848851|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
149921962|NCT01905592|540848852|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
149921963|NCT01905592|540848851|FG000|Overall Study|Protocol Violation|0|||
149921964|NCT01905592|540848852|FG001|Overall Study|Protocol Violation|1|||
149921965|NCT01905592|540848851|FG000|Overall Study|Sponsor's decision|1|||
149921966|NCT01905592|540848852|FG001|Overall Study|Sponsor's decision|1|||
149921967|NCT01905592|540848851|FG000|Overall Study|Not treated|7|||
149921968|NCT01905592|540848852|FG001|Overall Study|Not treated|3|||
149921969|NCT01905592|540848851|FG000|Overall Study|Withdrawal by Subject|10|||
149921970|NCT01905592|540848852|FG001|Overall Study|Withdrawal by Subject|2|||
149921971|NCT01483599|540848853|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
149921972|NCT01483599|540848854|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921973|NCT01483599|540848855|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921974|NCT01483599|540848856|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
149921975|NCT01483599|540848857|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
149921976|NCT01483599|540848858|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
149921977|NCT01483599|540848859|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
149921978|NCT01483599|540848860|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921979|NCT01483599|540848861|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921980|NCT01483599|540848862|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921981|NCT01483599|540848863|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921982|NCT01483599|540848864|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921983|NCT01483599|540848865|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921984|NCT01483599|540848866|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149921985|NCT01483599|540848853|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921986|NCT01483599|540848854|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
149921987|NCT01483599|540848855|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921988|NCT01483599|540848856|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
149921989|NCT01483599|540848857|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921990|NCT01483599|540848858|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921991|NCT01483599|540848859|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
149921992|NCT01483599|540848860|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921993|NCT01483599|540848861|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921994|NCT01483599|540848862|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921995|NCT01483599|540848863|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921996|NCT01483599|540848864|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921997|NCT01483599|540848865|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921998|NCT01483599|540848866|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149921999|NCT01483599|540848853|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
149922000|NCT01483599|540848854|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922001|NCT01483599|540848855|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922002|NCT01483599|540848856|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922003|NCT01483599|540848857|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922004|NCT01483599|540848858|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922005|NCT01483599|540848859|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922006|NCT01483599|540848860|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922007|NCT01483599|540848861|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922008|NCT01483599|540848862|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922009|NCT01483599|540848863|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922010|NCT01483599|540848864|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922011|NCT01483599|540848865|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922012|NCT01483599|540848866|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
149922013|NCT01483599|540848853|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
149922014|NCT01483599|540848854|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
149922015|NCT01483599|540848855|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
149922016|NCT01483599|540848856|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
150160803|NCT03212365|541721528|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
149922017|NCT01483599|540848857|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
150160804|NCT03212365|541721527|FG000|Overall Study|Refused study medication|3|||
149922018|NCT01483599|540848858|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
149922019|NCT01483599|540848859|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
149922020|NCT01483599|540848860|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
149922021|NCT01483599|540848861|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
149922022|NCT01483599|540848862|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
149922023|NCT01483599|540848863|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
149922024|NCT01483599|540848864|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
149922025|NCT01483599|540848865|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
149922026|NCT01483599|540848866|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
149922027|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
149922028|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
149922029|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
149922030|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
149922031|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
149922032|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
149922033|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
149922034|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
149922035|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
149922036|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
149922037|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
149922038|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
149922039|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
149922040|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
149922041|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922042|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922043|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922044|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922045|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922046|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922047|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922048|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
149922049|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
149922050|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922051|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
149922052|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
150160805|NCT03212365|541721528|FG001|Overall Study|Refused study medication|0|||
150160806|NCT03212365|541721527|FG000|Overall Study|Initiated heparin infusion on floor|1|||
150160807|NCT03212365|541721528|FG001|Overall Study|Initiated heparin infusion on floor|1|||
150160808|NCT03212365|541721527|FG000|Overall Study|Unexpected return to OR|1|||
150160809|NCT03212365|541721528|FG001|Overall Study|Unexpected return to OR|1|||
150160810|NCT03212365|541721527|FG000|Overall Study|Medication distribution error|1|||
150160811|NCT03212365|541721528|FG001|Overall Study|Medication distribution error|0|||
150160812|NCT03212365|541721527|FG000|Overall Study|Required epidural placement|1|||
150160813|NCT03212365|541721528|FG001|Overall Study|Required epidural placement|0|||
150160814|NCT03212365|541721527|FG000|Overall Study|Withdrawal by Subject|0|||
150160815|NCT03212365|541721528|FG001|Overall Study|Withdrawal by Subject|1|||
150160816|NCT03212365|541721527|FG000|Overall Study|developed acute renal failure|0|||
150160817|NCT03212365|541721528|FG001|Overall Study|developed acute renal failure|1|||
150160818|NCT01342887|541721530|FG000|Overall Study|Death|2|||
150160819|NCT04880161|541721532|FG000|Overall Study|Withdrawal by Subject|1|||
150160820|NCT04880161|541721533|FG001|Overall Study|Withdrawal by Subject|0|||
150160821|NCT04880161|541721532|FG000|Overall Study|Lack of Compliance|1|||
150160822|NCT04880161|541721533|FG001|Overall Study|Lack of Compliance|1|||
150160823|NCT04880161|541721532|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
150160824|NCT04880161|541721533|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
150160825|NCT04880161|541721532|FG000|Overall Study|Screen Failure|0|||
150160826|NCT04880161|541721533|FG001|Overall Study|Screen Failure|1|||
150160827|NCT01354106|541721534|FG000|Overall Study|Withdrawal by Subject|2|||
150160828|NCT00231179|541723583|FG000|Overall Study|Lost to Follow-up|21|||
150160829|NCT00231179|541723584|FG001|Overall Study|Lost to Follow-up|21|||
150160830|NCT00231179|541723583|FG000|Overall Study|Withdrawal by Subject|3|||
150160831|NCT00231179|541723584|FG001|Overall Study|Withdrawal by Subject|3|||
150160832|NCT01764386|541723586|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
150160833|NCT01764386|541723587|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
150160834|NCT01764386|541723586|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
150160835|NCT01764386|541723587|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
149922053|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
150160836|NCT01764386|541723586|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
150160837|NCT01764386|541723587|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
150160838|NCT01764386|541723586|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
149922054|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
149922055|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922056|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922057|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922058|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922059|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922060|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922061|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922062|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922063|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
149922064|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922065|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922066|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
149922067|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149922068|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
149922069|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922070|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922071|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922072|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
150160839|NCT01764386|541723587|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
149817580|NCT00368537|540463447|FG001|Baseline Participants|No susceptibility|0|||
149817581|NCT00368537|540463446|FG000|Baseline Participants|Patient uncompliant|0|||
149817582|NCT00368537|540463447|FG001|Baseline Participants|Patient uncompliant|1|||
149817583|NCT01368276|540463459|FG000|Overall Study|Death|1|||
149817584|NCT01368276|540463460|FG001|Overall Study|Death|10|||
149817585|NCT02041494|540463461|FG000|Overall Study|Death|1|||
149817586|NCT02041494|540463462|FG001|Overall Study|Death|3|||
149817587|NCT02041494|540463461|FG000|Overall Study|Lost to Follow-up|2|||
149817588|NCT02041494|540463462|FG001|Overall Study|Lost to Follow-up|6|||
149817589|NCT02041494|540463461|FG000|Overall Study|study terminated|16|||
149817590|NCT02041494|540463462|FG001|Overall Study|study terminated|11|||
149817591|NCT03341273|540463463|FG000|Overall Study|Lost to Follow-up|7|||
149817592|NCT03341273|540463464|FG001|Overall Study|Lost to Follow-up|7|||
149817593|NCT03341273|540463463|FG000|Overall Study|Withdrawal by Subject|4|||
149817594|NCT03341273|540463464|FG001|Overall Study|Withdrawal by Subject|2|||
149817595|NCT03341273|540463463|FG000|Overall Study|Physician Decision|1|||
149817596|NCT03341273|540463464|FG001|Overall Study|Physician Decision|0|||
149817597|NCT03341273|540463463|FG000|Overall Study|Protocol Violation|0|||
149817598|NCT03341273|540463464|FG001|Overall Study|Protocol Violation|1|||
149817599|NCT03341273|540463463|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
149817600|NCT03341273|540463464|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
149817601|NCT03341273|540463463|FG000|Overall Study|Became ineligible after enrollment|1|||
149817602|NCT03341273|540463464|FG001|Overall Study|Became ineligible after enrollment|0|||
149817603|NCT03341273|540463463|FG000|Overall Study|Not Eligible at Enrollment|0|||
149817604|NCT03341273|540463464|FG001|Overall Study|Not Eligible at Enrollment|1|||
149817605|NCT03341273|540463463|FG000|Overall Study|Participant incarcerated|1|||
149817606|NCT03341273|540463464|FG001|Overall Study|Participant incarcerated|0|||
149817607|NCT00685919|540463466|FG000|Overall Study|Withdrawal by Subject|0|||
149817608|NCT00685919|540463467|FG001|Overall Study|Withdrawal by Subject|0|||
149817609|NCT00685919|540463468|FG002|Overall Study|Withdrawal by Subject|1|||
149817610|NCT00685919|540463469|FG003|Overall Study|Withdrawal by Subject|0|||
149817611|NCT00685919|540463466|FG000|Overall Study|Physician Decision|1|||
149817612|NCT00685919|540463467|FG001|Overall Study|Physician Decision|0|||
149817613|NCT00685919|540463468|FG002|Overall Study|Physician Decision|0|||
149817614|NCT00685919|540463469|FG003|Overall Study|Physician Decision|0|||
149817615|NCT02732561|540463477|FG000|Overall Study|Lost to Follow-up|1|||
149817616|NCT02732561|540463478|FG001|Overall Study|Lost to Follow-up|1|||
149817617|NCT02732561|540463477|FG000|Overall Study|Withdrawal by Subject|1|||
149817618|NCT02732561|540463478|FG001|Overall Study|Withdrawal by Subject|0|||
149817619|NCT01886300|540463479|FG000|Overall Study|Trial terminated by sponsor|16|||
149817620|NCT01797120|540463482|FG000|Overall Study|Disesae progression|37|||
149817621|NCT01797120|540463483|FG001|Overall Study|Disesae progression|49|||
149817622|NCT01797120|540463482|FG000|Overall Study|Adverse Event|13|||
149817623|NCT01797120|540463483|FG001|Overall Study|Adverse Event|5|||
149817624|NCT01797120|540463482|FG000|Overall Study|Withdrawal by Subject|6|||
149817625|NCT01797120|540463483|FG001|Overall Study|Withdrawal by Subject|6|||
149817626|NCT01797120|540463482|FG000|Overall Study|Symptomatic progression|2|||
149817627|NCT01797120|540463483|FG001|Overall Study|Symptomatic progression|1|||
149817628|NCT01797120|540463482|FG000|Overall Study|Non-compliance|1|||
149817629|NCT01797120|540463483|FG001|Overall Study|Non-compliance|0|||
149817630|NCT01797120|540463482|FG000|Overall Study|Physician Decision|3|||
149817631|NCT01797120|540463483|FG001|Overall Study|Physician Decision|0|||
149922073|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922074|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922075|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922076|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922077|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
149922078|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922079|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
149922080|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922081|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
149922082|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
149922083|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922084|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922085|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922086|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922087|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922088|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922089|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922090|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922091|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
149922092|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922093|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922094|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
149922095|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
149922096|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
149922097|NCT01483599|540848853|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
149922098|NCT01483599|540848854|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
149922099|NCT01483599|540848855|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
149922100|NCT01483599|540848856|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
149922101|NCT01483599|540848857|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
149922102|NCT01483599|540848858|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
149922103|NCT01483599|540848859|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
149922104|NCT01483599|540848860|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
149922105|NCT01483599|540848861|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
149922106|NCT01483599|540848862|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
149922107|NCT01483599|540848863|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
149922108|NCT01483599|540848864|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
149922109|NCT01483599|540848865|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
149922110|NCT01483599|540848866|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
149922111|NCT03630705|540850558|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
149922112|NCT03630705|540850559|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
149922113|NCT03630705|540850560|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
149922114|NCT03630705|540850561|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149922115|NCT03630705|540850558|FG000|Overall Study|Lost to Follow-up|1|||
149922116|NCT03630705|540850559|FG001|Overall Study|Lost to Follow-up|2|||
149922117|NCT03630705|540850560|FG002|Overall Study|Lost to Follow-up|0|||
149922118|NCT03630705|540850561|FG003|Overall Study|Lost to Follow-up|0|||
149922119|NCT01128400|540850562|FG000|Overall Study|Lost to Follow-up|1|||
149922120|NCT01128400|540850563|FG001|Overall Study|Lost to Follow-up|0|||
149922121|NCT01128400|540850564|FG002|Overall Study|Lost to Follow-up|1|||
149922122|NCT01128400|540850562|FG000|Overall Study|Screening failure|1|||
149922123|NCT01128400|540850563|FG001|Overall Study|Screening failure|0|||
149922124|NCT01128400|540850564|FG002|Overall Study|Screening failure|0|||
149922125|NCT01128400|540850562|FG000|Overall Study|were not invited to participate on taste|0|||
149922126|NCT01128400|540850563|FG001|Overall Study|were not invited to participate on taste|0|||
149922127|NCT01128400|540850564|FG002|Overall Study|were not invited to participate on taste|15|||
149922128|NCT01128400|540850562|FG000|Overall Study|Excluded due to sinus problems|0|||
149922129|NCT01128400|540850563|FG001|Overall Study|Excluded due to sinus problems|1|||
149922130|NCT01128400|540850564|FG002|Overall Study|Excluded due to sinus problems|0|||
149922131|NCT02362425|540850565|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
149922132|NCT02362425|540850566|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
149922133|NCT02362425|540850567|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
149922134|NCT02362425|540850568|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
149922135|NCT02362425|540850565|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
149922136|NCT02362425|540850566|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
149922137|NCT02362425|540850567|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
149922138|NCT02362425|540850568|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
149922139|NCT02362425|540850565|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
149922140|NCT02362425|540850566|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
150259971|NCT00729378|542089233|FG001|24-months|Lost to Follow-up|51|||
149922141|NCT02362425|540850567|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
149922142|NCT02362425|540850568|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
149922143|NCT02362425|540850565|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
149922144|NCT02362425|540850566|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
149922145|NCT02362425|540850567|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
149922146|NCT02362425|540850568|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
149922147|NCT02362425|540850565|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
149922148|NCT02362425|540850566|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
149922149|NCT02362425|540850567|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
149922150|NCT02362425|540850568|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
149922151|NCT02362425|540850565|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
149922152|NCT02362425|540850566|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
149922153|NCT02362425|540850567|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
149922154|NCT02362425|540850568|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
149922155|NCT02362425|540850565|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
149922156|NCT02362425|540850566|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
149922157|NCT02362425|540850567|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
149922158|NCT02362425|540850568|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
149922159|NCT02362425|540850565|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
149922160|NCT02362425|540850566|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
149922161|NCT02362425|540850567|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
149922162|NCT02362425|540850568|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
149922163|NCT00314808|540850576|FG000|Overall Study|Disease Progression without AE|4|||
149922164|NCT00314808|540850576|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
149922165|NCT04304508|540850577|FG000|Overall Study|Subject Decision|29|||
149922166|NCT04304508|540850578|FG001|Overall Study|Subject Decision|39|||
149922167|NCT04304508|540850579|FG002|Overall Study|Subject Decision|37|||
149922168|NCT04304508|540850580|FG003|Overall Study|Subject Decision|48|||
149922169|NCT04304508|540850577|FG000|Overall Study|Death|6|||
149922170|NCT04304508|540850578|FG001|Overall Study|Death|1|||
149922171|NCT04304508|540850579|FG002|Overall Study|Death|8|||
149922172|NCT04304508|540850580|FG003|Overall Study|Death|5|||
149922173|NCT04304508|540850577|FG000|Overall Study|Non-compliance With Study Drug|3|||
149922174|NCT04304508|540850578|FG001|Overall Study|Non-compliance With Study Drug|1|||
149922175|NCT04304508|540850579|FG002|Overall Study|Non-compliance With Study Drug|2|||
149922176|NCT04304508|540850580|FG003|Overall Study|Non-compliance With Study Drug|0|||
149922177|NCT04304508|540850577|FG000|Overall Study|Switching To Other Therapy|1|||
149922178|NCT04304508|540850578|FG001|Overall Study|Switching To Other Therapy|1|||
149922179|NCT04304508|540850579|FG002|Overall Study|Switching To Other Therapy|1|||
149922180|NCT04304508|540850580|FG003|Overall Study|Switching To Other Therapy|2|||
149922181|NCT04304508|540850577|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
149922182|NCT04304508|540850578|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
149922183|NCT04304508|540850579|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
149922184|NCT04304508|540850580|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
149922185|NCT04304508|540850577|FG000|Overall Study|Withdrawal by Subject|7|||
149922186|NCT04304508|540850578|FG001|Overall Study|Withdrawal by Subject|5|||
149922187|NCT04304508|540850579|FG002|Overall Study|Withdrawal by Subject|11|||
149922188|NCT04304508|540850580|FG003|Overall Study|Withdrawal by Subject|6|||
149922189|NCT04304508|540850577|FG000|Overall Study|Logistical Difficulties|2|||
149922190|NCT04304508|540850578|FG001|Overall Study|Logistical Difficulties|2|||
149922191|NCT04304508|540850579|FG002|Overall Study|Logistical Difficulties|3|||
149922192|NCT04304508|540850580|FG003|Overall Study|Logistical Difficulties|2|||
149922193|NCT04304508|540850577|FG000|Overall Study|Missing Information|1|||
149922194|NCT04304508|540850578|FG001|Overall Study|Missing Information|2|||
149922195|NCT04304508|540850579|FG002|Overall Study|Missing Information|1|||
149922196|NCT04304508|540850580|FG003|Overall Study|Missing Information|3|||
149922197|NCT04304508|540850577|FG000|Overall Study|Other|7|||
149922198|NCT04304508|540850578|FG001|Overall Study|Other|6|||
149922199|NCT04304508|540850579|FG002|Overall Study|Other|5|||
149922200|NCT04304508|540850580|FG003|Overall Study|Other|4|||
149922201|NCT04304508|540850577|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
149922202|NCT04304508|540850578|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
149922203|NCT04304508|540850579|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
149922204|NCT04304508|540850580|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
149922205|NCT04304508|540850577|FG000|Overall Study|Physician Decision|3|||
149922206|NCT04304508|540850578|FG001|Overall Study|Physician Decision|4|||
149922207|NCT04304508|540850579|FG002|Overall Study|Physician Decision|9|||
149922208|NCT04304508|540850580|FG003|Overall Study|Physician Decision|7|||
149922209|NCT04304508|540850577|FG000|Overall Study|Study drug never administered|10|||
149922210|NCT04304508|540850578|FG001|Overall Study|Study drug never administered|4|||
149922211|NCT04304508|540850579|FG002|Overall Study|Study drug never administered|4|||
149922212|NCT04304508|540850580|FG003|Overall Study|Study drug never administered|4|||
149922213|NCT04304508|540850577|FG000|Overall Study|Adverse Event|49|||
149922214|NCT04304508|540850578|FG001|Overall Study|Adverse Event|50|||
149922215|NCT04304508|540850579|FG002|Overall Study|Adverse Event|51|||
149922216|NCT04304508|540850580|FG003|Overall Study|Adverse Event|56|||
149922217|NCT04304508|540850577|FG000|Overall Study|Lost to Follow-up|1|||
149922218|NCT04304508|540850578|FG001|Overall Study|Lost to Follow-up|5|||
149922219|NCT04304508|540850579|FG002|Overall Study|Lost to Follow-up|2|||
149922220|NCT04304508|540850580|FG003|Overall Study|Lost to Follow-up|3|||
149922221|NCT02688764|540850587|FG000|Overall Study|Adverse Event|3|||
149922222|NCT02688764|540850588|FG001|Overall Study|Adverse Event|3|||
149922223|NCT02688764|540850587|FG000|Overall Study|AE/Kidney transplant|1|||
149922224|NCT02688764|540850588|FG001|Overall Study|AE/Kidney transplant|0|||
149922225|NCT02688764|540850587|FG000|Overall Study|AE/Lack of efficacy|1|||
149922226|NCT02688764|540850588|FG001|Overall Study|AE/Lack of efficacy|0|||
149922227|NCT02688764|540850587|FG000|Overall Study|AE/Non-compl.|1|||
149922228|NCT02688764|540850588|FG001|Overall Study|AE/Non-compl.|0|||
149922229|NCT02688764|540850587|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
149922230|NCT02688764|540850588|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
149922231|NCT02688764|540850587|FG000|Overall Study|AE/Other|0|||
149922232|NCT02688764|540850588|FG001|Overall Study|AE/Other|1|||
149922233|NCT02688764|540850587|FG000|Overall Study|AE/Physician decision|1|||
149922234|NCT02688764|540850588|FG001|Overall Study|AE/Physician decision|0|||
149922235|NCT02688764|540850587|FG000|Overall Study|AE/Withd. parent|3|||
149922236|NCT02688764|540850588|FG001|Overall Study|AE/Withd. parent|0|||
149922237|NCT02688764|540850587|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
149922238|NCT02688764|540850588|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
149922239|NCT02688764|540850587|FG000|Overall Study|AE/Withd. subject|1|||
149922240|NCT02688764|540850588|FG001|Overall Study|AE/Withd. subject|0|||
149922241|NCT02688764|540850587|FG000|Overall Study|Kidney transplant|10|||
149922242|NCT02688764|540850588|FG001|Overall Study|Kidney transplant|4|||
149922243|NCT02688764|540850587|FG000|Overall Study|Lack of Efficacy|3|||
149922244|NCT02688764|540850588|FG001|Overall Study|Lack of Efficacy|2|||
149922245|NCT02688764|540850587|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
149922246|NCT02688764|540850588|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
149922247|NCT02688764|540850587|FG000|Overall Study|Non-compliance with study drug|4|||
149922248|NCT02688764|540850588|FG001|Overall Study|Non-compliance with study drug|0|||
149922249|NCT02688764|540850587|FG000|Overall Study|Non-compl./Physician decision|2|||
149922250|NCT02688764|540850588|FG001|Overall Study|Non-compl./Physician decision|0|||
149922251|NCT02688764|540850587|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
149922252|NCT02688764|540850588|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
149922253|NCT02688764|540850587|FG000|Overall Study|Non-compl./Withd. subject|0|||
149922254|NCT02688764|540850588|FG001|Overall Study|Non-compl./Withd. subject|2|||
149922255|NCT02688764|540850587|FG000|Overall Study|Phosphorus level outside safe range|0|||
149922256|NCT02688764|540850588|FG001|Overall Study|Phosphorus level outside safe range|1|||
149922257|NCT02688764|540850587|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
149922258|NCT02688764|540850588|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
149922259|NCT02688764|540850587|FG000|Overall Study|Study drug taste/Withd. parent|1|||
149922260|NCT02688764|540850588|FG001|Overall Study|Study drug taste/Withd. parent|0|||
149922261|NCT02688764|540850587|FG000|Overall Study|Subject moving out|2|||
149922262|NCT02688764|540850588|FG001|Overall Study|Subject moving out|0|||
149922263|NCT02688764|540850587|FG000|Overall Study|Subject taken off dialysis|1|||
149922264|NCT02688764|540850588|FG001|Overall Study|Subject taken off dialysis|0|||
149922265|NCT02688764|540850587|FG000|Overall Study|Withdrawal by parent|3|||
149922266|NCT02688764|540850588|FG001|Overall Study|Withdrawal by parent|0|||
149922267|NCT02113007|540850589|FG000|Overall Study|Progressive disease|2|||
149922268|NCT01775787|540850590|FG000|First 7-10 Days|Adverse Event|0|||
149922269|NCT01775787|540850591|FG001|First 7-10 Days|Adverse Event|1|||
149922270|NCT01775787|540850590|FG000|First 7-10 Days|family emergency|0|||
149922271|NCT01775787|540850591|FG001|First 7-10 Days|family emergency|1|||
149922272|NCT01775787|540850590|FG000|First 7-10 Days|time commitment|0|||
149922273|NCT01775787|540850591|FG001|First 7-10 Days|time commitment|2|||
149922274|NCT01775787|540850590|FG000|First 7-10 Days|concerns with using IV|1|||
149922275|NCT01775787|540850591|FG001|First 7-10 Days|concerns with using IV|2|||
149922276|NCT01775787|540850590|FG000|Second 7-10 Days|time commitment|0|||
150259972|NCT00729378|542089232|FG000|36-months|Lost to Follow-up|15|||
150259973|NCT00729378|542089233|FG001|36-months|Lost to Follow-up|6|||
149922277|NCT01775787|540850591|FG001|Second 7-10 Days|time commitment|1|||
149922278|NCT01775787|540850590|FG000|Second 7-10 Days|concerns with using IV|0|||
149922279|NCT01775787|540850591|FG001|Second 7-10 Days|concerns with using IV|1|||
149922280|NCT01299896|540850592|FG000|Overall Study|Withdrawal by Subject|1|||
149922281|NCT01299896|540850593|FG001|Overall Study|Withdrawal by Subject|7|||
149922282|NCT01299896|540850592|FG000|Overall Study|Lost to Follow-up|0|||
149922283|NCT01299896|540850593|FG001|Overall Study|Lost to Follow-up|11|||
149922284|NCT01502956|540850598|FG000|Overall Study|Death|0|||
150259974|NCT01586910|542089234|FG000|Overall Study|Death|4|||
149922285|NCT01502956|540850599|FG001|Overall Study|Death|2|||
149922286|NCT01502956|540850598|FG000|Overall Study|Lost to Follow-up|14|||
149922287|NCT01502956|540850599|FG001|Overall Study|Lost to Follow-up|11|||
149922288|NCT01502956|540850598|FG000|Overall Study|Physician Decision|2|||
149922289|NCT01502956|540850599|FG001|Overall Study|Physician Decision|3|||
149922290|NCT01502956|540850598|FG000|Overall Study|Withdrawal by Subject|8|||
149922291|NCT01502956|540850599|FG001|Overall Study|Withdrawal by Subject|10|||
149922292|NCT01616758|540850600|FG000|Overall Study|Adverse Event|1|||
149922293|NCT01616758|540850600|FG000|Overall Study|Withdrawal by Subject|2|||
149922294|NCT01616758|540850600|FG000|Overall Study|Disease progression|18|||
149922295|NCT01616758|540850600|FG000|Overall Study|Study termination by Sponsor|1|||
149922296|NCT03026283|540850601|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
149922297|NCT03026283|540850602|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
149922298|NCT03026283|540850603|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
149922299|NCT03026283|540850604|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
149922300|NCT03026283|540850605|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
149922301|NCT03026283|540850606|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
149922302|NCT03026283|540850607|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
149922303|NCT03026283|540850608|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
149922304|NCT03026283|540850601|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
149922305|NCT03026283|540850602|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
149922306|NCT03026283|540850603|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
149922307|NCT03026283|540850604|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
149922308|NCT03026283|540850605|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
149922309|NCT03026283|540850606|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
149922310|NCT03026283|540850607|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
149922311|NCT03026283|540850608|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
149922312|NCT03026283|540850601|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922313|NCT03026283|540850602|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
149922314|NCT03026283|540850603|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922315|NCT03026283|540850604|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922316|NCT03026283|540850605|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922317|NCT03026283|540850606|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922318|NCT03026283|540850607|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922319|NCT03026283|540850608|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
149922320|NCT03026283|540850601|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922321|NCT03026283|540850602|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922322|NCT03026283|540850603|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
149922323|NCT03026283|540850604|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922324|NCT03026283|540850605|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922325|NCT03026283|540850606|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922326|NCT03026283|540850607|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922327|NCT03026283|540850608|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
149922328|NCT03026283|540850601|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922329|NCT03026283|540850602|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922330|NCT03026283|540850603|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922331|NCT03026283|540850604|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
149922332|NCT03026283|540850605|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
149922333|NCT03026283|540850606|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922334|NCT03026283|540850607|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922335|NCT03026283|540850608|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
149922336|NCT03026283|540850601|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
149922337|NCT03026283|540850602|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
149922338|NCT03026283|540850603|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
149922339|NCT03026283|540850604|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
149922340|NCT03026283|540850605|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
149922341|NCT03026283|540850606|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
149922342|NCT03026283|540850607|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
149922343|NCT03026283|540850608|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
149922344|NCT03026283|540850601|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922345|NCT03026283|540850602|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922346|NCT03026283|540850603|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922347|NCT03026283|540850604|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
149922348|NCT03026283|540850605|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922349|NCT03026283|540850606|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
149922350|NCT03026283|540850607|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922351|NCT03026283|540850608|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
149922352|NCT03026283|540850601|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922353|NCT03026283|540850602|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922354|NCT03026283|540850603|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922355|NCT03026283|540850604|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
149922356|NCT03026283|540850605|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922357|NCT03026283|540850606|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922358|NCT03026283|540850607|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922359|NCT03026283|540850608|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
149922360|NCT03026283|540850601|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922361|NCT03026283|540850602|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922362|NCT03026283|540850603|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922363|NCT03026283|540850604|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922364|NCT03026283|540850605|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
149922365|NCT03026283|540850606|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
149922366|NCT03026283|540850607|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922367|NCT03026283|540850608|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
149922368|NCT01054222|540850609|FG000|Overall Study|Lack of Efficacy|1|||
149922369|NCT01054222|540850609|FG000|Overall Study|Lost to Follow-up|4|||
149922370|NCT01054222|540850609|FG000|Overall Study|Withdrawal by Subject|6|||
149922371|NCT00824655|540850610|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
149922372|NCT00824655|540850611|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
149922373|NCT00824655|540850610|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
149922374|NCT00824655|540850611|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
149922375|NCT03782571|540850612|FG000|Period 1|Withdrawal by Subject|1|||
149922376|NCT03782571|540850613|FG001|Period 1|Withdrawal by Subject|0|||
149922377|NCT03782571|540850614|FG002|Period 1|Withdrawal by Subject|0|||
149922378|NCT03782571|540850615|FG003|Period 1|Withdrawal by Subject|0|||
149922379|NCT03782571|540850612|FG000|Period 3|Subject Unable to Attend V5|1|||
149922380|NCT03782571|540850613|FG001|Period 3|Subject Unable to Attend V5|0|||
149922381|NCT03782571|540850614|FG002|Period 3|Subject Unable to Attend V5|0|||
149922382|NCT03782571|540850615|FG003|Period 3|Subject Unable to Attend V5|0|||
149922383|NCT03782571|540850612|FG000|Period 3|Adverse Event|1|||
149922384|NCT03782571|540850613|FG001|Period 3|Adverse Event|0|||
149922385|NCT03782571|540850614|FG002|Period 3|Adverse Event|0|||
149922386|NCT03782571|540850615|FG003|Period 3|Adverse Event|0|||
149922387|NCT03091738|540850616|FG000|Overall Study|Adverse Event|1|||
149922388|NCT03091738|540850616|FG000|Overall Study|Lost to Follow-up|1|||
149922389|NCT00199849|540850617|FG000|Overall Study|Unrelated illness or complication|0|||
149922390|NCT00199849|540850618|FG001|Overall Study|Unrelated illness or complication|1|||
149922391|NCT00199849|540850619|FG002|Overall Study|Unrelated illness or complication|0|||
149922392|NCT00199849|540850617|FG000|Overall Study|Progressive disease requiring intervention|0|||
149922393|NCT00199849|540850618|FG001|Overall Study|Progressive disease requiring intervention|0|||
149922394|NCT00199849|540850619|FG002|Overall Study|Progressive disease requiring intervention|1|||
149922395|NCT00199849|540850617|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
149922396|NCT00199849|540850618|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
149922397|NCT00199849|540850619|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
149922398|NCT01826981|540850623|FG000|Overall Study|Lack of Efficacy|0|||
149922399|NCT01826981|540850624|FG001|Overall Study|Lack of Efficacy|1|||
149922400|NCT01826981|540850625|FG002|Overall Study|Lack of Efficacy|0|||
149922401|NCT01826981|540850626|FG003|Overall Study|Lack of Efficacy|0|||
149922402|NCT01826981|540850627|FG004|Overall Study|Lack of Efficacy|5|||
149922403|NCT01826981|540850628|FG005|Overall Study|Lack of Efficacy|0|||
149922404|NCT01826981|540850629|FG006|Overall Study|Lack of Efficacy|0|||
149922405|NCT01826981|540850630|FG007|Overall Study|Lack of Efficacy|8|||
149922406|NCT01826981|540850631|FG008|Overall Study|Lack of Efficacy|7|||
149922407|NCT01826981|540850632|FG009|Overall Study|Lack of Efficacy|0|||
149922408|NCT01826981|540850633|FG010|Overall Study|Lack of Efficacy|1|||
149922409|NCT01826981|540850634|FG011|Overall Study|Lack of Efficacy|0|||
149922410|NCT01826981|540850635|FG012|Overall Study|Lack of Efficacy|0|||
149922411|NCT01826981|540850636|FG013|Overall Study|Lack of Efficacy|3|||
149922412|NCT01826981|540850637|FG014|Overall Study|Lack of Efficacy|0|||
149922413|NCT01826981|540850623|FG000|Overall Study|Lost to Follow-up|0|||
149922414|NCT01826981|540850624|FG001|Overall Study|Lost to Follow-up|0|||
149922415|NCT01826981|540850625|FG002|Overall Study|Lost to Follow-up|0|||
150160840|NCT01764386|541723586|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
150160841|NCT01764386|541723587|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
150160842|NCT01764386|541723586|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
150160843|NCT01764386|541723587|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
150160844|NCT01764386|541723586|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
150160845|NCT01764386|541723587|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
149922416|NCT01826981|540850626|FG003|Overall Study|Lost to Follow-up|0|||
149922417|NCT01826981|540850627|FG004|Overall Study|Lost to Follow-up|1|||
149922418|NCT01826981|540850628|FG005|Overall Study|Lost to Follow-up|1|||
149922419|NCT01826981|540850629|FG006|Overall Study|Lost to Follow-up|0|||
149922420|NCT01826981|540850630|FG007|Overall Study|Lost to Follow-up|1|||
149922421|NCT01826981|540850631|FG008|Overall Study|Lost to Follow-up|0|||
149922422|NCT01826981|540850632|FG009|Overall Study|Lost to Follow-up|1|||
149922423|NCT01826981|540850633|FG010|Overall Study|Lost to Follow-up|1|||
149922424|NCT01826981|540850634|FG011|Overall Study|Lost to Follow-up|1|||
149922425|NCT01826981|540850635|FG012|Overall Study|Lost to Follow-up|1|||
149922426|NCT01826981|540850636|FG013|Overall Study|Lost to Follow-up|0|||
149922427|NCT01826981|540850637|FG014|Overall Study|Lost to Follow-up|0|||
149922428|NCT01826981|540850623|FG000|Overall Study|Withdrew Consent|0|||
149922429|NCT01826981|540850624|FG001|Overall Study|Withdrew Consent|0|||
149922430|NCT01826981|540850625|FG002|Overall Study|Withdrew Consent|0|||
149922431|NCT01826981|540850626|FG003|Overall Study|Withdrew Consent|0|||
149922432|NCT01826981|540850627|FG004|Overall Study|Withdrew Consent|0|||
149922433|NCT01826981|540850628|FG005|Overall Study|Withdrew Consent|0|||
149922434|NCT01826981|540850629|FG006|Overall Study|Withdrew Consent|1|||
149922435|NCT01826981|540850630|FG007|Overall Study|Withdrew Consent|1|||
149922436|NCT01826981|540850631|FG008|Overall Study|Withdrew Consent|0|||
149922437|NCT01826981|540850632|FG009|Overall Study|Withdrew Consent|0|||
149922438|NCT01826981|540850633|FG010|Overall Study|Withdrew Consent|0|||
149922439|NCT01826981|540850634|FG011|Overall Study|Withdrew Consent|1|||
149922440|NCT01826981|540850635|FG012|Overall Study|Withdrew Consent|0|||
149922441|NCT01826981|540850636|FG013|Overall Study|Withdrew Consent|1|||
149922442|NCT01826981|540850637|FG014|Overall Study|Withdrew Consent|0|||
149922443|NCT01826981|540850623|FG000|Overall Study|Adverse Event|0|||
149922444|NCT01826981|540850624|FG001|Overall Study|Adverse Event|0|||
149922445|NCT01826981|540850625|FG002|Overall Study|Adverse Event|0|||
149922446|NCT01826981|540850626|FG003|Overall Study|Adverse Event|0|||
149922447|NCT01826981|540850627|FG004|Overall Study|Adverse Event|1|||
149922448|NCT01826981|540850628|FG005|Overall Study|Adverse Event|0|||
149922449|NCT01826981|540850629|FG006|Overall Study|Adverse Event|0|||
149922450|NCT01826981|540850630|FG007|Overall Study|Adverse Event|0|||
149922451|NCT01826981|540850631|FG008|Overall Study|Adverse Event|0|||
149922452|NCT01826981|540850632|FG009|Overall Study|Adverse Event|0|||
149922453|NCT01826981|540850633|FG010|Overall Study|Adverse Event|0|||
149922454|NCT01826981|540850634|FG011|Overall Study|Adverse Event|0|||
149922455|NCT01826981|540850635|FG012|Overall Study|Adverse Event|0|||
149922456|NCT01826981|540850636|FG013|Overall Study|Adverse Event|0|||
149922457|NCT01826981|540850637|FG014|Overall Study|Adverse Event|0|||
149922458|NCT01826981|540850623|FG000|Overall Study|Upper G-I Haemorrhage|0|||
149922459|NCT01826981|540850624|FG001|Overall Study|Upper G-I Haemorrhage|0|||
149922460|NCT01826981|540850625|FG002|Overall Study|Upper G-I Haemorrhage|0|||
149922461|NCT01826981|540850626|FG003|Overall Study|Upper G-I Haemorrhage|0|||
149922462|NCT01826981|540850627|FG004|Overall Study|Upper G-I Haemorrhage|0|||
149922463|NCT01826981|540850628|FG005|Overall Study|Upper G-I Haemorrhage|0|||
149922464|NCT01826981|540850629|FG006|Overall Study|Upper G-I Haemorrhage|0|||
149922465|NCT01826981|540850630|FG007|Overall Study|Upper G-I Haemorrhage|0|||
149922466|NCT01826981|540850631|FG008|Overall Study|Upper G-I Haemorrhage|0|||
149922467|NCT01826981|540850632|FG009|Overall Study|Upper G-I Haemorrhage|0|||
149922468|NCT01826981|540850633|FG010|Overall Study|Upper G-I Haemorrhage|0|||
149922469|NCT01826981|540850634|FG011|Overall Study|Upper G-I Haemorrhage|0|||
149922470|NCT01826981|540850635|FG012|Overall Study|Upper G-I Haemorrhage|0|||
149922471|NCT01826981|540850636|FG013|Overall Study|Upper G-I Haemorrhage|1|||
149922472|NCT01826981|540850637|FG014|Overall Study|Upper G-I Haemorrhage|0|||
149922473|NCT01826981|540850623|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922474|NCT01826981|540850624|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922475|NCT01826981|540850625|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922476|NCT01826981|540850626|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922477|NCT01826981|540850627|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922478|NCT01826981|540850628|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922479|NCT01826981|540850629|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922480|NCT01826981|540850630|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
149922481|NCT01826981|540850631|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922482|NCT01826981|540850632|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922483|NCT01826981|540850633|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922484|NCT01826981|540850634|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922485|NCT01826981|540850635|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922486|NCT01826981|540850636|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922487|NCT01826981|540850637|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
149922488|NCT03084302|540850642|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
149922489|NCT03084302|540850642|FG000|Overall Study|No valid objective monitor data|6|||
149922490|NCT01704755|540850643|FG000|Overall Study|Adverse Event|4|||
149922491|NCT01704755|540850644|FG001|Overall Study|Adverse Event|1|||
149922492|NCT01704755|540850643|FG000|Overall Study|Lost to Follow-up|3|||
149922493|NCT01704755|540850644|FG001|Overall Study|Lost to Follow-up|4|||
149922494|NCT01704755|540850643|FG000|Overall Study|Withdrew consent|1|||
149922495|NCT01704755|540850644|FG001|Overall Study|Withdrew consent|1|||
149922496|NCT01704755|540850643|FG000|Overall Study|Other (not specified)|3|||
149922497|NCT01704755|540850644|FG001|Overall Study|Other (not specified)|1|||
149922498|NCT01704755|540850643|FG000|Overall Study|Withdrew consent and personal issues|1|||
149922499|NCT01704755|540850644|FG001|Overall Study|Withdrew consent and personal issues|0|||
149922500|NCT02187029|540850659|FG000|Overall Study|Adverse Event|0|||
149922501|NCT02187029|540850660|FG001|Overall Study|Adverse Event|1|||
149922502|NCT02187029|540850661|FG002|Overall Study|Adverse Event|1|||
149922503|NCT02187029|540850662|FG003|Overall Study|Adverse Event|0|||
149922504|NCT02187029|540850659|FG000|Overall Study|Study Terminated by Sponsor|0|||
149922505|NCT02187029|540850660|FG001|Overall Study|Study Terminated by Sponsor|0|||
149922506|NCT02187029|540850661|FG002|Overall Study|Study Terminated by Sponsor|10|||
149922507|NCT02187029|540850662|FG003|Overall Study|Study Terminated by Sponsor|3|||
149922508|NCT02187029|540850659|FG000|Overall Study|Withdrawal by Subject|1|||
149922509|NCT02187029|540850660|FG001|Overall Study|Withdrawal by Subject|0|||
149922510|NCT02187029|540850661|FG002|Overall Study|Withdrawal by Subject|0|||
149922511|NCT02187029|540850662|FG003|Overall Study|Withdrawal by Subject|0|||
149922512|NCT00264290|540850663|FG000|Intervention (8 Weeks)|Adverse Event|1|||
149922513|NCT00264290|540850664|FG001|Intervention (8 Weeks)|Adverse Event|0|||
149922514|NCT02782377|540850666|FG000|Overall Study|Physician Decision|5|||
149922515|NCT01188668|540850668|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
149922516|NCT01188668|540850668|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
149922517|NCT01188668|540850668|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
149922518|NCT00303472|540850669|FG000|Treatment Period|Adverse Event|0|||
149922519|NCT00303472|540850670|FG001|Treatment Period|Adverse Event|0|||
149922520|NCT00303472|540850671|FG002|Treatment Period|Adverse Event|0|||
149922521|NCT00303472|540850672|FG003|Treatment Period|Adverse Event|0|||
149922522|NCT00303472|540850673|FG004|Treatment Period|Adverse Event|1|||
149922523|NCT00303472|540850674|FG005|Treatment Period|Adverse Event|0|||
149922524|NCT00303472|540850675|FG006|Treatment Period|Adverse Event|0|||
149922525|NCT00303472|540850669|FG000|Treatment Period|Death|0|||
149922526|NCT00303472|540850670|FG001|Treatment Period|Death|0|||
149922527|NCT00303472|540850671|FG002|Treatment Period|Death|0|||
149922528|NCT00303472|540850672|FG003|Treatment Period|Death|1|||
149922529|NCT00303472|540850673|FG004|Treatment Period|Death|0|||
149922530|NCT00303472|540850674|FG005|Treatment Period|Death|0|||
149922531|NCT00303472|540850675|FG006|Treatment Period|Death|1|||
149922532|NCT00303472|540850669|FG000|Treatment Period|Withdrawal by Subject|0|||
149922533|NCT00303472|540850670|FG001|Treatment Period|Withdrawal by Subject|0|||
149922534|NCT00303472|540850671|FG002|Treatment Period|Withdrawal by Subject|0|||
149922535|NCT00303472|540850672|FG003|Treatment Period|Withdrawal by Subject|1|||
149922536|NCT00303472|540850673|FG004|Treatment Period|Withdrawal by Subject|0|||
149922537|NCT00303472|540850674|FG005|Treatment Period|Withdrawal by Subject|1|||
149922538|NCT00303472|540850675|FG006|Treatment Period|Withdrawal by Subject|0|||
149922539|NCT00303472|540850669|FG000|Treatment Period|Other|0|||
149922540|NCT00303472|540850670|FG001|Treatment Period|Other|0|||
149922541|NCT00303472|540850671|FG002|Treatment Period|Other|0|||
149922542|NCT00303472|540850672|FG003|Treatment Period|Other|0|||
149922543|NCT00303472|540850673|FG004|Treatment Period|Other|1|||
149922544|NCT00303472|540850674|FG005|Treatment Period|Other|0|||
149922545|NCT00303472|540850675|FG006|Treatment Period|Other|1|||
149922546|NCT00303472|540850669|FG000|Treatment Period|Disease Progression (to AML)|0|||
149922547|NCT00303472|540850670|FG001|Treatment Period|Disease Progression (to AML)|0|||
149922548|NCT00303472|540850671|FG002|Treatment Period|Disease Progression (to AML)|0|||
149922549|NCT00303472|540850672|FG003|Treatment Period|Disease Progression (to AML)|0|||
149922550|NCT00303472|540850673|FG004|Treatment Period|Disease Progression (to AML)|1|||
149922551|NCT00303472|540850674|FG005|Treatment Period|Disease Progression (to AML)|0|||
149922552|NCT00303472|540850675|FG006|Treatment Period|Disease Progression (to AML)|0|||
149922553|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Adverse Event|1|||
149922554|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Adverse Event|0|||
149922555|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Adverse Event|1|||
149922556|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Adverse Event|0|||
149922557|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Adverse Event|0|||
149922558|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Adverse Event|0|||
149922559|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Adverse Event|0|||
149922560|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Death|2|||
149922561|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Death|0|||
149922562|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Death|1|||
149922563|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Death|0|||
149922564|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Death|0|||
149922565|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Death|0|||
149922566|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Death|0|||
150259975|NCT01586910|542089235|FG001|Overall Study|Death|4|||
149922567|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922568|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922569|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922570|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
149922571|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922572|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922573|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
149922574|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Physician Decision|0|||
149922575|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Physician Decision|4|||
149922576|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Physician Decision|2|||
149922577|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Physician Decision|3|||
149922578|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Physician Decision|2|||
149922579|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Physician Decision|0|||
149922580|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Physician Decision|0|||
149922581|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
149922582|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
149922583|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
149922584|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
149922585|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
149922586|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
149922587|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
149922588|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Other|0|||
149922589|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Other|2|||
149922590|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Other|4|||
149922591|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Other|2|||
149922592|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Other|1|||
149922593|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Other|0|||
149922594|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Other|0|||
149922595|NCT00303472|540850669|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
149922596|NCT00303472|540850670|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
149922597|NCT00303472|540850671|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
149922598|NCT00303472|540850672|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
149922599|NCT00303472|540850673|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
149922600|NCT00303472|540850674|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
149922601|NCT00303472|540850675|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
149922602|NCT04318132|540850678|FG000|Overall Study|Protocol Violation|0|||
149922603|NCT04318132|540850679|FG001|Overall Study|Protocol Violation|0|||
149922604|NCT04318132|540850680|FG002|Overall Study|Protocol Violation|3|||
149922605|NCT04318132|540850681|FG003|Overall Study|Protocol Violation|0|||
149922606|NCT02155322|540850682|FG000|Overall Study|Adverse Event|1|||
149922607|NCT02155322|540850682|FG000|Overall Study|Physician Decision|1|||
149922608|NCT02155322|540850682|FG000|Overall Study|Relapse/Recurrence|8|||
149922609|NCT02155322|540850682|FG000|Overall Study|Withdrawal by Subject|4|||
149922610|NCT00073008|540850684|FG000|Overall Study|Missing|6|||
149922611|NCT00073008|540850685|FG001|Overall Study|Missing|6|||
149922612|NCT00073008|540850684|FG000|Overall Study|Withdrawal by Subject|2|||
149922613|NCT00073008|540850685|FG001|Overall Study|Withdrawal by Subject|2|||
149922614|NCT00073008|540850684|FG000|Overall Study|Lost to Follow-up|1|||
149922615|NCT00073008|540850685|FG001|Overall Study|Lost to Follow-up|3|||
149922616|NCT00073008|540850684|FG000|Overall Study|Death|46|||
149922617|NCT00073008|540850685|FG001|Overall Study|Death|47|||
149922618|NCT00073008|540850684|FG000|Overall Study|"Other selected on Case Report Form"|7|||
149922619|NCT00073008|540850685|FG001|Overall Study|"Other selected on Case Report Form"|5|||
149922620|NCT03337048|540850695|FG000|Overall Study|Withdrawal by Subject|2|||
149922621|NCT03337048|540850696|FG001|Overall Study|Withdrawal by Subject|0|||
149922622|NCT03337048|540850697|FG002|Overall Study|Withdrawal by Subject|0|||
149922623|NCT00586898|540850701|FG000|Overall Study|Adverse Event|1|||
149922624|NCT00586898|540850701|FG000|Overall Study|Patiemt Non-compliance|1|||
149922625|NCT00586898|540850701|FG000|Overall Study|Evaluable for Toxicity Only|5|||
149922626|NCT00636961|540850702|FG000|Period 1|Administrative problems|1|||
149922627|NCT00636961|540850703|FG001|Period 1|Administrative problems|1|||
149922628|NCT00636961|540850702|FG000|Period 2|Adverse Event|1|||
149922629|NCT00636961|540850703|FG001|Period 2|Adverse Event|0|||
149922630|NCT00893971|540850705|FG000|Overall Study|Physician Decision|3|||
149922631|NCT03628716|540850706|FG000|Overall Study|Adverse Event|1|||
149922632|NCT03628716|540850707|FG001|Overall Study|Adverse Event|1|||
149922633|NCT03628716|540850706|FG000|Overall Study|Death|1|||
149922634|NCT03628716|540850707|FG001|Overall Study|Death|0|||
149922635|NCT03628716|540850706|FG000|Overall Study|Lack of Efficacy|15|||
149922636|NCT03628716|540850707|FG001|Overall Study|Lack of Efficacy|20|||
149922637|NCT03628716|540850706|FG000|Overall Study|Withdrawal by Subject|1|||
149922638|NCT03628716|540850707|FG001|Overall Study|Withdrawal by Subject|2|||
149922639|NCT03628716|540850706|FG000|Overall Study|Study Terminated by Sponsor|1|||
149922640|NCT03628716|540850707|FG001|Overall Study|Study Terminated by Sponsor|0|||
149922641|NCT00856843|540850708|FG000|Overall Study|Withdrawal by Subject|1|||
149922642|NCT00856843|540850709|FG001|Overall Study|Withdrawal by Subject|5|||
149922643|NCT00856843|540850708|FG000|Overall Study|Lack of Efficacy|1|||
149922644|NCT00856843|540850709|FG001|Overall Study|Lack of Efficacy|0|||
149922645|NCT00262002|540850710|FG000|Overall Study|Adverse Event|2|||
149922646|NCT00262002|540850711|FG001|Overall Study|Adverse Event|1|||
149922647|NCT00262002|540850712|FG002|Overall Study|Adverse Event|0|||
149922648|NCT00262002|540850713|FG003|Overall Study|Adverse Event|0|||
149922649|NCT00262002|540850714|FG004|Overall Study|Adverse Event|0|||
149922650|NCT00262002|540850715|FG005|Overall Study|Adverse Event|1|||
149922651|NCT00262002|540850716|FG006|Overall Study|Adverse Event|0|||
149922652|NCT00262002|540850710|FG000|Overall Study|Withdrawal by Subject|4|||
149922653|NCT00262002|540850711|FG001|Overall Study|Withdrawal by Subject|2|||
149922654|NCT00262002|540850712|FG002|Overall Study|Withdrawal by Subject|0|||
149922655|NCT00262002|540850713|FG003|Overall Study|Withdrawal by Subject|1|||
149922656|NCT00262002|540850714|FG004|Overall Study|Withdrawal by Subject|2|||
149922657|NCT00262002|540850715|FG005|Overall Study|Withdrawal by Subject|2|||
149922658|NCT00262002|540850716|FG006|Overall Study|Withdrawal by Subject|2|||
149922659|NCT00262002|540850710|FG000|Overall Study|Lost to Follow-up|2|||
149922660|NCT00262002|540850711|FG001|Overall Study|Lost to Follow-up|0|||
149922661|NCT00262002|540850712|FG002|Overall Study|Lost to Follow-up|0|||
149922662|NCT00262002|540850713|FG003|Overall Study|Lost to Follow-up|2|||
149922663|NCT00262002|540850714|FG004|Overall Study|Lost to Follow-up|0|||
149922664|NCT00262002|540850715|FG005|Overall Study|Lost to Follow-up|1|||
149817632|NCT01797120|540463482|FG000|Overall Study|still on treatment|2|||
149817633|NCT01797120|540463483|FG001|Overall Study|still on treatment|4|||
149817634|NCT01797120|540463482|FG000|Overall Study|never start protocol therapy|2|||
149817635|NCT01797120|540463483|FG001|Overall Study|never start protocol therapy|0|||
149817636|NCT00295854|540463484|FG000|Overall Study|Adverse Event|7|||
149817637|NCT00295854|540463485|FG001|Overall Study|Adverse Event|7|||
149817638|NCT00295854|540463486|FG002|Overall Study|Adverse Event|6|||
149817639|NCT00295854|540463484|FG000|Overall Study|Protocol Violation|1|||
149817640|NCT00295854|540463485|FG001|Overall Study|Protocol Violation|1|||
149817641|NCT00295854|540463486|FG002|Overall Study|Protocol Violation|1|||
149817642|NCT00295854|540463484|FG000|Overall Study|Lost to Follow-up|2|||
149817643|NCT00295854|540463485|FG001|Overall Study|Lost to Follow-up|0|||
149817644|NCT00295854|540463486|FG002|Overall Study|Lost to Follow-up|1|||
149817645|NCT00295854|540463484|FG000|Overall Study|Withdrawal by Subject|3|||
149817646|NCT00295854|540463485|FG001|Overall Study|Withdrawal by Subject|7|||
149817647|NCT00295854|540463486|FG002|Overall Study|Withdrawal by Subject|4|||
149817648|NCT00295854|540463484|FG000|Overall Study|did not continue to meet criteria|1|||
149817649|NCT00295854|540463485|FG001|Overall Study|did not continue to meet criteria|1|||
149817650|NCT00295854|540463486|FG002|Overall Study|did not continue to meet criteria|2|||
149817651|NCT00295854|540463484|FG000|Overall Study|required a prohibited medication|1|||
149817652|NCT00295854|540463485|FG001|Overall Study|required a prohibited medication|0|||
149817653|NCT00295854|540463486|FG002|Overall Study|required a prohibited medication|0|||
149817654|NCT00295854|540463484|FG000|Overall Study|Other|3|||
149817655|NCT00295854|540463485|FG001|Overall Study|Other|5|||
149817656|NCT00295854|540463486|FG002|Overall Study|Other|1|||
149817657|NCT00672620|540463487|FG000|Overall Study|Adverse Event|7|||
149817658|NCT00672620|540463488|FG001|Overall Study|Adverse Event|7|||
149817659|NCT00672620|540463489|FG002|Overall Study|Adverse Event|12|||
149817660|NCT00672620|540463490|FG003|Overall Study|Adverse Event|17|||
149817661|NCT00672620|540463487|FG000|Overall Study|Lack of Efficacy|1|||
149817662|NCT00672620|540463488|FG001|Overall Study|Lack of Efficacy|2|||
149817663|NCT00672620|540463489|FG002|Overall Study|Lack of Efficacy|2|||
149817664|NCT00672620|540463490|FG003|Overall Study|Lack of Efficacy|0|||
149817665|NCT00672620|540463487|FG000|Overall Study|Noncompliance with Study Drug|3|||
149817666|NCT00672620|540463488|FG001|Overall Study|Noncompliance with Study Drug|4|||
149817667|NCT00672620|540463489|FG002|Overall Study|Noncompliance with Study Drug|0|||
149817668|NCT00672620|540463490|FG003|Overall Study|Noncompliance with Study Drug|2|||
149817669|NCT00672620|540463487|FG000|Overall Study|Protocol Deviations|5|||
149817670|NCT00672620|540463488|FG001|Overall Study|Protocol Deviations|7|||
149817671|NCT00672620|540463489|FG002|Overall Study|Protocol Deviations|2|||
149817672|NCT00672620|540463490|FG003|Overall Study|Protocol Deviations|5|||
149817673|NCT00672620|540463487|FG000|Overall Study|Withdrawal of Consent|6|||
149817674|NCT00672620|540463488|FG001|Overall Study|Withdrawal of Consent|12|||
149817675|NCT00672620|540463489|FG002|Overall Study|Withdrawal of Consent|5|||
149817676|NCT00672620|540463490|FG003|Overall Study|Withdrawal of Consent|6|||
149817677|NCT00672620|540463487|FG000|Overall Study|Lost to Follow-up|8|||
149817678|NCT00672620|540463488|FG001|Overall Study|Lost to Follow-up|19|||
149817679|NCT00672620|540463489|FG002|Overall Study|Lost to Follow-up|8|||
149817680|NCT00672620|540463490|FG003|Overall Study|Lost to Follow-up|11|||
149922665|NCT00262002|540850716|FG006|Overall Study|Lost to Follow-up|0|||
149922666|NCT00262002|540850710|FG000|Overall Study|Inapropriate enrollment|0|||
149922667|NCT00262002|540850711|FG001|Overall Study|Inapropriate enrollment|1|||
149922668|NCT00262002|540850712|FG002|Overall Study|Inapropriate enrollment|0|||
149817681|NCT00672620|540463487|FG000|Overall Study|Reason not Specified|3|||
149817682|NCT00672620|540463488|FG001|Overall Study|Reason not Specified|3|||
149817683|NCT00672620|540463489|FG002|Overall Study|Reason not Specified|2|||
149922669|NCT00262002|540850713|FG003|Overall Study|Inapropriate enrollment|0|||
149922670|NCT00262002|540850714|FG004|Overall Study|Inapropriate enrollment|0|||
149922671|NCT00262002|540850715|FG005|Overall Study|Inapropriate enrollment|0|||
149922672|NCT00262002|540850716|FG006|Overall Study|Inapropriate enrollment|0|||
149922673|NCT00262002|540850710|FG000|Overall Study|Protocol Violation|3|||
149922674|NCT00262002|540850711|FG001|Overall Study|Protocol Violation|2|||
149922675|NCT00262002|540850712|FG002|Overall Study|Protocol Violation|0|||
149922676|NCT00262002|540850713|FG003|Overall Study|Protocol Violation|2|||
149922677|NCT00262002|540850714|FG004|Overall Study|Protocol Violation|5|||
149922678|NCT00262002|540850715|FG005|Overall Study|Protocol Violation|3|||
149922679|NCT00262002|540850716|FG006|Overall Study|Protocol Violation|2|||
149922680|NCT00262002|540850710|FG000|Overall Study|Unable to classify|0|||
149922681|NCT00262002|540850711|FG001|Overall Study|Unable to classify|0|||
149922682|NCT00262002|540850712|FG002|Overall Study|Unable to classify|0|||
149922683|NCT00262002|540850713|FG003|Overall Study|Unable to classify|0|||
149922684|NCT00262002|540850714|FG004|Overall Study|Unable to classify|0|||
149922685|NCT00262002|540850715|FG005|Overall Study|Unable to classify|0|||
149922686|NCT00262002|540850716|FG006|Overall Study|Unable to classify|2|||
149922687|NCT01085084|540850717|FG000|Overall Study|Withdrawal by Subject|1|||
149922688|NCT01085084|540850718|FG001|Overall Study|Withdrawal by Subject|0|||
149922689|NCT01085084|540850719|FG002|Overall Study|Withdrawal by Subject|0|||
149922690|NCT01085084|540850717|FG000|Overall Study|Lost to Follow-up|2|||
149922691|NCT01085084|540850718|FG001|Overall Study|Lost to Follow-up|1|||
149922692|NCT01085084|540850719|FG002|Overall Study|Lost to Follow-up|1|||
149922693|NCT01085084|540850717|FG000|Overall Study|Adverse Event|4|||
149922694|NCT01085084|540850718|FG001|Overall Study|Adverse Event|3|||
149922695|NCT01085084|540850719|FG002|Overall Study|Adverse Event|6|||
149922696|NCT01085084|540850717|FG000|Overall Study|Treatment Failure|0|||
149922697|NCT01085084|540850718|FG001|Overall Study|Treatment Failure|1|||
149922698|NCT01085084|540850719|FG002|Overall Study|Treatment Failure|2|||
149922699|NCT02070978|540850720|FG000|Overall Study|Adverse Event|6|||
149922700|NCT02070978|540850721|FG001|Overall Study|Adverse Event|2|||
149922701|NCT02070978|540850722|FG002|Overall Study|Adverse Event|0|||
149922702|NCT02070978|540850720|FG000|Overall Study|Lost to Follow-up|1|||
149922703|NCT02070978|540850721|FG001|Overall Study|Lost to Follow-up|3|||
149922704|NCT02070978|540850722|FG002|Overall Study|Lost to Follow-up|4|||
150259976|NCT01586910|542089234|FG000|Overall Study|Withdrawal by Subject|6|||
150259977|NCT01586910|542089235|FG001|Overall Study|Withdrawal by Subject|43|||
150259978|NCT01586910|542089234|FG000|Overall Study|Physician withdrew Subject|5|||
150259979|NCT01586910|542089235|FG001|Overall Study|Physician withdrew Subject|24|||
150259980|NCT01328717|542089244|FG000|Overall Study|Adverse Event|1|||
150259981|NCT00346268|542089245|FG000|Overall Study|Adverse Event|1|||
150259982|NCT00346268|542089246|FG001|Overall Study|Adverse Event|0|||
150259983|NCT00346268|542089245|FG000|Overall Study|Protocol Violation|1|||
150259984|NCT00346268|542089246|FG001|Overall Study|Protocol Violation|0|||
150259985|NCT00346268|542089245|FG000|Overall Study|Participant refused|0|||
150259986|NCT00346268|542089246|FG001|Overall Study|Participant refused|3|||
150259987|NCT00031551|542089247|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
150259988|NCT00031551|542089248|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
150259989|NCT01672723|542089249|FG000|First Intervention|Adverse Event|3|||
150259990|NCT01672723|542089250|FG001|First Intervention|Adverse Event|0|||
150259991|NCT00484289|542089255|FG000|Long Term Phase|Adverse Event|1|||
150259992|NCT00484289|542089256|FG001|Long Term Phase|Adverse Event|17|||
150259993|NCT00484289|542089257|FG002|Long Term Phase|Adverse Event|5|||
150259994|NCT00484289|542089255|FG000|Long Term Phase|Withdrawal by Subject|0|||
150259995|NCT00484289|542089256|FG001|Long Term Phase|Withdrawal by Subject|7|||
150259996|NCT00484289|542089257|FG002|Long Term Phase|Withdrawal by Subject|6|||
150259997|NCT00484289|542089255|FG000|Long Term Phase|Inadequate response|2|||
149922705|NCT02070978|540850720|FG000|Overall Study|Withdrawal by Subject|3|||
149922706|NCT02070978|540850721|FG001|Overall Study|Withdrawal by Subject|5|||
149922707|NCT02070978|540850722|FG002|Overall Study|Withdrawal by Subject|3|||
149922708|NCT02070978|540850720|FG000|Overall Study|Protocol Violation|1|||
149922709|NCT02070978|540850721|FG001|Overall Study|Protocol Violation|0|||
149922710|NCT02070978|540850722|FG002|Overall Study|Protocol Violation|3|||
149922711|NCT02070978|540850720|FG000|Overall Study|Lack of Efficacy|0|||
149922712|NCT02070978|540850721|FG001|Overall Study|Lack of Efficacy|1|||
149922713|NCT02070978|540850722|FG002|Overall Study|Lack of Efficacy|0|||
149922714|NCT02070978|540850720|FG000|Overall Study|Death|0|||
150259998|NCT00484289|542089256|FG001|Long Term Phase|Inadequate response|7|||
150259999|NCT00484289|542089257|FG002|Long Term Phase|Inadequate response|4|||
149922715|NCT02070978|540850721|FG001|Overall Study|Death|0|||
149922716|NCT02070978|540850722|FG002|Overall Study|Death|2|||
149922717|NCT02070978|540850720|FG000|Overall Study|Un-specified|3|||
149922718|NCT02070978|540850721|FG001|Overall Study|Un-specified|2|||
150260000|NCT00484289|542089255|FG000|Long Term Phase|Other Reason|0|||
150260001|NCT00484289|542089256|FG001|Long Term Phase|Other Reason|5|||
150260002|NCT00484289|542089257|FG002|Long Term Phase|Other Reason|1|||
150260003|NCT00484289|542089255|FG000|Post Marketing Phase|Adverse Event|0|||
150260004|NCT00484289|542089256|FG001|Post Marketing Phase|Adverse Event|1|||
149817684|NCT00672620|540463490|FG003|Overall Study|Reason not Specified|1|||
149817685|NCT02736227|540463491|FG000|Overall Study|Withdrawal by Subject|0|||
149817686|NCT02736227|540463492|FG001|Overall Study|Withdrawal by Subject|0|||
149817687|NCT02736227|540463493|FG002|Overall Study|Withdrawal by Subject|1|||
149817688|NCT02736227|540463491|FG000|Overall Study|Physician Decision|0|||
149817689|NCT02736227|540463492|FG001|Overall Study|Physician Decision|0|||
149817690|NCT02736227|540463493|FG002|Overall Study|Physician Decision|5|||
149817691|NCT02736227|540463491|FG000|Overall Study|Non Compliant|0|||
149817692|NCT02736227|540463492|FG001|Overall Study|Non Compliant|0|||
149817693|NCT02736227|540463493|FG002|Overall Study|Non Compliant|2|||
149817694|NCT02114931|540463501|FG000|Overall Study|Withdrawal by Subject|15|||
149817695|NCT02114931|540463502|FG001|Overall Study|Withdrawal by Subject|18|||
149817696|NCT02114931|540463501|FG000|Overall Study|Adverse Event|4|||
149817697|NCT02114931|540463502|FG001|Overall Study|Adverse Event|6|||
149817698|NCT02114931|540463501|FG000|Overall Study|Lost to Follow-up|3|||
149817699|NCT02114931|540463502|FG001|Overall Study|Lost to Follow-up|3|||
149817700|NCT02114931|540463501|FG000|Overall Study|Physician Decision|1|||
149817701|NCT02114931|540463502|FG001|Overall Study|Physician Decision|2|||
149817702|NCT02114931|540463501|FG000|Overall Study|Other|2|||
149817703|NCT02114931|540463502|FG001|Overall Study|Other|1|||
149817704|NCT03870997|540463503|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
149817705|NCT03870997|540463504|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
149817706|NCT03870997|540463505|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
149817707|NCT03870997|540463506|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
149817708|NCT03870997|540463507|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
150160846|NCT01764386|541723586|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
150160847|NCT01764386|541723587|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
150160848|NCT02788656|541723588|FG000|Overall Study|Withdrawal by Subject|1|||
150160849|NCT02788656|541723589|FG001|Overall Study|Withdrawal by Subject|0|||
150160850|NCT03169361|541723590|FG000|Overall Study|Protocol Violation|32|||
150160851|NCT02263885|541723591|FG000|Overall Study|Withdrawal by Subject|7|||
150160852|NCT02263885|541723591|FG000|Overall Study|Alternative Treatment|3|||
150160853|NCT02271594|541723592|FG000|Overall Study|Study closed; recruiting failure|19|||
150160854|NCT02271594|541723593|FG001|Overall Study|Study closed; recruiting failure|12|||
150160855|NCT00495469|541723598|FG000|Overall Study|Adverse Event|0|||
150160856|NCT00495469|541723599|FG001|Overall Study|Adverse Event|1|||
150160857|NCT00495469|541723600|FG002|Overall Study|Adverse Event|3|||
150160858|NCT00495469|541723601|FG003|Overall Study|Adverse Event|0|||
150160859|NCT00495469|541723602|FG004|Overall Study|Adverse Event|1|||
150160860|NCT00495469|541723603|FG005|Overall Study|Adverse Event|1|||
150160861|NCT00495469|541723604|FG006|Overall Study|Adverse Event|1|||
150160862|NCT00495469|541723598|FG000|Overall Study|Lost to Follow-up|1|||
150160863|NCT00495469|541723599|FG001|Overall Study|Lost to Follow-up|1|||
150160864|NCT00495469|541723600|FG002|Overall Study|Lost to Follow-up|3|||
150160865|NCT00495469|541723601|FG003|Overall Study|Lost to Follow-up|1|||
150160866|NCT00495469|541723602|FG004|Overall Study|Lost to Follow-up|0|||
150160867|NCT00495469|541723603|FG005|Overall Study|Lost to Follow-up|0|||
150160868|NCT00495469|541723604|FG006|Overall Study|Lost to Follow-up|0|||
150160869|NCT00495469|541723598|FG000|Overall Study|Protocol Violation|0|||
150160870|NCT00495469|541723599|FG001|Overall Study|Protocol Violation|0|||
150160871|NCT00495469|541723600|FG002|Overall Study|Protocol Violation|0|||
150160872|NCT00495469|541723601|FG003|Overall Study|Protocol Violation|0|||
150160873|NCT00495469|541723602|FG004|Overall Study|Protocol Violation|1|||
150160874|NCT00495469|541723603|FG005|Overall Study|Protocol Violation|2|||
150160875|NCT00495469|541723604|FG006|Overall Study|Protocol Violation|0|||
150160876|NCT00495469|541723598|FG000|Overall Study|Withdrawal by Subject|5|||
150160877|NCT00495469|541723599|FG001|Overall Study|Withdrawal by Subject|3|||
150160878|NCT00495469|541723600|FG002|Overall Study|Withdrawal by Subject|1|||
150160879|NCT00495469|541723601|FG003|Overall Study|Withdrawal by Subject|3|||
150160880|NCT00495469|541723602|FG004|Overall Study|Withdrawal by Subject|3|||
150160881|NCT00495469|541723603|FG005|Overall Study|Withdrawal by Subject|2|||
150160882|NCT00495469|541723604|FG006|Overall Study|Withdrawal by Subject|3|||
150160883|NCT00495469|541723598|FG000|Overall Study|Lack of Efficacy|0|||
150160884|NCT00495469|541723599|FG001|Overall Study|Lack of Efficacy|0|||
150160885|NCT00495469|541723600|FG002|Overall Study|Lack of Efficacy|0|||
150160886|NCT00495469|541723601|FG003|Overall Study|Lack of Efficacy|0|||
150160887|NCT00495469|541723602|FG004|Overall Study|Lack of Efficacy|0|||
150160888|NCT00495469|541723603|FG005|Overall Study|Lack of Efficacy|0|||
150160889|NCT00495469|541723604|FG006|Overall Study|Lack of Efficacy|1|||
150160890|NCT00495469|541723598|FG000|Overall Study|Liver function test abnormality|0|||
150160891|NCT00495469|541723599|FG001|Overall Study|Liver function test abnormality|1|||
150160892|NCT00495469|541723600|FG002|Overall Study|Liver function test abnormality|0|||
150160893|NCT00495469|541723601|FG003|Overall Study|Liver function test abnormality|0|||
150160894|NCT00495469|541723602|FG004|Overall Study|Liver function test abnormality|0|||
150160895|NCT00495469|541723603|FG005|Overall Study|Liver function test abnormality|0|||
150160896|NCT00495469|541723604|FG006|Overall Study|Liver function test abnormality|0|||
149922719|NCT02070978|540850722|FG002|Overall Study|Un-specified|2|||
149922720|NCT02070978|540850720|FG000|Overall Study|Terminated by Sponsor|33|||
149922721|NCT02070978|540850721|FG001|Overall Study|Terminated by Sponsor|40|||
149922722|NCT02070978|540850722|FG002|Overall Study|Terminated by Sponsor|39|||
149922723|NCT00376532|540852148|FG000|Overall Study|Lack sufficient blood sample|6|||
149922724|NCT00376532|540852149|FG001|Overall Study|Lack sufficient blood sample|6|||
149922725|NCT01133704|540852150|FG000|Overall Study|Death|44|||
149922726|NCT01133704|540852151|FG001|Overall Study|Death|26|||
149922727|NCT01133704|540852150|FG000|Overall Study|Patient refused to continue|4|||
149922728|NCT01133704|540852151|FG001|Overall Study|Patient refused to continue|0|||
149922729|NCT01133704|540852150|FG000|Overall Study|Study Closure|1|||
149922730|NCT01133704|540852151|FG001|Overall Study|Study Closure|0|||
149922731|NCT03479008|540852155|FG000|Overall Study|Withdrawal by Subject|3|||
149922732|NCT02753816|540852156|FG000|Overall Study|Protocol Violation|0|||
149922733|NCT02753816|540852157|FG001|Overall Study|Protocol Violation|1|||
149922734|NCT02753816|540852158|FG002|Overall Study|Protocol Violation|0|||
149922735|NCT02259400|540852159|FG000|Overall Study|Death|0|||
149922736|NCT02259400|540852160|FG001|Overall Study|Death|2|||
149922737|NCT02384538|540852161|FG000|Overall Study|Adverse Event|1|||
149922738|NCT02384538|540852162|FG001|Overall Study|Adverse Event|4|||
149922739|NCT02384538|540852161|FG000|Overall Study|Lack of Efficacy|4|||
149922740|NCT02384538|540852162|FG001|Overall Study|Lack of Efficacy|4|||
149922741|NCT02384538|540852161|FG000|Overall Study|Withdrew Consent|0|||
149922742|NCT02384538|540852162|FG001|Overall Study|Withdrew Consent|4|||
149922743|NCT02384538|540852161|FG000|Overall Study|Other|1|||
149922744|NCT02384538|540852162|FG001|Overall Study|Other|3|||
149922745|NCT00809094|540852166|FG000|Overall Study|Lost to Follow-up|0|||
149922746|NCT00809094|540852167|FG001|Overall Study|Lost to Follow-up|1|||
149922747|NCT01535443|540852168|FG000|Overall Study|Physician Decision|3|||
149922748|NCT02260817|540852172|FG000|Overall Study|Lost to Follow-up|0|||
149922749|NCT02260817|540852173|FG001|Overall Study|Lost to Follow-up|14|||
149922750|NCT02260817|540852172|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
149922751|NCT02260817|540852173|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
149922752|NCT02260817|540852172|FG000|Overall Study|Observation, no biopsy|0|||
149922753|NCT02260817|540852173|FG001|Overall Study|Observation, no biopsy|1|||
149922754|NCT02260817|540852172|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
149922755|NCT02260817|540852173|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
149922756|NCT02260817|540852172|FG000|Overall Study|Protocol Violation|0|||
149922757|NCT02260817|540852173|FG001|Overall Study|Protocol Violation|14|||
149922758|NCT03299101|540852174|FG000|Overall Study|Lost to Follow-up|1|||
149922759|NCT03299101|540852174|FG000|Overall Study|Withdrawal by Subject|5|||
149922760|NCT03299101|540852174|FG000|Overall Study|Surgery was changed|3|||
149922761|NCT03299101|540852174|FG000|Overall Study|Not enough time to complete prehab|1|||
149922762|NCT04217317|540852175|FG000|Overall Study|Lack of Efficacy|4|||
149922763|NCT04217317|540852175|FG000|Overall Study|Physician Decision|1|||
149922764|NCT03836209|540852176|FG000|Overall Study|Adverse Event|5|||
149922765|NCT03836209|540852177|FG001|Overall Study|Adverse Event|2|||
149922766|NCT03836209|540852176|FG000|Overall Study|Death|4|||
149922767|NCT03836209|540852177|FG001|Overall Study|Death|1|||
149922768|NCT03836209|540852176|FG000|Overall Study|Lack of Efficacy|7|||
149922769|NCT03836209|540852177|FG001|Overall Study|Lack of Efficacy|10|||
149922770|NCT03836209|540852176|FG000|Overall Study|Physician Decision|7|||
149922771|NCT03836209|540852177|FG001|Overall Study|Physician Decision|11|||
149922772|NCT03836209|540852176|FG000|Overall Study|Protocol Violation|0|||
149922773|NCT03836209|540852177|FG001|Overall Study|Protocol Violation|3|||
149922774|NCT03836209|540852176|FG000|Overall Study|Withdrawal by Subject|2|||
149922775|NCT03836209|540852177|FG001|Overall Study|Withdrawal by Subject|10|||
149922776|NCT03836209|540852176|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
149922777|NCT03836209|540852177|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
149922778|NCT03739710|540852178|FG000|Overall Study|Screen Failed|81|||
149922779|NCT01753115|540852179|FG000|Overall Study|Lost to Follow-up|3|||
149922780|NCT01753115|540852180|FG001|Overall Study|Lost to Follow-up|6|||
149922781|NCT01753115|540852181|FG002|Overall Study|Lost to Follow-up|8|||
149922782|NCT01753115|540852179|FG000|Overall Study|Withdrawal by Subject|6|||
149922783|NCT01753115|540852180|FG001|Overall Study|Withdrawal by Subject|5|||
149922784|NCT01753115|540852181|FG002|Overall Study|Withdrawal by Subject|6|||
149922785|NCT01753115|540852179|FG000|Overall Study|Subject non-compliant|3|||
149922786|NCT01753115|540852180|FG001|Overall Study|Subject non-compliant|3|||
149922787|NCT01753115|540852181|FG002|Overall Study|Subject non-compliant|0|||
149922788|NCT01753115|540852179|FG000|Overall Study|Used excluded drug|0|||
149922789|NCT01753115|540852180|FG001|Overall Study|Used excluded drug|1|||
149922790|NCT01753115|540852181|FG002|Overall Study|Used excluded drug|0|||
149922791|NCT04313400|540852187|FG000|Overall Study|Withdrawal by Subject|0|||
149922792|NCT04313400|540852188|FG001|Overall Study|Withdrawal by Subject|0|||
149922793|NCT04313400|540852189|FG002|Overall Study|Withdrawal by Subject|0|||
149922794|NCT04313400|540852190|FG003|Overall Study|Withdrawal by Subject|0|||
149922795|NCT04313400|540852191|FG004|Overall Study|Withdrawal by Subject|0|||
149922796|NCT04313400|540852192|FG005|Overall Study|Withdrawal by Subject|4|||
149922797|NCT04313400|540852193|FG006|Overall Study|Withdrawal by Subject|1|||
149922798|NCT04313400|540852187|FG000|Overall Study|Adverse Event|0|||
149922799|NCT04313400|540852188|FG001|Overall Study|Adverse Event|0|||
149922800|NCT04313400|540852189|FG002|Overall Study|Adverse Event|0|||
149922801|NCT04313400|540852190|FG003|Overall Study|Adverse Event|0|||
149922802|NCT04313400|540852191|FG004|Overall Study|Adverse Event|0|||
149922803|NCT04313400|540852192|FG005|Overall Study|Adverse Event|1|||
149922804|NCT04313400|540852193|FG006|Overall Study|Adverse Event|0|||
149922805|NCT04313400|540852187|FG000|Overall Study|Lost to Follow-up|0|||
149922806|NCT04313400|540852188|FG001|Overall Study|Lost to Follow-up|0|||
149922807|NCT04313400|540852189|FG002|Overall Study|Lost to Follow-up|0|||
149922808|NCT04313400|540852190|FG003|Overall Study|Lost to Follow-up|0|||
149922809|NCT04313400|540852191|FG004|Overall Study|Lost to Follow-up|0|||
149922810|NCT04313400|540852192|FG005|Overall Study|Lost to Follow-up|1|||
149922811|NCT04313400|540852193|FG006|Overall Study|Lost to Follow-up|0|||
149922812|NCT00329745|540852200|FG000|Overall Study|Protocol Violation|1|||
149922813|NCT00329745|540852201|FG001|Overall Study|Protocol Violation|0|||
149922814|NCT00329745|540852200|FG000|Overall Study|Withdrawal by Subject|0|||
149922815|NCT00329745|540852201|FG001|Overall Study|Withdrawal by Subject|1|||
149922816|NCT00329745|540852200|FG000|Overall Study|Lost to Follow-up|86|||
149922817|NCT00329745|540852201|FG001|Overall Study|Lost to Follow-up|101|||
149922818|NCT03224624|540852204|FG000|Overall Study|Lost to Follow-up|9|||
149922819|NCT03224624|540852205|FG001|Overall Study|Lost to Follow-up|4|||
149922820|NCT03224624|540852204|FG000|Overall Study|Death|1|||
149922821|NCT03224624|540852205|FG001|Overall Study|Death|0|||
149922822|NCT01884545|540852206|FG000|Overall Study|Lost to Follow-up|6|||
149922823|NCT01884545|540852207|FG001|Overall Study|Lost to Follow-up|4|||
149922824|NCT01884545|540852208|FG002|Overall Study|Lost to Follow-up|9|||
149922825|NCT01884545|540852209|FG003|Overall Study|Lost to Follow-up|4|||
149922826|NCT01884545|540852206|FG000|Overall Study|Patient withdrawn|7|||
149922827|NCT01884545|540852207|FG001|Overall Study|Patient withdrawn|12|||
149922828|NCT01884545|540852208|FG002|Overall Study|Patient withdrawn|5|||
149922829|NCT01884545|540852209|FG003|Overall Study|Patient withdrawn|5|||
149922830|NCT01884545|540852206|FG000|Overall Study|Non-adherence|0|||
149922831|NCT01884545|540852207|FG001|Overall Study|Non-adherence|2|||
149922832|NCT01884545|540852208|FG002|Overall Study|Non-adherence|0|||
149922833|NCT01884545|540852209|FG003|Overall Study|Non-adherence|0|||
149922834|NCT01424241|540852210|FG000|Overall Study|Withdrawal by Subject|1|||
149922835|NCT01424241|540852210|FG000|Overall Study|Time constraints|2|||
149922836|NCT02937636|540852212|FG000|Overall Study|Other (Not specified)|3|||
149922837|NCT02937636|540852213|FG001|Overall Study|Other (Not specified)|2|||
149922838|NCT00770913|540852214|FG000|Overall Study|Adverse Event|1|||
149922839|NCT00770913|540852215|FG001|Overall Study|Adverse Event|3|||
149922840|NCT00770913|540852216|FG002|Overall Study|Adverse Event|6|||
149922841|NCT00770913|540852214|FG000|Overall Study|Refusal to continue participation|6|||
149922842|NCT00770913|540852215|FG001|Overall Study|Refusal to continue participation|4|||
149922843|NCT00770913|540852216|FG002|Overall Study|Refusal to continue participation|5|||
149922844|NCT00770913|540852214|FG000|Overall Study|Physician Decision|0|||
149922845|NCT00770913|540852215|FG001|Overall Study|Physician Decision|1|||
149922846|NCT00770913|540852216|FG002|Overall Study|Physician Decision|1|||
149922847|NCT00770913|540852214|FG000|Overall Study|Protocol Violation|3|||
149922848|NCT00770913|540852215|FG001|Overall Study|Protocol Violation|0|||
149922849|NCT00770913|540852216|FG002|Overall Study|Protocol Violation|1|||
149922850|NCT00770913|540852214|FG000|Overall Study|Incorrect drug was allocated|1|||
149922851|NCT00770913|540852215|FG001|Overall Study|Incorrect drug was allocated|0|||
149922852|NCT00770913|540852216|FG002|Overall Study|Incorrect drug was allocated|0|||
149922853|NCT00359294|540852220|FG000|Overall Study|Progressive disease|1|||
149922854|NCT00359294|540852221|FG001|Overall Study|Progressive disease|1|||
149922855|NCT00359294|540852222|FG002|Overall Study|Progressive disease|2|||
149922856|NCT00359294|540852223|FG003|Overall Study|Progressive disease|3|||
149922857|NCT00359294|540852224|FG004|Overall Study|Progressive disease|2|||
149922858|NCT00359294|540852220|FG000|Overall Study|Withdrawal by Subject|0|||
149922859|NCT00359294|540852221|FG001|Overall Study|Withdrawal by Subject|0|||
149922860|NCT00359294|540852222|FG002|Overall Study|Withdrawal by Subject|0|||
149922861|NCT00359294|540852223|FG003|Overall Study|Withdrawal by Subject|0|||
149922862|NCT00359294|540852224|FG004|Overall Study|Withdrawal by Subject|1|||
149922863|NCT00359294|540852220|FG000|Overall Study|Not treated|0|||
149922864|NCT00359294|540852221|FG001|Overall Study|Not treated|0|||
149922865|NCT00359294|540852222|FG002|Overall Study|Not treated|0|||
149922866|NCT00359294|540852223|FG003|Overall Study|Not treated|1|||
149922867|NCT00359294|540852224|FG004|Overall Study|Not treated|0|||
149922868|NCT00359294|540852220|FG000|Overall Study|Physician Decision|0|||
149922869|NCT00359294|540852221|FG001|Overall Study|Physician Decision|0|||
149922870|NCT00359294|540852222|FG002|Overall Study|Physician Decision|1|||
149922871|NCT00359294|540852223|FG003|Overall Study|Physician Decision|0|||
149922872|NCT00359294|540852224|FG004|Overall Study|Physician Decision|0|||
149922873|NCT04208412|540852231|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
149975524|NCT00546481|541047866|FG002|Maintenance Phase (CERA)|Other Reason|1|||
149817709|NCT03870997|540463508|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
149817710|NCT01205529|540463511|FG000|Overall Study|Procedure Cancelled|4|||
149817711|NCT01205529|540463511|FG000|Overall Study|Withdrawal by Subject|2|||
149817712|NCT01205529|540463511|FG000|Overall Study|Physician Decision|4|||
149817713|NCT01205529|540463511|FG000|Overall Study|Unstable post op|15|||
149817714|NCT01205529|540463511|FG000|Overall Study|No longer met criteria|30|||
149817715|NCT00667719|540463512|FG000|Overall Study|Adverse Event|39|||
149817716|NCT00667719|540463512|FG000|Overall Study|Abnormal Test Procedure|1|||
149817717|NCT00667719|540463512|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149817718|NCT00667719|540463512|FG000|Overall Study|Protocol Violation|3|||
149817719|NCT00667719|540463512|FG000|Overall Study|Withdrawal by Subject|17|||
149817720|NCT00667719|540463512|FG000|Overall Study|Lost to Follow-up|8|||
149817721|NCT03840135|540463513|FG000|Overall Study|Protocol Violation|6|||
149817722|NCT03840135|540463514|FG001|Overall Study|Protocol Violation|1|||
149817723|NCT03840135|540463513|FG000|Overall Study|Withdrawal by Subject|1|||
149817724|NCT03840135|540463514|FG001|Overall Study|Withdrawal by Subject|0|||
149817725|NCT01827371|540463515|FG000|Overall Study|Adverse Event|0|||
149817726|NCT01827371|540463516|FG001|Overall Study|Adverse Event|0|||
149817727|NCT01827371|540463517|FG002|Overall Study|Adverse Event|4|||
149817728|NCT01827371|540463518|FG003|Overall Study|Adverse Event|2|||
149817729|NCT01827371|540463515|FG000|Overall Study|Lost to Follow-up|0|||
149817730|NCT01827371|540463516|FG001|Overall Study|Lost to Follow-up|2|||
149817731|NCT01827371|540463517|FG002|Overall Study|Lost to Follow-up|0|||
149817732|NCT01827371|540463518|FG003|Overall Study|Lost to Follow-up|4|||
149817733|NCT01827371|540463515|FG000|Overall Study|Protocol Violation|1|||
149817734|NCT01827371|540463516|FG001|Overall Study|Protocol Violation|0|||
149817735|NCT01827371|540463517|FG002|Overall Study|Protocol Violation|0|||
149817736|NCT01827371|540463518|FG003|Overall Study|Protocol Violation|0|||
149817737|NCT01827371|540463515|FG000|Overall Study|Withdrawal by Subject|1|||
149817738|NCT01827371|540463516|FG001|Overall Study|Withdrawal by Subject|2|||
149817739|NCT01827371|540463517|FG002|Overall Study|Withdrawal by Subject|2|||
149817740|NCT01827371|540463518|FG003|Overall Study|Withdrawal by Subject|3|||
149817741|NCT01827371|540463515|FG000|Overall Study|Physician Decision|0|||
149817742|NCT01827371|540463516|FG001|Overall Study|Physician Decision|1|||
149817743|NCT01827371|540463517|FG002|Overall Study|Physician Decision|0|||
149817744|NCT01827371|540463518|FG003|Overall Study|Physician Decision|1|||
149817745|NCT01827371|540463515|FG000|Overall Study|Temporary study halt to vaccinations|11|||
149817746|NCT01827371|540463516|FG001|Overall Study|Temporary study halt to vaccinations|2|||
149817747|NCT01827371|540463517|FG002|Overall Study|Temporary study halt to vaccinations|5|||
149817748|NCT01827371|540463518|FG003|Overall Study|Temporary study halt to vaccinations|13|||
149817749|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817750|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817751|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817752|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
149817753|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817754|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817755|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817756|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817757|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817758|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
149817759|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149817760|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149817761|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Adverse Event|1|||
149817762|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Adverse Event|1|||
149817763|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Adverse Event|1|||
149817764|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Adverse Event|1|||
149817765|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Adverse Event|0|||
149817766|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Adverse Event|0|||
149817767|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Adverse Event|0|||
149817768|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Adverse Event|0|||
149817769|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
149817770|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
149817771|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
149817772|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
149817773|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
149817774|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
149817775|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
149817776|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
149817777|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
149817778|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
149817779|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149817780|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
149922874|NCT04208412|540852232|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
149922875|NCT04208412|540852231|FG000|Overall Study|Withdrawal by Subject|1|||
149922876|NCT04208412|540852232|FG001|Overall Study|Withdrawal by Subject|0|||
149922877|NCT04208412|540852231|FG000|Overall Study|Lost to Follow-up|0|||
149922878|NCT04208412|540852232|FG001|Overall Study|Lost to Follow-up|1|||
149922879|NCT02347072|540852235|FG000|Overall Study|Adverse Event|2|||
149922880|NCT02347072|540852235|FG000|Overall Study|Withdrawal by Subject|6|||
149922881|NCT02347072|540852235|FG000|Overall Study|Physician Decision|1|||
149922882|NCT02347072|540852235|FG000|Overall Study|Lost to Follow-up|2|||
149922883|NCT02347072|540852235|FG000|Overall Study|Protocol Violation|1|||
149922884|NCT02347072|540852235|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
149922885|NCT01134393|540852241|FG000|Overall Study|Adverse Event|18|||
149922886|NCT01134393|540852241|FG000|Overall Study|Lack of Efficacy|2|||
149922887|NCT01134393|540852241|FG000|Overall Study|Protocol Violation|12|||
149922888|NCT01134393|540852241|FG000|Overall Study|Lost to Follow-up|3|||
149922889|NCT01134393|540852241|FG000|Overall Study|Withdrawal by Subject|11|||
149922890|NCT01134393|540852241|FG000|Overall Study|Other|6|||
149922891|NCT01808222|540852245|FG000|Overall Study|mpMR scan was not performed|1|||
149922892|NCT03762681|540852246|FG000|Part 1|Withdrawal by Subject|0|||
149922893|NCT03762681|540852247|FG001|Part 1|Withdrawal by Subject|0|||
149922894|NCT03762681|540852248|FG002|Part 1|Withdrawal by Subject|0|||
149922895|NCT03762681|540852249|FG003|Part 1|Withdrawal by Subject|1|||
149922896|NCT03762681|540852250|FG004|Part 1|Withdrawal by Subject|0|||
149922897|NCT03762681|540852251|FG005|Part 1|Withdrawal by Subject|0|||
149922898|NCT03762681|540852252|FG006|Part 1|Withdrawal by Subject|0|||
149922899|NCT03762681|540852253|FG007|Part 1|Withdrawal by Subject|0|||
149922900|NCT03762681|540852246|FG000|Part 2a|Pandemic Travel Restrictions|0|||
149922901|NCT03762681|540852247|FG001|Part 2a|Pandemic Travel Restrictions|0|||
149922902|NCT03762681|540852248|FG002|Part 2a|Pandemic Travel Restrictions|0|||
149922903|NCT03762681|540852249|FG003|Part 2a|Pandemic Travel Restrictions|0|||
149922904|NCT03762681|540852250|FG004|Part 2a|Pandemic Travel Restrictions|0|||
149922905|NCT03762681|540852251|FG005|Part 2a|Pandemic Travel Restrictions|0|||
149922906|NCT03762681|540852252|FG006|Part 2a|Pandemic Travel Restrictions|0|||
149922907|NCT03762681|540852253|FG007|Part 2a|Pandemic Travel Restrictions|1|||
149922908|NCT00524680|540852258|FG000|Overall Study|progression|0|||
149922909|NCT00524680|540852259|FG001|Overall Study|progression|0|||
149922910|NCT00524680|540852260|FG002|Overall Study|progression|0|||
149922911|NCT00524680|540852261|FG003|Overall Study|progression|1|||
149922912|NCT00524680|540852258|FG000|Overall Study|Adverse Event|2|||
149922913|NCT00524680|540852259|FG001|Overall Study|Adverse Event|0|||
149922914|NCT00524680|540852260|FG002|Overall Study|Adverse Event|0|||
149922915|NCT00524680|540852261|FG003|Overall Study|Adverse Event|1|||
149922916|NCT00524680|540852258|FG000|Overall Study|Other|0|||
149922917|NCT00524680|540852259|FG001|Overall Study|Other|1|||
149922918|NCT00524680|540852260|FG002|Overall Study|Other|2|||
149922919|NCT00524680|540852261|FG003|Overall Study|Other|3|||
149922920|NCT00524680|540852258|FG000|Overall Study|Withdrawal by Subject|1|||
149922921|NCT00524680|540852259|FG001|Overall Study|Withdrawal by Subject|0|||
149922922|NCT00524680|540852260|FG002|Overall Study|Withdrawal by Subject|1|||
149922923|NCT00524680|540852261|FG003|Overall Study|Withdrawal by Subject|1|||
149922924|NCT01146561|540852262|FG000|Overall Study|Withdrawal by Subject|1|||
149922925|NCT01146561|540852262|FG000|Overall Study|Lost to Follow-up|1|||
149922926|NCT00829829|540852268|FG000|Overall Study|Protocol Violation|0|||
149922927|NCT00829829|540852269|FG001|Overall Study|Protocol Violation|3|||
149922928|NCT00829829|540852270|FG002|Overall Study|Protocol Violation|0|||
149922929|NCT00829829|540852268|FG000|Overall Study|Adverse Event|4|||
149922930|NCT00829829|540852269|FG001|Overall Study|Adverse Event|4|||
149922931|NCT00829829|540852270|FG002|Overall Study|Adverse Event|3|||
149922932|NCT00829829|540852268|FG000|Overall Study|Withdrawal by Subject|8|||
149922933|NCT00829829|540852269|FG001|Overall Study|Withdrawal by Subject|4|||
149922934|NCT00829829|540852270|FG002|Overall Study|Withdrawal by Subject|2|||
149922935|NCT00829829|540852268|FG000|Overall Study|Decision by the Sponsor|1|||
149922936|NCT00829829|540852269|FG001|Overall Study|Decision by the Sponsor|0|||
149922937|NCT00829829|540852270|FG002|Overall Study|Decision by the Sponsor|2|||
149922938|NCT00829829|540852268|FG000|Overall Study|Lost to Follow-up|7|||
149922939|NCT00829829|540852269|FG001|Overall Study|Lost to Follow-up|3|||
149922940|NCT00829829|540852270|FG002|Overall Study|Lost to Follow-up|3|||
149922941|NCT00829829|540852268|FG000|Overall Study|Other than specified above|2|||
149922942|NCT00829829|540852269|FG001|Overall Study|Other than specified above|2|||
149922943|NCT00829829|540852270|FG002|Overall Study|Other than specified above|1|||
149922944|NCT02984267|540852271|FG000|Overall Study|Protocol Violation|1|||
149922945|NCT02984267|540852272|FG001|Overall Study|Protocol Violation|0|||
149922946|NCT02984267|540852271|FG000|Overall Study|Withdrawal by Subject|0|||
149922947|NCT02984267|540852272|FG001|Overall Study|Withdrawal by Subject|1|||
149922948|NCT01249833|540852273|FG000|Overall Study|Lost to Follow-up|0|||
149922949|NCT01249833|540852274|FG001|Overall Study|Lost to Follow-up|1|||
149922950|NCT03796676|540852275|FG000|Overall Study|Adverse Event|2|||
149922951|NCT03796676|540852276|FG001|Overall Study|Adverse Event|1|||
149922952|NCT03796676|540852277|FG002|Overall Study|Adverse Event|2|||
149922953|NCT03796676|540852275|FG000|Overall Study|Lost to Follow-up|2|||
149922954|NCT03796676|540852276|FG001|Overall Study|Lost to Follow-up|1|||
149922955|NCT03796676|540852277|FG002|Overall Study|Lost to Follow-up|0|||
149922956|NCT03796676|540852275|FG000|Overall Study|Protocol Violation|0|||
149922957|NCT03796676|540852276|FG001|Overall Study|Protocol Violation|0|||
149922958|NCT03796676|540852277|FG002|Overall Study|Protocol Violation|1|||
149922959|NCT03796676|540852275|FG000|Overall Study|Withdrawal by Subject|1|||
149922960|NCT03796676|540852276|FG001|Overall Study|Withdrawal by Subject|1|||
149922961|NCT03796676|540852277|FG002|Overall Study|Withdrawal by Subject|0|||
149922962|NCT03796676|540852275|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
149922963|NCT03796676|540852276|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
149922964|NCT03796676|540852277|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
149922965|NCT01900899|540852279|FG000|Overall Study|Withdrawal by Subject|7|||
149922966|NCT01900899|540852280|FG001|Overall Study|Withdrawal by Subject|1|||
149922967|NCT01900899|540852279|FG000|Overall Study|Migrated from study area|2|||
149922968|NCT01900899|540852280|FG001|Overall Study|Migrated from study area|0|||
149922969|NCT02772809|540852284|FG000|Overall Study|not completed some tasks|6|||
149922970|NCT00723697|540852287|FG000|Overall Study|Physician questionnaires not received|2|||
149922971|NCT00723697|540852287|FG000|Overall Study|Missing Informed Consent Form|10|||
149922972|NCT00723697|540852287|FG000|Overall Study|Other exclusion criteria applied|6|||
149922973|NCT00534105|540852288|FG000|Overall Study|Lost to Follow-up|23|||
149922974|NCT00534105|540852289|FG001|Overall Study|Lost to Follow-up|39|||
149922975|NCT00978341|540852292|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
149922976|NCT00978341|540852293|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
149922977|NCT03035916|540852294|FG000|Overall Study|Puncture failed|0|||
149922978|NCT03035916|540852295|FG001|Overall Study|Puncture failed|2|||
149922979|NCT03035916|540852296|FG002|Overall Study|Puncture failed|0|||
149922980|NCT03885999|540852297|FG000|Overall Study|Adverse Event|1|||
149922981|NCT02452554|540852298|FG000|Overall Study|Death|2|||
149922982|NCT02452554|540852299|FG001|Overall Study|Death|1|||
149922983|NCT02452554|540852300|FG002|Overall Study|Death|0|||
149922984|NCT02452554|540852301|FG003|Overall Study|Death|0|||
149922985|NCT02452554|540852302|FG004|Overall Study|Death|0|||
149922986|NCT02452554|540852303|FG005|Overall Study|Death|0|||
149922987|NCT02452554|540852298|FG000|Overall Study|Lack of Efficacy|13|||
149922988|NCT02452554|540852299|FG001|Overall Study|Lack of Efficacy|14|||
149922989|NCT02452554|540852300|FG002|Overall Study|Lack of Efficacy|9|||
149922990|NCT02452554|540852301|FG003|Overall Study|Lack of Efficacy|1|||
149922991|NCT02452554|540852302|FG004|Overall Study|Lack of Efficacy|5|||
149922992|NCT02452554|540852303|FG005|Overall Study|Lack of Efficacy|8|||
149922993|NCT02452554|540852298|FG000|Overall Study|Physician Decision|0|||
149922994|NCT02452554|540852299|FG001|Overall Study|Physician Decision|1|||
149922995|NCT02452554|540852300|FG002|Overall Study|Physician Decision|0|||
149922996|NCT02452554|540852301|FG003|Overall Study|Physician Decision|0|||
149922997|NCT02452554|540852302|FG004|Overall Study|Physician Decision|0|||
149922998|NCT02452554|540852303|FG005|Overall Study|Physician Decision|0|||
149922999|NCT02452554|540852298|FG000|Overall Study|Withdrawal by Subject|1|||
149923000|NCT02452554|540852299|FG001|Overall Study|Withdrawal by Subject|0|||
149923001|NCT02452554|540852300|FG002|Overall Study|Withdrawal by Subject|2|||
149923002|NCT02452554|540852301|FG003|Overall Study|Withdrawal by Subject|0|||
149923003|NCT02452554|540852302|FG004|Overall Study|Withdrawal by Subject|0|||
149923004|NCT02452554|540852303|FG005|Overall Study|Withdrawal by Subject|1|||
149923005|NCT02452554|540852298|FG000|Overall Study|Ineligible|0|||
149923006|NCT02452554|540852299|FG001|Overall Study|Ineligible|1|||
149923007|NCT02452554|540852300|FG002|Overall Study|Ineligible|0|||
149923008|NCT02452554|540852301|FG003|Overall Study|Ineligible|0|||
149923009|NCT02452554|540852302|FG004|Overall Study|Ineligible|0|||
149923010|NCT02452554|540852303|FG005|Overall Study|Ineligible|0|||
149923011|NCT02452554|540852298|FG000|Overall Study|Never Received Treatment|1|||
149923012|NCT02452554|540852299|FG001|Overall Study|Never Received Treatment|0|||
149923013|NCT02452554|540852300|FG002|Overall Study|Never Received Treatment|0|||
149923014|NCT02452554|540852301|FG003|Overall Study|Never Received Treatment|0|||
149923015|NCT02452554|540852302|FG004|Overall Study|Never Received Treatment|0|||
149923016|NCT02452554|540852303|FG005|Overall Study|Never Received Treatment|0|||
149923017|NCT02749799|540852304|FG000|Overall Study|Adverse Event|2|||
149923018|NCT02749799|540852304|FG000|Overall Study|Lost to Follow-up|4|||
150260005|NCT00484289|542089257|FG002|Post Marketing Phase|Adverse Event|0|||
149923019|NCT02749799|540852304|FG000|Overall Study|Protocol Violation|1|||
149923020|NCT02749799|540852304|FG000|Overall Study|Withdrawal by Subject|1|||
149923021|NCT00520767|540852305|FG000|Overall Study|Death|2|||
149923022|NCT00401193|540854894|FG000|Overall Study|Adverse Event|1|||
149923023|NCT00401193|540854895|FG001|Overall Study|Adverse Event|3|||
149923024|NCT00401193|540854896|FG002|Overall Study|Adverse Event|1|||
149923025|NCT00401193|540854894|FG000|Overall Study|Protocol Violation|3|||
149923026|NCT00401193|540854895|FG001|Overall Study|Protocol Violation|1|||
149923027|NCT00401193|540854896|FG002|Overall Study|Protocol Violation|1|||
149923028|NCT00401193|540854894|FG000|Overall Study|Lost to Follow-up|6|||
149923029|NCT00401193|540854895|FG001|Overall Study|Lost to Follow-up|5|||
150260006|NCT00192647|542089258|FG000|Overall Study|Death|1|||
149923030|NCT00401193|540854896|FG002|Overall Study|Lost to Follow-up|1|||
149923031|NCT00401193|540854894|FG000|Overall Study|Withdrawal by Subject|2|||
149923032|NCT00401193|540854895|FG001|Overall Study|Withdrawal by Subject|0|||
149923033|NCT00401193|540854896|FG002|Overall Study|Withdrawal by Subject|1|||
149923034|NCT00401193|540854894|FG000|Overall Study|Other Event|3|||
149923035|NCT00401193|540854895|FG001|Overall Study|Other Event|2|||
149923036|NCT00401193|540854896|FG002|Overall Study|Other Event|2|||
149923037|NCT02526160|540854897|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
149923038|NCT02526160|540854898|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
149923039|NCT02526160|540854897|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
149923040|NCT02526160|540854898|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
149923041|NCT02526160|540854897|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
149923042|NCT02526160|540854898|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
149923043|NCT02526160|540854897|FG000|Open-Label Treatment Extension Period I|Death|0|||
149923044|NCT02526160|540854898|FG001|Open-Label Treatment Extension Period I|Death|1|||
149923045|NCT02526160|540854897|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
149923046|NCT02526160|540854898|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
149923047|NCT02526160|540854897|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
149923048|NCT02526160|540854898|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
149923049|NCT02526160|540854897|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
149923050|NCT02526160|540854898|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
149923051|NCT02526160|540854897|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
149923052|NCT02526160|540854898|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
149923053|NCT00398216|540854899|FG000|Overall Study|Adverse Event|4|||
149923054|NCT00398216|540854900|FG001|Overall Study|Adverse Event|2|||
149923055|NCT00398216|540854901|FG002|Overall Study|Adverse Event|5|||
149923056|NCT00398216|540854902|FG003|Overall Study|Adverse Event|7|||
149923057|NCT00398216|540854903|FG004|Overall Study|Adverse Event|2|||
149923058|NCT00398216|540854899|FG000|Overall Study|Protocol Violation|2|||
149923059|NCT00398216|540854900|FG001|Overall Study|Protocol Violation|4|||
149923060|NCT00398216|540854901|FG002|Overall Study|Protocol Violation|5|||
149923061|NCT00398216|540854902|FG003|Overall Study|Protocol Violation|7|||
149923062|NCT00398216|540854903|FG004|Overall Study|Protocol Violation|5|||
149923063|NCT00398216|540854899|FG000|Overall Study|Lost to Follow-up|1|||
149923064|NCT00398216|540854900|FG001|Overall Study|Lost to Follow-up|6|||
149923065|NCT00398216|540854901|FG002|Overall Study|Lost to Follow-up|4|||
149923066|NCT00398216|540854902|FG003|Overall Study|Lost to Follow-up|4|||
149923067|NCT00398216|540854903|FG004|Overall Study|Lost to Follow-up|1|||
149923068|NCT00398216|540854899|FG000|Overall Study|Death|0|||
149923069|NCT00398216|540854900|FG001|Overall Study|Death|3|||
149923070|NCT00398216|540854901|FG002|Overall Study|Death|0|||
149923071|NCT00398216|540854902|FG003|Overall Study|Death|0|||
149923072|NCT00398216|540854903|FG004|Overall Study|Death|0|||
149923073|NCT00398216|540854899|FG000|Overall Study|Withdrawal by Subject|1|||
149923074|NCT00398216|540854900|FG001|Overall Study|Withdrawal by Subject|0|||
149923075|NCT00398216|540854901|FG002|Overall Study|Withdrawal by Subject|3|||
149923076|NCT00398216|540854902|FG003|Overall Study|Withdrawal by Subject|1|||
149923077|NCT00398216|540854903|FG004|Overall Study|Withdrawal by Subject|2|||
149923078|NCT00398216|540854899|FG000|Overall Study|administrative reasons|3|||
149923079|NCT00398216|540854900|FG001|Overall Study|administrative reasons|4|||
149923080|NCT00398216|540854901|FG002|Overall Study|administrative reasons|4|||
149923081|NCT00398216|540854902|FG003|Overall Study|administrative reasons|3|||
149923082|NCT00398216|540854903|FG004|Overall Study|administrative reasons|3|||
149923083|NCT00398216|540854899|FG000|Overall Study|entrance criteria|0|||
149923084|NCT00398216|540854900|FG001|Overall Study|entrance criteria|0|||
149923085|NCT00398216|540854901|FG002|Overall Study|entrance criteria|0|||
149923086|NCT00398216|540854902|FG003|Overall Study|entrance criteria|0|||
149923087|NCT00398216|540854903|FG004|Overall Study|entrance criteria|2|||
149923088|NCT01962948|540854906|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
149923089|NCT01962948|540854907|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
149923090|NCT01962948|540854908|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
149923091|NCT01962948|540854909|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
149923092|NCT02207400|540854910|FG000|Overall Study|Adverse Event|1|||
149923093|NCT02207400|540854911|FG001|Overall Study|Adverse Event|1|||
149923094|NCT02207400|540854910|FG000|Overall Study|Lost to Follow-up|6|||
149923095|NCT02207400|540854911|FG001|Overall Study|Lost to Follow-up|7|||
149923096|NCT02207400|540854910|FG000|Overall Study|Protocol Violation|1|||
149923097|NCT02207400|540854911|FG001|Overall Study|Protocol Violation|1|||
149923098|NCT02207400|540854910|FG000|Overall Study|Withdrawal by Subject|8|||
149923099|NCT02207400|540854911|FG001|Overall Study|Withdrawal by Subject|4|||
149923100|NCT02207400|540854910|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
149923101|NCT02207400|540854911|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
149923102|NCT03396822|540854912|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
149923103|NCT03396822|540854912|FG000|Overall Study|Physician Decision|1|||
149923104|NCT01763827|540854915|FG000|Overall Study|Withdrawal by Subject|1|||
149923105|NCT01763827|540854916|FG001|Overall Study|Withdrawal by Subject|0|||
149923106|NCT01763827|540854917|FG002|Overall Study|Withdrawal by Subject|0|||
149923107|NCT01763827|540854918|FG003|Overall Study|Withdrawal by Subject|0|||
149923108|NCT01763827|540854919|FG004|Overall Study|Withdrawal by Subject|2|||
149923109|NCT01763827|540854920|FG005|Overall Study|Withdrawal by Subject|0|||
149923110|NCT01763827|540854915|FG000|Overall Study|Decision by sponsor|2|||
149923111|NCT01763827|540854916|FG001|Overall Study|Decision by sponsor|0|||
149923112|NCT01763827|540854917|FG002|Overall Study|Decision by sponsor|3|||
149923113|NCT01763827|540854918|FG003|Overall Study|Decision by sponsor|0|||
149923114|NCT01763827|540854919|FG004|Overall Study|Decision by sponsor|2|||
149923115|NCT01763827|540854920|FG005|Overall Study|Decision by sponsor|1|||
149923116|NCT01763827|540854915|FG000|Overall Study|Lost to Follow-up|0|||
149923117|NCT01763827|540854916|FG001|Overall Study|Lost to Follow-up|1|||
149923118|NCT01763827|540854917|FG002|Overall Study|Lost to Follow-up|1|||
149923119|NCT01763827|540854918|FG003|Overall Study|Lost to Follow-up|1|||
149923120|NCT01763827|540854919|FG004|Overall Study|Lost to Follow-up|2|||
149923121|NCT01763827|540854920|FG005|Overall Study|Lost to Follow-up|1|||
149923122|NCT03746405|540854921|FG000|Overall Study|Withdrawal by Subject|3|||
149923123|NCT03746405|540854922|FG001|Overall Study|Withdrawal by Subject|0|||
149923124|NCT03746405|540854921|FG000|Overall Study|technical difficulties|0|||
149923125|NCT03746405|540854922|FG001|Overall Study|technical difficulties|2|||
149923126|NCT00412932|540854923|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
149923127|NCT00412932|540854923|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
149923128|NCT00412932|540854923|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
149923129|NCT00412932|540854923|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
149923130|NCT00412932|540854923|FG000|Olmesartan (Olm) 20 mg|Other|1|||
149923131|NCT00412932|540854923|FG000|Olmesartan 40 mg|Adverse Event|4|||
149923132|NCT00412932|540854923|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
149923133|NCT00412932|540854923|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
149923134|NCT00412932|540854923|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
149923135|NCT00412932|540854923|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
149923136|NCT00412932|540854923|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
149923137|NCT00412932|540854923|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
149923138|NCT02372383|540854927|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
149923139|NCT02372383|540854928|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
149923140|NCT02372383|540854929|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
149923141|NCT01763203|540854932|FG000|Overall Study|Death|4|||
149923142|NCT01763203|540854933|FG001|Overall Study|Death|7|||
149923143|NCT01763203|540854932|FG000|Overall Study|Lost to Follow-up|12|||
149923144|NCT01763203|540854933|FG001|Overall Study|Lost to Follow-up|12|||
149923145|NCT01763203|540854932|FG000|Overall Study|Withdrawal by Subject|8|||
149923146|NCT01763203|540854933|FG001|Overall Study|Withdrawal by Subject|12|||
149923147|NCT01763203|540854932|FG000|Overall Study|Moved out of study region|7|||
149923148|NCT01763203|540854933|FG001|Overall Study|Moved out of study region|10|||
149923149|NCT01763203|540854932|FG000|Overall Study|Physician Decision|2|||
149923150|NCT01763203|540854933|FG001|Overall Study|Physician Decision|1|||
149923151|NCT02187861|540854934|FG000|Overall Study|Adverse Event|2|||
149923152|NCT02187861|540854935|FG001|Overall Study|Adverse Event|1|||
149923153|NCT02187861|540854936|FG002|Overall Study|Adverse Event|2|||
149923154|NCT02187861|540854937|FG003|Overall Study|Adverse Event|1|||
149923155|NCT02187861|540854934|FG000|Overall Study|Death|0|||
149923156|NCT02187861|540854935|FG001|Overall Study|Death|3|||
149923157|NCT02187861|540854936|FG002|Overall Study|Death|1|||
149923158|NCT02187861|540854937|FG003|Overall Study|Death|2|||
149923159|NCT02187861|540854934|FG000|Overall Study|Physician Decision|0|||
149923160|NCT02187861|540854935|FG001|Overall Study|Physician Decision|1|||
149923161|NCT02187861|540854936|FG002|Overall Study|Physician Decision|0|||
149923162|NCT02187861|540854937|FG003|Overall Study|Physician Decision|3|||
149923163|NCT02187861|540854934|FG000|Overall Study|Progressive Disease|4|||
149923164|NCT02187861|540854935|FG001|Overall Study|Progressive Disease|42|||
149923165|NCT02187861|540854936|FG002|Overall Study|Progressive Disease|19|||
149923166|NCT02187861|540854937|FG003|Overall Study|Progressive Disease|22|||
149923167|NCT02187861|540854934|FG000|Overall Study|Withdrawal by Subject|0|||
149923168|NCT02187861|540854935|FG001|Overall Study|Withdrawal by Subject|0|||
149923169|NCT02187861|540854936|FG002|Overall Study|Withdrawal by Subject|3|||
149923170|NCT02187861|540854937|FG003|Overall Study|Withdrawal by Subject|3|||
149923171|NCT02187861|540854934|FG000|Overall Study|Other|0|||
149923172|NCT02187861|540854935|FG001|Overall Study|Other|1|||
149923173|NCT02187861|540854936|FG002|Overall Study|Other|7|||
149923174|NCT02187861|540854937|FG003|Overall Study|Other|1|||
149923175|NCT02756819|540854938|FG000|Overall Study|Lost for observation|23|||
149923176|NCT02756819|540854938|FG000|Overall Study|Patient's unwillingness|16|||
149923177|NCT02756819|540854938|FG000|Overall Study|Insufficient efficacy|2|||
149923178|NCT02756819|540854938|FG000|Overall Study|Adverse Event|2|||
149923179|NCT02756819|540854938|FG000|Overall Study|Reason not Specified|9|||
149923180|NCT01491841|540854939|FG000|Overall Study|Screen Failure|10|||
149923181|NCT01491841|540854939|FG000|Overall Study|Withdrawal by Subject|1|||
149923182|NCT00741598|540854940|FG000|Overall Study|Lost to Follow-up|3|||
149923183|NCT00741598|540854941|FG001|Overall Study|Lost to Follow-up|4|||
149923184|NCT00741598|540854940|FG000|Overall Study|Lack of Efficacy|1|||
149923185|NCT00741598|540854941|FG001|Overall Study|Lack of Efficacy|2|||
149923186|NCT00741598|540854940|FG000|Overall Study|Physician Decision|1|||
149923187|NCT00741598|540854941|FG001|Overall Study|Physician Decision|1|||
149923188|NCT00741598|540854940|FG000|Overall Study|Pregnancy|1|||
149923189|NCT00741598|540854941|FG001|Overall Study|Pregnancy|0|||
149923190|NCT00741598|540854940|FG000|Overall Study|Withdrawal by Subject|3|||
149923191|NCT00741598|540854941|FG001|Overall Study|Withdrawal by Subject|2|||
149923192|NCT04105842|540854942|FG000|Overall Study|Withdrawal by Subject|2|||
149923193|NCT02087670|540854943|FG000|Overall Study|Withdrawal by Subject|3|||
149923194|NCT02087670|540854944|FG001|Overall Study|Withdrawal by Subject|2|||
149923195|NCT03076996|540854945|FG000|Overall Study|Withdrawal by Subject|2|||
149923196|NCT03076996|540854945|FG000|Overall Study|Lost to Follow-up|3|||
149923197|NCT03076996|540854945|FG000|Overall Study|Literacy precluded participation|1|||
149923198|NCT02144077|540854950|FG000|Overall Study|Withdrawal by Subject|3|||
149923199|NCT02144077|540854951|FG001|Overall Study|Withdrawal by Subject|3|||
149923200|NCT02144077|540854950|FG000|Overall Study|Adverse Event|2|||
149923201|NCT02144077|540854951|FG001|Overall Study|Adverse Event|3|||
149923202|NCT02144077|540854950|FG000|Overall Study|Lost to Follow-up|2|||
149923203|NCT02144077|540854951|FG001|Overall Study|Lost to Follow-up|2|||
149923204|NCT02144077|540854950|FG000|Overall Study|Protocol Violation|1|||
149923205|NCT02144077|540854951|FG001|Overall Study|Protocol Violation|2|||
149923206|NCT02144077|540854950|FG000|Overall Study|Death|0|||
149923207|NCT02144077|540854951|FG001|Overall Study|Death|1|||
149923208|NCT02144077|540854950|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
149923209|NCT02144077|540854951|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
149923210|NCT00715299|540854961|FG000|Overall Study|Withdrawal by Subject|1|||
149923211|NCT00715299|540854961|FG000|Overall Study|Adverse Event|3|||
149923212|NCT00715299|540854961|FG000|Overall Study|failed the pre-screen exercise test|2|||
149923213|NCT02020889|540854962|FG000|Overall Study|Adverse Event|0|||
149923214|NCT02020889|540854963|FG001|Overall Study|Adverse Event|1|||
149923215|NCT02020889|540854962|FG000|Overall Study|Lack of Efficacy|1|||
149923216|NCT02020889|540854963|FG001|Overall Study|Lack of Efficacy|0|||
149923217|NCT02020889|540854962|FG000|Overall Study|Lost to Follow-up|1|||
149923218|NCT02020889|540854963|FG001|Overall Study|Lost to Follow-up|0|||
149923219|NCT02020889|540854962|FG000|Overall Study|Physician Decision|2|||
149923220|NCT02020889|540854963|FG001|Overall Study|Physician Decision|0|||
149923221|NCT02020889|540854962|FG000|Overall Study|Withdrawal by Subject|3|||
149923222|NCT02020889|540854963|FG001|Overall Study|Withdrawal by Subject|2|||
149923223|NCT01540981|540854964|FG000|Overall Study|Withdrawal by Subject|1|||
149923224|NCT01540981|540854965|FG001|Overall Study|Withdrawal by Subject|0|||
149923225|NCT00232557|540854966|FG000|Overall Study|Lost to Follow-up|3|||
149923226|NCT00232557|540854967|FG001|Overall Study|Lost to Follow-up|5|||
149923227|NCT04435808|540854970|FG000|Overall Study|Study stopped by DSMB|0|||
149923228|NCT04435808|540854971|FG001|Overall Study|Study stopped by DSMB|1|||
149923229|NCT02768792|540854973|FG000|Overall Study|Adverse Event|1|||
149923230|NCT02087943|540854974|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
149923231|NCT02087943|540854975|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
149923232|NCT02087943|540854976|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
149923233|NCT02087943|540854977|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
149923234|NCT02087943|540854978|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
149923235|NCT02087943|540854974|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
149923236|NCT02087943|540854975|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
149923237|NCT02087943|540854976|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
149923238|NCT02087943|540854977|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
149923239|NCT02087943|540854978|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
149923240|NCT02087943|540854974|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
149923241|NCT02087943|540854975|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
149923242|NCT02087943|540854976|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
149923243|NCT02087943|540854977|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
149923244|NCT02087943|540854978|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
149923245|NCT02087943|540854974|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
149923246|NCT02087943|540854975|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
149923247|NCT02087943|540854976|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
149923248|NCT02087943|540854977|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
149923249|NCT02087943|540854978|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
149923250|NCT02087943|540854974|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
149923251|NCT02087943|540854975|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
149923252|NCT02087943|540854976|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
149923253|NCT02087943|540854977|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
149923254|NCT02087943|540854978|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
149923255|NCT02087943|540854974|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
149923256|NCT02087943|540854975|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
149923257|NCT02087943|540854976|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
149923258|NCT02087943|540854977|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
149923259|NCT02087943|540854978|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
149923260|NCT02087943|540854974|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
149923261|NCT02087943|540854975|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
149923262|NCT02087943|540854976|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
149923263|NCT02087943|540854977|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
149923264|NCT02087943|540854978|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
149923265|NCT02087943|540854974|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
149923266|NCT02087943|540854975|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
149923267|NCT02087943|540854976|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
149923268|NCT02087943|540854977|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
149923269|NCT02087943|540854978|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
149923270|NCT02087943|540854974|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
149923271|NCT02087943|540854975|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
149923272|NCT02087943|540854976|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
149923273|NCT02087943|540854977|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
149923274|NCT02087943|540854978|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
149923275|NCT02087943|540854974|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
149923276|NCT02087943|540854975|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
149923277|NCT02087943|540854976|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
149923278|NCT02087943|540854977|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
149923279|NCT02087943|540854978|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
149923280|NCT01690299|540854980|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
149923281|NCT01690299|540854981|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
149923282|NCT01690299|540854982|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
149923283|NCT01690299|540854983|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
149923284|NCT01690299|540854984|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
149923285|NCT01690299|540854985|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
149923286|NCT01690299|540854980|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
149923287|NCT01690299|540854981|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149923288|NCT01690299|540854982|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149923289|NCT01690299|540854983|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149923290|NCT01690299|540854984|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149923291|NCT01690299|540854985|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149923292|NCT01690299|540854980|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
149923293|NCT01690299|540854981|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
149923294|NCT01690299|540854982|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149923295|NCT01690299|540854983|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149923296|NCT01690299|540854984|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149923297|NCT01690299|540854985|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149923298|NCT01690299|540854980|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
149923299|NCT01690299|540854981|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
149923300|NCT01690299|540854982|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
149923301|NCT01690299|540854983|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
149923302|NCT01690299|540854984|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
149923303|NCT01690299|540854985|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
149923304|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
149923305|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
149923306|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
149923307|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
149923308|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
149923309|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
149923310|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
149923311|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
149923312|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
149923313|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
149923314|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
149923315|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
149923316|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
149975525|NCT01847755|541047870|FG000|Overall Study|Adverse Event|2|||
149923317|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
149923318|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
149923319|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
149923320|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
149923321|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
149923322|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
149923323|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
149923324|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
149923325|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
149923326|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
149923327|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
149923328|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
149923329|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
149923330|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
149923331|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
149923332|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
149923333|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
149923334|NCT01690299|540854980|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
149923335|NCT01690299|540854981|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
149923336|NCT01690299|540854982|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
149923337|NCT01690299|540854983|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
149923338|NCT01690299|540854984|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
149923339|NCT01690299|540854985|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
149923340|NCT01563913|540854988|FG000|Overall Study|Physician Decision|1|||
149923341|NCT01563913|540854989|FG001|Overall Study|Physician Decision|0|||
149923342|NCT01563913|540854988|FG000|Overall Study|Spouse Passed Away|1|||
149923343|NCT01563913|540854989|FG001|Overall Study|Spouse Passed Away|0|||
149923344|NCT02091414|540854990|FG000|Overall Study|Withdrawal by Subject|2|||
149923345|NCT02091414|540854990|FG000|Overall Study|Death|2|||
149923346|NCT03146741|540854993|FG000|Overall Study|Txp with non-HCV+ heart|4|||
149923347|NCT03146741|540854993|FG000|Overall Study|Listeted for MOT|2|||
149923348|NCT03146741|540854993|FG000|Overall Study|Physician Decision|2|||
149923349|NCT03146741|540854993|FG000|Overall Study|Awaiting txp|2|||
149923350|NCT00551525|540854996|FG000|Overall Study|Protocol Violation|5|||
149923351|NCT04676724|540854997|FG000|Overall Study|Adverse Event|2|||
149923352|NCT04676724|540854998|FG001|Overall Study|Adverse Event|0|||
149923353|NCT04676724|540854997|FG000|Overall Study|Lost to Follow-up|1|||
149923354|NCT04676724|540854998|FG001|Overall Study|Lost to Follow-up|0|||
149923355|NCT04676724|540854997|FG000|Overall Study|Physician Decision|0|||
149923356|NCT04676724|540854998|FG001|Overall Study|Physician Decision|1|||
149923357|NCT04676724|540854997|FG000|Overall Study|Withdrawal by Subject|3|||
149923358|NCT04676724|540854998|FG001|Overall Study|Withdrawal by Subject|2|||
149923359|NCT01348100|540855002|FG000|Overall Study|Subject Withdrew Consent|0|||
149923360|NCT01348100|540855003|FG001|Overall Study|Subject Withdrew Consent|0|||
149923361|NCT01348100|540855004|FG002|Overall Study|Subject Withdrew Consent|2|||
149923362|NCT01348100|540855005|FG003|Overall Study|Subject Withdrew Consent|0|||
149923363|NCT01348100|540855006|FG004|Overall Study|Subject Withdrew Consent|1|||
149923364|NCT01348100|540855007|FG005|Overall Study|Subject Withdrew Consent|0|||
149923365|NCT01348100|540855008|FG006|Overall Study|Subject Withdrew Consent|1|||
149923366|NCT01348100|540855002|FG000|Overall Study|Protocol Deviation|0|||
149923367|NCT01348100|540855003|FG001|Overall Study|Protocol Deviation|0|||
149923368|NCT01348100|540855004|FG002|Overall Study|Protocol Deviation|0|||
149923369|NCT01348100|540855005|FG003|Overall Study|Protocol Deviation|1|||
149923370|NCT01348100|540855006|FG004|Overall Study|Protocol Deviation|0|||
149923371|NCT01348100|540855007|FG005|Overall Study|Protocol Deviation|0|||
149923372|NCT01348100|540855008|FG006|Overall Study|Protocol Deviation|0|||
149923373|NCT01348100|540855002|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923374|NCT01348100|540855003|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923375|NCT01348100|540855004|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923376|NCT01348100|540855005|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923377|NCT01348100|540855006|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923378|NCT01348100|540855007|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149923379|NCT01348100|540855008|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149923380|NCT01348100|540855002|FG000|Overall Study|Lost to Follow-up|0|||
149923381|NCT01348100|540855003|FG001|Overall Study|Lost to Follow-up|0|||
149923382|NCT01348100|540855004|FG002|Overall Study|Lost to Follow-up|0|||
149923383|NCT01348100|540855005|FG003|Overall Study|Lost to Follow-up|0|||
149923384|NCT01348100|540855006|FG004|Overall Study|Lost to Follow-up|0|||
149923385|NCT01348100|540855007|FG005|Overall Study|Lost to Follow-up|0|||
149923386|NCT01348100|540855008|FG006|Overall Study|Lost to Follow-up|1|||
149923387|NCT01348100|540855002|FG000|Overall Study|Administrative Problems|0|||
149923388|NCT01348100|540855003|FG001|Overall Study|Administrative Problems|0|||
149923389|NCT01348100|540855004|FG002|Overall Study|Administrative Problems|0|||
149923390|NCT01348100|540855005|FG003|Overall Study|Administrative Problems|0|||
149923391|NCT01348100|540855006|FG004|Overall Study|Administrative Problems|0|||
149923392|NCT01348100|540855007|FG005|Overall Study|Administrative Problems|1|||
149923393|NCT01348100|540855008|FG006|Overall Study|Administrative Problems|1|||
149923394|NCT03882957|540855011|FG000|Overall Study|Did not complete all three arms|1|||
149923395|NCT04399538|540855012|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
149923396|NCT04399538|540855013|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
149923397|NCT04399538|540855014|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
149923398|NCT04399538|540855015|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
149923399|NCT04399538|540855016|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
149923400|NCT04399538|540855012|FG000|Double-Blind Treatment|Adverse Event|0|||
149923401|NCT04399538|540855013|FG001|Double-Blind Treatment|Adverse Event|0|||
149923402|NCT04399538|540855014|FG002|Double-Blind Treatment|Adverse Event|0|||
149923403|NCT04399538|540855015|FG003|Double-Blind Treatment|Adverse Event|0|||
149923404|NCT04399538|540855016|FG004|Double-Blind Treatment|Adverse Event|1|||
149923405|NCT04399538|540855012|FG000|Follow-Up|Adverse Event|0|||
149923406|NCT04399538|540855013|FG001|Follow-Up|Adverse Event|0|||
149923407|NCT04399538|540855014|FG002|Follow-Up|Adverse Event|0|||
149923408|NCT04399538|540855015|FG003|Follow-Up|Adverse Event|0|||
149923409|NCT04399538|540855016|FG004|Follow-Up|Adverse Event|1|||
149923410|NCT04399538|540855012|FG000|Follow-Up|Withdrawal by Subject|0|||
149923411|NCT04399538|540855013|FG001|Follow-Up|Withdrawal by Subject|0|||
149923412|NCT04399538|540855014|FG002|Follow-Up|Withdrawal by Subject|0|||
149923413|NCT04399538|540855015|FG003|Follow-Up|Withdrawal by Subject|2|||
149923414|NCT04399538|540855016|FG004|Follow-Up|Withdrawal by Subject|0|||
149923415|NCT01926197|540855017|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
149923416|NCT01926197|540855018|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
149923417|NCT01926197|540855017|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
149923418|NCT01926197|540855018|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
149923419|NCT00492232|540855019|FG000|Placebo Run-in|Adverse Event|0|||
149923420|NCT00492232|540855020|FG001|Placebo Run-in|Adverse Event|2|||
149923421|NCT00492232|540855019|FG000|Placebo Run-in|Protocol Violation|0|||
149923422|NCT00492232|540855020|FG001|Placebo Run-in|Protocol Violation|3|||
149923423|NCT00492232|540855019|FG000|Placebo Run-in|Lost to Follow-up|0|||
149923424|NCT00492232|540855020|FG001|Placebo Run-in|Lost to Follow-up|3|||
149923425|NCT00492232|540855019|FG000|Placebo Run-in|Withdrawal by Subject|0|||
149923426|NCT00492232|540855020|FG001|Placebo Run-in|Withdrawal by Subject|8|||
149923427|NCT00492232|540855019|FG000|Placebo Run-in|Pregnancy|0|||
149923428|NCT00492232|540855020|FG001|Placebo Run-in|Pregnancy|1|||
149923429|NCT00492232|540855019|FG000|Placebo Run-in|Entrance criteria not met|0|||
149923430|NCT00492232|540855020|FG001|Placebo Run-in|Entrance criteria not met|45|||
149923431|NCT00492232|540855019|FG000|Placebo Run-in|Other|0|||
149923432|NCT00492232|540855020|FG001|Placebo Run-in|Other|6|||
149923433|NCT00492232|540855019|FG000|Placebo Run-in|Missing|0|||
149923434|NCT00492232|540855020|FG001|Placebo Run-in|Missing|2|||
149923435|NCT00492232|540855019|FG000|Double-Blind Treatment|Adverse Event|1|||
149923436|NCT00492232|540855020|FG001|Double-Blind Treatment|Adverse Event|2|||
149923437|NCT00492232|540855019|FG000|Double-Blind Treatment|Protocol Violation|3|||
149923438|NCT00492232|540855020|FG001|Double-Blind Treatment|Protocol Violation|7|||
149923439|NCT00492232|540855019|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
149923440|NCT00492232|540855020|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
149923441|NCT00492232|540855019|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
149923442|NCT00492232|540855020|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
149923443|NCT00492232|540855019|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
149923444|NCT00492232|540855020|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
149923445|NCT00492232|540855019|FG000|Double-Blind Treatment|Other|6|||
149923446|NCT00492232|540855020|FG001|Double-Blind Treatment|Other|5|||
149923447|NCT00492232|540855019|FG000|Double-Blind Treatment|Randomized not treated|1|||
149923448|NCT00492232|540855020|FG001|Double-Blind Treatment|Randomized not treated|0|||
149923449|NCT00492232|540855019|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
149923450|NCT00492232|540855020|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
149923451|NCT02756364|540855022|FG000|Overall Study|Site Terminated by Sponsor|24|||
149923452|NCT02756364|540855023|FG001|Overall Study|Site Terminated by Sponsor|30|||
149923453|NCT02756364|540855024|FG002|Overall Study|Site Terminated by Sponsor|21|||
149923454|NCT02756364|540855022|FG000|Overall Study|Death|20|||
149923455|NCT02756364|540855023|FG001|Overall Study|Death|15|||
149923456|NCT02756364|540855024|FG002|Overall Study|Death|18|||
149923457|NCT02756364|540855022|FG000|Overall Study|Withdrawal by Patient|2|||
149923458|NCT02756364|540855023|FG001|Overall Study|Withdrawal by Patient|1|||
149923459|NCT02756364|540855024|FG002|Overall Study|Withdrawal by Patient|8|||
149923460|NCT02756364|540855022|FG000|Overall Study|Lost to Follow-up|0|||
149923461|NCT02756364|540855023|FG001|Overall Study|Lost to Follow-up|1|||
149923462|NCT02756364|540855024|FG002|Overall Study|Lost to Follow-up|1|||
149923463|NCT02223364|540855025|FG000|Overall Study|Protocol Violation|3|||
149923464|NCT02223364|540855026|FG001|Overall Study|Protocol Violation|0|||
149923465|NCT02223364|540855027|FG002|Overall Study|Protocol Violation|3|||
149923466|NCT02223364|540855025|FG000|Overall Study|subject expired before surgery|1|||
149923467|NCT02223364|540855026|FG001|Overall Study|subject expired before surgery|0|||
149923468|NCT02223364|540855027|FG002|Overall Study|subject expired before surgery|0|||
149923469|NCT02223364|540855025|FG000|Overall Study|Physician Decision|1|||
149923470|NCT02223364|540855026|FG001|Overall Study|Physician Decision|0|||
149923471|NCT02223364|540855027|FG002|Overall Study|Physician Decision|0|||
149923472|NCT01416155|540855028|FG000|Overall Study|Adverse Event|8|||
149923473|NCT01416155|540855028|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
149923474|NCT01416155|540855028|FG000|Overall Study|Withdrawal by Subject|33|||
149923475|NCT01416155|540855028|FG000|Overall Study|Investigator decision|8|||
149923476|NCT01416155|540855028|FG000|Overall Study|Other|7|||
149923477|NCT02685072|540855029|FG000|Treatment Period|Lost to Follow-up|12|||
149923478|NCT02685072|540855030|FG001|Treatment Period|Lost to Follow-up|6|||
149923479|NCT02685072|540855029|FG000|Treatment Period|Withdrawal by Subject|1|||
149923480|NCT02685072|540855030|FG001|Treatment Period|Withdrawal by Subject|3|||
149923481|NCT02685072|540855029|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
149923482|NCT02685072|540855030|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
149923483|NCT03597139|540855032|FG000|Overall Study|Adverse Event|3|||
149923484|NCT03597139|540855033|FG001|Overall Study|Adverse Event|0|||
149923485|NCT03597139|540855032|FG000|Overall Study|Protocol Non-compliance|1|||
149923486|NCT03597139|540855033|FG001|Overall Study|Protocol Non-compliance|0|||
149923487|NCT04811664|540855036|FG000|Overall Study|Lost to Follow-up|78|||
149923488|NCT04811664|540855037|FG001|Overall Study|Lost to Follow-up|125|||
149923489|NCT04811664|540855038|FG002|Overall Study|Lost to Follow-up|46|||
149923490|NCT04811664|540855036|FG000|Overall Study|Withdrawal by Subject|39|||
149923491|NCT04811664|540855037|FG001|Overall Study|Withdrawal by Subject|76|||
149923492|NCT04811664|540855038|FG002|Overall Study|Withdrawal by Subject|12|||
149923493|NCT04811664|540855036|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
149923494|NCT04811664|540855037|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
149923495|NCT04811664|540855038|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
149923496|NCT04811664|540855036|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
149923497|NCT04811664|540855037|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
149923498|NCT04811664|540855038|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
149923499|NCT04811664|540855036|FG000|Overall Study|Protocol Violation|0|||
149923500|NCT04811664|540855037|FG001|Overall Study|Protocol Violation|5|||
149923501|NCT04811664|540855038|FG002|Overall Study|Protocol Violation|11|||
149923502|NCT04811664|540855036|FG000|Overall Study|Study Terminated by Sponsor|4|||
149923503|NCT04811664|540855037|FG001|Overall Study|Study Terminated by Sponsor|3|||
149923504|NCT04811664|540855038|FG002|Overall Study|Study Terminated by Sponsor|34|||
149923505|NCT04811664|540855036|FG000|Overall Study|Early Study Closure|3|||
149923506|NCT04811664|540855037|FG001|Overall Study|Early Study Closure|7|||
149923507|NCT04811664|540855038|FG002|Overall Study|Early Study Closure|79|||
149923508|NCT04811664|540855036|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
149923509|NCT04811664|540855037|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
149923510|NCT04811664|540855038|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
149923511|NCT00382109|540855039|FG000|Overall Study|Adverse Event|3|||
149923512|NCT00382109|540855040|FG001|Overall Study|Adverse Event|0|||
149923513|NCT00382109|540855039|FG000|Overall Study|Physician Decision|6|||
149923514|NCT00382109|540855040|FG001|Overall Study|Physician Decision|1|||
149923515|NCT00382109|540855039|FG000|Overall Study|Withdrawal by Subject|1|||
149923516|NCT00382109|540855040|FG001|Overall Study|Withdrawal by Subject|0|||
149923517|NCT00382109|540855039|FG000|Overall Study|ineligible|2|||
149923518|NCT00382109|540855040|FG001|Overall Study|ineligible|0|||
149923519|NCT00382109|540855039|FG000|Overall Study|Other|0|||
149923520|NCT00382109|540855040|FG001|Overall Study|Other|2|||
149923521|NCT00382109|540855039|FG000|Overall Study|consent withdrawal|0|||
149923522|NCT00382109|540855040|FG001|Overall Study|consent withdrawal|1|||
149923523|NCT02717442|540855041|FG000|Overall Study|Study Terminated by Sponsor|31|||
149923524|NCT02717442|540855042|FG001|Overall Study|Study Terminated by Sponsor|29|||
149923525|NCT02717442|540855041|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
149923526|NCT02717442|540855042|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
149923527|NCT02717442|540855041|FG000|Overall Study|Other - Not Specified|2|||
149923528|NCT02717442|540855042|FG001|Overall Study|Other - Not Specified|0|||
149923529|NCT05052697|540855043|FG000|Substudy A|Lost to Follow-up|0|||
149923530|NCT05052697|540855044|FG001|Substudy A|Lost to Follow-up|0|||
149923531|NCT05052697|540855045|FG002|Substudy A|Lost to Follow-up|0|||
149923532|NCT05052697|540855046|FG003|Substudy A|Lost to Follow-up|0|||
149923533|NCT05052697|540855047|FG004|Substudy A|Lost to Follow-up|0|||
149923534|NCT05052697|540855048|FG005|Substudy A|Lost to Follow-up|1|||
149923535|NCT05052697|540855049|FG006|Substudy A|Lost to Follow-up|0|||
149923536|NCT05052697|540855050|FG007|Substudy A|Lost to Follow-up|0|||
149923537|NCT05052697|540855051|FG008|Substudy A|Lost to Follow-up|0|||
149923538|NCT05052697|540855052|FG009|Substudy A|Lost to Follow-up|0|||
149923539|NCT05052697|540855053|FG010|Substudy A|Lost to Follow-up|0|||
149923540|NCT05052697|540855054|FG011|Substudy A|Lost to Follow-up|0|||
149923541|NCT05052697|540855055|FG012|Substudy A|Lost to Follow-up|0|||
149923542|NCT05052697|540855056|FG013|Substudy A|Lost to Follow-up|0|||
149817781|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
149817782|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
149817783|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
149817784|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
149817785|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
149817786|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
149817787|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
149817788|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
149923543|NCT05052697|540855057|FG014|Substudy A|Lost to Follow-up|0|||
149923544|NCT05052697|540855058|FG015|Substudy A|Lost to Follow-up|2|||
149923545|NCT05052697|540855059|FG016|Substudy A|Lost to Follow-up|0|||
149923546|NCT05052697|540855060|FG017|Substudy A|Lost to Follow-up|0|||
149923547|NCT05052697|540855061|FG018|Substudy A|Lost to Follow-up|0|||
149923548|NCT05052697|540855062|FG019|Substudy A|Lost to Follow-up|0|||
149923549|NCT05052697|540855063|FG020|Substudy A|Lost to Follow-up|0|||
149923550|NCT05052697|540855064|FG021|Substudy A|Lost to Follow-up|0|||
149923551|NCT05052697|540855065|FG022|Substudy A|Lost to Follow-up|0|||
149923552|NCT05052697|540855066|FG023|Substudy A|Lost to Follow-up|0|||
149923553|NCT05052697|540855067|FG024|Substudy A|Lost to Follow-up|0|||
149923554|NCT05052697|540855068|FG025|Substudy A|Lost to Follow-up|0|||
149923555|NCT05052697|540855069|FG026|Substudy A|Lost to Follow-up|0|||
149923556|NCT05052697|540855070|FG027|Substudy A|Lost to Follow-up|0|||
149923557|NCT05052697|540855071|FG028|Substudy A|Lost to Follow-up|0|||
149923558|NCT05052697|540855072|FG029|Substudy A|Lost to Follow-up|0|||
149923559|NCT05052697|540855073|FG030|Substudy A|Lost to Follow-up|0|||
149923560|NCT05052697|540855074|FG031|Substudy A|Lost to Follow-up|0|||
149923561|NCT05052697|540855075|FG032|Substudy A|Lost to Follow-up|0|||
149923562|NCT05052697|540855076|FG033|Substudy A|Lost to Follow-up|0|||
149923563|NCT05052697|540855043|FG000|Substudy A|No longer met eligibility criteria|0|||
149923564|NCT05052697|540855044|FG001|Substudy A|No longer met eligibility criteria|0|||
149923565|NCT05052697|540855045|FG002|Substudy A|No longer met eligibility criteria|0|||
149923566|NCT05052697|540855046|FG003|Substudy A|No longer met eligibility criteria|0|||
149923567|NCT05052697|540855047|FG004|Substudy A|No longer met eligibility criteria|0|||
149923568|NCT05052697|540855048|FG005|Substudy A|No longer met eligibility criteria|0|||
149923569|NCT05052697|540855049|FG006|Substudy A|No longer met eligibility criteria|0|||
149923570|NCT05052697|540855050|FG007|Substudy A|No longer met eligibility criteria|0|||
149923571|NCT05052697|540855051|FG008|Substudy A|No longer met eligibility criteria|0|||
149923572|NCT05052697|540855052|FG009|Substudy A|No longer met eligibility criteria|0|||
149923573|NCT05052697|540855053|FG010|Substudy A|No longer met eligibility criteria|0|||
149923574|NCT05052697|540855054|FG011|Substudy A|No longer met eligibility criteria|0|||
149923575|NCT05052697|540855055|FG012|Substudy A|No longer met eligibility criteria|0|||
149923576|NCT05052697|540855056|FG013|Substudy A|No longer met eligibility criteria|1|||
149923577|NCT05052697|540855057|FG014|Substudy A|No longer met eligibility criteria|0|||
149923578|NCT05052697|540855058|FG015|Substudy A|No longer met eligibility criteria|0|||
149923579|NCT05052697|540855059|FG016|Substudy A|No longer met eligibility criteria|0|||
149817789|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
149817790|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
149817791|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817792|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817793|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817794|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817795|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817796|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
149923580|NCT05052697|540855060|FG017|Substudy A|No longer met eligibility criteria|0|||
149923581|NCT05052697|540855061|FG018|Substudy A|No longer met eligibility criteria|0|||
150160897|NCT00495469|541723598|FG000|Overall Study|ST depression at randomisation in ECG|0|||
150160898|NCT00495469|541723599|FG001|Overall Study|ST depression at randomisation in ECG|1|||
150160899|NCT00495469|541723600|FG002|Overall Study|ST depression at randomisation in ECG|0|||
150160900|NCT00495469|541723601|FG003|Overall Study|ST depression at randomisation in ECG|0|||
150160901|NCT00495469|541723602|FG004|Overall Study|ST depression at randomisation in ECG|0|||
150160902|NCT00495469|541723603|FG005|Overall Study|ST depression at randomisation in ECG|0|||
150160903|NCT00495469|541723604|FG006|Overall Study|ST depression at randomisation in ECG|0|||
150160904|NCT04454567|541723609|FG000|Overall Study|Study Terminated by Sponsor|1|||
149923582|NCT05052697|540855062|FG019|Substudy A|No longer met eligibility criteria|0|||
149923583|NCT05052697|540855063|FG020|Substudy A|No longer met eligibility criteria|0|||
149923584|NCT05052697|540855064|FG021|Substudy A|No longer met eligibility criteria|0|||
149923585|NCT05052697|540855065|FG022|Substudy A|No longer met eligibility criteria|0|||
149923586|NCT05052697|540855066|FG023|Substudy A|No longer met eligibility criteria|0|||
149923587|NCT05052697|540855067|FG024|Substudy A|No longer met eligibility criteria|0|||
149817797|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149923588|NCT05052697|540855068|FG025|Substudy A|No longer met eligibility criteria|0|||
149923589|NCT05052697|540855069|FG026|Substudy A|No longer met eligibility criteria|0|||
149923590|NCT05052697|540855070|FG027|Substudy A|No longer met eligibility criteria|0|||
149923591|NCT05052697|540855071|FG028|Substudy A|No longer met eligibility criteria|0|||
149923592|NCT05052697|540855072|FG029|Substudy A|No longer met eligibility criteria|0|||
149923593|NCT05052697|540855073|FG030|Substudy A|No longer met eligibility criteria|0|||
149923594|NCT05052697|540855074|FG031|Substudy A|No longer met eligibility criteria|0|||
149923595|NCT05052697|540855075|FG032|Substudy A|No longer met eligibility criteria|0|||
149923596|NCT05052697|540855076|FG033|Substudy A|No longer met eligibility criteria|0|||
149923597|NCT05052697|540855043|FG000|Substudy A|Not vaccinated|0|||
149923598|NCT05052697|540855044|FG001|Substudy A|Not vaccinated|0|||
149923599|NCT05052697|540855045|FG002|Substudy A|Not vaccinated|0|||
149923600|NCT05052697|540855046|FG003|Substudy A|Not vaccinated|1|||
149923601|NCT05052697|540855047|FG004|Substudy A|Not vaccinated|0|||
149923602|NCT05052697|540855048|FG005|Substudy A|Not vaccinated|0|||
149817798|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
149817799|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817800|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817801|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817802|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817803|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
149817804|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
149817805|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817806|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817807|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817808|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149817809|NCT00950599|540463520|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
149817810|NCT00950599|540463521|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
149817811|NCT00950599|540463522|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
149817812|NCT00950599|540463523|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
149817813|NCT00950599|540463524|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
149817814|NCT00950599|540463525|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
149817815|NCT00950599|540463526|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
149817816|NCT00950599|540463527|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
149817817|NCT00950599|540463528|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
149817818|NCT00950599|540463529|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
149817819|NCT00950599|540463520|FG000|Follow-Up Period|Adverse Event|0|||
149817820|NCT00950599|540463521|FG001|Follow-Up Period|Adverse Event|0|||
149817821|NCT00950599|540463522|FG002|Follow-Up Period|Adverse Event|0|||
149817822|NCT00950599|540463523|FG003|Follow-Up Period|Adverse Event|0|||
149817823|NCT00950599|540463524|FG004|Follow-Up Period|Adverse Event|0|||
149817824|NCT00950599|540463525|FG005|Follow-Up Period|Adverse Event|0|||
149817825|NCT00950599|540463526|FG006|Follow-Up Period|Adverse Event|0|||
149817826|NCT00950599|540463527|FG007|Follow-Up Period|Adverse Event|0|||
149817827|NCT00950599|540463528|FG008|Follow-Up Period|Adverse Event|1|||
149817828|NCT00950599|540463529|FG009|Follow-Up Period|Adverse Event|0|||
149817829|NCT00950599|540463520|FG000|Follow-Up Period|Lack of Efficacy|0|||
149817830|NCT00950599|540463521|FG001|Follow-Up Period|Lack of Efficacy|0|||
149817831|NCT00950599|540463522|FG002|Follow-Up Period|Lack of Efficacy|0|||
149817832|NCT00950599|540463523|FG003|Follow-Up Period|Lack of Efficacy|0|||
149817833|NCT00950599|540463524|FG004|Follow-Up Period|Lack of Efficacy|0|||
149817834|NCT00950599|540463525|FG005|Follow-Up Period|Lack of Efficacy|0|||
149817835|NCT00950599|540463526|FG006|Follow-Up Period|Lack of Efficacy|0|||
149817836|NCT00950599|540463527|FG007|Follow-Up Period|Lack of Efficacy|0|||
149817837|NCT00950599|540463528|FG008|Follow-Up Period|Lack of Efficacy|3|||
149817838|NCT00950599|540463529|FG009|Follow-Up Period|Lack of Efficacy|0|||
149817839|NCT00950599|540463520|FG000|Follow-Up Period|Lost to Follow-up|0|||
149817840|NCT00950599|540463521|FG001|Follow-Up Period|Lost to Follow-up|0|||
149817841|NCT00950599|540463522|FG002|Follow-Up Period|Lost to Follow-up|0|||
149817842|NCT00950599|540463523|FG003|Follow-Up Period|Lost to Follow-up|0|||
149817843|NCT00950599|540463524|FG004|Follow-Up Period|Lost to Follow-up|0|||
149817844|NCT00950599|540463525|FG005|Follow-Up Period|Lost to Follow-up|0|||
149817845|NCT00950599|540463526|FG006|Follow-Up Period|Lost to Follow-up|0|||
149817846|NCT00950599|540463527|FG007|Follow-Up Period|Lost to Follow-up|0|||
149817847|NCT00950599|540463528|FG008|Follow-Up Period|Lost to Follow-up|5|||
149817848|NCT00950599|540463529|FG009|Follow-Up Period|Lost to Follow-up|1|||
149817849|NCT00950599|540463520|FG000|Follow-Up Period|Physician Decision|0|||
149817850|NCT00950599|540463521|FG001|Follow-Up Period|Physician Decision|0|||
149817851|NCT00950599|540463522|FG002|Follow-Up Period|Physician Decision|0|||
149923603|NCT05052697|540855049|FG006|Substudy A|Not vaccinated|0|||
149923604|NCT05052697|540855050|FG007|Substudy A|Not vaccinated|0|||
149923605|NCT05052697|540855051|FG008|Substudy A|Not vaccinated|1|||
149923606|NCT05052697|540855052|FG009|Substudy A|Not vaccinated|0|||
149923607|NCT05052697|540855053|FG010|Substudy A|Not vaccinated|0|||
149923608|NCT05052697|540855054|FG011|Substudy A|Not vaccinated|0|||
149923609|NCT05052697|540855055|FG012|Substudy A|Not vaccinated|0|||
149923610|NCT05052697|540855056|FG013|Substudy A|Not vaccinated|0|||
149923611|NCT05052697|540855057|FG014|Substudy A|Not vaccinated|0|||
149923612|NCT05052697|540855058|FG015|Substudy A|Not vaccinated|0|||
149923613|NCT05052697|540855059|FG016|Substudy A|Not vaccinated|0|||
149923614|NCT05052697|540855060|FG017|Substudy A|Not vaccinated|0|||
149923615|NCT05052697|540855061|FG018|Substudy A|Not vaccinated|0|||
149923616|NCT05052697|540855062|FG019|Substudy A|Not vaccinated|0|||
149817852|NCT00950599|540463523|FG003|Follow-Up Period|Physician Decision|0|||
149817853|NCT00950599|540463524|FG004|Follow-Up Period|Physician Decision|0|||
149817854|NCT00950599|540463525|FG005|Follow-Up Period|Physician Decision|0|||
149817855|NCT00950599|540463526|FG006|Follow-Up Period|Physician Decision|0|||
149817856|NCT00950599|540463527|FG007|Follow-Up Period|Physician Decision|0|||
149817857|NCT00950599|540463528|FG008|Follow-Up Period|Physician Decision|1|||
149817858|NCT00950599|540463529|FG009|Follow-Up Period|Physician Decision|0|||
149817859|NCT00950599|540463520|FG000|Follow-Up Period|Poor/Noncompliance|0|||
149817860|NCT00950599|540463521|FG001|Follow-Up Period|Poor/Noncompliance|0|||
149817861|NCT00950599|540463522|FG002|Follow-Up Period|Poor/Noncompliance|0|||
149817862|NCT00950599|540463523|FG003|Follow-Up Period|Poor/Noncompliance|0|||
149817863|NCT00950599|540463524|FG004|Follow-Up Period|Poor/Noncompliance|0|||
149817864|NCT00950599|540463525|FG005|Follow-Up Period|Poor/Noncompliance|0|||
149817865|NCT00950599|540463526|FG006|Follow-Up Period|Poor/Noncompliance|0|||
149817866|NCT00950599|540463527|FG007|Follow-Up Period|Poor/Noncompliance|0|||
149817867|NCT00950599|540463528|FG008|Follow-Up Period|Poor/Noncompliance|1|||
149817868|NCT00950599|540463529|FG009|Follow-Up Period|Poor/Noncompliance|0|||
149817869|NCT00950599|540463520|FG000|Follow-Up Period|Subject withdrew Consent|0|||
149817870|NCT00950599|540463521|FG001|Follow-Up Period|Subject withdrew Consent|0|||
149817871|NCT00950599|540463522|FG002|Follow-Up Period|Subject withdrew Consent|0|||
149817872|NCT00950599|540463523|FG003|Follow-Up Period|Subject withdrew Consent|0|||
149817873|NCT00950599|540463524|FG004|Follow-Up Period|Subject withdrew Consent|0|||
149817874|NCT00950599|540463525|FG005|Follow-Up Period|Subject withdrew Consent|0|||
149817875|NCT00950599|540463526|FG006|Follow-Up Period|Subject withdrew Consent|0|||
149817876|NCT00950599|540463527|FG007|Follow-Up Period|Subject withdrew Consent|0|||
149817877|NCT00950599|540463528|FG008|Follow-Up Period|Subject withdrew Consent|2|||
149817878|NCT00950599|540463529|FG009|Follow-Up Period|Subject withdrew Consent|1|||
149817879|NCT01361607|540463532|FG000|Overall Study|Adverse Event|38|||
149817880|NCT01361607|540463533|FG001|Overall Study|Adverse Event|29|||
149817881|NCT01361607|540463532|FG000|Overall Study|Withdrawal by Subject|19|||
149817882|NCT01361607|540463533|FG001|Overall Study|Withdrawal by Subject|8|||
149817883|NCT01361607|540463532|FG000|Overall Study|Withdrawal by Investigator|5|||
149817884|NCT01361607|540463533|FG001|Overall Study|Withdrawal by Investigator|3|||
149817885|NCT01361607|540463532|FG000|Overall Study|Lost to Follow-up|1|||
149817886|NCT01361607|540463533|FG001|Overall Study|Lost to Follow-up|0|||
149817887|NCT01361607|540463532|FG000|Overall Study|Met Withdrawal Criteria|1|||
149817888|NCT01361607|540463533|FG001|Overall Study|Met Withdrawal Criteria|1|||
149817889|NCT00373685|540463534|FG000|Overall Study|Death|2|||
149817890|NCT00373685|540463535|FG001|Overall Study|Death|1|||
149817891|NCT00373685|540463534|FG000|Overall Study|Adverse Event|278|||
149817892|NCT00373685|540463535|FG001|Overall Study|Adverse Event|253|||
149817893|NCT00373685|540463534|FG000|Overall Study|Insufficient clinical response|169|||
149817894|NCT00373685|540463535|FG001|Overall Study|Insufficient clinical response|119|||
149817895|NCT00373685|540463534|FG000|Overall Study|Did not meet entrance criteria|167|||
149817896|NCT00373685|540463535|FG001|Overall Study|Did not meet entrance criteria|184|||
149817897|NCT00373685|540463534|FG000|Overall Study|Lost to follow up|83|||
149817898|NCT00373685|540463535|FG001|Overall Study|Lost to follow up|103|||
149817899|NCT00373685|540463534|FG000|Overall Study|No longer willing to participate|337|||
149817900|NCT00373685|540463535|FG001|Overall Study|No longer willing to participate|352|||
149817901|NCT00373685|540463534|FG000|Overall Study|Other|149|||
149817902|NCT00373685|540463535|FG001|Overall Study|Other|146|||
149817903|NCT00373685|540463534|FG000|Overall Study|Protocol Violation|191|||
149817904|NCT00373685|540463535|FG001|Overall Study|Protocol Violation|182|||
149817905|NCT00373685|540463534|FG000|Overall Study|Final Status Unknown|12|||
149817906|NCT00373685|540463535|FG001|Overall Study|Final Status Unknown|4|||
149923617|NCT05052697|540855063|FG020|Substudy A|Not vaccinated|0|||
149923618|NCT05052697|540855064|FG021|Substudy A|Not vaccinated|0|||
149817907|NCT00373685|540463534|FG000|Overall Study|Randomized, not treated|51|||
149817908|NCT00373685|540463535|FG001|Overall Study|Randomized, not treated|77|||
149817909|NCT02570165|540463536|FG000|Overall Study|Adverse Event|1|||
149817910|NCT02570165|540463537|FG001|Overall Study|Adverse Event|0|||
149817911|NCT02570165|540463538|FG002|Overall Study|Adverse Event|2|||
149817912|NCT02570165|540463539|FG003|Overall Study|Adverse Event|0|||
149817913|NCT02570165|540463540|FG004|Overall Study|Adverse Event|0|||
149817914|NCT02570165|540463541|FG005|Overall Study|Adverse Event|0|||
149817915|NCT02570165|540463542|FG006|Overall Study|Adverse Event|0|||
149817916|NCT02570165|540463536|FG000|Overall Study|Lack of Efficacy|0|||
149923619|NCT05052697|540855065|FG022|Substudy A|Not vaccinated|0|||
149923620|NCT05052697|540855066|FG023|Substudy A|Not vaccinated|0|||
149923621|NCT05052697|540855067|FG024|Substudy A|Not vaccinated|0|||
149923622|NCT05052697|540855068|FG025|Substudy A|Not vaccinated|0|||
150260007|NCT00192647|542089259|FG001|Overall Study|Death|1|||
150260008|NCT00192647|542089258|FG000|Overall Study|Adverse Event|35|||
150260009|NCT00192647|542089259|FG001|Overall Study|Adverse Event|29|||
150260010|NCT00192647|542089258|FG000|Overall Study|Laboratory Test Abnormality|4|||
150260011|NCT00192647|542089259|FG001|Overall Study|Laboratory Test Abnormality|2|||
150260012|NCT00192647|542089258|FG000|Overall Study|Insufficient Therapeutic Response|53|||
149817917|NCT02570165|540463537|FG001|Overall Study|Lack of Efficacy|1|||
149817918|NCT02570165|540463538|FG002|Overall Study|Lack of Efficacy|0|||
149817919|NCT02570165|540463539|FG003|Overall Study|Lack of Efficacy|0|||
149817920|NCT02570165|540463540|FG004|Overall Study|Lack of Efficacy|4|||
149817921|NCT02570165|540463541|FG005|Overall Study|Lack of Efficacy|0|||
149817922|NCT02570165|540463542|FG006|Overall Study|Lack of Efficacy|0|||
149817923|NCT02570165|540463536|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
149817924|NCT02570165|540463537|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
149817925|NCT02570165|540463538|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
149817926|NCT02570165|540463539|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
149817927|NCT02570165|540463540|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
149817928|NCT02570165|540463541|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
149817929|NCT02570165|540463542|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
149817930|NCT02570165|540463536|FG000|Overall Study|Lost to Follow-up|0|||
149817931|NCT02570165|540463537|FG001|Overall Study|Lost to Follow-up|0|||
149817932|NCT02570165|540463538|FG002|Overall Study|Lost to Follow-up|1|||
149817933|NCT02570165|540463539|FG003|Overall Study|Lost to Follow-up|1|||
149817934|NCT02570165|540463540|FG004|Overall Study|Lost to Follow-up|0|||
149817935|NCT02570165|540463541|FG005|Overall Study|Lost to Follow-up|0|||
149817936|NCT02570165|540463542|FG006|Overall Study|Lost to Follow-up|0|||
149817937|NCT02570165|540463536|FG000|Overall Study|Physician Decision|0|||
149817938|NCT02570165|540463537|FG001|Overall Study|Physician Decision|1|||
149817939|NCT02570165|540463538|FG002|Overall Study|Physician Decision|0|||
149817940|NCT02570165|540463539|FG003|Overall Study|Physician Decision|0|||
149817941|NCT02570165|540463540|FG004|Overall Study|Physician Decision|0|||
149817942|NCT02570165|540463541|FG005|Overall Study|Physician Decision|0|||
149817943|NCT02570165|540463542|FG006|Overall Study|Physician Decision|0|||
149817944|NCT02570165|540463536|FG000|Overall Study|Withdrawal by Subject|0|||
149817945|NCT02570165|540463537|FG001|Overall Study|Withdrawal by Subject|0|||
149817946|NCT02570165|540463538|FG002|Overall Study|Withdrawal by Subject|0|||
149817947|NCT02570165|540463539|FG003|Overall Study|Withdrawal by Subject|2|||
149817948|NCT02570165|540463540|FG004|Overall Study|Withdrawal by Subject|1|||
149817949|NCT02570165|540463541|FG005|Overall Study|Withdrawal by Subject|0|||
149817950|NCT02570165|540463542|FG006|Overall Study|Withdrawal by Subject|0|||
149817951|NCT02570165|540463536|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817952|NCT02570165|540463537|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817953|NCT02570165|540463538|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817954|NCT02570165|540463539|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817955|NCT02570165|540463540|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817956|NCT02570165|540463541|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
149817957|NCT02570165|540463542|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
149817958|NCT02570165|540463536|FG000|Overall Study|Withdrawal Request by GSK|0|||
149817959|NCT02570165|540463537|FG001|Overall Study|Withdrawal Request by GSK|0|||
149817960|NCT02570165|540463538|FG002|Overall Study|Withdrawal Request by GSK|2|||
149817961|NCT02570165|540463539|FG003|Overall Study|Withdrawal Request by GSK|0|||
149817962|NCT02570165|540463540|FG004|Overall Study|Withdrawal Request by GSK|0|||
149817963|NCT02570165|540463541|FG005|Overall Study|Withdrawal Request by GSK|0|||
149817964|NCT02570165|540463542|FG006|Overall Study|Withdrawal Request by GSK|0|||
149817965|NCT05266456|540463545|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
149817966|NCT05266456|540463546|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
149817967|NCT05266456|540463547|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
149817968|NCT05266456|540463548|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
149817969|NCT05266456|540463545|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
149817970|NCT05266456|540463546|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
149817971|NCT05266456|540463547|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
149817972|NCT05266456|540463548|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
149817973|NCT05266456|540463545|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
149923623|NCT05052697|540855069|FG026|Substudy A|Not vaccinated|0|||
149817974|NCT05266456|540463546|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
149817975|NCT05266456|540463547|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
149817976|NCT05266456|540463548|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
149817977|NCT05266456|540463545|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
149817978|NCT05266456|540463546|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
149817979|NCT05266456|540463547|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
150260013|NCT00192647|542089259|FG001|Overall Study|Insufficient Therapeutic Response|83|||
149817980|NCT05266456|540463548|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
149817981|NCT05266456|540463545|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
149817982|NCT05266456|540463546|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
149817983|NCT05266456|540463547|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
149817984|NCT05266456|540463548|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
149817985|NCT01610167|540463549|FG000|Overall Study|Scheduling conflict.|0|||
149817986|NCT01610167|540463550|FG001|Overall Study|Scheduling conflict.|0|||
149817987|NCT01610167|540463551|FG002|Overall Study|Scheduling conflict.|2|||
149817988|NCT03276962|540463553|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
149817989|NCT03276962|540463554|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
149817990|NCT03276962|540463555|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
149817991|NCT03276962|540463556|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
149817992|NCT03276962|540463557|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
149817993|NCT03276962|540463553|FG000|Overall Study|Protocol Deviation|2|||
149817994|NCT03276962|540463554|FG001|Overall Study|Protocol Deviation|0|||
149817995|NCT03276962|540463555|FG002|Overall Study|Protocol Deviation|1|||
149817996|NCT03276962|540463556|FG003|Overall Study|Protocol Deviation|2|||
149817997|NCT03276962|540463557|FG004|Overall Study|Protocol Deviation|1|||
149817998|NCT03276962|540463553|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
149817999|NCT03276962|540463554|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
149818000|NCT03276962|540463555|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
149818001|NCT03276962|540463556|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
149818002|NCT03276962|540463557|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
149818003|NCT03276962|540463553|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
149818004|NCT03276962|540463554|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
149818005|NCT03276962|540463555|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
149818006|NCT03276962|540463556|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
149818007|NCT03276962|540463557|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
149818008|NCT03276962|540463553|FG000|Overall Study|Lost to Follow-up|10|||
149818009|NCT03276962|540463554|FG001|Overall Study|Lost to Follow-up|10|||
149818010|NCT03276962|540463555|FG002|Overall Study|Lost to Follow-up|4|||
149818011|NCT03276962|540463556|FG003|Overall Study|Lost to Follow-up|6|||
149818012|NCT03276962|540463557|FG004|Overall Study|Lost to Follow-up|10|||
149818013|NCT03276962|540463553|FG000|Overall Study|Other|0|||
149818014|NCT03276962|540463554|FG001|Overall Study|Other|2|||
149818015|NCT03276962|540463555|FG002|Overall Study|Other|0|||
149818016|NCT03276962|540463556|FG003|Overall Study|Other|2|||
149818017|NCT03276962|540463557|FG004|Overall Study|Other|1|||
149818018|NCT00411762|540463558|FG000|Overall Study|Withdrawal by Subject|5|||
149818019|NCT01238211|540463559|FG000|Overall Study|Continues active treatment|31|||
149818020|NCT01238211|540463559|FG000|Overall Study|Adverse Event|7|||
149818021|NCT01238211|540463559|FG000|Overall Study|Death|4|||
149818022|NCT01238211|540463559|FG000|Overall Study|Relapse/Progression|2|||
149818023|NCT01238211|540463559|FG000|Overall Study|Withdrawal by Subject|7|||
149818024|NCT01238211|540463559|FG000|Overall Study|Non-protocol treatment|4|||
149818025|NCT01238211|540463559|FG000|Overall Study|Investigator/Patient Decision|3|||
149818026|NCT04428502|540463560|FG000|Overall Study|Did not meet entrance criteria|14|||
149818027|NCT01358708|540463561|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
149818028|NCT01358708|540463562|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149818029|NCT01358708|540463561|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
149818030|NCT01358708|540463562|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
149818031|NCT03712228|540463566|FG000|Treatment Period 1|Lack of Efficacy|0|||
149818032|NCT03712228|540463567|FG001|Treatment Period 1|Lack of Efficacy|0|||
149818033|NCT03712228|540463568|FG002|Treatment Period 1|Lack of Efficacy|0|||
149818034|NCT03712228|540463569|FG003|Treatment Period 1|Lack of Efficacy|0|||
149818035|NCT03712228|540463570|FG004|Treatment Period 1|Lack of Efficacy|0|||
149818036|NCT03712228|540463571|FG005|Treatment Period 1|Lack of Efficacy|1|||
149818037|NCT03712228|540463566|FG000|Treatment Period 2|Pregnancy|0|||
149818038|NCT03712228|540463567|FG001|Treatment Period 2|Pregnancy|0|||
149818039|NCT03712228|540463568|FG002|Treatment Period 2|Pregnancy|0|||
149818040|NCT03712228|540463569|FG003|Treatment Period 2|Pregnancy|1|||
149818041|NCT03712228|540463570|FG004|Treatment Period 2|Pregnancy|0|||
149818042|NCT03712228|540463571|FG005|Treatment Period 2|Pregnancy|0|||
149818043|NCT03712228|540463566|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149818044|NCT03712228|540463567|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149818045|NCT03712228|540463568|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149818046|NCT03712228|540463569|FG003|Treatment Period 2|Withdrawal by Subject|1|||
149818047|NCT03712228|540463570|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149818048|NCT03712228|540463571|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149818049|NCT01964105|540463572|FG000|Overall Study|Lost to Follow-up|2|||
149818050|NCT01964105|540463573|FG001|Overall Study|Lost to Follow-up|13|||
149818051|NCT01964105|540463574|FG002|Overall Study|Lost to Follow-up|0|||
149818052|NCT01430104|540463575|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
149923624|NCT05052697|540855070|FG027|Substudy A|Not vaccinated|0|||
149923625|NCT05052697|540855071|FG028|Substudy A|Not vaccinated|0|||
149923626|NCT05052697|540855072|FG029|Substudy A|Not vaccinated|0|||
149923627|NCT05052697|540855073|FG030|Substudy A|Not vaccinated|0|||
149923628|NCT05052697|540855074|FG031|Substudy A|Not vaccinated|0|||
149923629|NCT05052697|540855075|FG032|Substudy A|Not vaccinated|0|||
149923630|NCT05052697|540855076|FG033|Substudy A|Not vaccinated|0|||
149923631|NCT05052697|540855043|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923632|NCT05052697|540855044|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923633|NCT05052697|540855045|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923634|NCT05052697|540855046|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923635|NCT05052697|540855047|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923636|NCT05052697|540855048|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923637|NCT05052697|540855049|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923638|NCT05052697|540855050|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923639|NCT05052697|540855051|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923640|NCT05052697|540855052|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923641|NCT05052697|540855053|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923642|NCT05052697|540855054|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923643|NCT05052697|540855055|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923644|NCT05052697|540855056|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923645|NCT05052697|540855057|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923646|NCT05052697|540855058|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923647|NCT05052697|540855059|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923648|NCT05052697|540855060|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923649|NCT05052697|540855061|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
149923650|NCT05052697|540855062|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
149923651|NCT05052697|540855063|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923652|NCT05052697|540855064|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
149923653|NCT05052697|540855065|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
149923654|NCT05052697|540855066|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923655|NCT05052697|540855067|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923656|NCT05052697|540855068|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923657|NCT05052697|540855069|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923658|NCT05052697|540855070|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923659|NCT05052697|540855071|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923660|NCT05052697|540855072|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923661|NCT05052697|540855073|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923662|NCT05052697|540855074|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923663|NCT05052697|540855075|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923664|NCT05052697|540855076|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149923665|NCT05052697|540855043|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923666|NCT05052697|540855044|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923667|NCT05052697|540855045|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923668|NCT05052697|540855046|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923669|NCT05052697|540855047|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923670|NCT05052697|540855048|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923671|NCT05052697|540855049|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923672|NCT05052697|540855050|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923673|NCT05052697|540855051|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923674|NCT05052697|540855052|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923675|NCT05052697|540855053|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923676|NCT05052697|540855054|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923677|NCT05052697|540855055|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923678|NCT05052697|540855056|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923679|NCT05052697|540855057|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923680|NCT05052697|540855058|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923681|NCT05052697|540855059|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923682|NCT05052697|540855060|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
149923683|NCT05052697|540855061|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923684|NCT05052697|540855062|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923685|NCT05052697|540855063|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923686|NCT05052697|540855064|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923687|NCT05052697|540855065|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923688|NCT05052697|540855066|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923689|NCT05052697|540855067|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923690|NCT05052697|540855068|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923691|NCT05052697|540855069|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923692|NCT05052697|540855070|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923693|NCT05052697|540855071|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923694|NCT05052697|540855072|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923695|NCT05052697|540855073|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923696|NCT05052697|540855074|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923697|NCT05052697|540855075|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923698|NCT05052697|540855076|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
149923699|NCT05052697|540855043|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923700|NCT05052697|540855044|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923701|NCT05052697|540855045|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923702|NCT05052697|540855046|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923703|NCT05052697|540855047|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923704|NCT05052697|540855048|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923705|NCT05052697|540855049|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923706|NCT05052697|540855050|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923707|NCT05052697|540855051|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923708|NCT05052697|540855052|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923709|NCT05052697|540855053|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923710|NCT05052697|540855054|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923711|NCT05052697|540855055|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923712|NCT05052697|540855056|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923713|NCT05052697|540855057|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923714|NCT05052697|540855058|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923715|NCT05052697|540855059|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923716|NCT05052697|540855060|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923717|NCT05052697|540855061|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923718|NCT05052697|540855062|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
149923719|NCT05052697|540855063|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923720|NCT05052697|540855064|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923721|NCT05052697|540855065|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923722|NCT05052697|540855066|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923723|NCT05052697|540855067|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923724|NCT05052697|540855068|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923725|NCT05052697|540855069|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923726|NCT05052697|540855070|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923727|NCT05052697|540855071|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923728|NCT05052697|540855072|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923729|NCT05052697|540855073|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923730|NCT05052697|540855074|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923731|NCT05052697|540855075|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923732|NCT05052697|540855076|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149923733|NCT05052697|540855043|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923734|NCT05052697|540855044|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923735|NCT05052697|540855045|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923736|NCT05052697|540855046|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923737|NCT05052697|540855047|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923738|NCT05052697|540855048|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923739|NCT05052697|540855049|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923740|NCT05052697|540855050|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923741|NCT05052697|540855051|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923742|NCT05052697|540855052|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923743|NCT05052697|540855053|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923744|NCT05052697|540855054|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923745|NCT05052697|540855055|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923746|NCT05052697|540855056|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923747|NCT05052697|540855057|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923748|NCT05052697|540855058|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923749|NCT05052697|540855059|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923750|NCT05052697|540855060|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
149923751|NCT05052697|540855061|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923752|NCT05052697|540855062|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923753|NCT05052697|540855063|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923754|NCT05052697|540855064|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923755|NCT05052697|540855065|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
150160905|NCT04454567|541723610|FG001|Overall Study|Study Terminated by Sponsor|1|||
149923756|NCT05052697|540855066|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923757|NCT05052697|540855067|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923758|NCT05052697|540855068|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
149923759|NCT05052697|540855069|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923760|NCT05052697|540855070|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
149923761|NCT05052697|540855071|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923762|NCT05052697|540855072|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923763|NCT05052697|540855073|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923764|NCT05052697|540855074|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923765|NCT05052697|540855075|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923766|NCT05052697|540855076|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
149923767|NCT05052697|540855043|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923768|NCT05052697|540855044|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923769|NCT05052697|540855045|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923770|NCT05052697|540855046|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923771|NCT05052697|540855047|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923772|NCT05052697|540855048|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923773|NCT05052697|540855049|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923774|NCT05052697|540855050|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923775|NCT05052697|540855051|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923776|NCT05052697|540855052|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923777|NCT05052697|540855053|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923778|NCT05052697|540855054|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923779|NCT05052697|540855055|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923780|NCT05052697|540855056|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923781|NCT05052697|540855057|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923782|NCT05052697|540855058|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923783|NCT05052697|540855059|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923784|NCT05052697|540855060|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923785|NCT05052697|540855061|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923786|NCT05052697|540855062|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923787|NCT05052697|540855063|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923788|NCT05052697|540855064|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923789|NCT05052697|540855065|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923790|NCT05052697|540855066|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923791|NCT05052697|540855067|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923792|NCT05052697|540855068|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923793|NCT05052697|540855069|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923794|NCT05052697|540855070|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923795|NCT05052697|540855071|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
149923796|NCT05052697|540855072|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923797|NCT05052697|540855073|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
149923798|NCT05052697|540855074|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
149923799|NCT05052697|540855075|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
149923800|NCT05052697|540855076|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
149923801|NCT05052697|540855043|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923802|NCT05052697|540855044|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923803|NCT05052697|540855045|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923804|NCT05052697|540855046|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923805|NCT05052697|540855047|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923806|NCT05052697|540855048|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923807|NCT05052697|540855049|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923808|NCT05052697|540855050|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923809|NCT05052697|540855051|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923810|NCT05052697|540855052|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923811|NCT05052697|540855053|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923812|NCT05052697|540855054|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923813|NCT05052697|540855055|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923814|NCT05052697|540855056|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923815|NCT05052697|540855057|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923816|NCT05052697|540855058|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923817|NCT05052697|540855059|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923818|NCT05052697|540855060|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923819|NCT05052697|540855061|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923820|NCT05052697|540855062|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923821|NCT05052697|540855063|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923822|NCT05052697|540855064|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923823|NCT05052697|540855065|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923824|NCT05052697|540855066|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923825|NCT05052697|540855067|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923826|NCT05052697|540855068|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923827|NCT05052697|540855069|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923828|NCT05052697|540855070|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923829|NCT05052697|540855071|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
149923830|NCT05052697|540855072|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
149923831|NCT05052697|540855073|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
149923832|NCT05052697|540855074|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
149923833|NCT05052697|540855075|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
149923834|NCT05052697|540855076|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
149923835|NCT05052697|540855043|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923836|NCT05052697|540855044|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923837|NCT05052697|540855045|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923838|NCT05052697|540855046|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923839|NCT05052697|540855047|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923840|NCT05052697|540855048|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923841|NCT05052697|540855049|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923842|NCT05052697|540855050|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923843|NCT05052697|540855051|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923844|NCT05052697|540855052|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923845|NCT05052697|540855053|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923846|NCT05052697|540855054|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923847|NCT05052697|540855055|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923848|NCT05052697|540855056|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923849|NCT05052697|540855057|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923850|NCT05052697|540855058|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923851|NCT05052697|540855059|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923852|NCT05052697|540855060|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923853|NCT05052697|540855061|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923854|NCT05052697|540855062|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923855|NCT05052697|540855063|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923856|NCT05052697|540855064|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923857|NCT05052697|540855065|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923858|NCT05052697|540855066|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923859|NCT05052697|540855067|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923860|NCT05052697|540855068|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923861|NCT05052697|540855069|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923862|NCT05052697|540855070|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923863|NCT05052697|540855071|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923864|NCT05052697|540855072|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923865|NCT05052697|540855073|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923866|NCT05052697|540855074|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923867|NCT05052697|540855075|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
149923868|NCT05052697|540855076|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
149923869|NCT05052697|540855043|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923870|NCT05052697|540855044|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923871|NCT05052697|540855045|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923872|NCT05052697|540855046|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923873|NCT05052697|540855047|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923874|NCT05052697|540855048|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923875|NCT05052697|540855049|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923876|NCT05052697|540855050|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923877|NCT05052697|540855051|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923878|NCT05052697|540855052|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923879|NCT05052697|540855053|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923880|NCT05052697|540855054|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923881|NCT05052697|540855055|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923882|NCT05052697|540855056|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923883|NCT05052697|540855057|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923884|NCT05052697|540855058|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923885|NCT05052697|540855059|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923886|NCT05052697|540855060|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923887|NCT05052697|540855061|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923888|NCT05052697|540855062|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923889|NCT05052697|540855063|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923890|NCT05052697|540855064|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923891|NCT05052697|540855065|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923892|NCT05052697|540855066|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923893|NCT05052697|540855067|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923894|NCT05052697|540855068|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923895|NCT05052697|540855069|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923896|NCT05052697|540855070|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923897|NCT05052697|540855071|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
149818053|NCT05288673|540463576|FG000|Overall Study|Consent withdrawn by subject|0|||
149818054|NCT05288673|540463577|FG001|Overall Study|Consent withdrawn by subject|0|||
149818055|NCT05288673|540463578|FG002|Overall Study|Consent withdrawn by subject|1|||
149818056|NCT00579254|540463584|FG000|Overall Study|Lost to Follow-up|39|||
149818057|NCT00579254|540463584|FG000|Overall Study|Discontinued when study terminated|73|||
149818058|NCT02557672|540463585|FG000|Overall Study|Withdrawal by Subject|4|||
149818059|NCT02557672|540463586|FG001|Overall Study|Withdrawal by Subject|2|||
149818060|NCT00343642|540465349|FG000|Overall Study|Lost to Follow-up|0|||
149818061|NCT00343642|540465350|FG001|Overall Study|Lost to Follow-up|1|||
149818062|NCT00343642|540465351|FG002|Overall Study|Lost to Follow-up|0|||
149818063|NCT00343642|540465349|FG000|Overall Study|Pregnancy|1|||
149818064|NCT00343642|540465350|FG001|Overall Study|Pregnancy|0|||
149818065|NCT00343642|540465351|FG002|Overall Study|Pregnancy|2|||
149818066|NCT00343642|540465349|FG000|Overall Study|Withdrawal by Subject|2|||
149818067|NCT00343642|540465350|FG001|Overall Study|Withdrawal by Subject|3|||
149818068|NCT00343642|540465351|FG002|Overall Study|Withdrawal by Subject|4|||
149818069|NCT00343642|540465349|FG000|Overall Study|Adverse Event|0|||
149818070|NCT00343642|540465350|FG001|Overall Study|Adverse Event|0|||
149818071|NCT00343642|540465351|FG002|Overall Study|Adverse Event|1|||
149818072|NCT00343642|540465349|FG000|Overall Study|Flare up|6|||
149818073|NCT00343642|540465350|FG001|Overall Study|Flare up|4|||
149818074|NCT00343642|540465351|FG002|Overall Study|Flare up|0|||
149818075|NCT00766506|540465354|FG000|Overall Study|Use rescue medication after 3 hours|3|||
149818076|NCT00766506|540465355|FG001|Overall Study|Use rescue medication after 3 hours|0|||
149818077|NCT00766506|540465354|FG000|Overall Study|Other|2|||
149818078|NCT00766506|540465355|FG001|Overall Study|Other|2|||
149818079|NCT00860574|540465356|FG000|Overall Study|Death|2|||
149818080|NCT00860574|540465356|FG000|Overall Study|Relapse|1|||
149818081|NCT03262233|540465358|FG000|Overall Study|Withdrawal by Subject|12|||
149818082|NCT03262233|540465359|FG001|Overall Study|Withdrawal by Subject|8|||
149818083|NCT03262233|540465360|FG002|Overall Study|Withdrawal by Subject|21|||
149818084|NCT03262233|540465361|FG003|Overall Study|Withdrawal by Subject|13|||
149818085|NCT03262233|540465358|FG000|Overall Study|Declined due to shock|1|||
149818086|NCT03262233|540465359|FG001|Overall Study|Declined due to shock|2|||
149818087|NCT03262233|540465360|FG002|Overall Study|Declined due to shock|2|||
149818088|NCT03262233|540465361|FG003|Overall Study|Declined due to shock|3|||
149818089|NCT03262233|540465358|FG000|Overall Study|Protocol Violation|5|||
149818090|NCT03262233|540465359|FG001|Overall Study|Protocol Violation|10|||
149818091|NCT03262233|540465360|FG002|Overall Study|Protocol Violation|2|||
149818092|NCT03262233|540465361|FG003|Overall Study|Protocol Violation|13|||
149818093|NCT03262233|540465358|FG000|Overall Study|data collection artifact|0|||
149818094|NCT03262233|540465359|FG001|Overall Study|data collection artifact|1|||
149818095|NCT03262233|540465360|FG002|Overall Study|data collection artifact|0|||
149818096|NCT03262233|540465361|FG003|Overall Study|data collection artifact|0|||
149818097|NCT03877237|540465362|FG000|Overall Study|Adverse Event|1|||
149818098|NCT03877237|540465363|FG001|Overall Study|Adverse Event|2|||
149818099|NCT03877237|540465362|FG000|Overall Study|Death|3|||
149818100|NCT03877237|540465363|FG001|Overall Study|Death|2|||
149818101|NCT03877237|540465362|FG000|Overall Study|Physician Decision|1|||
149818102|NCT03877237|540465363|FG001|Overall Study|Physician Decision|0|||
149818103|NCT03877237|540465362|FG000|Overall Study|Withdrawal by Subject|0|||
149818104|NCT03877237|540465363|FG001|Overall Study|Withdrawal by Subject|2|||
149818105|NCT03372083|540465364|FG000|Overall Study|Adverse Event|3|||
149818106|NCT03372083|540465364|FG000|Overall Study|Physician Decision|1|||
149818107|NCT03372083|540465364|FG000|Overall Study|Withdrawal by Subject|1|||
149818108|NCT02544633|540465365|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
149818109|NCT02544633|540465366|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
149818110|NCT02544633|540465367|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
149818111|NCT02544633|540465368|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
149818112|NCT02544633|540465365|FG000|Treatment Period|Adverse Event|7|||
149818113|NCT02544633|540465366|FG001|Treatment Period|Adverse Event|4|||
149818114|NCT02544633|540465367|FG002|Treatment Period|Adverse Event|0|||
149818115|NCT02544633|540465368|FG003|Treatment Period|Adverse Event|5|||
149818116|NCT02544633|540465365|FG000|Treatment Period|Lack of Efficacy|17|||
149818117|NCT02544633|540465366|FG001|Treatment Period|Lack of Efficacy|11|||
149818118|NCT02544633|540465367|FG002|Treatment Period|Lack of Efficacy|5|||
149818119|NCT02544633|540465368|FG003|Treatment Period|Lack of Efficacy|5|||
149818120|NCT02544633|540465365|FG000|Treatment Period|Global Deterioration of Health|3|||
149818121|NCT02544633|540465366|FG001|Treatment Period|Global Deterioration of Health|3|||
149818122|NCT02544633|540465367|FG002|Treatment Period|Global Deterioration of Health|0|||
149818123|NCT02544633|540465368|FG003|Treatment Period|Global Deterioration of Health|1|||
149818124|NCT02544633|540465365|FG000|Treatment Period|Withdrawal by Subject|1|||
149818125|NCT02544633|540465366|FG001|Treatment Period|Withdrawal by Subject|0|||
149818126|NCT02544633|540465367|FG002|Treatment Period|Withdrawal by Subject|0|||
149818127|NCT02544633|540465368|FG003|Treatment Period|Withdrawal by Subject|0|||
149818128|NCT02544633|540465365|FG000|Treatment Period|Lost to Follow-up|0|||
149818129|NCT02544633|540465366|FG001|Treatment Period|Lost to Follow-up|1|||
149818130|NCT02544633|540465367|FG002|Treatment Period|Lost to Follow-up|0|||
149923898|NCT05052697|540855072|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
149923899|NCT05052697|540855073|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
149923900|NCT05052697|540855074|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923901|NCT05052697|540855075|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923902|NCT05052697|540855076|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
149923903|NCT01289574|540855079|FG000|Overall Study|Lack of Efficacy|4|||
149923904|NCT01289574|540855080|FG001|Overall Study|Lack of Efficacy|0|||
149923905|NCT01289574|540855081|FG002|Overall Study|Lack of Efficacy|1|||
149923906|NCT01289574|540855079|FG000|Overall Study|Lost to Follow-up|2|||
149923907|NCT01289574|540855080|FG001|Overall Study|Lost to Follow-up|0|||
149923908|NCT01289574|540855081|FG002|Overall Study|Lost to Follow-up|1|||
149923909|NCT01289574|540855079|FG000|Overall Study|Withdrawal by Subject|1|||
149923910|NCT01289574|540855080|FG001|Overall Study|Withdrawal by Subject|1|||
149923911|NCT01289574|540855081|FG002|Overall Study|Withdrawal by Subject|1|||
149923912|NCT01289574|540855079|FG000|Overall Study|Adverse Event|0|||
149923913|NCT01289574|540855080|FG001|Overall Study|Adverse Event|1|||
149923914|NCT01289574|540855081|FG002|Overall Study|Adverse Event|0|||
149923915|NCT01289574|540855079|FG000|Overall Study|Subject wanted alternate treatment|0|||
149923916|NCT01289574|540855080|FG001|Overall Study|Subject wanted alternate treatment|1|||
149923917|NCT01289574|540855081|FG002|Overall Study|Subject wanted alternate treatment|0|||
149923918|NCT01402986|540855082|FG000|Overall Study|Withdrawal by Subject|7|||
149923919|NCT01402986|540855083|FG001|Overall Study|Withdrawal by Subject|10|||
149923920|NCT01402986|540855084|FG002|Overall Study|Withdrawal by Subject|7|||
149923921|NCT01402986|540855085|FG003|Overall Study|Withdrawal by Subject|13|||
149923922|NCT01402986|540855082|FG000|Overall Study|Death|0|||
149923923|NCT01402986|540855083|FG001|Overall Study|Death|0|||
149923924|NCT01402986|540855084|FG002|Overall Study|Death|0|||
149923925|NCT01402986|540855085|FG003|Overall Study|Death|2|||
149923926|NCT01402986|540855082|FG000|Overall Study|Lost to Follow-up|0|||
149923927|NCT01402986|540855083|FG001|Overall Study|Lost to Follow-up|0|||
149923928|NCT01402986|540855084|FG002|Overall Study|Lost to Follow-up|0|||
149923929|NCT01402986|540855085|FG003|Overall Study|Lost to Follow-up|1|||
149923930|NCT01402986|540855082|FG000|Overall Study|Other|2|||
149923931|NCT01402986|540855083|FG001|Overall Study|Other|5|||
149923932|NCT01402986|540855084|FG002|Overall Study|Other|1|||
149923933|NCT01402986|540855085|FG003|Overall Study|Other|6|||
149923934|NCT02634983|540855086|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
149923935|NCT02634983|540855087|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
149923936|NCT02226120|540855088|FG000|Overall Study|Adverse Event|60|||
149923937|NCT02226120|540855088|FG000|Overall Study|Death|172|||
149923938|NCT02226120|540855088|FG000|Overall Study|Study terminated by sponsor|1|||
149923939|NCT02226120|540855088|FG000|Overall Study|Technical problems|4|||
149923940|NCT02226120|540855088|FG000|Overall Study|Lost to Follow-up|13|||
149923941|NCT02226120|540855088|FG000|Overall Study|Physician Decision|21|||
149923942|NCT02226120|540855088|FG000|Overall Study|Withdrawal by parent/guardian|36|||
149923943|NCT02226120|540855088|FG000|Overall Study|Non-compliance with study drug|10|||
149923944|NCT02226120|540855088|FG000|Overall Study|Protocol deviation|1|||
149923945|NCT02226120|540855088|FG000|Overall Study|missing treatment disposition pages|2|||
149923946|NCT02669043|540855093|FG000|Overall Study|Didn't meet I/E criteria|4|||
149923947|NCT00467558|540855097|FG000|Overall Study|Lost to Follow-up|2|||
149923948|NCT00467558|540855098|FG001|Overall Study|Lost to Follow-up|0|||
149923949|NCT02636439|540855100|FG000|Overall Study|Adverse Event|2|||
149923950|NCT02636439|540855101|FG001|Overall Study|Adverse Event|2|||
150160906|NCT01123161|541723615|FG000|Overall Study|Lost to Follow-up|1|||
150160907|NCT01123161|541723616|FG001|Overall Study|Lost to Follow-up|0|||
150160908|NCT01123161|541723615|FG000|Overall Study|Withdrawal by Subject|1|||
150160909|NCT01123161|541723616|FG001|Overall Study|Withdrawal by Subject|0|||
149818131|NCT02544633|540465368|FG003|Treatment Period|Lost to Follow-up|0|||
149818132|NCT02544633|540465365|FG000|Treatment Period|Death|0|||
149818133|NCT02544633|540465366|FG001|Treatment Period|Death|0|||
149818134|NCT02544633|540465367|FG002|Treatment Period|Death|1|||
149818135|NCT02544633|540465368|FG003|Treatment Period|Death|0|||
149818136|NCT02544633|540465365|FG000|Treatment Period|Non-compliance|0|||
149818137|NCT02544633|540465366|FG001|Treatment Period|Non-compliance|0|||
149818138|NCT02544633|540465367|FG002|Treatment Period|Non-compliance|1|||
149818139|NCT02544633|540465368|FG003|Treatment Period|Non-compliance|0|||
149818140|NCT02544633|540465365|FG000|Treatment Period|Clinical Disease Progression|0|||
149818141|NCT02544633|540465366|FG001|Treatment Period|Clinical Disease Progression|0|||
149818142|NCT02544633|540465367|FG002|Treatment Period|Clinical Disease Progression|0|||
149818143|NCT02544633|540465368|FG003|Treatment Period|Clinical Disease Progression|1|||
149818144|NCT02544633|540465365|FG000|Survival Follow-up Period|Death|12|||
149818145|NCT02544633|540465366|FG001|Survival Follow-up Period|Death|14|||
149818146|NCT02544633|540465367|FG002|Survival Follow-up Period|Death|3|||
149923951|NCT02636439|540855100|FG000|Overall Study|Lost to Follow-up|1|||
150160910|NCT02459964|541723617|FG000|Overall Study|Withdrawal by Subject|0|||
149818147|NCT02544633|540465368|FG003|Survival Follow-up Period|Death|9|||
149923952|NCT02636439|540855101|FG001|Overall Study|Lost to Follow-up|0|||
149923953|NCT02636439|540855100|FG000|Overall Study|Non-compliance|1|||
149923954|NCT02636439|540855101|FG001|Overall Study|Non-compliance|1|||
149923955|NCT02636439|540855100|FG000|Overall Study|Personal reasons|2|||
149923956|NCT02636439|540855101|FG001|Overall Study|Personal reasons|0|||
149923957|NCT02494401|540855102|FG000|Overall Study|Lost to Follow-up|22|||
149923958|NCT02494401|540855103|FG001|Overall Study|Lost to Follow-up|25|||
149923959|NCT02494401|540855102|FG000|Overall Study|Withdrawal by Subject|3|||
149923960|NCT02494401|540855103|FG001|Overall Study|Withdrawal by Subject|2|||
149923961|NCT05188729|540855104|FG000|Overall Study|Withdrawal by Subject|0|||
149923962|NCT05188729|540855105|FG001|Overall Study|Withdrawal by Subject|0|||
149923963|NCT05188729|540855106|FG002|Overall Study|Withdrawal by Subject|0|||
149923964|NCT05188729|540855107|FG003|Overall Study|Withdrawal by Subject|0|||
149923965|NCT05188729|540855108|FG004|Overall Study|Withdrawal by Subject|0|||
149923966|NCT05188729|540855109|FG005|Overall Study|Withdrawal by Subject|0|||
149923967|NCT05188729|540855110|FG006|Overall Study|Withdrawal by Subject|0|||
149923968|NCT05188729|540855111|FG007|Overall Study|Withdrawal by Subject|0|||
149923969|NCT05188729|540855112|FG008|Overall Study|Withdrawal by Subject|0|||
149923970|NCT05188729|540855113|FG009|Overall Study|Withdrawal by Subject|1|||
149923971|NCT05188729|540855114|FG010|Overall Study|Withdrawal by Subject|0|||
149923972|NCT05188729|540855115|FG011|Overall Study|Withdrawal by Subject|0|||
149923973|NCT05188729|540855116|FG012|Overall Study|Withdrawal by Subject|0|||
149923974|NCT05188729|540855104|FG000|Overall Study|Lost to Follow-up|0|||
149923975|NCT05188729|540855105|FG001|Overall Study|Lost to Follow-up|0|||
149923976|NCT05188729|540855106|FG002|Overall Study|Lost to Follow-up|0|||
149923977|NCT05188729|540855107|FG003|Overall Study|Lost to Follow-up|0|||
149923978|NCT05188729|540855108|FG004|Overall Study|Lost to Follow-up|0|||
149923979|NCT05188729|540855109|FG005|Overall Study|Lost to Follow-up|0|||
149923980|NCT05188729|540855110|FG006|Overall Study|Lost to Follow-up|0|||
149923981|NCT05188729|540855111|FG007|Overall Study|Lost to Follow-up|0|||
149923982|NCT05188729|540855112|FG008|Overall Study|Lost to Follow-up|0|||
149923983|NCT05188729|540855113|FG009|Overall Study|Lost to Follow-up|0|||
149923984|NCT05188729|540855114|FG010|Overall Study|Lost to Follow-up|1|||
149923985|NCT05188729|540855115|FG011|Overall Study|Lost to Follow-up|1|||
149923986|NCT05188729|540855116|FG012|Overall Study|Lost to Follow-up|0|||
149923987|NCT02849704|540857263|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
149923988|NCT02849704|540857264|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
149923989|NCT02849704|540857263|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
149923990|NCT02849704|540857264|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
149923991|NCT02849704|540857263|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
149923992|NCT02849704|540857264|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
149923993|NCT03638466|540857266|FG000|Overall Study|Early Termination|0|||
149923994|NCT03638466|540857267|FG001|Overall Study|Early Termination|1|||
149923995|NCT03251482|540857268|FG000|Overall Study|Withdrawal by Subject|0|||
149923996|NCT03251482|540857269|FG001|Overall Study|Withdrawal by Subject|1|||
149923997|NCT03251482|540857270|FG002|Overall Study|Withdrawal by Subject|0|||
149923998|NCT03251482|540857271|FG003|Overall Study|Withdrawal by Subject|0|||
149923999|NCT03251482|540857272|FG004|Overall Study|Withdrawal by Subject|0|||
149924000|NCT02447328|540857275|FG000|Overall Study|Withdrawal by Subject|1|||
149924001|NCT02155309|540857279|FG000|Overall Study|Protocol Violation|0|||
149924002|NCT02155309|540857280|FG001|Overall Study|Protocol Violation|0|||
149924003|NCT02155309|540857281|FG002|Overall Study|Protocol Violation|1|||
149924004|NCT00802672|540857282|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
149924005|NCT00802672|540857283|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
149924006|NCT00802672|540857284|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
149924007|NCT00802672|540857282|FG000|Overall Study|Adverse Event|1|||
149924008|NCT00802672|540857283|FG001|Overall Study|Adverse Event|1|||
149924009|NCT00802672|540857284|FG002|Overall Study|Adverse Event|1|||
149924010|NCT00802672|540857282|FG000|Overall Study|Protocol Violation|2|||
149924011|NCT00802672|540857283|FG001|Overall Study|Protocol Violation|1|||
149924012|NCT00802672|540857284|FG002|Overall Study|Protocol Violation|1|||
149924013|NCT00802672|540857282|FG000|Overall Study|Lost to Follow-up|5|||
149924014|NCT00802672|540857283|FG001|Overall Study|Lost to Follow-up|5|||
149924015|NCT00802672|540857284|FG002|Overall Study|Lost to Follow-up|3|||
149924016|NCT00802672|540857282|FG000|Overall Study|Withdrawal by Subject|1|||
149924017|NCT00802672|540857283|FG001|Overall Study|Withdrawal by Subject|1|||
149924018|NCT00802672|540857284|FG002|Overall Study|Withdrawal by Subject|2|||
149924019|NCT00802672|540857282|FG000|Overall Study|other|3|||
149924020|NCT00802672|540857283|FG001|Overall Study|other|1|||
149924021|NCT00802672|540857284|FG002|Overall Study|other|2|||
149924022|NCT02579382|540857288|FG000|Main Study Phase|Lost to Follow-up|0|||
149924023|NCT02579382|540857289|FG001|Main Study Phase|Lost to Follow-up|0|||
149924024|NCT02579382|540857290|FG002|Main Study Phase|Lost to Follow-up|2|||
149924025|NCT02579382|540857291|FG003|Main Study Phase|Lost to Follow-up|0|||
149924026|NCT02579382|540857288|FG000|Main Study Phase|Withdrew Consent|0|||
149924027|NCT02579382|540857289|FG001|Main Study Phase|Withdrew Consent|0|||
149924028|NCT02579382|540857290|FG002|Main Study Phase|Withdrew Consent|0|||
149924029|NCT02579382|540857291|FG003|Main Study Phase|Withdrew Consent|2|||
149924030|NCT02579382|540857288|FG000|Main Study Phase|Lack of Efficacy|0|||
149924031|NCT02579382|540857289|FG001|Main Study Phase|Lack of Efficacy|0|||
149924032|NCT02579382|540857290|FG002|Main Study Phase|Lack of Efficacy|0|||
149924033|NCT02579382|540857291|FG003|Main Study Phase|Lack of Efficacy|1|||
149924034|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
149924035|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
149924036|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
149924037|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
149924038|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
149924039|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
149924040|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
149924041|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
149924042|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
149924043|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
149924044|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
149924045|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
149924046|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
149924047|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
149924048|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
149924049|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
149924050|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
149924051|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
149924052|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
149924053|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
149924054|NCT02579382|540857288|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
149924055|NCT02579382|540857289|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
149924056|NCT02579382|540857290|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
149924057|NCT02579382|540857291|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
149924058|NCT04336475|540857292|FG000|Overall Study|pain|1|||
149924059|NCT04336475|540857293|FG001|Overall Study|pain|0|||
149924060|NCT04336475|540857292|FG000|Overall Study|upper respiratory infection|1|||
149924061|NCT04336475|540857293|FG001|Overall Study|upper respiratory infection|0|||
149924062|NCT04336475|540857292|FG000|Overall Study|Lost to Follow-up|0|||
149924063|NCT04336475|540857293|FG001|Overall Study|Lost to Follow-up|2|||
149924064|NCT01990573|540857298|FG000|Overall Study|Physician Decision|0|||
149924065|NCT01990573|540857299|FG001|Overall Study|Physician Decision|0|||
149924066|NCT01990573|540857300|FG002|Overall Study|Physician Decision|1|||
149924067|NCT02906579|540857312|FG000|Overall Study|Adverse Event|1|||
149924068|NCT02906579|540857312|FG000|Overall Study|Physician Decision|1|||
149924069|NCT02030119|540857313|FG000|Overall Study|Withdrawal by Subject|3|||
149924070|NCT02030119|540857314|FG001|Overall Study|Withdrawal by Subject|1|||
149924071|NCT02030119|540857315|FG002|Overall Study|Withdrawal by Subject|5|||
149924072|NCT02030119|540857316|FG003|Overall Study|Withdrawal by Subject|3|||
149924073|NCT02030119|540857313|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
149924074|NCT02030119|540857314|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
149924075|NCT02030119|540857315|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
149924076|NCT02030119|540857316|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
149924077|NCT00759655|540857317|FG000|Overall Study|Termination of the study by sponsor|1|||
149924078|NCT03130959|540857327|FG000|Overall Study|Disease progression|19|||
149924079|NCT03130959|540857328|FG001|Overall Study|Disease progression|7|||
149924080|NCT03130959|540857329|FG002|Overall Study|Disease progression|12|||
149924081|NCT03130959|540857330|FG003|Overall Study|Disease progression|7|||
149924082|NCT03130959|540857331|FG004|Overall Study|Disease progression|12|||
149924083|NCT03130959|540857332|FG005|Overall Study|Disease progression|3|||
149924084|NCT03130959|540857333|FG006|Overall Study|Disease progression|6|||
149924085|NCT03130959|540857334|FG007|Overall Study|Disease progression|3|||
149924086|NCT03130959|540857335|FG008|Overall Study|Disease progression|15|||
149924087|NCT03130959|540857336|FG009|Overall Study|Disease progression|8|||
149924088|NCT03130959|540857327|FG000|Overall Study|Study drug toxicity|2|||
149924089|NCT03130959|540857328|FG001|Overall Study|Study drug toxicity|2|||
149924090|NCT03130959|540857329|FG002|Overall Study|Study drug toxicity|1|||
149924091|NCT03130959|540857330|FG003|Overall Study|Study drug toxicity|2|||
149924092|NCT03130959|540857331|FG004|Overall Study|Study drug toxicity|1|||
149924093|NCT03130959|540857332|FG005|Overall Study|Study drug toxicity|1|||
149924094|NCT03130959|540857333|FG006|Overall Study|Study drug toxicity|3|||
149924095|NCT03130959|540857334|FG007|Overall Study|Study drug toxicity|0|||
149924096|NCT03130959|540857335|FG008|Overall Study|Study drug toxicity|3|||
149924097|NCT03130959|540857336|FG009|Overall Study|Study drug toxicity|3|||
149924098|NCT03130959|540857327|FG000|Overall Study|Other reasons|0|||
149924099|NCT03130959|540857328|FG001|Overall Study|Other reasons|0|||
149924100|NCT03130959|540857329|FG002|Overall Study|Other reasons|0|||
149924101|NCT03130959|540857330|FG003|Overall Study|Other reasons|0|||
149924102|NCT03130959|540857331|FG004|Overall Study|Other reasons|0|||
149924103|NCT03130959|540857332|FG005|Overall Study|Other reasons|1|||
149924104|NCT03130959|540857333|FG006|Overall Study|Other reasons|1|||
149924105|NCT03130959|540857334|FG007|Overall Study|Other reasons|0|||
149924106|NCT03130959|540857335|FG008|Overall Study|Other reasons|0|||
149924107|NCT03130959|540857336|FG009|Overall Study|Other reasons|0|||
149924108|NCT03130959|540857327|FG000|Overall Study|Subject request to discontinue therapy|0|||
149924109|NCT03130959|540857328|FG001|Overall Study|Subject request to discontinue therapy|0|||
149924110|NCT03130959|540857329|FG002|Overall Study|Subject request to discontinue therapy|1|||
149924111|NCT03130959|540857330|FG003|Overall Study|Subject request to discontinue therapy|1|||
149924112|NCT03130959|540857331|FG004|Overall Study|Subject request to discontinue therapy|0|||
149924113|NCT03130959|540857332|FG005|Overall Study|Subject request to discontinue therapy|0|||
149924114|NCT03130959|540857333|FG006|Overall Study|Subject request to discontinue therapy|1|||
149924115|NCT03130959|540857334|FG007|Overall Study|Subject request to discontinue therapy|1|||
149924116|NCT03130959|540857335|FG008|Overall Study|Subject request to discontinue therapy|0|||
149818148|NCT02544633|540465365|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
149818149|NCT02544633|540465366|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
149818150|NCT02544633|540465367|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
149818151|NCT02544633|540465368|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
149818152|NCT02544633|540465365|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
149818153|NCT02544633|540465366|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
149818154|NCT02544633|540465367|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
149818155|NCT02544633|540465368|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
149818156|NCT02544633|540465365|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
149818157|NCT02544633|540465366|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
149818158|NCT02544633|540465367|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
149818159|NCT02544633|540465368|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
149818160|NCT02092961|540465369|FG000|Overall Study|Not reported|1|||
149818161|NCT02092961|540465370|FG001|Overall Study|Not reported|0|||
149818162|NCT02092961|540465371|FG002|Overall Study|Not reported|1|||
149818163|NCT02092961|540465369|FG000|Overall Study|Study stopped|13|||
149818164|NCT02092961|540465370|FG001|Overall Study|Study stopped|9|||
149818165|NCT02092961|540465371|FG002|Overall Study|Study stopped|12|||
149818166|NCT02092961|540465369|FG000|Overall Study|Lack of therapeutic response|2|||
149818167|NCT02092961|540465370|FG001|Overall Study|Lack of therapeutic response|1|||
149818168|NCT02092961|540465371|FG002|Overall Study|Lack of therapeutic response|3|||
149818169|NCT02092961|540465369|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
149818170|NCT02092961|540465370|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
149818171|NCT02092961|540465371|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
149818172|NCT02092961|540465369|FG000|Overall Study|Adverse Event|2|||
149818173|NCT02092961|540465370|FG001|Overall Study|Adverse Event|4|||
149818174|NCT02092961|540465371|FG002|Overall Study|Adverse Event|0|||
149818175|NCT02270983|540465372|FG000|Overall Study|Adverse Event|3|||
149818176|NCT02270983|540465373|FG001|Overall Study|Adverse Event|2|||
149818177|NCT02270983|540465374|FG002|Overall Study|Adverse Event|6|||
149818178|NCT02270983|540465372|FG000|Overall Study|Lack of Efficacy|2|||
149818179|NCT02270983|540465373|FG001|Overall Study|Lack of Efficacy|1|||
149818180|NCT02270983|540465374|FG002|Overall Study|Lack of Efficacy|1|||
149818181|NCT02270983|540465372|FG000|Overall Study|Withdrawal by Subject|1|||
149818182|NCT02270983|540465373|FG001|Overall Study|Withdrawal by Subject|0|||
149818183|NCT02270983|540465374|FG002|Overall Study|Withdrawal by Subject|2|||
149818184|NCT02270983|540465372|FG000|Overall Study|Lost to Follow-up|1|||
149818185|NCT02270983|540465373|FG001|Overall Study|Lost to Follow-up|1|||
149818186|NCT02270983|540465374|FG002|Overall Study|Lost to Follow-up|2|||
149818187|NCT02270983|540465372|FG000|Overall Study|Protocol Violation|1|||
149818188|NCT02270983|540465373|FG001|Overall Study|Protocol Violation|1|||
149818189|NCT02270983|540465374|FG002|Overall Study|Protocol Violation|1|||
149818190|NCT02270983|540465372|FG000|Overall Study|family emergency|0|||
149818191|NCT02270983|540465373|FG001|Overall Study|family emergency|1|||
149818192|NCT02270983|540465374|FG002|Overall Study|family emergency|0|||
149818193|NCT02270983|540465372|FG000|Overall Study|study procedure non-compliance|1|||
149818194|NCT02270983|540465373|FG001|Overall Study|study procedure non-compliance|0|||
149818195|NCT02270983|540465374|FG002|Overall Study|study procedure non-compliance|0|||
149818196|NCT02270983|540465372|FG000|Overall Study|moved away from study site|0|||
149818197|NCT02270983|540465373|FG001|Overall Study|moved away from study site|1|||
149818198|NCT02270983|540465374|FG002|Overall Study|moved away from study site|0|||
149818199|NCT01623830|540465377|FG000|Overall Study|Withdrawal by Subject|6|||
149818200|NCT01623830|540465378|FG001|Overall Study|Withdrawal by Subject|7|||
149818201|NCT01623830|540465377|FG000|Overall Study|Exclusion from Study|1|||
149818202|NCT01623830|540465378|FG001|Overall Study|Exclusion from Study|2|||
149818203|NCT00928252|540465379|FG000|Overall Study|Physician Decision|3|||
149818204|NCT01605461|540465380|FG000|Overall Study|Lost to Follow-up|3|||
149924117|NCT03130959|540857336|FG009|Overall Study|Subject request to discontinue therapy|0|||
149924118|NCT03130959|540857327|FG000|Overall Study|Not reported|0|||
149924119|NCT03130959|540857328|FG001|Overall Study|Not reported|0|||
149924120|NCT03130959|540857329|FG002|Overall Study|Not reported|0|||
149924121|NCT03130959|540857330|FG003|Overall Study|Not reported|1|||
149924122|NCT03130959|540857331|FG004|Overall Study|Not reported|0|||
149924123|NCT03130959|540857332|FG005|Overall Study|Not reported|1|||
149924124|NCT03130959|540857333|FG006|Overall Study|Not reported|0|||
149924125|NCT03130959|540857334|FG007|Overall Study|Not reported|0|||
149924126|NCT03130959|540857335|FG008|Overall Study|Not reported|0|||
149924127|NCT03130959|540857336|FG009|Overall Study|Not reported|1|||
149924128|NCT03130959|540857327|FG000|Overall Study|Adverse Event unrelated to drug|0|||
149924129|NCT03130959|540857328|FG001|Overall Study|Adverse Event unrelated to drug|0|||
149924130|NCT03130959|540857329|FG002|Overall Study|Adverse Event unrelated to drug|1|||
149924131|NCT03130959|540857330|FG003|Overall Study|Adverse Event unrelated to drug|1|||
149924132|NCT03130959|540857331|FG004|Overall Study|Adverse Event unrelated to drug|1|||
149924133|NCT03130959|540857332|FG005|Overall Study|Adverse Event unrelated to drug|0|||
149924134|NCT03130959|540857333|FG006|Overall Study|Adverse Event unrelated to drug|1|||
149924135|NCT03130959|540857334|FG007|Overall Study|Adverse Event unrelated to drug|0|||
149924136|NCT03130959|540857335|FG008|Overall Study|Adverse Event unrelated to drug|1|||
149924137|NCT03130959|540857336|FG009|Overall Study|Adverse Event unrelated to drug|1|||
149924138|NCT03130959|540857327|FG000|Overall Study|Participant withdrew consent|0|||
149924139|NCT03130959|540857328|FG001|Overall Study|Participant withdrew consent|1|||
149924140|NCT03130959|540857329|FG002|Overall Study|Participant withdrew consent|0|||
149924141|NCT03130959|540857330|FG003|Overall Study|Participant withdrew consent|2|||
149924142|NCT03130959|540857331|FG004|Overall Study|Participant withdrew consent|1|||
149924143|NCT03130959|540857332|FG005|Overall Study|Participant withdrew consent|0|||
149924144|NCT03130959|540857333|FG006|Overall Study|Participant withdrew consent|0|||
149924145|NCT03130959|540857334|FG007|Overall Study|Participant withdrew consent|0|||
149924146|NCT03130959|540857335|FG008|Overall Study|Participant withdrew consent|0|||
149924147|NCT03130959|540857336|FG009|Overall Study|Participant withdrew consent|2|||
149924148|NCT03130959|540857327|FG000|Overall Study|Administrative reason by sponsor|1|||
149924149|NCT03130959|540857328|FG001|Overall Study|Administrative reason by sponsor|0|||
149924150|NCT03130959|540857329|FG002|Overall Study|Administrative reason by sponsor|1|||
149924151|NCT03130959|540857330|FG003|Overall Study|Administrative reason by sponsor|0|||
149924152|NCT03130959|540857331|FG004|Overall Study|Administrative reason by sponsor|0|||
149924153|NCT03130959|540857332|FG005|Overall Study|Administrative reason by sponsor|0|||
149924154|NCT03130959|540857333|FG006|Overall Study|Administrative reason by sponsor|0|||
149924155|NCT03130959|540857334|FG007|Overall Study|Administrative reason by sponsor|0|||
149924156|NCT03130959|540857335|FG008|Overall Study|Administrative reason by sponsor|0|||
149924157|NCT03130959|540857336|FG009|Overall Study|Administrative reason by sponsor|0|||
149924158|NCT03130959|540857327|FG000|Overall Study|Lost to Follow-up|1|||
149924159|NCT03130959|540857328|FG001|Overall Study|Lost to Follow-up|0|||
149924160|NCT03130959|540857329|FG002|Overall Study|Lost to Follow-up|0|||
149924161|NCT03130959|540857330|FG003|Overall Study|Lost to Follow-up|0|||
149924162|NCT03130959|540857331|FG004|Overall Study|Lost to Follow-up|0|||
149924163|NCT03130959|540857332|FG005|Overall Study|Lost to Follow-up|0|||
149924164|NCT03130959|540857333|FG006|Overall Study|Lost to Follow-up|0|||
149924165|NCT03130959|540857334|FG007|Overall Study|Lost to Follow-up|0|||
149924166|NCT03130959|540857335|FG008|Overall Study|Lost to Follow-up|0|||
149924167|NCT03130959|540857336|FG009|Overall Study|Lost to Follow-up|0|||
149924168|NCT04446429|540857337|FG000|Overall Study|Lost to Follow-up|6|||
149924169|NCT04446429|540857338|FG001|Overall Study|Lost to Follow-up|0|||
149924170|NCT05205005|540857339|FG000|Overall Study|Withdrawal by Subject|1|||
149924171|NCT05205005|540857340|FG001|Overall Study|Withdrawal by Subject|0|||
149924172|NCT05205005|540857339|FG000|Overall Study|Adverse Event|1|||
149924173|NCT05205005|540857340|FG001|Overall Study|Adverse Event|0|||
149924174|NCT00694356|540857341|FG000|Overall Study|Adverse Event|1|||
149924175|NCT00694356|540857342|FG001|Overall Study|Adverse Event|0|||
149924176|NCT00694356|540857343|FG002|Overall Study|Adverse Event|0|||
150260014|NCT00192647|542089258|FG000|Overall Study|Entry Criteria Violation|6|||
150260015|NCT00192647|542089259|FG001|Overall Study|Entry Criteria Violation|6|||
149924177|NCT00694356|540857341|FG000|Overall Study|Progressive Disease|2|||
149924178|NCT00694356|540857342|FG001|Overall Study|Progressive Disease|6|||
149924179|NCT00694356|540857343|FG002|Overall Study|Progressive Disease|6|||
149924180|NCT03042910|540857348|FG000|Overall Study|Adverse Event|1|||
149924181|NCT03042910|540857348|FG000|Overall Study|Disease Progression|2|||
149924182|NCT03042910|540857348|FG000|Overall Study|Withdrawal by Subject|3|||
149924183|NCT03042910|540857348|FG000|Overall Study|Enrolled but not treated|1|||
149924184|NCT02933528|540857350|FG000|Overall Study|Lost to Follow-up|2|||
149924185|NCT01301079|540857353|FG000|Overall Study|Lost to Follow-up|2|||
149924186|NCT01301079|540857354|FG001|Overall Study|Lost to Follow-up|2|||
149924187|NCT00313586|540857355|FG000|Overall Study|Disease progression|14|||
149924188|NCT00313586|540857356|FG001|Overall Study|Disease progression|19|||
149924189|NCT00313586|540857357|FG002|Overall Study|Disease progression|10|||
149924190|NCT00313586|540857358|FG003|Overall Study|Disease progression|3|||
149924191|NCT00313586|540857355|FG000|Overall Study|Adverse Event|12|||
149924192|NCT00313586|540857356|FG001|Overall Study|Adverse Event|18|||
150260016|NCT00192647|542089258|FG000|Overall Study|Protocol Violation|3|||
149924193|NCT00313586|540857357|FG002|Overall Study|Adverse Event|3|||
149924194|NCT00313586|540857358|FG003|Overall Study|Adverse Event|10|||
149924195|NCT00313586|540857355|FG000|Overall Study|Death|11|||
149924196|NCT00313586|540857356|FG001|Overall Study|Death|8|||
149924197|NCT00313586|540857357|FG002|Overall Study|Death|1|||
149924198|NCT00313586|540857358|FG003|Overall Study|Death|7|||
149924199|NCT00313586|540857355|FG000|Overall Study|Withdrawal by Subject|13|||
149924200|NCT00313586|540857356|FG001|Overall Study|Withdrawal by Subject|6|||
149924201|NCT00313586|540857357|FG002|Overall Study|Withdrawal by Subject|6|||
149924202|NCT00313586|540857358|FG003|Overall Study|Withdrawal by Subject|2|||
149924203|NCT00313586|540857355|FG000|Overall Study|Alternative therapy|3|||
149924204|NCT00313586|540857356|FG001|Overall Study|Alternative therapy|6|||
149924205|NCT00313586|540857357|FG002|Overall Study|Alternative therapy|2|||
149924206|NCT00313586|540857358|FG003|Overall Study|Alternative therapy|0|||
149924207|NCT00313586|540857355|FG000|Overall Study|Other complicating disease|2|||
149924208|NCT00313586|540857356|FG001|Overall Study|Other complicating disease|2|||
149924209|NCT00313586|540857357|FG002|Overall Study|Other complicating disease|0|||
149924210|NCT00313586|540857358|FG003|Overall Study|Other complicating disease|0|||
149924211|NCT00313586|540857355|FG000|Overall Study|Did not achieve HI-major/better response|10|||
149924212|NCT00313586|540857356|FG001|Overall Study|Did not achieve HI-major/better response|7|||
149924213|NCT00313586|540857357|FG002|Overall Study|Did not achieve HI-major/better response|2|||
149924214|NCT00313586|540857358|FG003|Overall Study|Did not achieve HI-major/better response|1|||
149924215|NCT00313586|540857355|FG000|Overall Study|Physician Decision|2|||
149924216|NCT00313586|540857356|FG001|Overall Study|Physician Decision|1|||
149924217|NCT00313586|540857357|FG002|Overall Study|Physician Decision|0|||
149924218|NCT00313586|540857358|FG003|Overall Study|Physician Decision|0|||
149924219|NCT00313586|540857355|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
149924220|NCT00313586|540857356|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
149924221|NCT00313586|540857357|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
149924222|NCT00313586|540857358|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
149924223|NCT00313586|540857355|FG000|Overall Study|Lost insurance|0|||
149924224|NCT00313586|540857356|FG001|Overall Study|Lost insurance|1|||
149924225|NCT00313586|540857357|FG002|Overall Study|Lost insurance|0|||
149924226|NCT00313586|540857358|FG003|Overall Study|Lost insurance|0|||
149924227|NCT00313586|540857355|FG000|Overall Study|Moved|0|||
149924228|NCT00313586|540857356|FG001|Overall Study|Moved|1|||
149924229|NCT00313586|540857357|FG002|Overall Study|Moved|0|||
149924230|NCT00313586|540857358|FG003|Overall Study|Moved|0|||
149924231|NCT00313586|540857355|FG000|Overall Study|Death before starting treatment|1|||
149924232|NCT00313586|540857356|FG001|Overall Study|Death before starting treatment|0|||
149924233|NCT00313586|540857357|FG002|Overall Study|Death before starting treatment|0|||
149924234|NCT00313586|540857358|FG003|Overall Study|Death before starting treatment|0|||
149924235|NCT01639703|540857359|FG000|Overall Study|Withdrawal by Subject|5|||
149924236|NCT01639703|540857359|FG000|Overall Study|Other reason|7|||
149924237|NCT04472494|540857361|FG000|Pre-treatment|Other reasons|2|||
149924238|NCT04472494|540857362|FG001|Pre-treatment|Other reasons|0|||
149924239|NCT04472494|540857361|FG000|Treatment|Death|5|||
149924240|NCT04472494|540857362|FG001|Treatment|Death|2|||
149924241|NCT04472494|540857361|FG000|Treatment|Hospital discharge|1|||
149924242|NCT04472494|540857362|FG001|Treatment|Hospital discharge|1|||
149924243|NCT03519919|540857363|FG000|Overall Study|Withdrawal by Subject|1|||
149924244|NCT03519919|540857363|FG000|Overall Study|Lack of Efficacy|1|||
149924245|NCT03519919|540857363|FG000|Overall Study|Screen Failure|1|||
149924246|NCT00943592|540857364|FG000|Overall Study|Death|3|||
149924247|NCT01909973|540857365|FG000|Overall Study|Lost to Follow-up|1|||
149924248|NCT01909973|540857366|FG001|Overall Study|Lost to Follow-up|0|||
149924249|NCT00169104|540857367|FG000|Overall Study|Withdrawal by Subject|2|||
149924250|NCT00169104|540857368|FG001|Overall Study|Withdrawal by Subject|0|||
149924251|NCT00169104|540857367|FG000|Overall Study|Protocol Violation|0|||
149924252|NCT00169104|540857368|FG001|Overall Study|Protocol Violation|1|||
149924253|NCT00169104|540857367|FG000|Overall Study|Physician Decision|0|||
149924254|NCT00169104|540857368|FG001|Overall Study|Physician Decision|1|||
149924255|NCT02438280|540857371|FG000|Overall Study|Physician Decision|1|||
149924256|NCT02438280|540857372|FG001|Overall Study|Physician Decision|0|||
149924257|NCT02457195|540857373|FG000|Overall Study|Adverse Event|3|||
149924258|NCT02457195|540857373|FG000|Overall Study|Protocol Violation|2|||
149924259|NCT02457195|540857373|FG000|Overall Study|Withdrawal by Subject|4|||
149924260|NCT04819438|540857374|FG000|Overall Study|Withdrawal by Subject|1|||
149924261|NCT04819438|540857375|FG001|Overall Study|Withdrawal by Subject|0|||
149924262|NCT04819438|540857374|FG000|Overall Study|Adverse Event|0|||
149924263|NCT04819438|540857375|FG001|Overall Study|Adverse Event|1|||
149924264|NCT04819438|540857374|FG000|Overall Study|Protocol Violation|0|||
149924265|NCT04819438|540857375|FG001|Overall Study|Protocol Violation|1|||
149924266|NCT05359952|540857376|FG000|Overall Study|Lost to Follow-up|1|||
149924267|NCT05359952|540857377|FG001|Overall Study|Lost to Follow-up|0|||
149924268|NCT05980013|540857378|FG000|Overall Study|Withdrawal by Subject|0|||
149924269|NCT05980013|540857379|FG001|Overall Study|Withdrawal by Subject|1|||
149924270|NCT05980013|540857378|FG000|Overall Study|Device Error|0|||
149818205|NCT01605461|540465380|FG000|Overall Study|Withdrawal by Subject|1|||
149818206|NCT02024698|540465381|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
149818207|NCT02024698|540465382|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
149818208|NCT03549130|540465383|FG000|Overall Study|Adverse Event|0|||
149818209|NCT03549130|540465384|FG001|Overall Study|Adverse Event|1|||
149818210|NCT03549130|540465383|FG000|Overall Study|Lost to Follow-up|0|||
149818211|NCT03549130|540465384|FG001|Overall Study|Lost to Follow-up|1|||
149818212|NCT01078623|540465385|FG000|Treatment Period 1|Adverse Event|1|||
149818213|NCT01078623|540465386|FG001|Treatment Period 1|Adverse Event|1|||
149818214|NCT01078623|540465387|FG002|Treatment Period 1|Adverse Event|1|||
149818215|NCT01078623|540465388|FG003|Treatment Period 1|Adverse Event|0|||
149818216|NCT01078623|540465389|FG004|Treatment Period 1|Adverse Event|0|||
149818217|NCT01078623|540465390|FG005|Treatment Period 1|Adverse Event|0|||
149818218|NCT01078623|540465391|FG006|Treatment Period 1|Adverse Event|1|||
149818219|NCT01078623|540465392|FG007|Treatment Period 1|Adverse Event|0|||
149818220|NCT01078623|540465393|FG008|Treatment Period 1|Adverse Event|1|||
149818221|NCT01078623|540465394|FG009|Treatment Period 1|Adverse Event|1|||
149818222|NCT01078623|540465395|FG010|Treatment Period 1|Adverse Event|0|||
149818223|NCT01078623|540465396|FG011|Treatment Period 1|Adverse Event|0|||
149818224|NCT01078623|540465397|FG012|Treatment Period 1|Adverse Event|0|||
149818225|NCT01078623|540465398|FG013|Treatment Period 1|Adverse Event|0|||
149818226|NCT01078623|540465399|FG014|Treatment Period 1|Adverse Event|0|||
149818227|NCT01078623|540465400|FG015|Treatment Period 1|Adverse Event|0|||
149818228|NCT01078623|540465401|FG016|Treatment Period 1|Adverse Event|0|||
149818229|NCT01078623|540465402|FG017|Treatment Period 1|Adverse Event|0|||
149818230|NCT01078623|540465403|FG018|Treatment Period 1|Adverse Event|0|||
149818231|NCT01078623|540465404|FG019|Treatment Period 1|Adverse Event|0|||
149818232|NCT01078623|540465385|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149818233|NCT01078623|540465386|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149818234|NCT01078623|540465387|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149818235|NCT01078623|540465388|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149818236|NCT01078623|540465389|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149818237|NCT01078623|540465390|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149818238|NCT01078623|540465391|FG006|Treatment Period 1|Withdrawal by Subject|0|||
149818239|NCT01078623|540465392|FG007|Treatment Period 1|Withdrawal by Subject|1|||
149818240|NCT01078623|540465393|FG008|Treatment Period 1|Withdrawal by Subject|0|||
149818241|NCT01078623|540465394|FG009|Treatment Period 1|Withdrawal by Subject|0|||
149818242|NCT01078623|540465395|FG010|Treatment Period 1|Withdrawal by Subject|1|||
149818243|NCT01078623|540465396|FG011|Treatment Period 1|Withdrawal by Subject|0|||
149818244|NCT01078623|540465397|FG012|Treatment Period 1|Withdrawal by Subject|0|||
149818245|NCT01078623|540465398|FG013|Treatment Period 1|Withdrawal by Subject|0|||
149818246|NCT01078623|540465399|FG014|Treatment Period 1|Withdrawal by Subject|0|||
149818247|NCT01078623|540465400|FG015|Treatment Period 1|Withdrawal by Subject|0|||
149818248|NCT01078623|540465401|FG016|Treatment Period 1|Withdrawal by Subject|0|||
149818249|NCT01078623|540465402|FG017|Treatment Period 1|Withdrawal by Subject|0|||
149818250|NCT01078623|540465403|FG018|Treatment Period 1|Withdrawal by Subject|0|||
149818251|NCT01078623|540465404|FG019|Treatment Period 1|Withdrawal by Subject|0|||
149818252|NCT01078623|540465385|FG000|Treatment Period 1|Protocol Violation|0|||
149818253|NCT01078623|540465386|FG001|Treatment Period 1|Protocol Violation|0|||
149818254|NCT01078623|540465387|FG002|Treatment Period 1|Protocol Violation|0|||
149818255|NCT01078623|540465388|FG003|Treatment Period 1|Protocol Violation|0|||
149818256|NCT01078623|540465389|FG004|Treatment Period 1|Protocol Violation|0|||
149818257|NCT01078623|540465390|FG005|Treatment Period 1|Protocol Violation|1|||
149818258|NCT01078623|540465391|FG006|Treatment Period 1|Protocol Violation|0|||
149818259|NCT01078623|540465392|FG007|Treatment Period 1|Protocol Violation|0|||
149818260|NCT01078623|540465393|FG008|Treatment Period 1|Protocol Violation|0|||
149818261|NCT01078623|540465394|FG009|Treatment Period 1|Protocol Violation|0|||
149818262|NCT01078623|540465395|FG010|Treatment Period 1|Protocol Violation|0|||
149818263|NCT01078623|540465396|FG011|Treatment Period 1|Protocol Violation|0|||
149818264|NCT01078623|540465397|FG012|Treatment Period 1|Protocol Violation|0|||
149818265|NCT01078623|540465398|FG013|Treatment Period 1|Protocol Violation|0|||
149818266|NCT01078623|540465399|FG014|Treatment Period 1|Protocol Violation|0|||
149818267|NCT01078623|540465400|FG015|Treatment Period 1|Protocol Violation|0|||
149818268|NCT01078623|540465401|FG016|Treatment Period 1|Protocol Violation|0|||
149818269|NCT01078623|540465402|FG017|Treatment Period 1|Protocol Violation|0|||
149818270|NCT01078623|540465403|FG018|Treatment Period 1|Protocol Violation|0|||
149818271|NCT01078623|540465404|FG019|Treatment Period 1|Protocol Violation|0|||
149818272|NCT01078623|540465385|FG000|Treatment Period 2|Adverse Event|0|||
149818273|NCT01078623|540465386|FG001|Treatment Period 2|Adverse Event|0|||
149818274|NCT01078623|540465387|FG002|Treatment Period 2|Adverse Event|0|||
149818275|NCT01078623|540465388|FG003|Treatment Period 2|Adverse Event|0|||
149818276|NCT01078623|540465389|FG004|Treatment Period 2|Adverse Event|0|||
149818277|NCT01078623|540465390|FG005|Treatment Period 2|Adverse Event|0|||
149818278|NCT01078623|540465391|FG006|Treatment Period 2|Adverse Event|1|||
149818279|NCT01078623|540465392|FG007|Treatment Period 2|Adverse Event|0|||
149818280|NCT01078623|540465393|FG008|Treatment Period 2|Adverse Event|0|||
149818281|NCT01078623|540465394|FG009|Treatment Period 2|Adverse Event|0|||
149818282|NCT01078623|540465395|FG010|Treatment Period 2|Adverse Event|0|||
149924271|NCT05980013|540857379|FG001|Overall Study|Device Error|1|||
149924272|NCT01882803|540857380|FG000|Overall Study|Disease Progression|1|||
149924273|NCT01882803|540857380|FG000|Overall Study|Withdrawal by Subject|9|||
149924274|NCT01882803|540857380|FG000|Overall Study|Death|68|||
149924275|NCT01882803|540857380|FG000|Overall Study|Physician Decision|3|||
149924276|NCT01882803|540857380|FG000|Overall Study|Lost to Follow-up|3|||
149924277|NCT01882803|540857380|FG000|Overall Study|Follow-up Completed|39|||
149924278|NCT01882803|540857380|FG000|Overall Study|Study Terminated by the Sponsor|6|||
149924279|NCT02521792|540857384|FG000|Overall Study|Study Terminated|6|||
149924280|NCT00398047|540857385|FG000|Overall Study|all patient progressed before completion|3|||
149924281|NCT00237692|540857386|FG000|Overall Study|Lost to Follow-up|9|||
149924282|NCT00237692|540857387|FG001|Overall Study|Lost to Follow-up|3|||
149924283|NCT00237692|540857388|FG002|Overall Study|Lost to Follow-up|5|||
149924284|NCT00237692|540857389|FG003|Overall Study|Lost to Follow-up|3|||
149924285|NCT00237692|540857386|FG000|Overall Study|Death|1|||
149924286|NCT00237692|540857387|FG001|Overall Study|Death|2|||
149924287|NCT00237692|540857388|FG002|Overall Study|Death|2|||
149924288|NCT00237692|540857389|FG003|Overall Study|Death|3|||
149924289|NCT00237692|540857386|FG000|Overall Study|Excluded - did not meet criteria|4|||
149924290|NCT00237692|540857387|FG001|Overall Study|Excluded - did not meet criteria|3|||
149924291|NCT00237692|540857388|FG002|Overall Study|Excluded - did not meet criteria|5|||
149924292|NCT00237692|540857389|FG003|Overall Study|Excluded - did not meet criteria|9|||
149924293|NCT00237692|540857386|FG000|Overall Study|Withdrawal by Subject|4|||
149924294|NCT00237692|540857387|FG001|Overall Study|Withdrawal by Subject|6|||
149924295|NCT00237692|540857388|FG002|Overall Study|Withdrawal by Subject|10|||
149924296|NCT00237692|540857389|FG003|Overall Study|Withdrawal by Subject|4|||
149924297|NCT00902746|540857390|FG000|Overall Study|Protocol Violation|7|||
149924298|NCT00902746|540857390|FG000|Overall Study|Withdrawal by Subject|16|||
149924299|NCT00902746|540857390|FG000|Overall Study|Adverse Event|8|||
149924300|NCT00902746|540857390|FG000|Overall Study|Lost to Follow-up|3|||
149924301|NCT00902746|540857390|FG000|Overall Study|Physician Decision|2|||
149924302|NCT02081001|540857396|FG000|Overall Study|Adverse Event|0|||
149924303|NCT02081001|540857397|FG001|Overall Study|Adverse Event|0|||
149924304|NCT02081001|540857398|FG002|Overall Study|Adverse Event|0|||
149924305|NCT02081001|540857399|FG003|Overall Study|Adverse Event|0|||
149924306|NCT02081001|540857400|FG004|Overall Study|Adverse Event|1|||
149924307|NCT02081001|540857401|FG005|Overall Study|Adverse Event|0|||
149924308|NCT02081001|540857402|FG006|Overall Study|Adverse Event|0|||
149924309|NCT02081001|540857403|FG007|Overall Study|Adverse Event|0|||
149924310|NCT02081001|540857404|FG008|Overall Study|Adverse Event|0|||
149924311|NCT02081001|540857405|FG009|Overall Study|Adverse Event|0|||
149924312|NCT02081001|540857406|FG010|Overall Study|Adverse Event|0|||
149924313|NCT02081001|540857407|FG011|Overall Study|Adverse Event|0|||
149924314|NCT01151345|540857419|FG000|First Intervention Period|Protocol Violation|0|||
149924315|NCT01151345|540857420|FG001|First Intervention Period|Protocol Violation|1|||
149924316|NCT02588092|540857421|FG000|Overall Study|Death|4|||
149924317|NCT02588092|540857422|FG001|Overall Study|Death|3|||
149924318|NCT02588092|540857423|FG002|Overall Study|Death|3|||
149924319|NCT02588092|540857424|FG003|Overall Study|Death|3|||
149924320|NCT02588092|540857425|FG004|Overall Study|Death|2|||
149924321|NCT02588092|540857426|FG005|Overall Study|Death|2|||
149924322|NCT02588092|540857427|FG006|Overall Study|Death|2|||
149924323|NCT02588092|540857428|FG007|Overall Study|Death|1|||
149924324|NCT02588092|540857429|FG008|Overall Study|Death|5|||
149924325|NCT02588092|540857430|FG009|Overall Study|Death|2|||
149924326|NCT02588092|540857421|FG000|Overall Study|Withdrawal by Subject|0|||
149924327|NCT02588092|540857422|FG001|Overall Study|Withdrawal by Subject|0|||
149924328|NCT02588092|540857423|FG002|Overall Study|Withdrawal by Subject|0|||
149924329|NCT02588092|540857424|FG003|Overall Study|Withdrawal by Subject|0|||
149924330|NCT02588092|540857425|FG004|Overall Study|Withdrawal by Subject|0|||
149924331|NCT02588092|540857426|FG005|Overall Study|Withdrawal by Subject|1|||
149924332|NCT02588092|540857427|FG006|Overall Study|Withdrawal by Subject|1|||
149924333|NCT02588092|540857428|FG007|Overall Study|Withdrawal by Subject|2|||
149924334|NCT02588092|540857429|FG008|Overall Study|Withdrawal by Subject|0|||
149924335|NCT02588092|540857430|FG009|Overall Study|Withdrawal by Subject|0|||
149924336|NCT02588092|540857421|FG000|Overall Study|Started Another Treatment|0|||
149924337|NCT02588092|540857422|FG001|Overall Study|Started Another Treatment|0|||
149924338|NCT02588092|540857423|FG002|Overall Study|Started Another Treatment|0|||
149924339|NCT02588092|540857424|FG003|Overall Study|Started Another Treatment|0|||
149924340|NCT02588092|540857425|FG004|Overall Study|Started Another Treatment|1|||
149924341|NCT02588092|540857426|FG005|Overall Study|Started Another Treatment|0|||
149924342|NCT02588092|540857427|FG006|Overall Study|Started Another Treatment|0|||
149924343|NCT02588092|540857428|FG007|Overall Study|Started Another Treatment|1|||
149924344|NCT02588092|540857429|FG008|Overall Study|Started Another Treatment|0|||
149924345|NCT02588092|540857430|FG009|Overall Study|Started Another Treatment|0|||
149924346|NCT02588092|540857421|FG000|Overall Study|Sponsor Decision|0|||
149924347|NCT02588092|540857422|FG001|Overall Study|Sponsor Decision|0|||
149924348|NCT02588092|540857423|FG002|Overall Study|Sponsor Decision|0|||
149924349|NCT02588092|540857424|FG003|Overall Study|Sponsor Decision|0|||
150260017|NCT00192647|542089259|FG001|Overall Study|Protocol Violation|1|||
150260018|NCT00192647|542089258|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
150260019|NCT00192647|542089259|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
149818283|NCT01078623|540465396|FG011|Treatment Period 2|Adverse Event|0|||
149818284|NCT01078623|540465397|FG012|Treatment Period 2|Adverse Event|0|||
149818285|NCT01078623|540465398|FG013|Treatment Period 2|Adverse Event|0|||
149818286|NCT01078623|540465399|FG014|Treatment Period 2|Adverse Event|0|||
149818287|NCT01078623|540465400|FG015|Treatment Period 2|Adverse Event|0|||
149818288|NCT01078623|540465401|FG016|Treatment Period 2|Adverse Event|0|||
149818289|NCT01078623|540465402|FG017|Treatment Period 2|Adverse Event|0|||
149818290|NCT01078623|540465403|FG018|Treatment Period 2|Adverse Event|1|||
149818291|NCT01078623|540465404|FG019|Treatment Period 2|Adverse Event|0|||
149818292|NCT01078623|540465385|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149818293|NCT01078623|540465386|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149818294|NCT01078623|540465387|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149818295|NCT01078623|540465388|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149818296|NCT01078623|540465389|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149818297|NCT01078623|540465390|FG005|Treatment Period 2|Withdrawal by Subject|1|||
149818298|NCT01078623|540465391|FG006|Treatment Period 2|Withdrawal by Subject|0|||
149818299|NCT01078623|540465392|FG007|Treatment Period 2|Withdrawal by Subject|0|||
149818300|NCT01078623|540465393|FG008|Treatment Period 2|Withdrawal by Subject|0|||
149818301|NCT01078623|540465394|FG009|Treatment Period 2|Withdrawal by Subject|0|||
149818302|NCT01078623|540465395|FG010|Treatment Period 2|Withdrawal by Subject|0|||
149818303|NCT01078623|540465396|FG011|Treatment Period 2|Withdrawal by Subject|0|||
149818304|NCT01078623|540465397|FG012|Treatment Period 2|Withdrawal by Subject|0|||
149818305|NCT01078623|540465398|FG013|Treatment Period 2|Withdrawal by Subject|0|||
149818306|NCT01078623|540465399|FG014|Treatment Period 2|Withdrawal by Subject|0|||
149818307|NCT01078623|540465400|FG015|Treatment Period 2|Withdrawal by Subject|0|||
149818308|NCT01078623|540465401|FG016|Treatment Period 2|Withdrawal by Subject|0|||
149818309|NCT01078623|540465402|FG017|Treatment Period 2|Withdrawal by Subject|0|||
149818310|NCT01078623|540465403|FG018|Treatment Period 2|Withdrawal by Subject|0|||
149818311|NCT01078623|540465404|FG019|Treatment Period 2|Withdrawal by Subject|0|||
149818312|NCT01078623|540465385|FG000|Treatment Period 3|Adverse Event|0|||
149818313|NCT01078623|540465386|FG001|Treatment Period 3|Adverse Event|0|||
149818314|NCT01078623|540465387|FG002|Treatment Period 3|Adverse Event|0|||
149818315|NCT01078623|540465388|FG003|Treatment Period 3|Adverse Event|0|||
149818316|NCT01078623|540465389|FG004|Treatment Period 3|Adverse Event|1|||
149818317|NCT01078623|540465390|FG005|Treatment Period 3|Adverse Event|0|||
149818318|NCT01078623|540465391|FG006|Treatment Period 3|Adverse Event|0|||
149818319|NCT01078623|540465392|FG007|Treatment Period 3|Adverse Event|0|||
149818320|NCT01078623|540465393|FG008|Treatment Period 3|Adverse Event|0|||
149818321|NCT01078623|540465394|FG009|Treatment Period 3|Adverse Event|0|||
149818322|NCT01078623|540465395|FG010|Treatment Period 3|Adverse Event|0|||
149818323|NCT01078623|540465396|FG011|Treatment Period 3|Adverse Event|0|||
149818324|NCT01078623|540465397|FG012|Treatment Period 3|Adverse Event|0|||
149818325|NCT01078623|540465398|FG013|Treatment Period 3|Adverse Event|1|||
149818326|NCT01078623|540465399|FG014|Treatment Period 3|Adverse Event|0|||
149818327|NCT01078623|540465400|FG015|Treatment Period 3|Adverse Event|0|||
149818328|NCT01078623|540465401|FG016|Treatment Period 3|Adverse Event|0|||
149818329|NCT01078623|540465402|FG017|Treatment Period 3|Adverse Event|0|||
149818330|NCT01078623|540465403|FG018|Treatment Period 3|Adverse Event|0|||
149818331|NCT01078623|540465404|FG019|Treatment Period 3|Adverse Event|0|||
149818332|NCT01078623|540465385|FG000|Treatment Period 4|Adverse Event|0|||
149818333|NCT01078623|540465386|FG001|Treatment Period 4|Adverse Event|0|||
149818334|NCT01078623|540465387|FG002|Treatment Period 4|Adverse Event|1|||
149818335|NCT01078623|540465388|FG003|Treatment Period 4|Adverse Event|0|||
149818336|NCT01078623|540465389|FG004|Treatment Period 4|Adverse Event|0|||
149818337|NCT01078623|540465390|FG005|Treatment Period 4|Adverse Event|0|||
149818338|NCT01078623|540465391|FG006|Treatment Period 4|Adverse Event|0|||
149818339|NCT01078623|540465392|FG007|Treatment Period 4|Adverse Event|0|||
149818340|NCT01078623|540465393|FG008|Treatment Period 4|Adverse Event|0|||
149818341|NCT01078623|540465394|FG009|Treatment Period 4|Adverse Event|0|||
149818342|NCT01078623|540465395|FG010|Treatment Period 4|Adverse Event|0|||
149818343|NCT01078623|540465396|FG011|Treatment Period 4|Adverse Event|0|||
149818344|NCT01078623|540465397|FG012|Treatment Period 4|Adverse Event|0|||
149818345|NCT01078623|540465398|FG013|Treatment Period 4|Adverse Event|0|||
149818346|NCT01078623|540465399|FG014|Treatment Period 4|Adverse Event|0|||
149818347|NCT01078623|540465400|FG015|Treatment Period 4|Adverse Event|0|||
149818348|NCT01078623|540465401|FG016|Treatment Period 4|Adverse Event|0|||
149818349|NCT01078623|540465402|FG017|Treatment Period 4|Adverse Event|0|||
149818350|NCT01078623|540465403|FG018|Treatment Period 4|Adverse Event|0|||
149818351|NCT01078623|540465404|FG019|Treatment Period 4|Adverse Event|0|||
149818352|NCT01078623|540465385|FG000|Treatment Period 4|Withdrawal by Subject|0|||
149818353|NCT01078623|540465386|FG001|Treatment Period 4|Withdrawal by Subject|0|||
149818354|NCT01078623|540465387|FG002|Treatment Period 4|Withdrawal by Subject|0|||
149818355|NCT01078623|540465388|FG003|Treatment Period 4|Withdrawal by Subject|0|||
149818356|NCT01078623|540465389|FG004|Treatment Period 4|Withdrawal by Subject|0|||
149818357|NCT01078623|540465390|FG005|Treatment Period 4|Withdrawal by Subject|0|||
150260020|NCT00192647|542089258|FG000|Overall Study|Failure to Return|11|||
149924350|NCT02588092|540857425|FG004|Overall Study|Sponsor Decision|0|||
149924351|NCT02588092|540857426|FG005|Overall Study|Sponsor Decision|0|||
149924352|NCT02588092|540857427|FG006|Overall Study|Sponsor Decision|0|||
149924353|NCT02588092|540857428|FG007|Overall Study|Sponsor Decision|0|||
149924354|NCT02588092|540857429|FG008|Overall Study|Sponsor Decision|1|||
149924355|NCT02588092|540857430|FG009|Overall Study|Sponsor Decision|1|||
149924356|NCT01030718|540857431|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
149924357|NCT01030718|540857432|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
149924358|NCT01030718|540857433|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
149924359|NCT01030718|540857431|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
149924360|NCT01030718|540857432|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
149924361|NCT01030718|540857433|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
149924362|NCT01030718|540857431|FG000|Studies CA180-031 and -036 Combined|Death|0|||
149924363|NCT01030718|540857432|FG001|Studies CA180-031 and -036 Combined|Death|1|||
149924364|NCT01030718|540857433|FG002|Studies CA180-031 and -036 Combined|Death|0|||
149924365|NCT01030718|540857431|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
149924366|NCT01030718|540857432|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
149924367|NCT01030718|540857433|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
149924368|NCT01030718|540857431|FG000|Study CA180-036 Only|insufficient effect|1|||
149924369|NCT01030718|540857432|FG001|Study CA180-036 Only|insufficient effect|1|||
149924370|NCT01030718|540857433|FG002|Study CA180-036 Only|insufficient effect|5|||
149924371|NCT01030718|540857431|FG000|Study CA180-036 Only|Adverse Event|2|||
149924372|NCT01030718|540857432|FG001|Study CA180-036 Only|Adverse Event|3|||
149924373|NCT01030718|540857433|FG002|Study CA180-036 Only|Adverse Event|0|||
149924374|NCT01030718|540857431|FG000|Study CA180-036 Only|Death|0|||
149924375|NCT01030718|540857432|FG001|Study CA180-036 Only|Death|1|||
149924376|NCT01030718|540857433|FG002|Study CA180-036 Only|Death|0|||
149924377|NCT01030718|540857431|FG000|Study CA180-036 Only|Other Reasons|0|||
149924378|NCT01030718|540857432|FG001|Study CA180-036 Only|Other Reasons|2|||
149924379|NCT01030718|540857433|FG002|Study CA180-036 Only|Other Reasons|0|||
149924380|NCT03853291|540857434|FG000|Overall Study|Lost to Follow-up|1|||
149924381|NCT03853291|540857435|FG001|Overall Study|Lost to Follow-up|2|||
149924382|NCT03853291|540857436|FG002|Overall Study|Lost to Follow-up|0|||
149924383|NCT03853291|540857437|FG003|Overall Study|Lost to Follow-up|0|||
149924384|NCT03853291|540857438|FG004|Overall Study|Lost to Follow-up|0|||
149924385|NCT03853291|540857439|FG005|Overall Study|Lost to Follow-up|0|||
149924386|NCT03853291|540857434|FG000|Overall Study|Determined to be ineligible|1|||
149924387|NCT03853291|540857435|FG001|Overall Study|Determined to be ineligible|1|||
149924388|NCT03853291|540857436|FG002|Overall Study|Determined to be ineligible|0|||
149924389|NCT03853291|540857437|FG003|Overall Study|Determined to be ineligible|0|||
149924390|NCT03853291|540857438|FG004|Overall Study|Determined to be ineligible|0|||
149924391|NCT03853291|540857439|FG005|Overall Study|Determined to be ineligible|0|||
149924392|NCT01904032|540857441|FG000|Overall Study|Adverse Event|3|||
149924393|NCT01904032|540857442|FG001|Overall Study|Adverse Event|1|||
149924394|NCT01904032|540857441|FG000|Overall Study|Lost to Follow-up|4|||
149924395|NCT01904032|540857442|FG001|Overall Study|Lost to Follow-up|2|||
149924396|NCT03148067|540857447|FG000|Overall Study|Lost to Follow-up|3|||
149924397|NCT03148067|540857447|FG000|Overall Study|Death|1|||
149924398|NCT02774005|540857454|FG000|Overall Study|Adverse Event|8|||
149924399|NCT02774005|540857454|FG000|Overall Study|Withdrawal by Subject|23|||
149924400|NCT02774005|540857454|FG000|Overall Study|Lost to Follow-up|7|||
149924401|NCT02774005|540857454|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
149924402|NCT02774005|540857454|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
149924403|NCT02774005|540857454|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
149924404|NCT02774005|540857454|FG000|Overall Study|Death|1|||
149924405|NCT02774005|540857454|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
149924406|NCT02774005|540857454|FG000|Overall Study|Lack of compliance with study medication|4|||
149924407|NCT02774005|540857454|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
149924408|NCT02774005|540857454|FG000|Overall Study|another study|1|||
149924409|NCT02774005|540857454|FG000|Overall Study|cardiologist imposed travel restriction|1|||
149924410|NCT01451554|540857455|FG000|Overall Study|Withdrawal by Subject|14|||
149924411|NCT01451554|540857456|FG001|Overall Study|Withdrawal by Subject|9|||
149924412|NCT03178851|540857457|FG000|Overall Study|Death|48|||
149924413|NCT03178851|540857458|FG001|Overall Study|Death|2|||
149924414|NCT03178851|540857459|FG002|Overall Study|Death|25|||
149924415|NCT03178851|540857457|FG000|Overall Study|Withdrawal by Subject|8|||
149924416|NCT03178851|540857458|FG001|Overall Study|Withdrawal by Subject|0|||
149924417|NCT03178851|540857459|FG002|Overall Study|Withdrawal by Subject|0|||
149924418|NCT03178851|540857457|FG000|Overall Study|Lost to Follow-up|5|||
149924419|NCT03178851|540857458|FG001|Overall Study|Lost to Follow-up|2|||
149924420|NCT03178851|540857459|FG002|Overall Study|Lost to Follow-up|0|||
149924421|NCT03178851|540857457|FG000|Overall Study|Adverse Event|0|||
149924422|NCT03178851|540857458|FG001|Overall Study|Adverse Event|0|||
149924423|NCT03178851|540857459|FG002|Overall Study|Adverse Event|1|||
150260021|NCT00192647|542089259|FG001|Overall Study|Failure to Return|13|||
149818358|NCT01078623|540465391|FG006|Treatment Period 4|Withdrawal by Subject|0|||
149818359|NCT01078623|540465392|FG007|Treatment Period 4|Withdrawal by Subject|0|||
149818360|NCT01078623|540465393|FG008|Treatment Period 4|Withdrawal by Subject|0|||
149818361|NCT01078623|540465394|FG009|Treatment Period 4|Withdrawal by Subject|0|||
149818362|NCT01078623|540465395|FG010|Treatment Period 4|Withdrawal by Subject|0|||
149818363|NCT01078623|540465396|FG011|Treatment Period 4|Withdrawal by Subject|0|||
149818364|NCT01078623|540465397|FG012|Treatment Period 4|Withdrawal by Subject|0|||
149818365|NCT01078623|540465398|FG013|Treatment Period 4|Withdrawal by Subject|0|||
149818366|NCT01078623|540465399|FG014|Treatment Period 4|Withdrawal by Subject|0|||
149818367|NCT01078623|540465400|FG015|Treatment Period 4|Withdrawal by Subject|1|||
149818368|NCT01078623|540465401|FG016|Treatment Period 4|Withdrawal by Subject|0|||
149818369|NCT01078623|540465402|FG017|Treatment Period 4|Withdrawal by Subject|0|||
149818370|NCT01078623|540465403|FG018|Treatment Period 4|Withdrawal by Subject|0|||
149818371|NCT01078623|540465404|FG019|Treatment Period 4|Withdrawal by Subject|0|||
149818372|NCT00463866|540465405|FG000|Overall Study|Adverse Event|70|||
149818373|NCT00463866|540465406|FG001|Overall Study|Adverse Event|93|||
149818374|NCT00463866|540465405|FG000|Overall Study|Withdrawal by Subject|81|||
149818375|NCT00463866|540465406|FG001|Overall Study|Withdrawal by Subject|79|||
149818376|NCT00463866|540465405|FG000|Overall Study|Lost to Follow-up|46|||
149818377|NCT00463866|540465406|FG001|Overall Study|Lost to Follow-up|55|||
149818378|NCT00463866|540465405|FG000|Overall Study|Incorrect Enrolment|64|||
149818379|NCT00463866|540465406|FG001|Overall Study|Incorrect Enrolment|66|||
149818380|NCT00463866|540465405|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
149818381|NCT00463866|540465406|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
149818382|NCT00463866|540465405|FG000|Overall Study|Safety Reason|1|||
149818383|NCT00463866|540465406|FG001|Overall Study|Safety Reason|3|||
149818384|NCT00463866|540465405|FG000|Overall Study|Mis-Randomization of subject|0|||
149818385|NCT00463866|540465406|FG001|Overall Study|Mis-Randomization of subject|1|||
149818386|NCT00463866|540465405|FG000|Overall Study|Other|22|||
149818387|NCT00463866|540465406|FG001|Overall Study|Other|22|||
149818388|NCT03568500|540465412|FG000|Overall Study|Lost to Follow-up|1|||
149818389|NCT03568500|540465413|FG001|Overall Study|Lost to Follow-up|1|||
149818390|NCT03568500|540465414|FG002|Overall Study|Lost to Follow-up|2|||
149818391|NCT03568500|540465412|FG000|Overall Study|Adverse Event|1|||
149818392|NCT03568500|540465413|FG001|Overall Study|Adverse Event|1|||
149818393|NCT03568500|540465414|FG002|Overall Study|Adverse Event|2|||
149818394|NCT03568500|540465412|FG000|Overall Study|Physician Decision|1|||
149818395|NCT03568500|540465413|FG001|Overall Study|Physician Decision|0|||
149818396|NCT03568500|540465414|FG002|Overall Study|Physician Decision|0|||
149818397|NCT03568500|540465412|FG000|Overall Study|Withdrawal by Subject|4|||
149818398|NCT03568500|540465413|FG001|Overall Study|Withdrawal by Subject|2|||
149818399|NCT03568500|540465414|FG002|Overall Study|Withdrawal by Subject|0|||
149818400|NCT03568500|540465412|FG000|Overall Study|Technical Problems|2|||
149818401|NCT03568500|540465413|FG001|Overall Study|Technical Problems|1|||
149818402|NCT03568500|540465414|FG002|Overall Study|Technical Problems|0|||
149818403|NCT03568500|540465412|FG000|Overall Study|Participant Noncompliance|1|||
149818404|NCT03568500|540465413|FG001|Overall Study|Participant Noncompliance|1|||
149818405|NCT03568500|540465414|FG002|Overall Study|Participant Noncompliance|0|||
149818406|NCT04120194|540465430|FG000|Overall Study|Lost to Follow-up|11|||
149818407|NCT04120194|540465431|FG001|Overall Study|Lost to Follow-up|8|||
149818408|NCT04120194|540465430|FG000|Overall Study|Adverse Event|4|||
149818409|NCT04120194|540465431|FG001|Overall Study|Adverse Event|5|||
149818410|NCT04120194|540465430|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
149818411|NCT04120194|540465431|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
149818412|NCT04120194|540465430|FG000|Overall Study|Miscellaneous|4|||
149818413|NCT04120194|540465431|FG001|Overall Study|Miscellaneous|5|||
149818414|NCT02622074|540465438|FG000|Overall Study|Death|4|||
149818415|NCT02622074|540465439|FG001|Overall Study|Death|0|||
149818416|NCT02622074|540465440|FG002|Overall Study|Death|0|||
149818417|NCT02622074|540465441|FG003|Overall Study|Death|1|||
149818418|NCT02622074|540465442|FG004|Overall Study|Death|1|||
149818419|NCT02622074|540465443|FG005|Overall Study|Death|0|||
149818420|NCT02622074|540465438|FG000|Overall Study|Withdrawal by Subject|0|||
149818421|NCT02622074|540465439|FG001|Overall Study|Withdrawal by Subject|1|||
149818422|NCT02622074|540465440|FG002|Overall Study|Withdrawal by Subject|0|||
149818423|NCT02622074|540465441|FG003|Overall Study|Withdrawal by Subject|0|||
149818424|NCT02622074|540465442|FG004|Overall Study|Withdrawal by Subject|0|||
149818425|NCT02622074|540465443|FG005|Overall Study|Withdrawal by Subject|0|||
149818426|NCT01684722|540465447|FG000|Overall Study|Lost to Follow-up|78|||
149818427|NCT01684722|540465448|FG001|Overall Study|Lost to Follow-up|56|||
149818428|NCT01684722|540465449|FG002|Overall Study|Lost to Follow-up|75|||
149818429|NCT01684722|540465450|FG003|Overall Study|Lost to Follow-up|89|||
149818430|NCT01684722|540465447|FG000|Overall Study|Death|19|||
149818431|NCT01684722|540465448|FG001|Overall Study|Death|21|||
149818432|NCT01684722|540465449|FG002|Overall Study|Death|19|||
149818433|NCT01684722|540465450|FG003|Overall Study|Death|21|||
149818434|NCT00219557|540465451|FG000|Phase 1|Lack of Efficacy|3|||
149818435|NCT00219557|540465452|FG001|Phase 1|Lack of Efficacy|0|||
149818436|NCT00219557|540465453|FG002|Phase 1|Lack of Efficacy|0|||
149924424|NCT03178851|540857457|FG000|Overall Study|Study Termination by Sponsor|31|||
149924425|NCT03178851|540857458|FG001|Overall Study|Study Termination by Sponsor|7|||
149924426|NCT03178851|540857459|FG002|Overall Study|Study Termination by Sponsor|26|||
149924427|NCT02576977|540859428|FG000|Overall Study|Adverse Event|13|||
149924428|NCT02576977|540859429|FG001|Overall Study|Adverse Event|2|||
149924429|NCT02576977|540859428|FG000|Overall Study|Death|73|||
149924430|NCT02576977|540859429|FG001|Overall Study|Death|60|||
149924431|NCT02576977|540859428|FG000|Overall Study|Screen failure|1|||
149924432|NCT02576977|540859429|FG001|Overall Study|Screen failure|0|||
149924433|NCT02576977|540859428|FG000|Overall Study|Study Terminated at Selected Sites|27|||
149924434|NCT02576977|540859429|FG001|Overall Study|Study Terminated at Selected Sites|50|||
149924435|NCT02576977|540859428|FG000|Overall Study|Withdrawal by Subject|11|||
149924436|NCT02576977|540859429|FG001|Overall Study|Withdrawal by Subject|11|||
149924437|NCT02576977|540859428|FG000|Overall Study|Final Disposition Unknown|0|||
149924438|NCT02576977|540859429|FG001|Overall Study|Final Disposition Unknown|1|||
149924439|NCT02576977|540859428|FG000|Overall Study|Lost to Follow-up|1|||
149924440|NCT02576977|540859429|FG001|Overall Study|Lost to Follow-up|0|||
149924441|NCT02576977|540859428|FG000|Overall Study|Progressive Disease|0|||
149924442|NCT02576977|540859429|FG001|Overall Study|Progressive Disease|1|||
149924443|NCT01073163|540859434|FG000|Overall Study|Adverse Event|1|||
149924444|NCT01073163|540859434|FG000|Overall Study|Disease Progression|1|||
149924445|NCT01073163|540859434|FG000|Overall Study|Early termination|1|||
149924446|NCT00703677|540859435|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
149924447|NCT03859648|540859436|FG000|Overall Study|Lost to Follow-up|1|||
149924448|NCT03859648|540859436|FG000|Overall Study|Adverse Event|1|||
149924449|NCT02315664|540859437|FG000|Overall Study|Lost to Follow-up|1|||
149924450|NCT02315664|540859438|FG001|Overall Study|Lost to Follow-up|1|||
149924451|NCT02315664|540859437|FG000|Overall Study|Withdrawal by Subject|0|||
149924452|NCT02315664|540859438|FG001|Overall Study|Withdrawal by Subject|3|||
149924453|NCT01677182|540859439|FG000|Overall Study|Adverse Event|2|||
149924454|NCT01677182|540859440|FG001|Overall Study|Adverse Event|1|||
149924455|NCT01677182|540859441|FG002|Overall Study|Adverse Event|8|||
149924456|NCT01677182|540859439|FG000|Overall Study|Protocol Violation|5|||
149924457|NCT01677182|540859440|FG001|Overall Study|Protocol Violation|1|||
149924458|NCT01677182|540859441|FG002|Overall Study|Protocol Violation|4|||
149924459|NCT01677182|540859439|FG000|Overall Study|Lost to Follow-up|4|||
149924460|NCT01677182|540859440|FG001|Overall Study|Lost to Follow-up|0|||
149924461|NCT01677182|540859441|FG002|Overall Study|Lost to Follow-up|3|||
149924462|NCT01677182|540859439|FG000|Overall Study|Withdrawal by Subject|7|||
149924463|NCT01677182|540859440|FG001|Overall Study|Withdrawal by Subject|12|||
149924464|NCT01677182|540859441|FG002|Overall Study|Withdrawal by Subject|10|||
149924465|NCT01677182|540859439|FG000|Overall Study|Study termination|12|||
149924466|NCT01677182|540859440|FG001|Overall Study|Study termination|9|||
149924467|NCT01677182|540859441|FG002|Overall Study|Study termination|11|||
149924468|NCT01677182|540859439|FG000|Overall Study|Lack of Efficacy|3|||
149924469|NCT01677182|540859440|FG001|Overall Study|Lack of Efficacy|0|||
149924470|NCT01677182|540859441|FG002|Overall Study|Lack of Efficacy|1|||
149924471|NCT01677182|540859439|FG000|Overall Study|Other reasons|1|||
149924472|NCT01677182|540859440|FG001|Overall Study|Other reasons|5|||
149924473|NCT01677182|540859441|FG002|Overall Study|Other reasons|2|||
149924474|NCT02501161|540859442|FG000|Overall Study|Adverse Event|2|||
149924475|NCT02501161|540859443|FG001|Overall Study|Adverse Event|6|||
149924476|NCT02501161|540859442|FG000|Overall Study|Lost to Follow-up|7|||
149924477|NCT02501161|540859443|FG001|Overall Study|Lost to Follow-up|4|||
149924478|NCT02501161|540859442|FG000|Overall Study|Withdrawal by Subject|10|||
149924479|NCT02501161|540859443|FG001|Overall Study|Withdrawal by Subject|15|||
149924480|NCT02501161|540859442|FG000|Overall Study|Other|3|||
149924481|NCT02501161|540859443|FG001|Overall Study|Other|0|||
149924482|NCT00667992|540859446|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
149924483|NCT00667992|540859447|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
149924484|NCT00667992|540859446|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
149924485|NCT00667992|540859447|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
149924486|NCT00667992|540859446|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
149924487|NCT00667992|540859447|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
149924488|NCT00667992|540859446|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
149924489|NCT00667992|540859447|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
149924490|NCT00667992|540859446|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
149924491|NCT00667992|540859447|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
149924492|NCT00667992|540859446|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
149924493|NCT00667992|540859447|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
149924494|NCT00667992|540859446|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
149924495|NCT00667992|540859447|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
149924496|NCT00667992|540859446|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
150260022|NCT00192647|542089258|FG000|Overall Study|Other/Administrative|5|||
150260023|NCT00192647|542089259|FG001|Overall Study|Other/Administrative|3|||
149924497|NCT00667992|540859447|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
149924498|NCT00667992|540859446|FG000|Wash-out|Not within one doubling dilution|4|||
149924499|NCT00667992|540859447|FG001|Wash-out|Not within one doubling dilution|3|||
149924500|NCT00667992|540859446|FG000|Wash-out|Failure to wash-out|2|||
149924501|NCT00667992|540859447|FG001|Wash-out|Failure to wash-out|2|||
149924502|NCT00667992|540859446|FG000|Wash-out|Withdrawal by Subject|1|||
149924503|NCT00667992|540859447|FG001|Wash-out|Withdrawal by Subject|0|||
149924504|NCT00667992|540859446|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
149924505|NCT00667992|540859447|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
149924506|NCT00667992|540859446|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
149924507|NCT00667992|540859447|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
149924508|NCT00762762|540859448|FG000|Overall Study|Did not return for appointments|6|||
149924509|NCT00762762|540859449|FG001|Overall Study|Did not return for appointments|8|||
149818437|NCT00219557|540465451|FG000|Phase 1|Adverse Event|2|||
149818438|NCT00219557|540465452|FG001|Phase 1|Adverse Event|0|||
149818439|NCT00219557|540465453|FG002|Phase 1|Adverse Event|0|||
149818440|NCT00219557|540465451|FG000|Phase 1|Withdrawal by Subject|1|||
149818441|NCT00219557|540465452|FG001|Phase 1|Withdrawal by Subject|0|||
149818442|NCT00219557|540465453|FG002|Phase 1|Withdrawal by Subject|0|||
149818443|NCT00219557|540465451|FG000|Phase 1|Started chemotherapy at other institute|1|||
149818444|NCT00219557|540465452|FG001|Phase 1|Started chemotherapy at other institute|0|||
149818445|NCT00219557|540465453|FG002|Phase 1|Started chemotherapy at other institute|0|||
149818446|NCT00219557|540465451|FG000|Phase 2|Lack of Efficacy|0|||
149818447|NCT00219557|540465452|FG001|Phase 2|Lack of Efficacy|21|||
149818448|NCT00219557|540465453|FG002|Phase 2|Lack of Efficacy|15|||
149818449|NCT00219557|540465451|FG000|Phase 2|Adverse Event|0|||
149818450|NCT00219557|540465452|FG001|Phase 2|Adverse Event|22|||
149818451|NCT00219557|540465453|FG002|Phase 2|Adverse Event|2|||
149818452|NCT00219557|540465451|FG000|Phase 2|Death|0|||
149818453|NCT00219557|540465452|FG001|Phase 2|Death|8|||
149818454|NCT00219557|540465453|FG002|Phase 2|Death|2|||
149818455|NCT00219557|540465451|FG000|Phase 2|Other|0|||
149818456|NCT00219557|540465452|FG001|Phase 2|Other|8|||
149818457|NCT00219557|540465453|FG002|Phase 2|Other|6|||
149818458|NCT00219557|540465451|FG000|Phase 2|Withdrawal by Subject|0|||
149818459|NCT00219557|540465452|FG001|Phase 2|Withdrawal by Subject|9|||
149818460|NCT00219557|540465453|FG002|Phase 2|Withdrawal by Subject|5|||
149818461|NCT00219557|540465451|FG000|Phase 2|Treatment not received|0|||
149818462|NCT00219557|540465452|FG001|Phase 2|Treatment not received|1|||
149818463|NCT00219557|540465453|FG002|Phase 2|Treatment not received|3|||
149818464|NCT03063632|540465460|FG000|Overall Study|Death|4|||
149818465|NCT03063632|540465461|FG001|Overall Study|Death|6|||
149818466|NCT03063632|540465460|FG000|Overall Study|Lost to Follow-up|0|||
149818467|NCT03063632|540465461|FG001|Overall Study|Lost to Follow-up|1|||
149818468|NCT03063632|540465460|FG000|Overall Study|Withdrawal by Subject|0|||
149818469|NCT03063632|540465461|FG001|Overall Study|Withdrawal by Subject|2|||
149818470|NCT03063632|540465460|FG000|Overall Study|Physician Decision|2|||
149818471|NCT03063632|540465461|FG001|Overall Study|Physician Decision|0|||
149818472|NCT03063632|540465460|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
149818473|NCT03063632|540465461|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
149818474|NCT02741271|540465464|FG000|Overall Study|Lost to Follow-up|2|||
149818475|NCT02741271|540465465|FG001|Overall Study|Lost to Follow-up|0|||
149818476|NCT02741271|540465464|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149818477|NCT02741271|540465465|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
149818478|NCT03652961|540465466|FG000|Overall Study|Lost to Follow-up|3|||
149818479|NCT03652961|540465466|FG000|Overall Study|Screen Failure|1|||
149818480|NCT00410410|540465467|FG000|Induction Period (IP)|Death|1|||
149818481|NCT00410410|540465468|FG001|Induction Period (IP)|Death|0|||
149818482|NCT00410410|540465469|FG002|Induction Period (IP)|Death|0|||
149818483|NCT00410410|540465470|FG003|Induction Period (IP)|Death|0|||
149818484|NCT00410410|540465471|FG004|Induction Period (IP)|Death|0|||
149818485|NCT00410410|540465472|FG005|Induction Period (IP)|Death|0|||
149818486|NCT00410410|540465473|FG006|Induction Period (IP)|Death|0|||
149818487|NCT00410410|540465474|FG007|Induction Period (IP)|Death|0|||
149818488|NCT00410410|540465475|FG008|Induction Period (IP)|Death|0|||
149818489|NCT00410410|540465467|FG000|Induction Period (IP)|Adverse Event|3|||
149818490|NCT00410410|540465468|FG001|Induction Period (IP)|Adverse Event|4|||
149818491|NCT00410410|540465469|FG002|Induction Period (IP)|Adverse Event|2|||
149818492|NCT00410410|540465470|FG003|Induction Period (IP)|Adverse Event|4|||
149818493|NCT00410410|540465471|FG004|Induction Period (IP)|Adverse Event|1|||
149818494|NCT00410410|540465472|FG005|Induction Period (IP)|Adverse Event|0|||
149818495|NCT00410410|540465473|FG006|Induction Period (IP)|Adverse Event|0|||
149818496|NCT00410410|540465474|FG007|Induction Period (IP)|Adverse Event|0|||
149818497|NCT00410410|540465475|FG008|Induction Period (IP)|Adverse Event|0|||
149818498|NCT00410410|540465467|FG000|Induction Period (IP)|Lack of Efficacy|26|||
149818499|NCT00410410|540465468|FG001|Induction Period (IP)|Lack of Efficacy|24|||
149818500|NCT00410410|540465469|FG002|Induction Period (IP)|Lack of Efficacy|8|||
149818501|NCT00410410|540465470|FG003|Induction Period (IP)|Lack of Efficacy|8|||
149924510|NCT02489448|540859450|FG000|Overall Study|Death|3|||
149924511|NCT02489448|540859450|FG000|Overall Study|Withdrawal by Subject|2|||
149924512|NCT02630563|540859459|FG000|Overall Study|Administrative|1|||
149924513|NCT00929994|540859460|FG000|Overall Study|Withdrawal by Subject|1|||
149924514|NCT00929994|540859460|FG000|Overall Study|medical issue unrelated to intervention|4|||
149924515|NCT00929994|540859460|FG000|Overall Study|employment|1|||
149924516|NCT00621257|540859461|FG000|Overall Study|Lost to Follow-up|4|||
149924517|NCT00621257|540859462|FG001|Overall Study|Lost to Follow-up|0|||
149924518|NCT00621257|540859463|FG002|Overall Study|Lost to Follow-up|2|||
149924519|NCT00621257|540859464|FG003|Overall Study|Lost to Follow-up|4|||
149924520|NCT00621257|540859465|FG004|Overall Study|Lost to Follow-up|7|||
149924521|NCT00621257|540859461|FG000|Overall Study|Adverse Event|0|||
149924522|NCT00621257|540859462|FG001|Overall Study|Adverse Event|1|||
149924523|NCT00621257|540859463|FG002|Overall Study|Adverse Event|1|||
149924524|NCT00621257|540859464|FG003|Overall Study|Adverse Event|0|||
149924525|NCT00621257|540859465|FG004|Overall Study|Adverse Event|0|||
149924526|NCT00621257|540859461|FG000|Overall Study|Physician Decision|0|||
149924527|NCT00621257|540859462|FG001|Overall Study|Physician Decision|2|||
149924528|NCT00621257|540859463|FG002|Overall Study|Physician Decision|0|||
149924529|NCT00621257|540859464|FG003|Overall Study|Physician Decision|1|||
149924530|NCT00621257|540859465|FG004|Overall Study|Physician Decision|1|||
149924531|NCT00621257|540859461|FG000|Overall Study|Withdrawal by Subject|0|||
149924532|NCT00621257|540859462|FG001|Overall Study|Withdrawal by Subject|0|||
149924533|NCT00621257|540859463|FG002|Overall Study|Withdrawal by Subject|0|||
149924534|NCT00621257|540859464|FG003|Overall Study|Withdrawal by Subject|1|||
149924535|NCT00621257|540859465|FG004|Overall Study|Withdrawal by Subject|1|||
149924536|NCT01255904|540859466|FG000|Overall Study|Physician Decision|1|||
149924537|NCT01255904|540859467|FG001|Overall Study|Physician Decision|4|||
149924538|NCT02061813|540859469|FG000|Overall Study|Withdrawal by Subject|1|||
149924539|NCT02061813|540859469|FG000|Overall Study|Protocol Violation|2|||
149924540|NCT01705080|540859470|FG000|Overall Study|Missed visit|10|||
149924541|NCT01705080|540859471|FG001|Overall Study|Missed visit|4|||
149924542|NCT01705080|540859472|FG002|Overall Study|Missed visit|1|||
149924543|NCT01705080|540859470|FG000|Overall Study|Death|4|||
149924544|NCT01705080|540859471|FG001|Overall Study|Death|4|||
149924545|NCT01705080|540859472|FG002|Overall Study|Death|6|||
149924546|NCT01705080|540859470|FG000|Overall Study|Withdrawal by Subject|61|||
149924547|NCT01705080|540859471|FG001|Overall Study|Withdrawal by Subject|44|||
149924548|NCT01705080|540859472|FG002|Overall Study|Withdrawal by Subject|9|||
149924549|NCT02075008|540859479|FG000|Overall Study|Technical problems|1|||
149924550|NCT02075008|540859479|FG000|Overall Study|Pregnancy|1|||
149924551|NCT02075008|540859479|FG000|Overall Study|Physician Decision|1|||
149924552|NCT02075008|540859479|FG000|Overall Study|Lost to Follow-up|1|||
149924553|NCT02075008|540859479|FG000|Overall Study|Lack of Efficacy|1|||
149924554|NCT02075008|540859479|FG000|Overall Study|Death|1|||
149924555|NCT02075008|540859479|FG000|Overall Study|Adverse Event|5|||
149924556|NCT02075008|540859479|FG000|Overall Study|Withdrawal by Subject|6|||
149924557|NCT02075008|540859479|FG000|Overall Study|Study terminated by Sponsor|159|||
149924558|NCT00572455|540859480|FG000|Stage I (14 Days)|Adverse Event|0|||
149924559|NCT00572455|540859481|FG001|Stage I (14 Days)|Adverse Event|0|||
149924560|NCT00572455|540859482|FG002|Stage I (14 Days)|Adverse Event|0|||
149924561|NCT00572455|540859483|FG003|Stage I (14 Days)|Adverse Event|0|||
149924562|NCT00572455|540859484|FG004|Stage I (14 Days)|Adverse Event|0|||
149924563|NCT00572455|540859485|FG005|Stage I (14 Days)|Adverse Event|3|||
149924564|NCT00572455|540859486|FG006|Stage I (14 Days)|Adverse Event|0|||
149924565|NCT00572455|540859487|FG007|Stage I (14 Days)|Adverse Event|0|||
149924566|NCT00572455|540859488|FG008|Stage I (14 Days)|Adverse Event|0|||
149924567|NCT00572455|540859489|FG009|Stage I (14 Days)|Adverse Event|0|||
149924568|NCT00572455|540859490|FG010|Stage I (14 Days)|Adverse Event|0|||
149924569|NCT00572455|540859491|FG011|Stage I (14 Days)|Adverse Event|0|||
149924570|NCT00572455|540859492|FG012|Stage I (14 Days)|Adverse Event|0|||
149924571|NCT00572455|540859493|FG013|Stage I (14 Days)|Adverse Event|0|||
149924572|NCT00572455|540859480|FG000|Stage I (14 Days)|Other|0|||
149924573|NCT00572455|540859481|FG001|Stage I (14 Days)|Other|0|||
149924574|NCT00572455|540859482|FG002|Stage I (14 Days)|Other|0|||
149924575|NCT00572455|540859483|FG003|Stage I (14 Days)|Other|0|||
149924576|NCT00572455|540859484|FG004|Stage I (14 Days)|Other|1|||
149924577|NCT00572455|540859485|FG005|Stage I (14 Days)|Other|0|||
149924578|NCT00572455|540859486|FG006|Stage I (14 Days)|Other|0|||
149924579|NCT00572455|540859487|FG007|Stage I (14 Days)|Other|0|||
149924580|NCT00572455|540859488|FG008|Stage I (14 Days)|Other|0|||
149924581|NCT00572455|540859489|FG009|Stage I (14 Days)|Other|0|||
149924582|NCT00572455|540859490|FG010|Stage I (14 Days)|Other|0|||
149924583|NCT00572455|540859491|FG011|Stage I (14 Days)|Other|0|||
149924584|NCT00572455|540859492|FG012|Stage I (14 Days)|Other|0|||
149924585|NCT00572455|540859493|FG013|Stage I (14 Days)|Other|0|||
149924586|NCT00572455|540859480|FG000|Stage II (28 Days)|Adverse Event|0|||
149924587|NCT00572455|540859481|FG001|Stage II (28 Days)|Adverse Event|0|||
149924588|NCT00572455|540859482|FG002|Stage II (28 Days)|Adverse Event|0|||
149924589|NCT00572455|540859483|FG003|Stage II (28 Days)|Adverse Event|0|||
149924590|NCT00572455|540859484|FG004|Stage II (28 Days)|Adverse Event|0|||
149924591|NCT00572455|540859485|FG005|Stage II (28 Days)|Adverse Event|0|||
149924592|NCT00572455|540859486|FG006|Stage II (28 Days)|Adverse Event|0|||
149924593|NCT00572455|540859487|FG007|Stage II (28 Days)|Adverse Event|0|||
149924594|NCT00572455|540859488|FG008|Stage II (28 Days)|Adverse Event|1|||
149924595|NCT00572455|540859489|FG009|Stage II (28 Days)|Adverse Event|3|||
149924596|NCT00572455|540859490|FG010|Stage II (28 Days)|Adverse Event|3|||
149924597|NCT00572455|540859491|FG011|Stage II (28 Days)|Adverse Event|4|||
149924598|NCT00572455|540859492|FG012|Stage II (28 Days)|Adverse Event|5|||
149924599|NCT00572455|540859493|FG013|Stage II (28 Days)|Adverse Event|1|||
149924600|NCT00572455|540859480|FG000|Stage II (28 Days)|Death|0|||
149924601|NCT00572455|540859481|FG001|Stage II (28 Days)|Death|0|||
149924602|NCT00572455|540859482|FG002|Stage II (28 Days)|Death|0|||
149924603|NCT00572455|540859483|FG003|Stage II (28 Days)|Death|0|||
149924604|NCT00572455|540859484|FG004|Stage II (28 Days)|Death|0|||
149924605|NCT00572455|540859485|FG005|Stage II (28 Days)|Death|0|||
149924606|NCT00572455|540859486|FG006|Stage II (28 Days)|Death|0|||
149924607|NCT00572455|540859487|FG007|Stage II (28 Days)|Death|0|||
149924608|NCT00572455|540859488|FG008|Stage II (28 Days)|Death|1|||
149924609|NCT00572455|540859489|FG009|Stage II (28 Days)|Death|0|||
149924610|NCT00572455|540859490|FG010|Stage II (28 Days)|Death|0|||
149924611|NCT00572455|540859491|FG011|Stage II (28 Days)|Death|0|||
149924612|NCT00572455|540859492|FG012|Stage II (28 Days)|Death|0|||
149924613|NCT00572455|540859493|FG013|Stage II (28 Days)|Death|0|||
149924614|NCT00572455|540859480|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
149924615|NCT00572455|540859481|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
149924616|NCT00572455|540859482|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
149924617|NCT00572455|540859483|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
149924618|NCT00572455|540859484|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
149924619|NCT00572455|540859485|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
149924620|NCT00572455|540859486|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
149924621|NCT00572455|540859487|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
149924622|NCT00572455|540859488|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
149924623|NCT00572455|540859489|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
150160911|NCT02459964|541723618|FG001|Overall Study|Withdrawal by Subject|0|||
150160912|NCT02459964|541723619|FG002|Overall Study|Withdrawal by Subject|1|||
150160913|NCT02459964|541723617|FG000|Overall Study|Abnormal EKG changes|0|||
150160914|NCT02459964|541723618|FG001|Overall Study|Abnormal EKG changes|0|||
150160915|NCT02459964|541723619|FG002|Overall Study|Abnormal EKG changes|1|||
150160916|NCT00550732|541723620|FG000|Overall Study|Death|4|||
150160917|NCT00550732|541723620|FG000|Overall Study|Withdrawal by Subject|2|||
150160918|NCT00550732|541723620|FG000|Overall Study|Physician Decision|2|||
150160919|NCT00550732|541723620|FG000|Overall Study|Lost to Follow-up|1|||
150160920|NCT00550732|541723620|FG000|Overall Study|Palliative care|1|||
149818502|NCT00410410|540465471|FG004|Induction Period (IP)|Lack of Efficacy|7|||
149818503|NCT00410410|540465472|FG005|Induction Period (IP)|Lack of Efficacy|7|||
149818504|NCT00410410|540465473|FG006|Induction Period (IP)|Lack of Efficacy|0|||
149818505|NCT00410410|540465474|FG007|Induction Period (IP)|Lack of Efficacy|0|||
149818506|NCT00410410|540465475|FG008|Induction Period (IP)|Lack of Efficacy|0|||
149818507|NCT00410410|540465467|FG000|Induction Period (IP)|Lost to Follow-up|2|||
149818508|NCT00410410|540465468|FG001|Induction Period (IP)|Lost to Follow-up|2|||
149818509|NCT00410410|540465469|FG002|Induction Period (IP)|Lost to Follow-up|2|||
149818510|NCT00410410|540465470|FG003|Induction Period (IP)|Lost to Follow-up|3|||
149818511|NCT00410410|540465471|FG004|Induction Period (IP)|Lost to Follow-up|0|||
149818512|NCT00410410|540465472|FG005|Induction Period (IP)|Lost to Follow-up|1|||
149818513|NCT00410410|540465473|FG006|Induction Period (IP)|Lost to Follow-up|0|||
149818514|NCT00410410|540465474|FG007|Induction Period (IP)|Lost to Follow-up|0|||
149818515|NCT00410410|540465475|FG008|Induction Period (IP)|Lost to Follow-up|0|||
149818516|NCT00410410|540465467|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
149818517|NCT00410410|540465468|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
149818518|NCT00410410|540465469|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
149818519|NCT00410410|540465470|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
149818520|NCT00410410|540465471|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
149818521|NCT00410410|540465472|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
149818522|NCT00410410|540465473|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
149818523|NCT00410410|540465474|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
149818524|NCT00410410|540465475|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
149818525|NCT00410410|540465467|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818526|NCT00410410|540465468|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818527|NCT00410410|540465469|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
149818528|NCT00410410|540465470|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818529|NCT00410410|540465471|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818530|NCT00410410|540465472|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818531|NCT00410410|540465473|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149924624|NCT00572455|540859490|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
149924625|NCT00572455|540859491|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
149924626|NCT00572455|540859492|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
149924627|NCT00572455|540859493|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
149924628|NCT00572455|540859480|FG000|Stage II (28 Days)|Other|0|||
149924629|NCT00572455|540859481|FG001|Stage II (28 Days)|Other|0|||
149924630|NCT00572455|540859482|FG002|Stage II (28 Days)|Other|0|||
149924631|NCT00572455|540859483|FG003|Stage II (28 Days)|Other|0|||
149924632|NCT00572455|540859484|FG004|Stage II (28 Days)|Other|0|||
149924633|NCT00572455|540859485|FG005|Stage II (28 Days)|Other|0|||
149924634|NCT00572455|540859486|FG006|Stage II (28 Days)|Other|0|||
149924635|NCT00572455|540859487|FG007|Stage II (28 Days)|Other|0|||
149924636|NCT00572455|540859488|FG008|Stage II (28 Days)|Other|1|||
149924637|NCT00572455|540859489|FG009|Stage II (28 Days)|Other|0|||
149924638|NCT00572455|540859490|FG010|Stage II (28 Days)|Other|0|||
149924639|NCT00572455|540859491|FG011|Stage II (28 Days)|Other|0|||
149924640|NCT00572455|540859492|FG012|Stage II (28 Days)|Other|0|||
149924641|NCT00572455|540859493|FG013|Stage II (28 Days)|Other|0|||
149924642|NCT00572455|540859480|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
149924643|NCT00572455|540859481|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
149924644|NCT00572455|540859482|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
149924645|NCT00572455|540859483|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
149924646|NCT00572455|540859484|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
149924647|NCT00572455|540859485|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
149924648|NCT00572455|540859486|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
149924649|NCT00572455|540859487|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
149924650|NCT00572455|540859488|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
149924651|NCT00572455|540859489|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
149924652|NCT00572455|540859490|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
149924653|NCT00572455|540859491|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
149924654|NCT00572455|540859492|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
149924655|NCT00572455|540859493|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
149924656|NCT02821416|540859496|FG000|Overall Study|Adverse Event|0|||
149924657|NCT02821416|540859497|FG001|Overall Study|Adverse Event|1|||
149924658|NCT02821416|540859496|FG000|Overall Study|Withdrawal by Subject|2|||
149924659|NCT02821416|540859497|FG001|Overall Study|Withdrawal by Subject|0|||
149924660|NCT02821416|540859496|FG000|Overall Study|Lost to Follow-up|1|||
149924661|NCT02821416|540859497|FG001|Overall Study|Lost to Follow-up|0|||
149924662|NCT02256917|540859499|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
149924663|NCT02256917|540859499|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
149924664|NCT02256917|540859499|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
149924665|NCT02256917|540859499|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
149924666|NCT02256917|540859499|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
149924667|NCT01308463|540859503|FG000|Overall Study|Study Discontinued|23|||
149924668|NCT01308463|540859503|FG000|Overall Study|Death|4|||
149924669|NCT01308463|540859503|FG000|Overall Study|Revision|2|||
149924670|NCT01042392|540859504|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
149924671|NCT01042392|540859505|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
149924672|NCT01042392|540859506|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
149924673|NCT01042392|540859507|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
149924674|NCT01042392|540859504|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
149924675|NCT01042392|540859505|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
149924676|NCT01042392|540859506|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
149924677|NCT01042392|540859507|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
149924678|NCT01042392|540859504|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
149924679|NCT01042392|540859505|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
149924680|NCT01042392|540859506|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
149924681|NCT01042392|540859507|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
149924682|NCT01042392|540859504|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
149924683|NCT01042392|540859505|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
149924684|NCT01042392|540859506|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
149924685|NCT01042392|540859507|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
149924686|NCT01042392|540859504|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
149924687|NCT01042392|540859505|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
149924688|NCT01042392|540859506|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
149924689|NCT01042392|540859507|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
149924690|NCT01042392|540859504|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
149924691|NCT01042392|540859505|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
149924692|NCT01042392|540859506|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
149924693|NCT01042392|540859507|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
149924694|NCT01042392|540859504|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
149924695|NCT01042392|540859505|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
149924696|NCT01042392|540859506|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
149924697|NCT01042392|540859507|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
149924698|NCT01042392|540859504|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
149924699|NCT01042392|540859505|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
149924700|NCT01042392|540859506|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
149924701|NCT01042392|540859507|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
149924702|NCT01042392|540859504|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
149924703|NCT01042392|540859505|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
149924704|NCT01042392|540859506|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
149924705|NCT01042392|540859507|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
149924706|NCT03117361|540859508|FG000|Overall Study|Progressive disease|5|||
149924707|NCT03117361|540859508|FG000|Overall Study|Death|1|||
149924708|NCT03117361|540859508|FG000|Overall Study|Physician Decision|2|||
149924709|NCT03117361|540859508|FG000|Overall Study|On study treatment at the end of study|1|||
149924710|NCT03117361|540859508|FG000|Overall Study|Treatment-related adverse event|1|||
149924711|NCT00587795|540859509|FG000|Overall Study|Withdrawal by Subject|1|||
149924712|NCT00587795|540859510|FG001|Overall Study|Withdrawal by Subject|0|||
149924713|NCT00540644|540859511|FG000|Overall Study|Adverse Event|3|||
149924714|NCT00540644|540859512|FG001|Overall Study|Adverse Event|1|||
149924715|NCT00540644|540859511|FG000|Overall Study|Disease Progression|3|||
149924716|NCT00540644|540859512|FG001|Overall Study|Disease Progression|1|||
149924717|NCT00540644|540859511|FG000|Overall Study|Physician Decision|0|||
149924718|NCT00540644|540859512|FG001|Overall Study|Physician Decision|5|||
149924719|NCT00540644|540859511|FG000|Overall Study|Withdrawal by Subject|2|||
149924720|NCT00540644|540859512|FG001|Overall Study|Withdrawal by Subject|2|||
149924721|NCT00540644|540859511|FG000|Overall Study|Noncomplilance|1|||
149924722|NCT00540644|540859512|FG001|Overall Study|Noncomplilance|0|||
149924723|NCT01869777|540859513|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
149924724|NCT02072941|540859514|FG000|Overall Study|Withdrawal by Subject|29|||
149924725|NCT02072941|540859515|FG001|Overall Study|Withdrawal by Subject|21|||
149924726|NCT02072941|540859514|FG000|Overall Study|Lost to Follow-up|4|||
149924727|NCT02072941|540859515|FG001|Overall Study|Lost to Follow-up|4|||
149924728|NCT02072941|540859514|FG000|Overall Study|Death|3|||
149924729|NCT02072941|540859515|FG001|Overall Study|Death|2|||
149924730|NCT02072941|540859514|FG000|Overall Study|Removed by Study Staff|2|||
149924731|NCT02072941|540859515|FG001|Overall Study|Removed by Study Staff|2|||
149924732|NCT02982863|540859516|FG000|Overall Study|Not eligible patients|809|||
149924733|NCT02982863|540859517|FG001|Overall Study|Not eligible patients|4261|||
149924734|NCT02982863|540859518|FG002|Overall Study|Not eligible patients|1852|||
149924735|NCT02982863|540859519|FG003|Overall Study|Not eligible patients|1400|||
149924736|NCT02982863|540859520|FG004|Overall Study|Not eligible patients|492|||
149924737|NCT02869893|540859523|FG000|Overall Study|participant aversion to IV|5|||
149924738|NCT02869893|540859523|FG000|Overall Study|participant fear of MRI scanner|2|||
149924739|NCT03066778|540859524|FG000|Overall Study|Death|195|||
149924740|NCT03066778|540859525|FG001|Overall Study|Death|205|||
149924741|NCT03066778|540859524|FG000|Overall Study|Withdrawal by Subject|5|||
149924742|NCT03066778|540859525|FG001|Overall Study|Withdrawal by Subject|7|||
149924743|NCT01765569|540859529|FG000|Period B|Withdrawal by Subject|1|||
149924744|NCT01765569|540859529|FG000|Period C|Death|1|||
149924745|NCT00423813|540859530|FG000|Overall Study|Adverse Event|11|||
149924746|NCT00423813|540859531|FG001|Overall Study|Adverse Event|30|||
149924747|NCT00423813|540859532|FG002|Overall Study|Adverse Event|40|||
149924748|NCT00423813|540859530|FG000|Overall Study|Withdrawal by Subject|6|||
149924749|NCT00423813|540859531|FG001|Overall Study|Withdrawal by Subject|8|||
149924750|NCT00423813|540859532|FG002|Overall Study|Withdrawal by Subject|5|||
149924751|NCT00423813|540859530|FG000|Overall Study|Lost to Follow-up|5|||
149924752|NCT00423813|540859531|FG001|Overall Study|Lost to Follow-up|4|||
149924753|NCT00423813|540859532|FG002|Overall Study|Lost to Follow-up|4|||
149924754|NCT00423813|540859530|FG000|Overall Study|Lack of Efficacy|23|||
149924755|NCT00423813|540859531|FG001|Overall Study|Lack of Efficacy|18|||
149924756|NCT00423813|540859532|FG002|Overall Study|Lack of Efficacy|19|||
149924757|NCT00423813|540859530|FG000|Overall Study|Physician Decision|2|||
149924758|NCT00423813|540859531|FG001|Overall Study|Physician Decision|0|||
149924759|NCT00423813|540859532|FG002|Overall Study|Physician Decision|0|||
149924760|NCT00423813|540859530|FG000|Overall Study|Sponsor Decision|0|||
149924761|NCT00423813|540859531|FG001|Overall Study|Sponsor Decision|1|||
149924762|NCT00423813|540859532|FG002|Overall Study|Sponsor Decision|0|||
149924763|NCT00423813|540859530|FG000|Overall Study|Protocol Violation|9|||
149924764|NCT00423813|540859531|FG001|Overall Study|Protocol Violation|4|||
149924765|NCT00423813|540859532|FG002|Overall Study|Protocol Violation|4|||
149924766|NCT00423813|540859530|FG000|Overall Study|Pregnancy|0|||
149924767|NCT00423813|540859531|FG001|Overall Study|Pregnancy|0|||
149924768|NCT00423813|540859532|FG002|Overall Study|Pregnancy|1|||
149924769|NCT00423813|540859530|FG000|Overall Study|Subject started night shift work|1|||
149924770|NCT00423813|540859531|FG001|Overall Study|Subject started night shift work|0|||
149924771|NCT00423813|540859532|FG002|Overall Study|Subject started night shift work|0|||
149924772|NCT00423813|540859530|FG000|Overall Study|Will start exclusionary medications|0|||
149924773|NCT00423813|540859531|FG001|Overall Study|Will start exclusionary medications|1|||
150160921|NCT00550732|541723620|FG000|Overall Study|Adverse Event|1|||
150160922|NCT00926393|541723622|FG000|Overall Study|Withdrawal by Subject|1|||
150160923|NCT00926393|541723623|FG001|Overall Study|Withdrawal by Subject|2|||
150160924|NCT00926393|541723622|FG000|Overall Study|Adverse Event|1|||
150160925|NCT00926393|541723623|FG001|Overall Study|Adverse Event|1|||
150160926|NCT03302910|541723630|FG000|Overall Study|Protocol Violation|1|||
150160927|NCT03302910|541723631|FG001|Overall Study|Protocol Violation|0|||
150160928|NCT00051311|541723635|FG000|Overall Study|Starting new study|0|||
150160929|NCT00051311|541723636|FG001|Overall Study|Starting new study|1|||
150160930|NCT00051311|541723635|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
150160931|NCT00051311|541723636|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
150160932|NCT00051311|541723635|FG000|Overall Study|Death of recipient|8|||
150160933|NCT00051311|541723636|FG001|Overall Study|Death of recipient|8|||
150160934|NCT00051311|541723635|FG000|Overall Study|Recipient taken off study|4|||
150160935|NCT00051311|541723636|FG001|Overall Study|Recipient taken off study|4|||
150160936|NCT00953160|541723637|FG000|Overall Study|Lost to Follow-up|23|||
150160937|NCT00953160|541723637|FG000|Overall Study|Withdrawal by Subject|4|||
150160938|NCT01427907|541723638|FG000|Overall Study|Withdrawal by Subject|3|||
149818532|NCT00410410|540465474|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
150160939|NCT01427907|541723639|FG001|Overall Study|Withdrawal by Subject|4|||
150160940|NCT00335153|541723644|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
150160941|NCT00335153|541723644|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
150160942|NCT00335153|541723644|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
150160943|NCT00335153|541723644|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
150160944|NCT00335153|541723644|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
150160945|NCT00335153|541723644|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
150160946|NCT00335153|541723644|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
150160947|NCT00335153|541723644|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
150160948|NCT00335153|541723644|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
150160949|NCT00335153|541723644|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
150160950|NCT01113463|541723649|FG000|Overall Study|Physician Decision|5|||
150160951|NCT02478359|541723651|FG000|Overall Study|Disenrolled from health plan|106|||
150160952|NCT02478359|541723652|FG001|Overall Study|Disenrolled from health plan|65|||
150160953|NCT01818700|541723653|FG000|Overall Study|Adverse Event|67|||
150160954|NCT01818700|541723653|FG000|Overall Study|Lack of Efficacy|2|||
150160955|NCT01818700|541723653|FG000|Overall Study|Lost to Follow-up|5|||
150160956|NCT01818700|541723653|FG000|Overall Study|Withdrawal by Subject|27|||
150160957|NCT01818700|541723653|FG000|Overall Study|Protocol Violation|2|||
149818533|NCT00410410|540465475|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
149818534|NCT00410410|540465467|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818535|NCT00410410|540465468|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818536|NCT00410410|540465469|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818537|NCT00410410|540465470|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818538|NCT00410410|540465471|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
149818539|NCT00410410|540465472|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
149818540|NCT00410410|540465473|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818541|NCT00410410|540465474|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818542|NCT00410410|540465475|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
149818543|NCT00410410|540465467|FG000|Induction Period (IP)|Other|0|||
149818544|NCT00410410|540465468|FG001|Induction Period (IP)|Other|0|||
149818545|NCT00410410|540465469|FG002|Induction Period (IP)|Other|1|||
149818546|NCT00410410|540465470|FG003|Induction Period (IP)|Other|0|||
149818547|NCT00410410|540465471|FG004|Induction Period (IP)|Other|0|||
149818548|NCT00410410|540465472|FG005|Induction Period (IP)|Other|0|||
149818549|NCT00410410|540465473|FG006|Induction Period (IP)|Other|0|||
149818550|NCT00410410|540465474|FG007|Induction Period (IP)|Other|0|||
149818551|NCT00410410|540465475|FG008|Induction Period (IP)|Other|0|||
149818552|NCT00410410|540465467|FG000|Maintenance Period (MP)|Death|0|||
149818553|NCT00410410|540465468|FG001|Maintenance Period (MP)|Death|0|||
149818554|NCT00410410|540465469|FG002|Maintenance Period (MP)|Death|0|||
149818555|NCT00410410|540465470|FG003|Maintenance Period (MP)|Death|0|||
149818556|NCT00410410|540465471|FG004|Maintenance Period (MP)|Death|0|||
149818557|NCT00410410|540465472|FG005|Maintenance Period (MP)|Death|0|||
149818558|NCT00410410|540465473|FG006|Maintenance Period (MP)|Death|1|||
149818559|NCT00410410|540465474|FG007|Maintenance Period (MP)|Death|0|||
149818560|NCT00410410|540465475|FG008|Maintenance Period (MP)|Death|0|||
149818561|NCT00410410|540465467|FG000|Maintenance Period (MP)|Adverse Event|0|||
149818562|NCT00410410|540465468|FG001|Maintenance Period (MP)|Adverse Event|0|||
149818563|NCT00410410|540465469|FG002|Maintenance Period (MP)|Adverse Event|0|||
149818564|NCT00410410|540465470|FG003|Maintenance Period (MP)|Adverse Event|0|||
149818565|NCT00410410|540465471|FG004|Maintenance Period (MP)|Adverse Event|0|||
149818566|NCT00410410|540465472|FG005|Maintenance Period (MP)|Adverse Event|0|||
150160958|NCT01818700|541723653|FG000|Overall Study|Other|1|||
149818567|NCT00410410|540465473|FG006|Maintenance Period (MP)|Adverse Event|1|||
149924774|NCT00423813|540859532|FG002|Overall Study|Will start exclusionary medications|0|||
149924775|NCT00423813|540859530|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
149924776|NCT00423813|540859531|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
149924777|NCT00423813|540859532|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
149924778|NCT01386944|540859533|FG000|Overall Study|Adverse Event|26|||
149924779|NCT01386944|540859533|FG000|Overall Study|Lack of Efficacy|14|||
149924780|NCT01386944|540859533|FG000|Overall Study|Lost to Follow-up|8|||
149924781|NCT01386944|540859533|FG000|Overall Study|Unspecified reason|8|||
149924782|NCT03883477|540859534|FG000|Overall Study|Death|1|||
149924783|NCT03883477|540859535|FG001|Overall Study|Death|0|||
149924784|NCT03883477|540859534|FG000|Overall Study|Protocol Violation|0|||
149924785|NCT03883477|540859535|FG001|Overall Study|Protocol Violation|1|||
149924786|NCT01658904|540859536|FG000|Overall Study|Principal Investigator discretion|2|||
149924787|NCT01658904|540859537|FG001|Overall Study|Principal Investigator discretion|0|||
149924788|NCT01658904|540859538|FG002|Overall Study|Principal Investigator discretion|0|||
149924789|NCT00531947|540859539|FG000|Overall Study|Adverse Event|5|||
149924790|NCT00531947|540859540|FG001|Overall Study|Adverse Event|10|||
149924791|NCT00531947|540859539|FG000|Overall Study|Lost to Follow-up|12|||
149924792|NCT00531947|540859540|FG001|Overall Study|Lost to Follow-up|9|||
149924793|NCT00531947|540859539|FG000|Overall Study|Withdrawal by Subject|14|||
149924794|NCT00531947|540859540|FG001|Overall Study|Withdrawal by Subject|19|||
149924795|NCT00531947|540859539|FG000|Overall Study|Protocol Violation|2|||
149924796|NCT00531947|540859540|FG001|Overall Study|Protocol Violation|1|||
149924797|NCT00531947|540859539|FG000|Overall Study|Non-Compliance|4|||
149924798|NCT00531947|540859540|FG001|Overall Study|Non-Compliance|7|||
149924799|NCT00531947|540859539|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
149924800|NCT00531947|540859540|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
149924801|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
149924802|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
149924803|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
149924804|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
149924805|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
149924806|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
149924807|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
149924808|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
149924809|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
149924810|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
149924811|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
149924812|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
149924813|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
149924814|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
149924815|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
149924816|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
149924817|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
149924818|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
149924819|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
149924820|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
149924821|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924822|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924823|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
149924824|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924825|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924826|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924827|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924828|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924829|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924830|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
149924831|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924832|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924833|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924834|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924835|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924836|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
149924837|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924838|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
149924839|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924840|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
149924841|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
149924842|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
149924843|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
149924844|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
149924845|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
149924846|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
149924847|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
149924848|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
149924849|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
149924850|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
149924851|NCT04074330|540859549|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924852|NCT04074330|540859550|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
149924853|NCT04074330|540859551|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
149924854|NCT04074330|540859552|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
149924855|NCT04074330|540859553|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924856|NCT04074330|540859554|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
149924857|NCT04074330|540859555|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924858|NCT04074330|540859556|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924859|NCT04074330|540859557|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924860|NCT04074330|540859558|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
149924861|NCT04074330|540859549|FG000|Dose Expansion (up to 42 Months)|Death|0|||
149924862|NCT04074330|540859550|FG001|Dose Expansion (up to 42 Months)|Death|0|||
149924863|NCT04074330|540859551|FG002|Dose Expansion (up to 42 Months)|Death|0|||
149924864|NCT04074330|540859552|FG003|Dose Expansion (up to 42 Months)|Death|0|||
149924865|NCT04074330|540859553|FG004|Dose Expansion (up to 42 Months)|Death|0|||
149924866|NCT04074330|540859554|FG005|Dose Expansion (up to 42 Months)|Death|0|||
149924867|NCT04074330|540859555|FG006|Dose Expansion (up to 42 Months)|Death|0|||
149924868|NCT04074330|540859556|FG007|Dose Expansion (up to 42 Months)|Death|0|||
149924869|NCT04074330|540859557|FG008|Dose Expansion (up to 42 Months)|Death|1|||
149924870|NCT04074330|540859558|FG009|Dose Expansion (up to 42 Months)|Death|0|||
149924871|NCT04074330|540859549|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924872|NCT04074330|540859550|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924873|NCT04074330|540859551|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924874|NCT04074330|540859552|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924875|NCT04074330|540859553|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924876|NCT04074330|540859554|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924877|NCT04074330|540859555|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924878|NCT04074330|540859556|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
149924879|NCT04074330|540859557|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
149924880|NCT04074330|540859558|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
149924881|NCT03124537|540859560|FG000|Overall Study|Lost to Follow-up|3|||
149924882|NCT03124537|540859561|FG001|Overall Study|Lost to Follow-up|5|||
149924883|NCT03124537|540859560|FG000|Overall Study|App Crash, Incomplete Data|7|||
149924884|NCT03124537|540859561|FG001|Overall Study|App Crash, Incomplete Data|8|||
149924885|NCT03681184|540859562|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
150260024|NCT01828073|542089260|FG000|Overall Study|Lost to Follow-up|1|||
150260025|NCT01828073|542089261|FG001|Overall Study|Lost to Follow-up|2|||
150260026|NCT00690443|542089262|FG000|Overall Study|Adverse Event|1|||
150260027|NCT00690443|542089263|FG001|Overall Study|Adverse Event|2|||
150260028|NCT03057977|542089264|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
150260029|NCT03057977|542089265|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
150260030|NCT03057977|542089264|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
150260031|NCT03057977|542089265|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
150260032|NCT03057977|542089264|FG000|Discontinuation From Treatment|Protocol Violation|6|||
150260033|NCT03057977|542089265|FG001|Discontinuation From Treatment|Protocol Violation|5|||
150260034|NCT03057977|542089264|FG000|Discontinuation From Treatment|Not treated|4|||
150260035|NCT03057977|542089265|FG001|Discontinuation From Treatment|Not treated|0|||
150260036|NCT03057977|542089264|FG000|Discontinuation From Treatment|Adverse Event|343|||
150260037|NCT03057977|542089265|FG001|Discontinuation From Treatment|Adverse Event|337|||
150260038|NCT03057977|542089264|FG000|Discontinuation From Treatment|Reason Unknown|0|||
150260039|NCT03057977|542089265|FG001|Discontinuation From Treatment|Reason Unknown|1|||
150260040|NCT03057977|542089264|FG000|Discontinuation From Treatment|Personal Reasons|1|||
150260041|NCT03057977|542089265|FG001|Discontinuation From Treatment|Personal Reasons|1|||
150260042|NCT03057977|542089264|FG000|Discontinuation From Treatment|Unblinded medication|1|||
150260043|NCT03057977|542089265|FG001|Discontinuation From Treatment|Unblinded medication|0|||
150260044|NCT03057977|542089264|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
150260045|NCT03057977|542089265|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
150260046|NCT03057977|542089264|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
149924886|NCT03681184|540859563|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
149924887|NCT03162328|540859566|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
149924888|NCT03162328|540859567|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
149924889|NCT03162328|540859568|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
149924890|NCT03162328|540859566|FG000|Screening Period|Withdrawal by Subject|1|||
149924891|NCT03162328|540859567|FG001|Screening Period|Withdrawal by Subject|0|||
149924892|NCT03162328|540859568|FG002|Screening Period|Withdrawal by Subject|0|||
149924893|NCT03162328|540859566|FG000|Study Period|Withdrawal by Subject|0|||
149924894|NCT03162328|540859567|FG001|Study Period|Withdrawal by Subject|0|||
149924895|NCT03162328|540859568|FG002|Study Period|Withdrawal by Subject|1|||
149924896|NCT03301831|540859569|FG000|Overall Study|Lost to Follow-up|5|||
149924897|NCT03301831|540859570|FG001|Overall Study|Lost to Follow-up|3|||
149924898|NCT03301831|540859569|FG000|Overall Study|Protocol Violation|4|||
149924899|NCT03301831|540859570|FG001|Overall Study|Protocol Violation|0|||
149924900|NCT03301831|540859569|FG000|Overall Study|Withdrawal by Subject|11|||
149924901|NCT03301831|540859570|FG001|Overall Study|Withdrawal by Subject|0|||
149924902|NCT00913770|540859571|FG000|Overall Study|Unable to contact|24|||
149924903|NCT00913770|540859572|FG001|Overall Study|Unable to contact|19|||
149924904|NCT00913770|540859573|FG002|Overall Study|Unable to contact|13|||
149924905|NCT00913770|540859571|FG000|Overall Study|Refused|11|||
149924906|NCT00913770|540859572|FG001|Overall Study|Refused|10|||
149924907|NCT00913770|540859573|FG002|Overall Study|Refused|8|||
149924908|NCT02348008|540859574|FG000|Overall Study|Adverse Event|2|||
149924909|NCT02348008|540859575|FG001|Overall Study|Adverse Event|3|||
149924910|NCT02348008|540859576|FG002|Overall Study|Adverse Event|3|||
149924911|NCT02348008|540859574|FG000|Overall Study|Disease Progression|1|||
149924912|NCT02348008|540859575|FG001|Overall Study|Disease Progression|5|||
149924913|NCT02348008|540859576|FG002|Overall Study|Disease Progression|16|||
149924914|NCT02348008|540859574|FG000|Overall Study|Withdrawal by Subject|0|||
149924915|NCT02348008|540859575|FG001|Overall Study|Withdrawal by Subject|1|||
149924916|NCT02348008|540859576|FG002|Overall Study|Withdrawal by Subject|0|||
149924917|NCT02348008|540859574|FG000|Overall Study|Symptomatic Deterioration|0|||
149924918|NCT02348008|540859575|FG001|Overall Study|Symptomatic Deterioration|1|||
149924919|NCT02348008|540859576|FG002|Overall Study|Symptomatic Deterioration|0|||
149924920|NCT03268005|540859582|FG000|Overall Study|Death|2|||
149924921|NCT03268005|540859583|FG001|Overall Study|Death|1|||
149924922|NCT03268005|540859582|FG000|Overall Study|Lost to Follow-up|2|||
149924923|NCT03268005|540859583|FG001|Overall Study|Lost to Follow-up|2|||
149924924|NCT03268005|540859582|FG000|Overall Study|Withdrawal by Subject|11|||
149924925|NCT03268005|540859583|FG001|Overall Study|Withdrawal by Subject|11|||
149924926|NCT00980655|540859584|FG000|Overall Study|Adverse Event|13|||
149924927|NCT00980655|540859585|FG001|Overall Study|Adverse Event|31|||
149924928|NCT00980655|540859584|FG000|Overall Study|Death|0|||
149924929|NCT00980655|540859585|FG001|Overall Study|Death|7|||
149924930|NCT00980655|540859584|FG000|Overall Study|Protocol Violation|2|||
149924931|NCT00980655|540859585|FG001|Overall Study|Protocol Violation|7|||
149924932|NCT00980655|540859584|FG000|Overall Study|Withdrawal by Subject|0|||
149924933|NCT00980655|540859585|FG001|Overall Study|Withdrawal by Subject|4|||
149924934|NCT00980655|540859584|FG000|Overall Study|Lost to Follow-up|0|||
149924935|NCT00980655|540859585|FG001|Overall Study|Lost to Follow-up|1|||
149924936|NCT00980655|540859584|FG000|Overall Study|Parent/legal guardian request|1|||
149924937|NCT00980655|540859585|FG001|Overall Study|Parent/legal guardian request|0|||
149924938|NCT00980655|540859584|FG000|Overall Study|Other|0|||
149924939|NCT00980655|540859585|FG001|Overall Study|Other|1|||
149924940|NCT00248833|540859591|FG000|Overall Study|Adverse Event|2|||
149924941|NCT00248833|540859592|FG001|Overall Study|Adverse Event|0|||
149924942|NCT00248833|540859593|FG002|Overall Study|Adverse Event|0|||
149924943|NCT00248833|540859591|FG000|Overall Study|Withdrawal by Subject|0|||
149924944|NCT00248833|540859592|FG001|Overall Study|Withdrawal by Subject|1|||
149924945|NCT00248833|540859593|FG002|Overall Study|Withdrawal by Subject|1|||
149924946|NCT00248833|540859591|FG000|Overall Study|Lost to Follow-up|1|||
149924947|NCT00248833|540859592|FG001|Overall Study|Lost to Follow-up|1|||
149924948|NCT00248833|540859593|FG002|Overall Study|Lost to Follow-up|1|||
149924949|NCT00248833|540859591|FG000|Overall Study|Other|0|||
149924950|NCT00248833|540859592|FG001|Overall Study|Other|1|||
149924951|NCT00248833|540859593|FG002|Overall Study|Other|0|||
149924952|NCT02427802|540859594|FG000|Overall Study|Adverse Event|11|||
149924953|NCT02427802|540859595|FG001|Overall Study|Adverse Event|3|||
150160959|NCT01417000|541723654|FG000|Overall Study|Death|59|||
150160960|NCT01417000|541723655|FG001|Overall Study|Death|28|||
150160961|NCT01417000|541723654|FG000|Overall Study|Lost to Follow-up|1|||
150160962|NCT01417000|541723655|FG001|Overall Study|Lost to Follow-up|0|||
150160963|NCT01417000|541723654|FG000|Overall Study|Study Terminated by Sponsor|1|||
150160964|NCT01417000|541723655|FG001|Overall Study|Study Terminated by Sponsor|1|||
150160965|NCT00562965|541723656|FG000|Overall Study|Withdrawal by Subject|0|||
150160966|NCT00562965|541723657|FG001|Overall Study|Withdrawal by Subject|1|||
150160967|NCT00562965|541723656|FG000|Overall Study|Death|2|||
150160968|NCT00562965|541723657|FG001|Overall Study|Death|4|||
149924954|NCT02427802|540859596|FG002|Overall Study|Adverse Event|7|||
150260047|NCT03057977|542089265|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
150260048|NCT03057977|542089264|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
150260049|NCT03057977|542089265|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
150260050|NCT03057977|542089264|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
150260051|NCT03057977|542089265|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
150260052|NCT03057977|542089264|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
150260053|NCT03057977|542089265|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
150260054|NCT03057977|542089264|FG000|Discontinuation From Treatment|Not attending study visit|3|||
150260055|NCT03057977|542089265|FG001|Discontinuation From Treatment|Not attending study visit|10|||
149818568|NCT00410410|540465474|FG007|Maintenance Period (MP)|Adverse Event|3|||
150260056|NCT03057977|542089264|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
150260057|NCT03057977|542089265|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
150260058|NCT03057977|542089264|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
150260059|NCT03057977|542089265|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
150260060|NCT03057977|542089264|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
150260061|NCT03057977|542089265|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
150260062|NCT03057977|542089264|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
150260063|NCT03057977|542089265|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
150260064|NCT03057977|542089264|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
150260065|NCT03057977|542089265|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
150260066|NCT00953407|542089266|FG000|Overall Study|Failed inclusion criteria|1|||
150260067|NCT00953407|542089267|FG001|Overall Study|Failed inclusion criteria|1|||
150260068|NCT00953407|542089268|FG002|Overall Study|Failed inclusion criteria|1|||
150260069|NCT00953407|542089269|FG003|Overall Study|Failed inclusion criteria|1|||
150260070|NCT00953407|542089270|FG004|Overall Study|Failed inclusion criteria|1|||
150260071|NCT00953407|542089266|FG000|Overall Study|Lost to Follow-up|0|||
150260072|NCT00953407|542089267|FG001|Overall Study|Lost to Follow-up|0|||
150260073|NCT00953407|542089268|FG002|Overall Study|Lost to Follow-up|0|||
150260074|NCT00953407|542089269|FG003|Overall Study|Lost to Follow-up|1|||
150260075|NCT00953407|542089270|FG004|Overall Study|Lost to Follow-up|0|||
150260076|NCT02502097|542089271|FG000|Period 1|Adverse Event|0|||
150260077|NCT02502097|542089272|FG001|Period 1|Adverse Event|0|||
150260078|NCT02502097|542089273|FG002|Period 1|Adverse Event|1|||
149818569|NCT00410410|540465475|FG008|Maintenance Period (MP)|Adverse Event|0|||
149818570|NCT00410410|540465467|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
149818571|NCT00410410|540465468|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
149818572|NCT00410410|540465469|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
149818573|NCT00410410|540465470|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
149818574|NCT00410410|540465471|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
149818575|NCT00410410|540465472|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
149818576|NCT00410410|540465473|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
149818577|NCT00410410|540465474|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
149818578|NCT00410410|540465475|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
149818579|NCT00410410|540465467|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
149818580|NCT00410410|540465468|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
149818581|NCT00410410|540465469|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
149818582|NCT00410410|540465470|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
149818583|NCT00410410|540465471|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
149818584|NCT00410410|540465472|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
149818585|NCT00410410|540465473|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
149818586|NCT00410410|540465474|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
149818587|NCT00410410|540465475|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
149818588|NCT00410410|540465467|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818589|NCT00410410|540465468|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818590|NCT00410410|540465469|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818591|NCT00410410|540465470|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818592|NCT00410410|540465471|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818593|NCT00410410|540465472|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818594|NCT00410410|540465473|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
149818595|NCT00410410|540465474|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
149818596|NCT00410410|540465475|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
149818597|NCT00410410|540465467|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818598|NCT00410410|540465468|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818599|NCT00410410|540465469|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818600|NCT00410410|540465470|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818601|NCT00410410|540465471|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149924955|NCT02427802|540859594|FG000|Overall Study|Death|0|||
150260079|NCT02502097|542089274|FG003|Period 1|Adverse Event|0|||
150260080|NCT02502097|542089271|FG000|Wash Out Period|Adverse Event|0|||
150260081|NCT02502097|542089272|FG001|Wash Out Period|Adverse Event|1|||
150260082|NCT02502097|542089273|FG002|Wash Out Period|Adverse Event|1|||
149924956|NCT02427802|540859595|FG001|Overall Study|Death|4|||
149924957|NCT02427802|540859596|FG002|Overall Study|Death|1|||
149924958|NCT02427802|540859594|FG000|Overall Study|Lost to Follow-up|13|||
149924959|NCT02427802|540859595|FG001|Overall Study|Lost to Follow-up|8|||
149924960|NCT02427802|540859596|FG002|Overall Study|Lost to Follow-up|8|||
149924961|NCT02427802|540859594|FG000|Overall Study|Physician Decision|4|||
149924962|NCT02427802|540859595|FG001|Overall Study|Physician Decision|2|||
149924963|NCT02427802|540859596|FG002|Overall Study|Physician Decision|4|||
149924964|NCT02427802|540859594|FG000|Overall Study|Withdrawal by Subject|10|||
149924965|NCT02427802|540859595|FG001|Overall Study|Withdrawal by Subject|5|||
149924966|NCT02427802|540859596|FG002|Overall Study|Withdrawal by Subject|11|||
149924967|NCT02427802|540859594|FG000|Overall Study|Protocol Violation|3|||
149924968|NCT02427802|540859595|FG001|Overall Study|Protocol Violation|1|||
149924969|NCT02427802|540859596|FG002|Overall Study|Protocol Violation|1|||
149924970|NCT02427802|540859594|FG000|Overall Study|protocol specific treatment unrelated|18|||
149924971|NCT02427802|540859595|FG001|Overall Study|protocol specific treatment unrelated|11|||
150160969|NCT00562965|541723656|FG000|Overall Study|Lost to Follow-up|1|||
150160970|NCT00562965|541723657|FG001|Overall Study|Lost to Follow-up|0|||
150160971|NCT00562965|541723656|FG000|Overall Study|Other|0|||
150160972|NCT00562965|541723657|FG001|Overall Study|Other|1|||
150160973|NCT00958009|541723658|FG000|Overall Study|Adverse Event|1|||
150160974|NCT00958009|541723658|FG000|Overall Study|Subject found device difficult to use|1|||
150160975|NCT03379233|541723661|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
150160976|NCT03379233|541723662|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
150160977|NCT00965484|541723663|FG000|Overall Study|Protocol Violation|1|||
150160978|NCT00965484|541723663|FG000|Overall Study|Withdrawal by Subject|1|||
150160979|NCT00848211|541723664|FG000|Overall Study|Protocol Violation|0|||
150160980|NCT00848211|541723665|FG001|Overall Study|Protocol Violation|1|||
150160981|NCT00848211|541723666|FG002|Overall Study|Protocol Violation|1|||
150160982|NCT00848211|541723667|FG003|Overall Study|Protocol Violation|0|||
150160983|NCT00848211|541723664|FG000|Overall Study|Adverse Event|0|||
150160984|NCT00848211|541723665|FG001|Overall Study|Adverse Event|0|||
150160985|NCT00848211|541723666|FG002|Overall Study|Adverse Event|0|||
150160986|NCT00848211|541723667|FG003|Overall Study|Adverse Event|0|||
150160987|NCT01124617|541723668|FG000|Overall Study|Adverse Event|5|||
150160988|NCT01124617|541723669|FG001|Overall Study|Adverse Event|2|||
150160989|NCT01124617|541723668|FG000|Overall Study|Lack of Efficacy|2|||
150160990|NCT01124617|541723669|FG001|Overall Study|Lack of Efficacy|1|||
150160991|NCT01124617|541723668|FG000|Overall Study|Protocol Violation|1|||
150160992|NCT01124617|541723669|FG001|Overall Study|Protocol Violation|1|||
150160993|NCT01124617|541723668|FG000|Overall Study|Withdrawal by Subject|9|||
150160994|NCT01124617|541723669|FG001|Overall Study|Withdrawal by Subject|1|||
150160995|NCT01124617|541723668|FG000|Overall Study|Other|2|||
150160996|NCT01124617|541723669|FG001|Overall Study|Other|1|||
150160997|NCT00945477|541723670|FG000|Overall Study|Adverse Event|3|||
150160998|NCT00945477|541723670|FG000|Overall Study|Lack of Efficacy|2|||
150160999|NCT00945477|541723670|FG000|Overall Study|Withdrawal by Subject|1|||
150161000|NCT02825043|541723671|FG000|Overall Study|Lost to Follow-up|4|||
150161001|NCT03582137|541723675|FG000|Overall Study|Adverse Event|1|||
150161002|NCT03582137|541723676|FG001|Overall Study|Adverse Event|0|||
150161003|NCT00859014|541723681|FG000|Overall Study|Death|4|||
150161004|NCT00859014|541723681|FG000|Overall Study|Lost to Follow-up|1|||
150161005|NCT00162942|541723682|FG000|Overall Study|Adverse Event|10|||
150161006|NCT00162942|541723683|FG001|Overall Study|Adverse Event|6|||
150161007|NCT00162942|541723682|FG000|Overall Study|Death|1|||
150161008|NCT00162942|541723683|FG001|Overall Study|Death|0|||
150161009|NCT00162942|541723682|FG000|Overall Study|Withdrawal by Subject|3|||
150161010|NCT00162942|541723683|FG001|Overall Study|Withdrawal by Subject|6|||
150161011|NCT00162942|541723682|FG000|Overall Study|Physician Decision|1|||
150161012|NCT00162942|541723683|FG001|Overall Study|Physician Decision|0|||
150161013|NCT00162942|541723682|FG000|Overall Study|Enter Open-Label Study|76|||
150161014|NCT00162942|541723683|FG001|Overall Study|Enter Open-Label Study|35|||
150161015|NCT00162942|541723682|FG000|Overall Study|Alternate Therapy|6|||
150161016|NCT00162942|541723683|FG001|Overall Study|Alternate Therapy|2|||
150161017|NCT00162942|541723682|FG000|Overall Study|Lack of Efficacy|1|||
150161018|NCT00162942|541723683|FG001|Overall Study|Lack of Efficacy|0|||
150161019|NCT00162942|541723682|FG000|Overall Study|Flare During Active Treatment|7|||
150161020|NCT00162942|541723683|FG001|Overall Study|Flare During Active Treatment|3|||
150161021|NCT00162942|541723682|FG000|Overall Study|2 or more consecutive treatments missed|1|||
150161022|NCT00162942|541723683|FG001|Overall Study|2 or more consecutive treatments missed|0|||
150161023|NCT01253200|541723684|FG000|Overall Study|Death|1|||
150161024|NCT01253200|541723685|FG001|Overall Study|Death|0|||
150161025|NCT01253200|541723686|FG002|Overall Study|Death|0|||
150161026|NCT01253200|541723687|FG003|Overall Study|Death|0|||
150161027|NCT01253200|541723688|FG004|Overall Study|Death|0|||
149924972|NCT02427802|540859596|FG002|Overall Study|protocol specific treatment unrelated|11|||
149924973|NCT02823470|540861447|FG000|Overall Study|Adverse Event|1|||
150161028|NCT01253200|541723684|FG000|Overall Study|Lost to Follow-up|1|||
150161029|NCT01253200|541723685|FG001|Overall Study|Lost to Follow-up|1|||
149924974|NCT02823470|540861448|FG001|Overall Study|Adverse Event|0|||
149924975|NCT02823470|540861447|FG000|Overall Study|Study terminated by sponsor|8|||
149924976|NCT02823470|540861448|FG001|Overall Study|Study terminated by sponsor|15|||
149924977|NCT02748057|540861449|FG000|Overall Study|Adverse Event|1|||
149924978|NCT02748057|540861450|FG001|Overall Study|Adverse Event|0|||
149924979|NCT02748057|540861449|FG000|Overall Study|Physician Decision|0|||
149924980|NCT02748057|540861450|FG001|Overall Study|Physician Decision|1|||
149924981|NCT02748057|540861449|FG000|Overall Study|Protocol Violation|2|||
149924982|NCT02748057|540861450|FG001|Overall Study|Protocol Violation|1|||
149924983|NCT02748057|540861449|FG000|Overall Study|Participant Moved|1|||
149924984|NCT02748057|540861450|FG001|Overall Study|Participant Moved|0|||
149924985|NCT02748057|540861449|FG000|Overall Study|Withdrawal by Subject|1|||
149924986|NCT02748057|540861450|FG001|Overall Study|Withdrawal by Subject|0|||
149924987|NCT02793947|540861459|FG000|Overall Study|Death|1|||
149924988|NCT02793947|540861460|FG001|Overall Study|Death|0|||
149924989|NCT02793947|540861459|FG000|Overall Study|Physician Decision|1|||
149924990|NCT02793947|540861460|FG001|Overall Study|Physician Decision|5|||
149924991|NCT02213380|540861463|FG000|Underwent Randomization|Withdrawal by Subject|2|||
149818602|NCT00410410|540465472|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818603|NCT00410410|540465473|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
149818604|NCT00410410|540465474|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
149818605|NCT00410410|540465475|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
149818606|NCT00410410|540465467|FG000|Open-Label Period (OL)|Death|0|||
149818607|NCT00410410|540465468|FG001|Open-Label Period (OL)|Death|0|||
149818608|NCT00410410|540465469|FG002|Open-Label Period (OL)|Death|0|||
149818609|NCT00410410|540465470|FG003|Open-Label Period (OL)|Death|0|||
149818610|NCT00410410|540465471|FG004|Open-Label Period (OL)|Death|0|||
149818611|NCT00410410|540465472|FG005|Open-Label Period (OL)|Death|0|||
149818612|NCT00410410|540465473|FG006|Open-Label Period (OL)|Death|0|||
149818613|NCT00410410|540465474|FG007|Open-Label Period (OL)|Death|0|||
149818614|NCT00410410|540465475|FG008|Open-Label Period (OL)|Death|1|||
149818615|NCT00410410|540465467|FG000|Open-Label Period (OL)|Adverse Event|0|||
149818616|NCT00410410|540465468|FG001|Open-Label Period (OL)|Adverse Event|0|||
149818617|NCT00410410|540465469|FG002|Open-Label Period (OL)|Adverse Event|0|||
149818618|NCT00410410|540465470|FG003|Open-Label Period (OL)|Adverse Event|0|||
149818619|NCT00410410|540465471|FG004|Open-Label Period (OL)|Adverse Event|0|||
149818620|NCT00410410|540465472|FG005|Open-Label Period (OL)|Adverse Event|0|||
149818621|NCT00410410|540465473|FG006|Open-Label Period (OL)|Adverse Event|0|||
149818622|NCT00410410|540465474|FG007|Open-Label Period (OL)|Adverse Event|0|||
149818623|NCT00410410|540465475|FG008|Open-Label Period (OL)|Adverse Event|10|||
149818624|NCT00410410|540465467|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
149818625|NCT00410410|540465468|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
149818626|NCT00410410|540465469|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
149818627|NCT00410410|540465470|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
149818628|NCT00410410|540465471|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
149818629|NCT00410410|540465472|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
149818630|NCT00410410|540465473|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
149818631|NCT00410410|540465474|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
149818632|NCT00410410|540465475|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
149818633|NCT00410410|540465467|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
149818634|NCT00410410|540465468|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
149818635|NCT00410410|540465469|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
149818636|NCT00410410|540465470|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
149818637|NCT00410410|540465471|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
149818638|NCT00410410|540465472|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
149818639|NCT00410410|540465473|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
149818640|NCT00410410|540465474|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
149818641|NCT00410410|540465475|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
149818642|NCT00410410|540465467|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818643|NCT00410410|540465468|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818644|NCT00410410|540465469|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818645|NCT00410410|540465470|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
149924992|NCT02213380|540861464|FG001|Underwent Randomization|Withdrawal by Subject|0|||
149924993|NCT02213380|540861463|FG000|Underwent Randomization|Not treated|3|||
149924994|NCT02213380|540861464|FG001|Underwent Randomization|Not treated|3|||
149818646|NCT00410410|540465471|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818647|NCT00410410|540465472|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818648|NCT00410410|540465473|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818649|NCT00410410|540465474|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
149818650|NCT00410410|540465475|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
149818651|NCT00410410|540465467|FG000|Open-Label Period (OL)|Pregnancy|0|||
149818652|NCT00410410|540465468|FG001|Open-Label Period (OL)|Pregnancy|0|||
149818653|NCT00410410|540465469|FG002|Open-Label Period (OL)|Pregnancy|0|||
149924995|NCT02213380|540861463|FG000|Per-protocol Analysis|Protocol Violation|32|||
149818654|NCT00410410|540465470|FG003|Open-Label Period (OL)|Pregnancy|0|||
149924996|NCT02213380|540861464|FG001|Per-protocol Analysis|Protocol Violation|36|||
149924997|NCT01490840|540861469|FG000|Phase 1|Lost to Follow-up|1|||
149924998|NCT01490840|540861470|FG001|Phase 1|Lost to Follow-up|0|||
149924999|NCT01490840|540861469|FG000|Phase 1|Adverse Event|2|||
149925000|NCT01490840|540861470|FG001|Phase 1|Adverse Event|1|||
149925001|NCT01490840|540861469|FG000|Phase 1|Withdrawal by Subject|6|||
149925002|NCT01490840|540861470|FG001|Phase 1|Withdrawal by Subject|5|||
149925003|NCT01490840|540861469|FG000|Phase 1|Visit 6a omitted|1|||
149925004|NCT01490840|540861470|FG001|Phase 1|Visit 6a omitted|0|||
149925005|NCT01490840|540861469|FG000|Phase 2|Withdrawal by Subject|4|||
149925006|NCT01490840|540861470|FG001|Phase 2|Withdrawal by Subject|3|||
149925007|NCT01490840|540861469|FG000|Phase 2|Permanent interruption of fingolimod|0|||
149925008|NCT01490840|540861470|FG001|Phase 2|Permanent interruption of fingolimod|1|||
149925009|NCT01490840|540861469|FG000|Phase 2|Lost to Follow-up|1|||
149925010|NCT01490840|540861470|FG001|Phase 2|Lost to Follow-up|1|||
149925011|NCT01490840|540861469|FG000|Phase 2|Adverse Event|1|||
149925012|NCT01490840|540861470|FG001|Phase 2|Adverse Event|1|||
149925013|NCT01025284|540861474|FG000|Overall Study|Investigator Decision|0|||
149925014|NCT01025284|540861475|FG001|Overall Study|Investigator Decision|1|||
149925015|NCT01025284|540861476|FG002|Overall Study|Investigator Decision|0|||
149925016|NCT01025284|540861474|FG000|Overall Study|Withdrawal by Subject|0|||
149925017|NCT01025284|540861475|FG001|Overall Study|Withdrawal by Subject|1|||
149925018|NCT01025284|540861476|FG002|Overall Study|Withdrawal by Subject|0|||
149925019|NCT01465230|540861477|FG000|Overall Study|Withdrawal by Subject|2|||
149925020|NCT00905567|540861478|FG000|Washout|Withdrawal by Subject|0|||
149925021|NCT00905567|540861479|FG001|Washout|Withdrawal by Subject|1|||
149925022|NCT02542397|540861480|FG000|Overall Study|Death|2|||
149925023|NCT02542397|540861480|FG000|Overall Study|Physician Decision|6|||
149925024|NCT02542397|540861480|FG000|Overall Study|Withdrawal by Subject|6|||
149925025|NCT02542397|540861480|FG000|Overall Study|Lost to Follow-up|2|||
149925026|NCT01738919|540861486|FG000|Overall Study|Lost to Follow-up|1|||
149925027|NCT01738919|540861487|FG001|Overall Study|Lost to Follow-up|0|||
149925028|NCT01738919|540861486|FG000|Overall Study|Immigrated|0|||
149925029|NCT01738919|540861487|FG001|Overall Study|Immigrated|1|||
149925030|NCT01738919|540861486|FG000|Overall Study|Withdrawal by Subject|0|||
149925031|NCT01738919|540861487|FG001|Overall Study|Withdrawal by Subject|1|||
149925032|NCT01738919|540861486|FG000|Overall Study|Not treated in accordance to guidelines|0|||
149925033|NCT01738919|540861487|FG001|Overall Study|Not treated in accordance to guidelines|1|||
149925034|NCT01473940|540861488|FG000|Induction Therapy|Death|0|||
149925035|NCT01473940|540861489|FG001|Induction Therapy|Death|0|||
149925036|NCT01473940|540861490|FG002|Induction Therapy|Death|1|||
149925037|NCT01473940|540861491|FG003|Induction Therapy|Death|1|||
149925038|NCT01473940|540861488|FG000|Induction Therapy|Progressive Disease|0|||
149925039|NCT01473940|540861489|FG001|Induction Therapy|Progressive Disease|1|||
149925040|NCT01473940|540861490|FG002|Induction Therapy|Progressive Disease|1|||
149925041|NCT01473940|540861491|FG003|Induction Therapy|Progressive Disease|0|||
149925042|NCT01473940|540861488|FG000|Maintenance Therapy|Progressive Disease|1|||
149925043|NCT01473940|540861489|FG001|Maintenance Therapy|Progressive Disease|2|||
149925044|NCT01473940|540861490|FG002|Maintenance Therapy|Progressive Disease|1|||
149925045|NCT01473940|540861491|FG003|Maintenance Therapy|Progressive Disease|4|||
149925046|NCT00547248|540861492|FG000|Overall Study|Protocol Violation|0|||
149925047|NCT00547248|540861493|FG001|Overall Study|Protocol Violation|0|||
149925048|NCT00547248|540861494|FG002|Overall Study|Protocol Violation|1|||
149925049|NCT00547248|540861495|FG003|Overall Study|Protocol Violation|1|||
149925050|NCT00547248|540861492|FG000|Overall Study|Migrated/moved from study area|0|||
149925051|NCT00547248|540861493|FG001|Overall Study|Migrated/moved from study area|0|||
149925052|NCT00547248|540861494|FG002|Overall Study|Migrated/moved from study area|2|||
149925053|NCT00547248|540861495|FG003|Overall Study|Migrated/moved from study area|0|||
149925054|NCT00547248|540861492|FG000|Overall Study|Withdrawal by Subject|0|||
149925055|NCT00547248|540861493|FG001|Overall Study|Withdrawal by Subject|0|||
149925056|NCT00547248|540861494|FG002|Overall Study|Withdrawal by Subject|7|||
149925057|NCT00547248|540861495|FG003|Overall Study|Withdrawal by Subject|1|||
149925058|NCT00534248|540861496|FG000|Overall Study|Adverse Event|19|||
149925059|NCT00534248|540861497|FG001|Overall Study|Adverse Event|29|||
149925060|NCT00534248|540861496|FG000|Overall Study|Lost to Follow-up|353|||
149925061|NCT00534248|540861497|FG001|Overall Study|Lost to Follow-up|375|||
149925062|NCT00534248|540861496|FG000|Overall Study|Other protocol specified criteria|13|||
149925063|NCT00534248|540861497|FG001|Overall Study|Other protocol specified criteria|3|||
149925064|NCT00534248|540861496|FG000|Overall Study|Physician Decision|10|||
149925065|NCT00534248|540861497|FG001|Overall Study|Physician Decision|7|||
149925066|NCT00534248|540861496|FG000|Overall Study|Protocol Violation|3|||
149925067|NCT00534248|540861497|FG001|Overall Study|Protocol Violation|4|||
149925068|NCT00534248|540861496|FG000|Overall Study|Withdrawal by Subject|263|||
149925069|NCT00534248|540861497|FG001|Overall Study|Withdrawal by Subject|255|||
149925070|NCT02532257|540861500|FG000|Overall Study|Adverse Event|2|||
149925071|NCT02532257|540861500|FG000|Overall Study|Physician Decision|4|||
149925072|NCT02532257|540861500|FG000|Overall Study|Withdrawal by Subject|3|||
149925073|NCT02532257|540861500|FG000|Overall Study|Progressive Disease|10|||
149925074|NCT02849171|540861501|FG000|Overall Study|Withdrawal by Subject|1|||
149925075|NCT02849171|540861501|FG000|Overall Study|Not treated|1|||
149925076|NCT02090283|540861502|FG000|Overall Study|Withdrawal by Subject|6|||
149925077|NCT02090283|540861503|FG001|Overall Study|Withdrawal by Subject|6|||
149925078|NCT02090283|540861504|FG002|Overall Study|Withdrawal by Subject|6|||
149925079|NCT02090283|540861502|FG000|Overall Study|Sponsor Terminated Study|6|||
149925080|NCT02090283|540861503|FG001|Overall Study|Sponsor Terminated Study|6|||
149925081|NCT02090283|540861504|FG002|Overall Study|Sponsor Terminated Study|1|||
149925082|NCT02090283|540861502|FG000|Overall Study|Lost to Follow-up|2|||
149925083|NCT02090283|540861503|FG001|Overall Study|Lost to Follow-up|2|||
149925084|NCT02090283|540861504|FG002|Overall Study|Lost to Follow-up|3|||
149925085|NCT02090283|540861502|FG000|Overall Study|Adverse Event|1|||
149925086|NCT02090283|540861503|FG001|Overall Study|Adverse Event|1|||
149925087|NCT02090283|540861504|FG002|Overall Study|Adverse Event|0|||
149925088|NCT02090283|540861502|FG000|Overall Study|Protocol Violation|2|||
149925089|NCT02090283|540861503|FG001|Overall Study|Protocol Violation|0|||
149925090|NCT02090283|540861504|FG002|Overall Study|Protocol Violation|0|||
149925091|NCT00697593|540861510|FG000|Overall Study|Adverse Event|3|||
149925092|NCT00697593|540861510|FG000|Overall Study|Protocol Violation|1|||
149925093|NCT00697593|540861510|FG000|Overall Study|Lack of Efficacy|3|||
149925094|NCT00697593|540861510|FG000|Overall Study|Suspension of the study by sponsor|12|||
149925095|NCT03498313|540861511|FG000|Experimental Period 1|Adverse Event|1|||
149925096|NCT03498313|540861512|FG001|Experimental Period 1|Adverse Event|0|||
149925097|NCT03498313|540861513|FG002|Experimental Period 1|Adverse Event|0|||
149925098|NCT03498313|540861514|FG003|Experimental Period 1|Adverse Event|1|||
149925099|NCT03498313|540861515|FG004|Experimental Period 1|Adverse Event|0|||
149925100|NCT03498313|540861516|FG005|Experimental Period 1|Adverse Event|0|||
149925101|NCT03498313|540861511|FG000|Experimental Period 1|Withdrawal by Subject|0|||
149925102|NCT03498313|540861512|FG001|Experimental Period 1|Withdrawal by Subject|1|||
149925103|NCT03498313|540861513|FG002|Experimental Period 1|Withdrawal by Subject|0|||
149925104|NCT03498313|540861514|FG003|Experimental Period 1|Withdrawal by Subject|0|||
149925105|NCT03498313|540861515|FG004|Experimental Period 1|Withdrawal by Subject|0|||
149925106|NCT03498313|540861516|FG005|Experimental Period 1|Withdrawal by Subject|0|||
149925107|NCT03498313|540861511|FG000|Washout Period 1|Anovulation|1|||
149925108|NCT03498313|540861512|FG001|Washout Period 1|Anovulation|0|||
149925109|NCT03498313|540861513|FG002|Washout Period 1|Anovulation|0|||
149925110|NCT03498313|540861514|FG003|Washout Period 1|Anovulation|0|||
149925111|NCT03498313|540861515|FG004|Washout Period 1|Anovulation|0|||
149925112|NCT03498313|540861516|FG005|Washout Period 1|Anovulation|0|||
149925113|NCT03498313|540861511|FG000|Washout Period 1|Withdrawal by Subject|0|||
149925114|NCT03498313|540861512|FG001|Washout Period 1|Withdrawal by Subject|3|||
149925115|NCT03498313|540861513|FG002|Washout Period 1|Withdrawal by Subject|0|||
149925116|NCT03498313|540861514|FG003|Washout Period 1|Withdrawal by Subject|1|||
149925117|NCT03498313|540861515|FG004|Washout Period 1|Withdrawal by Subject|0|||
149925118|NCT03498313|540861516|FG005|Washout Period 1|Withdrawal by Subject|1|||
149925119|NCT03498313|540861511|FG000|Experimental Period 2|Adverse Event|0|||
149925120|NCT03498313|540861512|FG001|Experimental Period 2|Adverse Event|0|||
149925121|NCT03498313|540861513|FG002|Experimental Period 2|Adverse Event|0|||
149925122|NCT03498313|540861514|FG003|Experimental Period 2|Adverse Event|0|||
149925123|NCT03498313|540861515|FG004|Experimental Period 2|Adverse Event|1|||
149925124|NCT03498313|540861516|FG005|Experimental Period 2|Adverse Event|2|||
149925125|NCT03498313|540861511|FG000|Washout Period 2|Physician Decision|1|||
149925126|NCT03498313|540861512|FG001|Washout Period 2|Physician Decision|0|||
149925127|NCT03498313|540861513|FG002|Washout Period 2|Physician Decision|0|||
149925128|NCT03498313|540861514|FG003|Washout Period 2|Physician Decision|1|||
149925129|NCT03498313|540861515|FG004|Washout Period 2|Physician Decision|0|||
149925130|NCT03498313|540861516|FG005|Washout Period 2|Physician Decision|1|||
150260083|NCT02502097|542089274|FG003|Wash Out Period|Adverse Event|1|||
150260084|NCT02502097|542089271|FG000|Period 2|Adverse Event|0|||
149925131|NCT03498313|540861511|FG000|Washout Period 2|Withdrawal by Subject|3|||
149925132|NCT03498313|540861512|FG001|Washout Period 2|Withdrawal by Subject|2|||
149925133|NCT03498313|540861513|FG002|Washout Period 2|Withdrawal by Subject|0|||
149925134|NCT03498313|540861514|FG003|Washout Period 2|Withdrawal by Subject|0|||
149925135|NCT03498313|540861515|FG004|Washout Period 2|Withdrawal by Subject|2|||
149925136|NCT03498313|540861516|FG005|Washout Period 2|Withdrawal by Subject|0|||
149925137|NCT03498313|540861511|FG000|Washout Period 2|Anovulation|0|||
149925138|NCT03498313|540861512|FG001|Washout Period 2|Anovulation|0|||
149925139|NCT03498313|540861513|FG002|Washout Period 2|Anovulation|0|||
149925140|NCT03498313|540861514|FG003|Washout Period 2|Anovulation|0|||
149925141|NCT03498313|540861515|FG004|Washout Period 2|Anovulation|0|||
149925142|NCT03498313|540861516|FG005|Washout Period 2|Anovulation|1|||
149925143|NCT02964338|540861519|FG000|Overall Study|Sponsor terminated study for futility|12|||
149925144|NCT02964338|540861520|FG001|Overall Study|Sponsor terminated study for futility|15|||
149925145|NCT02964338|540861521|FG002|Overall Study|Sponsor terminated study for futility|14|||
149925146|NCT02964338|540861519|FG000|Overall Study|Lack of Efficacy|0|||
149925147|NCT02964338|540861520|FG001|Overall Study|Lack of Efficacy|3|||
149925148|NCT02964338|540861521|FG002|Overall Study|Lack of Efficacy|0|||
149925149|NCT02964338|540861519|FG000|Overall Study|Lost to Follow-up|1|||
150260085|NCT02502097|542089272|FG001|Period 2|Adverse Event|0|||
149925150|NCT02964338|540861520|FG001|Overall Study|Lost to Follow-up|0|||
149925151|NCT02964338|540861521|FG002|Overall Study|Lost to Follow-up|3|||
149925152|NCT02964338|540861519|FG000|Overall Study|Protocol Violation|0|||
149925153|NCT02964338|540861520|FG001|Overall Study|Protocol Violation|1|||
149925154|NCT02964338|540861521|FG002|Overall Study|Protocol Violation|0|||
149925155|NCT02964338|540861519|FG000|Overall Study|Withdrawal by Subject|1|||
149925156|NCT02964338|540861520|FG001|Overall Study|Withdrawal by Subject|3|||
149925157|NCT02964338|540861521|FG002|Overall Study|Withdrawal by Subject|1|||
149925158|NCT02964338|540861519|FG000|Overall Study|Adverse Event|2|||
149925159|NCT02964338|540861520|FG001|Overall Study|Adverse Event|1|||
149925160|NCT02964338|540861521|FG002|Overall Study|Adverse Event|1|||
149925161|NCT02964338|540861519|FG000|Overall Study|Non-compliant with e-diary|0|||
149925162|NCT02964338|540861520|FG001|Overall Study|Non-compliant with e-diary|1|||
149925163|NCT02964338|540861521|FG002|Overall Study|Non-compliant with e-diary|0|||
149925164|NCT02964338|540861519|FG000|Overall Study|Did not meet criteria|1|||
149925165|NCT02964338|540861520|FG001|Overall Study|Did not meet criteria|0|||
149925166|NCT02964338|540861521|FG002|Overall Study|Did not meet criteria|0|||
149925167|NCT02239640|540861524|FG000|Overall Study|Withdrawal by Subject|3|||
149925168|NCT02239640|540861524|FG000|Overall Study|Lost to Follow-up|72|||
149925169|NCT02239640|540861524|FG000|Overall Study|Death|142|||
149925170|NCT00184002|540861527|FG000|Overall Study|Adverse Event|9|||
149925171|NCT00184002|540861527|FG000|Overall Study|Death|3|||
149925172|NCT00184002|540861527|FG000|Overall Study|Physician Decision|1|||
149925173|NCT00184002|540861527|FG000|Overall Study|Withdrawal by Subject|4|||
149925174|NCT01724177|540861530|FG000|Overall Study|Adverse Event|8|||
149925175|NCT01724177|540861530|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
150260086|NCT02502097|542089273|FG002|Period 2|Adverse Event|1|||
150260087|NCT02502097|542089274|FG003|Period 2|Adverse Event|0|||
150260088|NCT00876928|542089275|FG000|Overall Study|Lost to Follow-up|2|||
150260089|NCT00876928|542089276|FG001|Overall Study|Lost to Follow-up|5|||
150260090|NCT00876928|542089275|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
150260091|NCT00876928|542089276|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
150260092|NCT02874924|542089277|FG000|Overall Study|Adverse Event|2|||
150260093|NCT02874924|542089278|FG001|Overall Study|Adverse Event|0|||
149925176|NCT01724177|540861530|FG000|Overall Study|Nervous participant|1|||
149925177|NCT01724177|540861530|FG000|Overall Study|Serious Adverse Event Related|1|||
149925178|NCT00206427|540861531|FG000|Overall Study|Adverse Event|2|||
149925179|NCT00281697|540861533|FG000|Overall Study|> 60 days since last dose of study drug|4|||
149925180|NCT00281697|540861534|FG001|Overall Study|> 60 days since last dose of study drug|4|||
149925181|NCT00281697|540861533|FG000|Overall Study|Adverse Event|54|||
149925182|NCT00281697|540861534|FG001|Overall Study|Adverse Event|15|||
149925183|NCT00281697|540861533|FG000|Overall Study|Death|8|||
149925184|NCT00281697|540861534|FG001|Overall Study|Death|3|||
149925185|NCT00281697|540861533|FG000|Overall Study|Disease progression|279|||
149925186|NCT00281697|540861534|FG001|Overall Study|Disease progression|149|||
149925187|NCT00281697|540861533|FG000|Overall Study|Other|5|||
149925188|NCT00281697|540861534|FG001|Overall Study|Other|6|||
149925189|NCT00281697|540861533|FG000|Overall Study|Physician's decision to withdraw|15|||
149925190|NCT00281697|540861534|FG001|Overall Study|Physician's decision to withdraw|12|||
149925191|NCT00281697|540861533|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
149925192|NCT00281697|540861534|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
149925193|NCT00281697|540861533|FG000|Overall Study|Did not receive study drug|3|||
149925194|NCT00281697|540861534|FG001|Overall Study|Did not receive study drug|2|||
149925195|NCT04892446|540861535|FG000|Overall Study|Death|4|||
149925196|NCT04892446|540861536|FG001|Overall Study|Death|4|||
149925197|NCT04892446|540861537|FG002|Overall Study|Death|0|||
149925198|NCT04892446|540861535|FG000|Overall Study|Withdrew consent|3|||
149925199|NCT04892446|540861536|FG001|Overall Study|Withdrew consent|0|||
149925200|NCT04892446|540861537|FG002|Overall Study|Withdrew consent|1|||
149925201|NCT04892446|540861535|FG000|Overall Study|Investigator's discretion|1|||
149925202|NCT04892446|540861536|FG001|Overall Study|Investigator's discretion|1|||
149925203|NCT04892446|540861537|FG002|Overall Study|Investigator's discretion|0|||
149925204|NCT04892446|540861535|FG000|Overall Study|Study terminated by sponsor|0|||
149925205|NCT04892446|540861536|FG001|Overall Study|Study terminated by sponsor|0|||
149925206|NCT04892446|540861537|FG002|Overall Study|Study terminated by sponsor|2|||
149925207|NCT03193047|540861538|FG000|Overall Study|Physician Decision|1|||
149925208|NCT03193047|540861539|FG001|Overall Study|Physician Decision|0|||
149925209|NCT03193047|540861538|FG000|Overall Study|Participant Left State|1|||
149925210|NCT03193047|540861539|FG001|Overall Study|Participant Left State|0|||
149925211|NCT02328937|540861540|FG000|Period 1|Lost to Follow-up|0|||
149925212|NCT02328937|540861541|FG001|Period 1|Lost to Follow-up|0|||
149925213|NCT02328937|540861542|FG002|Period 1|Lost to Follow-up|0|||
149925214|NCT02328937|540861543|FG003|Period 1|Lost to Follow-up|1|||
149925215|NCT02328937|540861544|FG004|Period 1|Lost to Follow-up|0|||
149925216|NCT02328937|540861545|FG005|Period 1|Lost to Follow-up|0|||
150260094|NCT02874924|542089279|FG002|Overall Study|Adverse Event|0|||
150260095|NCT02874924|542089277|FG000|Overall Study|Withdrawal by Subject|1|||
149925217|NCT02328937|540861540|FG000|Period 2|Adverse Event|0|||
149925218|NCT02328937|540861541|FG001|Period 2|Adverse Event|0|||
149925219|NCT02328937|540861542|FG002|Period 2|Adverse Event|1|||
149925220|NCT02328937|540861543|FG003|Period 2|Adverse Event|0|||
149925221|NCT02328937|540861544|FG004|Period 2|Adverse Event|0|||
149925222|NCT02328937|540861545|FG005|Period 2|Adverse Event|0|||
149925223|NCT00705341|540861546|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
149925224|NCT00705341|540861547|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
149925225|NCT00705341|540861548|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
149925226|NCT00705341|540861549|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
149925227|NCT00705341|540861546|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
149925228|NCT00705341|540861547|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
149925229|NCT00705341|540861548|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
149925230|NCT00705341|540861549|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
149925231|NCT03665077|540861552|FG000|Overall Study|Lost to Follow-up|2|||
149925232|NCT03665077|540861552|FG000|Overall Study|Physician Decision|2|||
149925233|NCT00435461|540861553|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
149925234|NCT00435461|540861554|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
149925235|NCT00435461|540861555|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
149925236|NCT00435461|540861553|FG000|Overall Study|Protocol Violation|6|||
149925237|NCT00435461|540861554|FG001|Overall Study|Protocol Violation|9|||
149925238|NCT00435461|540861555|FG002|Overall Study|Protocol Violation|10|||
149925239|NCT00435461|540861553|FG000|Overall Study|Participant randomized(inadequate score)|1|||
149925240|NCT00435461|540861554|FG001|Overall Study|Participant randomized(inadequate score)|0|||
149925241|NCT00435461|540861555|FG002|Overall Study|Participant randomized(inadequate score)|0|||
149925242|NCT00435461|540861553|FG000|Overall Study|Compliance less than 80 percent|1|||
149925243|NCT00435461|540861554|FG001|Overall Study|Compliance less than 80 percent|0|||
149925244|NCT00435461|540861555|FG002|Overall Study|Compliance less than 80 percent|0|||
149925245|NCT00435461|540861553|FG000|Overall Study|In error, two study medications switched|1|||
149925246|NCT00435461|540861554|FG001|Overall Study|In error, two study medications switched|0|||
149925247|NCT00435461|540861555|FG002|Overall Study|In error, two study medications switched|0|||
149925248|NCT00435461|540861553|FG000|Overall Study|Lack of Efficacy|2|||
149925249|NCT00435461|540861554|FG001|Overall Study|Lack of Efficacy|1|||
149925250|NCT00435461|540861555|FG002|Overall Study|Lack of Efficacy|0|||
149925251|NCT00435461|540861553|FG000|Overall Study|Withdrawal by Subject|1|||
149925252|NCT00435461|540861554|FG001|Overall Study|Withdrawal by Subject|0|||
149925253|NCT00435461|540861555|FG002|Overall Study|Withdrawal by Subject|2|||
149925254|NCT00435461|540861553|FG000|Overall Study|Randomized in error|1|||
149925255|NCT00435461|540861554|FG001|Overall Study|Randomized in error|0|||
149925256|NCT00435461|540861555|FG002|Overall Study|Randomized in error|0|||
149925257|NCT00435461|540861553|FG000|Overall Study|Participant could not tolerate symptoms|0|||
149925258|NCT00435461|540861554|FG001|Overall Study|Participant could not tolerate symptoms|0|||
149925259|NCT00435461|540861555|FG002|Overall Study|Participant could not tolerate symptoms|1|||
150161030|NCT01253200|541723686|FG002|Overall Study|Lost to Follow-up|0|||
150161031|NCT01253200|541723687|FG003|Overall Study|Lost to Follow-up|0|||
150161032|NCT01253200|541723688|FG004|Overall Study|Lost to Follow-up|0|||
150161033|NCT01253200|541723684|FG000|Overall Study|Withdrawal by Subject|2|||
150161034|NCT01253200|541723685|FG001|Overall Study|Withdrawal by Subject|0|||
150161035|NCT01253200|541723686|FG002|Overall Study|Withdrawal by Subject|0|||
150161036|NCT01253200|541723687|FG003|Overall Study|Withdrawal by Subject|0|||
150161037|NCT01253200|541723688|FG004|Overall Study|Withdrawal by Subject|0|||
150161038|NCT01253200|541723684|FG000|Overall Study|Protocol Violation|1|||
150161039|NCT01253200|541723685|FG001|Overall Study|Protocol Violation|4|||
150161040|NCT01253200|541723686|FG002|Overall Study|Protocol Violation|0|||
150161041|NCT01253200|541723687|FG003|Overall Study|Protocol Violation|0|||
150161042|NCT01253200|541723688|FG004|Overall Study|Protocol Violation|5|||
150161043|NCT01253200|541723684|FG000|Overall Study|intents|10|||
150161044|NCT01253200|541723685|FG001|Overall Study|intents|10|||
150161045|NCT01253200|541723686|FG002|Overall Study|intents|1|||
150161046|NCT01253200|541723687|FG003|Overall Study|intents|3|||
150161047|NCT01253200|541723688|FG004|Overall Study|intents|0|||
150161048|NCT01253200|541723684|FG000|Overall Study|Attempts|6|||
150161049|NCT01253200|541723685|FG001|Overall Study|Attempts|4|||
150161050|NCT01253200|541723686|FG002|Overall Study|Attempts|1|||
150161051|NCT01253200|541723687|FG003|Overall Study|Attempts|2|||
150161052|NCT01253200|541723688|FG004|Overall Study|Attempts|0|||
150161053|NCT02049437|541723689|FG000|Period 1|Adverse Event|1|||
150161054|NCT02049437|541723690|FG001|Period 1|Adverse Event|1|||
149925260|NCT00435461|540861553|FG000|Overall Study|Participant could not swallow capsule|0|||
149925261|NCT00435461|540861554|FG001|Overall Study|Participant could not swallow capsule|0|||
149925262|NCT00435461|540861555|FG002|Overall Study|Participant could not swallow capsule|1|||
150161055|NCT02049437|541723689|FG000|Period 1|Adverse Event|1|||
150161056|NCT02049437|541723690|FG001|Period 1|Adverse Event|0|||
150161057|NCT00783718|541723691|FG000|Induction Phase|Adverse Event|4|||
150161058|NCT00783718|541723692|FG001|Induction Phase|Adverse Event|0|||
150161059|NCT00783718|541723693|FG002|Induction Phase|Adverse Event|7|||
150161060|NCT00783718|541723694|FG003|Induction Phase|Adverse Event|0|||
150260096|NCT02874924|542089278|FG001|Overall Study|Withdrawal by Subject|0|||
150260097|NCT02874924|542089279|FG002|Overall Study|Withdrawal by Subject|0|||
150260098|NCT01689337|542089280|FG000|Overall Study|Study Discontinuation|1|||
150260099|NCT00642772|542089282|FG000|Overall Study|Lost to Follow-up|3|||
150260100|NCT00642772|542089282|FG000|Overall Study|Withdrawal by Subject|7|||
150260101|NCT05398237|542089289|FG000|Overall Study|Withdrawal by Subject|1|||
149818655|NCT00410410|540465471|FG004|Open-Label Period (OL)|Pregnancy|0|||
149818656|NCT00410410|540465472|FG005|Open-Label Period (OL)|Pregnancy|0|||
149818657|NCT00410410|540465473|FG006|Open-Label Period (OL)|Pregnancy|0|||
149818658|NCT00410410|540465474|FG007|Open-Label Period (OL)|Pregnancy|0|||
149818659|NCT00410410|540465475|FG008|Open-Label Period (OL)|Pregnancy|1|||
149818660|NCT00410410|540465467|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818661|NCT00410410|540465468|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818662|NCT00410410|540465469|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818663|NCT00410410|540465470|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818664|NCT00410410|540465471|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818665|NCT00410410|540465472|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818666|NCT00410410|540465473|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818667|NCT00410410|540465474|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
149818668|NCT00410410|540465475|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
149818669|NCT00410410|540465467|FG000|Open-Label Period (OL)|Other|0|||
149818670|NCT00410410|540465468|FG001|Open-Label Period (OL)|Other|0|||
149818671|NCT00410410|540465469|FG002|Open-Label Period (OL)|Other|0|||
149818672|NCT00410410|540465470|FG003|Open-Label Period (OL)|Other|0|||
149818673|NCT00410410|540465471|FG004|Open-Label Period (OL)|Other|0|||
149818674|NCT00410410|540465472|FG005|Open-Label Period (OL)|Other|0|||
149818675|NCT00410410|540465473|FG006|Open-Label Period (OL)|Other|0|||
149818676|NCT00410410|540465474|FG007|Open-Label Period (OL)|Other|0|||
149818677|NCT00410410|540465475|FG008|Open-Label Period (OL)|Other|7|||
149818678|NCT01783496|540465476|FG000|Overall Study|Lost to Follow-up|0|||
149818679|NCT01783496|540465477|FG001|Overall Study|Lost to Follow-up|0|||
149818680|NCT01783496|540465478|FG002|Overall Study|Lost to Follow-up|0|||
149818681|NCT01783496|540465479|FG003|Overall Study|Lost to Follow-up|2|||
149818682|NCT01783496|540465480|FG004|Overall Study|Lost to Follow-up|0|||
149818683|NCT01783496|540465481|FG005|Overall Study|Lost to Follow-up|1|||
149818684|NCT01783496|540465476|FG000|Overall Study|Withdrawal by Subject|1|||
149818685|NCT01783496|540465477|FG001|Overall Study|Withdrawal by Subject|0|||
149818686|NCT01783496|540465478|FG002|Overall Study|Withdrawal by Subject|0|||
149818687|NCT01783496|540465479|FG003|Overall Study|Withdrawal by Subject|0|||
149818688|NCT01783496|540465480|FG004|Overall Study|Withdrawal by Subject|0|||
149818689|NCT01783496|540465481|FG005|Overall Study|Withdrawal by Subject|0|||
149818690|NCT00106028|540465482|FG000|Overall Study|Adverse Event|3|||
149818691|NCT00106028|540465483|FG001|Overall Study|Adverse Event|2|||
149818692|NCT00106028|540465482|FG000|Overall Study|Protocol Violation|1|||
149818693|NCT00106028|540465483|FG001|Overall Study|Protocol Violation|1|||
149818694|NCT00106028|540465482|FG000|Overall Study|Withdrawal by Subject|2|||
149818695|NCT00106028|540465483|FG001|Overall Study|Withdrawal by Subject|8|||
149818696|NCT00106028|540465482|FG000|Overall Study|Lost to Follow-up|0|||
149818697|NCT00106028|540465483|FG001|Overall Study|Lost to Follow-up|1|||
149818698|NCT00947011|540465485|FG000|Overall Study|Study was terminated,PI left institution|12|||
149818699|NCT00449930|540465488|FG000|Overall Study|Adverse Event|9|||
149818700|NCT00449930|540465489|FG001|Overall Study|Adverse Event|19|||
149818701|NCT00449930|540465488|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
149818702|NCT00449930|540465489|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
149818703|NCT00449930|540465488|FG000|Overall Study|Lack of Efficacy|10|||
149818704|NCT00449930|540465489|FG001|Overall Study|Lack of Efficacy|1|||
149818705|NCT00449930|540465488|FG000|Overall Study|Lost to Follow-up|9|||
149818706|NCT00449930|540465489|FG001|Overall Study|Lost to Follow-up|14|||
149818707|NCT00449930|540465488|FG000|Overall Study|Physician Decision|1|||
149818708|NCT00449930|540465489|FG001|Overall Study|Physician Decision|2|||
149818709|NCT00449930|540465488|FG000|Overall Study|Protocol Violation|14|||
149925263|NCT00435461|540861553|FG000|Overall Study|Pregnancy|2|||
149925264|NCT00435461|540861554|FG001|Overall Study|Pregnancy|0|||
149818710|NCT00449930|540465489|FG001|Overall Study|Protocol Violation|15|||
149818711|NCT00449930|540465488|FG000|Overall Study|Withdrawal by Subject|16|||
149818712|NCT00449930|540465489|FG001|Overall Study|Withdrawal by Subject|23|||
149818713|NCT00449930|540465488|FG000|Overall Study|Glycemic discontinuation criteria|1|||
149818714|NCT00449930|540465489|FG001|Overall Study|Glycemic discontinuation criteria|1|||
149818715|NCT02746705|540465490|FG000|Overall Study|Physician Decision|1|||
149818716|NCT02746705|540465491|FG001|Overall Study|Physician Decision|1|||
149818717|NCT02746705|540465490|FG000|Overall Study|Lost to Follow-up|1|||
149818718|NCT02746705|540465491|FG001|Overall Study|Lost to Follow-up|0|||
149818719|NCT02746705|540465490|FG000|Overall Study|outlier scores deemed not valid|0|||
149818720|NCT02746705|540465491|FG001|Overall Study|outlier scores deemed not valid|1|||
149818721|NCT03124381|540465492|FG000|Overall Study|Lost to Follow-up|1|||
149818722|NCT03124381|540465493|FG001|Overall Study|Lost to Follow-up|1|||
149818723|NCT03124381|540465492|FG000|Overall Study|Withdrawal by Subject|6|||
150260102|NCT01312857|542089291|FG000|Overall Study|Adverse Event|1|||
150260103|NCT01312857|542089292|FG001|Overall Study|Adverse Event|1|||
150260104|NCT01312857|542089291|FG000|Overall Study|Lost to Follow-up|2|||
150260105|NCT01312857|542089292|FG001|Overall Study|Lost to Follow-up|0|||
150260106|NCT01312857|542089291|FG000|Overall Study|Physician Decision|3|||
150260107|NCT01312857|542089292|FG001|Overall Study|Physician Decision|0|||
150260108|NCT01312857|542089291|FG000|Overall Study|Withdrawal by Subject|2|||
149818724|NCT03124381|540465493|FG001|Overall Study|Withdrawal by Subject|3|||
149818725|NCT03124381|540465492|FG000|Overall Study|Protocol Violation|0|||
149818726|NCT03124381|540465493|FG001|Overall Study|Protocol Violation|1|||
149818727|NCT03124381|540465492|FG000|Overall Study|Adverse Event|1|||
149818728|NCT03124381|540465493|FG001|Overall Study|Adverse Event|1|||
149818729|NCT03124381|540465492|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
149818730|NCT03124381|540465493|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
149818731|NCT05017493|540465499|FG000|Overall Study|Withdrawal by Subject|26|||
149818732|NCT05017493|540465500|FG001|Overall Study|Withdrawal by Subject|0|||
149818733|NCT05017493|540465499|FG000|Overall Study|Physician Decision|15|||
149818734|NCT05017493|540465500|FG001|Overall Study|Physician Decision|0|||
149818735|NCT05017493|540465499|FG000|Overall Study|Protocol Violation|81|||
149818736|NCT05017493|540465500|FG001|Overall Study|Protocol Violation|0|||
149818737|NCT03940586|540465501|FG000|Overall Study|Death|3|||
149818738|NCT03940586|540465502|FG001|Overall Study|Death|2|||
149818739|NCT03940586|540465503|FG002|Overall Study|Death|0|||
149818740|NCT03940586|540465501|FG000|Overall Study|Physician Decision|1|||
149818741|NCT03940586|540465502|FG001|Overall Study|Physician Decision|0|||
149818742|NCT03940586|540465503|FG002|Overall Study|Physician Decision|1|||
149818743|NCT03940586|540465501|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
149818744|NCT03940586|540465502|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
149818745|NCT03940586|540465503|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
149818746|NCT03940586|540465501|FG000|Overall Study|Not Treated|0|||
149818747|NCT03940586|540465502|FG001|Overall Study|Not Treated|2|||
149818748|NCT03940586|540465503|FG002|Overall Study|Not Treated|0|||
149818749|NCT00738920|540465504|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
149818750|NCT00738920|540465505|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
149818751|NCT00738920|540465506|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
149818752|NCT00738920|540465504|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
149818753|NCT00738920|540465505|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
149818754|NCT00738920|540465506|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
149818755|NCT00738920|540465504|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
149818756|NCT00738920|540465505|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
149818757|NCT00738920|540465506|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
149818758|NCT00738920|540465504|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
149818759|NCT00738920|540465505|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
149818760|NCT00738920|540465506|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
149818761|NCT00738920|540465504|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
149818762|NCT00738920|540465505|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
149818763|NCT00738920|540465506|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
149818764|NCT00738920|540465504|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
149818765|NCT00738920|540465505|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
149818766|NCT00738920|540465506|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
149818767|NCT00738920|540465504|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
149818768|NCT00738920|540465505|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
149818769|NCT00738920|540465506|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
149818770|NCT00738920|540465504|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
150161061|NCT00783718|541723695|FG004|Induction Phase|Adverse Event|0|||
150161062|NCT00783718|541723696|FG005|Induction Phase|Adverse Event|0|||
150161063|NCT00783718|541723697|FG006|Induction Phase|Adverse Event|0|||
150161064|NCT00783718|541723691|FG000|Induction Phase|Protocol Violation|1|||
150161065|NCT00783718|541723692|FG001|Induction Phase|Protocol Violation|1|||
150161066|NCT00783718|541723693|FG002|Induction Phase|Protocol Violation|6|||
150161067|NCT00783718|541723694|FG003|Induction Phase|Protocol Violation|0|||
150161068|NCT00783718|541723695|FG004|Induction Phase|Protocol Violation|0|||
150161069|NCT00783718|541723696|FG005|Induction Phase|Protocol Violation|0|||
150161070|NCT00783718|541723697|FG006|Induction Phase|Protocol Violation|0|||
150161071|NCT00783718|541723691|FG000|Induction Phase|Lack of Efficacy|5|||
150161072|NCT00783718|541723692|FG001|Induction Phase|Lack of Efficacy|2|||
150161073|NCT00783718|541723693|FG002|Induction Phase|Lack of Efficacy|14|||
150161074|NCT00783718|541723694|FG003|Induction Phase|Lack of Efficacy|0|||
150161075|NCT00783718|541723695|FG004|Induction Phase|Lack of Efficacy|0|||
150161076|NCT00783718|541723696|FG005|Induction Phase|Lack of Efficacy|0|||
150161077|NCT00783718|541723697|FG006|Induction Phase|Lack of Efficacy|0|||
150161078|NCT00783718|541723691|FG000|Induction Phase|Withdrawal by Subject|3|||
150161079|NCT00783718|541723692|FG001|Induction Phase|Withdrawal by Subject|4|||
150260109|NCT01312857|542089292|FG001|Overall Study|Withdrawal by Subject|0|||
149925265|NCT00435461|540861555|FG002|Overall Study|Pregnancy|0|||
149925266|NCT00435461|540861553|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
149925267|NCT00435461|540861554|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
149925268|NCT00435461|540861555|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
149925269|NCT00435461|540861553|FG000|Overall Study|Participant ended study one day early|1|||
149925270|NCT00435461|540861554|FG001|Overall Study|Participant ended study one day early|0|||
149925271|NCT00435461|540861555|FG002|Overall Study|Participant ended study one day early|0|||
149925272|NCT00435461|540861553|FG000|Overall Study|Noncompliance with study requirements|1|||
149925273|NCT00435461|540861554|FG001|Overall Study|Noncompliance with study requirements|1|||
149925274|NCT00435461|540861555|FG002|Overall Study|Noncompliance with study requirements|1|||
149925275|NCT00435461|540861553|FG000|Overall Study|Adverse Event|1|||
149925276|NCT00435461|540861554|FG001|Overall Study|Adverse Event|2|||
149925277|NCT00435461|540861555|FG002|Overall Study|Adverse Event|6|||
149925278|NCT00435461|540861553|FG000|Overall Study|Non-Compliance of diary|2|||
149925279|NCT00435461|540861554|FG001|Overall Study|Non-Compliance of diary|0|||
149925280|NCT00435461|540861555|FG002|Overall Study|Non-Compliance of diary|1|||
149925281|NCT00435461|540861553|FG000|Overall Study|Lost to Follow-up|1|||
149925282|NCT00435461|540861554|FG001|Overall Study|Lost to Follow-up|1|||
149925283|NCT00435461|540861555|FG002|Overall Study|Lost to Follow-up|2|||
149925284|NCT01768559|540861560|FG000|Overall Study|Randomized but not treated|0|||
149925285|NCT01768559|540861561|FG001|Overall Study|Randomized but not treated|0|||
149925286|NCT01768559|540861562|FG002|Overall Study|Randomized but not treated|1|||
149925287|NCT01768559|540861560|FG000|Overall Study|Adverse Event|15|||
149925288|NCT01768559|540861561|FG001|Overall Study|Adverse Event|2|||
149925289|NCT01768559|540861562|FG002|Overall Study|Adverse Event|5|||
149925290|NCT01768559|540861560|FG000|Overall Study|Lack of Efficacy|6|||
149925291|NCT01768559|540861561|FG001|Overall Study|Lack of Efficacy|4|||
149925292|NCT01768559|540861562|FG002|Overall Study|Lack of Efficacy|0|||
149925293|NCT01768559|540861560|FG000|Overall Study|Poor compliance to protocol|0|||
149925294|NCT01768559|540861561|FG001|Overall Study|Poor compliance to protocol|3|||
149925295|NCT01768559|540861562|FG002|Overall Study|Poor compliance to protocol|2|||
149925296|NCT01768559|540861560|FG000|Overall Study|Other than specified|9|||
149925297|NCT01768559|540861561|FG001|Overall Study|Other than specified|8|||
149925298|NCT01768559|540861562|FG002|Overall Study|Other than specified|5|||
149925299|NCT02959918|540861563|FG000|Overall Study|Adverse Event|1|||
149925300|NCT02959918|540861564|FG001|Overall Study|Adverse Event|1|||
150161080|NCT00783718|541723693|FG002|Induction Phase|Withdrawal by Subject|8|||
150161081|NCT00783718|541723694|FG003|Induction Phase|Withdrawal by Subject|0|||
150161082|NCT00783718|541723695|FG004|Induction Phase|Withdrawal by Subject|0|||
150161083|NCT00783718|541723696|FG005|Induction Phase|Withdrawal by Subject|0|||
150161084|NCT00783718|541723697|FG006|Induction Phase|Withdrawal by Subject|0|||
150161085|NCT00783718|541723691|FG000|Induction Phase|Lost to Follow-up|1|||
150161086|NCT00783718|541723692|FG001|Induction Phase|Lost to Follow-up|0|||
150161087|NCT00783718|541723693|FG002|Induction Phase|Lost to Follow-up|1|||
150161088|NCT00783718|541723694|FG003|Induction Phase|Lost to Follow-up|0|||
150161089|NCT00783718|541723695|FG004|Induction Phase|Lost to Follow-up|0|||
150161090|NCT00783718|541723696|FG005|Induction Phase|Lost to Follow-up|0|||
150161091|NCT00783718|541723697|FG006|Induction Phase|Lost to Follow-up|0|||
150161092|NCT00783718|541723691|FG000|Maintenance Phase|Adverse Event|12|||
150161093|NCT00783718|541723692|FG001|Maintenance Phase|Adverse Event|0|||
150161094|NCT00783718|541723693|FG002|Maintenance Phase|Adverse Event|0|||
150161095|NCT00783718|541723694|FG003|Maintenance Phase|Adverse Event|15|||
150161096|NCT00783718|541723695|FG004|Maintenance Phase|Adverse Event|7|||
150161097|NCT00783718|541723696|FG005|Maintenance Phase|Adverse Event|6|||
150161098|NCT00783718|541723697|FG006|Maintenance Phase|Adverse Event|16|||
150161099|NCT00783718|541723691|FG000|Maintenance Phase|Protocol Violation|1|||
150161100|NCT00783718|541723692|FG001|Maintenance Phase|Protocol Violation|0|||
150161101|NCT00783718|541723693|FG002|Maintenance Phase|Protocol Violation|0|||
150161102|NCT00783718|541723694|FG003|Maintenance Phase|Protocol Violation|0|||
150161103|NCT00783718|541723695|FG004|Maintenance Phase|Protocol Violation|0|||
150161104|NCT00783718|541723696|FG005|Maintenance Phase|Protocol Violation|0|||
150161105|NCT00783718|541723697|FG006|Maintenance Phase|Protocol Violation|2|||
150161106|NCT00783718|541723691|FG000|Maintenance Phase|Lack of Efficacy|83|||
150161107|NCT00783718|541723692|FG001|Maintenance Phase|Lack of Efficacy|0|||
150161108|NCT00783718|541723693|FG002|Maintenance Phase|Lack of Efficacy|0|||
150161109|NCT00783718|541723694|FG003|Maintenance Phase|Lack of Efficacy|61|||
150161110|NCT00783718|541723695|FG004|Maintenance Phase|Lack of Efficacy|31|||
150161111|NCT00783718|541723696|FG005|Maintenance Phase|Lack of Efficacy|33|||
150161112|NCT00783718|541723697|FG006|Maintenance Phase|Lack of Efficacy|155|||
150161113|NCT00783718|541723691|FG000|Maintenance Phase|Withdrawal by Subject|6|||
150161114|NCT00783718|541723692|FG001|Maintenance Phase|Withdrawal by Subject|0|||
150161115|NCT00783718|541723693|FG002|Maintenance Phase|Withdrawal by Subject|0|||
150161116|NCT00783718|541723694|FG003|Maintenance Phase|Withdrawal by Subject|2|||
150161117|NCT00783718|541723695|FG004|Maintenance Phase|Withdrawal by Subject|5|||
150161118|NCT00783718|541723696|FG005|Maintenance Phase|Withdrawal by Subject|2|||
150161119|NCT00783718|541723697|FG006|Maintenance Phase|Withdrawal by Subject|20|||
149925301|NCT02959918|540861565|FG002|Overall Study|Adverse Event|2|||
149925302|NCT02959918|540861566|FG003|Overall Study|Adverse Event|0|||
149925303|NCT02959918|540861567|FG004|Overall Study|Adverse Event|0|||
149925304|NCT02959918|540861568|FG005|Overall Study|Adverse Event|2|||
149925305|NCT02959918|540861569|FG006|Overall Study|Adverse Event|2|||
149925306|NCT02959918|540861570|FG007|Overall Study|Adverse Event|1|||
149925307|NCT02959918|540861571|FG008|Overall Study|Adverse Event|2|||
149925308|NCT02959918|540861572|FG009|Overall Study|Adverse Event|1|||
149925309|NCT02959918|540861573|FG010|Overall Study|Adverse Event|1|||
149925310|NCT02959918|540861574|FG011|Overall Study|Adverse Event|3|||
149925311|NCT02959918|540861575|FG012|Overall Study|Adverse Event|2|||
149925312|NCT02959918|540861576|FG013|Overall Study|Adverse Event|4|||
149925313|NCT02959918|540861563|FG000|Overall Study|Lost to Follow-up|0|||
149925314|NCT02959918|540861564|FG001|Overall Study|Lost to Follow-up|0|||
149925315|NCT02959918|540861565|FG002|Overall Study|Lost to Follow-up|0|||
149925316|NCT02959918|540861566|FG003|Overall Study|Lost to Follow-up|0|||
149925317|NCT02959918|540861567|FG004|Overall Study|Lost to Follow-up|0|||
149925318|NCT02959918|540861568|FG005|Overall Study|Lost to Follow-up|0|||
149925319|NCT02959918|540861569|FG006|Overall Study|Lost to Follow-up|0|||
149925320|NCT02959918|540861570|FG007|Overall Study|Lost to Follow-up|0|||
149925321|NCT02959918|540861571|FG008|Overall Study|Lost to Follow-up|0|||
149925322|NCT02959918|540861572|FG009|Overall Study|Lost to Follow-up|1|||
149925323|NCT02959918|540861573|FG010|Overall Study|Lost to Follow-up|0|||
149925324|NCT02959918|540861574|FG011|Overall Study|Lost to Follow-up|0|||
149925325|NCT02959918|540861575|FG012|Overall Study|Lost to Follow-up|1|||
149925326|NCT02959918|540861576|FG013|Overall Study|Lost to Follow-up|0|||
149925327|NCT02959918|540861563|FG000|Overall Study|Withdrawal by Subject|0|||
149925328|NCT02959918|540861564|FG001|Overall Study|Withdrawal by Subject|0|||
149925329|NCT02959918|540861565|FG002|Overall Study|Withdrawal by Subject|1|||
149925330|NCT02959918|540861566|FG003|Overall Study|Withdrawal by Subject|2|||
149925331|NCT02959918|540861567|FG004|Overall Study|Withdrawal by Subject|0|||
149925332|NCT02959918|540861568|FG005|Overall Study|Withdrawal by Subject|0|||
149925333|NCT02959918|540861569|FG006|Overall Study|Withdrawal by Subject|1|||
149925334|NCT02959918|540861570|FG007|Overall Study|Withdrawal by Subject|0|||
149925335|NCT02959918|540861571|FG008|Overall Study|Withdrawal by Subject|1|||
149925336|NCT02959918|540861572|FG009|Overall Study|Withdrawal by Subject|1|||
149925337|NCT02959918|540861573|FG010|Overall Study|Withdrawal by Subject|2|||
149925338|NCT02959918|540861574|FG011|Overall Study|Withdrawal by Subject|3|||
149925339|NCT02959918|540861575|FG012|Overall Study|Withdrawal by Subject|1|||
149925340|NCT02959918|540861576|FG013|Overall Study|Withdrawal by Subject|1|||
149925341|NCT02959918|540861563|FG000|Overall Study|Protocol Violation|0|||
149925342|NCT02959918|540861564|FG001|Overall Study|Protocol Violation|0|||
149925343|NCT02959918|540861565|FG002|Overall Study|Protocol Violation|1|||
149925344|NCT02959918|540861566|FG003|Overall Study|Protocol Violation|0|||
149925345|NCT02959918|540861567|FG004|Overall Study|Protocol Violation|0|||
149925346|NCT02959918|540861568|FG005|Overall Study|Protocol Violation|1|||
149925347|NCT02959918|540861569|FG006|Overall Study|Protocol Violation|0|||
149925348|NCT02959918|540861570|FG007|Overall Study|Protocol Violation|0|||
149925349|NCT02959918|540861571|FG008|Overall Study|Protocol Violation|2|||
149925350|NCT02959918|540861572|FG009|Overall Study|Protocol Violation|1|||
149925351|NCT02959918|540861573|FG010|Overall Study|Protocol Violation|0|||
149925352|NCT02959918|540861574|FG011|Overall Study|Protocol Violation|1|||
149925353|NCT02959918|540861575|FG012|Overall Study|Protocol Violation|1|||
149925354|NCT02959918|540861576|FG013|Overall Study|Protocol Violation|0|||
149925355|NCT02959918|540861563|FG000|Overall Study|Stopping Rule Met|1|||
149925356|NCT02959918|540861564|FG001|Overall Study|Stopping Rule Met|0|||
149925357|NCT02959918|540861565|FG002|Overall Study|Stopping Rule Met|3|||
149925358|NCT02959918|540861566|FG003|Overall Study|Stopping Rule Met|4|||
149925359|NCT02959918|540861567|FG004|Overall Study|Stopping Rule Met|5|||
149925360|NCT02959918|540861568|FG005|Overall Study|Stopping Rule Met|3|||
149925361|NCT02959918|540861569|FG006|Overall Study|Stopping Rule Met|2|||
149925362|NCT02959918|540861570|FG007|Overall Study|Stopping Rule Met|4|||
149925363|NCT02959918|540861571|FG008|Overall Study|Stopping Rule Met|1|||
149925364|NCT02959918|540861572|FG009|Overall Study|Stopping Rule Met|1|||
149925365|NCT02959918|540861573|FG010|Overall Study|Stopping Rule Met|3|||
149925366|NCT02959918|540861574|FG011|Overall Study|Stopping Rule Met|5|||
149925367|NCT02959918|540861575|FG012|Overall Study|Stopping Rule Met|2|||
149925368|NCT02959918|540861576|FG013|Overall Study|Stopping Rule Met|1|||
149925369|NCT02959918|540861563|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
149925370|NCT02959918|540861564|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
149925371|NCT02959918|540861565|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
149925372|NCT02959918|540861566|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
149925373|NCT02959918|540861567|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925374|NCT02959918|540861568|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925375|NCT02959918|540861569|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925376|NCT02959918|540861570|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925377|NCT02959918|540861571|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925378|NCT02959918|540861572|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925379|NCT02959918|540861573|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925380|NCT02959918|540861574|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925381|NCT02959918|540861575|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925382|NCT02959918|540861576|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
149925383|NCT02959918|540861563|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925384|NCT02959918|540861564|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925385|NCT02959918|540861565|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925386|NCT02959918|540861566|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
150161120|NCT00783718|541723691|FG000|Maintenance Phase|Lost to Follow-up|3|||
150161121|NCT00783718|541723692|FG001|Maintenance Phase|Lost to Follow-up|0|||
150161122|NCT00783718|541723693|FG002|Maintenance Phase|Lost to Follow-up|0|||
150161123|NCT00783718|541723694|FG003|Maintenance Phase|Lost to Follow-up|0|||
150161124|NCT00783718|541723695|FG004|Maintenance Phase|Lost to Follow-up|2|||
150161125|NCT00783718|541723696|FG005|Maintenance Phase|Lost to Follow-up|0|||
150161126|NCT00783718|541723697|FG006|Maintenance Phase|Lost to Follow-up|2|||
150161127|NCT01163149|541723703|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
150161128|NCT01163149|541723704|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
150161129|NCT01163149|541723705|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
150161130|NCT01163149|541723703|FG000|Extension Treatment Period|Adverse Event|0|||
150161131|NCT01163149|541723704|FG001|Extension Treatment Period|Adverse Event|1|||
150161132|NCT01163149|541723705|FG002|Extension Treatment Period|Adverse Event|0|||
150161133|NCT01163149|541723703|FG000|Extension Treatment Period|Noncompliance|0|||
150161134|NCT01163149|541723704|FG001|Extension Treatment Period|Noncompliance|0|||
150161135|NCT01163149|541723705|FG002|Extension Treatment Period|Noncompliance|1|||
150161136|NCT01027871|541723706|FG000|Overall Study|Physician Decision|1|||
150161137|NCT01027871|541723707|FG001|Overall Study|Physician Decision|5|||
150161138|NCT01027871|541723708|FG002|Overall Study|Physician Decision|0|||
150161139|NCT01027871|541723706|FG000|Overall Study|Protocol Violation|0|||
150161140|NCT01027871|541723707|FG001|Overall Study|Protocol Violation|2|||
150161141|NCT01027871|541723708|FG002|Overall Study|Protocol Violation|2|||
150161142|NCT01027871|541723706|FG000|Overall Study|Withdrawal by Subject|1|||
150161143|NCT01027871|541723707|FG001|Overall Study|Withdrawal by Subject|2|||
150161144|NCT01027871|541723708|FG002|Overall Study|Withdrawal by Subject|2|||
150161145|NCT01027871|541723706|FG000|Overall Study|Adverse Event|0|||
150161146|NCT01027871|541723707|FG001|Overall Study|Adverse Event|2|||
150161147|NCT01027871|541723708|FG002|Overall Study|Adverse Event|2|||
150161148|NCT01027871|541723706|FG000|Overall Study|Sponsor Decision|0|||
150161149|NCT01027871|541723707|FG001|Overall Study|Sponsor Decision|2|||
150161150|NCT01027871|541723708|FG002|Overall Study|Sponsor Decision|0|||
150161151|NCT01027871|541723706|FG000|Overall Study|Discontinued Prior to Treatment|0|||
150161152|NCT01027871|541723707|FG001|Overall Study|Discontinued Prior to Treatment|0|||
150161153|NCT01027871|541723708|FG002|Overall Study|Discontinued Prior to Treatment|1|||
150161154|NCT03782727|541723709|FG000|Overall Study|Lost to Follow-up|32|||
150161155|NCT04887285|541723712|FG000|Overall Study|Lost to Follow-up|0|||
150161156|NCT04887285|541723713|FG001|Overall Study|Lost to Follow-up|2|||
150161157|NCT04887285|541723714|FG002|Overall Study|Lost to Follow-up|3|||
150161158|NCT04640571|541723715|FG000|Overall Study|Withdrawal by Subject|0|||
150161159|NCT04640571|541723716|FG001|Overall Study|Withdrawal by Subject|0|||
150161160|NCT04640571|541723717|FG002|Overall Study|Withdrawal by Subject|0|||
150161161|NCT04640571|541723718|FG003|Overall Study|Withdrawal by Subject|0|||
150161162|NCT04640571|541723719|FG004|Overall Study|Withdrawal by Subject|0|||
150161163|NCT04640571|541723720|FG005|Overall Study|Withdrawal by Subject|2|||
150161164|NCT04736056|541723724|FG000|Overall Study|Death|0|||
150161165|NCT04736056|541723725|FG001|Overall Study|Death|0|||
150161166|NCT04736056|541723726|FG002|Overall Study|Death|0|||
150161167|NCT04736056|541723727|FG003|Overall Study|Death|1|||
150161168|NCT04736056|541723724|FG000|Overall Study|Lost to Follow-up|1|||
150161169|NCT04736056|541723725|FG001|Overall Study|Lost to Follow-up|0|||
150161170|NCT04736056|541723726|FG002|Overall Study|Lost to Follow-up|1|||
150161171|NCT04736056|541723727|FG003|Overall Study|Lost to Follow-up|1|||
150161172|NCT04736056|541723724|FG000|Overall Study|Withdrawal by Subject|2|||
150161173|NCT04736056|541723725|FG001|Overall Study|Withdrawal by Subject|0|||
150161174|NCT04736056|541723726|FG002|Overall Study|Withdrawal by Subject|0|||
150161175|NCT04736056|541723727|FG003|Overall Study|Withdrawal by Subject|0|||
150161176|NCT04736056|541723724|FG000|Overall Study|Physician Decision|1|||
150161177|NCT04736056|541723725|FG001|Overall Study|Physician Decision|0|||
150161178|NCT04736056|541723726|FG002|Overall Study|Physician Decision|1|||
150161179|NCT04736056|541723727|FG003|Overall Study|Physician Decision|0|||
150161180|NCT04529538|541723728|FG000|Overall Study|Lost to Follow-up|3|||
150161181|NCT04529538|541723729|FG001|Overall Study|Lost to Follow-up|2|||
149925387|NCT02959918|540861567|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
150161182|NCT04529538|541723730|FG002|Overall Study|Lost to Follow-up|1|||
150161183|NCT04529538|541723731|FG003|Overall Study|Lost to Follow-up|0|||
150161184|NCT04529538|541723732|FG004|Overall Study|Lost to Follow-up|1|||
150161185|NCT04529538|541723733|FG005|Overall Study|Lost to Follow-up|1|||
150161186|NCT04529538|541723734|FG006|Overall Study|Lost to Follow-up|2|||
149925388|NCT02959918|540861568|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925389|NCT02959918|540861569|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925390|NCT02959918|540861570|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
149925391|NCT02959918|540861571|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925392|NCT02959918|540861572|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925393|NCT02959918|540861573|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925394|NCT02959918|540861574|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925395|NCT02959918|540861575|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925396|NCT02959918|540861576|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
149925397|NCT02959918|540861563|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925398|NCT02959918|540861564|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925399|NCT02959918|540861565|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925400|NCT02959918|540861566|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925401|NCT02959918|540861567|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925402|NCT02959918|540861568|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925403|NCT02959918|540861569|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925404|NCT02959918|540861570|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925405|NCT02959918|540861571|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
149925406|NCT02959918|540861572|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925407|NCT02959918|540861573|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925408|NCT02959918|540861574|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925409|NCT02959918|540861575|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925410|NCT02959918|540861576|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
149925411|NCT02959918|540861563|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925412|NCT02959918|540861564|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925413|NCT02959918|540861565|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925414|NCT02959918|540861566|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925415|NCT02959918|540861567|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925416|NCT02959918|540861568|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925417|NCT02959918|540861569|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925418|NCT02959918|540861570|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925419|NCT02959918|540861571|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925420|NCT02959918|540861572|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
149925421|NCT02959918|540861573|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925422|NCT02959918|540861574|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925423|NCT02959918|540861575|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925424|NCT02959918|540861576|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
149925425|NCT00837967|540861577|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
149925426|NCT00837967|540861578|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
149925427|NCT02504320|540861579|FG000|Treatment Period 1|Positive Drug Screen|0|||
149925428|NCT02504320|540861580|FG001|Treatment Period 1|Positive Drug Screen|0|||
149925429|NCT02504320|540861581|FG002|Treatment Period 1|Positive Drug Screen|1|||
149925430|NCT02504320|540861582|FG003|Treatment Period 1|Positive Drug Screen|0|||
149925431|NCT02504320|540861579|FG000|Treatment Period 2|Positive Drug Screen|0|||
149925432|NCT02504320|540861580|FG001|Treatment Period 2|Positive Drug Screen|1|||
149925433|NCT02504320|540861581|FG002|Treatment Period 2|Positive Drug Screen|0|||
149925434|NCT02504320|540861582|FG003|Treatment Period 2|Positive Drug Screen|0|||
149925435|NCT02504320|540861579|FG000|Treatment Period 3|Positive Drug Screen|0|||
149925436|NCT02504320|540861580|FG001|Treatment Period 3|Positive Drug Screen|0|||
150161187|NCT04529538|541723735|FG007|Overall Study|Lost to Follow-up|0|||
149818771|NCT00738920|540465505|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
149818772|NCT00738920|540465506|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
149818773|NCT00738920|540465504|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
149818774|NCT00738920|540465505|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
149818775|NCT00738920|540465506|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
149818776|NCT00738920|540465504|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
149818777|NCT00738920|540465505|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
149818778|NCT00738920|540465506|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
149818779|NCT00530439|540465508|FG000|Overall Study|GDM|9|||
149818780|NCT00530439|540465509|FG001|Overall Study|GDM|3|||
149818781|NCT00530439|540465508|FG000|Overall Study|Withdraw|18|||
149818782|NCT00530439|540465509|FG001|Overall Study|Withdraw|14|||
149818783|NCT00530439|540465508|FG000|Overall Study|Missed abortion|1|||
149818784|NCT00530439|540465509|FG001|Overall Study|Missed abortion|4|||
149818785|NCT00530439|540465508|FG000|Overall Study|Misclassification|2|||
149925437|NCT02504320|540861581|FG002|Treatment Period 3|Positive Drug Screen|0|||
150260110|NCT01248065|542089293|FG000|Overall Study|Lost to Follow-up|3|||
150260111|NCT01248065|542089294|FG001|Overall Study|Lost to Follow-up|5|||
150260112|NCT01248065|542089293|FG000|Overall Study|Withdrawal by Subject|14|||
150260113|NCT01248065|542089294|FG001|Overall Study|Withdrawal by Subject|11|||
149925438|NCT02504320|540861582|FG003|Treatment Period 3|Positive Drug Screen|1|||
149925439|NCT02504320|540861579|FG000|Treatment Period 3|Adverse Event|0|||
149925440|NCT02504320|540861580|FG001|Treatment Period 3|Adverse Event|0|||
149925441|NCT02504320|540861581|FG002|Treatment Period 3|Adverse Event|1|||
149925442|NCT02504320|540861582|FG003|Treatment Period 3|Adverse Event|0|||
149925443|NCT01210222|540861583|FG000|Overall Study|Ineligible|2|||
149925444|NCT01210222|540861583|FG000|Overall Study|Never treated|1|||
149925445|NCT01737879|540861584|FG000|Overall Study|Death|1|||
149925446|NCT01737879|540861584|FG000|Overall Study|Sponsor decision|40|||
149925447|NCT00685360|540861585|FG000|Overall Study|Lost to Follow-up|0|||
149925448|NCT00685360|540861586|FG001|Overall Study|Lost to Follow-up|1|||
149925449|NCT00685360|540861587|FG002|Overall Study|Lost to Follow-up|2|||
149925450|NCT00685360|540861585|FG000|Overall Study|Adverse Event|4|||
149925451|NCT00685360|540861586|FG001|Overall Study|Adverse Event|6|||
149925452|NCT00685360|540861587|FG002|Overall Study|Adverse Event|4|||
149925453|NCT00685360|540861585|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
149925454|NCT00685360|540861586|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
149925455|NCT00685360|540861587|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
149925456|NCT00685360|540861585|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
149925457|NCT00685360|540861586|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
149925458|NCT00685360|540861587|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
149925459|NCT00685360|540861585|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
149925460|NCT00685360|540861586|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
149925461|NCT00685360|540861587|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
149925462|NCT00685360|540861585|FG000|Overall Study|Protocol Deviation|0|||
149925463|NCT00685360|540861586|FG001|Overall Study|Protocol Deviation|1|||
149925464|NCT00685360|540861587|FG002|Overall Study|Protocol Deviation|1|||
149925465|NCT02497404|540861588|FG000|Overall Study|Adverse Event|1|||
149925466|NCT00547157|540861593|FG000|Overall Study|Other|1|||
149925467|NCT00547157|540861594|FG001|Overall Study|Other|0|||
150260114|NCT01248065|542089293|FG000|Overall Study|Adverse Event|3|||
150260115|NCT01248065|542089294|FG001|Overall Study|Adverse Event|0|||
150260116|NCT01248065|542089293|FG000|Overall Study|Third treatment failure event|3|||
149925468|NCT00547157|540861593|FG000|Overall Study|Death|38|||
149925469|NCT00547157|540861594|FG001|Overall Study|Death|18|||
149925470|NCT00547157|540861593|FG000|Overall Study|Withdrawal by Subject|3|||
149925471|NCT00547157|540861594|FG001|Overall Study|Withdrawal by Subject|1|||
149925472|NCT00547157|540861593|FG000|Overall Study|Administrative decision|3|||
149925473|NCT00547157|540861594|FG001|Overall Study|Administrative decision|2|||
149925474|NCT00547157|540861593|FG000|Overall Study|Lost to Follow-up|4|||
149925475|NCT00547157|540861594|FG001|Overall Study|Lost to Follow-up|2|||
149925476|NCT04186221|540861595|FG000|Overall Study|Death|1|||
149925477|NCT02383355|540861602|FG000|Overall Study|Adverse Event|2|||
149925478|NCT02383355|540861603|FG001|Overall Study|Adverse Event|0|||
150260117|NCT01248065|542089294|FG001|Overall Study|Third treatment failure event|1|||
150260118|NCT01248065|542089293|FG000|Overall Study|Other|3|||
150260119|NCT01248065|542089294|FG001|Overall Study|Other|5|||
150260120|NCT02781844|542089301|FG000|Treatment Period 1|Adverse Event|0|||
150260121|NCT02781844|542089302|FG001|Treatment Period 1|Adverse Event|0|||
150260122|NCT02781844|542089303|FG002|Treatment Period 1|Adverse Event|0|||
150260123|NCT02781844|542089304|FG003|Treatment Period 1|Adverse Event|0|||
150260124|NCT02781844|542089305|FG004|Treatment Period 1|Adverse Event|0|||
150260125|NCT02781844|542089306|FG005|Treatment Period 1|Adverse Event|1|||
150260126|NCT02781844|542089307|FG006|Treatment Period 1|Adverse Event|0|||
150260127|NCT02781844|542089308|FG007|Treatment Period 1|Adverse Event|0|||
150260128|NCT02518490|542089311|FG000|Overall Study|Withdrawal by Subject|1|||
150260129|NCT02518490|542089312|FG001|Overall Study|Withdrawal by Subject|1|||
150260130|NCT04256629|542089313|FG000|Overall Study|Adverse Event|0|||
150260131|NCT04256629|542089314|FG001|Overall Study|Adverse Event|0|||
150260132|NCT04256629|542089315|FG002|Overall Study|Adverse Event|0|||
150260133|NCT04256629|542089316|FG003|Overall Study|Adverse Event|0|||
150260134|NCT04256629|542089317|FG004|Overall Study|Adverse Event|0|||
150260135|NCT04256629|542089318|FG005|Overall Study|Adverse Event|1|||
150260136|NCT04256629|542089313|FG000|Overall Study|Protocol Violation|0|||
150260137|NCT04256629|542089314|FG001|Overall Study|Protocol Violation|1|||
150260138|NCT04256629|542089315|FG002|Overall Study|Protocol Violation|0|||
150260139|NCT04256629|542089316|FG003|Overall Study|Protocol Violation|0|||
150260140|NCT04256629|542089317|FG004|Overall Study|Protocol Violation|0|||
149925479|NCT02787083|540861604|FG000|Overall Study|Adverse Event|1|||
149925480|NCT02787083|540861605|FG001|Overall Study|Adverse Event|0|||
150260141|NCT04256629|542089318|FG005|Overall Study|Protocol Violation|0|||
150260142|NCT01383499|542089319|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
150161188|NCT04529538|541723728|FG000|Overall Study|Not eligible at enrollment|0|||
150161189|NCT04529538|541723729|FG001|Overall Study|Not eligible at enrollment|1|||
150161190|NCT04529538|541723730|FG002|Overall Study|Not eligible at enrollment|2|||
150161191|NCT04529538|541723731|FG003|Overall Study|Not eligible at enrollment|1|||
150161192|NCT04529538|541723732|FG004|Overall Study|Not eligible at enrollment|0|||
150161193|NCT04529538|541723733|FG005|Overall Study|Not eligible at enrollment|0|||
150161194|NCT04529538|541723734|FG006|Overall Study|Not eligible at enrollment|0|||
150260143|NCT01383499|542089320|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
150260144|NCT01383499|542089321|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
150260145|NCT01383499|542089322|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
150260146|NCT00346632|542089323|FG000|Overall Study|Progressive Disease|2|||
149925481|NCT02787083|540861604|FG000|Overall Study|Withdrawal by Subject|2|||
149925482|NCT02787083|540861605|FG001|Overall Study|Withdrawal by Subject|2|||
149925483|NCT01588405|540861606|FG000|Overall Study|Adverse Event|1|||
149925484|NCT01588405|540861606|FG000|Overall Study|Clinical Worsening|1|||
149925485|NCT00845676|540861607|FG000|Overall Study|Virologic breakthrough at week 20|1|||
149925486|NCT00845676|540861607|FG000|Overall Study|Adverse Event|1|||
149925487|NCT03275389|540861609|FG000|Overall Study|Lost to Follow-up|10|||
149925488|NCT03275389|540861610|FG001|Overall Study|Lost to Follow-up|10|||
149925489|NCT03275389|540861611|FG002|Overall Study|Lost to Follow-up|19|||
149925490|NCT03275389|540861612|FG003|Overall Study|Lost to Follow-up|12|||
149925491|NCT03275389|540861613|FG004|Overall Study|Lost to Follow-up|11|||
149925492|NCT03275389|540861614|FG005|Overall Study|Lost to Follow-up|12|||
149925493|NCT03275389|540861615|FG006|Overall Study|Lost to Follow-up|21|||
149925494|NCT03275389|540861616|FG007|Overall Study|Lost to Follow-up|15|||
149925495|NCT03275389|540861617|FG008|Overall Study|Lost to Follow-up|12|||
149925496|NCT03275389|540861618|FG009|Overall Study|Lost to Follow-up|14|||
149925497|NCT03275389|540861609|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925498|NCT03275389|540861610|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925499|NCT03275389|540861611|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925500|NCT03275389|540861612|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925501|NCT03275389|540861613|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925502|NCT03275389|540861614|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
149925503|NCT03275389|540861615|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925504|NCT03275389|540861616|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925505|NCT03275389|540861617|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
149925506|NCT03275389|540861618|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
149925507|NCT03275389|540861609|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
149925508|NCT03275389|540861610|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149925509|NCT03275389|540861611|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149925510|NCT03275389|540861612|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
149925511|NCT03275389|540861613|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
149925512|NCT03275389|540861614|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
149925513|NCT03275389|540861615|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
149925514|NCT03275389|540861616|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
149925515|NCT03275389|540861617|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
149925516|NCT03275389|540861618|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
149925517|NCT03275389|540861609|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925518|NCT03275389|540861610|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149925519|NCT03275389|540861611|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925520|NCT03275389|540861612|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
149925521|NCT03275389|540861613|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925522|NCT03275389|540861614|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925523|NCT03275389|540861615|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149925524|NCT03275389|540861616|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925525|NCT03275389|540861617|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149925526|NCT03275389|540861618|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150161195|NCT04529538|541723735|FG007|Overall Study|Not eligible at enrollment|1|||
150161196|NCT04529538|541723728|FG000|Overall Study|Withdrawal by Subject|0|||
150161197|NCT04529538|541723729|FG001|Overall Study|Withdrawal by Subject|1|||
150161198|NCT04529538|541723730|FG002|Overall Study|Withdrawal by Subject|1|||
150161199|NCT04529538|541723731|FG003|Overall Study|Withdrawal by Subject|2|||
150161200|NCT04529538|541723732|FG004|Overall Study|Withdrawal by Subject|0|||
150161201|NCT04529538|541723733|FG005|Overall Study|Withdrawal by Subject|2|||
150161202|NCT04529538|541723734|FG006|Overall Study|Withdrawal by Subject|3|||
150161203|NCT04529538|541723735|FG007|Overall Study|Withdrawal by Subject|0|||
150161204|NCT04529538|541723728|FG000|Overall Study|Other|0|||
150161205|NCT04529538|541723729|FG001|Overall Study|Other|1|||
150161206|NCT04529538|541723730|FG002|Overall Study|Other|0|||
150161207|NCT04529538|541723731|FG003|Overall Study|Other|0|||
150161208|NCT04529538|541723732|FG004|Overall Study|Other|0|||
150161209|NCT04529538|541723733|FG005|Overall Study|Other|0|||
150161210|NCT04529538|541723734|FG006|Overall Study|Other|0|||
150260147|NCT00346632|542089324|FG001|Overall Study|Progressive Disease|2|||
150161211|NCT04529538|541723735|FG007|Overall Study|Other|0|||
150161212|NCT04529538|541723728|FG000|Overall Study|Adverse Event|0|||
150161213|NCT04529538|541723729|FG001|Overall Study|Adverse Event|0|||
150161214|NCT04529538|541723730|FG002|Overall Study|Adverse Event|0|||
150161215|NCT04529538|541723731|FG003|Overall Study|Adverse Event|1|||
150161216|NCT04529538|541723732|FG004|Overall Study|Adverse Event|0|||
150161217|NCT04529538|541723733|FG005|Overall Study|Adverse Event|0|||
150161218|NCT04529538|541723734|FG006|Overall Study|Adverse Event|0|||
150161219|NCT04529538|541723735|FG007|Overall Study|Adverse Event|0|||
150161220|NCT04529538|541723728|FG000|Overall Study|Protocol Deviation|0|||
150161221|NCT04529538|541723729|FG001|Overall Study|Protocol Deviation|0|||
150161222|NCT04529538|541723730|FG002|Overall Study|Protocol Deviation|0|||
150161223|NCT04529538|541723731|FG003|Overall Study|Protocol Deviation|1|||
150161224|NCT04529538|541723732|FG004|Overall Study|Protocol Deviation|0|||
150161225|NCT04529538|541723733|FG005|Overall Study|Protocol Deviation|0|||
150161226|NCT04529538|541723734|FG006|Overall Study|Protocol Deviation|0|||
150161227|NCT04529538|541723735|FG007|Overall Study|Protocol Deviation|0|||
150161228|NCT04529538|541723728|FG000|Overall Study|Physician Decision|0|||
150161229|NCT04529538|541723729|FG001|Overall Study|Physician Decision|0|||
150161230|NCT04529538|541723730|FG002|Overall Study|Physician Decision|0|||
150161231|NCT04529538|541723731|FG003|Overall Study|Physician Decision|0|||
150161232|NCT04529538|541723732|FG004|Overall Study|Physician Decision|0|||
150161233|NCT04529538|541723733|FG005|Overall Study|Physician Decision|1|||
150161234|NCT04529538|541723734|FG006|Overall Study|Physician Decision|0|||
150161235|NCT04529538|541723735|FG007|Overall Study|Physician Decision|1|||
150161236|NCT02223182|541723736|FG000|Double-Blind Period|Adverse Event|0|||
150161237|NCT02223182|541723737|FG001|Double-Blind Period|Adverse Event|2|||
150161238|NCT02223182|541723738|FG002|Double-Blind Period|Adverse Event|1|||
150161239|NCT02223182|541723739|FG003|Double-Blind Period|Adverse Event|0|||
150161240|NCT02223182|541723736|FG000|Double-Blind Period|Withdrawal by Subject|1|||
150161241|NCT02223182|541723737|FG001|Double-Blind Period|Withdrawal by Subject|1|||
150161242|NCT02223182|541723738|FG002|Double-Blind Period|Withdrawal by Subject|1|||
150161243|NCT02223182|541723739|FG003|Double-Blind Period|Withdrawal by Subject|0|||
150161244|NCT02223182|541723736|FG000|Double-Blind Period|Lost to Follow-up|0|||
150161245|NCT02223182|541723737|FG001|Double-Blind Period|Lost to Follow-up|1|||
150161246|NCT02223182|541723738|FG002|Double-Blind Period|Lost to Follow-up|0|||
150161247|NCT02223182|541723739|FG003|Double-Blind Period|Lost to Follow-up|0|||
150161248|NCT02223182|541723736|FG000|Double-Blind Period|Non Compliance|0|||
150161249|NCT02223182|541723737|FG001|Double-Blind Period|Non Compliance|0|||
150161250|NCT02223182|541723738|FG002|Double-Blind Period|Non Compliance|0|||
150161251|NCT02223182|541723739|FG003|Double-Blind Period|Non Compliance|1|||
150161252|NCT02223182|541723736|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
150161253|NCT02223182|541723737|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
150161254|NCT02223182|541723738|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
150161255|NCT02223182|541723739|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
150161256|NCT02223182|541723736|FG000|Open-Label 500 Period|Adverse Event|1|||
150161257|NCT02223182|541723737|FG001|Open-Label 500 Period|Adverse Event|0|||
150161258|NCT02223182|541723738|FG002|Open-Label 500 Period|Adverse Event|2|||
150161259|NCT02223182|541723739|FG003|Open-Label 500 Period|Adverse Event|1|||
150161260|NCT02223182|541723736|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
150161261|NCT02223182|541723737|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
150161262|NCT02223182|541723738|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
150161263|NCT02223182|541723739|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
150161264|NCT02223182|541723736|FG000|Open-Label 500 Period|Physician Decision|0|||
150161265|NCT02223182|541723737|FG001|Open-Label 500 Period|Physician Decision|0|||
150161266|NCT02223182|541723738|FG002|Open-Label 500 Period|Physician Decision|0|||
150161267|NCT02223182|541723739|FG003|Open-Label 500 Period|Physician Decision|1|||
150161268|NCT02223182|541723736|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
150161269|NCT02223182|541723737|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
150161270|NCT02223182|541723738|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
150161271|NCT02223182|541723739|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
150161272|NCT02223182|541723736|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
150161273|NCT02223182|541723737|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
150161274|NCT02223182|541723738|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
150161275|NCT02223182|541723739|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
150161276|NCT02223182|541723736|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
150161277|NCT02223182|541723737|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
150161278|NCT02223182|541723738|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
150161279|NCT02223182|541723739|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
150161280|NCT02223182|541723736|FG000|Open-Label 300 Period|Non Compliance|0|||
150161281|NCT02223182|541723737|FG001|Open-Label 300 Period|Non Compliance|2|||
150161282|NCT02223182|541723738|FG002|Open-Label 300 Period|Non Compliance|1|||
150161283|NCT02223182|541723739|FG003|Open-Label 300 Period|Non Compliance|0|||
150161284|NCT00114959|541723744|FG000|Overall Study|Lack of Efficacy|6|||
149818786|NCT00530439|540465509|FG001|Overall Study|Misclassification|0|||
149818787|NCT00530439|540465508|FG000|Overall Study|Twin pregnancy|0|||
149818788|NCT00530439|540465509|FG001|Overall Study|Twin pregnancy|2|||
149818789|NCT00530439|540465508|FG000|Overall Study|Severe malformation/abortion|0|||
149818790|NCT00530439|540465509|FG001|Overall Study|Severe malformation/abortion|3|||
149818791|NCT04385199|540465516|FG000|Overall Study|Withdrawal by Subject|1|||
149818792|NCT04385199|540465517|FG001|Overall Study|Withdrawal by Subject|0|||
149818793|NCT03705169|540465518|FG000|Overall Study|Lost to Follow-up|0|||
149818794|NCT03705169|540465519|FG001|Overall Study|Lost to Follow-up|0|||
149818795|NCT03705169|540465520|FG002|Overall Study|Lost to Follow-up|0|||
149818796|NCT03705169|540465521|FG003|Overall Study|Lost to Follow-up|2|||
149818797|NCT03705169|540465522|FG004|Overall Study|Lost to Follow-up|0|||
149818798|NCT03705169|540465523|FG005|Overall Study|Lost to Follow-up|2|||
149818799|NCT03705169|540465524|FG006|Overall Study|Lost to Follow-up|1|||
149818800|NCT03705169|540465525|FG007|Overall Study|Lost to Follow-up|0|||
149818801|NCT03705169|540465526|FG008|Overall Study|Lost to Follow-up|0|||
149818802|NCT03705169|540465527|FG009|Overall Study|Lost to Follow-up|1|||
149818803|NCT03705169|540465518|FG000|Overall Study|Adverse Event|0|||
149818804|NCT03705169|540465519|FG001|Overall Study|Adverse Event|0|||
149818805|NCT03705169|540465520|FG002|Overall Study|Adverse Event|0|||
149818806|NCT03705169|540465521|FG003|Overall Study|Adverse Event|1|||
149818807|NCT03705169|540465522|FG004|Overall Study|Adverse Event|0|||
149818808|NCT03705169|540465523|FG005|Overall Study|Adverse Event|0|||
149818809|NCT03705169|540465524|FG006|Overall Study|Adverse Event|0|||
149818810|NCT03705169|540465525|FG007|Overall Study|Adverse Event|0|||
149818811|NCT03705169|540465526|FG008|Overall Study|Adverse Event|0|||
149818812|NCT03705169|540465527|FG009|Overall Study|Adverse Event|0|||
149818813|NCT03705169|540465518|FG000|Overall Study|Site Closure|0|||
149818814|NCT03705169|540465519|FG001|Overall Study|Site Closure|0|||
149818815|NCT03705169|540465520|FG002|Overall Study|Site Closure|0|||
149818816|NCT03705169|540465521|FG003|Overall Study|Site Closure|1|||
149818817|NCT03705169|540465522|FG004|Overall Study|Site Closure|0|||
149818818|NCT03705169|540465523|FG005|Overall Study|Site Closure|0|||
149818819|NCT03705169|540465524|FG006|Overall Study|Site Closure|0|||
149818820|NCT03705169|540465525|FG007|Overall Study|Site Closure|0|||
149818821|NCT03705169|540465526|FG008|Overall Study|Site Closure|0|||
149818822|NCT03705169|540465527|FG009|Overall Study|Site Closure|0|||
149818823|NCT03705169|540465518|FG000|Overall Study|Did not receive study treatment|0|||
149818824|NCT03705169|540465519|FG001|Overall Study|Did not receive study treatment|0|||
149818825|NCT03705169|540465520|FG002|Overall Study|Did not receive study treatment|0|||
149818826|NCT03705169|540465521|FG003|Overall Study|Did not receive study treatment|1|||
149818827|NCT03705169|540465522|FG004|Overall Study|Did not receive study treatment|0|||
149818828|NCT03705169|540465523|FG005|Overall Study|Did not receive study treatment|0|||
149818829|NCT03705169|540465524|FG006|Overall Study|Did not receive study treatment|0|||
149818830|NCT03705169|540465525|FG007|Overall Study|Did not receive study treatment|0|||
149818831|NCT03705169|540465526|FG008|Overall Study|Did not receive study treatment|0|||
149818832|NCT03705169|540465527|FG009|Overall Study|Did not receive study treatment|0|||
149818833|NCT03705169|540465518|FG000|Overall Study|Concerns about study visit compliance|0|||
149818834|NCT03705169|540465519|FG001|Overall Study|Concerns about study visit compliance|0|||
149818835|NCT03705169|540465520|FG002|Overall Study|Concerns about study visit compliance|0|||
149818836|NCT03705169|540465521|FG003|Overall Study|Concerns about study visit compliance|1|||
149818837|NCT03705169|540465522|FG004|Overall Study|Concerns about study visit compliance|0|||
149818838|NCT03705169|540465523|FG005|Overall Study|Concerns about study visit compliance|0|||
149818839|NCT03705169|540465524|FG006|Overall Study|Concerns about study visit compliance|0|||
149818840|NCT03705169|540465525|FG007|Overall Study|Concerns about study visit compliance|0|||
149818841|NCT03705169|540465526|FG008|Overall Study|Concerns about study visit compliance|0|||
149818842|NCT03705169|540465527|FG009|Overall Study|Concerns about study visit compliance|0|||
149818843|NCT00185211|540465528|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
149818844|NCT00185211|540465529|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
149818845|NCT00185211|540465528|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
149818846|NCT00185211|540465529|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
149818847|NCT00185211|540465528|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
149818848|NCT00185211|540465529|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
149818849|NCT00185211|540465528|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
149818850|NCT00185211|540465529|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
149818851|NCT00185211|540465528|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
149818852|NCT00185211|540465529|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
149818853|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
149818854|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
149818855|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
149818856|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
149818857|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
150161285|NCT00114959|541723744|FG000|Overall Study|Physician Decision|1|||
149925527|NCT03275389|540861609|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925528|NCT03275389|540861610|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925529|NCT03275389|540861611|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
149925530|NCT03275389|540861612|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925531|NCT03275389|540861613|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925532|NCT03275389|540861614|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925533|NCT03275389|540861615|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925534|NCT03275389|540861616|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925535|NCT03275389|540861617|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149925536|NCT03275389|540861618|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
149925537|NCT03275389|540861609|FG000|Overall Study|Other|0|||
149925538|NCT03275389|540861610|FG001|Overall Study|Other|4|||
149925539|NCT03275389|540861611|FG002|Overall Study|Other|3|||
149925540|NCT03275389|540861612|FG003|Overall Study|Other|2|||
149925541|NCT03275389|540861613|FG004|Overall Study|Other|2|||
149925542|NCT03275389|540861614|FG005|Overall Study|Other|2|||
149925543|NCT03275389|540861615|FG006|Overall Study|Other|0|||
149925544|NCT03275389|540861616|FG007|Overall Study|Other|0|||
149925545|NCT03275389|540861617|FG008|Overall Study|Other|1|||
149925546|NCT03275389|540861618|FG009|Overall Study|Other|0|||
149925547|NCT04441788|540863135|FG000|Overall Study|Voluntary Withdrawl|0|||
149925548|NCT04441788|540863136|FG001|Overall Study|Voluntary Withdrawl|1|||
149925549|NCT04441788|540863137|FG002|Overall Study|Voluntary Withdrawl|0|||
149925550|NCT04441788|540863135|FG000|Overall Study|Ineligibility|1|||
149925551|NCT04441788|540863136|FG001|Overall Study|Ineligibility|0|||
149925552|NCT04441788|540863137|FG002|Overall Study|Ineligibility|0|||
149925553|NCT04441788|540863135|FG000|Overall Study|Adverse Event|0|||
149925554|NCT04441788|540863136|FG001|Overall Study|Adverse Event|0|||
149925555|NCT04441788|540863137|FG002|Overall Study|Adverse Event|4|||
149925556|NCT04441788|540863135|FG000|Overall Study|Study Terminated by Sponsor|16|||
149925557|NCT04441788|540863136|FG001|Overall Study|Study Terminated by Sponsor|16|||
149925558|NCT04441788|540863137|FG002|Overall Study|Study Terminated by Sponsor|12|||
149925559|NCT01310127|540863146|FG000|Overall Study|Protocol Violation|1|||
149925560|NCT01310127|540863147|FG001|Overall Study|Protocol Violation|1|||
149925561|NCT01310127|540863146|FG000|Overall Study|advanced psc cataract outlier|1|||
149925562|NCT01310127|540863147|FG001|Overall Study|advanced psc cataract outlier|0|||
149925563|NCT02171429|540863155|FG000|Overall Study|Other|0|||
149925564|NCT02171429|540863156|FG001|Overall Study|Other|1|||
149925565|NCT02171429|540863157|FG002|Overall Study|Other|1|||
149925566|NCT02171429|540863155|FG000|Overall Study|Non-Compliance|0|||
149925567|NCT02171429|540863156|FG001|Overall Study|Non-Compliance|0|||
149925568|NCT02171429|540863157|FG002|Overall Study|Non-Compliance|1|||
149925569|NCT02171429|540863155|FG000|Overall Study|Physician Decision|0|||
149925570|NCT02171429|540863156|FG001|Overall Study|Physician Decision|0|||
149925571|NCT02171429|540863157|FG002|Overall Study|Physician Decision|1|||
149925572|NCT02171429|540863155|FG000|Overall Study|Withdrawal by Subject|1|||
149925573|NCT02171429|540863156|FG001|Overall Study|Withdrawal by Subject|1|||
149925574|NCT02171429|540863157|FG002|Overall Study|Withdrawal by Subject|1|||
149925575|NCT02171429|540863155|FG000|Overall Study|Lost to Follow-up|0|||
149925576|NCT02171429|540863156|FG001|Overall Study|Lost to Follow-up|1|||
149925577|NCT02171429|540863157|FG002|Overall Study|Lost to Follow-up|0|||
149925578|NCT02171429|540863155|FG000|Overall Study|Death|0|||
149925579|NCT02171429|540863156|FG001|Overall Study|Death|0|||
149925580|NCT02171429|540863157|FG002|Overall Study|Death|1|||
149925581|NCT00305227|540863160|FG000|Overall Study|Lost to Follow-up|7|||
149925582|NCT00305227|540863161|FG001|Overall Study|Lost to Follow-up|6|||
149925583|NCT03492437|540863166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149925584|NCT03492437|540863167|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149925585|NCT05133323|540863168|FG000|Overall Study|Lack of Efficacy|0|||
149925586|NCT05133323|540863169|FG001|Overall Study|Lack of Efficacy|0|||
149925587|NCT05133323|540863170|FG002|Overall Study|Lack of Efficacy|1|||
149925588|NCT05133323|540863168|FG000|Overall Study|Withdrawal by Subject|2|||
149925589|NCT05133323|540863169|FG001|Overall Study|Withdrawal by Subject|1|||
149925590|NCT05133323|540863170|FG002|Overall Study|Withdrawal by Subject|0|||
149925591|NCT00632125|540863171|FG000|Overall Study|Death|82|||
149925592|NCT00632125|540863171|FG000|Overall Study|Withdrawal by Subject|44|||
149925593|NCT00632125|540863171|FG000|Overall Study|Adverse Event|36|||
149925594|NCT00632125|540863171|FG000|Overall Study|Renal transplantation|17|||
149925595|NCT00632125|540863171|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
149925596|NCT00632125|540863171|FG000|Overall Study|Non-compliance|8|||
149925597|NCT00632125|540863171|FG000|Overall Study|Development of uncontrolled hypertension|5|||
149925598|NCT00632125|540863171|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
149925599|NCT00577772|540863180|FG000|Overall Study|Lost to Follow-up|0|||
149925600|NCT00577772|540863181|FG001|Overall Study|Lost to Follow-up|1|||
149925601|NCT04152083|540863182|FG000|Overall Study|Lost to Follow-up|2|||
149925602|NCT04152083|540863183|FG001|Overall Study|Lost to Follow-up|1|||
149925603|NCT04152083|540863182|FG000|Overall Study|Adverse Event|1|||
149925604|NCT04152083|540863183|FG001|Overall Study|Adverse Event|0|||
149925605|NCT04152083|540863182|FG000|Overall Study|Randomized but not treated|3|||
149925606|NCT04152083|540863183|FG001|Overall Study|Randomized but not treated|2|||
149925607|NCT03280056|540863184|FG000|Overall Study|Withdrawal by Subject|12|||
149925608|NCT03280056|540863185|FG001|Overall Study|Withdrawal by Subject|14|||
149925609|NCT03280056|540863184|FG000|Overall Study|Death|9|||
149925610|NCT03280056|540863185|FG001|Overall Study|Death|2|||
149925611|NCT03280056|540863184|FG000|Overall Study|Adverse Event|1|||
149925612|NCT03280056|540863185|FG001|Overall Study|Adverse Event|3|||
149925613|NCT03280056|540863184|FG000|Overall Study|Lost to Follow-up|1|||
149925614|NCT03280056|540863185|FG001|Overall Study|Lost to Follow-up|1|||
149925615|NCT03280056|540863184|FG000|Overall Study|Physician Decision|0|||
149925616|NCT03280056|540863185|FG001|Overall Study|Physician Decision|1|||
149925617|NCT03280056|540863184|FG000|Overall Study|Early Discontinuation|1|||
149925618|NCT03280056|540863185|FG001|Overall Study|Early Discontinuation|0|||
149925619|NCT00878800|540863188|FG000|Overall Study|Adverse Event|0|||
149925620|NCT00878800|540863189|FG001|Overall Study|Adverse Event|0|||
149925621|NCT00878800|540863190|FG002|Overall Study|Adverse Event|2|||
149925622|NCT00878800|540863191|FG003|Overall Study|Adverse Event|0|||
149925623|NCT00878800|540863192|FG004|Overall Study|Adverse Event|1|||
149925624|NCT00878800|540863188|FG000|Overall Study|Progressive disease|1|||
149925625|NCT00878800|540863189|FG001|Overall Study|Progressive disease|5|||
149925626|NCT00878800|540863190|FG002|Overall Study|Progressive disease|6|||
149925627|NCT00878800|540863191|FG003|Overall Study|Progressive disease|5|||
149925628|NCT00878800|540863192|FG004|Overall Study|Progressive disease|13|||
149925629|NCT00878800|540863188|FG000|Overall Study|Withdrew consent|1|||
149925630|NCT00878800|540863189|FG001|Overall Study|Withdrew consent|1|||
149925631|NCT00878800|540863190|FG002|Overall Study|Withdrew consent|0|||
149925632|NCT00878800|540863191|FG003|Overall Study|Withdrew consent|1|||
149925633|NCT00878800|540863192|FG004|Overall Study|Withdrew consent|1|||
149925634|NCT00878800|540863188|FG000|Overall Study|Death|0|||
149925635|NCT00878800|540863189|FG001|Overall Study|Death|0|||
149925636|NCT00878800|540863190|FG002|Overall Study|Death|1|||
149925637|NCT00878800|540863191|FG003|Overall Study|Death|0|||
149925638|NCT00878800|540863192|FG004|Overall Study|Death|0|||
149925639|NCT00878800|540863188|FG000|Overall Study|Other|1|||
149925640|NCT00878800|540863189|FG001|Overall Study|Other|1|||
149925641|NCT00878800|540863190|FG002|Overall Study|Other|0|||
149925642|NCT00878800|540863191|FG003|Overall Study|Other|0|||
149925643|NCT00878800|540863192|FG004|Overall Study|Other|1|||
149925644|NCT01135524|540863193|FG000|Overall Study|Withdrawal by Subject|14|||
149925645|NCT01135524|540863193|FG000|Overall Study|Adverse Event|20|||
149925646|NCT01135524|540863193|FG000|Overall Study|Lost to Follow-up|3|||
149925647|NCT01135524|540863193|FG000|Overall Study|Administrative|151|||
149925648|NCT01135524|540863193|FG000|Overall Study|Lack of Efficacy|8|||
149925649|NCT03318003|540863194|FG000|Overall Study|Withdrawal by Subject|1|||
149925650|NCT03318003|540863195|FG001|Overall Study|Withdrawal by Subject|1|||
149925651|NCT03318003|540863194|FG000|Overall Study|fetal loss|0|||
149925652|NCT03318003|540863195|FG001|Overall Study|fetal loss|1|||
149925653|NCT01247350|540863196|FG000|Overall Study|Adverse Event|0|||
149925654|NCT01247350|540863197|FG001|Overall Study|Adverse Event|0|||
149925655|NCT01247350|540863198|FG002|Overall Study|Adverse Event|1|||
149925656|NCT01247350|540863199|FG003|Overall Study|Adverse Event|0|||
149925657|NCT01247350|540863200|FG004|Overall Study|Adverse Event|0|||
149925658|NCT01247350|540863196|FG000|Overall Study|Withdrawal by Subject|0|||
149925659|NCT01247350|540863197|FG001|Overall Study|Withdrawal by Subject|0|||
149925660|NCT01247350|540863198|FG002|Overall Study|Withdrawal by Subject|0|||
149925661|NCT01247350|540863199|FG003|Overall Study|Withdrawal by Subject|1|||
149925662|NCT01247350|540863200|FG004|Overall Study|Withdrawal by Subject|0|||
149925663|NCT01247350|540863196|FG000|Overall Study|Entry criteria not met|0|||
149925664|NCT01247350|540863197|FG001|Overall Study|Entry criteria not met|0|||
149925665|NCT01247350|540863198|FG002|Overall Study|Entry criteria not met|0|||
149925666|NCT01247350|540863199|FG003|Overall Study|Entry criteria not met|0|||
149925667|NCT01247350|540863200|FG004|Overall Study|Entry criteria not met|1|||
149925668|NCT01029262|540863206|FG000|Overall Study|Adverse Event|9|||
149925669|NCT01029262|540863207|FG001|Overall Study|Adverse Event|52|||
149925670|NCT01029262|540863206|FG000|Overall Study|Lack of therapeutic effect|57|||
149925671|NCT01029262|540863207|FG001|Overall Study|Lack of therapeutic effect|76|||
149925672|NCT01029262|540863206|FG000|Overall Study|Withdrawal by Subject|10|||
149925673|NCT01029262|540863207|FG001|Overall Study|Withdrawal by Subject|17|||
149925674|NCT01029262|540863206|FG000|Overall Study|Protocol Violation|2|||
149925675|NCT01029262|540863207|FG001|Overall Study|Protocol Violation|3|||
149925676|NCT01029262|540863206|FG000|Overall Study|Miscellaneous|1|||
149925677|NCT01029262|540863207|FG001|Overall Study|Miscellaneous|9|||
149925678|NCT01029262|540863206|FG000|Overall Study|Death|0|||
149925679|NCT01029262|540863207|FG001|Overall Study|Death|3|||
149925680|NCT02620787|540863210|FG000|Overall Study|Adverse Event|1|||
149925681|NCT02620787|540863211|FG001|Overall Study|Adverse Event|0|||
149925682|NCT02620787|540863210|FG000|Overall Study|Eligibility Criteria Not Met|1|||
149925683|NCT02620787|540863211|FG001|Overall Study|Eligibility Criteria Not Met|0|||
149925684|NCT01896193|540863212|FG000|Overall Study|Lack of Efficacy|20|||
150260148|NCT00346632|542089325|FG002|Overall Study|Progressive Disease|4|||
150260149|NCT00346632|542089326|FG003|Overall Study|Progressive Disease|3|||
150260150|NCT00346632|542089327|FG004|Overall Study|Progressive Disease|3|||
150260151|NCT00346632|542089328|FG005|Overall Study|Progressive Disease|1|||
150260152|NCT00346632|542089329|FG006|Overall Study|Progressive Disease|2|||
150260153|NCT00346632|542089330|FG007|Overall Study|Progressive Disease|2|||
150260154|NCT00346632|542089331|FG008|Overall Study|Progressive Disease|2|||
150260155|NCT00346632|542089332|FG009|Overall Study|Progressive Disease|2|||
149818858|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
149818859|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
149818860|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
149818861|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
149818862|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
149818863|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
149818864|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
149818865|NCT00185211|540465528|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
149818866|NCT00185211|540465529|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
149818867|NCT01759537|540465530|FG000|Overall Study|Death|1|||
149818868|NCT01759537|540465531|FG001|Overall Study|Death|1|||
149818869|NCT01759537|540465530|FG000|Overall Study|Pregnancy|1|||
149818870|NCT01759537|540465531|FG001|Overall Study|Pregnancy|1|||
149818871|NCT01759537|540465530|FG000|Overall Study|Lost to Follow-up|9|||
149818872|NCT01759537|540465531|FG001|Overall Study|Lost to Follow-up|9|||
149818873|NCT01759537|540465530|FG000|Overall Study|Accident involving jaw fracture|1|||
149818874|NCT01759537|540465531|FG001|Overall Study|Accident involving jaw fracture|1|||
149818875|NCT01759537|540465530|FG000|Overall Study|Subcrestal implant too coronal|1|||
149818876|NCT01759537|540465531|FG001|Overall Study|Subcrestal implant too coronal|1|||
149818877|NCT01165242|540467132|FG000|Overall Study|Unreachable Subjects|1|||
149818878|NCT01165242|540467133|FG001|Overall Study|Unreachable Subjects|0|||
149818879|NCT01165242|540467134|FG002|Overall Study|Unreachable Subjects|0|||
149818880|NCT01165242|540467132|FG000|Overall Study|Incarcerated Subjects|0|||
149818881|NCT01165242|540467133|FG001|Overall Study|Incarcerated Subjects|1|||
149818882|NCT01165242|540467134|FG002|Overall Study|Incarcerated Subjects|0|||
149818883|NCT01165242|540467132|FG000|Overall Study|Visit 2 Declined by Subject|0|||
149818884|NCT01165242|540467133|FG001|Overall Study|Visit 2 Declined by Subject|0|||
149818885|NCT01165242|540467134|FG002|Overall Study|Visit 2 Declined by Subject|1|||
149818886|NCT01165242|540467132|FG000|Overall Study|Withdrawal by Subject|0|||
149818887|NCT01165242|540467133|FG001|Overall Study|Withdrawal by Subject|2|||
149818888|NCT01165242|540467134|FG002|Overall Study|Withdrawal by Subject|2|||
149818889|NCT01165242|540467132|FG000|Overall Study|Extended Holiday|0|||
149818890|NCT01165242|540467133|FG001|Overall Study|Extended Holiday|0|||
149818891|NCT01165242|540467134|FG002|Overall Study|Extended Holiday|1|||
149818892|NCT01165242|540467132|FG000|Overall Study|Lost to Follow-up|9|||
149818893|NCT01165242|540467133|FG001|Overall Study|Lost to Follow-up|7|||
149818894|NCT01165242|540467134|FG002|Overall Study|Lost to Follow-up|10|||
149818895|NCT01859390|540467139|FG000|Overall Study|Insufficient Sputum Collected|1|||
149818896|NCT01859390|540467140|FG001|Overall Study|Insufficient Sputum Collected|3|||
149818897|NCT01859390|540467139|FG000|Overall Study|Sample Missing Collection Date|0|||
149818898|NCT01859390|540467140|FG001|Overall Study|Sample Missing Collection Date|1|||
149818899|NCT01859390|540467139|FG000|Overall Study|Tube Cracked|0|||
149818900|NCT01859390|540467140|FG001|Overall Study|Tube Cracked|2|||
149818901|NCT01859390|540467139|FG000|Overall Study|Shipment Error|0|||
149818902|NCT01859390|540467140|FG001|Overall Study|Shipment Error|1|||
149818903|NCT01706198|540467142|FG000|Overall Study|Adverse Event|12|||
149818904|NCT01706198|540467143|FG001|Overall Study|Adverse Event|15|||
149818905|NCT01706198|540467142|FG000|Overall Study|Protocol Violation|7|||
149818906|NCT01706198|540467143|FG001|Overall Study|Protocol Violation|5|||
149818907|NCT01706198|540467142|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
149818908|NCT01706198|540467143|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
149818909|NCT01706198|540467142|FG000|Overall Study|Lost to Follow-up|97|||
149818910|NCT01706198|540467143|FG001|Overall Study|Lost to Follow-up|93|||
149818911|NCT01706198|540467142|FG000|Overall Study|Physician Decision|23|||
149818912|NCT01706198|540467143|FG001|Overall Study|Physician Decision|37|||
149818913|NCT01706198|540467142|FG000|Overall Study|Withdrawal by Subject|23|||
149818914|NCT01706198|540467143|FG001|Overall Study|Withdrawal by Subject|31|||
149818915|NCT01084005|540467144|FG000|Overall Study|Adverse Event|1|||
149818916|NCT01084005|540467145|FG001|Overall Study|Adverse Event|8|||
149818917|NCT01084005|540467144|FG000|Overall Study|Protocol Violation|3|||
149818918|NCT01084005|540467145|FG001|Overall Study|Protocol Violation|7|||
149818919|NCT01084005|540467144|FG000|Overall Study|Withdrawal by Subject|1|||
149818920|NCT01084005|540467145|FG001|Overall Study|Withdrawal by Subject|1|||
149818921|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
150260156|NCT00346632|542089323|FG000|Overall Study|Adverse Event|0|||
150260157|NCT00346632|542089324|FG001|Overall Study|Adverse Event|0|||
150260158|NCT00346632|542089325|FG002|Overall Study|Adverse Event|0|||
150260159|NCT00346632|542089326|FG003|Overall Study|Adverse Event|0|||
150260160|NCT00346632|542089327|FG004|Overall Study|Adverse Event|1|||
150260161|NCT00346632|542089328|FG005|Overall Study|Adverse Event|1|||
150260162|NCT00346632|542089329|FG006|Overall Study|Adverse Event|1|||
150260163|NCT00346632|542089330|FG007|Overall Study|Adverse Event|0|||
150260164|NCT00346632|542089331|FG008|Overall Study|Adverse Event|0|||
150260165|NCT00346632|542089332|FG009|Overall Study|Adverse Event|0|||
150260166|NCT00346632|542089323|FG000|Overall Study|Death|0|||
150260167|NCT00346632|542089324|FG001|Overall Study|Death|0|||
150260168|NCT00346632|542089325|FG002|Overall Study|Death|1|||
150260169|NCT00346632|542089326|FG003|Overall Study|Death|0|||
150260170|NCT00346632|542089327|FG004|Overall Study|Death|0|||
150260171|NCT00346632|542089328|FG005|Overall Study|Death|0|||
150260172|NCT00346632|542089329|FG006|Overall Study|Death|0|||
150260173|NCT00346632|542089330|FG007|Overall Study|Death|0|||
150260174|NCT00346632|542089331|FG008|Overall Study|Death|0|||
150260175|NCT00346632|542089332|FG009|Overall Study|Death|0|||
150260176|NCT00346632|542089323|FG000|Overall Study|Protocol Violation|0|||
150260177|NCT00346632|542089324|FG001|Overall Study|Protocol Violation|0|||
150260178|NCT00346632|542089325|FG002|Overall Study|Protocol Violation|0|||
150260179|NCT00346632|542089326|FG003|Overall Study|Protocol Violation|0|||
150260180|NCT00346632|542089327|FG004|Overall Study|Protocol Violation|0|||
150260181|NCT00346632|542089328|FG005|Overall Study|Protocol Violation|0|||
150260182|NCT00346632|542089329|FG006|Overall Study|Protocol Violation|1|||
150260183|NCT00346632|542089330|FG007|Overall Study|Protocol Violation|0|||
150260184|NCT00346632|542089331|FG008|Overall Study|Protocol Violation|0|||
150260185|NCT00346632|542089332|FG009|Overall Study|Protocol Violation|0|||
150260186|NCT00346632|542089323|FG000|Overall Study|Withdrawal by Subject|0|||
150260187|NCT00346632|542089324|FG001|Overall Study|Withdrawal by Subject|0|||
150260188|NCT00346632|542089325|FG002|Overall Study|Withdrawal by Subject|0|||
150260189|NCT00346632|542089326|FG003|Overall Study|Withdrawal by Subject|0|||
150260190|NCT00346632|542089327|FG004|Overall Study|Withdrawal by Subject|0|||
150260191|NCT00346632|542089328|FG005|Overall Study|Withdrawal by Subject|0|||
150260192|NCT00346632|542089329|FG006|Overall Study|Withdrawal by Subject|1|||
150260193|NCT00346632|542089330|FG007|Overall Study|Withdrawal by Subject|0|||
150260194|NCT00346632|542089331|FG008|Overall Study|Withdrawal by Subject|0|||
150260195|NCT00346632|542089332|FG009|Overall Study|Withdrawal by Subject|0|||
150260196|NCT00346632|542089323|FG000|Overall Study|Switched to alternative treatment|0|||
150260197|NCT00346632|542089324|FG001|Overall Study|Switched to alternative treatment|0|||
150260198|NCT00346632|542089325|FG002|Overall Study|Switched to alternative treatment|1|||
150260199|NCT00346632|542089326|FG003|Overall Study|Switched to alternative treatment|0|||
150260200|NCT00346632|542089327|FG004|Overall Study|Switched to alternative treatment|0|||
150260201|NCT00346632|542089328|FG005|Overall Study|Switched to alternative treatment|0|||
150260202|NCT00346632|542089329|FG006|Overall Study|Switched to alternative treatment|0|||
150260203|NCT00346632|542089330|FG007|Overall Study|Switched to alternative treatment|0|||
150161286|NCT00114959|541723744|FG000|Overall Study|Death|1|||
150161287|NCT00333138|541723745|FG000|Core Study (6 Months)|Adverse Event|4|||
150161288|NCT00333138|541723746|FG001|Core Study (6 Months)|Adverse Event|5|||
150161289|NCT00333138|541723747|FG002|Core Study (6 Months)|Adverse Event|8|||
150161290|NCT00333138|541723745|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
150161291|NCT00333138|541723746|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
150161292|NCT00333138|541723747|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
150161293|NCT00333138|541723745|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
150161294|NCT00333138|541723746|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
150161295|NCT00333138|541723747|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
150161296|NCT00333138|541723745|FG000|Core Study (6 Months)|Protocol Violation|1|||
150161297|NCT00333138|541723746|FG001|Core Study (6 Months)|Protocol Violation|0|||
150161298|NCT00333138|541723747|FG002|Core Study (6 Months)|Protocol Violation|1|||
150161299|NCT00333138|541723745|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
150161300|NCT00333138|541723746|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
150161301|NCT00333138|541723747|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
150161302|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
150161303|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
150161304|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
150161305|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
150161306|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
150161307|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
150260204|NCT00346632|542089331|FG008|Overall Study|Switched to alternative treatment|0|||
150260205|NCT00346632|542089332|FG009|Overall Study|Switched to alternative treatment|0|||
150260206|NCT00346632|542089323|FG000|Overall Study|Not Stated|1|||
150260207|NCT00346632|542089324|FG001|Overall Study|Not Stated|1|||
150260208|NCT00346632|542089325|FG002|Overall Study|Not Stated|0|||
150260209|NCT00346632|542089326|FG003|Overall Study|Not Stated|0|||
150260210|NCT00346632|542089327|FG004|Overall Study|Not Stated|0|||
150260211|NCT00346632|542089328|FG005|Overall Study|Not Stated|0|||
150260212|NCT00346632|542089329|FG006|Overall Study|Not Stated|0|||
150260213|NCT00346632|542089330|FG007|Overall Study|Not Stated|2|||
150260214|NCT00346632|542089331|FG008|Overall Study|Not Stated|2|||
150260215|NCT00346632|542089332|FG009|Overall Study|Not Stated|1|||
150260216|NCT02572882|542089333|FG000|Overall Study|Withdrawal by Subject|1|||
150260217|NCT02572882|542089333|FG000|Overall Study|Participant received kidney transplant|1|||
150260218|NCT04275089|542089334|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
150260219|NCT01079663|542089337|FG000|Overall Study|Adverse Event|0|||
150260220|NCT01079663|542089338|FG001|Overall Study|Adverse Event|2|||
150260221|NCT01079663|542089337|FG000|Overall Study|Protocol Violation|0|||
150260222|NCT01079663|542089338|FG001|Overall Study|Protocol Violation|2|||
150260223|NCT04447846|542089341|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
150260224|NCT03486457|542089343|FG000|Up to Month 3|Adverse Event|2|||
150260225|NCT03486457|542089344|FG001|Up to Month 3|Adverse Event|5|||
150260226|NCT03486457|542089343|FG000|Up to Month 3|Lack of Efficacy|1|||
150260227|NCT03486457|542089344|FG001|Up to Month 3|Lack of Efficacy|0|||
150260228|NCT03486457|542089343|FG000|Up to Month 3|Withdrawal by Subject|1|||
150260229|NCT03486457|542089344|FG001|Up to Month 3|Withdrawal by Subject|0|||
150260230|NCT03486457|542089343|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
150260231|NCT03486457|542089344|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
150260232|NCT03486457|542089343|FG000|Up to Month 3|Other|1|||
150260233|NCT03486457|542089344|FG001|Up to Month 3|Other|0|||
150260234|NCT03486457|542089343|FG000|Month 3 to Month 6|Adverse Event|2|||
150260235|NCT03486457|542089344|FG001|Month 3 to Month 6|Adverse Event|0|||
150260236|NCT03486457|542089343|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
150260237|NCT03486457|542089344|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
150260238|NCT03486457|542089343|FG000|Month 3 to Month 6|Pregnancy|0|||
150260239|NCT03486457|542089344|FG001|Month 3 to Month 6|Pregnancy|1|||
150260240|NCT03486457|542089343|FG000|Month 3 to Month 6|Other|1|||
150260241|NCT03486457|542089344|FG001|Month 3 to Month 6|Other|0|||
150260242|NCT01590017|542089345|FG000|Overall Study|Adverse Event|1|||
150260243|NCT01590017|542089345|FG000|Overall Study|Withdrawal by Subject|1|||
150260244|NCT01590017|542089345|FG000|Overall Study|Lack of Efficacy|1|||
150260245|NCT01590017|542089345|FG000|Overall Study|Physician Decision|1|||
150260246|NCT00093808|542089346|FG000|Overall Study|Cancel participation before receiving tx|1|||
150260247|NCT00093808|542089346|FG000|Overall Study|Protocol Violation|1|||
150260248|NCT00871780|542089347|FG000|Overall Study|Enrolled But Not Treated|6|||
150260249|NCT00871780|542089347|FG000|Overall Study|Withdrawal by Subject|9|||
150260250|NCT00871780|542089347|FG000|Overall Study|Adverse Event|6|||
150260251|NCT00871780|542089347|FG000|Overall Study|Voluntary Discontinuation|4|||
150260252|NCT00871780|542089347|FG000|Overall Study|Death|1|||
150260253|NCT00871780|542089347|FG000|Overall Study|Physician Decision|1|||
150260254|NCT02527343|542089348|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
150260255|NCT02527343|542089349|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
150260256|NCT02527343|542089350|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
150260257|NCT02527343|542089351|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
150260258|NCT02527343|542089352|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
150260259|NCT02527343|542089353|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
150260260|NCT02527343|542089348|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
150260261|NCT02527343|542089349|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
150260262|NCT02527343|542089350|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
150260263|NCT02527343|542089351|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
150260264|NCT02527343|542089352|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
150260265|NCT02527343|542089353|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
150260266|NCT02527343|542089348|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
150260267|NCT02527343|542089349|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
150260268|NCT02527343|542089350|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
150260269|NCT02527343|542089351|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
150260270|NCT02527343|542089352|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
150260271|NCT02527343|542089353|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
150260272|NCT02527343|542089348|FG000|RT Period: Weeks 1 to 52|Other|4|||
150260273|NCT02527343|542089349|FG001|RT Period: Weeks 1 to 52|Other|3|||
150260274|NCT02527343|542089350|FG002|RT Period: Weeks 1 to 52|Other|0|||
150260275|NCT02527343|542089351|FG003|RT Period: Weeks 1 to 52|Other|0|||
150260276|NCT02527343|542089352|FG004|RT Period: Weeks 1 to 52|Other|0|||
150260277|NCT02527343|542089353|FG005|RT Period: Weeks 1 to 52|Other|0|||
150260278|NCT02527343|542089348|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
150260279|NCT02527343|542089349|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
150260280|NCT02527343|542089350|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
150260281|NCT02527343|542089351|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
150260282|NCT02527343|542089352|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
150260283|NCT02527343|542089353|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
150260284|NCT02527343|542089348|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
150161308|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
150161309|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
150161310|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
150161311|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
150161312|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
150161313|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
150161314|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
150161315|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
150161316|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
150161317|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
150161318|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
150161319|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
150161320|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
150161321|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
150161322|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
150161323|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
150161324|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
150161325|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
150161326|NCT00333138|541723745|FG000|Extension Study (Month6 to End of Study)|Death|0|||
150161327|NCT00333138|541723746|FG001|Extension Study (Month6 to End of Study)|Death|1|||
150161328|NCT00333138|541723747|FG002|Extension Study (Month6 to End of Study)|Death|0|||
150161329|NCT00663962|541723748|FG000|Overall Study|somnolence|1|||
150161330|NCT00663962|541723749|FG001|Overall Study|somnolence|0|||
150161331|NCT01515319|541723775|FG000|Overall Study|Withdrawal by Subject|0|||
150161332|NCT01515319|541723776|FG001|Overall Study|Withdrawal by Subject|0|||
150161333|NCT01515319|541723777|FG002|Overall Study|Withdrawal by Subject|0|||
150161334|NCT01515319|541723778|FG003|Overall Study|Withdrawal by Subject|0|||
150161335|NCT01515319|541723779|FG004|Overall Study|Withdrawal by Subject|0|||
150161336|NCT01515319|541723780|FG005|Overall Study|Withdrawal by Subject|0|||
150161337|NCT01515319|541723781|FG006|Overall Study|Withdrawal by Subject|1|||
150161338|NCT01515319|541723782|FG007|Overall Study|Withdrawal by Subject|0|||
150161339|NCT01515319|541723783|FG008|Overall Study|Withdrawal by Subject|0|||
150161340|NCT01515319|541723784|FG009|Overall Study|Withdrawal by Subject|0|||
150161341|NCT01515319|541723775|FG000|Overall Study|Adverse Event|0|||
150161342|NCT01515319|541723776|FG001|Overall Study|Adverse Event|0|||
150161343|NCT01515319|541723777|FG002|Overall Study|Adverse Event|0|||
150161344|NCT01515319|541723778|FG003|Overall Study|Adverse Event|0|||
150161345|NCT01515319|541723779|FG004|Overall Study|Adverse Event|0|||
150161346|NCT01515319|541723780|FG005|Overall Study|Adverse Event|0|||
150161347|NCT01515319|541723781|FG006|Overall Study|Adverse Event|0|||
150161348|NCT01515319|541723782|FG007|Overall Study|Adverse Event|0|||
150161349|NCT01515319|541723783|FG008|Overall Study|Adverse Event|3|||
150161350|NCT01515319|541723784|FG009|Overall Study|Adverse Event|0|||
150161351|NCT01515319|541723775|FG000|Overall Study|Protocol Violation|0|||
150161352|NCT01515319|541723776|FG001|Overall Study|Protocol Violation|0|||
150161353|NCT01515319|541723777|FG002|Overall Study|Protocol Violation|0|||
150161354|NCT01515319|541723778|FG003|Overall Study|Protocol Violation|0|||
150161355|NCT01515319|541723779|FG004|Overall Study|Protocol Violation|0|||
150161356|NCT01515319|541723780|FG005|Overall Study|Protocol Violation|0|||
150161357|NCT01515319|541723781|FG006|Overall Study|Protocol Violation|0|||
150161358|NCT01515319|541723782|FG007|Overall Study|Protocol Violation|0|||
150161359|NCT01515319|541723783|FG008|Overall Study|Protocol Violation|2|||
150161360|NCT01515319|541723784|FG009|Overall Study|Protocol Violation|0|||
150161361|NCT02624778|541725381|FG000|Overall Study|Lost to Follow-up|0|||
150161362|NCT02624778|541725382|FG001|Overall Study|Lost to Follow-up|0|||
150161363|NCT02624778|541725383|FG002|Overall Study|Lost to Follow-up|1|||
150161364|NCT02624778|541725384|FG003|Overall Study|Lost to Follow-up|0|||
150161365|NCT02624778|541725385|FG004|Overall Study|Lost to Follow-up|0|||
149925685|NCT01896193|540863213|FG001|Overall Study|Lack of Efficacy|11|||
150161366|NCT02624778|541725386|FG005|Overall Study|Lost to Follow-up|0|||
150161367|NCT02624778|541725387|FG006|Overall Study|Lost to Follow-up|0|||
150161368|NCT02624778|541725388|FG007|Overall Study|Lost to Follow-up|0|||
150161369|NCT02624778|541725389|FG008|Overall Study|Lost to Follow-up|0|||
150161370|NCT02624778|541725381|FG000|Overall Study|Withdrawal by Subject|0|||
150161371|NCT02624778|541725382|FG001|Overall Study|Withdrawal by Subject|1|||
150161372|NCT02624778|541725383|FG002|Overall Study|Withdrawal by Subject|0|||
150161373|NCT02624778|541725384|FG003|Overall Study|Withdrawal by Subject|0|||
150161374|NCT02624778|541725385|FG004|Overall Study|Withdrawal by Subject|0|||
150161375|NCT02624778|541725386|FG005|Overall Study|Withdrawal by Subject|1|||
150161376|NCT02624778|541725387|FG006|Overall Study|Withdrawal by Subject|1|||
150161377|NCT02624778|541725388|FG007|Overall Study|Withdrawal by Subject|1|||
150161378|NCT02624778|541725389|FG008|Overall Study|Withdrawal by Subject|1|||
150161379|NCT02624778|541725381|FG000|Overall Study|Adverse Event|0|||
150161380|NCT02624778|541725382|FG001|Overall Study|Adverse Event|0|||
150260285|NCT02527343|542089349|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
150260286|NCT02527343|542089350|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
150260287|NCT02527343|542089351|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
150260288|NCT02527343|542089352|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
150260289|NCT02527343|542089353|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
150260290|NCT02527343|542089348|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
150260291|NCT02527343|542089349|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
150260292|NCT02527343|542089350|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
150260293|NCT02527343|542089351|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
150260294|NCT02527343|542089352|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
150260295|NCT02527343|542089353|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
150260296|NCT02527343|542089348|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
150260297|NCT02527343|542089349|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
150260298|NCT02527343|542089350|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
150260299|NCT02527343|542089351|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
150260300|NCT02527343|542089352|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
150260301|NCT02527343|542089353|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
150260302|NCT02527343|542089348|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
150260303|NCT02527343|542089349|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
150260304|NCT02527343|542089350|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
150260305|NCT02527343|542089351|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
150260306|NCT02527343|542089352|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
150260307|NCT02527343|542089353|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
150260308|NCT02527343|542089348|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
150260309|NCT02527343|542089349|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
150260310|NCT02527343|542089350|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
150260311|NCT02527343|542089351|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
150260312|NCT02527343|542089352|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
150260313|NCT02527343|542089353|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
150260314|NCT02527343|542089348|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
150260315|NCT02527343|542089349|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
150260316|NCT02527343|542089350|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
150260317|NCT02527343|542089351|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
150260318|NCT02527343|542089352|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
150260319|NCT02527343|542089353|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
150260320|NCT02527343|542089348|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
150260321|NCT02527343|542089349|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
150260322|NCT02527343|542089350|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
150260323|NCT02527343|542089351|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
150260324|NCT02527343|542089352|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
150260325|NCT02527343|542089353|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
150260326|NCT02527343|542089348|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
150260327|NCT02527343|542089349|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
150260328|NCT02527343|542089350|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
150260329|NCT02527343|542089351|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
150260330|NCT02527343|542089352|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
150260331|NCT02527343|542089353|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
150260332|NCT00701220|542089354|FG000|Overall Study|Withdrawal by Subject|0|||
150260333|NCT00701220|542089355|FG001|Overall Study|Withdrawal by Subject|2|||
150260334|NCT00701220|542089354|FG000|Overall Study|Protocol Violation|2|||
150260335|NCT00701220|542089355|FG001|Overall Study|Protocol Violation|0|||
150260336|NCT05767021|542089356|FG000|Overall Study|Adverse Event|2|||
150260337|NCT05767021|542089356|FG000|Overall Study|Protocol Deviation|1|||
150260338|NCT05767021|542089356|FG000|Overall Study|Withdrawal by Subject|1|||
150260339|NCT05767021|542089356|FG000|Overall Study|Physician Decision|1|||
150260340|NCT05767021|542089356|FG000|Overall Study|Lack of Efficacy|11|||
149818922|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149925686|NCT01896193|540863212|FG000|Overall Study|Protocol Violation|0|||
149925687|NCT01896193|540863213|FG001|Overall Study|Protocol Violation|1|||
149925688|NCT01896193|540863212|FG000|Overall Study|Withdrew Consent|1|||
150260341|NCT05767021|542089356|FG000|Overall Study|Assigned Treatment by Mistake|1|||
150260342|NCT01236339|542089363|FG000|Overall Study|Termination of study by sponsor|11|||
150260343|NCT01236339|542089364|FG001|Overall Study|Termination of study by sponsor|13|||
150260344|NCT02344004|542089365|FG000|Overall Study|Adverse Event|11|||
150260345|NCT02344004|542089366|FG001|Overall Study|Adverse Event|1|||
150260346|NCT02344004|542089365|FG000|Overall Study|Death|9|||
150260347|NCT02344004|542089366|FG001|Overall Study|Death|7|||
150260348|NCT02344004|542089365|FG000|Overall Study|Physician Decision|4|||
150260349|NCT02344004|542089366|FG001|Overall Study|Physician Decision|1|||
150260350|NCT02344004|542089365|FG000|Overall Study|Withdrawal by Subject|22|||
150260351|NCT02344004|542089366|FG001|Overall Study|Withdrawal by Subject|5|||
149925689|NCT01896193|540863213|FG001|Overall Study|Withdrew Consent|0|||
150260352|NCT02344004|542089365|FG000|Overall Study|Rescue Medication|2|||
150260353|NCT02344004|542089366|FG001|Overall Study|Rescue Medication|0|||
150260354|NCT02344004|542089365|FG000|Overall Study|Other Not Specified|12|||
150260355|NCT02344004|542089366|FG001|Overall Study|Other Not Specified|0|||
150260356|NCT02344004|542089365|FG000|Overall Study|Protocol Violation|1|||
150260357|NCT02344004|542089366|FG001|Overall Study|Protocol Violation|0|||
150260358|NCT01945060|542089367|FG000|Overall Study|Lost to follow up|1|||
150260359|NCT01945060|542089368|FG001|Overall Study|Lost to follow up|0|||
150260360|NCT01945060|542089367|FG000|Overall Study|Distress related to IV access|0|||
150260361|NCT01945060|542089368|FG001|Overall Study|Distress related to IV access|1|||
150260362|NCT00116753|542089370|FG000|Overall Study|Adverse Event|16|||
150260363|NCT00116753|542089371|FG001|Overall Study|Adverse Event|10|||
150260364|NCT00116753|542089372|FG002|Overall Study|Adverse Event|7|||
150260365|NCT00116753|542089370|FG000|Overall Study|Withdrawal by Subject|11|||
150260366|NCT00116753|542089371|FG001|Overall Study|Withdrawal by Subject|12|||
150260367|NCT00116753|542089372|FG002|Overall Study|Withdrawal by Subject|8|||
150260368|NCT00116753|542089370|FG000|Overall Study|Lost to Follow-up|0|||
150260369|NCT00116753|542089371|FG001|Overall Study|Lost to Follow-up|2|||
150260370|NCT00116753|542089372|FG002|Overall Study|Lost to Follow-up|1|||
150260371|NCT00116753|542089370|FG000|Overall Study|Protocol Violation|0|||
150260372|NCT00116753|542089371|FG001|Overall Study|Protocol Violation|0|||
150260373|NCT00116753|542089372|FG002|Overall Study|Protocol Violation|1|||
150260374|NCT00116753|542089370|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
150260375|NCT00116753|542089371|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
150260376|NCT00116753|542089372|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
150260377|NCT00116753|542089370|FG000|Overall Study|Disease Progression|3|||
150260378|NCT00116753|542089371|FG001|Overall Study|Disease Progression|4|||
150260379|NCT00116753|542089372|FG002|Overall Study|Disease Progression|3|||
150260380|NCT00116753|542089370|FG000|Overall Study|Abnormal Echocardiogram|0|||
150260381|NCT00116753|542089371|FG001|Overall Study|Abnormal Echocardiogram|0|||
150260382|NCT00116753|542089372|FG002|Overall Study|Abnormal Echocardiogram|1|||
150260383|NCT00116753|542089370|FG000|Overall Study|Progressive Parkinson's Disease|1|||
150260384|NCT00116753|542089371|FG001|Overall Study|Progressive Parkinson's Disease|0|||
150260385|NCT00116753|542089372|FG002|Overall Study|Progressive Parkinson's Disease|0|||
150260386|NCT00116753|542089370|FG000|Overall Study|Dosing Error|0|||
150260387|NCT00116753|542089371|FG001|Overall Study|Dosing Error|1|||
150260388|NCT00116753|542089372|FG002|Overall Study|Dosing Error|0|||
150260389|NCT00986973|542089373|FG000|Overall Study|Withdrawn by study team|1|||
150260390|NCT02009761|542089375|FG000|Overall Study|Adverse Event|4|||
150260391|NCT00950950|542089376|FG000|Overall Study|Adverse Event|1|||
150260392|NCT00950950|542089377|FG001|Overall Study|Adverse Event|0|||
150260393|NCT00950950|542089376|FG000|Overall Study|Withdrawal by Subject|0|||
150260394|NCT00950950|542089377|FG001|Overall Study|Withdrawal by Subject|1|||
150260395|NCT00757783|542089380|FG000|Overall Study|Adverse Event|0|||
150260396|NCT00757783|542089381|FG001|Overall Study|Adverse Event|2|||
150260397|NCT00757783|542089380|FG000|Overall Study|Lost to Follow-up|1|||
150260398|NCT00757783|542089381|FG001|Overall Study|Lost to Follow-up|1|||
150260399|NCT00757783|542089380|FG000|Overall Study|Protocol Violation|1|||
150260400|NCT00757783|542089381|FG001|Overall Study|Protocol Violation|0|||
150260401|NCT00757783|542089380|FG000|Overall Study|Withdrawal by Subject|2|||
150260402|NCT00757783|542089381|FG001|Overall Study|Withdrawal by Subject|1|||
150260403|NCT00757783|542089380|FG000|Overall Study|Other|1|||
150260404|NCT00757783|542089381|FG001|Overall Study|Other|2|||
150260405|NCT02372136|542089382|FG000|Overall Study|Death|3|||
150260406|NCT02372136|542089383|FG001|Overall Study|Death|1|||
150260407|NCT00743275|542091596|FG000|Overall Study|Protocol Violation|0|||
150260408|NCT00743275|542091597|FG001|Overall Study|Protocol Violation|1|||
150260409|NCT02831387|542091604|FG000|Overall Study|Withdrawal by Subject|1|||
150260410|NCT02831387|542091605|FG001|Overall Study|Withdrawal by Subject|1|||
150260411|NCT02831387|542091604|FG000|Overall Study|Discontinued due to stock recovery|0|||
150260412|NCT02831387|542091605|FG001|Overall Study|Discontinued due to stock recovery|1|||
150260413|NCT01016977|542091617|FG000|Overall Study|Lost to Follow-up|1|||
149925690|NCT00807612|540863214|FG000|Overall Study|Death|8|||
150260414|NCT01016977|542091618|FG001|Overall Study|Lost to Follow-up|0|||
150260415|NCT01016977|542091617|FG000|Overall Study|Withdrawal by Subject|2|||
150260416|NCT01016977|542091618|FG001|Overall Study|Withdrawal by Subject|2|||
150260417|NCT05081388|542091621|FG000|Overall Study|Adverse Event|1|||
150260418|NCT05081388|542091622|FG001|Overall Study|Adverse Event|0|||
150260419|NCT05081388|542091623|FG002|Overall Study|Adverse Event|0|||
150260420|NCT05081388|542091624|FG003|Overall Study|Adverse Event|0|||
150260421|NCT05081388|542091625|FG004|Overall Study|Adverse Event|0|||
150260422|NCT05081388|542091621|FG000|Overall Study|Lost to Follow-up|0|||
150260423|NCT05081388|542091622|FG001|Overall Study|Lost to Follow-up|1|||
150260424|NCT05081388|542091623|FG002|Overall Study|Lost to Follow-up|0|||
150260425|NCT05081388|542091624|FG003|Overall Study|Lost to Follow-up|0|||
150260426|NCT05081388|542091625|FG004|Overall Study|Lost to Follow-up|0|||
150260427|NCT05081388|542091621|FG000|Overall Study|Subject decision|0|||
150260428|NCT05081388|542091622|FG001|Overall Study|Subject decision|0|||
150260429|NCT05081388|542091623|FG002|Overall Study|Subject decision|0|||
150260430|NCT05081388|542091624|FG003|Overall Study|Subject decision|1|||
150260431|NCT05081388|542091625|FG004|Overall Study|Subject decision|0|||
150260432|NCT01776541|542091626|FG000|Overall Study|Administrative Reason|6|||
150260433|NCT01776541|542091627|FG001|Overall Study|Administrative Reason|2|||
150260434|NCT01776541|542091626|FG000|Overall Study|Death|4|||
150260435|NCT01776541|542091627|FG001|Overall Study|Death|0|||
150260436|NCT01776541|542091626|FG000|Overall Study|Lost to Follow-up|27|||
150260437|NCT01776541|542091627|FG001|Overall Study|Lost to Follow-up|48|||
150260438|NCT01776541|542091626|FG000|Overall Study|Unclassified|5|||
150260439|NCT01776541|542091627|FG001|Overall Study|Unclassified|4|||
150260440|NCT01776541|542091626|FG000|Overall Study|Protocol Violation|2|||
150260441|NCT01776541|542091627|FG001|Overall Study|Protocol Violation|1|||
150260442|NCT01776541|542091626|FG000|Overall Study|Withdrawal by Subject|12|||
150260443|NCT01776541|542091627|FG001|Overall Study|Withdrawal by Subject|20|||
150260444|NCT04279392|542091628|FG000|Overall Study|Physician Decision|1|||
150260445|NCT04279392|542091629|FG001|Overall Study|Physician Decision|0|||
150260446|NCT01171807|542091630|FG000|Overall Study|Treatment failure|2|||
150260447|NCT01171807|542091631|FG001|Overall Study|Treatment failure|4|||
150260448|NCT01171807|542091630|FG000|Overall Study|Non compliance|1|||
150260449|NCT01171807|542091631|FG001|Overall Study|Non compliance|0|||
150260450|NCT01171807|542091630|FG000|Overall Study|Lost to Follow-up|3|||
150260451|NCT01171807|542091631|FG001|Overall Study|Lost to Follow-up|0|||
150260452|NCT01901341|542091632|FG000|Overall Study|Adverse Event|4|||
150260453|NCT01901341|542091633|FG001|Overall Study|Adverse Event|2|||
150260454|NCT01901341|542091632|FG000|Overall Study|Lack of Efficacy|0|||
150260455|NCT01901341|542091633|FG001|Overall Study|Lack of Efficacy|2|||
150260456|NCT01901341|542091632|FG000|Overall Study|Lost to Follow-up|0|||
150260457|NCT01901341|542091633|FG001|Overall Study|Lost to Follow-up|1|||
150260458|NCT01901341|542091632|FG000|Overall Study|Protocol Violation|2|||
150260459|NCT01901341|542091633|FG001|Overall Study|Protocol Violation|0|||
150260460|NCT01901341|542091632|FG000|Overall Study|Study Terminated by Sponsor|13|||
150260461|NCT01901341|542091633|FG001|Overall Study|Study Terminated by Sponsor|15|||
150260462|NCT01901341|542091632|FG000|Overall Study|Withdrawal by Subject|1|||
150260463|NCT01901341|542091633|FG001|Overall Study|Withdrawal by Subject|1|||
150260464|NCT01981473|542091634|FG000|Overall Study|Incorrect diagnosis of RA|0|||
150260465|NCT01981473|542091635|FG001|Overall Study|Incorrect diagnosis of RA|0|||
150260466|NCT01981473|542091636|FG002|Overall Study|Incorrect diagnosis of RA|1|||
150260467|NCT01981473|542091634|FG000|Overall Study|Received treatment for < 6 months|0|||
150260468|NCT01981473|542091635|FG001|Overall Study|Received treatment for < 6 months|0|||
150260469|NCT01981473|542091636|FG002|Overall Study|Received treatment for < 6 months|1|||
150260470|NCT01981473|542091634|FG000|Overall Study|Received treatment for >24 months|2|||
150260471|NCT01981473|542091635|FG001|Overall Study|Received treatment for >24 months|0|||
150260472|NCT01981473|542091636|FG002|Overall Study|Received treatment for >24 months|6|||
150260473|NCT00738582|542091637|FG000|Combination Therapy|Completed Combination Therapy|1|||
150260474|NCT00738582|542091638|FG001|Combination Therapy|Completed Combination Therapy|0|||
150260475|NCT00738582|542091637|FG000|Combination Therapy|Physician Decision|1|||
150260476|NCT00738582|542091638|FG001|Combination Therapy|Physician Decision|0|||
150260477|NCT00738582|542091637|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
150260478|NCT00738582|542091638|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
150260479|NCT00738582|542091637|FG000|Combination Therapy|Other|5|||
150260480|NCT00738582|542091638|FG001|Combination Therapy|Other|0|||
150260481|NCT00738582|542091637|FG000|Combination Therapy|Adverse Event|16|||
150260482|NCT00738582|542091638|FG001|Combination Therapy|Adverse Event|0|||
150260483|NCT00738582|542091637|FG000|Combination Therapy|Progressive Disease|9|||
150260484|NCT00738582|542091638|FG001|Combination Therapy|Progressive Disease|0|||
150260485|NCT00738582|542091637|FG000|Maintenance Therapy|Other|0|||
150260486|NCT00738582|542091638|FG001|Maintenance Therapy|Other|2|||
150260487|NCT00738582|542091637|FG000|Maintenance Therapy|Adverse Event|0|||
150260488|NCT00738582|542091638|FG001|Maintenance Therapy|Adverse Event|6|||
150260489|NCT00738582|542091637|FG000|Maintenance Therapy|Progressive Disease|0|||
150260490|NCT00738582|542091638|FG001|Maintenance Therapy|Progressive Disease|47|||
150260491|NCT00738582|542091637|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
150260492|NCT00738582|542091638|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
150260493|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
150260494|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
150260495|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
150260496|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
150260497|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
150260498|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
150260499|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
150260500|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
150260501|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
150260502|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
150260503|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
150260504|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
150260505|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
150260506|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
150260507|NCT00757588|542091639|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
150260508|NCT00757588|542091640|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
150260509|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
150260510|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
150260511|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
150260512|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
150260513|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
150260514|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
150260515|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
150260516|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
150260517|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
150260518|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
150260519|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
150260520|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
150260521|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
150260522|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
150260523|NCT00757588|542091639|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
150260524|NCT00757588|542091640|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
150260525|NCT00799513|542091645|FG000|Overall Study|Physician Decision|1|||
150260526|NCT00799513|542091645|FG000|Overall Study|Adverse Event|1|||
150260527|NCT05062759|542091646|FG000|Overall Study|Death|0|||
150260528|NCT05062759|542091647|FG001|Overall Study|Death|1|||
150260529|NCT05062759|542091646|FG000|Overall Study|Lost to Follow-up|1|||
150260530|NCT05062759|542091647|FG001|Overall Study|Lost to Follow-up|0|||
150260531|NCT00903006|542091648|FG000|Overall Study|Withdrawal by Subject|2|||
150260532|NCT00903006|542091649|FG001|Overall Study|Withdrawal by Subject|0|||
150260533|NCT00903006|542091650|FG002|Overall Study|Withdrawal by Subject|0|||
150260534|NCT00903006|542091651|FG003|Overall Study|Withdrawal by Subject|0|||
150260535|NCT00903006|542091648|FG000|Overall Study|Progressive Disease|0|||
150260536|NCT00903006|542091649|FG001|Overall Study|Progressive Disease|3|||
150260537|NCT00903006|542091650|FG002|Overall Study|Progressive Disease|1|||
150260538|NCT00903006|542091651|FG003|Overall Study|Progressive Disease|0|||
150260539|NCT03536143|542091654|FG000|Overall Study|Early termination, Sponsor decision|1|||
150260540|NCT04055090|542091657|FG000|Overall Study|screen failure|1|||
149925691|NCT00807612|540863214|FG000|Overall Study|Study early termination|5|||
149925692|NCT00807612|540863214|FG000|Overall Study|Withdrawal by Subject|1|||
149925693|NCT04607135|540863216|FG000|Overall Study|Physician Decision|1|||
150161381|NCT02624778|541725383|FG002|Overall Study|Adverse Event|0|||
150161382|NCT02624778|541725384|FG003|Overall Study|Adverse Event|0|||
150161383|NCT02624778|541725385|FG004|Overall Study|Adverse Event|0|||
150161384|NCT02624778|541725386|FG005|Overall Study|Adverse Event|0|||
150161385|NCT02624778|541725387|FG006|Overall Study|Adverse Event|0|||
150161386|NCT02624778|541725388|FG007|Overall Study|Adverse Event|0|||
150161387|NCT02624778|541725389|FG008|Overall Study|Adverse Event|2|||
150161388|NCT02624778|541725381|FG000|Overall Study|Death|0|||
150161389|NCT02624778|541725382|FG001|Overall Study|Death|0|||
150161390|NCT02624778|541725383|FG002|Overall Study|Death|0|||
150161391|NCT02624778|541725384|FG003|Overall Study|Death|0|||
150161392|NCT02624778|541725385|FG004|Overall Study|Death|0|||
150161393|NCT02624778|541725386|FG005|Overall Study|Death|0|||
150161394|NCT02624778|541725387|FG006|Overall Study|Death|1|||
150161395|NCT02624778|541725388|FG007|Overall Study|Death|0|||
150161396|NCT02624778|541725389|FG008|Overall Study|Death|0|||
150161397|NCT02624778|541725381|FG000|Overall Study|Physician Decision|0|||
150161398|NCT02624778|541725382|FG001|Overall Study|Physician Decision|0|||
150161399|NCT02624778|541725383|FG002|Overall Study|Physician Decision|0|||
150161400|NCT02624778|541725384|FG003|Overall Study|Physician Decision|0|||
150161401|NCT02624778|541725385|FG004|Overall Study|Physician Decision|0|||
150161402|NCT02624778|541725386|FG005|Overall Study|Physician Decision|0|||
149925694|NCT04607135|540863216|FG000|Overall Study|Withdrawal by Subject|1|||
150161403|NCT02624778|541725387|FG006|Overall Study|Physician Decision|0|||
149925695|NCT04607135|540863216|FG000|Overall Study|Equipment not working|3|||
150161404|NCT02624778|541725388|FG007|Overall Study|Physician Decision|3|||
150161405|NCT02624778|541725389|FG008|Overall Study|Physician Decision|3|||
150161406|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
150161407|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
150161408|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
150161409|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
150161410|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
150260541|NCT04055090|542091658|FG001|Overall Study|screen failure|0|||
150260542|NCT04055090|542091657|FG000|Overall Study|Withdrawal by Subject|1|||
150260543|NCT04055090|542091658|FG001|Overall Study|Withdrawal by Subject|0|||
150161411|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
150161412|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
150161413|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
150161414|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
150161415|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
150161416|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
150161417|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
150161418|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
150161419|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
150161420|NCT04672460|541725390|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
150161421|NCT04672460|541725391|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
150161422|NCT04672460|541725390|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
150161423|NCT04672460|541725391|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
150161424|NCT04672460|541725390|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
150161425|NCT04672460|541725391|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
150161426|NCT04672460|541725390|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
150161427|NCT04672460|541725391|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
150161428|NCT04672460|541725390|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
150161429|NCT04672460|541725391|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
150161430|NCT04672460|541725390|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
150161431|NCT04672460|541725391|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
150161432|NCT04672460|541725390|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
150161433|NCT04672460|541725391|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
150161434|NCT04672460|541725390|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
150161435|NCT04672460|541725391|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
150161436|NCT04672460|541725390|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
150161437|NCT04672460|541725391|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
150161438|NCT04672460|541725390|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
150161439|NCT04672460|541725391|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
150161440|NCT02949271|541725396|FG000|Overall Study|Lack of Efficacy|5|||
150161441|NCT02949271|541725397|FG001|Overall Study|Lack of Efficacy|4|||
150161442|NCT02949271|541725396|FG000|Overall Study|Lost to Follow-up|3|||
150161443|NCT02949271|541725397|FG001|Overall Study|Lost to Follow-up|6|||
150161444|NCT02949271|541725396|FG000|Overall Study|Physician Decision|5|||
150161445|NCT02949271|541725397|FG001|Overall Study|Physician Decision|5|||
150161446|NCT02949271|541725396|FG000|Overall Study|Protocol Violation|6|||
150161447|NCT02949271|541725397|FG001|Overall Study|Protocol Violation|3|||
150161448|NCT02949271|541725396|FG000|Overall Study|Withdrawal by Subject|1|||
150161449|NCT02949271|541725397|FG001|Overall Study|Withdrawal by Subject|0|||
150161450|NCT02949271|541725396|FG000|Overall Study|Delivered prior to intervention|7|||
150161451|NCT02949271|541725397|FG001|Overall Study|Delivered prior to intervention|9|||
150161452|NCT02949271|541725396|FG000|Overall Study|Outside the window for cervical dilation|2|||
150161453|NCT02949271|541725397|FG001|Overall Study|Outside the window for cervical dilation|3|||
150161454|NCT03929302|541725402|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
150161455|NCT03929302|541725403|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
150161456|NCT03929302|541725404|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
150161457|NCT03929302|541725402|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
150161458|NCT03929302|541725403|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
150161459|NCT03929302|541725404|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
150161460|NCT03929302|541725402|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
150161461|NCT03929302|541725403|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
150161462|NCT03929302|541725404|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
150161463|NCT03239210|541725409|FG000|Overall Study|Lost to Follow-up|2|||
150161464|NCT03239210|541725410|FG001|Overall Study|Lost to Follow-up|2|||
150161465|NCT03239210|541725409|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
150161466|NCT03239210|541725410|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
150161467|NCT03239210|541725409|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
150161468|NCT03239210|541725410|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
150161469|NCT01575860|541725413|FG000|Overall Study|Withdrawal by Subject|1|||
150161470|NCT01575860|541725413|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
150161471|NCT01403987|541725414|FG000|Overall Study|Residents forgot their secret PIN|18|||
150161472|NCT01403987|541725415|FG001|Overall Study|Residents forgot their secret PIN|17|||
150161473|NCT01403987|541725416|FG002|Overall Study|Residents forgot their secret PIN|18|||
150161474|NCT00180674|541725418|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
150161475|NCT00180674|541725418|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
150161476|NCT00278564|541725419|FG000|Overall Study|Lack of Efficacy|4|||
150161477|NCT01094743|541725420|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
150161478|NCT02851511|541725421|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
150161479|NCT02851511|541725422|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
150161480|NCT02851511|541725423|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
150161481|NCT02851511|541725424|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
150161482|NCT02851511|541725421|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
150161483|NCT02851511|541725422|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
150161484|NCT02851511|541725423|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
150161485|NCT02851511|541725424|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
150161486|NCT02851511|541725421|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
150161487|NCT02851511|541725422|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
150161488|NCT02851511|541725423|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
150161489|NCT02851511|541725424|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
150161490|NCT02851511|541725421|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
150161491|NCT02851511|541725422|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
150161492|NCT02851511|541725423|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
150161493|NCT02851511|541725424|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
150161494|NCT02851511|541725421|FG000|Phase I|Physician Decision|0|||
150161495|NCT02851511|541725422|FG001|Phase I|Physician Decision|0|||
150161496|NCT02851511|541725423|FG002|Phase I|Physician Decision|0|||
150161497|NCT02851511|541725424|FG003|Phase I|Physician Decision|1|||
150161498|NCT02851511|541725421|FG000|Phase I|Withdrawal by Subject|2|||
150161499|NCT02851511|541725422|FG001|Phase I|Withdrawal by Subject|1|||
150161500|NCT02851511|541725423|FG002|Phase I|Withdrawal by Subject|0|||
150161501|NCT02851511|541725424|FG003|Phase I|Withdrawal by Subject|3|||
150161502|NCT02851511|541725421|FG000|Phase II|Physician Decision|18|||
150161503|NCT02851511|541725422|FG001|Phase II|Physician Decision|16|||
150161504|NCT02851511|541725423|FG002|Phase II|Physician Decision|0|||
150161505|NCT02851511|541725424|FG003|Phase II|Physician Decision|0|||
150161506|NCT02851511|541725421|FG000|Phase II|Withdrawal by Subject|18|||
150161507|NCT02851511|541725422|FG001|Phase II|Withdrawal by Subject|16|||
150161508|NCT02851511|541725423|FG002|Phase II|Withdrawal by Subject|0|||
150161509|NCT02851511|541725424|FG003|Phase II|Withdrawal by Subject|0|||
150161510|NCT02851511|541725421|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
150161511|NCT02851511|541725422|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
150161512|NCT02851511|541725423|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
150161513|NCT02851511|541725424|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
150161514|NCT02851511|541725421|FG000|Phase II|Lost to Follow-up|0|||
150161515|NCT02851511|541725422|FG001|Phase II|Lost to Follow-up|1|||
150161516|NCT02851511|541725423|FG002|Phase II|Lost to Follow-up|0|||
150161517|NCT02851511|541725424|FG003|Phase II|Lost to Follow-up|0|||
150161518|NCT02321540|541725425|FG000|Overall Study|Death|0|||
150161519|NCT02321540|541725426|FG001|Overall Study|Death|1|||
150161520|NCT02321540|541725425|FG000|Overall Study|Progression|3|||
150161521|NCT02321540|541725426|FG001|Overall Study|Progression|9|||
150161522|NCT03606460|541725427|FG000|Overall Study|Lost to Follow-up|1|||
150161523|NCT03606460|541725428|FG001|Overall Study|Lost to Follow-up|8|||
150161524|NCT02256969|541725433|FG000|Overall Study|Screenfailed or withdrew|2|||
150161525|NCT02256969|541725434|FG001|Overall Study|Screenfailed or withdrew|1|||
150161526|NCT02256969|541725435|FG002|Overall Study|Screenfailed or withdrew|1|||
150161527|NCT00372567|541725438|FG000|Phase 3 Study|Adverse Event|5|||
150161528|NCT00372567|541725439|FG001|Phase 3 Study|Adverse Event|1|||
150161529|NCT00372567|541725440|FG002|Phase 3 Study|Adverse Event|1|||
150161530|NCT00372567|541725438|FG000|Phase 3 Study|Death|1|||
150161531|NCT00372567|541725439|FG001|Phase 3 Study|Death|1|||
150161532|NCT00372567|541725440|FG002|Phase 3 Study|Death|0|||
150161533|NCT00372567|541725438|FG000|Phase 3 Study|Protocol Violation|0|||
150161534|NCT00372567|541725439|FG001|Phase 3 Study|Protocol Violation|0|||
150161535|NCT00372567|541725440|FG002|Phase 3 Study|Protocol Violation|1|||
150161536|NCT00372567|541725438|FG000|Phase 3 Study|Objective progression or relapse|10|||
150161537|NCT00372567|541725439|FG001|Phase 3 Study|Objective progression or relapse|13|||
150161538|NCT00372567|541725440|FG002|Phase 3 Study|Objective progression or relapse|4|||
150161539|NCT00372567|541725438|FG000|Phase 3 Study|Global deterioration of health status|0|||
150161540|NCT00372567|541725439|FG001|Phase 3 Study|Global deterioration of health status|1|||
150161541|NCT00372567|541725440|FG002|Phase 3 Study|Global deterioration of health status|0|||
150161542|NCT00372567|541725438|FG000|Phase 3 Study|Other|2|||
150161543|NCT00372567|541725439|FG001|Phase 3 Study|Other|2|||
150161544|NCT00372567|541725440|FG002|Phase 3 Study|Other|1|||
150161545|NCT00372567|541725438|FG000|Phase 3 Study|study terminated by sponsor|13|||
150161546|NCT00372567|541725439|FG001|Phase 3 Study|study terminated by sponsor|8|||
150161547|NCT00372567|541725440|FG002|Phase 3 Study|study terminated by sponsor|5|||
150161548|NCT02347943|541725442|FG000|Overall Study|Study was cancelled|140|||
150161549|NCT02347943|541725443|FG001|Overall Study|Study was cancelled|67|||
150161550|NCT02347943|541725444|FG002|Overall Study|Study was cancelled|45|||
150161551|NCT00303303|541725447|FG000|Overall Study|Withdrawal by Subject|0|||
150161552|NCT00303303|541725448|FG001|Overall Study|Withdrawal by Subject|0|||
150161553|NCT00303303|541725449|FG002|Overall Study|Withdrawal by Subject|1|||
150161554|NCT00691028|541725450|FG000|Open-label Period|Adverse Event|0|||
150260544|NCT04745026|542091659|FG000|Overall Study|Physician Decision|1|||
150260545|NCT04745026|542091660|FG001|Overall Study|Physician Decision|0|||
150161555|NCT00691028|541725451|FG001|Open-label Period|Adverse Event|0|||
150161556|NCT00691028|541725452|FG002|Open-label Period|Adverse Event|0|||
150161557|NCT00691028|541725453|FG003|Open-label Period|Adverse Event|16|||
150161558|NCT00691028|541725450|FG000|Open-label Period|Withdrawal by Subject|0|||
150161559|NCT00691028|541725451|FG001|Open-label Period|Withdrawal by Subject|0|||
150161560|NCT00691028|541725452|FG002|Open-label Period|Withdrawal by Subject|0|||
150161561|NCT00691028|541725453|FG003|Open-label Period|Withdrawal by Subject|3|||
150161562|NCT00691028|541725450|FG000|Open-label Period|not come to a hospital|0|||
150161563|NCT00691028|541725451|FG001|Open-label Period|not come to a hospital|0|||
150161564|NCT00691028|541725452|FG002|Open-label Period|not come to a hospital|0|||
150161565|NCT00691028|541725453|FG003|Open-label Period|not come to a hospital|1|||
150161566|NCT00691028|541725450|FG000|Double-blind Period|Adverse Event|8|||
150161567|NCT00691028|541725451|FG001|Double-blind Period|Adverse Event|9|||
150161568|NCT00691028|541725452|FG002|Double-blind Period|Adverse Event|6|||
150161569|NCT00691028|541725453|FG003|Double-blind Period|Adverse Event|0|||
150161570|NCT00691028|541725450|FG000|Double-blind Period|Lack of Efficacy|4|||
150161571|NCT00691028|541725451|FG001|Double-blind Period|Lack of Efficacy|3|||
150161572|NCT00691028|541725452|FG002|Double-blind Period|Lack of Efficacy|2|||
150161573|NCT00691028|541725453|FG003|Double-blind Period|Lack of Efficacy|0|||
150161574|NCT00691028|541725450|FG000|Double-blind Period|Withdrawal by Subject|1|||
150161575|NCT00691028|541725451|FG001|Double-blind Period|Withdrawal by Subject|0|||
150161576|NCT00691028|541725452|FG002|Double-blind Period|Withdrawal by Subject|1|||
150161577|NCT00691028|541725453|FG003|Double-blind Period|Withdrawal by Subject|0|||
150161578|NCT00691028|541725450|FG000|Double-blind Period|not come to a hospital.|0|||
150161579|NCT00691028|541725451|FG001|Double-blind Period|not come to a hospital.|1|||
150161580|NCT00691028|541725452|FG002|Double-blind Period|not come to a hospital.|0|||
150161581|NCT00691028|541725453|FG003|Double-blind Period|not come to a hospital.|0|||
150161582|NCT00058058|541725462|FG000|Overall Study|Withdrawal by Subject|4|||
150161583|NCT00058058|541725462|FG000|Overall Study|Ineligible|20|||
150161584|NCT00058058|541725462|FG000|Overall Study|Claustrophobic|5|||
150161585|NCT00058058|541725462|FG000|Overall Study|technical issues|6|||
150161586|NCT00058058|541725462|FG000|Overall Study|Poor positioning, illness,pain|3|||
150161587|NCT03085017|541725463|FG000|Overall Study|Death|0|||
150161588|NCT03085017|541725464|FG001|Overall Study|Death|3|||
150161589|NCT00582790|541725470|FG000|Overall Study|Rapid progression of disease|1|||
150161590|NCT04337489|541725471|FG000|Overall Study|Withdrawal by Subject|1|||
150161591|NCT00372528|541725472|FG000|Overall Study|Lack of Efficacy|1|||
150161592|NCT00372528|541725472|FG000|Overall Study|Adverse Event|1|||
150161593|NCT00372528|541725472|FG000|Overall Study|Study Terminated by Sponsor|18|||
150161594|NCT00372528|541725472|FG000|Overall Study|Other|1|||
150161595|NCT02412761|541725473|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150161596|NCT02412761|541725474|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
150161597|NCT02412761|541725475|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
150161598|NCT02412761|541725476|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150161599|NCT02412761|541725477|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150161600|NCT02412761|541725478|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
150161601|NCT04796935|541725479|FG000|Overall Study|Withdrawal by Subject|0|||
150161602|NCT04796935|541725480|FG001|Overall Study|Withdrawal by Subject|1|||
150161603|NCT04796935|541725479|FG000|Overall Study|Physician Decision|0|||
150161604|NCT04796935|541725480|FG001|Overall Study|Physician Decision|1|||
150161605|NCT04796935|541725479|FG000|Overall Study|Device not available|1|||
150161606|NCT04796935|541725480|FG001|Overall Study|Device not available|0|||
150161607|NCT04796935|541725479|FG000|Overall Study|Trained provider not available|1|||
150161608|NCT04796935|541725480|FG001|Overall Study|Trained provider not available|0|||
150161609|NCT01192295|541725481|FG000|Overall Study|Adverse Event|3|||
150161610|NCT01192295|541725482|FG001|Overall Study|Adverse Event|7|||
150161611|NCT01192295|541725481|FG000|Overall Study|Withdrawal by Subject|3|||
150161612|NCT01192295|541725482|FG001|Overall Study|Withdrawal by Subject|4|||
150161613|NCT01192295|541725481|FG000|Overall Study|Lost to Follow-up|0|||
150161614|NCT01192295|541725482|FG001|Overall Study|Lost to Follow-up|1|||
150161615|NCT01192295|541725481|FG000|Overall Study|Lack of Efficacy|0|||
150260546|NCT04745026|542091659|FG000|Overall Study|Adverse Event|2|||
150260547|NCT04745026|542091660|FG001|Overall Study|Adverse Event|2|||
150260548|NCT04745026|542091659|FG000|Overall Study|Protocol Violation|1|||
150260549|NCT04745026|542091660|FG001|Overall Study|Protocol Violation|3|||
150260550|NCT04745026|542091659|FG000|Overall Study|Lost to Follow-up|4|||
150161616|NCT01192295|541725482|FG001|Overall Study|Lack of Efficacy|5|||
150161617|NCT01192295|541725481|FG000|Overall Study|Administrative|4|||
150161618|NCT01192295|541725482|FG001|Overall Study|Administrative|6|||
150161619|NCT00630539|541725483|FG000|Overall Study|Adverse Event|1|||
150161620|NCT00630539|541725484|FG001|Overall Study|Adverse Event|3|||
150161621|NCT00630539|541725485|FG002|Overall Study|Adverse Event|1|||
150161622|NCT00630539|541725486|FG003|Overall Study|Adverse Event|2|||
150161623|NCT00630539|541725483|FG000|Overall Study|Withdrawal by Subject|0|||
150260551|NCT04745026|542091660|FG001|Overall Study|Lost to Follow-up|3|||
150161624|NCT00630539|541725484|FG001|Overall Study|Withdrawal by Subject|1|||
150161625|NCT00630539|541725485|FG002|Overall Study|Withdrawal by Subject|0|||
150161626|NCT00630539|541725486|FG003|Overall Study|Withdrawal by Subject|1|||
150161627|NCT01700530|541725490|FG000|Overall Study|Withdrawal by Subject|0|||
150161628|NCT01700530|541725491|FG001|Overall Study|Withdrawal by Subject|3|||
150161629|NCT01700530|541725492|FG002|Overall Study|Withdrawal by Subject|1|||
150161630|NCT04833855|541725498|FG000|Overall Study|Decision by sponsor|0|||
150161631|NCT04833855|541725499|FG001|Overall Study|Decision by sponsor|1|||
150161632|NCT04833855|541725500|FG002|Overall Study|Decision by sponsor|0|||
150161633|NCT04833855|541725501|FG003|Overall Study|Decision by sponsor|0|||
150161634|NCT04833855|541725498|FG000|Overall Study|Withdrawal by Subject|4|||
150161635|NCT04833855|541725499|FG001|Overall Study|Withdrawal by Subject|1|||
150161636|NCT04833855|541725500|FG002|Overall Study|Withdrawal by Subject|3|||
150161637|NCT04833855|541725501|FG003|Overall Study|Withdrawal by Subject|1|||
150161638|NCT04833855|541725498|FG000|Overall Study|Lost to Follow-up|1|||
150161639|NCT04833855|541725499|FG001|Overall Study|Lost to Follow-up|0|||
150161640|NCT04833855|541725500|FG002|Overall Study|Lost to Follow-up|2|||
150161641|NCT04833855|541725501|FG003|Overall Study|Lost to Follow-up|2|||
150161642|NCT04833855|541725498|FG000|Overall Study|Protocol specified criteria|0|||
150161643|NCT04833855|541725499|FG001|Overall Study|Protocol specified criteria|0|||
150161644|NCT04833855|541725500|FG002|Overall Study|Protocol specified criteria|2|||
150161645|NCT04833855|541725501|FG003|Overall Study|Protocol specified criteria|1|||
150161646|NCT02806336|541725502|FG000|Overall Study|Physician Decision|1|||
150161647|NCT02806336|541725503|FG001|Overall Study|Physician Decision|0|||
150161648|NCT02806336|541725502|FG000|Overall Study|Withdrawal by Subject|2|||
150161649|NCT02806336|541725503|FG001|Overall Study|Withdrawal by Subject|4|||
150161650|NCT02806336|541725502|FG000|Overall Study|COVID-19 research shut down|3|||
150161651|NCT02806336|541725503|FG001|Overall Study|COVID-19 research shut down|4|||
150161652|NCT02806336|541725502|FG000|Overall Study|Lack of Efficacy|0|||
150161653|NCT02806336|541725503|FG001|Overall Study|Lack of Efficacy|1|||
150161654|NCT02338609|541725507|FG000|Overall Study|Physician Decision|1|||
150161655|NCT02338609|541725507|FG000|Overall Study|Death|1|||
150161656|NCT05705167|541725508|FG000|Overall Study|Randomised but not Treated|0|||
150161657|NCT05705167|541725509|FG001|Overall Study|Randomised but not Treated|2|||
150161658|NCT05705167|541725510|FG002|Overall Study|Randomised but not Treated|0|||
150161659|NCT05705167|541725511|FG003|Overall Study|Randomised but not Treated|7|||
150161660|NCT05705167|541725512|FG004|Overall Study|Randomised but not Treated|0|||
150161661|NCT05705167|541725513|FG005|Overall Study|Randomised but not Treated|0|||
150161662|NCT05705167|541725514|FG006|Overall Study|Randomised but not Treated|0|||
150161663|NCT05705167|541725508|FG000|Overall Study|Death|0|||
150161664|NCT05705167|541725509|FG001|Overall Study|Death|0|||
150161665|NCT05705167|541725510|FG002|Overall Study|Death|3|||
150161666|NCT05705167|541725511|FG003|Overall Study|Death|0|||
150161667|NCT05705167|541725512|FG004|Overall Study|Death|1|||
150161668|NCT05705167|541725513|FG005|Overall Study|Death|1|||
150161669|NCT05705167|541725514|FG006|Overall Study|Death|1|||
150161670|NCT05705167|541725508|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
150161671|NCT05705167|541725509|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
150161672|NCT05705167|541725510|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
150161673|NCT05705167|541725511|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
150161674|NCT05705167|541725512|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
150161675|NCT05705167|541725513|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
150161676|NCT05705167|541725514|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
150161677|NCT02099539|541725517|FG000|Overall Study|Progressive Disease|3|||
150161678|NCT02099539|541725518|FG001|Overall Study|Progressive Disease|2|||
150161679|NCT02099539|541725519|FG002|Overall Study|Progressive Disease|2|||
150161680|NCT02099539|541725520|FG003|Overall Study|Progressive Disease|1|||
150161681|NCT02099539|541725521|FG004|Overall Study|Progressive Disease|4|||
150161682|NCT02099539|541725522|FG005|Overall Study|Progressive Disease|2|||
150161683|NCT02099539|541725523|FG006|Overall Study|Progressive Disease|0|||
150161684|NCT02099539|541725517|FG000|Overall Study|Adverse Event|0|||
150161685|NCT02099539|541725518|FG001|Overall Study|Adverse Event|0|||
150161686|NCT02099539|541725519|FG002|Overall Study|Adverse Event|1|||
150161687|NCT02099539|541725520|FG003|Overall Study|Adverse Event|1|||
150161688|NCT02099539|541725521|FG004|Overall Study|Adverse Event|0|||
150161689|NCT02099539|541725522|FG005|Overall Study|Adverse Event|0|||
150161690|NCT02099539|541725523|FG006|Overall Study|Adverse Event|0|||
150161691|NCT02099539|541725517|FG000|Overall Study|Physician Decision|0|||
150161692|NCT02099539|541725518|FG001|Overall Study|Physician Decision|0|||
150161693|NCT02099539|541725519|FG002|Overall Study|Physician Decision|0|||
150161694|NCT02099539|541725520|FG003|Overall Study|Physician Decision|0|||
150161695|NCT02099539|541725521|FG004|Overall Study|Physician Decision|0|||
150161696|NCT02099539|541725522|FG005|Overall Study|Physician Decision|1|||
150161697|NCT02099539|541725523|FG006|Overall Study|Physician Decision|0|||
150161698|NCT03473756|541725525|FG000|Overall Study|Withdrawal by Subject|1|||
150161699|NCT03473756|541725526|FG001|Overall Study|Withdrawal by Subject|4|||
150161700|NCT03473756|541725525|FG000|Overall Study|Adverse Event|6|||
150161701|NCT03473756|541725526|FG001|Overall Study|Adverse Event|7|||
150260552|NCT04745026|542091659|FG000|Overall Study|Withdrawal by Subject|5|||
150260553|NCT04745026|542091660|FG001|Overall Study|Withdrawal by Subject|5|||
150260554|NCT05478499|542091661|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
150260555|NCT05478499|542091662|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
150260556|NCT05478499|542091661|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
150260557|NCT05478499|542091662|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
150260558|NCT05478499|542091661|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
150260559|NCT05478499|542091662|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
150260560|NCT05478499|542091661|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
150260561|NCT05478499|542091662|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
150260562|NCT05478499|542091661|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
150260563|NCT05478499|542091662|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
150260564|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
150260565|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
150260566|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
150260567|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
150260568|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
150260569|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
150260570|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
150260571|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
150260572|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
150260573|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
150260574|NCT05478499|542091661|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
150260575|NCT05478499|542091662|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
150260576|NCT04426851|542091663|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
150260577|NCT04426851|542091664|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
150260578|NCT04426851|542091663|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
150260579|NCT04426851|542091664|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
150260580|NCT03256851|542091665|FG000|Overall Study|Withdrawal by Subject|1|||
150260581|NCT03256851|542091666|FG001|Overall Study|Withdrawal by Subject|0|||
150260582|NCT02476279|542091671|FG000|Overall Study|Lost to Follow-up|1|||
150260583|NCT02476279|542091672|FG001|Overall Study|Lost to Follow-up|1|||
150260584|NCT03545503|542091674|FG000|Overall Study|Protocol Violation|14|||
150260585|NCT03545503|542091675|FG001|Overall Study|Protocol Violation|16|||
150260586|NCT02128542|542091676|FG000|Overall Study|Lost to Follow-up|3|||
150260587|NCT02128542|542091677|FG001|Overall Study|Lost to Follow-up|0|||
150260588|NCT02128542|542091676|FG000|Overall Study|Withdrew Consent|1|||
150260589|NCT02128542|542091677|FG001|Overall Study|Withdrew Consent|0|||
150260590|NCT01098097|542091678|FG000|Overall Study|Adverse Event|17|||
150260591|NCT01098097|542091678|FG000|Overall Study|Lost to Follow-up|18|||
150260592|NCT01098097|542091678|FG000|Overall Study|Status unknown|16|||
150260593|NCT01098097|542091678|FG000|Overall Study|No reason reported|31|||
150260594|NCT00394082|542091679|FG000|Overall Study|Unacceptable toxicity|15|||
150260595|NCT00394082|542091679|FG000|Overall Study|Adverse Event|4|||
150260596|NCT00394082|542091679|FG000|Overall Study|Physician Decision|4|||
150260597|NCT00394082|542091679|FG000|Overall Study|Withdrawal by Subject|2|||
150260598|NCT00394082|542091679|FG000|Overall Study|Other|1|||
150260599|NCT00402597|542091680|FG000|Overall Study|Death|15|||
150260600|NCT00402597|542091681|FG001|Overall Study|Death|7|||
150260601|NCT00402597|542091682|FG002|Overall Study|Death|6|||
150260602|NCT00402597|542091683|FG003|Overall Study|Death|4|||
150260603|NCT00402597|542091684|FG004|Overall Study|Death|6|||
150260604|NCT00402597|542091680|FG000|Overall Study|Adverse Event|81|||
150260605|NCT00402597|542091681|FG001|Overall Study|Adverse Event|18|||
150260606|NCT00402597|542091682|FG002|Overall Study|Adverse Event|106|||
150260607|NCT00402597|542091683|FG003|Overall Study|Adverse Event|39|||
149925696|NCT03465709|540863217|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
149925697|NCT03465709|540863217|FG000|Overall Study|Withdrawal by Subject|3|||
149925698|NCT01408901|540863218|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
149925699|NCT01408901|540863219|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
149925700|NCT01408901|540863220|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
149925701|NCT01408901|540863221|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
149925702|NCT01408901|540863218|FG000|6-Week Follow-Up|Death|1|||
149925703|NCT01408901|540863219|FG001|6-Week Follow-Up|Death|0|||
149925704|NCT01408901|540863220|FG002|6-Week Follow-Up|Death|0|||
149925705|NCT01408901|540863221|FG003|6-Week Follow-Up|Death|0|||
149925706|NCT01408901|540863218|FG000|6-Week Follow-Up|Cancelled visit|0|||
150260608|NCT00402597|542091684|FG004|Overall Study|Adverse Event|71|||
150260609|NCT00402597|542091680|FG000|Overall Study|Lost to Follow-up|8|||
150260610|NCT00402597|542091681|FG001|Overall Study|Lost to Follow-up|1|||
150260611|NCT00402597|542091682|FG002|Overall Study|Lost to Follow-up|8|||
149925707|NCT01408901|540863219|FG001|6-Week Follow-Up|Cancelled visit|1|||
149925708|NCT01408901|540863220|FG002|6-Week Follow-Up|Cancelled visit|0|||
149925709|NCT01408901|540863221|FG003|6-Week Follow-Up|Cancelled visit|2|||
150260612|NCT00402597|542091683|FG003|Overall Study|Lost to Follow-up|2|||
150260613|NCT00402597|542091684|FG004|Overall Study|Lost to Follow-up|3|||
150161702|NCT03473756|541725525|FG000|Overall Study|Lack of Efficacy|3|||
150161703|NCT03473756|541725526|FG001|Overall Study|Lack of Efficacy|10|||
150161704|NCT03473756|541725525|FG000|Overall Study|Physician Decision|0|||
150161705|NCT03473756|541725526|FG001|Overall Study|Physician Decision|2|||
150161706|NCT03473756|541725525|FG000|Overall Study|End of study treatment|0|||
150161707|NCT03473756|541725526|FG001|Overall Study|End of study treatment|2|||
150161708|NCT03473756|541725525|FG000|Overall Study|Lost to Follow-up|0|||
150161709|NCT03473756|541725526|FG001|Overall Study|Lost to Follow-up|1|||
150161710|NCT03714022|541725527|FG000|Overall Study|Adverse Event|1|||
150161711|NCT03714022|541725528|FG001|Overall Study|Adverse Event|0|||
150161712|NCT03714022|541725527|FG000|Overall Study|Consent withdrawal|0|||
150161713|NCT03714022|541725528|FG001|Overall Study|Consent withdrawal|1|||
150161714|NCT03714022|541725527|FG000|Overall Study|Lost to Follow-up|3|||
150161715|NCT03714022|541725528|FG001|Overall Study|Lost to Follow-up|2|||
150161716|NCT02148718|541725529|FG000|Overall Study|Protocol Violation|26|||
150161717|NCT02148718|541725529|FG000|Overall Study|Discontinued Study Prematurely|5|||
150161718|NCT01007552|541725533|FG000|Overall Study|Withdrawal by Subject|1|||
150161719|NCT04482855|541725534|FG000|Overall Study|Lost to Follow-up|1|||
150161720|NCT04482855|541725535|FG001|Overall Study|Lost to Follow-up|0|||
150161721|NCT04482855|541725534|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
150161722|NCT04482855|541725535|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
150161723|NCT04482855|541725534|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
150161724|NCT04482855|541725535|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
150161725|NCT04438785|541725536|FG000|Overall Study|change of weight, give up intervention|2|||
150161726|NCT04438785|541725537|FG001|Overall Study|change of weight, give up intervention|10|||
150161727|NCT02027935|541725538|FG000|Overall Study|Death|1|||
150161728|NCT02027935|541725538|FG000|Overall Study|Lack of Efficacy|5|||
150161729|NCT02027935|541725538|FG000|Overall Study|Study Closure|1|||
150161730|NCT04873817|541725539|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
150161731|NCT04873817|541725539|FG000|Overall Study|Lost to Follow-up|4|||
150161732|NCT04873817|541725539|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
150161733|NCT04873817|541725539|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
150161734|NCT04873817|541725539|FG000|Overall Study|Other Reasons|3|||
150161735|NCT00924560|541725543|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
150161736|NCT00924560|541725544|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
150161737|NCT00924560|541725545|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
150161738|NCT00924560|541725543|FG000|Overall Study|Non Compliance with the Protocol|20|||
150161739|NCT00924560|541725544|FG001|Overall Study|Non Compliance with the Protocol|15|||
150161740|NCT00924560|541725545|FG002|Overall Study|Non Compliance with the Protocol|4|||
150161741|NCT00924560|541725543|FG000|Overall Study|Physician Decision|2|||
150161742|NCT00924560|541725544|FG001|Overall Study|Physician Decision|3|||
150161743|NCT00924560|541725545|FG002|Overall Study|Physician Decision|4|||
150161744|NCT00924560|541725543|FG000|Overall Study|Withdrawal by Subject|50|||
150161745|NCT00924560|541725544|FG001|Overall Study|Withdrawal by Subject|44|||
150161746|NCT00924560|541725545|FG002|Overall Study|Withdrawal by Subject|18|||
150161747|NCT00924560|541725543|FG000|Overall Study|Adverse Event|39|||
150161748|NCT00924560|541725544|FG001|Overall Study|Adverse Event|33|||
150161749|NCT00924560|541725545|FG002|Overall Study|Adverse Event|0|||
150161750|NCT00924560|541725543|FG000|Overall Study|Pregnancy|5|||
150161751|NCT00924560|541725544|FG001|Overall Study|Pregnancy|7|||
150161752|NCT00924560|541725545|FG002|Overall Study|Pregnancy|1|||
150161753|NCT00924560|541725543|FG000|Overall Study|Lost to Follow-up|78|||
150161754|NCT00924560|541725544|FG001|Overall Study|Lost to Follow-up|94|||
150161755|NCT00924560|541725545|FG002|Overall Study|Lost to Follow-up|45|||
150161756|NCT00924560|541725543|FG000|Overall Study|Miscellaneous Reasons|13|||
150161757|NCT00924560|541725544|FG001|Overall Study|Miscellaneous Reasons|10|||
150161758|NCT00924560|541725545|FG002|Overall Study|Miscellaneous Reasons|10|||
150161759|NCT00604786|541725548|FG000|Overall Study|Lost to Follow-up|2|||
150161760|NCT00604786|541725549|FG001|Overall Study|Lost to Follow-up|0|||
150161761|NCT00665561|541725554|FG000|Overall Study|Death recorded on subject summary pages|75|||
150161762|NCT00665561|541725555|FG001|Overall Study|Death recorded on subject summary pages|75|||
150161763|NCT00665561|541725554|FG000|Overall Study|Does not meet entrance criteria|19|||
150161764|NCT00665561|541725555|FG001|Overall Study|Does not meet entrance criteria|21|||
150161765|NCT00665561|541725554|FG000|Overall Study|Lost to Follow-up|203|||
150161766|NCT00665561|541725555|FG001|Overall Study|Lost to Follow-up|264|||
150161767|NCT00665561|541725554|FG000|Overall Study|Withdrawal by Subject|74|||
150161768|NCT00665561|541725555|FG001|Overall Study|Withdrawal by Subject|65|||
150161769|NCT00665561|541725554|FG000|Overall Study|Other|123|||
150161770|NCT00665561|541725555|FG001|Overall Study|Other|108|||
150161771|NCT00665561|541725554|FG000|Overall Study|Site closed|8|||
150161772|NCT00665561|541725555|FG001|Overall Study|Site closed|0|||
150161773|NCT00665561|541725554|FG000|Overall Study|Withdrawn due to pregnancy|0|||
150161774|NCT00665561|541725555|FG001|Overall Study|Withdrawn due to pregnancy|1|||
150161775|NCT02337361|541725556|FG000|3-month Follow-up|Lost to Follow-up|19|||
149925710|NCT01408901|540863218|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
149925711|NCT01408901|540863219|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
149925712|NCT01408901|540863220|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
149925713|NCT01408901|540863221|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
149925714|NCT01408901|540863218|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
149925715|NCT01408901|540863219|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
149925716|NCT01408901|540863220|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
149925717|NCT01408901|540863221|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
149925718|NCT01408901|540863218|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
149925719|NCT01408901|540863219|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
149925720|NCT01408901|540863220|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
149925721|NCT01408901|540863221|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
150161776|NCT02337361|541725557|FG001|3-month Follow-up|Lost to Follow-up|14|||
150161777|NCT02337361|541725556|FG000|6-month Follow-up|Lost to Follow-up|2|||
150161778|NCT02337361|541725557|FG001|6-month Follow-up|Lost to Follow-up|4|||
150161779|NCT01641861|541725558|FG000|Overall Study|Lost to Follow-up|21|||
150161780|NCT01641861|541725559|FG001|Overall Study|Lost to Follow-up|16|||
150161781|NCT01641861|541725558|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
150161782|NCT01641861|541725559|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
150161783|NCT01641861|541725558|FG000|Overall Study|Died due to drowning|0|||
150161784|NCT01641861|541725559|FG001|Overall Study|Died due to drowning|1|||
150161785|NCT00814489|541725560|FG000|Overall Study|Other|2|||
150161786|NCT00814489|541725561|FG001|Overall Study|Other|0|||
150161787|NCT00814489|541725562|FG002|Overall Study|Other|1|||
150161788|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Adverse Event|5|||
150161789|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Adverse Event|13|||
150161790|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Adverse Event|0|||
150161791|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
150161792|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
150161793|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
150161794|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
150161795|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
150161796|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
150161797|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
150161798|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
150161799|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
150161800|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
150161801|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
150161802|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
150161803|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
150161804|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
150161805|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
150161806|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Physician Decision|2|||
150161807|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Physician Decision|3|||
150161808|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Physician Decision|0|||
150161809|NCT01449929|541725563|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
150161810|NCT01449929|541725564|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
150161811|NCT01449929|541725565|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
150161812|NCT01449929|541725563|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
150161813|NCT01449929|541725564|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
150161814|NCT01449929|541725565|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
150161815|NCT01449929|541725563|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
150161816|NCT01449929|541725564|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
150161817|NCT01449929|541725565|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
150161818|NCT01449929|541725563|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
150161819|NCT01449929|541725564|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
150161820|NCT01449929|541725565|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
150161821|NCT04610684|541727944|FG000|Study Treatment|Withdrawal by Subject|1|||
150161822|NCT04610684|541727944|FG000|Study Treatment|Disease Progression|2|||
149925722|NCT01408901|540863218|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
149925723|NCT01408901|540863219|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
150161823|NCT04610684|541727944|FG000|Follow up|Death|2|||
150161824|NCT04610684|541727944|FG000|Follow up|Withdrawal by Subject|1|||
149925724|NCT01408901|540863220|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
149925725|NCT01408901|540863221|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
150161825|NCT02153788|541727946|FG000|Overall Study|Physician Decision|2|||
149925726|NCT01408901|540863218|FG000|26-Week Follow-Up|Death|0|||
150161826|NCT02153788|541727947|FG001|Overall Study|Physician Decision|1|||
150161827|NCT01876043|541727948|FG000|Overall Study|Death|1|||
150161828|NCT01876043|541727948|FG000|Overall Study|Withdrawal by Subject|1|||
150161829|NCT00079937|541727950|FG000|Overall Study|Adverse Event|2|||
150260614|NCT00402597|542091680|FG000|Overall Study|Withdrawal by Subject|57|||
150260615|NCT00402597|542091681|FG001|Overall Study|Withdrawal by Subject|16|||
150260616|NCT00402597|542091682|FG002|Overall Study|Withdrawal by Subject|65|||
150260617|NCT00402597|542091683|FG003|Overall Study|Withdrawal by Subject|15|||
150260618|NCT00402597|542091684|FG004|Overall Study|Withdrawal by Subject|24|||
150260619|NCT00402597|542091680|FG000|Overall Study|reason not specified|30|||
150260620|NCT00402597|542091681|FG001|Overall Study|reason not specified|4|||
150260621|NCT00402597|542091682|FG002|Overall Study|reason not specified|27|||
150260622|NCT00402597|542091683|FG003|Overall Study|reason not specified|14|||
150260623|NCT00402597|542091684|FG004|Overall Study|reason not specified|20|||
150260624|NCT01831856|542091685|FG000|Overall Study|Adverse Event|5|||
150260625|NCT01831856|542091686|FG001|Overall Study|Adverse Event|8|||
150260626|NCT01831856|542091685|FG000|Overall Study|Lack of Efficacy|13|||
150260627|NCT01831856|542091686|FG001|Overall Study|Lack of Efficacy|11|||
150260628|NCT01831856|542091685|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
150260629|NCT01831856|542091686|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
150260630|NCT05208866|542091687|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
150260631|NCT00577577|542091691|FG000|Overall Study|Adverse Event|3|||
150260632|NCT00577577|542091692|FG001|Overall Study|Adverse Event|2|||
150260633|NCT00577577|542091691|FG000|Overall Study|Lost to Follow-up|1|||
150260634|NCT00577577|542091692|FG001|Overall Study|Lost to Follow-up|0|||
150260635|NCT00577577|542091691|FG000|Overall Study|Protocol Violation|0|||
150260636|NCT00577577|542091692|FG001|Overall Study|Protocol Violation|3|||
150260637|NCT00577577|542091691|FG000|Overall Study|Transportation|1|||
150260638|NCT00577577|542091692|FG001|Overall Study|Transportation|0|||
150260639|NCT00232544|542091693|FG000|Overall Study|Lost to Follow-up|20|||
150260640|NCT00232544|542091694|FG001|Overall Study|Lost to Follow-up|15|||
150260641|NCT00598273|542091695|FG000|Overall Study|Adverse Event|4|||
150260642|NCT00598273|542091696|FG001|Overall Study|Adverse Event|5|||
150260643|NCT00598273|542091697|FG002|Overall Study|Adverse Event|2|||
150260644|NCT00598273|542091695|FG000|Overall Study|Death|6|||
150260645|NCT00598273|542091696|FG001|Overall Study|Death|12|||
150260646|NCT00598273|542091697|FG002|Overall Study|Death|8|||
150260647|NCT00598273|542091695|FG000|Overall Study|Lost to Follow-up|8|||
150260648|NCT00598273|542091696|FG001|Overall Study|Lost to Follow-up|3|||
150260649|NCT00598273|542091697|FG002|Overall Study|Lost to Follow-up|5|||
150260650|NCT00598273|542091695|FG000|Overall Study|Physician Decision|0|||
150260651|NCT00598273|542091696|FG001|Overall Study|Physician Decision|0|||
150260652|NCT00598273|542091697|FG002|Overall Study|Physician Decision|1|||
150260653|NCT00598273|542091695|FG000|Overall Study|Withdrawal by Subject|12|||
150260654|NCT00598273|542091696|FG001|Overall Study|Withdrawal by Subject|10|||
150260655|NCT00598273|542091697|FG002|Overall Study|Withdrawal by Subject|10|||
150260656|NCT00598273|542091695|FG000|Overall Study|Noncompliance|3|||
150260657|NCT00598273|542091696|FG001|Overall Study|Noncompliance|2|||
150260658|NCT00598273|542091697|FG002|Overall Study|Noncompliance|3|||
150260659|NCT00598273|542091695|FG000|Overall Study|Relocation|0|||
150260660|NCT00598273|542091696|FG001|Overall Study|Relocation|2|||
150260661|NCT00598273|542091697|FG002|Overall Study|Relocation|4|||
150260662|NCT00598273|542091695|FG000|Overall Study|Renal transplant|1|||
150260663|NCT00598273|542091696|FG001|Overall Study|Renal transplant|0|||
150260664|NCT00598273|542091697|FG002|Overall Study|Renal transplant|1|||
150260665|NCT00598273|542091695|FG000|Overall Study|Site elected to close|1|||
150260666|NCT00598273|542091696|FG001|Overall Study|Site elected to close|0|||
150260667|NCT00598273|542091697|FG002|Overall Study|Site elected to close|0|||
150260668|NCT00598273|542091695|FG000|Overall Study|Started dialysis|6|||
150260669|NCT00598273|542091696|FG001|Overall Study|Started dialysis|4|||
150260670|NCT00598273|542091697|FG002|Overall Study|Started dialysis|5|||
150260671|NCT00906945|542091698|FG000|Overall Study|Found to be not eligible|0|||
150260672|NCT00906945|542091699|FG001|Overall Study|Found to be not eligible|0|||
150260673|NCT00906945|542091700|FG002|Overall Study|Found to be not eligible|0|||
150260674|NCT00906945|542091701|FG003|Overall Study|Found to be not eligible|1|||
150260675|NCT00906945|542091702|FG004|Overall Study|Found to be not eligible|1|||
150260676|NCT00906945|542091703|FG005|Overall Study|Found to be not eligible|1|||
150260677|NCT00906945|542091698|FG000|Overall Study|Physician Decision|0|||
150260678|NCT00906945|542091699|FG001|Overall Study|Physician Decision|0|||
150260679|NCT00906945|542091700|FG002|Overall Study|Physician Decision|0|||
150260680|NCT00906945|542091701|FG003|Overall Study|Physician Decision|0|||
150260681|NCT00906945|542091702|FG004|Overall Study|Physician Decision|0|||
150260682|NCT00906945|542091703|FG005|Overall Study|Physician Decision|1|||
150260683|NCT01210664|542091705|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
150260684|NCT01210664|542091706|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
150260685|NCT01210664|542091707|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
150260686|NCT01210664|542091708|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
150260687|NCT01210664|542091705|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260688|NCT01210664|542091706|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260689|NCT01210664|542091707|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
150260690|NCT01210664|542091708|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260691|NCT01210664|542091705|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260692|NCT01210664|542091706|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260693|NCT01210664|542091707|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
150260694|NCT01210664|542091708|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
150260695|NCT01054170|542091709|FG000|Overall Study|Protocol Violation|1|||
150260696|NCT01054170|542091710|FG001|Overall Study|Protocol Violation|0|||
150260697|NCT01054170|542091709|FG000|Overall Study|Withdrawal by Subject|3|||
150260698|NCT01054170|542091710|FG001|Overall Study|Withdrawal by Subject|2|||
150260699|NCT01054170|542091709|FG000|Overall Study|Adverse Event|0|||
150260700|NCT01054170|542091710|FG001|Overall Study|Adverse Event|4|||
150260701|NCT02951767|542091711|FG000|Overall Study|Study Terminated By Sponsor|9|||
150260702|NCT02951767|542091711|FG000|Overall Study|Withdrawal by Subject|11|||
150260703|NCT02951767|542091711|FG000|Overall Study|Death|96|||
150260704|NCT02951767|542091711|FG000|Overall Study|Lost to Follow-up|2|||
150260705|NCT02951767|542091711|FG000|Overall Study|Physician Decision|1|||
150260706|NCT02751320|542091712|FG000|Overall Study|Adverse Event|2|||
150260707|NCT02751320|542091712|FG000|Overall Study|Withdrawal by Subject|1|||
150260708|NCT02549196|542091713|FG000|Overall Study|Protocol Violation|0|||
150260709|NCT02549196|542091714|FG001|Overall Study|Protocol Violation|0|||
150260710|NCT02549196|542091715|FG002|Overall Study|Protocol Violation|0|||
150260711|NCT02549196|542091716|FG003|Overall Study|Protocol Violation|1|||
150260712|NCT02549196|542091713|FG000|Overall Study|Withdrawal by Subject|1|||
150260713|NCT02549196|542091714|FG001|Overall Study|Withdrawal by Subject|0|||
150260714|NCT02549196|542091715|FG002|Overall Study|Withdrawal by Subject|1|||
150260715|NCT02549196|542091716|FG003|Overall Study|Withdrawal by Subject|0|||
150260716|NCT01442779|542091717|FG000|Overall Study|Withdrawal by Subject|3|||
150260717|NCT01442779|542091717|FG000|Overall Study|Death|3|||
150260718|NCT01442779|542091717|FG000|Overall Study|Non-compliance|1|||
150260719|NCT05249829|542091718|FG000|Overall Study|Participant Relocation|0|||
150260720|NCT05249829|542091719|FG001|Overall Study|Participant Relocation|1|||
150260721|NCT05249829|542091720|FG002|Overall Study|Participant Relocation|2|||
150260722|NCT05249829|542091721|FG003|Overall Study|Participant Relocation|2|||
150260723|NCT05249829|542091718|FG000|Overall Study|Withdrawal by Subject|9|||
150260724|NCT05249829|542091719|FG001|Overall Study|Withdrawal by Subject|17|||
150260725|NCT05249829|542091720|FG002|Overall Study|Withdrawal by Subject|40|||
150260726|NCT05249829|542091721|FG003|Overall Study|Withdrawal by Subject|35|||
150260727|NCT05249829|542091718|FG000|Overall Study|Physician Decision|1|||
150260728|NCT05249829|542091719|FG001|Overall Study|Physician Decision|0|||
150260729|NCT05249829|542091720|FG002|Overall Study|Physician Decision|0|||
150260730|NCT05249829|542091721|FG003|Overall Study|Physician Decision|0|||
150260731|NCT05249829|542091718|FG000|Overall Study|Lost to Follow-up|16|||
150260732|NCT05249829|542091719|FG001|Overall Study|Lost to Follow-up|16|||
150260733|NCT05249829|542091720|FG002|Overall Study|Lost to Follow-up|57|||
150260734|NCT05249829|542091721|FG003|Overall Study|Lost to Follow-up|60|||
150260735|NCT05249829|542091718|FG000|Overall Study|Adverse Event|2|||
150260736|NCT05249829|542091719|FG001|Overall Study|Adverse Event|2|||
150260737|NCT05249829|542091720|FG002|Overall Study|Adverse Event|2|||
150260738|NCT05249829|542091721|FG003|Overall Study|Adverse Event|2|||
150260739|NCT05249829|542091718|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
150260740|NCT05249829|542091719|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
150260741|NCT05249829|542091720|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
150260742|NCT05249829|542091721|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
150260743|NCT05249829|542091718|FG000|Overall Study|Protocol Violation|2|||
150260744|NCT05249829|542091719|FG001|Overall Study|Protocol Violation|0|||
150260745|NCT05249829|542091720|FG002|Overall Study|Protocol Violation|5|||
150260746|NCT05249829|542091721|FG003|Overall Study|Protocol Violation|3|||
150260747|NCT05249829|542091718|FG000|Overall Study|Death|0|||
150260748|NCT05249829|542091719|FG001|Overall Study|Death|1|||
150260749|NCT05249829|542091720|FG002|Overall Study|Death|2|||
150260750|NCT05249829|542091721|FG003|Overall Study|Death|4|||
150260751|NCT00513604|542091722|FG000|Overall Study|Not treated|2|||
150260752|NCT00513604|542091723|FG001|Overall Study|Not treated|0|||
150260753|NCT00513604|542091724|FG002|Overall Study|Not treated|1|||
150260754|NCT00513604|542091725|FG003|Overall Study|Not treated|0|||
150260755|NCT00513604|542091726|FG004|Overall Study|Not treated|0|||
150260756|NCT00513604|542091722|FG000|Overall Study|Death during treatment|0|||
150260757|NCT00513604|542091723|FG001|Overall Study|Death during treatment|3|||
150260758|NCT00513604|542091724|FG002|Overall Study|Death during treatment|2|||
150260759|NCT00513604|542091725|FG003|Overall Study|Death during treatment|0|||
150260760|NCT00513604|542091726|FG004|Overall Study|Death during treatment|0|||
150260761|NCT00196976|542091727|FG000|Primary Study|Migrated from study area|0|||
150260762|NCT00196976|542091728|FG001|Primary Study|Migrated from study area|0|||
150260763|NCT00196976|542091729|FG002|Primary Study|Migrated from study area|0|||
150260764|NCT00196976|542091730|FG003|Primary Study|Migrated from study area|0|||
150260765|NCT00196976|542091731|FG004|Primary Study|Migrated from study area|0|||
150260766|NCT00196976|542091732|FG005|Primary Study|Migrated from study area|0|||
150260767|NCT00196976|542091733|FG006|Primary Study|Migrated from study area|0|||
150260768|NCT00196976|542091734|FG007|Primary Study|Migrated from study area|1|||
149925727|NCT01408901|540863219|FG001|26-Week Follow-Up|Death|1|||
149925728|NCT01408901|540863220|FG002|26-Week Follow-Up|Death|0|||
150161830|NCT00079937|541727951|FG001|Overall Study|Adverse Event|1|||
150161831|NCT00079937|541727950|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150161832|NCT00079937|541727951|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150161833|NCT00079937|541727950|FG000|Overall Study|Subject no longer requires study drug|3|||
150161834|NCT00079937|541727951|FG001|Overall Study|Subject no longer requires study drug|0|||
150161835|NCT00079937|541727950|FG000|Overall Study|Protocol Violation|8|||
150161836|NCT00079937|541727951|FG001|Overall Study|Protocol Violation|6|||
150161837|NCT00079937|541727950|FG000|Overall Study|Withdrawal by Subject|21|||
150161838|NCT00079937|541727951|FG001|Overall Study|Withdrawal by Subject|7|||
150161839|NCT00079937|541727950|FG000|Overall Study|Lost to Follow-up|12|||
150161840|NCT00079937|541727951|FG001|Overall Study|Lost to Follow-up|5|||
150161841|NCT00079937|541727950|FG000|Overall Study|Administrative problems|22|||
150161842|NCT00079937|541727951|FG001|Overall Study|Administrative problems|11|||
150161843|NCT05458102|541727954|FG000|Overall Study|Withdrew consent|2|||
150161844|NCT05458102|541727955|FG001|Overall Study|Withdrew consent|0|||
150161845|NCT05458102|541727954|FG000|Overall Study|Adverse Event|1|||
150161846|NCT05458102|541727955|FG001|Overall Study|Adverse Event|0|||
150161847|NCT05458102|541727954|FG000|Overall Study|Enrolled but never treated|1|||
150161848|NCT05458102|541727955|FG001|Overall Study|Enrolled but never treated|0|||
150161849|NCT05458102|541727954|FG000|Overall Study|Protocol Violation|1|||
150161850|NCT05458102|541727955|FG001|Overall Study|Protocol Violation|0|||
150161851|NCT00852475|541727956|FG000|Overall Study|Lost to Follow-up|3|||
150161852|NCT00852475|541727957|FG001|Overall Study|Lost to Follow-up|4|||
150161853|NCT00498186|541727958|FG000|Overall Study|Protocol Violation|10|||
150161854|NCT00498186|541727958|FG000|Overall Study|Lack of Efficacy|31|||
150161855|NCT00498186|541727958|FG000|Overall Study|Adverse Event|89|||
150161856|NCT00498186|541727958|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
149925729|NCT01408901|540863221|FG003|26-Week Follow-Up|Death|0|||
149925730|NCT04978337|540863222|FG000|Overall Study|Withdrawal by Subject|0|||
150161857|NCT00498186|541727958|FG000|Overall Study|Withdrawal by Subject|18|||
150161858|NCT00498186|541727958|FG000|Overall Study|Lost to Follow-up|3|||
150161859|NCT00498186|541727958|FG000|Overall Study|Other|10|||
150161860|NCT00367237|541727959|FG000|Overall Study|Adverse Event|7|||
150161861|NCT00367237|541727960|FG001|Overall Study|Adverse Event|2|||
150161862|NCT00367237|541727959|FG000|Overall Study|Lost to Follow-up|1|||
150161863|NCT00367237|541727960|FG001|Overall Study|Lost to Follow-up|0|||
150161864|NCT00367237|541727959|FG000|Overall Study|Withdrawal by Subject|0|||
150161865|NCT00367237|541727960|FG001|Overall Study|Withdrawal by Subject|4|||
150161866|NCT00367237|541727959|FG000|Overall Study|Protocol Violation|2|||
150161867|NCT00367237|541727960|FG001|Overall Study|Protocol Violation|5|||
150161868|NCT01175707|541727961|FG000|Overall Study|Adverse Event|4|||
150161869|NCT01175707|541727962|FG001|Overall Study|Adverse Event|6|||
150161870|NCT04531540|541727971|FG000|Overall Study|Adverse Event|1|||
150161871|NCT04531540|541727971|FG000|Overall Study|Protocol Violation|3|||
150161872|NCT04531540|541727971|FG000|Overall Study|Withdrawal by Subject|4|||
150161873|NCT04531540|541727971|FG000|Overall Study|Found to be Ineligible|1|||
150161874|NCT00003377|541727972|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
150161875|NCT00003377|541727973|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
150161876|NCT00003377|541727974|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
150161877|NCT00003377|541727975|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
150161878|NCT00003377|541727976|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
150161879|NCT00003377|541727972|FG000|Period II|Ureteral stent complications|0|||
150161880|NCT00003377|541727973|FG001|Period II|Ureteral stent complications|0|||
150161881|NCT00003377|541727974|FG002|Period II|Ureteral stent complications|0|||
150161882|NCT00003377|541727975|FG003|Period II|Ureteral stent complications|0|||
150161883|NCT00003377|541727976|FG004|Period II|Ureteral stent complications|1|||
150161884|NCT04541186|541727981|FG000|Main Study|Adverse Event|0|||
150161885|NCT04541186|541727982|FG001|Main Study|Adverse Event|0|||
150161886|NCT04541186|541727983|FG002|Main Study|Adverse Event|4|||
150161887|NCT04541186|541727984|FG003|Main Study|Adverse Event|0|||
150161888|NCT04541186|541727985|FG004|Main Study|Adverse Event|0|||
150161889|NCT04541186|541727981|FG000|Main Study|Investigator Decision|0|||
150161890|NCT04541186|541727982|FG001|Main Study|Investigator Decision|0|||
150161891|NCT04541186|541727983|FG002|Main Study|Investigator Decision|1|||
150161892|NCT04541186|541727984|FG003|Main Study|Investigator Decision|1|||
150161893|NCT04541186|541727985|FG004|Main Study|Investigator Decision|0|||
150161894|NCT04541186|541727981|FG000|Main Study|Withdrawal by Subject|1|||
150161895|NCT04541186|541727982|FG001|Main Study|Withdrawal by Subject|1|||
150260769|NCT00196976|542091735|FG008|Primary Study|Migrated from study area|0|||
150161896|NCT04541186|541727983|FG002|Main Study|Withdrawal by Subject|0|||
150161897|NCT04541186|541727984|FG003|Main Study|Withdrawal by Subject|0|||
150161898|NCT04541186|541727985|FG004|Main Study|Withdrawal by Subject|0|||
150161899|NCT04541186|541727981|FG000|Main Study|COVID-19-related Dose Interruption|0|||
150161900|NCT04541186|541727982|FG001|Main Study|COVID-19-related Dose Interruption|0|||
150161901|NCT04541186|541727983|FG002|Main Study|COVID-19-related Dose Interruption|0|||
149925731|NCT04978337|540863223|FG001|Overall Study|Withdrawal by Subject|1|||
150161902|NCT04541186|541727984|FG003|Main Study|COVID-19-related Dose Interruption|0|||
150161903|NCT04541186|541727985|FG004|Main Study|COVID-19-related Dose Interruption|1|||
150161904|NCT04541186|541727981|FG000|Main Study|Randomized in Error Not Treated|0|||
150161905|NCT04541186|541727982|FG001|Main Study|Randomized in Error Not Treated|0|||
150161906|NCT04541186|541727983|FG002|Main Study|Randomized in Error Not Treated|1|||
150161907|NCT04541186|541727984|FG003|Main Study|Randomized in Error Not Treated|0|||
150161908|NCT04541186|541727985|FG004|Main Study|Randomized in Error Not Treated|0|||
150161909|NCT04541186|541727981|FG000|Fibrate Expansion Study|Other than Specified|0|||
150161910|NCT04541186|541727982|FG001|Fibrate Expansion Study|Other than Specified|0|||
150161911|NCT04541186|541727983|FG002|Fibrate Expansion Study|Other than Specified|0|||
150161912|NCT04541186|541727984|FG003|Fibrate Expansion Study|Other than Specified|0|||
150161913|NCT04541186|541727985|FG004|Fibrate Expansion Study|Other than Specified|1|||
150161914|NCT00578227|541727986|FG000|Overall Study|Lost to Follow-up|0|||
150161915|NCT00578227|541727987|FG001|Overall Study|Lost to Follow-up|1|||
150161916|NCT00578227|541727988|FG002|Overall Study|Lost to Follow-up|1|||
150161917|NCT00578227|541727986|FG000|Overall Study|Withdrawal by Subject|5|||
150161918|NCT00578227|541727987|FG001|Overall Study|Withdrawal by Subject|1|||
150161919|NCT00578227|541727988|FG002|Overall Study|Withdrawal by Subject|3|||
150161920|NCT01605136|541727997|FG000|Study Period|Withdrawal by Subject|2|||
150161921|NCT01605136|541727998|FG001|Study Period|Withdrawal by Subject|0|||
150161922|NCT01605136|541727997|FG000|Study Period|Physician Decision|1|||
150161923|NCT01605136|541727998|FG001|Study Period|Physician Decision|1|||
150161924|NCT01605136|541727997|FG000|Study Period|Lost to Follow-up|0|||
150161925|NCT01605136|541727998|FG001|Study Period|Lost to Follow-up|2|||
150161926|NCT01605136|541727997|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
150161927|NCT01605136|541727998|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
150161928|NCT01072929|541727999|FG000|Overall Study|Adverse Event|8|||
150161929|NCT01072929|541728000|FG001|Overall Study|Adverse Event|11|||
150161930|NCT01072929|541728001|FG002|Overall Study|Adverse Event|2|||
150161931|NCT01072929|541727999|FG000|Overall Study|Lack of Efficacy|7|||
150161932|NCT01072929|541728000|FG001|Overall Study|Lack of Efficacy|4|||
150161933|NCT01072929|541728001|FG002|Overall Study|Lack of Efficacy|0|||
150161934|NCT01072929|541727999|FG000|Overall Study|Withdrawal by Subject|7|||
150161935|NCT01072929|541728000|FG001|Overall Study|Withdrawal by Subject|15|||
150161936|NCT01072929|541728001|FG002|Overall Study|Withdrawal by Subject|3|||
150161937|NCT01072929|541727999|FG000|Overall Study|Protocol Violation|13|||
150161938|NCT01072929|541728000|FG001|Overall Study|Protocol Violation|11|||
150161939|NCT01072929|541728001|FG002|Overall Study|Protocol Violation|2|||
150161940|NCT01072929|541727999|FG000|Overall Study|Lost to Follow-up|8|||
150161941|NCT01072929|541728000|FG001|Overall Study|Lost to Follow-up|4|||
150161942|NCT01072929|541728001|FG002|Overall Study|Lost to Follow-up|1|||
150161943|NCT01072929|541727999|FG000|Overall Study|Noncompliance with study medication|0|||
150161944|NCT01072929|541728000|FG001|Overall Study|Noncompliance with study medication|3|||
150161945|NCT01072929|541728001|FG002|Overall Study|Noncompliance with study medication|0|||
150161946|NCT01072929|541727999|FG000|Overall Study|Noncompliance with study procedures|1|||
149818923|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149818924|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149818925|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149818926|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149818927|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149818928|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
149925732|NCT01436227|540863227|FG000|Overall Study|Adverse Event|7|||
149925733|NCT01436227|540863227|FG000|Overall Study|Death|1|||
149925734|NCT01436227|540863227|FG000|Overall Study|Lack of Efficacy|1|||
149925735|NCT01436227|540863227|FG000|Overall Study|Lost to Follow-up|3|||
149925736|NCT01436227|540863227|FG000|Overall Study|Physician Decision|1|||
149925737|NCT01436227|540863227|FG000|Overall Study|Withdrawal by Subject|7|||
149925738|NCT01436227|540863227|FG000|Overall Study|Disease progression, relapse|6|||
149925739|NCT04865419|540863230|FG000|Overall Study|Other|1|||
149925740|NCT04865419|540863231|FG001|Overall Study|Other|2|||
149925741|NCT04865419|540863232|FG002|Overall Study|Other|2|||
149925742|NCT04865419|540863233|FG003|Overall Study|Other|1|||
149925743|NCT04865419|540863234|FG004|Overall Study|Other|3|||
149925744|NCT04865419|540863235|FG005|Overall Study|Other|0|||
149925745|NCT04865419|540863236|FG006|Overall Study|Other|0|||
149925746|NCT04865419|540863237|FG007|Overall Study|Other|1|||
149925747|NCT04865419|540863238|FG008|Overall Study|Other|0|||
149925748|NCT04865419|540863239|FG009|Overall Study|Other|0|||
149925749|NCT04865419|540863240|FG010|Overall Study|Other|0|||
149925750|NCT04865419|540863230|FG000|Overall Study|Withdrawal by Subject|0|||
150161947|NCT01072929|541728000|FG001|Overall Study|Noncompliance with study procedures|0|||
150161948|NCT01072929|541728001|FG002|Overall Study|Noncompliance with study procedures|1|||
150161949|NCT01072929|541727999|FG000|Overall Study|Other|0|||
149925751|NCT04865419|540863231|FG001|Overall Study|Withdrawal by Subject|1|||
149925752|NCT04865419|540863232|FG002|Overall Study|Withdrawal by Subject|1|||
149925753|NCT04865419|540863233|FG003|Overall Study|Withdrawal by Subject|0|||
149925754|NCT04865419|540863234|FG004|Overall Study|Withdrawal by Subject|0|||
149925755|NCT04865419|540863235|FG005|Overall Study|Withdrawal by Subject|0|||
149925756|NCT04865419|540863236|FG006|Overall Study|Withdrawal by Subject|0|||
149925757|NCT04865419|540863237|FG007|Overall Study|Withdrawal by Subject|1|||
149925758|NCT04865419|540863238|FG008|Overall Study|Withdrawal by Subject|2|||
149925759|NCT04865419|540863239|FG009|Overall Study|Withdrawal by Subject|1|||
149925760|NCT04865419|540863240|FG010|Overall Study|Withdrawal by Subject|0|||
149925761|NCT04865419|540863230|FG000|Overall Study|Study terminated by Sponsor|0|||
149925762|NCT04865419|540863231|FG001|Overall Study|Study terminated by Sponsor|0|||
149925763|NCT04865419|540863232|FG002|Overall Study|Study terminated by Sponsor|0|||
149925764|NCT04865419|540863233|FG003|Overall Study|Study terminated by Sponsor|2|||
149925765|NCT04865419|540863234|FG004|Overall Study|Study terminated by Sponsor|2|||
149925766|NCT04865419|540863235|FG005|Overall Study|Study terminated by Sponsor|0|||
149925767|NCT04865419|540863236|FG006|Overall Study|Study terminated by Sponsor|0|||
149925768|NCT04865419|540863237|FG007|Overall Study|Study terminated by Sponsor|0|||
149925769|NCT04865419|540863238|FG008|Overall Study|Study terminated by Sponsor|0|||
149925770|NCT04865419|540863239|FG009|Overall Study|Study terminated by Sponsor|0|||
149925771|NCT04865419|540863240|FG010|Overall Study|Study terminated by Sponsor|1|||
149925772|NCT04865419|540863230|FG000|Overall Study|Death|3|||
149925773|NCT04865419|540863231|FG001|Overall Study|Death|1|||
149925774|NCT04865419|540863232|FG002|Overall Study|Death|4|||
149925775|NCT04865419|540863233|FG003|Overall Study|Death|2|||
149925776|NCT04865419|540863234|FG004|Overall Study|Death|5|||
149925777|NCT04865419|540863235|FG005|Overall Study|Death|2|||
149925778|NCT04865419|540863236|FG006|Overall Study|Death|1|||
149925779|NCT04865419|540863237|FG007|Overall Study|Death|1|||
149925780|NCT04865419|540863238|FG008|Overall Study|Death|2|||
149925781|NCT04865419|540863239|FG009|Overall Study|Death|2|||
149925782|NCT04865419|540863240|FG010|Overall Study|Death|1|||
149925783|NCT04865419|540863230|FG000|Overall Study|Lost to Follow-up|0|||
149925784|NCT04865419|540863231|FG001|Overall Study|Lost to Follow-up|0|||
149925785|NCT04865419|540863232|FG002|Overall Study|Lost to Follow-up|0|||
149925786|NCT04865419|540863233|FG003|Overall Study|Lost to Follow-up|0|||
149925787|NCT04865419|540863234|FG004|Overall Study|Lost to Follow-up|0|||
149925788|NCT04865419|540863235|FG005|Overall Study|Lost to Follow-up|0|||
149925789|NCT04865419|540863236|FG006|Overall Study|Lost to Follow-up|0|||
149925790|NCT04865419|540863237|FG007|Overall Study|Lost to Follow-up|0|||
149925791|NCT04865419|540863238|FG008|Overall Study|Lost to Follow-up|0|||
149925792|NCT04865419|540863239|FG009|Overall Study|Lost to Follow-up|1|||
149925793|NCT04865419|540863240|FG010|Overall Study|Lost to Follow-up|0|||
149925794|NCT05446142|540863241|FG000|Period 2|Adverse Event|1|||
149925795|NCT05446142|540863242|FG001|Period 2|Adverse Event|0|||
149925796|NCT05446142|540863243|FG002|Period 2|Adverse Event|0|||
149925797|NCT05446142|540863244|FG003|Period 2|Adverse Event|0|||
149925798|NCT05446142|540863245|FG004|Period 2|Adverse Event|0|||
149925799|NCT05446142|540863246|FG005|Period 2|Adverse Event|0|||
149925800|NCT02098395|540863251|FG000|Overall Study|Protocol Violation|2|||
149925801|NCT02098395|540863252|FG001|Overall Study|Protocol Violation|2|||
149925802|NCT02098395|540863253|FG002|Overall Study|Protocol Violation|0|||
149925803|NCT02098395|540863254|FG003|Overall Study|Protocol Violation|7|||
149925804|NCT02098395|540863251|FG000|Overall Study|Withdrawal by Subject|10|||
149925805|NCT02098395|540863252|FG001|Overall Study|Withdrawal by Subject|10|||
149925806|NCT02098395|540863253|FG002|Overall Study|Withdrawal by Subject|5|||
149925807|NCT02098395|540863254|FG003|Overall Study|Withdrawal by Subject|13|||
149925808|NCT02098395|540863251|FG000|Overall Study|Adverse Event|12|||
149925809|NCT02098395|540863252|FG001|Overall Study|Adverse Event|19|||
149925810|NCT02098395|540863253|FG002|Overall Study|Adverse Event|34|||
149925811|NCT02098395|540863254|FG003|Overall Study|Adverse Event|2|||
149925812|NCT02098395|540863251|FG000|Overall Study|Lost to Follow-up|2|||
149925813|NCT02098395|540863252|FG001|Overall Study|Lost to Follow-up|1|||
149925814|NCT02098395|540863253|FG002|Overall Study|Lost to Follow-up|0|||
149925815|NCT02098395|540863254|FG003|Overall Study|Lost to Follow-up|3|||
149925816|NCT02098395|540863251|FG000|Overall Study|Unclassified|0|||
150161950|NCT01072929|541728000|FG001|Overall Study|Other|3|||
150161951|NCT01072929|541728001|FG002|Overall Study|Other|0|||
149925817|NCT02098395|540863252|FG001|Overall Study|Unclassified|0|||
149925818|NCT02098395|540863253|FG002|Overall Study|Unclassified|3|||
150161952|NCT02929108|541728002|FG000|Overall Study|Hospice patient death|100|||
149925819|NCT02098395|540863254|FG003|Overall Study|Unclassified|2|||
149925820|NCT00282152|540863264|FG000|Overall Study|Withdrawal by Subject|1|||
149925821|NCT00282152|540863265|FG001|Overall Study|Withdrawal by Subject|0|||
149925822|NCT00585325|540863266|FG000|Overall Study|Withdrawal by Subject|1|||
149925823|NCT00585325|540863267|FG001|Overall Study|Withdrawal by Subject|1|||
149925824|NCT03092791|540863268|FG000|Overall Study|Lost to Follow-up|0|||
149925825|NCT03092791|540863269|FG001|Overall Study|Lost to Follow-up|0|||
149925826|NCT03092791|540863270|FG002|Overall Study|Lost to Follow-up|0|||
149925827|NCT03092791|540863271|FG003|Overall Study|Lost to Follow-up|0|||
149925828|NCT03092791|540863272|FG004|Overall Study|Lost to Follow-up|0|||
149925829|NCT03092791|540863273|FG005|Overall Study|Lost to Follow-up|0|||
150260770|NCT00196976|542091736|FG009|Primary Study|Migrated from study area|0|||
150260771|NCT00196976|542091737|FG010|Primary Study|Migrated from study area|0|||
150260772|NCT00196976|542091738|FG011|Primary Study|Migrated from study area|0|||
150260773|NCT00196976|542091739|FG012|Primary Study|Migrated from study area|0|||
150260774|NCT00196976|542091740|FG013|Primary Study|Migrated from study area|0|||
150260775|NCT00196976|542091727|FG000|Primary Study|Protocol Violation|0|||
150260776|NCT00196976|542091728|FG001|Primary Study|Protocol Violation|1|||
150260777|NCT00196976|542091729|FG002|Primary Study|Protocol Violation|1|||
150260778|NCT00196976|542091730|FG003|Primary Study|Protocol Violation|0|||
150260779|NCT00196976|542091731|FG004|Primary Study|Protocol Violation|0|||
150260780|NCT00196976|542091732|FG005|Primary Study|Protocol Violation|0|||
150260781|NCT00196976|542091733|FG006|Primary Study|Protocol Violation|0|||
150260782|NCT00196976|542091734|FG007|Primary Study|Protocol Violation|0|||
150260783|NCT00196976|542091735|FG008|Primary Study|Protocol Violation|0|||
150260784|NCT00196976|542091736|FG009|Primary Study|Protocol Violation|0|||
150260785|NCT00196976|542091737|FG010|Primary Study|Protocol Violation|0|||
150260786|NCT00196976|542091738|FG011|Primary Study|Protocol Violation|0|||
150260787|NCT00196976|542091739|FG012|Primary Study|Protocol Violation|0|||
150161953|NCT02929108|541728003|FG001|Overall Study|Hospice patient death|64|||
150161954|NCT02929108|541728004|FG002|Overall Study|Hospice patient death|28|||
150161955|NCT02929108|541728005|FG003|Overall Study|Hospice patient death|46|||
150161956|NCT02929108|541728006|FG004|Overall Study|Hospice patient death|55|||
150161957|NCT02929108|541728007|FG005|Overall Study|Hospice patient death|28|||
150161958|NCT02929108|541728008|FG006|Overall Study|Hospice patient death|78|||
150161959|NCT01008748|541728009|FG000|Overall Study|Lost to Follow-up|80|||
150161960|NCT01008748|541728009|FG000|Overall Study|Other|1|||
150161961|NCT00052962|541728010|FG000|Overall Study|Not evaluable|0|||
150161962|NCT00052962|541728011|FG001|Overall Study|Not evaluable|2|||
150161963|NCT00052962|541728010|FG000|Overall Study|Not randomized/not evaluable|1|||
150161964|NCT00052962|541728011|FG001|Overall Study|Not randomized/not evaluable|0|||
150161965|NCT01414166|541728013|FG000|Overall Study|Adverse Event|10|||
150161966|NCT01414166|541728014|FG001|Overall Study|Adverse Event|2|||
150161967|NCT01414166|541728013|FG000|Overall Study|Lost to Follow-up|4|||
150161968|NCT01414166|541728014|FG001|Overall Study|Lost to Follow-up|1|||
150161969|NCT01414166|541728013|FG000|Overall Study|Non-compliance with study drug|2|||
150161970|NCT01414166|541728014|FG001|Overall Study|Non-compliance with study drug|0|||
150161971|NCT01414166|541728013|FG000|Overall Study|Physician Decision|2|||
150161972|NCT01414166|541728014|FG001|Overall Study|Physician Decision|0|||
150161973|NCT01414166|541728013|FG000|Overall Study|Protocol Violation|2|||
150161974|NCT01414166|541728014|FG001|Overall Study|Protocol Violation|0|||
150161975|NCT01414166|541728013|FG000|Overall Study|Study terminated by Sponsor|68|||
150161976|NCT01414166|541728014|FG001|Overall Study|Study terminated by Sponsor|75|||
150161977|NCT01414166|541728013|FG000|Overall Study|Withdrawal by Subject|3|||
150161978|NCT01414166|541728014|FG001|Overall Study|Withdrawal by Subject|5|||
150161979|NCT03682536|541728015|FG000|Randomization|Withdrawal by Subject|0|||
150161980|NCT03682536|541728016|FG001|Randomization|Withdrawal by Subject|2|||
150161981|NCT03682536|541728015|FG000|Treatment|Other Reasons|8|||
150161982|NCT03682536|541728016|FG001|Treatment|Other Reasons|7|||
150161983|NCT03682536|541728015|FG000|Treatment|Physician Decision|5|||
150161984|NCT03682536|541728016|FG001|Treatment|Physician Decision|5|||
150161985|NCT03682536|541728015|FG000|Treatment|Protocol Violation|1|||
150161986|NCT03682536|541728016|FG001|Treatment|Protocol Violation|0|||
150161987|NCT03682536|541728015|FG000|Treatment|Study Terminated by Sponsor|1|||
150161988|NCT03682536|541728016|FG001|Treatment|Study Terminated by Sponsor|2|||
150161989|NCT03682536|541728015|FG000|Treatment|Lost to Follow-up|0|||
150161990|NCT03682536|541728016|FG001|Treatment|Lost to Follow-up|1|||
150161991|NCT03682536|541728015|FG000|Treatment|Withdrawal by Subject|16|||
150161992|NCT03682536|541728016|FG001|Treatment|Withdrawal by Subject|18|||
150161993|NCT03682536|541728015|FG000|Treatment|Lack of Efficacy|41|||
150161994|NCT03682536|541728016|FG001|Treatment|Lack of Efficacy|68|||
150161995|NCT03682536|541728015|FG000|Treatment|Disease Progression|9|||
150161996|NCT03682536|541728016|FG001|Treatment|Disease Progression|7|||
150161997|NCT03682536|541728015|FG000|Treatment|Adverse Event|9|||
150260788|NCT00196976|542091740|FG013|Primary Study|Protocol Violation|0|||
149925830|NCT03092791|540863274|FG006|Overall Study|Lost to Follow-up|1|||
149925831|NCT03092791|540863275|FG007|Overall Study|Lost to Follow-up|0|||
150161998|NCT03682536|541728016|FG001|Treatment|Adverse Event|5|||
150161999|NCT03682536|541728015|FG000|Treatment|Death|14|||
150162000|NCT03682536|541728016|FG001|Treatment|Death|13|||
150162001|NCT04824131|541728017|FG000|CAB LA Oral Phase|Adverse Event|1|||
150260789|NCT00196976|542091727|FG000|Primary Study|Withdrawal by Subject|1|||
150260790|NCT00196976|542091728|FG001|Primary Study|Withdrawal by Subject|0|||
150162002|NCT04824131|541728017|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
150162003|NCT04824131|541728017|FG000|Step 3|Withdrawal by Subject|2|||
150162004|NCT05489224|541728018|FG000|Treatment Period I|Withdrawal by Subject|6|||
150162005|NCT05489224|541728019|FG001|Treatment Period I|Withdrawal by Subject|5|||
150162006|NCT05489224|541728020|FG002|Treatment Period I|Withdrawal by Subject|0|||
150260791|NCT00196976|542091729|FG002|Primary Study|Withdrawal by Subject|1|||
150260792|NCT00196976|542091730|FG003|Primary Study|Withdrawal by Subject|1|||
149925832|NCT03092791|540863268|FG000|Overall Study|Withdrawal of Consent|0|||
149925833|NCT03092791|540863269|FG001|Overall Study|Withdrawal of Consent|0|||
150162007|NCT05489224|541728018|FG000|Treatment Period I|Adverse Event|3|||
150162008|NCT05489224|541728019|FG001|Treatment Period I|Adverse Event|11|||
150162009|NCT05489224|541728020|FG002|Treatment Period I|Adverse Event|0|||
150162010|NCT05489224|541728018|FG000|Treatment Period I|Lost to Follow-up|0|||
150162011|NCT05489224|541728019|FG001|Treatment Period I|Lost to Follow-up|1|||
150162012|NCT05489224|541728020|FG002|Treatment Period I|Lost to Follow-up|0|||
150162013|NCT05489224|541728018|FG000|Treatment Period I|Physician Decision|0|||
150162014|NCT05489224|541728019|FG001|Treatment Period I|Physician Decision|1|||
150162015|NCT05489224|541728020|FG002|Treatment Period I|Physician Decision|0|||
150162016|NCT05489224|541728018|FG000|Treatment Period II up to Week 32|Ongoing|222|||
150162017|NCT05489224|541728019|FG001|Treatment Period II up to Week 32|Ongoing|107|||
150162018|NCT05489224|541728020|FG002|Treatment Period II up to Week 32|Ongoing|107|||
150162019|NCT05489224|541728018|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
150162020|NCT05489224|541728019|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
150162021|NCT05489224|541728020|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
150162022|NCT05489224|541728018|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
150162023|NCT05489224|541728019|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
150162024|NCT05489224|541728020|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
150162025|NCT03686384|541728022|FG000|Overall Study|Lack of Efficacy|4|||
150162026|NCT03686384|541728023|FG001|Overall Study|Lack of Efficacy|13|||
150162027|NCT03686384|541728022|FG000|Overall Study|Lost to Follow-up|3|||
150162028|NCT03686384|541728023|FG001|Overall Study|Lost to Follow-up|0|||
150162029|NCT03686384|541728022|FG000|Overall Study|Physician Decision|0|||
150162030|NCT03686384|541728023|FG001|Overall Study|Physician Decision|1|||
150162031|NCT03686384|541728022|FG000|Overall Study|Took prohibited medication|0|||
150162032|NCT03686384|541728023|FG001|Overall Study|Took prohibited medication|1|||
150162033|NCT02820051|541728028|FG000|Overall Study|Lost to Follow-up|7|||
150162034|NCT02820051|541728029|FG001|Overall Study|Lost to Follow-up|4|||
150162035|NCT03008122|541728033|FG000|Overall Study|Physician Decision|3|||
150162036|NCT03008122|541728034|FG001|Overall Study|Physician Decision|2|||
150162037|NCT03008122|541728035|FG002|Overall Study|Physician Decision|0|||
150162038|NCT03008122|541728033|FG000|Overall Study|Withdrawal by Subject|1|||
150162039|NCT03008122|541728034|FG001|Overall Study|Withdrawal by Subject|3|||
150162040|NCT03008122|541728035|FG002|Overall Study|Withdrawal by Subject|0|||
150162041|NCT03008122|541728033|FG000|Overall Study|Lost to Follow-up|4|||
150162042|NCT03008122|541728034|FG001|Overall Study|Lost to Follow-up|8|||
150162043|NCT03008122|541728035|FG002|Overall Study|Lost to Follow-up|3|||
150162044|NCT03008122|541728033|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
150162045|NCT03008122|541728034|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
150162046|NCT03008122|541728035|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
150162047|NCT03008122|541728033|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
150162048|NCT03008122|541728034|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
150162049|NCT03008122|541728035|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
150162050|NCT03008122|541728033|FG000|Overall Study|Death|0|||
150162051|NCT03008122|541728034|FG001|Overall Study|Death|0|||
150162052|NCT03008122|541728035|FG002|Overall Study|Death|1|||
150162053|NCT01222247|541728036|FG000|Overall Study|Lost to Follow-up|2|||
150162054|NCT01222247|541728037|FG001|Overall Study|Lost to Follow-up|2|||
150162055|NCT02084082|541728038|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
150162056|NCT02084082|541728039|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
150162057|NCT02084082|541728040|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
150162058|NCT02084082|541728041|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
150162059|NCT02084082|541728038|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
150162060|NCT02084082|541728039|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
150162061|NCT02084082|541728040|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149818929|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818930|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818931|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818932|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818933|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818934|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
149818935|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
149818936|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818937|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818938|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818939|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818940|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818941|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
149818942|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
150162062|NCT02084082|541728041|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
149925834|NCT03092791|540863270|FG002|Overall Study|Withdrawal of Consent|0|||
150260793|NCT00196976|542091731|FG004|Primary Study|Withdrawal by Subject|2|||
150260794|NCT00196976|542091732|FG005|Primary Study|Withdrawal by Subject|1|||
149925835|NCT03092791|540863271|FG003|Overall Study|Withdrawal of Consent|0|||
149925836|NCT03092791|540863272|FG004|Overall Study|Withdrawal of Consent|4|||
149925837|NCT03092791|540863273|FG005|Overall Study|Withdrawal of Consent|12|||
149925838|NCT03092791|540863274|FG006|Overall Study|Withdrawal of Consent|6|||
149925839|NCT03092791|540863275|FG007|Overall Study|Withdrawal of Consent|4|||
149925840|NCT03092791|540863268|FG000|Overall Study|Study Termination|0|||
149925841|NCT03092791|540863269|FG001|Overall Study|Study Termination|0|||
149925842|NCT03092791|540863270|FG002|Overall Study|Study Termination|0|||
149925843|NCT03092791|540863271|FG003|Overall Study|Study Termination|0|||
149925844|NCT03092791|540863272|FG004|Overall Study|Study Termination|55|||
149925845|NCT03092791|540863273|FG005|Overall Study|Study Termination|46|||
150260795|NCT00196976|542091733|FG006|Primary Study|Withdrawal by Subject|0|||
150260796|NCT00196976|542091734|FG007|Primary Study|Withdrawal by Subject|0|||
150260797|NCT00196976|542091735|FG008|Primary Study|Withdrawal by Subject|0|||
150260798|NCT00196976|542091736|FG009|Primary Study|Withdrawal by Subject|1|||
150260799|NCT00196976|542091737|FG010|Primary Study|Withdrawal by Subject|0|||
150260800|NCT00196976|542091738|FG011|Primary Study|Withdrawal by Subject|0|||
150260801|NCT00196976|542091739|FG012|Primary Study|Withdrawal by Subject|0|||
150260802|NCT00196976|542091740|FG013|Primary Study|Withdrawal by Subject|0|||
150260803|NCT00196976|542091727|FG000|Primary Study|Lost to Follow-up|0|||
150260804|NCT00196976|542091728|FG001|Primary Study|Lost to Follow-up|0|||
150260805|NCT00196976|542091729|FG002|Primary Study|Lost to Follow-up|0|||
150260806|NCT00196976|542091730|FG003|Primary Study|Lost to Follow-up|0|||
150260807|NCT00196976|542091731|FG004|Primary Study|Lost to Follow-up|1|||
150260808|NCT00196976|542091732|FG005|Primary Study|Lost to Follow-up|1|||
150260809|NCT00196976|542091733|FG006|Primary Study|Lost to Follow-up|0|||
150260810|NCT00196976|542091734|FG007|Primary Study|Lost to Follow-up|2|||
150260811|NCT00196976|542091735|FG008|Primary Study|Lost to Follow-up|0|||
150260812|NCT00196976|542091736|FG009|Primary Study|Lost to Follow-up|0|||
150260813|NCT00196976|542091737|FG010|Primary Study|Lost to Follow-up|0|||
150260814|NCT00196976|542091738|FG011|Primary Study|Lost to Follow-up|0|||
150260815|NCT00196976|542091739|FG012|Primary Study|Lost to Follow-up|0|||
150260816|NCT00196976|542091740|FG013|Primary Study|Lost to Follow-up|0|||
150260817|NCT00196976|542091727|FG000|Primary Study|Other|0|||
150260818|NCT00196976|542091728|FG001|Primary Study|Other|0|||
150260819|NCT00196976|542091729|FG002|Primary Study|Other|2|||
150260820|NCT00196976|542091730|FG003|Primary Study|Other|0|||
150260821|NCT00196976|542091731|FG004|Primary Study|Other|0|||
150260822|NCT00196976|542091732|FG005|Primary Study|Other|0|||
150260823|NCT00196976|542091733|FG006|Primary Study|Other|0|||
150260824|NCT00196976|542091734|FG007|Primary Study|Other|0|||
150260825|NCT00196976|542091735|FG008|Primary Study|Other|0|||
150260826|NCT00196976|542091736|FG009|Primary Study|Other|0|||
150260827|NCT00196976|542091737|FG010|Primary Study|Other|0|||
150260828|NCT00196976|542091738|FG011|Primary Study|Other|0|||
150260829|NCT00196976|542091739|FG012|Primary Study|Other|0|||
150260830|NCT00196976|542091740|FG013|Primary Study|Other|0|||
150260831|NCT00196976|542091727|FG000|Booster Study|Withdrawal by Subject|0|||
150260832|NCT00196976|542091728|FG001|Booster Study|Withdrawal by Subject|0|||
150260833|NCT00196976|542091729|FG002|Booster Study|Withdrawal by Subject|0|||
150260834|NCT00196976|542091730|FG003|Booster Study|Withdrawal by Subject|0|||
150260835|NCT00196976|542091731|FG004|Booster Study|Withdrawal by Subject|0|||
150260836|NCT00196976|542091732|FG005|Booster Study|Withdrawal by Subject|0|||
150260837|NCT00196976|542091733|FG006|Booster Study|Withdrawal by Subject|0|||
150260838|NCT00196976|542091734|FG007|Booster Study|Withdrawal by Subject|0|||
150260839|NCT00196976|542091735|FG008|Booster Study|Withdrawal by Subject|0|||
150260840|NCT00196976|542091736|FG009|Booster Study|Withdrawal by Subject|0|||
150260841|NCT00196976|542091737|FG010|Booster Study|Withdrawal by Subject|1|||
150260842|NCT00196976|542091738|FG011|Booster Study|Withdrawal by Subject|0|||
150260843|NCT00196976|542091739|FG012|Booster Study|Withdrawal by Subject|0|||
149925846|NCT03092791|540863274|FG006|Overall Study|Study Termination|53|||
150260844|NCT00196976|542091740|FG013|Booster Study|Withdrawal by Subject|0|||
150260845|NCT00196976|542091727|FG000|Booster Study|Lost to Follow-up|0|||
150260846|NCT00196976|542091728|FG001|Booster Study|Lost to Follow-up|0|||
150260847|NCT00196976|542091729|FG002|Booster Study|Lost to Follow-up|0|||
150260848|NCT00196976|542091730|FG003|Booster Study|Lost to Follow-up|0|||
150260849|NCT00196976|542091731|FG004|Booster Study|Lost to Follow-up|0|||
150260850|NCT00196976|542091732|FG005|Booster Study|Lost to Follow-up|0|||
150260851|NCT00196976|542091733|FG006|Booster Study|Lost to Follow-up|0|||
150260852|NCT00196976|542091734|FG007|Booster Study|Lost to Follow-up|0|||
150260853|NCT00196976|542091735|FG008|Booster Study|Lost to Follow-up|0|||
150260854|NCT00196976|542091736|FG009|Booster Study|Lost to Follow-up|0|||
149925847|NCT03092791|540863275|FG007|Overall Study|Study Termination|55|||
149925848|NCT03092791|540863268|FG000|Overall Study|Death|0|||
149925849|NCT03092791|540863269|FG001|Overall Study|Death|0|||
150260855|NCT00196976|542091737|FG010|Booster Study|Lost to Follow-up|1|||
150260856|NCT00196976|542091738|FG011|Booster Study|Lost to Follow-up|2|||
150260857|NCT00196976|542091739|FG012|Booster Study|Lost to Follow-up|0|||
149925850|NCT03092791|540863270|FG002|Overall Study|Death|0|||
149925851|NCT03092791|540863271|FG003|Overall Study|Death|0|||
149925852|NCT03092791|540863272|FG004|Overall Study|Death|0|||
149925853|NCT03092791|540863273|FG005|Overall Study|Death|1|||
149925854|NCT03092791|540863274|FG006|Overall Study|Death|0|||
149925855|NCT03092791|540863275|FG007|Overall Study|Death|1|||
149925856|NCT03092791|540863268|FG000|Overall Study|Reason Not Specified|0|||
149925857|NCT03092791|540863269|FG001|Overall Study|Reason Not Specified|0|||
149925858|NCT03092791|540863270|FG002|Overall Study|Reason Not Specified|0|||
150162063|NCT00832780|541728042|FG000|Overall Study|Death|16|||
150162064|NCT00832780|541728042|FG000|Overall Study|Lost to Follow-up|4|||
150162065|NCT00832780|541728042|FG000|Overall Study|no reason given|2|||
150162066|NCT00832780|541728042|FG000|Overall Study|other complicating condition|2|||
150162067|NCT00832780|541728042|FG000|Overall Study|Physician Decision|1|||
150162068|NCT03289455|541728049|FG000|Overall Study|Death|1|||
150162069|NCT03289455|541728050|FG001|Overall Study|Death|0|||
150162070|NCT03289455|541728051|FG002|Overall Study|Death|0|||
150162071|NCT03289455|541728049|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
150162072|NCT03289455|541728050|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
150162073|NCT03289455|541728051|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
150162074|NCT03289455|541728049|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
150162075|NCT03289455|541728050|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
150162076|NCT03289455|541728051|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
150162077|NCT03289455|541728049|FG000|Overall Study|Progressive disease|3|||
150162078|NCT03289455|541728050|FG001|Overall Study|Progressive disease|4|||
150162079|NCT03289455|541728051|FG002|Overall Study|Progressive disease|5|||
150162080|NCT00333788|541728052|FG000|Overall Study|Adverse Event|44|||
150162081|NCT00333788|541728052|FG000|Overall Study|Lack of Efficacy|80|||
150162082|NCT00333788|541728052|FG000|Overall Study|Lost to Follow-up|2|||
150162083|NCT00333788|541728052|FG000|Overall Study|Withdrawal by Subject|24|||
150162084|NCT00333788|541728052|FG000|Overall Study|Other: Non-compliance|2|||
150162085|NCT00333788|541728052|FG000|Overall Study|Other: Moved|2|||
150162086|NCT00333788|541728052|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
150162087|NCT00333788|541728052|FG000|Overall Study|Other: Investigator decision|1|||
150162088|NCT00333788|541728052|FG000|Overall Study|Other: Quality of life concern|1|||
150162089|NCT00333788|541728052|FG000|Overall Study|Other: Sponsor decision|1|||
150162090|NCT00333788|541728052|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
150162091|NCT00333788|541728052|FG000|Overall Study|Other: Medical monitor decision|1|||
150162092|NCT00333788|541728052|FG000|Overall Study|Other: Physician decision|1|||
150162093|NCT00333788|541728052|FG000|Overall Study|Other: Signed consent for another study|1|||
150162094|NCT02322775|541728058|FG000|Overall Study|Adverse Event|1|||
150162095|NCT02322775|541728059|FG001|Overall Study|Adverse Event|0|||
150162096|NCT02322775|541728058|FG000|Overall Study|Lost to Follow-up|0|||
150162097|NCT02322775|541728059|FG001|Overall Study|Lost to Follow-up|1|||
150162098|NCT02322775|541728058|FG000|Overall Study|Protocol Violation|1|||
150162099|NCT02322775|541728059|FG001|Overall Study|Protocol Violation|0|||
150162100|NCT02322775|541728058|FG000|Overall Study|Withdrawal by Subject|3|||
150162101|NCT02322775|541728059|FG001|Overall Study|Withdrawal by Subject|4|||
150162102|NCT02322775|541728058|FG000|Overall Study|Not willing to perform all FU visits|0|||
150162103|NCT02322775|541728059|FG001|Overall Study|Not willing to perform all FU visits|1|||
150162104|NCT02956967|541728060|FG000|Overall Study|Adverse Event|3|||
150162105|NCT02956967|541728060|FG000|Overall Study|Reason non-related to neutropenia|10|||
150162106|NCT02956967|541728060|FG000|Overall Study|Lost to Follow-up|5|||
150162107|NCT02956967|541728060|FG000|Overall Study|Missing|1|||
150162108|NCT02956967|541728060|FG000|Overall Study|Termination of Nivestim administration|29|||
150162109|NCT00764868|541728065|FG000|Overall Study|Adverse Event|18|||
150162110|NCT00764868|541728065|FG000|Overall Study|Withdrawal by Subject|31|||
150162111|NCT00764868|541728065|FG000|Overall Study|Non-compliance|16|||
150162112|NCT00764868|541728065|FG000|Overall Study|Lost to Follow-up|25|||
150162113|NCT00764868|541728065|FG000|Overall Study|Lack of Efficacy|5|||
150162114|NCT00764868|541728065|FG000|Overall Study|Subject moved|7|||
150162115|NCT00764868|541728065|FG000|Overall Study|Pregnancy|3|||
150162116|NCT00764868|541728065|FG000|Overall Study|Prohibited medication|1|||
150162117|NCT00764868|541728065|FG000|Overall Study|Out of town|1|||
150162118|NCT00764868|541728065|FG000|Overall Study|Misuse and compliance of study drug|1|||
150162119|NCT00764868|541728065|FG000|Overall Study|Subject sent to boarding school|1|||
150162120|NCT00764868|541728065|FG000|Overall Study|Met an exclusion criteria|1|||
150162121|NCT00764868|541728065|FG000|Overall Study|Positive drug screen|2|||
150162122|NCT00764868|541728065|FG000|Overall Study|Sponsor requested withdrawal|1|||
150162123|NCT00783692|541728072|FG000|Induction Phase|Adverse Event|7|||
150162124|NCT00783692|541728073|FG001|Induction Phase|Adverse Event|9|||
150260858|NCT00196976|542091740|FG013|Booster Study|Lost to Follow-up|0|||
149925859|NCT03092791|540863271|FG003|Overall Study|Reason Not Specified|0|||
150162125|NCT00783692|541728074|FG002|Induction Phase|Adverse Event|24|||
150162126|NCT00783692|541728075|FG003|Induction Phase|Adverse Event|0|||
150162127|NCT00783692|541728076|FG004|Induction Phase|Adverse Event|0|||
150260859|NCT01535560|542091741|FG000|Overall Study|Adverse Event|12|||
150260860|NCT01535560|542091742|FG001|Overall Study|Adverse Event|7|||
150260861|NCT01535560|542091741|FG000|Overall Study|Lost to Follow-up|1|||
150260862|NCT01535560|542091742|FG001|Overall Study|Lost to Follow-up|3|||
150260863|NCT01535560|542091741|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
150260864|NCT01535560|542091742|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
150260865|NCT01535560|542091741|FG000|Overall Study|Treatment Failure|21|||
150260866|NCT01535560|542091742|FG001|Overall Study|Treatment Failure|83|||
150260867|NCT01535560|542091741|FG000|Overall Study|Other|0|||
150260868|NCT01535560|542091742|FG001|Overall Study|Other|1|||
150260869|NCT01535560|542091741|FG000|Overall Study|Randomized in Error|0|||
150260870|NCT01535560|542091742|FG001|Overall Study|Randomized in Error|1|||
150260871|NCT02842827|542091745|FG000|Overall Study|Adverse Event|0|||
150260872|NCT02842827|542091746|FG001|Overall Study|Adverse Event|1|||
150260873|NCT02842827|542091747|FG002|Overall Study|Adverse Event|0|||
150260874|NCT02842827|542091748|FG003|Overall Study|Adverse Event|1|||
150260875|NCT02842827|542091749|FG004|Overall Study|Adverse Event|0|||
150260876|NCT02842827|542091750|FG005|Overall Study|Adverse Event|1|||
150260877|NCT02842827|542091751|FG006|Overall Study|Adverse Event|0|||
150260878|NCT02842827|542091752|FG007|Overall Study|Adverse Event|0|||
150260879|NCT02842827|542091745|FG000|Overall Study|Death|1|||
150260880|NCT02842827|542091746|FG001|Overall Study|Death|0|||
150260881|NCT02842827|542091747|FG002|Overall Study|Death|2|||
150260882|NCT02842827|542091748|FG003|Overall Study|Death|3|||
150260883|NCT02842827|542091749|FG004|Overall Study|Death|2|||
150260884|NCT02842827|542091750|FG005|Overall Study|Death|1|||
150260885|NCT02842827|542091751|FG006|Overall Study|Death|0|||
150260886|NCT02842827|542091752|FG007|Overall Study|Death|4|||
150260887|NCT02842827|542091745|FG000|Overall Study|Physician Decision|1|||
150260888|NCT02842827|542091746|FG001|Overall Study|Physician Decision|3|||
150260889|NCT02842827|542091747|FG002|Overall Study|Physician Decision|0|||
150260890|NCT02842827|542091748|FG003|Overall Study|Physician Decision|0|||
150260891|NCT02842827|542091749|FG004|Overall Study|Physician Decision|1|||
150260892|NCT02842827|542091750|FG005|Overall Study|Physician Decision|4|||
150260893|NCT02842827|542091751|FG006|Overall Study|Physician Decision|2|||
150260894|NCT02842827|542091752|FG007|Overall Study|Physician Decision|1|||
150260895|NCT02842827|542091745|FG000|Overall Study|Protocol Defined Disease Progression|0|||
150260896|NCT02842827|542091746|FG001|Overall Study|Protocol Defined Disease Progression|0|||
150260897|NCT02842827|542091747|FG002|Overall Study|Protocol Defined Disease Progression|0|||
150260898|NCT02842827|542091748|FG003|Overall Study|Protocol Defined Disease Progression|0|||
150260899|NCT02842827|542091749|FG004|Overall Study|Protocol Defined Disease Progression|0|||
150260900|NCT02842827|542091750|FG005|Overall Study|Protocol Defined Disease Progression|1|||
150260901|NCT02842827|542091751|FG006|Overall Study|Protocol Defined Disease Progression|0|||
150260902|NCT02842827|542091752|FG007|Overall Study|Protocol Defined Disease Progression|0|||
150260903|NCT02842827|542091745|FG000|Overall Study|Participant Withdrawal of Consent|1|||
150260904|NCT02842827|542091746|FG001|Overall Study|Participant Withdrawal of Consent|2|||
150260905|NCT02842827|542091747|FG002|Overall Study|Participant Withdrawal of Consent|2|||
150260906|NCT02842827|542091748|FG003|Overall Study|Participant Withdrawal of Consent|2|||
150260907|NCT02842827|542091749|FG004|Overall Study|Participant Withdrawal of Consent|2|||
150260908|NCT02842827|542091750|FG005|Overall Study|Participant Withdrawal of Consent|1|||
150260909|NCT02842827|542091751|FG006|Overall Study|Participant Withdrawal of Consent|2|||
150260910|NCT02842827|542091752|FG007|Overall Study|Participant Withdrawal of Consent|1|||
150260911|NCT01815138|542091753|FG000|Overall Study|Withdrawal by Subject|0|||
150260912|NCT01815138|542091754|FG001|Overall Study|Withdrawal by Subject|1|||
150260913|NCT01815138|542091753|FG000|Overall Study|Physician Decision|8|||
150260914|NCT01815138|542091754|FG001|Overall Study|Physician Decision|5|||
150260915|NCT00825825|542091755|FG000|First Medication Period (14 Days)|Adverse Event|1|||
150260916|NCT00825825|542091756|FG001|First Medication Period (14 Days)|Adverse Event|0|||
150260917|NCT00825825|542091757|FG002|First Medication Period (14 Days)|Adverse Event|0|||
150260918|NCT00825825|542091758|FG003|First Medication Period (14 Days)|Adverse Event|0|||
150260919|NCT00825825|542091759|FG004|First Medication Period (14 Days)|Adverse Event|0|||
150260920|NCT00825825|542091760|FG005|First Medication Period (14 Days)|Adverse Event|1|||
150260921|NCT00825825|542091755|FG000|First Medication Period (14 Days)|Physician Decision|2|||
150260922|NCT00825825|542091756|FG001|First Medication Period (14 Days)|Physician Decision|0|||
150260923|NCT00825825|542091757|FG002|First Medication Period (14 Days)|Physician Decision|1|||
150260924|NCT00825825|542091758|FG003|First Medication Period (14 Days)|Physician Decision|0|||
149818943|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818944|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818945|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818946|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818947|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818948|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149818949|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
149818950|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
150260925|NCT00825825|542091759|FG004|First Medication Period (14 Days)|Physician Decision|0|||
150260926|NCT00825825|542091760|FG005|First Medication Period (14 Days)|Physician Decision|1|||
150260927|NCT00825825|542091755|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
150260928|NCT00825825|542091756|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
150260929|NCT00825825|542091757|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
150260930|NCT00825825|542091758|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
150260931|NCT00825825|542091759|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
150260932|NCT00825825|542091760|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
150260933|NCT00825825|542091755|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
150260934|NCT00825825|542091756|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
150260935|NCT00825825|542091757|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
150260936|NCT00825825|542091758|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
150260937|NCT00825825|542091759|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
150260938|NCT00825825|542091760|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
150260939|NCT00825825|542091755|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
150260940|NCT00825825|542091756|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
150260941|NCT00825825|542091757|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
150260942|NCT00825825|542091758|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
150260943|NCT00825825|542091759|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
150260944|NCT00825825|542091760|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
150260945|NCT00825825|542091755|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
150260946|NCT00825825|542091756|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
150260947|NCT00825825|542091757|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
150260948|NCT00825825|542091758|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
150260949|NCT00825825|542091759|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
150260950|NCT00825825|542091760|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
150260951|NCT00825825|542091755|FG000|Third Medication Period (14 Days)|poor data quality|0|||
150260952|NCT00825825|542091756|FG001|Third Medication Period (14 Days)|poor data quality|1|||
150260953|NCT00825825|542091757|FG002|Third Medication Period (14 Days)|poor data quality|0|||
150260954|NCT00825825|542091758|FG003|Third Medication Period (14 Days)|poor data quality|0|||
150260955|NCT00825825|542091759|FG004|Third Medication Period (14 Days)|poor data quality|0|||
150260956|NCT00825825|542091760|FG005|Third Medication Period (14 Days)|poor data quality|0|||
150260957|NCT00609765|542091763|FG000|Overall Study|Study ended prior to 12 months|1|||
150260958|NCT02649946|542091769|FG000|Overall Study|Withdrawal by Subject|1|||
150260959|NCT02649946|542091770|FG001|Overall Study|Withdrawal by Subject|1|||
150260960|NCT02649946|542091769|FG000|Overall Study|Death|7|||
150260961|NCT02649946|542091770|FG001|Overall Study|Death|9|||
149818951|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
149818952|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
149818953|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
149818954|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
149818955|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
149818956|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
149818957|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818958|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818959|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818960|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818961|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818962|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
149818963|NCT00606684|540467150|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
149818964|NCT00606684|540467151|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818965|NCT00606684|540467152|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818966|NCT00606684|540467153|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818967|NCT00606684|540467154|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818968|NCT00606684|540467155|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818969|NCT00606684|540467156|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
149818970|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149818971|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Adverse Event|3|||
149818972|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Adverse Event|2|||
149818973|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Adverse Event|4|||
149818974|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Adverse Event|2|||
149818975|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Adverse Event|0|||
149818976|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Adverse Event|1|||
149818977|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
149818978|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
149818979|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
149818980|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
150162128|NCT00783692|541728077|FG005|Induction Phase|Adverse Event|0|||
150162129|NCT00783692|541728078|FG006|Induction Phase|Adverse Event|0|||
150162130|NCT00783692|541728072|FG000|Induction Phase|Protocol Violation|0|||
150162131|NCT00783692|541728073|FG001|Induction Phase|Protocol Violation|0|||
150162132|NCT00783692|541728074|FG002|Induction Phase|Protocol Violation|1|||
150162133|NCT00783692|541728075|FG003|Induction Phase|Protocol Violation|0|||
150162134|NCT00783692|541728076|FG004|Induction Phase|Protocol Violation|0|||
150162135|NCT00783692|541728077|FG005|Induction Phase|Protocol Violation|0|||
150162136|NCT00783692|541728078|FG006|Induction Phase|Protocol Violation|0|||
149818981|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
149818982|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
149818983|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
149818984|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
149818985|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
149818986|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
149818987|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
149818988|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
149818989|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
149818990|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
149818991|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
149818992|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
149818993|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
149818994|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
149818995|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
149818996|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
149818997|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
149818998|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Physician Decision|0|||
149818999|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Physician Decision|5|||
149819000|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Physician Decision|1|||
149819001|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Physician Decision|0|||
149819002|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Physician Decision|3|||
149819003|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Physician Decision|1|||
149819004|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Physician Decision|2|||
149819005|NCT00606684|540467150|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149819006|NCT00606684|540467151|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149819007|NCT00606684|540467152|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149819008|NCT00606684|540467153|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149819009|NCT00606684|540467154|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149819010|NCT00606684|540467155|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149819011|NCT00606684|540467156|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149819012|NCT00472446|540467157|FG000|Overall Study|Protocol Violation|0|||
149819013|NCT00472446|540467158|FG001|Overall Study|Protocol Violation|0|||
149819014|NCT00472446|540467159|FG002|Overall Study|Protocol Violation|0|||
149819015|NCT00472446|540467160|FG003|Overall Study|Protocol Violation|1|||
149819016|NCT00472446|540467157|FG000|Overall Study|Reintervention|0|||
149819017|NCT00472446|540467158|FG001|Overall Study|Reintervention|0|||
149819018|NCT00472446|540467159|FG002|Overall Study|Reintervention|1|||
149819019|NCT00472446|540467160|FG003|Overall Study|Reintervention|1|||
149819020|NCT00472446|540467157|FG000|Overall Study|Questionnaires not returned|5|||
149819021|NCT00472446|540467158|FG001|Overall Study|Questionnaires not returned|6|||
149819022|NCT00472446|540467159|FG002|Overall Study|Questionnaires not returned|6|||
149819023|NCT00472446|540467160|FG003|Overall Study|Questionnaires not returned|4|||
149819024|NCT00772577|540467163|FG000|Overall Study|Adverse Event|6|||
149819025|NCT00772577|540467164|FG001|Overall Study|Adverse Event|3|||
149819026|NCT00772577|540467163|FG000|Overall Study|Abnormal laboratory values|0|||
149819027|NCT00772577|540467164|FG001|Overall Study|Abnormal laboratory values|1|||
149819028|NCT00772577|540467163|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149819029|NCT00772577|540467164|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
149819030|NCT00772577|540467163|FG000|Overall Study|Patient withdrew consent|8|||
149819031|NCT00772577|540467164|FG001|Overall Study|Patient withdrew consent|5|||
149819032|NCT00772577|540467163|FG000|Overall Study|Lost to Follow-up|4|||
149819033|NCT00772577|540467164|FG001|Overall Study|Lost to Follow-up|3|||
149819034|NCT00772577|540467163|FG000|Overall Study|Administrative problems|2|||
149819035|NCT00772577|540467164|FG001|Overall Study|Administrative problems|1|||
149819036|NCT00772577|540467163|FG000|Overall Study|Protocol Deviation|3|||
149819037|NCT00772577|540467164|FG001|Overall Study|Protocol Deviation|2|||
149819038|NCT03211156|540467165|FG000|Overall Study|Withdrawal by Subject|0|||
149819039|NCT03211156|540467166|FG001|Overall Study|Withdrawal by Subject|2|||
149819040|NCT03211156|540467165|FG000|Overall Study|Lost to Follow-up|1|||
150162137|NCT00783692|541728072|FG000|Induction Phase|Lack of Efficacy|1|||
150162138|NCT00783692|541728073|FG001|Induction Phase|Lack of Efficacy|3|||
150162139|NCT00783692|541728074|FG002|Induction Phase|Lack of Efficacy|28|||
150260962|NCT02649946|542091769|FG000|Overall Study|Physician Decision|1|||
150260963|NCT02649946|542091770|FG001|Overall Study|Physician Decision|0|||
150260964|NCT02649946|542091769|FG000|Overall Study|Lost to Follow-up|2|||
150260965|NCT02649946|542091770|FG001|Overall Study|Lost to Follow-up|1|||
150260966|NCT02649946|542091769|FG000|Overall Study|Erroneously enrolled|1|||
150260967|NCT02649946|542091770|FG001|Overall Study|Erroneously enrolled|0|||
150260968|NCT02649946|542091769|FG000|Overall Study|Missed 6-month follow-up visit|0|||
150260969|NCT02649946|542091770|FG001|Overall Study|Missed 6-month follow-up visit|4|||
150260970|NCT01047293|542091774|FG000|Overall Study|DLT criteria not fulfilled|1|||
150260971|NCT01047293|542091775|FG001|Overall Study|DLT criteria not fulfilled|1|||
150260972|NCT01047293|542091776|FG002|Overall Study|DLT criteria not fulfilled|0|||
150260973|NCT01047293|542091777|FG003|Overall Study|DLT criteria not fulfilled|0|||
150260974|NCT02054520|542091778|FG000|Overall Study|Adverse Event|1|||
150260975|NCT02054520|542091779|FG001|Overall Study|Adverse Event|4|||
150260976|NCT02054520|542091780|FG002|Overall Study|Adverse Event|2|||
150260977|NCT02054520|542091781|FG003|Overall Study|Adverse Event|1|||
150260978|NCT02054520|542091782|FG004|Overall Study|Adverse Event|1|||
150260979|NCT02054520|542091783|FG005|Overall Study|Adverse Event|0|||
150260980|NCT02054520|542091778|FG000|Overall Study|Lack of Efficacy|7|||
150260981|NCT02054520|542091779|FG001|Overall Study|Lack of Efficacy|0|||
150260982|NCT02054520|542091780|FG002|Overall Study|Lack of Efficacy|2|||
150260983|NCT02054520|542091781|FG003|Overall Study|Lack of Efficacy|1|||
150260984|NCT02054520|542091782|FG004|Overall Study|Lack of Efficacy|3|||
150260985|NCT02054520|542091783|FG005|Overall Study|Lack of Efficacy|2|||
150260986|NCT02054520|542091778|FG000|Overall Study|Withdrawal by Subject|1|||
150260987|NCT02054520|542091779|FG001|Overall Study|Withdrawal by Subject|0|||
150260988|NCT02054520|542091780|FG002|Overall Study|Withdrawal by Subject|0|||
150260989|NCT02054520|542091781|FG003|Overall Study|Withdrawal by Subject|2|||
150260990|NCT02054520|542091782|FG004|Overall Study|Withdrawal by Subject|1|||
150260991|NCT02054520|542091783|FG005|Overall Study|Withdrawal by Subject|0|||
150260992|NCT02054520|542091778|FG000|Overall Study|Physician Decision|0|||
150260993|NCT02054520|542091779|FG001|Overall Study|Physician Decision|1|||
150260994|NCT02054520|542091780|FG002|Overall Study|Physician Decision|0|||
150260995|NCT02054520|542091781|FG003|Overall Study|Physician Decision|1|||
150260996|NCT02054520|542091782|FG004|Overall Study|Physician Decision|0|||
150260997|NCT02054520|542091783|FG005|Overall Study|Physician Decision|1|||
149819041|NCT03211156|540467166|FG001|Overall Study|Lost to Follow-up|1|||
149819042|NCT03211156|540467165|FG000|Overall Study|Adverse Event|1|||
149819043|NCT03211156|540467166|FG001|Overall Study|Adverse Event|0|||
149819044|NCT00553540|540467173|FG000|Overall Study|discharged after first visit|2|||
149819045|NCT00553540|540467174|FG001|Overall Study|discharged after first visit|5|||
149819046|NCT03565211|540467175|FG000|Overall Study|Withdrawal by Subject|2|||
149819047|NCT03565211|540467175|FG000|Overall Study|Lost to Follow-up|1|||
149819048|NCT03565211|540467175|FG000|Overall Study|Adverse Event|44|||
149819049|NCT03565211|540467175|FG000|Overall Study|Personal issues|1|||
149819050|NCT00323609|540467176|FG000|Overall Study|Death|16|||
149819051|NCT00323609|540467177|FG001|Overall Study|Death|21|||
149819052|NCT00323609|540467178|FG002|Overall Study|Death|0|||
149819053|NCT00323609|540467179|FG003|Overall Study|Death|0|||
149819054|NCT00323609|540467176|FG000|Overall Study|Lost to Follow-up|9|||
149819055|NCT00323609|540467177|FG001|Overall Study|Lost to Follow-up|10|||
149819056|NCT00323609|540467178|FG002|Overall Study|Lost to Follow-up|0|||
149819057|NCT00323609|540467179|FG003|Overall Study|Lost to Follow-up|0|||
149819058|NCT00323609|540467176|FG000|Overall Study|Physician Decision|2|||
149819059|NCT00323609|540467177|FG001|Overall Study|Physician Decision|0|||
149819060|NCT00323609|540467178|FG002|Overall Study|Physician Decision|0|||
149819061|NCT00323609|540467179|FG003|Overall Study|Physician Decision|1|||
149819062|NCT00323609|540467176|FG000|Overall Study|Withdrawal by Subject|11|||
149819063|NCT00323609|540467177|FG001|Overall Study|Withdrawal by Subject|23|||
149819064|NCT00323609|540467178|FG002|Overall Study|Withdrawal by Subject|4|||
149819065|NCT00323609|540467179|FG003|Overall Study|Withdrawal by Subject|4|||
149819066|NCT00323609|540467176|FG000|Overall Study|Other non-VCF-related medical condition|3|||
149819067|NCT00323609|540467177|FG001|Overall Study|Other non-VCF-related medical condition|2|||
149925860|NCT03092791|540863272|FG004|Overall Study|Reason Not Specified|1|||
149925861|NCT03092791|540863273|FG005|Overall Study|Reason Not Specified|1|||
150260998|NCT02054520|542091778|FG000|Overall Study|Study terminated by Sponsor|0|||
150260999|NCT02054520|542091779|FG001|Overall Study|Study terminated by Sponsor|0|||
149819068|NCT00323609|540467178|FG002|Overall Study|Other non-VCF-related medical condition|0|||
149819069|NCT00323609|540467179|FG003|Overall Study|Other non-VCF-related medical condition|0|||
149925862|NCT03092791|540863274|FG006|Overall Study|Reason Not Specified|0|||
150261000|NCT02054520|542091780|FG002|Overall Study|Study terminated by Sponsor|2|||
150261001|NCT02054520|542091781|FG003|Overall Study|Study terminated by Sponsor|1|||
150261002|NCT02054520|542091782|FG004|Overall Study|Study terminated by Sponsor|0|||
150261003|NCT02054520|542091783|FG005|Overall Study|Study terminated by Sponsor|0|||
150261004|NCT01272804|542091784|FG000|Overall Study|Adverse Event|1|||
149925863|NCT03092791|540863275|FG007|Overall Study|Reason Not Specified|0|||
150162140|NCT00783692|541728075|FG003|Induction Phase|Lack of Efficacy|0|||
150162141|NCT00783692|541728076|FG004|Induction Phase|Lack of Efficacy|0|||
150162142|NCT00783692|541728077|FG005|Induction Phase|Lack of Efficacy|0|||
150162143|NCT00783692|541728078|FG006|Induction Phase|Lack of Efficacy|0|||
150162144|NCT00783692|541728072|FG000|Induction Phase|Withdrawal by Subject|3|||
150162145|NCT00783692|541728073|FG001|Induction Phase|Withdrawal by Subject|9|||
150162146|NCT00783692|541728074|FG002|Induction Phase|Withdrawal by Subject|16|||
150162147|NCT00783692|541728075|FG003|Induction Phase|Withdrawal by Subject|0|||
150162148|NCT00783692|541728076|FG004|Induction Phase|Withdrawal by Subject|0|||
150162149|NCT00783692|541728077|FG005|Induction Phase|Withdrawal by Subject|0|||
150162150|NCT00783692|541728078|FG006|Induction Phase|Withdrawal by Subject|0|||
150162151|NCT00783692|541728072|FG000|Induction Phase|Lost to Follow-up|0|||
150162152|NCT00783692|541728073|FG001|Induction Phase|Lost to Follow-up|0|||
150162153|NCT00783692|541728074|FG002|Induction Phase|Lost to Follow-up|3|||
150162154|NCT00783692|541728075|FG003|Induction Phase|Lost to Follow-up|0|||
150162155|NCT00783692|541728076|FG004|Induction Phase|Lost to Follow-up|0|||
150162156|NCT00783692|541728077|FG005|Induction Phase|Lost to Follow-up|0|||
150162157|NCT00783692|541728078|FG006|Induction Phase|Lost to Follow-up|0|||
150162158|NCT00783692|541728072|FG000|Induction Phase|Other|0|||
150162159|NCT00783692|541728073|FG001|Induction Phase|Other|0|||
150162160|NCT00783692|541728074|FG002|Induction Phase|Other|2|||
150162161|NCT00783692|541728075|FG003|Induction Phase|Other|0|||
150162162|NCT00783692|541728076|FG004|Induction Phase|Other|0|||
150162163|NCT00783692|541728077|FG005|Induction Phase|Other|0|||
150162164|NCT00783692|541728078|FG006|Induction Phase|Other|0|||
150162165|NCT00783692|541728072|FG000|Maintenance Phase|Adverse Event|7|||
150162166|NCT00783692|541728073|FG001|Maintenance Phase|Adverse Event|0|||
150162167|NCT00783692|541728074|FG002|Maintenance Phase|Adverse Event|0|||
150162168|NCT00783692|541728075|FG003|Maintenance Phase|Adverse Event|15|||
150162169|NCT00783692|541728076|FG004|Maintenance Phase|Adverse Event|12|||
150162170|NCT00783692|541728077|FG005|Maintenance Phase|Adverse Event|9|||
150162171|NCT00783692|541728078|FG006|Maintenance Phase|Adverse Event|38|||
150162172|NCT00783692|541728072|FG000|Maintenance Phase|Protocol Violation|0|||
150162173|NCT00783692|541728073|FG001|Maintenance Phase|Protocol Violation|0|||
150162174|NCT00783692|541728074|FG002|Maintenance Phase|Protocol Violation|0|||
150162175|NCT00783692|541728075|FG003|Maintenance Phase|Protocol Violation|1|||
150162176|NCT00783692|541728076|FG004|Maintenance Phase|Protocol Violation|2|||
150162177|NCT00783692|541728077|FG005|Maintenance Phase|Protocol Violation|3|||
150162178|NCT00783692|541728078|FG006|Maintenance Phase|Protocol Violation|4|||
150162179|NCT00783692|541728072|FG000|Maintenance Phase|Lack of Efficacy|79|||
150162180|NCT00783692|541728073|FG001|Maintenance Phase|Lack of Efficacy|0|||
150162181|NCT00783692|541728074|FG002|Maintenance Phase|Lack of Efficacy|0|||
150162182|NCT00783692|541728075|FG003|Maintenance Phase|Lack of Efficacy|64|||
150162183|NCT00783692|541728076|FG004|Maintenance Phase|Lack of Efficacy|58|||
150162184|NCT00783692|541728077|FG005|Maintenance Phase|Lack of Efficacy|48|||
150162185|NCT00783692|541728078|FG006|Maintenance Phase|Lack of Efficacy|177|||
150162186|NCT00783692|541728072|FG000|Maintenance Phase|Withdrawal by Subject|7|||
150162187|NCT00783692|541728073|FG001|Maintenance Phase|Withdrawal by Subject|0|||
150162188|NCT00783692|541728074|FG002|Maintenance Phase|Withdrawal by Subject|0|||
150162189|NCT00783692|541728075|FG003|Maintenance Phase|Withdrawal by Subject|7|||
150162190|NCT00783692|541728076|FG004|Maintenance Phase|Withdrawal by Subject|6|||
150162191|NCT00783692|541728077|FG005|Maintenance Phase|Withdrawal by Subject|9|||
150162192|NCT00783692|541728078|FG006|Maintenance Phase|Withdrawal by Subject|24|||
150162193|NCT00783692|541728072|FG000|Maintenance Phase|Lost to Follow-up|2|||
150162194|NCT00783692|541728073|FG001|Maintenance Phase|Lost to Follow-up|0|||
150162195|NCT00783692|541728074|FG002|Maintenance Phase|Lost to Follow-up|0|||
150162196|NCT00783692|541728075|FG003|Maintenance Phase|Lost to Follow-up|1|||
150162197|NCT00783692|541728076|FG004|Maintenance Phase|Lost to Follow-up|3|||
150162198|NCT00783692|541728077|FG005|Maintenance Phase|Lost to Follow-up|2|||
150162199|NCT00783692|541728078|FG006|Maintenance Phase|Lost to Follow-up|5|||
150162200|NCT00783692|541728072|FG000|Maintenance Phase|Other|0|||
150162201|NCT00783692|541728073|FG001|Maintenance Phase|Other|0|||
150162202|NCT00783692|541728074|FG002|Maintenance Phase|Other|0|||
150162203|NCT00783692|541728075|FG003|Maintenance Phase|Other|1|||
150162204|NCT00783692|541728076|FG004|Maintenance Phase|Other|0|||
150162205|NCT00783692|541728077|FG005|Maintenance Phase|Other|1|||
150162206|NCT00783692|541728078|FG006|Maintenance Phase|Other|1|||
150162207|NCT03005288|541728081|FG000|Overall Study|Withdrawal by Subject|7|||
150162208|NCT03005288|541728082|FG001|Overall Study|Withdrawal by Subject|5|||
150162209|NCT03005288|541728081|FG000|Overall Study|Lost to Follow-up|0|||
150162210|NCT03005288|541728082|FG001|Overall Study|Lost to Follow-up|1|||
150162211|NCT03005288|541728081|FG000|Overall Study|Adverse Event|5|||
150162212|NCT03005288|541728082|FG001|Overall Study|Adverse Event|0|||
150162213|NCT03005288|541728081|FG000|Overall Study|Protocol deviation|0|||
150162214|NCT03005288|541728082|FG001|Overall Study|Protocol deviation|1|||
150162215|NCT03005288|541728081|FG000|Overall Study|Physician Decision|0|||
150162216|NCT03005288|541728082|FG001|Overall Study|Physician Decision|1|||
150162217|NCT00819234|541728087|FG000|Overall Study|Withdrawal by Subject|8|||
149925864|NCT02182830|540863276|FG000|Overall Study|Not Treated|1|||
149925865|NCT02182830|540863277|FG001|Overall Study|Not Treated|1|||
149925866|NCT02182830|540863276|FG000|Overall Study|Trial stopped, reason missing|3|||
149925867|NCT02182830|540863277|FG001|Overall Study|Trial stopped, reason missing|3|||
150162218|NCT00819234|541728088|FG001|Overall Study|Withdrawal by Subject|13|||
150162219|NCT00819234|541728089|FG002|Overall Study|Withdrawal by Subject|6|||
150162220|NCT00819234|541728090|FG003|Overall Study|Withdrawal by Subject|3|||
150162221|NCT00819234|541728091|FG004|Overall Study|Withdrawal by Subject|0|||
150162222|NCT00819234|541728092|FG005|Overall Study|Withdrawal by Subject|4|||
150162223|NCT00819234|541728093|FG006|Overall Study|Withdrawal by Subject|4|||
150162224|NCT00819234|541728094|FG007|Overall Study|Withdrawal by Subject|8|||
150162225|NCT00819234|541728095|FG008|Overall Study|Withdrawal by Subject|5|||
150162226|NCT00819234|541728096|FG009|Overall Study|Withdrawal by Subject|3|||
150162227|NCT00819234|541728087|FG000|Overall Study|Adverse Event|0|||
150162228|NCT00819234|541728088|FG001|Overall Study|Adverse Event|0|||
150162229|NCT00819234|541728089|FG002|Overall Study|Adverse Event|1|||
150162230|NCT00819234|541728090|FG003|Overall Study|Adverse Event|0|||
150162231|NCT00819234|541728091|FG004|Overall Study|Adverse Event|0|||
150162232|NCT00819234|541728092|FG005|Overall Study|Adverse Event|2|||
150162233|NCT00819234|541728093|FG006|Overall Study|Adverse Event|0|||
150162234|NCT00819234|541728094|FG007|Overall Study|Adverse Event|0|||
150162235|NCT00819234|541728095|FG008|Overall Study|Adverse Event|0|||
150162236|NCT00819234|541728096|FG009|Overall Study|Adverse Event|0|||
150162237|NCT00819234|541728087|FG000|Overall Study|Physician Decision|0|||
150162238|NCT00819234|541728088|FG001|Overall Study|Physician Decision|0|||
150162239|NCT00819234|541728089|FG002|Overall Study|Physician Decision|0|||
150162240|NCT00819234|541728090|FG003|Overall Study|Physician Decision|1|||
150162241|NCT00819234|541728091|FG004|Overall Study|Physician Decision|0|||
150162242|NCT00819234|541728092|FG005|Overall Study|Physician Decision|0|||
150162243|NCT00819234|541728093|FG006|Overall Study|Physician Decision|0|||
150162244|NCT00819234|541728094|FG007|Overall Study|Physician Decision|0|||
150162245|NCT00819234|541728095|FG008|Overall Study|Physician Decision|0|||
150162246|NCT00819234|541728096|FG009|Overall Study|Physician Decision|2|||
150162247|NCT00819234|541728087|FG000|Overall Study|Protocol Violation|0|||
150162248|NCT00819234|541728088|FG001|Overall Study|Protocol Violation|0|||
150162249|NCT00819234|541728089|FG002|Overall Study|Protocol Violation|1|||
150162250|NCT00819234|541728090|FG003|Overall Study|Protocol Violation|0|||
150162251|NCT00819234|541728091|FG004|Overall Study|Protocol Violation|0|||
150162252|NCT00819234|541728092|FG005|Overall Study|Protocol Violation|0|||
150162253|NCT00819234|541728093|FG006|Overall Study|Protocol Violation|0|||
150162254|NCT00819234|541728094|FG007|Overall Study|Protocol Violation|0|||
150162255|NCT00819234|541728095|FG008|Overall Study|Protocol Violation|0|||
150162256|NCT00819234|541728096|FG009|Overall Study|Protocol Violation|0|||
150162257|NCT00819234|541728087|FG000|Overall Study|Lost to Follow-up|2|||
150162258|NCT00819234|541728088|FG001|Overall Study|Lost to Follow-up|2|||
150162259|NCT00819234|541728089|FG002|Overall Study|Lost to Follow-up|0|||
150162260|NCT00819234|541728090|FG003|Overall Study|Lost to Follow-up|2|||
150162261|NCT00819234|541728091|FG004|Overall Study|Lost to Follow-up|1|||
150162262|NCT00819234|541728092|FG005|Overall Study|Lost to Follow-up|1|||
150162263|NCT00819234|541728093|FG006|Overall Study|Lost to Follow-up|1|||
150162264|NCT00819234|541728094|FG007|Overall Study|Lost to Follow-up|1|||
150162265|NCT00819234|541728095|FG008|Overall Study|Lost to Follow-up|1|||
150162266|NCT00819234|541728096|FG009|Overall Study|Lost to Follow-up|2|||
150162267|NCT04011033|541728097|FG000|Overall Study|Physician Decision|2|||
150162268|NCT04011033|541728098|FG001|Overall Study|Physician Decision|3|||
150162269|NCT04011033|541728097|FG000|Overall Study|Withdrawal by Subject|1|||
150162270|NCT04011033|541728098|FG001|Overall Study|Withdrawal by Subject|0|||
150162271|NCT00209274|541728099|FG000|Overall Study|Missed visit|3|||
150162272|NCT00209274|541728100|FG001|Overall Study|Missed visit|2|||
150162273|NCT00209274|541728099|FG000|Overall Study|Death|32|||
150162274|NCT00209274|541728100|FG001|Overall Study|Death|15|||
150162275|NCT00209274|541728099|FG000|Overall Study|Withdrawal by Subject|30|||
150162276|NCT00209274|541728100|FG001|Overall Study|Withdrawal by Subject|15|||
150162277|NCT00209274|541728099|FG000|Overall Study|Randomized not treated (RNT)|6|||
150162278|NCT00209274|541728100|FG001|Overall Study|Randomized not treated (RNT)|15|||
150162279|NCT01394991|541728101|FG000|Overall Study|Adverse Event|0|||
150162280|NCT01394991|541728102|FG001|Overall Study|Adverse Event|4|||
150162281|NCT01394991|541728101|FG000|Overall Study|Lack of Efficacy|5|||
150162282|NCT01394991|541728102|FG001|Overall Study|Lack of Efficacy|7|||
150261005|NCT01272804|542091785|FG001|Overall Study|Adverse Event|0|||
149925868|NCT02182830|540863276|FG000|Overall Study|Consent withdrawn|8|||
149925869|NCT02182830|540863277|FG001|Overall Study|Consent withdrawn|8|||
150162283|NCT01394991|541728101|FG000|Overall Study|Lost to Follow-up|6|||
150162284|NCT01394991|541728102|FG001|Overall Study|Lost to Follow-up|8|||
150162285|NCT01394991|541728101|FG000|Overall Study|Physician Decision|1|||
150162286|NCT01394991|541728102|FG001|Overall Study|Physician Decision|3|||
150162287|NCT01394991|541728101|FG000|Overall Study|Protocol Violation|1|||
150162288|NCT01394991|541728102|FG001|Overall Study|Protocol Violation|1|||
150162289|NCT01394991|541728101|FG000|Overall Study|Withdrawal by Subject|20|||
150261006|NCT01272804|542091786|FG002|Overall Study|Adverse Event|0|||
150261007|NCT01272804|542091787|FG003|Overall Study|Adverse Event|0|||
150261008|NCT01272804|542091788|FG004|Overall Study|Adverse Event|2|||
150261009|NCT01272804|542091789|FG005|Overall Study|Adverse Event|1|||
150261010|NCT03801915|542091790|FG000|Overall Study|Screen failure|0|||
150261011|NCT03801915|542091791|FG001|Overall Study|Screen failure|0|||
150261012|NCT03801915|542091792|FG002|Overall Study|Screen failure|1|||
150261013|NCT03801915|542091790|FG000|Overall Study|Ineligible|1|||
150261014|NCT03801915|542091791|FG001|Overall Study|Ineligible|0|||
150261015|NCT03801915|542091792|FG002|Overall Study|Ineligible|0|||
150261016|NCT03801915|542091790|FG000|Overall Study|Physician Decision|2|||
150261017|NCT03801915|542091791|FG001|Overall Study|Physician Decision|1|||
150261018|NCT03801915|542091792|FG002|Overall Study|Physician Decision|0|||
150261019|NCT01588496|542091793|FG000|Overall Study|Withdrawal by Subject|0|||
150261020|NCT01588496|542091794|FG001|Overall Study|Withdrawal by Subject|1|||
150261021|NCT01588496|542091795|FG002|Overall Study|Withdrawal by Subject|0|||
150261022|NCT01551212|542091796|FG000|Overall Study|Graft loss/Retransplantation|0|||
150261023|NCT01551212|542091797|FG001|Overall Study|Graft loss/Retransplantation|1|||
149925870|NCT02182830|540863276|FG000|Overall Study|Lost to Follow-up|3|||
149925871|NCT02182830|540863277|FG001|Overall Study|Lost to Follow-up|3|||
149925872|NCT01990768|540863278|FG000|Intervention Started|Found to be ineligible|14|||
149925873|NCT01990768|540863279|FG001|Intervention Started|Found to be ineligible|13|||
149925874|NCT01990768|540863280|FG002|Intervention Started|Found to be ineligible|11|||
149925875|NCT01990768|540863278|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
149925876|NCT01990768|540863279|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
149925877|NCT01990768|540863280|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
149925878|NCT01990768|540863278|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
149925879|NCT01990768|540863279|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
149925880|NCT01990768|540863280|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
149925881|NCT01990768|540863278|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
149925882|NCT01990768|540863279|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
149925883|NCT01990768|540863280|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
149925884|NCT01990768|540863278|FG000|Intervention Started|Patient care priority|1|||
149925885|NCT01990768|540863279|FG001|Intervention Started|Patient care priority|2|||
149925886|NCT01990768|540863280|FG002|Intervention Started|Patient care priority|3|||
149925887|NCT01990768|540863278|FG000|Intervention Started|IV lost|2|||
149925888|NCT01990768|540863279|FG001|Intervention Started|IV lost|2|||
149925889|NCT01990768|540863280|FG002|Intervention Started|IV lost|2|||
149925890|NCT01990768|540863278|FG000|Intervention Started|Required CPR|1|||
149925891|NCT01990768|540863279|FG001|Intervention Started|Required CPR|1|||
149925892|NCT01990768|540863280|FG002|Intervention Started|Required CPR|0|||
149925893|NCT01990768|540863278|FG000|Intervention Started|Seizure or hx of seizure|0|||
149925894|NCT01990768|540863279|FG001|Intervention Started|Seizure or hx of seizure|0|||
149925895|NCT01990768|540863280|FG002|Intervention Started|Seizure or hx of seizure|2|||
149925896|NCT01990768|540863278|FG000|Intervention Started|Discovered to be pregnant|0|||
149925897|NCT01990768|540863279|FG001|Intervention Started|Discovered to be pregnant|1|||
149925898|NCT01990768|540863280|FG002|Intervention Started|Discovered to be pregnant|0|||
149925899|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
149925900|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
149925901|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
149925902|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
149925903|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
149925904|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
149925905|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
149925906|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
149925907|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
149925908|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
149925909|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
149925910|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
149925911|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Death|3|||
150261024|NCT01551212|542091796|FG000|Overall Study|Administrative problems|1|||
150261025|NCT01551212|542091797|FG001|Overall Study|Administrative problems|2|||
150261026|NCT01551212|542091796|FG000|Overall Study|Lost to Follow-up|0|||
150261027|NCT01551212|542091797|FG001|Overall Study|Lost to Follow-up|1|||
150261028|NCT01551212|542091796|FG000|Overall Study|Protocol Violation|0|||
149925912|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Death|1|||
149925913|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Death|1|||
149925914|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Discharged|2|||
150261029|NCT01551212|542091797|FG001|Overall Study|Protocol Violation|1|||
150261030|NCT01551212|542091796|FG000|Overall Study|Withdrawal by Subject|0|||
150261031|NCT01551212|542091797|FG001|Overall Study|Withdrawal by Subject|7|||
150261032|NCT01551212|542091796|FG000|Overall Study|Death|2|||
149925915|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Discharged|1|||
150162290|NCT01394991|541728102|FG001|Overall Study|Withdrawal by Subject|17|||
150162291|NCT01394991|541728101|FG000|Overall Study|Chemotherapy Termination|10|||
150162292|NCT01394991|541728102|FG001|Overall Study|Chemotherapy Termination|15|||
150162293|NCT01394991|541728101|FG000|Overall Study|Disease Progression|7|||
150162294|NCT01394991|541728102|FG001|Overall Study|Disease Progression|7|||
150162295|NCT01394991|541728101|FG000|Overall Study|Prematurely Termination of Trial|9|||
150162296|NCT01394991|541728102|FG001|Overall Study|Prematurely Termination of Trial|10|||
150162297|NCT03073005|541728103|FG000|Overall Study|Death|6|||
150162298|NCT03073005|541728104|FG001|Overall Study|Death|0|||
150162299|NCT03073005|541728105|FG002|Overall Study|Death|7|||
150162300|NCT03073005|541728106|FG003|Overall Study|Death|0|||
150162301|NCT03073005|541728103|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
150162302|NCT03073005|541728104|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
150162303|NCT03073005|541728105|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
150162304|NCT03073005|541728106|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
150162305|NCT03073005|541728103|FG000|Overall Study|Lost to Follow-up|2|||
150162306|NCT03073005|541728104|FG001|Overall Study|Lost to Follow-up|2|||
150162307|NCT03073005|541728105|FG002|Overall Study|Lost to Follow-up|1|||
150162308|NCT03073005|541728106|FG003|Overall Study|Lost to Follow-up|2|||
150162309|NCT03073005|541728103|FG000|Overall Study|Withdrawal by Subject|0|||
150162310|NCT03073005|541728104|FG001|Overall Study|Withdrawal by Subject|4|||
150162311|NCT03073005|541728105|FG002|Overall Study|Withdrawal by Subject|4|||
150162312|NCT03073005|541728106|FG003|Overall Study|Withdrawal by Subject|4|||
150162313|NCT01734811|541728107|FG000|Overall Study|Lost to Follow-up|2|||
150162314|NCT01734811|541728108|FG001|Overall Study|Lost to Follow-up|3|||
150162315|NCT01734811|541728107|FG000|Overall Study|Withdrawal by Subject|2|||
150162316|NCT01734811|541728108|FG001|Overall Study|Withdrawal by Subject|0|||
150162317|NCT02427646|541728109|FG000|Overall Study|Lack of Efficacy|2|||
150162318|NCT02427646|541728110|FG001|Overall Study|Lack of Efficacy|3|||
150162319|NCT02427646|541728109|FG000|Overall Study|Physician Decision|1|||
150162320|NCT02427646|541728110|FG001|Overall Study|Physician Decision|4|||
150162321|NCT02427646|541728109|FG000|Overall Study|Protocol Violation|3|||
150162322|NCT02427646|541728110|FG001|Overall Study|Protocol Violation|3|||
150162323|NCT02427646|541728109|FG000|Overall Study|Bothersome hand weakness|2|||
150162324|NCT02427646|541728110|FG001|Overall Study|Bothersome hand weakness|4|||
150162325|NCT03824236|541728111|FG000|Overall Study|Lost to Follow-up|0|||
150162326|NCT03824236|541728112|FG001|Overall Study|Lost to Follow-up|0|||
150162327|NCT03824236|541728113|FG002|Overall Study|Lost to Follow-up|1|||
150162328|NCT01290094|541728114|FG000|Overall Study|Withdrawal by Subject|1|||
150162329|NCT01290094|541728114|FG000|Overall Study|Lost to Follow-up|5|||
150162330|NCT01101542|541728117|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
150162331|NCT01101542|541728117|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
150162332|NCT01101542|541728117|FG000|Year 4 Surveillance Period|Other|287|||
150162333|NCT01101542|541728117|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
150162334|NCT01101542|541728117|FG000|Year 5 Surveillance Period|Pregnancy|1|||
150162335|NCT01101542|541728117|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
150162336|NCT01101542|541728117|FG000|Year 6 Surveillance Period|Pregnancy|1|||
150162337|NCT01101542|541728117|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
150162338|NCT00701311|541728118|FG000|Overall Study|Lack of Efficacy|3|||
150162339|NCT00701311|541728118|FG000|Overall Study|Adverse Event|3|||
150162340|NCT00701311|541728118|FG000|Overall Study|Withdrawal by Subject|2|||
150162341|NCT01712685|541728119|FG000|Overall Study|pt declined to participate before trmt|1|||
150162342|NCT01871285|541728120|FG000|First Intervention (1 Day)|Adverse Event|1|||
150162343|NCT01871285|541728121|FG001|First Intervention (1 Day)|Adverse Event|0|||
150162344|NCT01871285|541728122|FG002|First Intervention (1 Day)|Adverse Event|0|||
150162345|NCT01871285|541728123|FG003|First Intervention (1 Day)|Adverse Event|0|||
150162346|NCT01871285|541728120|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
150162347|NCT01871285|541728121|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
150162348|NCT01871285|541728122|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
150162349|NCT01871285|541728123|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
150162350|NCT03015740|541728124|FG000|Overall Study|Adverse Event|1|||
150162351|NCT03015740|541728125|FG001|Overall Study|Adverse Event|0|||
150261033|NCT01551212|542091797|FG001|Overall Study|Death|4|||
150162352|NCT03015740|541728126|FG002|Overall Study|Adverse Event|0|||
150162353|NCT03015740|541728124|FG000|Overall Study|Death|3|||
150162354|NCT03015740|541728125|FG001|Overall Study|Death|5|||
150162355|NCT03015740|541728126|FG002|Overall Study|Death|0|||
150162356|NCT03015740|541728124|FG000|Overall Study|Withdrawal by Subject|2|||
150162357|NCT03015740|541728125|FG001|Overall Study|Withdrawal by Subject|0|||
150162358|NCT03015740|541728126|FG002|Overall Study|Withdrawal by Subject|0|||
150162359|NCT03253653|541728131|FG000|Overall Study|Withdrawal by Subject|4|||
150162360|NCT03253653|541728132|FG001|Overall Study|Withdrawal by Subject|1|||
150261034|NCT01551212|542091796|FG000|Overall Study|Never Received Study Treatment|2|||
150261035|NCT01551212|542091797|FG001|Overall Study|Never Received Study Treatment|4|||
150162361|NCT03253653|541728131|FG000|Overall Study|Protocol Violation|0|||
150261036|NCT05924945|542091798|FG000|Overall Study|Withdrawal by Subject|3|||
150261037|NCT05924945|542091799|FG001|Overall Study|Withdrawal by Subject|4|||
150261038|NCT02471833|542091800|FG000|Overall Study|Lost to Follow-up|1|||
150261039|NCT02471833|542091801|FG001|Overall Study|Lost to Follow-up|0|||
150261040|NCT02471833|542091802|FG002|Overall Study|Lost to Follow-up|0|||
150261041|NCT02471833|542091800|FG000|Overall Study|Withdrawal by Subject|2|||
150261042|NCT02471833|542091801|FG001|Overall Study|Withdrawal by Subject|1|||
150261043|NCT02471833|542091802|FG002|Overall Study|Withdrawal by Subject|5|||
150261044|NCT01775124|542091803|FG000|Core Period|Disease Progression|0|||
150261045|NCT01775124|542091804|FG001|Core Period|Disease Progression|1|||
150261046|NCT01775124|542091803|FG000|Core Period|Physician Decision|1|||
150261047|NCT01775124|542091804|FG001|Core Period|Physician Decision|1|||
150261048|NCT01775124|542091803|FG000|Core Period|Death|0|||
150261049|NCT01775124|542091804|FG001|Core Period|Death|1|||
150261050|NCT01775124|542091803|FG000|Core Period|Administrative problems|1|||
150261051|NCT01775124|542091804|FG001|Core Period|Administrative problems|0|||
150261052|NCT01775124|542091803|FG000|Core Period|Withdrawal by Subject|4|||
150261053|NCT01775124|542091804|FG001|Core Period|Withdrawal by Subject|2|||
150261054|NCT01775124|542091803|FG000|Core Period|Adverse Event|5|||
150261055|NCT01775124|542091804|FG001|Core Period|Adverse Event|5|||
150261056|NCT01775124|542091803|FG000|Extension Period|Adverse Event|3|||
150261057|NCT01775124|542091804|FG001|Extension Period|Adverse Event|2|||
150261058|NCT01775124|542091803|FG000|Extension Period|Physician Decision|0|||
150261059|NCT01775124|542091804|FG001|Extension Period|Physician Decision|2|||
150261060|NCT01775124|542091803|FG000|Extension Period|Administrative problems|0|||
150261061|NCT01775124|542091804|FG001|Extension Period|Administrative problems|1|||
150261062|NCT01775124|542091803|FG000|Extension Period|Lost to Follow-up|0|||
150261063|NCT01775124|542091804|FG001|Extension Period|Lost to Follow-up|1|||
150261064|NCT01775124|542091803|FG000|Extension Period|Withdrawal by Subject|9|||
150261065|NCT01775124|542091804|FG001|Extension Period|Withdrawal by Subject|12|||
150261066|NCT02164383|542093686|FG000|Overall Study|Lost to Follow-up|1|||
150261067|NCT02164383|542093687|FG001|Overall Study|Lost to Follow-up|0|||
150261068|NCT01350336|542093688|FG000|Overall Study|Lost to Follow-up|31|||
150261069|NCT01350336|542093688|FG000|Overall Study|Withdrawal by Subject|14|||
150261070|NCT01350336|542093688|FG000|Overall Study|Physician Decision|8|||
150261071|NCT01350336|542093688|FG000|Overall Study|Death|4|||
150261072|NCT04964388|542093689|FG000|Overall Study|Lost to Follow-up|3|||
150261073|NCT04964388|542093690|FG001|Overall Study|Lost to Follow-up|2|||
150261074|NCT02563522|542093692|FG000|Overall Study|Adverse Event|2|||
150261075|NCT02563522|542093693|FG001|Overall Study|Adverse Event|3|||
150261076|NCT02563522|542093692|FG000|Overall Study|Lost to Follow-up|1|||
150261077|NCT02563522|542093693|FG001|Overall Study|Lost to Follow-up|0|||
150261078|NCT02563522|542093692|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
150261079|NCT02563522|542093693|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
150261080|NCT01052103|542093694|FG000|Overall Study|Adverse Event|10|||
150261081|NCT01052103|542093695|FG001|Overall Study|Adverse Event|6|||
150261082|NCT01052103|542093694|FG000|Overall Study|Entry Criteria Not Met|3|||
150261083|NCT01052103|542093695|FG001|Overall Study|Entry Criteria Not Met|1|||
150261084|NCT01052103|542093694|FG000|Overall Study|Lost to Follow-up|3|||
150261085|NCT01052103|542093695|FG001|Overall Study|Lost to Follow-up|5|||
150261086|NCT01052103|542093694|FG000|Overall Study|Protocol Violation|10|||
150261087|NCT01052103|542093695|FG001|Overall Study|Protocol Violation|4|||
150261088|NCT01052103|542093694|FG000|Overall Study|Scheduling conflict|2|||
150261089|NCT01052103|542093695|FG001|Overall Study|Scheduling conflict|1|||
150261090|NCT01052103|542093694|FG000|Overall Study|Sponsor Decision|2|||
150261091|NCT01052103|542093695|FG001|Overall Study|Sponsor Decision|0|||
150261092|NCT01052103|542093694|FG000|Overall Study|Withdrawal by Subject|3|||
150261093|NCT01052103|542093695|FG001|Overall Study|Withdrawal by Subject|6|||
150261094|NCT01052103|542093694|FG000|Overall Study|Perceived Lack of Efficacy|1|||
150261095|NCT01052103|542093695|FG001|Overall Study|Perceived Lack of Efficacy|0|||
150261096|NCT04874415|542093696|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261097|NCT04874415|542093697|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261098|NCT04874415|542093698|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261099|NCT04874415|542093699|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261100|NCT04874415|542093700|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261101|NCT04874415|542093701|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261102|NCT04874415|542093702|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
150261103|NCT04874415|542093703|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261104|NCT04874415|542093704|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
149819070|NCT00323609|540467176|FG000|Overall Study|Sponsor discontinued trial|29|||
150261105|NCT04874415|542093705|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
150261106|NCT04874415|542093706|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261107|NCT04874415|542093707|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
150261108|NCT04874415|542093708|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
150261109|NCT04874415|542093709|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
150261110|NCT04874415|542093710|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
150261111|NCT04874415|542093711|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
150261112|NCT04874415|542093696|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261113|NCT04874415|542093697|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261114|NCT04874415|542093698|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261115|NCT04874415|542093699|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261116|NCT04874415|542093700|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261117|NCT04874415|542093701|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261118|NCT04874415|542093702|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261119|NCT04874415|542093703|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261120|NCT04874415|542093704|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261121|NCT04874415|542093705|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
150261122|NCT04874415|542093706|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261123|NCT04874415|542093707|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261124|NCT04874415|542093708|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
150261125|NCT04874415|542093709|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
150261126|NCT04874415|542093710|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
149925916|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Discharged|0|||
149925917|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
150162362|NCT03253653|541728132|FG001|Overall Study|Protocol Violation|5|||
150162363|NCT04091672|541730047|FG000|Overall Study|Death|6|||
150162364|NCT04091672|541730048|FG001|Overall Study|Death|6|||
150162365|NCT04091672|541730047|FG000|Overall Study|Lost to Follow-up|7|||
150162366|NCT04091672|541730048|FG001|Overall Study|Lost to Follow-up|7|||
150162367|NCT04091672|541730047|FG000|Overall Study|Withdrawal by Subject|3|||
150162368|NCT04091672|541730048|FG001|Overall Study|Withdrawal by Subject|3|||
150162369|NCT04091672|541730047|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
150162370|NCT04091672|541730048|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
150162371|NCT05296629|541730049|FG000|Overall Study|Withdrawal by Subject|3|||
150162372|NCT05296629|541730050|FG001|Overall Study|Withdrawal by Subject|10|||
150162373|NCT05296629|541730051|FG002|Overall Study|Withdrawal by Subject|4|||
150162374|NCT05296629|541730049|FG000|Overall Study|Lost to Follow-up|2|||
150162375|NCT05296629|541730050|FG001|Overall Study|Lost to Follow-up|7|||
150162376|NCT05296629|541730051|FG002|Overall Study|Lost to Follow-up|1|||
150162377|NCT05296629|541730049|FG000|Overall Study|Adverse Event|0|||
150162378|NCT05296629|541730050|FG001|Overall Study|Adverse Event|4|||
150162379|NCT05296629|541730051|FG002|Overall Study|Adverse Event|2|||
150162380|NCT05296629|541730049|FG000|Overall Study|Protocol Violation|0|||
150162381|NCT05296629|541730050|FG001|Overall Study|Protocol Violation|2|||
150162382|NCT05296629|541730051|FG002|Overall Study|Protocol Violation|0|||
150162383|NCT02268396|541730055|FG000|Overall Study|Adverse Event|3|||
150162384|NCT02268396|541730055|FG000|Overall Study|Administrative|2|||
150162385|NCT02268396|541730055|FG000|Overall Study|Withdrawal by Subject|1|||
150162386|NCT02268396|541730055|FG000|Overall Study|Lost to Follow-up|2|||
150261127|NCT04874415|542093711|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
149819071|NCT00323609|540467177|FG001|Overall Study|Sponsor discontinued trial|29|||
149819072|NCT00323609|540467178|FG002|Overall Study|Sponsor discontinued trial|0|||
149819073|NCT00323609|540467179|FG003|Overall Study|Sponsor discontinued trial|0|||
149819074|NCT00323609|540467176|FG000|Overall Study|Unrelenting or severe back pain|1|||
149819075|NCT00323609|540467177|FG001|Overall Study|Unrelenting or severe back pain|1|||
149819076|NCT00323609|540467178|FG002|Overall Study|Unrelenting or severe back pain|0|||
149819077|NCT00323609|540467179|FG003|Overall Study|Unrelenting or severe back pain|0|||
149819078|NCT00323609|540467176|FG000|Overall Study|Logistical withdrawal|9|||
149819079|NCT00323609|540467177|FG001|Overall Study|Logistical withdrawal|5|||
149819080|NCT00323609|540467178|FG002|Overall Study|Logistical withdrawal|0|||
149819081|NCT00323609|540467179|FG003|Overall Study|Logistical withdrawal|1|||
149819082|NCT00323609|540467176|FG000|Overall Study|Other reason|11|||
149819083|NCT00323609|540467177|FG001|Overall Study|Other reason|8|||
149819084|NCT00323609|540467178|FG002|Overall Study|Other reason|4|||
149819085|NCT00323609|540467179|FG003|Overall Study|Other reason|9|||
149819086|NCT01023269|540467183|FG000|Overall Study|early termination of the study|2|||
149819087|NCT01023269|540467184|FG001|Overall Study|early termination of the study|0|||
149819088|NCT01953783|540467185|FG000|Overall Study|Progressive disease|2|||
149819089|NCT01789281|540467186|FG000|Overall Study|Disease progression|15|||
149819090|NCT01789281|540467187|FG001|Overall Study|Disease progression|4|||
149819091|NCT01789281|540467186|FG000|Overall Study|Adverse Event|5|||
149819092|NCT01789281|540467187|FG001|Overall Study|Adverse Event|5|||
149819093|NCT01789281|540467186|FG000|Overall Study|Withdrawal by Subject|1|||
149819094|NCT01789281|540467187|FG001|Overall Study|Withdrawal by Subject|0|||
149819095|NCT01789281|540467186|FG000|Overall Study|Lost to Follow-up|1|||
150162387|NCT02268396|541730055|FG000|Overall Study|Protocol-Specified Criteria|2|||
149819096|NCT01789281|540467187|FG001|Overall Study|Lost to Follow-up|0|||
149819097|NCT01789281|540467186|FG000|Overall Study|Administrative problems|0|||
150162388|NCT02268396|541730055|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
150261128|NCT04874415|542093696|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261129|NCT04874415|542093697|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261130|NCT04874415|542093698|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261131|NCT04874415|542093699|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261132|NCT04874415|542093700|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
150261133|NCT04874415|542093701|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261134|NCT04874415|542093702|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261135|NCT04874415|542093703|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261136|NCT04874415|542093704|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261137|NCT04874415|542093705|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261138|NCT04874415|542093706|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261139|NCT04874415|542093707|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261140|NCT04874415|542093708|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261141|NCT04874415|542093709|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261142|NCT04874415|542093710|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261143|NCT04874415|542093711|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
150261144|NCT03405792|542093712|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
150261145|NCT03405792|542093713|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
150261146|NCT03405792|542093712|FG000|Overall Study|o Did not receive pembrolizumab|1|||
150261147|NCT03405792|542093713|FG001|Overall Study|o Did not receive pembrolizumab|0|||
150261148|NCT00918580|542093714|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
150261149|NCT00918580|542093714|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
150261150|NCT00918580|542093714|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
150261151|NCT00918580|542093714|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
150261152|NCT00918580|542093714|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
150261153|NCT00918580|542093714|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
150261154|NCT00918580|542093714|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
150261155|NCT00372229|542093715|FG000|Study Phase|Graft loss|0|||
150261156|NCT00372229|542093716|FG001|Study Phase|Graft loss|3|||
150261157|NCT00372229|542093715|FG000|Study Phase|Protocol Violation|3|||
150261158|NCT00372229|542093716|FG001|Study Phase|Protocol Violation|4|||
150261159|NCT00372229|542093715|FG000|Study Phase|Consent withdrawn|16|||
150261160|NCT00372229|542093716|FG001|Study Phase|Consent withdrawn|14|||
150261161|NCT00372229|542093715|FG000|Study Phase|Refused treatment/did not cooperate|3|||
150261162|NCT00372229|542093716|FG001|Study Phase|Refused treatment/did not cooperate|1|||
150261163|NCT00372229|542093715|FG000|Study Phase|Death|3|||
150261164|NCT00372229|542093716|FG001|Study Phase|Death|2|||
150261165|NCT00372229|542093715|FG000|Study Phase|Reason not specified|3|||
150261166|NCT00372229|542093716|FG001|Study Phase|Reason not specified|2|||
150261167|NCT00372229|542093715|FG000|Study Phase|Lost to Follow-up|3|||
150261168|NCT00372229|542093716|FG001|Study Phase|Lost to Follow-up|3|||
150261169|NCT00372229|542093715|FG000|Follow-Up Phase|Graft loss|8|||
150261170|NCT00372229|542093716|FG001|Follow-Up Phase|Graft loss|7|||
150261171|NCT00372229|542093715|FG000|Follow-Up Phase|Consent withdrawn|13|||
150261172|NCT00372229|542093716|FG001|Follow-Up Phase|Consent withdrawn|19|||
150261173|NCT00372229|542093715|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
150261174|NCT00372229|542093716|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
150261175|NCT00372229|542093715|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
150261176|NCT00372229|542093716|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
150261177|NCT00372229|542093715|FG000|Follow-Up Phase|Death|9|||
150261178|NCT00372229|542093716|FG001|Follow-Up Phase|Death|12|||
150261179|NCT00372229|542093715|FG000|Follow-Up Phase|Administrative|1|||
150261180|NCT00372229|542093716|FG001|Follow-Up Phase|Administrative|0|||
150261181|NCT00372229|542093715|FG000|Follow-Up Phase|Reason not specified|2|||
150261182|NCT00372229|542093716|FG001|Follow-Up Phase|Reason not specified|3|||
150261183|NCT00372229|542093715|FG000|Follow-Up Phase|Lost to Follow-up|12|||
150261184|NCT00372229|542093716|FG001|Follow-Up Phase|Lost to Follow-up|10|||
150261185|NCT01347762|542093717|FG000|Overall Study|Lost to Follow-up|0|||
149819098|NCT01789281|540467187|FG001|Overall Study|Administrative problems|1|||
149819099|NCT00814658|540467188|FG000|Overall Study|Lost to Follow-up|0|||
149819100|NCT00814658|540467189|FG001|Overall Study|Lost to Follow-up|1|||
149819101|NCT00814658|540467188|FG000|Overall Study|Physician Decision|1|||
149819102|NCT00814658|540467189|FG001|Overall Study|Physician Decision|0|||
149819103|NCT00814658|540467188|FG000|Overall Study|Adverse Event|3|||
149819104|NCT00814658|540467189|FG001|Overall Study|Adverse Event|3|||
149819105|NCT01141283|540467191|FG000|Overall Study|Adverse Event|56|||
150261186|NCT01347762|542093718|FG001|Overall Study|Lost to Follow-up|1|||
150261187|NCT01347762|542093719|FG002|Overall Study|Lost to Follow-up|6|||
150261188|NCT01347762|542093720|FG003|Overall Study|Lost to Follow-up|5|||
150261189|NCT01347762|542093717|FG000|Overall Study|Withdrawal by Subject|4|||
150261190|NCT01347762|542093718|FG001|Overall Study|Withdrawal by Subject|1|||
150261191|NCT01347762|542093719|FG002|Overall Study|Withdrawal by Subject|3|||
150261192|NCT01347762|542093720|FG003|Overall Study|Withdrawal by Subject|3|||
150261193|NCT03235284|542093721|FG000|Overall Study|Adverse Event|1|||
150261194|NCT03235284|542093722|FG001|Overall Study|Adverse Event|2|||
150261195|NCT03235284|542093723|FG002|Overall Study|Adverse Event|1|||
150261196|NCT00310037|542093724|FG000|Overall Study|Adverse Event|7|||
150261197|NCT00310037|542093725|FG001|Overall Study|Adverse Event|14|||
150261198|NCT00310037|542093724|FG000|Overall Study|Withdrawal by Subject|4|||
150261199|NCT00310037|542093725|FG001|Overall Study|Withdrawal by Subject|3|||
150261200|NCT00310037|542093724|FG000|Overall Study|Progression|6|||
150261201|NCT00310037|542093725|FG001|Overall Study|Progression|0|||
150261202|NCT00310037|542093724|FG000|Overall Study|Non-protocol treatment|1|||
150261203|NCT00310037|542093725|FG001|Overall Study|Non-protocol treatment|0|||
150261204|NCT01382706|542093728|FG000|Overall Study|Adverse Event|1|||
150261205|NCT01382706|542093728|FG000|Overall Study|Withdrawal by Subject|1|||
150261206|NCT05559099|542093729|FG000|Overall Study|Death|5|||
150261207|NCT05559099|542093730|FG001|Overall Study|Death|4|||
150261208|NCT05559099|542093729|FG000|Overall Study|Lost to Follow-up|0|||
150261209|NCT05559099|542093730|FG001|Overall Study|Lost to Follow-up|2|||
150261210|NCT05559099|542093729|FG000|Overall Study|Adverse Event|1|||
150261211|NCT05559099|542093730|FG001|Overall Study|Adverse Event|1|||
150261212|NCT04018092|542093731|FG000|Overall Study|Withdrawal by Subject|1|||
150261213|NCT04018092|542093732|FG001|Overall Study|Withdrawal by Subject|1|||
150261214|NCT04018092|542093731|FG000|Overall Study|Withdrawal by Subject|1|||
150261215|NCT04018092|542093732|FG001|Overall Study|Withdrawal by Subject|1|||
150261216|NCT02208999|542093735|FG000|Overall Study|Lost to Follow-up|1|||
150261217|NCT00319839|542093736|FG000|Overall Study|Adverse Event|5|||
150261218|NCT00319839|542093736|FG000|Overall Study|Withdrawal by Subject|1|||
150261219|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
150261220|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
150261221|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
150261222|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
150261223|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
150261224|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
150261225|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
150261226|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261227|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261228|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261229|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261230|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
150261231|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261232|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
150261233|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261234|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261235|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261236|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261237|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
150261238|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261239|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
150261240|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261241|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261242|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261243|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
150261244|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
150261245|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261246|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261247|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
150261248|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
150261249|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
150261250|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
149925918|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
149925919|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
149925920|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
150261251|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
150261252|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
150261253|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
150261254|NCT04494256|542093737|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
150261255|NCT04494256|542093738|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
149925921|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
149925922|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
149925923|NCT01990768|540863278|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
149925924|NCT01990768|540863279|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
149925925|NCT01990768|540863280|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
149925926|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
149925927|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
149925928|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
149925929|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
150261256|NCT04494256|542093739|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
150261257|NCT04494256|542093740|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
150261258|NCT04494256|542093741|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
150261259|NCT04494256|542093742|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
150261260|NCT04494256|542093743|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
150261261|NCT04494256|542093737|FG000|Part 2: Open Label Period|Death|0|||
150261262|NCT04494256|542093738|FG001|Part 2: Open Label Period|Death|0|||
150261263|NCT04494256|542093739|FG002|Part 2: Open Label Period|Death|0|||
150261264|NCT04494256|542093740|FG003|Part 2: Open Label Period|Death|0|||
150261265|NCT04494256|542093741|FG004|Part 2: Open Label Period|Death|0|||
150261266|NCT04494256|542093742|FG005|Part 2: Open Label Period|Death|4|||
150261267|NCT04494256|542093743|FG006|Part 2: Open Label Period|Death|2|||
150261268|NCT04494256|542093737|FG000|Part 2: Open Label Period|Adverse Event|0|||
150261269|NCT04494256|542093738|FG001|Part 2: Open Label Period|Adverse Event|0|||
150162389|NCT01304706|541730058|FG000|Overall Study|Adverse Event|2|||
150162390|NCT01304706|541730058|FG000|Overall Study|Lack of Efficacy|1|||
150162391|NCT01304706|541730058|FG000|Overall Study|Death|3|||
150162392|NCT01304706|541730058|FG000|Overall Study|Withdrawal by Subject|3|||
150162393|NCT01304706|541730058|FG000|Overall Study|Lost to Follow-up|7|||
150162394|NCT01304706|541730058|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
150162395|NCT00359619|541730059|FG000|Overall Study|Adverse Event|0|||
150162396|NCT00359619|541730060|FG001|Overall Study|Adverse Event|0|||
150162397|NCT00359619|541730061|FG002|Overall Study|Adverse Event|1|||
150162398|NCT00359619|541730062|FG003|Overall Study|Adverse Event|0|||
150162399|NCT00359619|541730063|FG004|Overall Study|Adverse Event|0|||
150162400|NCT00359619|541730064|FG005|Overall Study|Adverse Event|0|||
150162401|NCT00359619|541730065|FG006|Overall Study|Adverse Event|1|||
150162402|NCT00359619|541730059|FG000|Overall Study|Withdrawal by Subject|3|||
150162403|NCT00359619|541730060|FG001|Overall Study|Withdrawal by Subject|1|||
150162404|NCT00359619|541730061|FG002|Overall Study|Withdrawal by Subject|4|||
150162405|NCT00359619|541730062|FG003|Overall Study|Withdrawal by Subject|2|||
150162406|NCT00359619|541730063|FG004|Overall Study|Withdrawal by Subject|2|||
150162407|NCT00359619|541730064|FG005|Overall Study|Withdrawal by Subject|0|||
150162408|NCT00359619|541730065|FG006|Overall Study|Withdrawal by Subject|3|||
150162409|NCT00359619|541730059|FG000|Overall Study|Other|1|||
150162410|NCT00359619|541730060|FG001|Overall Study|Other|0|||
150162411|NCT00359619|541730061|FG002|Overall Study|Other|0|||
150162412|NCT00359619|541730062|FG003|Overall Study|Other|0|||
150162413|NCT00359619|541730063|FG004|Overall Study|Other|0|||
150162414|NCT00359619|541730064|FG005|Overall Study|Other|0|||
150162415|NCT00359619|541730065|FG006|Overall Study|Other|0|||
150162416|NCT00359619|541730059|FG000|Overall Study|Lost to Follow-up|4|||
150162417|NCT00359619|541730060|FG001|Overall Study|Lost to Follow-up|4|||
150162418|NCT00359619|541730061|FG002|Overall Study|Lost to Follow-up|2|||
150162419|NCT00359619|541730062|FG003|Overall Study|Lost to Follow-up|1|||
150162420|NCT00359619|541730063|FG004|Overall Study|Lost to Follow-up|1|||
150162421|NCT00359619|541730064|FG005|Overall Study|Lost to Follow-up|5|||
150162422|NCT00359619|541730065|FG006|Overall Study|Lost to Follow-up|0|||
150162423|NCT04978363|541730071|FG000|Overall Study|Other medical issues unrelated to the study|0|||
150162424|NCT04978363|541730072|FG001|Overall Study|Other medical issues unrelated to the study|0|||
150162425|NCT04978363|541730073|FG002|Overall Study|Other medical issues unrelated to the study|0|||
150162426|NCT04978363|541730074|FG003|Overall Study|Other medical issues unrelated to the study|0|||
150162427|NCT04978363|541730075|FG004|Overall Study|Other medical issues unrelated to the study|1|||
150162428|NCT04978363|541730076|FG005|Overall Study|Other medical issues unrelated to the study|0|||
150162429|NCT04978363|541730077|FG006|Overall Study|Other medical issues unrelated to the study|0|||
150162430|NCT04978363|541730078|FG007|Overall Study|Other medical issues unrelated to the study|0|||
150162431|NCT04978363|541730079|FG008|Overall Study|Other medical issues unrelated to the study|0|||
150162432|NCT04978363|541730080|FG009|Overall Study|Other medical issues unrelated to the study|0|||
150162433|NCT04978363|541730081|FG010|Overall Study|Other medical issues unrelated to the study|0|||
150162434|NCT04978363|541730071|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
150162435|NCT04978363|541730072|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
150261270|NCT04494256|542093739|FG002|Part 2: Open Label Period|Adverse Event|0|||
150261271|NCT04494256|542093740|FG003|Part 2: Open Label Period|Adverse Event|0|||
150261272|NCT04494256|542093741|FG004|Part 2: Open Label Period|Adverse Event|0|||
150261273|NCT04494256|542093742|FG005|Part 2: Open Label Period|Adverse Event|0|||
150261274|NCT04494256|542093743|FG006|Part 2: Open Label Period|Adverse Event|2|||
150261275|NCT04494256|542093737|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
150261276|NCT04494256|542093738|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
150261277|NCT04494256|542093739|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
150261278|NCT04494256|542093740|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
150261279|NCT04494256|542093741|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
150261280|NCT04494256|542093742|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
150261281|NCT04494256|542093743|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
150261282|NCT04494256|542093737|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261283|NCT04494256|542093738|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261284|NCT04494256|542093739|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261285|NCT04494256|542093740|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261286|NCT04494256|542093741|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261287|NCT04494256|542093742|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
150261288|NCT04494256|542093743|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
150261289|NCT04494256|542093737|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
150261290|NCT04494256|542093738|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
150261291|NCT04494256|542093739|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
150261292|NCT04494256|542093740|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
150261293|NCT04494256|542093741|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
150261294|NCT04494256|542093742|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
150261295|NCT04494256|542093743|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
150261296|NCT04494256|542093737|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261297|NCT04494256|542093738|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261298|NCT04494256|542093739|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261299|NCT04494256|542093740|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261300|NCT04494256|542093741|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
150261301|NCT04494256|542093742|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
150261302|NCT04494256|542093743|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
150261303|NCT04494256|542093737|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
150261304|NCT04494256|542093738|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
150261305|NCT04494256|542093739|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
150261306|NCT04494256|542093740|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
150261307|NCT04494256|542093741|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
150261308|NCT04494256|542093742|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
150261309|NCT04494256|542093743|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
150261310|NCT00262951|542093744|FG000|Overall Study|Progressive disease/relapse|3|||
150261311|NCT00262951|542093744|FG000|Overall Study|Adverse Event|7|||
150261312|NCT00262951|542093744|FG000|Overall Study|Death|1|||
150261313|NCT00262951|542093744|FG000|Overall Study|Withdrawal by Subject|1|||
150261314|NCT00262951|542093744|FG000|Overall Study|Alternative treatment|3|||
150261315|NCT00262951|542093744|FG000|Overall Study|Off treatment for other disease|1|||
150261316|NCT01778023|542093745|FG000|Overall Study|Withdrawal by Subject|0|||
150261317|NCT01778023|542093746|FG001|Overall Study|Withdrawal by Subject|3|||
150261318|NCT00903630|542093747|FG000|Phase 2|Adverse Event|0|||
150261319|NCT00903630|542093748|FG001|Phase 2|Adverse Event|0|||
150261320|NCT00903630|542093749|FG002|Phase 2|Adverse Event|1|||
150261321|NCT04025580|542093750|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
150261322|NCT04025580|542093751|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
150261323|NCT04025580|542093752|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
150261324|NCT01768117|542093755|FG000|Overall Study|Lost to Follow-up|1|||
150261325|NCT01768117|542093755|FG000|Overall Study|Withdrawal by Subject|2|||
149819106|NCT01141283|540467191|FG000|Overall Study|Lost to Follow-up|4|||
149819107|NCT01141283|540467191|FG000|Overall Study|Withdrawal by Subject|14|||
149819108|NCT01141283|540467191|FG000|Overall Study|Administrative|4|||
149819109|NCT01141283|540467191|FG000|Overall Study|Lack of Efficacy|10|||
149819110|NCT06371079|540467192|FG000|Overall Study|Missing data|88|||
149819111|NCT06371079|540467193|FG001|Overall Study|Missing data|247|||
150261326|NCT01768117|542093755|FG000|Overall Study|Protocol Violation|3|||
150261327|NCT01249274|542093759|FG000|Overall Study|Lost to Follow-up|3|||
149819112|NCT00575328|540467194|FG000|Overall Study|Adverse Event|1|||
149819113|NCT00575328|540467195|FG001|Overall Study|Adverse Event|1|||
150261328|NCT01249274|542093760|FG001|Overall Study|Lost to Follow-up|4|||
150261329|NCT01249274|542093759|FG000|Overall Study|Received inpatient substance treatment|1|||
150261330|NCT01249274|542093760|FG001|Overall Study|Received inpatient substance treatment|2|||
150261331|NCT01000636|542093761|FG000|Overall Study|Withdrawal by Subject|1|||
150261332|NCT01000636|542093761|FG000|Overall Study|Adverse Event|1|||
150261333|NCT00138671|542093762|FG000|Overall Study|Death|0|||
150261334|NCT00138671|542093763|FG001|Overall Study|Death|3|||
150261335|NCT00138671|542093762|FG000|Overall Study|Adverse Event|6|||
150261336|NCT00138671|542093763|FG001|Overall Study|Adverse Event|3|||
150261337|NCT00138671|542093762|FG000|Overall Study|Lost to Follow-up|1|||
150261338|NCT00138671|542093763|FG001|Overall Study|Lost to Follow-up|2|||
150261339|NCT00138671|542093762|FG000|Overall Study|Withdrawal by Subject|3|||
150261340|NCT00138671|542093763|FG001|Overall Study|Withdrawal by Subject|5|||
150261341|NCT00138671|542093762|FG000|Overall Study|Other|3|||
150261342|NCT00138671|542093763|FG001|Overall Study|Other|3|||
150261343|NCT03658668|542093764|FG000|Overall Study|Time Commitment|1|||
150261344|NCT03658668|542093765|FG001|Overall Study|Time Commitment|1|||
150261345|NCT04634825|542093766|FG000|Overall Study|Death|10|||
150261346|NCT04634825|542093767|FG001|Overall Study|Death|3|||
150261347|NCT04634825|542093766|FG000|Overall Study|Lost to Follow-up|1|||
150261348|NCT04634825|542093767|FG001|Overall Study|Lost to Follow-up|0|||
150261349|NCT04634825|542093766|FG000|Overall Study|Study terminated by sponsor|35|||
150261350|NCT04634825|542093767|FG001|Overall Study|Study terminated by sponsor|11|||
150261351|NCT04634825|542093766|FG000|Overall Study|Withdrawal by Subject|2|||
150261352|NCT04634825|542093767|FG001|Overall Study|Withdrawal by Subject|0|||
150261353|NCT02581631|542093773|FG000|Overall Study|Disease progression|29|||
150261354|NCT02581631|542093774|FG001|Overall Study|Disease progression|19|||
150261355|NCT02581631|542093775|FG002|Overall Study|Disease progression|13|||
150261356|NCT02581631|542093776|FG003|Overall Study|Disease progression|5|||
150261357|NCT02581631|542093777|FG004|Overall Study|Disease progression|8|||
150261358|NCT02581631|542093773|FG000|Overall Study|Study drug toxicity|4|||
150261359|NCT02581631|542093774|FG001|Overall Study|Study drug toxicity|6|||
150261360|NCT02581631|542093775|FG002|Overall Study|Study drug toxicity|7|||
150261361|NCT02581631|542093776|FG003|Overall Study|Study drug toxicity|0|||
150261362|NCT02581631|542093777|FG004|Overall Study|Study drug toxicity|3|||
150261363|NCT02581631|542093773|FG000|Overall Study|AE unrelated to study drug|3|||
150261364|NCT02581631|542093774|FG001|Overall Study|AE unrelated to study drug|1|||
150261365|NCT02581631|542093775|FG002|Overall Study|AE unrelated to study drug|1|||
150261366|NCT02581631|542093776|FG003|Overall Study|AE unrelated to study drug|0|||
150261367|NCT02581631|542093777|FG004|Overall Study|AE unrelated to study drug|2|||
150261368|NCT02581631|542093773|FG000|Overall Study|Request to discontinue|1|||
150261369|NCT02581631|542093774|FG001|Overall Study|Request to discontinue|0|||
150261370|NCT02581631|542093775|FG002|Overall Study|Request to discontinue|3|||
150261371|NCT02581631|542093776|FG003|Overall Study|Request to discontinue|0|||
150261372|NCT02581631|542093777|FG004|Overall Study|Request to discontinue|1|||
150261373|NCT02581631|542093773|FG000|Overall Study|participant withdrew consent|3|||
150261374|NCT02581631|542093774|FG001|Overall Study|participant withdrew consent|0|||
150261375|NCT02581631|542093775|FG002|Overall Study|participant withdrew consent|1|||
150261376|NCT02581631|542093776|FG003|Overall Study|participant withdrew consent|0|||
150261377|NCT02581631|542093777|FG004|Overall Study|participant withdrew consent|0|||
150162436|NCT04978363|541730073|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
150162437|NCT04978363|541730074|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
150162438|NCT04978363|541730075|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
150162439|NCT04978363|541730076|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
150162440|NCT04978363|541730077|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
150162441|NCT04978363|541730078|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
150162442|NCT04978363|541730079|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
150162443|NCT04978363|541730080|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
150162444|NCT04978363|541730081|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
150162445|NCT04978363|541730071|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162446|NCT04978363|541730072|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
150162447|NCT04978363|541730073|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162448|NCT04978363|541730074|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150261378|NCT02581631|542093773|FG000|Overall Study|Maximum clinical benefit|1|||
150261379|NCT02581631|542093774|FG001|Overall Study|Maximum clinical benefit|7|||
150261380|NCT02581631|542093775|FG002|Overall Study|Maximum clinical benefit|1|||
150261381|NCT02581631|542093776|FG003|Overall Study|Maximum clinical benefit|3|||
150261382|NCT02581631|542093777|FG004|Overall Study|Maximum clinical benefit|13|||
150261383|NCT02581631|542093773|FG000|Overall Study|Other Reasons|1|||
150261384|NCT02581631|542093774|FG001|Overall Study|Other Reasons|0|||
150261385|NCT02581631|542093775|FG002|Overall Study|Other Reasons|2|||
150261386|NCT02581631|542093776|FG003|Overall Study|Other Reasons|2|||
150261387|NCT02581631|542093777|FG004|Overall Study|Other Reasons|3|||
150261388|NCT02581631|542093773|FG000|Overall Study|Poor/Non-Compliance|0|||
150261389|NCT02581631|542093774|FG001|Overall Study|Poor/Non-Compliance|0|||
150261390|NCT02581631|542093775|FG002|Overall Study|Poor/Non-Compliance|1|||
150261391|NCT02581631|542093776|FG003|Overall Study|Poor/Non-Compliance|0|||
150261392|NCT02581631|542093777|FG004|Overall Study|Poor/Non-Compliance|0|||
150261393|NCT00705523|542093778|FG000|Overall Study|Lost to Follow-up|2|||
150261394|NCT00705523|542093779|FG001|Overall Study|Lost to Follow-up|3|||
150261395|NCT01013285|542093780|FG000|Overall Study|Death|48|||
150261396|NCT01013285|542093781|FG001|Overall Study|Death|89|||
150261397|NCT02003573|542093796|FG000|Overall Study|Progressive disease|2|||
150261398|NCT02003573|542093797|FG001|Overall Study|Progressive disease|0|||
150261399|NCT02003573|542093798|FG002|Overall Study|Progressive disease|1|||
150261400|NCT02003573|542093796|FG000|Overall Study|Other Adverse event|0|||
150261401|NCT02003573|542093797|FG001|Overall Study|Other Adverse event|1|||
150261402|NCT02003573|542093798|FG002|Overall Study|Other Adverse event|1|||
150261403|NCT02003573|542093796|FG000|Overall Study|Refuse to take trial medication|0|||
150261404|NCT02003573|542093797|FG001|Overall Study|Refuse to take trial medication|1|||
150261405|NCT02003573|542093798|FG002|Overall Study|Refuse to take trial medication|1|||
150261406|NCT02003573|542093796|FG000|Overall Study|Other than specified|1|||
150261407|NCT02003573|542093797|FG001|Overall Study|Other than specified|2|||
150261408|NCT02003573|542093798|FG002|Overall Study|Other than specified|3|||
150261409|NCT02232243|542093805|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
150261410|NCT02232243|542093806|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
150261411|NCT02232243|542093807|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
150261412|NCT05026710|542093808|FG000|Overall Study|No longer met eligibility criteria|3|||
150261413|NCT05026710|542093809|FG001|Overall Study|No longer met eligibility criteria|1|||
150261414|NCT00490724|542093810|FG000|Period I|Physician Decision|0|||
150261415|NCT00490724|542093811|FG001|Period I|Physician Decision|0|||
150261416|NCT00490724|542093812|FG002|Period I|Physician Decision|1|||
150261417|NCT00490724|542093810|FG000|Period II|Treatment Discontinuation|3|||
150261418|NCT00490724|542093811|FG001|Period II|Treatment Discontinuation|1|||
150261419|NCT00490724|542093812|FG002|Period II|Treatment Discontinuation|3|||
150261420|NCT01395888|542093813|FG000|2-week Run-in Period|Adverse Event|2|||
150261421|NCT01395888|542093814|FG001|2-week Run-in Period|Adverse Event|0|||
150261422|NCT01395888|542093815|FG002|2-week Run-in Period|Adverse Event|0|||
150261423|NCT01395888|542093813|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
150261424|NCT01395888|542093814|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
150261425|NCT01395888|542093815|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
150261426|NCT01395888|542093813|FG000|2-week Run-in Period|Lost to Follow-up|1|||
150261427|NCT01395888|542093814|FG001|2-week Run-in Period|Lost to Follow-up|0|||
150261428|NCT01395888|542093815|FG002|2-week Run-in Period|Lost to Follow-up|0|||
150261429|NCT01395888|542093813|FG000|2-week Run-in Period|Protocol Violation|2|||
150261430|NCT01395888|542093814|FG001|2-week Run-in Period|Protocol Violation|0|||
150261431|NCT01395888|542093815|FG002|2-week Run-in Period|Protocol Violation|0|||
150261432|NCT01395888|542093813|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
150261433|NCT01395888|542093814|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
150261434|NCT01395888|542093815|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
150261435|NCT01395888|542093813|FG000|Treatment Period (TP)|Adverse Event|0|||
150261436|NCT01395888|542093814|FG001|Treatment Period (TP)|Adverse Event|7|||
150261437|NCT01395888|542093815|FG002|Treatment Period (TP)|Adverse Event|6|||
150261438|NCT01395888|542093813|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
150261439|NCT01395888|542093814|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
150261440|NCT01395888|542093815|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
150261441|NCT01395888|542093813|FG000|Treatment Period (TP)|Protocol Violation|0|||
150261442|NCT01395888|542093814|FG001|Treatment Period (TP)|Protocol Violation|1|||
150261443|NCT01395888|542093815|FG002|Treatment Period (TP)|Protocol Violation|5|||
150261444|NCT01395888|542093813|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
150261445|NCT01395888|542093814|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
150261446|NCT01395888|542093815|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
150261447|NCT01395888|542093813|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
150261448|NCT01395888|542093814|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
150261449|NCT01395888|542093815|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
150261450|NCT03218397|542093816|FG000|Overall Study|Prior positive blood culture|8|||
150261451|NCT03218397|542093817|FG001|Overall Study|Prior positive blood culture|13|||
150261452|NCT03218397|542093816|FG000|Overall Study|Comfort care|8|||
150261453|NCT03218397|542093817|FG001|Overall Study|Comfort care|5|||
150261454|NCT03218397|542093816|FG000|Overall Study|Comfort care and positive blood culture|1|||
150261455|NCT03218397|542093817|FG001|Overall Study|Comfort care and positive blood culture|0|||
150261456|NCT03218397|542093816|FG000|Overall Study|Comfort care and mixed culture|0|||
150261457|NCT03218397|542093817|FG001|Overall Study|Comfort care and mixed culture|1|||
150261458|NCT03218397|542093816|FG000|Overall Study|Mixed culture|2|||
150261459|NCT03218397|542093817|FG001|Overall Study|Mixed culture|2|||
150261460|NCT03218397|542093816|FG000|Overall Study|Inaccessible hospital records|2|||
150261461|NCT03218397|542093817|FG001|Overall Study|Inaccessible hospital records|5|||
150261462|NCT03218397|542093816|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
149925930|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
150162449|NCT04978363|541730075|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162450|NCT04978363|541730076|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162451|NCT04978363|541730077|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162452|NCT04978363|541730078|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162453|NCT04978363|541730079|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162454|NCT04978363|541730080|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162455|NCT04978363|541730081|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
150162456|NCT01251614|541730082|FG000|Overall Study|Adverse Event|1|||
150162457|NCT01251614|541730083|FG001|Overall Study|Adverse Event|0|||
150162458|NCT01251614|541730084|FG002|Overall Study|Adverse Event|1|||
150162459|NCT01251614|541730082|FG000|Overall Study|Lack of Efficacy|1|||
150162460|NCT01251614|541730083|FG001|Overall Study|Lack of Efficacy|9|||
150162461|NCT01251614|541730084|FG002|Overall Study|Lack of Efficacy|4|||
150162462|NCT01251614|541730082|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
150162463|NCT01251614|541730083|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
150162464|NCT01251614|541730084|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
150162465|NCT01251614|541730082|FG000|Overall Study|Pregnancy|0|||
150162466|NCT01251614|541730083|FG001|Overall Study|Pregnancy|0|||
150162467|NCT01251614|541730084|FG002|Overall Study|Pregnancy|2|||
150162468|NCT01251614|541730082|FG000|Overall Study|Loss of Disease Control|0|||
150162469|NCT01251614|541730083|FG001|Overall Study|Loss of Disease Control|1|||
150162470|NCT01251614|541730084|FG002|Overall Study|Loss of Disease Control|0|||
150162471|NCT01251614|541730082|FG000|Overall Study|Withdrawal by Subject|0|||
150162472|NCT01251614|541730083|FG001|Overall Study|Withdrawal by Subject|2|||
150162473|NCT01251614|541730084|FG002|Overall Study|Withdrawal by Subject|1|||
150162474|NCT01251614|541730082|FG000|Overall Study|Lost to Follow-up|0|||
150162475|NCT01251614|541730083|FG001|Overall Study|Lost to Follow-up|1|||
150162476|NCT01251614|541730084|FG002|Overall Study|Lost to Follow-up|0|||
150162477|NCT00049517|541730085|FG000|Induction|Disease progression|0|||
150162478|NCT00049517|541730086|FG001|Induction|Disease progression|0|||
150162479|NCT00049517|541730087|FG002|Induction|Disease progression|0|||
150162480|NCT00049517|541730088|FG003|Induction|Disease progression|0|||
150162481|NCT00049517|541730089|FG004|Induction|Disease progression|18|||
150162482|NCT00049517|541730090|FG005|Induction|Disease progression|11|||
150162483|NCT00049517|541730085|FG000|Induction|Adverse Event|0|||
150162484|NCT00049517|541730086|FG001|Induction|Adverse Event|0|||
150162485|NCT00049517|541730087|FG002|Induction|Adverse Event|0|||
150162486|NCT00049517|541730088|FG003|Induction|Adverse Event|0|||
150162487|NCT00049517|541730089|FG004|Induction|Adverse Event|5|||
150162488|NCT00049517|541730090|FG005|Induction|Adverse Event|7|||
150162489|NCT00049517|541730085|FG000|Induction|Death|0|||
150162490|NCT00049517|541730086|FG001|Induction|Death|0|||
150162491|NCT00049517|541730087|FG002|Induction|Death|0|||
150162492|NCT00049517|541730088|FG003|Induction|Death|0|||
150162493|NCT00049517|541730089|FG004|Induction|Death|9|||
150162494|NCT00049517|541730090|FG005|Induction|Death|6|||
150162495|NCT00049517|541730085|FG000|Induction|Withdrawal by Subject|0|||
150162496|NCT00049517|541730086|FG001|Induction|Withdrawal by Subject|0|||
150162497|NCT00049517|541730087|FG002|Induction|Withdrawal by Subject|0|||
150162498|NCT00049517|541730088|FG003|Induction|Withdrawal by Subject|0|||
150162499|NCT00049517|541730089|FG004|Induction|Withdrawal by Subject|1|||
150162500|NCT00049517|541730090|FG005|Induction|Withdrawal by Subject|3|||
150162501|NCT00049517|541730085|FG000|Induction|Alternative therapy|0|||
150162502|NCT00049517|541730086|FG001|Induction|Alternative therapy|0|||
150162503|NCT00049517|541730087|FG002|Induction|Alternative therapy|0|||
150162504|NCT00049517|541730088|FG003|Induction|Alternative therapy|0|||
150162505|NCT00049517|541730089|FG004|Induction|Alternative therapy|2|||
149925931|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
149925932|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
150162506|NCT00049517|541730090|FG005|Induction|Alternative therapy|2|||
150162507|NCT00049517|541730085|FG000|Induction|Other complicating disease|0|||
150162508|NCT00049517|541730086|FG001|Induction|Other complicating disease|0|||
150162509|NCT00049517|541730087|FG002|Induction|Other complicating disease|0|||
150162510|NCT00049517|541730088|FG003|Induction|Other complicating disease|0|||
150162511|NCT00049517|541730089|FG004|Induction|Other complicating disease|3|||
150162512|NCT00049517|541730090|FG005|Induction|Other complicating disease|0|||
150162513|NCT00049517|541730085|FG000|Induction|Reasons not reported|0|||
150162514|NCT00049517|541730086|FG001|Induction|Reasons not reported|0|||
150162515|NCT00049517|541730087|FG002|Induction|Reasons not reported|0|||
150162516|NCT00049517|541730088|FG003|Induction|Reasons not reported|0|||
150162517|NCT00049517|541730089|FG004|Induction|Reasons not reported|22|||
150162518|NCT00049517|541730090|FG005|Induction|Reasons not reported|25|||
150162519|NCT00049517|541730085|FG000|Conditioning/Transplant|Disease progression|14|||
150162520|NCT00049517|541730086|FG001|Conditioning/Transplant|Disease progression|6|||
150162521|NCT00049517|541730087|FG002|Conditioning/Transplant|Disease progression|10|||
150162522|NCT00049517|541730088|FG003|Conditioning/Transplant|Disease progression|6|||
150261463|NCT03218397|542093817|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
150261464|NCT03218397|542093816|FG000|Overall Study|Randomized during laboratory off hours|2|||
150261465|NCT03218397|542093817|FG001|Overall Study|Randomized during laboratory off hours|1|||
150261466|NCT01796548|542093818|FG000|Overall Study|Lost to Follow-up|1|||
150261467|NCT01796548|542093818|FG000|Overall Study|Other|2|||
150261468|NCT00126503|542093819|FG000|Overall Study|disease progression|23|||
150261469|NCT00126503|542093820|FG001|Overall Study|disease progression|14|||
150261470|NCT00126503|542093819|FG000|Overall Study|Withdrawal by Subject|0|||
150261471|NCT00126503|542093820|FG001|Overall Study|Withdrawal by Subject|1|||
150261472|NCT00126503|542093819|FG000|Overall Study|alternative therapy|1|||
150261473|NCT00126503|542093820|FG001|Overall Study|alternative therapy|1|||
150261474|NCT00126503|542093819|FG000|Overall Study|other complicating disease|4|||
150261475|NCT00126503|542093820|FG001|Overall Study|other complicating disease|1|||
150261476|NCT00126503|542093819|FG000|Overall Study|Death|3|||
150261477|NCT00126503|542093820|FG001|Overall Study|Death|0|||
150261478|NCT00126503|542093819|FG000|Overall Study|Adverse Event|13|||
150261479|NCT00126503|542093820|FG001|Overall Study|Adverse Event|3|||
150261480|NCT00126503|542093819|FG000|Overall Study|non-compliant|1|||
150261481|NCT00126503|542093820|FG001|Overall Study|non-compliant|0|||
150261482|NCT00126503|542093819|FG000|Overall Study|Physician Decision|2|||
150261483|NCT00126503|542093820|FG001|Overall Study|Physician Decision|1|||
150261484|NCT02457559|542093821|FG000|Overall Study|Progressive Disease|1|||
150261485|NCT02457559|542093822|FG001|Overall Study|Progressive Disease|2|||
150261486|NCT02457559|542093823|FG002|Overall Study|Progressive Disease|3|||
150261487|NCT02457559|542093824|FG003|Overall Study|Progressive Disease|0|||
150261488|NCT02457559|542093825|FG004|Overall Study|Progressive Disease|0|||
150261489|NCT02457559|542093826|FG005|Overall Study|Progressive Disease|2|||
150261490|NCT02457559|542093827|FG006|Overall Study|Progressive Disease|1|||
150261491|NCT02457559|542093828|FG007|Overall Study|Progressive Disease|0|||
150261492|NCT02457559|542093829|FG008|Overall Study|Progressive Disease|1|||
150261493|NCT02457559|542093830|FG009|Overall Study|Progressive Disease|1|||
150261494|NCT02457559|542093831|FG010|Overall Study|Progressive Disease|1|||
150261495|NCT02457559|542093821|FG000|Overall Study|Investigator's Discretion|0|||
150261496|NCT02457559|542093822|FG001|Overall Study|Investigator's Discretion|0|||
150261497|NCT02457559|542093823|FG002|Overall Study|Investigator's Discretion|2|||
150261498|NCT02457559|542093824|FG003|Overall Study|Investigator's Discretion|0|||
150162523|NCT00049517|541730089|FG004|Conditioning/Transplant|Disease progression|0|||
150162524|NCT00049517|541730090|FG005|Conditioning/Transplant|Disease progression|0|||
150162525|NCT00049517|541730085|FG000|Conditioning/Transplant|Adverse Event|2|||
150162526|NCT00049517|541730086|FG001|Conditioning/Transplant|Adverse Event|1|||
150162527|NCT00049517|541730087|FG002|Conditioning/Transplant|Adverse Event|4|||
150162528|NCT00049517|541730088|FG003|Conditioning/Transplant|Adverse Event|8|||
150162529|NCT00049517|541730089|FG004|Conditioning/Transplant|Adverse Event|0|||
150162530|NCT00049517|541730090|FG005|Conditioning/Transplant|Adverse Event|0|||
150162531|NCT00049517|541730085|FG000|Conditioning/Transplant|Death|1|||
150162532|NCT00049517|541730086|FG001|Conditioning/Transplant|Death|0|||
150162533|NCT00049517|541730087|FG002|Conditioning/Transplant|Death|0|||
150162534|NCT00049517|541730088|FG003|Conditioning/Transplant|Death|2|||
150162535|NCT00049517|541730089|FG004|Conditioning/Transplant|Death|0|||
150162536|NCT00049517|541730090|FG005|Conditioning/Transplant|Death|0|||
150162537|NCT00049517|541730085|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
150162538|NCT00049517|541730086|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
150162539|NCT00049517|541730087|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
150162540|NCT00049517|541730088|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
150162541|NCT00049517|541730089|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
150162542|NCT00049517|541730090|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
150162543|NCT00049517|541730085|FG000|Conditioning/Transplant|Alternative therapy|4|||
150162544|NCT00049517|541730086|FG001|Conditioning/Transplant|Alternative therapy|4|||
150162545|NCT00049517|541730087|FG002|Conditioning/Transplant|Alternative therapy|2|||
150162546|NCT00049517|541730088|FG003|Conditioning/Transplant|Alternative therapy|1|||
150162547|NCT00049517|541730089|FG004|Conditioning/Transplant|Alternative therapy|1|||
150162548|NCT00049517|541730090|FG005|Conditioning/Transplant|Alternative therapy|0|||
150162549|NCT00049517|541730085|FG000|Conditioning/Transplant|Other complicating disease|2|||
150162550|NCT00049517|541730086|FG001|Conditioning/Transplant|Other complicating disease|0|||
150162551|NCT00049517|541730087|FG002|Conditioning/Transplant|Other complicating disease|0|||
150162552|NCT00049517|541730088|FG003|Conditioning/Transplant|Other complicating disease|4|||
150261499|NCT02457559|542093825|FG004|Overall Study|Investigator's Discretion|1|||
150261500|NCT02457559|542093826|FG005|Overall Study|Investigator's Discretion|0|||
150261501|NCT02457559|542093827|FG006|Overall Study|Investigator's Discretion|1|||
150261502|NCT02457559|542093828|FG007|Overall Study|Investigator's Discretion|0|||
150261503|NCT02457559|542093829|FG008|Overall Study|Investigator's Discretion|1|||
150261504|NCT02457559|542093830|FG009|Overall Study|Investigator's Discretion|0|||
150261505|NCT02457559|542093831|FG010|Overall Study|Investigator's Discretion|1|||
150261506|NCT02457559|542093821|FG000|Overall Study|Adverse Event|0|||
150261507|NCT02457559|542093822|FG001|Overall Study|Adverse Event|1|||
150162553|NCT00049517|541730089|FG004|Conditioning/Transplant|Other complicating disease|0|||
150162554|NCT00049517|541730090|FG005|Conditioning/Transplant|Other complicating disease|1|||
150162555|NCT00049517|541730085|FG000|Conditioning/Transplant|Reasons not reported|25|||
150162556|NCT00049517|541730086|FG001|Conditioning/Transplant|Reasons not reported|31|||
150162557|NCT00049517|541730087|FG002|Conditioning/Transplant|Reasons not reported|18|||
150162558|NCT00049517|541730088|FG003|Conditioning/Transplant|Reasons not reported|15|||
150162559|NCT00049517|541730089|FG004|Conditioning/Transplant|Reasons not reported|5|||
150162560|NCT00049517|541730090|FG005|Conditioning/Transplant|Reasons not reported|5|||
150162561|NCT01419717|541730091|FG000|Overall Study|Protocol-specified Criteria|62|||
150162562|NCT01419717|541730091|FG000|Overall Study|Adverse Event|19|||
150162563|NCT01419717|541730091|FG000|Overall Study|Death|17|||
150162564|NCT01419717|541730091|FG000|Overall Study|Withdrawal by Subject|10|||
150162565|NCT01419717|541730091|FG000|Overall Study|Disease Progression|9|||
150162566|NCT01419717|541730091|FG000|Overall Study|Other|4|||
150162567|NCT01419717|541730091|FG000|Overall Study|Lost to Follow-up|2|||
150162568|NCT01419717|541730091|FG000|Overall Study|Administrative Decision|1|||
150162569|NCT01419717|541730091|FG000|Overall Study|Noncompliance|1|||
150162570|NCT02857283|541730092|FG000|First Exposure|Withdrawal by Subject|1|||
150162571|NCT02857283|541730093|FG001|First Exposure|Withdrawal by Subject|0|||
150162572|NCT00093795|541730094|FG000|Overall Study|No follow up data|20|||
150162573|NCT00093795|541730095|FG001|Overall Study|No follow up data|16|||
150162574|NCT00093795|541730096|FG002|Overall Study|No follow up data|17|||
150162575|NCT00940017|541730097|FG000|Overall Study|did not meet entrance criteria|3|||
150162576|NCT00940017|541730097|FG000|Overall Study|Adverse Event|1|||
150162577|NCT00613301|541730098|FG000|Overall Study|Adverse Event|49|||
150162578|NCT00613301|541730098|FG000|Overall Study|Lost to Follow-up|88|||
150162579|NCT00613301|541730098|FG000|Overall Study|Withdrawal by Subject|5|||
150162580|NCT00613301|541730098|FG000|Overall Study|Death|6|||
150162581|NCT00613301|541730098|FG000|Overall Study|Lack of Efficacy|13|||
150162582|NCT00613301|541730098|FG000|Overall Study|Physician Decision|2|||
150162583|NCT00613301|541730098|FG000|Overall Study|No data was collected|53|||
150162584|NCT00613301|541730098|FG000|Overall Study|Irregularly enrolled patients|12|||
150162585|NCT01684046|541730101|FG000|Period 1, First 30 Days|Adverse Event|0|||
150162586|NCT01684046|541730102|FG001|Period 1, First 30 Days|Adverse Event|2|||
150162587|NCT02790606|541730114|FG000|Overall Study|Death|27|||
150162588|NCT02790606|541730114|FG000|Overall Study|Lost to Follow-up|4|||
150162589|NCT02790606|541730114|FG000|Overall Study|Physician Decision|3|||
150162590|NCT02790606|541730114|FG000|Overall Study|Withdrawal by Subject|1|||
150162591|NCT02735915|541730115|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
150162592|NCT02735915|541730115|FG000|Overall Study|Withdrawal following SAE|2|||
150162593|NCT02735915|541730115|FG000|Overall Study|Withdrawal by Subject|1|||
150162594|NCT05328973|541730116|FG000|Overall Study|Withdrawal by Subject|0|||
150162595|NCT05328973|541730117|FG001|Overall Study|Withdrawal by Subject|1|||
150162596|NCT02680756|541730124|FG000|Overall Study|Adverse Event|10|||
150162597|NCT02680756|541730125|FG001|Overall Study|Adverse Event|2|||
150162598|NCT02680756|541730124|FG000|Overall Study|Lost to Follow-up|7|||
150162599|NCT02680756|541730125|FG001|Overall Study|Lost to Follow-up|6|||
150162600|NCT02680756|541730124|FG000|Overall Study|Withdrawal by Subject|5|||
150162601|NCT02680756|541730125|FG001|Overall Study|Withdrawal by Subject|5|||
150162602|NCT02680756|541730124|FG000|Overall Study|Physician Decision|4|||
150162603|NCT02680756|541730125|FG001|Overall Study|Physician Decision|1|||
150162604|NCT02680756|541730124|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
150162605|NCT02680756|541730125|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
150162606|NCT02680756|541730124|FG000|Overall Study|Blood transfusion for any reason|0|||
150162607|NCT02680756|541730125|FG001|Overall Study|Blood transfusion for any reason|1|||
150162608|NCT02680756|541730124|FG000|Overall Study|Death|1|||
150162609|NCT02680756|541730125|FG001|Overall Study|Death|0|||
150162610|NCT02680756|541730124|FG000|Overall Study|Protocol Violation|1|||
150162611|NCT02680756|541730125|FG001|Overall Study|Protocol Violation|0|||
150162612|NCT02680756|541730124|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
150162613|NCT02680756|541730125|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
150162614|NCT02680756|541730124|FG000|Overall Study|None of above or not recorded|3|||
150162615|NCT02680756|541730125|FG001|Overall Study|None of above or not recorded|2|||
150162616|NCT00480441|541730126|FG000|Screening|Not Eligible|37|||
150162617|NCT00480441|541730127|FG001|Screening|Not Eligible|0|||
150162618|NCT00480441|541730128|FG002|Screening|Not Eligible|0|||
150162619|NCT00480441|541730126|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
150162620|NCT00480441|541730127|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
150162621|NCT00480441|541730128|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
150162622|NCT00480441|541730126|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
150162623|NCT00480441|541730127|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
150162624|NCT00480441|541730128|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
150162625|NCT00480441|541730126|FG000|Baseline Functional MRI|physical contraindication|4|||
150162626|NCT00480441|541730127|FG001|Baseline Functional MRI|physical contraindication|0|||
150162627|NCT00480441|541730128|FG002|Baseline Functional MRI|physical contraindication|0|||
150162628|NCT00480441|541730126|FG000|Randomization|Lost to Follow-up|0|||
150261508|NCT02457559|542093823|FG002|Overall Study|Adverse Event|2|||
150261509|NCT02457559|542093824|FG003|Overall Study|Adverse Event|0|||
150261510|NCT02457559|542093825|FG004|Overall Study|Adverse Event|0|||
150261511|NCT02457559|542093826|FG005|Overall Study|Adverse Event|0|||
150261512|NCT02457559|542093827|FG006|Overall Study|Adverse Event|0|||
150261513|NCT02457559|542093828|FG007|Overall Study|Adverse Event|0|||
150261514|NCT02457559|542093829|FG008|Overall Study|Adverse Event|0|||
150261515|NCT02457559|542093830|FG009|Overall Study|Adverse Event|0|||
150261516|NCT02457559|542093831|FG010|Overall Study|Adverse Event|0|||
150261517|NCT02457559|542093821|FG000|Overall Study|Reason not Specified|1|||
150261518|NCT02457559|542093822|FG001|Overall Study|Reason not Specified|0|||
150261519|NCT02457559|542093823|FG002|Overall Study|Reason not Specified|0|||
150261520|NCT02457559|542093824|FG003|Overall Study|Reason not Specified|0|||
150261521|NCT02457559|542093825|FG004|Overall Study|Reason not Specified|0|||
150261522|NCT02457559|542093826|FG005|Overall Study|Reason not Specified|0|||
150261523|NCT02457559|542093827|FG006|Overall Study|Reason not Specified|0|||
150261524|NCT02457559|542093828|FG007|Overall Study|Reason not Specified|0|||
150261525|NCT02457559|542093829|FG008|Overall Study|Reason not Specified|0|||
150261526|NCT02457559|542093830|FG009|Overall Study|Reason not Specified|2|||
150261527|NCT02457559|542093831|FG010|Overall Study|Reason not Specified|0|||
150261528|NCT02457559|542093821|FG000|Overall Study|Death|0|||
150261529|NCT02457559|542093822|FG001|Overall Study|Death|0|||
150261530|NCT02457559|542093823|FG002|Overall Study|Death|0|||
150261531|NCT02457559|542093824|FG003|Overall Study|Death|0|||
150261532|NCT02457559|542093825|FG004|Overall Study|Death|0|||
150261533|NCT02457559|542093826|FG005|Overall Study|Death|0|||
150261534|NCT02457559|542093827|FG006|Overall Study|Death|0|||
150261535|NCT02457559|542093828|FG007|Overall Study|Death|0|||
150261536|NCT02457559|542093829|FG008|Overall Study|Death|1|||
150261537|NCT02457559|542093830|FG009|Overall Study|Death|1|||
150261538|NCT02457559|542093831|FG010|Overall Study|Death|0|||
150261539|NCT02374671|542093834|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
150261540|NCT02374671|542093835|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
150261541|NCT02374671|542093836|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
150261542|NCT02374671|542093834|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
150261543|NCT02374671|542093835|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
150261544|NCT02374671|542093836|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
150261545|NCT02374671|542093834|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
150261546|NCT02374671|542093835|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
150261547|NCT02374671|542093836|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
150261548|NCT02374671|542093834|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
150261549|NCT02374671|542093835|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
150261550|NCT02374671|542093836|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
150261551|NCT02374671|542093834|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
150261552|NCT02374671|542093835|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
150261553|NCT02374671|542093836|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
150261554|NCT00903682|542093837|FG000|Overall Study|Adverse Event|6|||
150261555|NCT00903682|542093838|FG001|Overall Study|Adverse Event|13|||
150261556|NCT00903682|542093837|FG000|Overall Study|Lost to Follow-up|1|||
150261557|NCT00903682|542093838|FG001|Overall Study|Lost to Follow-up|0|||
150261558|NCT00903682|542093837|FG000|Overall Study|Withdrawal by Subject|5|||
150261559|NCT00903682|542093838|FG001|Overall Study|Withdrawal by Subject|0|||
150261560|NCT00903682|542093837|FG000|Overall Study|Pregnancy|0|||
150261561|NCT00903682|542093838|FG001|Overall Study|Pregnancy|1|||
150261562|NCT00903682|542093837|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
150261563|NCT00903682|542093838|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
150261564|NCT00903682|542093837|FG000|Overall Study|Subject Non-Compliant|1|||
150261565|NCT00903682|542093838|FG001|Overall Study|Subject Non-Compliant|0|||
150261566|NCT00903682|542093837|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
150261567|NCT00903682|542093838|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
150261568|NCT00903682|542093837|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
150261569|NCT00903682|542093838|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
150261570|NCT03866473|542093841|FG000|Phase 1|Death|1|||
150261571|NCT03866473|542093842|FG001|Phase 1|Death|0|||
150261572|NCT03866473|542093841|FG000|Phase 2|Death|0|||
150261573|NCT03866473|542093842|FG001|Phase 2|Death|2|||
150261574|NCT03866473|542093841|FG000|Phase 2|Dropped|1|||
150261575|NCT03866473|542093842|FG001|Phase 2|Dropped|1|||
150261576|NCT03866473|542093841|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
150261577|NCT03866473|542093842|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
150261578|NCT02495792|542093843|FG000|Overall Study|Lost to Follow-up|5|||
150261579|NCT02495792|542093844|FG001|Overall Study|Lost to Follow-up|9|||
150261580|NCT02495792|542093843|FG000|Overall Study|Protocol Violation|32|||
150261581|NCT02495792|542093844|FG001|Overall Study|Protocol Violation|31|||
150261582|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
149925933|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
149925934|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
149925935|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
149925936|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
149925937|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
149925938|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
149925939|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
149925940|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
149925941|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
149925942|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
149925943|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
149925944|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
149925945|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
149925946|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
149925947|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
149925948|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
149925949|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
149925950|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
149925951|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
149925952|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
149925953|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
149925954|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
149925955|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
150162629|NCT00480441|541730127|FG001|Randomization|Lost to Follow-up|7|||
150162630|NCT00480441|541730128|FG002|Randomization|Lost to Follow-up|2|||
150162631|NCT02374957|541730129|FG000|Overall Study|Patient did not complete forms correctly|1|||
150162632|NCT02374957|541730130|FG001|Overall Study|Patient did not complete forms correctly|0|||
150162633|NCT03681691|541730131|FG000|Overall Study|COVID|1|||
150162634|NCT03681691|541730132|FG001|Overall Study|COVID|0|||
150162635|NCT03681691|541730131|FG000|Overall Study|prolonged bleeding|1|||
150162636|NCT03681691|541730132|FG001|Overall Study|prolonged bleeding|0|||
150162637|NCT03681691|541730131|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
150162638|NCT03681691|541730132|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
150162639|NCT00748969|541730133|FG000|Overall Study|Withdrawal by Subject|1|||
150162640|NCT00748969|541730134|FG001|Overall Study|Withdrawal by Subject|0|||
150162641|NCT00748969|541730133|FG000|Overall Study|Withdrawal by Subject|0|||
150162642|NCT00748969|541730134|FG001|Overall Study|Withdrawal by Subject|1|||
150162643|NCT02334306|541730135|FG000|Double-blind Period|Adverse Event|0|||
150162644|NCT02334306|541730136|FG001|Double-blind Period|Adverse Event|1|||
150162645|NCT02334306|541730135|FG000|Double-blind Period|Withdrawal by Subject|1|||
150162646|NCT02334306|541730136|FG001|Double-blind Period|Withdrawal by Subject|1|||
150162647|NCT01687270|541730137|FG000|Overall Study|Lack of Efficacy|11|||
150162648|NCT01687270|541730137|FG000|Overall Study|Lost to Follow-up|1|||
150162649|NCT00465985|541730138|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
150162650|NCT00465985|541730139|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
150162651|NCT00465985|541730138|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
150162652|NCT00465985|541730139|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
150162653|NCT00465985|541730138|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
150162654|NCT00465985|541730139|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
150162655|NCT00465985|541730138|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
150162656|NCT00465985|541730139|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
150162657|NCT03532178|541730140|FG000|First Period|Withdrawal by Subject|1|||
150162658|NCT03532178|541730141|FG001|First Period|Withdrawal by Subject|3|||
150162659|NCT03532178|541730140|FG000|First Period|technical issues in data collection Technical issues|0|||
150162660|NCT03532178|541730141|FG001|First Period|technical issues in data collection Technical issues|1|||
150162661|NCT03532178|541730140|FG000|Second Period|Withdrawal by Subject|1|||
150162662|NCT03532178|541730141|FG001|Second Period|Withdrawal by Subject|1|||
150162663|NCT03532178|541730140|FG000|Second Period|Technical issues|0|||
150162664|NCT03532178|541730141|FG001|Second Period|Technical issues|1|||
150162665|NCT03302156|541730142|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
150162666|NCT03302156|541730143|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
150162667|NCT03302156|541730144|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
150162668|NCT02390557|541730145|FG000|Wave 2|Survey non-respondent|72|||
150162669|NCT02390557|541730146|FG001|Wave 2|Survey non-respondent|41|||
150162670|NCT02390557|541730147|FG002|Wave 2|Survey non-respondent|23|||
150162671|NCT03278028|541730150|FG000|Overall Study|Lost to Follow-up|1|||
150261583|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
150261584|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
150261585|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
150261586|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
150261587|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
150261588|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
150261589|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
150261590|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
150261591|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
150261592|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
150261593|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
150261594|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
150261595|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
150261596|NCT00600886|542093845|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
150261597|NCT00600886|542093846|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
150261598|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
150261599|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
150261600|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
150261601|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
150261602|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
150261603|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
150261604|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
150261605|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
150261606|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
150261607|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
150261608|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
150261609|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
150261610|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Death|1|||
150261611|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Death|1|||
150261612|NCT00600886|542093845|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
150261613|NCT00600886|542093846|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
150261614|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
150261615|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
150261616|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
150261617|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
150261618|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
150261619|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
150261620|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
150261621|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
150261622|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
150261623|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
150261624|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
150261625|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
150261626|NCT00600886|542093845|FG000|Extension - After Crossover (CAS)|Death|1|||
150261627|NCT00600886|542093846|FG001|Extension - After Crossover (CAS)|Death|0|||
150261628|NCT02523599|542093847|FG000|Overall Study|Adverse Event|1|||
150261629|NCT02523599|542093848|FG001|Overall Study|Adverse Event|0|||
150261630|NCT02523599|542093847|FG000|Overall Study|Physician Decision|1|||
150261631|NCT02523599|542093848|FG001|Overall Study|Physician Decision|0|||
150261632|NCT02523599|542093847|FG000|Overall Study|Lost to Follow-up|4|||
150261633|NCT02523599|542093848|FG001|Overall Study|Lost to Follow-up|1|||
150261634|NCT02523599|542093847|FG000|Overall Study|Did not return for Day 30 visit|2|||
150261635|NCT02523599|542093848|FG001|Overall Study|Did not return for Day 30 visit|0|||
150261636|NCT05590884|542093849|FG000|Overall Study|Withdrawal by Subject|1|||
150261637|NCT05590884|542093850|FG001|Overall Study|Withdrawal by Subject|0|||
150261638|NCT05590884|542093851|FG002|Overall Study|Withdrawal by Subject|0|||
150261639|NCT04443153|542093853|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
150261640|NCT04443153|542093854|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
150261641|NCT04443153|542093853|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
150261642|NCT04443153|542093854|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
150261643|NCT04443153|542093853|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
150261644|NCT04443153|542093854|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
150261645|NCT04443153|542093853|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
150261646|NCT04443153|542093854|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
150261647|NCT05182125|542093855|FG000|Overall Study|Withdrawal by Subject|0|||
150261648|NCT05182125|542093856|FG001|Overall Study|Withdrawal by Subject|0|||
150261649|NCT05182125|542093857|FG002|Overall Study|Withdrawal by Subject|0|||
150261650|NCT05182125|542093858|FG003|Overall Study|Withdrawal by Subject|0|||
150261651|NCT05182125|542093859|FG004|Overall Study|Withdrawal by Subject|2|||
150261652|NCT05182125|542093860|FG005|Overall Study|Withdrawal by Subject|0|||
150261653|NCT05182125|542093855|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
150261654|NCT05182125|542093856|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
150261655|NCT05182125|542093857|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
150261656|NCT05182125|542093858|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
150261657|NCT05182125|542093859|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
150261658|NCT05182125|542093860|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
150261659|NCT05182125|542093855|FG000|Overall Study|Death|0|||
150261660|NCT05182125|542093856|FG001|Overall Study|Death|0|||
150261661|NCT05182125|542093857|FG002|Overall Study|Death|0|||
150261662|NCT05182125|542093858|FG003|Overall Study|Death|0|||
150261663|NCT05182125|542093859|FG004|Overall Study|Death|1|||
150261664|NCT05182125|542093860|FG005|Overall Study|Death|0|||
150261665|NCT04134845|542093866|FG000|Overall Study|withdrawl by PI|12|||
150261666|NCT04134845|542093867|FG001|Overall Study|withdrawl by PI|5|||
150261667|NCT03110224|542093868|FG000|Overall Study|Death|3|||
150261668|NCT03110224|542093868|FG000|Overall Study|Lost to Follow-up|132|||
150261669|NCT03110224|542093868|FG000|Overall Study|Physician Decision|2|||
150261670|NCT03110224|542093868|FG000|Overall Study|Site Closed by Physician|35|||
150261671|NCT03110224|542093868|FG000|Overall Study|Site Closed by Sponsor|202|||
150261672|NCT03110224|542093868|FG000|Overall Study|Withdrawal by Subject|9|||
150261673|NCT05328167|542093869|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
150261674|NCT05328167|542093869|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
150261675|NCT05195489|542095549|FG000|Overall Study|Lost to Follow-up|1|||
150261676|NCT05195489|542095550|FG001|Overall Study|Lost to Follow-up|0|||
150261677|NCT05195489|542095549|FG000|Overall Study|Protocol Violation|0|||
150261678|NCT05195489|542095550|FG001|Overall Study|Protocol Violation|2|||
150261679|NCT05195489|542095549|FG000|Overall Study|Withdrawal by Subject|1|||
150261680|NCT05195489|542095550|FG001|Overall Study|Withdrawal by Subject|1|||
150261681|NCT05195489|542095549|FG000|Overall Study|Removed|0|||
150261682|NCT05195489|542095550|FG001|Overall Study|Removed|1|||
150261683|NCT03440320|542095552|FG000|Overall Study|Withdrawal by Subject|0|||
150261684|NCT03440320|542095553|FG001|Overall Study|Withdrawal by Subject|1|||
150261685|NCT01201343|542095554|FG000|Overall Study|Adverse Event|6|||
150261686|NCT01201343|542095554|FG000|Overall Study|Withdrawal by Subject|5|||
150261687|NCT01201343|542095554|FG000|Overall Study|Lost to Follow-up|2|||
150261688|NCT01201343|542095554|FG000|Overall Study|Lack of Efficacy|2|||
150261689|NCT01201343|542095554|FG000|Overall Study|Participant wrongly included in trial|1|||
150261690|NCT01201343|542095554|FG000|Overall Study|Randomized, not treated|3|||
150261691|NCT01919814|542095555|FG000|Overall Study|Adverse Event|1|||
150261692|NCT01919814|542095556|FG001|Overall Study|Adverse Event|0|||
150261693|NCT01919814|542095555|FG000|Overall Study|Protocol Violation|1|||
150261694|NCT01919814|542095556|FG001|Overall Study|Protocol Violation|0|||
150261695|NCT01919814|542095555|FG000|Overall Study|Withdrawal by Subject|1|||
150261696|NCT01919814|542095556|FG001|Overall Study|Withdrawal by Subject|0|||
150261697|NCT01440374|542095558|FG000|Part 1: Open-label Phase|Adverse Event|5|||
150261698|NCT01440374|542095559|FG001|Part 1: Open-label Phase|Adverse Event|0|||
150261699|NCT01440374|542095560|FG002|Part 1: Open-label Phase|Adverse Event|0|||
150261700|NCT01440374|542095561|FG003|Part 1: Open-label Phase|Adverse Event|0|||
150261701|NCT01440374|542095558|FG000|Part 1: Open-label Phase|Physician Decision|1|||
150261702|NCT01440374|542095559|FG001|Part 1: Open-label Phase|Physician Decision|0|||
150261703|NCT01440374|542095560|FG002|Part 1: Open-label Phase|Physician Decision|0|||
150261704|NCT01440374|542095561|FG003|Part 1: Open-label Phase|Physician Decision|0|||
150261705|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
150261706|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
150261707|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
150261708|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
150261709|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
150261710|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
150261711|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
150261712|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
150261713|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
150261714|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
150261715|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
150261716|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
150261717|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
150261718|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
150261719|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
150261720|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
150261721|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
150261722|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
150261723|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
150261724|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
150261725|NCT01440374|542095558|FG000|Part 2; Double-blind Phase|Not treated|0|||
150261726|NCT01440374|542095559|FG001|Part 2; Double-blind Phase|Not treated|0|||
150261727|NCT01440374|542095560|FG002|Part 2; Double-blind Phase|Not treated|1|||
150261728|NCT01440374|542095561|FG003|Part 2; Double-blind Phase|Not treated|0|||
150261729|NCT01440374|542095558|FG000|Part 3: Extension|Withdrawal by Subject|0|||
150261730|NCT01440374|542095559|FG001|Part 3: Extension|Withdrawal by Subject|0|||
150261731|NCT01440374|542095560|FG002|Part 3: Extension|Withdrawal by Subject|0|||
150261732|NCT01440374|542095561|FG003|Part 3: Extension|Withdrawal by Subject|5|||
150261733|NCT01440374|542095558|FG000|Part 3: Extension|Adverse Event|0|||
150261734|NCT01440374|542095559|FG001|Part 3: Extension|Adverse Event|0|||
150261735|NCT01440374|542095560|FG002|Part 3: Extension|Adverse Event|0|||
150261736|NCT01440374|542095561|FG003|Part 3: Extension|Adverse Event|13|||
150261737|NCT01440374|542095558|FG000|Part 3: Extension|Physician Decision|0|||
150261738|NCT01440374|542095559|FG001|Part 3: Extension|Physician Decision|0|||
150261739|NCT01440374|542095560|FG002|Part 3: Extension|Physician Decision|0|||
150261740|NCT01440374|542095561|FG003|Part 3: Extension|Physician Decision|14|||
150261741|NCT01036763|542095562|FG000|Overall Study|Adverse Event|25|||
150261742|NCT01036763|542095562|FG000|Overall Study|Lost to Follow-up|28|||
150261743|NCT01036763|542095562|FG000|Overall Study|Other reason (not specified)|40|||
150261744|NCT04812548|542095564|FG000|Overall Study|Adverse Event|2|||
150261745|NCT04812548|542095565|FG001|Overall Study|Adverse Event|7|||
150261746|NCT04812548|542095564|FG000|Overall Study|HSCT Planned|2|||
150261747|NCT04812548|542095565|FG001|Overall Study|HSCT Planned|3|||
150261748|NCT04812548|542095564|FG000|Overall Study|Progressive Disease|0|||
150261749|NCT04812548|542095565|FG001|Overall Study|Progressive Disease|2|||
150261750|NCT04812548|542095564|FG000|Overall Study|Death|0|||
150261751|NCT04812548|542095565|FG001|Overall Study|Death|1|||
150261752|NCT04812548|542095564|FG000|Overall Study|Post Study Access to Treatment|0|||
150261753|NCT04812548|542095565|FG001|Overall Study|Post Study Access to Treatment|1|||
150261754|NCT04812548|542095564|FG000|Overall Study|Withdrawal by Subject|0|||
150261755|NCT04812548|542095565|FG001|Overall Study|Withdrawal by Subject|1|||
150261756|NCT04812548|542095564|FG000|Overall Study|Physician Decision|1|||
150261757|NCT04812548|542095565|FG001|Overall Study|Physician Decision|0|||
150261758|NCT02141984|542095571|FG000|Overall Study|Lack of Efficacy|2|||
150261759|NCT01177722|542095572|FG000|Overall Study|Serious Adverse Event|0|||
150261760|NCT01177722|542095573|FG001|Overall Study|Serious Adverse Event|0|||
150261761|NCT01177722|542095574|FG002|Overall Study|Serious Adverse Event|1|||
150261762|NCT01177722|542095575|FG003|Overall Study|Serious Adverse Event|0|||
150261763|NCT01177722|542095572|FG000|Overall Study|Protocol Violation|0|||
150261764|NCT01177722|542095573|FG001|Overall Study|Protocol Violation|0|||
150261765|NCT01177722|542095574|FG002|Overall Study|Protocol Violation|1|||
150261766|NCT01177722|542095575|FG003|Overall Study|Protocol Violation|0|||
150261767|NCT01177722|542095572|FG000|Overall Study|Lost to Follow-up|3|||
150261768|NCT01177722|542095573|FG001|Overall Study|Lost to Follow-up|4|||
150261769|NCT01177722|542095574|FG002|Overall Study|Lost to Follow-up|3|||
150261770|NCT01177722|542095575|FG003|Overall Study|Lost to Follow-up|1|||
150261771|NCT01177722|542095572|FG000|Overall Study|Withdrawal by Subject|10|||
150261772|NCT01177722|542095573|FG001|Overall Study|Withdrawal by Subject|6|||
150261773|NCT01177722|542095574|FG002|Overall Study|Withdrawal by Subject|4|||
150261774|NCT01177722|542095575|FG003|Overall Study|Withdrawal by Subject|6|||
150261775|NCT01201317|542095578|FG000|Overall Study|Withdrawal by Subject|5|||
150261776|NCT01201317|542095579|FG001|Overall Study|Withdrawal by Subject|0|||
150261777|NCT01201317|542095580|FG002|Overall Study|Withdrawal by Subject|3|||
150261778|NCT01201317|542095578|FG000|Overall Study|Adverse Event|2|||
150261779|NCT01201317|542095579|FG001|Overall Study|Adverse Event|2|||
150261780|NCT01201317|542095580|FG002|Overall Study|Adverse Event|2|||
150261781|NCT01201317|542095578|FG000|Overall Study|Screen failure|1|||
150261782|NCT01201317|542095579|FG001|Overall Study|Screen failure|1|||
150261783|NCT01201317|542095580|FG002|Overall Study|Screen failure|0|||
150261784|NCT01201317|542095578|FG000|Overall Study|Protocol Violation|0|||
150261785|NCT01201317|542095579|FG001|Overall Study|Protocol Violation|1|||
150261786|NCT01201317|542095580|FG002|Overall Study|Protocol Violation|1|||
149819114|NCT00575328|540467194|FG000|Overall Study|Lost to Follow-up|2|||
150261787|NCT01201317|542095578|FG000|Overall Study|Death|0|||
150261788|NCT01201317|542095579|FG001|Overall Study|Death|1|||
150261789|NCT01201317|542095580|FG002|Overall Study|Death|0|||
150261790|NCT01201317|542095578|FG000|Overall Study|Study-specific withdrawal criteria|0|||
150261791|NCT01201317|542095579|FG001|Overall Study|Study-specific withdrawal criteria|0|||
150261792|NCT01201317|542095580|FG002|Overall Study|Study-specific withdrawal criteria|1|||
150261793|NCT01201317|542095578|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
150261794|NCT01201317|542095579|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
149819115|NCT00575328|540467195|FG001|Overall Study|Lost to Follow-up|1|||
149819116|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
150261795|NCT01201317|542095580|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
150261796|NCT01201317|542095578|FG000|Overall Study|Decrease in renal function|0|||
150261797|NCT01201317|542095579|FG001|Overall Study|Decrease in renal function|1|||
150261798|NCT01201317|542095580|FG002|Overall Study|Decrease in renal function|0|||
149925956|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
149925957|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
150162672|NCT03278028|541730151|FG001|Overall Study|Lost to Follow-up|0|||
150162673|NCT03278028|541730150|FG000|Overall Study|Withdrawal by Subject|3|||
150162674|NCT03278028|541730151|FG001|Overall Study|Withdrawal by Subject|1|||
150162675|NCT03278028|541730150|FG000|Overall Study|Pregnancy|0|||
150162676|NCT03278028|541730151|FG001|Overall Study|Pregnancy|1|||
150162677|NCT03635112|541730152|FG000|Overall Study|Adverse Event|5|||
150162678|NCT03635112|541730153|FG001|Overall Study|Adverse Event|9|||
150162679|NCT03635112|541730154|FG002|Overall Study|Adverse Event|14|||
150162680|NCT03635112|541730152|FG000|Overall Study|Lost to Follow-up|1|||
150162681|NCT03635112|541730153|FG001|Overall Study|Lost to Follow-up|0|||
150162682|NCT03635112|541730154|FG002|Overall Study|Lost to Follow-up|1|||
150162683|NCT03635112|541730152|FG000|Overall Study|Physician Decision|5|||
150162684|NCT03635112|541730153|FG001|Overall Study|Physician Decision|7|||
150162685|NCT03635112|541730154|FG002|Overall Study|Physician Decision|5|||
150162686|NCT03635112|541730152|FG000|Overall Study|Protocol Violation|0|||
150162687|NCT03635112|541730153|FG001|Overall Study|Protocol Violation|0|||
150162688|NCT03635112|541730154|FG002|Overall Study|Protocol Violation|1|||
150162689|NCT03635112|541730152|FG000|Overall Study|Study Terminated by Sponsor|11|||
150162690|NCT03635112|541730153|FG001|Overall Study|Study Terminated by Sponsor|17|||
150162691|NCT03635112|541730154|FG002|Overall Study|Study Terminated by Sponsor|21|||
150162692|NCT03635112|541730152|FG000|Overall Study|Withdrawal by Subject|4|||
150162693|NCT03635112|541730153|FG001|Overall Study|Withdrawal by Subject|9|||
150162694|NCT03635112|541730154|FG002|Overall Study|Withdrawal by Subject|7|||
150162695|NCT03635112|541730152|FG000|Overall Study|Miscellaneous|0|||
150162696|NCT03635112|541730153|FG001|Overall Study|Miscellaneous|0|||
150162697|NCT03635112|541730154|FG002|Overall Study|Miscellaneous|1|||
150162698|NCT03283553|541730158|FG000|Patient Participant Flow|Death|5|||
150162699|NCT03283553|541730159|FG001|Patient Participant Flow|Death|10|||
150162700|NCT03283553|541730158|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
150162701|NCT03283553|541730159|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
150162702|NCT03283553|541730158|FG000|Patient Participant Flow|Lost to Follow-up|1|||
150162703|NCT03283553|541730159|FG001|Patient Participant Flow|Lost to Follow-up|1|||
150162704|NCT03283553|541730158|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
150162705|NCT03283553|541730159|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
150162706|NCT03283553|541730158|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
150162707|NCT03283553|541730159|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
150162708|NCT03283553|541730158|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
150162709|NCT03283553|541730159|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
150162710|NCT03686683|541730160|FG000|Overall Study|Withdrawal by Subject|52|||
150162711|NCT03686683|541730161|FG001|Overall Study|Withdrawal by Subject|32|||
150162712|NCT03686683|541730160|FG000|Overall Study|Lost to Follow-up|23|||
150162713|NCT03686683|541730161|FG001|Overall Study|Lost to Follow-up|19|||
150162714|NCT03686683|541730160|FG000|Overall Study|Adverse Event|1|||
150162715|NCT03686683|541730161|FG001|Overall Study|Adverse Event|0|||
150162716|NCT03686683|541730160|FG000|Overall Study|Death|10|||
150162717|NCT03686683|541730161|FG001|Overall Study|Death|5|||
150162718|NCT03686683|541730160|FG000|Overall Study|Progressive Disease|1|||
150162719|NCT03686683|541730161|FG001|Overall Study|Progressive Disease|1|||
150162720|NCT03686683|541730160|FG000|Overall Study|Noncompliance|1|||
150162721|NCT03686683|541730161|FG001|Overall Study|Noncompliance|0|||
150162722|NCT03686683|541730160|FG000|Overall Study|Physician Decision|1|||
150162723|NCT03686683|541730161|FG001|Overall Study|Physician Decision|1|||
150162724|NCT03686683|541730160|FG000|Overall Study|Screen fail post-randomization|1|||
150162725|NCT03686683|541730161|FG001|Overall Study|Screen fail post-randomization|0|||
150162726|NCT03686683|541730160|FG000|Overall Study|Protocol Violation|3|||
150162727|NCT03686683|541730161|FG001|Overall Study|Protocol Violation|0|||
150162728|NCT03686683|541730160|FG000|Overall Study|No data available|1|||
150162729|NCT03686683|541730161|FG001|Overall Study|No data available|0|||
150162730|NCT03255941|541730162|FG000|Overall Study|Not eligible or refused injection|37|||
150162731|NCT03255941|541730163|FG001|Overall Study|Not eligible or refused injection|44|||
150162732|NCT03255941|541730164|FG002|Overall Study|Not eligible or refused injection|5|||
150162733|NCT03255941|541730165|FG003|Overall Study|Not eligible or refused injection|6|||
150162734|NCT03255941|541730162|FG000|Overall Study|Did not complete exit interview|1|||
150162735|NCT03255941|541730163|FG001|Overall Study|Did not complete exit interview|2|||
150162736|NCT03255941|541730164|FG002|Overall Study|Did not complete exit interview|0|||
150162737|NCT03255941|541730165|FG003|Overall Study|Did not complete exit interview|0|||
150162738|NCT00372060|541730166|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
150162739|NCT00372060|541730167|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
150162740|NCT00372060|541730166|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
150162741|NCT00372060|541730167|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
150162742|NCT00372060|541730166|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
150162743|NCT00372060|541730167|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
150162744|NCT00372060|541730166|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
150261799|NCT01201317|542095578|FG000|Overall Study|Lack of Efficacy|1|||
150261800|NCT01201317|542095579|FG001|Overall Study|Lack of Efficacy|0|||
150261801|NCT01201317|542095580|FG002|Overall Study|Lack of Efficacy|0|||
150261802|NCT01201317|542095578|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
150261803|NCT01201317|542095579|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
150261804|NCT01201317|542095580|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
150261805|NCT02079610|542095581|FG000|Overall Study|Withdrawal by Subject|1|||
150261806|NCT02079610|542095582|FG001|Overall Study|Withdrawal by Subject|1|||
150261807|NCT02080221|542095584|FG000|Overall Study|Withdrawal by Subject|1|||
150261808|NCT02080221|542095584|FG000|Overall Study|Clinical Progression of Disease|1|||
150261809|NCT03184870|542095588|FG000|Initial Treatment|Death|6|||
150261810|NCT03184870|542095589|FG001|Initial Treatment|Death|6|||
150261811|NCT03184870|542095590|FG002|Initial Treatment|Death|8|||
150261812|NCT03184870|542095591|FG003|Initial Treatment|Death|8|||
150261813|NCT03184870|542095592|FG004|Initial Treatment|Death|6|||
150261814|NCT03184870|542095593|FG005|Initial Treatment|Death|6|||
150261815|NCT03184870|542095594|FG006|Initial Treatment|Death|6|||
150261816|NCT03184870|542095595|FG007|Initial Treatment|Death|7|||
150261817|NCT03184870|542095596|FG008|Initial Treatment|Death|1|||
150261818|NCT03184870|542095597|FG009|Initial Treatment|Death|2|||
150261819|NCT03184870|542095598|FG010|Initial Treatment|Death|26|||
150261820|NCT03184870|542095599|FG011|Initial Treatment|Death|28|||
150261821|NCT03184870|542095600|FG012|Initial Treatment|Death|10|||
150261822|NCT03184870|542095601|FG013|Initial Treatment|Death|33|||
150261823|NCT03184870|542095602|FG014|Initial Treatment|Death|34|||
150261824|NCT03184870|542095603|FG015|Initial Treatment|Death|26|||
150261825|NCT03184870|542095604|FG016|Initial Treatment|Death|20|||
150261826|NCT03184870|542095605|FG017|Initial Treatment|Death|18|||
150261827|NCT03184870|542095588|FG000|Initial Treatment|Other Reasons|2|||
150261828|NCT03184870|542095589|FG001|Initial Treatment|Other Reasons|2|||
150261829|NCT03184870|542095590|FG002|Initial Treatment|Other Reasons|0|||
150261830|NCT03184870|542095591|FG003|Initial Treatment|Other Reasons|1|||
150261831|NCT03184870|542095592|FG004|Initial Treatment|Other Reasons|0|||
150261832|NCT03184870|542095593|FG005|Initial Treatment|Other Reasons|0|||
150261833|NCT03184870|542095594|FG006|Initial Treatment|Other Reasons|0|||
150261834|NCT03184870|542095595|FG007|Initial Treatment|Other Reasons|2|||
150261835|NCT03184870|542095596|FG008|Initial Treatment|Other Reasons|0|||
150261836|NCT03184870|542095597|FG009|Initial Treatment|Other Reasons|0|||
150261837|NCT03184870|542095598|FG010|Initial Treatment|Other Reasons|4|||
150261838|NCT03184870|542095599|FG011|Initial Treatment|Other Reasons|2|||
150261839|NCT03184870|542095600|FG012|Initial Treatment|Other Reasons|2|||
150261840|NCT03184870|542095601|FG013|Initial Treatment|Other Reasons|0|||
150261841|NCT03184870|542095602|FG014|Initial Treatment|Other Reasons|0|||
150261842|NCT03184870|542095603|FG015|Initial Treatment|Other Reasons|1|||
150261843|NCT03184870|542095604|FG016|Initial Treatment|Other Reasons|0|||
150261844|NCT03184870|542095605|FG017|Initial Treatment|Other Reasons|2|||
150261845|NCT03184870|542095588|FG000|Initial Treatment|Lost to Follow-up|2|||
150261846|NCT03184870|542095589|FG001|Initial Treatment|Lost to Follow-up|0|||
150261847|NCT03184870|542095590|FG002|Initial Treatment|Lost to Follow-up|0|||
150261848|NCT03184870|542095591|FG003|Initial Treatment|Lost to Follow-up|1|||
150261849|NCT03184870|542095592|FG004|Initial Treatment|Lost to Follow-up|1|||
150261850|NCT03184870|542095593|FG005|Initial Treatment|Lost to Follow-up|1|||
150261851|NCT03184870|542095594|FG006|Initial Treatment|Lost to Follow-up|0|||
150261852|NCT03184870|542095595|FG007|Initial Treatment|Lost to Follow-up|2|||
150261853|NCT03184870|542095596|FG008|Initial Treatment|Lost to Follow-up|0|||
150261854|NCT03184870|542095597|FG009|Initial Treatment|Lost to Follow-up|0|||
150261855|NCT03184870|542095598|FG010|Initial Treatment|Lost to Follow-up|2|||
150261856|NCT03184870|542095599|FG011|Initial Treatment|Lost to Follow-up|0|||
150261857|NCT03184870|542095600|FG012|Initial Treatment|Lost to Follow-up|2|||
150261858|NCT03184870|542095601|FG013|Initial Treatment|Lost to Follow-up|2|||
150261859|NCT03184870|542095602|FG014|Initial Treatment|Lost to Follow-up|0|||
150261860|NCT03184870|542095603|FG015|Initial Treatment|Lost to Follow-up|0|||
150261861|NCT03184870|542095604|FG016|Initial Treatment|Lost to Follow-up|2|||
150261862|NCT03184870|542095605|FG017|Initial Treatment|Lost to Follow-up|2|||
150261863|NCT03184870|542095588|FG000|Initial Treatment|Withdrawal by Subject|0|||
150261864|NCT03184870|542095589|FG001|Initial Treatment|Withdrawal by Subject|0|||
150261865|NCT03184870|542095590|FG002|Initial Treatment|Withdrawal by Subject|2|||
149819117|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
150261866|NCT03184870|542095591|FG003|Initial Treatment|Withdrawal by Subject|1|||
150261867|NCT03184870|542095592|FG004|Initial Treatment|Withdrawal by Subject|1|||
150261868|NCT03184870|542095593|FG005|Initial Treatment|Withdrawal by Subject|0|||
150261869|NCT03184870|542095594|FG006|Initial Treatment|Withdrawal by Subject|1|||
150261870|NCT03184870|542095595|FG007|Initial Treatment|Withdrawal by Subject|0|||
150261871|NCT03184870|542095596|FG008|Initial Treatment|Withdrawal by Subject|0|||
150261872|NCT03184870|542095597|FG009|Initial Treatment|Withdrawal by Subject|0|||
150261873|NCT03184870|542095598|FG010|Initial Treatment|Withdrawal by Subject|0|||
150261874|NCT03184870|542095599|FG011|Initial Treatment|Withdrawal by Subject|2|||
150261875|NCT03184870|542095600|FG012|Initial Treatment|Withdrawal by Subject|3|||
150261876|NCT03184870|542095601|FG013|Initial Treatment|Withdrawal by Subject|0|||
150261877|NCT03184870|542095602|FG014|Initial Treatment|Withdrawal by Subject|1|||
150261878|NCT03184870|542095603|FG015|Initial Treatment|Withdrawal by Subject|5|||
150261879|NCT03184870|542095604|FG016|Initial Treatment|Withdrawal by Subject|2|||
150261880|NCT03184870|542095605|FG017|Initial Treatment|Withdrawal by Subject|2|||
150261881|NCT03184870|542095588|FG000|Initial Treatment|Moved to crossover treatment|0|||
150261882|NCT03184870|542095589|FG001|Initial Treatment|Moved to crossover treatment|0|||
150261883|NCT03184870|542095590|FG002|Initial Treatment|Moved to crossover treatment|0|||
150261884|NCT03184870|542095591|FG003|Initial Treatment|Moved to crossover treatment|0|||
150261885|NCT03184870|542095592|FG004|Initial Treatment|Moved to crossover treatment|0|||
150261886|NCT03184870|542095593|FG005|Initial Treatment|Moved to crossover treatment|0|||
150261887|NCT03184870|542095594|FG006|Initial Treatment|Moved to crossover treatment|0|||
150261888|NCT03184870|542095595|FG007|Initial Treatment|Moved to crossover treatment|0|||
150261889|NCT03184870|542095596|FG008|Initial Treatment|Moved to crossover treatment|0|||
150261890|NCT03184870|542095597|FG009|Initial Treatment|Moved to crossover treatment|0|||
150261891|NCT03184870|542095598|FG010|Initial Treatment|Moved to crossover treatment|0|||
150261892|NCT03184870|542095599|FG011|Initial Treatment|Moved to crossover treatment|0|||
150261893|NCT03184870|542095600|FG012|Initial Treatment|Moved to crossover treatment|9|||
150261894|NCT03184870|542095601|FG013|Initial Treatment|Moved to crossover treatment|0|||
150261895|NCT03184870|542095602|FG014|Initial Treatment|Moved to crossover treatment|0|||
150261896|NCT03184870|542095603|FG015|Initial Treatment|Moved to crossover treatment|0|||
150261897|NCT03184870|542095604|FG016|Initial Treatment|Moved to crossover treatment|0|||
150261898|NCT03184870|542095605|FG017|Initial Treatment|Moved to crossover treatment|0|||
150261899|NCT03184870|542095588|FG000|Crossover Treatment|Other reasons|0|||
150261900|NCT03184870|542095589|FG001|Crossover Treatment|Other reasons|0|||
150261901|NCT03184870|542095590|FG002|Crossover Treatment|Other reasons|0|||
150261902|NCT03184870|542095591|FG003|Crossover Treatment|Other reasons|0|||
150261903|NCT03184870|542095592|FG004|Crossover Treatment|Other reasons|0|||
150261904|NCT03184870|542095593|FG005|Crossover Treatment|Other reasons|0|||
150261905|NCT03184870|542095594|FG006|Crossover Treatment|Other reasons|0|||
150261906|NCT03184870|542095595|FG007|Crossover Treatment|Other reasons|0|||
150261907|NCT03184870|542095596|FG008|Crossover Treatment|Other reasons|0|||
149819118|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
149819119|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
149819120|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
149819121|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
149819122|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
149819123|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
149819124|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
149819125|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
150261908|NCT03184870|542095597|FG009|Crossover Treatment|Other reasons|0|||
150261909|NCT03184870|542095598|FG010|Crossover Treatment|Other reasons|0|||
150261910|NCT03184870|542095599|FG011|Crossover Treatment|Other reasons|0|||
150261911|NCT03184870|542095600|FG012|Crossover Treatment|Other reasons|0|||
150261912|NCT03184870|542095601|FG013|Crossover Treatment|Other reasons|0|||
150261913|NCT03184870|542095602|FG014|Crossover Treatment|Other reasons|0|||
150261914|NCT03184870|542095603|FG015|Crossover Treatment|Other reasons|0|||
150261915|NCT03184870|542095604|FG016|Crossover Treatment|Other reasons|0|||
150261916|NCT03184870|542095605|FG017|Crossover Treatment|Other reasons|2|||
150261917|NCT03184870|542095588|FG000|Crossover Treatment|Death|0|||
150261918|NCT03184870|542095589|FG001|Crossover Treatment|Death|0|||
150261919|NCT03184870|542095590|FG002|Crossover Treatment|Death|0|||
150261920|NCT03184870|542095591|FG003|Crossover Treatment|Death|0|||
149819126|NCT00124449|540467200|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
149819127|NCT00124449|540467201|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
149819128|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
149819129|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
149819130|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
150261921|NCT03184870|542095592|FG004|Crossover Treatment|Death|0|||
150261922|NCT03184870|542095593|FG005|Crossover Treatment|Death|0|||
150261923|NCT03184870|542095594|FG006|Crossover Treatment|Death|0|||
150261924|NCT03184870|542095595|FG007|Crossover Treatment|Death|0|||
150261925|NCT03184870|542095596|FG008|Crossover Treatment|Death|0|||
150261926|NCT03184870|542095597|FG009|Crossover Treatment|Death|0|||
150261927|NCT03184870|542095598|FG010|Crossover Treatment|Death|0|||
150261928|NCT03184870|542095599|FG011|Crossover Treatment|Death|0|||
150261929|NCT03184870|542095600|FG012|Crossover Treatment|Death|0|||
150261930|NCT03184870|542095601|FG013|Crossover Treatment|Death|0|||
150261931|NCT03184870|542095602|FG014|Crossover Treatment|Death|0|||
150261932|NCT03184870|542095603|FG015|Crossover Treatment|Death|0|||
150261933|NCT03184870|542095604|FG016|Crossover Treatment|Death|0|||
150261934|NCT03184870|542095605|FG017|Crossover Treatment|Death|7|||
150261935|NCT00250679|542095609|FG000|Overall Study|Adverse Event|12|||
150261936|NCT00250679|542095610|FG001|Overall Study|Adverse Event|15|||
150261937|NCT00250679|542095611|FG002|Overall Study|Adverse Event|16|||
150261938|NCT00250679|542095609|FG000|Overall Study|Protocol Violation|2|||
150261939|NCT00250679|542095610|FG001|Overall Study|Protocol Violation|4|||
150261940|NCT00250679|542095611|FG002|Overall Study|Protocol Violation|3|||
150261941|NCT00250679|542095609|FG000|Overall Study|Withdrawal by Subject|15|||
150261942|NCT00250679|542095610|FG001|Overall Study|Withdrawal by Subject|18|||
150261943|NCT00250679|542095611|FG002|Overall Study|Withdrawal by Subject|15|||
150261944|NCT00250679|542095609|FG000|Overall Study|Lost to Follow-up|3|||
150261945|NCT00250679|542095610|FG001|Overall Study|Lost to Follow-up|4|||
150261946|NCT00250679|542095611|FG002|Overall Study|Lost to Follow-up|2|||
150261947|NCT00250679|542095609|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
150261948|NCT00250679|542095610|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
150261949|NCT00250679|542095611|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
150261950|NCT00250679|542095609|FG000|Overall Study|Lack of Efficacy|0|||
150261951|NCT00250679|542095610|FG001|Overall Study|Lack of Efficacy|1|||
150261952|NCT00250679|542095611|FG002|Overall Study|Lack of Efficacy|3|||
150261953|NCT00250679|542095609|FG000|Overall Study|Technical Holter issues|1|||
150261954|NCT00250679|542095610|FG001|Overall Study|Technical Holter issues|0|||
150261955|NCT00250679|542095611|FG002|Overall Study|Technical Holter issues|2|||
150261956|NCT00250679|542095609|FG000|Overall Study|Moved|1|||
150261957|NCT00250679|542095610|FG001|Overall Study|Moved|1|||
150261958|NCT00250679|542095611|FG002|Overall Study|Moved|0|||
150261959|NCT00250679|542095609|FG000|Overall Study|Non-compliance|1|||
150261960|NCT00250679|542095610|FG001|Overall Study|Non-compliance|1|||
150261961|NCT00250679|542095611|FG002|Overall Study|Non-compliance|0|||
150261962|NCT00250679|542095609|FG000|Overall Study|various single events: hip surgery,diary|3|||
150261963|NCT00250679|542095610|FG001|Overall Study|various single events: hip surgery,diary|1|||
150261964|NCT00250679|542095611|FG002|Overall Study|various single events: hip surgery,diary|1|||
150261965|NCT00448279|542095612|FG000|Overall Study|Lost to Follow-up|2|||
150261966|NCT00448279|542095613|FG001|Overall Study|Lost to Follow-up|2|||
150261967|NCT00448279|542095612|FG000|Overall Study|Adverse Event|1|||
150261968|NCT00448279|542095613|FG001|Overall Study|Adverse Event|1|||
150261969|NCT00448279|542095612|FG000|Overall Study|Disease progression|16|||
150261970|NCT00448279|542095613|FG001|Overall Study|Disease progression|18|||
150261971|NCT00448279|542095612|FG000|Overall Study|Withdrawal by Subject|4|||
150261972|NCT00448279|542095613|FG001|Overall Study|Withdrawal by Subject|3|||
150261973|NCT00448279|542095612|FG000|Overall Study|Other|6|||
150261974|NCT00448279|542095613|FG001|Overall Study|Other|4|||
150261975|NCT00448279|542095612|FG000|Overall Study|Protocol Violation|0|||
150261976|NCT00448279|542095613|FG001|Overall Study|Protocol Violation|1|||
150261977|NCT03907410|542095614|FG000|Overall Study|Lost to Follow-up|4|||
150261978|NCT03907410|542095615|FG001|Overall Study|Lost to Follow-up|1|||
150261979|NCT03907410|542095616|FG002|Overall Study|Lost to Follow-up|1|||
150261980|NCT03907410|542095614|FG000|Overall Study|Lost to follow-up and research burden|0|||
150261981|NCT03907410|542095615|FG001|Overall Study|Lost to follow-up and research burden|0|||
150261982|NCT03907410|542095616|FG002|Overall Study|Lost to follow-up and research burden|1|||
150261983|NCT04776148|542095617|FG000|Overall Study|Death|249|||
150261984|NCT04776148|542095618|FG001|Overall Study|Death|260|||
150261985|NCT04776148|542095617|FG000|Overall Study|Lost to Follow-up|0|||
150261986|NCT04776148|542095618|FG001|Overall Study|Lost to Follow-up|1|||
150261987|NCT04776148|542095617|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150261988|NCT04776148|542095618|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149819131|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
149819132|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
149819133|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
149819134|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
149819135|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
149819136|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
149819137|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
149819138|NCT00124449|540467200|FG000|18-Month Untreated Observation Period|Relocated|1|||
149819139|NCT00124449|540467201|FG001|18-Month Untreated Observation Period|Relocated|0|||
149819140|NCT01504867|540467202|FG000|Overall Study|Inclusion criteria not met|2|||
149819141|NCT01504867|540467203|FG001|Overall Study|Inclusion criteria not met|2|||
149819142|NCT01504867|540467202|FG000|Overall Study|Consent revoked|5|||
149819143|NCT01504867|540467203|FG001|Overall Study|Consent revoked|1|||
149819144|NCT00571922|540467204|FG000|Overall Study|Completion unknown|36|||
149819145|NCT00571922|540467205|FG001|Overall Study|Completion unknown|36|||
149819146|NCT03210259|540467212|FG000|12-Week Run-in Period|Adverse Event|1|||
150261989|NCT04776148|542095617|FG000|Overall Study|Withdrawal by Subject|3|||
150261990|NCT04776148|542095618|FG001|Overall Study|Withdrawal by Subject|4|||
150261991|NCT04776148|542095617|FG000|Overall Study|Sponsor Decision|30|||
150261992|NCT04776148|542095618|FG001|Overall Study|Sponsor Decision|15|||
150261993|NCT00666679|542095622|FG000|First Intervention|Lost to Follow-up|1|||
150261994|NCT00666679|542095623|FG001|First Intervention|Lost to Follow-up|0|||
150261995|NCT00666679|542095622|FG000|First Intervention|Protocol Violation|1|||
150261996|NCT00666679|542095623|FG001|First Intervention|Protocol Violation|0|||
150261997|NCT00666679|542095622|FG000|First Intervention|Withdrawal by Subject|1|||
150261998|NCT00666679|542095623|FG001|First Intervention|Withdrawal by Subject|0|||
150261999|NCT00666679|542095622|FG000|First Intervention|Randomized did not start treatment|1|||
150262000|NCT00666679|542095623|FG001|First Intervention|Randomized did not start treatment|1|||
150262001|NCT00666679|542095622|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
150262002|NCT00666679|542095623|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
150262003|NCT00666679|542095622|FG000|Washout Period of 1 Week|Protocol Violation|0|||
150262004|NCT00666679|542095623|FG001|Washout Period of 1 Week|Protocol Violation|1|||
150262005|NCT00666679|542095622|FG000|Second Intervention|Adverse Event|1|||
150262006|NCT00666679|542095623|FG001|Second Intervention|Adverse Event|0|||
150262007|NCT00666679|542095622|FG000|Second Intervention|Death|0|||
150262008|NCT00666679|542095623|FG001|Second Intervention|Death|1|||
150262009|NCT04882995|542095626|FG000|Overall Study|Withdrawal by Subject|1|||
150262010|NCT04882995|542095627|FG001|Overall Study|Withdrawal by Subject|2|||
150262011|NCT04882995|542095626|FG000|Overall Study|Protocol Violation|4|||
150262012|NCT04882995|542095627|FG001|Overall Study|Protocol Violation|4|||
150262013|NCT04882995|542095626|FG000|Overall Study|Surgery postponed due to COVID|1|||
150262014|NCT04882995|542095627|FG001|Overall Study|Surgery postponed due to COVID|1|||
150262015|NCT04371198|542095628|FG000|Overall Study|inadequate sample|4|||
150262016|NCT00655486|542095633|FG000|Overall Study|Adverse Event|10|||
150262017|NCT00655486|542095633|FG000|Overall Study|Lack of Efficacy|8|||
150262018|NCT00655486|542095633|FG000|Overall Study|Withdrawal by Subject|4|||
150262019|NCT00655486|542095633|FG000|Overall Study|Protocol Violation|1|||
150262020|NCT00655486|542095633|FG000|Overall Study|Unsatisfactory compliance|2|||
150262021|NCT00655486|542095633|FG000|Overall Study|Other: Pregnancy|1|||
150262022|NCT00655486|542095633|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
150262023|NCT00655486|542095633|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
150262024|NCT00440999|542095644|FG000|Overall Study|Adverse Event|0|||
150262025|NCT00440999|542095645|FG001|Overall Study|Adverse Event|2|||
150262026|NCT00440999|542095644|FG000|Overall Study|Lack of Efficacy|6|||
150262027|NCT00440999|542095645|FG001|Overall Study|Lack of Efficacy|7|||
150262028|NCT00440999|542095644|FG000|Overall Study|Lost to Follow-up|19|||
150262029|NCT00440999|542095645|FG001|Overall Study|Lost to Follow-up|12|||
150262030|NCT00440999|542095644|FG000|Overall Study|Protocol Violation|1|||
150262031|NCT00440999|542095645|FG001|Overall Study|Protocol Violation|0|||
150262032|NCT00440999|542095644|FG000|Overall Study|Withdrawal by Subject|2|||
150262033|NCT00440999|542095645|FG001|Overall Study|Withdrawal by Subject|5|||
150262034|NCT00440999|542095644|FG000|Overall Study|Subjets missed the visit|1|||
150262035|NCT00440999|542095645|FG001|Overall Study|Subjets missed the visit|0|||
150262036|NCT00440999|542095644|FG000|Overall Study|Mixed infection at entry|1|||
150262037|NCT00440999|542095645|FG001|Overall Study|Mixed infection at entry|0|||
150262038|NCT00440999|542095644|FG000|Overall Study|P. falciparum malaria|5|||
150262039|NCT00440999|542095645|FG001|Overall Study|P. falciparum malaria|14|||
150262040|NCT00440999|542095644|FG000|Overall Study|Subj left hosp without inform staff|0|||
150262041|NCT00440999|542095645|FG001|Overall Study|Subj left hosp without inform staff|1|||
150262042|NCT04218084|542095646|FG000|Overall Study|Adverse Event|7|||
150262043|NCT04218084|542095647|FG001|Overall Study|Adverse Event|2|||
150262044|NCT04218084|542095646|FG000|Overall Study|Withdrawal of Consent|4|||
150262045|NCT04218084|542095647|FG001|Overall Study|Withdrawal of Consent|5|||
150262046|NCT04218084|542095646|FG000|Overall Study|Physician Decision|1|||
150262047|NCT04218084|542095647|FG001|Overall Study|Physician Decision|1|||
150262048|NCT04218084|542095646|FG000|Overall Study|Lost to Follow-up|1|||
150262049|NCT04218084|542095647|FG001|Overall Study|Lost to Follow-up|1|||
150262050|NCT04218084|542095646|FG000|Overall Study|Non-compliance with study drug|1|||
150262051|NCT04218084|542095647|FG001|Overall Study|Non-compliance with study drug|1|||
150162745|NCT00372060|541730167|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
150162746|NCT00372060|541730166|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
150162747|NCT00372060|541730167|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
150162748|NCT00372060|541730166|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
150162749|NCT00372060|541730167|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
150162750|NCT01579578|541730179|FG000|Overall Study|Death|4|||
150162751|NCT01579578|541730180|FG001|Overall Study|Death|1|||
150162752|NCT01579578|541730179|FG000|Overall Study|Lost to Follow-up|1|||
150162753|NCT01579578|541730180|FG001|Overall Study|Lost to Follow-up|1|||
150162754|NCT01579578|541730179|FG000|Overall Study|Withdrawal by Subject|2|||
150262052|NCT04218084|542095646|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
150262053|NCT04218084|542095647|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
150262054|NCT04218084|542095646|FG000|Overall Study|Other|0|||
150262055|NCT04218084|542095647|FG001|Overall Study|Other|1|||
150262056|NCT04218084|542095646|FG000|Overall Study|Ongoing at data cut-off date|62|||
150262057|NCT04218084|542095647|FG001|Overall Study|Ongoing at data cut-off date|58|||
150262058|NCT01100034|542095648|FG000|Overall Study|Lost to Follow-up|11|||
150262059|NCT01100034|542095648|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
150262060|NCT01100034|542095648|FG000|Overall Study|Withdrawal by Subject|4|||
149925958|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
149925959|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
150262061|NCT01100034|542095648|FG000|Overall Study|Sponsor decision|21|||
150262062|NCT01100034|542095648|FG000|Overall Study|Participated in another clinical trial|1|||
150262063|NCT01100034|542095648|FG000|Overall Study|Participants moved to another hospital|4|||
150262064|NCT01100034|542095648|FG000|Overall Study|Site closed due to non-responsiveness|1|||
150262065|NCT00836095|542095655|FG000|Overall Study|Physician Decision|0|||
150262066|NCT00836095|542095656|FG001|Overall Study|Physician Decision|3|||
150262067|NCT01602562|542095658|FG000|Overall Study|Adverse Event|3|||
150262068|NCT01602562|542095659|FG001|Overall Study|Adverse Event|1|||
150262069|NCT01602562|542095658|FG000|Overall Study|Physician Decision|1|||
150262070|NCT01602562|542095659|FG001|Overall Study|Physician Decision|1|||
150262071|NCT01602562|542095658|FG000|Overall Study|Withdrawal by Subject|1|||
150262072|NCT01602562|542095659|FG001|Overall Study|Withdrawal by Subject|1|||
150262073|NCT04964414|542095660|FG000|Overall Study|Lost to Follow-up|10|||
150262074|NCT04964414|542095661|FG001|Overall Study|Lost to Follow-up|8|||
150262075|NCT04964414|542095660|FG000|Overall Study|Withdrawal by Subject|1|||
150262076|NCT04964414|542095661|FG001|Overall Study|Withdrawal by Subject|1|||
150262077|NCT01718353|542095662|FG000|Overall Study|Lost to Follow-up|0|||
150262078|NCT01718353|542095663|FG001|Overall Study|Lost to Follow-up|1|||
150262079|NCT01718353|542095662|FG000|Overall Study|Principal Investigator's Decision|10|||
150262080|NCT01718353|542095663|FG001|Overall Study|Principal Investigator's Decision|4|||
150262081|NCT01718353|542095662|FG000|Overall Study|Randomized but not treated|2|||
150262082|NCT01718353|542095663|FG001|Overall Study|Randomized but not treated|0|||
150262083|NCT03333837|542095674|FG000|Overall Study|Adverse Event|2|||
150262084|NCT03333837|542095675|FG001|Overall Study|Adverse Event|1|||
150262085|NCT03333837|542095676|FG002|Overall Study|Adverse Event|1|||
149925960|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
149925961|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
149925962|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
149925963|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
149925964|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
149925965|NCT01990768|540863278|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
149925966|NCT01990768|540863279|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
149925967|NCT01990768|540863280|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
149925968|NCT01990768|540863278|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
149925969|NCT01990768|540863279|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
149925970|NCT01990768|540863280|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
149925971|NCT01990768|540863278|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
150262086|NCT03333837|542095677|FG003|Overall Study|Adverse Event|1|||
150262087|NCT03333837|542095678|FG004|Overall Study|Adverse Event|0|||
150262088|NCT03333837|542095674|FG000|Overall Study|Caregiver withdrew|0|||
150262089|NCT03333837|542095675|FG001|Overall Study|Caregiver withdrew|2|||
150262090|NCT03333837|542095676|FG002|Overall Study|Caregiver withdrew|1|||
150262091|NCT03333837|542095677|FG003|Overall Study|Caregiver withdrew|0|||
149925972|NCT01990768|540863279|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
149925973|NCT01990768|540863280|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
149925974|NCT01990768|540863278|FG000|6-Month Follow-up|No contact information|5|||
150162755|NCT01579578|541730180|FG001|Overall Study|Withdrawal by Subject|1|||
150162756|NCT01579578|541730179|FG000|Overall Study|Eligibility criteria|3|||
150162757|NCT01579578|541730180|FG001|Overall Study|Eligibility criteria|9|||
150162758|NCT01579578|541730179|FG000|Overall Study|Ongoing|3|||
150162759|NCT01579578|541730180|FG001|Overall Study|Ongoing|0|||
150162760|NCT03432533|541730181|FG000|Overall Study|Lost to Follow-up|1|||
150162761|NCT03432533|541730182|FG001|Overall Study|Lost to Follow-up|2|||
150162762|NCT03432533|541730181|FG000|Overall Study|Withdrawal by Subject|14|||
150162763|NCT03432533|541730182|FG001|Overall Study|Withdrawal by Subject|9|||
150162764|NCT01648283|541730183|FG000|Overall Study|Withdrawal by Subject|14|||
150162765|NCT00916006|541730189|FG000|Overall Study|Adverse Event|1|||
150162766|NCT00916006|541730190|FG001|Overall Study|Adverse Event|1|||
150162767|NCT00916006|541730189|FG000|Overall Study|Withdrawal by Subject|2|||
150162768|NCT00916006|541730190|FG001|Overall Study|Withdrawal by Subject|5|||
150162769|NCT00916006|541730189|FG000|Overall Study|Protocol Violation|0|||
150162770|NCT00916006|541730190|FG001|Overall Study|Protocol Violation|1|||
150162771|NCT02487446|541730196|FG000|Period 1|Physician Decision|0|||
150162772|NCT02487446|541730197|FG001|Period 1|Physician Decision|1|||
149925975|NCT01990768|540863279|FG001|6-Month Follow-up|No contact information|6|||
150162773|NCT02487446|541730196|FG000|Period 1|Lack of Efficacy|1|||
150162774|NCT02487446|541730197|FG001|Period 1|Lack of Efficacy|0|||
150162775|NCT02487446|541730196|FG000|Period 1|Protocol deviation|3|||
150162776|NCT02487446|541730197|FG001|Period 1|Protocol deviation|2|||
150262092|NCT03333837|542095678|FG004|Overall Study|Caregiver withdrew|0|||
150262093|NCT03333837|542095674|FG000|Overall Study|Withdrawal by Subject|0|||
150162777|NCT02487446|541730196|FG000|Period 1|Lost to Follow-up|2|||
150262094|NCT03333837|542095675|FG001|Overall Study|Withdrawal by Subject|0|||
150262095|NCT03333837|542095676|FG002|Overall Study|Withdrawal by Subject|1|||
150262096|NCT03333837|542095677|FG003|Overall Study|Withdrawal by Subject|1|||
150262097|NCT03333837|542095678|FG004|Overall Study|Withdrawal by Subject|3|||
150262098|NCT03333837|542095674|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
150262099|NCT03333837|542095675|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
150262100|NCT03333837|542095676|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
150262101|NCT03333837|542095677|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
150262102|NCT03333837|542095678|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
150262103|NCT03519971|542095682|FG000|Overall Study|Death|142|||
150262104|NCT03519971|542095683|FG001|Overall Study|Death|69|||
149925976|NCT01990768|540863280|FG002|6-Month Follow-up|No contact information|5|||
150262105|NCT03519971|542095682|FG000|Overall Study|Lost to Follow-up|0|||
150262106|NCT03519971|542095683|FG001|Overall Study|Lost to Follow-up|1|||
150262107|NCT03519971|542095682|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
150262108|NCT03519971|542095683|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
150262109|NCT03519971|542095682|FG000|Overall Study|Withdrawal by Subject|3|||
150262110|NCT03519971|542095683|FG001|Overall Study|Withdrawal by Subject|2|||
150262111|NCT03519971|542095682|FG000|Overall Study|Other|1|||
150262112|NCT03519971|542095683|FG001|Overall Study|Other|0|||
150262113|NCT06729606|542095686|FG000|Overall Study|Adverse Event|0|||
150262114|NCT06729606|542095687|FG001|Overall Study|Adverse Event|2|||
150262115|NCT06729606|542095686|FG000|Overall Study|Death|1|||
150262116|NCT06729606|542095687|FG001|Overall Study|Death|0|||
150262117|NCT06729606|542095686|FG000|Overall Study|Physician Decision|0|||
150262118|NCT06729606|542095687|FG001|Overall Study|Physician Decision|1|||
150262119|NCT06729606|542095686|FG000|Overall Study|Withdrawal by Subject|2|||
150262120|NCT06729606|542095687|FG001|Overall Study|Withdrawal by Subject|4|||
150262121|NCT00409773|542097622|FG000|Overall Study|Adverse Event|3|||
150262122|NCT00409773|542097623|FG001|Overall Study|Adverse Event|4|||
150262123|NCT00409773|542097624|FG002|Overall Study|Adverse Event|4|||
150262124|NCT00409773|542097625|FG003|Overall Study|Adverse Event|2|||
150262125|NCT00409773|542097626|FG004|Overall Study|Adverse Event|6|||
150262126|NCT00409773|542097622|FG000|Overall Study|Lost to Follow-up|6|||
150262127|NCT00409773|542097623|FG001|Overall Study|Lost to Follow-up|1|||
150262128|NCT00409773|542097624|FG002|Overall Study|Lost to Follow-up|2|||
150262129|NCT00409773|542097625|FG003|Overall Study|Lost to Follow-up|3|||
150262130|NCT00409773|542097626|FG004|Overall Study|Lost to Follow-up|1|||
150262131|NCT00409773|542097622|FG000|Overall Study|Physician Decision|0|||
150262132|NCT00409773|542097623|FG001|Overall Study|Physician Decision|0|||
150262133|NCT00409773|542097624|FG002|Overall Study|Physician Decision|0|||
150262134|NCT00409773|542097625|FG003|Overall Study|Physician Decision|2|||
150262135|NCT00409773|542097626|FG004|Overall Study|Physician Decision|0|||
150262136|NCT00409773|542097622|FG000|Overall Study|Protocol Violation|0|||
150262137|NCT00409773|542097623|FG001|Overall Study|Protocol Violation|2|||
150262138|NCT00409773|542097624|FG002|Overall Study|Protocol Violation|3|||
150262139|NCT00409773|542097625|FG003|Overall Study|Protocol Violation|3|||
150262140|NCT00409773|542097626|FG004|Overall Study|Protocol Violation|1|||
150262141|NCT00409773|542097622|FG000|Overall Study|Withdrawal by Subject|0|||
150262142|NCT00409773|542097623|FG001|Overall Study|Withdrawal by Subject|0|||
150262143|NCT00409773|542097624|FG002|Overall Study|Withdrawal by Subject|0|||
150262144|NCT00409773|542097625|FG003|Overall Study|Withdrawal by Subject|2|||
150262145|NCT00409773|542097626|FG004|Overall Study|Withdrawal by Subject|1|||
150262146|NCT00409773|542097622|FG000|Overall Study|Lack of Eligibility|0|||
149925977|NCT01990768|540863278|FG000|6-Month Follow-up|Homeless|4|||
149925978|NCT01990768|540863279|FG001|6-Month Follow-up|Homeless|3|||
149925979|NCT01990768|540863280|FG002|6-Month Follow-up|Homeless|6|||
149925980|NCT01990768|540863278|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
149925981|NCT01990768|540863279|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
149925982|NCT01990768|540863280|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
149925983|NCT01990768|540863278|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
149925984|NCT01990768|540863279|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
149925985|NCT01990768|540863280|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
149925986|NCT01990768|540863278|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
149925987|NCT01990768|540863279|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
149925988|NCT01990768|540863280|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
149925989|NCT00154375|540863281|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
150262147|NCT00409773|542097623|FG001|Overall Study|Lack of Eligibility|0|||
150262148|NCT00409773|542097624|FG002|Overall Study|Lack of Eligibility|0|||
150262149|NCT00409773|542097625|FG003|Overall Study|Lack of Eligibility|0|||
150262150|NCT00409773|542097626|FG004|Overall Study|Lack of Eligibility|1|||
150262151|NCT02401867|542097628|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
150262152|NCT02401867|542097628|FG000|Analysis|Cervical assay could not be conducted|9|||
150262153|NCT02795429|542097638|FG000|Overall Study|Adverse Event|1|||
150262154|NCT02795429|542097639|FG001|Overall Study|Adverse Event|2|||
150262155|NCT02795429|542097640|FG002|Overall Study|Adverse Event|1|||
150262156|NCT02795429|542097641|FG003|Overall Study|Adverse Event|2|||
150262157|NCT02795429|542097642|FG004|Overall Study|Adverse Event|1|||
149925990|NCT00154375|540863282|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
150262158|NCT02795429|542097638|FG000|Overall Study|Death|1|||
150262159|NCT02795429|542097639|FG001|Overall Study|Death|0|||
150262160|NCT02795429|542097640|FG002|Overall Study|Death|1|||
150262161|NCT02795429|542097641|FG003|Overall Study|Death|2|||
150262162|NCT02795429|542097642|FG004|Overall Study|Death|1|||
150262163|NCT02795429|542097638|FG000|Overall Study|Physician Decision|0|||
150262164|NCT02795429|542097639|FG001|Overall Study|Physician Decision|0|||
150262165|NCT02795429|542097640|FG002|Overall Study|Physician Decision|2|||
150262166|NCT02795429|542097641|FG003|Overall Study|Physician Decision|1|||
150262167|NCT02795429|542097642|FG004|Overall Study|Physician Decision|5|||
150262168|NCT02795429|542097638|FG000|Overall Study|Progressive disease|3|||
150262169|NCT02795429|542097639|FG001|Overall Study|Progressive disease|7|||
150262170|NCT02795429|542097640|FG002|Overall Study|Progressive disease|6|||
150262171|NCT02795429|542097641|FG003|Overall Study|Progressive disease|26|||
150262172|NCT02795429|542097642|FG004|Overall Study|Progressive disease|20|||
150262173|NCT02795429|542097638|FG000|Overall Study|Subject/guardian decision|1|||
150262174|NCT02795429|542097639|FG001|Overall Study|Subject/guardian decision|1|||
150262175|NCT02795429|542097640|FG002|Overall Study|Subject/guardian decision|1|||
150262176|NCT02795429|542097641|FG003|Overall Study|Subject/guardian decision|1|||
150262177|NCT02795429|542097642|FG004|Overall Study|Subject/guardian decision|3|||
150262178|NCT05220254|542097645|FG000|Overall Study|Withdrawal by Subject|4|||
150262179|NCT05220254|542097645|FG000|Overall Study|Removed due to ineligibility|1|||
150262180|NCT05220254|542097645|FG000|Overall Study|Lost to Follow-up|7|||
150262181|NCT03786783|542097648|FG000|Overall Study|Death|1|||
150262182|NCT03786783|542097648|FG000|Overall Study|Physician Decision|6|||
150262183|NCT03786783|542097648|FG000|Overall Study|Withdrawal by Subject|2|||
150262184|NCT03786783|542097648|FG000|Overall Study|Disease Progression|7|||
150262185|NCT03786783|542097648|FG000|Overall Study|Patient/Parent Refusal|4|||
150262186|NCT04363801|542097649|FG000|Overall Study|Death|18|||
150262187|NCT04363801|542097650|FG001|Overall Study|Death|14|||
150262188|NCT04363801|542097651|FG002|Overall Study|Death|16|||
150262189|NCT04363801|542097652|FG003|Overall Study|Death|48|||
150262190|NCT04363801|542097653|FG004|Overall Study|Death|38|||
150262191|NCT04363801|542097649|FG000|Overall Study|Withdrawal by Subject|1|||
150262192|NCT04363801|542097650|FG001|Overall Study|Withdrawal by Subject|6|||
150262193|NCT04363801|542097651|FG002|Overall Study|Withdrawal by Subject|1|||
150262194|NCT04363801|542097652|FG003|Overall Study|Withdrawal by Subject|4|||
150262195|NCT04363801|542097653|FG004|Overall Study|Withdrawal by Subject|14|||
150262196|NCT04363801|542097649|FG000|Overall Study|Sponsor Decision|6|||
150262197|NCT04363801|542097650|FG001|Overall Study|Sponsor Decision|4|||
150262198|NCT04363801|542097651|FG002|Overall Study|Sponsor Decision|10|||
150262199|NCT04363801|542097652|FG003|Overall Study|Sponsor Decision|33|||
150262200|NCT04363801|542097653|FG004|Overall Study|Sponsor Decision|32|||
150262201|NCT04363801|542097649|FG000|Overall Study|Lost to Follow-up|0|||
150262202|NCT04363801|542097650|FG001|Overall Study|Lost to Follow-up|0|||
150262203|NCT04363801|542097651|FG002|Overall Study|Lost to Follow-up|1|||
150262204|NCT04363801|542097652|FG003|Overall Study|Lost to Follow-up|0|||
150262205|NCT04363801|542097653|FG004|Overall Study|Lost to Follow-up|1|||
150262206|NCT04754477|542097654|FG000|Overall Study|Withdrawal by Subject|1|||
150262207|NCT05041101|542097655|FG000|Overall Study|Adverse Event|1|||
150262208|NCT05041101|542097656|FG001|Overall Study|Adverse Event|0|||
150262209|NCT05041101|542097657|FG002|Overall Study|Adverse Event|0|||
150262210|NCT05041101|542097655|FG000|Overall Study|Diease Progression|5|||
150262211|NCT05041101|542097656|FG001|Overall Study|Diease Progression|0|||
150262212|NCT05041101|542097657|FG002|Overall Study|Diease Progression|0|||
150262213|NCT00249002|542097658|FG000|Overall Study|Adverse Event|2|||
150262214|NCT00249002|542097658|FG000|Overall Study|Study cancellation|3|||
150262215|NCT00249002|542097658|FG000|Overall Study|Other|2|||
150262216|NCT00069108|542097659|FG000|Overall Study|Withdrawal by Subject|5|||
150262217|NCT00069108|542097660|FG001|Overall Study|Withdrawal by Subject|9|||
150262218|NCT00069108|542097659|FG000|Overall Study|Adverse Event|64|||
150262219|NCT00069108|542097660|FG001|Overall Study|Adverse Event|42|||
150262220|NCT00069108|542097659|FG000|Overall Study|Death|6|||
150262221|NCT00069108|542097660|FG001|Overall Study|Death|6|||
150262222|NCT00069108|542097659|FG000|Overall Study|Administration|15|||
150262223|NCT00069108|542097660|FG001|Overall Study|Administration|4|||
150262224|NCT00069108|542097659|FG000|Overall Study|Insufficient therapy|117|||
150262225|NCT00069108|542097660|FG001|Overall Study|Insufficient therapy|144|||
150262226|NCT00069108|542097659|FG000|Overall Study|Violation criteria|1|||
150262227|NCT00069108|542097660|FG001|Overall Study|Violation criteria|4|||
150262228|NCT00069108|542097659|FG000|Overall Study|Refused treatment|5|||
150262229|NCT00069108|542097660|FG001|Overall Study|Refused treatment|10|||
150262230|NCT01853137|542097661|FG000|Overall Study|Lost to Follow-up|4|||
150262231|NCT01853137|542097662|FG001|Overall Study|Lost to Follow-up|1|||
150262232|NCT03401229|542097663|FG000|Overall Study|Lost to Follow-up|2|||
150262233|NCT03401229|542097664|FG001|Overall Study|Lost to Follow-up|1|||
150262234|NCT03401229|542097663|FG000|Overall Study|Other|1|||
150262235|NCT03401229|542097664|FG001|Overall Study|Other|3|||
150262236|NCT03401229|542097663|FG000|Overall Study|Adverse Event|8|||
150262237|NCT03401229|542097664|FG001|Overall Study|Adverse Event|6|||
150262238|NCT03401229|542097663|FG000|Overall Study|Withdrawal by Subject|29|||
150262239|NCT03401229|542097664|FG001|Overall Study|Withdrawal by Subject|26|||
150262240|NCT03401229|542097663|FG000|Overall Study|COVID-19|0|||
150262241|NCT03401229|542097664|FG001|Overall Study|COVID-19|1|||
150262242|NCT00690820|542097665|FG000|Period 1|Withdrawal by Subject|0|||
150262243|NCT00690820|542097666|FG001|Period 1|Withdrawal by Subject|1|||
150262244|NCT05333224|542097667|FG000|Overall Study - Infants|Lost to Follow-up|1|||
150262245|NCT05333224|542097668|FG001|Overall Study - Infants|Lost to Follow-up|1|||
150262246|NCT01411215|542097670|FG000|Overall Study|Adverse Event|1|||
150262247|NCT01411215|542097671|FG001|Overall Study|Adverse Event|2|||
150262248|NCT01411215|542097670|FG000|Overall Study|Lack of Efficacy|2|||
150262249|NCT01411215|542097671|FG001|Overall Study|Lack of Efficacy|4|||
150262250|NCT01411215|542097670|FG000|Overall Study|Lost to Follow-up|12|||
150262251|NCT01411215|542097671|FG001|Overall Study|Lost to Follow-up|18|||
150262252|NCT01411215|542097670|FG000|Overall Study|Did not meet entrance criteria|0|||
150262253|NCT01411215|542097671|FG001|Overall Study|Did not meet entrance criteria|1|||
150262254|NCT01411215|542097670|FG000|Overall Study|Study terminated by sponsor|2|||
150262255|NCT01411215|542097671|FG001|Overall Study|Study terminated by sponsor|15|||
150262256|NCT01411215|542097670|FG000|Overall Study|Protocol Violation|3|||
150262257|NCT01411215|542097671|FG001|Overall Study|Protocol Violation|5|||
150262258|NCT01411215|542097670|FG000|Overall Study|Withdrawal by Subject|34|||
150262259|NCT01411215|542097671|FG001|Overall Study|Withdrawal by Subject|21|||
150262260|NCT01411215|542097670|FG000|Overall Study|Other|12|||
150262261|NCT01411215|542097671|FG001|Overall Study|Other|17|||
150262262|NCT01411215|542097670|FG000|Overall Study|Screen failure|0|||
150262263|NCT01411215|542097671|FG001|Overall Study|Screen failure|1|||
150262264|NCT03451162|542097672|FG000|Overall Study|Lost to Follow-up|1|||
150262265|NCT03451162|542097673|FG001|Overall Study|Lost to Follow-up|0|||
150262266|NCT03451162|542097674|FG002|Overall Study|Lost to Follow-up|0|||
150262267|NCT03451162|542097675|FG003|Overall Study|Lost to Follow-up|0|||
150262268|NCT03451162|542097676|FG004|Overall Study|Lost to Follow-up|0|||
150262269|NCT03451162|542097672|FG000|Overall Study|Physician Decision|0|||
150262270|NCT03451162|542097673|FG001|Overall Study|Physician Decision|1|||
150262271|NCT03451162|542097674|FG002|Overall Study|Physician Decision|0|||
150262272|NCT03451162|542097675|FG003|Overall Study|Physician Decision|0|||
150262273|NCT03451162|542097676|FG004|Overall Study|Physician Decision|0|||
150262274|NCT03451162|542097672|FG000|Overall Study|Withdrawal by Subject|1|||
150262275|NCT03451162|542097673|FG001|Overall Study|Withdrawal by Subject|1|||
150262276|NCT03451162|542097674|FG002|Overall Study|Withdrawal by Subject|0|||
150262277|NCT03451162|542097675|FG003|Overall Study|Withdrawal by Subject|0|||
150262278|NCT03451162|542097676|FG004|Overall Study|Withdrawal by Subject|0|||
150262279|NCT03305731|542097677|FG000|Overall Study|Protocol Violation|1|||
150262280|NCT01136772|542097678|FG000|Overall Study|Adverse Event|15|||
150262281|NCT01136772|542097679|FG001|Overall Study|Adverse Event|14|||
150262282|NCT01136772|542097678|FG000|Overall Study|Lack of Efficacy|42|||
150262283|NCT01136772|542097679|FG001|Overall Study|Lack of Efficacy|39|||
150262284|NCT01136772|542097678|FG000|Overall Study|Administrative|14|||
150262285|NCT01136772|542097679|FG001|Overall Study|Administrative|12|||
150262286|NCT01136772|542097678|FG000|Overall Study|Withdrawal by Subject|33|||
150262287|NCT01136772|542097679|FG001|Overall Study|Withdrawal by Subject|36|||
150262288|NCT01136772|542097678|FG000|Overall Study|Did not receive injection|10|||
150262289|NCT01136772|542097679|FG001|Overall Study|Did not receive injection|7|||
150262290|NCT01136772|542097678|FG000|Overall Study|Did not follow up after first injection|2|||
150262291|NCT01136772|542097679|FG001|Overall Study|Did not follow up after first injection|2|||
150262292|NCT01498653|542097680|FG000|Overall Study|Adverse Event|2|||
150262293|NCT01498653|542097681|FG001|Overall Study|Adverse Event|2|||
150262294|NCT01498653|542097680|FG000|Overall Study|Lack of Efficacy|12|||
150262295|NCT01498653|542097681|FG001|Overall Study|Lack of Efficacy|26|||
150262296|NCT01498653|542097680|FG000|Overall Study|Protocol Violation|0|||
150262297|NCT01498653|542097681|FG001|Overall Study|Protocol Violation|4|||
150262298|NCT01498653|542097680|FG000|Overall Study|Lost to Follow-up|1|||
150262299|NCT01498653|542097681|FG001|Overall Study|Lost to Follow-up|0|||
149925991|NCT00154375|540863281|FG000|Overall Study|Adverse Event|18|||
150262300|NCT01498653|542097680|FG000|Overall Study|Physician Decision|2|||
150262301|NCT01498653|542097681|FG001|Overall Study|Physician Decision|0|||
150262302|NCT01498653|542097680|FG000|Overall Study|Withdrawal by Subject|2|||
150262303|NCT01498653|542097681|FG001|Overall Study|Withdrawal by Subject|3|||
150262304|NCT03881553|542097683|FG000|Overall Study|Discharged prior to participation|1|||
150262305|NCT03881553|542097684|FG001|Overall Study|Discharged prior to participation|1|||
150262306|NCT03881553|542097685|FG002|Overall Study|Discharged prior to participation|0|||
150262307|NCT03881553|542097683|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
150262308|NCT03881553|542097684|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
150262309|NCT03881553|542097685|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
150262310|NCT00455325|542097686|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
150262311|NCT00455325|542097687|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
150262312|NCT00455325|542097688|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
150262313|NCT00455325|542097689|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
150262314|NCT00455325|542097686|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
150262315|NCT00455325|542097687|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
150262316|NCT00455325|542097688|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
150262317|NCT00455325|542097689|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
150262318|NCT00455325|542097686|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
150262319|NCT00455325|542097687|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
150262320|NCT00455325|542097688|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
150262321|NCT00455325|542097689|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
150262322|NCT00455325|542097686|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
150262323|NCT00455325|542097687|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
150262324|NCT00455325|542097688|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
150262325|NCT00455325|542097689|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
150262326|NCT00455325|542097686|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
150262327|NCT00455325|542097687|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
150262328|NCT00455325|542097688|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
150262329|NCT00455325|542097689|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
150262330|NCT00455325|542097686|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
150262331|NCT00455325|542097687|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
150262332|NCT00455325|542097688|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
150262333|NCT00455325|542097689|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
150262334|NCT00455325|542097686|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
150262335|NCT00455325|542097687|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
150262336|NCT00455325|542097688|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
150262337|NCT00455325|542097689|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
150262338|NCT01759368|542097696|FG000|Overall Study|Lost to Follow-up|1|||
150262339|NCT01759368|542097697|FG001|Overall Study|Lost to Follow-up|0|||
150262340|NCT01313689|542097698|FG000|24-Week Randomization 1|Adverse Event|10|||
150262341|NCT01313689|542097699|FG001|24-Week Randomization 1|Adverse Event|5|||
150262342|NCT01313689|542097700|FG002|24-Week Randomization 1|Adverse Event|0|||
150262343|NCT01313689|542097701|FG003|24-Week Randomization 1|Adverse Event|0|||
150262344|NCT01313689|542097702|FG004|24-Week Randomization 1|Adverse Event|0|||
150262345|NCT01313689|542097698|FG000|24-Week Randomization 1|Physician Decision|4|||
150262346|NCT01313689|542097699|FG001|24-Week Randomization 1|Physician Decision|5|||
150262347|NCT01313689|542097700|FG002|24-Week Randomization 1|Physician Decision|0|||
150262348|NCT01313689|542097701|FG003|24-Week Randomization 1|Physician Decision|0|||
150262349|NCT01313689|542097702|FG004|24-Week Randomization 1|Physician Decision|0|||
150262350|NCT01313689|542097698|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
150262351|NCT01313689|542097699|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
150262352|NCT01313689|542097700|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
150262353|NCT01313689|542097701|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
150262354|NCT01313689|542097702|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
150262355|NCT01313689|542097698|FG000|24-Week Randomization 2|Adverse Event|0|||
150262356|NCT01313689|542097699|FG001|24-Week Randomization 2|Adverse Event|0|||
150262357|NCT01313689|542097700|FG002|24-Week Randomization 2|Adverse Event|2|||
150262358|NCT01313689|542097701|FG003|24-Week Randomization 2|Adverse Event|0|||
150262359|NCT01313689|542097702|FG004|24-Week Randomization 2|Adverse Event|8|||
150262360|NCT01313689|542097698|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
150262361|NCT01313689|542097699|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
150262362|NCT01313689|542097700|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
150262363|NCT01313689|542097701|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
150262364|NCT01313689|542097702|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
150262365|NCT01313689|542097698|FG000|24-Week Randomization 2|Physician Decision|0|||
150262366|NCT01313689|542097699|FG001|24-Week Randomization 2|Physician Decision|0|||
150262367|NCT01313689|542097700|FG002|24-Week Randomization 2|Physician Decision|0|||
150262368|NCT01313689|542097701|FG003|24-Week Randomization 2|Physician Decision|0|||
150262369|NCT01313689|542097702|FG004|24-Week Randomization 2|Physician Decision|4|||
150262370|NCT01768637|542097703|FG000|Overall Study|Lost to Follow-up|2|||
149819147|NCT03210259|540467213|FG001|12-Week Run-in Period|Adverse Event|0|||
149819148|NCT03210259|540467214|FG002|12-Week Run-in Period|Adverse Event|0|||
149819149|NCT03210259|540467212|FG000|12-Week Run-in Period|Death|1|||
149819150|NCT03210259|540467213|FG001|12-Week Run-in Period|Death|0|||
150262371|NCT01768637|542097704|FG001|Overall Study|Lost to Follow-up|7|||
149819151|NCT03210259|540467214|FG002|12-Week Run-in Period|Death|0|||
149819152|NCT03210259|540467212|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
149819153|NCT03210259|540467213|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
149819154|NCT03210259|540467214|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
149819155|NCT03210259|540467212|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
150262372|NCT01768637|542097703|FG000|Overall Study|Difficult blood draw|1|||
150262373|NCT01768637|542097704|FG001|Overall Study|Difficult blood draw|0|||
149819156|NCT03210259|540467213|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
149819157|NCT03210259|540467214|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
149819158|NCT03210259|540467212|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
149819159|NCT03210259|540467213|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
150262374|NCT03426605|542097705|FG000|Overall Study|AML relapse or progression|2|||
150262375|NCT03426605|542097706|FG001|Overall Study|AML relapse or progression|1|||
150262376|NCT03426605|542097707|FG002|Overall Study|AML relapse or progression|2|||
150262377|NCT03426605|542097708|FG003|Overall Study|AML relapse or progression|2|||
150262378|NCT03426605|542097705|FG000|Overall Study|Treatment failure|3|||
150262379|NCT03426605|542097706|FG001|Overall Study|Treatment failure|2|||
150262380|NCT03426605|542097707|FG002|Overall Study|Treatment failure|0|||
150262381|NCT03426605|542097708|FG003|Overall Study|Treatment failure|0|||
150262382|NCT03426605|542097705|FG000|Overall Study|Adverse Event|1|||
150262383|NCT03426605|542097706|FG001|Overall Study|Adverse Event|0|||
150262384|NCT03426605|542097707|FG002|Overall Study|Adverse Event|1|||
150262385|NCT03426605|542097708|FG003|Overall Study|Adverse Event|1|||
150262386|NCT03426605|542097705|FG000|Overall Study|Withdrawal by Subject|0|||
150262387|NCT03426605|542097706|FG001|Overall Study|Withdrawal by Subject|0|||
150262388|NCT03426605|542097707|FG002|Overall Study|Withdrawal by Subject|1|||
150262389|NCT03426605|542097708|FG003|Overall Study|Withdrawal by Subject|1|||
150262390|NCT02308020|542097719|FG000|Overall Study|Lost to Follow-up|1|||
150262391|NCT02308020|542097720|FG001|Overall Study|Lost to Follow-up|7|||
150262392|NCT02308020|542097721|FG002|Overall Study|Lost to Follow-up|0|||
150262393|NCT02308020|542097722|FG003|Overall Study|Lost to Follow-up|0|||
150262394|NCT02308020|542097723|FG004|Overall Study|Lost to Follow-up|1|||
150262395|NCT02308020|542097724|FG005|Overall Study|Lost to Follow-up|2|||
150262396|NCT02308020|542097719|FG000|Overall Study|Sponsor Decision|0|||
150262397|NCT02308020|542097720|FG001|Overall Study|Sponsor Decision|8|||
150262398|NCT02308020|542097721|FG002|Overall Study|Sponsor Decision|0|||
150262399|NCT02308020|542097722|FG003|Overall Study|Sponsor Decision|2|||
150262400|NCT02308020|542097723|FG004|Overall Study|Sponsor Decision|2|||
150262401|NCT02308020|542097724|FG005|Overall Study|Sponsor Decision|1|||
150262402|NCT02308020|542097719|FG000|Overall Study|Withdrawal by Subject|3|||
150262403|NCT02308020|542097720|FG001|Overall Study|Withdrawal by Subject|5|||
150262404|NCT02308020|542097721|FG002|Overall Study|Withdrawal by Subject|3|||
150262405|NCT02308020|542097722|FG003|Overall Study|Withdrawal by Subject|2|||
150262406|NCT02308020|542097723|FG004|Overall Study|Withdrawal by Subject|1|||
150262407|NCT02308020|542097724|FG005|Overall Study|Withdrawal by Subject|2|||
150262408|NCT01211288|542097725|FG000|Overall Study|Lost to Follow-up|1|||
150262409|NCT01211288|542097726|FG001|Overall Study|Lost to Follow-up|1|||
150262410|NCT01270971|542097727|FG000|Overall Study|Withdrawal by Subject|24|||
150262411|NCT01270971|542097728|FG001|Overall Study|Withdrawal by Subject|11|||
150262412|NCT01270971|542097727|FG000|Overall Study|Lost to Follow-up|18|||
150262413|NCT01270971|542097728|FG001|Overall Study|Lost to Follow-up|5|||
150262414|NCT01270971|542097727|FG000|Overall Study|Adverse Event|1|||
150262415|NCT01270971|542097728|FG001|Overall Study|Adverse Event|2|||
150262416|NCT01270971|542097727|FG000|Overall Study|Non compliance|2|||
150262417|NCT01270971|542097728|FG001|Overall Study|Non compliance|2|||
150262418|NCT01270971|542097727|FG000|Overall Study|Non-specific|7|||
150262419|NCT01270971|542097728|FG001|Overall Study|Non-specific|3|||
150262420|NCT04217590|542097729|FG000|Overall Study|Other|1|||
150262421|NCT04217590|542097730|FG001|Overall Study|Other|1|||
150262422|NCT04217590|542097729|FG000|Overall Study|Withdrawal by Subject|3|||
150262423|NCT04217590|542097730|FG001|Overall Study|Withdrawal by Subject|1|||
150262424|NCT04217590|542097729|FG000|Overall Study|Death|0|||
150262425|NCT04217590|542097730|FG001|Overall Study|Death|1|||
150262426|NCT00704405|542097733|FG000|Overall Study (NC Population)|Adverse Event|1|||
150262427|NCT00704405|542097734|FG001|Overall Study (NC Population)|Adverse Event|0|||
150262428|NCT00704405|542097735|FG002|Overall Study (NC Population)|Adverse Event|0|||
150262429|NCT00704405|542097736|FG003|Overall Study (NC Population)|Adverse Event|0|||
150262430|NCT00704405|542097737|FG004|Overall Study (NC Population)|Adverse Event|0|||
150262431|NCT00704405|542097733|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
150262432|NCT00704405|542097734|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
150262433|NCT00704405|542097735|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
150262434|NCT00704405|542097736|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
150262435|NCT00704405|542097737|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
150262436|NCT00704405|542097733|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
149819160|NCT03210259|540467214|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
150262437|NCT00704405|542097734|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
150262438|NCT00704405|542097735|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
150262439|NCT00704405|542097736|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
150262440|NCT00704405|542097737|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
150262441|NCT00704405|542097733|FG000|Overall Study (NC Population)|Other|0|||
150262442|NCT00704405|542097734|FG001|Overall Study (NC Population)|Other|0|||
150262443|NCT00704405|542097735|FG002|Overall Study (NC Population)|Other|0|||
150262444|NCT00704405|542097736|FG003|Overall Study (NC Population)|Other|0|||
150262445|NCT00704405|542097737|FG004|Overall Study (NC Population)|Other|1|||
150262446|NCT00704405|542097733|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
150262447|NCT00704405|542097734|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
150262448|NCT00704405|542097735|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
150262449|NCT00704405|542097736|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
150262450|NCT00704405|542097737|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
150262451|NCT00704405|542097733|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
150262452|NCT00704405|542097734|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
150262453|NCT00704405|542097735|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
149925992|NCT00154375|540863282|FG001|Overall Study|Adverse Event|20|||
149925993|NCT00154375|540863281|FG000|Overall Study|Withdrawal by Subject|14|||
149925994|NCT00154375|540863282|FG001|Overall Study|Withdrawal by Subject|10|||
149925995|NCT00154375|540863281|FG000|Overall Study|Death|5|||
149925996|NCT00154375|540863282|FG001|Overall Study|Death|13|||
149925997|NCT00154375|540863281|FG000|Overall Study|Study drug no longer required|5|||
149925998|NCT00154375|540863282|FG001|Overall Study|Study drug no longer required|3|||
149925999|NCT00154375|540863281|FG000|Overall Study|Lost to Follow-up|2|||
149926000|NCT00154375|540863282|FG001|Overall Study|Lost to Follow-up|1|||
149926001|NCT00154375|540863281|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149926002|NCT00154375|540863282|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149926003|NCT00154375|540863281|FG000|Overall Study|Protocol Violation|0|||
149926004|NCT00154375|540863282|FG001|Overall Study|Protocol Violation|1|||
149926005|NCT00154375|540863281|FG000|Overall Study|Suspected progression of disease|44|||
149926006|NCT00154375|540863282|FG001|Overall Study|Suspected progression of disease|30|||
149926007|NCT04162795|540863284|FG000|Overall Study|Other|16|||
149926008|NCT04162795|540863284|FG000|Overall Study|Screen failures|10|||
149926009|NCT02029274|540863287|FG000|Overall Study|Adverse Event|1|||
149926010|NCT02029274|540863288|FG001|Overall Study|Adverse Event|0|||
149926011|NCT02029274|540863289|FG002|Overall Study|Adverse Event|2|||
149926012|NCT02029274|540863290|FG003|Overall Study|Adverse Event|2|||
149926013|NCT01790516|540863291|FG000|Overall Study|Physician Decision|1|||
149926014|NCT01790516|540863292|FG001|Overall Study|Physician Decision|0|||
149926015|NCT03749109|540863293|FG000|Overall Study|Adverse Event|2|||
149926016|NCT03749109|540863294|FG001|Overall Study|Adverse Event|0|||
149926017|NCT03034135|540863295|FG000|Overall Study|Withdrawal by Subject|2|||
149926018|NCT01972464|540863298|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
149926019|NCT01972464|540863299|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
149926020|NCT01972464|540863298|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
149926021|NCT01972464|540863299|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
149926022|NCT01972464|540863298|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
149926023|NCT01972464|540863299|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
149926024|NCT01972464|540863298|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
149926025|NCT01972464|540863299|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
149926026|NCT04530838|540865216|FG000|Overall Study|Other|2|||
149926027|NCT04530838|540865217|FG001|Overall Study|Other|1|||
149926028|NCT04530838|540865218|FG002|Overall Study|Other|0|||
149926029|NCT04530838|540865216|FG000|Overall Study|Physician Decision|0|||
149926030|NCT04530838|540865217|FG001|Overall Study|Physician Decision|0|||
149926031|NCT04530838|540865218|FG002|Overall Study|Physician Decision|1|||
149926032|NCT04530838|540865216|FG000|Overall Study|Death|0|||
149926033|NCT04530838|540865217|FG001|Overall Study|Death|0|||
149926034|NCT04530838|540865218|FG002|Overall Study|Death|1|||
149926035|NCT04530838|540865216|FG000|Overall Study|Adverse Event|0|||
149926036|NCT04530838|540865217|FG001|Overall Study|Adverse Event|1|||
149926037|NCT04530838|540865218|FG002|Overall Study|Adverse Event|0|||
149926038|NCT04530838|540865216|FG000|Overall Study|No longer meets eligibility criteria|1|||
149926039|NCT04530838|540865217|FG001|Overall Study|No longer meets eligibility criteria|0|||
149926040|NCT04530838|540865218|FG002|Overall Study|No longer meets eligibility criteria|2|||
149926041|NCT04530838|540865216|FG000|Overall Study|Withdrawal by parent/guardian|5|||
149926042|NCT04530838|540865217|FG001|Overall Study|Withdrawal by parent/guardian|2|||
149926043|NCT04530838|540865218|FG002|Overall Study|Withdrawal by parent/guardian|2|||
149926044|NCT00803712|540865219|FG000|Overall Study|Noncompliance|3|||
149926045|NCT00803712|540865220|FG001|Overall Study|Noncompliance|0|||
149926046|NCT00803712|540865219|FG000|Overall Study|Adverse Event|5|||
149926047|NCT00803712|540865220|FG001|Overall Study|Adverse Event|0|||
149926048|NCT00803712|540865219|FG000|Overall Study|Death|8|||
149926049|NCT00803712|540865220|FG001|Overall Study|Death|7|||
149926050|NCT00803712|540865219|FG000|Overall Study|Lost to Follow-up|3|||
149926051|NCT00803712|540865220|FG001|Overall Study|Lost to Follow-up|1|||
149926052|NCT00803712|540865219|FG000|Overall Study|Withdrawal by Subject|2|||
149926053|NCT00803712|540865220|FG001|Overall Study|Withdrawal by Subject|4|||
149926054|NCT00803712|540865219|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
150262454|NCT00704405|542097736|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
150262455|NCT00704405|542097737|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
150262456|NCT03169101|542097738|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
149926055|NCT00803712|540865220|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
149926056|NCT00803712|540865219|FG000|Overall Study|Protocol criteria (other)|0|||
149926057|NCT00803712|540865220|FG001|Overall Study|Protocol criteria (other)|2|||
149926058|NCT00803712|540865219|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
149926059|NCT00803712|540865220|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
149926060|NCT00803712|540865219|FG000|Overall Study|Administrative decision|2|||
149926061|NCT00803712|540865220|FG001|Overall Study|Administrative decision|3|||
149926062|NCT00803712|540865219|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
149926063|NCT00803712|540865220|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
150162778|NCT02487446|541730197|FG001|Period 1|Lost to Follow-up|0|||
150162779|NCT02487446|541730196|FG000|Period 1|Withdrawal by Subject|2|||
150162780|NCT02487446|541730197|FG001|Period 1|Withdrawal by Subject|0|||
150162781|NCT02487446|541730196|FG000|Period 1|Adverse Event|5|||
150162782|NCT02487446|541730197|FG001|Period 1|Adverse Event|5|||
150162783|NCT02487446|541730196|FG000|Washout|Lost to Follow-up|0|||
150162784|NCT02487446|541730197|FG001|Washout|Lost to Follow-up|2|||
150162785|NCT02487446|541730196|FG000|Washout|Withdrawal by Subject|1|||
150162786|NCT02487446|541730197|FG001|Washout|Withdrawal by Subject|4|||
150162787|NCT02487446|541730196|FG000|Washout|Adverse Event|2|||
150162788|NCT02487446|541730197|FG001|Washout|Adverse Event|2|||
150162789|NCT02487446|541730196|FG000|Period 2|Protocol deviation|0|||
150162790|NCT02487446|541730197|FG001|Period 2|Protocol deviation|1|||
150162791|NCT02487446|541730196|FG000|Period 2|Lost to Follow-up|1|||
150162792|NCT02487446|541730197|FG001|Period 2|Lost to Follow-up|1|||
150162793|NCT02487446|541730196|FG000|Period 2|Withdrawal by Subject|1|||
150162794|NCT02487446|541730197|FG001|Period 2|Withdrawal by Subject|1|||
150162795|NCT02487446|541730196|FG000|Period 2|Adverse Event|6|||
150162796|NCT02487446|541730197|FG001|Period 2|Adverse Event|2|||
150162797|NCT01823341|541730200|FG000|Overall Study|Failed run-in|7|||
150162798|NCT01823341|541730200|FG000|Overall Study|Withdrawal by Subject|7|||
150162799|NCT01823341|541730200|FG000|Overall Study|Adverse Event|1|||
150162800|NCT00689104|541730201|FG000|Overall Study|Eligibility criterion not met|5|||
150162801|NCT00689104|541730202|FG001|Overall Study|Eligibility criterion not met|8|||
150162802|NCT00689104|541730203|FG002|Overall Study|Eligibility criterion not met|0|||
150162803|NCT00689104|541730204|FG003|Overall Study|Eligibility criterion not met|4|||
150162804|NCT00689104|541730201|FG000|Overall Study|Adverse Event|13|||
150162805|NCT00689104|541730202|FG001|Overall Study|Adverse Event|25|||
150162806|NCT00689104|541730203|FG002|Overall Study|Adverse Event|16|||
150162807|NCT00689104|541730204|FG003|Overall Study|Adverse Event|24|||
150162808|NCT00689104|541730201|FG000|Overall Study|Lack of Efficacy|5|||
150162809|NCT00689104|541730202|FG001|Overall Study|Lack of Efficacy|6|||
150162810|NCT00689104|541730203|FG002|Overall Study|Lack of Efficacy|2|||
150162811|NCT00689104|541730204|FG003|Overall Study|Lack of Efficacy|3|||
150162812|NCT00689104|541730201|FG000|Overall Study|Withdrawal by Subject|12|||
150162813|NCT00689104|541730202|FG001|Overall Study|Withdrawal by Subject|11|||
150162814|NCT00689104|541730203|FG002|Overall Study|Withdrawal by Subject|18|||
150162815|NCT00689104|541730204|FG003|Overall Study|Withdrawal by Subject|11|||
150162816|NCT00689104|541730201|FG000|Overall Study|Lost to Follow-up|4|||
150162817|NCT00689104|541730202|FG001|Overall Study|Lost to Follow-up|3|||
150162818|NCT00689104|541730203|FG002|Overall Study|Lost to Follow-up|2|||
150162819|NCT00689104|541730204|FG003|Overall Study|Lost to Follow-up|5|||
150162820|NCT00689104|541730201|FG000|Overall Study|Protocol Violation|2|||
150162821|NCT00689104|541730202|FG001|Overall Study|Protocol Violation|3|||
150162822|NCT00689104|541730203|FG002|Overall Study|Protocol Violation|5|||
150162823|NCT00689104|541730204|FG003|Overall Study|Protocol Violation|3|||
150162824|NCT00689104|541730201|FG000|Overall Study|Randomized but never received study drug|2|||
150162825|NCT00689104|541730202|FG001|Overall Study|Randomized but never received study drug|1|||
150162826|NCT00689104|541730203|FG002|Overall Study|Randomized but never received study drug|1|||
150162827|NCT00689104|541730204|FG003|Overall Study|Randomized but never received study drug|0|||
150162828|NCT00689104|541730201|FG000|Overall Study|Physician Decision|1|||
150162829|NCT00689104|541730202|FG001|Overall Study|Physician Decision|0|||
150162830|NCT00689104|541730203|FG002|Overall Study|Physician Decision|0|||
150162831|NCT00689104|541730204|FG003|Overall Study|Physician Decision|0|||
150162832|NCT00689104|541730201|FG000|Overall Study|Non-compliance with study procedures|0|||
150162833|NCT00689104|541730202|FG001|Overall Study|Non-compliance with study procedures|0|||
150162834|NCT00689104|541730203|FG002|Overall Study|Non-compliance with study procedures|1|||
150162835|NCT00689104|541730204|FG003|Overall Study|Non-compliance with study procedures|0|||
150162836|NCT02698436|541730219|FG000|Overall Study|Adverse Event|1|||
150162837|NCT02698436|541730220|FG001|Overall Study|Adverse Event|0|||
150162838|NCT02698436|541730219|FG000|Overall Study|Withdrawal by Subject|3|||
150162839|NCT02698436|541730220|FG001|Overall Study|Withdrawal by Subject|3|||
150162840|NCT02698436|541730219|FG000|Overall Study|Lost to Follow-up|2|||
150162841|NCT02698436|541730220|FG001|Overall Study|Lost to Follow-up|4|||
150162842|NCT02698436|541730219|FG000|Overall Study|Non-compliance with study regimen|1|||
150162843|NCT02698436|541730220|FG001|Overall Study|Non-compliance with study regimen|0|||
150162844|NCT00097370|541730221|FG000|Stage 1|Adverse Event|3|||
150162845|NCT00097370|541730221|FG000|Stage 1|Withdrawal by Subject|1|||
149926064|NCT02861664|540865222|FG000|Overall Study|Withdrawal of Consent|0|||
149926065|NCT02861664|540865223|FG001|Overall Study|Withdrawal of Consent|1|||
149926066|NCT00905632|540865224|FG000|Overall Study|Adverse Event|0|||
150162846|NCT00097370|541730221|FG000|Stage 1|Lack of Efficacy|2|||
150162847|NCT00097370|541730221|FG000|Stage 2|Adverse Event|5|||
150162848|NCT00097370|541730221|FG000|Stage 2|Withdrawal by Subject|1|||
150162849|NCT00097370|541730221|FG000|Stage 2|Lack of Efficacy|3|||
150162850|NCT00097370|541730221|FG000|Stage 2|Pregnancy|1|||
150162851|NCT00097370|541730221|FG000|Stage 2|Sponsor Terminated Study|2|||
150162852|NCT00097370|541730221|FG000|Stage 2|Lost to Follow-up|1|||
150162853|NCT00097370|541730221|FG000|Stage 3|Adverse Event|2|||
150162854|NCT00097370|541730221|FG000|Stage 3|Withdrawal by Subject|3|||
150162855|NCT00097370|541730221|FG000|Stage 3|Lack of Efficacy|1|||
150162856|NCT00097370|541730221|FG000|Stage 3|Sponsor Terminated Study|52|||
150162857|NCT00097370|541730221|FG000|Stage 3|Lost to Follow-up|1|||
150162858|NCT00901485|541730226|FG000|Overall Study|Lack of Efficacy|0|||
150162859|NCT00901485|541730227|FG001|Overall Study|Lack of Efficacy|2|||
150162860|NCT00901485|541730226|FG000|Overall Study|Withdrawal by Subject|1|||
150162861|NCT00901485|541730227|FG001|Overall Study|Withdrawal by Subject|2|||
150162862|NCT01919619|541730228|FG000|Overall Study|Physician Decision|1|||
150162863|NCT01919619|541730229|FG001|Overall Study|Physician Decision|1|||
150162864|NCT00172185|541732083|FG000|Overall Study|Adverse Event|0|||
150162865|NCT00172185|541732084|FG001|Overall Study|Adverse Event|1|||
150162866|NCT00172185|541732085|FG002|Overall Study|Adverse Event|3|||
150162867|NCT00172185|541732086|FG003|Overall Study|Adverse Event|4|||
150162868|NCT00172185|541732083|FG000|Overall Study|Physician Decision|0|||
150162869|NCT00172185|541732084|FG001|Overall Study|Physician Decision|0|||
150162870|NCT00172185|541732085|FG002|Overall Study|Physician Decision|1|||
150162871|NCT00172185|541732086|FG003|Overall Study|Physician Decision|0|||
150162872|NCT00172185|541732083|FG000|Overall Study|SPONSOR Decision|0|||
150162873|NCT00172185|541732084|FG001|Overall Study|SPONSOR Decision|1|||
150162874|NCT00172185|541732085|FG002|Overall Study|SPONSOR Decision|0|||
150162875|NCT00172185|541732086|FG003|Overall Study|SPONSOR Decision|0|||
150162876|NCT00172185|541732083|FG000|Overall Study|Withdrawal by Subject|0|||
150162877|NCT00172185|541732084|FG001|Overall Study|Withdrawal by Subject|0|||
150162878|NCT00172185|541732085|FG002|Overall Study|Withdrawal by Subject|1|||
150162879|NCT00172185|541732086|FG003|Overall Study|Withdrawal by Subject|0|||
150162880|NCT00723294|541732089|FG000|Overall Study|Lobular histology|2|||
150162881|NCT00723294|541732089|FG000|Overall Study|>25% intraductal component|1|||
150162882|NCT00723294|541732089|FG000|Overall Study|No MRI tumor enhancement|1|||
150162883|NCT00723294|541732089|FG000|Overall Study|1.0-Tesla MRI|1|||
150162884|NCT00723294|541732089|FG000|Overall Study|No cryoabalation|2|||
150162885|NCT00723294|541732089|FG000|Overall Study|Did not undergo surgery|1|||
150162886|NCT00723294|541732089|FG000|Overall Study|Treated prior to registration|1|||
150162887|NCT00723294|541732089|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
150162888|NCT00723294|541732089|FG000|Overall Study|Benign lesion|1|||
150162889|NCT00723294|541732089|FG000|Overall Study|Withdrawal by Subject|1|||
150162890|NCT00723294|541732089|FG000|Overall Study|No treatment due to probe failure|1|||
150162891|NCT01257503|541732090|FG000|Overall Study|Lost to Follow-up|7|||
150162892|NCT01257503|541732091|FG001|Overall Study|Lost to Follow-up|10|||
150162893|NCT01257503|541732090|FG000|Overall Study|Over 5 years old at enrollment|0|||
150162894|NCT01257503|541732091|FG001|Overall Study|Over 5 years old at enrollment|1|||
150162895|NCT01257503|541732090|FG000|Overall Study|strep culture positive at enrollment|1|||
150162896|NCT01257503|541732091|FG001|Overall Study|strep culture positive at enrollment|0|||
150162897|NCT01211665|541732092|FG000|Overall Study|Withdrawal by Subject|1|||
150162898|NCT01211665|541732093|FG001|Overall Study|Withdrawal by Subject|0|||
150162899|NCT01211665|541732092|FG000|Overall Study|Death|1|||
150162900|NCT01211665|541732093|FG001|Overall Study|Death|0|||
150162901|NCT01456780|541732094|FG000|Overall Study|Lost to Follow-up|3|||
150162902|NCT01456780|541732095|FG001|Overall Study|Lost to Follow-up|3|||
150162903|NCT01456780|541732096|FG002|Overall Study|Lost to Follow-up|0|||
150162904|NCT02333630|541732103|FG000|Overall Study|Lost to Follow-up|5|||
150162905|NCT02333630|541732104|FG001|Overall Study|Lost to Follow-up|2|||
150162906|NCT05349864|541732105|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
150162907|NCT05349864|541732106|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
149926067|NCT00905632|540865225|FG001|Overall Study|Adverse Event|0|||
150162908|NCT00984282|541732107|FG000|Double Blind Treatment|Adverse Event|40|||
150162909|NCT00984282|541732108|FG001|Double Blind Treatment|Adverse Event|6|||
150162910|NCT00984282|541732107|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
150162911|NCT00984282|541732108|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
149926068|NCT00905632|540865226|FG002|Overall Study|Adverse Event|0|||
150162912|NCT00984282|541732107|FG000|Double Blind Treatment|Physician Decision|1|||
150162913|NCT00984282|541732108|FG001|Double Blind Treatment|Physician Decision|2|||
150162914|NCT00984282|541732107|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
150162915|NCT00984282|541732108|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
149926069|NCT00905632|540865227|FG003|Overall Study|Adverse Event|0|||
150162916|NCT00984282|541732107|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
150162917|NCT00984282|541732108|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
150262457|NCT03169101|542097739|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
150262458|NCT03169101|542097740|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
150262459|NCT03169101|542097741|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
150262460|NCT02641496|542097742|FG000|Overall Study|Lost to Follow-up|13|||
150262461|NCT02641496|542097743|FG001|Overall Study|Lost to Follow-up|12|||
150262462|NCT02641496|542097742|FG000|Overall Study|Withdrawal by Subject|1|||
150262463|NCT02641496|542097743|FG001|Overall Study|Withdrawal by Subject|0|||
150262464|NCT01028027|542097744|FG000|Overall Study|Lost to Follow-up|4|||
150262465|NCT01028027|542097745|FG001|Overall Study|Lost to Follow-up|1|||
150262466|NCT01028027|542097744|FG000|Overall Study|Withdrawal by Subject|5|||
150262467|NCT01028027|542097745|FG001|Overall Study|Withdrawal by Subject|3|||
150262468|NCT01028027|542097744|FG000|Overall Study|Adverse Event|4|||
150262469|NCT01028027|542097745|FG001|Overall Study|Adverse Event|7|||
150262470|NCT01028027|542097744|FG000|Overall Study|Protocol Violation|3|||
150262471|NCT01028027|542097745|FG001|Overall Study|Protocol Violation|1|||
150262472|NCT01028027|542097744|FG000|Overall Study|Lack of Efficacy|0|||
150262473|NCT01028027|542097745|FG001|Overall Study|Lack of Efficacy|1|||
150262474|NCT00790751|542097754|FG000|Overall Study|Protocol non-compliance|16|||
150262475|NCT00790751|542097755|FG001|Overall Study|Protocol non-compliance|16|||
150262476|NCT00790751|542097756|FG002|Overall Study|Protocol non-compliance|10|||
150262477|NCT00790751|542097757|FG003|Overall Study|Protocol non-compliance|11|||
150262478|NCT00790751|542097754|FG000|Overall Study|Lost to Follow-up|4|||
150262479|NCT00790751|542097755|FG001|Overall Study|Lost to Follow-up|9|||
150262480|NCT00790751|542097756|FG002|Overall Study|Lost to Follow-up|4|||
150262481|NCT00790751|542097757|FG003|Overall Study|Lost to Follow-up|5|||
150262482|NCT00790751|542097754|FG000|Overall Study|Adverse Event|5|||
150262483|NCT00790751|542097755|FG001|Overall Study|Adverse Event|3|||
150262484|NCT00790751|542097756|FG002|Overall Study|Adverse Event|5|||
150262485|NCT00790751|542097757|FG003|Overall Study|Adverse Event|4|||
150262486|NCT00790751|542097754|FG000|Overall Study|Requirement for restricted medication|0|||
150262487|NCT00790751|542097755|FG001|Overall Study|Requirement for restricted medication|2|||
150262488|NCT00790751|542097756|FG002|Overall Study|Requirement for restricted medication|0|||
150262489|NCT00790751|542097757|FG003|Overall Study|Requirement for restricted medication|0|||
150262490|NCT00790751|542097754|FG000|Overall Study|Death|0|||
150262491|NCT00790751|542097755|FG001|Overall Study|Death|0|||
150262492|NCT00790751|542097756|FG002|Overall Study|Death|1|||
150262493|NCT00790751|542097757|FG003|Overall Study|Death|0|||
150262494|NCT00790751|542097754|FG000|Overall Study|Physician Decision|0|||
150262495|NCT00790751|542097755|FG001|Overall Study|Physician Decision|0|||
150262496|NCT00790751|542097756|FG002|Overall Study|Physician Decision|0|||
150262497|NCT00790751|542097757|FG003|Overall Study|Physician Decision|1|||
150262498|NCT02572843|542097763|FG000|Accrual|Brain metastasis retrospectively detected|1|||
150262499|NCT02572843|542097763|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
150262500|NCT02572843|542097763|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
150262501|NCT02572843|542097763|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
150262502|NCT02572843|542097763|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
150262503|NCT02572843|542097763|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
150262504|NCT02572843|542097763|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
150262505|NCT02572843|542097763|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
150262506|NCT02572843|542097763|FG000|Surgery|lost to follow up|7|||
150262507|NCT02572843|542097763|FG000|Surgery|Death|1|||
150262508|NCT01078454|542097766|FG000|Overall Study|Adverse Event|1|||
150262509|NCT01078454|542097767|FG001|Overall Study|Adverse Event|1|||
150262510|NCT01078454|542097766|FG000|Overall Study|Death|0|||
150262511|NCT01078454|542097767|FG001|Overall Study|Death|1|||
150262512|NCT05227703|542097768|FG000|Overall Study|Adverse Event|2|||
150262513|NCT05227703|542097769|FG001|Overall Study|Adverse Event|6|||
150262514|NCT05227703|542097770|FG002|Overall Study|Adverse Event|4|||
150262515|NCT05227703|542097768|FG000|Overall Study|Lack of Efficacy|4|||
150262516|NCT05227703|542097769|FG001|Overall Study|Lack of Efficacy|0|||
150262517|NCT05227703|542097770|FG002|Overall Study|Lack of Efficacy|1|||
150262518|NCT05227703|542097768|FG000|Overall Study|Physician Decision|2|||
150262519|NCT05227703|542097769|FG001|Overall Study|Physician Decision|2|||
150262520|NCT05227703|542097770|FG002|Overall Study|Physician Decision|1|||
150262521|NCT05227703|542097768|FG000|Overall Study|Protocol Violation|2|||
150262522|NCT05227703|542097769|FG001|Overall Study|Protocol Violation|1|||
150262523|NCT05227703|542097770|FG002|Overall Study|Protocol Violation|0|||
150262524|NCT05227703|542097768|FG000|Overall Study|Withdrawal by Subject|17|||
150262525|NCT05227703|542097769|FG001|Overall Study|Withdrawal by Subject|26|||
150262526|NCT05227703|542097770|FG002|Overall Study|Withdrawal by Subject|32|||
150262527|NCT05227703|542097768|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
150262528|NCT05227703|542097769|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
149926070|NCT00905632|540865228|FG004|Overall Study|Adverse Event|0|||
149926071|NCT00905632|540865229|FG005|Overall Study|Adverse Event|1|||
150262529|NCT05227703|542097770|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
150262530|NCT05227703|542097768|FG000|Overall Study|Other|1|||
150262531|NCT05227703|542097769|FG001|Overall Study|Other|1|||
149926072|NCT00905632|540865230|FG006|Overall Study|Adverse Event|4|||
150262532|NCT05227703|542097770|FG002|Overall Study|Other|0|||
150262533|NCT03464097|542097771|FG000|Overall Study|Withdrawal by Subject|15|||
150262534|NCT03464097|542097772|FG001|Overall Study|Withdrawal by Subject|13|||
150262535|NCT03464097|542097773|FG002|Overall Study|Withdrawal by Subject|11|||
150262536|NCT03464097|542097771|FG000|Overall Study|Study terminated by sponsor|47|||
150262537|NCT03464097|542097772|FG001|Overall Study|Study terminated by sponsor|44|||
150262538|NCT03464097|542097773|FG002|Overall Study|Study terminated by sponsor|40|||
150262539|NCT03464097|542097771|FG000|Overall Study|Pregnancy|0|||
150262540|NCT03464097|542097772|FG001|Overall Study|Pregnancy|1|||
150262541|NCT03464097|542097773|FG002|Overall Study|Pregnancy|0|||
150262542|NCT03464097|542097771|FG000|Overall Study|Other reasons|5|||
150262543|NCT03464097|542097772|FG001|Overall Study|Other reasons|12|||
150262544|NCT03464097|542097773|FG002|Overall Study|Other reasons|14|||
150262545|NCT03464097|542097771|FG000|Overall Study|Lost to Follow-up|0|||
149926073|NCT02465437|540865233|FG000|Overall Study|Physician Decision|0|||
150262546|NCT03464097|542097772|FG001|Overall Study|Lost to Follow-up|1|||
150262547|NCT03464097|542097773|FG002|Overall Study|Lost to Follow-up|1|||
150262548|NCT03464097|542097771|FG000|Overall Study|Lack of Efficacy|11|||
150262549|NCT03464097|542097772|FG001|Overall Study|Lack of Efficacy|18|||
149926074|NCT02465437|540865234|FG001|Overall Study|Physician Decision|0|||
149926075|NCT02465437|540865235|FG002|Overall Study|Physician Decision|1|||
149926076|NCT02465437|540865236|FG003|Overall Study|Physician Decision|0|||
149926077|NCT02465437|540865233|FG000|Overall Study|Withdrawal by Subject|1|||
149926078|NCT02465437|540865234|FG001|Overall Study|Withdrawal by Subject|0|||
149926079|NCT02465437|540865235|FG002|Overall Study|Withdrawal by Subject|0|||
149926080|NCT02465437|540865236|FG003|Overall Study|Withdrawal by Subject|1|||
149926081|NCT02465437|540865233|FG000|Overall Study|Adverse Event|0|||
149926082|NCT02465437|540865234|FG001|Overall Study|Adverse Event|1|||
149926083|NCT02465437|540865235|FG002|Overall Study|Adverse Event|0|||
149926084|NCT02465437|540865236|FG003|Overall Study|Adverse Event|0|||
149926085|NCT01059773|540865237|FG000|Overall Study|Adverse Event|2|||
149926086|NCT01059773|540865238|FG001|Overall Study|Adverse Event|2|||
149926087|NCT01059773|540865237|FG000|Overall Study|Withdrawal by Subject|1|||
149926088|NCT01059773|540865238|FG001|Overall Study|Withdrawal by Subject|5|||
149926089|NCT01059773|540865237|FG000|Overall Study|Lost to Follow-up|1|||
149926090|NCT01059773|540865238|FG001|Overall Study|Lost to Follow-up|1|||
149926091|NCT01059773|540865237|FG000|Overall Study|Pregnancy|1|||
149926092|NCT01059773|540865238|FG001|Overall Study|Pregnancy|1|||
149926093|NCT01059773|540865237|FG000|Overall Study|Protocol Violation|6|||
149926094|NCT01059773|540865238|FG001|Overall Study|Protocol Violation|2|||
149926095|NCT01059773|540865237|FG000|Overall Study|Physician Decision|5|||
149926096|NCT01059773|540865238|FG001|Overall Study|Physician Decision|4|||
149926097|NCT01059773|540865237|FG000|Overall Study|Lack of Efficacy|3|||
149926098|NCT01059773|540865238|FG001|Overall Study|Lack of Efficacy|3|||
149926099|NCT01059773|540865237|FG000|Overall Study|Death|0|||
149926100|NCT01059773|540865238|FG001|Overall Study|Death|1|||
149926101|NCT01059773|540865237|FG000|Overall Study|Malignancy including squamous cell skin|0|||
149926102|NCT01059773|540865238|FG001|Overall Study|Malignancy including squamous cell skin|1|||
149926103|NCT01059773|540865237|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
149926104|NCT01059773|540865238|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
149926105|NCT01059773|540865237|FG000|Overall Study|Other|1|||
149926106|NCT01059773|540865238|FG001|Overall Study|Other|3|||
149926107|NCT03904420|540865240|FG000|Overall Study|Study terminated|2|||
149926108|NCT03904420|540865241|FG001|Overall Study|Study terminated|2|||
149926109|NCT00614874|540865242|FG000|Overall Study|Protocol Violation|1|||
149926110|NCT00614874|540865242|FG000|Overall Study|Withdrawal by Subject|1|||
149926111|NCT01001910|540865243|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
149926112|NCT03173456|540865245|FG000|Baseline|Medication dispensing system malfunction'|0|||
149926113|NCT03173456|540865246|FG001|Baseline|Medication dispensing system malfunction'|1|||
149926114|NCT03173456|540865247|FG002|Baseline|Medication dispensing system malfunction'|0|||
149926115|NCT03173456|540865248|FG003|Baseline|Medication dispensing system malfunction'|0|||
149926116|NCT03173456|540865249|FG004|Baseline|Medication dispensing system malfunction'|2|||
149926117|NCT03173456|540865245|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
150262550|NCT03464097|542097773|FG002|Overall Study|Lack of Efficacy|30|||
150262551|NCT03464097|542097771|FG000|Overall Study|Death|1|||
150262552|NCT03464097|542097772|FG001|Overall Study|Death|0|||
150262553|NCT03464097|542097773|FG002|Overall Study|Death|0|||
149926118|NCT03173456|540865246|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
149926119|NCT03173456|540865247|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
149926120|NCT03173456|540865248|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
149926121|NCT03173456|540865249|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
149926122|NCT01733121|540865250|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
149926123|NCT01733121|540865251|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
149926124|NCT01733121|540865250|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
150262554|NCT03464097|542097771|FG000|Overall Study|Adverse Event|13|||
150262555|NCT03464097|542097772|FG001|Overall Study|Adverse Event|6|||
150262556|NCT03464097|542097773|FG002|Overall Study|Adverse Event|8|||
149926125|NCT01733121|540865251|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
149926126|NCT01733121|540865250|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
149926127|NCT01733121|540865251|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
149926128|NCT01733121|540865250|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
149926129|NCT01733121|540865251|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
149926130|NCT03061188|540865252|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
149926131|NCT03061188|540865253|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
149926132|NCT03061188|540865254|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
149926133|NCT03061188|540865255|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
149926134|NCT03061188|540865252|FG000|On Follow-up for 3 Years|Death|0|||
149926135|NCT03061188|540865253|FG001|On Follow-up for 3 Years|Death|3|||
149926136|NCT03061188|540865254|FG002|On Follow-up for 3 Years|Death|5|||
149926137|NCT03061188|540865255|FG003|On Follow-up for 3 Years|Death|4|||
150262557|NCT03035201|542097774|FG000|Overall Study|Death|9|||
150262558|NCT03035201|542097775|FG001|Overall Study|Death|12|||
150262559|NCT03035201|542097776|FG002|Overall Study|Death|9|||
150262560|NCT03035201|542097777|FG003|Overall Study|Death|10|||
150262561|NCT03035201|542097774|FG000|Overall Study|Withdrawal by Subject|51|||
150262562|NCT03035201|542097775|FG001|Overall Study|Withdrawal by Subject|49|||
150262563|NCT03035201|542097776|FG002|Overall Study|Withdrawal by Subject|37|||
150262564|NCT03035201|542097777|FG003|Overall Study|Withdrawal by Subject|46|||
150262565|NCT03035201|542097774|FG000|Overall Study|Lost to Follow-up|67|||
150262566|NCT03035201|542097775|FG001|Overall Study|Lost to Follow-up|51|||
150262567|NCT03035201|542097776|FG002|Overall Study|Lost to Follow-up|64|||
150262568|NCT03035201|542097777|FG003|Overall Study|Lost to Follow-up|69|||
150262569|NCT00112047|542097784|FG000|Randomized Phase|Lost to Follow-up|26|||
150262570|NCT00112047|542097785|FG001|Randomized Phase|Lost to Follow-up|33|||
150262571|NCT00112047|542097784|FG000|Randomized Phase|Adverse Event|10|||
150262572|NCT00112047|542097785|FG001|Randomized Phase|Adverse Event|10|||
150262573|NCT00112047|542097784|FG000|Randomized Phase|Withrawal of consent|10|||
150262574|NCT00112047|542097785|FG001|Randomized Phase|Withrawal of consent|18|||
150262575|NCT00112047|542097784|FG000|Randomized Phase|Sub-optimal virological response|3|||
150262576|NCT00112047|542097785|FG001|Randomized Phase|Sub-optimal virological response|13|||
150262577|NCT00112047|542097784|FG000|Randomized Phase|Noncompliance|8|||
150262578|NCT00112047|542097785|FG001|Randomized Phase|Noncompliance|4|||
150262579|NCT00112047|542097784|FG000|Randomized Phase|Protocol Violation|2|||
150262580|NCT00112047|542097785|FG001|Randomized Phase|Protocol Violation|0|||
150262581|NCT00112047|542097784|FG000|Randomized Phase|Pregnancy|3|||
150262582|NCT00112047|542097785|FG001|Randomized Phase|Pregnancy|1|||
150262583|NCT00112047|542097784|FG000|Randomized Phase|Death|1|||
150262584|NCT00112047|542097785|FG001|Randomized Phase|Death|3|||
150262585|NCT00112047|542097784|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
150262586|NCT00112047|542097785|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
150262587|NCT00112047|542097784|FG000|Randomized Phase|Inability to swallow pills|0|||
150262588|NCT00112047|542097785|FG001|Randomized Phase|Inability to swallow pills|1|||
150262589|NCT00112047|542097784|FG000|Randomized Phase|Incarceration|3|||
150262590|NCT00112047|542097785|FG001|Randomized Phase|Incarceration|2|||
150262591|NCT00112047|542097784|FG000|Randomized Phase|Moved out of State|0|||
150262592|NCT00112047|542097785|FG001|Randomized Phase|Moved out of State|1|||
150262593|NCT00112047|542097784|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
150262594|NCT00112047|542097785|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
150262595|NCT00112047|542097784|FG000|Randomized Phase|High Hepatitis B DNA|0|||
150262596|NCT00112047|542097785|FG001|Randomized Phase|High Hepatitis B DNA|1|||
150262597|NCT00112047|542097784|FG000|Atripla Phase|Adverse Event|2|||
150262598|NCT00112047|542097785|FG001|Atripla Phase|Adverse Event|1|||
150262599|NCT00112047|542097784|FG000|Atripla Phase|Lost to Follow-up|5|||
150262600|NCT00112047|542097785|FG001|Atripla Phase|Lost to Follow-up|7|||
150262601|NCT00112047|542097784|FG000|Atripla Phase|Pregnancy|0|||
150262602|NCT00112047|542097785|FG001|Atripla Phase|Pregnancy|1|||
150262603|NCT00112047|542097784|FG000|Atripla Phase|Death|0|||
149926138|NCT03061188|540865252|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
149926139|NCT03061188|540865253|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
149926140|NCT03061188|540865254|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
149926141|NCT03061188|540865255|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
149926142|NCT02609984|540865259|FG000|Overall Study|Death|29|||
149926143|NCT02609984|540865260|FG001|Overall Study|Death|26|||
149926144|NCT02609984|540865259|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
150262604|NCT00112047|542097785|FG001|Atripla Phase|Death|2|||
150262605|NCT00112047|542097784|FG000|Atripla Phase|Withdrew consent|7|||
150262606|NCT00112047|542097785|FG001|Atripla Phase|Withdrew consent|7|||
150262607|NCT00112047|542097784|FG000|Atripla Phase|Sub-optimal virological response|0|||
150262608|NCT00112047|542097785|FG001|Atripla Phase|Sub-optimal virological response|1|||
149926145|NCT02609984|540865260|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
150262609|NCT00112047|542097784|FG000|Atripla Phase|Non-compliance|1|||
150262610|NCT00112047|542097785|FG001|Atripla Phase|Non-compliance|0|||
150262611|NCT00112047|542097784|FG000|Atripla Phase|Other|3|||
150262612|NCT00112047|542097785|FG001|Atripla Phase|Other|1|||
150262613|NCT03727438|542097786|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
150262614|NCT03727438|542097787|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
150262615|NCT03727438|542097786|FG000|Intervention Period|Excluded (health)|1|||
150262616|NCT03727438|542097787|FG001|Intervention Period|Excluded (health)|0|||
150262617|NCT03727438|542097786|FG000|Intervention Period|Withdrawal by Subject|3|||
150262618|NCT03727438|542097787|FG001|Intervention Period|Withdrawal by Subject|1|||
150262619|NCT03727438|542097786|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
150262620|NCT03727438|542097787|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
150262621|NCT03727438|542097786|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
150262622|NCT03727438|542097787|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
150262623|NCT03727438|542097786|FG000|8 Week Assessment|Withdrawal by Subject|6|||
150262624|NCT03727438|542097787|FG001|8 Week Assessment|Withdrawal by Subject|1|||
150262625|NCT03727438|542097786|FG000|6 mo Assessment|did not complete assessment|10|||
150262626|NCT03727438|542097787|FG001|6 mo Assessment|did not complete assessment|11|||
150262627|NCT03170349|542097788|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
150262628|NCT03170349|542097788|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
150262629|NCT03170349|542097788|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
150262630|NCT03170349|542097788|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
150262631|NCT03170349|542097788|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
150262632|NCT03170349|542097788|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
150262633|NCT03170349|542097788|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
150262634|NCT03170349|542097788|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
150262635|NCT03170349|542097788|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
150262636|NCT03170349|542097788|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
150262637|NCT03170349|542097788|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
150262638|NCT03170349|542097788|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
150262639|NCT03170349|542097788|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
150262640|NCT03170349|542097788|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
150262641|NCT03170349|542097788|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
150262642|NCT03170349|542097788|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
150262643|NCT01912456|542099732|FG000|Period 1|Physician Decision|0|||
150262644|NCT01912456|542099733|FG001|Period 1|Physician Decision|0|||
150262645|NCT01912456|542099734|FG002|Period 1|Physician Decision|1|||
150262646|NCT01912456|542099735|FG003|Period 1|Physician Decision|0|||
150262647|NCT01912456|542099732|FG000|Period 1|non-compliance|1|||
150262648|NCT01912456|542099733|FG001|Period 1|non-compliance|0|||
150262649|NCT01912456|542099734|FG002|Period 1|non-compliance|0|||
150262650|NCT01912456|542099735|FG003|Period 1|non-compliance|1|||
150262651|NCT01912456|542099732|FG000|Period 1|Adverse Event|1|||
150262652|NCT01912456|542099733|FG001|Period 1|Adverse Event|0|||
150262653|NCT01912456|542099734|FG002|Period 1|Adverse Event|0|||
150262654|NCT01912456|542099735|FG003|Period 1|Adverse Event|1|||
150262655|NCT01912456|542099732|FG000|Period 1|Withdrawal by Subject|0|||
150262656|NCT01912456|542099733|FG001|Period 1|Withdrawal by Subject|1|||
150262657|NCT01912456|542099734|FG002|Period 1|Withdrawal by Subject|1|||
150262658|NCT01912456|542099735|FG003|Period 1|Withdrawal by Subject|1|||
150262659|NCT01912456|542099732|FG000|Period 2|Lack of Efficacy|0|||
150262660|NCT01912456|542099733|FG001|Period 2|Lack of Efficacy|2|||
150262661|NCT01912456|542099734|FG002|Period 2|Lack of Efficacy|0|||
150262662|NCT01912456|542099735|FG003|Period 2|Lack of Efficacy|0|||
150262663|NCT01912456|542099732|FG000|Period 2|Adverse Event|0|||
150262664|NCT01912456|542099733|FG001|Period 2|Adverse Event|0|||
150262665|NCT01912456|542099734|FG002|Period 2|Adverse Event|0|||
150262666|NCT01912456|542099735|FG003|Period 2|Adverse Event|1|||
150262667|NCT03442985|542099736|FG000|Overall Study|Sponsor Request|55|||
150262668|NCT03442985|542099737|FG001|Overall Study|Sponsor Request|60|||
150262669|NCT03442985|542099738|FG002|Overall Study|Sponsor Request|54|||
150262670|NCT03442985|542099736|FG000|Overall Study|Lost to Follow-up|5|||
150262671|NCT03442985|542099737|FG001|Overall Study|Lost to Follow-up|2|||
150262672|NCT03442985|542099738|FG002|Overall Study|Lost to Follow-up|7|||
150262673|NCT03442985|542099736|FG000|Overall Study|Withdrawal by Subject|2|||
150262674|NCT03442985|542099737|FG001|Overall Study|Withdrawal by Subject|3|||
150262675|NCT03442985|542099738|FG002|Overall Study|Withdrawal by Subject|4|||
150262676|NCT03442985|542099736|FG000|Overall Study|Adverse Event|0|||
150262677|NCT03442985|542099737|FG001|Overall Study|Adverse Event|1|||
150262678|NCT03442985|542099738|FG002|Overall Study|Adverse Event|0|||
150262679|NCT01640054|542099739|FG000|Overall Study|Study-specific disc criteria|1|||
150262680|NCT01640054|542099739|FG000|Overall Study|Lack of Efficacy|3|||
150262681|NCT01640054|542099739|FG000|Overall Study|Adverse Event|2|||
150262682|NCT01620255|542099741|FG000|Overall Study|Withdrawal by Subject|4|||
150262683|NCT01620255|542099742|FG001|Overall Study|Withdrawal by Subject|1|||
150262684|NCT01620255|542099743|FG002|Overall Study|Withdrawal by Subject|1|||
150262685|NCT01620255|542099744|FG003|Overall Study|Withdrawal by Subject|2|||
149926146|NCT02609984|540865259|FG000|Overall Study|Lost to Follow-up|1|||
149926147|NCT02609984|540865260|FG001|Overall Study|Lost to Follow-up|2|||
149926148|NCT02609984|540865259|FG000|Overall Study|Withdrawal by Subject|0|||
149926149|NCT02609984|540865260|FG001|Overall Study|Withdrawal by Subject|1|||
149926150|NCT02609984|540865259|FG000|Overall Study|Disease Progression|2|||
149926151|NCT02609984|540865260|FG001|Overall Study|Disease Progression|0|||
149926152|NCT02306850|540865263|FG000|Overall Study|Lack of Efficacy|2|||
149926153|NCT02420262|540865264|FG000|Overall Study|Adverse Event|1|||
150162918|NCT00984282|541732107|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
150162919|NCT00984282|541732108|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
150162920|NCT00984282|541732107|FG000|Double Blind Treatment|Lost to Follow-up|3|||
150162921|NCT00984282|541732108|FG001|Double Blind Treatment|Lost to Follow-up|0|||
150162922|NCT00984282|541732107|FG000|Double Blind Treatment|Death|8|||
150162923|NCT00984282|541732108|FG001|Double Blind Treatment|Death|4|||
150162924|NCT00984282|541732107|FG000|Double Blind Treatment|Not treated|0|||
150162925|NCT00984282|541732108|FG001|Double Blind Treatment|Not treated|1|||
150162926|NCT00984282|541732107|FG000|Double Blind Treatment|Switched to commercial drug|6|||
150162927|NCT00984282|541732108|FG001|Double Blind Treatment|Switched to commercial drug|1|||
150162928|NCT00984282|541732107|FG000|Double Blind Treatment|protocol driven decision point|1|||
150162929|NCT00984282|541732108|FG001|Double Blind Treatment|protocol driven decision point|1|||
150162930|NCT00984282|541732107|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
150162931|NCT00984282|541732108|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
150162932|NCT00984282|541732107|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
150162933|NCT00984282|541732108|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
150162934|NCT00984282|541732107|FG000|Open-label Treatment|Adverse Event|20|||
150162935|NCT00984282|541732108|FG001|Open-label Treatment|Adverse Event|30|||
150162936|NCT00984282|541732107|FG000|Open-label Treatment|Withdrawal by Subject|6|||
150162937|NCT00984282|541732108|FG001|Open-label Treatment|Withdrawal by Subject|21|||
150162938|NCT00984282|541732107|FG000|Open-label Treatment|Death|7|||
150162939|NCT00984282|541732108|FG001|Open-label Treatment|Death|15|||
150162940|NCT00984282|541732107|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
150162941|NCT00984282|541732108|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
150162942|NCT00984282|541732107|FG000|Open-label Treatment|Lost to Follow-up|1|||
150162943|NCT00984282|541732108|FG001|Open-label Treatment|Lost to Follow-up|1|||
150162944|NCT00984282|541732107|FG000|Open-label Treatment|Patient convenience|1|||
150162945|NCT00984282|541732108|FG001|Open-label Treatment|Patient convenience|0|||
150162946|NCT00984282|541732107|FG000|Open-label Treatment|Non-compliant with study medication|1|||
150162947|NCT00984282|541732108|FG001|Open-label Treatment|Non-compliant with study medication|0|||
150162948|NCT00984282|541732107|FG000|Open-label Treatment|Target lesion removed|0|||
150162949|NCT00984282|541732108|FG001|Open-label Treatment|Target lesion removed|1|||
150162950|NCT00984282|541732107|FG000|Open-label Treatment|Protocol driven decision point|1|||
150162951|NCT00984282|541732108|FG001|Open-label Treatment|Protocol driven decision point|1|||
150162952|NCT00984282|541732107|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
150162953|NCT00984282|541732108|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
150162954|NCT00984282|541732107|FG000|Open-label Treatment|Switched to commercial drug|6|||
150162955|NCT00984282|541732108|FG001|Open-label Treatment|Switched to commercial drug|7|||
150162956|NCT00984282|541732107|FG000|Open-label Treatment|Physician Decision|1|||
150162957|NCT00984282|541732108|FG001|Open-label Treatment|Physician Decision|0|||
150162958|NCT00984282|541732107|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
150162959|NCT00984282|541732108|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
150162960|NCT00984282|541732107|FG000|Long Term Follow-up|Death|27|||
150162961|NCT00984282|541732108|FG001|Long Term Follow-up|Death|68|||
150162962|NCT00984282|541732107|FG000|Long Term Follow-up|Lost to Follow-up|3|||
150162963|NCT00984282|541732108|FG001|Long Term Follow-up|Lost to Follow-up|6|||
150162964|NCT00984282|541732107|FG000|Long Term Follow-up|Protocol driven decision point|25|||
150162965|NCT00984282|541732108|FG001|Long Term Follow-up|Protocol driven decision point|26|||
150162966|NCT00984282|541732107|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
150162967|NCT00984282|541732108|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
150162968|NCT00984282|541732107|FG000|Long Term Follow-up|Switched to commercial drug|4|||
150162969|NCT00984282|541732108|FG001|Long Term Follow-up|Switched to commercial drug|2|||
150162970|NCT00984282|541732107|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
150162971|NCT00984282|541732108|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
150162972|NCT02223793|541732109|FG000|Overall Study|Lost to Follow-up|10|||
150162973|NCT02223793|541732110|FG001|Overall Study|Lost to Follow-up|1|||
150162974|NCT02223793|541732111|FG002|Overall Study|Lost to Follow-up|2|||
150162975|NCT02223793|541732109|FG000|Overall Study|Withdrawal by Subject|3|||
150162976|NCT02223793|541732110|FG001|Overall Study|Withdrawal by Subject|2|||
150162977|NCT02223793|541732111|FG002|Overall Study|Withdrawal by Subject|3|||
150162978|NCT02223793|541732109|FG000|Overall Study|Moved/studycenter unable to participate|4|||
149926154|NCT02420262|540865265|FG001|Overall Study|Adverse Event|0|||
149926155|NCT02420262|540865264|FG000|Overall Study|Withdrawal by Subject|1|||
149926156|NCT02420262|540865265|FG001|Overall Study|Withdrawal by Subject|4|||
149926157|NCT02420262|540865264|FG000|Overall Study|Unclassified|0|||
149926158|NCT02420262|540865265|FG001|Overall Study|Unclassified|1|||
149926159|NCT00941304|540865266|FG000|Overall Study|Lost to Follow-up|1|||
149926160|NCT00941304|540865267|FG001|Overall Study|Lost to Follow-up|0|||
149926161|NCT00941304|540865268|FG002|Overall Study|Lost to Follow-up|0|||
149926162|NCT00941304|540865269|FG003|Overall Study|Lost to Follow-up|0|||
150162979|NCT02223793|541732110|FG001|Overall Study|Moved/studycenter unable to participate|6|||
150162980|NCT02223793|541732111|FG002|Overall Study|Moved/studycenter unable to participate|8|||
150162981|NCT00315055|541732112|FG000|Overall Study|Protocol Violation|2|||
150162982|NCT00315055|541732113|FG001|Overall Study|Protocol Violation|4|||
150162983|NCT00315055|541732112|FG000|Overall Study|Lost to Follow-up|1|||
150162984|NCT00315055|541732113|FG001|Overall Study|Lost to Follow-up|1|||
150162985|NCT02359435|541732114|FG000|Overall Study|Lost to Follow-up|4|||
150162986|NCT02359435|541732115|FG001|Overall Study|Lost to Follow-up|4|||
150162987|NCT00463151|541732122|FG000|Overall Study|Adverse Event|0|||
150162988|NCT00463151|541732123|FG001|Overall Study|Adverse Event|0|||
150162989|NCT00463151|541732124|FG002|Overall Study|Adverse Event|1|||
150162990|NCT00463151|541732125|FG003|Overall Study|Adverse Event|0|||
150162991|NCT00463151|541732122|FG000|Overall Study|Lack of Efficacy|2|||
150162992|NCT00463151|541732123|FG001|Overall Study|Lack of Efficacy|5|||
150162993|NCT00463151|541732124|FG002|Overall Study|Lack of Efficacy|2|||
150162994|NCT00463151|541732125|FG003|Overall Study|Lack of Efficacy|5|||
150162995|NCT00463151|541732122|FG000|Overall Study|Protocol Violation|0|||
150162996|NCT00463151|541732123|FG001|Overall Study|Protocol Violation|0|||
150162997|NCT00463151|541732124|FG002|Overall Study|Protocol Violation|0|||
150162998|NCT00463151|541732125|FG003|Overall Study|Protocol Violation|1|||
150162999|NCT00463151|541732122|FG000|Overall Study|Withdrawal by Subject|0|||
150163000|NCT00463151|541732123|FG001|Overall Study|Withdrawal by Subject|0|||
150163001|NCT00463151|541732124|FG002|Overall Study|Withdrawal by Subject|0|||
150163002|NCT00463151|541732125|FG003|Overall Study|Withdrawal by Subject|1|||
150163003|NCT05349084|541732126|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
150163004|NCT00972543|541732127|FG000|Overall Study|Adverse Event|1|||
150163005|NCT00972543|541732128|FG001|Overall Study|Adverse Event|0|||
150163006|NCT00972543|541732127|FG000|Overall Study|Early study termination by sponsor|4|||
150163007|NCT00972543|541732128|FG001|Overall Study|Early study termination by sponsor|1|||
150163008|NCT00293462|541732129|FG000|Overall Study|Withdrawal by Subject|4|||
150163009|NCT00293462|541732130|FG001|Overall Study|Withdrawal by Subject|3|||
150163010|NCT00293462|541732131|FG002|Overall Study|Withdrawal by Subject|8|||
150163011|NCT00293462|541732129|FG000|Overall Study|Death|1|||
150163012|NCT00293462|541732130|FG001|Overall Study|Death|0|||
150163013|NCT00293462|541732131|FG002|Overall Study|Death|0|||
150163014|NCT00293462|541732129|FG000|Overall Study|Lost to Follow-up|0|||
150163015|NCT00293462|541732130|FG001|Overall Study|Lost to Follow-up|1|||
150163016|NCT00293462|541732131|FG002|Overall Study|Lost to Follow-up|0|||
150163017|NCT00293462|541732129|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
150163018|NCT00293462|541732130|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
150163019|NCT00293462|541732131|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
150163020|NCT00293462|541732129|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
150163021|NCT00293462|541732130|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
150163022|NCT00293462|541732131|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
150163023|NCT00293462|541732129|FG000|Overall Study|Refuse Radiation Treatment|1|||
150262686|NCT01620255|542099745|FG004|Overall Study|Withdrawal by Subject|4|||
150262687|NCT01620255|542099741|FG000|Overall Study|Participant underwent fecal transplant|0|||
150262688|NCT01620255|542099742|FG001|Overall Study|Participant underwent fecal transplant|0|||
149926163|NCT00941304|540865270|FG004|Overall Study|Lost to Follow-up|0|||
149926164|NCT03293394|540865271|FG000|Follow-up (6 Months)|Adverse Event|4|||
149926165|NCT03293394|540865272|FG001|Follow-up (6 Months)|Adverse Event|2|||
149926166|NCT00784719|540865275|FG000|Overall Study|Adverse Event|0|||
149926167|NCT00784719|540865276|FG001|Overall Study|Adverse Event|2|||
149926168|NCT00784719|540865277|FG002|Overall Study|Adverse Event|0|||
149926169|NCT00784719|540865278|FG003|Overall Study|Adverse Event|0|||
149926170|NCT00784719|540865279|FG004|Overall Study|Adverse Event|1|||
149926171|NCT00784719|540865280|FG005|Overall Study|Adverse Event|1|||
149926172|NCT00784719|540865281|FG006|Overall Study|Adverse Event|1|||
149926173|NCT00784719|540865275|FG000|Overall Study|Lost to Follow-up|0|||
150163024|NCT00293462|541732130|FG001|Overall Study|Refuse Radiation Treatment|0|||
150163025|NCT00293462|541732131|FG002|Overall Study|Refuse Radiation Treatment|0|||
150163026|NCT00293462|541732129|FG000|Overall Study|No Show|0|||
150163027|NCT00293462|541732130|FG001|Overall Study|No Show|0|||
150262689|NCT01620255|542099743|FG002|Overall Study|Participant underwent fecal transplant|1|||
149926174|NCT00784719|540865276|FG001|Overall Study|Lost to Follow-up|0|||
149926175|NCT00784719|540865277|FG002|Overall Study|Lost to Follow-up|0|||
149926176|NCT00784719|540865278|FG003|Overall Study|Lost to Follow-up|0|||
149926177|NCT00784719|540865279|FG004|Overall Study|Lost to Follow-up|1|||
149926178|NCT00784719|540865280|FG005|Overall Study|Lost to Follow-up|1|||
150163028|NCT00293462|541732131|FG002|Overall Study|No Show|1|||
150163029|NCT00293462|541732129|FG000|Overall Study|Went back to his home country|0|||
150163030|NCT00293462|541732130|FG001|Overall Study|Went back to his home country|0|||
150163031|NCT00293462|541732131|FG002|Overall Study|Went back to his home country|1|||
150163032|NCT00293462|541732129|FG000|Overall Study|Blood clot after chemotherapy|0|||
150163033|NCT00293462|541732130|FG001|Overall Study|Blood clot after chemotherapy|0|||
150163034|NCT00293462|541732131|FG002|Overall Study|Blood clot after chemotherapy|1|||
150163035|NCT00293462|541732129|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
150163036|NCT00293462|541732130|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
150163037|NCT00293462|541732131|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
150163038|NCT00293462|541732129|FG000|Overall Study|Possible Tracheostomy leakage|0|||
150163039|NCT00293462|541732130|FG001|Overall Study|Possible Tracheostomy leakage|1|||
150163040|NCT00293462|541732131|FG002|Overall Study|Possible Tracheostomy leakage|0|||
150163041|NCT00293462|541732129|FG000|Overall Study|Low radiation dose in oral cavity|0|||
150163042|NCT00293462|541732130|FG001|Overall Study|Low radiation dose in oral cavity|1|||
150163043|NCT00293462|541732131|FG002|Overall Study|Low radiation dose in oral cavity|0|||
150163044|NCT00293462|541732129|FG000|Overall Study|Physician Decision|0|||
150163045|NCT00293462|541732130|FG001|Overall Study|Physician Decision|1|||
150163046|NCT00293462|541732131|FG002|Overall Study|Physician Decision|0|||
150163047|NCT00688688|541732132|FG000|Overall Study|Eligibility criterion not met|7|||
150163048|NCT00688688|541732133|FG001|Overall Study|Eligibility criterion not met|7|||
150163049|NCT00688688|541732134|FG002|Overall Study|Eligibility criterion not met|10|||
150163050|NCT00688688|541732132|FG000|Overall Study|Adverse Event|52|||
150163051|NCT00688688|541732133|FG001|Overall Study|Adverse Event|51|||
150163052|NCT00688688|541732134|FG002|Overall Study|Adverse Event|50|||
150163053|NCT00688688|541732132|FG000|Overall Study|Lack of Efficacy|34|||
150163054|NCT00688688|541732133|FG001|Overall Study|Lack of Efficacy|25|||
150163055|NCT00688688|541732134|FG002|Overall Study|Lack of Efficacy|45|||
150163056|NCT00688688|541732132|FG000|Overall Study|Withdrawal by Subject|66|||
150163057|NCT00688688|541732133|FG001|Overall Study|Withdrawal by Subject|75|||
150163058|NCT00688688|541732134|FG002|Overall Study|Withdrawal by Subject|65|||
150163059|NCT00688688|541732132|FG000|Overall Study|Lost to Follow-up|14|||
150163060|NCT00688688|541732133|FG001|Overall Study|Lost to Follow-up|7|||
150163061|NCT00688688|541732134|FG002|Overall Study|Lost to Follow-up|7|||
150163062|NCT00688688|541732132|FG000|Overall Study|Protocol Violation|6|||
150163063|NCT00688688|541732133|FG001|Overall Study|Protocol Violation|9|||
150163064|NCT00688688|541732134|FG002|Overall Study|Protocol Violation|11|||
150163065|NCT00688688|541732132|FG000|Overall Study|Randomized but never received study drug|1|||
150163066|NCT00688688|541732133|FG001|Overall Study|Randomized but never received study drug|0|||
150163067|NCT00688688|541732134|FG002|Overall Study|Randomized but never received study drug|0|||
150163068|NCT00688688|541732132|FG000|Overall Study|Non-compliance with study procedures|5|||
150163069|NCT00688688|541732133|FG001|Overall Study|Non-compliance with study procedures|3|||
150163070|NCT00688688|541732134|FG002|Overall Study|Non-compliance with study procedures|4|||
150163071|NCT00688688|541732132|FG000|Overall Study|Taking exclusionary medications|1|||
150163072|NCT00688688|541732133|FG001|Overall Study|Taking exclusionary medications|0|||
150163073|NCT00688688|541732134|FG002|Overall Study|Taking exclusionary medications|0|||
150163074|NCT00688688|541732132|FG000|Overall Study|Site closure|0|||
150163075|NCT00688688|541732133|FG001|Overall Study|Site closure|1|||
150163076|NCT00688688|541732134|FG002|Overall Study|Site closure|0|||
150163077|NCT00688688|541732132|FG000|Overall Study|Violation of exclusion criterion|0|||
150163078|NCT00688688|541732133|FG001|Overall Study|Violation of exclusion criterion|1|||
150163079|NCT00688688|541732134|FG002|Overall Study|Violation of exclusion criterion|0|||
150163080|NCT04296942|541732135|FG000|Overall Study|Study closure by sponsor|1|||
150163081|NCT04296942|541732136|FG001|Overall Study|Study closure by sponsor|0|||
150163082|NCT04296942|541732137|FG002|Overall Study|Study closure by sponsor|0|||
150163083|NCT01770860|541732138|FG000|Overall Study|Withdrawal by Subject|4|||
150163084|NCT01770860|541732138|FG000|Overall Study|Lost to Follow-up|1|||
150163085|NCT01770860|541732138|FG000|Overall Study|Administrative decision made by the PI|1|||
150163086|NCT01528709|541732139|FG000|Overall Study|Death|2|||
150163087|NCT01528709|541732140|FG001|Overall Study|Death|0|||
150163088|NCT01528709|541732139|FG000|Overall Study|Withdrawal by Subject|10|||
150163089|NCT01528709|541732140|FG001|Overall Study|Withdrawal by Subject|15|||
150163090|NCT01528709|541732139|FG000|Overall Study|allergy|1|||
150163091|NCT01528709|541732140|FG001|Overall Study|allergy|0|||
150163092|NCT01237678|541732142|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
150163093|NCT01237678|541732143|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
150163094|NCT01237678|541732144|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
150163095|NCT01237678|541732142|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
150163096|NCT01237678|541732143|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
150163097|NCT01237678|541732144|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
150163098|NCT01237678|541732142|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
150163099|NCT01237678|541732143|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
150262690|NCT01620255|542099744|FG003|Overall Study|Participant underwent fecal transplant|0|||
149926179|NCT00784719|540865281|FG006|Overall Study|Lost to Follow-up|0|||
149926180|NCT00784719|540865275|FG000|Overall Study|Other|2|||
149926181|NCT00784719|540865276|FG001|Overall Study|Other|1|||
149926182|NCT00784719|540865277|FG002|Overall Study|Other|1|||
149926183|NCT00784719|540865278|FG003|Overall Study|Other|0|||
149926184|NCT00784719|540865279|FG004|Overall Study|Other|2|||
149926185|NCT00784719|540865280|FG005|Overall Study|Other|1|||
149926186|NCT00784719|540865281|FG006|Overall Study|Other|3|||
149926187|NCT00784719|540865275|FG000|Overall Study|Withdrawal by Subject|1|||
149926188|NCT00784719|540865276|FG001|Overall Study|Withdrawal by Subject|0|||
149926189|NCT00784719|540865277|FG002|Overall Study|Withdrawal by Subject|0|||
150262691|NCT01620255|542099745|FG004|Overall Study|Participant underwent fecal transplant|0|||
150262692|NCT01620255|542099741|FG000|Overall Study|Non-compliance|0|||
150262693|NCT01620255|542099742|FG001|Overall Study|Non-compliance|1|||
150262694|NCT01620255|542099743|FG002|Overall Study|Non-compliance|0|||
150262695|NCT01620255|542099744|FG003|Overall Study|Non-compliance|0|||
150262696|NCT01620255|542099745|FG004|Overall Study|Non-compliance|0|||
150262697|NCT01620255|542099741|FG000|Overall Study|Adverse Event|0|||
150262698|NCT01620255|542099742|FG001|Overall Study|Adverse Event|4|||
150262699|NCT01620255|542099743|FG002|Overall Study|Adverse Event|0|||
150262700|NCT01620255|542099744|FG003|Overall Study|Adverse Event|1|||
150262701|NCT01620255|542099745|FG004|Overall Study|Adverse Event|1|||
150262702|NCT01620255|542099741|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
150262703|NCT01620255|542099742|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
150262704|NCT01620255|542099743|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
150262705|NCT01620255|542099744|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
150262706|NCT01620255|542099745|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
150262707|NCT01557283|542099749|FG000|Overall Study|Lost to Follow-up|7|||
150262708|NCT01557283|542099749|FG000|Overall Study|Non-responder|19|||
150262709|NCT01557283|542099749|FG000|Overall Study|Adverse Event|7|||
150262710|NCT01557283|542099749|FG000|Overall Study|Lack of Efficacy|1|||
149926190|NCT00784719|540865278|FG003|Overall Study|Withdrawal by Subject|0|||
149926191|NCT00784719|540865279|FG004|Overall Study|Withdrawal by Subject|2|||
149926192|NCT00784719|540865280|FG005|Overall Study|Withdrawal by Subject|0|||
149926193|NCT00784719|540865281|FG006|Overall Study|Withdrawal by Subject|1|||
149926194|NCT04633226|540865285|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149926195|NCT04633226|540865285|FG000|Overall Study|Randomized by mistake without study treatment|1|||
149926196|NCT05415462|540865288|FG000|Overall Study|Death|18|||
149926197|NCT05415462|540865289|FG001|Overall Study|Death|10|||
149926198|NCT05415462|540865288|FG000|Overall Study|Lost to Follow-up|72|||
149926199|NCT05415462|540865289|FG001|Overall Study|Lost to Follow-up|64|||
149926200|NCT05415462|540865288|FG000|Overall Study|Physician Decision|5|||
149926201|NCT05415462|540865289|FG001|Overall Study|Physician Decision|5|||
149926202|NCT05415462|540865288|FG000|Overall Study|Protocol Deviation|1|||
149926203|NCT05415462|540865289|FG001|Overall Study|Protocol Deviation|0|||
149926204|NCT05415462|540865288|FG000|Overall Study|Withdrawal by Subject|129|||
149926205|NCT05415462|540865289|FG001|Overall Study|Withdrawal by Subject|101|||
149926206|NCT05415462|540865288|FG000|Overall Study|Other Than Specified|8|||
149926207|NCT05415462|540865289|FG001|Overall Study|Other Than Specified|8|||
149926208|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
149926209|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
149926210|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
149926211|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
149926212|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
149926213|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
149926214|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
149926215|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
150262711|NCT01557283|542099749|FG000|Overall Study|Non-compliance|1|||
150262712|NCT01557283|542099749|FG000|Overall Study|Withdrawal by Subject|1|||
150262713|NCT01557283|542099749|FG000|Overall Study|Participant's weight too high for dose|1|||
150262714|NCT01557283|542099749|FG000|Overall Study|Worsening of psoriasis|1|||
150262715|NCT01557283|542099749|FG000|Overall Study|Other|6|||
150262716|NCT01716117|542099750|FG000|Overall Study|Death|5|||
150262717|NCT01716117|542099751|FG001|Overall Study|Death|2|||
150262718|NCT01716117|542099750|FG000|Overall Study|Withdrawal by Subject|2|||
150262719|NCT01716117|542099751|FG001|Overall Study|Withdrawal by Subject|0|||
150262720|NCT03645057|542099752|FG000|Randomization to Baseline|Lost to Follow-up|1|||
149926216|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
149926217|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
149926218|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
149926219|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
149926220|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
149926221|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
149926222|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
150262721|NCT03645057|542099753|FG001|Randomization to Baseline|Lost to Follow-up|0|||
149926223|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
149926224|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
150163100|NCT01237678|541732144|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
150163101|NCT01237678|541732142|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
150163102|NCT01237678|541732143|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
150163103|NCT01237678|541732144|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
150163104|NCT01237678|541732142|FG000|Phase II|Adverse Event|0|||
150163105|NCT01237678|541732143|FG001|Phase II|Adverse Event|39|||
150163106|NCT01237678|541732144|FG002|Phase II|Adverse Event|9|||
150163107|NCT01237678|541732142|FG000|Phase II|Death|0|||
150163108|NCT01237678|541732143|FG001|Phase II|Death|0|||
150163109|NCT01237678|541732144|FG002|Phase II|Death|2|||
150163110|NCT01237678|541732142|FG000|Phase II|Lack of Efficacy|0|||
150163111|NCT01237678|541732143|FG001|Phase II|Lack of Efficacy|25|||
150163112|NCT01237678|541732144|FG002|Phase II|Lack of Efficacy|3|||
150163113|NCT01237678|541732142|FG000|Phase II|Withdrawal by Subject|0|||
150163114|NCT01237678|541732143|FG001|Phase II|Withdrawal by Subject|1|||
150163115|NCT01237678|541732144|FG002|Phase II|Withdrawal by Subject|5|||
150163116|NCT01237678|541732142|FG000|Phase II|Completed Cycles 4-6|0|||
150163117|NCT01237678|541732143|FG001|Phase II|Completed Cycles 4-6|11|||
150163118|NCT01237678|541732144|FG002|Phase II|Completed Cycles 4-6|21|||
150163119|NCT01237678|541732142|FG000|Phase II|Sponsor Decision/Study Closed|0|||
150163120|NCT01237678|541732143|FG001|Phase II|Sponsor Decision/Study Closed|18|||
150163121|NCT01237678|541732144|FG002|Phase II|Sponsor Decision/Study Closed|7|||
150163122|NCT01237678|541732142|FG000|Phase II|Randomized but were not treated|0|||
150163123|NCT01237678|541732143|FG001|Phase II|Randomized but were not treated|4|||
150163124|NCT01237678|541732144|FG002|Phase II|Randomized but were not treated|3|||
150163125|NCT05124899|541732147|FG000|Overall Study|Lost to Follow-up|3|||
150163126|NCT00530777|541732156|FG000|Overall Study|Lost to Follow-up|0|||
150163127|NCT00530777|541732157|FG001|Overall Study|Lost to Follow-up|1|||
150163128|NCT00530777|541732156|FG000|Overall Study|Death|1|||
150163129|NCT00530777|541732157|FG001|Overall Study|Death|2|||
150163130|NCT00530777|541732156|FG000|Overall Study|Physician Decision|1|||
150163131|NCT00530777|541732157|FG001|Overall Study|Physician Decision|0|||
150163132|NCT00530777|541732156|FG000|Overall Study|Withdrawal by Subject|0|||
150163133|NCT00530777|541732157|FG001|Overall Study|Withdrawal by Subject|1|||
150163134|NCT00530777|541732156|FG000|Overall Study|Unable to adhere to visit schedule|5|||
150163135|NCT00530777|541732157|FG001|Overall Study|Unable to adhere to visit schedule|1|||
150163136|NCT01582243|541732159|FG000|Overall Study|Withdrawal by Subject|1|||
150163137|NCT01582243|541732159|FG000|Overall Study|Adverse Event|1|||
150163138|NCT01582243|541732159|FG000|Overall Study|Lost to Follow-up|1|||
150163139|NCT03382821|541732160|FG000|Overall Study|Did not receive allocated intervention.|0|||
150163140|NCT03382821|541732161|FG001|Overall Study|Did not receive allocated intervention.|3|||
150163141|NCT00797225|541732163|FG000|Weeks 1 to 12|Adverse Event|0|||
150163142|NCT00797225|541732164|FG001|Weeks 1 to 12|Adverse Event|0|||
150163143|NCT00797225|541732165|FG002|Weeks 1 to 12|Adverse Event|1|||
150163144|NCT00797225|541732166|FG003|Weeks 1 to 12|Adverse Event|0|||
150163145|NCT00797225|541732167|FG004|Weeks 1 to 12|Adverse Event|0|||
150163146|NCT00797225|541732168|FG005|Weeks 1 to 12|Adverse Event|0|||
150163147|NCT00797225|541732169|FG006|Weeks 1 to 12|Adverse Event|0|||
150163148|NCT00797225|541732170|FG007|Weeks 1 to 12|Adverse Event|0|||
150163149|NCT00797225|541732163|FG000|Weeks 1 to 12|Non-compliance|0|||
150163150|NCT00797225|541732164|FG001|Weeks 1 to 12|Non-compliance|1|||
150163151|NCT00797225|541732165|FG002|Weeks 1 to 12|Non-compliance|0|||
150163152|NCT00797225|541732166|FG003|Weeks 1 to 12|Non-compliance|0|||
150163153|NCT00797225|541732167|FG004|Weeks 1 to 12|Non-compliance|0|||
150163154|NCT00797225|541732168|FG005|Weeks 1 to 12|Non-compliance|0|||
150163155|NCT00797225|541732169|FG006|Weeks 1 to 12|Non-compliance|0|||
150163156|NCT00797225|541732170|FG007|Weeks 1 to 12|Non-compliance|0|||
150163157|NCT00797225|541732163|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
150163158|NCT00797225|541732164|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
150163159|NCT00797225|541732165|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
150163160|NCT00797225|541732166|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
150163161|NCT00797225|541732167|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
150163162|NCT00797225|541732168|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
150163163|NCT00797225|541732169|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
150163164|NCT00797225|541732170|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
150163165|NCT00797225|541732163|FG000|Weeks 1 to 12|Sponsor Decision|1|||
150163166|NCT00797225|541732164|FG001|Weeks 1 to 12|Sponsor Decision|0|||
150163167|NCT00797225|541732165|FG002|Weeks 1 to 12|Sponsor Decision|0|||
150163168|NCT00797225|541732166|FG003|Weeks 1 to 12|Sponsor Decision|0|||
149926225|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
150163169|NCT00797225|541732167|FG004|Weeks 1 to 12|Sponsor Decision|0|||
150163170|NCT00797225|541732168|FG005|Weeks 1 to 12|Sponsor Decision|0|||
150163171|NCT00797225|541732169|FG006|Weeks 1 to 12|Sponsor Decision|0|||
150163172|NCT00797225|541732170|FG007|Weeks 1 to 12|Sponsor Decision|0|||
150163173|NCT00797225|541732163|FG000|Weeks 13 to 24|Non-compliance|0|||
150163174|NCT00797225|541732164|FG001|Weeks 13 to 24|Non-compliance|2|||
150163175|NCT00797225|541732165|FG002|Weeks 13 to 24|Non-compliance|0|||
150262722|NCT03645057|542099754|FG002|Randomization to Baseline|Lost to Follow-up|1|||
150262723|NCT03645057|542099755|FG003|Randomization to Baseline|Lost to Follow-up|0|||
150262724|NCT03645057|542099752|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
150262725|NCT03645057|542099753|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
150262726|NCT03645057|542099754|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
150262727|NCT03645057|542099755|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
150262728|NCT03645057|542099752|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
150262729|NCT03645057|542099753|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
150262730|NCT03645057|542099754|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
150262731|NCT03645057|542099755|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
150262732|NCT03645057|542099752|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
150262733|NCT03645057|542099753|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
150262734|NCT03645057|542099754|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
150262735|NCT03645057|542099755|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
150262736|NCT01206777|542099756|FG000|Overall Study|Death|1|||
150262737|NCT01206777|542099756|FG000|Overall Study|Adverse Event|1|||
150262738|NCT01155375|542099761|FG000|Overall Study|Adverse Event|1|||
150262739|NCT01155375|542099762|FG001|Overall Study|Adverse Event|0|||
150262740|NCT00975507|542099763|FG000|Overall Study|Adverse Event|1|||
150262741|NCT00975507|542099764|FG001|Overall Study|Adverse Event|0|||
150262742|NCT00975507|542099763|FG000|Overall Study|Lost to Follow-up|7|||
150262743|NCT00975507|542099764|FG001|Overall Study|Lost to Follow-up|1|||
150262744|NCT00975507|542099763|FG000|Overall Study|Protocol Violation|2|||
150262745|NCT00975507|542099764|FG001|Overall Study|Protocol Violation|0|||
150262746|NCT00975507|542099763|FG000|Overall Study|Withdrawal by Subject|10|||
150262747|NCT00975507|542099764|FG001|Overall Study|Withdrawal by Subject|3|||
150262748|NCT01295034|542099765|FG000|Overall Study|Lost to Follow-up|5|||
150262749|NCT01295034|542099766|FG001|Overall Study|Lost to Follow-up|5|||
150262750|NCT03818204|542099767|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262751|NCT03818204|542099768|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262752|NCT03818204|542099769|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262753|NCT03818204|542099770|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262754|NCT03818204|542099771|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
150262755|NCT03818204|542099772|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262756|NCT03818204|542099773|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262757|NCT03818204|542099774|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262758|NCT03818204|542099775|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262759|NCT03818204|542099776|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262760|NCT03818204|542099777|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262761|NCT03818204|542099778|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262762|NCT03818204|542099779|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262763|NCT03818204|542099780|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
150262764|NCT03818204|542099781|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262765|NCT03818204|542099782|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262766|NCT03818204|542099783|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262767|NCT03818204|542099784|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262768|NCT03818204|542099785|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
150262769|NCT03818204|542099767|FG000|Overall Study|Physician Decision|0|||
150262770|NCT03818204|542099768|FG001|Overall Study|Physician Decision|0|||
150262771|NCT03818204|542099769|FG002|Overall Study|Physician Decision|0|||
150262772|NCT03818204|542099770|FG003|Overall Study|Physician Decision|0|||
150262773|NCT03818204|542099771|FG004|Overall Study|Physician Decision|0|||
150262774|NCT03818204|542099772|FG005|Overall Study|Physician Decision|0|||
150262775|NCT03818204|542099773|FG006|Overall Study|Physician Decision|0|||
150262776|NCT03818204|542099774|FG007|Overall Study|Physician Decision|0|||
150262777|NCT03818204|542099775|FG008|Overall Study|Physician Decision|0|||
150262778|NCT03818204|542099776|FG009|Overall Study|Physician Decision|0|||
150262779|NCT03818204|542099777|FG010|Overall Study|Physician Decision|0|||
150262780|NCT03818204|542099778|FG011|Overall Study|Physician Decision|0|||
150262781|NCT03818204|542099779|FG012|Overall Study|Physician Decision|0|||
150262782|NCT03818204|542099780|FG013|Overall Study|Physician Decision|0|||
150262783|NCT03818204|542099781|FG014|Overall Study|Physician Decision|1|||
150262784|NCT03818204|542099782|FG015|Overall Study|Physician Decision|0|||
150262785|NCT03818204|542099783|FG016|Overall Study|Physician Decision|0|||
150262786|NCT03818204|542099784|FG017|Overall Study|Physician Decision|0|||
150262787|NCT03818204|542099785|FG018|Overall Study|Physician Decision|0|||
150262788|NCT00887250|542099786|FG000|Overall Study|Adverse Event|3|||
150262789|NCT00887250|542099787|FG001|Overall Study|Adverse Event|0|||
150262790|NCT00887250|542099788|FG002|Overall Study|Adverse Event|7|||
150262791|NCT00887250|542099786|FG000|Overall Study|Lack of Efficacy|9|||
150262792|NCT00887250|542099787|FG001|Overall Study|Lack of Efficacy|6|||
150262793|NCT00887250|542099788|FG002|Overall Study|Lack of Efficacy|1|||
149926226|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
149926227|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
150262794|NCT00887250|542099786|FG000|Overall Study|Lost to Follow-up|2|||
150262795|NCT00887250|542099787|FG001|Overall Study|Lost to Follow-up|3|||
150262796|NCT00887250|542099788|FG002|Overall Study|Lost to Follow-up|1|||
150262797|NCT00887250|542099786|FG000|Overall Study|Protocol Violation|2|||
150262798|NCT00887250|542099787|FG001|Overall Study|Protocol Violation|2|||
150262799|NCT00887250|542099788|FG002|Overall Study|Protocol Violation|1|||
150262800|NCT00887250|542099786|FG000|Overall Study|Withdrawal by Subject|2|||
150262801|NCT00887250|542099787|FG001|Overall Study|Withdrawal by Subject|1|||
150262802|NCT00887250|542099788|FG002|Overall Study|Withdrawal by Subject|2|||
150262803|NCT00887250|542099786|FG000|Overall Study|Patient uncooperative|0|||
150262804|NCT00887250|542099787|FG001|Overall Study|Patient uncooperative|0|||
150262805|NCT00887250|542099788|FG002|Overall Study|Patient uncooperative|1|||
150262806|NCT05754333|542099789|FG000|Overall Study|Miscellaneous|3|||
150262807|NCT05754333|542099790|FG001|Overall Study|Miscellaneous|0|||
150262808|NCT05754333|542099791|FG002|Overall Study|Miscellaneous|0|||
150262809|NCT05754333|542099792|FG003|Overall Study|Miscellaneous|0|||
150262810|NCT05754333|542099789|FG000|Overall Study|Lost to Follow-up|2|||
150262811|NCT05754333|542099790|FG001|Overall Study|Lost to Follow-up|1|||
150262812|NCT05754333|542099791|FG002|Overall Study|Lost to Follow-up|0|||
150262813|NCT05754333|542099792|FG003|Overall Study|Lost to Follow-up|1|||
150262814|NCT03864146|542099793|FG000|Overall Study|Lost to Follow-up|14|||
150262815|NCT03864146|542099794|FG001|Overall Study|Lost to Follow-up|23|||
150262816|NCT03864146|542099793|FG000|Overall Study|Withdrawal by Subject|3|||
150262817|NCT03864146|542099794|FG001|Overall Study|Withdrawal by Subject|2|||
150262818|NCT00824161|542099795|FG000|Overall Study|Withdrawal by Subject|1|||
150262819|NCT00824161|542099795|FG000|Overall Study|Screen Failure|1|||
150262820|NCT04981366|542099796|FG000|Overall Study|Withdrawal by Subject|5|||
150262821|NCT04981366|542099797|FG001|Overall Study|Withdrawal by Subject|4|||
150262822|NCT04981366|542099798|FG002|Overall Study|Withdrawal by Subject|8|||
150262823|NCT04981366|542099796|FG000|Overall Study|Health issues unrelated to the trial|1|||
149926228|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
149926229|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
149926230|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
149926231|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
149926232|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
149926233|NCT02137226|540865313|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
149926234|NCT02137226|540865314|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
149926235|NCT02137226|540865315|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
149926236|NCT02137226|540865316|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
149926237|NCT02137226|540865317|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
149926238|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
149926239|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
149926240|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
149926241|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
149926242|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
150163176|NCT00797225|541732166|FG003|Weeks 13 to 24|Non-compliance|0|||
150163177|NCT00797225|541732167|FG004|Weeks 13 to 24|Non-compliance|0|||
150163178|NCT00797225|541732168|FG005|Weeks 13 to 24|Non-compliance|0|||
150163179|NCT00797225|541732169|FG006|Weeks 13 to 24|Non-compliance|0|||
150163180|NCT00797225|541732170|FG007|Weeks 13 to 24|Non-compliance|0|||
150163181|NCT00797225|541732163|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
150163182|NCT00797225|541732164|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
150163183|NCT00797225|541732165|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
150163184|NCT00797225|541732166|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
150163185|NCT00797225|541732167|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
150163186|NCT00797225|541732168|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
150163187|NCT00797225|541732169|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
150163188|NCT00797225|541732170|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
150163189|NCT00797225|541732163|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
150163190|NCT00797225|541732164|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
150163191|NCT00797225|541732165|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
150163192|NCT00797225|541732166|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
150163193|NCT00797225|541732167|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
150262824|NCT04981366|542099797|FG001|Overall Study|Health issues unrelated to the trial|2|||
150262825|NCT04981366|542099798|FG002|Overall Study|Health issues unrelated to the trial|0|||
150262826|NCT01112306|542099799|FG000|Overall Study|Death|175|||
150262827|NCT01112306|542099799|FG000|Overall Study|Lost to Follow-up|9|||
150262828|NCT01112306|542099799|FG000|Overall Study|Withdrawal by Subject|31|||
149926243|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
149926244|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
149926245|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
150163194|NCT00797225|541732168|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
150262829|NCT01112306|542099799|FG000|Overall Study|Other|70|||
149926246|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
149926247|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
149926248|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
149926249|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
149926250|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
149926251|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
149926252|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
149926253|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
149926254|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
149926255|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
149926256|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
149926257|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
149926258|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
149926259|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
149926260|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
149926261|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
149926262|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
149926263|NCT02137226|540865313|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
149926264|NCT02137226|540865314|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
149926265|NCT02137226|540865315|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
149926266|NCT02137226|540865316|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
149926267|NCT02137226|540865317|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
149926268|NCT02998996|540865318|FG000|Overall Study|Lost to Follow-up|0|||
149926269|NCT02998996|540865319|FG001|Overall Study|Lost to Follow-up|0|||
149926270|NCT02998996|540865320|FG002|Overall Study|Lost to Follow-up|1|||
149926271|NCT02998996|540865321|FG003|Overall Study|Lost to Follow-up|0|||
149926272|NCT02998996|540865322|FG004|Overall Study|Lost to Follow-up|0|||
149926273|NCT02998996|540865323|FG005|Overall Study|Lost to Follow-up|0|||
149926274|NCT02998996|540865318|FG000|Overall Study|Pregnancy|0|||
149926275|NCT02998996|540865319|FG001|Overall Study|Pregnancy|1|||
149926276|NCT02998996|540865320|FG002|Overall Study|Pregnancy|0|||
149926277|NCT02998996|540865321|FG003|Overall Study|Pregnancy|0|||
149926278|NCT02998996|540865322|FG004|Overall Study|Pregnancy|0|||
149926279|NCT02998996|540865323|FG005|Overall Study|Pregnancy|0|||
149926280|NCT02998996|540865318|FG000|Overall Study|Family reasons|0|||
149926281|NCT02998996|540865319|FG001|Overall Study|Family reasons|0|||
149926282|NCT02998996|540865320|FG002|Overall Study|Family reasons|0|||
149926283|NCT02998996|540865321|FG003|Overall Study|Family reasons|0|||
149926284|NCT02998996|540865322|FG004|Overall Study|Family reasons|1|||
149926285|NCT02998996|540865323|FG005|Overall Study|Family reasons|0|||
149926286|NCT00003896|540865328|FG000|Overall Study|Adverse Event|16|||
149926287|NCT00003896|540865328|FG000|Overall Study|Withdrawal by Subject|1|||
149926288|NCT00003896|540865328|FG000|Overall Study|Lack of Efficacy|1|||
149926289|NCT00003896|540865328|FG000|Overall Study|Death|3|||
149926290|NCT00003896|540865328|FG000|Overall Study|not protocol specified|3|||
150163195|NCT00797225|541732169|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
150163196|NCT00797225|541732170|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
150163197|NCT00797225|541732163|FG000|Weeks 13 to 24|Adverse Event|0|||
150163198|NCT00797225|541732164|FG001|Weeks 13 to 24|Adverse Event|1|||
150163199|NCT00797225|541732165|FG002|Weeks 13 to 24|Adverse Event|0|||
150163200|NCT00797225|541732166|FG003|Weeks 13 to 24|Adverse Event|0|||
150163201|NCT00797225|541732167|FG004|Weeks 13 to 24|Adverse Event|0|||
150163202|NCT00797225|541732168|FG005|Weeks 13 to 24|Adverse Event|0|||
150163203|NCT00797225|541732169|FG006|Weeks 13 to 24|Adverse Event|1|||
150163204|NCT00797225|541732170|FG007|Weeks 13 to 24|Adverse Event|0|||
150163205|NCT00797225|541732163|FG000|Weeks 13 to 24|Sponsor Decision|0|||
150163206|NCT00797225|541732164|FG001|Weeks 13 to 24|Sponsor Decision|0|||
150163207|NCT00797225|541732165|FG002|Weeks 13 to 24|Sponsor Decision|0|||
150163208|NCT00797225|541732166|FG003|Weeks 13 to 24|Sponsor Decision|0|||
150163209|NCT00797225|541732167|FG004|Weeks 13 to 24|Sponsor Decision|0|||
150163210|NCT00797225|541732168|FG005|Weeks 13 to 24|Sponsor Decision|0|||
150163211|NCT00797225|541732169|FG006|Weeks 13 to 24|Sponsor Decision|1|||
150163212|NCT00797225|541732170|FG007|Weeks 13 to 24|Sponsor Decision|0|||
150163213|NCT02096003|541732173|FG000|Overall Study|Protocol Violation|0|||
150163214|NCT02096003|541732174|FG001|Overall Study|Protocol Violation|2|||
150262830|NCT00881608|542099800|FG000|Overall Study|Study prematurely terminated|11|||
149926291|NCT00003896|540865328|FG000|Overall Study|ineligible|5|||
149926292|NCT01398358|540865329|FG000|Overall Study|Lost to Follow-up|11|||
149926293|NCT01398358|540865330|FG001|Overall Study|Lost to Follow-up|21|||
149926294|NCT01398358|540865331|FG002|Overall Study|Lost to Follow-up|18|||
149926295|NCT01398358|540865329|FG000|Overall Study|Withdrawal by Subject|3|||
149926296|NCT01398358|540865330|FG001|Overall Study|Withdrawal by Subject|2|||
149926297|NCT01398358|540865331|FG002|Overall Study|Withdrawal by Subject|2|||
149926298|NCT01398358|540865329|FG000|Overall Study|no longer eligible|1|||
149926299|NCT01398358|540865330|FG001|Overall Study|no longer eligible|0|||
150163215|NCT02096003|541732173|FG000|Overall Study|additional surgery|2|||
150163216|NCT02096003|541732174|FG001|Overall Study|additional surgery|1|||
150262831|NCT03214094|542099801|FG000|Overall Study|Case Report Forms Uncollected|14|||
150262832|NCT03214094|542099801|FG000|Overall Study|Protocol Deviation|46|||
150262833|NCT00848926|542099802|FG000|Treatment Period|Progressive disease|45|||
150262834|NCT00848926|542099802|FG000|Treatment Period|Adverse Event|20|||
150262835|NCT00848926|542099802|FG000|Treatment Period|Physician Decision|12|||
150262836|NCT00848926|542099802|FG000|Treatment Period|Withdrawal by Subject|7|||
150262837|NCT00848926|542099802|FG000|Follow-up Period|Lost to Follow-up|7|||
150262838|NCT00848926|542099802|FG000|Follow-up Period|Withdrawal by Subject|3|||
150262839|NCT00848926|542099802|FG000|Follow-up Period|Other|2|||
150262840|NCT00966277|542099804|FG000|Overall Study|Withdrawal by Subject|3|||
150262841|NCT00966277|542099805|FG001|Overall Study|Withdrawal by Subject|0|||
150262842|NCT00966277|542099804|FG000|Overall Study|Ineligible|1|||
150262843|NCT00966277|542099805|FG001|Overall Study|Ineligible|3|||
150262844|NCT00966277|542099804|FG000|Overall Study|Treatment Plan Changed|0|||
150262845|NCT00966277|542099805|FG001|Overall Study|Treatment Plan Changed|1|||
150262846|NCT01952054|542099807|FG000|Overall Study|Physician Decision|1|||
150262847|NCT03421431|542099808|FG000|Overall Study|Adverse Event|2|||
150262848|NCT03421431|542099809|FG001|Overall Study|Adverse Event|1|||
150262849|NCT03421431|542099810|FG002|Overall Study|Adverse Event|12|||
150262850|NCT03421431|542099808|FG000|Overall Study|Lost to Follow-up|1|||
150262851|NCT03421431|542099809|FG001|Overall Study|Lost to Follow-up|1|||
150262852|NCT03421431|542099810|FG002|Overall Study|Lost to Follow-up|1|||
150262853|NCT03421431|542099808|FG000|Overall Study|Withdrawal by Subject|3|||
150262854|NCT03421431|542099809|FG001|Overall Study|Withdrawal by Subject|2|||
150262855|NCT03421431|542099810|FG002|Overall Study|Withdrawal by Subject|1|||
150262856|NCT03421431|542099808|FG000|Overall Study|Protocol Violation|0|||
150262857|NCT03421431|542099809|FG001|Overall Study|Protocol Violation|1|||
150262858|NCT03421431|542099810|FG002|Overall Study|Protocol Violation|0|||
150262859|NCT03421431|542099808|FG000|Overall Study|Participant met Stopping Rules|0|||
150262860|NCT03421431|542099809|FG001|Overall Study|Participant met Stopping Rules|1|||
150262861|NCT03421431|542099810|FG002|Overall Study|Participant met Stopping Rules|0|||
150262862|NCT00141726|542099811|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
150262863|NCT01959516|542099816|FG000|Epoch 1|Adverse Event|4|||
150262864|NCT01959516|542099817|FG001|Epoch 1|Adverse Event|1|||
150262865|NCT01959516|542099816|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
150262866|NCT01959516|542099817|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
150262867|NCT01959516|542099816|FG000|Epoch 1|Subject withdrew consent|3|||
150262868|NCT01959516|542099817|FG001|Epoch 1|Subject withdrew consent|2|||
150262869|NCT01959516|542099816|FG000|Epoch 1|Administrative problems|1|||
150262870|NCT01959516|542099817|FG001|Epoch 1|Administrative problems|0|||
150262871|NCT01959516|542099816|FG000|Epoch 1|Use of prohibited treatment|1|||
150262872|NCT01959516|542099817|FG001|Epoch 1|Use of prohibited treatment|0|||
150262873|NCT01959516|542099816|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
150262874|NCT01959516|542099817|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
150262875|NCT01959516|542099816|FG000|Epoch 1|Protocol deviation|0|||
150262876|NCT01959516|542099817|FG001|Epoch 1|Protocol deviation|1|||
150262877|NCT01959516|542099816|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
150262878|NCT01959516|542099817|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
150262879|NCT01959516|542099816|FG000|Epoch 2|Subject withdrew consent|1|||
150262880|NCT01959516|542099817|FG001|Epoch 2|Subject withdrew consent|0|||
150262881|NCT01959516|542099816|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
150262882|NCT01959516|542099817|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
150262883|NCT01477333|542099818|FG000|Overall Study|Adverse Event|1|||
150262884|NCT01477333|542099818|FG000|Overall Study|Withdrawal by Subject|1|||
150262885|NCT01477333|542099818|FG000|Overall Study|Clinical Deterioration|1|||
150262886|NCT01178671|542099819|FG000|Overall Study|Adverse Event|4|||
150262887|NCT01178671|542099820|FG001|Overall Study|Adverse Event|6|||
150262888|NCT01178671|542099819|FG000|Overall Study|Protocol Violation|1|||
150262889|NCT01178671|542099820|FG001|Overall Study|Protocol Violation|1|||
150262890|NCT01178671|542099819|FG000|Overall Study|Lack of Efficacy|0|||
149819161|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
149819162|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
150262891|NCT01178671|542099820|FG001|Overall Study|Lack of Efficacy|1|||
149819163|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
149819164|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
149819165|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
149819166|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
149926300|NCT01398358|540865331|FG002|Overall Study|no longer eligible|1|||
150262892|NCT01178671|542099819|FG000|Overall Study|Lost to Follow-up|3|||
150262893|NCT01178671|542099820|FG001|Overall Study|Lost to Follow-up|1|||
150262894|NCT01178671|542099819|FG000|Overall Study|Physician Decision|4|||
150262895|NCT01178671|542099820|FG001|Overall Study|Physician Decision|6|||
150262896|NCT02435966|542099821|FG000|Overall Study|Withdrawal by Subject|0|||
150262897|NCT02435966|542099822|FG001|Overall Study|Withdrawal by Subject|1|||
150262898|NCT02435966|542099823|FG002|Overall Study|Withdrawal by Subject|0|||
150262899|NCT04620811|542099824|FG000|Overall Study|Withdrawal by Subject|18|||
150262900|NCT04620811|542099825|FG001|Overall Study|Withdrawal by Subject|15|||
149926301|NCT00985686|540865335|FG000|Overall Study|Lost to Follow-up|1|||
149926302|NCT00985686|540865336|FG001|Overall Study|Lost to Follow-up|1|||
149926303|NCT00985686|540865337|FG002|Overall Study|Lost to Follow-up|0|||
149926304|NCT00985686|540865338|FG003|Overall Study|Lost to Follow-up|2|||
149926305|NCT03134911|540865339|FG000|Overall Study|Screen failure|31|||
149926306|NCT03134911|540865339|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
149926307|NCT01087203|540865340|FG000|Overall Study|Lost to Follow-up|2|||
149926308|NCT01087203|540865341|FG001|Overall Study|Lost to Follow-up|0|||
149926309|NCT01087203|540865340|FG000|Overall Study|Withdrawal by Subject|2|||
149926310|NCT01087203|540865341|FG001|Overall Study|Withdrawal by Subject|6|||
149926311|NCT01087203|540865340|FG000|Overall Study|Lack of Efficacy|1|||
149926312|NCT01087203|540865341|FG001|Overall Study|Lack of Efficacy|2|||
149926313|NCT01087203|540865340|FG000|Overall Study|Study terminated by sponsor|27|||
149926314|NCT01087203|540865341|FG001|Overall Study|Study terminated by sponsor|27|||
149926315|NCT02559570|540865343|FG000|Overall Study|Adverse Event|0|||
149926316|NCT02559570|540865344|FG001|Overall Study|Adverse Event|2|||
149926317|NCT02559570|540865345|FG002|Overall Study|Adverse Event|0|||
150163217|NCT01511250|541732175|FG000|Overall Study|Withdrawal of Consent|1|||
150163218|NCT01511250|541732176|FG001|Overall Study|Withdrawal of Consent|0|||
150163219|NCT01511250|541732177|FG002|Overall Study|Withdrawal of Consent|0|||
150163220|NCT01511250|541732178|FG003|Overall Study|Withdrawal of Consent|0|||
150163221|NCT01511250|541732179|FG004|Overall Study|Withdrawal of Consent|0|||
150163222|NCT01511250|541732180|FG005|Overall Study|Withdrawal of Consent|0|||
150163223|NCT01511250|541732181|FG006|Overall Study|Withdrawal of Consent|0|||
150163224|NCT01511250|541732182|FG007|Overall Study|Withdrawal of Consent|1|||
150163225|NCT01511250|541732183|FG008|Overall Study|Withdrawal of Consent|1|||
150163226|NCT01511250|541732184|FG009|Overall Study|Withdrawal of Consent|0|||
150163227|NCT01511250|541732175|FG000|Overall Study|Sponsor/Investigator Decision|1|||
150163228|NCT01511250|541732176|FG001|Overall Study|Sponsor/Investigator Decision|0|||
150163229|NCT01511250|541732177|FG002|Overall Study|Sponsor/Investigator Decision|0|||
150163230|NCT01511250|541732178|FG003|Overall Study|Sponsor/Investigator Decision|0|||
150163231|NCT01511250|541732179|FG004|Overall Study|Sponsor/Investigator Decision|0|||
150163232|NCT01511250|541732180|FG005|Overall Study|Sponsor/Investigator Decision|0|||
150163233|NCT01511250|541732181|FG006|Overall Study|Sponsor/Investigator Decision|0|||
150163234|NCT01511250|541732182|FG007|Overall Study|Sponsor/Investigator Decision|0|||
150163235|NCT01511250|541732183|FG008|Overall Study|Sponsor/Investigator Decision|0|||
150163236|NCT01511250|541732184|FG009|Overall Study|Sponsor/Investigator Decision|0|||
150163237|NCT01511250|541732175|FG000|Overall Study|Lost to Follow-up|7|||
150163238|NCT01511250|541732176|FG001|Overall Study|Lost to Follow-up|3|||
150163239|NCT01511250|541732177|FG002|Overall Study|Lost to Follow-up|3|||
150163240|NCT01511250|541732178|FG003|Overall Study|Lost to Follow-up|3|||
150163241|NCT01511250|541732179|FG004|Overall Study|Lost to Follow-up|0|||
150163242|NCT01511250|541732180|FG005|Overall Study|Lost to Follow-up|0|||
150163243|NCT01511250|541732181|FG006|Overall Study|Lost to Follow-up|2|||
150163244|NCT01511250|541732182|FG007|Overall Study|Lost to Follow-up|3|||
150163245|NCT01511250|541732183|FG008|Overall Study|Lost to Follow-up|13|||
150163246|NCT01511250|541732184|FG009|Overall Study|Lost to Follow-up|5|||
150163247|NCT01511250|541732175|FG000|Overall Study|Protocol Violation|0|||
150163248|NCT01511250|541732176|FG001|Overall Study|Protocol Violation|2|||
150163249|NCT01511250|541732177|FG002|Overall Study|Protocol Violation|1|||
150163250|NCT01511250|541732178|FG003|Overall Study|Protocol Violation|0|||
150163251|NCT01511250|541732179|FG004|Overall Study|Protocol Violation|0|||
150163252|NCT01511250|541732180|FG005|Overall Study|Protocol Violation|0|||
150163253|NCT01511250|541732181|FG006|Overall Study|Protocol Violation|0|||
150163254|NCT01511250|541732182|FG007|Overall Study|Protocol Violation|0|||
150163255|NCT01511250|541732183|FG008|Overall Study|Protocol Violation|0|||
150163256|NCT01511250|541732184|FG009|Overall Study|Protocol Violation|0|||
150163257|NCT01763047|541732185|FG000|Period 1|Test Article Not Available|4|||
150163258|NCT01763047|541732186|FG001|Period 1|Test Article Not Available|1|||
150163259|NCT01763047|541732185|FG000|Period 1|Protocol Violation|4|||
150163260|NCT01763047|541732186|FG001|Period 1|Protocol Violation|4|||
150163261|NCT01763047|541732185|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
150163262|NCT01763047|541732186|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
150163263|NCT01763047|541732185|FG000|Period 1|Adverse Event|0|||
150163264|NCT01763047|541732186|FG001|Period 1|Adverse Event|1|||
150163265|NCT01763047|541732185|FG000|Period 1|Unsatisfactory Visual Response|0|||
150163266|NCT01763047|541732186|FG001|Period 1|Unsatisfactory Visual Response|3|||
149926318|NCT02559570|540865346|FG003|Overall Study|Adverse Event|1|||
150163267|NCT01763047|541732185|FG000|Period 1|Lens Power Not Available|0|||
150163268|NCT01763047|541732186|FG001|Period 1|Lens Power Not Available|1|||
150163269|NCT01763047|541732185|FG000|Period 1|Study Site office Closed|0|||
150163270|NCT01763047|541732186|FG001|Period 1|Study Site office Closed|1|||
150163271|NCT01763047|541732185|FG000|Period 2|Lens Discomfort|1|||
150163272|NCT01763047|541732186|FG001|Period 2|Lens Discomfort|0|||
149926319|NCT02559570|540865347|FG004|Overall Study|Adverse Event|0|||
149926320|NCT02559570|540865343|FG000|Overall Study|Withdrawal of Consent|0|||
150163273|NCT01763047|541732185|FG000|Period 2|No longer meets Eligibility Criteria|1|||
150163274|NCT01763047|541732186|FG001|Period 2|No longer meets Eligibility Criteria|0|||
150262901|NCT04620811|542099824|FG000|Overall Study|Adverse Event|6|||
150262902|NCT04620811|542099825|FG001|Overall Study|Adverse Event|11|||
150262903|NCT04620811|542099824|FG000|Overall Study|Lost to Follow-up|4|||
150262904|NCT04620811|542099825|FG001|Overall Study|Lost to Follow-up|8|||
150262905|NCT04620811|542099824|FG000|Overall Study|Physician Decision|1|||
150262906|NCT04620811|542099825|FG001|Overall Study|Physician Decision|4|||
150262907|NCT04620811|542099824|FG000|Overall Study|Sponsor Decision|0|||
150262908|NCT04620811|542099825|FG001|Overall Study|Sponsor Decision|1|||
150262909|NCT04620811|542099824|FG000|Overall Study|Elevation of ALT or AST|1|||
150262910|NCT04620811|542099825|FG001|Overall Study|Elevation of ALT or AST|0|||
150262911|NCT04620811|542099824|FG000|Overall Study|Other|3|||
150262912|NCT04620811|542099825|FG001|Overall Study|Other|5|||
150262913|NCT01078675|542099826|FG000|Overall Study|Withdrawal by Subject|7|||
150262914|NCT01078675|542099827|FG001|Overall Study|Withdrawal by Subject|3|||
150262915|NCT01078675|542099826|FG000|Overall Study|Protocol Violation|56|||
150262916|NCT01078675|542099827|FG001|Overall Study|Protocol Violation|0|||
150262917|NCT01078675|542099826|FG000|Overall Study|Provided in CRF for specific reasons|2|||
150262918|NCT01078675|542099827|FG001|Overall Study|Provided in CRF for specific reasons|3|||
150262919|NCT01078675|542099826|FG000|Overall Study|Adverse Event|3|||
150262920|NCT01078675|542099827|FG001|Overall Study|Adverse Event|0|||
150262921|NCT02745392|542099839|FG000|Overall Study|Lost to Follow-up|0|||
150262922|NCT02745392|542099840|FG001|Overall Study|Lost to Follow-up|1|||
150262923|NCT02745392|542099841|FG002|Overall Study|Lost to Follow-up|0|||
150262924|NCT02745392|542099842|FG003|Overall Study|Lost to Follow-up|0|||
150262925|NCT02513303|542099843|FG000|Overall Study|Withdrawal by Subject|9|||
150262926|NCT02513303|542099844|FG001|Overall Study|Withdrawal by Subject|7|||
150262927|NCT02513303|542099845|FG002|Overall Study|Withdrawal by Subject|2|||
150262928|NCT02513303|542099843|FG000|Overall Study|Lost to Follow-up|2|||
150262929|NCT02513303|542099844|FG001|Overall Study|Lost to Follow-up|4|||
150262930|NCT02513303|542099845|FG002|Overall Study|Lost to Follow-up|0|||
150262931|NCT02513303|542099843|FG000|Overall Study|Adverse Event|0|||
150262932|NCT02513303|542099844|FG001|Overall Study|Adverse Event|1|||
150262933|NCT02513303|542099845|FG002|Overall Study|Adverse Event|0|||
150262934|NCT02513303|542099843|FG000|Overall Study|Physician Decision|1|||
149926321|NCT02559570|540865344|FG001|Overall Study|Withdrawal of Consent|0|||
149926322|NCT02559570|540865345|FG002|Overall Study|Withdrawal of Consent|1|||
149926323|NCT02559570|540865346|FG003|Overall Study|Withdrawal of Consent|2|||
149926324|NCT02559570|540865347|FG004|Overall Study|Withdrawal of Consent|1|||
149926325|NCT02559570|540865343|FG000|Overall Study|Lost to Follow-up|1|||
149926326|NCT02559570|540865344|FG001|Overall Study|Lost to Follow-up|0|||
149926327|NCT02559570|540865345|FG002|Overall Study|Lost to Follow-up|0|||
149926328|NCT02559570|540865346|FG003|Overall Study|Lost to Follow-up|0|||
149926329|NCT02559570|540865347|FG004|Overall Study|Lost to Follow-up|0|||
149926330|NCT02559570|540865343|FG000|Overall Study|Protocol Violation|1|||
149926331|NCT02559570|540865344|FG001|Overall Study|Protocol Violation|0|||
149926332|NCT02559570|540865345|FG002|Overall Study|Protocol Violation|0|||
149926333|NCT02559570|540865346|FG003|Overall Study|Protocol Violation|0|||
149926334|NCT02559570|540865347|FG004|Overall Study|Protocol Violation|1|||
149926335|NCT02559570|540865343|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149926336|NCT02559570|540865344|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149926337|NCT02559570|540865345|FG002|Overall Study|Other Miscellaneous Reasons|1|||
149926338|NCT02559570|540865346|FG003|Overall Study|Other Miscellaneous Reasons|0|||
149926339|NCT02559570|540865347|FG004|Overall Study|Other Miscellaneous Reasons|0|||
149926340|NCT01903993|540865357|FG000|Overall Study|Death|118|||
149926341|NCT01903993|540865358|FG001|Overall Study|Death|121|||
149926342|NCT01903993|540865357|FG000|Overall Study|Withdrawal by Subject|15|||
149926343|NCT01903993|540865358|FG001|Overall Study|Withdrawal by Subject|4|||
149926344|NCT01903993|540865357|FG000|Overall Study|Lost to Follow-up|2|||
149926345|NCT01903993|540865358|FG001|Overall Study|Lost to Follow-up|3|||
149926346|NCT01903993|540865357|FG000|Overall Study|Study Terminated by Sponsor|8|||
149926347|NCT01903993|540865358|FG001|Overall Study|Study Terminated by Sponsor|14|||
149926348|NCT01903993|540865357|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
149926349|NCT01903993|540865358|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
150262935|NCT02513303|542099844|FG001|Overall Study|Physician Decision|1|||
149926350|NCT00184093|540865361|FG000|Overall Study|Adverse Event|3|||
150262936|NCT02513303|542099845|FG002|Overall Study|Physician Decision|0|||
150262937|NCT02513303|542099843|FG000|Overall Study|Death|8|||
150262938|NCT02513303|542099844|FG001|Overall Study|Death|4|||
150262939|NCT02513303|542099845|FG002|Overall Study|Death|2|||
149926351|NCT00184093|540865361|FG000|Overall Study|Lost to Follow-up|3|||
149926352|NCT00184093|540865361|FG000|Overall Study|Physician Decision|1|||
149926353|NCT00184093|540865361|FG000|Overall Study|Withdrawal by Subject|2|||
149926354|NCT05095311|540865362|FG000|Overall Study|Lost to Follow-up|7|||
149926355|NCT05095311|540865363|FG001|Overall Study|Lost to Follow-up|0|||
150262940|NCT02004353|542099846|FG000|Overall Study|Voluntary participation|1334|||
150262941|NCT01691768|542099847|FG000|Overall Study|Death|0|||
150262942|NCT01691768|542099848|FG001|Overall Study|Death|2|||
150262943|NCT01691768|542099847|FG000|Overall Study|Lost to Follow-up|4|||
150262944|NCT01691768|542099848|FG001|Overall Study|Lost to Follow-up|3|||
150262945|NCT01691768|542099847|FG000|Overall Study|Withdrawal by Subject|10|||
150262946|NCT01691768|542099848|FG001|Overall Study|Withdrawal by Subject|9|||
150262947|NCT01691768|542099847|FG000|Overall Study|Relocated|0|||
150262948|NCT01691768|542099848|FG001|Overall Study|Relocated|1|||
150262949|NCT01691768|542099847|FG000|Overall Study|Investigator decision|1|||
150262950|NCT01691768|542099848|FG001|Overall Study|Investigator decision|1|||
150262951|NCT00819390|542099852|FG000|Overall Study|Lost to Follow-up|1|||
150262952|NCT00819390|542099853|FG001|Overall Study|Lost to Follow-up|1|||
150262953|NCT00819390|542099854|FG002|Overall Study|Lost to Follow-up|0|||
150262954|NCT00819390|542099855|FG003|Overall Study|Lost to Follow-up|0|||
150262955|NCT00819390|542099852|FG000|Overall Study|Withdrawal by Subject|2|||
150262956|NCT00819390|542099853|FG001|Overall Study|Withdrawal by Subject|0|||
150262957|NCT00819390|542099854|FG002|Overall Study|Withdrawal by Subject|0|||
150262958|NCT00819390|542099855|FG003|Overall Study|Withdrawal by Subject|0|||
150262959|NCT00819390|542099852|FG000|Overall Study|Adverse Event|0|||
150262960|NCT00819390|542099853|FG001|Overall Study|Adverse Event|0|||
150262961|NCT00819390|542099854|FG002|Overall Study|Adverse Event|1|||
150262962|NCT00819390|542099855|FG003|Overall Study|Adverse Event|0|||
150262963|NCT01191268|542099856|FG000|Overall Study|Withdrawal by Subject|19|||
150262964|NCT01191268|542099857|FG001|Overall Study|Withdrawal by Subject|25|||
150262965|NCT01191268|542099858|FG002|Overall Study|Withdrawal by Subject|21|||
150262966|NCT01191268|542099856|FG000|Overall Study|Adverse Event|21|||
150262967|NCT01191268|542099857|FG001|Overall Study|Adverse Event|13|||
150262968|NCT01191268|542099858|FG002|Overall Study|Adverse Event|8|||
150262969|NCT01191268|542099856|FG000|Overall Study|Physician Decision|6|||
150262970|NCT01191268|542099857|FG001|Overall Study|Physician Decision|8|||
150262971|NCT01191268|542099858|FG002|Overall Study|Physician Decision|9|||
150262972|NCT01191268|542099856|FG000|Overall Study|Lost to Follow-up|8|||
150262973|NCT01191268|542099857|FG001|Overall Study|Lost to Follow-up|5|||
150262974|NCT01191268|542099858|FG002|Overall Study|Lost to Follow-up|9|||
150262975|NCT01191268|542099856|FG000|Overall Study|Entry Criteria Not Met|3|||
150262976|NCT01191268|542099857|FG001|Overall Study|Entry Criteria Not Met|1|||
150262977|NCT01191268|542099858|FG002|Overall Study|Entry Criteria Not Met|1|||
150262978|NCT01191268|542099856|FG000|Overall Study|Death|0|||
150262979|NCT01191268|542099857|FG001|Overall Study|Death|1|||
150262980|NCT01191268|542099858|FG002|Overall Study|Death|3|||
150262981|NCT01191268|542099856|FG000|Overall Study|Protocol Violation|1|||
150262982|NCT01191268|542099857|FG001|Overall Study|Protocol Violation|0|||
150262983|NCT01191268|542099858|FG002|Overall Study|Protocol Violation|1|||
150262984|NCT01191268|542099856|FG000|Overall Study|Sponsor Decision|0|||
150262985|NCT01191268|542099857|FG001|Overall Study|Sponsor Decision|2|||
150262986|NCT01191268|542099858|FG002|Overall Study|Sponsor Decision|0|||
150262987|NCT00336895|542099859|FG000|Overall Study|diarrhea|1|||
150262988|NCT00336895|542099859|FG000|Overall Study|nausea and upset stomach|1|||
150262989|NCT00336895|542099859|FG000|Overall Study|Physician Decision|1|||
149819167|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
149819168|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
149819169|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
149819170|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
149819171|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
149819172|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
149819173|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
149819174|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
149819175|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
149819176|NCT03210259|540467212|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
149819177|NCT03210259|540467213|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
149819178|NCT03210259|540467214|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
149819179|NCT02533999|540467215|FG000|Overall Study|Lost to Follow-up|3|||
149819180|NCT02533999|540467216|FG001|Overall Study|Lost to Follow-up|5|||
149819181|NCT02533999|540467215|FG000|Overall Study|Protocol Violation|3|||
149819182|NCT02533999|540467216|FG001|Overall Study|Protocol Violation|0|||
149819183|NCT02533999|540467215|FG000|Overall Study|Adverse Event|0|||
149819184|NCT02533999|540467216|FG001|Overall Study|Adverse Event|1|||
150262990|NCT00336895|542099859|FG000|Overall Study|screen failed|1|||
150262991|NCT01959334|542099860|FG000|Second Dose|Adverse Event|1|||
150262992|NCT01959334|542099861|FG001|Second Dose|Adverse Event|0|||
150262993|NCT01959334|542099860|FG000|Third Dose|Adverse Event|0|||
150262994|NCT01959334|542099861|FG001|Third Dose|Adverse Event|1|||
150262995|NCT01007448|542099863|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
150262996|NCT01007448|542099864|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
149819185|NCT02533999|540467215|FG000|Overall Study|Randomized but intervention not received|0|||
150262997|NCT01007448|542099863|FG000|Overall Study|Staph Skin Infection Flare|1|||
150262998|NCT01007448|542099864|FG001|Overall Study|Staph Skin Infection Flare|0|||
150262999|NCT01007448|542099863|FG000|Overall Study|Participant Leaving the Country|1|||
150263000|NCT01007448|542099864|FG001|Overall Study|Participant Leaving the Country|0|||
150263001|NCT01007448|542099863|FG000|Overall Study|Participant Given Prohibited Medication|1|||
150263002|NCT01007448|542099864|FG001|Overall Study|Participant Given Prohibited Medication|0|||
150263003|NCT01007448|542099863|FG000|Overall Study|Progressive Disease|1|||
150263004|NCT01007448|542099864|FG001|Overall Study|Progressive Disease|2|||
150263005|NCT01007448|542099863|FG000|Overall Study|Lack of Efficacy|2|||
150263006|NCT01007448|542099864|FG001|Overall Study|Lack of Efficacy|0|||
150263007|NCT01007448|542099863|FG000|Overall Study|Withdrawal by Subject|2|||
150263008|NCT01007448|542099864|FG001|Overall Study|Withdrawal by Subject|3|||
150263009|NCT01007448|542099863|FG000|Overall Study|Adverse Event|1|||
150263010|NCT01007448|542099864|FG001|Overall Study|Adverse Event|4|||
150263011|NCT02481947|542099865|FG000|Overall Study|Withdrawal by Subject|24|||
150263012|NCT02481947|542099866|FG001|Overall Study|Withdrawal by Subject|10|||
150263013|NCT02481947|542099865|FG000|Overall Study|Lost to Follow-up|11|||
150263014|NCT02481947|542099866|FG001|Overall Study|Lost to Follow-up|5|||
150263015|NCT02481947|542099865|FG000|Overall Study|Adverse Event|6|||
150263016|NCT02481947|542099866|FG001|Overall Study|Adverse Event|11|||
150263017|NCT02481947|542099865|FG000|Overall Study|Physician Decision|4|||
150263018|NCT02481947|542099866|FG001|Overall Study|Physician Decision|5|||
150263019|NCT02481947|542099865|FG000|Overall Study|Protocol Violation|1|||
150263020|NCT02481947|542099866|FG001|Overall Study|Protocol Violation|5|||
150263021|NCT01337115|542099867|FG000|Overall Study|Protocol Violation|2|||
150263022|NCT01337115|542099868|FG001|Overall Study|Protocol Violation|0|||
150263023|NCT03426267|542099869|FG000|Overall Study|Physician Decision|1|||
150263024|NCT03426267|542099870|FG001|Overall Study|Physician Decision|4|||
150263025|NCT03426267|542099869|FG000|Overall Study|Lost to Follow-up|1|||
150263026|NCT03426267|542099870|FG001|Overall Study|Lost to Follow-up|0|||
150263027|NCT03426267|542099869|FG000|Overall Study|Withdrawal by Subject|4|||
150263028|NCT03426267|542099870|FG001|Overall Study|Withdrawal by Subject|10|||
150263029|NCT03426267|542099869|FG000|Overall Study|Protocol Violation|1|||
150263030|NCT03426267|542099870|FG001|Overall Study|Protocol Violation|3|||
150263031|NCT03426267|542099869|FG000|Overall Study|Adverse Event|9|||
150263032|NCT03426267|542099870|FG001|Overall Study|Adverse Event|27|||
150263033|NCT03426267|542099869|FG000|Overall Study|Prohibited Treatment Intake|2|||
150263034|NCT03426267|542099870|FG001|Overall Study|Prohibited Treatment Intake|3|||
150263035|NCT03426267|542099869|FG000|Overall Study|Lack of Efficacy|0|||
150263036|NCT03426267|542099870|FG001|Overall Study|Lack of Efficacy|25|||
150263037|NCT03426267|542099869|FG000|Overall Study|other|3|||
150263038|NCT03426267|542099870|FG001|Overall Study|other|0|||
150263039|NCT01636960|542099873|FG000|Induction Phase|Adverse Event|2|||
150263040|NCT01636960|542099873|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
150263041|NCT01636960|542099873|FG000|Maintenance Phase|Adverse Event|3|||
150263042|NCT01636960|542099873|FG000|Maintenance Phase|Progressive disease|1|||
150263043|NCT01209780|542099874|FG000|Overall Study|Adverse Event|0|||
150263044|NCT01209780|542099875|FG001|Overall Study|Adverse Event|1|||
149926356|NCT05095311|540865364|FG002|Overall Study|Lost to Follow-up|0|||
149926357|NCT00972283|540865368|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
149926358|NCT00972283|540865369|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
149926359|NCT00972283|540865368|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
149926360|NCT00972283|540865369|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
149926361|NCT00972283|540865368|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
149926362|NCT00972283|540865369|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
149926363|NCT00972283|540865368|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
149926364|NCT00972283|540865369|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
149926365|NCT00972283|540865368|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
149926366|NCT00972283|540865369|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
149926367|NCT00972283|540865368|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
149926368|NCT00972283|540865369|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
149926369|NCT00972283|540865368|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
149926370|NCT00972283|540865369|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
149926371|NCT00972283|540865368|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
149926372|NCT00972283|540865369|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
149926373|NCT00972283|540865368|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
149926374|NCT00972283|540865369|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
149926375|NCT00972283|540865368|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
150263045|NCT01209780|542099876|FG002|Overall Study|Adverse Event|0|||
149926376|NCT00972283|540865369|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
149926377|NCT02903420|540865374|FG000|Overall Study|Death|3|||
149926378|NCT00334295|540865377|FG000|Overall Study|Patients received fewer than 3 injection|5|||
150263046|NCT01209780|542099877|FG003|Overall Study|Adverse Event|0|||
150263047|NCT01209780|542099878|FG004|Overall Study|Adverse Event|0|||
150263048|NCT01209780|542099874|FG000|Overall Study|Withdrawal by Subject|9|||
150263049|NCT01209780|542099875|FG001|Overall Study|Withdrawal by Subject|2|||
150263050|NCT01209780|542099876|FG002|Overall Study|Withdrawal by Subject|1|||
150263051|NCT01209780|542099877|FG003|Overall Study|Withdrawal by Subject|1|||
150263052|NCT01209780|542099878|FG004|Overall Study|Withdrawal by Subject|0|||
150263053|NCT01209780|542099874|FG000|Overall Study|Lost to Follow-up|17|||
149926379|NCT00792116|540865378|FG000|Overall Study|Lost to Follow-up|0|||
149926380|NCT00792116|540865379|FG001|Overall Study|Lost to Follow-up|1|||
149926381|NCT00792116|540865378|FG000|Overall Study|Discontnued intervention|1|||
149926382|NCT00792116|540865379|FG001|Overall Study|Discontnued intervention|0|||
149926383|NCT02453256|540865380|FG000|Double Blind Period|Death|1|||
149926384|NCT02453256|540865381|FG001|Double Blind Period|Death|1|||
149926385|NCT02453256|540865380|FG000|Double Blind Period|Adverse Event|3|||
149926386|NCT02453256|540865381|FG001|Double Blind Period|Adverse Event|2|||
149926387|NCT02453256|540865380|FG000|Double Blind Period|Withdrawal by Subject|9|||
149926388|NCT02453256|540865381|FG001|Double Blind Period|Withdrawal by Subject|5|||
149926389|NCT02453256|540865380|FG000|Double Blind Period|Other|0|||
149926390|NCT02453256|540865381|FG001|Double Blind Period|Other|1|||
149926391|NCT02453256|540865380|FG000|Open Label Period|Adverse Event|1|||
149926392|NCT02453256|540865381|FG001|Open Label Period|Adverse Event|3|||
149926393|NCT02453256|540865380|FG000|Open Label Period|Death|0|||
150163275|NCT01763047|541732185|FG000|Period 2|Study Site office Closed|1|||
150163276|NCT01763047|541732186|FG001|Period 2|Study Site office Closed|1|||
150163277|NCT01763047|541732185|FG000|Period 2|Unsatisfactory Visual Response|1|||
150163278|NCT01763047|541732186|FG001|Period 2|Unsatisfactory Visual Response|1|||
150163279|NCT01763047|541732185|FG000|Period 2|Protocol Violation|0|||
150163280|NCT01763047|541732186|FG001|Period 2|Protocol Violation|2|||
150163281|NCT01763047|541732185|FG000|Period 2|Unsatisfactory lens Fitting|0|||
150163282|NCT01763047|541732186|FG001|Period 2|Unsatisfactory lens Fitting|1|||
150163283|NCT01767909|541732192|FG000|Overall Study|Withdrawal by Subject|4|||
150163284|NCT01767909|541732193|FG001|Overall Study|Withdrawal by Subject|7|||
150163285|NCT01767909|541732192|FG000|Overall Study|Adverse Event|3|||
150163286|NCT01767909|541732193|FG001|Overall Study|Adverse Event|1|||
150163287|NCT01767909|541732192|FG000|Overall Study|Withdrawal by Study Partner|3|||
150163288|NCT01767909|541732193|FG001|Overall Study|Withdrawal by Study Partner|1|||
150163289|NCT01767909|541732192|FG000|Overall Study|Non-Compliance|2|||
150163290|NCT01767909|541732193|FG001|Overall Study|Non-Compliance|0|||
150163291|NCT01767909|541732192|FG000|Overall Study|Perceived Lack of Efficacy|1|||
150163292|NCT01767909|541732193|FG001|Overall Study|Perceived Lack of Efficacy|0|||
150163293|NCT01767909|541732192|FG000|Overall Study|Investigator Recommendation|0|||
150163294|NCT01767909|541732193|FG001|Overall Study|Investigator Recommendation|1|||
150163295|NCT01767909|541732192|FG000|Overall Study|Lost to Follow-up|0|||
150163296|NCT01767909|541732193|FG001|Overall Study|Lost to Follow-up|1|||
150163297|NCT01767909|541732192|FG000|Overall Study|LP uncessessful|0|||
150163298|NCT01767909|541732193|FG001|Overall Study|LP uncessessful|1|||
150163299|NCT04956692|541732199|FG000|Overall Study|Death|115|||
150163300|NCT04956692|541732200|FG001|Overall Study|Death|47|||
150163301|NCT04956692|541732199|FG000|Overall Study|Lost to Follow-up|0|||
150163302|NCT04956692|541732200|FG001|Overall Study|Lost to Follow-up|1|||
150163303|NCT04956692|541732199|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
150163304|NCT04956692|541732200|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150163305|NCT04956692|541732199|FG000|Overall Study|Withdrawal by Subject|5|||
150163306|NCT04956692|541732200|FG001|Overall Study|Withdrawal by Subject|2|||
150163307|NCT04956692|541732199|FG000|Overall Study|Ongoing in Study|236|||
150163308|NCT04956692|541732200|FG001|Overall Study|Ongoing in Study|123|||
150163309|NCT02234310|541732203|FG000|Overall Study|Physician Decision|1|||
150163310|NCT02234310|541732203|FG000|Overall Study|Adverse Event|1|||
150163311|NCT02234310|541732203|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
150163312|NCT02234310|541732203|FG000|Overall Study|Withdrawal by Subject|2|||
150163313|NCT01822821|541732204|FG000|Overall Study|Eligible surgery cancelled|1|||
150163314|NCT01822821|541732205|FG001|Overall Study|Eligible surgery cancelled|1|||
150163315|NCT01822821|541732204|FG000|Overall Study|Other reasons|1|||
150163316|NCT01822821|541732205|FG001|Overall Study|Other reasons|0|||
150163317|NCT03251378|541732206|FG000|Overall Study|Death|3|||
150163318|NCT03251378|541732207|FG001|Overall Study|Death|2|||
150163319|NCT03251378|541732208|FG002|Overall Study|Death|3|||
150163320|NCT03251378|541732209|FG003|Overall Study|Death|30|||
150163321|NCT03251378|541732210|FG004|Overall Study|Death|24|||
150163322|NCT03251378|541732211|FG005|Overall Study|Death|12|||
150163323|NCT03251378|541732212|FG006|Overall Study|Death|12|||
150163324|NCT03251378|541732206|FG000|Overall Study|Lost to Follow-up|0|||
150163325|NCT03251378|541732207|FG001|Overall Study|Lost to Follow-up|0|||
150163326|NCT03251378|541732208|FG002|Overall Study|Lost to Follow-up|1|||
150163327|NCT03251378|541732209|FG003|Overall Study|Lost to Follow-up|3|||
150163328|NCT03251378|541732210|FG004|Overall Study|Lost to Follow-up|0|||
150163329|NCT03251378|541732211|FG005|Overall Study|Lost to Follow-up|0|||
149926394|NCT02453256|540865381|FG001|Open Label Period|Death|1|||
149926395|NCT02453256|540865380|FG000|Open Label Period|Lost to Follow-up|1|||
149926396|NCT02453256|540865381|FG001|Open Label Period|Lost to Follow-up|0|||
149926397|NCT02453256|540865380|FG000|Open Label Period|Other|0|||
150163330|NCT03251378|541732212|FG006|Overall Study|Lost to Follow-up|0|||
150163331|NCT03251378|541732206|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
150163332|NCT03251378|541732207|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
150177806|NCT03036813|541788208|FG001|Overall Study|Withdrawal by Subject|6|||
150263054|NCT01209780|542099875|FG001|Overall Study|Lost to Follow-up|12|||
150263055|NCT01209780|542099876|FG002|Overall Study|Lost to Follow-up|3|||
150263056|NCT01209780|542099877|FG003|Overall Study|Lost to Follow-up|9|||
150263057|NCT01209780|542099878|FG004|Overall Study|Lost to Follow-up|4|||
150263058|NCT01209780|542099874|FG000|Overall Study|Protocol Violation|0|||
150263059|NCT01209780|542099875|FG001|Overall Study|Protocol Violation|1|||
150263060|NCT01209780|542099876|FG002|Overall Study|Protocol Violation|0|||
150263061|NCT01209780|542099877|FG003|Overall Study|Protocol Violation|0|||
150263062|NCT01209780|542099878|FG004|Overall Study|Protocol Violation|0|||
150263063|NCT01209780|542099874|FG000|Overall Study|Inappropriate enrollment|0|||
150263064|NCT01209780|542099875|FG001|Overall Study|Inappropriate enrollment|2|||
150263065|NCT01209780|542099876|FG002|Overall Study|Inappropriate enrollment|0|||
150263066|NCT01209780|542099877|FG003|Overall Study|Inappropriate enrollment|0|||
150263067|NCT01209780|542099878|FG004|Overall Study|Inappropriate enrollment|1|||
150263068|NCT02112708|542099880|FG000|Baseline|Physician Decision|16|||
150263069|NCT02112708|542099881|FG001|Baseline|Physician Decision|11|||
150263070|NCT02112708|542099880|FG000|Baseline|Lost to Follow-up|12|||
150263071|NCT02112708|542099881|FG001|Baseline|Lost to Follow-up|0|||
150263072|NCT02112708|542099880|FG000|4 Month|Death|0|||
150263073|NCT02112708|542099881|FG001|4 Month|Death|1|||
150263074|NCT02112708|542099880|FG000|4 Month|Withdrawal by Subject|12|||
150263075|NCT02112708|542099881|FG001|4 Month|Withdrawal by Subject|0|||
150263076|NCT03110185|542099882|FG000|Overall Study|Death|0|||
150263077|NCT03110185|542099883|FG001|Overall Study|Death|1|||
150263078|NCT03110185|542099882|FG000|Overall Study|Withdrawal by Subject|2|||
150263079|NCT03110185|542099883|FG001|Overall Study|Withdrawal by Subject|7|||
150263080|NCT03110185|542099882|FG000|Overall Study|Time Constraints|0|||
150263081|NCT03110185|542099883|FG001|Overall Study|Time Constraints|6|||
150263082|NCT03110185|542099882|FG000|Overall Study|Conflict with care|5|||
150263083|NCT03110185|542099883|FG001|Overall Study|Conflict with care|12|||
150263084|NCT03110185|542099882|FG000|Overall Study|Protocol Violation|1|||
150263085|NCT03110185|542099883|FG001|Overall Study|Protocol Violation|4|||
150263086|NCT03110185|542099882|FG000|Overall Study|MRI Incompatible|2|||
150263087|NCT03110185|542099883|FG001|Overall Study|MRI Incompatible|0|||
150263088|NCT03110185|542099882|FG000|Overall Study|Patient Refusal|0|||
150263089|NCT03110185|542099883|FG001|Overall Study|Patient Refusal|1|||
150263090|NCT03075410|542099886|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
150263091|NCT03075410|542099887|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263092|NCT03075410|542099888|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
150263093|NCT03075410|542099889|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263094|NCT03075410|542099890|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263095|NCT03075410|542099891|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263096|NCT03075410|542099892|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263097|NCT03075410|542099893|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263098|NCT03075410|542099894|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
150263099|NCT03075410|542099886|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
150263100|NCT03075410|542099887|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263101|NCT03075410|542099888|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263102|NCT03075410|542099889|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263103|NCT03075410|542099890|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263104|NCT03075410|542099891|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263105|NCT03075410|542099892|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263106|NCT03075410|542099893|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263107|NCT03075410|542099894|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
150263108|NCT02053792|542099895|FG000|Overall Study|Physician Decision|0|||
150263109|NCT02053792|542099896|FG001|Overall Study|Physician Decision|1|||
150263110|NCT02053792|542099895|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
150263111|NCT02053792|542099896|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
150263112|NCT02053792|542099895|FG000|Overall Study|Lack of Efficacy|1|||
150263113|NCT02053792|542099896|FG001|Overall Study|Lack of Efficacy|0|||
150263114|NCT02053792|542099895|FG000|Overall Study|Adverse Event|1|||
150263115|NCT02053792|542099896|FG001|Overall Study|Adverse Event|0|||
150263116|NCT02053792|542099895|FG000|Overall Study|Withdrawal by Subject|2|||
150263117|NCT02053792|542099896|FG001|Overall Study|Withdrawal by Subject|2|||
150263118|NCT02053792|542099895|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
150263119|NCT02053792|542099896|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
150263120|NCT02053792|542099895|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
150263121|NCT02053792|542099896|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
150263122|NCT01427751|542099897|FG000|Overall Study|Adverse Event|18|||
150263123|NCT01427751|542099898|FG001|Overall Study|Adverse Event|2|||
150263124|NCT01427751|542099897|FG000|Overall Study|No further treatment benefit expected|5|||
150263125|NCT01427751|542099898|FG001|Overall Study|No further treatment benefit expected|1|||
150263126|NCT01427751|542099897|FG000|Overall Study|Lost to Follow-up|3|||
150263127|NCT01427751|542099898|FG001|Overall Study|Lost to Follow-up|1|||
150263128|NCT01427751|542099897|FG000|Overall Study|Withdrawal of consent|2|||
150263129|NCT01427751|542099898|FG001|Overall Study|Withdrawal of consent|2|||
150263130|NCT01427751|542099897|FG000|Overall Study|Protocol Violation|6|||
150263131|NCT01427751|542099898|FG001|Overall Study|Protocol Violation|4|||
150263132|NCT01427751|542099897|FG000|Overall Study|Death|2|||
150263133|NCT01427751|542099898|FG001|Overall Study|Death|0|||
150263134|NCT01427751|542099897|FG000|Overall Study|Other miscellaneous reasons|6|||
150263135|NCT01427751|542099898|FG001|Overall Study|Other miscellaneous reasons|4|||
150263136|NCT04948333|542099899|FG000|Overall Study|Adverse Event|6|||
150263137|NCT04948333|542099900|FG001|Overall Study|Adverse Event|4|||
150263138|NCT04948333|542099901|FG002|Overall Study|Adverse Event|0|||
150263139|NCT04948333|542099902|FG003|Overall Study|Adverse Event|2|||
150263140|NCT04948333|542099899|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
150263141|NCT04948333|542099900|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
150263142|NCT04948333|542099901|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150263143|NCT04948333|542099902|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150263144|NCT04948333|542099899|FG000|Overall Study|Progressive Disease|1|||
150263145|NCT04948333|542099900|FG001|Overall Study|Progressive Disease|5|||
150263146|NCT04948333|542099901|FG002|Overall Study|Progressive Disease|0|||
150263147|NCT04948333|542099902|FG003|Overall Study|Progressive Disease|0|||
150263148|NCT04948333|542099899|FG000|Overall Study|Physician Decision|2|||
150263149|NCT04948333|542099900|FG001|Overall Study|Physician Decision|2|||
150263150|NCT04948333|542099901|FG002|Overall Study|Physician Decision|0|||
150263151|NCT04948333|542099902|FG003|Overall Study|Physician Decision|0|||
150263152|NCT04948333|542099899|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
150263153|NCT04948333|542099900|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
150263154|NCT04948333|542099901|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
150263155|NCT04948333|542099902|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
150263156|NCT04948333|542099899|FG000|Overall Study|Withdrawal by Subject|2|||
150263157|NCT04948333|542099900|FG001|Overall Study|Withdrawal by Subject|0|||
150263158|NCT04948333|542099901|FG002|Overall Study|Withdrawal by Subject|0|||
150263159|NCT04948333|542099902|FG003|Overall Study|Withdrawal by Subject|1|||
150263160|NCT04948333|542099899|FG000|Overall Study|Protocol Violation|0|||
150263161|NCT04948333|542099900|FG001|Overall Study|Protocol Violation|1|||
150263162|NCT04948333|542099901|FG002|Overall Study|Protocol Violation|0|||
150263163|NCT04948333|542099902|FG003|Overall Study|Protocol Violation|0|||
150263164|NCT04948333|542099899|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
150263165|NCT04948333|542099900|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
150263166|NCT04948333|542099901|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
150263167|NCT04948333|542099902|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
150263168|NCT05330312|542099904|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
150263169|NCT05330312|542099905|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
150263170|NCT05330312|542099906|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
150263171|NCT05330312|542099904|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
150263172|NCT05330312|542099905|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
150263173|NCT05330312|542099906|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
150263174|NCT05330312|542099904|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
150263175|NCT05330312|542099905|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
150263176|NCT05330312|542099906|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
150263177|NCT05330312|542099904|FG000|Pivotal Investigation - Part 2|Death|1|||
150263178|NCT05330312|542099905|FG001|Pivotal Investigation - Part 2|Death|4|||
150263179|NCT05330312|542099906|FG002|Pivotal Investigation - Part 2|Death|0|||
150263180|NCT05572021|542099911|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
150263181|NCT05572021|542099912|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
150263182|NCT03432260|542099913|FG000|Overall Study|Lost to Follow-up|1|||
150263183|NCT03432260|542099914|FG001|Overall Study|Lost to Follow-up|1|||
150263184|NCT03432260|542099915|FG002|Overall Study|Lost to Follow-up|0|||
150263185|NCT03432260|542099916|FG003|Overall Study|Lost to Follow-up|0|||
150263186|NCT03432260|542099917|FG004|Overall Study|Lost to Follow-up|1|||
150263187|NCT02186847|542099918|FG000|Overall Study|Protocol Violation|3|||
150263188|NCT02186847|542099919|FG001|Overall Study|Protocol Violation|0|||
150263189|NCT01307579|542099920|FG000|Overall Study|Death|3|||
150263190|NCT01307579|542099921|FG001|Overall Study|Death|6|||
150263191|NCT01307579|542099920|FG000|Overall Study|Physician Decision|26|||
150263192|NCT01307579|542099921|FG001|Overall Study|Physician Decision|29|||
150263193|NCT01307579|542099920|FG000|Overall Study|Withdrawal by Subject|7|||
150263194|NCT01307579|542099921|FG001|Overall Study|Withdrawal by Subject|3|||
150263195|NCT01307579|542099920|FG000|Overall Study|Institutional diagnosis of IFD|21|||
150263196|NCT01307579|542099921|FG001|Overall Study|Institutional diagnosis of IFD|36|||
150263197|NCT01307579|542099920|FG000|Overall Study|Begin conditioning for HSCT|42|||
149819186|NCT02533999|540467216|FG001|Overall Study|Randomized but intervention not received|1|||
149819187|NCT01154153|540467219|FG000|Overall Study|Poor compliance to protocol|2|||
149926398|NCT02453256|540865381|FG001|Open Label Period|Other|2|||
149926399|NCT02453256|540865380|FG000|Open Label Period|Withdrawal by Subject|5|||
149926400|NCT02453256|540865381|FG001|Open Label Period|Withdrawal by Subject|1|||
149926401|NCT01216332|540865382|FG000|Overall Study|Withdrawal by Subject|4|||
149926402|NCT01216332|540865383|FG001|Overall Study|Withdrawal by Subject|0|||
149926403|NCT01066871|540865385|FG000|Overall Study|Lost to Follow-up|0|||
149926404|NCT01066871|540865386|FG001|Overall Study|Lost to Follow-up|2|||
149926405|NCT01066871|540865387|FG002|Overall Study|Lost to Follow-up|2|||
149926406|NCT01066871|540865388|FG003|Overall Study|Lost to Follow-up|0|||
149926407|NCT01066871|540865385|FG000|Overall Study|Protocol Violation|1|||
149926408|NCT01066871|540865386|FG001|Overall Study|Protocol Violation|0|||
149926409|NCT01066871|540865387|FG002|Overall Study|Protocol Violation|3|||
149926410|NCT01066871|540865388|FG003|Overall Study|Protocol Violation|2|||
149926411|NCT01066871|540865385|FG000|Overall Study|Lack of Efficacy|0|||
149926412|NCT01066871|540865386|FG001|Overall Study|Lack of Efficacy|0|||
149926413|NCT01066871|540865387|FG002|Overall Study|Lack of Efficacy|0|||
149926414|NCT01066871|540865388|FG003|Overall Study|Lack of Efficacy|1|||
149926415|NCT01066871|540865385|FG000|Overall Study|Withdrawal by Subject|3|||
149926416|NCT01066871|540865386|FG001|Overall Study|Withdrawal by Subject|1|||
149926417|NCT01066871|540865387|FG002|Overall Study|Withdrawal by Subject|0|||
149926418|NCT01066871|540865388|FG003|Overall Study|Withdrawal by Subject|0|||
149926419|NCT01066871|540865385|FG000|Overall Study|Other|0|||
149926420|NCT01066871|540865386|FG001|Overall Study|Other|2|||
149926421|NCT01066871|540865387|FG002|Overall Study|Other|1|||
149926422|NCT01066871|540865388|FG003|Overall Study|Other|2|||
149926423|NCT01124292|540865391|FG000|Overall Study|Lost to Follow-up|2|||
149926424|NCT01124292|540865392|FG001|Overall Study|Lost to Follow-up|4|||
149926425|NCT01124292|540865393|FG002|Overall Study|Lost to Follow-up|3|||
149926426|NCT01124292|540865391|FG000|Overall Study|Physician Decision|0|||
149926427|NCT01124292|540865392|FG001|Overall Study|Physician Decision|3|||
149926428|NCT01124292|540865393|FG002|Overall Study|Physician Decision|2|||
149926429|NCT01124292|540865391|FG000|Overall Study|Withdrawal by Subject|0|||
149926430|NCT01124292|540865392|FG001|Overall Study|Withdrawal by Subject|6|||
149926431|NCT01124292|540865393|FG002|Overall Study|Withdrawal by Subject|2|||
149926432|NCT01124292|540865391|FG000|Overall Study|medical issue unrelated to the study|0|||
149926433|NCT01124292|540865392|FG001|Overall Study|medical issue unrelated to the study|0|||
150163333|NCT03251378|541732208|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
150163334|NCT03251378|541732209|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
150163335|NCT03251378|541732210|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
150163336|NCT03251378|541732211|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
150163337|NCT03251378|541732212|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
150163338|NCT03251378|541732206|FG000|Overall Study|Progressive disease|2|||
150163339|NCT03251378|541732207|FG001|Overall Study|Progressive disease|0|||
150163340|NCT03251378|541732208|FG002|Overall Study|Progressive disease|0|||
150163341|NCT03251378|541732209|FG003|Overall Study|Progressive disease|1|||
150163342|NCT03251378|541732210|FG004|Overall Study|Progressive disease|0|||
150163343|NCT03251378|541732211|FG005|Overall Study|Progressive disease|0|||
150163344|NCT03251378|541732212|FG006|Overall Study|Progressive disease|0|||
150163345|NCT03251378|541732206|FG000|Overall Study|Physician Decision|0|||
150163346|NCT03251378|541732207|FG001|Overall Study|Physician Decision|2|||
150163347|NCT03251378|541732208|FG002|Overall Study|Physician Decision|0|||
150163348|NCT03251378|541732209|FG003|Overall Study|Physician Decision|0|||
150163349|NCT03251378|541732210|FG004|Overall Study|Physician Decision|0|||
150163350|NCT03251378|541732211|FG005|Overall Study|Physician Decision|0|||
150163351|NCT03251378|541732212|FG006|Overall Study|Physician Decision|0|||
150163352|NCT03251378|541732206|FG000|Overall Study|Other|2|||
150163353|NCT03251378|541732207|FG001|Overall Study|Other|3|||
150163354|NCT03251378|541732208|FG002|Overall Study|Other|2|||
150163355|NCT03251378|541732209|FG003|Overall Study|Other|0|||
150163356|NCT03251378|541732210|FG004|Overall Study|Other|1|||
150163357|NCT03251378|541732211|FG005|Overall Study|Other|1|||
150163358|NCT03251378|541732212|FG006|Overall Study|Other|1|||
150163359|NCT03251378|541732206|FG000|Overall Study|Other|0|||
150163360|NCT03251378|541732207|FG001|Overall Study|Other|0|||
150163361|NCT03251378|541732208|FG002|Overall Study|Other|0|||
150163362|NCT03251378|541732209|FG003|Overall Study|Other|4|||
150163363|NCT03251378|541732210|FG004|Overall Study|Other|13|||
150163364|NCT03251378|541732211|FG005|Overall Study|Other|0|||
150163365|NCT03251378|541732212|FG006|Overall Study|Other|0|||
149926434|NCT01124292|540865393|FG002|Overall Study|medical issue unrelated to the study|2|||
149926435|NCT01124292|540865391|FG000|Overall Study|piercing track closed|0|||
149926436|NCT01124292|540865392|FG001|Overall Study|piercing track closed|2|||
149926437|NCT01124292|540865393|FG002|Overall Study|piercing track closed|1|||
149926438|NCT03373461|540865395|FG000|Part 2|Adverse Event|0|||
149926439|NCT03373461|540865396|FG001|Part 2|Adverse Event|1|||
149926440|NCT03373461|540865397|FG002|Part 2|Adverse Event|0|||
149926441|NCT03373461|540865398|FG003|Part 2|Adverse Event|0|||
149926442|NCT03373461|540865399|FG004|Part 2|Adverse Event|1|||
150263198|NCT01307579|542099921|FG001|Overall Study|Begin conditioning for HSCT|44|||
150263199|NCT01307579|542099920|FG000|Overall Study|Refractory or relapsed AML|38|||
150263200|NCT01307579|542099921|FG001|Overall Study|Refractory or relapsed AML|23|||
150263201|NCT01307579|542099920|FG000|Overall Study|Ineligible|3|||
150263202|NCT01307579|542099921|FG001|Overall Study|Ineligible|4|||
150263203|NCT04873232|542099925|FG000|Overall Study|Lost to Follow-up|1|||
150263204|NCT04873232|542099926|FG001|Overall Study|Lost to Follow-up|4|||
150263205|NCT04873232|542099925|FG000|Overall Study|Withdrawal by Subject|1|||
150263206|NCT04873232|542099926|FG001|Overall Study|Withdrawal by Subject|0|||
150263207|NCT03938545|542101691|FG000|Overall Study|Lost to Follow-up|0|||
150263208|NCT03938545|542101692|FG001|Overall Study|Lost to Follow-up|0|||
150263209|NCT03938545|542101693|FG002|Overall Study|Lost to Follow-up|0|||
150263210|NCT03938545|542101694|FG003|Overall Study|Lost to Follow-up|1|||
150263211|NCT03938545|542101691|FG000|Overall Study|Non-compliance with study drug|0|||
150263212|NCT03938545|542101692|FG001|Overall Study|Non-compliance with study drug|0|||
150263213|NCT03938545|542101693|FG002|Overall Study|Non-compliance with study drug|1|||
150263214|NCT03938545|542101694|FG003|Overall Study|Non-compliance with study drug|0|||
150263215|NCT03938545|542101691|FG000|Overall Study|Pregnancy|1|||
150263216|NCT03938545|542101692|FG001|Overall Study|Pregnancy|0|||
150263217|NCT03938545|542101693|FG002|Overall Study|Pregnancy|0|||
150263218|NCT03938545|542101694|FG003|Overall Study|Pregnancy|0|||
150263219|NCT03938545|542101691|FG000|Overall Study|Study terminated by sponsor|6|||
150263220|NCT03938545|542101692|FG001|Overall Study|Study terminated by sponsor|4|||
150263221|NCT03938545|542101693|FG002|Overall Study|Study terminated by sponsor|2|||
150263222|NCT03938545|542101694|FG003|Overall Study|Study terminated by sponsor|4|||
150263223|NCT03938545|542101691|FG000|Overall Study|Withdrawal by Subject|0|||
150263224|NCT03938545|542101692|FG001|Overall Study|Withdrawal by Subject|1|||
150263225|NCT03938545|542101693|FG002|Overall Study|Withdrawal by Subject|0|||
150263226|NCT03938545|542101694|FG003|Overall Study|Withdrawal by Subject|0|||
150263227|NCT03938545|542101691|FG000|Overall Study|Adverse Event|1|||
150263228|NCT03938545|542101692|FG001|Overall Study|Adverse Event|0|||
150263229|NCT03938545|542101693|FG002|Overall Study|Adverse Event|0|||
150263230|NCT03938545|542101694|FG003|Overall Study|Adverse Event|0|||
150263231|NCT01060540|542101695|FG000|Overall Study|Withdrawal by Subject|10|||
150263232|NCT01060540|542101696|FG001|Overall Study|Withdrawal by Subject|20|||
150263233|NCT01060540|542101695|FG000|Overall Study|Lost to Follow-up|52|||
150263234|NCT01060540|542101696|FG001|Overall Study|Lost to Follow-up|43|||
150263235|NCT01060540|542101695|FG000|Overall Study|Death|2|||
150263236|NCT01060540|542101696|FG001|Overall Study|Death|1|||
150263237|NCT01060540|542101695|FG000|Overall Study|Physician Decision|0|||
150263238|NCT01060540|542101696|FG001|Overall Study|Physician Decision|1|||
150263239|NCT01222507|542101700|FG000|Overall Study|Physician Decision|1|||
150263240|NCT01222507|542101700|FG000|Overall Study|Withdrawal by Subject|1|||
150263241|NCT02647320|542101701|FG000|Overall Study|Adverse Event|0|||
150263242|NCT02647320|542101702|FG001|Overall Study|Adverse Event|1|||
150263243|NCT02647320|542101703|FG002|Overall Study|Adverse Event|3|||
150263244|NCT02647320|542101704|FG003|Overall Study|Adverse Event|2|||
150263245|NCT02647320|542101705|FG004|Overall Study|Adverse Event|1|||
150263246|NCT02647320|542101701|FG000|Overall Study|Protocol Violation|0|||
150263247|NCT02647320|542101702|FG001|Overall Study|Protocol Violation|0|||
150263248|NCT02647320|542101703|FG002|Overall Study|Protocol Violation|3|||
150263249|NCT02647320|542101704|FG003|Overall Study|Protocol Violation|0|||
150263250|NCT02647320|542101705|FG004|Overall Study|Protocol Violation|0|||
150263251|NCT02647320|542101701|FG000|Overall Study|Withdrawal by Subject|7|||
150263252|NCT02647320|542101702|FG001|Overall Study|Withdrawal by Subject|4|||
150263253|NCT02647320|542101703|FG002|Overall Study|Withdrawal by Subject|2|||
150263254|NCT02647320|542101704|FG003|Overall Study|Withdrawal by Subject|2|||
150263255|NCT02647320|542101705|FG004|Overall Study|Withdrawal by Subject|7|||
150263256|NCT02647320|542101701|FG000|Overall Study|Persistent hyperglycemia|0|||
150263257|NCT02647320|542101702|FG001|Overall Study|Persistent hyperglycemia|1|||
150263258|NCT02647320|542101703|FG002|Overall Study|Persistent hyperglycemia|1|||
150263259|NCT02647320|542101704|FG003|Overall Study|Persistent hyperglycemia|1|||
150263260|NCT02647320|542101705|FG004|Overall Study|Persistent hyperglycemia|1|||
150263261|NCT02647320|542101701|FG000|Overall Study|Study terminated by sponsor|1|||
150263262|NCT02647320|542101702|FG001|Overall Study|Study terminated by sponsor|1|||
150263263|NCT02647320|542101703|FG002|Overall Study|Study terminated by sponsor|1|||
150263264|NCT02647320|542101704|FG003|Overall Study|Study terminated by sponsor|1|||
150263265|NCT02647320|542101705|FG004|Overall Study|Study terminated by sponsor|2|||
150263266|NCT02647320|542101701|FG000|Overall Study|Reason not provided|0|||
150263267|NCT02647320|542101702|FG001|Overall Study|Reason not provided|0|||
150263268|NCT02647320|542101703|FG002|Overall Study|Reason not provided|1|||
150263269|NCT02647320|542101704|FG003|Overall Study|Reason not provided|0|||
150263270|NCT02647320|542101705|FG004|Overall Study|Reason not provided|2|||
150263271|NCT02647320|542101701|FG000|Overall Study|Lost to Follow-up|1|||
150263272|NCT02647320|542101702|FG001|Overall Study|Lost to Follow-up|1|||
150263273|NCT02647320|542101703|FG002|Overall Study|Lost to Follow-up|0|||
150263274|NCT02647320|542101704|FG003|Overall Study|Lost to Follow-up|0|||
149819188|NCT01154153|540467220|FG001|Overall Study|Poor compliance to protocol|0|||
150263275|NCT02647320|542101705|FG004|Overall Study|Lost to Follow-up|0|||
149926443|NCT01243177|540865400|FG000|Overall Study|Lack of Efficacy|47|||
149926444|NCT01243177|540865401|FG001|Overall Study|Lack of Efficacy|31|||
149926445|NCT01243177|540865400|FG000|Overall Study|Protocol Violation|11|||
149926446|NCT01243177|540865401|FG001|Overall Study|Protocol Violation|10|||
149926447|NCT01243177|540865400|FG000|Overall Study|Lost to Follow-up|15|||
149926448|NCT01243177|540865401|FG001|Overall Study|Lost to Follow-up|18|||
149926449|NCT01243177|540865400|FG000|Overall Study|Withdrawal by Subject|46|||
149926450|NCT01243177|540865401|FG001|Overall Study|Withdrawal by Subject|38|||
149926451|NCT01243177|540865400|FG000|Overall Study|AE, serious fatal|0|||
149926452|NCT01243177|540865401|FG001|Overall Study|AE, serious fatal|1|||
149926453|NCT01243177|540865400|FG000|Overall Study|SAE, non-fatal|7|||
149926454|NCT01243177|540865401|FG001|Overall Study|SAE, non-fatal|9|||
149926455|NCT01243177|540865400|FG000|Overall Study|AE, non-serious non-fatal|40|||
149926456|NCT01243177|540865401|FG001|Overall Study|AE, non-serious non-fatal|58|||
149926457|NCT01243177|540865400|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
149926458|NCT01243177|540865401|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
149926459|NCT01243177|540865400|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
149926460|NCT01243177|540865401|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
149926461|NCT01243177|540865400|FG000|Overall Study|Other Reason|11|||
149926462|NCT01243177|540865401|FG001|Overall Study|Other Reason|12|||
149926463|NCT03335813|540867001|FG000|Overall Study|Withdrawal by Subject|1|||
149926464|NCT01639144|540867002|FG000|Overall Study|Withdrawal by Subject|4|||
149926465|NCT01639144|540867003|FG001|Overall Study|Withdrawal by Subject|2|||
149926466|NCT01639144|540867002|FG000|Overall Study|Physician Decision|2|||
149926467|NCT01639144|540867003|FG001|Overall Study|Physician Decision|0|||
149926468|NCT01639144|540867002|FG000|Overall Study|Met postoperative exclusion criteria|4|||
149926469|NCT01639144|540867003|FG001|Overall Study|Met postoperative exclusion criteria|3|||
149926470|NCT03872843|540867008|FG000|Overall Study|Lost to Follow-up|5|||
149926471|NCT03872843|540867009|FG001|Overall Study|Lost to Follow-up|7|||
149926472|NCT00856999|540867012|FG000|Overall Study|Withdrawal by Subject|5|||
150163366|NCT04739423|541732218|FG000|Overall Study|Protocol Violation|0|||
150163367|NCT04739423|541732219|FG001|Overall Study|Protocol Violation|1|||
150163368|NCT04739423|541732220|FG002|Overall Study|Protocol Violation|0|||
150163369|NCT04739423|541732221|FG003|Overall Study|Protocol Violation|0|||
150163370|NCT04739423|541732222|FG004|Overall Study|Protocol Violation|0|||
150163371|NCT04739423|541732223|FG005|Overall Study|Protocol Violation|0|||
150163372|NCT04739423|541732218|FG000|Overall Study|Adverse Event|0|||
150163373|NCT04739423|541732219|FG001|Overall Study|Adverse Event|0|||
150163374|NCT04739423|541732220|FG002|Overall Study|Adverse Event|1|||
150163375|NCT04739423|541732221|FG003|Overall Study|Adverse Event|0|||
150163376|NCT04739423|541732222|FG004|Overall Study|Adverse Event|1|||
150163377|NCT04739423|541732223|FG005|Overall Study|Adverse Event|0|||
150163378|NCT04739423|541732218|FG000|Overall Study|Withdrawal by Subject|0|||
150163379|NCT04739423|541732219|FG001|Overall Study|Withdrawal by Subject|0|||
150163380|NCT04739423|541732220|FG002|Overall Study|Withdrawal by Subject|0|||
150163381|NCT04739423|541732221|FG003|Overall Study|Withdrawal by Subject|0|||
150163382|NCT04739423|541732222|FG004|Overall Study|Withdrawal by Subject|0|||
150163383|NCT04739423|541732223|FG005|Overall Study|Withdrawal by Subject|1|||
150163384|NCT05174065|541732224|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
150163385|NCT05174065|541732225|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
150163386|NCT05174065|541732226|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
150163387|NCT05174065|541732224|FG000|Placebo-controlled Period|Other|0|||
150163388|NCT05174065|541732225|FG001|Placebo-controlled Period|Other|1|||
150163389|NCT05174065|541732226|FG002|Placebo-controlled Period|Other|0|||
150163390|NCT05174065|541732224|FG000|Placebo-controlled Period|Adverse Event|1|||
150163391|NCT05174065|541732225|FG001|Placebo-controlled Period|Adverse Event|1|||
150163392|NCT05174065|541732226|FG002|Placebo-controlled Period|Adverse Event|0|||
150163393|NCT05174065|541732224|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
150163394|NCT05174065|541732225|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
150163395|NCT05174065|541732226|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
150163396|NCT05174065|541732224|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
150163397|NCT05174065|541732225|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
150163398|NCT05174065|541732226|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
150163399|NCT05174065|541732224|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
150163400|NCT05174065|541732225|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
150163401|NCT05174065|541732226|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
150163402|NCT01737268|541732228|FG000|Overall Study|Adverse Event|6|||
150163403|NCT01737268|541732228|FG000|Overall Study|Worsening of Target Disease|2|||
150163404|NCT01737268|541732228|FG000|Overall Study|In consideration of the patient's safety|1|||
149926473|NCT02609386|540867013|FG000|Overall Study|Withdrawal by Subject|6|||
149926474|NCT02609386|540867014|FG001|Overall Study|Withdrawal by Subject|1|||
149926475|NCT02609386|540867013|FG000|Overall Study|Lost to Follow-up|3|||
149926476|NCT02609386|540867014|FG001|Overall Study|Lost to Follow-up|5|||
149926477|NCT02609386|540867013|FG000|Overall Study|Death|19|||
149926478|NCT02609386|540867014|FG001|Overall Study|Death|9|||
149926479|NCT02609386|540867013|FG000|Overall Study|Physician Decision|0|||
149926480|NCT02609386|540867014|FG001|Overall Study|Physician Decision|2|||
149926481|NCT00103662|540867015|FG000|Overall Study|Entered Rescue Procedure|0|||
149926482|NCT00103662|540867016|FG001|Overall Study|Entered Rescue Procedure|7|||
149926483|NCT00103662|540867015|FG000|Overall Study|Death|7|||
149926484|NCT00103662|540867016|FG001|Overall Study|Death|7|||
149926485|NCT00103662|540867015|FG000|Overall Study|Elective Withdrawal|5|||
149926486|NCT00103662|540867016|FG001|Overall Study|Elective Withdrawal|5|||
149926487|NCT00103662|540867015|FG000|Overall Study|Lost to Follow-up|0|||
149926488|NCT00103662|540867016|FG001|Overall Study|Lost to Follow-up|1|||
149926489|NCT00103662|540867015|FG000|Overall Study|Other|6|||
149926490|NCT00103662|540867016|FG001|Overall Study|Other|9|||
149926491|NCT00103662|540867015|FG000|Overall Study|Failed mobilization|0|||
149926492|NCT00103662|540867016|FG001|Overall Study|Failed mobilization|4|||
149926493|NCT00103662|540867015|FG000|Overall Study|Intercurrent illness|1|||
149926494|NCT00103662|540867016|FG001|Overall Study|Intercurrent illness|0|||
149926495|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
149926496|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
149926497|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
149926498|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
149926499|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
149926500|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
149926501|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
149926502|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
149926503|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
149926504|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
149926505|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
149926506|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
149926507|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
149926508|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
149926509|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Death|1|||
149926510|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Death|0|||
149926511|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
149926512|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
149926513|NCT00105989|540867018|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
149926514|NCT00105989|540867019|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
149926515|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
149926516|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
149926517|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
149926518|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
149926519|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
149926520|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
149926521|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
149926522|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
149926523|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
149926524|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
149926525|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
149926526|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
149926527|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
149926528|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
149926529|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Death|0|||
149926530|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Death|0|||
149926531|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
149926532|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
149926533|NCT00105989|540867018|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
149926534|NCT00105989|540867019|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
149926535|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
149926536|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
149926537|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
149926538|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
149926539|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
149926540|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
149926541|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
149926542|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
149926543|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
149926544|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
149926545|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
149926546|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
149926547|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
150263276|NCT02647320|542101701|FG000|Overall Study|Develop anemia|1|||
150263277|NCT02647320|542101702|FG001|Overall Study|Develop anemia|0|||
150263278|NCT02647320|542101703|FG002|Overall Study|Develop anemia|0|||
150263279|NCT02647320|542101704|FG003|Overall Study|Develop anemia|0|||
150263280|NCT02647320|542101705|FG004|Overall Study|Develop anemia|0|||
150263281|NCT02647320|542101701|FG000|Overall Study|Lack of Efficacy|0|||
150263282|NCT02647320|542101702|FG001|Overall Study|Lack of Efficacy|0|||
150263283|NCT02647320|542101703|FG002|Overall Study|Lack of Efficacy|0|||
150263284|NCT02647320|542101704|FG003|Overall Study|Lack of Efficacy|1|||
150263285|NCT02647320|542101705|FG004|Overall Study|Lack of Efficacy|0|||
150263286|NCT02647320|542101701|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
150263287|NCT02647320|542101702|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
150263288|NCT02647320|542101703|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
150263289|NCT02647320|542101704|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
150263290|NCT02647320|542101705|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
150263291|NCT00596427|542101706|FG000|Overall Study|Withdrawal by Subject|2|||
150263292|NCT00596427|542101707|FG001|Overall Study|Withdrawal by Subject|2|||
150263293|NCT00596427|542101706|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
150263294|NCT00596427|542101707|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
150263295|NCT00596427|542101706|FG000|Overall Study|Protocol Violation|1|||
150263296|NCT00596427|542101707|FG001|Overall Study|Protocol Violation|0|||
150263297|NCT00320541|542101708|FG000|Overall Study|Adverse Event|21|||
150263298|NCT00320541|542101709|FG001|Overall Study|Adverse Event|19|||
150263299|NCT00320541|542101708|FG000|Overall Study|Protocol Violation|0|||
150263300|NCT00320541|542101709|FG001|Overall Study|Protocol Violation|1|||
150263301|NCT00320541|542101708|FG000|Overall Study|Withdrawal by Subject|12|||
150263302|NCT00320541|542101709|FG001|Overall Study|Withdrawal by Subject|16|||
150263303|NCT00320541|542101708|FG000|Overall Study|Physician Decision|9|||
150263304|NCT00320541|542101709|FG001|Overall Study|Physician Decision|13|||
150263305|NCT00320541|542101708|FG000|Overall Study|Other|3|||
149926548|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
149926549|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
149926550|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
149926551|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
149926552|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
149926553|NCT00105989|540867018|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
149926554|NCT00105989|540867019|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
149926555|NCT00610168|540867020|FG000|Overall Study|Withdrawal by Subject|2|||
149926556|NCT00610168|540867021|FG001|Overall Study|Withdrawal by Subject|0|||
149926557|NCT00613821|540867032|FG000|Overall Study|Withdrawal by Subject|1|||
149926558|NCT00613821|540867033|FG001|Overall Study|Withdrawal by Subject|0|||
149926559|NCT00613821|540867032|FG000|Overall Study|Physician Decision|1|||
149926560|NCT00613821|540867033|FG001|Overall Study|Physician Decision|1|||
149926561|NCT01266824|540867035|FG000|Overall Study|Study terminated prior to completion|2|||
149926562|NCT01266824|540867036|FG001|Overall Study|Study terminated prior to completion|3|||
149926563|NCT02302846|540867037|FG000|Overall Study|Withdrawal by Subject|1|||
149926564|NCT00411450|540867038|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
149926565|NCT00397189|540867039|FG000|3 Weeks Period|Lost to Follow-up|5|||
149926566|NCT00397189|540867040|FG001|3 Weeks Period|Lost to Follow-up|4|||
149926567|NCT00397189|540867039|FG000|3 Weeks Period|Adverse Event|3|||
149926568|NCT00397189|540867040|FG001|3 Weeks Period|Adverse Event|2|||
149926569|NCT00397189|540867039|FG000|3 Weeks Period|Withdrawal by Subject|13|||
149926570|NCT00397189|540867040|FG001|3 Weeks Period|Withdrawal by Subject|9|||
149926571|NCT00397189|540867039|FG000|3 Weeks Period|Physician Decision|0|||
149926572|NCT00397189|540867040|FG001|3 Weeks Period|Physician Decision|2|||
149926573|NCT00397189|540867039|FG000|3 Weeks Period|Protocol Violation|0|||
149926574|NCT00397189|540867040|FG001|3 Weeks Period|Protocol Violation|3|||
149926575|NCT00397189|540867039|FG000|3 Weeks Period|Other|0|||
149926576|NCT00397189|540867040|FG001|3 Weeks Period|Other|2|||
149926577|NCT00141518|540867042|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
149926578|NCT00141518|540867043|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
149926579|NCT00141518|540867044|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
149926580|NCT00141518|540867042|FG000|Overall Study|Adverse Event|7|||
149926581|NCT00141518|540867043|FG001|Overall Study|Adverse Event|5|||
149926582|NCT00141518|540867044|FG002|Overall Study|Adverse Event|2|||
149926583|NCT00141518|540867042|FG000|Overall Study|Withdrawal by Subject|2|||
149926584|NCT00141518|540867043|FG001|Overall Study|Withdrawal by Subject|0|||
149926585|NCT00141518|540867044|FG002|Overall Study|Withdrawal by Subject|2|||
150263306|NCT00320541|542101709|FG001|Overall Study|Other|4|||
150263307|NCT00320541|542101708|FG000|Overall Study|Sponsor Decision|2|||
150263308|NCT00320541|542101709|FG001|Overall Study|Sponsor Decision|1|||
150263309|NCT00320541|542101708|FG000|Overall Study|Death due to Study Disease|1|||
150263310|NCT00320541|542101709|FG001|Overall Study|Death due to Study Disease|3|||
150263311|NCT00320541|542101708|FG000|Overall Study|Death due to Adverse Event(s)|1|||
149926586|NCT00141518|540867042|FG000|Overall Study|Protocol Violation|1|||
149926587|NCT00141518|540867043|FG001|Overall Study|Protocol Violation|1|||
150163405|NCT02753530|541732231|FG000|Overall Study|Adverse Event|7|||
150163406|NCT02753530|541732232|FG001|Overall Study|Adverse Event|1|||
150163407|NCT02753530|541732231|FG000|Overall Study|Death|0|||
150163408|NCT02753530|541732232|FG001|Overall Study|Death|1|||
150163409|NCT02753530|541732231|FG000|Overall Study|Physician Decision|0|||
150163410|NCT02753530|541732232|FG001|Overall Study|Physician Decision|1|||
150163411|NCT02753530|541732231|FG000|Overall Study|Protocol Violation|1|||
150163412|NCT02753530|541732232|FG001|Overall Study|Protocol Violation|0|||
150163413|NCT02753530|541732231|FG000|Overall Study|Withdrawal by Subject|4|||
150163414|NCT02753530|541732232|FG001|Overall Study|Withdrawal by Subject|3|||
150163415|NCT02696226|541732233|FG000|Overall Study|Study terminated - lack of enrollment|1|||
150163416|NCT02696226|541732234|FG001|Overall Study|Study terminated - lack of enrollment|0|||
150163417|NCT02696226|541732235|FG002|Overall Study|Study terminated - lack of enrollment|2|||
150163418|NCT02696226|541732236|FG003|Overall Study|Study terminated - lack of enrollment|0|||
150163419|NCT01221181|541732237|FG000|Overall Study|Lost to Follow-up|1|||
150163420|NCT03369951|541732238|FG000|Overall Study|Withdrawal by Subject|3|||
150163421|NCT03369951|541732238|FG000|Overall Study|Death|1|||
150163422|NCT03369951|541732238|FG000|Overall Study|Lost to Follow-up|1|||
150163423|NCT03369951|541732238|FG000|Overall Study|Protocol Violation|1|||
150163424|NCT00429793|541732239|FG000|Overall Study|Improper pre-protocol treatment|3|||
150163425|NCT00429793|541732239|FG000|Overall Study|Required test not done|1|||
150163426|NCT00429793|541732239|FG000|Overall Study|Never treated|1|||
150163427|NCT00429793|541732239|FG000|Overall Study|Non-measurable|1|||
150163428|NCT00062868|541732247|FG000|Dose Level 1|Death|2|||
150163429|NCT00062868|541732248|FG001|Dose Level 1|Death|0|||
150163430|NCT00062868|541732249|FG002|Dose Level 1|Death|0|||
150163431|NCT00062868|541732250|FG003|Dose Level 1|Death|2|||
150163432|NCT00062868|541732251|FG004|Dose Level 1|Death|0|||
150163433|NCT00062868|541732252|FG005|Dose Level 1|Death|0|||
150163434|NCT00062868|541732253|FG006|Dose Level 1|Death|3|||
150163435|NCT00062868|541732254|FG007|Dose Level 1|Death|0|||
150163436|NCT00062868|541732255|FG008|Dose Level 1|Death|0|||
150163437|NCT00062868|541732256|FG009|Dose Level 1|Death|0|||
150163438|NCT00062868|541732257|FG010|Dose Level 1|Death|0|||
150163439|NCT00062868|541732258|FG011|Dose Level 1|Death|0|||
150163440|NCT00062868|541732259|FG012|Dose Level 1|Death|0|||
150163441|NCT00062868|541732260|FG013|Dose Level 1|Death|0|||
150163442|NCT00062868|541732261|FG014|Dose Level 1|Death|0|||
150163443|NCT00062868|541732262|FG015|Dose Level 1|Death|0|||
150163444|NCT00062868|541732263|FG016|Dose Level 1|Death|0|||
150163445|NCT00062868|541732264|FG017|Dose Level 1|Death|0|||
150163446|NCT00062868|541732265|FG018|Dose Level 1|Death|7|||
150163447|NCT00062868|541732266|FG019|Dose Level 1|Death|0|||
150163448|NCT00062868|541732267|FG020|Dose Level 1|Death|1|||
150163449|NCT00062868|541732247|FG000|Dose Level 1|Lost to Follow-up|0|||
150163450|NCT00062868|541732248|FG001|Dose Level 1|Lost to Follow-up|0|||
150163451|NCT00062868|541732249|FG002|Dose Level 1|Lost to Follow-up|0|||
150163452|NCT00062868|541732250|FG003|Dose Level 1|Lost to Follow-up|0|||
150163453|NCT00062868|541732251|FG004|Dose Level 1|Lost to Follow-up|0|||
150163454|NCT00062868|541732252|FG005|Dose Level 1|Lost to Follow-up|0|||
150163455|NCT00062868|541732253|FG006|Dose Level 1|Lost to Follow-up|0|||
150163456|NCT00062868|541732254|FG007|Dose Level 1|Lost to Follow-up|0|||
150163457|NCT00062868|541732255|FG008|Dose Level 1|Lost to Follow-up|0|||
150163458|NCT00062868|541732256|FG009|Dose Level 1|Lost to Follow-up|0|||
150163459|NCT00062868|541732257|FG010|Dose Level 1|Lost to Follow-up|0|||
150163460|NCT00062868|541732258|FG011|Dose Level 1|Lost to Follow-up|0|||
150163461|NCT00062868|541732259|FG012|Dose Level 1|Lost to Follow-up|1|||
150163462|NCT00062868|541732260|FG013|Dose Level 1|Lost to Follow-up|0|||
150163463|NCT00062868|541732261|FG014|Dose Level 1|Lost to Follow-up|0|||
150163464|NCT00062868|541732262|FG015|Dose Level 1|Lost to Follow-up|0|||
150163465|NCT00062868|541732263|FG016|Dose Level 1|Lost to Follow-up|0|||
150163466|NCT00062868|541732264|FG017|Dose Level 1|Lost to Follow-up|0|||
150163467|NCT00062868|541732265|FG018|Dose Level 1|Lost to Follow-up|2|||
150163468|NCT00062868|541732266|FG019|Dose Level 1|Lost to Follow-up|0|||
150163469|NCT00062868|541732267|FG020|Dose Level 1|Lost to Follow-up|1|||
150263312|NCT00320541|542101709|FG001|Overall Study|Death due to Adverse Event(s)|0|||
150263313|NCT00320541|542101708|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
150163470|NCT00062868|541732247|FG000|Dose Level 2|Death|0|||
150163471|NCT00062868|541732248|FG001|Dose Level 2|Death|3|||
150163472|NCT00062868|541732249|FG002|Dose Level 2|Death|0|||
150163473|NCT00062868|541732250|FG003|Dose Level 2|Death|0|||
150163474|NCT00062868|541732251|FG004|Dose Level 2|Death|2|||
150163475|NCT00062868|541732252|FG005|Dose Level 2|Death|0|||
150163476|NCT00062868|541732253|FG006|Dose Level 2|Death|0|||
150163477|NCT00062868|541732254|FG007|Dose Level 2|Death|0|||
150163478|NCT00062868|541732255|FG008|Dose Level 2|Death|0|||
150163479|NCT00062868|541732256|FG009|Dose Level 2|Death|0|||
150163480|NCT00062868|541732257|FG010|Dose Level 2|Death|1|||
150163481|NCT00062868|541732258|FG011|Dose Level 2|Death|0|||
150163482|NCT00062868|541732259|FG012|Dose Level 2|Death|0|||
150163483|NCT00062868|541732260|FG013|Dose Level 2|Death|0|||
150163484|NCT00062868|541732261|FG014|Dose Level 2|Death|0|||
150263314|NCT00320541|542101709|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
150263315|NCT01650246|542101714|FG000|Overall Study|Adverse Event|23|||
150263316|NCT01650246|542101714|FG000|Overall Study|Protocol Violation|5|||
150263317|NCT01650246|542101714|FG000|Overall Study|Sponsor terminated study|53|||
150263318|NCT01650246|542101714|FG000|Overall Study|Lost to Follow-up|5|||
150263319|NCT01650246|542101714|FG000|Overall Study|Withdrawal by Subject|26|||
150263320|NCT01650246|542101714|FG000|Overall Study|Death|1|||
150263321|NCT01650246|542101714|FG000|Overall Study|Lack of Efficacy|30|||
150263322|NCT04281004|542101715|FG000|Overall Study|Physician Decision|1|||
150263323|NCT04281004|542101716|FG001|Overall Study|Physician Decision|0|||
150263324|NCT00701779|542101717|FG000|Overall Study|Adverse Event|6|||
150263325|NCT00701779|542101717|FG000|Overall Study|Lost to Follow-up|1|||
150263326|NCT00701779|542101717|FG000|Overall Study|Withdrawal by Subject|2|||
150263327|NCT01873495|542101722|FG000|Overall Study|Withdrawal by Subject|1|||
150263328|NCT01873495|542101722|FG000|Overall Study|Physician Decision|3|||
150263329|NCT01873495|542101722|FG000|Overall Study|Adverse Event|1|||
150263330|NCT01873495|542101722|FG000|Overall Study|Removed for Transplantation|1|||
150263331|NCT01873495|542101722|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
150263332|NCT00876694|542101723|FG000|Overall Study|Adverse Event|10|||
150263333|NCT00876694|542101724|FG001|Overall Study|Adverse Event|7|||
150263334|NCT00876694|542101723|FG000|Overall Study|Subject withdrew consent|6|||
150263335|NCT00876694|542101724|FG001|Overall Study|Subject withdrew consent|4|||
150263336|NCT00876694|542101723|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150263337|NCT00876694|542101724|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150263338|NCT00876694|542101723|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150263339|NCT00876694|542101724|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150263340|NCT00876694|542101723|FG000|Overall Study|Administrative problems|1|||
150263341|NCT00876694|542101724|FG001|Overall Study|Administrative problems|1|||
150263342|NCT00876694|542101723|FG000|Overall Study|Death|1|||
150263343|NCT00876694|542101724|FG001|Overall Study|Death|0|||
150263344|NCT00288509|542101725|FG000|Treatment Cycle 1|Adverse Event|1|||
150263345|NCT00288509|542101725|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
150263346|NCT00288509|542101725|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
150263347|NCT00288509|542101725|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
150263348|NCT00288509|542101725|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
150263349|NCT00288509|542101725|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
150263350|NCT00288509|542101725|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
150263351|NCT00288509|542101725|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
150263352|NCT00288509|542101725|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
150263353|NCT00288509|542101725|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
150263354|NCT00288509|542101725|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
150263355|NCT00288509|542101725|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
150263356|NCT00288509|542101725|FG000|Treatment Cycle 4|Physician Decision|4|||
150263357|NCT00288509|542101725|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
150263358|NCT02382016|542101726|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
150263359|NCT02382016|542101727|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
150263360|NCT02382016|542101726|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
150263361|NCT02382016|542101727|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
150263362|NCT02382016|542101726|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
150263363|NCT02382016|542101727|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
150263364|NCT02382016|542101726|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
150263365|NCT02382016|542101727|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
150263366|NCT02382016|542101726|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
150263367|NCT02382016|542101727|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
150263368|NCT02382016|542101726|FG000|Open-label (OL) Treatment Period|Death|4|||
150263369|NCT02382016|542101727|FG001|Open-label (OL) Treatment Period|Death|0|||
150263370|NCT02382016|542101726|FG000|OL Extension Period|Physician Decision|3|||
150263371|NCT02382016|542101727|FG001|OL Extension Period|Physician Decision|0|||
150263372|NCT02382016|542101726|FG000|OL Extension Period|Death|2|||
150263373|NCT02382016|542101727|FG001|OL Extension Period|Death|0|||
150263374|NCT02382016|542101726|FG000|OL Extension Period|Withdrawal by Subject|1|||
150263375|NCT02382016|542101727|FG001|OL Extension Period|Withdrawal by Subject|0|||
150263376|NCT00084266|542101728|FG000|Overall Study|Death|42|||
150263377|NCT00084266|542101729|FG001|Overall Study|Death|39|||
150263378|NCT00084266|542101728|FG000|Overall Study|Adverse Event|8|||
150263379|NCT00084266|542101729|FG001|Overall Study|Adverse Event|5|||
150263380|NCT00084266|542101728|FG000|Overall Study|Lack of Efficacy|2|||
150263381|NCT00084266|542101729|FG001|Overall Study|Lack of Efficacy|4|||
150263382|NCT00084266|542101728|FG000|Overall Study|Lost to Follow-up|5|||
150263383|NCT00084266|542101729|FG001|Overall Study|Lost to Follow-up|3|||
150263384|NCT00084266|542101728|FG000|Overall Study|Participant not willing to participate|3|||
150263385|NCT00084266|542101729|FG001|Overall Study|Participant not willing to participate|8|||
150263386|NCT00084266|542101728|FG000|Overall Study|Other|360|||
150263387|NCT00084266|542101729|FG001|Overall Study|Other|344|||
150263388|NCT00084266|542101728|FG000|Overall Study|Randomized not treated|21|||
149926588|NCT00141518|540867044|FG002|Overall Study|Protocol Violation|2|||
149926589|NCT00141518|540867042|FG000|Overall Study|Lack of Efficacy|5|||
149926590|NCT00141518|540867043|FG001|Overall Study|Lack of Efficacy|0|||
149926591|NCT00141518|540867044|FG002|Overall Study|Lack of Efficacy|0|||
149926592|NCT01806168|540867045|FG000|Overall Study|Adverse Event|1|||
149926593|NCT01806168|540867046|FG001|Overall Study|Adverse Event|0|||
149926594|NCT01806168|540867047|FG002|Overall Study|Adverse Event|0|||
149926595|NCT01806168|540867045|FG000|Overall Study|Withdrawal by Subject|0|||
149926596|NCT01806168|540867046|FG001|Overall Study|Withdrawal by Subject|1|||
149926597|NCT01806168|540867047|FG002|Overall Study|Withdrawal by Subject|2|||
149926598|NCT01806168|540867045|FG000|Overall Study|Protocol Violation|0|||
149926599|NCT01806168|540867046|FG001|Overall Study|Protocol Violation|0|||
149926600|NCT01806168|540867047|FG002|Overall Study|Protocol Violation|1|||
149926601|NCT03410992|540867048|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926602|NCT03410992|540867049|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
149926603|NCT03410992|540867050|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926604|NCT03410992|540867051|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926605|NCT03410992|540867052|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
150163485|NCT00062868|541732262|FG015|Dose Level 2|Death|0|||
150163486|NCT00062868|541732263|FG016|Dose Level 2|Death|2|||
150163487|NCT00062868|541732264|FG017|Dose Level 2|Death|0|||
150163488|NCT00062868|541732265|FG018|Dose Level 2|Death|0|||
150163489|NCT00062868|541732266|FG019|Dose Level 2|Death|0|||
150163490|NCT00062868|541732267|FG020|Dose Level 2|Death|0|||
150163491|NCT00062868|541732247|FG000|Dose Level 2|Lost to Follow-up|0|||
150163492|NCT00062868|541732248|FG001|Dose Level 2|Lost to Follow-up|0|||
150163493|NCT00062868|541732249|FG002|Dose Level 2|Lost to Follow-up|0|||
150163494|NCT00062868|541732250|FG003|Dose Level 2|Lost to Follow-up|0|||
150163495|NCT00062868|541732251|FG004|Dose Level 2|Lost to Follow-up|0|||
150163496|NCT00062868|541732252|FG005|Dose Level 2|Lost to Follow-up|0|||
150163497|NCT00062868|541732253|FG006|Dose Level 2|Lost to Follow-up|0|||
150163498|NCT00062868|541732254|FG007|Dose Level 2|Lost to Follow-up|0|||
150163499|NCT00062868|541732255|FG008|Dose Level 2|Lost to Follow-up|0|||
150163500|NCT00062868|541732256|FG009|Dose Level 2|Lost to Follow-up|0|||
150163501|NCT00062868|541732257|FG010|Dose Level 2|Lost to Follow-up|0|||
150163502|NCT00062868|541732258|FG011|Dose Level 2|Lost to Follow-up|0|||
150163503|NCT00062868|541732259|FG012|Dose Level 2|Lost to Follow-up|0|||
150163504|NCT00062868|541732260|FG013|Dose Level 2|Lost to Follow-up|1|||
150163505|NCT00062868|541732261|FG014|Dose Level 2|Lost to Follow-up|0|||
150163506|NCT00062868|541732262|FG015|Dose Level 2|Lost to Follow-up|0|||
150163507|NCT00062868|541732263|FG016|Dose Level 2|Lost to Follow-up|1|||
150163508|NCT00062868|541732264|FG017|Dose Level 2|Lost to Follow-up|0|||
150163509|NCT00062868|541732265|FG018|Dose Level 2|Lost to Follow-up|0|||
150163510|NCT00062868|541732266|FG019|Dose Level 2|Lost to Follow-up|0|||
150163511|NCT00062868|541732267|FG020|Dose Level 2|Lost to Follow-up|0|||
150163512|NCT00062868|541732247|FG000|Dose Level 3|Death|0|||
150163513|NCT00062868|541732248|FG001|Dose Level 3|Death|0|||
150163514|NCT00062868|541732249|FG002|Dose Level 3|Death|0|||
150163515|NCT00062868|541732250|FG003|Dose Level 3|Death|0|||
150163516|NCT00062868|541732251|FG004|Dose Level 3|Death|0|||
150163517|NCT00062868|541732252|FG005|Dose Level 3|Death|0|||
150163518|NCT00062868|541732253|FG006|Dose Level 3|Death|0|||
150163519|NCT00062868|541732254|FG007|Dose Level 3|Death|0|||
150163520|NCT00062868|541732255|FG008|Dose Level 3|Death|0|||
150163521|NCT00062868|541732256|FG009|Dose Level 3|Death|0|||
150163522|NCT00062868|541732257|FG010|Dose Level 3|Death|0|||
150163523|NCT00062868|541732258|FG011|Dose Level 3|Death|1|||
150163524|NCT00062868|541732259|FG012|Dose Level 3|Death|0|||
150163525|NCT00062868|541732260|FG013|Dose Level 3|Death|0|||
150163526|NCT00062868|541732261|FG014|Dose Level 3|Death|0|||
150163527|NCT00062868|541732262|FG015|Dose Level 3|Death|0|||
150163528|NCT00062868|541732263|FG016|Dose Level 3|Death|0|||
150163529|NCT00062868|541732264|FG017|Dose Level 3|Death|1|||
150163530|NCT00062868|541732265|FG018|Dose Level 3|Death|0|||
150163531|NCT00062868|541732266|FG019|Dose Level 3|Death|0|||
150163532|NCT00062868|541732267|FG020|Dose Level 3|Death|0|||
150163533|NCT00062868|541732247|FG000|Dose Level 3|Lost to Follow-up|0|||
150163534|NCT00062868|541732248|FG001|Dose Level 3|Lost to Follow-up|0|||
150163535|NCT00062868|541732249|FG002|Dose Level 3|Lost to Follow-up|0|||
150163536|NCT00062868|541732250|FG003|Dose Level 3|Lost to Follow-up|0|||
150163537|NCT00062868|541732251|FG004|Dose Level 3|Lost to Follow-up|0|||
150163538|NCT00062868|541732252|FG005|Dose Level 3|Lost to Follow-up|0|||
150163539|NCT00062868|541732253|FG006|Dose Level 3|Lost to Follow-up|0|||
150163540|NCT00062868|541732254|FG007|Dose Level 3|Lost to Follow-up|0|||
150163541|NCT00062868|541732255|FG008|Dose Level 3|Lost to Follow-up|0|||
150163542|NCT00062868|541732256|FG009|Dose Level 3|Lost to Follow-up|0|||
150163543|NCT00062868|541732257|FG010|Dose Level 3|Lost to Follow-up|0|||
150163544|NCT00062868|541732258|FG011|Dose Level 3|Lost to Follow-up|0|||
150163545|NCT00062868|541732259|FG012|Dose Level 3|Lost to Follow-up|0|||
150163546|NCT00062868|541732260|FG013|Dose Level 3|Lost to Follow-up|0|||
150163547|NCT00062868|541732261|FG014|Dose Level 3|Lost to Follow-up|1|||
150163548|NCT00062868|541732262|FG015|Dose Level 3|Lost to Follow-up|0|||
150263389|NCT00084266|542101729|FG001|Overall Study|Randomized not treated|20|||
150263390|NCT00730171|542101734|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
150263391|NCT00730171|542101734|FG000|Overall Study|Adverse Event|193|||
150263392|NCT00730171|542101734|FG000|Overall Study|Protocol Violation|48|||
150263393|NCT00730171|542101734|FG000|Overall Study|Withdrawal by Subject|202|||
150263394|NCT00730171|542101734|FG000|Overall Study|Lost to Follow-up|121|||
150263395|NCT00730171|542101734|FG000|Overall Study|Insufficient Therapeutic Response|141|||
150263396|NCT00730171|542101734|FG000|Overall Study|Other|61|||
150263397|NCT01386788|542101739|FG000|Overall Study|Lost to Follow-up|2|||
150263398|NCT00120406|542101740|FG000|Overall Study|Death|9|||
150263399|NCT00120406|542101741|FG001|Overall Study|Death|4|||
150263400|NCT00120406|542101740|FG000|Overall Study|Withdrawal by Subject|5|||
150263401|NCT00120406|542101741|FG001|Overall Study|Withdrawal by Subject|7|||
150263402|NCT00120406|542101740|FG000|Overall Study|Lost to Follow-up|5|||
150263403|NCT00120406|542101741|FG001|Overall Study|Lost to Follow-up|2|||
150263404|NCT00120406|542101740|FG000|Overall Study|received non-study stent|0|||
150263405|NCT00120406|542101741|FG001|Overall Study|received non-study stent|2|||
150263406|NCT00120406|542101740|FG000|Overall Study|patient moved but has not withdrawn|0|||
150263407|NCT00120406|542101741|FG001|Overall Study|patient moved but has not withdrawn|1|||
150263408|NCT00762970|542101742|FG000|Overall Study|Withdrawal by Subject|7|||
150263409|NCT00762970|542101743|FG001|Overall Study|Withdrawal by Subject|4|||
150263410|NCT00762970|542101744|FG002|Overall Study|Withdrawal by Subject|0|||
150263411|NCT00762970|542101742|FG000|Overall Study|Protocol Violation|3|||
150263412|NCT00762970|542101743|FG001|Overall Study|Protocol Violation|1|||
150263413|NCT00762970|542101744|FG002|Overall Study|Protocol Violation|1|||
150263414|NCT00762970|542101742|FG000|Overall Study|Lost to Follow-up|1|||
150263415|NCT00762970|542101743|FG001|Overall Study|Lost to Follow-up|2|||
150263416|NCT00762970|542101744|FG002|Overall Study|Lost to Follow-up|0|||
150263417|NCT00762970|542101742|FG000|Overall Study|Difficulty of handling lens|1|||
150263418|NCT00762970|542101743|FG001|Overall Study|Difficulty of handling lens|2|||
150263419|NCT00762970|542101744|FG002|Overall Study|Difficulty of handling lens|0|||
150263420|NCT00879762|542101745|FG000|Overall Study|Lost to Follow-up|3|||
149819189|NCT01154153|540467219|FG000|Overall Study|Unable to use labs|2|||
149819190|NCT01154153|540467220|FG001|Overall Study|Unable to use labs|3|||
149819191|NCT01154153|540467219|FG000|Overall Study|Withdrew consent|1|||
149819192|NCT01154153|540467220|FG001|Overall Study|Withdrew consent|0|||
149819193|NCT02473510|540467221|FG000|Overall Study|Lost to Follow-up|1|||
149819194|NCT02473510|540467222|FG001|Overall Study|Lost to Follow-up|2|||
149819195|NCT00964223|540467232|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
149819196|NCT02006147|540467233|FG000|Overall Study|Protocol Violation|1|||
149819197|NCT02006147|540467234|FG001|Overall Study|Protocol Violation|1|||
149819198|NCT02006147|540467235|FG002|Overall Study|Protocol Violation|0|||
149819199|NCT02006147|540467236|FG003|Overall Study|Protocol Violation|0|||
149819200|NCT02006147|540467233|FG000|Overall Study|Withdrawal by Subject|0|||
149819201|NCT02006147|540467234|FG001|Overall Study|Withdrawal by Subject|1|||
149819202|NCT02006147|540467235|FG002|Overall Study|Withdrawal by Subject|0|||
149819203|NCT02006147|540467236|FG003|Overall Study|Withdrawal by Subject|0|||
149819204|NCT02006147|540467233|FG000|Overall Study|Withdrawal by Sponsor|1|||
149819205|NCT02006147|540467234|FG001|Overall Study|Withdrawal by Sponsor|0|||
149819206|NCT02006147|540467235|FG002|Overall Study|Withdrawal by Sponsor|0|||
149819207|NCT02006147|540467236|FG003|Overall Study|Withdrawal by Sponsor|0|||
149819208|NCT03404206|540467237|FG000|Overall Study|Withdrawal by Subject|1|||
149819209|NCT03404206|540467238|FG001|Overall Study|Withdrawal by Subject|1|||
149819210|NCT03404206|540467239|FG002|Overall Study|Withdrawal by Subject|0|||
149819211|NCT03404206|540467237|FG000|Overall Study|Lost to Follow-up|3|||
149819212|NCT03404206|540467238|FG001|Overall Study|Lost to Follow-up|1|||
149819213|NCT03404206|540467239|FG002|Overall Study|Lost to Follow-up|0|||
149819214|NCT05478603|540467240|FG000|Overall Study|Withdrawal by Subject|0|||
149819215|NCT05478603|540467241|FG001|Overall Study|Withdrawal by Subject|1|||
149819216|NCT05478603|540467242|FG002|Overall Study|Withdrawal by Subject|0|||
149819217|NCT05478603|540467243|FG003|Overall Study|Withdrawal by Subject|0|||
149819218|NCT00345683|540467244|FG000|Overall Study|Lost to Follow-up|19|||
149819219|NCT00345683|540467245|FG001|Overall Study|Lost to Follow-up|7|||
149819220|NCT00345683|540467244|FG000|Overall Study|Other|6|||
149819221|NCT00345683|540467245|FG001|Overall Study|Other|2|||
149819222|NCT03634488|540467248|FG000|Overall Study|Death|1|||
149819223|NCT03634488|540467249|FG001|Overall Study|Death|0|||
149819224|NCT03634488|540467250|FG002|Overall Study|Death|0|||
149819225|NCT03634488|540467248|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
149819226|NCT03634488|540467249|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
150263421|NCT00879762|542101746|FG001|Overall Study|Lost to Follow-up|1|||
150263422|NCT01313637|542101749|FG000|Overall Study|Adverse Event|17|||
150263423|NCT01313637|542101750|FG001|Overall Study|Adverse Event|24|||
150263424|NCT01313637|542101751|FG002|Overall Study|Adverse Event|25|||
150263425|NCT01313637|542101752|FG003|Overall Study|Adverse Event|18|||
150263426|NCT01313637|542101749|FG000|Overall Study|Lack of Efficacy|44|||
150263427|NCT01313637|542101750|FG001|Overall Study|Lack of Efficacy|38|||
149926606|NCT03410992|540867053|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926607|NCT03410992|540867054|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926608|NCT03410992|540867055|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926609|NCT03410992|540867056|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926610|NCT03410992|540867057|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926611|NCT03410992|540867058|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149926612|NCT03410992|540867048|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
149926613|NCT03410992|540867049|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
149926614|NCT03410992|540867050|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926615|NCT03410992|540867051|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926616|NCT03410992|540867052|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926617|NCT03410992|540867053|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926618|NCT03410992|540867054|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926619|NCT03410992|540867055|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926620|NCT03410992|540867056|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926621|NCT03410992|540867057|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926622|NCT03410992|540867058|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
149926623|NCT03410992|540867048|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
149926624|NCT03410992|540867049|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
149926625|NCT03410992|540867050|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926626|NCT03410992|540867051|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926627|NCT03410992|540867052|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926628|NCT03410992|540867053|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926629|NCT03410992|540867054|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926630|NCT03410992|540867055|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926631|NCT03410992|540867056|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926632|NCT03410992|540867057|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926633|NCT03410992|540867058|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
149926634|NCT03410992|540867048|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
149926635|NCT03410992|540867049|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926636|NCT03410992|540867050|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926637|NCT03410992|540867051|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926638|NCT03410992|540867052|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926639|NCT03410992|540867053|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926640|NCT03410992|540867054|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926641|NCT03410992|540867055|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926642|NCT03410992|540867056|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926643|NCT03410992|540867057|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
150163549|NCT00062868|541732263|FG016|Dose Level 3|Lost to Follow-up|0|||
150163550|NCT00062868|541732264|FG017|Dose Level 3|Lost to Follow-up|0|||
150163551|NCT00062868|541732265|FG018|Dose Level 3|Lost to Follow-up|0|||
150163552|NCT00062868|541732266|FG019|Dose Level 3|Lost to Follow-up|0|||
150163553|NCT00062868|541732267|FG020|Dose Level 3|Lost to Follow-up|0|||
150163554|NCT00062868|541732247|FG000|Dose Level 3|Withdrew|0|||
150163555|NCT00062868|541732248|FG001|Dose Level 3|Withdrew|0|||
150163556|NCT00062868|541732249|FG002|Dose Level 3|Withdrew|2|||
150163557|NCT00062868|541732250|FG003|Dose Level 3|Withdrew|0|||
150163558|NCT00062868|541732251|FG004|Dose Level 3|Withdrew|0|||
150163559|NCT00062868|541732252|FG005|Dose Level 3|Withdrew|0|||
150163560|NCT00062868|541732253|FG006|Dose Level 3|Withdrew|0|||
150163561|NCT00062868|541732254|FG007|Dose Level 3|Withdrew|0|||
150163562|NCT00062868|541732255|FG008|Dose Level 3|Withdrew|0|||
150163563|NCT00062868|541732256|FG009|Dose Level 3|Withdrew|0|||
150163564|NCT00062868|541732257|FG010|Dose Level 3|Withdrew|0|||
150163565|NCT00062868|541732258|FG011|Dose Level 3|Withdrew|0|||
150163566|NCT00062868|541732259|FG012|Dose Level 3|Withdrew|0|||
150163567|NCT00062868|541732260|FG013|Dose Level 3|Withdrew|0|||
150163568|NCT00062868|541732261|FG014|Dose Level 3|Withdrew|0|||
150163569|NCT00062868|541732262|FG015|Dose Level 3|Withdrew|0|||
150163570|NCT00062868|541732263|FG016|Dose Level 3|Withdrew|0|||
150163571|NCT00062868|541732264|FG017|Dose Level 3|Withdrew|0|||
150163572|NCT00062868|541732265|FG018|Dose Level 3|Withdrew|0|||
150163573|NCT00062868|541732266|FG019|Dose Level 3|Withdrew|0|||
150163574|NCT00062868|541732267|FG020|Dose Level 3|Withdrew|0|||
150163575|NCT04949399|541732270|FG000|Overall Study|Lost to Follow-up|11|||
149926644|NCT03410992|540867058|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
149926645|NCT03410992|540867048|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
149926646|NCT03410992|540867049|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
150163576|NCT04949399|541732271|FG001|Overall Study|Lost to Follow-up|6|||
150163577|NCT04949399|541732270|FG000|Overall Study|Withdrawal by Subject|2|||
150163578|NCT04949399|541732271|FG001|Overall Study|Withdrawal by Subject|3|||
150163579|NCT00670540|541732272|FG000|Overall Study|ineligible|17|||
149926647|NCT03410992|540867050|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926648|NCT03410992|540867051|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926649|NCT03410992|540867052|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926650|NCT03410992|540867053|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926651|NCT03410992|540867054|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926652|NCT03410992|540867055|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926653|NCT03410992|540867056|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926654|NCT03410992|540867057|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926655|NCT03410992|540867058|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
149926656|NCT03410992|540867048|FG000|Week 16 Assessment|Incorrect escapers|0|||
149926657|NCT03410992|540867049|FG001|Week 16 Assessment|Incorrect escapers|6|||
149926658|NCT03410992|540867050|FG002|Week 16 Assessment|Incorrect escapers|0|||
149926659|NCT03410992|540867051|FG003|Week 16 Assessment|Incorrect escapers|0|||
149926660|NCT03410992|540867052|FG004|Week 16 Assessment|Incorrect escapers|0|||
149926661|NCT03410992|540867053|FG005|Week 16 Assessment|Incorrect escapers|0|||
149926662|NCT03410992|540867054|FG006|Week 16 Assessment|Incorrect escapers|0|||
149926663|NCT03410992|540867055|FG007|Week 16 Assessment|Incorrect escapers|0|||
149926664|NCT03410992|540867056|FG008|Week 16 Assessment|Incorrect escapers|0|||
149926665|NCT03410992|540867057|FG009|Week 16 Assessment|Incorrect escapers|0|||
149926666|NCT03410992|540867058|FG010|Week 16 Assessment|Incorrect escapers|0|||
149926667|NCT03410992|540867048|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926668|NCT03410992|540867049|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926669|NCT03410992|540867050|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926670|NCT03410992|540867051|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
149926671|NCT03410992|540867052|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
149926672|NCT03410992|540867053|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926673|NCT03410992|540867054|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926674|NCT03410992|540867055|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926675|NCT03410992|540867056|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926676|NCT03410992|540867057|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926677|NCT03410992|540867058|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
149926678|NCT03410992|540867048|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926679|NCT03410992|540867049|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926680|NCT03410992|540867050|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926681|NCT03410992|540867051|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
149926682|NCT03410992|540867052|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
149926683|NCT03410992|540867053|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
149926684|NCT03410992|540867054|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926685|NCT03410992|540867055|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926686|NCT03410992|540867056|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926687|NCT03410992|540867057|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926688|NCT03410992|540867058|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
149926689|NCT03410992|540867048|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926690|NCT03410992|540867049|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926691|NCT03410992|540867050|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926692|NCT03410992|540867051|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926693|NCT03410992|540867052|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926694|NCT03410992|540867053|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
149926695|NCT03410992|540867054|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926696|NCT03410992|540867055|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926697|NCT03410992|540867056|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
150163580|NCT00670540|541732272|FG000|Overall Study|not living in France|348|||
150163581|NCT00670540|541732272|FG000|Overall Study|refused to participate|189|||
150163582|NCT00670540|541732272|FG000|Overall Study|controls randomised for no follow up|2770|||
150163583|NCT00670540|541732272|FG000|Overall Study|missing information inclusion criteria|1|||
150163584|NCT01866917|541732273|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
150163585|NCT01866917|541732274|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
150163586|NCT01140347|541732281|FG000|Overall Study|Lost to Follow-up|5|||
150163587|NCT01140347|541732282|FG001|Overall Study|Lost to Follow-up|6|||
150163588|NCT01140347|541732281|FG000|Overall Study|Withdrawal by Subject|13|||
150163589|NCT01140347|541732282|FG001|Overall Study|Withdrawal by Subject|8|||
150163590|NCT00569946|541733830|FG000|Overall Study|Adverse Event|16|||
150163591|NCT00569946|541733830|FG000|Overall Study|Objective Progression or Relapse|42|||
150163592|NCT00569946|541733830|FG000|Overall Study|Global Deterioration of Health Status|1|||
150163593|NCT00587288|541733831|FG000|Overall Study|Adverse Event|0|||
150163594|NCT00587288|541733832|FG001|Overall Study|Adverse Event|1|||
150163595|NCT00587288|541733831|FG000|Overall Study|Lack of Efficacy|2|||
150163596|NCT00587288|541733832|FG001|Overall Study|Lack of Efficacy|8|||
150163597|NCT00587288|541733831|FG000|Overall Study|Protocol Violation|1|||
150163598|NCT00587288|541733832|FG001|Overall Study|Protocol Violation|0|||
150163599|NCT00797862|541733833|FG000|Overall Study|Adverse Event|86|||
150163600|NCT00797862|541733834|FG001|Overall Study|Adverse Event|44|||
150163601|NCT00797862|541733835|FG002|Overall Study|Adverse Event|58|||
150163602|NCT00797862|541733833|FG000|Overall Study|Abnormal Test Procedure Result|0|||
150163603|NCT00797862|541733834|FG001|Overall Study|Abnormal Test Procedure Result|1|||
150163604|NCT00797862|541733835|FG002|Overall Study|Abnormal Test Procedure Result|1|||
150163605|NCT00797862|541733833|FG000|Overall Study|Lack of Efficacy|1|||
150163606|NCT00797862|541733834|FG001|Overall Study|Lack of Efficacy|7|||
150163607|NCT00797862|541733835|FG002|Overall Study|Lack of Efficacy|6|||
150163608|NCT00797862|541733833|FG000|Overall Study|No longer required study medication|1|||
150163609|NCT00797862|541733834|FG001|Overall Study|No longer required study medication|0|||
150163610|NCT00797862|541733835|FG002|Overall Study|No longer required study medication|0|||
150163611|NCT00797862|541733833|FG000|Overall Study|Withdrawal by Subject|14|||
150163612|NCT00797862|541733834|FG001|Overall Study|Withdrawal by Subject|7|||
150163613|NCT00797862|541733835|FG002|Overall Study|Withdrawal by Subject|7|||
150163614|NCT00797862|541733833|FG000|Overall Study|Lost to Follow-up|11|||
150163615|NCT00797862|541733834|FG001|Overall Study|Lost to Follow-up|0|||
150163616|NCT00797862|541733835|FG002|Overall Study|Lost to Follow-up|5|||
150163617|NCT00797862|541733833|FG000|Overall Study|Administrative Problem|4|||
150163618|NCT00797862|541733834|FG001|Overall Study|Administrative Problem|0|||
150163619|NCT00797862|541733835|FG002|Overall Study|Administrative Problem|0|||
150163620|NCT00797862|541733833|FG000|Overall Study|Protocol Violation|4|||
150163621|NCT00797862|541733834|FG001|Overall Study|Protocol Violation|6|||
150163622|NCT00797862|541733835|FG002|Overall Study|Protocol Violation|8|||
150163623|NCT00797862|541733833|FG000|Overall Study|Mis-randomized|3|||
150163624|NCT00797862|541733834|FG001|Overall Study|Mis-randomized|3|||
150163625|NCT00797862|541733835|FG002|Overall Study|Mis-randomized|1|||
150163626|NCT05074498|541733838|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
150163627|NCT05074498|541733839|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
150163628|NCT05074498|541733840|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
150163629|NCT05074498|541733841|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
150163630|NCT05074498|541733842|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
150163631|NCT05074498|541733843|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
150163632|NCT05074498|541733838|FG000|Part 1 (Upto Day 104)|Other|1|||
150163633|NCT05074498|541733839|FG001|Part 1 (Upto Day 104)|Other|0|||
150163634|NCT05074498|541733840|FG002|Part 1 (Upto Day 104)|Other|0|||
150163635|NCT05074498|541733841|FG003|Part 1 (Upto Day 104)|Other|0|||
150163636|NCT05074498|541733842|FG004|Part 1 (Upto Day 104)|Other|0|||
150163637|NCT05074498|541733843|FG005|Part 1 (Upto Day 104)|Other|0|||
150163638|NCT05074498|541733838|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
150163639|NCT05074498|541733839|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
150163640|NCT05074498|541733840|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
150163641|NCT05074498|541733841|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
150163642|NCT05074498|541733842|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
150163643|NCT05074498|541733843|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
150163644|NCT05074498|541733838|FG000|Part 2 (Upto Day 104)|Death|0|||
150163645|NCT05074498|541733839|FG001|Part 2 (Upto Day 104)|Death|0|||
150163646|NCT05074498|541733840|FG002|Part 2 (Upto Day 104)|Death|0|||
150163647|NCT05074498|541733841|FG003|Part 2 (Upto Day 104)|Death|0|||
150163648|NCT05074498|541733842|FG004|Part 2 (Upto Day 104)|Death|1|||
150163649|NCT05074498|541733843|FG005|Part 2 (Upto Day 104)|Death|0|||
150163650|NCT05074498|541733838|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
150163651|NCT05074498|541733839|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
150163652|NCT05074498|541733840|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
150163653|NCT05074498|541733841|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
150163654|NCT05074498|541733842|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
150163655|NCT05074498|541733843|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
150163656|NCT05074498|541733838|FG000|Part 2 (Upto Day 104)|Other|0|||
150163657|NCT05074498|541733839|FG001|Part 2 (Upto Day 104)|Other|0|||
150163658|NCT05074498|541733840|FG002|Part 2 (Upto Day 104)|Other|0|||
150163659|NCT05074498|541733841|FG003|Part 2 (Upto Day 104)|Other|0|||
150163660|NCT05074498|541733842|FG004|Part 2 (Upto Day 104)|Other|1|||
150163661|NCT05074498|541733843|FG005|Part 2 (Upto Day 104)|Other|0|||
150163662|NCT01240356|541733844|FG000|Overall Study|Withdrawal by Subject|2|||
150163663|NCT01240356|541733845|FG001|Overall Study|Withdrawal by Subject|0|||
150163664|NCT01240356|541733844|FG000|Overall Study|MRI contraindication|1|||
150163665|NCT01240356|541733845|FG001|Overall Study|MRI contraindication|0|||
150163666|NCT01306331|541733846|FG000|Overall Study|Adverse Event|28|||
150163667|NCT01306331|541733847|FG001|Overall Study|Adverse Event|25|||
150163668|NCT01306331|541733846|FG000|Overall Study|Lost to Follow-up|321|||
150163669|NCT01306331|541733847|FG001|Overall Study|Lost to Follow-up|323|||
150163670|NCT01306331|541733846|FG000|Overall Study|Physician Decision|26|||
150163671|NCT01306331|541733847|FG001|Overall Study|Physician Decision|22|||
150163672|NCT01306331|541733846|FG000|Overall Study|Pregnancy|136|||
150163673|NCT01306331|541733847|FG001|Overall Study|Pregnancy|151|||
150163674|NCT01306331|541733846|FG000|Overall Study|Protocol Violation|154|||
150263428|NCT01313637|542101751|FG002|Overall Study|Lack of Efficacy|37|||
150263429|NCT01313637|542101752|FG003|Overall Study|Lack of Efficacy|24|||
150263430|NCT01313637|542101749|FG000|Overall Study|Protocol Violation|4|||
150263431|NCT01313637|542101750|FG001|Overall Study|Protocol Violation|3|||
150263432|NCT01313637|542101751|FG002|Overall Study|Protocol Violation|11|||
150263433|NCT01313637|542101752|FG003|Overall Study|Protocol Violation|5|||
150263434|NCT01313637|542101749|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
150263435|NCT01313637|542101750|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
150263436|NCT01313637|542101751|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
150263437|NCT01313637|542101752|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
150263438|NCT01313637|542101749|FG000|Overall Study|Lost to Follow-up|0|||
150263439|NCT01313637|542101750|FG001|Overall Study|Lost to Follow-up|2|||
150263440|NCT01313637|542101751|FG002|Overall Study|Lost to Follow-up|1|||
150263441|NCT01313637|542101752|FG003|Overall Study|Lost to Follow-up|3|||
150263442|NCT01313637|542101749|FG000|Overall Study|Withdrawal by Subject|11|||
150263443|NCT01313637|542101750|FG001|Overall Study|Withdrawal by Subject|13|||
150263444|NCT01313637|542101751|FG002|Overall Study|Withdrawal by Subject|18|||
150263445|NCT01313637|542101752|FG003|Overall Study|Withdrawal by Subject|15|||
150263446|NCT00795951|542101758|FG000|Overall Study|Lost to Follow-up|1|||
150263447|NCT00795951|542101758|FG000|Overall Study|Withdrawal by Subject|1|||
150263448|NCT04572841|542101761|FG000|Overall Study|Adverse Event|1|||
150263449|NCT04572841|542101762|FG001|Overall Study|Adverse Event|1|||
150263450|NCT04572841|542101761|FG000|Overall Study|Withdrawal by Subject|2|||
150263451|NCT04572841|542101762|FG001|Overall Study|Withdrawal by Subject|1|||
150263452|NCT06469242|542101763|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
150263453|NCT06469242|542101764|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
150263454|NCT06469242|542101763|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
150263455|NCT06469242|542101764|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
150263456|NCT01205152|542101765|FG000|Overall Study|Death|1|||
149926698|NCT03410992|540867057|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
149926699|NCT03410992|540867058|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
150163675|NCT01306331|541733847|FG001|Overall Study|Protocol Violation|124|||
150163676|NCT01306331|541733846|FG000|Overall Study|Withdrawal by Subject|163|||
150163677|NCT01306331|541733847|FG001|Overall Study|Withdrawal by Subject|152|||
150163678|NCT01306331|541733846|FG000|Overall Study|Not sexually active|29|||
150163679|NCT01306331|541733847|FG001|Overall Study|Not sexually active|28|||
150163680|NCT01306331|541733846|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
150163681|NCT01306331|541733847|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
150163682|NCT01306331|541733846|FG000|Overall Study|Other|34|||
150163683|NCT01306331|541733847|FG001|Overall Study|Other|32|||
150163684|NCT04048135|541733848|FG000|Overall Study|Withdrawal by Subject|1|||
150163685|NCT04048135|541733849|FG001|Overall Study|Withdrawal by Subject|1|||
150163686|NCT04048135|541733850|FG002|Overall Study|Withdrawal by Subject|1|||
150163687|NCT04048135|541733851|FG003|Overall Study|Withdrawal by Subject|2|||
150163688|NCT04048135|541733852|FG004|Overall Study|Withdrawal by Subject|0|||
150163689|NCT04048135|541733853|FG005|Overall Study|Withdrawal by Subject|0|||
150163690|NCT04048135|541733854|FG006|Overall Study|Withdrawal by Subject|1|||
150163691|NCT04048135|541733855|FG007|Overall Study|Withdrawal by Subject|1|||
150163692|NCT04048135|541733848|FG000|Overall Study|Adverse Event|0|||
150163693|NCT04048135|541733849|FG001|Overall Study|Adverse Event|0|||
150163694|NCT04048135|541733850|FG002|Overall Study|Adverse Event|0|||
150163695|NCT04048135|541733851|FG003|Overall Study|Adverse Event|1|||
150163696|NCT04048135|541733852|FG004|Overall Study|Adverse Event|1|||
150163697|NCT04048135|541733853|FG005|Overall Study|Adverse Event|0|||
150163698|NCT04048135|541733854|FG006|Overall Study|Adverse Event|0|||
150163699|NCT04048135|541733855|FG007|Overall Study|Adverse Event|0|||
150163700|NCT04048135|541733848|FG000|Overall Study|Protocol Violation|0|||
150163701|NCT04048135|541733849|FG001|Overall Study|Protocol Violation|0|||
150163702|NCT04048135|541733850|FG002|Overall Study|Protocol Violation|0|||
150163703|NCT04048135|541733851|FG003|Overall Study|Protocol Violation|0|||
150163704|NCT04048135|541733852|FG004|Overall Study|Protocol Violation|0|||
150163705|NCT04048135|541733853|FG005|Overall Study|Protocol Violation|1|||
150163706|NCT04048135|541733854|FG006|Overall Study|Protocol Violation|0|||
150163707|NCT04048135|541733855|FG007|Overall Study|Protocol Violation|0|||
150163708|NCT00409708|541733860|FG000|Treatment|Abnormal test procedure result(s)|1|||
150163709|NCT00409708|541733861|FG001|Treatment|Abnormal test procedure result(s)|0|||
150163710|NCT00409708|541733860|FG000|Treatment|Lack of Efficacy|0|||
150163711|NCT00409708|541733861|FG001|Treatment|Lack of Efficacy|1|||
150163712|NCT00409708|541733860|FG000|Treatment|Protocol Violation|6|||
150163713|NCT00409708|541733861|FG001|Treatment|Protocol Violation|2|||
150163714|NCT00409708|541733860|FG000|Treatment|Withdrawal by Subject|3|||
150163715|NCT00409708|541733861|FG001|Treatment|Withdrawal by Subject|8|||
150163716|NCT00409708|541733860|FG000|Treatment|Lost to Follow-up|0|||
150163717|NCT00409708|541733861|FG001|Treatment|Lost to Follow-up|6|||
149926700|NCT03410992|540867048|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926701|NCT03410992|540867049|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926702|NCT03410992|540867050|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926703|NCT03410992|540867051|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
149926704|NCT03410992|540867052|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
149926705|NCT03410992|540867053|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
149926706|NCT03410992|540867054|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926707|NCT03410992|540867055|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926708|NCT03410992|540867056|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926709|NCT03410992|540867057|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
150163718|NCT00409708|541733860|FG000|Treatment|Administrative problems|5|||
150163719|NCT00409708|541733861|FG001|Treatment|Administrative problems|0|||
150163720|NCT00409708|541733860|FG000|Washout|Lack of Efficacy|9|||
150163721|NCT00409708|541733861|FG001|Washout|Lack of Efficacy|1|||
150163722|NCT00409708|541733860|FG000|Washout|Protocol Violation|0|||
150163723|NCT00409708|541733861|FG001|Washout|Protocol Violation|1|||
150163724|NCT00409708|541733860|FG000|Washout|Withdrawal by Subject|11|||
150163725|NCT00409708|541733861|FG001|Washout|Withdrawal by Subject|5|||
150163726|NCT00409708|541733860|FG000|Washout|Lost to Follow-up|1|||
150163727|NCT00409708|541733861|FG001|Washout|Lost to Follow-up|3|||
150163728|NCT00946114|541733862|FG000|Overall Study|Death|5|||
150163729|NCT00946114|541733863|FG001|Overall Study|Death|2|||
150163730|NCT00946114|541733862|FG000|Overall Study|Other|1|||
150163731|NCT00946114|541733863|FG001|Overall Study|Other|0|||
150163732|NCT00946114|541733862|FG000|Overall Study|Withdrawal by Subject|2|||
150163733|NCT00946114|541733863|FG001|Overall Study|Withdrawal by Subject|0|||
150163734|NCT00088465|541733868|FG000|Overall Study|Withdrawal by Subject|290|||
150163735|NCT00088465|541733868|FG000|Overall Study|Adverse Event|77|||
150163736|NCT00088465|541733868|FG000|Overall Study|Lost to Follow-up|57|||
150163737|NCT00088465|541733868|FG000|Overall Study|Physician Decision|45|||
150163738|NCT00088465|541733868|FG000|Overall Study|Sponsor Decision|37|||
150163739|NCT00088465|541733868|FG000|Overall Study|Lack of Efficacy|27|||
150163740|NCT00088465|541733868|FG000|Overall Study|Protocol Violation|17|||
150163741|NCT00088465|541733868|FG000|Overall Study|Death|11|||
150163742|NCT00448864|541733869|FG000|Overall Study|Death|1|||
150163743|NCT00448864|541733870|FG001|Overall Study|Death|0|||
150163744|NCT00448864|541733871|FG002|Overall Study|Death|0|||
150163745|NCT00448864|541733869|FG000|Overall Study|Lost to Follow-up|3|||
150163746|NCT00448864|541733870|FG001|Overall Study|Lost to Follow-up|1|||
150163747|NCT00448864|541733871|FG002|Overall Study|Lost to Follow-up|0|||
150163748|NCT00448864|541733869|FG000|Overall Study|Physician Decision|1|||
150163749|NCT00448864|541733870|FG001|Overall Study|Physician Decision|0|||
150163750|NCT00448864|541733871|FG002|Overall Study|Physician Decision|1|||
150163751|NCT00448864|541733869|FG000|Overall Study|Withdrawal by Subject|0|||
150163752|NCT00448864|541733870|FG001|Overall Study|Withdrawal by Subject|2|||
150163753|NCT00448864|541733871|FG002|Overall Study|Withdrawal by Subject|0|||
150163754|NCT00448864|541733869|FG000|Overall Study|Protocol Violation|0|||
150163755|NCT00448864|541733870|FG001|Overall Study|Protocol Violation|2|||
150163756|NCT00448864|541733871|FG002|Overall Study|Protocol Violation|0|||
150163757|NCT01390857|541733872|FG000|Overall Study|Protocol Violation|2|||
149926710|NCT03410992|540867058|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
149926711|NCT03410992|540867048|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
150163758|NCT01390857|541733872|FG000|Overall Study|Lost to Follow-up|1|||
150163759|NCT01390857|541733872|FG000|Overall Study|No Visit after the First Visit|7|||
150163760|NCT02757885|541733873|FG000|Overall Study|Screen Failures|4|||
150163761|NCT01474538|541733875|FG000|Treatment Period 1|Death|1|||
150163762|NCT01474538|541733876|FG001|Treatment Period 1|Death|0|||
150163763|NCT01474538|541733875|FG000|Treatment Period 1|Physician Decision|1|||
150163764|NCT01474538|541733876|FG001|Treatment Period 1|Physician Decision|0|||
150163765|NCT01474538|541733875|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150163766|NCT01474538|541733876|FG001|Treatment Period 1|Withdrawal by Subject|3|||
150263457|NCT00211185|542101768|FG000|Overall Study|Death|2|||
150163767|NCT01474538|541733875|FG000|Treatment Period 1|Protocol Violation|0|||
150163768|NCT01474538|541733876|FG001|Treatment Period 1|Protocol Violation|1|||
150163769|NCT01474538|541733875|FG000|Treatment Period 2|Death|1|||
150263458|NCT00211185|542101768|FG000|Overall Study|Disease progression|7|||
150163770|NCT01474538|541733876|FG001|Treatment Period 2|Death|0|||
150163771|NCT01474538|541733875|FG000|Treatment Period 2|Adverse Event|1|||
150163772|NCT01474538|541733876|FG001|Treatment Period 2|Adverse Event|1|||
150163773|NCT01474538|541733875|FG000|Treatment Period 2|Withdrawal by Subject|2|||
150163774|NCT01474538|541733876|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150163775|NCT01474538|541733875|FG000|Treatment Period 2|Sponsor decision|1|||
150163776|NCT01474538|541733876|FG001|Treatment Period 2|Sponsor decision|0|||
150163777|NCT01474538|541733875|FG000|Treatment Period 2|Physician Decision|0|||
150163778|NCT01474538|541733876|FG001|Treatment Period 2|Physician Decision|1|||
150263459|NCT00211185|542101768|FG000|Overall Study|Withdrawal by Subject|6|||
150263460|NCT00211185|542101768|FG000|Overall Study|Physician Decision|5|||
150263461|NCT02783768|542101769|FG000|Overall Study|Lost to Follow-up|1|||
150263462|NCT02783768|542101770|FG001|Overall Study|Lost to Follow-up|0|||
150263463|NCT01323647|542101771|FG000|Overall Study|Migrated/moved from study area|2|||
149926712|NCT03410992|540867049|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926713|NCT03410992|540867050|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926714|NCT03410992|540867051|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926715|NCT03410992|540867052|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926716|NCT03410992|540867053|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
150263464|NCT01323647|542101772|FG001|Overall Study|Migrated/moved from study area|0|||
150263465|NCT01323647|542101771|FG000|Overall Study|Withdrawal by Subject|5|||
150263466|NCT01323647|542101772|FG001|Overall Study|Withdrawal by Subject|0|||
150263467|NCT01323647|542101771|FG000|Overall Study|Lost to Follow-up|2|||
150263468|NCT01323647|542101772|FG001|Overall Study|Lost to Follow-up|0|||
150263469|NCT00986674|542101773|FG000|Overall Study|Lack of Efficacy|28|||
150263470|NCT00986674|542101774|FG001|Overall Study|Lack of Efficacy|25|||
150263471|NCT00986674|542101775|FG002|Overall Study|Lack of Efficacy|23|||
150263472|NCT00986674|542101773|FG000|Overall Study|Adverse Event|4|||
150263473|NCT00986674|542101774|FG001|Overall Study|Adverse Event|8|||
150263474|NCT00986674|542101775|FG002|Overall Study|Adverse Event|9|||
150263475|NCT00986674|542101773|FG000|Overall Study|Death|5|||
150263476|NCT00986674|542101774|FG001|Overall Study|Death|0|||
150263477|NCT00986674|542101775|FG002|Overall Study|Death|4|||
150263478|NCT00986674|542101773|FG000|Overall Study|Withdrawal by Subject|6|||
150263479|NCT00986674|542101774|FG001|Overall Study|Withdrawal by Subject|2|||
150263480|NCT00986674|542101775|FG002|Overall Study|Withdrawal by Subject|1|||
150263481|NCT00986674|542101773|FG000|Overall Study|alternative therapy|0|||
150263482|NCT00986674|542101774|FG001|Overall Study|alternative therapy|0|||
150263483|NCT00986674|542101775|FG002|Overall Study|alternative therapy|1|||
150263484|NCT00986674|542101773|FG000|Overall Study|not start protocol therapy|4|||
150263485|NCT00986674|542101774|FG001|Overall Study|not start protocol therapy|3|||
150263486|NCT00986674|542101775|FG002|Overall Study|not start protocol therapy|1|||
150263487|NCT00986674|542101773|FG000|Overall Study|unknown/not specify|0|||
150263488|NCT00986674|542101774|FG001|Overall Study|unknown/not specify|7|||
150263489|NCT00986674|542101775|FG002|Overall Study|unknown/not specify|9|||
150263490|NCT00842985|542101778|FG000|Screening|Did not meet entrance requirements|27|||
150263491|NCT00842985|542101778|FG000|First Intervention|Withdrawal by Subject|3|||
150263492|NCT00842985|542101778|FG000|First Intervention|Protocol Violation|3|||
150263493|NCT00842985|542101778|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
150263494|NCT00842985|542101778|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
150263495|NCT01037244|542101779|FG000|Overall Study|Adverse Event|3|||
150263496|NCT01037244|542101780|FG001|Overall Study|Adverse Event|2|||
150263497|NCT01037244|542101781|FG002|Overall Study|Adverse Event|6|||
150263498|NCT01037244|542101782|FG003|Overall Study|Adverse Event|3|||
150263499|NCT01037244|542101779|FG000|Overall Study|Lack of Efficacy|1|||
150263500|NCT01037244|542101780|FG001|Overall Study|Lack of Efficacy|1|||
150263501|NCT01037244|542101781|FG002|Overall Study|Lack of Efficacy|0|||
150263502|NCT01037244|542101782|FG003|Overall Study|Lack of Efficacy|1|||
150263503|NCT01037244|542101779|FG000|Overall Study|Lost to Follow-up|3|||
150263504|NCT01037244|542101780|FG001|Overall Study|Lost to Follow-up|3|||
150263505|NCT01037244|542101781|FG002|Overall Study|Lost to Follow-up|4|||
150263506|NCT01037244|542101782|FG003|Overall Study|Lost to Follow-up|4|||
150263507|NCT01037244|542101779|FG000|Overall Study|Withdrawal by Subject|1|||
150263508|NCT01037244|542101780|FG001|Overall Study|Withdrawal by Subject|5|||
150263509|NCT01037244|542101781|FG002|Overall Study|Withdrawal by Subject|3|||
150263510|NCT01037244|542101782|FG003|Overall Study|Withdrawal by Subject|5|||
150263511|NCT01037244|542101779|FG000|Overall Study|Partner Withdrew Consent|2|||
150263512|NCT01037244|542101780|FG001|Overall Study|Partner Withdrew Consent|1|||
150263513|NCT01037244|542101781|FG002|Overall Study|Partner Withdrew Consent|0|||
150263514|NCT01037244|542101782|FG003|Overall Study|Partner Withdrew Consent|0|||
150263515|NCT01037244|542101779|FG000|Overall Study|Various|3|||
150263516|NCT01037244|542101780|FG001|Overall Study|Various|2|||
150263517|NCT01037244|542101781|FG002|Overall Study|Various|1|||
150263518|NCT01037244|542101782|FG003|Overall Study|Various|1|||
150263519|NCT02203695|542101783|FG000|Overall Study|Patient withdrew consent|1|||
150263520|NCT02203695|542101784|FG001|Overall Study|Patient withdrew consent|1|||
150263521|NCT02203695|542101783|FG000|Overall Study|Started non-study treatment|1|||
150263522|NCT02203695|542101784|FG001|Overall Study|Started non-study treatment|0|||
150263523|NCT01127139|542101786|FG000|Overall Study|Adverse Event|40|||
150263524|NCT01127139|542101786|FG000|Overall Study|Incompliance|12|||
149926717|NCT03410992|540867054|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
150263525|NCT01127139|542101786|FG000|Overall Study|Lack of Efficacy|4|||
150263526|NCT01127139|542101786|FG000|Overall Study|Reason not specified|1|||
150263527|NCT02070588|542101789|FG000|Overall Study|Withdrawal by Subject|29|||
150263528|NCT02070588|542101790|FG001|Overall Study|Withdrawal by Subject|1|||
150263529|NCT02070588|542101791|FG002|Overall Study|Withdrawal by Subject|0|||
150263530|NCT02070588|542101789|FG000|Overall Study|Writhdrawal due to early termination|9|||
150263531|NCT02070588|542101790|FG001|Overall Study|Writhdrawal due to early termination|0|||
149926718|NCT03410992|540867055|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
149926719|NCT03410992|540867056|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926720|NCT03410992|540867057|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926721|NCT03410992|540867058|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
149926722|NCT03410992|540867048|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
149926723|NCT03410992|540867049|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
150163779|NCT01474538|541733875|FG000|Treatment Period 2|Protocol Violation|1|||
150163780|NCT01474538|541733876|FG001|Treatment Period 2|Protocol Violation|0|||
150163781|NCT02688621|541733877|FG000|Overall Study|Pregnancy|1|||
150163782|NCT02688621|541733878|FG001|Overall Study|Pregnancy|3|||
150163783|NCT02688621|541733877|FG000|Overall Study|Lost to Follow-up|38|||
150163784|NCT02688621|541733878|FG001|Overall Study|Lost to Follow-up|15|||
150163785|NCT02688621|541733877|FG000|Overall Study|Withdrawal by Subject|1|||
150163786|NCT02688621|541733878|FG001|Overall Study|Withdrawal by Subject|0|||
150163787|NCT04565249|541733879|FG000|Overall Study|Death|0|||
150163788|NCT04565249|541733880|FG001|Overall Study|Death|0|||
150163789|NCT04565249|541733881|FG002|Overall Study|Death|0|||
150163790|NCT04565249|541733882|FG003|Overall Study|Death|1|||
150163791|NCT01289119|541733886|FG000|Overall Study|Adverse Event|2|||
150163792|NCT01289119|541733887|FG001|Overall Study|Adverse Event|1|||
150163793|NCT01289119|541733888|FG002|Overall Study|Adverse Event|0|||
150163794|NCT01289119|541733889|FG003|Overall Study|Adverse Event|2|||
150163795|NCT01289119|541733890|FG004|Overall Study|Adverse Event|1|||
150163796|NCT01289119|541733891|FG005|Overall Study|Adverse Event|0|||
150163797|NCT01289119|541733886|FG000|Overall Study|Major Protocol Deviation|2|||
150163798|NCT01289119|541733887|FG001|Overall Study|Major Protocol Deviation|1|||
150163799|NCT01289119|541733888|FG002|Overall Study|Major Protocol Deviation|3|||
150163800|NCT01289119|541733889|FG003|Overall Study|Major Protocol Deviation|0|||
150163801|NCT01289119|541733890|FG004|Overall Study|Major Protocol Deviation|2|||
150163802|NCT01289119|541733891|FG005|Overall Study|Major Protocol Deviation|1|||
150163803|NCT01289119|541733886|FG000|Overall Study|Lost to Follow-up|0|||
150163804|NCT01289119|541733887|FG001|Overall Study|Lost to Follow-up|3|||
150163805|NCT01289119|541733888|FG002|Overall Study|Lost to Follow-up|0|||
150163806|NCT01289119|541733889|FG003|Overall Study|Lost to Follow-up|0|||
150163807|NCT01289119|541733890|FG004|Overall Study|Lost to Follow-up|0|||
150163808|NCT01289119|541733891|FG005|Overall Study|Lost to Follow-up|1|||
150163809|NCT01289119|541733886|FG000|Overall Study|Withdrawal by Subject|4|||
150163810|NCT01289119|541733887|FG001|Overall Study|Withdrawal by Subject|2|||
150163811|NCT01289119|541733888|FG002|Overall Study|Withdrawal by Subject|4|||
150163812|NCT01289119|541733889|FG003|Overall Study|Withdrawal by Subject|3|||
150163813|NCT01289119|541733890|FG004|Overall Study|Withdrawal by Subject|1|||
150163814|NCT01289119|541733891|FG005|Overall Study|Withdrawal by Subject|1|||
150163815|NCT01289119|541733886|FG000|Overall Study|Pregnancy|0|||
150163816|NCT01289119|541733887|FG001|Overall Study|Pregnancy|1|||
150163817|NCT01289119|541733888|FG002|Overall Study|Pregnancy|0|||
150163818|NCT01289119|541733889|FG003|Overall Study|Pregnancy|0|||
150163819|NCT01289119|541733890|FG004|Overall Study|Pregnancy|0|||
150163820|NCT01289119|541733891|FG005|Overall Study|Pregnancy|0|||
150163821|NCT01289119|541733886|FG000|Overall Study|Lack of Efficacy|0|||
150163822|NCT01289119|541733887|FG001|Overall Study|Lack of Efficacy|1|||
150163823|NCT01289119|541733888|FG002|Overall Study|Lack of Efficacy|1|||
150163824|NCT01289119|541733889|FG003|Overall Study|Lack of Efficacy|1|||
150163825|NCT01289119|541733890|FG004|Overall Study|Lack of Efficacy|1|||
150163826|NCT01289119|541733891|FG005|Overall Study|Lack of Efficacy|1|||
150163827|NCT01289119|541733886|FG000|Overall Study|Other|1|||
150163828|NCT01289119|541733887|FG001|Overall Study|Other|0|||
150163829|NCT01289119|541733888|FG002|Overall Study|Other|1|||
150163830|NCT01289119|541733889|FG003|Overall Study|Other|0|||
150163831|NCT01289119|541733890|FG004|Overall Study|Other|0|||
150163832|NCT01289119|541733891|FG005|Overall Study|Other|0|||
150163833|NCT01704846|541733892|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150163834|NCT01704846|541733893|FG001|Treatment Period 2|Withdrawal by Subject|1|||
150163835|NCT00530335|541733894|FG000|Overall Study|Adverse Event|3|||
150163836|NCT00530335|541733894|FG000|Overall Study|Protocol Violation|1|||
149926724|NCT03410992|540867050|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
150163837|NCT00530335|541733894|FG000|Overall Study|Withdrawal by Subject|1|||
150163838|NCT00530335|541733894|FG000|Overall Study|Physician Decision|1|||
150163839|NCT01244984|541733895|FG000|Overall Study|Adverse Event|2|||
149926725|NCT03410992|540867051|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
149926726|NCT03410992|540867052|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
149926727|NCT03410992|540867053|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
150163840|NCT01244984|541733896|FG001|Overall Study|Adverse Event|11|||
150163841|NCT01244984|541733897|FG002|Overall Study|Adverse Event|2|||
150163842|NCT01244984|541733895|FG000|Overall Study|Protocol Violation|1|||
150163843|NCT01244984|541733896|FG001|Overall Study|Protocol Violation|0|||
150163844|NCT01244984|541733897|FG002|Overall Study|Protocol Violation|0|||
150163845|NCT01244984|541733895|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
150163846|NCT01244984|541733896|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
150263532|NCT02070588|542101791|FG002|Overall Study|Writhdrawal due to early termination|0|||
150263533|NCT02070588|542101789|FG000|Overall Study|Adverse Event|1|||
150263534|NCT02070588|542101790|FG001|Overall Study|Adverse Event|0|||
150263535|NCT02070588|542101791|FG002|Overall Study|Adverse Event|0|||
150263536|NCT02216357|542101795|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
150263537|NCT02216357|542101796|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
150263538|NCT00235326|542101798|FG000|Overall Study|Lost to Follow-up|746|||
150263539|NCT00235326|542101799|FG001|Overall Study|Lost to Follow-up|1400|||
150263540|NCT00928746|542101803|FG000|Overall Study|Adverse Event|2|||
150263541|NCT00928746|542101803|FG000|Overall Study|Protocol Violation|1|||
150263542|NCT00928746|542101803|FG000|Overall Study|Withdrawal by Subject|1|||
150263543|NCT00928746|542101803|FG000|Overall Study|Other|2|||
150263544|NCT02294227|542101805|FG000|Overall Study|Death|0|||
150263545|NCT02294227|542101806|FG001|Overall Study|Death|0|||
150263546|NCT02294227|542101807|FG002|Overall Study|Death|1|||
150263547|NCT02294227|542101805|FG000|Overall Study|Subject/Guardian Decision|6|||
150263548|NCT02294227|542101806|FG001|Overall Study|Subject/Guardian Decision|3|||
150263549|NCT02294227|542101807|FG002|Overall Study|Subject/Guardian Decision|7|||
150263550|NCT02294227|542101805|FG000|Overall Study|Physician Decision|1|||
150263551|NCT02294227|542101806|FG001|Overall Study|Physician Decision|2|||
150263552|NCT02294227|542101807|FG002|Overall Study|Physician Decision|1|||
150263553|NCT02294227|542101805|FG000|Overall Study|Lost to Follow-up|1|||
150263554|NCT02294227|542101806|FG001|Overall Study|Lost to Follow-up|0|||
150263555|NCT02294227|542101807|FG002|Overall Study|Lost to Follow-up|0|||
150263556|NCT02294227|542101805|FG000|Overall Study|Lack of Efficacy|11|||
150263557|NCT02294227|542101806|FG001|Overall Study|Lack of Efficacy|12|||
150263558|NCT02294227|542101807|FG002|Overall Study|Lack of Efficacy|8|||
150263559|NCT02294227|542101805|FG000|Overall Study|Adverse Event|6|||
150263560|NCT02294227|542101806|FG001|Overall Study|Adverse Event|8|||
150263561|NCT02294227|542101807|FG002|Overall Study|Adverse Event|2|||
150263562|NCT00887432|542101808|FG000|Overall Study|Start Excluded Therapy|3|||
150263563|NCT00887432|542101809|FG001|Overall Study|Start Excluded Therapy|0|||
150263564|NCT00887432|542101808|FG000|Overall Study|Did not complete treatment|6|||
150263565|NCT00887432|542101809|FG001|Overall Study|Did not complete treatment|8|||
150263566|NCT00887432|542101808|FG000|Overall Study|Protocol Violation|2|||
150263567|NCT00887432|542101809|FG001|Overall Study|Protocol Violation|3|||
150263568|NCT00887432|542101808|FG000|Overall Study|Withdrawal by Subject|3|||
150263569|NCT00887432|542101809|FG001|Overall Study|Withdrawal by Subject|2|||
150263570|NCT00887432|542101808|FG000|Overall Study|Lost to Follow-up|1|||
150263571|NCT00887432|542101809|FG001|Overall Study|Lost to Follow-up|0|||
150263572|NCT00887432|542101808|FG000|Overall Study|No reason provided|0|||
150263573|NCT00887432|542101809|FG001|Overall Study|No reason provided|1|||
150263574|NCT00899548|542101810|FG000|Overall Study|Physician Decision|3|||
150263575|NCT00551460|542101811|FG000|Overall Study|Adverse Event|1|||
150263576|NCT00551460|542101811|FG000|Overall Study|Withdrawal by Subject|1|||
150263577|NCT00551460|542101811|FG000|Overall Study|Physician Decision|1|||
150263578|NCT00551460|542101811|FG000|Overall Study|Death|7|||
150263579|NCT00551460|542101811|FG000|Overall Study|Ineligible|4|||
150263580|NCT00551460|542101811|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
150263581|NCT01580969|542101812|FG000|Overall Study|Physician Decision|3|||
150263582|NCT01580969|542101813|FG001|Overall Study|Physician Decision|0|||
150263583|NCT01580969|542101814|FG002|Overall Study|Physician Decision|0|||
150263584|NCT01745848|542101815|FG000|Overall Study|Adverse Event|6|||
150263585|NCT02027623|542101817|FG000|Overall Study|Lost to Follow-up|3|||
150263586|NCT02027623|542101818|FG001|Overall Study|Lost to Follow-up|3|||
150263587|NCT02027623|542101817|FG000|Overall Study|Withdrawal by Subject|6|||
150263588|NCT02027623|542101818|FG001|Overall Study|Withdrawal by Subject|9|||
150263589|NCT01886378|542101821|FG000|Overall Study|Adverse Event|1|||
150263590|NCT01886378|542101821|FG000|Overall Study|Withdrawal by Subject|4|||
150263591|NCT03513588|542101829|FG000|Overall Study|Lost to Follow-up|0|||
150263592|NCT03513588|542101830|FG001|Overall Study|Lost to Follow-up|1|||
150263593|NCT03513588|542101831|FG002|Overall Study|Lost to Follow-up|1|||
150263594|NCT03513588|542101829|FG000|Overall Study|Study dosing paused by sponsor|1|||
150263595|NCT03513588|542101830|FG001|Overall Study|Study dosing paused by sponsor|1|||
150263596|NCT03513588|542101831|FG002|Overall Study|Study dosing paused by sponsor|0|||
150263597|NCT03513588|542101829|FG000|Overall Study|Death|0|||
150263598|NCT03513588|542101830|FG001|Overall Study|Death|0|||
150263599|NCT03513588|542101831|FG002|Overall Study|Death|1|||
150263600|NCT00505284|542101832|FG000|Overall Study|Adverse Event|3|||
150263601|NCT00505284|542101833|FG001|Overall Study|Adverse Event|7|||
150263602|NCT00505284|542101834|FG002|Overall Study|Adverse Event|9|||
150263603|NCT00505284|542101835|FG003|Overall Study|Adverse Event|14|||
150263604|NCT00505284|542101836|FG004|Overall Study|Adverse Event|22|||
150263605|NCT00505284|542101832|FG000|Overall Study|Protocol Violation|0|||
150263606|NCT00505284|542101833|FG001|Overall Study|Protocol Violation|1|||
150263607|NCT00505284|542101834|FG002|Overall Study|Protocol Violation|1|||
150263608|NCT00505284|542101835|FG003|Overall Study|Protocol Violation|0|||
150263609|NCT00505284|542101836|FG004|Overall Study|Protocol Violation|0|||
150263610|NCT00505284|542101832|FG000|Overall Study|Withdrawal by Subject|2|||
149926728|NCT03410992|540867054|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
149926729|NCT03410992|540867055|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
149926730|NCT03410992|540867056|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
149926731|NCT03410992|540867057|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
150263611|NCT00505284|542101833|FG001|Overall Study|Withdrawal by Subject|6|||
150263612|NCT00505284|542101834|FG002|Overall Study|Withdrawal by Subject|1|||
150263613|NCT00505284|542101835|FG003|Overall Study|Withdrawal by Subject|0|||
150263614|NCT00505284|542101836|FG004|Overall Study|Withdrawal by Subject|6|||
150263615|NCT00505284|542101832|FG000|Overall Study|Lack of Efficacy|0|||
150263616|NCT00505284|542101833|FG001|Overall Study|Lack of Efficacy|1|||
150263617|NCT00505284|542101834|FG002|Overall Study|Lack of Efficacy|1|||
150263618|NCT00505284|542101835|FG003|Overall Study|Lack of Efficacy|1|||
150263619|NCT00505284|542101836|FG004|Overall Study|Lack of Efficacy|1|||
150263620|NCT00505284|542101832|FG000|Overall Study|Physician Decision|0|||
150263621|NCT00505284|542101833|FG001|Overall Study|Physician Decision|1|||
150263622|NCT00505284|542101834|FG002|Overall Study|Physician Decision|0|||
150263623|NCT00505284|542101835|FG003|Overall Study|Physician Decision|0|||
150263624|NCT00505284|542101836|FG004|Overall Study|Physician Decision|0|||
150263625|NCT00505284|542101832|FG000|Overall Study|Other|5|||
150263626|NCT00505284|542101833|FG001|Overall Study|Other|0|||
150263627|NCT00505284|542101834|FG002|Overall Study|Other|0|||
150263628|NCT00505284|542101835|FG003|Overall Study|Other|4|||
150263629|NCT00505284|542101836|FG004|Overall Study|Other|4|||
150263630|NCT00940108|542101837|FG000|Overall Study|Adverse Event|2|||
150263631|NCT00940108|542101838|FG001|Overall Study|Adverse Event|4|||
150263632|NCT00940108|542101839|FG002|Overall Study|Adverse Event|0|||
150263633|NCT00940108|542101840|FG003|Overall Study|Adverse Event|2|||
150263634|NCT00940108|542101837|FG000|Overall Study|Withdrew Consent|2|||
150263635|NCT00940108|542101838|FG001|Overall Study|Withdrew Consent|1|||
150263636|NCT00940108|542101839|FG002|Overall Study|Withdrew Consent|0|||
150263637|NCT00940108|542101840|FG003|Overall Study|Withdrew Consent|1|||
150263638|NCT00940108|542101837|FG000|Overall Study|Dose 2 contraindicated|1|||
150263639|NCT00940108|542101838|FG001|Overall Study|Dose 2 contraindicated|1|||
150263640|NCT00940108|542101839|FG002|Overall Study|Dose 2 contraindicated|0|||
150263641|NCT00940108|542101840|FG003|Overall Study|Dose 2 contraindicated|1|||
150263642|NCT00940108|542101837|FG000|Overall Study|Declined further vaccination|0|||
150263643|NCT00940108|542101838|FG001|Overall Study|Declined further vaccination|1|||
150263644|NCT00940108|542101839|FG002|Overall Study|Declined further vaccination|3|||
150263645|NCT00940108|542101840|FG003|Overall Study|Declined further vaccination|0|||
150263646|NCT00940108|542101837|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
150263647|NCT00940108|542101838|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
150263648|NCT00940108|542101839|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
150263649|NCT00940108|542101840|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
150263650|NCT00940108|542101837|FG000|Overall Study|Viral illness after Dose 1|0|||
150263651|NCT00940108|542101838|FG001|Overall Study|Viral illness after Dose 1|1|||
150263652|NCT00940108|542101839|FG002|Overall Study|Viral illness after Dose 1|0|||
150263653|NCT00940108|542101840|FG003|Overall Study|Viral illness after Dose 1|0|||
150263654|NCT00940108|542101837|FG000|Overall Study|Diagnosed with H1N1|0|||
150263655|NCT00940108|542101838|FG001|Overall Study|Diagnosed with H1N1|0|||
150263656|NCT00940108|542101839|FG002|Overall Study|Diagnosed with H1N1|0|||
150263657|NCT00940108|542101840|FG003|Overall Study|Diagnosed with H1N1|1|||
150263658|NCT01275131|542101841|FG000|Period 1|Withdrawal by Subject|1|||
150263659|NCT01275131|542101842|FG001|Period 1|Withdrawal by Subject|0|||
150263660|NCT01275131|542101843|FG002|Period 1|Withdrawal by Subject|3|||
150263661|NCT01275131|542101844|FG003|Period 1|Withdrawal by Subject|2|||
150263662|NCT01275131|542101841|FG000|Period 1|Physician Decision|1|||
150263663|NCT01275131|542101842|FG001|Period 1|Physician Decision|0|||
150263664|NCT01275131|542101843|FG002|Period 1|Physician Decision|0|||
150263665|NCT01275131|542101844|FG003|Period 1|Physician Decision|0|||
149926732|NCT03410992|540867058|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
150263666|NCT01275131|542101841|FG000|Period 2 (Crossover)|Adverse Event|0|||
149926733|NCT01468454|540867059|FG000|Overall Study|Did not have surgery after PET|9|||
150263667|NCT01275131|542101842|FG001|Period 2 (Crossover)|Adverse Event|1|||
150263668|NCT01275131|542101843|FG002|Period 2 (Crossover)|Adverse Event|0|||
150263669|NCT01275131|542101844|FG003|Period 2 (Crossover)|Adverse Event|0|||
150263670|NCT01275131|542101841|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
149926734|NCT01462630|540867062|FG000|Overall Study|Did not initiate therapy|3|||
149926735|NCT01462630|540867062|FG000|Overall Study|Death|1|||
149926736|NCT01462630|540867062|FG000|Overall Study|Protocol Violation|2|||
150263671|NCT01275131|542101842|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
150263672|NCT01275131|542101843|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
150263673|NCT01275131|542101844|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
150263674|NCT01740323|542101848|FG000|Overall Study|Adverse Event|1|||
150263675|NCT01740323|542101849|FG001|Overall Study|Adverse Event|0|||
150263676|NCT01740323|542101848|FG000|Overall Study|Randomized but did not take study drug|1|||
150263677|NCT01740323|542101849|FG001|Overall Study|Randomized but did not take study drug|0|||
150263678|NCT00001962|542103209|FG000|Overall Study|Lack of Efficacy|18|||
150263679|NCT00001962|542103209|FG000|Overall Study|Lack of Accrual|6|||
150263680|NCT00001962|542103209|FG000|Overall Study|Death|1|||
150263681|NCT00001962|542103209|FG000|Overall Study|Lost to Follow-up|2|||
150263682|NCT00001962|542103209|FG000|Overall Study|Adverse Event|1|||
150263683|NCT00171704|542103210|FG000|Overall Study|Adverse Event|24|||
150263684|NCT00171704|542103211|FG001|Overall Study|Adverse Event|33|||
150263685|NCT00171704|542103210|FG000|Overall Study|Disease Progression|14|||
150263686|NCT00171704|542103211|FG001|Overall Study|Disease Progression|9|||
150263687|NCT00171704|542103210|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
150263688|NCT00171704|542103211|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
150263689|NCT00171704|542103210|FG000|Overall Study|Administrative Problems|2|||
150263690|NCT00171704|542103211|FG001|Overall Study|Administrative Problems|1|||
150263691|NCT00171704|542103210|FG000|Overall Study|Death|2|||
150263692|NCT00171704|542103211|FG001|Overall Study|Death|2|||
150263693|NCT00171704|542103210|FG000|Overall Study|Withdrawal by Subject|1|||
150263694|NCT00171704|542103211|FG001|Overall Study|Withdrawal by Subject|3|||
150263695|NCT00171704|542103210|FG000|Overall Study|Protocol Violation|0|||
150263696|NCT00171704|542103211|FG001|Overall Study|Protocol Violation|1|||
150263697|NCT00081770|542103214|FG000|Overall Study|Adverse Event|130|||
150263698|NCT00081770|542103215|FG001|Overall Study|Adverse Event|98|||
150263699|NCT00081770|542103216|FG002|Overall Study|Adverse Event|136|||
150263700|NCT00081770|542103214|FG000|Overall Study|Lack of Efficacy|262|||
150263701|NCT00081770|542103215|FG001|Overall Study|Lack of Efficacy|357|||
150263702|NCT00081770|542103216|FG002|Overall Study|Lack of Efficacy|211|||
150263703|NCT00081770|542103214|FG000|Overall Study|Lost to Follow-up|45|||
150263704|NCT00081770|542103215|FG001|Overall Study|Lost to Follow-up|34|||
150263705|NCT00081770|542103216|FG002|Overall Study|Lost to Follow-up|45|||
150263706|NCT00081770|542103214|FG000|Overall Study|Protocol Violation|15|||
150263707|NCT00081770|542103215|FG001|Overall Study|Protocol Violation|10|||
150263708|NCT00081770|542103216|FG002|Overall Study|Protocol Violation|10|||
150263709|NCT00081770|542103214|FG000|Overall Study|Withdrawal by Subject|45|||
150263710|NCT00081770|542103215|FG001|Overall Study|Withdrawal by Subject|40|||
150263711|NCT00081770|542103216|FG002|Overall Study|Withdrawal by Subject|42|||
150263712|NCT00081770|542103214|FG000|Overall Study|Did not meet protocol eligibility|2|||
150263713|NCT00081770|542103215|FG001|Overall Study|Did not meet protocol eligibility|0|||
150263714|NCT00081770|542103216|FG002|Overall Study|Did not meet protocol eligibility|3|||
150263715|NCT00081770|542103214|FG000|Overall Study|Administrative|1|||
150263716|NCT00081770|542103215|FG001|Overall Study|Administrative|0|||
150263717|NCT00081770|542103216|FG002|Overall Study|Administrative|1|||
150263718|NCT00081770|542103214|FG000|Overall Study|Other|2|||
150263719|NCT00081770|542103215|FG001|Overall Study|Other|7|||
150263720|NCT00081770|542103216|FG002|Overall Study|Other|8|||
150263721|NCT03435497|542103218|FG000|Overall Study|Lost to Follow-up|1|||
150263722|NCT03435497|542103219|FG001|Overall Study|Lost to Follow-up|0|||
150263723|NCT03435497|542103218|FG000|Overall Study|Death|1|||
150263724|NCT03435497|542103219|FG001|Overall Study|Death|0|||
150263725|NCT03435497|542103218|FG000|Overall Study|Withdrawal by Subject|0|||
150263726|NCT03435497|542103219|FG001|Overall Study|Withdrawal by Subject|4|||
150263727|NCT03435497|542103218|FG000|Overall Study|Wrong survey administered|0|||
150263728|NCT03435497|542103219|FG001|Overall Study|Wrong survey administered|2|||
150263729|NCT01217957|542103222|FG000|Phase 1|Withdrawal by Patient|1|||
150263730|NCT01217957|542103223|FG001|Phase 1|Withdrawal by Patient|0|||
150263731|NCT01217957|542103224|FG002|Phase 1|Withdrawal by Patient|1|||
150263732|NCT01217957|542103225|FG003|Phase 1|Withdrawal by Patient|1|||
150263733|NCT01217957|542103226|FG004|Phase 1|Withdrawal by Patient|0|||
150263734|NCT01217957|542103222|FG000|Phase 2|Withdrawal by Patient|0|||
150263735|NCT01217957|542103223|FG001|Phase 2|Withdrawal by Patient|0|||
150263736|NCT01217957|542103224|FG002|Phase 2|Withdrawal by Patient|0|||
150263737|NCT01217957|542103225|FG003|Phase 2|Withdrawal by Patient|0|||
150263738|NCT01217957|542103226|FG004|Phase 2|Withdrawal by Patient|1|||
150263739|NCT01765192|542103227|FG000|Treatment Period 1|Adverse Event|0|||
150263740|NCT01765192|542103228|FG001|Treatment Period 1|Adverse Event|1|||
150263741|NCT01765192|542103227|FG000|Washout Period|Voluntary Withdrawal|1|||
150263742|NCT01765192|542103228|FG001|Washout Period|Voluntary Withdrawal|1|||
150263743|NCT01765192|542103227|FG000|Washout Period|Reason not specified|1|||
150263744|NCT01765192|542103228|FG001|Washout Period|Reason not specified|0|||
150263745|NCT01765192|542103227|FG000|Treatment Period 2|Reason not specified|0|||
150263746|NCT01765192|542103228|FG001|Treatment Period 2|Reason not specified|2|||
150263747|NCT01765192|542103227|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
150263748|NCT01765192|542103228|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
150263749|NCT01146054|542103229|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
150263750|NCT01146054|542103229|FG000|Overall Study|Rapid tumor progression|2|||
150263751|NCT01146054|542103229|FG000|Overall Study|Other illness precluded treatment|2|||
150263752|NCT01146054|542103229|FG000|Overall Study|Lost to Follow-up|1|||
150263753|NCT02901041|542103233|FG000|Overall Study|Withdrawal by PI|4|||
150263754|NCT02901041|542103234|FG001|Overall Study|Withdrawal by PI|8|||
150263755|NCT02901041|542103233|FG000|Overall Study|Withdrawal by Subject|7|||
150263756|NCT02901041|542103234|FG001|Overall Study|Withdrawal by Subject|3|||
149926737|NCT01462630|540867062|FG000|Overall Study|Adverse Event|1|||
149926738|NCT01048541|540867068|FG000|Overall Study|Withdrawal by Subject|1|||
149926739|NCT01048541|540867069|FG001|Overall Study|Withdrawal by Subject|0|||
150163847|NCT01244984|541733897|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
150163848|NCT01244984|541733895|FG000|Overall Study|Withdrawal by Subject|1|||
150163849|NCT01244984|541733896|FG001|Overall Study|Withdrawal by Subject|2|||
150163850|NCT01244984|541733897|FG002|Overall Study|Withdrawal by Subject|2|||
150163851|NCT01360840|541733900|FG000|Overall Study|Ongoing at data cut-off|10|||
150163852|NCT01360840|541733901|FG001|Overall Study|Ongoing at data cut-off|10|||
150163853|NCT01360840|541733902|FG002|Overall Study|Ongoing at data cut-off|9|||
150163854|NCT01004263|541733905|FG000|Overall Study|Adverse Event|15|||
150163855|NCT01004263|541733905|FG000|Overall Study|Withdrawal by Subject|58|||
150163856|NCT01004263|541733905|FG000|Overall Study|Protocol Violation|10|||
150163857|NCT01004263|541733905|FG000|Overall Study|Lost to Follow-up|64|||
150163858|NCT01004263|541733905|FG000|Overall Study|Lack of Efficacy|13|||
150163859|NCT01004263|541733905|FG000|Overall Study|Pregnancy|2|||
150163860|NCT01004263|541733905|FG000|Overall Study|Physician Decision|15|||
150163861|NCT01004263|541733905|FG000|Overall Study|Lack of Qualifying Event|2|||
150163862|NCT01982760|541733907|FG000|Overall Study|Physician Decision|1|||
150163863|NCT01982760|541733908|FG001|Overall Study|Physician Decision|0|||
150163864|NCT00821236|541733909|FG000|Overall Study|Lost to Follow-up|3|||
150163865|NCT00282438|541733913|FG000|Overall Study|Lack of Efficacy|1|||
150163866|NCT00282438|541733914|FG001|Overall Study|Lack of Efficacy|0|||
150163867|NCT00282438|541733913|FG000|Overall Study|Death|0|||
150163868|NCT00282438|541733914|FG001|Overall Study|Death|1|||
150163869|NCT02397889|541733915|FG000|Overall Study|Physician Decision|1|||
150163870|NCT02397889|541733916|FG001|Overall Study|Physician Decision|0|||
150163871|NCT03178201|541733922|FG000|Overall Study|Off study|5|||
150163872|NCT02282527|541733923|FG000|Overall Study|Lost to Follow-up|0|||
150163873|NCT02282527|541733924|FG001|Overall Study|Lost to Follow-up|1|||
150163874|NCT02282527|541733923|FG000|Overall Study|Lack of home health aid|1|||
150163875|NCT02282527|541733924|FG001|Overall Study|Lack of home health aid|0|||
150163876|NCT01872611|541733925|FG000|Overall Study|Adverse Event|3|||
150163877|NCT01872611|541733926|FG001|Overall Study|Adverse Event|1|||
150163878|NCT01872611|541733925|FG000|Overall Study|Adverse Event, prior to treatment|0|||
150163879|NCT01872611|541733926|FG001|Overall Study|Adverse Event, prior to treatment|1|||
150163880|NCT01872611|541733925|FG000|Overall Study|Death|0|||
150163881|NCT01872611|541733926|FG001|Overall Study|Death|1|||
150163882|NCT01872611|541733925|FG000|Overall Study|Death, prior to treatment|0|||
150163883|NCT01872611|541733926|FG001|Overall Study|Death, prior to treatment|1|||
150163884|NCT01872611|541733925|FG000|Overall Study|Lost to Follow-up|8|||
150163885|NCT01872611|541733926|FG001|Overall Study|Lost to Follow-up|1|||
150163886|NCT01872611|541733925|FG000|Overall Study|Physician Decision|1|||
150163887|NCT01872611|541733926|FG001|Overall Study|Physician Decision|0|||
150163888|NCT01872611|541733925|FG000|Overall Study|Withdrawal by Subject|6|||
150163889|NCT01872611|541733926|FG001|Overall Study|Withdrawal by Subject|1|||
150163890|NCT01872611|541733925|FG000|Overall Study|Reason not provided|6|||
150163891|NCT01872611|541733926|FG001|Overall Study|Reason not provided|6|||
150163892|NCT03537651|541733927|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
150163893|NCT03537651|541733927|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
150163894|NCT03537651|541733927|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
150163895|NCT03537651|541733927|FG000|Part A (Up to 96 Weeks)|Other|1|||
150163896|NCT03537651|541733927|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
150163897|NCT03537651|541733927|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
150163898|NCT03537651|541733927|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
150163899|NCT03537651|541733927|FG000|Part B (Up to 192 Weeks)|Other|1|||
150163900|NCT02696785|541733930|FG000|Blinded Treatment Period|Adverse Event|0|||
150163901|NCT02696785|541733931|FG001|Blinded Treatment Period|Adverse Event|1|||
150163902|NCT02696785|541733932|FG002|Blinded Treatment Period|Adverse Event|3|||
150163903|NCT02696785|541733933|FG003|Blinded Treatment Period|Adverse Event|0|||
150163904|NCT02696785|541733930|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
150163905|NCT02696785|541733931|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
150163906|NCT02696785|541733932|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
150163907|NCT02696785|541733933|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
150163908|NCT02696785|541733930|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
150163909|NCT02696785|541733931|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
150163910|NCT02696785|541733932|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
150163911|NCT02696785|541733933|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
150163912|NCT02696785|541733930|FG000|Blinded Treatment Period|Screen Failure|1|||
150163913|NCT02696785|541733931|FG001|Blinded Treatment Period|Screen Failure|0|||
150163914|NCT02696785|541733932|FG002|Blinded Treatment Period|Screen Failure|0|||
150163915|NCT02696785|541733933|FG003|Blinded Treatment Period|Screen Failure|0|||
150163916|NCT02696785|541733930|FG000|Washout Period|Withdrawal by Subject|0|||
150163917|NCT02696785|541733931|FG001|Washout Period|Withdrawal by Subject|1|||
150163918|NCT02696785|541733932|FG002|Washout Period|Withdrawal by Subject|0|||
150163919|NCT02696785|541733933|FG003|Washout Period|Withdrawal by Subject|0|||
150263757|NCT01480674|542103235|FG000|Overall Study|Death|23|||
150263758|NCT01480674|542103235|FG000|Overall Study|Lost to Follow-up|2|||
150263759|NCT01480674|542103235|FG000|Overall Study|visit not done|10|||
150263760|NCT03249714|542103236|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
150263761|NCT03249714|542103237|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
150263762|NCT03249714|542103236|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
150263763|NCT03249714|542103237|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
150263764|NCT03249714|542103236|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
150263765|NCT03249714|542103237|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
150263766|NCT03249714|542103236|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
150263767|NCT03249714|542103237|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
150263768|NCT00655863|542103245|FG000|Overall Study|Lost to Follow-up|0|||
150263769|NCT00655863|542103246|FG001|Overall Study|Lost to Follow-up|0|||
150263770|NCT00655863|542103247|FG002|Overall Study|Lost to Follow-up|1|||
150263771|NCT05580588|542103248|FG000|Overall Study|Lack of Efficacy|12|||
150263772|NCT00712673|542103251|FG000|Overall Study|Adverse Event|3|||
150263773|NCT00712673|542103252|FG001|Overall Study|Adverse Event|3|||
150263774|NCT00712673|542103253|FG002|Overall Study|Adverse Event|21|||
150263775|NCT00712673|542103254|FG003|Overall Study|Adverse Event|26|||
150263776|NCT00712673|542103251|FG000|Overall Study|Lack of Efficacy|2|||
150263777|NCT00712673|542103252|FG001|Overall Study|Lack of Efficacy|8|||
150263778|NCT00712673|542103253|FG002|Overall Study|Lack of Efficacy|8|||
150263779|NCT00712673|542103254|FG003|Overall Study|Lack of Efficacy|6|||
150263780|NCT00712673|542103251|FG000|Overall Study|Poor Compliance to Protocol|3|||
150263781|NCT00712673|542103252|FG001|Overall Study|Poor Compliance to Protocol|3|||
150263782|NCT00712673|542103253|FG002|Overall Study|Poor Compliance to Protocol|4|||
150263783|NCT00712673|542103254|FG003|Overall Study|Poor Compliance to Protocol|16|||
150263784|NCT00712673|542103251|FG000|Overall Study|Lost to Follow-up|1|||
150263785|NCT00712673|542103252|FG001|Overall Study|Lost to Follow-up|0|||
150263786|NCT00712673|542103253|FG002|Overall Study|Lost to Follow-up|2|||
150263787|NCT00712673|542103254|FG003|Overall Study|Lost to Follow-up|0|||
150263788|NCT00712673|542103251|FG000|Overall Study|Withdrawal by Subject|6|||
150263789|NCT00712673|542103252|FG001|Overall Study|Withdrawal by Subject|7|||
150263790|NCT00712673|542103253|FG002|Overall Study|Withdrawal by Subject|15|||
150263791|NCT00712673|542103254|FG003|Overall Study|Withdrawal by Subject|20|||
150263792|NCT00712673|542103251|FG000|Overall Study|Familial and Personal Reasons|5|||
150263793|NCT00712673|542103252|FG001|Overall Study|Familial and Personal Reasons|0|||
150263794|NCT00712673|542103253|FG002|Overall Study|Familial and Personal Reasons|5|||
150263795|NCT00712673|542103254|FG003|Overall Study|Familial and Personal Reasons|2|||
150263796|NCT00712673|542103251|FG000|Overall Study|Investigator's Decision|1|||
150263797|NCT00712673|542103252|FG001|Overall Study|Investigator's Decision|0|||
150263798|NCT00712673|542103253|FG002|Overall Study|Investigator's Decision|0|||
150263799|NCT00712673|542103254|FG003|Overall Study|Investigator's Decision|0|||
150263800|NCT00712673|542103251|FG000|Overall Study|Protocol Violation|0|||
150263801|NCT00712673|542103252|FG001|Overall Study|Protocol Violation|0|||
150263802|NCT00712673|542103253|FG002|Overall Study|Protocol Violation|2|||
150263803|NCT00712673|542103254|FG003|Overall Study|Protocol Violation|0|||
150263804|NCT03603028|542103255|FG000|Overall Study|Withdrawal by Subject|1|||
150263805|NCT02963610|542103256|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
150263806|NCT00063154|542103257|FG000|Overall Study|Disease progression|27|||
150263807|NCT00063154|542103257|FG000|Overall Study|Adverse Event|2|||
150263808|NCT00063154|542103257|FG000|Overall Study|Physician Decision|10|||
150263809|NCT00063154|542103257|FG000|Overall Study|Death|3|||
150263810|NCT00063154|542103257|FG000|Overall Study|Reason unspecified|1|||
150263811|NCT00063154|542103257|FG000|Overall Study|Did not receive treatment|8|||
150263812|NCT01122862|542103258|FG000|Period 1|Protocol Violation|0|||
150263813|NCT01122862|542103259|FG001|Period 1|Protocol Violation|1|||
150263814|NCT01122862|542103260|FG002|Period 1|Protocol Violation|0|||
150263815|NCT01122862|542103258|FG000|Period 2|Adverse Event|0|||
150263816|NCT01122862|542103259|FG001|Period 2|Adverse Event|0|||
150263817|NCT01122862|542103260|FG002|Period 2|Adverse Event|1|||
150263818|NCT00846391|542103262|FG000|Overall Study|Physician Decision|0|||
150263819|NCT00846391|542103263|FG001|Overall Study|Physician Decision|0|||
150263820|NCT00846391|542103264|FG002|Overall Study|Physician Decision|1|||
150263821|NCT00846391|542103262|FG000|Overall Study|Study Terminated by Sponsor|1|||
150263822|NCT00846391|542103263|FG001|Overall Study|Study Terminated by Sponsor|2|||
150263823|NCT00846391|542103264|FG002|Overall Study|Study Terminated by Sponsor|2|||
150263824|NCT02924064|542103265|FG000|Overall Study|Adverse Event|2|||
150263825|NCT02924064|542103266|FG001|Overall Study|Adverse Event|2|||
150263826|NCT02924064|542103265|FG000|Overall Study|Lost to Follow-up|0|||
150263827|NCT02924064|542103266|FG001|Overall Study|Lost to Follow-up|2|||
150263828|NCT02924064|542103265|FG000|Overall Study|Physician Decision|0|||
150263829|NCT02924064|542103266|FG001|Overall Study|Physician Decision|2|||
150263830|NCT02924064|542103265|FG000|Overall Study|Protocol Violation|1|||
150263831|NCT02924064|542103266|FG001|Overall Study|Protocol Violation|3|||
150263832|NCT02924064|542103265|FG000|Overall Study|Withdrawal by Subject|4|||
149926740|NCT03060291|540867070|FG000|3-month Follow-up|Declined to respond|8|||
149926741|NCT03060291|540867071|FG001|3-month Follow-up|Declined to respond|10|||
149926742|NCT03060291|540867072|FG002|3-month Follow-up|Declined to respond|2|||
149926743|NCT03060291|540867070|FG000|6-month Follow-up|Declined to respond|7|||
149926744|NCT03060291|540867071|FG001|6-month Follow-up|Declined to respond|13|||
149926745|NCT03060291|540867072|FG002|6-month Follow-up|Declined to respond|4|||
149926746|NCT03060291|540867070|FG000|12-month Follow-up|Declined to respond|7|||
149926747|NCT03060291|540867071|FG001|12-month Follow-up|Declined to respond|16|||
149926748|NCT03060291|540867072|FG002|12-month Follow-up|Declined to respond|6|||
149926749|NCT00618826|540867075|FG000|Overall Study|Adverse Event|1|||
149926750|NCT01509664|540867077|FG000|Overall Study|Lost to Follow-up|15|||
149926751|NCT01509664|540867078|FG001|Overall Study|Lost to Follow-up|21|||
149926752|NCT02105285|540867079|FG000|Overall Study|Adverse Event|1|||
149926753|NCT02105285|540867080|FG001|Overall Study|Adverse Event|1|||
149926754|NCT02105285|540867081|FG002|Overall Study|Adverse Event|0|||
149926755|NCT02105285|540867079|FG000|Overall Study|Protocol Violation|0|||
149926756|NCT02105285|540867080|FG001|Overall Study|Protocol Violation|1|||
149926757|NCT02105285|540867081|FG002|Overall Study|Protocol Violation|0|||
149926758|NCT02105285|540867079|FG000|Overall Study|Withdrawal by Subject|1|||
149926759|NCT02105285|540867080|FG001|Overall Study|Withdrawal by Subject|0|||
149926760|NCT02105285|540867081|FG002|Overall Study|Withdrawal by Subject|0|||
149926761|NCT02585713|540867082|FG000|Overall Study|Withdrew prior to treatment|2|||
149926762|NCT02585713|540867083|FG001|Overall Study|Withdrew prior to treatment|7|||
149926763|NCT02585713|540867082|FG000|Overall Study|Other|3|||
149926764|NCT02585713|540867083|FG001|Overall Study|Other|1|||
149926765|NCT00110357|540867092|FG000|Overall Study|Deterioration without progression|2|||
149926766|NCT00110357|540867093|FG001|Overall Study|Deterioration without progression|0|||
149926767|NCT00110357|540867092|FG000|Overall Study|Disease progression/relapse|20|||
149926768|NCT00110357|540867093|FG001|Overall Study|Disease progression/relapse|15|||
149926769|NCT00110357|540867092|FG000|Overall Study|Study Closure|1|||
149926770|NCT00110357|540867093|FG001|Overall Study|Study Closure|0|||
149926771|NCT00110357|540867092|FG000|Overall Study|Study Drug Toxicity|1|||
149926772|NCT00110357|540867093|FG001|Overall Study|Study Drug Toxicity|3|||
149926773|NCT00110357|540867092|FG000|Overall Study|Withdrawal by Subject|3|||
149926774|NCT00110357|540867093|FG001|Overall Study|Withdrawal by Subject|1|||
149926775|NCT00656175|540867096|FG000|Overall Study|Adverse Event|1|||
149926776|NCT00656175|540867097|FG001|Overall Study|Adverse Event|0|||
149926777|NCT00656175|540867096|FG000|Overall Study|Transportation issues|0|||
149926778|NCT00656175|540867097|FG001|Overall Study|Transportation issues|1|||
149926779|NCT03283930|540867102|FG000|Overall Study|Scheduling conflict|8|||
149926780|NCT03283930|540867103|FG001|Overall Study|Scheduling conflict|10|||
149926781|NCT03283930|540867102|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
149926782|NCT03283930|540867103|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
149926783|NCT03283930|540867102|FG000|Overall Study|Technical software issue|2|||
149926784|NCT03283930|540867103|FG001|Overall Study|Technical software issue|2|||
149926785|NCT00805129|540867104|FG000|Overall Study|Not treated|1|||
149926786|NCT02588664|540867105|FG000|Overall Study|Death|56|||
149926787|NCT02588664|540867106|FG001|Overall Study|Death|55|||
149926788|NCT02588664|540867105|FG000|Overall Study|Lost to Follow-up|1305|||
149926789|NCT02588664|540867106|FG001|Overall Study|Lost to Follow-up|990|||
149926790|NCT00396383|540867107|FG000|Overall Study|Death|2|||
149926791|NCT00396383|540867107|FG000|Overall Study|Lost to Follow-up|1|||
149926792|NCT01839916|540867108|FG000|Overall Study|Death|9|||
149926793|NCT01839916|540867108|FG000|Overall Study|Physician Decision|17|||
149926794|NCT01839916|540867108|FG000|Overall Study|Relapse|12|||
149926795|NCT01839916|540867108|FG000|Overall Study|GVHD|2|||
149926796|NCT01839916|540867108|FG000|Overall Study|Graft Failure|1|||
149926797|NCT00534638|540867109|FG000|Overall Study|Withdrawal by Subject|3|||
149926798|NCT00534638|540867110|FG001|Overall Study|Withdrawal by Subject|4|||
149926799|NCT00534638|540867109|FG000|Overall Study|Migrated/moved from study area|13|||
149926800|NCT00534638|540867110|FG001|Overall Study|Migrated/moved from study area|11|||
149926801|NCT00534638|540867109|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
149926802|NCT00534638|540867110|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
149926803|NCT00534638|540867109|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
149926804|NCT00534638|540867110|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
149926805|NCT00534638|540867109|FG000|Overall Study|Other|1685|||
149926806|NCT00534638|540867110|FG001|Overall Study|Other|902|||
149926807|NCT02500719|540867113|FG000|Overall Study|Lost to Follow-up|2|||
149926808|NCT02500719|540867114|FG001|Overall Study|Lost to Follow-up|3|||
149926809|NCT02500719|540867113|FG000|Overall Study|Trauma history|1|||
149926810|NCT02500719|540867114|FG001|Overall Study|Trauma history|0|||
149926811|NCT02500719|540867113|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
149926812|NCT02500719|540867114|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
149926813|NCT02500719|540867113|FG000|Overall Study|Did not meet criteria for PTSD|0|||
149926814|NCT02500719|540867114|FG001|Overall Study|Did not meet criteria for PTSD|1|||
149926815|NCT02500719|540867113|FG000|Overall Study|Claustrophobia|0|||
149926816|NCT02500719|540867114|FG001|Overall Study|Claustrophobia|1|||
149926817|NCT02500719|540867113|FG000|Overall Study|History of head trauma|0|||
149926818|NCT02500719|540867114|FG001|Overall Study|History of head trauma|1|||
149926819|NCT02710084|540867117|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
149926820|NCT02710084|540867118|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
149926821|NCT00181883|540867119|FG000|Overall Study|Lack of Efficacy|2|||
149926822|NCT00181883|540867119|FG000|Overall Study|Treatment Limiting AEs|3|||
149926823|NCT00181883|540867119|FG000|Overall Study|Withdrawal by Subject|4|||
149926824|NCT00181883|540867119|FG000|Overall Study|Lost to Follow-up|1|||
149926825|NCT05305989|540867120|FG000|Overall Study|Other|3|||
149926826|NCT05305989|540867121|FG001|Overall Study|Other|2|||
149926827|NCT05305989|540867122|FG002|Overall Study|Other|0|||
149926828|NCT05305989|540867120|FG000|Overall Study|Sponsor decision|2|||
149926829|NCT05305989|540867121|FG001|Overall Study|Sponsor decision|1|||
149926830|NCT05305989|540867122|FG002|Overall Study|Sponsor decision|0|||
149926831|NCT05305989|540867120|FG000|Overall Study|Protocol Violation|0|||
149926832|NCT05305989|540867121|FG001|Overall Study|Protocol Violation|1|||
149926833|NCT05305989|540867122|FG002|Overall Study|Protocol Violation|0|||
149926834|NCT05305989|540867120|FG000|Overall Study|Investigator decision|1|||
149926835|NCT05305989|540867121|FG001|Overall Study|Investigator decision|2|||
149926836|NCT05305989|540867122|FG002|Overall Study|Investigator decision|0|||
149926837|NCT05305989|540867120|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
149926838|NCT05305989|540867121|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
149926839|NCT05305989|540867122|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
149926840|NCT05305989|540867120|FG000|Overall Study|Adverse Event|1|||
149926841|NCT05305989|540867121|FG001|Overall Study|Adverse Event|1|||
149926842|NCT05305989|540867122|FG002|Overall Study|Adverse Event|0|||
149926843|NCT05305989|540867120|FG000|Overall Study|Enrolled but never dosed|3|||
149926844|NCT05305989|540867121|FG001|Overall Study|Enrolled but never dosed|2|||
149926845|NCT05305989|540867122|FG002|Overall Study|Enrolled but never dosed|1|||
149926846|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
149926847|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
149926848|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
149926849|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
149926850|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
149926851|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
149926852|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
149926853|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
149926854|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
149926855|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
150163920|NCT02696785|541733930|FG000|Washout Period|Lack of Efficacy|0|||
150163921|NCT02696785|541733931|FG001|Washout Period|Lack of Efficacy|1|||
150163922|NCT02696785|541733932|FG002|Washout Period|Lack of Efficacy|0|||
150163923|NCT02696785|541733933|FG003|Washout Period|Lack of Efficacy|0|||
150163924|NCT02696785|541733930|FG000|Extended Treatment Period|Adverse Event|2|||
150163925|NCT02696785|541733931|FG001|Extended Treatment Period|Adverse Event|3|||
150163926|NCT02696785|541733932|FG002|Extended Treatment Period|Adverse Event|2|||
150163927|NCT02696785|541733933|FG003|Extended Treatment Period|Adverse Event|1|||
150163928|NCT02696785|541733930|FG000|Extended Treatment Period|Lack of Efficacy|0|||
150163929|NCT02696785|541733931|FG001|Extended Treatment Period|Lack of Efficacy|1|||
150163930|NCT02696785|541733932|FG002|Extended Treatment Period|Lack of Efficacy|0|||
150163931|NCT02696785|541733933|FG003|Extended Treatment Period|Lack of Efficacy|0|||
150163932|NCT02696785|541733930|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
150163933|NCT02696785|541733931|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
150163934|NCT02696785|541733932|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
150163935|NCT02696785|541733933|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
150163936|NCT02696785|541733930|FG000|Follow-up Period|Adverse Event|0|||
150163937|NCT02696785|541733931|FG001|Follow-up Period|Adverse Event|0|||
150163938|NCT02696785|541733932|FG002|Follow-up Period|Adverse Event|8|||
150163939|NCT02696785|541733933|FG003|Follow-up Period|Adverse Event|2|||
150163940|NCT02696785|541733930|FG000|Follow-up Period|Lost to Follow-up|0|||
150163941|NCT02696785|541733931|FG001|Follow-up Period|Lost to Follow-up|0|||
150163942|NCT02696785|541733932|FG002|Follow-up Period|Lost to Follow-up|0|||
150163943|NCT02696785|541733933|FG003|Follow-up Period|Lost to Follow-up|1|||
150163944|NCT02696785|541733930|FG000|Follow-up Period|Lack of Efficacy|0|||
150163945|NCT02696785|541733931|FG001|Follow-up Period|Lack of Efficacy|0|||
150163946|NCT02696785|541733932|FG002|Follow-up Period|Lack of Efficacy|0|||
150163947|NCT02696785|541733933|FG003|Follow-up Period|Lack of Efficacy|1|||
150163948|NCT02696785|541733930|FG000|Follow-up Period|Withdrawal by Subject|1|||
150163949|NCT02696785|541733931|FG001|Follow-up Period|Withdrawal by Subject|0|||
149926856|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
150163950|NCT02696785|541733932|FG002|Follow-up Period|Withdrawal by Subject|5|||
150163951|NCT02696785|541733933|FG003|Follow-up Period|Withdrawal by Subject|4|||
150263833|NCT02924064|542103266|FG001|Overall Study|Withdrawal by Subject|5|||
150263834|NCT02924064|542103265|FG000|Overall Study|Other|17|||
150263835|NCT02924064|542103266|FG001|Overall Study|Other|29|||
150263836|NCT02699983|542103267|FG000|Overall Study|Withdrawal by Subject|1|||
150263837|NCT02699983|542103268|FG001|Overall Study|Withdrawal by Subject|0|||
150263838|NCT03575143|542103269|FG000|Overall Study|Lost to Follow-up|0|||
150263839|NCT03575143|542103270|FG001|Overall Study|Lost to Follow-up|0|||
150263840|NCT03575143|542103271|FG002|Overall Study|Lost to Follow-up|4|||
150263841|NCT03575143|542103269|FG000|Overall Study|Withdrawal by Subject|0|||
150263842|NCT03575143|542103270|FG001|Overall Study|Withdrawal by Subject|0|||
150263843|NCT03575143|542103271|FG002|Overall Study|Withdrawal by Subject|5|||
150263844|NCT03575143|542103269|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
150263845|NCT03575143|542103270|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
150263846|NCT03575143|542103271|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
150263847|NCT02875977|542103274|FG000|Overall Study|Lost to Follow-up|42|||
150263848|NCT02875977|542103275|FG001|Overall Study|Lost to Follow-up|29|||
150263849|NCT01790126|542103279|FG000|Overall Study|PSA Progression|12|||
150263850|NCT01790126|542103280|FG001|Overall Study|PSA Progression|16|||
150263851|NCT01790126|542103281|FG002|Overall Study|PSA Progression|16|||
150263852|NCT01790126|542103279|FG000|Overall Study|Other|5|||
150263853|NCT01790126|542103280|FG001|Overall Study|Other|4|||
150263854|NCT01790126|542103281|FG002|Overall Study|Other|8|||
150263855|NCT01790126|542103279|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
150263856|NCT01790126|542103280|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
150263857|NCT01790126|542103281|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
150263858|NCT01790126|542103279|FG000|Overall Study|Withdrawal by Physician|1|||
150263859|NCT01790126|542103280|FG001|Overall Study|Withdrawal by Physician|1|||
150263860|NCT01790126|542103281|FG002|Overall Study|Withdrawal by Physician|2|||
150263861|NCT01790126|542103279|FG000|Overall Study|Withdrawal by Subject|3|||
150263862|NCT01790126|542103280|FG001|Overall Study|Withdrawal by Subject|1|||
150263863|NCT01790126|542103281|FG002|Overall Study|Withdrawal by Subject|2|||
150263864|NCT01790126|542103279|FG000|Overall Study|Lost to Follow-up|1|||
150263865|NCT01790126|542103280|FG001|Overall Study|Lost to Follow-up|0|||
150263866|NCT01790126|542103281|FG002|Overall Study|Lost to Follow-up|1|||
150263867|NCT01790126|542103279|FG000|Overall Study|Adverse Event|0|||
150263868|NCT01790126|542103280|FG001|Overall Study|Adverse Event|2|||
150263869|NCT01790126|542103281|FG002|Overall Study|Adverse Event|0|||
150263870|NCT01790126|542103279|FG000|Overall Study|Death|2|||
150263871|NCT01790126|542103280|FG001|Overall Study|Death|0|||
150263872|NCT01790126|542103281|FG002|Overall Study|Death|0|||
150263873|NCT01790126|542103279|FG000|Overall Study|Radiographic Progression|3|||
150263874|NCT01790126|542103280|FG001|Overall Study|Radiographic Progression|1|||
150263875|NCT01790126|542103281|FG002|Overall Study|Radiographic Progression|0|||
150263876|NCT04781387|542103289|FG000|Overall Study|Withdrawal by Subject|1|||
150263877|NCT04781387|542103290|FG001|Overall Study|Withdrawal by Subject|0|||
150263878|NCT04781387|542103291|FG002|Overall Study|Withdrawal by Subject|1|||
150263879|NCT04781387|542103289|FG000|Overall Study|Lost to Follow-up|1|||
150263880|NCT04781387|542103290|FG001|Overall Study|Lost to Follow-up|0|||
150263881|NCT04781387|542103291|FG002|Overall Study|Lost to Follow-up|0|||
150263882|NCT00679627|542103292|FG000|Overall Study|Death|41|||
150263883|NCT00679627|542103293|FG001|Overall Study|Death|29|||
150263884|NCT00679627|542103292|FG000|Overall Study|Adverse Event|43|||
150263885|NCT00679627|542103293|FG001|Overall Study|Adverse Event|53|||
150263886|NCT00679627|542103292|FG000|Overall Study|Withdrawal by Subject|168|||
150263887|NCT00679627|542103293|FG001|Overall Study|Withdrawal by Subject|172|||
150263888|NCT00679627|542103292|FG000|Overall Study|Lost to Follow-up|22|||
150263889|NCT00679627|542103293|FG001|Overall Study|Lost to Follow-up|26|||
150263890|NCT00679627|542103292|FG000|Overall Study|Early Study Closure|425|||
150263891|NCT00679627|542103293|FG001|Overall Study|Early Study Closure|405|||
150263892|NCT00448123|542103294|FG000|Overall Study|Lost to Follow-up|9|||
150263893|NCT00448123|542103295|FG001|Overall Study|Lost to Follow-up|6|||
150263894|NCT00448123|542103294|FG000|Overall Study|Physician Decision|6|||
150263895|NCT00448123|542103295|FG001|Overall Study|Physician Decision|6|||
150263896|NCT02318797|542103296|FG000|Overall Study|Death|3|||
150263897|NCT02318797|542103297|FG001|Overall Study|Death|6|||
150263898|NCT02318797|542103296|FG000|Overall Study|Lost to Follow-up|85|||
150263899|NCT02318797|542103297|FG001|Overall Study|Lost to Follow-up|96|||
150263900|NCT00511472|542103302|FG000|Overall Study|Clinical Adverse Event|1|||
150263901|NCT00511472|542103303|FG001|Overall Study|Clinical Adverse Event|2|||
150263902|NCT00511472|542103302|FG000|Overall Study|Laboratory Adverse Event|0|||
150263903|NCT00511472|542103303|FG001|Overall Study|Laboratory Adverse Event|2|||
150263904|NCT00511472|542103302|FG000|Overall Study|Not reported|2|||
150263905|NCT00511472|542103303|FG001|Overall Study|Not reported|2|||
150263906|NCT01079741|542103304|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
150263907|NCT01079741|542103305|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
150263908|NCT01079741|542103306|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
150263909|NCT01079741|542103307|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
150263910|NCT01079741|542103308|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
150263911|NCT01079741|542103304|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
150263912|NCT01079741|542103305|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
150263913|NCT01079741|542103306|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
150263914|NCT01079741|542103307|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
150263915|NCT01079741|542103308|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
150263916|NCT02709096|542103309|FG000|Overall Study|non-compliance|1|||
150263917|NCT02709096|542103310|FG001|Overall Study|non-compliance|1|||
150263918|NCT00446992|542103311|FG000|Overall Study|Adverse Event|11|||
150263919|NCT00446992|542103311|FG000|Overall Study|Lost to Follow-up|5|||
150263920|NCT00406653|542103312|FG000|Induction Period|Adverse Event|1|||
150263921|NCT00406653|542103313|FG001|Induction Period|Adverse Event|10|||
150263922|NCT00406653|542103314|FG002|Induction Period|Adverse Event|4|||
150263923|NCT00406653|542103315|FG003|Induction Period|Adverse Event|11|||
150263924|NCT00406653|542103316|FG004|Induction Period|Adverse Event|0|||
150263925|NCT00406653|542103317|FG005|Induction Period|Adverse Event|0|||
150263926|NCT00406653|542103318|FG006|Induction Period|Adverse Event|0|||
150263927|NCT00406653|542103312|FG000|Induction Period|Lack of Efficacy|11|||
150263928|NCT00406653|542103313|FG001|Induction Period|Lack of Efficacy|14|||
150263929|NCT00406653|542103314|FG002|Induction Period|Lack of Efficacy|8|||
150263930|NCT00406653|542103315|FG003|Induction Period|Lack of Efficacy|10|||
150263931|NCT00406653|542103316|FG004|Induction Period|Lack of Efficacy|0|||
150263932|NCT00406653|542103317|FG005|Induction Period|Lack of Efficacy|0|||
150263933|NCT00406653|542103318|FG006|Induction Period|Lack of Efficacy|0|||
150263934|NCT00406653|542103312|FG000|Induction Period|Lost to Follow-up|0|||
150263935|NCT00406653|542103313|FG001|Induction Period|Lost to Follow-up|2|||
150263936|NCT00406653|542103314|FG002|Induction Period|Lost to Follow-up|0|||
150263937|NCT00406653|542103315|FG003|Induction Period|Lost to Follow-up|0|||
150263938|NCT00406653|542103316|FG004|Induction Period|Lost to Follow-up|0|||
150263939|NCT00406653|542103317|FG005|Induction Period|Lost to Follow-up|0|||
150263940|NCT00406653|542103318|FG006|Induction Period|Lost to Follow-up|0|||
150263941|NCT00406653|542103312|FG000|Induction Period|Withdrawal of Consent|2|||
149926857|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
149926858|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
149926859|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
149926860|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
149926861|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
149926862|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
149926863|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
149926864|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
149926865|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
149926866|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
149926867|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
149926868|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
149926869|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
149926870|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
149926871|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
149926872|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
149926873|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
149926874|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
149926875|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
149926876|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
149926877|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
149926878|NCT03538691|540867123|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
149926879|NCT03538691|540867124|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
149926880|NCT03538691|540867125|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
149926881|NCT03538691|540867126|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
149926882|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
149926883|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
150263942|NCT00406653|542103313|FG001|Induction Period|Withdrawal of Consent|5|||
150263943|NCT00406653|542103314|FG002|Induction Period|Withdrawal of Consent|1|||
150263944|NCT00406653|542103315|FG003|Induction Period|Withdrawal of Consent|2|||
150263945|NCT00406653|542103316|FG004|Induction Period|Withdrawal of Consent|0|||
150263946|NCT00406653|542103317|FG005|Induction Period|Withdrawal of Consent|0|||
150263947|NCT00406653|542103318|FG006|Induction Period|Withdrawal of Consent|0|||
150263948|NCT00406653|542103312|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
150263949|NCT00406653|542103313|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
150263950|NCT00406653|542103314|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
149926884|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
149926885|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
149926886|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
149926887|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
149926888|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
149926889|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
149926890|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
149926891|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
149926892|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
149926893|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
149926894|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
150163952|NCT04863898|541733937|FG000|Overall Study|Away from study clinic during intervention training period|2|||
150163953|NCT04863898|541733937|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
150163954|NCT04863898|541733937|FG000|Overall Study|Lost to Follow-up|3|||
150163955|NCT04863898|541733937|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
150163956|NCT04863898|541733937|FG000|Overall Study|No longer employed at clinic|3|||
150163957|NCT02431533|541733938|FG000|Overall Study|Withdrawal by Subject|1|||
150163958|NCT02431533|541733939|FG001|Overall Study|Withdrawal by Subject|3|||
150163959|NCT02431533|541733938|FG000|Overall Study|Developed Exclusionary criteria|1|||
150163960|NCT02431533|541733939|FG001|Overall Study|Developed Exclusionary criteria|0|||
150163961|NCT05780047|541733950|FG000|Overall Study|Did not submit baseline urine test kit|226|||
150163962|NCT05780047|541733950|FG000|Overall Study|Lost to Follow-up|34|||
150163963|NCT05780047|541733950|FG000|Overall Study|Did not submit second urine test kit|124|||
150163964|NCT01190176|541733957|FG000|Overall Study|Withdrawal by Subject|1|||
150163965|NCT01190176|541733957|FG000|Overall Study|Lost to Follow-up|1|||
150163966|NCT02909101|541733958|FG000|Overall Study|Lost to Follow-up|1|||
150163967|NCT02909101|541733959|FG001|Overall Study|Lost to Follow-up|1|||
150163968|NCT02189863|541733960|FG000|First 2 Weeks|Motion Sickness|4|||
150163969|NCT02189863|541733961|FG001|First 2 Weeks|Motion Sickness|2|||
150163970|NCT03697460|541733962|FG000|Overall Study|Withdrawal by Subject|3|||
150163971|NCT01959880|541733967|FG000|Overall Study|Withdrawal by Subject|11|||
150163972|NCT01959880|541733968|FG001|Overall Study|Withdrawal by Subject|13|||
150163973|NCT01959880|541733969|FG002|Overall Study|Withdrawal by Subject|8|||
150163974|NCT01959880|541733970|FG003|Overall Study|Withdrawal by Subject|7|||
150163975|NCT01959880|541733967|FG000|Overall Study|Death|1|||
150163976|NCT01959880|541733968|FG001|Overall Study|Death|10|||
150163977|NCT01959880|541733969|FG002|Overall Study|Death|1|||
150163978|NCT01959880|541733970|FG003|Overall Study|Death|2|||
150163979|NCT01959880|541733967|FG000|Overall Study|Lost to Follow-up|95|||
150163980|NCT01959880|541733968|FG001|Overall Study|Lost to Follow-up|18|||
150163981|NCT01959880|541733969|FG002|Overall Study|Lost to Follow-up|15|||
150163982|NCT01959880|541733970|FG003|Overall Study|Lost to Follow-up|8|||
150163983|NCT01959880|541733967|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
150163984|NCT01959880|541733968|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
150163985|NCT01959880|541733969|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
150163986|NCT01959880|541733970|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
150163987|NCT01959880|541733967|FG000|Overall Study|Study completed early-FDA approved|1003|||
150163988|NCT01959880|541733968|FG001|Overall Study|Study completed early-FDA approved|311|||
150163989|NCT01959880|541733969|FG002|Overall Study|Study completed early-FDA approved|179|||
150163990|NCT01959880|541733970|FG003|Overall Study|Study completed early-FDA approved|152|||
150163991|NCT01677936|541735528|FG000|Overall Study|Lost to Follow-up|4|||
150163992|NCT01677936|541735529|FG001|Overall Study|Lost to Follow-up|1|||
150163993|NCT01677936|541735528|FG000|Overall Study|Protocol Violation|3|||
150163994|NCT01677936|541735529|FG001|Overall Study|Protocol Violation|0|||
150163995|NCT01677936|541735528|FG000|Overall Study|Adverse Event|1|||
150163996|NCT01677936|541735529|FG001|Overall Study|Adverse Event|0|||
150163997|NCT01677936|541735528|FG000|Overall Study|Lost to Follow-up|1|||
150163998|NCT01677936|541735529|FG001|Overall Study|Lost to Follow-up|0|||
150163999|NCT01677936|541735528|FG000|Overall Study|Protocol Violation|0|||
150164000|NCT01677936|541735529|FG001|Overall Study|Protocol Violation|4|||
150164001|NCT03837028|541735530|FG000|Overall Study|Lost to Follow-up|4|||
150164002|NCT03837028|541735531|FG001|Overall Study|Lost to Follow-up|0|||
150164003|NCT03837028|541735532|FG002|Overall Study|Lost to Follow-up|2|||
150164004|NCT03837028|541735533|FG003|Overall Study|Lost to Follow-up|0|||
150164005|NCT03837028|541735530|FG000|Overall Study|Withdrawal by Subject|12|||
150164006|NCT03837028|541735531|FG001|Overall Study|Withdrawal by Subject|11|||
150164007|NCT03837028|541735532|FG002|Overall Study|Withdrawal by Subject|11|||
150164008|NCT03837028|541735533|FG003|Overall Study|Withdrawal by Subject|7|||
150164009|NCT00157014|541735534|FG000|Overall Study|Death|4|||
150164010|NCT00157014|541735535|FG001|Overall Study|Death|2|||
150164011|NCT00157014|541735536|FG002|Overall Study|Death|1|||
150164012|NCT00157014|541735537|FG003|Overall Study|Death|1|||
150164013|NCT00157014|541735534|FG000|Overall Study|Physician Decision|0|||
150263951|NCT00406653|542103315|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
150263952|NCT00406653|542103316|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
150263953|NCT00406653|542103317|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
150263954|NCT00406653|542103318|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
150263955|NCT00406653|542103312|FG000|Induction Period|Pregnancy|1|||
150263956|NCT00406653|542103313|FG001|Induction Period|Pregnancy|0|||
150263957|NCT00406653|542103314|FG002|Induction Period|Pregnancy|0|||
149926895|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
149926896|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
149926897|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
149926898|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
149926899|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
149926900|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
149926901|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
149926902|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
149926903|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
149926904|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
149926905|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
149926906|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
149926907|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
149926908|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
149926909|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
149926910|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
149926911|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
149926912|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
149926913|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
149926914|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
149926915|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
149926916|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
149926917|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
149926918|NCT03538691|540867123|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
149926919|NCT03538691|540867124|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
149926920|NCT03538691|540867125|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
149926921|NCT03538691|540867126|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
149926922|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
149926923|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
149926924|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
149926925|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
149926926|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
149926927|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
150164014|NCT00157014|541735535|FG001|Overall Study|Physician Decision|1|||
150164015|NCT00157014|541735536|FG002|Overall Study|Physician Decision|0|||
150164016|NCT00157014|541735537|FG003|Overall Study|Physician Decision|0|||
150164017|NCT00157014|541735534|FG000|Overall Study|Medications withdrawn on family request|0|||
150164018|NCT00157014|541735535|FG001|Overall Study|Medications withdrawn on family request|1|||
150164019|NCT00157014|541735536|FG002|Overall Study|Medications withdrawn on family request|0|||
150164020|NCT00157014|541735537|FG003|Overall Study|Medications withdrawn on family request|0|||
150164021|NCT00157014|541735534|FG000|Overall Study|Patient withdrawn by investigator|1|||
150164022|NCT00157014|541735535|FG001|Overall Study|Patient withdrawn by investigator|0|||
150164023|NCT00157014|541735536|FG002|Overall Study|Patient withdrawn by investigator|0|||
150164024|NCT00157014|541735537|FG003|Overall Study|Patient withdrawn by investigator|0|||
150164025|NCT00157014|541735534|FG000|Overall Study|Patient unable to return in nursing home|1|||
150164026|NCT00157014|541735535|FG001|Overall Study|Patient unable to return in nursing home|0|||
150164027|NCT00157014|541735536|FG002|Overall Study|Patient unable to return in nursing home|0|||
150164028|NCT00157014|541735537|FG003|Overall Study|Patient unable to return in nursing home|0|||
150164029|NCT00157014|541735534|FG000|Overall Study|Patient would not receive transplant|0|||
150164030|NCT00157014|541735535|FG001|Overall Study|Patient would not receive transplant|1|||
150164031|NCT00157014|541735536|FG002|Overall Study|Patient would not receive transplant|0|||
150164032|NCT00157014|541735537|FG003|Overall Study|Patient would not receive transplant|0|||
150164033|NCT00157014|541735534|FG000|Overall Study|Withdrawal by Subject|1|||
150164034|NCT00157014|541735535|FG001|Overall Study|Withdrawal by Subject|0|||
150164035|NCT00157014|541735536|FG002|Overall Study|Withdrawal by Subject|0|||
150164036|NCT00157014|541735537|FG003|Overall Study|Withdrawal by Subject|0|||
150164037|NCT01362491|541735538|FG000|Overall Study|Ineligible|1|||
150164038|NCT01362491|541735539|FG001|Overall Study|Ineligible|0|||
150164039|NCT01362491|541735540|FG002|Overall Study|Ineligible|0|||
150263958|NCT00406653|542103315|FG003|Induction Period|Pregnancy|0|||
150263959|NCT00406653|542103316|FG004|Induction Period|Pregnancy|0|||
150263960|NCT00406653|542103317|FG005|Induction Period|Pregnancy|0|||
150263961|NCT00406653|542103318|FG006|Induction Period|Pregnancy|0|||
150263962|NCT00406653|542103312|FG000|Induction Period|Declined participation but followup done|0|||
150263963|NCT00406653|542103313|FG001|Induction Period|Declined participation but followup done|2|||
150263964|NCT00406653|542103314|FG002|Induction Period|Declined participation but followup done|1|||
150263965|NCT00406653|542103315|FG003|Induction Period|Declined participation but followup done|1|||
150263966|NCT00406653|542103316|FG004|Induction Period|Declined participation but followup done|0|||
150263967|NCT00406653|542103317|FG005|Induction Period|Declined participation but followup done|0|||
150263968|NCT00406653|542103318|FG006|Induction Period|Declined participation but followup done|0|||
150263969|NCT00406653|542103312|FG000|Induction Period|Given prohibited drug|0|||
150263970|NCT00406653|542103313|FG001|Induction Period|Given prohibited drug|1|||
150263971|NCT00406653|542103314|FG002|Induction Period|Given prohibited drug|2|||
150263972|NCT00406653|542103315|FG003|Induction Period|Given prohibited drug|0|||
150263973|NCT00406653|542103316|FG004|Induction Period|Given prohibited drug|0|||
150263974|NCT00406653|542103317|FG005|Induction Period|Given prohibited drug|0|||
150263975|NCT00406653|542103318|FG006|Induction Period|Given prohibited drug|0|||
150263976|NCT00406653|542103312|FG000|Induction Period|Incarcerated|0|||
150263977|NCT00406653|542103313|FG001|Induction Period|Incarcerated|0|||
150263978|NCT00406653|542103314|FG002|Induction Period|Incarcerated|1|||
150263979|NCT00406653|542103315|FG003|Induction Period|Incarcerated|0|||
150263980|NCT00406653|542103316|FG004|Induction Period|Incarcerated|0|||
150263981|NCT00406653|542103317|FG005|Induction Period|Incarcerated|0|||
150263982|NCT00406653|542103318|FG006|Induction Period|Incarcerated|0|||
150263983|NCT00406653|542103312|FG000|Induction Period|Patient relocated|0|||
150263984|NCT00406653|542103313|FG001|Induction Period|Patient relocated|0|||
150263985|NCT00406653|542103314|FG002|Induction Period|Patient relocated|1|||
150263986|NCT00406653|542103315|FG003|Induction Period|Patient relocated|0|||
150263987|NCT00406653|542103316|FG004|Induction Period|Patient relocated|0|||
150263988|NCT00406653|542103317|FG005|Induction Period|Patient relocated|0|||
150263989|NCT00406653|542103318|FG006|Induction Period|Patient relocated|0|||
150263990|NCT00406653|542103312|FG000|Maintenance Period|Adverse Event|0|||
150263991|NCT00406653|542103313|FG001|Maintenance Period|Adverse Event|0|||
150263992|NCT00406653|542103314|FG002|Maintenance Period|Adverse Event|0|||
150263993|NCT00406653|542103315|FG003|Maintenance Period|Adverse Event|0|||
150263994|NCT00406653|542103316|FG004|Maintenance Period|Adverse Event|1|||
150263995|NCT00406653|542103317|FG005|Maintenance Period|Adverse Event|1|||
150263996|NCT00406653|542103318|FG006|Maintenance Period|Adverse Event|0|||
150263997|NCT00406653|542103312|FG000|Maintenance Period|Lack of Efficacy|0|||
150263998|NCT00406653|542103313|FG001|Maintenance Period|Lack of Efficacy|0|||
150263999|NCT00406653|542103314|FG002|Maintenance Period|Lack of Efficacy|0|||
150264000|NCT00406653|542103315|FG003|Maintenance Period|Lack of Efficacy|0|||
150264001|NCT00406653|542103316|FG004|Maintenance Period|Lack of Efficacy|20|||
150264002|NCT00406653|542103317|FG005|Maintenance Period|Lack of Efficacy|26|||
150264003|NCT00406653|542103318|FG006|Maintenance Period|Lack of Efficacy|0|||
150264004|NCT00406653|542103312|FG000|Maintenance Period|Lost to Follow-up|0|||
150264005|NCT00406653|542103313|FG001|Maintenance Period|Lost to Follow-up|0|||
150264006|NCT00406653|542103314|FG002|Maintenance Period|Lost to Follow-up|0|||
150264007|NCT00406653|542103315|FG003|Maintenance Period|Lost to Follow-up|0|||
150264008|NCT00406653|542103316|FG004|Maintenance Period|Lost to Follow-up|2|||
150264009|NCT00406653|542103317|FG005|Maintenance Period|Lost to Follow-up|1|||
150264010|NCT00406653|542103318|FG006|Maintenance Period|Lost to Follow-up|0|||
150264011|NCT00406653|542103312|FG000|Maintenance Period|Withdrawal of Consent|0|||
150264012|NCT00406653|542103313|FG001|Maintenance Period|Withdrawal of Consent|0|||
150264013|NCT00406653|542103314|FG002|Maintenance Period|Withdrawal of Consent|0|||
150264014|NCT00406653|542103315|FG003|Maintenance Period|Withdrawal of Consent|0|||
150264015|NCT00406653|542103316|FG004|Maintenance Period|Withdrawal of Consent|2|||
150264016|NCT00406653|542103317|FG005|Maintenance Period|Withdrawal of Consent|0|||
150264017|NCT00406653|542103318|FG006|Maintenance Period|Withdrawal of Consent|0|||
150264018|NCT00406653|542103312|FG000|Maintenance Period|Pregnancy|0|||
150264019|NCT00406653|542103313|FG001|Maintenance Period|Pregnancy|0|||
150264020|NCT00406653|542103314|FG002|Maintenance Period|Pregnancy|0|||
150264021|NCT00406653|542103315|FG003|Maintenance Period|Pregnancy|0|||
150264022|NCT00406653|542103316|FG004|Maintenance Period|Pregnancy|0|||
150264023|NCT00406653|542103317|FG005|Maintenance Period|Pregnancy|1|||
150264024|NCT00406653|542103318|FG006|Maintenance Period|Pregnancy|0|||
150264025|NCT00406653|542103312|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
150264026|NCT00406653|542103313|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
150264027|NCT00406653|542103314|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
150264028|NCT00406653|542103315|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
150264029|NCT00406653|542103316|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
150264030|NCT00406653|542103317|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
150264031|NCT00406653|542103318|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
150264032|NCT00406653|542103312|FG000|Maintenance Period|Error in disease score evaluation|0|||
150264033|NCT00406653|542103313|FG001|Maintenance Period|Error in disease score evaluation|0|||
150264034|NCT00406653|542103314|FG002|Maintenance Period|Error in disease score evaluation|0|||
150264035|NCT00406653|542103315|FG003|Maintenance Period|Error in disease score evaluation|0|||
150264036|NCT00406653|542103316|FG004|Maintenance Period|Error in disease score evaluation|1|||
150264037|NCT00406653|542103317|FG005|Maintenance Period|Error in disease score evaluation|0|||
150264038|NCT00406653|542103318|FG006|Maintenance Period|Error in disease score evaluation|0|||
150264039|NCT00406653|542103312|FG000|Open-Label Period|Death|0|||
150264040|NCT00406653|542103313|FG001|Open-Label Period|Death|0|||
150264041|NCT00406653|542103314|FG002|Open-Label Period|Death|0|||
150264042|NCT00406653|542103315|FG003|Open-Label Period|Death|0|||
150264043|NCT00406653|542103316|FG004|Open-Label Period|Death|0|||
150264044|NCT00406653|542103317|FG005|Open-Label Period|Death|0|||
150264045|NCT00406653|542103318|FG006|Open-Label Period|Death|1|||
150264046|NCT00406653|542103312|FG000|Open-Label Period|Adverse Event|0|||
150264047|NCT00406653|542103313|FG001|Open-Label Period|Adverse Event|0|||
150264048|NCT00406653|542103314|FG002|Open-Label Period|Adverse Event|0|||
150264049|NCT00406653|542103315|FG003|Open-Label Period|Adverse Event|0|||
150264050|NCT00406653|542103316|FG004|Open-Label Period|Adverse Event|0|||
150264051|NCT00406653|542103317|FG005|Open-Label Period|Adverse Event|0|||
150264052|NCT00406653|542103318|FG006|Open-Label Period|Adverse Event|18|||
150264053|NCT00406653|542103312|FG000|Open-Label Period|Lack of Efficacy|0|||
150264054|NCT00406653|542103313|FG001|Open-Label Period|Lack of Efficacy|0|||
150264055|NCT00406653|542103314|FG002|Open-Label Period|Lack of Efficacy|0|||
150264056|NCT00406653|542103315|FG003|Open-Label Period|Lack of Efficacy|0|||
150264057|NCT00406653|542103316|FG004|Open-Label Period|Lack of Efficacy|0|||
150264058|NCT00406653|542103317|FG005|Open-Label Period|Lack of Efficacy|0|||
150264059|NCT00406653|542103318|FG006|Open-Label Period|Lack of Efficacy|160|||
150264060|NCT00406653|542103312|FG000|Open-Label Period|Lost to Follow-up|0|||
150264061|NCT00406653|542103313|FG001|Open-Label Period|Lost to Follow-up|0|||
150264062|NCT00406653|542103314|FG002|Open-Label Period|Lost to Follow-up|0|||
150264063|NCT00406653|542103315|FG003|Open-Label Period|Lost to Follow-up|0|||
150264064|NCT00406653|542103316|FG004|Open-Label Period|Lost to Follow-up|0|||
149926928|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
149926929|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
149926930|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
149926931|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
149926932|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
149926933|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
149926934|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
149926935|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
149926936|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
149926937|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
149926938|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
149926939|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
149926940|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
149926941|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
149926942|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
149926943|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
149926944|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
149926945|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
150264065|NCT00406653|542103317|FG005|Open-Label Period|Lost to Follow-up|0|||
150264066|NCT00406653|542103318|FG006|Open-Label Period|Lost to Follow-up|6|||
150264067|NCT00406653|542103312|FG000|Open-Label Period|Withdrawal of Consent|0|||
150264068|NCT00406653|542103313|FG001|Open-Label Period|Withdrawal of Consent|0|||
150264069|NCT00406653|542103314|FG002|Open-Label Period|Withdrawal of Consent|0|||
150264070|NCT00406653|542103315|FG003|Open-Label Period|Withdrawal of Consent|0|||
150264071|NCT00406653|542103316|FG004|Open-Label Period|Withdrawal of Consent|0|||
150264072|NCT00406653|542103317|FG005|Open-Label Period|Withdrawal of Consent|0|||
150264073|NCT00406653|542103318|FG006|Open-Label Period|Withdrawal of Consent|11|||
150264074|NCT00406653|542103312|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
150264075|NCT00406653|542103313|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
150264076|NCT00406653|542103314|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
150264077|NCT00406653|542103315|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
150264078|NCT00406653|542103316|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
150264079|NCT00406653|542103317|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149926946|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
149926947|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
150264080|NCT00406653|542103318|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
150264081|NCT00406653|542103312|FG000|Open-Label Period|Pregnancy|0|||
150264082|NCT00406653|542103313|FG001|Open-Label Period|Pregnancy|0|||
150264083|NCT00406653|542103314|FG002|Open-Label Period|Pregnancy|0|||
149926948|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
149926949|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
149926950|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
149926951|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
149926952|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
149926953|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
150164040|NCT02950545|541735547|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
150164041|NCT02950545|541735548|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
150164042|NCT02950545|541735549|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
150164043|NCT02950545|541735550|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
150164044|NCT02950545|541735551|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
150164045|NCT02950545|541735552|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
150164046|NCT02950545|541735547|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
150164047|NCT02950545|541735548|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
150164048|NCT02950545|541735549|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
150164049|NCT02950545|541735550|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
150164050|NCT02950545|541735551|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
150164051|NCT02950545|541735552|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
150164052|NCT02950545|541735547|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
150164053|NCT02950545|541735548|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
150164054|NCT02950545|541735549|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
150164055|NCT02950545|541735550|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
150164056|NCT02950545|541735551|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
150164057|NCT02950545|541735552|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
150164058|NCT02950545|541735547|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
150164059|NCT02950545|541735548|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
150164060|NCT02950545|541735549|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
150164061|NCT02950545|541735550|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
150164062|NCT02950545|541735551|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
150164063|NCT02950545|541735552|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
150164064|NCT02950545|541735547|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
150164065|NCT02950545|541735548|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
150164066|NCT02950545|541735549|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
150164067|NCT02950545|541735550|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
150164068|NCT02950545|541735551|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
150164069|NCT02950545|541735552|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
150164070|NCT03398356|541735553|FG000|Before Treatment|Lost to Follow-up|1|||
150164071|NCT03398356|541735554|FG001|Before Treatment|Lost to Follow-up|2|||
150164072|NCT03398356|541735555|FG002|Before Treatment|Lost to Follow-up|0|||
150164073|NCT03398356|541735553|FG000|Before Treatment|drug intolerance|2|||
150164074|NCT03398356|541735554|FG001|Before Treatment|drug intolerance|1|||
150164075|NCT03398356|541735555|FG002|Before Treatment|drug intolerance|0|||
150164076|NCT03398356|541735553|FG000|Before Treatment|Withdrawal by Subject|0|||
150164077|NCT03398356|541735554|FG001|Before Treatment|Withdrawal by Subject|5|||
150164078|NCT03398356|541735555|FG002|Before Treatment|Withdrawal by Subject|0|||
150164079|NCT03398356|541735553|FG000|Before Treatment|Physician Decision|0|||
150164080|NCT03398356|541735554|FG001|Before Treatment|Physician Decision|0|||
150164081|NCT03398356|541735555|FG002|Before Treatment|Physician Decision|11|||
150164082|NCT03398356|541735553|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
150164083|NCT03398356|541735554|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
150164084|NCT03398356|541735555|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
150164085|NCT01928940|541735564|FG000|Overall Study|Adverse Event|0|||
150164086|NCT01928940|541735565|FG001|Overall Study|Adverse Event|1|||
150164087|NCT02954055|541735566|FG000|Overall Study|Did not initiate therapy|6|||
150164088|NCT02954055|541735567|FG001|Overall Study|Did not initiate therapy|1|||
150164089|NCT01352507|541735572|FG000|Treatment Period 1|Adverse Event|3|||
150164090|NCT01352507|541735573|FG001|Treatment Period 1|Adverse Event|0|||
150164091|NCT01352507|541735572|FG000|Treatment Period 1|Lost to Follow-up|3|||
150164092|NCT01352507|541735573|FG001|Treatment Period 1|Lost to Follow-up|4|||
150164093|NCT01352507|541735572|FG000|Treatment Period 1|Withdrawal by Subject|7|||
150164094|NCT01352507|541735573|FG001|Treatment Period 1|Withdrawal by Subject|5|||
150164095|NCT01352507|541735572|FG000|Treatment Period 1|Physician Decision|1|||
150164096|NCT01352507|541735573|FG001|Treatment Period 1|Physician Decision|0|||
149926954|NCT03538691|540867123|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
150164097|NCT01352507|541735572|FG000|Washout Period|Withdrawal by Subject|0|||
150164098|NCT01352507|541735573|FG001|Washout Period|Withdrawal by Subject|1|||
150164099|NCT01352507|541735572|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
150164100|NCT01352507|541735573|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
150164101|NCT01352507|541735572|FG000|Treatment Period 2|Withdrawal by Subject|4|||
150164102|NCT01352507|541735573|FG001|Treatment Period 2|Withdrawal by Subject|3|||
150164103|NCT01352507|541735572|FG000|Treatment Period 2|Lack of Efficacy|1|||
150164104|NCT01352507|541735573|FG001|Treatment Period 2|Lack of Efficacy|0|||
150164105|NCT01119703|541735574|FG000|Overall Study|Adverse Event|0|||
150164106|NCT01119703|541735575|FG001|Overall Study|Adverse Event|1|||
150164107|NCT04668144|541735576|FG000|Overall Study|Protocol Violation|0|||
150164108|NCT04668144|541735577|FG001|Overall Study|Protocol Violation|1|||
150164109|NCT04668144|541735578|FG002|Overall Study|Protocol Violation|2|||
150164110|NCT02095158|541735582|FG000|Overall Study|Adverse Event|14|||
150164111|NCT02095158|541735582|FG000|Overall Study|Lack of Efficacy|3|||
150164112|NCT02095158|541735582|FG000|Overall Study|Pregnancy|1|||
150164113|NCT02095158|541735582|FG000|Overall Study|Lost to Follow-up|20|||
150164114|NCT02095158|541735582|FG000|Overall Study|Personal Reasons|35|||
150164115|NCT02095158|541735582|FG000|Overall Study|Protocol Violation|1|||
150164116|NCT02095158|541735582|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150164117|NCT01941316|541735585|FG000|Overall Study|Adverse Event|0|||
150164118|NCT01941316|541735586|FG001|Overall Study|Adverse Event|1|||
150164119|NCT01941316|541735587|FG002|Overall Study|Adverse Event|0|||
150164120|NCT01941316|541735588|FG003|Overall Study|Adverse Event|7|||
150164121|NCT01941316|541735585|FG000|Overall Study|Progressive Disease|3|||
150164122|NCT01941316|541735586|FG001|Overall Study|Progressive Disease|6|||
150164123|NCT01941316|541735587|FG002|Overall Study|Progressive Disease|2|||
150164124|NCT01941316|541735588|FG003|Overall Study|Progressive Disease|29|||
150164125|NCT01941316|541735585|FG000|Overall Study|Withdrawal by Subject|0|||
150164126|NCT01941316|541735586|FG001|Overall Study|Withdrawal by Subject|2|||
150164127|NCT01941316|541735587|FG002|Overall Study|Withdrawal by Subject|1|||
150164128|NCT01941316|541735588|FG003|Overall Study|Withdrawal by Subject|8|||
150164129|NCT01941316|541735585|FG000|Overall Study|Death|0|||
150164130|NCT01941316|541735586|FG001|Overall Study|Death|0|||
150164131|NCT01941316|541735587|FG002|Overall Study|Death|0|||
150164132|NCT01941316|541735588|FG003|Overall Study|Death|3|||
150164133|NCT01941316|541735585|FG000|Overall Study|Physician Decision|0|||
150164134|NCT01941316|541735586|FG001|Overall Study|Physician Decision|0|||
150164135|NCT01941316|541735587|FG002|Overall Study|Physician Decision|0|||
150164136|NCT01941316|541735588|FG003|Overall Study|Physician Decision|3|||
150164137|NCT01941316|541735585|FG000|Overall Study|Protocol Violation|0|||
150164138|NCT01941316|541735586|FG001|Overall Study|Protocol Violation|0|||
150164139|NCT01941316|541735587|FG002|Overall Study|Protocol Violation|0|||
150164140|NCT01941316|541735588|FG003|Overall Study|Protocol Violation|3|||
150164141|NCT01941316|541735585|FG000|Overall Study|Intercurrent illness|0|||
150164142|NCT01941316|541735586|FG001|Overall Study|Intercurrent illness|0|||
150164143|NCT01941316|541735587|FG002|Overall Study|Intercurrent illness|0|||
150164144|NCT01941316|541735588|FG003|Overall Study|Intercurrent illness|1|||
150164145|NCT01941316|541735585|FG000|Overall Study|Other, not specified|0|||
150164146|NCT01941316|541735586|FG001|Overall Study|Other, not specified|0|||
150164147|NCT01941316|541735587|FG002|Overall Study|Other, not specified|0|||
150164148|NCT01941316|541735588|FG003|Overall Study|Other, not specified|1|||
150164149|NCT02775435|541735589|FG000|Overall Study|Adverse Event|32|||
150164150|NCT02775435|541735590|FG001|Overall Study|Adverse Event|27|||
150164151|NCT02775435|541735589|FG000|Overall Study|Lost to Follow-up|2|||
150164152|NCT02775435|541735590|FG001|Overall Study|Lost to Follow-up|2|||
150164153|NCT02775435|541735589|FG000|Overall Study|Sponsor decision|44|||
150164154|NCT02775435|541735590|FG001|Overall Study|Sponsor decision|19|||
150164155|NCT02775435|541735589|FG000|Overall Study|Withdrawal by Subject|4|||
150164156|NCT02775435|541735590|FG001|Overall Study|Withdrawal by Subject|9|||
150164157|NCT02775435|541735589|FG000|Overall Study|Death|196|||
150164158|NCT02775435|541735590|FG001|Overall Study|Death|224|||
150164159|NCT00941031|541735591|FG000|Induction Period|Lack of Efficacy|2|||
150164160|NCT00941031|541735592|FG001|Induction Period|Lack of Efficacy|1|||
150164161|NCT00941031|541735593|FG002|Induction Period|Lack of Efficacy|0|||
150164162|NCT00941031|541735594|FG003|Induction Period|Lack of Efficacy|5|||
150164163|NCT00941031|541735595|FG004|Induction Period|Lack of Efficacy|0|||
150164164|NCT00941031|541735596|FG005|Induction Period|Lack of Efficacy|0|||
150164165|NCT00941031|541735597|FG006|Induction Period|Lack of Efficacy|0|||
150164166|NCT00941031|541735591|FG000|Induction Period|Withdrawal by Subject|1|||
150164167|NCT00941031|541735592|FG001|Induction Period|Withdrawal by Subject|2|||
150164168|NCT00941031|541735593|FG002|Induction Period|Withdrawal by Subject|2|||
150164169|NCT00941031|541735594|FG003|Induction Period|Withdrawal by Subject|2|||
150164170|NCT00941031|541735595|FG004|Induction Period|Withdrawal by Subject|0|||
150164171|NCT00941031|541735596|FG005|Induction Period|Withdrawal by Subject|0|||
150164172|NCT00941031|541735597|FG006|Induction Period|Withdrawal by Subject|0|||
150164173|NCT00941031|541735591|FG000|Induction Period|Adminstative Problems|1|||
150164174|NCT00941031|541735592|FG001|Induction Period|Adminstative Problems|1|||
150164175|NCT00941031|541735593|FG002|Induction Period|Adminstative Problems|1|||
150164176|NCT00941031|541735594|FG003|Induction Period|Adminstative Problems|0|||
150164177|NCT00941031|541735595|FG004|Induction Period|Adminstative Problems|0|||
150164178|NCT00941031|541735596|FG005|Induction Period|Adminstative Problems|0|||
150164179|NCT00941031|541735597|FG006|Induction Period|Adminstative Problems|0|||
150164180|NCT00941031|541735591|FG000|Induction Period|Adverse Event|1|||
150264084|NCT00406653|542103315|FG003|Open-Label Period|Pregnancy|0|||
150264085|NCT00406653|542103316|FG004|Open-Label Period|Pregnancy|0|||
150264086|NCT00406653|542103317|FG005|Open-Label Period|Pregnancy|0|||
150264087|NCT00406653|542103318|FG006|Open-Label Period|Pregnancy|2|||
150264088|NCT00406653|542103312|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
150264089|NCT00406653|542103313|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
150264090|NCT00406653|542103314|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
150264091|NCT00406653|542103315|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
150264092|NCT00406653|542103316|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
150264093|NCT00406653|542103317|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
150264094|NCT00406653|542103318|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
150264095|NCT00406653|542103312|FG000|Open-Label Period|Declined participation but followup done|0|||
150264096|NCT00406653|542103313|FG001|Open-Label Period|Declined participation but followup done|0|||
150264097|NCT00406653|542103314|FG002|Open-Label Period|Declined participation but followup done|0|||
150264098|NCT00406653|542103315|FG003|Open-Label Period|Declined participation but followup done|0|||
150264099|NCT00406653|542103316|FG004|Open-Label Period|Declined participation but followup done|0|||
150264100|NCT00406653|542103317|FG005|Open-Label Period|Declined participation but followup done|0|||
150264101|NCT00406653|542103318|FG006|Open-Label Period|Declined participation but followup done|8|||
150264102|NCT00406653|542103312|FG000|Open-Label Period|Discontinued by Sponsor|0|||
150264103|NCT00406653|542103313|FG001|Open-Label Period|Discontinued by Sponsor|0|||
150264104|NCT00406653|542103314|FG002|Open-Label Period|Discontinued by Sponsor|0|||
150264105|NCT00406653|542103315|FG003|Open-Label Period|Discontinued by Sponsor|0|||
150264106|NCT00406653|542103316|FG004|Open-Label Period|Discontinued by Sponsor|0|||
150264107|NCT00406653|542103317|FG005|Open-Label Period|Discontinued by Sponsor|0|||
150264108|NCT00406653|542103318|FG006|Open-Label Period|Discontinued by Sponsor|1|||
150264109|NCT00406653|542103312|FG000|Open-Label Period|Refused followup|0|||
150264110|NCT00406653|542103313|FG001|Open-Label Period|Refused followup|0|||
150264111|NCT00406653|542103314|FG002|Open-Label Period|Refused followup|0|||
150264112|NCT00406653|542103315|FG003|Open-Label Period|Refused followup|0|||
150264113|NCT00406653|542103316|FG004|Open-Label Period|Refused followup|0|||
150264114|NCT00406653|542103317|FG005|Open-Label Period|Refused followup|0|||
150264115|NCT00406653|542103318|FG006|Open-Label Period|Refused followup|1|||
150264116|NCT00818649|542103319|FG000|Overall Study|Declining performance status|2|||
150264117|NCT00818649|542103319|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
150264118|NCT00818649|542103319|FG000|Overall Study|Adverse Event|1|||
150264119|NCT06338462|542103320|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
150264120|NCT00069238|542103324|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
150264121|NCT00069238|542103325|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
150264122|NCT00069238|542103326|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
150264123|NCT00069238|542103324|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
150264124|NCT00069238|542103325|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
150264125|NCT00069238|542103326|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
150264126|NCT00069238|542103324|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
150264127|NCT00069238|542103325|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
150264128|NCT00069238|542103326|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
150264129|NCT01001832|542103327|FG000|Short-term Period|Adverse Event|2|||
150264130|NCT01001832|542103328|FG001|Short-term Period|Adverse Event|3|||
150264131|NCT01001832|542103327|FG000|Long-term Period|Adverse Event|2|||
150264132|NCT01001832|542103328|FG001|Long-term Period|Adverse Event|1|||
150264133|NCT01001832|542103327|FG000|Long-term Period|Withdrawal by Subject|1|||
150264134|NCT01001832|542103328|FG001|Long-term Period|Withdrawal by Subject|0|||
150264135|NCT01001832|542103327|FG000|Long-term Period|Lack of Efficacy|0|||
150264136|NCT01001832|542103328|FG001|Long-term Period|Lack of Efficacy|2|||
150264137|NCT01001832|542103327|FG000|Long-term Period|Other|1|||
150264138|NCT01001832|542103328|FG001|Long-term Period|Other|2|||
150264139|NCT01001832|542103327|FG000|Follow-up Period|Withdrawal by Subject|1|||
150264140|NCT01001832|542103328|FG001|Follow-up Period|Withdrawal by Subject|0|||
150264141|NCT01001832|542103327|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
150264142|NCT01001832|542103328|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
150264143|NCT01001832|542103327|FG000|Follow-up Period|Other|2|||
150264144|NCT01001832|542103328|FG001|Follow-up Period|Other|1|||
150264145|NCT00953745|542103332|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
150264146|NCT00953745|542103333|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
150264147|NCT00953745|542103332|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
150264148|NCT00953745|542103333|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
150264149|NCT00953745|542103332|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
150264150|NCT00953745|542103333|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
150264151|NCT00953745|542103332|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
150264152|NCT00953745|542103333|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
150264153|NCT00953745|542103332|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
150264154|NCT00953745|542103333|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
150264155|NCT00953745|542103332|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
150264156|NCT00953745|542103333|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
150264157|NCT02427464|542103338|FG000|Overall Study|Adverse Event|6|||
150264158|NCT02427464|542103339|FG001|Overall Study|Adverse Event|1|||
150264159|NCT02427464|542103338|FG000|Overall Study|Lost to Follow-up|16|||
150264160|NCT02427464|542103339|FG001|Overall Study|Lost to Follow-up|5|||
150264161|NCT02427464|542103338|FG000|Overall Study|Physician Decision|2|||
150264162|NCT02427464|542103339|FG001|Overall Study|Physician Decision|0|||
150264163|NCT02427464|542103338|FG000|Overall Study|Withdrawal by Subject|10|||
150264164|NCT02427464|542103339|FG001|Overall Study|Withdrawal by Subject|8|||
150264165|NCT02427464|542103338|FG000|Overall Study|Noncompliance|16|||
150264166|NCT02427464|542103339|FG001|Overall Study|Noncompliance|10|||
150264167|NCT03756129|542103341|FG000|Overall Study|Adverse Event|1|||
150264168|NCT03756129|542103342|FG001|Overall Study|Adverse Event|1|||
150264169|NCT03756129|542103343|FG002|Overall Study|Adverse Event|0|||
150264170|NCT03756129|542103344|FG003|Overall Study|Adverse Event|2|||
150264171|NCT03756129|542103345|FG004|Overall Study|Adverse Event|0|||
150264172|NCT03756129|542103346|FG005|Overall Study|Adverse Event|0|||
150264173|NCT03756129|542103341|FG000|Overall Study|Withdrawal by Subject|2|||
150264174|NCT03756129|542103342|FG001|Overall Study|Withdrawal by Subject|1|||
150264175|NCT03756129|542103343|FG002|Overall Study|Withdrawal by Subject|3|||
150264176|NCT03756129|542103344|FG003|Overall Study|Withdrawal by Subject|1|||
150264177|NCT03756129|542103345|FG004|Overall Study|Withdrawal by Subject|1|||
150264178|NCT03756129|542103346|FG005|Overall Study|Withdrawal by Subject|3|||
150264179|NCT03756129|542103341|FG000|Overall Study|Lost to Follow-up|0|||
150264180|NCT03756129|542103342|FG001|Overall Study|Lost to Follow-up|0|||
150264181|NCT03756129|542103343|FG002|Overall Study|Lost to Follow-up|0|||
150264182|NCT03756129|542103344|FG003|Overall Study|Lost to Follow-up|0|||
150264183|NCT03756129|542103345|FG004|Overall Study|Lost to Follow-up|0|||
150264184|NCT03756129|542103346|FG005|Overall Study|Lost to Follow-up|1|||
150264185|NCT03756129|542103341|FG000|Overall Study|Physician Decision|0|||
150264186|NCT03756129|542103342|FG001|Overall Study|Physician Decision|0|||
150264187|NCT03756129|542103343|FG002|Overall Study|Physician Decision|0|||
150264188|NCT03756129|542103344|FG003|Overall Study|Physician Decision|0|||
150264189|NCT03756129|542103345|FG004|Overall Study|Physician Decision|0|||
150264190|NCT03756129|542103346|FG005|Overall Study|Physician Decision|1|||
150264191|NCT04576455|542103347|FG000|Overall Study|Ongoing in the Study|48|||
150264192|NCT04576455|542103348|FG001|Overall Study|Ongoing in the Study|58|||
150264193|NCT04576455|542103347|FG000|Overall Study|Death|83|||
150264194|NCT04576455|542103348|FG001|Overall Study|Death|77|||
150264195|NCT04576455|542103347|FG000|Overall Study|Lost to Follow-up|4|||
150264196|NCT04576455|542103348|FG001|Overall Study|Lost to Follow-up|5|||
150264197|NCT04576455|542103347|FG000|Overall Study|Withdrawal by Subject|16|||
150264198|NCT04576455|542103348|FG001|Overall Study|Withdrawal by Subject|12|||
150264199|NCT01340196|542104986|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
150264200|NCT00604279|542104991|FG000|Overall Study|Lack of Efficacy|22|||
150264201|NCT00604279|542104992|FG001|Overall Study|Lack of Efficacy|9|||
150264202|NCT00604279|542104991|FG000|Overall Study|Lost to Follow-up|9|||
150264203|NCT00604279|542104992|FG001|Overall Study|Lost to Follow-up|14|||
150264204|NCT00604279|542104991|FG000|Overall Study|Pregnancy|2|||
150264205|NCT00604279|542104992|FG001|Overall Study|Pregnancy|0|||
150264206|NCT00604279|542104991|FG000|Overall Study|Protocol Violation|3|||
150264207|NCT00604279|542104992|FG001|Overall Study|Protocol Violation|1|||
150264208|NCT00604279|542104991|FG000|Overall Study|Withdrawal by Subject|16|||
150264209|NCT00604279|542104992|FG001|Overall Study|Withdrawal by Subject|5|||
150264210|NCT00604279|542104991|FG000|Overall Study|Adverse Event|4|||
150264211|NCT00604279|542104992|FG001|Overall Study|Adverse Event|5|||
150264212|NCT00604279|542104991|FG000|Overall Study|Other|8|||
150264213|NCT00604279|542104992|FG001|Overall Study|Other|4|||
150264214|NCT00816400|542104993|FG000|Overall Study|Death|2|||
150264215|NCT00816400|542104994|FG001|Overall Study|Death|3|||
150264216|NCT00816400|542104995|FG002|Overall Study|Death|3|||
150264217|NCT00816400|542104996|FG003|Overall Study|Death|3|||
150264218|NCT00816400|542104997|FG004|Overall Study|Death|2|||
150264219|NCT00816400|542104998|FG005|Overall Study|Death|3|||
150264220|NCT00816400|542104999|FG006|Overall Study|Death|2|||
150264221|NCT00816400|542105000|FG007|Overall Study|Death|5|||
150264222|NCT00816400|542105001|FG008|Overall Study|Death|6|||
150264223|NCT00816400|542104993|FG000|Overall Study|In hospice care at the end of the study|0|||
150264224|NCT00816400|542104994|FG001|Overall Study|In hospice care at the end of the study|0|||
150264225|NCT00816400|542104995|FG002|Overall Study|In hospice care at the end of the study|2|||
150264226|NCT00816400|542104996|FG003|Overall Study|In hospice care at the end of the study|0|||
150264227|NCT00816400|542104997|FG004|Overall Study|In hospice care at the end of the study|0|||
150264228|NCT00816400|542104998|FG005|Overall Study|In hospice care at the end of the study|0|||
150264229|NCT00816400|542104999|FG006|Overall Study|In hospice care at the end of the study|0|||
150264230|NCT00816400|542105000|FG007|Overall Study|In hospice care at the end of the study|0|||
150264231|NCT00816400|542105001|FG008|Overall Study|In hospice care at the end of the study|0|||
150264232|NCT00601419|542105002|FG000|Overall Study|Lost to Follow-up|3|||
150264233|NCT00601419|542105002|FG000|Overall Study|Missed Visits|1|||
150164181|NCT00941031|541735592|FG001|Induction Period|Adverse Event|0|||
150164182|NCT00941031|541735593|FG002|Induction Period|Adverse Event|3|||
150164183|NCT00941031|541735594|FG003|Induction Period|Adverse Event|2|||
150164184|NCT00941031|541735595|FG004|Induction Period|Adverse Event|0|||
150164185|NCT00941031|541735596|FG005|Induction Period|Adverse Event|0|||
150164186|NCT00941031|541735597|FG006|Induction Period|Adverse Event|0|||
150164187|NCT00941031|541735591|FG000|Maintenance Period|Withdrawal by Subject|0|||
150164188|NCT00941031|541735592|FG001|Maintenance Period|Withdrawal by Subject|0|||
150164189|NCT00941031|541735593|FG002|Maintenance Period|Withdrawal by Subject|0|||
150164190|NCT00941031|541735594|FG003|Maintenance Period|Withdrawal by Subject|0|||
150164191|NCT00941031|541735595|FG004|Maintenance Period|Withdrawal by Subject|6|||
150164192|NCT00941031|541735596|FG005|Maintenance Period|Withdrawal by Subject|2|||
150164193|NCT00941031|541735597|FG006|Maintenance Period|Withdrawal by Subject|13|||
150164194|NCT00941031|541735591|FG000|Maintenance Period|Administrative Problems|0|||
150164195|NCT00941031|541735592|FG001|Maintenance Period|Administrative Problems|0|||
150164196|NCT00941031|541735593|FG002|Maintenance Period|Administrative Problems|0|||
150164197|NCT00941031|541735594|FG003|Maintenance Period|Administrative Problems|0|||
150164198|NCT00941031|541735595|FG004|Maintenance Period|Administrative Problems|1|||
150164199|NCT00941031|541735596|FG005|Maintenance Period|Administrative Problems|0|||
150164200|NCT00941031|541735597|FG006|Maintenance Period|Administrative Problems|1|||
150164201|NCT00941031|541735591|FG000|Maintenance Period|Protocol Violation|0|||
150164202|NCT00941031|541735592|FG001|Maintenance Period|Protocol Violation|0|||
150164203|NCT00941031|541735593|FG002|Maintenance Period|Protocol Violation|0|||
150164204|NCT00941031|541735594|FG003|Maintenance Period|Protocol Violation|0|||
150164205|NCT00941031|541735595|FG004|Maintenance Period|Protocol Violation|0|||
150164206|NCT00941031|541735596|FG005|Maintenance Period|Protocol Violation|0|||
150164207|NCT00941031|541735597|FG006|Maintenance Period|Protocol Violation|1|||
150164208|NCT00941031|541735591|FG000|Maintenance Period|Adverse Event|0|||
150164209|NCT00941031|541735592|FG001|Maintenance Period|Adverse Event|0|||
150164210|NCT00941031|541735593|FG002|Maintenance Period|Adverse Event|0|||
150164211|NCT00941031|541735594|FG003|Maintenance Period|Adverse Event|0|||
150164212|NCT00941031|541735595|FG004|Maintenance Period|Adverse Event|0|||
150164213|NCT00941031|541735596|FG005|Maintenance Period|Adverse Event|2|||
150164214|NCT00941031|541735597|FG006|Maintenance Period|Adverse Event|8|||
150164215|NCT00941031|541735591|FG000|Maintenance Period|Lost to Follow-up|0|||
150164216|NCT00941031|541735592|FG001|Maintenance Period|Lost to Follow-up|0|||
150164217|NCT00941031|541735593|FG002|Maintenance Period|Lost to Follow-up|0|||
150164218|NCT00941031|541735594|FG003|Maintenance Period|Lost to Follow-up|0|||
150164219|NCT00941031|541735595|FG004|Maintenance Period|Lost to Follow-up|2|||
150164220|NCT00941031|541735596|FG005|Maintenance Period|Lost to Follow-up|2|||
150164221|NCT00941031|541735597|FG006|Maintenance Period|Lost to Follow-up|7|||
150164222|NCT00941031|541735591|FG000|Maintenance Period|Lack of Efficacy|0|||
150164223|NCT00941031|541735592|FG001|Maintenance Period|Lack of Efficacy|0|||
150164224|NCT00941031|541735593|FG002|Maintenance Period|Lack of Efficacy|0|||
150164225|NCT00941031|541735594|FG003|Maintenance Period|Lack of Efficacy|0|||
150164226|NCT00941031|541735595|FG004|Maintenance Period|Lack of Efficacy|0|||
150164227|NCT00941031|541735596|FG005|Maintenance Period|Lack of Efficacy|0|||
150164228|NCT00941031|541735597|FG006|Maintenance Period|Lack of Efficacy|13|||
150164229|NCT04555044|541735600|FG000|Overall Study|Adverse Event|0|||
150164230|NCT04555044|541735601|FG001|Overall Study|Adverse Event|1|||
150164231|NCT01835899|541735602|FG000|Overall Study|Adverse Event|0|||
150164232|NCT01835899|541735603|FG001|Overall Study|Adverse Event|0|||
150164233|NCT01835899|541735604|FG002|Overall Study|Adverse Event|1|||
150164234|NCT01835899|541735602|FG000|Overall Study|Other than stated above|0|||
150164235|NCT01835899|541735603|FG001|Overall Study|Other than stated above|1|||
150164236|NCT01835899|541735604|FG002|Overall Study|Other than stated above|0|||
150164237|NCT00614744|541735613|FG000|Overall Study|Lost to Follow-up|5|||
150164238|NCT00614744|541735614|FG001|Overall Study|Lost to Follow-up|4|||
150164239|NCT00614744|541735613|FG000|Overall Study|Incomplete for Behavior Issues|0|||
150164240|NCT00614744|541735614|FG001|Overall Study|Incomplete for Behavior Issues|2|||
150164241|NCT03285711|541735615|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
150164242|NCT03285711|541735616|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
150164243|NCT03285711|541735617|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
150164244|NCT03285711|541735618|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
150164245|NCT03285711|541735615|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
150164246|NCT03285711|541735616|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
150164247|NCT03285711|541735617|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
150164248|NCT03285711|541735618|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
150164249|NCT03285711|541735615|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
150164250|NCT03285711|541735616|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
150164251|NCT03285711|541735617|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
150164252|NCT03285711|541735618|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
150164253|NCT03285711|541735615|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
150164254|NCT03285711|541735616|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
150264234|NCT01786174|542105003|FG000|Overall Study|Discontinued Study Drug|2|||
150264235|NCT01786174|542105004|FG001|Overall Study|Discontinued Study Drug|0|||
150264236|NCT01614197|542105005|FG000|Overall Study|Withdrawal by Subject|0|||
150264237|NCT01614197|542105006|FG001|Overall Study|Withdrawal by Subject|1|||
150264238|NCT01614197|542105007|FG002|Overall Study|Withdrawal by Subject|0|||
150264239|NCT01614197|542105008|FG003|Overall Study|Withdrawal by Subject|0|||
150264240|NCT03628898|542105010|FG000|Overall Study|Device deficiency|1|||
150264241|NCT02245672|542105011|FG000|Overall Study|Adverse Event|4|||
150264242|NCT02245672|542105012|FG001|Overall Study|Adverse Event|4|||
150264243|NCT02245672|542105013|FG002|Overall Study|Adverse Event|4|||
150264244|NCT02245672|542105011|FG000|Overall Study|Lost to Follow-up|3|||
150264245|NCT02245672|542105012|FG001|Overall Study|Lost to Follow-up|5|||
150264246|NCT02245672|542105013|FG002|Overall Study|Lost to Follow-up|1|||
150264247|NCT02245672|542105011|FG000|Overall Study|Withdrawal by Subject|6|||
150264248|NCT02245672|542105012|FG001|Overall Study|Withdrawal by Subject|3|||
150264249|NCT02245672|542105013|FG002|Overall Study|Withdrawal by Subject|0|||
150264250|NCT02245672|542105011|FG000|Overall Study|Randomized in error (not treated)|0|||
150264251|NCT02245672|542105012|FG001|Overall Study|Randomized in error (not treated)|1|||
150264252|NCT02245672|542105013|FG002|Overall Study|Randomized in error (not treated)|0|||
150264253|NCT00971932|542105014|FG000|Overall Study|Withdrawal by Subject|1|||
150264254|NCT00971932|542105014|FG000|Overall Study|Investigator's decision|2|||
150264255|NCT00971932|542105014|FG000|Overall Study|Ongoing|4|||
150264256|NCT01729156|542105017|FG000|Overall Study|Withdrawal by Subject|1|||
150264257|NCT01729156|542105018|FG001|Overall Study|Withdrawal by Subject|0|||
150264258|NCT01729156|542105019|FG002|Overall Study|Withdrawal by Subject|0|||
150264259|NCT01215422|542105020|FG000|Overall Study|Relocation|1|||
150264260|NCT01215422|542105021|FG001|Overall Study|Relocation|0|||
150264261|NCT01215422|542105022|FG002|Overall Study|Relocation|0|||
150264262|NCT01215422|542105023|FG003|Overall Study|Relocation|0|||
150264263|NCT01215422|542105020|FG000|Overall Study|Failed intubations|0|||
150264264|NCT01215422|542105021|FG001|Overall Study|Failed intubations|0|||
150264265|NCT01215422|542105022|FG002|Overall Study|Failed intubations|3|||
149926955|NCT03538691|540867124|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
149926956|NCT03538691|540867125|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
149926957|NCT03538691|540867126|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
149926958|NCT00481767|540867130|FG000|Overall Study|Withdrawal by Subject|16|||
149926959|NCT00481767|540867131|FG001|Overall Study|Withdrawal by Subject|11|||
149926960|NCT00481767|540867130|FG000|Overall Study|Lost to Follow-up|16|||
150164255|NCT03285711|541735617|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
150164256|NCT03285711|541735618|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
150164257|NCT00235495|541735619|FG000|Overall Study|Death|52|||
150164258|NCT00235495|541735620|FG001|Overall Study|Death|42|||
150164259|NCT00235495|541735619|FG000|Overall Study|Withdrawal by Subject|5|||
150164260|NCT00235495|541735620|FG001|Overall Study|Withdrawal by Subject|3|||
150164261|NCT00235495|541735619|FG000|Overall Study|Lost to Follow-up|11|||
150164262|NCT00235495|541735620|FG001|Overall Study|Lost to Follow-up|13|||
150164263|NCT00235495|541735619|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
150164264|NCT00235495|541735620|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
150164265|NCT00490555|541735621|FG000|Overall Study|noncompliant with drug administration|0|||
150164266|NCT00490555|541735622|FG001|Overall Study|noncompliant with drug administration|0|||
150164267|NCT00490555|541735623|FG002|Overall Study|noncompliant with drug administration|2|||
150164268|NCT00490555|541735624|FG003|Overall Study|noncompliant with drug administration|0|||
150164269|NCT02320253|541735625|FG000|Overall Study|Withdrawal by Subject|3|||
150164270|NCT02320253|541735626|FG001|Overall Study|Withdrawal by Subject|0|||
150164271|NCT02320253|541735627|FG002|Overall Study|Withdrawal by Subject|0|||
150164272|NCT02320253|541735625|FG000|Overall Study|Lost to Follow-up|2|||
150164273|NCT02320253|541735626|FG001|Overall Study|Lost to Follow-up|2|||
150164274|NCT02320253|541735627|FG002|Overall Study|Lost to Follow-up|1|||
150164275|NCT02320253|541735625|FG000|Overall Study|Death|1|||
150164276|NCT02320253|541735626|FG001|Overall Study|Death|0|||
150164277|NCT02320253|541735627|FG002|Overall Study|Death|1|||
150164278|NCT00603538|541735628|FG000|Overall Study|Adverse Event|0|||
150164279|NCT00603538|541735629|FG001|Overall Study|Adverse Event|4|||
150264266|NCT01215422|542105023|FG003|Overall Study|Failed intubations|8|||
150264267|NCT01215422|542105020|FG000|Overall Study|Did not complete all intubations|7|||
150264268|NCT01215422|542105021|FG001|Overall Study|Did not complete all intubations|0|||
150264269|NCT01215422|542105022|FG002|Overall Study|Did not complete all intubations|0|||
150164280|NCT00603538|541735630|FG002|Overall Study|Adverse Event|2|||
150164281|NCT00603538|541735628|FG000|Overall Study|Objective progression or relapse|3|||
150164282|NCT00603538|541735629|FG001|Overall Study|Objective progression or relapse|0|||
150264270|NCT01215422|542105023|FG003|Overall Study|Did not complete all intubations|0|||
150264271|NCT06336603|542105024|FG000|Overall Study|Withdrawal by Subject|1|||
150264272|NCT06336603|542105024|FG000|Overall Study|Lost to Follow-up|2|||
150264273|NCT04335812|542105027|FG000|Overall Study|Withdrawal by Subject|1|||
150264274|NCT04335812|542105028|FG001|Overall Study|Withdrawal by Subject|3|||
150264275|NCT04335812|542105027|FG000|Overall Study|Lost to Follow-up|12|||
150264276|NCT04335812|542105028|FG001|Overall Study|Lost to Follow-up|12|||
150264277|NCT04335812|542105027|FG000|Overall Study|Did not engage in the intervention|22|||
150264278|NCT04335812|542105028|FG001|Overall Study|Did not engage in the intervention|18|||
150264279|NCT02434939|542105038|FG000|Overall Study|Lack of Efficacy|34|||
150264280|NCT02434939|542105039|FG001|Overall Study|Lack of Efficacy|48|||
150264281|NCT02434939|542105038|FG000|Overall Study|Withdrawal by Subject|3|||
150264282|NCT02434939|542105039|FG001|Overall Study|Withdrawal by Subject|0|||
150264283|NCT02434939|542105038|FG000|Overall Study|Adverse Event|0|||
150264284|NCT02434939|542105039|FG001|Overall Study|Adverse Event|1|||
150264285|NCT03581825|542105040|FG000|Period 1|Lens Discomfort|1|||
150264286|NCT03581825|542105041|FG001|Period 1|Lens Discomfort|0|||
150264287|NCT03581825|542105040|FG000|Period 2|Unsatisfactory Vision to Test|0|||
150264288|NCT03581825|542105041|FG001|Period 2|Unsatisfactory Vision to Test|1|||
150264289|NCT01668667|542105042|FG000|Overall Study|Adverse Event|3|||
150264290|NCT01668667|542105043|FG001|Overall Study|Adverse Event|6|||
150264291|NCT01668667|542105044|FG002|Overall Study|Adverse Event|4|||
150264292|NCT01668667|542105045|FG003|Overall Study|Adverse Event|4|||
150264293|NCT01668667|542105042|FG000|Overall Study|Lack of Efficacy|3|||
150264294|NCT01668667|542105043|FG001|Overall Study|Lack of Efficacy|2|||
150264295|NCT01668667|542105044|FG002|Overall Study|Lack of Efficacy|2|||
150264296|NCT01668667|542105045|FG003|Overall Study|Lack of Efficacy|3|||
150264297|NCT01668667|542105042|FG000|Overall Study|Protocol Violation|6|||
150264298|NCT01668667|542105043|FG001|Overall Study|Protocol Violation|10|||
150264299|NCT01668667|542105044|FG002|Overall Study|Protocol Violation|12|||
150264300|NCT01668667|542105045|FG003|Overall Study|Protocol Violation|5|||
150264301|NCT01668667|542105042|FG000|Overall Study|Lost to Follow-up|9|||
150264302|NCT01668667|542105043|FG001|Overall Study|Lost to Follow-up|4|||
150264303|NCT01668667|542105044|FG002|Overall Study|Lost to Follow-up|7|||
150264304|NCT01668667|542105045|FG003|Overall Study|Lost to Follow-up|6|||
150264305|NCT01668667|542105042|FG000|Overall Study|Physician Decision|3|||
150264306|NCT01668667|542105043|FG001|Overall Study|Physician Decision|0|||
150264307|NCT01668667|542105044|FG002|Overall Study|Physician Decision|1|||
150264308|NCT01668667|542105045|FG003|Overall Study|Physician Decision|0|||
150264309|NCT01668667|542105042|FG000|Overall Study|Withdrawal by Subject|7|||
150264310|NCT01668667|542105043|FG001|Overall Study|Withdrawal by Subject|4|||
150264311|NCT01668667|542105044|FG002|Overall Study|Withdrawal by Subject|5|||
150264312|NCT01668667|542105045|FG003|Overall Study|Withdrawal by Subject|5|||
150264313|NCT03562247|542105050|FG000|Overall Study|Lost to Follow-up|3|||
150264314|NCT03562247|542105051|FG001|Overall Study|Lost to Follow-up|1|||
150264315|NCT03562247|542105052|FG002|Overall Study|Lost to Follow-up|1|||
150264316|NCT01723254|542105054|FG000|Overall Study|Conflict with work schedule|0|||
150264317|NCT01723254|542105055|FG001|Overall Study|Conflict with work schedule|0|||
150264318|NCT01723254|542105056|FG002|Overall Study|Conflict with work schedule|0|||
150264319|NCT01723254|542105057|FG003|Overall Study|Conflict with work schedule|0|||
150264320|NCT01723254|542105058|FG004|Overall Study|Conflict with work schedule|0|||
150264321|NCT01723254|542105059|FG005|Overall Study|Conflict with work schedule|0|||
150264322|NCT01723254|542105060|FG006|Overall Study|Conflict with work schedule|0|||
150264323|NCT01723254|542105061|FG007|Overall Study|Conflict with work schedule|1|||
150264324|NCT01723254|542105054|FG000|Overall Study|Personal issues|0|||
150264325|NCT01723254|542105055|FG001|Overall Study|Personal issues|0|||
150264326|NCT01723254|542105056|FG002|Overall Study|Personal issues|0|||
150264327|NCT01723254|542105057|FG003|Overall Study|Personal issues|0|||
150264328|NCT01723254|542105058|FG004|Overall Study|Personal issues|0|||
150264329|NCT01723254|542105059|FG005|Overall Study|Personal issues|1|||
150264330|NCT01723254|542105060|FG006|Overall Study|Personal issues|0|||
150264331|NCT01723254|542105061|FG007|Overall Study|Personal issues|0|||
150264332|NCT01723254|542105054|FG000|Overall Study|No longer have time to participate|0|||
150264333|NCT01723254|542105055|FG001|Overall Study|No longer have time to participate|0|||
150264334|NCT01723254|542105056|FG002|Overall Study|No longer have time to participate|0|||
150264335|NCT01723254|542105057|FG003|Overall Study|No longer have time to participate|1|||
150264336|NCT01723254|542105058|FG004|Overall Study|No longer have time to participate|0|||
150264337|NCT01723254|542105059|FG005|Overall Study|No longer have time to participate|0|||
150264338|NCT01723254|542105060|FG006|Overall Study|No longer have time to participate|0|||
150264339|NCT01723254|542105061|FG007|Overall Study|No longer have time to participate|0|||
150264340|NCT01723254|542105054|FG000|Overall Study|Move/Left to another country/city|0|||
150264341|NCT01723254|542105055|FG001|Overall Study|Move/Left to another country/city|0|||
150264342|NCT01723254|542105056|FG002|Overall Study|Move/Left to another country/city|2|||
150264343|NCT01723254|542105057|FG003|Overall Study|Move/Left to another country/city|1|||
150264344|NCT01723254|542105058|FG004|Overall Study|Move/Left to another country/city|1|||
150264345|NCT01723254|542105059|FG005|Overall Study|Move/Left to another country/city|0|||
150264346|NCT01723254|542105060|FG006|Overall Study|Move/Left to another country/city|0|||
150264347|NCT01723254|542105061|FG007|Overall Study|Move/Left to another country/city|0|||
150264348|NCT01723254|542105054|FG000|Overall Study|Protocol Violation|0|||
150264349|NCT01723254|542105055|FG001|Overall Study|Protocol Violation|1|||
150264350|NCT01723254|542105056|FG002|Overall Study|Protocol Violation|0|||
150264351|NCT01723254|542105057|FG003|Overall Study|Protocol Violation|0|||
150264352|NCT01723254|542105058|FG004|Overall Study|Protocol Violation|0|||
150264353|NCT01723254|542105059|FG005|Overall Study|Protocol Violation|0|||
150264354|NCT01723254|542105060|FG006|Overall Study|Protocol Violation|0|||
150264355|NCT01723254|542105061|FG007|Overall Study|Protocol Violation|0|||
150264356|NCT01723254|542105054|FG000|Overall Study|Withdrawal by Subject|1|||
150264357|NCT01723254|542105055|FG001|Overall Study|Withdrawal by Subject|2|||
150264358|NCT01723254|542105056|FG002|Overall Study|Withdrawal by Subject|1|||
150264359|NCT01723254|542105057|FG003|Overall Study|Withdrawal by Subject|0|||
150264360|NCT01723254|542105058|FG004|Overall Study|Withdrawal by Subject|1|||
150264361|NCT01723254|542105059|FG005|Overall Study|Withdrawal by Subject|1|||
150264362|NCT01723254|542105060|FG006|Overall Study|Withdrawal by Subject|1|||
150264363|NCT01723254|542105061|FG007|Overall Study|Withdrawal by Subject|2|||
150264364|NCT04640077|542105065|FG000|Period 1|Withdrawal by Subject|4|||
150264365|NCT04640077|542105066|FG001|Period 1|Withdrawal by Subject|5|||
150264366|NCT04640077|542105067|FG002|Period 1|Withdrawal by Subject|0|||
150264367|NCT04640077|542105065|FG000|Period 1|Adverse Event|1|||
150264368|NCT04640077|542105066|FG001|Period 1|Adverse Event|1|||
150264369|NCT04640077|542105067|FG002|Period 1|Adverse Event|0|||
150264370|NCT04640077|542105065|FG000|Period 1|Screen Failure|2|||
150264371|NCT04640077|542105066|FG001|Period 1|Screen Failure|0|||
150264372|NCT04640077|542105067|FG002|Period 1|Screen Failure|0|||
150264373|NCT04640077|542105065|FG000|Period 2|Withdrawal by Subject|0|||
150264374|NCT04640077|542105066|FG001|Period 2|Withdrawal by Subject|0|||
150264375|NCT04640077|542105067|FG002|Period 2|Withdrawal by Subject|18|||
150264376|NCT04640077|542105065|FG000|Period 2|Adverse Event|0|||
150264377|NCT04640077|542105066|FG001|Period 2|Adverse Event|0|||
150264378|NCT04640077|542105067|FG002|Period 2|Adverse Event|6|||
150264379|NCT04640077|542105065|FG000|Period 2|Lost to Follow-up|0|||
150264380|NCT04640077|542105066|FG001|Period 2|Lost to Follow-up|0|||
150264381|NCT04640077|542105067|FG002|Period 2|Lost to Follow-up|2|||
150264382|NCT04640077|542105065|FG000|Period 2|Death|0|||
150264383|NCT04640077|542105066|FG001|Period 2|Death|0|||
150264384|NCT04640077|542105067|FG002|Period 2|Death|2|||
150264385|NCT04640077|542105065|FG000|Period 2|Progressive Disease|0|||
150264386|NCT04640077|542105066|FG001|Period 2|Progressive Disease|0|||
150264387|NCT04640077|542105067|FG002|Period 2|Progressive Disease|1|||
150264388|NCT04640077|542105065|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
150264389|NCT04640077|542105066|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
150264390|NCT04640077|542105067|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
150264391|NCT01257425|542105068|FG000|Overall Study|Lack of Efficacy|3|||
150264392|NCT01257425|542105069|FG001|Overall Study|Lack of Efficacy|3|||
150264393|NCT01257425|542105068|FG000|Overall Study|Adverse Event|1|||
150264394|NCT01257425|542105069|FG001|Overall Study|Adverse Event|1|||
150264395|NCT01257425|542105068|FG000|Overall Study|Protocol Violation|1|||
150264396|NCT01257425|542105069|FG001|Overall Study|Protocol Violation|1|||
150264397|NCT01257425|542105068|FG000|Overall Study|Withdrawal by Subject|0|||
150264398|NCT01257425|542105069|FG001|Overall Study|Withdrawal by Subject|1|||
150264399|NCT01257425|542105068|FG000|Overall Study|Death|1|||
150264400|NCT01257425|542105069|FG001|Overall Study|Death|0|||
150264401|NCT00368992|542105074|FG000|Overall Study|Ineligible|5|||
150264402|NCT00368992|542105074|FG000|Overall Study|Refused treatment|3|||
150264403|NCT00368992|542105074|FG000|Overall Study|Lack of Efficacy|63|||
150264404|NCT00368992|542105074|FG000|Overall Study|Adverse Event|26|||
150264405|NCT00368992|542105074|FG000|Overall Study|Death|4|||
150264406|NCT00368992|542105074|FG000|Overall Study|Other|9|||
150264407|NCT02668185|542105081|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
150264408|NCT02668185|542105082|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
150264409|NCT02668185|542105081|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
150264410|NCT02668185|542105082|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
149926961|NCT00481767|540867131|FG001|Overall Study|Lost to Follow-up|10|||
149926962|NCT01366638|540867132|FG000|Overall Study|Withdrawal by Subject|0|||
149926963|NCT01366638|540867133|FG001|Overall Study|Withdrawal by Subject|0|||
149926964|NCT01366638|540867134|FG002|Overall Study|Withdrawal by Subject|6|||
149926965|NCT01366638|540867132|FG000|Overall Study|Other|1|||
149926966|NCT01366638|540867133|FG001|Overall Study|Other|0|||
150264411|NCT02668185|542105081|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
150264412|NCT02668185|542105082|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
150264413|NCT02668185|542105081|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
150264414|NCT02668185|542105082|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
150264415|NCT01013597|542105083|FG000|Overall Study|Withdrawal by Subject|1|||
150264416|NCT00427895|542105084|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264417|NCT00427895|542105085|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264418|NCT00427895|542105086|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264419|NCT00427895|542105087|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
150264420|NCT00427895|542105088|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264421|NCT00427895|542105089|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264422|NCT00427895|542105090|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
150264423|NCT00427895|542105091|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149926967|NCT01366638|540867134|FG002|Overall Study|Other|0|||
149926968|NCT00636636|540867135|FG000|Overall Study|Other reason|4|||
149926969|NCT00636636|540867136|FG001|Overall Study|Other reason|6|||
149926970|NCT00636636|540867135|FG000|Overall Study|Adverse Event|19|||
149926971|NCT00636636|540867136|FG001|Overall Study|Adverse Event|8|||
149926972|NCT00636636|540867135|FG000|Overall Study|Lack of Efficacy|7|||
149926973|NCT00636636|540867136|FG001|Overall Study|Lack of Efficacy|12|||
149926974|NCT00636636|540867135|FG000|Overall Study|Protocol Violation|2|||
149926975|NCT00636636|540867136|FG001|Overall Study|Protocol Violation|2|||
149926976|NCT00636636|540867135|FG000|Overall Study|Lost to Follow-up|0|||
149926977|NCT00636636|540867136|FG001|Overall Study|Lost to Follow-up|1|||
149926978|NCT00636636|540867135|FG000|Overall Study|Death|0|||
149926979|NCT00636636|540867136|FG001|Overall Study|Death|1|||
149926980|NCT00636636|540867135|FG000|Overall Study|Withdrawal by Subject|4|||
149926981|NCT00636636|540867136|FG001|Overall Study|Withdrawal by Subject|9|||
149926982|NCT01237327|540867137|FG000|Overall Study|Protocol Violation: Core Study|1|||
150264424|NCT00427895|542105084|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264425|NCT00427895|542105085|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264426|NCT00427895|542105086|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264427|NCT00427895|542105087|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264428|NCT00427895|542105088|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264429|NCT00427895|542105089|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264430|NCT00427895|542105090|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
150264431|NCT00427895|542105091|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
150264432|NCT00427895|542105084|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264433|NCT00427895|542105085|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264434|NCT00427895|542105086|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264435|NCT00427895|542105087|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264436|NCT00427895|542105088|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264437|NCT00427895|542105089|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264438|NCT00427895|542105090|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
150264439|NCT00427895|542105091|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
150264440|NCT00427895|542105084|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
150264441|NCT00427895|542105085|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
150264442|NCT00427895|542105086|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
150264443|NCT00427895|542105087|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
150264444|NCT00427895|542105088|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
150264445|NCT00427895|542105089|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
150264446|NCT00427895|542105090|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
150264447|NCT00427895|542105091|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
150264448|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
150264449|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
150264450|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
150264451|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
150264452|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
150264453|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
150264454|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
150264455|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
150264456|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
150264457|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
150264458|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
150264459|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
150264460|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
150264461|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
150264462|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
150264463|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
150264464|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
150264465|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
150264466|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
150264467|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
150264468|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
150264469|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
150264470|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
150264471|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149926983|NCT01237327|540867138|FG001|Overall Study|Protocol Violation: Core Study|0|||
149926984|NCT01237327|540867137|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
149926985|NCT01237327|540867138|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
149926986|NCT01237327|540867137|FG000|Overall Study|Progression of Disease: Core Study|18|||
149926987|NCT01237327|540867138|FG001|Overall Study|Progression of Disease: Core Study|22|||
149926988|NCT01237327|540867137|FG000|Overall Study|Progression of Disease: Extension Study|15|||
150164283|NCT00603538|541735630|FG002|Overall Study|Objective progression or relapse|0|||
150164284|NCT05750745|541735631|FG000|Overall Study|Adverse Event|1|||
150164285|NCT05750745|541735632|FG001|Overall Study|Adverse Event|0|||
150164286|NCT05750745|541735633|FG002|Overall Study|Adverse Event|0|||
150164287|NCT05750745|541735631|FG000|Overall Study|Protocol Violation|1|||
150164288|NCT05750745|541735632|FG001|Overall Study|Protocol Violation|0|||
150164289|NCT05750745|541735633|FG002|Overall Study|Protocol Violation|0|||
150164290|NCT05750745|541735631|FG000|Overall Study|Withdrawal by Subject|0|||
150164291|NCT05750745|541735632|FG001|Overall Study|Withdrawal by Subject|1|||
150164292|NCT05750745|541735633|FG002|Overall Study|Withdrawal by Subject|0|||
150164293|NCT04794179|541735635|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
150164294|NCT04794179|541735636|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
150164295|NCT01096056|541735639|FG000|Overall Study|Lost to Follow-up|0|||
150164296|NCT01096056|541735640|FG001|Overall Study|Lost to Follow-up|1|||
150164297|NCT03568162|541735641|FG000|Overall Study|Adverse Event|0|||
150164298|NCT03568162|541735642|FG001|Overall Study|Adverse Event|1|||
150164299|NCT03568162|541735643|FG002|Overall Study|Adverse Event|2|||
150164300|NCT03568162|541735644|FG003|Overall Study|Adverse Event|0|||
150164301|NCT03568162|541735645|FG004|Overall Study|Adverse Event|0|||
150164302|NCT03568162|541735646|FG005|Overall Study|Adverse Event|1|||
150164303|NCT03568162|541735641|FG000|Overall Study|Death|0|||
150164304|NCT03568162|541735642|FG001|Overall Study|Death|0|||
150164305|NCT03568162|541735643|FG002|Overall Study|Death|0|||
150164306|NCT03568162|541735644|FG003|Overall Study|Death|0|||
150164307|NCT03568162|541735645|FG004|Overall Study|Death|1|||
150164308|NCT03568162|541735646|FG005|Overall Study|Death|0|||
150164309|NCT03568162|541735641|FG000|Overall Study|Lost to Follow-up|3|||
150164310|NCT03568162|541735642|FG001|Overall Study|Lost to Follow-up|2|||
150164311|NCT03568162|541735643|FG002|Overall Study|Lost to Follow-up|4|||
150164312|NCT03568162|541735644|FG003|Overall Study|Lost to Follow-up|2|||
150164313|NCT03568162|541735645|FG004|Overall Study|Lost to Follow-up|3|||
150164314|NCT03568162|541735646|FG005|Overall Study|Lost to Follow-up|2|||
150164315|NCT03568162|541735641|FG000|Overall Study|Physician Decision|0|||
150164316|NCT03568162|541735642|FG001|Overall Study|Physician Decision|1|||
150164317|NCT03568162|541735643|FG002|Overall Study|Physician Decision|1|||
150164318|NCT03568162|541735644|FG003|Overall Study|Physician Decision|0|||
150164319|NCT03568162|541735645|FG004|Overall Study|Physician Decision|1|||
150164320|NCT03568162|541735646|FG005|Overall Study|Physician Decision|0|||
150164321|NCT03568162|541735641|FG000|Overall Study|Pregnancy|0|||
150164322|NCT03568162|541735642|FG001|Overall Study|Pregnancy|0|||
150164323|NCT03568162|541735643|FG002|Overall Study|Pregnancy|0|||
150164324|NCT03568162|541735644|FG003|Overall Study|Pregnancy|1|||
150164325|NCT03568162|541735645|FG004|Overall Study|Pregnancy|0|||
150164326|NCT03568162|541735646|FG005|Overall Study|Pregnancy|0|||
150164327|NCT03568162|541735641|FG000|Overall Study|Protocol Violation|1|||
150164328|NCT03568162|541735642|FG001|Overall Study|Protocol Violation|0|||
150164329|NCT03568162|541735643|FG002|Overall Study|Protocol Violation|1|||
150164330|NCT03568162|541735644|FG003|Overall Study|Protocol Violation|1|||
150164331|NCT03568162|541735645|FG004|Overall Study|Protocol Violation|1|||
150164332|NCT03568162|541735646|FG005|Overall Study|Protocol Violation|1|||
150164333|NCT03568162|541735641|FG000|Overall Study|Withdrawal by Subject|15|||
150164334|NCT03568162|541735642|FG001|Overall Study|Withdrawal by Subject|15|||
150164335|NCT03568162|541735643|FG002|Overall Study|Withdrawal by Subject|26|||
150164336|NCT03568162|541735644|FG003|Overall Study|Withdrawal by Subject|22|||
150164337|NCT03568162|541735645|FG004|Overall Study|Withdrawal by Subject|6|||
150164338|NCT03568162|541735646|FG005|Overall Study|Withdrawal by Subject|9|||
150164339|NCT03568162|541735641|FG000|Overall Study|Others|3|||
150164340|NCT03568162|541735642|FG001|Overall Study|Others|4|||
150164341|NCT03568162|541735643|FG002|Overall Study|Others|1|||
150164342|NCT03568162|541735644|FG003|Overall Study|Others|4|||
150164343|NCT03568162|541735645|FG004|Overall Study|Others|2|||
150164344|NCT03568162|541735646|FG005|Overall Study|Others|1|||
150164345|NCT00768066|541735647|FG000|Overall Study|Did not receive study product injection.|3|||
150164346|NCT00768066|541735648|FG001|Overall Study|Did not receive study product injection.|3|||
150164347|NCT00768066|541735649|FG002|Overall Study|Did not receive study product injection.|0|||
150164348|NCT04831775|541735650|FG000|Overall Study|Lost to Follow-up|11|||
150164349|NCT04831775|541735651|FG001|Overall Study|Lost to Follow-up|13|||
150164350|NCT00337818|541735652|FG000|Overall Study|Lost to Follow-up|289|||
150164351|NCT00337818|541735653|FG001|Overall Study|Lost to Follow-up|91|||
150164352|NCT00337818|541735654|FG002|Overall Study|Lost to Follow-up|107|||
150164353|NCT03115346|541735657|FG000|Overall Study|Did not have AAA surgery|28|||
150164354|NCT03115346|541735658|FG001|Overall Study|Did not have AAA surgery|15|||
150164355|NCT03115346|541735657|FG000|Overall Study|Death|3|||
150164356|NCT03115346|541735658|FG001|Overall Study|Death|1|||
150164357|NCT03115346|541735657|FG000|Overall Study|Withdrawal by Subject|0|||
150164358|NCT03115346|541735658|FG001|Overall Study|Withdrawal by Subject|3|||
150164359|NCT03115346|541735657|FG000|Overall Study|Lost to Follow-up|0|||
150164360|NCT03115346|541735658|FG001|Overall Study|Lost to Follow-up|3|||
150164361|NCT03590743|541735659|FG000|Overall Study|Withdrawal by Subject|0|||
150164362|NCT03590743|541735660|FG001|Overall Study|Withdrawal by Subject|1|||
149926989|NCT01237327|540867138|FG001|Overall Study|Progression of Disease: Extension Study|13|||
149926990|NCT01237327|540867137|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
149926991|NCT01237327|540867138|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
149926992|NCT01237327|540867137|FG000|Overall Study|Withdrawal by Subject|1|||
149926993|NCT01237327|540867138|FG001|Overall Study|Withdrawal by Subject|3|||
149926994|NCT01237327|540867137|FG000|Overall Study|Lost to Follow-up|3|||
149926995|NCT01237327|540867138|FG001|Overall Study|Lost to Follow-up|0|||
149926996|NCT00524173|540867139|FG000|Overall Study|Lost to Follow-up|0|||
149926997|NCT00524173|540867140|FG001|Overall Study|Lost to Follow-up|1|||
149926998|NCT00524173|540867139|FG000|Overall Study|Death|1|||
149926999|NCT00524173|540867140|FG001|Overall Study|Death|0|||
149927000|NCT00524173|540867139|FG000|Overall Study|Had not reached endpoint at study close|4|||
149927001|NCT00524173|540867140|FG001|Overall Study|Had not reached endpoint at study close|1|||
149927002|NCT02557516|540867143|FG000|Overall Study|Adverse Event|1|||
149927003|NCT02557516|540867144|FG001|Overall Study|Adverse Event|0|||
149927004|NCT02557516|540867145|FG002|Overall Study|Adverse Event|2|||
149927005|NCT02557516|540867146|FG003|Overall Study|Adverse Event|1|||
149927006|NCT02557516|540867143|FG000|Overall Study|Disease progression|0|||
149927007|NCT02557516|540867144|FG001|Overall Study|Disease progression|2|||
149927008|NCT02557516|540867145|FG002|Overall Study|Disease progression|0|||
149927009|NCT02557516|540867146|FG003|Overall Study|Disease progression|0|||
149927010|NCT02557516|540867143|FG000|Overall Study|Physician Decision|0|||
149927011|NCT02557516|540867144|FG001|Overall Study|Physician Decision|2|||
149927012|NCT02557516|540867145|FG002|Overall Study|Physician Decision|0|||
149927013|NCT02557516|540867146|FG003|Overall Study|Physician Decision|0|||
149927014|NCT02557516|540867143|FG000|Overall Study|Sponsor decision|0|||
149927015|NCT02557516|540867144|FG001|Overall Study|Sponsor decision|1|||
149927016|NCT02557516|540867145|FG002|Overall Study|Sponsor decision|2|||
149927017|NCT02557516|540867146|FG003|Overall Study|Sponsor decision|8|||
149927018|NCT00669318|540868862|FG000|Overall Study|Withdrawal by Subject|2|||
149927019|NCT00327340|540868867|FG000|Overall Study|Withdrawal by Subject|1|||
149927020|NCT00327340|540868868|FG001|Overall Study|Withdrawal by Subject|5|||
149927021|NCT00327340|540868867|FG000|Overall Study|Physician Decision|1|||
149927022|NCT00327340|540868868|FG001|Overall Study|Physician Decision|1|||
149927023|NCT00327340|540868867|FG000|Overall Study|Disease Progression|10|||
149927024|NCT00327340|540868868|FG001|Overall Study|Disease Progression|19|||
149927025|NCT00327340|540868867|FG000|Overall Study|Symptomatic Disease|0|||
149927026|NCT00327340|540868868|FG001|Overall Study|Symptomatic Disease|2|||
149927027|NCT00327340|540868867|FG000|Overall Study|Adverse Event|3|||
149927028|NCT00327340|540868868|FG001|Overall Study|Adverse Event|3|||
150164363|NCT00725010|541735666|FG000|Overall Study|Toxicity|9|||
150164364|NCT00725010|541735666|FG000|Overall Study|Tumor Progression|7|||
150164365|NCT00725010|541735666|FG000|Overall Study|Withdrawal by Subject|2|||
150164366|NCT00725010|541735666|FG000|Overall Study|Death|1|||
150164367|NCT00725010|541735666|FG000|Overall Study|Lost to Follow-up|1|||
150164368|NCT00725010|541735666|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
150164369|NCT00725010|541735666|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
150164370|NCT00725010|541735666|FG000|Overall Study|No further documentation|1|||
150164371|NCT00725010|541735666|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
150164372|NCT03499600|541735667|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
150164373|NCT03499600|541735668|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
150164374|NCT02414828|541735669|FG000|Overall Study|Lost to Follow-up|0|||
150164375|NCT02414828|541735670|FG001|Overall Study|Lost to Follow-up|1|||
150164376|NCT02414828|541735671|FG002|Overall Study|Lost to Follow-up|1|||
150164377|NCT02414828|541735672|FG003|Overall Study|Lost to Follow-up|2|||
150164378|NCT00389519|541735677|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
150164379|NCT00389519|541735678|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
150164380|NCT00389519|541735679|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
150164381|NCT00389519|541735680|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
150164382|NCT00389519|541735677|FG000|Placebo Run-In|Withdrawal by Subject|19|||
150164383|NCT00389519|541735678|FG001|Placebo Run-In|Withdrawal by Subject|0|||
150164384|NCT00389519|541735679|FG002|Placebo Run-In|Withdrawal by Subject|0|||
150164385|NCT00389519|541735680|FG003|Placebo Run-In|Withdrawal by Subject|0|||
149927029|NCT04085601|540868869|FG000|Overall Study|Lost to Follow-up|1|||
149927030|NCT04085601|540868870|FG001|Overall Study|Lost to Follow-up|0|||
149927031|NCT04085601|540868869|FG000|Overall Study|Death|1|||
149927032|NCT04085601|540868870|FG001|Overall Study|Death|1|||
150164386|NCT00389519|541735677|FG000|Placebo Run-In|Reason not specified|40|||
149927033|NCT00003483|540868872|FG000|Overall Study|Not evaluable|1|||
149927034|NCT01716663|540868873|FG000|Overall Study|Withdrawn prior to procedure|4|||
149927035|NCT01716663|540868873|FG000|Overall Study|Treated with non-study catheter|2|||
149927036|NCT01300247|540868877|FG000|Overall Study|Death|1|||
149927037|NCT01300247|540868878|FG001|Overall Study|Death|1|||
149927038|NCT01300247|540868877|FG000|Overall Study|Lost to Follow-up|2|||
149927039|NCT01300247|540868878|FG001|Overall Study|Lost to Follow-up|0|||
149927040|NCT01300247|540868877|FG000|Overall Study|Withdrawal by Subject|1|||
149927041|NCT01300247|540868878|FG001|Overall Study|Withdrawal by Subject|0|||
149927042|NCT01300247|540868877|FG000|Overall Study|Non-Compliance|0|||
149927043|NCT01300247|540868878|FG001|Overall Study|Non-Compliance|1|||
149927044|NCT00922116|540868879|FG000|Overall Study|Adverse Event|4|||
149927045|NCT00922116|540868879|FG000|Overall Study|Death|1|||
149927046|NCT00922116|540868879|FG000|Overall Study|Lost to Follow-up|1|||
149927047|NCT00922116|540868879|FG000|Overall Study|Withdrawal by Subject|4|||
149927048|NCT00922116|540868879|FG000|Overall Study|Other|5|||
149927049|NCT06060496|540868880|FG000|Overall Study|Withdrawal by Subject|2|||
149927050|NCT06060496|540868880|FG000|Overall Study|Lost to Follow-up|2|||
149927051|NCT02028507|540868881|FG000|Overall Study|Progressive Disease|122|||
149927052|NCT02028507|540868882|FG001|Overall Study|Progressive Disease|90|||
149927053|NCT02028507|540868883|FG002|Overall Study|Progressive Disease|102|||
149927054|NCT02028507|540868884|FG003|Overall Study|Progressive Disease|89|||
149927055|NCT02028507|540868881|FG000|Overall Study|Adverse Event|8|||
149927056|NCT02028507|540868882|FG001|Overall Study|Adverse Event|25|||
149927057|NCT02028507|540868883|FG002|Overall Study|Adverse Event|3|||
150164387|NCT00389519|541735678|FG001|Placebo Run-In|Reason not specified|0|||
150164388|NCT00389519|541735679|FG002|Placebo Run-In|Reason not specified|0|||
150164389|NCT00389519|541735680|FG003|Placebo Run-In|Reason not specified|0|||
150164390|NCT00389519|541735677|FG000|Randomized|Did not receive study drug|2|||
150164391|NCT00389519|541735678|FG001|Randomized|Did not receive study drug|0|||
150164392|NCT00389519|541735679|FG002|Randomized|Did not receive study drug|0|||
150164393|NCT00389519|541735680|FG003|Randomized|Did not receive study drug|0|||
150164394|NCT00389519|541735677|FG000|Treated|Adverse Event|1|||
150164395|NCT00389519|541735678|FG001|Treated|Adverse Event|0|||
150164396|NCT00389519|541735679|FG002|Treated|Adverse Event|0|||
150164397|NCT00389519|541735680|FG003|Treated|Adverse Event|2|||
150164398|NCT00389519|541735677|FG000|Treated|Reason not specified|1|||
150164399|NCT00389519|541735678|FG001|Treated|Reason not specified|1|||
150164400|NCT00389519|541735679|FG002|Treated|Reason not specified|0|||
150164401|NCT00389519|541735680|FG003|Treated|Reason not specified|2|||
150164402|NCT03425539|541735681|FG000|Overall Study|Randomized but not treated|0|||
150164403|NCT03425539|541735682|FG001|Overall Study|Randomized but not treated|1|||
150164404|NCT03425539|541735681|FG000|Overall Study|Adverse Event|2|||
150164405|NCT03425539|541735682|FG001|Overall Study|Adverse Event|2|||
150164406|NCT03425539|541735681|FG000|Overall Study|Withdrawal by Subject|3|||
150164407|NCT03425539|541735682|FG001|Overall Study|Withdrawal by Subject|0|||
150164408|NCT03425539|541735681|FG000|Overall Study|Lost to Follow-up|0|||
150164409|NCT03425539|541735682|FG001|Overall Study|Lost to Follow-up|1|||
150164410|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
150164411|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
150164412|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
150164413|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
150164414|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
150164415|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
150164416|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
150164417|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
150164418|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Death|1|||
150164419|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Death|0|||
150164420|NCT01080131|541735683|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
150164421|NCT01080131|541735684|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
150164422|NCT01080131|541735683|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
150164423|NCT01080131|541735684|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
150164424|NCT01080131|541735683|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
150164425|NCT01080131|541735684|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
150164426|NCT01080131|541735683|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
150164427|NCT01080131|541735684|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
150164428|NCT01080131|541735683|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
150164429|NCT01080131|541735684|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
150164430|NCT01080131|541735683|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
150164431|NCT01080131|541735684|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
150164432|NCT01080131|541735683|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
150164433|NCT01080131|541735684|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
150164434|NCT01080131|541735683|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
150164435|NCT01080131|541735684|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
150164436|NCT00299702|541735687|FG000|Overall Study|Death|1|||
150164437|NCT00299702|541735688|FG001|Overall Study|Death|0|||
150164438|NCT00299702|541735687|FG000|Overall Study|Adverse Event|0|||
149927058|NCT02028507|540868884|FG003|Overall Study|Adverse Event|16|||
150164439|NCT00299702|541735688|FG001|Overall Study|Adverse Event|4|||
150164440|NCT00299702|541735687|FG000|Overall Study|Lost to Follow-up|18|||
150164441|NCT00299702|541735688|FG001|Overall Study|Lost to Follow-up|10|||
150164442|NCT00299702|541735687|FG000|Overall Study|Withdrawal by Subject|25|||
149927059|NCT02028507|540868881|FG000|Overall Study|Withdrawal by Subject|6|||
150264472|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
150264473|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
150264474|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
150264475|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
150264476|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
150264477|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
150264478|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
150264479|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
150264480|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264481|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264482|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264483|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
150264484|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264485|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264486|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264487|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
150264488|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
150264489|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
150264490|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
150264491|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
150264492|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
150264493|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
150264494|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
150264495|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
150264496|NCT00427895|542105084|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264497|NCT00427895|542105085|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264498|NCT00427895|542105086|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
150264499|NCT00427895|542105087|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
150264500|NCT00427895|542105088|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264501|NCT00427895|542105089|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264502|NCT00427895|542105090|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264503|NCT00427895|542105091|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
150264504|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
150264505|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
150264506|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
150264507|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
150264508|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
150264509|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
150264510|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
150264511|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
150264512|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
150264513|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
150264514|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
150264515|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
150264516|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
150264517|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
150264518|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
150264519|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
150264520|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
150264521|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
150264522|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
150264523|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
150264524|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
150264525|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
150264526|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
150264527|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
150264528|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264529|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
150264530|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264531|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264532|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149927060|NCT02028507|540868882|FG001|Overall Study|Withdrawal by Subject|8|||
149927061|NCT02028507|540868883|FG002|Overall Study|Withdrawal by Subject|5|||
149927062|NCT02028507|540868884|FG003|Overall Study|Withdrawal by Subject|9|||
149927063|NCT02028507|540868881|FG000|Overall Study|Protocol Violation|2|||
150264533|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264534|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264535|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
150264536|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Death|1|||
150264537|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Death|0|||
150264538|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Death|0|||
150264539|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Death|0|||
150264540|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Death|0|||
150264541|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Death|0|||
150264542|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Death|0|||
150264543|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Death|0|||
150264544|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264545|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264546|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
150264547|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
150264548|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264549|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264550|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264551|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
150264552|NCT00427895|542105084|FG000|Vax 1/Year 1 Follow-up|Other|0|||
150264553|NCT00427895|542105085|FG001|Vax 1/Year 1 Follow-up|Other|0|||
150264554|NCT00427895|542105086|FG002|Vax 1/Year 1 Follow-up|Other|0|||
150264555|NCT00427895|542105087|FG003|Vax 1/Year 1 Follow-up|Other|2|||
150264556|NCT00427895|542105088|FG004|Vax 1/Year 1 Follow-up|Other|0|||
150264557|NCT00427895|542105089|FG005|Vax 1/Year 1 Follow-up|Other|0|||
150264558|NCT00427895|542105090|FG006|Vax 1/Year 1 Follow-up|Other|0|||
150264559|NCT00427895|542105091|FG007|Vax 1/Year 1 Follow-up|Other|0|||
150264560|NCT00427895|542105084|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
150264561|NCT00427895|542105085|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
150264562|NCT00427895|542105086|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
150264563|NCT00427895|542105087|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
150264564|NCT00427895|542105088|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
150264565|NCT00427895|542105089|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
150264566|NCT00427895|542105090|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
150264567|NCT00427895|542105091|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
150264568|NCT00585195|542105093|FG000|Overall Study|Adverse Event|0|||
150264569|NCT00585195|542105094|FG001|Overall Study|Adverse Event|0|||
150264570|NCT00585195|542105095|FG002|Overall Study|Adverse Event|0|||
150264571|NCT00585195|542105096|FG003|Overall Study|Adverse Event|0|||
150264572|NCT00585195|542105097|FG004|Overall Study|Adverse Event|2|||
150264573|NCT00585195|542105098|FG005|Overall Study|Adverse Event|1|||
150264574|NCT00585195|542105099|FG006|Overall Study|Adverse Event|0|||
150264575|NCT00585195|542105100|FG007|Overall Study|Adverse Event|1|||
150264576|NCT00585195|542105101|FG008|Overall Study|Adverse Event|0|||
150264577|NCT00585195|542105102|FG009|Overall Study|Adverse Event|0|||
150264578|NCT00585195|542105103|FG010|Overall Study|Adverse Event|3|||
150264579|NCT00585195|542105104|FG011|Overall Study|Adverse Event|0|||
150264580|NCT00585195|542105105|FG012|Overall Study|Adverse Event|8|||
150264581|NCT00585195|542105106|FG013|Overall Study|Adverse Event|6|||
150264582|NCT00585195|542105107|FG014|Overall Study|Adverse Event|4|||
150264583|NCT00585195|542105108|FG015|Overall Study|Adverse Event|1|||
150264584|NCT00585195|542105109|FG016|Overall Study|Adverse Event|14|||
150264585|NCT00585195|542105110|FG017|Overall Study|Adverse Event|9|||
150264586|NCT00585195|542105111|FG018|Overall Study|Adverse Event|2|||
150264587|NCT00585195|542105112|FG019|Overall Study|Adverse Event|3|||
150264588|NCT00585195|542105113|FG020|Overall Study|Adverse Event|1|||
150264589|NCT00585195|542105093|FG000|Overall Study|Progressive Disease|2|||
150264590|NCT00585195|542105094|FG001|Overall Study|Progressive Disease|2|||
150264591|NCT00585195|542105095|FG002|Overall Study|Progressive Disease|5|||
150264592|NCT00585195|542105096|FG003|Overall Study|Progressive Disease|4|||
150264593|NCT00585195|542105097|FG004|Overall Study|Progressive Disease|6|||
150264594|NCT00585195|542105098|FG005|Overall Study|Progressive Disease|4|||
150264595|NCT00585195|542105099|FG006|Overall Study|Progressive Disease|6|||
150264596|NCT00585195|542105100|FG007|Overall Study|Progressive Disease|3|||
150264597|NCT00585195|542105101|FG008|Overall Study|Progressive Disease|0|||
150264598|NCT00585195|542105102|FG009|Overall Study|Progressive Disease|5|||
150264599|NCT00585195|542105103|FG010|Overall Study|Progressive Disease|2|||
150264600|NCT00585195|542105104|FG011|Overall Study|Progressive Disease|25|||
150264601|NCT00585195|542105105|FG012|Overall Study|Progressive Disease|29|||
150264602|NCT00585195|542105106|FG013|Overall Study|Progressive Disease|26|||
149819227|NCT03634488|540467250|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
150264603|NCT00585195|542105107|FG014|Overall Study|Progressive Disease|21|||
150264604|NCT00585195|542105108|FG015|Overall Study|Progressive Disease|12|||
150264605|NCT00585195|542105109|FG016|Overall Study|Progressive Disease|94|||
150264606|NCT00585195|542105110|FG017|Overall Study|Progressive Disease|42|||
149819228|NCT03182686|540467251|FG000|Overall Study|Lost to Follow-up|2|||
150264607|NCT00585195|542105111|FG018|Overall Study|Progressive Disease|4|||
150264608|NCT00585195|542105112|FG019|Overall Study|Progressive Disease|9|||
150264609|NCT00585195|542105113|FG020|Overall Study|Progressive Disease|8|||
150264610|NCT00585195|542105093|FG000|Overall Study|Withdrawal by Subject|1|||
150264611|NCT00585195|542105094|FG001|Overall Study|Withdrawal by Subject|1|||
150264612|NCT00585195|542105095|FG002|Overall Study|Withdrawal by Subject|2|||
149927064|NCT02028507|540868882|FG001|Overall Study|Protocol Violation|4|||
149927065|NCT02028507|540868883|FG002|Overall Study|Protocol Violation|1|||
149927066|NCT02028507|540868884|FG003|Overall Study|Protocol Violation|3|||
149927067|NCT02028507|540868881|FG000|Overall Study|Physician Decision|0|||
149927068|NCT02028507|540868882|FG001|Overall Study|Physician Decision|4|||
149927069|NCT02028507|540868883|FG002|Overall Study|Physician Decision|0|||
149927070|NCT02028507|540868884|FG003|Overall Study|Physician Decision|0|||
149927071|NCT02028507|540868881|FG000|Overall Study|Death|1|||
149927072|NCT02028507|540868882|FG001|Overall Study|Death|0|||
149927073|NCT02028507|540868883|FG002|Overall Study|Death|1|||
149927074|NCT02028507|540868884|FG003|Overall Study|Death|3|||
149927075|NCT02028507|540868881|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
149927076|NCT02028507|540868882|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
149927077|NCT02028507|540868883|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
149927078|NCT02028507|540868884|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
149927079|NCT02028507|540868881|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
149927080|NCT02028507|540868882|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
149927081|NCT02028507|540868883|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
149927082|NCT02028507|540868884|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
149927083|NCT02028507|540868881|FG000|Overall Study|Randomized But Not Treated|3|||
149927084|NCT02028507|540868882|FG001|Overall Study|Randomized But Not Treated|6|||
149927085|NCT02028507|540868883|FG002|Overall Study|Randomized But Not Treated|0|||
149927086|NCT02028507|540868884|FG003|Overall Study|Randomized But Not Treated|4|||
150164443|NCT00299702|541735688|FG001|Overall Study|Withdrawal by Subject|23|||
150164444|NCT00299702|541735687|FG000|Overall Study|Pregnancy|0|||
150164445|NCT00299702|541735688|FG001|Overall Study|Pregnancy|1|||
150164446|NCT00299702|541735687|FG000|Overall Study|Insufficient Response|4|||
150164447|NCT00299702|541735688|FG001|Overall Study|Insufficient Response|3|||
150164448|NCT00299702|541735687|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
150164449|NCT00299702|541735688|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
150164450|NCT01560949|541735689|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
150164451|NCT01560949|541735689|FG000|Surgery Phase|Physician Decision|3|||
150164452|NCT00751036|541735690|FG000|Overall Study|Disease Progression|28|||
150164453|NCT00751036|541735691|FG001|Overall Study|Disease Progression|29|||
150164454|NCT00751036|541735690|FG000|Overall Study|Adverse Event|6|||
150164455|NCT00751036|541735691|FG001|Overall Study|Adverse Event|4|||
150164456|NCT00751036|541735690|FG000|Overall Study|Administrative Problems|3|||
150164457|NCT00751036|541735691|FG001|Overall Study|Administrative Problems|4|||
150164458|NCT00751036|541735690|FG000|Overall Study|Withdrawal by Subject|5|||
150164459|NCT00751036|541735691|FG001|Overall Study|Withdrawal by Subject|2|||
150164460|NCT00751036|541735690|FG000|Overall Study|Death|3|||
150164461|NCT00751036|541735691|FG001|Overall Study|Death|3|||
150164462|NCT00751036|541735690|FG000|Overall Study|Lost to Follow-up|0|||
150164463|NCT00751036|541735691|FG001|Overall Study|Lost to Follow-up|1|||
150164464|NCT00751036|541735690|FG000|Overall Study|Protocol Violation|1|||
150164465|NCT00751036|541735691|FG001|Overall Study|Protocol Violation|0|||
150164466|NCT00751036|541735690|FG000|Overall Study|Missing end of Treatment Page|2|||
150164467|NCT00751036|541735691|FG001|Overall Study|Missing end of Treatment Page|3|||
150164468|NCT04580407|541735692|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
150164469|NCT04155424|541735703|FG000|Overall Study|Other than specified|3|||
150164470|NCT04155424|541735703|FG000|Overall Study|Withdrawal by Subject|1|||
150164471|NCT04155424|541735703|FG000|Overall Study|Adverse Event|1|||
150164472|NCT04867902|541737366|FG000|Overall Study|Lost to Follow-up|1|||
150164473|NCT04867902|541737366|FG000|Overall Study|Withdrawal by Subject|2|||
150164474|NCT04867902|541737366|FG000|Overall Study|Protocol Violation|1|||
150164475|NCT02501629|541737367|FG000|Overall Study|Death|0|||
150164476|NCT02501629|541737368|FG001|Overall Study|Death|1|||
150164477|NCT02501629|541737367|FG000|Overall Study|Withdrawn from study by sponsor|1|||
150164478|NCT02501629|541737368|FG001|Overall Study|Withdrawn from study by sponsor|0|||
150164479|NCT02501629|541737367|FG000|Overall Study|Early termination by sponsor|1|||
150164480|NCT02501629|541737368|FG001|Overall Study|Early termination by sponsor|0|||
150164481|NCT02501629|541737367|FG000|Overall Study|Withdrawal by Subject|3|||
150164482|NCT02501629|541737368|FG001|Overall Study|Withdrawal by Subject|5|||
150164483|NCT02501629|541737367|FG000|Overall Study|Subject did not return to site|0|||
150164484|NCT02501629|541737368|FG001|Overall Study|Subject did not return to site|1|||
150164485|NCT03120676|541737371|FG000|Overall Study|Not treated|1|||
150164486|NCT00886613|541737372|FG000|Overall Study|Protocol deviation (Part B)|1|||
150164487|NCT00886613|541737373|FG001|Overall Study|Protocol deviation (Part B)|0|||
150164488|NCT00886613|541737374|FG002|Overall Study|Protocol deviation (Part B)|0|||
150264613|NCT00585195|542105096|FG003|Overall Study|Withdrawal by Subject|2|||
149927087|NCT02028507|540868881|FG000|Overall Study|Enzyme defect|0|||
150164489|NCT00886613|541737372|FG000|Overall Study|Lost to follow-up (Part B)|1|||
150164490|NCT00886613|541737373|FG001|Overall Study|Lost to follow-up (Part B)|0|||
149927088|NCT02028507|540868882|FG001|Overall Study|Enzyme defect|0|||
149927089|NCT02028507|540868883|FG002|Overall Study|Enzyme defect|0|||
149927090|NCT02028507|540868884|FG003|Overall Study|Enzyme defect|1|||
150164491|NCT00886613|541737374|FG002|Overall Study|Lost to follow-up (Part B)|1|||
150164492|NCT00886613|541737372|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
150164493|NCT00886613|541737373|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
150164494|NCT00886613|541737374|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
150164495|NCT04577183|541737376|FG000|Overall Study|Death|1|||
150164496|NCT04577183|541737376|FG000|Overall Study|Withdrawal by Subject|3|||
150164497|NCT04577183|541737376|FG000|Overall Study|Early termination|2|||
150164498|NCT02072226|541737380|FG000|Overall Study|Lost to Follow-up|11|||
150164499|NCT02072226|541737381|FG001|Overall Study|Lost to Follow-up|7|||
150164500|NCT02072226|541737380|FG000|Overall Study|Patient Non-compliance|2|||
150164501|NCT02072226|541737381|FG001|Overall Study|Patient Non-compliance|3|||
150164502|NCT02072226|541737380|FG000|Overall Study|Death|1|||
150164503|NCT02072226|541737381|FG001|Overall Study|Death|0|||
150164504|NCT02072226|541737380|FG000|Overall Study|Patient Withdrawal of Consent|1|||
150164505|NCT02072226|541737381|FG001|Overall Study|Patient Withdrawal of Consent|0|||
150164506|NCT03255018|541737383|FG000|Overall Study|Death on study|0|||
150164507|NCT03255018|541737384|FG001|Overall Study|Death on study|5|||
150164508|NCT03255018|541737383|FG000|Overall Study|Withdrawal by Subject|0|||
150164509|NCT03255018|541737384|FG001|Overall Study|Withdrawal by Subject|2|||
150164510|NCT01720043|541737386|FG000|Overall Study|Withdrawal by Subject|1|||
150164511|NCT01688973|541737387|FG000|Overall Study|Ineligible|2|||
150164512|NCT01688973|541737388|FG001|Overall Study|Ineligible|3|||
150164513|NCT01124162|541737391|FG000|First Intervention|Adverse Event|2|||
150164514|NCT01124162|541737392|FG001|First Intervention|Adverse Event|0|||
150164515|NCT01124162|541737391|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
150164516|NCT01124162|541737392|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
150164517|NCT03613129|541737400|FG000|Pre-treatment Assessment|Protocol Violation|2|||
150164518|NCT03613129|541737401|FG001|Pre-treatment Assessment|Protocol Violation|0|||
150164519|NCT03613129|541737402|FG002|Pre-treatment Assessment|Protocol Violation|0|||
150164520|NCT03613129|541737403|FG003|Pre-treatment Assessment|Protocol Violation|0|||
150164521|NCT03613129|541737404|FG004|Pre-treatment Assessment|Protocol Violation|0|||
150164522|NCT03613129|541737400|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
150164523|NCT03613129|541737401|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
150164524|NCT03613129|541737402|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
150164525|NCT03613129|541737403|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
150164526|NCT03613129|541737404|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
150164527|NCT00938340|541737405|FG000|Overall Study|Withdrawal by Subject|3|||
150164528|NCT00938340|541737405|FG000|Overall Study|Protocol Violation|1|||
150164529|NCT00938340|541737405|FG000|Overall Study|Adverse Event|1|||
150164530|NCT02534896|541737408|FG000|Overall Study|Adverse Event|2|||
150164531|NCT02534896|541737409|FG001|Overall Study|Adverse Event|1|||
150164532|NCT02534896|541737410|FG002|Overall Study|Adverse Event|1|||
150164533|NCT02534896|541737408|FG000|Overall Study|Insufficient therapeutic response|2|||
150164534|NCT02534896|541737409|FG001|Overall Study|Insufficient therapeutic response|0|||
150164535|NCT02534896|541737410|FG002|Overall Study|Insufficient therapeutic response|0|||
150164536|NCT00711646|541737411|FG000|Overall Study|Adverse Event|6|||
150164537|NCT00711646|541737412|FG001|Overall Study|Adverse Event|1|||
150164538|NCT00711646|541737411|FG000|Overall Study|Withdrawal by Subject|4|||
150164539|NCT00711646|541737412|FG001|Overall Study|Withdrawal by Subject|0|||
150164540|NCT00711646|541737411|FG000|Overall Study|Protocol Violation|0|||
150164541|NCT00711646|541737412|FG001|Overall Study|Protocol Violation|1|||
150164542|NCT00711646|541737411|FG000|Overall Study|Lost to Follow-up|1|||
150164543|NCT00711646|541737412|FG001|Overall Study|Lost to Follow-up|0|||
150164544|NCT00711646|541737411|FG000|Overall Study|administrative decision|0|||
150164545|NCT00711646|541737412|FG001|Overall Study|administrative decision|1|||
150164546|NCT00711646|541737411|FG000|Overall Study|patient non-compliance|1|||
150164547|NCT00711646|541737412|FG001|Overall Study|patient non-compliance|0|||
150164548|NCT04381494|541737413|FG000|Overall Study|Early termination of trial|19|||
150164549|NCT04381494|541737413|FG000|Overall Study|Investigator's discretion|1|||
150164550|NCT04381494|541737413|FG000|Overall Study|Withdrawal by Subject|9|||
150164551|NCT04381494|541737413|FG000|Overall Study|NSCLC disease progression|4|||
150164552|NCT04381494|541737413|FG000|Overall Study|Device-Related Adverse Event|2|||
150164553|NCT03441360|541737414|FG000|Overall Study|Radiological disease progression|5|||
150164554|NCT03441360|541737415|FG001|Overall Study|Radiological disease progression|6|||
150164555|NCT03441360|541737416|FG002|Overall Study|Radiological disease progression|4|||
150164556|NCT03441360|541737414|FG000|Overall Study|Clinical disease progression|2|||
150164557|NCT03441360|541737415|FG001|Overall Study|Clinical disease progression|2|||
150164558|NCT03441360|541737416|FG002|Overall Study|Clinical disease progression|0|||
150164559|NCT03441360|541737414|FG000|Overall Study|Adverse Event|1|||
149819229|NCT03182686|540467252|FG001|Overall Study|Lost to Follow-up|0|||
150164560|NCT03441360|541737415|FG001|Overall Study|Adverse Event|0|||
150164561|NCT03441360|541737416|FG002|Overall Study|Adverse Event|1|||
150164562|NCT00269399|541737417|FG000|Overall Study|Lack of Efficacy|27|||
149819230|NCT03182686|540467251|FG000|Overall Study|Adverse Event|2|||
149819231|NCT03182686|540467252|FG001|Overall Study|Adverse Event|0|||
149819232|NCT03182686|540467251|FG000|Overall Study|Withdrawal by Subject|3|||
150264614|NCT00585195|542105097|FG004|Overall Study|Withdrawal by Subject|0|||
150264615|NCT00585195|542105098|FG005|Overall Study|Withdrawal by Subject|0|||
150264616|NCT00585195|542105099|FG006|Overall Study|Withdrawal by Subject|0|||
150264617|NCT00585195|542105100|FG007|Overall Study|Withdrawal by Subject|1|||
150264618|NCT00585195|542105101|FG008|Overall Study|Withdrawal by Subject|0|||
150264619|NCT00585195|542105102|FG009|Overall Study|Withdrawal by Subject|0|||
150264620|NCT00585195|542105103|FG010|Overall Study|Withdrawal by Subject|3|||
150264621|NCT00585195|542105104|FG011|Overall Study|Withdrawal by Subject|8|||
150264622|NCT00585195|542105105|FG012|Overall Study|Withdrawal by Subject|15|||
150264623|NCT00585195|542105106|FG013|Overall Study|Withdrawal by Subject|0|||
150264624|NCT00585195|542105107|FG014|Overall Study|Withdrawal by Subject|3|||
150264625|NCT00585195|542105108|FG015|Overall Study|Withdrawal by Subject|0|||
150264626|NCT00585195|542105109|FG016|Overall Study|Withdrawal by Subject|7|||
150264627|NCT00585195|542105110|FG017|Overall Study|Withdrawal by Subject|1|||
150264628|NCT00585195|542105111|FG018|Overall Study|Withdrawal by Subject|2|||
150264629|NCT00585195|542105112|FG019|Overall Study|Withdrawal by Subject|2|||
150264630|NCT00585195|542105113|FG020|Overall Study|Withdrawal by Subject|0|||
150264631|NCT00585195|542105093|FG000|Overall Study|Other|0|||
150264632|NCT00585195|542105094|FG001|Overall Study|Other|1|||
150264633|NCT00585195|542105095|FG002|Overall Study|Other|1|||
150264634|NCT00585195|542105096|FG003|Overall Study|Other|1|||
150264635|NCT00585195|542105097|FG004|Overall Study|Other|0|||
150264636|NCT00585195|542105098|FG005|Overall Study|Other|1|||
150264637|NCT00585195|542105099|FG006|Overall Study|Other|0|||
150264638|NCT00585195|542105100|FG007|Overall Study|Other|0|||
150264639|NCT00585195|542105101|FG008|Overall Study|Other|2|||
150264640|NCT00585195|542105102|FG009|Overall Study|Other|1|||
150264641|NCT00585195|542105103|FG010|Overall Study|Other|0|||
150264642|NCT00585195|542105104|FG011|Overall Study|Other|19|||
150264643|NCT00585195|542105105|FG012|Overall Study|Other|24|||
150264644|NCT00585195|542105106|FG013|Overall Study|Other|7|||
150264645|NCT00585195|542105107|FG014|Overall Study|Other|11|||
150264646|NCT00585195|542105108|FG015|Overall Study|Other|3|||
150264647|NCT00585195|542105109|FG016|Overall Study|Other|28|||
150264648|NCT00585195|542105110|FG017|Overall Study|Other|12|||
150264649|NCT00585195|542105111|FG018|Overall Study|Other|10|||
150264650|NCT00585195|542105112|FG019|Overall Study|Other|4|||
150264651|NCT00585195|542105113|FG020|Overall Study|Other|2|||
150264652|NCT00585195|542105093|FG000|Overall Study|Randomized not treated|0|||
150264653|NCT00585195|542105094|FG001|Overall Study|Randomized not treated|0|||
150264654|NCT00585195|542105095|FG002|Overall Study|Randomized not treated|1|||
150264655|NCT00585195|542105096|FG003|Overall Study|Randomized not treated|0|||
150264656|NCT00585195|542105097|FG004|Overall Study|Randomized not treated|1|||
150264657|NCT00585195|542105098|FG005|Overall Study|Randomized not treated|0|||
150264658|NCT00585195|542105099|FG006|Overall Study|Randomized not treated|1|||
150264659|NCT00585195|542105100|FG007|Overall Study|Randomized not treated|0|||
150264660|NCT00585195|542105101|FG008|Overall Study|Randomized not treated|0|||
150264661|NCT00585195|542105102|FG009|Overall Study|Randomized not treated|0|||
150264662|NCT00585195|542105103|FG010|Overall Study|Randomized not treated|2|||
150264663|NCT00585195|542105104|FG011|Overall Study|Randomized not treated|0|||
150264664|NCT00585195|542105105|FG012|Overall Study|Randomized not treated|0|||
150264665|NCT00585195|542105106|FG013|Overall Study|Randomized not treated|0|||
150264666|NCT00585195|542105107|FG014|Overall Study|Randomized not treated|0|||
150264667|NCT00585195|542105108|FG015|Overall Study|Randomized not treated|1|||
150264668|NCT00585195|542105109|FG016|Overall Study|Randomized not treated|0|||
150264669|NCT00585195|542105110|FG017|Overall Study|Randomized not treated|1|||
150264670|NCT00585195|542105111|FG018|Overall Study|Randomized not treated|3|||
150264671|NCT00585195|542105112|FG019|Overall Study|Randomized not treated|0|||
150264672|NCT00585195|542105113|FG020|Overall Study|Randomized not treated|2|||
150264673|NCT00585195|542105093|FG000|Overall Study|Death|0|||
150264674|NCT00585195|542105094|FG001|Overall Study|Death|0|||
150264675|NCT00585195|542105095|FG002|Overall Study|Death|0|||
150264676|NCT00585195|542105096|FG003|Overall Study|Death|0|||
150264677|NCT00585195|542105097|FG004|Overall Study|Death|0|||
150264678|NCT00585195|542105098|FG005|Overall Study|Death|0|||
150264679|NCT00585195|542105099|FG006|Overall Study|Death|0|||
150264680|NCT00585195|542105100|FG007|Overall Study|Death|0|||
150264681|NCT00585195|542105101|FG008|Overall Study|Death|1|||
150264682|NCT00585195|542105102|FG009|Overall Study|Death|0|||
150264683|NCT00585195|542105103|FG010|Overall Study|Death|1|||
150264684|NCT00585195|542105104|FG011|Overall Study|Death|1|||
150264685|NCT00585195|542105105|FG012|Overall Study|Death|7|||
150264686|NCT00585195|542105106|FG013|Overall Study|Death|2|||
150264687|NCT00585195|542105107|FG014|Overall Study|Death|8|||
150264688|NCT00585195|542105108|FG015|Overall Study|Death|2|||
150264689|NCT00585195|542105109|FG016|Overall Study|Death|11|||
150264690|NCT00585195|542105110|FG017|Overall Study|Death|0|||
150264691|NCT00585195|542105111|FG018|Overall Study|Death|0|||
150264692|NCT00585195|542105112|FG019|Overall Study|Death|0|||
150264693|NCT00585195|542105113|FG020|Overall Study|Death|1|||
150264694|NCT00585195|542105093|FG000|Overall Study|Lost to Follow-up|0|||
150264695|NCT00585195|542105094|FG001|Overall Study|Lost to Follow-up|0|||
149927091|NCT02028507|540868881|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
149927092|NCT02028507|540868882|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
149927093|NCT02028507|540868883|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
149927094|NCT02028507|540868884|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
149927095|NCT02028507|540868881|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
149927096|NCT02028507|540868882|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
149927097|NCT02028507|540868883|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
149927098|NCT02028507|540868884|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
149927099|NCT02258659|540868885|FG000|Overall Study|Withdrawal by Subject|1|||
149927100|NCT03990051|540868886|FG000|Masked Period|Lost to Follow-up|1|||
149927101|NCT03990051|540868887|FG001|Masked Period|Lost to Follow-up|0|||
149927102|NCT03990051|540868886|FG000|Long Term Period|Death|1|||
149927103|NCT03990051|540868887|FG001|Long Term Period|Death|1|||
149927104|NCT03990051|540868886|FG000|Long Term Period|Lost to Follow-up|7|||
149927105|NCT03990051|540868887|FG001|Long Term Period|Lost to Follow-up|2|||
149927106|NCT00272844|540868888|FG000|Overall Study|Withdrawal by Subject|5|||
149927107|NCT03743025|540868889|FG000|Overall Study|Surgery was cancelled|2|||
149927108|NCT03743025|540868890|FG001|Overall Study|Surgery was cancelled|1|||
149927109|NCT00791700|540868893|FG000|Overall Study|Insufficient clinical response|1|||
149927110|NCT00791700|540868894|FG001|Overall Study|Insufficient clinical response|4|||
149927111|NCT00791700|540868895|FG002|Overall Study|Insufficient clinical response|1|||
149927112|NCT00791700|540868896|FG003|Overall Study|Insufficient clinical response|8|||
149927113|NCT00791700|540868893|FG000|Overall Study|No longer willing to participate|1|||
149927114|NCT00791700|540868894|FG001|Overall Study|No longer willing to participate|1|||
149927115|NCT00791700|540868895|FG002|Overall Study|No longer willing to participate|0|||
149927116|NCT00791700|540868896|FG003|Overall Study|No longer willing to participate|8|||
149927117|NCT00791700|540868893|FG000|Overall Study|Non-compliance with study treatment|0|||
149927118|NCT00791700|540868894|FG001|Overall Study|Non-compliance with study treatment|2|||
149927119|NCT00791700|540868895|FG002|Overall Study|Non-compliance with study treatment|0|||
149927120|NCT00791700|540868896|FG003|Overall Study|Non-compliance with study treatment|4|||
149927121|NCT00791700|540868893|FG000|Overall Study|Withdrawn due to pregnancy|0|||
149927122|NCT00791700|540868894|FG001|Overall Study|Withdrawn due to pregnancy|0|||
149927123|NCT00791700|540868895|FG002|Overall Study|Withdrawn due to pregnancy|0|||
149927124|NCT00791700|540868896|FG003|Overall Study|Withdrawn due to pregnancy|1|||
149927125|NCT00791700|540868893|FG000|Overall Study|Other|0|||
149927126|NCT00791700|540868894|FG001|Overall Study|Other|1|||
149927127|NCT00791700|540868895|FG002|Overall Study|Other|0|||
149927128|NCT00791700|540868896|FG003|Overall Study|Other|1|||
149927129|NCT00791700|540868893|FG000|Overall Study|Death|0|||
149927130|NCT00791700|540868894|FG001|Overall Study|Death|0|||
149927131|NCT00791700|540868895|FG002|Overall Study|Death|0|||
149927132|NCT00791700|540868896|FG003|Overall Study|Death|1|||
149927133|NCT00791700|540868893|FG000|Overall Study|Lost to Follow-up|4|||
149927134|NCT00791700|540868894|FG001|Overall Study|Lost to Follow-up|3|||
149927135|NCT00791700|540868895|FG002|Overall Study|Lost to Follow-up|4|||
149927136|NCT00791700|540868896|FG003|Overall Study|Lost to Follow-up|6|||
149927137|NCT00791700|540868893|FG000|Overall Study|Adverse Event|0|||
149927138|NCT00791700|540868894|FG001|Overall Study|Adverse Event|0|||
149927139|NCT00791700|540868895|FG002|Overall Study|Adverse Event|1|||
149927140|NCT00791700|540868896|FG003|Overall Study|Adverse Event|1|||
150164563|NCT00269399|541737418|FG001|Overall Study|Lack of Efficacy|10|||
150164564|NCT00269399|541737417|FG000|Overall Study|Adverse Event|10|||
150164565|NCT00269399|541737418|FG001|Overall Study|Adverse Event|4|||
150164566|NCT00269399|541737417|FG000|Overall Study|Withdrawal by Subject|2|||
150164567|NCT00269399|541737418|FG001|Overall Study|Withdrawal by Subject|5|||
150164568|NCT00269399|541737417|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
150164569|NCT00269399|541737418|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
150164570|NCT00269399|541737417|FG000|Overall Study|Other|0|||
150164571|NCT00269399|541737418|FG001|Overall Study|Other|4|||
150164572|NCT00269399|541737417|FG000|Overall Study|Development of exclusion criteria|0|||
150164573|NCT00269399|541737418|FG001|Overall Study|Development of exclusion criteria|1|||
150164574|NCT03396835|541737419|FG000|Overall Study|Withdrawn prior to completion|1|||
150164575|NCT03396835|541737419|FG000|Overall Study|Did not meet criteria for data analysis|1|||
150164576|NCT03439124|541737420|FG000|Overall Study|Adverse Event|2|||
150164577|NCT03439124|541737421|FG001|Overall Study|Adverse Event|0|||
150264696|NCT00585195|542105095|FG002|Overall Study|Lost to Follow-up|0|||
150264697|NCT00585195|542105096|FG003|Overall Study|Lost to Follow-up|0|||
150164578|NCT03439124|541737420|FG000|Overall Study|Lost to Follow-up|1|||
150164579|NCT03439124|541737421|FG001|Overall Study|Lost to Follow-up|0|||
150164580|NCT03439124|541737420|FG000|Overall Study|Other reasons|1|||
150164581|NCT03439124|541737421|FG001|Overall Study|Other reasons|0|||
150264698|NCT00585195|542105097|FG004|Overall Study|Lost to Follow-up|0|||
150264699|NCT00585195|542105098|FG005|Overall Study|Lost to Follow-up|0|||
149927141|NCT00996034|540868899|FG000|Overall Study|Lost to Follow-up|2|||
149927142|NCT00996034|540868899|FG000|Overall Study|withdrawn by PI|1|||
150264700|NCT00585195|542105099|FG006|Overall Study|Lost to Follow-up|0|||
150264701|NCT00585195|542105100|FG007|Overall Study|Lost to Follow-up|0|||
150264702|NCT00585195|542105101|FG008|Overall Study|Lost to Follow-up|0|||
150264703|NCT00585195|542105102|FG009|Overall Study|Lost to Follow-up|0|||
150264704|NCT00585195|542105103|FG010|Overall Study|Lost to Follow-up|0|||
150264705|NCT00585195|542105104|FG011|Overall Study|Lost to Follow-up|0|||
150264706|NCT00585195|542105105|FG012|Overall Study|Lost to Follow-up|1|||
149927143|NCT01720524|540868900|FG000|Part A|Insufficient Clinical Response|2|||
150264707|NCT00585195|542105106|FG013|Overall Study|Lost to Follow-up|0|||
150264708|NCT00585195|542105107|FG014|Overall Study|Lost to Follow-up|0|||
150264709|NCT00585195|542105108|FG015|Overall Study|Lost to Follow-up|0|||
150264710|NCT00585195|542105109|FG016|Overall Study|Lost to Follow-up|0|||
150264711|NCT00585195|542105110|FG017|Overall Study|Lost to Follow-up|2|||
150264712|NCT00585195|542105111|FG018|Overall Study|Lost to Follow-up|0|||
150264713|NCT00585195|542105112|FG019|Overall Study|Lost to Follow-up|0|||
150264714|NCT00585195|542105113|FG020|Overall Study|Lost to Follow-up|0|||
150264715|NCT00585195|542105093|FG000|Overall Study|Site Terminated by Sponsor|0|||
150264716|NCT00585195|542105094|FG001|Overall Study|Site Terminated by Sponsor|0|||
150264717|NCT00585195|542105095|FG002|Overall Study|Site Terminated by Sponsor|0|||
150264718|NCT00585195|542105096|FG003|Overall Study|Site Terminated by Sponsor|0|||
150264719|NCT00585195|542105097|FG004|Overall Study|Site Terminated by Sponsor|0|||
150264720|NCT00585195|542105098|FG005|Overall Study|Site Terminated by Sponsor|0|||
150264721|NCT00585195|542105099|FG006|Overall Study|Site Terminated by Sponsor|0|||
150264722|NCT00585195|542105100|FG007|Overall Study|Site Terminated by Sponsor|0|||
150264723|NCT00585195|542105101|FG008|Overall Study|Site Terminated by Sponsor|0|||
150264724|NCT00585195|542105102|FG009|Overall Study|Site Terminated by Sponsor|0|||
150264725|NCT00585195|542105103|FG010|Overall Study|Site Terminated by Sponsor|0|||
150264726|NCT00585195|542105104|FG011|Overall Study|Site Terminated by Sponsor|0|||
150264727|NCT00585195|542105105|FG012|Overall Study|Site Terminated by Sponsor|1|||
150264728|NCT00585195|542105106|FG013|Overall Study|Site Terminated by Sponsor|0|||
150264729|NCT00585195|542105107|FG014|Overall Study|Site Terminated by Sponsor|0|||
150264730|NCT00585195|542105108|FG015|Overall Study|Site Terminated by Sponsor|0|||
150264731|NCT00585195|542105109|FG016|Overall Study|Site Terminated by Sponsor|0|||
149927144|NCT01720524|540868901|FG001|Part A|Insufficient Clinical Response|4|||
149927145|NCT01720524|540868900|FG000|Part A|Adverse Event|2|||
149927146|NCT01720524|540868901|FG001|Part A|Adverse Event|2|||
149927147|NCT01720524|540868900|FG000|Part A|Death|2|||
149927148|NCT01720524|540868901|FG001|Part A|Death|1|||
149927149|NCT01720524|540868900|FG000|Part A|Lost to Follow-up|0|||
149927150|NCT01720524|540868901|FG001|Part A|Lost to Follow-up|1|||
149927151|NCT01720524|540868900|FG000|Part A|Missed 28 day follow-up visit|1|||
149927152|NCT01720524|540868901|FG001|Part A|Missed 28 day follow-up visit|1|||
149927153|NCT01720524|540868900|FG000|Part A|Withdrawal by Subject|0|||
149927154|NCT01720524|540868901|FG001|Part A|Withdrawal by Subject|1|||
149927155|NCT01720524|540868900|FG000|Part A|Other|0|||
149927156|NCT01720524|540868901|FG001|Part A|Other|1|||
149927157|NCT01720524|540868900|FG000|Part A|Lost to Follow-up|0|||
149927158|NCT01720524|540868901|FG001|Part A|Lost to Follow-up|1|||
149927159|NCT01720524|540868900|FG000|Part B|No longer willing to participate in study|1|||
149927160|NCT01720524|540868901|FG001|Part B|No longer willing to participate in study|4|||
149927161|NCT01720524|540868900|FG000|Part B|Other|2|||
149927162|NCT01720524|540868901|FG001|Part B|Other|0|||
149927163|NCT01720524|540868900|FG000|Part B|Lost to Follow-up|2|||
149927164|NCT01720524|540868901|FG001|Part B|Lost to Follow-up|3|||
149927165|NCT01720524|540868900|FG000|Part B|Death|0|||
149927166|NCT01720524|540868901|FG001|Part B|Death|2|||
149927167|NCT00527826|540868905|FG000|Overall Study|Adverse Event|10|||
149927168|NCT00527826|540868906|FG001|Overall Study|Adverse Event|10|||
149927169|NCT00527826|540868905|FG000|Overall Study|Lost to Follow-up|3|||
149927170|NCT00527826|540868906|FG001|Overall Study|Lost to Follow-up|2|||
149927171|NCT00527826|540868905|FG000|Overall Study|Withdrawal by Subject|5|||
149927172|NCT00527826|540868906|FG001|Overall Study|Withdrawal by Subject|8|||
149927173|NCT00527826|540868905|FG000|Overall Study|Inclusion Criteria Not Met|3|||
149927174|NCT00527826|540868906|FG001|Overall Study|Inclusion Criteria Not Met|3|||
149927175|NCT00527826|540868905|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
149927176|NCT00527826|540868906|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
149927177|NCT00527826|540868905|FG000|Overall Study|Additional Intake of Viani forte|0|||
149927178|NCT00527826|540868906|FG001|Overall Study|Additional Intake of Viani forte|1|||
149927179|NCT00527826|540868905|FG000|Overall Study|Participant moved away|0|||
149927180|NCT00527826|540868906|FG001|Overall Study|Participant moved away|1|||
150264732|NCT00585195|542105110|FG017|Overall Study|Site Terminated by Sponsor|0|||
150264733|NCT00585195|542105111|FG018|Overall Study|Site Terminated by Sponsor|0|||
150264734|NCT00585195|542105112|FG019|Overall Study|Site Terminated by Sponsor|0|||
150264735|NCT00585195|542105113|FG020|Overall Study|Site Terminated by Sponsor|0|||
150264736|NCT00585195|542105093|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
150264737|NCT00585195|542105094|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
149927181|NCT00158262|540868907|FG000|Overall Study|Lost to Follow-up|1|||
149927182|NCT00158262|540868908|FG001|Overall Study|Lost to Follow-up|1|||
150264738|NCT00585195|542105095|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
150264739|NCT00585195|542105096|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
150264740|NCT00585195|542105097|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
150264741|NCT00585195|542105098|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
150264742|NCT00585195|542105099|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
150264743|NCT00585195|542105100|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
150264744|NCT00585195|542105101|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
150264745|NCT00585195|542105102|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
150264746|NCT00585195|542105103|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
150264747|NCT00585195|542105104|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
150264748|NCT00585195|542105105|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
150264749|NCT00585195|542105106|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
150264750|NCT00585195|542105107|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
150264751|NCT00585195|542105108|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
150264752|NCT00585195|542105109|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
150264753|NCT00585195|542105110|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
150264754|NCT00585195|542105111|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
150264755|NCT00585195|542105112|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
150264756|NCT00585195|542105113|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
150264757|NCT02796560|542105119|FG000|Overall Study|Adverse Event|2|||
150264758|NCT02796560|542105120|FG001|Overall Study|Adverse Event|0|||
150264759|NCT02796560|542105119|FG000|Overall Study|Withdrawal by Subject|2|||
150264760|NCT02796560|542105120|FG001|Overall Study|Withdrawal by Subject|2|||
150264761|NCT03534284|542105121|FG000|Overall Study|Death|2|||
150264762|NCT03534284|542105122|FG001|Overall Study|Death|3|||
150264763|NCT03534284|542105123|FG002|Overall Study|Death|3|||
150264764|NCT03534284|542105121|FG000|Overall Study|Withdrawal by Subject|5|||
150264765|NCT03534284|542105122|FG001|Overall Study|Withdrawal by Subject|0|||
150264766|NCT03534284|542105123|FG002|Overall Study|Withdrawal by Subject|0|||
150264767|NCT04737187|542105124|FG000|Overall Study|Switched to marketed drug|32|||
150264768|NCT04737187|542105125|FG001|Overall Study|Switched to marketed drug|4|||
150264769|NCT04737187|542105124|FG000|Overall Study|Radiological Progressive Disease|145|||
150264770|NCT04737187|542105125|FG001|Overall Study|Radiological Progressive Disease|146|||
150264771|NCT04737187|542105124|FG000|Overall Study|Clinical Progressive Disease|20|||
150264772|NCT04737187|542105125|FG001|Overall Study|Clinical Progressive Disease|20|||
150264773|NCT04737187|542105124|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
150264774|NCT04737187|542105125|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
150264775|NCT04737187|542105124|FG000|Overall Study|Adverse Event|16|||
150264776|NCT04737187|542105125|FG001|Overall Study|Adverse Event|16|||
150264777|NCT04737187|542105124|FG000|Overall Study|Physician Decision|2|||
150264778|NCT04737187|542105125|FG001|Overall Study|Physician Decision|0|||
150264779|NCT04737187|542105124|FG000|Overall Study|Withdrawal by Subject|5|||
150264780|NCT04737187|542105125|FG001|Overall Study|Withdrawal by Subject|8|||
150264781|NCT02656823|542105128|FG000|Overall Study|Adverse Event|3|||
150264782|NCT02656823|542105128|FG000|Overall Study|Lost to Follow-up|2|||
150264783|NCT01009580|542105132|FG000|Overall Study|Adverse Event|4|||
150264784|NCT01009580|542105133|FG001|Overall Study|Adverse Event|4|||
150264785|NCT01009580|542105132|FG000|Overall Study|Lack of Efficacy|0|||
150264786|NCT01009580|542105133|FG001|Overall Study|Lack of Efficacy|1|||
150264787|NCT01009580|542105132|FG000|Overall Study|Protocol Violation|2|||
150264788|NCT01009580|542105133|FG001|Overall Study|Protocol Violation|3|||
150264789|NCT01009580|542105132|FG000|Overall Study|Withdrawal Criteria|4|||
150264790|NCT01009580|542105133|FG001|Overall Study|Withdrawal Criteria|6|||
150264791|NCT01009580|542105132|FG000|Overall Study|Unclassified|17|||
150264792|NCT01009580|542105133|FG001|Overall Study|Unclassified|21|||
150264793|NCT01439360|542105134|FG000|Overall Study|Adverse Event|4|||
150264794|NCT01439360|542105135|FG001|Overall Study|Adverse Event|16|||
150264795|NCT01439360|542105134|FG000|Overall Study|Lost to Follow-up|43|||
150264796|NCT01439360|542105135|FG001|Overall Study|Lost to Follow-up|58|||
150264797|NCT01439360|542105134|FG000|Overall Study|Others|10|||
150264798|NCT01439360|542105135|FG001|Overall Study|Others|5|||
150264799|NCT01439360|542105134|FG000|Overall Study|Protocol Violation|1|||
150264800|NCT01439360|542105135|FG001|Overall Study|Protocol Violation|0|||
150264801|NCT01439360|542105134|FG000|Overall Study|Withdrawal by Subject|140|||
150264802|NCT01439360|542105135|FG001|Overall Study|Withdrawal by Subject|129|||
150264803|NCT00345293|542105136|FG000|Overall Study|Unable to access line for sample|1|||
150264804|NCT00345293|542105137|FG001|Overall Study|Unable to access line for sample|0|||
150264805|NCT00345293|542105136|FG000|Overall Study|Withdrawal by Subject|1|||
150264806|NCT00345293|542105137|FG001|Overall Study|Withdrawal by Subject|0|||
150264807|NCT03319849|542105138|FG000|Overall Study|Adverse Event|1|||
150264808|NCT03319849|542105139|FG001|Overall Study|Adverse Event|0|||
150264809|NCT03319849|542105138|FG000|Overall Study|Physician Decision|0|||
150264810|NCT03319849|542105139|FG001|Overall Study|Physician Decision|1|||
150264811|NCT03319849|542105138|FG000|Overall Study|Withdrawal by Subject|0|||
150264812|NCT03319849|542105139|FG001|Overall Study|Withdrawal by Subject|1|||
150264813|NCT03319849|542105138|FG000|Overall Study|COVID-19|0|||
150264814|NCT03319849|542105139|FG001|Overall Study|COVID-19|1|||
150264815|NCT03319849|542105138|FG000|Overall Study|Other|1|||
149927183|NCT01421641|540868911|FG000|Overall Study|Protocol Violation|2|||
149927184|NCT01421641|540868912|FG001|Overall Study|Protocol Violation|2|||
149927185|NCT02420119|540868914|FG000|Overall Study|insufficient laboratory data|5|||
149927186|NCT02364388|540868915|FG000|Overall Study|Protocol Violation|1|||
149927187|NCT02364388|540868915|FG000|Overall Study|Technical Failure|3|||
149927188|NCT02364388|540868915|FG000|Overall Study|No OA/US data|2|||
149927189|NCT02364388|540868915|FG000|Overall Study|No Biopsy|2|||
150164582|NCT01451814|541737422|FG000|Overall Study|Withdrawal by Subject|1|||
150164583|NCT01451814|541737423|FG001|Overall Study|Withdrawal by Subject|1|||
150164584|NCT01451814|541737422|FG000|Overall Study|Lost to Follow-up|5|||
150164585|NCT01451814|541737423|FG001|Overall Study|Lost to Follow-up|4|||
150164586|NCT04353037|541737425|FG000|Overall Study|Lost to Follow-up|0|||
150164587|NCT04353037|541737426|FG001|Overall Study|Lost to Follow-up|1|||
150164588|NCT04353037|541737427|FG002|Overall Study|Lost to Follow-up|2|||
150164589|NCT04353037|541737428|FG003|Overall Study|Lost to Follow-up|3|||
150164590|NCT04353037|541737425|FG000|Overall Study|Withdrawal by Subject|0|||
150164591|NCT04353037|541737426|FG001|Overall Study|Withdrawal by Subject|2|||
150164592|NCT04353037|541737427|FG002|Overall Study|Withdrawal by Subject|3|||
150164593|NCT04353037|541737428|FG003|Overall Study|Withdrawal by Subject|5|||
150164594|NCT04353037|541737425|FG000|Overall Study|Adverse Event|0|||
150164595|NCT04353037|541737426|FG001|Overall Study|Adverse Event|0|||
150164596|NCT04353037|541737427|FG002|Overall Study|Adverse Event|2|||
150164597|NCT04353037|541737428|FG003|Overall Study|Adverse Event|0|||
150164598|NCT04353037|541737425|FG000|Overall Study|Exposure Change|0|||
150164599|NCT04353037|541737426|FG001|Overall Study|Exposure Change|0|||
150164600|NCT04353037|541737427|FG002|Overall Study|Exposure Change|0|||
150164601|NCT04353037|541737428|FG003|Overall Study|Exposure Change|2|||
150164602|NCT03710564|541737429|FG000|Overall Study|Study Terminated by Sponsor|104|||
150164603|NCT03710564|541737430|FG001|Overall Study|Study Terminated by Sponsor|55|||
150164604|NCT03710564|541737429|FG000|Overall Study|Withdrawal by Subject|57|||
150164605|NCT03710564|541737430|FG001|Overall Study|Withdrawal by Subject|25|||
150164606|NCT03710564|541737429|FG000|Overall Study|Death|10|||
150164607|NCT03710564|541737430|FG001|Overall Study|Death|4|||
150164608|NCT03710564|541737429|FG000|Overall Study|Lost to Follow-up|5|||
150164609|NCT03710564|541737430|FG001|Overall Study|Lost to Follow-up|4|||
150164610|NCT03710564|541737429|FG000|Overall Study|Protocol Violation|3|||
150164611|NCT03710564|541737430|FG001|Overall Study|Protocol Violation|2|||
150164612|NCT03710564|541737429|FG000|Overall Study|Adverse Event|3|||
150164613|NCT03710564|541737430|FG001|Overall Study|Adverse Event|0|||
150164614|NCT03710564|541737429|FG000|Overall Study|Physician Decision|2|||
150164615|NCT03710564|541737430|FG001|Overall Study|Physician Decision|3|||
150164616|NCT02993471|541737432|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
150164617|NCT02993471|541737432|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
150164618|NCT00920686|541737434|FG000|Overall Study|Lost to Follow-up|2|||
150164619|NCT00920686|541737435|FG001|Overall Study|Lost to Follow-up|3|||
150164620|NCT00920686|541737436|FG002|Overall Study|Lost to Follow-up|1|||
150164621|NCT00920686|541737434|FG000|Overall Study|Study drug dosing criteria not met|17|||
150164622|NCT00920686|541737435|FG001|Overall Study|Study drug dosing criteria not met|19|||
150164623|NCT00920686|541737436|FG002|Overall Study|Study drug dosing criteria not met|12|||
150164624|NCT03006341|541737437|FG000|Overall Study|Not linked in the EMR|25069|||
150164625|NCT03006341|541737438|FG001|Overall Study|Not linked in the EMR|67505|||
150164626|NCT03006341|541737439|FG002|Overall Study|Not linked in the EMR|30993|||
150164627|NCT03006341|541737440|FG003|Overall Study|Not linked in the EMR|10685|||
150164628|NCT03101592|541737443|FG000|Overall Study|participant files could not be located|111|||
150164629|NCT03101592|541737444|FG001|Overall Study|participant files could not be located|170|||
150164630|NCT03101592|541737445|FG002|Overall Study|participant files could not be located|118|||
150164631|NCT00647348|541737447|FG000|Overall Study|Lost to Follow-up|3|||
150164632|NCT00647348|541737448|FG001|Overall Study|Lost to Follow-up|6|||
150164633|NCT00619151|541737449|FG000|Overall Study|Study terminated prior to followup|1|||
150164634|NCT00619151|541737450|FG001|Overall Study|Study terminated prior to followup|0|||
150164635|NCT00631917|541737453|FG000|Overall Study|Adverse Event|34|||
150164636|NCT00631917|541737454|FG001|Overall Study|Adverse Event|45|||
150164637|NCT00631917|541737453|FG000|Overall Study|Abnormal laboratory value(s)|2|||
150164638|NCT00631917|541737454|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150164639|NCT00631917|541737453|FG000|Overall Study|Abnormal test procedure result(s)|3|||
150164640|NCT00631917|541737454|FG001|Overall Study|Abnormal test procedure result(s)|2|||
149927190|NCT02256839|540868916|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
149927191|NCT02256839|540868917|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
149927192|NCT01843803|540868918|FG000|Overall Study|not a Veteran, did not see provider|1|||
150164641|NCT00631917|541737453|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
150164642|NCT00631917|541737454|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
150164643|NCT00631917|541737453|FG000|Overall Study|No longer required study drug|0|||
150164644|NCT00631917|541737454|FG001|Overall Study|No longer required study drug|1|||
150164645|NCT00631917|541737453|FG000|Overall Study|Protocol deviation|6|||
150164646|NCT00631917|541737454|FG001|Overall Study|Protocol deviation|5|||
150164647|NCT00631917|541737453|FG000|Overall Study|Subject withdrew consent|25|||
150164648|NCT00631917|541737454|FG001|Overall Study|Subject withdrew consent|33|||
150164649|NCT00631917|541737453|FG000|Overall Study|Lost to Follow-up|7|||
149819233|NCT03182686|540467252|FG001|Overall Study|Withdrawal by Subject|0|||
150164650|NCT00631917|541737454|FG001|Overall Study|Lost to Follow-up|7|||
150164651|NCT00631917|541737453|FG000|Overall Study|Administrative problems|2|||
150164652|NCT00631917|541737454|FG001|Overall Study|Administrative problems|0|||
150164653|NCT00631917|541737453|FG000|Overall Study|Death|1|||
150164654|NCT00631917|541737454|FG001|Overall Study|Death|0|||
150164655|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
150164656|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
150164657|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
150164658|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Death|3|||
150164659|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Death|0|||
150164660|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Death|0|||
150164661|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
150164662|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
150164663|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
150164664|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
150164665|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
150164666|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
150164667|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
150164668|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
150164669|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
150164670|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
150164671|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
150164672|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
150164673|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
150164674|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
150164675|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
150164676|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Other|1|||
149819234|NCT01154127|540467259|FG000|Period 1 (21 Days)|Adverse Event|3|||
149819235|NCT01154127|540467260|FG001|Period 1 (21 Days)|Adverse Event|4|||
149819236|NCT01154127|540467259|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
149819237|NCT01154127|540467260|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
149819238|NCT01154127|540467259|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
149819239|NCT01154127|540467260|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
149819240|NCT01154127|540467259|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
149819241|NCT01154127|540467260|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
149819242|NCT01154127|540467259|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
149819243|NCT01154127|540467260|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
149819244|NCT01697449|540467261|FG000|Overall Study|Disease progression|47|||
149819245|NCT01697449|540467261|FG000|Overall Study|Adverse Event|7|||
149819246|NCT01697449|540467261|FG000|Overall Study|Lost to Follow-up|5|||
149819247|NCT01697449|540467261|FG000|Overall Study|Withdrawal by Subject|2|||
149819248|NCT01697449|540467261|FG000|Overall Study|Physician Decision|1|||
149819249|NCT01697449|540467261|FG000|Overall Study|Death|2|||
149819250|NCT01697449|540467261|FG000|Overall Study|Other|1|||
149819251|NCT01697449|540467261|FG000|Overall Study|Missing|25|||
149819252|NCT01169844|540467262|FG000|Overall Study|Adverse Event|0|||
149819253|NCT01169844|540467263|FG001|Overall Study|Adverse Event|1|||
149819254|NCT01169844|540467262|FG000|Overall Study|Patient withdrew consent|4|||
149819255|NCT01169844|540467263|FG001|Overall Study|Patient withdrew consent|0|||
149819256|NCT01169844|540467262|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149819257|NCT01169844|540467263|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149819258|NCT01337050|540467267|FG000|Overall Study|Death|0|||
149819259|NCT01337050|540467268|FG001|Overall Study|Death|0|||
149819260|NCT01337050|540467269|FG002|Overall Study|Death|4|||
149819261|NCT01337050|540467267|FG000|Overall Study|Other|4|||
149819262|NCT01337050|540467268|FG001|Overall Study|Other|6|||
149819263|NCT01337050|540467269|FG002|Overall Study|Other|8|||
149819264|NCT01337050|540467267|FG000|Overall Study|Participants refused further follow-up|0|||
149819265|NCT01337050|540467268|FG001|Overall Study|Participants refused further follow-up|7|||
149819266|NCT01337050|540467269|FG002|Overall Study|Participants refused further follow-up|7|||
149819267|NCT00003102|540467270|FG000|Overall Study|Physician Decision|1|||
149819268|NCT00003102|540467271|FG001|Overall Study|Physician Decision|1|||
149819269|NCT00003102|540467272|FG002|Overall Study|Physician Decision|0|||
149819270|NCT00003102|540467270|FG000|Overall Study|Progressive Disease|0|||
149819271|NCT00003102|540467271|FG001|Overall Study|Progressive Disease|1|||
149819272|NCT00003102|540467272|FG002|Overall Study|Progressive Disease|0|||
149819273|NCT00003102|540467270|FG000|Overall Study|Adverse Event|0|||
149819274|NCT00003102|540467271|FG001|Overall Study|Adverse Event|1|||
149819275|NCT00003102|540467272|FG002|Overall Study|Adverse Event|1|||
149819276|NCT00003102|540467270|FG000|Overall Study|Death|0|||
149819277|NCT00003102|540467271|FG001|Overall Study|Death|0|||
149819278|NCT00003102|540467272|FG002|Overall Study|Death|1|||
149927193|NCT01843803|540868919|FG001|Overall Study|not a Veteran, did not see provider|3|||
149927194|NCT00436826|540868923|FG000|Double Blind Period (DBP)|Adverse Event|2|||
149927195|NCT00436826|540868924|FG001|Double Blind Period (DBP)|Adverse Event|0|||
149927196|NCT00436826|540868925|FG002|Double Blind Period (DBP)|Adverse Event|0|||
150264816|NCT03319849|542105139|FG001|Overall Study|Other|2|||
150264817|NCT03319849|542105138|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
150264818|NCT03319849|542105139|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
150264819|NCT03319849|542105138|FG000|Overall Study|Lost to Follow-up|0|||
150264820|NCT03319849|542105139|FG001|Overall Study|Lost to Follow-up|2|||
150264821|NCT00355056|542106925|FG000|Randomization Period|Early Termination|4|||
150264822|NCT00355056|542106926|FG001|Randomization Period|Early Termination|6|||
150264823|NCT01072877|542106927|FG000|Overall Study|Lost to Follow-up|1|||
150264824|NCT01072877|542106928|FG001|Overall Study|Lost to Follow-up|1|||
150264825|NCT01072877|542106929|FG002|Overall Study|Lost to Follow-up|0|||
150264826|NCT01072877|542106930|FG003|Overall Study|Lost to Follow-up|2|||
150264827|NCT01072877|542106931|FG004|Overall Study|Lost to Follow-up|0|||
150264828|NCT00995020|542106932|FG000|Overall Study|margin analysis not performed|2|||
150264829|NCT00995020|542106933|FG001|Overall Study|margin analysis not performed|5|||
150264830|NCT00995020|542106932|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
150264831|NCT00995020|542106933|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
150264832|NCT02986334|542106935|FG000|Overall Study|Withdrawal by Subject|0|||
150264833|NCT02986334|542106936|FG001|Overall Study|Withdrawal by Subject|1|||
150264834|NCT02986334|542106937|FG002|Overall Study|Withdrawal by Subject|2|||
150264835|NCT02986334|542106935|FG000|Overall Study|Lost to Follow-up|1|||
150264836|NCT02986334|542106936|FG001|Overall Study|Lost to Follow-up|2|||
150264837|NCT02986334|542106937|FG002|Overall Study|Lost to Follow-up|1|||
150264838|NCT02986334|542106935|FG000|Overall Study|Adverse Event|0|||
150264839|NCT02986334|542106936|FG001|Overall Study|Adverse Event|2|||
150264840|NCT02986334|542106937|FG002|Overall Study|Adverse Event|1|||
150264841|NCT02986334|542106935|FG000|Overall Study|non compliance in phone ratings|2|||
150264842|NCT02986334|542106936|FG001|Overall Study|non compliance in phone ratings|1|||
150264843|NCT02986334|542106937|FG002|Overall Study|non compliance in phone ratings|2|||
150264844|NCT02986334|542106935|FG000|Overall Study|undisclosed comorbidities|0|||
150264845|NCT02986334|542106936|FG001|Overall Study|undisclosed comorbidities|1|||
150264846|NCT02986334|542106937|FG002|Overall Study|undisclosed comorbidities|1|||
150264847|NCT04142450|542106938|FG000|Overall Study|Screen Failure|1|||
150264848|NCT04142450|542106938|FG000|Overall Study|Lost to Follow-up|1|||
150264849|NCT01138007|542106941|FG000|Overall Study|Adverse Event|4|||
150264850|NCT01138007|542106942|FG001|Overall Study|Adverse Event|12|||
150264851|NCT01138007|542106943|FG002|Overall Study|Adverse Event|9|||
150264852|NCT01138007|542106941|FG000|Overall Study|Lack of Efficacy|2|||
150264853|NCT01138007|542106942|FG001|Overall Study|Lack of Efficacy|0|||
150264854|NCT01138007|542106943|FG002|Overall Study|Lack of Efficacy|6|||
150264855|NCT01138007|542106941|FG000|Overall Study|Protocol Violation|2|||
150264856|NCT01138007|542106942|FG001|Overall Study|Protocol Violation|3|||
150264857|NCT01138007|542106943|FG002|Overall Study|Protocol Violation|2|||
150264858|NCT01138007|542106941|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
150264859|NCT01138007|542106942|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
150264860|NCT01138007|542106943|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
150264861|NCT01138007|542106941|FG000|Overall Study|Lost to Follow-up|3|||
150264862|NCT01138007|542106942|FG001|Overall Study|Lost to Follow-up|3|||
150264863|NCT01138007|542106943|FG002|Overall Study|Lost to Follow-up|5|||
150264864|NCT01138007|542106941|FG000|Overall Study|Physician Decision|0|||
150264865|NCT01138007|542106942|FG001|Overall Study|Physician Decision|5|||
150264866|NCT01138007|542106943|FG002|Overall Study|Physician Decision|3|||
150264867|NCT01138007|542106941|FG000|Overall Study|Withdrawal by Subject|5|||
150264868|NCT01138007|542106942|FG001|Overall Study|Withdrawal by Subject|6|||
150264869|NCT01138007|542106943|FG002|Overall Study|Withdrawal by Subject|15|||
150264870|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
150264871|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
149927197|NCT00436826|540868926|FG003|Double Blind Period (DBP)|Adverse Event|0|||
149927198|NCT00436826|540868927|FG004|Double Blind Period (DBP)|Adverse Event|0|||
149927199|NCT00436826|540868928|FG005|Double Blind Period (DBP)|Adverse Event|0|||
150264872|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
150264873|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
150264874|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
150264875|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
150264876|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
150264877|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
150264878|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
150264879|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
150264880|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
150264881|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
150264882|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
149927200|NCT00436826|540868923|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
149927201|NCT00436826|540868924|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
149927202|NCT00436826|540868925|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
149927203|NCT00436826|540868926|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
149927204|NCT00436826|540868927|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
149927205|NCT00436826|540868928|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
149927206|NCT00436826|540868923|FG000|Double Blind Period (DBP)|Other|10|||
149927207|NCT00436826|540868924|FG001|Double Blind Period (DBP)|Other|11|||
149927208|NCT00436826|540868925|FG002|Double Blind Period (DBP)|Other|0|||
149927209|NCT00436826|540868926|FG003|Double Blind Period (DBP)|Other|0|||
149927210|NCT00436826|540868927|FG004|Double Blind Period (DBP)|Other|0|||
149927211|NCT00436826|540868928|FG005|Double Blind Period (DBP)|Other|0|||
149927212|NCT00436826|540868923|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
149927213|NCT00436826|540868924|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
149927214|NCT00436826|540868925|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
149927215|NCT00436826|540868926|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
149927216|NCT00436826|540868927|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
149927217|NCT00436826|540868928|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
149927218|NCT00436826|540868923|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
149927219|NCT00436826|540868924|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
149927220|NCT00436826|540868925|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
149927221|NCT00436826|540868926|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
149927222|NCT00436826|540868927|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
149927223|NCT00436826|540868928|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
149927224|NCT00436826|540868923|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
149927225|NCT00436826|540868924|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
149927226|NCT00436826|540868925|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
149927227|NCT00436826|540868926|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
149927228|NCT00436826|540868927|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
149927229|NCT00436826|540868928|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
149927230|NCT05285787|540868932|FG000|Overall Study|Withdrawal by Subject|1|||
149927231|NCT04004260|540868933|FG000|Overall Study|Withdrawal by Subject|7|||
149927232|NCT04004260|540868934|FG001|Overall Study|Withdrawal by Subject|3|||
149927233|NCT04004260|540868933|FG000|Overall Study|Lost to Follow-up|22|||
149927234|NCT04004260|540868934|FG001|Overall Study|Lost to Follow-up|12|||
149927235|NCT04004260|540868933|FG000|Overall Study|Did not engage in intervention|13|||
149927236|NCT04004260|540868934|FG001|Overall Study|Did not engage in intervention|17|||
149927237|NCT03382418|540868935|FG000|Overall Study|Withdrawal by Subject|1|||
149927238|NCT03382418|540868936|FG001|Overall Study|Withdrawal by Subject|0|||
149927239|NCT03382418|540868937|FG002|Overall Study|Withdrawal by Subject|0|||
149927240|NCT03382418|540868935|FG000|Overall Study|Lost to Follow-up|2|||
149927241|NCT03382418|540868936|FG001|Overall Study|Lost to Follow-up|3|||
149927242|NCT03382418|540868937|FG002|Overall Study|Lost to Follow-up|0|||
149927243|NCT02360280|540868938|FG000|Overall Study|Withdrawal by Subject|2|||
149927244|NCT02360280|540868939|FG001|Overall Study|Withdrawal by Subject|0|||
149927245|NCT02360280|540868938|FG000|Overall Study|Adverse Event|0|||
149927246|NCT02360280|540868939|FG001|Overall Study|Adverse Event|1|||
149927247|NCT02360280|540868938|FG000|Overall Study|Lost to Follow-up|1|||
149927248|NCT02360280|540868939|FG001|Overall Study|Lost to Follow-up|0|||
149927249|NCT05464420|540868947|FG000|Overall Study|Death|0|||
149927250|NCT05464420|540868948|FG001|Overall Study|Death|0|||
149927251|NCT05464420|540868949|FG002|Overall Study|Death|0|||
149927252|NCT05464420|540868950|FG003|Overall Study|Death|1|||
150164677|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Other|0|||
150164678|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Other|0|||
150164679|NCT02403323|541737455|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
150164680|NCT02403323|541737456|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
150164681|NCT02403323|541737457|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
150164682|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
150164683|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
150164684|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
150164685|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
149927253|NCT05464420|540868947|FG000|Overall Study|Lost to Follow-up|16|||
149927254|NCT05464420|540868948|FG001|Overall Study|Lost to Follow-up|11|||
149927255|NCT05464420|540868949|FG002|Overall Study|Lost to Follow-up|11|||
149927256|NCT05464420|540868950|FG003|Overall Study|Lost to Follow-up|11|||
149927257|NCT05464420|540868947|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
149927258|NCT05464420|540868948|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
149927259|NCT05464420|540868949|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
149927260|NCT05464420|540868950|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
150264883|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
150264884|NCT03548987|542106944|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
150264885|NCT03548987|542106945|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
150264886|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
150264887|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
150264888|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
150264889|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
150264890|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
149927261|NCT05464420|540868947|FG000|Overall Study|Withdrawal by Subject|4|||
149927262|NCT05464420|540868948|FG001|Overall Study|Withdrawal by Subject|8|||
149927263|NCT05464420|540868949|FG002|Overall Study|Withdrawal by Subject|3|||
150264891|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
150264892|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
150264893|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
150264894|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
150264895|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
150264896|NCT03548987|542106944|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
150264897|NCT03548987|542106945|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
150264898|NCT04661878|542106946|FG000|Overall Study|Lost to Follow-up|6|||
150264899|NCT04661878|542106947|FG001|Overall Study|Lost to Follow-up|5|||
150264900|NCT02768870|542106952|FG000|Overall Study|Death|1|||
150264901|NCT02768870|542106952|FG000|Overall Study|Reoperation|6|||
150264902|NCT02768870|542106952|FG000|Overall Study|Lost to Follow-up|1|||
150264903|NCT02768870|542106952|FG000|Overall Study|Exit|4|||
150264904|NCT01774110|542106953|FG000|Overall Study|Lost to Follow-up|7|||
149927264|NCT05464420|540868950|FG003|Overall Study|Withdrawal by Subject|1|||
149927265|NCT05464420|540868947|FG000|Overall Study|Protocol Violation|0|||
149927266|NCT05464420|540868948|FG001|Overall Study|Protocol Violation|0|||
149927267|NCT05464420|540868949|FG002|Overall Study|Protocol Violation|1|||
149927268|NCT05464420|540868950|FG003|Overall Study|Protocol Violation|1|||
149927269|NCT05464420|540868947|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
149927270|NCT05464420|540868948|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
149927271|NCT05464420|540868949|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
149927272|NCT05464420|540868950|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
149927273|NCT01383018|540868951|FG000|Overall Study|Adverse Event|14|||
149927274|NCT01383018|540868951|FG000|Overall Study|Death|10|||
149927275|NCT01383018|540868951|FG000|Overall Study|Lost to Follow-up|5|||
149927276|NCT01383018|540868951|FG000|Overall Study|Physician Decision|5|||
149927277|NCT01383018|540868951|FG000|Overall Study|Withdrawal by Subject|9|||
149927278|NCT01383018|540868951|FG000|Overall Study|Subject not implanted|76|||
149927279|NCT01383018|540868951|FG000|Overall Study|Missed Visit|247|||
149927280|NCT01383018|540868951|FG000|Overall Study|Site closed early-not compliance related|7|||
149927281|NCT01383018|540868951|FG000|Overall Study|Patient moved away from site|1|||
149927282|NCT01383018|540868951|FG000|Overall Study|Subject Incarcerated|1|||
149927283|NCT02472886|540868952|FG000|Overall Study|Lack of Efficacy|0|||
149927284|NCT02472886|540868953|FG001|Overall Study|Lack of Efficacy|2|||
149927285|NCT02472886|540868954|FG002|Overall Study|Lack of Efficacy|1|||
149927286|NCT01051817|540868955|FG000|Overall Study|Adverse Event|0|||
149927287|NCT01051817|540868956|FG001|Overall Study|Adverse Event|2|||
149927288|NCT01051817|540868955|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
149927289|NCT01051817|540868956|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
149927290|NCT01051817|540868955|FG000|Overall Study|Withdrawal by Subject|3|||
149927291|NCT01051817|540868956|FG001|Overall Study|Withdrawal by Subject|5|||
149927292|NCT01051817|540868955|FG000|Overall Study|Protocol Violation|0|||
149927293|NCT01051817|540868956|FG001|Overall Study|Protocol Violation|1|||
149927294|NCT00320788|540868958|FG000|Overall Study|Adverse Event|0|||
149927295|NCT00320788|540868959|FG001|Overall Study|Adverse Event|0|||
149927296|NCT00320788|540868960|FG002|Overall Study|Adverse Event|0|||
149927297|NCT00320788|540868961|FG003|Overall Study|Adverse Event|1|||
149927298|NCT00320788|540868962|FG004|Overall Study|Adverse Event|0|||
149927299|NCT00320788|540868958|FG000|Overall Study|Death|0|||
149927300|NCT00320788|540868959|FG001|Overall Study|Death|0|||
149927301|NCT00320788|540868960|FG002|Overall Study|Death|1|||
149927302|NCT00320788|540868961|FG003|Overall Study|Death|0|||
149927303|NCT00320788|540868962|FG004|Overall Study|Death|1|||
149927304|NCT00320788|540868958|FG000|Overall Study|Lost to Follow-up|0|||
149927305|NCT00320788|540868959|FG001|Overall Study|Lost to Follow-up|2|||
150264905|NCT00640016|542106954|FG000|Overall Study|Withdrawal by Subject|0|||
150264906|NCT00640016|542106955|FG001|Overall Study|Withdrawal by Subject|1|||
150264907|NCT00640016|542106956|FG002|Overall Study|Withdrawal by Subject|0|||
149927306|NCT00320788|540868960|FG002|Overall Study|Lost to Follow-up|1|||
149927307|NCT00320788|540868961|FG003|Overall Study|Lost to Follow-up|0|||
149927308|NCT00320788|540868962|FG004|Overall Study|Lost to Follow-up|0|||
149927309|NCT00320788|540868958|FG000|Overall Study|Decision by the Sponsor|1|||
150264908|NCT00640016|542106957|FG003|Overall Study|Withdrawal by Subject|0|||
150264909|NCT00640016|542106954|FG000|Overall Study|Study termination|2|||
149927310|NCT00320788|540868959|FG001|Overall Study|Decision by the Sponsor|1|||
149927311|NCT00320788|540868960|FG002|Overall Study|Decision by the Sponsor|0|||
149927312|NCT00320788|540868961|FG003|Overall Study|Decision by the Sponsor|0|||
149927313|NCT00320788|540868962|FG004|Overall Study|Decision by the Sponsor|1|||
149927314|NCT00320788|540868958|FG000|Overall Study|Other|1|||
149927315|NCT00320788|540868959|FG001|Overall Study|Other|2|||
149927316|NCT00320788|540868960|FG002|Overall Study|Other|1|||
149927317|NCT00320788|540868961|FG003|Overall Study|Other|1|||
149927318|NCT00320788|540868962|FG004|Overall Study|Other|1|||
149927319|NCT00320788|540868958|FG000|Overall Study|Physician Decision|1|||
149927320|NCT00320788|540868959|FG001|Overall Study|Physician Decision|1|||
149927321|NCT00320788|540868960|FG002|Overall Study|Physician Decision|0|||
149927322|NCT00320788|540868961|FG003|Overall Study|Physician Decision|0|||
149927323|NCT00320788|540868962|FG004|Overall Study|Physician Decision|0|||
149927324|NCT00320788|540868958|FG000|Overall Study|Protocol Violation|0|||
149927325|NCT00320788|540868959|FG001|Overall Study|Protocol Violation|0|||
149927326|NCT00320788|540868960|FG002|Overall Study|Protocol Violation|0|||
149927327|NCT00320788|540868961|FG003|Overall Study|Protocol Violation|0|||
149927328|NCT00320788|540868962|FG004|Overall Study|Protocol Violation|1|||
149927329|NCT00320788|540868958|FG000|Overall Study|Withdrawal by Subject|3|||
149927330|NCT00320788|540868959|FG001|Overall Study|Withdrawal by Subject|0|||
149927331|NCT00320788|540868960|FG002|Overall Study|Withdrawal by Subject|0|||
149927332|NCT00320788|540868961|FG003|Overall Study|Withdrawal by Subject|3|||
149927333|NCT00320788|540868962|FG004|Overall Study|Withdrawal by Subject|1|||
149927334|NCT04346199|540868963|FG000|Overall Study|Death|8|||
149927335|NCT04346199|540868964|FG001|Overall Study|Death|9|||
149927336|NCT04346199|540868963|FG000|Overall Study|Lost to Follow-up|0|||
149927337|NCT04346199|540868964|FG001|Overall Study|Lost to Follow-up|1|||
149927338|NCT04346199|540868963|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
149927339|NCT04346199|540868964|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
149927340|NCT04346199|540868963|FG000|Overall Study|Withdrawal by Subject|5|||
149927341|NCT04346199|540868964|FG001|Overall Study|Withdrawal by Subject|1|||
149927342|NCT00627926|540868965|FG000|Overall Study|Adverse Event|26|||
149927343|NCT00627926|540868966|FG001|Overall Study|Adverse Event|37|||
149927344|NCT00627926|540868967|FG002|Overall Study|Adverse Event|36|||
149927345|NCT00627926|540868965|FG000|Overall Study|Death|1|||
149927346|NCT00627926|540868966|FG001|Overall Study|Death|0|||
149927347|NCT00627926|540868967|FG002|Overall Study|Death|0|||
149927348|NCT00627926|540868965|FG000|Overall Study|Lost to Follow-up|4|||
149927349|NCT00627926|540868966|FG001|Overall Study|Lost to Follow-up|3|||
149927350|NCT00627926|540868967|FG002|Overall Study|Lost to Follow-up|4|||
149927351|NCT00627926|540868965|FG000|Overall Study|Withdrawal by Subject|2|||
149927352|NCT00627926|540868966|FG001|Overall Study|Withdrawal by Subject|1|||
149927353|NCT00627926|540868967|FG002|Overall Study|Withdrawal by Subject|0|||
149927354|NCT00627926|540868965|FG000|Overall Study|Lack of Efficacy|118|||
149927355|NCT00627926|540868966|FG001|Overall Study|Lack of Efficacy|40|||
149927356|NCT00627926|540868967|FG002|Overall Study|Lack of Efficacy|38|||
149927357|NCT00627926|540868965|FG000|Overall Study|Noncompliance/unspecified|8|||
149927358|NCT00627926|540868966|FG001|Overall Study|Noncompliance/unspecified|23|||
149927359|NCT00627926|540868967|FG002|Overall Study|Noncompliance/unspecified|17|||
149927360|NCT03414229|540868968|FG000|Overall Study|Adverse Event|1|||
149927361|NCT03414229|540868969|FG001|Overall Study|Adverse Event|0|||
149927362|NCT03414229|540868970|FG002|Overall Study|Adverse Event|2|||
149927363|NCT03414229|540868971|FG003|Overall Study|Adverse Event|1|||
149927364|NCT03414229|540868968|FG000|Overall Study|Lack of Efficacy|7|||
149927365|NCT03414229|540868969|FG001|Overall Study|Lack of Efficacy|4|||
150264910|NCT00640016|542106955|FG001|Overall Study|Study termination|1|||
150264911|NCT00640016|542106956|FG002|Overall Study|Study termination|3|||
150264912|NCT00640016|542106957|FG003|Overall Study|Study termination|2|||
150264913|NCT00640016|542106954|FG000|Overall Study|Adverse Event|0|||
150264914|NCT00640016|542106955|FG001|Overall Study|Adverse Event|0|||
150264915|NCT00640016|542106956|FG002|Overall Study|Adverse Event|0|||
149927366|NCT03414229|540868970|FG002|Overall Study|Lack of Efficacy|1|||
149927367|NCT03414229|540868971|FG003|Overall Study|Lack of Efficacy|9|||
149927368|NCT03414229|540868968|FG000|Overall Study|Change in therapy|1|||
150264916|NCT00640016|542106957|FG003|Overall Study|Adverse Event|1|||
149927369|NCT03414229|540868969|FG001|Overall Study|Change in therapy|0|||
150264917|NCT01287065|542106958|FG000|Treatment Period 1|Adverse Event|0|||
149927370|NCT03414229|540868970|FG002|Overall Study|Change in therapy|0|||
149927371|NCT03414229|540868971|FG003|Overall Study|Change in therapy|0|||
149927372|NCT03414229|540868968|FG000|Overall Study|Pregnancy|0|||
149927373|NCT03414229|540868969|FG001|Overall Study|Pregnancy|0|||
149927374|NCT03414229|540868970|FG002|Overall Study|Pregnancy|1|||
149927375|NCT03414229|540868971|FG003|Overall Study|Pregnancy|0|||
149927376|NCT03414229|540868968|FG000|Overall Study|Withdrawal by Subject|0|||
149927377|NCT03414229|540868969|FG001|Overall Study|Withdrawal by Subject|1|||
150264918|NCT01287065|542106959|FG001|Treatment Period 1|Adverse Event|0|||
150264919|NCT01287065|542106960|FG002|Treatment Period 1|Adverse Event|0|||
150264920|NCT01287065|542106961|FG003|Treatment Period 1|Adverse Event|0|||
150264921|NCT01287065|542106962|FG004|Treatment Period 1|Adverse Event|1|||
150264922|NCT01287065|542106963|FG005|Treatment Period 1|Adverse Event|0|||
150264923|NCT01287065|542106958|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150264924|NCT01287065|542106959|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150264925|NCT01287065|542106960|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150264926|NCT01287065|542106961|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150264927|NCT01287065|542106962|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150264928|NCT01287065|542106963|FG005|Treatment Period 1|Withdrawal by Subject|1|||
150264929|NCT01259726|542106964|FG000|Overall Study|Death|1|||
150264930|NCT01259726|542106965|FG001|Overall Study|Death|0|||
150264931|NCT01259726|542106966|FG002|Overall Study|Death|0|||
150264932|NCT01259726|542106967|FG003|Overall Study|Death|0|||
150264933|NCT01259726|542106964|FG000|Overall Study|Physician Decision|2|||
150264934|NCT01259726|542106965|FG001|Overall Study|Physician Decision|0|||
150264935|NCT01259726|542106966|FG002|Overall Study|Physician Decision|1|||
150264936|NCT01259726|542106967|FG003|Overall Study|Physician Decision|1|||
150264937|NCT01259726|542106964|FG000|Overall Study|Withdrawal by Subject|1|||
150264938|NCT01259726|542106965|FG001|Overall Study|Withdrawal by Subject|3|||
150264939|NCT01259726|542106966|FG002|Overall Study|Withdrawal by Subject|2|||
150264940|NCT01259726|542106967|FG003|Overall Study|Withdrawal by Subject|1|||
150264941|NCT01259726|542106964|FG000|Overall Study|Lost to Follow-up|1|||
150264942|NCT01259726|542106965|FG001|Overall Study|Lost to Follow-up|1|||
150264943|NCT01259726|542106966|FG002|Overall Study|Lost to Follow-up|1|||
150264944|NCT01259726|542106967|FG003|Overall Study|Lost to Follow-up|3|||
150264945|NCT01211197|542106969|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150264946|NCT01211197|542106970|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150264947|NCT01211197|542106971|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
150264948|NCT01211197|542106972|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150264949|NCT01211197|542106973|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150264950|NCT01211197|542106974|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150264951|NCT01211197|542106969|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
150264952|NCT01211197|542106970|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
150264953|NCT01211197|542106971|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
150264954|NCT01211197|542106972|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
150264955|NCT01211197|542106973|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
150264956|NCT01211197|542106974|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
150264957|NCT00261846|542106975|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
150264958|NCT00261846|542106976|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
150264959|NCT00261846|542106977|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
150264960|NCT00261846|542106978|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264961|NCT00261846|542106979|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264962|NCT00261846|542106980|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264963|NCT00261846|542106981|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264964|NCT00261846|542106982|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264965|NCT00261846|542106983|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264966|NCT00261846|542106984|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264967|NCT00261846|542106985|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264968|NCT00261846|542106986|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
150264969|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264970|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264971|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264972|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
150264973|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264974|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264975|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264976|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264977|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
150264978|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264979|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264980|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
150264981|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264982|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264983|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264984|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
150264985|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
149927378|NCT03414229|540868970|FG002|Overall Study|Withdrawal by Subject|1|||
149927379|NCT03414229|540868971|FG003|Overall Study|Withdrawal by Subject|0|||
150264986|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
150264987|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
149927380|NCT04533438|540868975|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
149927381|NCT04533438|540868976|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
149927382|NCT00099632|540868979|FG000|Overall Study|Lost to Follow-up|1|||
149927383|NCT00099632|540868980|FG001|Overall Study|Lost to Follow-up|0|||
150264988|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
150264989|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264990|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
150264991|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264992|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
150264993|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150264994|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150264995|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150264996|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
150264997|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
150264998|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150264999|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
150265000|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150265001|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
150265002|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
150265003|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
150265004|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
150265005|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
150265006|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
150265007|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
150265008|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
150265009|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
150265010|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
150265011|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
150265012|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
150265013|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
150265014|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
150265015|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
150265016|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
150265017|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
150265018|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
150265019|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
150265020|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
150265021|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
150265022|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
150265023|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
150265024|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
150265025|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
150265026|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
150265027|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
150265028|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
150265029|NCT00261846|542106975|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
150265030|NCT00261846|542106976|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
150265031|NCT00261846|542106977|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
150265032|NCT00261846|542106978|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
150265033|NCT00261846|542106979|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
150265034|NCT00261846|542106980|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
150265035|NCT00261846|542106981|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
150265036|NCT00261846|542106982|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
150265037|NCT00261846|542106983|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
150265038|NCT00261846|542106984|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
150265039|NCT00261846|542106985|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
150265040|NCT00261846|542106986|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
150265041|NCT00928447|542106993|FG000|Overall Study|Withdrawal by Subject|1|||
150265042|NCT00928447|542106993|FG000|Overall Study|Investigator's decision|1|||
150265043|NCT01259284|542106994|FG000|Overall Study|Study Termination|2|||
150265044|NCT01259284|542106995|FG001|Overall Study|Study Termination|0|||
150265045|NCT01259284|542106996|FG002|Overall Study|Study Termination|0|||
149927384|NCT00099632|540868981|FG002|Overall Study|Lost to Follow-up|3|||
149927385|NCT00099632|540868982|FG003|Overall Study|Lost to Follow-up|1|||
150265046|NCT00307125|542107000|FG000|Screening Phase|Adverse Event|1|||
150265047|NCT00307125|542107001|FG001|Screening Phase|Adverse Event|0|||
150265048|NCT00307125|542107002|FG002|Screening Phase|Adverse Event|0|||
150265049|NCT00307125|542107000|FG000|Screening Phase|Protocol Violation|27|||
150265050|NCT00307125|542107001|FG001|Screening Phase|Protocol Violation|0|||
150265051|NCT00307125|542107002|FG002|Screening Phase|Protocol Violation|0|||
150265052|NCT00307125|542107000|FG000|Screening Phase|Lost to Follow-up|87|||
149927386|NCT00099632|540868983|FG004|Overall Study|Lost to Follow-up|1|||
150265053|NCT00307125|542107001|FG001|Screening Phase|Lost to Follow-up|0|||
150265054|NCT00307125|542107002|FG002|Screening Phase|Lost to Follow-up|0|||
150265055|NCT00307125|542107000|FG000|Screening Phase|Death|10|||
150265056|NCT00307125|542107001|FG001|Screening Phase|Death|0|||
150265057|NCT00307125|542107002|FG002|Screening Phase|Death|0|||
150265058|NCT00307125|542107000|FG000|Screening Phase|Withdrawal by Subject|77|||
150265059|NCT00307125|542107001|FG001|Screening Phase|Withdrawal by Subject|0|||
150265060|NCT00307125|542107002|FG002|Screening Phase|Withdrawal by Subject|0|||
150265061|NCT00307125|542107000|FG000|Screening Phase|Physician Decision|26|||
150265062|NCT00307125|542107001|FG001|Screening Phase|Physician Decision|0|||
150265063|NCT00307125|542107002|FG002|Screening Phase|Physician Decision|0|||
150265064|NCT00307125|542107000|FG000|Screening Phase|Sponsor Decision|4|||
150265065|NCT00307125|542107001|FG001|Screening Phase|Sponsor Decision|0|||
150265066|NCT00307125|542107002|FG002|Screening Phase|Sponsor Decision|0|||
150265067|NCT00307125|542107000|FG000|Screening Phase|Study Terminated|17|||
150265068|NCT00307125|542107001|FG001|Screening Phase|Study Terminated|0|||
150265069|NCT00307125|542107002|FG002|Screening Phase|Study Terminated|0|||
150265070|NCT00307125|542107000|FG000|Screening Phase|Graft Loss|3|||
150265071|NCT00307125|542107001|FG001|Screening Phase|Graft Loss|0|||
150265072|NCT00307125|542107002|FG002|Screening Phase|Graft Loss|0|||
150265073|NCT00307125|542107000|FG000|Screening Phase|Graft Failure|8|||
150265074|NCT00307125|542107001|FG001|Screening Phase|Graft Failure|0|||
150265075|NCT00307125|542107002|FG002|Screening Phase|Graft Failure|0|||
150265076|NCT00307125|542107000|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
150265077|NCT00307125|542107001|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
150265078|NCT00307125|542107002|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
150265079|NCT00307125|542107000|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
150265080|NCT00307125|542107001|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
150265081|NCT00307125|542107002|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
150265082|NCT00307125|542107000|FG000|Screening Phase|Moved or transferred facilities|34|||
150265083|NCT00307125|542107001|FG001|Screening Phase|Moved or transferred facilities|0|||
150265084|NCT00307125|542107002|FG002|Screening Phase|Moved or transferred facilities|0|||
150265085|NCT00307125|542107000|FG000|Screening Phase|Received Pancreas Transplant|8|||
150265086|NCT00307125|542107001|FG001|Screening Phase|Received Pancreas Transplant|0|||
150265087|NCT00307125|542107002|FG002|Screening Phase|Received Pancreas Transplant|0|||
150265088|NCT00307125|542107000|FG000|Screening Phase|Ineligible for pilot|4|||
150265089|NCT00307125|542107001|FG001|Screening Phase|Ineligible for pilot|0|||
150265090|NCT00307125|542107002|FG002|Screening Phase|Ineligible for pilot|0|||
150265091|NCT00307125|542107000|FG000|Screening Phase|Try to get pregnant|1|||
150265092|NCT00307125|542107001|FG001|Screening Phase|Try to get pregnant|0|||
150265093|NCT00307125|542107002|FG002|Screening Phase|Try to get pregnant|0|||
150265094|NCT00307125|542107000|FG000|Screening Phase|Developed acute leukemia|1|||
150265095|NCT00307125|542107001|FG001|Screening Phase|Developed acute leukemia|0|||
150265096|NCT00307125|542107002|FG002|Screening Phase|Developed acute leukemia|0|||
150265097|NCT00307125|542107000|FG000|Screening Phase|Metastatic colon cancer|1|||
150265098|NCT00307125|542107001|FG001|Screening Phase|Metastatic colon cancer|0|||
150265099|NCT00307125|542107002|FG002|Screening Phase|Metastatic colon cancer|0|||
150265100|NCT00307125|542107000|FG000|Screening Phase|Malignancy|1|||
150265101|NCT00307125|542107001|FG001|Screening Phase|Malignancy|0|||
150265102|NCT00307125|542107002|FG002|Screening Phase|Malignancy|0|||
150265103|NCT00307125|542107000|FG000|Screening Phase|PAK|1|||
150265104|NCT00307125|542107001|FG001|Screening Phase|PAK|0|||
150265105|NCT00307125|542107002|FG002|Screening Phase|PAK|0|||
150265106|NCT00307125|542107000|FG000|Screening Phase|Ineligible|1|||
150265107|NCT00307125|542107001|FG001|Screening Phase|Ineligible|0|||
150265108|NCT00307125|542107002|FG002|Screening Phase|Ineligible|0|||
150265109|NCT00307125|542107000|FG000|Screening Phase|Screen Error|1|||
150265110|NCT00307125|542107001|FG001|Screening Phase|Screen Error|0|||
150265111|NCT00307125|542107002|FG002|Screening Phase|Screen Error|0|||
150265112|NCT00307125|542107000|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
150265113|NCT00307125|542107001|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
150265114|NCT00307125|542107002|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
150265115|NCT00307125|542107000|FG000|Screening Phase|AMR and treated with rituximab|1|||
149927387|NCT00099632|540868984|FG005|Overall Study|Lost to Follow-up|0|||
149927388|NCT00099632|540868979|FG000|Overall Study|Withdrawal by Subject|0|||
149927389|NCT00099632|540868980|FG001|Overall Study|Withdrawal by Subject|1|||
149927390|NCT00099632|540868981|FG002|Overall Study|Withdrawal by Subject|0|||
149927391|NCT00099632|540868982|FG003|Overall Study|Withdrawal by Subject|0|||
150265116|NCT00307125|542107001|FG001|Screening Phase|AMR and treated with rituximab|0|||
150265117|NCT00307125|542107002|FG002|Screening Phase|AMR and treated with rituximab|0|||
150265118|NCT00307125|542107000|FG000|Screening Phase|Coronary artery bypass|1|||
150265119|NCT00307125|542107001|FG001|Screening Phase|Coronary artery bypass|0|||
150265120|NCT00307125|542107002|FG002|Screening Phase|Coronary artery bypass|0|||
150265121|NCT00307125|542107000|FG000|Pilot Phase|Lost to Follow-up|0|||
150265122|NCT00307125|542107001|FG001|Pilot Phase|Lost to Follow-up|1|||
150265123|NCT00307125|542107002|FG002|Pilot Phase|Lost to Follow-up|0|||
150265124|NCT00307125|542107000|FG000|Pilot Phase|Withdrawal by Subject|0|||
150265125|NCT00307125|542107001|FG001|Pilot Phase|Withdrawal by Subject|1|||
150265126|NCT00307125|542107002|FG002|Pilot Phase|Withdrawal by Subject|1|||
149927392|NCT00099632|540868983|FG004|Overall Study|Withdrawal by Subject|0|||
149927393|NCT00099632|540868984|FG005|Overall Study|Withdrawal by Subject|1|||
149927394|NCT00099632|540868979|FG000|Overall Study|Protocol Violation|0|||
149927395|NCT00099632|540868980|FG001|Overall Study|Protocol Violation|0|||
149927396|NCT00099632|540868981|FG002|Overall Study|Protocol Violation|0|||
149927397|NCT00099632|540868982|FG003|Overall Study|Protocol Violation|0|||
149927398|NCT00099632|540868983|FG004|Overall Study|Protocol Violation|0|||
149927399|NCT00099632|540868984|FG005|Overall Study|Protocol Violation|1|||
149927400|NCT00571662|540868987|FG000|Overall Study|Withdrawal by Subject|2|||
149927401|NCT00571662|540868987|FG000|Overall Study|psychiatric instability|1|||
149927402|NCT00571662|540868987|FG000|Overall Study|Adverse Event|5|||
149927403|NCT01429298|540868990|FG000|Overall Study|Protocol Violation|4|||
149927404|NCT01429298|540868991|FG001|Overall Study|Protocol Violation|6|||
149927405|NCT02385110|540868994|FG000|Overall Study|Early Death|1|||
149927406|NCT02385110|540868995|FG001|Overall Study|Early Death|0|||
149927407|NCT03300180|540868997|FG000|Baseline|Withdrawal by Subject|4|||
149927408|NCT03300180|540868998|FG001|Baseline|Withdrawal by Subject|6|||
149927409|NCT03300180|540868999|FG002|Baseline|Withdrawal by Subject|4|||
149927410|NCT03300180|540868997|FG000|6 Month Outcome|Withdrawal by Subject|12|||
149927411|NCT03300180|540868998|FG001|6 Month Outcome|Withdrawal by Subject|12|||
149927412|NCT03300180|540868999|FG002|6 Month Outcome|Withdrawal by Subject|19|||
149927413|NCT03300180|540868997|FG000|6 Month Outcome|Death|2|||
149927414|NCT03300180|540868998|FG001|6 Month Outcome|Death|4|||
149927415|NCT03300180|540868999|FG002|6 Month Outcome|Death|3|||
149927416|NCT03300180|540868997|FG000|6 Month Outcome|Missed Assessment|43|||
149927417|NCT03300180|540868998|FG001|6 Month Outcome|Missed Assessment|52|||
149927418|NCT03300180|540868999|FG002|6 Month Outcome|Missed Assessment|46|||
149927419|NCT03300180|540868997|FG000|12 Month Outcome|Withdrawal by Subject|3|||
149927420|NCT03300180|540868998|FG001|12 Month Outcome|Withdrawal by Subject|6|||
149927421|NCT03300180|540868999|FG002|12 Month Outcome|Withdrawal by Subject|6|||
149927422|NCT03300180|540868997|FG000|12 Month Outcome|Death|9|||
149927423|NCT03300180|540868998|FG001|12 Month Outcome|Death|6|||
149927424|NCT03300180|540868999|FG002|12 Month Outcome|Death|6|||
149927425|NCT03300180|540868997|FG000|12 Month Outcome|Missed Assessment|62|||
149927426|NCT03300180|540868998|FG001|12 Month Outcome|Missed Assessment|59|||
149927427|NCT03300180|540868999|FG002|12 Month Outcome|Missed Assessment|58|||
149927428|NCT03300180|540868997|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
149927429|NCT03300180|540868998|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
149927430|NCT03300180|540868999|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
149927431|NCT03300180|540868997|FG000|18 Month Outcome Assessment|Death|8|||
149927432|NCT03300180|540868998|FG001|18 Month Outcome Assessment|Death|5|||
149927433|NCT03300180|540868999|FG002|18 Month Outcome Assessment|Death|5|||
149927434|NCT03300180|540868997|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
149927435|NCT03300180|540868998|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
149927436|NCT03300180|540868999|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
149927437|NCT03300180|540868997|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
150265127|NCT00051363|542107004|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
150265128|NCT00051363|542107005|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
150265129|NCT00051363|542107004|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
150265130|NCT00051363|542107005|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
150265131|NCT00051363|542107004|FG000|Overall Study|Death|2|||
150265132|NCT00051363|542107005|FG001|Overall Study|Death|2|||
150265133|NCT00051363|542107004|FG000|Overall Study|Excluded Pre-Randomization|2|||
150265134|NCT00051363|542107005|FG001|Overall Study|Excluded Pre-Randomization|5|||
150265135|NCT00926211|542107006|FG000|Overall Study|Lost to Follow-up|1|||
150265136|NCT01032382|542107007|FG000|Overall Study|Disease dissemination|1|||
150265137|NCT01032382|542107008|FG001|Overall Study|Disease dissemination|1|||
150265138|NCT01032382|542107007|FG000|Overall Study|Treatment failure|3|||
150265139|NCT01032382|542107008|FG001|Overall Study|Treatment failure|1|||
150265140|NCT01032382|542107007|FG000|Overall Study|Index lesion relapse|1|||
150265141|NCT01032382|542107008|FG001|Overall Study|Index lesion relapse|3|||
150265142|NCT01242800|542107009|FG000|Overall Study|Patient refusal|0|||
149927438|NCT03300180|540868998|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
149927439|NCT03300180|540868999|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
150265143|NCT01242800|542107010|FG001|Overall Study|Patient refusal|10|||
149927440|NCT03300180|540868997|FG000|24 Month Outcome Assessment|Death|13|||
149927441|NCT03300180|540868998|FG001|24 Month Outcome Assessment|Death|13|||
149927442|NCT03300180|540868999|FG002|24 Month Outcome Assessment|Death|3|||
149927443|NCT03300180|540868997|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
149927444|NCT03300180|540868998|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
149927445|NCT03300180|540868999|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
149927446|NCT01554163|540869002|FG000|Overall Study|Adverse Event|3|||
150265144|NCT01242800|542107009|FG000|Overall Study|Physician Decision|0|||
150265145|NCT01242800|542107010|FG001|Overall Study|Physician Decision|1|||
150265146|NCT01242800|542107009|FG000|Overall Study|Disease progression|0|||
150265147|NCT01242800|542107010|FG001|Overall Study|Disease progression|3|||
150265148|NCT01242800|542107009|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
150265149|NCT01242800|542107010|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
150265150|NCT01242800|542107009|FG000|Overall Study|Reasons not reported|0|||
150265151|NCT01242800|542107010|FG001|Overall Study|Reasons not reported|4|||
150265152|NCT02640157|542107012|FG000|Overall Study|Adverse Event|2|||
150265153|NCT02640157|542107013|FG001|Overall Study|Adverse Event|2|||
150265154|NCT02640157|542107014|FG002|Overall Study|Adverse Event|1|||
150265155|NCT02640157|542107012|FG000|Overall Study|Withdrew consent|2|||
150265156|NCT02640157|542107013|FG001|Overall Study|Withdrew consent|0|||
150265157|NCT02640157|542107014|FG002|Overall Study|Withdrew consent|2|||
150265158|NCT02640157|542107012|FG000|Overall Study|Lost to Follow-up|9|||
150265159|NCT02640157|542107013|FG001|Overall Study|Lost to Follow-up|2|||
150265160|NCT02640157|542107014|FG002|Overall Study|Lost to Follow-up|7|||
150265161|NCT02640157|542107012|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
150265162|NCT02640157|542107013|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
150265163|NCT02640157|542107014|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
150265164|NCT00710021|542107015|FG000|Overall Study|Lost to Follow-up|1|||
150265165|NCT00710021|542107016|FG001|Overall Study|Lost to Follow-up|0|||
150265166|NCT00710021|542107017|FG002|Overall Study|Lost to Follow-up|0|||
150265167|NCT00710021|542107015|FG000|Overall Study|Subject's Decision|0|||
150265168|NCT00710021|542107016|FG001|Overall Study|Subject's Decision|1|||
150265169|NCT00710021|542107017|FG002|Overall Study|Subject's Decision|0|||
150265170|NCT00710021|542107015|FG000|Overall Study|Subject misrandomized|0|||
150265171|NCT00710021|542107016|FG001|Overall Study|Subject misrandomized|1|||
150265172|NCT00710021|542107017|FG002|Overall Study|Subject misrandomized|1|||
150265173|NCT00710021|542107015|FG000|Overall Study|Physician Decision|0|||
150265174|NCT00710021|542107016|FG001|Overall Study|Physician Decision|1|||
150265175|NCT00710021|542107017|FG002|Overall Study|Physician Decision|0|||
150265176|NCT01679405|542107018|FG000|Overall Study|Death|2|||
150265177|NCT01679405|542107019|FG001|Overall Study|Death|5|||
150265178|NCT01536015|542107020|FG000|Overall Study|Adverse Event|1|||
150265179|NCT01536015|542107021|FG001|Overall Study|Adverse Event|4|||
150265180|NCT01536015|542107020|FG000|Overall Study|Lost to Follow-up|0|||
150265181|NCT01536015|542107021|FG001|Overall Study|Lost to Follow-up|1|||
150265182|NCT01536015|542107020|FG000|Overall Study|Inclusion Criterion not met|2|||
150265183|NCT01536015|542107021|FG001|Overall Study|Inclusion Criterion not met|0|||
149927447|NCT01554163|540869003|FG001|Overall Study|Adverse Event|0|||
149927448|NCT01554163|540869002|FG000|Overall Study|Lack of Efficacy|1|||
149927449|NCT01554163|540869003|FG001|Overall Study|Lack of Efficacy|0|||
149927450|NCT01554163|540869002|FG000|Overall Study|Lost to Follow-up|1|||
149927451|NCT01554163|540869003|FG001|Overall Study|Lost to Follow-up|0|||
149927452|NCT01554163|540869002|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149927453|NCT01554163|540869003|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149927454|NCT01554163|540869002|FG000|Overall Study|Protocol Violation|0|||
149927455|NCT01554163|540869003|FG001|Overall Study|Protocol Violation|4|||
149927456|NCT01554163|540869002|FG000|Overall Study|Withdrawal by Subject|1|||
149927457|NCT01554163|540869003|FG001|Overall Study|Withdrawal by Subject|5|||
149927458|NCT01554163|540869002|FG000|Overall Study|Not Treated|1|||
149927459|NCT01554163|540869003|FG001|Overall Study|Not Treated|0|||
149927460|NCT01941537|540869004|FG000|Overall Study|Lack of Efficacy|1|||
149927461|NCT01941537|540869005|FG001|Overall Study|Lack of Efficacy|2|||
149927462|NCT01941537|540869004|FG000|Overall Study|Lost to Follow-up|1|||
149927463|NCT01941537|540869005|FG001|Overall Study|Lost to Follow-up|0|||
149927464|NCT01941537|540869004|FG000|Overall Study|Pregnancy|1|||
149927465|NCT01941537|540869005|FG001|Overall Study|Pregnancy|0|||
149927466|NCT01941537|540869004|FG000|Overall Study|Adverse Event|1|||
149927467|NCT01941537|540869005|FG001|Overall Study|Adverse Event|0|||
149927468|NCT01941537|540869004|FG000|Overall Study|Withdrawal by Subject|0|||
149927469|NCT01941537|540869005|FG001|Overall Study|Withdrawal by Subject|1|||
149927470|NCT05259163|540870649|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
149927471|NCT05259163|540870650|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
149927472|NCT05251233|540870651|FG000|Overall Study|Disease progression - did not start treatment|0|||
149927473|NCT05251233|540870652|FG001|Overall Study|Disease progression - did not start treatment|0|||
149927474|NCT05251233|540870653|FG002|Overall Study|Disease progression - did not start treatment|5|||
149927475|NCT05251233|540870651|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
149927476|NCT05251233|540870652|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
149927477|NCT05251233|540870653|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
149927478|NCT05251233|540870651|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
150265184|NCT01536015|542107020|FG000|Overall Study|Study closure|5|||
150265185|NCT01536015|542107021|FG001|Overall Study|Study closure|5|||
150265186|NCT04508023|542107022|FG000|Overall Study|Withdrawal by Subject|1|||
150265187|NCT04508023|542107023|FG001|Overall Study|Withdrawal by Subject|2|||
150265188|NCT00511901|542107026|FG000|Overall Study|Withdrawal by Subject|1|||
150265189|NCT00511901|542107027|FG001|Overall Study|Withdrawal by Subject|3|||
150265190|NCT02447172|542107028|FG000|Overall Study|Adverse Event|11|||
150265191|NCT02447172|542107029|FG001|Overall Study|Adverse Event|8|||
149927479|NCT05251233|540870652|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
150265192|NCT02447172|542107030|FG002|Overall Study|Adverse Event|7|||
150265193|NCT02447172|542107028|FG000|Overall Study|Death|3|||
150265194|NCT02447172|542107029|FG001|Overall Study|Death|1|||
150265195|NCT02447172|542107030|FG002|Overall Study|Death|0|||
149927480|NCT05251233|540870653|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
149927481|NCT05251233|540870651|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
149927482|NCT05251233|540870652|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
149927483|NCT05251233|540870653|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
149927484|NCT05251233|540870651|FG000|Overall Study|Death - did not start treatment|3|||
149927485|NCT05251233|540870652|FG001|Overall Study|Death - did not start treatment|0|||
149927486|NCT05251233|540870653|FG002|Overall Study|Death - did not start treatment|0|||
149927487|NCT05251233|540870651|FG000|Overall Study|Withdrawal by Subject|2|||
149927488|NCT05251233|540870652|FG001|Overall Study|Withdrawal by Subject|2|||
149927489|NCT05251233|540870653|FG002|Overall Study|Withdrawal by Subject|0|||
149927490|NCT05251233|540870651|FG000|Overall Study|Other complicating disease|2|||
149927491|NCT05251233|540870652|FG001|Overall Study|Other complicating disease|1|||
149927492|NCT05251233|540870653|FG002|Overall Study|Other complicating disease|0|||
149927493|NCT05251233|540870651|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
149927494|NCT05251233|540870652|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
149927495|NCT05251233|540870653|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
149927496|NCT05251233|540870651|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
149927497|NCT05251233|540870652|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
149927498|NCT05251233|540870653|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
149927499|NCT01239394|540870654|FG000|Overall Study|Adverse Event|1|||
149927500|NCT00524771|540870656|FG000|Overall Study|Protocol Violation|220|||
149927501|NCT00524771|540870657|FG001|Overall Study|Protocol Violation|585|||
149927502|NCT00377637|540870658|FG000|Induction Phase|Adverse Event|12|||
149927503|NCT00377637|540870659|FG001|Induction Phase|Adverse Event|21|||
149927504|NCT00377637|540870660|FG002|Induction Phase|Adverse Event|0|||
149927505|NCT00377637|540870661|FG003|Induction Phase|Adverse Event|0|||
150265196|NCT02447172|542107028|FG000|Overall Study|Protocol Violation|2|||
150265197|NCT02447172|542107029|FG001|Overall Study|Protocol Violation|1|||
150265198|NCT02447172|542107030|FG002|Overall Study|Protocol Violation|2|||
150265199|NCT02447172|542107028|FG000|Overall Study|Lost to Follow-up|7|||
150265200|NCT02447172|542107029|FG001|Overall Study|Lost to Follow-up|4|||
150265201|NCT02447172|542107030|FG002|Overall Study|Lost to Follow-up|4|||
150265202|NCT02447172|542107028|FG000|Overall Study|Withdrawal by Subject|5|||
150265203|NCT02447172|542107029|FG001|Overall Study|Withdrawal by Subject|1|||
150265204|NCT02447172|542107030|FG002|Overall Study|Withdrawal by Subject|3|||
150265205|NCT02447172|542107028|FG000|Overall Study|protocol specific treatment unrelated|3|||
150265206|NCT02447172|542107029|FG001|Overall Study|protocol specific treatment unrelated|0|||
150265207|NCT02447172|542107030|FG002|Overall Study|protocol specific treatment unrelated|2|||
150265208|NCT01204398|542107031|FG000|Overall Study|Adverse Event|1|||
150265209|NCT03261700|542107032|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
150265210|NCT03261700|542107033|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
150265211|NCT00770341|542107034|FG000|Overall Study|Did not meet eligibility criteria|1|||
150265212|NCT00770341|542107035|FG001|Overall Study|Did not meet eligibility criteria|0|||
150265213|NCT00770341|542107036|FG002|Overall Study|Did not meet eligibility criteria|0|||
150265214|NCT00770341|542107034|FG000|Overall Study|Withdrawal by Subject|0|||
150265215|NCT00770341|542107035|FG001|Overall Study|Withdrawal by Subject|1|||
150265216|NCT00770341|542107036|FG002|Overall Study|Withdrawal by Subject|0|||
150265217|NCT00770341|542107034|FG000|Overall Study|Clinical Adverse Event|3|||
150265218|NCT00770341|542107035|FG001|Overall Study|Clinical Adverse Event|1|||
150265219|NCT00770341|542107036|FG002|Overall Study|Clinical Adverse Event|2|||
150265220|NCT00770341|542107034|FG000|Overall Study|Laboratory adverse event|3|||
150265221|NCT00770341|542107035|FG001|Overall Study|Laboratory adverse event|3|||
150265222|NCT00770341|542107036|FG002|Overall Study|Laboratory adverse event|0|||
150265223|NCT00770341|542107034|FG000|Overall Study|Lack of Efficacy|3|||
149927506|NCT00377637|540870658|FG000|Induction Phase|Deterioration/serum creatinine|2|||
149927507|NCT00377637|540870659|FG001|Induction Phase|Deterioration/serum creatinine|0|||
149927508|NCT00377637|540870660|FG002|Induction Phase|Deterioration/serum creatinine|0|||
149927509|NCT00377637|540870661|FG003|Induction Phase|Deterioration/serum creatinine|0|||
149927510|NCT00377637|540870658|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
149927511|NCT00377637|540870659|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
149927512|NCT00377637|540870660|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
149927513|NCT00377637|540870661|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
150265224|NCT00770341|542107035|FG001|Overall Study|Lack of Efficacy|0|||
149927514|NCT00377637|540870658|FG000|Induction Phase|Lost to Follow-up|2|||
150265225|NCT00770341|542107036|FG002|Overall Study|Lack of Efficacy|1|||
150265226|NCT00770341|542107034|FG000|Overall Study|Other|1|||
150265227|NCT00770341|542107035|FG001|Overall Study|Other|0|||
150265228|NCT00770341|542107036|FG002|Overall Study|Other|0|||
150265229|NCT00770341|542107034|FG000|Overall Study|Not treated|1|||
150265230|NCT00770341|542107035|FG001|Overall Study|Not treated|0|||
150265231|NCT00770341|542107036|FG002|Overall Study|Not treated|0|||
150265232|NCT02533570|542107038|FG000|Overall Study|Adverse Event|0|||
150265233|NCT02533570|542107039|FG001|Overall Study|Adverse Event|1|||
150265234|NCT02533570|542107040|FG002|Overall Study|Adverse Event|1|||
150265235|NCT00529958|542107041|FG000|2-Year Follow-up|Lost to Follow-up|1|||
150265236|NCT00529958|542107042|FG001|2-Year Follow-up|Lost to Follow-up|2|||
149927515|NCT00377637|540870659|FG001|Induction Phase|Lost to Follow-up|1|||
149927516|NCT00377637|540870660|FG002|Induction Phase|Lost to Follow-up|0|||
149927517|NCT00377637|540870661|FG003|Induction Phase|Lost to Follow-up|0|||
149927518|NCT00377637|540870658|FG000|Induction Phase|Death|1|||
149927519|NCT00377637|540870659|FG001|Induction Phase|Death|3|||
149927520|NCT00377637|540870660|FG002|Induction Phase|Death|0|||
149927521|NCT00377637|540870661|FG003|Induction Phase|Death|0|||
149927522|NCT00377637|540870658|FG000|Induction Phase|Withdrawal by Subject|5|||
149927523|NCT00377637|540870659|FG001|Induction Phase|Withdrawal by Subject|6|||
149927524|NCT00377637|540870660|FG002|Induction Phase|Withdrawal by Subject|0|||
149927525|NCT00377637|540870661|FG003|Induction Phase|Withdrawal by Subject|0|||
149927526|NCT00377637|540870658|FG000|Induction Phase|Physician Decision|3|||
149927527|NCT00377637|540870659|FG001|Induction Phase|Physician Decision|1|||
149927528|NCT00377637|540870660|FG002|Induction Phase|Physician Decision|0|||
149927529|NCT00377637|540870661|FG003|Induction Phase|Physician Decision|0|||
149927530|NCT00377637|540870658|FG000|Induction Phase|Sponsor decision|1|||
149927531|NCT00377637|540870659|FG001|Induction Phase|Sponsor decision|2|||
149927532|NCT00377637|540870660|FG002|Induction Phase|Sponsor decision|0|||
149927533|NCT00377637|540870661|FG003|Induction Phase|Sponsor decision|0|||
150265237|NCT00529958|542107043|FG002|2-Year Follow-up|Lost to Follow-up|2|||
150265238|NCT00529958|542107041|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
150265239|NCT00529958|542107042|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
150265240|NCT00529958|542107043|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
150265241|NCT00529958|542107041|FG000|5-Year Follow-up|Lost to Follow-up|2|||
150265242|NCT00529958|542107042|FG001|5-Year Follow-up|Lost to Follow-up|3|||
150265243|NCT00529958|542107043|FG002|5-Year Follow-up|Lost to Follow-up|1|||
150265244|NCT00529958|542107041|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
150265245|NCT00529958|542107042|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
150265246|NCT00529958|542107043|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
150265247|NCT03816332|542107044|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
150265248|NCT03816332|542107044|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
150265249|NCT03316300|542107047|FG000|Overall Study|Withdrawal by Subject|3|||
150265250|NCT03316300|542107048|FG001|Overall Study|Withdrawal by Subject|2|||
150265251|NCT03316300|542107047|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
150265252|NCT03316300|542107048|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
150265253|NCT03316300|542107047|FG000|Overall Study|Adverse Event|1|||
150265254|NCT03316300|542107048|FG001|Overall Study|Adverse Event|0|||
150265255|NCT03316300|542107047|FG000|Overall Study|COVID-19|0|||
150265256|NCT03316300|542107048|FG001|Overall Study|COVID-19|1|||
150265257|NCT03164564|542107049|FG000|Overall Study|Death|3|||
150265258|NCT03164564|542107050|FG001|Overall Study|Death|0|||
150265259|NCT03164564|542107049|FG000|Overall Study|Withdrawal by Subject|20|||
150265260|NCT03164564|542107050|FG001|Overall Study|Withdrawal by Subject|15|||
150265261|NCT03164564|542107049|FG000|Overall Study|Lost to Follow-up|2|||
150265262|NCT03164564|542107050|FG001|Overall Study|Lost to Follow-up|0|||
150265263|NCT03164564|542107049|FG000|Overall Study|Physician Decision|0|||
150265264|NCT03164564|542107050|FG001|Overall Study|Physician Decision|1|||
150265265|NCT03164564|542107049|FG000|Overall Study|Adverse Event|0|||
149927534|NCT00377637|540870658|FG000|Induction Phase|Non-Compliance|1|||
149927535|NCT00377637|540870659|FG001|Induction Phase|Non-Compliance|0|||
150265266|NCT03164564|542107050|FG001|Overall Study|Adverse Event|1|||
149927536|NCT00377637|540870660|FG002|Induction Phase|Non-Compliance|0|||
149927537|NCT00377637|540870661|FG003|Induction Phase|Non-Compliance|0|||
149927538|NCT00377637|540870658|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
150265267|NCT03164564|542107049|FG000|Overall Study|Ongoing|1586|||
150265268|NCT03164564|542107050|FG001|Overall Study|Ongoing|1586|||
150265269|NCT01910181|542107051|FG000|Overall Study|Death|37|||
150265270|NCT01910181|542107051|FG000|Overall Study|Lost to Follow-up|3|||
150265271|NCT01910181|542107051|FG000|Overall Study|Study Terminated by Sponsor|6|||
150265272|NCT01340651|542107052|FG000|Overall Study|Adverse Event|3|||
149927539|NCT00377637|540870659|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
149927540|NCT00377637|540870660|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
149927541|NCT00377637|540870661|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
149927542|NCT00377637|540870658|FG000|Maintenance Phase|Adverse Event|0|||
149927543|NCT00377637|540870659|FG001|Maintenance Phase|Adverse Event|0|||
150265273|NCT01340651|542107052|FG000|Overall Study|Consent Withdrawn|2|||
150265274|NCT01340651|542107052|FG000|Overall Study|Commercial Supply per Sponsor|12|||
150265275|NCT01315353|542107053|FG000|Overall Study|Death|2|||
149927544|NCT00377637|540870660|FG002|Maintenance Phase|Adverse Event|29|||
149927545|NCT00377637|540870661|FG003|Maintenance Phase|Adverse Event|43|||
149927546|NCT00377637|540870658|FG000|Maintenance Phase|Physician Decision|0|||
149927547|NCT00377637|540870659|FG001|Maintenance Phase|Physician Decision|0|||
149927548|NCT00377637|540870660|FG002|Maintenance Phase|Physician Decision|5|||
149927549|NCT00377637|540870661|FG003|Maintenance Phase|Physician Decision|4|||
150265276|NCT01315353|542107054|FG001|Overall Study|Death|1|||
150265277|NCT01315353|542107055|FG002|Overall Study|Death|0|||
149927550|NCT00377637|540870658|FG000|Maintenance Phase|Lost to Follow-up|0|||
149927551|NCT00377637|540870659|FG001|Maintenance Phase|Lost to Follow-up|0|||
149927552|NCT00377637|540870660|FG002|Maintenance Phase|Lost to Follow-up|3|||
149927553|NCT00377637|540870661|FG003|Maintenance Phase|Lost to Follow-up|1|||
149927554|NCT00377637|540870658|FG000|Maintenance Phase|Withdrawal by Subject|0|||
150265278|NCT01315353|542107053|FG000|Overall Study|Withdrawal by Subject|2|||
150265279|NCT01315353|542107054|FG001|Overall Study|Withdrawal by Subject|6|||
150265280|NCT01315353|542107055|FG002|Overall Study|Withdrawal by Subject|1|||
150265281|NCT01315353|542107053|FG000|Overall Study|Lost to Follow-up|13|||
150265282|NCT01315353|542107054|FG001|Overall Study|Lost to Follow-up|6|||
150265283|NCT01315353|542107055|FG002|Overall Study|Lost to Follow-up|6|||
150265284|NCT01315353|542107053|FG000|Overall Study|Unwilling to adhere to requirements|5|||
150265285|NCT01315353|542107054|FG001|Overall Study|Unwilling to adhere to requirements|5|||
150265286|NCT01315353|542107055|FG002|Overall Study|Unwilling to adhere to requirements|4|||
150265287|NCT01315353|542107053|FG000|Overall Study|Site closing|7|||
150265288|NCT01315353|542107054|FG001|Overall Study|Site closing|4|||
150265289|NCT01315353|542107055|FG002|Overall Study|Site closing|0|||
150265290|NCT01315353|542107053|FG000|Overall Study|Taken off study by site in error|0|||
150265291|NCT01315353|542107054|FG001|Overall Study|Taken off study by site in error|1|||
150265292|NCT01315353|542107055|FG002|Overall Study|Taken off study by site in error|0|||
150265293|NCT01315353|542107053|FG000|Overall Study|Inadvertent randomization/assignment|0|||
150265294|NCT01315353|542107054|FG001|Overall Study|Inadvertent randomization/assignment|0|||
150265295|NCT01315353|542107055|FG002|Overall Study|Inadvertent randomization/assignment|2|||
150265296|NCT03567434|542107056|FG000|Overall Study|Lost to Follow-up|1|||
150265297|NCT03567434|542107057|FG001|Overall Study|Lost to Follow-up|3|||
150265298|NCT04469270|542107058|FG000|Overall Study|Adverse Event|2|||
150265299|NCT04469270|542107059|FG001|Overall Study|Adverse Event|0|||
150265300|NCT04469270|542107058|FG000|Overall Study|Lost to Follow-up|4|||
150265301|NCT04469270|542107059|FG001|Overall Study|Lost to Follow-up|3|||
150265302|NCT04469270|542107058|FG000|Overall Study|Withdrawal by Subject|7|||
150265303|NCT04469270|542107059|FG001|Overall Study|Withdrawal by Subject|3|||
150265304|NCT04469270|542107058|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
150265305|NCT04469270|542107059|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
150265306|NCT04469270|542107058|FG000|Overall Study|missing|1|||
150265307|NCT04469270|542107059|FG001|Overall Study|missing|0|||
150265308|NCT05269355|542107062|FG000|Overall Study|Progressive Disease|104|||
150265309|NCT05269355|542107063|FG001|Overall Study|Progressive Disease|68|||
150265310|NCT05269355|542107062|FG000|Overall Study|Study Terminated by Sponsor|87|||
150265311|NCT05269355|542107063|FG001|Overall Study|Study Terminated by Sponsor|29|||
150265312|NCT05269355|542107062|FG000|Overall Study|Adverse Event|15|||
150265313|NCT05269355|542107063|FG001|Overall Study|Adverse Event|8|||
149927555|NCT00377637|540870659|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149927556|NCT00377637|540870660|FG002|Maintenance Phase|Withdrawal by Subject|3|||
149927557|NCT00377637|540870661|FG003|Maintenance Phase|Withdrawal by Subject|3|||
149927558|NCT00377637|540870658|FG000|Maintenance Phase|Sponsor decision|0|||
149927559|NCT00377637|540870659|FG001|Maintenance Phase|Sponsor decision|0|||
149927560|NCT00377637|540870660|FG002|Maintenance Phase|Sponsor decision|2|||
149927561|NCT00377637|540870661|FG003|Maintenance Phase|Sponsor decision|3|||
149927562|NCT00377637|540870658|FG000|Maintenance Phase|Non-compliance|0|||
149927563|NCT00377637|540870659|FG001|Maintenance Phase|Non-compliance|0|||
149927564|NCT00377637|540870660|FG002|Maintenance Phase|Non-compliance|1|||
149927565|NCT00377637|540870661|FG003|Maintenance Phase|Non-compliance|1|||
149927566|NCT00377637|540870658|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
149927567|NCT00377637|540870659|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
150265314|NCT05269355|542107062|FG000|Overall Study|Withdrawal by Subject|18|||
150265315|NCT05269355|542107063|FG001|Overall Study|Withdrawal by Subject|5|||
150265316|NCT05269355|542107062|FG000|Overall Study|Physician Decision|6|||
150265317|NCT05269355|542107063|FG001|Overall Study|Physician Decision|4|||
150265318|NCT05269355|542107062|FG000|Overall Study|Death|3|||
150265319|NCT05269355|542107063|FG001|Overall Study|Death|5|||
149927568|NCT00377637|540870660|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
149927569|NCT00377637|540870661|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
149927570|NCT00377637|540870658|FG000|Maintenance Phase|Death|0|||
149927571|NCT00377637|540870659|FG001|Maintenance Phase|Death|0|||
149927572|NCT00377637|540870660|FG002|Maintenance Phase|Death|0|||
150265320|NCT05269355|542107062|FG000|Overall Study|Other Than Specified|5|||
150265321|NCT05269355|542107063|FG001|Overall Study|Other Than Specified|1|||
150265322|NCT05269355|542107062|FG000|Overall Study|Randomized But Not Treated|1|||
150164686|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
150164687|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
150164688|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
150164689|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
150164690|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
150164691|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
150164692|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
150164693|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
150164694|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
150164695|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
150164696|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
150164697|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
150164698|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
150164699|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
150164700|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
150164701|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
150164702|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
150164703|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
150164704|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
150164705|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
150164706|NCT02403323|541737455|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
150164707|NCT02403323|541737456|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
150164708|NCT02403323|541737457|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
150164709|NCT00197236|541737461|FG000|Overall Study|Adverse Event|1|||
150164710|NCT00197236|541737462|FG001|Overall Study|Adverse Event|0|||
150164711|NCT00197236|541737463|FG002|Overall Study|Adverse Event|1|||
150164712|NCT00197236|541737461|FG000|Overall Study|Lost to Follow-up|5|||
150164713|NCT00197236|541737462|FG001|Overall Study|Lost to Follow-up|14|||
150164714|NCT00197236|541737463|FG002|Overall Study|Lost to Follow-up|6|||
150164715|NCT00197236|541737461|FG000|Overall Study|Protocol Violation|0|||
150164716|NCT00197236|541737462|FG001|Overall Study|Protocol Violation|0|||
150164717|NCT00197236|541737463|FG002|Overall Study|Protocol Violation|1|||
150164718|NCT00197236|541737461|FG000|Overall Study|Withdrawal by Subject|7|||
150164719|NCT00197236|541737462|FG001|Overall Study|Withdrawal by Subject|3|||
150164720|NCT00197236|541737463|FG002|Overall Study|Withdrawal by Subject|11|||
150164721|NCT00197236|541737461|FG000|Overall Study|Study drug/medication expiration|1|||
150164722|NCT00197236|541737462|FG001|Overall Study|Study drug/medication expiration|0|||
150164723|NCT00197236|541737463|FG002|Overall Study|Study drug/medication expiration|3|||
150164724|NCT00197236|541737461|FG000|Overall Study|Returned out of specified time window|0|||
150164725|NCT00197236|541737462|FG001|Overall Study|Returned out of specified time window|0|||
150164726|NCT00197236|541737463|FG002|Overall Study|Returned out of specified time window|1|||
150164727|NCT03885596|541737464|FG000|Overall Study|Withdrawal by Subject|2|||
150164728|NCT03885596|541737465|FG001|Overall Study|Withdrawal by Subject|1|||
150164729|NCT03885596|541737466|FG002|Overall Study|Withdrawal by Subject|0|||
150164730|NCT03885596|541737467|FG003|Overall Study|Withdrawal by Subject|0|||
150164731|NCT00746330|541737468|FG000|Period 1|Abnormal test procedure result|0|||
150164732|NCT00746330|541737469|FG001|Period 1|Abnormal test procedure result|0|||
150164733|NCT00746330|541737470|FG002|Period 1|Abnormal test procedure result|1|||
150164734|NCT00746330|541737471|FG003|Period 1|Abnormal test procedure result|0|||
150164735|NCT01076335|541737472|FG000|Overall Study|Withdrawal by Subject|3|||
150164736|NCT01076335|541737472|FG000|Overall Study|Withdrawal without treatment|1|||
150164737|NCT02616263|541737474|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
150164738|NCT02616263|541737475|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
150164739|NCT02616263|541737474|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
150164740|NCT02616263|541737475|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
150164741|NCT02616263|541737474|FG000|6 Month to 1.5 Year|Death|1|||
150164742|NCT02616263|541737475|FG001|6 Month to 1.5 Year|Death|0|||
150164743|NCT02616263|541737474|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
150164744|NCT02616263|541737475|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
150164745|NCT02616263|541737474|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
150164746|NCT02616263|541737475|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
150164747|NCT02616263|541737474|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
150164748|NCT02616263|541737475|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
150164749|NCT02939183|541737477|FG000|Overall Study|Death|0|||
150164750|NCT02939183|541737478|FG001|Overall Study|Death|0|||
150164751|NCT02939183|541737479|FG002|Overall Study|Death|1|||
150164752|NCT02939183|541737480|FG003|Overall Study|Death|0|||
150164753|NCT02939183|541737481|FG004|Overall Study|Death|0|||
150164754|NCT02939183|541737482|FG005|Overall Study|Death|2|||
150164755|NCT02939183|541737483|FG006|Overall Study|Death|1|||
150164756|NCT02939183|541737484|FG007|Overall Study|Death|0|||
150164757|NCT02939183|541737485|FG008|Overall Study|Death|0|||
149927573|NCT00377637|540870661|FG003|Maintenance Phase|Death|1|||
149927574|NCT00493012|540870663|FG000|Overall Study|Lost to Follow-up|18|||
149927575|NCT00493012|540870664|FG001|Overall Study|Lost to Follow-up|17|||
150164758|NCT02939183|541737477|FG000|Overall Study|Sponsor decision|0|||
150164759|NCT02939183|541737478|FG001|Overall Study|Sponsor decision|1|||
150164760|NCT02939183|541737479|FG002|Overall Study|Sponsor decision|0|||
150164761|NCT02939183|541737480|FG003|Overall Study|Sponsor decision|1|||
150164762|NCT02939183|541737481|FG004|Overall Study|Sponsor decision|2|||
150164763|NCT02939183|541737482|FG005|Overall Study|Sponsor decision|0|||
150164764|NCT02939183|541737483|FG006|Overall Study|Sponsor decision|3|||
150164765|NCT02939183|541737484|FG007|Overall Study|Sponsor decision|1|||
150164766|NCT02939183|541737485|FG008|Overall Study|Sponsor decision|4|||
150164767|NCT02939183|541737477|FG000|Overall Study|Withdrawal by Subject|0|||
150164768|NCT02939183|541737478|FG001|Overall Study|Withdrawal by Subject|2|||
150164769|NCT02939183|541737479|FG002|Overall Study|Withdrawal by Subject|0|||
150164770|NCT02939183|541737480|FG003|Overall Study|Withdrawal by Subject|1|||
150164771|NCT02939183|541737481|FG004|Overall Study|Withdrawal by Subject|0|||
150164772|NCT02939183|541737482|FG005|Overall Study|Withdrawal by Subject|0|||
150164773|NCT02939183|541737483|FG006|Overall Study|Withdrawal by Subject|2|||
150164774|NCT02939183|541737484|FG007|Overall Study|Withdrawal by Subject|2|||
150164775|NCT02939183|541737485|FG008|Overall Study|Withdrawal by Subject|2|||
150164776|NCT02939183|541737477|FG000|Overall Study|Not treated due to adverse event|0|||
150164777|NCT02939183|541737478|FG001|Overall Study|Not treated due to adverse event|0|||
150164778|NCT02939183|541737479|FG002|Overall Study|Not treated due to adverse event|0|||
150164779|NCT02939183|541737480|FG003|Overall Study|Not treated due to adverse event|1|||
150164780|NCT02939183|541737481|FG004|Overall Study|Not treated due to adverse event|0|||
150164781|NCT02939183|541737482|FG005|Overall Study|Not treated due to adverse event|0|||
150164782|NCT02939183|541737483|FG006|Overall Study|Not treated due to adverse event|1|||
150164783|NCT02939183|541737484|FG007|Overall Study|Not treated due to adverse event|0|||
150164784|NCT02939183|541737485|FG008|Overall Study|Not treated due to adverse event|0|||
150164785|NCT05015478|541737486|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
150164786|NCT05015478|541737487|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
150164787|NCT05015478|541737488|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
150164788|NCT05015478|541737489|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
150164789|NCT04319094|541737490|FG000|Baseline|Lost to Follow-up|4|||
150164790|NCT04319094|541737491|FG001|Baseline|Lost to Follow-up|5|||
150164791|NCT04319094|541737490|FG000|Baseline|Protocol Violation|0|||
150164792|NCT04319094|541737491|FG001|Baseline|Protocol Violation|3|||
150164793|NCT04319094|541737490|FG000|Baseline|Withdrawal by Subject|2|||
150164794|NCT04319094|541737491|FG001|Baseline|Withdrawal by Subject|1|||
150164795|NCT04319094|541737490|FG000|Post-Intervention|Death|0|||
150164796|NCT04319094|541737491|FG001|Post-Intervention|Death|1|||
150164797|NCT04319094|541737490|FG000|Post-Intervention|Lost to Follow-up|4|||
150164798|NCT04319094|541737491|FG001|Post-Intervention|Lost to Follow-up|4|||
150164799|NCT04319094|541737490|FG000|Post-Intervention|Withdrawal by Subject|8|||
150164800|NCT04319094|541737491|FG001|Post-Intervention|Withdrawal by Subject|5|||
150164801|NCT04319094|541737490|FG000|Post-Intervention|Incomplete Data Collection|1|||
150164802|NCT04319094|541737491|FG001|Post-Intervention|Incomplete Data Collection|3|||
150164803|NCT04319094|541737490|FG000|3-month|Death|1|||
150164804|NCT04319094|541737491|FG001|3-month|Death|0|||
150164805|NCT04319094|541737490|FG000|3-month|Lost to Follow-up|2|||
150164806|NCT04319094|541737491|FG001|3-month|Lost to Follow-up|2|||
150164807|NCT04319094|541737490|FG000|3-month|Withdrawal by Subject|0|||
150164808|NCT04319094|541737491|FG001|3-month|Withdrawal by Subject|3|||
150164809|NCT04319094|541737490|FG000|3-month|Incomplete data collection|9|||
150164810|NCT04319094|541737491|FG001|3-month|Incomplete data collection|7|||
150164811|NCT04319094|541737490|FG000|6-month|Lost to Follow-up|1|||
150164812|NCT04319094|541737491|FG001|6-month|Lost to Follow-up|1|||
150164813|NCT04319094|541737490|FG000|6-month|Withdrawal by Subject|0|||
150164814|NCT04319094|541737491|FG001|6-month|Withdrawal by Subject|3|||
150164815|NCT04319094|541737490|FG000|6-month|Incomplete data collection|14|||
150164816|NCT04319094|541737491|FG001|6-month|Incomplete data collection|9|||
150164817|NCT04319094|541737490|FG000|9-month|Lost to Follow-up|8|||
150164818|NCT04319094|541737491|FG001|9-month|Lost to Follow-up|4|||
150164819|NCT04319094|541737490|FG000|9-month|Withdrawal by Subject|0|||
150164820|NCT04319094|541737491|FG001|9-month|Withdrawal by Subject|1|||
149927576|NCT04147247|540870665|FG000|Overall Study|Progressive disease|3|||
150164821|NCT04319094|541737490|FG000|9-month|Incomplete data collection|8|||
150164822|NCT04319094|541737491|FG001|9-month|Incomplete data collection|5|||
150164823|NCT04319094|541737490|FG000|12-month|Lost to Follow-up|11|||
150164824|NCT04319094|541737491|FG001|12-month|Lost to Follow-up|8|||
150164825|NCT04639947|541737494|FG000|Overall Study|Screen fail|1|||
150164826|NCT00654238|541737495|FG000|Overall Study|Screen Failures|4|||
150164827|NCT00877851|541737496|FG000|Overall Study|Lost to Follow-up|5|||
150164828|NCT00877851|541737497|FG001|Overall Study|Lost to Follow-up|5|||
149927577|NCT04147247|540870666|FG001|Overall Study|Progressive disease|3|||
149927578|NCT04147247|540870667|FG002|Overall Study|Progressive disease|4|||
150164829|NCT00877851|541737496|FG000|Overall Study|computer problem|3|||
150265323|NCT05269355|542107063|FG001|Overall Study|Randomized But Not Treated|0|||
150265324|NCT01050790|542107064|FG000|Overall Study|Adverse Event|1|||
150265325|NCT01880528|542107065|FG000|Overall Study|Other|1|||
150265326|NCT01880528|542107066|FG001|Overall Study|Other|1|||
150265327|NCT00081497|542107067|FG000|Overall Study|Adverse Event|2|||
150265328|NCT00081497|542107068|FG001|Overall Study|Adverse Event|0|||
150265329|NCT00081497|542107067|FG000|Overall Study|Death|0|||
150265330|NCT00081497|542107068|FG001|Overall Study|Death|1|||
150265331|NCT00081497|542107067|FG000|Overall Study|Withdrawal by Subject|1|||
150265332|NCT00081497|542107068|FG001|Overall Study|Withdrawal by Subject|0|||
150265333|NCT00081497|542107067|FG000|Overall Study|Non-compliance|0|||
150265334|NCT00081497|542107068|FG001|Overall Study|Non-compliance|1|||
150265335|NCT02254278|542107069|FG000|Overall Study|Protocol Violation|1|||
150265336|NCT02254278|542107070|FG001|Overall Study|Protocol Violation|1|||
150265337|NCT05437510|542107072|FG000|Overall Study|Adverse Event|2|||
150265338|NCT05437510|542107073|FG001|Overall Study|Adverse Event|1|||
150265339|NCT05437510|542107072|FG000|Overall Study|Protocol Deviation|1|||
150265340|NCT05437510|542107073|FG001|Overall Study|Protocol Deviation|6|||
150265341|NCT05437510|542107072|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
150265342|NCT05437510|542107073|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
150265343|NCT05437510|542107072|FG000|Overall Study|Lost to Follow-up|265|||
150265344|NCT05437510|542107073|FG001|Overall Study|Lost to Follow-up|358|||
150265345|NCT03573401|542107074|FG000|Overall Study|Withdrawal by Subject|2|||
150265346|NCT03573401|542107075|FG001|Overall Study|Withdrawal by Subject|0|||
150265347|NCT03573401|542107074|FG000|Overall Study|Subject non-compliance with study schedule|1|||
150265348|NCT03573401|542107075|FG001|Overall Study|Subject non-compliance with study schedule|0|||
150265349|NCT03573401|542107074|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
150265350|NCT03573401|542107075|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
150265351|NCT03573401|542107074|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
150265352|NCT03573401|542107075|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
150265353|NCT01256658|542108548|FG000|Period 1|Lost to Follow-up|837|||
150265354|NCT01256658|542108549|FG001|Period 1|Lost to Follow-up|661|||
150265355|NCT01256658|542108548|FG000|Period 1|Withdrawal by Subject|35|||
150265356|NCT01256658|542108549|FG001|Period 1|Withdrawal by Subject|43|||
150265357|NCT01256658|542108548|FG000|Period 1|Death|48|||
150265358|NCT01256658|542108549|FG001|Period 1|Death|44|||
150265359|NCT00719563|542108554|FG000|Overall Study|Adverse Event|16|||
150265360|NCT00719563|542108555|FG001|Overall Study|Adverse Event|13|||
150265361|NCT00719563|542108554|FG000|Overall Study|Medical condition changed|3|||
150265362|NCT00719563|542108555|FG001|Overall Study|Medical condition changed|5|||
150265363|NCT00719563|542108554|FG000|Overall Study|Lack of Efficacy|3|||
150265364|NCT00719563|542108555|FG001|Overall Study|Lack of Efficacy|7|||
150265365|NCT00719563|542108554|FG000|Overall Study|Personal reasons|6|||
150265366|NCT00719563|542108555|FG001|Overall Study|Personal reasons|7|||
150265367|NCT00719563|542108554|FG000|Overall Study|Unknown reasons|4|||
150265368|NCT00719563|542108555|FG001|Overall Study|Unknown reasons|6|||
150265369|NCT00719563|542108554|FG000|Overall Study|Noncompliant|1|||
150265370|NCT00719563|542108555|FG001|Overall Study|Noncompliant|1|||
150265371|NCT00719563|542108554|FG000|Overall Study|Lost to Follow-up|5|||
150265372|NCT00719563|542108555|FG001|Overall Study|Lost to Follow-up|3|||
150265373|NCT00294554|542108556|FG000|Overall Study|Lack of Efficacy|0|||
150265374|NCT00294554|542108557|FG001|Overall Study|Lack of Efficacy|1|||
150265375|NCT00294554|542108556|FG000|Overall Study|Physician Decision|0|||
150265376|NCT00294554|542108557|FG001|Overall Study|Physician Decision|1|||
150265377|NCT00462865|542108558|FG000|Overall Study|Adverse Event|1|||
150265378|NCT02864381|542108559|FG000|Overall Study|Death|58|||
150265379|NCT02864381|542108560|FG001|Overall Study|Death|61|||
150265380|NCT02864381|542108559|FG000|Overall Study|Withdrew Consent|5|||
150265381|NCT02864381|542108560|FG001|Overall Study|Withdrew Consent|6|||
150265382|NCT02864381|542108559|FG000|Overall Study|Reason Unknown|7|||
150265383|NCT02864381|542108560|FG001|Overall Study|Reason Unknown|3|||
150265384|NCT02864381|542108559|FG000|Overall Study|Lost to Follow-up|1|||
150265385|NCT02864381|542108560|FG001|Overall Study|Lost to Follow-up|1|||
150265386|NCT02864381|542108559|FG000|Overall Study|Investigator's Discretion|1|||
150265387|NCT02864381|542108560|FG001|Overall Study|Investigator's Discretion|0|||
150265388|NCT02864381|542108559|FG000|Overall Study|Protocol Violation|0|||
150265389|NCT02864381|542108560|FG001|Overall Study|Protocol Violation|1|||
150265390|NCT02120625|542108561|FG000|Overall Study|Physician Decision|2|||
150265391|NCT00887679|542108564|FG000|Overall Study|Withdrawal by Subject|1|||
150265392|NCT00887679|542108564|FG000|Overall Study|Lost to Follow-up|4|||
150265393|NCT00887679|542108564|FG000|Overall Study|Physician Decision|5|||
150265394|NCT02683941|542108565|FG000|Double-blind Phase|Adverse Event|0|||
150265395|NCT02683941|542108566|FG001|Double-blind Phase|Adverse Event|1|||
150265396|NCT02683941|542108565|FG000|Double-blind Phase|Withdrawal by Subject|4|||
150265397|NCT02683941|542108566|FG001|Double-blind Phase|Withdrawal by Subject|2|||
150265398|NCT02683941|542108565|FG000|Double-blind Phase|Lost to Follow-up|1|||
150265399|NCT02683941|542108566|FG001|Double-blind Phase|Lost to Follow-up|0|||
150265400|NCT02683941|542108565|FG000|Double-blind Phase|Disease Progression|5|||
149927579|NCT04147247|540870668|FG003|Overall Study|Progressive disease|4|||
149927580|NCT04147247|540870669|FG004|Overall Study|Progressive disease|3|||
149927581|NCT04147247|540870665|FG000|Overall Study|Physician Decision|0|||
149927582|NCT04147247|540870666|FG001|Overall Study|Physician Decision|1|||
149927583|NCT04147247|540870667|FG002|Overall Study|Physician Decision|0|||
149927584|NCT04147247|540870668|FG003|Overall Study|Physician Decision|0|||
150265401|NCT02683941|542108566|FG001|Double-blind Phase|Disease Progression|2|||
150265402|NCT02683941|542108565|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
150265403|NCT02683941|542108566|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
150265404|NCT02683941|542108565|FG000|Open-label Treatment Phase|Disease Progression|1|||
150265405|NCT02683941|542108566|FG001|Open-label Treatment Phase|Disease Progression|2|||
150265406|NCT02683941|542108565|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
150265407|NCT02683941|542108566|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
150265408|NCT02683941|542108565|FG000|Open-label Treatment Phase|Other|1|||
150265409|NCT02683941|542108566|FG001|Open-label Treatment Phase|Other|0|||
150265410|NCT02683941|542108565|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
150265411|NCT02683941|542108566|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
150265412|NCT02683941|542108565|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
150265413|NCT02683941|542108566|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
150265414|NCT02683941|542108565|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
150265415|NCT02683941|542108566|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
150265416|NCT02683941|542108565|FG000|Open-label Follow-up Phase|Other|8|||
150265417|NCT02683941|542108566|FG001|Open-label Follow-up Phase|Other|1|||
150265418|NCT00325039|542108568|FG000|Overall Study|Lost to Follow-up|18|||
150265419|NCT00325039|542108569|FG001|Overall Study|Lost to Follow-up|14|||
150265420|NCT01009203|542108571|FG000|Overall Study|Withdrawal by Subject|1|||
150265421|NCT01009203|542108571|FG000|Overall Study|Adverse Event|5|||
150265422|NCT01009203|542108571|FG000|Overall Study|Treatment-unrelated death|1|||
150265423|NCT01776424|542108572|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
150265424|NCT01776424|542108573|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
150265425|NCT01776424|542108574|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
150265426|NCT01776424|542108572|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
150265427|NCT01776424|542108573|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
150265428|NCT01776424|542108574|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
150265429|NCT01776424|542108572|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
150265430|NCT01776424|542108573|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
150265431|NCT01776424|542108574|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
150265432|NCT01776424|542108572|FG000|LTOLE Part (Open Label)|Refused|5|||
150265433|NCT01776424|542108573|FG001|LTOLE Part (Open Label)|Refused|2|||
150265434|NCT01776424|542108574|FG002|LTOLE Part (Open Label)|Refused|11|||
150265435|NCT01776424|542108572|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
150265436|NCT01776424|542108573|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
150265437|NCT01776424|542108574|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
150265438|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
150265439|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
150265440|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
150265441|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
150265442|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
150265443|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
150265444|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
150265445|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
150265446|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
150265447|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
150265448|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
150265449|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
150265450|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
150265451|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
150265452|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
150265453|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
150265454|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
150265455|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
150265456|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
150265457|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
150265458|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
150265459|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
150265460|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
149927585|NCT04147247|540870669|FG004|Overall Study|Physician Decision|0|||
149927586|NCT04147247|540870665|FG000|Overall Study|Clinical Disease Progression|0|||
149927587|NCT04147247|540870666|FG001|Overall Study|Clinical Disease Progression|0|||
149927588|NCT04147247|540870667|FG002|Overall Study|Clinical Disease Progression|0|||
149927589|NCT04147247|540870668|FG003|Overall Study|Clinical Disease Progression|0|||
149927590|NCT04147247|540870669|FG004|Overall Study|Clinical Disease Progression|1|||
149927591|NCT04147247|540870665|FG000|Overall Study|Adverse Event|0|||
149927592|NCT04147247|540870666|FG001|Overall Study|Adverse Event|0|||
149927593|NCT04147247|540870667|FG002|Overall Study|Adverse Event|1|||
149927594|NCT04147247|540870668|FG003|Overall Study|Adverse Event|0|||
149927595|NCT04147247|540870669|FG004|Overall Study|Adverse Event|1|||
149927596|NCT02915159|540870670|FG000|Overall Study|Participant no longer meets criteria|2|||
149927597|NCT02915159|540870671|FG001|Overall Study|Participant no longer meets criteria|0|||
149927598|NCT02915159|540870670|FG000|Overall Study|poor/non-compliance|1|||
149927599|NCT02915159|540870671|FG001|Overall Study|poor/non-compliance|0|||
149927600|NCT02915159|540870670|FG000|Overall Study|Participant withdrew consent|5|||
149927601|NCT02915159|540870671|FG001|Overall Study|Participant withdrew consent|1|||
149927602|NCT02915159|540870670|FG000|Overall Study|Request to discontinue treatment|1|||
149927603|NCT02915159|540870671|FG001|Overall Study|Request to discontinue treatment|2|||
149927604|NCT02915159|540870670|FG000|Overall Study|Adverse Event|2|||
149927605|NCT02915159|540870671|FG001|Overall Study|Adverse Event|2|||
149927606|NCT02915159|540870670|FG000|Overall Study|Lack of Efficacy|0|||
149927607|NCT02915159|540870671|FG001|Overall Study|Lack of Efficacy|3|||
149927608|NCT04534517|540870672|FG000|Overall Study|Adverse Event|1|||
149927609|NCT04534517|540870672|FG000|Overall Study|Withdrawal by Subject|1|||
149927610|NCT04534517|540870672|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
149927611|NCT04534517|540870672|FG000|Overall Study|COVID-19 Related|1|||
149927612|NCT02121795|540870673|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
149927613|NCT02121795|540870674|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
149927614|NCT02121795|540870673|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
149927615|NCT02121795|540870674|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
149927616|NCT02121795|540870673|FG000|Double-Blind Phase|Lost to Follow-up|7|||
149927617|NCT02121795|540870674|FG001|Double-Blind Phase|Lost to Follow-up|4|||
149927618|NCT02121795|540870673|FG000|Double-Blind Phase|Physician Decision|2|||
149927619|NCT02121795|540870674|FG001|Double-Blind Phase|Physician Decision|5|||
149927620|NCT02121795|540870673|FG000|Double-Blind Phase|Adverse Event|5|||
149927621|NCT02121795|540870674|FG001|Double-Blind Phase|Adverse Event|0|||
149927622|NCT02121795|540870673|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
149927623|NCT02121795|540870674|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
149927624|NCT02121795|540870673|FG000|Double-Blind Phase|Protocol Violation|0|||
149927625|NCT02121795|540870674|FG001|Double-Blind Phase|Protocol Violation|3|||
149927626|NCT02121795|540870673|FG000|Double-Blind Phase|Death|1|||
149927627|NCT02121795|540870674|FG001|Double-Blind Phase|Death|1|||
149927628|NCT02121795|540870673|FG000|Open-Label Phase|Physician Decision|8|||
149927629|NCT02121795|540870674|FG001|Open-Label Phase|Physician Decision|8|||
149927630|NCT02121795|540870673|FG000|Open-Label Phase|Withdrawal by Subject|3|||
149927631|NCT02121795|540870674|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149927632|NCT02121795|540870673|FG000|Open-Label Phase|Lost to Follow-up|1|||
150265461|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
150265462|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
149927633|NCT02121795|540870674|FG001|Open-Label Phase|Lost to Follow-up|0|||
149927634|NCT00823264|540870675|FG000|Overall Study|Protocol Violation|2|||
150265463|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
150265464|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
150265465|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
150265466|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
150265467|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
150265468|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Other|10|||
150265469|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Other|7|||
150265470|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Other|8|||
150265471|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Other|8|||
150265472|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Other|0|||
150265473|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
150265474|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
150265475|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
149927635|NCT00823264|540870676|FG001|Overall Study|Protocol Violation|0|||
149927636|NCT03373760|540870683|FG000|Overall Study|Adverse Event|8|||
149927637|NCT03373760|540870683|FG000|Overall Study|Disease Progression|46|||
149927638|NCT03373760|540870683|FG000|Overall Study|Death|4|||
149927639|NCT01093586|540870684|FG000|Overall Study|Failed to engraft|3|||
149927640|NCT00613366|540870685|FG000|Overall Study|Withdrawal by Subject|3|||
149927641|NCT00613366|540870686|FG001|Overall Study|Withdrawal by Subject|2|||
149927642|NCT01968811|540870687|FG000|Overall Study|Protocol Violation|4|||
149927643|NCT01968811|540870687|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
149927644|NCT00872521|540870694|FG000|Completed PAD Induction|Patient choice|0|||
150265476|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
150265477|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
150265478|NCT00615836|542108577|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
150265479|NCT00615836|542108578|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
150265480|NCT00615836|542108579|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
150265481|NCT00615836|542108580|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
150265482|NCT00615836|542108581|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
150265483|NCT01630434|542108582|FG000|Overall Study|Donor lungs turned down|1|||
150265484|NCT01630434|542108583|FG001|Overall Study|Donor lungs turned down|0|||
150265485|NCT01630434|542108582|FG000|Overall Study|Protocol Violation|9|||
150265486|NCT01630434|542108583|FG001|Overall Study|Protocol Violation|4|||
150265487|NCT01630434|542108582|FG000|Overall Study|Death|20|||
150265488|NCT01630434|542108583|FG001|Overall Study|Death|26|||
150265489|NCT00687973|542108584|FG000|Overall Study|Adverse Event|18|||
150265490|NCT00687973|542108585|FG001|Overall Study|Adverse Event|28|||
150265491|NCT00687973|542108584|FG000|Overall Study|Lack of Efficacy|2|||
150265492|NCT00687973|542108585|FG001|Overall Study|Lack of Efficacy|3|||
150265493|NCT00687973|542108584|FG000|Overall Study|Protocol Violation|1|||
150265494|NCT00687973|542108585|FG001|Overall Study|Protocol Violation|2|||
150265495|NCT00687973|542108584|FG000|Overall Study|Administrative Reasons|0|||
150265496|NCT00687973|542108585|FG001|Overall Study|Administrative Reasons|2|||
150265497|NCT00687973|542108584|FG000|Overall Study|Withdrawal by Subject|3|||
150265498|NCT00687973|542108585|FG001|Overall Study|Withdrawal by Subject|3|||
150265499|NCT02121834|542108587|FG000|Overall Study|Protocol Violation|0|||
150265500|NCT02121834|542108588|FG001|Overall Study|Protocol Violation|1|||
150265501|NCT02121834|542108589|FG002|Overall Study|Protocol Violation|0|||
150265502|NCT02121834|542108590|FG003|Overall Study|Protocol Violation|0|||
150265503|NCT02121834|542108591|FG004|Overall Study|Protocol Violation|0|||
150265504|NCT02121834|542108592|FG005|Overall Study|Protocol Violation|0|||
150265505|NCT02121834|542108593|FG006|Overall Study|Protocol Violation|0|||
150265506|NCT02121834|542108587|FG000|Overall Study|Withdrawal by Subject|0|||
150265507|NCT02121834|542108588|FG001|Overall Study|Withdrawal by Subject|1|||
150265508|NCT02121834|542108589|FG002|Overall Study|Withdrawal by Subject|1|||
150265509|NCT02121834|542108590|FG003|Overall Study|Withdrawal by Subject|0|||
150265510|NCT02121834|542108591|FG004|Overall Study|Withdrawal by Subject|0|||
150265511|NCT02121834|542108592|FG005|Overall Study|Withdrawal by Subject|0|||
150265512|NCT02121834|542108593|FG006|Overall Study|Withdrawal by Subject|0|||
150265513|NCT02121834|542108587|FG000|Overall Study|Lost to Follow-up|0|||
150265514|NCT02121834|542108588|FG001|Overall Study|Lost to Follow-up|0|||
150265515|NCT02121834|542108589|FG002|Overall Study|Lost to Follow-up|1|||
150265516|NCT02121834|542108590|FG003|Overall Study|Lost to Follow-up|0|||
150265517|NCT02121834|542108591|FG004|Overall Study|Lost to Follow-up|0|||
150265518|NCT02121834|542108592|FG005|Overall Study|Lost to Follow-up|0|||
150265519|NCT02121834|542108593|FG006|Overall Study|Lost to Follow-up|0|||
150265520|NCT02578862|542108594|FG000|Overall Study|Withdrawal by Subject|0|||
150265521|NCT02578862|542108595|FG001|Overall Study|Withdrawal by Subject|1|||
150265522|NCT02578862|542108594|FG000|Overall Study|Unplanned unilateral procedure|0|||
150265523|NCT02578862|542108595|FG001|Overall Study|Unplanned unilateral procedure|1|||
150265524|NCT02075541|542108603|FG000|Overall Study|Serious Adverse Event|1|||
150265525|NCT02075541|542108604|FG001|Overall Study|Serious Adverse Event|4|||
150265526|NCT02075541|542108603|FG000|Overall Study|Protocol Violation|1|||
150265527|NCT02075541|542108604|FG001|Overall Study|Protocol Violation|0|||
150265528|NCT02075541|542108603|FG000|Overall Study|Withdrawal by Subject|1|||
150265529|NCT02075541|542108604|FG001|Overall Study|Withdrawal by Subject|3|||
150265530|NCT02075541|542108603|FG000|Overall Study|Sponsor study termination|0|||
150265531|NCT02075541|542108604|FG001|Overall Study|Sponsor study termination|1|||
150265532|NCT02075541|542108603|FG000|Overall Study|Other- unable to perform study procedure|1|||
150265533|NCT02075541|542108604|FG001|Overall Study|Other- unable to perform study procedure|0|||
150265534|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
150265535|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
150265536|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Death|0|||
150265537|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Death|2|||
150265538|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
150265539|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
150265540|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
150265541|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
150265542|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
150265543|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
150265544|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
150265545|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
150265546|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
150265547|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
150265548|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
150265549|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
150265550|NCT00343252|542108605|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
149927645|NCT00872521|540870695|FG001|Completed PAD Induction|Patient choice|1|||
149927646|NCT00872521|540870696|FG002|Completed PAD Induction|Patient choice|0|||
149927647|NCT00872521|540870694|FG000|Completed PAD Induction|Disease progression|0|||
149927648|NCT00872521|540870695|FG001|Completed PAD Induction|Disease progression|2|||
149927649|NCT00872521|540870696|FG002|Completed PAD Induction|Disease progression|0|||
149927650|NCT00872521|540870694|FG000|Completed PAD Induction|Adverse Event|4|||
149927651|NCT00872521|540870695|FG001|Completed PAD Induction|Adverse Event|0|||
149927652|NCT00872521|540870696|FG002|Completed PAD Induction|Adverse Event|0|||
149927653|NCT00872521|540870694|FG000|Completed PAD Induction|Death|1|||
149927654|NCT00872521|540870695|FG001|Completed PAD Induction|Death|1|||
149927655|NCT00872521|540870696|FG002|Completed PAD Induction|Death|0|||
149927656|NCT00872521|540870694|FG000|Primary Endpoint Analysis|Other|1|||
149927657|NCT00872521|540870695|FG001|Primary Endpoint Analysis|Other|2|||
149927658|NCT00872521|540870696|FG002|Primary Endpoint Analysis|Other|0|||
149927659|NCT00872521|540870694|FG000|Primary Endpoint Analysis|Patient choice|0|||
149927660|NCT00872521|540870695|FG001|Primary Endpoint Analysis|Patient choice|1|||
149927661|NCT00872521|540870696|FG002|Primary Endpoint Analysis|Patient choice|0|||
149927662|NCT00872521|540870694|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
149927663|NCT00872521|540870695|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
149927664|NCT00872521|540870696|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
149927665|NCT00872521|540870694|FG000|Primary Endpoint Analysis|Patient response missing|0|||
149927666|NCT00872521|540870695|FG001|Primary Endpoint Analysis|Patient response missing|0|||
149927667|NCT00872521|540870696|FG002|Primary Endpoint Analysis|Patient response missing|1|||
149927668|NCT00872521|540870694|FG000|Completed 3-month Follow up|Other|0|||
149927669|NCT00872521|540870695|FG001|Completed 3-month Follow up|Other|2|||
149927670|NCT00872521|540870696|FG002|Completed 3-month Follow up|Other|0|||
149927671|NCT00872521|540870694|FG000|Completed 3-month Follow up|Physician Decision|0|||
149927672|NCT00872521|540870695|FG001|Completed 3-month Follow up|Physician Decision|1|||
149927673|NCT00872521|540870696|FG002|Completed 3-month Follow up|Physician Decision|0|||
149927674|NCT00872521|540870694|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
149927675|NCT00872521|540870695|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
149927676|NCT00872521|540870696|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
149927677|NCT05225558|540870697|FG000|Overall Study|Withdrawal by Subject|4|||
149927678|NCT05225558|540870698|FG001|Overall Study|Withdrawal by Subject|3|||
149927679|NCT05225558|540870697|FG000|Overall Study|Adverse Event|1|||
149927680|NCT05225558|540870698|FG001|Overall Study|Adverse Event|0|||
149927681|NCT05225558|540870697|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
149927682|NCT05225558|540870698|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
149927683|NCT05225558|540870697|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
149927684|NCT05225558|540870698|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
149927685|NCT03006562|540870699|FG000|Overall Study|Lost to Follow-up|0|||
149927686|NCT03006562|540870700|FG001|Overall Study|Lost to Follow-up|1|||
149927687|NCT01089127|540870705|FG000|Overall Study|Adverse Event|5|||
149927688|NCT01089127|540870706|FG001|Overall Study|Adverse Event|1|||
149927689|NCT01089127|540870707|FG002|Overall Study|Adverse Event|1|||
149927690|NCT01089127|540870708|FG003|Overall Study|Adverse Event|0|||
149927691|NCT01089127|540870709|FG004|Overall Study|Adverse Event|0|||
149927692|NCT01089127|540870710|FG005|Overall Study|Adverse Event|1|||
149927693|NCT01089127|540870705|FG000|Overall Study|Subject withdrew consent|0|||
149927694|NCT01089127|540870706|FG001|Overall Study|Subject withdrew consent|1|||
149927695|NCT01089127|540870707|FG002|Overall Study|Subject withdrew consent|1|||
149927696|NCT01089127|540870708|FG003|Overall Study|Subject withdrew consent|1|||
149927697|NCT01089127|540870709|FG004|Overall Study|Subject withdrew consent|0|||
149927698|NCT01089127|540870710|FG005|Overall Study|Subject withdrew consent|2|||
149927699|NCT01089127|540870705|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149927700|NCT01089127|540870706|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149927701|NCT01089127|540870707|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149927702|NCT01089127|540870708|FG003|Overall Study|Abnormal test procedure result(s)|0|||
149927703|NCT01089127|540870709|FG004|Overall Study|Abnormal test procedure result(s)|0|||
149927704|NCT01089127|540870710|FG005|Overall Study|Abnormal test procedure result(s)|0|||
149927705|NCT01089127|540870705|FG000|Overall Study|Lost to Follow-up|1|||
149927706|NCT01089127|540870706|FG001|Overall Study|Lost to Follow-up|1|||
149927707|NCT01089127|540870707|FG002|Overall Study|Lost to Follow-up|0|||
149927708|NCT01089127|540870708|FG003|Overall Study|Lost to Follow-up|0|||
149927709|NCT01089127|540870709|FG004|Overall Study|Lost to Follow-up|1|||
149927710|NCT01089127|540870710|FG005|Overall Study|Lost to Follow-up|0|||
149927711|NCT01089127|540870705|FG000|Overall Study|Protocol deviation|0|||
149927712|NCT01089127|540870706|FG001|Overall Study|Protocol deviation|1|||
149927713|NCT01089127|540870707|FG002|Overall Study|Protocol deviation|0|||
149927714|NCT01089127|540870708|FG003|Overall Study|Protocol deviation|0|||
149927715|NCT01089127|540870709|FG004|Overall Study|Protocol deviation|1|||
149927716|NCT01089127|540870710|FG005|Overall Study|Protocol deviation|0|||
149927717|NCT03200548|540870711|FG000|Overall Study|Withdrawal by Subject|5|||
149927718|NCT03200548|540870712|FG001|Overall Study|Withdrawal by Subject|11|||
149927719|NCT03200548|540870713|FG002|Overall Study|Withdrawal by Subject|7|||
149927720|NCT03200548|540870714|FG003|Overall Study|Withdrawal by Subject|6|||
149927721|NCT00875563|540870716|FG000|Overall Study|Death|4|||
149927722|NCT00875563|540870716|FG000|Overall Study|Withdrawal by Subject|7|||
149927723|NCT00875563|540870716|FG000|Overall Study|No long-term (3-5 year) consent|6|||
149927724|NCT00875563|540870716|FG000|Overall Study|Still be eligible for follow-up|7|||
149927725|NCT02427841|540870719|FG000|Overall Study|Lack of Efficacy|5|||
149927726|NCT02427841|540870719|FG000|Overall Study|Physician Decision|2|||
149927727|NCT02427841|540870719|FG000|Overall Study|Withdrawal by Subject|1|||
149927728|NCT00511810|540870720|FG000|Overall Study|Lost to Follow-up|1|||
149927729|NCT00511810|540870721|FG001|Overall Study|Lost to Follow-up|2|||
149927730|NCT00511810|540870720|FG000|Overall Study|Lack of Efficacy|0|||
149927731|NCT00511810|540870721|FG001|Overall Study|Lack of Efficacy|2|||
149927732|NCT00511810|540870720|FG000|Overall Study|Refused second scn|0|||
149927733|NCT00511810|540870721|FG001|Overall Study|Refused second scn|1|||
149927734|NCT02896569|540870722|FG000|Overall Study|Lost to Follow-up|2|||
149927735|NCT02896569|540870723|FG001|Overall Study|Lost to Follow-up|1|||
149927736|NCT02896569|540870722|FG000|Overall Study|Physician Decision|1|||
149927737|NCT02896569|540870723|FG001|Overall Study|Physician Decision|3|||
149927738|NCT02896569|540870722|FG000|Overall Study|Adverse Event|0|||
149927739|NCT02896569|540870723|FG001|Overall Study|Adverse Event|1|||
149927740|NCT02896569|540870722|FG000|Overall Study|Withdrawal by Subject|1|||
149927741|NCT02896569|540870723|FG001|Overall Study|Withdrawal by Subject|0|||
149927742|NCT00313846|540870724|FG000|Overall Study|Withdrawal by Subject|2|||
149927743|NCT00313846|540870725|FG001|Overall Study|Withdrawal by Subject|0|||
149927744|NCT00313846|540870724|FG000|Overall Study|Adverse Event|1|||
149927745|NCT00313846|540870725|FG001|Overall Study|Adverse Event|8|||
149927746|NCT00313846|540870724|FG000|Overall Study|Administrative|2|||
149927747|NCT00313846|540870725|FG001|Overall Study|Administrative|3|||
149927748|NCT00970489|540870726|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
149927749|NCT00970489|540870727|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
149927750|NCT02592447|540870728|FG000|Overall Study|Lost to Follow-up|1|||
149927751|NCT02592447|540870729|FG001|Overall Study|Lost to Follow-up|0|||
149927752|NCT02592447|540870728|FG000|Overall Study|Ineligible after randomization|1|||
149927753|NCT02592447|540870729|FG001|Overall Study|Ineligible after randomization|0|||
149927754|NCT02592447|540870728|FG000|Overall Study|Withdrawal by Subject|0|||
149927755|NCT02592447|540870729|FG001|Overall Study|Withdrawal by Subject|1|||
149927756|NCT03428100|540870730|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
149927757|NCT03428100|540870731|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927758|NCT03428100|540870732|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
149927759|NCT03428100|540870733|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
149927760|NCT03428100|540870734|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927761|NCT03428100|540870735|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927762|NCT03428100|540870736|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927763|NCT03428100|540870737|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927764|NCT03428100|540870738|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927765|NCT03428100|540870739|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927766|NCT03428100|540870740|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927767|NCT03428100|540870741|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927768|NCT03428100|540870742|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927769|NCT03428100|540870743|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
150164830|NCT00877851|541737497|FG001|Overall Study|computer problem|0|||
150164831|NCT00877851|541737496|FG000|Overall Study|no longer interested in participating|1|||
150164832|NCT00877851|541737497|FG001|Overall Study|no longer interested in participating|0|||
150164833|NCT03424239|541737498|FG000|Overall Study|Withdrawal by Subject|2|||
150164834|NCT00770211|541737499|FG000|Overall Study|Lost to Follow-up|1|||
150164835|NCT00770211|541737500|FG001|Overall Study|Lost to Follow-up|0|||
150164836|NCT00770211|541737499|FG000|Overall Study|Withdrawal by Subject|0|||
150164837|NCT00770211|541737500|FG001|Overall Study|Withdrawal by Subject|2|||
150164838|NCT00318656|541737501|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
150164839|NCT00318656|541737502|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
150164840|NCT00318656|541737501|FG000|Overall Study|Did not receive any treatment|0|||
149927770|NCT03428100|540870744|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927771|NCT03428100|540870745|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927772|NCT03428100|540870746|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927773|NCT03428100|540870747|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927774|NCT03428100|540870748|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
149927775|NCT03428100|540870730|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
149927776|NCT03428100|540870731|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
149927777|NCT03428100|540870732|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
150164841|NCT00318656|541737502|FG001|Overall Study|Did not receive any treatment|1|||
150164842|NCT01446003|541737503|FG000|Period 1|Protocol Violation|2|||
149927778|NCT03428100|540870733|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
149927779|NCT03428100|540870734|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927780|NCT03428100|540870735|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927781|NCT03428100|540870736|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927782|NCT03428100|540870737|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927783|NCT03428100|540870738|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927784|NCT03428100|540870739|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927785|NCT03428100|540870740|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927786|NCT03428100|540870741|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927787|NCT03428100|540870742|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927788|NCT03428100|540870743|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927789|NCT03428100|540870744|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927790|NCT03428100|540870745|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927791|NCT03428100|540870746|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927792|NCT03428100|540870747|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927793|NCT03428100|540870748|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
149927794|NCT03428100|540870730|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927795|NCT03428100|540870731|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
149927796|NCT03428100|540870732|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
149927797|NCT03428100|540870733|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927798|NCT03428100|540870734|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927799|NCT03428100|540870735|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927800|NCT03428100|540870736|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927801|NCT03428100|540870737|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927802|NCT03428100|540870738|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927803|NCT03428100|540870739|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927804|NCT03428100|540870740|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927805|NCT03428100|540870741|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927806|NCT03428100|540870742|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927807|NCT03428100|540870743|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927808|NCT03428100|540870744|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927809|NCT03428100|540870745|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927810|NCT03428100|540870746|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927811|NCT03428100|540870747|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927812|NCT03428100|540870748|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
149927813|NCT03428100|540870730|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
149927814|NCT03428100|540870731|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927815|NCT03428100|540870732|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927816|NCT03428100|540870733|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927817|NCT03428100|540870734|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927818|NCT03428100|540870735|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927819|NCT03428100|540870736|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927820|NCT03428100|540870737|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927821|NCT03428100|540870738|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927822|NCT03428100|540870739|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927823|NCT03428100|540870740|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927824|NCT03428100|540870741|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927825|NCT03428100|540870742|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927826|NCT03428100|540870743|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927827|NCT03428100|540870744|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927828|NCT03428100|540870745|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927829|NCT03428100|540870746|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927830|NCT03428100|540870747|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927831|NCT03428100|540870748|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
149927832|NCT03428100|540870730|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927833|NCT03428100|540870731|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
149927834|NCT03428100|540870732|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927835|NCT03428100|540870733|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927836|NCT03428100|540870734|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927837|NCT03428100|540870735|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927838|NCT03428100|540870736|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
150164843|NCT01446003|541737504|FG001|Period 1|Protocol Violation|0|||
150164844|NCT01446003|541737503|FG000|Period 2|Adverse Event|1|||
149927839|NCT03428100|540870737|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927840|NCT03428100|540870738|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927841|NCT03428100|540870739|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927842|NCT03428100|540870740|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927843|NCT03428100|540870741|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927844|NCT03428100|540870742|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927845|NCT03428100|540870743|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927846|NCT03428100|540870744|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927847|NCT03428100|540870745|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927848|NCT03428100|540870746|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927849|NCT03428100|540870747|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927850|NCT03428100|540870748|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
149927851|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927852|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927853|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927854|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927855|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927856|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
149927857|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927858|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
149927859|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927860|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927861|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927862|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927863|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
149927864|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927865|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927866|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
149927867|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
149927868|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927869|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
149927870|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
149927871|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
149927872|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
149927873|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
149927874|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
149927875|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
149927876|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
149927877|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
149927878|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
149927879|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
149927880|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
149927881|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
149927882|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
149927883|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
149927884|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
149927885|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
149927886|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
149927887|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
149927888|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
149927889|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927890|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927891|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927892|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927893|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
149927894|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
149927895|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
149927896|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
149927897|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927898|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
149927899|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
149927900|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
149927901|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
149927902|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
149927903|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
149927904|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
149927905|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
149927906|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
149927907|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
149927908|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927909|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927910|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927911|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927912|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927913|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927914|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927915|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
149927916|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927917|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927918|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927919|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
149927920|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
149927921|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927922|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
149927923|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927924|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927925|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
149927926|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
149927927|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
149927928|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
149927929|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
149927930|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
149927931|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
149927932|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
149927933|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
149927934|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
149927935|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
149927936|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
149927937|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
149927938|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
149927939|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
149927940|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
149927941|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
149927942|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
149927943|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
149927944|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
149927945|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
149927946|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927947|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927948|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927949|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927950|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927951|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927952|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
149927953|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927954|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927955|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927956|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927957|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927958|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927959|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927960|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927961|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927962|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927963|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149927964|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
149927965|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
149927966|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
149927967|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
149927968|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
149927969|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
150265551|NCT00343252|542108606|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
150265552|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
150265553|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
149927970|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
149927971|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
149927972|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
149927973|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
149927974|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
149927975|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
149927976|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
149927977|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
149927978|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
149927979|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
149927980|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
149927981|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
149927982|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
149927983|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
149927984|NCT03428100|540870730|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927985|NCT03428100|540870731|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927986|NCT03428100|540870732|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927987|NCT03428100|540870733|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927988|NCT03428100|540870734|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
149927989|NCT03428100|540870735|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927990|NCT03428100|540870736|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
149927991|NCT03428100|540870737|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
149927992|NCT03428100|540870738|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149927993|NCT03428100|540870739|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
149927994|NCT03428100|540870740|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
149927995|NCT03428100|540870741|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
149927996|NCT03428100|540870742|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
149927997|NCT03428100|540870743|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
149927998|NCT03428100|540870744|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
149927999|NCT03428100|540870745|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149928000|NCT03428100|540870746|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
149928001|NCT03428100|540870747|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
149928002|NCT03428100|540870748|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
149928003|NCT01096160|540870753|FG000|Overall Study|Adverse Event|0|||
149928004|NCT01096160|540870754|FG001|Overall Study|Adverse Event|0|||
149928005|NCT01096160|540870755|FG002|Overall Study|Adverse Event|1|||
149928006|NCT01096160|540870756|FG003|Overall Study|Adverse Event|0|||
149928007|NCT01096160|540870757|FG004|Overall Study|Adverse Event|0|||
149928008|NCT01096160|540870758|FG005|Overall Study|Adverse Event|0|||
149928009|NCT01096160|540870759|FG006|Overall Study|Adverse Event|0|||
149928010|NCT01096160|540870760|FG007|Overall Study|Adverse Event|0|||
149928011|NCT01096160|540870761|FG008|Overall Study|Adverse Event|0|||
149928012|NCT01096160|540870762|FG009|Overall Study|Adverse Event|1|||
149928013|NCT01096160|540870753|FG000|Overall Study|Met stopping criteria per protocol|0|||
149928014|NCT01096160|540870754|FG001|Overall Study|Met stopping criteria per protocol|0|||
149928015|NCT01096160|540870755|FG002|Overall Study|Met stopping criteria per protocol|0|||
149928016|NCT01096160|540870756|FG003|Overall Study|Met stopping criteria per protocol|0|||
149928017|NCT01096160|540870757|FG004|Overall Study|Met stopping criteria per protocol|1|||
149928018|NCT01096160|540870758|FG005|Overall Study|Met stopping criteria per protocol|0|||
149928019|NCT01096160|540870759|FG006|Overall Study|Met stopping criteria per protocol|2|||
149928020|NCT01096160|540870760|FG007|Overall Study|Met stopping criteria per protocol|0|||
149928021|NCT01096160|540870761|FG008|Overall Study|Met stopping criteria per protocol|2|||
149928022|NCT01096160|540870762|FG009|Overall Study|Met stopping criteria per protocol|0|||
149928023|NCT00627497|540870763|FG000|Overall Study|Lost to Follow-up|1|||
149928024|NCT00627497|540870764|FG001|Overall Study|Lost to Follow-up|1|||
150265554|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Death|3|||
150265555|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Death|3|||
150265556|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
149928025|NCT00627497|540870765|FG002|Overall Study|Lost to Follow-up|0|||
149928026|NCT00627497|540870766|FG003|Overall Study|Lost to Follow-up|0|||
149928027|NCT01556932|540870769|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
150265557|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
150265558|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
149928028|NCT01556932|540870770|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
149928029|NCT03231306|540870771|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
149928030|NCT03231306|540870771|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
149928031|NCT03231306|540870771|FG000|Overall Study|Treatment delay > 21 days|2|||
149928032|NCT03231306|540870771|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
149928033|NCT03231306|540870771|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
149928034|NCT03231306|540870771|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
149928035|NCT03231306|540870771|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
149928036|NCT03231306|540870771|FG000|Overall Study|More than 1 Reason|2|||
149928037|NCT01808261|540870772|FG000|Overall Study|Physician Decision|0|||
149928038|NCT01808261|540870773|FG001|Overall Study|Physician Decision|2|||
149928039|NCT01808261|540870772|FG000|Overall Study|Study Closed/Terminated|25|||
149928040|NCT01808261|540870773|FG001|Overall Study|Study Closed/Terminated|23|||
149928041|NCT01808261|540870772|FG000|Overall Study|Adverse event, non-fatal|2|||
149928042|NCT01808261|540870773|FG001|Overall Study|Adverse event, non-fatal|0|||
149928043|NCT01808261|540870772|FG000|Overall Study|Consent withdrawn by subject|6|||
149928044|NCT01808261|540870773|FG001|Overall Study|Consent withdrawn by subject|7|||
149928045|NCT01808261|540870772|FG000|Overall Study|Lost to Follow-up|3|||
149928046|NCT01808261|540870773|FG001|Overall Study|Lost to Follow-up|1|||
149928047|NCT04501952|540870778|FG000|Overall Study|Adverse Event|0|||
149928048|NCT04501952|540870779|FG001|Overall Study|Adverse Event|3|||
149928049|NCT04501952|540870778|FG000|Overall Study|Investigator's Discretion|0|||
149928050|NCT04501952|540870779|FG001|Overall Study|Investigator's Discretion|1|||
149928051|NCT04501952|540870778|FG000|Overall Study|Protocol Violation|1|||
149928052|NCT04501952|540870779|FG001|Overall Study|Protocol Violation|1|||
149928053|NCT04501952|540870778|FG000|Overall Study|Withdrew Consent|5|||
149928054|NCT04501952|540870779|FG001|Overall Study|Withdrew Consent|4|||
149928055|NCT04501952|540870778|FG000|Overall Study|Lost to Follow-up|7|||
149928056|NCT04501952|540870779|FG001|Overall Study|Lost to Follow-up|2|||
150265559|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
149928057|NCT04501952|540870778|FG000|Overall Study|Randomized and Never Treated|13|||
150265560|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
150265561|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
150265562|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
150265563|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
150265564|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
150265565|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
150265566|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
150265567|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
149928058|NCT04501952|540870779|FG001|Overall Study|Randomized and Never Treated|9|||
149928059|NCT02080364|540870780|FG000|Baseline Period|Protocol Violation|2|||
149928060|NCT02080364|540870781|FG001|Baseline Period|Protocol Violation|1|||
149928061|NCT02080364|540870782|FG002|Baseline Period|Protocol Violation|0|||
149928062|NCT02080364|540870783|FG003|Baseline Period|Protocol Violation|0|||
149928063|NCT02080364|540870780|FG000|Baseline Period|Other|0|||
149928064|NCT02080364|540870781|FG001|Baseline Period|Other|1|||
149928065|NCT02080364|540870782|FG002|Baseline Period|Other|1|||
149928066|NCT02080364|540870783|FG003|Baseline Period|Other|0|||
149928067|NCT02080364|540870780|FG000|Treatment Period|Adverse Event|10|||
149928068|NCT02080364|540870781|FG001|Treatment Period|Adverse Event|15|||
149928069|NCT02080364|540870782|FG002|Treatment Period|Adverse Event|11|||
149928070|NCT02080364|540870783|FG003|Treatment Period|Adverse Event|14|||
149928071|NCT02080364|540870780|FG000|Treatment Period|Lost to Follow-up|2|||
149928072|NCT02080364|540870781|FG001|Treatment Period|Lost to Follow-up|3|||
149928073|NCT02080364|540870782|FG002|Treatment Period|Lost to Follow-up|5|||
149928074|NCT02080364|540870783|FG003|Treatment Period|Lost to Follow-up|0|||
149928075|NCT02080364|540870780|FG000|Treatment Period|Protocol Violation|5|||
149928076|NCT02080364|540870781|FG001|Treatment Period|Protocol Violation|3|||
149928077|NCT02080364|540870782|FG002|Treatment Period|Protocol Violation|5|||
149928078|NCT02080364|540870783|FG003|Treatment Period|Protocol Violation|1|||
149928079|NCT02080364|540870780|FG000|Treatment Period|Withdrawal by Subject|16|||
149928080|NCT02080364|540870781|FG001|Treatment Period|Withdrawal by Subject|16|||
149928081|NCT02080364|540870782|FG002|Treatment Period|Withdrawal by Subject|15|||
149928082|NCT02080364|540870783|FG003|Treatment Period|Withdrawal by Subject|10|||
149928083|NCT02080364|540870780|FG000|Treatment Period|Study Terminated by Sponsor|0|||
150265568|NCT00343252|542108605|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
150265569|NCT00343252|542108606|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
150265570|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
149928084|NCT02080364|540870781|FG001|Treatment Period|Study Terminated by Sponsor|0|||
149928085|NCT02080364|540870782|FG002|Treatment Period|Study Terminated by Sponsor|180|||
149928086|NCT02080364|540870783|FG003|Treatment Period|Study Terminated by Sponsor|183|||
149928087|NCT02080364|540870780|FG000|Treatment Period|Other|14|||
149928088|NCT02080364|540870781|FG001|Treatment Period|Other|12|||
149928089|NCT02080364|540870782|FG002|Treatment Period|Other|21|||
149928090|NCT02080364|540870783|FG003|Treatment Period|Other|16|||
149928091|NCT00991289|540870784|FG000|Overall Study|Adverse Event|1|||
149928092|NCT00991289|540870784|FG000|Overall Study|Physician Decision|2|||
149928093|NCT00991289|540870784|FG000|Overall Study|Withdrawal by Subject|3|||
149928094|NCT00991289|540870784|FG000|Overall Study|Lost to Follow-up|4|||
149928095|NCT00991289|540870784|FG000|Overall Study|Protocol Violation|2|||
149928096|NCT05568797|540870786|FG000|Overall Study|Adverse Event|0|||
149928097|NCT05568797|540870787|FG001|Overall Study|Adverse Event|8|||
149928098|NCT05568797|540870786|FG000|Overall Study|Lost to Follow-up|2|||
149928099|NCT05568797|540870787|FG001|Overall Study|Lost to Follow-up|3|||
149928100|NCT05568797|540870786|FG000|Overall Study|Withdrawal by Subject|1|||
149928101|NCT05568797|540870787|FG001|Overall Study|Withdrawal by Subject|10|||
149928102|NCT05568797|540870786|FG000|Overall Study|Other|2|||
149928103|NCT05568797|540870787|FG001|Overall Study|Other|2|||
149928104|NCT02797678|540870788|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
149928105|NCT02797678|540870789|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
149928106|NCT02797678|540870790|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
149928107|NCT02797678|540870791|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
149928108|NCT02797678|540870788|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
149928109|NCT02797678|540870789|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
149928110|NCT02797678|540870790|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
149928111|NCT02797678|540870791|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
149928112|NCT02797678|540870788|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
149928113|NCT02797678|540870789|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
149928114|NCT02797678|540870790|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
149928115|NCT02797678|540870791|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
149928116|NCT03131687|540870792|FG000|Overall Study|Adverse Event|0|||
149928117|NCT03131687|540870793|FG001|Overall Study|Adverse Event|1|||
149928118|NCT03131687|540870794|FG002|Overall Study|Adverse Event|0|||
149928119|NCT03131687|540870795|FG003|Overall Study|Adverse Event|1|||
149928120|NCT03131687|540870796|FG004|Overall Study|Adverse Event|2|||
149928121|NCT03131687|540870797|FG005|Overall Study|Adverse Event|2|||
149928122|NCT03131687|540870792|FG000|Overall Study|Death|1|||
149928123|NCT03131687|540870793|FG001|Overall Study|Death|0|||
149928124|NCT03131687|540870794|FG002|Overall Study|Death|0|||
149928125|NCT03131687|540870795|FG003|Overall Study|Death|0|||
149928126|NCT03131687|540870796|FG004|Overall Study|Death|0|||
149928127|NCT03131687|540870797|FG005|Overall Study|Death|0|||
149928128|NCT03131687|540870792|FG000|Overall Study|Withdrawal by Subject|3|||
149928129|NCT03131687|540870793|FG001|Overall Study|Withdrawal by Subject|3|||
149928130|NCT03131687|540870794|FG002|Overall Study|Withdrawal by Subject|3|||
149928131|NCT03131687|540870795|FG003|Overall Study|Withdrawal by Subject|1|||
149928132|NCT03131687|540870796|FG004|Overall Study|Withdrawal by Subject|2|||
149928133|NCT03131687|540870797|FG005|Overall Study|Withdrawal by Subject|1|||
149928134|NCT03131687|540870792|FG000|Overall Study|Lost to Follow-up|1|||
149928135|NCT03131687|540870793|FG001|Overall Study|Lost to Follow-up|4|||
149928136|NCT03131687|540870794|FG002|Overall Study|Lost to Follow-up|0|||
150164845|NCT01446003|541737504|FG001|Period 2|Adverse Event|0|||
150164846|NCT03905135|541737506|FG000|Dose Escalation|Adverse Event|1|||
150164847|NCT03905135|541737507|FG001|Dose Escalation|Adverse Event|1|||
150164848|NCT03905135|541737506|FG000|Dose Escalation|Progressive disease|3|||
150164849|NCT03905135|541737507|FG001|Dose Escalation|Progressive disease|1|||
150164850|NCT03905135|541737506|FG000|Dose Escalation|Intercurrent illness|1|||
150164851|NCT03905135|541737507|FG001|Dose Escalation|Intercurrent illness|0|||
150164852|NCT01740557|541737508|FG000|Overall Study|Ineligible|1|||
150164853|NCT01740557|541737508|FG000|Overall Study|Screen failure|1|||
150164854|NCT02042443|541737511|FG000|Overall Study|Adverse Event|2|||
150164855|NCT02042443|541737512|FG001|Overall Study|Adverse Event|1|||
150164856|NCT02042443|541737511|FG000|Overall Study|Withdrawal by Subject|0|||
150164857|NCT02042443|541737512|FG001|Overall Study|Withdrawal by Subject|1|||
150164858|NCT02042443|541737511|FG000|Overall Study|Progression|21|||
150164859|NCT02042443|541737512|FG001|Overall Study|Progression|17|||
150164860|NCT02042443|541737511|FG000|Overall Study|not protocol specified|1|||
150164861|NCT02042443|541737512|FG001|Overall Study|not protocol specified|1|||
150164862|NCT02042443|541737511|FG000|Overall Study|Not eligible/not analyzable|3|||
150164863|NCT02042443|541737512|FG001|Overall Study|Not eligible/not analyzable|6|||
150164864|NCT01007149|541737515|FG000|Overall Study|Administrative problems|0|||
150164865|NCT01007149|541737516|FG001|Overall Study|Administrative problems|1|||
150164866|NCT01913340|541737517|FG000|Overall Study|Death|2|||
149928137|NCT03131687|540870795|FG003|Overall Study|Lost to Follow-up|1|||
149928138|NCT03131687|540870796|FG004|Overall Study|Lost to Follow-up|4|||
149928139|NCT03131687|540870797|FG005|Overall Study|Lost to Follow-up|2|||
149928140|NCT03131687|540870792|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
149928141|NCT03131687|540870793|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
150164867|NCT01913340|541737518|FG001|Overall Study|Death|5|||
150265571|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
150265572|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Death|4|||
150265573|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Death|5|||
150265574|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
150265575|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
150265576|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
150265577|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
150265578|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
150265579|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
150265580|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
150265581|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
150265582|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
150265583|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
149928142|NCT03131687|540870794|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
149928143|NCT03131687|540870795|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
149928144|NCT03131687|540870796|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
149928145|NCT03131687|540870797|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
149928146|NCT03131687|540870792|FG000|Overall Study|Principle Investigator Decision|0|||
149928147|NCT03131687|540870793|FG001|Overall Study|Principle Investigator Decision|1|||
149928148|NCT03131687|540870794|FG002|Overall Study|Principle Investigator Decision|0|||
149928149|NCT03131687|540870795|FG003|Overall Study|Principle Investigator Decision|0|||
149928150|NCT03131687|540870796|FG004|Overall Study|Principle Investigator Decision|0|||
149928151|NCT03131687|540870797|FG005|Overall Study|Principle Investigator Decision|0|||
149928152|NCT03131687|540870792|FG000|Overall Study|Inadvertent Enrollment|0|||
149928153|NCT03131687|540870793|FG001|Overall Study|Inadvertent Enrollment|0|||
149928154|NCT03131687|540870794|FG002|Overall Study|Inadvertent Enrollment|0|||
149928155|NCT03131687|540870795|FG003|Overall Study|Inadvertent Enrollment|1|||
149928156|NCT03131687|540870796|FG004|Overall Study|Inadvertent Enrollment|0|||
149928157|NCT03131687|540870797|FG005|Overall Study|Inadvertent Enrollment|0|||
149928158|NCT02401035|540870798|FG000|Overall Study|Withdrawal by Subject|1|||
149928159|NCT02401035|540870799|FG001|Overall Study|Withdrawal by Subject|0|||
149928160|NCT00869128|540870800|FG000|Overall Study|lack of Compliance|6|||
149928161|NCT00869128|540870801|FG001|Overall Study|lack of Compliance|6|||
149928162|NCT01670045|540870807|FG000|Overall Study|Withdrawal by Subject|3|||
149928163|NCT01670045|540870807|FG000|Overall Study|Adverse Event|1|||
149928164|NCT01670045|540870807|FG000|Overall Study|Death|1|||
149928165|NCT01670045|540870807|FG000|Overall Study|Lost to Follow-up|11|||
149928166|NCT03046953|540870814|FG000|Overall Study|Relapse/progressive disease|21|||
149928167|NCT03046953|540870814|FG000|Overall Study|Death|2|||
149928168|NCT03046953|540870814|FG000|Overall Study|Withdrawal by Subject|3|||
149928169|NCT00420628|540870817|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
149928170|NCT00420628|540870818|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
149928171|NCT00420628|540870817|FG000|Overall Study|Lost to Follow-up|3|||
149928172|NCT00420628|540870818|FG001|Overall Study|Lost to Follow-up|2|||
149928173|NCT00420628|540870817|FG000|Overall Study|Adverse Event|1|||
149928174|NCT00420628|540870818|FG001|Overall Study|Adverse Event|0|||
149928175|NCT02716584|540870819|FG000|Overall Study|Lost to Follow-up|8|||
149928176|NCT02716584|540870820|FG001|Overall Study|Lost to Follow-up|5|||
149928177|NCT01868165|540870823|FG000|Overall Study|Withdrawal by Subject|36|||
149928178|NCT01868165|540870823|FG000|Overall Study|Physician Decision|2|||
149928179|NCT01868165|540870823|FG000|Overall Study|Lost to Follow-up|3|||
149928180|NCT01868165|540870823|FG000|Overall Study|Death|4|||
149928181|NCT00103285|540872476|FG000|Induction|Adverse Event|14|||
149928182|NCT00103285|540872477|FG001|Induction|Adverse Event|0|||
149928183|NCT00103285|540872478|FG002|Induction|Adverse Event|0|||
149928184|NCT00103285|540872479|FG003|Induction|Adverse Event|0|||
149928185|NCT00103285|540872480|FG004|Induction|Adverse Event|0|||
149928186|NCT00103285|540872481|FG005|Induction|Adverse Event|0|||
149928187|NCT00103285|540872482|FG006|Induction|Adverse Event|0|||
149928188|NCT00103285|540872483|FG007|Induction|Adverse Event|0|||
149928189|NCT00103285|540872476|FG000|Induction|Death|24|||
149928190|NCT00103285|540872477|FG001|Induction|Death|0|||
149928191|NCT00103285|540872478|FG002|Induction|Death|0|||
149928192|NCT00103285|540872479|FG003|Induction|Death|0|||
149928193|NCT00103285|540872480|FG004|Induction|Death|0|||
149928194|NCT00103285|540872481|FG005|Induction|Death|0|||
149928195|NCT00103285|540872482|FG006|Induction|Death|0|||
149928196|NCT00103285|540872483|FG007|Induction|Death|0|||
149928197|NCT00103285|540872476|FG000|Induction|Physician Decision|103|||
149928198|NCT00103285|540872477|FG001|Induction|Physician Decision|0|||
149928199|NCT00103285|540872478|FG002|Induction|Physician Decision|0|||
149928200|NCT00103285|540872479|FG003|Induction|Physician Decision|0|||
149928201|NCT00103285|540872480|FG004|Induction|Physician Decision|0|||
149928202|NCT00103285|540872481|FG005|Induction|Physician Decision|0|||
149928203|NCT00103285|540872482|FG006|Induction|Physician Decision|0|||
149928204|NCT00103285|540872483|FG007|Induction|Physician Decision|0|||
149928205|NCT00103285|540872476|FG000|Induction|Withdrawal by Subject|1|||
149928206|NCT00103285|540872477|FG001|Induction|Withdrawal by Subject|0|||
149928207|NCT00103285|540872478|FG002|Induction|Withdrawal by Subject|0|||
149928208|NCT00103285|540872479|FG003|Induction|Withdrawal by Subject|0|||
149928209|NCT00103285|540872480|FG004|Induction|Withdrawal by Subject|0|||
149928210|NCT00103285|540872481|FG005|Induction|Withdrawal by Subject|0|||
149928211|NCT00103285|540872482|FG006|Induction|Withdrawal by Subject|0|||
149928212|NCT00103285|540872483|FG007|Induction|Withdrawal by Subject|0|||
149928213|NCT00103285|540872476|FG000|Induction|Ineligible|43|||
149928214|NCT00103285|540872477|FG001|Induction|Ineligible|0|||
149928215|NCT00103285|540872478|FG002|Induction|Ineligible|0|||
149928216|NCT00103285|540872479|FG003|Induction|Ineligible|0|||
149928217|NCT00103285|540872480|FG004|Induction|Ineligible|0|||
149928218|NCT00103285|540872481|FG005|Induction|Ineligible|0|||
149928219|NCT00103285|540872482|FG006|Induction|Ineligible|0|||
149928220|NCT00103285|540872483|FG007|Induction|Ineligible|0|||
149928221|NCT00103285|540872476|FG000|Induction|Refusal|906|||
149928222|NCT00103285|540872477|FG001|Induction|Refusal|0|||
149928223|NCT00103285|540872478|FG002|Induction|Refusal|0|||
149928224|NCT00103285|540872479|FG003|Induction|Refusal|0|||
149928225|NCT00103285|540872480|FG004|Induction|Refusal|0|||
149928226|NCT00103285|540872481|FG005|Induction|Refusal|0|||
149928227|NCT00103285|540872482|FG006|Induction|Refusal|0|||
149928228|NCT00103285|540872483|FG007|Induction|Refusal|0|||
149928229|NCT00103285|540872476|FG000|Induction|Other|258|||
149928230|NCT00103285|540872477|FG001|Induction|Other|0|||
149928231|NCT00103285|540872478|FG002|Induction|Other|0|||
149928232|NCT00103285|540872479|FG003|Induction|Other|0|||
149928233|NCT00103285|540872480|FG004|Induction|Other|0|||
149928234|NCT00103285|540872481|FG005|Induction|Other|0|||
149928235|NCT00103285|540872482|FG006|Induction|Other|0|||
149928236|NCT00103285|540872483|FG007|Induction|Other|0|||
149928237|NCT00103285|540872476|FG000|Response Assignment|Adverse Event|0|||
149928238|NCT00103285|540872477|FG001|Response Assignment|Adverse Event|8|||
149928239|NCT00103285|540872478|FG002|Response Assignment|Adverse Event|3|||
149928240|NCT00103285|540872479|FG003|Response Assignment|Adverse Event|2|||
149928241|NCT00103285|540872480|FG004|Response Assignment|Adverse Event|3|||
149928242|NCT00103285|540872481|FG005|Response Assignment|Adverse Event|1|||
149928243|NCT00103285|540872482|FG006|Response Assignment|Adverse Event|1|||
149928244|NCT00103285|540872483|FG007|Response Assignment|Adverse Event|2|||
149928245|NCT00103285|540872476|FG000|Response Assignment|Death|0|||
149928246|NCT00103285|540872477|FG001|Response Assignment|Death|5|||
149928247|NCT00103285|540872478|FG002|Response Assignment|Death|2|||
149928248|NCT00103285|540872479|FG003|Response Assignment|Death|2|||
149928249|NCT00103285|540872480|FG004|Response Assignment|Death|3|||
149928250|NCT00103285|540872481|FG005|Response Assignment|Death|1|||
149928251|NCT00103285|540872482|FG006|Response Assignment|Death|0|||
149928252|NCT00103285|540872483|FG007|Response Assignment|Death|8|||
149928253|NCT00103285|540872476|FG000|Response Assignment|Lost to Follow-up|0|||
149928254|NCT00103285|540872477|FG001|Response Assignment|Lost to Follow-up|9|||
149928255|NCT00103285|540872478|FG002|Response Assignment|Lost to Follow-up|5|||
149928256|NCT00103285|540872479|FG003|Response Assignment|Lost to Follow-up|5|||
149928257|NCT00103285|540872480|FG004|Response Assignment|Lost to Follow-up|1|||
149928258|NCT00103285|540872481|FG005|Response Assignment|Lost to Follow-up|2|||
149928259|NCT00103285|540872482|FG006|Response Assignment|Lost to Follow-up|2|||
149928260|NCT00103285|540872483|FG007|Response Assignment|Lost to Follow-up|5|||
149928261|NCT00103285|540872476|FG000|Response Assignment|Physician Decision|0|||
149928262|NCT00103285|540872477|FG001|Response Assignment|Physician Decision|13|||
150265584|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
150265585|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
150265586|NCT00343252|542108605|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
150265587|NCT00343252|542108606|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
150265588|NCT02076178|542108607|FG000|Oral Phase|Adverse Event|0|||
150265589|NCT02076178|542108608|FG001|Oral Phase|Adverse Event|7|||
150265590|NCT02076178|542108607|FG000|Oral Phase|Withdrawal by Subject|0|||
149928263|NCT00103285|540872478|FG002|Response Assignment|Physician Decision|14|||
149928264|NCT00103285|540872479|FG003|Response Assignment|Physician Decision|9|||
149928265|NCT00103285|540872480|FG004|Response Assignment|Physician Decision|13|||
149928266|NCT00103285|540872481|FG005|Response Assignment|Physician Decision|7|||
149928267|NCT00103285|540872482|FG006|Response Assignment|Physician Decision|4|||
149928268|NCT00103285|540872483|FG007|Response Assignment|Physician Decision|35|||
149928269|NCT00103285|540872476|FG000|Response Assignment|Protocol Violation|0|||
149928270|NCT00103285|540872477|FG001|Response Assignment|Protocol Violation|2|||
149928271|NCT00103285|540872478|FG002|Response Assignment|Protocol Violation|0|||
149928272|NCT00103285|540872479|FG003|Response Assignment|Protocol Violation|0|||
149928273|NCT00103285|540872480|FG004|Response Assignment|Protocol Violation|0|||
149928274|NCT00103285|540872481|FG005|Response Assignment|Protocol Violation|0|||
149928275|NCT00103285|540872482|FG006|Response Assignment|Protocol Violation|0|||
149928276|NCT00103285|540872483|FG007|Response Assignment|Protocol Violation|0|||
149928277|NCT00103285|540872476|FG000|Response Assignment|Withdrawal by Subject|0|||
149928278|NCT00103285|540872477|FG001|Response Assignment|Withdrawal by Subject|4|||
150265591|NCT02076178|542108608|FG001|Oral Phase|Withdrawal by Subject|4|||
150265592|NCT02076178|542108607|FG000|Oral Phase|Physician Decision|0|||
149928279|NCT00103285|540872478|FG002|Response Assignment|Withdrawal by Subject|1|||
149928280|NCT00103285|540872479|FG003|Response Assignment|Withdrawal by Subject|1|||
149928281|NCT00103285|540872480|FG004|Response Assignment|Withdrawal by Subject|2|||
149928282|NCT00103285|540872481|FG005|Response Assignment|Withdrawal by Subject|2|||
149928283|NCT00103285|540872482|FG006|Response Assignment|Withdrawal by Subject|0|||
149928284|NCT00103285|540872483|FG007|Response Assignment|Withdrawal by Subject|2|||
149928285|NCT00103285|540872476|FG000|Response Assignment|Ineligible|0|||
149928286|NCT00103285|540872477|FG001|Response Assignment|Ineligible|8|||
150164868|NCT01913340|541737517|FG000|Overall Study|Lost to Follow-up|1|||
150164869|NCT01913340|541737518|FG001|Overall Study|Lost to Follow-up|1|||
150164870|NCT02784704|541737519|FG000|Overall Study|Adverse Event|4|||
150164871|NCT02784704|541737520|FG001|Overall Study|Adverse Event|2|||
150164872|NCT02784704|541737519|FG000|Overall Study|Lost to Follow-up|6|||
150164873|NCT02784704|541737520|FG001|Overall Study|Lost to Follow-up|4|||
150164874|NCT02784704|541737519|FG000|Overall Study|Withdrawal by Subject|1|||
150164875|NCT02784704|541737520|FG001|Overall Study|Withdrawal by Subject|3|||
150164876|NCT02784704|541737519|FG000|Overall Study|Subject Non Compliance|2|||
150164877|NCT02784704|541737520|FG001|Overall Study|Subject Non Compliance|0|||
150164878|NCT01516892|541737522|FG000|Overall Study|Adverse Event|25|||
150164879|NCT01516892|541737522|FG000|Overall Study|Lack of Efficacy|35|||
150164880|NCT01516892|541737522|FG000|Overall Study|Pregnancy|5|||
150164881|NCT01516892|541737522|FG000|Overall Study|Lost to Follow-up|82|||
150164882|NCT01516892|541737522|FG000|Overall Study|Subject Withdrew Consent|92|||
150164883|NCT01516892|541737522|FG000|Overall Study|Protocol Violation|60|||
150164884|NCT01516892|541737522|FG000|Overall Study|Other Miscellaneous Reasons|43|||
150164885|NCT01516892|541737522|FG000|Overall Study|Missing|1|||
150164886|NCT05355116|541739913|FG000|Overall Study|Withdrawal by Subject|2|||
150164887|NCT00868231|541739914|FG000|Treatment Period 1|Adverse Event|0|||
150164888|NCT00868231|541739915|FG001|Treatment Period 1|Adverse Event|0|||
150164889|NCT00868231|541739916|FG002|Treatment Period 1|Adverse Event|0|||
150164890|NCT00868231|541739917|FG003|Treatment Period 1|Adverse Event|0|||
150164891|NCT00868231|541739918|FG004|Treatment Period 1|Adverse Event|1|||
150164892|NCT00868231|541739919|FG005|Treatment Period 1|Adverse Event|0|||
150164893|NCT00868231|541739914|FG000|Treatment Period 2|Adverse Event|1|||
150164894|NCT00868231|541739915|FG001|Treatment Period 2|Adverse Event|0|||
150164895|NCT00868231|541739916|FG002|Treatment Period 2|Adverse Event|0|||
150164896|NCT00868231|541739917|FG003|Treatment Period 2|Adverse Event|0|||
150164897|NCT00868231|541739918|FG004|Treatment Period 2|Adverse Event|0|||
150164898|NCT00868231|541739919|FG005|Treatment Period 2|Adverse Event|0|||
150164899|NCT00868231|541739914|FG000|Treatment Period 3|Adverse Event|0|||
150164900|NCT00868231|541739915|FG001|Treatment Period 3|Adverse Event|0|||
150164901|NCT00868231|541739916|FG002|Treatment Period 3|Adverse Event|1|||
150164902|NCT00868231|541739917|FG003|Treatment Period 3|Adverse Event|0|||
150164903|NCT00868231|541739918|FG004|Treatment Period 3|Adverse Event|0|||
150164904|NCT00868231|541739919|FG005|Treatment Period 3|Adverse Event|0|||
150164905|NCT00672256|541739924|FG000|Overall Study|PI dropped, bad data|44|||
150164906|NCT01801930|541739925|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
150164907|NCT01801930|541739926|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
150164908|NCT01801930|541739927|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
150164909|NCT01801930|541739928|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
150164910|NCT01801930|541739925|FG000|Overall Study|DLT occurs|0|||
150164911|NCT01801930|541739926|FG001|Overall Study|DLT occurs|1|||
150164912|NCT01801930|541739927|FG002|Overall Study|DLT occurs|0|||
150164913|NCT01801930|541739928|FG003|Overall Study|DLT occurs|0|||
150164914|NCT01268891|541739933|FG000|Overall Study|Adverse Event|3|||
150164915|NCT01268891|541739934|FG001|Overall Study|Adverse Event|7|||
150164916|NCT01268891|541739933|FG000|Overall Study|Lack of Efficacy|1|||
150164917|NCT01268891|541739934|FG001|Overall Study|Lack of Efficacy|0|||
150164918|NCT01268891|541739933|FG000|Overall Study|Withdrawal of Consent|3|||
150164919|NCT01268891|541739934|FG001|Overall Study|Withdrawal of Consent|1|||
150164920|NCT01268891|541739933|FG000|Overall Study|Administrative or other reason(s)|1|||
150164921|NCT01268891|541739934|FG001|Overall Study|Administrative or other reason(s)|0|||
150164922|NCT00991276|541739935|FG000|First Intervention Period|Adverse Event|0|||
150164923|NCT00991276|541739936|FG001|First Intervention Period|Adverse Event|1|||
150164924|NCT00991276|541739937|FG002|First Intervention Period|Adverse Event|0|||
150164925|NCT00991276|541739938|FG003|First Intervention Period|Adverse Event|1|||
150265593|NCT02076178|542108608|FG001|Oral Phase|Physician Decision|1|||
149928287|NCT00103285|540872478|FG002|Response Assignment|Ineligible|6|||
149928288|NCT00103285|540872479|FG003|Response Assignment|Ineligible|2|||
149928289|NCT00103285|540872480|FG004|Response Assignment|Ineligible|0|||
150164926|NCT00991276|541739939|FG004|First Intervention Period|Adverse Event|0|||
150164927|NCT00991276|541739940|FG005|First Intervention Period|Adverse Event|0|||
150164928|NCT00991276|541739935|FG000|First Intervention Period|Protocol Violation|0|||
150164929|NCT00991276|541739936|FG001|First Intervention Period|Protocol Violation|0|||
150164930|NCT00991276|541739937|FG002|First Intervention Period|Protocol Violation|0|||
150164931|NCT00991276|541739938|FG003|First Intervention Period|Protocol Violation|0|||
150164932|NCT00991276|541739939|FG004|First Intervention Period|Protocol Violation|2|||
149928290|NCT00103285|540872481|FG005|Response Assignment|Ineligible|3|||
149928291|NCT00103285|540872482|FG006|Response Assignment|Ineligible|1|||
149928292|NCT00103285|540872483|FG007|Response Assignment|Ineligible|5|||
149928293|NCT00103285|540872476|FG000|Response Assignment|Refusal|0|||
149928294|NCT00103285|540872477|FG001|Response Assignment|Refusal|53|||
149928295|NCT00103285|540872478|FG002|Response Assignment|Refusal|5|||
149928296|NCT00103285|540872479|FG003|Response Assignment|Refusal|3|||
149928297|NCT00103285|540872480|FG004|Response Assignment|Refusal|25|||
149928298|NCT00103285|540872481|FG005|Response Assignment|Refusal|15|||
149928299|NCT00103285|540872482|FG006|Response Assignment|Refusal|30|||
149928300|NCT00103285|540872483|FG007|Response Assignment|Refusal|10|||
149928301|NCT00103285|540872476|FG000|Response Assignment|Other|0|||
149928302|NCT00103285|540872477|FG001|Response Assignment|Other|30|||
149928303|NCT00103285|540872478|FG002|Response Assignment|Other|48|||
149928304|NCT00103285|540872479|FG003|Response Assignment|Other|38|||
149928305|NCT00103285|540872480|FG004|Response Assignment|Other|37|||
149928306|NCT00103285|540872481|FG005|Response Assignment|Other|17|||
149928307|NCT00103285|540872482|FG006|Response Assignment|Other|11|||
149928308|NCT00103285|540872483|FG007|Response Assignment|Other|53|||
149928309|NCT00452439|540872484|FG000|Overall Study|Lost to Follow-up|1|||
149928310|NCT00452439|540872485|FG001|Overall Study|Lost to Follow-up|1|||
149928311|NCT00452439|540872484|FG000|Overall Study|Refused Treatment|4|||
149928312|NCT00452439|540872485|FG001|Overall Study|Refused Treatment|3|||
149928313|NCT00452439|540872484|FG000|Overall Study|Death|3|||
149928314|NCT00452439|540872485|FG001|Overall Study|Death|1|||
149928315|NCT00452439|540872484|FG000|Overall Study|Bone Marrow Transplant|0|||
149928316|NCT00452439|540872485|FG001|Overall Study|Bone Marrow Transplant|1|||
149928317|NCT00452439|540872484|FG000|Overall Study|Too Ill to Continue|0|||
149928318|NCT00452439|540872485|FG001|Overall Study|Too Ill to Continue|1|||
149928319|NCT00452439|540872484|FG000|Overall Study|Failed to achieve complete response|2|||
149928320|NCT00452439|540872485|FG001|Overall Study|Failed to achieve complete response|0|||
149928321|NCT00452439|540872484|FG000|Overall Study|Relapse|3|||
149928322|NCT00452439|540872485|FG001|Overall Study|Relapse|0|||
149928323|NCT00452439|540872484|FG000|Overall Study|Fracture|1|||
149928324|NCT00452439|540872485|FG001|Overall Study|Fracture|0|||
149928325|NCT01381926|540872486|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
149928326|NCT01381926|540872487|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
149928327|NCT01381926|540872486|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
149928328|NCT01381926|540872487|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
149928329|NCT02624947|540872492|FG000|Maternal Participants|Adverse Event|5|||
149928330|NCT02624947|540872493|FG001|Maternal Participants|Adverse Event|0|||
149928331|NCT02624947|540872492|FG000|Maternal Participants|Investigator Decision|5|||
149928332|NCT02624947|540872493|FG001|Maternal Participants|Investigator Decision|3|||
149928333|NCT02624947|540872492|FG000|Maternal Participants|Lost to Follow-up|54|||
149928334|NCT02624947|540872493|FG001|Maternal Participants|Lost to Follow-up|24|||
149928335|NCT02624947|540872492|FG000|Maternal Participants|Non Compliance|8|||
149928336|NCT02624947|540872493|FG001|Maternal Participants|Non Compliance|5|||
149928337|NCT02624947|540872492|FG000|Maternal Participants|Sponsor Request|1|||
149928338|NCT02624947|540872493|FG001|Maternal Participants|Sponsor Request|1|||
149928339|NCT02624947|540872492|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
149928340|NCT02624947|540872493|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
149928341|NCT02624947|540872492|FG000|Maternal Participants|Miscellaneous|23|||
149928342|NCT02624947|540872493|FG001|Maternal Participants|Miscellaneous|15|||
149928343|NCT02624947|540872492|FG000|Infant Participants|Adverse Event|18|||
149928344|NCT02624947|540872493|FG001|Infant Participants|Adverse Event|11|||
149928345|NCT02624947|540872492|FG000|Infant Participants|Investigator Decision|5|||
149928346|NCT02624947|540872493|FG001|Infant Participants|Investigator Decision|4|||
149928347|NCT02624947|540872492|FG000|Infant Participants|Lost to Follow-up|93|||
149928348|NCT02624947|540872493|FG001|Infant Participants|Lost to Follow-up|58|||
149928349|NCT02624947|540872492|FG000|Infant Participants|Non Compliance|17|||
149928350|NCT02624947|540872493|FG001|Infant Participants|Non Compliance|7|||
149928351|NCT02624947|540872492|FG000|Infant Participants|Sponsor Request|0|||
149928352|NCT02624947|540872493|FG001|Infant Participants|Sponsor Request|1|||
149928353|NCT02624947|540872492|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
149928354|NCT02624947|540872493|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
149928355|NCT02624947|540872492|FG000|Infant Participants|Miscellaneous|50|||
149928356|NCT02624947|540872493|FG001|Infant Participants|Miscellaneous|26|||
149928357|NCT03654729|540872504|FG000|Overall Study|Death|9|||
149928358|NCT03654729|540872505|FG001|Overall Study|Death|9|||
149928359|NCT03654729|540872506|FG002|Overall Study|Death|16|||
149928360|NCT03654729|540872504|FG000|Overall Study|Withdrawal by Subject|8|||
149928361|NCT03654729|540872505|FG001|Overall Study|Withdrawal by Subject|6|||
149928362|NCT03654729|540872506|FG002|Overall Study|Withdrawal by Subject|4|||
149928363|NCT03654729|540872504|FG000|Overall Study|Study terminated by Sponsor|3|||
149928364|NCT03654729|540872505|FG001|Overall Study|Study terminated by Sponsor|5|||
149928365|NCT03654729|540872506|FG002|Overall Study|Study terminated by Sponsor|4|||
149928366|NCT03654729|540872504|FG000|Overall Study|Not reported|2|||
149928367|NCT03654729|540872505|FG001|Overall Study|Not reported|4|||
149928368|NCT03654729|540872506|FG002|Overall Study|Not reported|5|||
149928369|NCT03654729|540872504|FG000|Overall Study|Progressive disease|3|||
149928370|NCT03654729|540872505|FG001|Overall Study|Progressive disease|0|||
149928371|NCT03654729|540872506|FG002|Overall Study|Progressive disease|0|||
149928372|NCT03654729|540872504|FG000|Overall Study|Lost to Follow-up|2|||
149928373|NCT03654729|540872505|FG001|Overall Study|Lost to Follow-up|0|||
149928374|NCT03654729|540872506|FG002|Overall Study|Lost to Follow-up|0|||
149928375|NCT03654729|540872504|FG000|Overall Study|Physician Decision|2|||
149928376|NCT03654729|540872505|FG001|Overall Study|Physician Decision|0|||
149928377|NCT03654729|540872506|FG002|Overall Study|Physician Decision|0|||
149928378|NCT03654729|540872504|FG000|Overall Study|Protocol Violation|1|||
149928379|NCT03654729|540872505|FG001|Overall Study|Protocol Violation|1|||
149928380|NCT03654729|540872506|FG002|Overall Study|Protocol Violation|0|||
149928381|NCT03654729|540872504|FG000|Overall Study|Non-compliance with study drug|0|||
149928382|NCT03654729|540872505|FG001|Overall Study|Non-compliance with study drug|1|||
149928383|NCT03654729|540872506|FG002|Overall Study|Non-compliance with study drug|0|||
149928384|NCT03654729|540872504|FG000|Overall Study|Site terminated by Sponsor|1|||
149928385|NCT03654729|540872505|FG001|Overall Study|Site terminated by Sponsor|0|||
149928386|NCT03654729|540872506|FG002|Overall Study|Site terminated by Sponsor|0|||
149928387|NCT01919164|540872521|FG000|Overall Study|Adverse Event|6|||
149928388|NCT01919164|540872522|FG001|Overall Study|Adverse Event|4|||
149928389|NCT01919164|540872523|FG002|Overall Study|Adverse Event|9|||
149928390|NCT01919164|540872524|FG003|Overall Study|Adverse Event|3|||
149928391|NCT01919164|540872525|FG004|Overall Study|Adverse Event|2|||
149928392|NCT01919164|540872521|FG000|Overall Study|Lost to Follow-up|2|||
149928393|NCT01919164|540872522|FG001|Overall Study|Lost to Follow-up|2|||
149928394|NCT01919164|540872523|FG002|Overall Study|Lost to Follow-up|2|||
149928395|NCT01919164|540872524|FG003|Overall Study|Lost to Follow-up|0|||
149928396|NCT01919164|540872525|FG004|Overall Study|Lost to Follow-up|4|||
149928397|NCT01919164|540872521|FG000|Overall Study|Death|1|||
149928398|NCT01919164|540872522|FG001|Overall Study|Death|0|||
149928399|NCT01919164|540872523|FG002|Overall Study|Death|0|||
149928400|NCT01919164|540872524|FG003|Overall Study|Death|0|||
149928401|NCT01919164|540872525|FG004|Overall Study|Death|0|||
149928402|NCT01919164|540872521|FG000|Overall Study|Protocol Violation|6|||
149928403|NCT01919164|540872522|FG001|Overall Study|Protocol Violation|0|||
149928404|NCT01919164|540872523|FG002|Overall Study|Protocol Violation|3|||
149928405|NCT01919164|540872524|FG003|Overall Study|Protocol Violation|2|||
149928406|NCT01919164|540872525|FG004|Overall Study|Protocol Violation|2|||
149928407|NCT01919164|540872521|FG000|Overall Study|Disease progression|2|||
149928408|NCT01919164|540872522|FG001|Overall Study|Disease progression|2|||
149928409|NCT01919164|540872523|FG002|Overall Study|Disease progression|1|||
149928410|NCT01919164|540872524|FG003|Overall Study|Disease progression|2|||
149928411|NCT01919164|540872525|FG004|Overall Study|Disease progression|1|||
149928412|NCT01919164|540872521|FG000|Overall Study|Withdrew consent|13|||
149928413|NCT01919164|540872522|FG001|Overall Study|Withdrew consent|13|||
150265594|NCT02076178|542108607|FG000|Injection Phase|Protocol defined stopping criteria|1|||
150265595|NCT02076178|542108608|FG001|Injection Phase|Protocol defined stopping criteria|0|||
150265596|NCT02076178|542108607|FG000|Injection Phase|Withdrawal by Subject|0|||
150265597|NCT02076178|542108608|FG001|Injection Phase|Withdrawal by Subject|3|||
150265598|NCT02076178|542108607|FG000|Injection Phase|Physician Decision|0|||
150265599|NCT02076178|542108608|FG001|Injection Phase|Physician Decision|3|||
150265600|NCT02076178|542108607|FG000|Injection Phase|Lost to Follow-up|0|||
150265601|NCT02076178|542108608|FG001|Injection Phase|Lost to Follow-up|1|||
150265602|NCT00731120|542108609|FG000|Overall Study|Adverse Event|7|||
150265603|NCT00731120|542108610|FG001|Overall Study|Adverse Event|6|||
150265604|NCT00731120|542108611|FG002|Overall Study|Adverse Event|8|||
150265605|NCT00731120|542108609|FG000|Overall Study|Lack of Efficacy|4|||
149928414|NCT01919164|540872523|FG002|Overall Study|Withdrew consent|14|||
149928415|NCT01919164|540872524|FG003|Overall Study|Withdrew consent|14|||
149928416|NCT01919164|540872525|FG004|Overall Study|Withdrew consent|9|||
149928417|NCT01919164|540872521|FG000|Overall Study|Other Un-specified|13|||
149928418|NCT01919164|540872522|FG001|Overall Study|Other Un-specified|9|||
149928419|NCT01919164|540872523|FG002|Overall Study|Other Un-specified|8|||
149928420|NCT01919164|540872524|FG003|Overall Study|Other Un-specified|7|||
149928421|NCT01919164|540872525|FG004|Overall Study|Other Un-specified|15|||
149928422|NCT00588146|540872527|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
149928423|NCT00588146|540872528|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
149928424|NCT02100839|540872529|FG000|Multiple Ascending Dose|Adverse Event|2|||
149928425|NCT02100839|540872530|FG001|Multiple Ascending Dose|Adverse Event|0|||
149928426|NCT02100839|540872529|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
149928427|NCT02100839|540872530|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
149928428|NCT00463801|540872535|FG000|Overall Study|Protocol Violation|1|||
149928429|NCT00463801|540872535|FG000|Overall Study|Lack of Efficacy|2|||
150265606|NCT00731120|542108610|FG001|Overall Study|Lack of Efficacy|5|||
150265607|NCT00731120|542108611|FG002|Overall Study|Lack of Efficacy|4|||
150265608|NCT00731120|542108609|FG000|Overall Study|Noncompliance with Study Drug|3|||
150265609|NCT00731120|542108610|FG001|Overall Study|Noncompliance with Study Drug|3|||
150265610|NCT00731120|542108611|FG002|Overall Study|Noncompliance with Study Drug|1|||
150265611|NCT00731120|542108609|FG000|Overall Study|Protocol Deviations|1|||
150265612|NCT00731120|542108610|FG001|Overall Study|Protocol Deviations|6|||
150265613|NCT00731120|542108611|FG002|Overall Study|Protocol Deviations|1|||
150265614|NCT00731120|542108609|FG000|Overall Study|Withdrawal of Consent|13|||
150265615|NCT00731120|542108610|FG001|Overall Study|Withdrawal of Consent|8|||
150265616|NCT00731120|542108611|FG002|Overall Study|Withdrawal of Consent|4|||
150265617|NCT00731120|542108609|FG000|Overall Study|Lost to Follow-up|10|||
150265618|NCT00731120|542108610|FG001|Overall Study|Lost to Follow-up|15|||
150265619|NCT00731120|542108611|FG002|Overall Study|Lost to Follow-up|17|||
150265620|NCT00731120|542108609|FG000|Overall Study|Other|4|||
150265621|NCT00731120|542108610|FG001|Overall Study|Other|0|||
150265622|NCT00731120|542108611|FG002|Overall Study|Other|1|||
150265623|NCT02019927|542108614|FG000|Overall Study|Lost to Follow-up|2|||
150265624|NCT02019927|542108615|FG001|Overall Study|Lost to Follow-up|4|||
150265625|NCT02019927|542108616|FG002|Overall Study|Lost to Follow-up|1|||
150265626|NCT02019927|542108617|FG003|Overall Study|Lost to Follow-up|2|||
150265627|NCT02019927|542108618|FG004|Overall Study|Lost to Follow-up|3|||
150265628|NCT02019927|542108619|FG005|Overall Study|Lost to Follow-up|1|||
149819279|NCT00096486|540467275|FG000|Overall Study|Withdrawal by Subject|0|||
149819280|NCT00096486|540467276|FG001|Overall Study|Withdrawal by Subject|0|||
149819281|NCT00096486|540467277|FG002|Overall Study|Withdrawal by Subject|1|||
149819282|NCT00096486|540467278|FG003|Overall Study|Withdrawal by Subject|1|||
149819283|NCT00096486|540467275|FG000|Overall Study|Not Treated|0|||
149819284|NCT00096486|540467276|FG001|Overall Study|Not Treated|0|||
149819285|NCT00096486|540467277|FG002|Overall Study|Not Treated|1|||
149819286|NCT00096486|540467278|FG003|Overall Study|Not Treated|1|||
149819287|NCT01559818|540467279|FG000|Overall Study|Physician Decision|1|||
149819288|NCT01559818|540467279|FG000|Overall Study|Pregnancy|1|||
149819289|NCT01559818|540467279|FG000|Overall Study|Study terminated by Sponsor|4|||
149819290|NCT01559818|540467279|FG000|Overall Study|Withdrawal by Subject|1|||
149819291|NCT04071626|540467280|FG000|Overall Study|Withdrawal by Subject|1|||
149819292|NCT04071626|540467281|FG001|Overall Study|Withdrawal by Subject|1|||
149819293|NCT04071626|540467280|FG000|Overall Study|Protocol Violation|0|||
149819294|NCT04071626|540467281|FG001|Overall Study|Protocol Violation|1|||
149819295|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
149819296|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
149819297|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
149819298|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
149819299|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
149819300|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
149819301|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
149819302|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
149819303|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
149819304|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
149819305|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
149819306|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
149819307|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
149819308|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
149819309|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
149819310|NCT00529568|540467282|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
149819311|NCT00529568|540467283|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
149819312|NCT00529568|540467284|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
149819313|NCT00529568|540467282|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
149819314|NCT00529568|540467283|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
149819315|NCT00529568|540467284|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
149819316|NCT00529568|540467282|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
149819317|NCT00529568|540467283|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
149819318|NCT00529568|540467284|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
149819319|NCT00529568|540467282|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
149819320|NCT00529568|540467283|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
149819321|NCT00529568|540467284|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
149819322|NCT00529568|540467282|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
150265629|NCT00394953|542108620|FG000|First Treatment Period|Adverse Event|1|||
150265630|NCT00394953|542108621|FG001|First Treatment Period|Adverse Event|2|||
150265631|NCT00394953|542108620|FG000|First Treatment Period|Death|6|||
150265632|NCT00394953|542108621|FG001|First Treatment Period|Death|7|||
150265633|NCT00394953|542108620|FG000|First Treatment Period|Lack of Efficacy|1|||
150265634|NCT00394953|542108621|FG001|First Treatment Period|Lack of Efficacy|1|||
150265635|NCT00394953|542108620|FG000|First Treatment Period|Withdrawal by Subject|6|||
150265636|NCT00394953|542108621|FG001|First Treatment Period|Withdrawal by Subject|3|||
150265637|NCT00394953|542108620|FG000|First Treatment Period|Lost to Follow-up|0|||
150265638|NCT00394953|542108621|FG001|First Treatment Period|Lost to Follow-up|1|||
149928430|NCT00463801|540872535|FG000|Overall Study|Adverse Event|4|||
149928431|NCT00463801|540872535|FG000|Overall Study|Lost to Follow-up|5|||
149928432|NCT00463801|540872535|FG000|Overall Study|No longer require therapy|1|||
149928433|NCT03272347|540872536|FG000|Overall Study|Death|0|||
149928434|NCT03272347|540872537|FG001|Overall Study|Death|0|||
149928435|NCT03272347|540872538|FG002|Overall Study|Death|0|||
149928436|NCT03272347|540872539|FG003|Overall Study|Death|1|||
149928437|NCT03272347|540872536|FG000|Overall Study|Lost to Follow-up|1|||
149928438|NCT03272347|540872537|FG001|Overall Study|Lost to Follow-up|3|||
149928439|NCT03272347|540872538|FG002|Overall Study|Lost to Follow-up|5|||
149928440|NCT03272347|540872539|FG003|Overall Study|Lost to Follow-up|1|||
149928441|NCT03272347|540872536|FG000|Overall Study|Physician Decision|4|||
149928442|NCT03272347|540872537|FG001|Overall Study|Physician Decision|2|||
149928443|NCT03272347|540872538|FG002|Overall Study|Physician Decision|5|||
149928444|NCT03272347|540872539|FG003|Overall Study|Physician Decision|4|||
149928445|NCT03272347|540872536|FG000|Overall Study|Screen Failure|1|||
149928446|NCT03272347|540872537|FG001|Overall Study|Screen Failure|0|||
149928447|NCT03272347|540872538|FG002|Overall Study|Screen Failure|0|||
149928448|NCT03272347|540872539|FG003|Overall Study|Screen Failure|0|||
149928449|NCT03272347|540872536|FG000|Overall Study|Withdrawal by Subject|5|||
149928450|NCT03272347|540872537|FG001|Overall Study|Withdrawal by Subject|1|||
149928451|NCT03272347|540872538|FG002|Overall Study|Withdrawal by Subject|2|||
149928452|NCT03272347|540872539|FG003|Overall Study|Withdrawal by Subject|1|||
149928453|NCT00940888|540872540|FG000|Overall Study|Unsuccessful Implant|4|||
149928454|NCT00940888|540872540|FG000|Overall Study|Death|461|||
149928455|NCT00940888|540872540|FG000|Overall Study|Withdrawn - Non-Death|364|||
149928456|NCT00940888|540872540|FG000|Overall Study|Lost to Follow-up|6|||
149928457|NCT01971567|540872544|FG000|Overall Study|Withdrawal by Subject|3|||
149928458|NCT01971567|540872545|FG001|Overall Study|Withdrawal by Subject|2|||
149928459|NCT01971567|540872544|FG000|Overall Study|Lost to Follow-up|1|||
149928460|NCT01971567|540872545|FG001|Overall Study|Lost to Follow-up|0|||
149928461|NCT00391872|540872546|FG000|Overall Study|Protocol Violation|7|||
149928462|NCT00391872|540872547|FG001|Overall Study|Protocol Violation|2|||
149928463|NCT00391872|540872546|FG000|Overall Study|Withdrawal by Subject|296|||
150164933|NCT00991276|541739940|FG005|First Intervention Period|Protocol Violation|0|||
150164934|NCT00991276|541739935|FG000|First Intervention Period|Insufficient clinical response|0|||
150164935|NCT00991276|541739936|FG001|First Intervention Period|Insufficient clinical response|0|||
150164936|NCT00991276|541739937|FG002|First Intervention Period|Insufficient clinical response|0|||
150164937|NCT00991276|541739938|FG003|First Intervention Period|Insufficient clinical response|0|||
150164938|NCT00991276|541739939|FG004|First Intervention Period|Insufficient clinical response|1|||
150164939|NCT00991276|541739940|FG005|First Intervention Period|Insufficient clinical response|0|||
150164940|NCT00991276|541739935|FG000|First Intervention Period|Other|0|||
150164941|NCT00991276|541739936|FG001|First Intervention Period|Other|0|||
150164942|NCT00991276|541739937|FG002|First Intervention Period|Other|0|||
150164943|NCT00991276|541739938|FG003|First Intervention Period|Other|1|||
150164944|NCT00991276|541739939|FG004|First Intervention Period|Other|1|||
150164945|NCT00991276|541739940|FG005|First Intervention Period|Other|0|||
150164946|NCT00991276|541739935|FG000|First Intervention Period|Withdrawal by Subject|0|||
150164947|NCT00991276|541739936|FG001|First Intervention Period|Withdrawal by Subject|1|||
150164948|NCT00991276|541739937|FG002|First Intervention Period|Withdrawal by Subject|0|||
150164949|NCT00991276|541739938|FG003|First Intervention Period|Withdrawal by Subject|1|||
150164950|NCT00991276|541739939|FG004|First Intervention Period|Withdrawal by Subject|0|||
150164951|NCT00991276|541739940|FG005|First Intervention Period|Withdrawal by Subject|1|||
150164952|NCT00991276|541739935|FG000|First Intervention Period|Lost to Follow-up|0|||
150164953|NCT00991276|541739936|FG001|First Intervention Period|Lost to Follow-up|1|||
150164954|NCT00991276|541739937|FG002|First Intervention Period|Lost to Follow-up|0|||
150164955|NCT00991276|541739938|FG003|First Intervention Period|Lost to Follow-up|1|||
150164956|NCT00991276|541739939|FG004|First Intervention Period|Lost to Follow-up|0|||
150164957|NCT00991276|541739940|FG005|First Intervention Period|Lost to Follow-up|0|||
150164958|NCT00991276|541739935|FG000|Second Intervention Period|Adverse Event|0|||
150164959|NCT00991276|541739936|FG001|Second Intervention Period|Adverse Event|2|||
150164960|NCT00991276|541739937|FG002|Second Intervention Period|Adverse Event|0|||
150164961|NCT00991276|541739938|FG003|Second Intervention Period|Adverse Event|1|||
150164962|NCT00991276|541739939|FG004|Second Intervention Period|Adverse Event|1|||
150164963|NCT00991276|541739940|FG005|Second Intervention Period|Adverse Event|0|||
150164964|NCT00991276|541739935|FG000|Second Intervention Period|Protocol Violation|1|||
150164965|NCT00991276|541739936|FG001|Second Intervention Period|Protocol Violation|0|||
150265639|NCT00394953|542108620|FG000|First Treatment Period|Renal transplant|11|||
150265640|NCT00394953|542108621|FG001|First Treatment Period|Renal transplant|7|||
150265641|NCT00394953|542108620|FG000|First Treatment Period|Not defined|4|||
150265642|NCT00394953|542108621|FG001|First Treatment Period|Not defined|1|||
150164966|NCT00991276|541739937|FG002|Second Intervention Period|Protocol Violation|0|||
150164967|NCT00991276|541739938|FG003|Second Intervention Period|Protocol Violation|0|||
150265643|NCT00394953|542108620|FG000|Second Treatment Period|Adverse Event|2|||
149928464|NCT00391872|540872547|FG001|Overall Study|Withdrawal by Subject|249|||
149928465|NCT00391872|540872546|FG000|Overall Study|Reason unknown|2|||
150265644|NCT00394953|542108621|FG001|Second Treatment Period|Adverse Event|5|||
149928466|NCT00391872|540872547|FG001|Overall Study|Reason unknown|4|||
149928467|NCT00391872|540872546|FG000|Overall Study|Lost to Follow-up|2|||
149928468|NCT00391872|540872547|FG001|Overall Study|Lost to Follow-up|0|||
149928469|NCT01409915|540872548|FG000|Overall Study|Adverse Event|0|||
149928470|NCT01409915|540872549|FG001|Overall Study|Adverse Event|2|||
149928471|NCT01409915|540872548|FG000|Overall Study|Withdrawal by Subject|0|||
149928472|NCT01409915|540872549|FG001|Overall Study|Withdrawal by Subject|1|||
149928473|NCT01409915|540872548|FG000|Overall Study|Protocol Violation|1|||
149928474|NCT01409915|540872549|FG001|Overall Study|Protocol Violation|0|||
149928475|NCT04826484|540872551|FG000|Overall Study|Lost to Follow-up|2|||
149928476|NCT04826484|540872552|FG001|Overall Study|Lost to Follow-up|0|||
149928477|NCT02250300|540872553|FG000|Expansion Phase|Death|6|||
149928478|NCT02250300|540872554|FG001|Expansion Phase|Death|7|||
149928479|NCT02250300|540872555|FG002|Expansion Phase|Death|0|||
149928480|NCT02250300|540872556|FG003|Expansion Phase|Death|0|||
149928481|NCT00215644|540872559|FG000|Overall Study|Disease Progression|28|||
149928482|NCT00215644|540872560|FG001|Overall Study|Disease Progression|10|||
149928483|NCT00215644|540872559|FG000|Overall Study|Adverse Event|2|||
149928484|NCT00215644|540872560|FG001|Overall Study|Adverse Event|9|||
149928485|NCT00215644|540872559|FG000|Overall Study|Death|1|||
149928486|NCT00215644|540872560|FG001|Overall Study|Death|2|||
149928487|NCT00215644|540872559|FG000|Overall Study|Withdrawal by Subject|1|||
149928488|NCT00215644|540872560|FG001|Overall Study|Withdrawal by Subject|0|||
149928489|NCT00215644|540872559|FG000|Overall Study|Other|3|||
149928490|NCT00215644|540872560|FG001|Overall Study|Other|15|||
149928491|NCT00215644|540872559|FG000|Overall Study|Randomized but Not Treated|1|||
149928492|NCT00215644|540872560|FG001|Overall Study|Randomized but Not Treated|0|||
149928493|NCT03512353|540872562|FG000|Overall Study|Sponsor Decision|3|||
149928494|NCT03512353|540872562|FG000|Overall Study|Death|1|||
149928495|NCT02581488|540872570|FG000|Overall Study|Adverse Event|6|||
149928496|NCT02581488|540872571|FG001|Overall Study|Adverse Event|7|||
149928497|NCT02581488|540872570|FG000|Overall Study|Lost to Follow-up|1|||
149928498|NCT02581488|540872571|FG001|Overall Study|Lost to Follow-up|0|||
149928499|NCT02581488|540872570|FG000|Overall Study|Withdrawal by Subject|1|||
149928500|NCT02581488|540872571|FG001|Overall Study|Withdrawal by Subject|0|||
149928501|NCT02581488|540872570|FG000|Overall Study|Non-Compliance|1|||
149928502|NCT02581488|540872571|FG001|Overall Study|Non-Compliance|0|||
149928503|NCT02581488|540872570|FG000|Overall Study|Protocol Violation|0|||
149928504|NCT02581488|540872571|FG001|Overall Study|Protocol Violation|4|||
149928505|NCT01223404|540872572|FG000|First Intervention (1 Day)|Adverse Event|0|||
149928506|NCT01223404|540872573|FG001|First Intervention (1 Day)|Adverse Event|0|||
149928507|NCT01223404|540872574|FG002|First Intervention (1 Day)|Adverse Event|0|||
149928508|NCT01223404|540872575|FG003|First Intervention (1 Day)|Adverse Event|1|||
149928509|NCT01223404|540872576|FG004|First Intervention (1 Day)|Adverse Event|0|||
149928510|NCT01223404|540872577|FG005|First Intervention (1 Day)|Adverse Event|0|||
149928511|NCT01223404|540872572|FG000|Second Intervention (1 Day)|Adverse Event|1|||
150265645|NCT00394953|542108620|FG000|Second Treatment Period|Death|8|||
150265646|NCT00394953|542108621|FG001|Second Treatment Period|Death|4|||
150265647|NCT00394953|542108620|FG000|Second Treatment Period|Lack of Efficacy|9|||
150265648|NCT00394953|542108621|FG001|Second Treatment Period|Lack of Efficacy|47|||
150265649|NCT00394953|542108620|FG000|Second Treatment Period|Withdrawal by Subject|3|||
150265650|NCT00394953|542108621|FG001|Second Treatment Period|Withdrawal by Subject|3|||
150265651|NCT00394953|542108620|FG000|Second Treatment Period|Lost to Follow-up|0|||
150265652|NCT00394953|542108621|FG001|Second Treatment Period|Lost to Follow-up|1|||
150265653|NCT00394953|542108620|FG000|Second Treatment Period|Renal transplant|4|||
150265654|NCT00394953|542108621|FG001|Second Treatment Period|Renal transplant|6|||
150265655|NCT00394953|542108620|FG000|Second Treatment Period|Not defined|3|||
150265656|NCT00394953|542108621|FG001|Second Treatment Period|Not defined|8|||
149928512|NCT01223404|540872573|FG001|Second Intervention (1 Day)|Adverse Event|0|||
149928513|NCT01223404|540872574|FG002|Second Intervention (1 Day)|Adverse Event|0|||
149928514|NCT01223404|540872575|FG003|Second Intervention (1 Day)|Adverse Event|0|||
149928515|NCT01223404|540872576|FG004|Second Intervention (1 Day)|Adverse Event|0|||
149928516|NCT01223404|540872577|FG005|Second Intervention (1 Day)|Adverse Event|0|||
149928517|NCT01223404|540872572|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
149928518|NCT01223404|540872573|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
149928519|NCT01223404|540872574|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
149928520|NCT01223404|540872575|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
149928521|NCT01223404|540872576|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
149928522|NCT01223404|540872577|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
149928523|NCT00707057|540872578|FG000|Overall Study|Withdrawal by Subject|8|||
149928524|NCT00707057|540872579|FG001|Overall Study|Withdrawal by Subject|3|||
149928525|NCT00707057|540872578|FG000|Overall Study|Dosed incorrectly|0|||
149928526|NCT00707057|540872579|FG001|Overall Study|Dosed incorrectly|1|||
150265657|NCT03181451|542108622|FG000|Overall Study|Adverse Event|0|||
150265658|NCT03181451|542108623|FG001|Overall Study|Adverse Event|1|||
149928527|NCT02492165|540872580|FG000|Overall Study|Withdrawal by Subject|0|||
149928528|NCT02492165|540872581|FG001|Overall Study|Withdrawal by Subject|1|||
149819323|NCT00529568|540467283|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
149819324|NCT00529568|540467284|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
149819325|NCT00529568|540467282|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
149819326|NCT00529568|540467283|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
149819327|NCT00529568|540467284|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
149819328|NCT04049552|540467285|FG000|Overall Study|Lost to Follow-up|1|||
149819329|NCT01201356|540467286|FG000|Overall Study|Adverse Event|170|||
149819330|NCT01201356|540467286|FG000|Overall Study|Abnormal laboratory value(s)|51|||
149819331|NCT01201356|540467286|FG000|Overall Study|Abnormal test procedure result(s)|3|||
149819332|NCT01201356|540467286|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
149819333|NCT01201356|540467286|FG000|Overall Study|Condition no longer requires study drug|12|||
149819334|NCT01201356|540467286|FG000|Overall Study|Withdrawal by Subject|144|||
149819335|NCT01201356|540467286|FG000|Overall Study|Lost to Follow-up|50|||
149819336|NCT01201356|540467286|FG000|Overall Study|administrative problems|74|||
149819337|NCT01201356|540467286|FG000|Overall Study|Death|16|||
149819338|NCT01201356|540467286|FG000|Overall Study|Protocol Violation|12|||
149819339|NCT00931385|540467287|FG000|Overall Study|Adverse Event|2|||
149819340|NCT00931385|540467288|FG001|Overall Study|Adverse Event|1|||
149819341|NCT00931385|540467289|FG002|Overall Study|Adverse Event|0|||
149819342|NCT00931385|540467290|FG003|Overall Study|Adverse Event|3|||
149819343|NCT00931385|540467287|FG000|Overall Study|Protocol Violation|0|||
149819344|NCT00931385|540467288|FG001|Overall Study|Protocol Violation|0|||
149819345|NCT00931385|540467289|FG002|Overall Study|Protocol Violation|1|||
149819346|NCT00931385|540467290|FG003|Overall Study|Protocol Violation|0|||
149819347|NCT00931385|540467287|FG000|Overall Study|Withdrawal by Subject|0|||
149819348|NCT00931385|540467288|FG001|Overall Study|Withdrawal by Subject|1|||
149819349|NCT00931385|540467289|FG002|Overall Study|Withdrawal by Subject|0|||
149819350|NCT00931385|540467290|FG003|Overall Study|Withdrawal by Subject|1|||
149819351|NCT00931385|540467287|FG000|Overall Study|Lost to Follow-up|0|||
149819352|NCT00931385|540467288|FG001|Overall Study|Lost to Follow-up|0|||
149819353|NCT00931385|540467289|FG002|Overall Study|Lost to Follow-up|0|||
149819354|NCT00931385|540467290|FG003|Overall Study|Lost to Follow-up|1|||
149819355|NCT00811070|540467292|FG000|Overall Study|Death|0|||
149819356|NCT00811070|540467293|FG001|Overall Study|Death|0|||
149819357|NCT00811070|540467294|FG002|Overall Study|Death|0|||
149819358|NCT00811070|540467295|FG003|Overall Study|Death|2|||
149819359|NCT00811070|540467296|FG004|Overall Study|Death|5|||
149819360|NCT00811070|540467297|FG005|Overall Study|Death|0|||
149819361|NCT00811070|540467292|FG000|Overall Study|Other|1|||
149819362|NCT00811070|540467293|FG001|Overall Study|Other|0|||
149819363|NCT00811070|540467294|FG002|Overall Study|Other|0|||
149819364|NCT00811070|540467295|FG003|Overall Study|Other|0|||
149819365|NCT00811070|540467296|FG004|Overall Study|Other|0|||
149819366|NCT00811070|540467297|FG005|Overall Study|Other|0|||
149819367|NCT00811070|540467292|FG000|Overall Study|Withdrawal by Subject|0|||
149819368|NCT00811070|540467293|FG001|Overall Study|Withdrawal by Subject|1|||
149819369|NCT00811070|540467294|FG002|Overall Study|Withdrawal by Subject|0|||
149819370|NCT00811070|540467295|FG003|Overall Study|Withdrawal by Subject|0|||
149819371|NCT00811070|540467296|FG004|Overall Study|Withdrawal by Subject|0|||
149819372|NCT00811070|540467297|FG005|Overall Study|Withdrawal by Subject|0|||
149819373|NCT00811070|540467292|FG000|Overall Study|Physician Decision|0|||
149819374|NCT00811070|540467293|FG001|Overall Study|Physician Decision|0|||
149819375|NCT00811070|540467294|FG002|Overall Study|Physician Decision|0|||
149819376|NCT00811070|540467295|FG003|Overall Study|Physician Decision|0|||
149819377|NCT00811070|540467296|FG004|Overall Study|Physician Decision|0|||
149819378|NCT00811070|540467297|FG005|Overall Study|Physician Decision|1|||
149819379|NCT00665626|540467302|FG000|Overall Study|Lack of Efficacy|8|||
149819380|NCT00665626|540467303|FG001|Overall Study|Lack of Efficacy|5|||
149819381|NCT00665626|540467302|FG000|Overall Study|Lost to Follow-up|0|||
149819382|NCT00665626|540467303|FG001|Overall Study|Lost to Follow-up|2|||
149819383|NCT00665626|540467302|FG000|Overall Study|Withdrawal by Subject|0|||
149819384|NCT00665626|540467303|FG001|Overall Study|Withdrawal by Subject|1|||
149819385|NCT00665626|540467302|FG000|Overall Study|Protocol Violation|0|||
149819386|NCT00665626|540467303|FG001|Overall Study|Protocol Violation|2|||
149819387|NCT00665626|540467302|FG000|Overall Study|Adverse Event|1|||
149819388|NCT00665626|540467303|FG001|Overall Study|Adverse Event|9|||
149819389|NCT00665626|540467302|FG000|Overall Study|Due to exclusion criteria|0|||
149819390|NCT00665626|540467303|FG001|Overall Study|Due to exclusion criteria|1|||
149819391|NCT00665626|540467302|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
149819392|NCT00665626|540467303|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
149819393|NCT00665626|540467302|FG000|Overall Study|Unably to comply with dosing regimen|0|||
149819394|NCT00665626|540467303|FG001|Overall Study|Unably to comply with dosing regimen|1|||
149819395|NCT00665626|540467302|FG000|Overall Study|Death|1|||
149819396|NCT00665626|540467303|FG001|Overall Study|Death|0|||
149819397|NCT00585039|540467304|FG000|Overall Study|medication spilled|2|||
149819398|NCT00585039|540467305|FG001|Overall Study|medication spilled|0|||
149819399|NCT01629693|540467308|FG000|Overall Study|Lost to Follow-up|2|||
149928529|NCT02492165|540872582|FG002|Overall Study|Withdrawal by Subject|0|||
150265659|NCT03181451|542108624|FG002|Overall Study|Adverse Event|0|||
149928530|NCT02492165|540872583|FG003|Overall Study|Withdrawal by Subject|0|||
149928531|NCT01957579|540872589|FG000|Overall Study|Withdrawal of concent|0|||
149928532|NCT01957579|540872590|FG001|Overall Study|Withdrawal of concent|1|||
149928533|NCT01957579|540872591|FG002|Overall Study|Withdrawal of concent|0|||
149928534|NCT01957579|540872592|FG003|Overall Study|Withdrawal of concent|0|||
149928535|NCT01957579|540872589|FG000|Overall Study|Death|0|||
149928536|NCT01957579|540872590|FG001|Overall Study|Death|0|||
149928537|NCT01957579|540872591|FG002|Overall Study|Death|2|||
149928538|NCT01957579|540872592|FG003|Overall Study|Death|0|||
149928539|NCT01000974|540872593|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
149928540|NCT01000974|540872594|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
149928541|NCT01000974|540872595|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
149928542|NCT01000974|540872593|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
149928543|NCT01000974|540872594|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
149928544|NCT01000974|540872595|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
149928545|NCT01000974|540872593|FG000|Primary Vaccination Phase|Protocol Violation|40|||
149928546|NCT01000974|540872594|FG001|Primary Vaccination Phase|Protocol Violation|3|||
149928547|NCT01000974|540872595|FG002|Primary Vaccination Phase|Protocol Violation|2|||
150265660|NCT03181451|542108622|FG000|Overall Study|Withdrawal by Subject|0|||
150265661|NCT03181451|542108623|FG001|Overall Study|Withdrawal by Subject|1|||
150265662|NCT03181451|542108624|FG002|Overall Study|Withdrawal by Subject|0|||
149928548|NCT01000974|540872593|FG000|Primary Vaccination Phase|Adverse Event|14|||
149928549|NCT01000974|540872594|FG001|Primary Vaccination Phase|Adverse Event|2|||
149928550|NCT01000974|540872595|FG002|Primary Vaccination Phase|Adverse Event|2|||
149928551|NCT01000974|540872593|FG000|Primary Vaccination Phase|Other|4|||
149928552|NCT01000974|540872594|FG001|Primary Vaccination Phase|Other|9|||
149928553|NCT01000974|540872595|FG002|Primary Vaccination Phase|Other|12|||
149928554|NCT01000974|540872593|FG000|Booster Vaccination Phase|Protocol Violation|0|||
149928555|NCT01000974|540872594|FG001|Booster Vaccination Phase|Protocol Violation|0|||
149928556|NCT01000974|540872595|FG002|Booster Vaccination Phase|Protocol Violation|2|||
149928557|NCT01000974|540872593|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
149928558|NCT01000974|540872594|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
149928559|NCT01000974|540872595|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
149928560|NCT01000974|540872593|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
149928561|NCT01000974|540872594|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
149928562|NCT01000974|540872595|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
149928563|NCT01000974|540872593|FG000|Booster Vaccination Phase|Other|24|||
149928564|NCT01000974|540872594|FG001|Booster Vaccination Phase|Other|6|||
149928565|NCT01000974|540872595|FG002|Booster Vaccination Phase|Other|4|||
149928566|NCT01307891|540872597|FG000|Overall Study|Progressive Disease|3|||
149928567|NCT01307891|540872598|FG001|Overall Study|Progressive Disease|1|||
149928568|NCT03365934|540872599|FG000|Overall Study|Adverse Event|1|||
149928569|NCT03365934|540872599|FG000|Overall Study|Withdrawal by Subject|1|||
149928570|NCT02750332|540872600|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149928571|NCT02750332|540872601|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149928572|NCT02937740|540872602|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
149928573|NCT02937740|540872603|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
149928574|NCT02937740|540872602|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
149928575|NCT02937740|540872603|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
149928576|NCT02937740|540872602|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
149928577|NCT02937740|540872603|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
149928578|NCT02937740|540872602|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
149928579|NCT02937740|540872603|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
149928580|NCT02937740|540872602|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
149928581|NCT02937740|540872603|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
149928582|NCT02937740|540872602|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
149928583|NCT02937740|540872603|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
149928584|NCT04194489|540872604|FG000|Overall Study|Withdrawal by Subject|5|||
149928585|NCT04194489|540872604|FG000|Overall Study|Lost to Follow-up|48|||
149928586|NCT02485483|540872610|FG000|Overall Study|Depression at baseline|15|||
149928587|NCT02485483|540872611|FG001|Overall Study|Depression at baseline|0|||
149928588|NCT02485483|540872610|FG000|Overall Study|Discontinued after baseline|39|||
149928589|NCT02485483|540872611|FG001|Overall Study|Discontinued after baseline|0|||
149928590|NCT02291029|540872613|FG000|Overall Study|Withdrawal by Subject|0|||
149928591|NCT02291029|540872614|FG001|Overall Study|Withdrawal by Subject|0|||
149928592|NCT02291029|540872615|FG002|Overall Study|Withdrawal by Subject|1|||
149928593|NCT02291029|540872616|FG003|Overall Study|Withdrawal by Subject|0|||
149928594|NCT02291029|540872617|FG004|Overall Study|Withdrawal by Subject|0|||
150265663|NCT01592864|542108636|FG000|Overall Study|Withdrawal by Subject|0|||
149928595|NCT02291029|540872618|FG005|Overall Study|Withdrawal by Subject|0|||
149928596|NCT02291029|540872613|FG000|Overall Study|Adverse Event|0|||
149928597|NCT02291029|540872614|FG001|Overall Study|Adverse Event|1|||
150265664|NCT01592864|542108637|FG001|Overall Study|Withdrawal by Subject|1|||
150265665|NCT01326533|542108638|FG000|Overall Study|Lost to Follow-up|2|||
150265666|NCT01326533|542108639|FG001|Overall Study|Lost to Follow-up|0|||
150265667|NCT01326533|542108638|FG000|Overall Study|Withdrawal by Subject|1|||
150265668|NCT01326533|542108639|FG001|Overall Study|Withdrawal by Subject|0|||
150265669|NCT01326533|542108638|FG000|Overall Study|Adverse Event|1|||
150265670|NCT01326533|542108639|FG001|Overall Study|Adverse Event|0|||
150265671|NCT04677179|542108641|FG000|Induction Treatment Period|Adverse Event|1|||
150265672|NCT04677179|542108642|FG001|Induction Treatment Period|Adverse Event|0|||
150265673|NCT04677179|542108643|FG002|Induction Treatment Period|Adverse Event|0|||
150265674|NCT04677179|542108644|FG003|Induction Treatment Period|Adverse Event|0|||
150265675|NCT04677179|542108645|FG004|Induction Treatment Period|Adverse Event|0|||
150265676|NCT04677179|542108646|FG005|Induction Treatment Period|Adverse Event|0|||
150265677|NCT04677179|542108647|FG006|Induction Treatment Period|Adverse Event|0|||
150265678|NCT04677179|542108648|FG007|Induction Treatment Period|Adverse Event|0|||
150265679|NCT04677179|542108649|FG008|Induction Treatment Period|Adverse Event|0|||
149928598|NCT02291029|540872615|FG002|Overall Study|Adverse Event|0|||
149928599|NCT02291029|540872616|FG003|Overall Study|Adverse Event|0|||
150265680|NCT04677179|542108650|FG009|Induction Treatment Period|Adverse Event|0|||
150265681|NCT04677179|542108641|FG000|Induction Treatment Period|Physician Decision|1|||
150265682|NCT04677179|542108642|FG001|Induction Treatment Period|Physician Decision|0|||
150265683|NCT04677179|542108643|FG002|Induction Treatment Period|Physician Decision|1|||
150265684|NCT04677179|542108644|FG003|Induction Treatment Period|Physician Decision|0|||
150265685|NCT04677179|542108645|FG004|Induction Treatment Period|Physician Decision|0|||
150265686|NCT04677179|542108646|FG005|Induction Treatment Period|Physician Decision|0|||
150265687|NCT04677179|542108647|FG006|Induction Treatment Period|Physician Decision|0|||
150265688|NCT04677179|542108648|FG007|Induction Treatment Period|Physician Decision|0|||
150265689|NCT04677179|542108649|FG008|Induction Treatment Period|Physician Decision|0|||
150265690|NCT04677179|542108650|FG009|Induction Treatment Period|Physician Decision|0|||
149928600|NCT02291029|540872617|FG004|Overall Study|Adverse Event|0|||
149928601|NCT02291029|540872618|FG005|Overall Study|Adverse Event|0|||
149928602|NCT00522548|540872619|FG000|Overall Study|Adverse Event|2|||
149928603|NCT00522548|540872620|FG001|Overall Study|Adverse Event|2|||
149928604|NCT00522548|540872619|FG000|Overall Study|Withdrawal by Subject|0|||
149928605|NCT00522548|540872620|FG001|Overall Study|Withdrawal by Subject|2|||
149928606|NCT04155463|540872621|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
149928607|NCT04155463|540872622|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
149928608|NCT00113295|540872623|FG000|Overall Study|Adverse Event|4|||
149928609|NCT00113295|540872624|FG001|Overall Study|Adverse Event|1|||
149928610|NCT00113295|540872623|FG000|Overall Study|Unrelated Medical Illness|1|||
149928611|NCT00113295|540872624|FG001|Overall Study|Unrelated Medical Illness|0|||
149928612|NCT01714544|540872625|FG000|Overall Study|Lost to Follow-up|1|||
149928613|NCT01714544|540872625|FG000|Overall Study|Physician Decision|1|||
149928614|NCT01714544|540872625|FG000|Overall Study|Withdrawal by Subject|1|||
149928615|NCT02143024|540872626|FG000|Overall Study|Lost to Follow-up|1|||
149928616|NCT02143024|540872627|FG001|Overall Study|Lost to Follow-up|1|||
149928617|NCT02143024|540872626|FG000|Overall Study|Withdrawal by Subject|1|||
149928618|NCT02143024|540872627|FG001|Overall Study|Withdrawal by Subject|0|||
149928619|NCT06597084|540872628|FG000|Overall Study|Withdrawal by Subject|4|||
149928620|NCT06597084|540872629|FG001|Overall Study|Withdrawal by Subject|9|||
149928621|NCT06597084|540872628|FG000|Overall Study|Consent was not given by the patient until V2|0|||
149928622|NCT06597084|540872629|FG001|Overall Study|Consent was not given by the patient until V2|3|||
149928623|NCT06597084|540872628|FG000|Overall Study|Physician Decision|1|||
149928624|NCT06597084|540872629|FG001|Overall Study|Physician Decision|0|||
149928625|NCT06597084|540872628|FG000|Overall Study|Adverse Event|3|||
149928626|NCT06597084|540872629|FG001|Overall Study|Adverse Event|2|||
149928627|NCT06597084|540872628|FG000|Overall Study|Death|4|||
149928628|NCT06597084|540872629|FG001|Overall Study|Death|0|||
149928629|NCT06597084|540872628|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
149928630|NCT06597084|540872629|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
149928631|NCT06597084|540872628|FG000|Overall Study|Lost to Follow-up|4|||
149928632|NCT06597084|540872629|FG001|Overall Study|Lost to Follow-up|2|||
150265691|NCT04677179|542108641|FG000|Induction Treatment Period|Protocol Violation|0|||
150265692|NCT04677179|542108642|FG001|Induction Treatment Period|Protocol Violation|1|||
149928633|NCT06597084|540872628|FG000|Overall Study|Other. Not specified|1|||
149928634|NCT06597084|540872629|FG001|Overall Study|Other. Not specified|0|||
149928635|NCT05219968|540872630|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
149928636|NCT05219968|540872631|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
149928637|NCT05219968|540872632|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
149928638|NCT05219968|540872633|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
150265693|NCT04677179|542108643|FG002|Induction Treatment Period|Protocol Violation|0|||
150265694|NCT04677179|542108644|FG003|Induction Treatment Period|Protocol Violation|0|||
150265695|NCT04677179|542108645|FG004|Induction Treatment Period|Protocol Violation|0|||
149928639|NCT05219968|540872634|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
149928640|NCT05219968|540872630|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
149928641|NCT05219968|540872631|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
149928642|NCT05219968|540872632|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
149928643|NCT05219968|540872633|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
149928644|NCT05219968|540872634|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
150164968|NCT00991276|541739939|FG004|Second Intervention Period|Protocol Violation|0|||
150164969|NCT00991276|541739940|FG005|Second Intervention Period|Protocol Violation|0|||
150164970|NCT00991276|541739935|FG000|Second Intervention Period|Other|0|||
150164971|NCT00991276|541739936|FG001|Second Intervention Period|Other|0|||
150164972|NCT00991276|541739937|FG002|Second Intervention Period|Other|0|||
150164973|NCT00991276|541739938|FG003|Second Intervention Period|Other|1|||
150164974|NCT00991276|541739939|FG004|Second Intervention Period|Other|0|||
150164975|NCT00991276|541739940|FG005|Second Intervention Period|Other|1|||
150164976|NCT00991276|541739935|FG000|Third Intervention Period|Protocol Violation|1|||
150164977|NCT00991276|541739936|FG001|Third Intervention Period|Protocol Violation|0|||
150164978|NCT00991276|541739937|FG002|Third Intervention Period|Protocol Violation|0|||
150164979|NCT00991276|541739938|FG003|Third Intervention Period|Protocol Violation|0|||
150164980|NCT00991276|541739939|FG004|Third Intervention Period|Protocol Violation|0|||
150164981|NCT00991276|541739940|FG005|Third Intervention Period|Protocol Violation|0|||
150164982|NCT00991276|541739935|FG000|Third Intervention Period|Other|0|||
150164983|NCT00991276|541739936|FG001|Third Intervention Period|Other|0|||
150164984|NCT00991276|541739937|FG002|Third Intervention Period|Other|0|||
150164985|NCT00991276|541739938|FG003|Third Intervention Period|Other|0|||
150164986|NCT00991276|541739939|FG004|Third Intervention Period|Other|0|||
150164987|NCT00991276|541739940|FG005|Third Intervention Period|Other|1|||
150164988|NCT00991276|541739935|FG000|Third Intervention Period|Adverse Event|0|||
150164989|NCT00991276|541739936|FG001|Third Intervention Period|Adverse Event|0|||
150164990|NCT00991276|541739937|FG002|Third Intervention Period|Adverse Event|1|||
150164991|NCT00991276|541739938|FG003|Third Intervention Period|Adverse Event|0|||
150164992|NCT00991276|541739939|FG004|Third Intervention Period|Adverse Event|0|||
150164993|NCT00991276|541739940|FG005|Third Intervention Period|Adverse Event|0|||
150164994|NCT00991276|541739935|FG000|Third Intervention Period|Withdrawal by Subject|0|||
150164995|NCT00991276|541739936|FG001|Third Intervention Period|Withdrawal by Subject|0|||
150164996|NCT00991276|541739937|FG002|Third Intervention Period|Withdrawal by Subject|0|||
150164997|NCT00991276|541739938|FG003|Third Intervention Period|Withdrawal by Subject|1|||
150164998|NCT00991276|541739939|FG004|Third Intervention Period|Withdrawal by Subject|0|||
150164999|NCT00991276|541739940|FG005|Third Intervention Period|Withdrawal by Subject|0|||
150165000|NCT03441984|541739943|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165001|NCT03441984|541739944|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165002|NCT03441984|541739945|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
150165003|NCT03441984|541739946|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165004|NCT03441984|541739947|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165005|NCT03441984|541739948|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165006|NCT03441984|541739949|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165007|NCT03441984|541739950|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165008|NCT03441984|541739951|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165009|NCT03441984|541739952|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165010|NCT03441984|541739953|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165011|NCT03441984|541739954|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
150165012|NCT04088188|541739957|FG000|Overall Study|Withdrawal by Subject|2|||
150165013|NCT04088188|541739958|FG001|Overall Study|Withdrawal by Subject|0|||
150165014|NCT04088188|541739957|FG000|Overall Study|Adverse Event|2|||
150165015|NCT04088188|541739958|FG001|Overall Study|Adverse Event|0|||
150165016|NCT03124108|541739959|FG000|Overall Study|Adverse Event|0|||
150165017|NCT03124108|541739960|FG001|Overall Study|Adverse Event|1|||
150165018|NCT03124108|541739961|FG002|Overall Study|Adverse Event|0|||
150165019|NCT01670019|541739971|FG000|Overall Study|Adverse Event|3|||
150165020|NCT01670019|541739972|FG001|Overall Study|Adverse Event|0|||
150165021|NCT01670019|541739971|FG000|Overall Study|Withdrawal by Subject|6|||
150165022|NCT01670019|541739972|FG001|Overall Study|Withdrawal by Subject|0|||
150165023|NCT05487703|541739975|FG000|Overall Study|Other|19|||
150165024|NCT05487703|541739975|FG000|Overall Study|Participant not well|5|||
150165025|NCT05487703|541739975|FG000|Overall Study|Insurance Reasons|6|||
150165026|NCT05487703|541739975|FG000|Overall Study|Physician Decision|19|||
150165027|NCT05487703|541739975|FG000|Overall Study|Lack of Efficacy|60|||
150165028|NCT04939428|541739977|FG000|Overall Study|Death|0|||
150165029|NCT04939428|541739978|FG001|Overall Study|Death|1|||
150165030|NCT04939428|541739979|FG002|Overall Study|Death|0|||
150165031|NCT04939428|541739977|FG000|Overall Study|Lost to Follow-up|0|||
150165032|NCT04939428|541739978|FG001|Overall Study|Lost to Follow-up|5|||
149928645|NCT05219968|540872630|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
149928646|NCT05219968|540872631|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
149928647|NCT05219968|540872632|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
149928648|NCT05219968|540872633|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
149928649|NCT05219968|540872634|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
149928650|NCT05219968|540872630|FG000|Week 24 Treatment Period|Adverse Event|3|||
149928651|NCT05219968|540872631|FG001|Week 24 Treatment Period|Adverse Event|0|||
149928652|NCT05219968|540872632|FG002|Week 24 Treatment Period|Adverse Event|0|||
149928653|NCT05219968|540872633|FG003|Week 24 Treatment Period|Adverse Event|0|||
149928654|NCT05219968|540872634|FG004|Week 24 Treatment Period|Adverse Event|0|||
149928655|NCT05219968|540872630|FG000|Week 24 Treatment Period|Physician Decision|0|||
149928656|NCT05219968|540872631|FG001|Week 24 Treatment Period|Physician Decision|1|||
149928657|NCT05219968|540872632|FG002|Week 24 Treatment Period|Physician Decision|0|||
149928658|NCT05219968|540872633|FG003|Week 24 Treatment Period|Physician Decision|0|||
149928659|NCT05219968|540872634|FG004|Week 24 Treatment Period|Physician Decision|0|||
149928660|NCT05219968|540872630|FG000|Week 24 Treatment Period|Other, not specified|3|||
149928661|NCT05219968|540872631|FG001|Week 24 Treatment Period|Other, not specified|0|||
149928662|NCT05219968|540872632|FG002|Week 24 Treatment Period|Other, not specified|0|||
149928663|NCT05219968|540872633|FG003|Week 24 Treatment Period|Other, not specified|0|||
149928664|NCT05219968|540872634|FG004|Week 24 Treatment Period|Other, not specified|0|||
149928665|NCT05219968|540872630|FG000|Safety Extension Period|Treatment administration failure|0|||
149928666|NCT05219968|540872631|FG001|Safety Extension Period|Treatment administration failure|0|||
149928667|NCT05219968|540872632|FG002|Safety Extension Period|Treatment administration failure|0|||
149928668|NCT05219968|540872633|FG003|Safety Extension Period|Treatment administration failure|1|||
149928669|NCT05219968|540872634|FG004|Safety Extension Period|Treatment administration failure|4|||
149928670|NCT05219968|540872630|FG000|Safety Extension Period|Bilateral dislodgement|0|||
149928671|NCT05219968|540872631|FG001|Safety Extension Period|Bilateral dislodgement|0|||
149928672|NCT05219968|540872632|FG002|Safety Extension Period|Bilateral dislodgement|4|||
149928673|NCT05219968|540872633|FG003|Safety Extension Period|Bilateral dislodgement|0|||
149928674|NCT05219968|540872634|FG004|Safety Extension Period|Bilateral dislodgement|1|||
149928675|NCT05219968|540872630|FG000|Safety Extension Period|Withdrawal by Subject|0|||
149928676|NCT05219968|540872631|FG001|Safety Extension Period|Withdrawal by Subject|0|||
149928677|NCT05219968|540872632|FG002|Safety Extension Period|Withdrawal by Subject|2|||
149928678|NCT05219968|540872633|FG003|Safety Extension Period|Withdrawal by Subject|0|||
149928679|NCT05219968|540872634|FG004|Safety Extension Period|Withdrawal by Subject|4|||
149928680|NCT05219968|540872630|FG000|Safety Extension Period|Adverse Event|0|||
149928681|NCT05219968|540872631|FG001|Safety Extension Period|Adverse Event|0|||
149928682|NCT05219968|540872632|FG002|Safety Extension Period|Adverse Event|2|||
149928683|NCT05219968|540872633|FG003|Safety Extension Period|Adverse Event|1|||
149928684|NCT05219968|540872634|FG004|Safety Extension Period|Adverse Event|1|||
149928685|NCT05219968|540872630|FG000|Safety Extension Period|Lost to Follow-up|0|||
149928686|NCT05219968|540872631|FG001|Safety Extension Period|Lost to Follow-up|0|||
149928687|NCT05219968|540872632|FG002|Safety Extension Period|Lost to Follow-up|0|||
149928688|NCT05219968|540872633|FG003|Safety Extension Period|Lost to Follow-up|1|||
149928689|NCT05219968|540872634|FG004|Safety Extension Period|Lost to Follow-up|0|||
149928690|NCT04587336|540872635|FG000|Overall Study|Lost to Follow-up|1|||
149928691|NCT04587336|540872636|FG001|Overall Study|Lost to Follow-up|0|||
149928692|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
149928693|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
149928694|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
149928695|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
149928696|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
149928697|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
149928698|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
149928699|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
149928700|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
149928701|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
149928702|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
149928703|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
149928704|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
149928705|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
149928706|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
149928707|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
150165033|NCT04939428|541739979|FG002|Overall Study|Lost to Follow-up|0|||
150165034|NCT04939428|541739977|FG000|Overall Study|Physician Decision|1|||
150165035|NCT04939428|541739978|FG001|Overall Study|Physician Decision|0|||
149928708|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
149928709|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
149928710|NCT03569098|540874678|FG000|Double-Blind Treatment Cycle 1|Other|1|||
150165036|NCT04939428|541739979|FG002|Overall Study|Physician Decision|0|||
150165037|NCT04939428|541739977|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149819400|NCT01629693|540467309|FG001|Overall Study|Lost to Follow-up|4|||
149819401|NCT01629693|540467308|FG000|Overall Study|Withdrawal by Subject|2|||
149819402|NCT01629693|540467309|FG001|Overall Study|Withdrawal by Subject|2|||
149819403|NCT01629693|540467308|FG000|Overall Study|Adverse Event|1|||
149819404|NCT01629693|540467309|FG001|Overall Study|Adverse Event|0|||
149819405|NCT01629693|540467308|FG000|Overall Study|Investigator decision|0|||
149819406|NCT01629693|540467309|FG001|Overall Study|Investigator decision|1|||
149819407|NCT01629693|540467308|FG000|Overall Study|Poor comfort of study lenses|0|||
149819408|NCT01629693|540467309|FG001|Overall Study|Poor comfort of study lenses|2|||
149819409|NCT01629693|540467308|FG000|Overall Study|Subject decision unrelated to AE|0|||
149819410|NCT01629693|540467309|FG001|Overall Study|Subject decision unrelated to AE|1|||
149819411|NCT04079842|540467311|FG000|Overall Study|Request of subject|2|||
149819412|NCT04079842|540467311|FG000|Overall Study|Unable to draw Arterial samples|1|||
149819413|NCT01025193|540467312|FG000|Overall Study|Protocol Violation|1|||
149819414|NCT01025193|540467312|FG000|Overall Study|Adverse Event|3|||
149819415|NCT02904200|540467313|FG000|Overall Study|Withdrawal by Subject|1|||
149819416|NCT02904200|540467314|FG001|Overall Study|Withdrawal by Subject|0|||
149819417|NCT02133352|540467317|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
149819418|NCT02257632|540469135|FG000|Overall Study|Withdrawal by Subject|0|||
149819419|NCT02257632|540469136|FG001|Overall Study|Withdrawal by Subject|1|||
149819420|NCT02257632|540469135|FG000|Overall Study|Adverse Event|1|||
150165038|NCT04939428|541739978|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150165039|NCT04939428|541739979|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150165040|NCT04939428|541739977|FG000|Overall Study|Withdrawal by Subject|10|||
150165041|NCT04939428|541739978|FG001|Overall Study|Withdrawal by Subject|11|||
150165042|NCT04939428|541739979|FG002|Overall Study|Withdrawal by Subject|0|||
150165043|NCT04939428|541739977|FG000|Overall Study|Unkown|6|||
150165044|NCT04939428|541739978|FG001|Overall Study|Unkown|3|||
150165045|NCT04939428|541739979|FG002|Overall Study|Unkown|0|||
150165046|NCT04939428|541739977|FG000|Overall Study|Discotinued per protocol|0|||
150165047|NCT04939428|541739978|FG001|Overall Study|Discotinued per protocol|0|||
150165048|NCT04939428|541739979|FG002|Overall Study|Discotinued per protocol|902|||
150165049|NCT03781804|541739982|FG000|Overall Study|Adverse Event|2|||
150165050|NCT03781804|541739983|FG001|Overall Study|Adverse Event|2|||
150165051|NCT03781804|541739984|FG002|Overall Study|Adverse Event|3|||
150165052|NCT03781804|541739982|FG000|Overall Study|Lost to Follow-up|1|||
150165053|NCT03781804|541739983|FG001|Overall Study|Lost to Follow-up|1|||
150165054|NCT03781804|541739984|FG002|Overall Study|Lost to Follow-up|2|||
150165055|NCT03781804|541739982|FG000|Overall Study|Lack of Efficacy|4|||
150165056|NCT03781804|541739983|FG001|Overall Study|Lack of Efficacy|2|||
150165057|NCT03781804|541739984|FG002|Overall Study|Lack of Efficacy|9|||
150165058|NCT03781804|541739982|FG000|Overall Study|Protocol Violation|0|||
150165059|NCT03781804|541739983|FG001|Overall Study|Protocol Violation|0|||
150165060|NCT03781804|541739984|FG002|Overall Study|Protocol Violation|1|||
150165061|NCT03781804|541739982|FG000|Overall Study|Withdrawal by Subject|0|||
150165062|NCT03781804|541739983|FG001|Overall Study|Withdrawal by Subject|1|||
150165063|NCT03781804|541739984|FG002|Overall Study|Withdrawal by Subject|1|||
149819421|NCT02257632|540469136|FG001|Overall Study|Adverse Event|2|||
149819422|NCT02468557|540469137|FG000|Overall Study|Adverse Event|1|||
149819423|NCT02468557|540469137|FG000|Overall Study|Death|1|||
149819424|NCT02468557|540469137|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
149819425|NCT02468557|540469137|FG000|Overall Study|All Enrolled but Never Dosed|4|||
149819426|NCT01312779|540469138|FG000|Overall Study|Withdrawal by Subject|2|||
149819427|NCT01312779|540469138|FG000|Overall Study|Death|3|||
149819428|NCT01312779|540469138|FG000|Overall Study|Not Implanted with Device|27|||
149819429|NCT01621490|540469139|FG000|Overall Study|Subject no longer meets study criteria|0|||
149819430|NCT01621490|540469140|FG001|Overall Study|Subject no longer meets study criteria|0|||
149819431|NCT01621490|540469141|FG002|Overall Study|Subject no longer meets study criteria|0|||
149819432|NCT01621490|540469142|FG003|Overall Study|Subject no longer meets study criteria|0|||
149819433|NCT01621490|540469143|FG004|Overall Study|Subject no longer meets study criteria|1|||
149819434|NCT01621490|540469144|FG005|Overall Study|Subject no longer meets study criteria|0|||
149819435|NCT01621490|540469145|FG006|Overall Study|Subject no longer meets study criteria|0|||
149819436|NCT01621490|540469146|FG007|Overall Study|Subject no longer meets study criteria|0|||
149819437|NCT01621490|540469147|FG008|Overall Study|Subject no longer meets study criteria|0|||
149819438|NCT01621490|540469148|FG009|Overall Study|Subject no longer meets study criteria|0|||
149819439|NCT01621490|540469149|FG010|Overall Study|Subject no longer meets study criteria|0|||
149819440|NCT01621490|540469139|FG000|Overall Study|Maximum clinical benefit|3|||
149819441|NCT01621490|540469140|FG001|Overall Study|Maximum clinical benefit|2|||
149819442|NCT01621490|540469141|FG002|Overall Study|Maximum clinical benefit|0|||
149819443|NCT01621490|540469142|FG003|Overall Study|Maximum clinical benefit|0|||
149819444|NCT01621490|540469143|FG004|Overall Study|Maximum clinical benefit|0|||
149819445|NCT01621490|540469144|FG005|Overall Study|Maximum clinical benefit|0|||
149819446|NCT01621490|540469145|FG006|Overall Study|Maximum clinical benefit|1|||
149928711|NCT03569098|540874679|FG001|Double-Blind Treatment Cycle 1|Other|0|||
149928712|NCT03569098|540874680|FG002|Double-Blind Treatment Cycle 1|Other|1|||
149928713|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
149928714|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
149928715|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
149928716|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
150265696|NCT04677179|542108646|FG005|Induction Treatment Period|Protocol Violation|0|||
150265697|NCT04677179|542108647|FG006|Induction Treatment Period|Protocol Violation|0|||
150265698|NCT04677179|542108648|FG007|Induction Treatment Period|Protocol Violation|0|||
150265699|NCT04677179|542108649|FG008|Induction Treatment Period|Protocol Violation|0|||
150265700|NCT04677179|542108650|FG009|Induction Treatment Period|Protocol Violation|0|||
150265701|NCT04677179|542108641|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
150265702|NCT04677179|542108642|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
150265703|NCT04677179|542108643|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
150265704|NCT04677179|542108644|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
150265705|NCT04677179|542108645|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
150265706|NCT04677179|542108646|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
150265707|NCT04677179|542108647|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
150265708|NCT04677179|542108648|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
150265709|NCT04677179|542108649|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
150265710|NCT04677179|542108650|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
150265711|NCT04677179|542108641|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
150265712|NCT04677179|542108642|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
150265713|NCT04677179|542108643|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
150265714|NCT04677179|542108644|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
150265715|NCT04677179|542108645|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
149928717|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
149928718|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
149928719|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
149928720|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
149928721|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
149928722|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
149928723|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
149928724|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
149928725|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
149928726|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
149928727|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
149928728|NCT03569098|540874678|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
149928729|NCT03569098|540874679|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
149928730|NCT03569098|540874680|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
149928731|NCT00758498|540874681|FG000|Overall Study|Adverse Event|2|||
149928732|NCT00758498|540874682|FG001|Overall Study|Adverse Event|2|||
149928733|NCT00758498|540874683|FG002|Overall Study|Adverse Event|3|||
149928734|NCT00758498|540874681|FG000|Overall Study|Subject legally detained out of state|1|||
149928735|NCT00758498|540874682|FG001|Overall Study|Subject legally detained out of state|0|||
149928736|NCT00758498|540874683|FG002|Overall Study|Subject legally detained out of state|0|||
149928737|NCT00758498|540874681|FG000|Overall Study|Withdrawal by Subject|0|||
149928738|NCT00758498|540874682|FG001|Overall Study|Withdrawal by Subject|0|||
149928739|NCT00758498|540874683|FG002|Overall Study|Withdrawal by Subject|1|||
149928740|NCT00758498|540874681|FG000|Overall Study|Noncompliance to study procedures|0|||
149928741|NCT00758498|540874682|FG001|Overall Study|Noncompliance to study procedures|0|||
149928742|NCT00758498|540874683|FG002|Overall Study|Noncompliance to study procedures|1|||
149928743|NCT01516736|540874684|FG000|Overall Study|Withdrawal by Subject|10|||
149928744|NCT01516736|540874685|FG001|Overall Study|Withdrawal by Subject|4|||
149928745|NCT01516736|540874684|FG000|Overall Study|Adverse Event|4|||
149928746|NCT01516736|540874685|FG001|Overall Study|Adverse Event|5|||
149928747|NCT01516736|540874684|FG000|Overall Study|Death|3|||
149928748|NCT01516736|540874685|FG001|Overall Study|Death|1|||
149928749|NCT01516736|540874684|FG000|Overall Study|Physician Decision|2|||
149928750|NCT01516736|540874685|FG001|Overall Study|Physician Decision|1|||
149928751|NCT01516736|540874684|FG000|Overall Study|Lack of Efficacy|1|||
150265716|NCT04677179|542108646|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
149928752|NCT01516736|540874685|FG001|Overall Study|Lack of Efficacy|0|||
149928753|NCT01516736|540874684|FG000|Overall Study|Protocol Violation|0|||
149928754|NCT01516736|540874685|FG001|Overall Study|Protocol Violation|1|||
149928755|NCT01516736|540874684|FG000|Overall Study|Other (not specified)|0|||
149928756|NCT01516736|540874685|FG001|Overall Study|Other (not specified)|1|||
150265717|NCT04677179|542108647|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
150265718|NCT04677179|542108648|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
150265719|NCT04677179|542108649|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
149928757|NCT02781818|540874688|FG000|Overall Study|Lost to Follow-up|4|||
150165064|NCT03781804|541739982|FG000|Overall Study|Reason not provided|2|||
150165065|NCT03781804|541739983|FG001|Overall Study|Reason not provided|2|||
150165066|NCT03781804|541739984|FG002|Overall Study|Reason not provided|0|||
150165067|NCT03717194|541739985|FG000|Overall Study|Withdrawal by Subject|2|||
150165068|NCT03717194|541739986|FG001|Overall Study|Withdrawal by Subject|4|||
150165069|NCT03717194|541739985|FG000|Overall Study|Adverse Event|1|||
150165070|NCT03717194|541739986|FG001|Overall Study|Adverse Event|1|||
149819447|NCT01621490|540469146|FG007|Overall Study|Maximum clinical benefit|2|||
149819448|NCT01621490|540469147|FG008|Overall Study|Maximum clinical benefit|2|||
149819449|NCT01621490|540469148|FG009|Overall Study|Maximum clinical benefit|0|||
149819450|NCT01621490|540469149|FG010|Overall Study|Maximum clinical benefit|0|||
149819451|NCT01621490|540469139|FG000|Overall Study|Withdrawal by Subject|1|||
149819452|NCT01621490|540469140|FG001|Overall Study|Withdrawal by Subject|0|||
149819453|NCT01621490|540469141|FG002|Overall Study|Withdrawal by Subject|0|||
149819454|NCT01621490|540469142|FG003|Overall Study|Withdrawal by Subject|0|||
149819455|NCT01621490|540469143|FG004|Overall Study|Withdrawal by Subject|0|||
149819456|NCT01621490|540469144|FG005|Overall Study|Withdrawal by Subject|1|||
149819457|NCT01621490|540469145|FG006|Overall Study|Withdrawal by Subject|0|||
149819458|NCT01621490|540469146|FG007|Overall Study|Withdrawal by Subject|0|||
149819459|NCT01621490|540469147|FG008|Overall Study|Withdrawal by Subject|0|||
149819460|NCT01621490|540469148|FG009|Overall Study|Withdrawal by Subject|0|||
149819461|NCT01621490|540469149|FG010|Overall Study|Withdrawal by Subject|0|||
149819462|NCT01621490|540469139|FG000|Overall Study|Subject request to discontinue study|1|||
149819463|NCT01621490|540469140|FG001|Overall Study|Subject request to discontinue study|3|||
149819464|NCT01621490|540469141|FG002|Overall Study|Subject request to discontinue study|1|||
149819465|NCT01621490|540469142|FG003|Overall Study|Subject request to discontinue study|1|||
149819466|NCT01621490|540469143|FG004|Overall Study|Subject request to discontinue study|0|||
149819467|NCT01621490|540469144|FG005|Overall Study|Subject request to discontinue study|2|||
149819468|NCT01621490|540469145|FG006|Overall Study|Subject request to discontinue study|1|||
149819469|NCT01621490|540469146|FG007|Overall Study|Subject request to discontinue study|0|||
149819470|NCT01621490|540469147|FG008|Overall Study|Subject request to discontinue study|1|||
149819471|NCT01621490|540469148|FG009|Overall Study|Subject request to discontinue study|0|||
149819472|NCT01621490|540469149|FG010|Overall Study|Subject request to discontinue study|0|||
149819473|NCT01621490|540469139|FG000|Overall Study|Adverse event unrelated to study drug|1|||
149819474|NCT01621490|540469140|FG001|Overall Study|Adverse event unrelated to study drug|1|||
149819475|NCT01621490|540469141|FG002|Overall Study|Adverse event unrelated to study drug|0|||
149819476|NCT01621490|540469142|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149819477|NCT01621490|540469143|FG004|Overall Study|Adverse event unrelated to study drug|0|||
149819478|NCT01621490|540469144|FG005|Overall Study|Adverse event unrelated to study drug|0|||
149819479|NCT01621490|540469145|FG006|Overall Study|Adverse event unrelated to study drug|0|||
149819480|NCT01621490|540469146|FG007|Overall Study|Adverse event unrelated to study drug|2|||
149819481|NCT01621490|540469147|FG008|Overall Study|Adverse event unrelated to study drug|0|||
149819482|NCT01621490|540469148|FG009|Overall Study|Adverse event unrelated to study drug|0|||
149819483|NCT01621490|540469149|FG010|Overall Study|Adverse event unrelated to study drug|0|||
149819484|NCT01621490|540469139|FG000|Overall Study|Disease progression|27|||
149819485|NCT01621490|540469140|FG001|Overall Study|Disease progression|28|||
149819486|NCT01621490|540469141|FG002|Overall Study|Disease progression|1|||
149819487|NCT01621490|540469142|FG003|Overall Study|Disease progression|5|||
149819488|NCT01621490|540469143|FG004|Overall Study|Disease progression|3|||
149819489|NCT01621490|540469144|FG005|Overall Study|Disease progression|8|||
149819490|NCT01621490|540469145|FG006|Overall Study|Disease progression|7|||
149819491|NCT01621490|540469146|FG007|Overall Study|Disease progression|1|||
149819492|NCT01621490|540469147|FG008|Overall Study|Disease progression|4|||
149819493|NCT01621490|540469148|FG009|Overall Study|Disease progression|1|||
149819494|NCT01621490|540469149|FG010|Overall Study|Disease progression|1|||
149819495|NCT01621490|540469139|FG000|Overall Study|Study drug toxicity|1|||
149819496|NCT01621490|540469140|FG001|Overall Study|Study drug toxicity|4|||
149819497|NCT01621490|540469141|FG002|Overall Study|Study drug toxicity|5|||
149819498|NCT01621490|540469142|FG003|Overall Study|Study drug toxicity|3|||
149819499|NCT01621490|540469143|FG004|Overall Study|Study drug toxicity|1|||
149819500|NCT01621490|540469144|FG005|Overall Study|Study drug toxicity|10|||
149819501|NCT01621490|540469145|FG006|Overall Study|Study drug toxicity|1|||
149819502|NCT01621490|540469146|FG007|Overall Study|Study drug toxicity|4|||
149819503|NCT01621490|540469147|FG008|Overall Study|Study drug toxicity|1|||
149819504|NCT01621490|540469148|FG009|Overall Study|Study drug toxicity|0|||
149819505|NCT01621490|540469149|FG010|Overall Study|Study drug toxicity|0|||
149819506|NCT01621490|540469139|FG000|Overall Study|Death|0|||
149819507|NCT01621490|540469140|FG001|Overall Study|Death|0|||
149819508|NCT01621490|540469141|FG002|Overall Study|Death|0|||
149819509|NCT01621490|540469142|FG003|Overall Study|Death|0|||
149819510|NCT01621490|540469143|FG004|Overall Study|Death|0|||
150165071|NCT00561574|541739988|FG000|Overall Study|Adverse Event|21|||
149819511|NCT01621490|540469144|FG005|Overall Study|Death|0|||
149819512|NCT01621490|540469145|FG006|Overall Study|Death|0|||
149928758|NCT02781818|540874689|FG001|Overall Study|Lost to Follow-up|2|||
149928759|NCT02781818|540874690|FG002|Overall Study|Lost to Follow-up|1|||
149928760|NCT01877668|540874691|FG000|Overall Study|Death|0|||
149928761|NCT01877668|540874692|FG001|Overall Study|Death|0|||
149928762|NCT01877668|540874693|FG002|Overall Study|Death|0|||
149928763|NCT01877668|540874694|FG003|Overall Study|Death|1|||
149928764|NCT01877668|540874695|FG004|Overall Study|Death|0|||
149928765|NCT01877668|540874691|FG000|Overall Study|No longer met study criteria|1|||
149928766|NCT01877668|540874692|FG001|Overall Study|No longer met study criteria|0|||
149928767|NCT01877668|540874693|FG002|Overall Study|No longer met study criteria|1|||
149928768|NCT01877668|540874694|FG003|Overall Study|No longer met study criteria|0|||
149928769|NCT01877668|540874695|FG004|Overall Study|No longer met study criteria|0|||
149928770|NCT01877668|540874691|FG000|Overall Study|Insufficient clinical response|0|||
149928771|NCT01877668|540874692|FG001|Overall Study|Insufficient clinical response|1|||
149928772|NCT01877668|540874693|FG002|Overall Study|Insufficient clinical response|2|||
149928773|NCT01877668|540874694|FG003|Overall Study|Insufficient clinical response|2|||
149928774|NCT01877668|540874695|FG004|Overall Study|Insufficient clinical response|0|||
149928775|NCT01877668|540874691|FG000|Overall Study|Lost to Follow-up|0|||
149928776|NCT01877668|540874692|FG001|Overall Study|Lost to Follow-up|2|||
149928777|NCT01877668|540874693|FG002|Overall Study|Lost to Follow-up|1|||
149928778|NCT01877668|540874694|FG003|Overall Study|Lost to Follow-up|0|||
149928779|NCT01877668|540874695|FG004|Overall Study|Lost to Follow-up|0|||
149928780|NCT01877668|540874691|FG000|Overall Study|Withdrawal by Subject|2|||
149928781|NCT01877668|540874692|FG001|Overall Study|Withdrawal by Subject|0|||
149928782|NCT01877668|540874693|FG002|Overall Study|Withdrawal by Subject|3|||
149928783|NCT01877668|540874694|FG003|Overall Study|Withdrawal by Subject|2|||
149928784|NCT01877668|540874695|FG004|Overall Study|Withdrawal by Subject|2|||
149928785|NCT01877668|540874691|FG000|Overall Study|Other|1|||
149928786|NCT01877668|540874692|FG001|Overall Study|Other|1|||
149928787|NCT01877668|540874693|FG002|Overall Study|Other|1|||
149928788|NCT01877668|540874694|FG003|Overall Study|Other|1|||
149928789|NCT01877668|540874695|FG004|Overall Study|Other|3|||
149928790|NCT01877668|540874691|FG000|Overall Study|Protocol Violation|1|||
149928791|NCT01877668|540874692|FG001|Overall Study|Protocol Violation|1|||
149928792|NCT01877668|540874693|FG002|Overall Study|Protocol Violation|0|||
149928793|NCT01877668|540874694|FG003|Overall Study|Protocol Violation|0|||
149928794|NCT01877668|540874695|FG004|Overall Study|Protocol Violation|3|||
149928795|NCT01877668|540874691|FG000|Overall Study|Adverse event related to study drug|2|||
149928796|NCT01877668|540874692|FG001|Overall Study|Adverse event related to study drug|2|||
149928797|NCT01877668|540874693|FG002|Overall Study|Adverse event related to study drug|2|||
149928798|NCT01877668|540874694|FG003|Overall Study|Adverse event related to study drug|2|||
149928799|NCT01877668|540874695|FG004|Overall Study|Adverse event related to study drug|1|||
149928800|NCT01877668|540874691|FG000|Overall Study|Adverse event unrelated to study drug|4|||
149928801|NCT01877668|540874692|FG001|Overall Study|Adverse event unrelated to study drug|1|||
149928802|NCT01877668|540874693|FG002|Overall Study|Adverse event unrelated to study drug|2|||
149928803|NCT01877668|540874694|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149928804|NCT01877668|540874695|FG004|Overall Study|Adverse event unrelated to study drug|1|||
149928805|NCT01302418|540874696|FG000|Overall Study|Protocol Violation|9|||
149928806|NCT01302418|540874696|FG000|Overall Study|Non-evaluable|9|||
149928807|NCT01697800|540874697|FG000|Overall Study|Death|0|||
149928808|NCT01697800|540874698|FG001|Overall Study|Death|1|||
149928809|NCT00954122|540874699|FG000|Overall Study|Withdrawal by Subject|5|||
149928810|NCT00954122|540874699|FG000|Overall Study|Adverse Event|1|||
149928811|NCT00954122|540874699|FG000|Overall Study|Safety Reason|1|||
150165072|NCT00561574|541739989|FG001|Overall Study|Adverse Event|24|||
150165073|NCT00561574|541739988|FG000|Overall Study|Lack of Efficacy|11|||
150165074|NCT00561574|541739989|FG001|Overall Study|Lack of Efficacy|21|||
150165075|NCT00561574|541739988|FG000|Overall Study|Withdrawal by Subject|4|||
150165076|NCT00561574|541739989|FG001|Overall Study|Withdrawal by Subject|4|||
150165077|NCT00561574|541739988|FG000|Overall Study|Reason Unrelated to Trial|6|||
150165078|NCT00561574|541739989|FG001|Overall Study|Reason Unrelated to Trial|2|||
150165079|NCT00561574|541739988|FG000|Overall Study|Lost to Follow-up|1|||
150165080|NCT00561574|541739989|FG001|Overall Study|Lost to Follow-up|0|||
150165081|NCT00561574|541739988|FG000|Overall Study|Other|5|||
150165082|NCT00561574|541739989|FG001|Overall Study|Other|7|||
149928812|NCT00666211|540874700|FG000|Overall Study|Withdrawal by Subject|10|||
149928813|NCT00666211|540874701|FG001|Overall Study|Withdrawal by Subject|13|||
149928814|NCT00666211|540874700|FG000|Overall Study|went off medication, no more pain|1|||
149928815|NCT00666211|540874701|FG001|Overall Study|went off medication, no more pain|0|||
149928816|NCT00666211|540874700|FG000|Overall Study|patient non-compliant|6|||
149928817|NCT00666211|540874701|FG001|Overall Study|patient non-compliant|6|||
149928818|NCT00666211|540874700|FG000|Overall Study|disease progression|1|||
149928819|NCT00666211|540874701|FG001|Overall Study|disease progression|8|||
149928820|NCT00666211|540874700|FG000|Overall Study|Lost to Follow-up|2|||
150165083|NCT00445692|541739990|FG000|Overall Study|Adverse Event|11|||
150165084|NCT00445692|541739990|FG000|Overall Study|Lack of Efficacy|5|||
149928821|NCT00666211|540874701|FG001|Overall Study|Lost to Follow-up|0|||
149928822|NCT00666211|540874700|FG000|Overall Study|toxicity|0|||
149928823|NCT00666211|540874701|FG001|Overall Study|toxicity|2|||
149928824|NCT00666211|540874700|FG000|Overall Study|hospital admission|0|||
149928825|NCT00666211|540874701|FG001|Overall Study|hospital admission|5|||
149928826|NCT00666211|540874700|FG000|Overall Study|Death|0|||
149928827|NCT00666211|540874701|FG001|Overall Study|Death|2|||
149928828|NCT00666211|540874700|FG000|Overall Study|off tx for other complicating disease|0|||
149928829|NCT00666211|540874701|FG001|Overall Study|off tx for other complicating disease|1|||
149928830|NCT00666211|540874700|FG000|Overall Study|Physician Decision|0|||
149928831|NCT00666211|540874701|FG001|Overall Study|Physician Decision|1|||
149928832|NCT02999789|540874704|FG000|Overall Study|Withdrawal by Subject|0|||
149928833|NCT02999789|540874705|FG001|Overall Study|Withdrawal by Subject|1|||
149928834|NCT02999789|540874704|FG000|Overall Study|Became ineligible|1|||
149928835|NCT02999789|540874705|FG001|Overall Study|Became ineligible|2|||
149928836|NCT04878055|540874708|FG000|Overall Study|Patient transferred in another department|0|||
149928837|NCT04878055|540874709|FG001|Overall Study|Patient transferred in another department|2|||
149928838|NCT04878055|540874708|FG000|Overall Study|Physician Decision|1|||
149928839|NCT04878055|540874709|FG001|Overall Study|Physician Decision|1|||
149928840|NCT04878055|540874708|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
149928841|NCT04878055|540874709|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
149928842|NCT04878055|540874708|FG000|Overall Study|Adverse Event|12|||
149928843|NCT04878055|540874709|FG001|Overall Study|Adverse Event|7|||
149928844|NCT04878055|540874708|FG000|Overall Study|Other|5|||
149928845|NCT04878055|540874709|FG001|Overall Study|Other|0|||
149928846|NCT04878055|540874708|FG000|Overall Study|Withdrawal by Subject|7|||
149928847|NCT04878055|540874709|FG001|Overall Study|Withdrawal by Subject|3|||
149928848|NCT04878055|540874708|FG000|Overall Study|Lost to Follow-up|10|||
149928849|NCT04878055|540874709|FG001|Overall Study|Lost to Follow-up|1|||
149928850|NCT02907463|540874710|FG000|Overall Study|Lost to Follow-up|17|||
149928851|NCT02907463|540874710|FG000|Overall Study|Death|10|||
149928852|NCT02907463|540874710|FG000|Overall Study|Withdrawal by Subject|4|||
149928853|NCT02907463|540874710|FG000|Overall Study|MIS Approach was not used|2|||
150165085|NCT00630864|541739996|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
150165086|NCT00630864|541739996|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
150165087|NCT00430677|541739997|FG000|Short-term Period|Death|1|||
150165088|NCT00430677|541739998|FG001|Short-term Period|Death|1|||
150165089|NCT00430677|541739999|FG002|Short-term Period|Death|5|||
150165090|NCT00430677|541739997|FG000|Short-term Period|Adverse Event|15|||
150165091|NCT00430677|541739998|FG001|Short-term Period|Adverse Event|13|||
150165092|NCT00430677|541739999|FG002|Short-term Period|Adverse Event|9|||
150165093|NCT00430677|541739997|FG000|Short-term Period|Lack of Efficacy|5|||
150165094|NCT00430677|541739998|FG001|Short-term Period|Lack of Efficacy|6|||
150165095|NCT00430677|541739999|FG002|Short-term Period|Lack of Efficacy|4|||
150165096|NCT00430677|541739997|FG000|Short-term Period|Withdrawal by Subject|1|||
150165097|NCT00430677|541739998|FG001|Short-term Period|Withdrawal by Subject|1|||
150165098|NCT00430677|541739999|FG002|Short-term Period|Withdrawal by Subject|2|||
150165099|NCT00430677|541739997|FG000|Short-term Period|Participant no longer met study criteria|1|||
150165100|NCT00430677|541739998|FG001|Short-term Period|Participant no longer met study criteria|1|||
150165101|NCT00430677|541739999|FG002|Short-term Period|Participant no longer met study criteria|2|||
150165102|NCT00430677|541739997|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
150165103|NCT00430677|541739998|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
150165104|NCT00430677|541739999|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
150165105|NCT00430677|541739997|FG000|Short-term Period|Pregnancy|0|||
150165106|NCT00430677|541739998|FG001|Short-term Period|Pregnancy|2|||
150165107|NCT00430677|541739999|FG002|Short-term Period|Pregnancy|0|||
150165108|NCT00430677|541739997|FG000|Long-term Extension Period|Death|1|||
150165109|NCT00430677|541739998|FG001|Long-term Extension Period|Death|0|||
149928854|NCT02907463|540874710|FG000|Overall Study|Not Implanted with Study Device|2|||
149928855|NCT02907463|540874710|FG000|Overall Study|Device Explanted|1|||
149928856|NCT02907463|540874710|FG000|Overall Study|Missing Exit Form|1|||
150165110|NCT00430677|541739999|FG002|Long-term Extension Period|Death|0|||
150165111|NCT00430677|541739997|FG000|Long-term Extension Period|Adverse Event|3|||
150165112|NCT00430677|541739998|FG001|Long-term Extension Period|Adverse Event|2|||
150165113|NCT00430677|541739999|FG002|Long-term Extension Period|Adverse Event|5|||
150165114|NCT00430677|541739997|FG000|Long-term Extension Period|Lack of Efficacy|5|||
150165115|NCT00430677|541739998|FG001|Long-term Extension Period|Lack of Efficacy|3|||
150165116|NCT00430677|541739999|FG002|Long-term Extension Period|Lack of Efficacy|8|||
150165117|NCT00430677|541739997|FG000|Long-term Extension Period|Lost to Follow-up|1|||
150165118|NCT00430677|541739998|FG001|Long-term Extension Period|Lost to Follow-up|1|||
149928857|NCT01447407|540874711|FG000|Overall Study|Withdrawal by Subject|2|||
149928858|NCT01447407|540874712|FG001|Overall Study|Withdrawal by Subject|0|||
150165119|NCT00430677|541739999|FG002|Long-term Extension Period|Lost to Follow-up|1|||
150165120|NCT00430677|541739997|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
149928859|NCT01447407|540874713|FG002|Overall Study|Withdrawal by Subject|0|||
149928860|NCT01447407|540874714|FG003|Overall Study|Withdrawal by Subject|1|||
150265720|NCT04677179|542108650|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
150265721|NCT04677179|542108641|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
150265722|NCT04677179|542108642|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
150265723|NCT04677179|542108643|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
150265724|NCT04677179|542108644|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
150265725|NCT04677179|542108645|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
150265726|NCT04677179|542108646|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
150265727|NCT04677179|542108647|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
150265728|NCT04677179|542108648|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
150265729|NCT04677179|542108649|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
150265730|NCT04677179|542108650|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
150265731|NCT04677179|542108641|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265732|NCT04677179|542108642|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265733|NCT04677179|542108643|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265734|NCT04677179|542108644|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
150265735|NCT04677179|542108645|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265736|NCT04677179|542108646|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265737|NCT04677179|542108647|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265738|NCT04677179|542108648|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265739|NCT04677179|542108649|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
149928861|NCT01447407|540874711|FG000|Overall Study|Physician Decision|0|||
149928862|NCT01447407|540874712|FG001|Overall Study|Physician Decision|0|||
149928863|NCT01447407|540874713|FG002|Overall Study|Physician Decision|1|||
149928864|NCT01447407|540874714|FG003|Overall Study|Physician Decision|1|||
149928865|NCT01719380|540874717|FG000|Overall Study|Adverse Event|0|||
149928866|NCT01719380|540874718|FG001|Overall Study|Adverse Event|0|||
149928867|NCT01719380|540874719|FG002|Overall Study|Adverse Event|1|||
149928868|NCT01719380|540874720|FG003|Overall Study|Adverse Event|2|||
149928869|NCT01719380|540874721|FG004|Overall Study|Adverse Event|0|||
149928870|NCT01719380|540874722|FG005|Overall Study|Adverse Event|1|||
149928871|NCT01719380|540874723|FG006|Overall Study|Adverse Event|0|||
149928872|NCT01719380|540874724|FG007|Overall Study|Adverse Event|1|||
149928873|NCT01719380|540874725|FG008|Overall Study|Adverse Event|4|||
149928874|NCT01719380|540874726|FG009|Overall Study|Adverse Event|3|||
149928875|NCT01719380|540874717|FG000|Overall Study|Death|0|||
149928876|NCT01719380|540874718|FG001|Overall Study|Death|1|||
149928877|NCT01719380|540874719|FG002|Overall Study|Death|0|||
149928878|NCT01719380|540874720|FG003|Overall Study|Death|0|||
149928879|NCT01719380|540874721|FG004|Overall Study|Death|0|||
149928880|NCT01719380|540874722|FG005|Overall Study|Death|0|||
149928881|NCT01719380|540874723|FG006|Overall Study|Death|0|||
149928882|NCT01719380|540874724|FG007|Overall Study|Death|0|||
149928883|NCT01719380|540874725|FG008|Overall Study|Death|3|||
149928884|NCT01719380|540874726|FG009|Overall Study|Death|3|||
149928885|NCT01719380|540874717|FG000|Overall Study|Participant/Guardian Decision|0|||
149928886|NCT01719380|540874718|FG001|Overall Study|Participant/Guardian Decision|0|||
149928887|NCT01719380|540874719|FG002|Overall Study|Participant/Guardian Decision|1|||
149928888|NCT01719380|540874720|FG003|Overall Study|Participant/Guardian Decision|0|||
149928889|NCT01719380|540874721|FG004|Overall Study|Participant/Guardian Decision|0|||
149928890|NCT01719380|540874722|FG005|Overall Study|Participant/Guardian Decision|0|||
149928891|NCT01719380|540874723|FG006|Overall Study|Participant/Guardian Decision|0|||
149928892|NCT01719380|540874724|FG007|Overall Study|Participant/Guardian Decision|0|||
149928893|NCT01719380|540874725|FG008|Overall Study|Participant/Guardian Decision|2|||
149928894|NCT01719380|540874726|FG009|Overall Study|Participant/Guardian Decision|2|||
149928895|NCT01719380|540874717|FG000|Overall Study|Physician Decision|0|||
149928896|NCT01719380|540874718|FG001|Overall Study|Physician Decision|0|||
149928897|NCT01719380|540874719|FG002|Overall Study|Physician Decision|2|||
149928898|NCT01719380|540874720|FG003|Overall Study|Physician Decision|0|||
149928899|NCT01719380|540874721|FG004|Overall Study|Physician Decision|0|||
149928900|NCT01719380|540874722|FG005|Overall Study|Physician Decision|0|||
149928901|NCT01719380|540874723|FG006|Overall Study|Physician Decision|0|||
150265740|NCT04677179|542108650|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
150265741|NCT04677179|542108641|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265742|NCT04677179|542108642|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
149928902|NCT01719380|540874724|FG007|Overall Study|Physician Decision|0|||
149928903|NCT01719380|540874725|FG008|Overall Study|Physician Decision|1|||
149928904|NCT01719380|540874726|FG009|Overall Study|Physician Decision|1|||
149928905|NCT01719380|540874717|FG000|Overall Study|Lack of Efficacy|2|||
149928906|NCT01719380|540874718|FG001|Overall Study|Lack of Efficacy|6|||
149928907|NCT01719380|540874719|FG002|Overall Study|Lack of Efficacy|5|||
149928908|NCT01719380|540874720|FG003|Overall Study|Lack of Efficacy|6|||
149928909|NCT01719380|540874721|FG004|Overall Study|Lack of Efficacy|3|||
149928910|NCT01719380|540874722|FG005|Overall Study|Lack of Efficacy|7|||
149928911|NCT01719380|540874723|FG006|Overall Study|Lack of Efficacy|10|||
149928912|NCT01719380|540874724|FG007|Overall Study|Lack of Efficacy|6|||
149819513|NCT01621490|540469146|FG007|Overall Study|Death|0|||
149819514|NCT01621490|540469147|FG008|Overall Study|Death|1|||
149819515|NCT01621490|540469148|FG009|Overall Study|Death|0|||
149819516|NCT01621490|540469149|FG010|Overall Study|Death|0|||
149819517|NCT01621490|540469139|FG000|Overall Study|Other reasons|7|||
149819518|NCT01621490|540469140|FG001|Overall Study|Other reasons|6|||
149819519|NCT01621490|540469141|FG002|Overall Study|Other reasons|4|||
149819520|NCT01621490|540469142|FG003|Overall Study|Other reasons|1|||
149819521|NCT01621490|540469143|FG004|Overall Study|Other reasons|1|||
150165121|NCT00430677|541739998|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
150165122|NCT00430677|541739999|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
150165123|NCT00430677|541739997|FG000|Long-term Extension Period|Pregnancy|1|||
150165124|NCT00430677|541739998|FG001|Long-term Extension Period|Pregnancy|1|||
149819522|NCT01621490|540469144|FG005|Overall Study|Other reasons|3|||
149819523|NCT01621490|540469145|FG006|Overall Study|Other reasons|1|||
149819524|NCT01621490|540469146|FG007|Overall Study|Other reasons|1|||
149819525|NCT01621490|540469147|FG008|Overall Study|Other reasons|1|||
149819526|NCT01621490|540469148|FG009|Overall Study|Other reasons|0|||
149819527|NCT01621490|540469149|FG010|Overall Study|Other reasons|0|||
149819528|NCT00506753|540469150|FG000|Overall Study|Lost to Follow-up|21|||
149819529|NCT00506753|540469151|FG001|Overall Study|Lost to Follow-up|15|||
150165125|NCT00430677|541739999|FG002|Long-term Extension Period|Pregnancy|0|||
150165126|NCT00430677|541739997|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
150165127|NCT00430677|541739998|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
150165128|NCT00430677|541739999|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
150165129|NCT00430677|541739997|FG000|Long-term Extension Period|Other|2|||
150165130|NCT00430677|541739998|FG001|Long-term Extension Period|Other|1|||
150165131|NCT00430677|541739999|FG002|Long-term Extension Period|Other|1|||
150165132|NCT00430677|541739997|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
150165133|NCT00430677|541739998|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
149819530|NCT00125359|540469152|FG000|Overall Study|Death|4|||
149819531|NCT00125359|540469152|FG000|Overall Study|Adverse Event|5|||
149819532|NCT00125359|540469152|FG000|Overall Study|Physician Decision|14|||
149819533|NCT01764854|540469155|FG000|Overall Study|Adverse Event|0|||
149819534|NCT01764854|540469156|FG001|Overall Study|Adverse Event|0|||
149819535|NCT01764854|540469157|FG002|Overall Study|Adverse Event|2|||
149819536|NCT01764854|540469158|FG003|Overall Study|Adverse Event|0|||
149819537|NCT01764854|540469155|FG000|Overall Study|Withdrawal by Subject|0|||
149819538|NCT01764854|540469156|FG001|Overall Study|Withdrawal by Subject|0|||
149928913|NCT01719380|540874725|FG008|Overall Study|Lack of Efficacy|39|||
149928914|NCT01719380|540874726|FG009|Overall Study|Lack of Efficacy|42|||
149928915|NCT01719380|540874717|FG000|Overall Study|Progressive Disease|0|||
149928916|NCT01719380|540874718|FG001|Overall Study|Progressive Disease|0|||
149928917|NCT01719380|540874719|FG002|Overall Study|Progressive Disease|0|||
149928918|NCT01719380|540874720|FG003|Overall Study|Progressive Disease|0|||
149928919|NCT01719380|540874721|FG004|Overall Study|Progressive Disease|0|||
149928920|NCT01719380|540874722|FG005|Overall Study|Progressive Disease|0|||
149928921|NCT01719380|540874723|FG006|Overall Study|Progressive Disease|0|||
149928922|NCT01719380|540874724|FG007|Overall Study|Progressive Disease|0|||
149928923|NCT01719380|540874725|FG008|Overall Study|Progressive Disease|1|||
149928924|NCT01719380|540874726|FG009|Overall Study|Progressive Disease|0|||
149928925|NCT02532374|540874730|FG000|Overall Study|Withdrawal by Subject|1|||
149928926|NCT02532374|540874730|FG000|Overall Study|Physician Decision|1|||
150165134|NCT00430677|541739999|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
150165135|NCT02040844|541740002|FG000|Overall Study|Adverse Event|0|||
150165136|NCT02040844|541740003|FG001|Overall Study|Adverse Event|0|||
150165137|NCT02040844|541740004|FG002|Overall Study|Adverse Event|1|||
150165138|NCT02040844|541740002|FG000|Overall Study|Withdrawal by Subject|16|||
150165139|NCT02040844|541740003|FG001|Overall Study|Withdrawal by Subject|22|||
150165140|NCT02040844|541740004|FG002|Overall Study|Withdrawal by Subject|25|||
150165141|NCT02040844|541740002|FG000|Overall Study|Lost to Follow-up|12|||
150165142|NCT02040844|541740003|FG001|Overall Study|Lost to Follow-up|9|||
150165143|NCT02040844|541740004|FG002|Overall Study|Lost to Follow-up|13|||
150165144|NCT02040844|541740002|FG000|Overall Study|Missing|13|||
150165145|NCT02040844|541740003|FG001|Overall Study|Missing|3|||
150165146|NCT02040844|541740004|FG002|Overall Study|Missing|2|||
150165147|NCT02040844|541740002|FG000|Overall Study|Non-specified|8|||
150165148|NCT02040844|541740003|FG001|Overall Study|Non-specified|2|||
150165149|NCT02040844|541740004|FG002|Overall Study|Non-specified|5|||
150165150|NCT02040844|541740002|FG000|Overall Study|Concomitant medication|1|||
150165151|NCT02040844|541740003|FG001|Overall Study|Concomitant medication|3|||
150165152|NCT02040844|541740004|FG002|Overall Study|Concomitant medication|1|||
150165153|NCT00946192|541740005|FG000|Overall Study|Lost to Follow-up|6|||
150165154|NCT00946192|541740006|FG001|Overall Study|Lost to Follow-up|11|||
149819539|NCT01764854|540469157|FG002|Overall Study|Withdrawal by Subject|1|||
149819540|NCT01764854|540469158|FG003|Overall Study|Withdrawal by Subject|0|||
149819541|NCT01764854|540469155|FG000|Overall Study|relocation|0|||
149819542|NCT01764854|540469156|FG001|Overall Study|relocation|0|||
149928927|NCT01765296|540874735|FG000|Overall Study|Protocol Violation|0|||
149928928|NCT01765296|540874736|FG001|Overall Study|Protocol Violation|5|||
149928929|NCT01765296|540874737|FG002|Overall Study|Protocol Violation|4|||
149928930|NCT01765296|540874735|FG000|Overall Study|Withdrawal by Subject|4|||
149928931|NCT01765296|540874736|FG001|Overall Study|Withdrawal by Subject|2|||
149928932|NCT01765296|540874737|FG002|Overall Study|Withdrawal by Subject|2|||
149928933|NCT01765296|540874735|FG000|Overall Study|Adverse Event|1|||
149928934|NCT01765296|540874736|FG001|Overall Study|Adverse Event|13|||
149928935|NCT01765296|540874737|FG002|Overall Study|Adverse Event|5|||
149928936|NCT01765296|540874735|FG000|Overall Study|Lack of Efficacy|0|||
149928937|NCT01765296|540874736|FG001|Overall Study|Lack of Efficacy|0|||
149928938|NCT01765296|540874737|FG002|Overall Study|Lack of Efficacy|2|||
149928939|NCT03257436|540874738|FG000|Overall Study|Withdrawal by Subject|76|||
149928940|NCT03257436|540874738|FG000|Overall Study|Death|19|||
149928941|NCT01619852|540874739|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
149928942|NCT01619852|540874740|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
149928943|NCT01619852|540874739|FG000|3 Month Follow up|Lost to Follow-up|31|||
149928944|NCT01619852|540874740|FG001|3 Month Follow up|Lost to Follow-up|34|||
149928945|NCT02659943|540874741|FG000|Overall Study|Switched to alternative treatment|1|||
149928946|NCT02659943|540874742|FG001|Overall Study|Switched to alternative treatment|1|||
149928947|NCT02659943|540874743|FG002|Overall Study|Switched to alternative treatment|0|||
149928948|NCT02659943|540874744|FG003|Overall Study|Switched to alternative treatment|2|||
149928949|NCT02659943|540874745|FG004|Overall Study|Switched to alternative treatment|1|||
149928950|NCT02659943|540874746|FG005|Overall Study|Switched to alternative treatment|0|||
149928951|NCT02659943|540874747|FG006|Overall Study|Switched to alternative treatment|1|||
149928952|NCT02659943|540874741|FG000|Overall Study|Disease progression on study|0|||
149928953|NCT02659943|540874742|FG001|Overall Study|Disease progression on study|1|||
149928954|NCT02659943|540874743|FG002|Overall Study|Disease progression on study|1|||
149928955|NCT02659943|540874744|FG003|Overall Study|Disease progression on study|1|||
149928956|NCT02659943|540874745|FG004|Overall Study|Disease progression on study|1|||
149928957|NCT02659943|540874746|FG005|Overall Study|Disease progression on study|4|||
149928958|NCT02659943|540874747|FG006|Overall Study|Disease progression on study|0|||
149928959|NCT02659943|540874741|FG000|Overall Study|Patient's condition per principal investigator|0|||
149928960|NCT02659943|540874742|FG001|Overall Study|Patient's condition per principal investigator|0|||
149928961|NCT02659943|540874743|FG002|Overall Study|Patient's condition per principal investigator|0|||
149928962|NCT02659943|540874744|FG003|Overall Study|Patient's condition per principal investigator|0|||
149928963|NCT02659943|540874745|FG004|Overall Study|Patient's condition per principal investigator|0|||
149928964|NCT02659943|540874746|FG005|Overall Study|Patient's condition per principal investigator|1|||
149928965|NCT02659943|540874747|FG006|Overall Study|Patient's condition per principal investigator|0|||
149928966|NCT02659943|540874741|FG000|Overall Study|Ineligible|0|||
149928967|NCT02659943|540874742|FG001|Overall Study|Ineligible|0|||
149928968|NCT02659943|540874743|FG002|Overall Study|Ineligible|0|||
149928969|NCT02659943|540874744|FG003|Overall Study|Ineligible|0|||
149928970|NCT02659943|540874745|FG004|Overall Study|Ineligible|0|||
149928971|NCT02659943|540874746|FG005|Overall Study|Ineligible|0|||
149928972|NCT02659943|540874747|FG006|Overall Study|Ineligible|1|||
149928973|NCT02659943|540874741|FG000|Overall Study|No longer meets eligibility|0|||
149928974|NCT02659943|540874742|FG001|Overall Study|No longer meets eligibility|0|||
149928975|NCT02659943|540874743|FG002|Overall Study|No longer meets eligibility|0|||
149928976|NCT02659943|540874744|FG003|Overall Study|No longer meets eligibility|0|||
149928977|NCT02659943|540874745|FG004|Overall Study|No longer meets eligibility|0|||
149928978|NCT02659943|540874746|FG005|Overall Study|No longer meets eligibility|0|||
149928979|NCT02659943|540874747|FG006|Overall Study|No longer meets eligibility|1|||
149928980|NCT02659943|540874741|FG000|Overall Study|No treatment, per protocol|0|||
149928981|NCT02659943|540874742|FG001|Overall Study|No treatment, per protocol|0|||
149928982|NCT02659943|540874743|FG002|Overall Study|No treatment, per protocol|0|||
149928983|NCT02659943|540874744|FG003|Overall Study|No treatment, per protocol|0|||
149928984|NCT02659943|540874745|FG004|Overall Study|No treatment, per protocol|0|||
149928985|NCT02659943|540874746|FG005|Overall Study|No treatment, per protocol|0|||
149928986|NCT02659943|540874747|FG006|Overall Study|No treatment, per protocol|3|||
149928987|NCT01723072|540874752|FG000|Overall Study|Withdrawal by Subject|7|||
149928988|NCT01723072|540874753|FG001|Overall Study|Withdrawal by Subject|13|||
149928989|NCT01723072|540874752|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
149928990|NCT01723072|540874753|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
149928991|NCT01723072|540874752|FG000|Overall Study|Other|4|||
149928992|NCT01723072|540874753|FG001|Overall Study|Other|3|||
149928993|NCT01841970|540874754|FG000|Overall Study|Withdrawal by Subject|1|||
149928994|NCT01841970|540874754|FG000|Overall Study|Physician Decision|2|||
149928995|NCT01841970|540874754|FG000|Overall Study|Lost to Follow-up|8|||
149928996|NCT03478371|540874755|FG000|Overall Study|non-compliance|1|||
149928997|NCT03478371|540874755|FG000|Overall Study|Lost to Follow-up|4|||
149928998|NCT01411852|540874756|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
149928999|NCT01411852|540874757|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
149929000|NCT01411852|540874756|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
149929001|NCT01411852|540874757|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
149929002|NCT01411852|540874756|FG000|Prehospital Intervention Phase|Found to be under age|0|||
149929003|NCT01411852|540874757|FG001|Prehospital Intervention Phase|Found to be under age|1|||
149929004|NCT01411852|540874756|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
149929005|NCT01411852|540874757|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
149929006|NCT01411852|540874756|FG000|Hospital Intervention Phase|Severe head injury|5|||
149929007|NCT01411852|540874757|FG001|Hospital Intervention Phase|Severe head injury|4|||
149929008|NCT01411852|540874756|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
149929009|NCT01411852|540874757|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
149929010|NCT01411852|540874756|FG000|Hospital Intervention Phase|Miscommunication error|1|||
149929011|NCT01411852|540874757|FG001|Hospital Intervention Phase|Miscommunication error|2|||
149929012|NCT01411852|540874756|FG000|Hospital Intervention Phase|CPR administered|3|||
149929013|NCT01411852|540874757|FG001|Hospital Intervention Phase|CPR administered|1|||
149929014|NCT01411852|540874756|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
149929015|NCT01411852|540874757|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
149929016|NCT01411852|540874756|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
149929017|NCT01411852|540874757|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
149929018|NCT01411852|540874756|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
149929019|NCT01411852|540874757|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
149929020|NCT01411852|540874756|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
149929021|NCT01411852|540874757|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
149929022|NCT01411852|540874756|FG000|Hospital Intervention Phase|Other ineligible|2|||
149929023|NCT01411852|540874757|FG001|Hospital Intervention Phase|Other ineligible|2|||
149929024|NCT01411852|540874756|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
149929025|NCT01411852|540874757|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
149929026|NCT01411852|540874756|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
149929027|NCT01411852|540874757|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
149929028|NCT01411852|540874756|FG000|Hospital Intervention Phase|Vascular access failed|1|||
149929029|NCT01411852|540874757|FG001|Hospital Intervention Phase|Vascular access failed|0|||
149929030|NCT01118663|540874760|FG000|Overall Study|Adverse Event|2|||
149929031|NCT01118663|540874761|FG001|Overall Study|Adverse Event|1|||
149929032|NCT01118663|540874760|FG000|Overall Study|Withdrawal by Subject|0|||
149929033|NCT01118663|540874761|FG001|Overall Study|Withdrawal by Subject|1|||
149929034|NCT04039204|540874762|FG000|Overall Study|Withdrawal by Subject|0|||
149929035|NCT04039204|540874763|FG001|Overall Study|Withdrawal by Subject|2|||
149929036|NCT01189461|540874764|FG000|Overall Study|Lack of Efficacy|13|||
149929037|NCT01189461|540874764|FG000|Overall Study|Lost to Follow-up|1|||
149929038|NCT01189461|540874764|FG000|Overall Study|Withdrawal by Subject|6|||
149929039|NCT01189461|540874764|FG000|Overall Study|Protocol Violation|1|||
149929040|NCT01189461|540874764|FG000|Overall Study|Adverse Event|2|||
149929041|NCT01189461|540874764|FG000|Overall Study|Did not meet entrance criteria|3|||
149929042|NCT01189461|540874764|FG000|Overall Study|Other|8|||
149929043|NCT02149264|540874765|FG000|Overall Study|Withdrawal by Subject|9|||
149929044|NCT02149264|540874765|FG000|Overall Study|Adverse Event|7|||
149929045|NCT02149264|540874765|FG000|Overall Study|Physician Decision|3|||
149929046|NCT02149264|540874765|FG000|Overall Study|Protocol Violation|1|||
149929047|NCT02824627|540874768|FG000|Overall Study|Adverse Event|1|||
149929048|NCT02824627|540874769|FG001|Overall Study|Adverse Event|2|||
149929049|NCT02824627|540874768|FG000|Overall Study|Lost to Follow-up|2|||
149929050|NCT02824627|540874769|FG001|Overall Study|Lost to Follow-up|1|||
149929051|NCT01938846|540874770|FG000|Overall Study|Progressive disease|26|||
149929052|NCT01938846|540874771|FG001|Overall Study|Progressive disease|18|||
149929053|NCT01938846|540874772|FG002|Overall Study|Progressive disease|16|||
149929054|NCT01938846|540874770|FG000|Overall Study|Adverse Event|8|||
149929055|NCT01938846|540874771|FG001|Overall Study|Adverse Event|4|||
149929056|NCT01938846|540874772|FG002|Overall Study|Adverse Event|3|||
149929057|NCT01938846|540874770|FG000|Overall Study|Withdrawal by Subject|2|||
149929058|NCT01938846|540874771|FG001|Overall Study|Withdrawal by Subject|2|||
149929059|NCT01938846|540874772|FG002|Overall Study|Withdrawal by Subject|1|||
149929060|NCT01938846|540874770|FG000|Overall Study|Other than listed|5|||
149929061|NCT01938846|540874771|FG001|Overall Study|Other than listed|1|||
149929062|NCT01938846|540874772|FG002|Overall Study|Other than listed|4|||
149929063|NCT02499120|540874775|FG000|Overall Study|Death|52|||
149929064|NCT02499120|540874776|FG001|Overall Study|Death|43|||
149929065|NCT02499120|540874775|FG000|Overall Study|Lost to Follow-up|1|||
149929066|NCT02499120|540874776|FG001|Overall Study|Lost to Follow-up|2|||
149929067|NCT02499120|540874775|FG000|Overall Study|Participant refused further follow-up|1|||
149929068|NCT02499120|540874776|FG001|Overall Study|Participant refused further follow-up|0|||
149929069|NCT02499120|540874775|FG000|Overall Study|Withdrawal by Subject|2|||
149929070|NCT02499120|540874776|FG001|Overall Study|Withdrawal by Subject|5|||
149929071|NCT02499120|540874775|FG000|Overall Study|Other|9|||
149929072|NCT02499120|540874776|FG001|Overall Study|Other|10|||
149929073|NCT02282163|540874781|FG000|Overall Study|Protocol Violation|1|||
149929074|NCT00964028|540874782|FG000|Overall Study|Withdrawal by Subject|0|||
149929075|NCT00964028|540874783|FG001|Overall Study|Withdrawal by Subject|1|||
149929076|NCT03472521|540874784|FG000|Overall Study|Lost to Follow-up|3|||
149929077|NCT03472521|540874785|FG001|Overall Study|Lost to Follow-up|2|||
149929078|NCT03472521|540874784|FG000|Overall Study|Discontinued intervention|3|||
149929079|NCT03472521|540874785|FG001|Overall Study|Discontinued intervention|1|||
149929080|NCT01603407|540874786|FG000|Overall Study|Adverse Event|1|||
149929081|NCT01603407|540874787|FG001|Overall Study|Adverse Event|1|||
149929082|NCT01603407|540874788|FG002|Overall Study|Adverse Event|1|||
149929083|NCT01603407|540874786|FG000|Overall Study|Protocol Violation|2|||
149929084|NCT01603407|540874787|FG001|Overall Study|Protocol Violation|2|||
149929085|NCT01603407|540874788|FG002|Overall Study|Protocol Violation|0|||
149929086|NCT01603407|540874786|FG000|Overall Study|Withdrawal by Subject|8|||
149929087|NCT01603407|540874787|FG001|Overall Study|Withdrawal by Subject|5|||
149929088|NCT01603407|540874788|FG002|Overall Study|Withdrawal by Subject|7|||
149929089|NCT01603407|540874786|FG000|Overall Study|Lost to Follow-up|0|||
149929090|NCT01603407|540874787|FG001|Overall Study|Lost to Follow-up|3|||
149929091|NCT01603407|540874788|FG002|Overall Study|Lost to Follow-up|2|||
149929092|NCT02106351|540874793|FG000|Treatment Cycle 1|Adverse Event|2|||
149929093|NCT02106351|540874794|FG001|Treatment Cycle 1|Adverse Event|0|||
149929094|NCT02106351|540874795|FG002|Treatment Cycle 1|Adverse Event|0|||
149929095|NCT02106351|540874793|FG000|Treatment Cycle 1|Consent withdrawn|1|||
149929096|NCT02106351|540874794|FG001|Treatment Cycle 1|Consent withdrawn|0|||
149929097|NCT02106351|540874795|FG002|Treatment Cycle 1|Consent withdrawn|2|||
149929098|NCT02106351|540874793|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
149929099|NCT02106351|540874794|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
149929100|NCT02106351|540874795|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
149929101|NCT02106351|540874793|FG000|Treatment Cycle 1|Other|0|||
149929102|NCT02106351|540874794|FG001|Treatment Cycle 1|Other|3|||
149929103|NCT02106351|540874795|FG002|Treatment Cycle 1|Other|1|||
149929104|NCT02106351|540874793|FG000|Treatment Cycle 1|Randomised but not treated|1|||
149929105|NCT02106351|540874794|FG001|Treatment Cycle 1|Randomised but not treated|0|||
149929106|NCT02106351|540874795|FG002|Treatment Cycle 1|Randomised but not treated|1|||
149929107|NCT02106351|540874793|FG000|Treatment Cycle 2|Adverse Event|0|||
149929108|NCT02106351|540874794|FG001|Treatment Cycle 2|Adverse Event|2|||
149929109|NCT02106351|540874795|FG002|Treatment Cycle 2|Adverse Event|0|||
149929110|NCT02106351|540874793|FG000|Treatment Cycle 2|Consent withdrawn|0|||
149929111|NCT02106351|540874794|FG001|Treatment Cycle 2|Consent withdrawn|1|||
149929112|NCT02106351|540874795|FG002|Treatment Cycle 2|Consent withdrawn|1|||
149929113|NCT02106351|540874793|FG000|Treatment Cycle 2|Other|0|||
149929114|NCT02106351|540874794|FG001|Treatment Cycle 2|Other|2|||
149929115|NCT02106351|540874795|FG002|Treatment Cycle 2|Other|2|||
149929116|NCT02106351|540874793|FG000|Treatment Cycle 3|Adverse Event|0|||
149929117|NCT02106351|540874794|FG001|Treatment Cycle 3|Adverse Event|1|||
149929118|NCT02106351|540874795|FG002|Treatment Cycle 3|Adverse Event|0|||
149929119|NCT02106351|540874793|FG000|Treatment Cycle 3|Consent withdrawn|0|||
149929120|NCT02106351|540874794|FG001|Treatment Cycle 3|Consent withdrawn|0|||
149929121|NCT02106351|540874795|FG002|Treatment Cycle 3|Consent withdrawn|2|||
149929122|NCT02106351|540874793|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
149929123|NCT02106351|540874794|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
149929124|NCT02106351|540874795|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
149929125|NCT02106351|540874793|FG000|Treatment Cycle 3|Other|0|||
149929126|NCT02106351|540874794|FG001|Treatment Cycle 3|Other|2|||
149929127|NCT02106351|540874795|FG002|Treatment Cycle 3|Other|3|||
150165155|NCT00946192|541740007|FG002|Overall Study|Lost to Follow-up|9|||
150165156|NCT00946192|541740005|FG000|Overall Study|Withdrawal by Subject|10|||
150165157|NCT00946192|541740006|FG001|Overall Study|Withdrawal by Subject|7|||
150165158|NCT00946192|541740007|FG002|Overall Study|Withdrawal by Subject|3|||
150165159|NCT00946192|541740005|FG000|Overall Study|Did not start medication|2|||
150165160|NCT00946192|541740006|FG001|Overall Study|Did not start medication|0|||
150165161|NCT00946192|541740007|FG002|Overall Study|Did not start medication|0|||
150165162|NCT02014558|541740008|FG000|Overall Study|Never Received Study Drug|0|||
150165163|NCT02014558|541740009|FG001|Overall Study|Never Received Study Drug|0|||
150165164|NCT02014558|541740010|FG002|Overall Study|Never Received Study Drug|0|||
150165165|NCT02014558|541740011|FG003|Overall Study|Never Received Study Drug|0|||
149929128|NCT02106351|540874793|FG000|Treatment Cycle 4|Consent withdrawn|0|||
149929129|NCT02106351|540874794|FG001|Treatment Cycle 4|Consent withdrawn|0|||
149929130|NCT02106351|540874795|FG002|Treatment Cycle 4|Consent withdrawn|2|||
149929131|NCT02106351|540874793|FG000|Treatment Cycle 4|Other|0|||
149929132|NCT02106351|540874794|FG001|Treatment Cycle 4|Other|1|||
149929133|NCT02106351|540874795|FG002|Treatment Cycle 4|Other|0|||
149929134|NCT00069823|540874800|FG000|Overall Study|Did not have follow-up diary cards|6|||
149929135|NCT00069823|540874801|FG001|Overall Study|Did not have follow-up diary cards|3|||
149929136|NCT03560869|540874804|FG000|Overall Study|Withdrawal by Subject|3|||
149929137|NCT03560869|540874805|FG001|Overall Study|Withdrawal by Subject|4|||
149929138|NCT03560869|540874804|FG000|Overall Study|Screening failure|4|||
149929139|NCT03560869|540874805|FG001|Overall Study|Screening failure|4|||
149929140|NCT03560869|540874804|FG000|Overall Study|Withdrawal by PI|0|||
149929141|NCT03560869|540874805|FG001|Overall Study|Withdrawal by PI|1|||
149929142|NCT01801111|540874806|FG000|Overall Study|Adverse Event|12|||
149929143|NCT01801111|540874806|FG000|Overall Study|Death|8|||
149929144|NCT01801111|540874806|FG000|Overall Study|Physician Decision|5|||
149929145|NCT01801111|540874806|FG000|Overall Study|Other|1|||
149929146|NCT01801111|540874806|FG000|Overall Study|Withdrawal by Subject|4|||
149929147|NCT01801111|540874806|FG000|Overall Study|Study Terminated by Sponsor|27|||
149929148|NCT01801111|540874806|FG000|Overall Study|Progressive Disease|81|||
150265743|NCT04677179|542108643|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265744|NCT04677179|542108644|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
150265745|NCT04677179|542108645|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
150265746|NCT04677179|542108646|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
150265747|NCT04677179|542108647|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265748|NCT04677179|542108648|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265749|NCT04677179|542108649|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265750|NCT04677179|542108650|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
150265751|NCT04677179|542108641|FG000|Extension Treatment Period|Lack of Efficacy|0|||
150265752|NCT04677179|542108642|FG001|Extension Treatment Period|Lack of Efficacy|0|||
150265753|NCT04677179|542108643|FG002|Extension Treatment Period|Lack of Efficacy|0|||
150265754|NCT04677179|542108644|FG003|Extension Treatment Period|Lack of Efficacy|0|||
150265755|NCT04677179|542108645|FG004|Extension Treatment Period|Lack of Efficacy|0|||
150265756|NCT04677179|542108646|FG005|Extension Treatment Period|Lack of Efficacy|0|||
150265757|NCT04677179|542108647|FG006|Extension Treatment Period|Lack of Efficacy|6|||
150265758|NCT04677179|542108648|FG007|Extension Treatment Period|Lack of Efficacy|0|||
150265759|NCT04677179|542108649|FG008|Extension Treatment Period|Lack of Efficacy|0|||
150265760|NCT04677179|542108650|FG009|Extension Treatment Period|Lack of Efficacy|0|||
150265761|NCT04677179|542108641|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
150265762|NCT04677179|542108642|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
150265763|NCT04677179|542108643|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
150265764|NCT04677179|542108644|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
150265765|NCT04677179|542108645|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
150265766|NCT04677179|542108646|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
150265767|NCT04677179|542108647|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
150265768|NCT04677179|542108648|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
150265769|NCT04677179|542108649|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
150265770|NCT04677179|542108650|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
150265771|NCT04677179|542108641|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
149929149|NCT01210482|540874807|FG000|Overall Study|Protocol Violation|1|||
149929150|NCT01210482|540874807|FG000|Overall Study|Case Report Forms were not collected|18|||
149929151|NCT01210482|540874807|FG000|Overall Study|Duplicated|2|||
149929152|NCT01210482|540874807|FG000|Overall Study|No Drug Administration|28|||
149929153|NCT01223937|540874808|FG000|Overall Study|Withdrawal by Subject|3|||
149929154|NCT01223937|540874809|FG001|Overall Study|Withdrawal by Subject|2|||
149929155|NCT01223937|540874808|FG000|Overall Study|Lost to Follow-up|1|||
149929156|NCT01223937|540874809|FG001|Overall Study|Lost to Follow-up|4|||
149929157|NCT01223937|540874808|FG000|Overall Study|Adverse Event|1|||
149929158|NCT01223937|540874809|FG001|Overall Study|Adverse Event|4|||
149929159|NCT01223937|540874808|FG000|Overall Study|Protocol Violation|8|||
149929160|NCT01223937|540874809|FG001|Overall Study|Protocol Violation|7|||
149929161|NCT01223937|540874808|FG000|Overall Study|Other|4|||
149929162|NCT01223937|540874809|FG001|Overall Study|Other|1|||
149929163|NCT03284853|540874810|FG000|Overall Study|Adverse Event|40|||
149929164|NCT03284853|540874811|FG001|Overall Study|Adverse Event|4|||
149929165|NCT03284853|540874810|FG000|Overall Study|Withdrawal by Subject|5|||
149929166|NCT03284853|540874811|FG001|Overall Study|Withdrawal by Subject|1|||
149929167|NCT03284853|540874810|FG000|Overall Study|Lost to Follow-up|1|||
149929168|NCT03284853|540874811|FG001|Overall Study|Lost to Follow-up|0|||
149929169|NCT03284853|540874810|FG000|Overall Study|Lack of Efficacy|1|||
149929170|NCT03284853|540874811|FG001|Overall Study|Lack of Efficacy|0|||
149929171|NCT03284853|540874810|FG000|Overall Study|Disallowed Concurrent Medication|1|||
149929172|NCT03284853|540874811|FG001|Overall Study|Disallowed Concurrent Medication|1|||
149929173|NCT03284853|540874810|FG000|Overall Study|Protocol Violation|3|||
149929174|NCT03284853|540874811|FG001|Overall Study|Protocol Violation|3|||
149929175|NCT03284853|540874810|FG000|Overall Study|Death|0|||
149929176|NCT03284853|540874811|FG001|Overall Study|Death|1|||
149929177|NCT03284853|540874810|FG000|Overall Study|Other - Reason not reported in CSR|4|||
149929178|NCT03284853|540874811|FG001|Overall Study|Other - Reason not reported in CSR|3|||
149929179|NCT05176717|540874812|FG000|Overall Study|Sponsor Decision|1|||
149929180|NCT05176717|540874813|FG001|Overall Study|Sponsor Decision|2|||
149929181|NCT05176717|540874814|FG002|Overall Study|Sponsor Decision|2|||
149929182|NCT00765817|540874815|FG000|Overall Study|Adverse Event|13|||
149929183|NCT00765817|540874816|FG001|Overall Study|Adverse Event|1|||
149929184|NCT00765817|540874815|FG000|Overall Study|Death|0|||
149929185|NCT00765817|540874816|FG001|Overall Study|Death|1|||
149929186|NCT00765817|540874815|FG000|Overall Study|Entry criteria not met|2|||
149929187|NCT00765817|540874816|FG001|Overall Study|Entry criteria not met|2|||
149929188|NCT00765817|540874815|FG000|Overall Study|Loss of glucose control|0|||
149929189|NCT00765817|540874816|FG001|Overall Study|Loss of glucose control|2|||
149929190|NCT00765817|540874815|FG000|Overall Study|Lost to Follow-up|1|||
149929191|NCT00765817|540874816|FG001|Overall Study|Lost to Follow-up|3|||
149929192|NCT00765817|540874815|FG000|Overall Study|Physician Decision|2|||
149929193|NCT00765817|540874816|FG001|Overall Study|Physician Decision|1|||
149929194|NCT00765817|540874815|FG000|Overall Study|Protocol Violation|1|||
149929195|NCT00765817|540874816|FG001|Overall Study|Protocol Violation|1|||
149929196|NCT00765817|540874815|FG000|Overall Study|Subject decision|7|||
149929197|NCT00765817|540874816|FG001|Overall Study|Subject decision|11|||
149929198|NCT02308228|540874818|FG000|Overall Study|Adverse Event|3|||
149929199|NCT02308228|540874819|FG001|Overall Study|Adverse Event|4|||
149929200|NCT02308228|540874818|FG000|Overall Study|Withdrawal by Subject|5|||
149929201|NCT02308228|540874819|FG001|Overall Study|Withdrawal by Subject|3|||
149929202|NCT03999749|540874822|FG000|Overall Study|Toxicity|16|||
149929203|NCT03999749|540874822|FG000|Overall Study|Withdrawal by Subject|3|||
149929204|NCT03999749|540874822|FG000|Overall Study|Disease progression|26|||
149929205|NCT03999749|540874822|FG000|Overall Study|Physician Decision|4|||
149929206|NCT03999749|540874822|FG000|Overall Study|Death|5|||
149929207|NCT03999749|540874822|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
149929208|NCT00255164|540874823|FG000|Overall Study|Adverse Event|10|||
149929209|NCT00255164|540874824|FG001|Overall Study|Adverse Event|6|||
149929210|NCT00255164|540874825|FG002|Overall Study|Adverse Event|9|||
149929211|NCT00255164|540874823|FG000|Overall Study|Lost to Follow-up|4|||
149929212|NCT00255164|540874824|FG001|Overall Study|Lost to Follow-up|3|||
149929213|NCT00255164|540874825|FG002|Overall Study|Lost to Follow-up|4|||
149929214|NCT00255164|540874823|FG000|Overall Study|Withdrawal by Subject|18|||
149929215|NCT00255164|540874824|FG001|Overall Study|Withdrawal by Subject|17|||
149929216|NCT00255164|540874825|FG002|Overall Study|Withdrawal by Subject|8|||
149929217|NCT00255164|540874823|FG000|Overall Study|Noncompliance|0|||
149929218|NCT00255164|540874824|FG001|Overall Study|Noncompliance|1|||
149929219|NCT00255164|540874825|FG002|Overall Study|Noncompliance|2|||
149929220|NCT00255164|540874823|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
149929221|NCT00255164|540874824|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
149929222|NCT00255164|540874825|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
149929223|NCT00255164|540874823|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
149929224|NCT00255164|540874824|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
149929225|NCT00255164|540874825|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
149929226|NCT00255164|540874823|FG000|Overall Study|Possible Barrett's Esophagus|1|||
149929227|NCT00255164|540874824|FG001|Overall Study|Possible Barrett's Esophagus|3|||
149929228|NCT00255164|540874825|FG002|Overall Study|Possible Barrett's Esophagus|8|||
150165166|NCT02014558|541740012|FG004|Overall Study|Never Received Study Drug|1|||
150165167|NCT02014558|541740013|FG005|Overall Study|Never Received Study Drug|0|||
150165168|NCT02014558|541740014|FG006|Overall Study|Never Received Study Drug|1|||
150165169|NCT02014558|541740015|FG007|Overall Study|Never Received Study Drug|0|||
150165170|NCT02014558|541740016|FG008|Overall Study|Never Received Study Drug|2|||
150165171|NCT02014558|541740017|FG009|Overall Study|Never Received Study Drug|0|||
150165172|NCT02014558|541740018|FG010|Overall Study|Never Received Study Drug|2|||
150165173|NCT02014558|541740019|FG011|Overall Study|Never Received Study Drug|2|||
150165174|NCT02014558|541740020|FG012|Overall Study|Never Received Study Drug|0|||
150165175|NCT02014558|541740008|FG000|Overall Study|Adverse Event|0|||
150165176|NCT02014558|541740009|FG001|Overall Study|Adverse Event|0|||
150165177|NCT02014558|541740010|FG002|Overall Study|Adverse Event|0|||
150165178|NCT02014558|541740011|FG003|Overall Study|Adverse Event|0|||
150165179|NCT02014558|541740012|FG004|Overall Study|Adverse Event|1|||
150165180|NCT02014558|541740013|FG005|Overall Study|Adverse Event|0|||
150165181|NCT02014558|541740014|FG006|Overall Study|Adverse Event|0|||
150165182|NCT02014558|541740015|FG007|Overall Study|Adverse Event|0|||
150165183|NCT02014558|541740016|FG008|Overall Study|Adverse Event|2|||
150165184|NCT02014558|541740017|FG009|Overall Study|Adverse Event|2|||
150165185|NCT02014558|541740018|FG010|Overall Study|Adverse Event|5|||
150165186|NCT02014558|541740019|FG011|Overall Study|Adverse Event|21|||
150165187|NCT02014558|541740020|FG012|Overall Study|Adverse Event|3|||
150165188|NCT02014558|541740008|FG000|Overall Study|Death|1|||
150165189|NCT02014558|541740009|FG001|Overall Study|Death|0|||
150165190|NCT02014558|541740010|FG002|Overall Study|Death|0|||
150165191|NCT02014558|541740011|FG003|Overall Study|Death|0|||
150165192|NCT02014558|541740012|FG004|Overall Study|Death|0|||
150165193|NCT02014558|541740013|FG005|Overall Study|Death|0|||
150165194|NCT02014558|541740014|FG006|Overall Study|Death|1|||
149929229|NCT00255164|540874823|FG000|Overall Study|Esophageal Stricture|0|||
149929230|NCT00255164|540874824|FG001|Overall Study|Esophageal Stricture|0|||
149929231|NCT00255164|540874825|FG002|Overall Study|Esophageal Stricture|1|||
149929232|NCT00255164|540874823|FG000|Overall Study|Therapeutic Failure|11|||
149929233|NCT00255164|540874824|FG001|Overall Study|Therapeutic Failure|2|||
149929234|NCT00255164|540874825|FG002|Overall Study|Therapeutic Failure|3|||
150165195|NCT02014558|541740015|FG007|Overall Study|Death|1|||
150165196|NCT02014558|541740016|FG008|Overall Study|Death|2|||
150165197|NCT02014558|541740017|FG009|Overall Study|Death|5|||
150165198|NCT02014558|541740018|FG010|Overall Study|Death|5|||
150165199|NCT02014558|541740019|FG011|Overall Study|Death|19|||
150165200|NCT02014558|541740020|FG012|Overall Study|Death|2|||
150165201|NCT02014558|541740008|FG000|Overall Study|Lack of Efficacy|1|||
150165202|NCT02014558|541740009|FG001|Overall Study|Lack of Efficacy|2|||
150165203|NCT02014558|541740010|FG002|Overall Study|Lack of Efficacy|1|||
150165204|NCT02014558|541740011|FG003|Overall Study|Lack of Efficacy|1|||
150165205|NCT02014558|541740012|FG004|Overall Study|Lack of Efficacy|0|||
150165206|NCT02014558|541740013|FG005|Overall Study|Lack of Efficacy|0|||
150165207|NCT02014558|541740014|FG006|Overall Study|Lack of Efficacy|1|||
150165208|NCT02014558|541740015|FG007|Overall Study|Lack of Efficacy|3|||
150165209|NCT02014558|541740016|FG008|Overall Study|Lack of Efficacy|3|||
150165210|NCT02014558|541740017|FG009|Overall Study|Lack of Efficacy|3|||
150165211|NCT02014558|541740018|FG010|Overall Study|Lack of Efficacy|16|||
150165212|NCT02014558|541740019|FG011|Overall Study|Lack of Efficacy|8|||
150165213|NCT02014558|541740020|FG012|Overall Study|Lack of Efficacy|5|||
150165214|NCT02014558|541740008|FG000|Overall Study|Lost to Follow-up|0|||
150165215|NCT02014558|541740009|FG001|Overall Study|Lost to Follow-up|0|||
150165216|NCT02014558|541740010|FG002|Overall Study|Lost to Follow-up|0|||
150165217|NCT02014558|541740011|FG003|Overall Study|Lost to Follow-up|0|||
150165218|NCT02014558|541740012|FG004|Overall Study|Lost to Follow-up|0|||
150165219|NCT02014558|541740013|FG005|Overall Study|Lost to Follow-up|0|||
150165220|NCT02014558|541740014|FG006|Overall Study|Lost to Follow-up|0|||
150165221|NCT02014558|541740015|FG007|Overall Study|Lost to Follow-up|0|||
150165222|NCT02014558|541740016|FG008|Overall Study|Lost to Follow-up|0|||
150165223|NCT02014558|541740017|FG009|Overall Study|Lost to Follow-up|0|||
150165224|NCT02014558|541740018|FG010|Overall Study|Lost to Follow-up|1|||
150165225|NCT02014558|541740019|FG011|Overall Study|Lost to Follow-up|0|||
150165226|NCT02014558|541740020|FG012|Overall Study|Lost to Follow-up|0|||
150165227|NCT02014558|541740008|FG000|Overall Study|Progressive Disease|1|||
150165228|NCT02014558|541740009|FG001|Overall Study|Progressive Disease|0|||
150165229|NCT02014558|541740010|FG002|Overall Study|Progressive Disease|1|||
150165230|NCT02014558|541740011|FG003|Overall Study|Progressive Disease|1|||
150165231|NCT02014558|541740012|FG004|Overall Study|Progressive Disease|1|||
150165232|NCT02014558|541740013|FG005|Overall Study|Progressive Disease|2|||
150165233|NCT02014558|541740014|FG006|Overall Study|Progressive Disease|1|||
150165234|NCT02014558|541740015|FG007|Overall Study|Progressive Disease|6|||
150165235|NCT02014558|541740016|FG008|Overall Study|Progressive Disease|5|||
150165236|NCT02014558|541740017|FG009|Overall Study|Progressive Disease|6|||
150165237|NCT02014558|541740018|FG010|Overall Study|Progressive Disease|22|||
150165238|NCT02014558|541740019|FG011|Overall Study|Progressive Disease|31|||
150165239|NCT02014558|541740020|FG012|Overall Study|Progressive Disease|6|||
150165240|NCT02014558|541740008|FG000|Overall Study|Withdrawal by Subject|0|||
150165241|NCT02014558|541740009|FG001|Overall Study|Withdrawal by Subject|0|||
150165242|NCT02014558|541740010|FG002|Overall Study|Withdrawal by Subject|0|||
150165243|NCT02014558|541740011|FG003|Overall Study|Withdrawal by Subject|0|||
150165244|NCT02014558|541740012|FG004|Overall Study|Withdrawal by Subject|1|||
150165245|NCT02014558|541740013|FG005|Overall Study|Withdrawal by Subject|0|||
150165246|NCT02014558|541740014|FG006|Overall Study|Withdrawal by Subject|0|||
150165247|NCT02014558|541740015|FG007|Overall Study|Withdrawal by Subject|0|||
150165248|NCT02014558|541740016|FG008|Overall Study|Withdrawal by Subject|0|||
150165249|NCT02014558|541740017|FG009|Overall Study|Withdrawal by Subject|2|||
150165250|NCT02014558|541740018|FG010|Overall Study|Withdrawal by Subject|6|||
150165251|NCT02014558|541740019|FG011|Overall Study|Withdrawal by Subject|10|||
150165252|NCT02014558|541740020|FG012|Overall Study|Withdrawal by Subject|0|||
150165253|NCT02014558|541740008|FG000|Overall Study|Miscellaneous|2|||
150165254|NCT02014558|541740009|FG001|Overall Study|Miscellaneous|1|||
150165255|NCT02014558|541740010|FG002|Overall Study|Miscellaneous|1|||
150165256|NCT02014558|541740011|FG003|Overall Study|Miscellaneous|1|||
150165257|NCT02014558|541740012|FG004|Overall Study|Miscellaneous|0|||
150165258|NCT02014558|541740013|FG005|Overall Study|Miscellaneous|1|||
150165259|NCT02014558|541740014|FG006|Overall Study|Miscellaneous|0|||
150165260|NCT02014558|541740015|FG007|Overall Study|Miscellaneous|1|||
150165261|NCT02014558|541740016|FG008|Overall Study|Miscellaneous|1|||
150165262|NCT02014558|541740017|FG009|Overall Study|Miscellaneous|3|||
150165263|NCT02014558|541740018|FG010|Overall Study|Miscellaneous|12|||
150165264|NCT02014558|541740019|FG011|Overall Study|Miscellaneous|11|||
150165265|NCT02014558|541740020|FG012|Overall Study|Miscellaneous|1|||
150165266|NCT05460663|541740025|FG000|Overall Study|Withdrawal by Subject|2|||
150165267|NCT05460663|541740026|FG001|Overall Study|Withdrawal by Subject|5|||
150165268|NCT00681811|541740027|FG000|Overall Study|Adverse Event|1|||
150165269|NCT00681811|541740028|FG001|Overall Study|Adverse Event|1|||
150165270|NCT00681811|541740027|FG000|Overall Study|Withdrawal by Subject|2|||
150165271|NCT00681811|541740028|FG001|Overall Study|Withdrawal by Subject|2|||
150165272|NCT00681811|541740027|FG000|Overall Study|Non-compliance|0|||
150165273|NCT00681811|541740028|FG001|Overall Study|Non-compliance|1|||
150165274|NCT02068885|541740029|FG000|Overall Study|Withdrew|3|||
150165275|NCT02068885|541740030|FG001|Overall Study|Withdrew|5|||
150165276|NCT02068885|541740031|FG002|Overall Study|Withdrew|8|||
150165277|NCT00828919|541740032|FG000|Overall Study|Death|0|||
150165278|NCT00828919|541740033|FG001|Overall Study|Death|1|||
150165279|NCT00828919|541740034|FG002|Overall Study|Death|2|||
149929235|NCT03677869|540874826|FG000|Overall Study|Withdrawal by Subject|1|||
149929236|NCT01845597|540876271|FG000|Overall Study|Death|8|||
149929237|NCT01845597|540876271|FG000|Overall Study|Lost to Follow-up|22|||
149929238|NCT03506438|540876273|FG000|Overall Study|Lost to Follow-up|8|||
149929239|NCT03506438|540876274|FG001|Overall Study|Lost to Follow-up|7|||
149929240|NCT03506438|540876275|FG002|Overall Study|Lost to Follow-up|8|||
149929241|NCT03506438|540876276|FG003|Overall Study|Lost to Follow-up|7|||
149929242|NCT03506438|540876277|FG004|Overall Study|Lost to Follow-up|0|||
149929243|NCT03506438|540876278|FG005|Overall Study|Lost to Follow-up|0|||
149929244|NCT01128296|540876279|FG000|Overall Study|Physician Decision|0|||
149929245|NCT01128296|540876280|FG001|Overall Study|Physician Decision|0|||
149929246|NCT01128296|540876281|FG002|Overall Study|Physician Decision|0|||
149929247|NCT01128296|540876282|FG003|Overall Study|Physician Decision|0|||
149929248|NCT01128296|540876283|FG004|Overall Study|Physician Decision|0|||
149929249|NCT01128296|540876284|FG005|Overall Study|Physician Decision|3|||
149929250|NCT01128296|540876279|FG000|Overall Study|Withdrawal by Subject|0|||
149929251|NCT01128296|540876280|FG001|Overall Study|Withdrawal by Subject|0|||
149929252|NCT01128296|540876281|FG002|Overall Study|Withdrawal by Subject|0|||
149929253|NCT01128296|540876282|FG003|Overall Study|Withdrawal by Subject|0|||
149929254|NCT01128296|540876283|FG004|Overall Study|Withdrawal by Subject|0|||
149929255|NCT01128296|540876284|FG005|Overall Study|Withdrawal by Subject|2|||
149929256|NCT01914393|540876285|FG000|Overall Study|Protocol Violation|11|||
149929257|NCT01914393|540876286|FG001|Overall Study|Protocol Violation|3|||
149929258|NCT01914393|540876287|FG002|Overall Study|Protocol Violation|19|||
149929259|NCT01914393|540876285|FG000|Overall Study|Lack of Efficacy|11|||
149929260|NCT01914393|540876286|FG001|Overall Study|Lack of Efficacy|16|||
149929261|NCT01914393|540876287|FG002|Overall Study|Lack of Efficacy|5|||
149929262|NCT01914393|540876285|FG000|Overall Study|no reason given|14|||
149929263|NCT01914393|540876286|FG001|Overall Study|no reason given|8|||
149929264|NCT01914393|540876287|FG002|Overall Study|no reason given|16|||
149929265|NCT01914393|540876285|FG000|Overall Study|Adverse Event|29|||
149929266|NCT01914393|540876286|FG001|Overall Study|Adverse Event|18|||
149929267|NCT01914393|540876287|FG002|Overall Study|Adverse Event|31|||
149929268|NCT01914393|540876285|FG000|Overall Study|Withdrawal by Subject|38|||
149929269|NCT01914393|540876286|FG001|Overall Study|Withdrawal by Subject|20|||
149929270|NCT01914393|540876287|FG002|Overall Study|Withdrawal by Subject|47|||
149929271|NCT01914393|540876285|FG000|Overall Study|Lost to Follow-up|12|||
149929272|NCT01914393|540876286|FG001|Overall Study|Lost to Follow-up|6|||
149929273|NCT01914393|540876287|FG002|Overall Study|Lost to Follow-up|19|||
149929274|NCT01914393|540876285|FG000|Overall Study|subject never dosed|0|||
149929275|NCT01914393|540876286|FG001|Overall Study|subject never dosed|0|||
149929276|NCT01914393|540876287|FG002|Overall Study|subject never dosed|1|||
149929277|NCT02806713|540876288|FG000|Overall Study|Urethral injury during procedure|1|||
149929278|NCT02806713|540876289|FG001|Overall Study|Urethral injury during procedure|0|||
149929279|NCT02806713|540876288|FG000|Overall Study|cancelled surgery|1|||
149929280|NCT02806713|540876289|FG001|Overall Study|cancelled surgery|2|||
149929281|NCT02824224|540876290|FG000|Overall Study|Discontinued, IUS expulsion|0|||
149929282|NCT02824224|540876291|FG001|Overall Study|Discontinued, IUS expulsion|1|||
149929283|NCT02824224|540876290|FG000|Overall Study|Did not show up for allocation visit|2|||
149929284|NCT02824224|540876291|FG001|Overall Study|Did not show up for allocation visit|0|||
149929285|NCT00368108|540876294|FG000|Overall Study|Adverse Event|38|||
149929286|NCT00368108|540876295|FG001|Overall Study|Adverse Event|26|||
149929287|NCT00368108|540876296|FG002|Overall Study|Adverse Event|44|||
149929288|NCT00368108|540876294|FG000|Overall Study|Abnormal Laboratory Value|0|||
149929289|NCT00368108|540876295|FG001|Overall Study|Abnormal Laboratory Value|0|||
149929290|NCT00368108|540876296|FG002|Overall Study|Abnormal Laboratory Value|3|||
150265772|NCT04677179|542108642|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
150265773|NCT04677179|542108643|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
150265774|NCT04677179|542108644|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
150265775|NCT04677179|542108645|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
149929291|NCT00368108|540876294|FG000|Overall Study|Protocol Violation|5|||
149929292|NCT00368108|540876295|FG001|Overall Study|Protocol Violation|9|||
149929293|NCT00368108|540876296|FG002|Overall Study|Protocol Violation|9|||
149929294|NCT00368108|540876294|FG000|Overall Study|Withdrawal by Subject|9|||
149929295|NCT00368108|540876295|FG001|Overall Study|Withdrawal by Subject|3|||
149929296|NCT00368108|540876296|FG002|Overall Study|Withdrawal by Subject|5|||
149929297|NCT00368108|540876294|FG000|Overall Study|Lack of Efficacy|7|||
149929298|NCT00368108|540876295|FG001|Overall Study|Lack of Efficacy|8|||
149929299|NCT00368108|540876296|FG002|Overall Study|Lack of Efficacy|5|||
149929300|NCT00368108|540876294|FG000|Overall Study|Physician Decision|2|||
149929301|NCT00368108|540876295|FG001|Overall Study|Physician Decision|0|||
149929302|NCT00368108|540876296|FG002|Overall Study|Physician Decision|1|||
149929303|NCT00368108|540876294|FG000|Overall Study|Other|3|||
149929304|NCT00368108|540876295|FG001|Overall Study|Other|7|||
149929305|NCT00368108|540876296|FG002|Overall Study|Other|1|||
149929306|NCT02299388|540876299|FG000|Overall Study|Withdrawal by Subject|0|||
149929307|NCT02299388|540876300|FG001|Overall Study|Withdrawal by Subject|1|||
149929308|NCT03334188|540876303|FG000|Overall Study|Withdrawal by Subject|0|||
149929309|NCT03334188|540876304|FG001|Overall Study|Withdrawal by Subject|1|||
149929310|NCT03334188|540876303|FG000|Overall Study|Death|1|||
149929311|NCT03334188|540876304|FG001|Overall Study|Death|0|||
149929312|NCT03334188|540876303|FG000|Overall Study|Never had qualifying clinic visit|7|||
149929313|NCT03334188|540876304|FG001|Overall Study|Never had qualifying clinic visit|7|||
149929314|NCT00003537|540876307|FG000|Overall Study|Not evalauable|1|||
149929315|NCT03442088|540876312|FG000|Overall Study|Adverse Event|1|||
149929316|NCT03442088|540876312|FG000|Overall Study|Lack of Efficacy|2|||
149929317|NCT03442088|540876312|FG000|Overall Study|Lost to Follow-up|2|||
149929318|NCT01001520|540876313|FG000|Medication Period 1|Withdrawal by Subject|2|||
149929319|NCT01001520|540876314|FG001|Medication Period 1|Withdrawal by Subject|2|||
149929320|NCT01001520|540876313|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
149929321|NCT01001520|540876314|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
149929322|NCT01001520|540876313|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
149929323|NCT01001520|540876314|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
149929324|NCT01001520|540876313|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
149929325|NCT01001520|540876314|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
149929326|NCT01001520|540876313|FG000|Washout Period|Withdrawal by Subject|2|||
149929327|NCT01001520|540876314|FG001|Washout Period|Withdrawal by Subject|1|||
149929328|NCT01001520|540876313|FG000|Medication Period 2|Withdrawal by Subject|0|||
149929329|NCT01001520|540876314|FG001|Medication Period 2|Withdrawal by Subject|3|||
149929330|NCT00357877|540876315|FG000|Overall Study|Death|2|||
149929331|NCT00357877|540876316|FG001|Overall Study|Death|1|||
149929332|NCT00357877|540876315|FG000|Overall Study|Lost to Follow-up|20|||
149929333|NCT00357877|540876316|FG001|Overall Study|Lost to Follow-up|23|||
149929334|NCT00357877|540876315|FG000|Overall Study|Withdrawal by Subject|3|||
149929335|NCT00357877|540876316|FG001|Overall Study|Withdrawal by Subject|3|||
149929336|NCT00357877|540876315|FG000|Overall Study|Administrative withdrawal|1|||
149929337|NCT00357877|540876316|FG001|Overall Study|Administrative withdrawal|1|||
149929338|NCT00357877|540876315|FG000|Overall Study|Other|0|||
149929339|NCT00357877|540876316|FG001|Overall Study|Other|2|||
149929340|NCT01051557|540876319|FG000|Overall Study|Physician Decision|1|||
149929341|NCT01051557|540876320|FG001|Overall Study|Physician Decision|0|||
149929342|NCT01051557|540876321|FG002|Overall Study|Physician Decision|0|||
149929343|NCT01051557|540876322|FG003|Overall Study|Physician Decision|0|||
149929344|NCT01051557|540876323|FG004|Overall Study|Physician Decision|0|||
149929345|NCT01051557|540876324|FG005|Overall Study|Physician Decision|0|||
149929346|NCT01051557|540876325|FG006|Overall Study|Physician Decision|0|||
149929347|NCT01051557|540876319|FG000|Overall Study|disease progression|3|||
149929348|NCT01051557|540876320|FG001|Overall Study|disease progression|3|||
149929349|NCT01051557|540876321|FG002|Overall Study|disease progression|5|||
149929350|NCT01051557|540876322|FG003|Overall Study|disease progression|2|||
149929351|NCT01051557|540876323|FG004|Overall Study|disease progression|4|||
149929352|NCT01051557|540876324|FG005|Overall Study|disease progression|3|||
149929353|NCT01051557|540876325|FG006|Overall Study|disease progression|1|||
149929354|NCT01051557|540876319|FG000|Overall Study|Withdrawal by Subject|0|||
149929355|NCT01051557|540876320|FG001|Overall Study|Withdrawal by Subject|0|||
149929356|NCT01051557|540876321|FG002|Overall Study|Withdrawal by Subject|1|||
149929357|NCT01051557|540876322|FG003|Overall Study|Withdrawal by Subject|0|||
149929358|NCT01051557|540876323|FG004|Overall Study|Withdrawal by Subject|2|||
149929359|NCT01051557|540876324|FG005|Overall Study|Withdrawal by Subject|0|||
149929360|NCT01051557|540876325|FG006|Overall Study|Withdrawal by Subject|1|||
149929361|NCT01051557|540876319|FG000|Overall Study|Adverse Event|0|||
149929362|NCT01051557|540876320|FG001|Overall Study|Adverse Event|0|||
149929363|NCT01051557|540876321|FG002|Overall Study|Adverse Event|0|||
149929364|NCT01051557|540876322|FG003|Overall Study|Adverse Event|1|||
149929365|NCT01051557|540876323|FG004|Overall Study|Adverse Event|1|||
149929366|NCT01051557|540876324|FG005|Overall Study|Adverse Event|3|||
150165280|NCT00828919|541740035|FG003|Overall Study|Death|0|||
150165281|NCT00828919|541740036|FG004|Overall Study|Death|0|||
150165282|NCT00828919|541740032|FG000|Overall Study|Adverse Event|2|||
149929367|NCT01051557|540876325|FG006|Overall Study|Adverse Event|4|||
149929368|NCT04668209|540876326|FG000|Overall Study|Withdrawal by Subject|2|||
149929369|NCT04668209|540876327|FG001|Overall Study|Withdrawal by Subject|2|||
149929370|NCT04668209|540876326|FG000|Overall Study|Lost to Follow-up|3|||
149929371|NCT04668209|540876327|FG001|Overall Study|Lost to Follow-up|4|||
149929372|NCT04668209|540876326|FG000|Overall Study|Subject Expired|2|||
150165283|NCT00828919|541740033|FG001|Overall Study|Adverse Event|2|||
149929373|NCT04668209|540876327|FG001|Overall Study|Subject Expired|0|||
149929374|NCT04668209|540876326|FG000|Overall Study|Withdrawn from study|0|||
149929375|NCT04668209|540876327|FG001|Overall Study|Withdrawn from study|1|||
149929376|NCT04668209|540876326|FG000|Overall Study|Adverse Event|0|||
149929377|NCT04668209|540876327|FG001|Overall Study|Adverse Event|1|||
149929378|NCT00130689|540876338|FG000|Overall Study|Progressive Disease|29|||
149929379|NCT00130689|540876338|FG000|Overall Study|Death|1|||
149929380|NCT00130689|540876338|FG000|Overall Study|Clinical Deterioration|4|||
149929381|NCT00130689|540876338|FG000|Overall Study|Withdrawal by Subject|3|||
149929382|NCT00130689|540876338|FG000|Overall Study|Ineligible|6|||
149929383|NCT00268983|540876339|FG000|Overall Study|Death|3|||
149929384|NCT00268983|540876340|FG001|Overall Study|Death|0|||
149929385|NCT01348139|540876341|FG000|Period 1|Adverse Event|1|||
149929386|NCT01348139|540876342|FG001|Period 1|Adverse Event|0|||
149929387|NCT01348139|540876343|FG002|Period 1|Adverse Event|0|||
149929388|NCT01348139|540876344|FG003|Period 1|Adverse Event|0|||
149929389|NCT01348139|540876345|FG004|Period 1|Adverse Event|0|||
149929390|NCT01348139|540876346|FG005|Period 1|Adverse Event|0|||
150165284|NCT00828919|541740034|FG002|Overall Study|Adverse Event|2|||
150165285|NCT00828919|541740035|FG003|Overall Study|Adverse Event|1|||
150165286|NCT00828919|541740036|FG004|Overall Study|Adverse Event|3|||
150165287|NCT00828919|541740032|FG000|Overall Study|Objective progression or relapse|4|||
150165288|NCT00828919|541740033|FG001|Overall Study|Objective progression or relapse|4|||
150165289|NCT00828919|541740034|FG002|Overall Study|Objective progression or relapse|11|||
150165290|NCT00828919|541740035|FG003|Overall Study|Objective progression or relapse|0|||
150165291|NCT00828919|541740036|FG004|Overall Study|Objective progression or relapse|5|||
150165292|NCT00828919|541740032|FG000|Overall Study|No longer willing to participate in study|0|||
150165293|NCT00828919|541740033|FG001|Overall Study|No longer willing to participate in study|0|||
150165294|NCT00828919|541740034|FG002|Overall Study|No longer willing to participate in study|2|||
150165295|NCT00828919|541740035|FG003|Overall Study|No longer willing to participate in study|0|||
150165296|NCT00828919|541740036|FG004|Overall Study|No longer willing to participate in study|0|||
150165297|NCT00828919|541740032|FG000|Overall Study|Insufficient Clinical Response|0|||
150165298|NCT00828919|541740033|FG001|Overall Study|Insufficient Clinical Response|1|||
150165299|NCT00828919|541740034|FG002|Overall Study|Insufficient Clinical Response|2|||
150165300|NCT00828919|541740035|FG003|Overall Study|Insufficient Clinical Response|0|||
150165301|NCT00828919|541740036|FG004|Overall Study|Insufficient Clinical Response|0|||
150165302|NCT00828919|541740032|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
150165303|NCT00828919|541740033|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
150165304|NCT00828919|541740034|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
150165305|NCT00828919|541740035|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
150165306|NCT00828919|541740036|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
150165307|NCT00828919|541740032|FG000|Overall Study|Other|1|||
150165308|NCT00828919|541740033|FG001|Overall Study|Other|0|||
150165309|NCT00828919|541740034|FG002|Overall Study|Other|1|||
150165310|NCT00828919|541740035|FG003|Overall Study|Other|1|||
150165311|NCT00828919|541740036|FG004|Overall Study|Other|0|||
150165312|NCT00828919|541740032|FG000|Overall Study|Lost to Follow-up|0|||
150165313|NCT00828919|541740033|FG001|Overall Study|Lost to Follow-up|1|||
150165314|NCT00828919|541740034|FG002|Overall Study|Lost to Follow-up|0|||
150165315|NCT00828919|541740035|FG003|Overall Study|Lost to Follow-up|0|||
150165316|NCT00828919|541740036|FG004|Overall Study|Lost to Follow-up|0|||
150165317|NCT01562743|541740037|FG000|Overall Study|Adverse Event|29|||
150165318|NCT01562743|541740037|FG000|Overall Study|Lack of Efficacy|3|||
150165319|NCT01562743|541740037|FG000|Overall Study|Withdrawal by Subject|13|||
150165320|NCT01562743|541740037|FG000|Overall Study|Protocol Violation|1|||
150165321|NCT01562743|541740037|FG000|Overall Study|Discontinuation criteria|2|||
150165322|NCT01562743|541740037|FG000|Overall Study|Lost to Follow-up|2|||
150165323|NCT01562743|541740037|FG000|Overall Study|Physician Decision|2|||
150165324|NCT05567159|541740038|FG000|Overall Study|Adverse Event|4|||
150165325|NCT05567159|541740038|FG000|Overall Study|Physician Decision|3|||
150165326|NCT05567159|541740038|FG000|Overall Study|Protocol deviation|1|||
150165327|NCT04159506|541740041|FG000|Overall Study|Lost to Follow-up|2|||
150165328|NCT04159506|541740042|FG001|Overall Study|Lost to Follow-up|5|||
150165329|NCT02449044|541740043|FG000|Overall Study|Lost to Follow-up|2|||
150165330|NCT02449044|541740043|FG000|Overall Study|Withdrawal by Subject|13|||
150165331|NCT02449044|541740043|FG000|Overall Study|Adverse Event|30|||
150165332|NCT02449044|541740043|FG000|Overall Study|Met Withdrawal Criteria|7|||
150165333|NCT02449044|541740043|FG000|Overall Study|Physician Decision|9|||
150165334|NCT02449044|541740043|FG000|Overall Study|Sponsor Discontinued Trial|3|||
150165335|NCT02501811|541740045|FG000|Overall Study|Death|1|||
150165336|NCT02501811|541740046|FG001|Overall Study|Death|3|||
150165337|NCT02501811|541740047|FG002|Overall Study|Death|2|||
150165338|NCT02501811|541740048|FG003|Overall Study|Death|3|||
150165339|NCT02501811|541740045|FG000|Overall Study|Withdrawal by Subject|3|||
150165340|NCT02501811|541740046|FG001|Overall Study|Withdrawal by Subject|3|||
150165341|NCT02501811|541740047|FG002|Overall Study|Withdrawal by Subject|2|||
150165342|NCT02501811|541740048|FG003|Overall Study|Withdrawal by Subject|3|||
150165343|NCT02501811|541740045|FG000|Overall Study|Lost to Follow-up|0|||
150165344|NCT02501811|541740046|FG001|Overall Study|Lost to Follow-up|0|||
149929391|NCT02762084|540876349|FG000|Overall Study|Withdrawal by Subject|1|||
149929392|NCT02762084|540876350|FG001|Overall Study|Withdrawal by Subject|0|||
150165345|NCT02501811|541740047|FG002|Overall Study|Lost to Follow-up|2|||
150165346|NCT02501811|541740048|FG003|Overall Study|Lost to Follow-up|1|||
150165347|NCT00662909|541740049|FG000|Overall Study|Adverse Event|17|||
150165348|NCT00662909|541740050|FG001|Overall Study|Adverse Event|18|||
150165349|NCT00662909|541740051|FG002|Overall Study|Adverse Event|19|||
149929393|NCT02762084|540876351|FG002|Overall Study|Withdrawal by Subject|0|||
149929394|NCT02762084|540876349|FG000|Overall Study|Adverse Event|0|||
149929395|NCT02762084|540876350|FG001|Overall Study|Adverse Event|0|||
149929396|NCT02762084|540876351|FG002|Overall Study|Adverse Event|1|||
149929397|NCT02254772|540876352|FG000|Overall Study|Ineligible|1|||
149929398|NCT02254772|540876352|FG000|Overall Study|Withdrawal by Subject|1|||
149929399|NCT00716456|540876353|FG000|Overall Study|Adverse Event|0|||
149929400|NCT00716456|540876354|FG001|Overall Study|Adverse Event|2|||
149929401|NCT00716456|540876355|FG002|Overall Study|Adverse Event|0|||
149929402|NCT00447772|540876356|FG000|Overall Study|Lack of Efficacy|3|||
149929403|NCT00447772|540876356|FG000|Overall Study|Insufficient compliance|6|||
149929404|NCT00447772|540876356|FG000|Overall Study|Discontinuation of drug therapy|1|||
149929405|NCT00447772|540876356|FG000|Overall Study|Lost to Follow-up|9|||
149929406|NCT00447772|540876356|FG000|Overall Study|Withdrawal by Subject|1|||
149929407|NCT00447772|540876356|FG000|Overall Study|Unable to attend all study visits|2|||
149929408|NCT00447772|540876356|FG000|Overall Study|Adverse Event|1|||
149929409|NCT00447772|540876356|FG000|Overall Study|Patient relocated|1|||
149929410|NCT00447772|540876356|FG000|Overall Study|Incomplete documentation at visit 1|1|||
149929411|NCT00447772|540876356|FG000|Overall Study|Chemotherapy for lung cancer|1|||
149929412|NCT00447772|540876356|FG000|Overall Study|Premature re-injection required|1|||
149929413|NCT04556760|540876357|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
149929414|NCT04556760|540876358|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
149929415|NCT04556760|540876359|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
149929416|NCT04556760|540876360|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
149929417|NCT04556760|540876361|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
149929418|NCT04556760|540876362|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
149929419|NCT04556760|540876357|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
149929420|NCT04556760|540876358|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
149929421|NCT04556760|540876359|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
149929422|NCT04556760|540876360|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
149929423|NCT04556760|540876361|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
149929424|NCT04556760|540876362|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
149929425|NCT02849743|540876366|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
149929426|NCT02849743|540876367|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
149929427|NCT02849743|540876366|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
149929428|NCT02849743|540876367|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
149929429|NCT03874013|540876376|FG000|Overall Study|Adverse Event|0|||
149929430|NCT03874013|540876377|FG001|Overall Study|Adverse Event|1|||
149929431|NCT01026948|540876396|FG000|Overall Study|Physician Decision|8|||
149929432|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
149929433|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
149929434|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Adverse Event|57|||
149929435|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Adverse Event|49|||
149929436|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
149929437|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
149929438|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Site closure|3|||
149929439|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Site closure|2|||
149929440|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
149929441|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
149929442|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Physician Decision|48|||
149929443|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Physician Decision|38|||
149929444|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
149929445|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
149929446|NCT01705977|540876397|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
149929447|NCT01705977|540876398|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
149929448|NCT01705977|540876397|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
149929449|NCT01705977|540876398|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
149929450|NCT01705977|540876397|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
149929451|NCT01705977|540876398|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
149929452|NCT01705977|540876397|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
149929453|NCT01705977|540876398|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
149929454|NCT01705977|540876397|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
149929455|NCT01705977|540876398|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
149929456|NCT02989402|540876400|FG000|Overall Study|Adverse event, or serious adverse event|4|||
149929457|NCT02989402|540876400|FG000|Overall Study|Death|2|||
149929458|NCT02989402|540876400|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
149929459|NCT02989402|540876400|FG000|Overall Study|Lost to Follow-up|8|||
149929460|NCT02989402|540876400|FG000|Overall Study|Patient no longer on monotherapy|1|||
149929461|NCT02989402|540876400|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
149929462|NCT02989402|540876400|FG000|Overall Study|Withdrawal by Subject|7|||
149929463|NCT02989402|540876400|FG000|Overall Study|Other|2|||
149929464|NCT02039778|540876402|FG000|Overall Study|Death|2|||
149929465|NCT02039778|540876402|FG000|Overall Study|Withdrawal by Subject|1|||
149929466|NCT02039778|540876402|FG000|Overall Study|Never started the protocol treatment|1|||
149929467|NCT01462110|540876416|FG000|Overall Study|Adverse Event|1|||
149929468|NCT01462110|540876417|FG001|Overall Study|Adverse Event|0|||
150265776|NCT04677179|542108646|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
150265777|NCT04677179|542108647|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
150265778|NCT04677179|542108648|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
150265779|NCT04677179|542108649|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
150265780|NCT04677179|542108650|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
150265781|NCT04677179|542108641|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
150265782|NCT04677179|542108642|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
150265783|NCT04677179|542108643|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
150265784|NCT04677179|542108644|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
150265785|NCT04677179|542108645|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
150265786|NCT04677179|542108646|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
150265787|NCT04677179|542108647|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
150265788|NCT04677179|542108648|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
150265789|NCT04677179|542108649|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
150265790|NCT04677179|542108650|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
150265791|NCT04677179|542108641|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265792|NCT04677179|542108642|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265793|NCT04677179|542108643|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265794|NCT04677179|542108644|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265795|NCT04677179|542108645|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265796|NCT04677179|542108646|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265797|NCT04677179|542108647|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265798|NCT04677179|542108648|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
150265799|NCT04677179|542108649|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
150265800|NCT04677179|542108650|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
150265801|NCT04677179|542108641|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265802|NCT04677179|542108642|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265803|NCT04677179|542108643|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265804|NCT04677179|542108644|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265805|NCT04677179|542108645|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265806|NCT04677179|542108646|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265807|NCT04677179|542108647|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265808|NCT04677179|542108648|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
150265809|NCT04677179|542108649|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265810|NCT04677179|542108650|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
150265811|NCT04677179|542108641|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149929469|NCT00753675|540876418|FG000|Overall Study|other reason|11|||
150265812|NCT04677179|542108642|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265813|NCT04677179|542108643|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265814|NCT04677179|542108644|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265815|NCT04677179|542108645|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265816|NCT04677179|542108646|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265817|NCT04677179|542108647|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265818|NCT04677179|542108648|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
150265819|NCT04677179|542108649|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
150265820|NCT04677179|542108650|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
150265821|NCT04677179|542108641|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265822|NCT04677179|542108642|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265823|NCT04677179|542108643|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265824|NCT04677179|542108644|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265825|NCT04677179|542108645|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265826|NCT04677179|542108646|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265827|NCT04677179|542108647|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
150265828|NCT04677179|542108648|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
150265829|NCT04677179|542108649|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
150265830|NCT04677179|542108650|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
150265831|NCT02988622|542108658|FG000|Overall Study|Lost to Follow-up|17|||
149929470|NCT00753675|540876419|FG001|Overall Study|other reason|12|||
149929471|NCT00753675|540876420|FG002|Overall Study|other reason|13|||
149929472|NCT00753675|540876418|FG000|Overall Study|Death|1|||
149929473|NCT00753675|540876419|FG001|Overall Study|Death|2|||
149929474|NCT00753675|540876420|FG002|Overall Study|Death|4|||
149929475|NCT00753675|540876418|FG000|Overall Study|Adverse Event|11|||
149929476|NCT00753675|540876419|FG001|Overall Study|Adverse Event|9|||
150265832|NCT00983931|542108659|FG000|14 Day Washout Period|Physician Decision|1|||
149929477|NCT00753675|540876420|FG002|Overall Study|Adverse Event|4|||
149929478|NCT00753675|540876418|FG000|Overall Study|Objective progression of disease|35|||
149929479|NCT00753675|540876419|FG001|Overall Study|Objective progression of disease|35|||
149929480|NCT00753675|540876420|FG002|Overall Study|Objective progression of disease|35|||
149929481|NCT00753675|540876418|FG000|Overall Study|Withdrawal by Subject|0|||
149929482|NCT00753675|540876419|FG001|Overall Study|Withdrawal by Subject|1|||
149929483|NCT00753675|540876420|FG002|Overall Study|Withdrawal by Subject|0|||
149929484|NCT00753675|540876418|FG000|Overall Study|Lost to Follow-up|1|||
149929485|NCT00753675|540876419|FG001|Overall Study|Lost to Follow-up|0|||
149929486|NCT00753675|540876420|FG002|Overall Study|Lost to Follow-up|0|||
149929487|NCT05279131|540876422|FG000|Overall Study|Lost to Follow-up|1|||
149929488|NCT05279131|540876422|FG000|Overall Study|Death|1|||
149929489|NCT05279131|540876422|FG000|Overall Study|Physician Decision|1|||
149929490|NCT00672633|540876432|FG000|Overall Study|Withdrawal by Subject|0|||
149929491|NCT00672633|540876433|FG001|Overall Study|Withdrawal by Subject|1|||
149929492|NCT02317991|540878254|FG000|Overall Study|Adverse Event|12|||
149929493|NCT02317991|540878254|FG000|Overall Study|Death|4|||
149929494|NCT02317991|540878254|FG000|Overall Study|Withdrawal by Subject|8|||
149929495|NCT02317991|540878254|FG000|Overall Study|Progressive Disease|41|||
149929496|NCT02019550|540878255|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149929497|NCT02019550|540878256|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
149929498|NCT04771013|540878263|FG000|Overall Study|Withdrawal by Subject|2|||
149929499|NCT04771013|540878264|FG001|Overall Study|Withdrawal by Subject|0|||
149929500|NCT04771013|540878263|FG000|Overall Study|Death|0|||
149929501|NCT04771013|540878264|FG001|Overall Study|Death|5|||
149929502|NCT04771013|540878263|FG000|Overall Study|Referred to another hospital before day 20|0|||
149929503|NCT04771013|540878264|FG001|Overall Study|Referred to another hospital before day 20|1|||
149929504|NCT00823134|540878265|FG000|Overall Study|Invalid measurement|1|||
149929505|NCT00379834|540878268|FG000|Overall Study|Time constraints|2|||
149929506|NCT01519817|540878269|FG000|Overall Study|Withdrawal by Subject|1|||
149929507|NCT01519817|540878270|FG001|Overall Study|Withdrawal by Subject|0|||
149929508|NCT01519817|540878271|FG002|Overall Study|Withdrawal by Subject|0|||
149929509|NCT01519817|540878272|FG003|Overall Study|Withdrawal by Subject|0|||
149929510|NCT01519817|540878269|FG000|Overall Study|Off study due to infection|0|||
149929511|NCT01519817|540878270|FG001|Overall Study|Off study due to infection|0|||
149929512|NCT01519817|540878271|FG002|Overall Study|Off study due to infection|0|||
149929513|NCT01519817|540878272|FG003|Overall Study|Off study due to infection|1|||
149929514|NCT02922153|540878273|FG000|Overall Study|Death|8|||
149929515|NCT02922153|540878274|FG001|Overall Study|Death|1|||
149929516|NCT02922153|540878273|FG000|Overall Study|Lost to Follow-up|1|||
149929517|NCT02922153|540878274|FG001|Overall Study|Lost to Follow-up|0|||
149929518|NCT02922153|540878273|FG000|Overall Study|Physician Decision|1|||
149929519|NCT02922153|540878274|FG001|Overall Study|Physician Decision|1|||
149929520|NCT00956839|540878275|FG000|Overall Study|Lost to Follow-up|3|||
149929521|NCT00956839|540878276|FG001|Overall Study|Lost to Follow-up|0|||
149929522|NCT00956839|540878277|FG002|Overall Study|Lost to Follow-up|3|||
149929523|NCT00994110|540878280|FG000|Overall Study|Withdrawal by Subject|9|||
149929524|NCT00994110|540878281|FG001|Overall Study|Withdrawal by Subject|9|||
149929525|NCT00994110|540878280|FG000|Overall Study|Not Treated|4|||
149929526|NCT00994110|540878281|FG001|Overall Study|Not Treated|8|||
149929527|NCT00994110|540878280|FG000|Overall Study|Adverse Event|1|||
149929528|NCT00994110|540878281|FG001|Overall Study|Adverse Event|0|||
149929529|NCT00994110|540878280|FG000|Overall Study|Patient not resected|41|||
149929530|NCT00994110|540878281|FG001|Overall Study|Patient not resected|52|||
149929531|NCT00994110|540878280|FG000|Overall Study|Pt not eligible|10|||
149929532|NCT00994110|540878281|FG001|Overall Study|Pt not eligible|5|||
150165350|NCT00662909|541740049|FG000|Overall Study|Lack of Efficacy|9|||
150165351|NCT00662909|541740050|FG001|Overall Study|Lack of Efficacy|1|||
150165352|NCT00662909|541740051|FG002|Overall Study|Lack of Efficacy|5|||
150165353|NCT00662909|541740049|FG000|Overall Study|Withdrawal by Subject|29|||
150165354|NCT00662909|541740050|FG001|Overall Study|Withdrawal by Subject|22|||
150165355|NCT00662909|541740051|FG002|Overall Study|Withdrawal by Subject|16|||
150165356|NCT00662909|541740049|FG000|Overall Study|Lost to Follow-up|2|||
150165357|NCT00662909|541740050|FG001|Overall Study|Lost to Follow-up|9|||
150265833|NCT02409368|542108660|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
149929533|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
149929534|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
149929535|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
149929536|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
149929537|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
149929538|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
149929539|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
149929540|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
149929541|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
150165358|NCT00662909|541740051|FG002|Overall Study|Lost to Follow-up|3|||
150165359|NCT00662909|541740049|FG000|Overall Study|Protocol Violation|7|||
149929542|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
149929543|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
149929544|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
149929545|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
149929546|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
149929547|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
149929548|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
149929549|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149929550|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149929551|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149929552|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149929553|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
149929554|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
149929555|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
149929556|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
149929557|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
149929558|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
149929559|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
149929560|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
149929561|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
149929562|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
149929563|NCT01111565|540878282|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
149929564|NCT01111565|540878283|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
149929565|NCT01111565|540878284|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
149929566|NCT01111565|540878285|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
149929567|NCT01111565|540878286|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
149929568|NCT01111565|540878282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149929569|NCT01111565|540878283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149929570|NCT01111565|540878284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149929571|NCT01111565|540878285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
149929572|NCT01111565|540878286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149929573|NCT01111565|540878282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149929574|NCT01111565|540878283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149929575|NCT01111565|540878284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
149929576|NCT01111565|540878285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149929577|NCT01111565|540878286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149929578|NCT01111565|540878282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
149929579|NCT01111565|540878283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
149929580|NCT01111565|540878284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
149929581|NCT01111565|540878285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
149929582|NCT01111565|540878286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
149929583|NCT01111565|540878282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
149929584|NCT01111565|540878283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
149929585|NCT01111565|540878284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
149929586|NCT01111565|540878285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
149929587|NCT01111565|540878286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
149929588|NCT01111565|540878282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
149929589|NCT01111565|540878283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
149929590|NCT01111565|540878284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
149929591|NCT01111565|540878285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
149929592|NCT01111565|540878286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
149929593|NCT02683239|540878287|FG000|Overall Study|Protocol Violation|35|||
149929594|NCT02683239|540878288|FG001|Overall Study|Protocol Violation|23|||
149929595|NCT02683239|540878289|FG002|Overall Study|Protocol Violation|26|||
149929596|NCT02683239|540878290|FG003|Overall Study|Protocol Violation|4|||
149929597|NCT02683239|540878291|FG004|Overall Study|Protocol Violation|35|||
149929598|NCT02683239|540878292|FG005|Overall Study|Protocol Violation|4|||
149929599|NCT02683239|540878293|FG006|Overall Study|Protocol Violation|5|||
149929600|NCT02683239|540878287|FG000|Overall Study|Adverse Event|64|||
149929601|NCT02683239|540878288|FG001|Overall Study|Adverse Event|39|||
149929602|NCT02683239|540878289|FG002|Overall Study|Adverse Event|42|||
149929603|NCT02683239|540878290|FG003|Overall Study|Adverse Event|16|||
149929604|NCT02683239|540878291|FG004|Overall Study|Adverse Event|189|||
149929605|NCT02683239|540878292|FG005|Overall Study|Adverse Event|9|||
149929606|NCT02683239|540878293|FG006|Overall Study|Adverse Event|9|||
149929607|NCT02683239|540878287|FG000|Overall Study|Physician Decision|38|||
149929608|NCT02683239|540878288|FG001|Overall Study|Physician Decision|19|||
149929609|NCT02683239|540878289|FG002|Overall Study|Physician Decision|14|||
150165360|NCT00662909|541740050|FG001|Overall Study|Protocol Violation|4|||
150165361|NCT00662909|541740051|FG002|Overall Study|Protocol Violation|5|||
150165362|NCT00662909|541740049|FG000|Overall Study|Randomized- never received study drug|1|||
150165363|NCT00662909|541740050|FG001|Overall Study|Randomized- never received study drug|0|||
150165364|NCT00662909|541740051|FG002|Overall Study|Randomized- never received study drug|0|||
150165365|NCT00662909|541740049|FG000|Overall Study|Non-compliance with study procedures|3|||
150165366|NCT00662909|541740050|FG001|Overall Study|Non-compliance with study procedures|3|||
150165367|NCT00662909|541740051|FG002|Overall Study|Non-compliance with study procedures|2|||
150165368|NCT00662909|541740049|FG000|Overall Study|Physician Decision|1|||
150165369|NCT00662909|541740050|FG001|Overall Study|Physician Decision|1|||
150165370|NCT00662909|541740051|FG002|Overall Study|Physician Decision|2|||
150165371|NCT00662909|541740049|FG000|Overall Study|Eligibility criterion not met|0|||
150165372|NCT00662909|541740050|FG001|Overall Study|Eligibility criterion not met|1|||
150165373|NCT00662909|541740051|FG002|Overall Study|Eligibility criterion not met|1|||
150165374|NCT02738840|541741521|FG000|Overall Study|MRI Scan not Performed|5|||
150165375|NCT02738840|541741521|FG000|Overall Study|Lost to Follow-up|1|||
150165376|NCT02738840|541741521|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
150165377|NCT02738840|541741521|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
150165378|NCT01311648|541741524|FG000|Main Study|Protocol Violation|0|||
150165379|NCT01311648|541741525|FG001|Main Study|Protocol Violation|1|||
150165380|NCT01311648|541741524|FG000|Main Study|Adverse Event|0|||
150165381|NCT01311648|541741525|FG001|Main Study|Adverse Event|1|||
150165382|NCT01311648|541741524|FG000|Main Study|Inhibitor management|0|||
150165383|NCT01311648|541741525|FG001|Main Study|Inhibitor management|17|||
150165384|NCT01311648|541741524|FG000|Main Study|Withdrawal by Subject|0|||
150165385|NCT01311648|541741525|FG001|Main Study|Withdrawal by Subject|2|||
150165386|NCT01311648|541741524|FG000|Extension Study|Physician Decision|0|||
150165387|NCT01311648|541741525|FG001|Extension Study|Physician Decision|1|||
150165388|NCT01311648|541741524|FG000|Extension Study|ITI therapy with marketed product|0|||
150165389|NCT01311648|541741525|FG001|Extension Study|ITI therapy with marketed product|1|||
150165390|NCT01311648|541741524|FG000|Extension Study|Incorrect visit planning|0|||
150165391|NCT01311648|541741525|FG001|Extension Study|Incorrect visit planning|1|||
150165392|NCT01311648|541741524|FG000|Extension Study|Family's decision|0|||
150165393|NCT01311648|541741525|FG001|Extension Study|Family's decision|1|||
150165394|NCT01311648|541741524|FG000|Extension Study|Failure of ITI therapy|0|||
150165395|NCT01311648|541741525|FG001|Extension Study|Failure of ITI therapy|3|||
150165396|NCT01311648|541741524|FG000|Extension Study|Long travel|0|||
150165397|NCT01311648|541741525|FG001|Extension Study|Long travel|1|||
150165398|NCT01311648|541741524|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
150165399|NCT01311648|541741525|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
150165400|NCT01311648|541741524|FG000|Extension Study|Withdrawal by Subject|0|||
150165401|NCT01311648|541741525|FG001|Extension Study|Withdrawal by Subject|1|||
150165402|NCT01311648|541741524|FG000|Extension Study|Inhibitor management|0|||
150165403|NCT01311648|541741525|FG001|Extension Study|Inhibitor management|2|||
150165404|NCT01645111|541741526|FG000|Overall Study|Did not require Clevidipine|15|||
150165405|NCT05526911|541741532|FG000|Overall Study|Adverse Event|2|||
150165406|NCT05025449|541741533|FG000|Overall Study|Withdrawal by Subject|1|||
150165407|NCT05025449|541741533|FG000|Overall Study|Patient emergently taken to operating room|1|||
150165408|NCT00256308|541741534|FG000|Overall Study|Death|2|||
150165409|NCT01537133|541741535|FG000|Overall Study|Withdrawal by Subject|2|||
150165410|NCT01537133|541741536|FG001|Overall Study|Withdrawal by Subject|0|||
150165411|NCT01537133|541741537|FG002|Overall Study|Withdrawal by Subject|0|||
150165412|NCT01537133|541741538|FG003|Overall Study|Withdrawal by Subject|0|||
150165413|NCT01537133|541741535|FG000|Overall Study|Lost to Follow-up|1|||
150165414|NCT01537133|541741536|FG001|Overall Study|Lost to Follow-up|0|||
150165415|NCT01537133|541741537|FG002|Overall Study|Lost to Follow-up|0|||
150165416|NCT01537133|541741538|FG003|Overall Study|Lost to Follow-up|0|||
150165417|NCT00762463|541741540|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
150165418|NCT00762463|541741541|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
150165419|NCT00762463|541741542|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
150165420|NCT00762463|541741543|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
150165421|NCT00762463|541741540|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
150165422|NCT00762463|541741541|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
149929610|NCT02683239|540878290|FG003|Overall Study|Physician Decision|73|||
150165423|NCT00762463|541741542|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
150165424|NCT00762463|541741543|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
150165425|NCT00762463|541741540|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
150165426|NCT00762463|541741541|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
150165427|NCT00762463|541741542|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
150165428|NCT00762463|541741543|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
150165429|NCT00762463|541741540|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
149929611|NCT02683239|540878291|FG004|Overall Study|Physician Decision|143|||
149929612|NCT02683239|540878292|FG005|Overall Study|Physician Decision|14|||
149929613|NCT02683239|540878293|FG006|Overall Study|Physician Decision|15|||
149929614|NCT02683239|540878287|FG000|Overall Study|Withdrawal by Subject|187|||
149929615|NCT02683239|540878288|FG001|Overall Study|Withdrawal by Subject|99|||
149929616|NCT02683239|540878289|FG002|Overall Study|Withdrawal by Subject|91|||
149929617|NCT02683239|540878290|FG003|Overall Study|Withdrawal by Subject|18|||
149929618|NCT02683239|540878291|FG004|Overall Study|Withdrawal by Subject|248|||
149929619|NCT02683239|540878292|FG005|Overall Study|Withdrawal by Subject|22|||
149929620|NCT02683239|540878293|FG006|Overall Study|Withdrawal by Subject|28|||
149929621|NCT02683239|540878287|FG000|Overall Study|Lost to Follow-up|77|||
149929622|NCT02683239|540878288|FG001|Overall Study|Lost to Follow-up|24|||
149929623|NCT02683239|540878289|FG002|Overall Study|Lost to Follow-up|25|||
149929624|NCT02683239|540878290|FG003|Overall Study|Lost to Follow-up|7|||
149929625|NCT02683239|540878291|FG004|Overall Study|Lost to Follow-up|88|||
149929626|NCT02683239|540878292|FG005|Overall Study|Lost to Follow-up|8|||
149929627|NCT02683239|540878293|FG006|Overall Study|Lost to Follow-up|11|||
149929628|NCT02683239|540878287|FG000|Overall Study|Death|9|||
149929629|NCT02683239|540878288|FG001|Overall Study|Death|5|||
149929630|NCT02683239|540878289|FG002|Overall Study|Death|8|||
149929631|NCT02683239|540878290|FG003|Overall Study|Death|0|||
149929632|NCT02683239|540878291|FG004|Overall Study|Death|12|||
149929633|NCT02683239|540878292|FG005|Overall Study|Death|1|||
149929634|NCT02683239|540878293|FG006|Overall Study|Death|0|||
149929635|NCT02683239|540878287|FG000|Overall Study|Lack of Efficacy|50|||
149929636|NCT02683239|540878288|FG001|Overall Study|Lack of Efficacy|23|||
149929637|NCT02683239|540878289|FG002|Overall Study|Lack of Efficacy|12|||
149929638|NCT02683239|540878290|FG003|Overall Study|Lack of Efficacy|2|||
149929639|NCT02683239|540878291|FG004|Overall Study|Lack of Efficacy|29|||
149929640|NCT02683239|540878292|FG005|Overall Study|Lack of Efficacy|2|||
149929641|NCT02683239|540878293|FG006|Overall Study|Lack of Efficacy|3|||
149929642|NCT02683239|540878287|FG000|Overall Study|Missing data|0|||
149929643|NCT02683239|540878288|FG001|Overall Study|Missing data|1|||
149929644|NCT02683239|540878289|FG002|Overall Study|Missing data|1|||
149929645|NCT02683239|540878290|FG003|Overall Study|Missing data|0|||
149929646|NCT02683239|540878291|FG004|Overall Study|Missing data|1|||
149929647|NCT02683239|540878292|FG005|Overall Study|Missing data|0|||
149929648|NCT02683239|540878293|FG006|Overall Study|Missing data|0|||
149929649|NCT04131712|540878296|FG000|Overall Study|COVID related|0|||
149929650|NCT04131712|540878297|FG001|Overall Study|COVID related|0|||
149929651|NCT04131712|540878298|FG002|Overall Study|COVID related|2|||
149929652|NCT04131712|540878299|FG003|Overall Study|COVID related|0|||
149929653|NCT04131712|540878296|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
149929654|NCT04131712|540878297|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
149929655|NCT04131712|540878298|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
149929656|NCT04131712|540878299|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
149929657|NCT04613739|540878302|FG000|Overall Study|Lost to Follow-up|6|||
149929658|NCT04613739|540878303|FG001|Overall Study|Lost to Follow-up|9|||
149929659|NCT04613739|540878302|FG000|Overall Study|potentially duplicative/fraudulent|1|||
149929660|NCT04613739|540878303|FG001|Overall Study|potentially duplicative/fraudulent|3|||
149929661|NCT00766597|540878304|FG000|Overall Study|Unexpected closure of study|4|||
149929662|NCT00766597|540878304|FG000|Overall Study|Without CCR5-tropic virus|5|||
149929663|NCT00943397|540878305|FG000|Overall Study|Adverse Event|0|||
149929664|NCT00943397|540878306|FG001|Overall Study|Adverse Event|6|||
149929665|NCT00943397|540878305|FG000|Overall Study|Lost to Follow-up|0|||
149929666|NCT00943397|540878306|FG001|Overall Study|Lost to Follow-up|4|||
149929667|NCT00943397|540878305|FG000|Overall Study|Protocol Violation|2|||
149929668|NCT00943397|540878306|FG001|Overall Study|Protocol Violation|5|||
149929669|NCT00943397|540878305|FG000|Overall Study|Withdrawal by Subject|1|||
149929670|NCT00943397|540878306|FG001|Overall Study|Withdrawal by Subject|1|||
149929671|NCT00943397|540878305|FG000|Overall Study|Site terminated and other|12|||
149929672|NCT00943397|540878306|FG001|Overall Study|Site terminated and other|56|||
149929673|NCT01254656|540878307|FG000|Overall Study|Discontinued due to termination of study|40|||
149929674|NCT01254656|540878308|FG001|Overall Study|Discontinued due to termination of study|39|||
149929675|NCT01254656|540878309|FG002|Overall Study|Discontinued due to termination of study|13|||
149929676|NCT01254656|540878307|FG000|Overall Study|Lack of Efficacy|3|||
150265834|NCT02409368|542108661|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
150265835|NCT02409368|542108662|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
149929677|NCT01254656|540878308|FG001|Overall Study|Lack of Efficacy|0|||
149929678|NCT01254656|540878309|FG002|Overall Study|Lack of Efficacy|0|||
149929679|NCT01254656|540878307|FG000|Overall Study|Lost to Follow-up|1|||
149929680|NCT01254656|540878308|FG001|Overall Study|Lost to Follow-up|0|||
149929681|NCT01254656|540878309|FG002|Overall Study|Lost to Follow-up|2|||
149929682|NCT01254656|540878307|FG000|Overall Study|Withdrawal by Subject|2|||
149929683|NCT01254656|540878308|FG001|Overall Study|Withdrawal by Subject|2|||
149929684|NCT01254656|540878309|FG002|Overall Study|Withdrawal by Subject|1|||
149929685|NCT01254656|540878307|FG000|Overall Study|Pregnancy|0|||
150265836|NCT02409368|542108663|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
150265837|NCT02409368|542108660|FG000|ECOG Reclassification|Death|1|||
150265838|NCT02409368|542108661|FG001|ECOG Reclassification|Death|5|||
150265839|NCT02409368|542108662|FG002|ECOG Reclassification|Death|0|||
150265840|NCT02409368|542108663|FG003|ECOG Reclassification|Death|0|||
150265841|NCT02409368|542108660|FG000|ECOG Reclassification|Disease Progression|113|||
150265842|NCT02409368|542108661|FG001|ECOG Reclassification|Disease Progression|382|||
150265843|NCT02409368|542108662|FG002|ECOG Reclassification|Disease Progression|70|||
150265844|NCT02409368|542108663|FG003|ECOG Reclassification|Disease Progression|1|||
150265845|NCT02409368|542108660|FG000|ECOG Reclassification|Lost to Follow-up|1|||
150265846|NCT02409368|542108661|FG001|ECOG Reclassification|Lost to Follow-up|5|||
150265847|NCT02409368|542108662|FG002|ECOG Reclassification|Lost to Follow-up|0|||
150265848|NCT02409368|542108663|FG003|ECOG Reclassification|Lost to Follow-up|0|||
149819543|NCT01764854|540469157|FG002|Overall Study|relocation|2|||
149819544|NCT01764854|540469158|FG003|Overall Study|relocation|0|||
149819545|NCT01764854|540469155|FG000|Overall Study|Protocol Violation|0|||
149819546|NCT01764854|540469156|FG001|Overall Study|Protocol Violation|0|||
150165430|NCT00762463|541741541|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
150165431|NCT00762463|541741542|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
150165432|NCT00762463|541741543|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
150165433|NCT00762463|541741540|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
150165434|NCT00762463|541741541|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
150165435|NCT00762463|541741542|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
150165436|NCT00762463|541741543|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
150165437|NCT00762463|541741540|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
150165438|NCT00762463|541741541|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
150165439|NCT00762463|541741542|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
150165440|NCT00762463|541741543|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
150165441|NCT00762463|541741540|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
150165442|NCT00762463|541741541|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
150165443|NCT00762463|541741542|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
150165444|NCT00762463|541741543|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
150165445|NCT00762463|541741540|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
150165446|NCT00762463|541741541|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
150165447|NCT00762463|541741542|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
150165448|NCT00762463|541741543|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
150165449|NCT00531479|541741544|FG000|Overall Study|Death|68|||
150165450|NCT00531479|541741545|FG001|Overall Study|Death|71|||
150165451|NCT00531479|541741544|FG000|Overall Study|Lost to Follow-up|0|||
150165452|NCT00531479|541741545|FG001|Overall Study|Lost to Follow-up|2|||
150165453|NCT00531479|541741544|FG000|Overall Study|Other|0|||
150165454|NCT00531479|541741545|FG001|Overall Study|Other|1|||
150165455|NCT00531479|541741544|FG000|Overall Study|Withdrawal by Subject|6|||
150165456|NCT00531479|541741545|FG001|Overall Study|Withdrawal by Subject|6|||
150165457|NCT00531479|541741544|FG000|Overall Study|Did not receive treatment|2|||
150165458|NCT00531479|541741545|FG001|Overall Study|Did not receive treatment|3|||
150165459|NCT02466516|541741548|FG000|Overall Study|Adverse Event|1|||
150165460|NCT02466516|541741549|FG001|Overall Study|Adverse Event|1|||
150165461|NCT02466516|541741550|FG002|Overall Study|Adverse Event|0|||
150165462|NCT02466516|541741551|FG003|Overall Study|Adverse Event|0|||
150165463|NCT02466516|541741552|FG004|Overall Study|Adverse Event|0|||
150165464|NCT02466516|541741548|FG000|Overall Study|Withdrew Consent|1|||
150165465|NCT02466516|541741549|FG001|Overall Study|Withdrew Consent|0|||
150165466|NCT02466516|541741550|FG002|Overall Study|Withdrew Consent|0|||
150165467|NCT02466516|541741551|FG003|Overall Study|Withdrew Consent|0|||
150165468|NCT02466516|541741552|FG004|Overall Study|Withdrew Consent|0|||
150165469|NCT02466516|541741548|FG000|Overall Study|Lost to Follow-up|2|||
150165470|NCT02466516|541741549|FG001|Overall Study|Lost to Follow-up|0|||
150165471|NCT02466516|541741550|FG002|Overall Study|Lost to Follow-up|1|||
150165472|NCT02466516|541741551|FG003|Overall Study|Lost to Follow-up|0|||
150165473|NCT02466516|541741552|FG004|Overall Study|Lost to Follow-up|0|||
150165474|NCT04358549|541741553|FG000|Overall Study|Adverse Event|0|||
150165475|NCT04358549|541741554|FG001|Overall Study|Adverse Event|1|||
150165476|NCT04358549|541741553|FG000|Overall Study|Death|1|||
150165477|NCT04358549|541741554|FG001|Overall Study|Death|0|||
150165478|NCT04358549|541741553|FG000|Overall Study|Lost to Follow-up|2|||
150165479|NCT04358549|541741554|FG001|Overall Study|Lost to Follow-up|1|||
150165480|NCT04358549|541741553|FG000|Overall Study|Withdrawal by Subject|6|||
150165481|NCT04358549|541741554|FG001|Overall Study|Withdrawal by Subject|6|||
150165482|NCT04358549|541741553|FG000|Overall Study|Start remdesivir|1|||
150265849|NCT02409368|542108660|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
150265850|NCT02409368|542108661|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
149819547|NCT01764854|540469157|FG002|Overall Study|Protocol Violation|1|||
150265851|NCT02409368|542108662|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
150265852|NCT02409368|542108663|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
150265853|NCT02409368|542108660|FG000|ECOG Reclassification|Poor/non-compliance|0|||
150265854|NCT02409368|542108661|FG001|ECOG Reclassification|Poor/non-compliance|3|||
150265855|NCT02409368|542108662|FG002|ECOG Reclassification|Poor/non-compliance|2|||
150265856|NCT02409368|542108663|FG003|ECOG Reclassification|Poor/non-compliance|0|||
150265857|NCT02409368|542108660|FG000|ECOG Reclassification|Study drug toxicity|17|||
150265858|NCT02409368|542108661|FG001|ECOG Reclassification|Study drug toxicity|42|||
150265859|NCT02409368|542108662|FG002|ECOG Reclassification|Study drug toxicity|7|||
150265860|NCT02409368|542108663|FG003|ECOG Reclassification|Study drug toxicity|0|||
149819548|NCT01764854|540469158|FG003|Overall Study|Protocol Violation|2|||
149819549|NCT01759381|540469159|FG000|Overall Study|Death|1|||
149819550|NCT01759381|540469160|FG001|Overall Study|Death|0|||
149819551|NCT03377556|540469169|FG000|Overall Study|Adverse Event|5|||
149819552|NCT03377556|540469169|FG000|Overall Study|Refusal unrelated to adverse events|1|||
149819553|NCT03377556|540469169|FG000|Overall Study|Progression/relapse|38|||
149819554|NCT03377556|540469169|FG000|Overall Study|Death|3|||
149819555|NCT00910858|540469170|FG000|Pharmacokinetic Phase|Adverse Event|1|||
149819556|NCT00910858|540469171|FG001|Pharmacokinetic Phase|Adverse Event|0|||
149819557|NCT00910858|540469172|FG002|Pharmacokinetic Phase|Adverse Event|0|||
149819558|NCT00910858|540469170|FG000|Monotherapy Phase|Adverse Event|3|||
149819559|NCT00910858|540469171|FG001|Monotherapy Phase|Adverse Event|2|||
149819560|NCT00910858|540469172|FG002|Monotherapy Phase|Adverse Event|0|||
149819561|NCT00910858|540469170|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
149819562|NCT00910858|540469171|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
149819563|NCT00910858|540469172|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
150265861|NCT02409368|542108660|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
150265862|NCT02409368|542108661|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
150265863|NCT02409368|542108662|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
150265864|NCT02409368|542108663|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
150265865|NCT02409368|542108660|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
150265866|NCT02409368|542108661|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
150265867|NCT02409368|542108662|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
150265868|NCT02409368|542108663|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
150265869|NCT02409368|542108660|FG000|ECOG Reclassification|Participant withdrew consent|2|||
150265870|NCT02409368|542108661|FG001|ECOG Reclassification|Participant withdrew consent|3|||
150265871|NCT02409368|542108662|FG002|ECOG Reclassification|Participant withdrew consent|4|||
150265872|NCT02409368|542108663|FG003|ECOG Reclassification|Participant withdrew consent|0|||
150265873|NCT02409368|542108660|FG000|ECOG Reclassification|Other Reasons|5|||
150265874|NCT02409368|542108661|FG001|ECOG Reclassification|Other Reasons|26|||
150265875|NCT02409368|542108662|FG002|ECOG Reclassification|Other Reasons|2|||
150265876|NCT02409368|542108663|FG003|ECOG Reclassification|Other Reasons|0|||
150265877|NCT02409368|542108660|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
150265878|NCT02409368|542108661|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
150265879|NCT02409368|542108662|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
150265880|NCT02409368|542108663|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
150265881|NCT01296347|542108664|FG000|Allocation|Withdrawal by Subject|1|||
150265882|NCT01296347|542108665|FG001|Allocation|Withdrawal by Subject|2|||
150265883|NCT01296347|542108664|FG000|Allocation|Lack of Efficacy|1|||
150265884|NCT01296347|542108665|FG001|Allocation|Lack of Efficacy|2|||
150265885|NCT01296347|542108664|FG000|Allocation|not received infusion|1|||
150265886|NCT01296347|542108665|FG001|Allocation|not received infusion|0|||
150265887|NCT01296347|542108664|FG000|6 Week Follow up|Death|0|||
150265888|NCT01296347|542108665|FG001|6 Week Follow up|Death|1|||
150265889|NCT01296347|542108664|FG000|3 Month Follow up|Death|1|||
150265890|NCT01296347|542108665|FG001|3 Month Follow up|Death|0|||
150265891|NCT01296347|542108664|FG000|3 Month Follow up|Lost to Follow-up|0|||
150265892|NCT01296347|542108665|FG001|3 Month Follow up|Lost to Follow-up|1|||
150265893|NCT01296347|542108664|FG000|6 Month Follow up|Death|2|||
150265894|NCT01296347|542108665|FG001|6 Month Follow up|Death|1|||
150265895|NCT01296347|542108664|FG000|6 Month Follow up|Lost to Follow-up|0|||
150265896|NCT01296347|542108665|FG001|6 Month Follow up|Lost to Follow-up|1|||
150265897|NCT01296347|542108664|FG000|12 Month Follow up|Lost to Follow-up|3|||
150265898|NCT01296347|542108665|FG001|12 Month Follow up|Lost to Follow-up|1|||
150265899|NCT01296347|542108664|FG000|12 Month Follow up|Death|1|||
150265900|NCT01296347|542108665|FG001|12 Month Follow up|Death|1|||
150265901|NCT01296347|542108664|FG000|12 Month Follow up|Withdrawal by Subject|0|||
150265902|NCT01296347|542108665|FG001|12 Month Follow up|Withdrawal by Subject|1|||
150265903|NCT03343301|542108666|FG000|Overall Study|Withdrawal by Subject|1|||
149819564|NCT00910858|540469170|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
150265904|NCT03343301|542108667|FG001|Overall Study|Withdrawal by Subject|1|||
149819565|NCT00910858|540469171|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
149929686|NCT01254656|540878308|FG001|Overall Study|Pregnancy|0|||
149929687|NCT01254656|540878309|FG002|Overall Study|Pregnancy|2|||
150265905|NCT03343301|542108666|FG000|Overall Study|Death|0|||
150265906|NCT03343301|542108667|FG001|Overall Study|Death|2|||
150265907|NCT03343301|542108666|FG000|Overall Study|Other|0|||
150265908|NCT03343301|542108667|FG001|Overall Study|Other|6|||
150265909|NCT03343301|542108666|FG000|Overall Study|Missing|2|||
150265910|NCT03343301|542108667|FG001|Overall Study|Missing|0|||
150265911|NCT02041520|542108668|FG000|Overall Study|Adverse Event|2|||
150265912|NCT02041520|542108669|FG001|Overall Study|Adverse Event|1|||
150265913|NCT02041520|542108668|FG000|Overall Study|Withdrawal by Subject|3|||
150265914|NCT02041520|542108669|FG001|Overall Study|Withdrawal by Subject|4|||
150265915|NCT02041520|542108668|FG000|Overall Study|Protocol Violation|1|||
150265916|NCT02041520|542108669|FG001|Overall Study|Protocol Violation|0|||
150265917|NCT02041520|542108668|FG000|Overall Study|Lost to Follow-up|0|||
150265918|NCT02041520|542108669|FG001|Overall Study|Lost to Follow-up|1|||
150265919|NCT02041520|542108668|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
149929688|NCT01254656|540878307|FG000|Overall Study|Adverse Event|1|||
149929689|NCT01254656|540878308|FG001|Overall Study|Adverse Event|1|||
149929690|NCT01254656|540878309|FG002|Overall Study|Adverse Event|0|||
149929691|NCT01254656|540878307|FG000|Overall Study|Death|0|||
149929692|NCT01254656|540878308|FG001|Overall Study|Death|1|||
149929693|NCT01254656|540878309|FG002|Overall Study|Death|0|||
149929694|NCT01178125|540878310|FG000|Overall Study|Lost to Follow-up|397|||
149929695|NCT01178125|540878310|FG000|Overall Study|Adverse Event|244|||
149929696|NCT01178125|540878310|FG000|Overall Study|Withdrawal by Subject|209|||
149929697|NCT01178125|540878310|FG000|Overall Study|Noncompliance|184|||
150265920|NCT02041520|542108669|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
150265921|NCT03705832|542108673|FG000|Overall Study|Physician Decision|0|||
150265922|NCT03705832|542108674|FG001|Overall Study|Physician Decision|1|||
150265923|NCT03705832|542108673|FG000|Overall Study|Withdrawal by Subject|1|||
150265924|NCT03705832|542108674|FG001|Overall Study|Withdrawal by Subject|0|||
150265925|NCT05677893|542110103|FG000|Overall Study|Withdrawal by Subject|0|||
150265926|NCT05677893|542110104|FG001|Overall Study|Withdrawal by Subject|0|||
150265927|NCT05677893|542110105|FG002|Overall Study|Withdrawal by Subject|0|||
150265928|NCT05677893|542110106|FG003|Overall Study|Withdrawal by Subject|0|||
150265929|NCT05677893|542110107|FG004|Overall Study|Withdrawal by Subject|1|||
150265930|NCT05677893|542110108|FG005|Overall Study|Withdrawal by Subject|1|||
150265931|NCT05677893|542110109|FG006|Overall Study|Withdrawal by Subject|0|||
150265932|NCT05677893|542110103|FG000|Overall Study|Others|1|||
150265933|NCT05677893|542110104|FG001|Overall Study|Others|0|||
150265934|NCT05677893|542110105|FG002|Overall Study|Others|0|||
150265935|NCT05677893|542110106|FG003|Overall Study|Others|0|||
150265936|NCT05677893|542110107|FG004|Overall Study|Others|0|||
150265937|NCT05677893|542110108|FG005|Overall Study|Others|0|||
150265938|NCT05677893|542110109|FG006|Overall Study|Others|0|||
150265939|NCT01101477|542110110|FG000|Overall Study|Protocol Violation|5|||
150265940|NCT01101477|542110111|FG001|Overall Study|Protocol Violation|3|||
150265941|NCT01101477|542110112|FG002|Overall Study|Protocol Violation|1|||
150265942|NCT00720941|542110113|FG000|Overall Study|Protocol Violation|1|||
150265943|NCT00720941|542110114|FG001|Overall Study|Protocol Violation|2|||
150265944|NCT00720941|542110113|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
150265945|NCT00720941|542110114|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
150265946|NCT00720941|542110113|FG000|Overall Study|Lost to Follow-up|20|||
150265947|NCT00720941|542110114|FG001|Overall Study|Lost to Follow-up|15|||
150265948|NCT00720941|542110113|FG000|Overall Study|Physician Decision|14|||
150265949|NCT00720941|542110114|FG001|Overall Study|Physician Decision|12|||
150265950|NCT00720941|542110113|FG000|Overall Study|Withdrawal by Subject|29|||
150265951|NCT00720941|542110114|FG001|Overall Study|Withdrawal by Subject|36|||
150265952|NCT01128738|542110117|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
150265953|NCT01128738|542110118|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
150265954|NCT01128738|542110117|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
150265955|NCT01128738|542110118|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
150265956|NCT01128738|542110117|FG000|Second TP|Lost to Follow-up|0|||
150265957|NCT01128738|542110118|FG001|Second TP|Lost to Follow-up|1|||
150265958|NCT01128738|542110117|FG000|Second TP|Withdrawal by Subject|0|||
150265959|NCT01128738|542110118|FG001|Second TP|Withdrawal by Subject|2|||
150265960|NCT00892723|542110124|FG000|Overall Study|Lost to Follow-up|1|||
150265961|NCT00892723|542110125|FG001|Overall Study|Lost to Follow-up|3|||
150265962|NCT00892723|542110126|FG002|Overall Study|Lost to Follow-up|1|||
150265963|NCT00892723|542110124|FG000|Overall Study|Withdrawal by Subject|1|||
150265964|NCT00892723|542110125|FG001|Overall Study|Withdrawal by Subject|1|||
150265965|NCT00892723|542110126|FG002|Overall Study|Withdrawal by Subject|1|||
150265966|NCT01026454|542110128|FG000|Second Intervention|Pregnancy|1|||
150265967|NCT01026454|542110129|FG001|Second Intervention|Pregnancy|1|||
150265968|NCT01142596|542110130|FG000|Overall Study|Withdrawal by Subject|9|||
150265969|NCT01142596|542110131|FG001|Overall Study|Withdrawal by Subject|35|||
149929698|NCT01178125|540878310|FG000|Overall Study|Pregnancy|55|||
149929699|NCT01178125|540878310|FG000|Overall Study|Other Reason|39|||
150265970|NCT01142596|542110130|FG000|Overall Study|Adverse Event|8|||
149929700|NCT01178125|540878310|FG000|Overall Study|Sponsor Decision|28|||
149929701|NCT01178125|540878310|FG000|Overall Study|Protocol Violation|17|||
149929702|NCT01178125|540878310|FG000|Overall Study|Investigator Decision|5|||
149929703|NCT02948829|540878311|FG000|Overall Study|Lost to Follow-up|2|||
150265971|NCT01142596|542110131|FG001|Overall Study|Adverse Event|35|||
149929704|NCT02948829|540878311|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
149929705|NCT02948829|540878311|FG000|Overall Study|Pregnancy|1|||
149929706|NCT02948829|540878311|FG000|Overall Study|Other: Reason not Specified|8|||
149929707|NCT01004978|540878312|FG000|Overall Study|Disease progression|31|||
150265972|NCT01142596|542110130|FG000|Overall Study|Lack of Efficacy|5|||
150265973|NCT01142596|542110131|FG001|Overall Study|Lack of Efficacy|9|||
150265974|NCT01142596|542110130|FG000|Overall Study|Lost to Follow-up|2|||
150265975|NCT01142596|542110131|FG001|Overall Study|Lost to Follow-up|3|||
149819566|NCT00910858|540469172|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
149819567|NCT00910858|540469170|FG000|Monotherapy Phase|Protocol Violation|1|||
149819568|NCT00910858|540469171|FG001|Monotherapy Phase|Protocol Violation|0|||
149819569|NCT00910858|540469172|FG002|Monotherapy Phase|Protocol Violation|0|||
149819570|NCT00910858|540469170|FG000|Monotherapy Phase|Other|3|||
149819571|NCT00910858|540469171|FG001|Monotherapy Phase|Other|4|||
149819572|NCT00910858|540469172|FG002|Monotherapy Phase|Other|2|||
149819573|NCT00910858|540469170|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
149819574|NCT00910858|540469171|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
149819575|NCT00910858|540469172|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
149819576|NCT00910858|540469170|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
149819577|NCT00910858|540469171|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
149819578|NCT00910858|540469172|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
149819579|NCT00910858|540469170|FG000|Combined Treatment Phase|Protocol Violation|1|||
149819580|NCT00910858|540469171|FG001|Combined Treatment Phase|Protocol Violation|0|||
149819581|NCT00910858|540469172|FG002|Combined Treatment Phase|Protocol Violation|0|||
149819582|NCT00910858|540469170|FG000|Combined Treatment Phase|Other|0|||
149819583|NCT00910858|540469171|FG001|Combined Treatment Phase|Other|2|||
149819584|NCT00910858|540469172|FG002|Combined Treatment Phase|Other|1|||
149819585|NCT00827827|540469173|FG000|Overall Study|Lost to Follow-up|3|||
149819586|NCT00827827|540469174|FG001|Overall Study|Lost to Follow-up|0|||
149819587|NCT00827827|540469173|FG000|Overall Study|Fall at home- hospitalization|1|||
149819588|NCT00827827|540469174|FG001|Overall Study|Fall at home- hospitalization|0|||
149819589|NCT00827827|540469173|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
149819590|NCT00827827|540469174|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
149819591|NCT00827827|540469173|FG000|Overall Study|Gout|1|||
149819592|NCT00827827|540469174|FG001|Overall Study|Gout|0|||
149819593|NCT00827827|540469173|FG000|Overall Study|Transportation issues|1|||
149819594|NCT00827827|540469174|FG001|Overall Study|Transportation issues|0|||
149819595|NCT00827827|540469173|FG000|Overall Study|Burned with water at home|1|||
149819596|NCT00827827|540469174|FG001|Overall Study|Burned with water at home|0|||
149819597|NCT00447603|540469181|FG000|Screening|Withdrawal by Subject|1|||
149819598|NCT00447603|540469182|FG001|Screening|Withdrawal by Subject|0|||
149819599|NCT00447603|540469183|FG002|Screening|Withdrawal by Subject|0|||
149819600|NCT00447603|540469181|FG000|Screening|Protocol Violation|1|||
149819601|NCT00447603|540469182|FG001|Screening|Protocol Violation|0|||
149819602|NCT00447603|540469183|FG002|Screening|Protocol Violation|0|||
149819603|NCT00447603|540469181|FG000|Screening|Screen Failure|4|||
149819604|NCT00447603|540469182|FG001|Screening|Screen Failure|0|||
149819605|NCT00447603|540469183|FG002|Screening|Screen Failure|0|||
149819606|NCT00447603|540469181|FG000|Screening|Study Terminated by Sponsor|15|||
149819607|NCT00447603|540469182|FG001|Screening|Study Terminated by Sponsor|0|||
149819608|NCT00447603|540469183|FG002|Screening|Study Terminated by Sponsor|0|||
149819609|NCT00447603|540469181|FG000|Filter Period|Adverse Event|0|||
149819610|NCT00447603|540469182|FG001|Filter Period|Adverse Event|0|||
149819611|NCT00447603|540469183|FG002|Filter Period|Adverse Event|1|||
149819612|NCT00447603|540469181|FG000|Filter Period|Screen Failure|0|||
149819613|NCT00447603|540469182|FG001|Filter Period|Screen Failure|3|||
149819614|NCT00447603|540469183|FG002|Filter Period|Screen Failure|4|||
149819615|NCT00447603|540469181|FG000|Filter Period|Study terminated by Sponsor|0|||
149819616|NCT00447603|540469182|FG001|Filter Period|Study terminated by Sponsor|1|||
149819617|NCT00447603|540469183|FG002|Filter Period|Study terminated by Sponsor|10|||
149819618|NCT01907737|540469194|FG000|Overall Study|Withdrawal by Subject|1|||
149819619|NCT02008721|540469201|FG000|Overall Study|Withdrawal by Subject|5|||
149819620|NCT02008721|540469202|FG001|Overall Study|Withdrawal by Subject|1|||
149819621|NCT02008721|540469201|FG000|Overall Study|Death|4|||
149819622|NCT02008721|540469202|FG001|Overall Study|Death|2|||
149819623|NCT02008721|540469201|FG000|Overall Study|Adverse Event|3|||
149819624|NCT02008721|540469202|FG001|Overall Study|Adverse Event|5|||
149819625|NCT02008721|540469201|FG000|Overall Study|Protocol Violation|3|||
149819626|NCT02008721|540469202|FG001|Overall Study|Protocol Violation|2|||
149929708|NCT01004978|540878313|FG001|Overall Study|Disease progression|48|||
149929709|NCT01004978|540878312|FG000|Overall Study|Adverse Event|42|||
150265976|NCT01142596|542110130|FG000|Overall Study|Other reason (not specified)|5|||
149929710|NCT01004978|540878313|FG001|Overall Study|Adverse Event|22|||
149929711|NCT01004978|540878312|FG000|Overall Study|Death|3|||
149929712|NCT01004978|540878313|FG001|Overall Study|Death|2|||
149929713|NCT01004978|540878312|FG000|Overall Study|Withdrawal by Subject|16|||
149929714|NCT01004978|540878313|FG001|Overall Study|Withdrawal by Subject|16|||
149929715|NCT01004978|540878312|FG000|Overall Study|Alternative therapy|4|||
149929716|NCT01004978|540878313|FG001|Overall Study|Alternative therapy|8|||
149929717|NCT01004978|540878312|FG000|Overall Study|Physician Decision|6|||
149929718|NCT01004978|540878313|FG001|Overall Study|Physician Decision|3|||
149929719|NCT01004978|540878312|FG000|Overall Study|Other complicating disease|2|||
149929720|NCT01004978|540878313|FG001|Overall Study|Other complicating disease|2|||
149929721|NCT01004978|540878312|FG000|Overall Study|Protocol Violation|2|||
149929722|NCT01004978|540878313|FG001|Overall Study|Protocol Violation|3|||
149929723|NCT01004978|540878312|FG000|Overall Study|Non-compliance|3|||
149929724|NCT01004978|540878313|FG001|Overall Study|Non-compliance|2|||
149929725|NCT01004978|540878312|FG000|Overall Study|Ineligible|1|||
149929726|NCT01004978|540878313|FG001|Overall Study|Ineligible|0|||
149929727|NCT01004978|540878312|FG000|Overall Study|Unblinded|0|||
149929728|NCT01004978|540878313|FG001|Overall Study|Unblinded|1|||
149929729|NCT01004978|540878312|FG000|Overall Study|Performance status worsening|0|||
149929730|NCT01004978|540878313|FG001|Overall Study|Performance status worsening|1|||
149929731|NCT01004978|540878312|FG000|Overall Study|Never started treatment|8|||
149929732|NCT01004978|540878313|FG001|Overall Study|Never started treatment|9|||
149929733|NCT00369915|540878314|FG000|Overall Study|expected side effects|2|||
149929734|NCT00369915|540878315|FG001|Overall Study|expected side effects|1|||
149929735|NCT00369915|540878314|FG000|Overall Study|Withdrawal by Subject|4|||
149929736|NCT00369915|540878315|FG001|Overall Study|Withdrawal by Subject|1|||
149929737|NCT00369915|540878314|FG000|Overall Study|W/drawl by investigators|0|||
150165483|NCT04358549|541741554|FG001|Overall Study|Start remdesivir|0|||
150165484|NCT03712930|541741555|FG000|Overall Study|Death|7|||
150165485|NCT03712930|541741555|FG000|Overall Study|Physician Decision|1|||
150165486|NCT03712930|541741555|FG000|Overall Study|Study Terminated by Sponsor|3|||
150165487|NCT03712930|541741555|FG000|Overall Study|Progressive Disease|2|||
150165488|NCT01168401|541741559|FG000|Overall Study|Lost to Follow-up|1|||
150165489|NCT01168401|541741560|FG001|Overall Study|Lost to Follow-up|1|||
150165490|NCT01168401|541741561|FG002|Overall Study|Lost to Follow-up|2|||
150165491|NCT01168401|541741562|FG003|Overall Study|Lost to Follow-up|1|||
150165492|NCT01168401|541741563|FG004|Overall Study|Lost to Follow-up|0|||
150165493|NCT01168401|541741564|FG005|Overall Study|Lost to Follow-up|0|||
150165494|NCT01168401|541741565|FG006|Overall Study|Lost to Follow-up|0|||
150165495|NCT01168401|541741566|FG007|Overall Study|Lost to Follow-up|0|||
150165496|NCT01168401|541741567|FG008|Overall Study|Lost to Follow-up|0|||
150165497|NCT01168401|541741568|FG009|Overall Study|Lost to Follow-up|0|||
150165498|NCT01168401|541741569|FG010|Overall Study|Lost to Follow-up|0|||
150165499|NCT01168401|541741559|FG000|Overall Study|Withdrawal by Subject|0|||
150165500|NCT01168401|541741560|FG001|Overall Study|Withdrawal by Subject|0|||
150165501|NCT01168401|541741561|FG002|Overall Study|Withdrawal by Subject|0|||
150165502|NCT01168401|541741562|FG003|Overall Study|Withdrawal by Subject|1|||
150165503|NCT01168401|541741563|FG004|Overall Study|Withdrawal by Subject|0|||
150165504|NCT01168401|541741564|FG005|Overall Study|Withdrawal by Subject|0|||
150165505|NCT01168401|541741565|FG006|Overall Study|Withdrawal by Subject|0|||
150165506|NCT01168401|541741566|FG007|Overall Study|Withdrawal by Subject|0|||
150165507|NCT01168401|541741567|FG008|Overall Study|Withdrawal by Subject|0|||
150165508|NCT01168401|541741568|FG009|Overall Study|Withdrawal by Subject|0|||
150165509|NCT01168401|541741569|FG010|Overall Study|Withdrawal by Subject|0|||
150165510|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
150165511|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
150165512|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
149929738|NCT00369915|540878315|FG001|Overall Study|W/drawl by investigators|1|||
149929739|NCT01265394|540878338|FG000|Overall Study|Subjects withdrawn|37|||
149929740|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
149929741|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
149929742|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
149929743|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Death|0|||
149929744|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Death|1|||
150165513|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
150165514|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Adverse Event|198|||
150165515|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Adverse Event|0|||
150165516|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Adverse Event|0|||
150165517|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Adverse Event|0|||
150165518|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Death|62|||
150165519|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Death|0|||
150165520|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Death|0|||
150165521|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Death|0|||
150165522|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
150165523|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
150165524|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
150265977|NCT01142596|542110131|FG001|Overall Study|Other reason (not specified)|4|||
150265978|NCT03021954|542110137|FG000|Overall Study|Lost to Follow-up|10|||
150265979|NCT03021954|542110138|FG001|Overall Study|Lost to Follow-up|43|||
150265980|NCT03021954|542110137|FG000|Overall Study|Subjects had avulsion trauma|4|||
150265981|NCT03021954|542110138|FG001|Overall Study|Subjects had avulsion trauma|1|||
150265982|NCT02196714|542110141|FG000|Overall Study|Protocol Violation|0|||
150265983|NCT02196714|542110142|FG001|Overall Study|Protocol Violation|0|||
150265984|NCT02196714|542110143|FG002|Overall Study|Protocol Violation|1|||
150265985|NCT02196714|542110144|FG003|Overall Study|Protocol Violation|0|||
150265986|NCT04079803|542110147|FG000|Overall Study|Withdrawal by Subject|0|||
150265987|NCT04079803|542110148|FG001|Overall Study|Withdrawal by Subject|0|||
150265988|NCT04079803|542110149|FG002|Overall Study|Withdrawal by Subject|1|||
150265989|NCT03353350|542110150|FG000|30-week Core Treatment Period|Protocol Violation|1|||
150265990|NCT03353350|542110151|FG001|30-week Core Treatment Period|Protocol Violation|1|||
150265991|NCT03353350|542110152|FG002|30-week Core Treatment Period|Protocol Violation|1|||
150265992|NCT03353350|542110153|FG003|30-week Core Treatment Period|Protocol Violation|0|||
150265993|NCT03353350|542110150|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
150265994|NCT03353350|542110151|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
150265995|NCT03353350|542110152|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
150265996|NCT03353350|542110153|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
150265997|NCT03353350|542110150|FG000|30-week Core Treatment Period|Adverse Event|0|||
150265998|NCT03353350|542110151|FG001|30-week Core Treatment Period|Adverse Event|4|||
150265999|NCT03353350|542110152|FG002|30-week Core Treatment Period|Adverse Event|2|||
150266000|NCT03353350|542110153|FG003|30-week Core Treatment Period|Adverse Event|3|||
150266001|NCT03353350|542110150|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
150266002|NCT03353350|542110151|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
150266003|NCT03353350|542110152|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
150266004|NCT03353350|542110153|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
150266005|NCT03353350|542110150|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
150266006|NCT03353350|542110151|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
150266007|NCT03353350|542110152|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
150266008|NCT03353350|542110153|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
150266009|NCT03353350|542110150|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
150266010|NCT03353350|542110151|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
150266011|NCT03353350|542110152|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
150266012|NCT03353350|542110153|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
150266013|NCT03353350|542110150|FG000|26-week Treatment Extension Period|Adverse Event|1|||
150266014|NCT03353350|542110151|FG001|26-week Treatment Extension Period|Adverse Event|0|||
150266015|NCT03353350|542110152|FG002|26-week Treatment Extension Period|Adverse Event|0|||
150266016|NCT03353350|542110153|FG003|26-week Treatment Extension Period|Adverse Event|1|||
150266017|NCT03353350|542110150|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
150266018|NCT03353350|542110151|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
150266019|NCT03353350|542110152|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
150266020|NCT03353350|542110153|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
150266021|NCT03037619|542110154|FG000|Overall Study|Lost to Follow-up|0|||
150266022|NCT03037619|542110155|FG001|Overall Study|Lost to Follow-up|1|||
150266023|NCT01881750|542110160|FG000|Overall Study|Changes in concomitant therapies|2|||
150266024|NCT01881750|542110161|FG001|Overall Study|Changes in concomitant therapies|3|||
150266025|NCT01881750|542110160|FG000|Overall Study|Lost to Follow-up|0|||
150266026|NCT01881750|542110161|FG001|Overall Study|Lost to Follow-up|1|||
150266027|NCT00807235|542110164|FG000|Overall Study|Adverse Event|1|||
150266028|NCT00807235|542110165|FG001|Overall Study|Adverse Event|0|||
150266029|NCT01012713|542110168|FG000|Overall Study|Lack of Efficacy|3|||
150266030|NCT01596621|542110169|FG000|Overall Study|Death|4|||
150266031|NCT01596621|542110169|FG000|Overall Study|Withdrawal by Subject|9|||
150266032|NCT01596621|542110169|FG000|Overall Study|Disease Progression|49|||
150266033|NCT01596621|542110169|FG000|Overall Study|Lost to Follow-up|3|||
150266034|NCT01596621|542110169|FG000|Overall Study|Other than specified|13|||
150266035|NCT00178126|542110170|FG000|Overall Study|Lost to Follow-up|21|||
150266036|NCT00178126|542110171|FG001|Overall Study|Lost to Follow-up|21|||
150266037|NCT00178126|542110170|FG000|Overall Study|did not receive intervention|4|||
149929745|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Death|0|||
149929746|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
150266038|NCT00178126|542110171|FG001|Overall Study|did not receive intervention|6|||
150266039|NCT01281969|542110174|FG000|Overall Study|not randomized didn't meet criteria|0|||
150266040|NCT01281969|542110175|FG001|Overall Study|not randomized didn't meet criteria|0|||
150266041|NCT01281969|542110176|FG002|Overall Study|not randomized didn't meet criteria|7|||
150266042|NCT01281969|542110174|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
150266043|NCT01281969|542110175|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
150266044|NCT01281969|542110176|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
150266045|NCT01281969|542110174|FG000|Overall Study|not randomized, child consent not given|0|||
149929747|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
150266046|NCT01281969|542110175|FG001|Overall Study|not randomized, child consent not given|0|||
149929748|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
150266047|NCT01281969|542110176|FG002|Overall Study|not randomized, child consent not given|2|||
150266048|NCT01201265|542110177|FG000|Overall Study|Death|14|||
150266049|NCT01201265|542110177|FG000|Overall Study|Insufficient Therapeutic Response|3|||
150266050|NCT01201265|542110177|FG000|Overall Study|Lost to Follow-up|10|||
150266051|NCT01201265|542110177|FG000|Overall Study|Withdrawal by Subject|7|||
149929749|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
149929750|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
149929751|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
150266052|NCT01201265|542110177|FG000|Overall Study|Disease Progression|4|||
150266053|NCT01575028|542110178|FG000|Overall Study|Physician Decision|0|||
150266054|NCT01575028|542110179|FG001|Overall Study|Physician Decision|1|||
150266055|NCT02240693|542110180|FG000|Overall Study|Adverse Event|0|||
149929752|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149929753|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149929754|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149929755|NCT01064414|540878342|FG000|Core Period: Baseline to Week 26|Other|4|||
149929756|NCT01064414|540878343|FG001|Core Period: Baseline to Week 26|Other|7|||
149929757|NCT01064414|540878344|FG002|Core Period: Baseline to Week 26|Other|2|||
149929758|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149929759|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
149929760|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149929761|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Death|0|||
149929762|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Death|1|||
149929763|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Death|0|||
149929764|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
149929765|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149929766|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149929767|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
149929768|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149929769|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149929770|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149929771|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
149929772|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149929773|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
149929774|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
149929775|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
149929776|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149929777|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149929778|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149929779|NCT01064414|540878342|FG000|Extension Period: Week 26 to Week 52|Other|5|||
149929780|NCT01064414|540878343|FG001|Extension Period: Week 26 to Week 52|Other|2|||
149929781|NCT01064414|540878344|FG002|Extension Period: Week 26 to Week 52|Other|1|||
149929782|NCT00249873|540878345|FG000|Overall Study|Not treated|7|||
149929783|NCT00249873|540878346|FG001|Overall Study|Not treated|8|||
149929784|NCT00249873|540878345|FG000|Overall Study|Significant thrombocytopenia|9|||
149929785|NCT00249873|540878346|FG001|Overall Study|Significant thrombocytopenia|8|||
149929786|NCT00249873|540878345|FG000|Overall Study|Severe allergic reaction|8|||
149929787|NCT00249873|540878346|FG001|Overall Study|Severe allergic reaction|1|||
150266056|NCT02240693|542110181|FG001|Overall Study|Adverse Event|0|||
150266057|NCT02240693|542110182|FG002|Overall Study|Adverse Event|0|||
150266058|NCT02240693|542110183|FG003|Overall Study|Adverse Event|0|||
149929788|NCT00249873|540878345|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
149929789|NCT00249873|540878346|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
149929790|NCT00249873|540878345|FG000|Overall Study|Other Serious Adverse Event|86|||
149929791|NCT00249873|540878346|FG001|Overall Study|Other Serious Adverse Event|97|||
149929792|NCT00249873|540878345|FG000|Overall Study|Qualifying condition not present|20|||
149929793|NCT00249873|540878346|FG001|Overall Study|Qualifying condition not present|23|||
149929794|NCT00249873|540878345|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
149929795|NCT00249873|540878346|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
149929796|NCT00249873|540878345|FG000|Overall Study|Withdrawal by Subject|504|||
149929797|NCT00249873|540878346|FG001|Overall Study|Withdrawal by Subject|466|||
149929798|NCT00249873|540878345|FG000|Overall Study|Lost to Follow-up|4|||
150266059|NCT02240693|542110184|FG004|Overall Study|Adverse Event|1|||
150266060|NCT02240693|542110180|FG000|Overall Study|Withdrawal by Subject|0|||
150266061|NCT02240693|542110181|FG001|Overall Study|Withdrawal by Subject|0|||
150266062|NCT02240693|542110182|FG002|Overall Study|Withdrawal by Subject|2|||
150266063|NCT02240693|542110183|FG003|Overall Study|Withdrawal by Subject|1|||
149929799|NCT00249873|540878346|FG001|Overall Study|Lost to Follow-up|7|||
149929800|NCT00249873|540878345|FG000|Overall Study|Minor bleeding|99|||
149929801|NCT00249873|540878346|FG001|Overall Study|Minor bleeding|37|||
149929802|NCT00249873|540878345|FG000|Overall Study|Non-compliance|41|||
149929803|NCT00249873|540878346|FG001|Overall Study|Non-compliance|46|||
149929804|NCT00249873|540878345|FG000|Overall Study|Other non serious Adverse Event|112|||
149929805|NCT00249873|540878346|FG001|Overall Study|Other non serious Adverse Event|108|||
149929806|NCT00249873|540878345|FG000|Overall Study|Other contraindicated medication|1|||
149929807|NCT00249873|540878346|FG001|Overall Study|Other contraindicated medication|0|||
149929808|NCT00249873|540878345|FG000|Overall Study|Patient not wish to continue after May08|3|||
149929809|NCT00249873|540878346|FG001|Overall Study|Patient not wish to continue after May08|4|||
149929810|NCT00249873|540878345|FG000|Overall Study|Physician withdrew consent|59|||
149929811|NCT00249873|540878346|FG001|Overall Study|Physician withdrew consent|60|||
149929812|NCT00249873|540878345|FG000|Overall Study|Open label clopidogrel required|31|||
149929813|NCT00249873|540878346|FG001|Overall Study|Open label clopidogrel required|42|||
149929814|NCT00249873|540878345|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
149929815|NCT00249873|540878346|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
149929816|NCT00249873|540878345|FG000|Overall Study|Oral anticoagulant required|159|||
149929817|NCT00249873|540878346|FG001|Overall Study|Oral anticoagulant required|157|||
149929818|NCT00249873|540878345|FG000|Overall Study|Study drug intolerance|5|||
149929819|NCT00249873|540878346|FG001|Overall Study|Study drug intolerance|0|||
149929820|NCT00249873|540878345|FG000|Overall Study|Surgery/ procedure|9|||
149929821|NCT00249873|540878346|FG001|Overall Study|Surgery/ procedure|9|||
149929822|NCT00249873|540878345|FG000|Overall Study|Event related to cardiac condition|12|||
149929823|NCT00249873|540878346|FG001|Overall Study|Event related to cardiac condition|21|||
149929824|NCT00249873|540878345|FG000|Overall Study|Thromboembolic/outcome event|82|||
149929825|NCT00249873|540878346|FG001|Overall Study|Thromboembolic/outcome event|122|||
149929826|NCT01781962|540878351|FG000|Overall Study|Other Miscellaneous Reasons|5|||
149929827|NCT05417412|540878354|FG000|Overall Study|Lost to Follow-up|2|||
149929828|NCT01576575|540878355|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
149929829|NCT01576575|540878355|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
149929830|NCT01576575|540878355|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
149929831|NCT03075267|540878357|FG000|Overall Study|Protocol Violation|1|||
149929832|NCT03075267|540878358|FG001|Overall Study|Protocol Violation|0|||
149929833|NCT03075267|540878359|FG002|Overall Study|Protocol Violation|0|||
149929834|NCT02168491|540878360|FG000|Overall Study|Withdrawal by Subject|1|||
149929835|NCT00809445|540878361|FG000|1 Month Follow-up|Lost contact|1|||
149929836|NCT00809445|540878362|FG001|1 Month Follow-up|Lost contact|2|||
149929837|NCT00809445|540878363|FG002|1 Month Follow-up|Lost contact|1|||
149929838|NCT00809445|540878361|FG000|1 Month Follow-up|Withdrew consent|1|||
149929839|NCT00809445|540878362|FG001|1 Month Follow-up|Withdrew consent|1|||
149929840|NCT00809445|540878363|FG002|1 Month Follow-up|Withdrew consent|1|||
149929841|NCT00809445|540878361|FG000|1 Month Follow-up|Death|0|||
149929842|NCT00809445|540878362|FG001|1 Month Follow-up|Death|1|||
149929843|NCT00809445|540878363|FG002|1 Month Follow-up|Death|1|||
149929844|NCT00809445|540878361|FG000|1 Month Follow-up|Incarcerated|0|||
149929845|NCT00809445|540878362|FG001|1 Month Follow-up|Incarcerated|0|||
149929846|NCT00809445|540878363|FG002|1 Month Follow-up|Incarcerated|1|||
149929847|NCT00809445|540878361|FG000|6 Month Follow-up|Lost contact|16|||
149929848|NCT00809445|540878362|FG001|6 Month Follow-up|Lost contact|14|||
149929849|NCT00809445|540878363|FG002|6 Month Follow-up|Lost contact|14|||
149929850|NCT00809445|540878361|FG000|6 Month Follow-up|Death|2|||
149929851|NCT00809445|540878362|FG001|6 Month Follow-up|Death|1|||
149929852|NCT00809445|540878363|FG002|6 Month Follow-up|Death|1|||
149929853|NCT00809445|540878361|FG000|6 Month Follow-up|Incarcerated|6|||
149929854|NCT00809445|540878362|FG001|6 Month Follow-up|Incarcerated|8|||
149929855|NCT00809445|540878363|FG002|6 Month Follow-up|Incarcerated|8|||
149929856|NCT00809445|540878361|FG000|6 Month Follow-up|Withdrew consent|0|||
149929857|NCT00809445|540878362|FG001|6 Month Follow-up|Withdrew consent|0|||
149929858|NCT00809445|540878363|FG002|6 Month Follow-up|Withdrew consent|1|||
149929859|NCT01566604|540878365|FG000|Overall Study|Patient's inability to use the device|1|||
149929860|NCT01566604|540878366|FG001|Overall Study|Patient's inability to use the device|0|||
149929861|NCT01566604|540878365|FG000|Overall Study|Administrative problems|1|||
149929862|NCT01566604|540878366|FG001|Overall Study|Administrative problems|0|||
149929863|NCT01566604|540878365|FG000|Overall Study|Lack of Efficacy|1|||
149929864|NCT01566604|540878366|FG001|Overall Study|Lack of Efficacy|2|||
149929865|NCT01566604|540878365|FG000|Overall Study|Protocol deviation|2|||
149929866|NCT01566604|540878366|FG001|Overall Study|Protocol deviation|0|||
149929867|NCT01566604|540878365|FG000|Overall Study|Abnormal laboratory value|2|||
149929868|NCT01566604|540878366|FG001|Overall Study|Abnormal laboratory value|0|||
149929869|NCT01566604|540878365|FG000|Overall Study|Death|4|||
149929870|NCT01566604|540878366|FG001|Overall Study|Death|1|||
149929871|NCT01566604|540878365|FG000|Overall Study|Adverse Event|4|||
149929872|NCT01566604|540878366|FG001|Overall Study|Adverse Event|2|||
149929873|NCT01566604|540878365|FG000|Overall Study|Withdrawal by Subject|9|||
149929874|NCT01566604|540878366|FG001|Overall Study|Withdrawal by Subject|6|||
149929875|NCT01610037|540878368|FG000|All Patients|Adverse Event|27|||
150266064|NCT02240693|542110184|FG004|Overall Study|Withdrawal by Subject|0|||
150266065|NCT02240693|542110180|FG000|Overall Study|Other than specified|0|||
150266066|NCT02240693|542110181|FG001|Overall Study|Other than specified|0|||
150266067|NCT02240693|542110182|FG002|Overall Study|Other than specified|2|||
150266068|NCT02240693|542110183|FG003|Overall Study|Other than specified|0|||
150266069|NCT02240693|542110184|FG004|Overall Study|Other than specified|0|||
150266070|NCT01585987|542110185|FG000|Randomized|Withdrawal by Subject|0|||
150266071|NCT01585987|542110186|FG001|Randomized|Withdrawal by Subject|4|||
150266072|NCT01585987|542110185|FG000|Randomized|No longer met criteria|0|||
150266073|NCT01585987|542110186|FG001|Randomized|No longer met criteria|2|||
150266074|NCT01585987|542110185|FG000|Treated|Disease Progression|39|||
150266075|NCT01585987|542110186|FG001|Treated|Disease Progression|36|||
150266076|NCT01585987|542110185|FG000|Treated|Study Drug Toxicity|9|||
150266077|NCT01585987|542110186|FG001|Treated|Study Drug Toxicity|5|||
150266078|NCT01585987|542110185|FG000|Treated|Adverse Event|3|||
150266079|NCT01585987|542110186|FG001|Treated|Adverse Event|0|||
150266080|NCT01585987|542110185|FG000|Treated|Withdrawal by Subject|1|||
150266081|NCT01585987|542110186|FG001|Treated|Withdrawal by Subject|2|||
150266082|NCT01585987|542110185|FG000|Treated|Death|1|||
150266083|NCT01585987|542110186|FG001|Treated|Death|0|||
150266084|NCT01585987|542110185|FG000|Treated|Lost to Follow-up|0|||
150266085|NCT01585987|542110186|FG001|Treated|Lost to Follow-up|1|||
150266086|NCT01585987|542110185|FG000|Treated|Maximum Clinical Benefit|0|||
150266087|NCT01585987|542110186|FG001|Treated|Maximum Clinical Benefit|1|||
150266088|NCT01585987|542110185|FG000|Treated|Non-Specified|1|||
150266089|NCT01585987|542110186|FG001|Treated|Non-Specified|2|||
150266090|NCT01585987|542110185|FG000|Treated|Subject Request|0|||
150266091|NCT01585987|542110186|FG001|Treated|Subject Request|1|||
150266092|NCT01585987|542110185|FG000|Treated|Poor/Non-Compliance|0|||
150266093|NCT01585987|542110186|FG001|Treated|Poor/Non-Compliance|1|||
150266094|NCT00413972|542110187|FG000|Overall Study|Adverse Event|2|||
150266095|NCT00413972|542110188|FG001|Overall Study|Adverse Event|1|||
150266096|NCT00413972|542110189|FG002|Overall Study|Adverse Event|0|||
150266097|NCT00413972|542110190|FG003|Overall Study|Adverse Event|0|||
150266098|NCT00413972|542110187|FG000|Overall Study|Lost to Follow-up|1|||
150266099|NCT00413972|542110188|FG001|Overall Study|Lost to Follow-up|2|||
150266100|NCT00413972|542110189|FG002|Overall Study|Lost to Follow-up|1|||
150266101|NCT00413972|542110190|FG003|Overall Study|Lost to Follow-up|0|||
150266102|NCT00413972|542110187|FG000|Overall Study|Withdrawal by Subject|4|||
150266103|NCT00413972|542110188|FG001|Overall Study|Withdrawal by Subject|5|||
150266104|NCT00413972|542110189|FG002|Overall Study|Withdrawal by Subject|7|||
150266105|NCT00413972|542110190|FG003|Overall Study|Withdrawal by Subject|2|||
149819627|NCT01567306|540469204|FG000|Overall Study|Protocol Violation|2|||
149819628|NCT01567306|540469205|FG001|Overall Study|Protocol Violation|2|||
149819629|NCT01567306|540469206|FG002|Overall Study|Protocol Violation|0|||
149819630|NCT01567306|540469207|FG003|Overall Study|Protocol Violation|3|||
149819631|NCT01567306|540469208|FG004|Overall Study|Protocol Violation|1|||
149819632|NCT01567306|540469209|FG005|Overall Study|Protocol Violation|1|||
149819633|NCT01567306|540469204|FG000|Overall Study|Change site living|1|||
149819634|NCT01567306|540469205|FG001|Overall Study|Change site living|0|||
149819635|NCT01567306|540469206|FG002|Overall Study|Change site living|0|||
149819636|NCT01567306|540469207|FG003|Overall Study|Change site living|0|||
149819637|NCT01567306|540469208|FG004|Overall Study|Change site living|0|||
149819638|NCT01567306|540469209|FG005|Overall Study|Change site living|0|||
149819639|NCT01567306|540469204|FG000|Overall Study|Adverse Event|0|||
149819640|NCT01567306|540469205|FG001|Overall Study|Adverse Event|0|||
149819641|NCT01567306|540469206|FG002|Overall Study|Adverse Event|0|||
149819642|NCT01567306|540469207|FG003|Overall Study|Adverse Event|2|||
149819643|NCT01567306|540469208|FG004|Overall Study|Adverse Event|4|||
149819644|NCT01567306|540469209|FG005|Overall Study|Adverse Event|1|||
149819645|NCT01567306|540469204|FG000|Overall Study|Lost to Follow-up|0|||
149819646|NCT01567306|540469205|FG001|Overall Study|Lost to Follow-up|0|||
149819647|NCT01567306|540469206|FG002|Overall Study|Lost to Follow-up|0|||
149819648|NCT01567306|540469207|FG003|Overall Study|Lost to Follow-up|0|||
149819649|NCT01567306|540469208|FG004|Overall Study|Lost to Follow-up|2|||
149819650|NCT01567306|540469209|FG005|Overall Study|Lost to Follow-up|0|||
149819651|NCT01567306|540469204|FG000|Overall Study|Withdrawal by Subject|0|||
149819652|NCT01567306|540469205|FG001|Overall Study|Withdrawal by Subject|0|||
149819653|NCT01567306|540469206|FG002|Overall Study|Withdrawal by Subject|0|||
149819654|NCT01567306|540469207|FG003|Overall Study|Withdrawal by Subject|0|||
149819655|NCT01567306|540469208|FG004|Overall Study|Withdrawal by Subject|0|||
149819656|NCT01567306|540469209|FG005|Overall Study|Withdrawal by Subject|1|||
149819657|NCT04272775|540469215|FG000|Overall Study|Study Terminated by Sponsor|1|||
149819658|NCT04272775|540469216|FG001|Overall Study|Study Terminated by Sponsor|0|||
150266106|NCT00413972|542110187|FG000|Overall Study|Protocol Violation|0|||
150266107|NCT00413972|542110188|FG001|Overall Study|Protocol Violation|0|||
150266108|NCT00413972|542110189|FG002|Overall Study|Protocol Violation|2|||
150266109|NCT00413972|542110190|FG003|Overall Study|Protocol Violation|0|||
149819659|NCT04272775|540469215|FG000|Overall Study|Protocol Violation|0|||
150266110|NCT00413972|542110187|FG000|Overall Study|Other|0|||
150266111|NCT00413972|542110188|FG001|Overall Study|Other|0|||
149929876|NCT01610037|540878369|FG001|All Patients|Adverse Event|22|||
149929877|NCT01610037|540878370|FG002|All Patients|Adverse Event|26|||
149929878|NCT01610037|540878368|FG000|All Patients|Withdrawal by Subject|12|||
149929879|NCT01610037|540878369|FG001|All Patients|Withdrawal by Subject|10|||
149929880|NCT01610037|540878370|FG002|All Patients|Withdrawal by Subject|20|||
149929881|NCT01610037|540878368|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
149929882|NCT01610037|540878369|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
149929883|NCT01610037|540878370|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
149929884|NCT01610037|540878368|FG000|All Patients|Death|4|||
149929885|NCT01610037|540878369|FG001|All Patients|Death|2|||
149929886|NCT01610037|540878370|FG002|All Patients|Death|1|||
149929887|NCT01610037|540878368|FG000|All Patients|Protocol deviation|4|||
149929888|NCT01610037|540878369|FG001|All Patients|Protocol deviation|3|||
149929889|NCT01610037|540878370|FG002|All Patients|Protocol deviation|3|||
149929890|NCT01610037|540878368|FG000|All Patients|Abnormal laboratory value|1|||
149929891|NCT01610037|540878369|FG001|All Patients|Abnormal laboratory value|1|||
149929892|NCT01610037|540878370|FG002|All Patients|Abnormal laboratory value|0|||
149929893|NCT01610037|540878368|FG000|All Patients|Administrative problems|1|||
149929894|NCT01610037|540878369|FG001|All Patients|Administrative problems|4|||
149929895|NCT01610037|540878370|FG002|All Patients|Administrative problems|4|||
149929896|NCT01610037|540878368|FG000|All Patients|Lost to Follow-up|1|||
149929897|NCT01610037|540878369|FG001|All Patients|Lost to Follow-up|0|||
149929898|NCT01610037|540878370|FG002|All Patients|Lost to Follow-up|0|||
149929899|NCT01610037|540878368|FG000|All Patients|Abnormal test procedure result(s)|0|||
149929900|NCT01610037|540878369|FG001|All Patients|Abnormal test procedure result(s)|1|||
149929901|NCT01610037|540878370|FG002|All Patients|Abnormal test procedure result(s)|3|||
149929902|NCT01610037|540878368|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
149929903|NCT01610037|540878369|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
149929904|NCT01610037|540878370|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
149929905|NCT01610037|540878368|FG000|Treatment and Follow up Period|Death|10|||
149929906|NCT01610037|540878369|FG001|Treatment and Follow up Period|Death|5|||
149929907|NCT01610037|540878370|FG002|Treatment and Follow up Period|Death|4|||
149929908|NCT01610037|540878368|FG000|Treatment and Follow up Period|Administrative problems|1|||
149929909|NCT01610037|540878369|FG001|Treatment and Follow up Period|Administrative problems|3|||
149929910|NCT01610037|540878370|FG002|Treatment and Follow up Period|Administrative problems|2|||
149929911|NCT01610037|540878368|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
149929912|NCT01610037|540878369|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
149929913|NCT01610037|540878370|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
149929914|NCT00661089|540878378|FG000|Overall Study|1 subject withdrawal|0|||
149929915|NCT00661089|540878379|FG001|Overall Study|1 subject withdrawal|1|||
149929916|NCT00661089|540878378|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
149929917|NCT00661089|540878379|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
149929918|NCT00274742|540878380|FG000|Overall Study|Adverse Event|0|||
149929919|NCT00274742|540878381|FG001|Overall Study|Adverse Event|4|||
149929920|NCT00274742|540878382|FG002|Overall Study|Adverse Event|1|||
149929921|NCT00274742|540878383|FG003|Overall Study|Adverse Event|4|||
149929922|NCT00274742|540878384|FG004|Overall Study|Adverse Event|12|||
149929923|NCT00274742|540878385|FG005|Overall Study|Adverse Event|3|||
149929924|NCT00274742|540878380|FG000|Overall Study|Lost to Follow-up|0|||
149929925|NCT00274742|540878381|FG001|Overall Study|Lost to Follow-up|0|||
149929926|NCT00274742|540878382|FG002|Overall Study|Lost to Follow-up|0|||
149929927|NCT00274742|540878383|FG003|Overall Study|Lost to Follow-up|0|||
149929928|NCT00274742|540878384|FG004|Overall Study|Lost to Follow-up|1|||
150165525|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
150165526|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Complicating disease|13|||
150165527|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Complicating disease|0|||
150165528|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Complicating disease|0|||
150165529|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Complicating disease|0|||
150165530|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
150165531|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
150165532|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
149929929|NCT00274742|540878385|FG005|Overall Study|Lost to Follow-up|0|||
149929930|NCT00274742|540878380|FG000|Overall Study|End of Study|0|||
149929931|NCT00274742|540878381|FG001|Overall Study|End of Study|0|||
149929932|NCT00274742|540878382|FG002|Overall Study|End of Study|0|||
150165533|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
149929933|NCT00274742|540878383|FG003|Overall Study|End of Study|1|||
149929934|NCT00274742|540878384|FG004|Overall Study|End of Study|0|||
149929935|NCT00274742|540878385|FG005|Overall Study|End of Study|0|||
149929936|NCT00274742|540878380|FG000|Overall Study|Disease Progression|0|||
149929937|NCT00274742|540878381|FG001|Overall Study|Disease Progression|1|||
149929938|NCT00274742|540878382|FG002|Overall Study|Disease Progression|1|||
149929939|NCT00274742|540878383|FG003|Overall Study|Disease Progression|0|||
149929940|NCT00274742|540878384|FG004|Overall Study|Disease Progression|1|||
149929941|NCT00274742|540878385|FG005|Overall Study|Disease Progression|0|||
150266112|NCT00413972|542110189|FG002|Overall Study|Other|0|||
149929942|NCT00274742|540878380|FG000|Overall Study|Other|0|||
149929943|NCT00274742|540878381|FG001|Overall Study|Other|3|||
149929944|NCT00274742|540878382|FG002|Overall Study|Other|0|||
149929945|NCT00274742|540878383|FG003|Overall Study|Other|0|||
149929946|NCT00274742|540878384|FG004|Overall Study|Other|2|||
149929947|NCT00274742|540878385|FG005|Overall Study|Other|0|||
149929948|NCT03361306|540878396|FG000|Overall Study|Death|6|||
149929949|NCT00321906|540878399|FG000|Overall Study|Adverse Event|36|||
149929950|NCT00321906|540878400|FG001|Overall Study|Adverse Event|44|||
149929951|NCT00321906|540878399|FG000|Overall Study|Death|9|||
149929952|NCT00321906|540878400|FG001|Overall Study|Death|6|||
149929953|NCT00321906|540878399|FG000|Overall Study|Lost to Follow-up|1|||
149929954|NCT00321906|540878400|FG001|Overall Study|Lost to Follow-up|2|||
149929955|NCT00321906|540878399|FG000|Overall Study|Withdrawal by Subject|0|||
149929956|NCT00321906|540878400|FG001|Overall Study|Withdrawal by Subject|4|||
149929957|NCT00807885|540878406|FG000|Overall Study|Lost to Follow-up|0|||
149929958|NCT00807885|540878407|FG001|Overall Study|Lost to Follow-up|0|||
149929959|NCT00807885|540878408|FG002|Overall Study|Lost to Follow-up|0|||
149929960|NCT00807885|540878409|FG003|Overall Study|Lost to Follow-up|0|||
149929961|NCT00807885|540878410|FG004|Overall Study|Lost to Follow-up|0|||
149929962|NCT00807885|540878411|FG005|Overall Study|Lost to Follow-up|1|||
149929963|NCT00807885|540878412|FG006|Overall Study|Lost to Follow-up|0|||
149929964|NCT00807885|540878413|FG007|Overall Study|Lost to Follow-up|0|||
149929965|NCT00807885|540878414|FG008|Overall Study|Lost to Follow-up|0|||
149929966|NCT03489343|540878415|FG000|Overall Study|Documented progressive disease|1|||
149929967|NCT03489343|540878416|FG001|Overall Study|Documented progressive disease|0|||
149929968|NCT03489343|540878417|FG002|Overall Study|Documented progressive disease|3|||
149929969|NCT03489343|540878418|FG003|Overall Study|Documented progressive disease|1|||
149929970|NCT03489343|540878419|FG004|Overall Study|Documented progressive disease|3|||
149929971|NCT03489343|540878420|FG005|Overall Study|Documented progressive disease|5|||
149929972|NCT03489343|540878421|FG006|Overall Study|Documented progressive disease|4|||
149929973|NCT03489343|540878415|FG000|Overall Study|Adverse Event|0|||
149929974|NCT03489343|540878416|FG001|Overall Study|Adverse Event|1|||
149929975|NCT03489343|540878417|FG002|Overall Study|Adverse Event|0|||
149929976|NCT03489343|540878418|FG003|Overall Study|Adverse Event|0|||
149929977|NCT03489343|540878419|FG004|Overall Study|Adverse Event|0|||
149929978|NCT03489343|540878420|FG005|Overall Study|Adverse Event|1|||
149929979|NCT03489343|540878421|FG006|Overall Study|Adverse Event|0|||
149929980|NCT03489343|540878415|FG000|Overall Study|Withdrawal by Subject|0|||
149929981|NCT03489343|540878416|FG001|Overall Study|Withdrawal by Subject|0|||
149929982|NCT03489343|540878417|FG002|Overall Study|Withdrawal by Subject|0|||
149929983|NCT03489343|540878418|FG003|Overall Study|Withdrawal by Subject|1|||
149929984|NCT03489343|540878419|FG004|Overall Study|Withdrawal by Subject|0|||
149929985|NCT03489343|540878420|FG005|Overall Study|Withdrawal by Subject|1|||
149929986|NCT03489343|540878421|FG006|Overall Study|Withdrawal by Subject|1|||
149929987|NCT03489343|540878415|FG000|Overall Study|Clinical progression|0|||
149929988|NCT03489343|540878416|FG001|Overall Study|Clinical progression|0|||
149929989|NCT03489343|540878417|FG002|Overall Study|Clinical progression|0|||
149929990|NCT03489343|540878418|FG003|Overall Study|Clinical progression|1|||
149929991|NCT03489343|540878419|FG004|Overall Study|Clinical progression|0|||
149929992|NCT03489343|540878420|FG005|Overall Study|Clinical progression|0|||
149929993|NCT03489343|540878421|FG006|Overall Study|Clinical progression|1|||
149929994|NCT00327717|540878422|FG000|Overall Study|Adverse Event|6|||
149929995|NCT00327717|540878423|FG001|Overall Study|Adverse Event|6|||
149929996|NCT00327717|540878422|FG000|Overall Study|Lack of Efficacy|0|||
149929997|NCT00327717|540878423|FG001|Overall Study|Lack of Efficacy|1|||
149929998|NCT00327717|540878422|FG000|Overall Study|Withdrawal by Subject|3|||
149929999|NCT00327717|540878423|FG001|Overall Study|Withdrawal by Subject|7|||
149930000|NCT01630135|540878426|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
150165534|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
150165535|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
150165536|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
150165537|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
150165538|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Non-compliance|4|||
150165539|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Non-compliance|0|||
149930001|NCT01630135|540878427|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
149930002|NCT04767373|540878428|FG000|Overall Study|Death|6|||
149930003|NCT04767373|540878429|FG001|Overall Study|Death|3|||
149930004|NCT04767373|540878428|FG000|Overall Study|Lost to Follow-up|67|||
149930005|NCT04767373|540878429|FG001|Overall Study|Lost to Follow-up|35|||
149930006|NCT04767373|540878428|FG000|Overall Study|Physician Decision|15|||
149930007|NCT04767373|540878429|FG001|Overall Study|Physician Decision|4|||
150165540|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Non-compliance|0|||
150165541|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Non-compliance|0|||
150165542|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Pain|4|||
149930008|NCT04767373|540878428|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149930009|NCT04767373|540878429|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149930010|NCT04767373|540878428|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
149930011|NCT04767373|540878429|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
149930012|NCT04767373|540878428|FG000|Overall Study|Other|1|||
149930013|NCT04767373|540878429|FG001|Overall Study|Other|2|||
149930014|NCT01502033|540878430|FG000|Overall Study|1 participant had scalp discomfort|1|||
149930015|NCT01502033|540878430|FG000|Overall Study|1 participant had worsening depression|1|||
149930016|NCT01502033|540878430|FG000|Overall Study|1 participant went back to school|1|||
149930017|NCT02658669|540878431|FG000|Overall Study|Lost to Follow-up|7|||
149930018|NCT02658669|540878432|FG001|Overall Study|Lost to Follow-up|5|||
149930019|NCT00186485|540878433|FG000|Overall Study|Lost to Follow-up|3|||
149930020|NCT03804268|540878444|FG000|Overall Study|Adverse Event|2|||
149930021|NCT03804268|540878445|FG001|Overall Study|Adverse Event|2|||
149930022|NCT03804268|540878444|FG000|Overall Study|Withdrawal by Subject|2|||
149930023|NCT03804268|540878445|FG001|Overall Study|Withdrawal by Subject|0|||
149930024|NCT03804268|540878444|FG000|Overall Study|Lost to Follow-up|1|||
149930025|NCT03804268|540878445|FG001|Overall Study|Lost to Follow-up|0|||
149930026|NCT03804268|540878444|FG000|Overall Study|Physician Decision|2|||
149930027|NCT03804268|540878445|FG001|Overall Study|Physician Decision|0|||
149930028|NCT00838097|540878448|FG000|Overall Study|Ineligibility determined|6|||
149930029|NCT00838097|540878448|FG000|Overall Study|Adverse Event|2|||
149930030|NCT00838097|540878448|FG000|Overall Study|Withdrawal by Subject|3|||
149930031|NCT00838097|540878448|FG000|Overall Study|Requirement for alternative therapy|2|||
149930032|NCT00838097|540878448|FG000|Overall Study|Physician Decision|4|||
149930033|NCT00838097|540878448|FG000|Overall Study|Lost to Follow-up|11|||
149930034|NCT00838097|540878448|FG000|Overall Study|Death|6|||
149930035|NCT00838097|540878448|FG000|Overall Study|Protocol-specified criteria|142|||
149930036|NCT03311841|540878451|FG000|14-day Wash-out|Adverse Event|0|||
149930037|NCT03311841|540878452|FG001|14-day Wash-out|Adverse Event|1|||
149930038|NCT03311841|540878453|FG002|14-day Wash-out|Adverse Event|0|||
149930039|NCT03311841|540878454|FG003|14-day Wash-out|Adverse Event|0|||
149930040|NCT03311841|540878455|FG004|14-day Wash-out|Adverse Event|0|||
149930041|NCT03311841|540878451|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
149930042|NCT03311841|540878452|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
149930043|NCT03311841|540878453|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
149930044|NCT03311841|540878454|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
149930045|NCT03311841|540878455|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
149930046|NCT02358031|540879797|FG000|Overall Study|Death|253|||
149930047|NCT02358031|540879798|FG001|Overall Study|Death|237|||
149930048|NCT02358031|540879799|FG002|Overall Study|Death|266|||
149930049|NCT02358031|540879797|FG000|Overall Study|Lost to Follow-up|1|||
149930050|NCT02358031|540879798|FG001|Overall Study|Lost to Follow-up|1|||
149930051|NCT02358031|540879799|FG002|Overall Study|Lost to Follow-up|0|||
149930052|NCT02358031|540879797|FG000|Overall Study|Withdrawal by Subject|19|||
149930053|NCT02358031|540879798|FG001|Overall Study|Withdrawal by Subject|14|||
149930054|NCT02358031|540879799|FG002|Overall Study|Withdrawal by Subject|18|||
149930055|NCT02358031|540879797|FG000|Overall Study|Sponsor Decision|26|||
149930056|NCT02358031|540879798|FG001|Overall Study|Sponsor Decision|28|||
149930057|NCT02358031|540879799|FG002|Overall Study|Sponsor Decision|16|||
149930058|NCT01212094|540879800|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
149930059|NCT01212094|540879801|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
149930060|NCT01212094|540879802|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
149930061|NCT01212094|540879800|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
149930062|NCT01212094|540879801|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
149930063|NCT01212094|540879802|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
149930064|NCT01212094|540879800|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
149930065|NCT01212094|540879801|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
149930066|NCT01212094|540879802|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
150165543|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Pain|0|||
150165544|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Pain|0|||
150165545|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Pain|0|||
150165546|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
150165547|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
150165548|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
150165549|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
150165550|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Hospice care|1|||
149930067|NCT01212094|540879800|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
149930068|NCT01212094|540879801|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
149930069|NCT01212094|540879802|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
149930070|NCT01212094|540879800|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
149930071|NCT01212094|540879801|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
149930072|NCT01212094|540879802|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
149930073|NCT01212094|540879800|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
149930074|NCT01212094|540879801|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
149930075|NCT01212094|540879802|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
150165551|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Hospice care|0|||
150266113|NCT00413972|542110190|FG003|Overall Study|Other|1|||
150266114|NCT02520284|542110193|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
150266115|NCT02520284|542110194|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
150266116|NCT02520284|542110195|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
150266117|NCT02520284|542110193|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
150266118|NCT02520284|542110194|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
150266119|NCT02520284|542110195|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
150266120|NCT02520284|542110193|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
149930076|NCT04980014|540879809|FG000|Overall Study|Participants who are Duplicated|1|||
149930077|NCT04980014|540879809|FG000|Overall Study|Follow-up Failure|13|||
149930078|NCT04980014|540879809|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
149930079|NCT04980014|540879809|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
149930080|NCT04980014|540879809|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
149930081|NCT00715559|540879810|FG000|Overall Study|medication not tolerated - nausea|1|||
149930082|NCT02787304|540879813|FG000|Overall Study|Adverse Event|9|||
149930083|NCT02787304|540879814|FG001|Overall Study|Adverse Event|3|||
149930084|NCT02787304|540879815|FG002|Overall Study|Adverse Event|8|||
149930085|NCT02787304|540879816|FG003|Overall Study|Adverse Event|1|||
149930086|NCT02787304|540879813|FG000|Overall Study|Withdrawal by Subject|1|||
149930087|NCT02787304|540879814|FG001|Overall Study|Withdrawal by Subject|4|||
149930088|NCT02787304|540879815|FG002|Overall Study|Withdrawal by Subject|0|||
149930089|NCT02787304|540879816|FG003|Overall Study|Withdrawal by Subject|0|||
149930090|NCT02787304|540879813|FG000|Overall Study|Lost to Follow-up|1|||
149930091|NCT02787304|540879814|FG001|Overall Study|Lost to Follow-up|0|||
149930092|NCT02787304|540879815|FG002|Overall Study|Lost to Follow-up|0|||
149930093|NCT02787304|540879816|FG003|Overall Study|Lost to Follow-up|1|||
149930094|NCT02787304|540879813|FG000|Overall Study|Noncompliance with study drug|0|||
149930095|NCT02787304|540879814|FG001|Overall Study|Noncompliance with study drug|0|||
149930096|NCT02787304|540879815|FG002|Overall Study|Noncompliance with study drug|1|||
149930097|NCT02787304|540879816|FG003|Overall Study|Noncompliance with study drug|0|||
149930098|NCT02787304|540879813|FG000|Overall Study|Physician Decision|0|||
149930099|NCT02787304|540879814|FG001|Overall Study|Physician Decision|0|||
149930100|NCT02787304|540879815|FG002|Overall Study|Physician Decision|1|||
149930101|NCT02787304|540879816|FG003|Overall Study|Physician Decision|0|||
149930102|NCT02787304|540879813|FG000|Overall Study|Study terminated by sponsor|25|||
149930103|NCT02787304|540879814|FG001|Overall Study|Study terminated by sponsor|31|||
149930104|NCT02787304|540879815|FG002|Overall Study|Study terminated by sponsor|31|||
149930105|NCT02787304|540879816|FG003|Overall Study|Study terminated by sponsor|32|||
149930106|NCT00419757|540879821|FG000|Overall Study|Adverse Event|1|||
149930107|NCT00419757|540879822|FG001|Overall Study|Adverse Event|4|||
149930108|NCT00419757|540879821|FG000|Overall Study|Lost to Follow-up|1|||
149930109|NCT00419757|540879822|FG001|Overall Study|Lost to Follow-up|4|||
149930110|NCT00419757|540879821|FG000|Overall Study|Withdrawal by Subject|7|||
149930111|NCT00419757|540879822|FG001|Overall Study|Withdrawal by Subject|1|||
149930112|NCT00419757|540879821|FG000|Overall Study|Protocol Violation|2|||
149930113|NCT00419757|540879822|FG001|Overall Study|Protocol Violation|3|||
149930114|NCT00419757|540879821|FG000|Overall Study|Study specific discontinuation criteria|4|||
149930115|NCT00419757|540879822|FG001|Overall Study|Study specific discontinuation criteria|8|||
149930116|NCT00419757|540879821|FG000|Overall Study|Multiple reasons|3|||
149930117|NCT00419757|540879822|FG001|Overall Study|Multiple reasons|1|||
149930118|NCT00737100|540879832|FG000|Overall Study|Adverse Event|6|||
149930119|NCT00737100|540879833|FG001|Overall Study|Adverse Event|5|||
149930120|NCT00737100|540879834|FG002|Overall Study|Adverse Event|3|||
149930121|NCT00737100|540879832|FG000|Overall Study|Lost to Follow-up|0|||
149930122|NCT00737100|540879833|FG001|Overall Study|Lost to Follow-up|1|||
149930123|NCT00737100|540879834|FG002|Overall Study|Lost to Follow-up|0|||
149930124|NCT00737100|540879832|FG000|Overall Study|Withdrawal by Subject|0|||
149930125|NCT00737100|540879833|FG001|Overall Study|Withdrawal by Subject|0|||
149930126|NCT00737100|540879834|FG002|Overall Study|Withdrawal by Subject|3|||
149930127|NCT00737100|540879832|FG000|Overall Study|Reason discontinued not explained above|1|||
149930128|NCT00737100|540879833|FG001|Overall Study|Reason discontinued not explained above|1|||
149930129|NCT00737100|540879834|FG002|Overall Study|Reason discontinued not explained above|1|||
149930130|NCT00705757|540879837|FG000|Overall Study|Lack of Efficacy|5|||
149930131|NCT00705757|540879838|FG001|Overall Study|Lack of Efficacy|1|||
149930132|NCT00705757|540879839|FG002|Overall Study|Lack of Efficacy|3|||
150266121|NCT02520284|542110194|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
150266122|NCT02520284|542110195|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
150266123|NCT02520284|542110193|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
150266124|NCT02520284|542110194|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
150266125|NCT02520284|542110195|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
149930133|NCT00705757|540879837|FG000|Overall Study|Lost to Follow-up|7|||
149930134|NCT00705757|540879838|FG001|Overall Study|Lost to Follow-up|6|||
149930135|NCT00705757|540879839|FG002|Overall Study|Lost to Follow-up|6|||
149930136|NCT00705757|540879837|FG000|Overall Study|Withdrawal by Subject|1|||
149930137|NCT00705757|540879838|FG001|Overall Study|Withdrawal by Subject|1|||
149930138|NCT00705757|540879839|FG002|Overall Study|Withdrawal by Subject|2|||
149930139|NCT01443858|540879840|FG000|Overall Study|Withdrawal by Subject|9|||
149930140|NCT01443858|540879841|FG001|Overall Study|Withdrawal by Subject|8|||
149930141|NCT01443858|540879842|FG002|Overall Study|Withdrawal by Subject|5|||
149930142|NCT01443858|540879840|FG000|Overall Study|Lack of Efficacy|1|||
149930143|NCT01443858|540879841|FG001|Overall Study|Lack of Efficacy|0|||
149930144|NCT01443858|540879842|FG002|Overall Study|Lack of Efficacy|0|||
149930145|NCT01443858|540879840|FG000|Overall Study|Lost to Follow-up|5|||
149930146|NCT01443858|540879841|FG001|Overall Study|Lost to Follow-up|5|||
149930147|NCT01443858|540879842|FG002|Overall Study|Lost to Follow-up|2|||
149930148|NCT01272908|540879843|FG000|Initial Treatment Period|Adverse Event|1|||
149930149|NCT01272908|540879843|FG000|Initial Treatment Period|Lack of Efficacy|5|||
149930150|NCT01272908|540879843|FG000|Initial Treatment Period|Protocol Violation|1|||
149930151|NCT01272908|540879843|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
149930152|NCT01272908|540879843|FG000|Re-Treatment Period|Adverse Event|2|||
149930153|NCT01272908|540879843|FG000|Re-Treatment Period|Lack of Efficacy|3|||
149930154|NCT01272908|540879843|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
149930155|NCT02221648|540879844|FG000|Overall Study|Withdrawal by Subject|3|||
149930156|NCT02221648|540879845|FG001|Overall Study|Withdrawal by Subject|3|||
149930157|NCT00149396|540879846|FG000|Overall Study|Death|15|||
149930158|NCT00149396|540879846|FG000|Overall Study|Withdrawal by Subject|1|||
149930159|NCT00149396|540879846|FG000|Overall Study|Subject noncompliance|2|||
149930160|NCT00149396|540879846|FG000|Overall Study|other treatment|5|||
149930161|NCT00810069|540879850|FG000|Lead-in Period I|Adverse Event|43|||
149930162|NCT00810069|540879851|FG001|Lead-in Period I|Adverse Event|0|||
149930163|NCT00810069|540879852|FG002|Lead-in Period I|Adverse Event|0|||
149930164|NCT00810069|540879850|FG000|Lead-in Period I|Lack of Efficacy|1|||
149930165|NCT00810069|540879851|FG001|Lead-in Period I|Lack of Efficacy|0|||
149930166|NCT00810069|540879852|FG002|Lead-in Period I|Lack of Efficacy|0|||
149930167|NCT00810069|540879850|FG000|Lead-in Period I|Lost to Follow-up|19|||
149930168|NCT00810069|540879851|FG001|Lead-in Period I|Lost to Follow-up|0|||
149930169|NCT00810069|540879852|FG002|Lead-in Period I|Lost to Follow-up|0|||
149930170|NCT00810069|540879850|FG000|Lead-in Period I|Physician Decision|1|||
149930171|NCT00810069|540879851|FG001|Lead-in Period I|Physician Decision|0|||
149930172|NCT00810069|540879852|FG002|Lead-in Period I|Physician Decision|0|||
149930173|NCT00810069|540879850|FG000|Lead-in Period I|Protocol Violation|1|||
149930174|NCT00810069|540879851|FG001|Lead-in Period I|Protocol Violation|0|||
149930175|NCT00810069|540879852|FG002|Lead-in Period I|Protocol Violation|0|||
149930176|NCT00810069|540879850|FG000|Lead-in Period I|Withdrawal by Subject|46|||
149930177|NCT00810069|540879851|FG001|Lead-in Period I|Withdrawal by Subject|0|||
149930178|NCT00810069|540879852|FG002|Lead-in Period I|Withdrawal by Subject|0|||
149930179|NCT00810069|540879850|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
149930180|NCT00810069|540879851|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
149930181|NCT00810069|540879852|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
149930182|NCT00810069|540879850|FG000|Lead-in Period I|Randomization criteria not met|158|||
149930183|NCT00810069|540879851|FG001|Lead-in Period I|Randomization criteria not met|0|||
149930184|NCT00810069|540879852|FG002|Lead-in Period I|Randomization criteria not met|0|||
149930185|NCT00810069|540879850|FG000|Double-Blind Period II|Adverse Event|0|||
149930186|NCT00810069|540879851|FG001|Double-Blind Period II|Adverse Event|9|||
149930187|NCT00810069|540879852|FG002|Double-Blind Period II|Adverse Event|8|||
149930188|NCT00810069|540879850|FG000|Double-Blind Period II|Lack of Efficacy|0|||
149930189|NCT00810069|540879851|FG001|Double-Blind Period II|Lack of Efficacy|7|||
149930190|NCT00810069|540879852|FG002|Double-Blind Period II|Lack of Efficacy|12|||
149930191|NCT00810069|540879850|FG000|Double-Blind Period II|Lost to Follow-up|0|||
149930192|NCT00810069|540879851|FG001|Double-Blind Period II|Lost to Follow-up|9|||
149930193|NCT00810069|540879852|FG002|Double-Blind Period II|Lost to Follow-up|9|||
149930194|NCT00810069|540879850|FG000|Double-Blind Period II|Physician Decision|0|||
149930195|NCT00810069|540879851|FG001|Double-Blind Period II|Physician Decision|0|||
150165552|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Hospice care|0|||
150165553|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Hospice care|0|||
150165554|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Physician Decision|1|||
150165555|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Physician Decision|0|||
150165556|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Physician Decision|0|||
150165557|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Physician Decision|0|||
149930196|NCT00810069|540879852|FG002|Double-Blind Period II|Physician Decision|1|||
149930197|NCT00810069|540879850|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
149930198|NCT00810069|540879851|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
149930199|NCT00810069|540879852|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
149930200|NCT00810069|540879850|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
149930201|NCT00810069|540879851|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
149930202|NCT00810069|540879852|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
149930203|NCT00810069|540879850|FG000|Double-Blind Period II|Clinical relapse|0|||
149930204|NCT00810069|540879851|FG001|Double-Blind Period II|Clinical relapse|3|||
149930205|NCT00810069|540879852|FG002|Double-Blind Period II|Clinical relapse|0|||
149930206|NCT00810069|540879850|FG000|Double-Blind Period II|Protocol Violation|0|||
149930207|NCT00810069|540879851|FG001|Double-Blind Period II|Protocol Violation|7|||
149930208|NCT00810069|540879852|FG002|Double-Blind Period II|Protocol Violation|6|||
149930209|NCT02899065|540879855|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
149930210|NCT02899065|540879856|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
149930211|NCT02899065|540879855|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
149930212|NCT02899065|540879856|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
149930213|NCT02899065|540879855|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
149930214|NCT02899065|540879856|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
149930215|NCT02983045|540879857|FG000|Overall Study|Withdrawal by Subject|0|||
149930216|NCT02983045|540879858|FG001|Overall Study|Withdrawal by Subject|1|||
149930217|NCT02983045|540879859|FG002|Overall Study|Withdrawal by Subject|0|||
149930218|NCT02983045|540879860|FG003|Overall Study|Withdrawal by Subject|5|||
149930219|NCT02983045|540879861|FG004|Overall Study|Withdrawal by Subject|0|||
149930220|NCT02983045|540879862|FG005|Overall Study|Withdrawal by Subject|72|||
149930221|NCT02983045|540879863|FG006|Overall Study|Withdrawal by Subject|0|||
149930222|NCT02983045|540879864|FG007|Overall Study|Withdrawal by Subject|0|||
149930223|NCT02983045|540879865|FG008|Overall Study|Withdrawal by Subject|0|||
149930224|NCT02983045|540879866|FG009|Overall Study|Withdrawal by Subject|2|||
149930225|NCT02983045|540879857|FG000|Overall Study|Lost to Follow-up|0|||
149930226|NCT02983045|540879858|FG001|Overall Study|Lost to Follow-up|0|||
149930227|NCT02983045|540879859|FG002|Overall Study|Lost to Follow-up|0|||
149930228|NCT02983045|540879860|FG003|Overall Study|Lost to Follow-up|0|||
149930229|NCT02983045|540879861|FG004|Overall Study|Lost to Follow-up|0|||
149930230|NCT02983045|540879862|FG005|Overall Study|Lost to Follow-up|10|||
149930231|NCT02983045|540879863|FG006|Overall Study|Lost to Follow-up|0|||
149930232|NCT02983045|540879864|FG007|Overall Study|Lost to Follow-up|0|||
149930233|NCT02983045|540879865|FG008|Overall Study|Lost to Follow-up|0|||
149930234|NCT02983045|540879866|FG009|Overall Study|Lost to Follow-up|0|||
149930235|NCT05225389|540879869|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
149930236|NCT01585246|540879870|FG000|Overall Study|Lost to Follow-up|0|||
149930237|NCT01585246|540879871|FG001|Overall Study|Lost to Follow-up|0|||
149930238|NCT01585246|540879872|FG002|Overall Study|Lost to Follow-up|2|||
149930239|NCT01585246|540879873|FG003|Overall Study|Lost to Follow-up|1|||
149930240|NCT01585246|540879874|FG004|Overall Study|Lost to Follow-up|0|||
149930241|NCT01585246|540879870|FG000|Overall Study|Protocol Violation|0|||
149930242|NCT01585246|540879871|FG001|Overall Study|Protocol Violation|0|||
149930243|NCT01585246|540879872|FG002|Overall Study|Protocol Violation|0|||
149930244|NCT01585246|540879873|FG003|Overall Study|Protocol Violation|0|||
149930245|NCT01585246|540879874|FG004|Overall Study|Protocol Violation|1|||
149930246|NCT01585246|540879870|FG000|Overall Study|Withdrawal by Subject|0|||
149930247|NCT01585246|540879871|FG001|Overall Study|Withdrawal by Subject|0|||
149930248|NCT01585246|540879872|FG002|Overall Study|Withdrawal by Subject|1|||
149930249|NCT01585246|540879873|FG003|Overall Study|Withdrawal by Subject|2|||
149930250|NCT01585246|540879874|FG004|Overall Study|Withdrawal by Subject|1|||
149930251|NCT01585246|540879870|FG000|Overall Study|Other|0|||
149930252|NCT01585246|540879871|FG001|Overall Study|Other|1|||
149930253|NCT01585246|540879872|FG002|Overall Study|Other|1|||
149930254|NCT01585246|540879873|FG003|Overall Study|Other|1|||
149930255|NCT01585246|540879874|FG004|Overall Study|Other|0|||
149930256|NCT03421379|540879875|FG000|Period 1|Withdrawal by Subject|0|||
149930257|NCT03421379|540879876|FG001|Period 1|Withdrawal by Subject|1|||
149930258|NCT03421379|540879875|FG000|Period 1|Physician Decision|1|||
149930259|NCT03421379|540879876|FG001|Period 1|Physician Decision|1|||
149930260|NCT03421379|540879875|FG000|Period 1|Did not receive treatment|1|||
149930261|NCT03421379|540879876|FG001|Period 1|Did not receive treatment|2|||
149930262|NCT01951417|540879877|FG000|Overall Study|Withdrawal by Subject|1|||
149930263|NCT01951417|540879877|FG000|Overall Study|Protocol Violation|2|||
149930264|NCT01951417|540879877|FG000|Overall Study|Lost to Follow-up|6|||
149930265|NCT00977613|540879878|FG000|Overall Study|Lost to Follow-up|16|||
149930266|NCT01598610|540879881|FG000|Overall Study|Adverse Event|1|||
149930267|NCT03771963|540879886|FG000|Overall Study|Lost to Follow-up|22|||
149930268|NCT03771963|540879886|FG000|Overall Study|Withdrawal of Consent|10|||
149930269|NCT03066830|540879887|FG000|Overall Study|At the Participant's own Request|16|||
149930270|NCT03066830|540879888|FG001|Overall Study|At the Participant's own Request|17|||
149930271|NCT03066830|540879887|FG000|Overall Study|Other|3|||
149930272|NCT03066830|540879888|FG001|Overall Study|Other|0|||
149930273|NCT03066830|540879887|FG000|Overall Study|Poor Compliance to Protocol|1|||
149930274|NCT03066830|540879888|FG001|Overall Study|Poor Compliance to Protocol|0|||
149930275|NCT03066830|540879887|FG000|Overall Study|Adverse Event|2|||
149930276|NCT03066830|540879888|FG001|Overall Study|Adverse Event|2|||
149930277|NCT03066830|540879887|FG000|Overall Study|Lost to Follow-up|11|||
149930278|NCT03066830|540879888|FG001|Overall Study|Lost to Follow-up|3|||
149930279|NCT03360019|540879889|FG000|Overall Study|Withdrawal by Subject|2|||
149930280|NCT03360019|540879890|FG001|Overall Study|Withdrawal by Subject|0|||
149930281|NCT03360019|540879891|FG002|Overall Study|Withdrawal by Subject|0|||
149930282|NCT03360019|540879889|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
149930283|NCT03360019|540879890|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
149930284|NCT03360019|540879891|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
149930285|NCT00520039|540879894|FG000|Overall Study|Exclusion criteria met at first visit|7|||
149930286|NCT00520039|540879895|FG001|Overall Study|Exclusion criteria met at first visit|5|||
149930287|NCT00325819|540879896|FG000|Overall Study|Study product lost in mail|2|||
149930288|NCT00325819|540879897|FG001|Overall Study|Study product lost in mail|1|||
149930289|NCT00325819|540879896|FG000|Overall Study|Did not take a dose of study product|4|||
149930290|NCT00325819|540879897|FG001|Overall Study|Did not take a dose of study product|9|||
149930291|NCT00325819|540879896|FG000|Overall Study|Lost to Follow-up|3|||
149930292|NCT00325819|540879897|FG001|Overall Study|Lost to Follow-up|3|||
149930293|NCT02058589|540879900|FG000|Overall Study|Serious Adverse Event|1|||
149930294|NCT02058589|540879901|FG001|Overall Study|Serious Adverse Event|1|||
149930295|NCT02058589|540879900|FG000|Overall Study|Non-Serious Adverse Event|1|||
149930296|NCT02058589|540879901|FG001|Overall Study|Non-Serious Adverse Event|0|||
149930297|NCT02058589|540879900|FG000|Overall Study|Withdrawal by Subject|0|||
149930298|NCT02058589|540879901|FG001|Overall Study|Withdrawal by Subject|1|||
149930299|NCT00490971|540879903|FG000|Acute/Continuation|Adverse Event|62|||
149930300|NCT00490971|540879904|FG001|Acute/Continuation|Adverse Event|13|||
149930301|NCT00490971|540879905|FG002|Acute/Continuation|Adverse Event|0|||
149930302|NCT00490971|540879906|FG003|Acute/Continuation|Adverse Event|0|||
149930303|NCT00490971|540879907|FG004|Acute/Continuation|Adverse Event|0|||
149930304|NCT00490971|540879903|FG000|Acute/Continuation|Death|2|||
149930305|NCT00490971|540879904|FG001|Acute/Continuation|Death|0|||
149930306|NCT00490971|540879905|FG002|Acute/Continuation|Death|0|||
149930307|NCT00490971|540879906|FG003|Acute/Continuation|Death|0|||
149930308|NCT00490971|540879907|FG004|Acute/Continuation|Death|0|||
149930309|NCT00490971|540879903|FG000|Acute/Continuation|Lack of Efficacy|106|||
149930310|NCT00490971|540879904|FG001|Acute/Continuation|Lack of Efficacy|12|||
149930311|NCT00490971|540879905|FG002|Acute/Continuation|Lack of Efficacy|0|||
149930312|NCT00490971|540879906|FG003|Acute/Continuation|Lack of Efficacy|0|||
149930313|NCT00490971|540879907|FG004|Acute/Continuation|Lack of Efficacy|0|||
149930314|NCT00490971|540879903|FG000|Acute/Continuation|Lost to Follow-up|23|||
149930315|NCT00490971|540879904|FG001|Acute/Continuation|Lost to Follow-up|7|||
149930316|NCT00490971|540879905|FG002|Acute/Continuation|Lost to Follow-up|0|||
149930317|NCT00490971|540879906|FG003|Acute/Continuation|Lost to Follow-up|0|||
149930318|NCT00490971|540879907|FG004|Acute/Continuation|Lost to Follow-up|0|||
149930319|NCT00490971|540879903|FG000|Acute/Continuation|Protocol Violation|10|||
149930320|NCT00490971|540879904|FG001|Acute/Continuation|Protocol Violation|2|||
149930321|NCT00490971|540879905|FG002|Acute/Continuation|Protocol Violation|0|||
149930322|NCT00490971|540879906|FG003|Acute/Continuation|Protocol Violation|0|||
149930323|NCT00490971|540879907|FG004|Acute/Continuation|Protocol Violation|0|||
149930324|NCT00490971|540879903|FG000|Acute/Continuation|Withdrawal by Subject|92|||
149930325|NCT00490971|540879904|FG001|Acute/Continuation|Withdrawal by Subject|24|||
149930326|NCT00490971|540879905|FG002|Acute/Continuation|Withdrawal by Subject|0|||
149930327|NCT00490971|540879906|FG003|Acute/Continuation|Withdrawal by Subject|0|||
149930328|NCT00490971|540879907|FG004|Acute/Continuation|Withdrawal by Subject|0|||
149930329|NCT00490971|540879903|FG000|Acute/Continuation|Other|11|||
149930330|NCT00490971|540879904|FG001|Acute/Continuation|Other|4|||
149930331|NCT00490971|540879905|FG002|Acute/Continuation|Other|0|||
149930332|NCT00490971|540879906|FG003|Acute/Continuation|Other|0|||
149930333|NCT00490971|540879907|FG004|Acute/Continuation|Other|0|||
149930334|NCT00490971|540879903|FG000|Maintenance|Adverse Event|0|||
149930335|NCT00490971|540879904|FG001|Maintenance|Adverse Event|0|||
149930336|NCT00490971|540879905|FG002|Maintenance|Adverse Event|4|||
149930337|NCT00490971|540879906|FG003|Maintenance|Adverse Event|5|||
149930338|NCT00490971|540879907|FG004|Maintenance|Adverse Event|7|||
149930339|NCT00490971|540879903|FG000|Maintenance|Death|0|||
149930340|NCT00490971|540879904|FG001|Maintenance|Death|0|||
149930341|NCT00490971|540879905|FG002|Maintenance|Death|0|||
149930342|NCT00490971|540879906|FG003|Maintenance|Death|2|||
150165558|NCT01107626|541741577|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
150165559|NCT01107626|541741578|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
150165560|NCT01107626|541741579|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
150165561|NCT01107626|541741580|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
150165562|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
149930343|NCT00490971|540879907|FG004|Maintenance|Death|0|||
149930344|NCT00490971|540879903|FG000|Maintenance|Lost to Follow-up|0|||
149930345|NCT00490971|540879904|FG001|Maintenance|Lost to Follow-up|0|||
149930346|NCT00490971|540879905|FG002|Maintenance|Lost to Follow-up|5|||
149930347|NCT00490971|540879906|FG003|Maintenance|Lost to Follow-up|8|||
149930348|NCT00490971|540879907|FG004|Maintenance|Lost to Follow-up|10|||
149930349|NCT00490971|540879903|FG000|Maintenance|Pregnancy|0|||
149930350|NCT00490971|540879904|FG001|Maintenance|Pregnancy|0|||
149930351|NCT00490971|540879905|FG002|Maintenance|Pregnancy|1|||
149930352|NCT00490971|540879906|FG003|Maintenance|Pregnancy|0|||
149930353|NCT00490971|540879907|FG004|Maintenance|Pregnancy|0|||
149930354|NCT00490971|540879903|FG000|Maintenance|Protocol Violation|0|||
149930355|NCT00490971|540879904|FG001|Maintenance|Protocol Violation|0|||
149930356|NCT00490971|540879905|FG002|Maintenance|Protocol Violation|4|||
149930357|NCT00490971|540879906|FG003|Maintenance|Protocol Violation|1|||
149930358|NCT00490971|540879907|FG004|Maintenance|Protocol Violation|1|||
149930359|NCT00490971|540879903|FG000|Maintenance|Withdrawal by Subject|0|||
149930360|NCT00490971|540879904|FG001|Maintenance|Withdrawal by Subject|0|||
149930361|NCT00490971|540879905|FG002|Maintenance|Withdrawal by Subject|26|||
149930362|NCT00490971|540879906|FG003|Maintenance|Withdrawal by Subject|28|||
149930363|NCT00490971|540879907|FG004|Maintenance|Withdrawal by Subject|18|||
149930364|NCT00490971|540879903|FG000|Maintenance|Other|0|||
149930365|NCT00490971|540879904|FG001|Maintenance|Other|0|||
149930366|NCT00490971|540879905|FG002|Maintenance|Other|11|||
149930367|NCT00490971|540879906|FG003|Maintenance|Other|9|||
149930368|NCT00490971|540879907|FG004|Maintenance|Other|3|||
149930369|NCT04754542|540879913|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
149930370|NCT04754542|540879914|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
149930371|NCT05664581|540881827|FG000|Overall Study|Withdrawal by Subject|2|||
149930372|NCT03101150|540881830|FG000|Overall Study|Lost to Follow-up|2|||
149930373|NCT03101150|540881831|FG001|Overall Study|Lost to Follow-up|4|||
149930374|NCT03101150|540881830|FG000|Overall Study|Miscarriage|3|||
149930375|NCT03101150|540881831|FG001|Overall Study|Miscarriage|6|||
149930376|NCT01317641|540881832|FG000|Overall Study|Not treated|0|||
149930377|NCT01317641|540881833|FG001|Overall Study|Not treated|0|||
149930378|NCT01317641|540881834|FG002|Overall Study|Not treated|0|||
149930379|NCT01317641|540881835|FG003|Overall Study|Not treated|0|||
149930380|NCT01317641|540881836|FG004|Overall Study|Not treated|0|||
149930381|NCT01317641|540881837|FG005|Overall Study|Not treated|0|||
149930382|NCT01317641|540881838|FG006|Overall Study|Not treated|0|||
149930383|NCT01317641|540881839|FG007|Overall Study|Not treated|1|||
149930384|NCT01317641|540881840|FG008|Overall Study|Not treated|1|||
149930385|NCT01317641|540881832|FG000|Overall Study|Adverse Event|0|||
149930386|NCT01317641|540881833|FG001|Overall Study|Adverse Event|1|||
149930387|NCT01317641|540881834|FG002|Overall Study|Adverse Event|0|||
149930388|NCT01317641|540881835|FG003|Overall Study|Adverse Event|1|||
149930389|NCT01317641|540881836|FG004|Overall Study|Adverse Event|0|||
149930390|NCT01317641|540881837|FG005|Overall Study|Adverse Event|0|||
149930391|NCT01317641|540881838|FG006|Overall Study|Adverse Event|2|||
149930392|NCT01317641|540881839|FG007|Overall Study|Adverse Event|1|||
149930393|NCT01317641|540881840|FG008|Overall Study|Adverse Event|0|||
149930394|NCT01317641|540881832|FG000|Overall Study|Protocol Violation|1|||
149930395|NCT01317641|540881833|FG001|Overall Study|Protocol Violation|0|||
149930396|NCT01317641|540881834|FG002|Overall Study|Protocol Violation|0|||
149930397|NCT01317641|540881835|FG003|Overall Study|Protocol Violation|0|||
149930398|NCT01317641|540881836|FG004|Overall Study|Protocol Violation|0|||
149930399|NCT01317641|540881837|FG005|Overall Study|Protocol Violation|0|||
149930400|NCT01317641|540881838|FG006|Overall Study|Protocol Violation|0|||
149930401|NCT01317641|540881839|FG007|Overall Study|Protocol Violation|0|||
149930402|NCT01317641|540881840|FG008|Overall Study|Protocol Violation|0|||
149930403|NCT01317641|540881832|FG000|Overall Study|Disease progression|0|||
149930404|NCT01317641|540881833|FG001|Overall Study|Disease progression|0|||
149930405|NCT01317641|540881834|FG002|Overall Study|Disease progression|0|||
149930406|NCT01317641|540881835|FG003|Overall Study|Disease progression|0|||
149930407|NCT01317641|540881836|FG004|Overall Study|Disease progression|0|||
149930408|NCT01317641|540881837|FG005|Overall Study|Disease progression|0|||
149930409|NCT01317641|540881838|FG006|Overall Study|Disease progression|0|||
149930410|NCT01317641|540881839|FG007|Overall Study|Disease progression|3|||
149930411|NCT01317641|540881840|FG008|Overall Study|Disease progression|4|||
149930412|NCT01317641|540881832|FG000|Overall Study|Withdrawal by Subject|0|||
149930413|NCT01317641|540881833|FG001|Overall Study|Withdrawal by Subject|0|||
149930414|NCT01317641|540881834|FG002|Overall Study|Withdrawal by Subject|0|||
149930415|NCT01317641|540881835|FG003|Overall Study|Withdrawal by Subject|0|||
149930416|NCT01317641|540881836|FG004|Overall Study|Withdrawal by Subject|0|||
149930417|NCT01317641|540881837|FG005|Overall Study|Withdrawal by Subject|0|||
149930418|NCT01317641|540881838|FG006|Overall Study|Withdrawal by Subject|1|||
149930419|NCT01317641|540881839|FG007|Overall Study|Withdrawal by Subject|0|||
149930420|NCT01317641|540881840|FG008|Overall Study|Withdrawal by Subject|0|||
149930421|NCT01051921|540881841|FG000|Overall Study|Physician Decision|9|||
149930422|NCT01051921|540881841|FG000|Overall Study|Adverse Event|8|||
149930423|NCT01051921|540881841|FG000|Overall Study|Withdrawal by Subject|7|||
149930424|NCT01051921|540881841|FG000|Overall Study|Lost to Follow-up|4|||
149930425|NCT01051921|540881841|FG000|Overall Study|virological failure|1|||
149930426|NCT01051921|540881841|FG000|Overall Study|patient moved|1|||
149930427|NCT01325350|540881844|FG000|Overall Study|Adverse Event|3|||
149930428|NCT01325350|540881845|FG001|Overall Study|Adverse Event|3|||
149930429|NCT01325350|540881846|FG002|Overall Study|Adverse Event|3|||
149930430|NCT01325350|540881847|FG003|Overall Study|Adverse Event|1|||
149930431|NCT01325350|540881848|FG004|Overall Study|Adverse Event|2|||
149930432|NCT01325350|540881844|FG000|Overall Study|Pregnancy|0|||
149930433|NCT01325350|540881845|FG001|Overall Study|Pregnancy|0|||
149930434|NCT01325350|540881846|FG002|Overall Study|Pregnancy|1|||
150266126|NCT02520284|542110193|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
150266127|NCT02520284|542110194|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
150266128|NCT02520284|542110195|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
150266129|NCT02520284|542110193|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
150266130|NCT02520284|542110194|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
150266131|NCT02520284|542110195|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
150266132|NCT02520284|542110193|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
150266133|NCT02520284|542110194|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
150266134|NCT02520284|542110195|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
150266135|NCT02520284|542110193|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
150266136|NCT02520284|542110194|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
150266137|NCT02520284|542110195|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
150266138|NCT02520284|542110193|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
150266139|NCT02520284|542110194|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
150266140|NCT02520284|542110195|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
150266141|NCT02520284|542110193|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
150266142|NCT02520284|542110194|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
150266143|NCT02520284|542110195|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
150266144|NCT02520284|542110193|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
150266145|NCT02520284|542110194|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
150266146|NCT02520284|542110195|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
150266147|NCT01898923|542110196|FG000|Overall Study|Lack of Efficacy|5|||
149819660|NCT04272775|540469216|FG001|Overall Study|Protocol Violation|1|||
149819661|NCT04272775|540469215|FG000|Overall Study|Symptomatic Deterioration|1|||
149819662|NCT04272775|540469216|FG001|Overall Study|Symptomatic Deterioration|1|||
149819663|NCT04272775|540469215|FG000|Overall Study|Withdrawal by Subject|1|||
149819664|NCT04272775|540469216|FG001|Overall Study|Withdrawal by Subject|2|||
149819665|NCT04272775|540469215|FG000|Overall Study|Adverse Event|1|||
149819666|NCT04272775|540469216|FG001|Overall Study|Adverse Event|2|||
149819667|NCT04272775|540469215|FG000|Overall Study|Progressive Disease|3|||
149819668|NCT04272775|540469216|FG001|Overall Study|Progressive Disease|1|||
149819669|NCT00738673|540469217|FG000|Overall Study|Adverse Event|1|||
149819670|NCT00738673|540469218|FG001|Overall Study|Adverse Event|0|||
149819671|NCT00738673|540469217|FG000|Overall Study|Lack of Efficacy|19|||
149819672|NCT00738673|540469218|FG001|Overall Study|Lack of Efficacy|8|||
149819673|NCT00738673|540469217|FG000|Overall Study|Protocol Violation|1|||
149819674|NCT00738673|540469218|FG001|Overall Study|Protocol Violation|2|||
149819675|NCT00738673|540469217|FG000|Overall Study|Withdrawal by Subject|3|||
149819676|NCT00738673|540469218|FG001|Overall Study|Withdrawal by Subject|1|||
149819677|NCT01967888|540469219|FG000|Overall Study|Lost to Follow-up|6|||
149819678|NCT01967888|540469220|FG001|Overall Study|Lost to Follow-up|4|||
149819679|NCT01967888|540469219|FG000|Overall Study|Withdrawal by Subject|1|||
149819680|NCT01967888|540469220|FG001|Overall Study|Withdrawal by Subject|1|||
149819681|NCT01967888|540469219|FG000|Overall Study|Did Not Have Transplant|1|||
149819682|NCT01967888|540469220|FG001|Overall Study|Did Not Have Transplant|0|||
149819683|NCT01967888|540469219|FG000|Overall Study|Research visit not done, data recorded|1|||
149819684|NCT01967888|540469220|FG001|Overall Study|Research visit not done, data recorded|0|||
149819685|NCT01967888|540469219|FG000|Overall Study|Subject excluded after randomization|1|||
149819686|NCT01967888|540469220|FG001|Overall Study|Subject excluded after randomization|0|||
149819687|NCT01967888|540469219|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
149819688|NCT01967888|540469220|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
149819689|NCT01967888|540469219|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
149819690|NCT01967888|540469220|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
149819691|NCT02436135|540469225|FG000|Overall Study|Progressive Disease|3|||
149819692|NCT02436135|540469226|FG001|Overall Study|Progressive Disease|1|||
149819693|NCT02436135|540469225|FG000|Overall Study|Investigator Discretion|1|||
149819694|NCT02436135|540469226|FG001|Overall Study|Investigator Discretion|2|||
149819695|NCT02436135|540469225|FG000|Overall Study|Adverse Event|1|||
149819696|NCT02436135|540469226|FG001|Overall Study|Adverse Event|0|||
149819697|NCT02436135|540469225|FG000|Overall Study|Withdrawal by Participant|1|||
149819698|NCT02436135|540469226|FG001|Overall Study|Withdrawal by Participant|0|||
149819699|NCT02436135|540469225|FG000|Overall Study|Study Terminated By Sponsor|0|||
149819700|NCT02436135|540469226|FG001|Overall Study|Study Terminated By Sponsor|1|||
149819701|NCT02063698|540469227|FG000|Overall Study|did not complete booklet for days 2-8|1|||
149819702|NCT02063698|540469228|FG001|Overall Study|did not complete booklet for days 2-8|2|||
149819703|NCT00297479|540469229|FG000|Overall Study|Lost to Follow-up|37|||
149819704|NCT00297479|540469230|FG001|Overall Study|Lost to Follow-up|54|||
149819705|NCT00297479|540469231|FG002|Overall Study|Lost to Follow-up|51|||
149819706|NCT01664494|540469232|FG000|Overall Study|Withdrawal by Subject|27|||
149930435|NCT01325350|540881847|FG003|Overall Study|Pregnancy|0|||
149930436|NCT01325350|540881848|FG004|Overall Study|Pregnancy|1|||
149930437|NCT01325350|540881844|FG000|Overall Study|Lost to Follow-up|1|||
149930438|NCT01325350|540881845|FG001|Overall Study|Lost to Follow-up|0|||
149930439|NCT01325350|540881846|FG002|Overall Study|Lost to Follow-up|5|||
149930440|NCT01325350|540881847|FG003|Overall Study|Lost to Follow-up|1|||
149930441|NCT01325350|540881848|FG004|Overall Study|Lost to Follow-up|5|||
149930442|NCT01325350|540881844|FG000|Overall Study|Personal Reasons|2|||
149930443|NCT01325350|540881845|FG001|Overall Study|Personal Reasons|1|||
150165563|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
150165564|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
150165565|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
150165566|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
150165567|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
150165568|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
150165569|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
150165570|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Death|0|||
150165571|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Death|8|||
150165572|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Death|2|||
150165573|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Death|13|||
150165574|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
150165575|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
150165576|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
150165577|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
150165578|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
150165579|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
150165580|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
150165581|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
150165582|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
150165583|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
150165584|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
150165585|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
150165586|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
150165587|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
150165588|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
150165589|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
150165590|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
150165591|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
150165592|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
150165593|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
150165594|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
150165595|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
150165596|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
150165597|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
150165598|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
150165599|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
150165600|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
150165601|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
150165602|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
150165603|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
150165604|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
150165605|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
150165606|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
150165607|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
150165608|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
150165609|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
150165610|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
150165611|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
150165612|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
150165613|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
150165614|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Pain|0|||
150165615|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Pain|0|||
150165616|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Pain|0|||
150165617|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Pain|1|||
150165618|NCT01107626|541741577|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
150165619|NCT01107626|541741578|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
149930444|NCT01325350|540881846|FG002|Overall Study|Personal Reasons|6|||
149930445|NCT01325350|540881847|FG003|Overall Study|Personal Reasons|5|||
149930446|NCT01325350|540881848|FG004|Overall Study|Personal Reasons|3|||
149930447|NCT01325350|540881844|FG000|Overall Study|Protocol Violation|0|||
149930448|NCT01325350|540881845|FG001|Overall Study|Protocol Violation|0|||
149930449|NCT01325350|540881846|FG002|Overall Study|Protocol Violation|0|||
149930450|NCT01325350|540881847|FG003|Overall Study|Protocol Violation|1|||
149930451|NCT01325350|540881848|FG004|Overall Study|Protocol Violation|0|||
149930452|NCT01325350|540881844|FG000|Overall Study|Withdrawal by Subject|0|||
149930453|NCT01325350|540881845|FG001|Overall Study|Withdrawal by Subject|0|||
149930454|NCT01325350|540881846|FG002|Overall Study|Withdrawal by Subject|1|||
149930455|NCT01325350|540881847|FG003|Overall Study|Withdrawal by Subject|1|||
149930456|NCT01325350|540881848|FG004|Overall Study|Withdrawal by Subject|0|||
149930457|NCT01325350|540881844|FG000|Overall Study|Did Not Receive Treatment|0|||
149930458|NCT01325350|540881845|FG001|Overall Study|Did Not Receive Treatment|1|||
149930459|NCT01325350|540881846|FG002|Overall Study|Did Not Receive Treatment|1|||
149930460|NCT01325350|540881847|FG003|Overall Study|Did Not Receive Treatment|0|||
149930461|NCT01325350|540881848|FG004|Overall Study|Did Not Receive Treatment|1|||
149930462|NCT01716806|540881855|FG000|Overall Study|Patient withdrawal of consent|4|||
149930463|NCT01716806|540881856|FG001|Overall Study|Patient withdrawal of consent|2|||
149930464|NCT01716806|540881857|FG002|Overall Study|Patient withdrawal of consent|4|||
149930465|NCT01716806|540881858|FG003|Overall Study|Patient withdrawal of consent|3|||
149930466|NCT01716806|540881859|FG004|Overall Study|Patient withdrawal of consent|2|||
149930467|NCT01716806|540881860|FG005|Overall Study|Patient withdrawal of consent|0|||
149930468|NCT01716806|540881855|FG000|Overall Study|Lost to Follow-up|3|||
149930469|NCT01716806|540881856|FG001|Overall Study|Lost to Follow-up|3|||
149930470|NCT01716806|540881857|FG002|Overall Study|Lost to Follow-up|0|||
149930471|NCT01716806|540881858|FG003|Overall Study|Lost to Follow-up|2|||
149930472|NCT01716806|540881859|FG004|Overall Study|Lost to Follow-up|1|||
149930473|NCT01716806|540881860|FG005|Overall Study|Lost to Follow-up|0|||
149930474|NCT01716806|540881855|FG000|Overall Study|Death|13|||
149930475|NCT01716806|540881856|FG001|Overall Study|Death|9|||
149930476|NCT01716806|540881857|FG002|Overall Study|Death|12|||
149930477|NCT01716806|540881858|FG003|Overall Study|Death|4|||
149930478|NCT01716806|540881859|FG004|Overall Study|Death|10|||
149930479|NCT01716806|540881860|FG005|Overall Study|Death|5|||
149930480|NCT01716806|540881855|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
149930481|NCT01716806|540881856|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
149930482|NCT01716806|540881857|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
149930483|NCT01716806|540881858|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
149930484|NCT01716806|540881859|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
149930485|NCT01716806|540881860|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
149930486|NCT01716806|540881855|FG000|Overall Study|PI decision|0|||
149930487|NCT01716806|540881856|FG001|Overall Study|PI decision|0|||
149930488|NCT01716806|540881857|FG002|Overall Study|PI decision|0|||
150165620|NCT01107626|541741579|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
150165621|NCT01107626|541741580|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
150165622|NCT04310579|541741581|FG000|Overall Study|Adverse Event|0|||
150165623|NCT04310579|541741582|FG001|Overall Study|Adverse Event|0|||
150165624|NCT04310579|541741583|FG002|Overall Study|Adverse Event|0|||
150165625|NCT04310579|541741584|FG003|Overall Study|Adverse Event|0|||
150165626|NCT04310579|541741585|FG004|Overall Study|Adverse Event|0|||
150165627|NCT04310579|541741586|FG005|Overall Study|Adverse Event|0|||
150165628|NCT04310579|541741587|FG006|Overall Study|Adverse Event|2|||
150165629|NCT04310579|541741588|FG007|Overall Study|Adverse Event|0|||
150165630|NCT04310579|541741589|FG008|Overall Study|Adverse Event|1|||
150165631|NCT04310579|541741590|FG009|Overall Study|Adverse Event|1|||
150165632|NCT04310579|541741591|FG010|Overall Study|Adverse Event|0|||
150165633|NCT04310579|541741581|FG000|Overall Study|Withdrawal by Subject|0|||
150165634|NCT04310579|541741582|FG001|Overall Study|Withdrawal by Subject|0|||
150165635|NCT04310579|541741583|FG002|Overall Study|Withdrawal by Subject|0|||
150165636|NCT04310579|541741584|FG003|Overall Study|Withdrawal by Subject|0|||
150165637|NCT04310579|541741585|FG004|Overall Study|Withdrawal by Subject|0|||
150165638|NCT04310579|541741586|FG005|Overall Study|Withdrawal by Subject|1|||
150165639|NCT04310579|541741587|FG006|Overall Study|Withdrawal by Subject|0|||
150165640|NCT04310579|541741588|FG007|Overall Study|Withdrawal by Subject|0|||
149930489|NCT01716806|540881858|FG003|Overall Study|PI decision|0|||
149930490|NCT01716806|540881859|FG004|Overall Study|PI decision|1|||
149930491|NCT01716806|540881860|FG005|Overall Study|PI decision|0|||
149930492|NCT01716806|540881855|FG000|Overall Study|Change in performance status|1|||
150165641|NCT04310579|541741589|FG008|Overall Study|Withdrawal by Subject|0|||
150165642|NCT04310579|541741590|FG009|Overall Study|Withdrawal by Subject|0|||
149930493|NCT01716806|540881856|FG001|Overall Study|Change in performance status|0|||
149930494|NCT01716806|540881857|FG002|Overall Study|Change in performance status|0|||
149930495|NCT01716806|540881858|FG003|Overall Study|Change in performance status|0|||
149930496|NCT01716806|540881859|FG004|Overall Study|Change in performance status|0|||
149930497|NCT01716806|540881860|FG005|Overall Study|Change in performance status|0|||
150165643|NCT04310579|541741591|FG010|Overall Study|Withdrawal by Subject|0|||
149930498|NCT01716806|540881855|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
149930499|NCT01716806|540881856|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
149930500|NCT01716806|540881857|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
149930501|NCT01716806|540881858|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
149930502|NCT01716806|540881859|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
149930503|NCT01716806|540881860|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
149930504|NCT01716806|540881855|FG000|Overall Study|Sponsor direction|7|||
149930505|NCT01716806|540881856|FG001|Overall Study|Sponsor direction|8|||
149930506|NCT01716806|540881857|FG002|Overall Study|Sponsor direction|5|||
149930507|NCT01716806|540881858|FG003|Overall Study|Sponsor direction|12|||
149930508|NCT01716806|540881859|FG004|Overall Study|Sponsor direction|16|||
149930509|NCT01716806|540881860|FG005|Overall Study|Sponsor direction|1|||
149930510|NCT02692586|540881861|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
149930511|NCT02692586|540881861|FG000|Overall Study|Received adjunctive thrombolytics|2|||
149930512|NCT03316586|540881868|FG000|Overall Study|Adverse Event|2|||
149930513|NCT03316586|540881868|FG000|Overall Study|Physician Decision|3|||
149930514|NCT03316586|540881868|FG000|Overall Study|Lack of Efficacy|10|||
149930515|NCT03316586|540881868|FG000|Overall Study|still on treatment|1|||
149930516|NCT03316586|540881868|FG000|Overall Study|Patient needed radiation therapy|1|||
149930517|NCT03316586|540881868|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
149930518|NCT03934216|540881871|FG000|Overall Study|Other Reasons|5|||
149930519|NCT03934216|540881872|FG001|Overall Study|Other Reasons|5|||
149930520|NCT03934216|540881871|FG000|Overall Study|Adverse Event|22|||
149930521|NCT03934216|540881872|FG001|Overall Study|Adverse Event|11|||
149930522|NCT03934216|540881871|FG000|Overall Study|Lack of Efficacy|8|||
149930523|NCT03934216|540881872|FG001|Overall Study|Lack of Efficacy|7|||
149930524|NCT03934216|540881871|FG000|Overall Study|Lost to Follow-up|2|||
149930525|NCT03934216|540881872|FG001|Overall Study|Lost to Follow-up|0|||
149930526|NCT03934216|540881871|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149930527|NCT03934216|540881872|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149930528|NCT03934216|540881871|FG000|Overall Study|Pregnancy|1|||
149930529|NCT03934216|540881872|FG001|Overall Study|Pregnancy|0|||
149930530|NCT03934216|540881871|FG000|Overall Study|Withdrawal by Subject|18|||
149930531|NCT03934216|540881872|FG001|Overall Study|Withdrawal by Subject|6|||
149930532|NCT03934216|540881871|FG000|Overall Study|Randomized but not treated|1|||
149930533|NCT03934216|540881872|FG001|Overall Study|Randomized but not treated|1|||
149930534|NCT01053741|540881873|FG000|2nd Study Intervention|Physician Decision|0|||
149930535|NCT01053741|540881874|FG001|2nd Study Intervention|Physician Decision|1|||
149930536|NCT00619827|540881875|FG000|Overall Study|Adverse Event|1|||
149930537|NCT00619827|540881876|FG001|Overall Study|Adverse Event|2|||
149930538|NCT00619827|540881875|FG000|Overall Study|Withdrawal by Subject|2|||
149930539|NCT00619827|540881876|FG001|Overall Study|Withdrawal by Subject|2|||
149930540|NCT01396083|540881878|FG000|Overall Study|Adverse Event|2|||
149930541|NCT01396083|540881879|FG001|Overall Study|Adverse Event|28|||
149930542|NCT01396083|540881878|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149930543|NCT01396083|540881879|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
149930544|NCT01396083|540881878|FG000|Overall Study|Consent withdrawn|4|||
149930545|NCT01396083|540881879|FG001|Overall Study|Consent withdrawn|5|||
149930546|NCT01396083|540881878|FG000|Overall Study|Protocol deviation(s)|0|||
149930547|NCT01396083|540881879|FG001|Overall Study|Protocol deviation(s)|1|||
149930548|NCT01396083|540881878|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149930549|NCT01396083|540881879|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149930550|NCT01396083|540881878|FG000|Overall Study|Administrative problems|1|||
149930551|NCT01396083|540881879|FG001|Overall Study|Administrative problems|0|||
149930552|NCT01396083|540881878|FG000|Overall Study|Lost to Follow-up|1|||
150165644|NCT04310579|541741581|FG000|Overall Study|Positive COVID-19 test|0|||
150165645|NCT04310579|541741582|FG001|Overall Study|Positive COVID-19 test|0|||
150165646|NCT04310579|541741583|FG002|Overall Study|Positive COVID-19 test|0|||
150165647|NCT04310579|541741584|FG003|Overall Study|Positive COVID-19 test|0|||
150165648|NCT04310579|541741585|FG004|Overall Study|Positive COVID-19 test|0|||
150165649|NCT04310579|541741586|FG005|Overall Study|Positive COVID-19 test|0|||
150165650|NCT04310579|541741587|FG006|Overall Study|Positive COVID-19 test|0|||
150165651|NCT04310579|541741588|FG007|Overall Study|Positive COVID-19 test|0|||
149930553|NCT01396083|540881879|FG001|Overall Study|Lost to Follow-up|0|||
149930554|NCT01063855|540881880|FG000|Overall Study|Adverse Event|4|||
149930555|NCT01063855|540881881|FG001|Overall Study|Adverse Event|4|||
149930556|NCT01063855|540881880|FG000|Overall Study|Death|0|||
149930557|NCT01063855|540881881|FG001|Overall Study|Death|1|||
149930558|NCT01063855|540881880|FG000|Overall Study|Lost to Follow-up|8|||
149930559|NCT01063855|540881881|FG001|Overall Study|Lost to Follow-up|4|||
149930560|NCT01063855|540881880|FG000|Overall Study|Pregnancy|1|||
149930561|NCT01063855|540881881|FG001|Overall Study|Pregnancy|0|||
149930562|NCT01063855|540881880|FG000|Overall Study|Lack of Efficacy|0|||
149930563|NCT01063855|540881881|FG001|Overall Study|Lack of Efficacy|1|||
149930564|NCT01063855|540881880|FG000|Overall Study|Withdrawal by Subject|11|||
150165652|NCT04310579|541741589|FG008|Overall Study|Positive COVID-19 test|0|||
149930565|NCT01063855|540881881|FG001|Overall Study|Withdrawal by Subject|8|||
149930566|NCT01063855|540881880|FG000|Overall Study|Reason not specified|13|||
149930567|NCT01063855|540881881|FG001|Overall Study|Reason not specified|11|||
149930568|NCT00735709|540881882|FG000|Overall Study|Adverse Event|2|||
149930569|NCT00735709|540881883|FG001|Overall Study|Adverse Event|3|||
149930570|NCT00735709|540881884|FG002|Overall Study|Adverse Event|1|||
149930571|NCT00735709|540881885|FG003|Overall Study|Adverse Event|5|||
149930572|NCT00735709|540881882|FG000|Overall Study|Lack of Efficacy|8|||
150266148|NCT01898923|542110197|FG001|Overall Study|Lack of Efficacy|6|||
150266149|NCT01898923|542110196|FG000|Overall Study|Adverse Event|3|||
150266150|NCT01898923|542110197|FG001|Overall Study|Adverse Event|1|||
150266151|NCT01898923|542110196|FG000|Overall Study|Lost to Follow-up|0|||
150266152|NCT01898923|542110197|FG001|Overall Study|Lost to Follow-up|1|||
150266153|NCT01898923|542110196|FG000|Overall Study|Withdrawal by Subject|4|||
150266154|NCT01898923|542110197|FG001|Overall Study|Withdrawal by Subject|7|||
150266155|NCT01898923|542110196|FG000|Overall Study|Physician Decision|3|||
150266156|NCT01898923|542110197|FG001|Overall Study|Physician Decision|4|||
150266157|NCT01898923|542110196|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
150266158|NCT01898923|542110197|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
150266159|NCT02678247|542110200|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
150165653|NCT04310579|541741590|FG009|Overall Study|Positive COVID-19 test|0|||
150165654|NCT04310579|541741591|FG010|Overall Study|Positive COVID-19 test|1|||
150165655|NCT03467724|541741592|FG000|Overall Study|Lost to Follow-up|5|||
150165656|NCT03467724|541741592|FG000|Overall Study|Withdrawal by Subject|1|||
150165657|NCT03467724|541741592|FG000|Overall Study|Protocol Violation|1|||
150165658|NCT03467724|541741592|FG000|Overall Study|Adverse Event|1|||
150165659|NCT02236559|541741593|FG000|Overall Study|Met Exclusion|3|||
150165660|NCT02236559|541741594|FG001|Overall Study|Met Exclusion|6|||
150266160|NCT02678247|542110201|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
150266161|NCT02678247|542110200|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
150266162|NCT02678247|542110201|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
150266163|NCT02678247|542110200|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
150266164|NCT02678247|542110201|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
150266165|NCT02678247|542110200|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
150266166|NCT02678247|542110201|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
150266167|NCT02678247|542110200|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
149930573|NCT00735709|540881883|FG001|Overall Study|Lack of Efficacy|4|||
149930574|NCT00735709|540881884|FG002|Overall Study|Lack of Efficacy|2|||
149930575|NCT00735709|540881885|FG003|Overall Study|Lack of Efficacy|3|||
149930576|NCT00735709|540881882|FG000|Overall Study|Noncompliance|0|||
149930577|NCT00735709|540881883|FG001|Overall Study|Noncompliance|0|||
149930578|NCT00735709|540881884|FG002|Overall Study|Noncompliance|1|||
149930579|NCT00735709|540881885|FG003|Overall Study|Noncompliance|0|||
149930580|NCT00735709|540881882|FG000|Overall Study|Protocol deviations|1|||
149930581|NCT00735709|540881883|FG001|Overall Study|Protocol deviations|2|||
149930582|NCT00735709|540881884|FG002|Overall Study|Protocol deviations|1|||
149930583|NCT00735709|540881885|FG003|Overall Study|Protocol deviations|1|||
149930584|NCT00735709|540881882|FG000|Overall Study|Voluntary Withdrawal|1|||
149930585|NCT00735709|540881883|FG001|Overall Study|Voluntary Withdrawal|3|||
149930586|NCT00735709|540881884|FG002|Overall Study|Voluntary Withdrawal|5|||
149930587|NCT00735709|540881885|FG003|Overall Study|Voluntary Withdrawal|7|||
149930588|NCT00735709|540881882|FG000|Overall Study|Lost to Follow-up|0|||
149930589|NCT00735709|540881883|FG001|Overall Study|Lost to Follow-up|1|||
149930590|NCT00735709|540881884|FG002|Overall Study|Lost to Follow-up|1|||
149930591|NCT00735709|540881885|FG003|Overall Study|Lost to Follow-up|1|||
149930592|NCT00735709|540881882|FG000|Overall Study|Excluded medication|1|||
149930593|NCT00735709|540881883|FG001|Overall Study|Excluded medication|0|||
149930594|NCT00735709|540881884|FG002|Overall Study|Excluded medication|0|||
150165661|NCT02236559|541741593|FG000|Overall Study|Did not Meet Inclusion|3|||
150165662|NCT02236559|541741594|FG001|Overall Study|Did not Meet Inclusion|3|||
150165663|NCT02236559|541741593|FG000|Overall Study|Subject Did Not Consent|4|||
150165664|NCT02236559|541741594|FG001|Overall Study|Subject Did Not Consent|2|||
150266168|NCT02678247|542110201|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
149930595|NCT00735709|540881885|FG003|Overall Study|Excluded medication|1|||
150165665|NCT02236559|541741593|FG000|Overall Study|Physician Decision|1|||
150266169|NCT02678247|542110200|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
150165666|NCT02236559|541741594|FG001|Overall Study|Physician Decision|1|||
150165667|NCT02236559|541741593|FG000|Overall Study|Withdrawal by Subject|1|||
150266170|NCT02678247|542110201|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
149930596|NCT01165307|540881886|FG000|Overall Study|Lost to Follow-up|11|||
149930597|NCT01165307|540881887|FG001|Overall Study|Lost to Follow-up|3|||
149930598|NCT01165307|540881886|FG000|Overall Study|Withdrawal by Subject|2|||
149930599|NCT01165307|540881887|FG001|Overall Study|Withdrawal by Subject|0|||
149930600|NCT01165307|540881886|FG000|Overall Study|Subject not available for contact|1|||
149930601|NCT01165307|540881887|FG001|Overall Study|Subject not available for contact|0|||
150266171|NCT00723021|542110206|FG000|Intervention Period 4|Adverse Event|0|||
150266172|NCT00723021|542110207|FG001|Intervention Period 4|Adverse Event|0|||
150266173|NCT00723021|542110208|FG002|Intervention Period 4|Adverse Event|0|||
150266174|NCT00723021|542110209|FG003|Intervention Period 4|Adverse Event|0|||
150266175|NCT00723021|542110210|FG004|Intervention Period 4|Adverse Event|1|||
150266176|NCT02739360|542110212|FG000|Overall Study|Adverse Event|1|||
150266177|NCT02739360|542110212|FG000|Overall Study|Study terminated by Sponsor|2|||
150266178|NCT01163916|542110215|FG000|Overall Study|Withdrawal by Subject|2|||
150266179|NCT01163916|542110216|FG001|Overall Study|Withdrawal by Subject|0|||
150266180|NCT01163916|542110217|FG002|Overall Study|Withdrawal by Subject|2|||
150266181|NCT01163916|542110215|FG000|Overall Study|Adverse Event|2|||
150266182|NCT01163916|542110216|FG001|Overall Study|Adverse Event|0|||
150266183|NCT01163916|542110217|FG002|Overall Study|Adverse Event|1|||
150266184|NCT01163916|542110215|FG000|Overall Study|Lack of Efficacy|2|||
150266185|NCT01163916|542110216|FG001|Overall Study|Lack of Efficacy|0|||
150266186|NCT01163916|542110217|FG002|Overall Study|Lack of Efficacy|1|||
150266187|NCT01163916|542110215|FG000|Overall Study|Other|24|||
149930602|NCT02163395|540881892|FG000|Overall Study|Withdrawal by Subject|1|||
149930603|NCT02163395|540881892|FG000|Overall Study|Lost to Follow-up|3|||
149930604|NCT02163395|540881892|FG000|Overall Study|Adverse Event|1|||
149930605|NCT00521365|540881910|FG000|Overall Study|Adverse Event|3|||
149930606|NCT00521365|540881910|FG000|Overall Study|Lost to Follow-up|6|||
149930607|NCT00521365|540881910|FG000|Overall Study|Protocol deviation|2|||
149930608|NCT00521365|540881910|FG000|Overall Study|Drug compliance|3|||
149930609|NCT00521365|540881910|FG000|Overall Study|Usage of not allowed drugs|6|||
149930610|NCT03627832|540881911|FG000|Overall Study|Withdrawal by Subject|10|||
149930611|NCT03627832|540881912|FG001|Overall Study|Withdrawal by Subject|1|||
149930612|NCT03150082|540881913|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
149930613|NCT03150082|540881914|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
149930614|NCT01718483|540881915|FG000|Overall Study|Withdrawal by Subject|14|||
149930615|NCT01718483|540881916|FG001|Overall Study|Withdrawal by Subject|12|||
149930616|NCT01718483|540881915|FG000|Overall Study|Adverse Event|5|||
149930617|NCT01718483|540881916|FG001|Overall Study|Adverse Event|12|||
149930618|NCT01718483|540881915|FG000|Overall Study|Lost to Follow-up|8|||
149930619|NCT01718483|540881916|FG001|Overall Study|Lost to Follow-up|3|||
149930620|NCT01718483|540881915|FG000|Overall Study|Protocol Violation|4|||
149930621|NCT01718483|540881916|FG001|Overall Study|Protocol Violation|2|||
149930622|NCT01718483|540881915|FG000|Overall Study|Other|1|||
149930623|NCT01718483|540881916|FG001|Overall Study|Other|4|||
149930624|NCT01718483|540881915|FG000|Overall Study|Pregnancy|1|||
149930625|NCT01718483|540881916|FG001|Overall Study|Pregnancy|1|||
149930626|NCT01718483|540881915|FG000|Overall Study|Lack of Efficacy|1|||
149930627|NCT01718483|540881916|FG001|Overall Study|Lack of Efficacy|0|||
149930628|NCT04547140|540881919|FG000|Overall Study|Adverse Event|0|||
149930629|NCT04547140|540881920|FG001|Overall Study|Adverse Event|1|||
149930630|NCT04547140|540881919|FG000|Overall Study|Withdrawal by Subject|0|||
149930631|NCT04547140|540881920|FG001|Overall Study|Withdrawal by Subject|1|||
149930632|NCT04547140|540881919|FG000|Overall Study|Lost to Follow-up|3|||
149930633|NCT04547140|540881920|FG001|Overall Study|Lost to Follow-up|1|||
149930634|NCT04547140|540881919|FG000|Overall Study|Death|2|||
149930635|NCT04547140|540881920|FG001|Overall Study|Death|1|||
149930636|NCT04547140|540881919|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
149930637|NCT04547140|540881920|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
149930638|NCT04547140|540881919|FG000|Overall Study|Pregnancy|1|||
149930639|NCT04547140|540881920|FG001|Overall Study|Pregnancy|0|||
149930640|NCT04547140|540881919|FG000|Overall Study|Reason Not Specified|4|||
149930641|NCT04547140|540881920|FG001|Overall Study|Reason Not Specified|1|||
149930642|NCT02119299|540881921|FG000|Overall Study|Withdrawal by Subject|7|||
149930643|NCT02119299|540881921|FG000|Overall Study|Lack of Efficacy|1|||
149930644|NCT02119299|540881921|FG000|Overall Study|Pregnancy|1|||
150266188|NCT01163916|542110216|FG001|Overall Study|Other|4|||
150266189|NCT01163916|542110217|FG002|Overall Study|Other|16|||
149930645|NCT00873730|540881922|FG000|Overall Study|Protocol Deviation|5|||
149930646|NCT00873730|540881923|FG001|Overall Study|Protocol Deviation|2|||
149930647|NCT00873730|540881922|FG000|Overall Study|Adverse Event|0|||
149930648|NCT00873730|540881923|FG001|Overall Study|Adverse Event|2|||
149930649|NCT00873730|540881922|FG000|Overall Study|Withdrawal by Subject|0|||
149930650|NCT00873730|540881923|FG001|Overall Study|Withdrawal by Subject|1|||
149930651|NCT00873730|540881922|FG000|Overall Study|Sponsor decision|1|||
149930652|NCT00873730|540881923|FG001|Overall Study|Sponsor decision|0|||
149930653|NCT00048035|540881926|FG000|Core Period|Early Withdrawals|4|||
149930654|NCT00048035|540881927|FG001|Core Period|Early Withdrawals|2|||
149930655|NCT00048035|540881928|FG002|Core Period|Early Withdrawals|1|||
149930656|NCT00048035|540881929|FG003|Core Period|Early Withdrawals|1|||
149930657|NCT00048035|540881930|FG004|Core Period|Early Withdrawals|1|||
150266190|NCT00026208|542110218|FG000|Overall Study|Complications of auto accident|1|||
149930658|NCT00048035|540881931|FG005|Core Period|Early Withdrawals|1|||
150266191|NCT00026208|542110219|FG001|Overall Study|Complications of auto accident|0|||
150266192|NCT04002401|542110221|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
149930659|NCT00048035|540881932|FG006|Core Period|Early Withdrawals|0|||
149930660|NCT00048035|540881933|FG007|Core Period|Early Withdrawals|0|||
149930661|NCT00048035|540881926|FG000|Extension Year 1|Early Withdrawals|0|||
149930662|NCT00048035|540881927|FG001|Extension Year 1|Early Withdrawals|0|||
149930663|NCT00048035|540881928|FG002|Extension Year 1|Early Withdrawals|0|||
149930664|NCT00048035|540881929|FG003|Extension Year 1|Early Withdrawals|0|||
149930665|NCT00048035|540881930|FG004|Extension Year 1|Early Withdrawals|0|||
149930666|NCT00048035|540881931|FG005|Extension Year 1|Early Withdrawals|0|||
149930667|NCT00048035|540881932|FG006|Extension Year 1|Early Withdrawals|11|||
149930668|NCT00048035|540881933|FG007|Extension Year 1|Early Withdrawals|11|||
149930669|NCT00048035|540881926|FG000|Extension Year 2|Early Withdrawals|0|||
149930670|NCT00048035|540881927|FG001|Extension Year 2|Early Withdrawals|0|||
149930671|NCT00048035|540881928|FG002|Extension Year 2|Early Withdrawals|0|||
149930672|NCT00048035|540881929|FG003|Extension Year 2|Early Withdrawals|0|||
149930673|NCT00048035|540881930|FG004|Extension Year 2|Early Withdrawals|0|||
149930674|NCT00048035|540881931|FG005|Extension Year 2|Early Withdrawals|0|||
149930675|NCT00048035|540881932|FG006|Extension Year 2|Early Withdrawals|3|||
149930676|NCT00048035|540881933|FG007|Extension Year 2|Early Withdrawals|3|||
149930677|NCT04110314|540881934|FG000|Overall Study|Did not meet inclusion criteria|35255|||
149930678|NCT04110314|540881935|FG001|Overall Study|Did not meet inclusion criteria|35104|||
149930679|NCT04110314|540881936|FG002|Overall Study|Did not meet inclusion criteria|35636|||
149930680|NCT04110314|540881937|FG003|Overall Study|Did not meet inclusion criteria|35135|||
149930681|NCT04110314|540881938|FG004|Overall Study|Did not meet inclusion criteria|35247|||
149930682|NCT04110314|540881939|FG005|Overall Study|Did not meet inclusion criteria|35727|||
149930683|NCT05137717|540881940|FG000|Overall Study|Death|2|||
149930684|NCT05137717|540881940|FG000|Overall Study|Withdrawal by Subject|6|||
149930685|NCT02619617|540881942|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
149930686|NCT02619617|540881943|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
149930687|NCT02619617|540881942|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
149930688|NCT02619617|540881943|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
149930689|NCT00509899|540881944|FG000|Overall Study|Progressive disease|1|||
149930690|NCT00509899|540881945|FG001|Overall Study|Progressive disease|3|||
149930691|NCT00509899|540881946|FG002|Overall Study|Progressive disease|5|||
149930692|NCT00509899|540881947|FG003|Overall Study|Progressive disease|1|||
149930693|NCT00509899|540881948|FG004|Overall Study|Progressive disease|0|||
149930694|NCT00509899|540881949|FG005|Overall Study|Progressive disease|1|||
149930695|NCT00509899|540881950|FG006|Overall Study|Progressive disease|0|||
149930696|NCT00509899|540881951|FG007|Overall Study|Progressive disease|0|||
149930697|NCT00509899|540881944|FG000|Overall Study|Unacceptable Toxicity|1|||
149930698|NCT00509899|540881945|FG001|Overall Study|Unacceptable Toxicity|0|||
149930699|NCT00509899|540881946|FG002|Overall Study|Unacceptable Toxicity|0|||
149930700|NCT00509899|540881947|FG003|Overall Study|Unacceptable Toxicity|2|||
149930701|NCT00509899|540881948|FG004|Overall Study|Unacceptable Toxicity|0|||
149930702|NCT00509899|540881949|FG005|Overall Study|Unacceptable Toxicity|0|||
149930703|NCT00509899|540881950|FG006|Overall Study|Unacceptable Toxicity|0|||
149930704|NCT00509899|540881951|FG007|Overall Study|Unacceptable Toxicity|0|||
149930705|NCT00509899|540881944|FG000|Overall Study|Withdrawal by Subject|6|||
149930706|NCT00509899|540881945|FG001|Overall Study|Withdrawal by Subject|2|||
149930707|NCT00509899|540881946|FG002|Overall Study|Withdrawal by Subject|3|||
149930708|NCT00509899|540881947|FG003|Overall Study|Withdrawal by Subject|0|||
149930709|NCT00509899|540881948|FG004|Overall Study|Withdrawal by Subject|3|||
149930710|NCT00509899|540881949|FG005|Overall Study|Withdrawal by Subject|2|||
149930711|NCT00509899|540881950|FG006|Overall Study|Withdrawal by Subject|0|||
149930712|NCT00509899|540881951|FG007|Overall Study|Withdrawal by Subject|0|||
149930713|NCT00509899|540881944|FG000|Overall Study|Physician Decision|4|||
149930714|NCT00509899|540881945|FG001|Overall Study|Physician Decision|2|||
149930715|NCT00509899|540881946|FG002|Overall Study|Physician Decision|7|||
149930716|NCT00509899|540881947|FG003|Overall Study|Physician Decision|0|||
149930717|NCT00509899|540881948|FG004|Overall Study|Physician Decision|1|||
149930718|NCT00509899|540881949|FG005|Overall Study|Physician Decision|4|||
149930719|NCT00509899|540881950|FG006|Overall Study|Physician Decision|0|||
149930720|NCT00509899|540881951|FG007|Overall Study|Physician Decision|0|||
149930721|NCT00509899|540881944|FG000|Overall Study|Intercurrent Illness|1|||
150165668|NCT02236559|541741594|FG001|Overall Study|Withdrawal by Subject|0|||
150165669|NCT02049866|541741595|FG000|Overall Study|Withdrawal by Subject|1|||
150165670|NCT00763282|541741600|FG000|Overall Study|Withdrawal by Subject|6|||
149930722|NCT00509899|540881945|FG001|Overall Study|Intercurrent Illness|0|||
149930723|NCT00509899|540881946|FG002|Overall Study|Intercurrent Illness|0|||
149930724|NCT00509899|540881947|FG003|Overall Study|Intercurrent Illness|1|||
149930725|NCT00509899|540881948|FG004|Overall Study|Intercurrent Illness|0|||
149930726|NCT00509899|540881949|FG005|Overall Study|Intercurrent Illness|1|||
149930727|NCT00509899|540881950|FG006|Overall Study|Intercurrent Illness|0|||
149930728|NCT00509899|540881951|FG007|Overall Study|Intercurrent Illness|0|||
149930729|NCT00509899|540881944|FG000|Overall Study|Death|2|||
149930730|NCT00509899|540881945|FG001|Overall Study|Death|2|||
149930731|NCT00509899|540881946|FG002|Overall Study|Death|3|||
149930732|NCT00509899|540881947|FG003|Overall Study|Death|0|||
149930733|NCT00509899|540881948|FG004|Overall Study|Death|1|||
149930734|NCT00509899|540881949|FG005|Overall Study|Death|1|||
149930735|NCT00509899|540881950|FG006|Overall Study|Death|1|||
149930736|NCT00509899|540881951|FG007|Overall Study|Death|1|||
149930737|NCT00509899|540881944|FG000|Overall Study|Lack of Efficacy|1|||
149930738|NCT00509899|540881945|FG001|Overall Study|Lack of Efficacy|0|||
149930739|NCT00509899|540881946|FG002|Overall Study|Lack of Efficacy|2|||
149930740|NCT00509899|540881947|FG003|Overall Study|Lack of Efficacy|0|||
149930741|NCT00509899|540881948|FG004|Overall Study|Lack of Efficacy|0|||
149930742|NCT00509899|540881949|FG005|Overall Study|Lack of Efficacy|1|||
149930743|NCT00509899|540881950|FG006|Overall Study|Lack of Efficacy|0|||
149930744|NCT00509899|540881951|FG007|Overall Study|Lack of Efficacy|0|||
149930745|NCT01711983|540881954|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
149930746|NCT01711983|540881954|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
149930747|NCT01711983|540881954|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
149930748|NCT01711983|540881954|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
149930749|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930750|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
149930751|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
149930752|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930753|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930754|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930755|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930756|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930757|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930758|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930759|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930760|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930761|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930762|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930763|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149930764|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
149930765|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
149930766|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930767|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930768|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930769|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930770|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930771|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930772|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930773|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930774|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930775|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930776|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930777|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930778|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149930779|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
149930780|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
149930781|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149930782|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930783|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930784|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930785|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930786|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930787|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930788|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930789|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930790|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930791|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930792|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930793|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149930794|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930795|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930796|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
149930797|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930798|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930799|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930800|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930801|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930802|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930803|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930804|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930805|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930806|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930807|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930808|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
149930809|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930810|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930811|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
149930812|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930813|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930814|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930815|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930816|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930817|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930818|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930819|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930820|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930821|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930822|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930823|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
149930824|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930825|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930826|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
149930827|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930828|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930829|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930830|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930831|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930832|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930833|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930834|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930835|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930836|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930837|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930838|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
149930839|NCT02326272|540881955|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930840|NCT02326272|540881956|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930841|NCT02326272|540881957|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
149930842|NCT02326272|540881958|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930843|NCT02326272|540881959|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930844|NCT02326272|540881960|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930845|NCT02326272|540881961|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930846|NCT02326272|540881962|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930847|NCT02326272|540881963|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930848|NCT02326272|540881964|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930849|NCT02326272|540881965|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930850|NCT02326272|540881966|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930851|NCT02326272|540881967|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930852|NCT02326272|540881968|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930853|NCT02326272|540881969|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
149930854|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930855|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930856|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930857|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930858|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
149930859|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
149930860|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
149930861|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
149930862|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
149930863|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930864|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930865|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930866|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930867|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930868|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149930869|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930870|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930871|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930872|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930873|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930874|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
149930875|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
149930876|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930877|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
149930878|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
149930879|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930880|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930881|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930882|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150266193|NCT04002401|542110221|FG000|Overall Study|Death|10|||
150266194|NCT04002401|542110221|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
150266195|NCT04002401|542110221|FG000|Overall Study|Enrolled but Never Treated|1|||
150266196|NCT04002401|542110221|FG000|Overall Study|Lost to Follow-up|1|||
150266197|NCT00423930|542110222|FG000|Overall Study|Withdrawal by Subject|2|||
150266198|NCT02337751|542110223|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
150266199|NCT02337751|542110224|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
150266200|NCT02337751|542110223|FG000|Overall Study|Voluntary Withdrawal|6|||
150266201|NCT02337751|542110224|FG001|Overall Study|Voluntary Withdrawal|8|||
150266202|NCT02337751|542110223|FG000|Overall Study|Lack of Efficacy|2|||
150266203|NCT02337751|542110224|FG001|Overall Study|Lack of Efficacy|5|||
150266204|NCT02337751|542110223|FG000|Overall Study|Investigator's Judgement|1|||
150266205|NCT02337751|542110224|FG001|Overall Study|Investigator's Judgement|0|||
150266206|NCT02881957|542110233|FG000|Overall Study|Comfort care|0|||
150266207|NCT02881957|542110234|FG001|Overall Study|Comfort care|1|||
150266208|NCT02881957|542110233|FG000|Overall Study|Concurrent trial enrollment|0|||
150266209|NCT02881957|542110234|FG001|Overall Study|Concurrent trial enrollment|1|||
150266210|NCT02881957|542110233|FG000|Overall Study|Discharged within 48 hours|0|||
150266211|NCT02881957|542110234|FG001|Overall Study|Discharged within 48 hours|1|||
150266212|NCT02881957|542110233|FG000|Overall Study|Withdrawal by Subject|2|||
150266213|NCT02881957|542110234|FG001|Overall Study|Withdrawal by Subject|1|||
150266214|NCT02881957|542110233|FG000|Overall Study|Protocol Violation|1|||
150266215|NCT02881957|542110234|FG001|Overall Study|Protocol Violation|0|||
150266216|NCT02390245|542110240|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
149930883|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
149930884|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930885|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930886|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930887|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930888|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930889|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
149930890|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930891|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
149930892|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930893|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930894|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930895|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930896|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930897|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930898|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149930899|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150266217|NCT02390245|542110241|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
150266218|NCT02390245|542110242|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
150266219|NCT02390245|542110240|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
150266220|NCT02390245|542110241|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
149930900|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930901|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930902|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149930903|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930904|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
149930905|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149930906|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149930907|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930908|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149930909|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930910|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930911|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930912|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930913|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149930914|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930915|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930916|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930917|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930918|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930919|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930920|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930921|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
149930922|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930923|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930924|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930925|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930926|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930927|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930928|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149930929|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930930|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930931|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930932|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930933|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930934|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930935|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
149930936|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930937|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930938|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930939|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930940|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930941|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930942|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930943|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149930944|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
150165671|NCT00763282|541741601|FG001|Overall Study|Withdrawal by Subject|5|||
150165672|NCT00763282|541741600|FG000|Overall Study|Death|4|||
150165673|NCT00763282|541741601|FG001|Overall Study|Death|3|||
150165674|NCT00763282|541741600|FG000|Overall Study|Lost to Follow-up|22|||
150165675|NCT00763282|541741601|FG001|Overall Study|Lost to Follow-up|26|||
150165676|NCT02219490|541741606|FG000|Overall Study|Adverse Event|24|||
150165677|NCT02219490|541741606|FG000|Overall Study|Withdrew consent|96|||
150165678|NCT02219490|541741606|FG000|Overall Study|Lost to Follow-up|126|||
150165679|NCT02219490|541741606|FG000|Overall Study|COVID-19 infection|2|||
150165680|NCT02219490|541741606|FG000|Overall Study|COVID-19 logistical restrictions|33|||
150165681|NCT02219490|541741606|FG000|Overall Study|Other, not specified|57|||
150165682|NCT00335556|541741607|FG000|Overall Study|Death|0|||
150165683|NCT00335556|541741608|FG001|Overall Study|Death|5|||
150165684|NCT00335556|541741609|FG002|Overall Study|Death|0|||
150165685|NCT00335556|541741610|FG003|Overall Study|Death|0|||
150165686|NCT00335556|541741611|FG004|Overall Study|Death|1|||
150165687|NCT00335556|541741612|FG005|Overall Study|Death|0|||
150165688|NCT00335556|541741607|FG000|Overall Study|Lack of Efficacy|0|||
150165689|NCT00335556|541741608|FG001|Overall Study|Lack of Efficacy|19|||
150165690|NCT00335556|541741609|FG002|Overall Study|Lack of Efficacy|3|||
150165691|NCT00335556|541741610|FG003|Overall Study|Lack of Efficacy|3|||
150165692|NCT00335556|541741611|FG004|Overall Study|Lack of Efficacy|0|||
150165693|NCT00335556|541741612|FG005|Overall Study|Lack of Efficacy|1|||
150165694|NCT00335556|541741607|FG000|Overall Study|Physician Decision|0|||
150165695|NCT00335556|541741608|FG001|Overall Study|Physician Decision|6|||
150165696|NCT00335556|541741609|FG002|Overall Study|Physician Decision|2|||
150165697|NCT00335556|541741610|FG003|Overall Study|Physician Decision|1|||
150165698|NCT00335556|541741611|FG004|Overall Study|Physician Decision|0|||
150165699|NCT00335556|541741612|FG005|Overall Study|Physician Decision|0|||
150165700|NCT00335556|541741607|FG000|Overall Study|Ineligible|2|||
150165701|NCT00335556|541741608|FG001|Overall Study|Ineligible|0|||
150165702|NCT00335556|541741609|FG002|Overall Study|Ineligible|0|||
150165703|NCT00335556|541741610|FG003|Overall Study|Ineligible|0|||
150165704|NCT00335556|541741611|FG004|Overall Study|Ineligible|0|||
150165705|NCT00335556|541741612|FG005|Overall Study|Ineligible|0|||
150165706|NCT00335556|541741607|FG000|Overall Study|Refusal of further protocol therapy|0|||
150165707|NCT00335556|541741608|FG001|Overall Study|Refusal of further protocol therapy|4|||
150165708|NCT00335556|541741609|FG002|Overall Study|Refusal of further protocol therapy|0|||
150165709|NCT00335556|541741610|FG003|Overall Study|Refusal of further protocol therapy|1|||
150165710|NCT00335556|541741611|FG004|Overall Study|Refusal of further protocol therapy|0|||
150165711|NCT00335556|541741612|FG005|Overall Study|Refusal of further protocol therapy|0|||
149819707|NCT01664494|540469232|FG000|Overall Study|Death|18|||
149819708|NCT01664494|540469232|FG000|Overall Study|Other|49|||
149819709|NCT01664494|540469232|FG000|Overall Study|Lost to Follow-up|99|||
149819710|NCT03263819|540469233|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
149819711|NCT03263819|540469234|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
149819712|NCT01427803|540469236|FG000|Overall Study|Lost to Follow-up|32|||
149819713|NCT01427803|540469237|FG001|Overall Study|Lost to Follow-up|26|||
149819714|NCT01427803|540469236|FG000|Overall Study|Withdrawal by Subject|20|||
149819715|NCT01427803|540469237|FG001|Overall Study|Withdrawal by Subject|0|||
149819716|NCT01427803|540469236|FG000|Overall Study|Unable to complete full treatment period|6|||
149819717|NCT01427803|540469237|FG001|Overall Study|Unable to complete full treatment period|0|||
149819718|NCT01427803|540469236|FG000|Overall Study|Protocol Violation|1|||
149819719|NCT01427803|540469237|FG001|Overall Study|Protocol Violation|0|||
149819720|NCT01427803|540469236|FG000|Overall Study|Physician Decision|3|||
149819721|NCT01427803|540469237|FG001|Overall Study|Physician Decision|0|||
149819722|NCT01427803|540469236|FG000|Overall Study|did not take product|1|||
149819723|NCT01427803|540469237|FG001|Overall Study|did not take product|0|||
149819724|NCT01612156|540469238|FG000|Overall Study|Protocol Violation|2|||
149819725|NCT01612156|540469239|FG001|Overall Study|Protocol Violation|0|||
149819726|NCT00686920|540469240|FG000|Overall Study|Death|45|||
149819727|NCT00686920|540469241|FG001|Overall Study|Death|14|||
149819728|NCT00686920|540469240|FG000|Overall Study|Liver Transplant|23|||
149819729|NCT00686920|540469241|FG001|Overall Study|Liver Transplant|8|||
149819730|NCT00686920|540469240|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
149819731|NCT00686920|540469241|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
149819732|NCT00686920|540469240|FG000|Overall Study|Withdrawal by Subject|23|||
149819733|NCT00686920|540469241|FG001|Overall Study|Withdrawal by Subject|5|||
149819734|NCT00686920|540469240|FG000|Overall Study|Protocol Violation|2|||
149819735|NCT00686920|540469241|FG001|Overall Study|Protocol Violation|1|||
149819736|NCT00686920|540469240|FG000|Overall Study|Adverse Event|10|||
149819737|NCT00686920|540469241|FG001|Overall Study|Adverse Event|2|||
149819738|NCT00686920|540469240|FG000|Overall Study|Personal Reason|0|||
149819739|NCT00686920|540469241|FG001|Overall Study|Personal Reason|1|||
149819740|NCT00686920|540469240|FG000|Overall Study|Lost to Follow-up|15|||
149819741|NCT00686920|540469241|FG001|Overall Study|Lost to Follow-up|3|||
149819742|NCT00686920|540469240|FG000|Overall Study|Moved to Another State|1|||
149819743|NCT00686920|540469241|FG001|Overall Study|Moved to Another State|0|||
149819744|NCT00686920|540469240|FG000|Overall Study|Transferred to Nursing Home|1|||
149819745|NCT00686920|540469241|FG001|Overall Study|Transferred to Nursing Home|0|||
149819746|NCT00686920|540469240|FG000|Overall Study|Noncompliance|9|||
149819747|NCT00686920|540469241|FG001|Overall Study|Noncompliance|0|||
149819748|NCT00686920|540469240|FG000|Overall Study|Principal Investigator Decision|2|||
149819749|NCT00686920|540469241|FG001|Overall Study|Principal Investigator Decision|0|||
149819750|NCT02974114|540469248|FG000|Overall Study|Other (Not specified)|0|||
149819751|NCT02974114|540469249|FG001|Overall Study|Other (Not specified)|1|||
149819752|NCT02974114|540469250|FG002|Overall Study|Other (Not specified)|2|||
149819753|NCT01138150|540469253|FG000|Overall Study|blood unable to be processed|0|||
149819754|NCT01138150|540469254|FG001|Overall Study|blood unable to be processed|1|||
149819755|NCT01138150|540469253|FG000|Overall Study|Physician Decision|1|||
149819756|NCT01138150|540469254|FG001|Overall Study|Physician Decision|0|||
149819757|NCT00545233|540469255|FG000|Overall Study|Adverse Event|10|||
149819758|NCT00545233|540469256|FG001|Overall Study|Adverse Event|5|||
149819759|NCT00545233|540469255|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
149819760|NCT00545233|540469256|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
149819761|NCT00545233|540469255|FG000|Overall Study|Protocol Violation|2|||
149819762|NCT00545233|540469256|FG001|Overall Study|Protocol Violation|0|||
149930945|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149819763|NCT00545233|540469255|FG000|Overall Study|Refused Treatment|9|||
149930946|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930947|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930948|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930949|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930950|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930951|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930952|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
149930953|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930954|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930955|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930956|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930957|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930958|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
149930959|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930960|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930961|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930962|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930963|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930964|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
149930965|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
149930966|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
149930967|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
149930968|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930969|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930970|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930971|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930972|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930973|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
149930974|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930975|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930976|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930977|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930978|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930979|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
149930980|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930981|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930982|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930983|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930984|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930985|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930986|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930987|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
149930988|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
150165712|NCT02365298|541741613|FG000|Period 2|incorrect Rx dispensed|1|||
150165713|NCT02365298|541741614|FG001|Period 2|incorrect Rx dispensed|0|||
150165714|NCT02365298|541741613|FG000|Period 2|Discontinued at request of Sponsor|1|||
150165715|NCT02365298|541741614|FG001|Period 2|Discontinued at request of Sponsor|0|||
150165716|NCT02365298|541741613|FG000|Period 2|Test Article longer available|0|||
150165717|NCT02365298|541741614|FG001|Period 2|Test Article longer available|1|||
150165718|NCT02365298|541741613|FG000|Period 2|Protocol Violation|0|||
150165719|NCT02365298|541741614|FG001|Period 2|Protocol Violation|1|||
150165720|NCT03736785|541741617|FG000|Overall Study|Adverse Event|1|||
150165721|NCT03736785|541741618|FG001|Overall Study|Adverse Event|1|||
150165722|NCT03736785|541741619|FG002|Overall Study|Adverse Event|1|||
150165723|NCT03736785|541741617|FG000|Overall Study|Death|1|||
150165724|NCT03736785|541741618|FG001|Overall Study|Death|0|||
150165725|NCT03736785|541741619|FG002|Overall Study|Death|1|||
150165726|NCT03736785|541741617|FG000|Overall Study|Lost to Follow-up|0|||
150165727|NCT03736785|541741618|FG001|Overall Study|Lost to Follow-up|2|||
150165728|NCT03736785|541741619|FG002|Overall Study|Lost to Follow-up|3|||
150165729|NCT03736785|541741617|FG000|Overall Study|Non compliance with study drug|1|||
150165730|NCT03736785|541741618|FG001|Overall Study|Non compliance with study drug|1|||
150165731|NCT03736785|541741619|FG002|Overall Study|Non compliance with study drug|0|||
150165732|NCT03736785|541741617|FG000|Overall Study|Physician Decision|0|||
150266221|NCT02390245|542110242|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
150266222|NCT00959647|542110244|FG000|Overall Study|Adverse Event|2|||
149930989|NCT02326272|540881955|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930990|NCT02326272|540881956|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930991|NCT02326272|540881957|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930992|NCT02326272|540881958|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930993|NCT02326272|540881959|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930994|NCT02326272|540881960|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930995|NCT02326272|540881961|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
149930996|NCT02326272|540881962|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930997|NCT02326272|540881963|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930998|NCT02326272|540881964|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149930999|NCT02326272|540881965|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149931000|NCT02326272|540881966|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149931001|NCT02326272|540881967|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149931002|NCT02326272|540881968|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149931003|NCT02326272|540881969|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
149931004|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
149931005|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
149931006|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
149931007|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
149931008|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
149931009|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
149931010|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
149931011|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
149931012|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
149931013|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
149931014|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
149931015|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
149931016|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
149931017|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
149931018|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
149931019|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931020|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931021|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931022|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931023|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931024|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931025|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931026|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931027|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931028|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149931029|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
149931030|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
149931031|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
149931032|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
150165733|NCT03736785|541741618|FG001|Overall Study|Physician Decision|1|||
150165734|NCT03736785|541741619|FG002|Overall Study|Physician Decision|1|||
150165735|NCT03736785|541741617|FG000|Overall Study|Protocol Violation|1|||
150165736|NCT03736785|541741618|FG001|Overall Study|Protocol Violation|4|||
150165737|NCT03736785|541741619|FG002|Overall Study|Protocol Violation|3|||
150165738|NCT03736785|541741617|FG000|Overall Study|Sponsor Decision|1|||
150165739|NCT03736785|541741618|FG001|Overall Study|Sponsor Decision|0|||
150165740|NCT03736785|541741619|FG002|Overall Study|Sponsor Decision|0|||
150165741|NCT03736785|541741617|FG000|Overall Study|Unknown/Missing data|3|||
150165742|NCT03736785|541741618|FG001|Overall Study|Unknown/Missing data|2|||
150165743|NCT03736785|541741619|FG002|Overall Study|Unknown/Missing data|1|||
150165744|NCT03736785|541741617|FG000|Overall Study|Withdrawal by Subject|9|||
150165745|NCT03736785|541741618|FG001|Overall Study|Withdrawal by Subject|6|||
150165746|NCT03736785|541741619|FG002|Overall Study|Withdrawal by Subject|4|||
150165747|NCT02974010|541741620|FG000|Overall Study|Lost to Follow-up|3|||
150165748|NCT02974010|541741621|FG001|Overall Study|Lost to Follow-up|1|||
150165749|NCT02974010|541741622|FG002|Overall Study|Lost to Follow-up|0|||
150165750|NCT02974010|541741623|FG003|Overall Study|Lost to Follow-up|0|||
150165751|NCT02974010|541741620|FG000|Overall Study|Withdrawal by Subject|2|||
150266223|NCT00959647|542110244|FG000|Overall Study|Progressive disease|6|||
150266224|NCT00959647|542110244|FG000|Overall Study|Study terminated by sponsor|4|||
150266225|NCT00959647|542110244|FG000|Overall Study|Withdrawal by Subject|7|||
150165752|NCT02974010|541741621|FG001|Overall Study|Withdrawal by Subject|1|||
150165753|NCT02974010|541741622|FG002|Overall Study|Withdrawal by Subject|0|||
149931033|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
149931034|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931035|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931036|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931037|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931038|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931039|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931040|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931041|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931042|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931043|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931044|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
149931045|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931046|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
149931047|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931048|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149931049|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
150266226|NCT02101034|542112498|FG000|Overall Study|Enrolled but did not start treatment|0|||
149931050|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931051|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931052|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931053|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931054|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931055|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931056|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931057|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931058|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931059|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931060|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
149931061|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931062|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931063|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149931064|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931065|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931066|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931067|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931068|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931069|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931070|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931071|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931072|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931073|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931074|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
149931075|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931076|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
149931077|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149931078|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
149931079|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931080|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931081|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931082|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931083|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931084|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931085|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931086|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931087|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931088|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931089|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931090|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
150266227|NCT02101034|542112499|FG001|Overall Study|Enrolled but did not start treatment|0|||
150266228|NCT02101034|542112500|FG002|Overall Study|Enrolled but did not start treatment|1|||
150266229|NCT02101034|542112501|FG003|Overall Study|Enrolled but did not start treatment|0|||
150266230|NCT02101034|542112502|FG004|Overall Study|Enrolled but did not start treatment|0|||
150266231|NCT02720536|542112507|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
149931091|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931092|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149931093|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
149931094|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931095|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931096|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931097|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931098|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931099|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931100|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931101|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931102|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931103|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931104|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931105|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
149931106|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
149931107|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149931108|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
149931109|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931110|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931111|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931112|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931113|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931114|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931115|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931116|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
150266232|NCT02720536|542112507|FG000|Overall Study|PR - pregnancy|2|||
150266233|NCT02720536|542112507|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
149931117|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931118|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931119|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931120|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
149931121|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931122|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931123|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
149931124|NCT02326272|540881955|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931125|NCT02326272|540881956|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931126|NCT02326272|540881957|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931127|NCT02326272|540881958|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931128|NCT02326272|540881959|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
150266234|NCT02720536|542112507|FG000|Overall Study|PR - death|1|||
150266235|NCT02720536|542112507|FG000|Overall Study|PR - adverse event|1|||
150266236|NCT02720536|542112507|FG000|Overall Study|PR - abnormal lab value(s)|1|||
150266237|NCT02720536|542112507|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
150266238|NCT01028222|542112508|FG000|Overall Study|Protocol deviation|1|||
150266239|NCT01028222|542112509|FG001|Overall Study|Protocol deviation|0|||
150266240|NCT01028222|542112508|FG000|Overall Study|Disease progression|33|||
150266241|NCT01028222|542112509|FG001|Overall Study|Disease progression|9|||
149931129|NCT02326272|540881960|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931130|NCT02326272|540881961|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931131|NCT02326272|540881962|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931132|NCT02326272|540881963|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931133|NCT02326272|540881964|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931134|NCT02326272|540881965|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931135|NCT02326272|540881966|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931136|NCT02326272|540881967|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
149931137|NCT02326272|540881968|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931138|NCT02326272|540881969|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
149931139|NCT00735943|540881974|FG000|Overall Study|Lost to Follow-up|1|||
149931140|NCT00735943|540881974|FG000|Overall Study|Adverse Event|1|||
149931141|NCT00115778|540881975|FG000|Overall Study|Withdrawal by Subject|0|||
149931142|NCT00115778|540881976|FG001|Overall Study|Withdrawal by Subject|1|||
149931143|NCT02185417|540881979|FG000|Overall Study|Death|448|||
149931144|NCT02185417|540881980|FG001|Overall Study|Death|446|||
149931145|NCT02185417|540881981|FG002|Overall Study|Death|0|||
149931146|NCT02185417|540881979|FG000|Overall Study|Withdrawal by Subject|7|||
150266242|NCT01028222|542112508|FG000|Overall Study|Administrative problems|1|||
150266243|NCT01028222|542112509|FG001|Overall Study|Administrative problems|1|||
150266244|NCT01028222|542112508|FG000|Overall Study|Lost to Follow-up|0|||
149931147|NCT02185417|540881980|FG001|Overall Study|Withdrawal by Subject|12|||
149931148|NCT02185417|540881981|FG002|Overall Study|Withdrawal by Subject|0|||
149931149|NCT02595502|540881984|FG000|Period 1|Adverse Event|0|||
149931150|NCT02595502|540881985|FG001|Period 1|Adverse Event|1|||
149931151|NCT02595502|540881984|FG000|Period 1|Withdrawal by Subject|1|||
149931152|NCT02595502|540881985|FG001|Period 1|Withdrawal by Subject|0|||
149931153|NCT02595502|540881984|FG000|Period 1|Lost to Follow-up|0|||
149931154|NCT02595502|540881985|FG001|Period 1|Lost to Follow-up|1|||
149931155|NCT02595502|540881984|FG000|Period 2|Adverse Event|1|||
149931156|NCT02595502|540881985|FG001|Period 2|Adverse Event|1|||
149931157|NCT02595502|540881984|FG000|Period 2|Received incorrect lens at Period 1|0|||
149931158|NCT02595502|540881985|FG001|Period 2|Received incorrect lens at Period 1|1|||
149931159|NCT02595502|540881984|FG000|Period 3|Protocol Violation|0|||
149931160|NCT02595502|540881985|FG001|Period 3|Protocol Violation|1|||
149931161|NCT02595502|540881984|FG000|Period 3|Lost to Follow-up|1|||
149931162|NCT02595502|540881985|FG001|Period 3|Lost to Follow-up|0|||
149931163|NCT02595502|540881984|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
149931164|NCT02595502|540881985|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
149931165|NCT01278342|540881988|FG000|Overall Study|Physician Decision|0|||
149931166|NCT01278342|540881989|FG001|Overall Study|Physician Decision|1|||
149931167|NCT01278342|540881990|FG002|Overall Study|Physician Decision|0|||
149931168|NCT01278342|540881988|FG000|Overall Study|Lost to Follow-up|1|||
149931169|NCT01278342|540881989|FG001|Overall Study|Lost to Follow-up|0|||
149931170|NCT01278342|540881990|FG002|Overall Study|Lost to Follow-up|0|||
149931171|NCT01278342|540881988|FG000|Overall Study|Administrative problems|2|||
149931172|NCT01278342|540881989|FG001|Overall Study|Administrative problems|0|||
149931173|NCT01278342|540881990|FG002|Overall Study|Administrative problems|0|||
149931174|NCT01278342|540881988|FG000|Overall Study|Other|1|||
149931175|NCT01278342|540881989|FG001|Overall Study|Other|0|||
149931176|NCT01278342|540881990|FG002|Overall Study|Other|0|||
149931177|NCT03225170|540881992|FG000|Overall Study|Lost to Follow-up|4|||
149931178|NCT03225170|540881993|FG001|Overall Study|Lost to Follow-up|4|||
149931179|NCT03225170|540881994|FG002|Overall Study|Lost to Follow-up|0|||
149931180|NCT03225170|540881992|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
149931181|NCT03225170|540881993|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
149931182|NCT03225170|540881994|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
149931183|NCT04073303|540881998|FG000|Overall Study|Adverse Event|0|||
149931184|NCT04073303|540881999|FG001|Overall Study|Adverse Event|2|||
149931185|NCT04073303|540881998|FG000|Overall Study|Withdrawal by Subject|16|||
149931186|NCT04073303|540881999|FG001|Overall Study|Withdrawal by Subject|36|||
149931187|NCT04073303|540881998|FG000|Overall Study|Lost to Follow-up|6|||
149931188|NCT04073303|540881999|FG001|Overall Study|Lost to Follow-up|1|||
149931189|NCT04073303|540881998|FG000|Overall Study|Protocol Deviation|0|||
149931190|NCT04073303|540881999|FG001|Overall Study|Protocol Deviation|4|||
149931191|NCT04073303|540881998|FG000|Overall Study|Other|1|||
149931192|NCT04073303|540881999|FG001|Overall Study|Other|1|||
149931193|NCT01158261|540882000|FG000|Overall Study|Lost to Follow-up|9|||
149931194|NCT01158261|540882000|FG000|Overall Study|Death|7|||
149931195|NCT01158261|540882000|FG000|Overall Study|Withdrawal by Subject|1|||
149931196|NCT00971867|540882001|FG000|Overall Study|Adverse Event|4|||
149931197|NCT00971867|540882001|FG000|Overall Study|Participant Withdrew Consent|1|||
149931198|NCT00971867|540882001|FG000|Overall Study|Disease Progression|6|||
149931199|NCT00905424|540882003|FG000|Overall Study|Lost to Follow-up|3|||
149931200|NCT00905424|540882004|FG001|Overall Study|Lost to Follow-up|3|||
149931201|NCT00905424|540882003|FG000|Overall Study|Withdrawal by Subject|1|||
149931202|NCT00905424|540882004|FG001|Overall Study|Withdrawal by Subject|2|||
149931203|NCT00905424|540882003|FG000|Overall Study|Adverse Event|4|||
149931204|NCT00905424|540882004|FG001|Overall Study|Adverse Event|2|||
149931205|NCT00905424|540882003|FG000|Overall Study|Non-compliance with study medication|2|||
149931206|NCT00905424|540882004|FG001|Overall Study|Non-compliance with study medication|0|||
149931207|NCT00905424|540882003|FG000|Overall Study|Sponsor decision|1|||
149931208|NCT00905424|540882004|FG001|Overall Study|Sponsor decision|0|||
149931209|NCT00905424|540882003|FG000|Overall Study|Positive urine drug screen|0|||
149931210|NCT00905424|540882004|FG001|Overall Study|Positive urine drug screen|1|||
149931211|NCT00905424|540882003|FG000|Overall Study|Non-adherence to visit schedule|0|||
149931212|NCT00905424|540882004|FG001|Overall Study|Non-adherence to visit schedule|1|||
149931213|NCT00379899|540882005|FG000|Overall Study|Adverse Event|7|||
149931214|NCT00379899|540882006|FG001|Overall Study|Adverse Event|3|||
149931215|NCT00379899|540882005|FG000|Overall Study|Death|10|||
149931216|NCT00379899|540882006|FG001|Overall Study|Death|10|||
149931217|NCT00379899|540882005|FG000|Overall Study|Lost to Follow-up|2|||
149931218|NCT00379899|540882006|FG001|Overall Study|Lost to Follow-up|4|||
149931219|NCT00379899|540882005|FG000|Overall Study|Physician Decision|3|||
149931220|NCT00379899|540882006|FG001|Overall Study|Physician Decision|4|||
149931221|NCT00379899|540882005|FG000|Overall Study|Withdrawal by Subject|5|||
149931222|NCT00379899|540882006|FG001|Overall Study|Withdrawal by Subject|5|||
149931223|NCT00379899|540882005|FG000|Overall Study|Ineligibility determined|0|||
149931224|NCT00379899|540882006|FG001|Overall Study|Ineligibility determined|1|||
150266245|NCT01028222|542112509|FG001|Overall Study|Lost to Follow-up|1|||
150266246|NCT01028222|542112508|FG000|Overall Study|Withdrawal by Subject|1|||
150266247|NCT01028222|542112509|FG001|Overall Study|Withdrawal by Subject|0|||
150266248|NCT01028222|542112508|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
150266249|NCT01028222|542112509|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
150266250|NCT01028222|542112508|FG000|Overall Study|Adverse Event|2|||
150266251|NCT01028222|542112509|FG001|Overall Study|Adverse Event|0|||
150266252|NCT00146328|542112510|FG000|Overall Study|Adverse Event|39|||
150266253|NCT00146328|542112511|FG001|Overall Study|Adverse Event|48|||
150266254|NCT00146328|542112512|FG002|Overall Study|Adverse Event|79|||
150266255|NCT00146328|542112510|FG000|Overall Study|Protocol Violation|11|||
150266256|NCT00146328|542112511|FG001|Overall Study|Protocol Violation|6|||
150266257|NCT00146328|542112512|FG002|Overall Study|Protocol Violation|12|||
149819764|NCT00545233|540469256|FG001|Overall Study|Refused Treatment|7|||
149819765|NCT00545233|540469255|FG000|Overall Study|Failure to Return|4|||
149819766|NCT00545233|540469256|FG001|Overall Study|Failure to Return|6|||
149819767|NCT00545233|540469255|FG000|Overall Study|Insufficient response|14|||
149819768|NCT00545233|540469256|FG001|Overall Study|Insufficient response|15|||
149819769|NCT00545233|540469255|FG000|Overall Study|Physician Decision|2|||
149819770|NCT00545233|540469256|FG001|Overall Study|Physician Decision|1|||
149819771|NCT02124746|540469259|FG000|Overall Study|Adverse Event|2|||
149819772|NCT02124746|540469260|FG001|Overall Study|Adverse Event|1|||
149819773|NCT02124746|540469261|FG002|Overall Study|Adverse Event|2|||
149819774|NCT02124746|540469259|FG000|Overall Study|Death|2|||
149819775|NCT02124746|540469260|FG001|Overall Study|Death|1|||
149819776|NCT02124746|540469261|FG002|Overall Study|Death|3|||
149819777|NCT02124746|540469259|FG000|Overall Study|Lack of Efficacy|3|||
149819778|NCT02124746|540469260|FG001|Overall Study|Lack of Efficacy|2|||
149819779|NCT02124746|540469261|FG002|Overall Study|Lack of Efficacy|2|||
149819780|NCT02124746|540469259|FG000|Overall Study|Physician Decision|6|||
149819781|NCT02124746|540469260|FG001|Overall Study|Physician Decision|4|||
149819782|NCT02124746|540469261|FG002|Overall Study|Physician Decision|5|||
149819783|NCT02124746|540469259|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149819784|NCT02124746|540469260|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149819785|NCT02124746|540469261|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149819786|NCT02124746|540469259|FG000|Overall Study|Withdrawal by Subject|3|||
149819787|NCT02124746|540469260|FG001|Overall Study|Withdrawal by Subject|3|||
149819788|NCT02124746|540469261|FG002|Overall Study|Withdrawal by Subject|0|||
149819789|NCT02124746|540469259|FG000|Overall Study|Study Terminated by Sponsor|0|||
149819790|NCT02124746|540469260|FG001|Overall Study|Study Terminated by Sponsor|0|||
149819791|NCT02124746|540469261|FG002|Overall Study|Study Terminated by Sponsor|6|||
149819792|NCT02124746|540469259|FG000|Overall Study|Disease Progression|3|||
149819793|NCT02124746|540469260|FG001|Overall Study|Disease Progression|6|||
149819794|NCT02124746|540469261|FG002|Overall Study|Disease Progression|4|||
149819795|NCT03811249|540469266|FG000|Overall Study|Withdrawal by Subject|44|||
149819796|NCT03811249|540469266|FG000|Overall Study|Missed Visit|24|||
149819797|NCT01783730|540469275|FG000|Overall Study|Failed to meet inclusion criteria|6|||
149819798|NCT02151461|540469276|FG000|Overall Study|Adverse Event|5|||
149819799|NCT02151461|540469277|FG001|Overall Study|Adverse Event|1|||
149819800|NCT02151461|540469278|FG002|Overall Study|Adverse Event|0|||
149819801|NCT02151461|540469279|FG003|Overall Study|Adverse Event|2|||
149819802|NCT02151461|540469276|FG000|Overall Study|Lost to Follow-up|0|||
149819803|NCT02151461|540469277|FG001|Overall Study|Lost to Follow-up|0|||
149819804|NCT02151461|540469278|FG002|Overall Study|Lost to Follow-up|1|||
149819805|NCT02151461|540469279|FG003|Overall Study|Lost to Follow-up|1|||
149819806|NCT02151461|540469276|FG000|Overall Study|Withdrawal by Subject|1|||
149819807|NCT02151461|540469277|FG001|Overall Study|Withdrawal by Subject|0|||
149819808|NCT02151461|540469278|FG002|Overall Study|Withdrawal by Subject|1|||
149819809|NCT02151461|540469279|FG003|Overall Study|Withdrawal by Subject|1|||
149819810|NCT02151461|540469276|FG000|Overall Study|Treatment discontinuation|0|||
149819811|NCT02151461|540469277|FG001|Overall Study|Treatment discontinuation|0|||
149819812|NCT02151461|540469278|FG002|Overall Study|Treatment discontinuation|1|||
149819813|NCT02151461|540469279|FG003|Overall Study|Treatment discontinuation|0|||
149819814|NCT04304950|540469280|FG000|Overall Study|Lost to Follow-up|1|||
149819815|NCT04304950|540469281|FG001|Overall Study|Lost to Follow-up|1|||
149819816|NCT00408876|540469282|FG000|Overall Study|Adverse Event|9|||
149819817|NCT00408876|540469283|FG001|Overall Study|Adverse Event|17|||
149819818|NCT00408876|540469284|FG002|Overall Study|Adverse Event|27|||
149819819|NCT00408876|540469285|FG003|Overall Study|Adverse Event|10|||
149819820|NCT00408876|540469282|FG000|Overall Study|Withdrawal by Subject|3|||
149819821|NCT00408876|540469283|FG001|Overall Study|Withdrawal by Subject|6|||
149819822|NCT00408876|540469284|FG002|Overall Study|Withdrawal by Subject|6|||
149819823|NCT00408876|540469285|FG003|Overall Study|Withdrawal by Subject|14|||
149819824|NCT00408876|540469282|FG000|Overall Study|Lack of Efficacy|2|||
149819825|NCT00408876|540469283|FG001|Overall Study|Lack of Efficacy|4|||
149819826|NCT00408876|540469284|FG002|Overall Study|Lack of Efficacy|5|||
149819827|NCT00408876|540469285|FG003|Overall Study|Lack of Efficacy|6|||
149819828|NCT00408876|540469282|FG000|Overall Study|Lost to Follow-up|1|||
149819829|NCT00408876|540469283|FG001|Overall Study|Lost to Follow-up|6|||
149819830|NCT00408876|540469284|FG002|Overall Study|Lost to Follow-up|5|||
149819831|NCT00408876|540469285|FG003|Overall Study|Lost to Follow-up|2|||
149819832|NCT00408876|540469282|FG000|Overall Study|Protocol Violation|0|||
149819833|NCT00408876|540469283|FG001|Overall Study|Protocol Violation|3|||
149819834|NCT00408876|540469284|FG002|Overall Study|Protocol Violation|4|||
149819835|NCT00408876|540469285|FG003|Overall Study|Protocol Violation|3|||
149819836|NCT00408876|540469282|FG000|Overall Study|Physician Decision|1|||
149819837|NCT00408876|540469283|FG001|Overall Study|Physician Decision|0|||
149819838|NCT00408876|540469284|FG002|Overall Study|Physician Decision|3|||
149819839|NCT00408876|540469285|FG003|Overall Study|Physician Decision|0|||
149819840|NCT01512979|540469292|FG000|Overall Study|Adverse Event|2|||
149819841|NCT01512979|540469293|FG001|Overall Study|Adverse Event|2|||
149819842|NCT01512979|540469292|FG000|Overall Study|Protocol Violation|1|||
149819843|NCT01512979|540469293|FG001|Overall Study|Protocol Violation|4|||
149819844|NCT01512979|540469292|FG000|Overall Study|Lost to Follow-up|2|||
149819845|NCT01512979|540469293|FG001|Overall Study|Lost to Follow-up|5|||
149819846|NCT01512979|540469292|FG000|Overall Study|Withdrawal by Subject|1|||
149819847|NCT01512979|540469293|FG001|Overall Study|Withdrawal by Subject|2|||
149819848|NCT01512979|540469292|FG000|Overall Study|Reason other than stated above|13|||
149819849|NCT01512979|540469293|FG001|Overall Study|Reason other than stated above|9|||
149819850|NCT01606137|540469296|FG000|Overall Study|Adverse Event|85|||
149819851|NCT01606137|540469296|FG000|Overall Study|Withdrawal by Subject|74|||
149819852|NCT01606137|540469296|FG000|Overall Study|Lack of Efficacy|56|||
149819853|NCT01606137|540469296|FG000|Overall Study|Lost to Follow-up|15|||
149819854|NCT01606137|540469296|FG000|Overall Study|Protocol Violation|1|||
149819855|NCT01606137|540469296|FG000|Overall Study|Patient non-compliance|9|||
149819856|NCT01606137|540469296|FG000|Overall Study|Death|1|||
149819857|NCT01606137|540469296|FG000|Overall Study|Decreased/no pain|4|||
149819858|NCT01606137|540469296|FG000|Overall Study|Issues with driving|4|||
149819859|NCT01606137|540469296|FG000|Overall Study|multiple sclerosis less stable|1|||
149819860|NCT01606137|540469296|FG000|Overall Study|Increased bilirubin|1|||
149819861|NCT01606137|540469296|FG000|Overall Study|Spray causes nausea|1|||
149819862|NCT01606137|540469296|FG000|Overall Study|Not enough improvement|4|||
149819863|NCT01606137|540469296|FG000|Overall Study|Wanted to try another treatment|1|||
149819864|NCT01606137|540469296|FG000|Overall Study|Patient leaving country|1|||
149819865|NCT01606137|540469296|FG000|Overall Study|Personal reasons|1|||
149819866|NCT01606137|540469296|FG000|Overall Study|Unable to tolerate study med. taste|1|||
149819867|NCT01606137|540469296|FG000|Overall Study|Patient moving|1|||
149819868|NCT01606137|540469296|FG000|Overall Study|Unable to collect consistent data|1|||
149819869|NCT00066807|540469297|FG000|Overall Study|Study was terminated early|14|||
149819870|NCT00066807|540469298|FG001|Overall Study|Study was terminated early|15|||
149819871|NCT00420290|540469299|FG000|Overall Study|Adverse Event|3|||
149819872|NCT00420290|540469300|FG001|Overall Study|Adverse Event|1|||
149819873|NCT00420290|540469299|FG000|Overall Study|Withdrawal by Subject|0|||
149819874|NCT00420290|540469300|FG001|Overall Study|Withdrawal by Subject|2|||
149819875|NCT00420290|540469299|FG000|Overall Study|did not meet inclusion/exclusion|1|||
149819876|NCT00420290|540469300|FG001|Overall Study|did not meet inclusion/exclusion|1|||
149819877|NCT05028751|540469301|FG000|Overall Study|Study Terminated by Sponsor|3|||
149819878|NCT05028751|540469302|FG001|Overall Study|Study Terminated by Sponsor|0|||
149819879|NCT05028751|540469303|FG002|Overall Study|Study Terminated by Sponsor|0|||
149819880|NCT05028751|540469304|FG003|Overall Study|Study Terminated by Sponsor|0|||
149819881|NCT05028751|540469301|FG000|Overall Study|Death|9|||
149819882|NCT05028751|540469302|FG001|Overall Study|Death|3|||
149819883|NCT05028751|540469303|FG002|Overall Study|Death|2|||
149819884|NCT05028751|540469304|FG003|Overall Study|Death|4|||
149819885|NCT05028751|540469301|FG000|Overall Study|Withdrawal by Subject|0|||
149819886|NCT05028751|540469302|FG001|Overall Study|Withdrawal by Subject|0|||
149819887|NCT05028751|540469303|FG002|Overall Study|Withdrawal by Subject|1|||
149819888|NCT05028751|540469304|FG003|Overall Study|Withdrawal by Subject|0|||
149819889|NCT05028751|540469301|FG000|Overall Study|Miscellaneous|2|||
149819890|NCT05028751|540469302|FG001|Overall Study|Miscellaneous|0|||
149819891|NCT05028751|540469303|FG002|Overall Study|Miscellaneous|0|||
149819892|NCT05028751|540469304|FG003|Overall Study|Miscellaneous|0|||
149819893|NCT03322462|540471608|FG000|Overall Study|Technical difficulties|2|||
149819894|NCT03322462|540471608|FG000|Overall Study|Other|1|||
149819895|NCT01393990|540471609|FG000|Overall Study|Adverse Event|0|||
149819896|NCT01393990|540471610|FG001|Overall Study|Adverse Event|0|||
149819897|NCT01393990|540471611|FG002|Overall Study|Adverse Event|0|||
149819898|NCT01393990|540471612|FG003|Overall Study|Adverse Event|0|||
149819899|NCT01393990|540471613|FG004|Overall Study|Adverse Event|0|||
149819900|NCT01393990|540471614|FG005|Overall Study|Adverse Event|0|||
149819901|NCT01393990|540471615|FG006|Overall Study|Adverse Event|0|||
149819902|NCT01393990|540471616|FG007|Overall Study|Adverse Event|0|||
149819903|NCT01393990|540471617|FG008|Overall Study|Adverse Event|0|||
149819904|NCT01393990|540471618|FG009|Overall Study|Adverse Event|0|||
149819905|NCT01393990|540471619|FG010|Overall Study|Adverse Event|0|||
149819906|NCT01393990|540471620|FG011|Overall Study|Adverse Event|0|||
149819907|NCT01393990|540471621|FG012|Overall Study|Adverse Event|0|||
149931225|NCT00379899|540882005|FG000|Overall Study|Noncompliance|1|||
149931226|NCT00379899|540882006|FG001|Overall Study|Noncompliance|1|||
149931227|NCT00379899|540882005|FG000|Overall Study|Parathyroidectomy|0|||
149931228|NCT00379899|540882006|FG001|Overall Study|Parathyroidectomy|2|||
149931229|NCT00379899|540882005|FG000|Overall Study|Renal transplantation|5|||
149931230|NCT00379899|540882006|FG001|Overall Study|Renal transplantation|4|||
149931231|NCT00379899|540882005|FG000|Overall Study|Coronary artery bypass graft|1|||
149931232|NCT00379899|540882006|FG001|Overall Study|Coronary artery bypass graft|1|||
149931233|NCT00379899|540882005|FG000|Overall Study|Other protocol-specified criteria|3|||
149931234|NCT00379899|540882006|FG001|Overall Study|Other protocol-specified criteria|4|||
149931235|NCT00379899|540882005|FG000|Overall Study|Other|3|||
149931236|NCT00379899|540882006|FG001|Overall Study|Other|1|||
149931237|NCT01261390|540882007|FG000|Overall Study|Significant Concurrent Illness|1|||
149931238|NCT01261390|540882008|FG001|Overall Study|Significant Concurrent Illness|0|||
149931239|NCT01261390|540882009|FG002|Overall Study|Significant Concurrent Illness|1|||
150165754|NCT02974010|541741623|FG003|Overall Study|Withdrawal by Subject|0|||
150165755|NCT02974010|541741620|FG000|Overall Study|Adverse Event|0|||
150165756|NCT02974010|541741621|FG001|Overall Study|Adverse Event|1|||
150165757|NCT02974010|541741622|FG002|Overall Study|Adverse Event|0|||
150165758|NCT02974010|541741623|FG003|Overall Study|Adverse Event|0|||
150266258|NCT00146328|542112510|FG000|Overall Study|Lost to Follow-up|7|||
150266259|NCT00146328|542112511|FG001|Overall Study|Lost to Follow-up|4|||
150165759|NCT02974010|541741620|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
150165760|NCT02974010|541741621|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
150165761|NCT02974010|541741622|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
150266260|NCT00146328|542112512|FG002|Overall Study|Lost to Follow-up|7|||
150266261|NCT00146328|542112510|FG000|Overall Study|Withdrawal by Subject|16|||
150266262|NCT00146328|542112511|FG001|Overall Study|Withdrawal by Subject|16|||
150266263|NCT00146328|542112512|FG002|Overall Study|Withdrawal by Subject|22|||
149931240|NCT01261390|540882010|FG003|Overall Study|Significant Concurrent Illness|0|||
149931241|NCT01261390|540882007|FG000|Overall Study|Dissatisfaction with Treatment|2|||
149931242|NCT01261390|540882008|FG001|Overall Study|Dissatisfaction with Treatment|1|||
149931243|NCT01261390|540882009|FG002|Overall Study|Dissatisfaction with Treatment|1|||
149931244|NCT01261390|540882010|FG003|Overall Study|Dissatisfaction with Treatment|2|||
149931245|NCT01261390|540882007|FG000|Overall Study|Relocation|0|||
149931246|NCT01261390|540882008|FG001|Overall Study|Relocation|1|||
149931247|NCT01261390|540882009|FG002|Overall Study|Relocation|0|||
149931248|NCT01261390|540882010|FG003|Overall Study|Relocation|0|||
149931249|NCT01261390|540882007|FG000|Overall Study|Loss of Interest in the Study|3|||
150266264|NCT00146328|542112510|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
150266265|NCT00146328|542112511|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
150266266|NCT00146328|542112512|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
149931250|NCT01261390|540882008|FG001|Overall Study|Loss of Interest in the Study|1|||
149931251|NCT01261390|540882009|FG002|Overall Study|Loss of Interest in the Study|0|||
149931252|NCT01261390|540882010|FG003|Overall Study|Loss of Interest in the Study|0|||
149931253|NCT01261390|540882007|FG000|Overall Study|Lost to Follow-up|1|||
149931254|NCT01261390|540882008|FG001|Overall Study|Lost to Follow-up|6|||
149931255|NCT01261390|540882009|FG002|Overall Study|Lost to Follow-up|5|||
149931256|NCT01261390|540882010|FG003|Overall Study|Lost to Follow-up|6|||
149931257|NCT04235504|540882012|FG000|Study Phase|Withdrawal by Subject|5|||
149931258|NCT04235504|540882013|FG001|Study Phase|Withdrawal by Subject|2|||
149931259|NCT04235504|540882014|FG002|Study Phase|Withdrawal by Subject|0|||
149931260|NCT04235504|540882015|FG003|Study Phase|Withdrawal by Subject|0|||
149931261|NCT04235504|540882012|FG000|Continuation Phase|Withdrawal by Subject|0|||
149931262|NCT04235504|540882013|FG001|Continuation Phase|Withdrawal by Subject|4|||
149931263|NCT04235504|540882014|FG002|Continuation Phase|Withdrawal by Subject|0|||
149931264|NCT04235504|540882015|FG003|Continuation Phase|Withdrawal by Subject|0|||
149931265|NCT04235504|540882012|FG000|Continuation Phase|Adverse Event|0|||
149931266|NCT04235504|540882013|FG001|Continuation Phase|Adverse Event|1|||
149931267|NCT04235504|540882014|FG002|Continuation Phase|Adverse Event|0|||
149931268|NCT04235504|540882015|FG003|Continuation Phase|Adverse Event|0|||
149931269|NCT04235504|540882012|FG000|Continuation Phase|Physician Decision|1|||
149931270|NCT04235504|540882013|FG001|Continuation Phase|Physician Decision|2|||
149931271|NCT04235504|540882014|FG002|Continuation Phase|Physician Decision|1|||
149931272|NCT04235504|540882015|FG003|Continuation Phase|Physician Decision|0|||
149931273|NCT04001803|540882016|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
149931274|NCT04001803|540882016|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
149931275|NCT04001803|540882016|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
150266267|NCT00146328|542112510|FG000|Overall Study|Trial ended/site closed|8|||
150266268|NCT00146328|542112511|FG001|Overall Study|Trial ended/site closed|2|||
149931276|NCT04001803|540882016|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
149931277|NCT04001803|540882016|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
149931278|NCT04001803|540882016|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
150165762|NCT02974010|541741623|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
150266269|NCT00146328|542112512|FG002|Overall Study|Trial ended/site closed|19|||
149931279|NCT04001803|540882016|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
149931280|NCT04001803|540882016|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
149931281|NCT04001803|540882016|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
149931282|NCT04001803|540882016|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
149931283|NCT02329327|540882017|FG000|Overall Study|Death|78|||
149931284|NCT02329327|540882018|FG001|Overall Study|Death|0|||
149931285|NCT02329327|540882017|FG000|Overall Study|Withdrawal by Subject|3|||
149931286|NCT02329327|540882018|FG001|Overall Study|Withdrawal by Subject|0|||
149931287|NCT02329327|540882017|FG000|Overall Study|Lost to Follow-up|4|||
149931288|NCT02329327|540882018|FG001|Overall Study|Lost to Follow-up|0|||
149931289|NCT04888494|540882019|FG000|Overall Study|Lost to Follow-up|2|||
149931290|NCT04888494|540882020|FG001|Overall Study|Lost to Follow-up|3|||
149931291|NCT04888494|540882019|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
149931292|NCT04888494|540882020|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
149931293|NCT03430856|540882021|FG000|Overall Study|Adverse Event|0|||
149931294|NCT03430856|540882022|FG001|Overall Study|Adverse Event|1|||
149931295|NCT03430856|540882023|FG002|Overall Study|Adverse Event|0|||
149931296|NCT03430856|540882021|FG000|Overall Study|Rescue criteria|1|||
149931297|NCT03430856|540882022|FG001|Overall Study|Rescue criteria|1|||
149931298|NCT03430856|540882023|FG002|Overall Study|Rescue criteria|0|||
149931299|NCT03430856|540882021|FG000|Overall Study|Voluntary withdrawal of consent|1|||
149931300|NCT03430856|540882022|FG001|Overall Study|Voluntary withdrawal of consent|1|||
149931301|NCT03430856|540882023|FG002|Overall Study|Voluntary withdrawal of consent|1|||
149931302|NCT00565604|540882024|FG000|Overall Study|Failure to treat|2|||
149931303|NCT00565604|540882024|FG000|Overall Study|Lost to Follow-up|2|||
149931304|NCT03713684|540883881|FG000|Overall Study|Adverse Event|1|||
149931305|NCT03713684|540883882|FG001|Overall Study|Adverse Event|3|||
150165763|NCT02974010|541741620|FG000|Overall Study|Lack of Efficacy|0|||
150165764|NCT02974010|541741621|FG001|Overall Study|Lack of Efficacy|0|||
150165765|NCT02974010|541741622|FG002|Overall Study|Lack of Efficacy|1|||
150165766|NCT02974010|541741623|FG003|Overall Study|Lack of Efficacy|0|||
150165767|NCT00320489|541741626|FG000|Overall Study|Adverse Event|26|||
150165768|NCT00320489|541741627|FG001|Overall Study|Adverse Event|25|||
150165769|NCT00320489|541741626|FG000|Overall Study|Clinical Relapse|26|||
150165770|NCT00320489|541741627|FG001|Overall Study|Clinical Relapse|20|||
150165771|NCT00320489|541741626|FG000|Overall Study|Death|0|||
150165772|NCT00320489|541741627|FG001|Overall Study|Death|2|||
150165773|NCT00320489|541741626|FG000|Overall Study|Entry Criteria Exclusion|2|||
150165774|NCT00320489|541741627|FG001|Overall Study|Entry Criteria Exclusion|4|||
150165775|NCT00320489|541741626|FG000|Overall Study|Lack of Efficacy|16|||
150165776|NCT00320489|541741627|FG001|Overall Study|Lack of Efficacy|7|||
150165777|NCT00320489|541741626|FG000|Overall Study|Lost to Follow-up|21|||
150165778|NCT00320489|541741627|FG001|Overall Study|Lost to Follow-up|22|||
150165779|NCT00320489|541741626|FG000|Overall Study|Physician Decision|8|||
150165780|NCT00320489|541741627|FG001|Overall Study|Physician Decision|8|||
150165781|NCT00320489|541741626|FG000|Overall Study|Protocol Violation|4|||
150165782|NCT00320489|541741627|FG001|Overall Study|Protocol Violation|4|||
150165783|NCT00320489|541741626|FG000|Overall Study|Sponsor Decision|3|||
150165784|NCT00320489|541741627|FG001|Overall Study|Sponsor Decision|3|||
150165785|NCT00320489|541741626|FG000|Overall Study|Withdrawal by Subject|39|||
150165786|NCT00320489|541741627|FG001|Overall Study|Withdrawal by Subject|41|||
150165787|NCT05650333|541741630|FG000|Treatment Period (7 Days)|Adverse Event|1|||
150165788|NCT03852433|541741633|FG000|Overall Study|Withdrawal of consent|5|||
150165789|NCT03852433|541741634|FG001|Overall Study|Withdrawal of consent|8|||
150165790|NCT03852433|541741635|FG002|Overall Study|Withdrawal of consent|1|||
150165791|NCT03852433|541741636|FG003|Overall Study|Withdrawal of consent|1|||
150165792|NCT03852433|541741633|FG000|Overall Study|Adverse Event|1|||
150165793|NCT03852433|541741634|FG001|Overall Study|Adverse Event|1|||
150165794|NCT03852433|541741635|FG002|Overall Study|Adverse Event|1|||
150165795|NCT03852433|541741636|FG003|Overall Study|Adverse Event|1|||
150165796|NCT03852433|541741633|FG000|Overall Study|Lost to Follow-up|0|||
150165797|NCT03852433|541741634|FG001|Overall Study|Lost to Follow-up|1|||
150165798|NCT03852433|541741635|FG002|Overall Study|Lost to Follow-up|0|||
150266270|NCT00146328|542112510|FG000|Overall Study|Patient decision to end|0|||
150165799|NCT03852433|541741636|FG003|Overall Study|Lost to Follow-up|1|||
150165800|NCT03852433|541741633|FG000|Overall Study|Pregnancy|0|||
150266271|NCT00146328|542112511|FG001|Overall Study|Patient decision to end|1|||
149931306|NCT03713684|540883883|FG002|Overall Study|Adverse Event|1|||
149931307|NCT03713684|540883884|FG003|Overall Study|Adverse Event|0|||
149931308|NCT03713684|540883881|FG000|Overall Study|Poor compliance to protocol|2|||
149931309|NCT03713684|540883882|FG001|Overall Study|Poor compliance to protocol|1|||
150165801|NCT03852433|541741634|FG001|Overall Study|Pregnancy|1|||
150165802|NCT03852433|541741635|FG002|Overall Study|Pregnancy|1|||
150165803|NCT03852433|541741636|FG003|Overall Study|Pregnancy|0|||
150165804|NCT03852433|541741633|FG000|Overall Study|Protocol Violation|0|||
150165805|NCT03852433|541741634|FG001|Overall Study|Protocol Violation|0|||
150165806|NCT03852433|541741635|FG002|Overall Study|Protocol Violation|1|||
150165807|NCT03852433|541741636|FG003|Overall Study|Protocol Violation|1|||
149931310|NCT03713684|540883883|FG002|Overall Study|Poor compliance to protocol|0|||
149931311|NCT03713684|540883884|FG003|Overall Study|Poor compliance to protocol|1|||
149931312|NCT03713684|540883881|FG000|Overall Study|Withdrawal by Subject|14|||
149931313|NCT03713684|540883882|FG001|Overall Study|Withdrawal by Subject|6|||
149931314|NCT03713684|540883883|FG002|Overall Study|Withdrawal by Subject|14|||
149931315|NCT03713684|540883884|FG003|Overall Study|Withdrawal by Subject|16|||
149931316|NCT03713684|540883881|FG000|Overall Study|Other than specified|69|||
149931317|NCT03713684|540883882|FG001|Overall Study|Other than specified|77|||
149931318|NCT03713684|540883883|FG002|Overall Study|Other than specified|73|||
149931319|NCT03713684|540883884|FG003|Overall Study|Other than specified|70|||
149931320|NCT00528424|540883885|FG000|Overall Study|Lost to Follow-up|13|||
149931321|NCT00528424|540883885|FG000|Overall Study|Withdrew consent|2|||
149931322|NCT00528424|540883885|FG000|Overall Study|Administrative reason|2|||
149931323|NCT00528424|540883885|FG000|Overall Study|Other|12|||
149931324|NCT00974311|540883886|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
149931325|NCT00974311|540883887|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
149931326|NCT00974311|540883886|FG000|DB Phase (up to 24 Months)|Death|561|||
149931327|NCT00974311|540883887|FG001|DB Phase (up to 24 Months)|Death|298|||
149931328|NCT00974311|540883886|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
149931329|NCT00974311|540883887|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
149931330|NCT00974311|540883886|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
149931331|NCT00974311|540883887|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
149931332|NCT00974311|540883886|FG000|DB Phase (up to 24 Months)|Other|1|||
149931333|NCT00974311|540883887|FG001|DB Phase (up to 24 Months)|Other|0|||
149931334|NCT00974311|540883886|FG000|OLE Phase (up to 77 Months)|Death|14|||
149931335|NCT00974311|540883887|FG001|OLE Phase (up to 77 Months)|Death|21|||
149931336|NCT00974311|540883886|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
149931337|NCT00974311|540883887|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
149931338|NCT00974311|540883886|FG000|OLE Phase (up to 77 Months)|Other|15|||
149931339|NCT00974311|540883887|FG001|OLE Phase (up to 77 Months)|Other|2|||
149931340|NCT00974311|540883886|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
149931341|NCT00974311|540883887|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
149931342|NCT03131167|540883888|FG000|Overall Study|Other (Unspecified)|0|||
149931343|NCT03131167|540883889|FG001|Overall Study|Other (Unspecified)|0|||
149931344|NCT03131167|540883890|FG002|Overall Study|Other (Unspecified)|0|||
149931345|NCT03131167|540883891|FG003|Overall Study|Other (Unspecified)|0|||
149931346|NCT03131167|540883892|FG004|Overall Study|Other (Unspecified)|0|||
150165808|NCT03852433|541741633|FG000|Overall Study|Death|0|||
150165809|NCT03852433|541741634|FG001|Overall Study|Death|0|||
150165810|NCT03852433|541741635|FG002|Overall Study|Death|1|||
150165811|NCT03852433|541741636|FG003|Overall Study|Death|0|||
150165812|NCT03852433|541741633|FG000|Overall Study|Lack of Efficacy|0|||
150165813|NCT03852433|541741634|FG001|Overall Study|Lack of Efficacy|1|||
150165814|NCT03852433|541741635|FG002|Overall Study|Lack of Efficacy|0|||
150165815|NCT03852433|541741636|FG003|Overall Study|Lack of Efficacy|0|||
150165816|NCT03852433|541741633|FG000|Overall Study|Non-compliance with study drug|0|||
150165817|NCT03852433|541741634|FG001|Overall Study|Non-compliance with study drug|0|||
150165818|NCT03852433|541741635|FG002|Overall Study|Non-compliance with study drug|0|||
150165819|NCT03852433|541741636|FG003|Overall Study|Non-compliance with study drug|1|||
150165820|NCT03852433|541741633|FG000|Overall Study|Physician Decision|1|||
150165821|NCT03852433|541741634|FG001|Overall Study|Physician Decision|0|||
150165822|NCT03852433|541741635|FG002|Overall Study|Physician Decision|0|||
150165823|NCT03852433|541741636|FG003|Overall Study|Physician Decision|0|||
150165824|NCT03852433|541741633|FG000|Overall Study|Randomized but never treated|1|||
150165825|NCT03852433|541741634|FG001|Overall Study|Randomized but never treated|0|||
150165826|NCT03852433|541741635|FG002|Overall Study|Randomized but never treated|0|||
150165827|NCT03852433|541741636|FG003|Overall Study|Randomized but never treated|0|||
150165828|NCT02524288|541741637|FG000|Overall Study|Adverse Event|115|||
150165829|NCT02524288|541741637|FG000|Overall Study|Lost to Follow-up|216|||
150165830|NCT02524288|541741637|FG000|Overall Study|Non-Compliance With Protocol|32|||
150165831|NCT02524288|541741637|FG000|Overall Study|Non-Compliance With Study Drug|14|||
150165832|NCT02524288|541741637|FG000|Overall Study|Pregnancy Wish|6|||
150165833|NCT02524288|541741637|FG000|Overall Study|Protocol Violation|6|||
150165834|NCT02524288|541741637|FG000|Overall Study|Screen Failure|2|||
150165835|NCT02524288|541741637|FG000|Overall Study|Site Discontinued Study Participation|1|||
150165836|NCT02524288|541741637|FG000|Overall Study|Study Terminated By Sponsor|1417|||
150165837|NCT02524288|541741637|FG000|Overall Study|Subject Moved|32|||
149931347|NCT03131167|540883893|FG005|Overall Study|Other (Unspecified)|1|||
149931348|NCT03131167|540883894|FG006|Overall Study|Other (Unspecified)|0|||
150165838|NCT02524288|541741637|FG000|Overall Study|Withdrawal by Subject|76|||
149931349|NCT03131167|540883895|FG007|Overall Study|Other (Unspecified)|0|||
150165839|NCT02524288|541741637|FG000|Overall Study|Pregnancy|22|||
150165840|NCT02524288|541741637|FG000|Overall Study|Physician Decision|2|||
149931350|NCT03131167|540883896|FG008|Overall Study|Other (Unspecified)|0|||
150165841|NCT00517933|541741638|FG000|Period 1|Death|2|||
150165842|NCT00517933|541741639|FG001|Period 1|Death|1|||
150165843|NCT00517933|541741638|FG000|Period 1|Adverse Event|4|||
149931351|NCT03131167|540883897|FG009|Overall Study|Other (Unspecified)|0|||
149931352|NCT03131167|540883898|FG010|Overall Study|Other (Unspecified)|0|||
149931353|NCT03131167|540883899|FG011|Overall Study|Other (Unspecified)|0|||
149931354|NCT03131167|540883900|FG012|Overall Study|Other (Unspecified)|0|||
149931355|NCT03286218|540883901|FG000|Qualification Phase Period 1|Adverse Event|1|||
149931356|NCT03286218|540883902|FG001|Qualification Phase Period 1|Adverse Event|0|||
149931357|NCT03286218|540883903|FG002|Qualification Phase Period 1|Adverse Event|0|||
149931358|NCT03286218|540883904|FG003|Qualification Phase Period 1|Adverse Event|0|||
149931359|NCT03286218|540883905|FG004|Qualification Phase Period 1|Adverse Event|0|||
149931360|NCT03286218|540883906|FG005|Qualification Phase Period 1|Adverse Event|0|||
149931361|NCT03286218|540883907|FG006|Qualification Phase Period 1|Adverse Event|0|||
149931362|NCT03286218|540883908|FG007|Qualification Phase Period 1|Adverse Event|0|||
149931363|NCT03286218|540883909|FG008|Qualification Phase Period 1|Adverse Event|0|||
149931364|NCT03286218|540883910|FG009|Qualification Phase Period 1|Adverse Event|0|||
149931365|NCT03286218|540883911|FG010|Qualification Phase Period 1|Adverse Event|0|||
149931366|NCT03286218|540883912|FG011|Qualification Phase Period 1|Adverse Event|0|||
149931367|NCT03286218|540883901|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931368|NCT03286218|540883902|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
149931369|NCT03286218|540883903|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931370|NCT03286218|540883904|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931371|NCT03286218|540883905|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931372|NCT03286218|540883906|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931373|NCT03286218|540883907|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931374|NCT03286218|540883908|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931375|NCT03286218|540883909|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931376|NCT03286218|540883910|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931377|NCT03286218|540883911|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931378|NCT03286218|540883912|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
149931379|NCT03286218|540883901|FG000|Qualification Phase Period 2|Adverse Event|0|||
149931380|NCT03286218|540883902|FG001|Qualification Phase Period 2|Adverse Event|1|||
149931381|NCT03286218|540883903|FG002|Qualification Phase Period 2|Adverse Event|0|||
149931382|NCT03286218|540883904|FG003|Qualification Phase Period 2|Adverse Event|0|||
149931383|NCT03286218|540883905|FG004|Qualification Phase Period 2|Adverse Event|0|||
149931384|NCT03286218|540883906|FG005|Qualification Phase Period 2|Adverse Event|0|||
149931385|NCT03286218|540883907|FG006|Qualification Phase Period 2|Adverse Event|0|||
149931386|NCT03286218|540883908|FG007|Qualification Phase Period 2|Adverse Event|0|||
149931387|NCT03286218|540883909|FG008|Qualification Phase Period 2|Adverse Event|0|||
149931388|NCT03286218|540883910|FG009|Qualification Phase Period 2|Adverse Event|0|||
149931389|NCT03286218|540883911|FG010|Qualification Phase Period 2|Adverse Event|0|||
149931390|NCT03286218|540883912|FG011|Qualification Phase Period 2|Adverse Event|0|||
149931391|NCT03286218|540883901|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
149931392|NCT03286218|540883902|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
149931393|NCT03286218|540883903|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931394|NCT03286218|540883904|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931395|NCT03286218|540883905|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931396|NCT03286218|540883906|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931397|NCT03286218|540883907|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931398|NCT03286218|540883908|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931399|NCT03286218|540883909|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931400|NCT03286218|540883910|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931401|NCT03286218|540883911|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931402|NCT03286218|540883912|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
149931403|NCT03286218|540883901|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
149931404|NCT03286218|540883902|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
149931405|NCT03286218|540883903|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
149931406|NCT03286218|540883904|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
149931407|NCT03286218|540883905|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
149931408|NCT03286218|540883906|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
149931409|NCT03286218|540883907|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
149931410|NCT03286218|540883908|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
149931411|NCT03286218|540883909|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
149931412|NCT03286218|540883910|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
149931413|NCT03286218|540883911|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
149931414|NCT03286218|540883912|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
149931415|NCT03286218|540883901|FG000|Qualification Phase Period 2|Protocol Violation|2|||
150266272|NCT00146328|542112512|FG002|Overall Study|Patient decision to end|6|||
150266273|NCT00146328|542112510|FG000|Overall Study|Enroll into other trial|2|||
149931416|NCT03286218|540883902|FG001|Qualification Phase Period 2|Protocol Violation|0|||
149931417|NCT03286218|540883903|FG002|Qualification Phase Period 2|Protocol Violation|0|||
149931418|NCT03286218|540883904|FG003|Qualification Phase Period 2|Protocol Violation|0|||
149931419|NCT03286218|540883905|FG004|Qualification Phase Period 2|Protocol Violation|0|||
149931420|NCT03286218|540883906|FG005|Qualification Phase Period 2|Protocol Violation|0|||
149931421|NCT03286218|540883907|FG006|Qualification Phase Period 2|Protocol Violation|0|||
149931422|NCT03286218|540883908|FG007|Qualification Phase Period 2|Protocol Violation|0|||
149931423|NCT03286218|540883909|FG008|Qualification Phase Period 2|Protocol Violation|0|||
149931424|NCT03286218|540883910|FG009|Qualification Phase Period 2|Protocol Violation|0|||
149931425|NCT03286218|540883911|FG010|Qualification Phase Period 2|Protocol Violation|0|||
149931426|NCT03286218|540883912|FG011|Qualification Phase Period 2|Protocol Violation|0|||
149931427|NCT03286218|540883901|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
149931428|NCT03286218|540883902|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
149931429|NCT03286218|540883903|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931430|NCT03286218|540883904|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931431|NCT03286218|540883905|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931432|NCT03286218|540883906|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931433|NCT03286218|540883907|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931434|NCT03286218|540883908|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931435|NCT03286218|540883909|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931436|NCT03286218|540883910|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931437|NCT03286218|540883911|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931438|NCT03286218|540883912|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
149931439|NCT03286218|540883901|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931440|NCT03286218|540883902|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931441|NCT03286218|540883903|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
149931442|NCT03286218|540883904|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
149931443|NCT03286218|540883905|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931444|NCT03286218|540883906|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
149931445|NCT03286218|540883907|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931446|NCT03286218|540883908|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931447|NCT03286218|540883909|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931448|NCT03286218|540883910|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931449|NCT03286218|540883911|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
149931450|NCT03286218|540883912|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
149931451|NCT03286218|540883901|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931452|NCT03286218|540883902|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931453|NCT03286218|540883903|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931454|NCT03286218|540883904|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931455|NCT03286218|540883905|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931456|NCT03286218|540883906|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931457|NCT03286218|540883907|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931458|NCT03286218|540883908|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931459|NCT03286218|540883909|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931460|NCT03286218|540883910|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931461|NCT03286218|540883911|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
149931462|NCT03286218|540883912|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
149931463|NCT00458003|540883913|FG000|Overall Study|Non protocol spinal anesthesia|1|||
149931464|NCT00458003|540883914|FG001|Overall Study|Non protocol spinal anesthesia|1|||
149931465|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Death|20|||
149931466|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Death|26|||
149931467|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
149931468|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
149931469|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
149931470|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
149931471|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
149931472|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
149931473|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
149931474|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
149931475|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
150165844|NCT00517933|541741639|FG001|Period 1|Adverse Event|4|||
150165845|NCT00517933|541741638|FG000|Period 1|Lost to Follow-up|2|||
150165846|NCT00517933|541741639|FG001|Period 1|Lost to Follow-up|0|||
150165847|NCT00517933|541741638|FG000|Period 1|Underwent lung transplant|0|||
149931476|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
149931477|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
149931478|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
150165848|NCT00517933|541741639|FG001|Period 1|Underwent lung transplant|1|||
150165849|NCT00517933|541741638|FG000|Period 2|Death|2|||
149931479|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
149931480|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
149931481|NCT00643201|540883917|FG000|Randomized, Completed 6 Months of Study|Other|107|||
149931482|NCT00643201|540883918|FG001|Randomized, Completed 6 Months of Study|Other|107|||
149931483|NCT00643201|540883917|FG000|Completed Study Follow Up|Death|28|||
149931484|NCT00643201|540883918|FG001|Completed Study Follow Up|Death|34|||
149931485|NCT00643201|540883917|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
149931486|NCT00643201|540883918|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
149931487|NCT00643201|540883917|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
149931488|NCT00643201|540883918|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
149931489|NCT00643201|540883917|FG000|Completed Study Follow Up|non-specified|1|||
149931490|NCT00643201|540883918|FG001|Completed Study Follow Up|non-specified|0|||
149931491|NCT02976519|540883919|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931492|NCT02976519|540883920|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
149931493|NCT02976519|540883921|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931494|NCT02976519|540883922|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931495|NCT02976519|540883923|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931496|NCT02976519|540883924|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931497|NCT02976519|540883925|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149931498|NCT02976519|540883919|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931499|NCT02976519|540883920|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931500|NCT02976519|540883921|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931501|NCT02976519|540883922|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
149931502|NCT02976519|540883923|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931503|NCT02976519|540883924|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931504|NCT02976519|540883925|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
149931505|NCT02976519|540883919|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931506|NCT02976519|540883920|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931507|NCT02976519|540883921|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931508|NCT02976519|540883922|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931509|NCT02976519|540883923|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931510|NCT02976519|540883924|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
149931511|NCT02976519|540883925|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
149931512|NCT02976519|540883919|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931513|NCT02976519|540883920|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931514|NCT02976519|540883921|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931515|NCT02976519|540883922|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931516|NCT02976519|540883923|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931517|NCT02976519|540883924|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
149931518|NCT02976519|540883925|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
149931519|NCT02976519|540883919|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931520|NCT02976519|540883920|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931521|NCT02976519|540883921|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931522|NCT02976519|540883922|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931523|NCT02976519|540883923|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931524|NCT02976519|540883924|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
149931525|NCT02976519|540883925|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
149931526|NCT00928434|540883926|FG000|Overall Study|Adverse Event|14|||
149931527|NCT00928434|540883927|FG001|Overall Study|Adverse Event|5|||
149931528|NCT00928434|540883928|FG002|Overall Study|Adverse Event|18|||
149931529|NCT00928434|540883926|FG000|Overall Study|Protocol Violation|5|||
149931530|NCT00928434|540883927|FG001|Overall Study|Protocol Violation|0|||
149931531|NCT00928434|540883928|FG002|Overall Study|Protocol Violation|8|||
149931532|NCT00928434|540883926|FG000|Overall Study|Physician Decision|2|||
149931533|NCT00928434|540883927|FG001|Overall Study|Physician Decision|0|||
149931534|NCT00928434|540883928|FG002|Overall Study|Physician Decision|3|||
149931535|NCT00928434|540883926|FG000|Overall Study|Lost to Follow-up|1|||
149931536|NCT00928434|540883927|FG001|Overall Study|Lost to Follow-up|0|||
149931537|NCT00928434|540883928|FG002|Overall Study|Lost to Follow-up|3|||
149931538|NCT00928434|540883926|FG000|Overall Study|Withdrawal by Subject|5|||
150165850|NCT00517933|541741639|FG001|Period 2|Death|4|||
150165851|NCT00517933|541741638|FG000|Period 2|Adverse Event|2|||
150165852|NCT00517933|541741639|FG001|Period 2|Adverse Event|4|||
150165853|NCT00517933|541741638|FG000|Period 2|Physician Decision|1|||
150165854|NCT00517933|541741639|FG001|Period 2|Physician Decision|0|||
150165855|NCT00517933|541741638|FG000|Period 2|Withdrawal by Subject|1|||
150165856|NCT00517933|541741639|FG001|Period 2|Withdrawal by Subject|3|||
150165857|NCT00517933|541741638|FG000|Period 2|Underwent lung transplant|0|||
150165858|NCT00517933|541741639|FG001|Period 2|Underwent lung transplant|2|||
150165859|NCT05096884|541741640|FG000|Overall Study|Excluded based on negative tilt table test|4|||
150165860|NCT04927975|541741641|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
150165861|NCT04927975|541741642|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
150165862|NCT04927975|541741643|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
150165863|NCT04927975|541741644|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
150165864|NCT04927975|541741645|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
150165865|NCT04927975|541741646|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
150165866|NCT04927975|541741641|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149931539|NCT00928434|540883927|FG001|Overall Study|Withdrawal by Subject|3|||
150165867|NCT04927975|541741642|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
150165868|NCT04927975|541741643|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149819908|NCT01393990|540471622|FG013|Overall Study|Adverse Event|0|||
149819909|NCT01393990|540471623|FG014|Overall Study|Adverse Event|1|||
149819910|NCT01393990|540471624|FG015|Overall Study|Adverse Event|1|||
149819911|NCT01393990|540471625|FG016|Overall Study|Adverse Event|0|||
149819912|NCT01393990|540471626|FG017|Overall Study|Adverse Event|0|||
149819913|NCT01393990|540471609|FG000|Overall Study|Progressive Disease|1|||
149819914|NCT01393990|540471610|FG001|Overall Study|Progressive Disease|0|||
149819915|NCT01393990|540471611|FG002|Overall Study|Progressive Disease|0|||
149819916|NCT01393990|540471612|FG003|Overall Study|Progressive Disease|1|||
149819917|NCT01393990|540471613|FG004|Overall Study|Progressive Disease|1|||
149819918|NCT01393990|540471614|FG005|Overall Study|Progressive Disease|1|||
149819919|NCT01393990|540471615|FG006|Overall Study|Progressive Disease|1|||
149819920|NCT01393990|540471616|FG007|Overall Study|Progressive Disease|1|||
149819921|NCT01393990|540471617|FG008|Overall Study|Progressive Disease|3|||
149819922|NCT01393990|540471618|FG009|Overall Study|Progressive Disease|1|||
149819923|NCT01393990|540471619|FG010|Overall Study|Progressive Disease|0|||
149819924|NCT01393990|540471620|FG011|Overall Study|Progressive Disease|0|||
149819925|NCT01393990|540471621|FG012|Overall Study|Progressive Disease|0|||
149819926|NCT01393990|540471622|FG013|Overall Study|Progressive Disease|1|||
149819927|NCT01393990|540471623|FG014|Overall Study|Progressive Disease|6|||
149819928|NCT01393990|540471624|FG015|Overall Study|Progressive Disease|1|||
149819929|NCT01393990|540471625|FG016|Overall Study|Progressive Disease|0|||
149819930|NCT01393990|540471626|FG017|Overall Study|Progressive Disease|0|||
149819931|NCT01393990|540471609|FG000|Overall Study|Death|0|||
149819932|NCT01393990|540471610|FG001|Overall Study|Death|0|||
149819933|NCT01393990|540471611|FG002|Overall Study|Death|0|||
149819934|NCT01393990|540471612|FG003|Overall Study|Death|0|||
149819935|NCT01393990|540471613|FG004|Overall Study|Death|1|||
149819936|NCT01393990|540471614|FG005|Overall Study|Death|0|||
149819937|NCT01393990|540471615|FG006|Overall Study|Death|0|||
149819938|NCT01393990|540471616|FG007|Overall Study|Death|0|||
149819939|NCT01393990|540471617|FG008|Overall Study|Death|0|||
149819940|NCT01393990|540471618|FG009|Overall Study|Death|0|||
149819941|NCT01393990|540471619|FG010|Overall Study|Death|0|||
149819942|NCT01393990|540471620|FG011|Overall Study|Death|0|||
149819943|NCT01393990|540471621|FG012|Overall Study|Death|0|||
149819944|NCT01393990|540471622|FG013|Overall Study|Death|1|||
149819945|NCT01393990|540471623|FG014|Overall Study|Death|1|||
149819946|NCT01393990|540471624|FG015|Overall Study|Death|0|||
149819947|NCT01393990|540471625|FG016|Overall Study|Death|0|||
149819948|NCT01393990|540471626|FG017|Overall Study|Death|0|||
149819949|NCT01393990|540471609|FG000|Overall Study|Withdrawal by Subject|0|||
149819950|NCT01393990|540471610|FG001|Overall Study|Withdrawal by Subject|0|||
149819951|NCT01393990|540471611|FG002|Overall Study|Withdrawal by Subject|0|||
149819952|NCT01393990|540471612|FG003|Overall Study|Withdrawal by Subject|0|||
149819953|NCT01393990|540471613|FG004|Overall Study|Withdrawal by Subject|0|||
149819954|NCT01393990|540471614|FG005|Overall Study|Withdrawal by Subject|0|||
149819955|NCT01393990|540471615|FG006|Overall Study|Withdrawal by Subject|0|||
149819956|NCT01393990|540471616|FG007|Overall Study|Withdrawal by Subject|0|||
149819957|NCT01393990|540471617|FG008|Overall Study|Withdrawal by Subject|0|||
149819958|NCT01393990|540471618|FG009|Overall Study|Withdrawal by Subject|0|||
149819959|NCT01393990|540471619|FG010|Overall Study|Withdrawal by Subject|0|||
149819960|NCT01393990|540471620|FG011|Overall Study|Withdrawal by Subject|0|||
149819961|NCT01393990|540471621|FG012|Overall Study|Withdrawal by Subject|0|||
149819962|NCT01393990|540471622|FG013|Overall Study|Withdrawal by Subject|0|||
149819963|NCT01393990|540471623|FG014|Overall Study|Withdrawal by Subject|1|||
149819964|NCT01393990|540471624|FG015|Overall Study|Withdrawal by Subject|1|||
149819965|NCT01393990|540471625|FG016|Overall Study|Withdrawal by Subject|0|||
149819966|NCT01393990|540471626|FG017|Overall Study|Withdrawal by Subject|0|||
149819967|NCT00720798|540471633|FG000|Overall Study|Adverse Event|304|||
149819968|NCT00720798|540471633|FG000|Overall Study|Death|39|||
149819969|NCT00720798|540471633|FG000|Overall Study|Insufficient Therapeutic Response|129|||
149819970|NCT00720798|540471633|FG000|Overall Study|Protocol Violation|4|||
149819971|NCT00720798|540471633|FG000|Overall Study|Refused Treatment|151|||
149819972|NCT00720798|540471633|FG000|Overall Study|Failure to Return|46|||
149819973|NCT00720798|540471633|FG000|Overall Study|Reason not Specified|83|||
149819974|NCT00433381|540471634|FG000|Overall Study|Ineligible / no protocol treatment|3|||
149819975|NCT00433381|540471635|FG001|Overall Study|Ineligible / no protocol treatment|3|||
149931540|NCT00928434|540883928|FG002|Overall Study|Withdrawal by Subject|2|||
149931541|NCT00928434|540883926|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
149931542|NCT00928434|540883927|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
149931543|NCT00928434|540883928|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
149931544|NCT00928434|540883926|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
149931545|NCT00928434|540883927|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
149931546|NCT00928434|540883928|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
149931547|NCT00928434|540883926|FG000|Overall Study|Other (not meeting above criteria)|5|||
149931548|NCT00928434|540883927|FG001|Overall Study|Other (not meeting above criteria)|1|||
149931549|NCT00928434|540883928|FG002|Overall Study|Other (not meeting above criteria)|2|||
149931550|NCT02154139|540883940|FG000|Overall Study|Injection not administered|2|||
149931551|NCT02154139|540883940|FG000|Overall Study|Other|2|||
149931552|NCT02154139|540883940|FG000|Overall Study|Investigator transferred|3|||
149931553|NCT00473655|540883943|FG000|Overall Study|Lost to Follow-up|9|||
149931554|NCT00473655|540883944|FG001|Overall Study|Lost to Follow-up|5|||
149931555|NCT00473655|540883945|FG002|Overall Study|Lost to Follow-up|8|||
149931556|NCT03933449|540883946|FG000|Overall Study|Adverse Event|6|||
149931557|NCT03933449|540883947|FG001|Overall Study|Adverse Event|4|||
149931558|NCT03933449|540883946|FG000|Overall Study|Death|55|||
149931559|NCT03933449|540883947|FG001|Overall Study|Death|57|||
149931560|NCT03933449|540883946|FG000|Overall Study|Sponsor Decision|1|||
149931561|NCT03933449|540883947|FG001|Overall Study|Sponsor Decision|0|||
149931562|NCT02087774|540883948|FG000|Overall Study|Were absent day of data collection|8|||
149931563|NCT02087774|540883949|FG001|Overall Study|Were absent day of data collection|20|||
149931564|NCT02513550|540883957|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
149931565|NCT02513550|540883958|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
149931566|NCT02513550|540883959|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
149931567|NCT02513550|540883960|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
149931568|NCT02513550|540883961|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149931569|NCT02513550|540883962|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
149931570|NCT02513550|540883957|FG000|Double Blind Treatment Period|Adverse Event|5|||
149931571|NCT02513550|540883958|FG001|Double Blind Treatment Period|Adverse Event|13|||
149931572|NCT02513550|540883959|FG002|Double Blind Treatment Period|Adverse Event|17|||
149931573|NCT02513550|540883960|FG003|Double Blind Treatment Period|Adverse Event|0|||
149931574|NCT02513550|540883961|FG004|Double Blind Treatment Period|Adverse Event|1|||
149931575|NCT02513550|540883962|FG005|Double Blind Treatment Period|Adverse Event|0|||
149931576|NCT02513550|540883957|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
149931577|NCT02513550|540883958|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
149931578|NCT02513550|540883959|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
149931579|NCT02513550|540883960|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
149931580|NCT02513550|540883961|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
149931581|NCT02513550|540883962|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
149931582|NCT02513550|540883957|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
149931583|NCT02513550|540883958|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
149819976|NCT02806232|540471636|FG000|Overall Study|Lost to Follow-up|1|||
149819977|NCT02806232|540471637|FG001|Overall Study|Lost to Follow-up|2|||
149819978|NCT02806232|540471638|FG002|Overall Study|Lost to Follow-up|1|||
149819979|NCT02806232|540471639|FG003|Overall Study|Lost to Follow-up|0|||
149819980|NCT02806232|540471640|FG004|Overall Study|Lost to Follow-up|0|||
149819981|NCT02806232|540471641|FG005|Overall Study|Lost to Follow-up|1|||
149819982|NCT02806232|540471642|FG006|Overall Study|Lost to Follow-up|0|||
149819983|NCT02806232|540471643|FG007|Overall Study|Lost to Follow-up|0|||
149819984|NCT02806232|540471644|FG008|Overall Study|Lost to Follow-up|0|||
149819985|NCT02806232|540471636|FG000|Overall Study|Withdrawal by Subject|0|||
149819986|NCT02806232|540471637|FG001|Overall Study|Withdrawal by Subject|2|||
149819987|NCT02806232|540471638|FG002|Overall Study|Withdrawal by Subject|0|||
149819988|NCT02806232|540471639|FG003|Overall Study|Withdrawal by Subject|0|||
149819989|NCT02806232|540471640|FG004|Overall Study|Withdrawal by Subject|2|||
149819990|NCT02806232|540471641|FG005|Overall Study|Withdrawal by Subject|1|||
149819991|NCT02806232|540471642|FG006|Overall Study|Withdrawal by Subject|0|||
149819992|NCT02806232|540471643|FG007|Overall Study|Withdrawal by Subject|0|||
149819993|NCT02806232|540471644|FG008|Overall Study|Withdrawal by Subject|0|||
149819994|NCT00434161|540471647|FG000|Overall Study|Adverse Event|5|||
149819995|NCT00434161|540471648|FG001|Overall Study|Adverse Event|1|||
149819996|NCT00434161|540471649|FG002|Overall Study|Adverse Event|4|||
149819997|NCT00434161|540471647|FG000|Overall Study|Lost to Follow-up|0|||
149819998|NCT00434161|540471648|FG001|Overall Study|Lost to Follow-up|1|||
149819999|NCT00434161|540471649|FG002|Overall Study|Lost to Follow-up|0|||
149820000|NCT00434161|540471647|FG000|Overall Study|Death|1|||
149820001|NCT00434161|540471648|FG001|Overall Study|Death|0|||
149820002|NCT00434161|540471649|FG002|Overall Study|Death|1|||
149820003|NCT00434161|540471647|FG000|Overall Study|Non-Compliance|1|||
149820004|NCT00434161|540471648|FG001|Overall Study|Non-Compliance|1|||
149820005|NCT00434161|540471649|FG002|Overall Study|Non-Compliance|0|||
149820006|NCT00434161|540471647|FG000|Overall Study|Withdrawal by Subject|2|||
149931584|NCT02513550|540883959|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
149931585|NCT02513550|540883960|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
149931586|NCT02513550|540883961|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
149931587|NCT02513550|540883962|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
149931588|NCT02513550|540883957|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149931589|NCT02513550|540883958|FG001|Double Blind Treatment Period|Protocol Violation|1|||
149931590|NCT02513550|540883959|FG002|Double Blind Treatment Period|Protocol Violation|4|||
149931591|NCT02513550|540883960|FG003|Double Blind Treatment Period|Protocol Violation|0|||
149931592|NCT02513550|540883961|FG004|Double Blind Treatment Period|Protocol Violation|0|||
149931593|NCT02513550|540883962|FG005|Double Blind Treatment Period|Protocol Violation|0|||
149931594|NCT02513550|540883957|FG000|Double Blind Treatment Period|Physician Decision|2|||
149931595|NCT02513550|540883958|FG001|Double Blind Treatment Period|Physician Decision|0|||
149931596|NCT02513550|540883959|FG002|Double Blind Treatment Period|Physician Decision|4|||
149931597|NCT02513550|540883960|FG003|Double Blind Treatment Period|Physician Decision|0|||
149931598|NCT02513550|540883961|FG004|Double Blind Treatment Period|Physician Decision|0|||
149931599|NCT02513550|540883962|FG005|Double Blind Treatment Period|Physician Decision|0|||
149931600|NCT02513550|540883957|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
149931601|NCT02513550|540883958|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
149931602|NCT02513550|540883959|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
149931603|NCT02513550|540883960|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
149931604|NCT02513550|540883961|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
149931605|NCT02513550|540883962|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
149931606|NCT02513550|540883957|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
149931607|NCT02513550|540883958|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
149931608|NCT02513550|540883959|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
149931609|NCT02513550|540883960|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
149931610|NCT02513550|540883961|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
149931611|NCT02513550|540883962|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
149931612|NCT02513550|540883957|FG000|Double Blind Treatment Period|Due to personal business|2|||
149931613|NCT02513550|540883958|FG001|Double Blind Treatment Period|Due to personal business|0|||
149931614|NCT02513550|540883959|FG002|Double Blind Treatment Period|Due to personal business|1|||
149931615|NCT02513550|540883960|FG003|Double Blind Treatment Period|Due to personal business|0|||
149931616|NCT02513550|540883961|FG004|Double Blind Treatment Period|Due to personal business|0|||
149931617|NCT02513550|540883962|FG005|Double Blind Treatment Period|Due to personal business|0|||
149931618|NCT02513550|540883957|FG000|Double Blind Treatment Period|Death|1|||
149931619|NCT02513550|540883958|FG001|Double Blind Treatment Period|Death|0|||
149931620|NCT02513550|540883959|FG002|Double Blind Treatment Period|Death|2|||
149931621|NCT02513550|540883960|FG003|Double Blind Treatment Period|Death|0|||
149931622|NCT02513550|540883961|FG004|Double Blind Treatment Period|Death|0|||
149931623|NCT02513550|540883962|FG005|Double Blind Treatment Period|Death|0|||
149931624|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
149931625|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
149931626|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
149931627|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149931628|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149931629|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149931630|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
149931631|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
149931632|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
149931633|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
149931634|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
149931635|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
149931636|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
149931637|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
149931638|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
149931639|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149931640|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149931641|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149931642|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
149931643|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
149931644|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
149931645|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
149931646|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
149931647|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
149931648|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
149931649|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
149931650|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
149931651|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
149931652|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
149931653|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
149931654|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Death|0|||
149931655|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Death|0|||
149931656|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Death|1|||
149931657|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Death|0|||
149931658|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Death|0|||
149931659|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Death|0|||
149931660|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
149931661|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
149931662|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
149931663|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
149931664|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
149931665|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
149931666|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
149931667|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
149931668|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
149931669|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
149931670|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
149931671|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
149931672|NCT02513550|540883957|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
149931673|NCT02513550|540883958|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
149931674|NCT02513550|540883959|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
149931675|NCT02513550|540883960|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
149931676|NCT02513550|540883961|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
149931677|NCT02513550|540883962|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
149931678|NCT00243919|540883963|FG000|Overall Study|Death|3|||
149931679|NCT00243919|540883964|FG001|Overall Study|Death|4|||
149931680|NCT00243919|540883965|FG002|Overall Study|Death|6|||
149931681|NCT00243919|540883963|FG000|Overall Study|Withdrawal by Subject|6|||
149931682|NCT00243919|540883964|FG001|Overall Study|Withdrawal by Subject|6|||
149931683|NCT00243919|540883965|FG002|Overall Study|Withdrawal by Subject|2|||
149931684|NCT00243919|540883963|FG000|Overall Study|Lost to Follow-up|6|||
149931685|NCT00243919|540883964|FG001|Overall Study|Lost to Follow-up|7|||
149931686|NCT00243919|540883965|FG002|Overall Study|Lost to Follow-up|3|||
149931687|NCT00243919|540883963|FG000|Overall Study|Administrative Error|1|||
149931688|NCT00243919|540883964|FG001|Overall Study|Administrative Error|0|||
149931689|NCT00243919|540883965|FG002|Overall Study|Administrative Error|0|||
149931690|NCT00243919|540883963|FG000|Overall Study|Physician Decision|1|||
149931691|NCT00243919|540883964|FG001|Overall Study|Physician Decision|1|||
149931692|NCT00243919|540883965|FG002|Overall Study|Physician Decision|0|||
149931693|NCT04176939|540883967|FG000|Overall Study|Withdrawal by Subject|5|||
149931694|NCT04176939|540883967|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
149931695|NCT04176939|540883967|FG000|Overall Study|Lost to Follow-up|2|||
149931696|NCT04176939|540883967|FG000|Overall Study|Unspecified reason|4|||
149931697|NCT04176939|540883967|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
149931698|NCT04742673|540883970|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
149931699|NCT04742673|540883971|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
149931700|NCT00426764|540883978|FG000|Overall Study|Protocol Violation|1|||
149931701|NCT00426764|540883978|FG000|Overall Study|Withdrawal by Subject|4|||
149931702|NCT00426764|540883978|FG000|Overall Study|Physician Decision|6|||
149931703|NCT00426764|540883978|FG000|Overall Study|Compassionate Use|1|||
149931704|NCT00426764|540883978|FG000|Overall Study|Progressive Disease|83|||
149931705|NCT00426764|540883978|FG000|Overall Study|Adverse Event|24|||
149931706|NCT00426764|540883978|FG000|Overall Study|Other|1|||
149931707|NCT00426764|540883978|FG000|Overall Study|Death|1|||
149931708|NCT00426764|540883978|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
149931709|NCT01922258|540883979|FG000|Overall Study|Lost to Follow-up|1|||
149931710|NCT01922258|540883980|FG001|Overall Study|Lost to Follow-up|1|||
149931711|NCT01922258|540883979|FG000|Overall Study|Adverse Event|9|||
149931712|NCT01922258|540883980|FG001|Overall Study|Adverse Event|2|||
149931713|NCT01922258|540883979|FG000|Overall Study|Met Withdrawal Criteria|0|||
149931714|NCT01922258|540883980|FG001|Overall Study|Met Withdrawal Criteria|4|||
149931715|NCT01922258|540883979|FG000|Overall Study|Withdrawn by the Investigator|1|||
149931716|NCT01922258|540883980|FG001|Overall Study|Withdrawn by the Investigator|4|||
149931717|NCT01922258|540883979|FG000|Overall Study|Withdrawal by participant|5|||
149931718|NCT01922258|540883980|FG001|Overall Study|Withdrawal by participant|5|||
149931719|NCT04396626|540883981|FG000|Overall Study|Premature termination of study|975|||
149931720|NCT04552132|540883982|FG000|Overall Study|Lost to Follow-up|4|||
149931721|NCT04552132|540883983|FG001|Overall Study|Lost to Follow-up|3|||
149931722|NCT04552132|540883982|FG000|Overall Study|Protocol Violation|1|||
149931723|NCT04552132|540883983|FG001|Overall Study|Protocol Violation|0|||
149931724|NCT01657162|540883984|FG000|Overall Study|Adverse Event|26|||
149931725|NCT01657162|540883985|FG001|Overall Study|Adverse Event|36|||
149931726|NCT01657162|540883984|FG000|Overall Study|Withdrawal by Subject|13|||
149931727|NCT01657162|540883985|FG001|Overall Study|Withdrawal by Subject|13|||
149931728|NCT01657162|540883984|FG000|Overall Study|Continuing Significant Deterioration|9|||
149931729|NCT01657162|540883985|FG001|Overall Study|Continuing Significant Deterioration|3|||
149931730|NCT01657162|540883984|FG000|Overall Study|Refusal of Treatment|4|||
149931731|NCT01657162|540883985|FG001|Overall Study|Refusal of Treatment|6|||
149931732|NCT01657162|540883984|FG000|Overall Study|Lost to Follow-up|3|||
149931733|NCT01657162|540883985|FG001|Overall Study|Lost to Follow-up|4|||
149931734|NCT01657162|540883984|FG000|Overall Study|Death|2|||
149931735|NCT01657162|540883985|FG001|Overall Study|Death|3|||
149931736|NCT01657162|540883984|FG000|Overall Study|Inability to Complete Study Procedures|1|||
149931737|NCT01657162|540883985|FG001|Overall Study|Inability to Complete Study Procedures|7|||
149931738|NCT01657162|540883984|FG000|Overall Study|Protocol Violation|1|||
149931739|NCT01657162|540883985|FG001|Overall Study|Protocol Violation|0|||
149931740|NCT01657162|540883984|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
149931741|NCT01657162|540883985|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
149931742|NCT01657162|540883984|FG000|Overall Study|Other than Specified|0|||
149931743|NCT01657162|540883985|FG001|Overall Study|Other than Specified|2|||
149931744|NCT01497067|540883988|FG000|Overall Study|Lost to Follow-up|56|||
149931745|NCT01497067|540883988|FG000|Overall Study|Adverse Event|3|||
149931746|NCT01497067|540883988|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
149931747|NCT01497067|540883988|FG000|Overall Study|Other|13|||
149931748|NCT00096538|540883996|FG000|Overall Study|Withdrawal by Subject|1|||
149931749|NCT02686164|540883998|FG000|Overall Study|Adverse Event|1|||
149931750|NCT02686164|540883998|FG000|Overall Study|Withdrawal of consent|1|||
149931751|NCT02686164|540883998|FG000|Overall Study|Clinical progression|1|||
149931752|NCT01691378|540883999|FG000|Overall Study|Withdrawal by Subject|2|||
149931753|NCT01691378|540884000|FG001|Overall Study|Withdrawal by Subject|0|||
149931754|NCT01691378|540883999|FG000|Overall Study|Lost to Follow-up|5|||
149931755|NCT01691378|540884000|FG001|Overall Study|Lost to Follow-up|2|||
149931756|NCT02324361|540884003|FG000|Overall Study|Lost to Follow-up|5|||
149931757|NCT02324361|540884004|FG001|Overall Study|Lost to Follow-up|2|||
149931758|NCT03839394|540884014|FG000|Overall Study|Lost to Follow-up|6|||
149931759|NCT03839394|540884015|FG001|Overall Study|Lost to Follow-up|8|||
149931760|NCT03839394|540884014|FG000|Overall Study|Withdrawal by Subject|0|||
149931761|NCT03839394|540884015|FG001|Overall Study|Withdrawal by Subject|2|||
149931762|NCT00101868|540884016|FG000|Overall Study|Death|10|||
149931763|NCT00101868|540884017|FG001|Overall Study|Death|10|||
149931764|NCT00101868|540884016|FG000|Overall Study|Withdrawal by Subject|8|||
149931765|NCT00101868|540884017|FG001|Overall Study|Withdrawal by Subject|9|||
149931766|NCT00101868|540884016|FG000|Overall Study|Protocol Violation|3|||
149931767|NCT00101868|540884017|FG001|Overall Study|Protocol Violation|0|||
149931768|NCT00101868|540884016|FG000|Overall Study|Lost to Follow-up|8|||
149931769|NCT00101868|540884017|FG001|Overall Study|Lost to Follow-up|13|||
149931770|NCT01931397|540884020|FG000|Overall Study|Physician Decision|2|||
149931771|NCT01931397|540884020|FG000|Overall Study|Withdrawal by Subject|8|||
149931772|NCT01931397|540884020|FG000|Overall Study|moved out of state|1|||
149931773|NCT01367249|540884024|FG000|Overall Study|Withdrawal by Subject|6|||
149931774|NCT01367249|540884025|FG001|Overall Study|Withdrawal by Subject|6|||
149931775|NCT01367249|540884024|FG000|Overall Study|Other|3|||
149931776|NCT01367249|540884025|FG001|Overall Study|Other|10|||
149931777|NCT02493517|540884026|FG000|Overall Study|Protocol Violation|1|||
149931778|NCT02493517|540884027|FG001|Overall Study|Protocol Violation|2|||
149931779|NCT02493517|540884026|FG000|Overall Study|Withdrawal by Subject|1|||
149931780|NCT02493517|540884027|FG001|Overall Study|Withdrawal by Subject|2|||
149931781|NCT02493517|540884026|FG000|Overall Study|Adverse Event|0|||
149931782|NCT02493517|540884027|FG001|Overall Study|Adverse Event|2|||
149931783|NCT02493517|540884026|FG000|Overall Study|Missed study visit|0|||
149931784|NCT02493517|540884027|FG001|Overall Study|Missed study visit|1|||
149931785|NCT03718429|540884029|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
149931786|NCT03718429|540884030|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
149931787|NCT03718429|540884031|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
149931788|NCT03718429|540884032|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
149931789|NCT05404711|540884033|FG000|Completed Study Visit|Withdrawal by Subject|1|||
149931790|NCT05404711|540884033|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
149931791|NCT05404711|540884033|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
149931792|NCT05404711|540884033|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
149931793|NCT05404711|540884033|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
149931794|NCT05404711|540884033|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
149931795|NCT02346877|540884034|FG000|Overall Study|Adverse Event|1|||
149931796|NCT02346877|540884035|FG001|Overall Study|Adverse Event|0|||
149931797|NCT02346877|540884034|FG000|Overall Study|Administrative Decision|1|||
149820007|NCT00434161|540471648|FG001|Overall Study|Withdrawal by Subject|0|||
149820008|NCT00434161|540471649|FG002|Overall Study|Withdrawal by Subject|3|||
149820009|NCT00434161|540471647|FG000|Overall Study|Logistical error study assessments|1|||
149820010|NCT00434161|540471648|FG001|Overall Study|Logistical error study assessments|0|||
149820011|NCT00434161|540471649|FG002|Overall Study|Logistical error study assessments|3|||
149820012|NCT03342898|540471650|FG000|Overall Study|Adverse Event|3|||
149820013|NCT03342898|540471651|FG001|Overall Study|Adverse Event|1|||
149820014|NCT03342898|540471652|FG002|Overall Study|Adverse Event|0|||
149820015|NCT03342898|540471650|FG000|Overall Study|Lost to Follow-up|44|||
149820016|NCT03342898|540471651|FG001|Overall Study|Lost to Follow-up|40|||
149820017|NCT03342898|540471652|FG002|Overall Study|Lost to Follow-up|42|||
149820018|NCT03342898|540471650|FG000|Overall Study|Withdrawal of Consent|5|||
149820019|NCT03342898|540471651|FG001|Overall Study|Withdrawal of Consent|9|||
149820020|NCT03342898|540471652|FG002|Overall Study|Withdrawal of Consent|11|||
149820021|NCT03342898|540471650|FG000|Overall Study|Death|0|||
149820022|NCT03342898|540471651|FG001|Overall Study|Death|1|||
149820023|NCT03342898|540471652|FG002|Overall Study|Death|1|||
149820024|NCT03342898|540471650|FG000|Overall Study|Reason not Specified|2|||
149820025|NCT03342898|540471651|FG001|Overall Study|Reason not Specified|2|||
149820026|NCT03342898|540471652|FG002|Overall Study|Reason not Specified|0|||
149820027|NCT01387282|540471653|FG000|Overall Study|Death|47|||
149820028|NCT01387282|540471654|FG001|Overall Study|Death|16|||
149820029|NCT01387282|540471653|FG000|Overall Study|Other|5|||
149820030|NCT01387282|540471654|FG001|Overall Study|Other|1|||
149820031|NCT01387282|540471653|FG000|Overall Study|Unrelated AE|6|||
149820032|NCT01387282|540471654|FG001|Overall Study|Unrelated AE|4|||
149820033|NCT01387282|540471653|FG000|Overall Study|Withdrawal by patient|33|||
149820034|NCT01387282|540471654|FG001|Overall Study|Withdrawal by patient|23|||
149820035|NCT01387282|540471653|FG000|Overall Study|Study drug-related AE|2|||
149820036|NCT01387282|540471654|FG001|Overall Study|Study drug-related AE|2|||
149820037|NCT01387282|540471653|FG000|Overall Study|Lost to Follow-up|4|||
149820038|NCT01387282|540471654|FG001|Overall Study|Lost to Follow-up|1|||
149820039|NCT03997448|540471657|FG000|Study Treatment|Disease Progression|1|||
149820040|NCT03997448|540471657|FG000|Study Treatment|Symptomatic Deterioration|1|||
149820041|NCT03997448|540471657|FG000|Follow up|Death|2|||
149820042|NCT03997448|540471657|FG000|Follow up|study terminated|1|||
149820043|NCT02451670|540471658|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
149820044|NCT02451670|540471659|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
149820045|NCT00461500|540471660|FG000|Overall Study|Adverse Event|1|||
149820046|NCT00461500|540471661|FG001|Overall Study|Adverse Event|0|||
149820047|NCT00461500|540471660|FG000|Overall Study|Lack of Efficacy|0|||
149820048|NCT00461500|540471661|FG001|Overall Study|Lack of Efficacy|1|||
149820049|NCT00461500|540471660|FG000|Overall Study|Expired Drug Treatment|1|||
149820050|NCT00461500|540471661|FG001|Overall Study|Expired Drug Treatment|1|||
149820051|NCT00461500|540471660|FG000|Overall Study|Study Stopped|1|||
149820052|NCT00461500|540471661|FG001|Overall Study|Study Stopped|2|||
149820053|NCT00461500|540471660|FG000|Overall Study|Drug Treatment Misuse|1|||
149820054|NCT00461500|540471661|FG001|Overall Study|Drug Treatment Misuse|0|||
149820055|NCT00461500|540471660|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
149820056|NCT00461500|540471661|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
149820057|NCT00461500|540471660|FG000|Overall Study|Lost to Follow-up|2|||
149820058|NCT00461500|540471661|FG001|Overall Study|Lost to Follow-up|2|||
149820059|NCT01513551|540471666|FG000|Overall Study|Death|0|||
149820060|NCT01513551|540471667|FG001|Overall Study|Death|1|||
149820061|NCT01513551|540471668|FG002|Overall Study|Death|0|||
149820062|NCT01513551|540471666|FG000|Overall Study|Lost to Follow-up|3|||
149820063|NCT01513551|540471667|FG001|Overall Study|Lost to Follow-up|5|||
149820064|NCT01513551|540471668|FG002|Overall Study|Lost to Follow-up|2|||
149820065|NCT01513551|540471666|FG000|Overall Study|Withdrawal by Subject|1|||
149820066|NCT01513551|540471667|FG001|Overall Study|Withdrawal by Subject|0|||
149820067|NCT01513551|540471668|FG002|Overall Study|Withdrawal by Subject|2|||
149820068|NCT01513551|540471666|FG000|Overall Study|Randomized but not vaccinated|0|||
149820069|NCT01513551|540471667|FG001|Overall Study|Randomized but not vaccinated|0|||
149820070|NCT01513551|540471668|FG002|Overall Study|Randomized but not vaccinated|1|||
149820071|NCT01267266|540471672|FG000|Enrollment Phase|Withdrawal by Subject|2|||
149820072|NCT01267266|540471673|FG001|Enrollment Phase|Withdrawal by Subject|0|||
149820073|NCT01267266|540471672|FG000|Lead-in Phase|Lack of Efficacy|20|||
149820074|NCT01267266|540471673|FG001|Lead-in Phase|Lack of Efficacy|0|||
149820075|NCT01267266|540471672|FG000|Lead-in Phase|Adverse Event|2|||
149820076|NCT01267266|540471673|FG001|Lead-in Phase|Adverse Event|0|||
149820077|NCT01267266|540471672|FG000|Lead-in Phase|Withdrawal by Subject|1|||
149820078|NCT01267266|540471673|FG001|Lead-in Phase|Withdrawal by Subject|0|||
149820079|NCT01335477|540471674|FG000|Overall Study|Adverse Event|30|||
149820080|NCT01335477|540471675|FG001|Overall Study|Adverse Event|42|||
149820081|NCT01335477|540471674|FG000|Overall Study|Non compliant with protocol|0|||
149820082|NCT01335477|540471675|FG001|Overall Study|Non compliant with protocol|2|||
149820083|NCT01335477|540471674|FG000|Overall Study|Lost to Follow-up|1|||
149820084|NCT01335477|540471675|FG001|Overall Study|Lost to Follow-up|2|||
149931798|NCT02346877|540884035|FG001|Overall Study|Administrative Decision|0|||
149931799|NCT02346877|540884034|FG000|Overall Study|Sponsor Decision|12|||
149931800|NCT02346877|540884035|FG001|Overall Study|Sponsor Decision|0|||
149931801|NCT02346877|540884034|FG000|Overall Study|Missing|5|||
149931802|NCT02346877|540884035|FG001|Overall Study|Missing|0|||
149931803|NCT01683604|540884037|FG000|Overall Study|Adverse Event|2|||
149931804|NCT01683604|540884037|FG000|Overall Study|Lack of Efficacy|1|||
149931805|NCT01683604|540884037|FG000|Overall Study|Other|2|||
149931806|NCT01395810|540884045|FG000|Overall Study|Adverse Event|0|||
149931807|NCT01395810|540884046|FG001|Overall Study|Adverse Event|1|||
149931808|NCT01395810|540884047|FG002|Overall Study|Adverse Event|0|||
149931809|NCT01395810|540884048|FG003|Overall Study|Adverse Event|0|||
149931810|NCT01395810|540884045|FG000|Overall Study|Lack of Efficacy|0|||
149931811|NCT01395810|540884046|FG001|Overall Study|Lack of Efficacy|1|||
149931812|NCT01395810|540884047|FG002|Overall Study|Lack of Efficacy|0|||
149931813|NCT01395810|540884048|FG003|Overall Study|Lack of Efficacy|0|||
149931814|NCT01395810|540884045|FG000|Overall Study|Withdrawal criteria|0|||
149931815|NCT01395810|540884046|FG001|Overall Study|Withdrawal criteria|2|||
149931816|NCT01395810|540884047|FG002|Overall Study|Withdrawal criteria|0|||
149931817|NCT01395810|540884048|FG003|Overall Study|Withdrawal criteria|0|||
149931818|NCT01395810|540884045|FG000|Overall Study|Unclassified|2|||
149931819|NCT01395810|540884046|FG001|Overall Study|Unclassified|0|||
149931820|NCT01395810|540884047|FG002|Overall Study|Unclassified|0|||
149931821|NCT01395810|540884048|FG003|Overall Study|Unclassified|0|||
149931822|NCT03877224|540884051|FG000|Overall Study|Death|3|||
149931823|NCT03877224|540884052|FG001|Overall Study|Death|2|||
149931824|NCT03877224|540884051|FG000|Overall Study|Withdrawal by Subject|1|||
149931825|NCT03877224|540884052|FG001|Overall Study|Withdrawal by Subject|6|||
149931826|NCT03877224|540884051|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
149931827|NCT03877224|540884052|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
149931828|NCT01001429|540886074|FG000|Overall Study|surgery cancelled|0|||
149931829|NCT01001429|540886075|FG001|Overall Study|surgery cancelled|1|||
149931830|NCT03234036|540886080|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
149931831|NCT03234036|540886081|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
149931832|NCT03234036|540886082|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
149931833|NCT03234036|540886083|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
149931834|NCT01607593|540886090|FG000|Overall Study|Adverse Event|15|||
149931835|NCT01607593|540886090|FG000|Overall Study|Lack of Efficacy|16|||
149931836|NCT01607593|540886090|FG000|Overall Study|Lost to Follow-up|25|||
149931837|NCT01607593|540886090|FG000|Overall Study|Continuation|33|||
149931838|NCT01607593|540886090|FG000|Overall Study|Other|4|||
149931839|NCT02515630|540886093|FG000|Overall Study|Withdrawal by Subject|5|||
149931840|NCT02515630|540886093|FG000|Overall Study|Adverse Event|4|||
149931841|NCT02515630|540886093|FG000|Overall Study|Physician Decision|4|||
149931842|NCT02515630|540886093|FG000|Overall Study|Death|2|||
149931843|NCT02515630|540886093|FG000|Overall Study|Disease Progression|1|||
149931844|NCT00165503|540886094|FG000|Overall Study|Death|1|||
149931845|NCT00165503|540886094|FG000|Overall Study|Lost to Follow-up|12|||
149931846|NCT00165503|540886094|FG000|Overall Study|Unresectable|3|||
149931847|NCT02346708|540886095|FG000|Overall Study|Adverse Event|2|||
149931848|NCT02346708|540886096|FG001|Overall Study|Adverse Event|0|||
149931849|NCT02346708|540886095|FG000|Overall Study|Protocol Violation|0|||
149931850|NCT02346708|540886096|FG001|Overall Study|Protocol Violation|1|||
149931851|NCT00483652|540886099|FG000|Double-blind Treatment Period|Protocol Violation|2|||
149931852|NCT00483652|540886100|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149931853|NCT00483652|540886099|FG000|Double-blind Treatment Period|Adverse Event|3|||
149931854|NCT00483652|540886100|FG001|Double-blind Treatment Period|Adverse Event|4|||
149931855|NCT00483652|540886099|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
149931856|NCT00483652|540886100|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
149931857|NCT00483652|540886099|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
149931858|NCT00483652|540886100|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
149931859|NCT00891813|540886102|FG000|Overall Study|Adverse Event|3|||
149931860|NCT00891813|540886102|FG000|Overall Study|Withdrawal by Subject|1|||
149931861|NCT00891813|540886102|FG000|Overall Study|Patient Noncompliance|6|||
149931862|NCT00891813|540886102|FG000|Overall Study|Protocol Violation|2|||
149931863|NCT02157519|540886114|FG000|Overall Study|Death|3|||
149931864|NCT02157519|540886115|FG001|Overall Study|Death|1|||
149931865|NCT02157519|540886114|FG000|Overall Study|Withdrawal by Subject|7|||
149931866|NCT02157519|540886115|FG001|Overall Study|Withdrawal by Subject|0|||
149931867|NCT02157519|540886114|FG000|Overall Study|Lost to Follow-up|1|||
149931868|NCT02157519|540886115|FG001|Overall Study|Lost to Follow-up|0|||
149931869|NCT01656395|540886116|FG000|Overall Study|Adverse Event|1|||
149931870|NCT01656395|540886117|FG001|Overall Study|Adverse Event|14|||
149931871|NCT01656395|540886118|FG002|Overall Study|Adverse Event|5|||
149931872|NCT01656395|540886119|FG003|Overall Study|Adverse Event|4|||
149931873|NCT01656395|540886120|FG004|Overall Study|Adverse Event|5|||
149931874|NCT01656395|540886121|FG005|Overall Study|Adverse Event|7|||
149931875|NCT01656395|540886122|FG006|Overall Study|Adverse Event|0|||
149931876|NCT01656395|540886123|FG007|Overall Study|Adverse Event|0|||
149931877|NCT01656395|540886116|FG000|Overall Study|Lack of Efficacy|1|||
149931878|NCT01656395|540886117|FG001|Overall Study|Lack of Efficacy|8|||
149931879|NCT01656395|540886118|FG002|Overall Study|Lack of Efficacy|6|||
149931880|NCT01656395|540886119|FG003|Overall Study|Lack of Efficacy|1|||
149931881|NCT01656395|540886120|FG004|Overall Study|Lack of Efficacy|1|||
149931882|NCT01656395|540886121|FG005|Overall Study|Lack of Efficacy|6|||
149931883|NCT01656395|540886122|FG006|Overall Study|Lack of Efficacy|0|||
149931884|NCT01656395|540886123|FG007|Overall Study|Lack of Efficacy|0|||
149931885|NCT01656395|540886116|FG000|Overall Study|Lost to Follow-up|1|||
149931886|NCT01656395|540886117|FG001|Overall Study|Lost to Follow-up|0|||
149931887|NCT01656395|540886118|FG002|Overall Study|Lost to Follow-up|0|||
149931888|NCT01656395|540886119|FG003|Overall Study|Lost to Follow-up|0|||
149931889|NCT01656395|540886120|FG004|Overall Study|Lost to Follow-up|0|||
149931890|NCT01656395|540886121|FG005|Overall Study|Lost to Follow-up|0|||
149931891|NCT01656395|540886122|FG006|Overall Study|Lost to Follow-up|0|||
149931892|NCT01656395|540886123|FG007|Overall Study|Lost to Follow-up|0|||
149931893|NCT01656395|540886116|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149931894|NCT01656395|540886117|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149931895|NCT01656395|540886118|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149931896|NCT01656395|540886119|FG003|Overall Study|Non-Compliance with Study Drug|0|||
149931897|NCT01656395|540886120|FG004|Overall Study|Non-Compliance with Study Drug|1|||
149931898|NCT01656395|540886121|FG005|Overall Study|Non-Compliance with Study Drug|1|||
149931899|NCT01656395|540886122|FG006|Overall Study|Non-Compliance with Study Drug|0|||
149931900|NCT01656395|540886123|FG007|Overall Study|Non-Compliance with Study Drug|0|||
149931901|NCT01656395|540886116|FG000|Overall Study|Other|0|||
149931902|NCT01656395|540886117|FG001|Overall Study|Other|0|||
149931903|NCT01656395|540886118|FG002|Overall Study|Other|1|||
149931904|NCT01656395|540886119|FG003|Overall Study|Other|0|||
149931905|NCT01656395|540886120|FG004|Overall Study|Other|0|||
150266274|NCT00146328|542112511|FG001|Overall Study|Enroll into other trial|4|||
150266275|NCT00146328|542112512|FG002|Overall Study|Enroll into other trial|2|||
150266276|NCT00146328|542112510|FG000|Overall Study|Death|0|||
150266277|NCT00146328|542112511|FG001|Overall Study|Death|1|||
150266278|NCT00146328|542112512|FG002|Overall Study|Death|1|||
150266279|NCT00146328|542112510|FG000|Overall Study|Moved|2|||
150266280|NCT00146328|542112511|FG001|Overall Study|Moved|0|||
150266281|NCT00146328|542112512|FG002|Overall Study|Moved|0|||
150266282|NCT00146328|542112510|FG000|Overall Study|Interaction with other medication|2|||
149931906|NCT01656395|540886121|FG005|Overall Study|Other|1|||
149931907|NCT01656395|540886122|FG006|Overall Study|Other|0|||
149931908|NCT01656395|540886123|FG007|Overall Study|Other|0|||
149931909|NCT01656395|540886116|FG000|Overall Study|Physician Decision|2|||
149931910|NCT01656395|540886117|FG001|Overall Study|Physician Decision|3|||
149931911|NCT01656395|540886118|FG002|Overall Study|Physician Decision|3|||
149931912|NCT01656395|540886119|FG003|Overall Study|Physician Decision|2|||
149931913|NCT01656395|540886120|FG004|Overall Study|Physician Decision|3|||
149931914|NCT01656395|540886121|FG005|Overall Study|Physician Decision|3|||
149931915|NCT01656395|540886122|FG006|Overall Study|Physician Decision|0|||
149931916|NCT01656395|540886123|FG007|Overall Study|Physician Decision|0|||
149931917|NCT01656395|540886116|FG000|Overall Study|Pregnancy|0|||
149931918|NCT01656395|540886117|FG001|Overall Study|Pregnancy|0|||
149931919|NCT01656395|540886118|FG002|Overall Study|Pregnancy|1|||
149931920|NCT01656395|540886119|FG003|Overall Study|Pregnancy|0|||
150266283|NCT00146328|542112511|FG001|Overall Study|Interaction with other medication|0|||
149931921|NCT01656395|540886120|FG004|Overall Study|Pregnancy|0|||
149931922|NCT01656395|540886121|FG005|Overall Study|Pregnancy|0|||
149931923|NCT01656395|540886122|FG006|Overall Study|Pregnancy|0|||
149931924|NCT01656395|540886123|FG007|Overall Study|Pregnancy|0|||
149931925|NCT01656395|540886116|FG000|Overall Study|Progressive Disease|0|||
149931926|NCT01656395|540886117|FG001|Overall Study|Progressive Disease|0|||
149931927|NCT01656395|540886118|FG002|Overall Study|Progressive Disease|0|||
149931928|NCT01656395|540886119|FG003|Overall Study|Progressive Disease|0|||
149931929|NCT01656395|540886120|FG004|Overall Study|Progressive Disease|0|||
150266284|NCT00146328|542112512|FG002|Overall Study|Interaction with other medication|1|||
150266285|NCT00300781|542112513|FG000|Overall Study|Disease Progression|55|||
149931930|NCT01656395|540886121|FG005|Overall Study|Progressive Disease|1|||
149931931|NCT01656395|540886122|FG006|Overall Study|Progressive Disease|0|||
149931932|NCT01656395|540886123|FG007|Overall Study|Progressive Disease|0|||
149931933|NCT01656395|540886116|FG000|Overall Study|Protocol Violation|6|||
149931934|NCT01656395|540886117|FG001|Overall Study|Protocol Violation|6|||
149931935|NCT01656395|540886118|FG002|Overall Study|Protocol Violation|9|||
149931936|NCT01656395|540886119|FG003|Overall Study|Protocol Violation|2|||
149931937|NCT01656395|540886120|FG004|Overall Study|Protocol Violation|4|||
149931938|NCT01656395|540886121|FG005|Overall Study|Protocol Violation|10|||
149931939|NCT01656395|540886122|FG006|Overall Study|Protocol Violation|0|||
149931940|NCT01656395|540886123|FG007|Overall Study|Protocol Violation|0|||
149931941|NCT01656395|540886116|FG000|Overall Study|Screen Failure|2|||
149931942|NCT01656395|540886117|FG001|Overall Study|Screen Failure|1|||
150266286|NCT00300781|542112514|FG001|Overall Study|Disease Progression|52|||
150266287|NCT00300781|542112513|FG000|Overall Study|Adverse Event|5|||
149931943|NCT01656395|540886118|FG002|Overall Study|Screen Failure|7|||
149931944|NCT01656395|540886119|FG003|Overall Study|Screen Failure|1|||
149931945|NCT01656395|540886120|FG004|Overall Study|Screen Failure|0|||
149931946|NCT01656395|540886121|FG005|Overall Study|Screen Failure|8|||
149931947|NCT01656395|540886122|FG006|Overall Study|Screen Failure|0|||
149931948|NCT01656395|540886123|FG007|Overall Study|Screen Failure|0|||
149931949|NCT01656395|540886116|FG000|Overall Study|Withdrawal by Subject|3|||
149931950|NCT01656395|540886117|FG001|Overall Study|Withdrawal by Subject|1|||
149931951|NCT01656395|540886118|FG002|Overall Study|Withdrawal by Subject|4|||
149931952|NCT01656395|540886119|FG003|Overall Study|Withdrawal by Subject|2|||
149931953|NCT01656395|540886120|FG004|Overall Study|Withdrawal by Subject|0|||
149931954|NCT01656395|540886121|FG005|Overall Study|Withdrawal by Subject|3|||
149931955|NCT01656395|540886122|FG006|Overall Study|Withdrawal by Subject|0|||
149931956|NCT01656395|540886123|FG007|Overall Study|Withdrawal by Subject|0|||
149931957|NCT04919317|540886127|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
149931958|NCT04919317|540886128|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
149931959|NCT04919317|540886127|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
149931960|NCT04919317|540886128|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
149931961|NCT00230048|540886129|FG000|Overall Study|Lost to Follow-up|13|||
149931962|NCT00230048|540886130|FG001|Overall Study|Lost to Follow-up|18|||
149931963|NCT02869789|540886131|FG000|Overall Study|Disease progression|184|||
149931964|NCT02869789|540886132|FG001|Overall Study|Disease progression|109|||
149931965|NCT02869789|540886133|FG002|Overall Study|Disease progression|260|||
149931966|NCT02869789|540886134|FG003|Overall Study|Disease progression|19|||
149931967|NCT02869789|540886131|FG000|Overall Study|Study drug toxicity|90|||
149931968|NCT02869789|540886132|FG001|Overall Study|Study drug toxicity|32|||
149931969|NCT02869789|540886133|FG002|Overall Study|Study drug toxicity|55|||
149931970|NCT02869789|540886134|FG003|Overall Study|Study drug toxicity|14|||
149931971|NCT02869789|540886131|FG000|Overall Study|Death|7|||
149931972|NCT02869789|540886132|FG001|Overall Study|Death|3|||
149931973|NCT02869789|540886133|FG002|Overall Study|Death|5|||
149931974|NCT02869789|540886134|FG003|Overall Study|Death|1|||
149931975|NCT02869789|540886131|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
149931976|NCT02869789|540886132|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
149931977|NCT02869789|540886133|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
149931978|NCT02869789|540886134|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
149931979|NCT02869789|540886131|FG000|Overall Study|Participant request to discontinue study treatment|10|||
149931980|NCT02869789|540886132|FG001|Overall Study|Participant request to discontinue study treatment|5|||
149931981|NCT02869789|540886133|FG002|Overall Study|Participant request to discontinue study treatment|5|||
149931982|NCT02869789|540886134|FG003|Overall Study|Participant request to discontinue study treatment|3|||
149931983|NCT02869789|540886131|FG000|Overall Study|Withdrawal by Subject|5|||
149931984|NCT02869789|540886132|FG001|Overall Study|Withdrawal by Subject|2|||
149931985|NCT02869789|540886133|FG002|Overall Study|Withdrawal by Subject|7|||
149931986|NCT02869789|540886134|FG003|Overall Study|Withdrawal by Subject|2|||
149931987|NCT02869789|540886131|FG000|Overall Study|Lost to Follow-up|0|||
149931988|NCT02869789|540886132|FG001|Overall Study|Lost to Follow-up|0|||
149931989|NCT02869789|540886133|FG002|Overall Study|Lost to Follow-up|2|||
149931990|NCT02869789|540886134|FG003|Overall Study|Lost to Follow-up|0|||
149931991|NCT02869789|540886131|FG000|Overall Study|Maximum clinical benefit|5|||
149931992|NCT02869789|540886132|FG001|Overall Study|Maximum clinical benefit|2|||
149931993|NCT02869789|540886133|FG002|Overall Study|Maximum clinical benefit|1|||
149931994|NCT02869789|540886134|FG003|Overall Study|Maximum clinical benefit|0|||
149931995|NCT02869789|540886131|FG000|Overall Study|Poor/Non-compliance|0|||
149931996|NCT02869789|540886132|FG001|Overall Study|Poor/Non-compliance|2|||
149931997|NCT02869789|540886133|FG002|Overall Study|Poor/Non-compliance|1|||
149931998|NCT02869789|540886134|FG003|Overall Study|Poor/Non-compliance|0|||
149931999|NCT02869789|540886131|FG000|Overall Study|Participant no longer meets study criteria|0|||
149932000|NCT02869789|540886132|FG001|Overall Study|Participant no longer meets study criteria|1|||
149932001|NCT02869789|540886133|FG002|Overall Study|Participant no longer meets study criteria|1|||
149932002|NCT02869789|540886134|FG003|Overall Study|Participant no longer meets study criteria|0|||
150165869|NCT04927975|541741644|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
150165870|NCT04927975|541741645|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
150165871|NCT04927975|541741646|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
150165872|NCT04927975|541741641|FG000|Period 1 (Baseline-Week 24)|Death|0|||
150165873|NCT04927975|541741642|FG001|Period 1 (Baseline-Week 24)|Death|0|||
150165874|NCT04927975|541741643|FG002|Period 1 (Baseline-Week 24)|Death|0|||
150165875|NCT04927975|541741644|FG003|Period 1 (Baseline-Week 24)|Death|0|||
149932003|NCT02869789|540886131|FG000|Overall Study|Administrative reason by sponsor|0|||
149932004|NCT02869789|540886132|FG001|Overall Study|Administrative reason by sponsor|0|||
149932005|NCT02869789|540886133|FG002|Overall Study|Administrative reason by sponsor|1|||
149932006|NCT02869789|540886134|FG003|Overall Study|Administrative reason by sponsor|0|||
149932007|NCT02869789|540886131|FG000|Overall Study|Other reasons|4|||
149932008|NCT02869789|540886132|FG001|Overall Study|Other reasons|8|||
150165876|NCT04927975|541741645|FG004|Period 1 (Baseline-Week 24)|Death|0|||
150165877|NCT04927975|541741646|FG005|Period 1 (Baseline-Week 24)|Death|1|||
149932009|NCT02869789|540886133|FG002|Overall Study|Other reasons|6|||
149932010|NCT02869789|540886134|FG003|Overall Study|Other reasons|0|||
149932011|NCT00676403|540886137|FG000|Overall Study|Adverse Event|1|||
149932012|NCT00676403|540886138|FG001|Overall Study|Adverse Event|2|||
149932013|NCT00676403|540886139|FG002|Overall Study|Adverse Event|0|||
149932014|NCT00676403|540886140|FG003|Overall Study|Adverse Event|5|||
149932015|NCT00676403|540886141|FG004|Overall Study|Adverse Event|1|||
149932016|NCT00676403|540886142|FG005|Overall Study|Adverse Event|2|||
149932017|NCT00676403|540886137|FG000|Overall Study|Lost to Follow-up|0|||
149932018|NCT00676403|540886138|FG001|Overall Study|Lost to Follow-up|0|||
149932019|NCT00676403|540886139|FG002|Overall Study|Lost to Follow-up|0|||
149932020|NCT00676403|540886140|FG003|Overall Study|Lost to Follow-up|0|||
149932021|NCT00676403|540886141|FG004|Overall Study|Lost to Follow-up|0|||
149932022|NCT00676403|540886142|FG005|Overall Study|Lost to Follow-up|1|||
149932023|NCT00676403|540886137|FG000|Overall Study|Reason Unspecified|1|||
149932024|NCT00676403|540886138|FG001|Overall Study|Reason Unspecified|0|||
149932025|NCT00676403|540886139|FG002|Overall Study|Reason Unspecified|1|||
149932026|NCT00676403|540886140|FG003|Overall Study|Reason Unspecified|0|||
149932027|NCT00676403|540886141|FG004|Overall Study|Reason Unspecified|0|||
149932028|NCT00676403|540886142|FG005|Overall Study|Reason Unspecified|1|||
149932029|NCT00676403|540886137|FG000|Overall Study|Withdrawal by Subject|0|||
149932030|NCT00676403|540886138|FG001|Overall Study|Withdrawal by Subject|0|||
149932031|NCT00676403|540886139|FG002|Overall Study|Withdrawal by Subject|0|||
149932032|NCT00676403|540886140|FG003|Overall Study|Withdrawal by Subject|0|||
149932033|NCT00676403|540886141|FG004|Overall Study|Withdrawal by Subject|0|||
149932034|NCT00676403|540886142|FG005|Overall Study|Withdrawal by Subject|1|||
149932035|NCT00297648|540886144|FG000|Overall Study|Adverse Event|13|||
149932036|NCT00297648|540886144|FG000|Overall Study|Lack of Efficacy|18|||
149932037|NCT00297648|540886144|FG000|Overall Study|Lost to Follow-up|1|||
149932038|NCT00297648|540886144|FG000|Overall Study|Withdrawal by Subject|3|||
149932039|NCT00297648|540886144|FG000|Overall Study|Other: Incompliance|1|||
149932040|NCT05209880|540886149|FG000|1-Month Follow-up|Spoke with Doctor|5|||
149932041|NCT05209880|540886150|FG001|1-Month Follow-up|Spoke with Doctor|5|||
150165878|NCT04927975|541741641|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
150165879|NCT04927975|541741642|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
150165880|NCT04927975|541741643|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
150165881|NCT04927975|541741644|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
150165882|NCT04927975|541741645|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
150165883|NCT04927975|541741646|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
150165884|NCT04927975|541741641|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
150165885|NCT04927975|541741642|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
150165886|NCT04927975|541741643|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
150165887|NCT04927975|541741644|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
150165888|NCT04927975|541741645|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
150165889|NCT04927975|541741646|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
150165890|NCT04678830|541741647|FG000|Overall Study|Lack of Efficacy|2|||
150165891|NCT04678830|541741648|FG001|Overall Study|Lack of Efficacy|0|||
150165892|NCT04678830|541741647|FG000|Overall Study|Withdrawal by Subject|0|||
150165893|NCT04678830|541741648|FG001|Overall Study|Withdrawal by Subject|1|||
150165894|NCT05550337|541741649|FG000|Overall Study|Lack of Efficacy|0|||
150165895|NCT05550337|541741650|FG001|Overall Study|Lack of Efficacy|0|||
150165896|NCT05550337|541741651|FG002|Overall Study|Lack of Efficacy|1|||
150165897|NCT05550337|541741649|FG000|Overall Study|Adverse Event|1|||
150165898|NCT05550337|541741650|FG001|Overall Study|Adverse Event|5|||
150165899|NCT05550337|541741651|FG002|Overall Study|Adverse Event|0|||
150165900|NCT05550337|541741649|FG000|Overall Study|Withdrawal by Subject|8|||
150165901|NCT05550337|541741650|FG001|Overall Study|Withdrawal by Subject|14|||
150165902|NCT05550337|541741651|FG002|Overall Study|Withdrawal by Subject|10|||
150165903|NCT05550337|541741649|FG000|Overall Study|Pregnancy|0|||
150165904|NCT05550337|541741650|FG001|Overall Study|Pregnancy|0|||
150165905|NCT05550337|541741651|FG002|Overall Study|Pregnancy|1|||
150165906|NCT05550337|541741649|FG000|Overall Study|Protocol Violation|1|||
150165907|NCT05550337|541741650|FG001|Overall Study|Protocol Violation|3|||
150165908|NCT05550337|541741651|FG002|Overall Study|Protocol Violation|4|||
150165909|NCT05550337|541741649|FG000|Overall Study|Physician Decision|2|||
150165910|NCT05550337|541741650|FG001|Overall Study|Physician Decision|1|||
150266288|NCT00300781|542112514|FG001|Overall Study|Adverse Event|6|||
149932042|NCT05209880|540886149|FG000|1-Month Follow-up|Lost to Follow-up|7|||
149932043|NCT05209880|540886150|FG001|1-Month Follow-up|Lost to Follow-up|9|||
149932044|NCT05209880|540886149|FG000|1-Month Follow-up|Discontinued|0|||
149932045|NCT05209880|540886150|FG001|1-Month Follow-up|Discontinued|1|||
149932046|NCT05209880|540886149|FG000|3-Month Follow-up|Spoke with Doctor|17|||
150165911|NCT05550337|541741651|FG002|Overall Study|Physician Decision|1|||
150266289|NCT00300781|542112513|FG000|Overall Study|Withdrawal by Subject|1|||
150165912|NCT05550337|541741649|FG000|Overall Study|Lost to Follow-up|16|||
150165913|NCT05550337|541741650|FG001|Overall Study|Lost to Follow-up|11|||
150165914|NCT05550337|541741651|FG002|Overall Study|Lost to Follow-up|11|||
150165915|NCT01836458|541741652|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
150165916|NCT01836458|541741653|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149932047|NCT05209880|540886150|FG001|3-Month Follow-up|Spoke with Doctor|7|||
149932048|NCT05209880|540886149|FG000|3-Month Follow-up|Lost to Follow-up|8|||
149932049|NCT05209880|540886150|FG001|3-Month Follow-up|Lost to Follow-up|10|||
149932050|NCT05209880|540886149|FG000|3-Month Follow-up|Discontinued|1|||
149932051|NCT05209880|540886150|FG001|3-Month Follow-up|Discontinued|3|||
149932052|NCT05209880|540886149|FG000|6-Month Follow-up|Spoke with Doctor|25|||
149932053|NCT05209880|540886150|FG001|6-Month Follow-up|Spoke with Doctor|14|||
149932054|NCT05209880|540886149|FG000|6-Month Follow-up|Lost to Follow-up|9|||
149932055|NCT05209880|540886150|FG001|6-Month Follow-up|Lost to Follow-up|14|||
149932056|NCT05209880|540886149|FG000|6-Month Follow-up|Discontinued|1|||
149932057|NCT05209880|540886150|FG001|6-Month Follow-up|Discontinued|3|||
149932058|NCT03143101|540886158|FG000|Overall Study|Withdrawal by Subject|0|||
149932059|NCT03143101|540886159|FG001|Overall Study|Withdrawal by Subject|1|||
149932060|NCT03143101|540886160|FG002|Overall Study|Withdrawal by Subject|0|||
149932061|NCT03143101|540886158|FG000|Overall Study|Lost to Follow-up|2|||
149932062|NCT03143101|540886159|FG001|Overall Study|Lost to Follow-up|2|||
149932063|NCT03143101|540886160|FG002|Overall Study|Lost to Follow-up|0|||
149932064|NCT05227118|540886161|FG000|Overall Study|Adverse Event|0|||
149932065|NCT05227118|540886162|FG001|Overall Study|Adverse Event|0|||
149932066|NCT05227118|540886163|FG002|Overall Study|Adverse Event|1|||
149932067|NCT05227118|540886164|FG003|Overall Study|Adverse Event|0|||
149932068|NCT05227118|540886161|FG000|Overall Study|Withdrawal by Subject|0|||
149932069|NCT05227118|540886162|FG001|Overall Study|Withdrawal by Subject|0|||
149932070|NCT05227118|540886163|FG002|Overall Study|Withdrawal by Subject|2|||
149932071|NCT05227118|540886164|FG003|Overall Study|Withdrawal by Subject|0|||
149932072|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
149932073|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
149932074|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
149932075|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
149932076|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
149932077|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
149932078|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
149932079|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
149932080|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
149932081|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
149932082|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
149932083|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
149932084|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
149932085|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
149932086|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
149932087|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
149932088|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
149932089|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
149932090|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
149932091|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
149932092|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
149932093|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
149932094|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
149932095|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
149932096|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
149932097|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932098|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932099|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932100|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932101|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932102|NCT01435759|540886165|FG000|Antidepressant Lead-in Phase|Other|119|||
149932103|NCT01435759|540886166|FG001|Antidepressant Lead-in Phase|Other|0|||
149932104|NCT01435759|540886167|FG002|Antidepressant Lead-in Phase|Other|0|||
149932105|NCT01435759|540886168|FG003|Antidepressant Lead-in Phase|Other|0|||
149932106|NCT01435759|540886169|FG004|Antidepressant Lead-in Phase|Other|0|||
149932107|NCT01435759|540886170|FG005|Antidepressant Lead-in Phase|Other|0|||
149932108|NCT01435759|540886165|FG000|Double-blind Phase|Adverse Event|7|||
149932109|NCT01435759|540886166|FG001|Double-blind Phase|Adverse Event|0|||
149932110|NCT01435759|540886167|FG002|Double-blind Phase|Adverse Event|1|||
149932111|NCT01435759|540886168|FG003|Double-blind Phase|Adverse Event|1|||
149932112|NCT01435759|540886169|FG004|Double-blind Phase|Adverse Event|1|||
149932113|NCT01435759|540886170|FG005|Double-blind Phase|Adverse Event|3|||
149932114|NCT01435759|540886165|FG000|Double-blind Phase|Protocol Violation|2|||
149932115|NCT01435759|540886166|FG001|Double-blind Phase|Protocol Violation|0|||
150165917|NCT01836458|541741654|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
150165918|NCT01836458|541741655|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
149932116|NCT01435759|540886167|FG002|Double-blind Phase|Protocol Violation|1|||
149932117|NCT01435759|540886168|FG003|Double-blind Phase|Protocol Violation|2|||
149932118|NCT01435759|540886169|FG004|Double-blind Phase|Protocol Violation|0|||
149932119|NCT01435759|540886170|FG005|Double-blind Phase|Protocol Violation|1|||
149932120|NCT01435759|540886165|FG000|Double-blind Phase|Withdrawal by Subject|17|||
149932121|NCT01435759|540886166|FG001|Double-blind Phase|Withdrawal by Subject|4|||
149932122|NCT01435759|540886167|FG002|Double-blind Phase|Withdrawal by Subject|3|||
149932123|NCT01435759|540886168|FG003|Double-blind Phase|Withdrawal by Subject|4|||
149932124|NCT01435759|540886169|FG004|Double-blind Phase|Withdrawal by Subject|2|||
149932125|NCT01435759|540886170|FG005|Double-blind Phase|Withdrawal by Subject|2|||
149932126|NCT01435759|540886165|FG000|Double-blind Phase|Lost to Follow-up|31|||
149932127|NCT01435759|540886166|FG001|Double-blind Phase|Lost to Follow-up|1|||
149932128|NCT01435759|540886167|FG002|Double-blind Phase|Lost to Follow-up|2|||
149932129|NCT01435759|540886168|FG003|Double-blind Phase|Lost to Follow-up|0|||
149932130|NCT01435759|540886169|FG004|Double-blind Phase|Lost to Follow-up|3|||
149932131|NCT01435759|540886170|FG005|Double-blind Phase|Lost to Follow-up|3|||
149932132|NCT01435759|540886165|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
149932133|NCT01435759|540886166|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932134|NCT01435759|540886167|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932135|NCT01435759|540886168|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932136|NCT01435759|540886169|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
149932137|NCT01435759|540886170|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
149932138|NCT01435759|540886165|FG000|Double-blind Phase|Other|8|||
149932139|NCT01435759|540886166|FG001|Double-blind Phase|Other|2|||
149932140|NCT01435759|540886167|FG002|Double-blind Phase|Other|0|||
149932141|NCT01435759|540886168|FG003|Double-blind Phase|Other|2|||
149932142|NCT01435759|540886169|FG004|Double-blind Phase|Other|0|||
149932143|NCT01435759|540886170|FG005|Double-blind Phase|Other|0|||
149932144|NCT03727841|540886173|FG000|Overall Study|Physician Decision|3|||
149932145|NCT03727841|540886174|FG001|Overall Study|Physician Decision|1|||
149932146|NCT01601496|540886175|FG000|Overall Study|Physician Decision|1|||
149932147|NCT01601496|540886175|FG000|Overall Study|Withdrawal by Subject|1|||
149932148|NCT01601496|540886175|FG000|Overall Study|Lost to Follow-up|6|||
149932149|NCT01601496|540886175|FG000|Overall Study|Death|4|||
149932150|NCT01601496|540886175|FG000|Overall Study|Other: patient refusal to continue|3|||
149932151|NCT03126786|540886176|FG000|Overall Study|Adverse Event|3|||
149932152|NCT03126786|540886177|FG001|Overall Study|Adverse Event|0|||
149932153|NCT03126786|540886176|FG000|Overall Study|Lost to Follow-up|0|||
149932154|NCT03126786|540886177|FG001|Overall Study|Lost to Follow-up|1|||
149932155|NCT03126786|540886176|FG000|Overall Study|Withdrawal by Subject|3|||
149932156|NCT03126786|540886177|FG001|Overall Study|Withdrawal by Subject|1|||
149932157|NCT03243305|540886178|FG000|Overall Study|Lost to Follow-up|250|||
149932158|NCT03243305|540886178|FG000|Overall Study|Withdrawal by Subject|170|||
149932159|NCT03243305|540886178|FG000|Overall Study|Pregnancy|104|||
149932160|NCT03243305|540886178|FG000|Overall Study|Non-Compliance with Study Drug|38|||
149932161|NCT03243305|540886178|FG000|Overall Study|Adverse Event|23|||
149932162|NCT03243305|540886178|FG000|Overall Study|No sexually active|26|||
149932163|NCT03243305|540886178|FG000|Overall Study|Physician Decision|22|||
149932164|NCT03243305|540886178|FG000|Overall Study|Protocol Violation|22|||
149932165|NCT03243305|540886178|FG000|Overall Study|Study method no longer primary method|12|||
149932166|NCT03243305|540886178|FG000|Overall Study|Study Terminated by Sponsor|1|||
149932167|NCT03243305|540886178|FG000|Overall Study|Early terminations|267|||
149932168|NCT02689804|540886179|FG000|Overall Study|Withdrawal by Subject|2|||
149932169|NCT02689804|540886180|FG001|Overall Study|Withdrawal by Subject|0|||
149932170|NCT00227539|540886181|FG000|Overall Study|Protocol Violation|1|||
149932171|NCT00673257|540886183|FG000|Overall Study|Withdrawal by Subject|4|||
149932172|NCT00673257|540886183|FG000|Overall Study|Unable to obtain specimen|1|||
149932173|NCT01166750|540886190|FG000|Overall Study|Lost to Follow-up|1|||
149932174|NCT01166750|540886191|FG001|Overall Study|Lost to Follow-up|0|||
149932175|NCT02417753|540886194|FG000|Overall Study|Death|1|||
149932176|NCT03113968|540886195|FG000|Overall Study|Withdrawal by Subject|31|||
149932177|NCT03113968|540886196|FG001|Overall Study|Withdrawal by Subject|4|||
149932178|NCT04805671|540886199|FG000|Overall Study|Death|2|||
149932179|NCT04805671|540886200|FG001|Overall Study|Death|7|||
149932180|NCT04805671|540886199|FG000|Overall Study|Lost to Follow-up|1|||
149932181|NCT04805671|540886200|FG001|Overall Study|Lost to Follow-up|0|||
149932182|NCT04805671|540886199|FG000|Overall Study|Withdrawal by Subject|9|||
149932183|NCT04805671|540886200|FG001|Overall Study|Withdrawal by Subject|7|||
149932184|NCT04805671|540886199|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
149932185|NCT04805671|540886200|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
149932186|NCT02111174|540886201|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
149932187|NCT02111174|540886202|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
149932188|NCT02111174|540886201|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
149932189|NCT02111174|540886202|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
149932190|NCT02111174|540886201|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
149932191|NCT02111174|540886202|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
149932192|NCT02111174|540886201|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
149932193|NCT02111174|540886202|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
149932194|NCT00901342|540886203|FG000|Overall Study|Adverse Event|1|||
149932195|NCT00901342|540886203|FG000|Overall Study|Death|4|||
149932196|NCT00901342|540886203|FG000|Overall Study|Disease progression|1|||
149932197|NCT00901342|540886203|FG000|Overall Study|Withdrawal by Subject|9|||
149932198|NCT02849587|540886204|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
149932199|NCT02849587|540886205|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
149932200|NCT02849587|540886206|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
149932201|NCT02849587|540886204|FG000|Overall Study|Withdrawal by Subject|0|||
149932202|NCT02849587|540886205|FG001|Overall Study|Withdrawal by Subject|1|||
149932203|NCT02849587|540886206|FG002|Overall Study|Withdrawal by Subject|0|||
149932204|NCT03380377|540886209|FG000|Overall Study|Physician Decision|1|||
149932205|NCT03380377|540886209|FG000|Overall Study|Withdrawal by Subject|1|||
149932206|NCT02716779|540886210|FG000|Monotherapy|Adverse Event|0|||
149932207|NCT02716779|540886211|FG001|Monotherapy|Adverse Event|1|||
149932208|NCT02716779|540886212|FG002|Monotherapy|Adverse Event|1|||
149932209|NCT02716779|540886210|FG000|Combination Therapy|Adverse Event|0|||
149932210|NCT02716779|540886211|FG001|Combination Therapy|Adverse Event|2|||
149932211|NCT02716779|540886212|FG002|Combination Therapy|Adverse Event|1|||
149932212|NCT02600923|540886215|FG000|Overall Study|Death|10|||
149932213|NCT02600923|540886215|FG000|Overall Study|Adverse Event|3|||
149932214|NCT02600923|540886215|FG000|Overall Study|Global deterioration of health status|2|||
149932215|NCT02600923|540886215|FG000|Overall Study|Insufficient clinical response|6|||
149932216|NCT02600923|540886215|FG000|Overall Study|Lost to Follow-up|1|||
149932217|NCT02600923|540886215|FG000|Overall Study|Withdrawal by Subject|5|||
149932218|NCT02600923|540886215|FG000|Overall Study|Objective progression or relapse|50|||
149932219|NCT02600923|540886215|FG000|Overall Study|Study terminated by Sponsor|53|||
149932220|NCT02600923|540886215|FG000|Overall Study|Not treated|1|||
149932221|NCT00792909|540886216|FG000|Overall Study|Withdrawal by Subject|0|||
149932222|NCT00792909|540886217|FG001|Overall Study|Withdrawal by Subject|1|||
149932223|NCT00792909|540886218|FG002|Overall Study|Withdrawal by Subject|0|||
149932224|NCT01275144|540886222|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
149932225|NCT01275144|540886223|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
149932226|NCT05607576|540886224|FG000|Overall Study|immediate sensor error|2|||
149932227|NCT05607576|540886224|FG000|Overall Study|Physician Decision|2|||
149932228|NCT00003471|540886229|FG000|Overall Study|Not evaluable|4|||
149932229|NCT00735007|540886234|FG000|Overall Study|Adverse Event|4|||
149932230|NCT00735007|540886234|FG000|Overall Study|Protocol Violation|1|||
149932231|NCT00715403|540886235|FG000|Overall Study|Progressive disease|0|||
149932232|NCT00715403|540886236|FG001|Overall Study|Progressive disease|1|||
149932233|NCT00715403|540886237|FG002|Overall Study|Progressive disease|3|||
149932234|NCT00715403|540886238|FG003|Overall Study|Progressive disease|9|||
149932235|NCT00715403|540886239|FG004|Overall Study|Progressive disease|5|||
149932236|NCT00715403|540886240|FG005|Overall Study|Progressive disease|14|||
149932237|NCT00715403|540886241|FG006|Overall Study|Progressive disease|1|||
149932238|NCT00715403|540886235|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932239|NCT00715403|540886236|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932240|NCT00715403|540886237|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932241|NCT00715403|540886238|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932242|NCT00715403|540886239|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932243|NCT00715403|540886240|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
149932244|NCT00715403|540886241|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
149932245|NCT00715403|540886235|FG000|Overall Study|Other Adverse Event than DLT|1|||
149932246|NCT00715403|540886236|FG001|Overall Study|Other Adverse Event than DLT|0|||
149932247|NCT00715403|540886237|FG002|Overall Study|Other Adverse Event than DLT|0|||
149932248|NCT00715403|540886238|FG003|Overall Study|Other Adverse Event than DLT|0|||
149932249|NCT00715403|540886239|FG004|Overall Study|Other Adverse Event than DLT|0|||
149932250|NCT00715403|540886240|FG005|Overall Study|Other Adverse Event than DLT|2|||
149932251|NCT00715403|540886241|FG006|Overall Study|Other Adverse Event than DLT|0|||
149932252|NCT00715403|540886235|FG000|Overall Study|Protocol Violation|0|||
149932253|NCT00715403|540886236|FG001|Overall Study|Protocol Violation|0|||
149932254|NCT00715403|540886237|FG002|Overall Study|Protocol Violation|0|||
149932255|NCT00715403|540886238|FG003|Overall Study|Protocol Violation|0|||
149932256|NCT00715403|540886239|FG004|Overall Study|Protocol Violation|0|||
150165919|NCT02931396|541741658|FG000|Overall Study|Lost to Follow-up|3|||
150165920|NCT02931396|541741659|FG001|Overall Study|Lost to Follow-up|0|||
150165921|NCT02931396|541741658|FG000|Overall Study|Withdrawal by Subject|2|||
149932257|NCT00715403|540886240|FG005|Overall Study|Protocol Violation|1|||
149932258|NCT00715403|540886241|FG006|Overall Study|Protocol Violation|0|||
149932259|NCT00715403|540886235|FG000|Overall Study|Other reason not defined above|0|||
149932260|NCT00715403|540886236|FG001|Overall Study|Other reason not defined above|0|||
149932261|NCT00715403|540886237|FG002|Overall Study|Other reason not defined above|1|||
150165922|NCT02931396|541741659|FG001|Overall Study|Withdrawal by Subject|0|||
149932262|NCT00715403|540886238|FG003|Overall Study|Other reason not defined above|0|||
149932263|NCT00715403|540886239|FG004|Overall Study|Other reason not defined above|1|||
149932264|NCT00715403|540886240|FG005|Overall Study|Other reason not defined above|1|||
149932265|NCT00715403|540886241|FG006|Overall Study|Other reason not defined above|0|||
149932266|NCT02104895|540886242|FG000|Overall Study|Withdrawal by Subject|0|||
149932267|NCT02104895|540886243|FG001|Overall Study|Withdrawal by Subject|14|||
149932268|NCT01817075|540886246|FG000|Overall Study|Adverse Event|7|||
149932269|NCT01817075|540886247|FG001|Overall Study|Adverse Event|5|||
149932270|NCT01817075|540886246|FG000|Overall Study|Physician Decision|9|||
149932271|NCT01817075|540886247|FG001|Overall Study|Physician Decision|12|||
149932272|NCT01817075|540886246|FG000|Overall Study|Withdrawal by Subject|31|||
149932273|NCT01817075|540886247|FG001|Overall Study|Withdrawal by Subject|15|||
149932274|NCT01817075|540886246|FG000|Overall Study|Received Sorafenib after enrollment|0|||
149932275|NCT01817075|540886247|FG001|Overall Study|Received Sorafenib after enrollment|1|||
149932276|NCT01817075|540886246|FG000|Overall Study|Ineligible|0|||
149932277|NCT01817075|540886247|FG001|Overall Study|Ineligible|2|||
149932278|NCT02481050|540887730|FG000|Overall Study|Adverse Event|1|||
149932279|NCT02481050|540887730|FG000|Overall Study|Disease Progression|47|||
149932280|NCT02481050|540887730|FG000|Overall Study|Withdrawal by Subject|7|||
149932281|NCT02481050|540887730|FG000|Overall Study|Other|3|||
149932282|NCT01386606|540887731|FG000|Overall Study|Adverse Event|0|||
149932283|NCT01386606|540887732|FG001|Overall Study|Adverse Event|1|||
149932284|NCT01386606|540887733|FG002|Overall Study|Adverse Event|0|||
149932285|NCT01386606|540887734|FG003|Overall Study|Adverse Event|0|||
149932286|NCT01386606|540887731|FG000|Overall Study|Withdrawal by Subject|0|||
149932287|NCT01386606|540887732|FG001|Overall Study|Withdrawal by Subject|1|||
149932288|NCT01386606|540887733|FG002|Overall Study|Withdrawal by Subject|1|||
149932289|NCT01386606|540887734|FG003|Overall Study|Withdrawal by Subject|0|||
149932290|NCT01386606|540887731|FG000|Overall Study|Protocol Violation|1|||
149932291|NCT01386606|540887732|FG001|Overall Study|Protocol Violation|0|||
149932292|NCT01386606|540887733|FG002|Overall Study|Protocol Violation|1|||
149932293|NCT01386606|540887734|FG003|Overall Study|Protocol Violation|1|||
149932294|NCT01386606|540887731|FG000|Overall Study|Lost to Follow-up|2|||
149932295|NCT01386606|540887732|FG001|Overall Study|Lost to Follow-up|0|||
149932296|NCT01386606|540887733|FG002|Overall Study|Lost to Follow-up|0|||
149932297|NCT01386606|540887734|FG003|Overall Study|Lost to Follow-up|0|||
149932298|NCT01386606|540887731|FG000|Overall Study|Subject incarcerated|0|||
149932299|NCT01386606|540887732|FG001|Overall Study|Subject incarcerated|1|||
149932300|NCT01386606|540887733|FG002|Overall Study|Subject incarcerated|0|||
149932301|NCT01386606|540887734|FG003|Overall Study|Subject incarcerated|0|||
149932302|NCT01386606|540887731|FG000|Overall Study|Unable to draw PK|1|||
149932303|NCT01386606|540887732|FG001|Overall Study|Unable to draw PK|0|||
149932304|NCT01386606|540887733|FG002|Overall Study|Unable to draw PK|0|||
149932305|NCT01386606|540887734|FG003|Overall Study|Unable to draw PK|0|||
149932306|NCT01386606|540887731|FG000|Overall Study|T levels too high|0|||
149932307|NCT01386606|540887732|FG001|Overall Study|T levels too high|1|||
149932308|NCT01386606|540887733|FG002|Overall Study|T levels too high|1|||
149932309|NCT01386606|540887734|FG003|Overall Study|T levels too high|0|||
149932310|NCT02357459|540887737|FG000|Overall Study|Adverse Event|0|||
149932311|NCT02357459|540887738|FG001|Overall Study|Adverse Event|1|||
149932312|NCT02357459|540887739|FG002|Overall Study|Adverse Event|1|||
149932313|NCT02357459|540887737|FG000|Overall Study|Withdrawal by Subject|5|||
149932314|NCT02357459|540887738|FG001|Overall Study|Withdrawal by Subject|3|||
149932315|NCT02357459|540887739|FG002|Overall Study|Withdrawal by Subject|3|||
149932316|NCT02357459|540887737|FG000|Overall Study|Physician Decision|0|||
149932317|NCT02357459|540887738|FG001|Overall Study|Physician Decision|2|||
149932318|NCT02357459|540887739|FG002|Overall Study|Physician Decision|0|||
149932319|NCT02357459|540887737|FG000|Overall Study|Protocol Violation|1|||
149932320|NCT02357459|540887738|FG001|Overall Study|Protocol Violation|1|||
149932321|NCT02357459|540887739|FG002|Overall Study|Protocol Violation|0|||
149932322|NCT02357459|540887737|FG000|Overall Study|Lost to Follow-up|1|||
149932323|NCT02357459|540887738|FG001|Overall Study|Lost to Follow-up|3|||
149932324|NCT02357459|540887739|FG002|Overall Study|Lost to Follow-up|0|||
149932325|NCT02357459|540887737|FG000|Overall Study|Lack of Efficacy|7|||
149932326|NCT02357459|540887738|FG001|Overall Study|Lack of Efficacy|4|||
149932327|NCT02357459|540887739|FG002|Overall Study|Lack of Efficacy|4|||
149932328|NCT02357459|540887737|FG000|Overall Study|Patient Relocated|2|||
149932329|NCT02357459|540887738|FG001|Overall Study|Patient Relocated|0|||
149932330|NCT02357459|540887739|FG002|Overall Study|Patient Relocated|0|||
149932331|NCT02357459|540887737|FG000|Overall Study|Instruction from PCP|1|||
149932332|NCT02357459|540887738|FG001|Overall Study|Instruction from PCP|0|||
149932333|NCT02357459|540887739|FG002|Overall Study|Instruction from PCP|0|||
149932334|NCT02357459|540887737|FG000|Overall Study|Incarceration|0|||
149932335|NCT02357459|540887738|FG001|Overall Study|Incarceration|0|||
149932336|NCT02357459|540887739|FG002|Overall Study|Incarceration|1|||
149932337|NCT02357459|540887737|FG000|Overall Study|Pre-planned Knee surgery|0|||
149932338|NCT02357459|540887738|FG001|Overall Study|Pre-planned Knee surgery|0|||
149932339|NCT02357459|540887739|FG002|Overall Study|Pre-planned Knee surgery|2|||
149932340|NCT02357459|540887737|FG000|Overall Study|Job Commitments|0|||
149932341|NCT02357459|540887738|FG001|Overall Study|Job Commitments|0|||
149932342|NCT02357459|540887739|FG002|Overall Study|Job Commitments|1|||
149932343|NCT03246347|540887740|FG000|Overall Study|On Study|23|||
149932344|NCT01548599|540887741|FG000|Overall Study|Lost to Follow-up|0|||
149932345|NCT01548599|540887742|FG001|Overall Study|Lost to Follow-up|1|||
149932346|NCT01548599|540887741|FG000|Overall Study|Withdrawal by Subject|4|||
149932347|NCT01548599|540887742|FG001|Overall Study|Withdrawal by Subject|0|||
149932348|NCT01548599|540887741|FG000|Overall Study|Death|2|||
149932349|NCT01548599|540887742|FG001|Overall Study|Death|1|||
149932350|NCT02188160|540887743|FG000|Overall Study|Adverse Event|1|||
149932351|NCT02188160|540887744|FG001|Overall Study|Adverse Event|0|||
149932352|NCT02188160|540887743|FG000|Overall Study|Use of an excluded medication|0|||
149932353|NCT02188160|540887744|FG001|Overall Study|Use of an excluded medication|1|||
149932354|NCT04113694|540887745|FG000|Overall Study|Adverse Event|2|||
149932355|NCT04113694|540887745|FG000|Overall Study|Lost to Follow-up|2|||
149932356|NCT04113694|540887745|FG000|Overall Study|Withdrawal by Subject|6|||
149932357|NCT04113694|540887745|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
149932358|NCT00916578|540887748|FG000|Overall Study|Physician Decision|2|||
149932359|NCT00916578|540887748|FG000|Overall Study|Withdrawal by Subject|3|||
149932360|NCT00916578|540887748|FG000|Overall Study|Insurance Denial|2|||
149932361|NCT01228591|540887749|FG000|Baseline|Lack of Efficacy|1|||
149932362|NCT01228591|540887750|FG001|Baseline|Lack of Efficacy|2|||
149932363|NCT00754741|540887751|FG000|Overall Study|Died or disenrolled|57|||
149932364|NCT00754741|540887752|FG001|Overall Study|Died or disenrolled|69|||
149932365|NCT00754741|540887753|FG002|Overall Study|Died or disenrolled|54|||
149932366|NCT04152200|540887755|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
149932367|NCT04152200|540887756|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
149932368|NCT04969289|540887757|FG000|Overall Study|Lost to Follow-up|13|||
149932369|NCT04969289|540887758|FG001|Overall Study|Lost to Follow-up|9|||
149932370|NCT00593814|540887759|FG000|Overall Study|Death|7|||
149932371|NCT00593814|540887760|FG001|Overall Study|Death|0|||
149932372|NCT00593814|540887759|FG000|Overall Study|Withdrawal by Subject|7|||
149932373|NCT00593814|540887760|FG001|Overall Study|Withdrawal by Subject|0|||
149932374|NCT00593814|540887759|FG000|Overall Study|Lost to Follow-up|7|||
149932375|NCT00593814|540887760|FG001|Overall Study|Lost to Follow-up|0|||
149932376|NCT00593814|540887759|FG000|Overall Study|Physician Decision|3|||
149932377|NCT00593814|540887760|FG001|Overall Study|Physician Decision|0|||
149932378|NCT02699996|540887761|FG000|Overall Study|Withdrawal by Subject|5|||
149932379|NCT02699996|540887762|FG001|Overall Study|Withdrawal by Subject|2|||
149932380|NCT01921517|540887763|FG000|Overall Study|Lost to Follow-up|5|||
149932381|NCT01921517|540887764|FG001|Overall Study|Lost to Follow-up|0|||
149932382|NCT01921517|540887763|FG000|Overall Study|Newly diagnosed health concern|2|||
149932383|NCT01921517|540887764|FG001|Overall Study|Newly diagnosed health concern|0|||
149932384|NCT01921517|540887763|FG000|Overall Study|Physician Decision|0|||
149932385|NCT01921517|540887764|FG001|Overall Study|Physician Decision|2|||
149932386|NCT01921517|540887763|FG000|Overall Study|Withdrawal by Subject|7|||
149932387|NCT01921517|540887764|FG001|Overall Study|Withdrawal by Subject|3|||
149932388|NCT01921517|540887763|FG000|Overall Study|Subject missed final imaging|1|||
149932389|NCT01921517|540887764|FG001|Overall Study|Subject missed final imaging|4|||
149932390|NCT02723188|540887765|FG000|Overall Study|Withdrawal by Subject|1|||
149932391|NCT02723188|540887766|FG001|Overall Study|Withdrawal by Subject|0|||
149932392|NCT02723188|540887767|FG002|Overall Study|Withdrawal by Subject|0|||
149932393|NCT01095835|540887768|FG000|Overall Study|Adverse Event|8|||
149932394|NCT01095835|540887769|FG001|Overall Study|Adverse Event|6|||
149932395|NCT01095835|540887770|FG002|Overall Study|Adverse Event|6|||
149932396|NCT01095835|540887768|FG000|Overall Study|Lack of Efficacy|0|||
149932397|NCT01095835|540887769|FG001|Overall Study|Lack of Efficacy|1|||
149932398|NCT01095835|540887770|FG002|Overall Study|Lack of Efficacy|0|||
149932399|NCT01095835|540887768|FG000|Overall Study|Physician Decision|0|||
149932400|NCT01095835|540887769|FG001|Overall Study|Physician Decision|0|||
149932401|NCT01095835|540887770|FG002|Overall Study|Physician Decision|1|||
149932402|NCT01095835|540887768|FG000|Overall Study|Withdrawal by Subject|1|||
149932403|NCT01095835|540887769|FG001|Overall Study|Withdrawal by Subject|3|||
149932404|NCT01095835|540887770|FG002|Overall Study|Withdrawal by Subject|0|||
149932405|NCT01095835|540887768|FG000|Overall Study|Non study compliance|0|||
149932406|NCT01095835|540887769|FG001|Overall Study|Non study compliance|0|||
149932407|NCT01095835|540887770|FG002|Overall Study|Non study compliance|1|||
149932408|NCT01095835|540887768|FG000|Overall Study|Protocol Violation|1|||
149932409|NCT01095835|540887769|FG001|Overall Study|Protocol Violation|2|||
149932410|NCT01095835|540887770|FG002|Overall Study|Protocol Violation|0|||
149932411|NCT02486692|540887776|FG000|Overall Study|did not login for randomization|4|||
149932412|NCT02486692|540887777|FG001|Overall Study|did not login for randomization|7|||
149932413|NCT03110354|540887778|FG000|Overall Study|Death|1|||
149932414|NCT03110354|540887779|FG001|Overall Study|Death|0|||
149932415|NCT03110354|540887780|FG002|Overall Study|Death|0|||
149932416|NCT03110354|540887781|FG003|Overall Study|Death|1|||
149932417|NCT03110354|540887782|FG004|Overall Study|Death|0|||
149932418|NCT03110354|540887778|FG000|Overall Study|Start of new therapy|0|||
149932419|NCT03110354|540887779|FG001|Overall Study|Start of new therapy|0|||
149932420|NCT03110354|540887780|FG002|Overall Study|Start of new therapy|0|||
149932421|NCT03110354|540887781|FG003|Overall Study|Start of new therapy|0|||
149932422|NCT03110354|540887782|FG004|Overall Study|Start of new therapy|1|||
149932423|NCT03110354|540887778|FG000|Overall Study|Failure to achieve response|2|||
149932424|NCT03110354|540887779|FG001|Overall Study|Failure to achieve response|3|||
149932425|NCT03110354|540887780|FG002|Overall Study|Failure to achieve response|0|||
149932426|NCT03110354|540887781|FG003|Overall Study|Failure to achieve response|2|||
149932427|NCT03110354|540887782|FG004|Overall Study|Failure to achieve response|1|||
149932428|NCT03110354|540887778|FG000|Overall Study|Progressive disease|1|||
149932429|NCT03110354|540887779|FG001|Overall Study|Progressive disease|1|||
149932430|NCT03110354|540887780|FG002|Overall Study|Progressive disease|3|||
149932431|NCT03110354|540887781|FG003|Overall Study|Progressive disease|4|||
149932432|NCT03110354|540887782|FG004|Overall Study|Progressive disease|2|||
149932433|NCT03110354|540887778|FG000|Overall Study|Adverse Event|0|||
149932434|NCT03110354|540887779|FG001|Overall Study|Adverse Event|0|||
149932435|NCT03110354|540887780|FG002|Overall Study|Adverse Event|0|||
149932436|NCT03110354|540887781|FG003|Overall Study|Adverse Event|2|||
149932437|NCT03110354|540887782|FG004|Overall Study|Adverse Event|2|||
149932438|NCT03110354|540887778|FG000|Overall Study|Other|0|||
149932439|NCT03110354|540887779|FG001|Overall Study|Other|0|||
149932440|NCT03110354|540887780|FG002|Overall Study|Other|0|||
149932441|NCT03110354|540887781|FG003|Overall Study|Other|1|||
149932442|NCT03110354|540887782|FG004|Overall Study|Other|1|||
149932443|NCT00116688|540887790|FG000|Overall Study|Protocol deviation|1|||
149932444|NCT00116688|540887791|FG001|Overall Study|Protocol deviation|0|||
149932445|NCT00116688|540887790|FG000|Overall Study|Noncompliance|3|||
149932446|NCT00116688|540887791|FG001|Overall Study|Noncompliance|1|||
149932447|NCT00116688|540887790|FG000|Overall Study|Adverse Event|11|||
149932448|NCT00116688|540887791|FG001|Overall Study|Adverse Event|0|||
149932449|NCT00116688|540887790|FG000|Overall Study|Withdrawal by Subject|26|||
149932450|NCT00116688|540887791|FG001|Overall Study|Withdrawal by Subject|2|||
149932451|NCT00116688|540887790|FG000|Overall Study|Requirement for alternative therapy|11|||
149932452|NCT00116688|540887791|FG001|Overall Study|Requirement for alternative therapy|1|||
149932453|NCT00116688|540887790|FG000|Overall Study|Physician Decision|7|||
149932454|NCT00116688|540887791|FG001|Overall Study|Physician Decision|0|||
149932455|NCT00116688|540887790|FG000|Overall Study|Lost to Follow-up|3|||
149932456|NCT00116688|540887791|FG001|Overall Study|Lost to Follow-up|0|||
149932457|NCT00116688|540887790|FG000|Overall Study|Death|15|||
149932458|NCT00116688|540887791|FG001|Overall Study|Death|0|||
149932459|NCT00116688|540887790|FG000|Overall Study|Protocol-specified criteria|3|||
149932460|NCT00116688|540887791|FG001|Overall Study|Protocol-specified criteria|0|||
149932461|NCT00116688|540887790|FG000|Overall Study|Pregnancy|1|||
149932462|NCT00116688|540887791|FG001|Overall Study|Pregnancy|0|||
149932463|NCT00116688|540887790|FG000|Overall Study|Other|11|||
149932464|NCT00116688|540887791|FG001|Overall Study|Other|0|||
149932465|NCT01775670|540887796|FG000|Overall Study|Lost to Follow-up|1|||
149932466|NCT01775670|540887797|FG001|Overall Study|Lost to Follow-up|1|||
149932467|NCT01298700|540887799|FG000|Overall Study|Adverse Event|50|||
149932468|NCT01298700|540887800|FG001|Overall Study|Adverse Event|51|||
149932469|NCT01298700|540887799|FG000|Overall Study|Lack of Efficacy|9|||
149932470|NCT01298700|540887800|FG001|Overall Study|Lack of Efficacy|14|||
149932471|NCT01298700|540887799|FG000|Overall Study|Lost to Follow-up|5|||
149932472|NCT01298700|540887800|FG001|Overall Study|Lost to Follow-up|2|||
149932473|NCT01298700|540887799|FG000|Overall Study|Withdrawal by Subject|12|||
149932474|NCT01298700|540887800|FG001|Overall Study|Withdrawal by Subject|9|||
149932475|NCT01298700|540887799|FG000|Overall Study|Protocol Violation|6|||
149932476|NCT01298700|540887800|FG001|Overall Study|Protocol Violation|4|||
149932477|NCT01298700|540887799|FG000|Overall Study|Other Miscellaneous Reasons|16|||
149932478|NCT01298700|540887800|FG001|Overall Study|Other Miscellaneous Reasons|15|||
149932479|NCT01298700|540887799|FG000|Overall Study|Did not Receive Study Drug|3|||
150165923|NCT04057196|541743382|FG000|Overall Study|Withdrawal by Subject|3|||
149932480|NCT01298700|540887800|FG001|Overall Study|Did not Receive Study Drug|5|||
149932481|NCT04006145|540887801|FG000|Overall Study|Lost to Follow-up|0|||
149932482|NCT04006145|540887802|FG001|Overall Study|Lost to Follow-up|1|||
149932483|NCT04006145|540887801|FG000|Overall Study|Other|1|||
149932484|NCT04006145|540887802|FG001|Overall Study|Other|2|||
149932485|NCT00010257|540887805|FG000|Overall Study|Withdrawal by Subject|1|||
149932486|NCT00010257|540887806|FG001|Overall Study|Withdrawal by Subject|0|||
149932487|NCT00643760|540887809|FG000|Overall Study|Adverse Event|11|||
149932488|NCT00643760|540887810|FG001|Overall Study|Adverse Event|5|||
149932489|NCT00643760|540887811|FG002|Overall Study|Adverse Event|12|||
149932490|NCT00643760|540887812|FG003|Overall Study|Adverse Event|21|||
149932491|NCT00643760|540887813|FG004|Overall Study|Adverse Event|6|||
149932492|NCT00643760|540887809|FG000|Overall Study|Lack of Efficacy|3|||
149932493|NCT00643760|540887810|FG001|Overall Study|Lack of Efficacy|1|||
149932494|NCT00643760|540887811|FG002|Overall Study|Lack of Efficacy|0|||
149932495|NCT00643760|540887812|FG003|Overall Study|Lack of Efficacy|4|||
149932496|NCT00643760|540887813|FG004|Overall Study|Lack of Efficacy|3|||
149932497|NCT00643760|540887809|FG000|Overall Study|Protocol Violation|7|||
149932498|NCT00643760|540887810|FG001|Overall Study|Protocol Violation|6|||
149932499|NCT00643760|540887811|FG002|Overall Study|Protocol Violation|4|||
149932500|NCT00643760|540887812|FG003|Overall Study|Protocol Violation|4|||
149932501|NCT00643760|540887813|FG004|Overall Study|Protocol Violation|6|||
149932502|NCT00643760|540887809|FG000|Overall Study|Lost to Follow-up|6|||
149932503|NCT00643760|540887810|FG001|Overall Study|Lost to Follow-up|2|||
149932504|NCT00643760|540887811|FG002|Overall Study|Lost to Follow-up|1|||
149932505|NCT00643760|540887812|FG003|Overall Study|Lost to Follow-up|3|||
149932506|NCT00643760|540887813|FG004|Overall Study|Lost to Follow-up|3|||
149932507|NCT00643760|540887809|FG000|Overall Study|Investigator Discretion|0|||
149932508|NCT00643760|540887810|FG001|Overall Study|Investigator Discretion|0|||
149932509|NCT00643760|540887811|FG002|Overall Study|Investigator Discretion|0|||
149932510|NCT00643760|540887812|FG003|Overall Study|Investigator Discretion|2|||
149932511|NCT00643760|540887813|FG004|Overall Study|Investigator Discretion|0|||
149932512|NCT00643760|540887809|FG000|Overall Study|Withdrawal by Subject|3|||
149932513|NCT00643760|540887810|FG001|Overall Study|Withdrawal by Subject|1|||
149932514|NCT00643760|540887811|FG002|Overall Study|Withdrawal by Subject|2|||
149932515|NCT00643760|540887812|FG003|Overall Study|Withdrawal by Subject|4|||
149932516|NCT00643760|540887813|FG004|Overall Study|Withdrawal by Subject|1|||
149932517|NCT02063672|540887814|FG000|Overall Study|Ongoing Follow-up|27|||
149932518|NCT02063672|540887815|FG001|Overall Study|Ongoing Follow-up|14|||
150165924|NCT04057196|541743382|FG000|Overall Study|Death|3|||
149932519|NCT02063672|540887814|FG000|Overall Study|Death|5|||
149932520|NCT02063672|540887815|FG001|Overall Study|Death|3|||
149932521|NCT02063672|540887814|FG000|Overall Study|Lost to Follow-up|1|||
149932522|NCT02063672|540887815|FG001|Overall Study|Lost to Follow-up|3|||
149932523|NCT02063672|540887814|FG000|Overall Study|Withdrawal by Subject|2|||
149932524|NCT02063672|540887815|FG001|Overall Study|Withdrawal by Subject|2|||
149932525|NCT01307787|540887819|FG000|Overall Study|Withdrawal by Subject|2|||
149932526|NCT01307787|540887820|FG001|Overall Study|Withdrawal by Subject|0|||
149932527|NCT03353792|540887825|FG000|Overall Study|Lost to Follow-up|1|||
149932528|NCT03353792|540887826|FG001|Overall Study|Lost to Follow-up|0|||
149932529|NCT03353792|540887825|FG000|Overall Study|Participant Unable to Manage Device|1|||
149932530|NCT03353792|540887826|FG001|Overall Study|Participant Unable to Manage Device|0|||
149932531|NCT00789321|540887827|FG000|Overall Study|Adverse Event|0|||
149932532|NCT00789321|540887828|FG001|Overall Study|Adverse Event|1|||
149932533|NCT01965327|540887829|FG000|Overall Study|Physician Decision|2|||
149932534|NCT00104052|540887830|FG000|Overall Study|Adverse Event|1|||
149932535|NCT00104052|540887830|FG000|Overall Study|Lack of Efficacy|26|||
149932536|NCT00104052|540887830|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
149932537|NCT02498678|540887833|FG000|Overall Study|interference from the surgical team|0|||
149932538|NCT02498678|540887834|FG001|Overall Study|interference from the surgical team|2|||
149932539|NCT01294423|540887835|FG000|Overall Study|Adverse Event|1|||
149932540|NCT01294423|540887836|FG001|Overall Study|Adverse Event|2|||
149932541|NCT01294423|540887837|FG002|Overall Study|Adverse Event|3|||
149932542|NCT01294423|540887835|FG000|Overall Study|Withdrawal by Subject|1|||
149932543|NCT01294423|540887836|FG001|Overall Study|Withdrawal by Subject|2|||
149932544|NCT01294423|540887837|FG002|Overall Study|Withdrawal by Subject|2|||
149932545|NCT01294423|540887835|FG000|Overall Study|subject no longer meets study criteria|2|||
149932546|NCT01294423|540887836|FG001|Overall Study|subject no longer meets study criteria|5|||
149932547|NCT01294423|540887837|FG002|Overall Study|subject no longer meets study criteria|2|||
149932548|NCT01294423|540887835|FG000|Overall Study|poor/non-compliance|1|||
149932549|NCT01294423|540887836|FG001|Overall Study|poor/non-compliance|0|||
149932550|NCT01294423|540887837|FG002|Overall Study|poor/non-compliance|1|||
149932551|NCT01145482|540887838|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
149932552|NCT01145482|540887839|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
149932553|NCT01405560|540887842|FG000|Overall Study|Physician Decision|1|||
150165925|NCT01118377|541743383|FG000|Overall Study|Did Not Receive Study Medication|1|||
150165926|NCT01118377|541743383|FG000|Overall Study|Death|38|||
150165927|NCT01118377|541743383|FG000|Overall Study|Failure to Return|3|||
150165928|NCT00739102|541743388|FG000|Overall Study|Death|5|||
150165929|NCT00739102|541743388|FG000|Overall Study|Withdrawal by Subject|10|||
150165930|NCT01062126|541743389|FG000|Overall Study|Death|209|||
150165931|NCT01062126|541743389|FG000|Overall Study|All Withdrawals|324|||
150165932|NCT00646451|541743390|FG000|Overall Study|Adverse Event|3|||
149932554|NCT01699750|540887845|FG000|Overall Study|Withdrew Consent|0|||
149932555|NCT01699750|540887846|FG001|Overall Study|Withdrew Consent|1|||
149932556|NCT01699750|540887845|FG000|Overall Study|Other|0|||
149932557|NCT01699750|540887846|FG001|Overall Study|Other|2|||
149932558|NCT01484951|540887848|FG000|Overall Study|Adverse Event|3|||
149932559|NCT01484951|540887848|FG000|Overall Study|Personal Reasons|1|||
149932560|NCT01484951|540887848|FG000|Overall Study|Non-Compliance|1|||
150266290|NCT00300781|542112514|FG001|Overall Study|Withdrawal by Subject|2|||
149932561|NCT02452047|540887849|FG000|Overall Study|Adverse Event|0|||
149932562|NCT02452047|540887850|FG001|Overall Study|Adverse Event|1|||
150165933|NCT00646451|541743391|FG001|Overall Study|Adverse Event|0|||
150165934|NCT00646451|541743390|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
149932563|NCT02452047|540887851|FG002|Overall Study|Adverse Event|1|||
149932564|NCT02452047|540887849|FG000|Overall Study|Death|1|||
149932565|NCT02452047|540887850|FG001|Overall Study|Death|3|||
149932566|NCT02452047|540887851|FG002|Overall Study|Death|1|||
149932567|NCT02452047|540887849|FG000|Overall Study|Physician Decision|1|||
149932568|NCT02452047|540887850|FG001|Overall Study|Physician Decision|0|||
149932569|NCT02452047|540887851|FG002|Overall Study|Physician Decision|0|||
149932570|NCT02452047|540887849|FG000|Overall Study|Lost to Follow-up|1|||
149932571|NCT02452047|540887850|FG001|Overall Study|Lost to Follow-up|1|||
150266291|NCT00300781|542112513|FG000|Overall Study|Physician Decision|1|||
150266292|NCT00300781|542112514|FG001|Overall Study|Physician Decision|0|||
149932572|NCT02452047|540887851|FG002|Overall Study|Lost to Follow-up|0|||
149932573|NCT02452047|540887849|FG000|Overall Study|Withdrawal by Subject|1|||
149932574|NCT02452047|540887850|FG001|Overall Study|Withdrawal by Subject|0|||
149932575|NCT02452047|540887851|FG002|Overall Study|Withdrawal by Subject|0|||
149932576|NCT01868646|540887852|FG000|Overall Study|Do not meet inclusion criteria|3|||
149932577|NCT01868646|540887853|FG001|Overall Study|Do not meet inclusion criteria|5|||
149932578|NCT01831427|540887854|FG000|Overall Study|Adverse Event|0|||
149932579|NCT01831427|540887855|FG001|Overall Study|Adverse Event|1|||
149932580|NCT01831427|540887856|FG002|Overall Study|Adverse Event|0|||
149932581|NCT01831427|540887857|FG003|Overall Study|Adverse Event|0|||
149932582|NCT01831427|540887858|FG004|Overall Study|Adverse Event|0|||
149932583|NCT01831427|540887859|FG005|Overall Study|Adverse Event|1|||
150266293|NCT00300781|542112513|FG000|Overall Study|Not Recorded|0|||
150266294|NCT00300781|542112514|FG001|Overall Study|Not Recorded|1|||
150266295|NCT00300781|542112513|FG000|Overall Study|Symptomatic Deterioration|1|||
150266296|NCT00300781|542112514|FG001|Overall Study|Symptomatic Deterioration|0|||
150266297|NCT00300781|542112513|FG000|Overall Study|Lost to Follow-up|0|||
150266298|NCT00300781|542112514|FG001|Overall Study|Lost to Follow-up|1|||
150266299|NCT01717989|542112517|FG000|Overall Study|Ineligibility determined|6|||
150266300|NCT01717989|542112517|FG000|Overall Study|Protocol deviation|6|||
150266301|NCT01717989|542112517|FG000|Overall Study|Withdrawal by Subject|11|||
150266302|NCT01717989|542112517|FG000|Overall Study|Physician Decision|2|||
150266303|NCT01717989|542112517|FG000|Overall Study|Lost to Follow-up|11|||
150266304|NCT01717989|542112517|FG000|Overall Study|Death|439|||
150266305|NCT01717989|542112517|FG000|Overall Study|Protocol-specified criteria|551|||
150266306|NCT01717989|542112517|FG000|Overall Study|Other|40|||
150266307|NCT03224325|542112518|FG000|Overall Study|Adverse Event|1|||
150266308|NCT03224325|542112519|FG001|Overall Study|Adverse Event|0|||
150266309|NCT03224325|542112520|FG002|Overall Study|Adverse Event|0|||
150266310|NCT03224325|542112521|FG003|Overall Study|Adverse Event|0|||
150266311|NCT03224325|542112522|FG004|Overall Study|Adverse Event|0|||
149932584|NCT01831427|540887860|FG006|Overall Study|Adverse Event|0|||
149932585|NCT01831427|540887861|FG007|Overall Study|Adverse Event|1|||
149932586|NCT01831427|540887862|FG008|Overall Study|Adverse Event|0|||
149932587|NCT01831427|540887863|FG009|Overall Study|Adverse Event|0|||
149932588|NCT01831427|540887864|FG010|Overall Study|Adverse Event|2|||
149932589|NCT01831427|540887854|FG000|Overall Study|Investigator's Discretion|0|||
149932590|NCT01831427|540887855|FG001|Overall Study|Investigator's Discretion|0|||
149932591|NCT01831427|540887856|FG002|Overall Study|Investigator's Discretion|0|||
149932592|NCT01831427|540887857|FG003|Overall Study|Investigator's Discretion|1|||
149932593|NCT01831427|540887858|FG004|Overall Study|Investigator's Discretion|0|||
149932594|NCT01831427|540887859|FG005|Overall Study|Investigator's Discretion|0|||
149932595|NCT01831427|540887860|FG006|Overall Study|Investigator's Discretion|0|||
149932596|NCT01831427|540887861|FG007|Overall Study|Investigator's Discretion|0|||
149932597|NCT01831427|540887862|FG008|Overall Study|Investigator's Discretion|0|||
149932598|NCT01831427|540887863|FG009|Overall Study|Investigator's Discretion|0|||
149932599|NCT01831427|540887864|FG010|Overall Study|Investigator's Discretion|0|||
149932600|NCT01831427|540887854|FG000|Overall Study|Withdrew Consent|0|||
149932601|NCT01831427|540887855|FG001|Overall Study|Withdrew Consent|0|||
149932602|NCT01831427|540887856|FG002|Overall Study|Withdrew Consent|0|||
149932603|NCT01831427|540887857|FG003|Overall Study|Withdrew Consent|0|||
149932604|NCT01831427|540887858|FG004|Overall Study|Withdrew Consent|0|||
149932605|NCT01831427|540887859|FG005|Overall Study|Withdrew Consent|0|||
149932606|NCT01831427|540887860|FG006|Overall Study|Withdrew Consent|2|||
149932607|NCT01831427|540887861|FG007|Overall Study|Withdrew Consent|0|||
150266312|NCT03224325|542112523|FG005|Overall Study|Adverse Event|0|||
149932608|NCT01831427|540887862|FG008|Overall Study|Withdrew Consent|0|||
150266313|NCT03224325|542112524|FG006|Overall Study|Adverse Event|1|||
150266314|NCT03224325|542112518|FG000|Overall Study|Withdrawal by Subject|0|||
150266315|NCT03224325|542112519|FG001|Overall Study|Withdrawal by Subject|0|||
150266316|NCT03224325|542112520|FG002|Overall Study|Withdrawal by Subject|0|||
150266317|NCT03224325|542112521|FG003|Overall Study|Withdrawal by Subject|1|||
150266318|NCT03224325|542112522|FG004|Overall Study|Withdrawal by Subject|0|||
150266319|NCT03224325|542112523|FG005|Overall Study|Withdrawal by Subject|0|||
149932609|NCT01831427|540887863|FG009|Overall Study|Withdrew Consent|1|||
149932610|NCT01831427|540887864|FG010|Overall Study|Withdrew Consent|1|||
149932611|NCT02169505|540887865|FG000|Overall Study|Withdrawal by Subject|1|||
149932612|NCT02035553|540887866|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
149932613|NCT02035553|540887867|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
149932614|NCT02035553|540887866|FG000|Overall Study|Adverse Event|10|||
149932615|NCT02035553|540887867|FG001|Overall Study|Adverse Event|6|||
149932616|NCT02035553|540887866|FG000|Overall Study|Physician Decision|3|||
149932617|NCT02035553|540887867|FG001|Overall Study|Physician Decision|2|||
149932618|NCT02035553|540887866|FG000|Overall Study|Lack of Efficacy|1|||
149932619|NCT02035553|540887867|FG001|Overall Study|Lack of Efficacy|1|||
149932620|NCT02035553|540887866|FG000|Overall Study|Withdrawal by Subject|4|||
149932621|NCT02035553|540887867|FG001|Overall Study|Withdrawal by Subject|7|||
149932622|NCT02035553|540887866|FG000|Overall Study|Non-compliance with Study Drug|0|||
149932623|NCT02035553|540887867|FG001|Overall Study|Non-compliance with Study Drug|1|||
149932624|NCT02035553|540887866|FG000|Overall Study|Lost to Follow-up|0|||
149932625|NCT02035553|540887867|FG001|Overall Study|Lost to Follow-up|1|||
149932626|NCT02035553|540887866|FG000|Overall Study|Other Reason|0|||
149932627|NCT02035553|540887867|FG001|Overall Study|Other Reason|4|||
149932628|NCT02735980|540887868|FG000|Overall Study|Adverse Event|0|||
149932629|NCT02735980|540887869|FG001|Overall Study|Adverse Event|4|||
149932630|NCT02735980|540887870|FG002|Overall Study|Adverse Event|1|||
149932631|NCT02735980|540887868|FG000|Overall Study|Death|5|||
149932632|NCT02735980|540887869|FG001|Overall Study|Death|4|||
149932633|NCT02735980|540887870|FG002|Overall Study|Death|0|||
149932634|NCT02735980|540887868|FG000|Overall Study|Physician Decision|3|||
149932635|NCT02735980|540887869|FG001|Overall Study|Physician Decision|1|||
149932636|NCT02735980|540887870|FG002|Overall Study|Physician Decision|0|||
149932637|NCT02735980|540887868|FG000|Overall Study|Screen failure|1|||
149932638|NCT02735980|540887869|FG001|Overall Study|Screen failure|0|||
149932639|NCT02735980|540887870|FG002|Overall Study|Screen failure|0|||
149932640|NCT02735980|540887868|FG000|Overall Study|Withdrawal by Subject|1|||
149932641|NCT02735980|540887869|FG001|Overall Study|Withdrawal by Subject|2|||
149932642|NCT02735980|540887870|FG002|Overall Study|Withdrawal by Subject|0|||
149932643|NCT01854697|540887871|FG000|Overall Study|Adverse Event|1|||
149932644|NCT01854697|540887872|FG001|Overall Study|Adverse Event|0|||
149932645|NCT01854697|540887873|FG002|Overall Study|Adverse Event|0|||
150165935|NCT00646451|541743391|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
150165936|NCT03784963|541743392|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
150165937|NCT03784963|541743393|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
150165938|NCT03784963|541743394|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
150165939|NCT03784963|541743395|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
150165940|NCT00349908|541743396|FG000|Overall Study|Withdrawal by Subject|0|||
150165941|NCT00349908|541743397|FG001|Overall Study|Withdrawal by Subject|4|||
150165942|NCT00109967|541743398|FG000|Overall Study|Cancel Prior to Treatment|2|||
150165943|NCT00109967|541743399|FG001|Overall Study|Cancel Prior to Treatment|0|||
150165944|NCT00109967|541743398|FG000|Overall Study|Adverse Event|12|||
150165945|NCT00109967|541743399|FG001|Overall Study|Adverse Event|1|||
150165946|NCT00109967|541743398|FG000|Overall Study|Withdrawal by Subject|5|||
150165947|NCT00109967|541743399|FG001|Overall Study|Withdrawal by Subject|0|||
150165948|NCT00109967|541743398|FG000|Overall Study|Physician Decision|1|||
150165949|NCT00109967|541743399|FG001|Overall Study|Physician Decision|3|||
150165950|NCT00109967|541743398|FG000|Overall Study|Death|0|||
150165951|NCT00109967|541743399|FG001|Overall Study|Death|2|||
150165952|NCT01117480|541743412|FG000|Overall Study|Protocol Violation|8|||
150165953|NCT01117480|541743412|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
150165954|NCT02955069|541743413|FG000|Overall Study|Adverse Event|7|||
150165955|NCT02955069|541743414|FG001|Overall Study|Adverse Event|2|||
150165956|NCT02955069|541743413|FG000|Overall Study|Death|7|||
150165957|NCT02955069|541743414|FG001|Overall Study|Death|3|||
150165958|NCT02955069|541743413|FG000|Overall Study|Physician Decision|10|||
150165959|NCT02955069|541743414|FG001|Overall Study|Physician Decision|2|||
150165960|NCT02955069|541743413|FG000|Overall Study|Progressive disease|64|||
150165961|NCT02955069|541743414|FG001|Overall Study|Progressive disease|13|||
150165962|NCT02955069|541743413|FG000|Overall Study|Study terminated by sponsor|4|||
150165963|NCT02955069|541743414|FG001|Overall Study|Study terminated by sponsor|0|||
150266320|NCT03224325|542112524|FG006|Overall Study|Withdrawal by Subject|0|||
149932646|NCT01854697|540887874|FG003|Overall Study|Adverse Event|0|||
149932647|NCT01854697|540887875|FG004|Overall Study|Adverse Event|1|||
149932648|NCT01854697|540887871|FG000|Overall Study|Lost to Follow-up|4|||
149932649|NCT01854697|540887872|FG001|Overall Study|Lost to Follow-up|1|||
149932650|NCT01854697|540887873|FG002|Overall Study|Lost to Follow-up|1|||
149932651|NCT01854697|540887874|FG003|Overall Study|Lost to Follow-up|2|||
149932652|NCT01854697|540887875|FG004|Overall Study|Lost to Follow-up|0|||
149932653|NCT01854697|540887871|FG000|Overall Study|To enter another AbbVie study|1|||
149932654|NCT01854697|540887872|FG001|Overall Study|To enter another AbbVie study|0|||
150165964|NCT02955069|541743413|FG000|Overall Study|Subject/Guardian decision|3|||
150165965|NCT02955069|541743414|FG001|Overall Study|Subject/Guardian decision|1|||
150165966|NCT03721016|541743415|FG000|Overall Study|Adverse Event|0|||
150165967|NCT03721016|541743416|FG001|Overall Study|Adverse Event|1|||
149932655|NCT01854697|540887873|FG002|Overall Study|To enter another AbbVie study|0|||
149932656|NCT01854697|540887874|FG003|Overall Study|To enter another AbbVie study|0|||
149932657|NCT01854697|540887875|FG004|Overall Study|To enter another AbbVie study|1|||
149932658|NCT01854697|540887871|FG000|Overall Study|Withdrew Consent|0|||
149932659|NCT01854697|540887872|FG001|Overall Study|Withdrew Consent|1|||
149932660|NCT01854697|540887873|FG002|Overall Study|Withdrew Consent|0|||
149932661|NCT01854697|540887874|FG003|Overall Study|Withdrew Consent|1|||
149932662|NCT01854697|540887875|FG004|Overall Study|Withdrew Consent|0|||
149932663|NCT01854697|540887871|FG000|Overall Study|Other|0|||
149932664|NCT01854697|540887872|FG001|Overall Study|Other|1|||
149932665|NCT01854697|540887873|FG002|Overall Study|Other|1|||
149932666|NCT01854697|540887874|FG003|Overall Study|Other|0|||
149932667|NCT01854697|540887875|FG004|Overall Study|Other|0|||
149932668|NCT00917124|540887879|FG000|Overall Study|Protocol Violation|4|||
149932669|NCT00917124|540887880|FG001|Overall Study|Protocol Violation|6|||
149932670|NCT02048722|540887886|FG000|2 Cycles of Treatment|Adverse Event|2|||
149932671|NCT02048722|540887886|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
149932672|NCT02048722|540887886|FG000|2 Cycles of Treatment|Progressive Disease|2|||
149932673|NCT02048722|540887886|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
149932674|NCT02048722|540887886|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
149932675|NCT02048722|540887886|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
149932676|NCT01529606|540887888|FG000|Overall Study|Lost to Follow-up|21|||
149932677|NCT01529606|540887889|FG001|Overall Study|Lost to Follow-up|18|||
149932678|NCT05635045|540887892|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
149932679|NCT05635045|540887893|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
149932680|NCT05635045|540887894|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
149932681|NCT05635045|540887895|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
149932682|NCT01022203|540889552|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
149932683|NCT01022203|540889553|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
149932684|NCT01022203|540889552|FG000|Post Treatment Assessment|Physician Decision|2|||
149932685|NCT01022203|540889553|FG001|Post Treatment Assessment|Physician Decision|0|||
149932686|NCT01022203|540889552|FG000|Post Treatment Assessment|Adverse Event|0|||
149932687|NCT01022203|540889553|FG001|Post Treatment Assessment|Adverse Event|2|||
149932688|NCT01022203|540889552|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
149932689|NCT01022203|540889553|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
149932690|NCT03638128|540889556|FG000|Overall Study|Withdrawal by Subject|1|||
149932691|NCT03638128|540889557|FG001|Overall Study|Withdrawal by Subject|7|||
149932692|NCT03638128|540889558|FG002|Overall Study|Withdrawal by Subject|6|||
149932693|NCT03638128|540889556|FG000|Overall Study|Sponsor Decision|15|||
149932694|NCT03638128|540889557|FG001|Overall Study|Sponsor Decision|12|||
149932695|NCT03638128|540889558|FG002|Overall Study|Sponsor Decision|19|||
149932696|NCT03638128|540889556|FG000|Overall Study|Lost to Follow-up|0|||
150165968|NCT03721016|541743417|FG002|Overall Study|Adverse Event|1|||
150165969|NCT03721016|541743415|FG000|Overall Study|Withdrawal by Subject|8|||
150165970|NCT03721016|541743416|FG001|Overall Study|Withdrawal by Subject|16|||
150165971|NCT03721016|541743417|FG002|Overall Study|Withdrawal by Subject|13|||
149820085|NCT01335477|540471674|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
149820086|NCT01335477|540471675|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
149820087|NCT01335477|540471674|FG000|Overall Study|Not treated|1|||
149820088|NCT01335477|540471675|FG001|Overall Study|Not treated|2|||
149820089|NCT01335477|540471674|FG000|Overall Study|Reason other than those stated above|2|||
149820090|NCT01335477|540471675|FG001|Overall Study|Reason other than those stated above|2|||
149820091|NCT00549198|540471676|FG000|Overall Study|Adverse Event|28|||
149820092|NCT00549198|540471677|FG001|Overall Study|Adverse Event|26|||
149820093|NCT00549198|540471676|FG000|Overall Study|Insufficient Viral Load Response|4|||
149820094|NCT00549198|540471677|FG001|Overall Study|Insufficient Viral Load Response|2|||
149820095|NCT00549198|540471676|FG000|Overall Study|Protocol-defined Virological Failure|7|||
149820096|NCT00549198|540471677|FG001|Overall Study|Protocol-defined Virological Failure|0|||
149820097|NCT00549198|540471676|FG000|Overall Study|Non-compliance|2|||
149820098|NCT00549198|540471677|FG001|Overall Study|Non-compliance|4|||
149820099|NCT00549198|540471676|FG000|Overall Study|Lost to Follow-up|7|||
149820100|NCT00549198|540471677|FG001|Overall Study|Lost to Follow-up|8|||
149820101|NCT00549198|540471676|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
149820102|NCT00549198|540471677|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
149820103|NCT00549198|540471676|FG000|Overall Study|Protocol Violation|7|||
149820104|NCT00549198|540471677|FG001|Overall Study|Protocol Violation|2|||
149820105|NCT00549198|540471676|FG000|Overall Study|Investigator Decision|4|||
149820106|NCT00549198|540471677|FG001|Overall Study|Investigator Decision|3|||
149932697|NCT03638128|540889557|FG001|Overall Study|Lost to Follow-up|0|||
149932698|NCT03638128|540889558|FG002|Overall Study|Lost to Follow-up|1|||
149932699|NCT03163446|540889559|FG000|Overall Study|Unable to return for Day 180 visit|2|||
149932700|NCT03163446|540889560|FG001|Overall Study|Unable to return for Day 180 visit|0|||
149932701|NCT03163446|540889559|FG000|Overall Study|Withdrawal by Subject|2|||
150165972|NCT03721016|541743415|FG000|Overall Study|Lost to Follow-up|4|||
149932702|NCT03163446|540889560|FG001|Overall Study|Withdrawal by Subject|6|||
149932703|NCT03163446|540889559|FG000|Overall Study|Death|16|||
149932704|NCT03163446|540889560|FG001|Overall Study|Death|5|||
149932705|NCT03163446|540889559|FG000|Overall Study|Lost to Follow-up|6|||
149932706|NCT03163446|540889560|FG001|Overall Study|Lost to Follow-up|5|||
149932707|NCT03163446|540889559|FG000|Overall Study|Physician Decision|1|||
149932708|NCT03163446|540889560|FG001|Overall Study|Physician Decision|1|||
150165973|NCT03721016|541743416|FG001|Overall Study|Lost to Follow-up|6|||
150165974|NCT03721016|541743417|FG002|Overall Study|Lost to Follow-up|5|||
150165975|NCT03721016|541743415|FG000|Overall Study|Physician Decision|0|||
150165976|NCT03721016|541743416|FG001|Overall Study|Physician Decision|1|||
150165977|NCT03721016|541743417|FG002|Overall Study|Physician Decision|2|||
150165978|NCT03721016|541743415|FG000|Overall Study|Protocol Violation|0|||
150165979|NCT03721016|541743416|FG001|Overall Study|Protocol Violation|1|||
150165980|NCT03721016|541743417|FG002|Overall Study|Protocol Violation|0|||
150165981|NCT03721016|541743415|FG000|Overall Study|Site terminated by sponsor|3|||
150165982|NCT03721016|541743416|FG001|Overall Study|Site terminated by sponsor|7|||
150165983|NCT03721016|541743417|FG002|Overall Study|Site terminated by sponsor|6|||
150165984|NCT03721016|541743415|FG000|Overall Study|Subject exited early due to COVID-19|1|||
150165985|NCT03721016|541743416|FG001|Overall Study|Subject exited early due to COVID-19|0|||
150165986|NCT03721016|541743417|FG002|Overall Study|Subject exited early due to COVID-19|0|||
150165987|NCT04148937|541743419|FG000|Overall Study|Withdrawal by Subject|0|||
150165988|NCT04148937|541743420|FG001|Overall Study|Withdrawal by Subject|0|||
150165989|NCT04148937|541743421|FG002|Overall Study|Withdrawal by Subject|0|||
150165990|NCT04148937|541743422|FG003|Overall Study|Withdrawal by Subject|1|||
150165991|NCT04148937|541743423|FG004|Overall Study|Withdrawal by Subject|0|||
150165992|NCT04148937|541743424|FG005|Overall Study|Withdrawal by Subject|1|||
150165993|NCT04148937|541743425|FG006|Overall Study|Withdrawal by Subject|1|||
150165994|NCT04148937|541743426|FG007|Overall Study|Withdrawal by Subject|0|||
150165995|NCT04148937|541743419|FG000|Overall Study|Lost to Follow-up|0|||
150165996|NCT04148937|541743420|FG001|Overall Study|Lost to Follow-up|0|||
150165997|NCT04148937|541743421|FG002|Overall Study|Lost to Follow-up|1|||
150165998|NCT04148937|541743422|FG003|Overall Study|Lost to Follow-up|0|||
150165999|NCT04148937|541743423|FG004|Overall Study|Lost to Follow-up|0|||
150166000|NCT04148937|541743424|FG005|Overall Study|Lost to Follow-up|2|||
150166001|NCT04148937|541743425|FG006|Overall Study|Lost to Follow-up|0|||
150166002|NCT04148937|541743426|FG007|Overall Study|Lost to Follow-up|0|||
150166003|NCT01149681|541743429|FG000|Overall Study|Withdrawal by Subject|7|||
150166004|NCT01149681|541743429|FG000|Overall Study|Progressive disease|1|||
150166005|NCT01149681|541743429|FG000|Overall Study|Physician Decision|2|||
150166006|NCT01149681|541743429|FG000|Overall Study|adverse events nonrelated study drug|2|||
150166007|NCT02232178|541743430|FG000|Overall Study|Lost to Follow-up|0|||
150166008|NCT02232178|541743431|FG001|Overall Study|Lost to Follow-up|1|||
150166009|NCT02232178|541743432|FG002|Overall Study|Lost to Follow-up|0|||
150166010|NCT02232178|541743430|FG000|Overall Study|ineligibility|0|||
150166011|NCT02232178|541743431|FG001|Overall Study|ineligibility|0|||
150166012|NCT02232178|541743432|FG002|Overall Study|ineligibility|1|||
150166013|NCT02232178|541743430|FG000|Overall Study|surgical complication|1|||
150166014|NCT02232178|541743431|FG001|Overall Study|surgical complication|0|||
150166015|NCT02232178|541743432|FG002|Overall Study|surgical complication|0|||
150166016|NCT00817635|541743433|FG000|Overall Study|Adverse Event|1|||
150166017|NCT00817635|541743434|FG001|Overall Study|Adverse Event|0|||
150166018|NCT00817635|541743435|FG002|Overall Study|Adverse Event|0|||
150166019|NCT00817635|541743436|FG003|Overall Study|Adverse Event|1|||
150166020|NCT00817635|541743437|FG004|Overall Study|Adverse Event|1|||
150166021|NCT00817635|541743433|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
150166022|NCT00817635|541743434|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
150166023|NCT00817635|541743435|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
150166024|NCT00817635|541743436|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
150166025|NCT00817635|541743437|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
150166026|NCT00817635|541743433|FG000|Overall Study|Withdrawal by Subject|2|||
150166027|NCT00817635|541743434|FG001|Overall Study|Withdrawal by Subject|1|||
150166028|NCT00817635|541743435|FG002|Overall Study|Withdrawal by Subject|0|||
150166029|NCT00817635|541743436|FG003|Overall Study|Withdrawal by Subject|1|||
150166030|NCT00817635|541743437|FG004|Overall Study|Withdrawal by Subject|2|||
150166031|NCT00817635|541743433|FG000|Overall Study|Lost to Follow-up|0|||
150166032|NCT00817635|541743434|FG001|Overall Study|Lost to Follow-up|1|||
150166033|NCT00817635|541743435|FG002|Overall Study|Lost to Follow-up|0|||
150166034|NCT00817635|541743436|FG003|Overall Study|Lost to Follow-up|1|||
149932709|NCT03163446|540889559|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
150166035|NCT00817635|541743437|FG004|Overall Study|Lost to Follow-up|0|||
150166036|NCT00817635|541743433|FG000|Overall Study|Administrative Problems|0|||
150166037|NCT00817635|541743434|FG001|Overall Study|Administrative Problems|0|||
150166038|NCT00817635|541743435|FG002|Overall Study|Administrative Problems|0|||
150166039|NCT00817635|541743436|FG003|Overall Study|Administrative Problems|0|||
150166040|NCT00817635|541743437|FG004|Overall Study|Administrative Problems|1|||
150166041|NCT00817635|541743433|FG000|Overall Study|Protocol Violation|5|||
150266321|NCT02525861|542112525|FG000|Overall Study|Adverse Event|1|||
150266322|NCT02525861|542112526|FG001|Overall Study|Adverse Event|0|||
150266323|NCT02525861|542112525|FG000|Overall Study|Withdrawal by Subject|0|||
150266324|NCT02525861|542112526|FG001|Overall Study|Withdrawal by Subject|1|||
150266325|NCT02525861|542112525|FG000|Overall Study|Physician Decision|0|||
150266326|NCT02525861|542112526|FG001|Overall Study|Physician Decision|1|||
150266327|NCT02544217|542112527|FG000|Overall Study|Withdrawal by Subject|1|||
150266328|NCT02544217|542112528|FG001|Overall Study|Withdrawal by Subject|1|||
150266329|NCT02544217|542112529|FG002|Overall Study|Withdrawal by Subject|0|||
150266330|NCT02544217|542112530|FG003|Overall Study|Withdrawal by Subject|0|||
150266331|NCT02544217|542112531|FG004|Overall Study|Withdrawal by Subject|0|||
150266332|NCT02544217|542112532|FG005|Overall Study|Withdrawal by Subject|0|||
150266333|NCT00667355|542112534|FG000|Overall Study|Adverse Event|5|||
150266334|NCT00667355|542112534|FG000|Overall Study|Lost to Follow-up|1|||
150266335|NCT00667355|542112534|FG000|Overall Study|Other reason was not specified|5|||
150266336|NCT03278106|542112535|FG000|Overall Study|No protocol treatment|1|||
150266337|NCT02175004|542112536|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
150266338|NCT02175004|542112537|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
150266339|NCT02175004|542112536|FG000|Overall Study|Investigator Judgment|1|||
150266340|NCT02175004|542112537|FG001|Overall Study|Investigator Judgment|4|||
150266341|NCT02175004|542112536|FG000|Overall Study|Voluntary Withdrawal|6|||
149932710|NCT03163446|540889560|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
149932711|NCT00611806|540889561|FG000|Overall Study|Withdrawal by Subject|8|||
149932712|NCT00611806|540889562|FG001|Overall Study|Withdrawal by Subject|2|||
149932713|NCT00611806|540889561|FG000|Overall Study|Adverse Event|2|||
149932714|NCT00611806|540889562|FG001|Overall Study|Adverse Event|1|||
149932715|NCT00611806|540889561|FG000|Overall Study|Lost to Follow-up|6|||
149932716|NCT00611806|540889562|FG001|Overall Study|Lost to Follow-up|0|||
149932717|NCT00329108|540889564|FG000|Overall Study|Adverse Event|2|||
149932718|NCT00329108|540889565|FG001|Overall Study|Adverse Event|2|||
149932719|NCT00329108|540889564|FG000|Overall Study|Lack of Efficacy|3|||
149932720|NCT00329108|540889565|FG001|Overall Study|Lack of Efficacy|3|||
149932721|NCT00329108|540889564|FG000|Overall Study|Withdrawal by Subject|0|||
149932722|NCT00329108|540889565|FG001|Overall Study|Withdrawal by Subject|2|||
149932723|NCT00329108|540889564|FG000|Overall Study|symptomatic deterioration|1|||
149932724|NCT00329108|540889565|FG001|Overall Study|symptomatic deterioration|1|||
149932725|NCT00329108|540889564|FG000|Overall Study|Subject no longer willing to participate|2|||
149932726|NCT00329108|540889565|FG001|Overall Study|Subject no longer willing to participate|2|||
149932727|NCT00329108|540889564|FG000|Overall Study|study terminated by sponsor|1|||
149932728|NCT00329108|540889565|FG001|Overall Study|study terminated by sponsor|0|||
149932729|NCT00329108|540889564|FG000|Overall Study|withdrew patient after SAE resolved|1|||
149932730|NCT00329108|540889565|FG001|Overall Study|withdrew patient after SAE resolved|0|||
149932731|NCT00329108|540889564|FG000|Overall Study|Protocol Violation|0|||
149932732|NCT00329108|540889565|FG001|Overall Study|Protocol Violation|2|||
149932733|NCT02371616|540889566|FG000|Overall Study|Protocol Violation|2|||
149932734|NCT02371616|540889567|FG001|Overall Study|Protocol Violation|1|||
149932735|NCT02371616|540889566|FG000|Overall Study|Adverse Event|0|||
149932736|NCT02371616|540889567|FG001|Overall Study|Adverse Event|1|||
149932737|NCT02371616|540889566|FG000|Overall Study|Withdrawal of Consent|1|||
149932738|NCT02371616|540889567|FG001|Overall Study|Withdrawal of Consent|0|||
149932739|NCT02371616|540889566|FG000|Overall Study|Other (Not specified)|1|||
149932740|NCT02371616|540889567|FG001|Overall Study|Other (Not specified)|5|||
149932741|NCT04069715|540889572|FG000|Overall Study|Lost to Follow-up|1|||
149932742|NCT04069715|540889573|FG001|Overall Study|Lost to Follow-up|1|||
149932743|NCT04069715|540889572|FG000|Overall Study|Physician Decision|1|||
149932744|NCT04069715|540889573|FG001|Overall Study|Physician Decision|1|||
149932745|NCT04069715|540889572|FG000|Overall Study|Withdrawal by Subject|3|||
149932746|NCT04069715|540889573|FG001|Overall Study|Withdrawal by Subject|3|||
149932747|NCT03205150|540889574|FG000|Overall Study|Protocol deviation|1|||
149932748|NCT03205150|540889575|FG001|Overall Study|Protocol deviation|3|||
149932749|NCT03205150|540889576|FG002|Overall Study|Protocol deviation|0|||
149932750|NCT03205150|540889574|FG000|Overall Study|Patient/guardian decision|0|||
149932751|NCT03205150|540889575|FG001|Overall Study|Patient/guardian decision|3|||
149932752|NCT03205150|540889576|FG002|Overall Study|Patient/guardian decision|0|||
149932753|NCT03205150|540889574|FG000|Overall Study|Adverse Event|1|||
149932754|NCT03205150|540889575|FG001|Overall Study|Adverse Event|1|||
149932755|NCT03205150|540889576|FG002|Overall Study|Adverse Event|1|||
149932756|NCT03205150|540889574|FG000|Overall Study|Lost to Follow-up|0|||
150266342|NCT02175004|542112537|FG001|Overall Study|Voluntary Withdrawal|19|||
150266343|NCT02175004|542112536|FG000|Overall Study|Liver Transplant|1|||
149932757|NCT03205150|540889575|FG001|Overall Study|Lost to Follow-up|0|||
149932758|NCT03205150|540889576|FG002|Overall Study|Lost to Follow-up|1|||
149932759|NCT03652818|540889578|FG000|Overall Study|Adverse Event|1|||
149932760|NCT03652818|540889579|FG001|Overall Study|Adverse Event|0|||
149932761|NCT03652818|540889580|FG002|Overall Study|Adverse Event|0|||
150266344|NCT02175004|542112537|FG001|Overall Study|Liver Transplant|0|||
150266345|NCT02175004|542112536|FG000|Overall Study|Disease Progression|1|||
150266346|NCT02175004|542112537|FG001|Overall Study|Disease Progression|0|||
150266347|NCT02175004|542112536|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
149932762|NCT03652818|540889581|FG003|Overall Study|Adverse Event|0|||
149932763|NCT03652818|540889582|FG004|Overall Study|Adverse Event|0|||
149932764|NCT03652818|540889578|FG000|Overall Study|Physician Decision|1|||
149932765|NCT03652818|540889579|FG001|Overall Study|Physician Decision|0|||
149932766|NCT03652818|540889580|FG002|Overall Study|Physician Decision|0|||
149932767|NCT03652818|540889581|FG003|Overall Study|Physician Decision|0|||
149932768|NCT03652818|540889582|FG004|Overall Study|Physician Decision|0|||
149932769|NCT03652818|540889578|FG000|Overall Study|Lost to Follow-up|0|||
149932770|NCT03652818|540889579|FG001|Overall Study|Lost to Follow-up|1|||
149932771|NCT03652818|540889580|FG002|Overall Study|Lost to Follow-up|2|||
149932772|NCT03652818|540889581|FG003|Overall Study|Lost to Follow-up|1|||
149932773|NCT03652818|540889582|FG004|Overall Study|Lost to Follow-up|1|||
149932774|NCT03964207|540889583|FG000|First Treatment|Withdrawal by Subject|1|||
149932775|NCT03964207|540889584|FG001|First Treatment|Withdrawal by Subject|2|||
149932776|NCT03964207|540889583|FG000|First Treatment|Protocol Violation|1|||
149932777|NCT03964207|540889584|FG001|First Treatment|Protocol Violation|0|||
149932778|NCT03964207|540889583|FG000|First Treatment|Lost to Follow-up|1|||
149932779|NCT03964207|540889584|FG001|First Treatment|Lost to Follow-up|0|||
149932780|NCT03964207|540889583|FG000|Second Treatment|Lost to Follow-up|0|||
149932781|NCT03964207|540889584|FG001|Second Treatment|Lost to Follow-up|1|||
149932782|NCT03964207|540889583|FG000|Second Treatment|Adverse Event|1|||
149932783|NCT03964207|540889584|FG001|Second Treatment|Adverse Event|2|||
149932784|NCT00830219|540889585|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149932785|NCT00830219|540889586|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
149932786|NCT01241279|540889591|FG000|Overall Study|Lost to Follow-up|0|||
149932787|NCT01241279|540889592|FG001|Overall Study|Lost to Follow-up|1|||
149932788|NCT00239720|540889596|FG000|Overall Study|Adverse Event|1|||
149932789|NCT00239720|540889597|FG001|Overall Study|Adverse Event|0|||
149932790|NCT00239720|540889596|FG000|Overall Study|Lost to Follow-up|0|||
149932791|NCT00239720|540889597|FG001|Overall Study|Lost to Follow-up|1|||
149932792|NCT01783743|540889598|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
149932793|NCT01783743|540889599|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
149932794|NCT01783743|540889598|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
149932795|NCT01783743|540889599|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
149932796|NCT01783743|540889598|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
149932797|NCT01783743|540889599|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
149932798|NCT02771275|540889600|FG000|Overall Study|Reoperation|3|||
149932799|NCT02771275|540889600|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
149932800|NCT05556148|540889601|FG000|Overall Study|Early Termination|29|||
149932801|NCT05556148|540889601|FG000|Overall Study|Baseline Tasks Expired|4|||
149932802|NCT05556148|540889601|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
149932803|NCT05556148|540889601|FG000|Overall Study|No Longer Wished to Participate|1|||
149932804|NCT05556148|540889601|FG000|Overall Study|Bacterial Conjunctivitis|1|||
149932805|NCT03191799|540889602|FG000|Overall Study|Withdrawal by Subject|4|||
149932806|NCT03191799|540889602|FG000|Overall Study|Physician Decision|2|||
149932807|NCT03191799|540889602|FG000|Overall Study|Lost to Follow-up|1|||
149932808|NCT03191799|540889602|FG000|Overall Study|Death|2|||
149932809|NCT01746862|540889616|FG000|Overall Study|Withdrawal by Subject|1|||
149932810|NCT01746862|540889617|FG001|Overall Study|Withdrawal by Subject|1|||
149932811|NCT01746862|540889616|FG000|Overall Study|Protocol Violation|1|||
149932812|NCT01746862|540889617|FG001|Overall Study|Protocol Violation|0|||
149932813|NCT01746862|540889616|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
149932814|NCT01746862|540889617|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
149932815|NCT01746862|540889616|FG000|Overall Study|Entered puberty during the study|1|||
149932816|NCT01746862|540889617|FG001|Overall Study|Entered puberty during the study|0|||
149932817|NCT03834493|540889625|FG000|Overall Study|Participants Ongoing|311|||
149932818|NCT03834493|540889626|FG001|Overall Study|Participants Ongoing|324|||
149932819|NCT03834493|540889625|FG000|Overall Study|Withdrawal by Subject|20|||
149932820|NCT03834493|540889626|FG001|Overall Study|Withdrawal by Subject|17|||
150266348|NCT02175004|542112537|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
149932821|NCT03834493|540889625|FG000|Overall Study|Physician Decision|1|||
150266349|NCT01137955|542112538|FG000|Overall Study|Withdrawal by Subject|5|||
150266350|NCT01137955|542112539|FG001|Overall Study|Withdrawal by Subject|4|||
150266351|NCT00756470|542112540|FG000|Overall Study|Withdrawal by Subject|1|||
149932822|NCT03834493|540889626|FG001|Overall Study|Physician Decision|0|||
149932823|NCT03834493|540889625|FG000|Overall Study|Death|289|||
149932824|NCT03834493|540889626|FG001|Overall Study|Death|282|||
149932825|NCT04144322|540889628|FG000|Overall Study|Lack of Efficacy|2|||
149932826|NCT04144322|540889629|FG001|Overall Study|Lack of Efficacy|2|||
149932827|NCT02277028|540889630|FG000|Overall Study|Lost to Follow-up|1|||
149932828|NCT02277028|540889631|FG001|Overall Study|Lost to Follow-up|0|||
149932829|NCT02277028|540889630|FG000|Overall Study|Withdrawal by Subject|0|||
149932830|NCT02277028|540889631|FG001|Overall Study|Withdrawal by Subject|1|||
149932831|NCT02718911|540889632|FG000|Overall Study|Adverse Event|0|||
149932832|NCT02718911|540889633|FG001|Overall Study|Adverse Event|0|||
149932833|NCT02718911|540889634|FG002|Overall Study|Adverse Event|0|||
149932834|NCT02718911|540889635|FG003|Overall Study|Adverse Event|0|||
149932835|NCT02718911|540889636|FG004|Overall Study|Adverse Event|0|||
149932836|NCT02718911|540889637|FG005|Overall Study|Adverse Event|0|||
149932837|NCT02718911|540889638|FG006|Overall Study|Adverse Event|0|||
149932838|NCT02718911|540889639|FG007|Overall Study|Adverse Event|0|||
149932839|NCT02718911|540889640|FG008|Overall Study|Adverse Event|0|||
149932840|NCT02718911|540889641|FG009|Overall Study|Adverse Event|2|||
149932841|NCT02718911|540889632|FG000|Overall Study|Death|2|||
149932842|NCT02718911|540889633|FG001|Overall Study|Death|3|||
149932843|NCT02718911|540889634|FG002|Overall Study|Death|1|||
149932844|NCT02718911|540889635|FG003|Overall Study|Death|0|||
149932845|NCT02718911|540889636|FG004|Overall Study|Death|1|||
149932846|NCT02718911|540889637|FG005|Overall Study|Death|3|||
149932847|NCT02718911|540889638|FG006|Overall Study|Death|1|||
149932848|NCT02718911|540889639|FG007|Overall Study|Death|1|||
149932849|NCT02718911|540889640|FG008|Overall Study|Death|4|||
149932850|NCT02718911|540889641|FG009|Overall Study|Death|3|||
149932851|NCT02718911|540889632|FG000|Overall Study|Lost to Follow-up|0|||
149932852|NCT02718911|540889633|FG001|Overall Study|Lost to Follow-up|0|||
149932853|NCT02718911|540889634|FG002|Overall Study|Lost to Follow-up|0|||
149932854|NCT02718911|540889635|FG003|Overall Study|Lost to Follow-up|0|||
149932855|NCT02718911|540889636|FG004|Overall Study|Lost to Follow-up|0|||
149932856|NCT02718911|540889637|FG005|Overall Study|Lost to Follow-up|0|||
149932857|NCT02718911|540889638|FG006|Overall Study|Lost to Follow-up|0|||
149932858|NCT02718911|540889639|FG007|Overall Study|Lost to Follow-up|0|||
149932859|NCT02718911|540889640|FG008|Overall Study|Lost to Follow-up|1|||
149932860|NCT02718911|540889641|FG009|Overall Study|Lost to Follow-up|0|||
149932861|NCT02718911|540889632|FG000|Overall Study|Physician Decision|2|||
149932862|NCT02718911|540889633|FG001|Overall Study|Physician Decision|0|||
149932863|NCT02718911|540889634|FG002|Overall Study|Physician Decision|1|||
149932864|NCT02718911|540889635|FG003|Overall Study|Physician Decision|1|||
149932865|NCT02718911|540889636|FG004|Overall Study|Physician Decision|0|||
149932866|NCT02718911|540889637|FG005|Overall Study|Physician Decision|0|||
149932867|NCT02718911|540889638|FG006|Overall Study|Physician Decision|0|||
149932868|NCT02718911|540889639|FG007|Overall Study|Physician Decision|1|||
149932869|NCT02718911|540889640|FG008|Overall Study|Physician Decision|2|||
149932870|NCT02718911|540889641|FG009|Overall Study|Physician Decision|1|||
149932871|NCT02718911|540889632|FG000|Overall Study|Withdrawal by Subject|0|||
149932872|NCT02718911|540889633|FG001|Overall Study|Withdrawal by Subject|0|||
149932873|NCT02718911|540889634|FG002|Overall Study|Withdrawal by Subject|0|||
149932874|NCT02718911|540889635|FG003|Overall Study|Withdrawal by Subject|0|||
149932875|NCT02718911|540889636|FG004|Overall Study|Withdrawal by Subject|1|||
149932876|NCT02718911|540889637|FG005|Overall Study|Withdrawal by Subject|0|||
149932877|NCT02718911|540889638|FG006|Overall Study|Withdrawal by Subject|0|||
149932878|NCT02718911|540889639|FG007|Overall Study|Withdrawal by Subject|0|||
149932879|NCT02718911|540889640|FG008|Overall Study|Withdrawal by Subject|1|||
149932880|NCT02718911|540889641|FG009|Overall Study|Withdrawal by Subject|4|||
149932881|NCT02718911|540889632|FG000|Overall Study|Reason Not Collected|0|||
149932882|NCT02718911|540889633|FG001|Overall Study|Reason Not Collected|0|||
149932883|NCT02718911|540889634|FG002|Overall Study|Reason Not Collected|1|||
149932884|NCT02718911|540889635|FG003|Overall Study|Reason Not Collected|0|||
149932885|NCT02718911|540889636|FG004|Overall Study|Reason Not Collected|0|||
149932886|NCT02718911|540889637|FG005|Overall Study|Reason Not Collected|0|||
149932887|NCT02718911|540889638|FG006|Overall Study|Reason Not Collected|2|||
149932888|NCT02718911|540889639|FG007|Overall Study|Reason Not Collected|1|||
149932889|NCT02718911|540889640|FG008|Overall Study|Reason Not Collected|4|||
149932890|NCT02718911|540889641|FG009|Overall Study|Reason Not Collected|9|||
149932891|NCT04817332|540889642|FG000|Overall Study|Lost to Follow-up|3|||
149932892|NCT04817332|540889643|FG001|Overall Study|Lost to Follow-up|3|||
149932893|NCT04817332|540889642|FG000|Overall Study|Protocol Violation|2|||
149932894|NCT04817332|540889643|FG001|Overall Study|Protocol Violation|0|||
149932895|NCT01867008|540889644|FG000|Overall Study|Withdrawal by Subject|1|||
149932896|NCT00983372|540889645|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
149932897|NCT00983372|540889645|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
149932898|NCT00983372|540889645|FG000|Diltiazem ER Alone|Adverse Event|1|||
149932899|NCT00385918|540889654|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
149932900|NCT00385918|540889655|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
149932901|NCT00385918|540889656|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
149932902|NCT00385918|540889654|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
149932903|NCT00385918|540889655|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
149932904|NCT00385918|540889656|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
149932905|NCT00385918|540889654|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
149932906|NCT00385918|540889655|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
149932907|NCT00385918|540889656|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
150266352|NCT00756470|542112540|FG000|Overall Study|Adverse Event|4|||
150266353|NCT00820027|542112541|FG000|Overall Study|Adverse Event|15|||
150266354|NCT00820027|542112542|FG001|Overall Study|Adverse Event|8|||
150266355|NCT00820027|542112543|FG002|Overall Study|Adverse Event|10|||
150266356|NCT00820027|542112544|FG003|Overall Study|Adverse Event|5|||
150266357|NCT00820027|542112541|FG000|Overall Study|Lack of Efficacy|2|||
150266358|NCT00820027|542112542|FG001|Overall Study|Lack of Efficacy|1|||
150266359|NCT00820027|542112543|FG002|Overall Study|Lack of Efficacy|2|||
150266360|NCT00820027|542112544|FG003|Overall Study|Lack of Efficacy|2|||
150266361|NCT00820027|542112541|FG000|Overall Study|Physician Decision|0|||
150266362|NCT00820027|542112542|FG001|Overall Study|Physician Decision|1|||
150266363|NCT00820027|542112543|FG002|Overall Study|Physician Decision|1|||
150266364|NCT00820027|542112544|FG003|Overall Study|Physician Decision|0|||
150266365|NCT00820027|542112541|FG000|Overall Study|Protocol Violation|3|||
150266366|NCT00820027|542112542|FG001|Overall Study|Protocol Violation|0|||
150266367|NCT00820027|542112543|FG002|Overall Study|Protocol Violation|4|||
150266368|NCT00820027|542112544|FG003|Overall Study|Protocol Violation|0|||
150266369|NCT00820027|542112541|FG000|Overall Study|Withdrawal by Subject|6|||
150266370|NCT00820027|542112542|FG001|Overall Study|Withdrawal by Subject|4|||
150266371|NCT00820027|542112543|FG002|Overall Study|Withdrawal by Subject|4|||
150266372|NCT00820027|542112544|FG003|Overall Study|Withdrawal by Subject|6|||
150266373|NCT01978262|542112545|FG000|Overall Study|Withdrawal by Subject|9|||
150266374|NCT01978262|542112545|FG000|Overall Study|Lost to Follow-up|2|||
150266375|NCT02982187|542112546|FG000|Overall Study|Withdrawal by Subject|0|||
150266376|NCT02982187|542112547|FG001|Overall Study|Withdrawal by Subject|0|||
150266377|NCT02982187|542112548|FG002|Overall Study|Withdrawal by Subject|0|||
150266378|NCT02982187|542112549|FG003|Overall Study|Withdrawal by Subject|0|||
150266379|NCT02982187|542112550|FG004|Overall Study|Withdrawal by Subject|0|||
150266380|NCT02982187|542112551|FG005|Overall Study|Withdrawal by Subject|0|||
150266381|NCT02982187|542112552|FG006|Overall Study|Withdrawal by Subject|1|||
149932908|NCT00385918|540889654|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
149932909|NCT00385918|540889655|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
149932910|NCT00385918|540889656|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
149932911|NCT00385918|540889654|FG000|Intervention Phase After Randomization|Physician Decision|1|||
149932912|NCT00385918|540889655|FG001|Intervention Phase After Randomization|Physician Decision|0|||
149932913|NCT00385918|540889656|FG002|Intervention Phase After Randomization|Physician Decision|0|||
149932914|NCT00385918|540889654|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
149932915|NCT00385918|540889655|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
149932916|NCT00385918|540889656|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
149932917|NCT00128661|540889657|FG000|Overall Study|Adverse Event|14|||
149932918|NCT00128661|540889658|FG001|Overall Study|Adverse Event|11|||
149932919|NCT00128661|540889657|FG000|Overall Study|Lost to Follow-up|10|||
149932920|NCT00128661|540889658|FG001|Overall Study|Lost to Follow-up|7|||
149932921|NCT00128661|540889657|FG000|Overall Study|Withdrawal by Subject|243|||
149932922|NCT00128661|540889658|FG001|Overall Study|Withdrawal by Subject|232|||
149932923|NCT00128661|540889657|FG000|Overall Study|Other|7|||
149932924|NCT00128661|540889658|FG001|Overall Study|Other|8|||
149932925|NCT02782741|540889661|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
149932926|NCT02782741|540889662|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
149932927|NCT02782741|540889663|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
149932928|NCT02782741|540889661|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
149932929|NCT02782741|540889662|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
149932930|NCT02782741|540889663|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
149932931|NCT02782741|540889661|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
149932932|NCT02782741|540889662|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
149932933|NCT02782741|540889663|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
149932934|NCT02782741|540889661|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
149932935|NCT02782741|540889662|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
149932936|NCT02782741|540889663|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
149932937|NCT02782741|540889661|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
149932938|NCT02782741|540889662|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
149932939|NCT02782741|540889663|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
149932940|NCT04157088|540889664|FG000|Overall Study|Study terminated by sponsor|23|||
149932941|NCT04157088|540889664|FG000|Overall Study|Withdrawal by Subject|4|||
150266382|NCT02982187|542112553|FG007|Overall Study|Withdrawal by Subject|0|||
150266383|NCT02604433|542112554|FG000|Overall Study|Withdrawal by Subject|37|||
150266384|NCT02604433|542112555|FG001|Overall Study|Withdrawal by Subject|16|||
150266385|NCT02604433|542112554|FG000|Overall Study|Adverse Event|4|||
150266386|NCT02604433|542112555|FG001|Overall Study|Adverse Event|0|||
150266387|NCT02604433|542112554|FG000|Overall Study|Other reasons|3|||
150266388|NCT02604433|542112555|FG001|Overall Study|Other reasons|5|||
150266389|NCT02604433|542112554|FG000|Overall Study|Death|4|||
150266390|NCT02604433|542112555|FG001|Overall Study|Death|1|||
150266391|NCT02604433|542112554|FG000|Overall Study|Transition to Rollover Protocol|169|||
149932942|NCT04157088|540889664|FG000|Overall Study|Lost to Follow-up|2|||
149932943|NCT04157088|540889664|FG000|Overall Study|Death|1|||
149932944|NCT02421419|540889665|FG000|Overall Study|Physician Decision|0|||
150266392|NCT02604433|542112555|FG001|Overall Study|Transition to Rollover Protocol|82|||
150266393|NCT02604433|542112554|FG000|Overall Study|Physician Decision|1|||
150266394|NCT02604433|542112555|FG001|Overall Study|Physician Decision|1|||
150266395|NCT02604433|542112554|FG000|Overall Study|Lack of Efficacy|0|||
150266396|NCT02604433|542112555|FG001|Overall Study|Lack of Efficacy|1|||
150266397|NCT03285178|542112556|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
150266398|NCT03285178|542112557|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266399|NCT03285178|542112558|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266400|NCT03285178|542112559|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266401|NCT03285178|542112560|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266402|NCT03285178|542112561|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266403|NCT03285178|542112562|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
150266404|NCT03285178|542112556|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
150266405|NCT03285178|542112557|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266406|NCT03285178|542112558|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266407|NCT03285178|542112559|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266408|NCT03285178|542112560|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266409|NCT03285178|542112561|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266410|NCT03285178|542112562|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
150266411|NCT03285178|542112556|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
150266412|NCT03285178|542112557|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
150266413|NCT03285178|542112558|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
150266414|NCT03285178|542112559|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
150266415|NCT03285178|542112560|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
150266416|NCT03285178|542112561|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
150266417|NCT03285178|542112562|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
150266418|NCT03285178|542112556|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
150266419|NCT03285178|542112557|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266420|NCT03285178|542112558|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266421|NCT03285178|542112559|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266422|NCT03285178|542112560|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266423|NCT03285178|542112561|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266424|NCT03285178|542112562|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
150266425|NCT03285178|542112556|FG000|Single-Blind Run-In Period|Physician Decision|2|||
150266426|NCT03285178|542112557|FG001|Single-Blind Run-In Period|Physician Decision|0|||
150266427|NCT03285178|542112558|FG002|Single-Blind Run-In Period|Physician Decision|0|||
150266428|NCT03285178|542112559|FG003|Single-Blind Run-In Period|Physician Decision|0|||
150266429|NCT03285178|542112560|FG004|Single-Blind Run-In Period|Physician Decision|0|||
150266430|NCT03285178|542112561|FG005|Single-Blind Run-In Period|Physician Decision|0|||
150266431|NCT03285178|542112562|FG006|Single-Blind Run-In Period|Physician Decision|0|||
150266432|NCT03285178|542112556|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
150266433|NCT03285178|542112557|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
150266434|NCT03285178|542112558|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
150266435|NCT03285178|542112559|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
150266436|NCT03285178|542112560|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
150266437|NCT03285178|542112561|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
150266438|NCT03285178|542112562|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
150266439|NCT03285178|542112556|FG000|Double-Blind Treatment Period|Adverse Event|0|||
150266440|NCT03285178|542112557|FG001|Double-Blind Treatment Period|Adverse Event|0|||
150266441|NCT03285178|542112558|FG002|Double-Blind Treatment Period|Adverse Event|0|||
150266442|NCT03285178|542112559|FG003|Double-Blind Treatment Period|Adverse Event|0|||
150266443|NCT03285178|542112560|FG004|Double-Blind Treatment Period|Adverse Event|0|||
150266444|NCT03285178|542112561|FG005|Double-Blind Treatment Period|Adverse Event|0|||
150266445|NCT03285178|542112562|FG006|Double-Blind Treatment Period|Adverse Event|2|||
150266446|NCT03285178|542112556|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150266447|NCT03285178|542112557|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
150266448|NCT03285178|542112558|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
149932945|NCT02421419|540889666|FG001|Overall Study|Physician Decision|0|||
149932946|NCT02421419|540889667|FG002|Overall Study|Physician Decision|1|||
150266449|NCT03285178|542112559|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
150266450|NCT03285178|542112560|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
150266451|NCT03285178|542112561|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
149932947|NCT01676701|540889669|FG000|Overall Study|Protocol Violation|1|||
149932948|NCT01676701|540889670|FG001|Overall Study|Protocol Violation|0|||
149932949|NCT01676701|540889669|FG000|Overall Study|Sponsor Decision|3|||
149932950|NCT01676701|540889670|FG001|Overall Study|Sponsor Decision|4|||
149932951|NCT02115607|540889671|FG000|Overall Study|Withdrawal by Subject|1|||
149932952|NCT00196105|540889675|FG000|Overall Study|Lost to Follow-up|4|||
149932953|NCT00196105|540889676|FG001|Overall Study|Lost to Follow-up|5|||
149932954|NCT00196105|540889677|FG002|Overall Study|Lost to Follow-up|7|||
149932955|NCT04863872|540889678|FG000|Overall Study|Withdrawal by Subject|4|||
149932956|NCT04863872|540889679|FG001|Overall Study|Withdrawal by Subject|15|||
149932957|NCT04863872|540889678|FG000|Overall Study|Death|5|||
149932958|NCT04863872|540889679|FG001|Overall Study|Death|2|||
149932959|NCT04863872|540889678|FG000|Overall Study|Lost to Follow-up|2|||
149932960|NCT04863872|540889679|FG001|Overall Study|Lost to Follow-up|1|||
149932961|NCT04058028|540889683|FG000|Overall Study|Withdrawal of Consent from Study|12|||
149932962|NCT04058028|540889684|FG001|Overall Study|Withdrawal of Consent from Study|8|||
149932963|NCT04058028|540889685|FG002|Overall Study|Withdrawal of Consent from Study|6|||
149932964|NCT04058028|540889686|FG003|Overall Study|Withdrawal of Consent from Study|7|||
149932965|NCT04058028|540889683|FG000|Overall Study|Decision by Sponsor|13|||
149932966|NCT04058028|540889684|FG001|Overall Study|Decision by Sponsor|4|||
149932967|NCT04058028|540889685|FG002|Overall Study|Decision by Sponsor|1|||
149932968|NCT04058028|540889686|FG003|Overall Study|Decision by Sponsor|35|||
149932969|NCT04058028|540889683|FG000|Overall Study|Lost to Follow-up|1|||
149932970|NCT04058028|540889684|FG001|Overall Study|Lost to Follow-up|1|||
149932971|NCT04058028|540889685|FG002|Overall Study|Lost to Follow-up|1|||
149932972|NCT04058028|540889686|FG003|Overall Study|Lost to Follow-up|0|||
149932973|NCT04058028|540889683|FG000|Overall Study|Death|0|||
149932974|NCT04058028|540889684|FG001|Overall Study|Death|1|||
149932975|NCT04058028|540889685|FG002|Overall Study|Death|0|||
149932976|NCT04058028|540889686|FG003|Overall Study|Death|0|||
149932977|NCT04010461|540889687|FG000|Overall Study|COVID based withdrawal|5|||
149932978|NCT04010461|540889687|FG000|Overall Study|Withdrawal by Subject|5|||
149932979|NCT04010461|540889687|FG000|Overall Study|Adverse Event|1|||
149932980|NCT04010461|540889687|FG000|Overall Study|No Motor Threshold obtainable|1|||
149932981|NCT04010461|540889687|FG000|Overall Study|Physician Decision|1|||
149932982|NCT02227784|540889688|FG000|Double-Blind Phase|Adverse Event|3|||
149932983|NCT02227784|540889689|FG001|Double-Blind Phase|Adverse Event|2|||
149932984|NCT02227784|540889690|FG002|Double-Blind Phase|Adverse Event|1|||
149932985|NCT02227784|540889691|FG003|Double-Blind Phase|Adverse Event|3|||
149932986|NCT02227784|540889692|FG004|Double-Blind Phase|Adverse Event|0|||
149932987|NCT02227784|540889688|FG000|Double-Blind Phase|Physician Decision|1|||
149932988|NCT02227784|540889689|FG001|Double-Blind Phase|Physician Decision|0|||
149932989|NCT02227784|540889690|FG002|Double-Blind Phase|Physician Decision|0|||
150166042|NCT00817635|541743434|FG001|Overall Study|Protocol Violation|1|||
150166043|NCT00817635|541743435|FG002|Overall Study|Protocol Violation|3|||
150166044|NCT00817635|541743436|FG003|Overall Study|Protocol Violation|2|||
150166045|NCT00817635|541743437|FG004|Overall Study|Protocol Violation|3|||
150166046|NCT00918957|541743438|FG000|Overall Study|Adverse Event|2|||
150166047|NCT00918957|541743439|FG001|Overall Study|Adverse Event|0|||
150166048|NCT00918957|541743438|FG000|Overall Study|Withdrawal by Subject|1|||
150166049|NCT00918957|541743439|FG001|Overall Study|Withdrawal by Subject|0|||
150166050|NCT03107611|541743440|FG000|Overall Study|Adverse Event|1|||
150166051|NCT03107611|541743441|FG001|Overall Study|Adverse Event|0|||
150166052|NCT03107611|541743442|FG002|Overall Study|Adverse Event|2|||
150166053|NCT03107611|541743440|FG000|Overall Study|Lost to Follow-up|3|||
150166054|NCT03107611|541743441|FG001|Overall Study|Lost to Follow-up|3|||
150166055|NCT03107611|541743442|FG002|Overall Study|Lost to Follow-up|3|||
150166056|NCT03107611|541743440|FG000|Overall Study|Protocol Violation|0|||
150166057|NCT03107611|541743441|FG001|Overall Study|Protocol Violation|0|||
150166058|NCT03107611|541743442|FG002|Overall Study|Protocol Violation|1|||
150166059|NCT03107611|541743440|FG000|Overall Study|Withdrawal by Subject|1|||
150166060|NCT03107611|541743441|FG001|Overall Study|Withdrawal by Subject|0|||
150166061|NCT03107611|541743442|FG002|Overall Study|Withdrawal by Subject|1|||
150166062|NCT03107611|541743440|FG000|Overall Study|Worsening signs/symptoms|2|||
150166063|NCT03107611|541743441|FG001|Overall Study|Worsening signs/symptoms|1|||
150166064|NCT03107611|541743442|FG002|Overall Study|Worsening signs/symptoms|2|||
150166065|NCT01720446|541743445|FG000|Overall Study|Lost to Follow-up|12|||
150166066|NCT01720446|541743446|FG001|Overall Study|Lost to Follow-up|6|||
150166067|NCT01720446|541743447|FG002|Overall Study|Lost to Follow-up|16|||
150166068|NCT01720446|541743448|FG003|Overall Study|Lost to Follow-up|16|||
150166069|NCT01720446|541743445|FG000|Overall Study|Withdrawal by Subject|2|||
150166070|NCT01720446|541743446|FG001|Overall Study|Withdrawal by Subject|5|||
150166071|NCT01720446|541743447|FG002|Overall Study|Withdrawal by Subject|4|||
150166072|NCT01720446|541743448|FG003|Overall Study|Withdrawal by Subject|4|||
150166073|NCT01020838|541743449|FG000|Overall Study|Death|90|||
149932990|NCT02227784|540889691|FG003|Double-Blind Phase|Physician Decision|1|||
149932991|NCT02227784|540889692|FG004|Double-Blind Phase|Physician Decision|0|||
149932992|NCT02227784|540889688|FG000|Double-Blind Phase|Protocol Violation|0|||
149932993|NCT02227784|540889689|FG001|Double-Blind Phase|Protocol Violation|0|||
149932994|NCT02227784|540889690|FG002|Double-Blind Phase|Protocol Violation|1|||
149932995|NCT02227784|540889691|FG003|Double-Blind Phase|Protocol Violation|1|||
149932996|NCT02227784|540889692|FG004|Double-Blind Phase|Protocol Violation|0|||
149932997|NCT02227784|540889688|FG000|Double-Blind Phase|Sponsor Decision|34|||
149932998|NCT02227784|540889689|FG001|Double-Blind Phase|Sponsor Decision|15|||
149932999|NCT02227784|540889690|FG002|Double-Blind Phase|Sponsor Decision|14|||
149933000|NCT02227784|540889691|FG003|Double-Blind Phase|Sponsor Decision|32|||
149933001|NCT02227784|540889692|FG004|Double-Blind Phase|Sponsor Decision|0|||
149933002|NCT02227784|540889688|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
149933003|NCT02227784|540889689|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
149933004|NCT02227784|540889690|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
150266452|NCT03285178|542112562|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
150266453|NCT03285178|542112556|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150266454|NCT03285178|542112557|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150266455|NCT03285178|542112558|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149933005|NCT02227784|540889691|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
149933006|NCT02227784|540889692|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149933007|NCT02227784|540889688|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
149933008|NCT02227784|540889689|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
149933009|NCT02227784|540889690|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
149933010|NCT02227784|540889691|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
149933011|NCT02227784|540889692|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
149933012|NCT02227784|540889688|FG000|Open-Label Extension Phase (OLE)|Death|0|||
149933013|NCT02227784|540889689|FG001|Open-Label Extension Phase (OLE)|Death|0|||
149933014|NCT02227784|540889690|FG002|Open-Label Extension Phase (OLE)|Death|0|||
149933015|NCT02227784|540889691|FG003|Open-Label Extension Phase (OLE)|Death|0|||
149933016|NCT02227784|540889692|FG004|Open-Label Extension Phase (OLE)|Death|1|||
149933017|NCT02227784|540889688|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
149933018|NCT02227784|540889689|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
149933019|NCT02227784|540889690|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
149933020|NCT02227784|540889691|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
149933021|NCT02227784|540889692|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
149933022|NCT02227784|540889688|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
149933023|NCT02227784|540889689|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
149933024|NCT02227784|540889690|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
149933025|NCT02227784|540889691|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
149933026|NCT02227784|540889692|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
149933027|NCT00102596|540889693|FG000|Part A|Screen failures|6|||
149933028|NCT00102596|540889694|FG001|Part A|Screen failures|0|||
149933029|NCT00102596|540889693|FG000|Part A|Adverse Event|1|||
149933030|NCT00102596|540889694|FG001|Part A|Adverse Event|0|||
149933031|NCT01827592|540889696|FG000|Overall Study|Adverse Event|11|||
149933032|NCT01827592|540889697|FG001|Overall Study|Adverse Event|9|||
149933033|NCT01827592|540889698|FG002|Overall Study|Adverse Event|2|||
149933034|NCT01827592|540889696|FG000|Overall Study|Physician Decision|0|||
149933035|NCT01827592|540889697|FG001|Overall Study|Physician Decision|2|||
149933036|NCT01827592|540889698|FG002|Overall Study|Physician Decision|1|||
149933037|NCT01827592|540889696|FG000|Overall Study|Protocol Violation|2|||
149933038|NCT01827592|540889697|FG001|Overall Study|Protocol Violation|1|||
149933039|NCT01827592|540889698|FG002|Overall Study|Protocol Violation|0|||
149933040|NCT01827592|540889696|FG000|Overall Study|Lost to Follow-up|1|||
149933041|NCT01827592|540889697|FG001|Overall Study|Lost to Follow-up|2|||
149933042|NCT01827592|540889698|FG002|Overall Study|Lost to Follow-up|2|||
149933043|NCT01827592|540889696|FG000|Overall Study|Withdrawal by Subject|12|||
149933044|NCT01827592|540889697|FG001|Overall Study|Withdrawal by Subject|11|||
149933045|NCT01827592|540889698|FG002|Overall Study|Withdrawal by Subject|11|||
149933046|NCT01827592|540889696|FG000|Overall Study|Patient's substantial non-compliance|1|||
149933047|NCT01827592|540889697|FG001|Overall Study|Patient's substantial non-compliance|1|||
149933048|NCT01827592|540889698|FG002|Overall Study|Patient's substantial non-compliance|6|||
149933049|NCT01827592|540889696|FG000|Overall Study|Trial terminated by Sponsor|47|||
150266456|NCT03285178|542112559|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
150266457|NCT03285178|542112560|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149933050|NCT01827592|540889697|FG001|Overall Study|Trial terminated by Sponsor|53|||
150266458|NCT03285178|542112561|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149933051|NCT01827592|540889698|FG002|Overall Study|Trial terminated by Sponsor|51|||
149933052|NCT01827592|540889696|FG000|Overall Study|Others|0|||
149933053|NCT01827592|540889697|FG001|Overall Study|Others|1|||
149933054|NCT01827592|540889698|FG002|Overall Study|Others|3|||
149933055|NCT00808067|540889701|FG000|Overall Study|Major/minor bleed|30|||
149933056|NCT00808067|540889702|FG001|Overall Study|Major/minor bleed|44|||
149933057|NCT00808067|540889701|FG000|Overall Study|Outcome event - other|33|||
149933058|NCT00808067|540889702|FG001|Overall Study|Outcome event - other|25|||
149933059|NCT00808067|540889701|FG000|Overall Study|Adverse Event|111|||
149933060|NCT00808067|540889702|FG001|Overall Study|Adverse Event|121|||
149933061|NCT00808067|540889701|FG000|Overall Study|Hospitalization (not including surgery)|18|||
149933062|NCT00808067|540889702|FG001|Overall Study|Hospitalization (not including surgery)|17|||
149933063|NCT00808067|540889701|FG000|Overall Study|Hospitalization due to surgery|37|||
149933064|NCT00808067|540889702|FG001|Overall Study|Hospitalization due to surgery|40|||
149933065|NCT00808067|540889701|FG000|Overall Study|Reduced creatinine clearance|53|||
149933066|NCT00808067|540889702|FG001|Overall Study|Reduced creatinine clearance|55|||
149933067|NCT00808067|540889701|FG000|Overall Study|Elevated LFT results|7|||
149933068|NCT00808067|540889702|FG001|Overall Study|Elevated LFT results|3|||
149933069|NCT00808067|540889701|FG000|Overall Study|Patient refused to take study medication|65|||
149933070|NCT00808067|540889702|FG001|Overall Study|Patient refused to take study medication|76|||
149933071|NCT00808067|540889701|FG000|Overall Study|Missing|1|||
149933072|NCT00808067|540889702|FG001|Overall Study|Missing|0|||
149933073|NCT00808067|540889701|FG000|Overall Study|Death|1|||
149933074|NCT00808067|540889702|FG001|Overall Study|Death|1|||
149933075|NCT00808067|540889701|FG000|Overall Study|Procedure|6|||
149933076|NCT00808067|540889702|FG001|Overall Study|Procedure|7|||
149933077|NCT00808067|540889701|FG000|Overall Study|Withdrawal by Subject|21|||
149933078|NCT00808067|540889702|FG001|Overall Study|Withdrawal by Subject|25|||
149933079|NCT00808067|540889701|FG000|Overall Study|Site closed|4|||
149933080|NCT00808067|540889702|FG001|Overall Study|Site closed|3|||
149933081|NCT00808067|540889701|FG000|Overall Study|Physician Decision|47|||
149933082|NCT00808067|540889702|FG001|Overall Study|Physician Decision|38|||
149933083|NCT00808067|540889701|FG000|Overall Study|Protocol Violation|3|||
149933084|NCT00808067|540889702|FG001|Overall Study|Protocol Violation|11|||
149933085|NCT00808067|540889701|FG000|Overall Study|Patient elected|7|||
149933086|NCT00808067|540889702|FG001|Overall Study|Patient elected|9|||
149933087|NCT00808067|540889701|FG000|Overall Study|Site closed for cause|19|||
149933088|NCT00808067|540889702|FG001|Overall Study|Site closed for cause|19|||
150166074|NCT01020838|541743449|FG000|Overall Study|Adverse Event|1|||
149933089|NCT00808067|540889701|FG000|Overall Study|Other reason not defined above|5|||
149933090|NCT00808067|540889702|FG001|Overall Study|Other reason not defined above|5|||
149933091|NCT00808067|540889701|FG000|Overall Study|Excluded from analysis|13|||
149933092|NCT00808067|540889702|FG001|Overall Study|Excluded from analysis|19|||
149933093|NCT00689338|540889703|FG000|Overall Study|Death|65|||
149933094|NCT00689338|540889703|FG000|Overall Study|Adverse Event|13|||
149933095|NCT00689338|540889703|FG000|Overall Study|Insufficient Clinical Response|1|||
149933096|NCT00689338|540889703|FG000|Overall Study|Lack of Efficacy|6|||
149933097|NCT00689338|540889703|FG000|Overall Study|Other|8|||
149933098|NCT00689338|540889703|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
149933099|NCT00689338|540889703|FG000|Overall Study|Lost to Follow-up|5|||
149933100|NCT00689338|540889703|FG000|Overall Study|Withdrawal by Subject|3|||
149933101|NCT00689338|540889703|FG000|Overall Study|Protocol Violation|15|||
149933102|NCT04414787|540889706|FG000|Overall Study|Patient Death|18|||
149933103|NCT04414787|540889707|FG001|Overall Study|Patient Death|18|||
149933104|NCT04414787|540889708|FG002|Overall Study|Patient Death|15|||
149933105|NCT04414787|540889709|FG003|Overall Study|Patient Death|15|||
150166075|NCT01020838|541743449|FG000|Overall Study|Withdrawal by Subject|9|||
150166076|NCT01020838|541743449|FG000|Overall Study|Lost to Follow-up|6|||
150166077|NCT01020838|541743449|FG000|Overall Study|Most common: Study ended by sponsor|77|||
150166078|NCT01167426|541743450|FG000|Overall Study|Lost to Follow-up|6|||
150166079|NCT01167426|541743450|FG000|Overall Study|Protocol Violation|1|||
150166080|NCT01167426|541743450|FG000|Overall Study|Withdrawal by Subject|2|||
150166081|NCT01167426|541743450|FG000|Overall Study|Sponsor Decision|1|||
150166082|NCT04176458|541743452|FG000|Overall Study|Covid 19|4|||
150166083|NCT02131324|541743453|FG000|Overall Study|Withdrawal by Subject|1|||
150166084|NCT02131324|541743454|FG001|Overall Study|Withdrawal by Subject|2|||
150166085|NCT02131324|541743453|FG000|Overall Study|Lost to Follow-up|1|||
150166086|NCT02131324|541743454|FG001|Overall Study|Lost to Follow-up|1|||
150166087|NCT00891618|541743455|FG000|Overall Study|Withdrawal by Subject|1|||
149933106|NCT04414787|540889706|FG000|Overall Study|Patient Hospitalization|1|||
149933107|NCT04414787|540889707|FG001|Overall Study|Patient Hospitalization|1|||
149933108|NCT04414787|540889708|FG002|Overall Study|Patient Hospitalization|2|||
149933109|NCT04414787|540889709|FG003|Overall Study|Patient Hospitalization|2|||
149933110|NCT04414787|540889706|FG000|Overall Study|Lost to Follow-up|7|||
150166088|NCT04582877|541743456|FG000|Overall Study|Did not use device measurement|5|||
150166089|NCT04582877|541743456|FG000|Overall Study|No fractional flow reserve test results|2|||
150166090|NCT04582877|541743456|FG000|Overall Study|Protocol Violation|1|||
149933111|NCT04414787|540889707|FG001|Overall Study|Lost to Follow-up|7|||
149933112|NCT04414787|540889708|FG002|Overall Study|Lost to Follow-up|5|||
149933113|NCT04414787|540889709|FG003|Overall Study|Lost to Follow-up|5|||
149933114|NCT04414787|540889706|FG000|Overall Study|Residence in post-acute care facility|3|||
149933115|NCT04414787|540889707|FG001|Overall Study|Residence in post-acute care facility|3|||
150166091|NCT00003656|541743457|FG000|Overall Study|Adverse Event|0|||
149933116|NCT04414787|540889708|FG002|Overall Study|Residence in post-acute care facility|5|||
149933117|NCT04414787|540889709|FG003|Overall Study|Residence in post-acute care facility|5|||
149933118|NCT02532283|540889712|FG000|Overall Study|Adverse Event|0|||
149933119|NCT02532283|540889713|FG001|Overall Study|Adverse Event|1|||
149933120|NCT02532283|540889712|FG000|Overall Study|Death|1|||
149933121|NCT02532283|540889713|FG001|Overall Study|Death|0|||
149933122|NCT02532283|540889712|FG000|Overall Study|Lost to Follow-up|0|||
149933123|NCT02532283|540889713|FG001|Overall Study|Lost to Follow-up|1|||
149933124|NCT02532283|540889712|FG000|Overall Study|Withdrawal by Subject|8|||
149933125|NCT02532283|540889713|FG001|Overall Study|Withdrawal by Subject|3|||
149933126|NCT01945944|540889714|FG000|Overall Study|Adverse Event|0|||
149933127|NCT01945944|540889715|FG001|Overall Study|Adverse Event|2|||
149933128|NCT01945944|540889714|FG000|Overall Study|Physician Decision|1|||
149933129|NCT01945944|540889715|FG001|Overall Study|Physician Decision|0|||
149933130|NCT01945944|540889714|FG000|Overall Study|Withdrawal by Subject|0|||
149933131|NCT01945944|540889715|FG001|Overall Study|Withdrawal by Subject|1|||
149933132|NCT04376515|540889716|FG000|Overall Study|Found to have been vaccinated before study start|6|||
149933133|NCT04376515|540889717|FG001|Overall Study|Found to have been vaccinated before study start|6|||
149933134|NCT03811821|540889718|FG000|Overall Study|Adverse Event|1|||
149933135|NCT03811821|540889719|FG001|Overall Study|Adverse Event|1|||
149933136|NCT03811821|540889718|FG000|Overall Study|Withdrawal by Subject|5|||
149933137|NCT03811821|540889719|FG001|Overall Study|Withdrawal by Subject|4|||
149933138|NCT03811821|540889718|FG000|Overall Study|Lost to Follow-up|2|||
149933139|NCT03811821|540889719|FG001|Overall Study|Lost to Follow-up|2|||
149933140|NCT03811821|540889718|FG000|Overall Study|Contraindication for treatment|0|||
149933141|NCT03811821|540889719|FG001|Overall Study|Contraindication for treatment|1|||
149933142|NCT03811821|540889718|FG000|Overall Study|Tolerability|0|||
149933143|NCT03811821|540889719|FG001|Overall Study|Tolerability|3|||
149933144|NCT03811821|540889718|FG000|Overall Study|Comorbidities|0|||
149933145|NCT03811821|540889719|FG001|Overall Study|Comorbidities|2|||
149933146|NCT05027815|540889723|FG000|Overall Study|Death|2|||
149933147|NCT05027815|540889724|FG001|Overall Study|Death|1|||
149933148|NCT00447902|540889729|FG000|Overall Study|Adverse Event|0|||
149933149|NCT00447902|540889730|FG001|Overall Study|Adverse Event|3|||
149933150|NCT00447902|540889729|FG000|Overall Study|Protocol Violation|1|||
149933151|NCT00447902|540889730|FG001|Overall Study|Protocol Violation|0|||
149933152|NCT00447902|540889729|FG000|Overall Study|Withdrawal by Subject|0|||
149933153|NCT00447902|540889730|FG001|Overall Study|Withdrawal by Subject|1|||
149933154|NCT00447902|540889729|FG000|Overall Study|included patients who discontinued|1|||
149933155|NCT00447902|540889730|FG001|Overall Study|included patients who discontinued|1|||
149933156|NCT00447902|540889729|FG000|Overall Study|Lack of Efficacy|2|||
149933157|NCT00447902|540889730|FG001|Overall Study|Lack of Efficacy|1|||
149933158|NCT00126594|540891651|FG000|Overall Study|Ineligible|2|||
149933159|NCT00126594|540891652|FG001|Overall Study|Ineligible|0|||
149933160|NCT00126594|540891651|FG000|Overall Study|Withdrawal by Subject|0|||
149933161|NCT00126594|540891652|FG001|Overall Study|Withdrawal by Subject|4|||
149933162|NCT00126594|540891651|FG000|Overall Study|Physician Decision|1|||
149933163|NCT00126594|540891652|FG001|Overall Study|Physician Decision|3|||
149933164|NCT00126594|540891651|FG000|Overall Study|Adverse Event|7|||
149933165|NCT00126594|540891652|FG001|Overall Study|Adverse Event|5|||
149933166|NCT00126594|540891651|FG000|Overall Study|Non-compliance|0|||
149933167|NCT00126594|540891652|FG001|Overall Study|Non-compliance|1|||
149933168|NCT00126594|540891651|FG000|Overall Study|Disease Progression|29|||
149933169|NCT00126594|540891652|FG001|Overall Study|Disease Progression|24|||
149933170|NCT00468585|540891653|FG000|Overall Study|Patient not treated|1|||
149933171|NCT00468585|540891654|FG001|Overall Study|Patient not treated|0|||
149933172|NCT00468585|540891655|FG002|Overall Study|Patient not treated|1|||
149933173|NCT00468585|540891656|FG003|Overall Study|Patient not treated|0|||
150166092|NCT00003656|541743458|FG001|Overall Study|Adverse Event|1|||
150166093|NCT00742274|541743459|FG000|Overall Study|Death|1|||
150166094|NCT00742274|541743460|FG001|Overall Study|Death|0|||
150166095|NCT00742274|541743459|FG000|Overall Study|Withdrawal by Subject|1|||
149933174|NCT00468585|540891653|FG000|Overall Study|Patient found to be ineligible|0|||
149933175|NCT00468585|540891654|FG001|Overall Study|Patient found to be ineligible|0|||
149933176|NCT00468585|540891655|FG002|Overall Study|Patient found to be ineligible|1|||
149933177|NCT00468585|540891656|FG003|Overall Study|Patient found to be ineligible|0|||
149933178|NCT00468585|540891653|FG000|Overall Study|Adverse Event|0|||
149933179|NCT00468585|540891654|FG001|Overall Study|Adverse Event|0|||
149933180|NCT00468585|540891655|FG002|Overall Study|Adverse Event|1|||
149933181|NCT00468585|540891656|FG003|Overall Study|Adverse Event|0|||
149933182|NCT00468585|540891653|FG000|Overall Study|Withdrawal by Subject|0|||
149933183|NCT00468585|540891654|FG001|Overall Study|Withdrawal by Subject|0|||
150166096|NCT00742274|541743460|FG001|Overall Study|Withdrawal by Subject|2|||
149933184|NCT00468585|540891655|FG002|Overall Study|Withdrawal by Subject|2|||
149933185|NCT00468585|540891656|FG003|Overall Study|Withdrawal by Subject|1|||
149933186|NCT03769649|540891657|FG000|Overall Study|Lost to Follow-up|4|||
149933187|NCT02059239|540891662|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
150166097|NCT00742274|541743459|FG000|Overall Study|Removed for medical reasons|1|||
149933188|NCT02059239|540891663|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
149933189|NCT02059239|540891662|FG000|Overall Study|Physician Decision|1|||
149933190|NCT02059239|540891663|FG001|Overall Study|Physician Decision|0|||
149933191|NCT02204917|540891664|FG000|Overall Study|Protocol Violation|1|||
149933192|NCT02219685|540891665|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
149933193|NCT02219685|540891666|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
149933194|NCT02219685|540891665|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
149933195|NCT02219685|540891666|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
149933196|NCT00698815|540891667|FG000|Overall Study|Death|1|||
149933197|NCT00698815|540891668|FG001|Overall Study|Death|2|||
150166098|NCT00742274|541743460|FG001|Overall Study|Removed for medical reasons|1|||
150166099|NCT04523181|541743462|FG000|Overall Study|Withdrawal by Subject|4|||
150166100|NCT04523181|541743463|FG001|Overall Study|Withdrawal by Subject|5|||
150166101|NCT04523181|541743462|FG000|Overall Study|Lost to Follow-up|2|||
150166102|NCT04523181|541743463|FG001|Overall Study|Lost to Follow-up|3|||
150166103|NCT04523181|541743462|FG000|Overall Study|Physician Decision|1|||
150166104|NCT04523181|541743463|FG001|Overall Study|Physician Decision|0|||
150166105|NCT04523181|541743462|FG000|Overall Study|Transferred to external facility.|1|||
150166106|NCT04523181|541743463|FG001|Overall Study|Transferred to external facility.|1|||
150166107|NCT04305912|541743471|FG000|First Intervention|COVID-19 Suspension|2|||
150166108|NCT04305912|541743472|FG001|First Intervention|COVID-19 Suspension|0|||
150166109|NCT04305912|541743471|FG000|First Intervention|Withdrawal by Subject|0|||
150166110|NCT04305912|541743472|FG001|First Intervention|Withdrawal by Subject|1|||
150166111|NCT04305912|541743471|FG000|Second Intervention|Adverse Event|0|||
150166112|NCT04305912|541743472|FG001|Second Intervention|Adverse Event|1|||
150166113|NCT01268566|541743474|FG000|Overall Study|Lost to Follow-up|1|||
150166114|NCT01268566|541743474|FG000|Overall Study|Withdrawal by Subject|12|||
150166115|NCT01268566|541743474|FG000|Overall Study|Death|30|||
150166116|NCT01649427|541743479|FG000|Overall Study|Adverse Event|1|||
150166117|NCT01649427|541743480|FG001|Overall Study|Adverse Event|1|||
150166118|NCT01649427|541743479|FG000|Overall Study|Withdrawal by Subject|8|||
150166119|NCT01649427|541743480|FG001|Overall Study|Withdrawal by Subject|7|||
150166120|NCT01649427|541743479|FG000|Overall Study|Lost to Follow-up|0|||
150166121|NCT01649427|541743480|FG001|Overall Study|Lost to Follow-up|1|||
150166122|NCT01649427|541743479|FG000|Overall Study|Graft loss|0|||
150166123|NCT01649427|541743480|FG001|Overall Study|Graft loss|1|||
150166124|NCT01649427|541743479|FG000|Overall Study|Surgical problems during nephrectomy|2|||
150166125|NCT01649427|541743480|FG001|Overall Study|Surgical problems during nephrectomy|2|||
150166126|NCT02138916|541743481|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
150166127|NCT02138916|541743482|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
150166128|NCT02138916|541743483|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
150166129|NCT02138916|541743481|FG000|Overall Study|Death|14|||
150166130|NCT02138916|541743482|FG001|Overall Study|Death|11|||
150166131|NCT02138916|541743483|FG002|Overall Study|Death|12|||
150166132|NCT02138916|541743481|FG000|Overall Study|Withdrawal by Subject|27|||
150166133|NCT02138916|541743482|FG001|Overall Study|Withdrawal by Subject|31|||
150166134|NCT02138916|541743483|FG002|Overall Study|Withdrawal by Subject|32|||
150166135|NCT02138916|541743481|FG000|Overall Study|Study specific withdrawal criteria|0|||
150166136|NCT02138916|541743482|FG001|Overall Study|Study specific withdrawal criteria|0|||
150166137|NCT02138916|541743483|FG002|Overall Study|Study specific withdrawal criteria|1|||
150166138|NCT02138916|541743481|FG000|Overall Study|incorrect enrolment|1|||
150166139|NCT02138916|541743482|FG001|Overall Study|incorrect enrolment|1|||
150166140|NCT02138916|541743483|FG002|Overall Study|incorrect enrolment|0|||
150166141|NCT02138916|541743481|FG000|Overall Study|Severe non-compliance|1|||
150166142|NCT02138916|541743482|FG001|Overall Study|Severe non-compliance|2|||
150166143|NCT02138916|541743483|FG002|Overall Study|Severe non-compliance|1|||
150166144|NCT02138916|541743481|FG000|Overall Study|Lost to Follow-up|4|||
150166145|NCT02138916|541743482|FG001|Overall Study|Lost to Follow-up|2|||
150166146|NCT02138916|541743483|FG002|Overall Study|Lost to Follow-up|3|||
150166147|NCT02138916|541743481|FG000|Overall Study|Adverse Event|4|||
150166148|NCT02138916|541743482|FG001|Overall Study|Adverse Event|4|||
150166149|NCT02138916|541743483|FG002|Overall Study|Adverse Event|3|||
150166150|NCT01348087|541743484|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
150166151|NCT01348087|541743484|FG000|Overall Study|Administrative problems|79|||
150166152|NCT01348087|541743484|FG000|Overall Study|protocol deviation|1|||
150166153|NCT01348087|541743484|FG000|Overall Study|Lost to Follow-up|1|||
150166154|NCT01348087|541743484|FG000|Overall Study|Subject withdrew consent|7|||
150166155|NCT01348087|541743484|FG000|Overall Study|Adverse Event|25|||
150166156|NCT00117988|541743488|FG000|Overall Study|Death|3|||
150166157|NCT00117988|541743488|FG000|Overall Study|Adverse Event|1|||
150266459|NCT03285178|542112562|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149933198|NCT00698815|540891669|FG002|Overall Study|Death|4|||
149933199|NCT00698815|540891667|FG000|Overall Study|Withdrawal by Subject|6|||
149933200|NCT00698815|540891668|FG001|Overall Study|Withdrawal by Subject|3|||
150166158|NCT02482233|541743496|FG000|Overall Study|Lost to Follow-up|1|||
150166159|NCT02482233|541743497|FG001|Overall Study|Lost to Follow-up|1|||
150166160|NCT04888585|541743498|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
149933201|NCT00698815|540891669|FG002|Overall Study|Withdrawal by Subject|2|||
149933202|NCT00698815|540891667|FG000|Overall Study|MD discretion|2|||
149933203|NCT00698815|540891668|FG001|Overall Study|MD discretion|7|||
149933204|NCT00698815|540891669|FG002|Overall Study|MD discretion|2|||
150266460|NCT03285178|542112556|FG000|Double-Blind Treatment Period|COVID-19|0|||
150266461|NCT03285178|542112557|FG001|Double-Blind Treatment Period|COVID-19|0|||
150266462|NCT03285178|542112558|FG002|Double-Blind Treatment Period|COVID-19|1|||
150266463|NCT03285178|542112559|FG003|Double-Blind Treatment Period|COVID-19|0|||
150266464|NCT03285178|542112560|FG004|Double-Blind Treatment Period|COVID-19|0|||
150266465|NCT03285178|542112561|FG005|Double-Blind Treatment Period|COVID-19|0|||
150266466|NCT03285178|542112562|FG006|Double-Blind Treatment Period|COVID-19|0|||
150266467|NCT01128894|542112563|FG000|Overall Study|Adverse Event|31|||
150266468|NCT01128894|542112564|FG001|Overall Study|Adverse Event|41|||
150266469|NCT01128894|542112563|FG000|Overall Study|Protocol Violation|2|||
150266470|NCT01128894|542112564|FG001|Overall Study|Protocol Violation|1|||
150266471|NCT01128894|542112563|FG000|Overall Study|Noncompliance|4|||
150266472|NCT01128894|542112564|FG001|Overall Study|Noncompliance|5|||
150266473|NCT01128894|542112563|FG000|Overall Study|Lost to Follow-up|8|||
150266474|NCT01128894|542112564|FG001|Overall Study|Lost to Follow-up|8|||
150266475|NCT01128894|542112563|FG000|Overall Study|Withdrawal by Subject|10|||
150266476|NCT01128894|542112564|FG001|Overall Study|Withdrawal by Subject|12|||
150266477|NCT01128894|542112563|FG000|Overall Study|Physician Decision|2|||
150266478|NCT01128894|542112564|FG001|Overall Study|Physician Decision|1|||
150266479|NCT01128894|542112563|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
150266480|NCT01128894|542112564|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
150266481|NCT03437278|542112565|FG000|Overall Study|Adverse Event|0|||
150266482|NCT03437278|542112566|FG001|Overall Study|Adverse Event|0|||
150266483|NCT03437278|542112567|FG002|Overall Study|Adverse Event|1|||
150266484|NCT03437278|542112565|FG000|Overall Study|Progressive disease|1|||
150266485|NCT03437278|542112566|FG001|Overall Study|Progressive disease|0|||
149820107|NCT00549198|540471676|FG000|Overall Study|Withdrawal by Subject|7|||
149820108|NCT00549198|540471677|FG001|Overall Study|Withdrawal by Subject|7|||
149820109|NCT00549198|540471676|FG000|Overall Study|Disease Progression|1|||
149820110|NCT00549198|540471677|FG001|Overall Study|Disease Progression|0|||
149820111|NCT00549198|540471676|FG000|Overall Study|Participant Moved|2|||
149820112|NCT00549198|540471677|FG001|Overall Study|Participant Moved|0|||
149820113|NCT00549198|540471676|FG000|Overall Study|Participant not able to perform Week 96|1|||
149820114|NCT00549198|540471677|FG001|Overall Study|Participant not able to perform Week 96|0|||
149820115|NCT00549198|540471676|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
149820116|NCT00549198|540471677|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
149820117|NCT00549198|540471676|FG000|Overall Study|Prohibited Medication|1|||
149820118|NCT00549198|540471677|FG001|Overall Study|Prohibited Medication|2|||
149820119|NCT00549198|540471676|FG000|Overall Study|Participant planning pregnancy|1|||
149820120|NCT00549198|540471677|FG001|Overall Study|Participant planning pregnancy|0|||
149820121|NCT00549198|540471676|FG000|Overall Study|Participant overweight, no scan possible|1|||
149820122|NCT00549198|540471677|FG001|Overall Study|Participant overweight, no scan possible|0|||
149820123|NCT00549198|540471676|FG000|Overall Study|No scan facilities|0|||
149820124|NCT00549198|540471677|FG001|Overall Study|No scan facilities|2|||
149820125|NCT00549198|540471676|FG000|Overall Study|Pregnancy|0|||
149820126|NCT00549198|540471677|FG001|Overall Study|Pregnancy|3|||
149820127|NCT00549198|540471676|FG000|Overall Study|Not Exposed to Study Drug|3|||
149820128|NCT00549198|540471677|FG001|Overall Study|Not Exposed to Study Drug|4|||
149820129|NCT01473758|540471678|FG000|Cycle 1|Adverse Event|10|||
149820130|NCT01473758|540471679|FG001|Cycle 1|Adverse Event|2|||
149820131|NCT01473758|540471680|FG002|Cycle 1|Adverse Event|0|||
149820132|NCT01473758|540471681|FG003|Cycle 1|Adverse Event|0|||
149820133|NCT01473758|540471678|FG000|Cycle 1|Withdrawal by Subject|1|||
149820134|NCT01473758|540471679|FG001|Cycle 1|Withdrawal by Subject|1|||
149820135|NCT01473758|540471680|FG002|Cycle 1|Withdrawal by Subject|0|||
149820136|NCT01473758|540471681|FG003|Cycle 1|Withdrawal by Subject|0|||
149820137|NCT01473758|540471678|FG000|Cycle 2|Adverse Event|0|||
149820138|NCT01473758|540471679|FG001|Cycle 2|Adverse Event|0|||
149820139|NCT01473758|540471680|FG002|Cycle 2|Adverse Event|5|||
149820140|NCT01473758|540471681|FG003|Cycle 2|Adverse Event|0|||
149820141|NCT02480010|540471682|FG000|Overall Study|Adverse Event|3|||
149820142|NCT02480010|540471683|FG001|Overall Study|Adverse Event|1|||
149820143|NCT02480010|540471682|FG000|Overall Study|Death|1|||
149820144|NCT02480010|540471683|FG001|Overall Study|Death|0|||
149820145|NCT02480010|540471682|FG000|Overall Study|Insufficient therapeutic response|31|||
149820146|NCT02480010|540471683|FG001|Overall Study|Insufficient therapeutic response|29|||
149820147|NCT02480010|540471682|FG000|Overall Study|Refused Treatment|0|||
149820148|NCT02480010|540471683|FG001|Overall Study|Refused Treatment|3|||
149820149|NCT01165684|540471693|FG000|Overall Study|Adverse Event|1|||
149820150|NCT01165684|540471694|FG001|Overall Study|Adverse Event|1|||
149820151|NCT01165684|540471693|FG000|Overall Study|Lack of Efficacy|2|||
149820152|NCT01165684|540471694|FG001|Overall Study|Lack of Efficacy|1|||
149820153|NCT01165684|540471693|FG000|Overall Study|Protocol Violation|7|||
149820154|NCT01165684|540471694|FG001|Overall Study|Protocol Violation|15|||
150266486|NCT03437278|542112567|FG002|Overall Study|Progressive disease|0|||
150266487|NCT03437278|542112565|FG000|Overall Study|Physician Decision|1|||
150266488|NCT03437278|542112566|FG001|Overall Study|Physician Decision|0|||
150266489|NCT03437278|542112567|FG002|Overall Study|Physician Decision|1|||
150266490|NCT00973362|542112568|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
150266491|NCT00973362|542112569|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
150266492|NCT00973362|542112568|FG000|Baseline Evaluation|No colposcopy visit|62|||
150266493|NCT00973362|542112569|FG001|Baseline Evaluation|No colposcopy visit|0|||
150266494|NCT00973362|542112568|FG000|Baseline Evaluation|Inevaluable|686|||
150266495|NCT00973362|542112569|FG001|Baseline Evaluation|Inevaluable|223|||
150266496|NCT00973362|542112568|FG000|3-Year Follow-up|Lost to Follow-up|17|||
150266497|NCT00973362|542112569|FG001|3-Year Follow-up|Lost to Follow-up|0|||
150266498|NCT05116046|542112570|FG000|Overall Study|Withdrawal by parent/guardian|2|||
150266499|NCT05116046|542112571|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149933205|NCT00698815|540891667|FG000|Overall Study|Did not receive protocol treatment|1|||
150266500|NCT05116046|542112572|FG002|Overall Study|Withdrawal by parent/guardian|1|||
150266501|NCT05116046|542112570|FG000|Overall Study|Study terminated by sponsor|14|||
150266502|NCT05116046|542112571|FG001|Overall Study|Study terminated by sponsor|16|||
150266503|NCT05116046|542112572|FG002|Overall Study|Study terminated by sponsor|1|||
150266504|NCT02168842|542112573|FG000|Overall Study|Withdrawal by Subject|5|||
150266505|NCT02168842|542112574|FG001|Overall Study|Withdrawal by Subject|3|||
150266506|NCT02168842|542112573|FG000|Overall Study|Lost to Follow-up|0|||
150266507|NCT02168842|542112574|FG001|Overall Study|Lost to Follow-up|2|||
150266508|NCT02168842|542112573|FG000|Overall Study|Death|2|||
150266509|NCT02168842|542112574|FG001|Overall Study|Death|1|||
150266510|NCT02168842|542112573|FG000|Overall Study|Physician Decision|1|||
150266511|NCT02168842|542112574|FG001|Overall Study|Physician Decision|2|||
150266512|NCT02147353|542112575|FG000|Overall Study|Lost to Follow-up|2|||
150266513|NCT02147353|542112576|FG001|Overall Study|Lost to Follow-up|0|||
150266514|NCT02147353|542112575|FG000|Overall Study|unable to make visits|4|||
150266515|NCT02147353|542112576|FG001|Overall Study|unable to make visits|0|||
150266516|NCT02147353|542112575|FG000|Overall Study|medication noncompliance|3|||
150266517|NCT02147353|542112576|FG001|Overall Study|medication noncompliance|0|||
150266518|NCT02974088|542112577|FG000|Overall Study|Lost to Follow-up|0|||
150266519|NCT02974088|542112578|FG001|Overall Study|Lost to Follow-up|2|||
150266520|NCT02974088|542112577|FG000|Overall Study|Adverse Event|0|||
150266521|NCT02974088|542112578|FG001|Overall Study|Adverse Event|1|||
150266522|NCT00150969|542112579|FG000|24 Month Main Study|Adverse Event|3|||
150266523|NCT00150969|542112580|FG001|24 Month Main Study|Adverse Event|4|||
150266524|NCT00150969|542112579|FG000|24 Month Main Study|Death|1|||
150266525|NCT00150969|542112580|FG001|24 Month Main Study|Death|1|||
150266526|NCT00150969|542112579|FG000|24 Month Main Study|Lack of Efficacy|1|||
150266527|NCT00150969|542112580|FG001|24 Month Main Study|Lack of Efficacy|8|||
150266528|NCT00150969|542112579|FG000|24 Month Main Study|Lost to Follow-up|3|||
150266529|NCT00150969|542112580|FG001|24 Month Main Study|Lost to Follow-up|2|||
150266530|NCT00150969|542112579|FG000|24 Month Main Study|Protocol Violation|4|||
150266531|NCT00150969|542112580|FG001|24 Month Main Study|Protocol Violation|2|||
150266532|NCT00150969|542112579|FG000|24 Month Main Study|Withdrawal by Subject|7|||
150266533|NCT00150969|542112580|FG001|24 Month Main Study|Withdrawal by Subject|4|||
150266534|NCT00150969|542112579|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
150266535|NCT00150969|542112580|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
149933206|NCT00698815|540891668|FG001|Overall Study|Did not receive protocol treatment|2|||
149933207|NCT00698815|540891669|FG002|Overall Study|Did not receive protocol treatment|2|||
149933208|NCT00731822|540891673|FG000|Overall Study|Adverse Event|2|||
149933209|NCT00731822|540891674|FG001|Overall Study|Adverse Event|1|||
149933210|NCT00731822|540891673|FG000|Overall Study|Protocol Violation|1|||
149933211|NCT00731822|540891674|FG001|Overall Study|Protocol Violation|0|||
149933212|NCT00731822|540891673|FG000|Overall Study|Lost to Follow-up|1|||
149933213|NCT00731822|540891674|FG001|Overall Study|Lost to Follow-up|0|||
149933214|NCT02127658|540891675|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
149933215|NCT02127658|540891676|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
149933216|NCT02127658|540891675|FG000|Overall Study|Withdrawal by Subject|0|||
149933217|NCT02127658|540891676|FG001|Overall Study|Withdrawal by Subject|2|||
149933218|NCT02127658|540891675|FG000|Overall Study|Physician Decision|0|||
149933219|NCT02127658|540891676|FG001|Overall Study|Physician Decision|1|||
149933220|NCT02131064|540891682|FG000|Overall Study|Death|5|||
149933221|NCT02131064|540891683|FG001|Overall Study|Death|6|||
149933222|NCT02131064|540891682|FG000|Overall Study|Lost to Follow-up|4|||
149933223|NCT02131064|540891683|FG001|Overall Study|Lost to Follow-up|8|||
150266536|NCT00150969|542112579|FG000|24-48 Month Extension|Lack of Efficacy|0|||
150266537|NCT00150969|542112580|FG001|24-48 Month Extension|Lack of Efficacy|1|||
150266538|NCT00150969|542112579|FG000|24-48 Month Extension|Adverse Event|1|||
150266539|NCT00150969|542112580|FG001|24-48 Month Extension|Adverse Event|3|||
150266540|NCT00150969|542112579|FG000|24-48 Month Extension|Other Reason|81|||
150266541|NCT00150969|542112580|FG001|24-48 Month Extension|Other Reason|91|||
150266542|NCT02893930|542112584|FG000|Overall Study|Adverse Event|3|||
150266543|NCT02893930|542112584|FG000|Overall Study|Death|1|||
150166161|NCT04888585|541743499|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
150166162|NCT04888585|541743500|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
150166163|NCT04888585|541743501|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
150166164|NCT04888585|541743502|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
150166165|NCT04888585|541743503|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166166|NCT04888585|541743504|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166167|NCT04888585|541743505|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166168|NCT04888585|541743506|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166169|NCT04888585|541743507|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166170|NCT04888585|541743508|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
150166171|NCT04888585|541743498|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166172|NCT04888585|541743499|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
150166173|NCT04888585|541743500|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
150166174|NCT04888585|541743501|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
150166175|NCT04888585|541743502|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
150166176|NCT04888585|541743503|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166177|NCT04888585|541743504|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166178|NCT04888585|541743505|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166179|NCT04888585|541743506|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166180|NCT04888585|541743507|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166181|NCT04888585|541743508|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
150166182|NCT04888585|541743498|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166183|NCT04888585|541743499|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166184|NCT04888585|541743500|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
150166185|NCT04888585|541743501|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166186|NCT04888585|541743502|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
150166187|NCT04888585|541743503|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166188|NCT04888585|541743504|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166189|NCT04888585|541743505|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166190|NCT04888585|541743506|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166191|NCT04888585|541743507|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166192|NCT04888585|541743508|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
150166193|NCT04888585|541743498|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166194|NCT04888585|541743499|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166195|NCT04888585|541743500|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166196|NCT04888585|541743501|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166197|NCT04888585|541743502|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166198|NCT04888585|541743503|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166199|NCT04888585|541743504|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166200|NCT04888585|541743505|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
150166201|NCT04888585|541743506|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166202|NCT04888585|541743507|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
150166203|NCT04888585|541743508|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
150166204|NCT04888585|541743498|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
150166205|NCT04888585|541743499|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
150166206|NCT04888585|541743500|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
150166207|NCT04888585|541743501|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
150166208|NCT04888585|541743502|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
150166209|NCT04888585|541743503|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
150166210|NCT04888585|541743504|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
150166211|NCT04888585|541743505|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
150166212|NCT04888585|541743506|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
150166213|NCT04888585|541743507|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
150166214|NCT04888585|541743508|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
150166215|NCT04888585|541743498|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
150166216|NCT04888585|541743499|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
150166217|NCT04888585|541743500|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
150166218|NCT04888585|541743501|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
150166219|NCT04888585|541743502|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
150166220|NCT04888585|541743503|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
150166221|NCT04888585|541743504|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
150166222|NCT04888585|541743505|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
150166223|NCT04888585|541743506|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
149933224|NCT02131064|540891682|FG000|Overall Study|Withdrawal by Subject|14|||
150266544|NCT02893930|542112584|FG000|Overall Study|Disease progression|5|||
149933225|NCT02131064|540891683|FG001|Overall Study|Withdrawal by Subject|18|||
149933226|NCT02131064|540891682|FG000|Overall Study|Other|2|||
149933227|NCT02131064|540891683|FG001|Overall Study|Other|2|||
149933228|NCT00593918|540891684|FG000|Overall Study|Withdrawal by Subject|5|||
149933229|NCT00593918|540891685|FG001|Overall Study|Withdrawal by Subject|24|||
149933230|NCT00570401|540891696|FG000|Overall Study|Adverse Event|2|||
149933231|NCT00871234|540891697|FG000|Overall Study|Adverse Event|2|||
149933232|NCT00871234|540891697|FG000|Overall Study|Lost to Follow-up|3|||
149933233|NCT01710020|540891698|FG000|Period 1|Protocol Violation|1|||
149933234|NCT01764841|540891699|FG000|Overall Study|Logistical Difficulties|0|||
149933235|NCT01764841|540891700|FG001|Overall Study|Logistical Difficulties|1|||
150266545|NCT02893930|542112584|FG000|Overall Study|Withdrawal by Subject|2|||
150266546|NCT02893930|542112584|FG000|Overall Study|Physician Decision|1|||
150266547|NCT02893930|542112584|FG000|Overall Study|Ineligible|1|||
150266548|NCT01054846|542112585|FG000|Overall Study|Lost to Follow-up|76|||
150266549|NCT01054846|542112586|FG001|Overall Study|Lost to Follow-up|17|||
149933236|NCT01764841|540891701|FG002|Overall Study|Logistical Difficulties|0|||
149933237|NCT01764841|540891702|FG003|Overall Study|Logistical Difficulties|0|||
149933238|NCT01764841|540891699|FG000|Overall Study|Death|3|||
149933239|NCT01764841|540891700|FG001|Overall Study|Death|0|||
149933240|NCT01764841|540891701|FG002|Overall Study|Death|1|||
149933241|NCT01764841|540891702|FG003|Overall Study|Death|4|||
149933242|NCT01764841|540891699|FG000|Overall Study|No Follow Up|1|||
149933243|NCT01764841|540891700|FG001|Overall Study|No Follow Up|0|||
149933244|NCT01764841|540891701|FG002|Overall Study|No Follow Up|1|||
149933245|NCT01764841|540891702|FG003|Overall Study|No Follow Up|0|||
149933246|NCT01764841|540891699|FG000|Overall Study|Protocol Violation|0|||
149933247|NCT01764841|540891700|FG001|Overall Study|Protocol Violation|1|||
149933248|NCT01764841|540891701|FG002|Overall Study|Protocol Violation|0|||
149933249|NCT01764841|540891702|FG003|Overall Study|Protocol Violation|0|||
149933250|NCT01764841|540891699|FG000|Overall Study|Withdrawal by Subject|16|||
149933251|NCT01764841|540891700|FG001|Overall Study|Withdrawal by Subject|24|||
149933252|NCT01764841|540891701|FG002|Overall Study|Withdrawal by Subject|11|||
149933253|NCT01764841|540891702|FG003|Overall Study|Withdrawal by Subject|15|||
149933254|NCT01764841|540891699|FG000|Overall Study|Lost to Follow-up|3|||
149933255|NCT01764841|540891700|FG001|Overall Study|Lost to Follow-up|0|||
149933256|NCT01764841|540891701|FG002|Overall Study|Lost to Follow-up|1|||
149933257|NCT01764841|540891702|FG003|Overall Study|Lost to Follow-up|0|||
149933258|NCT04202497|540891704|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
149933259|NCT04202497|540891705|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
149933260|NCT04202497|540891706|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
149933261|NCT04202497|540891707|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
149933262|NCT04344301|540891708|FG000|Overall Study|Withdrawal by Subject|1|||
149933263|NCT04344301|540891709|FG001|Overall Study|Withdrawal by Subject|0|||
149933264|NCT04344301|540891708|FG000|Overall Study|Death|0|||
149933265|NCT04344301|540891709|FG001|Overall Study|Death|1|||
149933266|NCT01747499|540891710|FG000|Overall Study|Steroid refractory aGvHD|1|||
149933267|NCT01747499|540891711|FG001|Overall Study|Steroid refractory aGvHD|0|||
149933268|NCT01747499|540891712|FG002|Overall Study|Steroid refractory aGvHD|0|||
149933269|NCT01747499|540891713|FG003|Overall Study|Steroid refractory aGvHD|1|||
149933270|NCT01747499|540891714|FG004|Overall Study|Steroid refractory aGvHD|4|||
149933271|NCT01747499|540891710|FG000|Overall Study|Physician Decision|0|||
149933272|NCT01747499|540891711|FG001|Overall Study|Physician Decision|1|||
149933273|NCT01747499|540891712|FG002|Overall Study|Physician Decision|0|||
149933274|NCT01747499|540891713|FG003|Overall Study|Physician Decision|0|||
149933275|NCT01747499|540891714|FG004|Overall Study|Physician Decision|2|||
150166224|NCT04888585|541743507|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
150166225|NCT04888585|541743508|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
150166226|NCT04888585|541743498|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
150166227|NCT04888585|541743499|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
150166228|NCT04888585|541743500|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
150166229|NCT04888585|541743501|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
150166230|NCT04888585|541743502|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
150166231|NCT04888585|541743503|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
150166232|NCT04888585|541743504|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
150166233|NCT04888585|541743505|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
150266550|NCT02446886|542112589|FG000|Overall Study|Adverse Event|1|||
150266551|NCT02446886|542112590|FG001|Overall Study|Adverse Event|3|||
150266552|NCT02446886|542112589|FG000|Overall Study|Withdrawal by Subject|1|||
150266553|NCT02446886|542112590|FG001|Overall Study|Withdrawal by Subject|1|||
149933276|NCT01747499|540891710|FG000|Overall Study|Death|0|||
149933277|NCT01747499|540891711|FG001|Overall Study|Death|0|||
149933278|NCT01747499|540891712|FG002|Overall Study|Death|0|||
149933279|NCT01747499|540891713|FG003|Overall Study|Death|1|||
149933280|NCT01747499|540891714|FG004|Overall Study|Death|1|||
149933281|NCT01747499|540891710|FG000|Overall Study|Withdrawal by Subject|0|||
149933282|NCT01747499|540891711|FG001|Overall Study|Withdrawal by Subject|0|||
149933283|NCT01747499|540891712|FG002|Overall Study|Withdrawal by Subject|0|||
149933284|NCT01747499|540891713|FG003|Overall Study|Withdrawal by Subject|0|||
149933285|NCT01747499|540891714|FG004|Overall Study|Withdrawal by Subject|6|||
149933286|NCT01747499|540891710|FG000|Overall Study|Developed AML and death|0|||
149933287|NCT01747499|540891711|FG001|Overall Study|Developed AML and death|0|||
149933288|NCT01747499|540891712|FG002|Overall Study|Developed AML and death|0|||
149933289|NCT01747499|540891713|FG003|Overall Study|Developed AML and death|0|||
149933290|NCT01747499|540891714|FG004|Overall Study|Developed AML and death|1|||
149933291|NCT01747499|540891710|FG000|Overall Study|Determined not to be eligible|0|||
149933292|NCT01747499|540891711|FG001|Overall Study|Determined not to be eligible|0|||
149933293|NCT01747499|540891712|FG002|Overall Study|Determined not to be eligible|0|||
149933294|NCT01747499|540891713|FG003|Overall Study|Determined not to be eligible|0|||
149933295|NCT01747499|540891714|FG004|Overall Study|Determined not to be eligible|1|||
149933296|NCT00072410|540891715|FG000|Overall Study|Progressive disease|0|||
149933297|NCT00072410|540891716|FG001|Overall Study|Progressive disease|3|||
149933298|NCT00549549|540891719|FG000|Overall Study|Adverse Event|5|||
149933299|NCT00549549|540891720|FG001|Overall Study|Adverse Event|3|||
149933300|NCT00549549|540891721|FG002|Overall Study|Adverse Event|1|||
149933301|NCT00549549|540891722|FG003|Overall Study|Adverse Event|9|||
149933302|NCT00549549|540891719|FG000|Overall Study|Lack of Efficacy|9|||
149933303|NCT00549549|540891720|FG001|Overall Study|Lack of Efficacy|6|||
149933304|NCT00549549|540891721|FG002|Overall Study|Lack of Efficacy|4|||
149933305|NCT00549549|540891722|FG003|Overall Study|Lack of Efficacy|2|||
149933306|NCT00549549|540891719|FG000|Overall Study|Lost to Follow-up|1|||
150266554|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
150266555|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
150266556|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
150266557|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
150266558|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
150266559|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
150266560|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
150266561|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
150266562|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
150266563|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
150266564|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
150266565|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
150266566|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
150266567|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
150266568|NCT01294683|542112600|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
150266569|NCT01294683|542112601|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
150266570|NCT01294683|542112600|FG000|Post Crossover (Period III)|Adverse Event|6|||
150266571|NCT01294683|542112601|FG001|Post Crossover (Period III)|Adverse Event|6|||
149933307|NCT00549549|540891720|FG001|Overall Study|Lost to Follow-up|0|||
149933308|NCT00549549|540891721|FG002|Overall Study|Lost to Follow-up|1|||
149933309|NCT00549549|540891722|FG003|Overall Study|Lost to Follow-up|2|||
149933310|NCT00549549|540891719|FG000|Overall Study|Withdrawal by Subject|0|||
149933311|NCT00549549|540891720|FG001|Overall Study|Withdrawal by Subject|4|||
149933312|NCT00549549|540891721|FG002|Overall Study|Withdrawal by Subject|1|||
149933313|NCT00549549|540891722|FG003|Overall Study|Withdrawal by Subject|0|||
149933314|NCT00549549|540891719|FG000|Overall Study|Other|9|||
149933315|NCT00549549|540891720|FG001|Overall Study|Other|9|||
149933316|NCT00549549|540891721|FG002|Overall Study|Other|9|||
149933317|NCT00549549|540891722|FG003|Overall Study|Other|11|||
149933318|NCT00549549|540891719|FG000|Overall Study|Randomized but not treated|0|||
149933319|NCT00549549|540891720|FG001|Overall Study|Randomized but not treated|0|||
149933320|NCT00549549|540891721|FG002|Overall Study|Randomized but not treated|1|||
149933321|NCT00549549|540891722|FG003|Overall Study|Randomized but not treated|1|||
149933322|NCT02155699|540891723|FG000|Overall Study|Withdrawal by Subject|0|||
149933323|NCT02155699|540891724|FG001|Overall Study|Withdrawal by Subject|3|||
149933324|NCT02155699|540891725|FG002|Overall Study|Withdrawal by Subject|6|||
149933325|NCT02155699|540891726|FG003|Overall Study|Withdrawal by Subject|1|||
149933326|NCT02155699|540891723|FG000|Overall Study|Lost to Follow-up|0|||
149933327|NCT02155699|540891724|FG001|Overall Study|Lost to Follow-up|0|||
149933328|NCT02155699|540891725|FG002|Overall Study|Lost to Follow-up|0|||
149933329|NCT02155699|540891726|FG003|Overall Study|Lost to Follow-up|3|||
149933330|NCT02155699|540891723|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
150266572|NCT01294683|542112600|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
150266573|NCT01294683|542112601|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
149933331|NCT02155699|540891724|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
149933332|NCT02155699|540891725|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
149933333|NCT02155699|540891726|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
149933334|NCT02688933|540891729|FG000|Overall Study|Adverse Event|3|||
150266574|NCT01294683|542112600|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
149933335|NCT02688933|540891730|FG001|Overall Study|Adverse Event|1|||
149933336|NCT02688933|540891729|FG000|Overall Study|Lack of Efficacy|2|||
149933337|NCT02688933|540891730|FG001|Overall Study|Lack of Efficacy|2|||
149933338|NCT02688933|540891729|FG000|Overall Study|Poor compliance to protocol|7|||
149933339|NCT02688933|540891730|FG001|Overall Study|Poor compliance to protocol|4|||
149933340|NCT02688933|540891729|FG000|Overall Study|Hypoglycemia|2|||
149933341|NCT02688933|540891730|FG001|Overall Study|Hypoglycemia|0|||
149933342|NCT02688933|540891729|FG000|Overall Study|Other than Specified|14|||
149933343|NCT02688933|540891730|FG001|Overall Study|Other than Specified|25|||
149933344|NCT02688933|540891729|FG000|Overall Study|Lost to Follow-up|1|||
149933345|NCT02688933|540891730|FG001|Overall Study|Lost to Follow-up|5|||
149933346|NCT00248651|540891731|FG000|Overall Study|Withdrawal by Subject|28|||
149933347|NCT00248651|540891732|FG001|Overall Study|Withdrawal by Subject|40|||
149933348|NCT00248651|540891733|FG002|Overall Study|Withdrawal by Subject|32|||
149933349|NCT00828113|540891734|FG000|Overall Study|Withdrawal by Subject|27|||
149933350|NCT00828113|540891735|FG001|Overall Study|Withdrawal by Subject|26|||
149933351|NCT00828113|540891734|FG000|Overall Study|Lost to Follow-up|3|||
149933352|NCT00828113|540891735|FG001|Overall Study|Lost to Follow-up|5|||
149933353|NCT01365130|540891736|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
149933354|NCT05547386|540891737|FG000|Overall Study|Withdrawal by Subject|7|||
149933355|NCT04622969|540891738|FG000|Overall Study|Withdrawal by Subject|2|||
149933356|NCT04622969|540891739|FG001|Overall Study|Withdrawal by Subject|3|||
149933357|NCT05616013|540891740|FG000|Overall Study|Adverse Event|6|||
149933358|NCT05616013|540891741|FG001|Overall Study|Adverse Event|12|||
149933359|NCT05616013|540891742|FG002|Overall Study|Adverse Event|8|||
149933360|NCT05616013|540891743|FG003|Overall Study|Adverse Event|4|||
149933361|NCT05616013|540891744|FG004|Overall Study|Adverse Event|6|||
149933362|NCT05616013|540891745|FG005|Overall Study|Adverse Event|8|||
149933363|NCT05616013|540891746|FG006|Overall Study|Adverse Event|3|||
149933364|NCT05616013|540891747|FG007|Overall Study|Adverse Event|6|||
149933365|NCT05616013|540891748|FG008|Overall Study|Adverse Event|1|||
149933366|NCT05616013|540891740|FG000|Overall Study|Lost to Follow-up|5|||
149933367|NCT05616013|540891741|FG001|Overall Study|Lost to Follow-up|4|||
149933368|NCT05616013|540891742|FG002|Overall Study|Lost to Follow-up|3|||
149933369|NCT05616013|540891743|FG003|Overall Study|Lost to Follow-up|2|||
150166234|NCT04888585|541743506|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
150166235|NCT04888585|541743507|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
150166236|NCT04888585|541743508|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
150166237|NCT04888585|541743498|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166238|NCT04888585|541743499|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166239|NCT04888585|541743500|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166240|NCT04888585|541743501|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166241|NCT04888585|541743502|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166242|NCT04888585|541743503|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166243|NCT04888585|541743504|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
150166244|NCT04888585|541743505|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
150166245|NCT04888585|541743506|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
150166246|NCT04888585|541743507|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
150166247|NCT04888585|541743508|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
150166248|NCT03822351|541743509|FG000|Overall Study|Death|27|||
150166249|NCT03822351|541743510|FG001|Overall Study|Death|23|||
150166250|NCT03822351|541743511|FG002|Overall Study|Death|24|||
150166251|NCT03822351|541743509|FG000|Overall Study|Lost to Follow-up|6|||
150166252|NCT03822351|541743510|FG001|Overall Study|Lost to Follow-up|2|||
150166253|NCT03822351|541743511|FG002|Overall Study|Lost to Follow-up|1|||
150166254|NCT03822351|541743509|FG000|Overall Study|Withdrawal by Subject|10|||
150166255|NCT03822351|541743510|FG001|Overall Study|Withdrawal by Subject|4|||
150166256|NCT03822351|541743511|FG002|Overall Study|Withdrawal by Subject|6|||
150166257|NCT03822351|541743509|FG000|Overall Study|Progressive Disease|2|||
150166258|NCT03822351|541743510|FG001|Overall Study|Progressive Disease|1|||
150166259|NCT03822351|541743511|FG002|Overall Study|Progressive Disease|0|||
150166260|NCT03822351|541743509|FG000|Overall Study|Not Treated|1|||
150166261|NCT03822351|541743510|FG001|Overall Study|Not Treated|1|||
150166262|NCT03822351|541743511|FG002|Overall Study|Not Treated|1|||
149933370|NCT05616013|540891744|FG004|Overall Study|Lost to Follow-up|0|||
149933371|NCT05616013|540891745|FG005|Overall Study|Lost to Follow-up|5|||
149933372|NCT05616013|540891746|FG006|Overall Study|Lost to Follow-up|2|||
149933373|NCT05616013|540891747|FG007|Overall Study|Lost to Follow-up|1|||
149933374|NCT05616013|540891748|FG008|Overall Study|Lost to Follow-up|2|||
149933375|NCT05616013|540891740|FG000|Overall Study|Non-compliance with study requirements|2|||
150166263|NCT02081391|541743520|FG000|12-hour Treatment|Withdrawal by Subject|3|||
150166264|NCT02081391|541743521|FG001|12-hour Treatment|Withdrawal by Subject|2|||
150166265|NCT02081391|541743522|FG002|12-hour Treatment|Withdrawal by Subject|0|||
150166266|NCT02081391|541743523|FG003|12-hour Treatment|Withdrawal by Subject|0|||
149933376|NCT05616013|540891741|FG001|Overall Study|Non-compliance with study requirements|2|||
149933377|NCT05616013|540891742|FG002|Overall Study|Non-compliance with study requirements|2|||
149933378|NCT05616013|540891743|FG003|Overall Study|Non-compliance with study requirements|3|||
149933379|NCT05616013|540891744|FG004|Overall Study|Non-compliance with study requirements|0|||
149933380|NCT05616013|540891745|FG005|Overall Study|Non-compliance with study requirements|2|||
149933381|NCT05616013|540891746|FG006|Overall Study|Non-compliance with study requirements|1|||
149933382|NCT05616013|540891747|FG007|Overall Study|Non-compliance with study requirements|1|||
149933383|NCT05616013|540891748|FG008|Overall Study|Non-compliance with study requirements|4|||
149933384|NCT05616013|540891740|FG000|Overall Study|Withdrawal by Subject|11|||
149933385|NCT05616013|540891741|FG001|Overall Study|Withdrawal by Subject|9|||
149933386|NCT05616013|540891742|FG002|Overall Study|Withdrawal by Subject|8|||
149933387|NCT05616013|540891743|FG003|Overall Study|Withdrawal by Subject|6|||
149933388|NCT05616013|540891744|FG004|Overall Study|Withdrawal by Subject|3|||
149933389|NCT05616013|540891745|FG005|Overall Study|Withdrawal by Subject|4|||
149933390|NCT05616013|540891746|FG006|Overall Study|Withdrawal by Subject|6|||
149933391|NCT05616013|540891747|FG007|Overall Study|Withdrawal by Subject|5|||
149933392|NCT05616013|540891748|FG008|Overall Study|Withdrawal by Subject|4|||
149933393|NCT05616013|540891740|FG000|Overall Study|Physician Decision|0|||
149933394|NCT05616013|540891741|FG001|Overall Study|Physician Decision|0|||
149933395|NCT05616013|540891742|FG002|Overall Study|Physician Decision|1|||
149933396|NCT05616013|540891743|FG003|Overall Study|Physician Decision|0|||
149933397|NCT05616013|540891744|FG004|Overall Study|Physician Decision|0|||
149933398|NCT05616013|540891745|FG005|Overall Study|Physician Decision|1|||
149933399|NCT05616013|540891746|FG006|Overall Study|Physician Decision|3|||
149933400|NCT05616013|540891747|FG007|Overall Study|Physician Decision|0|||
149933401|NCT05616013|540891748|FG008|Overall Study|Physician Decision|0|||
149933402|NCT05616013|540891740|FG000|Overall Study|Protocol Violation|0|||
149933403|NCT05616013|540891741|FG001|Overall Study|Protocol Violation|0|||
149933404|NCT05616013|540891742|FG002|Overall Study|Protocol Violation|0|||
149933405|NCT05616013|540891743|FG003|Overall Study|Protocol Violation|0|||
149933406|NCT05616013|540891744|FG004|Overall Study|Protocol Violation|0|||
149933407|NCT05616013|540891745|FG005|Overall Study|Protocol Violation|0|||
149933408|NCT05616013|540891746|FG006|Overall Study|Protocol Violation|1|||
149933409|NCT05616013|540891747|FG007|Overall Study|Protocol Violation|0|||
149933410|NCT05616013|540891748|FG008|Overall Study|Protocol Violation|2|||
149933411|NCT05616013|540891740|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
149933412|NCT05616013|540891741|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933413|NCT05616013|540891742|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933414|NCT05616013|540891743|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933415|NCT05616013|540891744|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933416|NCT05616013|540891745|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933417|NCT05616013|540891746|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933418|NCT05616013|540891747|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933419|NCT05616013|540891748|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
149933420|NCT05616013|540891740|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
149933421|NCT05616013|540891741|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933422|NCT05616013|540891742|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933423|NCT05616013|540891743|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933424|NCT05616013|540891744|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933425|NCT05616013|540891745|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933426|NCT05616013|540891746|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
149933427|NCT05616013|540891747|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
150266575|NCT01294683|542112601|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
150266576|NCT01294683|542112600|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
150266577|NCT01294683|542112601|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
150266578|NCT01290601|542112602|FG000|Overall Study|Adverse Event|0|||
150266579|NCT01290601|542112603|FG001|Overall Study|Adverse Event|2|||
150266580|NCT01290601|542112604|FG002|Overall Study|Adverse Event|0|||
150266581|NCT01290601|542112605|FG003|Overall Study|Adverse Event|0|||
149933428|NCT05616013|540891748|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
150266582|NCT01290601|542112602|FG000|Overall Study|Lack of Efficacy|2|||
150266583|NCT01290601|542112603|FG001|Overall Study|Lack of Efficacy|1|||
150266584|NCT01290601|542112604|FG002|Overall Study|Lack of Efficacy|0|||
150266585|NCT01290601|542112605|FG003|Overall Study|Lack of Efficacy|0|||
150266586|NCT01290601|542112602|FG000|Overall Study|Lost to Follow-up|7|||
150266587|NCT01290601|542112603|FG001|Overall Study|Lost to Follow-up|2|||
150266588|NCT01290601|542112604|FG002|Overall Study|Lost to Follow-up|0|||
150266589|NCT01290601|542112605|FG003|Overall Study|Lost to Follow-up|0|||
150266590|NCT01290601|542112602|FG000|Overall Study|Other|1|||
150266591|NCT01290601|542112603|FG001|Overall Study|Other|0|||
150266592|NCT01290601|542112604|FG002|Overall Study|Other|0|||
150266593|NCT01290601|542112605|FG003|Overall Study|Other|0|||
150266594|NCT01290601|542112602|FG000|Overall Study|Protocol Violation|1|||
150266595|NCT01290601|542112603|FG001|Overall Study|Protocol Violation|0|||
149933429|NCT05616013|540891740|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
149933430|NCT05616013|540891741|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933431|NCT05616013|540891742|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933432|NCT05616013|540891743|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933433|NCT05616013|540891744|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933434|NCT05616013|540891745|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933435|NCT05616013|540891746|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933436|NCT05616013|540891747|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
149933437|NCT05616013|540891748|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
150166267|NCT02081391|541743520|FG000|12-hour Treatment|Physician Decision|4|||
150166268|NCT02081391|541743521|FG001|12-hour Treatment|Physician Decision|1|||
150166269|NCT02081391|541743522|FG002|12-hour Treatment|Physician Decision|0|||
150166270|NCT02081391|541743523|FG003|12-hour Treatment|Physician Decision|0|||
150166271|NCT02081391|541743520|FG000|12-hour Treatment|Lack of Efficacy|3|||
150166272|NCT02081391|541743521|FG001|12-hour Treatment|Lack of Efficacy|0|||
150166273|NCT02081391|541743522|FG002|12-hour Treatment|Lack of Efficacy|0|||
150166274|NCT02081391|541743523|FG003|12-hour Treatment|Lack of Efficacy|0|||
150166275|NCT02081391|541743520|FG000|12-hour Treatment|Adverse Event|4|||
150166276|NCT02081391|541743521|FG001|12-hour Treatment|Adverse Event|2|||
150166277|NCT02081391|541743522|FG002|12-hour Treatment|Adverse Event|0|||
150166278|NCT02081391|541743523|FG003|12-hour Treatment|Adverse Event|0|||
150166279|NCT02081391|541743520|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
150166280|NCT02081391|541743521|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
150166281|NCT02081391|541743522|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
150166282|NCT02081391|541743523|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
150166283|NCT02081391|541743520|FG000|12-hour Treatment|Further reasons|2|||
150166284|NCT02081391|541743521|FG001|12-hour Treatment|Further reasons|1|||
150166285|NCT02081391|541743522|FG002|12-hour Treatment|Further reasons|0|||
150166286|NCT02081391|541743523|FG003|12-hour Treatment|Further reasons|0|||
150166287|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
150166288|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
150166289|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
150166290|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
150166291|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
150166292|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
150166293|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
150166294|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
150166295|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
150166296|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
150166297|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
150166298|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
150166299|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
150166300|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
150166301|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
150166302|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
150166303|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
150166304|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
150166305|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
150166306|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
150166307|NCT02081391|541743520|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
150166308|NCT02081391|541743521|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
150166309|NCT02081391|541743522|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
150166310|NCT02081391|541743523|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
150166311|NCT01458275|541743524|FG000|Overall Study|Adverse Event|3|||
150166312|NCT01458275|541743525|FG001|Overall Study|Adverse Event|4|||
150166313|NCT01458275|541743526|FG002|Overall Study|Adverse Event|1|||
150166314|NCT01458275|541743524|FG000|Overall Study|Lost to Follow-up|3|||
150166315|NCT01458275|541743525|FG001|Overall Study|Lost to Follow-up|2|||
150166316|NCT01458275|541743526|FG002|Overall Study|Lost to Follow-up|5|||
150166317|NCT01458275|541743524|FG000|Overall Study|Protocol Violation|5|||
150166318|NCT01458275|541743525|FG001|Overall Study|Protocol Violation|5|||
150166319|NCT01458275|541743526|FG002|Overall Study|Protocol Violation|2|||
150166320|NCT01458275|541743524|FG000|Overall Study|Withdrawal by Subject|3|||
150166321|NCT01458275|541743525|FG001|Overall Study|Withdrawal by Subject|2|||
150166322|NCT01458275|541743526|FG002|Overall Study|Withdrawal by Subject|1|||
150166323|NCT00813488|541743527|FG000|Titration Period 1|Adverse Event|6|||
150166324|NCT00813488|541743528|FG001|Titration Period 1|Adverse Event|1|||
150166325|NCT00813488|541743527|FG000|Titration Period 1|Lack of Efficacy|9|||
150166326|NCT00813488|541743528|FG001|Titration Period 1|Lack of Efficacy|7|||
150266596|NCT01290601|542112604|FG002|Overall Study|Protocol Violation|0|||
150266597|NCT01290601|542112605|FG003|Overall Study|Protocol Violation|0|||
150266598|NCT02571049|542112606|FG000|Screening|Did not meet entry criteria|2|||
150266599|NCT02571049|542112607|FG001|Screening|Did not meet entry criteria|2|||
150266600|NCT02571049|542112606|FG000|Randomization|No migraine attack|0|||
150266601|NCT02571049|542112607|FG001|Randomization|No migraine attack|1|||
150266602|NCT02571049|542112606|FG000|Randomization|Adverse Event|0|||
150266603|NCT02571049|542112607|FG001|Randomization|Adverse Event|1|||
150266604|NCT00985153|542112608|FG000|Overall Study|Lost to Follow-up|16|||
150266605|NCT00985153|542112609|FG001|Overall Study|Lost to Follow-up|19|||
150266606|NCT00985153|542112610|FG002|Overall Study|Lost to Follow-up|17|||
150266607|NCT00985153|542112611|FG003|Overall Study|Lost to Follow-up|20|||
150266608|NCT00985153|542112608|FG000|Overall Study|Protocol Violation|3|||
150266609|NCT00985153|542112609|FG001|Overall Study|Protocol Violation|2|||
150266610|NCT00985153|542112610|FG002|Overall Study|Protocol Violation|4|||
150266611|NCT00985153|542112611|FG003|Overall Study|Protocol Violation|3|||
150266612|NCT00985153|542112608|FG000|Overall Study|Withdrawal by Subject|6|||
150266613|NCT00985153|542112609|FG001|Overall Study|Withdrawal by Subject|11|||
150266614|NCT00985153|542112610|FG002|Overall Study|Withdrawal by Subject|11|||
150266615|NCT00985153|542112611|FG003|Overall Study|Withdrawal by Subject|10|||
150266616|NCT00985153|542112608|FG000|Overall Study|Missed One or More Bleeds|7|||
150266617|NCT00985153|542112609|FG001|Overall Study|Missed One or More Bleeds|7|||
150266618|NCT00985153|542112610|FG002|Overall Study|Missed One or More Bleeds|8|||
150266619|NCT00985153|542112611|FG003|Overall Study|Missed One or More Bleeds|10|||
150266620|NCT00985153|542112608|FG000|Overall Study|Incomplete Safety Follow-up|3|||
150266621|NCT00985153|542112609|FG001|Overall Study|Incomplete Safety Follow-up|5|||
150266622|NCT00985153|542112610|FG002|Overall Study|Incomplete Safety Follow-up|4|||
150266623|NCT00985153|542112611|FG003|Overall Study|Incomplete Safety Follow-up|4|||
150266624|NCT03370471|542112615|FG000|Overall Study|Withdrawal by Subject|6|||
150266625|NCT03370471|542112616|FG001|Overall Study|Withdrawal by Subject|1|||
150266626|NCT03370471|542112615|FG000|Overall Study|Unable to access veins for blood draw|0|||
150266627|NCT03370471|542112616|FG001|Overall Study|Unable to access veins for blood draw|1|||
150266628|NCT03370471|542112615|FG000|Overall Study|Screen fail|1|||
150266629|NCT03370471|542112616|FG001|Overall Study|Screen fail|0|||
150266630|NCT00561951|542112617|FG000|Overall Study|Adverse Event|11|||
150266631|NCT00561951|542112618|FG001|Overall Study|Adverse Event|14|||
150266632|NCT00561951|542112619|FG002|Overall Study|Adverse Event|14|||
150266633|NCT00561951|542112617|FG000|Overall Study|Lack of Efficacy|5|||
150266634|NCT00561951|542112618|FG001|Overall Study|Lack of Efficacy|3|||
150266635|NCT00561951|542112619|FG002|Overall Study|Lack of Efficacy|2|||
150266636|NCT00561951|542112617|FG000|Overall Study|Lost to Follow-up|1|||
150266637|NCT00561951|542112618|FG001|Overall Study|Lost to Follow-up|1|||
150266638|NCT00561951|542112619|FG002|Overall Study|Lost to Follow-up|0|||
150266639|NCT00561951|542112617|FG000|Overall Study|Withdrawal by Subject|10|||
150266640|NCT00561951|542112618|FG001|Overall Study|Withdrawal by Subject|9|||
150266641|NCT00561951|542112619|FG002|Overall Study|Withdrawal by Subject|10|||
150266642|NCT00561951|542112617|FG000|Overall Study|Protocol Violation|4|||
150266643|NCT00561951|542112618|FG001|Overall Study|Protocol Violation|3|||
150266644|NCT00561951|542112619|FG002|Overall Study|Protocol Violation|4|||
150266645|NCT00561951|542112617|FG000|Overall Study|Physician Decision|1|||
150266646|NCT00561951|542112618|FG001|Overall Study|Physician Decision|0|||
150266647|NCT00561951|542112619|FG002|Overall Study|Physician Decision|0|||
150266648|NCT00561951|542112617|FG000|Overall Study|Pregnancy|0|||
150266649|NCT00561951|542112618|FG001|Overall Study|Pregnancy|1|||
150266650|NCT00561951|542112619|FG002|Overall Study|Pregnancy|0|||
150266651|NCT00561951|542112617|FG000|Overall Study|Meet Withdrawal Criterion|0|||
150266652|NCT00561951|542112618|FG001|Overall Study|Meet Withdrawal Criterion|1|||
150266653|NCT00561951|542112619|FG002|Overall Study|Meet Withdrawal Criterion|1|||
150266654|NCT00561951|542112617|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
150266655|NCT00561951|542112618|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
150266656|NCT00561951|542112619|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
150266657|NCT01765179|542112620|FG000|Overall Study|Adverse Event|3|||
150266658|NCT01765179|542112620|FG000|Overall Study|Lost to Follow-up|5|||
150266659|NCT01765179|542112620|FG000|Overall Study|Non-compliance with study drug|2|||
150266660|NCT01765179|542112620|FG000|Overall Study|Protocol Violation|1|||
150266661|NCT01765179|542112620|FG000|Overall Study|Withdrawal by Subject|8|||
150266662|NCT01765179|542112620|FG000|Overall Study|Hematocrit >54%|3|||
150266663|NCT01765179|542112620|FG000|Overall Study|prohibited med|1|||
150266664|NCT01765179|542112620|FG000|Overall Study|Out of country unable to finish study|1|||
150266665|NCT01765179|542112620|FG000|Overall Study|lack of venous access|1|||
150266666|NCT01765179|542112620|FG000|Overall Study|work conflict|1|||
150266667|NCT01765179|542112620|FG000|Overall Study|Ca elevated 10.6|1|||
150266668|NCT02903368|542112621|FG000|Part 1|Adverse Event|3|||
150266669|NCT02903368|542112622|FG001|Part 1|Adverse Event|0|||
150266670|NCT02903368|542112623|FG002|Part 1|Adverse Event|0|||
150266671|NCT02903368|542112624|FG003|Part 1|Adverse Event|0|||
150266672|NCT02903368|542112621|FG000|Part 1|Withdrawal by Subject|1|||
150266673|NCT02903368|542112622|FG001|Part 1|Withdrawal by Subject|0|||
149820155|NCT01165684|540471693|FG000|Overall Study|Withdrawal Criteria|2|||
149820156|NCT01165684|540471694|FG001|Overall Study|Withdrawal Criteria|13|||
149820157|NCT01165684|540471693|FG000|Overall Study|Unclassified|16|||
149820158|NCT01165684|540471694|FG001|Overall Study|Unclassified|22|||
149820159|NCT00901628|540471711|FG000|Overall Study|disconnection of catheter|4|||
149820160|NCT00901628|540471712|FG001|Overall Study|disconnection of catheter|8|||
149820161|NCT00901628|540471711|FG000|Overall Study|disconnection of drain|0|||
149820162|NCT00901628|540471712|FG001|Overall Study|disconnection of drain|1|||
150166327|NCT00813488|541743527|FG000|Titration Period 1|Withdrawal by Subject|2|||
150166328|NCT00813488|541743528|FG001|Titration Period 1|Withdrawal by Subject|2|||
150166329|NCT00813488|541743527|FG000|Titration Period 1|Protocol Violation|4|||
150166330|NCT00813488|541743528|FG001|Titration Period 1|Protocol Violation|3|||
150166331|NCT00813488|541743527|FG000|Titration Period 1|Non-compliance to study medication|4|||
150166332|NCT00813488|541743528|FG001|Titration Period 1|Non-compliance to study medication|1|||
150166333|NCT00813488|541743527|FG000|Titration Period 1|Non-compliance to study procedures|2|||
150166334|NCT00813488|541743528|FG001|Titration Period 1|Non-compliance to study procedures|2|||
150166335|NCT00813488|541743527|FG000|Titration Period 1|Technical Difficulties|0|||
150166336|NCT00813488|541743528|FG001|Titration Period 1|Technical Difficulties|1|||
150166337|NCT00813488|541743527|FG000|Titration Period 2|Adverse Event|2|||
150166338|NCT00813488|541743528|FG001|Titration Period 2|Adverse Event|3|||
150166339|NCT00813488|541743527|FG000|Titration Period 2|Lack of Efficacy|8|||
150166340|NCT00813488|541743528|FG001|Titration Period 2|Lack of Efficacy|4|||
150166341|NCT00813488|541743527|FG000|Titration Period 2|Protocol Violation|3|||
150166342|NCT00813488|541743528|FG001|Titration Period 2|Protocol Violation|2|||
150166343|NCT00813488|541743527|FG000|Titration Period 2|Lost to Follow-up|1|||
150166344|NCT00813488|541743528|FG001|Titration Period 2|Lost to Follow-up|0|||
150166345|NCT00813488|541743527|FG000|Titration Period 2|Non-compliance with study procedures|2|||
150166346|NCT00813488|541743528|FG001|Titration Period 2|Non-compliance with study procedures|1|||
150166347|NCT00813488|541743527|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
150166348|NCT00813488|541743528|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
150166349|NCT00813488|541743527|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
150166350|NCT00813488|541743528|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
150166351|NCT00813488|541743527|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
150166352|NCT00813488|541743528|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
150166353|NCT00813488|541743527|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
150166354|NCT00813488|541743528|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
150166355|NCT00813488|541743527|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
150166356|NCT00813488|541743528|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
150166357|NCT00813488|541743527|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
150166358|NCT00813488|541743528|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
150166359|NCT00813488|541743527|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
150166360|NCT00813488|541743528|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
150166361|NCT00813488|541743527|FG000|Double-blind Treatment Period 2|Other|1|||
150166362|NCT00813488|541743528|FG001|Double-blind Treatment Period 2|Other|0|||
150166363|NCT00813488|541743527|FG000|Open-label Extension|Adverse Event|1|||
150166364|NCT00813488|541743528|FG001|Open-label Extension|Adverse Event|2|||
150166365|NCT00813488|541743527|FG000|Open-label Extension|Lack of Efficacy|3|||
150166366|NCT00813488|541743528|FG001|Open-label Extension|Lack of Efficacy|0|||
150166367|NCT00813488|541743527|FG000|Open-label Extension|Withdrawal by Subject|0|||
150166368|NCT00813488|541743528|FG001|Open-label Extension|Withdrawal by Subject|2|||
150166369|NCT00813488|541743527|FG000|Open-label Extension|Protocol Violation|1|||
150166370|NCT00813488|541743528|FG001|Open-label Extension|Protocol Violation|2|||
150166371|NCT00813488|541743527|FG000|Open-label Extension|Non-compliance study medication|4|||
150166372|NCT00813488|541743528|FG001|Open-label Extension|Non-compliance study medication|0|||
150166373|NCT00813488|541743527|FG000|Open-label Extension|Non-compliance study procedures|2|||
150166374|NCT00813488|541743528|FG001|Open-label Extension|Non-compliance study procedures|1|||
150166375|NCT00813488|541743527|FG000|Open-label Extension|Other|1|||
150166376|NCT00813488|541743528|FG001|Open-label Extension|Other|0|||
150166377|NCT01559090|541743529|FG000|Stage I|Withdrawal by Subject|2|||
150166378|NCT01559090|541743530|FG001|Stage I|Withdrawal by Subject|2|||
150166379|NCT01559090|541743531|FG002|Stage I|Withdrawal by Subject|3|||
150166380|NCT01559090|541743529|FG000|Stage II|Withdrawal by Subject|1|||
150166381|NCT01559090|541743530|FG001|Stage II|Withdrawal by Subject|0|||
150166382|NCT01559090|541743531|FG002|Stage II|Withdrawal by Subject|0|||
150166383|NCT03677375|541743532|FG000|Overall Study|Incomplete procedure|8|||
150166384|NCT03677375|541743532|FG000|Overall Study|Adverse Event|3|||
150166385|NCT03677375|541743532|FG000|Overall Study|Physician Decision|1|||
150166386|NCT03971357|541743535|FG000|Overall Study|Lack of Efficacy|0|||
150166387|NCT03971357|541743536|FG001|Overall Study|Lack of Efficacy|1|||
150166388|NCT01143077|541743537|FG000|Overall Study|Lack of Efficacy|0|||
150166389|NCT01143077|541743538|FG001|Overall Study|Lack of Efficacy|2|||
150166390|NCT01143077|541743539|FG002|Overall Study|Lack of Efficacy|1|||
150166391|NCT01143077|541743537|FG000|Overall Study|Adverse Event|5|||
150166392|NCT01143077|541743538|FG001|Overall Study|Adverse Event|6|||
150266674|NCT02903368|542112623|FG002|Part 1|Withdrawal by Subject|0|||
150266675|NCT02903368|542112624|FG003|Part 1|Withdrawal by Subject|0|||
150266676|NCT02903368|542112621|FG000|Part 2|Adverse Event|0|||
150266677|NCT02903368|542112622|FG001|Part 2|Adverse Event|0|||
150266678|NCT02903368|542112623|FG002|Part 2|Adverse Event|5|||
150266679|NCT02903368|542112624|FG003|Part 2|Adverse Event|0|||
150266680|NCT02903368|542112621|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
150266681|NCT02903368|542112622|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
150266682|NCT02903368|542112623|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
150266683|NCT02903368|542112624|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
150266684|NCT02903368|542112621|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
150266685|NCT02903368|542112622|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
150266686|NCT02903368|542112623|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
150266687|NCT02903368|542112624|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
150266688|NCT02903368|542112621|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
150266689|NCT02903368|542112622|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
150266690|NCT02903368|542112623|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
150266691|NCT02903368|542112624|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
150266692|NCT06515483|542112629|FG000|Overall Study|Subject withdraw due to family issues|1|||
150266693|NCT06515483|542112630|FG001|Overall Study|Subject withdraw due to family issues|0|||
150266694|NCT05959629|542112631|FG000|Overall Study|partially necrotic/technical issues|2|||
150266695|NCT05959629|542112632|FG001|Overall Study|partially necrotic/technical issues|2|||
150266696|NCT00147823|542112636|FG000|Overall Study|Lost to Follow-up|6|||
150266697|NCT00147823|542112637|FG001|Overall Study|Lost to Follow-up|12|||
150266698|NCT00147823|542112636|FG000|Overall Study|Physician Decision|1|||
150266699|NCT00147823|542112637|FG001|Overall Study|Physician Decision|0|||
150266700|NCT00147823|542112636|FG000|Overall Study|Withdrawal by Subject|0|||
150266701|NCT00147823|542112637|FG001|Overall Study|Withdrawal by Subject|1|||
150266702|NCT00147823|542112636|FG000|Overall Study|Did not receive vitoss due to infection|6|||
150266703|NCT00147823|542112637|FG001|Overall Study|Did not receive vitoss due to infection|2|||
150266704|NCT03217266|542114229|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
149933438|NCT05616013|540891740|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933439|NCT05616013|540891741|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
149933440|NCT05616013|540891742|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933441|NCT05616013|540891743|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933442|NCT05616013|540891744|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933443|NCT05616013|540891745|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933444|NCT05616013|540891746|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933445|NCT05616013|540891747|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
150166393|NCT01143077|541743539|FG002|Overall Study|Adverse Event|5|||
150166394|NCT01143077|541743537|FG000|Overall Study|Lost to Follow-up|2|||
150166395|NCT01143077|541743538|FG001|Overall Study|Lost to Follow-up|3|||
150166396|NCT01143077|541743539|FG002|Overall Study|Lost to Follow-up|4|||
150166397|NCT01143077|541743537|FG000|Overall Study|Protocol Violation|2|||
150166398|NCT01143077|541743538|FG001|Overall Study|Protocol Violation|0|||
150166399|NCT01143077|541743539|FG002|Overall Study|Protocol Violation|0|||
150166400|NCT01143077|541743537|FG000|Overall Study|Withdrawal by Subject|4|||
150166401|NCT01143077|541743538|FG001|Overall Study|Withdrawal by Subject|3|||
150166402|NCT01143077|541743539|FG002|Overall Study|Withdrawal by Subject|3|||
150166403|NCT01143077|541743537|FG000|Overall Study|Non-compliance with study drug|0|||
150166404|NCT01143077|541743538|FG001|Overall Study|Non-compliance with study drug|1|||
150166405|NCT01143077|541743539|FG002|Overall Study|Non-compliance with study drug|1|||
150166406|NCT01143077|541743537|FG000|Overall Study|Administrative|1|||
150166407|NCT01143077|541743538|FG001|Overall Study|Administrative|0|||
150166408|NCT01143077|541743539|FG002|Overall Study|Administrative|0|||
150166409|NCT01143077|541743537|FG000|Overall Study|Principal Investigator Decision|2|||
150166410|NCT01143077|541743538|FG001|Overall Study|Principal Investigator Decision|0|||
150166411|NCT01143077|541743539|FG002|Overall Study|Principal Investigator Decision|1|||
150166412|NCT01555762|541743540|FG000|Overall Study|No information on Bevacizumab intake|11|||
150166413|NCT01555762|541743540|FG000|Overall Study|Missing start date of infusion|8|||
150166414|NCT01555762|541743540|FG000|Overall Study|75 years old or more ticked No|1|||
150166415|NCT01555762|541743540|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
150166416|NCT01555762|541743540|FG000|Overall Study|Death linked to progression of disease|165|||
150166417|NCT01555762|541743540|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
150166418|NCT01555762|541743540|FG000|Overall Study|Investigator's decision|10|||
150166419|NCT01555762|541743540|FG000|Overall Study|Participant not wishing to continue|5|||
150266705|NCT03217266|542114230|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
150266706|NCT03217266|542114231|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
149933446|NCT05616013|540891748|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
149933447|NCT05616013|540891740|FG000|Overall Study|Participant Decision, Time Constraints|0|||
149933448|NCT05616013|540891741|FG001|Overall Study|Participant Decision, Time Constraints|1|||
149933449|NCT05616013|540891742|FG002|Overall Study|Participant Decision, Time Constraints|0|||
149933450|NCT05616013|540891743|FG003|Overall Study|Participant Decision, Time Constraints|0|||
149933451|NCT05616013|540891744|FG004|Overall Study|Participant Decision, Time Constraints|0|||
149933452|NCT05616013|540891745|FG005|Overall Study|Participant Decision, Time Constraints|0|||
149933453|NCT05616013|540891746|FG006|Overall Study|Participant Decision, Time Constraints|0|||
149933454|NCT05616013|540891747|FG007|Overall Study|Participant Decision, Time Constraints|0|||
149933455|NCT05616013|540891748|FG008|Overall Study|Participant Decision, Time Constraints|0|||
149933456|NCT05616013|540891740|FG000|Overall Study|Prohibited Concomitant Medication|0|||
149933457|NCT05616013|540891741|FG001|Overall Study|Prohibited Concomitant Medication|0|||
149933458|NCT05616013|540891742|FG002|Overall Study|Prohibited Concomitant Medication|1|||
149933459|NCT05616013|540891743|FG003|Overall Study|Prohibited Concomitant Medication|0|||
149933460|NCT05616013|540891744|FG004|Overall Study|Prohibited Concomitant Medication|0|||
149933461|NCT05616013|540891745|FG005|Overall Study|Prohibited Concomitant Medication|0|||
149933462|NCT05616013|540891746|FG006|Overall Study|Prohibited Concomitant Medication|0|||
150166420|NCT01555762|541743540|FG000|Overall Study|Missing data|1|||
150166421|NCT01555762|541743540|FG000|Overall Study|Death linked to an adverse event|14|||
150166422|NCT01333514|541743541|FG000|Overall Study|Withdrawal by Subject|1|||
150166423|NCT01333514|541743542|FG001|Overall Study|Withdrawal by Subject|0|||
150166424|NCT00819910|541743543|FG000|Overall Study|Adverse Event|0|||
150166425|NCT00819910|541743544|FG001|Overall Study|Adverse Event|0|||
150166426|NCT00819910|541743545|FG002|Overall Study|Adverse Event|2|||
150166427|NCT00819910|541743546|FG003|Overall Study|Adverse Event|1|||
150166428|NCT00819910|541743543|FG000|Overall Study|Withdrawal by Subject|1|||
150166429|NCT00819910|541743544|FG001|Overall Study|Withdrawal by Subject|1|||
150166430|NCT00819910|541743545|FG002|Overall Study|Withdrawal by Subject|1|||
150166431|NCT00819910|541743546|FG003|Overall Study|Withdrawal by Subject|0|||
150166432|NCT00819910|541743543|FG000|Overall Study|Lost to Follow-up|1|||
150166433|NCT00819910|541743544|FG001|Overall Study|Lost to Follow-up|0|||
150166434|NCT00819910|541743545|FG002|Overall Study|Lost to Follow-up|0|||
150166435|NCT00819910|541743546|FG003|Overall Study|Lost to Follow-up|0|||
150166436|NCT00836810|541743547|FG000|Overall Study|New diagnosis|1|||
150166437|NCT00836810|541743548|FG001|Overall Study|New diagnosis|0|||
150166438|NCT00871429|541743550|FG000|Overall Study|Lost to Follow-up|6|||
150166439|NCT00871429|541743550|FG000|Overall Study|Withdrawal by Subject|17|||
150166440|NCT00871429|541743550|FG000|Overall Study|Questionnaire not completed|1|||
150166441|NCT03102242|541743551|FG000|Overall Study|Adverse Event|2|||
150166442|NCT05273801|541743552|FG000|Overall Study|Physician Decision|1|||
150166443|NCT04257058|541745041|FG000|Overall Study|Lost to Follow-up|31|||
150166444|NCT03227757|541745042|FG000|Overall Study|Death|25|||
150166445|NCT03227757|541745042|FG000|Overall Study|Withdrawal|10|||
150166446|NCT03227757|541745042|FG000|Overall Study|Missed visits|1|||
150166447|NCT03227757|541745042|FG000|Overall Study|Lost to Follow-up|2|||
150166448|NCT01144468|541745044|FG000|Overall Study|Lost to Follow-up|4|||
150166449|NCT01144468|541745045|FG001|Overall Study|Lost to Follow-up|7|||
150166450|NCT01144468|541745044|FG000|Overall Study|Adverse Event|3|||
150166451|NCT01144468|541745045|FG001|Overall Study|Adverse Event|2|||
150166452|NCT01144468|541745044|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
150166453|NCT01144468|541745045|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
150166454|NCT02960659|541745046|FG000|Overall Study|Withdrawal by Subject|1|||
150166455|NCT02960659|541745047|FG001|Overall Study|Withdrawal by Subject|0|||
150166456|NCT02960659|541745046|FG000|Overall Study|Poor compliance|0|||
150166457|NCT02960659|541745047|FG001|Overall Study|Poor compliance|1|||
150166458|NCT04199728|541745051|FG000|Overall Study|Adverse Event|1|||
150166459|NCT04199728|541745052|FG001|Overall Study|Adverse Event|0|||
150166460|NCT04199728|541745051|FG000|Overall Study|Withdrawal by Subject|8|||
150166461|NCT04199728|541745052|FG001|Overall Study|Withdrawal by Subject|3|||
150166462|NCT04199728|541745051|FG000|Overall Study|Screen fail after consent|0|||
150166463|NCT04199728|541745052|FG001|Overall Study|Screen fail after consent|1|||
150166464|NCT04199728|541745051|FG000|Overall Study|Early withdraw criteria met|0|||
150166465|NCT04199728|541745052|FG001|Overall Study|Early withdraw criteria met|1|||
150166466|NCT04199728|541745051|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
150166467|NCT04199728|541745052|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
150166468|NCT03068468|541745053|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
150166469|NCT03068468|541745054|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
150166470|NCT03068468|541745055|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
150166471|NCT03068468|541745056|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
150166472|NCT03068468|541745053|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
150166473|NCT03068468|541745054|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
150166474|NCT03068468|541745055|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
150166475|NCT03068468|541745056|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
149933463|NCT05616013|540891747|FG007|Overall Study|Prohibited Concomitant Medication|0|||
149933464|NCT05616013|540891748|FG008|Overall Study|Prohibited Concomitant Medication|0|||
149933465|NCT05616013|540891740|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
150266707|NCT03217266|542114232|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
150266708|NCT03217266|542114229|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
150266709|NCT03217266|542114230|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
150266710|NCT03217266|542114231|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
150266711|NCT03217266|542114232|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
150266712|NCT03217266|542114229|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
150266713|NCT03217266|542114230|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
150266714|NCT03217266|542114231|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
150266715|NCT03217266|542114232|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
150266716|NCT01390181|542114233|FG000|Overall Study|Lost to Follow-up|1|||
150266717|NCT01390181|542114233|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
150266718|NCT00792805|542114240|FG000|Overall Study|Adverse Event|12|||
150266719|NCT00792805|542114241|FG001|Overall Study|Adverse Event|10|||
150266720|NCT00792805|542114242|FG002|Overall Study|Adverse Event|10|||
150266721|NCT00792805|542114240|FG000|Overall Study|Subject withdrew consent|5|||
150266722|NCT00792805|542114241|FG001|Overall Study|Subject withdrew consent|6|||
150266723|NCT00792805|542114242|FG002|Overall Study|Subject withdrew consent|5|||
150266724|NCT00792805|542114240|FG000|Overall Study|Administrative problems|2|||
150266725|NCT00792805|542114241|FG001|Overall Study|Administrative problems|0|||
150266726|NCT00792805|542114242|FG002|Overall Study|Administrative problems|4|||
150266727|NCT00792805|542114240|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150266728|NCT00792805|542114241|FG001|Overall Study|Abnormal test procedure result(s)|2|||
150266729|NCT00792805|542114242|FG002|Overall Study|Abnormal test procedure result(s)|0|||
150266730|NCT00792805|542114240|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150266731|NCT00792805|542114241|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
150266732|NCT00792805|542114242|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
150266733|NCT00792805|542114240|FG000|Overall Study|Lost to Follow-up|1|||
150266734|NCT00792805|542114241|FG001|Overall Study|Lost to Follow-up|1|||
150266735|NCT00792805|542114242|FG002|Overall Study|Lost to Follow-up|6|||
150266736|NCT00792805|542114240|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150266737|NCT00792805|542114241|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150266738|NCT00792805|542114242|FG002|Overall Study|Abnormal laboratory value(s)|1|||
150266739|NCT00792805|542114240|FG000|Overall Study|Protocol deviation|0|||
150266740|NCT00792805|542114241|FG001|Overall Study|Protocol deviation|1|||
150266741|NCT00792805|542114242|FG002|Overall Study|Protocol deviation|1|||
150266742|NCT02598557|542114243|FG000|Overall Study|Withdrawal by Subject|1|||
150166476|NCT03068468|541745053|FG000|Placebo-Controlled Period|Adverse Event|16|||
150166477|NCT03068468|541745054|FG001|Placebo-Controlled Period|Adverse Event|21|||
150166478|NCT03068468|541745055|FG002|Placebo-Controlled Period|Adverse Event|0|||
150166479|NCT03068468|541745056|FG003|Placebo-Controlled Period|Adverse Event|0|||
150166480|NCT03068468|541745053|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
150166481|NCT03068468|541745054|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
150166482|NCT03068468|541745055|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
150166483|NCT03068468|541745056|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
150166484|NCT03068468|541745053|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
150166485|NCT03068468|541745054|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
150166486|NCT03068468|541745055|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150166487|NCT03068468|541745056|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150166488|NCT03068468|541745053|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
150166489|NCT03068468|541745054|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
150166490|NCT03068468|541745055|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
150166491|NCT03068468|541745056|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
150166492|NCT03068468|541745053|FG000|Placebo-Controlled Period|Death|0|||
150166493|NCT03068468|541745054|FG001|Placebo-Controlled Period|Death|1|||
150166494|NCT03068468|541745055|FG002|Placebo-Controlled Period|Death|0|||
150166495|NCT03068468|541745056|FG003|Placebo-Controlled Period|Death|0|||
150166496|NCT03068468|541745053|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
150166497|NCT03068468|541745054|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
150166498|NCT03068468|541745055|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
150166499|NCT03068468|541745056|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
150166500|NCT03068468|541745053|FG000|Open-Label Extension Period|Adverse Event|0|||
150166501|NCT03068468|541745054|FG001|Open-Label Extension Period|Adverse Event|0|||
150166502|NCT03068468|541745055|FG002|Open-Label Extension Period|Adverse Event|13|||
150266743|NCT02598557|542114244|FG001|Overall Study|Withdrawal by Subject|0|||
150266744|NCT02598557|542114245|FG002|Overall Study|Withdrawal by Subject|1|||
149975526|NCT01847755|541047870|FG000|Overall Study|Withdrawal by Subject|2|||
150166503|NCT03068468|541745056|FG003|Open-Label Extension Period|Adverse Event|17|||
150166504|NCT03068468|541745053|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
150166505|NCT03068468|541745054|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
149933466|NCT05616013|540891741|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933467|NCT05616013|540891742|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
149933468|NCT05616013|540891743|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933469|NCT05616013|540891744|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933470|NCT05616013|540891745|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933471|NCT05616013|540891746|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933472|NCT05616013|540891747|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933473|NCT05616013|540891748|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
149933474|NCT05616013|540891740|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933475|NCT05616013|540891741|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933476|NCT05616013|540891742|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933477|NCT05616013|540891743|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
149933478|NCT05616013|540891744|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933479|NCT05616013|540891745|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933480|NCT05616013|540891746|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933481|NCT05616013|540891747|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933482|NCT05616013|540891748|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
149933483|NCT05616013|540891740|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933484|NCT05616013|540891741|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933485|NCT05616013|540891742|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933486|NCT05616013|540891743|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933487|NCT05616013|540891744|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933488|NCT05616013|540891745|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
150166506|NCT03068468|541745055|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
150166507|NCT03068468|541745056|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
150166508|NCT03068468|541745053|FG000|Open-Label Extension Period|Death|0|||
150166509|NCT03068468|541745054|FG001|Open-Label Extension Period|Death|0|||
150166510|NCT03068468|541745055|FG002|Open-Label Extension Period|Death|0|||
150166511|NCT03068468|541745056|FG003|Open-Label Extension Period|Death|1|||
150166512|NCT03068468|541745053|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
150166513|NCT03068468|541745054|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
150166514|NCT03068468|541745055|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
150166515|NCT03068468|541745056|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
150166516|NCT03068468|541745053|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
150166517|NCT03068468|541745054|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
150166518|NCT03068468|541745055|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
150166519|NCT03068468|541745056|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
150166520|NCT03068468|541745053|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
150166521|NCT03068468|541745054|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
150166522|NCT03068468|541745055|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
150166523|NCT03068468|541745056|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
150166524|NCT03068468|541745053|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
150166525|NCT03068468|541745054|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
150166526|NCT03068468|541745055|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
150166527|NCT03068468|541745056|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
150166528|NCT03068468|541745053|FG000|Open-Label Extension Period|Reason not Specified|0|||
150166529|NCT03068468|541745054|FG001|Open-Label Extension Period|Reason not Specified|0|||
150166530|NCT03068468|541745055|FG002|Open-Label Extension Period|Reason not Specified|1|||
150166531|NCT03068468|541745056|FG003|Open-Label Extension Period|Reason not Specified|4|||
150166532|NCT03895034|541745058|FG000|Overall Study|Lost to Follow-up|2|||
150166533|NCT01510912|541745059|FG000|Overall Study|Adverse Event|99|||
150166534|NCT01510912|541745059|FG000|Overall Study|Lack of Efficacy|12|||
150166535|NCT01510912|541745059|FG000|Overall Study|Non-compliance with trial drug|23|||
150166536|NCT01510912|541745059|FG000|Overall Study|Withdrawal by Subject|49|||
150166537|NCT01510912|541745059|FG000|Overall Study|Physician Decision|1|||
150166538|NCT01510912|541745059|FG000|Overall Study|Protocol Violation|27|||
150166539|NCT01510912|541745059|FG000|Overall Study|Lost to Follow-up|26|||
150166540|NCT01510912|541745059|FG000|Overall Study|Other, including joint replacement|5|||
150166541|NCT03181958|541745060|FG000|Overall Study|Lost to Follow-up|17|||
150166542|NCT03181958|541745061|FG001|Overall Study|Lost to Follow-up|21|||
150166543|NCT03181958|541745062|FG002|Overall Study|Lost to Follow-up|15|||
150166544|NCT01063036|541745067|FG000|Participants Treated With Study Drug|Adverse Event|1|||
150166545|NCT01063036|541745067|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
150166546|NCT01063036|541745067|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
150166547|NCT01063036|541745067|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
150266745|NCT02598557|542114243|FG000|Overall Study|Participant did not start treatment|2|||
150266746|NCT02598557|542114244|FG001|Overall Study|Participant did not start treatment|1|||
150266747|NCT02598557|542114245|FG002|Overall Study|Participant did not start treatment|1|||
150266748|NCT02598557|542114243|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
150266749|NCT02598557|542114244|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
150266750|NCT02598557|542114245|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
150266751|NCT02598557|542114243|FG000|Overall Study|Adverse Event|1|||
150266752|NCT02598557|542114244|FG001|Overall Study|Adverse Event|1|||
150266753|NCT02598557|542114245|FG002|Overall Study|Adverse Event|0|||
150266754|NCT02072434|542114249|FG000|Overall Study|Protocol Violation|10|||
150266755|NCT02072434|542114250|FG001|Overall Study|Protocol Violation|9|||
150266756|NCT02072434|542114249|FG000|Overall Study|Physician Decision|5|||
150266757|NCT02072434|542114250|FG001|Overall Study|Physician Decision|10|||
150266758|NCT02072434|542114249|FG000|Overall Study|Adverse event, serious fatal|1|||
150266759|NCT02072434|542114250|FG001|Overall Study|Adverse event, serious fatal|6|||
150266760|NCT02072434|542114249|FG000|Overall Study|Adverse Event|7|||
150266761|NCT02072434|542114250|FG001|Overall Study|Adverse Event|6|||
150266762|NCT02072434|542114249|FG000|Overall Study|Withdrawal by Subject|17|||
150266763|NCT02072434|542114250|FG001|Overall Study|Withdrawal by Subject|29|||
150266764|NCT02072434|542114249|FG000|Overall Study|Other|14|||
150266765|NCT02072434|542114250|FG001|Overall Study|Other|29|||
150266766|NCT02072434|542114249|FG000|Overall Study|Lost to Follow-up|0|||
150266767|NCT02072434|542114250|FG001|Overall Study|Lost to Follow-up|1|||
150266768|NCT00402363|542114253|FG000|Overall Study|Adverse Event|9|||
150266769|NCT00402363|542114254|FG001|Overall Study|Adverse Event|14|||
150266770|NCT00402363|542114255|FG002|Overall Study|Adverse Event|2|||
150266771|NCT00402363|542114256|FG003|Overall Study|Adverse Event|2|||
150266772|NCT00402363|542114253|FG000|Overall Study|Withdrew Consent|10|||
150266773|NCT00402363|542114254|FG001|Overall Study|Withdrew Consent|5|||
150266774|NCT00402363|542114255|FG002|Overall Study|Withdrew Consent|2|||
150266775|NCT00402363|542114256|FG003|Overall Study|Withdrew Consent|1|||
150266776|NCT00402363|542114253|FG000|Overall Study|Protocol Violation|3|||
150266777|NCT00402363|542114254|FG001|Overall Study|Protocol Violation|5|||
150266778|NCT00402363|542114255|FG002|Overall Study|Protocol Violation|0|||
150266779|NCT00402363|542114256|FG003|Overall Study|Protocol Violation|3|||
150266780|NCT00402363|542114253|FG000|Overall Study|Lost to Follow-up|5|||
150266781|NCT00402363|542114254|FG001|Overall Study|Lost to Follow-up|4|||
150266782|NCT00402363|542114255|FG002|Overall Study|Lost to Follow-up|0|||
150266783|NCT00402363|542114256|FG003|Overall Study|Lost to Follow-up|2|||
150266784|NCT00402363|542114253|FG000|Overall Study|"Captured as Other"|6|||
150266785|NCT00402363|542114254|FG001|Overall Study|"Captured as Other"|2|||
150266786|NCT00402363|542114255|FG002|Overall Study|"Captured as Other"|2|||
150266787|NCT00402363|542114256|FG003|Overall Study|"Captured as Other"|2|||
150266788|NCT00937833|542114265|FG000|Overall Study|Protocol Violation|1|||
150266789|NCT00937833|542114266|FG001|Overall Study|Protocol Violation|2|||
150266790|NCT00937833|542114265|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
150266791|NCT00937833|542114266|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
150266792|NCT00937833|542114265|FG000|Overall Study|Lost to Follow-up|10|||
150266793|NCT00937833|542114266|FG001|Overall Study|Lost to Follow-up|8|||
150266794|NCT00937833|542114265|FG000|Overall Study|Withdrawal by Subject|4|||
150266795|NCT00937833|542114266|FG001|Overall Study|Withdrawal by Subject|6|||
150266796|NCT01607554|542114269|FG000|Overall Study|Disease progression|2|||
150266797|NCT00162032|542114270|FG000|Overall Study|Lost to Follow-up|4|||
150266798|NCT00162032|542114271|FG001|Overall Study|Lost to Follow-up|2|||
150266799|NCT00162032|542114270|FG000|Overall Study|Reason not specified|1|||
150266800|NCT00162032|542114271|FG001|Overall Study|Reason not specified|0|||
150266801|NCT03952806|542114272|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
150266802|NCT03952806|542114273|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
150266803|NCT03952806|542114272|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
150266804|NCT03952806|542114273|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
150266805|NCT03952806|542114272|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
150266806|NCT03952806|542114273|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
150266807|NCT03952806|542114272|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
150266808|NCT03952806|542114273|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
150266809|NCT03952806|542114272|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
150266810|NCT03952806|542114273|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
149820163|NCT00901628|540471711|FG000|Overall Study|peroneal nerve palsy|0|||
150266811|NCT03952806|542114272|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
150266812|NCT03952806|542114273|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
150266813|NCT03952806|542114272|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
150266814|NCT03952806|542114273|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
149820164|NCT00901628|540471712|FG001|Overall Study|peroneal nerve palsy|1|||
149820165|NCT00608205|540471715|FG000|Overall Study|Adverse Event|3|||
149820166|NCT00608205|540471716|FG001|Overall Study|Adverse Event|2|||
149820167|NCT00608205|540471715|FG000|Overall Study|Patient non-compliant|0|||
150266815|NCT03952806|542114272|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
150266816|NCT03952806|542114273|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
150266817|NCT03952806|542114272|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
150266818|NCT03952806|542114273|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
150266819|NCT03952806|542114272|FG000|OLE Phase (48 Weeks)|Other|16|||
150266820|NCT03952806|542114273|FG001|OLE Phase (48 Weeks)|Other|13|||
150266821|NCT00818389|542114274|FG000|Overall Study|Death|1|||
150266822|NCT00818389|542114275|FG001|Overall Study|Death|3|||
150266823|NCT00818389|542114274|FG000|Overall Study|ALS Disease Progression|1|||
150266824|NCT00818389|542114275|FG001|Overall Study|ALS Disease Progression|0|||
150266825|NCT00818389|542114274|FG000|Overall Study|Withdrawal by Subject|2|||
150266826|NCT00818389|542114275|FG001|Overall Study|Withdrawal by Subject|2|||
150266827|NCT00818389|542114274|FG000|Overall Study|Adverse Event|0|||
150266828|NCT00818389|542114275|FG001|Overall Study|Adverse Event|1|||
150266829|NCT02027701|542114279|FG000|Overall Study|Adverse Event|3|||
150266830|NCT02027701|542114279|FG000|Overall Study|Lack of Efficacy|8|||
150266831|NCT02027701|542114279|FG000|Overall Study|Physician Decision|2|||
150266832|NCT02027701|542114279|FG000|Overall Study|Withdrawal by Subject|3|||
150266833|NCT00146757|542114280|FG000|Overall Study|Death|1|||
150266834|NCT00146757|542114281|FG001|Overall Study|Death|0|||
150266835|NCT00146757|542114280|FG000|Overall Study|Adverse Event|1|||
150266836|NCT00146757|542114281|FG001|Overall Study|Adverse Event|0|||
150266837|NCT02349360|542114286|FG000|Overall Study|Withdrawal by Subject|0|||
150266838|NCT02349360|542114287|FG001|Overall Study|Withdrawal by Subject|1|||
150266839|NCT01971203|542114296|FG000|Overall Study|Protocol Violation|3|||
150266840|NCT01971203|542114297|FG001|Overall Study|Protocol Violation|2|||
150266841|NCT01971203|542114296|FG000|Overall Study|Withdrawal by Subject|5|||
150266842|NCT01971203|542114297|FG001|Overall Study|Withdrawal by Subject|6|||
150266843|NCT01971203|542114296|FG000|Overall Study|Adverse Event|1|||
150266844|NCT01971203|542114297|FG001|Overall Study|Adverse Event|0|||
150266845|NCT01498289|542114299|FG000|Overall Study|Adverse Event|16|||
150266846|NCT01498289|542114300|FG001|Overall Study|Adverse Event|18|||
150266847|NCT01498289|542114299|FG000|Overall Study|Death|6|||
150266848|NCT01498289|542114300|FG001|Overall Study|Death|8|||
150266849|NCT01498289|542114299|FG000|Overall Study|Withdrawal unrelated to AE|16|||
150266850|NCT01498289|542114300|FG001|Overall Study|Withdrawal unrelated to AE|16|||
150266851|NCT01498289|542114299|FG000|Overall Study|Progression/relapse|53|||
150266852|NCT01498289|542114300|FG001|Overall Study|Progression/relapse|59|||
150266853|NCT01498289|542114299|FG000|Overall Study|Not protocol specified|7|||
150266854|NCT01498289|542114300|FG001|Overall Study|Not protocol specified|2|||
150266855|NCT01498289|542114299|FG000|Overall Study|Reason under review|0|||
150266856|NCT01498289|542114300|FG001|Overall Study|Reason under review|1|||
150266857|NCT01794923|542114301|FG000|Overall Study|Adverse Event|0|||
150266858|NCT01794923|542114302|FG001|Overall Study|Adverse Event|0|||
150266859|NCT01794923|542114303|FG002|Overall Study|Adverse Event|1|||
150266860|NCT01423253|542114304|FG000|Overall Study|Adverse Event|2|||
150266861|NCT01423253|542114304|FG000|Overall Study|Lack of Efficacy|2|||
150266862|NCT01423253|542114304|FG000|Overall Study|Lost to Follow-up|1|||
150266863|NCT01423253|542114304|FG000|Overall Study|Protocol Violation|2|||
150266864|NCT01423253|542114304|FG000|Overall Study|Withdrawal by Subject|2|||
150266865|NCT00752622|542114309|FG000|Induction Phase|Adverse Event|3|||
150266866|NCT00752622|542114309|FG000|Induction Phase|Other|3|||
150266867|NCT00752622|542114309|FG000|Induction Phase|Non-responder|14|||
149820168|NCT00608205|540471716|FG001|Overall Study|Patient non-compliant|1|||
149820169|NCT01003886|540471717|FG000|Overall Study|Lack of Efficacy|5|||
150266868|NCT00752622|542114309|FG000|Induction Phase|Withdrawal by Subject|1|||
150266869|NCT00752622|542114309|FG000|Induction Phase|Premature study termination|14|||
150266870|NCT00752622|542114309|FG000|Observational Phase|Premature Study Termination|36|||
150266871|NCT00752622|542114309|FG000|Observational Phase|Non-responder|2|||
150266872|NCT00752622|542114309|FG000|Observational Phase|Withdrawal by Subject|2|||
150266873|NCT00752622|542114309|FG000|Observational Phase|Adverse Event|1|||
150266874|NCT00752622|542114309|FG000|Observational Phase|Other|2|||
150266875|NCT00752622|542114309|FG000|Interventional Phase|Non-responder|2|||
150266876|NCT00752622|542114309|FG000|Interventional Phase|Physician Decision|1|||
150266877|NCT00752622|542114309|FG000|Interventional Phase|Premature Study Termination|5|||
150266878|NCT00576836|542114310|FG000|Overall Study|Death|0|||
150266879|NCT00576836|542114311|FG001|Overall Study|Death|1|||
150266880|NCT00576836|542114310|FG000|Overall Study|Physician Decision|0|||
150266881|NCT00576836|542114311|FG001|Overall Study|Physician Decision|1|||
150266882|NCT00392327|542114312|FG000|Overall Study|Death|1|||
150266883|NCT00392327|542114313|FG001|Overall Study|Death|0|||
150266884|NCT00392327|542114314|FG002|Overall Study|Death|1|||
149820170|NCT01003886|540471717|FG000|Overall Study|Lost to Follow-up|169|||
149820171|NCT01003886|540471717|FG000|Overall Study|Withdrawal by Subject|39|||
149820172|NCT01003886|540471717|FG000|Overall Study|Other|14|||
149820173|NCT01003886|540471717|FG000|Overall Study|Adverse Event|3|||
149820174|NCT00909727|540471738|FG000|Overall Study|Adverse Event|1|||
149820175|NCT00909727|540471739|FG001|Overall Study|Adverse Event|0|||
149820176|NCT00909727|540471738|FG000|Overall Study|Wrong Genotype|1|||
150266885|NCT00392327|542114315|FG003|Overall Study|Death|0|||
150266886|NCT00392327|542114316|FG004|Overall Study|Death|0|||
150266887|NCT00392327|542114317|FG005|Overall Study|Death|0|||
150266888|NCT00392327|542114318|FG006|Overall Study|Death|0|||
150266889|NCT00392327|542114319|FG007|Overall Study|Death|0|||
150266890|NCT00392327|542114312|FG000|Overall Study|Lack of Efficacy|8|||
150266891|NCT00392327|542114313|FG001|Overall Study|Lack of Efficacy|8|||
150266892|NCT00392327|542114314|FG002|Overall Study|Lack of Efficacy|9|||
150266893|NCT00392327|542114315|FG003|Overall Study|Lack of Efficacy|6|||
150266894|NCT00392327|542114316|FG004|Overall Study|Lack of Efficacy|3|||
150266895|NCT00392327|542114317|FG005|Overall Study|Lack of Efficacy|3|||
150266896|NCT00392327|542114318|FG006|Overall Study|Lack of Efficacy|3|||
150266897|NCT00392327|542114319|FG007|Overall Study|Lack of Efficacy|3|||
150266898|NCT00392327|542114312|FG000|Overall Study|Physician Decision|3|||
150266899|NCT00392327|542114313|FG001|Overall Study|Physician Decision|5|||
149933489|NCT05616013|540891746|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
149933490|NCT05616013|540891747|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933491|NCT05616013|540891748|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
149933492|NCT05616013|540891740|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
150266900|NCT00392327|542114314|FG002|Overall Study|Physician Decision|2|||
150266901|NCT00392327|542114315|FG003|Overall Study|Physician Decision|2|||
150266902|NCT00392327|542114316|FG004|Overall Study|Physician Decision|0|||
150266903|NCT00392327|542114317|FG005|Overall Study|Physician Decision|1|||
150266904|NCT00392327|542114318|FG006|Overall Study|Physician Decision|5|||
150266905|NCT00392327|542114319|FG007|Overall Study|Physician Decision|3|||
150266906|NCT00392327|542114312|FG000|Overall Study|Protocol Violation|0|||
150266907|NCT00392327|542114313|FG001|Overall Study|Protocol Violation|0|||
150266908|NCT00392327|542114314|FG002|Overall Study|Protocol Violation|1|||
150266909|NCT00392327|542114315|FG003|Overall Study|Protocol Violation|0|||
150266910|NCT00392327|542114316|FG004|Overall Study|Protocol Violation|0|||
150266911|NCT00392327|542114317|FG005|Overall Study|Protocol Violation|0|||
150266912|NCT00392327|542114318|FG006|Overall Study|Protocol Violation|0|||
150266913|NCT00392327|542114319|FG007|Overall Study|Protocol Violation|0|||
150266914|NCT00392327|542114312|FG000|Overall Study|Withdrawal by Subject|3|||
150266915|NCT00392327|542114313|FG001|Overall Study|Withdrawal by Subject|2|||
150266916|NCT00392327|542114314|FG002|Overall Study|Withdrawal by Subject|4|||
150266917|NCT00392327|542114315|FG003|Overall Study|Withdrawal by Subject|6|||
150266918|NCT00392327|542114316|FG004|Overall Study|Withdrawal by Subject|0|||
150266919|NCT00392327|542114317|FG005|Overall Study|Withdrawal by Subject|1|||
150266920|NCT00392327|542114318|FG006|Overall Study|Withdrawal by Subject|1|||
150266921|NCT00392327|542114319|FG007|Overall Study|Withdrawal by Subject|5|||
150266922|NCT00392327|542114312|FG000|Overall Study|Ineligible|0|||
150266923|NCT00392327|542114313|FG001|Overall Study|Ineligible|4|||
150266924|NCT00392327|542114314|FG002|Overall Study|Ineligible|3|||
150266925|NCT00392327|542114315|FG003|Overall Study|Ineligible|2|||
150266926|NCT00392327|542114316|FG004|Overall Study|Ineligible|0|||
150266927|NCT00392327|542114317|FG005|Overall Study|Ineligible|0|||
150266928|NCT00392327|542114318|FG006|Overall Study|Ineligible|0|||
150266929|NCT00392327|542114319|FG007|Overall Study|Ineligible|0|||
150266930|NCT03267940|542114320|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
150266931|NCT03267940|542114321|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
150266932|NCT03267940|542114322|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
150266933|NCT03267940|542114323|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
150266934|NCT03267940|542114324|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
150266935|NCT03267940|542114325|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
150266936|NCT03267940|542114320|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
150266937|NCT03267940|542114321|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
149933493|NCT05616013|540891741|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933494|NCT05616013|540891742|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933495|NCT05616013|540891743|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933496|NCT05616013|540891744|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933497|NCT05616013|540891745|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933498|NCT05616013|540891746|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149933499|NCT05616013|540891747|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
149975527|NCT01847755|541047870|FG000|Overall Study|Physician Decision|1|||
150266938|NCT03267940|542114322|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
150266939|NCT03267940|542114323|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
150266940|NCT03267940|542114324|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
150266941|NCT03267940|542114325|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
150266942|NCT03267940|542114320|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
150266943|NCT03267940|542114321|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
150266944|NCT03267940|542114322|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
150266945|NCT03267940|542114323|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
150266946|NCT03267940|542114324|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
150266947|NCT03267940|542114325|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
150266948|NCT03267940|542114320|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
150266949|NCT03267940|542114321|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
150266950|NCT03267940|542114322|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
150266951|NCT03267940|542114323|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
150266952|NCT03267940|542114324|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
150266953|NCT03267940|542114325|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
150266954|NCT03267940|542114320|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
150266955|NCT03267940|542114321|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
150266956|NCT03267940|542114322|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
150266957|NCT03267940|542114323|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
150266958|NCT03267940|542114324|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
150266959|NCT03267940|542114325|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
150266960|NCT03267940|542114320|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
150266961|NCT03267940|542114321|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
150266962|NCT03267940|542114322|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
150266963|NCT03267940|542114323|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
150266964|NCT03267940|542114324|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
150266965|NCT03267940|542114325|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
150266966|NCT03267940|542114320|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
150266967|NCT03267940|542114321|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
150266968|NCT03267940|542114322|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
150266969|NCT03267940|542114323|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
150266970|NCT03267940|542114324|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
150266971|NCT03267940|542114325|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
150266972|NCT03267940|542114320|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
150266973|NCT03267940|542114321|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
150266974|NCT03267940|542114322|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
150266975|NCT03267940|542114323|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
150266976|NCT03267940|542114324|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
150266977|NCT03267940|542114325|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
150266978|NCT03267940|542114320|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
150266979|NCT03267940|542114321|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
150266980|NCT03267940|542114322|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
150266981|NCT03267940|542114323|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
150266982|NCT03267940|542114324|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
150266983|NCT03267940|542114325|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
150266984|NCT01074216|542114326|FG000|Overall Study|Physician Decision|1|||
150266985|NCT01074216|542114326|FG000|Overall Study|Not Treated|12|||
150266986|NCT01323634|542114329|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
150266987|NCT01323634|542114330|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
150266988|NCT01323634|542114331|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
150266989|NCT01323634|542114329|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
150266990|NCT01323634|542114330|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
150266991|NCT01323634|542114331|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
150266992|NCT01323634|542114329|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
150266993|NCT01323634|542114330|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
150266994|NCT01323634|542114331|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
150266995|NCT01323634|542114329|FG000|2-week Run-in Period|Physician Decision|5|||
150266996|NCT01323634|542114330|FG001|2-week Run-in Period|Physician Decision|0|||
150266997|NCT01323634|542114331|FG002|2-week Run-in Period|Physician Decision|0|||
150266998|NCT01323634|542114329|FG000|2-week Run-in Period|Protocol Violation|1|||
150266999|NCT01323634|542114330|FG001|2-week Run-in Period|Protocol Violation|0|||
149820177|NCT00909727|540471739|FG001|Overall Study|Wrong Genotype|0|||
149820178|NCT00909727|540471738|FG000|Overall Study|Withdrawal of Consent|1|||
149820179|NCT00909727|540471739|FG001|Overall Study|Withdrawal of Consent|0|||
149820180|NCT00909727|540471738|FG000|Overall Study|Prohibited Medication|1|||
149820181|NCT00909727|540471739|FG001|Overall Study|Prohibited Medication|0|||
149820182|NCT01339910|540471741|FG000|Overall Study|Withdrawal by Subject|1|||
149820183|NCT01339910|540471742|FG001|Overall Study|Withdrawal by Subject|0|||
149820184|NCT01339910|540471741|FG000|Overall Study|Physician Decision|1|||
149820185|NCT01339910|540471742|FG001|Overall Study|Physician Decision|0|||
149820186|NCT01339910|540471741|FG000|Overall Study|Disease relapse|1|||
150267000|NCT01323634|542114331|FG002|2-week Run-in Period|Protocol Violation|0|||
150267001|NCT01323634|542114329|FG000|2-week Run-in Period|Adverse Event|1|||
150267002|NCT01323634|542114330|FG001|2-week Run-in Period|Adverse Event|0|||
150267003|NCT01323634|542114331|FG002|2-week Run-in Period|Adverse Event|0|||
150267004|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
150267005|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
150267006|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
150267007|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
150267008|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
150267009|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
150267010|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
150267011|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
149933500|NCT05616013|540891748|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
149933501|NCT05616013|540891740|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933502|NCT05616013|540891741|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933503|NCT05616013|540891742|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933504|NCT05616013|540891743|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
149975528|NCT01193101|541047871|FG000|Overall Study|Adverse Event|0|||
150166548|NCT01063036|541745067|FG000|Participants Treated With Study Drug|Pregnancy|1|||
150166549|NCT01063036|541745067|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
150166550|NCT01063036|541745067|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
150166551|NCT01063036|541745067|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
150166552|NCT01977612|541745068|FG000|Overall Study|Lost to Follow-up|1|||
150166553|NCT01977612|541745069|FG001|Overall Study|Lost to Follow-up|1|||
150166554|NCT02715258|541745070|FG000|Overall Study|Withdrawal by Subject|6|||
150166555|NCT02715258|541745071|FG001|Overall Study|Withdrawal by Subject|1|||
150166556|NCT02715258|541745070|FG000|Overall Study|Lost to Follow-up|7|||
150166557|NCT02715258|541745071|FG001|Overall Study|Lost to Follow-up|1|||
150166558|NCT02715258|541745070|FG000|Overall Study|Terminated by Sponsor|0|||
150166559|NCT02715258|541745071|FG001|Overall Study|Terminated by Sponsor|1|||
150166560|NCT02715258|541745070|FG000|Overall Study|Death|0|||
150166561|NCT02715258|541745071|FG001|Overall Study|Death|1|||
150166562|NCT02715258|541745070|FG000|Overall Study|Subject non-compliant|1|||
150166563|NCT02715258|541745071|FG001|Overall Study|Subject non-compliant|1|||
150166564|NCT02715258|541745070|FG000|Overall Study|GCP violation|2|||
150166565|NCT02715258|541745071|FG001|Overall Study|GCP violation|1|||
150166566|NCT00943605|541745073|FG000|Overall Study|Study termination|30|||
150166567|NCT00943605|541745074|FG001|Overall Study|Study termination|30|||
150166568|NCT01956669|541745076|FG000|Overall Study|Disease Progression|12|||
150166569|NCT01956669|541745077|FG001|Overall Study|Disease Progression|7|||
150166570|NCT01956669|541745078|FG002|Overall Study|Disease Progression|7|||
150166571|NCT01956669|541745079|FG003|Overall Study|Disease Progression|8|||
150166572|NCT01956669|541745080|FG004|Overall Study|Disease Progression|4|||
150166573|NCT01956669|541745081|FG005|Overall Study|Disease Progression|3|||
150166574|NCT01956669|541745082|FG006|Overall Study|Disease Progression|5|||
150166575|NCT01956669|541745076|FG000|Overall Study|Adverse Event|0|||
150166576|NCT01956669|541745077|FG001|Overall Study|Adverse Event|2|||
150166577|NCT01956669|541745078|FG002|Overall Study|Adverse Event|2|||
150166578|NCT01956669|541745079|FG003|Overall Study|Adverse Event|1|||
150166579|NCT01956669|541745080|FG004|Overall Study|Adverse Event|0|||
150166580|NCT01956669|541745081|FG005|Overall Study|Adverse Event|0|||
150166581|NCT01956669|541745082|FG006|Overall Study|Adverse Event|0|||
150166582|NCT01956669|541745076|FG000|Overall Study|Physician Decision|0|||
150166583|NCT01956669|541745077|FG001|Overall Study|Physician Decision|2|||
150166584|NCT01956669|541745078|FG002|Overall Study|Physician Decision|0|||
150166585|NCT01956669|541745079|FG003|Overall Study|Physician Decision|0|||
150166586|NCT01956669|541745080|FG004|Overall Study|Physician Decision|0|||
150166587|NCT01956669|541745081|FG005|Overall Study|Physician Decision|1|||
150166588|NCT01956669|541745082|FG006|Overall Study|Physician Decision|0|||
150166589|NCT01956669|541745076|FG000|Overall Study|Withdrawal by Subject|0|||
150166590|NCT01956669|541745077|FG001|Overall Study|Withdrawal by Subject|0|||
150166591|NCT01956669|541745078|FG002|Overall Study|Withdrawal by Subject|1|||
150166592|NCT01956669|541745079|FG003|Overall Study|Withdrawal by Subject|1|||
150166593|NCT01956669|541745080|FG004|Overall Study|Withdrawal by Subject|0|||
150166594|NCT01956669|541745081|FG005|Overall Study|Withdrawal by Subject|0|||
150166595|NCT01956669|541745082|FG006|Overall Study|Withdrawal by Subject|1|||
150166596|NCT01908634|541745083|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
150166597|NCT01908634|541745083|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
150166598|NCT00464672|541745085|FG000|Overall Study|withdrawal of consent|0|||
150166599|NCT00464672|541745086|FG001|Overall Study|withdrawal of consent|0|||
150166600|NCT00464672|541745087|FG002|Overall Study|withdrawal of consent|0|||
150166601|NCT00464672|541745088|FG003|Overall Study|withdrawal of consent|1|||
150166602|NCT00464672|541745089|FG004|Overall Study|withdrawal of consent|9|||
150267012|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
149933505|NCT05616013|540891744|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933506|NCT05616013|540891745|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933507|NCT05616013|540891746|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933508|NCT05616013|540891747|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
149933509|NCT05616013|540891748|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
149933510|NCT05116202|540891749|FG000|Overall Study|Study Terminated by Sponsor|21|||
150166603|NCT00464672|541745090|FG005|Overall Study|withdrawal of consent|4|||
150166604|NCT00464672|541745085|FG000|Overall Study|Lost to Follow-up|25|||
150166605|NCT00464672|541745086|FG001|Overall Study|Lost to Follow-up|10|||
150166606|NCT00464672|541745087|FG002|Overall Study|Lost to Follow-up|0|||
150166607|NCT00464672|541745088|FG003|Overall Study|Lost to Follow-up|0|||
150166608|NCT00464672|541745089|FG004|Overall Study|Lost to Follow-up|1|||
150166609|NCT00464672|541745090|FG005|Overall Study|Lost to Follow-up|0|||
150166610|NCT00601640|541745091|FG000|Overall Study|Withdrawal by Subject|3|||
150166611|NCT00601640|541745092|FG001|Overall Study|Withdrawal by Subject|0|||
150166612|NCT00601640|541745093|FG002|Overall Study|Withdrawal by Subject|7|||
150166613|NCT00601640|541745091|FG000|Overall Study|Death|1|||
150166614|NCT00601640|541745092|FG001|Overall Study|Death|0|||
150166615|NCT00601640|541745093|FG002|Overall Study|Death|0|||
150166616|NCT00601640|541745091|FG000|Overall Study|Adverse Event|0|||
150166617|NCT00601640|541745092|FG001|Overall Study|Adverse Event|4|||
150166618|NCT00601640|541745093|FG002|Overall Study|Adverse Event|2|||
150166619|NCT00601640|541745091|FG000|Overall Study|intercurrent illness|1|||
150166620|NCT00601640|541745092|FG001|Overall Study|intercurrent illness|0|||
150166621|NCT00601640|541745093|FG002|Overall Study|intercurrent illness|0|||
150166622|NCT00601640|541745091|FG000|Overall Study|change in eligibility status|0|||
150166623|NCT00601640|541745092|FG001|Overall Study|change in eligibility status|1|||
150166624|NCT00601640|541745093|FG002|Overall Study|change in eligibility status|1|||
150166625|NCT01710514|541745094|FG000|Overall Study|Adverse Event|6|||
150166626|NCT01710514|541745095|FG001|Overall Study|Adverse Event|7|||
150166627|NCT01710514|541745094|FG000|Overall Study|Withdrawal by Subject|1|||
150166628|NCT01710514|541745095|FG001|Overall Study|Withdrawal by Subject|0|||
150166629|NCT03586167|541745105|FG000|Overall Study|Other|1|||
150166630|NCT03586167|541745106|FG001|Overall Study|Other|0|||
150166631|NCT00591838|541745107|FG000|Overall Study|Withdrawal by Subject|0|||
150166632|NCT00591838|541745108|FG001|Overall Study|Withdrawal by Subject|0|||
150166633|NCT00591838|541745109|FG002|Overall Study|Withdrawal by Subject|0|||
150166634|NCT00591838|541745110|FG003|Overall Study|Withdrawal by Subject|1|||
150166635|NCT00591838|541745111|FG004|Overall Study|Withdrawal by Subject|0|||
150166636|NCT03761784|541745112|FG000|Overall Study|Adverse Event|4|||
150166637|NCT03761784|541745113|FG001|Overall Study|Adverse Event|0|||
150166638|NCT03761784|541745112|FG000|Overall Study|Lost to Follow-up|10|||
150166639|NCT03761784|541745113|FG001|Overall Study|Lost to Follow-up|7|||
150166640|NCT03761784|541745112|FG000|Overall Study|Pregnancy|1|||
150166641|NCT03761784|541745113|FG001|Overall Study|Pregnancy|0|||
150166642|NCT03761784|541745112|FG000|Overall Study|Protocol Violation|2|||
150166643|NCT03761784|541745113|FG001|Overall Study|Protocol Violation|0|||
150166644|NCT03761784|541745112|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
150166645|NCT03761784|541745113|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
150166646|NCT03761784|541745112|FG000|Overall Study|Withdrawal by Subject|9|||
150166647|NCT03761784|541745113|FG001|Overall Study|Withdrawal by Subject|4|||
150166648|NCT03761784|541745112|FG000|Overall Study|Physician Decision|1|||
150166649|NCT03761784|541745113|FG001|Overall Study|Physician Decision|0|||
150166650|NCT03761784|541745112|FG000|Overall Study|Other Than Specified|1|||
150166651|NCT03761784|541745113|FG001|Overall Study|Other Than Specified|0|||
150166652|NCT04163458|541745116|FG000|Overall Study|Protocol Deviation|7|||
150166653|NCT04163458|541745117|FG001|Overall Study|Protocol Deviation|13|||
150166654|NCT04163458|541745116|FG000|Overall Study|Adverse Event|5|||
150166655|NCT04163458|541745117|FG001|Overall Study|Adverse Event|8|||
150166656|NCT04163458|541745116|FG000|Overall Study|Due to COVID-19 pandemic|4|||
150267013|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149820187|NCT01339910|540471742|FG001|Overall Study|Disease relapse|4|||
149820188|NCT02965820|540471744|FG000|Period 2, Second 30 Days|Adverse Event|1|||
149820189|NCT02965820|540471745|FG001|Period 2, Second 30 Days|Adverse Event|1|||
149820190|NCT00829413|540471746|FG000|Overall Study|No study drug admimnistered|13|||
149820191|NCT00829413|540471746|FG000|Overall Study|Training Patients|67|||
149820192|NCT00829413|540471746|FG000|Overall Study|No truth standard procedure available|9|||
149820193|NCT00829413|540471746|FG000|Overall Study|Technically inadequate truth standard|2|||
149820194|NCT00829413|540471746|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
149820195|NCT00891774|540471747|FG000|Overall Study|Lost to Follow-up|5|||
149820196|NCT00891774|540471747|FG000|Overall Study|Illness (Self/Mother)|3|||
149820197|NCT00891774|540471747|FG000|Overall Study|Withdrawal by Subject|2|||
149820198|NCT00891774|540471747|FG000|Overall Study|Protocol Violation|4|||
149820199|NCT03175120|540471749|FG000|Overall Study|Adverse Event|2|||
149820200|NCT03175120|540471750|FG001|Overall Study|Adverse Event|2|||
149820201|NCT03175120|540471749|FG000|Overall Study|Protocol Violation|5|||
150267014|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
150267015|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
150267016|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
150267017|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
150267018|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
150267019|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150267020|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
150267021|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
150267022|NCT01323634|542114329|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
150267023|NCT01323634|542114330|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
150267024|NCT01323634|542114331|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
150267025|NCT05056987|542114332|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
150267026|NCT05056987|542114333|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
149933511|NCT05116202|540891750|FG001|Overall Study|Study Terminated by Sponsor|38|||
149933512|NCT05116202|540891751|FG002|Overall Study|Study Terminated by Sponsor|17|||
149933513|NCT05116202|540891752|FG003|Overall Study|Study Terminated by Sponsor|18|||
149933514|NCT05116202|540891753|FG004|Overall Study|Study Terminated by Sponsor|0|||
149933515|NCT05116202|540891749|FG000|Overall Study|Withdrawal by Subject|0|||
149933516|NCT05116202|540891750|FG001|Overall Study|Withdrawal by Subject|1|||
149933517|NCT05116202|540891751|FG002|Overall Study|Withdrawal by Subject|1|||
149933518|NCT05116202|540891752|FG003|Overall Study|Withdrawal by Subject|1|||
149933519|NCT05116202|540891753|FG004|Overall Study|Withdrawal by Subject|1|||
149933520|NCT05116202|540891749|FG000|Overall Study|Lost to Follow-up|0|||
149933521|NCT05116202|540891750|FG001|Overall Study|Lost to Follow-up|0|||
149933522|NCT05116202|540891751|FG002|Overall Study|Lost to Follow-up|0|||
149933523|NCT05116202|540891752|FG003|Overall Study|Lost to Follow-up|0|||
149933524|NCT05116202|540891753|FG004|Overall Study|Lost to Follow-up|2|||
149933525|NCT05116202|540891749|FG000|Overall Study|Death|1|||
149933526|NCT05116202|540891750|FG001|Overall Study|Death|1|||
149933527|NCT05116202|540891751|FG002|Overall Study|Death|2|||
149933528|NCT05116202|540891752|FG003|Overall Study|Death|1|||
149933529|NCT05116202|540891753|FG004|Overall Study|Death|5|||
149933530|NCT03834506|540891754|FG000|Overall Study|Death|336|||
149933531|NCT03834506|540891755|FG001|Overall Study|Death|326|||
149933532|NCT03834506|540891754|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149933533|NCT03834506|540891755|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149933534|NCT03834506|540891754|FG000|Overall Study|Withdrawal by Subject|10|||
149933535|NCT03834506|540891755|FG001|Overall Study|Withdrawal by Subject|8|||
149933536|NCT03834506|540891754|FG000|Overall Study|Sponsor decision|165|||
149933537|NCT03834506|540891755|FG001|Overall Study|Sponsor decision|178|||
149933538|NCT03834506|540891754|FG000|Overall Study|Physician Decision|3|||
149933539|NCT03834506|540891755|FG001|Overall Study|Physician Decision|1|||
149933540|NCT03834506|540891754|FG000|Overall Study|Lost to Follow-up|0|||
149933541|NCT03834506|540891755|FG001|Overall Study|Lost to Follow-up|1|||
149933542|NCT05067972|540891756|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
149933543|NCT05067972|540891757|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
149933544|NCT05067972|540891758|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
149933545|NCT05067972|540891759|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
149933546|NCT05067972|540891760|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
149933547|NCT05067972|540891761|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
149933548|NCT05067972|540891762|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
149933549|NCT05067972|540891756|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
149933550|NCT05067972|540891757|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
149933551|NCT05067972|540891758|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
149933552|NCT05067972|540891759|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
149933553|NCT05067972|540891760|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
149933554|NCT05067972|540891761|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
149933555|NCT05067972|540891762|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
149933556|NCT05067972|540891756|FG000|Part 1: Treatment|Progressive Disease|3|||
149933557|NCT05067972|540891757|FG001|Part 1: Treatment|Progressive Disease|3|||
149933558|NCT05067972|540891758|FG002|Part 1: Treatment|Progressive Disease|4|||
149933559|NCT05067972|540891759|FG003|Part 1: Treatment|Progressive Disease|2|||
149933560|NCT05067972|540891760|FG004|Part 1: Treatment|Progressive Disease|3|||
149933561|NCT05067972|540891761|FG005|Part 1: Treatment|Progressive Disease|0|||
149933562|NCT05067972|540891762|FG006|Part 1: Treatment|Progressive Disease|2|||
150267027|NCT05056987|542114332|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
149933563|NCT05067972|540891756|FG000|Part 1: Treatment|Physician Decision|0|||
149933564|NCT05067972|540891757|FG001|Part 1: Treatment|Physician Decision|0|||
149933565|NCT05067972|540891758|FG002|Part 1: Treatment|Physician Decision|0|||
149933566|NCT05067972|540891759|FG003|Part 1: Treatment|Physician Decision|1|||
149933567|NCT05067972|540891760|FG004|Part 1: Treatment|Physician Decision|0|||
149933568|NCT05067972|540891761|FG005|Part 1: Treatment|Physician Decision|0|||
149933569|NCT05067972|540891762|FG006|Part 1: Treatment|Physician Decision|0|||
150267028|NCT05056987|542114333|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
150267029|NCT01182194|542114334|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
150267030|NCT01182194|542114335|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
150267031|NCT01948908|542114336|FG000|Overall Study|Protocol Violation|1|||
150267032|NCT01948908|542114337|FG001|Overall Study|Protocol Violation|0|||
150267033|NCT01948908|542114338|FG002|Overall Study|Protocol Violation|2|||
150267034|NCT00796120|542114339|FG000|Overall Study|Death|3|||
150267035|NCT00796120|542114340|FG001|Overall Study|Death|0|||
150267036|NCT00796120|542114339|FG000|Overall Study|Adverse Event|11|||
150267037|NCT00796120|542114340|FG001|Overall Study|Adverse Event|6|||
150267038|NCT00796120|542114339|FG000|Overall Study|Progressive disease|22|||
150267039|NCT00796120|542114340|FG001|Overall Study|Progressive disease|13|||
150267040|NCT00796120|542114339|FG000|Overall Study|Participant refusal|3|||
150267041|NCT00796120|542114340|FG001|Overall Study|Participant refusal|4|||
150267042|NCT00796120|542114339|FG000|Overall Study|Other|6|||
150267043|NCT00796120|542114340|FG001|Overall Study|Other|17|||
150267044|NCT00796120|542114339|FG000|Overall Study|Physician Decision|16|||
150267045|NCT00796120|542114340|FG001|Overall Study|Physician Decision|17|||
150267046|NCT00796120|542114339|FG000|Overall Study|Randomized but not treated|0|||
150267047|NCT00796120|542114340|FG001|Overall Study|Randomized but not treated|3|||
149933570|NCT05067972|540891756|FG000|Part 1: Treatment|Death|0|||
149933571|NCT05067972|540891757|FG001|Part 1: Treatment|Death|0|||
149933572|NCT05067972|540891758|FG002|Part 1: Treatment|Death|0|||
149933573|NCT05067972|540891759|FG003|Part 1: Treatment|Death|2|||
149933574|NCT05067972|540891760|FG004|Part 1: Treatment|Death|0|||
150267048|NCT03737474|542114344|FG000|Overall Study|Adverse Event|18|||
150267049|NCT03737474|542114345|FG001|Overall Study|Adverse Event|48|||
150267050|NCT03737474|542114344|FG000|Overall Study|Lack of Efficacy|1|||
150267051|NCT03737474|542114345|FG001|Overall Study|Lack of Efficacy|3|||
150267052|NCT03737474|542114344|FG000|Overall Study|Protocol Violation|0|||
150267053|NCT03737474|542114345|FG001|Overall Study|Protocol Violation|8|||
150267054|NCT03737474|542114344|FG000|Overall Study|Withdrawal by Subject|5|||
150267055|NCT03737474|542114345|FG001|Overall Study|Withdrawal by Subject|20|||
150267056|NCT03737474|542114344|FG000|Overall Study|Non-compliance With Study Drug|0|||
150267057|NCT03737474|542114345|FG001|Overall Study|Non-compliance With Study Drug|1|||
150267058|NCT03737474|542114344|FG000|Overall Study|Physician Decision|1|||
150267059|NCT03737474|542114345|FG001|Overall Study|Physician Decision|4|||
150267060|NCT00971243|542114346|FG000|Double Blind Period|Adverse Event|2|||
150267061|NCT00971243|542114347|FG001|Double Blind Period|Adverse Event|3|||
150267062|NCT00971243|542114348|FG002|Double Blind Period|Adverse Event|2|||
150267063|NCT00971243|542114349|FG003|Double Blind Period|Adverse Event|2|||
150267064|NCT00971243|542114350|FG004|Double Blind Period|Adverse Event|3|||
150267065|NCT00971243|542114346|FG000|Double Blind Period|Lost to Follow-up|0|||
149933575|NCT05067972|540891761|FG005|Part 1: Treatment|Death|0|||
149933576|NCT05067972|540891762|FG006|Part 1: Treatment|Death|0|||
149933577|NCT05067972|540891756|FG000|Part 1: Treatment|Adverse Event|0|||
149933578|NCT05067972|540891757|FG001|Part 1: Treatment|Adverse Event|0|||
149933579|NCT05067972|540891758|FG002|Part 1: Treatment|Adverse Event|0|||
149933580|NCT05067972|540891759|FG003|Part 1: Treatment|Adverse Event|0|||
149933581|NCT05067972|540891760|FG004|Part 1: Treatment|Adverse Event|0|||
149933582|NCT05067972|540891761|FG005|Part 1: Treatment|Adverse Event|2|||
149933583|NCT05067972|540891762|FG006|Part 1: Treatment|Adverse Event|1|||
149933584|NCT05067972|540891756|FG000|Part 1: Follow-up|Adverse Event|0|||
149933585|NCT05067972|540891757|FG001|Part 1: Follow-up|Adverse Event|0|||
149933586|NCT05067972|540891758|FG002|Part 1: Follow-up|Adverse Event|0|||
149933587|NCT05067972|540891759|FG003|Part 1: Follow-up|Adverse Event|0|||
149933588|NCT05067972|540891760|FG004|Part 1: Follow-up|Adverse Event|0|||
149933589|NCT05067972|540891761|FG005|Part 1: Follow-up|Adverse Event|1|||
149933590|NCT05067972|540891762|FG006|Part 1: Follow-up|Adverse Event|0|||
149933591|NCT05067972|540891756|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
149933592|NCT05067972|540891757|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
149933593|NCT05067972|540891758|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
149933594|NCT05067972|540891759|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
149933595|NCT05067972|540891760|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
149933596|NCT05067972|540891761|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
149933597|NCT05067972|540891762|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
150267066|NCT00971243|542114347|FG001|Double Blind Period|Lost to Follow-up|1|||
150267067|NCT00971243|542114348|FG002|Double Blind Period|Lost to Follow-up|1|||
150267068|NCT00971243|542114349|FG003|Double Blind Period|Lost to Follow-up|0|||
150267069|NCT00971243|542114350|FG004|Double Blind Period|Lost to Follow-up|1|||
150267070|NCT00971243|542114346|FG000|Double Blind Period|Physician Decision|10|||
149933598|NCT05067972|540891756|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
149933599|NCT05067972|540891757|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
149933600|NCT05067972|540891758|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
149933601|NCT05067972|540891759|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
150267071|NCT00971243|542114347|FG001|Double Blind Period|Physician Decision|6|||
150267072|NCT00971243|542114348|FG002|Double Blind Period|Physician Decision|7|||
150267073|NCT00971243|542114349|FG003|Double Blind Period|Physician Decision|6|||
150267074|NCT00971243|542114350|FG004|Double Blind Period|Physician Decision|7|||
150267075|NCT00971243|542114346|FG000|Double Blind Period|Protocol Violation|2|||
150267076|NCT00971243|542114347|FG001|Double Blind Period|Protocol Violation|0|||
150267077|NCT00971243|542114348|FG002|Double Blind Period|Protocol Violation|3|||
150267078|NCT00971243|542114349|FG003|Double Blind Period|Protocol Violation|2|||
150267079|NCT00971243|542114350|FG004|Double Blind Period|Protocol Violation|2|||
150267080|NCT00971243|542114346|FG000|Double Blind Period|Withdrawal by Subject|4|||
150267081|NCT00971243|542114347|FG001|Double Blind Period|Withdrawal by Subject|1|||
150267082|NCT00971243|542114348|FG002|Double Blind Period|Withdrawal by Subject|4|||
150267083|NCT00971243|542114349|FG003|Double Blind Period|Withdrawal by Subject|4|||
150267084|NCT00971243|542114350|FG004|Double Blind Period|Withdrawal by Subject|4|||
150267085|NCT00971243|542114346|FG000|Double Blind Period|Other reasons|1|||
150267086|NCT00971243|542114347|FG001|Double Blind Period|Other reasons|0|||
150267087|NCT00971243|542114348|FG002|Double Blind Period|Other reasons|2|||
150267088|NCT00971243|542114349|FG003|Double Blind Period|Other reasons|0|||
150267089|NCT00971243|542114350|FG004|Double Blind Period|Other reasons|1|||
150267090|NCT00971243|542114346|FG000|Open-label Period|Adverse Event|1|||
150267091|NCT00971243|542114347|FG001|Open-label Period|Adverse Event|0|||
150267092|NCT00971243|542114348|FG002|Open-label Period|Adverse Event|1|||
150267093|NCT00971243|542114349|FG003|Open-label Period|Adverse Event|1|||
150267094|NCT00971243|542114350|FG004|Open-label Period|Adverse Event|0|||
150267095|NCT00971243|542114346|FG000|Open-label Period|Physician Decision|5|||
150267096|NCT00971243|542114347|FG001|Open-label Period|Physician Decision|9|||
150267097|NCT00971243|542114348|FG002|Open-label Period|Physician Decision|3|||
150267098|NCT00971243|542114349|FG003|Open-label Period|Physician Decision|7|||
150267099|NCT00971243|542114350|FG004|Open-label Period|Physician Decision|2|||
150267100|NCT00971243|542114346|FG000|Open-label Period|Protocol Violation|1|||
150267101|NCT00971243|542114347|FG001|Open-label Period|Protocol Violation|1|||
150267102|NCT00971243|542114348|FG002|Open-label Period|Protocol Violation|1|||
150267103|NCT00971243|542114349|FG003|Open-label Period|Protocol Violation|0|||
150267104|NCT00971243|542114350|FG004|Open-label Period|Protocol Violation|1|||
150267105|NCT00971243|542114346|FG000|Open-label Period|Withdrawal by Subject|1|||
150267106|NCT00971243|542114347|FG001|Open-label Period|Withdrawal by Subject|0|||
150267107|NCT00971243|542114348|FG002|Open-label Period|Withdrawal by Subject|0|||
150267108|NCT00971243|542114349|FG003|Open-label Period|Withdrawal by Subject|2|||
150267109|NCT00971243|542114350|FG004|Open-label Period|Withdrawal by Subject|1|||
150267110|NCT00971243|542114346|FG000|Open-label Period|Other reason|0|||
150267111|NCT00971243|542114347|FG001|Open-label Period|Other reason|0|||
150267112|NCT00971243|542114348|FG002|Open-label Period|Other reason|0|||
150267113|NCT00971243|542114349|FG003|Open-label Period|Other reason|0|||
150267114|NCT00971243|542114350|FG004|Open-label Period|Other reason|2|||
150267115|NCT00803270|542114351|FG000|Overall Study|Lost to Follow-up|1|||
150267116|NCT00803270|542114352|FG001|Overall Study|Lost to Follow-up|2|||
150267117|NCT02370043|542114358|FG000|Overall Study|Withdrawal by Subject|0|||
150267118|NCT02370043|542114359|FG001|Overall Study|Withdrawal by Subject|0|||
150267119|NCT02370043|542114360|FG002|Overall Study|Withdrawal by Subject|0|||
150267120|NCT02370043|542114361|FG003|Overall Study|Withdrawal by Subject|0|||
150267121|NCT02370043|542114362|FG004|Overall Study|Withdrawal by Subject|1|||
150267122|NCT02370043|542114363|FG005|Overall Study|Withdrawal by Subject|1|||
150267123|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
150267124|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
150267125|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
150267126|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
150267127|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
150267128|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
150267129|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
150267130|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
150267131|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
150267132|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
150267133|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
150267134|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
150267135|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
150267136|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
150267137|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
150267138|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
150267139|NCT01231516|542114364|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
150267140|NCT01231516|542114365|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
150267141|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
150267142|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
150267143|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
150267144|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
150267145|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
149933602|NCT05067972|540891760|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
149933603|NCT05067972|540891761|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
149933604|NCT05067972|540891762|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
149933605|NCT05067972|540891756|FG000|Part 1: Follow-up|Physician Decision|0|||
149933606|NCT05067972|540891757|FG001|Part 1: Follow-up|Physician Decision|0|||
149933607|NCT05067972|540891758|FG002|Part 1: Follow-up|Physician Decision|0|||
150166657|NCT04163458|541745117|FG001|Overall Study|Due to COVID-19 pandemic|2|||
150166658|NCT04163458|541745116|FG000|Overall Study|Participant withdrew consent|2|||
150166659|NCT04163458|541745117|FG001|Overall Study|Participant withdrew consent|3|||
150166660|NCT04163458|541745116|FG000|Overall Study|Randomization failure|2|||
150166661|NCT04163458|541745117|FG001|Overall Study|Randomization failure|2|||
150166662|NCT04163458|541745116|FG000|Overall Study|Other|4|||
150166663|NCT04163458|541745117|FG001|Overall Study|Other|2|||
150166664|NCT01981850|541745119|FG000|Main Phase Stage 1|Death|2|||
150166665|NCT01981850|541745120|FG001|Main Phase Stage 1|Death|0|||
150166666|NCT01981850|541745121|FG002|Main Phase Stage 1|Death|0|||
150166667|NCT01981850|541745122|FG003|Main Phase Stage 1|Death|0|||
150166668|NCT01981850|541745123|FG004|Main Phase Stage 1|Death|0|||
150166669|NCT01981850|541745124|FG005|Main Phase Stage 1|Death|0|||
150166670|NCT01981850|541745125|FG006|Main Phase Stage 1|Death|0|||
150166671|NCT01981850|541745126|FG007|Main Phase Stage 1|Death|0|||
150166672|NCT01981850|541745127|FG008|Main Phase Stage 1|Death|0|||
150166673|NCT01981850|541745128|FG009|Main Phase Stage 1|Death|0|||
150166674|NCT01981850|541745119|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
150166675|NCT01981850|541745120|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166676|NCT01981850|541745121|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166677|NCT01981850|541745122|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166678|NCT01981850|541745123|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166679|NCT01981850|541745124|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166680|NCT01981850|541745125|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166681|NCT01981850|541745126|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166682|NCT01981850|541745127|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166683|NCT01981850|541745128|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
150166684|NCT01981850|541745119|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
150166685|NCT01981850|541745120|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
150166686|NCT01981850|541745121|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
150166687|NCT01981850|541745122|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
150166688|NCT01981850|541745123|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
150166689|NCT01981850|541745124|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
150166690|NCT01981850|541745125|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
150166691|NCT01981850|541745126|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
150166692|NCT01981850|541745127|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
150166693|NCT01981850|541745128|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
150166694|NCT01981850|541745119|FG000|Main Phase Stage 1|Various reasons|0|||
150166695|NCT01981850|541745120|FG001|Main Phase Stage 1|Various reasons|0|||
150166696|NCT01981850|541745121|FG002|Main Phase Stage 1|Various reasons|2|||
150166697|NCT01981850|541745122|FG003|Main Phase Stage 1|Various reasons|0|||
150166698|NCT01981850|541745123|FG004|Main Phase Stage 1|Various reasons|0|||
150166699|NCT01981850|541745124|FG005|Main Phase Stage 1|Various reasons|0|||
150166700|NCT01981850|541745125|FG006|Main Phase Stage 1|Various reasons|0|||
150166701|NCT01981850|541745126|FG007|Main Phase Stage 1|Various reasons|0|||
150166702|NCT01981850|541745127|FG008|Main Phase Stage 1|Various reasons|0|||
150166703|NCT01981850|541745128|FG009|Main Phase Stage 1|Various reasons|0|||
150166704|NCT01981850|541745119|FG000|Main Phase Stage 2|Adverse Event|0|||
150166705|NCT01981850|541745120|FG001|Main Phase Stage 2|Adverse Event|0|||
150166706|NCT01981850|541745121|FG002|Main Phase Stage 2|Adverse Event|0|||
150166707|NCT01981850|541745122|FG003|Main Phase Stage 2|Adverse Event|0|||
150166708|NCT01981850|541745123|FG004|Main Phase Stage 2|Adverse Event|6|||
150166709|NCT01981850|541745124|FG005|Main Phase Stage 2|Adverse Event|5|||
150166710|NCT01981850|541745125|FG006|Main Phase Stage 2|Adverse Event|7|||
150166711|NCT01981850|541745126|FG007|Main Phase Stage 2|Adverse Event|0|||
150166712|NCT01981850|541745127|FG008|Main Phase Stage 2|Adverse Event|0|||
150166713|NCT01981850|541745128|FG009|Main Phase Stage 2|Adverse Event|0|||
150166714|NCT01981850|541745119|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150166715|NCT01981850|541745120|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150166716|NCT01981850|541745121|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150166717|NCT01981850|541745122|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150166718|NCT01981850|541745123|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
150166719|NCT01981850|541745124|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
150267146|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
150166720|NCT01981850|541745125|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
150166721|NCT01981850|541745126|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150166722|NCT01981850|541745127|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
150267147|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
150267148|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
149933608|NCT05067972|540891759|FG003|Part 1: Follow-up|Physician Decision|1|||
149933609|NCT05067972|540891760|FG004|Part 1: Follow-up|Physician Decision|0|||
149933610|NCT05067972|540891761|FG005|Part 1: Follow-up|Physician Decision|0|||
149933611|NCT05067972|540891762|FG006|Part 1: Follow-up|Physician Decision|0|||
149933612|NCT05067972|540891756|FG000|Part 1: Follow-up|Death|1|||
149933613|NCT05067972|540891757|FG001|Part 1: Follow-up|Death|2|||
149933614|NCT05067972|540891758|FG002|Part 1: Follow-up|Death|1|||
149933615|NCT05067972|540891759|FG003|Part 1: Follow-up|Death|0|||
149933616|NCT05067972|540891760|FG004|Part 1: Follow-up|Death|1|||
149933617|NCT05067972|540891761|FG005|Part 1: Follow-up|Death|0|||
149933618|NCT05067972|540891762|FG006|Part 1: Follow-up|Death|1|||
149933619|NCT04391842|540891763|FG000|Overall Study|Withdrawal by Subject|2|||
149933620|NCT00810199|540891764|FG000|Overall Study|Adverse Event|24|||
149933621|NCT00810199|540891765|FG001|Overall Study|Adverse Event|26|||
149933622|NCT00810199|540891764|FG000|Overall Study|Death|4|||
150166723|NCT01981850|541745128|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149933623|NCT00810199|540891765|FG001|Overall Study|Death|6|||
149933624|NCT00810199|540891764|FG000|Overall Study|Withdrew consent|9|||
149933625|NCT00810199|540891765|FG001|Overall Study|Withdrew consent|12|||
149933626|NCT00810199|540891764|FG000|Overall Study|Insufficient therapeutic response|5|||
149933627|NCT00810199|540891765|FG001|Overall Study|Insufficient therapeutic response|14|||
150166724|NCT01981850|541745119|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
150166725|NCT01981850|541745120|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
150166726|NCT01981850|541745121|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
150166727|NCT01981850|541745122|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
150166728|NCT01981850|541745123|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
150166729|NCT01981850|541745124|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
150166730|NCT01981850|541745125|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
150166731|NCT01981850|541745126|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
150166732|NCT01981850|541745127|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
150166733|NCT01981850|541745128|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
150166734|NCT01981850|541745119|FG000|Main Phase Stage 2|Various reasons|0|||
150166735|NCT01981850|541745120|FG001|Main Phase Stage 2|Various reasons|0|||
150166736|NCT01981850|541745121|FG002|Main Phase Stage 2|Various reasons|0|||
150166737|NCT01981850|541745122|FG003|Main Phase Stage 2|Various reasons|0|||
150166738|NCT01981850|541745123|FG004|Main Phase Stage 2|Various reasons|2|||
150166739|NCT01981850|541745124|FG005|Main Phase Stage 2|Various reasons|0|||
150166740|NCT01981850|541745125|FG006|Main Phase Stage 2|Various reasons|1|||
150166741|NCT01981850|541745126|FG007|Main Phase Stage 2|Various reasons|0|||
150166742|NCT01981850|541745127|FG008|Main Phase Stage 2|Various reasons|0|||
150166743|NCT01981850|541745128|FG009|Main Phase Stage 2|Various reasons|0|||
150166744|NCT01981850|541745119|FG000|Main Phase Stage 2|Progressive Disease|0|||
150166745|NCT01981850|541745120|FG001|Main Phase Stage 2|Progressive Disease|0|||
150166746|NCT01981850|541745121|FG002|Main Phase Stage 2|Progressive Disease|0|||
150166747|NCT01981850|541745122|FG003|Main Phase Stage 2|Progressive Disease|0|||
150166748|NCT01981850|541745123|FG004|Main Phase Stage 2|Progressive Disease|0|||
150166749|NCT01981850|541745124|FG005|Main Phase Stage 2|Progressive Disease|6|||
150166750|NCT01981850|541745125|FG006|Main Phase Stage 2|Progressive Disease|6|||
150166751|NCT01981850|541745126|FG007|Main Phase Stage 2|Progressive Disease|0|||
150166752|NCT01981850|541745127|FG008|Main Phase Stage 2|Progressive Disease|0|||
150166753|NCT01981850|541745128|FG009|Main Phase Stage 2|Progressive Disease|0|||
150166754|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Adverse Event|0|||
150166755|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Adverse Event|0|||
150166756|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Adverse Event|0|||
150166757|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Adverse Event|0|||
150166758|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Adverse Event|0|||
150166759|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Adverse Event|0|||
150166760|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Adverse Event|0|||
150166761|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Adverse Event|2|||
150166762|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Adverse Event|1|||
150166763|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Adverse Event|8|||
150166764|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166765|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166766|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166767|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166768|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166769|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
149933628|NCT00810199|540891764|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
150166770|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
150166771|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
150166772|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
150166773|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
150166774|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Various reasons|0|||
150166775|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Various reasons|0|||
149933629|NCT00810199|540891765|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
150267149|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
150267150|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
150267151|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
150267152|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
150267153|NCT01231516|542114364|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
150267154|NCT01231516|542114365|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
150267155|NCT05266586|542114366|FG000|Overall Study|Adverse Event|2|||
150267156|NCT05266586|542114367|FG001|Overall Study|Adverse Event|2|||
150267157|NCT05266586|542114368|FG002|Overall Study|Adverse Event|1|||
150267158|NCT05266586|542114366|FG000|Overall Study|Withdrawal by Subject|1|||
150267159|NCT05266586|542114367|FG001|Overall Study|Withdrawal by Subject|0|||
150267160|NCT05266586|542114368|FG002|Overall Study|Withdrawal by Subject|1|||
150267161|NCT05266586|542114366|FG000|Overall Study|Non-compliance with study drug|0|||
149933630|NCT00810199|540891764|FG000|Overall Study|Administrative/Other|5|||
150166776|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Various reasons|0|||
150166777|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Various reasons|0|||
150166778|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Various reasons|0|||
150166779|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Various reasons|0|||
150166780|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Various reasons|0|||
150166781|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Various reasons|3|||
150166782|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Various reasons|1|||
150166783|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Various reasons|3|||
150166784|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
150166785|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
150166786|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
150166787|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
150166788|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
150166789|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
150166790|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
150166791|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
150166792|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
150166793|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
150166794|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166795|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166796|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166797|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166798|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166799|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166800|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166801|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166802|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
150166803|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
150166804|NCT01981850|541745119|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166805|NCT01981850|541745120|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166806|NCT01981850|541745121|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166807|NCT01981850|541745122|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166808|NCT01981850|541745123|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166809|NCT01981850|541745124|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166810|NCT01981850|541745125|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166811|NCT01981850|541745126|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166812|NCT01981850|541745127|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
150166813|NCT01981850|541745128|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
150166814|NCT01467700|541745129|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
150166815|NCT01467700|541745130|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
150166816|NCT01467700|541745131|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
150166817|NCT01467700|541745132|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
150166818|NCT01467700|541745129|FG000|Overall Study|Major Protocol Deviation|3|||
150166819|NCT01467700|541745130|FG001|Overall Study|Major Protocol Deviation|3|||
150166820|NCT01467700|541745131|FG002|Overall Study|Major Protocol Deviation|2|||
150166821|NCT01467700|541745132|FG003|Overall Study|Major Protocol Deviation|3|||
150166822|NCT01467700|541745129|FG000|Overall Study|Lost to Follow-up|6|||
150166823|NCT01467700|541745130|FG001|Overall Study|Lost to Follow-up|5|||
150166824|NCT01467700|541745131|FG002|Overall Study|Lost to Follow-up|2|||
150166825|NCT01467700|541745132|FG003|Overall Study|Lost to Follow-up|3|||
150166826|NCT01467700|541745129|FG000|Overall Study|Voluntary Withdrawal|5|||
150166827|NCT01467700|541745130|FG001|Overall Study|Voluntary Withdrawal|7|||
150166828|NCT01467700|541745131|FG002|Overall Study|Voluntary Withdrawal|6|||
150166829|NCT01467700|541745132|FG003|Overall Study|Voluntary Withdrawal|2|||
150166830|NCT01467700|541745129|FG000|Overall Study|Study Termination|6|||
149820202|NCT03175120|540471750|FG001|Overall Study|Protocol Violation|2|||
150267162|NCT05266586|542114367|FG001|Overall Study|Non-compliance with study drug|1|||
150267163|NCT05266586|542114368|FG002|Overall Study|Non-compliance with study drug|0|||
150267164|NCT05266586|542114366|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
150267165|NCT05266586|542114367|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
150267166|NCT05266586|542114368|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
150267167|NCT02225353|542114369|FG000|Overall Study|Lost to Follow-up|0|||
150267168|NCT02225353|542114370|FG001|Overall Study|Lost to Follow-up|1|||
150267169|NCT02225353|542114371|FG002|Overall Study|Lost to Follow-up|3|||
150267170|NCT02225353|542114369|FG000|Overall Study|Protocol Violation|4|||
150267171|NCT02225353|542114370|FG001|Overall Study|Protocol Violation|5|||
150267172|NCT02225353|542114371|FG002|Overall Study|Protocol Violation|12|||
150267173|NCT01193920|542114372|FG000|Overall Study|Withdrawal by Subject|1|||
150267174|NCT01193920|542114373|FG001|Overall Study|Withdrawal by Subject|0|||
150267175|NCT01193920|542114374|FG002|Overall Study|Withdrawal by Subject|5|||
150267176|NCT01193920|542114375|FG003|Overall Study|Withdrawal by Subject|1|||
150267177|NCT01193920|542114376|FG004|Overall Study|Withdrawal by Subject|3|||
150267178|NCT01193920|542114377|FG005|Overall Study|Withdrawal by Subject|1|||
150267179|NCT01193920|542114378|FG006|Overall Study|Withdrawal by Subject|3|||
150267180|NCT01193920|542114379|FG007|Overall Study|Withdrawal by Subject|0|||
150267181|NCT01193920|542114380|FG008|Overall Study|Withdrawal by Subject|1|||
150267182|NCT01193920|542114381|FG009|Overall Study|Withdrawal by Subject|0|||
150267183|NCT01193920|542114372|FG000|Overall Study|Lost to Follow-up|1|||
150267184|NCT01193920|542114373|FG001|Overall Study|Lost to Follow-up|0|||
150267185|NCT01193920|542114374|FG002|Overall Study|Lost to Follow-up|1|||
150267186|NCT01193920|542114375|FG003|Overall Study|Lost to Follow-up|1|||
150267187|NCT01193920|542114376|FG004|Overall Study|Lost to Follow-up|3|||
150267188|NCT01193920|542114377|FG005|Overall Study|Lost to Follow-up|3|||
150267189|NCT01193920|542114378|FG006|Overall Study|Lost to Follow-up|1|||
150267190|NCT01193920|542114379|FG007|Overall Study|Lost to Follow-up|0|||
150267191|NCT01193920|542114380|FG008|Overall Study|Lost to Follow-up|2|||
150267192|NCT01193920|542114381|FG009|Overall Study|Lost to Follow-up|3|||
150267193|NCT01193920|542114372|FG000|Overall Study|Protocol Violation|1|||
150267194|NCT01193920|542114373|FG001|Overall Study|Protocol Violation|0|||
150267195|NCT01193920|542114374|FG002|Overall Study|Protocol Violation|0|||
150267196|NCT01193920|542114375|FG003|Overall Study|Protocol Violation|0|||
150267197|NCT01193920|542114376|FG004|Overall Study|Protocol Violation|0|||
150267198|NCT01193920|542114377|FG005|Overall Study|Protocol Violation|0|||
150267199|NCT01193920|542114378|FG006|Overall Study|Protocol Violation|0|||
150267200|NCT01193920|542114379|FG007|Overall Study|Protocol Violation|0|||
150267201|NCT01193920|542114380|FG008|Overall Study|Protocol Violation|0|||
150267202|NCT01193920|542114381|FG009|Overall Study|Protocol Violation|0|||
150267203|NCT01193920|542114372|FG000|Overall Study|Death|0|||
150267204|NCT01193920|542114373|FG001|Overall Study|Death|0|||
150267205|NCT01193920|542114374|FG002|Overall Study|Death|0|||
150267206|NCT01193920|542114375|FG003|Overall Study|Death|1|||
150267207|NCT01193920|542114376|FG004|Overall Study|Death|0|||
150267208|NCT01193920|542114377|FG005|Overall Study|Death|0|||
150267209|NCT01193920|542114378|FG006|Overall Study|Death|2|||
150267210|NCT01193920|542114379|FG007|Overall Study|Death|3|||
150267211|NCT01193920|542114380|FG008|Overall Study|Death|2|||
150267212|NCT01193920|542114381|FG009|Overall Study|Death|4|||
150267213|NCT01193920|542114372|FG000|Overall Study|Unable to classify|0|||
150267214|NCT01193920|542114373|FG001|Overall Study|Unable to classify|0|||
150267215|NCT01193920|542114374|FG002|Overall Study|Unable to classify|0|||
150267216|NCT01193920|542114375|FG003|Overall Study|Unable to classify|1|||
150267217|NCT01193920|542114376|FG004|Overall Study|Unable to classify|0|||
150267218|NCT01193920|542114377|FG005|Overall Study|Unable to classify|0|||
150267219|NCT01193920|542114378|FG006|Overall Study|Unable to classify|0|||
150267220|NCT01193920|542114379|FG007|Overall Study|Unable to classify|1|||
150267221|NCT01193920|542114380|FG008|Overall Study|Unable to classify|0|||
150267222|NCT01193920|542114381|FG009|Overall Study|Unable to classify|0|||
150267223|NCT04683731|542114383|FG000|Overall Study|Withdrawal by Subject|1|||
150267224|NCT04683731|542114384|FG001|Overall Study|Withdrawal by Subject|0|||
150267225|NCT04683731|542114385|FG002|Overall Study|Withdrawal by Subject|3|||
150267226|NCT04683731|542114386|FG003|Overall Study|Withdrawal by Subject|2|||
150267227|NCT04683731|542114383|FG000|Overall Study|Determined patient was not eligible|3|||
150267228|NCT04683731|542114384|FG001|Overall Study|Determined patient was not eligible|3|||
150267229|NCT04683731|542114385|FG002|Overall Study|Determined patient was not eligible|12|||
150267230|NCT04683731|542114386|FG003|Overall Study|Determined patient was not eligible|3|||
150267231|NCT02910739|542114387|FG000|Overall Study|Adverse Event|1|||
150267232|NCT02910739|542114388|FG001|Overall Study|Adverse Event|0|||
150267233|NCT02910739|542114389|FG002|Overall Study|Adverse Event|0|||
150267234|NCT02910739|542114390|FG003|Overall Study|Adverse Event|0|||
150267235|NCT03226275|542114393|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
150267236|NCT03226275|542114394|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
150267237|NCT03226275|542114395|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
150267238|NCT03226275|542114396|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
150166831|NCT01467700|541745130|FG001|Overall Study|Study Termination|5|||
150166832|NCT01467700|541745131|FG002|Overall Study|Study Termination|10|||
150166833|NCT01467700|541745132|FG003|Overall Study|Study Termination|7|||
150166834|NCT01467700|541745129|FG000|Overall Study|Pregnancy|0|||
150166835|NCT01467700|541745130|FG001|Overall Study|Pregnancy|1|||
150166836|NCT01467700|541745131|FG002|Overall Study|Pregnancy|1|||
150166837|NCT01467700|541745132|FG003|Overall Study|Pregnancy|0|||
150166838|NCT01467700|541745129|FG000|Overall Study|Lack of Efficacy|2|||
150166839|NCT01467700|541745130|FG001|Overall Study|Lack of Efficacy|0|||
150166840|NCT01467700|541745131|FG002|Overall Study|Lack of Efficacy|2|||
150166841|NCT01467700|541745132|FG003|Overall Study|Lack of Efficacy|1|||
150166842|NCT01467700|541745129|FG000|Overall Study|Reason not Specified|1|||
150166843|NCT01467700|541745130|FG001|Overall Study|Reason not Specified|3|||
150166844|NCT01467700|541745131|FG002|Overall Study|Reason not Specified|2|||
150166845|NCT01467700|541745132|FG003|Overall Study|Reason not Specified|8|||
150166846|NCT00121199|541745140|FG000|Overall Study|Adverse Event|11|||
150166847|NCT00121199|541745140|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
150166848|NCT00121199|541745140|FG000|Overall Study|Progression/Relapse|1|||
150166849|NCT00121199|541745140|FG000|Overall Study|Death|3|||
150166850|NCT00121199|541745140|FG000|Overall Study|Other - Not Protocol Specified|3|||
150166851|NCT00121199|541745140|FG000|Overall Study|Ineligible|9|||
150166852|NCT03168438|541745141|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
150166853|NCT03168438|541745142|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
150166854|NCT04109118|541745145|FG000|Overall Study|Lost to Follow-up|3|||
150166855|NCT03235349|541745148|FG000|Overall Study|Adverse Event|1|||
150166856|NCT03235349|541745148|FG000|Overall Study|Other|1|||
150166857|NCT03394027|541745149|FG000|Overall Study|Ineligible|3|||
150166858|NCT03394027|541745150|FG001|Overall Study|Ineligible|1|||
150166859|NCT03394027|541745151|FG002|Overall Study|Ineligible|3|||
150166860|NCT03394027|541745149|FG000|Overall Study|Participant declined to participate before treatment started|0|||
150166861|NCT03394027|541745150|FG001|Overall Study|Participant declined to participate before treatment started|0|||
150166862|NCT03394027|541745151|FG002|Overall Study|Participant declined to participate before treatment started|1|||
150166863|NCT01018511|541745155|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
150166864|NCT01018511|541745156|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
150166865|NCT01018511|541745157|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
150166866|NCT01018511|541745158|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
150166867|NCT01018511|541745155|FG000|Overall Study|Adverse Event|5|||
150166868|NCT01018511|541745156|FG001|Overall Study|Adverse Event|9|||
150166869|NCT01018511|541745157|FG002|Overall Study|Adverse Event|13|||
150166870|NCT01018511|541745158|FG003|Overall Study|Adverse Event|10|||
150166871|NCT01018511|541745155|FG000|Overall Study|Lack of Efficacy|4|||
150166872|NCT01018511|541745156|FG001|Overall Study|Lack of Efficacy|1|||
149933631|NCT00810199|540891765|FG001|Overall Study|Administrative/Other|6|||
149933632|NCT00810199|540891764|FG000|Overall Study|Protocol Violation|2|||
149933633|NCT00810199|540891765|FG001|Overall Study|Protocol Violation|6|||
149933634|NCT00810199|540891764|FG000|Overall Study|Failure to return|1|||
149933635|NCT00810199|540891765|FG001|Overall Study|Failure to return|4|||
149933636|NCT00810199|540891764|FG000|Overall Study|Did not receive study drug|2|||
150166873|NCT01018511|541745157|FG002|Overall Study|Lack of Efficacy|1|||
150166874|NCT01018511|541745158|FG003|Overall Study|Lack of Efficacy|2|||
150166875|NCT01018511|541745155|FG000|Overall Study|Withdrawal by Subject|6|||
150166876|NCT01018511|541745156|FG001|Overall Study|Withdrawal by Subject|5|||
150166877|NCT01018511|541745157|FG002|Overall Study|Withdrawal by Subject|11|||
150166878|NCT01018511|541745158|FG003|Overall Study|Withdrawal by Subject|9|||
150166879|NCT01018511|541745155|FG000|Overall Study|Lost to Follow-up|0|||
150166880|NCT01018511|541745156|FG001|Overall Study|Lost to Follow-up|0|||
150166881|NCT01018511|541745157|FG002|Overall Study|Lost to Follow-up|1|||
150166882|NCT01018511|541745158|FG003|Overall Study|Lost to Follow-up|0|||
150166883|NCT01018511|541745155|FG000|Overall Study|Protocol Violation|5|||
150166884|NCT01018511|541745156|FG001|Overall Study|Protocol Violation|8|||
150166885|NCT01018511|541745157|FG002|Overall Study|Protocol Violation|7|||
150166886|NCT01018511|541745158|FG003|Overall Study|Protocol Violation|9|||
150166887|NCT01018511|541745155|FG000|Overall Study|Miscellaneous|0|||
150166888|NCT01018511|541745156|FG001|Overall Study|Miscellaneous|2|||
149933637|NCT00810199|540891765|FG001|Overall Study|Did not receive study drug|1|||
150166889|NCT01018511|541745157|FG002|Overall Study|Miscellaneous|0|||
150166890|NCT01018511|541745158|FG003|Overall Study|Miscellaneous|0|||
149933638|NCT00992017|540891767|FG000|Overall Study|Lost to Follow-up|2|||
149933639|NCT00992017|540891767|FG000|Overall Study|Withdrawal by Subject|2|||
150166891|NCT02926937|541745160|FG000|Overall Study|Adverse Event|0|||
150166892|NCT02926937|541745161|FG001|Overall Study|Adverse Event|1|||
150166893|NCT02926937|541745162|FG002|Overall Study|Adverse Event|1|||
150166894|NCT02926937|541745160|FG000|Overall Study|Poor Compliance to Protocol|1|||
150166895|NCT02926937|541745161|FG001|Overall Study|Poor Compliance to Protocol|0|||
150166896|NCT02926937|541745162|FG002|Overall Study|Poor Compliance to Protocol|0|||
150166897|NCT02926937|541745160|FG000|Overall Study|Lost to Follow-up|4|||
150166898|NCT02926937|541745161|FG001|Overall Study|Lost to Follow-up|5|||
150166899|NCT02926937|541745162|FG002|Overall Study|Lost to Follow-up|0|||
150267239|NCT03226275|542114393|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
150267240|NCT03226275|542114394|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
150267241|NCT03226275|542114395|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
150267242|NCT03226275|542114396|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
150267243|NCT03769181|542116149|FG000|Overall Study|Adverse Event|1|||
150267244|NCT03769181|542116150|FG001|Overall Study|Adverse Event|0|||
150267245|NCT03769181|542116151|FG002|Overall Study|Adverse Event|2|||
150267246|NCT03769181|542116152|FG003|Overall Study|Adverse Event|4|||
150267247|NCT03769181|542116149|FG000|Overall Study|Withdrawal by Subject|1|||
150267248|NCT03769181|542116150|FG001|Overall Study|Withdrawal by Subject|0|||
150267249|NCT03769181|542116151|FG002|Overall Study|Withdrawal by Subject|2|||
150267250|NCT03769181|542116152|FG003|Overall Study|Withdrawal by Subject|1|||
150267251|NCT03769181|542116149|FG000|Overall Study|Progressive disease|9|||
150267252|NCT03769181|542116150|FG001|Overall Study|Progressive disease|7|||
150267253|NCT03769181|542116151|FG002|Overall Study|Progressive disease|13|||
150267254|NCT03769181|542116152|FG003|Overall Study|Progressive disease|6|||
150267255|NCT03769181|542116149|FG000|Overall Study|Other - Unspecified|2|||
150267256|NCT03769181|542116150|FG001|Overall Study|Other - Unspecified|1|||
150267257|NCT03769181|542116151|FG002|Overall Study|Other - Unspecified|0|||
150267258|NCT03769181|542116152|FG003|Overall Study|Other - Unspecified|0|||
150267259|NCT03971422|542116153|FG000|Overall Study|Lost to Follow-up|0|||
150267260|NCT03971422|542116154|FG001|Overall Study|Lost to Follow-up|1|||
150267261|NCT03971422|542116155|FG002|Overall Study|Lost to Follow-up|0|||
150267262|NCT03971422|542116153|FG000|Overall Study|Lack of Efficacy|5|||
150267263|NCT03971422|542116154|FG001|Overall Study|Lack of Efficacy|1|||
150267264|NCT03971422|542116155|FG002|Overall Study|Lack of Efficacy|1|||
150267265|NCT03971422|542116153|FG000|Overall Study|Adverse event, not fatal|2|||
150267266|NCT03971422|542116154|FG001|Overall Study|Adverse event, not fatal|2|||
150267267|NCT03971422|542116155|FG002|Overall Study|Adverse event, not fatal|5|||
150267268|NCT03971422|542116153|FG000|Overall Study|Worsening of MG Symptoms|1|||
150267269|NCT03971422|542116154|FG001|Overall Study|Worsening of MG Symptoms|4|||
150267270|NCT03971422|542116155|FG002|Overall Study|Worsening of MG Symptoms|2|||
150267271|NCT03971422|542116153|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
150267272|NCT03971422|542116154|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
150267273|NCT03971422|542116155|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
150267274|NCT03971422|542116153|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
150267275|NCT03971422|542116154|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
150267276|NCT03971422|542116155|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
150267277|NCT03971422|542116153|FG000|Overall Study|Due to COVID-19 pandemic|0|||
150267278|NCT03971422|542116154|FG001|Overall Study|Due to COVID-19 pandemic|1|||
150267279|NCT03971422|542116155|FG002|Overall Study|Due to COVID-19 pandemic|1|||
150267280|NCT04751656|542116158|FG000|Overall Study|Lost to Follow-up|1|||
150267281|NCT01485354|542116161|FG000|Overall Study|Withdrawal by Subject|5|||
150267282|NCT03566810|542116162|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
150267283|NCT03566810|542116163|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
150267284|NCT03566810|542116164|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
150267285|NCT03566810|542116165|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
150267286|NCT01103245|542116166|FG000|Overall Study|Withdrawal by Subject|1|||
150267287|NCT01103245|542116167|FG001|Overall Study|Withdrawal by Subject|0|||
150267288|NCT01103245|542116168|FG002|Overall Study|Withdrawal by Subject|3|||
150267289|NCT01103245|542116169|FG003|Overall Study|Withdrawal by Subject|0|||
150267290|NCT01103245|542116166|FG000|Overall Study|Inadequate IV access|1|||
150267291|NCT01103245|542116167|FG001|Overall Study|Inadequate IV access|0|||
150267292|NCT01103245|542116168|FG002|Overall Study|Inadequate IV access|0|||
150267293|NCT01103245|542116169|FG003|Overall Study|Inadequate IV access|0|||
150267294|NCT01103245|542116166|FG000|Overall Study|Adverse Event|0|||
150267295|NCT01103245|542116167|FG001|Overall Study|Adverse Event|2|||
150267296|NCT01103245|542116168|FG002|Overall Study|Adverse Event|1|||
150267297|NCT01103245|542116169|FG003|Overall Study|Adverse Event|0|||
150267298|NCT01103245|542116166|FG000|Overall Study|Physician Decision|1|||
150267299|NCT01103245|542116167|FG001|Overall Study|Physician Decision|0|||
150267300|NCT01103245|542116168|FG002|Overall Study|Physician Decision|0|||
150267301|NCT01103245|542116169|FG003|Overall Study|Physician Decision|0|||
150267302|NCT00826111|542116170|FG000|Overall Study|Lost to Follow-up|0|||
150267303|NCT00826111|542116171|FG001|Overall Study|Lost to Follow-up|1|||
150267304|NCT00826111|542116170|FG000|Overall Study|Protocol Violation|1|||
150267305|NCT00826111|542116171|FG001|Overall Study|Protocol Violation|0|||
150267306|NCT00826111|542116170|FG000|Overall Study|Withdrawal by Subject|5|||
150267307|NCT00826111|542116171|FG001|Overall Study|Withdrawal by Subject|0|||
150267308|NCT00826111|542116170|FG000|Overall Study|Physician Decision|1|||
150267309|NCT00826111|542116171|FG001|Overall Study|Physician Decision|1|||
150267310|NCT02805725|542116172|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
150267311|NCT02805725|542116173|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
150267312|NCT02805725|542116174|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
150267313|NCT02805725|542116175|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
150166900|NCT02926937|541745160|FG000|Overall Study|At the Participant's own Request|11|||
150166901|NCT02926937|541745161|FG001|Overall Study|At the Participant's own Request|5|||
150166902|NCT02926937|541745162|FG002|Overall Study|At the Participant's own Request|8|||
150166903|NCT02926937|541745160|FG000|Overall Study|Reason not Specified|3|||
150166904|NCT02926937|541745161|FG001|Overall Study|Reason not Specified|4|||
150166905|NCT02926937|541745162|FG002|Overall Study|Reason not Specified|2|||
150166906|NCT01729871|541745164|FG000|Overall Study|Adverse Event|7|||
150166907|NCT01729871|541745165|FG001|Overall Study|Adverse Event|7|||
150166908|NCT01729871|541745164|FG000|Overall Study|Death|0|||
150166909|NCT01729871|541745165|FG001|Overall Study|Death|1|||
150166910|NCT01729871|541745164|FG000|Overall Study|Lack of Efficacy|0|||
150166911|NCT01729871|541745165|FG001|Overall Study|Lack of Efficacy|1|||
150166912|NCT01729871|541745164|FG000|Overall Study|Physician Decision|0|||
150166913|NCT01729871|541745165|FG001|Overall Study|Physician Decision|2|||
150166914|NCT01729871|541745164|FG000|Overall Study|Protocol Violation|1|||
150166915|NCT01729871|541745165|FG001|Overall Study|Protocol Violation|0|||
150166916|NCT01729871|541745164|FG000|Overall Study|Withdrawal by Subject|0|||
150166917|NCT01729871|541745165|FG001|Overall Study|Withdrawal by Subject|3|||
150166918|NCT01729871|541745164|FG000|Overall Study|Other|4|||
150166919|NCT01729871|541745165|FG001|Overall Study|Other|9|||
150166920|NCT01137292|541745166|FG000|Overall Study|Death|30|||
150166921|NCT01137292|541745166|FG000|Overall Study|Adverse Event|3|||
150166922|NCT01137292|541745166|FG000|Overall Study|Lack of Efficacy|13|||
150166923|NCT01137292|541745166|FG000|Overall Study|Lost to Follow-up|1|||
150166924|NCT01137292|541745166|FG000|Overall Study|Other|7|||
150166925|NCT01772719|541745167|FG000|Overall Study|Withdrawal by Subject|3|||
150166926|NCT01772719|541745167|FG000|Overall Study|Adverse Event|2|||
150166927|NCT01772719|541745167|FG000|Overall Study|Protocol Violation|1|||
150166928|NCT01772719|541745167|FG000|Overall Study|Lost to Follow-up|1|||
150166929|NCT00477412|541745172|FG000|Overall Study|Death|0|||
150166930|NCT00477412|541745173|FG001|Overall Study|Death|0|||
150166931|NCT00477412|541745174|FG002|Overall Study|Death|0|||
150166932|NCT00477412|541745175|FG003|Overall Study|Death|4|||
150166933|NCT00477412|541745172|FG000|Overall Study|Lost to Follow-up|0|||
150166934|NCT00477412|541745173|FG001|Overall Study|Lost to Follow-up|0|||
150166935|NCT00477412|541745174|FG002|Overall Study|Lost to Follow-up|0|||
150166936|NCT00477412|541745175|FG003|Overall Study|Lost to Follow-up|1|||
150166937|NCT00477412|541745172|FG000|Overall Study|Withdrawal by Subject|0|||
150166938|NCT00477412|541745173|FG001|Overall Study|Withdrawal by Subject|0|||
150166939|NCT00477412|541745174|FG002|Overall Study|Withdrawal by Subject|0|||
150166940|NCT00477412|541745175|FG003|Overall Study|Withdrawal by Subject|2|||
150166941|NCT00477412|541745172|FG000|Overall Study|Second Malignancy|0|||
150166942|NCT00477412|541745173|FG001|Overall Study|Second Malignancy|0|||
150166943|NCT00477412|541745174|FG002|Overall Study|Second Malignancy|0|||
150166944|NCT00477412|541745175|FG003|Overall Study|Second Malignancy|1|||
150166945|NCT00477412|541745172|FG000|Overall Study|Adverse Event|1|||
150166946|NCT00477412|541745173|FG001|Overall Study|Adverse Event|0|||
150166947|NCT00477412|541745174|FG002|Overall Study|Adverse Event|1|||
150166948|NCT00477412|541745175|FG003|Overall Study|Adverse Event|0|||
150166949|NCT00661778|541747669|FG000|Overall Study|Disease Progression|23|||
150166950|NCT00661778|541747669|FG000|Overall Study|Adverse Event|18|||
150166951|NCT00661778|541747669|FG000|Overall Study|Reason not Specified|6|||
150166952|NCT00661778|541747669|FG000|Overall Study|Protocol Violation|2|||
150166953|NCT00661778|541747669|FG000|Overall Study|Withdrawal of Consent|1|||
150166954|NCT01249092|541747675|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
150166955|NCT01249092|541747675|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
150166956|NCT00151996|541747678|FG000|Overall Study|Adverse Event|3|||
150166957|NCT00151996|541747679|FG001|Overall Study|Adverse Event|2|||
150166958|NCT00151996|541747678|FG000|Overall Study|Withdrawal by Subject|1|||
150166959|NCT00151996|541747679|FG001|Overall Study|Withdrawal by Subject|1|||
150166960|NCT00151996|541747678|FG000|Overall Study|Protocol Violation|1|||
150166961|NCT00151996|541747679|FG001|Overall Study|Protocol Violation|2|||
150166962|NCT00151996|541747678|FG000|Overall Study|Sponsor's decision|0|||
150166963|NCT00151996|541747679|FG001|Overall Study|Sponsor's decision|2|||
150166964|NCT02001623|541747684|FG000|Overall Study|Disease Progression|2|||
150166965|NCT02001623|541747685|FG001|Overall Study|Disease Progression|2|||
150166966|NCT02001623|541747686|FG002|Overall Study|Disease Progression|3|||
150166967|NCT02001623|541747687|FG003|Overall Study|Disease Progression|2|||
150166968|NCT02001623|541747688|FG004|Overall Study|Disease Progression|3|||
150166969|NCT02001623|541747689|FG005|Overall Study|Disease Progression|2|||
150166970|NCT02001623|541747690|FG006|Overall Study|Disease Progression|3|||
150166971|NCT02001623|541747691|FG007|Overall Study|Disease Progression|3|||
150166972|NCT02001623|541747692|FG008|Overall Study|Disease Progression|7|||
150166973|NCT02001623|541747693|FG009|Overall Study|Disease Progression|40|||
150166974|NCT02001623|541747694|FG010|Overall Study|Disease Progression|5|||
150166975|NCT02001623|541747695|FG011|Overall Study|Disease Progression|9|||
150166976|NCT02001623|541747696|FG012|Overall Study|Disease Progression|9|||
150166977|NCT02001623|541747697|FG013|Overall Study|Disease Progression|20|||
150166978|NCT02001623|541747698|FG014|Overall Study|Disease Progression|9|||
150267314|NCT02805725|542116176|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
150267315|NCT02805725|542116172|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
150267316|NCT02805725|542116173|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
150267317|NCT02805725|542116174|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
150267318|NCT02805725|542116175|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
150267319|NCT02805725|542116176|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
150267320|NCT02805725|542116172|FG000|Phase II|Protocol Violation|0|||
150267321|NCT02805725|542116173|FG001|Phase II|Protocol Violation|0|||
149933640|NCT00992017|540891767|FG000|Overall Study|Unable to get to clinic|5|||
149933641|NCT00992017|540891767|FG000|Overall Study|Not adhere to study requirements|1|||
149933642|NCT02864407|540891768|FG000|Overall Study|Protocol Violation|3|||
149933643|NCT02864407|540891768|FG000|Overall Study|Lost to Follow-up|115|||
149933644|NCT02864407|540891768|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
150166979|NCT02001623|541747684|FG000|Overall Study|Physician Decision|0|||
150166980|NCT02001623|541747685|FG001|Overall Study|Physician Decision|0|||
150166981|NCT02001623|541747686|FG002|Overall Study|Physician Decision|0|||
150166982|NCT02001623|541747687|FG003|Overall Study|Physician Decision|0|||
150166983|NCT02001623|541747688|FG004|Overall Study|Physician Decision|0|||
150166984|NCT02001623|541747689|FG005|Overall Study|Physician Decision|0|||
150166985|NCT02001623|541747690|FG006|Overall Study|Physician Decision|0|||
150166986|NCT02001623|541747691|FG007|Overall Study|Physician Decision|0|||
150166987|NCT02001623|541747692|FG008|Overall Study|Physician Decision|3|||
150166988|NCT02001623|541747693|FG009|Overall Study|Physician Decision|2|||
150166989|NCT02001623|541747694|FG010|Overall Study|Physician Decision|3|||
150166990|NCT02001623|541747695|FG011|Overall Study|Physician Decision|3|||
150166991|NCT02001623|541747696|FG012|Overall Study|Physician Decision|1|||
150166992|NCT02001623|541747697|FG013|Overall Study|Physician Decision|2|||
150166993|NCT02001623|541747698|FG014|Overall Study|Physician Decision|1|||
150166994|NCT02001623|541747684|FG000|Overall Study|Death|0|||
150166995|NCT02001623|541747685|FG001|Overall Study|Death|1|||
150166996|NCT02001623|541747686|FG002|Overall Study|Death|0|||
150166997|NCT02001623|541747687|FG003|Overall Study|Death|0|||
150166998|NCT02001623|541747688|FG004|Overall Study|Death|0|||
150166999|NCT02001623|541747689|FG005|Overall Study|Death|0|||
150167000|NCT02001623|541747690|FG006|Overall Study|Death|0|||
150167001|NCT02001623|541747691|FG007|Overall Study|Death|0|||
150167002|NCT02001623|541747692|FG008|Overall Study|Death|0|||
150167003|NCT02001623|541747693|FG009|Overall Study|Death|0|||
150167004|NCT02001623|541747694|FG010|Overall Study|Death|0|||
150167005|NCT02001623|541747695|FG011|Overall Study|Death|0|||
150167006|NCT02001623|541747696|FG012|Overall Study|Death|0|||
150167007|NCT02001623|541747697|FG013|Overall Study|Death|0|||
150167008|NCT02001623|541747698|FG014|Overall Study|Death|0|||
150167009|NCT02001623|541747684|FG000|Overall Study|Adverse Event|0|||
150167010|NCT02001623|541747685|FG001|Overall Study|Adverse Event|0|||
150167011|NCT02001623|541747686|FG002|Overall Study|Adverse Event|0|||
150167012|NCT02001623|541747687|FG003|Overall Study|Adverse Event|0|||
150167013|NCT02001623|541747688|FG004|Overall Study|Adverse Event|0|||
150167014|NCT02001623|541747689|FG005|Overall Study|Adverse Event|1|||
150167015|NCT02001623|541747690|FG006|Overall Study|Adverse Event|0|||
150167016|NCT02001623|541747691|FG007|Overall Study|Adverse Event|3|||
150167017|NCT02001623|541747692|FG008|Overall Study|Adverse Event|4|||
150167018|NCT02001623|541747693|FG009|Overall Study|Adverse Event|6|||
150167019|NCT02001623|541747694|FG010|Overall Study|Adverse Event|4|||
150167020|NCT02001623|541747695|FG011|Overall Study|Adverse Event|0|||
150167021|NCT02001623|541747696|FG012|Overall Study|Adverse Event|3|||
150167022|NCT02001623|541747697|FG013|Overall Study|Adverse Event|5|||
150167023|NCT02001623|541747698|FG014|Overall Study|Adverse Event|6|||
150167024|NCT02001623|541747684|FG000|Overall Study|Other - Miscellaneous|0|||
150167025|NCT02001623|541747685|FG001|Overall Study|Other - Miscellaneous|0|||
150167026|NCT02001623|541747686|FG002|Overall Study|Other - Miscellaneous|0|||
150167027|NCT02001623|541747687|FG003|Overall Study|Other - Miscellaneous|0|||
150167028|NCT02001623|541747688|FG004|Overall Study|Other - Miscellaneous|0|||
150167029|NCT02001623|541747689|FG005|Overall Study|Other - Miscellaneous|0|||
150167030|NCT02001623|541747690|FG006|Overall Study|Other - Miscellaneous|0|||
150167031|NCT02001623|541747691|FG007|Overall Study|Other - Miscellaneous|0|||
150167032|NCT02001623|541747692|FG008|Overall Study|Other - Miscellaneous|0|||
150267322|NCT02805725|542116174|FG002|Phase II|Protocol Violation|0|||
149933645|NCT02864407|540891768|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
150167033|NCT02001623|541747693|FG009|Overall Study|Other - Miscellaneous|1|||
150167034|NCT02001623|541747694|FG010|Overall Study|Other - Miscellaneous|0|||
150167035|NCT02001623|541747695|FG011|Overall Study|Other - Miscellaneous|0|||
150167036|NCT02001623|541747696|FG012|Overall Study|Other - Miscellaneous|0|||
150167037|NCT02001623|541747697|FG013|Overall Study|Other - Miscellaneous|1|||
150167038|NCT02001623|541747698|FG014|Overall Study|Other - Miscellaneous|0|||
150167039|NCT02001623|541747684|FG000|Overall Study|Withdrawal by Subject|1|||
150167040|NCT02001623|541747685|FG001|Overall Study|Withdrawal by Subject|0|||
150167041|NCT02001623|541747686|FG002|Overall Study|Withdrawal by Subject|0|||
150167042|NCT02001623|541747687|FG003|Overall Study|Withdrawal by Subject|0|||
149933646|NCT02864407|540891768|FG000|Overall Study|Consent prior to the contract date|1|||
149933647|NCT02287038|540891778|FG000|Overall Study|Stopped attending appointments|3|||
149933648|NCT02287038|540891779|FG001|Overall Study|Stopped attending appointments|2|||
149933649|NCT02287038|540891778|FG000|Overall Study|Anxiety after starting medication|0|||
149933650|NCT02287038|540891779|FG001|Overall Study|Anxiety after starting medication|1|||
149933651|NCT02287038|540891778|FG000|Overall Study|Nausea after starting medication|1|||
149933652|NCT02287038|540891779|FG001|Overall Study|Nausea after starting medication|0|||
149933653|NCT02287038|540891778|FG000|Overall Study|Abnormal ECG after starting medication|1|||
149933654|NCT02287038|540891779|FG001|Overall Study|Abnormal ECG after starting medication|0|||
149933655|NCT05502302|540891787|FG000|Overall Study|Lost to Follow-up|6|||
149933656|NCT05502302|540891787|FG000|Overall Study|Death|2|||
149933657|NCT02155985|540891796|FG000|Overall Study|Withdrawal by Subject|0|||
149933658|NCT02155985|540891797|FG001|Overall Study|Withdrawal by Subject|0|||
149933659|NCT02155985|540891798|FG002|Overall Study|Withdrawal by Subject|1|||
149933660|NCT02155985|540891796|FG000|Overall Study|Lost to Follow-up|1|||
149933661|NCT02155985|540891797|FG001|Overall Study|Lost to Follow-up|0|||
149933662|NCT02155985|540891798|FG002|Overall Study|Lost to Follow-up|0|||
149933663|NCT02998151|540891799|FG000|Overall Study|Withdrawal by Subject|3|||
150167043|NCT02001623|541747688|FG004|Overall Study|Withdrawal by Subject|0|||
150167044|NCT02001623|541747689|FG005|Overall Study|Withdrawal by Subject|0|||
150167045|NCT02001623|541747690|FG006|Overall Study|Withdrawal by Subject|0|||
150167046|NCT02001623|541747691|FG007|Overall Study|Withdrawal by Subject|0|||
150167047|NCT02001623|541747692|FG008|Overall Study|Withdrawal by Subject|1|||
150167048|NCT02001623|541747693|FG009|Overall Study|Withdrawal by Subject|3|||
150167049|NCT02001623|541747694|FG010|Overall Study|Withdrawal by Subject|2|||
150167050|NCT02001623|541747695|FG011|Overall Study|Withdrawal by Subject|2|||
150167051|NCT02001623|541747696|FG012|Overall Study|Withdrawal by Subject|1|||
150167052|NCT02001623|541747697|FG013|Overall Study|Withdrawal by Subject|5|||
150167053|NCT02001623|541747698|FG014|Overall Study|Withdrawal by Subject|2|||
150167054|NCT02001623|541747684|FG000|Overall Study|Lost to Follow-up|0|||
150167055|NCT02001623|541747685|FG001|Overall Study|Lost to Follow-up|0|||
150167056|NCT02001623|541747686|FG002|Overall Study|Lost to Follow-up|0|||
150167057|NCT02001623|541747687|FG003|Overall Study|Lost to Follow-up|0|||
150167058|NCT02001623|541747688|FG004|Overall Study|Lost to Follow-up|0|||
150167059|NCT02001623|541747689|FG005|Overall Study|Lost to Follow-up|0|||
150167060|NCT02001623|541747690|FG006|Overall Study|Lost to Follow-up|0|||
150167061|NCT02001623|541747691|FG007|Overall Study|Lost to Follow-up|0|||
150167062|NCT02001623|541747692|FG008|Overall Study|Lost to Follow-up|0|||
150167063|NCT02001623|541747693|FG009|Overall Study|Lost to Follow-up|1|||
150167064|NCT02001623|541747694|FG010|Overall Study|Lost to Follow-up|0|||
150167065|NCT02001623|541747695|FG011|Overall Study|Lost to Follow-up|0|||
150167066|NCT02001623|541747696|FG012|Overall Study|Lost to Follow-up|0|||
150167067|NCT02001623|541747697|FG013|Overall Study|Lost to Follow-up|0|||
150167068|NCT02001623|541747698|FG014|Overall Study|Lost to Follow-up|0|||
150167069|NCT02001623|541747684|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
150167070|NCT02001623|541747685|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
150167071|NCT02001623|541747686|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
150167072|NCT02001623|541747687|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
150167073|NCT02001623|541747688|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
150167074|NCT02001623|541747689|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
150167075|NCT02001623|541747690|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
150167076|NCT02001623|541747691|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
150167077|NCT02001623|541747692|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
150167078|NCT02001623|541747693|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
150167079|NCT02001623|541747694|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
150167080|NCT02001623|541747695|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
150167081|NCT02001623|541747696|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
150167082|NCT02001623|541747697|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
150167083|NCT02001623|541747698|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
150167084|NCT02001623|541747684|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
150167085|NCT02001623|541747685|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
150167086|NCT02001623|541747686|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
150167087|NCT02001623|541747687|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
150167088|NCT02001623|541747688|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
150167089|NCT02001623|541747689|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
150167090|NCT02001623|541747690|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
150167091|NCT02001623|541747691|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
150167092|NCT02001623|541747692|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
150167093|NCT02001623|541747693|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
150167094|NCT02001623|541747694|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
150167095|NCT02001623|541747695|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
150167096|NCT02001623|541747696|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
150167097|NCT02001623|541747697|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
150167098|NCT02001623|541747698|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
150167099|NCT01570751|541747705|FG000|Period A (16 Weeks)|Protocol Violation|1|||
150267323|NCT02805725|542116175|FG003|Phase II|Protocol Violation|0|||
150267324|NCT02805725|542116176|FG004|Phase II|Protocol Violation|6|||
150267325|NCT01195545|542116177|FG000|Overall Study|Protocol Violation|4|||
150267326|NCT03511053|542116181|FG000|Overall Study|Withdrawal by Subject|1|||
150267327|NCT02425644|542116182|FG000|Overall Study|Lost to Follow-up|2|||
150267328|NCT02425644|542116183|FG001|Overall Study|Lost to Follow-up|3|||
150267329|NCT02425644|542116182|FG000|Overall Study|Withdrawal by Subject|41|||
150267330|NCT02425644|542116183|FG001|Overall Study|Withdrawal by Subject|36|||
150267331|NCT02425644|542116182|FG000|Overall Study|Lack of Efficacy|3|||
150267332|NCT02425644|542116183|FG001|Overall Study|Lack of Efficacy|10|||
150267333|NCT02425644|542116182|FG000|Overall Study|Adverse Event|13|||
150267334|NCT02425644|542116183|FG001|Overall Study|Adverse Event|3|||
150267335|NCT02425644|542116182|FG000|Overall Study|Death|0|||
150267336|NCT02425644|542116183|FG001|Overall Study|Death|2|||
150267337|NCT02425644|542116182|FG000|Overall Study|Other|18|||
150267338|NCT02425644|542116183|FG001|Overall Study|Other|17|||
150267339|NCT00567268|542116184|FG000|Overall Study|Protocol Violation|7|||
150267340|NCT00567268|542116184|FG000|Overall Study|Lost to Follow-up|36|||
150267341|NCT00567268|542116184|FG000|Overall Study|No Visit After First Day of Treatment|2|||
150267342|NCT00567268|542116184|FG000|Overall Study|No Drug Administration|4|||
150267343|NCT00567268|542116184|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
150267344|NCT00888433|542116187|FG000|Overall Study|Withdrawal by Subject|1|||
150267345|NCT00888433|542116188|FG001|Overall Study|Withdrawal by Subject|2|||
150267346|NCT00888433|542116187|FG000|Overall Study|Missed Visit|2|||
150267347|NCT00888433|542116188|FG001|Overall Study|Missed Visit|1|||
150267348|NCT02202551|542116190|FG000|Overall Study|Adverse Event|8|||
150267349|NCT02202551|542116191|FG001|Overall Study|Adverse Event|19|||
150267350|NCT02202551|542116192|FG002|Overall Study|Adverse Event|5|||
150267351|NCT02202551|542116193|FG003|Overall Study|Adverse Event|9|||
150267352|NCT02202551|542116190|FG000|Overall Study|Death|3|||
150267353|NCT02202551|542116191|FG001|Overall Study|Death|2|||
150267354|NCT02202551|542116192|FG002|Overall Study|Death|1|||
150267355|NCT02202551|542116193|FG003|Overall Study|Death|1|||
150267356|NCT02202551|542116190|FG000|Overall Study|Lost to Follow-up|0|||
150267357|NCT02202551|542116191|FG001|Overall Study|Lost to Follow-up|1|||
150267358|NCT02202551|542116192|FG002|Overall Study|Lost to Follow-up|0|||
150267359|NCT02202551|542116193|FG003|Overall Study|Lost to Follow-up|1|||
150267360|NCT02202551|542116190|FG000|Overall Study|Needed to take excluded medication|0|||
150267361|NCT02202551|542116191|FG001|Overall Study|Needed to take excluded medication|2|||
150267362|NCT02202551|542116192|FG002|Overall Study|Needed to take excluded medication|0|||
150267363|NCT02202551|542116193|FG003|Overall Study|Needed to take excluded medication|1|||
150267364|NCT02202551|542116190|FG000|Overall Study|Subject moved away|0|||
150267365|NCT02202551|542116191|FG001|Overall Study|Subject moved away|1|||
150267366|NCT02202551|542116192|FG002|Overall Study|Subject moved away|0|||
150267367|NCT02202551|542116193|FG003|Overall Study|Subject moved away|0|||
150267368|NCT02202551|542116190|FG000|Overall Study|DBS surgery|3|||
150267369|NCT02202551|542116191|FG001|Overall Study|DBS surgery|0|||
150267370|NCT02202551|542116192|FG002|Overall Study|DBS surgery|0|||
150267371|NCT02202551|542116193|FG003|Overall Study|DBS surgery|0|||
150267372|NCT02202551|542116190|FG000|Overall Study|Dyskinesia upon taper|1|||
150267373|NCT02202551|542116191|FG001|Overall Study|Dyskinesia upon taper|0|||
150267374|NCT02202551|542116192|FG002|Overall Study|Dyskinesia upon taper|0|||
150267375|NCT02202551|542116193|FG003|Overall Study|Dyskinesia upon taper|0|||
150267376|NCT02202551|542116190|FG000|Overall Study|Lack of Efficacy|0|||
150267377|NCT02202551|542116191|FG001|Overall Study|Lack of Efficacy|1|||
150267378|NCT02202551|542116192|FG002|Overall Study|Lack of Efficacy|0|||
150267379|NCT02202551|542116193|FG003|Overall Study|Lack of Efficacy|0|||
149933664|NCT02998151|540891799|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
150267380|NCT02202551|542116190|FG000|Overall Study|Physician Decision|1|||
150267381|NCT02202551|542116191|FG001|Overall Study|Physician Decision|0|||
150267382|NCT02202551|542116192|FG002|Overall Study|Physician Decision|0|||
150267383|NCT02202551|542116193|FG003|Overall Study|Physician Decision|0|||
150267384|NCT02202551|542116190|FG000|Overall Study|Site closure|3|||
150267385|NCT02202551|542116191|FG001|Overall Study|Site closure|0|||
150267386|NCT02202551|542116192|FG002|Overall Study|Site closure|0|||
150267387|NCT02202551|542116193|FG003|Overall Study|Site closure|1|||
150267388|NCT02202551|542116190|FG000|Overall Study|Unable to complete visits per protocol|1|||
150267389|NCT02202551|542116191|FG001|Overall Study|Unable to complete visits per protocol|0|||
150267390|NCT02202551|542116192|FG002|Overall Study|Unable to complete visits per protocol|0|||
150267391|NCT02202551|542116193|FG003|Overall Study|Unable to complete visits per protocol|0|||
150267392|NCT02202551|542116190|FG000|Overall Study|Worsening Dyskinesia|0|||
150267393|NCT02202551|542116191|FG001|Overall Study|Worsening Dyskinesia|0|||
150267394|NCT02202551|542116192|FG002|Overall Study|Worsening Dyskinesia|0|||
150267395|NCT02202551|542116193|FG003|Overall Study|Worsening Dyskinesia|1|||
150267396|NCT02202551|542116190|FG000|Overall Study|Protocol Violation|0|||
150267397|NCT02202551|542116191|FG001|Overall Study|Protocol Violation|1|||
150267398|NCT02202551|542116192|FG002|Overall Study|Protocol Violation|0|||
150267399|NCT02202551|542116193|FG003|Overall Study|Protocol Violation|0|||
150267400|NCT02202551|542116190|FG000|Overall Study|Sponsor's decision|2|||
150267401|NCT02202551|542116191|FG001|Overall Study|Sponsor's decision|0|||
150267402|NCT02202551|542116192|FG002|Overall Study|Sponsor's decision|0|||
150267403|NCT02202551|542116193|FG003|Overall Study|Sponsor's decision|0|||
150267404|NCT02202551|542116190|FG000|Overall Study|Subject unwilling to proceed|1|||
150267405|NCT02202551|542116191|FG001|Overall Study|Subject unwilling to proceed|5|||
150267406|NCT02202551|542116192|FG002|Overall Study|Subject unwilling to proceed|3|||
150267407|NCT02202551|542116193|FG003|Overall Study|Subject unwilling to proceed|5|||
150267408|NCT02202551|542116190|FG000|Overall Study|Subject consent withdrawn|0|||
150267409|NCT02202551|542116191|FG001|Overall Study|Subject consent withdrawn|3|||
150267410|NCT02202551|542116192|FG002|Overall Study|Subject consent withdrawn|1|||
150267411|NCT02202551|542116193|FG003|Overall Study|Subject consent withdrawn|2|||
150267412|NCT02202551|542116190|FG000|Overall Study|eGFR<50mL/min/m2|2|||
150267413|NCT02202551|542116191|FG001|Overall Study|eGFR<50mL/min/m2|2|||
150267414|NCT02202551|542116192|FG002|Overall Study|eGFR<50mL/min/m2|0|||
150267415|NCT02202551|542116193|FG003|Overall Study|eGFR<50mL/min/m2|1|||
150267416|NCT02349451|542116194|FG000|Overall Study|Withdrawal by Subject|0|||
150267417|NCT02349451|542116195|FG001|Overall Study|Withdrawal by Subject|1|||
150267418|NCT02349451|542116196|FG002|Overall Study|Withdrawal by Subject|2|||
150267419|NCT02349451|542116197|FG003|Overall Study|Withdrawal by Subject|1|||
150267420|NCT01176773|542116205|FG000|Overall Study|Screen Failure|2|||
150267421|NCT01176773|542116205|FG000|Overall Study|Withdrew consent|1|||
150267422|NCT02804178|542116213|FG000|Overall Study|Adverse Event|1|||
150267423|NCT00564018|542116232|FG000|Overall Study|Withdrawal by Subject|2|||
150267424|NCT00564018|542116233|FG001|Overall Study|Withdrawal by Subject|3|||
150267425|NCT00564018|542116234|FG002|Overall Study|Withdrawal by Subject|1|||
150267426|NCT00986440|542116235|FG000|Overall Study|Progressive disease|27|||
150267427|NCT00986440|542116236|FG001|Overall Study|Progressive disease|37|||
150267428|NCT00986440|542116235|FG000|Overall Study|Serious adverse event or adverse event|9|||
150267429|NCT00986440|542116236|FG001|Overall Study|Serious adverse event or adverse event|2|||
150267430|NCT00986440|542116235|FG000|Overall Study|Withdrawal by Subject|1|||
150267431|NCT00986440|542116236|FG001|Overall Study|Withdrawal by Subject|2|||
150267432|NCT00986440|542116235|FG000|Overall Study|Screen failure (not dosed)|4|||
150267433|NCT00986440|542116236|FG001|Overall Study|Screen failure (not dosed)|2|||
150267434|NCT00388154|542116243|FG000|Overall Study|Withdrawal by Subject|1|||
150267435|NCT00421707|542116244|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
149933665|NCT02998151|540891799|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
149933666|NCT01628848|540891803|FG000|Overall Study|Adverse Event|9|||
149933667|NCT01628848|540891804|FG001|Overall Study|Adverse Event|7|||
149933668|NCT01628848|540891803|FG000|Overall Study|Lack of Efficacy|0|||
149933669|NCT01628848|540891804|FG001|Overall Study|Lack of Efficacy|4|||
149933670|NCT01628848|540891803|FG000|Overall Study|Withdrawal by Subject|0|||
149933671|NCT01628848|540891804|FG001|Overall Study|Withdrawal by Subject|2|||
149933672|NCT01628848|540891803|FG000|Overall Study|Physician Decision|3|||
150267436|NCT00421707|542116245|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
150267437|NCT00421707|542116244|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
150267438|NCT00421707|542116245|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
150267439|NCT00421707|542116244|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
150267440|NCT00421707|542116245|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
150267441|NCT00421707|542116244|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
150267442|NCT00421707|542116245|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
150267443|NCT00421707|542116244|FG000|Period 2: Washout|Adverse Event|1|||
150267444|NCT00421707|542116245|FG001|Period 2: Washout|Adverse Event|1|||
150267445|NCT00421707|542116244|FG000|Period 2: Washout|Withdrawal by Subject|0|||
150267446|NCT00421707|542116245|FG001|Period 2: Washout|Withdrawal by Subject|1|||
150267447|NCT00421707|542116244|FG000|Period 2: Washout|Lost to Follow-up|0|||
150267448|NCT00421707|542116245|FG001|Period 2: Washout|Lost to Follow-up|1|||
150267449|NCT00421707|542116244|FG000|Period 2: Washout|Other: Pregnancy|0|||
150267450|NCT00421707|542116245|FG001|Period 2: Washout|Other: Pregnancy|1|||
150267451|NCT00421707|542116244|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
150267452|NCT00421707|542116245|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
150267453|NCT00421707|542116244|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
150267454|NCT00421707|542116245|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
149933673|NCT01628848|540891804|FG001|Overall Study|Physician Decision|1|||
149933674|NCT02667301|540891805|FG000|Overall Study|Adverse Event|1|||
150267455|NCT00421707|542116244|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
150267456|NCT00421707|542116245|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
150267457|NCT03291587|542116246|FG000|Overall Study|Lost to Follow-up|62|||
150267458|NCT03291587|542116247|FG001|Overall Study|Lost to Follow-up|43|||
150267459|NCT03291587|542116246|FG000|Overall Study|Refused to Answer|5|||
150267460|NCT03291587|542116247|FG001|Overall Study|Refused to Answer|2|||
150267461|NCT03291587|542116246|FG000|Overall Study|Death|2|||
150267462|NCT03291587|542116247|FG001|Overall Study|Death|4|||
150267463|NCT03291587|542116246|FG000|Overall Study|Not interested in participating|8|||
150267464|NCT03291587|542116247|FG001|Overall Study|Not interested in participating|6|||
149933675|NCT02667301|540891805|FG000|Overall Study|Lack of Efficacy|1|||
150267465|NCT03291587|542116246|FG000|Overall Study|Too busy to participate|4|||
150267466|NCT03291587|542116247|FG001|Overall Study|Too busy to participate|2|||
150267467|NCT01759407|542116248|FG000|Overall Study|Protocol Violation|0|||
150267468|NCT01759407|542116249|FG001|Overall Study|Protocol Violation|2|||
150267469|NCT02513745|542116252|FG000|Overall Study|Criteria at time of surgery not met.|3|||
150267470|NCT02513745|542116253|FG001|Overall Study|Criteria at time of surgery not met.|3|||
150267471|NCT01116882|542116254|FG000|30-day|Lost to Follow-up|50|||
150267472|NCT01116882|542116255|FG001|30-day|Lost to Follow-up|21|||
150267473|NCT01116882|542116254|FG000|30-day|Withdrawal by Subject|2|||
150267474|NCT01116882|542116255|FG001|30-day|Withdrawal by Subject|4|||
150267475|NCT01116882|542116254|FG000|30-day|Other Reasons|16|||
150267476|NCT01116882|542116255|FG001|30-day|Other Reasons|6|||
150267477|NCT01116882|542116254|FG000|12-month|Lost to Follow-up|111|||
150267478|NCT01116882|542116255|FG001|12-month|Lost to Follow-up|42|||
150267479|NCT01116882|542116254|FG000|12-month|Other Reasons|151|||
150267480|NCT01116882|542116255|FG001|12-month|Other Reasons|49|||
150267481|NCT01116882|542116254|FG000|12-month|Withdrawal by Subject|5|||
150267482|NCT01116882|542116255|FG001|12-month|Withdrawal by Subject|8|||
150267483|NCT00547365|542116256|FG000|Overall Study|Physician Decision|1|||
150267484|NCT00547365|542116256|FG000|Overall Study|Lost to Follow-up|1|||
150267485|NCT00547365|542116256|FG000|Overall Study|Protocol Violation|2|||
150267486|NCT00547365|542116256|FG000|Overall Study|death (not related to study)|4|||
150267487|NCT01139658|542116257|FG000|Overall Study|Adverse Event|10|||
150267488|NCT01139658|542116258|FG001|Overall Study|Adverse Event|27|||
150267489|NCT01139658|542116257|FG000|Overall Study|Lack of Efficacy|15|||
150267490|NCT01139658|542116258|FG001|Overall Study|Lack of Efficacy|7|||
150267491|NCT01139658|542116257|FG000|Overall Study|Withdrawal by Subject|2|||
150267492|NCT01139658|542116258|FG001|Overall Study|Withdrawal by Subject|4|||
150267493|NCT01139658|542116257|FG000|Overall Study|No documentation of treatment|1|||
150267494|NCT01139658|542116258|FG001|Overall Study|No documentation of treatment|0|||
150267495|NCT01139658|542116257|FG000|Overall Study|Other|28|||
150267496|NCT01139658|542116258|FG001|Overall Study|Other|75|||
150267497|NCT00504881|542116261|FG000|Overall Study|Lack of Efficacy|1|||
150267498|NCT00504881|542116262|FG001|Overall Study|Lack of Efficacy|5|||
150267499|NCT00504881|542116261|FG000|Overall Study|Lost to Follow-up|0|||
150267500|NCT00504881|542116262|FG001|Overall Study|Lost to Follow-up|2|||
150267501|NCT00504881|542116261|FG000|Overall Study|Withdrawal by Subject|1|||
150267502|NCT00504881|542116262|FG001|Overall Study|Withdrawal by Subject|4|||
150267503|NCT00504881|542116261|FG000|Overall Study|Non-Compliance|1|||
150267504|NCT00504881|542116262|FG001|Overall Study|Non-Compliance|0|||
150267505|NCT00504881|542116261|FG000|Overall Study|No Birth Control|0|||
150267506|NCT00504881|542116262|FG001|Overall Study|No Birth Control|1|||
150267507|NCT00504881|542116261|FG000|Overall Study|Safety Visit not performed|0|||
150267508|NCT00504881|542116262|FG001|Overall Study|Safety Visit not performed|1|||
150267509|NCT00504881|542116261|FG000|Overall Study|AE, serious fatal|0|||
150267510|NCT00504881|542116262|FG001|Overall Study|AE, serious fatal|1|||
150267511|NCT00504881|542116261|FG000|Overall Study|SAE, non-fatal|2|||
150267512|NCT00504881|542116262|FG001|Overall Study|SAE, non-fatal|6|||
150267513|NCT00504881|542116261|FG000|Overall Study|AE, non-serious non-fatal|4|||
150267514|NCT00504881|542116262|FG001|Overall Study|AE, non-serious non-fatal|14|||
150267515|NCT00504881|542116261|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
150267516|NCT00504881|542116262|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
150267517|NCT00504881|542116261|FG000|Overall Study|AE of unknown type|1|||
150267518|NCT00504881|542116262|FG001|Overall Study|AE of unknown type|0|||
150267519|NCT01777269|542116263|FG000|Overall Study|Adverse Event|24|||
150267520|NCT01777269|542116264|FG001|Overall Study|Adverse Event|33|||
150267521|NCT01777269|542116263|FG000|Overall Study|Lack of Efficacy|8|||
150267522|NCT01777269|542116264|FG001|Overall Study|Lack of Efficacy|10|||
150267523|NCT01777269|542116263|FG000|Overall Study|Protocol Violation|4|||
149820203|NCT03175120|540471749|FG000|Overall Study|Lost to Follow-up|1|||
149933676|NCT01939314|540891806|FG000|Overall Study|Withdrawal by Subject|3|||
150267524|NCT01777269|542116264|FG001|Overall Study|Protocol Violation|4|||
150267525|NCT01777269|542116263|FG000|Overall Study|Participants reached stopping criteria|1|||
150267526|NCT01777269|542116264|FG001|Overall Study|Participants reached stopping criteria|1|||
150267527|NCT01777269|542116263|FG000|Overall Study|Lost to Follow-up|4|||
150267528|NCT01777269|542116264|FG001|Overall Study|Lost to Follow-up|0|||
150267529|NCT01777269|542116263|FG000|Overall Study|Physician Decision|5|||
150267530|NCT01777269|542116264|FG001|Overall Study|Physician Decision|2|||
150267531|NCT01777269|542116263|FG000|Overall Study|Withdrawal by Subject|9|||
150267532|NCT01777269|542116264|FG001|Overall Study|Withdrawal by Subject|9|||
150267533|NCT00753272|542116272|FG000|Overall Study|Adverse Event|878|||
150267534|NCT00753272|542116273|FG001|Overall Study|Adverse Event|869|||
150267535|NCT00753272|542116272|FG000|Overall Study|Protocol Violation|28|||
150267536|NCT00753272|542116273|FG001|Overall Study|Protocol Violation|46|||
150267537|NCT00753272|542116272|FG000|Overall Study|Withdrawal by Subject|2481|||
150267538|NCT00753272|542116273|FG001|Overall Study|Withdrawal by Subject|2407|||
150267539|NCT00753272|542116272|FG000|Overall Study|Lost to Follow-up|491|||
149820204|NCT03175120|540471750|FG001|Overall Study|Lost to Follow-up|0|||
149820205|NCT03175120|540471749|FG000|Overall Study|Withdrawal by Subject|2|||
150267540|NCT00753272|542116273|FG001|Overall Study|Lost to Follow-up|497|||
150267541|NCT00753272|542116272|FG000|Overall Study|Other|1104|||
149933677|NCT01939314|540891807|FG001|Overall Study|Withdrawal by Subject|1|||
149933678|NCT01939314|540891806|FG000|Overall Study|Protocol Violation|1|||
150267542|NCT00753272|542116273|FG001|Overall Study|Other|1088|||
150267543|NCT02092220|542116275|FG000|Period 1|Unrelated Illness|0|||
150267544|NCT02092220|542116276|FG001|Period 1|Unrelated Illness|2|||
150267545|NCT02092220|542116275|FG000|Period 2|Severe Hypoglycaemia|1|||
150267546|NCT02092220|542116276|FG001|Period 2|Severe Hypoglycaemia|0|||
150267547|NCT02092220|542116275|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
150267548|NCT02092220|542116276|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
150267549|NCT00960531|542116277|FG000|Overall Study|Lack of Efficacy|1|||
150267550|NCT00960531|542116278|FG001|Overall Study|Lack of Efficacy|0|||
150267551|NCT00960531|542116279|FG002|Overall Study|Lack of Efficacy|0|||
150267552|NCT00960531|542116280|FG003|Overall Study|Lack of Efficacy|0|||
150267553|NCT00960531|542116281|FG004|Overall Study|Lack of Efficacy|0|||
150267554|NCT00960531|542116282|FG005|Overall Study|Lack of Efficacy|0|||
150267555|NCT00960531|542116283|FG006|Overall Study|Lack of Efficacy|0|||
150267556|NCT00960531|542116284|FG007|Overall Study|Lack of Efficacy|0|||
150267557|NCT00960531|542116285|FG008|Overall Study|Lack of Efficacy|0|||
150267558|NCT00960531|542116286|FG009|Overall Study|Lack of Efficacy|0|||
150267559|NCT00960531|542116277|FG000|Overall Study|Withdrawal by Subject|1|||
150267560|NCT00960531|542116278|FG001|Overall Study|Withdrawal by Subject|0|||
150267561|NCT00960531|542116279|FG002|Overall Study|Withdrawal by Subject|5|||
150267562|NCT00960531|542116280|FG003|Overall Study|Withdrawal by Subject|2|||
150267563|NCT00960531|542116281|FG004|Overall Study|Withdrawal by Subject|0|||
150267564|NCT00960531|542116282|FG005|Overall Study|Withdrawal by Subject|0|||
150267565|NCT00960531|542116283|FG006|Overall Study|Withdrawal by Subject|2|||
150267566|NCT00960531|542116284|FG007|Overall Study|Withdrawal by Subject|0|||
150267567|NCT00960531|542116285|FG008|Overall Study|Withdrawal by Subject|1|||
150267568|NCT00960531|542116286|FG009|Overall Study|Withdrawal by Subject|0|||
150267569|NCT00960531|542116277|FG000|Overall Study|Caregiver Request|2|||
150267570|NCT00960531|542116278|FG001|Overall Study|Caregiver Request|0|||
150267571|NCT00960531|542116279|FG002|Overall Study|Caregiver Request|6|||
150267572|NCT00960531|542116280|FG003|Overall Study|Caregiver Request|5|||
150267573|NCT00960531|542116281|FG004|Overall Study|Caregiver Request|0|||
150267574|NCT00960531|542116282|FG005|Overall Study|Caregiver Request|2|||
150267575|NCT00960531|542116283|FG006|Overall Study|Caregiver Request|3|||
150267576|NCT00960531|542116284|FG007|Overall Study|Caregiver Request|1|||
150267577|NCT00960531|542116285|FG008|Overall Study|Caregiver Request|3|||
150267578|NCT00960531|542116286|FG009|Overall Study|Caregiver Request|0|||
150267579|NCT00960531|542116277|FG000|Overall Study|Investigator Request|0|||
150267580|NCT00960531|542116278|FG001|Overall Study|Investigator Request|0|||
150267581|NCT00960531|542116279|FG002|Overall Study|Investigator Request|1|||
150267582|NCT00960531|542116280|FG003|Overall Study|Investigator Request|0|||
150267583|NCT00960531|542116281|FG004|Overall Study|Investigator Request|0|||
150267584|NCT00960531|542116282|FG005|Overall Study|Investigator Request|0|||
150267585|NCT00960531|542116283|FG006|Overall Study|Investigator Request|0|||
150267586|NCT00960531|542116284|FG007|Overall Study|Investigator Request|0|||
150267587|NCT00960531|542116285|FG008|Overall Study|Investigator Request|0|||
150267588|NCT00960531|542116286|FG009|Overall Study|Investigator Request|0|||
150267589|NCT00960531|542116277|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
150267590|NCT00960531|542116278|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
150267591|NCT00960531|542116279|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
150267592|NCT00960531|542116280|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
150267593|NCT00960531|542116281|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
150267594|NCT00960531|542116282|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
150267595|NCT00960531|542116283|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
149933679|NCT01939314|540891807|FG001|Overall Study|Protocol Violation|0|||
149933680|NCT01939314|540891806|FG000|Overall Study|Pregnancy|0|||
149933681|NCT01939314|540891807|FG001|Overall Study|Pregnancy|1|||
149933682|NCT01939314|540891806|FG000|Overall Study|Lost to Follow-up|5|||
149933683|NCT01939314|540891807|FG001|Overall Study|Lost to Follow-up|6|||
149933684|NCT01107925|540891815|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
149933685|NCT01107925|540891816|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
150267596|NCT00960531|542116284|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
150267597|NCT00960531|542116285|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
150267598|NCT00960531|542116286|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
150267599|NCT00960531|542116277|FG000|Overall Study|Lost to Follow-up|0|||
150267600|NCT00960531|542116278|FG001|Overall Study|Lost to Follow-up|0|||
150267601|NCT00960531|542116279|FG002|Overall Study|Lost to Follow-up|1|||
150267602|NCT00960531|542116280|FG003|Overall Study|Lost to Follow-up|0|||
150267603|NCT00960531|542116281|FG004|Overall Study|Lost to Follow-up|0|||
150267604|NCT00960531|542116282|FG005|Overall Study|Lost to Follow-up|0|||
150267605|NCT00960531|542116283|FG006|Overall Study|Lost to Follow-up|1|||
150267606|NCT00960531|542116284|FG007|Overall Study|Lost to Follow-up|0|||
150267607|NCT00960531|542116285|FG008|Overall Study|Lost to Follow-up|0|||
149933686|NCT01107925|540891817|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
149933687|NCT01107925|540891818|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
149933688|NCT01107925|540891819|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
149933689|NCT01107925|540891820|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
149933690|NCT01107925|540891815|FG000|Period 2|Withdrawal by Subject|0|||
150167100|NCT01570751|541747706|FG001|Period A (16 Weeks)|Protocol Violation|1|||
150167101|NCT01570751|541747705|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
150167102|NCT01570751|541747706|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
150167103|NCT01570751|541747705|FG000|Period A (16 Weeks)|Unclassified|2|||
150167104|NCT01570751|541747706|FG001|Period A (16 Weeks)|Unclassified|3|||
150167105|NCT01570751|541747705|FG000|Period B (16 Weeks)|Adverse Event|1|||
150167106|NCT01570751|541747706|FG001|Period B (16 Weeks)|Adverse Event|0|||
150167107|NCT01570751|541747705|FG000|Period B (16 Weeks)|Protocol Violation|0|||
150167108|NCT01570751|541747706|FG001|Period B (16 Weeks)|Protocol Violation|1|||
150167109|NCT01072357|541747707|FG000|Overall Study|Lost to Follow-up|0|||
150167110|NCT01072357|541747708|FG001|Overall Study|Lost to Follow-up|1|||
150167111|NCT01876511|541747709|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
150167112|NCT01876511|541747710|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
150167113|NCT01876511|541747711|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
150167114|NCT01876511|541747709|FG000|Overall Study|Death (unrelated)|3|||
150167115|NCT01876511|541747710|FG001|Overall Study|Death (unrelated)|0|||
150167116|NCT01876511|541747711|FG002|Overall Study|Death (unrelated)|2|||
150167117|NCT01876511|541747709|FG000|Overall Study|Drug-related Toxicity|5|||
150167118|NCT01876511|541747710|FG001|Overall Study|Drug-related Toxicity|1|||
150167119|NCT01876511|541747711|FG002|Overall Study|Drug-related Toxicity|6|||
150167120|NCT01876511|541747709|FG000|Overall Study|Patient Decision|3|||
150167121|NCT01876511|541747710|FG001|Overall Study|Patient Decision|0|||
150167122|NCT01876511|541747711|FG002|Overall Study|Patient Decision|6|||
150167123|NCT01876511|541747709|FG000|Overall Study|Physician Decision|1|||
150167124|NCT01876511|541747710|FG001|Overall Study|Physician Decision|0|||
150167125|NCT01876511|541747711|FG002|Overall Study|Physician Decision|1|||
150167126|NCT05419557|541747716|FG000|Overall Study|Lost to Follow-up|11|||
150167127|NCT05419557|541747717|FG001|Overall Study|Lost to Follow-up|4|||
150167128|NCT01196988|541747719|FG000|Overall Study|Adverse Event|1|||
150167129|NCT01196988|541747720|FG001|Overall Study|Adverse Event|2|||
150167130|NCT01196988|541747721|FG002|Overall Study|Adverse Event|0|||
150167131|NCT01196988|541747722|FG003|Overall Study|Adverse Event|0|||
150167132|NCT01196988|541747719|FG000|Overall Study|Withdrawal by Subject|5|||
150167133|NCT01196988|541747720|FG001|Overall Study|Withdrawal by Subject|1|||
150167134|NCT01196988|541747721|FG002|Overall Study|Withdrawal by Subject|4|||
150167135|NCT01196988|541747722|FG003|Overall Study|Withdrawal by Subject|0|||
150167136|NCT01196988|541747719|FG000|Overall Study|Lost to Follow-up|16|||
150167137|NCT01196988|541747720|FG001|Overall Study|Lost to Follow-up|29|||
150167138|NCT01196988|541747721|FG002|Overall Study|Lost to Follow-up|21|||
150167139|NCT01196988|541747722|FG003|Overall Study|Lost to Follow-up|1|||
150167140|NCT01196988|541747719|FG000|Overall Study|Other|2|||
150167141|NCT01196988|541747720|FG001|Overall Study|Other|0|||
150167142|NCT01196988|541747721|FG002|Overall Study|Other|0|||
150167143|NCT01196988|541747722|FG003|Overall Study|Other|0|||
150167144|NCT04012853|541747724|FG000|Overall Study|Withdrawal by Subject|1|||
150167145|NCT04012853|541747725|FG001|Overall Study|Withdrawal by Subject|1|||
150167146|NCT04012853|541747724|FG000|Overall Study|Protocol Violation|1|||
150167147|NCT04012853|541747725|FG001|Overall Study|Protocol Violation|0|||
150167148|NCT04012853|541747724|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
150167149|NCT04012853|541747725|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
150167150|NCT04304534|541747726|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
150167151|NCT04304534|541747727|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
150167152|NCT04304534|541747728|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
150167153|NCT04304534|541747729|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
150167154|NCT04304534|541747726|FG000|Overall Study|Non-Compliance with study drug|0|||
150167155|NCT04304534|541747727|FG001|Overall Study|Non-Compliance with study drug|1|||
150167156|NCT04304534|541747728|FG002|Overall Study|Non-Compliance with study drug|1|||
150167157|NCT04304534|541747729|FG003|Overall Study|Non-Compliance with study drug|1|||
150167158|NCT04304534|541747726|FG000|Overall Study|Lost to Follow-up|0|||
150167159|NCT04304534|541747727|FG001|Overall Study|Lost to Follow-up|1|||
150167160|NCT04304534|541747728|FG002|Overall Study|Lost to Follow-up|2|||
150167161|NCT04304534|541747729|FG003|Overall Study|Lost to Follow-up|3|||
150167162|NCT04304534|541747726|FG000|Overall Study|Unspecific|4|||
150167163|NCT04304534|541747727|FG001|Overall Study|Unspecific|2|||
150167164|NCT04304534|541747728|FG002|Overall Study|Unspecific|2|||
150167165|NCT04304534|541747729|FG003|Overall Study|Unspecific|2|||
150167166|NCT04304534|541747726|FG000|Overall Study|Technical Problems|2|||
149933691|NCT01107925|540891816|FG001|Period 2|Withdrawal by Subject|1|||
150167167|NCT04304534|541747727|FG001|Overall Study|Technical Problems|2|||
150167168|NCT04304534|541747728|FG002|Overall Study|Technical Problems|3|||
150167169|NCT04304534|541747729|FG003|Overall Study|Technical Problems|4|||
150167170|NCT04304534|541747726|FG000|Overall Study|Death|7|||
149933692|NCT01107925|540891817|FG002|Period 2|Withdrawal by Subject|0|||
149933693|NCT01107925|540891818|FG003|Period 2|Withdrawal by Subject|0|||
150167171|NCT04304534|541747727|FG001|Overall Study|Death|2|||
150167172|NCT04304534|541747728|FG002|Overall Study|Death|4|||
150167173|NCT04304534|541747729|FG003|Overall Study|Death|3|||
150167174|NCT04304534|541747726|FG000|Overall Study|Withdrawal by Subject|7|||
150167175|NCT04304534|541747727|FG001|Overall Study|Withdrawal by Subject|2|||
150167176|NCT04304534|541747728|FG002|Overall Study|Withdrawal by Subject|7|||
150167177|NCT04304534|541747729|FG003|Overall Study|Withdrawal by Subject|4|||
150167178|NCT04304534|541747726|FG000|Overall Study|Physician Decision|4|||
150167179|NCT04304534|541747727|FG001|Overall Study|Physician Decision|9|||
150167180|NCT04304534|541747728|FG002|Overall Study|Physician Decision|9|||
150167181|NCT04304534|541747729|FG003|Overall Study|Physician Decision|5|||
150167182|NCT04304534|541747726|FG000|Overall Study|Subject Decision|34|||
150167183|NCT04304534|541747727|FG001|Overall Study|Subject Decision|25|||
150167184|NCT04304534|541747728|FG002|Overall Study|Subject Decision|25|||
150167185|NCT04304534|541747729|FG003|Overall Study|Subject Decision|26|||
150167186|NCT04304534|541747726|FG000|Overall Study|Adverse Event|35|||
150167187|NCT04304534|541747727|FG001|Overall Study|Adverse Event|40|||
150167188|NCT04304534|541747728|FG002|Overall Study|Adverse Event|39|||
150167189|NCT04304534|541747729|FG003|Overall Study|Adverse Event|44|||
150167190|NCT01695317|541747730|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
150167191|NCT01695317|541747731|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
150167192|NCT01695317|541747730|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
150167193|NCT01695317|541747731|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
150167194|NCT03055767|541747732|FG000|Open-Label Period|Lost to Follow-up|0|||
150167195|NCT03055767|541747733|FG001|Open-Label Period|Lost to Follow-up|0|||
150167196|NCT03055767|541747734|FG002|Open-Label Period|Lost to Follow-up|2|||
150167197|NCT03055767|541747735|FG003|Open-Label Period|Lost to Follow-up|0|||
150167198|NCT03055767|541747732|FG000|Open-Label Period|Withdrawal by Subject|0|||
150167199|NCT03055767|541747733|FG001|Open-Label Period|Withdrawal by Subject|0|||
150167200|NCT03055767|541747734|FG002|Open-Label Period|Withdrawal by Subject|0|||
150167201|NCT03055767|541747735|FG003|Open-Label Period|Withdrawal by Subject|1|||
150167202|NCT02759731|541747738|FG000|Overall Study|Did not complete treatment.|8|||
150167203|NCT01466881|541747740|FG000|Overall Study|Ineligible|5|||
150167204|NCT01466881|541747740|FG000|Overall Study|Adverse Event|6|||
150167205|NCT01466881|541747740|FG000|Overall Study|Progression/relapse|20|||
150167206|NCT01466881|541747740|FG000|Overall Study|Death|4|||
150167207|NCT01466881|541747740|FG000|Overall Study|Other reason not protocol specified|5|||
150167208|NCT00606580|541747741|FG000|Overall Study|Lost to Follow-up|1|||
150167209|NCT00606580|541747742|FG001|Overall Study|Lost to Follow-up|1|||
150167210|NCT00606580|541747743|FG002|Overall Study|Lost to Follow-up|4|||
150167211|NCT00606580|541747741|FG000|Overall Study|Clinical failures|1|||
150167212|NCT00606580|541747742|FG001|Overall Study|Clinical failures|0|||
150167213|NCT00606580|541747743|FG002|Overall Study|Clinical failures|12|||
150167214|NCT00606580|541747741|FG000|Overall Study|Withdrawal by investigator|0|||
150167215|NCT00606580|541747742|FG001|Overall Study|Withdrawal by investigator|1|||
150167216|NCT00606580|541747743|FG002|Overall Study|Withdrawal by investigator|6|||
150167217|NCT00606580|541747741|FG000|Overall Study|Withdrawal by Subject|0|||
150167218|NCT00606580|541747742|FG001|Overall Study|Withdrawal by Subject|1|||
150167219|NCT00606580|541747743|FG002|Overall Study|Withdrawal by Subject|0|||
150167220|NCT01101165|541747744|FG000|Period 1|Adverse Event|1|||
150167221|NCT01101165|541747745|FG001|Period 1|Adverse Event|2|||
150167222|NCT01101165|541747744|FG000|Period 1|Withdrawal by Subject|0|||
150167223|NCT01101165|541747745|FG001|Period 1|Withdrawal by Subject|2|||
150167224|NCT01101165|541747744|FG000|Period 1|Positive Drug Screen|0|||
150167225|NCT01101165|541747745|FG001|Period 1|Positive Drug Screen|1|||
150167226|NCT01101165|541747744|FG000|Period 1|Lost to Follow-up|1|||
150167227|NCT01101165|541747745|FG001|Period 1|Lost to Follow-up|0|||
150167228|NCT01101165|541747744|FG000|Period 2|Withdrawal by Subject|3|||
150167229|NCT01101165|541747745|FG001|Period 2|Withdrawal by Subject|1|||
150167230|NCT01101165|541747744|FG000|Period 2|Adverse Event|1|||
150167231|NCT01101165|541747745|FG001|Period 2|Adverse Event|0|||
150167232|NCT04580303|541747746|FG000|Overall Study|Adverse Event|0|||
150167233|NCT04580303|541747747|FG001|Overall Study|Adverse Event|1|||
150167234|NCT04580303|541747748|FG002|Overall Study|Adverse Event|0|||
150167235|NCT04580303|541747749|FG003|Overall Study|Adverse Event|0|||
150167236|NCT04580303|541747746|FG000|Overall Study|Withdrawal by Subject|0|||
150167237|NCT04580303|541747747|FG001|Overall Study|Withdrawal by Subject|0|||
150167238|NCT04580303|541747748|FG002|Overall Study|Withdrawal by Subject|1|||
150167239|NCT04580303|541747749|FG003|Overall Study|Withdrawal by Subject|0|||
150167240|NCT01833065|541747750|FG000|Overall Study|Adverse Event|6|||
150167241|NCT01833065|541747751|FG001|Overall Study|Adverse Event|1|||
150167242|NCT01833065|541747752|FG002|Overall Study|Adverse Event|0|||
149933694|NCT01107925|540891819|FG004|Period 2|Withdrawal by Subject|0|||
149933695|NCT01107925|540891820|FG005|Period 2|Withdrawal by Subject|1|||
150167243|NCT01833065|541747753|FG003|Overall Study|Adverse Event|2|||
150167244|NCT01833065|541747754|FG004|Overall Study|Adverse Event|3|||
150167245|NCT01833065|541747750|FG000|Overall Study|Protocol Violation|1|||
150267608|NCT00960531|542116286|FG009|Overall Study|Lost to Follow-up|0|||
150267609|NCT00960531|542116277|FG000|Overall Study|Failed to Return|2|||
150267610|NCT00960531|542116278|FG001|Overall Study|Failed to Return|0|||
150267611|NCT00960531|542116279|FG002|Overall Study|Failed to Return|0|||
150267612|NCT00960531|542116280|FG003|Overall Study|Failed to Return|0|||
150267613|NCT00960531|542116281|FG004|Overall Study|Failed to Return|0|||
150267614|NCT00960531|542116282|FG005|Overall Study|Failed to Return|0|||
150267615|NCT00960531|542116283|FG006|Overall Study|Failed to Return|0|||
150267616|NCT00960531|542116284|FG007|Overall Study|Failed to Return|2|||
150267617|NCT00960531|542116285|FG008|Overall Study|Failed to Return|0|||
150267618|NCT00960531|542116286|FG009|Overall Study|Failed to Return|0|||
150267619|NCT00960531|542116277|FG000|Overall Study|Adverse Event (AE)|2|||
150267620|NCT00960531|542116278|FG001|Overall Study|Adverse Event (AE)|0|||
150267621|NCT00960531|542116279|FG002|Overall Study|Adverse Event (AE)|0|||
150267622|NCT00960531|542116280|FG003|Overall Study|Adverse Event (AE)|0|||
150267623|NCT00960531|542116281|FG004|Overall Study|Adverse Event (AE)|0|||
150267624|NCT00960531|542116282|FG005|Overall Study|Adverse Event (AE)|1|||
150267625|NCT00960531|542116283|FG006|Overall Study|Adverse Event (AE)|2|||
150267626|NCT00960531|542116284|FG007|Overall Study|Adverse Event (AE)|0|||
150267627|NCT00960531|542116285|FG008|Overall Study|Adverse Event (AE)|2|||
150267628|NCT00960531|542116286|FG009|Overall Study|Adverse Event (AE)|0|||
150267629|NCT00960531|542116277|FG000|Overall Study|Reason not Specified|2|||
150267630|NCT00960531|542116278|FG001|Overall Study|Reason not Specified|1|||
150267631|NCT00960531|542116279|FG002|Overall Study|Reason not Specified|13|||
150267632|NCT00960531|542116280|FG003|Overall Study|Reason not Specified|1|||
150267633|NCT00960531|542116281|FG004|Overall Study|Reason not Specified|2|||
150267634|NCT00960531|542116282|FG005|Overall Study|Reason not Specified|0|||
150267635|NCT00960531|542116283|FG006|Overall Study|Reason not Specified|16|||
150267636|NCT00960531|542116284|FG007|Overall Study|Reason not Specified|0|||
150267637|NCT00960531|542116285|FG008|Overall Study|Reason not Specified|8|||
150267638|NCT00960531|542116286|FG009|Overall Study|Reason not Specified|1|||
150267639|NCT00593957|542116287|FG000|Overall Study|Physician Decision|0|||
150267640|NCT00593957|542116288|FG001|Overall Study|Physician Decision|1|||
150267641|NCT00593957|542116289|FG002|Overall Study|Physician Decision|2|||
150267642|NCT02411578|542116292|FG000|Crossover Trial Phase|Pregnancy|0|||
150267643|NCT02411578|542116293|FG001|Crossover Trial Phase|Pregnancy|1|||
150267644|NCT00494481|542116294|FG000|Overall Study|Condition under investigation worsened|11|||
150267645|NCT00494481|542116295|FG001|Overall Study|Condition under investigation worsened|13|||
150267646|NCT00494481|542116294|FG000|Overall Study|Adverse Event|15|||
150267647|NCT00494481|542116295|FG001|Overall Study|Adverse Event|11|||
150267648|NCT00494481|542116294|FG000|Overall Study|Other|1|||
150267649|NCT00494481|542116295|FG001|Overall Study|Other|0|||
150267650|NCT00494481|542116294|FG000|Overall Study|Never received IP|2|||
150267651|NCT00494481|542116295|FG001|Overall Study|Never received IP|0|||
150267652|NCT01030198|542116296|FG000|Overall Study|Could not measure efficacy accurately|0|||
150267653|NCT01030198|542116297|FG001|Overall Study|Could not measure efficacy accurately|7|||
150267654|NCT00332189|542116298|FG000|Overall Study|Adverse Event|3|||
150267655|NCT00332189|542116298|FG000|Overall Study|Uncooperative/Noncompliant|3|||
150267656|NCT00332189|542116298|FG000|Overall Study|Withdrawal by Subject|9|||
150267657|NCT00332189|542116298|FG000|Overall Study|Lack of Efficacy|4|||
150267658|NCT00332189|542116298|FG000|Overall Study|Moved out of country|2|||
150267659|NCT03707925|542116299|FG000|Overall Study|Inevaluable|1|||
150267660|NCT02876835|542116301|FG000|Treatment Period (51.1 Month)|Other|1|||
150267661|NCT02876835|542116302|FG001|Treatment Period (51.1 Month)|Other|0|||
150267662|NCT02876835|542116301|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
150267663|NCT02876835|542116302|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
150267664|NCT02876835|542116301|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
150267665|NCT02876835|542116302|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
150267666|NCT02876835|542116301|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
150267667|NCT02876835|542116302|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
150267668|NCT01117857|542116303|FG000|Overall Study|Lost to Follow-up|4|||
150267669|NCT01117857|542116303|FG000|Overall Study|Withdrawal by Subject|4|||
150267670|NCT01117857|542116303|FG000|Overall Study|Physician Decision|1|||
150267671|NCT00883051|542116305|FG000|Overall Study|Lost to Follow-up|0|||
150267672|NCT00883051|542116306|FG001|Overall Study|Lost to Follow-up|0|||
150267673|NCT00883051|542116307|FG002|Overall Study|Lost to Follow-up|0|||
149933696|NCT04877990|540891821|FG000|Treatment|Other reasons|3|||
150267674|NCT00883051|542116308|FG003|Overall Study|Lost to Follow-up|0|||
150267675|NCT00883051|542116309|FG004|Overall Study|Lost to Follow-up|1|||
150267676|NCT00883051|542116305|FG000|Overall Study|Did not use study medication|24|||
150267677|NCT00883051|542116306|FG001|Overall Study|Did not use study medication|22|||
150267678|NCT00883051|542116307|FG002|Overall Study|Did not use study medication|29|||
150267679|NCT00883051|542116308|FG003|Overall Study|Did not use study medication|29|||
150267680|NCT00883051|542116309|FG004|Overall Study|Did not use study medication|17|||
150267681|NCT01411839|542116310|FG000|Overall Study|Lost to Follow-up|4|||
150267682|NCT01411839|542116311|FG001|Overall Study|Lost to Follow-up|3|||
149933697|NCT04877990|540891822|FG001|Treatment|Other reasons|1|||
150267683|NCT03282240|542116312|FG000|Overall Study|Adverse Event|2|||
150267684|NCT03282240|542116313|FG001|Overall Study|Adverse Event|2|||
150267685|NCT03282240|542116314|FG002|Overall Study|Adverse Event|0|||
150267686|NCT03282240|542116312|FG000|Overall Study|Lost to Follow-up|3|||
150267687|NCT03282240|542116313|FG001|Overall Study|Lost to Follow-up|0|||
150267688|NCT03282240|542116314|FG002|Overall Study|Lost to Follow-up|0|||
150267689|NCT03282240|542116312|FG000|Overall Study|Protocol Deviation|4|||
150267690|NCT03282240|542116313|FG001|Overall Study|Protocol Deviation|1|||
150267691|NCT03282240|542116314|FG002|Overall Study|Protocol Deviation|2|||
150267692|NCT03282240|542116312|FG000|Overall Study|Withdrawal by Subject|1|||
150267693|NCT03282240|542116313|FG001|Overall Study|Withdrawal by Subject|0|||
150267694|NCT03282240|542116314|FG002|Overall Study|Withdrawal by Subject|1|||
150267695|NCT01675479|542116315|FG000|Overall Study|Lost to Follow-up|11|||
150267696|NCT04223856|542116316|FG000|Overall Study|Progressive disease|153|||
150267697|NCT04223856|542116317|FG001|Overall Study|Progressive disease|73|||
150267698|NCT04223856|542116316|FG000|Overall Study|Adverse Event|97|||
150267699|NCT04223856|542116317|FG001|Overall Study|Adverse Event|62|||
150267700|NCT04223856|542116316|FG000|Overall Study|Physician Decision|9|||
150267701|NCT04223856|542116317|FG001|Overall Study|Physician Decision|28|||
150267702|NCT04223856|542116316|FG000|Overall Study|Withdrawal by Subject|22|||
150267703|NCT04223856|542116317|FG001|Overall Study|Withdrawal by Subject|24|||
150267704|NCT04223856|542116316|FG000|Overall Study|Other|7|||
150267705|NCT04223856|542116317|FG001|Overall Study|Other|2|||
150267706|NCT04223856|542116316|FG000|Overall Study|Randomized but not treated|2|||
150267707|NCT04223856|542116317|FG001|Overall Study|Randomized but not treated|11|||
150267708|NCT04223856|542116316|FG000|Overall Study|On-treatment|144|||
150267709|NCT04223856|542116317|FG001|Overall Study|On-treatment|0|||
150267710|NCT03442114|542116318|FG000|Overall Study|Lost to Follow-up|13|||
150267711|NCT03442114|542116319|FG001|Overall Study|Lost to Follow-up|13|||
150267712|NCT03442114|542116318|FG000|Overall Study|Physician Decision|2|||
150267713|NCT03442114|542116319|FG001|Overall Study|Physician Decision|2|||
150267714|NCT03442114|542116318|FG000|Overall Study|Protocol Violation|0|||
150267715|NCT03442114|542116319|FG001|Overall Study|Protocol Violation|2|||
150267716|NCT03442114|542116318|FG000|Overall Study|Withdrawal by Subject|1|||
150267717|NCT03442114|542116319|FG001|Overall Study|Withdrawal by Subject|3|||
150267718|NCT03442114|542116318|FG000|Overall Study|Guardianship Change|0|||
150267719|NCT03442114|542116319|FG001|Overall Study|Guardianship Change|1|||
150267720|NCT01444651|542118807|FG000|Overall Study|Adverse Event|3|||
150267721|NCT01444651|542118808|FG001|Overall Study|Adverse Event|2|||
150267722|NCT01444651|542118807|FG000|Overall Study|Lost to Follow-up|5|||
150267723|NCT01444651|542118808|FG001|Overall Study|Lost to Follow-up|5|||
150267724|NCT01444651|542118807|FG000|Overall Study|Non-fasting|2|||
150267725|NCT01444651|542118808|FG001|Overall Study|Non-fasting|1|||
150267726|NCT01444651|542118807|FG000|Overall Study|Missing data|1|||
150267727|NCT01444651|542118808|FG001|Overall Study|Missing data|1|||
150267728|NCT03338192|542118811|FG000|Year One to Year Two|High Blood Pressure|7|||
150267729|NCT03338192|542118812|FG001|Year One to Year Two|High Blood Pressure|1|||
150267730|NCT03338192|542118811|FG000|Year One to Year Two|HIV +|1|||
150267731|NCT03338192|542118812|FG001|Year One to Year Two|HIV +|0|||
150267732|NCT03338192|542118811|FG000|Year Two to Year Four|High Blood Pressure|1|||
150267733|NCT03338192|542118812|FG001|Year Two to Year Four|High Blood Pressure|0|||
150267734|NCT03338192|542118811|FG000|Year Two to Year Four|HIV +|2|||
150267735|NCT03338192|542118812|FG001|Year Two to Year Four|HIV +|0|||
150267736|NCT03338192|542118811|FG000|Year Four to Year Six|High Blood Pressure|2|||
150267737|NCT03338192|542118812|FG001|Year Four to Year Six|High Blood Pressure|1|||
150267738|NCT01929980|542118815|FG000|Overall Study|Physician Decision|1|||
150267739|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
150267740|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
150267741|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
150267742|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
150267743|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
150267744|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
150267745|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
150267746|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
150267747|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
150267748|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
150267749|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
150267750|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
150267751|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Death|3|||
150267752|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Death|1|||
150267753|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
150267754|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
150267755|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Adverse Event|7|||
150267756|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Adverse Event|8|||
150267757|NCT03236246|542118816|FG000|24-Week Dose Titration Period|Captured as Other|1|||
150267758|NCT03236246|542118817|FG001|24-Week Dose Titration Period|Captured as Other|2|||
150267759|NCT03236246|542118816|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
150267760|NCT03236246|542118817|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
150267761|NCT03236246|542118816|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
150267762|NCT03236246|542118817|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
150267763|NCT03236246|542118816|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
150267764|NCT03236246|542118817|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
150267765|NCT03236246|542118816|FG000|24-Week Dose Maintenance Period|Death|0|||
150267766|NCT03236246|542118817|FG001|24-Week Dose Maintenance Period|Death|1|||
150267767|NCT03236246|542118816|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
150267768|NCT03236246|542118817|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
150267769|NCT02952001|542118820|FG000|Overall Study|Adverse Event|3|||
150267770|NCT02952001|542118821|FG001|Overall Study|Adverse Event|0|||
150267771|NCT02952001|542118820|FG000|Overall Study|Prohibited therapy|10|||
150267772|NCT02952001|542118821|FG001|Overall Study|Prohibited therapy|3|||
150267773|NCT02952001|542118820|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
150267774|NCT02952001|542118821|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
150267775|NCT02276872|542118824|FG000|Overall Study|Adverse Event|1|||
150267776|NCT02276872|542118825|FG001|Overall Study|Adverse Event|0|||
150267777|NCT02276872|542118826|FG002|Overall Study|Adverse Event|0|||
150267778|NCT04175808|542118827|FG000|Part A|Miscellaneous|2|||
150267779|NCT04175808|542118828|FG001|Part A|Miscellaneous|0|||
150267780|NCT04175808|542118829|FG002|Part A|Miscellaneous|0|||
150267781|NCT04175808|542118830|FG003|Part A|Miscellaneous|0|||
150267782|NCT04175808|542118831|FG004|Part A|Miscellaneous|0|||
150267783|NCT04175808|542118832|FG005|Part A|Miscellaneous|0|||
150267784|NCT04175808|542118833|FG006|Part A|Miscellaneous|0|||
150267785|NCT05972733|542118837|FG000|Overall Study|Lost to Follow-up|2|||
150267786|NCT05972733|542118837|FG000|Overall Study|Withdrawal by Subject|1|||
150267787|NCT01637623|542118840|FG000|Overall Study|Lost to Follow-up|0|||
150267788|NCT01637623|542118841|FG001|Overall Study|Lost to Follow-up|0|||
150267789|NCT01637623|542118842|FG002|Overall Study|Lost to Follow-up|2|||
150267790|NCT01637623|542118840|FG000|Overall Study|Physician Decision|1|||
150267791|NCT01637623|542118841|FG001|Overall Study|Physician Decision|0|||
150267792|NCT01637623|542118842|FG002|Overall Study|Physician Decision|1|||
150267793|NCT00568321|542118847|FG000|Overall Study|Adverse Event|1|||
150267794|NCT00568321|542118848|FG001|Overall Study|Adverse Event|0|||
150267795|NCT00568321|542118849|FG002|Overall Study|Adverse Event|0|||
150267796|NCT00568321|542118847|FG000|Overall Study|Lack of Efficacy|8|||
150267797|NCT00568321|542118848|FG001|Overall Study|Lack of Efficacy|5|||
150267798|NCT00568321|542118849|FG002|Overall Study|Lack of Efficacy|6|||
150267799|NCT00568321|542118847|FG000|Overall Study|Lost to Follow-up|0|||
150267800|NCT00568321|542118848|FG001|Overall Study|Lost to Follow-up|0|||
150267801|NCT00568321|542118849|FG002|Overall Study|Lost to Follow-up|1|||
150267802|NCT00568321|542118847|FG000|Overall Study|Withdrawal by Subject|2|||
150267803|NCT00568321|542118848|FG001|Overall Study|Withdrawal by Subject|0|||
150267804|NCT00568321|542118849|FG002|Overall Study|Withdrawal by Subject|0|||
150267805|NCT00568321|542118847|FG000|Overall Study|Protocol Violation|0|||
150267806|NCT00568321|542118848|FG001|Overall Study|Protocol Violation|0|||
150267807|NCT00568321|542118849|FG002|Overall Study|Protocol Violation|1|||
150267808|NCT00568321|542118847|FG000|Overall Study|Randomized, not treated|2|||
150267809|NCT00568321|542118848|FG001|Overall Study|Randomized, not treated|0|||
150267810|NCT00568321|542118849|FG002|Overall Study|Randomized, not treated|1|||
150267811|NCT00823901|542118851|FG000|Overall Study|Adverse Event|1|||
150267812|NCT00823901|542118852|FG001|Overall Study|Adverse Event|1|||
150267813|NCT00823901|542118851|FG000|Overall Study|Lack of Efficacy|1|||
150267814|NCT00823901|542118852|FG001|Overall Study|Lack of Efficacy|0|||
150267815|NCT00823901|542118851|FG000|Overall Study|Lost to Follow-up|2|||
150267816|NCT00823901|542118852|FG001|Overall Study|Lost to Follow-up|1|||
150267817|NCT01369511|542118853|FG000|Overall Study|Adverse Event|1|||
150267818|NCT01369511|542118854|FG001|Overall Study|Adverse Event|1|||
150267819|NCT01369511|542118855|FG002|Overall Study|Adverse Event|5|||
150267820|NCT01369511|542118856|FG003|Overall Study|Adverse Event|0|||
150267821|NCT01369511|542118853|FG000|Overall Study|Entry criteria not met|2|||
150267822|NCT01369511|542118854|FG001|Overall Study|Entry criteria not met|0|||
150267823|NCT01369511|542118855|FG002|Overall Study|Entry criteria not met|0|||
150267824|NCT01369511|542118856|FG003|Overall Study|Entry criteria not met|1|||
150267825|NCT01369511|542118853|FG000|Overall Study|Lost to Follow-up|0|||
150267826|NCT01369511|542118854|FG001|Overall Study|Lost to Follow-up|1|||
150267827|NCT01369511|542118855|FG002|Overall Study|Lost to Follow-up|1|||
150267828|NCT01369511|542118856|FG003|Overall Study|Lost to Follow-up|2|||
150267829|NCT01369511|542118853|FG000|Overall Study|Protocol Violation|0|||
150267830|NCT01369511|542118854|FG001|Overall Study|Protocol Violation|1|||
150267831|NCT01369511|542118855|FG002|Overall Study|Protocol Violation|0|||
150267832|NCT01369511|542118856|FG003|Overall Study|Protocol Violation|2|||
150267833|NCT01369511|542118853|FG000|Overall Study|Physician Decision|3|||
150267834|NCT01369511|542118854|FG001|Overall Study|Physician Decision|4|||
150267835|NCT01369511|542118855|FG002|Overall Study|Physician Decision|0|||
150267836|NCT01369511|542118856|FG003|Overall Study|Physician Decision|0|||
150267837|NCT01369511|542118853|FG000|Overall Study|Sponsor decision|2|||
150267838|NCT01369511|542118854|FG001|Overall Study|Sponsor decision|0|||
150267839|NCT01369511|542118855|FG002|Overall Study|Sponsor decision|1|||
150267840|NCT01369511|542118856|FG003|Overall Study|Sponsor decision|0|||
150267841|NCT01369511|542118853|FG000|Overall Study|Withdrawal by Subject|5|||
150267842|NCT01369511|542118854|FG001|Overall Study|Withdrawal by Subject|6|||
150267843|NCT01369511|542118855|FG002|Overall Study|Withdrawal by Subject|4|||
150267844|NCT01369511|542118856|FG003|Overall Study|Withdrawal by Subject|6|||
150267845|NCT01376349|542118858|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
150267846|NCT01376349|542118859|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
150267847|NCT01376349|542118860|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
150267848|NCT01376349|542118858|FG000|Raondomized Treatment|Adverse Event|13|||
150267849|NCT01376349|542118859|FG001|Raondomized Treatment|Adverse Event|17|||
150267850|NCT01376349|542118860|FG002|Raondomized Treatment|Adverse Event|14|||
150267851|NCT01376349|542118858|FG000|Raondomized Treatment|Unkown|1|||
150267852|NCT01376349|542118859|FG001|Raondomized Treatment|Unkown|2|||
150267853|NCT01376349|542118860|FG002|Raondomized Treatment|Unkown|1|||
150267854|NCT01376349|542118858|FG000|Raondomized Treatment|Alternative Treatment|0|||
150267855|NCT01376349|542118859|FG001|Raondomized Treatment|Alternative Treatment|0|||
150267856|NCT01376349|542118860|FG002|Raondomized Treatment|Alternative Treatment|1|||
150267857|NCT01176968|542118861|FG000|Overall Study|Adverse Event|10|||
150267858|NCT01176968|542118862|FG001|Overall Study|Adverse Event|11|||
150267859|NCT01176968|542118861|FG000|Overall Study|Death|2|||
150267860|NCT01176968|542118862|FG001|Overall Study|Death|3|||
150267861|NCT01176968|542118861|FG000|Overall Study|Lack of Efficacy|0|||
150267862|NCT01176968|542118862|FG001|Overall Study|Lack of Efficacy|1|||
150267863|NCT01176968|542118861|FG000|Overall Study|Lost to Follow-up|16|||
150267864|NCT01176968|542118862|FG001|Overall Study|Lost to Follow-up|14|||
150267865|NCT01176968|542118861|FG000|Overall Study|Withdrawal by Subject|48|||
150267866|NCT01176968|542118862|FG001|Overall Study|Withdrawal by Subject|48|||
150267867|NCT01176968|542118861|FG000|Overall Study|Protocol Violation|2|||
150267868|NCT01176968|542118862|FG001|Overall Study|Protocol Violation|1|||
150267869|NCT01176968|542118861|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
150267870|NCT01176968|542118862|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
150267871|NCT01176968|542118861|FG000|Overall Study|Study terminated by sponsor|0|||
150267872|NCT01176968|542118862|FG001|Overall Study|Study terminated by sponsor|1|||
150267873|NCT01176968|542118861|FG000|Overall Study|Reason not defined|5|||
150267874|NCT01176968|542118862|FG001|Overall Study|Reason not defined|3|||
150267875|NCT00718640|542118863|FG000|Overall Study|Adverse Event|4|||
150267876|NCT00718640|542118863|FG000|Overall Study|Death|1|||
150267877|NCT00718640|542118863|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
150267878|NCT04263909|542118866|FG000|Overall Study|Physician Decision|1|||
150267879|NCT04263909|542118867|FG001|Overall Study|Physician Decision|0|||
150267880|NCT04263909|542118868|FG002|Overall Study|Physician Decision|0|||
150267881|NCT04263909|542118866|FG000|Overall Study|Adverse Event|3|||
150267882|NCT04263909|542118867|FG001|Overall Study|Adverse Event|0|||
150267883|NCT04263909|542118868|FG002|Overall Study|Adverse Event|0|||
150267884|NCT04263909|542118866|FG000|Overall Study|Protocol Violation|5|||
150267885|NCT04263909|542118867|FG001|Overall Study|Protocol Violation|0|||
150267886|NCT04263909|542118868|FG002|Overall Study|Protocol Violation|0|||
150267887|NCT00068588|542118869|FG000|Overall Study|Adverse Event|0|||
150267888|NCT00068588|542118870|FG001|Overall Study|Adverse Event|0|||
150267889|NCT00068588|542118871|FG002|Overall Study|Adverse Event|2|||
150267890|NCT00068588|542118869|FG000|Overall Study|Withdrawal by Subject|0|||
150267891|NCT00068588|542118870|FG001|Overall Study|Withdrawal by Subject|0|||
150267892|NCT00068588|542118871|FG002|Overall Study|Withdrawal by Subject|1|||
150267893|NCT00068588|542118869|FG000|Overall Study|Poor KPS|0|||
150267894|NCT00068588|542118870|FG001|Overall Study|Poor KPS|0|||
150267895|NCT00068588|542118871|FG002|Overall Study|Poor KPS|1|||
150267896|NCT05193500|542118872|FG000|Overall Study|Withdrawal by Subject|7|||
150267897|NCT05193500|542118873|FG001|Overall Study|Withdrawal by Subject|4|||
150267898|NCT05193500|542118874|FG002|Overall Study|Withdrawal by Subject|3|||
150267899|NCT05193500|542118875|FG003|Overall Study|Withdrawal by Subject|5|||
150267900|NCT03840486|542118876|FG000|Overall Study|Withdrawal by Subject|0|||
150267901|NCT03840486|542118877|FG001|Overall Study|Withdrawal by Subject|1|||
150267902|NCT03840486|542118878|FG002|Overall Study|Withdrawal by Subject|0|||
150267903|NCT03840486|542118879|FG003|Overall Study|Withdrawal by Subject|0|||
150267904|NCT03840486|542118880|FG004|Overall Study|Withdrawal by Subject|0|||
150267905|NCT03840486|542118881|FG005|Overall Study|Withdrawal by Subject|0|||
150267906|NCT03840486|542118882|FG006|Overall Study|Withdrawal by Subject|0|||
150267907|NCT03840486|542118883|FG007|Overall Study|Withdrawal by Subject|0|||
150267908|NCT03840486|542118884|FG008|Overall Study|Withdrawal by Subject|0|||
150267909|NCT03840486|542118885|FG009|Overall Study|Withdrawal by Subject|0|||
150267910|NCT03840486|542118886|FG010|Overall Study|Withdrawal by Subject|0|||
150267911|NCT03840486|542118887|FG011|Overall Study|Withdrawal by Subject|0|||
150267912|NCT04098068|542118888|FG000|Overall Study|Disease Progression|7|||
150267913|NCT04098068|542118888|FG000|Overall Study|Withdrawal by Subject|2|||
150267914|NCT04098068|542118888|FG000|Overall Study|New Cancer Diagnosis|1|||
150267915|NCT03871829|542118889|FG000|Overall Study|Lost to Follow-up|0|||
150267916|NCT03871829|542118890|FG001|Overall Study|Lost to Follow-up|1|||
150267917|NCT03871829|542118889|FG000|Overall Study|Withdrawal by Subject|1|||
150267918|NCT03871829|542118890|FG001|Overall Study|Withdrawal by Subject|1|||
150267919|NCT03871829|542118889|FG000|Overall Study|Death|12|||
150267920|NCT03871829|542118890|FG001|Overall Study|Death|8|||
150267921|NCT03871829|542118889|FG000|Overall Study|Study terminated by sponsor|31|||
150267922|NCT03871829|542118890|FG001|Overall Study|Study terminated by sponsor|34|||
150267923|NCT02993523|542118891|FG000|Overall Study|Withdrew Consent|0|||
150267924|NCT02993523|542118892|FG001|Overall Study|Withdrew Consent|0|||
150267925|NCT02993523|542118893|FG002|Overall Study|Withdrew Consent|2|||
150267926|NCT02993523|542118894|FG003|Overall Study|Withdrew Consent|9|||
150267927|NCT02993523|542118895|FG004|Overall Study|Withdrew Consent|0|||
150267928|NCT02993523|542118891|FG000|Overall Study|Lost to Follow-up|0|||
150267929|NCT02993523|542118892|FG001|Overall Study|Lost to Follow-up|0|||
150267930|NCT02993523|542118893|FG002|Overall Study|Lost to Follow-up|3|||
150267931|NCT02993523|542118894|FG003|Overall Study|Lost to Follow-up|6|||
150267932|NCT02993523|542118895|FG004|Overall Study|Lost to Follow-up|0|||
150267933|NCT02993523|542118891|FG000|Overall Study|Death|1|||
150267934|NCT02993523|542118892|FG001|Overall Study|Death|1|||
150267935|NCT02993523|542118893|FG002|Overall Study|Death|138|||
150267936|NCT02993523|542118894|FG003|Overall Study|Death|222|||
150267937|NCT02993523|542118895|FG004|Overall Study|Death|6|||
150267938|NCT02993523|542118891|FG000|Overall Study|Reason not Specified|0|||
150267939|NCT02993523|542118892|FG001|Overall Study|Reason not Specified|0|||
150267940|NCT02993523|542118893|FG002|Overall Study|Reason not Specified|1|||
150267941|NCT02993523|542118894|FG003|Overall Study|Reason not Specified|1|||
150267942|NCT02993523|542118895|FG004|Overall Study|Reason not Specified|0|||
150267943|NCT03694418|542118896|FG000|Overall Study|Lost to Follow-up|115|||
150267944|NCT03694418|542118897|FG001|Overall Study|Lost to Follow-up|23|||
150267945|NCT03694418|542118898|FG002|Overall Study|Lost to Follow-up|12|||
150267946|NCT03694418|542118899|FG003|Overall Study|Lost to Follow-up|12|||
150267947|NCT03694418|542118900|FG004|Overall Study|Lost to Follow-up|13|||
150267948|NCT04288778|542118903|FG000|Overall Study|Withdrawal by Subject|2|||
150267949|NCT04288778|542118903|FG000|Overall Study|Adverse Event|5|||
150267950|NCT04288778|542118903|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150267951|NCT04288778|542118903|FG000|Overall Study|Other|1|||
150267952|NCT04288778|542118903|FG000|Overall Study|Started but not treated|2|||
150267953|NCT04442737|542118904|FG000|Overall Study|Lost to Follow-up|1|||
150267954|NCT04442737|542118905|FG001|Overall Study|Lost to Follow-up|3|||
150267955|NCT04442737|542118904|FG000|Overall Study|Withdrawal by Subject|3|||
150267956|NCT04442737|542118905|FG001|Overall Study|Withdrawal by Subject|2|||
150267957|NCT04442737|542118904|FG000|Overall Study|Adverse Event|3|||
150267958|NCT04442737|542118905|FG001|Overall Study|Adverse Event|2|||
150267959|NCT04442737|542118904|FG000|Overall Study|Death|0|||
150267960|NCT04442737|542118905|FG001|Overall Study|Death|1|||
150267961|NCT04442737|542118904|FG000|Overall Study|Protocol Violation|0|||
150267962|NCT04442737|542118905|FG001|Overall Study|Protocol Violation|2|||
150267963|NCT04442737|542118904|FG000|Overall Study|Other|1|||
150267964|NCT04442737|542118905|FG001|Overall Study|Other|1|||
150267965|NCT00744523|542118906|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
150267966|NCT00744523|542118907|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
150267967|NCT01139021|542118908|FG000|Overall Study|Adverse Event|0|||
150267968|NCT01139021|542118909|FG001|Overall Study|Adverse Event|0|||
150267969|NCT01139021|542118910|FG002|Overall Study|Adverse Event|0|||
150267970|NCT01139021|542118911|FG003|Overall Study|Adverse Event|0|||
150267971|NCT01139021|542118912|FG004|Overall Study|Adverse Event|1|||
150267972|NCT01139021|542118913|FG005|Overall Study|Adverse Event|0|||
150267973|NCT01139021|542118908|FG000|Overall Study|Lost to Follow-up|0|||
150267974|NCT01139021|542118909|FG001|Overall Study|Lost to Follow-up|0|||
150267975|NCT01139021|542118910|FG002|Overall Study|Lost to Follow-up|0|||
150267976|NCT01139021|542118911|FG003|Overall Study|Lost to Follow-up|0|||
150267977|NCT01139021|542118912|FG004|Overall Study|Lost to Follow-up|2|||
150267978|NCT01139021|542118913|FG005|Overall Study|Lost to Follow-up|0|||
150267979|NCT01139021|542118908|FG000|Overall Study|Protocol Violation|1|||
150267980|NCT01139021|542118909|FG001|Overall Study|Protocol Violation|0|||
150267981|NCT01139021|542118910|FG002|Overall Study|Protocol Violation|0|||
150267982|NCT01139021|542118911|FG003|Overall Study|Protocol Violation|0|||
150267983|NCT01139021|542118912|FG004|Overall Study|Protocol Violation|2|||
150267984|NCT01139021|542118913|FG005|Overall Study|Protocol Violation|0|||
150267985|NCT01139021|542118908|FG000|Overall Study|Withdrawal by Subject|0|||
150267986|NCT01139021|542118909|FG001|Overall Study|Withdrawal by Subject|0|||
150267987|NCT01139021|542118910|FG002|Overall Study|Withdrawal by Subject|0|||
150267988|NCT01139021|542118911|FG003|Overall Study|Withdrawal by Subject|1|||
150267989|NCT01139021|542118912|FG004|Overall Study|Withdrawal by Subject|4|||
150267990|NCT01139021|542118913|FG005|Overall Study|Withdrawal by Subject|0|||
150267991|NCT00784693|542118915|FG000|Overall Study|Lost to Follow-up|0|||
150267992|NCT00784693|542118916|FG001|Overall Study|Lost to Follow-up|1|||
150267993|NCT00784693|542118915|FG000|Overall Study|Lack of Efficacy|1|||
150267994|NCT00784693|542118916|FG001|Overall Study|Lack of Efficacy|1|||
150267995|NCT00784693|542118915|FG000|Overall Study|Withdrawal by Subject|0|||
150167246|NCT01833065|541747751|FG001|Overall Study|Protocol Violation|0|||
150167247|NCT01833065|541747752|FG002|Overall Study|Protocol Violation|0|||
150167248|NCT01833065|541747753|FG003|Overall Study|Protocol Violation|0|||
150167249|NCT01833065|541747754|FG004|Overall Study|Protocol Violation|2|||
150167250|NCT01833065|541747750|FG000|Overall Study|Lost to Follow-up|1|||
150167251|NCT01833065|541747751|FG001|Overall Study|Lost to Follow-up|0|||
150167252|NCT01833065|541747752|FG002|Overall Study|Lost to Follow-up|0|||
150167253|NCT01833065|541747753|FG003|Overall Study|Lost to Follow-up|0|||
150167254|NCT01833065|541747754|FG004|Overall Study|Lost to Follow-up|3|||
150167255|NCT01833065|541747750|FG000|Overall Study|Withdrawal by Subject|6|||
150167256|NCT01833065|541747751|FG001|Overall Study|Withdrawal by Subject|2|||
150167257|NCT01833065|541747752|FG002|Overall Study|Withdrawal by Subject|4|||
150167258|NCT01833065|541747753|FG003|Overall Study|Withdrawal by Subject|3|||
150167259|NCT01833065|541747754|FG004|Overall Study|Withdrawal by Subject|11|||
150167260|NCT01833065|541747750|FG000|Overall Study|Subject's substantial non-compliance|0|||
150167261|NCT01833065|541747751|FG001|Overall Study|Subject's substantial non-compliance|1|||
150167262|NCT01833065|541747752|FG002|Overall Study|Subject's substantial non-compliance|0|||
150167263|NCT01833065|541747753|FG003|Overall Study|Subject's substantial non-compliance|0|||
150167264|NCT01833065|541747754|FG004|Overall Study|Subject's substantial non-compliance|0|||
150167265|NCT01833065|541747750|FG000|Overall Study|Trial terminated by sponsor|8|||
150167266|NCT01833065|541747751|FG001|Overall Study|Trial terminated by sponsor|8|||
150167267|NCT01833065|541747752|FG002|Overall Study|Trial terminated by sponsor|7|||
150167268|NCT01833065|541747753|FG003|Overall Study|Trial terminated by sponsor|3|||
150167269|NCT01833065|541747754|FG004|Overall Study|Trial terminated by sponsor|13|||
150167270|NCT01833065|541747750|FG000|Overall Study|Others|2|||
150167271|NCT01833065|541747751|FG001|Overall Study|Others|1|||
150167272|NCT01833065|541747752|FG002|Overall Study|Others|1|||
150167273|NCT01833065|541747753|FG003|Overall Study|Others|1|||
150167274|NCT01833065|541747754|FG004|Overall Study|Others|4|||
150167275|NCT02299635|541747758|FG000|Overall Study|Adverse Event|2|||
150167276|NCT02299635|541747758|FG000|Overall Study|Death|1|||
150167277|NCT02299635|541747758|FG000|Overall Study|Global deterioration of health status|1|||
150167278|NCT02299635|541747758|FG000|Overall Study|Objective progression or relapse|10|||
150167279|NCT02299635|541747758|FG000|Overall Study|Withdrawal by Subject|2|||
150167280|NCT02299635|541747758|FG000|Overall Study|Other|3|||
150167281|NCT00828672|541747759|FG000|Study Treatment|Lost to Follow-up|1|||
150167282|NCT00828672|541747760|FG001|Study Treatment|Lost to Follow-up|0|||
150167283|NCT00828672|541747759|FG000|Study Treatment|Adverse Event|0|||
150167284|NCT00828672|541747760|FG001|Study Treatment|Adverse Event|1|||
150167285|NCT00828672|541747759|FG000|Study Treatment|Complete response, no surgery|1|||
150167286|NCT00828672|541747760|FG001|Study Treatment|Complete response, no surgery|1|||
150167287|NCT00828672|541747759|FG000|Post-surgery (<30 Days)|No central review materials|0|||
150167288|NCT00828672|541747760|FG001|Post-surgery (<30 Days)|No central review materials|1|||
150167289|NCT00015457|541747767|FG000|First Intervention|Adverse Event|0|||
150167290|NCT00015457|541747768|FG001|First Intervention|Adverse Event|2|||
150167291|NCT00015457|541747767|FG000|First Intervention|Lack of Efficacy|0|||
150167292|NCT00015457|541747768|FG001|First Intervention|Lack of Efficacy|1|||
150167293|NCT00015457|541747767|FG000|Second Intervention|Withdrawal by Subject|1|||
150167294|NCT00015457|541747768|FG001|Second Intervention|Withdrawal by Subject|0|||
150167295|NCT01456936|541747773|FG000|Overall Study|Other reason|41|||
150167296|NCT01456936|541747774|FG001|Overall Study|Other reason|30|||
150167297|NCT01456936|541747775|FG002|Overall Study|Other reason|36|||
150167298|NCT01456936|541747776|FG003|Overall Study|Other reason|33|||
150167299|NCT01456936|541747773|FG000|Overall Study|No longer meets eligibility criteria|4|||
150167300|NCT01456936|541747774|FG001|Overall Study|No longer meets eligibility criteria|8|||
150167301|NCT01456936|541747775|FG002|Overall Study|No longer meets eligibility criteria|6|||
150167302|NCT01456936|541747776|FG003|Overall Study|No longer meets eligibility criteria|5|||
150167303|NCT01456936|541747773|FG000|Overall Study|Protocol Violation|4|||
150167304|NCT01456936|541747774|FG001|Overall Study|Protocol Violation|2|||
150167305|NCT01456936|541747775|FG002|Overall Study|Protocol Violation|5|||
150167306|NCT01456936|541747776|FG003|Overall Study|Protocol Violation|5|||
150167307|NCT01456936|541747773|FG000|Overall Study|Pregnancy|1|||
150167308|NCT01456936|541747774|FG001|Overall Study|Pregnancy|0|||
150167309|NCT01456936|541747775|FG002|Overall Study|Pregnancy|0|||
150167310|NCT01456936|541747776|FG003|Overall Study|Pregnancy|1|||
150167311|NCT01456936|541747773|FG000|Overall Study|Insufficient clinical response|4|||
150167312|NCT01456936|541747774|FG001|Overall Study|Insufficient clinical response|4|||
150167313|NCT01456936|541747775|FG002|Overall Study|Insufficient clinical response|14|||
150167314|NCT01456936|541747776|FG003|Overall Study|Insufficient clinical response|13|||
150167315|NCT01456936|541747773|FG000|Overall Study|No longer willing to participate|195|||
150167316|NCT01456936|541747774|FG001|Overall Study|No longer willing to participate|218|||
150167317|NCT01456936|541747775|FG002|Overall Study|No longer willing to participate|224|||
150167318|NCT01456936|541747776|FG003|Overall Study|No longer willing to participate|248|||
150167319|NCT01456936|541747773|FG000|Overall Study|Lost to Follow-up|135|||
150267996|NCT00784693|542118916|FG001|Overall Study|Withdrawal by Subject|4|||
150167320|NCT01456936|541747774|FG001|Overall Study|Lost to Follow-up|126|||
150267997|NCT00784693|542118915|FG000|Overall Study|Randomized but not Treated|1|||
150267998|NCT00784693|542118916|FG001|Overall Study|Randomized but not Treated|0|||
150267999|NCT00784693|542118915|FG000|Overall Study|Other|1|||
150268000|NCT00784693|542118916|FG001|Overall Study|Other|0|||
150268001|NCT05458479|542118917|FG000|Overall Study|Lost to Follow-up|1|||
150268002|NCT03588728|542118920|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
150268003|NCT03588728|542118921|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
150268004|NCT03588728|542118922|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
150268005|NCT03588728|542118923|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
150268006|NCT03588728|542118920|FG000|Overall Study|Lab shut down due to COVID-19|0|||
150268007|NCT03588728|542118921|FG001|Overall Study|Lab shut down due to COVID-19|0|||
150268008|NCT03588728|542118922|FG002|Overall Study|Lab shut down due to COVID-19|0|||
150268009|NCT03588728|542118923|FG003|Overall Study|Lab shut down due to COVID-19|1|||
150268010|NCT03588728|542118920|FG000|Overall Study|multiple technical issues|1|||
150268011|NCT03588728|542118921|FG001|Overall Study|multiple technical issues|0|||
150268012|NCT03588728|542118922|FG002|Overall Study|multiple technical issues|0|||
150268013|NCT03588728|542118923|FG003|Overall Study|multiple technical issues|0|||
150268014|NCT03588728|542118920|FG000|Overall Study|Hospitalized for COVID|1|||
150268015|NCT03588728|542118921|FG001|Overall Study|Hospitalized for COVID|0|||
150268016|NCT03588728|542118922|FG002|Overall Study|Hospitalized for COVID|0|||
150268017|NCT03588728|542118923|FG003|Overall Study|Hospitalized for COVID|0|||
150268018|NCT03588728|542118920|FG000|Overall Study|Schedule change unable to attend sessions|1|||
150268019|NCT03588728|542118921|FG001|Overall Study|Schedule change unable to attend sessions|0|||
150268020|NCT03588728|542118922|FG002|Overall Study|Schedule change unable to attend sessions|0|||
150268021|NCT03588728|542118923|FG003|Overall Study|Schedule change unable to attend sessions|0|||
150268022|NCT01388790|542118924|FG000|Overall Study|Ongoing at data cut-off date|8|||
150268023|NCT00195507|542118925|FG000|Overall Study|Adverse Event|24|||
150268024|NCT00195507|542118926|FG001|Overall Study|Adverse Event|13|||
150268025|NCT00195507|542118925|FG000|Overall Study|Death|0|||
150268026|NCT00195507|542118926|FG001|Overall Study|Death|1|||
150268027|NCT00195507|542118925|FG000|Overall Study|Failed to Return|4|||
150268028|NCT00195507|542118926|FG001|Overall Study|Failed to Return|3|||
150268029|NCT00195507|542118925|FG000|Overall Study|Physician Decision|1|||
150268030|NCT00195507|542118926|FG001|Overall Study|Physician Decision|2|||
150268031|NCT00195507|542118925|FG000|Overall Study|Lost to Follow-up|3|||
150268032|NCT00195507|542118926|FG001|Overall Study|Lost to Follow-up|2|||
150268033|NCT00195507|542118925|FG000|Overall Study|Protocol Violation|5|||
150268034|NCT00195507|542118926|FG001|Overall Study|Protocol Violation|4|||
150268035|NCT00195507|542118925|FG000|Overall Study|Lack of Efficacy|40|||
150268036|NCT00195507|542118926|FG001|Overall Study|Lack of Efficacy|67|||
150268037|NCT00195507|542118925|FG000|Overall Study|Withdrawal by Subject|16|||
150268038|NCT00195507|542118926|FG001|Overall Study|Withdrawal by Subject|23|||
150268039|NCT00195507|542118925|FG000|Overall Study|Protocol Deviation|6|||
150268040|NCT00195507|542118926|FG001|Overall Study|Protocol Deviation|3|||
150268041|NCT00528866|542118927|FG000|Overall Study|Protocol Violation|6|||
150268042|NCT00993915|542118931|FG000|Overall Study|Insufficient clinical response|3|||
150268043|NCT00993915|542118931|FG000|Overall Study|Withdrawal by Subject|2|||
150268044|NCT00993915|542118931|FG000|Overall Study|Other|1|||
150268045|NCT00993915|542118931|FG000|Overall Study|Ongoing|3|||
150268046|NCT01386658|542118932|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
150268047|NCT01386658|542118933|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
150268048|NCT01386658|542118932|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
150268049|NCT01386658|542118933|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
150268050|NCT02465463|542118936|FG000|Overall Study|Lost to Follow-up|2|||
150268051|NCT02465463|542118937|FG001|Overall Study|Lost to Follow-up|1|||
150268052|NCT02465463|542118936|FG000|Overall Study|Death|1|||
150268053|NCT02465463|542118937|FG001|Overall Study|Death|0|||
150268054|NCT02465463|542118936|FG000|Overall Study|Protocol Violation|1|||
150268055|NCT02465463|542118937|FG001|Overall Study|Protocol Violation|0|||
150268056|NCT00769860|542118946|FG000|Overall Study|Withdrawal by Subject|2|||
150268057|NCT00769860|542118947|FG001|Overall Study|Withdrawal by Subject|0|||
150268058|NCT00412971|542118952|FG000|Overall Study|Lost to Follow-up|17|||
150268059|NCT00412971|542118953|FG001|Overall Study|Lost to Follow-up|9|||
150268060|NCT00412971|542118952|FG000|Overall Study|Protocol Violation|13|||
150268061|NCT00412971|542118953|FG001|Overall Study|Protocol Violation|1|||
150268062|NCT01106404|542118954|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
150268063|NCT01106404|542118955|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
150268064|NCT01106404|542118954|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
150268065|NCT01106404|542118955|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
150268066|NCT01106404|542118954|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
150268067|NCT01106404|542118955|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
150268068|NCT01106404|542118954|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
150268069|NCT01106404|542118955|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
150268070|NCT00775450|542118956|FG000|Overall Study|Serious Adverse Event|2|||
150268071|NCT00775450|542118957|FG001|Overall Study|Serious Adverse Event|0|||
150268072|NCT00775450|542118958|FG002|Overall Study|Serious Adverse Event|0|||
150268073|NCT00775450|542118959|FG003|Overall Study|Serious Adverse Event|0|||
150268074|NCT00775450|542118960|FG004|Overall Study|Serious Adverse Event|0|||
150268075|NCT00775450|542118956|FG000|Overall Study|Protocol Violation|0|||
150268076|NCT00775450|542118957|FG001|Overall Study|Protocol Violation|0|||
150268077|NCT00775450|542118958|FG002|Overall Study|Protocol Violation|0|||
150268078|NCT00775450|542118959|FG003|Overall Study|Protocol Violation|0|||
150268079|NCT00775450|542118960|FG004|Overall Study|Protocol Violation|1|||
150268080|NCT00775450|542118956|FG000|Overall Study|Withdrawal by Subject|1|||
150268081|NCT00775450|542118957|FG001|Overall Study|Withdrawal by Subject|0|||
150268082|NCT00775450|542118958|FG002|Overall Study|Withdrawal by Subject|0|||
150268083|NCT00775450|542118959|FG003|Overall Study|Withdrawal by Subject|0|||
150268084|NCT00775450|542118960|FG004|Overall Study|Withdrawal by Subject|1|||
150268085|NCT01749540|542118961|FG000|Overall Study|Protocol Violation|0|||
150268086|NCT01749540|542118962|FG001|Overall Study|Protocol Violation|0|||
150268087|NCT01749540|542118963|FG002|Overall Study|Protocol Violation|0|||
150268088|NCT01749540|542118964|FG003|Overall Study|Protocol Violation|0|||
150268089|NCT01749540|542118965|FG004|Overall Study|Protocol Violation|0|||
150268090|NCT01749540|542118966|FG005|Overall Study|Protocol Violation|1|||
150268091|NCT01749540|542118967|FG006|Overall Study|Protocol Violation|1|||
150268092|NCT01749540|542118961|FG000|Overall Study|Withdrawal by Subject|0|||
150268093|NCT01749540|542118962|FG001|Overall Study|Withdrawal by Subject|0|||
150268094|NCT01749540|542118963|FG002|Overall Study|Withdrawal by Subject|0|||
150268095|NCT01749540|542118964|FG003|Overall Study|Withdrawal by Subject|1|||
150268096|NCT01749540|542118965|FG004|Overall Study|Withdrawal by Subject|0|||
150268097|NCT01749540|542118966|FG005|Overall Study|Withdrawal by Subject|0|||
150268098|NCT01749540|542118967|FG006|Overall Study|Withdrawal by Subject|0|||
150268099|NCT01749540|542118961|FG000|Overall Study|Initiated into extension study A536-06|0|||
150268100|NCT01749540|542118962|FG001|Overall Study|Initiated into extension study A536-06|0|||
150268101|NCT01749540|542118963|FG002|Overall Study|Initiated into extension study A536-06|0|||
150268102|NCT01749540|542118964|FG003|Overall Study|Initiated into extension study A536-06|0|||
150268103|NCT01749540|542118965|FG004|Overall Study|Initiated into extension study A536-06|0|||
150268104|NCT01749540|542118966|FG005|Overall Study|Initiated into extension study A536-06|2|||
150268105|NCT01749540|542118967|FG006|Overall Study|Initiated into extension study A536-06|24|||
150268106|NCT01055262|542118968|FG000|Overall Study|Adverse Event|5|||
150268107|NCT01055262|542118968|FG000|Overall Study|Protocol Violation|3|||
150268108|NCT01055262|542118968|FG000|Overall Study|Uncooperativeness|1|||
150268109|NCT00894686|542118969|FG000|Overall Study|Withdrawal by Subject|50|||
150268110|NCT00894686|542118969|FG000|Overall Study|Physician Decision|1|||
150268111|NCT00894686|542118969|FG000|Overall Study|Other|5|||
150268112|NCT01209143|542118973|FG000|Overall Study|Adverse Event|2|||
150268113|NCT01209143|542118974|FG001|Overall Study|Adverse Event|1|||
150268114|NCT01209143|542118973|FG000|Overall Study|Death|0|||
150268115|NCT01209143|542118974|FG001|Overall Study|Death|1|||
150268116|NCT01209143|542118973|FG000|Overall Study|Physician Decision|3|||
150268117|NCT01209143|542118974|FG001|Overall Study|Physician Decision|1|||
150268118|NCT01209143|542118973|FG000|Overall Study|Lost to Follow-up|1|||
150268119|NCT01209143|542118974|FG001|Overall Study|Lost to Follow-up|0|||
150268120|NCT01209143|542118973|FG000|Overall Study|Withdrawal by Subject|2|||
150268121|NCT01209143|542118974|FG001|Overall Study|Withdrawal by Subject|1|||
150268122|NCT01209143|542118973|FG000|Overall Study|Disease progression|11|||
150268123|NCT01209143|542118974|FG001|Overall Study|Disease progression|16|||
150268124|NCT01145755|542118975|FG000|Overall Study|Adverse Event|2|||
150268125|NCT01145755|542118976|FG001|Overall Study|Adverse Event|4|||
150268126|NCT01145755|542118977|FG002|Overall Study|Adverse Event|2|||
150268127|NCT01145755|542118975|FG000|Overall Study|Withdrawal by Subject|2|||
150268128|NCT01145755|542118976|FG001|Overall Study|Withdrawal by Subject|2|||
150268129|NCT01145755|542118977|FG002|Overall Study|Withdrawal by Subject|2|||
150268130|NCT01145755|542118975|FG000|Overall Study|Lost to Follow-up|2|||
150268131|NCT01145755|542118976|FG001|Overall Study|Lost to Follow-up|3|||
150268132|NCT01145755|542118977|FG002|Overall Study|Lost to Follow-up|1|||
150268133|NCT01145755|542118975|FG000|Overall Study|Protocol Violation|0|||
150268134|NCT01145755|542118976|FG001|Overall Study|Protocol Violation|3|||
150268135|NCT01145755|542118977|FG002|Overall Study|Protocol Violation|1|||
150268136|NCT01145755|542118975|FG000|Overall Study|Study Closure|14|||
150268137|NCT01145755|542118976|FG001|Overall Study|Study Closure|14|||
150268138|NCT01145755|542118977|FG002|Overall Study|Study Closure|17|||
150268139|NCT01145755|542118975|FG000|Overall Study|Lack of Efficacy|0|||
150268140|NCT01145755|542118976|FG001|Overall Study|Lack of Efficacy|1|||
150268141|NCT01145755|542118977|FG002|Overall Study|Lack of Efficacy|0|||
150268142|NCT01145755|542118975|FG000|Overall Study|Patient could not swollow medication|0|||
150268143|NCT01145755|542118976|FG001|Overall Study|Patient could not swollow medication|0|||
150268144|NCT01145755|542118977|FG002|Overall Study|Patient could not swollow medication|1|||
150268145|NCT01145755|542118975|FG000|Overall Study|Withdrawal by Subject|0|||
150268146|NCT01145755|542118976|FG001|Overall Study|Withdrawal by Subject|0|||
150268147|NCT01145755|542118977|FG002|Overall Study|Withdrawal by Subject|1|||
150268148|NCT01145755|542118975|FG000|Overall Study|Positive urine ethanol|0|||
150268149|NCT01145755|542118976|FG001|Overall Study|Positive urine ethanol|1|||
150268150|NCT01145755|542118977|FG002|Overall Study|Positive urine ethanol|0|||
150268151|NCT05245097|542118980|FG000|Overall Study|Adverse Event|13|||
150268152|NCT05245097|542118981|FG001|Overall Study|Adverse Event|2|||
150268153|NCT05245097|542118980|FG000|Overall Study|Protocol Violation|8|||
150268154|NCT05245097|542118981|FG001|Overall Study|Protocol Violation|6|||
150268155|NCT05245097|542118980|FG000|Overall Study|Withdrawal by Subject|18|||
150268156|NCT05245097|542118981|FG001|Overall Study|Withdrawal by Subject|0|||
150268157|NCT05245097|542118980|FG000|Overall Study|Death|6|||
150268158|NCT05245097|542118981|FG001|Overall Study|Death|7|||
150268159|NCT05245097|542118980|FG000|Overall Study|Physician Decision|6|||
150268160|NCT05245097|542118981|FG001|Overall Study|Physician Decision|0|||
150268161|NCT05245097|542118980|FG000|Overall Study|Relocation|4|||
150268162|NCT05245097|542118981|FG001|Overall Study|Relocation|3|||
150268163|NCT03231943|542118986|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268164|NCT03231943|542118987|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
150268165|NCT03231943|542118988|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
150268166|NCT03231943|542118989|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268167|NCT03231943|542118990|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268168|NCT03231943|542118991|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268169|NCT03231943|542118992|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268170|NCT03231943|542118993|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268171|NCT03231943|542118994|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268172|NCT03231943|542118995|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268173|NCT03231943|542118996|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268174|NCT03231943|542118997|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268175|NCT03231943|542118998|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
150268176|NCT03231943|542118986|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268177|NCT03231943|542118987|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
150268178|NCT03231943|542118988|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268179|NCT03231943|542118989|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268180|NCT03231943|542118990|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268181|NCT03231943|542118991|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268182|NCT03231943|542118992|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268183|NCT03231943|542118993|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268184|NCT03231943|542118994|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268185|NCT03231943|542118995|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268186|NCT03231943|542118996|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268187|NCT03231943|542118997|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268188|NCT03231943|542118998|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
150268189|NCT03231943|542118986|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
150268190|NCT03231943|542118987|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268191|NCT03231943|542118988|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268192|NCT03231943|542118989|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268193|NCT03231943|542118990|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268194|NCT03231943|542118991|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268195|NCT03231943|542118992|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268196|NCT03231943|542118993|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268197|NCT03231943|542118994|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268198|NCT03231943|542118995|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268199|NCT03231943|542118996|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268200|NCT03231943|542118997|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268201|NCT03231943|542118998|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
150268202|NCT03231943|542118986|FG000|Part 2|Adverse Event|0|||
150268203|NCT03231943|542118987|FG001|Part 2|Adverse Event|0|||
150268204|NCT03231943|542118988|FG002|Part 2|Adverse Event|0|||
150268205|NCT03231943|542118989|FG003|Part 2|Adverse Event|0|||
150268206|NCT03231943|542118990|FG004|Part 2|Adverse Event|0|||
150268207|NCT03231943|542118991|FG005|Part 2|Adverse Event|0|||
150268208|NCT03231943|542118992|FG006|Part 2|Adverse Event|0|||
150268209|NCT03231943|542118993|FG007|Part 2|Adverse Event|0|||
150268210|NCT03231943|542118994|FG008|Part 2|Adverse Event|0|||
150268211|NCT03231943|542118995|FG009|Part 2|Adverse Event|0|||
150268212|NCT03231943|542118996|FG010|Part 2|Adverse Event|1|||
150268213|NCT03231943|542118997|FG011|Part 2|Adverse Event|0|||
150268214|NCT03231943|542118998|FG012|Part 2|Adverse Event|0|||
150268215|NCT03231943|542118986|FG000|Part 2|Withdrawal by Subject|0|||
150268216|NCT03231943|542118987|FG001|Part 2|Withdrawal by Subject|0|||
150268217|NCT03231943|542118988|FG002|Part 2|Withdrawal by Subject|0|||
150268218|NCT03231943|542118989|FG003|Part 2|Withdrawal by Subject|0|||
150268219|NCT03231943|542118990|FG004|Part 2|Withdrawal by Subject|0|||
150268220|NCT03231943|542118991|FG005|Part 2|Withdrawal by Subject|0|||
150268221|NCT03231943|542118992|FG006|Part 2|Withdrawal by Subject|0|||
150268222|NCT03231943|542118993|FG007|Part 2|Withdrawal by Subject|0|||
150268223|NCT03231943|542118994|FG008|Part 2|Withdrawal by Subject|0|||
150268224|NCT03231943|542118995|FG009|Part 2|Withdrawal by Subject|0|||
150268225|NCT03231943|542118996|FG010|Part 2|Withdrawal by Subject|0|||
150268226|NCT03231943|542118997|FG011|Part 2|Withdrawal by Subject|1|||
150268227|NCT03231943|542118998|FG012|Part 2|Withdrawal by Subject|0|||
150268228|NCT01572922|542118999|FG000|Overall Study|Adverse Event|1|||
150268229|NCT01572922|542118999|FG000|Overall Study|Protocol Violation|1|||
150268230|NCT01572922|542118999|FG000|Overall Study|Death|1|||
150268231|NCT04821869|542119000|FG000|Overall Study|Adverse Event|4|||
150268232|NCT04821869|542119000|FG000|Overall Study|Withdrawal by Subject|2|||
150268233|NCT04821869|542119000|FG000|Overall Study|Did not meet FEV1 criteria|1|||
150268234|NCT03444324|542119001|FG000|Overall Study|Withdrawal by Subject|0|||
150268235|NCT03444324|542119002|FG001|Overall Study|Withdrawal by Subject|1|||
150268236|NCT03444324|542119001|FG000|Overall Study|Lost to Follow-up|4|||
150268237|NCT03444324|542119002|FG001|Overall Study|Lost to Follow-up|2|||
150268238|NCT03444324|542119001|FG000|Overall Study|Protocol Violation|0|||
150268239|NCT03444324|542119002|FG001|Overall Study|Protocol Violation|1|||
150268240|NCT03444324|542119001|FG000|Overall Study|Lack of Trial Compliance|1|||
150268241|NCT03444324|542119002|FG001|Overall Study|Lack of Trial Compliance|1|||
150268242|NCT03444324|542119001|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
150268243|NCT03444324|542119002|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
150268244|NCT01117454|542120748|FG000|Overall Study|Pregnancy|0|||
150268245|NCT01117454|542120749|FG001|Overall Study|Pregnancy|1|||
150268246|NCT01794520|542120752|FG000|Overall Study|Adverse events- related to progression|0|||
150268247|NCT01794520|542120753|FG001|Overall Study|Adverse events- related to progression|0|||
150268248|NCT01794520|542120754|FG002|Overall Study|Adverse events- related to progression|1|||
150268249|NCT01794520|542120755|FG003|Overall Study|Adverse events- related to progression|2|||
150268250|NCT01794520|542120756|FG004|Overall Study|Adverse events- related to progression|0|||
150268251|NCT01794520|542120757|FG005|Overall Study|Adverse events- related to progression|1|||
150268252|NCT01794520|542120758|FG006|Overall Study|Adverse events- related to progression|0|||
150268253|NCT01794520|542120752|FG000|Overall Study|Adverse event- not related to progression|1|||
150268254|NCT01794520|542120753|FG001|Overall Study|Adverse event- not related to progression|1|||
150268255|NCT01794520|542120754|FG002|Overall Study|Adverse event- not related to progression|0|||
150268256|NCT01794520|542120755|FG003|Overall Study|Adverse event- not related to progression|0|||
150268257|NCT01794520|542120756|FG004|Overall Study|Adverse event- not related to progression|2|||
150268258|NCT01794520|542120757|FG005|Overall Study|Adverse event- not related to progression|0|||
150268259|NCT01794520|542120758|FG006|Overall Study|Adverse event- not related to progression|0|||
150268260|NCT01794520|542120752|FG000|Overall Study|Progressive disease|5|||
150268261|NCT01794520|542120753|FG001|Overall Study|Progressive disease|6|||
150268262|NCT01794520|542120754|FG002|Overall Study|Progressive disease|2|||
150268263|NCT01794520|542120755|FG003|Overall Study|Progressive disease|5|||
150268264|NCT01794520|542120756|FG004|Overall Study|Progressive disease|27|||
150268265|NCT01794520|542120757|FG005|Overall Study|Progressive disease|18|||
150268266|NCT01794520|542120758|FG006|Overall Study|Progressive disease|0|||
150268267|NCT01794520|542120752|FG000|Overall Study|Withdrew consent|0|||
150268268|NCT01794520|542120753|FG001|Overall Study|Withdrew consent|0|||
150268269|NCT01794520|542120754|FG002|Overall Study|Withdrew consent|1|||
150268270|NCT01794520|542120755|FG003|Overall Study|Withdrew consent|1|||
150268271|NCT01794520|542120756|FG004|Overall Study|Withdrew consent|0|||
150268272|NCT01794520|542120757|FG005|Overall Study|Withdrew consent|0|||
150268273|NCT01794520|542120758|FG006|Overall Study|Withdrew consent|0|||
150268274|NCT01794520|542120752|FG000|Overall Study|Lost to Follow-up|0|||
150268275|NCT01794520|542120753|FG001|Overall Study|Lost to Follow-up|0|||
150268276|NCT01794520|542120754|FG002|Overall Study|Lost to Follow-up|0|||
150268277|NCT01794520|542120755|FG003|Overall Study|Lost to Follow-up|0|||
150268278|NCT01794520|542120756|FG004|Overall Study|Lost to Follow-up|1|||
150268279|NCT01794520|542120757|FG005|Overall Study|Lost to Follow-up|0|||
150268280|NCT01794520|542120758|FG006|Overall Study|Lost to Follow-up|0|||
150268281|NCT01794520|542120752|FG000|Overall Study|Toxicity|0|||
150268282|NCT01794520|542120753|FG001|Overall Study|Toxicity|2|||
150268283|NCT01794520|542120754|FG002|Overall Study|Toxicity|0|||
150268284|NCT01794520|542120755|FG003|Overall Study|Toxicity|0|||
150268285|NCT01794520|542120756|FG004|Overall Study|Toxicity|0|||
150268286|NCT01794520|542120757|FG005|Overall Study|Toxicity|0|||
150268287|NCT01794520|542120758|FG006|Overall Study|Toxicity|0|||
150268288|NCT01794520|542120752|FG000|Overall Study|Study terminated by sponsor|0|||
150268289|NCT01794520|542120753|FG001|Overall Study|Study terminated by sponsor|0|||
150268290|NCT01794520|542120754|FG002|Overall Study|Study terminated by sponsor|1|||
150268291|NCT01794520|542120755|FG003|Overall Study|Study terminated by sponsor|0|||
150268292|NCT01794520|542120756|FG004|Overall Study|Study terminated by sponsor|1|||
150268293|NCT01794520|542120757|FG005|Overall Study|Study terminated by sponsor|0|||
150268294|NCT01794520|542120758|FG006|Overall Study|Study terminated by sponsor|7|||
150268295|NCT01794520|542120752|FG000|Overall Study|Death|0|||
150268296|NCT01794520|542120753|FG001|Overall Study|Death|0|||
150268297|NCT01794520|542120754|FG002|Overall Study|Death|0|||
150268298|NCT01794520|542120755|FG003|Overall Study|Death|0|||
150268299|NCT01794520|542120756|FG004|Overall Study|Death|1|||
150268300|NCT01794520|542120757|FG005|Overall Study|Death|0|||
150268301|NCT01794520|542120758|FG006|Overall Study|Death|22|||
150268302|NCT01794520|542120752|FG000|Overall Study|Other, not specified|0|||
150268303|NCT01794520|542120753|FG001|Overall Study|Other, not specified|0|||
150268304|NCT01794520|542120754|FG002|Overall Study|Other, not specified|1|||
150268305|NCT01794520|542120755|FG003|Overall Study|Other, not specified|1|||
150268306|NCT01794520|542120756|FG004|Overall Study|Other, not specified|4|||
150268307|NCT01794520|542120757|FG005|Overall Study|Other, not specified|1|||
150268308|NCT01794520|542120758|FG006|Overall Study|Other, not specified|2|||
150268309|NCT04796896|542120759|FG000|Overall Study|Adverse Event|1|||
150268310|NCT04796896|542120760|FG001|Overall Study|Adverse Event|0|||
150268311|NCT04796896|542120761|FG002|Overall Study|Adverse Event|0|||
150268312|NCT04796896|542120762|FG003|Overall Study|Adverse Event|0|||
150268313|NCT04796896|542120763|FG004|Overall Study|Adverse Event|0|||
150268314|NCT04796896|542120764|FG005|Overall Study|Adverse Event|1|||
150268315|NCT04796896|542120765|FG006|Overall Study|Adverse Event|1|||
150268316|NCT04796896|542120766|FG007|Overall Study|Adverse Event|0|||
150268317|NCT04796896|542120767|FG008|Overall Study|Adverse Event|1|||
150268318|NCT04796896|542120768|FG009|Overall Study|Adverse Event|1|||
150268319|NCT04796896|542120769|FG010|Overall Study|Adverse Event|1|||
150268320|NCT04796896|542120770|FG011|Overall Study|Adverse Event|0|||
150268321|NCT04796896|542120759|FG000|Overall Study|Lost to Follow-up|24|||
150268322|NCT04796896|542120760|FG001|Overall Study|Lost to Follow-up|15|||
150268323|NCT04796896|542120761|FG002|Overall Study|Lost to Follow-up|6|||
150268324|NCT04796896|542120762|FG003|Overall Study|Lost to Follow-up|4|||
150268325|NCT04796896|542120763|FG004|Overall Study|Lost to Follow-up|21|||
150268326|NCT04796896|542120764|FG005|Overall Study|Lost to Follow-up|55|||
150268327|NCT04796896|542120765|FG006|Overall Study|Lost to Follow-up|237|||
150268328|NCT04796896|542120766|FG007|Overall Study|Lost to Follow-up|52|||
150268329|NCT04796896|542120767|FG008|Overall Study|Lost to Follow-up|221|||
150268330|NCT04796896|542120768|FG009|Overall Study|Lost to Follow-up|43|||
150268331|NCT04796896|542120769|FG010|Overall Study|Lost to Follow-up|142|||
150268332|NCT04796896|542120770|FG011|Overall Study|Lost to Follow-up|18|||
150268333|NCT04796896|542120759|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
150268334|NCT04796896|542120760|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
150268335|NCT04796896|542120761|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
150268336|NCT04796896|542120762|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
150268337|NCT04796896|542120763|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
150268338|NCT04796896|542120764|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
150268339|NCT04796896|542120765|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
150268340|NCT04796896|542120766|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
150268341|NCT04796896|542120767|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
150268342|NCT04796896|542120768|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
150268343|NCT04796896|542120769|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
150268344|NCT04796896|542120770|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
150268345|NCT04796896|542120759|FG000|Overall Study|Physician Decision|1|||
150268346|NCT04796896|542120760|FG001|Overall Study|Physician Decision|0|||
150268347|NCT04796896|542120761|FG002|Overall Study|Physician Decision|0|||
150268348|NCT04796896|542120762|FG003|Overall Study|Physician Decision|0|||
150268349|NCT04796896|542120763|FG004|Overall Study|Physician Decision|0|||
150268350|NCT04796896|542120764|FG005|Overall Study|Physician Decision|3|||
150268351|NCT04796896|542120765|FG006|Overall Study|Physician Decision|18|||
150268352|NCT04796896|542120766|FG007|Overall Study|Physician Decision|1|||
150268353|NCT04796896|542120767|FG008|Overall Study|Physician Decision|7|||
150268354|NCT04796896|542120768|FG009|Overall Study|Physician Decision|0|||
150268355|NCT04796896|542120769|FG010|Overall Study|Physician Decision|5|||
150268356|NCT04796896|542120770|FG011|Overall Study|Physician Decision|0|||
150268357|NCT04796896|542120759|FG000|Overall Study|Withdrawal by Subject|36|||
150268358|NCT04796896|542120760|FG001|Overall Study|Withdrawal by Subject|31|||
150268359|NCT04796896|542120761|FG002|Overall Study|Withdrawal by Subject|11|||
150268360|NCT04796896|542120762|FG003|Overall Study|Withdrawal by Subject|8|||
150268361|NCT04796896|542120763|FG004|Overall Study|Withdrawal by Subject|16|||
150268362|NCT04796896|542120764|FG005|Overall Study|Withdrawal by Subject|162|||
150268363|NCT04796896|542120765|FG006|Overall Study|Withdrawal by Subject|299|||
150268364|NCT04796896|542120766|FG007|Overall Study|Withdrawal by Subject|149|||
150268365|NCT04796896|542120767|FG008|Overall Study|Withdrawal by Subject|303|||
150268366|NCT04796896|542120768|FG009|Overall Study|Withdrawal by Subject|94|||
150268367|NCT04796896|542120769|FG010|Overall Study|Withdrawal by Subject|192|||
150268368|NCT04796896|542120770|FG011|Overall Study|Withdrawal by Subject|16|||
150268369|NCT04796896|542120759|FG000|Overall Study|Other Than Specified|6|||
150268370|NCT04796896|542120760|FG001|Overall Study|Other Than Specified|5|||
150268371|NCT04796896|542120761|FG002|Overall Study|Other Than Specified|3|||
150268372|NCT04796896|542120762|FG003|Overall Study|Other Than Specified|2|||
150268373|NCT04796896|542120763|FG004|Overall Study|Other Than Specified|6|||
150268374|NCT04796896|542120764|FG005|Overall Study|Other Than Specified|31|||
150268375|NCT04796896|542120765|FG006|Overall Study|Other Than Specified|86|||
150268376|NCT04796896|542120766|FG007|Overall Study|Other Than Specified|66|||
150268377|NCT04796896|542120767|FG008|Overall Study|Other Than Specified|388|||
150268378|NCT04796896|542120768|FG009|Overall Study|Other Than Specified|48|||
150268379|NCT04796896|542120769|FG010|Overall Study|Other Than Specified|258|||
150268380|NCT04796896|542120770|FG011|Overall Study|Other Than Specified|4|||
150268381|NCT04796896|542120759|FG000|Overall Study|Protocol Deviation|0|||
150268382|NCT04796896|542120760|FG001|Overall Study|Protocol Deviation|0|||
150268383|NCT04796896|542120761|FG002|Overall Study|Protocol Deviation|0|||
150268384|NCT04796896|542120762|FG003|Overall Study|Protocol Deviation|1|||
150268385|NCT04796896|542120763|FG004|Overall Study|Protocol Deviation|1|||
150268386|NCT04796896|542120764|FG005|Overall Study|Protocol Deviation|2|||
150268387|NCT04796896|542120765|FG006|Overall Study|Protocol Deviation|2|||
150268388|NCT04796896|542120766|FG007|Overall Study|Protocol Deviation|2|||
150268389|NCT04796896|542120767|FG008|Overall Study|Protocol Deviation|2|||
150268390|NCT04796896|542120768|FG009|Overall Study|Protocol Deviation|1|||
150268391|NCT04796896|542120769|FG010|Overall Study|Protocol Deviation|0|||
150268392|NCT04796896|542120770|FG011|Overall Study|Protocol Deviation|0|||
150268393|NCT04796896|542120759|FG000|Overall Study|Missing|0|||
150268394|NCT04796896|542120760|FG001|Overall Study|Missing|0|||
150268395|NCT04796896|542120761|FG002|Overall Study|Missing|0|||
149933698|NCT04877990|540891821|FG000|Treatment|Administrative reasons by sponsor|17|||
149933699|NCT04877990|540891822|FG001|Treatment|Administrative reasons by sponsor|33|||
150167321|NCT01456936|541747775|FG002|Overall Study|Lost to Follow-up|144|||
150167322|NCT01456936|541747776|FG003|Overall Study|Lost to Follow-up|127|||
150167323|NCT01456936|541747773|FG000|Overall Study|Medication error|0|||
150167324|NCT01456936|541747774|FG001|Overall Study|Medication error|1|||
150167325|NCT01456936|541747775|FG002|Overall Study|Medication error|0|||
150167326|NCT01456936|541747776|FG003|Overall Study|Medication error|1|||
150167327|NCT01456936|541747773|FG000|Overall Study|Adverse event (study drug)|25|||
150167328|NCT01456936|541747774|FG001|Overall Study|Adverse event (study drug)|21|||
150167329|NCT01456936|541747775|FG002|Overall Study|Adverse event (study drug)|26|||
150167330|NCT01456936|541747776|FG003|Overall Study|Adverse event (study drug)|17|||
150167331|NCT01456936|541747773|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
150167332|NCT01456936|541747774|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
150167333|NCT01456936|541747775|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
150167334|NCT01456936|541747776|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
150167335|NCT01456936|541747773|FG000|Overall Study|Death|0|||
150167336|NCT01456936|541747774|FG001|Overall Study|Death|3|||
150167337|NCT01456936|541747775|FG002|Overall Study|Death|1|||
150167338|NCT01456936|541747776|FG003|Overall Study|Death|3|||
150167339|NCT01456936|541747773|FG000|Overall Study|Randomized but not treated|21|||
150167340|NCT01456936|541747774|FG001|Overall Study|Randomized but not treated|28|||
150167341|NCT01456936|541747775|FG002|Overall Study|Randomized but not treated|16|||
150167342|NCT01456936|541747776|FG003|Overall Study|Randomized but not treated|21|||
150167343|NCT03095508|541747777|FG000|Overall Study|Adverse Event|0|||
150167344|NCT03095508|541747778|FG001|Overall Study|Adverse Event|1|||
150167345|NCT02317705|541747779|FG000|Overall Study|Withdrawal by Subject|3|||
150167346|NCT02317705|541747779|FG000|Overall Study|Physician Decision|1|||
150167347|NCT02317705|541747779|FG000|Overall Study|Drug not usable|1|||
150167348|NCT01674569|541747780|FG000|Overall Study|Adverse Event|0|||
150167349|NCT01674569|541747781|FG001|Overall Study|Adverse Event|2|||
150167350|NCT01674569|541747782|FG002|Overall Study|Adverse Event|0|||
150167351|NCT01674569|541747783|FG003|Overall Study|Adverse Event|1|||
150167352|NCT01674569|541747784|FG004|Overall Study|Adverse Event|2|||
150167353|NCT01674569|541747785|FG005|Overall Study|Adverse Event|2|||
150167354|NCT01674569|541747780|FG000|Overall Study|Protocol Violation|0|||
150167355|NCT01674569|541747781|FG001|Overall Study|Protocol Violation|1|||
150167356|NCT01674569|541747782|FG002|Overall Study|Protocol Violation|1|||
150167357|NCT01674569|541747783|FG003|Overall Study|Protocol Violation|0|||
150167358|NCT01674569|541747784|FG004|Overall Study|Protocol Violation|0|||
150167359|NCT01674569|541747785|FG005|Overall Study|Protocol Violation|0|||
150167360|NCT01674569|541747780|FG000|Overall Study|Withdrawal by Subject|0|||
150167361|NCT01674569|541747781|FG001|Overall Study|Withdrawal by Subject|0|||
150167362|NCT01674569|541747782|FG002|Overall Study|Withdrawal by Subject|1|||
150167363|NCT01674569|541747783|FG003|Overall Study|Withdrawal by Subject|0|||
150167364|NCT01674569|541747784|FG004|Overall Study|Withdrawal by Subject|0|||
150167365|NCT01674569|541747785|FG005|Overall Study|Withdrawal by Subject|0|||
150167366|NCT01599325|541747786|FG000|Primary Parent Phase|Adverse Event|5|||
150167367|NCT01599325|541747786|FG000|Primary Parent Phase|Disease Progression|7|||
150167368|NCT01599325|541747786|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
150167369|NCT01599325|541747786|FG000|Primary Parent Phase|Death|13|||
150167370|NCT01599325|541747786|FG000|Primary Parent Phase|Protocol Violation|1|||
150167371|NCT01599325|541747786|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
150268396|NCT04796896|542120762|FG003|Overall Study|Missing|0|||
150268397|NCT04796896|542120763|FG004|Overall Study|Missing|0|||
149933700|NCT04877990|540891821|FG000|Treatment|Withdrawal by Subject|2|||
150167372|NCT01599325|541747786|FG000|Primary Parent Phase|Other|2|||
150268398|NCT04796896|542120764|FG005|Overall Study|Missing|0|||
150268399|NCT04796896|542120765|FG006|Overall Study|Missing|2|||
150268400|NCT04796896|542120766|FG007|Overall Study|Missing|1|||
150167373|NCT01599325|541747786|FG000|Extension Phase|Study Closure|1|||
150167374|NCT01599325|541747786|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
150167375|NCT01599325|541747786|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
150167376|NCT01599325|541747786|FG000|Extension Phase|Disease Progression|1|||
150167377|NCT01599325|541747786|FG000|Extension Phase|Withdrawal by Subject|8|||
150167378|NCT01878890|541747787|FG000|Overall Study|Protocol Violation|0|||
150167379|NCT01878890|541747788|FG001|Overall Study|Protocol Violation|1|||
150167380|NCT01878890|541747789|FG002|Overall Study|Protocol Violation|0|||
150167381|NCT01878890|541747790|FG003|Overall Study|Protocol Violation|0|||
150167382|NCT02701361|541747795|FG000|Overall Study|Lost to Follow-up|5|||
150167383|NCT02701361|541747796|FG001|Overall Study|Lost to Follow-up|2|||
150167384|NCT02701361|541747797|FG002|Overall Study|Lost to Follow-up|1|||
150167385|NCT02701361|541747795|FG000|Overall Study|Withdrawal by Subject|4|||
150167386|NCT02701361|541747796|FG001|Overall Study|Withdrawal by Subject|0|||
150167387|NCT02701361|541747797|FG002|Overall Study|Withdrawal by Subject|0|||
150167388|NCT02701361|541747795|FG000|Overall Study|timed out in rehab center|0|||
150167389|NCT02701361|541747796|FG001|Overall Study|timed out in rehab center|1|||
150167390|NCT02701361|541747797|FG002|Overall Study|timed out in rehab center|0|||
150167391|NCT02701361|541747795|FG000|Overall Study|incarceration|0|||
150167392|NCT02701361|541747796|FG001|Overall Study|incarceration|0|||
150167393|NCT02701361|541747797|FG002|Overall Study|incarceration|1|||
150167394|NCT02430532|541747801|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
150167395|NCT02430532|541747802|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
150167396|NCT02430532|541747801|FG000|Overall Study|Consent Withdrawn|0|||
150167397|NCT02430532|541747802|FG001|Overall Study|Consent Withdrawn|2|||
150167398|NCT02430532|541747801|FG000|Overall Study|Adverse Event|0|||
150167399|NCT02430532|541747802|FG001|Overall Study|Adverse Event|1|||
150167400|NCT03256344|541747803|FG000|Overall Study|Death|6|||
150167401|NCT03256344|541747804|FG001|Overall Study|Death|22|||
150167402|NCT03256344|541747803|FG000|Overall Study|Withdrawal by Subject|3|||
150167403|NCT03256344|541747804|FG001|Overall Study|Withdrawal by Subject|3|||
150167404|NCT03256344|541747803|FG000|Overall Study|Sponsor Decision|1|||
150167405|NCT03256344|541747804|FG001|Overall Study|Sponsor Decision|0|||
150167406|NCT00580801|541747812|FG000|Overall Study|Physician Decision|1|||
150167407|NCT00580801|541747813|FG001|Overall Study|Physician Decision|0|||
150167408|NCT00580801|541747814|FG002|Overall Study|Physician Decision|0|||
150167409|NCT00580801|541747812|FG000|Overall Study|Adverse Event|2|||
150167410|NCT00580801|541747813|FG001|Overall Study|Adverse Event|0|||
150167411|NCT00580801|541747814|FG002|Overall Study|Adverse Event|0|||
150167412|NCT00580801|541747812|FG000|Overall Study|Lost to Follow-up|2|||
150167413|NCT00580801|541747813|FG001|Overall Study|Lost to Follow-up|0|||
150167414|NCT00580801|541747814|FG002|Overall Study|Lost to Follow-up|0|||
150167415|NCT00580801|541747812|FG000|Overall Study|Reached a virologic endpoint|0|||
150167416|NCT00580801|541747813|FG001|Overall Study|Reached a virologic endpoint|1|||
150167417|NCT00580801|541747814|FG002|Overall Study|Reached a virologic endpoint|2|||
150167418|NCT00580801|541747812|FG000|Overall Study|Participant non-compliant|0|||
150167419|NCT00580801|541747813|FG001|Overall Study|Participant non-compliant|0|||
150167420|NCT00580801|541747814|FG002|Overall Study|Participant non-compliant|1|||
150167421|NCT00580801|541747812|FG000|Overall Study|Travel|1|||
150167422|NCT00580801|541747813|FG001|Overall Study|Travel|0|||
150167423|NCT00580801|541747814|FG002|Overall Study|Travel|0|||
150167424|NCT02595398|541747815|FG000|Overall Study|Non-compliance|1|||
150167425|NCT02595398|541747816|FG001|Overall Study|Non-compliance|0|||
150167426|NCT02595398|541747815|FG000|Overall Study|Withdrawal by Subject|2|||
150167427|NCT02595398|541747816|FG001|Overall Study|Withdrawal by Subject|1|||
150167428|NCT02595398|541747815|FG000|Overall Study|Lost to Follow-up|1|||
150167429|NCT02595398|541747816|FG001|Overall Study|Lost to Follow-up|0|||
150167430|NCT00502593|541747817|FG000|Overall Study|Withdrawn unspecified reason|1|||
150268401|NCT04796896|542120767|FG008|Overall Study|Missing|2|||
150268402|NCT04796896|542120768|FG009|Overall Study|Missing|1|||
150268403|NCT04796896|542120769|FG010|Overall Study|Missing|1|||
150268404|NCT04796896|542120770|FG011|Overall Study|Missing|0|||
150268405|NCT04796896|542120759|FG000|Overall Study|Death|0|||
150268406|NCT04796896|542120760|FG001|Overall Study|Death|0|||
150268407|NCT04796896|542120761|FG002|Overall Study|Death|0|||
150268408|NCT04796896|542120762|FG003|Overall Study|Death|0|||
150268409|NCT04796896|542120763|FG004|Overall Study|Death|0|||
150268410|NCT04796896|542120764|FG005|Overall Study|Death|0|||
150167431|NCT00502593|541747818|FG001|Overall Study|Withdrawn unspecified reason|1|||
150167432|NCT00502593|541747819|FG002|Overall Study|Withdrawn unspecified reason|3|||
150167433|NCT00502593|541747820|FG003|Overall Study|Withdrawn unspecified reason|1|||
150167434|NCT00502593|541747821|FG004|Overall Study|Withdrawn unspecified reason|2|||
150167435|NCT00502593|541747822|FG005|Overall Study|Withdrawn unspecified reason|0|||
150167436|NCT00502593|541747823|FG006|Overall Study|Withdrawn unspecified reason|2|||
150268411|NCT04796896|542120765|FG006|Overall Study|Death|0|||
150167437|NCT00502593|541747824|FG007|Overall Study|Withdrawn unspecified reason|0|||
150268412|NCT04796896|542120766|FG007|Overall Study|Death|0|||
150268413|NCT04796896|542120767|FG008|Overall Study|Death|1|||
150268414|NCT04796896|542120768|FG009|Overall Study|Death|0|||
150167438|NCT00502593|541747825|FG008|Overall Study|Withdrawn unspecified reason|0|||
150167439|NCT00502593|541747826|FG009|Overall Study|Withdrawn unspecified reason|0|||
150167440|NCT00502593|541747827|FG010|Overall Study|Withdrawn unspecified reason|0|||
150167441|NCT00502593|541747828|FG011|Overall Study|Withdrawn unspecified reason|0|||
150167442|NCT00502593|541747817|FG000|Overall Study|Withdrawal by Subject|0|||
150167443|NCT00502593|541747818|FG001|Overall Study|Withdrawal by Subject|0|||
150167444|NCT00502593|541747819|FG002|Overall Study|Withdrawal by Subject|6|||
150167445|NCT00502593|541747820|FG003|Overall Study|Withdrawal by Subject|2|||
150167446|NCT00502593|541747821|FG004|Overall Study|Withdrawal by Subject|2|||
150167447|NCT00502593|541747822|FG005|Overall Study|Withdrawal by Subject|0|||
150167448|NCT00502593|541747823|FG006|Overall Study|Withdrawal by Subject|3|||
150167449|NCT00502593|541747824|FG007|Overall Study|Withdrawal by Subject|0|||
150167450|NCT00502593|541747825|FG008|Overall Study|Withdrawal by Subject|3|||
150167451|NCT00502593|541747826|FG009|Overall Study|Withdrawal by Subject|0|||
150167452|NCT00502593|541747827|FG010|Overall Study|Withdrawal by Subject|1|||
150167453|NCT00502593|541747828|FG011|Overall Study|Withdrawal by Subject|0|||
150167454|NCT00502593|541747817|FG000|Overall Study|Lost to Follow-up|2|||
150167455|NCT00502593|541747818|FG001|Overall Study|Lost to Follow-up|1|||
150167456|NCT00502593|541747819|FG002|Overall Study|Lost to Follow-up|1|||
150167457|NCT00502593|541747820|FG003|Overall Study|Lost to Follow-up|1|||
150167458|NCT00502593|541747821|FG004|Overall Study|Lost to Follow-up|0|||
150167459|NCT00502593|541747822|FG005|Overall Study|Lost to Follow-up|0|||
150167460|NCT00502593|541747823|FG006|Overall Study|Lost to Follow-up|0|||
150167461|NCT00502593|541747824|FG007|Overall Study|Lost to Follow-up|0|||
150167462|NCT00502593|541747825|FG008|Overall Study|Lost to Follow-up|3|||
150167463|NCT00502593|541747826|FG009|Overall Study|Lost to Follow-up|0|||
150167464|NCT00502593|541747827|FG010|Overall Study|Lost to Follow-up|1|||
150167465|NCT00502593|541747828|FG011|Overall Study|Lost to Follow-up|0|||
150167466|NCT00880906|541747830|FG000|Overall Study|Lost to Follow-up|0|||
150167467|NCT00880906|541747831|FG001|Overall Study|Lost to Follow-up|1|||
150167468|NCT00880906|541747830|FG000|Overall Study|Did not meet criteria following patholog|12|||
150167469|NCT00880906|541747831|FG001|Overall Study|Did not meet criteria following patholog|6|||
150167470|NCT00544440|541747834|FG000|Overall Study|Other|1|||
150167471|NCT00544440|541747834|FG000|Overall Study|Adverse Event|1|||
150167472|NCT00544440|541747834|FG000|Overall Study|Withdrawal by Subject|2|||
150167473|NCT00544440|541747834|FG000|Overall Study|Subject Non-compliance|1|||
150167474|NCT00544440|541747834|FG000|Overall Study|Progressive Disease|47|||
150167475|NCT00544440|541747834|FG000|Overall Study|Other|5|||
150167476|NCT03601507|541747835|FG000|Overall Study|Adverse Event|1|||
150167477|NCT01664104|541747836|FG000|Overall Study|Adverse Event|6|||
150167478|NCT01664104|541747836|FG000|Overall Study|Lack of Efficacy|2|||
150167479|NCT01664104|541747836|FG000|Overall Study|Withdrawal by Subject|1|||
150167480|NCT01664104|541747836|FG000|Overall Study|Lost to Follow-up|4|||
150167481|NCT01664104|541747836|FG000|Overall Study|Other|1|||
150167482|NCT01664104|541747836|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
150167483|NCT01460342|541747839|FG000|Overall Study|Adverse Event|5|||
150167484|NCT01460342|541747840|FG001|Overall Study|Adverse Event|4|||
150167485|NCT01460342|541747839|FG000|Overall Study|Lost to Follow-up|1|||
150167486|NCT01460342|541747840|FG001|Overall Study|Lost to Follow-up|2|||
150167487|NCT01460342|541747839|FG000|Overall Study|Protocol Violation|0|||
150167488|NCT01460342|541747840|FG001|Overall Study|Protocol Violation|1|||
150167489|NCT01460342|541747839|FG000|Overall Study|Withdrawal by Subject|3|||
150167490|NCT01460342|541747840|FG001|Overall Study|Withdrawal by Subject|4|||
150167491|NCT01460342|541747839|FG000|Overall Study|Physician Decision|1|||
150167492|NCT01460342|541747840|FG001|Overall Study|Physician Decision|3|||
150167493|NCT01460342|541747839|FG000|Overall Study|Lack of Efficacy|1|||
150167494|NCT01460342|541747840|FG001|Overall Study|Lack of Efficacy|0|||
150167495|NCT02107014|541747841|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
150167496|NCT00586339|541747842|FG000|Overall Study|Withdrawal by Subject|1|||
150167497|NCT00586339|541747843|FG001|Overall Study|Withdrawal by Subject|3|||
150167498|NCT00586339|541747844|FG002|Overall Study|Withdrawal by Subject|1|||
150167499|NCT00586339|541747842|FG000|Overall Study|Migrated/moved from study area|3|||
150167500|NCT00586339|541747843|FG001|Overall Study|Migrated/moved from study area|2|||
150167501|NCT00586339|541747844|FG002|Overall Study|Migrated/moved from study area|4|||
150167502|NCT00586339|541747842|FG000|Overall Study|Lost to Follow-up|3|||
150167503|NCT00586339|541747843|FG001|Overall Study|Lost to Follow-up|2|||
150167504|NCT00586339|541747844|FG002|Overall Study|Lost to Follow-up|1|||
150167505|NCT03523962|541747845|FG000|Closed Fractures|Death|86|||
150167506|NCT03523962|541747846|FG001|Closed Fractures|Death|71|||
150167507|NCT03523962|541747847|FG002|Closed Fractures|Death|0|||
150167508|NCT03523962|541747848|FG003|Closed Fractures|Death|0|||
150167509|NCT03523962|541747845|FG000|Closed Fractures|Lost to Follow-up|62|||
150167510|NCT03523962|541747846|FG001|Closed Fractures|Lost to Follow-up|36|||
150167511|NCT03523962|541747847|FG002|Closed Fractures|Lost to Follow-up|0|||
150167512|NCT03523962|541747848|FG003|Closed Fractures|Lost to Follow-up|0|||
150167513|NCT03523962|541747845|FG000|Closed Fractures|Withdrawal by Subject|19|||
150167514|NCT03523962|541747846|FG001|Closed Fractures|Withdrawal by Subject|29|||
150167515|NCT03523962|541747847|FG002|Closed Fractures|Withdrawal by Subject|0|||
150167516|NCT03523962|541747848|FG003|Closed Fractures|Withdrawal by Subject|0|||
150167517|NCT03523962|541747845|FG000|Closed Fractures|Incarceration|1|||
150167518|NCT03523962|541747846|FG001|Closed Fractures|Incarceration|4|||
150167519|NCT03523962|541747847|FG002|Closed Fractures|Incarceration|0|||
150167520|NCT03523962|541747848|FG003|Closed Fractures|Incarceration|0|||
150167521|NCT03523962|541747845|FG000|Open Fractures|Death|0|||
150167522|NCT03523962|541747846|FG001|Open Fractures|Death|0|||
150167523|NCT03523962|541747847|FG002|Open Fractures|Death|11|||
150167524|NCT03523962|541747848|FG003|Open Fractures|Death|6|||
150167525|NCT03523962|541747845|FG000|Open Fractures|Lost to Follow-up|0|||
150167526|NCT03523962|541747846|FG001|Open Fractures|Lost to Follow-up|0|||
150167527|NCT03523962|541747847|FG002|Open Fractures|Lost to Follow-up|15|||
150167528|NCT03523962|541747848|FG003|Open Fractures|Lost to Follow-up|8|||
150167529|NCT03523962|541747845|FG000|Open Fractures|Withdrawal by Subject|0|||
150167530|NCT03523962|541747846|FG001|Open Fractures|Withdrawal by Subject|0|||
150167531|NCT03523962|541747847|FG002|Open Fractures|Withdrawal by Subject|6|||
150167532|NCT03523962|541747848|FG003|Open Fractures|Withdrawal by Subject|2|||
150167533|NCT03523962|541747845|FG000|Open Fractures|Incarceration|0|||
150167534|NCT03523962|541747846|FG001|Open Fractures|Incarceration|0|||
150167535|NCT03523962|541747847|FG002|Open Fractures|Incarceration|1|||
150167536|NCT03523962|541747848|FG003|Open Fractures|Incarceration|0|||
150167537|NCT01081145|541747851|FG000|Open-Label Phase|Lack of Efficacy|56|||
150167538|NCT01081145|541747852|FG001|Open-Label Phase|Lack of Efficacy|0|||
150167539|NCT01081145|541747851|FG000|Open-Label Phase|Response criteria not met|46|||
150167540|NCT01081145|541747852|FG001|Open-Label Phase|Response criteria not met|0|||
150167541|NCT01081145|541747851|FG000|Open-Label Phase|Adverse Event|42|||
150167542|NCT01081145|541747852|FG001|Open-Label Phase|Adverse Event|0|||
150167543|NCT01081145|541747851|FG000|Open-Label Phase|Withdrawal by Subject|41|||
150167544|NCT01081145|541747852|FG001|Open-Label Phase|Withdrawal by Subject|0|||
150167545|NCT01081145|541747851|FG000|Open-Label Phase|Other|12|||
150167546|NCT01081145|541747852|FG001|Open-Label Phase|Other|0|||
150167547|NCT01081145|541747851|FG000|Open-Label Phase|Lost to Follow-up|11|||
150167548|NCT01081145|541747852|FG001|Open-Label Phase|Lost to Follow-up|0|||
150167549|NCT01081145|541747851|FG000|Open-Label Phase|Protocol Violation|4|||
150167550|NCT01081145|541747852|FG001|Open-Label Phase|Protocol Violation|0|||
150167551|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
150167552|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
150167553|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
150167554|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
150167555|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
150167556|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
150167557|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
150167558|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
150167559|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
150167560|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
150167561|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
150167562|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
150167563|NCT01081145|541747851|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
150167564|NCT01081145|541747852|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
150167565|NCT01311713|541747854|FG000|Overall Study|Death|0|||
150167566|NCT01311713|541747855|FG001|Overall Study|Death|0|||
150167567|NCT01311713|541747856|FG002|Overall Study|Death|1|||
150167568|NCT01311713|541747857|FG003|Overall Study|Death|1|||
150167569|NCT01311713|541747858|FG004|Overall Study|Death|0|||
150167570|NCT01311713|541747859|FG005|Overall Study|Death|1|||
150167571|NCT01311713|541747860|FG006|Overall Study|Death|0|||
150167572|NCT01311713|541747854|FG000|Overall Study|Adverse Event|0|||
150167573|NCT01311713|541747855|FG001|Overall Study|Adverse Event|1|||
150167574|NCT01311713|541747856|FG002|Overall Study|Adverse Event|0|||
150167575|NCT01311713|541747857|FG003|Overall Study|Adverse Event|2|||
150167576|NCT01311713|541747858|FG004|Overall Study|Adverse Event|0|||
150167577|NCT01311713|541747859|FG005|Overall Study|Adverse Event|0|||
149933701|NCT04877990|540891822|FG001|Treatment|Withdrawal by Subject|6|||
150167578|NCT01311713|541747860|FG006|Overall Study|Adverse Event|2|||
150167579|NCT01311713|541747854|FG000|Overall Study|Withdrawal by Subject|0|||
150167580|NCT01311713|541747855|FG001|Overall Study|Withdrawal by Subject|1|||
150167581|NCT01311713|541747856|FG002|Overall Study|Withdrawal by Subject|1|||
150167582|NCT01311713|541747857|FG003|Overall Study|Withdrawal by Subject|0|||
150167583|NCT01311713|541747858|FG004|Overall Study|Withdrawal by Subject|0|||
150167584|NCT01311713|541747859|FG005|Overall Study|Withdrawal by Subject|1|||
150167585|NCT01311713|541747860|FG006|Overall Study|Withdrawal by Subject|2|||
150167586|NCT01311713|541747854|FG000|Overall Study|Disease progression|3|||
150167587|NCT01311713|541747855|FG001|Overall Study|Disease progression|4|||
150167588|NCT01311713|541747856|FG002|Overall Study|Disease progression|3|||
150167589|NCT01311713|541747857|FG003|Overall Study|Disease progression|2|||
150167590|NCT01311713|541747858|FG004|Overall Study|Disease progression|4|||
150268415|NCT04796896|542120769|FG010|Overall Study|Death|0|||
150268416|NCT04796896|542120770|FG011|Overall Study|Death|0|||
150268417|NCT02021292|542120771|FG000|Overall Study|Physician Decision|0|||
150268418|NCT02021292|542120772|FG001|Overall Study|Physician Decision|1|||
150268419|NCT02021292|542120771|FG000|Overall Study|Lost to Follow-up|0|||
150268420|NCT02021292|542120772|FG001|Overall Study|Lost to Follow-up|1|||
150268421|NCT02021292|542120771|FG000|Overall Study|Death|0|||
150268422|NCT02021292|542120772|FG001|Overall Study|Death|1|||
150268423|NCT04356183|542120773|FG000|Overall Study|Lost to Follow-up|1|||
150268424|NCT04356183|542120774|FG001|Overall Study|Lost to Follow-up|0|||
150268425|NCT04356183|542120773|FG000|Overall Study|Withdrawal by Subject|1|||
150268426|NCT04356183|542120774|FG001|Overall Study|Withdrawal by Subject|1|||
150268427|NCT01177787|542120775|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
150268428|NCT01177787|542120775|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
150268429|NCT01177787|542120775|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
150268430|NCT02824263|542120776|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
150268431|NCT02824263|542120777|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
150268432|NCT02824263|542120776|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
150268433|NCT02824263|542120777|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
150268434|NCT00992511|542120779|FG000|Overall Study|Migrated/moved from study area|1|||
150268435|NCT00992511|542120780|FG001|Overall Study|Migrated/moved from study area|0|||
150268436|NCT00992511|542120781|FG002|Overall Study|Migrated/moved from study area|1|||
150268437|NCT00992511|542120782|FG003|Overall Study|Migrated/moved from study area|2|||
150268438|NCT00992511|542120779|FG000|Overall Study|Lost to Follow-up|1|||
150268439|NCT00992511|542120780|FG001|Overall Study|Lost to Follow-up|0|||
150268440|NCT00992511|542120781|FG002|Overall Study|Lost to Follow-up|0|||
150268441|NCT00992511|542120782|FG003|Overall Study|Lost to Follow-up|2|||
150268442|NCT00992511|542120779|FG000|Overall Study|Withdrawal by Subject|0|||
150268443|NCT00992511|542120780|FG001|Overall Study|Withdrawal by Subject|0|||
150268444|NCT00992511|542120781|FG002|Overall Study|Withdrawal by Subject|1|||
150268445|NCT00992511|542120782|FG003|Overall Study|Withdrawal by Subject|1|||
150268446|NCT01676909|542120783|FG000|Overall Study|Withdrawal by Subject|3|||
150268447|NCT01676909|542120784|FG001|Overall Study|Withdrawal by Subject|5|||
150268448|NCT01676909|542120783|FG000|Overall Study|Lost to Follow-up|15|||
150268449|NCT01676909|542120784|FG001|Overall Study|Lost to Follow-up|9|||
150268450|NCT04615247|542120785|FG000|Overall Study|Adverse Event|0|||
150268451|NCT04615247|542120786|FG001|Overall Study|Adverse Event|2|||
150268452|NCT04615247|542120785|FG000|Overall Study|Withdrawal by Subject|1|||
150268453|NCT04615247|542120786|FG001|Overall Study|Withdrawal by Subject|1|||
150268454|NCT02076113|542120791|FG000|Overall Study|Lost to Follow-up|4|||
150268455|NCT02076113|542120792|FG001|Overall Study|Lost to Follow-up|1|||
150268456|NCT02076113|542120791|FG000|Overall Study|Withdrawal by Subject|2|||
150268457|NCT02076113|542120792|FG001|Overall Study|Withdrawal by Subject|3|||
150268458|NCT02076113|542120791|FG000|Overall Study|Death|1|||
150268459|NCT02076113|542120792|FG001|Overall Study|Death|3|||
150268460|NCT01180998|542120793|FG000|Overall Study|Poor Vision|0|||
150268461|NCT01180998|542120794|FG001|Overall Study|Poor Vision|2|||
150268462|NCT01180998|542120795|FG002|Overall Study|Poor Vision|2|||
150268463|NCT01180998|542120793|FG000|Overall Study|Lost to Follow-up|0|||
150268464|NCT01180998|542120794|FG001|Overall Study|Lost to Follow-up|0|||
150268465|NCT01180998|542120795|FG002|Overall Study|Lost to Follow-up|1|||
150268466|NCT01180998|542120793|FG000|Overall Study|Protocol Violation|1|||
150268467|NCT01180998|542120794|FG001|Overall Study|Protocol Violation|2|||
150268468|NCT01180998|542120795|FG002|Overall Study|Protocol Violation|0|||
150268469|NCT01180998|542120793|FG000|Overall Study|Withdrawal by Subject|0|||
150268470|NCT01180998|542120794|FG001|Overall Study|Withdrawal by Subject|0|||
150268471|NCT01180998|542120795|FG002|Overall Study|Withdrawal by Subject|1|||
150268472|NCT01180998|542120793|FG000|Overall Study|Poor comfort|3|||
150268473|NCT01180998|542120794|FG001|Overall Study|Poor comfort|0|||
150268474|NCT01180998|542120795|FG002|Overall Study|Poor comfort|4|||
149820206|NCT03175120|540471750|FG001|Overall Study|Withdrawal by Subject|5|||
150268475|NCT01180998|542120793|FG000|Overall Study|Poor lens handling|0|||
150268476|NCT01180998|542120794|FG001|Overall Study|Poor lens handling|0|||
150268477|NCT01180998|542120795|FG002|Overall Study|Poor lens handling|2|||
150268478|NCT05057247|542120816|FG000|Overall Study|Death|4|||
150268479|NCT05057247|542120816|FG000|Overall Study|Physician Decision|3|||
150268480|NCT05057247|542120816|FG000|Overall Study|Progressive Disease|7|||
150268481|NCT05057247|542120816|FG000|Overall Study|Withdrawal by Subject|3|||
150268482|NCT05057247|542120816|FG000|Overall Study|Adverse Event|6|||
150268483|NCT05057247|542120816|FG000|Overall Study|Subject Non-Compliance|1|||
150268484|NCT05057247|542120816|FG000|Overall Study|On treatment|2|||
150268485|NCT01067326|542120817|FG000|Overall Study|Adverse Event|0|||
150268486|NCT01067326|542120818|FG001|Overall Study|Adverse Event|2|||
150268487|NCT01067326|542120817|FG000|Overall Study|Withdrawal by Subject|1|||
150268488|NCT01067326|542120818|FG001|Overall Study|Withdrawal by Subject|0|||
150268489|NCT01067326|542120817|FG000|Overall Study|Early Study Termination|1|||
150268490|NCT01067326|542120818|FG001|Overall Study|Early Study Termination|1|||
150268491|NCT02430051|542120820|FG000|Overall Study|Withdrawal by Subject|6|||
150268492|NCT02430051|542120821|FG001|Overall Study|Withdrawal by Subject|3|||
150268493|NCT02430051|542120820|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
150268494|NCT02430051|542120821|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
150268495|NCT02430051|542120820|FG000|Overall Study|Protocol Violation|1|||
150268496|NCT02430051|542120821|FG001|Overall Study|Protocol Violation|0|||
150268497|NCT02030405|542120827|FG000|Overall Study|Withdrawal by Subject|1|||
150268498|NCT02030405|542120827|FG000|Overall Study|Lost to Follow-up|1|||
150268499|NCT04526197|542120828|FG000|Period 1|Adverse Event|0|||
150268500|NCT04526197|542120829|FG001|Period 1|Adverse Event|1|||
150268501|NCT04526197|542120828|FG000|Period 1|Withdrawal by Subject|1|||
150268502|NCT04526197|542120829|FG001|Period 1|Withdrawal by Subject|0|||
150268503|NCT04526197|542120828|FG000|Period 2|Adverse Event|0|||
150268504|NCT04526197|542120829|FG001|Period 2|Adverse Event|1|||
150268505|NCT04526197|542120828|FG000|Period 2|Withdrawal by Subject|0|||
150268506|NCT04526197|542120829|FG001|Period 2|Withdrawal by Subject|1|||
150268507|NCT00381303|542120830|FG000|Overall Study|Lost to Follow-up|25|||
150268508|NCT00381303|542120831|FG001|Overall Study|Lost to Follow-up|9|||
150268509|NCT00381303|542120830|FG000|Overall Study|AE/HIV-related event|22|||
150268510|NCT00381303|542120831|FG001|Overall Study|AE/HIV-related event|6|||
150268511|NCT00381303|542120830|FG000|Overall Study|Non-Adherence|13|||
150268512|NCT00381303|542120831|FG001|Overall Study|Non-Adherence|6|||
150268513|NCT00381303|542120830|FG000|Overall Study|Withdrawal by Subject|13|||
150268514|NCT00381303|542120831|FG001|Overall Study|Withdrawal by Subject|6|||
150268515|NCT00381303|542120830|FG000|Overall Study|Virologic failure|6|||
150268516|NCT00381303|542120831|FG001|Overall Study|Virologic failure|4|||
150268517|NCT00381303|542120830|FG000|Overall Study|Ineligible to continue the trial|2|||
150268518|NCT00381303|542120831|FG001|Overall Study|Ineligible to continue the trial|1|||
150268519|NCT00381303|542120830|FG000|Overall Study|Pregnancy|2|||
150268520|NCT00381303|542120831|FG001|Overall Study|Pregnancy|0|||
150268521|NCT00381303|542120830|FG000|Overall Study|Physician Decision|1|||
150268522|NCT00381303|542120831|FG001|Overall Study|Physician Decision|0|||
150268523|NCT00381303|542120830|FG000|Overall Study|Physician's decision to close the site|3|||
150268524|NCT00381303|542120831|FG001|Overall Study|Physician's decision to close the site|1|||
150268525|NCT00381303|542120830|FG000|Overall Study|Subject moved out of state|2|||
150268526|NCT00381303|542120831|FG001|Overall Study|Subject moved out of state|0|||
150268527|NCT00381303|542120830|FG000|Overall Study|Subject taking too many different meds|1|||
150268528|NCT00381303|542120831|FG001|Overall Study|Subject taking too many different meds|0|||
150268529|NCT00381303|542120830|FG000|Overall Study|No virologic response by week 12|1|||
150268530|NCT00381303|542120831|FG001|Overall Study|No virologic response by week 12|0|||
150268531|NCT00381303|542120830|FG000|Overall Study|Subject was too busy for appointments|1|||
150268532|NCT00381303|542120831|FG001|Overall Study|Subject was too busy for appointments|0|||
150268533|NCT00381303|542120830|FG000|Overall Study|Subject did not continue visits|1|||
150268534|NCT00381303|542120831|FG001|Overall Study|Subject did not continue visits|0|||
150268535|NCT00381303|542120830|FG000|Overall Study|Subject primary physician's decision|1|||
150268536|NCT00381303|542120831|FG001|Overall Study|Subject primary physician's decision|0|||
150268537|NCT01136811|542120834|FG000|Overall Study|Physician Decision|11|||
150268538|NCT01211522|542120835|FG000|Overall Study|Withdrawal by Subject|3|||
150268539|NCT01211522|542120836|FG001|Overall Study|Withdrawal by Subject|7|||
150268540|NCT01211522|542120837|FG002|Overall Study|Withdrawal by Subject|5|||
150268541|NCT00372385|542120844|FG000|Overall Study|Adverse Event|6|||
150268542|NCT00372385|542120845|FG001|Overall Study|Adverse Event|11|||
150268543|NCT00372385|542120846|FG002|Overall Study|Adverse Event|9|||
150268544|NCT00372385|542120847|FG003|Overall Study|Adverse Event|7|||
150268545|NCT00372385|542120844|FG000|Overall Study|Noncompliance|0|||
150268546|NCT00372385|542120845|FG001|Overall Study|Noncompliance|1|||
150268547|NCT00372385|542120846|FG002|Overall Study|Noncompliance|1|||
150268548|NCT00372385|542120847|FG003|Overall Study|Noncompliance|1|||
150268549|NCT00372385|542120844|FG000|Overall Study|Physician Decision|1|||
150268550|NCT00372385|542120845|FG001|Overall Study|Physician Decision|0|||
150268551|NCT00372385|542120846|FG002|Overall Study|Physician Decision|0|||
150268552|NCT00372385|542120847|FG003|Overall Study|Physician Decision|0|||
150268553|NCT00372385|542120844|FG000|Overall Study|Lost to Follow-up|2|||
150268554|NCT00372385|542120845|FG001|Overall Study|Lost to Follow-up|0|||
150268555|NCT00372385|542120846|FG002|Overall Study|Lost to Follow-up|0|||
150268556|NCT00372385|542120847|FG003|Overall Study|Lost to Follow-up|0|||
150268557|NCT00372385|542120844|FG000|Overall Study|Withdrawal by Subject|2|||
150268558|NCT00372385|542120845|FG001|Overall Study|Withdrawal by Subject|1|||
150268559|NCT00372385|542120846|FG002|Overall Study|Withdrawal by Subject|0|||
150268560|NCT00372385|542120847|FG003|Overall Study|Withdrawal by Subject|0|||
150268561|NCT00372385|542120844|FG000|Overall Study|Refusal of Treatment|3|||
150268562|NCT00372385|542120845|FG001|Overall Study|Refusal of Treatment|6|||
150268563|NCT00372385|542120846|FG002|Overall Study|Refusal of Treatment|0|||
150268564|NCT00372385|542120847|FG003|Overall Study|Refusal of Treatment|0|||
150268565|NCT00372385|542120844|FG000|Overall Study|No Response|1|||
150268566|NCT00372385|542120845|FG001|Overall Study|No Response|1|||
150268567|NCT00372385|542120846|FG002|Overall Study|No Response|0|||
150268568|NCT00372385|542120847|FG003|Overall Study|No Response|0|||
150268569|NCT00372385|542120844|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
150268570|NCT00372385|542120845|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
150268571|NCT00372385|542120846|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
150268572|NCT00372385|542120847|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
150268573|NCT00372385|542120844|FG000|Overall Study|Virologic Stopping Rule|17|||
150268574|NCT00372385|542120845|FG001|Overall Study|Virologic Stopping Rule|0|||
150268575|NCT00372385|542120846|FG002|Overall Study|Virologic Stopping Rule|0|||
150268576|NCT00372385|542120847|FG003|Overall Study|Virologic Stopping Rule|0|||
150268577|NCT01966471|542120848|FG000|Overall Study|Death|44|||
150268578|NCT01966471|542120849|FG001|Overall Study|Death|56|||
150268579|NCT01966471|542120848|FG000|Overall Study|Lost to Follow-up|46|||
150268580|NCT01966471|542120849|FG001|Overall Study|Lost to Follow-up|39|||
150268581|NCT01966471|542120848|FG000|Overall Study|Various reasons|4|||
150268582|NCT01966471|542120849|FG001|Overall Study|Various reasons|4|||
150268583|NCT01966471|542120848|FG000|Overall Study|Physician Decision|7|||
150268584|NCT01966471|542120849|FG001|Overall Study|Physician Decision|5|||
150268585|NCT01966471|542120848|FG000|Overall Study|Study Terminated By Sponsor|758|||
150268586|NCT01966471|542120849|FG001|Overall Study|Study Terminated By Sponsor|773|||
150268587|NCT01966471|542120848|FG000|Overall Study|Withdrawal by Subject|59|||
150268588|NCT01966471|542120849|FG001|Overall Study|Withdrawal by Subject|51|||
150268589|NCT02279862|542120850|FG000|Overall Study|Study drug toxicity|3|||
150268590|NCT02279862|542120851|FG001|Overall Study|Study drug toxicity|6|||
150268591|NCT02279862|542120850|FG000|Overall Study|No longer meets criteria|0|||
150268592|NCT02279862|542120851|FG001|Overall Study|No longer meets criteria|1|||
150268593|NCT02279862|542120850|FG000|Overall Study|Administrative reason by sponsor|0|||
150167591|NCT01311713|541747859|FG005|Overall Study|Disease progression|4|||
150167592|NCT01311713|541747860|FG006|Overall Study|Disease progression|5|||
150167593|NCT01311713|541747854|FG000|Overall Study|Lost to Follow-up|0|||
150167594|NCT01311713|541747855|FG001|Overall Study|Lost to Follow-up|0|||
150167595|NCT01311713|541747856|FG002|Overall Study|Lost to Follow-up|1|||
150167596|NCT01311713|541747857|FG003|Overall Study|Lost to Follow-up|0|||
150167597|NCT01311713|541747858|FG004|Overall Study|Lost to Follow-up|0|||
150167598|NCT01311713|541747859|FG005|Overall Study|Lost to Follow-up|0|||
150167599|NCT01311713|541747860|FG006|Overall Study|Lost to Follow-up|0|||
150167600|NCT01311713|541747854|FG000|Overall Study|Stopped taking study medication|0|||
150167601|NCT01311713|541747855|FG001|Overall Study|Stopped taking study medication|0|||
150167602|NCT01311713|541747856|FG002|Overall Study|Stopped taking study medication|0|||
150167603|NCT01311713|541747857|FG003|Overall Study|Stopped taking study medication|1|||
150167604|NCT01311713|541747858|FG004|Overall Study|Stopped taking study medication|1|||
150167605|NCT01311713|541747859|FG005|Overall Study|Stopped taking study medication|0|||
150167606|NCT01311713|541747860|FG006|Overall Study|Stopped taking study medication|0|||
150167607|NCT01311713|541747854|FG000|Overall Study|Enrolled but not treated|0|||
150167608|NCT01311713|541747855|FG001|Overall Study|Enrolled but not treated|0|||
150167609|NCT01311713|541747856|FG002|Overall Study|Enrolled but not treated|1|||
150167610|NCT01311713|541747857|FG003|Overall Study|Enrolled but not treated|0|||
150167611|NCT01311713|541747858|FG004|Overall Study|Enrolled but not treated|0|||
150167612|NCT01311713|541747859|FG005|Overall Study|Enrolled but not treated|0|||
150167613|NCT01311713|541747860|FG006|Overall Study|Enrolled but not treated|0|||
150167614|NCT01311713|541747854|FG000|Overall Study|Other than specified|0|||
150167615|NCT01311713|541747855|FG001|Overall Study|Other than specified|1|||
150167616|NCT01311713|541747856|FG002|Overall Study|Other than specified|2|||
150167617|NCT01311713|541747857|FG003|Overall Study|Other than specified|0|||
150167618|NCT01311713|541747858|FG004|Overall Study|Other than specified|0|||
150167619|NCT01311713|541747859|FG005|Overall Study|Other than specified|0|||
150167620|NCT01311713|541747860|FG006|Overall Study|Other than specified|0|||
150167621|NCT01331824|541749521|FG000|Overall Study|Adverse Event|2|||
150167622|NCT01331824|541749521|FG000|Overall Study|Death|1|||
150167623|NCT01331824|541749521|FG000|Overall Study|Disease Progression|9|||
150167624|NCT01331824|541749521|FG000|Overall Study|Withdrawal by Subject|1|||
150167625|NCT01091454|541749524|FG000|Overall Study|Ineligible|1|||
150167626|NCT02030028|541749525|FG000|Overall Study|Withdrawal by Subject|4|||
150167627|NCT02030028|541749525|FG000|Overall Study|lack of transportation|1|||
150167628|NCT05298111|541749534|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
150268594|NCT02279862|542120851|FG001|Overall Study|Administrative reason by sponsor|1|||
150268595|NCT02279862|542120850|FG000|Overall Study|Disease progression|5|||
150268596|NCT02279862|542120851|FG001|Overall Study|Disease progression|2|||
150268597|NCT02279862|542120850|FG000|Overall Study|Study closed by sponsor|16|||
150268598|NCT02279862|542120851|FG001|Overall Study|Study closed by sponsor|13|||
150167629|NCT05298111|541749535|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
150167630|NCT02380742|541749536|FG000|Overall Study|Withdrawal by Subject|1|||
150167631|NCT02380742|541749537|FG001|Overall Study|Withdrawal by Subject|0|||
150167632|NCT03518112|541749538|FG000|Overall Study|Withdrawal by Subject|1|||
150167633|NCT02814643|541749543|FG000|Overall Study|Lost to Follow-up|0|||
150167634|NCT02814643|541749544|FG001|Overall Study|Lost to Follow-up|1|||
150167635|NCT02814643|541749543|FG000|Overall Study|Withdrawal by Subject|1|||
150167636|NCT02814643|541749544|FG001|Overall Study|Withdrawal by Subject|2|||
150268599|NCT02279862|542120850|FG000|Overall Study|Other|1|||
150268600|NCT02279862|542120851|FG001|Overall Study|Other|2|||
150268601|NCT02279862|542120850|FG000|Overall Study|Withdrawal by Subject|1|||
150268602|NCT02279862|542120851|FG001|Overall Study|Withdrawal by Subject|0|||
150268603|NCT03431857|542120852|FG000|Overall Study|Death|6|||
150268604|NCT03431857|542120852|FG000|Overall Study|Lost to Follow-up|41|||
150268605|NCT03431857|542120852|FG000|Overall Study|Adverse Event|6|||
150268606|NCT03431857|542120852|FG000|Overall Study|Withdrawal by Subject|1|||
150268607|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
150268608|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
150268609|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
150268610|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
150268611|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
150268612|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
150268613|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
150268614|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
150167637|NCT02263508|541749545|FG000|Overall Study|Withdrawal by Subject|1|||
150167638|NCT02263508|541749546|FG001|Overall Study|Withdrawal by Subject|23|||
150167639|NCT02263508|541749547|FG002|Overall Study|Withdrawal by Subject|17|||
150167640|NCT02263508|541749545|FG000|Overall Study|Sponsor Decision|12|||
150167641|NCT02263508|541749546|FG001|Overall Study|Sponsor Decision|165|||
150167642|NCT02263508|541749547|FG002|Overall Study|Sponsor Decision|182|||
150167643|NCT02263508|541749545|FG000|Overall Study|Lost to Follow-up|2|||
150167644|NCT02263508|541749546|FG001|Overall Study|Lost to Follow-up|7|||
150167645|NCT02263508|541749547|FG002|Overall Study|Lost to Follow-up|7|||
150167646|NCT02263508|541749545|FG000|Overall Study|Death|6|||
150167647|NCT02263508|541749546|FG001|Overall Study|Death|151|||
150167648|NCT02263508|541749547|FG002|Overall Study|Death|140|||
150167649|NCT01280591|541749548|FG000|Overall Study|Withdrawal by Subject|0|||
150167650|NCT01280591|541749549|FG001|Overall Study|Withdrawal by Subject|0|||
150167651|NCT01280591|541749550|FG002|Overall Study|Withdrawal by Subject|0|||
150167652|NCT01280591|541749551|FG003|Overall Study|Withdrawal by Subject|2|||
150167653|NCT01280591|541749548|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
150167654|NCT01280591|541749549|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
150167655|NCT01280591|541749550|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
150167656|NCT01280591|541749551|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
150167657|NCT03357341|541749552|FG000|Overall Study|Withdrawal by Subject|3|||
150268615|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
150268616|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
150268617|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
150268618|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
150268619|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
150268620|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
150268621|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
150268622|NCT01323621|542120853|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
150268623|NCT01323621|542120854|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
150268624|NCT01323621|542120855|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
150268625|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
150268626|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
150268627|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
150268628|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
150268629|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
150268630|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
150268631|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
150268632|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
150268633|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
150268634|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150268635|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
150268636|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150268637|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
150268638|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
150268639|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
150268640|NCT01323621|542120853|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
150268641|NCT01323621|542120854|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
150167658|NCT03357341|541749553|FG001|Overall Study|Withdrawal by Subject|6|||
150167659|NCT03357341|541749552|FG000|Overall Study|Lost to Follow-up|4|||
150268642|NCT01323621|542120855|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
150268643|NCT00651157|542120856|FG000|Overall Study|Death|1|||
150268644|NCT00651157|542120856|FG000|Overall Study|Protocol Violation|1|||
150167660|NCT03357341|541749553|FG001|Overall Study|Lost to Follow-up|5|||
150167661|NCT03357341|541749552|FG000|Overall Study|Death|0|||
150167662|NCT03357341|541749553|FG001|Overall Study|Death|1|||
150268645|NCT01119001|542120858|FG000|Overall Study|Withdrawal by Subject|2|||
150268646|NCT04343248|542120859|FG000|Overall Study|Withdrawal by Subject|5|||
150268647|NCT04343248|542120860|FG001|Overall Study|Withdrawal by Subject|6|||
150268648|NCT04343248|542120859|FG000|Overall Study|Death|1|||
150268649|NCT04343248|542120860|FG001|Overall Study|Death|2|||
150268650|NCT04343248|542120859|FG000|Overall Study|Lost to Follow-up|9|||
150268651|NCT04343248|542120860|FG001|Overall Study|Lost to Follow-up|6|||
150268652|NCT04343248|542120859|FG000|Overall Study|Physician Decision|0|||
150268653|NCT04343248|542120860|FG001|Overall Study|Physician Decision|1|||
150268654|NCT04343248|542120859|FG000|Overall Study|Adverse Event|1|||
150268655|NCT04343248|542120860|FG001|Overall Study|Adverse Event|0|||
150268656|NCT03604523|542120863|FG000|Overall Study|Physician Decision|1|||
150268657|NCT03604523|542120864|FG001|Overall Study|Physician Decision|0|||
150268658|NCT00458341|542120865|FG000|Cycle 1|Adverse Event|1|||
150268659|NCT00458341|542120866|FG001|Cycle 1|Adverse Event|0|||
150268660|NCT05461794|542120867|FG000|Overall Study|Withdrawal by Subject|1|||
150268661|NCT05461794|542120868|FG001|Overall Study|Withdrawal by Subject|1|||
150268662|NCT05461794|542120869|FG002|Overall Study|Withdrawal by Subject|3|||
150268663|NCT05461794|542120867|FG000|Overall Study|Study Terminated By Sponsor|18|||
150268664|NCT05461794|542120868|FG001|Overall Study|Study Terminated By Sponsor|13|||
150268665|NCT05461794|542120869|FG002|Overall Study|Study Terminated By Sponsor|16|||
150268666|NCT05461794|542120867|FG000|Overall Study|Death|20|||
150268667|NCT05461794|542120868|FG001|Overall Study|Death|5|||
150268668|NCT05461794|542120869|FG002|Overall Study|Death|19|||
150268669|NCT00810394|542120874|FG000|Overall Study|Withdrawal by Subject|3|||
150268670|NCT00467285|542120875|FG000|Overall Study|Lost to Follow-up|4|||
150268671|NCT00467285|542120876|FG001|Overall Study|Lost to Follow-up|4|||
150268672|NCT03891524|542120877|FG000|Overall Study|Death|0|||
150268673|NCT03891524|542120878|FG001|Overall Study|Death|0|||
150167663|NCT00930813|541749554|FG000|Overall Study|Death|4|||
150167664|NCT00930813|541749555|FG001|Overall Study|Death|5|||
150167665|NCT00930813|541749554|FG000|Overall Study|Withdrawal by Subject|2|||
150167666|NCT00930813|541749555|FG001|Overall Study|Withdrawal by Subject|5|||
150167667|NCT00930813|541749554|FG000|Overall Study|Lost to Follow-up|2|||
150167668|NCT00930813|541749555|FG001|Overall Study|Lost to Follow-up|4|||
150167669|NCT05790408|541749556|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
150167670|NCT01048788|541749557|FG000|Overall Study|Adverse Event|5|||
150167671|NCT01048788|541749558|FG001|Overall Study|Adverse Event|1|||
150167672|NCT01048788|541749559|FG002|Overall Study|Adverse Event|1|||
150167673|NCT01048788|541749557|FG000|Overall Study|Lack of Efficacy|0|||
150167674|NCT01048788|541749558|FG001|Overall Study|Lack of Efficacy|0|||
150167675|NCT01048788|541749559|FG002|Overall Study|Lack of Efficacy|1|||
150167676|NCT01048788|541749557|FG000|Overall Study|Withdrawal by Subject|0|||
150167677|NCT01048788|541749558|FG001|Overall Study|Withdrawal by Subject|1|||
150167678|NCT01048788|541749559|FG002|Overall Study|Withdrawal by Subject|0|||
150167679|NCT01131494|541749560|FG000|Overall Study|Withdrawal by Subject|2|||
150167680|NCT02145182|541749561|FG000|Overall Study|Adverse Event|4|||
150167681|NCT02145182|541749562|FG001|Overall Study|Adverse Event|1|||
150167682|NCT02145182|541749561|FG000|Overall Study|Death|7|||
150167683|NCT02145182|541749562|FG001|Overall Study|Death|7|||
150167684|NCT02145182|541749561|FG000|Overall Study|Lost to Follow-up|2|||
150167685|NCT02145182|541749562|FG001|Overall Study|Lost to Follow-up|2|||
150167686|NCT02145182|541749561|FG000|Overall Study|Pre-transplant Withdrawal|0|||
150167687|NCT02145182|541749562|FG001|Overall Study|Pre-transplant Withdrawal|2|||
150167688|NCT02145182|541749561|FG000|Overall Study|Withdrawal by Subject|5|||
150167689|NCT02145182|541749562|FG001|Overall Study|Withdrawal by Subject|4|||
150167690|NCT00588666|541749563|FG000|Overall Study|Adverse Event|4|||
150167691|NCT01233050|541749564|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
150167692|NCT01233050|541749565|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
150167693|NCT03999554|541749566|FG000|Overall Study|Lost to Follow-up|4|||
150167694|NCT03999554|541749567|FG001|Overall Study|Lost to Follow-up|5|||
150167695|NCT03999554|541749568|FG002|Overall Study|Lost to Follow-up|4|||
150167696|NCT03999554|541749569|FG003|Overall Study|Lost to Follow-up|5|||
150167697|NCT03999554|541749570|FG004|Overall Study|Lost to Follow-up|8|||
150167698|NCT03999554|541749566|FG000|Overall Study|Protocol Violation|0|||
150167699|NCT03999554|541749567|FG001|Overall Study|Protocol Violation|0|||
150167700|NCT03999554|541749568|FG002|Overall Study|Protocol Violation|5|||
150167701|NCT03999554|541749569|FG003|Overall Study|Protocol Violation|0|||
150167702|NCT03999554|541749570|FG004|Overall Study|Protocol Violation|0|||
150268674|NCT03891524|542120879|FG002|Overall Study|Death|0|||
150268675|NCT03891524|542120880|FG003|Overall Study|Death|0|||
150268676|NCT03891524|542120881|FG004|Overall Study|Death|0|||
150268677|NCT03891524|542120882|FG005|Overall Study|Death|0|||
150268678|NCT03891524|542120883|FG006|Overall Study|Death|0|||
150167703|NCT03999554|541749566|FG000|Overall Study|Pregnancy|0|||
150167704|NCT03999554|541749567|FG001|Overall Study|Pregnancy|0|||
150167705|NCT03999554|541749568|FG002|Overall Study|Pregnancy|1|||
150268679|NCT03891524|542120884|FG007|Overall Study|Death|1|||
150268680|NCT03891524|542120877|FG000|Overall Study|Withdrawal by Subject|0|||
150268681|NCT03891524|542120878|FG001|Overall Study|Withdrawal by Subject|1|||
150268682|NCT03891524|542120879|FG002|Overall Study|Withdrawal by Subject|2|||
150268683|NCT03891524|542120880|FG003|Overall Study|Withdrawal by Subject|1|||
150268684|NCT03891524|542120881|FG004|Overall Study|Withdrawal by Subject|2|||
150268685|NCT03891524|542120882|FG005|Overall Study|Withdrawal by Subject|2|||
150268686|NCT03891524|542120883|FG006|Overall Study|Withdrawal by Subject|2|||
150268687|NCT03891524|542120884|FG007|Overall Study|Withdrawal by Subject|1|||
150268688|NCT00475033|542120887|FG000|Infant Series|Failed to return|3|||
150268689|NCT00475033|542120888|FG001|Infant Series|Failed to return|4|||
150268690|NCT00475033|542120887|FG000|Infant Series|Parent or legal guardian request|1|||
150268691|NCT00475033|542120888|FG001|Infant Series|Parent or legal guardian request|5|||
150268692|NCT00475033|542120887|FG000|Infant Series|Protocol Violation|1|||
150268693|NCT00475033|542120888|FG001|Infant Series|Protocol Violation|2|||
150268694|NCT00475033|542120887|FG000|Infant Series|Lost to Follow-up|2|||
150268695|NCT00475033|542120888|FG001|Infant Series|Lost to Follow-up|0|||
150268696|NCT00475033|542120887|FG000|Infant Series|Adverse Event|0|||
150268697|NCT00475033|542120888|FG001|Infant Series|Adverse Event|2|||
150268698|NCT00475033|542120887|FG000|After the Infant Series|Adverse Event|0|||
150268699|NCT00475033|542120888|FG001|After the Infant Series|Adverse Event|4|||
150268700|NCT00475033|542120887|FG000|After the Infant Series|Parent or legal guardian request|2|||
150268701|NCT00475033|542120888|FG001|After the Infant Series|Parent or legal guardian request|2|||
150268702|NCT00475033|542120887|FG000|After the Infant Series|Failed to return|2|||
150268703|NCT00475033|542120888|FG001|After the Infant Series|Failed to return|1|||
150268704|NCT00475033|542120887|FG000|After the Infant Series|Protocol Violation|1|||
150268705|NCT00475033|542120888|FG001|After the Infant Series|Protocol Violation|0|||
150268706|NCT00475033|542120887|FG000|After the Infant Series|Lost to Follow-up|1|||
150268707|NCT00475033|542120888|FG001|After the Infant Series|Lost to Follow-up|0|||
150268708|NCT00475033|542120887|FG000|After the Infant Series|Other|0|||
150268709|NCT00475033|542120888|FG001|After the Infant Series|Other|1|||
150268710|NCT00475033|542120887|FG000|Toddler Dose|Parent or legal guardian request|2|||
150268711|NCT00475033|542120888|FG001|Toddler Dose|Parent or legal guardian request|0|||
150268712|NCT00475033|542120887|FG000|Toddler Dose|Failed to return|1|||
150268713|NCT00475033|542120888|FG001|Toddler Dose|Failed to return|0|||
150268714|NCT00475033|542120887|FG000|Toddler Dose|Lost to Follow-up|1|||
150268715|NCT00475033|542120888|FG001|Toddler Dose|Lost to Follow-up|0|||
150268716|NCT04484831|542120889|FG000|Overall Study|Withdrawal by Subject|1|||
150268717|NCT04484831|542120890|FG001|Overall Study|Withdrawal by Subject|0|||
150268718|NCT02818920|542120892|FG000|Overall Study|Unresectable|4|||
149933702|NCT04877990|540891821|FG000|Treatment|Adverse Event|2|||
149933703|NCT04877990|540891822|FG001|Treatment|Adverse Event|1|||
149933704|NCT02895295|540891823|FG000|Overall Study|Survey Non-response|71|||
149933705|NCT02895295|540891824|FG001|Overall Study|Survey Non-response|94|||
149933706|NCT02895295|540891825|FG002|Overall Study|Survey Non-response|92|||
149933707|NCT01949142|540891830|FG000|Overall Study|Withdrawal of consent|1|||
149933708|NCT01949142|540891831|FG001|Overall Study|Withdrawal of consent|0|||
150167706|NCT03999554|541749569|FG003|Overall Study|Pregnancy|0|||
150167707|NCT03999554|541749570|FG004|Overall Study|Pregnancy|0|||
150167708|NCT03999554|541749566|FG000|Overall Study|Withdrawal by Subject|2|||
150167709|NCT03999554|541749567|FG001|Overall Study|Withdrawal by Subject|2|||
150167710|NCT03999554|541749568|FG002|Overall Study|Withdrawal by Subject|2|||
150167711|NCT03999554|541749569|FG003|Overall Study|Withdrawal by Subject|1|||
150167712|NCT03999554|541749570|FG004|Overall Study|Withdrawal by Subject|1|||
150167713|NCT03999554|541749566|FG000|Overall Study|failure to comply with protocol requirements|0|||
150167714|NCT03999554|541749567|FG001|Overall Study|failure to comply with protocol requirements|0|||
150167715|NCT03999554|541749568|FG002|Overall Study|failure to comply with protocol requirements|0|||
150167716|NCT03999554|541749569|FG003|Overall Study|failure to comply with protocol requirements|1|||
150167717|NCT03999554|541749570|FG004|Overall Study|failure to comply with protocol requirements|0|||
150167718|NCT00703911|541749571|FG000|Overall Study|Death|1|||
150167719|NCT00703911|541749571|FG000|Overall Study|Physician Decision|6|||
150167720|NCT00703911|541749571|FG000|Overall Study|Lost to Follow-up|1|||
150167721|NCT00703911|541749571|FG000|Overall Study|Withdrawal by Subject|2|||
150167722|NCT02082158|541749572|FG000|Overall Study|Withdrawal by Subject|0|||
150167723|NCT02082158|541749573|FG001|Overall Study|Withdrawal by Subject|0|||
150167724|NCT02082158|541749574|FG002|Overall Study|Withdrawal by Subject|0|||
150167725|NCT02082158|541749575|FG003|Overall Study|Withdrawal by Subject|0|||
150167726|NCT02082158|541749576|FG004|Overall Study|Withdrawal by Subject|1|||
150167727|NCT02082158|541749577|FG005|Overall Study|Withdrawal by Subject|0|||
150167728|NCT02082158|541749572|FG000|Overall Study|Failed Fit-testing|8|||
150268719|NCT02818920|542120892|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
150268720|NCT02818920|542120892|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
150268721|NCT02818920|542120892|FG000|Overall Study|Adverse Event|3|||
150268722|NCT02818920|542120892|FG000|Overall Study|Developed Other Disease|1|||
150268723|NCT02818920|542120892|FG000|Overall Study|Refused Further Treatment|1|||
150268724|NCT01335009|542120893|FG000|Overall Study|Too ill to travel to study sites|1|||
150268725|NCT01335009|542120894|FG001|Overall Study|Too ill to travel to study sites|0|||
150268726|NCT01335009|542120893|FG000|Overall Study|Death|28|||
150268727|NCT01335009|542120894|FG001|Overall Study|Death|32|||
150268728|NCT01335009|542120893|FG000|Overall Study|Withdrawal by Subject|1|||
150268729|NCT01335009|542120894|FG001|Overall Study|Withdrawal by Subject|1|||
150268730|NCT01335009|542120893|FG000|Overall Study|Lost to Follow-up|1|||
150268731|NCT01335009|542120894|FG001|Overall Study|Lost to Follow-up|0|||
150268732|NCT00445068|542120895|FG000|Overall Study|Disease progression|26|||
150268733|NCT00445068|542120895|FG000|Overall Study|Adverse Event|5|||
150268734|NCT00445068|542120895|FG000|Overall Study|Abnormal laboratory value|2|||
150268735|NCT00445068|542120895|FG000|Overall Study|Withdrawal by Subject|2|||
150268736|NCT00445068|542120895|FG000|Overall Study|Death|1|||
150268737|NCT04824521|542120896|FG000|Overall Study|Lost to Follow-up|1|||
150268738|NCT01598311|542120897|FG000|Overall Study|Physician Decision|4|||
150268739|NCT01598311|542120898|FG001|Overall Study|Physician Decision|5|||
150268740|NCT01598311|542120897|FG000|Overall Study|Adverse Event|9|||
150268741|NCT01598311|542120898|FG001|Overall Study|Adverse Event|13|||
150268742|NCT01598311|542120897|FG000|Overall Study|Lost to Follow-up|7|||
150268743|NCT01598311|542120898|FG001|Overall Study|Lost to Follow-up|12|||
150268744|NCT01598311|542120897|FG000|Overall Study|Withdrawal by Subject|9|||
150268745|NCT01598311|542120898|FG001|Overall Study|Withdrawal by Subject|13|||
150268746|NCT01598311|542120897|FG000|Overall Study|No reason provided.|0|||
150268747|NCT01598311|542120898|FG001|Overall Study|No reason provided.|5|||
150268748|NCT01598311|542120897|FG000|Overall Study|Randomized but never treated|8|||
150268749|NCT01598311|542120898|FG001|Overall Study|Randomized but never treated|5|||
150268750|NCT01598311|542120897|FG000|Overall Study|Treated but no confirmed CDAD|9|||
150268751|NCT01598311|542120898|FG001|Overall Study|Treated but no confirmed CDAD|8|||
150268752|NCT01598311|542120897|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
150268753|NCT01598311|542120898|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
150268754|NCT00658684|542120899|FG000|Overall Study|Adverse Event|10|||
150268755|NCT00658684|542120900|FG001|Overall Study|Adverse Event|8|||
150268756|NCT00658684|542120901|FG002|Overall Study|Adverse Event|2|||
150268757|NCT00658684|542120902|FG003|Overall Study|Adverse Event|0|||
150268758|NCT00658684|542120899|FG000|Overall Study|Withdrawal by Subject|6|||
150268759|NCT00658684|542120900|FG001|Overall Study|Withdrawal by Subject|4|||
150268760|NCT00658684|542120901|FG002|Overall Study|Withdrawal by Subject|1|||
150268761|NCT00658684|542120902|FG003|Overall Study|Withdrawal by Subject|1|||
150268762|NCT00658684|542120899|FG000|Overall Study|Lack of Efficacy|1|||
150268763|NCT00658684|542120900|FG001|Overall Study|Lack of Efficacy|1|||
150268764|NCT00658684|542120901|FG002|Overall Study|Lack of Efficacy|0|||
150268765|NCT00658684|542120902|FG003|Overall Study|Lack of Efficacy|0|||
150268766|NCT00658684|542120899|FG000|Overall Study|Protocol Violation|1|||
150268767|NCT00658684|542120900|FG001|Overall Study|Protocol Violation|1|||
150268768|NCT00658684|542120901|FG002|Overall Study|Protocol Violation|0|||
150268769|NCT00658684|542120902|FG003|Overall Study|Protocol Violation|0|||
150268770|NCT00658684|542120899|FG000|Overall Study|Pregnancy|1|||
150268771|NCT00658684|542120900|FG001|Overall Study|Pregnancy|1|||
150268772|NCT00658684|542120901|FG002|Overall Study|Pregnancy|0|||
150268773|NCT00658684|542120902|FG003|Overall Study|Pregnancy|0|||
150268774|NCT00688103|542120903|FG000|Overall Study|Adverse Event|4|||
150268775|NCT00688103|542120904|FG001|Overall Study|Adverse Event|1|||
150268776|NCT00688103|542120903|FG000|Overall Study|Lack of Efficacy|11|||
150268777|NCT00688103|542120904|FG001|Overall Study|Lack of Efficacy|1|||
150268778|NCT00688103|542120903|FG000|Overall Study|Withdrawal by Subject|4|||
150268779|NCT00688103|542120904|FG001|Overall Study|Withdrawal by Subject|2|||
150268780|NCT00688103|542120903|FG000|Overall Study|complex reasons|11|||
150268781|NCT00688103|542120904|FG001|Overall Study|complex reasons|9|||
150268782|NCT03144804|542120906|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
150268783|NCT03078907|542121942|FG000|Overall Study|Adverse Event|2|||
150268784|NCT03078907|542121943|FG001|Overall Study|Adverse Event|0|||
150268785|NCT03078907|542121942|FG000|Overall Study|Other|1|||
150268786|NCT03078907|542121943|FG001|Overall Study|Other|0|||
150268787|NCT03078907|542121942|FG000|Overall Study|Protocol Violation|0|||
150268788|NCT03078907|542121943|FG001|Overall Study|Protocol Violation|1|||
150268789|NCT01955122|542121944|FG000|Overall Study|Physician Decision|5|||
150268790|NCT01955122|542121945|FG001|Overall Study|Physician Decision|5|||
150268791|NCT01672788|542121946|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
150268792|NCT01672788|542121947|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
150268793|NCT01672788|542121948|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
150268794|NCT01672788|542121949|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
150268795|NCT03329196|542121952|FG000|Overall Study|Adverse Event|10|||
150268796|NCT03329196|542121953|FG001|Overall Study|Adverse Event|5|||
150268797|NCT03329196|542121952|FG000|Overall Study|Physician Decision|2|||
150268798|NCT03329196|542121953|FG001|Overall Study|Physician Decision|2|||
150268799|NCT03329196|542121952|FG000|Overall Study|Withdrawal by Subject|11|||
150268800|NCT03329196|542121953|FG001|Overall Study|Withdrawal by Subject|3|||
150268801|NCT03329196|542121952|FG000|Overall Study|Hepatic function abnormalities|0|||
150268802|NCT03329196|542121953|FG001|Overall Study|Hepatic function abnormalities|1|||
150268803|NCT03329196|542121952|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
150268804|NCT03329196|542121953|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
150268805|NCT03329196|542121952|FG000|Overall Study|Difficult to control Hb|2|||
150268806|NCT03329196|542121953|FG001|Overall Study|Difficult to control Hb|3|||
150268807|NCT03329196|542121952|FG000|Overall Study|Dialysis or renal transplant|13|||
150268808|NCT03329196|542121953|FG001|Overall Study|Dialysis or renal transplant|15|||
150268809|NCT01128361|542121954|FG000|Overall Study|Lost to Follow-up|0|||
150268810|NCT01128361|542121955|FG001|Overall Study|Lost to Follow-up|1|||
150268811|NCT01128361|542121954|FG000|Overall Study|Withdrawal by Subject|5|||
150268812|NCT01128361|542121955|FG001|Overall Study|Withdrawal by Subject|2|||
150268813|NCT00985166|542121956|FG000|Overall Study|Lost to Follow-up|3|||
150268814|NCT00985166|542121957|FG001|Overall Study|Lost to Follow-up|2|||
150268815|NCT00985166|542121958|FG002|Overall Study|Lost to Follow-up|2|||
150268816|NCT00985166|542121956|FG000|Overall Study|Withdrawal by Subject|3|||
150268817|NCT00985166|542121957|FG001|Overall Study|Withdrawal by Subject|2|||
150268818|NCT00985166|542121958|FG002|Overall Study|Withdrawal by Subject|0|||
150268819|NCT00985166|542121956|FG000|Overall Study|Test not done|2|||
150268820|NCT00985166|542121957|FG001|Overall Study|Test not done|0|||
150268821|NCT00985166|542121958|FG002|Overall Study|Test not done|4|||
150268822|NCT00985166|542121956|FG000|Overall Study|Other|1|||
150268823|NCT00985166|542121957|FG001|Overall Study|Other|0|||
150268824|NCT00985166|542121958|FG002|Overall Study|Other|1|||
150268825|NCT02464228|542121959|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
150268826|NCT02464228|542121960|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
150268827|NCT02464228|542121961|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
150268828|NCT02464228|542121962|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
150268829|NCT02464228|542121959|FG000|Overall Study|Physician Decision|2|||
150268830|NCT02464228|542121960|FG001|Overall Study|Physician Decision|0|||
150268831|NCT02464228|542121961|FG002|Overall Study|Physician Decision|1|||
150268832|NCT02464228|542121962|FG003|Overall Study|Physician Decision|0|||
150268833|NCT02464228|542121959|FG000|Overall Study|Miscellaneous|1|||
150268834|NCT02464228|542121960|FG001|Overall Study|Miscellaneous|0|||
150268835|NCT02464228|542121961|FG002|Overall Study|Miscellaneous|1|||
150268836|NCT02464228|542121962|FG003|Overall Study|Miscellaneous|0|||
150268837|NCT02464228|542121959|FG000|Overall Study|Adverse Event|9|||
150268838|NCT02464228|542121960|FG001|Overall Study|Adverse Event|0|||
150268839|NCT02464228|542121961|FG002|Overall Study|Adverse Event|3|||
150268840|NCT02464228|542121962|FG003|Overall Study|Adverse Event|0|||
150268841|NCT02464228|542121959|FG000|Overall Study|Withdrawal by Subject|1|||
150268842|NCT02464228|542121960|FG001|Overall Study|Withdrawal by Subject|1|||
150268843|NCT02464228|542121961|FG002|Overall Study|Withdrawal by Subject|1|||
150268844|NCT02464228|542121962|FG003|Overall Study|Withdrawal by Subject|0|||
150268845|NCT02464228|542121959|FG000|Overall Study|Disease Progression|22|||
150268846|NCT02464228|542121960|FG001|Overall Study|Disease Progression|12|||
150268847|NCT02464228|542121961|FG002|Overall Study|Disease Progression|5|||
150268848|NCT02464228|542121962|FG003|Overall Study|Disease Progression|2|||
150268849|NCT01681628|542121967|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
150268850|NCT01681628|542121968|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
150268851|NCT01681628|542121967|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
150268852|NCT01681628|542121968|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
150268853|NCT01681628|542121967|FG000|19 Months Follow-up|Death|1|||
150268854|NCT01681628|542121968|FG001|19 Months Follow-up|Death|0|||
150268855|NCT01681628|542121967|FG000|19 Months Follow-up|Lost to Follow-up|61|||
150268856|NCT01681628|542121968|FG001|19 Months Follow-up|Lost to Follow-up|43|||
150268857|NCT05736211|542121982|FG000|Overall Study|Lost to Follow-up|6|||
150268858|NCT05736211|542121983|FG001|Overall Study|Lost to Follow-up|0|||
150268859|NCT02634346|542121984|FG000|Overall Study|Withdrawal by Subject|8|||
150268860|NCT02634346|542121985|FG001|Overall Study|Withdrawal by Subject|9|||
150268861|NCT02634346|542121986|FG002|Overall Study|Withdrawal by Subject|8|||
150268862|NCT02634346|542121984|FG000|Overall Study|Adverse Event|2|||
150268863|NCT02634346|542121985|FG001|Overall Study|Adverse Event|2|||
150268864|NCT02634346|542121986|FG002|Overall Study|Adverse Event|7|||
150268865|NCT02634346|542121984|FG000|Overall Study|Lack of Efficacy|1|||
150268866|NCT02634346|542121985|FG001|Overall Study|Lack of Efficacy|2|||
150268867|NCT02634346|542121986|FG002|Overall Study|Lack of Efficacy|8|||
150268868|NCT02634346|542121984|FG000|Overall Study|Lost to Follow-up|1|||
150268869|NCT02634346|542121985|FG001|Overall Study|Lost to Follow-up|0|||
150268870|NCT02634346|542121986|FG002|Overall Study|Lost to Follow-up|0|||
150268871|NCT02634346|542121984|FG000|Overall Study|Protocol Violation|0|||
150268872|NCT02634346|542121985|FG001|Overall Study|Protocol Violation|1|||
150268873|NCT02634346|542121986|FG002|Overall Study|Protocol Violation|0|||
150268874|NCT04485104|542121990|FG000|Overall Study|Physician Decision|2|||
150268875|NCT04485104|542121991|FG001|Overall Study|Physician Decision|0|||
150268876|NCT04485104|542121990|FG000|Overall Study|Decision by sponsor|0|||
150268877|NCT04485104|542121991|FG001|Overall Study|Decision by sponsor|1|||
150268878|NCT00908232|542121992|FG000|Cycle 1 to 4|Death|5|||
150268879|NCT00908232|542121993|FG001|Cycle 1 to 4|Death|0|||
150268880|NCT00908232|542121994|FG002|Cycle 1 to 4|Death|0|||
150268881|NCT00908232|542121995|FG003|Cycle 1 to 4|Death|0|||
150268882|NCT00908232|542121992|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
150268883|NCT00908232|542121993|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
150268884|NCT00908232|542121994|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
150268885|NCT00908232|542121995|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
150268886|NCT00908232|542121992|FG000|Cycle 1 to 4|Progressive Disease|6|||
150268887|NCT00908232|542121993|FG001|Cycle 1 to 4|Progressive Disease|0|||
150268888|NCT00908232|542121994|FG002|Cycle 1 to 4|Progressive Disease|0|||
150268889|NCT00908232|542121995|FG003|Cycle 1 to 4|Progressive Disease|0|||
150268890|NCT00908232|542121992|FG000|Cycle 1 to 4|Adverse Event|12|||
150268891|NCT00908232|542121993|FG001|Cycle 1 to 4|Adverse Event|0|||
150268892|NCT00908232|542121994|FG002|Cycle 1 to 4|Adverse Event|0|||
150268893|NCT00908232|542121995|FG003|Cycle 1 to 4|Adverse Event|0|||
150268894|NCT00908232|542121992|FG000|Cycle 1 to 4|Other|1|||
150268895|NCT00908232|542121993|FG001|Cycle 1 to 4|Other|0|||
150268896|NCT00908232|542121994|FG002|Cycle 1 to 4|Other|0|||
150268897|NCT00908232|542121995|FG003|Cycle 1 to 4|Other|0|||
150268898|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
150268899|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
150268900|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
150268901|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
150268902|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
150268903|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
150268904|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
150268905|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
150268906|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
150268907|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
150268908|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
150268909|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
150268910|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
150268911|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
150268912|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
150268913|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
150268914|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
150268915|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
150268916|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
150268917|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
150268918|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
150268919|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
150268920|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
150268921|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
150268922|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
150268923|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
150268924|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
150268925|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
150268926|NCT00908232|542121992|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
150268927|NCT00908232|542121993|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
150268928|NCT00908232|542121994|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
150268929|NCT00908232|542121995|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
150268930|NCT00132496|542121996|FG000|Overall Study|Withdrawal by Subject|1|||
150268931|NCT00132496|542121997|FG001|Overall Study|Withdrawal by Subject|2|||
150268932|NCT00132496|542121996|FG000|Overall Study|Physician Decision|1|||
150268933|NCT00132496|542121997|FG001|Overall Study|Physician Decision|0|||
150268934|NCT03170154|542122000|FG000|Overall Study|Lost to Follow-up|4|||
150268935|NCT03170154|542122000|FG000|Overall Study|Death|2|||
150268936|NCT03170154|542122000|FG000|Overall Study|Withdrawal by Subject|2|||
150268937|NCT01163721|542122001|FG000|Overall Study|Adverse Event|5|||
150268938|NCT01163721|542122002|FG001|Overall Study|Adverse Event|6|||
150268939|NCT01163721|542122001|FG000|Overall Study|Withdrawal by Subject|3|||
150268940|NCT01163721|542122002|FG001|Overall Study|Withdrawal by Subject|4|||
150268941|NCT01163721|542122001|FG000|Overall Study|Lost to Follow-up|0|||
150268942|NCT01163721|542122002|FG001|Overall Study|Lost to Follow-up|1|||
150268943|NCT01163721|542122001|FG000|Overall Study|Physician Decision|0|||
150268944|NCT01163721|542122002|FG001|Overall Study|Physician Decision|1|||
150268945|NCT00954421|542122006|FG000|Screening|screen failures|3|||
150268946|NCT00954421|542122006|FG000|6 Months of DBS|Withdrawal by Subject|1|||
150268947|NCT00954421|542122006|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
150268948|NCT01891721|542122007|FG000|Overall Study|Lost to Follow-up|10|||
150268949|NCT01891721|542122008|FG001|Overall Study|Lost to Follow-up|5|||
150268950|NCT01891721|542122009|FG002|Overall Study|Lost to Follow-up|1|||
150268951|NCT03254485|542122034|FG000|Overall Study|Adverse Event|3|||
150268952|NCT03254485|542122035|FG001|Overall Study|Adverse Event|0|||
150268953|NCT03254485|542122036|FG002|Overall Study|Adverse Event|0|||
150268954|NCT03254485|542122037|FG003|Overall Study|Adverse Event|6|||
150268955|NCT03254485|542122034|FG000|Overall Study|Protocol Violation|6|||
150268956|NCT03254485|542122035|FG001|Overall Study|Protocol Violation|0|||
150268957|NCT03254485|542122036|FG002|Overall Study|Protocol Violation|0|||
150268958|NCT03254485|542122037|FG003|Overall Study|Protocol Violation|2|||
150268959|NCT03254485|542122034|FG000|Overall Study|Withdrawal by Subject|1|||
150268960|NCT03254485|542122035|FG001|Overall Study|Withdrawal by Subject|0|||
150268961|NCT03254485|542122036|FG002|Overall Study|Withdrawal by Subject|0|||
150268962|NCT03254485|542122037|FG003|Overall Study|Withdrawal by Subject|4|||
150268963|NCT03254485|542122034|FG000|Overall Study|Death|0|||
150268964|NCT03254485|542122035|FG001|Overall Study|Death|0|||
150268965|NCT03254485|542122036|FG002|Overall Study|Death|0|||
150268966|NCT03254485|542122037|FG003|Overall Study|Death|1|||
150268967|NCT03254485|542122034|FG000|Overall Study|Lost to Follow-up|1|||
150268968|NCT03254485|542122035|FG001|Overall Study|Lost to Follow-up|0|||
150268969|NCT03254485|542122036|FG002|Overall Study|Lost to Follow-up|0|||
150268970|NCT03254485|542122037|FG003|Overall Study|Lost to Follow-up|0|||
150268971|NCT03254485|542122034|FG000|Overall Study|Other|1|||
150268972|NCT03254485|542122035|FG001|Overall Study|Other|0|||
150268973|NCT03254485|542122036|FG002|Overall Study|Other|0|||
150268974|NCT03254485|542122037|FG003|Overall Study|Other|2|||
150268975|NCT02958267|542122039|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
150268976|NCT02958267|542122040|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
150268977|NCT02958267|542122039|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
150268978|NCT02958267|542122040|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
150268979|NCT02958267|542122039|FG000|Follow-up Visits|Additional treatment pursued|2|||
150268980|NCT02958267|542122040|FG001|Follow-up Visits|Additional treatment pursued|1|||
150268981|NCT00777946|542122041|FG000|Overall Study|Adverse Event|11|||
150268982|NCT00777946|542122042|FG001|Overall Study|Adverse Event|1|||
150268983|NCT00777946|542122043|FG002|Overall Study|Adverse Event|3|||
150268984|NCT00777946|542122041|FG000|Overall Study|Lack of Efficacy|0|||
150268985|NCT00777946|542122042|FG001|Overall Study|Lack of Efficacy|0|||
150268986|NCT00777946|542122043|FG002|Overall Study|Lack of Efficacy|9|||
150268987|NCT00777946|542122041|FG000|Overall Study|Condition no longer required study drug|1|||
150268988|NCT00777946|542122042|FG001|Overall Study|Condition no longer required study drug|0|||
150268989|NCT00777946|542122043|FG002|Overall Study|Condition no longer required study drug|0|||
150268990|NCT00777946|542122041|FG000|Overall Study|Patient withdrew consent|3|||
150268991|NCT00777946|542122042|FG001|Overall Study|Patient withdrew consent|2|||
150268992|NCT00777946|542122043|FG002|Overall Study|Patient withdrew consent|3|||
150268993|NCT00777946|542122041|FG000|Overall Study|Lost to Follow-up|3|||
150268994|NCT00777946|542122042|FG001|Overall Study|Lost to Follow-up|1|||
150268995|NCT00777946|542122043|FG002|Overall Study|Lost to Follow-up|0|||
150268996|NCT00777946|542122041|FG000|Overall Study|Protocol deviation|2|||
150268997|NCT00777946|542122042|FG001|Overall Study|Protocol deviation|1|||
150268998|NCT00777946|542122043|FG002|Overall Study|Protocol deviation|1|||
150268999|NCT00777946|542122041|FG000|Overall Study|Randomized in error|1|||
150269000|NCT00777946|542122042|FG001|Overall Study|Randomized in error|1|||
150269001|NCT00777946|542122043|FG002|Overall Study|Randomized in error|0|||
150269002|NCT02244996|542122050|FG000|Overall Study|Lack of Efficacy|2|||
150269003|NCT02244996|542122051|FG001|Overall Study|Lack of Efficacy|6|||
150269004|NCT00174265|542122052|FG000|Overall Study|Adverse Event|7|||
150269005|NCT00174265|542122053|FG001|Overall Study|Adverse Event|4|||
150269006|NCT00174265|542122052|FG000|Overall Study|Lack of Efficacy|2|||
150269007|NCT00174265|542122053|FG001|Overall Study|Lack of Efficacy|2|||
150269008|NCT00174265|542122052|FG000|Overall Study|Withdrawal by Subject|3|||
150269009|NCT00174265|542122053|FG001|Overall Study|Withdrawal by Subject|5|||
150269010|NCT00174265|542122052|FG000|Overall Study|Lost to Follow-up|1|||
150269011|NCT00174265|542122053|FG001|Overall Study|Lost to Follow-up|0|||
150269012|NCT00174265|542122052|FG000|Overall Study|Other (Not specified)|16|||
150269013|NCT00174265|542122053|FG001|Overall Study|Other (Not specified)|10|||
150269014|NCT00047320|542122055|FG000|Overall Study|Lack of Efficacy|8|||
150269015|NCT00047320|542122055|FG000|Overall Study|Lost to Follow-up|1|||
150269016|NCT00047320|542122055|FG000|Overall Study|Physician Decision|8|||
150269017|NCT00047320|542122055|FG000|Overall Study|Withdrawal by Subject|9|||
150269018|NCT00047320|542122055|FG000|Overall Study|Ineligible|2|||
150269019|NCT03471871|542122056|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
150269020|NCT03471871|542122057|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
150269021|NCT03471871|542122058|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
150269022|NCT03471871|542122059|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
150269023|NCT03471871|542122060|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
150269024|NCT03471871|542122056|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
150269025|NCT03471871|542122057|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
150269026|NCT03471871|542122058|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
150269027|NCT03471871|542122059|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
150269028|NCT03471871|542122060|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
150269029|NCT03471871|542122056|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
150167729|NCT02082158|541749573|FG001|Overall Study|Failed Fit-testing|8|||
150167730|NCT02082158|541749574|FG002|Overall Study|Failed Fit-testing|14|||
150167731|NCT02082158|541749575|FG003|Overall Study|Failed Fit-testing|4|||
150167732|NCT02082158|541749576|FG004|Overall Study|Failed Fit-testing|3|||
150167733|NCT02082158|541749577|FG005|Overall Study|Failed Fit-testing|7|||
150167734|NCT00957229|541749578|FG000|Study Start|Adverse Event|0|||
150167735|NCT00957229|541749579|FG001|Study Start|Adverse Event|3|||
150167736|NCT00957229|541749578|FG000|Study Start|Disease Progression|1|||
150167737|NCT00957229|541749579|FG001|Study Start|Disease Progression|0|||
150167738|NCT00957229|541749578|FG000|Reallocated to or Continued Vismodegib|Death|1|||
150167739|NCT00957229|541749579|FG001|Reallocated to or Continued Vismodegib|Death|1|||
150167740|NCT00957229|541749578|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
150167741|NCT00957229|541749579|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
150167742|NCT00927823|541749580|FG000|Continuous Dosing Period|Death|0|||
150167743|NCT00927823|541749581|FG001|Continuous Dosing Period|Death|0|||
150167744|NCT00927823|541749582|FG002|Continuous Dosing Period|Death|6|||
150167745|NCT00927823|541749583|FG003|Continuous Dosing Period|Death|0|||
150167746|NCT00927823|541749580|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
150167747|NCT00927823|541749581|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
150167748|NCT00927823|541749582|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
150167749|NCT00927823|541749583|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
150167750|NCT00927823|541749580|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
150167751|NCT00927823|541749581|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
150167752|NCT00927823|541749582|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
150167753|NCT00927823|541749583|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
150167754|NCT00927823|541749580|FG000|Continuous Dosing Period|Other|1|||
150167755|NCT00927823|541749581|FG001|Continuous Dosing Period|Other|2|||
150167756|NCT00927823|541749582|FG002|Continuous Dosing Period|Other|9|||
150167757|NCT00927823|541749583|FG003|Continuous Dosing Period|Other|3|||
150167758|NCT00543725|541749584|FG000|Overall Study|Adverse Event|18|||
150167759|NCT00543725|541749585|FG001|Overall Study|Adverse Event|27|||
150167760|NCT00543725|541749584|FG000|Overall Study|Sponsor's Decision|0|||
150167761|NCT00543725|541749585|FG001|Overall Study|Sponsor's Decision|1|||
150167762|NCT00543725|541749584|FG000|Overall Study|Subject Non-Compliant|4|||
150167763|NCT00543725|541749585|FG001|Overall Study|Subject Non-Compliant|4|||
150167764|NCT00543725|541749584|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
150167765|NCT00543725|541749585|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
150167766|NCT00543725|541749584|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
150167767|NCT00543725|541749585|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
150167768|NCT00543725|541749584|FG000|Overall Study|Protocol Violation|0|||
150167769|NCT00543725|541749585|FG001|Overall Study|Protocol Violation|1|||
150167770|NCT00543725|541749584|FG000|Overall Study|Withdrawal by Subject|4|||
150167771|NCT00543725|541749585|FG001|Overall Study|Withdrawal by Subject|13|||
150167772|NCT00543725|541749584|FG000|Overall Study|Lost to Follow-up|15|||
150167773|NCT00543725|541749585|FG001|Overall Study|Lost to Follow-up|11|||
150167774|NCT00543725|541749584|FG000|Overall Study|Other|3|||
150167775|NCT00543725|541749585|FG001|Overall Study|Other|3|||
150167776|NCT00906698|541749586|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
150167777|NCT00906698|541749587|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
150167778|NCT00906698|541749588|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
150167779|NCT00906698|541749589|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
150167780|NCT00906698|541749590|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
150167781|NCT00906698|541749591|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
150167782|NCT00906698|541749586|FG000|Overall Study|Adverse Event|0|||
150167783|NCT00906698|541749587|FG001|Overall Study|Adverse Event|0|||
150167784|NCT00906698|541749588|FG002|Overall Study|Adverse Event|2|||
150167785|NCT00906698|541749589|FG003|Overall Study|Adverse Event|0|||
150167786|NCT00906698|541749590|FG004|Overall Study|Adverse Event|4|||
150167787|NCT00906698|541749591|FG005|Overall Study|Adverse Event|1|||
150167788|NCT00906698|541749586|FG000|Overall Study|Disease progression|3|||
150167789|NCT00906698|541749587|FG001|Overall Study|Disease progression|12|||
150167790|NCT00906698|541749588|FG002|Overall Study|Disease progression|4|||
150167791|NCT00906698|541749589|FG003|Overall Study|Disease progression|4|||
150167792|NCT00906698|541749590|FG004|Overall Study|Disease progression|12|||
150167793|NCT00906698|541749591|FG005|Overall Study|Disease progression|4|||
150167794|NCT00906698|541749586|FG000|Overall Study|Withdrawal by Subject|0|||
150167795|NCT00906698|541749587|FG001|Overall Study|Withdrawal by Subject|0|||
150167796|NCT00906698|541749588|FG002|Overall Study|Withdrawal by Subject|0|||
150167797|NCT00906698|541749589|FG003|Overall Study|Withdrawal by Subject|0|||
150167798|NCT00906698|541749590|FG004|Overall Study|Withdrawal by Subject|1|||
150167799|NCT00906698|541749591|FG005|Overall Study|Withdrawal by Subject|0|||
150167800|NCT00906698|541749586|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
150167801|NCT00906698|541749587|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
150167802|NCT00906698|541749588|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
150167803|NCT00906698|541749589|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
150167804|NCT00906698|541749590|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
150269030|NCT03471871|542122057|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
150269031|NCT03471871|542122058|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
150269032|NCT03471871|542122059|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
150269033|NCT03471871|542122060|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
150269034|NCT03471871|542122056|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
150269035|NCT03471871|542122057|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
150269036|NCT03471871|542122058|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
150269037|NCT03471871|542122059|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
150269038|NCT03471871|542122060|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
150269039|NCT03471871|542122056|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
150269040|NCT03471871|542122057|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
150269041|NCT03471871|542122058|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
150269042|NCT03471871|542122059|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
150269043|NCT03471871|542122060|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
150269044|NCT03040622|542122061|FG000|Overall Study|unable to implant device|3|||
150269045|NCT03434353|542123221|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
150269046|NCT03434353|542123222|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
150269047|NCT03434353|542123223|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
150269048|NCT03434353|542123224|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
150269049|NCT03434353|542123225|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
150269050|NCT03434353|542123221|FG000|Overall Study|Withdrew consent|1|||
150269051|NCT03434353|542123222|FG001|Overall Study|Withdrew consent|0|||
150269052|NCT03434353|542123223|FG002|Overall Study|Withdrew consent|3|||
150269053|NCT03434353|542123224|FG003|Overall Study|Withdrew consent|0|||
150269054|NCT03434353|542123225|FG004|Overall Study|Withdrew consent|0|||
150269055|NCT03434353|542123221|FG000|Overall Study|Adverse Event|1|||
150269056|NCT03434353|542123222|FG001|Overall Study|Adverse Event|0|||
150269057|NCT03434353|542123223|FG002|Overall Study|Adverse Event|0|||
150269058|NCT03434353|542123224|FG003|Overall Study|Adverse Event|0|||
150269059|NCT03434353|542123225|FG004|Overall Study|Adverse Event|1|||
150269060|NCT03434353|542123221|FG000|Overall Study|Lost to Follow-up|2|||
150269061|NCT03434353|542123222|FG001|Overall Study|Lost to Follow-up|0|||
150269062|NCT03434353|542123223|FG002|Overall Study|Lost to Follow-up|0|||
150269063|NCT03434353|542123224|FG003|Overall Study|Lost to Follow-up|0|||
150269064|NCT03434353|542123225|FG004|Overall Study|Lost to Follow-up|0|||
150269065|NCT00234494|542123226|FG000|Overall Study|Protocol Violation|2|||
150269066|NCT01831544|542123227|FG000|Overall Study|Death|1|||
150269067|NCT01831544|542123227|FG000|Overall Study|Still on original MVAD device|2|||
150269068|NCT01521897|542123228|FG000|Overall Study|Protocol Violation|18|||
150269069|NCT01521897|542123228|FG000|Overall Study|Lost to Follow-up|5|||
150269070|NCT02194062|542123229|FG000|Overall Study|Lost to Follow-up|2|||
150269071|NCT02194062|542123230|FG001|Overall Study|Lost to Follow-up|2|||
150269072|NCT02194062|542123231|FG002|Overall Study|Lost to Follow-up|5|||
150269073|NCT03422172|542123232|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
150269074|NCT03422172|542123232|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
150269075|NCT03422172|542123232|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
150269076|NCT00293722|542123235|FG000|Overall Study|Other|427|||
150269077|NCT04658186|542123238|FG000|Overall Study|Adverse Event|4|||
150269078|NCT04658186|542123239|FG001|Overall Study|Adverse Event|18|||
150269079|NCT04658186|542123240|FG002|Overall Study|Adverse Event|15|||
150269080|NCT04658186|542123238|FG000|Overall Study|Lack of Efficacy|1|||
150269081|NCT04658186|542123239|FG001|Overall Study|Lack of Efficacy|1|||
150269082|NCT04658186|542123240|FG002|Overall Study|Lack of Efficacy|0|||
150269083|NCT04658186|542123238|FG000|Overall Study|Protocol Violation|0|||
150269084|NCT04658186|542123239|FG001|Overall Study|Protocol Violation|0|||
150269085|NCT04658186|542123240|FG002|Overall Study|Protocol Violation|1|||
150269086|NCT04658186|542123238|FG000|Overall Study|Lost to Follow-up|0|||
150269087|NCT04658186|542123239|FG001|Overall Study|Lost to Follow-up|0|||
150269088|NCT04658186|542123240|FG002|Overall Study|Lost to Follow-up|2|||
150269089|NCT04658186|542123238|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
150269090|NCT04658186|542123239|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
150269091|NCT04658186|542123240|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
150269092|NCT04658186|542123238|FG000|Overall Study|Participant is Moving in Another Province|0|||
150269093|NCT04658186|542123239|FG001|Overall Study|Participant is Moving in Another Province|1|||
150269094|NCT04658186|542123240|FG002|Overall Study|Participant is Moving in Another Province|0|||
150269095|NCT04658186|542123238|FG000|Overall Study|Non-Compliance|0|||
150269096|NCT04658186|542123239|FG001|Overall Study|Non-Compliance|1|||
150269097|NCT04658186|542123240|FG002|Overall Study|Non-Compliance|1|||
150269098|NCT04658186|542123238|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
150269099|NCT04658186|542123239|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
150269100|NCT04658186|542123240|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
150269101|NCT04658186|542123238|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
150269102|NCT04658186|542123239|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
150269103|NCT04658186|542123240|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
150269104|NCT04658186|542123238|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
150269105|NCT04658186|542123239|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
150269106|NCT04658186|542123240|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
150269107|NCT04658186|542123238|FG000|Overall Study|PI Decision due to Participant Safety|0|||
150269108|NCT04658186|542123239|FG001|Overall Study|PI Decision due to Participant Safety|0|||
150269109|NCT04658186|542123240|FG002|Overall Study|PI Decision due to Participant Safety|1|||
150269110|NCT04658186|542123238|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
150269111|NCT04658186|542123239|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
150269112|NCT04658186|542123240|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
150269113|NCT03153137|542123241|FG000|Overall Study|Lost to Follow-up|1|||
150269114|NCT03153137|542123242|FG001|Overall Study|Lost to Follow-up|0|||
150269115|NCT03153137|542123241|FG000|Overall Study|Withdrawal by Subject|2|||
150269116|NCT03153137|542123242|FG001|Overall Study|Withdrawal by Subject|1|||
150269117|NCT03153137|542123241|FG000|Overall Study|Physician Decision|0|||
150269118|NCT03153137|542123242|FG001|Overall Study|Physician Decision|3|||
150269119|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
150269120|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
150269121|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
150269122|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
150269123|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
150269124|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
150269125|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
150269126|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
150269127|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Death|1|||
150269128|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Death|1|||
150269129|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
150269130|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
150269131|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
150269132|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
150269133|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
150269134|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
150269135|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
150269136|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
150269137|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
150269138|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
150269139|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
150269140|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
150269141|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
150269142|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
150269143|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
150269144|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
150269145|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
150269146|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
150269147|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
150269148|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
150269149|NCT00559585|542123251|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
150269150|NCT00559585|542123252|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
150269151|NCT00559585|542123251|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
150269152|NCT00559585|542123252|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
150269153|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
150269154|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
150269155|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
150269156|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
150269157|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
150269158|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
150269159|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
150269160|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
150269161|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
150269162|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
150269163|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
150269164|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
150269165|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
150269166|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
150269167|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
150269168|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
150269169|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
150269170|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
150269171|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
150269172|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
150269173|NCT00559585|542123251|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
150269174|NCT00559585|542123252|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
150269175|NCT00867113|542123253|FG000|Treatment Period|Adverse Event|15|||
150269176|NCT00867113|542123253|FG000|Treatment Period|Death|2|||
150269177|NCT00867113|542123253|FG000|Treatment Period|Withdrawal by Subject|19|||
150269178|NCT00867113|542123253|FG000|Treatment Period|Lost to Follow-up|3|||
150269179|NCT00867113|542123253|FG000|Treatment Period|Administrative problems|1|||
150269180|NCT00867113|542123253|FG000|Treatment Period|Disease progression/relapse|1|||
150269181|NCT00867113|542123253|FG000|Treatment Period|Protocol Violation|4|||
150269182|NCT00867113|542123253|FG000|Post Treatment After Survival Follow-up|Death|1|||
150269183|NCT00867113|542123253|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
150269184|NCT00867113|542123253|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
150269185|NCT00867113|542123253|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
150269186|NCT01230788|542123256|FG000|Overall Study|Prescribed exclusion drug|1|||
150269187|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
150269188|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
150269189|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Death|0|||
150269190|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Death|1|||
150269191|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
150269192|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
150269193|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
150269194|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
150269195|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
150269196|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
150269197|NCT00323297|542123257|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
150269198|NCT00323297|542123258|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
150269199|NCT00323297|542123257|FG000|Part B (Open-label)|Death|0|||
150269200|NCT00323297|542123258|FG001|Part B (Open-label)|Death|1|||
150269201|NCT00323297|542123257|FG000|Part B (Open-label)|Reason unspecified|0|||
150269202|NCT00323297|542123258|FG001|Part B (Open-label)|Reason unspecified|1|||
150269203|NCT00323297|542123257|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
150269204|NCT00323297|542123258|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
150269205|NCT00323297|542123257|FG000|Part B (Open-label)|Lack of Efficacy|3|||
150269206|NCT00323297|542123258|FG001|Part B (Open-label)|Lack of Efficacy|1|||
150269207|NCT00323297|542123257|FG000|Part B (Open-label)|Adverse Event|5|||
150269208|NCT00323297|542123258|FG001|Part B (Open-label)|Adverse Event|5|||
150269209|NCT00323297|542123257|FG000|Part B (Open-label)|Protocol Violation|0|||
150269210|NCT00323297|542123258|FG001|Part B (Open-label)|Protocol Violation|1|||
150269211|NCT01774084|542123260|FG000|Overall Study|Personal reasons|1|||
150269212|NCT01774084|542123261|FG001|Overall Study|Personal reasons|0|||
150269213|NCT02973048|542123262|FG000|Overall Study|Epidural catheter insertion failure|1|||
150269214|NCT02973048|542123263|FG001|Overall Study|Epidural catheter insertion failure|0|||
150269215|NCT02973048|542123262|FG000|Overall Study|Withdrawal by Subject|0|||
150269216|NCT02973048|542123263|FG001|Overall Study|Withdrawal by Subject|3|||
150269217|NCT01906346|542123264|FG000|Overall Study|AEs|1|||
150269218|NCT04226833|542123265|FG000|Overall Study|Death|0|||
150269219|NCT04226833|542123266|FG001|Overall Study|Death|0|||
150269220|NCT04226833|542123267|FG002|Overall Study|Death|1|||
150269221|NCT04226833|542123268|FG003|Overall Study|Death|0|||
150269222|NCT01050205|542123274|FG000|Overall Study|Lost to Follow-up|7|||
150269223|NCT01050205|542123275|FG001|Overall Study|Lost to Follow-up|1|||
150269224|NCT01050205|542123274|FG000|Overall Study|Withdrawal by Subject|1|||
150269225|NCT01050205|542123275|FG001|Overall Study|Withdrawal by Subject|1|||
150269226|NCT01050205|542123274|FG000|Overall Study|Relocated from area|1|||
150269227|NCT01050205|542123275|FG001|Overall Study|Relocated from area|2|||
150269228|NCT01050205|542123274|FG000|Overall Study|Discontinued Intervention|2|||
150269229|NCT01050205|542123275|FG001|Overall Study|Discontinued Intervention|0|||
150269230|NCT00364156|542123276|FG000|Overall Study|Withdrawal by Subject|73|||
150269231|NCT00364156|542123277|FG001|Overall Study|Withdrawal by Subject|80|||
150269232|NCT00364156|542123276|FG000|Overall Study|Protocol Violation|6|||
150269233|NCT00364156|542123277|FG001|Overall Study|Protocol Violation|1|||
150269234|NCT01472380|542123278|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
150269235|NCT01472380|542123278|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
150269236|NCT02511678|542123279|FG000|Overall Study|Withdrawal by Subject|2|||
150269237|NCT02511678|542123279|FG000|Overall Study|Lost to Follow-up|4|||
150269238|NCT02511678|542123279|FG000|Overall Study|Death|19|||
150269239|NCT02511678|542123279|FG000|Overall Study|Adverse Event|1|||
150269240|NCT02511678|542123279|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
150269241|NCT02511678|542123279|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
150269242|NCT02511678|542123279|FG000|Overall Study|Required Radiofrequency Ablation|1|||
150269243|NCT02511678|542123279|FG000|Overall Study|Biopsy was Negative|1|||
150269244|NCT02511678|542123279|FG000|Overall Study|Protocol Violation|1|||
150269245|NCT02511678|542123279|FG000|Overall Study|Received Radiation Treatment|1|||
150269246|NCT01295281|542123282|FG000|First Intervention (7 Days)|Death|0|||
150269247|NCT01295281|542123283|FG001|First Intervention (7 Days)|Death|1|||
150269248|NCT00292461|542123284|FG000|Overall Study|Adverse Event|4|||
150269249|NCT00292461|542123285|FG001|Overall Study|Adverse Event|2|||
150269250|NCT00292461|542123284|FG000|Overall Study|Lack of Efficacy|1|||
150269251|NCT00292461|542123285|FG001|Overall Study|Lack of Efficacy|0|||
150269252|NCT00292461|542123284|FG000|Overall Study|Withdrawal by Subject|0|||
150269253|NCT00292461|542123285|FG001|Overall Study|Withdrawal by Subject|1|||
150269254|NCT00292461|542123284|FG000|Overall Study|Protocol Violation|4|||
150269255|NCT00292461|542123285|FG001|Overall Study|Protocol Violation|3|||
150269256|NCT00292461|542123284|FG000|Overall Study|Lost to Follow-up|1|||
150269257|NCT00292461|542123285|FG001|Overall Study|Lost to Follow-up|0|||
150269258|NCT02730598|542123288|FG000|Overall Study|Withdrawal by Subject|3|||
150269259|NCT02730598|542123289|FG001|Overall Study|Withdrawal by Subject|3|||
150269260|NCT02730598|542123288|FG000|Overall Study|Protocol Violation|0|||
150269261|NCT02730598|542123289|FG001|Overall Study|Protocol Violation|1|||
150269262|NCT02730598|542123288|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
150269263|NCT02730598|542123289|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
150269264|NCT01210118|542123292|FG000|Overall Study|Lost to Follow-up|1|||
150269265|NCT01210118|542123293|FG001|Overall Study|Lost to Follow-up|1|||
150269266|NCT01210118|542123292|FG000|Overall Study|Protocol Violation|1|||
150269267|NCT01210118|542123293|FG001|Overall Study|Protocol Violation|1|||
150269268|NCT01210118|542123292|FG000|Overall Study|Spontaneous abortion|1|||
150269269|NCT01210118|542123293|FG001|Overall Study|Spontaneous abortion|3|||
150269270|NCT05066724|542123295|FG000|Overall Study|Adverse Event|1|||
150269271|NCT05066724|542123295|FG000|Overall Study|Non-Compliance With Study Drug|5|||
150269272|NCT05066724|542123295|FG000|Overall Study|Withdrawal by Subject|6|||
150269273|NCT05066724|542123295|FG000|Overall Study|Physician Decision|2|||
150269274|NCT01696942|542123310|FG000|Overall Study|Withdrawal by Subject|1|||
150269275|NCT01696942|542123311|FG001|Overall Study|Withdrawal by Subject|0|||
150269276|NCT01696942|542123310|FG000|Overall Study|Protocol Violation|1|||
150269277|NCT01696942|542123311|FG001|Overall Study|Protocol Violation|2|||
150269278|NCT01696942|542123310|FG000|Overall Study|screen failure|0|||
150269279|NCT01696942|542123311|FG001|Overall Study|screen failure|1|||
150269280|NCT01422850|542123312|FG000|Overall Study|Physician Decision|3|||
150269281|NCT02673619|542123313|FG000|Overall Study|Lost to Follow-up|1|||
150269282|NCT02673619|542123314|FG001|Overall Study|Lost to Follow-up|0|||
150269283|NCT02673619|542123315|FG002|Overall Study|Lost to Follow-up|0|||
150269284|NCT02673619|542123316|FG003|Overall Study|Lost to Follow-up|0|||
150269285|NCT02673619|542123313|FG000|Overall Study|Withdrawal by Subject|1|||
150269286|NCT02673619|542123314|FG001|Overall Study|Withdrawal by Subject|1|||
150269287|NCT02673619|542123315|FG002|Overall Study|Withdrawal by Subject|1|||
150269288|NCT02673619|542123316|FG003|Overall Study|Withdrawal by Subject|0|||
150269289|NCT02673619|542123313|FG000|Overall Study|Adverse Event|0|||
150269290|NCT02673619|542123314|FG001|Overall Study|Adverse Event|0|||
150269291|NCT02673619|542123315|FG002|Overall Study|Adverse Event|1|||
150269292|NCT02673619|542123316|FG003|Overall Study|Adverse Event|0|||
150269293|NCT02673619|542123313|FG000|Overall Study|Lack of Efficacy|0|||
150269294|NCT02673619|542123314|FG001|Overall Study|Lack of Efficacy|0|||
150269295|NCT02673619|542123315|FG002|Overall Study|Lack of Efficacy|1|||
150269296|NCT02673619|542123316|FG003|Overall Study|Lack of Efficacy|0|||
150269297|NCT01313117|542123320|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
150269298|NCT01313117|542123320|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
150269299|NCT03602261|542123325|FG000|Overall Study|Adverse Event|5|||
150269300|NCT03602261|542123326|FG001|Overall Study|Adverse Event|1|||
150269301|NCT03602261|542123325|FG000|Overall Study|Physician Decision|1|||
150269302|NCT03602261|542123326|FG001|Overall Study|Physician Decision|0|||
150269303|NCT03602261|542123325|FG000|Overall Study|Withdrawal by Subject|1|||
150269304|NCT03602261|542123326|FG001|Overall Study|Withdrawal by Subject|1|||
150269305|NCT03602261|542123325|FG000|Overall Study|Lack of Efficacy|0|||
150269306|NCT03602261|542123326|FG001|Overall Study|Lack of Efficacy|1|||
150269307|NCT03602261|542123325|FG000|Overall Study|Subject moving out of state|1|||
150269308|NCT03602261|542123326|FG001|Overall Study|Subject moving out of state|0|||
150269309|NCT01990534|542125188|FG000|Overall Study|Death|22|||
150269310|NCT01990534|542125188|FG000|Overall Study|Progressive disease|3|||
150269311|NCT01990534|542125188|FG000|Overall Study|Protocol Violation|1|||
150269312|NCT01990534|542125188|FG000|Overall Study|Withdrawal of Informed Consent|2|||
150269313|NCT01990534|542125188|FG000|Overall Study|Symptomatic Deterioration|1|||
150269314|NCT01990534|542125188|FG000|Overall Study|Withdrawal by Subject|3|||
150269315|NCT01990534|542125188|FG000|Overall Study|Reason not Specified|2|||
150269316|NCT01990534|542125188|FG000|Overall Study|Lost to Follow-up|1|||
150269317|NCT04498169|542125190|FG000|Study Completion|Adverse Event|1|||
150269318|NCT04498169|542125191|FG001|Study Completion|Adverse Event|1|||
150269319|NCT01383161|542125192|FG000|Overall Study|Adverse Event|5|||
150269320|NCT01383161|542125193|FG001|Overall Study|Adverse Event|1|||
150269321|NCT01383161|542125192|FG000|Overall Study|Withdrawal by Subject|0|||
150269322|NCT01383161|542125193|FG001|Overall Study|Withdrawal by Subject|2|||
150269323|NCT01383161|542125192|FG000|Overall Study|Lack of Efficacy|0|||
150269324|NCT01383161|542125193|FG001|Overall Study|Lack of Efficacy|1|||
150269325|NCT03942406|542125194|FG000|Overall Study|Lost to Follow-up|4|||
150269326|NCT03942406|542125195|FG001|Overall Study|Lost to Follow-up|5|||
150269327|NCT03942406|542125196|FG002|Overall Study|Lost to Follow-up|3|||
150269328|NCT03942406|542125197|FG003|Overall Study|Lost to Follow-up|7|||
150269329|NCT03942406|542125198|FG004|Overall Study|Lost to Follow-up|1|||
150269330|NCT03942406|542125199|FG005|Overall Study|Lost to Follow-up|0|||
150269331|NCT03942406|542125200|FG006|Overall Study|Lost to Follow-up|0|||
150269332|NCT03942406|542125194|FG000|Overall Study|Withdrawal by Subject|3|||
150269333|NCT03942406|542125195|FG001|Overall Study|Withdrawal by Subject|1|||
150269334|NCT03942406|542125196|FG002|Overall Study|Withdrawal by Subject|1|||
150269335|NCT03942406|542125197|FG003|Overall Study|Withdrawal by Subject|3|||
150269336|NCT03942406|542125198|FG004|Overall Study|Withdrawal by Subject|0|||
150269337|NCT03942406|542125199|FG005|Overall Study|Withdrawal by Subject|0|||
150269338|NCT03942406|542125200|FG006|Overall Study|Withdrawal by Subject|0|||
150269339|NCT03942406|542125194|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
150269340|NCT03942406|542125195|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
150269341|NCT03942406|542125196|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
150269342|NCT03942406|542125197|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
150269343|NCT03942406|542125198|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
150269344|NCT03942406|542125199|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
150269345|NCT03942406|542125200|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
150269346|NCT01207596|542125201|FG000|Overall Study|Physician Decision|4|||
150269347|NCT01207596|542125201|FG000|Overall Study|Lack of Efficacy|1|||
150269348|NCT01207596|542125201|FG000|Overall Study|Adverse Event|3|||
150269349|NCT01207596|542125201|FG000|Overall Study|Withdrawal by Subject|1|||
150269350|NCT00216203|542125202|FG000|Overall Study|Withdrawal by Subject|2|||
150269351|NCT06069778|542125203|FG000|Overall Study|Withdrawal by Subject|1|||
150269352|NCT02856893|542125204|FG000|Overall Study|Lack of Efficacy|27|||
150269353|NCT02856893|542125205|FG001|Overall Study|Lack of Efficacy|15|||
150269354|NCT02856893|542125206|FG002|Overall Study|Lack of Efficacy|19|||
150269355|NCT02856893|542125204|FG000|Overall Study|Death|1|||
150269356|NCT02856893|542125205|FG001|Overall Study|Death|0|||
150269357|NCT02856893|542125206|FG002|Overall Study|Death|0|||
150269358|NCT02856893|542125204|FG000|Overall Study|Adverse Event|2|||
150269359|NCT02856893|542125205|FG001|Overall Study|Adverse Event|0|||
150269360|NCT02856893|542125206|FG002|Overall Study|Adverse Event|0|||
150269361|NCT02856893|542125204|FG000|Overall Study|Physician Decision|0|||
150269362|NCT02856893|542125205|FG001|Overall Study|Physician Decision|2|||
150269363|NCT02856893|542125206|FG002|Overall Study|Physician Decision|3|||
150269364|NCT02856893|542125204|FG000|Overall Study|Withdrawal by Subject|1|||
150269365|NCT02856893|542125205|FG001|Overall Study|Withdrawal by Subject|1|||
150269366|NCT02856893|542125206|FG002|Overall Study|Withdrawal by Subject|0|||
150269367|NCT02856893|542125204|FG000|Overall Study|Other reasons|2|||
150269368|NCT02856893|542125205|FG001|Overall Study|Other reasons|1|||
150269369|NCT02856893|542125206|FG002|Overall Study|Other reasons|2|||
150269370|NCT03801902|542125207|FG000|Overall Study|Did not receive protocol treatment.|1|||
150269371|NCT03801902|542125208|FG001|Overall Study|Did not receive protocol treatment.|0|||
150269372|NCT03801902|542125209|FG002|Overall Study|Did not receive protocol treatment.|0|||
150269373|NCT03801902|542125210|FG003|Overall Study|Did not receive protocol treatment.|0|||
150269374|NCT02310672|542125214|FG000|Overall Study|Death|1|||
150269375|NCT02310672|542125214|FG000|Overall Study|Lost to Follow-up|1|||
150269376|NCT02310672|542125214|FG000|Overall Study|Withdrawal by Subject|1|||
150269377|NCT02310672|542125214|FG000|Overall Study|Sponsor's decision|12|||
150269378|NCT04704336|542125218|FG000|Overall Study|Death|2|||
150269379|NCT04704336|542125219|FG001|Overall Study|Death|2|||
150269380|NCT04704336|542125218|FG000|Overall Study|Lost to Follow-up|33|||
150269381|NCT04704336|542125219|FG001|Overall Study|Lost to Follow-up|40|||
150269382|NCT03118674|542125220|FG000|Overall Study|Lost to Follow-up|2|||
150269383|NCT03118674|542125220|FG000|Overall Study|Screen Faliure|8|||
150269384|NCT03118674|542125220|FG000|Overall Study|Withdrawal by Subject|5|||
150269385|NCT02260882|542125221|FG000|Overall Study|Protocol Violation|0|||
150269386|NCT02260882|542125222|FG001|Overall Study|Protocol Violation|1|||
150269387|NCT02119325|542125223|FG000|Washout Period 1|Adverse Event|0|||
150269388|NCT02119325|542125224|FG001|Washout Period 1|Adverse Event|1|||
150269389|NCT00954174|542125233|FG000|Overall Study|Adverse Event|28|||
150269390|NCT00954174|542125234|FG001|Overall Study|Adverse Event|23|||
150269391|NCT00954174|542125235|FG002|Overall Study|Adverse Event|4|||
150269392|NCT00954174|542125236|FG003|Overall Study|Adverse Event|9|||
150269393|NCT00954174|542125233|FG000|Overall Study|Death|4|||
150269394|NCT00954174|542125234|FG001|Overall Study|Death|2|||
150269395|NCT00954174|542125235|FG002|Overall Study|Death|0|||
150269396|NCT00954174|542125236|FG003|Overall Study|Death|0|||
149933709|NCT01949142|540891830|FG000|Overall Study|Lost to Follow-up|1|||
149933710|NCT01949142|540891831|FG001|Overall Study|Lost to Follow-up|1|||
149933711|NCT01949142|540891830|FG000|Overall Study|Parent changed their mind|1|||
149933712|NCT01949142|540891831|FG001|Overall Study|Parent changed their mind|0|||
149933713|NCT00490919|540891832|FG000|Open-label Run-in Period|Adverse Event|239|||
149933714|NCT00490919|540891833|FG001|Open-label Run-in Period|Adverse Event|0|||
149933715|NCT00490919|540891834|FG002|Open-label Run-in Period|Adverse Event|0|||
149933716|NCT00490919|540891832|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
149933717|NCT00490919|540891833|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
149933718|NCT00490919|540891834|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
149933719|NCT00490919|540891832|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
149933720|NCT00490919|540891833|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
149933721|NCT00490919|540891834|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
149933722|NCT00490919|540891832|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
149933723|NCT00490919|540891833|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
149933724|NCT00490919|540891834|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
149933725|NCT00490919|540891832|FG000|Open-label Run-in Period|Administrative|40|||
149933726|NCT00490919|540891833|FG001|Open-label Run-in Period|Administrative|0|||
149933727|NCT00490919|540891834|FG002|Open-label Run-in Period|Administrative|0|||
149933728|NCT00490919|540891832|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
149933729|NCT00490919|540891833|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
150269397|NCT00954174|542125233|FG000|Overall Study|Lack of Efficacy|32|||
150269398|NCT00954174|542125234|FG001|Overall Study|Lack of Efficacy|22|||
150269399|NCT00954174|542125235|FG002|Overall Study|Lack of Efficacy|8|||
150269400|NCT00954174|542125236|FG003|Overall Study|Lack of Efficacy|6|||
150269401|NCT00954174|542125233|FG000|Overall Study|Withdrawal by Subject|14|||
150269402|NCT00954174|542125234|FG001|Overall Study|Withdrawal by Subject|10|||
150269403|NCT00954174|542125235|FG002|Overall Study|Withdrawal by Subject|4|||
150269404|NCT00954174|542125236|FG003|Overall Study|Withdrawal by Subject|3|||
150269405|NCT00954174|542125233|FG000|Overall Study|Medical Reason|4|||
150269406|NCT00954174|542125234|FG001|Overall Study|Medical Reason|2|||
150269407|NCT00954174|542125235|FG002|Overall Study|Medical Reason|1|||
150269408|NCT00954174|542125236|FG003|Overall Study|Medical Reason|0|||
150269409|NCT00954174|542125233|FG000|Overall Study|Ineligible|40|||
150269410|NCT00954174|542125234|FG001|Overall Study|Ineligible|47|||
150269411|NCT00954174|542125235|FG002|Overall Study|Ineligible|7|||
150269412|NCT00954174|542125236|FG003|Overall Study|Ineligible|4|||
150269413|NCT00954174|542125233|FG000|Overall Study|Never Treated|4|||
150269414|NCT00954174|542125234|FG001|Overall Study|Never Treated|17|||
150269415|NCT00954174|542125235|FG002|Overall Study|Never Treated|0|||
150269416|NCT00954174|542125236|FG003|Overall Study|Never Treated|3|||
150269417|NCT02234323|542125237|FG000|All Enrolled|Not Treated: Completed study in database|2|||
150269418|NCT02234323|542125237|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
150269419|NCT02234323|542125237|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
150269420|NCT02234323|542125237|FG000|All Treated|Death|1|||
150269421|NCT02234323|542125237|FG000|All Treated|Physician Decision|5|||
150269422|NCT02234323|542125237|FG000|All Treated|Lack of Efficacy|3|||
150269423|NCT02234323|542125237|FG000|All Treated|Exceeded lab value limit|2|||
150269424|NCT02234323|542125237|FG000|All Treated|Other|7|||
150269425|NCT04209621|542125238|FG000|Overall Study|Death|1|||
150269426|NCT04209621|542125238|FG000|Overall Study|Study Terminated Early|2|||
150269427|NCT02249767|542125239|FG000|Overall Study|Did not use medication|8|||
150269428|NCT02249767|542125240|FG001|Overall Study|Did not use medication|9|||
150269429|NCT02249767|542125241|FG002|Overall Study|Did not use medication|8|||
150269430|NCT01372410|542125242|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
150269431|NCT01372410|542125243|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
150269432|NCT01372410|542125244|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
150269433|NCT01372410|542125245|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
150269434|NCT01372410|542125246|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
150269435|NCT01372410|542125247|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
150269436|NCT01372410|542125248|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
150269437|NCT01372410|542125249|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
150269438|NCT01372410|542125242|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269439|NCT01372410|542125243|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
150269440|NCT01372410|542125244|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269441|NCT01372410|542125245|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269442|NCT01372410|542125246|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269443|NCT01372410|542125247|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269444|NCT01372410|542125248|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
150269445|NCT01372410|542125249|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
150269446|NCT01372410|542125242|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150269447|NCT01372410|542125243|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150269448|NCT01372410|542125244|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150269449|NCT01372410|542125245|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150269450|NCT01372410|542125246|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
149933730|NCT00490919|540891834|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
149933731|NCT00490919|540891832|FG000|Double-blind Phase|Adverse Event|0|||
149933732|NCT00490919|540891833|FG001|Double-blind Phase|Adverse Event|40|||
149933733|NCT00490919|540891834|FG002|Double-blind Phase|Adverse Event|20|||
149933734|NCT00490919|540891832|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149933735|NCT00490919|540891833|FG001|Double-blind Phase|Withdrawal by Subject|10|||
149933736|NCT00490919|540891834|FG002|Double-blind Phase|Withdrawal by Subject|11|||
149933737|NCT00490919|540891832|FG000|Double-blind Phase|Lost to Follow-up|0|||
149933738|NCT00490919|540891833|FG001|Double-blind Phase|Lost to Follow-up|8|||
149933739|NCT00490919|540891834|FG002|Double-blind Phase|Lost to Follow-up|11|||
149933740|NCT00490919|540891832|FG000|Double-blind Phase|Lack of Efficacy|0|||
149933741|NCT00490919|540891833|FG001|Double-blind Phase|Lack of Efficacy|22|||
149933742|NCT00490919|540891834|FG002|Double-blind Phase|Lack of Efficacy|36|||
149933743|NCT00490919|540891832|FG000|Double-blind Phase|Administrative|0|||
149933744|NCT00490919|540891833|FG001|Double-blind Phase|Administrative|6|||
149933745|NCT00490919|540891834|FG002|Double-blind Phase|Administrative|6|||
149933746|NCT01317940|540894362|FG000|Overall Study|Death|1|||
149933747|NCT01317940|540894363|FG001|Overall Study|Death|0|||
149933748|NCT01317940|540894364|FG002|Overall Study|Death|1|||
149933749|NCT01317940|540894365|FG003|Overall Study|Death|0|||
149933750|NCT01317940|540894366|FG004|Overall Study|Death|0|||
149933751|NCT01317940|540894367|FG005|Overall Study|Death|0|||
149933752|NCT01317940|540894362|FG000|Overall Study|Lost to Follow-up|0|||
149933753|NCT01317940|540894363|FG001|Overall Study|Lost to Follow-up|0|||
149933754|NCT01317940|540894364|FG002|Overall Study|Lost to Follow-up|1|||
149933755|NCT01317940|540894365|FG003|Overall Study|Lost to Follow-up|1|||
149933756|NCT01317940|540894366|FG004|Overall Study|Lost to Follow-up|1|||
149933757|NCT01317940|540894367|FG005|Overall Study|Lost to Follow-up|0|||
149933758|NCT01317940|540894362|FG000|Overall Study|Change in therapy plan|0|||
149933759|NCT01317940|540894363|FG001|Overall Study|Change in therapy plan|0|||
149933760|NCT01317940|540894364|FG002|Overall Study|Change in therapy plan|3|||
149933761|NCT01317940|540894365|FG003|Overall Study|Change in therapy plan|0|||
149933762|NCT01317940|540894366|FG004|Overall Study|Change in therapy plan|0|||
149933763|NCT01317940|540894367|FG005|Overall Study|Change in therapy plan|0|||
149933764|NCT03256578|540894368|FG000|Overall Study|Excluded Post Randomization|66|||
149933765|NCT03256578|540894369|FG001|Overall Study|Excluded Post Randomization|56|||
149933766|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
149933767|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
149933768|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
149933769|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
149933770|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
149933771|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
149933772|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
149933773|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
149933774|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
149933775|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
149933776|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
149933777|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
149933778|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
149933779|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
149933780|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
149933781|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
149933782|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
149933783|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
149933784|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
149933785|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
149933786|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
149933787|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
149933788|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
149933789|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
149933790|NCT01198002|540894370|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
149933791|NCT01198002|540894371|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
149933792|NCT01198002|540894372|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
149933793|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
149933794|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
149933795|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
149933796|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
149933797|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
149933798|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
149933799|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
149933800|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
149933801|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
149933802|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
149933803|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
149933804|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
149933805|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
149933806|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
149933807|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
149933808|NCT01198002|540894370|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
149933809|NCT01198002|540894371|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
149933810|NCT01198002|540894372|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
149933811|NCT01811732|540894375|FG000|Overall Study|Lost to Follow-up|24|||
149933812|NCT01811732|540894376|FG001|Overall Study|Lost to Follow-up|30|||
149933813|NCT01811732|540894375|FG000|Overall Study|Withdrawal by Subject|16|||
149933814|NCT01811732|540894376|FG001|Overall Study|Withdrawal by Subject|10|||
149933815|NCT01811732|540894375|FG000|Overall Study|Adverse Event|3|||
149933816|NCT01811732|540894376|FG001|Overall Study|Adverse Event|9|||
149933817|NCT01811732|540894375|FG000|Overall Study|Lack of Efficacy|3|||
149933818|NCT01811732|540894376|FG001|Overall Study|Lack of Efficacy|1|||
149933819|NCT01811732|540894375|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
149933820|NCT01811732|540894376|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
149933821|NCT01811732|540894375|FG000|Overall Study|Physician Decision|2|||
149933822|NCT01811732|540894376|FG001|Overall Study|Physician Decision|0|||
149933823|NCT01811732|540894375|FG000|Overall Study|Death|1|||
149933824|NCT01811732|540894376|FG001|Overall Study|Death|1|||
149933825|NCT01811732|540894375|FG000|Overall Study|Insufficient venous access|0|||
149933826|NCT01811732|540894376|FG001|Overall Study|Insufficient venous access|1|||
149933827|NCT01811732|540894375|FG000|Overall Study|Protocol Violation|0|||
149933828|NCT01811732|540894376|FG001|Overall Study|Protocol Violation|1|||
149933829|NCT01811732|540894375|FG000|Overall Study|Subject incarcerated|1|||
149933830|NCT01811732|540894376|FG001|Overall Study|Subject incarcerated|2|||
149933831|NCT01811732|540894375|FG000|Overall Study|Admitted to another facility|1|||
149933832|NCT01811732|540894376|FG001|Overall Study|Admitted to another facility|0|||
149933833|NCT01811732|540894375|FG000|Overall Study|Correct study drug not available on site|1|||
149933834|NCT01811732|540894376|FG001|Overall Study|Correct study drug not available on site|0|||
149933835|NCT00536510|540894379|FG000|Overall Study|Adverse Event|27|||
149933836|NCT00536510|540894380|FG001|Overall Study|Adverse Event|4|||
149933837|NCT00536510|540894379|FG000|Overall Study|Lost to Follow-up|11|||
149933838|NCT00536510|540894380|FG001|Overall Study|Lost to Follow-up|8|||
149933839|NCT00536510|540894379|FG000|Overall Study|Protocol Violation|4|||
149933840|NCT00536510|540894380|FG001|Overall Study|Protocol Violation|5|||
149933841|NCT00536510|540894379|FG000|Overall Study|Withdrawal by Subject|16|||
149933842|NCT00536510|540894380|FG001|Overall Study|Withdrawal by Subject|9|||
149933843|NCT00536510|540894379|FG000|Overall Study|Flushing with Product|20|||
149933844|NCT00536510|540894380|FG001|Overall Study|Flushing with Product|0|||
149933845|NCT00536510|540894379|FG000|Overall Study|Laboratory Adverse Event|2|||
149933846|NCT00536510|540894380|FG001|Overall Study|Laboratory Adverse Event|1|||
149933847|NCT00536510|540894379|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
149933848|NCT00536510|540894380|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
149933849|NCT02026141|540894381|FG000|Overall Study|Protocol Violation|0|||
149933850|NCT02026141|540894382|FG001|Overall Study|Protocol Violation|1|||
149933851|NCT01249417|540894383|FG000|Randomised Population|Study treatment not received|0|||
149933852|NCT01249417|540894384|FG001|Randomised Population|Study treatment not received|0|||
149933853|NCT01249417|540894385|FG002|Randomised Population|Study treatment not received|2|||
149933854|NCT01249417|540894383|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
149933855|NCT01249417|540894384|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
149933856|NCT01249417|540894385|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
149933857|NCT01249417|540894383|FG000|Treatment Phase - ITT Population|Other|0|||
149933858|NCT01249417|540894384|FG001|Treatment Phase - ITT Population|Other|0|||
149933859|NCT01249417|540894385|FG002|Treatment Phase - ITT Population|Other|1|||
149933860|NCT01249417|540894383|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
149933861|NCT01249417|540894384|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
149933862|NCT01249417|540894385|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
149933863|NCT01249417|540894383|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
149933864|NCT01249417|540894384|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
149933865|NCT01249417|540894385|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
149933866|NCT01249417|540894383|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
149933867|NCT01249417|540894384|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
149933868|NCT01249417|540894385|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
149933869|NCT03102762|540894386|FG000|Overall Study|Lost to Follow-up|1|||
149933870|NCT03102762|540894387|FG001|Overall Study|Lost to Follow-up|0|||
150269451|NCT01372410|542125247|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149933871|NCT03074695|540894392|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
149933872|NCT03074695|540894393|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
150269452|NCT01372410|542125248|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149933873|NCT03074695|540894392|FG000|Overall Study|Research staff not available|1|||
149933874|NCT03074695|540894393|FG001|Overall Study|Research staff not available|2|||
149933875|NCT03074695|540894392|FG000|Overall Study|Did not receive neuraxial block|2|||
149933876|NCT03074695|540894393|FG001|Overall Study|Did not receive neuraxial block|2|||
149933877|NCT00960193|540894394|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
149933878|NCT00728494|540894397|FG000|Overall Study|Adverse Event|7|||
149933879|NCT00728494|540894398|FG001|Overall Study|Adverse Event|0|||
149933880|NCT00728494|540894397|FG000|Overall Study|Withdrawal by Subject|0|||
149933881|NCT00728494|540894398|FG001|Overall Study|Withdrawal by Subject|2|||
149933882|NCT00728494|540894397|FG000|Overall Study|Lack of Efficacy|2|||
149933883|NCT00728494|540894398|FG001|Overall Study|Lack of Efficacy|4|||
149933884|NCT00728494|540894397|FG000|Overall Study|No data available|0|||
149933885|NCT00728494|540894398|FG001|Overall Study|No data available|1|||
149933886|NCT01232790|540894403|FG000|Randomization|Withdrawal by Subject|2|||
149933887|NCT01232790|540894404|FG001|Randomization|Withdrawal by Subject|0|||
149933888|NCT01232790|540894403|FG000|Randomization|Protocol Violation|0|||
149933889|NCT01232790|540894404|FG001|Randomization|Protocol Violation|1|||
149933890|NCT01232790|540894403|FG000|Randomization|Physician Decision|0|||
149933891|NCT01232790|540894404|FG001|Randomization|Physician Decision|1|||
149933892|NCT01232790|540894403|FG000|Initial Assessment|Withdrawal by Subject|0|||
149933893|NCT01232790|540894404|FG001|Initial Assessment|Withdrawal by Subject|1|||
149933894|NCT01232790|540894403|FG000|First Crossover|Withdrawal by Subject|1|||
149933895|NCT01232790|540894404|FG001|First Crossover|Withdrawal by Subject|0|||
149933896|NCT01232790|540894403|FG000|Second Crossover|Withdrawal by Subject|1|||
149933897|NCT01232790|540894404|FG001|Second Crossover|Withdrawal by Subject|2|||
149933898|NCT00083915|540894405|FG000|Overall Study|Death|6|||
149933899|NCT00083915|540894406|FG001|Overall Study|Death|3|||
150269453|NCT01372410|542125249|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150269454|NCT01372410|542125242|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269455|NCT01372410|542125243|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269456|NCT01372410|542125244|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269457|NCT01372410|542125245|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269458|NCT01372410|542125246|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269459|NCT01372410|542125247|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269460|NCT01372410|542125248|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
150269461|NCT01372410|542125249|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
150269462|NCT01372410|542125242|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
150269463|NCT01372410|542125243|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269464|NCT01372410|542125244|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269465|NCT01372410|542125245|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269466|NCT01372410|542125246|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269467|NCT01372410|542125247|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269468|NCT01372410|542125248|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
150269469|NCT01372410|542125249|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
150269470|NCT01372410|542125242|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269471|NCT01372410|542125243|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269472|NCT01372410|542125244|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269473|NCT01372410|542125245|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269474|NCT01372410|542125246|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
150269475|NCT01372410|542125247|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269476|NCT01372410|542125248|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269477|NCT01372410|542125249|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
150269478|NCT01372410|542125242|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
150269479|NCT01372410|542125243|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
150269480|NCT01372410|542125244|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
150269481|NCT01372410|542125245|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
150269482|NCT01372410|542125246|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
150269483|NCT01372410|542125247|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
150269484|NCT01372410|542125248|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
150269485|NCT01372410|542125249|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
149933900|NCT00083915|540894405|FG000|Overall Study|Physician Decision|11|||
149933901|NCT00083915|540894406|FG001|Overall Study|Physician Decision|6|||
149933902|NCT00083915|540894405|FG000|Overall Study|Withdrawal by Subject|8|||
149933903|NCT00083915|540894406|FG001|Overall Study|Withdrawal by Subject|3|||
149933904|NCT00083915|540894405|FG000|Overall Study|disease progression|18|||
149933905|NCT00083915|540894406|FG001|Overall Study|disease progression|23|||
149933906|NCT00083915|540894405|FG000|Overall Study|Failure to collect|3|||
149933907|NCT00083915|540894406|FG001|Overall Study|Failure to collect|0|||
149820207|NCT03175120|540471749|FG000|Overall Study|Other|2|||
149933908|NCT00083915|540894405|FG000|Overall Study|No response|3|||
149933909|NCT00083915|540894406|FG001|Overall Study|No response|1|||
150269486|NCT01372410|542125242|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269487|NCT01372410|542125243|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269488|NCT01372410|542125244|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269489|NCT01372410|542125245|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269490|NCT01372410|542125246|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269491|NCT01372410|542125247|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269492|NCT01372410|542125248|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
150269493|NCT01372410|542125249|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
150269494|NCT01372410|542125242|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269495|NCT01372410|542125243|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269496|NCT01372410|542125244|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
150269497|NCT01372410|542125245|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269498|NCT01372410|542125246|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269499|NCT01372410|542125247|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269500|NCT01372410|542125248|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269501|NCT01372410|542125249|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
150269502|NCT01372410|542125242|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269503|NCT01372410|542125243|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269504|NCT01372410|542125244|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269505|NCT01372410|542125245|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269506|NCT01372410|542125246|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269507|NCT01372410|542125247|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
150269508|NCT01372410|542125248|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269509|NCT01372410|542125249|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
150269510|NCT02644941|542125250|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
150269511|NCT02644941|542125251|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
150269512|NCT04585646|542125252|FG000|First Intervention|Physician Decision|1|||
150269513|NCT04585646|542125253|FG001|First Intervention|Physician Decision|0|||
150269514|NCT04585646|542125252|FG000|First Intervention|Lost to Follow-up|0|||
150269515|NCT04585646|542125253|FG001|First Intervention|Lost to Follow-up|3|||
150269516|NCT04585646|542125252|FG000|First Intervention|Withdrawal by Subject|0|||
150269517|NCT04585646|542125253|FG001|First Intervention|Withdrawal by Subject|1|||
150269518|NCT01145495|542125254|FG000|Overall Study|Adverse Event|6|||
150269519|NCT01145495|542125254|FG000|Overall Study|Withdrawal by Subject|6|||
150269520|NCT01145495|542125254|FG000|Overall Study|Disease progression after respone|2|||
150269521|NCT01886313|542125257|FG000|Overall Study|Adverse Event|1|||
150269522|NCT01886313|542125258|FG001|Overall Study|Adverse Event|1|||
150269523|NCT04614662|542125259|FG000|Overall Study|Withdrawal by Subject|0|||
150269524|NCT04614662|542125260|FG001|Overall Study|Withdrawal by Subject|1|||
150269525|NCT01387230|542125267|FG000|Overall Study|Adverse Event|0|||
150269526|NCT01387230|542125268|FG001|Overall Study|Adverse Event|1|||
150269527|NCT01387230|542125269|FG002|Overall Study|Adverse Event|3|||
150269528|NCT01387230|542125267|FG000|Overall Study|Lack of Efficacy|8|||
150269529|NCT01387230|542125268|FG001|Overall Study|Lack of Efficacy|5|||
150269530|NCT01387230|542125269|FG002|Overall Study|Lack of Efficacy|4|||
150269531|NCT01387230|542125267|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
150269532|NCT01387230|542125268|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
150269533|NCT01387230|542125269|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
150269534|NCT01387230|542125267|FG000|Overall Study|Lost to Follow-up|0|||
150269535|NCT01387230|542125268|FG001|Overall Study|Lost to Follow-up|0|||
150269536|NCT01387230|542125269|FG002|Overall Study|Lost to Follow-up|1|||
150269537|NCT01387230|542125267|FG000|Overall Study|Withdrawal by Subject|4|||
150269538|NCT01387230|542125268|FG001|Overall Study|Withdrawal by Subject|1|||
150269539|NCT01387230|542125269|FG002|Overall Study|Withdrawal by Subject|0|||
150269540|NCT00688181|542125273|FG000|Overall Study|Lost to Follow-up|17|||
150269541|NCT00688181|542125273|FG000|Overall Study|Unknown Reason|4|||
150269542|NCT00688181|542125273|FG000|Overall Study|Non-clinical Reason|2|||
150269543|NCT00403754|542125274|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
150269544|NCT00403754|542125275|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
150269545|NCT00403754|542125276|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
150269546|NCT00403754|542125277|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
150269547|NCT00403754|542125274|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
150269548|NCT00403754|542125275|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
150269549|NCT00403754|542125276|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
150269550|NCT00403754|542125277|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
150269551|NCT00633061|542125278|FG000|Overall Study|Study closed|86|||
150269552|NCT00633061|542125279|FG001|Overall Study|Study closed|0|||
150269553|NCT02000427|542125280|FG000|Overall Study|Death|22|||
150269554|NCT02708095|542125283|FG000|Overall Study|Adverse Event|4|||
150269555|NCT02708095|542125284|FG001|Overall Study|Adverse Event|10|||
149933910|NCT00083915|540894405|FG000|Overall Study|Insurance issues|1|||
150269556|NCT02708095|542125285|FG002|Overall Study|Adverse Event|11|||
150269557|NCT02708095|542125283|FG000|Overall Study|Lack of Efficacy|9|||
150269558|NCT02708095|542125284|FG001|Overall Study|Lack of Efficacy|3|||
150269559|NCT02708095|542125285|FG002|Overall Study|Lack of Efficacy|0|||
149933911|NCT00083915|540894406|FG001|Overall Study|Insurance issues|1|||
149933912|NCT01239797|540894407|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
149933913|NCT01239797|540894408|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
149933914|NCT01239797|540894407|FG000|Randomized Participants|Participant withdrew consent|1|||
149933915|NCT01239797|540894408|FG001|Randomized Participants|Participant withdrew consent|7|||
149933916|NCT01239797|540894407|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
149933917|NCT01239797|540894408|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
149933918|NCT01239797|540894407|FG000|Treated Participants|Disease progression|185|||
149933919|NCT01239797|540894408|FG001|Treated Participants|Disease progression|185|||
149933920|NCT01239797|540894407|FG000|Treated Participants|Study drug toxicity|39|||
149933921|NCT01239797|540894408|FG001|Treated Participants|Study drug toxicity|45|||
149933922|NCT01239797|540894407|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
150167805|NCT00906698|541749591|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
150167806|NCT01250002|541749592|FG000|Overall Study|Change to open surgical procedure|4|||
150167807|NCT01250002|541749593|FG001|Overall Study|Change to open surgical procedure|3|||
150167808|NCT03404843|541749606|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
150167809|NCT03404843|541749607|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
150167810|NCT00567164|541749608|FG000|Overall Study|Withdrawal by Subject|171|||
150167811|NCT00567164|541749609|FG001|Overall Study|Withdrawal by Subject|21|||
150167812|NCT00567164|541749610|FG002|Overall Study|Withdrawal by Subject|17|||
150167813|NCT00567164|541749608|FG000|Overall Study|Protocol Violation|23|||
150167814|NCT00567164|541749609|FG001|Overall Study|Protocol Violation|4|||
150167815|NCT00567164|541749610|FG002|Overall Study|Protocol Violation|2|||
150167816|NCT00567164|541749608|FG000|Overall Study|Adverse Event|92|||
150167817|NCT00567164|541749609|FG001|Overall Study|Adverse Event|13|||
150167818|NCT00567164|541749610|FG002|Overall Study|Adverse Event|9|||
150167819|NCT00567164|541749608|FG000|Overall Study|Death|0|||
150167820|NCT00567164|541749609|FG001|Overall Study|Death|0|||
150167821|NCT00567164|541749610|FG002|Overall Study|Death|1|||
150167822|NCT00567164|541749608|FG000|Overall Study|Lost to Follow-up|202|||
150167823|NCT00567164|541749609|FG001|Overall Study|Lost to Follow-up|23|||
150167824|NCT00567164|541749610|FG002|Overall Study|Lost to Follow-up|21|||
150167825|NCT00567164|541749608|FG000|Overall Study|Pregnancy|20|||
150167826|NCT00567164|541749609|FG001|Overall Study|Pregnancy|4|||
150167827|NCT00567164|541749610|FG002|Overall Study|Pregnancy|6|||
150167828|NCT00567164|541749608|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
150167829|NCT00567164|541749609|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
150167830|NCT00567164|541749610|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
150167831|NCT00567164|541749608|FG000|Overall Study|Missing|1|||
150167832|NCT00567164|541749609|FG001|Overall Study|Missing|0|||
150167833|NCT00567164|541749610|FG002|Overall Study|Missing|0|||
150167834|NCT04044664|541749611|FG000|Stage 1|Adverse Event|3|||
150167835|NCT04044664|541749612|FG001|Stage 1|Adverse Event|3|||
150167836|NCT04044664|541749613|FG002|Stage 1|Adverse Event|1|||
150167837|NCT04044664|541749611|FG000|Stage 1|Lost to Follow-up|3|||
150167838|NCT04044664|541749612|FG001|Stage 1|Lost to Follow-up|2|||
150167839|NCT04044664|541749613|FG002|Stage 1|Lost to Follow-up|2|||
150167840|NCT04044664|541749611|FG000|Stage 1|Withdrawal by Subject|9|||
150167841|NCT04044664|541749612|FG001|Stage 1|Withdrawal by Subject|1|||
150167842|NCT04044664|541749613|FG002|Stage 1|Withdrawal by Subject|0|||
150167843|NCT04044664|541749611|FG000|Stage 1|noncompliance, personal reason|2|||
150167844|NCT04044664|541749612|FG001|Stage 1|noncompliance, personal reason|0|||
150167845|NCT04044664|541749613|FG002|Stage 1|noncompliance, personal reason|0|||
150167846|NCT04044664|541749611|FG000|Stage 1|randomization error|0|||
150167847|NCT04044664|541749612|FG001|Stage 1|randomization error|1|||
150167848|NCT04044664|541749613|FG002|Stage 1|randomization error|0|||
150167849|NCT04044664|541749611|FG000|Stage 2|Adverse Event|2|||
150167850|NCT04044664|541749612|FG001|Stage 2|Adverse Event|0|||
150167851|NCT04044664|541749613|FG002|Stage 2|Adverse Event|0|||
150167852|NCT04044664|541749611|FG000|Stage 2|Lost to Follow-up|3|||
150167853|NCT04044664|541749612|FG001|Stage 2|Lost to Follow-up|2|||
150167854|NCT04044664|541749613|FG002|Stage 2|Lost to Follow-up|1|||
150167855|NCT04044664|541749611|FG000|Stage 2|Withdrawal by Subject|3|||
150167856|NCT04044664|541749612|FG001|Stage 2|Withdrawal by Subject|0|||
150167857|NCT04044664|541749613|FG002|Stage 2|Withdrawal by Subject|0|||
150167858|NCT04044664|541749611|FG000|Stage 2|protocol deviation|1|||
150167859|NCT04044664|541749612|FG001|Stage 2|protocol deviation|0|||
150167860|NCT04044664|541749613|FG002|Stage 2|protocol deviation|0|||
150167861|NCT00001575|541749617|FG000|Overall Study|Screening failures-Ph I portion|22|||
150167862|NCT00001575|541749617|FG000|Overall Study|Withdrawn/deaths|23|||
149933923|NCT01239797|540894408|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
150167863|NCT00831792|541749620|FG000|Overall Study|Not Eligible|3|||
150167864|NCT00831792|541749620|FG000|Overall Study|Adverse Event|1|||
150167865|NCT00831792|541749620|FG000|Overall Study|Death|1|||
150167866|NCT00831792|541749620|FG000|Overall Study|Lack of Efficacy|1|||
150167867|NCT01744691|541749622|FG000|Overall Study|Progressive Disease|18|||
150167868|NCT01744691|541749622|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
149820208|NCT03175120|540471750|FG001|Overall Study|Other|3|||
150269560|NCT02708095|542125283|FG000|Overall Study|Lost to Follow-up|2|||
150269561|NCT02708095|542125284|FG001|Overall Study|Lost to Follow-up|0|||
150269562|NCT02708095|542125285|FG002|Overall Study|Lost to Follow-up|0|||
150269563|NCT02708095|542125283|FG000|Overall Study|Physician Decision|2|||
150269564|NCT02708095|542125284|FG001|Overall Study|Physician Decision|3|||
150269565|NCT02708095|542125285|FG002|Overall Study|Physician Decision|2|||
150269566|NCT02708095|542125283|FG000|Overall Study|Protocol Violation|0|||
150269567|NCT02708095|542125284|FG001|Overall Study|Protocol Violation|0|||
150269568|NCT02708095|542125285|FG002|Overall Study|Protocol Violation|1|||
150269569|NCT02708095|542125283|FG000|Overall Study|Withdrawal by Subject|5|||
150269570|NCT02708095|542125284|FG001|Overall Study|Withdrawal by Subject|3|||
150269571|NCT02708095|542125285|FG002|Overall Study|Withdrawal by Subject|4|||
150269572|NCT05125679|542125286|FG000|Overall Study|Study Terminated by Sponsor|2|||
150269573|NCT05125679|542125287|FG001|Overall Study|Study Terminated by Sponsor|5|||
150269574|NCT03829319|542125288|FG000|Overall Study|Sponsor's Decision|4|||
150269575|NCT03829319|542125289|FG001|Overall Study|Sponsor's Decision|90|||
150269576|NCT03829319|542125290|FG002|Overall Study|Sponsor's Decision|102|||
150269577|NCT03829319|542125288|FG000|Overall Study|Withdrawal by Subject|1|||
150269578|NCT03829319|542125289|FG001|Overall Study|Withdrawal by Subject|5|||
149933924|NCT01239797|540894407|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
149933925|NCT01239797|540894408|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
150269579|NCT03829319|542125290|FG002|Overall Study|Withdrawal by Subject|4|||
150269580|NCT03829319|542125288|FG000|Overall Study|Physician Decision|0|||
150269581|NCT03829319|542125289|FG001|Overall Study|Physician Decision|3|||
150269582|NCT03829319|542125290|FG002|Overall Study|Physician Decision|0|||
150269583|NCT03829319|542125288|FG000|Overall Study|Lost to Follow-up|0|||
150269584|NCT03829319|542125289|FG001|Overall Study|Lost to Follow-up|0|||
150269585|NCT03829319|542125290|FG002|Overall Study|Lost to Follow-up|1|||
150269586|NCT03829319|542125288|FG000|Overall Study|Death|8|||
150269587|NCT03829319|542125289|FG001|Overall Study|Death|277|||
150269588|NCT03829319|542125290|FG002|Overall Study|Death|266|||
150269589|NCT04498832|542125291|FG000|Overall Study|Adverse Event|1|||
150269590|NCT04498832|542125292|FG001|Overall Study|Adverse Event|3|||
150269591|NCT04498832|542125291|FG000|Overall Study|Withdrawal by Subject|0|||
150269592|NCT04498832|542125292|FG001|Overall Study|Withdrawal by Subject|1|||
150269593|NCT05359003|542125293|FG000|Overall Study|Withdrawal by Subject|1|||
150269594|NCT05359003|542125294|FG001|Overall Study|Withdrawal by Subject|3|||
150269595|NCT00607022|542125298|FG000|Overall Study|Withdrawal by Subject|1|||
150269596|NCT00607022|542125299|FG001|Overall Study|Withdrawal by Subject|0|||
150269597|NCT00607022|542125300|FG002|Overall Study|Withdrawal by Subject|0|||
150269598|NCT04540133|542125301|FG000|Overall Study|Lost to Follow-up|1|||
150269599|NCT04540133|542125302|FG001|Overall Study|Lost to Follow-up|0|||
150269600|NCT06268288|542125303|FG000|Overall Study|Withdrawal by Subject|1|||
150269601|NCT06268288|542125304|FG001|Overall Study|Withdrawal by Subject|2|||
150269602|NCT03049735|542125305|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
150269603|NCT03049735|542125306|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
150269604|NCT03049735|542125307|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
150269605|NCT03049735|542125305|FG000|Overall Study|Other|5|||
150269606|NCT03049735|542125306|FG001|Overall Study|Other|3|||
150269607|NCT03049735|542125307|FG002|Overall Study|Other|1|||
150269608|NCT03049735|542125305|FG000|Overall Study|Lack of Efficacy|4|||
149933926|NCT01239797|540894407|FG000|Treated Participants|Administrative reason by sponsor|13|||
149933927|NCT01239797|540894408|FG001|Treated Participants|Administrative reason by sponsor|4|||
149933928|NCT01239797|540894407|FG000|Treated Participants|Other reasons|14|||
149933929|NCT01239797|540894408|FG001|Treated Participants|Other reasons|14|||
149933930|NCT01239797|540894407|FG000|Treated Participants|Participant withdrew consent|6|||
149933931|NCT01239797|540894408|FG001|Treated Participants|Participant withdrew consent|11|||
149933932|NCT01239797|540894407|FG000|Treated Participants|Death|1|||
149933933|NCT01239797|540894408|FG001|Treated Participants|Death|1|||
149933934|NCT01239797|540894407|FG000|Treated Participants|Participant no longer meets study criteria|1|||
149933935|NCT01239797|540894408|FG001|Treated Participants|Participant no longer meets study criteria|1|||
149933936|NCT01239797|540894407|FG000|Treated Participants|Poor/non-compliance|0|||
150269609|NCT03049735|542125306|FG001|Overall Study|Lack of Efficacy|0|||
150269610|NCT03049735|542125307|FG002|Overall Study|Lack of Efficacy|3|||
150269611|NCT03049735|542125305|FG000|Overall Study|Protocol deviation|1|||
149933937|NCT01239797|540894408|FG001|Treated Participants|Poor/non-compliance|1|||
149933938|NCT00853762|540894409|FG000|Overall Study|Premature Termination|16|||
149933939|NCT00853762|540894410|FG001|Overall Study|Premature Termination|15|||
149933940|NCT00853762|540894411|FG002|Overall Study|Premature Termination|14|||
150269612|NCT03049735|542125306|FG001|Overall Study|Protocol deviation|0|||
150269613|NCT03049735|542125307|FG002|Overall Study|Protocol deviation|0|||
150269614|NCT03049735|542125305|FG000|Overall Study|Pregnancy|0|||
150269615|NCT03049735|542125306|FG001|Overall Study|Pregnancy|0|||
150269616|NCT03049735|542125307|FG002|Overall Study|Pregnancy|1|||
150269617|NCT03049735|542125305|FG000|Overall Study|Adverse Event|7|||
150269618|NCT03049735|542125306|FG001|Overall Study|Adverse Event|18|||
150269619|NCT03049735|542125307|FG002|Overall Study|Adverse Event|5|||
149933941|NCT00853762|540894412|FG003|Overall Study|Premature Termination|21|||
149933942|NCT00853762|540894409|FG000|Overall Study|Protocol Violation|0|||
149933943|NCT00853762|540894410|FG001|Overall Study|Protocol Violation|0|||
149933944|NCT00853762|540894411|FG002|Overall Study|Protocol Violation|0|||
149933945|NCT00853762|540894412|FG003|Overall Study|Protocol Violation|1|||
149933946|NCT00853762|540894409|FG000|Overall Study|Withdrawal by Subject|0|||
149933947|NCT00853762|540894410|FG001|Overall Study|Withdrawal by Subject|0|||
149933948|NCT00853762|540894411|FG002|Overall Study|Withdrawal by Subject|1|||
149933949|NCT00853762|540894412|FG003|Overall Study|Withdrawal by Subject|0|||
149933950|NCT00853762|540894409|FG000|Overall Study|Other|0|||
149933951|NCT00853762|540894410|FG001|Overall Study|Other|2|||
149933952|NCT00853762|540894411|FG002|Overall Study|Other|0|||
149933953|NCT00853762|540894412|FG003|Overall Study|Other|0|||
149933954|NCT00853762|540894409|FG000|Overall Study|Randomised but not Treated|0|||
149933955|NCT00853762|540894410|FG001|Overall Study|Randomised but not Treated|2|||
149933956|NCT00853762|540894411|FG002|Overall Study|Randomised but not Treated|2|||
149933957|NCT00853762|540894412|FG003|Overall Study|Randomised but not Treated|0|||
150269620|NCT03049735|542125305|FG000|Overall Study|Withdrawal by Subject|10|||
150269621|NCT03049735|542125306|FG001|Overall Study|Withdrawal by Subject|3|||
150269622|NCT03049735|542125307|FG002|Overall Study|Withdrawal by Subject|7|||
150269623|NCT03049735|542125305|FG000|Overall Study|Lost to Follow-up|1|||
150269624|NCT03049735|542125306|FG001|Overall Study|Lost to Follow-up|5|||
149933958|NCT01290718|540894416|FG000|Overall Study|Early termination of the study|4|||
149933959|NCT02631941|540894419|FG000|Overall Study|Physician Decision|0|||
149933960|NCT02631941|540894420|FG001|Overall Study|Physician Decision|1|||
150167869|NCT01744691|541749622|FG000|Overall Study|Withdrawal of consent for treatment|3|||
150167870|NCT01744691|541749622|FG000|Overall Study|Physician Decision|4|||
150167871|NCT04588480|541749624|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
150167872|NCT04588480|541749625|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
150167873|NCT04588480|541749626|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
150167874|NCT04588480|541749624|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
150167875|NCT04588480|541749625|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
150167876|NCT04588480|541749626|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
150167877|NCT01242085|541749627|FG000|Overall Study|Withdrawal by Subject|4|||
150167878|NCT01242085|541749628|FG001|Overall Study|Withdrawal by Subject|2|||
150167879|NCT01242085|541749629|FG002|Overall Study|Withdrawal by Subject|0|||
150167880|NCT01242085|541749627|FG000|Overall Study|medically unable to have surgery|4|||
150167881|NCT01242085|541749628|FG001|Overall Study|medically unable to have surgery|5|||
150167882|NCT01242085|541749629|FG002|Overall Study|medically unable to have surgery|0|||
150167883|NCT01178762|541749630|FG000|Overall Study|Lost to Follow-up|15|||
150167884|NCT02377362|541749631|FG000|Part A Second Treatment|Protocol Violation|0|||
150167885|NCT02377362|541749632|FG001|Part A Second Treatment|Protocol Violation|0|||
150167886|NCT02377362|541749633|FG002|Part A Second Treatment|Protocol Violation|0|||
150167887|NCT02377362|541749634|FG003|Part A Second Treatment|Protocol Violation|0|||
150167888|NCT02377362|541749635|FG004|Part A Second Treatment|Protocol Violation|1|||
150167889|NCT02377362|541749636|FG005|Part A Second Treatment|Protocol Violation|0|||
150167890|NCT02377362|541749637|FG006|Part A Second Treatment|Protocol Violation|0|||
150167891|NCT02377362|541749638|FG007|Part A Second Treatment|Protocol Violation|0|||
150167892|NCT02377362|541749639|FG008|Part A Second Treatment|Protocol Violation|0|||
150167893|NCT02377362|541749640|FG009|Part A Second Treatment|Protocol Violation|0|||
150167894|NCT02377362|541749641|FG010|Part A Second Treatment|Protocol Violation|0|||
150167895|NCT02377362|541749642|FG011|Part A Second Treatment|Protocol Violation|0|||
150167896|NCT02377362|541749643|FG012|Part A Second Treatment|Protocol Violation|0|||
150167897|NCT02377362|541749631|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167898|NCT02377362|541749632|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167899|NCT02377362|541749633|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167900|NCT02377362|541749634|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
150167901|NCT02377362|541749635|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
150167902|NCT02377362|541749636|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
150167903|NCT02377362|541749637|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167904|NCT02377362|541749638|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167905|NCT02377362|541749639|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167906|NCT02377362|541749640|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167907|NCT02377362|541749641|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
150167908|NCT02377362|541749642|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
150269625|NCT03049735|542125307|FG002|Overall Study|Lost to Follow-up|5|||
150269626|NCT02146326|542125308|FG000|Overall Study|Lost to Follow-up|3|||
149933961|NCT02631941|540894421|FG002|Overall Study|Physician Decision|0|||
149933962|NCT02631941|540894422|FG003|Overall Study|Physician Decision|0|||
149933963|NCT02631941|540894423|FG004|Overall Study|Physician Decision|0|||
149933964|NCT02631941|540894424|FG005|Overall Study|Physician Decision|0|||
149933965|NCT02631941|540894425|FG006|Overall Study|Physician Decision|0|||
150167909|NCT02377362|541749643|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
150269627|NCT02146326|542125309|FG001|Overall Study|Lost to Follow-up|3|||
150269628|NCT02146326|542125310|FG002|Overall Study|Lost to Follow-up|11|||
150269629|NCT02146326|542125311|FG003|Overall Study|Lost to Follow-up|19|||
150269630|NCT02146326|542125308|FG000|Overall Study|Withdrawal by Subject|2|||
150269631|NCT02146326|542125309|FG001|Overall Study|Withdrawal by Subject|1|||
150269632|NCT02146326|542125310|FG002|Overall Study|Withdrawal by Subject|15|||
150269633|NCT02146326|542125311|FG003|Overall Study|Withdrawal by Subject|11|||
149933966|NCT02631941|540894426|FG007|Overall Study|Physician Decision|0|||
149933967|NCT02631941|540894427|FG008|Overall Study|Physician Decision|0|||
149933968|NCT02631941|540894428|FG009|Overall Study|Physician Decision|0|||
149933969|NCT02631941|540894419|FG000|Overall Study|Adverse Event|0|||
149933970|NCT02631941|540894420|FG001|Overall Study|Adverse Event|1|||
149933971|NCT02631941|540894421|FG002|Overall Study|Adverse Event|0|||
149933972|NCT02631941|540894422|FG003|Overall Study|Adverse Event|0|||
149933973|NCT02631941|540894423|FG004|Overall Study|Adverse Event|0|||
149933974|NCT02631941|540894424|FG005|Overall Study|Adverse Event|0|||
149933975|NCT02631941|540894425|FG006|Overall Study|Adverse Event|0|||
149933976|NCT02631941|540894426|FG007|Overall Study|Adverse Event|0|||
149933977|NCT02631941|540894427|FG008|Overall Study|Adverse Event|0|||
149933978|NCT02631941|540894428|FG009|Overall Study|Adverse Event|0|||
149933979|NCT02631941|540894419|FG000|Overall Study|Withdrawal by Subject|0|||
149933980|NCT02631941|540894420|FG001|Overall Study|Withdrawal by Subject|0|||
149933981|NCT02631941|540894421|FG002|Overall Study|Withdrawal by Subject|0|||
149933982|NCT02631941|540894422|FG003|Overall Study|Withdrawal by Subject|0|||
149933983|NCT02631941|540894423|FG004|Overall Study|Withdrawal by Subject|1|||
149933984|NCT02631941|540894424|FG005|Overall Study|Withdrawal by Subject|0|||
149933985|NCT02631941|540894425|FG006|Overall Study|Withdrawal by Subject|0|||
149933986|NCT02631941|540894426|FG007|Overall Study|Withdrawal by Subject|1|||
149933987|NCT02631941|540894427|FG008|Overall Study|Withdrawal by Subject|0|||
149933988|NCT02631941|540894428|FG009|Overall Study|Withdrawal by Subject|0|||
149933989|NCT02631941|540894419|FG000|Overall Study|Lost to Follow-up|0|||
149933990|NCT02631941|540894420|FG001|Overall Study|Lost to Follow-up|0|||
149933991|NCT02631941|540894421|FG002|Overall Study|Lost to Follow-up|0|||
149933992|NCT02631941|540894422|FG003|Overall Study|Lost to Follow-up|0|||
149933993|NCT02631941|540894423|FG004|Overall Study|Lost to Follow-up|0|||
149933994|NCT02631941|540894424|FG005|Overall Study|Lost to Follow-up|0|||
149933995|NCT02631941|540894425|FG006|Overall Study|Lost to Follow-up|0|||
149933996|NCT02631941|540894426|FG007|Overall Study|Lost to Follow-up|0|||
149933997|NCT02631941|540894427|FG008|Overall Study|Lost to Follow-up|1|||
149933998|NCT02631941|540894428|FG009|Overall Study|Lost to Follow-up|0|||
149933999|NCT00719901|540894431|FG000|Overall Study|Adverse Event|5|||
149934000|NCT00719901|540894431|FG000|Overall Study|Withdrawal by Subject|1|||
149934001|NCT00719901|540894431|FG000|Overall Study|Alternate Treatment|1|||
149934002|NCT00719901|540894431|FG000|Overall Study|Disease Progression|3|||
149934003|NCT00719901|540894431|FG000|Overall Study|Availability of Study Drug|1|||
149934004|NCT04456686|540894434|FG000|Overall Study|Adverse Event|2|||
149934005|NCT04456686|540894435|FG001|Overall Study|Adverse Event|1|||
149934006|NCT04456686|540894434|FG000|Overall Study|Lack of Efficacy|3|||
149934007|NCT04456686|540894435|FG001|Overall Study|Lack of Efficacy|1|||
149934008|NCT04456686|540894434|FG000|Overall Study|Withdrew consent|3|||
149934009|NCT04456686|540894435|FG001|Overall Study|Withdrew consent|1|||
149934010|NCT04456686|540894434|FG000|Overall Study|Physician Decision|2|||
149934011|NCT04456686|540894435|FG001|Overall Study|Physician Decision|2|||
149934012|NCT04456686|540894434|FG000|Overall Study|Withdrawal by Subject|5|||
149934013|NCT04456686|540894435|FG001|Overall Study|Withdrawal by Subject|1|||
149934014|NCT04456686|540894434|FG000|Overall Study|Protocol Violation|0|||
149934015|NCT04456686|540894435|FG001|Overall Study|Protocol Violation|1|||
149934016|NCT02858401|540894437|FG000|Overall Study|Withdrew Consent|0|||
149934017|NCT02858401|540894438|FG001|Overall Study|Withdrew Consent|0|||
149934018|NCT02858401|540894439|FG002|Overall Study|Withdrew Consent|0|||
149934019|NCT02858401|540894440|FG003|Overall Study|Withdrew Consent|0|||
149934020|NCT02858401|540894441|FG004|Overall Study|Withdrew Consent|0|||
149934021|NCT02858401|540894442|FG005|Overall Study|Withdrew Consent|1|||
149934022|NCT02858401|540894443|FG006|Overall Study|Withdrew Consent|0|||
149934023|NCT02858401|540894437|FG000|Overall Study|Lost to Follow-up|0|||
149934024|NCT02858401|540894438|FG001|Overall Study|Lost to Follow-up|1|||
149934025|NCT02858401|540894439|FG002|Overall Study|Lost to Follow-up|0|||
149934026|NCT02858401|540894440|FG003|Overall Study|Lost to Follow-up|0|||
150269634|NCT02146326|542125308|FG000|Overall Study|Separated from mental health center|23|||
150269635|NCT02146326|542125309|FG001|Overall Study|Separated from mental health center|33|||
149934027|NCT02858401|540894441|FG004|Overall Study|Lost to Follow-up|0|||
149934028|NCT02858401|540894442|FG005|Overall Study|Lost to Follow-up|0|||
149934029|NCT02858401|540894443|FG006|Overall Study|Lost to Follow-up|0|||
149934030|NCT03722576|540894444|FG000|Overall Study|Withdrawal by Subject|3|||
149934031|NCT03722576|540894444|FG000|Overall Study|Adverse Event|2|||
149934032|NCT03722576|540894444|FG000|Overall Study|Physician Decision|1|||
149934033|NCT03722576|540894444|FG000|Overall Study|Lost to Follow-up|1|||
149934034|NCT00748241|540894445|FG000|Overall Study|Implant failure|1|||
149934035|NCT00748241|540894445|FG000|Overall Study|Lost to Follow-up|5|||
149934036|NCT00748241|540894445|FG000|Overall Study|Death|2|||
149934037|NCT01240382|540894446|FG000|Overall Study|Adverse Event|2|||
149934038|NCT01240382|540894447|FG001|Overall Study|Adverse Event|1|||
149934039|NCT01240382|540894446|FG000|Overall Study|Lack of Efficacy|0|||
150167910|NCT02377362|541749631|FG000|Part B Overall|Protocol Violation|0|||
150167911|NCT02377362|541749632|FG001|Part B Overall|Protocol Violation|0|||
150167912|NCT02377362|541749633|FG002|Part B Overall|Protocol Violation|0|||
150167913|NCT02377362|541749634|FG003|Part B Overall|Protocol Violation|0|||
150167914|NCT02377362|541749635|FG004|Part B Overall|Protocol Violation|0|||
150167915|NCT02377362|541749636|FG005|Part B Overall|Protocol Violation|0|||
150167916|NCT02377362|541749637|FG006|Part B Overall|Protocol Violation|0|||
150167917|NCT02377362|541749638|FG007|Part B Overall|Protocol Violation|0|||
150167918|NCT02377362|541749639|FG008|Part B Overall|Protocol Violation|0|||
150167919|NCT02377362|541749640|FG009|Part B Overall|Protocol Violation|1|||
150167920|NCT02377362|541749641|FG010|Part B Overall|Protocol Violation|0|||
150167921|NCT02377362|541749642|FG011|Part B Overall|Protocol Violation|0|||
150167922|NCT02377362|541749643|FG012|Part B Overall|Protocol Violation|0|||
150167923|NCT02377362|541749631|FG000|Part B Overall|Adverse Event|0|||
150167924|NCT02377362|541749632|FG001|Part B Overall|Adverse Event|0|||
150167925|NCT02377362|541749633|FG002|Part B Overall|Adverse Event|0|||
150167926|NCT02377362|541749634|FG003|Part B Overall|Adverse Event|0|||
150167927|NCT02377362|541749635|FG004|Part B Overall|Adverse Event|0|||
150167928|NCT02377362|541749636|FG005|Part B Overall|Adverse Event|0|||
150167929|NCT02377362|541749637|FG006|Part B Overall|Adverse Event|1|||
150167930|NCT02377362|541749638|FG007|Part B Overall|Adverse Event|1|||
150167931|NCT02377362|541749639|FG008|Part B Overall|Adverse Event|0|||
150167932|NCT02377362|541749640|FG009|Part B Overall|Adverse Event|0|||
150167933|NCT02377362|541749641|FG010|Part B Overall|Adverse Event|0|||
150167934|NCT02377362|541749642|FG011|Part B Overall|Adverse Event|0|||
150167935|NCT02377362|541749643|FG012|Part B Overall|Adverse Event|0|||
150167936|NCT02377362|541749631|FG000|Part B Overall|Withdrawal by Subject|0|||
150167937|NCT02377362|541749632|FG001|Part B Overall|Withdrawal by Subject|0|||
150167938|NCT02377362|541749633|FG002|Part B Overall|Withdrawal by Subject|0|||
150167939|NCT02377362|541749634|FG003|Part B Overall|Withdrawal by Subject|0|||
150167940|NCT02377362|541749635|FG004|Part B Overall|Withdrawal by Subject|0|||
150167941|NCT02377362|541749636|FG005|Part B Overall|Withdrawal by Subject|0|||
150167942|NCT02377362|541749637|FG006|Part B Overall|Withdrawal by Subject|1|||
150167943|NCT02377362|541749638|FG007|Part B Overall|Withdrawal by Subject|0|||
150167944|NCT02377362|541749639|FG008|Part B Overall|Withdrawal by Subject|0|||
150167945|NCT02377362|541749640|FG009|Part B Overall|Withdrawal by Subject|0|||
150167946|NCT02377362|541749641|FG010|Part B Overall|Withdrawal by Subject|0|||
150167947|NCT02377362|541749642|FG011|Part B Overall|Withdrawal by Subject|1|||
150167948|NCT02377362|541749643|FG012|Part B Overall|Withdrawal by Subject|0|||
150167949|NCT01190150|541749646|FG000|First Treatment|Withdrawal by Subject|1|||
150167950|NCT01190150|541749647|FG001|First Treatment|Withdrawal by Subject|0|||
150167951|NCT01190150|541749646|FG000|Washout|Withdrawal by Subject|0|||
150167952|NCT01190150|541749647|FG001|Washout|Withdrawal by Subject|1|||
150167953|NCT01190150|541749646|FG000|Washout|Difficulty in adherence|0|||
150167954|NCT01190150|541749647|FG001|Washout|Difficulty in adherence|1|||
150167955|NCT02750709|541749650|FG000|Treatment Period 1|Adverse Event|0|||
150167956|NCT02750709|541749651|FG001|Treatment Period 1|Adverse Event|0|||
150167957|NCT02750709|541749652|FG002|Treatment Period 1|Adverse Event|0|||
150167958|NCT02750709|541749653|FG003|Treatment Period 1|Adverse Event|0|||
150167959|NCT02750709|541749654|FG004|Treatment Period 1|Adverse Event|0|||
150167960|NCT02750709|541749655|FG005|Treatment Period 1|Adverse Event|1|||
150167961|NCT00404079|541749656|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
150167962|NCT00404079|541749657|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
150167963|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Other|4|||
150167964|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Other|0|||
150167965|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
150167966|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
150167967|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
150167968|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
150167969|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
150167970|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
149934040|NCT01240382|540894447|FG001|Overall Study|Lack of Efficacy|2|||
149934041|NCT01240382|540894446|FG000|Overall Study|Fear of adverse events|0|||
150167971|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
150167972|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
150167973|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
150167974|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
150167975|NCT00853827|541749659|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
150167976|NCT00853827|541749660|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
150167977|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
150167978|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
150167979|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
150269636|NCT02146326|542125310|FG002|Overall Study|Separated from mental health center|0|||
150269637|NCT02146326|542125311|FG003|Overall Study|Separated from mental health center|0|||
150269638|NCT02146326|542125308|FG000|Overall Study|Incarcerated|0|||
150269639|NCT02146326|542125309|FG001|Overall Study|Incarcerated|0|||
150269640|NCT02146326|542125310|FG002|Overall Study|Incarcerated|3|||
150269641|NCT02146326|542125311|FG003|Overall Study|Incarcerated|8|||
150269642|NCT02146326|542125308|FG000|Overall Study|Death|0|||
150269643|NCT02146326|542125309|FG001|Overall Study|Death|0|||
150269644|NCT02146326|542125310|FG002|Overall Study|Death|4|||
150269645|NCT02146326|542125311|FG003|Overall Study|Death|4|||
150269646|NCT02146326|542125308|FG000|Overall Study|Unable to complete interview|0|||
150269647|NCT02146326|542125309|FG001|Overall Study|Unable to complete interview|0|||
150269648|NCT02146326|542125310|FG002|Overall Study|Unable to complete interview|10|||
150269649|NCT02146326|542125311|FG003|Overall Study|Unable to complete interview|6|||
150269650|NCT03153111|542125312|FG000|Overall Study|Death|2|||
150269651|NCT03153111|542125313|FG001|Overall Study|Death|5|||
150269652|NCT03153111|542125312|FG000|Overall Study|Lost to Follow-up|1|||
150269653|NCT03153111|542125313|FG001|Overall Study|Lost to Follow-up|0|||
150269654|NCT03153111|542125312|FG000|Overall Study|Physician Decision|5|||
150269655|NCT03153111|542125313|FG001|Overall Study|Physician Decision|1|||
150269656|NCT03153111|542125312|FG000|Overall Study|Withdrawal by Subject|3|||
150269657|NCT03153111|542125313|FG001|Overall Study|Withdrawal by Subject|3|||
150269658|NCT02684357|542125316|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
150269659|NCT02684357|542125317|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
150269660|NCT02684357|542125318|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
150269661|NCT02684357|542125319|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
150269662|NCT02684357|542125320|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
150269663|NCT02684357|542125321|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
150269664|NCT02684357|542125316|FG000|Part A|Lost to Follow-up|0|||
150269665|NCT02684357|542125317|FG001|Part A|Lost to Follow-up|2|||
150269666|NCT02684357|542125318|FG002|Part A|Lost to Follow-up|2|||
150269667|NCT02684357|542125319|FG003|Part A|Lost to Follow-up|0|||
150269668|NCT02684357|542125320|FG004|Part A|Lost to Follow-up|0|||
150269669|NCT02684357|542125321|FG005|Part A|Lost to Follow-up|0|||
150269670|NCT02684357|542125316|FG000|Part A|Withdrawal by Subject|3|||
150269671|NCT02684357|542125317|FG001|Part A|Withdrawal by Subject|0|||
150269672|NCT02684357|542125318|FG002|Part A|Withdrawal by Subject|0|||
150269673|NCT02684357|542125319|FG003|Part A|Withdrawal by Subject|0|||
150269674|NCT02684357|542125320|FG004|Part A|Withdrawal by Subject|0|||
150269675|NCT02684357|542125321|FG005|Part A|Withdrawal by Subject|0|||
150269676|NCT02684357|542125316|FG000|Part A|Other|0|||
150269677|NCT02684357|542125317|FG001|Part A|Other|1|||
150269678|NCT02684357|542125318|FG002|Part A|Other|0|||
150269679|NCT02684357|542125319|FG003|Part A|Other|0|||
150269680|NCT02684357|542125320|FG004|Part A|Other|0|||
150269681|NCT02684357|542125321|FG005|Part A|Other|0|||
150269682|NCT02684357|542125316|FG000|Part B|Adverse Event (Other)|0|||
150269683|NCT02684357|542125317|FG001|Part B|Adverse Event (Other)|0|||
150269684|NCT02684357|542125318|FG002|Part B|Adverse Event (Other)|0|||
150269685|NCT02684357|542125319|FG003|Part B|Adverse Event (Other)|1|||
150269686|NCT02684357|542125320|FG004|Part B|Adverse Event (Other)|1|||
150269687|NCT02684357|542125321|FG005|Part B|Adverse Event (Other)|1|||
150269688|NCT02684357|542125316|FG000|Part B|Lost to Follow-up|0|||
150269689|NCT02684357|542125317|FG001|Part B|Lost to Follow-up|0|||
150269690|NCT02684357|542125318|FG002|Part B|Lost to Follow-up|0|||
150269691|NCT02684357|542125319|FG003|Part B|Lost to Follow-up|1|||
150269692|NCT02684357|542125320|FG004|Part B|Lost to Follow-up|1|||
150269693|NCT02684357|542125321|FG005|Part B|Lost to Follow-up|7|||
150269694|NCT02684357|542125316|FG000|Part B|Withdrawal by Subject|0|||
150269695|NCT02684357|542125317|FG001|Part B|Withdrawal by Subject|0|||
150269696|NCT02684357|542125318|FG002|Part B|Withdrawal by Subject|0|||
149934042|NCT01240382|540894447|FG001|Overall Study|Fear of adverse events|1|||
149934043|NCT02456727|540894448|FG000|Overall Study|Lost to Follow-up|63|||
149934044|NCT02456727|540894449|FG001|Overall Study|Lost to Follow-up|65|||
149934045|NCT02456727|540894448|FG000|Overall Study|Death|2|||
150269697|NCT02684357|542125319|FG003|Part B|Withdrawal by Subject|0|||
150269698|NCT02684357|542125320|FG004|Part B|Withdrawal by Subject|2|||
149934046|NCT02456727|540894449|FG001|Overall Study|Death|1|||
150269699|NCT02684357|542125321|FG005|Part B|Withdrawal by Subject|4|||
150269700|NCT02684357|542125316|FG000|Part B|Other|0|||
150269701|NCT02684357|542125317|FG001|Part B|Other|0|||
150269702|NCT02684357|542125318|FG002|Part B|Other|0|||
150269703|NCT02684357|542125319|FG003|Part B|Other|1|||
150269704|NCT02684357|542125320|FG004|Part B|Other|0|||
150269705|NCT02684357|542125321|FG005|Part B|Other|1|||
150269706|NCT01079130|542125322|FG000|Overall Study|Adverse Event|1|||
150269707|NCT01079130|542125323|FG001|Overall Study|Adverse Event|1|||
150269708|NCT01079130|542125324|FG002|Overall Study|Adverse Event|0|||
150269709|NCT01079130|542125325|FG003|Overall Study|Adverse Event|1|||
150269710|NCT01079130|542125326|FG004|Overall Study|Adverse Event|5|||
150269711|NCT01079130|542125327|FG005|Overall Study|Adverse Event|1|||
150269712|NCT01079130|542125322|FG000|Overall Study|Administrative problems|1|||
149934047|NCT02456727|540894448|FG000|Overall Study|Withdrawal by Subject|1|||
149934048|NCT02456727|540894449|FG001|Overall Study|Withdrawal by Subject|10|||
149934049|NCT02456727|540894448|FG000|Overall Study|Never Initiated Treatment|43|||
149934050|NCT02456727|540894449|FG001|Overall Study|Never Initiated Treatment|30|||
149934051|NCT02643693|540894450|FG000|Overall Study|Physician Decision|0|||
149934052|NCT02643693|540894451|FG001|Overall Study|Physician Decision|1|||
149934053|NCT02643693|540894452|FG002|Overall Study|Physician Decision|0|||
149934054|NCT02643693|540894453|FG003|Overall Study|Physician Decision|0|||
149934055|NCT02643693|540894454|FG004|Overall Study|Physician Decision|0|||
149934056|NCT02643693|540894455|FG005|Overall Study|Physician Decision|0|||
149934057|NCT02643693|540894450|FG000|Overall Study|Withdrawal by Subject|0|||
149934058|NCT02643693|540894451|FG001|Overall Study|Withdrawal by Subject|1|||
149934059|NCT02643693|540894452|FG002|Overall Study|Withdrawal by Subject|0|||
149934060|NCT02643693|540894453|FG003|Overall Study|Withdrawal by Subject|0|||
149934061|NCT02643693|540894454|FG004|Overall Study|Withdrawal by Subject|0|||
149934062|NCT02643693|540894455|FG005|Overall Study|Withdrawal by Subject|0|||
149934063|NCT02643693|540894450|FG000|Overall Study|Protocol Adherence Issues|2|||
149934064|NCT02643693|540894451|FG001|Overall Study|Protocol Adherence Issues|0|||
149934065|NCT02643693|540894452|FG002|Overall Study|Protocol Adherence Issues|1|||
149934066|NCT02643693|540894453|FG003|Overall Study|Protocol Adherence Issues|0|||
149934067|NCT02643693|540894454|FG004|Overall Study|Protocol Adherence Issues|0|||
149934068|NCT02643693|540894455|FG005|Overall Study|Protocol Adherence Issues|1|||
149934069|NCT00492297|540894456|FG000|Treatment|Death|2|||
149934070|NCT00492297|540894456|FG000|Treatment|Study terminated by sponsor|3|||
149934071|NCT00492297|540894456|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
149934072|NCT00492297|540894456|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
149934073|NCT00492297|540894456|FG000|Survival Only Follow-up|Death|46|||
149934074|NCT00492297|540894456|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
149934075|NCT00492297|540894456|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
149934076|NCT01408706|540894458|FG000|Overall Study|Physician Decision|1|||
149934077|NCT01408706|540894459|FG001|Overall Study|Physician Decision|0|||
149934078|NCT01268267|540894460|FG000|Overall Study|Protocol Violation|1|||
149934079|NCT01222104|540894461|FG000|Overall Study|Lost to Follow-up|37|||
149934080|NCT01222104|540894461|FG000|Overall Study|Death|10|||
149934081|NCT00888654|540894463|FG000|Overall Study|Problems swallowing oral meds.|1|||
149934082|NCT00888654|540894463|FG000|Overall Study|Not enough oral meds before surgery|3|||
149934083|NCT00888654|540894463|FG000|Overall Study|Surgery aborted|2|||
149934084|NCT00888654|540894463|FG000|Overall Study|Withdrawal by Subject|1|||
149934085|NCT00888654|540894463|FG000|Overall Study|Inelig. due to contraindication of med|1|||
149934086|NCT00888654|540894463|FG000|Overall Study|Change in surg date|1|||
149934087|NCT00888654|540894463|FG000|Overall Study|Stopped meds due to headaches|1|||
149934088|NCT01418339|540894464|FG000|Overall Study|Adverse Event|5|||
149934089|NCT01418339|540894465|FG001|Overall Study|Adverse Event|2|||
149975529|NCT01193101|541047872|FG001|Overall Study|Adverse Event|1|||
150167980|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
150167981|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
150167982|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
150167983|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
150167984|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
150167985|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
150167986|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
150167987|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
150167988|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
150167989|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
150167990|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
150167991|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
150167992|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
150167993|NCT00853827|541749659|FG000|Double Blind Period (103 Weeks)|Death|1|||
150167994|NCT00853827|541749660|FG001|Double Blind Period (103 Weeks)|Death|6|||
150167995|NCT00290732|541749662|FG000|Overall Study|Inability to instill drug intraductally.|0|||
150167996|NCT00290732|541749663|FG001|Overall Study|Inability to instill drug intraductally.|1|||
150167997|NCT00290732|541749664|FG002|Overall Study|Inability to instill drug intraductally.|1|||
150167998|NCT00290732|541749665|FG003|Overall Study|Inability to instill drug intraductally.|0|||
150167999|NCT00290732|541749666|FG004|Overall Study|Inability to instill drug intraductally.|0|||
150168000|NCT00843193|541749667|FG000|Overall Study|Adverse Event|2|||
150168001|NCT00843193|541749668|FG001|Overall Study|Adverse Event|4|||
150168002|NCT00843193|541749667|FG000|Overall Study|Lack of Efficacy|1|||
150168003|NCT00843193|541749668|FG001|Overall Study|Lack of Efficacy|1|||
150168004|NCT00843193|541749667|FG000|Overall Study|Protocol Violation|1|||
150168005|NCT00843193|541749668|FG001|Overall Study|Protocol Violation|2|||
150168006|NCT00843193|541749667|FG000|Overall Study|Lost to Follow-up|1|||
150168007|NCT00843193|541749668|FG001|Overall Study|Lost to Follow-up|0|||
150168008|NCT00843193|541749667|FG000|Overall Study|Physician Decision|0|||
150168009|NCT00843193|541749668|FG001|Overall Study|Physician Decision|1|||
150269713|NCT01079130|542125323|FG001|Overall Study|Administrative problems|3|||
150269714|NCT01079130|542125324|FG002|Overall Study|Administrative problems|0|||
150269715|NCT01079130|542125325|FG003|Overall Study|Administrative problems|0|||
150269716|NCT01079130|542125326|FG004|Overall Study|Administrative problems|0|||
150269717|NCT01079130|542125327|FG005|Overall Study|Administrative problems|1|||
150269718|NCT01079130|542125322|FG000|Overall Study|Withdrawal by Subject|0|||
150269719|NCT01079130|542125323|FG001|Overall Study|Withdrawal by Subject|1|||
150269720|NCT01079130|542125324|FG002|Overall Study|Withdrawal by Subject|0|||
150269721|NCT01079130|542125325|FG003|Overall Study|Withdrawal by Subject|0|||
150269722|NCT01079130|542125326|FG004|Overall Study|Withdrawal by Subject|1|||
150269723|NCT01079130|542125327|FG005|Overall Study|Withdrawal by Subject|3|||
150269724|NCT01079130|542125322|FG000|Overall Study|Protocol deviation|0|||
150269725|NCT01079130|542125323|FG001|Overall Study|Protocol deviation|2|||
150269726|NCT01079130|542125324|FG002|Overall Study|Protocol deviation|1|||
150269727|NCT01079130|542125325|FG003|Overall Study|Protocol deviation|2|||
150269728|NCT01079130|542125326|FG004|Overall Study|Protocol deviation|0|||
150269729|NCT01079130|542125327|FG005|Overall Study|Protocol deviation|0|||
150269730|NCT01079130|542125322|FG000|Overall Study|Abnormal test procedure result(s)|0|||
150269731|NCT01079130|542125323|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150269732|NCT01079130|542125324|FG002|Overall Study|Abnormal test procedure result(s)|0|||
150269733|NCT01079130|542125325|FG003|Overall Study|Abnormal test procedure result(s)|0|||
150269734|NCT01079130|542125326|FG004|Overall Study|Abnormal test procedure result(s)|1|||
150269735|NCT01079130|542125327|FG005|Overall Study|Abnormal test procedure result(s)|0|||
150269736|NCT01079130|542125322|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150269737|NCT01079130|542125323|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150269738|NCT01079130|542125324|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
150269739|NCT01079130|542125325|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
150269740|NCT01079130|542125326|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
150269741|NCT01079130|542125327|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
150269742|NCT01079130|542125322|FG000|Overall Study|Lost to Follow-up|0|||
150269743|NCT01079130|542125323|FG001|Overall Study|Lost to Follow-up|0|||
150269744|NCT01079130|542125324|FG002|Overall Study|Lost to Follow-up|0|||
150269745|NCT01079130|542125325|FG003|Overall Study|Lost to Follow-up|0|||
150269746|NCT01079130|542125326|FG004|Overall Study|Lost to Follow-up|1|||
150269747|NCT01079130|542125327|FG005|Overall Study|Lost to Follow-up|0|||
150269748|NCT01853982|542125328|FG000|Overall Study|Withdrawal by Subject|1|||
150269749|NCT01853982|542125329|FG001|Overall Study|Withdrawal by Subject|0|||
150269750|NCT01853982|542125328|FG000|Overall Study|Death|1|||
150269751|NCT01853982|542125329|FG001|Overall Study|Death|0|||
150269752|NCT01853982|542125328|FG000|Overall Study|Lost to Follow-up|0|||
150269753|NCT01853982|542125329|FG001|Overall Study|Lost to Follow-up|1|||
150269754|NCT00390910|542125330|FG000|Overall Study|Adverse Event|1|||
150269755|NCT00390910|542125331|FG001|Overall Study|Adverse Event|0|||
150269756|NCT00390910|542125332|FG002|Overall Study|Adverse Event|0|||
150269757|NCT00390910|542125330|FG000|Overall Study|Lost to Follow-up|0|||
150269758|NCT00390910|542125331|FG001|Overall Study|Lost to Follow-up|1|||
150269759|NCT00390910|542125332|FG002|Overall Study|Lost to Follow-up|5|||
150269760|NCT00390910|542125330|FG000|Overall Study|Withdrawal by Subject|1|||
150269761|NCT00390910|542125331|FG001|Overall Study|Withdrawal by Subject|3|||
150269762|NCT00390910|542125332|FG002|Overall Study|Withdrawal by Subject|2|||
150269763|NCT00390910|542125330|FG000|Overall Study|Migrated/moved from study area|0|||
150269764|NCT00390910|542125331|FG001|Overall Study|Migrated/moved from study area|0|||
150269765|NCT00390910|542125332|FG002|Overall Study|Migrated/moved from study area|3|||
150269766|NCT01839487|542125333|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
150269767|NCT01839487|542125334|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
150269768|NCT01839487|542125335|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149934090|NCT01418339|540894464|FG000|Overall Study|Subject Withdrew Consent|1|||
150269769|NCT01839487|542125336|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
150269770|NCT01839487|542125337|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149934091|NCT01418339|540894465|FG001|Overall Study|Subject Withdrew Consent|2|||
149934092|NCT01418339|540894464|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
149934093|NCT01418339|540894465|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
149934094|NCT03669549|540894468|FG000|Overall Study|Adverse Event|4|||
149934095|NCT03669549|540894468|FG000|Overall Study|Withdrawal by Subject|1|||
150269771|NCT01839487|542125338|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
150269772|NCT01839487|542125333|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
150269773|NCT01839487|542125334|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
150269774|NCT01839487|542125335|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
150269775|NCT01839487|542125336|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
150269776|NCT01839487|542125337|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
150269777|NCT01839487|542125338|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
150269778|NCT01839487|542125333|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
150269779|NCT01839487|542125334|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
149934096|NCT03669549|540894468|FG000|Overall Study|Study terminated by the Sponsor|1|||
149934097|NCT00909844|540894469|FG000|Overall Study|Adverse Event|1|||
149934098|NCT00909844|540894469|FG000|Overall Study|Withdrawal by Subject|1|||
149934099|NCT00909844|540894469|FG000|Overall Study|Lost to Follow-up|2|||
149934100|NCT02974868|540894471|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
149934101|NCT02974868|540894472|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
149934102|NCT02974868|540894473|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
149934103|NCT02974868|540894474|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
149934104|NCT02974868|540894471|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
149934105|NCT02974868|540894472|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
150269780|NCT01839487|542125335|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
150269781|NCT01839487|542125336|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
150269782|NCT01839487|542125337|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
150269783|NCT01839487|542125338|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
150269784|NCT01839487|542125333|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
150269785|NCT01839487|542125334|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
150269786|NCT01839487|542125335|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
150269787|NCT01839487|542125336|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
150269788|NCT01839487|542125337|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
150269789|NCT01839487|542125338|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
150269790|NCT01839487|542125333|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
150269791|NCT01839487|542125334|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
150269792|NCT01839487|542125335|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
150269793|NCT01839487|542125336|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
150269794|NCT01839487|542125337|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
150269795|NCT01839487|542125338|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
150269796|NCT01839487|542125333|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
150269797|NCT01839487|542125334|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
150269798|NCT01839487|542125335|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
150269799|NCT01839487|542125336|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
150269800|NCT01839487|542125337|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
150269801|NCT01839487|542125338|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
150269802|NCT01839487|542125333|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
150269803|NCT01839487|542125334|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
150269804|NCT01839487|542125335|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
150269805|NCT01839487|542125336|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
150269806|NCT01839487|542125337|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
150269807|NCT01839487|542125338|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
150269808|NCT01839487|542125333|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
150269809|NCT01839487|542125334|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
150269810|NCT01839487|542125335|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
150269811|NCT01839487|542125336|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
150269812|NCT01839487|542125337|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
150269813|NCT01839487|542125338|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
150269814|NCT01839487|542125333|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
150269815|NCT01839487|542125334|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
150269816|NCT01839487|542125335|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
150269817|NCT01839487|542125336|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
150269818|NCT01839487|542125337|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
150269819|NCT01839487|542125338|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
150269820|NCT01658826|542125344|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
150269821|NCT01658826|542125345|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
150269822|NCT01658826|542125344|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
150269823|NCT01658826|542125345|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
150269824|NCT01658826|542125344|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
150269825|NCT01658826|542125345|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
150269826|NCT01658826|542125344|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
150269827|NCT01658826|542125345|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
150269828|NCT01658826|542125344|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
149934106|NCT02974868|540894473|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
149934107|NCT02974868|540894474|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
149934108|NCT02974868|540894471|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
149934109|NCT02974868|540894472|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
150269829|NCT01658826|542125345|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
149934110|NCT02974868|540894473|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
149934111|NCT02974868|540894474|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
149934112|NCT02974868|540894471|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
149934113|NCT02974868|540894472|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
149934114|NCT02974868|540894473|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
149934115|NCT02974868|540894474|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
149934116|NCT00706004|540894475|FG000|Overall Study|Did not meet eligibility criteria|2|||
149934117|NCT02674516|540894476|FG000|Overall Study|Lost to Follow-up|3|||
149934118|NCT02674516|540894477|FG001|Overall Study|Lost to Follow-up|0|||
149934119|NCT02674516|540894476|FG000|Overall Study|Protocol Violation|0|||
149934120|NCT02674516|540894477|FG001|Overall Study|Protocol Violation|4|||
150168010|NCT00843193|541749667|FG000|Overall Study|Withdrawal by Subject|3|||
150168011|NCT00843193|541749668|FG001|Overall Study|Withdrawal by Subject|3|||
150168012|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
150168013|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
150168014|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
150168015|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
150168016|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
150168017|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
150168018|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
150168019|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
150168020|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
150168021|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
150168022|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
150168023|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
150168024|NCT02057718|541749669|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
150168025|NCT02057718|541749670|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
150168026|NCT02057718|541749669|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
150168027|NCT02057718|541749670|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
150168028|NCT02057718|541749669|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
150168029|NCT02057718|541749670|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
150168030|NCT02057718|541749669|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
150168031|NCT02057718|541749670|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
150168032|NCT02057718|541749669|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
150168033|NCT02057718|541749670|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
150168034|NCT02512042|541749673|FG000|Overall Study|Adverse Event|0|||
150168035|NCT02512042|541749674|FG001|Overall Study|Adverse Event|4|||
150168036|NCT02512042|541749673|FG000|Overall Study|Withdrawal by Subject|6|||
150168037|NCT02512042|541749674|FG001|Overall Study|Withdrawal by Subject|6|||
150168038|NCT02512042|541749673|FG000|Overall Study|Non-compliance with study drug|1|||
150168039|NCT02512042|541749674|FG001|Overall Study|Non-compliance with study drug|2|||
150168040|NCT02512042|541749673|FG000|Overall Study|Lost to Follow-up|5|||
150168041|NCT02512042|541749674|FG001|Overall Study|Lost to Follow-up|2|||
150168042|NCT02512042|541749673|FG000|Overall Study|Other|11|||
150168043|NCT02512042|541749674|FG001|Overall Study|Other|11|||
150168044|NCT03563053|541749677|FG000|Overall Study|Withdrawal by Subject|17|||
150168045|NCT03563053|541749677|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
150168046|NCT03563053|541749677|FG000|Overall Study|Adverse Event|3|||
150168047|NCT03563053|541749677|FG000|Overall Study|Physician Decision|1|||
150168048|NCT03563053|541749677|FG000|Overall Study|study terminated by sponsor|71|||
150168049|NCT00124982|541749678|FG000|Short-term Period|Death|1|||
150168050|NCT00124982|541749679|FG001|Short-term Period|Death|1|||
150168051|NCT00124982|541749680|FG002|Short-term Period|Death|0|||
150168052|NCT00124982|541749678|FG000|Short-term Period|Adverse Event|17|||
150168053|NCT00124982|541749679|FG001|Short-term Period|Adverse Event|22|||
150168054|NCT00124982|541749680|FG002|Short-term Period|Adverse Event|0|||
150168055|NCT00124982|541749678|FG000|Short-term Period|Lack of Efficacy|32|||
150168056|NCT00124982|541749679|FG001|Short-term Period|Lack of Efficacy|73|||
150168057|NCT00124982|541749680|FG002|Short-term Period|Lack of Efficacy|0|||
150168058|NCT00124982|541749678|FG000|Short-term Period|Lost to Follow-up|8|||
150168059|NCT00124982|541749679|FG001|Short-term Period|Lost to Follow-up|5|||
150168060|NCT00124982|541749680|FG002|Short-term Period|Lost to Follow-up|0|||
150168061|NCT00124982|541749678|FG000|Short-term Period|Withdrawal of Consent|7|||
150168062|NCT00124982|541749679|FG001|Short-term Period|Withdrawal of Consent|9|||
150168063|NCT00124982|541749680|FG002|Short-term Period|Withdrawal of Consent|0|||
150168064|NCT00124982|541749678|FG000|Short-term Period|Poor/Non-compliance|3|||
150168065|NCT00124982|541749679|FG001|Short-term Period|Poor/Non-compliance|1|||
150168066|NCT00124982|541749680|FG002|Short-term Period|Poor/Non-compliance|0|||
150168067|NCT00124982|541749678|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
150168068|NCT00124982|541749679|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
150168069|NCT00124982|541749680|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
150269830|NCT01658826|542125344|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
150269831|NCT01658826|542125345|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
150269832|NCT01658826|542125344|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
150269833|NCT01658826|542125345|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
150269834|NCT01658826|542125344|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
150269835|NCT01658826|542125345|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
150269836|NCT01658826|542125344|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
150269837|NCT01658826|542125345|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
150269838|NCT06071754|542125346|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
150269839|NCT04567615|542125347|FG000|Randomization|Participant withdrew consent|1|||
150269840|NCT04567615|542125348|FG001|Randomization|Participant withdrew consent|0|||
150269841|NCT04567615|542125349|FG002|Randomization|Participant withdrew consent|0|||
150269842|NCT04567615|542125347|FG000|Randomization|Adverse event unrelated to study drug|0|||
150269843|NCT04567615|542125348|FG001|Randomization|Adverse event unrelated to study drug|1|||
150269844|NCT04567615|542125349|FG002|Randomization|Adverse event unrelated to study drug|0|||
150269845|NCT04567615|542125347|FG000|Treatment Period|Participant Withdrew Consent|2|||
150269846|NCT04567615|542125348|FG001|Treatment Period|Participant Withdrew Consent|5|||
150269847|NCT04567615|542125349|FG002|Treatment Period|Participant Withdrew Consent|1|||
150269848|NCT04567615|542125347|FG000|Treatment Period|Death|1|||
150269849|NCT04567615|542125348|FG001|Treatment Period|Death|2|||
150269850|NCT04567615|542125349|FG002|Treatment Period|Death|0|||
150269851|NCT04567615|542125347|FG000|Treatment Period|Lost to Follow-up|0|||
150269852|NCT04567615|542125348|FG001|Treatment Period|Lost to Follow-up|1|||
150269853|NCT04567615|542125349|FG002|Treatment Period|Lost to Follow-up|0|||
150269854|NCT04567615|542125347|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
150269855|NCT04567615|542125348|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
150269856|NCT04567615|542125349|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
150269857|NCT04567615|542125347|FG000|Treatment Period|Disease Progression|85|||
150269858|NCT04567615|542125348|FG001|Treatment Period|Disease Progression|63|||
150269859|NCT04567615|542125349|FG002|Treatment Period|Disease Progression|16|||
150269860|NCT04567615|542125347|FG000|Treatment Period|Study Drug Toxicity|3|||
150269861|NCT04567615|542125348|FG001|Treatment Period|Study Drug Toxicity|10|||
150269862|NCT04567615|542125349|FG002|Treatment Period|Study Drug Toxicity|4|||
149934121|NCT02674516|540894476|FG000|Overall Study|Knowledge of study hypothesis|1|||
150269863|NCT04567615|542125347|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
150269864|NCT04567615|542125348|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
150269865|NCT04567615|542125349|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
150269866|NCT04567615|542125347|FG000|Treatment Period|Other Reasons|1|||
150269867|NCT04567615|542125348|FG001|Treatment Period|Other Reasons|2|||
150269868|NCT04567615|542125349|FG002|Treatment Period|Other Reasons|0|||
150269869|NCT04567615|542125347|FG000|Treatment Period|Still On-going Treatment|21|||
150269870|NCT04567615|542125348|FG001|Treatment Period|Still On-going Treatment|22|||
150269871|NCT04567615|542125349|FG002|Treatment Period|Still On-going Treatment|2|||
150269872|NCT05028517|542125350|FG000|Overall Study|Lost to Follow-up|13|||
150269873|NCT05028517|542125351|FG001|Overall Study|Lost to Follow-up|20|||
150269874|NCT05028517|542125352|FG002|Overall Study|Lost to Follow-up|12|||
150269875|NCT05028517|542125350|FG000|Overall Study|Withdrawal by Subject|0|||
150269876|NCT05028517|542125351|FG001|Overall Study|Withdrawal by Subject|0|||
150269877|NCT05028517|542125352|FG002|Overall Study|Withdrawal by Subject|1|||
150269878|NCT00909792|542127301|FG000|Period 1|Did not meet inclusion criteria|0|||
150269879|NCT00909792|542127302|FG001|Period 1|Did not meet inclusion criteria|1|||
150269880|NCT00909792|542127301|FG000|Period 2|Biomicroscopy|1|||
150269881|NCT00909792|542127302|FG001|Period 2|Biomicroscopy|0|||
150269882|NCT00909792|542127301|FG000|Period 2|Lost to Follow-up|0|||
150269883|NCT00909792|542127302|FG001|Period 2|Lost to Follow-up|1|||
150269884|NCT04964960|542127303|FG000|Overall Study|Withdrawal by Subject|1|||
149934122|NCT02674516|540894477|FG001|Overall Study|Knowledge of study hypothesis|0|||
149934123|NCT01064479|540894478|FG000|Overall Study|Death|10|||
149934124|NCT01064479|540894479|FG001|Overall Study|Death|11|||
150269885|NCT04964960|542127303|FG000|Overall Study|Did not complete cycles|1|||
150269886|NCT02960854|542127304|FG000|Overall Study|Not Disclosed|2|||
150269887|NCT02960854|542127305|FG001|Overall Study|Not Disclosed|2|||
150269888|NCT02960854|542127304|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
150269889|NCT02960854|542127305|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
150269890|NCT02960854|542127304|FG000|Overall Study|Subject Withdrew Consent|0|||
150269891|NCT02960854|542127305|FG001|Overall Study|Subject Withdrew Consent|1|||
150269892|NCT02960854|542127304|FG000|Overall Study|Death|4|||
150269893|NCT02960854|542127305|FG001|Overall Study|Death|6|||
150269894|NCT00221195|542127306|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
149934125|NCT01064479|540894478|FG000|Overall Study|Withdrawal by Subject|2|||
149934126|NCT01064479|540894479|FG001|Overall Study|Withdrawal by Subject|2|||
150269895|NCT00221195|542127307|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
150269896|NCT00221195|542127306|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
150269897|NCT00221195|542127307|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
150269898|NCT00221195|542127306|FG000|Washout Period (Months 7-9)|Death|0|||
150269899|NCT00221195|542127307|FG001|Washout Period (Months 7-9)|Death|1|||
150269900|NCT00221195|542127306|FG000|Therapy 2 (Months 10-15)|Death|1|||
150269901|NCT00221195|542127307|FG001|Therapy 2 (Months 10-15)|Death|0|||
150269902|NCT00221195|542127306|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
150269903|NCT00221195|542127307|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
150269904|NCT00833911|542127309|FG000|Titration|Adverse Event|18|||
150269905|NCT00833911|542127309|FG000|Titration|Withdrawal by Subject|3|||
150269906|NCT00833911|542127309|FG000|Maintenance Phase I|Adverse Event|73|||
150269907|NCT00833911|542127309|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
150269908|NCT00833911|542127309|FG000|Maintenance Phase I|Physician Decision|10|||
150269909|NCT00833911|542127309|FG000|Maintenance Phase I|Lack of Efficacy|4|||
150269910|NCT00833911|542127309|FG000|Maintenance Phase II|Adverse Event|6|||
150269911|NCT00833911|542127309|FG000|Maintenance Phase II|Physician Decision|2|||
150269912|NCT00833911|542127309|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
150269913|NCT00833911|542127309|FG000|Maintenance Phase II|Lack of Efficacy|1|||
150269914|NCT01423812|542127318|FG000|Overall Study|Lost to Follow-up|2|||
150269915|NCT01423812|542127319|FG001|Overall Study|Lost to Follow-up|2|||
150269916|NCT01423812|542127318|FG000|Overall Study|Withdrawal by Subject|1|||
150269917|NCT01423812|542127319|FG001|Overall Study|Withdrawal by Subject|2|||
150269918|NCT02596620|542127322|FG000|Overall Study|Lost to Follow-up|1|||
150269919|NCT02596620|542127323|FG001|Overall Study|Lost to Follow-up|1|||
150029381|NCT05635461|541244185|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
150029382|NCT05635461|541244186|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
150029383|NCT05635461|541244187|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
150029384|NCT05635461|541244188|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
150269920|NCT03155373|542127324|FG000|Overall Study|No longer required surgery|1|||
150269921|NCT03155373|542127324|FG000|Overall Study|Protocol Violation|1|||
150269922|NCT03155373|542127324|FG000|Overall Study|Death|2|||
150269923|NCT03155373|542127324|FG000|Overall Study|Withdrawal by Subject|3|||
150269924|NCT01054144|542127325|FG000|Overall Study|Death|2|||
150269925|NCT02616614|542127326|FG000|Overall Study|Withdrawal by Subject|10|||
150029385|NCT05635461|541244183|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
150029386|NCT05635461|541244184|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
150029387|NCT05635461|541244185|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
150029388|NCT05635461|541244186|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
150029389|NCT05635461|541244187|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
150029390|NCT05635461|541244188|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
150029391|NCT05635461|541244183|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
150029392|NCT05635461|541244184|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
150029393|NCT05635461|541244185|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
150029394|NCT05635461|541244186|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
150029395|NCT05635461|541244187|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
150029396|NCT05635461|541244188|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
150029397|NCT01620060|541244189|FG000|Overall Study|Adverse Event|9|||
150029398|NCT01620060|541244189|FG000|Overall Study|Protocol Violation|1|||
150029399|NCT01620060|541244189|FG000|Overall Study|Withdrawal by Subject|1|||
150029400|NCT01620060|541244189|FG000|Overall Study|Did not comply with Study Produre|1|||
150029401|NCT01620060|541244189|FG000|Overall Study|Family emergency|1|||
150029402|NCT01620060|541244189|FG000|Overall Study|Per Sponsor Decision|2|||
150029403|NCT02269124|541244190|FG000|Overall Study|Lost to Follow-up|1|||
150029404|NCT02269124|541244191|FG001|Overall Study|Lost to Follow-up|0|||
150029405|NCT02269124|541244190|FG000|Overall Study|Withdrawal by Subject|0|||
150029406|NCT02269124|541244191|FG001|Overall Study|Withdrawal by Subject|2|||
150029407|NCT03452540|541244193|FG000|Overall Study|Adverse Event|1|||
150029408|NCT03452540|541244193|FG000|Overall Study|Withdrawal by Subject|1|||
150029409|NCT03452540|541244193|FG000|Overall Study|Other SAE and AE|2|||
150029410|NCT01582061|541244194|FG000|Overall Study|Lack of Efficacy|3|||
150029411|NCT01582061|541244195|FG001|Overall Study|Lack of Efficacy|23|||
150029412|NCT01582061|541244194|FG000|Overall Study|Adverse Event|12|||
150029413|NCT01582061|541244195|FG001|Overall Study|Adverse Event|8|||
150029414|NCT01582061|541244194|FG000|Overall Study|Withdrawal by Subject|10|||
150029415|NCT01582061|541244195|FG001|Overall Study|Withdrawal by Subject|4|||
150029416|NCT01582061|541244194|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150029417|NCT01582061|541244195|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150029418|NCT01582061|541244194|FG000|Overall Study|Death|0|||
150029419|NCT01582061|541244195|FG001|Overall Study|Death|1|||
150029420|NCT01582061|541244194|FG000|Overall Study|condition no longer requires study drug|1|||
150029421|NCT01582061|541244195|FG001|Overall Study|condition no longer requires study drug|0|||
150029422|NCT01582061|541244194|FG000|Overall Study|Lost to Follow-up|1|||
150029423|NCT01582061|541244195|FG001|Overall Study|Lost to Follow-up|0|||
150269926|NCT02616614|542127327|FG001|Overall Study|Withdrawal by Subject|5|||
150269927|NCT02616614|542127328|FG002|Overall Study|Withdrawal by Subject|6|||
149934127|NCT01064479|540894478|FG000|Overall Study|Disease progression|1|||
149934128|NCT01064479|540894479|FG001|Overall Study|Disease progression|1|||
149934129|NCT01064479|540894478|FG000|Overall Study|Toxicity|1|||
149934130|NCT01064479|540894479|FG001|Overall Study|Toxicity|1|||
149934131|NCT01064479|540894478|FG000|Overall Study|Other|1|||
149934132|NCT01064479|540894479|FG001|Overall Study|Other|2|||
149934133|NCT01900444|540894484|FG000|Overall Study|Protocol Violation|2|||
149934134|NCT01900444|540894484|FG000|Overall Study|Lost to Follow-up|1|||
149934135|NCT00072384|540894485|FG000|Overall Study|Physician Decision|1|||
150168070|NCT00124982|541749678|FG000|Short-term Period|Participant Decision|1|||
150029424|NCT01045460|541244198|FG000|Overall Study|Physician Decision|3|||
150029425|NCT01045460|541244199|FG001|Overall Study|Physician Decision|2|||
150029426|NCT01045460|541244198|FG000|Overall Study|Lost to Follow-up|0|||
150029427|NCT01045460|541244199|FG001|Overall Study|Lost to Follow-up|1|||
150029428|NCT01045460|541244198|FG000|Overall Study|Lack of Efficacy|3|||
150029429|NCT01045460|541244199|FG001|Overall Study|Lack of Efficacy|0|||
150029430|NCT04664153|541244200|FG000|Overall Study|Lack of Efficacy|0|||
150029431|NCT04664153|541244201|FG001|Overall Study|Lack of Efficacy|0|||
150029432|NCT04664153|541244202|FG002|Overall Study|Lack of Efficacy|1|||
150029433|NCT04664153|541244203|FG003|Overall Study|Lack of Efficacy|0|||
150029434|NCT04664153|541244200|FG000|Overall Study|Physician Decision|0|||
150029435|NCT04664153|541244201|FG001|Overall Study|Physician Decision|0|||
150029436|NCT04664153|541244202|FG002|Overall Study|Physician Decision|1|||
150029437|NCT04664153|541244203|FG003|Overall Study|Physician Decision|0|||
150029438|NCT04664153|541244200|FG000|Overall Study|Withdrawal by Subject|3|||
150029439|NCT04664153|541244201|FG001|Overall Study|Withdrawal by Subject|2|||
150029440|NCT04664153|541244202|FG002|Overall Study|Withdrawal by Subject|1|||
150029441|NCT04664153|541244203|FG003|Overall Study|Withdrawal by Subject|2|||
150029442|NCT04664153|541244200|FG000|Overall Study|Other|0|||
150029443|NCT04664153|541244201|FG001|Overall Study|Other|1|||
150029444|NCT04664153|541244202|FG002|Overall Study|Other|0|||
150029445|NCT04664153|541244203|FG003|Overall Study|Other|0|||
150029446|NCT04664153|541244200|FG000|Overall Study|Adverse Event|4|||
150029447|NCT04664153|541244201|FG001|Overall Study|Adverse Event|0|||
150029448|NCT04664153|541244202|FG002|Overall Study|Adverse Event|1|||
150168071|NCT00124982|541749679|FG001|Short-term Period|Participant Decision|0|||
150168072|NCT00124982|541749680|FG002|Short-term Period|Participant Decision|0|||
150168073|NCT00124982|541749678|FG000|Short-term Period|Participant Chose Own Doctor|0|||
150168074|NCT00124982|541749679|FG001|Short-term Period|Participant Chose Own Doctor|1|||
150168075|NCT00124982|541749680|FG002|Short-term Period|Participant Chose Own Doctor|0|||
150168076|NCT00124982|541749678|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
150168077|NCT00124982|541749679|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
150168078|NCT00124982|541749680|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
150168079|NCT00124982|541749678|FG000|Short-term Period|Participant Had Lymphopenia|1|||
150168080|NCT00124982|541749679|FG001|Short-term Period|Participant Had Lymphopenia|0|||
150168081|NCT00124982|541749680|FG002|Short-term Period|Participant Had Lymphopenia|0|||
150168082|NCT00124982|541749678|FG000|Long-term Period|Death|0|||
150168083|NCT00124982|541749679|FG001|Long-term Period|Death|0|||
150168084|NCT00124982|541749680|FG002|Long-term Period|Death|1|||
150168085|NCT00124982|541749678|FG000|Long-term Period|Adverse Event|0|||
150168086|NCT00124982|541749679|FG001|Long-term Period|Adverse Event|0|||
150168087|NCT00124982|541749680|FG002|Long-term Period|Adverse Event|17|||
150168088|NCT00124982|541749678|FG000|Long-term Period|Lack of Efficacy|0|||
150168089|NCT00124982|541749679|FG001|Long-term Period|Lack of Efficacy|0|||
150168090|NCT00124982|541749680|FG002|Long-term Period|Lack of Efficacy|46|||
150168091|NCT00124982|541749678|FG000|Long-term Period|Lost to Follow-up|0|||
150168092|NCT00124982|541749679|FG001|Long-term Period|Lost to Follow-up|0|||
150168093|NCT00124982|541749680|FG002|Long-term Period|Lost to Follow-up|4|||
150168094|NCT00124982|541749678|FG000|Long-term Period|Withdrawal by Subject|0|||
150168095|NCT00124982|541749679|FG001|Long-term Period|Withdrawal by Subject|0|||
150168096|NCT00124982|541749680|FG002|Long-term Period|Withdrawal by Subject|16|||
150168097|NCT00124982|541749678|FG000|Long-term Period|Pregnancy|0|||
150168098|NCT00124982|541749679|FG001|Long-term Period|Pregnancy|0|||
150168099|NCT00124982|541749680|FG002|Long-term Period|Pregnancy|1|||
150168100|NCT00124982|541749678|FG000|Long-term Period|Poor/Non-compliance|0|||
150168101|NCT00124982|541749679|FG001|Long-term Period|Poor/Non-compliance|0|||
150168102|NCT00124982|541749680|FG002|Long-term Period|Poor/Non-compliance|2|||
150168103|NCT00124982|541749678|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
150168104|NCT00124982|541749679|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
150168105|NCT00124982|541749680|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
150168106|NCT00124982|541749678|FG000|Long-term Period|Neurologist Recommendation|0|||
150168107|NCT00124982|541749679|FG001|Long-term Period|Neurologist Recommendation|0|||
150029449|NCT04664153|541244203|FG003|Overall Study|Adverse Event|0|||
150168108|NCT00124982|541749680|FG002|Long-term Period|Neurologist Recommendation|1|||
150168109|NCT00482729|541751016|FG000|Overall Study|Adverse Event|29|||
150168110|NCT00482729|541751017|FG001|Overall Study|Adverse Event|33|||
150029450|NCT00097500|541244204|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
149934136|NCT00072384|540894485|FG000|Overall Study|Ineligible|8|||
150029451|NCT00097500|541244205|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
150029452|NCT00097500|541244204|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
150029453|NCT00097500|541244205|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
149934137|NCT01825200|540894486|FG000|Overall Study|Lost to Follow-up|5|||
149934138|NCT01825200|540894487|FG001|Overall Study|Lost to Follow-up|6|||
149934139|NCT01825200|540894486|FG000|Overall Study|Withdrawal by Subject|0|||
149934140|NCT01825200|540894487|FG001|Overall Study|Withdrawal by Subject|1|||
150029454|NCT00097500|541244204|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
150029455|NCT00097500|541244205|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
150029456|NCT00097500|541244204|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
150029457|NCT00097500|541244205|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
149934141|NCT01255163|540894488|FG000|Overall Study|Withdrawal by Subject|1|||
149934142|NCT01255163|540894489|FG001|Overall Study|Withdrawal by Subject|0|||
149934143|NCT01255163|540894488|FG000|Overall Study|Lost to Follow-up|2|||
149934144|NCT01255163|540894489|FG001|Overall Study|Lost to Follow-up|0|||
149934145|NCT01255163|540894488|FG000|Overall Study|Adverse Event|0|||
149934146|NCT01255163|540894489|FG001|Overall Study|Adverse Event|2|||
149934147|NCT01255163|540894488|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
149934148|NCT01255163|540894489|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
149934149|NCT00490035|540894490|FG000|Overall Study|AE, non-serious non-fatal|3|||
149934150|NCT00490035|540894491|FG001|Overall Study|AE, non-serious non-fatal|4|||
149934151|NCT00490035|540894492|FG002|Overall Study|AE, non-serious non-fatal|4|||
149934152|NCT00490035|540894493|FG003|Overall Study|AE, non-serious non-fatal|5|||
149934153|NCT00490035|540894490|FG000|Overall Study|Lost to Follow-up|2|||
149934154|NCT00490035|540894491|FG001|Overall Study|Lost to Follow-up|0|||
149934155|NCT00490035|540894492|FG002|Overall Study|Lost to Follow-up|1|||
149934156|NCT00490035|540894493|FG003|Overall Study|Lost to Follow-up|0|||
149934157|NCT00490035|540894490|FG000|Overall Study|Withdrawal by Subject|2|||
149934158|NCT00490035|540894491|FG001|Overall Study|Withdrawal by Subject|1|||
149934159|NCT00490035|540894492|FG002|Overall Study|Withdrawal by Subject|1|||
149934160|NCT00490035|540894493|FG003|Overall Study|Withdrawal by Subject|0|||
149934161|NCT00490035|540894490|FG000|Overall Study|Other reason|0|||
149934162|NCT00490035|540894491|FG001|Overall Study|Other reason|1|||
149934163|NCT00490035|540894492|FG002|Overall Study|Other reason|3|||
149934164|NCT00490035|540894493|FG003|Overall Study|Other reason|1|||
149934165|NCT00490035|540894490|FG000|Overall Study|AE, serious fatal|1|||
149934166|NCT00490035|540894491|FG001|Overall Study|AE, serious fatal|0|||
149934167|NCT00490035|540894492|FG002|Overall Study|AE, serious fatal|0|||
149934168|NCT00490035|540894493|FG003|Overall Study|AE, serious fatal|0|||
149934169|NCT00490035|540894490|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
149934170|NCT00490035|540894491|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
149934171|NCT00490035|540894492|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
149934172|NCT00490035|540894493|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
149934173|NCT00490035|540894490|FG000|Overall Study|AE of unknown type|0|||
149934174|NCT00490035|540894491|FG001|Overall Study|AE of unknown type|0|||
149934175|NCT00490035|540894492|FG002|Overall Study|AE of unknown type|2|||
149934176|NCT00490035|540894493|FG003|Overall Study|AE of unknown type|0|||
149934177|NCT06058390|540894494|FG000|Overall Study|Lost to Follow-up|0|||
149934178|NCT06058390|540894495|FG001|Overall Study|Lost to Follow-up|0|||
149934179|NCT06058390|540894496|FG002|Overall Study|Lost to Follow-up|2|||
149934180|NCT06058390|540894497|FG003|Overall Study|Lost to Follow-up|1|||
149934181|NCT06058390|540894494|FG000|Overall Study|Physician Decision|0|||
149934182|NCT06058390|540894495|FG001|Overall Study|Physician Decision|0|||
149934183|NCT06058390|540894496|FG002|Overall Study|Physician Decision|0|||
149934184|NCT06058390|540894497|FG003|Overall Study|Physician Decision|1|||
149934185|NCT06058390|540894494|FG000|Overall Study|Participants did not receive any study intervention|0|||
149934186|NCT06058390|540894495|FG001|Overall Study|Participants did not receive any study intervention|0|||
149934187|NCT06058390|540894496|FG002|Overall Study|Participants did not receive any study intervention|0|||
149934188|NCT06058390|540894497|FG003|Overall Study|Participants did not receive any study intervention|1|||
149934189|NCT02495389|540894498|FG000|Overall Study|Withdrawal by Subject|40|||
150029458|NCT00097500|541244204|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
150029459|NCT00097500|541244205|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
149934190|NCT03585270|540894502|FG000|Overall Study|Withdrawal by Subject|2|||
149934191|NCT03585270|540894503|FG001|Overall Study|Withdrawal by Subject|6|||
149934192|NCT03585270|540894502|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
149934193|NCT03585270|540894503|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
150029460|NCT00097500|541244204|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
150029461|NCT00097500|541244205|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
150029462|NCT00097500|541244204|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
149934194|NCT03585270|540894502|FG000|Overall Study|Adverse Event|5|||
150269928|NCT02616614|542127326|FG000|Overall Study|Physician Decision|2|||
149934195|NCT03585270|540894503|FG001|Overall Study|Adverse Event|2|||
149934196|NCT03585270|540894502|FG000|Overall Study|Lost to Follow-up|1|||
149934197|NCT03585270|540894503|FG001|Overall Study|Lost to Follow-up|4|||
149934198|NCT03585270|540894502|FG000|Overall Study|Death|5|||
149934199|NCT03585270|540894503|FG001|Overall Study|Death|3|||
149934200|NCT03585270|540894502|FG000|Overall Study|Other reasons|2|||
149934201|NCT03585270|540894503|FG001|Overall Study|Other reasons|2|||
149934202|NCT05559905|540894504|FG000|Overall Study|Withdrawal by Subject|1|||
149934203|NCT05559905|540894505|FG001|Overall Study|Withdrawal by Subject|0|||
149934204|NCT05559905|540894506|FG002|Overall Study|Withdrawal by Subject|0|||
149934205|NCT05559905|540894504|FG000|Overall Study|Not Reported|1|||
149934206|NCT05559905|540894505|FG001|Overall Study|Not Reported|0|||
149934207|NCT05559905|540894506|FG002|Overall Study|Not Reported|0|||
149934208|NCT04003103|540894507|FG000|Overall Study|Death|1|||
149934209|NCT04003103|540894508|FG001|Overall Study|Death|0|||
149934210|NCT04003103|540894509|FG002|Overall Study|Death|0|||
149934211|NCT04003103|540894507|FG000|Overall Study|Lost to Follow-up|4|||
149934212|NCT04003103|540894508|FG001|Overall Study|Lost to Follow-up|3|||
149934213|NCT04003103|540894509|FG002|Overall Study|Lost to Follow-up|2|||
149934214|NCT04003103|540894507|FG000|Overall Study|Withdrawal by Subject|10|||
149934215|NCT04003103|540894508|FG001|Overall Study|Withdrawal by Subject|1|||
149934216|NCT04003103|540894509|FG002|Overall Study|Withdrawal by Subject|1|||
149934217|NCT04003103|540894507|FG000|Overall Study|Status not recorded|0|||
149934218|NCT04003103|540894508|FG001|Overall Study|Status not recorded|2|||
149934219|NCT04003103|540894509|FG002|Overall Study|Status not recorded|0|||
149934220|NCT01211145|540894511|FG000|Overall Study|Reason not specified|3|||
149934221|NCT01211145|540894512|FG001|Overall Study|Reason not specified|2|||
149934222|NCT01211145|540894513|FG002|Overall Study|Reason not specified|2|||
149934223|NCT01211145|540894514|FG003|Overall Study|Reason not specified|1|||
149934224|NCT01211145|540894511|FG000|Overall Study|Lost to Follow-up|3|||
149934225|NCT01211145|540894512|FG001|Overall Study|Lost to Follow-up|2|||
149934226|NCT01211145|540894513|FG002|Overall Study|Lost to Follow-up|1|||
149934227|NCT01211145|540894514|FG003|Overall Study|Lost to Follow-up|2|||
149934228|NCT01211145|540894511|FG000|Overall Study|Study-specific withdrawal criteria|1|||
149934229|NCT01211145|540894512|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149934230|NCT01211145|540894513|FG002|Overall Study|Study-specific withdrawal criteria|0|||
149934231|NCT01211145|540894514|FG003|Overall Study|Study-specific withdrawal criteria|0|||
149934232|NCT01211145|540894511|FG000|Overall Study|Severe noncompliance to protocol|1|||
149934233|NCT01211145|540894512|FG001|Overall Study|Severe noncompliance to protocol|0|||
149934234|NCT01211145|540894513|FG002|Overall Study|Severe noncompliance to protocol|0|||
149934235|NCT01211145|540894514|FG003|Overall Study|Severe noncompliance to protocol|0|||
149934236|NCT01211145|540894511|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
149934237|NCT01211145|540894512|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
149934238|NCT01211145|540894513|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
149934239|NCT01211145|540894514|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
149934240|NCT01211145|540894511|FG000|Overall Study|Patient decision|2|||
149934241|NCT01211145|540894512|FG001|Overall Study|Patient decision|1|||
149934242|NCT01211145|540894513|FG002|Overall Study|Patient decision|0|||
149934243|NCT01211145|540894514|FG003|Overall Study|Patient decision|2|||
149934244|NCT00791999|540894515|FG000|Overall Study|Protocol planed withdrawal|14|||
149934245|NCT00791999|540894516|FG001|Overall Study|Protocol planed withdrawal|11|||
149934246|NCT00791999|540894517|FG002|Overall Study|Protocol planed withdrawal|11|||
149934247|NCT00791999|540894518|FG003|Overall Study|Protocol planed withdrawal|45|||
149934248|NCT00791999|540894515|FG000|Overall Study|Withdrawal by Subject|0|||
149934249|NCT00791999|540894516|FG001|Overall Study|Withdrawal by Subject|1|||
149934250|NCT00791999|540894517|FG002|Overall Study|Withdrawal by Subject|0|||
149934251|NCT00791999|540894518|FG003|Overall Study|Withdrawal by Subject|2|||
149934252|NCT00791999|540894515|FG000|Overall Study|Protocol Violation|3|||
149934253|NCT00791999|540894516|FG001|Overall Study|Protocol Violation|0|||
149934254|NCT00791999|540894517|FG002|Overall Study|Protocol Violation|1|||
149934255|NCT00791999|540894518|FG003|Overall Study|Protocol Violation|0|||
149934256|NCT00791999|540894515|FG000|Overall Study|Adverse Event|3|||
149934257|NCT00791999|540894516|FG001|Overall Study|Adverse Event|3|||
149934258|NCT00791999|540894517|FG002|Overall Study|Adverse Event|7|||
149934259|NCT00791999|540894518|FG003|Overall Study|Adverse Event|3|||
149934260|NCT00791999|540894515|FG000|Overall Study|Lack of Efficacy|0|||
149934261|NCT00791999|540894516|FG001|Overall Study|Lack of Efficacy|1|||
149934262|NCT00791999|540894517|FG002|Overall Study|Lack of Efficacy|0|||
149934263|NCT00791999|540894518|FG003|Overall Study|Lack of Efficacy|2|||
149934264|NCT00791999|540894515|FG000|Overall Study|Reason other than those above|1|||
149934265|NCT00791999|540894516|FG001|Overall Study|Reason other than those above|0|||
149934266|NCT00791999|540894517|FG002|Overall Study|Reason other than those above|1|||
149934267|NCT00791999|540894518|FG003|Overall Study|Reason other than those above|0|||
149934268|NCT00617357|540894519|FG000|Overall Study|Lost to Follow-up|7|||
149934269|NCT00617357|540894519|FG000|Overall Study|Death|5|||
149934270|NCT00617357|540894519|FG000|Overall Study|insurance concerns|2|||
149934271|NCT00617357|540894519|FG000|Overall Study|Withdrawal by Subject|1|||
149934272|NCT00617357|540894519|FG000|Overall Study|Physician Decision|1|||
149934273|NCT00427908|540894520|FG000|Primary Phase|Lost to Follow-up|4|||
149934274|NCT00427908|540894521|FG001|Primary Phase|Lost to Follow-up|0|||
149934275|NCT00427908|540894522|FG002|Primary Phase|Lost to Follow-up|2|||
150029463|NCT00097500|541244205|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
150029464|NCT00524485|541244209|FG000|Overall Study|Withdrawal by Subject|5|||
150029465|NCT01600885|541244210|FG000|First Period|Adverse Event|1|||
150029466|NCT01600885|541244211|FG001|First Period|Adverse Event|1|||
150029467|NCT01600885|541244210|FG000|First Period|moved out of area|1|||
150029468|NCT01600885|541244211|FG001|First Period|moved out of area|0|||
150029469|NCT00642356|541244217|FG000|Overall Study|Adverse Event|1|||
150029470|NCT00642356|541244218|FG001|Overall Study|Adverse Event|0|||
150029471|NCT00642356|541244217|FG000|Overall Study|Protocol Violation|0|||
150029472|NCT00642356|541244218|FG001|Overall Study|Protocol Violation|3|||
150029473|NCT00642356|541244217|FG000|Overall Study|Lack of Efficacy|1|||
150029474|NCT00642356|541244218|FG001|Overall Study|Lack of Efficacy|0|||
150029475|NCT01009060|541244221|FG000|Overall Study|Adverse Event|1|||
150029476|NCT01009060|541244222|FG001|Overall Study|Adverse Event|2|||
150029477|NCT01009060|541244221|FG000|Overall Study|Protocol Violation|0|||
150029478|NCT01009060|541244222|FG001|Overall Study|Protocol Violation|1|||
149934276|NCT00427908|540894523|FG003|Primary Phase|Lost to Follow-up|0|||
149934277|NCT00427908|540894520|FG000|Primary Phase|Withdrawal by Subject|1|||
149934278|NCT00427908|540894521|FG001|Primary Phase|Withdrawal by Subject|2|||
149934279|NCT00427908|540894522|FG002|Primary Phase|Withdrawal by Subject|1|||
149934280|NCT00427908|540894523|FG003|Primary Phase|Withdrawal by Subject|0|||
149934281|NCT00427908|540894520|FG000|Primary Phase|Adverse Event|0|||
149934282|NCT00427908|540894521|FG001|Primary Phase|Adverse Event|1|||
149934283|NCT00427908|540894522|FG002|Primary Phase|Adverse Event|0|||
149934284|NCT00427908|540894523|FG003|Primary Phase|Adverse Event|0|||
149934285|NCT00485069|540894526|FG000|Overall Study|Adverse Event|10|||
149934286|NCT00485069|540894527|FG001|Overall Study|Adverse Event|4|||
149934287|NCT00485069|540894526|FG000|Overall Study|Lack of Efficacy|2|||
149934288|NCT00485069|540894527|FG001|Overall Study|Lack of Efficacy|1|||
149934289|NCT00485069|540894526|FG000|Overall Study|Protocol Violation|0|||
149934290|NCT00485069|540894527|FG001|Overall Study|Protocol Violation|1|||
149934291|NCT00485069|540894526|FG000|Overall Study|Withdrawal by Subject|6|||
149934292|NCT00485069|540894527|FG001|Overall Study|Withdrawal by Subject|6|||
149934293|NCT02573259|540894531|FG000|Overall Study|Death|1|||
149934294|NCT02573259|540894532|FG001|Overall Study|Death|6|||
149934295|NCT02573259|540894533|FG002|Overall Study|Death|5|||
149934296|NCT02573259|540894534|FG003|Overall Study|Death|6|||
149934297|NCT02573259|540894535|FG004|Overall Study|Death|9|||
149934298|NCT02573259|540894536|FG005|Overall Study|Death|32|||
149934299|NCT02573259|540894537|FG006|Overall Study|Death|21|||
149934300|NCT02573259|540894531|FG000|Overall Study|Lost to Follow-up|0|||
149934301|NCT02573259|540894532|FG001|Overall Study|Lost to Follow-up|0|||
149934302|NCT02573259|540894533|FG002|Overall Study|Lost to Follow-up|0|||
149934303|NCT02573259|540894534|FG003|Overall Study|Lost to Follow-up|0|||
149934304|NCT02573259|540894535|FG004|Overall Study|Lost to Follow-up|0|||
149934305|NCT02573259|540894536|FG005|Overall Study|Lost to Follow-up|2|||
149934306|NCT02573259|540894537|FG006|Overall Study|Lost to Follow-up|1|||
149934307|NCT02573259|540894531|FG000|Overall Study|Participant refused further follow-up|0|||
149934308|NCT02573259|540894532|FG001|Overall Study|Participant refused further follow-up|2|||
149934309|NCT02573259|540894533|FG002|Overall Study|Participant refused further follow-up|1|||
149934310|NCT02573259|540894534|FG003|Overall Study|Participant refused further follow-up|0|||
149934311|NCT02573259|540894535|FG004|Overall Study|Participant refused further follow-up|3|||
149934312|NCT02573259|540894536|FG005|Overall Study|Participant refused further follow-up|20|||
149934313|NCT02573259|540894537|FG006|Overall Study|Participant refused further follow-up|7|||
149934314|NCT02573259|540894531|FG000|Overall Study|Other|0|||
149934315|NCT02573259|540894532|FG001|Overall Study|Other|0|||
149934316|NCT02573259|540894533|FG002|Overall Study|Other|0|||
149934317|NCT02573259|540894534|FG003|Overall Study|Other|0|||
149934318|NCT02573259|540894535|FG004|Overall Study|Other|1|||
149934319|NCT02573259|540894536|FG005|Overall Study|Other|4|||
149934320|NCT02573259|540894537|FG006|Overall Study|Other|5|||
149934321|NCT00751140|540894538|FG000|Overall Study|benign angioma excluded from analysis|1|||
149934322|NCT03160716|540894539|FG000|Overall Study|Lost to Follow-up|1|||
149934323|NCT05630196|540896623|FG000|Overall Study|Adverse Event|2|||
149934324|NCT05630196|540896624|FG001|Overall Study|Adverse Event|1|||
149934325|NCT05630196|540896623|FG000|Overall Study|Lost to Follow-up|1|||
150029479|NCT01009060|541244221|FG000|Overall Study|Lost to Follow-up|1|||
150029480|NCT01009060|541244222|FG001|Overall Study|Lost to Follow-up|0|||
150029481|NCT01009060|541244221|FG000|Overall Study|Physician Decision|1|||
150029482|NCT01009060|541244222|FG001|Overall Study|Physician Decision|1|||
150029483|NCT01009060|541244221|FG000|Overall Study|Withdrawal by Subject|1|||
149934326|NCT05630196|540896624|FG001|Overall Study|Lost to Follow-up|1|||
150029484|NCT01009060|541244222|FG001|Overall Study|Withdrawal by Subject|1|||
149934327|NCT05630196|540896623|FG000|Overall Study|Protocol Violation|2|||
150029485|NCT00088530|541244227|FG000|Overall Study|Progressive/Relapsed Disease|28|||
149934328|NCT05630196|540896624|FG001|Overall Study|Protocol Violation|3|||
149934329|NCT05630196|540896623|FG000|Overall Study|Physician Decision|1|||
149934330|NCT05630196|540896624|FG001|Overall Study|Physician Decision|0|||
149934331|NCT05630196|540896623|FG000|Overall Study|Withdrawal by Subject|3|||
149934332|NCT05630196|540896624|FG001|Overall Study|Withdrawal by Subject|4|||
149934333|NCT00903201|540896626|FG000|Overall Study|Adverse Event|1|||
149934334|NCT00903201|540896627|FG001|Overall Study|Adverse Event|4|||
149934335|NCT00903201|540896628|FG002|Overall Study|Adverse Event|0|||
149934336|NCT00903201|540896626|FG000|Overall Study|Protocol Violation|2|||
149934337|NCT00903201|540896627|FG001|Overall Study|Protocol Violation|1|||
149934338|NCT00903201|540896628|FG002|Overall Study|Protocol Violation|0|||
149934339|NCT00903201|540896626|FG000|Overall Study|Lost to Follow-up|0|||
149934340|NCT00903201|540896627|FG001|Overall Study|Lost to Follow-up|1|||
149934341|NCT00903201|540896628|FG002|Overall Study|Lost to Follow-up|0|||
149934342|NCT00903201|540896626|FG000|Overall Study|Physician Decision|1|||
149934343|NCT00903201|540896627|FG001|Overall Study|Physician Decision|0|||
149934344|NCT00903201|540896628|FG002|Overall Study|Physician Decision|1|||
149934345|NCT00903201|540896626|FG000|Overall Study|Withdrawal by Subject|1|||
149934346|NCT00903201|540896627|FG001|Overall Study|Withdrawal by Subject|0|||
149934347|NCT00903201|540896628|FG002|Overall Study|Withdrawal by Subject|1|||
149934348|NCT01094288|540896629|FG000|Overall Study|Adverse Event|0|||
149934349|NCT01094288|540896630|FG001|Overall Study|Adverse Event|3|||
149934350|NCT01094288|540896631|FG002|Overall Study|Adverse Event|1|||
149934351|NCT01094288|540896632|FG003|Overall Study|Adverse Event|1|||
149934352|NCT01094288|540896633|FG004|Overall Study|Adverse Event|0|||
149934353|NCT01094288|540896634|FG005|Overall Study|Adverse Event|0|||
149934354|NCT01094288|540896635|FG006|Overall Study|Adverse Event|0|||
149934355|NCT01094288|540896636|FG007|Overall Study|Adverse Event|0|||
149934356|NCT01094288|540896629|FG000|Overall Study|Withdrawal by Subject|0|||
149934357|NCT01094288|540896630|FG001|Overall Study|Withdrawal by Subject|1|||
149934358|NCT01094288|540896631|FG002|Overall Study|Withdrawal by Subject|2|||
149934359|NCT01094288|540896632|FG003|Overall Study|Withdrawal by Subject|0|||
149934360|NCT01094288|540896633|FG004|Overall Study|Withdrawal by Subject|0|||
149934361|NCT01094288|540896634|FG005|Overall Study|Withdrawal by Subject|0|||
149934362|NCT01094288|540896635|FG006|Overall Study|Withdrawal by Subject|0|||
149934363|NCT01094288|540896636|FG007|Overall Study|Withdrawal by Subject|2|||
149934364|NCT01094288|540896629|FG000|Overall Study|Initiation of Alternative Therapy|0|||
149934365|NCT01094288|540896630|FG001|Overall Study|Initiation of Alternative Therapy|0|||
149934366|NCT01094288|540896631|FG002|Overall Study|Initiation of Alternative Therapy|1|||
149934367|NCT01094288|540896632|FG003|Overall Study|Initiation of Alternative Therapy|0|||
149934368|NCT01094288|540896633|FG004|Overall Study|Initiation of Alternative Therapy|0|||
149934369|NCT01094288|540896634|FG005|Overall Study|Initiation of Alternative Therapy|0|||
149934370|NCT01094288|540896635|FG006|Overall Study|Initiation of Alternative Therapy|0|||
149934371|NCT01094288|540896636|FG007|Overall Study|Initiation of Alternative Therapy|0|||
149934372|NCT01094288|540896629|FG000|Overall Study|Reason not Specified|2|||
149934373|NCT01094288|540896630|FG001|Overall Study|Reason not Specified|3|||
149934374|NCT01094288|540896631|FG002|Overall Study|Reason not Specified|0|||
149934375|NCT01094288|540896632|FG003|Overall Study|Reason not Specified|1|||
149934376|NCT01094288|540896633|FG004|Overall Study|Reason not Specified|0|||
149934377|NCT01094288|540896634|FG005|Overall Study|Reason not Specified|0|||
149934378|NCT01094288|540896635|FG006|Overall Study|Reason not Specified|0|||
149934379|NCT01094288|540896636|FG007|Overall Study|Reason not Specified|0|||
149934380|NCT01094288|540896629|FG000|Overall Study|Ongoing Participants|0|||
149934381|NCT01094288|540896630|FG001|Overall Study|Ongoing Participants|3|||
149934382|NCT01094288|540896631|FG002|Overall Study|Ongoing Participants|0|||
149934383|NCT01094288|540896632|FG003|Overall Study|Ongoing Participants|0|||
149934384|NCT01094288|540896633|FG004|Overall Study|Ongoing Participants|0|||
149934385|NCT01094288|540896634|FG005|Overall Study|Ongoing Participants|0|||
149934386|NCT01094288|540896635|FG006|Overall Study|Ongoing Participants|0|||
149934387|NCT01094288|540896636|FG007|Overall Study|Ongoing Participants|0|||
149934388|NCT02611882|540896639|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
149934389|NCT02611882|540896640|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
149934390|NCT02611882|540896641|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
150168111|NCT00482729|541751016|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
150168112|NCT00482729|541751017|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
150168113|NCT00482729|541751016|FG000|Overall Study|Hyperglycemia Criteria|7|||
150168114|NCT00482729|541751017|FG001|Overall Study|Hyperglycemia Criteria|5|||
150168115|NCT00482729|541751016|FG000|Overall Study|Lack of Efficacy|4|||
150168116|NCT00482729|541751017|FG001|Overall Study|Lack of Efficacy|16|||
150168117|NCT00482729|541751016|FG000|Overall Study|Lost to Follow-up|86|||
150168118|NCT00482729|541751017|FG001|Overall Study|Lost to Follow-up|66|||
150168119|NCT00482729|541751016|FG000|Overall Study|Physician Decision|10|||
150168120|NCT00482729|541751017|FG001|Overall Study|Physician Decision|7|||
150168121|NCT00482729|541751016|FG000|Overall Study|Pregnancy|4|||
150168122|NCT00482729|541751017|FG001|Overall Study|Pregnancy|2|||
150168123|NCT00482729|541751016|FG000|Overall Study|Protocol Violation|10|||
150168124|NCT00482729|541751017|FG001|Overall Study|Protocol Violation|18|||
149934391|NCT01389232|540896642|FG000|Overall Study|Had scaffold removed|15|||
149934392|NCT01389232|540896642|FG000|Overall Study|Personal reasons|2|||
149934393|NCT01389232|540896642|FG000|Overall Study|Adverse Event|1|||
150029486|NCT00088530|541244228|FG001|Overall Study|Progressive/Relapsed Disease|39|||
150029487|NCT00088530|541244227|FG000|Overall Study|Adverse Event|15|||
150029488|NCT00088530|541244228|FG001|Overall Study|Adverse Event|9|||
150029489|NCT00088530|541244227|FG000|Overall Study|Withdrawal by Subject|2|||
150029490|NCT00088530|541244228|FG001|Overall Study|Withdrawal by Subject|5|||
150029491|NCT00088530|541244227|FG000|Overall Study|Lost to Follow-up|2|||
150029492|NCT00088530|541244228|FG001|Overall Study|Lost to Follow-up|0|||
150029493|NCT00088530|541244227|FG000|Overall Study|Physician Decision|2|||
150029494|NCT00088530|541244228|FG001|Overall Study|Physician Decision|0|||
150029495|NCT00088530|541244227|FG000|Overall Study|Sponsor decision|0|||
150029496|NCT00088530|541244228|FG001|Overall Study|Sponsor decision|1|||
150029497|NCT00088530|541244227|FG000|Overall Study|Patient never treated|1|||
150029498|NCT00088530|541244228|FG001|Overall Study|Patient never treated|0|||
150029499|NCT00300755|541244229|FG000|Overall Study|Adverse Event|1|||
150029500|NCT00300755|541244230|FG001|Overall Study|Adverse Event|2|||
150029501|NCT00300755|541244231|FG002|Overall Study|Adverse Event|1|||
150029502|NCT00300755|541244229|FG000|Overall Study|Withdrawal by Subject|0|||
150029503|NCT00300755|541244230|FG001|Overall Study|Withdrawal by Subject|2|||
150029504|NCT00300755|541244231|FG002|Overall Study|Withdrawal by Subject|0|||
150029505|NCT00300755|541244229|FG000|Overall Study|Protocol Violation|0|||
150029506|NCT00300755|541244230|FG001|Overall Study|Protocol Violation|0|||
150029507|NCT00300755|541244231|FG002|Overall Study|Protocol Violation|1|||
150029508|NCT04571944|541244232|FG000|Overall Study|Death|1|||
149934394|NCT01389232|540896642|FG000|Overall Study|Death|1|||
149934395|NCT00945243|540896644|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
149934396|NCT01162343|540896645|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
149934397|NCT01162343|540896645|FG000|Overall Study|Refused psychiatrist assessment|12|||
149934398|NCT00641056|540896646|FG000|Overall Study|Adverse Event|12|||
149934399|NCT00641056|540896647|FG001|Overall Study|Adverse Event|2|||
149934400|NCT00641056|540896646|FG000|Overall Study|Lost to Follow-up|2|||
149934401|NCT00641056|540896647|FG001|Overall Study|Lost to Follow-up|1|||
149934402|NCT00641056|540896646|FG000|Overall Study|Physician Decision|3|||
149934403|NCT00641056|540896647|FG001|Overall Study|Physician Decision|1|||
149934404|NCT00641056|540896646|FG000|Overall Study|Protocol Violation|2|||
149934405|NCT00641056|540896647|FG001|Overall Study|Protocol Violation|0|||
149934406|NCT00641056|540896646|FG000|Overall Study|Entry Criteria Not Met|3|||
149934407|NCT00641056|540896647|FG001|Overall Study|Entry Criteria Not Met|0|||
149934408|NCT00641056|540896646|FG000|Overall Study|Subject Decision|6|||
149934409|NCT00641056|540896647|FG001|Overall Study|Subject Decision|19|||
149934410|NCT00641056|540896646|FG000|Overall Study|Sponsor Decision|1|||
149934411|NCT00641056|540896647|FG001|Overall Study|Sponsor Decision|2|||
149934412|NCT00896493|540896648|FG000|Overall Study|Early disease relapse|3|||
149934413|NCT01774981|540896651|FG000|Overall Study|Adverse Event|0|||
149934414|NCT01774981|540896652|FG001|Overall Study|Adverse Event|0|||
149934415|NCT01774981|540896653|FG002|Overall Study|Adverse Event|0|||
149934416|NCT01774981|540896654|FG003|Overall Study|Adverse Event|0|||
149934417|NCT01774981|540896655|FG004|Overall Study|Adverse Event|0|||
149934418|NCT01774981|540896656|FG005|Overall Study|Adverse Event|1|||
149934419|NCT01774981|540896657|FG006|Overall Study|Adverse Event|0|||
149934420|NCT01774981|540896658|FG007|Overall Study|Adverse Event|0|||
149934421|NCT01774981|540896651|FG000|Overall Study|Withdrawal by Subject|0|||
149934422|NCT01774981|540896652|FG001|Overall Study|Withdrawal by Subject|0|||
149934423|NCT01774981|540896653|FG002|Overall Study|Withdrawal by Subject|0|||
149934424|NCT01774981|540896654|FG003|Overall Study|Withdrawal by Subject|0|||
149934425|NCT01774981|540896655|FG004|Overall Study|Withdrawal by Subject|0|||
149934426|NCT01774981|540896656|FG005|Overall Study|Withdrawal by Subject|0|||
149934427|NCT01774981|540896657|FG006|Overall Study|Withdrawal by Subject|0|||
149934428|NCT01774981|540896658|FG007|Overall Study|Withdrawal by Subject|1|||
149934429|NCT01774981|540896651|FG000|Overall Study|Death|0|||
149934430|NCT01774981|540896652|FG001|Overall Study|Death|0|||
150029509|NCT04571944|541244233|FG001|Overall Study|Death|0|||
149934431|NCT01774981|540896653|FG002|Overall Study|Death|0|||
149934432|NCT01774981|540896654|FG003|Overall Study|Death|0|||
149934433|NCT01774981|540896655|FG004|Overall Study|Death|1|||
149934434|NCT01774981|540896656|FG005|Overall Study|Death|0|||
149934435|NCT01774981|540896657|FG006|Overall Study|Death|0|||
149934436|NCT01774981|540896658|FG007|Overall Study|Death|0|||
149934437|NCT00902577|540896659|FG000|Overall Study|Withdrawal by Subject|6|||
149934438|NCT00902577|540896659|FG000|Overall Study|FMISO production failure|2|||
149934439|NCT03322293|540896660|FG000|Overall Study|Lost to Follow-up|0|||
150029510|NCT04571944|541244232|FG000|Overall Study|Withdrawal by Subject|3|||
150029511|NCT04571944|541244233|FG001|Overall Study|Withdrawal by Subject|0|||
150029512|NCT04571944|541244232|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
149820209|NCT03882047|540471751|FG000|Overall Study|Adverse Event|0|||
149934440|NCT03322293|540896661|FG001|Overall Study|Lost to Follow-up|0|||
149934441|NCT03322293|540896662|FG002|Overall Study|Lost to Follow-up|1|||
149934442|NCT02000921|540896667|FG000|Overall Study|Withdrawal by Subject|3|||
149934443|NCT02000921|540896668|FG001|Overall Study|Withdrawal by Subject|10|||
150269929|NCT02616614|542127327|FG001|Overall Study|Physician Decision|1|||
150269930|NCT02616614|542127328|FG002|Overall Study|Physician Decision|0|||
150269931|NCT02616614|542127326|FG000|Overall Study|Adverse Event|1|||
150269932|NCT02616614|542127327|FG001|Overall Study|Adverse Event|4|||
150269933|NCT02616614|542127328|FG002|Overall Study|Adverse Event|1|||
150269934|NCT02616614|542127326|FG000|Overall Study|Protocol Violation|0|||
150269935|NCT02616614|542127327|FG001|Overall Study|Protocol Violation|3|||
150269936|NCT02616614|542127328|FG002|Overall Study|Protocol Violation|1|||
149934444|NCT02000921|540896669|FG002|Overall Study|Withdrawal by Subject|5|||
149934445|NCT02000921|540896667|FG000|Overall Study|Lost to Follow-up|2|||
149934446|NCT02000921|540896668|FG001|Overall Study|Lost to Follow-up|4|||
149934447|NCT02000921|540896669|FG002|Overall Study|Lost to Follow-up|5|||
149934448|NCT02000921|540896667|FG000|Overall Study|Physician Decision|0|||
149934449|NCT02000921|540896668|FG001|Overall Study|Physician Decision|2|||
149934450|NCT02000921|540896669|FG002|Overall Study|Physician Decision|0|||
149934451|NCT02914834|540896670|FG000|Overall Study|Study halted due to COVID|1|||
149934452|NCT02914834|540896671|FG001|Overall Study|Study halted due to COVID|1|||
149934453|NCT02914834|540896670|FG000|Overall Study|1 subject withdrew|0|||
149934454|NCT02914834|540896671|FG001|Overall Study|1 subject withdrew|1|||
149934455|NCT03885908|540896676|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
149934456|NCT03885908|540896677|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
149934457|NCT03885908|540896676|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
149934458|NCT03885908|540896677|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
149934459|NCT03885908|540896676|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
149975530|NCT01193101|541047873|FG002|Overall Study|Adverse Event|1|||
149975531|NCT01193101|541047874|FG003|Overall Study|Adverse Event|3|||
149975532|NCT01193101|541047871|FG000|Overall Study|Lack of Efficacy|3|||
149975533|NCT01193101|541047872|FG001|Overall Study|Lack of Efficacy|1|||
149975534|NCT01193101|541047873|FG002|Overall Study|Lack of Efficacy|0|||
149975535|NCT01193101|541047874|FG003|Overall Study|Lack of Efficacy|8|||
149975536|NCT01193101|541047871|FG000|Overall Study|Withdrawal by Subject|2|||
149975537|NCT01193101|541047872|FG001|Overall Study|Withdrawal by Subject|4|||
149975538|NCT01193101|541047873|FG002|Overall Study|Withdrawal by Subject|1|||
149975539|NCT01193101|541047874|FG003|Overall Study|Withdrawal by Subject|1|||
149975540|NCT01193101|541047871|FG000|Overall Study|Administrative problems|0|||
149975541|NCT01193101|541047872|FG001|Overall Study|Administrative problems|0|||
149975542|NCT01193101|541047873|FG002|Overall Study|Administrative problems|1|||
149975543|NCT01193101|541047874|FG003|Overall Study|Administrative problems|0|||
149975544|NCT01193101|541047871|FG000|Overall Study|Abnormal test procedure results|0|||
149975545|NCT01193101|541047872|FG001|Overall Study|Abnormal test procedure results|1|||
149975546|NCT01193101|541047873|FG002|Overall Study|Abnormal test procedure results|0|||
149975547|NCT01193101|541047874|FG003|Overall Study|Abnormal test procedure results|0|||
149975548|NCT02347085|541047877|FG000|Overall Study|Adverse Event|2|||
149975549|NCT02347085|541047877|FG000|Overall Study|Lack of Efficacy|1|||
149975550|NCT02347085|541047877|FG000|Overall Study|Withdrawal by Subject|4|||
149975551|NCT02347085|541047877|FG000|Overall Study|Lost to Follow-up|1|||
149975552|NCT02347085|541047877|FG000|Overall Study|Protocol Criteria|2|||
149975553|NCT02761642|541047880|FG000|Overall Study|Did not Receive Study Treatment|3|||
149975554|NCT02761642|541047880|FG000|Overall Study|Adverse Event|13|||
149975555|NCT02761642|541047880|FG000|Overall Study|Withdrawal by Subject|2|||
149975556|NCT02761642|541047880|FG000|Overall Study|Non-compliant|7|||
149975557|NCT02761642|541047880|FG000|Overall Study|Death|3|||
149975558|NCT02761642|541047880|FG000|Overall Study|Lack of Efficacy|20|||
149975559|NCT02761642|541047880|FG000|Overall Study|Physician Decision|1|||
149975560|NCT02761642|541047880|FG000|Overall Study|Reason Unspecified|21|||
149975561|NCT00950651|541047881|FG000|Overall Study|Adverse Event|17|||
149975562|NCT00950651|541047882|FG001|Overall Study|Adverse Event|20|||
149975563|NCT00950651|541047881|FG000|Overall Study|Death|1|||
149975564|NCT00950651|541047882|FG001|Overall Study|Death|0|||
149975565|NCT00950651|541047881|FG000|Overall Study|Lack of Efficacy|2|||
149975566|NCT00950651|541047882|FG001|Overall Study|Lack of Efficacy|2|||
149975567|NCT00950651|541047881|FG000|Overall Study|Protocol Violation|3|||
149975568|NCT00950651|541047882|FG001|Overall Study|Protocol Violation|4|||
149975569|NCT00950651|541047881|FG000|Overall Study|Withdrawal by Subject|8|||
149975570|NCT00950651|541047882|FG001|Overall Study|Withdrawal by Subject|9|||
149975571|NCT03783780|541047885|FG000|Overall Study|Withdrawn prior to completion|1|||
149975572|NCT02850978|541047891|FG000|Overall Study|Uncollectable CRF|27|||
149975573|NCT02850978|541047891|FG000|Overall Study|No visit since the first visit|35|||
149975574|NCT02850978|541047891|FG000|Overall Study|Adverse Event|81|||
149975575|NCT02850978|541047891|FG000|Overall Study|Lack of Efficacy|40|||
149975576|NCT02850978|541047891|FG000|Overall Study|Improvement in condition|34|||
149975577|NCT02850978|541047891|FG000|Overall Study|Lost to Follow-up|121|||
149975578|NCT02850978|541047891|FG000|Overall Study|Reason not listed|88|||
149975579|NCT00114127|541047892|FG000|Overall Study|Adverse Event|2|||
149975580|NCT00114127|541047893|FG001|Overall Study|Adverse Event|1|||
149975581|NCT00114127|541047892|FG000|Overall Study|Lost to Follow-up|1|||
150029513|NCT04571944|541244233|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
150029514|NCT00667888|541244236|FG000|Overall Study|Death|1|||
150029515|NCT00667888|541244237|FG001|Overall Study|Death|1|||
150029516|NCT00667888|541244236|FG000|Overall Study|Withdrawal by Subject|6|||
150029517|NCT00667888|541244237|FG001|Overall Study|Withdrawal by Subject|3|||
150029518|NCT00667888|541244236|FG000|Overall Study|Proceed with other treatment|3|||
150029519|NCT00667888|541244237|FG001|Overall Study|Proceed with other treatment|3|||
150029520|NCT00667888|541244236|FG000|Overall Study|Ineligible after SIM|0|||
150029521|NCT00667888|541244237|FG001|Overall Study|Ineligible after SIM|2|||
150029522|NCT00626275|541244238|FG000|Part A - Treatment Period 1|Adverse Event|1|||
150029523|NCT00626275|541244239|FG001|Part A - Treatment Period 1|Adverse Event|0|||
150029524|NCT00626275|541244240|FG002|Part A - Treatment Period 1|Adverse Event|0|||
150029525|NCT00626275|541244241|FG003|Part A - Treatment Period 1|Adverse Event|0|||
150029526|NCT00626275|541244242|FG004|Part A - Treatment Period 1|Adverse Event|0|||
150029527|NCT00626275|541244243|FG005|Part A - Treatment Period 1|Adverse Event|0|||
150029528|NCT00626275|541244244|FG006|Part A - Treatment Period 1|Adverse Event|0|||
150029529|NCT00626275|541244245|FG007|Part A - Treatment Period 1|Adverse Event|0|||
150029530|NCT00626275|541244238|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029531|NCT00626275|541244239|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029532|NCT00626275|541244240|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
150029533|NCT00626275|541244241|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029534|NCT00626275|541244242|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029535|NCT00626275|541244243|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029536|NCT00626275|541244244|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029537|NCT00626275|541244245|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
150029538|NCT00626275|541244238|FG000|Part B|Lost to Follow-up|0|||
150029539|NCT00626275|541244239|FG001|Part B|Lost to Follow-up|0|||
150029540|NCT00626275|541244240|FG002|Part B|Lost to Follow-up|0|||
150029541|NCT00626275|541244241|FG003|Part B|Lost to Follow-up|0|||
150029542|NCT00626275|541244242|FG004|Part B|Lost to Follow-up|0|||
150029543|NCT00626275|541244243|FG005|Part B|Lost to Follow-up|0|||
150029544|NCT00626275|541244244|FG006|Part B|Lost to Follow-up|1|||
150029545|NCT00626275|541244245|FG007|Part B|Lost to Follow-up|0|||
150029546|NCT00626275|541244238|FG000|Part B|Withdrawal by Subject|0|||
150029547|NCT00626275|541244239|FG001|Part B|Withdrawal by Subject|0|||
150029548|NCT00626275|541244240|FG002|Part B|Withdrawal by Subject|0|||
150029549|NCT00626275|541244241|FG003|Part B|Withdrawal by Subject|0|||
150029550|NCT00626275|541244242|FG004|Part B|Withdrawal by Subject|0|||
150029551|NCT00626275|541244243|FG005|Part B|Withdrawal by Subject|0|||
150029552|NCT00626275|541244244|FG006|Part B|Withdrawal by Subject|0|||
149934460|NCT03885908|540896677|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
149934461|NCT03885908|540896676|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
149934462|NCT03885908|540896677|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
149934463|NCT01663402|540896681|FG000|Overall Study|Randomized but not treated|19|||
149934464|NCT01663402|540896682|FG001|Overall Study|Randomized but not treated|11|||
149934465|NCT01663402|540896681|FG000|Overall Study|Adverse Event|347|||
149934466|NCT01663402|540896682|FG001|Overall Study|Adverse Event|362|||
149934467|NCT01663402|540896681|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
149934468|NCT01663402|540896682|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
149934469|NCT01663402|540896681|FG000|Overall Study|Poor compliance to protocol|529|||
149934470|NCT01663402|540896682|FG001|Overall Study|Poor compliance to protocol|454|||
149934471|NCT01663402|540896681|FG000|Overall Study|Physician Decision|77|||
149934472|NCT01663402|540896682|FG001|Overall Study|Physician Decision|62|||
149934473|NCT01663402|540896681|FG000|Overall Study|Site terminated by sponsor|1|||
149934474|NCT01663402|540896682|FG001|Overall Study|Site terminated by sponsor|3|||
149934475|NCT01663402|540896681|FG000|Overall Study|Participant moved|139|||
149934476|NCT01663402|540896682|FG001|Overall Study|Participant moved|104|||
150029553|NCT00626275|541244245|FG007|Part B|Withdrawal by Subject|1|||
149934477|NCT01663402|540896681|FG000|Overall Study|Withdrawal by Subject|118|||
150029554|NCT01362348|541244246|FG000|Overall Study|Protocol-defined stopping criteria|9|||
150029555|NCT01362348|541244246|FG000|Overall Study|Study closed/terminated|5|||
150029556|NCT02734693|541244247|FG000|Overall Study|Adverse Event|1|||
150029557|NCT02734693|541244248|FG001|Overall Study|Adverse Event|3|||
150029558|NCT02734693|541244249|FG002|Overall Study|Adverse Event|3|||
149934478|NCT01663402|540896682|FG001|Overall Study|Withdrawal by Subject|91|||
149934479|NCT01663402|540896681|FG000|Overall Study|Related to study drug administration|96|||
149934480|NCT01663402|540896682|FG001|Overall Study|Related to study drug administration|105|||
150029559|NCT02734693|541244247|FG000|Overall Study|Lack of Efficacy|1|||
150029560|NCT02734693|541244248|FG001|Overall Study|Lack of Efficacy|0|||
150029561|NCT02734693|541244249|FG002|Overall Study|Lack of Efficacy|0|||
150029562|NCT02734693|541244247|FG000|Overall Study|Lost to Follow-up|2|||
150029563|NCT02734693|541244248|FG001|Overall Study|Lost to Follow-up|0|||
150029564|NCT02734693|541244249|FG002|Overall Study|Lost to Follow-up|0|||
150029565|NCT02734693|541244247|FG000|Overall Study|Protocol Violation|1|||
150029566|NCT02734693|541244248|FG001|Overall Study|Protocol Violation|0|||
150029567|NCT02734693|541244249|FG002|Overall Study|Protocol Violation|0|||
150029568|NCT02734693|541244247|FG000|Overall Study|Withdrawal by Subject|1|||
150029569|NCT02734693|541244248|FG001|Overall Study|Withdrawal by Subject|0|||
150029570|NCT02734693|541244249|FG002|Overall Study|Withdrawal by Subject|0|||
150029571|NCT00758771|541244250|FG000|Overall Study|Withdrawal by Subject|1|||
150029572|NCT00758771|541244251|FG001|Overall Study|Withdrawal by Subject|1|||
150029573|NCT00758771|541244250|FG000|Overall Study|Did not meet eligibility criteria|2|||
150029574|NCT00758771|541244251|FG001|Overall Study|Did not meet eligibility criteria|4|||
150029575|NCT00960063|541244252|FG000|Overall Study|Adverse Event|1|||
150029576|NCT00960063|541244253|FG001|Overall Study|Adverse Event|0|||
150029577|NCT00960063|541244254|FG002|Overall Study|Adverse Event|0|||
150029578|NCT00960063|541244252|FG000|Overall Study|Progression of Disease|0|||
150029579|NCT00960063|541244253|FG001|Overall Study|Progression of Disease|0|||
150029580|NCT00960063|541244254|FG002|Overall Study|Progression of Disease|3|||
150029581|NCT00539981|541244255|FG000|Overall Study|Adverse events (AE)|3|||
150029582|NCT00539981|541244256|FG001|Overall Study|Adverse events (AE)|3|||
150029583|NCT00539981|541244255|FG000|Overall Study|Lost to Follow-up|260|||
150029584|NCT00539981|541244256|FG001|Overall Study|Lost to Follow-up|251|||
150029585|NCT00539981|541244255|FG000|Overall Study|Withdrew consent|22|||
150029586|NCT00539981|541244256|FG001|Overall Study|Withdrew consent|14|||
150029587|NCT00539981|541244255|FG000|Overall Study|Death|1|||
150029588|NCT00539981|541244256|FG001|Overall Study|Death|1|||
150029589|NCT00539981|541244255|FG000|Overall Study|Other reason-unspecified|9|||
150029590|NCT00539981|541244256|FG001|Overall Study|Other reason-unspecified|13|||
150029591|NCT02675907|541244257|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
150029592|NCT02675907|541244258|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
150029593|NCT02675907|541244257|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
150029594|NCT02675907|541244258|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
150029595|NCT02675907|541244257|FG000|Study Overall|Lack of Efficacy|1|||
150029596|NCT02675907|541244258|FG001|Study Overall|Lack of Efficacy|0|||
150029597|NCT02675907|541244257|FG000|Study Overall|Withdrawal by Subject|2|||
150029598|NCT02675907|541244258|FG001|Study Overall|Withdrawal by Subject|2|||
150029599|NCT02675907|541244257|FG000|Study Overall|Lost to Follow-up|0|||
150029600|NCT02675907|541244258|FG001|Study Overall|Lost to Follow-up|2|||
150029601|NCT01611792|541244259|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
150029602|NCT01611792|541244260|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
150029603|NCT01611792|541244259|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
150029604|NCT01611792|541244260|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
149934481|NCT01663402|540896681|FG000|Overall Study|Lost to Follow-up|17|||
149934482|NCT01663402|540896682|FG001|Overall Study|Lost to Follow-up|15|||
149934483|NCT01663402|540896681|FG000|Overall Study|Other than specified above|172|||
149934484|NCT01663402|540896682|FG001|Overall Study|Other than specified above|147|||
149934485|NCT03575702|540896685|FG000|Overall Study|Withdrawal by Subject|1|||
149934486|NCT03575702|540896686|FG001|Overall Study|Withdrawal by Subject|1|||
149934487|NCT03575702|540896685|FG000|Overall Study|Lost to Follow-up|1|||
149934488|NCT03575702|540896686|FG001|Overall Study|Lost to Follow-up|2|||
149934489|NCT03575702|540896685|FG000|Overall Study|Protocol Violation|0|||
149934490|NCT03575702|540896686|FG001|Overall Study|Protocol Violation|1|||
149934491|NCT03575702|540896685|FG000|Overall Study|Patient non compliance|4|||
149934492|NCT03575702|540896686|FG001|Overall Study|Patient non compliance|0|||
149934493|NCT03903172|540896687|FG000|Overall Study|screen fail|4|||
149934494|NCT03903172|540896688|FG001|Overall Study|screen fail|1|||
149934495|NCT01545388|540896689|FG000|Overall Study|Adverse Event|2|||
149934496|NCT01545388|540896690|FG001|Overall Study|Adverse Event|4|||
149934497|NCT01545388|540896691|FG002|Overall Study|Adverse Event|1|||
149934498|NCT01545388|540896689|FG000|Overall Study|Lack of Efficacy|3|||
149934499|NCT01545388|540896690|FG001|Overall Study|Lack of Efficacy|2|||
149934500|NCT01545388|540896691|FG002|Overall Study|Lack of Efficacy|5|||
149934501|NCT01545388|540896689|FG000|Overall Study|Participant moved or relocated|1|||
150029605|NCT01759420|541244264|FG000|Overall Study|Screen failure|5|||
150029606|NCT01759420|541244264|FG000|Overall Study|Inaccurate EKG machine readings|1|||
150029607|NCT01129622|541244267|FG000|Overall Study|Withdrawal by Subject|2|||
149934502|NCT01545388|540896690|FG001|Overall Study|Participant moved or relocated|0|||
149934503|NCT01545388|540896691|FG002|Overall Study|Participant moved or relocated|0|||
149934504|NCT01545388|540896689|FG000|Overall Study|Withdrawal by Subject|1|||
149934505|NCT01545388|540896690|FG001|Overall Study|Withdrawal by Subject|4|||
149934506|NCT01545388|540896691|FG002|Overall Study|Withdrawal by Subject|2|||
149934507|NCT01545388|540896689|FG000|Overall Study|Other|1|||
149934508|NCT01545388|540896690|FG001|Overall Study|Other|1|||
149934509|NCT01545388|540896691|FG002|Overall Study|Other|0|||
149934510|NCT01802385|540896694|FG000|Overall Study|Death|106|||
150029608|NCT02051764|541244268|FG000|Overall Study|Study terminated by sponsor|0|||
150029609|NCT02051764|541244269|FG001|Overall Study|Study terminated by sponsor|7|||
149934511|NCT01802385|540896695|FG001|Overall Study|Death|120|||
149934512|NCT01664091|540896699|FG000|Overall Study|Death|1|||
149934513|NCT01664091|540896699|FG000|Overall Study|Disease Progression|2|||
149934514|NCT01664091|540896699|FG000|Overall Study|Lost to Follow-up|2|||
150029610|NCT00591006|541244270|FG000|Overall Study|Withdrawal by Subject|0|||
150029611|NCT00591006|541244271|FG001|Overall Study|Withdrawal by Subject|0|||
150029612|NCT00591006|541244272|FG002|Overall Study|Withdrawal by Subject|0|||
150029613|NCT00591006|541244273|FG003|Overall Study|Withdrawal by Subject|0|||
150029614|NCT00591006|541244274|FG004|Overall Study|Withdrawal by Subject|0|||
150029615|NCT00591006|541244275|FG005|Overall Study|Withdrawal by Subject|0|||
150029616|NCT00591006|541244276|FG006|Overall Study|Withdrawal by Subject|0|||
150029617|NCT00591006|541244277|FG007|Overall Study|Withdrawal by Subject|0|||
150029618|NCT00591006|541244278|FG008|Overall Study|Withdrawal by Subject|0|||
150029619|NCT00591006|541244279|FG009|Overall Study|Withdrawal by Subject|0|||
150029620|NCT00591006|541244280|FG010|Overall Study|Withdrawal by Subject|0|||
150029621|NCT00591006|541244281|FG011|Overall Study|Withdrawal by Subject|0|||
150029622|NCT00591006|541244282|FG012|Overall Study|Withdrawal by Subject|0|||
149934515|NCT01664091|540896699|FG000|Overall Study|Withdrawal by Subject|1|||
149934516|NCT01172873|540896701|FG000|Overall Study|Withdrawal by Subject|3|||
149934517|NCT01172873|540896702|FG001|Overall Study|Withdrawal by Subject|2|||
149934518|NCT05518539|540896703|FG000|Overall Study|Lost to Follow-up|6|||
149934519|NCT02053493|540896706|FG000|Overall Study|Withdrawal by Subject|1|||
149934520|NCT02053493|540896707|FG001|Overall Study|Withdrawal by Subject|1|||
149934521|NCT03589807|540896710|FG000|Overall Study|Lost to Follow-up|0|||
149934522|NCT03589807|540896711|FG001|Overall Study|Lost to Follow-up|2|||
149934523|NCT03589807|540896712|FG002|Overall Study|Lost to Follow-up|2|||
149934524|NCT03589807|540896713|FG003|Overall Study|Lost to Follow-up|3|||
149934525|NCT03589807|540896714|FG004|Overall Study|Lost to Follow-up|1|||
149934526|NCT03589807|540896715|FG005|Overall Study|Lost to Follow-up|1|||
149934527|NCT03589807|540896710|FG000|Overall Study|Withdrawal by Subject|0|||
149934528|NCT03589807|540896711|FG001|Overall Study|Withdrawal by Subject|5|||
149934529|NCT03589807|540896712|FG002|Overall Study|Withdrawal by Subject|0|||
149934530|NCT03589807|540896713|FG003|Overall Study|Withdrawal by Subject|0|||
149934531|NCT03589807|540896714|FG004|Overall Study|Withdrawal by Subject|0|||
149934532|NCT03589807|540896715|FG005|Overall Study|Withdrawal by Subject|0|||
149934533|NCT03589807|540896710|FG000|Overall Study|Protocol Violation|0|||
149934534|NCT03589807|540896711|FG001|Overall Study|Protocol Violation|0|||
149934535|NCT03589807|540896712|FG002|Overall Study|Protocol Violation|0|||
149934536|NCT03589807|540896713|FG003|Overall Study|Protocol Violation|1|||
149934537|NCT03589807|540896714|FG004|Overall Study|Protocol Violation|0|||
149934538|NCT03589807|540896715|FG005|Overall Study|Protocol Violation|0|||
149934539|NCT03589807|540896710|FG000|Overall Study|Enrolled but treatment not administered|0|||
149934540|NCT03589807|540896711|FG001|Overall Study|Enrolled but treatment not administered|0|||
149934541|NCT03589807|540896712|FG002|Overall Study|Enrolled but treatment not administered|0|||
149934542|NCT03589807|540896713|FG003|Overall Study|Enrolled but treatment not administered|0|||
149934543|NCT03589807|540896714|FG004|Overall Study|Enrolled but treatment not administered|1|||
149934544|NCT03589807|540896715|FG005|Overall Study|Enrolled but treatment not administered|0|||
149934545|NCT01076543|540896716|FG000|Overall Study|Withdrawal by Subject|2|||
149934546|NCT01076543|540896717|FG001|Overall Study|Withdrawal by Subject|0|||
149934547|NCT01076543|540896718|FG002|Overall Study|Withdrawal by Subject|0|||
149934548|NCT01076543|540896719|FG003|Overall Study|Withdrawal by Subject|0|||
149934549|NCT01076543|540896720|FG004|Overall Study|Withdrawal by Subject|0|||
149934550|NCT01076543|540896721|FG005|Overall Study|Withdrawal by Subject|0|||
149934551|NCT00338741|540896722|FG000|Overall Study|Lost to Follow-up|2|||
149934552|NCT00338741|540896723|FG001|Overall Study|Lost to Follow-up|0|||
149934553|NCT01534273|540896724|FG000|Period 1|Physician Decision|0|||
149934554|NCT01534273|540896725|FG001|Period 1|Physician Decision|0|||
149934555|NCT01534273|540896726|FG002|Period 1|Physician Decision|0|||
149934556|NCT01534273|540896727|FG003|Period 1|Physician Decision|1|||
149934557|NCT01534273|540896728|FG004|Period 1|Physician Decision|0|||
149934558|NCT01534273|540896729|FG005|Period 1|Physician Decision|0|||
149934559|NCT01534273|540896730|FG006|Period 1|Physician Decision|0|||
149934560|NCT01619865|540896731|FG000|Overall Study|Adverse Event|1|||
149934561|NCT01619865|540896731|FG000|Overall Study|Death|2|||
149934562|NCT01619865|540896731|FG000|Overall Study|subject not able to comply|1|||
149934563|NCT03586050|540896732|FG000|Overall Study|Death|3|||
149934564|NCT03586050|540896732|FG000|Overall Study|Withdrawal by Subject|2|||
150029623|NCT00591006|541244283|FG013|Overall Study|Withdrawal by Subject|0|||
150029624|NCT00591006|541244284|FG014|Overall Study|Withdrawal by Subject|0|||
150029625|NCT00591006|541244285|FG015|Overall Study|Withdrawal by Subject|1|||
149934565|NCT01494818|540896733|FG000|Overall Study|Relocation|1|||
149934566|NCT01494818|540896734|FG001|Overall Study|Relocation|2|||
150029626|NCT00591006|541244286|FG016|Overall Study|Withdrawal by Subject|0|||
150029627|NCT00591006|541244287|FG017|Overall Study|Withdrawal by Subject|0|||
149934567|NCT01494818|540896733|FG000|Overall Study|Lost to Follow-up|1|||
149934568|NCT01494818|540896734|FG001|Overall Study|Lost to Follow-up|0|||
149934569|NCT01791985|540896735|FG000|Overall Study|Adverse Event|7|||
149934570|NCT01791985|540896735|FG000|Overall Study|Withdrawal by Subject|1|||
149934571|NCT00086190|540896748|FG000|Overall Study|Adverse Event|6|||
149934572|NCT00086190|540896749|FG001|Overall Study|Adverse Event|2|||
149934573|NCT00086190|540896750|FG002|Overall Study|Adverse Event|2|||
150029628|NCT00591006|541244288|FG018|Overall Study|Withdrawal by Subject|0|||
149934574|NCT00086190|540896748|FG000|Overall Study|Withdrawal by Subject|0|||
149934575|NCT00086190|540896749|FG001|Overall Study|Withdrawal by Subject|2|||
149934576|NCT00086190|540896750|FG002|Overall Study|Withdrawal by Subject|2|||
149934577|NCT00086190|540896748|FG000|Overall Study|Protocol Violation|1|||
149934578|NCT00086190|540896749|FG001|Overall Study|Protocol Violation|0|||
149934579|NCT00086190|540896750|FG002|Overall Study|Protocol Violation|0|||
149934580|NCT00086190|540896748|FG000|Overall Study|Moved|1|||
149934581|NCT00086190|540896749|FG001|Overall Study|Moved|0|||
149934582|NCT00086190|540896750|FG002|Overall Study|Moved|0|||
149934583|NCT00086190|540896748|FG000|Overall Study|Worsening depression|0|||
149934584|NCT00086190|540896749|FG001|Overall Study|Worsening depression|0|||
149934585|NCT00086190|540896750|FG002|Overall Study|Worsening depression|2|||
149934586|NCT00249834|540896751|FG000|Overall Study|Ovarian stimulation failed|1|||
149934587|NCT00249834|540896752|FG001|Overall Study|Ovarian stimulation failed|0|||
149934588|NCT00249834|540896753|FG002|Overall Study|Ovarian stimulation failed|0|||
149934589|NCT00249834|540896754|FG003|Overall Study|Ovarian stimulation failed|0|||
149934590|NCT00249834|540896755|FG004|Overall Study|Ovarian stimulation failed|0|||
149934591|NCT00249834|540896756|FG005|Overall Study|Ovarian stimulation failed|0|||
149934592|NCT00249834|540896757|FG006|Overall Study|Ovarian stimulation failed|0|||
149934593|NCT00249834|540896758|FG007|Overall Study|Ovarian stimulation failed|0|||
149934594|NCT00249834|540896751|FG000|Overall Study|Failure of down-regulation|0|||
149934595|NCT00249834|540896752|FG001|Overall Study|Failure of down-regulation|0|||
149934596|NCT00249834|540896753|FG002|Overall Study|Failure of down-regulation|0|||
149934597|NCT00249834|540896754|FG003|Overall Study|Failure of down-regulation|0|||
149934598|NCT00249834|540896755|FG004|Overall Study|Failure of down-regulation|0|||
149934599|NCT00249834|540896756|FG005|Overall Study|Failure of down-regulation|0|||
149934600|NCT00249834|540896757|FG006|Overall Study|Failure of down-regulation|1|||
149934601|NCT00249834|540896758|FG007|Overall Study|Failure of down-regulation|0|||
149934602|NCT00249834|540896751|FG000|Overall Study|Protocol Violation|0|||
149934603|NCT00249834|540896752|FG001|Overall Study|Protocol Violation|19|||
149934604|NCT00249834|540896753|FG002|Overall Study|Protocol Violation|14|||
149934605|NCT00249834|540896754|FG003|Overall Study|Protocol Violation|8|||
149934606|NCT00249834|540896755|FG004|Overall Study|Protocol Violation|5|||
149934607|NCT00249834|540896756|FG005|Overall Study|Protocol Violation|2|||
149934608|NCT00249834|540896757|FG006|Overall Study|Protocol Violation|0|||
149934609|NCT00249834|540896758|FG007|Overall Study|Protocol Violation|0|||
149934610|NCT03902613|540896764|FG000|Overall Study|Physician Decision|1|||
149934611|NCT04467515|540896765|FG000|Overall Study|Lost to Follow-up|1|||
149934612|NCT04467515|540896766|FG001|Overall Study|Lost to Follow-up|0|||
149934613|NCT04467515|540896767|FG002|Overall Study|Lost to Follow-up|0|||
149934614|NCT04467515|540896765|FG000|Overall Study|Withdrawal by Subject|1|||
149934615|NCT04467515|540896766|FG001|Overall Study|Withdrawal by Subject|0|||
149934616|NCT04467515|540896767|FG002|Overall Study|Withdrawal by Subject|1|||
149934617|NCT04467515|540896765|FG000|Overall Study|Progressive Disease|0|||
149934618|NCT04467515|540896766|FG001|Overall Study|Progressive Disease|1|||
149934619|NCT04467515|540896767|FG002|Overall Study|Progressive Disease|3|||
149934620|NCT04467515|540896765|FG000|Overall Study|Death|0|||
149934621|NCT04467515|540896766|FG001|Overall Study|Death|1|||
149934622|NCT04467515|540896767|FG002|Overall Study|Death|0|||
149934623|NCT03014206|540896770|FG000|Overall Study|Registration Violation|12|||
149934624|NCT01091246|540896771|FG000|Overall Study|Lost to Follow-up|23|||
149934625|NCT01091246|540896772|FG001|Overall Study|Lost to Follow-up|11|||
149934626|NCT01091246|540896773|FG002|Overall Study|Lost to Follow-up|7|||
149934627|NCT01091246|540896771|FG000|Overall Study|Adverse Event|1|||
149934628|NCT01091246|540896772|FG001|Overall Study|Adverse Event|0|||
149934629|NCT01091246|540896773|FG002|Overall Study|Adverse Event|1|||
149934630|NCT01091246|540896771|FG000|Overall Study|Withdrawal by Subject|9|||
149934631|NCT01091246|540896772|FG001|Overall Study|Withdrawal by Subject|5|||
149934632|NCT01091246|540896773|FG002|Overall Study|Withdrawal by Subject|4|||
149934633|NCT01091246|540896771|FG000|Overall Study|Subject not dosed|2|||
149934634|NCT01091246|540896772|FG001|Overall Study|Subject not dosed|0|||
149934635|NCT01091246|540896773|FG002|Overall Study|Subject not dosed|1|||
149934636|NCT01676012|540896774|FG000|Overall Study|Adverse Event|2|||
149934637|NCT01676012|540896774|FG000|Overall Study|incomplete set of videos|1|||
149934638|NCT04460326|540896784|FG000|Completed at Least 4 Meals|Early discharge|5|||
149934639|NCT04460326|540896785|FG001|Completed at Least 4 Meals|Early discharge|5|||
149934640|NCT04460326|540896784|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
149934641|NCT04460326|540896785|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
149934642|NCT04460326|540896784|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
149934643|NCT04460326|540896785|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
149820210|NCT03882047|540471752|FG001|Overall Study|Adverse Event|2|||
149934644|NCT04460326|540896784|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
149934645|NCT04460326|540896785|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
149934646|NCT04460326|540896784|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
149934647|NCT04460326|540896785|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
149934648|NCT04460326|540896784|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
149975582|NCT00114127|541047893|FG001|Overall Study|Lost to Follow-up|0|||
149934649|NCT04460326|540896785|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
149934650|NCT04794751|540896786|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
149934651|NCT04794751|540896787|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
149934652|NCT04794751|540896786|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
149934653|NCT04794751|540896787|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
149934654|NCT04794751|540896786|FG000|Period 1|Protocol Violation|0|||
149934655|NCT04794751|540896787|FG001|Period 1|Protocol Violation|2|||
149934656|NCT04794751|540896786|FG000|Period 1|Withdrawal by Subject|0|||
149934657|NCT04794751|540896787|FG001|Period 1|Withdrawal by Subject|1|||
149934658|NCT04794751|540896786|FG000|Period 2|Withdrawal by Subject|0|||
149934659|NCT04794751|540896787|FG001|Period 2|Withdrawal by Subject|1|||
149934660|NCT04794751|540896786|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
149934661|NCT04794751|540896787|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
149934662|NCT04794751|540896786|FG000|Period 2|Protocol Violation|1|||
149934663|NCT04794751|540896787|FG001|Period 2|Protocol Violation|0|||
149934664|NCT03528551|540896789|FG000|Overall Study|Lost to Follow-up|0|||
149934665|NCT03528551|540896790|FG001|Overall Study|Lost to Follow-up|1|||
149934666|NCT03528551|540896791|FG002|Overall Study|Lost to Follow-up|0|||
149934667|NCT03528551|540896789|FG000|Overall Study|Transferred to other arm/group|2|||
149934668|NCT03528551|540896790|FG001|Overall Study|Transferred to other arm/group|3|||
149934669|NCT03528551|540896791|FG002|Overall Study|Transferred to other arm/group|0|||
149934670|NCT03528551|540896789|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149934671|NCT03528551|540896790|FG001|Overall Study|Withdrawal by parent/guardian|5|||
149934672|NCT03528551|540896791|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149934673|NCT03528551|540896789|FG000|Overall Study|Protocol Violation|0|||
149934674|NCT03528551|540896790|FG001|Overall Study|Protocol Violation|3|||
149934675|NCT03528551|540896791|FG002|Overall Study|Protocol Violation|0|||
149934676|NCT03528551|540896789|FG000|Overall Study|Withdrawal by Subject|0|||
149934677|NCT03528551|540896790|FG001|Overall Study|Withdrawal by Subject|7|||
149934678|NCT03528551|540896791|FG002|Overall Study|Withdrawal by Subject|0|||
149934679|NCT00969228|540896792|FG000|Overall Study|Adverse Event|1|||
149934680|NCT00969228|540896793|FG001|Overall Study|Adverse Event|0|||
149934681|NCT00969228|540896792|FG000|Overall Study|Withdrawal by Subject|4|||
149934682|NCT00969228|540896793|FG001|Overall Study|Withdrawal by Subject|0|||
149934683|NCT00969228|540896792|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
149934684|NCT00969228|540896793|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
149934685|NCT03311945|540896794|FG000|Overall Study|Adverse Event|2|||
149934686|NCT03311945|540896794|FG000|Overall Study|Lack of Efficacy|1|||
149934687|NCT01619878|540896795|FG000|6 Week Follow-up Phase|Adverse Event|1|||
149934688|NCT01619878|540896795|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
149934689|NCT01619878|540896795|FG000|Follow-up at 12 Months of Age|Death|2|||
149934690|NCT01883895|540896796|FG000|Overall Study|Lost to Follow-up|2|||
149934691|NCT02007720|540896803|FG000|Overall Study|Withdrawal by Subject|9|||
149934692|NCT02007720|540896804|FG001|Overall Study|Withdrawal by Subject|11|||
149934693|NCT02007720|540896803|FG000|Overall Study|study terminated by sponsor|58|||
149934694|NCT02007720|540896804|FG001|Overall Study|study terminated by sponsor|54|||
149934695|NCT02007720|540896803|FG000|Overall Study|technical problem|4|||
149934696|NCT02007720|540896804|FG001|Overall Study|technical problem|2|||
149934697|NCT02007720|540896803|FG000|Overall Study|patient followd less than 165 days|11|||
149934698|NCT02007720|540896804|FG001|Overall Study|patient followd less than 165 days|5|||
149934699|NCT03810456|540896805|FG000|Treatment|Urgent Family Matters|3|||
149934700|NCT03810456|540896806|FG001|Treatment|Urgent Family Matters|0|||
149934701|NCT03810456|540896807|FG002|Treatment|Urgent Family Matters|0|||
149934702|NCT03810456|540896805|FG000|Treatment|Scheduling Conflicts|0|||
149934703|NCT03810456|540896806|FG001|Treatment|Scheduling Conflicts|11|||
149934704|NCT03810456|540896807|FG002|Treatment|Scheduling Conflicts|0|||
149934705|NCT03810456|540896805|FG000|Treatment|No Longer Interested|0|||
149934706|NCT03810456|540896806|FG001|Treatment|No Longer Interested|12|||
149934707|NCT03810456|540896807|FG002|Treatment|No Longer Interested|0|||
149934708|NCT03810456|540896805|FG000|Treatment|Transportation Issues|0|||
149934709|NCT03810456|540896806|FG001|Treatment|Transportation Issues|1|||
149934710|NCT03810456|540896807|FG002|Treatment|Transportation Issues|0|||
149934711|NCT03810456|540896805|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
149934712|NCT03810456|540896806|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
149934713|NCT03810456|540896807|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
149934714|NCT03810456|540896805|FG000|1 Month Follow-Up|Relocated to Different State|1|||
149934715|NCT03810456|540896806|FG001|1 Month Follow-Up|Relocated to Different State|0|||
149934716|NCT03810456|540896807|FG002|1 Month Follow-Up|Relocated to Different State|1|||
149934717|NCT03810456|540896805|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
149934718|NCT03810456|540896806|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
149934719|NCT03810456|540896807|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
149934720|NCT03810456|540896805|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
149934721|NCT03810456|540896806|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
149934722|NCT03810456|540896807|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
149934723|NCT03810456|540896805|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
149934724|NCT03810456|540896806|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
149934725|NCT03810456|540896807|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
149934726|NCT03810456|540896805|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
149934727|NCT03810456|540896806|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
149934728|NCT03810456|540896807|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
149934729|NCT03810456|540896805|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
149934730|NCT03810456|540896806|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
149934731|NCT03810456|540896807|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
149934732|NCT01655901|540898669|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
149934733|NCT01655901|540898670|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
149934734|NCT01655901|540898671|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
149934735|NCT01655901|540898672|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
149934736|NCT01655901|540898673|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
149934737|NCT01655901|540898674|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
149934738|NCT00352118|540898675|FG000|Overall Study|Physician Decision|4|||
149934739|NCT02997163|540898676|FG000|Overall Study|Adverse Event|1|||
149934740|NCT02997163|540898677|FG001|Overall Study|Adverse Event|0|||
149934741|NCT02997163|540898678|FG002|Overall Study|Adverse Event|0|||
149934742|NCT02997163|540898679|FG003|Overall Study|Adverse Event|1|||
149934743|NCT00922636|540898680|FG000|Overall Study|Adverse Event|3|||
149934744|NCT00922636|540898681|FG001|Overall Study|Adverse Event|3|||
149934745|NCT00922636|540898682|FG002|Overall Study|Adverse Event|2|||
149934746|NCT00922636|540898683|FG003|Overall Study|Adverse Event|3|||
149934747|NCT00922636|540898684|FG004|Overall Study|Adverse Event|2|||
149934748|NCT00922636|540898680|FG000|Overall Study|Lack of Efficacy|1|||
149934749|NCT00922636|540898681|FG001|Overall Study|Lack of Efficacy|7|||
149934750|NCT00922636|540898682|FG002|Overall Study|Lack of Efficacy|3|||
149934751|NCT00922636|540898683|FG003|Overall Study|Lack of Efficacy|2|||
149934752|NCT00922636|540898684|FG004|Overall Study|Lack of Efficacy|4|||
149934753|NCT00922636|540898680|FG000|Overall Study|Sponsor Decision|0|||
149934754|NCT00922636|540898681|FG001|Overall Study|Sponsor Decision|0|||
149934755|NCT00922636|540898682|FG002|Overall Study|Sponsor Decision|2|||
149934756|NCT00922636|540898683|FG003|Overall Study|Sponsor Decision|0|||
149934757|NCT00922636|540898684|FG004|Overall Study|Sponsor Decision|0|||
149934758|NCT00922636|540898680|FG000|Overall Study|Withdrawal by Subject|0|||
149934759|NCT00922636|540898681|FG001|Overall Study|Withdrawal by Subject|0|||
149934760|NCT00922636|540898682|FG002|Overall Study|Withdrawal by Subject|5|||
149934761|NCT00922636|540898683|FG003|Overall Study|Withdrawal by Subject|2|||
149934762|NCT00922636|540898684|FG004|Overall Study|Withdrawal by Subject|4|||
149934763|NCT00922636|540898680|FG000|Overall Study|Protocol Violation|0|||
149934764|NCT00922636|540898681|FG001|Overall Study|Protocol Violation|0|||
149934765|NCT00922636|540898682|FG002|Overall Study|Protocol Violation|2|||
149934766|NCT00922636|540898683|FG003|Overall Study|Protocol Violation|2|||
150029629|NCT00591006|541244289|FG019|Overall Study|Withdrawal by Subject|0|||
150029630|NCT00591006|541244290|FG020|Overall Study|Withdrawal by Subject|0|||
150029631|NCT00591006|541244291|FG021|Overall Study|Withdrawal by Subject|0|||
150029632|NCT00591006|541244292|FG022|Overall Study|Withdrawal by Subject|0|||
150029633|NCT00591006|541244293|FG023|Overall Study|Withdrawal by Subject|1|||
150029634|NCT00591006|541244270|FG000|Overall Study|Adverse Event|0|||
150029635|NCT00591006|541244271|FG001|Overall Study|Adverse Event|0|||
150029636|NCT00591006|541244272|FG002|Overall Study|Adverse Event|0|||
150029637|NCT00591006|541244273|FG003|Overall Study|Adverse Event|0|||
150029638|NCT00591006|541244274|FG004|Overall Study|Adverse Event|0|||
150029639|NCT00591006|541244275|FG005|Overall Study|Adverse Event|0|||
150029640|NCT00591006|541244276|FG006|Overall Study|Adverse Event|0|||
150029641|NCT00591006|541244277|FG007|Overall Study|Adverse Event|0|||
150029642|NCT00591006|541244278|FG008|Overall Study|Adverse Event|0|||
150029643|NCT00591006|541244279|FG009|Overall Study|Adverse Event|0|||
149934767|NCT00922636|540898684|FG004|Overall Study|Protocol Violation|0|||
149934768|NCT00922636|540898680|FG000|Overall Study|Entry Criteria Not Met|0|||
149934769|NCT00922636|540898681|FG001|Overall Study|Entry Criteria Not Met|0|||
149934770|NCT00922636|540898682|FG002|Overall Study|Entry Criteria Not Met|1|||
149934771|NCT00922636|540898683|FG003|Overall Study|Entry Criteria Not Met|1|||
149934772|NCT00922636|540898684|FG004|Overall Study|Entry Criteria Not Met|0|||
149934773|NCT00922636|540898680|FG000|Overall Study|Parent/Caregiver Decision|2|||
149934774|NCT00922636|540898681|FG001|Overall Study|Parent/Caregiver Decision|4|||
150029644|NCT00591006|541244280|FG010|Overall Study|Adverse Event|0|||
150029645|NCT00591006|541244281|FG011|Overall Study|Adverse Event|0|||
150029646|NCT00591006|541244282|FG012|Overall Study|Adverse Event|0|||
150029647|NCT00591006|541244283|FG013|Overall Study|Adverse Event|0|||
149934775|NCT00922636|540898682|FG002|Overall Study|Parent/Caregiver Decision|3|||
149934776|NCT00922636|540898683|FG003|Overall Study|Parent/Caregiver Decision|5|||
149934777|NCT00922636|540898684|FG004|Overall Study|Parent/Caregiver Decision|2|||
149934778|NCT00922636|540898680|FG000|Overall Study|Lost to Follow-up|1|||
149934779|NCT00922636|540898681|FG001|Overall Study|Lost to Follow-up|2|||
150029648|NCT00591006|541244284|FG014|Overall Study|Adverse Event|0|||
150029649|NCT00591006|541244285|FG015|Overall Study|Adverse Event|0|||
150029650|NCT00591006|541244286|FG016|Overall Study|Adverse Event|0|||
150029651|NCT00591006|541244287|FG017|Overall Study|Adverse Event|0|||
150029652|NCT00591006|541244288|FG018|Overall Study|Adverse Event|0|||
150029653|NCT00591006|541244289|FG019|Overall Study|Adverse Event|0|||
150029654|NCT00591006|541244290|FG020|Overall Study|Adverse Event|0|||
150029655|NCT00591006|541244291|FG021|Overall Study|Adverse Event|0|||
150029656|NCT00591006|541244292|FG022|Overall Study|Adverse Event|1|||
150029657|NCT00591006|541244293|FG023|Overall Study|Adverse Event|0|||
150029658|NCT02898454|541244294|FG000|Overall Study|Adverse Event|4|||
150029659|NCT02898454|541244295|FG001|Overall Study|Adverse Event|1|||
150029660|NCT02898454|541244296|FG002|Overall Study|Adverse Event|2|||
150029661|NCT02898454|541244294|FG000|Overall Study|Protocol Violation|1|||
150029662|NCT02898454|541244295|FG001|Overall Study|Protocol Violation|0|||
150029663|NCT02898454|541244296|FG002|Overall Study|Protocol Violation|1|||
150029664|NCT02898454|541244294|FG000|Overall Study|Lack of Efficacy|4|||
150029665|NCT02898454|541244295|FG001|Overall Study|Lack of Efficacy|1|||
150029666|NCT02898454|541244296|FG002|Overall Study|Lack of Efficacy|0|||
150029667|NCT02898454|541244294|FG000|Overall Study|Withdrawal by Subject|6|||
150029668|NCT02898454|541244295|FG001|Overall Study|Withdrawal by Subject|3|||
150029669|NCT02898454|541244296|FG002|Overall Study|Withdrawal by Subject|3|||
149934780|NCT00922636|540898682|FG002|Overall Study|Lost to Follow-up|2|||
149934781|NCT00922636|540898683|FG003|Overall Study|Lost to Follow-up|2|||
149934782|NCT00922636|540898684|FG004|Overall Study|Lost to Follow-up|4|||
149934783|NCT00870727|540898685|FG000|Overall Study|Lost to Follow-up|0|||
149934784|NCT00870727|540898686|FG001|Overall Study|Lost to Follow-up|1|||
149934785|NCT00870727|540898685|FG000|Overall Study|Lack of Efficacy|1|||
149934786|NCT00870727|540898686|FG001|Overall Study|Lack of Efficacy|3|||
149934787|NCT00870727|540898685|FG000|Overall Study|Adverse Event|0|||
149934788|NCT00870727|540898686|FG001|Overall Study|Adverse Event|1|||
149934789|NCT00557466|540898687|FG000|Overall Study|Adverse Event|3|||
149934790|NCT00557466|540898688|FG001|Overall Study|Adverse Event|1|||
149934791|NCT00557466|540898689|FG002|Overall Study|Adverse Event|4|||
149934792|NCT00557466|540898690|FG003|Overall Study|Adverse Event|1|||
149934793|NCT00557466|540898691|FG004|Overall Study|Adverse Event|2|||
149934794|NCT00557466|540898692|FG005|Overall Study|Adverse Event|4|||
149934795|NCT00557466|540898687|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149934796|NCT00557466|540898688|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149934797|NCT00557466|540898689|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149934798|NCT00557466|540898690|FG003|Overall Study|Abnormal laboratory value(s)|0|||
149934799|NCT00557466|540898691|FG004|Overall Study|Abnormal laboratory value(s)|0|||
149934800|NCT00557466|540898692|FG005|Overall Study|Abnormal laboratory value(s)|0|||
149934801|NCT00557466|540898687|FG000|Overall Study|Protocol deviation|0|||
149934802|NCT00557466|540898688|FG001|Overall Study|Protocol deviation|1|||
149934803|NCT00557466|540898689|FG002|Overall Study|Protocol deviation|0|||
149934804|NCT00557466|540898690|FG003|Overall Study|Protocol deviation|2|||
149934805|NCT00557466|540898691|FG004|Overall Study|Protocol deviation|0|||
149934806|NCT00557466|540898692|FG005|Overall Study|Protocol deviation|0|||
149934807|NCT00557466|540898687|FG000|Overall Study|Subject withdrew consent|0|||
149934808|NCT00557466|540898688|FG001|Overall Study|Subject withdrew consent|0|||
149934809|NCT00557466|540898689|FG002|Overall Study|Subject withdrew consent|0|||
149934810|NCT00557466|540898690|FG003|Overall Study|Subject withdrew consent|0|||
149934811|NCT00557466|540898691|FG004|Overall Study|Subject withdrew consent|1|||
149934812|NCT00557466|540898692|FG005|Overall Study|Subject withdrew consent|2|||
149934813|NCT00557466|540898687|FG000|Overall Study|Administrative problems|0|||
149934814|NCT00557466|540898688|FG001|Overall Study|Administrative problems|1|||
149934815|NCT00557466|540898689|FG002|Overall Study|Administrative problems|1|||
149934816|NCT00557466|540898690|FG003|Overall Study|Administrative problems|0|||
149934817|NCT00557466|540898691|FG004|Overall Study|Administrative problems|0|||
149934818|NCT00557466|540898692|FG005|Overall Study|Administrative problems|0|||
149934819|NCT00557466|540898687|FG000|Overall Study|Abnormal test procedure results|0|||
149934820|NCT00557466|540898688|FG001|Overall Study|Abnormal test procedure results|0|||
149934821|NCT00557466|540898689|FG002|Overall Study|Abnormal test procedure results|1|||
149934822|NCT00557466|540898690|FG003|Overall Study|Abnormal test procedure results|0|||
150029670|NCT02898454|541244294|FG000|Overall Study|Lost to Follow-up|1|||
150029671|NCT02898454|541244295|FG001|Overall Study|Lost to Follow-up|0|||
150029672|NCT02898454|541244296|FG002|Overall Study|Lost to Follow-up|0|||
150029673|NCT02898454|541244294|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
150029674|NCT02898454|541244295|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
150029675|NCT02898454|541244296|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
149934823|NCT00557466|540898691|FG004|Overall Study|Abnormal test procedure results|0|||
149934824|NCT00557466|540898692|FG005|Overall Study|Abnormal test procedure results|0|||
149934825|NCT00557466|540898687|FG000|Overall Study|Lost to Follow-up|0|||
149934826|NCT00557466|540898688|FG001|Overall Study|Lost to Follow-up|0|||
149934827|NCT00557466|540898689|FG002|Overall Study|Lost to Follow-up|0|||
149934828|NCT00557466|540898690|FG003|Overall Study|Lost to Follow-up|1|||
149934829|NCT00557466|540898691|FG004|Overall Study|Lost to Follow-up|0|||
149934830|NCT00557466|540898692|FG005|Overall Study|Lost to Follow-up|0|||
150029676|NCT04264442|541244300|FG000|Overall Study|Lack of Efficacy|6|||
150029677|NCT04264442|541244300|FG000|Overall Study|Lost to Follow-up|2|||
150029678|NCT04264442|541244300|FG000|Overall Study|Sponsor Decision|23|||
150029679|NCT04264442|541244300|FG000|Overall Study|Withdrawal by Subject|11|||
150029680|NCT04264442|541244300|FG000|Overall Study|Study Termination|5|||
150029681|NCT01290523|541244302|FG000|Overall Study|Death|3|||
150029682|NCT03071263|541244303|FG000|Overall Study|Adverse Event|1|||
149934831|NCT01712516|540898693|FG000|Overall Study|Technical problems|0|||
149934832|NCT01712516|540898694|FG001|Overall Study|Technical problems|0|||
149934833|NCT01712516|540898695|FG002|Overall Study|Technical problems|0|||
149934834|NCT01712516|540898696|FG003|Overall Study|Technical problems|2|||
149934835|NCT01712516|540898693|FG000|Overall Study|Lost to Follow-up|0|||
149934836|NCT01712516|540898694|FG001|Overall Study|Lost to Follow-up|0|||
149934837|NCT01712516|540898695|FG002|Overall Study|Lost to Follow-up|2|||
149934838|NCT01712516|540898696|FG003|Overall Study|Lost to Follow-up|1|||
149934839|NCT01712516|540898693|FG000|Overall Study|Death|0|||
149934840|NCT01712516|540898694|FG001|Overall Study|Death|1|||
149934841|NCT01712516|540898695|FG002|Overall Study|Death|0|||
149934842|NCT01712516|540898696|FG003|Overall Study|Death|0|||
149934843|NCT01712516|540898693|FG000|Overall Study|Protocol deviation|1|||
149934844|NCT01712516|540898694|FG001|Overall Study|Protocol deviation|0|||
149934845|NCT01712516|540898695|FG002|Overall Study|Protocol deviation|1|||
149934846|NCT01712516|540898696|FG003|Overall Study|Protocol deviation|0|||
149934847|NCT01712516|540898693|FG000|Overall Study|Physician Decision|2|||
149934848|NCT01712516|540898694|FG001|Overall Study|Physician Decision|0|||
149934849|NCT01712516|540898695|FG002|Overall Study|Physician Decision|0|||
149934850|NCT01712516|540898696|FG003|Overall Study|Physician Decision|1|||
149934851|NCT01712516|540898693|FG000|Overall Study|Withdrawal by Subject|3|||
149934852|NCT01712516|540898694|FG001|Overall Study|Withdrawal by Subject|9|||
149934853|NCT01712516|540898695|FG002|Overall Study|Withdrawal by Subject|3|||
149934854|NCT01712516|540898696|FG003|Overall Study|Withdrawal by Subject|9|||
149934855|NCT01251952|540898699|FG000|Overall Study|Adverse Event|1|||
149934856|NCT00496769|540898700|FG000|Double Blind|>=1 reason assigned per patient|558|||
149934857|NCT00496769|540898701|FG001|Double Blind|>=1 reason assigned per patient|649|||
149934858|NCT00496769|540898702|FG002|Double Blind|>=1 reason assigned per patient|0|||
149934859|NCT00496769|540898700|FG000|Open Label|>=1 reason assigned per patient|0|||
149934860|NCT00496769|540898701|FG001|Open Label|>=1 reason assigned per patient|0|||
149934861|NCT00496769|540898702|FG002|Open Label|>=1 reason assigned per patient|1011|||
149934862|NCT03028142|540898703|FG000|Overall Study|Adverse Event|1|||
149934863|NCT03028142|540898704|FG001|Overall Study|Adverse Event|1|||
149934864|NCT03028142|540898705|FG002|Overall Study|Adverse Event|0|||
149934865|NCT03028142|540898706|FG003|Overall Study|Adverse Event|0|||
149934866|NCT03028142|540898707|FG004|Overall Study|Adverse Event|0|||
149934867|NCT03028142|540898708|FG005|Overall Study|Adverse Event|1|||
149934868|NCT03028142|540898703|FG000|Overall Study|Withdrawal by Subject|0|||
149934869|NCT03028142|540898704|FG001|Overall Study|Withdrawal by Subject|0|||
149934870|NCT03028142|540898705|FG002|Overall Study|Withdrawal by Subject|0|||
149934871|NCT03028142|540898706|FG003|Overall Study|Withdrawal by Subject|0|||
149934872|NCT03028142|540898707|FG004|Overall Study|Withdrawal by Subject|1|||
149934873|NCT03028142|540898708|FG005|Overall Study|Withdrawal by Subject|0|||
149934874|NCT02308046|540898709|FG000|Overall Study|Negative yeast culture at Baseline|32|||
149934875|NCT02308046|540898710|FG001|Overall Study|Negative yeast culture at Baseline|33|||
149934876|NCT02308046|540898709|FG000|Overall Study|Positive for STD at Baseline|1|||
149934877|NCT02308046|540898710|FG001|Overall Study|Positive for STD at Baseline|2|||
149934878|NCT02308046|540898709|FG000|Overall Study|Lost to Follow-up|1|||
149934879|NCT02308046|540898710|FG001|Overall Study|Lost to Follow-up|3|||
149934880|NCT02810418|540898716|FG000|Arm A Dose Escalation|Adverse Event|2|||
149934881|NCT02810418|540898717|FG001|Arm A Dose Escalation|Adverse Event|1|||
149934882|NCT02810418|540898718|FG002|Arm A Dose Escalation|Adverse Event|0|||
149934883|NCT02810418|540898719|FG003|Arm A Dose Escalation|Adverse Event|0|||
149934884|NCT02810418|540898720|FG004|Arm A Dose Escalation|Adverse Event|0|||
149934885|NCT02810418|540898721|FG005|Arm A Dose Escalation|Adverse Event|0|||
150029683|NCT03071263|541244304|FG001|Overall Study|Adverse Event|3|||
149934886|NCT02810418|540898722|FG006|Arm A Dose Escalation|Adverse Event|0|||
149934887|NCT02810418|540898716|FG000|Dose Expansion|Adverse Event|0|||
150029684|NCT03071263|541244303|FG000|Overall Study|Withdrawal by Subject|1|||
149934888|NCT02810418|540898717|FG001|Dose Expansion|Adverse Event|1|||
149934889|NCT02810418|540898718|FG002|Dose Expansion|Adverse Event|1|||
149934890|NCT02810418|540898719|FG003|Dose Expansion|Adverse Event|0|||
149934891|NCT02810418|540898720|FG004|Dose Expansion|Adverse Event|0|||
149934892|NCT02810418|540898721|FG005|Dose Expansion|Adverse Event|0|||
149934893|NCT02810418|540898722|FG006|Dose Expansion|Adverse Event|0|||
149934894|NCT02810418|540898716|FG000|Dose Expansion|Physician Decision|0|||
149934895|NCT02810418|540898717|FG001|Dose Expansion|Physician Decision|0|||
149934896|NCT02810418|540898718|FG002|Dose Expansion|Physician Decision|2|||
149934897|NCT02810418|540898719|FG003|Dose Expansion|Physician Decision|0|||
149934898|NCT02810418|540898720|FG004|Dose Expansion|Physician Decision|0|||
149934899|NCT02810418|540898721|FG005|Dose Expansion|Physician Decision|0|||
149934900|NCT02810418|540898722|FG006|Dose Expansion|Physician Decision|0|||
150029685|NCT03071263|541244304|FG001|Overall Study|Withdrawal by Subject|3|||
149934901|NCT02810418|540898716|FG000|Arm B Dose Escalation|Adverse Event|0|||
149934902|NCT02810418|540898717|FG001|Arm B Dose Escalation|Adverse Event|0|||
149934903|NCT02810418|540898718|FG002|Arm B Dose Escalation|Adverse Event|0|||
149934904|NCT02810418|540898719|FG003|Arm B Dose Escalation|Adverse Event|0|||
149934905|NCT02810418|540898720|FG004|Arm B Dose Escalation|Adverse Event|1|||
149934906|NCT02810418|540898721|FG005|Arm B Dose Escalation|Adverse Event|2|||
149934907|NCT02810418|540898722|FG006|Arm B Dose Escalation|Adverse Event|0|||
149934908|NCT02224625|540898723|FG000|Irritation|Adverse Event|6|||
149934909|NCT02224625|540898723|FG000|Sensitization|Adverse Event|55|||
149934910|NCT01181167|540898724|FG000|Overall Study|Adverse Event|11|||
149934911|NCT01181167|540898725|FG001|Overall Study|Adverse Event|21|||
149934912|NCT01181167|540898724|FG000|Overall Study|Lost to Follow-up|1|||
149934913|NCT01181167|540898725|FG001|Overall Study|Lost to Follow-up|0|||
149934914|NCT01181167|540898724|FG000|Overall Study|Physician Decision|2|||
149934915|NCT01181167|540898725|FG001|Overall Study|Physician Decision|3|||
149934916|NCT01181167|540898724|FG000|Overall Study|Protocol Violation|3|||
149934917|NCT01181167|540898725|FG001|Overall Study|Protocol Violation|0|||
149934918|NCT01181167|540898724|FG000|Overall Study|Withdrawal by Subject|6|||
150029686|NCT03071263|541244303|FG000|Overall Study|Physician Decision|1|||
150029687|NCT03071263|541244304|FG001|Overall Study|Physician Decision|0|||
150029688|NCT03071263|541244303|FG000|Overall Study|Participant moved to another city|0|||
149934919|NCT01181167|540898725|FG001|Overall Study|Withdrawal by Subject|8|||
149934920|NCT02812186|540898726|FG000|Period 1|Post randomization screen failure|5|||
149934921|NCT02812186|540898727|FG001|Period 1|Post randomization screen failure|9|||
149934922|NCT02812186|540898726|FG000|Period 1|nonevaluable data sets|6|||
149934923|NCT02812186|540898727|FG001|Period 1|nonevaluable data sets|6|||
149934924|NCT01573000|540898728|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
149934925|NCT01573000|540898729|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
149934926|NCT01573000|540898728|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
149934927|NCT01573000|540898729|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
149934928|NCT01573000|540898728|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
149934929|NCT01573000|540898729|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
149934930|NCT01573000|540898728|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
149934931|NCT01573000|540898729|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
149934932|NCT01573000|540898728|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
149934933|NCT01573000|540898729|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
149934934|NCT01573000|540898728|FG000|Crossover Phase|Lack of Efficacy|0|||
149934935|NCT01573000|540898729|FG001|Crossover Phase|Lack of Efficacy|13|||
149934936|NCT01573000|540898728|FG000|Crossover Phase|Lost to Follow-up|0|||
149934937|NCT01573000|540898729|FG001|Crossover Phase|Lost to Follow-up|2|||
149934938|NCT01573000|540898728|FG000|Crossover Phase|Death|0|||
149934939|NCT01573000|540898729|FG001|Crossover Phase|Death|3|||
149934940|NCT01573000|540898728|FG000|Long-Term Follow-Up|Death|3|||
149934941|NCT01573000|540898729|FG001|Long-Term Follow-Up|Death|0|||
149934942|NCT01573000|540898728|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
149934943|NCT01573000|540898729|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
149934944|NCT01100853|540898738|FG000|Overall Study|Lost to Follow-up|11|||
149934945|NCT01100853|540898739|FG001|Overall Study|Lost to Follow-up|6|||
149934946|NCT01100853|540898738|FG000|Overall Study|Received <4 study injections|10|||
149934947|NCT01100853|540898739|FG001|Overall Study|Received <4 study injections|13|||
149934948|NCT01100853|540898738|FG000|Overall Study|Withdrawal by Subject|6|||
149934949|NCT01100853|540898739|FG001|Overall Study|Withdrawal by Subject|4|||
149934950|NCT01384877|540898740|FG000|Treatment 2|Lost to Follow-up|2|||
149934951|NCT01384877|540898741|FG001|Treatment 2|Lost to Follow-up|2|||
149934952|NCT04161391|540898744|FG000|Overall Study|Adverse Event|0|||
149934953|NCT04161391|540898745|FG001|Overall Study|Adverse Event|1|||
149934954|NCT04161391|540898746|FG002|Overall Study|Adverse Event|0|||
149934955|NCT04161391|540898747|FG003|Overall Study|Adverse Event|1|||
149934956|NCT04161391|540898748|FG004|Overall Study|Adverse Event|0|||
150029689|NCT03071263|541244304|FG001|Overall Study|Participant moved to another city|1|||
150029690|NCT03289208|541244308|FG000|Overall Study|Adverse Event|1|||
149934957|NCT04161391|540898749|FG005|Overall Study|Adverse Event|0|||
149934958|NCT04161391|540898750|FG006|Overall Study|Adverse Event|0|||
149934959|NCT04161391|540898751|FG007|Overall Study|Adverse Event|3|||
149934960|NCT04161391|540898752|FG008|Overall Study|Adverse Event|0|||
149934961|NCT04161391|540898744|FG000|Overall Study|Death|0|||
149934962|NCT04161391|540898745|FG001|Overall Study|Death|0|||
149934963|NCT04161391|540898746|FG002|Overall Study|Death|0|||
149934964|NCT04161391|540898747|FG003|Overall Study|Death|0|||
149934965|NCT04161391|540898748|FG004|Overall Study|Death|0|||
149934966|NCT04161391|540898749|FG005|Overall Study|Death|0|||
149934967|NCT04161391|540898750|FG006|Overall Study|Death|0|||
149934968|NCT04161391|540898751|FG007|Overall Study|Death|1|||
149934969|NCT04161391|540898752|FG008|Overall Study|Death|0|||
149934970|NCT04161391|540898744|FG000|Overall Study|Physician Decision|0|||
149934971|NCT04161391|540898745|FG001|Overall Study|Physician Decision|0|||
150029691|NCT03289208|541244309|FG001|Overall Study|Adverse Event|0|||
149934972|NCT04161391|540898746|FG002|Overall Study|Physician Decision|1|||
149934973|NCT04161391|540898747|FG003|Overall Study|Physician Decision|2|||
149934974|NCT04161391|540898748|FG004|Overall Study|Physician Decision|0|||
149934975|NCT04161391|540898749|FG005|Overall Study|Physician Decision|0|||
149934976|NCT04161391|540898750|FG006|Overall Study|Physician Decision|2|||
149934977|NCT04161391|540898751|FG007|Overall Study|Physician Decision|0|||
149934978|NCT04161391|540898752|FG008|Overall Study|Physician Decision|0|||
149934979|NCT04161391|540898744|FG000|Overall Study|Progressive Disease|4|||
149934980|NCT04161391|540898745|FG001|Overall Study|Progressive Disease|3|||
149934981|NCT04161391|540898746|FG002|Overall Study|Progressive Disease|3|||
149934982|NCT04161391|540898747|FG003|Overall Study|Progressive Disease|5|||
149934983|NCT04161391|540898748|FG004|Overall Study|Progressive Disease|3|||
149934984|NCT04161391|540898749|FG005|Overall Study|Progressive Disease|3|||
149934985|NCT04161391|540898750|FG006|Overall Study|Progressive Disease|5|||
149934986|NCT04161391|540898751|FG007|Overall Study|Progressive Disease|2|||
149934987|NCT04161391|540898752|FG008|Overall Study|Progressive Disease|2|||
149934988|NCT01130272|540898755|FG000|Overall Study|Adverse Event|2|||
149934989|NCT01130272|540898756|FG001|Overall Study|Adverse Event|5|||
149934990|NCT01130272|540898757|FG002|Overall Study|Adverse Event|6|||
149934991|NCT01130272|540898758|FG003|Overall Study|Adverse Event|22|||
149934992|NCT01130272|540898759|FG004|Overall Study|Adverse Event|7|||
149934993|NCT01130272|540898755|FG000|Overall Study|IVRS-confirmed constipation|0|||
149934994|NCT01130272|540898756|FG001|Overall Study|IVRS-confirmed constipation|1|||
149934995|NCT01130272|540898757|FG002|Overall Study|IVRS-confirmed constipation|1|||
149934996|NCT01130272|540898758|FG003|Overall Study|IVRS-confirmed constipation|2|||
149934997|NCT01130272|540898759|FG004|Overall Study|IVRS-confirmed constipation|0|||
149934998|NCT01130272|540898755|FG000|Overall Study|Rescue medications due to diarrhea|3|||
149934999|NCT01130272|540898756|FG001|Overall Study|Rescue medications due to diarrhea|5|||
149935000|NCT01130272|540898757|FG002|Overall Study|Rescue medications due to diarrhea|8|||
149935001|NCT01130272|540898758|FG003|Overall Study|Rescue medications due to diarrhea|8|||
149935002|NCT01130272|540898759|FG004|Overall Study|Rescue medications due to diarrhea|6|||
149935003|NCT01130272|540898755|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
149935004|NCT01130272|540898756|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
149935005|NCT01130272|540898757|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
149935006|NCT01130272|540898758|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
149935007|NCT01130272|540898759|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
149935008|NCT01130272|540898755|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
149935009|NCT01130272|540898756|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
149935010|NCT01130272|540898757|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
149935011|NCT01130272|540898758|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
149935012|NCT01130272|540898759|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
149935013|NCT01130272|540898755|FG000|Overall Study|Protocol Violation|0|||
149935014|NCT01130272|540898756|FG001|Overall Study|Protocol Violation|0|||
149935015|NCT01130272|540898757|FG002|Overall Study|Protocol Violation|3|||
149935016|NCT01130272|540898758|FG003|Overall Study|Protocol Violation|5|||
149935017|NCT01130272|540898759|FG004|Overall Study|Protocol Violation|5|||
149935018|NCT01130272|540898755|FG000|Overall Study|Lost to Follow-up|4|||
149935019|NCT01130272|540898756|FG001|Overall Study|Lost to Follow-up|3|||
149935020|NCT01130272|540898757|FG002|Overall Study|Lost to Follow-up|4|||
149935021|NCT01130272|540898758|FG003|Overall Study|Lost to Follow-up|7|||
149935022|NCT01130272|540898759|FG004|Overall Study|Lost to Follow-up|6|||
149935023|NCT01130272|540898755|FG000|Overall Study|Withdrawal by Subject|4|||
149935024|NCT01130272|540898756|FG001|Overall Study|Withdrawal by Subject|11|||
149935025|NCT01130272|540898757|FG002|Overall Study|Withdrawal by Subject|10|||
149935026|NCT01130272|540898758|FG003|Overall Study|Withdrawal by Subject|9|||
149935027|NCT01130272|540898759|FG004|Overall Study|Withdrawal by Subject|8|||
149935028|NCT01130272|540898755|FG000|Overall Study|Physician Decision|1|||
149935029|NCT01130272|540898756|FG001|Overall Study|Physician Decision|1|||
149935030|NCT01130272|540898757|FG002|Overall Study|Physician Decision|0|||
149935031|NCT01130272|540898758|FG003|Overall Study|Physician Decision|1|||
149935032|NCT01130272|540898759|FG004|Overall Study|Physician Decision|2|||
149935033|NCT01130272|540898755|FG000|Overall Study|Sponsor decision|6|||
149935034|NCT01130272|540898756|FG001|Overall Study|Sponsor decision|15|||
149935035|NCT01130272|540898757|FG002|Overall Study|Sponsor decision|16|||
150029692|NCT03289208|541244310|FG002|Overall Study|Adverse Event|0|||
150029693|NCT02354235|541244312|FG000|Overall Study|Adverse Event|2|||
150029694|NCT02354235|541244313|FG001|Overall Study|Adverse Event|2|||
150029695|NCT02354235|541244312|FG000|Overall Study|Physician Decision|0|||
150029696|NCT02354235|541244313|FG001|Overall Study|Physician Decision|1|||
150029697|NCT02354235|541244312|FG000|Overall Study|Withdrawal by Subject|1|||
150029698|NCT02354235|541244313|FG001|Overall Study|Withdrawal by Subject|3|||
150029699|NCT02354235|541244312|FG000|Overall Study|Conflict with the stopping criteria|0|||
150029700|NCT02354235|541244313|FG001|Overall Study|Conflict with the stopping criteria|1|||
150029701|NCT03069352|541244314|FG000|Overall Study|Ongoing|12|||
149935036|NCT01130272|540898758|FG003|Overall Study|Sponsor decision|13|||
149935037|NCT01130272|540898759|FG004|Overall Study|Sponsor decision|16|||
149935038|NCT01130272|540898755|FG000|Overall Study|Study arm discontinued|38|||
149935039|NCT01130272|540898756|FG001|Overall Study|Study arm discontinued|0|||
150168125|NCT00482729|541751016|FG000|Overall Study|Withdrawal by Subject|67|||
150168126|NCT00482729|541751017|FG001|Overall Study|Withdrawal by Subject|69|||
150168127|NCT03179787|541751021|FG000|Overall Study|Lost to Follow-up|15|||
150168128|NCT03179787|541751021|FG000|Overall Study|Case report failures|2|||
150168129|NCT03179787|541751021|FG000|Overall Study|Treatment not administered|1|||
150168130|NCT01729819|541751022|FG000|Overall Study|Adverse Event|2|||
150168131|NCT01729819|541751023|FG001|Overall Study|Adverse Event|4|||
150168132|NCT01729819|541751022|FG000|Overall Study|Lack of Efficacy|1|||
150168133|NCT01729819|541751023|FG001|Overall Study|Lack of Efficacy|0|||
150168134|NCT01729819|541751022|FG000|Overall Study|Lost to Follow-up|2|||
150029702|NCT03069352|541244315|FG001|Overall Study|Ongoing|40|||
150029703|NCT02621424|541244316|FG000|Overall Study|Withdrawal by Subject|1|||
150029704|NCT02621424|541244317|FG001|Overall Study|Withdrawal by Subject|2|||
150029705|NCT05148234|541244319|FG000|Phase I|Ineligible|0|||
150029706|NCT05148234|541244320|FG001|Phase I|Ineligible|0|||
150029707|NCT05148234|541244321|FG002|Phase I|Ineligible|0|||
150029708|NCT05148234|541244322|FG003|Phase I|Ineligible|0|||
150029709|NCT05148234|541244323|FG004|Phase I|Ineligible|0|||
150029710|NCT05148234|541244324|FG005|Phase I|Ineligible|0|||
150029711|NCT05148234|541244325|FG006|Phase I|Ineligible|0|||
150029712|NCT05148234|541244326|FG007|Phase I|Ineligible|1|||
150029713|NCT05148234|541244319|FG000|Phase I|Company closed the trial.|0|||
150029714|NCT05148234|541244320|FG001|Phase I|Company closed the trial.|1|||
150029715|NCT05148234|541244321|FG002|Phase I|Company closed the trial.|0|||
150029716|NCT05148234|541244322|FG003|Phase I|Company closed the trial.|0|||
150029717|NCT05148234|541244323|FG004|Phase I|Company closed the trial.|0|||
150029718|NCT05148234|541244324|FG005|Phase I|Company closed the trial.|0|||
150029719|NCT05148234|541244325|FG006|Phase I|Company closed the trial.|0|||
150029720|NCT05148234|541244326|FG007|Phase I|Company closed the trial.|0|||
150168135|NCT01729819|541751023|FG001|Overall Study|Lost to Follow-up|0|||
150168136|NCT01729819|541751022|FG000|Overall Study|Other reason|1|||
150168137|NCT01729819|541751023|FG001|Overall Study|Other reason|0|||
150168138|NCT01729819|541751022|FG000|Overall Study|Protocol Violation|0|||
150168139|NCT01729819|541751023|FG001|Overall Study|Protocol Violation|1|||
150168140|NCT01729819|541751022|FG000|Overall Study|Withdrawal by Subject|0|||
150168141|NCT01729819|541751023|FG001|Overall Study|Withdrawal by Subject|2|||
150168142|NCT00377455|541751024|FG000|Overall Study|Withdrawal by Subject|1|||
150168143|NCT01259102|541751026|FG000|Overall Study|Adverse Event|1|||
150168144|NCT01259102|541751027|FG001|Overall Study|Adverse Event|0|||
150168145|NCT01259102|541751028|FG002|Overall Study|Adverse Event|1|||
150168146|NCT01259102|541751029|FG003|Overall Study|Adverse Event|1|||
150168147|NCT01259102|541751030|FG004|Overall Study|Adverse Event|0|||
150168148|NCT01259102|541751026|FG000|Overall Study|Other|0|||
150168149|NCT01259102|541751027|FG001|Overall Study|Other|0|||
150168150|NCT01259102|541751028|FG002|Overall Study|Other|1|||
150168151|NCT01259102|541751029|FG003|Overall Study|Other|1|||
150168152|NCT01259102|541751030|FG004|Overall Study|Other|1|||
150168153|NCT00686517|541751031|FG000|Treatment|Serious Adverse Event|1|||
150168154|NCT00686517|541751032|FG001|Treatment|Serious Adverse Event|2|||
150168155|NCT00686517|541751033|FG002|Treatment|Serious Adverse Event|1|||
150168156|NCT00686517|541751031|FG000|Treatment|Adverse Event|2|||
150168157|NCT00686517|541751032|FG001|Treatment|Adverse Event|0|||
150168158|NCT00686517|541751033|FG002|Treatment|Adverse Event|0|||
150168159|NCT00686517|541751031|FG000|Treatment|Poor Protocol Compliance|1|||
150168160|NCT00686517|541751032|FG001|Treatment|Poor Protocol Compliance|0|||
150168161|NCT00686517|541751033|FG002|Treatment|Poor Protocol Compliance|0|||
150168162|NCT00686517|541751031|FG000|Treatment|Protocol Violation|2|||
150168163|NCT00686517|541751032|FG001|Treatment|Protocol Violation|1|||
150168164|NCT00686517|541751033|FG002|Treatment|Protocol Violation|0|||
150168165|NCT01803646|541751036|FG000|Overall Study|Protocol Violation|1|||
150168166|NCT01803646|541751037|FG001|Overall Study|Protocol Violation|0|||
150168167|NCT01803646|541751036|FG000|Overall Study|Adverse Event|1|||
150168168|NCT01803646|541751037|FG001|Overall Study|Adverse Event|1|||
150168169|NCT01803646|541751036|FG000|Overall Study|Withdrawal by Subject|9|||
150168170|NCT01803646|541751037|FG001|Overall Study|Withdrawal by Subject|6|||
150168171|NCT01803646|541751036|FG000|Overall Study|Randomization error|1|||
150168172|NCT01803646|541751037|FG001|Overall Study|Randomization error|2|||
150168173|NCT01803646|541751036|FG000|Overall Study|Lost to Follow-up|5|||
150168174|NCT01803646|541751037|FG001|Overall Study|Lost to Follow-up|1|||
150168175|NCT01693614|541751039|FG000|Overall Study|Adverse Event|7|||
150168176|NCT01693614|541751040|FG001|Overall Study|Adverse Event|11|||
150168177|NCT01693614|541751041|FG002|Overall Study|Adverse Event|5|||
150168178|NCT01693614|541751039|FG000|Overall Study|Disease progression|11|||
150168179|NCT01693614|541751040|FG001|Overall Study|Disease progression|8|||
150168180|NCT01693614|541751041|FG002|Overall Study|Disease progression|7|||
150168181|NCT01693614|541751039|FG000|Overall Study|Protocol Violation|5|||
150168182|NCT01693614|541751040|FG001|Overall Study|Protocol Violation|2|||
150168183|NCT01693614|541751041|FG002|Overall Study|Protocol Violation|1|||
150168184|NCT01693614|541751039|FG000|Overall Study|Death|1|||
150168185|NCT01693614|541751040|FG001|Overall Study|Death|0|||
150168186|NCT01693614|541751041|FG002|Overall Study|Death|0|||
150029721|NCT01928927|541244327|FG000|Overall Study|Lost to Follow-up|1|||
150029722|NCT01928927|541244328|FG001|Overall Study|Lost to Follow-up|0|||
150029723|NCT01928927|541244327|FG000|Overall Study|Withdrawal by Subject|1|||
150029724|NCT01928927|541244328|FG001|Overall Study|Withdrawal by Subject|1|||
150051980|NCT00717236|541332848|FG001|Double-Blind Period|Withdrawal by Subject|2|||
150051981|NCT00717236|541332847|FG000|Double-Blind Period|Loss of efficacy|3|||
150051982|NCT00717236|541332848|FG001|Double-Blind Period|Loss of efficacy|0|||
150051983|NCT00717236|541332847|FG000|Double-Blind Period|Other: Death|1|||
150051984|NCT00717236|541332848|FG001|Double-Blind Period|Other: Death|0|||
150051985|NCT00717236|541332847|FG000|Double-Blind Period|Other: Pregnancy|1|||
150051986|NCT00717236|541332848|FG001|Double-Blind Period|Other: Pregnancy|0|||
150051987|NCT00717236|541332847|FG000|Double-Blind Period|Other: Protocol Violation|2|||
150051988|NCT00717236|541332848|FG001|Double-Blind Period|Other: Protocol Violation|0|||
150051989|NCT00717236|541332847|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
150051990|NCT00717236|541332848|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
150051991|NCT00717236|541332847|FG000|Double-Blind Period|Other: Site withdrew|2|||
150168187|NCT01693614|541751039|FG000|Overall Study|Physician Decision|1|||
150168188|NCT01693614|541751040|FG001|Overall Study|Physician Decision|1|||
150168189|NCT01693614|541751041|FG002|Overall Study|Physician Decision|4|||
150168190|NCT01693614|541751039|FG000|Overall Study|Withdrawal by subject/guardian|0|||
150168191|NCT01693614|541751040|FG001|Overall Study|Withdrawal by subject/guardian|0|||
150168192|NCT01693614|541751041|FG002|Overall Study|Withdrawal by subject/guardian|2|||
150168193|NCT01693614|541751039|FG000|Overall Study|Withdrawal by Subject|1|||
150168194|NCT01693614|541751040|FG001|Overall Study|Withdrawal by Subject|0|||
150168195|NCT01693614|541751041|FG002|Overall Study|Withdrawal by Subject|5|||
150168196|NCT00420316|541751045|FG000|Overall Study|Withdrawal by Subject|0|||
150029725|NCT00179621|541245844|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
150029726|NCT00179621|541245845|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
150029727|NCT00179621|541245846|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
150029728|NCT00179621|541245847|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
150029729|NCT00179621|541245844|FG000|Double-Blind Period|Adverse Event|2|||
150029730|NCT00179621|541245845|FG001|Double-Blind Period|Adverse Event|7|||
150029731|NCT00179621|541245846|FG002|Double-Blind Period|Adverse Event|4|||
150029732|NCT00179621|541245847|FG003|Double-Blind Period|Adverse Event|0|||
150029733|NCT00179621|541245844|FG000|Double-Blind Period|Withdrawal by Subject|2|||
150029734|NCT00179621|541245845|FG001|Double-Blind Period|Withdrawal by Subject|1|||
150029735|NCT00179621|541245846|FG002|Double-Blind Period|Withdrawal by Subject|3|||
150029736|NCT00179621|541245847|FG003|Double-Blind Period|Withdrawal by Subject|0|||
150029737|NCT00179621|541245844|FG000|Double-Blind Period|Death|0|||
150029738|NCT00179621|541245845|FG001|Double-Blind Period|Death|1|||
150029739|NCT00179621|541245846|FG002|Double-Blind Period|Death|2|||
150029740|NCT00179621|541245847|FG003|Double-Blind Period|Death|0|||
150029741|NCT00179621|541245844|FG000|Double-Blind Period|Protocol Violation|1|||
150029742|NCT00179621|541245845|FG001|Double-Blind Period|Protocol Violation|0|||
150029743|NCT00179621|541245846|FG002|Double-Blind Period|Protocol Violation|0|||
150029744|NCT00179621|541245847|FG003|Double-Blind Period|Protocol Violation|0|||
150029745|NCT00179621|541245844|FG000|Double-Blind Period|Other|0|||
150029746|NCT00179621|541245845|FG001|Double-Blind Period|Other|2|||
150029747|NCT00179621|541245846|FG002|Double-Blind Period|Other|2|||
150029748|NCT00179621|541245847|FG003|Double-Blind Period|Other|0|||
150029749|NCT00179621|541245844|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
150029750|NCT00179621|541245845|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
150029751|NCT00179621|541245846|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
150029752|NCT00179621|541245847|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
150029753|NCT00179621|541245844|FG000|Open-Label Period|Adverse Event|0|||
150029754|NCT00179621|541245845|FG001|Open-Label Period|Adverse Event|6|||
150029755|NCT00179621|541245846|FG002|Open-Label Period|Adverse Event|5|||
150029756|NCT00179621|541245847|FG003|Open-Label Period|Adverse Event|6|||
150029757|NCT00179621|541245844|FG000|Open-Label Period|Withdrawal by Subject|0|||
150029758|NCT00179621|541245845|FG001|Open-Label Period|Withdrawal by Subject|2|||
150029759|NCT00179621|541245846|FG002|Open-Label Period|Withdrawal by Subject|2|||
150029760|NCT00179621|541245847|FG003|Open-Label Period|Withdrawal by Subject|2|||
150029761|NCT00179621|541245844|FG000|Open-Label Period|Death|0|||
150029762|NCT00179621|541245845|FG001|Open-Label Period|Death|0|||
150029763|NCT00179621|541245846|FG002|Open-Label Period|Death|1|||
150029764|NCT00179621|541245847|FG003|Open-Label Period|Death|2|||
150029765|NCT00179621|541245844|FG000|Open-Label Period|Other|0|||
150029766|NCT00179621|541245845|FG001|Open-Label Period|Other|1|||
150029767|NCT00179621|541245846|FG002|Open-Label Period|Other|1|||
150029768|NCT00179621|541245847|FG003|Open-Label Period|Other|2|||
150029769|NCT00262860|541245853|FG000|Overall Study|Adverse Event|2|||
150029770|NCT02973100|541245854|FG000|Overall Study|Adverse Event|1|||
150029771|NCT02973100|541245855|FG001|Overall Study|Adverse Event|2|||
150029772|NCT02973100|541245856|FG002|Overall Study|Adverse Event|1|||
150029773|NCT02973100|541245857|FG003|Overall Study|Adverse Event|2|||
150029774|NCT02973100|541245854|FG000|Overall Study|Lost to Follow-up|3|||
150029775|NCT02973100|541245855|FG001|Overall Study|Lost to Follow-up|1|||
150029776|NCT02973100|541245856|FG002|Overall Study|Lost to Follow-up|1|||
150029777|NCT02973100|541245857|FG003|Overall Study|Lost to Follow-up|0|||
150029778|NCT02973100|541245854|FG000|Overall Study|Withdrawal by Subject|3|||
150029779|NCT02973100|541245855|FG001|Overall Study|Withdrawal by Subject|5|||
150029780|NCT02973100|541245856|FG002|Overall Study|Withdrawal by Subject|1|||
150029781|NCT02973100|541245857|FG003|Overall Study|Withdrawal by Subject|4|||
150029782|NCT02973100|541245854|FG000|Overall Study|Notification of change in address|0|||
150029783|NCT02973100|541245855|FG001|Overall Study|Notification of change in address|0|||
150029784|NCT02973100|541245856|FG002|Overall Study|Notification of change in address|0|||
150029785|NCT02973100|541245857|FG003|Overall Study|Notification of change in address|1|||
150029786|NCT02973100|541245854|FG000|Overall Study|Failed to attend Safety followup period|0|||
150269937|NCT02616614|542127326|FG000|Overall Study|Prohibited Medication|12|||
149820211|NCT03882047|540471753|FG002|Overall Study|Adverse Event|2|||
149820212|NCT03882047|540471751|FG000|Overall Study|Treatment Failure|3|||
149820213|NCT03882047|540471752|FG001|Overall Study|Treatment Failure|3|||
150029787|NCT02973100|541245855|FG001|Overall Study|Failed to attend Safety followup period|0|||
150029788|NCT02973100|541245856|FG002|Overall Study|Failed to attend Safety followup period|1|||
150029789|NCT02973100|541245857|FG003|Overall Study|Failed to attend Safety followup period|0|||
150168197|NCT00420316|541751046|FG001|Overall Study|Withdrawal by Subject|1|||
150168198|NCT00420316|541751045|FG000|Overall Study|Lost to Follow-up|12|||
150168199|NCT00420316|541751046|FG001|Overall Study|Lost to Follow-up|8|||
150168200|NCT02281318|541751047|FG000|Overall Study|Adverse Event|2|||
150168201|NCT02281318|541751048|FG001|Overall Study|Adverse Event|2|||
150168202|NCT02281318|541751047|FG000|Overall Study|Lack of Efficacy|2|||
150168203|NCT02281318|541751048|FG001|Overall Study|Lack of Efficacy|0|||
150168204|NCT02281318|541751047|FG000|Overall Study|Lost to Follow-up|2|||
150168205|NCT02281318|541751048|FG001|Overall Study|Lost to Follow-up|1|||
149935040|NCT01130272|540898757|FG002|Overall Study|Study arm discontinued|0|||
149935041|NCT01130272|540898758|FG003|Overall Study|Study arm discontinued|0|||
149935042|NCT01130272|540898759|FG004|Overall Study|Study arm discontinued|0|||
149935043|NCT01548404|540898760|FG000|Overall Study|Adverse Event|3|||
149935044|NCT01548404|540898761|FG001|Overall Study|Adverse Event|1|||
149935045|NCT01548404|540898760|FG000|Overall Study|Physician Decision|2|||
149935046|NCT01548404|540898761|FG001|Overall Study|Physician Decision|1|||
149935047|NCT01548404|540898760|FG000|Overall Study|Inadequate response to study treatment|23|||
149935048|NCT01548404|540898761|FG001|Overall Study|Inadequate response to study treatment|7|||
149935049|NCT01548404|540898760|FG000|Overall Study|Lost to Follow-up|2|||
150029790|NCT01419236|541245858|FG000|Overall Study|Adverse Event|1|||
150029791|NCT01419236|541245859|FG001|Overall Study|Adverse Event|0|||
149935050|NCT01548404|540898761|FG001|Overall Study|Lost to Follow-up|0|||
149935051|NCT01548404|540898760|FG000|Overall Study|Withdrawal by Subject|0|||
149935052|NCT01548404|540898761|FG001|Overall Study|Withdrawal by Subject|3|||
149935053|NCT01548404|540898760|FG000|Overall Study|Other than specified above|0|||
149935054|NCT01548404|540898761|FG001|Overall Study|Other than specified above|2|||
149935055|NCT01248455|540898769|FG000|Overall Study|switched to alternate treatment|1|||
149935056|NCT01117870|540898770|FG000|Overall Study|Inability to place needle|1|||
149935057|NCT01117870|540898771|FG001|Overall Study|Inability to place needle|0|||
149935058|NCT01324102|540898772|FG000|Overall Study|illness|1|||
149935059|NCT01324102|540898773|FG001|Overall Study|illness|6|||
149935060|NCT03238417|540898774|FG000|Overall|non-response|955|||
149935061|NCT03238417|540898775|FG001|Overall|non-response|1920|||
149935062|NCT03238417|540898774|FG000|Overall|partial completion|48|||
149935063|NCT03238417|540898775|FG001|Overall|partial completion|68|||
149935064|NCT03238417|540898774|FG000|Baseline|Partial completion|17|||
149935065|NCT03238417|540898775|FG001|Baseline|Partial completion|48|||
149935066|NCT03238417|540898774|FG000|Baseline|non-response|372|||
149935067|NCT03238417|540898775|FG001|Baseline|non-response|669|||
149935068|NCT03238417|540898774|FG000|12-month|non-response|296|||
149935069|NCT03238417|540898775|FG001|12-month|non-response|669|||
149935070|NCT03238417|540898774|FG000|12-month|partial completion|23|||
149935071|NCT03238417|540898775|FG001|12-month|partial completion|37|||
149935072|NCT03238417|540898774|FG000|24-month|non-response|287|||
149935073|NCT03238417|540898775|FG001|24-month|non-response|594|||
150029792|NCT01419236|541245858|FG000|Overall Study|Lack of Efficacy|0|||
150029793|NCT01419236|541245859|FG001|Overall Study|Lack of Efficacy|1|||
150029794|NCT01419236|541245858|FG000|Overall Study|Lost to Follow-up|1|||
150029795|NCT01419236|541245859|FG001|Overall Study|Lost to Follow-up|0|||
150029796|NCT01419236|541245858|FG000|Overall Study|Physician Decision|1|||
150029797|NCT01419236|541245859|FG001|Overall Study|Physician Decision|0|||
150029798|NCT01419236|541245858|FG000|Overall Study|Withdrawal by Subject|1|||
150029799|NCT01419236|541245859|FG001|Overall Study|Withdrawal by Subject|4|||
149935074|NCT03238417|540898774|FG000|24-month|partial completion|8|||
149935075|NCT03238417|540898775|FG001|24-month|partial completion|31|||
149935076|NCT01249131|540898778|FG000|Washout Period of 10 Days|Adverse Event|0|||
149935077|NCT01249131|540898779|FG001|Washout Period of 10 Days|Adverse Event|0|||
149935078|NCT01249131|540898780|FG002|Washout Period of 10 Days|Adverse Event|0|||
150029800|NCT01419236|541245858|FG000|Overall Study|Entry Criteria Not Met|1|||
150029801|NCT01419236|541245859|FG001|Overall Study|Entry Criteria Not Met|0|||
150029802|NCT03224130|541245862|FG000|Overall Study|consent issue|0|||
150029803|NCT03224130|541245863|FG001|Overall Study|consent issue|1|||
149935079|NCT01249131|540898781|FG003|Washout Period of 10 Days|Adverse Event|0|||
149935080|NCT01249131|540898782|FG004|Washout Period of 10 Days|Adverse Event|1|||
149935081|NCT01249131|540898783|FG005|Washout Period of 10 Days|Adverse Event|0|||
149935082|NCT00433836|540898784|FG000|Overall Study|Adverse Event|7|||
150029804|NCT03598036|541245868|FG000|Overall Study|Withdrawal by Subject|1|||
149935083|NCT00433836|540898785|FG001|Overall Study|Adverse Event|0|||
149935084|NCT00433836|540898784|FG000|Overall Study|Lost to Follow-up|3|||
149935085|NCT00433836|540898785|FG001|Overall Study|Lost to Follow-up|0|||
149935086|NCT00433836|540898784|FG000|Overall Study|Withdrawal by Subject|2|||
149935087|NCT00433836|540898785|FG001|Overall Study|Withdrawal by Subject|1|||
149935088|NCT00433836|540898784|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149935089|NCT00433836|540898785|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149935090|NCT00433836|540898784|FG000|Overall Study|Protocol Violation|0|||
149935091|NCT00433836|540898785|FG001|Overall Study|Protocol Violation|2|||
149935092|NCT00433836|540898784|FG000|Overall Study|Condition no longer requires study drug|0|||
149935093|NCT00433836|540898785|FG001|Overall Study|Condition no longer requires study drug|1|||
149935094|NCT00433836|540898784|FG000|Overall Study|Abnormal laboratory values|0|||
149935095|NCT00433836|540898785|FG001|Overall Study|Abnormal laboratory values|1|||
149935096|NCT00192114|540898786|FG000|Overall Study|Objective Tumor Progression|19|||
149935097|NCT00192114|540898786|FG000|Overall Study|Adverse Event|2|||
149935098|NCT00192114|540898786|FG000|Overall Study|Clinical Progression|2|||
149935099|NCT00192114|540898786|FG000|Overall Study|Death|1|||
149935100|NCT00113607|540898787|FG000|Overall Study|Adverse Event|40|||
149935101|NCT00113607|540898788|FG001|Overall Study|Adverse Event|71|||
149935102|NCT00113607|540898787|FG000|Overall Study|Death|8|||
149935103|NCT00113607|540898788|FG001|Overall Study|Death|8|||
149935104|NCT00113607|540898787|FG000|Overall Study|Withdrawal by Subject|50|||
149935105|NCT00113607|540898788|FG001|Overall Study|Withdrawal by Subject|58|||
149935106|NCT00113607|540898787|FG000|Overall Study|Lost to Follow-up|0|||
149935107|NCT00113607|540898788|FG001|Overall Study|Lost to Follow-up|2|||
149935108|NCT00113607|540898787|FG000|Overall Study|Disease Progression|180|||
149935109|NCT00113607|540898788|FG001|Overall Study|Disease Progression|142|||
149935110|NCT00113607|540898787|FG000|Overall Study|Complete Response (Confirmed)|14|||
150029805|NCT03598036|541245869|FG001|Overall Study|Withdrawal by Subject|0|||
150029806|NCT04124939|541245872|FG000|Overall Study|Lost to Follow-up|1|||
150029807|NCT04124939|541245873|FG001|Overall Study|Lost to Follow-up|3|||
150029808|NCT04607668|541245878|FG000|Overall Study|Death|49|||
150029809|NCT04607668|541245879|FG001|Overall Study|Death|26|||
150029810|NCT04607668|541245878|FG000|Overall Study|Lost to Follow-up|3|||
150029811|NCT04607668|541245879|FG001|Overall Study|Lost to Follow-up|4|||
150029812|NCT04607668|541245878|FG000|Overall Study|Study terminated by Sponsor|92|||
150029813|NCT04607668|541245879|FG001|Overall Study|Study terminated by Sponsor|114|||
150029814|NCT04607668|541245878|FG000|Overall Study|Withdrawal by Subject|12|||
149935111|NCT00113607|540898788|FG001|Overall Study|Complete Response (Confirmed)|24|||
149935112|NCT00113607|540898787|FG000|Overall Study|Other|43|||
149935113|NCT00113607|540898788|FG001|Overall Study|Other|32|||
149935114|NCT00749398|540898790|FG000|Overall Study|Lack of Efficacy|7|||
149935115|NCT00749398|540898790|FG000|Overall Study|Adverse Event|4|||
150029815|NCT04607668|541245879|FG001|Overall Study|Withdrawal by Subject|11|||
150029816|NCT04607668|541245878|FG000|Overall Study|Other, unspecified|8|||
149935116|NCT00749398|540898790|FG000|Overall Study|Serious adverse event|11|||
149935117|NCT00749398|540898790|FG000|Overall Study|Withdrawal by Subject|17|||
149935118|NCT00749398|540898790|FG000|Overall Study|Lost to Follow-up|11|||
149935119|NCT00749398|540898790|FG000|Overall Study|Reason not specified|2|||
149935120|NCT00749398|540898790|FG000|Overall Study|Unknown reason|1|||
149935121|NCT04219189|540898802|FG000|Overall Study|Withdrawal by Subject|1|||
149935122|NCT04219189|540898803|FG001|Overall Study|Withdrawal by Subject|2|||
149935123|NCT04219189|540898802|FG000|Overall Study|Protocol Violation|0|||
149935124|NCT04219189|540898803|FG001|Overall Study|Protocol Violation|1|||
149935125|NCT04219189|540898802|FG000|Overall Study|Lost to Follow-up|0|||
149935126|NCT04219189|540898803|FG001|Overall Study|Lost to Follow-up|1|||
149935127|NCT04219189|540898802|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
149935128|NCT04219189|540898803|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
149935129|NCT03863353|540898804|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
149935130|NCT03863353|540898805|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
149935131|NCT04079790|540898806|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
149935132|NCT04079790|540898807|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
149935133|NCT04079790|540898808|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
149935134|NCT04079790|540898809|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
149935135|NCT04079790|540898806|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
149935136|NCT04079790|540898807|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
149935137|NCT04079790|540898808|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
149935138|NCT04079790|540898809|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
149935139|NCT04079790|540898806|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
149935140|NCT04079790|540898807|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
149935141|NCT04079790|540898808|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
149935142|NCT04079790|540898809|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
149935143|NCT05817669|540898810|FG000|Overall Study|Prohibited medication used|1|||
149935144|NCT05817669|540898811|FG001|Overall Study|Prohibited medication used|2|||
149935145|NCT05817669|540898810|FG000|Overall Study|Adverse Event|1|||
149935146|NCT05817669|540898811|FG001|Overall Study|Adverse Event|0|||
149935147|NCT05817669|540898810|FG000|Overall Study|Withdrawal by Subject|1|||
149935148|NCT05817669|540898811|FG001|Overall Study|Withdrawal by Subject|2|||
149935149|NCT00323063|540898813|FG000|Overall Study|Adverse Event|1|||
149935150|NCT00323063|540898814|FG001|Overall Study|Adverse Event|0|||
149935151|NCT00323063|540898813|FG000|Overall Study|brain mets discovered prior to treatment|1|||
149935152|NCT00323063|540898814|FG001|Overall Study|brain mets discovered prior to treatment|0|||
149935153|NCT03055936|540898815|FG000|Overall Study|Adverse Event|0|||
149935154|NCT03055936|540898816|FG001|Overall Study|Adverse Event|1|||
149935155|NCT03055936|540898817|FG002|Overall Study|Adverse Event|1|||
149935156|NCT03055936|540898818|FG003|Overall Study|Adverse Event|1|||
149935157|NCT03055936|540898815|FG000|Overall Study|Personal reason|2|||
149935158|NCT03055936|540898816|FG001|Overall Study|Personal reason|0|||
149935159|NCT03055936|540898817|FG002|Overall Study|Personal reason|1|||
149935160|NCT03055936|540898818|FG003|Overall Study|Personal reason|0|||
149935161|NCT05002972|540898821|FG000|Overall Study|Withdrawal by Subject|2|||
149935162|NCT04613518|540898827|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
149935163|NCT04613518|540898828|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
149935164|NCT04613518|540898829|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
149935165|NCT04613518|540898827|FG000|Double-Blind Treatment Period|Adverse Event|2|||
150168206|NCT02281318|541751047|FG000|Overall Study|Physician Decision|2|||
150168207|NCT02281318|541751048|FG001|Overall Study|Physician Decision|0|||
150168208|NCT02281318|541751047|FG000|Overall Study|Withdrawal by Subject|6|||
150168209|NCT02281318|541751048|FG001|Overall Study|Withdrawal by Subject|2|||
150168210|NCT01281813|541751049|FG000|Overall Study|Adverse Event|0|||
150168211|NCT01281813|541751050|FG001|Overall Study|Adverse Event|0|||
150168212|NCT01281813|541751051|FG002|Overall Study|Adverse Event|10|||
150168213|NCT01281813|541751049|FG000|Overall Study|Lost to Follow-up|0|||
150168214|NCT01281813|541751050|FG001|Overall Study|Lost to Follow-up|0|||
150168215|NCT01281813|541751051|FG002|Overall Study|Lost to Follow-up|31|||
150168216|NCT01281813|541751049|FG000|Overall Study|Withdrawal by Subject|0|||
150168217|NCT01281813|541751050|FG001|Overall Study|Withdrawal by Subject|0|||
150168218|NCT01281813|541751051|FG002|Overall Study|Withdrawal by Subject|13|||
150168219|NCT01281813|541751049|FG000|Overall Study|Subject Non-Compliant|0|||
150168220|NCT01281813|541751050|FG001|Overall Study|Subject Non-Compliant|0|||
150168221|NCT01281813|541751051|FG002|Overall Study|Subject Non-Compliant|6|||
150168222|NCT01281813|541751049|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
150168223|NCT01281813|541751050|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
150168224|NCT01281813|541751051|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
150168225|NCT01281813|541751049|FG000|Overall Study|Sponsor's Decision|4|||
150168226|NCT01281813|541751050|FG001|Overall Study|Sponsor's Decision|3|||
150168227|NCT01281813|541751051|FG002|Overall Study|Sponsor's Decision|7|||
150168228|NCT01281813|541751049|FG000|Overall Study|Switched to Commercially Available Medication|0|||
150168229|NCT01281813|541751050|FG001|Overall Study|Switched to Commercially Available Medication|0|||
150168230|NCT01281813|541751051|FG002|Overall Study|Switched to Commercially Available Medication|26|||
150168231|NCT01281813|541751049|FG000|Overall Study|Other|0|||
150168232|NCT01281813|541751050|FG001|Overall Study|Other|1|||
150168233|NCT01281813|541751051|FG002|Overall Study|Other|39|||
150168234|NCT05257798|541751052|FG000|Follow-up Phase|Lost to Follow-up|1|||
150168235|NCT05257798|541751053|FG001|Follow-up Phase|Lost to Follow-up|0|||
150168236|NCT01064817|541751056|FG000|Study Completion|Physician Decision|1|||
150168237|NCT01064817|541751057|FG001|Study Completion|Physician Decision|0|||
150168238|NCT01064817|541751056|FG000|Study Completion|Withdrawal by Subject|1|||
150168239|NCT01064817|541751057|FG001|Study Completion|Withdrawal by Subject|0|||
150168240|NCT02274493|541751058|FG000|Overall Study|Withdrawal by Subject|1|||
150168241|NCT00558363|541751059|FG000|Overall Study|Physician Decision|18|||
150168242|NCT00558363|541751060|FG001|Overall Study|Physician Decision|4|||
150168243|NCT00558363|541751059|FG000|Overall Study|Withdrawal by Subject|11|||
150168244|NCT00558363|541751060|FG001|Overall Study|Withdrawal by Subject|4|||
150168245|NCT00558363|541751059|FG000|Overall Study|Adverse Event|5|||
150168246|NCT00558363|541751060|FG001|Overall Study|Adverse Event|5|||
150168247|NCT00558363|541751059|FG000|Overall Study|Lack of Efficacy|2|||
150168248|NCT00558363|541751060|FG001|Overall Study|Lack of Efficacy|2|||
150168249|NCT00558363|541751059|FG000|Overall Study|Protocol Violation|2|||
150168250|NCT00558363|541751060|FG001|Overall Study|Protocol Violation|1|||
150168251|NCT00558363|541751059|FG000|Overall Study|Lost to Follow-up|0|||
150168252|NCT00558363|541751060|FG001|Overall Study|Lost to Follow-up|1|||
150168253|NCT00558363|541751059|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
150168254|NCT00558363|541751060|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
150168255|NCT00558363|541751059|FG000|Overall Study|Randomized in Error|1|||
150168256|NCT00558363|541751060|FG001|Overall Study|Randomized in Error|2|||
150168257|NCT00558363|541751059|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
150168258|NCT00558363|541751060|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
150168259|NCT03102710|541751061|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
150168260|NCT03102710|541751062|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
150168261|NCT03102710|541751063|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
150168262|NCT03102710|541751061|FG000|Overall Study|Technical issues during final MRI scan|0|||
150168263|NCT03102710|541751062|FG001|Overall Study|Technical issues during final MRI scan|1|||
150168264|NCT03102710|541751063|FG002|Overall Study|Technical issues during final MRI scan|0|||
150168265|NCT03102710|541751061|FG000|Overall Study|Nausea during MRI scan|0|||
150168266|NCT03102710|541751062|FG001|Overall Study|Nausea during MRI scan|1|||
150168267|NCT03102710|541751063|FG002|Overall Study|Nausea during MRI scan|0|||
150168268|NCT03102710|541751061|FG000|Overall Study|Subject unable to attend final session|0|||
150029817|NCT04607668|541245879|FG001|Overall Study|Other, unspecified|7|||
150029818|NCT02250326|541245880|FG000|Treatment|Death|1|||
150029819|NCT02250326|541245881|FG001|Treatment|Death|13|||
150029820|NCT02250326|541245882|FG002|Treatment|Death|2|||
150029821|NCT02250326|541245880|FG000|Treatment|Adverse Event|8|||
150029822|NCT02250326|541245881|FG001|Treatment|Adverse Event|8|||
150029823|NCT02250326|541245882|FG002|Treatment|Adverse Event|9|||
150029824|NCT02250326|541245880|FG000|Treatment|Progressive Disease|42|||
150029825|NCT02250326|541245881|FG001|Treatment|Progressive Disease|40|||
150029826|NCT02250326|541245882|FG002|Treatment|Progressive Disease|47|||
150029827|NCT02250326|541245880|FG000|Treatment|Symptomatic Deterioration|9|||
150029828|NCT02250326|541245881|FG001|Treatment|Symptomatic Deterioration|4|||
150029829|NCT02250326|541245882|FG002|Treatment|Symptomatic Deterioration|10|||
150029830|NCT02250326|541245880|FG000|Treatment|Withdrawal by Subject|11|||
150029831|NCT02250326|541245881|FG001|Treatment|Withdrawal by Subject|6|||
150029832|NCT02250326|541245882|FG002|Treatment|Withdrawal by Subject|4|||
150029833|NCT02250326|541245880|FG000|Treatment|Other reasons|8|||
150029834|NCT02250326|541245881|FG001|Treatment|Other reasons|7|||
150029835|NCT02250326|541245882|FG002|Treatment|Other reasons|7|||
150029836|NCT02250326|541245880|FG000|Extension Period|Progressive Disease|0|||
150029837|NCT02250326|541245881|FG001|Extension Period|Progressive Disease|2|||
150269938|NCT02616614|542127327|FG001|Overall Study|Prohibited Medication|9|||
150269939|NCT02616614|542127328|FG002|Overall Study|Prohibited Medication|5|||
150029838|NCT02250326|541245882|FG002|Extension Period|Progressive Disease|0|||
150029839|NCT02250326|541245880|FG000|Extension Period|Withdrawal by Subject|0|||
150029840|NCT02250326|541245881|FG001|Extension Period|Withdrawal by Subject|1|||
150029841|NCT02250326|541245882|FG002|Extension Period|Withdrawal by Subject|0|||
150029842|NCT02250326|541245880|FG000|Extension Period|Withdrawal by investigator|0|||
150029843|NCT02250326|541245881|FG001|Extension Period|Withdrawal by investigator|1|||
150029844|NCT02250326|541245882|FG002|Extension Period|Withdrawal by investigator|0|||
150029845|NCT04516746|541245883|FG000|Overall Study|Randomized but not Treated|51|||
150029846|NCT04516746|541245884|FG001|Overall Study|Randomized but not Treated|19|||
150029847|NCT04516746|541245883|FG000|Overall Study|Adverse Event|0|||
150029848|NCT04516746|541245884|FG001|Overall Study|Adverse Event|1|||
150029849|NCT04516746|541245883|FG000|Overall Study|Death|62|||
150029850|NCT04516746|541245884|FG001|Overall Study|Death|32|||
150029851|NCT04516746|541245883|FG000|Overall Study|Lost to Follow-up|3431|||
150029852|NCT04516746|541245884|FG001|Overall Study|Lost to Follow-up|1831|||
150029853|NCT04516746|541245883|FG000|Overall Study|Withdrawal by Subject|1946|||
150029854|NCT04516746|541245884|FG001|Overall Study|Withdrawal by Subject|1696|||
150029855|NCT04516746|541245883|FG000|Overall Study|Physician Decision|10|||
150029856|NCT04516746|541245884|FG001|Overall Study|Physician Decision|8|||
150029857|NCT04516746|541245883|FG000|Overall Study|Other|35|||
150029858|NCT04516746|541245884|FG001|Overall Study|Other|16|||
150029859|NCT00768989|541245888|FG000|Prior to Week 24|Withdrawal by Subject|1|||
150029860|NCT00768989|541245889|FG001|Prior to Week 24|Withdrawal by Subject|0|||
150029861|NCT00768989|541245888|FG000|Prior to Week 24|Adverse Event|3|||
150029862|NCT00768989|541245889|FG001|Prior to Week 24|Adverse Event|0|||
150029863|NCT00768989|541245888|FG000|Prior to Week 24|Lost to Follow-up|0|||
150029864|NCT00768989|541245889|FG001|Prior to Week 24|Lost to Follow-up|1|||
150029865|NCT00768989|541245888|FG000|Prior to Week 24|Protocol Violation|0|||
150029866|NCT00768989|541245889|FG001|Prior to Week 24|Protocol Violation|2|||
150029867|NCT00768989|541245888|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
150029868|NCT00768989|541245889|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
150029869|NCT00768989|541245888|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
150029870|NCT00768989|541245889|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
150029871|NCT00768989|541245888|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
150029872|NCT00768989|541245889|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
150029873|NCT00768989|541245888|FG000|On or After Week 36|Lack of Efficacy|1|||
150029874|NCT00768989|541245889|FG001|On or After Week 36|Lack of Efficacy|0|||
150029875|NCT00768989|541245888|FG000|On or After Week 36|Adverse Event|0|||
150029876|NCT00768989|541245889|FG001|On or After Week 36|Adverse Event|1|||
150029877|NCT00768989|541245888|FG000|On or After Week 36|Lost to Follow-up|1|||
149820214|NCT03882047|540471753|FG002|Overall Study|Treatment Failure|12|||
149820215|NCT03882047|540471751|FG000|Overall Study|Lost to Follow-up|0|||
149820216|NCT03882047|540471752|FG001|Overall Study|Lost to Follow-up|1|||
149820217|NCT03882047|540471753|FG002|Overall Study|Lost to Follow-up|0|||
149820218|NCT03882047|540471751|FG000|Overall Study|Did Not Wish to Continue|1|||
149820219|NCT03882047|540471752|FG001|Overall Study|Did Not Wish to Continue|4|||
150269940|NCT02616614|542127326|FG000|Overall Study|More than 3 applications missed|6|||
150269941|NCT02616614|542127327|FG001|Overall Study|More than 3 applications missed|8|||
150269942|NCT02616614|542127328|FG002|Overall Study|More than 3 applications missed|1|||
150269943|NCT02616614|542127326|FG000|Overall Study|Lost to Follow-up|31|||
149820220|NCT03882047|540471753|FG002|Overall Study|Did Not Wish to Continue|1|||
149820221|NCT03882047|540471751|FG000|Overall Study|Noncompliance With Protocol|2|||
149820222|NCT03882047|540471752|FG001|Overall Study|Noncompliance With Protocol|0|||
150029878|NCT00768989|541245889|FG001|On or After Week 36|Lost to Follow-up|0|||
150269944|NCT02616614|542127327|FG001|Overall Study|Lost to Follow-up|28|||
150269945|NCT02616614|542127328|FG002|Overall Study|Lost to Follow-up|13|||
150269946|NCT02616614|542127326|FG000|Overall Study|Pregnancy|2|||
150269947|NCT02616614|542127327|FG001|Overall Study|Pregnancy|0|||
150269948|NCT02616614|542127328|FG002|Overall Study|Pregnancy|1|||
150029879|NCT00768989|541245888|FG000|On or After Week 36|Poor Compliance|1|||
150029880|NCT00768989|541245889|FG001|On or After Week 36|Poor Compliance|0|||
149820223|NCT03882047|540471753|FG002|Overall Study|Noncompliance With Protocol|0|||
149820224|NCT03882047|540471751|FG000|Overall Study|Did Not Meet Eligibility|0|||
149820225|NCT03882047|540471752|FG001|Overall Study|Did Not Meet Eligibility|0|||
149820226|NCT03882047|540471753|FG002|Overall Study|Did Not Meet Eligibility|1|||
149820227|NCT00723554|540471754|FG000|Overall Study|Adverse Event|12|||
150029881|NCT00768989|541245888|FG000|On or After Week 36|Protocol Violation|1|||
150029882|NCT00768989|541245889|FG001|On or After Week 36|Protocol Violation|0|||
150029883|NCT00768989|541245888|FG000|On or After Week 36|Did not attend termination visit|2|||
150029884|NCT00768989|541245889|FG001|On or After Week 36|Did not attend termination visit|0|||
150029885|NCT00768989|541245888|FG000|On or After Week 36|Sponsor Termination|45|||
150029886|NCT00768989|541245889|FG001|On or After Week 36|Sponsor Termination|26|||
150029887|NCT01194830|541245890|FG000|Overall Study|Adverse Event|3|||
150029888|NCT01194830|541245891|FG001|Overall Study|Adverse Event|2|||
150029889|NCT01194830|541245890|FG000|Overall Study|Protocol Violation|5|||
150029890|NCT01194830|541245891|FG001|Overall Study|Protocol Violation|4|||
150029891|NCT01194830|541245890|FG000|Overall Study|Lost to Follow-up|9|||
150029892|NCT01194830|541245891|FG001|Overall Study|Lost to Follow-up|7|||
150029893|NCT01194830|541245890|FG000|Overall Study|Withdrawal by Subject|2|||
150029894|NCT01194830|541245891|FG001|Overall Study|Withdrawal by Subject|1|||
150029895|NCT01194830|541245890|FG000|Overall Study|Lack of Efficacy|1|||
150029896|NCT01194830|541245891|FG001|Overall Study|Lack of Efficacy|1|||
150029897|NCT01194830|541245890|FG000|Overall Study|Non-compliance issues|4|||
150029898|NCT01194830|541245891|FG001|Overall Study|Non-compliance issues|4|||
150029899|NCT01194830|541245890|FG000|Overall Study|Other Reason|12|||
150029900|NCT01194830|541245891|FG001|Overall Study|Other Reason|8|||
150029901|NCT00435409|541245897|FG000|Overall Study|Protocol Violation|1|||
150029902|NCT00435409|541245898|FG001|Overall Study|Protocol Violation|2|||
150029903|NCT00435409|541245899|FG002|Overall Study|Protocol Violation|0|||
150029904|NCT00435409|541245897|FG000|Overall Study|Lost to Follow-up|1|||
150029905|NCT00435409|541245898|FG001|Overall Study|Lost to Follow-up|2|||
150029906|NCT00435409|541245899|FG002|Overall Study|Lost to Follow-up|0|||
150029907|NCT00435409|541245897|FG000|Overall Study|Death|8|||
150029908|NCT00435409|541245898|FG001|Overall Study|Death|6|||
150029909|NCT00435409|541245899|FG002|Overall Study|Death|6|||
150029910|NCT00435409|541245897|FG000|Overall Study|Objective progression or relapse|158|||
150029911|NCT00435409|541245898|FG001|Overall Study|Objective progression or relapse|93|||
150029912|NCT00435409|541245899|FG002|Overall Study|Objective progression or relapse|58|||
150029913|NCT00435409|541245897|FG000|Overall Study|Global deterioration of health status|0|||
150029914|NCT00435409|541245898|FG001|Overall Study|Global deterioration of health status|0|||
150029915|NCT00435409|541245899|FG002|Overall Study|Global deterioration of health status|4|||
150029916|NCT00435409|541245897|FG000|Overall Study|Withdrawal by Subject|8|||
150029917|NCT00435409|541245898|FG001|Overall Study|Withdrawal by Subject|7|||
150029918|NCT00435409|541245899|FG002|Overall Study|Withdrawal by Subject|1|||
150029919|NCT00435409|541245897|FG000|Overall Study|Other|45|||
150029920|NCT00435409|541245898|FG001|Overall Study|Other|30|||
150029921|NCT00435409|541245899|FG002|Overall Study|Other|1|||
150029922|NCT00435409|541245897|FG000|Overall Study|Adverse Event|0|||
150029923|NCT00435409|541245898|FG001|Overall Study|Adverse Event|0|||
150029924|NCT00435409|541245899|FG002|Overall Study|Adverse Event|8|||
150029925|NCT00435409|541245897|FG000|Overall Study|Sponsor decision|0|||
150029926|NCT00435409|541245898|FG001|Overall Study|Sponsor decision|3|||
150029927|NCT00435409|541245899|FG002|Overall Study|Sponsor decision|0|||
150029928|NCT03562195|541245906|FG000|Overall Study|Adverse Event|0|||
150029929|NCT03562195|541245907|FG001|Overall Study|Adverse Event|6|||
150029930|NCT03562195|541245906|FG000|Overall Study|Lack of Efficacy|0|||
150029931|NCT03562195|541245907|FG001|Overall Study|Lack of Efficacy|5|||
150029932|NCT03562195|541245906|FG000|Overall Study|Protocol Violation|0|||
149820228|NCT00723554|540471754|FG000|Overall Study|Investigator's judgement|5|||
149820229|NCT00723554|540471754|FG000|Overall Study|Inhaled medication other than iloprost|4|||
149820230|NCT00723554|540471754|FG000|Overall Study|Withdrawal of consent|3|||
149820231|NCT00723554|540471754|FG000|Overall Study|Other|3|||
149820232|NCT00723554|540471754|FG000|Overall Study|Lost to Follow-up|1|||
149820233|NCT00723554|540471754|FG000|Overall Study|Non-compliance|1|||
149820234|NCT01894984|540471758|FG000|Overall Study|Other|314|||
149820235|NCT01894984|540471759|FG001|Overall Study|Other|175|||
149820236|NCT00827359|540471760|FG000|Overall Study|Progressive Diseas|19|||
149820237|NCT00827359|540471760|FG000|Overall Study|Unacceptable Toxicity|5|||
150029933|NCT03562195|541245907|FG001|Overall Study|Protocol Violation|1|||
150029934|NCT03562195|541245906|FG000|Overall Study|Lost to Follow-up|0|||
150029935|NCT03562195|541245907|FG001|Overall Study|Lost to Follow-up|1|||
150029936|NCT03562195|541245906|FG000|Overall Study|Physician Decision|1|||
150029937|NCT03562195|541245907|FG001|Overall Study|Physician Decision|0|||
150269949|NCT02616614|542127326|FG000|Overall Study|Other|1|||
150029938|NCT03562195|541245906|FG000|Overall Study|Withdrawal by Subject|3|||
150029939|NCT03562195|541245907|FG001|Overall Study|Withdrawal by Subject|0|||
150029940|NCT02529852|541245908|FG000|Overall Study|Withdrawal by Subject|2|||
150029941|NCT00117637|541245909|FG000|First Intervention (Period 1)|Adverse Event|11|||
150029942|NCT00117637|541245910|FG001|First Intervention (Period 1)|Adverse Event|16|||
150029943|NCT00117637|541245909|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
150029944|NCT00117637|541245910|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
150029945|NCT00117637|541245909|FG000|First Intervention (Period 1)|Protocol Violation|1|||
150029946|NCT00117637|541245910|FG001|First Intervention (Period 1)|Protocol Violation|0|||
150029947|NCT00117637|541245909|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
150029948|NCT00117637|541245910|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
150029949|NCT00117637|541245909|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
150029950|NCT00117637|541245910|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
150029951|NCT00117637|541245909|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
150029952|NCT00117637|541245910|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
150029953|NCT00117637|541245909|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
149935166|NCT04613518|540898828|FG001|Double-Blind Treatment Period|Adverse Event|0|||
150029954|NCT00117637|541245910|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
150029955|NCT00117637|541245909|FG000|First Intervention (Period 1)|reason not reported|0|||
149935167|NCT04613518|540898829|FG002|Double-Blind Treatment Period|Adverse Event|1|||
150168269|NCT03102710|541751062|FG001|Overall Study|Subject unable to attend final session|1|||
150168270|NCT03102710|541751063|FG002|Overall Study|Subject unable to attend final session|0|||
150168271|NCT01368406|541751064|FG000|Overall Study|Lost to Follow-up|8|||
150168272|NCT01368406|541751065|FG001|Overall Study|Lost to Follow-up|4|||
150168273|NCT01368406|541751064|FG000|Overall Study|Withdrawal by Subject|8|||
150168274|NCT01368406|541751065|FG001|Overall Study|Withdrawal by Subject|4|||
150168275|NCT01368406|541751064|FG000|Overall Study|relapse of the disease|3|||
150168276|NCT01368406|541751065|FG001|Overall Study|relapse of the disease|2|||
150168277|NCT01368406|541751064|FG000|Overall Study|started working|2|||
150168278|NCT01368406|541751065|FG001|Overall Study|started working|3|||
150168279|NCT01313182|541751070|FG000|Overall Study|Protocol Violation|66|||
150168280|NCT01313182|541751071|FG001|Overall Study|Protocol Violation|92|||
150168281|NCT02846415|541751074|FG000|Overall Study|Lost to Follow-up|2|||
150168282|NCT02846415|541751075|FG001|Overall Study|Lost to Follow-up|0|||
150168283|NCT02846415|541751074|FG000|Overall Study|Withdrawal by Subject|1|||
150168284|NCT02846415|541751075|FG001|Overall Study|Withdrawal by Subject|1|||
150168285|NCT02322216|541751078|FG000|Overall Study|Adverse Event|1|||
150168286|NCT02322216|541751079|FG001|Overall Study|Adverse Event|0|||
150168287|NCT02322216|541751078|FG000|Overall Study|Withdrawal by Subject|1|||
150168288|NCT02322216|541751079|FG001|Overall Study|Withdrawal by Subject|4|||
150168289|NCT01651949|541751080|FG000|Overall Study|Unknown status|4|||
150168290|NCT01651949|541751081|FG001|Overall Study|Unknown status|4|||
150168291|NCT01651949|541751082|FG002|Overall Study|Unknown status|0|||
150168292|NCT01651949|541751080|FG000|Overall Study|Lost to Follow-up|30|||
150168293|NCT01651949|541751081|FG001|Overall Study|Lost to Follow-up|56|||
150168294|NCT01651949|541751082|FG002|Overall Study|Lost to Follow-up|20|||
150168295|NCT01651949|541751080|FG000|Overall Study|Protocol Violation|0|||
150168296|NCT01651949|541751081|FG001|Overall Study|Protocol Violation|2|||
150168297|NCT01651949|541751082|FG002|Overall Study|Protocol Violation|1|||
150168298|NCT01651949|541751080|FG000|Overall Study|Physician Decision|0|||
150168299|NCT01651949|541751081|FG001|Overall Study|Physician Decision|2|||
150168300|NCT01651949|541751082|FG002|Overall Study|Physician Decision|0|||
150168301|NCT01651949|541751080|FG000|Overall Study|Adverse Event|0|||
150168302|NCT01651949|541751081|FG001|Overall Study|Adverse Event|2|||
150168303|NCT01651949|541751082|FG002|Overall Study|Adverse Event|1|||
150168304|NCT01651949|541751080|FG000|Overall Study|Screen failure|2|||
150168305|NCT01651949|541751081|FG001|Overall Study|Screen failure|2|||
150168306|NCT01651949|541751082|FG002|Overall Study|Screen failure|0|||
150168307|NCT01651949|541751080|FG000|Overall Study|Withdrawal by Subject|17|||
150168308|NCT01651949|541751081|FG001|Overall Study|Withdrawal by Subject|18|||
150168309|NCT01651949|541751082|FG002|Overall Study|Withdrawal by Subject|9|||
150168310|NCT00678795|541751083|FG000|Overall Study|Adverse Event|7|||
150029956|NCT00117637|541245910|FG001|First Intervention (Period 1)|reason not reported|1|||
150029957|NCT00117637|541245909|FG000|Second Intervention (Period 2)|Adverse Event|0|||
150029958|NCT00117637|541245910|FG001|Second Intervention (Period 2)|Adverse Event|9|||
150029959|NCT00117637|541245909|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
150029960|NCT00117637|541245910|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
150029961|NCT00117637|541245909|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
150029962|NCT00117637|541245910|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
150029963|NCT00117637|541245909|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
150029964|NCT00117637|541245910|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
149820238|NCT00827359|540471760|FG000|Overall Study|Ineligible|1|||
150029965|NCT00117637|541245909|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
150029966|NCT00117637|541245910|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
150029967|NCT00117637|541245909|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
150029968|NCT00117637|541245910|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
150029969|NCT00117637|541245909|FG000|Second Intervention (Period 2)|reason not reported|1|||
150029970|NCT00117637|541245910|FG001|Second Intervention (Period 2)|reason not reported|0|||
150029971|NCT00614575|541245911|FG000|Overall Study|Adverse Event|106|||
150029972|NCT00614575|541245911|FG000|Overall Study|Lost to Follow-up|55|||
150029973|NCT00614575|541245911|FG000|Overall Study|Lack of Efficacy|14|||
150029974|NCT00614575|541245911|FG000|Overall Study|Withdrawal by Subject|6|||
150269950|NCT02616614|542127327|FG001|Overall Study|Other|2|||
150269951|NCT02616614|542127328|FG002|Overall Study|Other|1|||
150269952|NCT02748018|542127329|FG000|Study Period|Adverse Event|1|||
150269953|NCT02748018|542127330|FG001|Study Period|Adverse Event|3|||
150269954|NCT02748018|542127331|FG002|Study Period|Adverse Event|4|||
150269955|NCT02748018|542127332|FG003|Study Period|Adverse Event|0|||
150269956|NCT02748018|542127333|FG004|Study Period|Adverse Event|3|||
150269957|NCT02748018|542127334|FG005|Study Period|Adverse Event|3|||
150269958|NCT02748018|542127329|FG000|Study Period|Withdrawal by Subject|7|||
150269959|NCT02748018|542127330|FG001|Study Period|Withdrawal by Subject|4|||
150269960|NCT02748018|542127331|FG002|Study Period|Withdrawal by Subject|4|||
150269961|NCT02748018|542127332|FG003|Study Period|Withdrawal by Subject|11|||
150269962|NCT02748018|542127333|FG004|Study Period|Withdrawal by Subject|12|||
150269963|NCT02748018|542127334|FG005|Study Period|Withdrawal by Subject|10|||
150269964|NCT02748018|542127329|FG000|Study Period|Pregnancy|0|||
150269965|NCT02748018|542127330|FG001|Study Period|Pregnancy|1|||
150269966|NCT02748018|542127331|FG002|Study Period|Pregnancy|0|||
150269967|NCT02748018|542127332|FG003|Study Period|Pregnancy|0|||
150269968|NCT02748018|542127333|FG004|Study Period|Pregnancy|1|||
150269969|NCT02748018|542127334|FG005|Study Period|Pregnancy|0|||
150269970|NCT02748018|542127329|FG000|Study Period|Physician Decision|2|||
150269971|NCT02748018|542127330|FG001|Study Period|Physician Decision|2|||
150269972|NCT02748018|542127331|FG002|Study Period|Physician Decision|1|||
150269973|NCT02748018|542127332|FG003|Study Period|Physician Decision|0|||
149820239|NCT00475852|540471761|FG000|Overall Study|Death|444|||
149820240|NCT00475852|540471762|FG001|Overall Study|Death|456|||
149820241|NCT00475852|540471761|FG000|Overall Study|Withdrawal by Subject|19|||
149820242|NCT00475852|540471762|FG001|Overall Study|Withdrawal by Subject|24|||
149820243|NCT00475852|540471761|FG000|Overall Study|Lost to Follow-up|54|||
149820244|NCT00475852|540471762|FG001|Overall Study|Lost to Follow-up|68|||
149820245|NCT01809314|540471763|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
149820246|NCT01809314|540471763|FG000|Overall Study|Adverse Event|6|||
149820247|NCT01809314|540471763|FG000|Overall Study|Insufficient Therapeutic Response|14|||
149820248|NCT01809314|540471763|FG000|Overall Study|Lost to Follow-up|724|||
149820249|NCT00863057|540471764|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
149820250|NCT00863057|540471765|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
149820251|NCT00863057|540471766|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
149820252|NCT00863057|540471767|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
149820253|NCT00863057|540471764|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
149820254|NCT00863057|540471765|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
149820255|NCT00863057|540471766|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
149820256|NCT00863057|540471767|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
149820257|NCT00863057|540471764|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
149820258|NCT00863057|540471765|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
149820259|NCT00863057|540471766|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
149820260|NCT00863057|540471767|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
149820261|NCT00863057|540471764|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
149820262|NCT00863057|540471765|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
149820263|NCT00863057|540471766|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
149820264|NCT00863057|540471767|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
149820265|NCT03412019|540471770|FG000|Overall Study|Withdrawal by Subject|1|||
149820266|NCT03412019|540471771|FG001|Overall Study|Withdrawal by Subject|1|||
149820267|NCT01698320|540471775|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
149820268|NCT01698320|540471776|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
150269974|NCT02748018|542127333|FG004|Study Period|Physician Decision|2|||
150269975|NCT02748018|542127334|FG005|Study Period|Physician Decision|0|||
150029975|NCT00614575|541245911|FG000|Overall Study|Death|3|||
150029976|NCT00614575|541245911|FG000|Overall Study|Physician Decision|2|||
150269976|NCT02748018|542127329|FG000|Study Period|Lost to Follow-up|0|||
150269977|NCT02748018|542127330|FG001|Study Period|Lost to Follow-up|0|||
150269978|NCT02748018|542127331|FG002|Study Period|Lost to Follow-up|0|||
150029977|NCT00614575|541245911|FG000|Overall Study|No data were collected.|18|||
150029978|NCT00614575|541245911|FG000|Overall Study|Irregularly enrolled patients|23|||
150029979|NCT00614575|541245911|FG000|Overall Study|No treatment|1|||
150029980|NCT03119259|541245912|FG000|Overall Study|Withdrawn as no longer eligible|1|||
150029981|NCT03119259|541245913|FG001|Overall Study|Withdrawn as no longer eligible|0|||
150029982|NCT03119259|541245912|FG000|Overall Study|Withdrawal by Subject|4|||
150029983|NCT03119259|541245913|FG001|Overall Study|Withdrawal by Subject|2|||
150029984|NCT03119259|541245912|FG000|Overall Study|Lost to Follow-up|0|||
150029985|NCT03119259|541245913|FG001|Overall Study|Lost to Follow-up|1|||
150029986|NCT03535974|541245914|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
150029987|NCT03535974|541245915|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
150029988|NCT03535974|541245916|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
150029989|NCT03535974|541245914|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
150029990|NCT03535974|541245915|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
150029991|NCT03535974|541245916|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
150029992|NCT04059549|541245917|FG000|Overall Study|Withdrawal by Subject|2|||
150029993|NCT04059549|541245918|FG001|Overall Study|Withdrawal by Subject|0|||
150029994|NCT01919229|541245920|FG000|Overall Study|Subject/guardian decision|0|||
150029995|NCT01919229|541245921|FG001|Overall Study|Subject/guardian decision|0|||
150029996|NCT01919229|541245922|FG002|Overall Study|Subject/guardian decision|1|||
150029997|NCT01011673|541245923|FG000|Randomized|Secondary headache|2|||
150029998|NCT01011673|541245924|FG001|Randomized|Secondary headache|1|||
150029999|NCT01011673|541245923|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
149935168|NCT04613518|540898827|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
150030000|NCT01011673|541245924|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
150030001|NCT00549640|541245926|FG000|Overall Study|Withdrawal by Subject|6|||
150030002|NCT00549640|541245927|FG001|Overall Study|Withdrawal by Subject|12|||
149935169|NCT04613518|540898828|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
149935170|NCT04613518|540898829|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
149935171|NCT04613518|540898827|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
149935172|NCT04613518|540898828|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
149935173|NCT04613518|540898829|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
150030003|NCT00549640|541245926|FG000|Overall Study|Adverse Event|5|||
150030004|NCT00549640|541245927|FG001|Overall Study|Adverse Event|0|||
150030005|NCT00549640|541245926|FG000|Overall Study|Lost to Follow-up|7|||
150030006|NCT00549640|541245927|FG001|Overall Study|Lost to Follow-up|4|||
150030007|NCT03261336|541245930|FG000|Overall Study|Adverse Event|1|||
150030008|NCT00292942|541245932|FG000|Overall Study|Withdrawal by Subject|0|||
150269979|NCT02748018|542127332|FG003|Study Period|Lost to Follow-up|2|||
150269980|NCT02748018|542127333|FG004|Study Period|Lost to Follow-up|0|||
150269981|NCT02748018|542127334|FG005|Study Period|Lost to Follow-up|1|||
150269982|NCT02748018|542127329|FG000|Continuation Period|Adverse Event|2|||
150269983|NCT02748018|542127330|FG001|Continuation Period|Adverse Event|0|||
150269984|NCT02748018|542127331|FG002|Continuation Period|Adverse Event|1|||
150269985|NCT02748018|542127332|FG003|Continuation Period|Adverse Event|1|||
150269986|NCT02748018|542127333|FG004|Continuation Period|Adverse Event|1|||
150269987|NCT02748018|542127334|FG005|Continuation Period|Adverse Event|4|||
150269988|NCT02748018|542127329|FG000|Continuation Period|Withdrawal by Subject|3|||
150269989|NCT02748018|542127330|FG001|Continuation Period|Withdrawal by Subject|5|||
150269990|NCT02748018|542127331|FG002|Continuation Period|Withdrawal by Subject|3|||
150269991|NCT02748018|542127332|FG003|Continuation Period|Withdrawal by Subject|9|||
150269992|NCT02748018|542127333|FG004|Continuation Period|Withdrawal by Subject|11|||
150269993|NCT02748018|542127334|FG005|Continuation Period|Withdrawal by Subject|1|||
150269994|NCT02748018|542127329|FG000|Continuation Period|Lost to Follow-up|0|||
150269995|NCT02748018|542127330|FG001|Continuation Period|Lost to Follow-up|2|||
150269996|NCT02748018|542127331|FG002|Continuation Period|Lost to Follow-up|1|||
150269997|NCT02748018|542127332|FG003|Continuation Period|Lost to Follow-up|0|||
150269998|NCT02748018|542127333|FG004|Continuation Period|Lost to Follow-up|1|||
150269999|NCT02748018|542127334|FG005|Continuation Period|Lost to Follow-up|0|||
150270000|NCT02748018|542127329|FG000|Continuation Period|Pregnancy|1|||
150270001|NCT02748018|542127330|FG001|Continuation Period|Pregnancy|2|||
150270002|NCT02748018|542127331|FG002|Continuation Period|Pregnancy|0|||
150270003|NCT02748018|542127332|FG003|Continuation Period|Pregnancy|0|||
150270004|NCT02748018|542127333|FG004|Continuation Period|Pregnancy|0|||
150270005|NCT02748018|542127334|FG005|Continuation Period|Pregnancy|0|||
150270006|NCT02748018|542127329|FG000|Continuation Period|Physician Decision|0|||
150030009|NCT00292942|541245933|FG001|Overall Study|Withdrawal by Subject|0|||
150030010|NCT00292942|541245934|FG002|Overall Study|Withdrawal by Subject|1|||
150030011|NCT00292942|541245935|FG003|Overall Study|Withdrawal by Subject|0|||
150030012|NCT00292942|541245932|FG000|Overall Study|Adverse Event|0|||
150030013|NCT00292942|541245933|FG001|Overall Study|Adverse Event|0|||
150030014|NCT00292942|541245934|FG002|Overall Study|Adverse Event|0|||
150030015|NCT00292942|541245935|FG003|Overall Study|Adverse Event|1|||
150030016|NCT00644358|541245936|FG000|Overall Study|Adverse Event|124|||
150030017|NCT00644358|541245936|FG000|Overall Study|Lost to Follow-up|105|||
150030018|NCT00644358|541245936|FG000|Overall Study|Consent Withdrawal|64|||
150030019|NCT00644358|541245936|FG000|Overall Study|Lack of Effectiveness|39|||
150030020|NCT00644358|541245936|FG000|Overall Study|Protocol Violation|5|||
150030021|NCT00644358|541245936|FG000|Overall Study|Noncompliance|14|||
150030022|NCT00644358|541245936|FG000|Overall Study|Other Unspecified|11|||
150030023|NCT00651924|541245942|FG000|Overall Study|Withdrawal by PI|0|||
150030024|NCT00651924|541245943|FG001|Overall Study|Withdrawal by PI|2|||
150030025|NCT00651924|541245942|FG000|Overall Study|Withdrawal by Subject|0|||
150030026|NCT00651924|541245943|FG001|Overall Study|Withdrawal by Subject|5|||
150030027|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
150030028|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
150030029|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
150030030|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
150030031|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
150030032|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
150030033|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
150030034|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
150030035|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
150030036|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
150030037|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
150030038|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
150030039|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
150030040|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
150030041|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
150030042|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
150168311|NCT00678795|541751084|FG001|Overall Study|Adverse Event|3|||
150168312|NCT00678795|541751083|FG000|Overall Study|Withdrawal by Subject|3|||
150168313|NCT00678795|541751084|FG001|Overall Study|Withdrawal by Subject|0|||
150168314|NCT00678795|541751083|FG000|Overall Study|Protocol Violation|0|||
150270007|NCT02748018|542127330|FG001|Continuation Period|Physician Decision|1|||
150270008|NCT02748018|542127331|FG002|Continuation Period|Physician Decision|2|||
150168315|NCT00678795|541751084|FG001|Overall Study|Protocol Violation|1|||
150168316|NCT00678795|541751083|FG000|Overall Study|Lost to Follow-up|0|||
150168317|NCT00678795|541751084|FG001|Overall Study|Lost to Follow-up|1|||
150168318|NCT00678795|541751083|FG000|Overall Study|Lack of Efficacy|1|||
150168319|NCT00678795|541751084|FG001|Overall Study|Lack of Efficacy|1|||
150168320|NCT00542386|541751087|FG000|Overall Study|Adverse Event|1|||
150168321|NCT00542386|541751088|FG001|Overall Study|Adverse Event|7|||
150168322|NCT00542386|541751089|FG002|Overall Study|Adverse Event|7|||
150168323|NCT00542386|541751090|FG003|Overall Study|Adverse Event|8|||
150168324|NCT00542386|541751091|FG004|Overall Study|Adverse Event|13|||
150168325|NCT00542386|541751092|FG005|Overall Study|Adverse Event|4|||
150168326|NCT00542386|541751087|FG000|Overall Study|Death|0|||
150168327|NCT00542386|541751088|FG001|Overall Study|Death|0|||
150168328|NCT00542386|541751089|FG002|Overall Study|Death|1|||
150168329|NCT00542386|541751090|FG003|Overall Study|Death|2|||
150168330|NCT00542386|541751091|FG004|Overall Study|Death|1|||
150168331|NCT00542386|541751092|FG005|Overall Study|Death|2|||
150168332|NCT00542386|541751087|FG000|Overall Study|Lack of Efficacy|32|||
150168333|NCT00542386|541751088|FG001|Overall Study|Lack of Efficacy|12|||
150168334|NCT00542386|541751089|FG002|Overall Study|Lack of Efficacy|10|||
150168335|NCT00542386|541751090|FG003|Overall Study|Lack of Efficacy|13|||
150168336|NCT00542386|541751091|FG004|Overall Study|Lack of Efficacy|7|||
150168337|NCT00542386|541751092|FG005|Overall Study|Lack of Efficacy|31|||
150168338|NCT00542386|541751087|FG000|Overall Study|Physician Decision|1|||
150168339|NCT00542386|541751088|FG001|Overall Study|Physician Decision|0|||
150168340|NCT00542386|541751089|FG002|Overall Study|Physician Decision|0|||
150168341|NCT00542386|541751090|FG003|Overall Study|Physician Decision|1|||
150168342|NCT00542386|541751091|FG004|Overall Study|Physician Decision|0|||
150168343|NCT00542386|541751092|FG005|Overall Study|Physician Decision|0|||
150168344|NCT00542386|541751087|FG000|Overall Study|Protocol Violation|0|||
150168345|NCT00542386|541751088|FG001|Overall Study|Protocol Violation|0|||
150168346|NCT00542386|541751089|FG002|Overall Study|Protocol Violation|1|||
150168347|NCT00542386|541751090|FG003|Overall Study|Protocol Violation|0|||
150168348|NCT00542386|541751091|FG004|Overall Study|Protocol Violation|0|||
150168349|NCT00542386|541751092|FG005|Overall Study|Protocol Violation|4|||
150168350|NCT00542386|541751087|FG000|Overall Study|Withdrawal by Subject|5|||
150168351|NCT00542386|541751088|FG001|Overall Study|Withdrawal by Subject|8|||
150168352|NCT00542386|541751089|FG002|Overall Study|Withdrawal by Subject|10|||
150168353|NCT00542386|541751090|FG003|Overall Study|Withdrawal by Subject|11|||
150168354|NCT00542386|541751091|FG004|Overall Study|Withdrawal by Subject|15|||
150168355|NCT00542386|541751092|FG005|Overall Study|Withdrawal by Subject|7|||
150168356|NCT00542386|541751087|FG000|Overall Study|Other Reasons|4|||
150168357|NCT00542386|541751088|FG001|Overall Study|Other Reasons|1|||
150168358|NCT00542386|541751089|FG002|Overall Study|Other Reasons|4|||
150168359|NCT00542386|541751090|FG003|Overall Study|Other Reasons|3|||
150168360|NCT00542386|541751091|FG004|Overall Study|Other Reasons|4|||
150168361|NCT00542386|541751092|FG005|Overall Study|Other Reasons|2|||
150168362|NCT00608907|541751095|FG000|Overall Study|Adverse Event|6|||
150270009|NCT02748018|542127332|FG003|Continuation Period|Physician Decision|0|||
150270010|NCT02748018|542127333|FG004|Continuation Period|Physician Decision|2|||
150270011|NCT02748018|542127334|FG005|Continuation Period|Physician Decision|1|||
150168363|NCT00608907|541751096|FG001|Overall Study|Adverse Event|0|||
150168364|NCT00608907|541751097|FG002|Overall Study|Adverse Event|1|||
150168365|NCT00608907|541751095|FG000|Overall Study|Death|1|||
150168366|NCT00608907|541751096|FG001|Overall Study|Death|0|||
150168367|NCT00608907|541751097|FG002|Overall Study|Death|0|||
150168368|NCT00608907|541751095|FG000|Overall Study|Withdrawal by Subject|4|||
150168369|NCT00608907|541751096|FG001|Overall Study|Withdrawal by Subject|0|||
150168370|NCT00608907|541751097|FG002|Overall Study|Withdrawal by Subject|0|||
150168371|NCT00608907|541751095|FG000|Overall Study|Progressive Disease|1|||
150168372|NCT00608907|541751096|FG001|Overall Study|Progressive Disease|0|||
150168373|NCT00608907|541751097|FG002|Overall Study|Progressive Disease|0|||
150168374|NCT01689519|541751098|FG000|Intent to Treat|Death|157|||
150168375|NCT01689519|541751099|FG001|Intent to Treat|Death|167|||
150168376|NCT01689519|541751098|FG000|Intent to Treat|Lost to Follow-up|4|||
150168377|NCT01689519|541751099|FG001|Intent to Treat|Lost to Follow-up|8|||
150168378|NCT01689519|541751098|FG000|Intent to Treat|Other|2|||
150168379|NCT01689519|541751099|FG001|Intent to Treat|Other|4|||
150168380|NCT01689519|541751098|FG000|Intent to Treat|Physician Decision|4|||
150168381|NCT01689519|541751099|FG001|Intent to Treat|Physician Decision|1|||
150168382|NCT01689519|541751098|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
150168383|NCT01689519|541751099|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
150168384|NCT01689519|541751098|FG000|Intent to Treat|Withdrawal by Subject|21|||
150168385|NCT01689519|541751099|FG001|Intent to Treat|Withdrawal by Subject|20|||
150168386|NCT01689519|541751098|FG000|Safety Population|Death|158|||
150168387|NCT01689519|541751099|FG001|Safety Population|Death|165|||
150168388|NCT01689519|541751098|FG000|Safety Population|Lost to Follow-up|4|||
150168389|NCT01689519|541751099|FG001|Safety Population|Lost to Follow-up|8|||
150168390|NCT01689519|541751098|FG000|Safety Population|Other|2|||
150168391|NCT01689519|541751099|FG001|Safety Population|Other|4|||
150168392|NCT01689519|541751098|FG000|Safety Population|Physician Decision|4|||
150270012|NCT02748018|542127329|FG000|Continuation Period|Protocol Violation|0|||
150270013|NCT02748018|542127330|FG001|Continuation Period|Protocol Violation|1|||
150030043|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
150030044|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
150030045|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
150030046|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
150030047|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
150030048|NCT00550407|541245944|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
150030049|NCT00550407|541245945|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
150030050|NCT00550407|541245946|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
150030051|NCT00550407|541245944|FG000|26-Week Randomized Phase|Adverse Event|0|||
150030052|NCT00550407|541245945|FG001|26-Week Randomized Phase|Adverse Event|5|||
150030053|NCT00550407|541245946|FG002|26-Week Randomized Phase|Adverse Event|2|||
150030054|NCT00550407|541245944|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
150030055|NCT00550407|541245945|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
150030056|NCT00550407|541245946|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
150030057|NCT00550407|541245944|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
150030058|NCT00550407|541245945|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
150030059|NCT00550407|541245946|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
150030060|NCT00550407|541245944|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
150030061|NCT00550407|541245945|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
150030062|NCT00550407|541245946|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
150030063|NCT00584415|541245947|FG000|Overall Study|Adverse Event|7|||
150030064|NCT00556894|541245948|FG000|Overall Study|Adverse Event|2|||
150030065|NCT00556894|541245949|FG001|Overall Study|Adverse Event|3|||
150030066|NCT00556894|541245950|FG002|Overall Study|Adverse Event|3|||
150030067|NCT00556894|541245948|FG000|Overall Study|Death|1|||
150030068|NCT00556894|541245949|FG001|Overall Study|Death|0|||
150030069|NCT00556894|541245950|FG002|Overall Study|Death|0|||
150030070|NCT00556894|541245948|FG000|Overall Study|regulatory decision in Bulgaria|10|||
150030071|NCT00556894|541245949|FG001|Overall Study|regulatory decision in Bulgaria|14|||
150030072|NCT00556894|541245950|FG002|Overall Study|regulatory decision in Bulgaria|13|||
150168393|NCT01689519|541751099|FG001|Safety Population|Physician Decision|1|||
150168394|NCT01689519|541751098|FG000|Safety Population|Study Terminated By Sponsor|60|||
150168395|NCT01689519|541751099|FG001|Safety Population|Study Terminated By Sponsor|47|||
150168396|NCT01689519|541751098|FG000|Safety Population|Withdrawal by Subject|20|||
150168397|NCT01689519|541751099|FG001|Safety Population|Withdrawal by Subject|20|||
150030073|NCT00556894|541245948|FG000|Overall Study|Change in therapy|2|||
150030074|NCT00556894|541245949|FG001|Overall Study|Change in therapy|1|||
150030075|NCT00556894|541245950|FG002|Overall Study|Change in therapy|2|||
150168398|NCT02982213|541751105|FG000|Overall Study|Did not complete follow up questionnaire|5|||
150168399|NCT02982213|541751106|FG001|Overall Study|Did not complete follow up questionnaire|1|||
150030076|NCT00556894|541245948|FG000|Overall Study|Withdrawal by Subject|1|||
150030077|NCT00556894|541245949|FG001|Overall Study|Withdrawal by Subject|1|||
150030078|NCT00556894|541245950|FG002|Overall Study|Withdrawal by Subject|1|||
150030079|NCT03883581|541245951|FG000|Overall Study|Withdrawal by Subject|4|||
150030080|NCT05190120|541245955|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
150030081|NCT05190120|541245956|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
150030082|NCT05190120|541245957|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
150030083|NCT05190120|541245958|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
150030084|NCT05190120|541245955|FG000|Overall Study|Lost to Follow-up|5|||
150030085|NCT05190120|541245956|FG001|Overall Study|Lost to Follow-up|0|||
150030086|NCT05190120|541245957|FG002|Overall Study|Lost to Follow-up|2|||
150030087|NCT05190120|541245958|FG003|Overall Study|Lost to Follow-up|3|||
150030088|NCT03062358|541245960|FG000|Overall Study|Death|269|||
150030089|NCT03062358|541245961|FG001|Overall Study|Death|145|||
150030090|NCT03062358|541245960|FG000|Overall Study|Withdrawal by Subject|2|||
150030091|NCT03062358|541245961|FG001|Overall Study|Withdrawal by Subject|1|||
150030092|NCT03062358|541245960|FG000|Overall Study|Sponsor Decision|29|||
150030093|NCT03062358|541245961|FG001|Overall Study|Sponsor Decision|7|||
150030094|NCT04750642|541245962|FG000|Overall Study|Adverse Event|1|||
150030095|NCT04750642|541245963|FG001|Overall Study|Adverse Event|0|||
150030096|NCT04750642|541245962|FG000|Overall Study|Withdrawal by Subject|0|||
150030097|NCT04750642|541245963|FG001|Overall Study|Withdrawal by Subject|1|||
150030098|NCT04750642|541245962|FG000|Overall Study|Protocol Violation|0|||
150030099|NCT04750642|541245963|FG001|Overall Study|Protocol Violation|1|||
150030100|NCT01650194|541245965|FG000|Overall Study|Progressive Disease (PD)|35|||
150030101|NCT01650194|541245965|FG000|Overall Study|Withdrawal by Subject|2|||
150030102|NCT01650194|541245965|FG000|Overall Study|Miscellaneous|10|||
150030103|NCT04158583|541245966|FG000|Overall Study|Withdrawal by Subject|1|||
150030104|NCT04158583|541245967|FG001|Overall Study|Withdrawal by Subject|1|||
150030105|NCT04158583|541245968|FG002|Overall Study|Withdrawal by Subject|0|||
150030106|NCT04158583|541245969|FG003|Overall Study|Withdrawal by Subject|0|||
150030107|NCT04158583|541245970|FG004|Overall Study|Withdrawal by Subject|1|||
150030108|NCT04158583|541245971|FG005|Overall Study|Withdrawal by Subject|0|||
150030109|NCT04158583|541245972|FG006|Overall Study|Withdrawal by Subject|0|||
150030110|NCT04158583|541245973|FG007|Overall Study|Withdrawal by Subject|0|||
150030111|NCT04158583|541245974|FG008|Overall Study|Withdrawal by Subject|2|||
150030112|NCT04158583|541245975|FG009|Overall Study|Withdrawal by Subject|0|||
150030113|NCT04158583|541245966|FG000|Overall Study|Study Terminated by Sponsor|0|||
150030114|NCT04158583|541245967|FG001|Overall Study|Study Terminated by Sponsor|0|||
150030115|NCT04158583|541245968|FG002|Overall Study|Study Terminated by Sponsor|0|||
150030116|NCT04158583|541245969|FG003|Overall Study|Study Terminated by Sponsor|1|||
150030117|NCT04158583|541245970|FG004|Overall Study|Study Terminated by Sponsor|0|||
150030118|NCT04158583|541245971|FG005|Overall Study|Study Terminated by Sponsor|0|||
150030119|NCT04158583|541245972|FG006|Overall Study|Study Terminated by Sponsor|0|||
150030120|NCT04158583|541245973|FG007|Overall Study|Study Terminated by Sponsor|0|||
149820269|NCT01698320|540471777|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
149820270|NCT01698320|540471775|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
149820271|NCT01698320|540471776|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
149820272|NCT01698320|540471777|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
149820273|NCT01698320|540471775|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
149820274|NCT01698320|540471776|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
149820275|NCT01698320|540471777|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
149820276|NCT01698320|540471775|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
149820277|NCT01698320|540471776|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
149820278|NCT01698320|540471777|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
149820279|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Adverse Event|0|||
149820280|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Adverse Event|1|||
149820281|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Adverse Event|1|||
149820282|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
149820283|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
149820284|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
149820285|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
149820286|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
149820287|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
149820288|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Pregnancy|0|||
149820289|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Pregnancy|1|||
150030121|NCT04158583|541245974|FG008|Overall Study|Study Terminated by Sponsor|0|||
150030122|NCT04158583|541245975|FG009|Overall Study|Study Terminated by Sponsor|0|||
150030123|NCT04158583|541245966|FG000|Overall Study|Progressive Disease|1|||
150030124|NCT04158583|541245967|FG001|Overall Study|Progressive Disease|0|||
150030125|NCT04158583|541245968|FG002|Overall Study|Progressive Disease|3|||
149820290|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Pregnancy|1|||
149935174|NCT04613518|540898827|FG000|Double-Blind Treatment Period|Other Reasons|2|||
149935175|NCT04613518|540898828|FG001|Double-Blind Treatment Period|Other Reasons|0|||
149935176|NCT04613518|540898829|FG002|Double-Blind Treatment Period|Other Reasons|0|||
149935177|NCT04613518|540898827|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
149935178|NCT04613518|540898828|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
149935179|NCT04613518|540898829|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
149935180|NCT04613518|540898827|FG000|Open-Label Treatment Period|Adverse Event|1|||
149935181|NCT04613518|540898828|FG001|Open-Label Treatment Period|Adverse Event|0|||
149935182|NCT04613518|540898829|FG002|Open-Label Treatment Period|Adverse Event|3|||
149935183|NCT04613518|540898827|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
149935184|NCT04613518|540898828|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
149935185|NCT04613518|540898829|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
149935186|NCT04613518|540898827|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
149935187|NCT04613518|540898828|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
149935188|NCT04613518|540898829|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
149935189|NCT04613518|540898827|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
149935190|NCT04613518|540898828|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
149935191|NCT04613518|540898829|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
149935192|NCT04613518|540898827|FG000|Open-Label Treatment Period|Other reasons|1|||
149935193|NCT04613518|540898828|FG001|Open-Label Treatment Period|Other reasons|0|||
149935194|NCT04613518|540898829|FG002|Open-Label Treatment Period|Other reasons|0|||
149935195|NCT03217591|540898830|FG000|Overall Study|Adverse Event|1|||
149935196|NCT03217591|540898831|FG001|Overall Study|Adverse Event|2|||
150270014|NCT02748018|542127331|FG002|Continuation Period|Protocol Violation|0|||
150270015|NCT02748018|542127332|FG003|Continuation Period|Protocol Violation|0|||
149935197|NCT03217591|540898832|FG002|Overall Study|Adverse Event|6|||
149935198|NCT03217591|540898830|FG000|Overall Study|Withdrawal by Subject|0|||
149935199|NCT03217591|540898831|FG001|Overall Study|Withdrawal by Subject|1|||
149935200|NCT03217591|540898832|FG002|Overall Study|Withdrawal by Subject|3|||
149935201|NCT03217591|540898830|FG000|Overall Study|Lost to Follow-up|1|||
150270016|NCT02748018|542127333|FG004|Continuation Period|Protocol Violation|0|||
150270017|NCT02748018|542127334|FG005|Continuation Period|Protocol Violation|0|||
150030126|NCT04158583|541245969|FG003|Overall Study|Progressive Disease|5|||
150030127|NCT04158583|541245970|FG004|Overall Study|Progressive Disease|0|||
150030128|NCT04158583|541245971|FG005|Overall Study|Progressive Disease|1|||
150030129|NCT04158583|541245972|FG006|Overall Study|Progressive Disease|6|||
150030130|NCT04158583|541245973|FG007|Overall Study|Progressive Disease|2|||
149935202|NCT03217591|540898831|FG001|Overall Study|Lost to Follow-up|0|||
149935203|NCT03217591|540898832|FG002|Overall Study|Lost to Follow-up|0|||
149935204|NCT03217591|540898830|FG000|Overall Study|Protocol Violation|1|||
149935205|NCT03217591|540898831|FG001|Overall Study|Protocol Violation|0|||
150030131|NCT04158583|541245974|FG008|Overall Study|Progressive Disease|1|||
149935206|NCT03217591|540898832|FG002|Overall Study|Protocol Violation|1|||
149935207|NCT04577794|540898833|FG000|Overall Study|Adverse Event|1|||
150030132|NCT04158583|541245975|FG009|Overall Study|Progressive Disease|2|||
149935208|NCT04577794|540898834|FG001|Overall Study|Adverse Event|1|||
149935209|NCT02849080|540898837|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
149935210|NCT02849080|540898838|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
150030133|NCT04158583|541245966|FG000|Overall Study|Lost to Follow-up|0|||
150030134|NCT04158583|541245967|FG001|Overall Study|Lost to Follow-up|0|||
150270018|NCT01324323|542127342|FG000|Overall Study|Withdrawal by Subject|1|||
150270019|NCT00537485|542127343|FG000|Overall Study|Adverse Event|10|||
150270020|NCT00537485|542127344|FG001|Overall Study|Adverse Event|5|||
150270021|NCT00537485|542127343|FG000|Overall Study|Withdrawal by Subject|3|||
150270022|NCT00537485|542127344|FG001|Overall Study|Withdrawal by Subject|2|||
150270023|NCT00537485|542127343|FG000|Overall Study|Withdrawal by Subject|1|||
150270024|NCT00537485|542127344|FG001|Overall Study|Withdrawal by Subject|3|||
150270025|NCT00537485|542127343|FG000|Overall Study|Physician Decision|1|||
150270026|NCT00537485|542127344|FG001|Overall Study|Physician Decision|0|||
150270027|NCT01284062|542127345|FG000|Overall Study|Adverse Event|4|||
150270028|NCT01284062|542127346|FG001|Overall Study|Adverse Event|5|||
150270029|NCT01284062|542127347|FG002|Overall Study|Adverse Event|0|||
150270030|NCT01284062|542127348|FG003|Overall Study|Adverse Event|5|||
150270031|NCT01284062|542127345|FG000|Overall Study|Lack of Efficacy|3|||
150270032|NCT01284062|542127346|FG001|Overall Study|Lack of Efficacy|2|||
150270033|NCT01284062|542127347|FG002|Overall Study|Lack of Efficacy|2|||
150270034|NCT01284062|542127348|FG003|Overall Study|Lack of Efficacy|1|||
150270035|NCT01284062|542127345|FG000|Overall Study|Medication error without adverse event|0|||
150270036|NCT01284062|542127346|FG001|Overall Study|Medication error without adverse event|0|||
150270037|NCT01284062|542127347|FG002|Overall Study|Medication error without adverse event|1|||
150270038|NCT01284062|542127348|FG003|Overall Study|Medication error without adverse event|0|||
150270039|NCT01284062|542127345|FG000|Overall Study|Protocol Violation|1|||
150270040|NCT01284062|542127346|FG001|Overall Study|Protocol Violation|0|||
150270041|NCT01284062|542127347|FG002|Overall Study|Protocol Violation|0|||
150270042|NCT01284062|542127348|FG003|Overall Study|Protocol Violation|2|||
150270043|NCT01284062|542127345|FG000|Overall Study|Withdrawal by Subject|3|||
150270044|NCT01284062|542127346|FG001|Overall Study|Withdrawal by Subject|1|||
150270045|NCT01284062|542127347|FG002|Overall Study|Withdrawal by Subject|2|||
150270046|NCT01284062|542127348|FG003|Overall Study|Withdrawal by Subject|5|||
150270047|NCT01284062|542127345|FG000|Overall Study|Other|0|||
150270048|NCT01284062|542127346|FG001|Overall Study|Other|0|||
150270049|NCT01284062|542127347|FG002|Overall Study|Other|0|||
150270050|NCT01284062|542127348|FG003|Overall Study|Other|1|||
150270051|NCT01284062|542127345|FG000|Overall Study|Site Closed|0|||
150270052|NCT01284062|542127346|FG001|Overall Study|Site Closed|0|||
150270053|NCT01284062|542127347|FG002|Overall Study|Site Closed|1|||
150270054|NCT01284062|542127348|FG003|Overall Study|Site Closed|0|||
150270055|NCT01603082|542127354|FG000|Overall Study|Adverse Event|0|||
150270056|NCT01603082|542127355|FG001|Overall Study|Adverse Event|1|||
150270057|NCT01603082|542127354|FG000|Overall Study|Withdrawal by Subject|1|||
150270058|NCT01603082|542127355|FG001|Overall Study|Withdrawal by Subject|0|||
150270059|NCT01603082|542127354|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
150270060|NCT01603082|542127355|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
150270061|NCT00634010|542127361|FG000|Overall Study|Adverse Event|2|||
150270062|NCT00634010|542127362|FG001|Overall Study|Adverse Event|5|||
150270063|NCT00634010|542127361|FG000|Overall Study|Withdrawal by Subject|5|||
150270064|NCT00634010|542127362|FG001|Overall Study|Withdrawal by Subject|6|||
150270065|NCT00634010|542127361|FG000|Overall Study|Physician Decision|1|||
150270066|NCT00634010|542127362|FG001|Overall Study|Physician Decision|1|||
150270067|NCT00634010|542127361|FG000|Overall Study|Disease Progression|1|||
150030135|NCT04158583|541245968|FG002|Overall Study|Lost to Follow-up|1|||
150030136|NCT04158583|541245969|FG003|Overall Study|Lost to Follow-up|1|||
150030137|NCT04158583|541245970|FG004|Overall Study|Lost to Follow-up|1|||
150030138|NCT04158583|541245971|FG005|Overall Study|Lost to Follow-up|0|||
149935211|NCT02849080|540898839|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
149935212|NCT02849080|540898840|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
149935213|NCT02849080|540898837|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
149935214|NCT02849080|540898838|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
149935215|NCT02849080|540898839|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
149935216|NCT02849080|540898840|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
149935217|NCT02849080|540898837|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
149935218|NCT02849080|540898838|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
149935219|NCT02849080|540898839|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
149935220|NCT02849080|540898840|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
149935221|NCT02849080|540898837|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
149935222|NCT02849080|540898838|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
149935223|NCT02849080|540898839|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
149935224|NCT02849080|540898840|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
149935225|NCT02849080|540898837|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
149935226|NCT02849080|540898838|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
149935227|NCT02849080|540898839|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
149935228|NCT02849080|540898840|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
149935229|NCT02849080|540898837|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
149935230|NCT02849080|540898838|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
149935231|NCT02849080|540898839|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
149935232|NCT02849080|540898840|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
149935233|NCT01819727|540898843|FG000|Overall Study|Adverse Event|8|||
149935234|NCT01819727|540898844|FG001|Overall Study|Adverse Event|9|||
149935235|NCT01819727|540898843|FG000|Overall Study|Death|1|||
149935236|NCT01819727|540898844|FG001|Overall Study|Death|0|||
149935237|NCT01819727|540898843|FG000|Overall Study|Lost to Follow-up|1|||
149935238|NCT01819727|540898844|FG001|Overall Study|Lost to Follow-up|1|||
149935239|NCT01819727|540898843|FG000|Overall Study|Physician Decision|3|||
149935240|NCT01819727|540898844|FG001|Overall Study|Physician Decision|2|||
149935241|NCT01819727|540898843|FG000|Overall Study|Pregnancy|1|||
149935242|NCT01819727|540898844|FG001|Overall Study|Pregnancy|0|||
149935243|NCT01819727|540898843|FG000|Overall Study|Protocol Violation|0|||
149935244|NCT01819727|540898844|FG001|Overall Study|Protocol Violation|2|||
149935245|NCT01819727|540898843|FG000|Overall Study|Study Terminated by Sponsor|0|||
149935246|NCT01819727|540898844|FG001|Overall Study|Study Terminated by Sponsor|1|||
149935247|NCT01819727|540898843|FG000|Overall Study|Withdrawal by Subject|6|||
149935248|NCT01819727|540898844|FG001|Overall Study|Withdrawal by Subject|11|||
149935249|NCT01819727|540898843|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
149935250|NCT01819727|540898844|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
149935251|NCT01819727|540898843|FG000|Overall Study|Quit due to lack of health benifits|0|||
149935252|NCT01819727|540898844|FG001|Overall Study|Quit due to lack of health benifits|1|||
149935253|NCT01121263|540898849|FG000|Overall Study|Death|3|||
149935254|NCT01121263|540898850|FG001|Overall Study|Death|2|||
149935255|NCT01121263|540898849|FG000|Overall Study|Lost to Follow-up|22|||
149935256|NCT01121263|540898850|FG001|Overall Study|Lost to Follow-up|12|||
149935257|NCT01121263|540898849|FG000|Overall Study|Withdrawal by Subject|0|||
149935258|NCT01121263|540898850|FG001|Overall Study|Withdrawal by Subject|1|||
150030139|NCT04158583|541245972|FG006|Overall Study|Lost to Follow-up|0|||
150030140|NCT04158583|541245973|FG007|Overall Study|Lost to Follow-up|0|||
150030141|NCT04158583|541245974|FG008|Overall Study|Lost to Follow-up|0|||
150030142|NCT04158583|541245975|FG009|Overall Study|Lost to Follow-up|0|||
150030143|NCT04158583|541245966|FG000|Overall Study|Due To Patient Status|0|||
150030144|NCT04158583|541245967|FG001|Overall Study|Due To Patient Status|0|||
150030145|NCT04158583|541245968|FG002|Overall Study|Due To Patient Status|0|||
150030146|NCT04158583|541245969|FG003|Overall Study|Due To Patient Status|0|||
150030147|NCT04158583|541245970|FG004|Overall Study|Due To Patient Status|0|||
150030148|NCT04158583|541245971|FG005|Overall Study|Due To Patient Status|0|||
150030149|NCT04158583|541245972|FG006|Overall Study|Due To Patient Status|0|||
150030150|NCT04158583|541245973|FG007|Overall Study|Due To Patient Status|0|||
150030151|NCT04158583|541245974|FG008|Overall Study|Due To Patient Status|1|||
150030152|NCT04158583|541245975|FG009|Overall Study|Due To Patient Status|0|||
150030153|NCT04158583|541245966|FG000|Overall Study|Death|3|||
150030154|NCT04158583|541245967|FG001|Overall Study|Death|4|||
150030155|NCT04158583|541245968|FG002|Overall Study|Death|2|||
150030156|NCT04158583|541245969|FG003|Overall Study|Death|2|||
150030157|NCT04158583|541245970|FG004|Overall Study|Death|4|||
150030158|NCT04158583|541245971|FG005|Overall Study|Death|3|||
150030159|NCT04158583|541245972|FG006|Overall Study|Death|5|||
150030160|NCT04158583|541245973|FG007|Overall Study|Death|2|||
150030161|NCT04158583|541245974|FG008|Overall Study|Death|0|||
150030162|NCT04158583|541245975|FG009|Overall Study|Death|1|||
150030163|NCT04158583|541245966|FG000|Overall Study|Clinical Progression Disease|0|||
149820291|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
149820292|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
150030164|NCT04158583|541245967|FG001|Overall Study|Clinical Progression Disease|0|||
150030165|NCT04158583|541245968|FG002|Overall Study|Clinical Progression Disease|0|||
150030166|NCT04158583|541245969|FG003|Overall Study|Clinical Progression Disease|1|||
150030167|NCT04158583|541245970|FG004|Overall Study|Clinical Progression Disease|0|||
150030168|NCT04158583|541245971|FG005|Overall Study|Clinical Progression Disease|0|||
150030169|NCT04158583|541245972|FG006|Overall Study|Clinical Progression Disease|0|||
150030170|NCT04158583|541245973|FG007|Overall Study|Clinical Progression Disease|0|||
150030171|NCT04158583|541245974|FG008|Overall Study|Clinical Progression Disease|0|||
150030172|NCT04158583|541245975|FG009|Overall Study|Clinical Progression Disease|0|||
150030173|NCT04158583|541245966|FG000|Overall Study|Clinical Progression|0|||
150030174|NCT04158583|541245967|FG001|Overall Study|Clinical Progression|0|||
150030175|NCT04158583|541245968|FG002|Overall Study|Clinical Progression|0|||
150030176|NCT04158583|541245969|FG003|Overall Study|Clinical Progression|0|||
150030177|NCT04158583|541245970|FG004|Overall Study|Clinical Progression|1|||
150030178|NCT04158583|541245971|FG005|Overall Study|Clinical Progression|0|||
150030179|NCT04158583|541245972|FG006|Overall Study|Clinical Progression|2|||
150030180|NCT04158583|541245973|FG007|Overall Study|Clinical Progression|0|||
150030181|NCT04158583|541245974|FG008|Overall Study|Clinical Progression|0|||
150030182|NCT04158583|541245975|FG009|Overall Study|Clinical Progression|0|||
150030183|NCT04158583|541245966|FG000|Overall Study|Clinical Deterioration|0|||
150030184|NCT04158583|541245967|FG001|Overall Study|Clinical Deterioration|0|||
150030185|NCT04158583|541245968|FG002|Overall Study|Clinical Deterioration|0|||
150030186|NCT04158583|541245969|FG003|Overall Study|Clinical Deterioration|1|||
150030187|NCT04158583|541245970|FG004|Overall Study|Clinical Deterioration|0|||
150030188|NCT04158583|541245971|FG005|Overall Study|Clinical Deterioration|0|||
150030189|NCT04158583|541245972|FG006|Overall Study|Clinical Deterioration|0|||
150030190|NCT04158583|541245973|FG007|Overall Study|Clinical Deterioration|0|||
150030191|NCT04158583|541245974|FG008|Overall Study|Clinical Deterioration|0|||
150030192|NCT04158583|541245975|FG009|Overall Study|Clinical Deterioration|1|||
150030193|NCT00740220|541247636|FG000|Overall Study|screen failures (non-COPD patients)|9|||
150030194|NCT01602224|541247637|FG000|Overall Study|Adverse Event|0|||
150030195|NCT01602224|541247638|FG001|Overall Study|Adverse Event|1|||
150030196|NCT01602224|541247639|FG002|Overall Study|Adverse Event|0|||
150030197|NCT01602224|541247637|FG000|Overall Study|Investigator Decison|1|||
150030198|NCT01602224|541247638|FG001|Overall Study|Investigator Decison|0|||
150030199|NCT01602224|541247639|FG002|Overall Study|Investigator Decison|0|||
150030200|NCT01602224|541247637|FG000|Overall Study|Lost to Follow-up|0|||
150030201|NCT01602224|541247638|FG001|Overall Study|Lost to Follow-up|0|||
150030202|NCT01602224|541247639|FG002|Overall Study|Lost to Follow-up|1|||
150030203|NCT01602224|541247637|FG000|Overall Study|Protocol Violation|0|||
150030204|NCT01602224|541247638|FG001|Overall Study|Protocol Violation|1|||
150030205|NCT01602224|541247639|FG002|Overall Study|Protocol Violation|0|||
150030206|NCT01602224|541247637|FG000|Overall Study|Sponsor Decision|2|||
150030207|NCT01602224|541247638|FG001|Overall Study|Sponsor Decision|3|||
150030208|NCT01602224|541247639|FG002|Overall Study|Sponsor Decision|2|||
150030209|NCT01602224|541247637|FG000|Overall Study|Withdrawal by Subject|5|||
150030210|NCT01602224|541247638|FG001|Overall Study|Withdrawal by Subject|3|||
150030211|NCT01602224|541247639|FG002|Overall Study|Withdrawal by Subject|3|||
150030212|NCT00633477|541247640|FG000|Overall Study|Death|1|||
150030213|NCT00633477|541247641|FG001|Overall Study|Death|0|||
150030214|NCT00633477|541247640|FG000|Overall Study|Randomized but not treated|1|||
150030215|NCT00633477|541247641|FG001|Overall Study|Randomized but not treated|0|||
150030216|NCT00770653|541247645|FG000|Overall Study|Adverse Event|13|||
150030217|NCT00770653|541247646|FG001|Overall Study|Adverse Event|5|||
150030218|NCT00770653|541247645|FG000|Overall Study|Protocol Violation|8|||
150030219|NCT00770653|541247646|FG001|Overall Study|Protocol Violation|6|||
150030220|NCT00770653|541247645|FG000|Overall Study|Withdrawal by Subject|4|||
150030221|NCT00770653|541247646|FG001|Overall Study|Withdrawal by Subject|7|||
150030222|NCT00770653|541247645|FG000|Overall Study|Lack of Compliance|1|||
150030223|NCT00770653|541247646|FG001|Overall Study|Lack of Compliance|4|||
150030224|NCT00770653|541247645|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
150030225|NCT00770653|541247646|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
150030226|NCT00770653|541247645|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
150030227|NCT00770653|541247646|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
150030228|NCT00770653|541247645|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
150030229|NCT00770653|541247646|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
150030230|NCT00770653|541247645|FG000|Overall Study|Lost to Follow-up|1|||
150030231|NCT00770653|541247646|FG001|Overall Study|Lost to Follow-up|2|||
150030232|NCT00770653|541247645|FG000|Overall Study|Physician Decision|1|||
150030233|NCT00770653|541247646|FG001|Overall Study|Physician Decision|0|||
149935259|NCT00161213|540900298|FG000|Overall Study|Withdrawal by Subject|1|||
149935260|NCT00161213|540900298|FG000|Overall Study|Evaluable for toxicity but not response|1|||
149935261|NCT03103503|540900299|FG000|Overall Study|Death|64|||
149935262|NCT03103503|540900299|FG000|Overall Study|Physician Decision|57|||
149935263|NCT03103503|540900299|FG000|Overall Study|Withdrawal by Subject|10|||
149935264|NCT03103503|540900299|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
149935265|NCT03103503|540900299|FG000|Overall Study|Lost to Follow-up|3|||
149935266|NCT03103503|540900299|FG000|Overall Study|Study Closure|757|||
149935267|NCT03342001|540900301|FG000|Overall Study|Adverse Event|1|||
149935268|NCT03342001|540900301|FG000|Overall Study|Lost to Follow-up|1|||
149935269|NCT01433159|540900302|FG000|Overall Study|Adverse Event|1|||
149935270|NCT01433159|540900303|FG001|Overall Study|Adverse Event|0|||
149935271|NCT01433159|540900302|FG000|Overall Study|Physician Decision|1|||
149935272|NCT01433159|540900303|FG001|Overall Study|Physician Decision|0|||
149935273|NCT01433159|540900302|FG000|Overall Study|Protocol Violation|0|||
149935274|NCT01433159|540900303|FG001|Overall Study|Protocol Violation|1|||
149935275|NCT00301834|540900304|FG000|Overall Study|Death|1|||
149935276|NCT02870868|540900305|FG000|Overall Study|Withdrawal by Subject|2|||
149935277|NCT02870868|540900306|FG001|Overall Study|Withdrawal by Subject|1|||
149935278|NCT00288912|540900307|FG000|Overall Study|Developed exclusion criterion|4|||
149935279|NCT00288912|540900308|FG001|Overall Study|Developed exclusion criterion|6|||
149935280|NCT00288912|540900309|FG002|Overall Study|Developed exclusion criterion|7|||
149935281|NCT00288912|540900307|FG000|Overall Study|Lost to Follow-up|9|||
149935282|NCT00288912|540900308|FG001|Overall Study|Lost to Follow-up|6|||
149935283|NCT00288912|540900309|FG002|Overall Study|Lost to Follow-up|9|||
149935284|NCT00288912|540900307|FG000|Overall Study|Withdrawal by Subject|4|||
149935285|NCT00288912|540900308|FG001|Overall Study|Withdrawal by Subject|5|||
149935286|NCT00288912|540900309|FG002|Overall Study|Withdrawal by Subject|12|||
149935287|NCT00183430|540900312|FG000|Overall Study|Adverse Event|1|||
149935288|NCT00183430|540900313|FG001|Overall Study|Adverse Event|0|||
149935289|NCT00183430|540900312|FG000|Overall Study|Lost to Follow-up|3|||
149935290|NCT00183430|540900313|FG001|Overall Study|Lost to Follow-up|0|||
149935291|NCT00183430|540900312|FG000|Overall Study|did not meet inclusion criteria|1|||
149935292|NCT00183430|540900313|FG001|Overall Study|did not meet inclusion criteria|0|||
149935293|NCT00183430|540900312|FG000|Overall Study|Withdrawal by Subject|1|||
149935294|NCT00183430|540900313|FG001|Overall Study|Withdrawal by Subject|0|||
149935295|NCT00883181|540900314|FG000|Overall Study|Hematological Adverse Event|26|||
149935296|NCT00883181|540900314|FG000|Overall Study|Non-hematological Adverse Event|55|||
149935297|NCT00883181|540900314|FG000|Overall Study|Disease Progression|94|||
149935298|NCT00883181|540900314|FG000|Overall Study|Administrative Reason|24|||
149935299|NCT00883181|540900314|FG000|Overall Study|Withdrawal by Subject|4|||
149935300|NCT00883181|540900314|FG000|Overall Study|Death|31|||
149935301|NCT00883181|540900314|FG000|Overall Study|Other|38|||
149935302|NCT00883181|540900314|FG000|Overall Study|Protocol Deviation|3|||
149935303|NCT00883181|540900314|FG000|Overall Study|Noncompliance|3|||
149935304|NCT04040439|540900315|FG000|Overall Study|Invalid registration|11|||
149935305|NCT04040439|540900315|FG000|Overall Study|No IC* on publication of study results|2|||
149935306|NCT00426270|540900318|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
149935307|NCT00426270|540900318|FG000|Overall Study|Adverse Event|5|||
149935308|NCT01309386|540900319|FG000|Overall Study|Other|2|||
149935309|NCT01309386|540900320|FG001|Overall Study|Other|0|||
149935310|NCT01309386|540900319|FG000|Overall Study|Withdrawal by Subject|2|||
149935311|NCT01309386|540900320|FG001|Overall Study|Withdrawal by Subject|0|||
149935312|NCT01309386|540900319|FG000|Overall Study|Progressive disease|9|||
149935313|NCT01309386|540900320|FG001|Overall Study|Progressive disease|11|||
149935314|NCT01309386|540900319|FG000|Overall Study|Physician Decision|1|||
149935315|NCT01309386|540900320|FG001|Overall Study|Physician Decision|1|||
150168400|NCT01549652|541751107|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
150168401|NCT01549652|541751108|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
150168402|NCT01549652|541751109|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
150168403|NCT01549652|541751110|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
150168404|NCT01549652|541751107|FG000|Overall Study|Study Drug Titration Failure|5|||
150168405|NCT01549652|541751108|FG001|Overall Study|Study Drug Titration Failure|6|||
150168406|NCT01549652|541751109|FG002|Overall Study|Study Drug Titration Failure|0|||
150030234|NCT04906499|541247652|FG000|Overall Study|Lack of time|1|||
149935316|NCT01309386|540900319|FG000|Overall Study|Lack of Efficacy|3|||
149935317|NCT01309386|540900320|FG001|Overall Study|Lack of Efficacy|1|||
149935318|NCT01309386|540900319|FG000|Overall Study|Adverse Event|5|||
149935319|NCT01309386|540900320|FG001|Overall Study|Adverse Event|8|||
149935320|NCT02062437|540900321|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
149935321|NCT02062437|540900321|FG000|Overall Study|Patient not available for the 2y visit|18|||
149935322|NCT02062437|540900321|FG000|Overall Study|Death|2|||
149935323|NCT02062437|540900321|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
150030235|NCT01908426|541247653|FG000|Overall Study|Adverse Event|98|||
149935324|NCT01674725|540900322|FG000|Overall Study|Adverse Event|1|||
149935325|NCT01674725|540900323|FG001|Overall Study|Adverse Event|0|||
150270068|NCT00634010|542127362|FG001|Overall Study|Disease Progression|1|||
150030236|NCT01908426|541247654|FG001|Overall Study|Adverse Event|11|||
150030237|NCT01908426|541247653|FG000|Overall Study|Clinical Deterioration|72|||
150030238|NCT01908426|541247654|FG001|Overall Study|Clinical Deterioration|38|||
149935326|NCT01674725|540900322|FG000|Overall Study|Did not receive study drug|1|||
149935327|NCT01674725|540900323|FG001|Overall Study|Did not receive study drug|0|||
149935328|NCT01674725|540900322|FG000|Overall Study|Withdrawal by Subject|1|||
149935329|NCT01674725|540900323|FG001|Overall Study|Withdrawal by Subject|0|||
149935330|NCT01674725|540900322|FG000|Overall Study|Lost to Follow-up|0|||
149935331|NCT01674725|540900323|FG001|Overall Study|Lost to Follow-up|1|||
149935332|NCT02089347|540900324|FG000|Overall Study|Protocol Violation|1|||
149935333|NCT02089347|540900325|FG001|Overall Study|Protocol Violation|0|||
149935334|NCT00001566|540900326|FG000|Overall Study|patients' choice to discontinue protocol|3|||
149935335|NCT00001566|540900326|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
149935336|NCT00001566|540900326|FG000|Overall Study|Death|13|||
149935337|NCT00001566|540900326|FG000|Overall Study|Lost to Follow-up|1|||
149935338|NCT00001566|540900326|FG000|Overall Study|unable to complete initial apheresis|1|||
149935339|NCT03439137|540900327|FG000|Overall Study|Adverse Event|16|||
149935340|NCT03439137|540900328|FG001|Overall Study|Adverse Event|12|||
149935341|NCT03439137|540900327|FG000|Overall Study|Physician Decision|0|||
149935342|NCT03439137|540900328|FG001|Overall Study|Physician Decision|5|||
149935343|NCT03439137|540900327|FG000|Overall Study|Withdrawal by Subject|14|||
149935344|NCT03439137|540900328|FG001|Overall Study|Withdrawal by Subject|4|||
149935345|NCT03439137|540900327|FG000|Overall Study|Conducting rescue therapy|2|||
149935346|NCT03439137|540900328|FG001|Overall Study|Conducting rescue therapy|1|||
149935347|NCT03439137|540900327|FG000|Overall Study|Difficult to control Hb|10|||
149935348|NCT03439137|540900328|FG001|Overall Study|Difficult to control Hb|2|||
149935349|NCT03439137|540900327|FG000|Overall Study|Initiation of a renal transplant|0|||
149935350|NCT03439137|540900328|FG001|Overall Study|Initiation of a renal transplant|2|||
149935351|NCT02378662|540900329|FG000|Overall Study|Early Discontinuation|2|||
149935352|NCT02378662|540900330|FG001|Overall Study|Early Discontinuation|0|||
149935353|NCT01474486|540900331|FG000|Overall Study|Death|2|||
149935354|NCT01474486|540900331|FG000|Overall Study|Withdrawal by Subject|4|||
149935355|NCT01474486|540900331|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
149935356|NCT05222880|540900333|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
149935357|NCT05222880|540900333|FG000|Overall Study|Withdrew Consent during Study|1|||
149935358|NCT05222880|540900333|FG000|Overall Study|COVID-19 Related|1|||
149935359|NCT01077323|540900336|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
149935360|NCT01077323|540900337|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
149935361|NCT01077323|540900338|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
149935362|NCT01077323|540900336|FG000|Overall Study|Dispensing of drug in baseline period|0|||
149935363|NCT01077323|540900337|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
149935364|NCT01077323|540900338|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
149935365|NCT01077323|540900336|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
149935366|NCT01077323|540900337|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
149935367|NCT01077323|540900338|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
149935368|NCT02848664|540900347|FG000|Overall Study|Withdrawal by Subject|2|||
149935369|NCT02848664|540900347|FG000|Overall Study|Adverse Event|1|||
149935370|NCT02848664|540900347|FG000|Overall Study|no assistance for device training|1|||
149935371|NCT00732069|540900348|FG000|Washout After First Study Drug|Adverse Event|1|||
149935372|NCT00732069|540900349|FG001|Washout After First Study Drug|Adverse Event|0|||
149935373|NCT00732069|540900350|FG002|Washout After First Study Drug|Adverse Event|0|||
149935374|NCT00732069|540900351|FG003|Washout After First Study Drug|Adverse Event|0|||
149935375|NCT00732069|540900352|FG004|Washout After First Study Drug|Adverse Event|0|||
149935376|NCT00732069|540900353|FG005|Washout After First Study Drug|Adverse Event|0|||
149935377|NCT00577317|540900354|FG000|Overall Study|Study Terminated|0|||
149935378|NCT00577317|540900355|FG001|Overall Study|Study Terminated|2|||
149935379|NCT01405898|540900357|FG000|Overall Study|Withdrawal by Subject|2|||
150030239|NCT01908426|541247653|FG000|Overall Study|Lack of Efficacy|3|||
150030240|NCT01908426|541247654|FG001|Overall Study|Lack of Efficacy|0|||
149935380|NCT01405898|540900358|FG001|Overall Study|Withdrawal by Subject|2|||
149935381|NCT02283658|540900359|FG000|Overall Study|Withdrawal by Subject|1|||
149935382|NCT01687218|540900361|FG000|Overall Study|Withdrawal by Subject|2|||
149935383|NCT01687218|540900362|FG001|Overall Study|Withdrawal by Subject|3|||
149935384|NCT01687218|540900363|FG002|Overall Study|Withdrawal by Subject|0|||
149935385|NCT01687218|540900364|FG003|Overall Study|Withdrawal by Subject|1|||
149935386|NCT01687218|540900365|FG004|Overall Study|Withdrawal by Subject|1|||
149935387|NCT01687218|540900366|FG005|Overall Study|Withdrawal by Subject|0|||
149935388|NCT01687218|540900361|FG000|Overall Study|Relocated, no follow-up planned|1|||
149935389|NCT01687218|540900362|FG001|Overall Study|Relocated, no follow-up planned|0|||
149935390|NCT01687218|540900363|FG002|Overall Study|Relocated, no follow-up planned|1|||
149935391|NCT01687218|540900364|FG003|Overall Study|Relocated, no follow-up planned|1|||
149935392|NCT01687218|540900365|FG004|Overall Study|Relocated, no follow-up planned|0|||
150030241|NCT01908426|541247653|FG000|Overall Study|Lost to Follow-up|0|||
150030242|NCT01908426|541247654|FG001|Overall Study|Lost to Follow-up|1|||
150030243|NCT01908426|541247653|FG000|Overall Study|Physician Decision|3|||
150030244|NCT01908426|541247654|FG001|Overall Study|Physician Decision|3|||
150030245|NCT01908426|541247653|FG000|Overall Study|Withdrawal by Subject|11|||
150030246|NCT01908426|541247654|FG001|Overall Study|Withdrawal by Subject|6|||
150030247|NCT01908426|541247653|FG000|Overall Study|Progressive Disease|206|||
150030248|NCT01908426|541247654|FG001|Overall Study|Progressive Disease|152|||
150030249|NCT01908426|541247653|FG000|Overall Study|Protocol Violation|1|||
149935393|NCT01687218|540900366|FG005|Overall Study|Relocated, no follow-up planned|0|||
149935394|NCT01789047|540900375|FG000|Overall Study|Adverse Event|3|||
149935395|NCT01789047|540900376|FG001|Overall Study|Adverse Event|2|||
149935396|NCT01789047|540900375|FG000|Overall Study|Withdrawal by Subject|1|||
149935397|NCT01789047|540900376|FG001|Overall Study|Withdrawal by Subject|2|||
149935398|NCT03644017|540900377|FG000|Overall Study|Access Abandonment|5|||
149935399|NCT03644017|540900377|FG000|Overall Study|Kidney Transplant|2|||
149935400|NCT02700048|540900378|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
149935401|NCT02700048|540900379|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
149935402|NCT02175225|540900380|FG000|Overall Study|Withdrawal by Subject|1|||
149935403|NCT02175225|540900381|FG001|Overall Study|Withdrawal by Subject|2|||
149935404|NCT02175225|540900380|FG000|Overall Study|Lost to Follow-up|6|||
149935405|NCT02175225|540900381|FG001|Overall Study|Lost to Follow-up|7|||
149935406|NCT02175225|540900380|FG000|Overall Study|Study drug not administered|1|||
149935407|NCT02175225|540900381|FG001|Overall Study|Study drug not administered|2|||
149935408|NCT02340000|540900382|FG000|Time Period 1|Withdrawal by Subject|6|||
149935409|NCT02340000|540900383|FG001|Time Period 1|Withdrawal by Subject|8|||
149935410|NCT02340000|540900382|FG000|Time Period 1|Lost to Follow-up|6|||
149935411|NCT02340000|540900383|FG001|Time Period 1|Lost to Follow-up|7|||
149935412|NCT02340000|540900382|FG000|Time Period 2|Withdrawal by Subject|9|||
149935413|NCT02340000|540900383|FG001|Time Period 2|Withdrawal by Subject|7|||
149935414|NCT02340000|540900382|FG000|Time Period 2|Lost to Follow-up|10|||
149935415|NCT02340000|540900383|FG001|Time Period 2|Lost to Follow-up|8|||
149935416|NCT02668640|540900384|FG000|Overall Study|Lost to Follow-up|13|||
149935417|NCT02668640|540900384|FG000|Overall Study|Other, not specified|1|||
149935418|NCT01305564|540900387|FG000|Overall Study|Death|21|||
149935419|NCT01305564|540900387|FG000|Overall Study|Lost to Follow-up|12|||
149935420|NCT01305564|540900387|FG000|Overall Study|Withdrawal by Subject|1|||
149935421|NCT01305564|540900387|FG000|Overall Study|Physician Decision|3|||
149935422|NCT02322749|540900391|FG000|Period 2|Adverse Event|0|||
149935423|NCT02322749|540900392|FG001|Period 2|Adverse Event|0|||
149935424|NCT02322749|540900393|FG002|Period 2|Adverse Event|0|||
149935425|NCT02322749|540900394|FG003|Period 2|Adverse Event|1|||
149935426|NCT02322749|540900395|FG004|Period 2|Adverse Event|0|||
149935427|NCT02322749|540900396|FG005|Period 2|Adverse Event|0|||
149935428|NCT02322749|540900391|FG000|Period 2|Withdrawal by Subject|0|||
149935429|NCT02322749|540900392|FG001|Period 2|Withdrawal by Subject|0|||
149935430|NCT02322749|540900393|FG002|Period 2|Withdrawal by Subject|0|||
149935431|NCT02322749|540900394|FG003|Period 2|Withdrawal by Subject|1|||
149935432|NCT02322749|540900395|FG004|Period 2|Withdrawal by Subject|0|||
149935433|NCT02322749|540900396|FG005|Period 2|Withdrawal by Subject|0|||
149935434|NCT02322749|540900391|FG000|Period 3|Withdrawal by Subject|0|||
149935435|NCT02322749|540900392|FG001|Period 3|Withdrawal by Subject|0|||
149935436|NCT02322749|540900393|FG002|Period 3|Withdrawal by Subject|1|||
149935437|NCT02322749|540900394|FG003|Period 3|Withdrawal by Subject|0|||
149935438|NCT02322749|540900395|FG004|Period 3|Withdrawal by Subject|0|||
149935439|NCT02322749|540900396|FG005|Period 3|Withdrawal by Subject|0|||
149935440|NCT00073918|540900401|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
149935441|NCT00073918|540900401|FG000|Overall Study|Rapid disease progression|2|||
149935442|NCT00073918|540900401|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
149935443|NCT01190813|540900404|FG000|Overall Study|Lost to Follow-up|1|||
149935444|NCT01190813|540900405|FG001|Overall Study|Lost to Follow-up|2|||
150030250|NCT01908426|541247654|FG001|Overall Study|Protocol Violation|0|||
149935445|NCT01190813|540900404|FG000|Overall Study|Withdrawal by Subject|2|||
149935446|NCT01190813|540900405|FG001|Overall Study|Withdrawal by Subject|1|||
149935447|NCT01190813|540900404|FG000|Overall Study|Refused study treatment after randomized|1|||
149935448|NCT01190813|540900405|FG001|Overall Study|Refused study treatment after randomized|0|||
149935449|NCT01190813|540900404|FG000|Overall Study|Adverse Event|0|||
149935450|NCT01190813|540900405|FG001|Overall Study|Adverse Event|1|||
149935451|NCT02033759|540900406|FG000|Overall Study|Withdrawal by Subject|2|||
149935452|NCT02033759|540900407|FG001|Overall Study|Withdrawal by Subject|1|||
149935453|NCT02033759|540900406|FG000|Overall Study|Protocol Violation|1|||
149935454|NCT02033759|540900407|FG001|Overall Study|Protocol Violation|1|||
149935455|NCT00807365|540900412|FG000|Overall Study|Study Terminated|5|||
149935456|NCT04821830|540900415|FG000|Overall Study|Withdrawal by Subject|1|||
149935457|NCT04821830|540900416|FG001|Overall Study|Withdrawal by Subject|0|||
149935458|NCT00919633|540900418|FG000|Overall Study|Adverse Event|1|||
149935459|NCT00919633|540900419|FG001|Overall Study|Adverse Event|9|||
149935460|NCT00919633|540900420|FG002|Overall Study|Adverse Event|12|||
150030251|NCT01908426|541247653|FG000|Overall Study|No Study Treatment Given|3|||
150030252|NCT01908426|541247654|FG001|Overall Study|No Study Treatment Given|0|||
150030253|NCT03346434|541247655|FG000|Overall Study|Randomized in Error|0|||
150030254|NCT03346434|541247656|FG001|Overall Study|Randomized in Error|0|||
150030255|NCT03346434|541247657|FG002|Overall Study|Randomized in Error|0|||
150030256|NCT03346434|541247658|FG003|Overall Study|Randomized in Error|0|||
150030257|NCT03346434|541247659|FG004|Overall Study|Randomized in Error|1|||
150030258|NCT03346434|541247660|FG005|Overall Study|Randomized in Error|0|||
150030259|NCT03346434|541247655|FG000|Overall Study|Withdrawal by Subject|0|||
150030260|NCT03346434|541247656|FG001|Overall Study|Withdrawal by Subject|0|||
150030261|NCT03346434|541247657|FG002|Overall Study|Withdrawal by Subject|1|||
150030262|NCT03346434|541247658|FG003|Overall Study|Withdrawal by Subject|0|||
150030263|NCT03346434|541247659|FG004|Overall Study|Withdrawal by Subject|1|||
150030264|NCT03346434|541247660|FG005|Overall Study|Withdrawal by Subject|0|||
150030265|NCT03346434|541247655|FG000|Overall Study|Lost to Follow-up|0|||
150030266|NCT03346434|541247656|FG001|Overall Study|Lost to Follow-up|0|||
150030267|NCT03346434|541247657|FG002|Overall Study|Lost to Follow-up|0|||
150030268|NCT03346434|541247658|FG003|Overall Study|Lost to Follow-up|0|||
150030269|NCT03346434|541247659|FG004|Overall Study|Lost to Follow-up|1|||
150030270|NCT03346434|541247660|FG005|Overall Study|Lost to Follow-up|1|||
150030271|NCT03346434|541247655|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
150030272|NCT03346434|541247656|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
150030273|NCT03346434|541247657|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
150030274|NCT03346434|541247658|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
150030275|NCT03346434|541247659|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
150030276|NCT03346434|541247660|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
150030277|NCT03525444|541247661|FG000|Overall Study|Adverse Event|0|||
150030278|NCT03525444|541247662|FG001|Overall Study|Adverse Event|1|||
150030279|NCT03525444|541247661|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
150030280|NCT03525444|541247662|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
150030281|NCT03525444|541247661|FG000|Overall Study|Other|0|||
150030282|NCT03525444|541247662|FG001|Overall Study|Other|1|||
150030283|NCT02741128|541247665|FG000|Overall Study|Protocol Violation|4|||
150030284|NCT02741128|541247666|FG001|Overall Study|Protocol Violation|1|||
150030285|NCT02741128|541247665|FG000|Overall Study|Withdrawal by Subject|2|||
150030286|NCT02741128|541247666|FG001|Overall Study|Withdrawal by Subject|0|||
150030287|NCT02741128|541247665|FG000|Overall Study|Lost to Follow-up|1|||
150030288|NCT02741128|541247666|FG001|Overall Study|Lost to Follow-up|0|||
150030289|NCT01419769|541247667|FG000|Overall Study|Did not receive the AXIOS stent|3|||
150030290|NCT01419769|541247667|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
150030291|NCT00878501|541247668|FG000|Overall Study|Adverse Event|11|||
150030292|NCT00878501|541247669|FG001|Overall Study|Adverse Event|3|||
150030293|NCT00878501|541247670|FG002|Overall Study|Adverse Event|3|||
150030294|NCT00878501|541247668|FG000|Overall Study|Lack of Efficacy|2|||
150030295|NCT00878501|541247669|FG001|Overall Study|Lack of Efficacy|1|||
149935461|NCT00919633|540900421|FG003|Overall Study|Adverse Event|10|||
149935462|NCT00919633|540900418|FG000|Overall Study|Death|0|||
149935463|NCT00919633|540900419|FG001|Overall Study|Death|0|||
149935464|NCT00919633|540900420|FG002|Overall Study|Death|2|||
149935465|NCT00919633|540900421|FG003|Overall Study|Death|0|||
149935466|NCT00919633|540900418|FG000|Overall Study|Lack of Efficacy|17|||
149935467|NCT00919633|540900419|FG001|Overall Study|Lack of Efficacy|3|||
149935468|NCT00919633|540900420|FG002|Overall Study|Lack of Efficacy|2|||
149935469|NCT00919633|540900421|FG003|Overall Study|Lack of Efficacy|3|||
149935470|NCT00919633|540900418|FG000|Overall Study|Withdrawal by Subject|1|||
149935471|NCT00919633|540900419|FG001|Overall Study|Withdrawal by Subject|2|||
149935472|NCT00919633|540900420|FG002|Overall Study|Withdrawal by Subject|4|||
149935473|NCT00919633|540900421|FG003|Overall Study|Withdrawal by Subject|3|||
149935474|NCT00919633|540900418|FG000|Overall Study|Lost to Follow-up|3|||
149935475|NCT00919633|540900419|FG001|Overall Study|Lost to Follow-up|1|||
149935476|NCT00919633|540900420|FG002|Overall Study|Lost to Follow-up|0|||
149935477|NCT00919633|540900421|FG003|Overall Study|Lost to Follow-up|2|||
149935478|NCT00919633|540900418|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
150030296|NCT00878501|541247670|FG002|Overall Study|Lack of Efficacy|0|||
150030297|NCT00878501|541247668|FG000|Overall Study|Withdrawal by Subject|2|||
150030298|NCT00878501|541247669|FG001|Overall Study|Withdrawal by Subject|1|||
150030299|NCT00878501|541247670|FG002|Overall Study|Withdrawal by Subject|2|||
149935479|NCT00919633|540900419|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
149935480|NCT00919633|540900420|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
149935481|NCT00919633|540900421|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
150030300|NCT00878501|541247668|FG000|Overall Study|Protocol Violation|0|||
150030301|NCT00878501|541247669|FG001|Overall Study|Protocol Violation|0|||
150030302|NCT00878501|541247670|FG002|Overall Study|Protocol Violation|1|||
149935482|NCT00919633|540900418|FG000|Overall Study|Protocol Violation|0|||
149935483|NCT00919633|540900419|FG001|Overall Study|Protocol Violation|0|||
149935484|NCT00919633|540900420|FG002|Overall Study|Protocol Violation|0|||
149935485|NCT00919633|540900421|FG003|Overall Study|Protocol Violation|1|||
150030303|NCT00878501|541247668|FG000|Overall Study|Incorrect enrolment|1|||
149935486|NCT00919633|540900418|FG000|Overall Study|Physician Decision|0|||
149935487|NCT00919633|540900419|FG001|Overall Study|Physician Decision|0|||
149935488|NCT00919633|540900420|FG002|Overall Study|Physician Decision|0|||
149935489|NCT00919633|540900421|FG003|Overall Study|Physician Decision|1|||
150030304|NCT00878501|541247669|FG001|Overall Study|Incorrect enrolment|2|||
150030305|NCT00878501|541247670|FG002|Overall Study|Incorrect enrolment|0|||
150030306|NCT00878501|541247668|FG000|Overall Study|Intake of prohibited concom. medication|0|||
150030307|NCT00878501|541247669|FG001|Overall Study|Intake of prohibited concom. medication|0|||
150030308|NCT00878501|541247670|FG002|Overall Study|Intake of prohibited concom. medication|1|||
150030309|NCT00878501|541247668|FG000|Overall Study|Mis-randomisation of patient|1|||
150030310|NCT00878501|541247669|FG001|Overall Study|Mis-randomisation of patient|0|||
150030311|NCT00878501|541247670|FG002|Overall Study|Mis-randomisation of patient|0|||
150030312|NCT00878501|541247668|FG000|Overall Study|Administrative|0|||
150030313|NCT00878501|541247669|FG001|Overall Study|Administrative|0|||
150030314|NCT00878501|541247670|FG002|Overall Study|Administrative|1|||
150030315|NCT04416204|541247671|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
150030316|NCT04416204|541247672|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
150030317|NCT04416204|541247673|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
150030318|NCT04416204|541247674|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
150030319|NCT00812708|541247675|FG000|Overall Study|Device could not be implanted|2|||
150030320|NCT00812708|541247675|FG000|Overall Study|Lack of medical insurance|1|||
150030321|NCT00812708|541247675|FG000|Overall Study|Switched to another study|1|||
150030322|NCT00812708|541247675|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
150030323|NCT00812708|541247675|FG000|Overall Study|Signed consent but later withdrew|3|||
149935490|NCT00919633|540900418|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
149935491|NCT00919633|540900419|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
149935492|NCT00919633|540900420|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
149935493|NCT00919633|540900421|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
149935494|NCT00919633|540900418|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
149935495|NCT00919633|540900419|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
149935496|NCT00919633|540900420|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
149935497|NCT00919633|540900421|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
149935498|NCT01526785|540900422|FG000|Overall Study|Study Terminated by Sponsor|8|||
149935499|NCT01526785|540900422|FG000|Overall Study|Death|2|||
149935500|NCT01526785|540900422|FG000|Overall Study|Physician Decision|1|||
149935501|NCT01526785|540900422|FG000|Overall Study|Withdrawal by Subject|2|||
149935502|NCT00960804|540900425|FG000|Overall Study|Adverse Event|1|||
149935503|NCT00960804|540900426|FG001|Overall Study|Adverse Event|0|||
149935504|NCT00960804|540900427|FG002|Overall Study|Adverse Event|0|||
149935505|NCT00960804|540900425|FG000|Overall Study|Withdrawal by Subject|1|||
149935506|NCT00960804|540900426|FG001|Overall Study|Withdrawal by Subject|0|||
149935507|NCT00960804|540900427|FG002|Overall Study|Withdrawal by Subject|0|||
149935508|NCT00960804|540900425|FG000|Overall Study|Study terminated by the sponsor|5|||
149935509|NCT00960804|540900426|FG001|Overall Study|Study terminated by the sponsor|4|||
149935510|NCT00960804|540900427|FG002|Overall Study|Study terminated by the sponsor|10|||
149935511|NCT02100124|540900432|FG000|Overall Study|Lost to Follow-up|5|||
149935512|NCT02100124|540900433|FG001|Overall Study|Lost to Follow-up|11|||
149935513|NCT02100124|540900434|FG002|Overall Study|Lost to Follow-up|3|||
149935514|NCT02100124|540900432|FG000|Overall Study|Withdrawal by Subject|1|||
149935515|NCT02100124|540900433|FG001|Overall Study|Withdrawal by Subject|0|||
149935516|NCT02100124|540900434|FG002|Overall Study|Withdrawal by Subject|0|||
149935517|NCT04350827|540900435|FG000|Overall Study|Lost to Follow-up|1|||
149935518|NCT04350827|540900436|FG001|Overall Study|Lost to Follow-up|2|||
149935519|NCT04265261|540900437|FG000|Overall Study|Adverse Event|2|||
149935520|NCT04265261|540900438|FG001|Overall Study|Adverse Event|0|||
149935521|NCT04265261|540900439|FG002|Overall Study|Adverse Event|0|||
149935522|NCT04265261|540900437|FG000|Overall Study|Death|1|||
150030324|NCT01959503|541247679|FG000|Overall Study|Death|2|||
150030325|NCT01959503|541247680|FG001|Overall Study|Death|1|||
149935523|NCT04265261|540900438|FG001|Overall Study|Death|0|||
149935524|NCT04265261|540900439|FG002|Overall Study|Death|0|||
149935525|NCT04265261|540900437|FG000|Overall Study|Lost to Follow-up|4|||
149935526|NCT04265261|540900438|FG001|Overall Study|Lost to Follow-up|1|||
149935527|NCT04265261|540900439|FG002|Overall Study|Lost to Follow-up|3|||
149935528|NCT04265261|540900437|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149935529|NCT04265261|540900438|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149935530|NCT04265261|540900439|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150030326|NCT01959503|541247679|FG000|Overall Study|Randomized but not treated|1|||
150030327|NCT01959503|541247680|FG001|Overall Study|Randomized but not treated|1|||
150030328|NCT01838694|541247684|FG000|Overall Study|Adverse Event|0|||
150030329|NCT01838694|541247685|FG001|Overall Study|Adverse Event|1|||
150030330|NCT02587520|541247687|FG000|Overall Study|Protocol Violation|2|||
150030331|NCT02587520|541247688|FG001|Overall Study|Protocol Violation|0|||
149935531|NCT04265261|540900437|FG000|Overall Study|Physician Decision|0|||
149935532|NCT04265261|540900438|FG001|Overall Study|Physician Decision|0|||
149935533|NCT04265261|540900439|FG002|Overall Study|Physician Decision|1|||
149935534|NCT04265261|540900437|FG000|Overall Study|Protocol Deviation|0|||
149935535|NCT04265261|540900438|FG001|Overall Study|Protocol Deviation|2|||
149935536|NCT04265261|540900439|FG002|Overall Study|Protocol Deviation|0|||
149935537|NCT04265261|540900437|FG000|Overall Study|Withdrawal by Subject|2|||
149935538|NCT04265261|540900438|FG001|Overall Study|Withdrawal by Subject|1|||
149935539|NCT04265261|540900439|FG002|Overall Study|Withdrawal by Subject|4|||
149935540|NCT02990000|540902061|FG000|Overall Study|Failed to provide data beyond baseline|36|||
149935541|NCT02990000|540902062|FG001|Overall Study|Failed to provide data beyond baseline|34|||
149935542|NCT02579629|540902083|FG000|Overall Study|Withdrawal by Subject|0|||
149935543|NCT02579629|540902084|FG001|Overall Study|Withdrawal by Subject|1|||
149935544|NCT02579629|540902085|FG002|Overall Study|Withdrawal by Subject|0|||
149935545|NCT02579629|540902083|FG000|Overall Study|Screen Failure|2|||
149935546|NCT02579629|540902084|FG001|Overall Study|Screen Failure|0|||
149935547|NCT02579629|540902085|FG002|Overall Study|Screen Failure|2|||
149935548|NCT01930539|540902086|FG000|Overall Study|Withdrawal by Subject|2|||
149935549|NCT01930539|540902087|FG001|Overall Study|Withdrawal by Subject|2|||
149935550|NCT01190891|540902088|FG000|Overall Study|Protocol Violation|1|||
149935551|NCT01190891|540902089|FG001|Overall Study|Protocol Violation|0|||
149935552|NCT01190891|540902088|FG000|Overall Study|Withdrawal by Subject|5|||
149935553|NCT01190891|540902089|FG001|Overall Study|Withdrawal by Subject|0|||
149935554|NCT01739335|540902090|FG000|Overall Study|Lost to Follow-up|7|||
149935555|NCT01739335|540902091|FG001|Overall Study|Lost to Follow-up|4|||
149935556|NCT01739335|540902090|FG000|Overall Study|Ineligible patient randomized|0|||
149935557|NCT01739335|540902091|FG001|Overall Study|Ineligible patient randomized|1|||
149935558|NCT01218308|540902094|FG000|Overall Study|Adverse Event|1|||
149935559|NCT01218308|540902095|FG001|Overall Study|Adverse Event|2|||
149935560|NCT01218308|540902094|FG000|Overall Study|Protocol Violation|0|||
149935561|NCT01218308|540902095|FG001|Overall Study|Protocol Violation|2|||
149935562|NCT01218308|540902094|FG000|Overall Study|Withdrawal by Subject|61|||
149935563|NCT01218308|540902095|FG001|Overall Study|Withdrawal by Subject|64|||
149935564|NCT01218308|540902094|FG000|Overall Study|Lost to Follow-up|27|||
149935565|NCT01218308|540902095|FG001|Overall Study|Lost to Follow-up|31|||
149935566|NCT01218308|540902094|FG000|Overall Study|Other|14|||
149935567|NCT01218308|540902095|FG001|Overall Study|Other|21|||
149935568|NCT00723229|540902096|FG000|First Intervention|Lost to Follow-up|7|||
149935569|NCT00723229|540902097|FG001|First Intervention|Lost to Follow-up|3|||
149935570|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
149935571|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
149935572|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
149935573|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
149935574|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
149935575|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
149935576|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
149935577|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
149935578|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
149935579|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
149935580|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
149935581|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
149935582|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
149935583|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
149935584|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
149935585|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
149935586|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
150030332|NCT02587520|541247689|FG002|Overall Study|Protocol Violation|0|||
150168407|NCT01549652|541751110|FG003|Overall Study|Study Drug Titration Failure|0|||
150168408|NCT01549652|541751107|FG000|Overall Study|Withdrawal Effect|0|||
150168409|NCT01549652|541751108|FG001|Overall Study|Withdrawal Effect|2|||
150168410|NCT01549652|541751109|FG002|Overall Study|Withdrawal Effect|0|||
150168411|NCT01549652|541751110|FG003|Overall Study|Withdrawal Effect|0|||
150168412|NCT01549652|541751107|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
150168413|NCT01549652|541751108|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
150168414|NCT01549652|541751109|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
150168415|NCT01549652|541751110|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
150168416|NCT01549652|541751107|FG000|Overall Study|Problem with Infusion|1|||
150168417|NCT01549652|541751108|FG001|Overall Study|Problem with Infusion|0|||
150168418|NCT01549652|541751109|FG002|Overall Study|Problem with Infusion|0|||
150168419|NCT01549652|541751110|FG003|Overall Study|Problem with Infusion|0|||
150168420|NCT01549652|541751107|FG000|Overall Study|Titration Non-Compliance|1|||
150168421|NCT01549652|541751108|FG001|Overall Study|Titration Non-Compliance|3|||
150168422|NCT01549652|541751109|FG002|Overall Study|Titration Non-Compliance|4|||
150168423|NCT01549652|541751110|FG003|Overall Study|Titration Non-Compliance|5|||
150168424|NCT01549652|541751107|FG000|Overall Study|Titration Side Effects|0|||
149935587|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
149935588|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
149935589|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
149935590|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
149935591|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
150270069|NCT00634010|542127361|FG000|Overall Study|Non-Compliant|1|||
150270070|NCT00634010|542127362|FG001|Overall Study|Non-Compliant|1|||
150270071|NCT01026142|542127363|FG000|Overall Study|Death|136|||
149935592|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
149935593|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
149935594|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
149935595|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
149935596|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
149935597|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
149935598|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
149935599|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
149935600|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
149935601|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
149935602|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
149935603|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
149935604|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
149935605|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
149935606|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
149935607|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
149935608|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
149935609|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
149935610|NCT02709746|540902098|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
149935611|NCT02709746|540902099|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
149935612|NCT02709746|540902100|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
149935613|NCT02709746|540902101|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
149935614|NCT02709746|540902102|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
149935615|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
149935616|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
149935617|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
149935618|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
149935619|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
149935620|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
149935621|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
149935622|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
149935623|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
149935624|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
149935625|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
149935626|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
149935627|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
149935628|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
149935629|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
149935630|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
149935631|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
149935632|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
149935633|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
149935634|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
149935635|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
150270072|NCT01026142|542127364|FG001|Overall Study|Death|134|||
150270073|NCT01026142|542127363|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
150270074|NCT01026142|542127364|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
150270075|NCT01862640|542127368|FG000|Overall Study|Adverse Event|4|||
150270076|NCT01862640|542127369|FG001|Overall Study|Adverse Event|10|||
150270077|NCT01862640|542127370|FG002|Overall Study|Adverse Event|6|||
150270078|NCT01862640|542127371|FG003|Overall Study|Adverse Event|8|||
150030333|NCT02587520|541247690|FG003|Overall Study|Protocol Violation|2|||
150030334|NCT02587520|541247691|FG004|Overall Study|Protocol Violation|0|||
150030335|NCT02587520|541247692|FG005|Overall Study|Protocol Violation|1|||
150030336|NCT02587520|541247693|FG006|Overall Study|Protocol Violation|1|||
149935636|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
150030337|NCT02587520|541247694|FG007|Overall Study|Protocol Violation|1|||
150270079|NCT01862640|542127368|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
150270080|NCT01862640|542127369|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
150270081|NCT01862640|542127370|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
150270082|NCT01862640|542127371|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
150270083|NCT01862640|542127368|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
150270084|NCT01862640|542127369|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
150270085|NCT01862640|542127370|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
150270086|NCT01862640|542127371|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
150270087|NCT01862640|542127368|FG000|Overall Study|Withdrawal by Subject|2|||
150270088|NCT01862640|542127369|FG001|Overall Study|Withdrawal by Subject|4|||
149935637|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
149935638|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
149935639|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
149935640|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
149935641|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
149935642|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
149935643|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
149935644|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
149935645|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
149935646|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
149935647|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
149935648|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
149935649|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
149935650|NCT02709746|540902098|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
149935651|NCT02709746|540902099|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
149935652|NCT02709746|540902100|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
149935653|NCT02709746|540902101|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
149935654|NCT02709746|540902102|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
149935655|NCT02900352|540902103|FG000|Overall Study|Lost to Follow-up|28|||
149935656|NCT02900352|540902104|FG001|Overall Study|Lost to Follow-up|17|||
149935657|NCT00752089|540902105|FG000|Overall Study|Adverse Event|1|||
149935658|NCT00752089|540902105|FG000|Overall Study|Protocol Deviation|2|||
149935659|NCT00752089|540902105|FG000|Overall Study|Could not attend visit 9|1|||
149935660|NCT00752089|540902105|FG000|Overall Study|Not capable of wearing partial denture|1|||
149935661|NCT00752089|540902105|FG000|Overall Study|Cannot continue the study|1|||
149935662|NCT00975416|540902113|FG000|Overall Study|early discharge from tx|3|||
149935663|NCT00975416|540902114|FG001|Overall Study|early discharge from tx|5|||
149935664|NCT00106002|540902115|FG000|Overall Study|Did not take any study drug|1|||
149935665|NCT00106002|540902115|FG000|Overall Study|Ineligible after Registration|1|||
149935666|NCT01245101|540902119|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
149935667|NCT01245101|540902120|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
149935668|NCT01245101|540902119|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
149935669|NCT01245101|540902120|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
149935670|NCT01245101|540902119|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
149935671|NCT01245101|540902120|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
149935672|NCT01225549|540902121|FG000|Period 4 - Washout|Disallowed medication|0|||
149935673|NCT01225549|540902122|FG001|Period 4 - Washout|Disallowed medication|1|||
149935674|NCT01225549|540902123|FG002|Period 4 - Washout|Disallowed medication|0|||
149935675|NCT01225549|540902124|FG003|Period 4 - Washout|Disallowed medication|0|||
149935676|NCT01225549|540902125|FG004|Period 4 - Washout|Disallowed medication|0|||
149935677|NCT01225549|540902126|FG005|Period 4 - Washout|Disallowed medication|0|||
149935678|NCT01225549|540902127|FG006|Period 4 - Washout|Disallowed medication|0|||
149935679|NCT01225549|540902128|FG007|Period 4 - Washout|Disallowed medication|0|||
149935680|NCT01225549|540902129|FG008|Period 4 - Washout|Disallowed medication|0|||
149935681|NCT01225549|540902130|FG009|Period 4 - Washout|Disallowed medication|0|||
149935682|NCT01225549|540902121|FG000|Period 6 - Washout|Disallowed medication|0|||
149935683|NCT01225549|540902122|FG001|Period 6 - Washout|Disallowed medication|0|||
149935684|NCT01225549|540902123|FG002|Period 6 - Washout|Disallowed medication|0|||
149935685|NCT01225549|540902124|FG003|Period 6 - Washout|Disallowed medication|1|||
149935686|NCT01225549|540902125|FG004|Period 6 - Washout|Disallowed medication|0|||
149935687|NCT01225549|540902126|FG005|Period 6 - Washout|Disallowed medication|0|||
149935688|NCT01225549|540902127|FG006|Period 6 - Washout|Disallowed medication|0|||
149935689|NCT01225549|540902128|FG007|Period 6 - Washout|Disallowed medication|0|||
149935690|NCT01225549|540902129|FG008|Period 6 - Washout|Disallowed medication|0|||
149935691|NCT01225549|540902130|FG009|Period 6 - Washout|Disallowed medication|0|||
149935692|NCT01122173|540902133|FG000|Overall Study|Lost to Follow-up|3|||
149935693|NCT01122173|540902133|FG000|Overall Study|Withdrawal by Subject|3|||
150270089|NCT01862640|542127370|FG002|Overall Study|Withdrawal by Subject|8|||
150270090|NCT01862640|542127371|FG003|Overall Study|Withdrawal by Subject|5|||
149935694|NCT01122173|540902133|FG000|Overall Study|Left study for other reasons|3|||
149935695|NCT00473083|540902136|FG000|Overall Study|Adverse Event|1|||
149935696|NCT00473083|540902137|FG001|Overall Study|Adverse Event|0|||
150270091|NCT01862640|542127368|FG000|Overall Study|Protocol Deviation|0|||
150270092|NCT01862640|542127369|FG001|Overall Study|Protocol Deviation|0|||
150270093|NCT01862640|542127370|FG002|Overall Study|Protocol Deviation|1|||
150270094|NCT01862640|542127371|FG003|Overall Study|Protocol Deviation|0|||
150270095|NCT01019317|542127372|FG000|Overall Study|Not Eligible|4|||
150270096|NCT02178553|542127373|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
150030338|NCT02587520|541247695|FG008|Overall Study|Protocol Violation|3|||
150030339|NCT02587520|541247696|FG009|Overall Study|Protocol Violation|3|||
150030340|NCT02587520|541247697|FG010|Overall Study|Protocol Violation|1|||
150030341|NCT02587520|541247698|FG011|Overall Study|Protocol Violation|2|||
150030342|NCT02587520|541247699|FG012|Overall Study|Protocol Violation|0|||
149935697|NCT00473083|540902138|FG002|Overall Study|Adverse Event|0|||
149935698|NCT02915835|540902139|FG000|Overall Study|Physician Decision|1|||
149935699|NCT02915835|540902140|FG001|Overall Study|Physician Decision|0|||
149935700|NCT02915835|540902139|FG000|Overall Study|Withdrawal by Subject|0|||
149935701|NCT02915835|540902140|FG001|Overall Study|Withdrawal by Subject|1|||
149935702|NCT01184872|540902141|FG000|Overall Study|Adverse Event|3|||
149935703|NCT01184872|540902142|FG001|Overall Study|Adverse Event|4|||
149935704|NCT01184872|540902141|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
149935705|NCT01184872|540902142|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149935706|NCT01184872|540902141|FG000|Overall Study|Withdrawal by Subject|2|||
149935707|NCT01184872|540902142|FG001|Overall Study|Withdrawal by Subject|0|||
149935708|NCT01184872|540902141|FG000|Overall Study|Lost to Follow-up|0|||
149935709|NCT01184872|540902142|FG001|Overall Study|Lost to Follow-up|1|||
149935710|NCT01184872|540902141|FG000|Overall Study|Administrative problems|1|||
149935711|NCT01184872|540902142|FG001|Overall Study|Administrative problems|1|||
149935712|NCT01184872|540902141|FG000|Overall Study|Protocol deviation|1|||
149935713|NCT01184872|540902142|FG001|Overall Study|Protocol deviation|0|||
149935714|NCT03426345|540902143|FG000|Overall Study|Adverse Event|4|||
149935715|NCT03426345|540902144|FG001|Overall Study|Adverse Event|4|||
149935716|NCT03426345|540902143|FG000|Overall Study|Lack of Efficacy|1|||
149935717|NCT03426345|540902144|FG001|Overall Study|Lack of Efficacy|0|||
149935718|NCT03426345|540902143|FG000|Overall Study|Withdrawal by Subject|5|||
149935719|NCT03426345|540902144|FG001|Overall Study|Withdrawal by Subject|6|||
149935720|NCT03426345|540902143|FG000|Overall Study|Lost to Follow-up|3|||
149935721|NCT03426345|540902144|FG001|Overall Study|Lost to Follow-up|1|||
149935722|NCT03426345|540902143|FG000|Overall Study|Protocol Deviation|3|||
149935723|NCT03426345|540902144|FG001|Overall Study|Protocol Deviation|4|||
149935724|NCT03426345|540902143|FG000|Overall Study|Reason Not Specified|1|||
149935725|NCT03426345|540902144|FG001|Overall Study|Reason Not Specified|2|||
149935726|NCT03426345|540902143|FG000|Overall Study|Missing Completion Status|1|||
149935727|NCT03426345|540902144|FG001|Overall Study|Missing Completion Status|0|||
149935728|NCT02446691|540902151|FG000|Overall Study|Withdrawal by Subject|2|||
149935729|NCT02446691|540902151|FG000|Overall Study|Lost to Follow-up|8|||
149935730|NCT02446691|540902151|FG000|Overall Study|Protocol Violation|1|||
149935731|NCT04210986|540902154|FG000|Overall Study|Lost to Follow-up|5|||
149935732|NCT04210986|540902155|FG001|Overall Study|Lost to Follow-up|2|||
149935733|NCT04210986|540902154|FG000|Overall Study|Withdrawal by Subject|3|||
149935734|NCT04210986|540902155|FG001|Overall Study|Withdrawal by Subject|1|||
149935735|NCT04210986|540902154|FG000|Overall Study|Protocol Violation|1|||
149935736|NCT04210986|540902155|FG001|Overall Study|Protocol Violation|1|||
149935737|NCT04210986|540902154|FG000|Overall Study|Physician Decision|0|||
149935738|NCT04210986|540902155|FG001|Overall Study|Physician Decision|1|||
149935739|NCT02984982|540902163|FG000|Overall Study|Adverse Event|2|||
149935740|NCT02984982|540902164|FG001|Overall Study|Adverse Event|5|||
149935741|NCT02984982|540902163|FG000|Overall Study|Poor Compliance to Protocol|4|||
149935742|NCT02984982|540902164|FG001|Overall Study|Poor Compliance to Protocol|4|||
149935743|NCT02984982|540902163|FG000|Overall Study|Withdrawal by Subject|2|||
149935744|NCT02984982|540902164|FG001|Overall Study|Withdrawal by Subject|0|||
149935745|NCT02984982|540902163|FG000|Overall Study|Randomized but not treated|0|||
149935746|NCT02984982|540902164|FG001|Overall Study|Randomized but not treated|1|||
149935747|NCT02153918|540902167|FG000|Overall Study|Refused further treatment|1|||
149935748|NCT02144701|540902168|FG000|Overall Study|development of relapse, GVHD or death|9|||
149935749|NCT02144701|540902169|FG001|Overall Study|development of relapse, GVHD or death|3|||
149935750|NCT02616783|540902170|FG000|Overall Study|Randomized but Not Treated|1|||
149935751|NCT02616783|540902171|FG001|Overall Study|Randomized but Not Treated|0|||
149935752|NCT02616783|540902170|FG000|Overall Study|Adverse Event|1|||
149935753|NCT02616783|540902171|FG001|Overall Study|Adverse Event|0|||
149935754|NCT02616783|540902170|FG000|Overall Study|Death|1|||
149935755|NCT02616783|540902171|FG001|Overall Study|Death|0|||
149935756|NCT02616783|540902170|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149935757|NCT02616783|540902171|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149935758|NCT02616783|540902170|FG000|Overall Study|Protocol Violation|1|||
150030343|NCT02587520|541247700|FG013|Overall Study|Protocol Violation|0|||
150030344|NCT02587520|541247701|FG014|Overall Study|Protocol Violation|0|||
150030345|NCT02587520|541247702|FG015|Overall Study|Protocol Violation|0|||
149935759|NCT02616783|540902171|FG001|Overall Study|Protocol Violation|1|||
150270097|NCT02178553|542127374|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
149935760|NCT02616783|540902170|FG000|Overall Study|Withdrew Consent|1|||
149935761|NCT02616783|540902171|FG001|Overall Study|Withdrew Consent|1|||
149935762|NCT03327324|540902172|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935763|NCT03327324|540902173|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
149935764|NCT03327324|540902174|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935765|NCT03327324|540902175|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
149935766|NCT03327324|540902176|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935767|NCT03327324|540902177|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
149935768|NCT03327324|540902172|FG000|Baseline (Month 0-Month 3)|Refused|0|||
149935769|NCT03327324|540902173|FG001|Baseline (Month 0-Month 3)|Refused|0|||
149935770|NCT03327324|540902174|FG002|Baseline (Month 0-Month 3)|Refused|0|||
149935771|NCT03327324|540902175|FG003|Baseline (Month 0-Month 3)|Refused|0|||
149935772|NCT03327324|540902176|FG004|Baseline (Month 0-Month 3)|Refused|1|||
149935773|NCT03327324|540902177|FG005|Baseline (Month 0-Month 3)|Refused|0|||
149935774|NCT03327324|540902172|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
149935775|NCT03327324|540902173|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
149935776|NCT03327324|540902174|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
149935777|NCT03327324|540902175|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
149935778|NCT03327324|540902176|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
149935779|NCT03327324|540902177|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
149935780|NCT03327324|540902172|FG000|Baseline (Month 0-Month 3)|Death|0|||
149935781|NCT03327324|540902173|FG001|Baseline (Month 0-Month 3)|Death|0|||
149935782|NCT03327324|540902174|FG002|Baseline (Month 0-Month 3)|Death|0|||
149935783|NCT03327324|540902175|FG003|Baseline (Month 0-Month 3)|Death|0|||
149935784|NCT03327324|540902176|FG004|Baseline (Month 0-Month 3)|Death|1|||
149935785|NCT03327324|540902177|FG005|Baseline (Month 0-Month 3)|Death|0|||
149935786|NCT03327324|540902172|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935787|NCT03327324|540902173|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935788|NCT03327324|540902174|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935789|NCT03327324|540902175|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935790|NCT03327324|540902176|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
150030346|NCT02587520|541247703|FG016|Overall Study|Protocol Violation|0|||
149935791|NCT03327324|540902177|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
149935792|NCT03327324|540902172|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935793|NCT03327324|540902173|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935794|NCT03327324|540902174|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
150030347|NCT02587520|541247704|FG017|Overall Study|Protocol Violation|0|||
150030348|NCT02587520|541247687|FG000|Overall Study|Adverse Event|0|||
150030349|NCT02587520|541247688|FG001|Overall Study|Adverse Event|0|||
150030350|NCT02587520|541247689|FG002|Overall Study|Adverse Event|0|||
150030351|NCT02587520|541247690|FG003|Overall Study|Adverse Event|0|||
150030352|NCT02587520|541247691|FG004|Overall Study|Adverse Event|0|||
149935795|NCT03327324|540902175|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935796|NCT03327324|540902176|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935797|NCT03327324|540902177|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935798|NCT03327324|540902172|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
149935799|NCT03327324|540902173|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
150030353|NCT02587520|541247692|FG005|Overall Study|Adverse Event|0|||
150030354|NCT02587520|541247693|FG006|Overall Study|Adverse Event|0|||
150030355|NCT02587520|541247694|FG007|Overall Study|Adverse Event|0|||
150030356|NCT02587520|541247695|FG008|Overall Study|Adverse Event|0|||
150030357|NCT02587520|541247696|FG009|Overall Study|Adverse Event|0|||
150030358|NCT02587520|541247697|FG010|Overall Study|Adverse Event|0|||
150030359|NCT02587520|541247698|FG011|Overall Study|Adverse Event|1|||
150030360|NCT02587520|541247699|FG012|Overall Study|Adverse Event|0|||
150030361|NCT02587520|541247700|FG013|Overall Study|Adverse Event|0|||
150030362|NCT02587520|541247701|FG014|Overall Study|Adverse Event|0|||
150030363|NCT02587520|541247702|FG015|Overall Study|Adverse Event|0|||
150030364|NCT02587520|541247703|FG016|Overall Study|Adverse Event|0|||
150030365|NCT02587520|541247704|FG017|Overall Study|Adverse Event|0|||
150270098|NCT02178553|542127373|FG000|Overall Study|Physician Decision|0|||
150270099|NCT02178553|542127374|FG001|Overall Study|Physician Decision|4|||
150270100|NCT02178553|542127373|FG000|Overall Study|Technical problem with injection|1|||
150030366|NCT02587520|541247687|FG000|Overall Study|Withdrawal by Subject|0|||
149935800|NCT03327324|540902174|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
149935801|NCT03327324|540902175|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
149935802|NCT03327324|540902176|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
149935803|NCT03327324|540902177|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
149935804|NCT03327324|540902172|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
149935805|NCT03327324|540902173|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
149935806|NCT03327324|540902174|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
149935807|NCT03327324|540902175|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
149935808|NCT03327324|540902176|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
149935809|NCT03327324|540902177|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
149935810|NCT03327324|540902172|FG000|Intervention (Month 3-Month 6)|Death|1|||
149935811|NCT03327324|540902173|FG001|Intervention (Month 3-Month 6)|Death|0|||
149935812|NCT03327324|540902174|FG002|Intervention (Month 3-Month 6)|Death|1|||
149935813|NCT03327324|540902175|FG003|Intervention (Month 3-Month 6)|Death|1|||
149935814|NCT03327324|540902176|FG004|Intervention (Month 3-Month 6)|Death|1|||
149935815|NCT03327324|540902177|FG005|Intervention (Month 3-Month 6)|Death|0|||
149935816|NCT03327324|540902172|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935817|NCT03327324|540902173|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935818|NCT03327324|540902174|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935819|NCT03327324|540902175|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935820|NCT03327324|540902176|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935821|NCT03327324|540902177|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
149935822|NCT03327324|540902172|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
149935823|NCT03327324|540902173|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935824|NCT03327324|540902174|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935825|NCT03327324|540902175|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935826|NCT03327324|540902176|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935827|NCT03327324|540902177|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
149935828|NCT03327324|540902172|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
149935829|NCT03327324|540902173|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
149935830|NCT03327324|540902174|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
149935831|NCT03327324|540902175|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
149935832|NCT03327324|540902176|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
149935833|NCT03327324|540902177|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
149935834|NCT03327324|540902172|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
149935835|NCT03327324|540902173|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
149935836|NCT03327324|540902174|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
149935837|NCT03327324|540902175|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
149935838|NCT03327324|540902176|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
149935839|NCT03327324|540902177|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
149935840|NCT03327324|540902172|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935841|NCT03327324|540902173|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935842|NCT03327324|540902174|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935843|NCT03327324|540902175|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
149935844|NCT03327324|540902176|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
149935845|NCT03327324|540902177|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
149935846|NCT03327324|540902172|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
149935847|NCT03327324|540902173|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
149935848|NCT03327324|540902174|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
149935849|NCT03327324|540902175|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
149935850|NCT03327324|540902176|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
149935851|NCT03327324|540902177|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
149935852|NCT03327324|540902172|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
149935853|NCT03327324|540902173|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
149935854|NCT03327324|540902174|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
149935855|NCT03327324|540902175|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
150030367|NCT02587520|541247688|FG001|Overall Study|Withdrawal by Subject|0|||
150030368|NCT02587520|541247689|FG002|Overall Study|Withdrawal by Subject|1|||
150030369|NCT02587520|541247690|FG003|Overall Study|Withdrawal by Subject|1|||
150030370|NCT02587520|541247691|FG004|Overall Study|Withdrawal by Subject|0|||
150030371|NCT02587520|541247692|FG005|Overall Study|Withdrawal by Subject|1|||
150030372|NCT02587520|541247693|FG006|Overall Study|Withdrawal by Subject|1|||
150030373|NCT02587520|541247694|FG007|Overall Study|Withdrawal by Subject|0|||
150030374|NCT02587520|541247695|FG008|Overall Study|Withdrawal by Subject|0|||
150030375|NCT02587520|541247696|FG009|Overall Study|Withdrawal by Subject|0|||
150030376|NCT02587520|541247697|FG010|Overall Study|Withdrawal by Subject|0|||
150030377|NCT02587520|541247698|FG011|Overall Study|Withdrawal by Subject|0|||
149935856|NCT03327324|540902176|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
149935857|NCT03327324|540902177|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
149935858|NCT01103323|540902178|FG000|Without/Before Drug Switch|Adverse Event|50|||
149935859|NCT01103323|540902179|FG001|Without/Before Drug Switch|Adverse Event|7|||
149935860|NCT01103323|540902178|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
149935861|NCT01103323|540902179|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
149935862|NCT01103323|540902178|FG000|Without/Before Drug Switch|Protocol Violation|2|||
149935863|NCT01103323|540902179|FG001|Without/Before Drug Switch|Protocol Violation|0|||
149935864|NCT01103323|540902178|FG000|Without/Before Drug Switch|Physician Decision|2|||
149935865|NCT01103323|540902179|FG001|Without/Before Drug Switch|Physician Decision|0|||
149935866|NCT01103323|540902178|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
149935867|NCT01103323|540902179|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
149935868|NCT01103323|540902178|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
149935869|NCT01103323|540902179|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
149935870|NCT01103323|540902178|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
149935871|NCT01103323|540902179|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
149935872|NCT00372424|540902180|FG000|Overall Study|Adverse Event|2|||
149935873|NCT00372424|540902180|FG000|Overall Study|Withdrawal by Subject|1|||
149935874|NCT00372424|540902180|FG000|Overall Study|Death|1|||
149935875|NCT00372424|540902180|FG000|Overall Study|Objective Progression or Relapse|14|||
149935876|NCT00372424|540902180|FG000|Overall Study|Other|7|||
149935877|NCT00372424|540902180|FG000|Overall Study|Enrolled, Not Treated|1|||
149935878|NCT05214118|540902185|FG000|Overall Study|Lost to Follow-up|0|||
149935879|NCT05214118|540902186|FG001|Overall Study|Lost to Follow-up|2|||
149935880|NCT05214118|540902185|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
149935881|NCT05214118|540902186|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
149935882|NCT05214118|540902185|FG000|Overall Study|moved|1|||
149935883|NCT05214118|540902186|FG001|Overall Study|moved|0|||
149935884|NCT03797898|540902187|FG000|Overall Study|Lost to Follow-up|60|||
149935885|NCT03797898|540902188|FG001|Overall Study|Lost to Follow-up|69|||
149935886|NCT03797898|540902187|FG000|Overall Study|Withdrawal by Subject|9|||
149935887|NCT03797898|540902188|FG001|Overall Study|Withdrawal by Subject|7|||
149935888|NCT03797898|540902187|FG000|Overall Study|Became ineligible|5|||
149935889|NCT03797898|540902188|FG001|Overall Study|Became ineligible|2|||
149935890|NCT02314728|540902189|FG000|Overall Study|Protocol Violation|1|||
149935891|NCT02314728|540902190|FG001|Overall Study|Protocol Violation|0|||
149935892|NCT02314728|540902189|FG000|Overall Study|Lost to Follow-up|0|||
149935893|NCT02314728|540902190|FG001|Overall Study|Lost to Follow-up|1|||
149935894|NCT01614470|540902191|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
149935895|NCT01614470|540902192|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149935896|NCT01614470|540902193|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149935897|NCT01614470|540902191|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
149935898|NCT01614470|540902192|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
149935899|NCT01614470|540902193|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
149935900|NCT00069264|540902205|FG000|Overall Study|Adverse Event|3|||
149935901|NCT00069264|540902205|FG000|Overall Study|Progressive Disease|23|||
149935902|NCT00069264|540902205|FG000|Overall Study|Withdrawal by Subject|3|||
149935903|NCT00069264|540902205|FG000|Overall Study|Discon Therapy|3|||
149935904|NCT03177148|540902206|FG000|Overall Study|Lost to Follow-up|50|||
149935905|NCT03177148|540902207|FG001|Overall Study|Lost to Follow-up|1|||
149935906|NCT03177148|540902206|FG000|Overall Study|Death|1|||
149935907|NCT03177148|540902207|FG001|Overall Study|Death|0|||
149935908|NCT00846586|540902210|FG000|Overall Study|Adverse Event|20|||
149935909|NCT00846586|540902211|FG001|Overall Study|Adverse Event|10|||
149935910|NCT00846586|540902210|FG000|Overall Study|Subject withdrew consent|8|||
149935911|NCT00846586|540902211|FG001|Overall Study|Subject withdrew consent|10|||
149935912|NCT00846586|540902210|FG000|Overall Study|Administrative problems|5|||
149935913|NCT00846586|540902211|FG001|Overall Study|Administrative problems|4|||
149935914|NCT00846586|540902210|FG000|Overall Study|Death|2|||
149935915|NCT00846586|540902211|FG001|Overall Study|Death|0|||
149935916|NCT00846586|540902210|FG000|Overall Study|Protocol deviation|2|||
149935917|NCT00846586|540902211|FG001|Overall Study|Protocol deviation|6|||
149935918|NCT00846586|540902210|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149935919|NCT00846586|540902211|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149935920|NCT00846586|540902210|FG000|Overall Study|Lost to Follow-up|1|||
149935921|NCT00846586|540902211|FG001|Overall Study|Lost to Follow-up|4|||
149935922|NCT00846586|540902210|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149935923|NCT00846586|540902211|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149935924|NCT00875810|540902212|FG000|Overall Study|Withdrawal by Subject|1|||
149935925|NCT00875810|540902212|FG000|Overall Study|Physician Decision|3|||
149935926|NCT00875810|540902212|FG000|Overall Study|Lost to Follow-up|39|||
149935927|NCT00875810|540902212|FG000|Overall Study|Patient enroled but not implanted|2|||
149935928|NCT00875810|540902212|FG000|Overall Study|Device explanted|1|||
149935929|NCT00780975|540902213|FG000|Overall Study|Progressive disease|3|||
149935930|NCT00780975|540902213|FG000|Overall Study|Toxicity|5|||
149935931|NCT01061606|540902214|FG000|Overall Study|Adverse Event|1|||
149935932|NCT01061606|540902214|FG000|Overall Study|Death|1|||
149935933|NCT01061606|540902214|FG000|Overall Study|Disease Progression|4|||
149935934|NCT01061606|540902214|FG000|Overall Study|alternative therapy|2|||
149935935|NCT01204671|540902215|FG000|Overall Study|Adverse Event|4|||
149935936|NCT01204671|540902216|FG001|Overall Study|Adverse Event|3|||
149935937|NCT01204671|540902217|FG002|Overall Study|Adverse Event|3|||
149935938|NCT01204671|540902218|FG003|Overall Study|Adverse Event|3|||
149935939|NCT01204671|540902219|FG004|Overall Study|Adverse Event|1|||
149935940|NCT01204671|540902215|FG000|Overall Study|Withdrawal by Subject|2|||
149935941|NCT01204671|540902216|FG001|Overall Study|Withdrawal by Subject|3|||
149935942|NCT01204671|540902217|FG002|Overall Study|Withdrawal by Subject|4|||
149935943|NCT01204671|540902218|FG003|Overall Study|Withdrawal by Subject|5|||
149935944|NCT01204671|540902219|FG004|Overall Study|Withdrawal by Subject|3|||
149935945|NCT01204671|540902215|FG000|Overall Study|Lost to Follow-up|7|||
149935946|NCT01204671|540902216|FG001|Overall Study|Lost to Follow-up|8|||
149935947|NCT01204671|540902217|FG002|Overall Study|Lost to Follow-up|6|||
149935948|NCT01204671|540902218|FG003|Overall Study|Lost to Follow-up|4|||
149935949|NCT01204671|540902219|FG004|Overall Study|Lost to Follow-up|0|||
149935950|NCT01204671|540902215|FG000|Overall Study|Unknown Completion Status|1|||
149935951|NCT01204671|540902216|FG001|Overall Study|Unknown Completion Status|1|||
149935952|NCT01204671|540902217|FG002|Overall Study|Unknown Completion Status|0|||
149935953|NCT01204671|540902218|FG003|Overall Study|Unknown Completion Status|0|||
149935954|NCT01204671|540902219|FG004|Overall Study|Unknown Completion Status|0|||
149935955|NCT01204671|540902215|FG000|Overall Study|Physician Decision|0|||
149935956|NCT01204671|540902216|FG001|Overall Study|Physician Decision|0|||
149935957|NCT01204671|540902217|FG002|Overall Study|Physician Decision|0|||
149935958|NCT01204671|540902218|FG003|Overall Study|Physician Decision|1|||
149935959|NCT01204671|540902219|FG004|Overall Study|Physician Decision|0|||
149935960|NCT03106077|540902222|FG000|Overall Study|Screen Failure|94|||
149935961|NCT03106077|540902223|FG001|Overall Study|Screen Failure|0|||
149935962|NCT01274533|540902224|FG000|Overall Study|Withdrawal by Subject|1|||
149935963|NCT01274533|540902224|FG000|Overall Study|Non-compliance|1|||
149935964|NCT01274533|540902224|FG000|Overall Study|Disease progression|2|||
149935965|NCT03669588|540902225|FG000|Overall Study|Adverse Event|1|||
149935966|NCT03669588|540902226|FG001|Overall Study|Adverse Event|0|||
149935967|NCT03669588|540902225|FG000|Overall Study|Physician Decision|0|||
149935968|NCT03669588|540902226|FG001|Overall Study|Physician Decision|1|||
149935969|NCT03669588|540902225|FG000|Overall Study|Protocol Violation|1|||
149935970|NCT03669588|540902226|FG001|Overall Study|Protocol Violation|0|||
149935971|NCT03669588|540902225|FG000|Overall Study|Sponsor Decision|1|||
149935972|NCT03669588|540902226|FG001|Overall Study|Sponsor Decision|1|||
149935973|NCT03669588|540902225|FG000|Overall Study|Withdrawal by Subject|1|||
149935974|NCT03669588|540902226|FG001|Overall Study|Withdrawal by Subject|4|||
149935975|NCT03669588|540902225|FG000|Overall Study|Rescue Therapy Needed|0|||
150168425|NCT01549652|541751108|FG001|Overall Study|Titration Side Effects|0|||
150168426|NCT01549652|541751109|FG002|Overall Study|Titration Side Effects|6|||
150168427|NCT01549652|541751110|FG003|Overall Study|Titration Side Effects|3|||
150168428|NCT01549652|541751107|FG000|Overall Study|Withdrawal by Subject|0|||
150168429|NCT01549652|541751108|FG001|Overall Study|Withdrawal by Subject|0|||
150168430|NCT01549652|541751109|FG002|Overall Study|Withdrawal by Subject|5|||
150168431|NCT01549652|541751110|FG003|Overall Study|Withdrawal by Subject|3|||
150168432|NCT00559949|541751111|FG000|Overall Study|Progressive Disease during cycle 1|1|||
150030378|NCT02587520|541247699|FG012|Overall Study|Withdrawal by Subject|0|||
149935976|NCT03669588|540902226|FG001|Overall Study|Rescue Therapy Needed|1|||
149935977|NCT02008526|540902227|FG000|Overall Study|Death|0|||
149935978|NCT02008526|540902228|FG001|Overall Study|Death|2|||
149935979|NCT02008526|540902229|FG002|Overall Study|Death|1|||
149935980|NCT02008526|540902227|FG000|Overall Study|Withdrawal by Subject|3|||
149935981|NCT02008526|540902228|FG001|Overall Study|Withdrawal by Subject|3|||
149935982|NCT02008526|540902229|FG002|Overall Study|Withdrawal by Subject|2|||
149935983|NCT02008526|540902227|FG000|Overall Study|Lost to Follow-up|5|||
150030379|NCT02587520|541247700|FG013|Overall Study|Withdrawal by Subject|1|||
149935984|NCT02008526|540902228|FG001|Overall Study|Lost to Follow-up|9|||
149935985|NCT02008526|540902229|FG002|Overall Study|Lost to Follow-up|6|||
149935986|NCT00492726|540902230|FG000|Overall Study|Adverse Event|10|||
149935987|NCT00492726|540902231|FG001|Overall Study|Adverse Event|6|||
150030380|NCT02587520|541247701|FG014|Overall Study|Withdrawal by Subject|0|||
150030381|NCT02587520|541247702|FG015|Overall Study|Withdrawal by Subject|0|||
150030382|NCT02587520|541247703|FG016|Overall Study|Withdrawal by Subject|0|||
150030383|NCT02587520|541247704|FG017|Overall Study|Withdrawal by Subject|0|||
150030384|NCT02587520|541247687|FG000|Overall Study|Lost to Follow-up|0|||
150030385|NCT02587520|541247688|FG001|Overall Study|Lost to Follow-up|2|||
150030386|NCT02587520|541247689|FG002|Overall Study|Lost to Follow-up|0|||
150030387|NCT02587520|541247690|FG003|Overall Study|Lost to Follow-up|2|||
150030388|NCT02587520|541247691|FG004|Overall Study|Lost to Follow-up|0|||
150030389|NCT02587520|541247692|FG005|Overall Study|Lost to Follow-up|1|||
150030390|NCT02587520|541247693|FG006|Overall Study|Lost to Follow-up|1|||
150030391|NCT02587520|541247694|FG007|Overall Study|Lost to Follow-up|1|||
150030392|NCT02587520|541247695|FG008|Overall Study|Lost to Follow-up|0|||
150030393|NCT02587520|541247696|FG009|Overall Study|Lost to Follow-up|2|||
150030394|NCT02587520|541247697|FG010|Overall Study|Lost to Follow-up|2|||
150030395|NCT02587520|541247698|FG011|Overall Study|Lost to Follow-up|1|||
150030396|NCT02587520|541247699|FG012|Overall Study|Lost to Follow-up|0|||
150030397|NCT02587520|541247700|FG013|Overall Study|Lost to Follow-up|0|||
150030398|NCT02587520|541247701|FG014|Overall Study|Lost to Follow-up|0|||
150030399|NCT02587520|541247702|FG015|Overall Study|Lost to Follow-up|0|||
150030400|NCT02587520|541247703|FG016|Overall Study|Lost to Follow-up|0|||
150030401|NCT02587520|541247704|FG017|Overall Study|Lost to Follow-up|0|||
150030402|NCT00672555|541247705|FG000|Overall Study|Lost to Follow-up|4|||
150030403|NCT00672555|541247705|FG000|Overall Study|Did not want to answer questionnaire|2|||
150030404|NCT02153086|541247711|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
150030405|NCT02153086|541247711|FG000|Overall Study|Other|2|||
150030406|NCT00446849|541247712|FG000|Acute Phase|Lack of Efficacy|64|||
150030407|NCT00446849|541247712|FG000|Acute Phase|Protocol Violation|10|||
150030408|NCT00446849|541247712|FG000|Acute Phase|Consent withdrawn|4|||
150030409|NCT00446849|541247712|FG000|Acute Phase|Lost to Follow-up|2|||
150030410|NCT00446849|541247712|FG000|Acute Phase|Physician Decision|1|||
150030411|NCT00446849|541247712|FG000|Acute Phase|noncompliance|1|||
150030412|NCT00446849|541247712|FG000|Maintenance Phase|Lack of Efficacy|40|||
150030413|NCT00446849|541247712|FG000|Maintenance Phase|Protocol Violation|7|||
150030414|NCT00446849|541247712|FG000|Maintenance Phase|Adverse Event|6|||
150030415|NCT00446849|541247712|FG000|Maintenance Phase|Consent withdrawn|5|||
150030416|NCT00446849|541247712|FG000|Maintenance Phase|Lost to Follow-up|3|||
150030417|NCT00446849|541247712|FG000|Maintenance Phase|Pregnancy|1|||
150030418|NCT00446849|541247712|FG000|Maintenance Phase|noncompliance|2|||
150030419|NCT00446849|541247712|FG000|Maintenance Phase|prohibited medication use|2|||
150030420|NCT00446849|541247712|FG000|Maintenance Phase|antibiotic use|1|||
150030421|NCT00446849|541247712|FG000|Maintenance Phase|study closure|1|||
150030422|NCT00446849|541247712|FG000|Maintenance Phase|hydrocodone use|1|||
150030423|NCT00446849|541247712|FG000|Maintenance Phase|concomitant medication use|1|||
150030424|NCT03115359|541247713|FG000|Overall Study|Withdrawal by Subject|29|||
150030425|NCT03115359|541247714|FG001|Overall Study|Withdrawal by Subject|39|||
150030426|NCT03115359|541247713|FG000|Overall Study|Scheduling conflict|25|||
150030427|NCT03115359|541247714|FG001|Overall Study|Scheduling conflict|23|||
150030428|NCT03115359|541247713|FG000|Overall Study|Personal reasons including health|12|||
150030429|NCT03115359|541247714|FG001|Overall Study|Personal reasons including health|9|||
150030430|NCT03115359|541247713|FG000|Overall Study|Transportation barriers|3|||
150030431|NCT03115359|541247714|FG001|Overall Study|Transportation barriers|0|||
150030432|NCT03115359|541247713|FG000|Overall Study|No longer interested|5|||
150030433|NCT03115359|541247714|FG001|Overall Study|No longer interested|4|||
150030434|NCT03115359|541247713|FG000|Overall Study|No reason provided|45|||
150030435|NCT03115359|541247714|FG001|Overall Study|No reason provided|47|||
150030436|NCT01815918|541247715|FG000|Overall Study|Patient samples not analyzable|3|||
150030437|NCT01815918|541247716|FG001|Overall Study|Patient samples not analyzable|4|||
150270101|NCT02178553|542127374|FG001|Overall Study|Technical problem with injection|3|||
150270102|NCT05085665|542127375|FG000|Overall Study|Physician Decision|2|||
150270103|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
150270104|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
150270105|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
150270106|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
150270107|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
150270108|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
150270109|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
150270110|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
150270111|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
150270112|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
150270113|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
150030438|NCT01815918|541247715|FG000|Overall Study|Lack of Efficacy|15|||
150030439|NCT01815918|541247716|FG001|Overall Study|Lack of Efficacy|15|||
150030440|NCT02412306|541247720|FG000|Overall Study|Lost to Follow-up|0|||
150030441|NCT02412306|541247721|FG001|Overall Study|Lost to Follow-up|1|||
150030442|NCT02412306|541247722|FG002|Overall Study|Lost to Follow-up|0|||
149935988|NCT00492726|540902230|FG000|Overall Study|Death|7|||
149935989|NCT00492726|540902231|FG001|Overall Study|Death|2|||
149935990|NCT00492726|540902230|FG000|Overall Study|Lack of Efficacy|0|||
149935991|NCT00492726|540902231|FG001|Overall Study|Lack of Efficacy|2|||
149935992|NCT00492726|540902230|FG000|Overall Study|Lost to Follow-up|27|||
149935993|NCT00492726|540902231|FG001|Overall Study|Lost to Follow-up|19|||
149935994|NCT00492726|540902230|FG000|Overall Study|Physician Decision|0|||
149935995|NCT00492726|540902231|FG001|Overall Study|Physician Decision|1|||
149935996|NCT00492726|540902230|FG000|Overall Study|Withdrawal by Subject|6|||
150168433|NCT00559949|541751111|FG000|Overall Study|Adverse Event|1|||
150168434|NCT00559949|541751111|FG000|Overall Study|Withdrawal by Subject|4|||
150168435|NCT00559949|541751111|FG000|Overall Study|No disease evaluation per protocol|1|||
150168436|NCT00835380|541751121|FG000|Overall Study|Withdrawal by Subject|2|||
150168437|NCT03247543|541751122|FG000|Overall Study|Adverse Event|3|||
150168438|NCT03247543|541751123|FG001|Overall Study|Adverse Event|6|||
150168439|NCT03247543|541751124|FG002|Overall Study|Adverse Event|4|||
150168440|NCT03247543|541751122|FG000|Overall Study|Lost to Follow-up|10|||
150168441|NCT03247543|541751123|FG001|Overall Study|Lost to Follow-up|7|||
150168442|NCT03247543|541751124|FG002|Overall Study|Lost to Follow-up|8|||
150168443|NCT03247543|541751122|FG000|Overall Study|Consent withdrawn by caregiver|2|||
150168444|NCT03247543|541751123|FG001|Overall Study|Consent withdrawn by caregiver|2|||
150168445|NCT03247543|541751124|FG002|Overall Study|Consent withdrawn by caregiver|9|||
150168446|NCT03247543|541751122|FG000|Overall Study|Withdrawal by Subject|0|||
150168447|NCT03247543|541751123|FG001|Overall Study|Withdrawal by Subject|0|||
150168448|NCT03247543|541751124|FG002|Overall Study|Withdrawal by Subject|1|||
150168449|NCT03247543|541751122|FG000|Overall Study|Failure to Follow study procedures|1|||
150168450|NCT03247543|541751123|FG001|Overall Study|Failure to Follow study procedures|3|||
150168451|NCT03247543|541751124|FG002|Overall Study|Failure to Follow study procedures|1|||
150168452|NCT03247543|541751122|FG000|Overall Study|Lack of Efficacy|1|||
150168453|NCT03247543|541751123|FG001|Overall Study|Lack of Efficacy|0|||
150168454|NCT03247543|541751124|FG002|Overall Study|Lack of Efficacy|0|||
150168455|NCT03247543|541751122|FG000|Overall Study|Non-compliance with study visits|0|||
150168456|NCT03247543|541751123|FG001|Overall Study|Non-compliance with study visits|1|||
150168457|NCT03247543|541751124|FG002|Overall Study|Non-compliance with study visits|0|||
150168458|NCT02059980|541751128|FG000|Overall Study|Lost to Follow-up|2|||
150168459|NCT02059980|541751129|FG001|Overall Study|Lost to Follow-up|1|||
150168460|NCT01104415|541751130|FG000|Core Phase|Consent withdrawn by subjects|1|||
150168461|NCT01104415|541751131|FG001|Core Phase|Consent withdrawn by subjects|0|||
150168462|NCT01104415|541751130|FG000|Extension Period|Progressive disease|0|||
150168463|NCT01104415|541751131|FG001|Extension Period|Progressive disease|4|||
150168464|NCT01104415|541751130|FG000|Extension Period|Death|0|||
150168465|NCT01104415|541751131|FG001|Extension Period|Death|1|||
150168466|NCT01104415|541751130|FG000|Extension Period|Physician Decision|0|||
150168467|NCT01104415|541751131|FG001|Extension Period|Physician Decision|1|||
150168468|NCT01104415|541751130|FG000|Extension Period|Transition to Study LX1606.302|0|||
150168469|NCT01104415|541751131|FG001|Extension Period|Transition to Study LX1606.302|4|||
150168470|NCT01104415|541751130|FG000|Extension Period|Heart surgery/feeling miserable|0|||
150168471|NCT01104415|541751131|FG001|Extension Period|Heart surgery/feeling miserable|1|||
150168472|NCT01582945|541751133|FG000|Overall Study|Intolerable side-effects|1|||
150168473|NCT01582945|541751133|FG000|Overall Study|Scheduling conflicts|1|||
150168474|NCT01726023|541751134|FG000|Overall Study|Death|1|||
150168475|NCT01726023|541751135|FG001|Overall Study|Death|1|||
150168476|NCT01726023|541751134|FG000|Overall Study|Lost to Follow-up|5|||
150168477|NCT01726023|541751135|FG001|Overall Study|Lost to Follow-up|10|||
150168478|NCT01726023|541751134|FG000|Overall Study|Other Eligibility criteria|7|||
150168479|NCT01726023|541751135|FG001|Overall Study|Other Eligibility criteria|7|||
150168480|NCT01726023|541751134|FG000|Overall Study|Withdrawal by Subject|16|||
150168481|NCT01726023|541751135|FG001|Overall Study|Withdrawal by Subject|8|||
150168482|NCT04858425|541751136|FG000|Overall Study|Adverse Event|2|||
150168483|NCT04858425|541751137|FG001|Overall Study|Adverse Event|2|||
150168484|NCT04858425|541751136|FG000|Overall Study|Withdrawal by Subject|3|||
150168485|NCT04858425|541751137|FG001|Overall Study|Withdrawal by Subject|1|||
150168486|NCT04858425|541751136|FG000|Overall Study|Lost to Follow-up|4|||
150168487|NCT04858425|541751137|FG001|Overall Study|Lost to Follow-up|2|||
150168488|NCT04858425|541751136|FG000|Overall Study|Lost to Follow-up|1|||
150168489|NCT04858425|541751137|FG001|Overall Study|Lost to Follow-up|0|||
150168490|NCT02824432|541751139|FG000|Overall Study|Major Protocol Deviation|1|||
150168491|NCT02824432|541751140|FG001|Overall Study|Major Protocol Deviation|0|||
150168492|NCT05196737|541751142|FG000|Non-intervention Week|Lost to Follow-up|2|||
150168493|NCT05196737|541751142|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
150168494|NCT05824351|541751143|FG000|Overall Study|Adverse Event|6|||
150168495|NCT00828945|541751144|FG000|Overall Study|Death|4|||
149935997|NCT00492726|540902231|FG001|Overall Study|Withdrawal by Subject|3|||
150168496|NCT00828945|541751144|FG000|Overall Study|Participant was missing|1|||
150168497|NCT00828945|541751144|FG000|Overall Study|Other|36|||
150168498|NCT02698241|541751147|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
150168499|NCT02698241|541751147|FG000|Overall Study|Screening not met|7|||
150030443|NCT02412306|541247723|FG003|Overall Study|Lost to Follow-up|0|||
150030444|NCT02412306|541247724|FG004|Overall Study|Lost to Follow-up|0|||
150030445|NCT02412306|541247720|FG000|Overall Study|Withdrawal by Subject|0|||
150030446|NCT02412306|541247721|FG001|Overall Study|Withdrawal by Subject|0|||
150030447|NCT02412306|541247722|FG002|Overall Study|Withdrawal by Subject|1|||
150030448|NCT02412306|541247723|FG003|Overall Study|Withdrawal by Subject|0|||
150030449|NCT02412306|541247724|FG004|Overall Study|Withdrawal by Subject|0|||
150030450|NCT02412306|541247720|FG000|Overall Study|Death|5|||
150030451|NCT02412306|541247721|FG001|Overall Study|Death|7|||
150030452|NCT02412306|541247722|FG002|Overall Study|Death|15|||
150030453|NCT02412306|541247723|FG003|Overall Study|Death|0|||
150030454|NCT02412306|541247724|FG004|Overall Study|Death|2|||
150030455|NCT03661723|541247731|FG000|Overall Study|Disease Progression|4|||
150030456|NCT03661723|541247732|FG001|Overall Study|Disease Progression|24|||
150030457|NCT03661723|541247733|FG002|Overall Study|Disease Progression|4|||
150030458|NCT03661723|541247734|FG003|Overall Study|Disease Progression|19|||
150030459|NCT03661723|541247731|FG000|Overall Study|Withdrawal by Subject|1|||
150030460|NCT03661723|541247732|FG001|Overall Study|Withdrawal by Subject|0|||
150030461|NCT03661723|541247733|FG002|Overall Study|Withdrawal by Subject|2|||
150030462|NCT03661723|541247734|FG003|Overall Study|Withdrawal by Subject|4|||
150030463|NCT03661723|541247731|FG000|Overall Study|Physician Decision|1|||
150030464|NCT03661723|541247732|FG001|Overall Study|Physician Decision|0|||
150030465|NCT03661723|541247733|FG002|Overall Study|Physician Decision|0|||
150168500|NCT02698241|541751147|FG000|Overall Study|Withdrawal by Subject|7|||
150168501|NCT02698241|541751147|FG000|Overall Study|Physician Decision|2|||
150168502|NCT02698241|541751147|FG000|Overall Study|Subject underwent system modification|2|||
150168503|NCT02698241|541751147|FG000|Overall Study|Lost to Follow-up|3|||
150168504|NCT02698241|541751147|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
150168505|NCT02698241|541751147|FG000|Overall Study|geographic and licensing issue|1|||
150168506|NCT02698241|541751147|FG000|Overall Study|Death|2|||
150168507|NCT03722446|541751148|FG000|Overall Study|Protocol Violation|15|||
150168508|NCT03722446|541751149|FG001|Overall Study|Protocol Violation|2|||
150168509|NCT01875250|541752476|FG000|Overall Study|Adverse Event|2|||
150168510|NCT01875250|541752477|FG001|Overall Study|Adverse Event|0|||
150168511|NCT03140176|541752483|FG000|Overall Study|Reason missing|23|||
150168512|NCT03140176|541752483|FG000|Overall Study|Death|33|||
150030466|NCT03661723|541247734|FG003|Overall Study|Physician Decision|0|||
150168513|NCT03140176|541752483|FG000|Overall Study|Disease progression|1|||
150030467|NCT03661723|541247731|FG000|Overall Study|Clinical Deterioration|0|||
150030468|NCT03661723|541247732|FG001|Overall Study|Clinical Deterioration|0|||
150030469|NCT03661723|541247733|FG002|Overall Study|Clinical Deterioration|0|||
150030470|NCT03661723|541247734|FG003|Overall Study|Clinical Deterioration|1|||
150030471|NCT04750824|541247737|FG000|Overall Study|Toxicity/intolerability|3|||
150030472|NCT04750824|541247738|FG001|Overall Study|Toxicity/intolerability|1|||
150030473|NCT04750824|541247737|FG000|Overall Study|Death|1|||
150030474|NCT04750824|541247738|FG001|Overall Study|Death|3|||
150168514|NCT03140176|541752483|FG000|Overall Study|Physician Decision|1|||
150168515|NCT03140176|541752483|FG000|Overall Study|Withdrawal by Subject|1|||
150168516|NCT03140176|541752483|FG000|Overall Study|Lost to Follow-up|15|||
150168517|NCT01090024|541752490|FG000|Period 1|Met exclusion criteria|0|||
150168518|NCT01090024|541752491|FG001|Period 1|Met exclusion criteria|0|||
150168519|NCT01090024|541752492|FG002|Period 1|Met exclusion criteria|0|||
150168520|NCT01090024|541752493|FG003|Period 1|Met exclusion criteria|0|||
150168521|NCT01090024|541752494|FG004|Period 1|Met exclusion criteria|0|||
150168522|NCT01090024|541752495|FG005|Period 1|Met exclusion criteria|0|||
150168523|NCT01090024|541752496|FG006|Period 1|Met exclusion criteria|0|||
150168524|NCT01090024|541752497|FG007|Period 1|Met exclusion criteria|0|||
150168525|NCT01090024|541752498|FG008|Period 1|Met exclusion criteria|0|||
150168526|NCT01090024|541752499|FG009|Period 1|Met exclusion criteria|0|||
150168527|NCT01090024|541752500|FG010|Period 1|Met exclusion criteria|0|||
150168528|NCT01090024|541752501|FG011|Period 1|Met exclusion criteria|0|||
150168529|NCT01090024|541752502|FG012|Period 1|Met exclusion criteria|0|||
150168530|NCT01090024|541752503|FG013|Period 1|Met exclusion criteria|0|||
150168531|NCT01090024|541752504|FG014|Period 1|Met exclusion criteria|1|||
150168532|NCT01090024|541752505|FG015|Period 1|Met exclusion criteria|0|||
150168533|NCT01090024|541752506|FG016|Period 1|Met exclusion criteria|0|||
150168534|NCT01090024|541752507|FG017|Period 1|Met exclusion criteria|0|||
150168535|NCT01090024|541752490|FG000|Period 1|Adverse Event|0|||
150168536|NCT01090024|541752491|FG001|Period 1|Adverse Event|0|||
150168537|NCT01090024|541752492|FG002|Period 1|Adverse Event|0|||
150168538|NCT01090024|541752493|FG003|Period 1|Adverse Event|0|||
150168539|NCT01090024|541752494|FG004|Period 1|Adverse Event|0|||
150168540|NCT01090024|541752495|FG005|Period 1|Adverse Event|0|||
150168541|NCT01090024|541752496|FG006|Period 1|Adverse Event|0|||
150168542|NCT01090024|541752497|FG007|Period 1|Adverse Event|0|||
150168543|NCT01090024|541752498|FG008|Period 1|Adverse Event|0|||
150168544|NCT01090024|541752499|FG009|Period 1|Adverse Event|1|||
150168545|NCT01090024|541752500|FG010|Period 1|Adverse Event|0|||
150168546|NCT01090024|541752501|FG011|Period 1|Adverse Event|1|||
150168547|NCT01090024|541752502|FG012|Period 1|Adverse Event|0|||
150030475|NCT04750824|541247737|FG000|Overall Study|Scheduled duration of therapy complete|1|||
150030476|NCT04750824|541247738|FG001|Overall Study|Scheduled duration of therapy complete|9|||
150030477|NCT04750824|541247737|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
150030478|NCT04750824|541247738|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
150030479|NCT00807911|541247739|FG000|Overall Study|Withdrawal by Subject|12|||
150030480|NCT00807911|541247740|FG001|Overall Study|Withdrawal by Subject|10|||
150030481|NCT00807911|541247739|FG000|Overall Study|Ineligible|0|||
150030482|NCT00807911|541247740|FG001|Overall Study|Ineligible|4|||
150030483|NCT03532542|541247745|FG000|Overall Study|Death|1|||
150030484|NCT03532542|541247746|FG001|Overall Study|Death|0|||
150030485|NCT03532542|541247745|FG000|Overall Study|Study Terminated by Sponsor|41|||
150030486|NCT03532542|541247746|FG001|Overall Study|Study Terminated by Sponsor|65|||
150030487|NCT03532542|541247745|FG000|Overall Study|Withdrawal by Subject|6|||
150030488|NCT03532542|541247746|FG001|Overall Study|Withdrawal by Subject|5|||
150030489|NCT00836589|541247747|FG000|Overall Study|Lost to Follow-up|246|||
150030490|NCT00836589|541247747|FG000|Overall Study|Death|429|||
150030491|NCT00836589|541247747|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
150030492|NCT02914639|541247750|FG000|Overall Study|Withdrawal by Subject|0|||
150030493|NCT02914639|541247751|FG001|Overall Study|Withdrawal by Subject|2|||
150030494|NCT01018030|541247752|FG000|Overall Study|Adverse Event|10|||
150030495|NCT01018030|541247753|FG001|Overall Study|Adverse Event|5|||
150030496|NCT01018030|541247754|FG002|Overall Study|Adverse Event|5|||
150030497|NCT01018030|541247752|FG000|Overall Study|Withdrawal by Subject|2|||
150030498|NCT01018030|541247753|FG001|Overall Study|Withdrawal by Subject|2|||
150030499|NCT01018030|541247754|FG002|Overall Study|Withdrawal by Subject|4|||
150030500|NCT01018030|541247752|FG000|Overall Study|Lost to Follow-up|2|||
150030501|NCT01018030|541247753|FG001|Overall Study|Lost to Follow-up|0|||
150030502|NCT01018030|541247754|FG002|Overall Study|Lost to Follow-up|3|||
150030503|NCT01018030|541247752|FG000|Overall Study|Protocol Violation|2|||
150030504|NCT01018030|541247753|FG001|Overall Study|Protocol Violation|1|||
150030505|NCT01018030|541247754|FG002|Overall Study|Protocol Violation|0|||
150030506|NCT01018030|541247752|FG000|Overall Study|Physician Decision|1|||
150030507|NCT01018030|541247753|FG001|Overall Study|Physician Decision|0|||
150030508|NCT01018030|541247754|FG002|Overall Study|Physician Decision|1|||
150030509|NCT01018030|541247752|FG000|Overall Study|Lack of Efficacy|1|||
150030510|NCT01018030|541247753|FG001|Overall Study|Lack of Efficacy|0|||
150030511|NCT01018030|541247754|FG002|Overall Study|Lack of Efficacy|0|||
150030512|NCT01018030|541247752|FG000|Overall Study|Did Not Receive Study Drug|1|||
150030513|NCT01018030|541247753|FG001|Overall Study|Did Not Receive Study Drug|3|||
150030514|NCT01018030|541247754|FG002|Overall Study|Did Not Receive Study Drug|0|||
150030515|NCT00436332|541247755|FG000|Overall Study|Adverse Event|9|||
150030516|NCT00436332|541247755|FG000|Overall Study|Withdrawal by Subject|2|||
150030517|NCT00436332|541247755|FG000|Overall Study|Progression|59|||
150030518|NCT00436332|541247755|FG000|Overall Study|Death|2|||
150030519|NCT00436332|541247755|FG000|Overall Study|Not Protocol Specified|6|||
150030520|NCT00436332|541247755|FG000|Overall Study|Ineligible|2|||
150030521|NCT00436332|541247755|FG000|Overall Study|Never Received Treatment|3|||
150030522|NCT01924845|541247756|FG000|Overall Study|Adverse Event|3|||
150030523|NCT01924845|541247756|FG000|Overall Study|Withdrawal by Subject|2|||
150030524|NCT01924845|541247756|FG000|Overall Study|Protocol Violation|1|||
150030525|NCT00062439|541247757|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
150030526|NCT00062439|541247757|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
150030527|NCT00062439|541247757|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
149820293|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
150030528|NCT00062439|541247757|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
150030529|NCT00062439|541247757|FG000|Post Chemoradiation Assessment|Death|1|||
150030530|NCT00062439|541247757|FG000|Post Chemoradiation Assessment|Disease progression|2|||
150168548|NCT01090024|541752503|FG013|Period 1|Adverse Event|0|||
150168549|NCT01090024|541752504|FG014|Period 1|Adverse Event|0|||
150168550|NCT01090024|541752505|FG015|Period 1|Adverse Event|0|||
150168551|NCT01090024|541752506|FG016|Period 1|Adverse Event|0|||
150168552|NCT01090024|541752507|FG017|Period 1|Adverse Event|1|||
150168553|NCT01090024|541752490|FG000|Period 1|Withdrawal by Subject|0|||
150168554|NCT01090024|541752491|FG001|Period 1|Withdrawal by Subject|0|||
150168555|NCT01090024|541752492|FG002|Period 1|Withdrawal by Subject|0|||
150168556|NCT01090024|541752493|FG003|Period 1|Withdrawal by Subject|1|||
150168557|NCT01090024|541752494|FG004|Period 1|Withdrawal by Subject|0|||
150168558|NCT01090024|541752495|FG005|Period 1|Withdrawal by Subject|0|||
150168559|NCT01090024|541752496|FG006|Period 1|Withdrawal by Subject|0|||
150168560|NCT01090024|541752497|FG007|Period 1|Withdrawal by Subject|0|||
150168561|NCT01090024|541752498|FG008|Period 1|Withdrawal by Subject|0|||
150168562|NCT01090024|541752499|FG009|Period 1|Withdrawal by Subject|0|||
150168563|NCT01090024|541752500|FG010|Period 1|Withdrawal by Subject|0|||
150168564|NCT01090024|541752501|FG011|Period 1|Withdrawal by Subject|0|||
150168565|NCT01090024|541752502|FG012|Period 1|Withdrawal by Subject|0|||
150168566|NCT01090024|541752503|FG013|Period 1|Withdrawal by Subject|0|||
150168567|NCT01090024|541752504|FG014|Period 1|Withdrawal by Subject|0|||
150030531|NCT00062439|541247757|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
150030532|NCT00062439|541247757|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
150030533|NCT00062439|541247757|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
150030534|NCT00062439|541247757|FG000|Surgery|Physician Decision|4|||
150030535|NCT00062439|541247757|FG000|Surgery|Death|1|||
150030536|NCT00062439|541247757|FG000|Surgery|Adverse Event|2|||
150030537|NCT00062439|541247757|FG000|Consolidation Chemotherapy|Adverse Event|2|||
150030538|NCT00286442|541247758|FG000|Overall Study|Hyperglycemic Rescue|19|||
150030539|NCT00286442|541247759|FG001|Overall Study|Hyperglycemic Rescue|17|||
150030540|NCT00286442|541247760|FG002|Overall Study|Hyperglycemic Rescue|25|||
150030541|NCT00286442|541247758|FG000|Overall Study|Adverse Event|7|||
150030542|NCT00286442|541247759|FG001|Overall Study|Adverse Event|6|||
150030543|NCT00286442|541247760|FG002|Overall Study|Adverse Event|1|||
150030544|NCT00286442|541247758|FG000|Overall Study|Protocol Violation|2|||
150030545|NCT00286442|541247759|FG001|Overall Study|Protocol Violation|4|||
150030546|NCT00286442|541247760|FG002|Overall Study|Protocol Violation|2|||
150030547|NCT00286442|541247758|FG000|Overall Study|Lost to Follow-up|5|||
150030548|NCT00286442|541247759|FG001|Overall Study|Lost to Follow-up|2|||
150030549|NCT00286442|541247760|FG002|Overall Study|Lost to Follow-up|1|||
150030550|NCT00286442|541247758|FG000|Overall Study|Physician Decision|1|||
149935998|NCT00492726|540902230|FG000|Overall Study|Non compliant with study medication|0|||
150030551|NCT00286442|541247759|FG001|Overall Study|Physician Decision|1|||
150030552|NCT00286442|541247760|FG002|Overall Study|Physician Decision|1|||
150030553|NCT00286442|541247758|FG000|Overall Study|Administrative Error|1|||
150030554|NCT00286442|541247759|FG001|Overall Study|Administrative Error|1|||
150030555|NCT00286442|541247760|FG002|Overall Study|Administrative Error|0|||
150030556|NCT00286442|541247758|FG000|Overall Study|Withdrawal by Subject|2|||
150030557|NCT00286442|541247759|FG001|Overall Study|Withdrawal by Subject|14|||
150030558|NCT00286442|541247760|FG002|Overall Study|Withdrawal by Subject|2|||
150030559|NCT02140047|541247761|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150030560|NCT02140047|541247762|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150030561|NCT02140047|541247763|FG002|Overall Study|Withdrawal by parent/guardian|0|||
150030562|NCT02174731|541247764|FG000|Overall Study|Participant decision|67|||
150030563|NCT02174731|541247765|FG001|Overall Study|Participant decision|64|||
150030564|NCT02174731|541247764|FG000|Overall Study|Incorrect enrolment before randomization|0|||
150030565|NCT02174731|541247765|FG001|Overall Study|Incorrect enrolment before randomization|1|||
150030566|NCT02174731|541247764|FG000|Overall Study|Missing|2|||
150030567|NCT02174731|541247765|FG001|Overall Study|Missing|0|||
150030568|NCT00079040|541247766|FG000|Overall Study|Withdrew before treatment|1|||
150030569|NCT00079040|541247766|FG000|Overall Study|Ineligible|1|||
150030570|NCT00325897|541247767|FG000|Overall Study|Lost to Follow-up|12|||
150030571|NCT00325897|541247768|FG001|Overall Study|Lost to Follow-up|13|||
150030572|NCT04079296|541247769|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
150030573|NCT04079296|541247770|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
150030574|NCT04079296|541247771|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
150030575|NCT04079296|541247772|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
150030576|NCT04079296|541247773|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
150030577|NCT04079296|541247769|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
150030578|NCT04079296|541247770|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
150030579|NCT04079296|541247771|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
150030580|NCT04079296|541247772|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
150030581|NCT04079296|541247773|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
150030582|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
150030583|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
150030584|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
150030585|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
150030586|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
150030587|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
150030588|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
149935999|NCT00492726|540902231|FG001|Overall Study|Non compliant with study medication|3|||
149936000|NCT04386902|540902232|FG000|Overall Study|Withdrawal by Subject|5|||
149936001|NCT04386902|540902232|FG000|Overall Study|Technical problems in the recording|5|||
149936002|NCT01100502|540902233|FG000|Overall Study|Withdrawal by Subject|18|||
149936003|NCT01100502|540902234|FG001|Overall Study|Withdrawal by Subject|25|||
150030589|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
150030590|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
150030591|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
149936004|NCT01100502|540902233|FG000|Overall Study|Lost to Follow-up|13|||
149936005|NCT01100502|540902234|FG001|Overall Study|Lost to Follow-up|28|||
149936006|NCT01100502|540902233|FG000|Overall Study|Site request to end participation in study|0|||
150030592|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
150030593|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
150030594|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
149936007|NCT01100502|540902234|FG001|Overall Study|Site request to end participation in study|1|||
149936008|NCT01100502|540902233|FG000|Overall Study|Death|45|||
149936009|NCT01100502|540902234|FG001|Overall Study|Death|40|||
149936010|NCT00721799|540902235|FG000|Overall Study|Withdrawal by Subject|7|||
149936011|NCT00721799|540902235|FG000|Overall Study|withdraw by subject after scan 1|1|||
149936012|NCT02337764|540904491|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
149936013|NCT02337764|540904491|FG000|Overall Study|Voluntary Withdrawal|12|||
149936014|NCT02337764|540904491|FG000|Overall Study|Lack of Efficacy|2|||
149936015|NCT01926028|540904495|FG000|Overall Study|Lost to Follow-up|7|||
149936016|NCT01926028|540904496|FG001|Overall Study|Lost to Follow-up|6|||
150270114|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
150270115|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
150270116|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
150270117|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
150270118|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
150270119|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
150270120|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
150030595|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
150030596|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
149936017|NCT01926028|540904497|FG002|Overall Study|Lost to Follow-up|0|||
150168568|NCT01090024|541752505|FG015|Period 1|Withdrawal by Subject|0|||
150168569|NCT01090024|541752506|FG016|Period 1|Withdrawal by Subject|0|||
150168570|NCT01090024|541752507|FG017|Period 1|Withdrawal by Subject|0|||
150168571|NCT01090024|541752490|FG000|Period 1|Lost to Follow-up|0|||
150168572|NCT01090024|541752491|FG001|Period 1|Lost to Follow-up|1|||
150168573|NCT01090024|541752492|FG002|Period 1|Lost to Follow-up|0|||
150168574|NCT01090024|541752493|FG003|Period 1|Lost to Follow-up|0|||
150168575|NCT01090024|541752494|FG004|Period 1|Lost to Follow-up|0|||
150168576|NCT01090024|541752495|FG005|Period 1|Lost to Follow-up|0|||
150168577|NCT01090024|541752496|FG006|Period 1|Lost to Follow-up|0|||
150168578|NCT01090024|541752497|FG007|Period 1|Lost to Follow-up|0|||
150168579|NCT01090024|541752498|FG008|Period 1|Lost to Follow-up|0|||
150168580|NCT01090024|541752499|FG009|Period 1|Lost to Follow-up|0|||
150168581|NCT01090024|541752500|FG010|Period 1|Lost to Follow-up|0|||
150168582|NCT01090024|541752501|FG011|Period 1|Lost to Follow-up|0|||
150168583|NCT01090024|541752502|FG012|Period 1|Lost to Follow-up|0|||
150168584|NCT01090024|541752503|FG013|Period 1|Lost to Follow-up|0|||
150168585|NCT01090024|541752504|FG014|Period 1|Lost to Follow-up|0|||
150168586|NCT01090024|541752505|FG015|Period 1|Lost to Follow-up|0|||
150168587|NCT01090024|541752506|FG016|Period 1|Lost to Follow-up|0|||
150168588|NCT01090024|541752507|FG017|Period 1|Lost to Follow-up|0|||
150168589|NCT01090024|541752490|FG000|Period 2|Lost to Follow-up|0|||
150168590|NCT01090024|541752491|FG001|Period 2|Lost to Follow-up|0|||
150168591|NCT01090024|541752492|FG002|Period 2|Lost to Follow-up|0|||
150168592|NCT01090024|541752493|FG003|Period 2|Lost to Follow-up|1|||
150168593|NCT01090024|541752494|FG004|Period 2|Lost to Follow-up|0|||
150168594|NCT01090024|541752495|FG005|Period 2|Lost to Follow-up|0|||
150168595|NCT01090024|541752496|FG006|Period 2|Lost to Follow-up|0|||
150168596|NCT01090024|541752497|FG007|Period 2|Lost to Follow-up|0|||
150168597|NCT01090024|541752498|FG008|Period 2|Lost to Follow-up|0|||
150168598|NCT01090024|541752499|FG009|Period 2|Lost to Follow-up|0|||
150168599|NCT01090024|541752500|FG010|Period 2|Lost to Follow-up|0|||
150168600|NCT01090024|541752501|FG011|Period 2|Lost to Follow-up|0|||
150168601|NCT01090024|541752502|FG012|Period 2|Lost to Follow-up|0|||
150168602|NCT01090024|541752503|FG013|Period 2|Lost to Follow-up|0|||
150168603|NCT01090024|541752504|FG014|Period 2|Lost to Follow-up|0|||
150168604|NCT01090024|541752505|FG015|Period 2|Lost to Follow-up|0|||
150168605|NCT01090024|541752506|FG016|Period 2|Lost to Follow-up|0|||
150168606|NCT01090024|541752507|FG017|Period 2|Lost to Follow-up|0|||
150168607|NCT01090024|541752490|FG000|Period 2|Adverse Event|1|||
150168608|NCT01090024|541752491|FG001|Period 2|Adverse Event|0|||
150168609|NCT01090024|541752492|FG002|Period 2|Adverse Event|0|||
150168610|NCT01090024|541752493|FG003|Period 2|Adverse Event|0|||
150168611|NCT01090024|541752494|FG004|Period 2|Adverse Event|0|||
150030597|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
150168612|NCT01090024|541752495|FG005|Period 2|Adverse Event|0|||
149936018|NCT01926028|540904495|FG000|Overall Study|Physician Decision|1|||
149936019|NCT01926028|540904496|FG001|Overall Study|Physician Decision|5|||
149936020|NCT01926028|540904497|FG002|Overall Study|Physician Decision|0|||
150168613|NCT01090024|541752496|FG006|Period 2|Adverse Event|0|||
150168614|NCT01090024|541752497|FG007|Period 2|Adverse Event|0|||
150168615|NCT01090024|541752498|FG008|Period 2|Adverse Event|0|||
150168616|NCT01090024|541752499|FG009|Period 2|Adverse Event|0|||
150168617|NCT01090024|541752500|FG010|Period 2|Adverse Event|0|||
150168618|NCT01090024|541752501|FG011|Period 2|Adverse Event|0|||
150168619|NCT01090024|541752502|FG012|Period 2|Adverse Event|0|||
150168620|NCT01090024|541752503|FG013|Period 2|Adverse Event|0|||
150168621|NCT01090024|541752504|FG014|Period 2|Adverse Event|0|||
150168622|NCT01090024|541752505|FG015|Period 2|Adverse Event|0|||
149936021|NCT01926028|540904495|FG000|Overall Study|Withdrawal by Subject|9|||
149936022|NCT01926028|540904496|FG001|Overall Study|Withdrawal by Subject|9|||
149936023|NCT01926028|540904497|FG002|Overall Study|Withdrawal by Subject|2|||
149936024|NCT01926028|540904495|FG000|Overall Study|Non compliance or other reasons|4|||
149936025|NCT01926028|540904496|FG001|Overall Study|Non compliance or other reasons|2|||
149936026|NCT01926028|540904497|FG002|Overall Study|Non compliance or other reasons|0|||
149936027|NCT00737048|540904498|FG000|Overall Study|Physician Decision|0|||
149936028|NCT00737048|540904499|FG001|Overall Study|Physician Decision|0|||
149936029|NCT00737048|540904500|FG002|Overall Study|Physician Decision|1|||
149936030|NCT00737048|540904498|FG000|Overall Study|Adverse Event|0|||
149936031|NCT00737048|540904499|FG001|Overall Study|Adverse Event|1|||
149936032|NCT00737048|540904500|FG002|Overall Study|Adverse Event|0|||
149936033|NCT00737048|540904498|FG000|Overall Study|Worsening of the symptoms|3|||
149936034|NCT00737048|540904499|FG001|Overall Study|Worsening of the symptoms|5|||
150168623|NCT01090024|541752506|FG016|Period 2|Adverse Event|0|||
150168624|NCT01090024|541752507|FG017|Period 2|Adverse Event|0|||
149936035|NCT00737048|540904500|FG002|Overall Study|Worsening of the symptoms|3|||
149936036|NCT04635839|540904501|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
149936037|NCT04635839|540904502|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
149936038|NCT02737358|540904503|FG000|Overall Study|Withdrawal by Subject|7|||
149936039|NCT02737358|540904504|FG001|Overall Study|Withdrawal by Subject|12|||
149936040|NCT02737358|540904503|FG000|Overall Study|Lost to Follow-up|2|||
149936041|NCT02737358|540904504|FG001|Overall Study|Lost to Follow-up|3|||
149936042|NCT00744939|540904506|FG000|Overall Study|Withdrawal by Subject|9|||
149936043|NCT00744939|540904506|FG000|Overall Study|Protocol Violation|13|||
149936044|NCT00744939|540904506|FG000|Overall Study|Death|24|||
149936045|NCT00744939|540904506|FG000|Overall Study|distance|4|||
149936046|NCT00744939|540904506|FG000|Overall Study|Lost to Follow-up|12|||
149936047|NCT00744939|540904506|FG000|Overall Study|Medical history exclusionary|1|||
149936048|NCT00744939|540904506|FG000|Overall Study|Did not receive Magnevist|7|||
149936049|NCT00744939|540904506|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
149936050|NCT00744939|540904506|FG000|Overall Study|coma|1|||
149936051|NCT00744939|540904506|FG000|Overall Study|incorrect race|1|||
149936052|NCT01587885|540904507|FG000|Treatment Period 1|Failure to Return|0|||
149936053|NCT01587885|540904508|FG001|Treatment Period 1|Failure to Return|1|||
149936054|NCT01587885|540904507|FG000|Treatment Period 1|Protocol Violation|0|||
149936055|NCT01587885|540904508|FG001|Treatment Period 1|Protocol Violation|2|||
149936056|NCT01118299|540904510|FG000|Overall Study|Death|7|||
149936057|NCT01118299|540904511|FG001|Overall Study|Death|5|||
149936058|NCT01118299|540904510|FG000|Overall Study|Withdrawal by Subject|8|||
149936059|NCT01118299|540904511|FG001|Overall Study|Withdrawal by Subject|8|||
149936060|NCT01118299|540904510|FG000|Overall Study|Lost to Follow-up|2|||
149936061|NCT01118299|540904511|FG001|Overall Study|Lost to Follow-up|1|||
149936062|NCT01118299|540904510|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
149936063|NCT01118299|540904511|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
149936064|NCT02932943|540904512|FG000|Overall Study|Lost to Follow-up|0|||
149936065|NCT02932943|540904513|FG001|Overall Study|Lost to Follow-up|2|||
149936066|NCT02932943|540904512|FG000|Overall Study|Adverse Event|2|||
149936067|NCT02932943|540904513|FG001|Overall Study|Adverse Event|2|||
149936068|NCT02932943|540904512|FG000|Overall Study|Withdrawal by Subject|3|||
149936069|NCT02932943|540904513|FG001|Overall Study|Withdrawal by Subject|3|||
150168625|NCT01090024|541752490|FG000|Period 3|Withdrawal by Subject|0|||
149936070|NCT02337491|540904514|FG000|Overall Study|Death|1|||
149936071|NCT02337491|540904515|FG001|Overall Study|Death|1|||
149936072|NCT02337491|540904514|FG000|Overall Study|Adverse Event|0|||
149936073|NCT02337491|540904515|FG001|Overall Study|Adverse Event|1|||
149936074|NCT02337491|540904514|FG000|Overall Study|Withdrawal by Subject|3|||
149936075|NCT02337491|540904515|FG001|Overall Study|Withdrawal by Subject|0|||
149936076|NCT02337491|540904514|FG000|Overall Study|Progressive Disease|44|||
149936077|NCT02337491|540904515|FG001|Overall Study|Progressive Disease|28|||
149936078|NCT02337491|540904514|FG000|Overall Study|On Treatment|2|||
149936079|NCT02337491|540904515|FG001|Overall Study|On Treatment|0|||
149936080|NCT00386334|540904516|FG000|Double Blind Period|Adverse Event|9|||
149936081|NCT00386334|540904517|FG001|Double Blind Period|Adverse Event|14|||
149936082|NCT00386334|540904516|FG000|Double Blind Period|Protocol Violation|1|||
149936083|NCT00386334|540904517|FG001|Double Blind Period|Protocol Violation|1|||
149936084|NCT00386334|540904516|FG000|Double Blind Period|Withdrawal by Subject|9|||
149936085|NCT00386334|540904517|FG001|Double Blind Period|Withdrawal by Subject|13|||
149936086|NCT00386334|540904516|FG000|Double Blind Period|Lack of Efficacy|20|||
150168626|NCT01090024|541752491|FG001|Period 3|Withdrawal by Subject|0|||
150168627|NCT01090024|541752492|FG002|Period 3|Withdrawal by Subject|0|||
149936087|NCT00386334|540904517|FG001|Double Blind Period|Lack of Efficacy|11|||
149936088|NCT00386334|540904516|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
149936089|NCT00386334|540904517|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
149936090|NCT00386334|540904516|FG000|Double Blind Period|Other|3|||
149936091|NCT00386334|540904517|FG001|Double Blind Period|Other|3|||
150168628|NCT01090024|541752493|FG003|Period 3|Withdrawal by Subject|0|||
150168629|NCT01090024|541752494|FG004|Period 3|Withdrawal by Subject|0|||
149936092|NCT00386334|540904516|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
149936093|NCT00386334|540904517|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
149936094|NCT02133508|540904519|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
149936095|NCT02133508|540904519|FG000|Overall Study|Death|12|||
149936096|NCT02133508|540904519|FG000|Overall Study|Lost to Follow-up|2|||
149936097|NCT01026493|540904520|FG000|Overall Study|Protocol Violation|0|||
149936098|NCT01026493|540904521|FG001|Overall Study|Protocol Violation|1|||
149936099|NCT01026493|540904522|FG002|Overall Study|Protocol Violation|0|||
149936100|NCT01026493|540904523|FG003|Overall Study|Protocol Violation|0|||
149936101|NCT01026493|540904524|FG004|Overall Study|Protocol Violation|2|||
149936102|NCT01026493|540904525|FG005|Overall Study|Protocol Violation|3|||
149936103|NCT01026493|540904526|FG006|Overall Study|Protocol Violation|4|||
149936104|NCT01026493|540904527|FG007|Overall Study|Protocol Violation|1|||
149936105|NCT03093181|540904531|FG000|Overall Study|Withdrawal by Subject|2|||
149936106|NCT03093181|540904532|FG001|Overall Study|Withdrawal by Subject|1|||
149936107|NCT03093181|540904533|FG002|Overall Study|Withdrawal by Subject|2|||
149936108|NCT03093181|540904531|FG000|Overall Study|Other (Not specified)|1|||
149936109|NCT03093181|540904532|FG001|Overall Study|Other (Not specified)|0|||
149936110|NCT03093181|540904533|FG002|Overall Study|Other (Not specified)|0|||
149820294|NCT01698320|540471775|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
149820295|NCT01698320|540471776|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
149820296|NCT01698320|540471777|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
149820297|NCT01698320|540471775|FG000|40-Week Open-Label Period|Adverse Event|0|||
149820298|NCT01698320|540471776|FG001|40-Week Open-Label Period|Adverse Event|3|||
149820299|NCT01698320|540471777|FG002|40-Week Open-Label Period|Adverse Event|2|||
149820300|NCT01698320|540471775|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
149820301|NCT01698320|540471776|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
149820302|NCT01698320|540471777|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
149820303|NCT01698320|540471775|FG000|40-Week Open-Label Period|Pregnancy|0|||
149820304|NCT01698320|540471776|FG001|40-Week Open-Label Period|Pregnancy|2|||
149820305|NCT01698320|540471777|FG002|40-Week Open-Label Period|Pregnancy|1|||
149820306|NCT01698320|540471775|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
149820307|NCT01698320|540471776|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
149820308|NCT01698320|540471777|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
149820309|NCT01698320|540471775|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
149820310|NCT01698320|540471776|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
149820311|NCT01698320|540471777|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
149820312|NCT02040766|540471784|FG000|Overall Study|Adverse Event|1|||
149820313|NCT02040766|540471785|FG001|Overall Study|Adverse Event|1|||
149820314|NCT02040766|540471786|FG002|Overall Study|Adverse Event|1|||
149820315|NCT02040766|540471787|FG003|Overall Study|Adverse Event|0|||
149820316|NCT02040766|540471788|FG004|Overall Study|Adverse Event|2|||
149820317|NCT02040766|540471784|FG000|Overall Study|Withdrawal by Subject|4|||
149820318|NCT02040766|540471785|FG001|Overall Study|Withdrawal by Subject|3|||
149820319|NCT02040766|540471786|FG002|Overall Study|Withdrawal by Subject|2|||
149820320|NCT02040766|540471787|FG003|Overall Study|Withdrawal by Subject|3|||
149820321|NCT02040766|540471788|FG004|Overall Study|Withdrawal by Subject|2|||
149820322|NCT02040766|540471784|FG000|Overall Study|Non-compliance|0|||
149820323|NCT02040766|540471785|FG001|Overall Study|Non-compliance|1|||
149820324|NCT02040766|540471786|FG002|Overall Study|Non-compliance|0|||
149820325|NCT02040766|540471787|FG003|Overall Study|Non-compliance|0|||
149820326|NCT02040766|540471788|FG004|Overall Study|Non-compliance|0|||
149820327|NCT02040766|540471784|FG000|Overall Study|Protocol Violation|2|||
149820328|NCT02040766|540471785|FG001|Overall Study|Protocol Violation|1|||
149820329|NCT02040766|540471786|FG002|Overall Study|Protocol Violation|2|||
149820330|NCT02040766|540471787|FG003|Overall Study|Protocol Violation|3|||
149820331|NCT02040766|540471788|FG004|Overall Study|Protocol Violation|0|||
149820332|NCT02040766|540471784|FG000|Overall Study|Lost to Follow-up|4|||
149820333|NCT02040766|540471785|FG001|Overall Study|Lost to Follow-up|1|||
149820334|NCT02040766|540471786|FG002|Overall Study|Lost to Follow-up|3|||
149820335|NCT02040766|540471787|FG003|Overall Study|Lost to Follow-up|1|||
149820336|NCT02040766|540471788|FG004|Overall Study|Lost to Follow-up|4|||
149820337|NCT02040766|540471784|FG000|Overall Study|Not reported|1|||
149936111|NCT03093181|540904531|FG000|Overall Study|Adverse Event|0|||
149936112|NCT03093181|540904532|FG001|Overall Study|Adverse Event|1|||
149936113|NCT03093181|540904533|FG002|Overall Study|Adverse Event|0|||
150168630|NCT01090024|541752495|FG005|Period 3|Withdrawal by Subject|0|||
149820338|NCT02040766|540471785|FG001|Overall Study|Not reported|0|||
149820339|NCT02040766|540471786|FG002|Overall Study|Not reported|0|||
149820340|NCT02040766|540471787|FG003|Overall Study|Not reported|0|||
149820341|NCT02040766|540471788|FG004|Overall Study|Not reported|0|||
149820342|NCT02040766|540471784|FG000|Overall Study|Lack of Efficacy|6|||
149820343|NCT02040766|540471785|FG001|Overall Study|Lack of Efficacy|3|||
149820344|NCT02040766|540471786|FG002|Overall Study|Lack of Efficacy|4|||
149820345|NCT02040766|540471787|FG003|Overall Study|Lack of Efficacy|6|||
149936114|NCT03093181|540904531|FG000|Overall Study|Other (Protocol violation)|0|||
149936115|NCT03093181|540904532|FG001|Overall Study|Other (Protocol violation)|0|||
149936116|NCT03093181|540904533|FG002|Overall Study|Other (Protocol violation)|1|||
149936117|NCT03154086|540904536|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936118|NCT03154086|540904537|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936119|NCT03154086|540904538|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936120|NCT03154086|540904539|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
149936121|NCT03154086|540904540|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936122|NCT03154086|540904541|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936123|NCT03154086|540904542|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936124|NCT03154086|540904543|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936125|NCT03154086|540904544|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936126|NCT03154086|540904545|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936127|NCT03154086|540904546|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936128|NCT03154086|540904547|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936129|NCT03154086|540904548|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936130|NCT03154086|540904549|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936131|NCT03154086|540904550|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
149936132|NCT03154086|540904536|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936133|NCT03154086|540904537|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
149936134|NCT03154086|540904538|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936135|NCT03154086|540904539|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936136|NCT03154086|540904540|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936137|NCT03154086|540904541|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936138|NCT03154086|540904542|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936139|NCT03154086|540904543|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936140|NCT03154086|540904544|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936141|NCT03154086|540904545|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936142|NCT03154086|540904546|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936143|NCT03154086|540904547|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936144|NCT03154086|540904548|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936145|NCT03154086|540904549|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936146|NCT03154086|540904550|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
149936147|NCT03154086|540904536|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936148|NCT03154086|540904537|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936149|NCT03154086|540904538|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
149936150|NCT03154086|540904539|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936151|NCT03154086|540904540|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936152|NCT03154086|540904541|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936153|NCT03154086|540904542|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936154|NCT03154086|540904543|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936155|NCT03154086|540904544|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936156|NCT03154086|540904545|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936157|NCT03154086|540904546|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936158|NCT03154086|540904547|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936159|NCT03154086|540904548|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936160|NCT03154086|540904549|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936161|NCT03154086|540904550|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
149936162|NCT03154086|540904536|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
149936163|NCT03154086|540904537|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936164|NCT03154086|540904538|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936165|NCT03154086|540904539|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936166|NCT03154086|540904540|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936167|NCT03154086|540904541|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936168|NCT03154086|540904542|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936169|NCT03154086|540904543|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936170|NCT03154086|540904544|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936171|NCT03154086|540904545|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936172|NCT03154086|540904546|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
150030598|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
150168631|NCT01090024|541752496|FG006|Period 3|Withdrawal by Subject|0|||
149936173|NCT03154086|540904547|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936174|NCT03154086|540904548|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936175|NCT03154086|540904549|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936176|NCT03154086|540904550|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
149936177|NCT03154086|540904536|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936178|NCT03154086|540904537|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936179|NCT03154086|540904538|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936180|NCT03154086|540904539|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936181|NCT03154086|540904540|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936182|NCT03154086|540904541|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936183|NCT03154086|540904542|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936184|NCT03154086|540904543|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936185|NCT03154086|540904544|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
149936186|NCT03154086|540904545|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936187|NCT03154086|540904546|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936188|NCT03154086|540904547|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936189|NCT03154086|540904548|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936190|NCT03154086|540904549|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936191|NCT03154086|540904550|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
149936192|NCT03154086|540904536|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936193|NCT03154086|540904537|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936194|NCT03154086|540904538|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936195|NCT03154086|540904539|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936196|NCT03154086|540904540|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936197|NCT03154086|540904541|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936198|NCT03154086|540904542|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936199|NCT03154086|540904543|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
149936200|NCT03154086|540904544|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936201|NCT03154086|540904545|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936202|NCT03154086|540904546|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936203|NCT03154086|540904547|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936204|NCT03154086|540904548|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936205|NCT03154086|540904549|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936206|NCT03154086|540904550|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
149936207|NCT03154086|540904536|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
149936208|NCT03154086|540904537|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
149936209|NCT03154086|540904538|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
149936210|NCT03154086|540904539|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
149936211|NCT03154086|540904540|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
149936212|NCT03154086|540904541|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
149936213|NCT03154086|540904542|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
149936214|NCT03154086|540904543|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
149936215|NCT03154086|540904544|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
149936216|NCT03154086|540904545|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
149936217|NCT03154086|540904546|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
149936218|NCT03154086|540904547|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
149936219|NCT03154086|540904548|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
149936220|NCT03154086|540904549|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
149936221|NCT03154086|540904550|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
149936222|NCT01701245|540904552|FG000|Overall Study|Protocol Violation|1|||
149936223|NCT01701245|540904553|FG001|Overall Study|Protocol Violation|3|||
149936224|NCT01701245|540904552|FG000|Overall Study|Did not complete the open label period|11|||
149936225|NCT01701245|540904553|FG001|Overall Study|Did not complete the open label period|12|||
149936226|NCT01774591|540904554|FG000|Overall Study|Physician Decision|1|||
149936227|NCT01774591|540904555|FG001|Overall Study|Physician Decision|1|||
149936228|NCT01774591|540904554|FG000|Overall Study|Withdrawal by Subject|0|||
149936229|NCT01774591|540904555|FG001|Overall Study|Withdrawal by Subject|1|||
149936230|NCT01774591|540904554|FG000|Overall Study|Adverse Event|0|||
150168632|NCT01090024|541752497|FG007|Period 3|Withdrawal by Subject|0|||
150168633|NCT01090024|541752498|FG008|Period 3|Withdrawal by Subject|0|||
150168634|NCT01090024|541752499|FG009|Period 3|Withdrawal by Subject|0|||
150168635|NCT01090024|541752500|FG010|Period 3|Withdrawal by Subject|0|||
150168636|NCT01090024|541752501|FG011|Period 3|Withdrawal by Subject|0|||
150168637|NCT01090024|541752502|FG012|Period 3|Withdrawal by Subject|0|||
150168638|NCT01090024|541752503|FG013|Period 3|Withdrawal by Subject|0|||
150168639|NCT01090024|541752504|FG014|Period 3|Withdrawal by Subject|0|||
150168640|NCT01090024|541752505|FG015|Period 3|Withdrawal by Subject|1|||
150168641|NCT01090024|541752506|FG016|Period 3|Withdrawal by Subject|0|||
150168642|NCT01090024|541752507|FG017|Period 3|Withdrawal by Subject|0|||
150168643|NCT01090024|541752490|FG000|Period 3|Protocol Violation|0|||
150168644|NCT01090024|541752491|FG001|Period 3|Protocol Violation|0|||
150168645|NCT01090024|541752492|FG002|Period 3|Protocol Violation|0|||
150168646|NCT01090024|541752493|FG003|Period 3|Protocol Violation|0|||
150168647|NCT01090024|541752494|FG004|Period 3|Protocol Violation|0|||
150168648|NCT01090024|541752495|FG005|Period 3|Protocol Violation|0|||
150168649|NCT01090024|541752496|FG006|Period 3|Protocol Violation|0|||
150168650|NCT01090024|541752497|FG007|Period 3|Protocol Violation|0|||
150168651|NCT01090024|541752498|FG008|Period 3|Protocol Violation|1|||
150030599|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
150030600|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
150030601|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
150030602|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
150030603|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
150030604|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
150030605|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
150030606|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
150030607|NCT04079296|541247769|FG000|Dose Expansion Phase (168 Days)|Death|0|||
150030608|NCT04079296|541247770|FG001|Dose Expansion Phase (168 Days)|Death|0|||
150030609|NCT04079296|541247771|FG002|Dose Expansion Phase (168 Days)|Death|0|||
150030610|NCT04079296|541247772|FG003|Dose Expansion Phase (168 Days)|Death|1|||
150030611|NCT04079296|541247773|FG004|Dose Expansion Phase (168 Days)|Death|0|||
150030612|NCT01317472|541249904|FG000|Overall Study|Withdrawal by Subject|1|||
150030613|NCT01317472|541249905|FG001|Overall Study|Withdrawal by Subject|0|||
150030614|NCT01317472|541249904|FG000|Overall Study|Unrelated hospitalization|1|||
150030615|NCT01317472|541249905|FG001|Overall Study|Unrelated hospitalization|0|||
150030616|NCT04890652|541249913|FG000|Overall Study|Withdrawal by Subject|2|||
150030617|NCT03192176|541249920|FG000|Overall Study|Adverse Event|1|||
150030618|NCT03192176|541249921|FG001|Overall Study|Adverse Event|0|||
150030619|NCT03192176|541249922|FG002|Overall Study|Adverse Event|4|||
150030620|NCT03192176|541249923|FG003|Overall Study|Adverse Event|5|||
150030621|NCT03192176|541249924|FG004|Overall Study|Adverse Event|3|||
150030622|NCT03192176|541249925|FG005|Overall Study|Adverse Event|2|||
150030623|NCT03192176|541249926|FG006|Overall Study|Adverse Event|3|||
150030624|NCT03192176|541249927|FG007|Overall Study|Adverse Event|3|||
150030625|NCT03192176|541249920|FG000|Overall Study|Lost to Follow-up|0|||
150030626|NCT03192176|541249921|FG001|Overall Study|Lost to Follow-up|0|||
150030627|NCT03192176|541249922|FG002|Overall Study|Lost to Follow-up|1|||
150030628|NCT03192176|541249923|FG003|Overall Study|Lost to Follow-up|2|||
150030629|NCT03192176|541249924|FG004|Overall Study|Lost to Follow-up|3|||
150030630|NCT03192176|541249925|FG005|Overall Study|Lost to Follow-up|1|||
150030631|NCT03192176|541249926|FG006|Overall Study|Lost to Follow-up|1|||
150030632|NCT03192176|541249927|FG007|Overall Study|Lost to Follow-up|1|||
150030633|NCT03192176|541249920|FG000|Overall Study|Physician Decision|1|||
150030634|NCT03192176|541249921|FG001|Overall Study|Physician Decision|0|||
150030635|NCT03192176|541249922|FG002|Overall Study|Physician Decision|0|||
150030636|NCT03192176|541249923|FG003|Overall Study|Physician Decision|0|||
150030637|NCT03192176|541249924|FG004|Overall Study|Physician Decision|0|||
150030638|NCT03192176|541249925|FG005|Overall Study|Physician Decision|2|||
150030639|NCT03192176|541249926|FG006|Overall Study|Physician Decision|1|||
150030640|NCT03192176|541249927|FG007|Overall Study|Physician Decision|0|||
150030641|NCT03192176|541249920|FG000|Overall Study|Protocol Deviation|1|||
150030642|NCT03192176|541249921|FG001|Overall Study|Protocol Deviation|1|||
150030643|NCT03192176|541249922|FG002|Overall Study|Protocol Deviation|0|||
150030644|NCT03192176|541249923|FG003|Overall Study|Protocol Deviation|0|||
150030645|NCT03192176|541249924|FG004|Overall Study|Protocol Deviation|2|||
150030646|NCT03192176|541249925|FG005|Overall Study|Protocol Deviation|0|||
150030647|NCT03192176|541249926|FG006|Overall Study|Protocol Deviation|0|||
150030648|NCT03192176|541249927|FG007|Overall Study|Protocol Deviation|0|||
150030649|NCT03192176|541249920|FG000|Overall Study|Withdrawal by Subject|3|||
150030650|NCT03192176|541249921|FG001|Overall Study|Withdrawal by Subject|4|||
150030651|NCT03192176|541249922|FG002|Overall Study|Withdrawal by Subject|0|||
150030652|NCT03192176|541249923|FG003|Overall Study|Withdrawal by Subject|4|||
150030653|NCT03192176|541249924|FG004|Overall Study|Withdrawal by Subject|3|||
150030654|NCT03192176|541249925|FG005|Overall Study|Withdrawal by Subject|4|||
150030655|NCT03192176|541249926|FG006|Overall Study|Withdrawal by Subject|4|||
149820346|NCT02040766|540471788|FG004|Overall Study|Lack of Efficacy|5|||
149820347|NCT00479401|540471790|FG000|Overall Study|Adverse Event|24|||
149820348|NCT00479401|540471791|FG001|Overall Study|Adverse Event|20|||
149820349|NCT00479401|540471792|FG002|Overall Study|Adverse Event|4|||
149820350|NCT00479401|540471790|FG000|Overall Study|Lack of Efficacy|2|||
149820351|NCT00479401|540471791|FG001|Overall Study|Lack of Efficacy|2|||
149820352|NCT00479401|540471792|FG002|Overall Study|Lack of Efficacy|4|||
149820353|NCT00479401|540471790|FG000|Overall Study|Protocol Violation|2|||
149820354|NCT00479401|540471791|FG001|Overall Study|Protocol Violation|1|||
149820355|NCT00479401|540471792|FG002|Overall Study|Protocol Violation|1|||
149820356|NCT00479401|540471790|FG000|Overall Study|Lost to Follow-up|1|||
149820357|NCT00479401|540471791|FG001|Overall Study|Lost to Follow-up|1|||
149820358|NCT00479401|540471792|FG002|Overall Study|Lost to Follow-up|1|||
149820359|NCT00479401|540471790|FG000|Overall Study|Withdrawal by Subject|16|||
149820360|NCT00479401|540471791|FG001|Overall Study|Withdrawal by Subject|10|||
149820361|NCT00479401|540471792|FG002|Overall Study|Withdrawal by Subject|2|||
149820362|NCT00479401|540471790|FG000|Overall Study|Exclusion criteria, relocation|4|||
149820363|NCT00479401|540471791|FG001|Overall Study|Exclusion criteria, relocation|3|||
149820364|NCT00479401|540471792|FG002|Overall Study|Exclusion criteria, relocation|0|||
149820365|NCT01208402|540471795|FG000|Overall Study|Withdrawal by Subject|1|||
150168652|NCT01090024|541752499|FG009|Period 3|Protocol Violation|0|||
150030656|NCT03192176|541249927|FG007|Overall Study|Withdrawal by Subject|2|||
150030657|NCT03192176|541249920|FG000|Overall Study|Miscellaneous|1|||
150030658|NCT03192176|541249921|FG001|Overall Study|Miscellaneous|0|||
150030659|NCT03192176|541249922|FG002|Overall Study|Miscellaneous|1|||
150030660|NCT03192176|541249923|FG003|Overall Study|Miscellaneous|1|||
150030661|NCT03192176|541249924|FG004|Overall Study|Miscellaneous|1|||
150030662|NCT03192176|541249925|FG005|Overall Study|Miscellaneous|2|||
150030663|NCT03192176|541249926|FG006|Overall Study|Miscellaneous|0|||
150030664|NCT03192176|541249927|FG007|Overall Study|Miscellaneous|1|||
149936231|NCT01774591|540904555|FG001|Overall Study|Adverse Event|2|||
149936232|NCT01159574|540904556|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
149936233|NCT01159574|540904556|FG000|Treatment Phase|Adverse Event|3|||
149936234|NCT01159574|540904556|FG000|Treatment Phase|Death|6|||
149936235|NCT01159574|540904556|FG000|Treatment Phase|Physician Decision|2|||
149936236|NCT01159574|540904556|FG000|Treatment Phase|Withdrawal by Subject|7|||
149936237|NCT01159574|540904556|FG000|Treatment Phase|still on treatment|2|||
149936238|NCT01159574|540904556|FG000|Follow Up Phase|Lost to Follow-up|2|||
149936239|NCT01159574|540904556|FG000|Follow Up Phase|still being followed for overall surviva|18|||
149936240|NCT03555149|540904559|FG000|Overall Study|Death|18|||
149936241|NCT03555149|540904560|FG001|Overall Study|Death|15|||
149936242|NCT03555149|540904561|FG002|Overall Study|Death|15|||
149936243|NCT03555149|540904562|FG003|Overall Study|Death|4|||
149936244|NCT03555149|540904563|FG004|Overall Study|Death|4|||
149936245|NCT03555149|540904564|FG005|Overall Study|Death|11|||
149936246|NCT03555149|540904565|FG006|Overall Study|Death|12|||
149936247|NCT03555149|540904566|FG007|Overall Study|Death|1|||
149936248|NCT03555149|540904559|FG000|Overall Study|Lost to Follow-up|1|||
149936249|NCT03555149|540904560|FG001|Overall Study|Lost to Follow-up|0|||
149936250|NCT03555149|540904561|FG002|Overall Study|Lost to Follow-up|0|||
149936251|NCT03555149|540904562|FG003|Overall Study|Lost to Follow-up|0|||
149936252|NCT03555149|540904563|FG004|Overall Study|Lost to Follow-up|0|||
149936253|NCT03555149|540904564|FG005|Overall Study|Lost to Follow-up|1|||
149936254|NCT03555149|540904565|FG006|Overall Study|Lost to Follow-up|0|||
149936255|NCT03555149|540904566|FG007|Overall Study|Lost to Follow-up|0|||
149936256|NCT03555149|540904559|FG000|Overall Study|Physician Decision|1|||
149936257|NCT03555149|540904560|FG001|Overall Study|Physician Decision|0|||
149936258|NCT03555149|540904561|FG002|Overall Study|Physician Decision|0|||
149936259|NCT03555149|540904562|FG003|Overall Study|Physician Decision|0|||
149936260|NCT03555149|540904563|FG004|Overall Study|Physician Decision|0|||
149936261|NCT03555149|540904564|FG005|Overall Study|Physician Decision|0|||
149936262|NCT03555149|540904565|FG006|Overall Study|Physician Decision|0|||
149936263|NCT03555149|540904566|FG007|Overall Study|Physician Decision|0|||
149936264|NCT03555149|540904559|FG000|Overall Study|Study Terminated By Sponsor|1|||
149936265|NCT03555149|540904560|FG001|Overall Study|Study Terminated By Sponsor|0|||
149936266|NCT03555149|540904561|FG002|Overall Study|Study Terminated By Sponsor|0|||
149936267|NCT03555149|540904562|FG003|Overall Study|Study Terminated By Sponsor|0|||
149936268|NCT03555149|540904563|FG004|Overall Study|Study Terminated By Sponsor|0|||
149936269|NCT03555149|540904564|FG005|Overall Study|Study Terminated By Sponsor|2|||
149936270|NCT03555149|540904565|FG006|Overall Study|Study Terminated By Sponsor|3|||
149936271|NCT03555149|540904566|FG007|Overall Study|Study Terminated By Sponsor|1|||
149936272|NCT03555149|540904559|FG000|Overall Study|Withdrawal by Subject|3|||
149936273|NCT03555149|540904560|FG001|Overall Study|Withdrawal by Subject|0|||
149936274|NCT03555149|540904561|FG002|Overall Study|Withdrawal by Subject|0|||
149936275|NCT03555149|540904562|FG003|Overall Study|Withdrawal by Subject|2|||
149936276|NCT03555149|540904563|FG004|Overall Study|Withdrawal by Subject|0|||
149936277|NCT03555149|540904564|FG005|Overall Study|Withdrawal by Subject|1|||
149936278|NCT03555149|540904565|FG006|Overall Study|Withdrawal by Subject|0|||
149936279|NCT03555149|540904566|FG007|Overall Study|Withdrawal by Subject|0|||
149936280|NCT02666222|540904570|FG000|Overall Study|Death|2|||
149936281|NCT00630916|540904571|FG000|Overall Study|Death|110|||
149936282|NCT00630916|540904571|FG000|Overall Study|Explant|8|||
149936283|NCT00630916|540904571|FG000|Overall Study|Lost to Follow-up|5|||
149936284|NCT00630916|540904571|FG000|Overall Study|Withdrawal by Subject|30|||
149936285|NCT00630916|540904571|FG000|Overall Study|Protocol Violation|7|||
149936286|NCT00630916|540904571|FG000|Overall Study|Physician Decision|47|||
149936287|NCT00630916|540904571|FG000|Overall Study|Lack of Efficacy|3|||
150030665|NCT02399215|541249939|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
149936288|NCT02295644|540904573|FG000|Overall Study|Did not meet inclusion criterion|0|||
149936289|NCT02295644|540904574|FG001|Overall Study|Did not meet inclusion criterion|0|||
150030666|NCT02399215|541249939|FG000|Overall Study|Withdrawal by Subject|1|||
149936290|NCT02295644|540904575|FG002|Overall Study|Did not meet inclusion criterion|1|||
150030667|NCT00772538|541249940|FG000|Overall Study|Adverse Event|6|||
149936291|NCT02295644|540904576|FG003|Overall Study|Did not meet inclusion criterion|2|||
149936292|NCT02147626|540904577|FG000|Overall Study|Lost to Follow-up|4|||
149936293|NCT02147626|540904578|FG001|Overall Study|Lost to Follow-up|4|||
149936294|NCT02147626|540904577|FG000|Overall Study|Pregnancy|1|||
149936295|NCT02147626|540904578|FG001|Overall Study|Pregnancy|2|||
149936296|NCT02147626|540904577|FG000|Overall Study|Withdrawal by Subject|0|||
150030668|NCT00772538|541249941|FG001|Overall Study|Adverse Event|6|||
149936297|NCT02147626|540904578|FG001|Overall Study|Withdrawal by Subject|1|||
149936298|NCT03504917|540904579|FG000|Blinded Treatment Period|Protocol Violation|1|||
149936299|NCT03504917|540904580|FG001|Blinded Treatment Period|Protocol Violation|0|||
149936300|NCT03504917|540904579|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
149936301|NCT03504917|540904580|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
149936302|NCT03504917|540904579|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
149936303|NCT03504917|540904580|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
149936304|NCT03504917|540904579|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
149936305|NCT03504917|540904580|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
149936306|NCT03504917|540904579|FG000|Blinded Treatment Period|Adverse Event|4|||
149936307|NCT03504917|540904580|FG001|Blinded Treatment Period|Adverse Event|4|||
149936308|NCT03504917|540904579|FG000|Blinded Treatment Period|Physician Decision|1|||
149936309|NCT03504917|540904580|FG001|Blinded Treatment Period|Physician Decision|0|||
149936310|NCT03504917|540904579|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
149936311|NCT03504917|540904580|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
149936312|NCT03504917|540904579|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
149936313|NCT03504917|540904580|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
149936314|NCT03504917|540904579|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
149936315|NCT03504917|540904580|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
149936316|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
149936317|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
149936318|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
149936319|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
149936320|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
149936321|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
149936322|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
149936323|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
149936324|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
149936325|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
149936326|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
149936327|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
149936328|NCT03504917|540904579|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
149936329|NCT03504917|540904580|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
149936330|NCT01299584|540904581|FG000|Overall Study|Protocol Violation|9|||
149936331|NCT00572832|540904582|FG000|Overall Study|Lost to Follow-up|0|||
149936332|NCT00572832|540904583|FG001|Overall Study|Lost to Follow-up|11|||
149936333|NCT00572832|540904582|FG000|Overall Study|Pregnancy|0|||
149936334|NCT00572832|540904583|FG001|Overall Study|Pregnancy|1|||
149936335|NCT00324155|540904587|FG000|Enrolled and Randomized|No longer met study criteria|3|||
149936336|NCT00324155|540904588|FG001|Enrolled and Randomized|No longer met study criteria|0|||
149936337|NCT00324155|540904587|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
149936338|NCT00324155|540904588|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
149936339|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
149936340|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
149936341|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
149936342|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
149936343|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Death|8|||
149936344|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Death|15|||
149936345|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
149936346|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
149936347|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
150030669|NCT00772538|541249940|FG000|Overall Study|Protocol Violation|3|||
150168653|NCT01090024|541752500|FG010|Period 3|Protocol Violation|0|||
150168654|NCT01090024|541752501|FG011|Period 3|Protocol Violation|0|||
150168655|NCT01090024|541752502|FG012|Period 3|Protocol Violation|0|||
150168656|NCT01090024|541752503|FG013|Period 3|Protocol Violation|0|||
150168657|NCT01090024|541752504|FG014|Period 3|Protocol Violation|0|||
150168658|NCT01090024|541752505|FG015|Period 3|Protocol Violation|0|||
150168659|NCT01090024|541752506|FG016|Period 3|Protocol Violation|0|||
150168660|NCT01090024|541752507|FG017|Period 3|Protocol Violation|0|||
150168661|NCT01090024|541752490|FG000|Period 3|Adverse Event|0|||
150168662|NCT01090024|541752491|FG001|Period 3|Adverse Event|0|||
150168663|NCT01090024|541752492|FG002|Period 3|Adverse Event|0|||
150168664|NCT01090024|541752493|FG003|Period 3|Adverse Event|0|||
150168665|NCT01090024|541752494|FG004|Period 3|Adverse Event|0|||
150168666|NCT01090024|541752495|FG005|Period 3|Adverse Event|1|||
150168667|NCT01090024|541752496|FG006|Period 3|Adverse Event|0|||
150168668|NCT01090024|541752497|FG007|Period 3|Adverse Event|0|||
150168669|NCT01090024|541752498|FG008|Period 3|Adverse Event|0|||
150168670|NCT01090024|541752499|FG009|Period 3|Adverse Event|0|||
150168671|NCT01090024|541752500|FG010|Period 3|Adverse Event|0|||
149936348|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
149936349|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
149936350|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
149936351|NCT00324155|540904587|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
150168672|NCT01090024|541752501|FG011|Period 3|Adverse Event|0|||
150168673|NCT01090024|541752502|FG012|Period 3|Adverse Event|0|||
150168674|NCT01090024|541752503|FG013|Period 3|Adverse Event|0|||
150168675|NCT01090024|541752504|FG014|Period 3|Adverse Event|0|||
150168676|NCT01090024|541752505|FG015|Period 3|Adverse Event|0|||
150168677|NCT01090024|541752506|FG016|Period 3|Adverse Event|0|||
150168678|NCT01090024|541752507|FG017|Period 3|Adverse Event|0|||
150168679|NCT00149630|541752508|FG000|Overall Study|Incarceration|2|||
150168680|NCT00149630|541752509|FG001|Overall Study|Incarceration|0|||
150168681|NCT00149630|541752508|FG000|Overall Study|Treatment Programs|4|||
150168682|NCT00149630|541752509|FG001|Overall Study|Treatment Programs|5|||
150168683|NCT00149630|541752508|FG000|Overall Study|Adverse Event|2|||
150168684|NCT00149630|541752509|FG001|Overall Study|Adverse Event|0|||
150168685|NCT00567879|541752511|FG000|Overall Study|Adverse Event|2|||
150168686|NCT00567879|541752512|FG001|Overall Study|Adverse Event|0|||
150168687|NCT00567879|541752513|FG002|Overall Study|Adverse Event|1|||
150168688|NCT00567879|541752514|FG003|Overall Study|Adverse Event|0|||
150168689|NCT00567879|541752515|FG004|Overall Study|Adverse Event|1|||
150168690|NCT00567879|541752516|FG005|Overall Study|Adverse Event|0|||
150168691|NCT00567879|541752511|FG000|Overall Study|Abnormal test procedure(s)|0|||
150168692|NCT00567879|541752512|FG001|Overall Study|Abnormal test procedure(s)|0|||
150168693|NCT00567879|541752513|FG002|Overall Study|Abnormal test procedure(s)|1|||
150168694|NCT00567879|541752514|FG003|Overall Study|Abnormal test procedure(s)|0|||
150168695|NCT00567879|541752515|FG004|Overall Study|Abnormal test procedure(s)|0|||
150168696|NCT00567879|541752516|FG005|Overall Study|Abnormal test procedure(s)|0|||
150168697|NCT00567879|541752511|FG000|Overall Study|Withdrawal by Subject|0|||
150168698|NCT00567879|541752512|FG001|Overall Study|Withdrawal by Subject|0|||
150168699|NCT00567879|541752513|FG002|Overall Study|Withdrawal by Subject|3|||
150168700|NCT00567879|541752514|FG003|Overall Study|Withdrawal by Subject|1|||
150168701|NCT00567879|541752515|FG004|Overall Study|Withdrawal by Subject|0|||
150168702|NCT00567879|541752516|FG005|Overall Study|Withdrawal by Subject|0|||
150168703|NCT00567879|541752511|FG000|Overall Study|New cancer therapy|0|||
150168704|NCT00567879|541752512|FG001|Overall Study|New cancer therapy|0|||
150168705|NCT00567879|541752513|FG002|Overall Study|New cancer therapy|1|||
150168706|NCT00567879|541752514|FG003|Overall Study|New cancer therapy|0|||
150168707|NCT00567879|541752515|FG004|Overall Study|New cancer therapy|0|||
150168708|NCT00567879|541752516|FG005|Overall Study|New cancer therapy|0|||
150168709|NCT00567879|541752511|FG000|Overall Study|Disease progression|5|||
150168710|NCT00567879|541752512|FG001|Overall Study|Disease progression|7|||
150168711|NCT00567879|541752513|FG002|Overall Study|Disease progression|15|||
150168712|NCT00567879|541752514|FG003|Overall Study|Disease progression|5|||
150168713|NCT00567879|541752515|FG004|Overall Study|Disease progression|11|||
150168714|NCT00567879|541752516|FG005|Overall Study|Disease progression|3|||
150168715|NCT01546155|541752519|FG000|Overall Study|could not tolerate long scan duration|3|||
150168716|NCT02930343|541752520|FG000|Overall Study|Lost to Follow-up|9|||
150168717|NCT02930343|541752521|FG001|Overall Study|Lost to Follow-up|7|||
150168718|NCT00486759|541752526|FG000|Treatment|Adverse event/intercurrent illness|86|||
150168719|NCT00486759|541752527|FG001|Treatment|Adverse event/intercurrent illness|39|||
150168720|NCT00486759|541752526|FG000|Treatment|Insufficient therapeutic response|37|||
150168721|NCT00486759|541752527|FG001|Treatment|Insufficient therapeutic response|39|||
150168722|NCT00486759|541752526|FG000|Treatment|Death|17|||
150168723|NCT00486759|541752527|FG001|Treatment|Death|10|||
150168724|NCT00486759|541752526|FG000|Treatment|Withdrew consent|15|||
150168725|NCT00486759|541752527|FG001|Treatment|Withdrew consent|12|||
150168726|NCT00486759|541752526|FG000|Treatment|Administrative/reason not specified|17|||
150168727|NCT00486759|541752527|FG001|Treatment|Administrative/reason not specified|21|||
150168728|NCT00486759|541752526|FG000|Treatment|Refused treatment|10|||
150168729|NCT00486759|541752527|FG001|Treatment|Refused treatment|7|||
150168730|NCT00486759|541752526|FG000|Treatment|Violation of selection criteria at entry|3|||
150168731|NCT00486759|541752527|FG001|Treatment|Violation of selection criteria at entry|3|||
150168732|NCT00486759|541752526|FG000|Treatment|Other protocol violation|1|||
150168733|NCT00486759|541752527|FG001|Treatment|Other protocol violation|5|||
150168734|NCT00486759|541752526|FG000|Treatment|Failure to return|1|||
150168735|NCT00486759|541752527|FG001|Treatment|Failure to return|1|||
150168736|NCT00486759|541752526|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
150168737|NCT00486759|541752527|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
150168738|NCT00486759|541752526|FG000|Safety Follow-up|Death|40|||
150168739|NCT00486759|541752527|FG001|Safety Follow-up|Death|29|||
150168740|NCT00486759|541752526|FG000|Safety Follow-up|Withdrew consent|32|||
150168741|NCT00486759|541752527|FG001|Safety Follow-up|Withdrew consent|23|||
150168742|NCT00486759|541752526|FG000|Safety Follow-up|Failure to return|9|||
150168743|NCT00486759|541752527|FG001|Safety Follow-up|Failure to return|6|||
150168744|NCT00486759|541752526|FG000|Safety Follow-up|Administrative/not specified|8|||
149936352|NCT00324155|540904588|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
149936353|NCT00324155|540904587|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
149936354|NCT00324155|540904588|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
149936355|NCT00324155|540904587|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
149936356|NCT00324155|540904588|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
149936357|NCT00324155|540904587|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
149936358|NCT00324155|540904588|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
149936359|NCT00324155|540904587|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
149936360|NCT00324155|540904588|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
149936361|NCT00324155|540904587|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
149936362|NCT00324155|540904588|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
149936363|NCT00324155|540904587|FG000|Follow-up Phase|On-going participants still on drug|11|||
149936364|NCT00324155|540904588|FG001|Follow-up Phase|On-going participants still on drug|6|||
149936365|NCT00390689|540904589|FG000|Overall Study|Adverse Event|2|||
149936366|NCT00390689|540904590|FG001|Overall Study|Adverse Event|5|||
149936367|NCT00390689|540904591|FG002|Overall Study|Adverse Event|2|||
149936368|NCT00390689|540904589|FG000|Overall Study|Lack of Efficacy|0|||
149936369|NCT00390689|540904590|FG001|Overall Study|Lack of Efficacy|0|||
149936370|NCT00390689|540904591|FG002|Overall Study|Lack of Efficacy|1|||
149936371|NCT00390689|540904589|FG000|Overall Study|Protocol Violation|1|||
149936372|NCT00390689|540904590|FG001|Overall Study|Protocol Violation|0|||
149936373|NCT00390689|540904591|FG002|Overall Study|Protocol Violation|0|||
149936374|NCT00390689|540904589|FG000|Overall Study|Investigator's judgement|2|||
149936375|NCT00390689|540904590|FG001|Overall Study|Investigator's judgement|0|||
149936376|NCT00390689|540904591|FG002|Overall Study|Investigator's judgement|0|||
149936377|NCT01253161|540904592|FG000|Overall Study|Adverse Event|1|||
149936378|NCT03101020|540904594|FG000|Overall Study|Lack of time to participate|1|||
149936379|NCT03101020|540904595|FG001|Overall Study|Lack of time to participate|0|||
149936380|NCT03101020|540904594|FG000|Overall Study|Ran over by a car|0|||
149936381|NCT03101020|540904595|FG001|Overall Study|Ran over by a car|1|||
149936382|NCT03101020|540904594|FG000|Overall Study|Withdrawal by Subject|0|||
149936383|NCT03101020|540904595|FG001|Overall Study|Withdrawal by Subject|2|||
149936384|NCT01924533|540904596|FG000|Overall Study|Death|181|||
149936385|NCT01924533|540904597|FG001|Overall Study|Death|200|||
149936386|NCT01924533|540904596|FG000|Overall Study|Lost to Follow-up|0|||
149936387|NCT01924533|540904597|FG001|Overall Study|Lost to Follow-up|1|||
149936388|NCT01924533|540904596|FG000|Overall Study|Withdrawal by Subject|7|||
149936389|NCT01924533|540904597|FG001|Overall Study|Withdrawal by Subject|3|||
149936390|NCT01924533|540904596|FG000|Overall Study|Other Eligibility criteria|1|||
149936391|NCT01924533|540904597|FG001|Overall Study|Other Eligibility criteria|1|||
149936392|NCT04233879|540904598|FG000|Overall Study|Death|2|||
149936393|NCT04233879|540904599|FG001|Overall Study|Death|0|||
149936394|NCT04233879|540904598|FG000|Overall Study|Lost to Follow-up|3|||
149936395|NCT04233879|540904599|FG001|Overall Study|Lost to Follow-up|8|||
149936396|NCT04233879|540904598|FG000|Overall Study|Physician Decision|4|||
149936397|NCT04233879|540904599|FG001|Overall Study|Physician Decision|4|||
149936398|NCT04233879|540904598|FG000|Overall Study|Withdrawal by Subject|7|||
149936399|NCT04233879|540904599|FG001|Overall Study|Withdrawal by Subject|10|||
149936400|NCT04233879|540904598|FG000|Overall Study|Other|281|||
149936401|NCT04233879|540904599|FG001|Overall Study|Other|279|||
149936402|NCT03292016|540904600|FG000|Second Washout|Adverse Event|0|||
149936403|NCT03292016|540904601|FG001|Second Washout|Adverse Event|1|||
149936404|NCT03292016|540904602|FG002|Second Washout|Adverse Event|0|||
149936405|NCT03292016|540904603|FG003|Second Washout|Adverse Event|0|||
149936406|NCT03292016|540904604|FG004|Second Washout|Adverse Event|0|||
149936407|NCT03292016|540904605|FG005|Second Washout|Adverse Event|0|||
149936408|NCT03810183|540904606|FG000|Overall Study|Study terminated by Sponsor|2|||
149936409|NCT03810183|540904607|FG001|Overall Study|Study terminated by Sponsor|1|||
149936410|NCT04275336|540904609|FG000|Overall Study|First venipuncture failed|4|||
149936411|NCT04275336|540904610|FG001|Overall Study|First venipuncture failed|6|||
149936412|NCT04275336|540904611|FG002|Overall Study|First venipuncture failed|5|||
150168745|NCT00486759|541752527|FG001|Safety Follow-up|Administrative/not specified|6|||
149936413|NCT04275336|540904609|FG000|Overall Study|Unscheduled venipuncture|9|||
149936414|NCT04275336|540904610|FG001|Overall Study|Unscheduled venipuncture|13|||
149936415|NCT04275336|540904611|FG002|Overall Study|Unscheduled venipuncture|7|||
149936416|NCT04275336|540904609|FG000|Overall Study|Failed specimen of saliva|4|||
149936417|NCT04275336|540904610|FG001|Overall Study|Failed specimen of saliva|3|||
149936418|NCT04275336|540904611|FG002|Overall Study|Failed specimen of saliva|4|||
149936419|NCT03167242|540904612|FG000|Overall Study|Patient/Guardian Decision|0|||
150168746|NCT00486759|541752526|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
150168747|NCT00486759|541752527|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
149936420|NCT03167242|540904613|FG001|Overall Study|Patient/Guardian Decision|1|||
149936421|NCT03167242|540904614|FG002|Overall Study|Patient/Guardian Decision|2|||
149936422|NCT03167242|540904615|FG003|Overall Study|Patient/Guardian Decision|1|||
150030670|NCT00772538|541249941|FG001|Overall Study|Protocol Violation|3|||
150030671|NCT00772538|541249940|FG000|Overall Study|Lost to Follow-up|1|||
150030672|NCT00772538|541249941|FG001|Overall Study|Lost to Follow-up|1|||
150030673|NCT00772538|541249940|FG000|Overall Study|Withdrawal by Subject|3|||
150030674|NCT00772538|541249941|FG001|Overall Study|Withdrawal by Subject|8|||
150030675|NCT00772538|541249940|FG000|Overall Study|Lack of Efficacy|0|||
150030676|NCT00772538|541249941|FG001|Overall Study|Lack of Efficacy|1|||
150030677|NCT00772538|541249940|FG000|Overall Study|Other|7|||
150030678|NCT00772538|541249941|FG001|Overall Study|Other|7|||
150030679|NCT00189540|541249942|FG000|Overall Study|Withdrawal by Subject|3|||
150030680|NCT00189540|541249943|FG001|Overall Study|Withdrawal by Subject|0|||
150030681|NCT00189540|541249942|FG000|Overall Study|Death|4|||
150030682|NCT00189540|541249943|FG001|Overall Study|Death|1|||
150270121|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
150270122|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
150270123|NCT01641809|542127377|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
150270124|NCT01641809|542127378|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
150030683|NCT01089504|541249944|FG000|Overall Study|Lost to Follow-up|1|||
150030684|NCT01089504|541249945|FG001|Overall Study|Lost to Follow-up|1|||
150030685|NCT01089504|541249944|FG000|Overall Study|Withdrawal by Subject|2|||
150030686|NCT01089504|541249945|FG001|Overall Study|Withdrawal by Subject|0|||
150030687|NCT00001832|541249946|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
150030688|NCT00001832|541249947|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
150030689|NCT00001832|541249948|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
150030690|NCT00001832|541249949|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
150030691|NCT00001832|541249950|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
150030692|NCT00001832|541249951|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
150030693|NCT00001832|541249952|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
150030694|NCT00001832|541249953|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
150030695|NCT00001832|541249954|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
150030696|NCT00001832|541249955|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
150030697|NCT00001832|541249956|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
150030698|NCT00001832|541249957|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
150030699|NCT00001832|541249958|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
149936423|NCT03167242|540904616|FG004|Overall Study|Patient/Guardian Decision|1|||
149936424|NCT03167242|540904617|FG005|Overall Study|Patient/Guardian Decision|1|||
149936425|NCT03167242|540904618|FG006|Overall Study|Patient/Guardian Decision|0|||
149936426|NCT03167242|540904619|FG007|Overall Study|Patient/Guardian Decision|0|||
149936427|NCT03167242|540904620|FG008|Overall Study|Patient/Guardian Decision|0|||
149936428|NCT03167242|540904621|FG009|Overall Study|Patient/Guardian Decision|0|||
149936429|NCT03167242|540904622|FG010|Overall Study|Patient/Guardian Decision|1|||
149936430|NCT03167242|540904623|FG011|Overall Study|Patient/Guardian Decision|0|||
149936431|NCT03167242|540904612|FG000|Overall Study|Lost to Follow-up|0|||
149936432|NCT03167242|540904613|FG001|Overall Study|Lost to Follow-up|0|||
149936433|NCT03167242|540904614|FG002|Overall Study|Lost to Follow-up|1|||
149936434|NCT03167242|540904615|FG003|Overall Study|Lost to Follow-up|0|||
149936435|NCT03167242|540904616|FG004|Overall Study|Lost to Follow-up|0|||
150030700|NCT00001832|541249959|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
150030701|NCT00001832|541249960|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
150030702|NCT00001832|541249946|FG000|Treatment Period|Death during treatment|0|||
150030703|NCT00001832|541249947|FG001|Treatment Period|Death during treatment|0|||
150030704|NCT00001832|541249948|FG002|Treatment Period|Death during treatment|0|||
150030705|NCT00001832|541249949|FG003|Treatment Period|Death during treatment|0|||
150030706|NCT00001832|541249950|FG004|Treatment Period|Death during treatment|0|||
150030707|NCT00001832|541249951|FG005|Treatment Period|Death during treatment|1|||
150030708|NCT00001832|541249952|FG006|Treatment Period|Death during treatment|0|||
150030709|NCT00001832|541249953|FG007|Treatment Period|Death during treatment|0|||
150030710|NCT00001832|541249954|FG008|Treatment Period|Death during treatment|0|||
150030711|NCT00001832|541249955|FG009|Treatment Period|Death during treatment|0|||
150030712|NCT00001832|541249956|FG010|Treatment Period|Death during treatment|0|||
150030713|NCT00001832|541249957|FG011|Treatment Period|Death during treatment|0|||
150030714|NCT00001832|541249958|FG012|Treatment Period|Death during treatment|0|||
150030715|NCT00001832|541249959|FG013|Treatment Period|Death during treatment|0|||
150030716|NCT00001832|541249960|FG014|Treatment Period|Death during treatment|0|||
150030717|NCT00001832|541249946|FG000|Treatment Period|Not treated|0|||
150030718|NCT00001832|541249947|FG001|Treatment Period|Not treated|0|||
150030719|NCT00001832|541249948|FG002|Treatment Period|Not treated|0|||
150030720|NCT00001832|541249949|FG003|Treatment Period|Not treated|0|||
150030721|NCT00001832|541249950|FG004|Treatment Period|Not treated|0|||
150030722|NCT00001832|541249951|FG005|Treatment Period|Not treated|0|||
149936436|NCT03167242|540904617|FG005|Overall Study|Lost to Follow-up|1|||
150030723|NCT00001832|541249952|FG006|Treatment Period|Not treated|0|||
150030724|NCT00001832|541249953|FG007|Treatment Period|Not treated|1|||
150030725|NCT00001832|541249954|FG008|Treatment Period|Not treated|0|||
150030726|NCT00001832|541249955|FG009|Treatment Period|Not treated|0|||
150030727|NCT00001832|541249956|FG010|Treatment Period|Not treated|0|||
150030728|NCT00001832|541249957|FG011|Treatment Period|Not treated|0|||
150030729|NCT00001832|541249958|FG012|Treatment Period|Not treated|0|||
150030730|NCT00001832|541249959|FG013|Treatment Period|Not treated|0|||
150030731|NCT00001832|541249960|FG014|Treatment Period|Not treated|0|||
150030732|NCT00713609|541249961|FG000|Overall Study|Adverse Event|2|||
150030733|NCT00713609|541249962|FG001|Overall Study|Adverse Event|0|||
150030734|NCT00713609|541249963|FG002|Overall Study|Adverse Event|2|||
150030735|NCT00713609|541249964|FG003|Overall Study|Adverse Event|2|||
150030736|NCT00713609|541249965|FG004|Overall Study|Adverse Event|3|||
150030737|NCT00713609|541249966|FG005|Overall Study|Adverse Event|1|||
150030738|NCT00713609|541249961|FG000|Overall Study|Lost to Follow-up|5|||
150030739|NCT00713609|541249962|FG001|Overall Study|Lost to Follow-up|7|||
150030740|NCT00713609|541249963|FG002|Overall Study|Lost to Follow-up|5|||
150030741|NCT00713609|541249964|FG003|Overall Study|Lost to Follow-up|5|||
150030742|NCT00713609|541249965|FG004|Overall Study|Lost to Follow-up|7|||
150030743|NCT00713609|541249966|FG005|Overall Study|Lost to Follow-up|0|||
150030744|NCT00713609|541249961|FG000|Overall Study|Lack of Efficacy|1|||
150030745|NCT00713609|541249962|FG001|Overall Study|Lack of Efficacy|3|||
150030746|NCT00713609|541249963|FG002|Overall Study|Lack of Efficacy|0|||
150030747|NCT00713609|541249964|FG003|Overall Study|Lack of Efficacy|0|||
150030748|NCT00713609|541249965|FG004|Overall Study|Lack of Efficacy|1|||
150030749|NCT00713609|541249966|FG005|Overall Study|Lack of Efficacy|0|||
150030750|NCT00713609|541249961|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
150030751|NCT00713609|541249962|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
150030752|NCT00713609|541249963|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
150030753|NCT00713609|541249964|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
150030754|NCT00713609|541249965|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
150030755|NCT00713609|541249966|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
150030756|NCT00713609|541249961|FG000|Overall Study|Withdrawal by Subject|6|||
150030757|NCT00713609|541249962|FG001|Overall Study|Withdrawal by Subject|1|||
150030758|NCT00713609|541249963|FG002|Overall Study|Withdrawal by Subject|5|||
150030759|NCT00713609|541249964|FG003|Overall Study|Withdrawal by Subject|1|||
150030760|NCT00713609|541249965|FG004|Overall Study|Withdrawal by Subject|5|||
150030761|NCT00713609|541249966|FG005|Overall Study|Withdrawal by Subject|7|||
150030762|NCT00713609|541249961|FG000|Overall Study|Protocol Violation|6|||
150030763|NCT00713609|541249962|FG001|Overall Study|Protocol Violation|3|||
150030764|NCT00713609|541249963|FG002|Overall Study|Protocol Violation|1|||
150030765|NCT00713609|541249964|FG003|Overall Study|Protocol Violation|1|||
150030766|NCT00713609|541249965|FG004|Overall Study|Protocol Violation|2|||
150030767|NCT00713609|541249966|FG005|Overall Study|Protocol Violation|0|||
150030768|NCT01903356|541249967|FG000|Overall Study|Lost to Follow-up|7|||
150030769|NCT01903356|541249967|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
150030770|NCT01903356|541249967|FG000|Overall Study|Violated the dosage and administration|3|||
150030771|NCT04529083|541249968|FG000|Overall Study|Withdrawal by Subject|3|||
150030772|NCT04196686|541249973|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
150030773|NCT04196686|541249974|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
150030774|NCT00265564|541249979|FG000|Overall Study|Lost to Follow-up|5|||
150030775|NCT00265564|541249980|FG001|Overall Study|Lost to Follow-up|7|||
150030776|NCT00265564|541249979|FG000|Overall Study|met exclusion criteria|5|||
150030777|NCT00265564|541249980|FG001|Overall Study|met exclusion criteria|2|||
150030778|NCT01553084|541249983|FG000|Overall Study|Withdrawal by Subject|15|||
150030779|NCT01553084|541249984|FG001|Overall Study|Withdrawal by Subject|13|||
150030780|NCT01553084|541249985|FG002|Overall Study|Withdrawal by Subject|35|||
150030781|NCT04698343|541249986|FG000|Overall Study|Withdrawal by Subject|6|||
150030782|NCT04698343|541249986|FG000|Overall Study|Physician Decision|2|||
150030783|NCT04698343|541249986|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
150030784|NCT04698343|541249986|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
150030785|NCT04698343|541249986|FG000|Overall Study|Personal reasons|3|||
150030786|NCT04698343|541249986|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
150030787|NCT02756338|541249990|FG000|Overall Study|Withdrawn by Investigator|1|||
150030788|NCT02756338|541249990|FG000|Overall Study|Device Replaced with Pacemaker|4|||
150030789|NCT01339689|541249993|FG000|Overall Study|Adverse Event|1|||
150030790|NCT01339689|541249994|FG001|Overall Study|Adverse Event|2|||
150030791|NCT01339689|541249993|FG000|Overall Study|Lost to Follow-up|9|||
150030792|NCT01339689|541249994|FG001|Overall Study|Lost to Follow-up|3|||
150030793|NCT01339689|541249993|FG000|Overall Study|Withdrawal by Subject|3|||
150030794|NCT01339689|541249994|FG001|Overall Study|Withdrawal by Subject|0|||
150030795|NCT01339689|541249993|FG000|Overall Study|Noncompliance|1|||
150030796|NCT01339689|541249994|FG001|Overall Study|Noncompliance|0|||
150030797|NCT01339689|541249993|FG000|Overall Study|Relocated out of area|0|||
150030798|NCT01339689|541249994|FG001|Overall Study|Relocated out of area|1|||
150030799|NCT01339689|541249993|FG000|Overall Study|Other|2|||
150030800|NCT01339689|541249994|FG001|Overall Study|Other|2|||
150030801|NCT01339689|541249993|FG000|Overall Study|multiple reasons|1|||
150030802|NCT01339689|541249994|FG001|Overall Study|multiple reasons|1|||
150030803|NCT00659061|541249995|FG000|Overall Study|Migration due to political unrest|21|||
150030804|NCT00659061|541249996|FG001|Overall Study|Migration due to political unrest|15|||
150030805|NCT00467740|541250002|FG000|Overall Study|Adverse Event|0|||
150030806|NCT00467740|541250003|FG001|Overall Study|Adverse Event|0|||
150030807|NCT00467740|541250004|FG002|Overall Study|Adverse Event|1|||
150030808|NCT00467740|541250005|FG003|Overall Study|Adverse Event|0|||
150030809|NCT00467740|541250006|FG004|Overall Study|Adverse Event|0|||
150030810|NCT00467740|541250002|FG000|Overall Study|Protocol Violation|0|||
150030811|NCT00467740|541250003|FG001|Overall Study|Protocol Violation|0|||
150030812|NCT00467740|541250004|FG002|Overall Study|Protocol Violation|1|||
150030813|NCT00467740|541250005|FG003|Overall Study|Protocol Violation|0|||
150030814|NCT00467740|541250006|FG004|Overall Study|Protocol Violation|0|||
150030815|NCT00467740|541250002|FG000|Overall Study|Lost to Follow-up|0|||
150030816|NCT00467740|541250003|FG001|Overall Study|Lost to Follow-up|1|||
150030817|NCT00467740|541250004|FG002|Overall Study|Lost to Follow-up|0|||
150030818|NCT00467740|541250005|FG003|Overall Study|Lost to Follow-up|0|||
150030819|NCT00467740|541250006|FG004|Overall Study|Lost to Follow-up|0|||
150030820|NCT00467740|541250002|FG000|Overall Study|Withdrawal by Subject|1|||
150030821|NCT00467740|541250003|FG001|Overall Study|Withdrawal by Subject|1|||
150030822|NCT00467740|541250004|FG002|Overall Study|Withdrawal by Subject|0|||
150030823|NCT00467740|541250005|FG003|Overall Study|Withdrawal by Subject|1|||
150030824|NCT00467740|541250006|FG004|Overall Study|Withdrawal by Subject|0|||
150030825|NCT00467740|541250002|FG000|Overall Study|Lack of Efficacy|0|||
150030826|NCT00467740|541250003|FG001|Overall Study|Lack of Efficacy|1|||
150030827|NCT00467740|541250004|FG002|Overall Study|Lack of Efficacy|0|||
150030828|NCT00467740|541250005|FG003|Overall Study|Lack of Efficacy|0|||
150030829|NCT00467740|541250006|FG004|Overall Study|Lack of Efficacy|0|||
150030830|NCT00475670|541250007|FG000|Overall Study|Death|0|||
150030831|NCT00475670|541250008|FG001|Overall Study|Death|1|||
150030832|NCT00475670|541250007|FG000|Overall Study|Lack of Efficacy|3|||
150030833|NCT00475670|541250008|FG001|Overall Study|Lack of Efficacy|34|||
150030834|NCT00475670|541250007|FG000|Overall Study|Refused treatment|0|||
150030835|NCT00475670|541250008|FG001|Overall Study|Refused treatment|2|||
150030836|NCT00475670|541250007|FG000|Overall Study|Failure to Return|0|||
150030837|NCT00475670|541250008|FG001|Overall Study|Failure to Return|1|||
150030838|NCT00475670|541250007|FG000|Overall Study|Other|0|||
150030839|NCT00475670|541250008|FG001|Overall Study|Other|3|||
150030840|NCT00730158|541250009|FG000|Overall Study|Withdrawal by Subject|1|||
150030841|NCT00730158|541250010|FG001|Overall Study|Withdrawal by Subject|1|||
150030842|NCT01168349|541250011|FG000|Overall Study|Death|157|||
150030843|NCT01168349|541250011|FG000|Overall Study|Lost to Follow-up|34|||
150030844|NCT01168349|541250011|FG000|Overall Study|Withdrawal by Subject|9|||
150030845|NCT01168349|541250011|FG000|Overall Study|Kidney transplantation|3|||
150030846|NCT01168349|541250011|FG000|Overall Study|Other|22|||
150030847|NCT01168349|541250011|FG000|Overall Study|Protocol Violation|76|||
150030848|NCT02678351|541250012|FG000|Overall Study|Withdrawal by Subject|1|||
150030849|NCT01632020|541250013|FG000|Overall Study|Withdrawal by Subject|1|||
150030850|NCT01632020|541250014|FG001|Overall Study|Withdrawal by Subject|0|||
150030851|NCT01632020|541250013|FG000|Overall Study|Adverse Event|1|||
150030852|NCT01632020|541250014|FG001|Overall Study|Adverse Event|0|||
150030853|NCT04999839|541250015|FG000|Overall Study|Adverse Event|1|||
150030854|NCT04999839|541250016|FG001|Overall Study|Adverse Event|1|||
150030855|NCT04999839|541250017|FG002|Overall Study|Adverse Event|1|||
150030856|NCT04999839|541250018|FG003|Overall Study|Adverse Event|1|||
150030857|NCT04999839|541250019|FG004|Overall Study|Adverse Event|1|||
150030858|NCT04999839|541250015|FG000|Overall Study|Lost to Follow-up|2|||
150030859|NCT04999839|541250016|FG001|Overall Study|Lost to Follow-up|0|||
150030860|NCT04999839|541250017|FG002|Overall Study|Lost to Follow-up|2|||
150030861|NCT04999839|541250018|FG003|Overall Study|Lost to Follow-up|4|||
150030862|NCT04999839|541250019|FG004|Overall Study|Lost to Follow-up|1|||
150030863|NCT04999839|541250015|FG000|Overall Study|Withdrawal by Subject|6|||
150030864|NCT04999839|541250016|FG001|Overall Study|Withdrawal by Subject|5|||
150030865|NCT04999839|541250017|FG002|Overall Study|Withdrawal by Subject|3|||
150030866|NCT04999839|541250018|FG003|Overall Study|Withdrawal by Subject|2|||
150030867|NCT04999839|541250019|FG004|Overall Study|Withdrawal by Subject|2|||
150030868|NCT04999839|541250015|FG000|Overall Study|Lack of Efficacy|0|||
150030869|NCT04999839|541250016|FG001|Overall Study|Lack of Efficacy|1|||
150030870|NCT04999839|541250017|FG002|Overall Study|Lack of Efficacy|0|||
150030871|NCT04999839|541250018|FG003|Overall Study|Lack of Efficacy|0|||
150030872|NCT04999839|541250019|FG004|Overall Study|Lack of Efficacy|0|||
150030873|NCT04999839|541250015|FG000|Overall Study|Physician Decision|0|||
150030874|NCT04999839|541250016|FG001|Overall Study|Physician Decision|0|||
150030875|NCT04999839|541250017|FG002|Overall Study|Physician Decision|0|||
150030876|NCT04999839|541250018|FG003|Overall Study|Physician Decision|0|||
150030877|NCT04999839|541250019|FG004|Overall Study|Physician Decision|1|||
150030878|NCT04999839|541250015|FG000|Overall Study|Sponsor request|0|||
150030879|NCT04999839|541250016|FG001|Overall Study|Sponsor request|1|||
150030880|NCT04999839|541250017|FG002|Overall Study|Sponsor request|0|||
150030881|NCT04999839|541250018|FG003|Overall Study|Sponsor request|0|||
150030882|NCT04999839|541250019|FG004|Overall Study|Sponsor request|0|||
150030883|NCT04999839|541250015|FG000|Overall Study|Other|0|||
149936437|NCT03167242|540904618|FG006|Overall Study|Lost to Follow-up|2|||
149936438|NCT03167242|540904619|FG007|Overall Study|Lost to Follow-up|1|||
149936439|NCT03167242|540904620|FG008|Overall Study|Lost to Follow-up|0|||
149936440|NCT03167242|540904621|FG009|Overall Study|Lost to Follow-up|0|||
149936441|NCT03167242|540904622|FG010|Overall Study|Lost to Follow-up|1|||
149936442|NCT03167242|540904623|FG011|Overall Study|Lost to Follow-up|1|||
149936443|NCT03167242|540904612|FG000|Overall Study|Reason not provided|0|||
149936444|NCT03167242|540904613|FG001|Overall Study|Reason not provided|0|||
149936445|NCT03167242|540904614|FG002|Overall Study|Reason not provided|0|||
149936446|NCT03167242|540904615|FG003|Overall Study|Reason not provided|0|||
149936447|NCT03167242|540904616|FG004|Overall Study|Reason not provided|0|||
149936448|NCT03167242|540904617|FG005|Overall Study|Reason not provided|0|||
149936449|NCT03167242|540904618|FG006|Overall Study|Reason not provided|0|||
149936450|NCT03167242|540904619|FG007|Overall Study|Reason not provided|0|||
149936451|NCT03167242|540904620|FG008|Overall Study|Reason not provided|1|||
149936452|NCT03167242|540904621|FG009|Overall Study|Reason not provided|0|||
149936453|NCT03167242|540904622|FG010|Overall Study|Reason not provided|0|||
149936454|NCT03167242|540904623|FG011|Overall Study|Reason not provided|0|||
149936455|NCT01909804|540904627|FG000|Overall Study|Randomized but Never Treated|0|||
149936456|NCT01909804|540904628|FG001|Overall Study|Randomized but Never Treated|0|||
149936457|NCT01909804|540904629|FG002|Overall Study|Randomized but Never Treated|0|||
149936458|NCT01909804|540904630|FG003|Overall Study|Randomized but Never Treated|0|||
149936459|NCT01909804|540904631|FG004|Overall Study|Randomized but Never Treated|0|||
149936460|NCT01909804|540904632|FG005|Overall Study|Randomized but Never Treated|0|||
149936461|NCT01909804|540904633|FG006|Overall Study|Randomized but Never Treated|1|||
149936462|NCT01909804|540904634|FG007|Overall Study|Randomized but Never Treated|0|||
149936463|NCT01909804|540904635|FG008|Overall Study|Randomized but Never Treated|0|||
149936464|NCT01909804|540904636|FG009|Overall Study|Randomized but Never Treated|0|||
149936465|NCT01909804|540904637|FG010|Overall Study|Randomized but Never Treated|0|||
149936466|NCT01909804|540904638|FG011|Overall Study|Randomized but Never Treated|1|||
149936467|NCT01909804|540904627|FG000|Overall Study|Death|0|||
149936468|NCT01909804|540904628|FG001|Overall Study|Death|0|||
149936469|NCT01909804|540904629|FG002|Overall Study|Death|0|||
149936470|NCT01909804|540904630|FG003|Overall Study|Death|0|||
149936471|NCT01909804|540904631|FG004|Overall Study|Death|0|||
149936472|NCT01909804|540904632|FG005|Overall Study|Death|0|||
149936473|NCT01909804|540904633|FG006|Overall Study|Death|0|||
149936474|NCT01909804|540904634|FG007|Overall Study|Death|0|||
149936475|NCT01909804|540904635|FG008|Overall Study|Death|0|||
149936476|NCT01909804|540904636|FG009|Overall Study|Death|0|||
149936477|NCT01909804|540904637|FG010|Overall Study|Death|1|||
149936478|NCT01909804|540904638|FG011|Overall Study|Death|0|||
149936479|NCT01909804|540904627|FG000|Overall Study|Lack of Efficacy|4|||
149936480|NCT01909804|540904628|FG001|Overall Study|Lack of Efficacy|1|||
149936481|NCT01909804|540904629|FG002|Overall Study|Lack of Efficacy|0|||
149936482|NCT01909804|540904630|FG003|Overall Study|Lack of Efficacy|0|||
149936483|NCT01909804|540904631|FG004|Overall Study|Lack of Efficacy|7|||
149936484|NCT01909804|540904632|FG005|Overall Study|Lack of Efficacy|3|||
149936485|NCT01909804|540904633|FG006|Overall Study|Lack of Efficacy|1|||
149936486|NCT01909804|540904634|FG007|Overall Study|Lack of Efficacy|1|||
149936487|NCT01909804|540904635|FG008|Overall Study|Lack of Efficacy|0|||
149936488|NCT01909804|540904636|FG009|Overall Study|Lack of Efficacy|1|||
149936489|NCT01909804|540904637|FG010|Overall Study|Lack of Efficacy|0|||
149936490|NCT01909804|540904638|FG011|Overall Study|Lack of Efficacy|1|||
149936491|NCT01909804|540904627|FG000|Overall Study|Withdrew Consent|0|||
149936492|NCT01909804|540904628|FG001|Overall Study|Withdrew Consent|0|||
149936493|NCT01909804|540904629|FG002|Overall Study|Withdrew Consent|0|||
149936494|NCT01909804|540904630|FG003|Overall Study|Withdrew Consent|0|||
149936495|NCT01909804|540904631|FG004|Overall Study|Withdrew Consent|1|||
149936496|NCT01909804|540904632|FG005|Overall Study|Withdrew Consent|1|||
149936497|NCT01909804|540904633|FG006|Overall Study|Withdrew Consent|0|||
149936498|NCT01909804|540904634|FG007|Overall Study|Withdrew Consent|0|||
149936499|NCT01909804|540904635|FG008|Overall Study|Withdrew Consent|0|||
150168748|NCT00486759|541752526|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
150168749|NCT00486759|541752527|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
150168750|NCT01025843|541752528|FG000|Washout 4|Withdrawal by Subject|0|||
150168751|NCT01025843|541752529|FG001|Washout 4|Withdrawal by Subject|0|||
150168752|NCT01025843|541752530|FG002|Washout 4|Withdrawal by Subject|1|||
150168753|NCT01025843|541752531|FG003|Washout 4|Withdrawal by Subject|1|||
150168754|NCT01025843|541752532|FG004|Washout 4|Withdrawal by Subject|0|||
150168755|NCT01025843|541752533|FG005|Washout 4|Withdrawal by Subject|0|||
150168756|NCT01025843|541752534|FG006|Washout 4|Withdrawal by Subject|0|||
149936500|NCT01909804|540904636|FG009|Overall Study|Withdrew Consent|0|||
149936501|NCT01909804|540904637|FG010|Overall Study|Withdrew Consent|0|||
149936502|NCT01909804|540904638|FG011|Overall Study|Withdrew Consent|0|||
150168757|NCT01025843|541752535|FG007|Washout 4|Withdrawal by Subject|0|||
150168758|NCT01025843|541752536|FG008|Washout 4|Withdrawal by Subject|0|||
150168759|NCT01025843|541752537|FG009|Washout 4|Withdrawal by Subject|0|||
149936503|NCT01909804|540904627|FG000|Overall Study|Protocol Violation|0|||
149936504|NCT01909804|540904628|FG001|Overall Study|Protocol Violation|0|||
150030884|NCT04999839|541250016|FG001|Overall Study|Other|0|||
150030885|NCT04999839|541250017|FG002|Overall Study|Other|1|||
150030886|NCT04999839|541250018|FG003|Overall Study|Other|0|||
150030887|NCT04999839|541250019|FG004|Overall Study|Other|0|||
150030888|NCT03740048|541250020|FG000|Overall Study|Withdrawal by Subject|1|||
150030889|NCT03740048|541250021|FG001|Overall Study|Withdrawal by Subject|1|||
150030890|NCT03740048|541250020|FG000|Overall Study|Death|1|||
150030891|NCT03740048|541250021|FG001|Overall Study|Death|6|||
150030892|NCT03740048|541250020|FG000|Overall Study|Switched to thrice-weekly HD|2|||
150030893|NCT03740048|541250021|FG001|Overall Study|Switched to thrice-weekly HD|0|||
150030894|NCT03740048|541250020|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
150030895|NCT03740048|541250021|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
150030896|NCT03740048|541250020|FG000|Overall Study|Lost to Follow-up|0|||
150030897|NCT03740048|541250021|FG001|Overall Study|Lost to Follow-up|1|||
150030898|NCT03740048|541250020|FG000|Overall Study|Non-compliance with HD|0|||
150030899|NCT03740048|541250021|FG001|Overall Study|Non-compliance with HD|1|||
150030900|NCT01476722|541250023|FG000|Overall Study|Adverse Event|1|||
150030901|NCT00528957|541250024|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
150030902|NCT00528957|541250025|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
150030903|NCT00528957|541250024|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
150030904|NCT00528957|541250025|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
150030905|NCT00528957|541250024|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
150030906|NCT00528957|541250025|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
150030907|NCT00528957|541250024|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
150030908|NCT00528957|541250025|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
150030909|NCT00528957|541250024|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
150030910|NCT00528957|541250025|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
150030911|NCT00528957|541250024|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
150030912|NCT00528957|541250025|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
150030913|NCT00528957|541250024|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
150030914|NCT00528957|541250025|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
150030915|NCT00528957|541250024|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
150030916|NCT00528957|541250025|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
150030917|NCT00528957|541250024|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
150030918|NCT00528957|541250025|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
150030919|NCT00528957|541250024|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
150030920|NCT00528957|541250025|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
150030921|NCT00528957|541250024|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
150030922|NCT00528957|541250025|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
150030923|NCT00528957|541250024|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
150030924|NCT00528957|541250025|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
150030925|NCT00528957|541250024|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
150030926|NCT00528957|541250025|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
150270125|NCT01641809|542127379|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
150270126|NCT01641809|542127380|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
150270127|NCT01641809|542127377|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
150030927|NCT00528957|541250024|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
150030928|NCT00528957|541250025|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
150030929|NCT00528957|541250024|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
150030930|NCT00528957|541250025|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
150030931|NCT00528957|541250024|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
150030932|NCT00528957|541250025|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
150030933|NCT03416868|541250038|FG000|Overall Study|Withdrawal by Subject|2|||
150030934|NCT03416868|541250038|FG000|Overall Study|Lost to Follow-up|1|||
150030935|NCT01323582|541250039|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
150030936|NCT01323582|541250040|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
150030937|NCT01323582|541250039|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
150030938|NCT01323582|541250040|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
150030939|NCT01323582|541250039|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
150030940|NCT01323582|541250040|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
150030941|NCT03353675|541250065|FG000|Overall Study|Adverse Event|4|||
150030942|NCT00402168|541250066|FG000|Randomized|Lost to Follow-up|1|||
150030943|NCT00402168|541250067|FG001|Randomized|Lost to Follow-up|0|||
149820366|NCT01208402|540471796|FG001|Overall Study|Withdrawal by Subject|0|||
149820367|NCT01571635|540471797|FG000|Overall Study|Adverse Event|3|||
149820368|NCT01571635|540471798|FG001|Overall Study|Adverse Event|0|||
149820369|NCT01571635|540471799|FG002|Overall Study|Adverse Event|2|||
150270128|NCT01641809|542127378|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
150270129|NCT01641809|542127379|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
150270130|NCT01641809|542127380|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
150270131|NCT01641809|542127377|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
150270132|NCT01641809|542127378|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
150270133|NCT01641809|542127379|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
150270134|NCT01641809|542127380|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
150030944|NCT00402168|541250066|FG000|Randomized|Withdrawal by Subject|0|||
150030945|NCT00402168|541250067|FG001|Randomized|Withdrawal by Subject|1|||
150030946|NCT00402168|541250066|FG000|Treatment (up to 12 Months)|Death|0|||
150030947|NCT00402168|541250067|FG001|Treatment (up to 12 Months)|Death|1|||
150030948|NCT00402168|541250066|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
150030949|NCT00402168|541250067|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
150030950|NCT00402168|541250066|FG000|Treatment (up to 12 Months)|non-specified|0|||
150030951|NCT00402168|541250067|FG001|Treatment (up to 12 Months)|non-specified|1|||
150030952|NCT00402168|541250066|FG000|Long Term (LT)|Adverse Event|1|||
150030953|NCT00402168|541250067|FG001|Long Term (LT)|Adverse Event|5|||
150030954|NCT00402168|541250066|FG000|Long Term (LT)|Withdrawal by Subject|4|||
150030955|NCT00402168|541250067|FG001|Long Term (LT)|Withdrawal by Subject|7|||
150030956|NCT00402168|541250066|FG000|Long Term (LT)|Pregnancy|0|||
150030957|NCT00402168|541250067|FG001|Long Term (LT)|Pregnancy|1|||
150030958|NCT00402168|541250066|FG000|Long Term (LT)|Lost to Follow-up|1|||
150030959|NCT00402168|541250067|FG001|Long Term (LT)|Lost to Follow-up|0|||
150030960|NCT00402168|541250066|FG000|Long Term (LT)|Death|4|||
150030961|NCT00402168|541250067|FG001|Long Term (LT)|Death|0|||
150030962|NCT00402168|541250066|FG000|Long Term (LT)|Lack of Efficacy|0|||
150030963|NCT00402168|541250067|FG001|Long Term (LT)|Lack of Efficacy|2|||
150030964|NCT00402168|541250066|FG000|Long Term (LT)|non-specified|1|||
150030965|NCT00402168|541250067|FG001|Long Term (LT)|non-specified|2|||
150030966|NCT00402168|541250066|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
150030967|NCT00402168|541250067|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
150030968|NCT00402168|541250066|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
150030969|NCT00402168|541250067|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
150030970|NCT02370420|541250073|FG000|Overall Study|Physician Decision|3|||
150030971|NCT02370420|541250074|FG001|Overall Study|Physician Decision|3|||
150030972|NCT02370420|541250073|FG000|Overall Study|Lost to Follow-up|11|||
150030973|NCT02370420|541250074|FG001|Overall Study|Lost to Follow-up|9|||
150030974|NCT00410956|541250077|FG000|Overall Study|Adverse Event|1|||
150030975|NCT00410956|541250077|FG000|Overall Study|Death|2|||
150030976|NCT00410956|541250077|FG000|Overall Study|Lack of Efficacy|10|||
150030977|NCT00410956|541250077|FG000|Overall Study|Physician Decision|6|||
150030978|NCT00880698|541250080|FG000|Overall Study|Death|0|||
150030979|NCT00880698|541250081|FG001|Overall Study|Death|0|||
150030980|NCT00880698|541250082|FG002|Overall Study|Death|1|||
150030981|NCT00880698|541250083|FG003|Overall Study|Death|2|||
150030982|NCT00880698|541250080|FG000|Overall Study|Lost to Follow-up|1|||
150030983|NCT00880698|541250081|FG001|Overall Study|Lost to Follow-up|3|||
150030984|NCT00880698|541250082|FG002|Overall Study|Lost to Follow-up|0|||
150030985|NCT00880698|541250083|FG003|Overall Study|Lost to Follow-up|1|||
150030986|NCT03284710|541252493|FG000|Overall Study|Withdrawal by Subject|1|||
150030987|NCT03284710|541252494|FG001|Overall Study|Withdrawal by Subject|0|||
150030988|NCT03284710|541252495|FG002|Overall Study|Withdrawal by Subject|1|||
150030989|NCT03284710|541252496|FG003|Overall Study|Withdrawal by Subject|6|||
150030990|NCT03284710|541252493|FG000|Overall Study|Lost to Follow-up|3|||
150030991|NCT03284710|541252494|FG001|Overall Study|Lost to Follow-up|3|||
150030992|NCT03284710|541252495|FG002|Overall Study|Lost to Follow-up|1|||
150030993|NCT03284710|541252496|FG003|Overall Study|Lost to Follow-up|0|||
150030994|NCT03284710|541252493|FG000|Overall Study|Physician Decision|1|||
150030995|NCT03284710|541252494|FG001|Overall Study|Physician Decision|0|||
150030996|NCT03284710|541252495|FG002|Overall Study|Physician Decision|0|||
150030997|NCT03284710|541252496|FG003|Overall Study|Physician Decision|0|||
150030998|NCT03284710|541252493|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
150030999|NCT03284710|541252494|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
150031000|NCT03284710|541252495|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
150031001|NCT03284710|541252496|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
150031002|NCT03284710|541252493|FG000|Overall Study|HIV Infection|0|||
150031003|NCT03284710|541252494|FG001|Overall Study|HIV Infection|2|||
150031004|NCT03284710|541252495|FG002|Overall Study|HIV Infection|2|||
150031005|NCT03284710|541252496|FG003|Overall Study|HIV Infection|1|||
150031006|NCT05546476|541252498|FG000|Period 1: Part A|Adverse Event|2|||
150031007|NCT05546476|541252499|FG001|Period 1: Part A|Adverse Event|0|||
150031008|NCT05546476|541252500|FG002|Period 1: Part A|Adverse Event|0|||
150031009|NCT05546476|541252501|FG003|Period 1: Part A|Adverse Event|1|||
150031010|NCT05546476|541252498|FG000|Period 1: Part A|Death|4|||
150031011|NCT05546476|541252499|FG001|Period 1: Part A|Death|4|||
150031012|NCT05546476|541252500|FG002|Period 1: Part A|Death|5|||
150031013|NCT05546476|541252501|FG003|Period 1: Part A|Death|6|||
149936505|NCT01909804|540904629|FG002|Overall Study|Protocol Violation|0|||
149936506|NCT01909804|540904630|FG003|Overall Study|Protocol Violation|0|||
149936507|NCT01909804|540904631|FG004|Overall Study|Protocol Violation|0|||
149936508|NCT01909804|540904632|FG005|Overall Study|Protocol Violation|0|||
149936509|NCT01909804|540904633|FG006|Overall Study|Protocol Violation|0|||
149936510|NCT01909804|540904634|FG007|Overall Study|Protocol Violation|0|||
149936511|NCT01909804|540904635|FG008|Overall Study|Protocol Violation|0|||
149936512|NCT01909804|540904636|FG009|Overall Study|Protocol Violation|0|||
149936513|NCT01909804|540904637|FG010|Overall Study|Protocol Violation|0|||
149936514|NCT01909804|540904638|FG011|Overall Study|Protocol Violation|1|||
149936515|NCT05401565|540904639|FG000|Overall Study|Lost to Follow-up|1|||
149936516|NCT05401565|540904640|FG001|Overall Study|Lost to Follow-up|0|||
149936517|NCT05401565|540904639|FG000|Overall Study|Adverse Event|2|||
149936518|NCT05401565|540904640|FG001|Overall Study|Adverse Event|0|||
149936519|NCT03080935|540904643|FG000|Overall Study|Death|34|||
149936520|NCT03080935|540904644|FG001|Overall Study|Death|50|||
149936521|NCT03080935|540904643|FG000|Overall Study|Lost to Follow-up|5|||
149936522|NCT03080935|540904644|FG001|Overall Study|Lost to Follow-up|4|||
149936523|NCT03080935|540904643|FG000|Overall Study|Withdrawal by Subject|11|||
149936524|NCT03080935|540904644|FG001|Overall Study|Withdrawal by Subject|15|||
149936525|NCT03118934|540904645|FG000|Overall Study|Adverse Event|0|||
149936526|NCT03118934|540904646|FG001|Overall Study|Adverse Event|0|||
149936527|NCT03118934|540904647|FG002|Overall Study|Adverse Event|0|||
149936528|NCT03118934|540904648|FG003|Overall Study|Adverse Event|0|||
149936529|NCT03118934|540904649|FG004|Overall Study|Adverse Event|0|||
149936530|NCT03118934|540904650|FG005|Overall Study|Adverse Event|1|||
149936531|NCT03118934|540904645|FG000|Overall Study|Physician Decision|0|||
149936532|NCT03118934|540904646|FG001|Overall Study|Physician Decision|0|||
149936533|NCT03118934|540904647|FG002|Overall Study|Physician Decision|0|||
149936534|NCT03118934|540904648|FG003|Overall Study|Physician Decision|0|||
149936535|NCT03118934|540904649|FG004|Overall Study|Physician Decision|0|||
149936536|NCT03118934|540904650|FG005|Overall Study|Physician Decision|1|||
149936537|NCT03118934|540904645|FG000|Overall Study|Discontinued prior to exposure|0|||
149936538|NCT03118934|540904646|FG001|Overall Study|Discontinued prior to exposure|1|||
149936539|NCT03118934|540904647|FG002|Overall Study|Discontinued prior to exposure|1|||
149936540|NCT03118934|540904648|FG003|Overall Study|Discontinued prior to exposure|1|||
149936541|NCT03118934|540904649|FG004|Overall Study|Discontinued prior to exposure|2|||
149936542|NCT03118934|540904650|FG005|Overall Study|Discontinued prior to exposure|0|||
149936543|NCT04249427|540904652|FG000|Overall Study|Adverse Event|3|||
149936544|NCT04249427|540904653|FG001|Overall Study|Adverse Event|1|||
149936545|NCT04249427|540904652|FG000|Overall Study|Lack of Efficacy|0|||
149936546|NCT04249427|540904653|FG001|Overall Study|Lack of Efficacy|1|||
149936547|NCT04249427|540904652|FG000|Overall Study|Withdrawal by Subject|1|||
149936548|NCT04249427|540904653|FG001|Overall Study|Withdrawal by Subject|2|||
149936549|NCT03886272|540904654|FG000|Period 1|Withdrawal by Subject|0|||
149936550|NCT03886272|540904655|FG001|Period 1|Withdrawal by Subject|0|||
149936551|NCT03886272|540904656|FG002|Period 1|Withdrawal by Subject|0|||
149936552|NCT03886272|540904657|FG003|Period 1|Withdrawal by Subject|0|||
149936553|NCT03886272|540904658|FG004|Period 1|Withdrawal by Subject|0|||
149936554|NCT03886272|540904659|FG005|Period 1|Withdrawal by Subject|1|||
149936555|NCT03886272|540904660|FG006|Period 1|Withdrawal by Subject|0|||
149936556|NCT00402727|540904663|FG000|Overall Study|Adverse Event|10|||
149936557|NCT00402727|540904664|FG001|Overall Study|Adverse Event|6|||
149936558|NCT00402727|540904663|FG000|Overall Study|Death|1|||
149936559|NCT00402727|540904664|FG001|Overall Study|Death|0|||
149936560|NCT00402727|540904663|FG000|Overall Study|Lack of Efficacy|1|||
149936561|NCT00402727|540904664|FG001|Overall Study|Lack of Efficacy|3|||
149936562|NCT00402727|540904663|FG000|Overall Study|Lost to Follow-up|24|||
149936563|NCT00402727|540904664|FG001|Overall Study|Lost to Follow-up|11|||
149936564|NCT00402727|540904663|FG000|Overall Study|Physician Decision|1|||
149936565|NCT00402727|540904664|FG001|Overall Study|Physician Decision|1|||
149936566|NCT00402727|540904663|FG000|Overall Study|Protocol Violation|0|||
149936567|NCT00402727|540904664|FG001|Overall Study|Protocol Violation|4|||
149936568|NCT00402727|540904663|FG000|Overall Study|Withdrawal by Subject|3|||
149936569|NCT00402727|540904664|FG001|Overall Study|Withdrawal by Subject|7|||
149936570|NCT00402727|540904663|FG000|Overall Study|supply problems|2|||
149936571|NCT00402727|540904664|FG001|Overall Study|supply problems|1|||
149936572|NCT00402727|540904663|FG000|Overall Study|non-compliance|0|||
149936573|NCT00402727|540904664|FG001|Overall Study|non-compliance|1|||
149936574|NCT03372798|540904665|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
150168760|NCT01649791|541752540|FG000|Overall Study|Disease Progression|2|||
150168761|NCT01649791|541752540|FG000|Overall Study|Adverse Event|1|||
150168762|NCT02987543|541752541|FG000|Overall Study|Ongoing study at data cut off|49|||
150168763|NCT02987543|541752542|FG001|Overall Study|Ongoing study at data cut off|21|||
149936575|NCT03372798|540904666|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
149936576|NCT03372798|540904665|FG000|Overall Study|Failure of imaging probe|0|||
149936577|NCT03372798|540904666|FG001|Overall Study|Failure of imaging probe|1|||
150168764|NCT02987543|541752543|FG002|Overall Study|Ongoing study at data cut off|19|||
149936578|NCT03608826|540904667|FG000|Overall Study|Death|3|||
150031014|NCT05546476|541252498|FG000|Period 1: Part A|Lack of Efficacy|0|||
150031015|NCT05546476|541252499|FG001|Period 1: Part A|Lack of Efficacy|0|||
150031016|NCT05546476|541252500|FG002|Period 1: Part A|Lack of Efficacy|0|||
150031017|NCT05546476|541252501|FG003|Period 1: Part A|Lack of Efficacy|1|||
150031018|NCT05546476|541252498|FG000|Period 1: Part A|Lost to Follow-up|0|||
150031019|NCT05546476|541252499|FG001|Period 1: Part A|Lost to Follow-up|0|||
150031020|NCT05546476|541252500|FG002|Period 1: Part A|Lost to Follow-up|0|||
150031021|NCT05546476|541252501|FG003|Period 1: Part A|Lost to Follow-up|1|||
150270135|NCT01641809|542127377|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
150270136|NCT01641809|542127378|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
150270137|NCT01641809|542127379|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
150270138|NCT01641809|542127380|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
150270139|NCT01641809|542127377|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
150270140|NCT01641809|542127378|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
150270141|NCT01641809|542127379|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
150270142|NCT01641809|542127380|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
150270143|NCT01641809|542127377|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
150270144|NCT01641809|542127378|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
150270145|NCT01641809|542127379|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
150270146|NCT01641809|542127380|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
150270147|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
150270148|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
150270149|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
150270150|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
150270151|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
150270152|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
150270153|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
150270154|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
150270155|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
150270156|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
150270157|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
150270158|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
150270159|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
150270160|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
150270161|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
150270162|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
150270163|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
150270164|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
150270165|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
150270166|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
150270167|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
150270168|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
150270169|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
150270170|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
150270171|NCT01641809|542127377|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
150270172|NCT01641809|542127378|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
150270173|NCT01641809|542127379|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
150270174|NCT01641809|542127380|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
150270175|NCT03294109|542127383|FG000|Overall Study|Withdrawal by Subject|6|||
150270176|NCT03294109|542127384|FG001|Overall Study|Withdrawal by Subject|5|||
150270177|NCT03690141|542127385|FG000|Overall Study|Adverse Event|5|||
150270178|NCT03690141|542127385|FG000|Overall Study|Withdrawal by Subject|3|||
150270179|NCT03690141|542127385|FG000|Overall Study|Physician Decision|4|||
150270180|NCT03690141|542127385|FG000|Overall Study|Disease progression|4|||
150270181|NCT04744285|542127386|FG000|Overall Study|Withdrawal by Subject|1|||
150270182|NCT04744285|542127387|FG001|Overall Study|Withdrawal by Subject|1|||
150270183|NCT04744285|542127388|FG002|Overall Study|Withdrawal by Subject|2|||
150270184|NCT04744285|542127389|FG003|Overall Study|Withdrawal by Subject|1|||
150270185|NCT01717768|542127390|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150031022|NCT05546476|541252498|FG000|Period 1: Part A|Physician Decision|1|||
150031023|NCT05546476|541252499|FG001|Period 1: Part A|Physician Decision|0|||
150031024|NCT05546476|541252500|FG002|Period 1: Part A|Physician Decision|0|||
150031025|NCT05546476|541252501|FG003|Period 1: Part A|Physician Decision|0|||
150031026|NCT05546476|541252498|FG000|Period 1: Part A|Progressive disease|3|||
150031027|NCT05546476|541252499|FG001|Period 1: Part A|Progressive disease|5|||
150031028|NCT05546476|541252500|FG002|Period 1: Part A|Progressive disease|0|||
150031029|NCT05546476|541252501|FG003|Period 1: Part A|Progressive disease|1|||
150031030|NCT05546476|541252498|FG000|Period 1: Part A|Withdrawal by Subject|1|||
149820370|NCT01571635|540471800|FG003|Overall Study|Adverse Event|3|||
150031031|NCT05546476|541252499|FG001|Period 1: Part A|Withdrawal by Subject|1|||
149936579|NCT03608826|540904667|FG000|Overall Study|Heart Transplant|3|||
149936580|NCT03608826|540904667|FG000|Overall Study|Physician Decision|4|||
149936581|NCT00887484|540904693|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
149936582|NCT00887484|540904693|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
149936583|NCT00887484|540904693|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
149936584|NCT03044314|540904699|FG000|Overall Study|Physician Decision|2|||
149936585|NCT03044314|540904699|FG000|Overall Study|Withdrawal by Subject|1|||
149936586|NCT03044314|540904699|FG000|Overall Study|Connector tubing not available|1|||
149936587|NCT00264147|540904700|FG000|Treatment I Period|Adverse Event|3|||
149936588|NCT00264147|540904701|FG001|Treatment I Period|Adverse Event|6|||
149936589|NCT00264147|540904702|FG002|Treatment I Period|Adverse Event|3|||
149936590|NCT00264147|540904703|FG003|Treatment I Period|Adverse Event|5|||
149936591|NCT00264147|540904704|FG004|Treatment I Period|Adverse Event|7|||
149936592|NCT00264147|540904705|FG005|Treatment I Period|Adverse Event|0|||
149936593|NCT00264147|540904700|FG000|Treatment I Period|Laboratory Adverse Event|0|||
149936594|NCT00264147|540904701|FG001|Treatment I Period|Laboratory Adverse Event|0|||
149936595|NCT00264147|540904702|FG002|Treatment I Period|Laboratory Adverse Event|0|||
149936596|NCT00264147|540904703|FG003|Treatment I Period|Laboratory Adverse Event|1|||
149936597|NCT00264147|540904704|FG004|Treatment I Period|Laboratory Adverse Event|0|||
149936598|NCT00264147|540904705|FG005|Treatment I Period|Laboratory Adverse Event|0|||
149936599|NCT00264147|540904700|FG000|Treatment I Period|Lack of Efficacy|6|||
149936600|NCT00264147|540904701|FG001|Treatment I Period|Lack of Efficacy|2|||
149936601|NCT00264147|540904702|FG002|Treatment I Period|Lack of Efficacy|8|||
149936602|NCT00264147|540904703|FG003|Treatment I Period|Lack of Efficacy|0|||
149936603|NCT00264147|540904704|FG004|Treatment I Period|Lack of Efficacy|1|||
149936604|NCT00264147|540904705|FG005|Treatment I Period|Lack of Efficacy|0|||
149936605|NCT00264147|540904700|FG000|Treatment I Period|Lost to Follow-up|1|||
149936606|NCT00264147|540904701|FG001|Treatment I Period|Lost to Follow-up|0|||
149936607|NCT00264147|540904702|FG002|Treatment I Period|Lost to Follow-up|0|||
149936608|NCT00264147|540904703|FG003|Treatment I Period|Lost to Follow-up|1|||
149936609|NCT00264147|540904704|FG004|Treatment I Period|Lost to Follow-up|1|||
149936610|NCT00264147|540904705|FG005|Treatment I Period|Lost to Follow-up|0|||
149936611|NCT00264147|540904700|FG000|Treatment I Period|Protocol Violation|2|||
149936612|NCT00264147|540904701|FG001|Treatment I Period|Protocol Violation|2|||
149936613|NCT00264147|540904702|FG002|Treatment I Period|Protocol Violation|0|||
149936614|NCT00264147|540904703|FG003|Treatment I Period|Protocol Violation|0|||
149936615|NCT00264147|540904704|FG004|Treatment I Period|Protocol Violation|0|||
149936616|NCT00264147|540904705|FG005|Treatment I Period|Protocol Violation|0|||
149936617|NCT00264147|540904700|FG000|Treatment I Period|Withdrawal by Subject|2|||
149936618|NCT00264147|540904701|FG001|Treatment I Period|Withdrawal by Subject|0|||
149936619|NCT00264147|540904702|FG002|Treatment I Period|Withdrawal by Subject|0|||
149936620|NCT00264147|540904703|FG003|Treatment I Period|Withdrawal by Subject|2|||
149936621|NCT00264147|540904704|FG004|Treatment I Period|Withdrawal by Subject|2|||
149936622|NCT00264147|540904705|FG005|Treatment I Period|Withdrawal by Subject|0|||
149936623|NCT00264147|540904700|FG000|Treatment I Period|Patient out of town for an extended time|0|||
149936624|NCT00264147|540904701|FG001|Treatment I Period|Patient out of town for an extended time|1|||
149936625|NCT00264147|540904702|FG002|Treatment I Period|Patient out of town for an extended time|0|||
149936626|NCT00264147|540904703|FG003|Treatment I Period|Patient out of town for an extended time|0|||
149936627|NCT00264147|540904704|FG004|Treatment I Period|Patient out of town for an extended time|0|||
149936628|NCT00264147|540904705|FG005|Treatment I Period|Patient out of town for an extended time|0|||
149936629|NCT00264147|540904700|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
149936630|NCT00264147|540904701|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
149936631|NCT00264147|540904702|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
149936632|NCT00264147|540904703|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
149936633|NCT00264147|540904704|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
149936634|NCT00264147|540904705|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
149936635|NCT00264147|540904700|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
149936636|NCT00264147|540904701|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
149936637|NCT00264147|540904702|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
149936638|NCT00264147|540904703|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
149936639|NCT00264147|540904704|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
150168765|NCT02987543|541752544|FG003|Overall Study|Ongoing study at data cut off|12|||
150168766|NCT02987543|541752541|FG000|Overall Study|Death|88|||
150168767|NCT02987543|541752542|FG001|Overall Study|Death|54|||
150168768|NCT02987543|541752543|FG002|Overall Study|Death|67|||
150168769|NCT02987543|541752544|FG003|Overall Study|Death|28|||
150168770|NCT02987543|541752541|FG000|Overall Study|Lost to Follow-up|3|||
150168771|NCT02987543|541752542|FG001|Overall Study|Lost to Follow-up|0|||
149936640|NCT00264147|540904705|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
149936641|NCT00264147|540904700|FG000|Treatment II Period|Adverse Event|0|||
149936642|NCT00264147|540904701|FG001|Treatment II Period|Adverse Event|0|||
150168772|NCT02987543|541752543|FG002|Overall Study|Lost to Follow-up|1|||
150168773|NCT02987543|541752544|FG003|Overall Study|Lost to Follow-up|0|||
150031032|NCT05546476|541252500|FG002|Period 1: Part A|Withdrawal by Subject|1|||
150031033|NCT05546476|541252501|FG003|Period 1: Part A|Withdrawal by Subject|2|||
150031034|NCT05546476|541252498|FG000|Period 1: Part A|Global deterioration of health status|2|||
150031035|NCT05546476|541252499|FG001|Period 1: Part A|Global deterioration of health status|2|||
150031036|NCT05546476|541252500|FG002|Period 1: Part A|Global deterioration of health status|1|||
150031037|NCT05546476|541252501|FG003|Period 1: Part A|Global deterioration of health status|4|||
150031038|NCT05546476|541252498|FG000|Period 1: Part A|Other: Unspecified|0|||
150031039|NCT05546476|541252499|FG001|Period 1: Part A|Other: Unspecified|2|||
149936643|NCT00264147|540904702|FG002|Treatment II Period|Adverse Event|0|||
149936644|NCT00264147|540904703|FG003|Treatment II Period|Adverse Event|0|||
149936645|NCT00264147|540904704|FG004|Treatment II Period|Adverse Event|9|||
149936646|NCT00264147|540904705|FG005|Treatment II Period|Adverse Event|9|||
149936647|NCT00264147|540904700|FG000|Treatment II Period|Laboratory Adverse Event|0|||
149936648|NCT00264147|540904701|FG001|Treatment II Period|Laboratory Adverse Event|0|||
149936649|NCT00264147|540904702|FG002|Treatment II Period|Laboratory Adverse Event|0|||
149936650|NCT00264147|540904703|FG003|Treatment II Period|Laboratory Adverse Event|0|||
149936651|NCT00264147|540904704|FG004|Treatment II Period|Laboratory Adverse Event|0|||
149936652|NCT00264147|540904705|FG005|Treatment II Period|Laboratory Adverse Event|1|||
149936653|NCT00264147|540904700|FG000|Treatment II Period|Lack of Efficacy|0|||
149936654|NCT00264147|540904701|FG001|Treatment II Period|Lack of Efficacy|0|||
149936655|NCT00264147|540904702|FG002|Treatment II Period|Lack of Efficacy|0|||
149936656|NCT00264147|540904703|FG003|Treatment II Period|Lack of Efficacy|0|||
149936657|NCT00264147|540904704|FG004|Treatment II Period|Lack of Efficacy|20|||
149936658|NCT00264147|540904705|FG005|Treatment II Period|Lack of Efficacy|19|||
149936659|NCT00264147|540904700|FG000|Treatment II Period|Lost to Follow-up|0|||
149936660|NCT00264147|540904701|FG001|Treatment II Period|Lost to Follow-up|0|||
149936661|NCT00264147|540904702|FG002|Treatment II Period|Lost to Follow-up|0|||
149936662|NCT00264147|540904703|FG003|Treatment II Period|Lost to Follow-up|0|||
149936663|NCT00264147|540904704|FG004|Treatment II Period|Lost to Follow-up|1|||
149936664|NCT00264147|540904705|FG005|Treatment II Period|Lost to Follow-up|1|||
149936665|NCT00264147|540904700|FG000|Treatment II Period|Withdrawal by Subject|0|||
149936666|NCT00264147|540904701|FG001|Treatment II Period|Withdrawal by Subject|0|||
149936667|NCT00264147|540904702|FG002|Treatment II Period|Withdrawal by Subject|0|||
149936668|NCT00264147|540904703|FG003|Treatment II Period|Withdrawal by Subject|0|||
149936669|NCT00264147|540904704|FG004|Treatment II Period|Withdrawal by Subject|3|||
149936670|NCT00264147|540904705|FG005|Treatment II Period|Withdrawal by Subject|2|||
149936671|NCT00264147|540904700|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
149936672|NCT00264147|540904701|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
149936673|NCT00264147|540904702|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
149936674|NCT00264147|540904703|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
149936675|NCT00264147|540904704|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
149936676|NCT00264147|540904705|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
149936677|NCT01316224|540904706|FG000|Overall Study|Protocol Violation|3|||
149936678|NCT01316224|540904706|FG000|Overall Study|Adverse Event|3|||
149936679|NCT01316224|540904706|FG000|Overall Study|Lack of Efficacy|1|||
149936680|NCT01316224|540904706|FG000|Overall Study|Withdrawal by Subject|1|||
149936681|NCT01316224|540904706|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
149936682|NCT01316224|540904706|FG000|Overall Study|Other|1|||
149936683|NCT05158140|540904707|FG000|Overall Study|Death|0|||
149936684|NCT05158140|540904708|FG001|Overall Study|Death|0|||
149936685|NCT05158140|540904709|FG002|Overall Study|Death|0|||
149936686|NCT05158140|540904710|FG003|Overall Study|Death|1|||
149936687|NCT05158140|540904707|FG000|Overall Study|Lost to Follow-up|3|||
149936688|NCT05158140|540904708|FG001|Overall Study|Lost to Follow-up|6|||
149936689|NCT05158140|540904709|FG002|Overall Study|Lost to Follow-up|4|||
149936690|NCT05158140|540904710|FG003|Overall Study|Lost to Follow-up|3|||
149936691|NCT05158140|540904707|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149936692|NCT05158140|540904708|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149936693|NCT05158140|540904709|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
149936694|NCT05158140|540904710|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
150031040|NCT05546476|541252500|FG002|Period 1: Part A|Other: Unspecified|0|||
150031041|NCT05546476|541252501|FG003|Period 1: Part A|Other: Unspecified|0|||
150031042|NCT05546476|541252498|FG000|Period 2: Part B|Ongoing|26|||
150031043|NCT05546476|541252499|FG001|Period 2: Part B|Ongoing|27|||
150031044|NCT05546476|541252500|FG002|Period 2: Part B|Ongoing|35|||
150031045|NCT05546476|541252501|FG003|Period 2: Part B|Ongoing|29|||
150031046|NCT03760029|541252504|FG000|Overall Study|Death|1|||
149936695|NCT05158140|540904707|FG000|Overall Study|Withdrawal by Subject|3|||
149936696|NCT05158140|540904708|FG001|Overall Study|Withdrawal by Subject|7|||
149936697|NCT05158140|540904709|FG002|Overall Study|Withdrawal by Subject|3|||
149936698|NCT05158140|540904710|FG003|Overall Study|Withdrawal by Subject|7|||
149936699|NCT03312738|540906567|FG000|Overall Study|Progressive disease|58|||
149936700|NCT03312738|540906568|FG001|Overall Study|Progressive disease|67|||
150031047|NCT03760029|541252505|FG001|Overall Study|Death|0|||
150031048|NCT03760029|541252506|FG002|Overall Study|Death|0|||
150031049|NCT03760029|541252504|FG000|Overall Study|Lost to Follow-up|0|||
150031050|NCT03760029|541252505|FG001|Overall Study|Lost to Follow-up|2|||
150031051|NCT03760029|541252506|FG002|Overall Study|Lost to Follow-up|1|||
150031052|NCT03760029|541252504|FG000|Overall Study|Withdrawal by Subject|1|||
150031053|NCT03760029|541252505|FG001|Overall Study|Withdrawal by Subject|4|||
150031054|NCT03760029|541252506|FG002|Overall Study|Withdrawal by Subject|1|||
150031055|NCT03760029|541252504|FG000|Overall Study|Withdrawal by parent/guardian|4|||
150031056|NCT03760029|541252505|FG001|Overall Study|Withdrawal by parent/guardian|4|||
150031057|NCT03760029|541252506|FG002|Overall Study|Withdrawal by parent/guardian|1|||
150031058|NCT03760029|541252504|FG000|Overall Study|Other|2|||
150031059|NCT03760029|541252505|FG001|Overall Study|Other|1|||
150031060|NCT03760029|541252506|FG002|Overall Study|Other|0|||
150031061|NCT01706458|541252511|FG000|Overall Study|Physician Decision|3|||
150031062|NCT01706458|541252512|FG001|Overall Study|Physician Decision|4|||
150031063|NCT02384551|541252517|FG000|Overall Study|Lost to Follow-up|13|||
150031064|NCT02384551|541252518|FG001|Overall Study|Lost to Follow-up|14|||
150031065|NCT02384551|541252519|FG002|Overall Study|Lost to Follow-up|14|||
150031066|NCT02384551|541252520|FG003|Overall Study|Lost to Follow-up|14|||
150031067|NCT04349891|541252521|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
150031068|NCT04349891|541252522|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
150031069|NCT04349891|541252521|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
150031070|NCT04349891|541252522|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
150031071|NCT04349891|541252521|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
150031072|NCT04349891|541252522|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
150031073|NCT04349891|541252521|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
150031074|NCT04349891|541252522|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
150031075|NCT03448406|541252525|FG000|Overall Study|Noncompliance of scheduled visits|1|||
150031076|NCT03448406|541252526|FG001|Overall Study|Noncompliance of scheduled visits|2|||
150031077|NCT03448406|541252525|FG000|Overall Study|Withdrawal by Subject|1|||
150031078|NCT03448406|541252526|FG001|Overall Study|Withdrawal by Subject|2|||
150031079|NCT03448406|541252525|FG000|Overall Study|Protocol Violation|1|||
150031080|NCT03448406|541252526|FG001|Overall Study|Protocol Violation|0|||
150031081|NCT03448406|541252525|FG000|Overall Study|Adverse Event|8|||
150031082|NCT03448406|541252526|FG001|Overall Study|Adverse Event|9|||
150031083|NCT00087152|541252527|FG000|Overall Study|Ineligible|6|||
150031084|NCT01292486|541252528|FG000|Overall Study|Protocol Violation|2|||
150031085|NCT01292486|541252528|FG000|Overall Study|Did not meet screening criteria|2|||
150031086|NCT01292486|541252528|FG000|Overall Study|Adverse Event|1|||
150031087|NCT01292486|541252528|FG000|Overall Study|Physician Decision|1|||
150031088|NCT04602390|541252534|FG000|Overall Study|Withdrawal by Subject|0|||
150031089|NCT04602390|541252535|FG001|Overall Study|Withdrawal by Subject|0|||
150031090|NCT04602390|541252536|FG002|Overall Study|Withdrawal by Subject|0|||
149936701|NCT03312738|540906567|FG000|Overall Study|Patient/guardian decision|13|||
149936702|NCT03312738|540906568|FG001|Overall Study|Patient/guardian decision|5|||
149936703|NCT03312738|540906567|FG000|Overall Study|Adverse Event|5|||
149936704|NCT03312738|540906568|FG001|Overall Study|Adverse Event|3|||
150031091|NCT04602390|541252537|FG003|Overall Study|Withdrawal by Subject|0|||
150031092|NCT04602390|541252538|FG004|Overall Study|Withdrawal by Subject|1|||
150031093|NCT04602390|541252539|FG005|Overall Study|Withdrawal by Subject|0|||
150031094|NCT04602390|541252534|FG000|Overall Study|Adverse Event|0|||
150031095|NCT04602390|541252535|FG001|Overall Study|Adverse Event|0|||
150031096|NCT04602390|541252536|FG002|Overall Study|Adverse Event|0|||
149936705|NCT03312738|540906567|FG000|Overall Study|Protocol deviation|2|||
149936706|NCT03312738|540906568|FG001|Overall Study|Protocol deviation|0|||
149936707|NCT03312738|540906567|FG000|Overall Study|Technical problems|0|||
149936708|NCT03312738|540906568|FG001|Overall Study|Technical problems|1|||
149936709|NCT03312738|540906567|FG000|Overall Study|Physician Decision|2|||
149936710|NCT03312738|540906568|FG001|Overall Study|Physician Decision|3|||
150031097|NCT04602390|541252537|FG003|Overall Study|Adverse Event|0|||
150031098|NCT04602390|541252538|FG004|Overall Study|Adverse Event|0|||
150031099|NCT04602390|541252539|FG005|Overall Study|Adverse Event|1|||
150031100|NCT03882021|541252542|FG000|Enrollment|Procedure aborted/cancelled|2|||
150031101|NCT03882021|541252542|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
150031102|NCT03882021|541252542|FG000|Enrollment to 3-Month|Death|1|||
150031103|NCT03882021|541252542|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
150031104|NCT03882021|541252542|FG000|Enrollment to 3-Month|Missed Visit|4|||
150031105|NCT03882021|541252542|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
150031106|NCT03882021|541252542|FG000|6-Month to 12-Month Visit|Death|1|||
150031107|NCT03882021|541252542|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
150031108|NCT01546857|541252543|FG000|Overall Study|Withdrawal by Subject|2|||
149936711|NCT01863771|540906579|FG000|Induction Phase|Adverse Event|9|||
150031109|NCT01546857|541252544|FG001|Overall Study|Withdrawal by Subject|3|||
150031110|NCT03582215|541252545|FG000|Overall Study|Adverse Event|1|||
150031111|NCT03582215|541252546|FG001|Overall Study|Adverse Event|0|||
150031112|NCT03582215|541252547|FG002|Overall Study|Adverse Event|0|||
150031113|NCT03582215|541252548|FG003|Overall Study|Adverse Event|0|||
150031114|NCT03582215|541252549|FG004|Overall Study|Adverse Event|0|||
150031115|NCT03582215|541252550|FG005|Overall Study|Adverse Event|0|||
150031116|NCT03582215|541252551|FG006|Overall Study|Adverse Event|2|||
150031117|NCT03582215|541252552|FG007|Overall Study|Adverse Event|2|||
150031118|NCT04913610|541252553|FG000|Randomized Participants|Did Not Receive Treatment|0|||
149936712|NCT01863771|540906580|FG001|Induction Phase|Adverse Event|0|||
149936713|NCT01863771|540906581|FG002|Induction Phase|Adverse Event|0|||
149936714|NCT01863771|540906582|FG003|Induction Phase|Adverse Event|0|||
149936715|NCT01863771|540906579|FG000|Induction Phase|Lack of Efficacy|10|||
149936716|NCT01863771|540906580|FG001|Induction Phase|Lack of Efficacy|0|||
149936717|NCT01863771|540906581|FG002|Induction Phase|Lack of Efficacy|0|||
149936718|NCT01863771|540906582|FG003|Induction Phase|Lack of Efficacy|0|||
149936719|NCT01863771|540906579|FG000|Induction Phase|Withdrawal by Subject|2|||
149936720|NCT01863771|540906580|FG001|Induction Phase|Withdrawal by Subject|0|||
149936721|NCT01863771|540906581|FG002|Induction Phase|Withdrawal by Subject|0|||
149936722|NCT01863771|540906582|FG003|Induction Phase|Withdrawal by Subject|0|||
149936723|NCT01863771|540906579|FG000|Maintenance Phase|Adverse Event|0|||
149936724|NCT01863771|540906580|FG001|Maintenance Phase|Adverse Event|0|||
149936725|NCT01863771|540906581|FG002|Maintenance Phase|Adverse Event|1|||
149936726|NCT01863771|540906582|FG003|Maintenance Phase|Adverse Event|1|||
149936727|NCT01863771|540906579|FG000|Maintenance Phase|Lack of Efficacy|0|||
149936728|NCT01863771|540906580|FG001|Maintenance Phase|Lack of Efficacy|3|||
149936729|NCT01863771|540906581|FG002|Maintenance Phase|Lack of Efficacy|7|||
149936730|NCT01863771|540906582|FG003|Maintenance Phase|Lack of Efficacy|38|||
149936731|NCT01863771|540906579|FG000|Maintenance Phase|Physician Decision|0|||
149936732|NCT01863771|540906580|FG001|Maintenance Phase|Physician Decision|0|||
149936733|NCT01863771|540906581|FG002|Maintenance Phase|Physician Decision|2|||
149936734|NCT01863771|540906582|FG003|Maintenance Phase|Physician Decision|1|||
149936735|NCT01863771|540906579|FG000|Maintenance Phase|Pregnancy|0|||
149936736|NCT01863771|540906580|FG001|Maintenance Phase|Pregnancy|1|||
149936737|NCT01863771|540906581|FG002|Maintenance Phase|Pregnancy|0|||
149936738|NCT01863771|540906582|FG003|Maintenance Phase|Pregnancy|0|||
149936739|NCT01863771|540906579|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149936740|NCT01863771|540906580|FG001|Maintenance Phase|Withdrawal by Subject|1|||
149936741|NCT01863771|540906581|FG002|Maintenance Phase|Withdrawal by Subject|2|||
149936742|NCT01863771|540906582|FG003|Maintenance Phase|Withdrawal by Subject|3|||
149936743|NCT03499795|540906583|FG000|Overall Study|Adverse Event|1|||
149936744|NCT03499795|540906583|FG000|Overall Study|Lost to Follow-up|1|||
149936745|NCT03636256|540906584|FG000|Overall Study|Lost to Follow-up|3|||
149936746|NCT03636256|540906585|FG001|Overall Study|Lost to Follow-up|0|||
149936747|NCT03636256|540906586|FG002|Overall Study|Lost to Follow-up|2|||
149936748|NCT03636256|540906587|FG003|Overall Study|Lost to Follow-up|1|||
149936749|NCT03636256|540906588|FG004|Overall Study|Lost to Follow-up|0|||
149936750|NCT03636256|540906589|FG005|Overall Study|Lost to Follow-up|4|||
149936751|NCT03636256|540906590|FG006|Overall Study|Lost to Follow-up|2|||
149936752|NCT03636256|540906591|FG007|Overall Study|Lost to Follow-up|0|||
149936753|NCT03636256|540906592|FG008|Overall Study|Lost to Follow-up|4|||
149936754|NCT03636256|540906584|FG000|Overall Study|Withdrawal by Subject|0|||
149936755|NCT03636256|540906585|FG001|Overall Study|Withdrawal by Subject|0|||
149936756|NCT03636256|540906586|FG002|Overall Study|Withdrawal by Subject|0|||
149936757|NCT03636256|540906587|FG003|Overall Study|Withdrawal by Subject|0|||
149936758|NCT03636256|540906588|FG004|Overall Study|Withdrawal by Subject|0|||
149936759|NCT03636256|540906589|FG005|Overall Study|Withdrawal by Subject|0|||
149936760|NCT03636256|540906590|FG006|Overall Study|Withdrawal by Subject|0|||
149936761|NCT03636256|540906591|FG007|Overall Study|Withdrawal by Subject|0|||
149936762|NCT03636256|540906592|FG008|Overall Study|Withdrawal by Subject|1|||
149936763|NCT02426684|540906593|FG000|Overall Study|Physician Decision|1|||
149936764|NCT04748718|540906598|FG000|Overall Study|Lost to Follow-up|50|||
149936765|NCT01450813|540906599|FG000|Overall Study|Physician Decision|1|||
149936766|NCT01450813|540906600|FG001|Overall Study|Physician Decision|1|||
149936767|NCT01450813|540906601|FG002|Overall Study|Physician Decision|0|||
149936768|NCT01450813|540906602|FG003|Overall Study|Physician Decision|3|||
149936769|NCT01935089|540906604|FG000|Overall Study|Adverse Event|2|||
150031119|NCT04913610|541252554|FG001|Randomized Participants|Did Not Receive Treatment|0|||
149936770|NCT01935089|540906604|FG000|Overall Study|Withdrawal by Subject|1|||
149936771|NCT00785356|540906607|FG000|Overall Study|Study prematurely terminated|8|||
149936772|NCT01079780|540906608|FG000|Overall Study|Disease progression|43|||
149936773|NCT01079780|540906609|FG001|Overall Study|Disease progression|7|||
149936774|NCT01079780|540906610|FG002|Overall Study|Disease progression|31|||
150031120|NCT04913610|541252555|FG002|Randomized Participants|Did Not Receive Treatment|1|||
149936775|NCT01079780|540906608|FG000|Overall Study|Adverse Event|13|||
149936776|NCT01079780|540906609|FG001|Overall Study|Adverse Event|5|||
149936777|NCT01079780|540906610|FG002|Overall Study|Adverse Event|7|||
149936778|NCT01079780|540906608|FG000|Overall Study|Death|2|||
149936779|NCT01079780|540906609|FG001|Overall Study|Death|0|||
149936780|NCT01079780|540906610|FG002|Overall Study|Death|2|||
149936781|NCT01079780|540906608|FG000|Overall Study|Withdrawal by Subject|6|||
149936782|NCT01079780|540906609|FG001|Overall Study|Withdrawal by Subject|4|||
149936783|NCT01079780|540906610|FG002|Overall Study|Withdrawal by Subject|4|||
149936784|NCT01079780|540906608|FG000|Overall Study|Alternative therapy|2|||
149936785|NCT01079780|540906609|FG001|Overall Study|Alternative therapy|0|||
149936786|NCT01079780|540906610|FG002|Overall Study|Alternative therapy|2|||
149936787|NCT01079780|540906608|FG000|Overall Study|Physician Decision|1|||
149936788|NCT01079780|540906609|FG001|Overall Study|Physician Decision|0|||
149936789|NCT01079780|540906610|FG002|Overall Study|Physician Decision|1|||
149936790|NCT01079780|540906608|FG000|Overall Study|Error made in lesion measurement|1|||
149936791|NCT01079780|540906609|FG001|Overall Study|Error made in lesion measurement|0|||
149936792|NCT01079780|540906610|FG002|Overall Study|Error made in lesion measurement|0|||
149936793|NCT01079780|540906608|FG000|Overall Study|Patient had surgery|1|||
149936794|NCT01079780|540906609|FG001|Overall Study|Patient had surgery|0|||
149936795|NCT01079780|540906610|FG002|Overall Study|Patient had surgery|0|||
149936796|NCT01079780|540906608|FG000|Overall Study|Treatment cycle delay|0|||
149936797|NCT01079780|540906609|FG001|Overall Study|Treatment cycle delay|0|||
149936798|NCT01079780|540906610|FG002|Overall Study|Treatment cycle delay|1|||
149936799|NCT01079780|540906608|FG000|Overall Study|Never started treatment|1|||
149936800|NCT01079780|540906609|FG001|Overall Study|Never started treatment|0|||
149936801|NCT01079780|540906610|FG002|Overall Study|Never started treatment|2|||
149936802|NCT01178294|540906616|FG000|Overall Study|Adverse Event|4|||
149936803|NCT01178294|540906616|FG000|Overall Study|Lost to Follow-up|2|||
149936804|NCT01178294|540906616|FG000|Overall Study|Lack of Efficacy|1|||
149936805|NCT01178294|540906616|FG000|Overall Study|Death|1|||
149936806|NCT01178294|540906616|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
149936807|NCT01178294|540906616|FG000|Overall Study|Subject status is terminal|1|||
149936808|NCT01178294|540906616|FG000|Overall Study|Completion status could not be verified|1|||
149936809|NCT02783066|540906617|FG000|Overall Study|Withdrawal by Subject|13|||
149936810|NCT02251275|540906618|FG000|Overall Study|Adverse Event|23|||
149936811|NCT02251275|540906619|FG001|Overall Study|Adverse Event|60|||
149936812|NCT02251275|540906620|FG002|Overall Study|Adverse Event|28|||
149936813|NCT02251275|540906621|FG003|Overall Study|Adverse Event|0|||
149936814|NCT02251275|540906622|FG004|Overall Study|Adverse Event|0|||
149936815|NCT02251275|540906618|FG000|Overall Study|Lost to Follow-up|5|||
149936816|NCT02251275|540906619|FG001|Overall Study|Lost to Follow-up|6|||
149936817|NCT02251275|540906620|FG002|Overall Study|Lost to Follow-up|4|||
149936818|NCT02251275|540906621|FG003|Overall Study|Lost to Follow-up|0|||
149936819|NCT02251275|540906622|FG004|Overall Study|Lost to Follow-up|0|||
149936820|NCT02251275|540906618|FG000|Overall Study|Physician Decision|19|||
149936821|NCT02251275|540906619|FG001|Overall Study|Physician Decision|30|||
149936822|NCT02251275|540906620|FG002|Overall Study|Physician Decision|26|||
149936823|NCT02251275|540906621|FG003|Overall Study|Physician Decision|0|||
149936824|NCT02251275|540906622|FG004|Overall Study|Physician Decision|1|||
149936825|NCT02251275|540906618|FG000|Overall Study|Protocol Deviation|0|||
149936826|NCT02251275|540906619|FG001|Overall Study|Protocol Deviation|0|||
149936827|NCT02251275|540906620|FG002|Overall Study|Protocol Deviation|1|||
149936828|NCT02251275|540906621|FG003|Overall Study|Protocol Deviation|0|||
149936829|NCT02251275|540906622|FG004|Overall Study|Protocol Deviation|0|||
149936830|NCT02251275|540906618|FG000|Overall Study|Withdrawal by Subject|25|||
149936831|NCT02251275|540906619|FG001|Overall Study|Withdrawal by Subject|51|||
150168774|NCT02987543|541752541|FG000|Overall Study|Screen failure|0|||
150168775|NCT02987543|541752542|FG001|Overall Study|Screen failure|0|||
150168776|NCT02987543|541752543|FG002|Overall Study|Screen failure|0|||
150168777|NCT02987543|541752544|FG003|Overall Study|Screen failure|1|||
150168778|NCT02987543|541752541|FG000|Overall Study|Withdrawal by Subject|21|||
150168779|NCT02987543|541752542|FG001|Overall Study|Withdrawal by Subject|7|||
150168780|NCT02987543|541752543|FG002|Overall Study|Withdrawal by Subject|7|||
150168781|NCT02987543|541752544|FG003|Overall Study|Withdrawal by Subject|6|||
150168782|NCT02987543|541752541|FG000|Overall Study|Study terminated by sponsor|1|||
150168783|NCT02987543|541752542|FG001|Overall Study|Study terminated by sponsor|0|||
150168784|NCT02987543|541752543|FG002|Overall Study|Study terminated by sponsor|0|||
150168785|NCT02987543|541752544|FG003|Overall Study|Study terminated by sponsor|0|||
150168786|NCT02987543|541752541|FG000|Overall Study|Investigator decision|0|||
150168787|NCT02987543|541752542|FG001|Overall Study|Investigator decision|1|||
150168788|NCT02987543|541752543|FG002|Overall Study|Investigator decision|0|||
150168789|NCT02987543|541752544|FG003|Overall Study|Investigator decision|0|||
150168790|NCT02987543|541752541|FG000|Overall Study|Disease progression|0|||
150168791|NCT02987543|541752542|FG001|Overall Study|Disease progression|0|||
150168792|NCT02987543|541752543|FG002|Overall Study|Disease progression|0|||
150168793|NCT02987543|541752544|FG003|Overall Study|Disease progression|1|||
150168794|NCT03646669|541752547|FG000|Overall Study|Withdrawal by Subject|5|||
150168795|NCT03646669|541752548|FG001|Overall Study|Withdrawal by Subject|0|||
150168796|NCT00309452|541752549|FG000|Overall Study|Withdrawal by Subject|3|||
150168797|NCT00309452|541752550|FG001|Overall Study|Withdrawal by Subject|0|||
150168798|NCT00771667|541752551|FG000|Induction Phase|Adverse Event|5|||
150168799|NCT00771667|541752552|FG001|Induction Phase|Adverse Event|2|||
150168800|NCT00771667|541752553|FG002|Induction Phase|Adverse Event|4|||
150168801|NCT00771667|541752554|FG003|Induction Phase|Adverse Event|1|||
150168802|NCT00771667|541752555|FG004|Induction Phase|Adverse Event|0|||
149936832|NCT02251275|540906620|FG002|Overall Study|Withdrawal by Subject|35|||
150031121|NCT04913610|541252556|FG003|Randomized Participants|Did Not Receive Treatment|1|||
150031122|NCT04913610|541252557|FG004|Randomized Participants|Did Not Receive Treatment|0|||
150031123|NCT04913610|541252553|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
150031124|NCT04913610|541252554|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
150031125|NCT04913610|541252555|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
150031126|NCT04913610|541252556|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
150031127|NCT04913610|541252557|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
150031128|NCT03186209|541252560|FG000|Overall Study|Withdrawal by Subject|11|||
150031129|NCT03186209|541252561|FG001|Overall Study|Withdrawal by Subject|22|||
150031130|NCT03186209|541252560|FG000|Overall Study|Pregnancy|1|||
150031131|NCT03186209|541252561|FG001|Overall Study|Pregnancy|0|||
150031132|NCT03186209|541252560|FG000|Overall Study|Adverse Event|4|||
150031133|NCT03186209|541252561|FG001|Overall Study|Adverse Event|0|||
150031134|NCT03186209|541252560|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
150031135|NCT03186209|541252561|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
150031136|NCT03186209|541252560|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
150031137|NCT03186209|541252561|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
150031138|NCT03186209|541252560|FG000|Overall Study|Fail to meet randomization criteria|0|||
150031139|NCT03186209|541252561|FG001|Overall Study|Fail to meet randomization criteria|1|||
150031140|NCT03186209|541252560|FG000|Overall Study|Lost to Follow-up|0|||
150270186|NCT01717768|542127391|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
150270187|NCT01717768|542127392|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270188|NCT01717768|542127393|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270189|NCT01717768|542127394|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270190|NCT01717768|542127395|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270191|NCT01717768|542127396|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270192|NCT01717768|542127397|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270193|NCT01717768|542127398|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270194|NCT01717768|542127399|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270195|NCT01717768|542127400|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270196|NCT01717768|542127401|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
150270197|NCT01717768|542127390|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270198|NCT01717768|542127391|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270199|NCT01717768|542127392|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270200|NCT01717768|542127393|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270201|NCT01717768|542127394|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270202|NCT01717768|542127395|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270203|NCT01717768|542127396|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270204|NCT01717768|542127397|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270205|NCT01717768|542127398|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270206|NCT01717768|542127399|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270207|NCT01717768|542127400|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
150270208|NCT01717768|542127401|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
150270209|NCT01717768|542127390|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270210|NCT01717768|542127391|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270211|NCT01717768|542127392|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270212|NCT01717768|542127393|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270213|NCT01717768|542127394|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270214|NCT01717768|542127395|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270215|NCT01717768|542127396|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149936833|NCT02251275|540906621|FG003|Overall Study|Withdrawal by Subject|1|||
149936834|NCT02251275|540906622|FG004|Overall Study|Withdrawal by Subject|0|||
149936835|NCT01004614|540906623|FG000|Washout|Withdrawal by Subject|0|||
149936836|NCT01004614|540906624|FG001|Washout|Withdrawal by Subject|1|||
149936837|NCT01004614|540906625|FG002|Washout|Withdrawal by Subject|0|||
149936838|NCT01004614|540906626|FG003|Washout|Withdrawal by Subject|0|||
149936839|NCT01569022|540906628|FG000|First Intervention|Lost to Follow-up|2|||
149936840|NCT01569022|540906629|FG001|First Intervention|Lost to Follow-up|1|||
149936841|NCT01569022|540906628|FG000|Second Intervention|Lost to Follow-up|2|||
149936842|NCT01569022|540906629|FG001|Second Intervention|Lost to Follow-up|2|||
149936843|NCT00116142|540906630|FG000|Overall Study|Adverse Event|8|||
150270216|NCT01717768|542127397|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
150270217|NCT01717768|542127398|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270218|NCT01717768|542127399|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270219|NCT01717768|542127400|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149936844|NCT00116142|540906631|FG001|Overall Study|Adverse Event|7|||
149820371|NCT01571635|540471801|FG004|Overall Study|Adverse Event|5|||
149936845|NCT00116142|540906630|FG000|Overall Study|Protocol Violation|2|||
149936846|NCT00116142|540906631|FG001|Overall Study|Protocol Violation|1|||
149936847|NCT00116142|540906630|FG000|Overall Study|Withdrawal by Subject|5|||
149936848|NCT00116142|540906631|FG001|Overall Study|Withdrawal by Subject|5|||
149936849|NCT00116142|540906630|FG000|Overall Study|Physician Decision|3|||
149936850|NCT00116142|540906631|FG001|Overall Study|Physician Decision|1|||
149936851|NCT00116142|540906630|FG000|Overall Study|Delayed Radiation Therapy|1|||
149936852|NCT00116142|540906631|FG001|Overall Study|Delayed Radiation Therapy|0|||
149936853|NCT00116142|540906630|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
149936854|NCT00116142|540906631|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
149936855|NCT00116142|540906630|FG000|Overall Study|Patient stopped due to depression|0|||
149936856|NCT00116142|540906631|FG001|Overall Study|Patient stopped due to depression|1|||
149936857|NCT00116142|540906630|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
149936858|NCT00116142|540906631|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
149936859|NCT00116142|540906630|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
149936860|NCT00116142|540906631|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
149936861|NCT00116142|540906630|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
149936862|NCT00116142|540906631|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
149936863|NCT01302899|540906636|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
149936864|NCT01302899|540906637|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
149936865|NCT01302899|540906636|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
149936866|NCT01302899|540906637|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
149936867|NCT04076917|540906638|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
149936868|NCT04076917|540906638|FG000|Overall Study|Study closure|13|||
149936869|NCT04076917|540906638|FG000|Overall Study|Physician Decision|3|||
149936870|NCT04076917|540906638|FG000|Overall Study|Death|1|||
149936871|NCT04076917|540906638|FG000|Overall Study|Lost to Follow-up|1|||
149936872|NCT04076917|540906638|FG000|Overall Study|Withdrawal by Subject|1|||
149936873|NCT04076917|540906638|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
149936874|NCT02785939|540906642|FG000|Overall Study|Progression|25|||
149936875|NCT02785939|540906643|FG001|Overall Study|Progression|8|||
149936876|NCT02785939|540906642|FG000|Overall Study|Adverse Event|3|||
149936877|NCT02785939|540906643|FG001|Overall Study|Adverse Event|1|||
149936878|NCT02785939|540906642|FG000|Overall Study|Death|1|||
149936879|NCT02785939|540906643|FG001|Overall Study|Death|0|||
149936880|NCT02785939|540906642|FG000|Overall Study|Refusal|1|||
149936881|NCT02785939|540906643|FG001|Overall Study|Refusal|0|||
149936882|NCT02785939|540906642|FG000|Overall Study|Deteriorating health|1|||
149936883|NCT02785939|540906643|FG001|Overall Study|Deteriorating health|0|||
149936884|NCT02785939|540906642|FG000|Overall Study|Not protocol specified|0|||
149936885|NCT02785939|540906643|FG001|Overall Study|Not protocol specified|1|||
149936886|NCT01787552|540906644|FG000|Overall Study|Withdrawal by Subject|2|||
149936887|NCT01787552|540906645|FG001|Overall Study|Withdrawal by Subject|0|||
149936888|NCT01787552|540906646|FG002|Overall Study|Withdrawal by Subject|0|||
149936889|NCT01787552|540906647|FG003|Overall Study|Withdrawal by Subject|4|||
149936890|NCT01787552|540906644|FG000|Overall Study|Physician Decision|2|||
149936891|NCT01787552|540906645|FG001|Overall Study|Physician Decision|2|||
149936892|NCT01787552|540906646|FG002|Overall Study|Physician Decision|1|||
149936893|NCT01787552|540906647|FG003|Overall Study|Physician Decision|2|||
149936894|NCT01787552|540906644|FG000|Overall Study|Death|0|||
149936895|NCT01787552|540906645|FG001|Overall Study|Death|0|||
149936896|NCT01787552|540906646|FG002|Overall Study|Death|0|||
149936897|NCT01787552|540906647|FG003|Overall Study|Death|1|||
149936898|NCT01787552|540906644|FG000|Overall Study|Adverse Event|2|||
149936899|NCT01787552|540906645|FG001|Overall Study|Adverse Event|5|||
149936900|NCT01787552|540906646|FG002|Overall Study|Adverse Event|2|||
149936901|NCT01787552|540906647|FG003|Overall Study|Adverse Event|16|||
149936902|NCT01787552|540906644|FG000|Overall Study|Study terminated by Sponsor|0|||
149936903|NCT01787552|540906645|FG001|Overall Study|Study terminated by Sponsor|0|||
149936904|NCT01787552|540906646|FG002|Overall Study|Study terminated by Sponsor|1|||
149936905|NCT01787552|540906647|FG003|Overall Study|Study terminated by Sponsor|3|||
149936906|NCT01787552|540906644|FG000|Overall Study|Progressive Disease|2|||
149936907|NCT01787552|540906645|FG001|Overall Study|Progressive Disease|2|||
149936908|NCT01787552|540906646|FG002|Overall Study|Progressive Disease|1|||
149936909|NCT01787552|540906647|FG003|Overall Study|Progressive Disease|1|||
149936910|NCT01038687|540906648|FG000|Overall Study|Adverse Event|0|||
149936911|NCT01038687|540906649|FG001|Overall Study|Adverse Event|2|||
149936912|NCT01038687|540906650|FG002|Overall Study|Adverse Event|1|||
149936913|NCT02175121|540906651|FG000|Overall Study|Lack of Efficacy|1|||
149936914|NCT02175121|540906652|FG001|Overall Study|Lack of Efficacy|0|||
149936915|NCT02175121|540906653|FG002|Overall Study|Lack of Efficacy|0|||
149936916|NCT02175121|540906654|FG003|Overall Study|Lack of Efficacy|0|||
149936917|NCT02175121|540906655|FG004|Overall Study|Lack of Efficacy|0|||
149936918|NCT02175121|540906651|FG000|Overall Study|Lost to Follow-up|0|||
149936919|NCT02175121|540906652|FG001|Overall Study|Lost to Follow-up|1|||
149936920|NCT02175121|540906653|FG002|Overall Study|Lost to Follow-up|0|||
149936921|NCT02175121|540906654|FG003|Overall Study|Lost to Follow-up|1|||
150270220|NCT01717768|542127401|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
150270221|NCT01717768|542127390|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270222|NCT01717768|542127391|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270223|NCT01717768|542127392|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270224|NCT01717768|542127393|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270225|NCT01717768|542127394|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270226|NCT01717768|542127395|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270227|NCT01717768|542127396|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270228|NCT01717768|542127397|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270229|NCT01717768|542127398|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270230|NCT01717768|542127399|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
150270231|NCT01717768|542127400|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270232|NCT01717768|542127401|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
150270233|NCT00448435|542127402|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
150270234|NCT00448435|542127403|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
150270235|NCT04195581|542127406|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
150270236|NCT04195581|542127406|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
150270237|NCT04195581|542127406|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
150270238|NCT04195581|542127406|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
150270239|NCT04195581|542127406|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
150270240|NCT04195581|542127406|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
150270241|NCT00821431|542127407|FG000|Overall Study|Adverse Event|6|||
150270242|NCT00821431|542127408|FG001|Overall Study|Adverse Event|3|||
150270243|NCT00821431|542127407|FG000|Overall Study|Withdrawal by Subject|5|||
150270244|NCT00821431|542127408|FG001|Overall Study|Withdrawal by Subject|0|||
149936922|NCT02175121|540906655|FG004|Overall Study|Lost to Follow-up|0|||
149936923|NCT02175121|540906651|FG000|Overall Study|Personal emergency|0|||
149936924|NCT02175121|540906652|FG001|Overall Study|Personal emergency|0|||
149936925|NCT02175121|540906653|FG002|Overall Study|Personal emergency|0|||
149936926|NCT02175121|540906654|FG003|Overall Study|Personal emergency|0|||
149936927|NCT02175121|540906655|FG004|Overall Study|Personal emergency|1|||
149936928|NCT02175121|540906651|FG000|Overall Study|Schedule conflict|0|||
149936929|NCT02175121|540906652|FG001|Overall Study|Schedule conflict|0|||
150270245|NCT00821431|542127407|FG000|Overall Study|Lost to Follow-up|1|||
150270246|NCT00821431|542127408|FG001|Overall Study|Lost to Follow-up|0|||
150270247|NCT00821431|542127407|FG000|Overall Study|Protocol Violation|3|||
150270248|NCT00821431|542127408|FG001|Overall Study|Protocol Violation|1|||
150270249|NCT00821431|542127407|FG000|Overall Study|Physician Decision|0|||
150270250|NCT00821431|542127408|FG001|Overall Study|Physician Decision|1|||
150270251|NCT03026127|542127411|FG000|CRISP R61|Adverse Event|5|||
150270252|NCT03026127|542127412|FG001|CRISP R61|Adverse Event|0|||
150270253|NCT03026127|542127413|FG002|CRISP R61|Adverse Event|0|||
150270254|NCT03026127|542127411|FG000|CRISP R61|Lost to Follow-up|2|||
150270255|NCT03026127|542127412|FG001|CRISP R61|Lost to Follow-up|0|||
150270256|NCT03026127|542127413|FG002|CRISP R61|Lost to Follow-up|0|||
150270257|NCT03026127|542127411|FG000|CRISP R61|Dropped before therapy|5|||
150270258|NCT03026127|542127412|FG001|CRISP R61|Dropped before therapy|0|||
150270259|NCT03026127|542127413|FG002|CRISP R61|Dropped before therapy|0|||
150270260|NCT03026127|542127411|FG000|CRISP R33|Lost to Follow-up|0|||
150270261|NCT03026127|542127412|FG001|CRISP R33|Lost to Follow-up|5|||
150270262|NCT03026127|542127413|FG002|CRISP R33|Lost to Follow-up|4|||
149936930|NCT02175121|540906653|FG002|Overall Study|Schedule conflict|1|||
149936931|NCT02175121|540906654|FG003|Overall Study|Schedule conflict|0|||
150270263|NCT03026127|542127411|FG000|CRISP R33|Adverse Event|0|||
150270264|NCT03026127|542127412|FG001|CRISP R33|Adverse Event|9|||
150270265|NCT03026127|542127413|FG002|CRISP R33|Adverse Event|5|||
150270266|NCT03026127|542127411|FG000|CRISP R33|Withdrawal by Subject|0|||
150270267|NCT03026127|542127412|FG001|CRISP R33|Withdrawal by Subject|9|||
150270268|NCT03026127|542127413|FG002|CRISP R33|Withdrawal by Subject|1|||
150270269|NCT03026127|542127411|FG000|CRISP R33|Lack of Efficacy|0|||
150270270|NCT03026127|542127412|FG001|CRISP R33|Lack of Efficacy|3|||
150270271|NCT03026127|542127413|FG002|CRISP R33|Lack of Efficacy|2|||
150270272|NCT03026127|542127411|FG000|CRISP R33|Physician Decision|0|||
150270273|NCT03026127|542127412|FG001|CRISP R33|Physician Decision|3|||
149936932|NCT02175121|540906655|FG004|Overall Study|Schedule conflict|0|||
150270274|NCT03026127|542127413|FG002|CRISP R33|Physician Decision|1|||
150270275|NCT03026127|542127411|FG000|CRISP R33|Transportation|0|||
150270276|NCT03026127|542127412|FG001|CRISP R33|Transportation|2|||
150270277|NCT03026127|542127413|FG002|CRISP R33|Transportation|1|||
150270278|NCT01182766|542127417|FG000|Overall Study|Lost to Follow-up|32|||
150270279|NCT01182766|542127418|FG001|Overall Study|Lost to Follow-up|36|||
149936933|NCT02175121|540906651|FG000|Overall Study|Time issues|0|||
149936934|NCT02175121|540906652|FG001|Overall Study|Time issues|0|||
149936935|NCT02175121|540906653|FG002|Overall Study|Time issues|1|||
150270280|NCT01182766|542127419|FG002|Overall Study|Lost to Follow-up|29|||
149936936|NCT02175121|540906654|FG003|Overall Study|Time issues|0|||
150270281|NCT01182766|542127417|FG000|Overall Study|Withdrawal by Subject|14|||
150270282|NCT01182766|542127418|FG001|Overall Study|Withdrawal by Subject|3|||
150270283|NCT01182766|542127419|FG002|Overall Study|Withdrawal by Subject|6|||
150270284|NCT01182766|542127417|FG000|Overall Study|Physician Decision|1|||
150270285|NCT01182766|542127418|FG001|Overall Study|Physician Decision|0|||
150270286|NCT01182766|542127419|FG002|Overall Study|Physician Decision|0|||
150270287|NCT01182766|542127417|FG000|Overall Study|Non-compliance|1|||
150270288|NCT01182766|542127418|FG001|Overall Study|Non-compliance|1|||
150270289|NCT01182766|542127419|FG002|Overall Study|Non-compliance|1|||
150270290|NCT03027557|542127420|FG000|Overall Study|Adverse Event|1|||
150270291|NCT03027557|542127421|FG001|Overall Study|Adverse Event|0|||
150270292|NCT03027557|542127422|FG002|Overall Study|Adverse Event|0|||
150270293|NCT01699789|542127425|FG000|Overall Study|Withdrawal by Subject|18|||
150270294|NCT01699789|542127426|FG001|Overall Study|Withdrawal by Subject|23|||
150270295|NCT01699789|542127425|FG000|Overall Study|Death|1|||
150270296|NCT01699789|542127426|FG001|Overall Study|Death|2|||
150270297|NCT01699789|542127425|FG000|Overall Study|Lost to Follow-up|83|||
150270298|NCT01699789|542127426|FG001|Overall Study|Lost to Follow-up|101|||
150270299|NCT01009554|542127427|FG000|Overall Study|Adverse Event|1|||
150270300|NCT01009554|542127428|FG001|Overall Study|Adverse Event|1|||
150270301|NCT01009554|542127427|FG000|Overall Study|Withdrawal by Subject|1|||
150270302|NCT01009554|542127428|FG001|Overall Study|Withdrawal by Subject|3|||
150270303|NCT01009554|542127427|FG000|Overall Study|Noncompliant with Study Product|0|||
150270304|NCT01009554|542127428|FG001|Overall Study|Noncompliant with Study Product|3|||
150270305|NCT01605253|542127429|FG000|Overall Study|Physician Decision|3|||
150270306|NCT01605253|542127430|FG001|Overall Study|Physician Decision|2|||
150270307|NCT01605253|542127429|FG000|Overall Study|Lost to Follow-up|3|||
150270308|NCT01605253|542127430|FG001|Overall Study|Lost to Follow-up|1|||
150270309|NCT02554903|542127431|FG000|Overall Study|Death|1|||
150270310|NCT02554903|542127432|FG001|Overall Study|Death|1|||
150270311|NCT02554903|542127431|FG000|Overall Study|Physician Decision|2|||
150270312|NCT02554903|542127432|FG001|Overall Study|Physician Decision|2|||
150270313|NCT02554903|542127431|FG000|Overall Study|Heart Transplant|1|||
150270314|NCT02554903|542127432|FG001|Overall Study|Heart Transplant|2|||
150270315|NCT04427501|542127435|FG000|Overall Study|Death|0|||
150270316|NCT04427501|542127436|FG001|Overall Study|Death|0|||
150270317|NCT04427501|542127437|FG002|Overall Study|Death|0|||
150270318|NCT04427501|542127438|FG003|Overall Study|Death|0|||
150270319|NCT04427501|542127439|FG004|Overall Study|Death|0|||
150270320|NCT04427501|542127440|FG005|Overall Study|Death|15|||
150270321|NCT04427501|542127441|FG006|Overall Study|Death|0|||
150270322|NCT04427501|542127442|FG007|Overall Study|Death|0|||
150270323|NCT04427501|542127443|FG008|Overall Study|Death|0|||
150270324|NCT04427501|542127444|FG009|Overall Study|Death|0|||
150270325|NCT04427501|542127445|FG010|Overall Study|Death|0|||
150270326|NCT04427501|542127446|FG011|Overall Study|Death|0|||
150270327|NCT04427501|542127435|FG000|Overall Study|Lost to Follow-up|5|||
150270328|NCT04427501|542127436|FG001|Overall Study|Lost to Follow-up|1|||
150270329|NCT04427501|542127437|FG002|Overall Study|Lost to Follow-up|2|||
150270330|NCT04427501|542127438|FG003|Overall Study|Lost to Follow-up|0|||
150270331|NCT04427501|542127439|FG004|Overall Study|Lost to Follow-up|2|||
150270332|NCT04427501|542127440|FG005|Overall Study|Lost to Follow-up|11|||
150270333|NCT04427501|542127441|FG006|Overall Study|Lost to Follow-up|10|||
150270334|NCT04427501|542127442|FG007|Overall Study|Lost to Follow-up|10|||
150270335|NCT04427501|542127443|FG008|Overall Study|Lost to Follow-up|2|||
150270336|NCT04427501|542127444|FG009|Overall Study|Lost to Follow-up|5|||
150270337|NCT04427501|542127445|FG010|Overall Study|Lost to Follow-up|2|||
150270338|NCT04427501|542127446|FG011|Overall Study|Lost to Follow-up|0|||
150270339|NCT04427501|542127435|FG000|Overall Study|Physician Decision|0|||
150270340|NCT04427501|542127436|FG001|Overall Study|Physician Decision|3|||
150270341|NCT04427501|542127437|FG002|Overall Study|Physician Decision|0|||
150270342|NCT04427501|542127438|FG003|Overall Study|Physician Decision|0|||
150270343|NCT04427501|542127439|FG004|Overall Study|Physician Decision|0|||
150270344|NCT04427501|542127440|FG005|Overall Study|Physician Decision|0|||
150270345|NCT04427501|542127441|FG006|Overall Study|Physician Decision|2|||
150270346|NCT04427501|542127442|FG007|Overall Study|Physician Decision|0|||
150270347|NCT04427501|542127443|FG008|Overall Study|Physician Decision|0|||
150270348|NCT04427501|542127444|FG009|Overall Study|Physician Decision|0|||
150270349|NCT04427501|542127445|FG010|Overall Study|Physician Decision|0|||
150270350|NCT04427501|542127446|FG011|Overall Study|Physician Decision|0|||
150270351|NCT04427501|542127435|FG000|Overall Study|Withdrawal by Subject|9|||
150270352|NCT04427501|542127436|FG001|Overall Study|Withdrawal by Subject|2|||
150270353|NCT04427501|542127437|FG002|Overall Study|Withdrawal by Subject|2|||
150270354|NCT04427501|542127438|FG003|Overall Study|Withdrawal by Subject|3|||
150270355|NCT04427501|542127439|FG004|Overall Study|Withdrawal by Subject|7|||
150270356|NCT04427501|542127440|FG005|Overall Study|Withdrawal by Subject|25|||
150270357|NCT04427501|542127441|FG006|Overall Study|Withdrawal by Subject|15|||
150270358|NCT04427501|542127442|FG007|Overall Study|Withdrawal by Subject|7|||
150270359|NCT04427501|542127443|FG008|Overall Study|Withdrawal by Subject|4|||
150270360|NCT04427501|542127444|FG009|Overall Study|Withdrawal by Subject|1|||
150270361|NCT04427501|542127445|FG010|Overall Study|Withdrawal by Subject|4|||
150270362|NCT04427501|542127446|FG011|Overall Study|Withdrawal by Subject|0|||
149936937|NCT02175121|540906655|FG004|Overall Study|Time issues|0|||
149936938|NCT02895347|540906666|FG000|Overall Study|Withdrawal by Subject|3|||
149936939|NCT02895347|540906667|FG001|Overall Study|Withdrawal by Subject|1|||
149936940|NCT01673178|540906671|FG000|Overall Study|Lost to Follow-up|0|||
149936941|NCT01673178|540906672|FG001|Overall Study|Lost to Follow-up|1|||
149936942|NCT01673178|540906673|FG002|Overall Study|Lost to Follow-up|0|||
149936943|NCT01673178|540906674|FG003|Overall Study|Lost to Follow-up|0|||
149936944|NCT01673178|540906675|FG004|Overall Study|Lost to Follow-up|0|||
149936945|NCT01673178|540906671|FG000|Overall Study|Withdrawal by Subject|0|||
149936946|NCT01673178|540906672|FG001|Overall Study|Withdrawal by Subject|0|||
149936947|NCT01673178|540906673|FG002|Overall Study|Withdrawal by Subject|1|||
149936948|NCT01673178|540906674|FG003|Overall Study|Withdrawal by Subject|4|||
149936949|NCT01673178|540906675|FG004|Overall Study|Withdrawal by Subject|2|||
149936950|NCT01673178|540906671|FG000|Overall Study|Protocol Violation|1|||
149936951|NCT01673178|540906672|FG001|Overall Study|Protocol Violation|1|||
149936952|NCT01673178|540906673|FG002|Overall Study|Protocol Violation|0|||
149936953|NCT01673178|540906674|FG003|Overall Study|Protocol Violation|1|||
149936954|NCT01673178|540906675|FG004|Overall Study|Protocol Violation|0|||
149936955|NCT01673178|540906671|FG000|Overall Study|Adverse Event|1|||
149936956|NCT01673178|540906672|FG001|Overall Study|Adverse Event|0|||
149936957|NCT01673178|540906673|FG002|Overall Study|Adverse Event|0|||
149936958|NCT01673178|540906674|FG003|Overall Study|Adverse Event|2|||
149936959|NCT01673178|540906675|FG004|Overall Study|Adverse Event|0|||
149936960|NCT01673178|540906671|FG000|Overall Study|Other|1|||
149936961|NCT01673178|540906672|FG001|Overall Study|Other|0|||
149936962|NCT01673178|540906673|FG002|Overall Study|Other|2|||
149936963|NCT01673178|540906674|FG003|Overall Study|Other|1|||
149936964|NCT01673178|540906675|FG004|Overall Study|Other|0|||
149936965|NCT02557399|540906676|FG000|Overall Study|Adverse Event|6|||
149936966|NCT02557399|540906677|FG001|Overall Study|Adverse Event|5|||
149936967|NCT02557399|540906676|FG000|Overall Study|Protocol Violation|0|||
149936968|NCT02557399|540906677|FG001|Overall Study|Protocol Violation|1|||
149936969|NCT02557399|540906676|FG000|Overall Study|Protocol-defined stopping criteria|0|||
149936970|NCT02557399|540906677|FG001|Overall Study|Protocol-defined stopping criteria|1|||
149936971|NCT02557399|540906676|FG000|Overall Study|Withdrawal by Subject|1|||
149936972|NCT02557399|540906677|FG001|Overall Study|Withdrawal by Subject|1|||
149936973|NCT00931632|540906679|FG000|Overall Study|Withdrawal by Subject|2|||
149936974|NCT00931632|540906680|FG001|Overall Study|Withdrawal by Subject|3|||
149936975|NCT00931632|540906679|FG000|Overall Study|Adverse Event|19|||
149936976|NCT00931632|540906680|FG001|Overall Study|Adverse Event|15|||
149936977|NCT01419314|540906682|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
149936978|NCT01419314|540906683|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
149936979|NCT01419314|540906682|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
149936980|NCT01419314|540906683|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
149936981|NCT01419314|540906682|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
149936982|NCT01419314|540906683|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
149936983|NCT03139552|540906687|FG000|Overall Study|unable to attend tasting due to schedule|3|||
149936984|NCT03122171|540906688|FG000|Overall Study|Withdrawal by Subject|1|||
149936985|NCT03234465|540906689|FG000|Overall Study|Adverse Event|4|||
149936986|NCT03234465|540906690|FG001|Overall Study|Adverse Event|2|||
149936987|NCT03234465|540906689|FG000|Overall Study|Death|0|||
149936988|NCT03234465|540906690|FG001|Overall Study|Death|1|||
149936989|NCT03234465|540906689|FG000|Overall Study|Lost to Follow-up|1|||
149936990|NCT03234465|540906690|FG001|Overall Study|Lost to Follow-up|1|||
149936991|NCT03234465|540906689|FG000|Overall Study|Withdrawal by Subject|12|||
149936992|NCT03234465|540906690|FG001|Overall Study|Withdrawal by Subject|27|||
149936993|NCT03234465|540906689|FG000|Overall Study|Symptomatic deterioration|0|||
150270363|NCT04427501|542127435|FG000|Overall Study|Other - as reported by the investigator|1|||
150270364|NCT04427501|542127436|FG001|Overall Study|Other - as reported by the investigator|0|||
150270365|NCT04427501|542127437|FG002|Overall Study|Other - as reported by the investigator|0|||
150270366|NCT04427501|542127438|FG003|Overall Study|Other - as reported by the investigator|0|||
150270367|NCT04427501|542127439|FG004|Overall Study|Other - as reported by the investigator|0|||
150270368|NCT04427501|542127440|FG005|Overall Study|Other - as reported by the investigator|6|||
149936994|NCT03234465|540906690|FG001|Overall Study|Symptomatic deterioration|1|||
149936995|NCT03234465|540906689|FG000|Overall Study|Non-compliance|2|||
149936996|NCT03234465|540906690|FG001|Overall Study|Non-compliance|0|||
149936997|NCT03234465|540906689|FG000|Overall Study|Other|14|||
149936998|NCT03234465|540906690|FG001|Overall Study|Other|8|||
149936999|NCT00449163|540906691|FG000|Overall Study|Physician Decision|3|||
149937000|NCT00606307|540906696|FG000|Overall Study|Adverse Event|2|||
149937001|NCT00606307|540906696|FG000|Overall Study|Withdrawal by Subject|2|||
149937002|NCT00606307|540906696|FG000|Overall Study|Disease progression|6|||
149937003|NCT00606307|540906696|FG000|Overall Study|QTc prolongation|1|||
149937004|NCT02563899|540906705|FG000|Overall Study|Protocol Violation|1|||
149937005|NCT02563899|540906706|FG001|Overall Study|Protocol Violation|0|||
149937006|NCT02563899|540906707|FG002|Overall Study|Protocol Violation|0|||
150270369|NCT04427501|542127441|FG006|Overall Study|Other - as reported by the investigator|6|||
150270370|NCT04427501|542127442|FG007|Overall Study|Other - as reported by the investigator|0|||
150270371|NCT04427501|542127443|FG008|Overall Study|Other - as reported by the investigator|0|||
150270372|NCT04427501|542127444|FG009|Overall Study|Other - as reported by the investigator|0|||
149937007|NCT02563899|540906708|FG003|Overall Study|Protocol Violation|0|||
149937008|NCT02563899|540906705|FG000|Overall Study|Withdrawal by Subject|0|||
149937009|NCT02563899|540906706|FG001|Overall Study|Withdrawal by Subject|0|||
149937010|NCT02563899|540906707|FG002|Overall Study|Withdrawal by Subject|1|||
149937011|NCT02563899|540906708|FG003|Overall Study|Withdrawal by Subject|0|||
149937012|NCT03368807|540906709|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
149937013|NCT03368807|540906709|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
149937014|NCT03368807|540906709|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
149937015|NCT03368807|540906709|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
149937016|NCT02949947|540906725|FG000|Overall Study|Non Compliance|0|||
149937017|NCT02949947|540906726|FG001|Overall Study|Non Compliance|1|||
149937018|NCT02949947|540906725|FG000|Overall Study|Insurance change|1|||
149937019|NCT02949947|540906726|FG001|Overall Study|Insurance change|0|||
149937020|NCT01677741|540906727|FG000|Overall Study|Death|0|||
149937021|NCT01677741|540906728|FG001|Overall Study|Death|0|||
149937022|NCT01677741|540906729|FG002|Overall Study|Death|0|||
149937023|NCT01677741|540906730|FG003|Overall Study|Death|1|||
149937024|NCT01677741|540906731|FG004|Overall Study|Death|0|||
149937025|NCT01677741|540906732|FG005|Overall Study|Death|1|||
149937026|NCT01677741|540906733|FG006|Overall Study|Death|0|||
149937027|NCT01677741|540906734|FG007|Overall Study|Death|0|||
149937028|NCT01677741|540906727|FG000|Overall Study|Withdrawal by Subject|2|||
149937029|NCT01677741|540906728|FG001|Overall Study|Withdrawal by Subject|7|||
149937030|NCT01677741|540906729|FG002|Overall Study|Withdrawal by Subject|5|||
149937031|NCT01677741|540906730|FG003|Overall Study|Withdrawal by Subject|4|||
149937032|NCT01677741|540906731|FG004|Overall Study|Withdrawal by Subject|11|||
149937033|NCT01677741|540906732|FG005|Overall Study|Withdrawal by Subject|20|||
149937034|NCT01677741|540906733|FG006|Overall Study|Withdrawal by Subject|4|||
149937035|NCT01677741|540906734|FG007|Overall Study|Withdrawal by Subject|2|||
149937036|NCT01677741|540906727|FG000|Overall Study|Enrolled in a rollover study|0|||
149937037|NCT01677741|540906728|FG001|Overall Study|Enrolled in a rollover study|3|||
149937038|NCT01677741|540906729|FG002|Overall Study|Enrolled in a rollover study|2|||
149937039|NCT01677741|540906730|FG003|Overall Study|Enrolled in a rollover study|1|||
149937040|NCT01677741|540906731|FG004|Overall Study|Enrolled in a rollover study|6|||
149937041|NCT01677741|540906732|FG005|Overall Study|Enrolled in a rollover study|6|||
149937042|NCT01677741|540906733|FG006|Overall Study|Enrolled in a rollover study|7|||
149937043|NCT01677741|540906734|FG007|Overall Study|Enrolled in a rollover study|0|||
149937044|NCT01677741|540906727|FG000|Overall Study|Progressive disease|1|||
149937045|NCT01677741|540906728|FG001|Overall Study|Progressive disease|0|||
149937046|NCT01677741|540906729|FG002|Overall Study|Progressive disease|1|||
149937047|NCT01677741|540906730|FG003|Overall Study|Progressive disease|0|||
149937048|NCT01677741|540906731|FG004|Overall Study|Progressive disease|0|||
149937049|NCT01677741|540906732|FG005|Overall Study|Progressive disease|1|||
149937050|NCT01677741|540906733|FG006|Overall Study|Progressive disease|0|||
149937051|NCT01677741|540906734|FG007|Overall Study|Progressive disease|0|||
149937052|NCT01973218|540906735|FG000|Overall Study|Adverse Event|1|||
149937053|NCT01973218|540906736|FG001|Overall Study|Adverse Event|0|||
149937054|NCT01973218|540906735|FG000|Overall Study|Withdrawal by Subject|1|||
149937055|NCT01973218|540906736|FG001|Overall Study|Withdrawal by Subject|0|||
149937056|NCT02247466|540906737|FG000|Overall Study|Procedure changed to open surgery|0|||
149937057|NCT02247466|540906738|FG001|Overall Study|Procedure changed to open surgery|3|||
149937058|NCT00350545|540907963|FG000|Overall Study|Withdrawal by Subject|2|||
149937059|NCT00434252|540907967|FG000|Overall Study|Lack of Efficacy|50|||
149937060|NCT00434252|540907968|FG001|Overall Study|Lack of Efficacy|100|||
149937061|NCT00434252|540907967|FG000|Overall Study|Adverse Event|6|||
149937062|NCT00434252|540907968|FG001|Overall Study|Adverse Event|13|||
149937063|NCT00434252|540907967|FG000|Overall Study|Death|1|||
149937064|NCT00434252|540907968|FG001|Overall Study|Death|2|||
149937065|NCT00434252|540907967|FG000|Overall Study|Lost to Follow-up|0|||
149937066|NCT00434252|540907968|FG001|Overall Study|Lost to Follow-up|1|||
149937067|NCT00434252|540907967|FG000|Overall Study|Physician Decision|4|||
149937068|NCT00434252|540907968|FG001|Overall Study|Physician Decision|8|||
149937069|NCT00434252|540907967|FG000|Overall Study|Withdrawal by Subject|3|||
149937070|NCT00434252|540907968|FG001|Overall Study|Withdrawal by Subject|7|||
149937071|NCT00720278|540907977|FG000|Overall Study|Adverse Event|5|||
149937072|NCT00720278|540907978|FG001|Overall Study|Adverse Event|3|||
149937073|NCT00720278|540907979|FG002|Overall Study|Adverse Event|4|||
149937074|NCT00720278|540907977|FG000|Overall Study|Withdrawal by Subject|0|||
150270373|NCT04427501|542127445|FG010|Overall Study|Other - as reported by the investigator|0|||
149937075|NCT00720278|540907978|FG001|Overall Study|Withdrawal by Subject|1|||
149937076|NCT00720278|540907979|FG002|Overall Study|Withdrawal by Subject|0|||
149937077|NCT00720278|540907977|FG000|Overall Study|Lost to Follow-up|0|||
149937078|NCT00720278|540907978|FG001|Overall Study|Lost to Follow-up|0|||
149937079|NCT00720278|540907979|FG002|Overall Study|Lost to Follow-up|1|||
149937080|NCT00720278|540907977|FG000|Overall Study|Non-compliance|1|||
149937081|NCT00720278|540907978|FG001|Overall Study|Non-compliance|0|||
149937082|NCT00720278|540907979|FG002|Overall Study|Non-compliance|0|||
149937083|NCT00720278|540907977|FG000|Overall Study|eligibility criteria violation|1|||
149937084|NCT00720278|540907978|FG001|Overall Study|eligibility criteria violation|0|||
149937085|NCT00720278|540907979|FG002|Overall Study|eligibility criteria violation|1|||
149937086|NCT03630393|540907983|FG000|Overall Study|Death|1|||
149937087|NCT03630393|540907984|FG001|Overall Study|Death|0|||
149937088|NCT00408499|540907985|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
149937089|NCT00408499|540907986|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
149937090|NCT00408499|540907987|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
149937091|NCT00408499|540907988|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
149937092|NCT00408499|540907989|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
149937093|NCT00408499|540907985|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
149937094|NCT00408499|540907986|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
149937095|NCT00408499|540907987|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
149937096|NCT00408499|540907988|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
149937097|NCT00408499|540907989|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
149937098|NCT00408499|540907985|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
149937099|NCT00408499|540907986|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
149937100|NCT00408499|540907987|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
149937101|NCT00408499|540907988|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
149937102|NCT00408499|540907989|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
149937103|NCT00408499|540907985|FG000|Phase II- MTD Expansion|Adverse Event|0|||
149937104|NCT00408499|540907986|FG001|Phase II- MTD Expansion|Adverse Event|0|||
149937105|NCT00408499|540907987|FG002|Phase II- MTD Expansion|Adverse Event|0|||
149937106|NCT00408499|540907988|FG003|Phase II- MTD Expansion|Adverse Event|0|||
149937107|NCT00408499|540907989|FG004|Phase II- MTD Expansion|Adverse Event|9|||
149937108|NCT00408499|540907985|FG000|Phase II- MTD Expansion|Death|0|||
149937109|NCT00408499|540907986|FG001|Phase II- MTD Expansion|Death|0|||
149937110|NCT00408499|540907987|FG002|Phase II- MTD Expansion|Death|0|||
149937111|NCT00408499|540907988|FG003|Phase II- MTD Expansion|Death|0|||
149937112|NCT00408499|540907989|FG004|Phase II- MTD Expansion|Death|2|||
149937113|NCT00408499|540907985|FG000|Phase II- MTD Expansion|Physician Decision|0|||
149937114|NCT00408499|540907986|FG001|Phase II- MTD Expansion|Physician Decision|0|||
149937115|NCT00408499|540907987|FG002|Phase II- MTD Expansion|Physician Decision|0|||
149937116|NCT00408499|540907988|FG003|Phase II- MTD Expansion|Physician Decision|0|||
149937117|NCT00408499|540907989|FG004|Phase II- MTD Expansion|Physician Decision|1|||
149937118|NCT00408499|540907985|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
149937119|NCT00408499|540907986|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
149937120|NCT00408499|540907987|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
149937121|NCT00408499|540907988|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
149937122|NCT00408499|540907989|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
149937123|NCT00408499|540907985|FG000|Phase II- MTD Expansion|treatment delay|0|||
149937124|NCT00408499|540907986|FG001|Phase II- MTD Expansion|treatment delay|0|||
149937125|NCT00408499|540907987|FG002|Phase II- MTD Expansion|treatment delay|0|||
149937126|NCT00408499|540907988|FG003|Phase II- MTD Expansion|treatment delay|0|||
149937127|NCT00408499|540907989|FG004|Phase II- MTD Expansion|treatment delay|3|||
149937128|NCT01586195|540907991|FG000|Overall Study|Death|11|||
149937129|NCT01586195|540907991|FG000|Overall Study|Withdrawal of Consent|5|||
149937130|NCT01586195|540907991|FG000|Overall Study|Started new anti-melanoma therapy|1|||
149937131|NCT01586195|540907991|FG000|Overall Study|Reason not specified|9|||
149937132|NCT00997334|540907992|FG000|Overall Study|still on therapy|12|||
149937133|NCT00997334|540907992|FG000|Overall Study|Adverse Event|3|||
149937134|NCT00997334|540907992|FG000|Overall Study|Patient non-compliance|1|||
149937135|NCT00997334|540907992|FG000|Overall Study|Withdrawal by Subject|3|||
149937136|NCT00997334|540907992|FG000|Overall Study|Death|2|||
149937137|NCT00997334|540907992|FG000|Overall Study|Urgent Palliative Care|2|||
149937138|NCT00997334|540907992|FG000|Overall Study|No lesion amenable|1|||
149937139|NCT00997334|540907992|FG000|Overall Study|Ineligible|1|||
149937140|NCT01855958|540907993|FG000|Overall Study|Withdrawal by Subject|1|||
149937141|NCT01855958|540907994|FG001|Overall Study|Withdrawal by Subject|0|||
149937142|NCT00266708|540908000|FG000|Overall Study|No renal function|1|||
149937143|NCT00266708|540908001|FG001|Overall Study|No renal function|1|||
149937144|NCT00266708|540908000|FG000|Overall Study|Refused biopsy|3|||
149937145|NCT00266708|540908001|FG001|Overall Study|Refused biopsy|6|||
149937146|NCT00266708|540908000|FG000|Overall Study|Asthma|0|||
149937147|NCT00266708|540908001|FG001|Overall Study|Asthma|2|||
149937148|NCT02791269|540908002|FG000|Overall Study|Lost to Follow-up|0|||
149937149|NCT02791269|540908003|FG001|Overall Study|Lost to Follow-up|1|||
149937150|NCT02351934|540908004|FG000|Allocation|POD weight<pre-op weight|3|||
149937151|NCT02351934|540908005|FG001|Allocation|POD weight<pre-op weight|0|||
149937152|NCT02351934|540908004|FG000|Allocation|Hypotension preventing administration|2|||
149937153|NCT02351934|540908005|FG001|Allocation|Hypotension preventing administration|0|||
150270374|NCT04427501|542127446|FG011|Overall Study|Other - as reported by the investigator|0|||
150270375|NCT04427501|542127435|FG000|Overall Study|Other|0|||
150270376|NCT04427501|542127436|FG001|Overall Study|Other|0|||
150270377|NCT04427501|542127437|FG002|Overall Study|Other|0|||
150270378|NCT04427501|542127438|FG003|Overall Study|Other|0|||
150270379|NCT04427501|542127439|FG004|Overall Study|Other|0|||
150270380|NCT04427501|542127440|FG005|Overall Study|Other|0|||
150270381|NCT04427501|542127441|FG006|Overall Study|Other|0|||
150270382|NCT04427501|542127442|FG007|Overall Study|Other|0|||
150270383|NCT04427501|542127443|FG008|Overall Study|Other|0|||
150270384|NCT04427501|542127444|FG009|Overall Study|Other|0|||
150270385|NCT04427501|542127445|FG010|Overall Study|Other|0|||
150270386|NCT04427501|542127446|FG011|Overall Study|Other|1|||
150270387|NCT04936841|542127449|FG000|Overall Study|Death|1|||
150270388|NCT00639223|542127450|FG000|Overall Study|Lost to Follow-up|0|||
150270389|NCT00639223|542127451|FG001|Overall Study|Lost to Follow-up|2|||
150270390|NCT04201821|542127456|FG000|Overall Study|Withdrawal by Subject|2|||
150270391|NCT02846532|542127464|FG000|Overall Study|Lost to Follow-up|0|||
150270392|NCT02846532|542127465|FG001|Overall Study|Lost to Follow-up|1|||
150270393|NCT02846532|542127466|FG002|Overall Study|Lost to Follow-up|1|||
150270394|NCT02846532|542127464|FG000|Overall Study|Withdrawal by Subject|1|||
150270395|NCT02846532|542127465|FG001|Overall Study|Withdrawal by Subject|2|||
150270396|NCT02846532|542127466|FG002|Overall Study|Withdrawal by Subject|0|||
150270397|NCT04484259|542127467|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
150270398|NCT04484259|542127468|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
150270399|NCT04484259|542127469|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
150270400|NCT04484259|542127470|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
150270401|NCT04484259|542127471|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
150270402|NCT04484259|542127467|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
150270403|NCT04484259|542127468|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
150270404|NCT04484259|542127469|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
150270405|NCT04484259|542127470|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
150270406|NCT04484259|542127471|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
150270407|NCT04484259|542127467|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
150270408|NCT04484259|542127468|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
150270409|NCT04484259|542127469|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
150270410|NCT04484259|542127470|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
150270411|NCT04484259|542127471|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
150270412|NCT04484259|542127467|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
150270413|NCT04484259|542127468|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
150270414|NCT04484259|542127469|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
150270415|NCT04484259|542127470|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
150270416|NCT04484259|542127471|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
150270417|NCT04484259|542127467|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
150270418|NCT04484259|542127468|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
150270419|NCT04484259|542127469|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
150270420|NCT04484259|542127470|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
150270421|NCT04484259|542127471|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
150270422|NCT04484259|542127467|FG000|Randomized Treatment|Withdrawal by Subject|1|||
150270423|NCT04484259|542127468|FG001|Randomized Treatment|Withdrawal by Subject|0|||
150270424|NCT04484259|542127469|FG002|Randomized Treatment|Withdrawal by Subject|0|||
150270425|NCT04484259|542127470|FG003|Randomized Treatment|Withdrawal by Subject|0|||
150270426|NCT04484259|542127471|FG004|Randomized Treatment|Withdrawal by Subject|0|||
150270427|NCT03951220|542127472|FG000|Overall Study|Withdrawal by Subject|9|||
150270428|NCT03951220|542127473|FG001|Overall Study|Withdrawal by Subject|2|||
150270429|NCT03951220|542127474|FG002|Overall Study|Withdrawal by Subject|0|||
149937154|NCT02351934|540908004|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
150270430|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
150270431|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
150270432|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
150270433|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
150270434|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
150270435|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
150270436|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
150270437|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
150270438|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
149937155|NCT02351934|540908005|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
149937156|NCT02351934|540908004|FG000|Follow-Up|POD weight<pre-op weight|3|||
149937157|NCT02351934|540908005|FG001|Follow-Up|POD weight<pre-op weight|0|||
150270439|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
150270440|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
150270441|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
150270442|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
150270443|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
150270444|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
150270445|NCT04908189|542127475|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
150270446|NCT04908189|542127476|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
150270447|NCT04908189|542127477|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
150270448|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
150270449|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
150270450|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
150270451|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
150270452|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
150270453|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
150270454|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
150270455|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
150270456|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
150270457|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
150270458|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
150270459|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
150270460|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
150270461|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
150270462|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
150270463|NCT04908189|542127475|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
150270464|NCT04908189|542127476|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
150270465|NCT04908189|542127477|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
150270466|NCT01306890|542128902|FG000|Overall Study|Adverse Event|2|||
150270467|NCT01306890|542128902|FG000|Overall Study|Death|1223|||
150270468|NCT01306890|542128902|FG000|Overall Study|Lost to Follow-up|58|||
150270469|NCT01306890|542128902|FG000|Overall Study|Withdrawal by Subject|88|||
150270470|NCT01306890|542128902|FG000|Overall Study|Unspecified reasons|104|||
150270471|NCT01306890|542128902|FG000|Overall Study|Study Termination|3|||
150270472|NCT01306890|542128902|FG000|Overall Study|No discontinuation documentation|41|||
150270473|NCT02217436|542128903|FG000|Overall Study|Protocol Violation|1|||
150270474|NCT02217436|542128904|FG001|Overall Study|Protocol Violation|1|||
150270475|NCT02217436|542128903|FG000|Overall Study|Incomplete data|0|||
150270476|NCT02217436|542128904|FG001|Overall Study|Incomplete data|1|||
150270477|NCT01890148|542128914|FG000|Overall Study|Adverse Event|1|||
150270478|NCT01215175|542128915|FG000|Overall Study|Lost to Follow-up|0|||
150270479|NCT01215175|542128916|FG001|Overall Study|Lost to Follow-up|1|||
150270480|NCT01215175|542128917|FG002|Overall Study|Lost to Follow-up|0|||
150270481|NCT01215175|542128918|FG003|Overall Study|Lost to Follow-up|1|||
150270482|NCT01215175|542128919|FG004|Overall Study|Lost to Follow-up|0|||
150270483|NCT03872453|542128920|FG000|Overall Study|Adverse Event|1|||
150270484|NCT03872453|542128921|FG001|Overall Study|Adverse Event|1|||
150270485|NCT03872453|542128922|FG002|Overall Study|Adverse Event|0|||
150270486|NCT03872453|542128923|FG003|Overall Study|Adverse Event|0|||
150270487|NCT03872453|542128920|FG000|Overall Study|Lost to Follow-up|8|||
150270488|NCT03872453|542128921|FG001|Overall Study|Lost to Follow-up|7|||
150270489|NCT03872453|542128922|FG002|Overall Study|Lost to Follow-up|4|||
150270490|NCT03872453|542128923|FG003|Overall Study|Lost to Follow-up|4|||
150270491|NCT03872453|542128920|FG000|Overall Study|Never Treated Migraine|19|||
150270492|NCT03872453|542128921|FG001|Overall Study|Never Treated Migraine|17|||
150270493|NCT03872453|542128922|FG002|Overall Study|Never Treated Migraine|13|||
150270494|NCT03872453|542128923|FG003|Overall Study|Never Treated Migraine|12|||
150270495|NCT03872453|542128920|FG000|Overall Study|Pregnancy|1|||
150270496|NCT03872453|542128921|FG001|Overall Study|Pregnancy|0|||
150270497|NCT03872453|542128922|FG002|Overall Study|Pregnancy|0|||
150270498|NCT03872453|542128923|FG003|Overall Study|Pregnancy|0|||
150270499|NCT03872453|542128920|FG000|Overall Study|Protocol Deviation|2|||
150270500|NCT03872453|542128921|FG001|Overall Study|Protocol Deviation|0|||
150270501|NCT03872453|542128922|FG002|Overall Study|Protocol Deviation|0|||
150270502|NCT03872453|542128923|FG003|Overall Study|Protocol Deviation|2|||
150270503|NCT03872453|542128920|FG000|Overall Study|Withdrawal by Subject|0|||
150270504|NCT03872453|542128921|FG001|Overall Study|Withdrawal by Subject|1|||
150270505|NCT03872453|542128922|FG002|Overall Study|Withdrawal by Subject|2|||
150270506|NCT03872453|542128923|FG003|Overall Study|Withdrawal by Subject|0|||
150270507|NCT03872453|542128920|FG000|Overall Study|Other Than Specified|1|||
150270508|NCT03872453|542128921|FG001|Overall Study|Other Than Specified|0|||
150270509|NCT03872453|542128922|FG002|Overall Study|Other Than Specified|0|||
150270510|NCT03872453|542128923|FG003|Overall Study|Other Than Specified|0|||
150270511|NCT01678209|542128924|FG000|Overall Study|could not scan twice|1|||
150270512|NCT01678209|542128925|FG001|Overall Study|could not scan twice|1|||
150270513|NCT01678209|542128926|FG002|Overall Study|could not scan twice|1|||
150270514|NCT01678209|542128924|FG000|Overall Study|scheduling conflicts|0|||
150270515|NCT01678209|542128925|FG001|Overall Study|scheduling conflicts|0|||
150270516|NCT01678209|542128926|FG002|Overall Study|scheduling conflicts|1|||
150270517|NCT01678209|542128924|FG000|Overall Study|screen fail|16|||
150270518|NCT01678209|542128925|FG001|Overall Study|screen fail|17|||
150270519|NCT01678209|542128926|FG002|Overall Study|screen fail|16|||
150270520|NCT03756350|542128927|FG000|Overall Study|Lost to Follow-up|1|||
150270521|NCT01096342|542128930|FG000|Overall Study|Protocol Violation|1|||
150270522|NCT03739762|542128931|FG000|Overall Study|Lost to Follow-up|1|||
150270523|NCT03739762|542128932|FG001|Overall Study|Lost to Follow-up|1|||
150270524|NCT03739762|542128931|FG000|Overall Study|Withdrawal by Subject|2|||
150270525|NCT03739762|542128932|FG001|Overall Study|Withdrawal by Subject|6|||
150270526|NCT00607880|542128933|FG000|Overall Study|Unable to place port due to occlusion|1|||
150270527|NCT00607880|542128934|FG001|Overall Study|Unable to place port due to occlusion|0|||
150270528|NCT05104476|542128939|FG000|Overall Study|Randomized But Not Treated|1|||
150270529|NCT05104476|542128940|FG001|Overall Study|Randomized But Not Treated|2|||
150270530|NCT05104476|542128939|FG000|Overall Study|Adverse Event|2|||
150270531|NCT05104476|542128940|FG001|Overall Study|Adverse Event|2|||
150270532|NCT05104476|542128939|FG000|Overall Study|Withdrawal by Subject|3|||
150270533|NCT05104476|542128940|FG001|Overall Study|Withdrawal by Subject|3|||
150270534|NCT05104476|542128939|FG000|Overall Study|Other Than Specified|0|||
150270535|NCT05104476|542128940|FG001|Overall Study|Other Than Specified|3|||
150270536|NCT02170389|542128943|FG000|Overall Study|Study terminated prior to start of treat|1|||
150270537|NCT01008696|542128944|FG000|Overall Study|Participant's evasion of hospital visit|5|||
150270538|NCT01008696|542128945|FG001|Overall Study|Participant's evasion of hospital visit|4|||
150270539|NCT01008696|542128944|FG000|Overall Study|Withdrawal by Subject|2|||
150270540|NCT01008696|542128945|FG001|Overall Study|Withdrawal by Subject|4|||
150270541|NCT01008696|542128944|FG000|Overall Study|Physician Decision|5|||
150270542|NCT01008696|542128945|FG001|Overall Study|Physician Decision|1|||
150270543|NCT01008696|542128944|FG000|Overall Study|Adverse Event|1|||
150270544|NCT01008696|542128945|FG001|Overall Study|Adverse Event|0|||
150270545|NCT01008696|542128944|FG000|Overall Study|Participants' non-cooperation|2|||
150270546|NCT01008696|542128945|FG001|Overall Study|Participants' non-cooperation|3|||
150270547|NCT01008696|542128944|FG000|Overall Study|Other|2|||
150270548|NCT01008696|542128945|FG001|Overall Study|Other|3|||
150270549|NCT01008696|542128944|FG000|Overall Study|Other|0|||
150270550|NCT01008696|542128945|FG001|Overall Study|Other|2|||
150270551|NCT02366728|542128946|FG000|Overall Study|Death|0|||
150270552|NCT02366728|542128947|FG001|Overall Study|Death|0|||
150270553|NCT02366728|542128948|FG002|Overall Study|Death|1|||
150270554|NCT02366728|542128946|FG000|Overall Study|Adverse Event|1|||
150270555|NCT02366728|542128947|FG001|Overall Study|Adverse Event|0|||
150270556|NCT02366728|542128948|FG002|Overall Study|Adverse Event|0|||
150270557|NCT02366728|542128946|FG000|Overall Study|Screen Failure|2|||
150270558|NCT02366728|542128947|FG001|Overall Study|Screen Failure|1|||
150270559|NCT02366728|542128948|FG002|Overall Study|Screen Failure|0|||
150270560|NCT02366728|542128946|FG000|Overall Study|Only yielded 2 vaccines|1|||
150270561|NCT02366728|542128947|FG001|Overall Study|Only yielded 2 vaccines|0|||
150270562|NCT02366728|542128948|FG002|Overall Study|Only yielded 2 vaccines|0|||
150270563|NCT03083847|542128949|FG000|Main|Physician Decision|0|||
150270564|NCT03083847|542128950|FG001|Main|Physician Decision|0|||
150270565|NCT03083847|542128951|FG002|Main|Physician Decision|0|||
150270566|NCT03083847|542128952|FG003|Main|Physician Decision|0|||
150270567|NCT03083847|542128953|FG004|Main|Physician Decision|0|||
150270568|NCT03083847|542128954|FG005|Main|Physician Decision|1|||
150270569|NCT03083847|542128955|FG006|Main|Physician Decision|0|||
150270570|NCT03083847|542128956|FG007|Main|Physician Decision|0|||
150270571|NCT03083847|542128957|FG008|Main|Physician Decision|0|||
150270572|NCT03083847|542128958|FG009|Main|Physician Decision|0|||
150270573|NCT03083847|542128949|FG000|Main|Pregnancy|0|||
150270574|NCT03083847|542128950|FG001|Main|Pregnancy|0|||
150270575|NCT03083847|542128951|FG002|Main|Pregnancy|0|||
150270576|NCT03083847|542128952|FG003|Main|Pregnancy|0|||
150270577|NCT03083847|542128953|FG004|Main|Pregnancy|0|||
150270578|NCT03083847|542128954|FG005|Main|Pregnancy|0|||
150270579|NCT03083847|542128955|FG006|Main|Pregnancy|0|||
150270580|NCT03083847|542128956|FG007|Main|Pregnancy|1|||
150270581|NCT03083847|542128957|FG008|Main|Pregnancy|0|||
150270582|NCT03083847|542128958|FG009|Main|Pregnancy|0|||
150270583|NCT03083847|542128949|FG000|Main|Adverse Event|0|||
150270584|NCT03083847|542128950|FG001|Main|Adverse Event|0|||
150270585|NCT03083847|542128951|FG002|Main|Adverse Event|0|||
150270586|NCT03083847|542128952|FG003|Main|Adverse Event|0|||
150270587|NCT03083847|542128953|FG004|Main|Adverse Event|0|||
150270588|NCT03083847|542128954|FG005|Main|Adverse Event|0|||
150270589|NCT03083847|542128955|FG006|Main|Adverse Event|0|||
150270590|NCT03083847|542128956|FG007|Main|Adverse Event|2|||
150270591|NCT03083847|542128957|FG008|Main|Adverse Event|0|||
150270592|NCT03083847|542128958|FG009|Main|Adverse Event|0|||
150270593|NCT03083847|542128949|FG000|Main|Withdrawal by Subject|0|||
150270594|NCT03083847|542128950|FG001|Main|Withdrawal by Subject|0|||
150270595|NCT03083847|542128951|FG002|Main|Withdrawal by Subject|0|||
150270596|NCT03083847|542128952|FG003|Main|Withdrawal by Subject|0|||
150270597|NCT03083847|542128953|FG004|Main|Withdrawal by Subject|0|||
150270598|NCT03083847|542128954|FG005|Main|Withdrawal by Subject|0|||
150270599|NCT03083847|542128955|FG006|Main|Withdrawal by Subject|1|||
150270600|NCT03083847|542128956|FG007|Main|Withdrawal by Subject|1|||
150270601|NCT03083847|542128957|FG008|Main|Withdrawal by Subject|0|||
150270602|NCT03083847|542128958|FG009|Main|Withdrawal by Subject|0|||
150270603|NCT01601847|542128968|FG000|Overall Study|Death|1|||
150270604|NCT01601847|542128969|FG001|Overall Study|Death|0|||
150270605|NCT01601847|542128968|FG000|Overall Study|Withdrawal by Subject|11|||
150270606|NCT01601847|542128969|FG001|Overall Study|Withdrawal by Subject|7|||
150270607|NCT01601847|542128968|FG000|Overall Study|Lost to Follow-up|1|||
150270608|NCT01601847|542128969|FG001|Overall Study|Lost to Follow-up|3|||
150270609|NCT01807923|542128970|FG000|Overall Study|Adverse Event|2|||
150270610|NCT01807923|542128971|FG001|Overall Study|Adverse Event|1|||
150270611|NCT01807923|542128972|FG002|Overall Study|Adverse Event|2|||
149937158|NCT02351934|540908004|FG000|Follow-Up|Acute Kidney Injury|1|||
149937159|NCT02351934|540908005|FG001|Follow-Up|Acute Kidney Injury|0|||
149937160|NCT02351934|540908004|FG000|Follow-Up|Early dismissal|3|||
149937161|NCT02351934|540908005|FG001|Follow-Up|Early dismissal|0|||
149937162|NCT02351934|540908004|FG000|Follow-Up|Hypotension|3|||
149937163|NCT02351934|540908005|FG001|Follow-Up|Hypotension|0|||
149937164|NCT02351934|540908004|FG000|Follow-Up|No documentation|2|||
149937165|NCT02351934|540908005|FG001|Follow-Up|No documentation|0|||
149937166|NCT02351934|540908004|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
149937167|NCT02351934|540908005|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
149937168|NCT02351934|540908004|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
149937169|NCT02351934|540908005|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
149937170|NCT02683109|540908006|FG000|Overall Study|Adverse Event|1|||
149937171|NCT02683109|540908007|FG001|Overall Study|Adverse Event|0|||
149937172|NCT00368251|540908008|FG000|Overall Study|SAE, non-fatal|1|||
149937173|NCT00368251|540908009|FG001|Overall Study|SAE, non-fatal|0|||
149937174|NCT00368251|540908010|FG002|Overall Study|SAE, non-fatal|0|||
149937175|NCT00368251|540908008|FG000|Overall Study|AE, non-serious non-fatal|0|||
149937176|NCT00368251|540908009|FG001|Overall Study|AE, non-serious non-fatal|0|||
149937177|NCT00368251|540908010|FG002|Overall Study|AE, non-serious non-fatal|1|||
149937178|NCT00499122|540908012|FG000|Overall Study|Withdrawal by Subject|2|||
149937179|NCT02669849|540908016|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
149937180|NCT02669849|540908017|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
149937181|NCT02669849|540908018|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
149937182|NCT02669849|540908016|FG000|Overall Study|Lost to Follow-up|1|||
149937183|NCT02669849|540908017|FG001|Overall Study|Lost to Follow-up|0|||
149937184|NCT02669849|540908018|FG002|Overall Study|Lost to Follow-up|3|||
149937185|NCT02669849|540908016|FG000|Overall Study|Death|1|||
149937186|NCT02669849|540908017|FG001|Overall Study|Death|1|||
149937187|NCT02669849|540908018|FG002|Overall Study|Death|2|||
149937188|NCT02669849|540908016|FG000|Overall Study|Study terminated by sponsor|16|||
149937189|NCT02669849|540908017|FG001|Overall Study|Study terminated by sponsor|1|||
149937190|NCT02669849|540908018|FG002|Overall Study|Study terminated by sponsor|14|||
149937191|NCT02669849|540908016|FG000|Overall Study|Other|0|||
149937192|NCT02669849|540908017|FG001|Overall Study|Other|0|||
149937193|NCT02669849|540908018|FG002|Overall Study|Other|2|||
149937194|NCT04745351|540908019|FG000|Overall Study|Death|51|||
149937195|NCT04745351|540908020|FG001|Overall Study|Death|25|||
149937196|NCT04745351|540908019|FG000|Overall Study|Lost to Follow-up|9|||
149937197|NCT04745351|540908020|FG001|Overall Study|Lost to Follow-up|3|||
149937198|NCT04745351|540908019|FG000|Overall Study|Randomized but Never Treated|3|||
149937199|NCT04745351|540908020|FG001|Overall Study|Randomized but Never Treated|3|||
149937200|NCT04745351|540908019|FG000|Overall Study|Adverse Event|4|||
149937201|NCT04745351|540908020|FG001|Overall Study|Adverse Event|0|||
149937202|NCT04745351|540908019|FG000|Overall Study|Withdrew Consent|1|||
150270612|NCT01807923|542128970|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
150270613|NCT01807923|542128971|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
149937203|NCT04745351|540908020|FG001|Overall Study|Withdrew Consent|2|||
149937204|NCT04745351|540908019|FG000|Overall Study|Investigator's Discretion|2|||
150270614|NCT01807923|542128972|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
150270615|NCT01807923|542128970|FG000|Overall Study|Physician Decision|0|||
149937205|NCT04745351|540908020|FG001|Overall Study|Investigator's Discretion|0|||
149937206|NCT04745351|540908019|FG000|Overall Study|Protocol Violation|1|||
149937207|NCT04745351|540908020|FG001|Overall Study|Protocol Violation|0|||
149937208|NCT02014272|540908021|FG000|Intervention Period 1|Withdrawal by Subject|1|||
150270616|NCT01807923|542128971|FG001|Overall Study|Physician Decision|0|||
150270617|NCT01807923|542128972|FG002|Overall Study|Physician Decision|1|||
150270618|NCT01807923|542128970|FG000|Overall Study|Not Eligible (Genotype)|0|||
150270619|NCT01807923|542128971|FG001|Overall Study|Not Eligible (Genotype)|0|||
150270620|NCT01807923|542128972|FG002|Overall Study|Not Eligible (Genotype)|1|||
149937209|NCT02014272|540908022|FG001|Intervention Period 1|Withdrawal by Subject|0|||
149937210|NCT02014272|540908021|FG000|Intervention Period 1|Adverse Event|0|||
149937211|NCT02014272|540908022|FG001|Intervention Period 1|Adverse Event|1|||
149937212|NCT01483118|540908023|FG000|Overall Study|Lost to Follow-up|12|||
149937213|NCT01483118|540908024|FG001|Overall Study|Lost to Follow-up|16|||
149937214|NCT00551369|540908025|FG000|Overall Study|Protocol Violation|5|||
149937215|NCT00551369|540908025|FG000|Overall Study|Withdrawal by Subject|1|||
149937216|NCT00551369|540908025|FG000|Overall Study|Not treated per protocol and re|1|||
149937217|NCT02051296|540908026|FG000|Overall Study|Lost to Follow-up|1|||
149937218|NCT02051296|540908027|FG001|Overall Study|Lost to Follow-up|2|||
149937219|NCT02051296|540908026|FG000|Overall Study|withdraw prior to treatment|7|||
149937220|NCT02051296|540908027|FG001|Overall Study|withdraw prior to treatment|7|||
149937221|NCT05379920|540908028|FG000|Overall Study|Lost to Follow-up|0|||
149937222|NCT05379920|540908029|FG001|Overall Study|Lost to Follow-up|5|||
149937223|NCT05379920|540908030|FG002|Overall Study|Lost to Follow-up|0|||
149937224|NCT05379920|540908031|FG003|Overall Study|Lost to Follow-up|0|||
149937225|NCT03176771|540908034|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
149937226|NCT03176771|540908035|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
149937227|NCT03176771|540908036|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
149937228|NCT03176771|540908037|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
149937229|NCT03176771|540908038|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
149937230|NCT03176771|540908034|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
149937231|NCT03176771|540908035|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
149937232|NCT03176771|540908036|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
149937233|NCT03176771|540908037|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
149937234|NCT03176771|540908038|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
149937235|NCT03176771|540908034|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
149937236|NCT03176771|540908035|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
149937237|NCT03176771|540908036|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
149937238|NCT03176771|540908037|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
149937239|NCT03176771|540908038|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
149937240|NCT03176771|540908034|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
149937241|NCT03176771|540908035|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
149937242|NCT03176771|540908036|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
149937243|NCT03176771|540908037|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
149937244|NCT03176771|540908038|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
149937245|NCT03176771|540908034|FG000|Double-Blind Extension Period|Adverse Event|0|||
149937246|NCT03176771|540908035|FG001|Double-Blind Extension Period|Adverse Event|0|||
149937247|NCT03176771|540908036|FG002|Double-Blind Extension Period|Adverse Event|0|||
149937248|NCT03176771|540908037|FG003|Double-Blind Extension Period|Adverse Event|15|||
149937249|NCT03176771|540908038|FG004|Double-Blind Extension Period|Adverse Event|18|||
149937250|NCT03176771|540908034|FG000|Double-Blind Extension Period|Death|0|||
149937251|NCT03176771|540908035|FG001|Double-Blind Extension Period|Death|0|||
149937252|NCT03176771|540908036|FG002|Double-Blind Extension Period|Death|0|||
149937253|NCT03176771|540908037|FG003|Double-Blind Extension Period|Death|3|||
149937254|NCT03176771|540908038|FG004|Double-Blind Extension Period|Death|4|||
149937255|NCT03176771|540908034|FG000|Double-Blind Extension Period|Physician Decision|0|||
149937256|NCT03176771|540908035|FG001|Double-Blind Extension Period|Physician Decision|0|||
149937257|NCT03176771|540908036|FG002|Double-Blind Extension Period|Physician Decision|0|||
149937258|NCT03176771|540908037|FG003|Double-Blind Extension Period|Physician Decision|3|||
149937259|NCT03176771|540908038|FG004|Double-Blind Extension Period|Physician Decision|1|||
149937260|NCT03176771|540908034|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
149937261|NCT03176771|540908035|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
149937262|NCT03176771|540908036|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
149937263|NCT03176771|540908037|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
149937264|NCT03176771|540908038|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
149937265|NCT02265510|540908040|FG000|Overall Study|Withdrawal by Subject|1|||
149937266|NCT02265510|540908041|FG001|Overall Study|Withdrawal by Subject|1|||
149937267|NCT02265510|540908042|FG002|Overall Study|Withdrawal by Subject|2|||
149937268|NCT02265510|540908043|FG003|Overall Study|Withdrawal by Subject|1|||
149937269|NCT02265510|540908044|FG004|Overall Study|Withdrawal by Subject|0|||
149937270|NCT02265510|540908045|FG005|Overall Study|Withdrawal by Subject|2|||
149937271|NCT02265510|540908046|FG006|Overall Study|Withdrawal by Subject|0|||
149937272|NCT02265510|540908047|FG007|Overall Study|Withdrawal by Subject|2|||
149937273|NCT02265510|540908048|FG008|Overall Study|Withdrawal by Subject|0|||
149937274|NCT02265510|540908049|FG009|Overall Study|Withdrawal by Subject|0|||
149937275|NCT02265510|540908050|FG010|Overall Study|Withdrawal by Subject|0|||
149937276|NCT02265510|540908051|FG011|Overall Study|Withdrawal by Subject|0|||
149937277|NCT02265510|540908052|FG012|Overall Study|Withdrawal by Subject|1|||
149937278|NCT02265510|540908053|FG013|Overall Study|Withdrawal by Subject|0|||
149937279|NCT02265510|540908040|FG000|Overall Study|Disease Progression|0|||
150270621|NCT01807923|542128970|FG000|Overall Study|Randomized But Not Treated|3|||
150270622|NCT01807923|542128971|FG001|Overall Study|Randomized But Not Treated|2|||
150270623|NCT01807923|542128972|FG002|Overall Study|Randomized But Not Treated|5|||
150270624|NCT03836807|542128974|FG000|Overall Study|Physician Decision|1|||
150270625|NCT03836807|542128975|FG001|Overall Study|Physician Decision|0|||
150270626|NCT00685685|542128976|FG000|Washout Period of 7 Days|Adverse Event|2|||
150270627|NCT00685685|542128977|FG001|Washout Period of 7 Days|Adverse Event|0|||
150270628|NCT00685685|542128976|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
150270629|NCT00685685|542128977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
150270630|NCT04029116|542128978|FG000|Overall Study|Adverse Event|0|||
150270631|NCT04029116|542128979|FG001|Overall Study|Adverse Event|2|||
150270632|NCT04029116|542128978|FG000|Overall Study|Lost to Follow-up|3|||
150270633|NCT04029116|542128979|FG001|Overall Study|Lost to Follow-up|5|||
149937280|NCT02265510|540908041|FG001|Overall Study|Disease Progression|1|||
149937281|NCT02265510|540908042|FG002|Overall Study|Disease Progression|2|||
149937282|NCT02265510|540908043|FG003|Overall Study|Disease Progression|1|||
149937283|NCT02265510|540908044|FG004|Overall Study|Disease Progression|1|||
149937284|NCT02265510|540908045|FG005|Overall Study|Disease Progression|0|||
149937285|NCT02265510|540908046|FG006|Overall Study|Disease Progression|0|||
149937286|NCT02265510|540908047|FG007|Overall Study|Disease Progression|0|||
149937287|NCT02265510|540908048|FG008|Overall Study|Disease Progression|0|||
149937288|NCT02265510|540908049|FG009|Overall Study|Disease Progression|0|||
149937289|NCT02265510|540908050|FG010|Overall Study|Disease Progression|0|||
149937290|NCT02265510|540908051|FG011|Overall Study|Disease Progression|0|||
149937291|NCT02265510|540908052|FG012|Overall Study|Disease Progression|0|||
149937292|NCT02265510|540908053|FG013|Overall Study|Disease Progression|0|||
149937293|NCT02265510|540908040|FG000|Overall Study|Death|2|||
149937294|NCT02265510|540908041|FG001|Overall Study|Death|0|||
149937295|NCT02265510|540908042|FG002|Overall Study|Death|2|||
149937296|NCT02265510|540908043|FG003|Overall Study|Death|2|||
149937297|NCT02265510|540908044|FG004|Overall Study|Death|1|||
149937298|NCT02265510|540908045|FG005|Overall Study|Death|3|||
149937299|NCT02265510|540908046|FG006|Overall Study|Death|2|||
149937300|NCT02265510|540908047|FG007|Overall Study|Death|1|||
149937301|NCT02265510|540908048|FG008|Overall Study|Death|3|||
149937302|NCT02265510|540908049|FG009|Overall Study|Death|3|||
149937303|NCT02265510|540908050|FG010|Overall Study|Death|4|||
149937304|NCT02265510|540908051|FG011|Overall Study|Death|12|||
149937305|NCT02265510|540908052|FG012|Overall Study|Death|7|||
149937306|NCT02265510|540908053|FG013|Overall Study|Death|6|||
149937307|NCT02265510|540908040|FG000|Overall Study|Lost to Follow-up|0|||
149937308|NCT02265510|540908041|FG001|Overall Study|Lost to Follow-up|0|||
149937309|NCT02265510|540908042|FG002|Overall Study|Lost to Follow-up|0|||
149937310|NCT02265510|540908043|FG003|Overall Study|Lost to Follow-up|0|||
149937311|NCT02265510|540908044|FG004|Overall Study|Lost to Follow-up|1|||
149937312|NCT02265510|540908045|FG005|Overall Study|Lost to Follow-up|0|||
149937313|NCT02265510|540908046|FG006|Overall Study|Lost to Follow-up|0|||
149937314|NCT02265510|540908047|FG007|Overall Study|Lost to Follow-up|0|||
149937315|NCT02265510|540908048|FG008|Overall Study|Lost to Follow-up|0|||
149937316|NCT02265510|540908049|FG009|Overall Study|Lost to Follow-up|2|||
149937317|NCT02265510|540908050|FG010|Overall Study|Lost to Follow-up|0|||
149937318|NCT02265510|540908051|FG011|Overall Study|Lost to Follow-up|0|||
149937319|NCT02265510|540908052|FG012|Overall Study|Lost to Follow-up|0|||
149937320|NCT02265510|540908053|FG013|Overall Study|Lost to Follow-up|2|||
149937321|NCT02265510|540908040|FG000|Overall Study|Other|0|||
149937322|NCT02265510|540908041|FG001|Overall Study|Other|1|||
149937323|NCT02265510|540908042|FG002|Overall Study|Other|0|||
149937324|NCT02265510|540908043|FG003|Overall Study|Other|0|||
149937325|NCT02265510|540908044|FG004|Overall Study|Other|0|||
149937326|NCT02265510|540908045|FG005|Overall Study|Other|0|||
149937327|NCT02265510|540908046|FG006|Overall Study|Other|0|||
149937328|NCT02265510|540908047|FG007|Overall Study|Other|0|||
149937329|NCT02265510|540908048|FG008|Overall Study|Other|0|||
149937330|NCT02265510|540908049|FG009|Overall Study|Other|0|||
149937331|NCT02265510|540908050|FG010|Overall Study|Other|0|||
149937332|NCT02265510|540908051|FG011|Overall Study|Other|0|||
149937333|NCT02265510|540908052|FG012|Overall Study|Other|0|||
149937334|NCT02265510|540908053|FG013|Overall Study|Other|0|||
149937335|NCT02265510|540908040|FG000|Overall Study|Study Terminated by Sponsor|0|||
149937336|NCT02265510|540908041|FG001|Overall Study|Study Terminated by Sponsor|0|||
149937337|NCT02265510|540908042|FG002|Overall Study|Study Terminated by Sponsor|0|||
149937338|NCT02265510|540908043|FG003|Overall Study|Study Terminated by Sponsor|0|||
149937339|NCT02265510|540908044|FG004|Overall Study|Study Terminated by Sponsor|0|||
149937340|NCT02265510|540908045|FG005|Overall Study|Study Terminated by Sponsor|1|||
150270634|NCT04029116|542128978|FG000|Overall Study|Physician Decision|2|||
149937341|NCT02265510|540908046|FG006|Overall Study|Study Terminated by Sponsor|1|||
149937342|NCT02265510|540908047|FG007|Overall Study|Study Terminated by Sponsor|1|||
149937343|NCT02265510|540908048|FG008|Overall Study|Study Terminated by Sponsor|1|||
149937344|NCT02265510|540908049|FG009|Overall Study|Study Terminated by Sponsor|2|||
150031141|NCT03186209|541252561|FG001|Overall Study|Lost to Follow-up|1|||
150270635|NCT04029116|542128979|FG001|Overall Study|Physician Decision|0|||
150270636|NCT04029116|542128978|FG000|Overall Study|Pregnancy|1|||
150270637|NCT04029116|542128979|FG001|Overall Study|Pregnancy|2|||
150270638|NCT04029116|542128978|FG000|Overall Study|Withdrawal by Subject|4|||
150270639|NCT04029116|542128979|FG001|Overall Study|Withdrawal by Subject|6|||
150270640|NCT04029116|542128978|FG000|Overall Study|Other|2|||
150270641|NCT04029116|542128979|FG001|Overall Study|Other|1|||
150270642|NCT02469896|542128982|FG000|Overall Study|Withdrawal by Subject|2|||
150270643|NCT02469896|542128983|FG001|Overall Study|Withdrawal by Subject|0|||
150270644|NCT02510560|542128984|FG000|Overall Study|Discontinued from Treatment|27|||
150270645|NCT02510560|542128985|FG001|Overall Study|Discontinued from Treatment|18|||
150270646|NCT02510560|542128986|FG002|Overall Study|Discontinued from Treatment|19|||
150270647|NCT02510560|542128984|FG000|Overall Study|Other|4|||
150270648|NCT02510560|542128985|FG001|Overall Study|Other|4|||
150270649|NCT02510560|542128986|FG002|Overall Study|Other|3|||
150270650|NCT00882310|542128987|FG000|Overall Study|Screen Failure|10|||
150270651|NCT00882310|542128987|FG000|Overall Study|Never received treatment|1|||
150270652|NCT00882310|542128987|FG000|Overall Study|Death|6|||
150270653|NCT00882310|542128987|FG000|Overall Study|Progression of disease|4|||
150270654|NCT00882310|542128987|FG000|Overall Study|Adverse Event|1|||
150270655|NCT04233164|542128992|FG000|Overall Study|Unable to obtain specimen|0|||
150270656|NCT04233164|542128993|FG001|Overall Study|Unable to obtain specimen|1|||
150270657|NCT02540538|542129001|FG000|Overall Study|Pregnancy|0|||
150270658|NCT02540538|542129002|FG001|Overall Study|Pregnancy|1|||
150270659|NCT02540538|542129003|FG002|Overall Study|Pregnancy|0|||
150270660|NCT01557348|542129004|FG000|Overall Study|Adverse Event|6|||
150270661|NCT01557348|542129005|FG001|Overall Study|Adverse Event|16|||
150270662|NCT01557348|542129004|FG000|Overall Study|Infusion reaction event|5|||
150270663|NCT01557348|542129005|FG001|Overall Study|Infusion reaction event|5|||
150270664|NCT01557348|542129004|FG000|Overall Study|Death|7|||
150270665|NCT01557348|542129005|FG001|Overall Study|Death|4|||
150270666|NCT01557348|542129004|FG000|Overall Study|Insufficient Therapeutic Response|13|||
150270667|NCT01557348|542129005|FG001|Overall Study|Insufficient Therapeutic Response|28|||
150270668|NCT01557348|542129004|FG000|Overall Study|Withdrawal by Subject|5|||
150270669|NCT01557348|542129005|FG001|Overall Study|Withdrawal by Subject|4|||
150270670|NCT01557348|542129004|FG000|Overall Study|Lost to Follow-up|26|||
150270671|NCT01557348|542129005|FG001|Overall Study|Lost to Follow-up|22|||
150270672|NCT01557348|542129004|FG000|Overall Study|Administrative|18|||
150270673|NCT01557348|542129005|FG001|Overall Study|Administrative|11|||
150270674|NCT04598477|542129008|FG000|Overall Study|Adverse Event|2|||
150270675|NCT04598477|542129009|FG001|Overall Study|Adverse Event|0|||
150270676|NCT04598477|542129008|FG000|Overall Study|Death|0|||
150270677|NCT04598477|542129009|FG001|Overall Study|Death|1|||
150270678|NCT04598477|542129008|FG000|Overall Study|Lost to Follow-up|1|||
150270679|NCT04598477|542129009|FG001|Overall Study|Lost to Follow-up|0|||
150270680|NCT04598477|542129008|FG000|Overall Study|Physician Decision|7|||
150270681|NCT04598477|542129009|FG001|Overall Study|Physician Decision|2|||
150270682|NCT04598477|542129008|FG000|Overall Study|Pregnancy|0|||
150270683|NCT04598477|542129009|FG001|Overall Study|Pregnancy|1|||
150270684|NCT04598477|542129008|FG000|Overall Study|Requires Prohibited Medication|0|||
150270685|NCT04598477|542129009|FG001|Overall Study|Requires Prohibited Medication|1|||
150270686|NCT04598477|542129008|FG000|Overall Study|Study Terminated by Sponsor|18|||
150270687|NCT04598477|542129009|FG001|Overall Study|Study Terminated by Sponsor|12|||
150270688|NCT04598477|542129008|FG000|Overall Study|Withdrawal by Subject|16|||
150270689|NCT04598477|542129009|FG001|Overall Study|Withdrawal by Subject|12|||
150270690|NCT04598477|542129008|FG000|Overall Study|Other|15|||
150270691|NCT04598477|542129009|FG001|Overall Study|Other|8|||
150270692|NCT05579990|542129015|FG000|Overall Study|Lost to Follow-up|3|||
149937345|NCT02265510|540908050|FG010|Overall Study|Study Terminated by Sponsor|1|||
149937346|NCT02265510|540908051|FG011|Overall Study|Study Terminated by Sponsor|4|||
149937347|NCT02265510|540908052|FG012|Overall Study|Study Terminated by Sponsor|1|||
149937348|NCT02265510|540908053|FG013|Overall Study|Study Terminated by Sponsor|2|||
149937349|NCT02530385|540908054|FG000|Overall Study|Withdrawal by Subject|0|||
149937350|NCT02530385|540908055|FG001|Overall Study|Withdrawal by Subject|1|||
150270693|NCT05118204|542129016|FG000|Overall Study|Lost to Follow-up|3|||
149937351|NCT02111083|540908060|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
150270694|NCT05118204|542129017|FG001|Overall Study|Lost to Follow-up|2|||
150270695|NCT05118204|542129016|FG000|Overall Study|Withdrawal by Subject|0|||
150270696|NCT05118204|542129017|FG001|Overall Study|Withdrawal by Subject|2|||
150270697|NCT01313650|542129019|FG000|Overall Study|Adverse Event|9|||
150270698|NCT01313650|542129020|FG001|Overall Study|Adverse Event|34|||
150270699|NCT01313650|542129021|FG002|Overall Study|Adverse Event|24|||
150270700|NCT01313650|542129022|FG003|Overall Study|Adverse Event|23|||
150270701|NCT01313650|542129019|FG000|Overall Study|Lack of Efficacy|37|||
149937352|NCT02111083|540908061|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
149937353|NCT00644059|540908062|FG000|Overall Study|Lost to Follow-up|37|||
149937354|NCT00644059|540908063|FG001|Overall Study|Lost to Follow-up|34|||
150270702|NCT01313650|542129020|FG001|Overall Study|Lack of Efficacy|20|||
150270703|NCT01313650|542129021|FG002|Overall Study|Lack of Efficacy|32|||
150270704|NCT01313650|542129022|FG003|Overall Study|Lack of Efficacy|20|||
150270705|NCT01313650|542129019|FG000|Overall Study|Lost to Follow-up|1|||
150270706|NCT01313650|542129020|FG001|Overall Study|Lost to Follow-up|0|||
150270707|NCT01313650|542129021|FG002|Overall Study|Lost to Follow-up|3|||
150270708|NCT01313650|542129022|FG003|Overall Study|Lost to Follow-up|2|||
150270709|NCT01313650|542129019|FG000|Overall Study|Withdrawal by Subject|16|||
150270710|NCT01313650|542129020|FG001|Overall Study|Withdrawal by Subject|20|||
150270711|NCT01313650|542129021|FG002|Overall Study|Withdrawal by Subject|15|||
150270712|NCT01313650|542129022|FG003|Overall Study|Withdrawal by Subject|15|||
150270713|NCT01313650|542129019|FG000|Overall Study|Protocol Violation|4|||
150270714|NCT01313650|542129020|FG001|Overall Study|Protocol Violation|7|||
150270715|NCT01313650|542129021|FG002|Overall Study|Protocol Violation|5|||
150270716|NCT01313650|542129022|FG003|Overall Study|Protocol Violation|6|||
150270717|NCT01313650|542129019|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
150270718|NCT01313650|542129020|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
150270719|NCT01313650|542129021|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
150270720|NCT01313650|542129022|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
150270721|NCT05393037|542129025|FG000|Part A|Death|1|||
150270722|NCT05393037|542129026|FG001|Part A|Death|0|||
150270723|NCT05393037|542129025|FG000|Part A|Lost to Follow-up|1|||
150270724|NCT05393037|542129026|FG001|Part A|Lost to Follow-up|1|||
150270725|NCT05393037|542129025|FG000|Part A|Withdrawal by Subject|2|||
150270726|NCT05393037|542129026|FG001|Part A|Withdrawal by Subject|4|||
150270727|NCT05393037|542129025|FG000|Part B|Lost to Follow-up|1|||
150270728|NCT05393037|542129026|FG001|Part B|Lost to Follow-up|0|||
150270729|NCT01012739|542129027|FG000|Treatment Period 1|Adverse Event|0|||
150270730|NCT01012739|542129028|FG001|Treatment Period 1|Adverse Event|0|||
150270731|NCT01012739|542129029|FG002|Treatment Period 1|Adverse Event|0|||
150270732|NCT01012739|542129030|FG003|Treatment Period 1|Adverse Event|1|||
150270733|NCT01012739|542129027|FG000|Treatment Period 2|Abnormal test procedure results|0|||
150270734|NCT01012739|542129028|FG001|Treatment Period 2|Abnormal test procedure results|0|||
149937355|NCT00644059|540908064|FG002|Overall Study|Lost to Follow-up|16|||
149937356|NCT00644059|540908062|FG000|Overall Study|Withdrawal by Subject|52|||
149937357|NCT00644059|540908063|FG001|Overall Study|Withdrawal by Subject|60|||
149937358|NCT00644059|540908064|FG002|Overall Study|Withdrawal by Subject|30|||
149937359|NCT00644059|540908062|FG000|Overall Study|Adverse Event|8|||
149937360|NCT00644059|540908063|FG001|Overall Study|Adverse Event|5|||
149937361|NCT00644059|540908064|FG002|Overall Study|Adverse Event|1|||
149937362|NCT00644059|540908062|FG000|Overall Study|Inappropriate Enrollment|1|||
149937363|NCT00644059|540908063|FG001|Overall Study|Inappropriate Enrollment|3|||
149937364|NCT00644059|540908064|FG002|Overall Study|Inappropriate Enrollment|0|||
149937365|NCT00644059|540908062|FG000|Overall Study|Protocol Deviation/violation|20|||
149937366|NCT00644059|540908063|FG001|Overall Study|Protocol Deviation/violation|19|||
149937367|NCT00644059|540908064|FG002|Overall Study|Protocol Deviation/violation|15|||
149937368|NCT00644059|540908062|FG000|Overall Study|Unable to classify|6|||
149937369|NCT00644059|540908063|FG001|Overall Study|Unable to classify|2|||
149937370|NCT00644059|540908064|FG002|Overall Study|Unable to classify|3|||
149937371|NCT02152007|540908065|FG000|Overall Study|Withdrawal by Subject|1|||
149937372|NCT02497469|540908066|FG000|Overall Study|Randomized but not Treated|0|||
149937373|NCT02497469|540908067|FG001|Overall Study|Randomized but not Treated|2|||
149937374|NCT02497469|540908066|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
149937375|NCT02497469|540908067|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
149937376|NCT02497469|540908066|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
149937377|NCT02497469|540908067|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
149937378|NCT02497469|540908066|FG000|Overall Study|Significant Protocol Deviation|4|||
149937379|NCT02497469|540908067|FG001|Overall Study|Significant Protocol Deviation|5|||
149937380|NCT02497469|540908066|FG000|Overall Study|Lost to Follow-up|14|||
149937381|NCT02497469|540908067|FG001|Overall Study|Lost to Follow-up|4|||
149937382|NCT02497469|540908066|FG000|Overall Study|Voluntary Withdrawal|39|||
149937383|NCT02497469|540908067|FG001|Overall Study|Voluntary Withdrawal|41|||
149937384|NCT02497469|540908066|FG000|Overall Study|Pregnancy|1|||
149937385|NCT02497469|540908067|FG001|Overall Study|Pregnancy|1|||
149937386|NCT02497469|540908066|FG000|Overall Study|Lack of Efficacy|86|||
149937387|NCT02497469|540908067|FG001|Overall Study|Lack of Efficacy|40|||
149937388|NCT02497469|540908066|FG000|Overall Study|Reason not Specified|6|||
149937389|NCT02497469|540908067|FG001|Overall Study|Reason not Specified|6|||
149937390|NCT03786380|540908072|FG000|Overall Study|Adverse Event|1|||
149937391|NCT03786380|540908073|FG001|Overall Study|Adverse Event|0|||
149937392|NCT03786380|540908074|FG002|Overall Study|Adverse Event|0|||
149937393|NCT03786380|540908075|FG003|Overall Study|Adverse Event|3|||
150270735|NCT01012739|542129029|FG002|Treatment Period 2|Abnormal test procedure results|0|||
150270736|NCT01012739|542129030|FG003|Treatment Period 2|Abnormal test procedure results|1|||
150270737|NCT04029480|542129031|FG000|Overall Study|Physician Decision|0|||
150270738|NCT04029480|542129032|FG001|Overall Study|Physician Decision|0|||
150270739|NCT04029480|542129033|FG002|Overall Study|Physician Decision|2|||
150270740|NCT04029480|542129034|FG003|Overall Study|Physician Decision|1|||
149937394|NCT03786380|540908076|FG004|Overall Study|Adverse Event|1|||
149937395|NCT03786380|540908072|FG000|Overall Study|Lack of Efficacy|0|||
149937396|NCT03786380|540908073|FG001|Overall Study|Lack of Efficacy|0|||
150270741|NCT04029480|542129031|FG000|Overall Study|Withdrawal by Subject|2|||
150270742|NCT04029480|542129032|FG001|Overall Study|Withdrawal by Subject|0|||
150270743|NCT04029480|542129033|FG002|Overall Study|Withdrawal by Subject|1|||
150270744|NCT04029480|542129034|FG003|Overall Study|Withdrawal by Subject|1|||
150270745|NCT04786119|542129035|FG000|Overall Study|Withdrawal by Subject|4|||
150270746|NCT04786119|542129036|FG001|Overall Study|Withdrawal by Subject|5|||
150270747|NCT04786119|542129035|FG000|Overall Study|Lost to Follow-up|5|||
150270748|NCT04786119|542129036|FG001|Overall Study|Lost to Follow-up|5|||
149937397|NCT03786380|540908074|FG002|Overall Study|Lack of Efficacy|0|||
149937398|NCT03786380|540908075|FG003|Overall Study|Lack of Efficacy|0|||
149937399|NCT03786380|540908076|FG004|Overall Study|Lack of Efficacy|1|||
149937400|NCT03786380|540908072|FG000|Overall Study|Withdrawal by Subject|1|||
149937401|NCT03786380|540908073|FG001|Overall Study|Withdrawal by Subject|2|||
149937402|NCT03786380|540908074|FG002|Overall Study|Withdrawal by Subject|2|||
149937403|NCT03786380|540908075|FG003|Overall Study|Withdrawal by Subject|1|||
149937404|NCT03786380|540908076|FG004|Overall Study|Withdrawal by Subject|2|||
149937405|NCT03786380|540908072|FG000|Overall Study|Lost to Follow-up|3|||
149937406|NCT03786380|540908073|FG001|Overall Study|Lost to Follow-up|0|||
149937407|NCT03786380|540908074|FG002|Overall Study|Lost to Follow-up|1|||
149937408|NCT03786380|540908075|FG003|Overall Study|Lost to Follow-up|2|||
149937409|NCT03786380|540908076|FG004|Overall Study|Lost to Follow-up|0|||
149937410|NCT03786380|540908072|FG000|Overall Study|Physician Decision|0|||
150270749|NCT04786119|542129035|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
150270750|NCT04786119|542129036|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
150270751|NCT02593786|542129041|FG000|Overall Study|Disease progression|12|||
150270752|NCT02593786|542129042|FG001|Overall Study|Disease progression|16|||
150270753|NCT02593786|542129043|FG002|Overall Study|Disease progression|10|||
150270754|NCT02593786|542129044|FG003|Overall Study|Disease progression|7|||
150270755|NCT02593786|542129041|FG000|Overall Study|Study drug toxicity|1|||
150270756|NCT02593786|542129042|FG001|Overall Study|Study drug toxicity|0|||
150270757|NCT02593786|542129043|FG002|Overall Study|Study drug toxicity|0|||
150270758|NCT02593786|542129044|FG003|Overall Study|Study drug toxicity|0|||
150270759|NCT02593786|542129041|FG000|Overall Study|Adverse event unrelated to study drug|1|||
150270760|NCT02593786|542129042|FG001|Overall Study|Adverse event unrelated to study drug|1|||
150270761|NCT02593786|542129043|FG002|Overall Study|Adverse event unrelated to study drug|1|||
150270762|NCT02593786|542129044|FG003|Overall Study|Adverse event unrelated to study drug|0|||
150270763|NCT02593786|542129041|FG000|Overall Study|Participant request to discontinue study therapy|0|||
150270764|NCT02593786|542129042|FG001|Overall Study|Participant request to discontinue study therapy|2|||
150270765|NCT02593786|542129043|FG002|Overall Study|Participant request to discontinue study therapy|0|||
150270766|NCT02593786|542129044|FG003|Overall Study|Participant request to discontinue study therapy|0|||
150270767|NCT02593786|542129041|FG000|Overall Study|Other reasons|1|||
150270768|NCT02593786|542129042|FG001|Overall Study|Other reasons|1|||
150270769|NCT02593786|542129043|FG002|Overall Study|Other reasons|0|||
150270770|NCT02593786|542129044|FG003|Overall Study|Other reasons|5|||
150270771|NCT02383589|542129054|FG000|Treatment Period|Adverse Event|1|||
150270772|NCT02383589|542129055|FG001|Treatment Period|Adverse Event|3|||
150270773|NCT02383589|542129054|FG000|Treatment Period|Lost to Follow-up|0|||
150270774|NCT02383589|542129055|FG001|Treatment Period|Lost to Follow-up|1|||
150270775|NCT02383589|542129054|FG000|Treatment Period|Withdrawal by Subject|0|||
150270776|NCT02383589|542129055|FG001|Treatment Period|Withdrawal by Subject|5|||
150270777|NCT02383589|542129054|FG000|Treatment Period|Non-compliance with study drug|0|||
150270778|NCT02383589|542129055|FG001|Treatment Period|Non-compliance with study drug|1|||
150270779|NCT02383589|542129054|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
150270780|NCT02383589|542129055|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
150270781|NCT02383589|542129054|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
150270782|NCT02383589|542129055|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
150270783|NCT02383589|542129054|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
150270784|NCT02383589|542129055|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
150270785|NCT02408861|542129060|FG000|Overall Study|Death|0|||
150270786|NCT02408861|542129061|FG001|Overall Study|Death|3|||
150270787|NCT02408861|542129062|FG002|Overall Study|Death|1|||
150270788|NCT02408861|542129063|FG003|Overall Study|Death|2|||
150270789|NCT02408861|542129064|FG004|Overall Study|Death|4|||
150270790|NCT02408861|542129065|FG005|Overall Study|Death|1|||
150270791|NCT02408861|542129066|FG006|Overall Study|Death|0|||
150270792|NCT02408861|542129060|FG000|Overall Study|Lost to Follow-up|0|||
150270793|NCT02408861|542129061|FG001|Overall Study|Lost to Follow-up|0|||
150270794|NCT02408861|542129062|FG002|Overall Study|Lost to Follow-up|1|||
150270795|NCT02408861|542129063|FG003|Overall Study|Lost to Follow-up|1|||
150270796|NCT02408861|542129064|FG004|Overall Study|Lost to Follow-up|4|||
150270797|NCT02408861|542129065|FG005|Overall Study|Lost to Follow-up|2|||
149937411|NCT03786380|540908073|FG001|Overall Study|Physician Decision|0|||
149937412|NCT03786380|540908074|FG002|Overall Study|Physician Decision|1|||
149937413|NCT03786380|540908075|FG003|Overall Study|Physician Decision|0|||
149937414|NCT03786380|540908076|FG004|Overall Study|Physician Decision|0|||
149937415|NCT03786380|540908072|FG000|Overall Study|Study Terminated by the Sponsor|30|||
149937416|NCT03786380|540908073|FG001|Overall Study|Study Terminated by the Sponsor|20|||
149937417|NCT03786380|540908074|FG002|Overall Study|Study Terminated by the Sponsor|50|||
149937418|NCT03786380|540908075|FG003|Overall Study|Study Terminated by the Sponsor|57|||
149937419|NCT03786380|540908076|FG004|Overall Study|Study Terminated by the Sponsor|23|||
149937420|NCT03786380|540908072|FG000|Overall Study|Reason Not Specified|0|||
149937421|NCT03786380|540908073|FG001|Overall Study|Reason Not Specified|0|||
149937422|NCT03786380|540908074|FG002|Overall Study|Reason Not Specified|0|||
149937423|NCT03786380|540908075|FG003|Overall Study|Reason Not Specified|0|||
149937424|NCT03786380|540908076|FG004|Overall Study|Reason Not Specified|1|||
149937425|NCT01118052|540908079|FG000|Overall Study|Never treated|2|||
149937426|NCT00843492|540908085|FG000|Overall Study|Adverse Event|0|||
149937427|NCT00843492|540908086|FG001|Overall Study|Adverse Event|3|||
149937428|NCT00843492|540908085|FG000|Overall Study|Lost to Follow-up|4|||
149937429|NCT00843492|540908086|FG001|Overall Study|Lost to Follow-up|4|||
149937430|NCT00843492|540908085|FG000|Overall Study|Withdrawal by Subject|0|||
149937431|NCT00843492|540908086|FG001|Overall Study|Withdrawal by Subject|4|||
149937432|NCT00843492|540908085|FG000|Overall Study|Immobilization Stopped|1|||
149937433|NCT00843492|540908086|FG001|Overall Study|Immobilization Stopped|0|||
149937434|NCT00843492|540908085|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
149937435|NCT00843492|540908086|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
149937436|NCT00843492|540908085|FG000|Overall Study|Orthopedic Surgery|0|||
149937437|NCT00843492|540908086|FG001|Overall Study|Orthopedic Surgery|2|||
149937438|NCT00843492|540908085|FG000|Overall Study|Visit Not Performed|1|||
149937439|NCT00843492|540908086|FG001|Overall Study|Visit Not Performed|0|||
149937440|NCT00843492|540908085|FG000|Overall Study|Deep-vein Thrombosis|1|||
149937441|NCT00843492|540908086|FG001|Overall Study|Deep-vein Thrombosis|0|||
149937442|NCT00369343|540908087|FG000|Double-blind Phase|Adverse Event|19|||
149937443|NCT00369343|540908088|FG001|Double-blind Phase|Adverse Event|4|||
149937444|NCT00369343|540908087|FG000|Double-blind Phase|Failed to return|2|||
149937445|NCT00369343|540908088|FG001|Double-blind Phase|Failed to return|0|||
149937446|NCT00369343|540908087|FG000|Double-blind Phase|Lost to Follow-up|9|||
149937447|NCT00369343|540908088|FG001|Double-blind Phase|Lost to Follow-up|2|||
149937448|NCT00369343|540908087|FG000|Double-blind Phase|Protocol Violation|2|||
149937449|NCT00369343|540908088|FG001|Double-blind Phase|Protocol Violation|0|||
149937450|NCT00369343|540908087|FG000|Double-blind Phase|Withdrawal by Subject|8|||
149937451|NCT00369343|540908088|FG001|Double-blind Phase|Withdrawal by Subject|6|||
149937452|NCT00369343|540908087|FG000|Double-blind Phase|Lack of Efficacy|0|||
149937453|NCT00369343|540908088|FG001|Double-blind Phase|Lack of Efficacy|4|||
149937454|NCT00369343|540908087|FG000|Double-blind Phase|Protocol deviation|4|||
149937455|NCT00369343|540908088|FG001|Double-blind Phase|Protocol deviation|0|||
149937456|NCT00369343|540908087|FG000|Open-label Phase|Adverse Event|19|||
149937457|NCT00369343|540908088|FG001|Open-label Phase|Adverse Event|7|||
149937458|NCT00369343|540908087|FG000|Open-label Phase|Failed to return|4|||
149937459|NCT00369343|540908088|FG001|Open-label Phase|Failed to return|0|||
150168803|NCT00771667|541752556|FG005|Induction Phase|Adverse Event|0|||
150168804|NCT00771667|541752557|FG006|Induction Phase|Adverse Event|0|||
150168805|NCT00771667|541752558|FG007|Induction Phase|Adverse Event|0|||
150168806|NCT00771667|541752559|FG008|Induction Phase|Adverse Event|0|||
150168807|NCT00771667|541752560|FG009|Induction Phase|Adverse Event|0|||
150168808|NCT00771667|541752551|FG000|Induction Phase|Lack of Efficacy|9|||
150168809|NCT00771667|541752552|FG001|Induction Phase|Lack of Efficacy|2|||
150168810|NCT00771667|541752553|FG002|Induction Phase|Lack of Efficacy|4|||
150168811|NCT00771667|541752554|FG003|Induction Phase|Lack of Efficacy|3|||
150168812|NCT00771667|541752555|FG004|Induction Phase|Lack of Efficacy|0|||
150168813|NCT00771667|541752556|FG005|Induction Phase|Lack of Efficacy|0|||
150168814|NCT00771667|541752557|FG006|Induction Phase|Lack of Efficacy|0|||
150168815|NCT00771667|541752558|FG007|Induction Phase|Lack of Efficacy|0|||
150168816|NCT00771667|541752559|FG008|Induction Phase|Lack of Efficacy|0|||
150168817|NCT00771667|541752560|FG009|Induction Phase|Lack of Efficacy|0|||
150168818|NCT00771667|541752551|FG000|Induction Phase|Lost to Follow-up|1|||
150168819|NCT00771667|541752552|FG001|Induction Phase|Lost to Follow-up|0|||
150168820|NCT00771667|541752553|FG002|Induction Phase|Lost to Follow-up|1|||
150168821|NCT00771667|541752554|FG003|Induction Phase|Lost to Follow-up|0|||
150168822|NCT00771667|541752555|FG004|Induction Phase|Lost to Follow-up|0|||
150168823|NCT00771667|541752556|FG005|Induction Phase|Lost to Follow-up|0|||
150168824|NCT00771667|541752557|FG006|Induction Phase|Lost to Follow-up|0|||
150168825|NCT00771667|541752558|FG007|Induction Phase|Lost to Follow-up|0|||
149937460|NCT00369343|540908087|FG000|Open-label Phase|Physician Decision|2|||
150168826|NCT00771667|541752559|FG008|Induction Phase|Lost to Follow-up|0|||
149937461|NCT00369343|540908088|FG001|Open-label Phase|Physician Decision|0|||
150168827|NCT00771667|541752560|FG009|Induction Phase|Lost to Follow-up|0|||
150168828|NCT00771667|541752551|FG000|Induction Phase|Other|4|||
150168829|NCT00771667|541752552|FG001|Induction Phase|Other|6|||
150168830|NCT00771667|541752553|FG002|Induction Phase|Other|3|||
150168831|NCT00771667|541752554|FG003|Induction Phase|Other|4|||
150168832|NCT00771667|541752555|FG004|Induction Phase|Other|0|||
150168833|NCT00771667|541752556|FG005|Induction Phase|Other|0|||
150168834|NCT00771667|541752557|FG006|Induction Phase|Other|0|||
150168835|NCT00771667|541752558|FG007|Induction Phase|Other|0|||
150168836|NCT00771667|541752559|FG008|Induction Phase|Other|0|||
150168837|NCT00771667|541752560|FG009|Induction Phase|Other|0|||
150168838|NCT00771667|541752551|FG000|Maintenance Phase|Adverse Event|0|||
150168839|NCT00771667|541752552|FG001|Maintenance Phase|Adverse Event|0|||
150168840|NCT00771667|541752553|FG002|Maintenance Phase|Adverse Event|0|||
150168841|NCT00771667|541752554|FG003|Maintenance Phase|Adverse Event|0|||
150168842|NCT00771667|541752555|FG004|Maintenance Phase|Adverse Event|1|||
150168843|NCT00771667|541752556|FG005|Maintenance Phase|Adverse Event|3|||
150168844|NCT00771667|541752557|FG006|Maintenance Phase|Adverse Event|5|||
150168845|NCT00771667|541752558|FG007|Maintenance Phase|Adverse Event|1|||
150168846|NCT00771667|541752559|FG008|Maintenance Phase|Adverse Event|8|||
150168847|NCT00771667|541752560|FG009|Maintenance Phase|Adverse Event|7|||
150168848|NCT00771667|541752551|FG000|Maintenance Phase|Lack of Efficacy|0|||
150168849|NCT00771667|541752552|FG001|Maintenance Phase|Lack of Efficacy|0|||
150168850|NCT00771667|541752553|FG002|Maintenance Phase|Lack of Efficacy|0|||
150168851|NCT00771667|541752554|FG003|Maintenance Phase|Lack of Efficacy|0|||
150168852|NCT00771667|541752555|FG004|Maintenance Phase|Lack of Efficacy|1|||
150168853|NCT00771667|541752556|FG005|Maintenance Phase|Lack of Efficacy|3|||
150168854|NCT00771667|541752557|FG006|Maintenance Phase|Lack of Efficacy|3|||
150168855|NCT00771667|541752558|FG007|Maintenance Phase|Lack of Efficacy|2|||
150168856|NCT00771667|541752559|FG008|Maintenance Phase|Lack of Efficacy|11|||
150168857|NCT00771667|541752560|FG009|Maintenance Phase|Lack of Efficacy|7|||
150168858|NCT00771667|541752551|FG000|Maintenance Phase|Other|0|||
150168859|NCT00771667|541752552|FG001|Maintenance Phase|Other|0|||
150168860|NCT00771667|541752553|FG002|Maintenance Phase|Other|0|||
150168861|NCT00771667|541752554|FG003|Maintenance Phase|Other|0|||
150168862|NCT00771667|541752555|FG004|Maintenance Phase|Other|0|||
150168863|NCT00771667|541752556|FG005|Maintenance Phase|Other|1|||
150168864|NCT00771667|541752557|FG006|Maintenance Phase|Other|2|||
150168865|NCT00771667|541752558|FG007|Maintenance Phase|Other|2|||
150168866|NCT00771667|541752559|FG008|Maintenance Phase|Other|3|||
150168867|NCT00771667|541752560|FG009|Maintenance Phase|Other|3|||
150168868|NCT01897233|541752561|FG000|Part B (24 Weeks)|Adverse Event|1|||
150168869|NCT01897233|541752561|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
150168870|NCT01897233|541752561|FG000|Part B (24 Weeks)|Physician Decision|1|||
150168871|NCT03265210|541752567|FG000|Overall Study|Withdrawal by Subject|7|||
150168872|NCT03265210|541752568|FG001|Overall Study|Withdrawal by Subject|9|||
150168873|NCT03265210|541752567|FG000|Overall Study|Lost to Follow-up|2|||
150168874|NCT03265210|541752568|FG001|Overall Study|Lost to Follow-up|0|||
150168875|NCT03265210|541752567|FG000|Overall Study|Physician Decision|2|||
150168876|NCT03265210|541752568|FG001|Overall Study|Physician Decision|0|||
150168877|NCT03265210|541752567|FG000|Overall Study|Adverse Event|1|||
150168878|NCT03265210|541752568|FG001|Overall Study|Adverse Event|0|||
150168879|NCT01883492|541752569|FG000|Overall Study|Lost to Follow-up|3|||
150168880|NCT01883492|541752570|FG001|Overall Study|Lost to Follow-up|4|||
150168881|NCT01883492|541752569|FG000|Overall Study|Surgery on contra-lateral hip|0|||
150168882|NCT01883492|541752570|FG001|Overall Study|Surgery on contra-lateral hip|1|||
150168883|NCT01883492|541752569|FG000|Overall Study|Poor X-ray quality|7|||
150168884|NCT01883492|541752570|FG001|Overall Study|Poor X-ray quality|4|||
150168885|NCT01883492|541752569|FG000|Overall Study|Withdrawal by Subject|1|||
150168886|NCT01883492|541752570|FG001|Overall Study|Withdrawal by Subject|0|||
150168887|NCT01883492|541752569|FG000|Overall Study|inappropriate implant used|1|||
150168888|NCT01883492|541752570|FG001|Overall Study|inappropriate implant used|1|||
150168889|NCT01883492|541752569|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
150168890|NCT01883492|541752570|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
150168891|NCT03383887|541752575|FG000|Overall Study|Lost to Follow-up|0|||
150168892|NCT03383887|541752576|FG001|Overall Study|Lost to Follow-up|1|||
150168893|NCT01806714|541752584|FG000|Overall Study|No functioning phone number|200|||
150168894|NCT01806714|541752585|FG001|Overall Study|No functioning phone number|170|||
150168895|NCT02155829|541752586|FG000|Overall Study|Adverse Event|1|||
150168896|NCT02155829|541752587|FG001|Overall Study|Adverse Event|0|||
150168897|NCT02155829|541752586|FG000|Overall Study|Withdrawal by Subject|3|||
150168898|NCT02155829|541752587|FG001|Overall Study|Withdrawal by Subject|3|||
150168899|NCT02155829|541752586|FG000|Overall Study|Protocol Violation|2|||
150168900|NCT02155829|541752587|FG001|Overall Study|Protocol Violation|0|||
150168901|NCT04107805|541752590|FG000|Overall Study|Adverse Event|0|||
150168902|NCT04107805|541752591|FG001|Overall Study|Adverse Event|0|||
150168903|NCT04107805|541752592|FG002|Overall Study|Adverse Event|0|||
150168904|NCT04107805|541752593|FG003|Overall Study|Adverse Event|1|||
150168905|NCT04107805|541752594|FG004|Overall Study|Adverse Event|0|||
150168906|NCT04107805|541752595|FG005|Overall Study|Adverse Event|1|||
150168907|NCT04107805|541752596|FG006|Overall Study|Adverse Event|0|||
150168908|NCT04107805|541752597|FG007|Overall Study|Adverse Event|0|||
150168909|NCT04107805|541752598|FG008|Overall Study|Adverse Event|1|||
150168910|NCT01253226|541752599|FG000|Overall Study|Adverse Event|0|||
150168911|NCT01253226|541752600|FG001|Overall Study|Adverse Event|0|||
150270798|NCT02408861|542129066|FG006|Overall Study|Lost to Follow-up|1|||
150270799|NCT02408861|542129060|FG000|Overall Study|Disease Progression|0|||
149937462|NCT00369343|540908087|FG000|Open-label Phase|Lost to Follow-up|5|||
149937463|NCT00369343|540908088|FG001|Open-label Phase|Lost to Follow-up|3|||
149937464|NCT00369343|540908087|FG000|Open-label Phase|inadvertently reported study completers|3|||
149937465|NCT00369343|540908088|FG001|Open-label Phase|inadvertently reported study completers|2|||
149937466|NCT00369343|540908087|FG000|Open-label Phase|Protocol Violation|1|||
149937467|NCT00369343|540908088|FG001|Open-label Phase|Protocol Violation|3|||
149937468|NCT00369343|540908087|FG000|Open-label Phase|Withdrawal by Subject|15|||
149937469|NCT00369343|540908088|FG001|Open-label Phase|Withdrawal by Subject|6|||
149937470|NCT00369343|540908087|FG000|Open-label Phase|Lack of Efficacy|4|||
149937471|NCT00369343|540908088|FG001|Open-label Phase|Lack of Efficacy|3|||
149937472|NCT00369343|540908087|FG000|Open-label Phase|Lack of continuance tolerability|3|||
149937473|NCT00369343|540908088|FG001|Open-label Phase|Lack of continuance tolerability|4|||
149937474|NCT00369343|540908087|FG000|Open-label Phase|did not take study drug|1|||
149937475|NCT00369343|540908088|FG001|Open-label Phase|did not take study drug|2|||
149937476|NCT00794664|540908089|FG000|Treatment Period|Withdrawal by Subject|0|||
149937477|NCT00794664|540908090|FG001|Treatment Period|Withdrawal by Subject|2|||
149937478|NCT00794664|540908089|FG000|Treatment Period|Protocol non-compliance|0|||
149937479|NCT00794664|540908090|FG001|Treatment Period|Protocol non-compliance|1|||
149937480|NCT00794664|540908089|FG000|Treatment Period|Other|0|||
149937481|NCT00794664|540908090|FG001|Treatment Period|Other|1|||
149937482|NCT00794664|540908089|FG000|Treatment Period|Adverse Event|1|||
149937483|NCT00794664|540908090|FG001|Treatment Period|Adverse Event|8|||
149937484|NCT00794664|540908089|FG000|Follow-up Period|Other|1|||
149937485|NCT00794664|540908090|FG001|Follow-up Period|Other|2|||
149937486|NCT00794664|540908089|FG000|Follow-up Period|Withdrawal by Subject|0|||
149937487|NCT00794664|540908090|FG001|Follow-up Period|Withdrawal by Subject|2|||
149937488|NCT00794664|540908089|FG000|Follow-up Period|Protocol non-compliance|0|||
149937489|NCT00794664|540908090|FG001|Follow-up Period|Protocol non-compliance|1|||
149937490|NCT00720499|540908091|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
149937491|NCT00720499|540908092|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149937492|NCT00720499|540908091|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
149937493|NCT00720499|540908092|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
149937494|NCT00720499|540908091|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
149937495|NCT00720499|540908092|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
149937496|NCT01618968|540908095|FG000|Overall Study|Adverse Event|1|||
149937497|NCT01618968|540908096|FG001|Overall Study|Adverse Event|0|||
149937498|NCT01618968|540908097|FG002|Overall Study|Adverse Event|0|||
149937499|NCT01618968|540908098|FG003|Overall Study|Adverse Event|0|||
149937500|NCT01618968|540908095|FG000|Overall Study|Death|0|||
149937501|NCT01618968|540908096|FG001|Overall Study|Death|0|||
149937502|NCT01618968|540908097|FG002|Overall Study|Death|0|||
149937503|NCT01618968|540908098|FG003|Overall Study|Death|1|||
149937504|NCT02230891|540908106|FG000|Baseline|Did not meet inclusion|0|||
149937505|NCT02230891|540908107|FG001|Baseline|Did not meet inclusion|1|||
149937506|NCT02230891|540908108|FG002|Baseline|Did not meet inclusion|1|||
149937507|NCT02230891|540908106|FG000|2 Week|Withdrawal by Subject|2|||
149937508|NCT02230891|540908107|FG001|2 Week|Withdrawal by Subject|2|||
149937509|NCT02230891|540908108|FG002|2 Week|Withdrawal by Subject|0|||
149937510|NCT02230891|540908106|FG000|2 Week|Consent withdrawn|1|||
149937511|NCT02230891|540908107|FG001|2 Week|Consent withdrawn|0|||
149937512|NCT02230891|540908108|FG002|2 Week|Consent withdrawn|0|||
149937513|NCT02230891|540908106|FG000|6 Month|Withdrawal by Subject|1|||
149937514|NCT02230891|540908107|FG001|6 Month|Withdrawal by Subject|1|||
149937515|NCT02230891|540908108|FG002|6 Month|Withdrawal by Subject|1|||
149937516|NCT02230891|540908106|FG000|6 Month|Physician Decision|0|||
149937517|NCT02230891|540908107|FG001|6 Month|Physician Decision|2|||
149937518|NCT02230891|540908108|FG002|6 Month|Physician Decision|0|||
149937519|NCT02230891|540908106|FG000|12 Month|Death|1|||
149937520|NCT02230891|540908107|FG001|12 Month|Death|0|||
149937521|NCT02230891|540908108|FG002|12 Month|Death|0|||
149937522|NCT02230891|540908106|FG000|12 Month|Lost to Follow-up|0|||
149937523|NCT02230891|540908107|FG001|12 Month|Lost to Follow-up|1|||
149937524|NCT02230891|540908108|FG002|12 Month|Lost to Follow-up|0|||
149937525|NCT02230891|540908106|FG000|12 Month|Withdrawal by Subject|0|||
149937526|NCT02230891|540908107|FG001|12 Month|Withdrawal by Subject|2|||
150270800|NCT02408861|542129061|FG001|Overall Study|Disease Progression|0|||
150270801|NCT02408861|542129062|FG002|Overall Study|Disease Progression|1|||
150270802|NCT02408861|542129063|FG003|Overall Study|Disease Progression|0|||
149937527|NCT02230891|540908108|FG002|12 Month|Withdrawal by Subject|0|||
149937528|NCT02230891|540908106|FG000|18 Month End of Study|Death|0|||
149937529|NCT02230891|540908107|FG001|18 Month End of Study|Death|0|||
149937530|NCT02230891|540908108|FG002|18 Month End of Study|Death|1|||
149937531|NCT02230891|540908106|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
149937532|NCT02230891|540908107|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
149937533|NCT02230891|540908108|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
149975583|NCT00114127|541047892|FG000|Overall Study|Withdrawal by Subject|1|||
150270803|NCT02408861|542129064|FG004|Overall Study|Disease Progression|3|||
150270804|NCT02408861|542129065|FG005|Overall Study|Disease Progression|1|||
150270805|NCT02408861|542129066|FG006|Overall Study|Disease Progression|1|||
150270806|NCT02408861|542129060|FG000|Overall Study|Adverse Event|1|||
150270807|NCT02408861|542129061|FG001|Overall Study|Adverse Event|0|||
150270808|NCT02408861|542129062|FG002|Overall Study|Adverse Event|1|||
150270809|NCT02408861|542129063|FG003|Overall Study|Adverse Event|0|||
150270810|NCT02408861|542129064|FG004|Overall Study|Adverse Event|2|||
150270811|NCT02408861|542129065|FG005|Overall Study|Adverse Event|0|||
150270812|NCT02408861|542129066|FG006|Overall Study|Adverse Event|0|||
150270813|NCT02408861|542129060|FG000|Overall Study|Physician Decision|1|||
150270814|NCT02408861|542129061|FG001|Overall Study|Physician Decision|1|||
150270815|NCT02408861|542129062|FG002|Overall Study|Physician Decision|1|||
150270816|NCT02408861|542129063|FG003|Overall Study|Physician Decision|0|||
150270817|NCT02408861|542129064|FG004|Overall Study|Physician Decision|0|||
150270818|NCT02408861|542129065|FG005|Overall Study|Physician Decision|1|||
150270819|NCT02408861|542129066|FG006|Overall Study|Physician Decision|0|||
150270820|NCT02408861|542129060|FG000|Overall Study|Protocol Violation|1|||
150270821|NCT02408861|542129061|FG001|Overall Study|Protocol Violation|0|||
150270822|NCT02408861|542129062|FG002|Overall Study|Protocol Violation|0|||
150270823|NCT02408861|542129063|FG003|Overall Study|Protocol Violation|0|||
150270824|NCT02408861|542129064|FG004|Overall Study|Protocol Violation|0|||
150270825|NCT02408861|542129065|FG005|Overall Study|Protocol Violation|0|||
150270826|NCT02408861|542129066|FG006|Overall Study|Protocol Violation|0|||
150270827|NCT02408861|542129060|FG000|Overall Study|Withdrawal by Subject|0|||
150270828|NCT02408861|542129061|FG001|Overall Study|Withdrawal by Subject|0|||
150270829|NCT02408861|542129062|FG002|Overall Study|Withdrawal by Subject|0|||
150270830|NCT02408861|542129063|FG003|Overall Study|Withdrawal by Subject|0|||
150270831|NCT02408861|542129064|FG004|Overall Study|Withdrawal by Subject|1|||
150270832|NCT02408861|542129065|FG005|Overall Study|Withdrawal by Subject|1|||
150270833|NCT02408861|542129066|FG006|Overall Study|Withdrawal by Subject|0|||
150270834|NCT02408861|542129060|FG000|Overall Study|Other Treatment|0|||
150270835|NCT02408861|542129061|FG001|Overall Study|Other Treatment|0|||
150270836|NCT02408861|542129062|FG002|Overall Study|Other Treatment|0|||
150270837|NCT02408861|542129063|FG003|Overall Study|Other Treatment|0|||
150270838|NCT02408861|542129064|FG004|Overall Study|Other Treatment|0|||
150270839|NCT02408861|542129065|FG005|Overall Study|Other Treatment|1|||
150270840|NCT02408861|542129066|FG006|Overall Study|Other Treatment|1|||
150270841|NCT03808688|542130973|FG000|Overall Study|Adverse Event|13|||
150270842|NCT03808688|542130974|FG001|Overall Study|Adverse Event|17|||
150270843|NCT03808688|542130973|FG000|Overall Study|Lack of Efficacy|2|||
150270844|NCT03808688|542130974|FG001|Overall Study|Lack of Efficacy|0|||
150270845|NCT03808688|542130973|FG000|Overall Study|Lost to Follow-up|0|||
150270846|NCT03808688|542130974|FG001|Overall Study|Lost to Follow-up|2|||
150270847|NCT03808688|542130973|FG000|Overall Study|Withdrawal by Subject|1|||
150270848|NCT03808688|542130974|FG001|Overall Study|Withdrawal by Subject|0|||
150270849|NCT03808688|542130973|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
150270850|NCT03808688|542130974|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
150270851|NCT03808688|542130973|FG000|Overall Study|IOP Too High|1|||
150270852|NCT03808688|542130974|FG001|Overall Study|IOP Too High|1|||
150270853|NCT03808688|542130973|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
150270854|NCT03808688|542130974|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
150270855|NCT03808688|542130973|FG000|Overall Study|Visit Out of Window|0|||
150270856|NCT03808688|542130974|FG001|Overall Study|Visit Out of Window|1|||
150270857|NCT03808688|542130973|FG000|Overall Study|Medication Non-Compliance|0|||
150270858|NCT03808688|542130974|FG001|Overall Study|Medication Non-Compliance|1|||
150270859|NCT04641299|542130981|FG000|Overall Study|Adverse Event|0|||
150270860|NCT04641299|542130982|FG001|Overall Study|Adverse Event|0|||
150270861|NCT04641299|542130983|FG002|Overall Study|Adverse Event|2|||
150270862|NCT04641299|542130984|FG003|Overall Study|Adverse Event|0|||
150270863|NCT04641299|542130981|FG000|Overall Study|Lost to Follow-up|0|||
150270864|NCT04641299|542130982|FG001|Overall Study|Lost to Follow-up|1|||
150270865|NCT04641299|542130983|FG002|Overall Study|Lost to Follow-up|0|||
150270866|NCT04641299|542130984|FG003|Overall Study|Lost to Follow-up|0|||
150270867|NCT04641299|542130981|FG000|Overall Study|Withdrawal by Subject|1|||
150270868|NCT04641299|542130982|FG001|Overall Study|Withdrawal by Subject|0|||
150270869|NCT04641299|542130983|FG002|Overall Study|Withdrawal by Subject|0|||
150270870|NCT04641299|542130984|FG003|Overall Study|Withdrawal by Subject|0|||
150270871|NCT04641299|542130981|FG000|Overall Study|Reason not given|1|||
150270872|NCT04641299|542130982|FG001|Overall Study|Reason not given|0|||
150270873|NCT04641299|542130983|FG002|Overall Study|Reason not given|0|||
150270874|NCT04641299|542130984|FG003|Overall Study|Reason not given|0|||
150270875|NCT01940354|542130989|FG000|Overall Study|Withdrawal by Subject|4|||
150270876|NCT01940354|542130990|FG001|Overall Study|Withdrawal by Subject|2|||
150270877|NCT02020863|542130991|FG000|Overall Study|Discovery of Metastatic disease|4|||
150270878|NCT02020863|542130991|FG000|Overall Study|Team chose not to place an a line|1|||
150270879|NCT00352885|542130992|FG000|Overall Study|Withdrawal by Subject|0|||
150270880|NCT00352885|542130993|FG001|Overall Study|Withdrawal by Subject|3|||
150270881|NCT00352885|542130992|FG000|Overall Study|Development of major depression|0|||
150270882|NCT00352885|542130993|FG001|Overall Study|Development of major depression|1|||
150270883|NCT00352885|542130992|FG000|Overall Study|Progression of metastatic melanoma|5|||
150270884|NCT00352885|542130993|FG001|Overall Study|Progression of metastatic melanoma|3|||
150270885|NCT00352885|542130992|FG000|Overall Study|Side effects of IL-2 administration|1|||
150270886|NCT00352885|542130993|FG001|Overall Study|Side effects of IL-2 administration|0|||
150270887|NCT01920594|542130994|FG000|Overall Study|Adverse Event|4|||
150270888|NCT01920594|542130995|FG001|Overall Study|Adverse Event|2|||
150270889|NCT01920594|542130994|FG000|Overall Study|Lost to Follow-up|1|||
150270890|NCT01920594|542130995|FG001|Overall Study|Lost to Follow-up|0|||
150270891|NCT01920594|542130994|FG000|Overall Study|Recovery|2|||
150270892|NCT01920594|542130995|FG001|Overall Study|Recovery|0|||
150270893|NCT01920594|542130994|FG000|Overall Study|Investigator discretion|0|||
150270894|NCT01920594|542130995|FG001|Overall Study|Investigator discretion|1|||
150270895|NCT00928564|542130996|FG000|Overall Study|Lost to Follow-up|6|||
150270896|NCT00928564|542130997|FG001|Overall Study|Lost to Follow-up|0|||
150270897|NCT04906616|542130998|FG000|Overall Study|Divorce|3|||
150270898|NCT04906616|542130999|FG001|Overall Study|Divorce|2|||
150270899|NCT00929656|542131000|FG000|Overall Study|Lost to Follow-up|0|||
150270900|NCT00929656|542131001|FG001|Overall Study|Lost to Follow-up|1|||
150270901|NCT00385203|542131004|FG000|Overall Study|Adverse Event|5|||
150270902|NCT00385203|542131005|FG001|Overall Study|Adverse Event|4|||
150270903|NCT00385203|542131004|FG000|Overall Study|Death|1|||
150270904|NCT00385203|542131005|FG001|Overall Study|Death|0|||
150270905|NCT00385203|542131004|FG000|Overall Study|Condition under investigation worsened|18|||
150270906|NCT00385203|542131005|FG001|Overall Study|Condition under investigation worsened|3|||
150270907|NCT00385203|542131004|FG000|Overall Study|Incorrect enrollment|2|||
150270908|NCT00385203|542131005|FG001|Overall Study|Incorrect enrollment|0|||
150270909|NCT03308942|542131006|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
150270910|NCT03308942|542131007|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
150270911|NCT03308942|542131008|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
150270912|NCT03308942|542131009|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
150270913|NCT03308942|542131010|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
150270914|NCT03308942|542131006|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
150270915|NCT03308942|542131007|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
150270916|NCT03308942|542131008|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
150270917|NCT03308942|542131009|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
150270918|NCT03308942|542131010|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
150270919|NCT03308942|542131006|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
150270920|NCT03308942|542131007|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
150270921|NCT03308942|542131008|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
150270922|NCT03308942|542131009|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
150270923|NCT03308942|542131010|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
150270924|NCT03308942|542131006|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
150270925|NCT03308942|542131007|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
150270926|NCT03308942|542131008|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
150270927|NCT03308942|542131009|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
150270928|NCT03308942|542131010|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
150270929|NCT03308942|542131006|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
150270930|NCT03308942|542131007|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
150270931|NCT03308942|542131008|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
150270932|NCT03308942|542131009|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
150270933|NCT03308942|542131010|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
150270934|NCT03308942|542131006|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
150270935|NCT03308942|542131007|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
150270936|NCT03308942|542131008|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
150270937|NCT03308942|542131009|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
150270938|NCT03308942|542131010|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
150270939|NCT03308942|542131006|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
150270940|NCT03308942|542131007|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
150270941|NCT03308942|542131008|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
150270942|NCT03308942|542131009|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
150270943|NCT03308942|542131010|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
150270944|NCT01131351|542131011|FG000|Overall Study|Adverse Event|0|||
150270945|NCT01131351|542131012|FG001|Overall Study|Adverse Event|2|||
150270946|NCT01131351|542131011|FG000|Overall Study|Protocol Deviation|0|||
150270947|NCT01131351|542131012|FG001|Overall Study|Protocol Deviation|1|||
150270948|NCT04147234|542131013|FG000|Overall Study|Clinical deterioration|0|||
150270949|NCT04147234|542131014|FG001|Overall Study|Clinical deterioration|0|||
150270950|NCT04147234|542131015|FG002|Overall Study|Clinical deterioration|1|||
150270951|NCT04147234|542131016|FG003|Overall Study|Clinical deterioration|0|||
150270952|NCT04147234|542131017|FG004|Overall Study|Clinical deterioration|0|||
150270953|NCT04147234|542131018|FG005|Overall Study|Clinical deterioration|0|||
150270954|NCT04147234|542131019|FG006|Overall Study|Clinical deterioration|0|||
150270955|NCT04147234|542131013|FG000|Overall Study|Withdrawal by Subject|0|||
150270956|NCT04147234|542131014|FG001|Overall Study|Withdrawal by Subject|1|||
150270957|NCT04147234|542131015|FG002|Overall Study|Withdrawal by Subject|1|||
150270958|NCT04147234|542131016|FG003|Overall Study|Withdrawal by Subject|0|||
150270959|NCT04147234|542131017|FG004|Overall Study|Withdrawal by Subject|0|||
150270960|NCT04147234|542131018|FG005|Overall Study|Withdrawal by Subject|0|||
150270961|NCT04147234|542131019|FG006|Overall Study|Withdrawal by Subject|0|||
150270962|NCT04147234|542131013|FG000|Overall Study|Clinical disease progression|1|||
150270963|NCT04147234|542131014|FG001|Overall Study|Clinical disease progression|3|||
150270964|NCT04147234|542131015|FG002|Overall Study|Clinical disease progression|1|||
150270965|NCT04147234|542131016|FG003|Overall Study|Clinical disease progression|1|||
150270966|NCT04147234|542131017|FG004|Overall Study|Clinical disease progression|0|||
150270967|NCT04147234|542131018|FG005|Overall Study|Clinical disease progression|1|||
150270968|NCT04147234|542131019|FG006|Overall Study|Clinical disease progression|0|||
150270969|NCT04147234|542131013|FG000|Overall Study|Objective disease progression|6|||
150270970|NCT04147234|542131014|FG001|Overall Study|Objective disease progression|4|||
150270971|NCT04147234|542131015|FG002|Overall Study|Objective disease progression|3|||
150270972|NCT04147234|542131016|FG003|Overall Study|Objective disease progression|3|||
150270973|NCT04147234|542131017|FG004|Overall Study|Objective disease progression|5|||
149937534|NCT04356937|540908109|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
149937535|NCT04356937|540908110|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
149937536|NCT00921024|540908111|FG000|Overall Study|Lost to Follow-up|2|||
149937537|NCT00921024|540908112|FG001|Overall Study|Lost to Follow-up|0|||
149937538|NCT00921024|540908111|FG000|Overall Study|Received concomittant therapy|2|||
149937539|NCT00921024|540908112|FG001|Overall Study|Received concomittant therapy|0|||
149937540|NCT00921024|540908111|FG000|Overall Study|Withdrawal by Subject|0|||
149937541|NCT00921024|540908112|FG001|Overall Study|Withdrawal by Subject|3|||
149937542|NCT04158219|540908113|FG000|Overall Study|Lost to Follow-up|1|||
149937543|NCT01814007|540908114|FG000|Overall Study|Withdrawal by Subject|1|||
149937544|NCT01324947|540908116|FG000|Overall Study|Adverse Event|7|||
149937545|NCT01324947|540908116|FG000|Overall Study|Death|10|||
149937546|NCT01324947|540908116|FG000|Overall Study|Other|3|||
149937547|NCT01324947|540908116|FG000|Overall Study|Progressive Disease|50|||
149937548|NCT01324947|540908116|FG000|Overall Study|Withdrawal by Subject|3|||
149937549|NCT01324947|540908116|FG000|Overall Study|1 discontinued before starting drug|1|||
149937550|NCT04194814|540908119|FG000|Overall Study|Physician Decision|3|||
149937551|NCT04194814|540908120|FG001|Overall Study|Physician Decision|0|||
149937552|NCT04194814|540908119|FG000|Overall Study|Withdrawal by Subject|0|||
149937553|NCT04194814|540908120|FG001|Overall Study|Withdrawal by Subject|2|||
149937554|NCT02873689|540910396|FG000|Overall Study|Lack of Efficacy|1|||
149937555|NCT02873689|540910397|FG001|Overall Study|Lack of Efficacy|0|||
149937556|NCT02873689|540910396|FG000|Overall Study|Withdrawal by Subject|2|||
149937557|NCT02873689|540910397|FG001|Overall Study|Withdrawal by Subject|2|||
149937558|NCT02873689|540910396|FG000|Overall Study|Protocol Violation|1|||
149937559|NCT02873689|540910397|FG001|Overall Study|Protocol Violation|0|||
149937560|NCT02873689|540910396|FG000|Overall Study|Adverse Event|2|||
149937561|NCT02873689|540910397|FG001|Overall Study|Adverse Event|2|||
149937562|NCT02873689|540910396|FG000|Overall Study|Randomized but not Treated|1|||
149937563|NCT02873689|540910397|FG001|Overall Study|Randomized but not Treated|1|||
149937564|NCT00750269|540910414|FG000|Overall Study|Protocol Violation|0|||
149937565|NCT00750269|540910415|FG001|Overall Study|Protocol Violation|1|||
149937566|NCT00750269|540910416|FG002|Overall Study|Protocol Violation|1|||
149937567|NCT00750269|540910417|FG003|Overall Study|Protocol Violation|2|||
149937568|NCT00750269|540910418|FG004|Overall Study|Protocol Violation|4|||
150168912|NCT01253226|541752601|FG002|Overall Study|Adverse Event|1|||
150168913|NCT01253226|541752602|FG003|Overall Study|Adverse Event|0|||
150168914|NCT01253226|541752603|FG004|Overall Study|Adverse Event|0|||
150168915|NCT01253226|541752599|FG000|Overall Study|Death|0|||
150168916|NCT01253226|541752600|FG001|Overall Study|Death|1|||
150168917|NCT01253226|541752601|FG002|Overall Study|Death|0|||
150168918|NCT01253226|541752602|FG003|Overall Study|Death|0|||
150168919|NCT01253226|541752603|FG004|Overall Study|Death|0|||
150168920|NCT01253226|541752599|FG000|Overall Study|Physician Decision|0|||
149937569|NCT00750269|540910414|FG000|Overall Study|Withdrawal by Subject|0|||
149937570|NCT00750269|540910415|FG001|Overall Study|Withdrawal by Subject|0|||
149937571|NCT00750269|540910416|FG002|Overall Study|Withdrawal by Subject|2|||
149937572|NCT00750269|540910417|FG003|Overall Study|Withdrawal by Subject|2|||
149937573|NCT00750269|540910418|FG004|Overall Study|Withdrawal by Subject|2|||
150168921|NCT01253226|541752600|FG001|Overall Study|Physician Decision|0|||
150168922|NCT01253226|541752601|FG002|Overall Study|Physician Decision|0|||
150270974|NCT04147234|542131018|FG005|Overall Study|Objective disease progression|2|||
150270975|NCT04147234|542131019|FG006|Overall Study|Objective disease progression|3|||
150270976|NCT04147234|542131013|FG000|Overall Study|Adverse Event|0|||
149937574|NCT00750269|540910414|FG000|Overall Study|Physician Decision|0|||
149937575|NCT00750269|540910415|FG001|Overall Study|Physician Decision|0|||
149937576|NCT00750269|540910416|FG002|Overall Study|Physician Decision|0|||
149937577|NCT00750269|540910417|FG003|Overall Study|Physician Decision|0|||
149937578|NCT00750269|540910418|FG004|Overall Study|Physician Decision|2|||
149937579|NCT00750269|540910414|FG000|Overall Study|Patient too large for positioning|0|||
149937580|NCT00750269|540910415|FG001|Overall Study|Patient too large for positioning|0|||
149937581|NCT00750269|540910416|FG002|Overall Study|Patient too large for positioning|1|||
149937582|NCT00750269|540910417|FG003|Overall Study|Patient too large for positioning|0|||
149937583|NCT00750269|540910418|FG004|Overall Study|Patient too large for positioning|0|||
149937584|NCT00750269|540910414|FG000|Overall Study|Site error|0|||
149937585|NCT00750269|540910415|FG001|Overall Study|Site error|0|||
149937586|NCT00750269|540910416|FG002|Overall Study|Site error|0|||
149937587|NCT00750269|540910417|FG003|Overall Study|Site error|1|||
149937588|NCT00750269|540910418|FG004|Overall Study|Site error|0|||
149937589|NCT00750269|540910414|FG000|Overall Study|SBRT plan could not be drawn|0|||
149937590|NCT00750269|540910415|FG001|Overall Study|SBRT plan could not be drawn|0|||
149937591|NCT00750269|540910416|FG002|Overall Study|SBRT plan could not be drawn|0|||
149937592|NCT00750269|540910417|FG003|Overall Study|SBRT plan could not be drawn|0|||
149937593|NCT00750269|540910418|FG004|Overall Study|SBRT plan could not be drawn|1|||
149937594|NCT00750269|540910414|FG000|Overall Study|Fiducials could not be placed|0|||
149937595|NCT00750269|540910415|FG001|Overall Study|Fiducials could not be placed|0|||
149937596|NCT00750269|540910416|FG002|Overall Study|Fiducials could not be placed|0|||
149937597|NCT00750269|540910417|FG003|Overall Study|Fiducials could not be placed|0|||
149937598|NCT00750269|540910418|FG004|Overall Study|Fiducials could not be placed|1|||
149937599|NCT04539275|540910422|FG000|Overall Study|Death|2|||
149937600|NCT04539275|540910423|FG001|Overall Study|Death|4|||
149937601|NCT04539275|540910422|FG000|Overall Study|Lost to Follow-up|1|||
149937602|NCT04539275|540910423|FG001|Overall Study|Lost to Follow-up|1|||
149937603|NCT04539275|540910422|FG000|Overall Study|Withdrawal by Subject|3|||
149937604|NCT04539275|540910423|FG001|Overall Study|Withdrawal by Subject|0|||
149937605|NCT02466399|540910424|FG000|Overall Study|Adverse Event|1|||
149937606|NCT02466399|540910425|FG001|Overall Study|Adverse Event|0|||
149937607|NCT02466399|540910424|FG000|Overall Study|Early exit due to family emergency|1|||
149937608|NCT02466399|540910425|FG001|Overall Study|Early exit due to family emergency|0|||
149937609|NCT01373164|540910426|FG000|Overall Study|Lost to Follow-up|0|||
149937610|NCT01373164|540910427|FG001|Overall Study|Lost to Follow-up|0|||
149937611|NCT01373164|540910428|FG002|Overall Study|Lost to Follow-up|1|||
149937612|NCT01373164|540910429|FG003|Overall Study|Lost to Follow-up|2|||
149937613|NCT01373164|540910430|FG004|Overall Study|Lost to Follow-up|0|||
149937614|NCT01373164|540910426|FG000|Overall Study|Withdrawal by Subject|0|||
149937615|NCT01373164|540910427|FG001|Overall Study|Withdrawal by Subject|1|||
149937616|NCT01373164|540910428|FG002|Overall Study|Withdrawal by Subject|0|||
149937617|NCT01373164|540910429|FG003|Overall Study|Withdrawal by Subject|10|||
149937618|NCT01373164|540910430|FG004|Overall Study|Withdrawal by Subject|2|||
149937619|NCT00607893|540910431|FG000|Overall Study|Lost to Follow-up|4|||
149937620|NCT00607893|540910432|FG001|Overall Study|Lost to Follow-up|0|||
149937621|NCT00607893|540910431|FG000|Overall Study|withdrew due to loss of interest|0|||
149937622|NCT00607893|540910432|FG001|Overall Study|withdrew due to loss of interest|1|||
150270977|NCT04147234|542131014|FG001|Overall Study|Adverse Event|0|||
150270978|NCT04147234|542131015|FG002|Overall Study|Adverse Event|0|||
150270979|NCT04147234|542131016|FG003|Overall Study|Adverse Event|0|||
150270980|NCT04147234|542131017|FG004|Overall Study|Adverse Event|1|||
150270981|NCT04147234|542131018|FG005|Overall Study|Adverse Event|0|||
150270982|NCT04147234|542131019|FG006|Overall Study|Adverse Event|0|||
150270983|NCT01524133|542131028|FG000|Treatment Phase|Withdrawal by Subject|13|||
150270984|NCT01524133|542131029|FG001|Treatment Phase|Withdrawal by Subject|28|||
150270985|NCT01524133|542131030|FG002|Treatment Phase|Withdrawal by Subject|31|||
150270986|NCT01524133|542131028|FG000|Treatment Phase|Physician Decision|6|||
150270987|NCT01524133|542131029|FG001|Treatment Phase|Physician Decision|3|||
150270988|NCT01524133|542131030|FG002|Treatment Phase|Physician Decision|3|||
149937623|NCT00607893|540910431|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
149937624|NCT00607893|540910432|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
149937625|NCT00607893|540910431|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
149937626|NCT00607893|540910432|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
150270989|NCT01524133|542131028|FG000|Treatment Phase|Lost to Follow-up|0|||
150270990|NCT01524133|542131029|FG001|Treatment Phase|Lost to Follow-up|1|||
149937627|NCT00607893|540910431|FG000|Overall Study|Declined to be treated|1|||
149937628|NCT00607893|540910432|FG001|Overall Study|Declined to be treated|0|||
149937629|NCT00607893|540910431|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
149937630|NCT00607893|540910432|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
149937631|NCT01799941|540910433|FG000|Overall Study|Adverse Event|34|||
150270991|NCT01524133|542131030|FG002|Treatment Phase|Lost to Follow-up|2|||
150270992|NCT01524133|542131028|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
149937632|NCT01799941|540910433|FG000|Overall Study|Withdrawal by Subject|21|||
150270993|NCT01524133|542131029|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
150270994|NCT01524133|542131030|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
150270995|NCT01524133|542131028|FG000|Overall Study 52 Weeks|Physician Decision|1|||
150270996|NCT01524133|542131029|FG001|Overall Study 52 Weeks|Physician Decision|0|||
150270997|NCT01524133|542131030|FG002|Overall Study 52 Weeks|Physician Decision|2|||
150270998|NCT01524133|542131028|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
150270999|NCT01524133|542131029|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
150271000|NCT01524133|542131030|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
150271001|NCT05352048|542131034|FG000|Overall Study|Lost to Follow-up|1|||
150271002|NCT05352048|542131034|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
150271003|NCT01214187|542131035|FG000|Overall Study|Adverse Event|6|||
150271004|NCT01214187|542131036|FG001|Overall Study|Adverse Event|2|||
150271005|NCT01214187|542131035|FG000|Overall Study|Death|1|||
150271006|NCT01214187|542131036|FG001|Overall Study|Death|1|||
150271007|NCT01214187|542131035|FG000|Overall Study|Withdrawal by Subject|0|||
150271008|NCT01214187|542131036|FG001|Overall Study|Withdrawal by Subject|3|||
150271009|NCT01233869|542131037|FG000|Initial Treatment Period (24 Months)|Death|1|||
150271010|NCT01233869|542131038|FG001|Initial Treatment Period (24 Months)|Death|0|||
150271011|NCT01233869|542131039|FG002|Initial Treatment Period (24 Months)|Death|0|||
150271012|NCT01233869|542131040|FG003|Initial Treatment Period (24 Months)|Death|0|||
150271013|NCT01233869|542131037|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
150271014|NCT01233869|542131038|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
150271015|NCT01233869|542131039|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
150271016|NCT01233869|542131040|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
150271017|NCT01233869|542131037|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
150271018|NCT01233869|542131038|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
150271019|NCT01233869|542131039|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
150271020|NCT01233869|542131040|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
150271021|NCT01233869|542131037|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
150271022|NCT01233869|542131038|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
150271023|NCT01233869|542131039|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
150271024|NCT01233869|542131040|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
149820372|NCT01571635|540471797|FG000|Overall Study|Other reasons|2|||
149820373|NCT01571635|540471798|FG001|Overall Study|Other reasons|1|||
149820374|NCT01571635|540471799|FG002|Overall Study|Other reasons|2|||
149820375|NCT01571635|540471800|FG003|Overall Study|Other reasons|2|||
149937633|NCT01799941|540910433|FG000|Overall Study|Death|2|||
149937634|NCT01799941|540910433|FG000|Overall Study|Investigator Decision|4|||
149937635|NCT01799941|540910433|FG000|Overall Study|Lack of Efficacy|3|||
149937636|NCT01799941|540910433|FG000|Overall Study|Lost to Follow-up|17|||
149937637|NCT01799941|540910433|FG000|Overall Study|Other|15|||
149937638|NCT03408899|540910436|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
149937639|NCT00606008|540910437|FG000|Overall Study|Adverse Event|1|||
149937640|NCT00606008|540910437|FG000|Overall Study|Withdrawal by Subject|4|||
149937641|NCT00547339|540910450|FG000|Overall Study|Physician Decision|0|||
149937642|NCT00547339|540910451|FG001|Overall Study|Physician Decision|0|||
150271025|NCT01233869|542131037|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
150271026|NCT01233869|542131038|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
149820376|NCT01571635|540471801|FG004|Overall Study|Other reasons|1|||
149820377|NCT01571635|540471797|FG000|Overall Study|Study terminated by sponsor|0|||
149820378|NCT01571635|540471798|FG001|Overall Study|Study terminated by sponsor|4|||
149820379|NCT01571635|540471799|FG002|Overall Study|Study terminated by sponsor|1|||
149820380|NCT01571635|540471800|FG003|Overall Study|Study terminated by sponsor|3|||
149820381|NCT01571635|540471801|FG004|Overall Study|Study terminated by sponsor|1|||
149820382|NCT01571635|540471797|FG000|Overall Study|Withdrew consent|1|||
149820383|NCT01571635|540471798|FG001|Overall Study|Withdrew consent|1|||
149820384|NCT01571635|540471799|FG002|Overall Study|Withdrew consent|2|||
149820385|NCT01571635|540471800|FG003|Overall Study|Withdrew consent|3|||
149820386|NCT01571635|540471801|FG004|Overall Study|Withdrew consent|0|||
149820387|NCT01571635|540471797|FG000|Overall Study|Lack of Efficacy|0|||
149820388|NCT01571635|540471798|FG001|Overall Study|Lack of Efficacy|2|||
150271027|NCT01233869|542131039|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
150271028|NCT01233869|542131040|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
150271029|NCT01233869|542131037|FG000|Extended Treatment Period (46 Months)|Other|3|||
149820389|NCT01571635|540471799|FG002|Overall Study|Lack of Efficacy|0|||
149820390|NCT01571635|540471800|FG003|Overall Study|Lack of Efficacy|1|||
149820391|NCT01571635|540471801|FG004|Overall Study|Lack of Efficacy|2|||
149820392|NCT02868281|540471802|FG000|Overall Study|Adverse Event|2|||
149937643|NCT00547339|540910452|FG002|Overall Study|Physician Decision|1|||
149937644|NCT00547339|540910453|FG003|Overall Study|Physician Decision|0|||
150271030|NCT01233869|542131038|FG001|Extended Treatment Period (46 Months)|Other|0|||
150271031|NCT01233869|542131039|FG002|Extended Treatment Period (46 Months)|Other|0|||
150271032|NCT01233869|542131040|FG003|Extended Treatment Period (46 Months)|Other|3|||
150271033|NCT01233869|542131037|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
149820393|NCT02868281|540471803|FG001|Overall Study|Adverse Event|2|||
150271034|NCT01233869|542131038|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
150271035|NCT01233869|542131039|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
150271036|NCT01233869|542131040|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
150271037|NCT00631189|542131049|FG000|Initial Phase|Protocol Violation|347|||
150271038|NCT00631189|542131050|FG001|Initial Phase|Protocol Violation|0|||
150271039|NCT00631189|542131051|FG002|Initial Phase|Protocol Violation|0|||
150271040|NCT00631189|542131052|FG003|Initial Phase|Protocol Violation|0|||
150271041|NCT00631189|542131049|FG000|Initial Phase|Withdrawal by Subject|4|||
150271042|NCT00631189|542131050|FG001|Initial Phase|Withdrawal by Subject|0|||
150271043|NCT00631189|542131051|FG002|Initial Phase|Withdrawal by Subject|0|||
150271044|NCT00631189|542131052|FG003|Initial Phase|Withdrawal by Subject|0|||
150271045|NCT00631189|542131049|FG000|Treatment Phase|Withdrawal by Subject|0|||
150271046|NCT00631189|542131050|FG001|Treatment Phase|Withdrawal by Subject|2|||
150271047|NCT00631189|542131051|FG002|Treatment Phase|Withdrawal by Subject|1|||
150271048|NCT00631189|542131052|FG003|Treatment Phase|Withdrawal by Subject|1|||
150271049|NCT00631189|542131049|FG000|Treatment Phase|Protocol Violation|0|||
150271050|NCT00631189|542131050|FG001|Treatment Phase|Protocol Violation|1|||
150271051|NCT00631189|542131051|FG002|Treatment Phase|Protocol Violation|6|||
150271052|NCT00631189|542131052|FG003|Treatment Phase|Protocol Violation|2|||
150271053|NCT00631189|542131049|FG000|Treatment Phase|Adverse Event|0|||
150271054|NCT00631189|542131050|FG001|Treatment Phase|Adverse Event|3|||
150271055|NCT00631189|542131051|FG002|Treatment Phase|Adverse Event|2|||
150271056|NCT00631189|542131052|FG003|Treatment Phase|Adverse Event|4|||
150271057|NCT00631189|542131049|FG000|Treatment Phase|Lost to Follow-up|0|||
150271058|NCT00631189|542131050|FG001|Treatment Phase|Lost to Follow-up|1|||
150271059|NCT00631189|542131051|FG002|Treatment Phase|Lost to Follow-up|0|||
150271060|NCT00631189|542131052|FG003|Treatment Phase|Lost to Follow-up|0|||
150271061|NCT00631189|542131049|FG000|Treatment Phase|Pregnancy|0|||
150271062|NCT00631189|542131050|FG001|Treatment Phase|Pregnancy|0|||
150271063|NCT00631189|542131051|FG002|Treatment Phase|Pregnancy|1|||
150271064|NCT00631189|542131052|FG003|Treatment Phase|Pregnancy|0|||
150271065|NCT00631189|542131049|FG000|Treatment Phase|patient did not take pravastatin|0|||
150271066|NCT00631189|542131050|FG001|Treatment Phase|patient did not take pravastatin|0|||
150271067|NCT00631189|542131051|FG002|Treatment Phase|patient did not take pravastatin|1|||
150271068|NCT00631189|542131052|FG003|Treatment Phase|patient did not take pravastatin|0|||
150271069|NCT04464265|542131053|FG000|Overall Study|Physician Decision|2|||
150271070|NCT00974090|542131054|FG000|Period 1: Double Blind Period|Adverse Event|2|||
150271071|NCT00974090|542131055|FG001|Period 1: Double Blind Period|Adverse Event|1|||
150271072|NCT00974090|542131054|FG000|Period 1: Double Blind Period|Physician Decision|1|||
150271073|NCT00974090|542131055|FG001|Period 1: Double Blind Period|Physician Decision|0|||
150271074|NCT00974090|542131054|FG000|Period 2: Open-label Period|Adverse Event|4|||
150271075|NCT00974090|542131055|FG001|Period 2: Open-label Period|Adverse Event|6|||
150271076|NCT00974090|542131054|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
150271077|NCT00974090|542131055|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
150271078|NCT00974090|542131054|FG000|Period 2: Open-label Period|Physician Decision|0|||
150271079|NCT00974090|542131055|FG001|Period 2: Open-label Period|Physician Decision|3|||
150271080|NCT00974090|542131054|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
150271081|NCT00974090|542131055|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
150271082|NCT00056862|542131056|FG000|Overall Study|Protocol Violation|1|||
150271083|NCT00056862|542131057|FG001|Overall Study|Protocol Violation|0|||
150271084|NCT01822522|542131058|FG000|Overall Study|Adverse Event|1|||
150271085|NCT01822522|542131059|FG001|Overall Study|Adverse Event|1|||
150271086|NCT01822522|542131060|FG002|Overall Study|Adverse Event|1|||
150271087|NCT01822522|542131061|FG003|Overall Study|Adverse Event|0|||
150271088|NCT01822522|542131062|FG004|Overall Study|Adverse Event|0|||
150271089|NCT01822522|542131063|FG005|Overall Study|Adverse Event|1|||
150271090|NCT01822522|542131058|FG000|Overall Study|Death|3|||
150271091|NCT01822522|542131059|FG001|Overall Study|Death|0|||
149820394|NCT02868281|540471802|FG000|Overall Study|Protocol Violation|13|||
150271092|NCT01822522|542131060|FG002|Overall Study|Death|2|||
150271093|NCT01822522|542131061|FG003|Overall Study|Death|0|||
150271094|NCT01822522|542131062|FG004|Overall Study|Death|0|||
150271095|NCT01822522|542131063|FG005|Overall Study|Death|0|||
150271096|NCT01822522|542131058|FG000|Overall Study|Lost to Follow-up|0|||
150271097|NCT01822522|542131059|FG001|Overall Study|Lost to Follow-up|0|||
150271098|NCT01822522|542131060|FG002|Overall Study|Lost to Follow-up|1|||
150271099|NCT01822522|542131061|FG003|Overall Study|Lost to Follow-up|1|||
150271100|NCT01822522|542131062|FG004|Overall Study|Lost to Follow-up|0|||
150271101|NCT01822522|542131063|FG005|Overall Study|Lost to Follow-up|1|||
150271102|NCT01822522|542131058|FG000|Overall Study|Withdrawal by Subject|0|||
150271103|NCT01822522|542131059|FG001|Overall Study|Withdrawal by Subject|0|||
150271104|NCT01822522|542131060|FG002|Overall Study|Withdrawal by Subject|0|||
150271105|NCT01822522|542131061|FG003|Overall Study|Withdrawal by Subject|1|||
150271106|NCT01822522|542131062|FG004|Overall Study|Withdrawal by Subject|0|||
150271107|NCT01822522|542131063|FG005|Overall Study|Withdrawal by Subject|0|||
150271108|NCT01822522|542131058|FG000|Overall Study|Lack of Efficacy|0|||
150271109|NCT01822522|542131059|FG001|Overall Study|Lack of Efficacy|0|||
150271110|NCT01822522|542131060|FG002|Overall Study|Lack of Efficacy|0|||
150271111|NCT01822522|542131061|FG003|Overall Study|Lack of Efficacy|0|||
150271112|NCT01822522|542131062|FG004|Overall Study|Lack of Efficacy|0|||
150271113|NCT01822522|542131063|FG005|Overall Study|Lack of Efficacy|2|||
150271114|NCT01272947|542131068|FG000|Overall Study|Abnormal Laboratory Value|2|||
150271115|NCT01272947|542131069|FG001|Overall Study|Abnormal Laboratory Value|2|||
150271116|NCT02019420|542131070|FG000|Overall Study|Did not receive study drug|2|||
150271117|NCT02019420|542131071|FG001|Overall Study|Did not receive study drug|2|||
150271118|NCT02019420|542131070|FG000|Overall Study|Withdrawal by Subject|1|||
150271119|NCT02019420|542131071|FG001|Overall Study|Withdrawal by Subject|3|||
150271120|NCT02019420|542131070|FG000|Overall Study|At request of sponsor or investigator|0|||
150271121|NCT02019420|542131071|FG001|Overall Study|At request of sponsor or investigator|1|||
150271122|NCT02019420|542131070|FG000|Overall Study|Death|104|||
150271123|NCT02019420|542131071|FG001|Overall Study|Death|99|||
150271124|NCT02019420|542131070|FG000|Overall Study|Transferred to other care facility|1|||
150271125|NCT02019420|542131071|FG001|Overall Study|Transferred to other care facility|1|||
150271126|NCT01093625|542131072|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
150271127|NCT01093625|542131073|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
150271128|NCT01093625|542131072|FG000|2-Week Visit|Withdrawal by Subject|1|||
150271129|NCT01093625|542131073|FG001|2-Week Visit|Withdrawal by Subject|0|||
150271130|NCT01093625|542131072|FG000|1-Month Visit|Lost to Follow-up|2|||
150271131|NCT01093625|542131073|FG001|1-Month Visit|Lost to Follow-up|0|||
150271132|NCT01093625|542131072|FG000|3-Month Visit|Lost to Follow-up|2|||
150271133|NCT01093625|542131073|FG001|3-Month Visit|Lost to Follow-up|0|||
150271134|NCT01093625|542131072|FG000|6-Month Visit|Withdrawal by Subject|6|||
150271135|NCT01093625|542131073|FG001|6-Month Visit|Withdrawal by Subject|7|||
150271136|NCT01093625|542131072|FG000|6-Month Visit|Lost to Follow-up|2|||
150271137|NCT01093625|542131073|FG001|6-Month Visit|Lost to Follow-up|2|||
150271138|NCT01093625|542131072|FG000|1-Year Visit|Lost to Follow-up|5|||
150271139|NCT01093625|542131073|FG001|1-Year Visit|Lost to Follow-up|3|||
150271140|NCT01843218|542131076|FG000|Overall Study|Withdrawal by Subject|5|||
150271141|NCT01431534|542131077|FG000|Treatment Phase|Adverse Event|0|||
150271142|NCT01431534|542131078|FG001|Treatment Phase|Adverse Event|0|||
150271143|NCT01431534|542131079|FG002|Treatment Phase|Adverse Event|1|||
150271144|NCT01431534|542131077|FG000|Treatment Phase|Progressive Disease|4|||
150271145|NCT01431534|542131078|FG001|Treatment Phase|Progressive Disease|3|||
150271146|NCT01431534|542131079|FG002|Treatment Phase|Progressive Disease|10|||
150271147|NCT02742766|542131080|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271148|NCT02742766|542131081|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271149|NCT02742766|542131082|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271150|NCT02742766|542131083|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271151|NCT02742766|542131084|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271152|NCT02742766|542131085|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271153|NCT02742766|542131086|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271154|NCT02742766|542131087|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271155|NCT02742766|542131088|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271156|NCT02742766|542131089|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271157|NCT02742766|542131090|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271158|NCT02742766|542131091|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271159|NCT02742766|542131092|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271160|NCT02742766|542131093|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
150271161|NCT02742766|542131094|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149937645|NCT01516216|540910454|FG000|Overall Study|Adverse Event|2|||
149937646|NCT01516216|540910455|FG001|Overall Study|Adverse Event|4|||
149937647|NCT01516216|540910454|FG000|Overall Study|Disease Progression|38|||
149937648|NCT01516216|540910455|FG001|Overall Study|Disease Progression|34|||
149937649|NCT01516216|540910454|FG000|Overall Study|Withdrawal by Subject|9|||
149937650|NCT01516216|540910455|FG001|Overall Study|Withdrawal by Subject|11|||
149937651|NCT01516216|540910454|FG000|Overall Study|Potentially Curative Resection|6|||
149937652|NCT01516216|540910455|FG001|Overall Study|Potentially Curative Resection|12|||
149937653|NCT01516216|540910454|FG000|Overall Study|Nonadherence|2|||
149937654|NCT01516216|540910455|FG001|Overall Study|Nonadherence|3|||
150271162|NCT02742766|542131095|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271163|NCT02742766|542131096|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271164|NCT02742766|542131097|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271165|NCT02742766|542131098|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
150271166|NCT02742766|542131080|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271167|NCT02742766|542131081|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271168|NCT02742766|542131082|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271169|NCT02742766|542131083|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271170|NCT02742766|542131084|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
149937655|NCT01516216|540910454|FG000|Overall Study|Physician Decision|6|||
149937656|NCT01516216|540910455|FG001|Overall Study|Physician Decision|3|||
149937657|NCT01516216|540910454|FG000|Overall Study|Prolonged Treatment Delay|5|||
149937658|NCT01516216|540910455|FG001|Overall Study|Prolonged Treatment Delay|1|||
150271171|NCT02742766|542131085|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271172|NCT02742766|542131086|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271173|NCT02742766|542131087|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271174|NCT02742766|542131088|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271175|NCT02742766|542131089|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271176|NCT02742766|542131090|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
149937659|NCT01516216|540910454|FG000|Overall Study|Intercurrent Illness|1|||
149937660|NCT01516216|540910455|FG001|Overall Study|Intercurrent Illness|0|||
149937661|NCT01516216|540910454|FG000|Overall Study|Death|1|||
149937662|NCT01516216|540910455|FG001|Overall Study|Death|1|||
149937663|NCT03736967|540910456|FG000|Overall Study|Withdrawal by Subject|26|||
149937664|NCT03736967|540910457|FG001|Overall Study|Withdrawal by Subject|25|||
149937665|NCT03736967|540910458|FG002|Overall Study|Withdrawal by Subject|23|||
149937666|NCT03736967|540910459|FG003|Overall Study|Withdrawal by Subject|26|||
149937667|NCT03736967|540910456|FG000|Overall Study|Lost to Follow-up|3|||
149937668|NCT03736967|540910457|FG001|Overall Study|Lost to Follow-up|2|||
149937669|NCT03736967|540910458|FG002|Overall Study|Lost to Follow-up|1|||
149937670|NCT03736967|540910459|FG003|Overall Study|Lost to Follow-up|1|||
149937671|NCT03736967|540910456|FG000|Overall Study|Physician Decision|1|||
149937672|NCT03736967|540910457|FG001|Overall Study|Physician Decision|0|||
149937673|NCT03736967|540910458|FG002|Overall Study|Physician Decision|0|||
149937674|NCT03736967|540910459|FG003|Overall Study|Physician Decision|1|||
149937675|NCT03736967|540910456|FG000|Overall Study|Adverse Event|0|||
149937676|NCT03736967|540910457|FG001|Overall Study|Adverse Event|1|||
149937677|NCT03736967|540910458|FG002|Overall Study|Adverse Event|0|||
149937678|NCT03736967|540910459|FG003|Overall Study|Adverse Event|1|||
149937679|NCT03736967|540910456|FG000|Overall Study|Death|0|||
149937680|NCT03736967|540910457|FG001|Overall Study|Death|0|||
149937681|NCT03736967|540910458|FG002|Overall Study|Death|0|||
149937682|NCT03736967|540910459|FG003|Overall Study|Death|1|||
149937683|NCT03736967|540910456|FG000|Overall Study|Randomized but never treated|1|||
149937684|NCT03736967|540910457|FG001|Overall Study|Randomized but never treated|0|||
149937685|NCT03736967|540910458|FG002|Overall Study|Randomized but never treated|0|||
149937686|NCT03736967|540910459|FG003|Overall Study|Randomized but never treated|0|||
149937687|NCT02369653|540910460|FG000|Overall Study|Lost to Follow-up|0|||
149937688|NCT02369653|540910461|FG001|Overall Study|Lost to Follow-up|1|||
149937689|NCT02369653|540910460|FG000|Overall Study|Administrative reason by sponsor|0|||
149937690|NCT02369653|540910461|FG001|Overall Study|Administrative reason by sponsor|1|||
149937691|NCT02369653|540910460|FG000|Overall Study|Death|1|||
149937692|NCT02369653|540910461|FG001|Overall Study|Death|2|||
149937693|NCT02369653|540910460|FG000|Overall Study|Participant withdrew consent|13|||
149937694|NCT02369653|540910461|FG001|Overall Study|Participant withdrew consent|3|||
149937695|NCT03587636|540910462|FG000|Overall Study|Lost to Follow-up|2|||
149937696|NCT03587636|540910463|FG001|Overall Study|Lost to Follow-up|5|||
149937697|NCT01458587|540910464|FG000|Overall Study|Withdrawal by Subject|1|||
149937698|NCT01458587|540910465|FG001|Overall Study|Withdrawal by Subject|0|||
149937699|NCT01603602|540910466|FG000|Overall Study|Adverse Event|1|||
149937700|NCT01603602|540910467|FG001|Overall Study|Adverse Event|0|||
149937701|NCT01603602|540910468|FG002|Overall Study|Adverse Event|0|||
149937702|NCT01603602|540910466|FG000|Overall Study|Personal Reasons|1|||
149937703|NCT01603602|540910467|FG001|Overall Study|Personal Reasons|0|||
149937704|NCT01603602|540910468|FG002|Overall Study|Personal Reasons|1|||
149937705|NCT01006629|540910469|FG000|Overall Study|Adverse Event|1|||
149937706|NCT01006629|540910469|FG000|Overall Study|Parent refused to continue participation|1|||
149937707|NCT01006629|540910469|FG000|Overall Study|Parent unable to perform site visit|4|||
149937708|NCT00316004|540910470|FG000|Overall Study|Subject was not given study fluid.|14|||
149937709|NCT00316004|540910471|FG001|Overall Study|Subject was not given study fluid.|14|||
149937710|NCT00316004|540910472|FG002|Overall Study|Subject was not given study fluid.|21|||
149937711|NCT02665117|540910475|FG000|Overall Study|Physician Decision|1|||
149937712|NCT02665117|540910476|FG001|Overall Study|Physician Decision|0|||
149937713|NCT00977197|540910480|FG000|Overall Study|Withdrawal by Subject|3|||
149937714|NCT00977197|540910481|FG001|Overall Study|Withdrawal by Subject|4|||
149937715|NCT00977197|540910480|FG000|Overall Study|Adverse Event|3|||
149937716|NCT00977197|540910481|FG001|Overall Study|Adverse Event|1|||
149937717|NCT00977197|540910480|FG000|Overall Study|Lack of Efficacy|1|||
149937718|NCT00977197|540910481|FG001|Overall Study|Lack of Efficacy|0|||
149937719|NCT00977197|540910480|FG000|Overall Study|Lost to Follow-up|1|||
149937720|NCT00977197|540910481|FG001|Overall Study|Lost to Follow-up|3|||
149937721|NCT00977197|540910480|FG000|Overall Study|Nonadherence|1|||
149937722|NCT00977197|540910481|FG001|Overall Study|Nonadherence|1|||
149937723|NCT01432951|540910482|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
150271177|NCT02742766|542131091|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271178|NCT02742766|542131092|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
149937724|NCT00958074|540910483|FG000|Overall Study|Withdrawal by Subject|0|||
149937725|NCT00958074|540910484|FG001|Overall Study|Withdrawal by Subject|1|||
149937726|NCT00095979|540910487|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
149937727|NCT03712280|540910489|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
150271179|NCT02742766|542131093|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
150271180|NCT02742766|542131094|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271181|NCT02742766|542131095|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
150271182|NCT02742766|542131096|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271183|NCT02742766|542131097|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271184|NCT02742766|542131098|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
150271185|NCT01395316|542131100|FG000|Overall Study|Lost to Follow-up|2|||
150271186|NCT01395316|542131100|FG000|Overall Study|poor MRI quality|1|||
150271187|NCT00708175|542131107|FG000|Overall Study|Adverse Event|4|||
150271188|NCT00708175|542131108|FG001|Overall Study|Adverse Event|5|||
150271189|NCT00708175|542131107|FG000|Overall Study|Protocol Violation|2|||
150271190|NCT00708175|542131108|FG001|Overall Study|Protocol Violation|3|||
150271191|NCT00708175|542131107|FG000|Overall Study|Lost to Follow-up|5|||
150271192|NCT00708175|542131108|FG001|Overall Study|Lost to Follow-up|3|||
150271193|NCT00708175|542131107|FG000|Overall Study|Withdrawal by Subject|5|||
150271194|NCT00708175|542131108|FG001|Overall Study|Withdrawal by Subject|7|||
150271195|NCT00708175|542131107|FG000|Overall Study|BMD loss >7%|2|||
150271196|NCT00708175|542131108|FG001|Overall Study|BMD loss >7%|3|||
150271197|NCT02038920|542131110|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
150271198|NCT02038920|542131111|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
150271199|NCT02038920|542131112|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
150271200|NCT02038920|542131113|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
150271201|NCT02038920|542131114|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
150271202|NCT02038920|542131115|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
150271203|NCT02038920|542131110|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
150271204|NCT02038920|542131111|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
150271205|NCT02038920|542131112|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
150271206|NCT02038920|542131113|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
150271207|NCT02038920|542131114|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
150271208|NCT02038920|542131115|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
150271209|NCT02038920|542131110|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
150271210|NCT02038920|542131111|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
150271211|NCT02038920|542131112|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
150271212|NCT02038920|542131113|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
150271213|NCT02038920|542131114|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
150271214|NCT02038920|542131115|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
150271215|NCT02038920|542131110|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
150271216|NCT02038920|542131111|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
150271217|NCT02038920|542131112|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
150271218|NCT02038920|542131113|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
150271219|NCT02038920|542131114|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
150271220|NCT02038920|542131115|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
150271221|NCT02038920|542131110|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
150271222|NCT02038920|542131111|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
150271223|NCT02038920|542131112|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
150271224|NCT02038920|542131113|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
150271225|NCT02038920|542131114|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
150271226|NCT02038920|542131115|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
150271227|NCT02038920|542131110|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
150271228|NCT02038920|542131111|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
150271229|NCT02038920|542131112|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
150271230|NCT02038920|542131113|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
150271231|NCT02038920|542131114|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
150031142|NCT01277744|541252562|FG000|Overall Study|Physician Decision|2|||
150271232|NCT02038920|542131115|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
150271233|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
150271234|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
150271235|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
150271236|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
150271237|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
150271238|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
150271239|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
150271240|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
150271241|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
150271242|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
150271243|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
150271244|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
150271245|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
150271246|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
150271247|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
150271248|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
150271249|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
150271250|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
149937728|NCT03712280|540910490|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
149937729|NCT03712280|540910491|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
149937730|NCT03712280|540910492|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
149937731|NCT03712280|540910489|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
149937732|NCT03712280|540910490|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
149937733|NCT03712280|540910491|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
149937734|NCT03712280|540910492|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
149937735|NCT03712280|540910489|FG000|Overall Study|Adverse Event|0|||
149937736|NCT03712280|540910490|FG001|Overall Study|Adverse Event|0|||
149937737|NCT03712280|540910491|FG002|Overall Study|Adverse Event|1|||
149937738|NCT03712280|540910492|FG003|Overall Study|Adverse Event|0|||
149937739|NCT03558516|540910493|FG000|Overall Study|Protocol Violation|2|||
149937740|NCT03558516|540910494|FG001|Overall Study|Protocol Violation|2|||
149937741|NCT00472420|540910495|FG000|Induction Treatment Period|Physician Decision|9|||
149937742|NCT00472420|540910495|FG000|Induction Treatment Period|Adverse Event|3|||
149937743|NCT00472420|540910495|FG000|Induction Treatment Period|Non-compliance|1|||
149937744|NCT00472420|540910495|FG000|Induction Treatment Period|Death|3|||
149937745|NCT00472420|540910495|FG000|Follow-up Period|Death|5|||
149937746|NCT00472420|540910495|FG000|Follow-up Period|Physician Decision|9|||
149937747|NCT00472420|540910495|FG000|Follow-up Period|Lost to Follow-up|2|||
149937748|NCT00472420|540910495|FG000|Follow-up Period|Protocol Violation|1|||
149937749|NCT01462942|540910500|FG000|Overall Study|Adverse Event|7|||
149937750|NCT01462942|540910501|FG001|Overall Study|Adverse Event|12|||
149937751|NCT01462942|540910502|FG002|Overall Study|Adverse Event|10|||
149937752|NCT01462942|540910503|FG003|Overall Study|Adverse Event|11|||
149937753|NCT01462942|540910504|FG004|Overall Study|Adverse Event|11|||
149937754|NCT01462942|540910500|FG000|Overall Study|Other, including COPD exacerbation|3|||
149937755|NCT01462942|540910501|FG001|Overall Study|Other, including COPD exacerbation|5|||
149937756|NCT01462942|540910502|FG002|Overall Study|Other, including COPD exacerbation|2|||
149937757|NCT01462942|540910503|FG003|Overall Study|Other, including COPD exacerbation|8|||
149937758|NCT01462942|540910504|FG004|Overall Study|Other, including COPD exacerbation|5|||
149937759|NCT01462942|540910500|FG000|Overall Study|Withdrawal by Subject|14|||
149937760|NCT01462942|540910501|FG001|Overall Study|Withdrawal by Subject|10|||
149937761|NCT01462942|540910502|FG002|Overall Study|Withdrawal by Subject|14|||
149937762|NCT01462942|540910503|FG003|Overall Study|Withdrawal by Subject|16|||
149937763|NCT01462942|540910504|FG004|Overall Study|Withdrawal by Subject|19|||
149937764|NCT01462942|540910500|FG000|Overall Study|Lack of Efficacy|6|||
149937765|NCT01462942|540910501|FG001|Overall Study|Lack of Efficacy|0|||
149937766|NCT01462942|540910502|FG002|Overall Study|Lack of Efficacy|4|||
149937767|NCT01462942|540910503|FG003|Overall Study|Lack of Efficacy|5|||
149937768|NCT01462942|540910504|FG004|Overall Study|Lack of Efficacy|3|||
149937769|NCT01462942|540910500|FG000|Overall Study|Lost to Follow-up|0|||
149937770|NCT01462942|540910501|FG001|Overall Study|Lost to Follow-up|1|||
149937771|NCT01462942|540910502|FG002|Overall Study|Lost to Follow-up|1|||
149937772|NCT01462942|540910503|FG003|Overall Study|Lost to Follow-up|1|||
149937773|NCT01462942|540910504|FG004|Overall Study|Lost to Follow-up|1|||
149937774|NCT01462942|540910500|FG000|Overall Study|Protocol Violation|4|||
149937775|NCT01462942|540910501|FG001|Overall Study|Protocol Violation|6|||
149937776|NCT01462942|540910502|FG002|Overall Study|Protocol Violation|9|||
149937777|NCT01462942|540910503|FG003|Overall Study|Protocol Violation|9|||
149937778|NCT01462942|540910504|FG004|Overall Study|Protocol Violation|6|||
149937779|NCT02737722|540910507|FG000|Overall Study|Physician Decision|0|||
149937780|NCT02737722|540910508|FG001|Overall Study|Physician Decision|0|||
149937781|NCT02737722|540910509|FG002|Overall Study|Physician Decision|1|||
149937782|NCT02737722|540910510|FG003|Overall Study|Physician Decision|0|||
149937783|NCT02662569|540910511|FG000|Overall Study|Withdrawal by Subject|6|||
149937784|NCT02662569|540910512|FG001|Overall Study|Withdrawal by Subject|1|||
149937785|NCT02662569|540910513|FG002|Overall Study|Withdrawal by Subject|6|||
149937786|NCT02662569|540910514|FG003|Overall Study|Withdrawal by Subject|4|||
149937787|NCT02662569|540910511|FG000|Overall Study|Lost to Follow-up|1|||
150271251|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
150271252|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
150271253|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
150271254|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149937788|NCT02662569|540910512|FG001|Overall Study|Lost to Follow-up|0|||
149937789|NCT02662569|540910513|FG002|Overall Study|Lost to Follow-up|0|||
149937790|NCT02662569|540910514|FG003|Overall Study|Lost to Follow-up|0|||
149937791|NCT00423046|540910523|FG000|Overall Study|Other|340|||
149937792|NCT00423046|540910524|FG001|Overall Study|Other|345|||
149937793|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
149937794|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937795|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937796|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937797|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937798|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937799|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
149937800|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
149937801|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937802|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937803|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937804|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937805|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937806|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
149937807|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
149937808|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
149937809|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
149937810|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
149937811|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
149937812|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
149937813|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
150271255|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
150271256|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
150271257|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
150271258|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
150271259|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
150271260|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
150271261|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
150271262|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
150271263|NCT02038920|542131110|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
150271264|NCT02038920|542131111|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
150271265|NCT02038920|542131112|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
150271266|NCT02038920|542131113|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
150271267|NCT02038920|542131114|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
150271268|NCT02038920|542131115|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
150271269|NCT00866697|542131116|FG000|Overall Study|Study closed/terminated|156|||
150271270|NCT00866697|542131117|FG001|Overall Study|Study closed/terminated|138|||
150271271|NCT00866697|542131116|FG000|Overall Study|Lost to Follow-up|22|||
150271272|NCT00866697|542131117|FG001|Overall Study|Lost to Follow-up|28|||
150271273|NCT00866697|542131116|FG000|Overall Study|Physician Decision|3|||
150271274|NCT00866697|542131117|FG001|Overall Study|Physician Decision|5|||
150271275|NCT00866697|542131116|FG000|Overall Study|Withdrawal by Subject|33|||
150271276|NCT00866697|542131117|FG001|Overall Study|Withdrawal by Subject|57|||
150271277|NCT02906787|542131118|FG000|Overall Study|Withdrawal by Subject|12|||
150271278|NCT02906787|542131119|FG001|Overall Study|Withdrawal by Subject|10|||
150271279|NCT02906787|542131118|FG000|Overall Study|Missed|24|||
150271280|NCT02906787|542131119|FG001|Overall Study|Missed|22|||
150271281|NCT00447382|542131120|FG000|Overall Study|Adverse Event|1|||
150271282|NCT00447382|542131121|FG001|Overall Study|Adverse Event|1|||
150271283|NCT00447382|542131120|FG000|Overall Study|Lack of Efficacy|1|||
150271284|NCT00447382|542131121|FG001|Overall Study|Lack of Efficacy|0|||
150271285|NCT00447382|542131120|FG000|Overall Study|Protocol Violation|2|||
150271286|NCT00447382|542131121|FG001|Overall Study|Protocol Violation|0|||
150271287|NCT00447382|542131120|FG000|Overall Study|Unclassified|2|||
150271288|NCT00447382|542131121|FG001|Overall Study|Unclassified|5|||
150271289|NCT03901053|542131124|FG000|Overall Study|Lost to Follow-up|6|||
150271290|NCT03901053|542131125|FG001|Overall Study|Lost to Follow-up|2|||
150271291|NCT03901053|542131124|FG000|Overall Study|Withdrawal by Subject|4|||
150271292|NCT03901053|542131125|FG001|Overall Study|Withdrawal by Subject|3|||
149820395|NCT02868281|540471803|FG001|Overall Study|Protocol Violation|10|||
149937814|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937815|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937816|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
150271293|NCT03901053|542131124|FG000|Overall Study|Unsatisfactory Device|1|||
150271294|NCT03901053|542131125|FG001|Overall Study|Unsatisfactory Device|2|||
150271295|NCT03901053|542131124|FG000|Overall Study|No longer meets study criteria|1|||
150271296|NCT03901053|542131125|FG001|Overall Study|No longer meets study criteria|3|||
150271297|NCT03901053|542131124|FG000|Overall Study|Subject's Medical Status|0|||
150271298|NCT03901053|542131125|FG001|Overall Study|Subject's Medical Status|1|||
150271299|NCT03901053|542131124|FG000|Overall Study|Screening Failure|1|||
150271300|NCT03901053|542131125|FG001|Overall Study|Screening Failure|0|||
150271301|NCT04600336|542131126|FG000|Initial Treatment|Withdrawal by Subject|1|||
150271302|NCT04600336|542131127|FG001|Initial Treatment|Withdrawal by Subject|2|||
150271303|NCT04600336|542131128|FG002|Initial Treatment|Withdrawal by Subject|0|||
150271304|NCT04600336|542131129|FG003|Initial Treatment|Withdrawal by Subject|0|||
150271305|NCT04600336|542131126|FG000|Initial Treatment|Adverse Event|0|||
150271306|NCT04600336|542131127|FG001|Initial Treatment|Adverse Event|2|||
150271307|NCT04600336|542131128|FG002|Initial Treatment|Adverse Event|0|||
150271308|NCT04600336|542131129|FG003|Initial Treatment|Adverse Event|0|||
150271309|NCT04600336|542131126|FG000|Initial Treatment|Other complicating disease|0|||
150271310|NCT04600336|542131127|FG001|Initial Treatment|Other complicating disease|0|||
150271311|NCT04600336|542131128|FG002|Initial Treatment|Other complicating disease|1|||
150271312|NCT04600336|542131129|FG003|Initial Treatment|Other complicating disease|0|||
150271313|NCT04600336|542131126|FG000|Crossover Treatment|Withdrawal by Subject|0|||
149937817|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937818|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937819|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937820|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
149937821|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937822|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937823|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
149937824|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937825|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937826|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937827|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
149937828|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937829|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937830|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
149937831|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937832|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937833|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937834|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
149937835|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937836|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937837|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937838|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
149937839|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937840|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937841|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
149937842|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937843|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937844|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937845|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
149937846|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937847|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937848|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
149937849|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937850|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937851|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937852|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937853|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
149937854|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937855|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
149937856|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937857|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937858|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937859|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937860|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
149937861|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937862|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
149937863|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
149937864|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
149937865|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
150271314|NCT04600336|542131127|FG001|Crossover Treatment|Withdrawal by Subject|0|||
150271315|NCT04600336|542131128|FG002|Crossover Treatment|Withdrawal by Subject|2|||
150271316|NCT04600336|542131129|FG003|Crossover Treatment|Withdrawal by Subject|1|||
149937866|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
149937867|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
149937868|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
149937869|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
149937870|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937871|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937872|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937873|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937874|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
149937875|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937876|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
149937877|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937878|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937879|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937880|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937881|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937882|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
149937883|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
149937884|NCT01791595|540910525|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937885|NCT01791595|540910526|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937886|NCT01791595|540910527|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937887|NCT01791595|540910528|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937888|NCT01791595|540910529|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937889|NCT01791595|540910530|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
149937890|NCT01791595|540910531|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
149937891|NCT01791595|540910525|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937892|NCT01791595|540910526|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937893|NCT01791595|540910527|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937894|NCT01791595|540910528|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937895|NCT01791595|540910529|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937896|NCT01791595|540910530|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
149937897|NCT01791595|540910531|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
149937898|NCT01791595|540910525|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937899|NCT01791595|540910526|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937900|NCT01791595|540910527|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937901|NCT01791595|540910528|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937902|NCT01791595|540910529|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937903|NCT01791595|540910530|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
149937904|NCT01791595|540910531|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
149937905|NCT01791595|540910525|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937906|NCT01791595|540910526|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937907|NCT01791595|540910527|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937908|NCT01791595|540910528|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937909|NCT01791595|540910529|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937910|NCT01791595|540910530|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
149937911|NCT01791595|540910531|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
149937912|NCT01791595|540910525|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937913|NCT01791595|540910526|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937914|NCT01791595|540910527|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937915|NCT01791595|540910528|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937916|NCT01791595|540910529|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937917|NCT01791595|540910530|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
149937918|NCT01791595|540910531|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
149937919|NCT03329885|540910532|FG000|Overall Study|Sponsor discontinued the study early|0|||
149937920|NCT03329885|540910533|FG001|Overall Study|Sponsor discontinued the study early|0|||
149937921|NCT03329885|540910534|FG002|Overall Study|Sponsor discontinued the study early|0|||
149937922|NCT03329885|540910535|FG003|Overall Study|Sponsor discontinued the study early|0|||
150168923|NCT01253226|541752602|FG003|Overall Study|Physician Decision|0|||
150168924|NCT01253226|541752603|FG004|Overall Study|Physician Decision|2|||
150168925|NCT01253226|541752599|FG000|Overall Study|Withdrawal by Subject|0|||
150168926|NCT01253226|541752600|FG001|Overall Study|Withdrawal by Subject|0|||
150168927|NCT01253226|541752601|FG002|Overall Study|Withdrawal by Subject|0|||
150168928|NCT01253226|541752602|FG003|Overall Study|Withdrawal by Subject|1|||
150168929|NCT01253226|541752603|FG004|Overall Study|Withdrawal by Subject|0|||
150168930|NCT03643211|541752607|FG000|Overall Study|Contract violation/deficiency|12|||
150168931|NCT03643211|541752607|FG000|Overall Study|Invalid registration|3|||
150271317|NCT04600336|542131126|FG000|Crossover Treatment|Adverse Event|0|||
150271318|NCT04600336|542131127|FG001|Crossover Treatment|Adverse Event|0|||
150271319|NCT04600336|542131128|FG002|Crossover Treatment|Adverse Event|1|||
149937923|NCT03329885|540910536|FG004|Overall Study|Sponsor discontinued the study early|0|||
149937924|NCT03329885|540910537|FG005|Overall Study|Sponsor discontinued the study early|0|||
149937925|NCT03329885|540910538|FG006|Overall Study|Sponsor discontinued the study early|1|||
149937926|NCT03329885|540910539|FG007|Overall Study|Sponsor discontinued the study early|1|||
149937927|NCT03329885|540910540|FG008|Overall Study|Sponsor discontinued the study early|0|||
149937928|NCT02027025|540910541|FG000|Overall Study|Adverse Event|0|||
149937929|NCT02027025|540910542|FG001|Overall Study|Adverse Event|1|||
149937930|NCT02027025|540910543|FG002|Overall Study|Adverse Event|1|||
149937931|NCT02027025|540910541|FG000|Overall Study|Protocol Violation|1|||
149937932|NCT02027025|540910542|FG001|Overall Study|Protocol Violation|0|||
149937933|NCT02027025|540910543|FG002|Overall Study|Protocol Violation|0|||
149937934|NCT02027025|540910541|FG000|Overall Study|Lost to Follow-up|0|||
149937935|NCT02027025|540910542|FG001|Overall Study|Lost to Follow-up|2|||
149937936|NCT02027025|540910543|FG002|Overall Study|Lost to Follow-up|0|||
149937937|NCT02027025|540910541|FG000|Overall Study|Withdrawal by Subject|0|||
149937938|NCT02027025|540910542|FG001|Overall Study|Withdrawal by Subject|1|||
149937939|NCT02027025|540910543|FG002|Overall Study|Withdrawal by Subject|0|||
149937940|NCT02027025|540910541|FG000|Overall Study|Sponsor's decision|0|||
149937941|NCT02027025|540910542|FG001|Overall Study|Sponsor's decision|1|||
149937942|NCT02027025|540910543|FG002|Overall Study|Sponsor's decision|0|||
149937943|NCT00828711|540910545|FG000|Overall Study|Lost to Follow-up|1|||
149937944|NCT00828711|540910546|FG001|Overall Study|Lost to Follow-up|0|||
149937945|NCT00828711|540910547|FG002|Overall Study|Lost to Follow-up|0|||
149937946|NCT03883386|540910548|FG000|First Assignment|Lost to Follow-up|1|||
149937947|NCT03883386|540910549|FG001|First Assignment|Lost to Follow-up|0|||
149937948|NCT03883386|540910548|FG000|First Assignment|Withdrawal by Subject|1|||
149937949|NCT03883386|540910549|FG001|First Assignment|Withdrawal by Subject|1|||
149937950|NCT01326871|540910550|FG000|Overall Study|Major surgery|0|||
149937951|NCT01326871|540910551|FG001|Overall Study|Major surgery|1|||
149937952|NCT01326871|540910552|FG002|Overall Study|Major surgery|0|||
149937953|NCT01326871|540910550|FG000|Overall Study|SAE and death|0|||
149937954|NCT01326871|540910551|FG001|Overall Study|SAE and death|2|||
149937955|NCT01326871|540910552|FG002|Overall Study|SAE and death|0|||
149937956|NCT01326871|540910550|FG000|Overall Study|Physician decision and decreased performance status|0|||
149937957|NCT01326871|540910551|FG001|Overall Study|Physician decision and decreased performance status|1|||
149937958|NCT01326871|540910552|FG002|Overall Study|Physician decision and decreased performance status|0|||
149937959|NCT01326871|540910550|FG000|Overall Study|Disease progression|0|||
149937960|NCT01326871|540910551|FG001|Overall Study|Disease progression|11|||
149937961|NCT01326871|540910552|FG002|Overall Study|Disease progression|5|||
149937962|NCT01326871|540910550|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
149937963|NCT01326871|540910551|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
149937964|NCT01326871|540910552|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
149937965|NCT01326871|540910550|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
149937966|NCT01326871|540910551|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
149937967|NCT01326871|540910552|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
149937968|NCT01326871|540910550|FG000|Overall Study|Withdrawal by Subject|0|||
149937969|NCT01326871|540910551|FG001|Overall Study|Withdrawal by Subject|1|||
149937970|NCT01326871|540910552|FG002|Overall Study|Withdrawal by Subject|0|||
149937971|NCT01326871|540910550|FG000|Overall Study|DLT|0|||
149937972|NCT01326871|540910551|FG001|Overall Study|DLT|2|||
149937973|NCT01326871|540910552|FG002|Overall Study|DLT|0|||
149937974|NCT01326871|540910550|FG000|Overall Study|SAE, disease progression and subject decision|0|||
149937975|NCT01326871|540910551|FG001|Overall Study|SAE, disease progression and subject decision|1|||
149937976|NCT01326871|540910552|FG002|Overall Study|SAE, disease progression and subject decision|0|||
149937977|NCT01326871|540910550|FG000|Overall Study|Death|0|||
149937978|NCT01326871|540910551|FG001|Overall Study|Death|1|||
149937979|NCT01326871|540910552|FG002|Overall Study|Death|0|||
149937980|NCT01326871|540910550|FG000|Overall Study|Other|0|||
150271320|NCT04600336|542131129|FG003|Crossover Treatment|Adverse Event|1|||
150271321|NCT04313153|542132704|FG000|Overall Study|Adverse Event (includes Death)|14|||
150271322|NCT04313153|542132705|FG001|Overall Study|Adverse Event (includes Death)|19|||
150271323|NCT04313153|542132706|FG002|Overall Study|Adverse Event (includes Death)|10|||
149937981|NCT01326871|540910551|FG001|Overall Study|Other|3|||
149937982|NCT01326871|540910552|FG002|Overall Study|Other|0|||
149937983|NCT01326871|540910550|FG000|Overall Study|SAE and disease progression|0|||
149937984|NCT01326871|540910551|FG001|Overall Study|SAE and disease progression|0|||
149937985|NCT01326871|540910552|FG002|Overall Study|SAE and disease progression|1|||
150271324|NCT04313153|542132704|FG000|Overall Study|Physician Decision|4|||
149937986|NCT01326871|540910550|FG000|Overall Study|SAE and physician decision|0|||
149937987|NCT01326871|540910551|FG001|Overall Study|SAE and physician decision|0|||
149937988|NCT01326871|540910552|FG002|Overall Study|SAE and physician decision|1|||
150271325|NCT04313153|542132705|FG001|Overall Study|Physician Decision|2|||
150271326|NCT04313153|542132706|FG002|Overall Study|Physician Decision|1|||
150271327|NCT04313153|542132704|FG000|Overall Study|Withdrawal by Subject|7|||
150271328|NCT04313153|542132705|FG001|Overall Study|Withdrawal by Subject|6|||
150271329|NCT04313153|542132706|FG002|Overall Study|Withdrawal by Subject|2|||
150271330|NCT04313153|542132704|FG000|Overall Study|Lack of Efficacy|3|||
150271331|NCT04313153|542132705|FG001|Overall Study|Lack of Efficacy|3|||
150271332|NCT04313153|542132706|FG002|Overall Study|Lack of Efficacy|0|||
150271333|NCT04313153|542132704|FG000|Overall Study|Lost to Follow-up|1|||
150271334|NCT04313153|542132705|FG001|Overall Study|Lost to Follow-up|0|||
150271335|NCT04313153|542132706|FG002|Overall Study|Lost to Follow-up|2|||
150271336|NCT04313153|542132704|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
150271337|NCT04313153|542132705|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
150271338|NCT04313153|542132706|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
150271339|NCT04313153|542132704|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
150271340|NCT04313153|542132705|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
150271341|NCT04313153|542132706|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
150271342|NCT04313153|542132704|FG000|Overall Study|Change in Dialysis Modality|0|||
150271343|NCT04313153|542132705|FG001|Overall Study|Change in Dialysis Modality|1|||
150271344|NCT04313153|542132706|FG002|Overall Study|Change in Dialysis Modality|2|||
150271345|NCT04313153|542132704|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
150271346|NCT04313153|542132705|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
150271347|NCT04313153|542132706|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
150271348|NCT04313153|542132704|FG000|Overall Study|Other|5|||
150271349|NCT04313153|542132705|FG001|Overall Study|Other|3|||
150271350|NCT04313153|542132706|FG002|Overall Study|Other|2|||
150271351|NCT00523718|542132707|FG000|Overall Study|Withdrawal by Subject|1|||
150271352|NCT00523718|542132708|FG001|Overall Study|Withdrawal by Subject|0|||
150271353|NCT00523718|542132707|FG000|Overall Study|Protocol Violation|2|||
150271354|NCT00523718|542132708|FG001|Overall Study|Protocol Violation|0|||
150271355|NCT01436071|542132709|FG000|Overall Study|Adverse Event|1|||
150271356|NCT01436071|542132710|FG001|Overall Study|Adverse Event|0|||
150271357|NCT01436071|542132709|FG000|Overall Study|Lack of Efficacy|16|||
150271358|NCT01436071|542132710|FG001|Overall Study|Lack of Efficacy|7|||
150271359|NCT01436071|542132709|FG000|Overall Study|Protocol Violation|0|||
150271360|NCT01436071|542132710|FG001|Overall Study|Protocol Violation|1|||
150271361|NCT01436071|542132709|FG000|Overall Study|Lost to Follow-up|3|||
150271362|NCT01436071|542132710|FG001|Overall Study|Lost to Follow-up|1|||
150271363|NCT01436071|542132709|FG000|Overall Study|Physician Decision|1|||
150271364|NCT01436071|542132710|FG001|Overall Study|Physician Decision|0|||
150271365|NCT01436071|542132709|FG000|Overall Study|Withdrawal by Subject|2|||
150271366|NCT01436071|542132710|FG001|Overall Study|Withdrawal by Subject|2|||
150271367|NCT01436071|542132709|FG000|Overall Study|Did Not Receive Trial Medication|3|||
150271368|NCT01436071|542132710|FG001|Overall Study|Did Not Receive Trial Medication|3|||
150271369|NCT03335163|542132716|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
150271370|NCT03335163|542132716|FG000|Overall Study|Withdrawal by Subject|18|||
150271371|NCT01016964|542132719|FG000|Overall Study|Lost to Follow-up|3|||
150271372|NCT01016964|542132720|FG001|Overall Study|Lost to Follow-up|3|||
150271373|NCT03873493|542132721|FG000|Overall Study|Withdrawal by Subject|1|||
150271374|NCT03873493|542132721|FG000|Overall Study|Death|9|||
150271375|NCT03873493|542132721|FG000|Overall Study|Lost to Follow-up|1|||
150271376|NCT03873493|542132721|FG000|Overall Study|Study Terminated by Sponsor|1|||
150271377|NCT03873493|542132721|FG000|Overall Study|Other|2|||
150271378|NCT00702845|542132723|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
150271379|NCT00702845|542132724|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
150271380|NCT00702845|542132723|FG000|Overall Study|Too high ovarian response|5|||
150271381|NCT00702845|542132724|FG001|Overall Study|Too high ovarian response|1|||
150271382|NCT00702845|542132723|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
150271383|NCT00702845|542132724|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
150271384|NCT00702845|542132723|FG000|Overall Study|Insufficient ovarian response|1|||
150271385|NCT00702845|542132724|FG001|Overall Study|Insufficient ovarian response|0|||
150271386|NCT00702845|542132723|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
150271387|NCT00702845|542132724|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
150271388|NCT00702845|542132723|FG000|Overall Study|No or abnormal fertilization|4|||
150271389|NCT00702845|542132724|FG001|Overall Study|No or abnormal fertilization|2|||
150271390|NCT00702845|542132723|FG000|Overall Study|Patient's decision|2|||
150271391|NCT00702845|542132724|FG001|Overall Study|Patient's decision|1|||
150271392|NCT00702845|542132723|FG000|Overall Study|Not randomized|0|||
150271393|NCT00702845|542132724|FG001|Overall Study|Not randomized|1|||
150271394|NCT01448213|542132729|FG000|Overall Study|Lost to Follow-up|12|||
150271395|NCT01448213|542132730|FG001|Overall Study|Lost to Follow-up|10|||
150271396|NCT01448213|542132729|FG000|Overall Study|Adverse Event|4|||
150271397|NCT01448213|542132730|FG001|Overall Study|Adverse Event|10|||
150271398|NCT01448213|542132729|FG000|Overall Study|Protocol Violation|1|||
150271399|NCT01448213|542132730|FG001|Overall Study|Protocol Violation|2|||
150271400|NCT04606771|542132735|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
149820396|NCT02868281|540471802|FG000|Overall Study|Lost to Follow-up|3|||
149820397|NCT02868281|540471803|FG001|Overall Study|Lost to Follow-up|6|||
149820398|NCT02868281|540471802|FG000|Overall Study|Withdrawal by Subject|11|||
149820399|NCT02868281|540471803|FG001|Overall Study|Withdrawal by Subject|15|||
149937989|NCT01326871|540910550|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
149937990|NCT01326871|540910551|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
149937991|NCT01326871|540910552|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
149937992|NCT01326871|540910550|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
149937993|NCT01326871|540910551|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
149937994|NCT01326871|540910552|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
149937995|NCT01326871|540910550|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
149937996|NCT01326871|540910551|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
149937997|NCT01326871|540910552|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
149937998|NCT01326871|540910550|FG000|Overall Study|Physician Decision|0|||
149937999|NCT01326871|540910551|FG001|Overall Study|Physician Decision|0|||
149938000|NCT01326871|540910552|FG002|Overall Study|Physician Decision|1|||
149938001|NCT01326871|540910550|FG000|Overall Study|SAE|0|||
149938002|NCT01326871|540910551|FG001|Overall Study|SAE|0|||
149938003|NCT01326871|540910552|FG002|Overall Study|SAE|1|||
149938004|NCT01326871|540910550|FG000|Overall Study|Disease progression and death|0|||
149938005|NCT01326871|540910551|FG001|Overall Study|Disease progression and death|0|||
149938006|NCT01326871|540910552|FG002|Overall Study|Disease progression and death|1|||
149938007|NCT01326871|540910550|FG000|Overall Study|Subject decision|0|||
149938008|NCT01326871|540910551|FG001|Overall Study|Subject decision|0|||
149938009|NCT01326871|540910552|FG002|Overall Study|Subject decision|1|||
149938010|NCT01387269|540910553|FG000|Overall Study|Death|38|||
149938011|NCT01387269|540910554|FG001|Overall Study|Death|20|||
149938012|NCT01387269|540910553|FG000|Overall Study|Other|8|||
149938013|NCT01387269|540910554|FG001|Overall Study|Other|7|||
149938014|NCT01387269|540910553|FG000|Overall Study|Unrelated AE|12|||
149938015|NCT01387269|540910554|FG001|Overall Study|Unrelated AE|3|||
149938016|NCT01387269|540910553|FG000|Overall Study|Withdrawal by patient|32|||
149938017|NCT01387269|540910554|FG001|Overall Study|Withdrawal by patient|10|||
149938018|NCT01387269|540910553|FG000|Overall Study|Study drug-related AE|1|||
149938019|NCT01387269|540910554|FG001|Overall Study|Study drug-related AE|0|||
149938020|NCT01387269|540910553|FG000|Overall Study|Lost to Follow-up|1|||
149938021|NCT01387269|540910554|FG001|Overall Study|Lost to Follow-up|0|||
149938022|NCT01200329|540910557|FG000|Overall Study|Lack of financial coverage|2|||
149938023|NCT01200329|540910557|FG000|Overall Study|Progressive disease|1|||
149938024|NCT03087058|540910561|FG000|Overall Study|Withdrawal by Subject|2|||
149938025|NCT03087058|540910562|FG001|Overall Study|Withdrawal by Subject|0|||
149938026|NCT03087058|540910563|FG002|Overall Study|Withdrawal by Subject|0|||
149938027|NCT02078817|540910566|FG000|Overall Study|Withdrawal by Subject|1|||
149938028|NCT01441973|540910572|FG000|Overall Study|Disease progression|8|||
149938029|NCT01441973|540910573|FG001|Overall Study|Disease progression|6|||
149938030|NCT01441973|540910572|FG000|Overall Study|Adverse event unrelated to study drug|3|||
149938031|NCT01441973|540910573|FG001|Overall Study|Adverse event unrelated to study drug|2|||
150271401|NCT04606771|542132736|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
149938032|NCT01441973|540910572|FG000|Overall Study|Participant request to discontinue|1|||
149938033|NCT01441973|540910573|FG001|Overall Study|Participant request to discontinue|1|||
149938034|NCT01441973|540910572|FG000|Overall Study|Poor compliance/noncompliance|0|||
149938035|NCT01441973|540910573|FG001|Overall Study|Poor compliance/noncompliance|1|||
149938036|NCT01441973|540910572|FG000|Overall Study|Administrative reason by sponsor|3|||
149938037|NCT01441973|540910573|FG001|Overall Study|Administrative reason by sponsor|5|||
150271402|NCT04606771|542132735|FG000|Overall Study|Death|5|||
150271403|NCT04606771|542132736|FG001|Overall Study|Death|6|||
150271404|NCT04606771|542132735|FG000|Overall Study|Wrong randomisation|0|||
149938038|NCT01441973|540910572|FG000|Overall Study|Participant withdrew consent|0|||
150271405|NCT04606771|542132736|FG001|Overall Study|Wrong randomisation|1|||
149820400|NCT02868281|540471802|FG000|Overall Study|Physician Decision|2|||
149938039|NCT01441973|540910573|FG001|Overall Study|Participant withdrew consent|1|||
149938040|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
149938041|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
149938042|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
150271406|NCT00733304|542132741|FG000|Overall Study|Adverse Event|3|||
150271407|NCT00733304|542132742|FG001|Overall Study|Adverse Event|0|||
149820401|NCT02868281|540471803|FG001|Overall Study|Physician Decision|0|||
149938043|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
149938044|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
149820402|NCT02868281|540471802|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
150271408|NCT00733304|542132743|FG002|Overall Study|Adverse Event|0|||
150271409|NCT00733304|542132741|FG000|Overall Study|Lack of Efficacy|0|||
150271410|NCT00733304|542132742|FG001|Overall Study|Lack of Efficacy|0|||
150271411|NCT00733304|542132743|FG002|Overall Study|Lack of Efficacy|2|||
150271412|NCT00733304|542132741|FG000|Overall Study|Lost to Follow-up|0|||
150271413|NCT00733304|542132742|FG001|Overall Study|Lost to Follow-up|1|||
150271414|NCT00733304|542132743|FG002|Overall Study|Lost to Follow-up|0|||
150271415|NCT00733304|542132741|FG000|Overall Study|Physician Decision|3|||
150271416|NCT00733304|542132742|FG001|Overall Study|Physician Decision|1|||
150271417|NCT00733304|542132743|FG002|Overall Study|Physician Decision|3|||
150271418|NCT00733304|542132741|FG000|Overall Study|Withdrawal by Subject|1|||
150271419|NCT00733304|542132742|FG001|Overall Study|Withdrawal by Subject|1|||
150271420|NCT00733304|542132743|FG002|Overall Study|Withdrawal by Subject|0|||
150271421|NCT01187550|542132744|FG000|Overall Study|Protocol Violation|3|||
150271422|NCT01187550|542132745|FG001|Overall Study|Protocol Violation|1|||
150271423|NCT01187550|542132744|FG000|Overall Study|Other|3|||
149938045|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
149938046|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
149938047|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
149938048|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
149938049|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
149938050|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
149938051|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
149938052|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
149938053|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
149938054|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
149938055|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
149938056|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
149938057|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
149938058|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
149938059|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
149938060|NCT01149655|540910574|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
149938061|NCT01149655|540910575|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
149938062|NCT01149655|540910576|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
149938063|NCT01149655|540910577|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
149938064|NCT01149655|540910574|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
149938065|NCT01149655|540910575|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
149938066|NCT01149655|540910576|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
149938067|NCT01149655|540910577|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
149938068|NCT01149655|540910574|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
149938069|NCT01149655|540910575|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
149938070|NCT01149655|540910576|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
149938071|NCT01149655|540910577|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
149938072|NCT01149655|540910574|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
149938073|NCT01149655|540910575|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
149938074|NCT01149655|540910576|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
149938075|NCT01149655|540910577|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
149938076|NCT01149655|540910574|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
149938077|NCT01149655|540910575|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
149938078|NCT01149655|540910576|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
149938079|NCT01149655|540910577|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
149938080|NCT01149655|540910574|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
149938081|NCT01149655|540910575|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
149938082|NCT01149655|540910576|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
149938083|NCT01149655|540910577|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
149938084|NCT01149655|540910574|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
149938085|NCT01149655|540910575|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
149938086|NCT01149655|540910576|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
149938087|NCT01149655|540910577|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
149938088|NCT01149655|540910574|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
149938089|NCT01149655|540910575|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
149938090|NCT01149655|540910576|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
149938091|NCT01149655|540910577|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
149938092|NCT01149655|540910574|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
149938093|NCT01149655|540910575|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
149938094|NCT01149655|540910576|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
150271424|NCT01187550|542132745|FG001|Overall Study|Other|0|||
150271425|NCT01187550|542132744|FG000|Overall Study|Randomized but not treated|8|||
150271426|NCT01187550|542132745|FG001|Overall Study|Randomized but not treated|0|||
150271427|NCT00129623|542132746|FG000|Overall Study|Adverse Event|3|||
150271428|NCT00129623|542132747|FG001|Overall Study|Adverse Event|7|||
150271429|NCT00129623|542132746|FG000|Overall Study|Refused Treatment|5|||
150271430|NCT00129623|542132747|FG001|Overall Study|Refused Treatment|3|||
150271431|NCT00129623|542132746|FG000|Overall Study|Failure to Return|1|||
150271432|NCT00129623|542132747|FG001|Overall Study|Failure to Return|1|||
150271433|NCT00129623|542132746|FG000|Overall Study|Relocated job out of state|1|||
150271434|NCT00129623|542132747|FG001|Overall Study|Relocated job out of state|0|||
150271435|NCT00129623|542132746|FG000|Overall Study|Uncertainty to return|0|||
150271436|NCT00129623|542132747|FG001|Overall Study|Uncertainty to return|1|||
150271437|NCT02445755|542132748|FG000|Overall Study|Withdrawal by Subject|2|||
150271438|NCT02445755|542132748|FG000|Overall Study|Protocol Violation|6|||
150271439|NCT02445755|542132748|FG000|Overall Study|Screen Failure|5|||
150271440|NCT03189862|542132749|FG000|Overall Study|Withdrawal by Subject|1|||
150271441|NCT03189862|542132750|FG001|Overall Study|Withdrawal by Subject|0|||
150271442|NCT03189862|542132749|FG000|Overall Study|Lost to Follow-up|54|||
150271443|NCT03189862|542132750|FG001|Overall Study|Lost to Follow-up|62|||
150271444|NCT03974334|542132753|FG000|Overall Study|Lost to Follow-up|1|||
150271445|NCT01109173|542132755|FG000|Overall Study|Adverse Event|15|||
150271446|NCT01109173|542132756|FG001|Overall Study|Adverse Event|17|||
150271447|NCT01109173|542132757|FG002|Overall Study|Adverse Event|9|||
150271448|NCT01109173|542132758|FG003|Overall Study|Adverse Event|6|||
150271449|NCT01109173|542132755|FG000|Overall Study|Lost to Follow-up|0|||
150271450|NCT01109173|542132756|FG001|Overall Study|Lost to Follow-up|1|||
150271451|NCT01109173|542132757|FG002|Overall Study|Lost to Follow-up|0|||
150271452|NCT01109173|542132758|FG003|Overall Study|Lost to Follow-up|0|||
150271453|NCT01109173|542132755|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
150271454|NCT01109173|542132756|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
150271455|NCT01109173|542132757|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
150271456|NCT01109173|542132758|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
150271457|NCT01109173|542132755|FG000|Overall Study|Noncompliance|0|||
150271458|NCT01109173|542132756|FG001|Overall Study|Noncompliance|1|||
150271459|NCT01109173|542132757|FG002|Overall Study|Noncompliance|0|||
150271460|NCT01109173|542132758|FG003|Overall Study|Noncompliance|0|||
150271461|NCT01109173|542132755|FG000|Overall Study|Treatment Failure|25|||
150271462|NCT01109173|542132756|FG001|Overall Study|Treatment Failure|32|||
150271463|NCT01109173|542132757|FG002|Overall Study|Treatment Failure|69|||
150271464|NCT01109173|542132758|FG003|Overall Study|Treatment Failure|64|||
150271465|NCT01109173|542132755|FG000|Overall Study|Protocol Violation|4|||
150271466|NCT01109173|542132756|FG001|Overall Study|Protocol Violation|5|||
150271467|NCT01109173|542132757|FG002|Overall Study|Protocol Violation|1|||
150271468|NCT01109173|542132758|FG003|Overall Study|Protocol Violation|2|||
150271469|NCT01109173|542132755|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
150271470|NCT01109173|542132756|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
150271471|NCT01109173|542132757|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
150271472|NCT01109173|542132758|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
149938095|NCT01149655|540910577|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
149938096|NCT01149655|540910574|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
149938097|NCT01149655|540910575|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
149938098|NCT01149655|540910576|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
149938099|NCT01149655|540910577|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
149938100|NCT01149655|540910574|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
149938101|NCT01149655|540910575|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
149938102|NCT01149655|540910576|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
149938103|NCT01149655|540910577|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
149938104|NCT01265498|540910578|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
149938105|NCT01265498|540910579|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
149938106|NCT00617279|540910586|FG000|Overall Study|Study terminated by Sponsor|10|||
149938107|NCT00617279|540910587|FG001|Overall Study|Study terminated by Sponsor|15|||
149938108|NCT00617279|540910586|FG000|Overall Study|Graft abandonment|2|||
149938109|NCT00617279|540910587|FG001|Overall Study|Graft abandonment|0|||
149938110|NCT00617279|540910586|FG000|Overall Study|Lost to Follow-up|1|||
149938111|NCT00617279|540910587|FG001|Overall Study|Lost to Follow-up|0|||
149938112|NCT00617279|540910586|FG000|Overall Study|Death|1|||
150271473|NCT01109173|542132755|FG000|Overall Study|Not Specifiied|5|||
150271474|NCT01109173|542132756|FG001|Overall Study|Not Specifiied|4|||
150271475|NCT01109173|542132757|FG002|Overall Study|Not Specifiied|9|||
149938113|NCT00617279|540910587|FG001|Overall Study|Death|2|||
150271476|NCT01109173|542132758|FG003|Overall Study|Not Specifiied|14|||
150271477|NCT02252536|542132759|FG000|Overall Study|Lost to Follow-up|5|||
150271478|NCT02252536|542132760|FG001|Overall Study|Lost to Follow-up|3|||
150271479|NCT01438151|542132762|FG000|Overall Study|study terminated|8|||
150271480|NCT00006392|542132769|FG000|Overall Study|Ineligible|11|||
150271481|NCT00006392|542132770|FG001|Overall Study|Ineligible|3|||
150271482|NCT00006392|542132771|FG002|Overall Study|Ineligible|5|||
150271483|NCT00006392|542132772|FG003|Overall Study|Ineligible|5|||
150271484|NCT00006392|542132769|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
150271485|NCT00006392|542132770|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
150271486|NCT00006392|542132771|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
150271487|NCT00006392|542132772|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
150271488|NCT02459769|542132773|FG000|Overall Study|Withdrawal by Subject|7|||
150271489|NCT02459769|542132774|FG001|Overall Study|Withdrawal by Subject|4|||
150271490|NCT02459769|542132775|FG002|Overall Study|Withdrawal by Subject|8|||
150271491|NCT02459769|542132776|FG003|Overall Study|Withdrawal by Subject|5|||
150271492|NCT02459769|542132773|FG000|Overall Study|Lost to Follow-up|1|||
150271493|NCT02459769|542132774|FG001|Overall Study|Lost to Follow-up|0|||
150271494|NCT02459769|542132775|FG002|Overall Study|Lost to Follow-up|1|||
150271495|NCT02459769|542132776|FG003|Overall Study|Lost to Follow-up|0|||
150271496|NCT02378220|542132777|FG000|Overall Study|Death|6|||
150271497|NCT02378220|542132778|FG001|Overall Study|Death|1|||
150271498|NCT05105789|542132779|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
150271499|NCT01271803|542132780|FG000|Overall Study|Progressive disease|0|||
150271500|NCT01271803|542132781|FG001|Overall Study|Progressive disease|0|||
150271501|NCT01271803|542132782|FG002|Overall Study|Progressive disease|2|||
150271502|NCT01271803|542132780|FG000|Overall Study|Death|53|||
150271503|NCT01271803|542132781|FG001|Overall Study|Death|34|||
150271504|NCT01271803|542132782|FG002|Overall Study|Death|0|||
150271505|NCT01271803|542132780|FG000|Overall Study|Withdrawal by Subject|1|||
150271506|NCT01271803|542132781|FG001|Overall Study|Withdrawal by Subject|5|||
150271507|NCT01271803|542132782|FG002|Overall Study|Withdrawal by Subject|0|||
150271508|NCT01271803|542132780|FG000|Overall Study|Lost to Follow-up|1|||
149938114|NCT01898078|540912183|FG000|Overall Study|Progressive Disease|1|||
149938115|NCT01898078|540912184|FG001|Overall Study|Progressive Disease|5|||
149938116|NCT01898078|540912183|FG000|Overall Study|Adverse Event|2|||
149938117|NCT01898078|540912184|FG001|Overall Study|Adverse Event|1|||
150271509|NCT01271803|542132781|FG001|Overall Study|Lost to Follow-up|0|||
150271510|NCT01271803|542132782|FG002|Overall Study|Lost to Follow-up|0|||
150271511|NCT01975428|542132786|FG000|Overall Study|Lost to Follow-up|17|||
150271512|NCT01975428|542132787|FG001|Overall Study|Lost to Follow-up|4|||
150271513|NCT01975428|542132786|FG000|Overall Study|Withdrawal by Subject|3|||
150271514|NCT01975428|542132787|FG001|Overall Study|Withdrawal by Subject|10|||
150271515|NCT00628251|542132788|FG000|Randomised Part|Withdrawal by Subject|0|||
150271516|NCT00628251|542132789|FG001|Randomised Part|Withdrawal by Subject|0|||
150271517|NCT00628251|542132790|FG002|Randomised Part|Withdrawal by Subject|1|||
150271518|NCT00628251|542132788|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
150271519|NCT00628251|542132789|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
150271520|NCT00628251|542132790|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
150271521|NCT00628251|542132788|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
150271522|NCT00628251|542132789|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
150271523|NCT00628251|542132790|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
150271524|NCT00628251|542132788|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
150271525|NCT00628251|542132789|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
150271526|NCT00628251|542132790|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
150271527|NCT00628251|542132788|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
150271528|NCT00628251|542132789|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
150271529|NCT00628251|542132790|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
150271530|NCT00628251|542132788|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
150271531|NCT00628251|542132789|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
150271532|NCT00628251|542132790|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
150271533|NCT00728481|542132791|FG000|Overall Study|Withdrawal by Subject|0|||
150271534|NCT00728481|542132792|FG001|Overall Study|Withdrawal by Subject|1|||
150271535|NCT00728481|542132791|FG000|Overall Study|Adverse Event|0|||
150271536|NCT00728481|542132792|FG001|Overall Study|Adverse Event|1|||
150271537|NCT00728481|542132791|FG000|Overall Study|Study medication non-compliance|0|||
150271538|NCT00728481|542132792|FG001|Overall Study|Study medication non-compliance|2|||
150271539|NCT00728481|542132791|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
150271540|NCT00728481|542132792|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
150271541|NCT02545322|542132793|FG000|Overall Study|Withdrawal by Subject|3|||
150271542|NCT00041067|542132794|FG000|Overall Study|Adverse Event|20|||
150271543|NCT00041067|542132794|FG000|Overall Study|Progression|19|||
149938118|NCT01898078|540912183|FG000|Overall Study|Withdrawal by Subject|1|||
149938119|NCT01898078|540912184|FG001|Overall Study|Withdrawal by Subject|1|||
150271544|NCT00041067|542132794|FG000|Overall Study|Patient refusal|12|||
150271545|NCT00041067|542132794|FG000|Overall Study|Other reasons|23|||
150271546|NCT00041067|542132794|FG000|Overall Study|Ineligible|2|||
149938120|NCT01898078|540912183|FG000|Overall Study|Symptomatic Deterioration|2|||
150271547|NCT00778622|542132795|FG000|Overall Study|Adverse Event|5|||
150271548|NCT00778622|542132796|FG001|Overall Study|Adverse Event|4|||
150271549|NCT00778622|542132797|FG002|Overall Study|Adverse Event|7|||
150271550|NCT00778622|542132795|FG000|Overall Study|Withdrawal by Subject|4|||
150271551|NCT00778622|542132796|FG001|Overall Study|Withdrawal by Subject|5|||
150271552|NCT00778622|542132797|FG002|Overall Study|Withdrawal by Subject|5|||
150271553|NCT00778622|542132795|FG000|Overall Study|Lost to Follow-up|3|||
150271554|NCT00778622|542132796|FG001|Overall Study|Lost to Follow-up|3|||
150271555|NCT00778622|542132797|FG002|Overall Study|Lost to Follow-up|2|||
150271556|NCT00778622|542132795|FG000|Overall Study|Protocol Violation|0|||
150271557|NCT00778622|542132796|FG001|Overall Study|Protocol Violation|3|||
150271558|NCT00778622|542132797|FG002|Overall Study|Protocol Violation|0|||
150271559|NCT00778622|542132795|FG000|Overall Study|Lack of Efficacy|2|||
150271560|NCT00778622|542132796|FG001|Overall Study|Lack of Efficacy|0|||
150271561|NCT00778622|542132797|FG002|Overall Study|Lack of Efficacy|0|||
150271562|NCT00778622|542132795|FG000|Overall Study|immigration|1|||
150271563|NCT00778622|542132796|FG001|Overall Study|immigration|0|||
150271564|NCT00778622|542132797|FG002|Overall Study|immigration|0|||
150271565|NCT00778622|542132795|FG000|Overall Study|Other|1|||
150271566|NCT00778622|542132796|FG001|Overall Study|Other|0|||
150271567|NCT00778622|542132797|FG002|Overall Study|Other|1|||
150271568|NCT01251120|542132799|FG000|Overall Study|Lack of Efficacy|0|||
150271569|NCT01251120|542132800|FG001|Overall Study|Lack of Efficacy|1|||
150271570|NCT01968070|542132801|FG000|Period 1|Withdrawal by Subject|0|||
150271571|NCT01968070|542132802|FG001|Period 1|Withdrawal by Subject|1|||
150271572|NCT01968070|542132803|FG002|Period 1|Withdrawal by Subject|0|||
150271573|NCT01968070|542132804|FG003|Period 1|Withdrawal by Subject|0|||
150271574|NCT01968070|542132805|FG004|Period 1|Withdrawal by Subject|0|||
150271575|NCT01968070|542132806|FG005|Period 1|Withdrawal by Subject|0|||
150271576|NCT01968070|542132807|FG006|Period 1|Withdrawal by Subject|1|||
150271577|NCT01968070|542132808|FG007|Period 1|Withdrawal by Subject|0|||
150271578|NCT01968070|542132809|FG008|Period 1|Withdrawal by Subject|0|||
150271579|NCT01968070|542132810|FG009|Period 1|Withdrawal by Subject|0|||
150271580|NCT01968070|542132811|FG010|Period 1|Withdrawal by Subject|0|||
150271581|NCT01968070|542132812|FG011|Period 1|Withdrawal by Subject|0|||
150271582|NCT01968070|542132813|FG012|Period 1|Withdrawal by Subject|0|||
150271583|NCT01968070|542132814|FG013|Period 1|Withdrawal by Subject|0|||
150271584|NCT01968070|542132815|FG014|Period 1|Withdrawal by Subject|0|||
150271585|NCT01968070|542132816|FG015|Period 1|Withdrawal by Subject|1|||
150271586|NCT01968070|542132817|FG016|Period 1|Withdrawal by Subject|0|||
150271587|NCT01968070|542132818|FG017|Period 1|Withdrawal by Subject|0|||
150271588|NCT01968070|542132801|FG000|Period 1|Protocol Violation|0|||
150271589|NCT01968070|542132802|FG001|Period 1|Protocol Violation|0|||
150271590|NCT01968070|542132803|FG002|Period 1|Protocol Violation|0|||
150271591|NCT01968070|542132804|FG003|Period 1|Protocol Violation|1|||
150271592|NCT01968070|542132805|FG004|Period 1|Protocol Violation|1|||
150271593|NCT01968070|542132806|FG005|Period 1|Protocol Violation|0|||
150271594|NCT01968070|542132807|FG006|Period 1|Protocol Violation|0|||
150271595|NCT01968070|542132808|FG007|Period 1|Protocol Violation|0|||
150271596|NCT01968070|542132809|FG008|Period 1|Protocol Violation|0|||
150271597|NCT01968070|542132810|FG009|Period 1|Protocol Violation|0|||
150271598|NCT01968070|542132811|FG010|Period 1|Protocol Violation|0|||
150271599|NCT01968070|542132812|FG011|Period 1|Protocol Violation|0|||
150271600|NCT01968070|542132813|FG012|Period 1|Protocol Violation|0|||
150271601|NCT01968070|542132814|FG013|Period 1|Protocol Violation|0|||
150271602|NCT01968070|542132815|FG014|Period 1|Protocol Violation|0|||
150271603|NCT01968070|542132816|FG015|Period 1|Protocol Violation|0|||
150271604|NCT01968070|542132817|FG016|Period 1|Protocol Violation|0|||
150271605|NCT01968070|542132818|FG017|Period 1|Protocol Violation|0|||
150271606|NCT01968070|542132801|FG000|Period 1|Lost to Follow-up|0|||
150271607|NCT01968070|542132802|FG001|Period 1|Lost to Follow-up|0|||
150271608|NCT01968070|542132803|FG002|Period 1|Lost to Follow-up|0|||
150271609|NCT01968070|542132804|FG003|Period 1|Lost to Follow-up|1|||
150271610|NCT01968070|542132805|FG004|Period 1|Lost to Follow-up|0|||
150271611|NCT01968070|542132806|FG005|Period 1|Lost to Follow-up|0|||
150271612|NCT01968070|542132807|FG006|Period 1|Lost to Follow-up|0|||
150271613|NCT01968070|542132808|FG007|Period 1|Lost to Follow-up|0|||
150271614|NCT01968070|542132809|FG008|Period 1|Lost to Follow-up|0|||
150271615|NCT01968070|542132810|FG009|Period 1|Lost to Follow-up|0|||
150271616|NCT01968070|542132811|FG010|Period 1|Lost to Follow-up|0|||
150271617|NCT01968070|542132812|FG011|Period 1|Lost to Follow-up|0|||
150271618|NCT01968070|542132813|FG012|Period 1|Lost to Follow-up|0|||
150271619|NCT01968070|542132814|FG013|Period 1|Lost to Follow-up|0|||
150271620|NCT01968070|542132815|FG014|Period 1|Lost to Follow-up|0|||
150271621|NCT01968070|542132816|FG015|Period 1|Lost to Follow-up|0|||
150271622|NCT01968070|542132817|FG016|Period 1|Lost to Follow-up|0|||
150271623|NCT01968070|542132818|FG017|Period 1|Lost to Follow-up|0|||
150271624|NCT01968070|542132801|FG000|Period 1|Adverse Event|0|||
150271625|NCT01968070|542132802|FG001|Period 1|Adverse Event|0|||
150271626|NCT01968070|542132803|FG002|Period 1|Adverse Event|0|||
150271627|NCT01968070|542132804|FG003|Period 1|Adverse Event|0|||
150271628|NCT01968070|542132805|FG004|Period 1|Adverse Event|0|||
150271629|NCT01968070|542132806|FG005|Period 1|Adverse Event|0|||
150271630|NCT01968070|542132807|FG006|Period 1|Adverse Event|1|||
150271631|NCT01968070|542132808|FG007|Period 1|Adverse Event|0|||
150271632|NCT01968070|542132809|FG008|Period 1|Adverse Event|0|||
150271633|NCT01968070|542132810|FG009|Period 1|Adverse Event|0|||
150271634|NCT01968070|542132811|FG010|Period 1|Adverse Event|0|||
150271635|NCT01968070|542132812|FG011|Period 1|Adverse Event|0|||
150271636|NCT01968070|542132813|FG012|Period 1|Adverse Event|0|||
150271637|NCT01968070|542132814|FG013|Period 1|Adverse Event|0|||
150271638|NCT01968070|542132815|FG014|Period 1|Adverse Event|0|||
150271639|NCT01968070|542132816|FG015|Period 1|Adverse Event|0|||
150271640|NCT01968070|542132817|FG016|Period 1|Adverse Event|0|||
150271641|NCT01968070|542132818|FG017|Period 1|Adverse Event|0|||
150271642|NCT01968070|542132801|FG000|Period 1|Physician Decision|0|||
150271643|NCT01968070|542132802|FG001|Period 1|Physician Decision|0|||
150271644|NCT01968070|542132803|FG002|Period 1|Physician Decision|0|||
150271645|NCT01968070|542132804|FG003|Period 1|Physician Decision|0|||
150271646|NCT01968070|542132805|FG004|Period 1|Physician Decision|0|||
150271647|NCT01968070|542132806|FG005|Period 1|Physician Decision|0|||
150271648|NCT01968070|542132807|FG006|Period 1|Physician Decision|0|||
150271649|NCT01968070|542132808|FG007|Period 1|Physician Decision|0|||
150271650|NCT01968070|542132809|FG008|Period 1|Physician Decision|0|||
150271651|NCT01968070|542132810|FG009|Period 1|Physician Decision|0|||
149938121|NCT01898078|540912184|FG001|Overall Study|Symptomatic Deterioration|0|||
150271652|NCT01968070|542132811|FG010|Period 1|Physician Decision|0|||
150271653|NCT01968070|542132812|FG011|Period 1|Physician Decision|1|||
150271654|NCT01968070|542132813|FG012|Period 1|Physician Decision|0|||
150271655|NCT01968070|542132814|FG013|Period 1|Physician Decision|0|||
150271656|NCT01968070|542132815|FG014|Period 1|Physician Decision|0|||
150271657|NCT01968070|542132816|FG015|Period 1|Physician Decision|0|||
150271658|NCT01968070|542132817|FG016|Period 1|Physician Decision|0|||
150271659|NCT01968070|542132818|FG017|Period 1|Physician Decision|0|||
150271660|NCT01968070|542132801|FG000|Period 2|Withdrawal by Subject|0|||
150271661|NCT01968070|542132802|FG001|Period 2|Withdrawal by Subject|0|||
150271662|NCT01968070|542132803|FG002|Period 2|Withdrawal by Subject|0|||
150271663|NCT01968070|542132804|FG003|Period 2|Withdrawal by Subject|0|||
150271664|NCT01968070|542132805|FG004|Period 2|Withdrawal by Subject|1|||
150271665|NCT01968070|542132806|FG005|Period 2|Withdrawal by Subject|0|||
150271666|NCT01968070|542132807|FG006|Period 2|Withdrawal by Subject|0|||
150271667|NCT01968070|542132808|FG007|Period 2|Withdrawal by Subject|0|||
150271668|NCT01968070|542132809|FG008|Period 2|Withdrawal by Subject|0|||
150271669|NCT01968070|542132810|FG009|Period 2|Withdrawal by Subject|0|||
150271670|NCT01968070|542132811|FG010|Period 2|Withdrawal by Subject|0|||
150271671|NCT01968070|542132812|FG011|Period 2|Withdrawal by Subject|0|||
150271672|NCT01968070|542132813|FG012|Period 2|Withdrawal by Subject|0|||
150271673|NCT01968070|542132814|FG013|Period 2|Withdrawal by Subject|0|||
150271674|NCT01968070|542132815|FG014|Period 2|Withdrawal by Subject|0|||
150271675|NCT01968070|542132816|FG015|Period 2|Withdrawal by Subject|0|||
150271676|NCT01968070|542132817|FG016|Period 2|Withdrawal by Subject|0|||
150271677|NCT01968070|542132818|FG017|Period 2|Withdrawal by Subject|0|||
150271678|NCT00890929|542132819|FG000|Overall Study|Death before treatment|2|||
150271679|NCT00890929|542132819|FG000|Overall Study|Withdrawal by Subject|3|||
150271680|NCT00890929|542132819|FG000|Overall Study|Physician Decision|1|||
150271681|NCT00108069|542132820|FG000|Overall Study|Never rec'd study drug|0|||
149938122|NCT01898078|540912183|FG000|Overall Study|Reason not Specified|0|||
149938123|NCT01898078|540912184|FG001|Overall Study|Reason not Specified|1|||
149938124|NCT01075048|540912186|FG000|Overall Study|Death|4|||
149938125|NCT01075048|540912187|FG001|Overall Study|Death|17|||
149938126|NCT01075048|540912188|FG002|Overall Study|Death|12|||
149938127|NCT01075048|540912186|FG000|Overall Study|Start of other or new therapy|4|||
149938128|NCT01075048|540912187|FG001|Overall Study|Start of other or new therapy|36|||
149938129|NCT01075048|540912188|FG002|Overall Study|Start of other or new therapy|46|||
149938130|NCT01075048|540912186|FG000|Overall Study|Withdrawal by Subject|1|||
149938131|NCT01075048|540912187|FG001|Overall Study|Withdrawal by Subject|6|||
149938132|NCT01075048|540912188|FG002|Overall Study|Withdrawal by Subject|3|||
149938133|NCT01075048|540912186|FG000|Overall Study|Lost to Follow-up|0|||
150271682|NCT00108069|542132821|FG001|Overall Study|Never rec'd study drug|1|||
150271683|NCT00108069|542132820|FG000|Overall Study|Adverse Event|1|||
150271684|NCT00108069|542132821|FG001|Overall Study|Adverse Event|1|||
150271685|NCT00108069|542132820|FG000|Overall Study|Withdrawal by Subject|1|||
150271686|NCT00108069|542132821|FG001|Overall Study|Withdrawal by Subject|0|||
149938134|NCT01075048|540912187|FG001|Overall Study|Lost to Follow-up|1|||
149938135|NCT01075048|540912188|FG002|Overall Study|Lost to Follow-up|1|||
150271687|NCT00108069|542132820|FG000|Overall Study|Death|1|||
150271688|NCT00108069|542132821|FG001|Overall Study|Death|0|||
150271689|NCT00108069|542132820|FG000|Overall Study|Progessive disease|27|||
150271690|NCT00108069|542132821|FG001|Overall Study|Progessive disease|11|||
150271691|NCT02558231|542132822|FG000|Overall Study|Death|4|||
150271692|NCT02558231|542132823|FG001|Overall Study|Death|12|||
150271693|NCT02558231|542132822|FG000|Overall Study|Lost to Follow-up|7|||
149938136|NCT00761319|540912191|FG000|Overall Study|Protocol Violation|21|||
150271694|NCT02558231|542132823|FG001|Overall Study|Lost to Follow-up|4|||
150271695|NCT02558231|542132822|FG000|Overall Study|Withdrawal by Subject|7|||
150271696|NCT02558231|542132823|FG001|Overall Study|Withdrawal by Subject|4|||
150271697|NCT02558231|542132822|FG000|Overall Study|Physician Decision|7|||
150271698|NCT02558231|542132823|FG001|Overall Study|Physician Decision|5|||
150271699|NCT02558231|542132822|FG000|Overall Study|Sponsor Decision|0|||
150271700|NCT02558231|542132823|FG001|Overall Study|Sponsor Decision|1|||
150271701|NCT00995007|542132824|FG000|Overall Study|Withdrew consent|1|||
150271702|NCT00995007|542132825|FG001|Overall Study|Withdrew consent|0|||
150271703|NCT00995007|542132824|FG000|Overall Study|Refused further treatment|8|||
150271704|NCT00995007|542132825|FG001|Overall Study|Refused further treatment|2|||
150271705|NCT00995007|542132824|FG000|Overall Study|Toxicity|8|||
150271706|NCT00995007|542132825|FG001|Overall Study|Toxicity|0|||
150271707|NCT03933397|542132826|FG000|Overall Study|No emergency department visit|65|||
150271708|NCT03933397|542132827|FG001|Overall Study|No emergency department visit|71|||
150271709|NCT03933397|542132826|FG000|Overall Study|Missed emergency department visit|25|||
150271710|NCT03933397|542132827|FG001|Overall Study|Missed emergency department visit|30|||
150271711|NCT03933397|542132826|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
150271712|NCT03933397|542132827|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
150271713|NCT03933397|542132826|FG000|Overall Study|Withdrawal by Subject|1|||
150271714|NCT03933397|542132827|FG001|Overall Study|Withdrawal by Subject|0|||
150271715|NCT03933397|542132826|FG000|Overall Study|Physician Decision|1|||
150271716|NCT03933397|542132827|FG001|Overall Study|Physician Decision|1|||
150271717|NCT03933397|542132826|FG000|Overall Study|missing pain score|1|||
150271718|NCT03933397|542132827|FG001|Overall Study|missing pain score|1|||
150271719|NCT03933397|542132826|FG000|Overall Study|Confirmed COVID-19|1|||
150271720|NCT03933397|542132827|FG001|Overall Study|Confirmed COVID-19|2|||
150271721|NCT02066051|542132832|FG000|Overall Study|Subject developed active GVHD|1|||
150271722|NCT01237340|542132833|FG000|Overall Study|Adverse Event|3|||
150271723|NCT01237340|542132833|FG000|Overall Study|Withdrawal by Subject|1|||
150271724|NCT01237340|542132833|FG000|Overall Study|Early termination of the trial|36|||
149820403|NCT02868281|540471803|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
149820404|NCT02868281|540471802|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
149820405|NCT02868281|540471803|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
149820406|NCT02868281|540471802|FG000|Overall Study|Long journey/moving away|1|||
149820407|NCT02868281|540471803|FG001|Overall Study|Long journey/moving away|1|||
149820408|NCT01722266|540471804|FG000|Overall Study|Withdrawal by Subject|1|||
149820409|NCT01722266|540471805|FG001|Overall Study|Withdrawal by Subject|2|||
149820410|NCT01722266|540471806|FG002|Overall Study|Withdrawal by Subject|0|||
149820411|NCT01722266|540471807|FG003|Overall Study|Withdrawal by Subject|0|||
149820412|NCT01722266|540471804|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
150271725|NCT01610687|542132834|FG000|Overall Study|Lack of Efficacy|26|||
150271726|NCT01610687|542132834|FG000|Overall Study|Adverse Event|18|||
150271727|NCT01610687|542132834|FG000|Overall Study|Moved out of area|6|||
150271728|NCT01610687|542132834|FG000|Overall Study|Withdrawal by Subject|7|||
150271729|NCT01610687|542132834|FG000|Overall Study|Lost to Follow-up|4|||
150271730|NCT01610687|542132834|FG000|Overall Study|Symptom control without study medication|2|||
150271731|NCT01610687|542132834|FG000|Overall Study|Unable to make journey|1|||
150271732|NCT01610687|542132834|FG000|Overall Study|Death|1|||
149820413|NCT01722266|540471805|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
149820414|NCT01722266|540471806|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
149938137|NCT00761319|540912192|FG001|Overall Study|Protocol Violation|14|||
149938138|NCT00761319|540912191|FG000|Overall Study|Adverse Event|11|||
149938139|NCT00761319|540912192|FG001|Overall Study|Adverse Event|7|||
150271733|NCT01610687|542132834|FG000|Overall Study|Cannabis affecting job|1|||
150271734|NCT01610687|542132834|FG000|Overall Study|Felt more alter without study medication|1|||
150271735|NCT02401412|542132835|FG000|Overall Study|Lost to Follow-up|1|||
150271736|NCT02401412|542132836|FG001|Overall Study|Lost to Follow-up|0|||
150271737|NCT02401412|542132835|FG000|Overall Study|Discontinued Intervention|15|||
150271738|NCT02401412|542132836|FG001|Overall Study|Discontinued Intervention|21|||
150271739|NCT02401412|542132835|FG000|Overall Study|Withdrawal by Subject|4|||
150271740|NCT02401412|542132836|FG001|Overall Study|Withdrawal by Subject|4|||
150271741|NCT02401412|542132835|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
150271742|NCT02401412|542132836|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
150271743|NCT02401412|542132835|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
150271744|NCT02401412|542132836|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
150271745|NCT02014740|542132841|FG000|Overall Study|Lost to Follow-up|4|||
150271746|NCT02014740|542132842|FG001|Overall Study|Lost to Follow-up|4|||
150271747|NCT02014740|542132841|FG000|Overall Study|Withdrawal by Subject|2|||
150271748|NCT02014740|542132842|FG001|Overall Study|Withdrawal by Subject|1|||
149820415|NCT01722266|540471807|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
149938140|NCT00761319|540912191|FG000|Overall Study|Withdrawal by Subject|8|||
150271749|NCT03684642|542132843|FG000|Overall Study|Adverse Event|6|||
150271750|NCT03684642|542132844|FG001|Overall Study|Adverse Event|15|||
150271751|NCT03684642|542132845|FG002|Overall Study|Adverse Event|11|||
150271752|NCT03684642|542132843|FG000|Overall Study|Withdrawal by Subject|35|||
149820416|NCT01722266|540471804|FG000|Overall Study|Dropped out due to Nausea|0|||
149820417|NCT01722266|540471805|FG001|Overall Study|Dropped out due to Nausea|0|||
150271753|NCT03684642|542132844|FG001|Overall Study|Withdrawal by Subject|53|||
150271754|NCT03684642|542132845|FG002|Overall Study|Withdrawal by Subject|23|||
150271755|NCT03684642|542132843|FG000|Overall Study|Lack of Efficacy|0|||
150271756|NCT03684642|542132844|FG001|Overall Study|Lack of Efficacy|0|||
150271757|NCT03684642|542132845|FG002|Overall Study|Lack of Efficacy|1|||
150271758|NCT03684642|542132843|FG000|Overall Study|Poor compliance to protocol|0|||
150271759|NCT03684642|542132844|FG001|Overall Study|Poor compliance to protocol|4|||
150271760|NCT03684642|542132845|FG002|Overall Study|Poor compliance to protocol|1|||
150271761|NCT03684642|542132843|FG000|Overall Study|Other than specified|62|||
150271762|NCT03684642|542132844|FG001|Overall Study|Other than specified|60|||
150271763|NCT03684642|542132845|FG002|Overall Study|Other than specified|67|||
150271764|NCT03684642|542132843|FG000|Overall Study|Randomized and not treated|0|||
150271765|NCT03684642|542132844|FG001|Overall Study|Randomized and not treated|0|||
150271766|NCT03684642|542132845|FG002|Overall Study|Randomized and not treated|1|||
150271767|NCT03684642|542132843|FG000|Overall Study|Missing completion status but alive at last contact|0|||
150271768|NCT03684642|542132844|FG001|Overall Study|Missing completion status but alive at last contact|1|||
150271769|NCT03684642|542132845|FG002|Overall Study|Missing completion status but alive at last contact|2|||
150271770|NCT01840605|542132849|FG000|Overall Study|Adverse Event|0|||
150271771|NCT01840605|542132850|FG001|Overall Study|Adverse Event|1|||
150271772|NCT01840605|542132849|FG000|Overall Study|Physician Decision|2|||
150271773|NCT01840605|542132850|FG001|Overall Study|Physician Decision|1|||
150271774|NCT03739437|542132851|FG000|Overall Study|Lost to Follow-up|2|||
150271775|NCT03739437|542132852|FG001|Overall Study|Lost to Follow-up|5|||
150271776|NCT01351623|542132853|FG000|Overall Study|Protocol Violation|2|||
150271777|NCT01351623|542132853|FG000|Overall Study|Adverse Event|4|||
150271778|NCT01351623|542132853|FG000|Overall Study|Withdrawal by Subject|1|||
150271779|NCT01351623|542132853|FG000|Overall Study|Death|2|||
150271780|NCT01130974|542132854|FG000|Overall Study|Protocol Violation|10|||
150271781|NCT01130974|542132855|FG001|Overall Study|Protocol Violation|10|||
150271782|NCT01130974|542132854|FG000|Overall Study|Withdrawal by Subject|0|||
150271783|NCT01130974|542132855|FG001|Overall Study|Withdrawal by Subject|1|||
150271784|NCT01130974|542132854|FG000|Overall Study|Ineligibility criteria|5|||
150271785|NCT01130974|542132855|FG001|Overall Study|Ineligibility criteria|2|||
150271786|NCT03359590|542132856|FG000|First Intervention|Withdrawal by Subject|1|||
150271787|NCT03359590|542132857|FG001|First Intervention|Withdrawal by Subject|1|||
150271788|NCT03359590|542132856|FG000|First Intervention|Protocol Violation|0|||
150271789|NCT03359590|542132857|FG001|First Intervention|Protocol Violation|1|||
150271790|NCT06132425|542132858|FG000|Overall Study|Withdrawal by Subject|3|||
150271791|NCT06132425|542132859|FG001|Overall Study|Withdrawal by Subject|0|||
150271792|NCT06132425|542132858|FG000|Overall Study|Did not follow study instructions|0|||
150271793|NCT06132425|542132859|FG001|Overall Study|Did not follow study instructions|2|||
150271794|NCT06132425|542132858|FG000|Overall Study|Lost to Follow-up|3|||
150271795|NCT06132425|542132859|FG001|Overall Study|Lost to Follow-up|5|||
150271796|NCT06308666|542132860|FG000|Overall Study|Withdrawal by Subject|1|||
150271797|NCT06308666|542132860|FG000|Overall Study|Protocol Violation|2|||
150271798|NCT00835120|542132861|FG000|Overall Study|Lack of Efficacy|1|||
150271799|NCT00835120|542132861|FG000|Overall Study|Lost to Follow-up|3|||
150271800|NCT00835120|542132861|FG000|Overall Study|Adverse Event|2|||
150271801|NCT00835120|542132861|FG000|Overall Study|Withdrawal by Subject|2|||
150271802|NCT01019980|542132862|FG000|Overall Study|Drug not available.|2|||
150271803|NCT01019980|542132863|FG001|Overall Study|Drug not available.|0|||
150271804|NCT04275297|542132865|FG000|Overall Study|Lost to Follow-up|1|||
150271805|NCT04275297|542132866|FG001|Overall Study|Lost to Follow-up|1|||
150271806|NCT04435782|542132869|FG000|Overall Study|Study terminated by sponsor|4|||
150271807|NCT03672461|542132870|FG000|Overall Study|COVID Related|4|||
150271808|NCT03672461|542132871|FG001|Overall Study|COVID Related|2|||
150271809|NCT03672461|542132870|FG000|Overall Study|Adverse Event|2|||
150271810|NCT03672461|542132871|FG001|Overall Study|Adverse Event|0|||
150271811|NCT03672461|542132870|FG000|Overall Study|Serious Adverse Event|0|||
150271812|NCT03672461|542132871|FG001|Overall Study|Serious Adverse Event|1|||
150271813|NCT03672461|542132870|FG000|Overall Study|Too Busy|3|||
150271814|NCT03672461|542132871|FG001|Overall Study|Too Busy|1|||
150271815|NCT03672461|542132870|FG000|Overall Study|Lost to Follow-up|1|||
150271816|NCT03672461|542132871|FG001|Overall Study|Lost to Follow-up|2|||
150271817|NCT03672461|542132870|FG000|Overall Study|Family|2|||
150271818|NCT03672461|542132871|FG001|Overall Study|Family|2|||
150271819|NCT03672461|542132870|FG000|Overall Study|No remote technology access|0|||
150271820|NCT03672461|542132871|FG001|Overall Study|No remote technology access|1|||
150271821|NCT03672461|542132870|FG000|Overall Study|Withdrawal by Subject|1|||
150271822|NCT03672461|542132871|FG001|Overall Study|Withdrawal by Subject|0|||
150271823|NCT03672461|542132870|FG000|Overall Study|Cannot tolerate intervention|1|||
150271824|NCT03672461|542132871|FG001|Overall Study|Cannot tolerate intervention|0|||
150271825|NCT03672461|542132870|FG000|Overall Study|Incomplete outcome data|6|||
150271826|NCT03672461|542132871|FG001|Overall Study|Incomplete outcome data|1|||
150271827|NCT04225806|542132872|FG000|Overall Study|Trial termination|15|||
150271828|NCT04890054|542134739|FG000|Overall Study|Lost to Follow-up|202|||
150271829|NCT04890054|542134740|FG001|Overall Study|Lost to Follow-up|219|||
150271830|NCT05586269|542134741|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
150271831|NCT05586269|542134742|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
150271832|NCT05586269|542134743|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
150271833|NCT05586269|542134744|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
150271834|NCT05586269|542134741|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
150271835|NCT05586269|542134742|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
150271836|NCT05586269|542134743|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
150271837|NCT05586269|542134744|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
150271838|NCT04752475|542134745|FG000|Overall Study|Withdrawal by Subject|1|||
150271839|NCT04752475|542134746|FG001|Overall Study|Withdrawal by Subject|1|||
150271840|NCT02113579|542134754|FG000|Overall Study|Adverse Event|1|||
150271841|NCT02113579|542134755|FG001|Overall Study|Adverse Event|0|||
150271842|NCT02113579|542134754|FG000|Overall Study|Withdrawal by Subject|3|||
150271843|NCT02113579|542134755|FG001|Overall Study|Withdrawal by Subject|2|||
150271844|NCT02113579|542134754|FG000|Overall Study|Lost to Follow-up|6|||
150271845|NCT02113579|542134755|FG001|Overall Study|Lost to Follow-up|2|||
150271846|NCT00726622|542134756|FG000|Overall Study|Withdrawal by Subject|16|||
150271847|NCT00726622|542134757|FG001|Overall Study|Withdrawal by Subject|2|||
150271848|NCT00726622|542134756|FG000|Overall Study|Physician Decision|0|||
150271849|NCT00726622|542134757|FG001|Overall Study|Physician Decision|1|||
150271850|NCT00726622|542134756|FG000|Overall Study|Metastasis|2|||
150271851|NCT00726622|542134757|FG001|Overall Study|Metastasis|0|||
150271852|NCT00440700|542134760|FG000|Overall Study|Withdrawal by Subject|8|||
150271853|NCT00440700|542134761|FG001|Overall Study|Withdrawal by Subject|8|||
150271854|NCT00440700|542134762|FG002|Overall Study|Withdrawal by Subject|4|||
150271855|NCT02973425|542134763|FG000|Overall Study|Lost to Follow-up|49|||
150271856|NCT02973425|542134764|FG001|Overall Study|Lost to Follow-up|53|||
150271857|NCT01754857|542134774|FG000|Overall Study|Adverse Event|7|||
150271858|NCT01754857|542134774|FG000|Overall Study|Disease progression|3|||
150271859|NCT01754857|542134774|FG000|Overall Study|Physician Decision|2|||
150271860|NCT01754857|542134774|FG000|Overall Study|Withdrawal by Subject|3|||
150271861|NCT01754857|542134774|FG000|Overall Study|other complicating disease|1|||
150271862|NCT01754857|542134774|FG000|Overall Study|ineligible to continue onto maintenance|1|||
150271863|NCT01754857|542134774|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
150271864|NCT01754857|542134774|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
150271865|NCT00059839|542134777|FG000|Overall Study|Death|1|||
150271866|NCT00059839|542134778|FG001|Overall Study|Death|1|||
150271867|NCT00059839|542134777|FG000|Overall Study|Lack of Efficacy|6|||
150271868|NCT00059839|542134778|FG001|Overall Study|Lack of Efficacy|5|||
150271869|NCT00059839|542134777|FG000|Overall Study|Lost to Follow-up|2|||
150271870|NCT00059839|542134778|FG001|Overall Study|Lost to Follow-up|0|||
150271871|NCT00059839|542134777|FG000|Overall Study|Physician Decision|1|||
150271872|NCT00059839|542134778|FG001|Overall Study|Physician Decision|2|||
150271873|NCT00059839|542134777|FG000|Overall Study|Withdrawal by Subject|1|||
150271874|NCT00059839|542134778|FG001|Overall Study|Withdrawal by Subject|6|||
150271875|NCT00059839|542134777|FG000|Overall Study|Ineligible|1|||
150271876|NCT00059839|542134778|FG001|Overall Study|Ineligible|3|||
150271877|NCT03842163|542134779|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
150271878|NCT03842163|542134779|FG000|Overall Study|Scintigraphy was not performed|44|||
150271879|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
150271880|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
150271881|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
150271882|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
150271883|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
150271884|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
150271885|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
150271886|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
150271887|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
149938141|NCT00761319|540912192|FG001|Overall Study|Withdrawal by Subject|7|||
149938142|NCT00761319|540912191|FG000|Overall Study|Noncompliance|4|||
149938143|NCT00761319|540912192|FG001|Overall Study|Noncompliance|3|||
149938144|NCT00761319|540912191|FG000|Overall Study|Lost to Follow-up|1|||
149938145|NCT00761319|540912192|FG001|Overall Study|Lost to Follow-up|1|||
149938146|NCT00761319|540912191|FG000|Overall Study|Nonspecified|2|||
149938147|NCT00761319|540912192|FG001|Overall Study|Nonspecified|2|||
149938148|NCT00761319|540912191|FG000|Overall Study|Missing|1|||
149938149|NCT00761319|540912192|FG001|Overall Study|Missing|0|||
149938150|NCT01715831|540912197|FG000|Overall Study|Adverse Event|1|||
149938151|NCT00900562|540912200|FG000|Overall Study|Progressive disease|9|||
149938152|NCT00900562|540912201|FG001|Overall Study|Progressive disease|5|||
149938153|NCT00900562|540912200|FG000|Overall Study|Toxicity|1|||
149938154|NCT00900562|540912201|FG001|Overall Study|Toxicity|0|||
150271888|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
150271889|NCT03829241|542134783|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
150271890|NCT03829241|542134784|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
150271891|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
150271892|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
150271893|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
150271894|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
150271895|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
150271896|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
150271897|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
150271898|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
150271899|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
150271900|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
150271901|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
150271902|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
149938155|NCT00900562|540912200|FG000|Overall Study|Death|1|||
149938156|NCT00900562|540912201|FG001|Overall Study|Death|1|||
149938157|NCT00900562|540912200|FG000|Overall Study|Withdrawal by Subject|0|||
149938158|NCT00900562|540912201|FG001|Overall Study|Withdrawal by Subject|1|||
149938159|NCT00900562|540912200|FG000|Overall Study|Unrelated adverse event|1|||
149938160|NCT00900562|540912201|FG001|Overall Study|Unrelated adverse event|0|||
149938161|NCT03098979|540912202|FG000|Overall Study|Adverse Event|1|||
149938162|NCT03098979|540912203|FG001|Overall Study|Adverse Event|0|||
149938163|NCT03098979|540912204|FG002|Overall Study|Adverse Event|1|||
149938164|NCT03098979|540912205|FG003|Overall Study|Adverse Event|4|||
149938165|NCT03098979|540912206|FG004|Overall Study|Adverse Event|6|||
149938166|NCT03098979|540912207|FG005|Overall Study|Adverse Event|1|||
149938167|NCT03098979|540912202|FG000|Overall Study|Withdrawal by Subject|2|||
149938168|NCT03098979|540912203|FG001|Overall Study|Withdrawal by Subject|1|||
149938169|NCT03098979|540912204|FG002|Overall Study|Withdrawal by Subject|1|||
149938170|NCT03098979|540912205|FG003|Overall Study|Withdrawal by Subject|1|||
150168932|NCT03643211|541752607|FG000|Overall Study|No treatment information|2|||
150168933|NCT03643211|541752607|FG000|Overall Study|No adverse event information - No revisit|4|||
150271903|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
150271904|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
150271905|NCT03829241|542134783|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
150271906|NCT03829241|542134784|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
150271907|NCT00698451|542134785|FG000|Overall Study|Adverse Event|22|||
150271908|NCT00698451|542134785|FG000|Overall Study|Physician Decision|2|||
150271909|NCT00698451|542134785|FG000|Overall Study|Protocol Violation|6|||
150271910|NCT00698451|542134785|FG000|Overall Study|Withdrawal by Subject|6|||
150271911|NCT00698451|542134785|FG000|Overall Study|Disease progression|3|||
150271912|NCT02224599|542134788|FG000|Overall Study|Physician Decision|1|||
150271913|NCT02224599|542134788|FG000|Overall Study|Progression of Disease|1|||
150271914|NCT00596934|542134789|FG000|Overall Study|Protocol Violation|1|||
150271915|NCT00596934|542134789|FG000|Overall Study|Withdrawal by Subject|1|||
150271916|NCT02315898|542134792|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
150271917|NCT02315898|542134793|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
150271918|NCT02315898|542134794|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
150271919|NCT02315898|542134795|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
149938171|NCT03098979|540912206|FG004|Overall Study|Withdrawal by Subject|2|||
149938172|NCT03098979|540912207|FG005|Overall Study|Withdrawal by Subject|1|||
149938173|NCT03098979|540912202|FG000|Overall Study|Death|1|||
149938174|NCT03098979|540912203|FG001|Overall Study|Death|0|||
150168934|NCT04536077|541752608|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
150168935|NCT04536077|541752609|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
150168936|NCT04536077|541752608|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
150168937|NCT04536077|541752609|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
150168938|NCT01155869|541752619|FG000|Overall Study|Lost to Follow-up|3|||
150168939|NCT01155869|541752620|FG001|Overall Study|Lost to Follow-up|1|||
150168940|NCT00881335|541752624|FG000|Overall Study|Lost to Follow-up|3|||
150168941|NCT00881335|541752625|FG001|Overall Study|Lost to Follow-up|2|||
150168942|NCT00554801|541752627|FG000|Overall Study|left area before completion|5|||
150168943|NCT00554801|541752628|FG001|Overall Study|left area before completion|0|||
150168944|NCT00554801|541752627|FG000|Overall Study|Withdrawal by Subject|14|||
150168945|NCT00554801|541752628|FG001|Overall Study|Withdrawal by Subject|0|||
150168946|NCT02908464|541752631|FG000|Overall Study|Withdrawal by Subject|2|||
150168947|NCT02908464|541752632|FG001|Overall Study|Withdrawal by Subject|1|||
150168948|NCT02908464|541752631|FG000|Overall Study|Found ineligible after randomization|0|||
150168949|NCT02908464|541752632|FG001|Overall Study|Found ineligible after randomization|2|||
150168950|NCT02163915|541752633|FG000|Overall Study|Withdrawal by Subject|2|||
150168951|NCT02163915|541752634|FG001|Overall Study|Withdrawal by Subject|0|||
150168952|NCT02163915|541752635|FG002|Overall Study|Withdrawal by Subject|2|||
149938175|NCT03098979|540912204|FG002|Overall Study|Death|2|||
149938176|NCT03098979|540912205|FG003|Overall Study|Death|0|||
150271920|NCT01330914|542134796|FG000|Overall Study|Withdrawal by Subject|4|||
150271921|NCT01330914|542134796|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
150271922|NCT02308007|542134809|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
150271923|NCT02308007|542134810|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
150271924|NCT02308007|542134811|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
150271925|NCT02308007|542134809|FG000|Overall Study|Positive for STD at Baseline|7|||
150271926|NCT02308007|542134810|FG001|Overall Study|Positive for STD at Baseline|11|||
149938177|NCT03098979|540912206|FG004|Overall Study|Death|1|||
149938178|NCT03098979|540912207|FG005|Overall Study|Death|0|||
149938179|NCT03098979|540912202|FG000|Overall Study|Physician Decision|2|||
149938180|NCT03098979|540912203|FG001|Overall Study|Physician Decision|1|||
149938181|NCT03098979|540912204|FG002|Overall Study|Physician Decision|0|||
149938182|NCT03098979|540912205|FG003|Overall Study|Physician Decision|0|||
149938183|NCT03098979|540912206|FG004|Overall Study|Physician Decision|0|||
149938184|NCT03098979|540912207|FG005|Overall Study|Physician Decision|0|||
149938185|NCT03098979|540912202|FG000|Overall Study|Non-compliance|0|||
150271927|NCT02308007|542134811|FG002|Overall Study|Positive for STD at Baseline|7|||
150271928|NCT02308007|542134809|FG000|Overall Study|Lost to Follow-up|3|||
150271929|NCT02308007|542134810|FG001|Overall Study|Lost to Follow-up|0|||
150271930|NCT02308007|542134811|FG002|Overall Study|Lost to Follow-up|1|||
150271931|NCT00528567|542134812|FG000|Overall Study|Death|4|||
150271932|NCT00528567|542134813|FG001|Overall Study|Death|5|||
149938186|NCT03098979|540912203|FG001|Overall Study|Non-compliance|0|||
149938187|NCT03098979|540912204|FG002|Overall Study|Non-compliance|0|||
149938188|NCT03098979|540912205|FG003|Overall Study|Non-compliance|0|||
149938189|NCT03098979|540912206|FG004|Overall Study|Non-compliance|0|||
149938190|NCT03098979|540912207|FG005|Overall Study|Non-compliance|1|||
149938191|NCT03098979|540912202|FG000|Overall Study|Protocol Violation|0|||
149938192|NCT03098979|540912203|FG001|Overall Study|Protocol Violation|0|||
149938193|NCT03098979|540912204|FG002|Overall Study|Protocol Violation|0|||
150271933|NCT00528567|542134812|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
150271934|NCT00528567|542134813|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
150271935|NCT00528567|542134812|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
150271936|NCT00528567|542134813|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
150271937|NCT00528567|542134812|FG000|Overall Study|Violation Criteria at Entry|3|||
150271938|NCT00528567|542134813|FG001|Overall Study|Violation Criteria at Entry|17|||
150271939|NCT00528567|542134812|FG000|Overall Study|Withdrew Consent|59|||
150271940|NCT00528567|542134813|FG001|Overall Study|Withdrew Consent|55|||
150271941|NCT00528567|542134812|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
150271942|NCT00528567|542134813|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
150271943|NCT00528567|542134812|FG000|Overall Study|Failure to Return|1|||
150271944|NCT00528567|542134813|FG001|Overall Study|Failure to Return|4|||
150271945|NCT00528567|542134812|FG000|Overall Study|Other Protocol Violation|5|||
150271946|NCT00528567|542134813|FG001|Overall Study|Other Protocol Violation|21|||
150271947|NCT00528567|542134812|FG000|Overall Study|Administrative/Other|22|||
150271948|NCT00528567|542134813|FG001|Overall Study|Administrative/Other|75|||
150271949|NCT03085758|542134818|FG000|Overall Study|Death|26|||
150271950|NCT03085758|542134819|FG001|Overall Study|Death|24|||
150271951|NCT03085758|542134820|FG002|Overall Study|Death|53|||
150271952|NCT03085758|542134818|FG000|Overall Study|Lost to Follow-up|1|||
150271953|NCT03085758|542134819|FG001|Overall Study|Lost to Follow-up|1|||
150271954|NCT03085758|542134820|FG002|Overall Study|Lost to Follow-up|1|||
149938194|NCT03098979|540912205|FG003|Overall Study|Protocol Violation|0|||
149938195|NCT03098979|540912206|FG004|Overall Study|Protocol Violation|0|||
150271955|NCT03085758|542134818|FG000|Overall Study|Withdrawal by Subject|2|||
150271956|NCT03085758|542134819|FG001|Overall Study|Withdrawal by Subject|2|||
150271957|NCT03085758|542134820|FG002|Overall Study|Withdrawal by Subject|1|||
150271958|NCT03085758|542134818|FG000|Overall Study|Refusal to recall it up to day 90|0|||
150271959|NCT03085758|542134819|FG001|Overall Study|Refusal to recall it up to day 90|0|||
150271960|NCT03085758|542134820|FG002|Overall Study|Refusal to recall it up to day 90|1|||
150271961|NCT03085758|542134818|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
150271962|NCT03085758|542134819|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
150271963|NCT03085758|542134820|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
149938196|NCT03098979|540912207|FG005|Overall Study|Protocol Violation|1|||
149938197|NCT02419807|540912208|FG000|Overall Study|Withdrawal by Subject|4|||
150271964|NCT01122576|542134821|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
150271965|NCT01122576|542134822|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
149938198|NCT02419807|540912208|FG000|Overall Study|Physician Decision|1|||
149938199|NCT02419807|540912208|FG000|Overall Study|Protocol Violation|5|||
149938200|NCT01065818|540912209|FG000|Overall Study|Withdrawal by Subject|1|||
149938201|NCT01065818|540912209|FG000|Overall Study|Not a candidate for surgery|1|||
149820418|NCT01722266|540471806|FG002|Overall Study|Dropped out due to Nausea|2|||
149938202|NCT04459338|540912212|FG000|Overall Study|Loss of IV during study|1|||
149820419|NCT01722266|540471807|FG003|Overall Study|Dropped out due to Nausea|0|||
149938203|NCT04459338|540912213|FG001|Overall Study|Loss of IV during study|0|||
150031143|NCT01791244|541252563|FG000|Overall Study|Adverse Event|5|||
150271966|NCT01122576|542134823|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
150271967|NCT01122576|542134821|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
150271968|NCT01122576|542134822|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
150271969|NCT01122576|542134823|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
150271970|NCT01122576|542134821|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
150271971|NCT01122576|542134822|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
150271972|NCT01122576|542134823|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
150271973|NCT05696236|542134824|FG000|Overall Study|Lost to Follow-up|1|||
150271974|NCT05696236|542134825|FG001|Overall Study|Lost to Follow-up|0|||
150271975|NCT05696236|542134824|FG000|Overall Study|Later determined to not be eligible for participation|0|||
150271976|NCT05696236|542134825|FG001|Overall Study|Later determined to not be eligible for participation|1|||
150271977|NCT05696236|542134824|FG000|Overall Study|Withdrawal by Subject|2|||
150271978|NCT05696236|542134825|FG001|Overall Study|Withdrawal by Subject|2|||
150271979|NCT01829360|542134826|FG000|Overall Study|Protocol Violation|0|||
150271980|NCT01829360|542134827|FG001|Overall Study|Protocol Violation|0|||
150271981|NCT01829360|542134828|FG002|Overall Study|Protocol Violation|1|||
150271982|NCT01829360|542134829|FG003|Overall Study|Protocol Violation|0|||
150271983|NCT00931944|542134834|FG000|Overall Study|Adverse Event|4|||
150271984|NCT00931944|542134834|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
150271985|NCT00931944|542134834|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
150271986|NCT00931944|542134834|FG000|Overall Study|Death|28|||
150271987|NCT00931944|542134834|FG000|Overall Study|Other|2|||
150271988|NCT01132612|542134838|FG000|Overall Study|Death|0|||
150271989|NCT01132612|542134839|FG001|Overall Study|Death|0|||
150271990|NCT01132612|542134840|FG002|Overall Study|Death|1|||
150271991|NCT01132612|542134838|FG000|Overall Study|Protocol deviation|0|||
150271992|NCT01132612|542134839|FG001|Overall Study|Protocol deviation|0|||
150271993|NCT01132612|542134840|FG002|Overall Study|Protocol deviation|3|||
150271994|NCT01132612|542134838|FG000|Overall Study|Lost to Follow-up|2|||
150271995|NCT01132612|542134839|FG001|Overall Study|Lost to Follow-up|2|||
149938204|NCT03157089|540912214|FG000|Overall Study|Treated only with pembrolizumab|1|||
149938205|NCT03157089|540912215|FG001|Overall Study|Treated only with pembrolizumab|0|||
150271996|NCT01132612|542134840|FG002|Overall Study|Lost to Follow-up|7|||
150271997|NCT01132612|542134838|FG000|Overall Study|Adverse Event|5|||
150271998|NCT01132612|542134839|FG001|Overall Study|Adverse Event|2|||
150271999|NCT01132612|542134840|FG002|Overall Study|Adverse Event|15|||
150272000|NCT01132612|542134838|FG000|Overall Study|Withdrawal by Subject|5|||
150272001|NCT01132612|542134839|FG001|Overall Study|Withdrawal by Subject|8|||
150272002|NCT01132612|542134840|FG002|Overall Study|Withdrawal by Subject|19|||
150272003|NCT01132612|542134838|FG000|Overall Study|Administrative problems|5|||
149938206|NCT03157089|540912214|FG000|Overall Study|Adverse Event|5|||
149938207|NCT03157089|540912215|FG001|Overall Study|Adverse Event|4|||
149938208|NCT03157089|540912214|FG000|Overall Study|Progressive disease|6|||
149938209|NCT03157089|540912215|FG001|Overall Study|Progressive disease|8|||
150272004|NCT01132612|542134839|FG001|Overall Study|Administrative problems|1|||
150272005|NCT01132612|542134840|FG002|Overall Study|Administrative problems|52|||
150272006|NCT01132612|542134838|FG000|Overall Study|Lack of Efficacy|23|||
150272007|NCT01132612|542134839|FG001|Overall Study|Lack of Efficacy|22|||
150272008|NCT01132612|542134840|FG002|Overall Study|Lack of Efficacy|73|||
150272009|NCT03838198|542134843|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
150272010|NCT03838198|542134844|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
150272011|NCT03838198|542134845|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
150272012|NCT03838198|542134846|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
150272013|NCT03838198|542134843|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
150272014|NCT03838198|542134844|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
150272015|NCT03838198|542134845|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
150272016|NCT03838198|542134846|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
150272017|NCT00578786|542134847|FG000|Overall Study|Adverse Event|27|||
150272018|NCT00578786|542134848|FG001|Overall Study|Adverse Event|37|||
149938210|NCT00784875|540912216|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
149938211|NCT00784875|540912217|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
150272019|NCT00578786|542134849|FG002|Overall Study|Adverse Event|17|||
150272020|NCT00578786|542134847|FG000|Overall Study|Lack of Efficacy|2|||
150272021|NCT00578786|542134848|FG001|Overall Study|Lack of Efficacy|5|||
149938212|NCT00784875|540912218|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
149938213|NCT00784875|540912219|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
149938214|NCT00784875|540912216|FG000|Period A - Baseline|Adverse Event|0|||
149938215|NCT00784875|540912217|FG001|Period A - Baseline|Adverse Event|0|||
149938216|NCT00784875|540912218|FG002|Period A - Baseline|Adverse Event|0|||
150272022|NCT00578786|542134849|FG002|Overall Study|Lack of Efficacy|2|||
150272023|NCT00578786|542134847|FG000|Overall Study|Early Escape from Prior Study|2|||
150272024|NCT00578786|542134848|FG001|Overall Study|Early Escape from Prior Study|1|||
149820420|NCT00706706|540471808|FG000|Overall Study|Death|53|||
149938217|NCT00784875|540912219|FG003|Period A - Baseline|Adverse Event|8|||
149938218|NCT00784875|540912216|FG000|Period A - Baseline|Protocol Violation|0|||
149938219|NCT00784875|540912217|FG001|Period A - Baseline|Protocol Violation|0|||
149938220|NCT00784875|540912218|FG002|Period A - Baseline|Protocol Violation|0|||
150272025|NCT00578786|542134849|FG002|Overall Study|Early Escape from Prior Study|2|||
150272026|NCT00578786|542134847|FG000|Overall Study|Withdrawal by Subject|7|||
150272027|NCT00578786|542134848|FG001|Overall Study|Withdrawal by Subject|8|||
150272028|NCT00578786|542134849|FG002|Overall Study|Withdrawal by Subject|5|||
150272029|NCT00578786|542134847|FG000|Overall Study|Protocol Violation|0|||
150272030|NCT00578786|542134848|FG001|Overall Study|Protocol Violation|3|||
150272031|NCT00578786|542134849|FG002|Overall Study|Protocol Violation|1|||
150272032|NCT00578786|542134847|FG000|Overall Study|Physician Decision|1|||
150272033|NCT00578786|542134848|FG001|Overall Study|Physician Decision|0|||
150272034|NCT00578786|542134849|FG002|Overall Study|Physician Decision|1|||
150272035|NCT00578786|542134847|FG000|Overall Study|Sponsor Decision|0|||
150272036|NCT00578786|542134848|FG001|Overall Study|Sponsor Decision|0|||
150272037|NCT00578786|542134849|FG002|Overall Study|Sponsor Decision|1|||
150272038|NCT00578786|542134847|FG000|Overall Study|Lost to Follow-up|0|||
149938221|NCT00784875|540912219|FG003|Period A - Baseline|Protocol Violation|25|||
150272039|NCT00578786|542134848|FG001|Overall Study|Lost to Follow-up|4|||
150272040|NCT00578786|542134849|FG002|Overall Study|Lost to Follow-up|0|||
150272041|NCT00578786|542134847|FG000|Overall Study|Pregnancy|0|||
150272042|NCT00578786|542134848|FG001|Overall Study|Pregnancy|1|||
150272043|NCT00578786|542134849|FG002|Overall Study|Pregnancy|0|||
150272044|NCT00578786|542134847|FG000|Overall Study|Not Otherwise Specified|0|||
150272045|NCT00578786|542134848|FG001|Overall Study|Not Otherwise Specified|4|||
150272046|NCT00578786|542134849|FG002|Overall Study|Not Otherwise Specified|1|||
150272047|NCT00578786|542134847|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
150272048|NCT00578786|542134848|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
150272049|NCT00578786|542134849|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
150272050|NCT00312221|542134850|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
150272051|NCT00312221|542134851|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
150272052|NCT00312221|542134852|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
150272053|NCT00312221|542134853|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
150272054|NCT00312221|542134850|FG000|Open-label Run-in Period|Adverse Event|74|||
150272055|NCT00312221|542134851|FG001|Open-label Run-in Period|Adverse Event|0|||
150272056|NCT00312221|542134852|FG002|Open-label Run-in Period|Adverse Event|0|||
150272057|NCT00312221|542134853|FG003|Open-label Run-in Period|Adverse Event|0|||
150272058|NCT00312221|542134850|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
150272059|NCT00312221|542134851|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
150272060|NCT00312221|542134852|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
150272061|NCT00312221|542134853|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
150272062|NCT00312221|542134850|FG000|Open-label Run-in Period|Administrative|42|||
150272063|NCT00312221|542134851|FG001|Open-label Run-in Period|Administrative|0|||
150272064|NCT00312221|542134852|FG002|Open-label Run-in Period|Administrative|0|||
150272065|NCT00312221|542134853|FG003|Open-label Run-in Period|Administrative|0|||
150272066|NCT00312221|542134850|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
150272067|NCT00312221|542134851|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
150272068|NCT00312221|542134852|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
150272069|NCT00312221|542134853|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
150272070|NCT00312221|542134850|FG000|Open-label Run-in Period|Did not qualify|5|||
150272071|NCT00312221|542134851|FG001|Open-label Run-in Period|Did not qualify|0|||
150272072|NCT00312221|542134852|FG002|Open-label Run-in Period|Did not qualify|0|||
150272073|NCT00312221|542134853|FG003|Open-label Run-in Period|Did not qualify|0|||
150272074|NCT00312221|542134850|FG000|Double-blind Phase|Withdrawal by Subject|0|||
150272075|NCT00312221|542134851|FG001|Double-blind Phase|Withdrawal by Subject|6|||
150272076|NCT00312221|542134852|FG002|Double-blind Phase|Withdrawal by Subject|8|||
150272077|NCT00312221|542134853|FG003|Double-blind Phase|Withdrawal by Subject|7|||
150272078|NCT00312221|542134850|FG000|Double-blind Phase|Adverse Event|0|||
150272079|NCT00312221|542134851|FG001|Double-blind Phase|Adverse Event|10|||
150272080|NCT00312221|542134852|FG002|Double-blind Phase|Adverse Event|19|||
150272081|NCT00312221|542134853|FG003|Double-blind Phase|Adverse Event|18|||
149938222|NCT00784875|540912216|FG000|Period A - Baseline|Withdrawal by Subject|0|||
150272082|NCT00312221|542134850|FG000|Double-blind Phase|Lost to Follow-up|0|||
150272083|NCT00312221|542134851|FG001|Double-blind Phase|Lost to Follow-up|0|||
150272084|NCT00312221|542134852|FG002|Double-blind Phase|Lost to Follow-up|2|||
150272085|NCT00312221|542134853|FG003|Double-blind Phase|Lost to Follow-up|2|||
150272086|NCT00312221|542134850|FG000|Double-blind Phase|Administrative|0|||
150272087|NCT00312221|542134851|FG001|Double-blind Phase|Administrative|26|||
150272088|NCT00312221|542134852|FG002|Double-blind Phase|Administrative|37|||
150272089|NCT00312221|542134853|FG003|Double-blind Phase|Administrative|33|||
150272090|NCT00312221|542134850|FG000|Double-blind Phase|Lack of Efficacy|0|||
150272091|NCT00312221|542134851|FG001|Double-blind Phase|Lack of Efficacy|17|||
150272092|NCT00312221|542134852|FG002|Double-blind Phase|Lack of Efficacy|6|||
150272093|NCT00312221|542134853|FG003|Double-blind Phase|Lack of Efficacy|10|||
150272094|NCT02060721|542134854|FG000|Overall Study|Lost to Follow-up|1|||
150272095|NCT02060721|542134854|FG000|Overall Study|Physician Decision|2|||
150272096|NCT02060721|542134854|FG000|Overall Study|Death|14|||
150272097|NCT02060721|542134854|FG000|Overall Study|Withdrawal by Subject|2|||
150272098|NCT02060721|542134854|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
150272099|NCT00866723|542134855|FG000|Overall Study|Withdrawal by Subject|1|||
150272100|NCT00866723|542134855|FG000|Overall Study|Disease Progression|4|||
150272101|NCT04178967|542134859|FG000|Induction Period|Adverse Event|4|||
150272102|NCT04178967|542134860|FG001|Induction Period|Adverse Event|6|||
150272103|NCT04178967|542134861|FG002|Induction Period|Adverse Event|0|||
150272104|NCT04178967|542134862|FG003|Induction Period|Adverse Event|0|||
150272105|NCT04178967|542134863|FG004|Induction Period|Adverse Event|0|||
150272106|NCT04178967|542134864|FG005|Induction Period|Adverse Event|0|||
150272107|NCT04178967|542134865|FG006|Induction Period|Adverse Event|0|||
150272108|NCT04178967|542134866|FG007|Induction Period|Adverse Event|0|||
150272109|NCT04178967|542134867|FG008|Induction Period|Adverse Event|0|||
150272110|NCT04178967|542134868|FG009|Induction Period|Adverse Event|0|||
150272111|NCT04178967|542134869|FG010|Induction Period|Adverse Event|0|||
150272112|NCT04178967|542134859|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
150272113|NCT04178967|542134860|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
150272114|NCT04178967|542134861|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
150272115|NCT04178967|542134862|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
150272116|NCT04178967|542134863|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
150272117|NCT04178967|542134864|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
150272118|NCT04178967|542134865|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
150272119|NCT04178967|542134866|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
150272120|NCT04178967|542134867|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
150272121|NCT04178967|542134868|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
150272122|NCT04178967|542134869|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
150272123|NCT04178967|542134859|FG000|Induction Period|Lack of Efficacy|4|||
150272124|NCT04178967|542134860|FG001|Induction Period|Lack of Efficacy|1|||
150272125|NCT04178967|542134861|FG002|Induction Period|Lack of Efficacy|0|||
150272126|NCT04178967|542134862|FG003|Induction Period|Lack of Efficacy|0|||
150272127|NCT04178967|542134863|FG004|Induction Period|Lack of Efficacy|0|||
150272128|NCT04178967|542134864|FG005|Induction Period|Lack of Efficacy|0|||
150272129|NCT04178967|542134865|FG006|Induction Period|Lack of Efficacy|0|||
150272130|NCT04178967|542134866|FG007|Induction Period|Lack of Efficacy|0|||
150272131|NCT04178967|542134867|FG008|Induction Period|Lack of Efficacy|0|||
150272132|NCT04178967|542134868|FG009|Induction Period|Lack of Efficacy|0|||
150272133|NCT04178967|542134869|FG010|Induction Period|Lack of Efficacy|0|||
150272134|NCT04178967|542134859|FG000|Induction Period|Protocol Violation|0|||
150272135|NCT04178967|542134860|FG001|Induction Period|Protocol Violation|6|||
150272136|NCT04178967|542134861|FG002|Induction Period|Protocol Violation|0|||
150272137|NCT04178967|542134862|FG003|Induction Period|Protocol Violation|0|||
150272138|NCT04178967|542134863|FG004|Induction Period|Protocol Violation|0|||
150272139|NCT04178967|542134864|FG005|Induction Period|Protocol Violation|0|||
150272140|NCT04178967|542134865|FG006|Induction Period|Protocol Violation|0|||
150272141|NCT04178967|542134866|FG007|Induction Period|Protocol Violation|0|||
150272142|NCT04178967|542134867|FG008|Induction Period|Protocol Violation|0|||
150272143|NCT04178967|542134868|FG009|Induction Period|Protocol Violation|0|||
150272144|NCT04178967|542134869|FG010|Induction Period|Protocol Violation|0|||
150272145|NCT04178967|542134859|FG000|Induction Period|Withdrawal by Subject|6|||
150272146|NCT04178967|542134860|FG001|Induction Period|Withdrawal by Subject|4|||
150272147|NCT04178967|542134861|FG002|Induction Period|Withdrawal by Subject|0|||
150272148|NCT04178967|542134862|FG003|Induction Period|Withdrawal by Subject|0|||
150272149|NCT04178967|542134863|FG004|Induction Period|Withdrawal by Subject|0|||
150272150|NCT04178967|542134864|FG005|Induction Period|Withdrawal by Subject|0|||
150272151|NCT04178967|542134865|FG006|Induction Period|Withdrawal by Subject|0|||
150272152|NCT04178967|542134866|FG007|Induction Period|Withdrawal by Subject|0|||
150272153|NCT04178967|542134867|FG008|Induction Period|Withdrawal by Subject|0|||
150272154|NCT04178967|542134868|FG009|Induction Period|Withdrawal by Subject|0|||
150272155|NCT04178967|542134869|FG010|Induction Period|Withdrawal by Subject|0|||
150272156|NCT04178967|542134859|FG000|Induction Period|Lost to Follow-up|2|||
150272157|NCT04178967|542134860|FG001|Induction Period|Lost to Follow-up|0|||
150272158|NCT04178967|542134861|FG002|Induction Period|Lost to Follow-up|0|||
150272159|NCT04178967|542134862|FG003|Induction Period|Lost to Follow-up|0|||
150272160|NCT04178967|542134863|FG004|Induction Period|Lost to Follow-up|0|||
150272161|NCT04178967|542134864|FG005|Induction Period|Lost to Follow-up|0|||
150272162|NCT04178967|542134865|FG006|Induction Period|Lost to Follow-up|0|||
150272163|NCT04178967|542134866|FG007|Induction Period|Lost to Follow-up|0|||
150272164|NCT04178967|542134867|FG008|Induction Period|Lost to Follow-up|0|||
150272165|NCT04178967|542134868|FG009|Induction Period|Lost to Follow-up|0|||
150272166|NCT04178967|542134869|FG010|Induction Period|Lost to Follow-up|0|||
150272167|NCT04178967|542134859|FG000|Induction Period|Participant Missed Study Visits|0|||
150272168|NCT04178967|542134860|FG001|Induction Period|Participant Missed Study Visits|1|||
150272169|NCT04178967|542134861|FG002|Induction Period|Participant Missed Study Visits|0|||
150272170|NCT04178967|542134862|FG003|Induction Period|Participant Missed Study Visits|0|||
150272171|NCT04178967|542134863|FG004|Induction Period|Participant Missed Study Visits|0|||
150272172|NCT04178967|542134864|FG005|Induction Period|Participant Missed Study Visits|0|||
150272173|NCT04178967|542134865|FG006|Induction Period|Participant Missed Study Visits|0|||
150272174|NCT04178967|542134866|FG007|Induction Period|Participant Missed Study Visits|0|||
150272175|NCT04178967|542134867|FG008|Induction Period|Participant Missed Study Visits|0|||
150272176|NCT04178967|542134868|FG009|Induction Period|Participant Missed Study Visits|0|||
150272177|NCT04178967|542134869|FG010|Induction Period|Participant Missed Study Visits|0|||
150272178|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272179|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272180|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272181|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272182|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272183|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
150272184|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
150272185|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
150272186|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272187|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
149820421|NCT00706706|540471808|FG000|Overall Study|Lost to Follow-up|7|||
149820422|NCT00706706|540471808|FG000|Overall Study|Study endpoint had reached|45|||
149820423|NCT02191579|540471809|FG000|Treatment 1|Multiple Reasons Specified|27|||
149820424|NCT02191579|540471810|FG001|Treatment 1|Multiple Reasons Specified|58|||
149820425|NCT02191579|540471809|FG000|Treatment 2|Multiple Reasons Specified|0|||
149820426|NCT02191579|540471810|FG001|Treatment 2|Multiple Reasons Specified|25|||
149820427|NCT00331630|540473616|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
149820428|NCT00331630|540473616|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
149820429|NCT00331630|540473616|FG000|Follow up for 5 Years|Death|5|||
149820430|NCT00331630|540473616|FG000|Follow up for 5 Years|Data collection was stopped|24|||
149820431|NCT01133821|540473617|FG000|Overall Study|Lost to Follow-up|8|||
149820432|NCT01133821|540473618|FG001|Overall Study|Lost to Follow-up|11|||
149820433|NCT01133821|540473617|FG000|Overall Study|Withdrawal by Subject|8|||
149820434|NCT01133821|540473618|FG001|Overall Study|Withdrawal by Subject|3|||
149820435|NCT01133821|540473617|FG000|Overall Study|preferred other treatment|1|||
149820436|NCT01133821|540473618|FG001|Overall Study|preferred other treatment|1|||
149820437|NCT01133821|540473617|FG000|Overall Study|Protocol Violation|0|||
149820438|NCT01133821|540473618|FG001|Overall Study|Protocol Violation|1|||
149820439|NCT01133821|540473617|FG000|Overall Study|Refused participation|1|||
149820440|NCT01133821|540473618|FG001|Overall Study|Refused participation|3|||
149820441|NCT02038634|540473625|FG000|Overall Study|Lost to Follow-up|0|||
149820442|NCT02038634|540473626|FG001|Overall Study|Lost to Follow-up|1|||
149820443|NCT02763579|540473628|FG000|Global Period|Death|167|||
149820444|NCT02763579|540473629|FG001|Global Period|Death|151|||
149820445|NCT02763579|540473630|FG002|Global Period|Death|0|||
149820446|NCT02763579|540473631|FG003|Global Period|Death|0|||
149820447|NCT02763579|540473628|FG000|Global Period|Lost to Follow-up|2|||
149820448|NCT02763579|540473629|FG001|Global Period|Lost to Follow-up|4|||
149820449|NCT02763579|540473630|FG002|Global Period|Lost to Follow-up|0|||
150272188|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
150272189|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272190|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149820450|NCT02763579|540473631|FG003|Global Period|Lost to Follow-up|0|||
149820451|NCT02763579|540473628|FG000|Global Period|Physician Decision|0|||
149820452|NCT02763579|540473629|FG001|Global Period|Physician Decision|2|||
149820453|NCT02763579|540473630|FG002|Global Period|Physician Decision|0|||
149820454|NCT02763579|540473631|FG003|Global Period|Physician Decision|0|||
149820455|NCT02763579|540473628|FG000|Global Period|Study Terminated By Sponsor|21|||
149820456|NCT02763579|540473629|FG001|Global Period|Study Terminated By Sponsor|26|||
149820457|NCT02763579|540473630|FG002|Global Period|Study Terminated By Sponsor|0|||
149820458|NCT02763579|540473631|FG003|Global Period|Study Terminated By Sponsor|0|||
149820459|NCT02763579|540473628|FG000|Global Period|Withdrawal by Subject|12|||
149820460|NCT02763579|540473629|FG001|Global Period|Withdrawal by Subject|18|||
149938223|NCT00784875|540912217|FG001|Period A - Baseline|Withdrawal by Subject|0|||
149938224|NCT00784875|540912218|FG002|Period A - Baseline|Withdrawal by Subject|0|||
149938225|NCT00784875|540912219|FG003|Period A - Baseline|Withdrawal by Subject|27|||
149938226|NCT00784875|540912216|FG000|Period A - Baseline|Physician Decision|0|||
149820461|NCT02763579|540473630|FG002|Global Period|Withdrawal by Subject|0|||
149820462|NCT02763579|540473631|FG003|Global Period|Withdrawal by Subject|0|||
149938227|NCT00784875|540912217|FG001|Period A - Baseline|Physician Decision|0|||
149938228|NCT00784875|540912218|FG002|Period A - Baseline|Physician Decision|0|||
149938229|NCT00784875|540912219|FG003|Period A - Baseline|Physician Decision|2|||
149820463|NCT02763579|540473628|FG000|China Period|Death|0|||
149820464|NCT02763579|540473629|FG001|China Period|Death|0|||
149820465|NCT02763579|540473630|FG002|China Period|Death|46|||
149938230|NCT00784875|540912216|FG000|Period A - Baseline|Sponsor Decision|0|||
149820466|NCT02763579|540473631|FG003|China Period|Death|48|||
149820467|NCT02763579|540473628|FG000|China Period|Lost to Follow-up|0|||
149820468|NCT02763579|540473629|FG001|China Period|Lost to Follow-up|0|||
149820469|NCT02763579|540473630|FG002|China Period|Lost to Follow-up|1|||
149820470|NCT02763579|540473631|FG003|China Period|Lost to Follow-up|1|||
149820471|NCT02763579|540473628|FG000|China Period|Physician Decision|0|||
149820472|NCT02763579|540473629|FG001|China Period|Physician Decision|0|||
149820473|NCT02763579|540473630|FG002|China Period|Physician Decision|0|||
149820474|NCT02763579|540473631|FG003|China Period|Physician Decision|1|||
149820475|NCT02763579|540473628|FG000|China Period|Study Terminated By Sponsor|0|||
149820476|NCT02763579|540473629|FG001|China Period|Study Terminated By Sponsor|0|||
149820477|NCT02763579|540473630|FG002|China Period|Study Terminated By Sponsor|3|||
149820478|NCT02763579|540473631|FG003|China Period|Study Terminated By Sponsor|4|||
149820479|NCT02763579|540473628|FG000|China Period|Withdrawal by Subject|0|||
149820480|NCT02763579|540473629|FG001|China Period|Withdrawal by Subject|0|||
149820481|NCT02763579|540473630|FG002|China Period|Withdrawal by Subject|3|||
149820482|NCT02763579|540473631|FG003|China Period|Withdrawal by Subject|3|||
149820483|NCT02668783|540473635|FG000|Overall Study|Pregnancy|0|||
149820484|NCT02668783|540473636|FG001|Overall Study|Pregnancy|1|||
149820485|NCT02668783|540473635|FG000|Overall Study|Protocol Violation|2|||
149820486|NCT02668783|540473636|FG001|Overall Study|Protocol Violation|1|||
149820487|NCT02668783|540473635|FG000|Overall Study|Study terminated by sponsor|9|||
149820488|NCT02668783|540473636|FG001|Overall Study|Study terminated by sponsor|10|||
149820489|NCT02668783|540473635|FG000|Overall Study|Subject moved|1|||
149820490|NCT02668783|540473636|FG001|Overall Study|Subject moved|0|||
149820491|NCT02668783|540473635|FG000|Overall Study|Withdrawal by Subject|1|||
149820492|NCT02668783|540473636|FG001|Overall Study|Withdrawal by Subject|0|||
149820493|NCT00112489|540473637|FG000|Overall Study|Refused further treatment|8|||
149820494|NCT00112489|540473637|FG000|Overall Study|Adverse Event|12|||
149820495|NCT00112489|540473637|FG000|Overall Study|Death|2|||
149820496|NCT00112489|540473637|FG000|Overall Study|Other, Not Specified|9|||
149820497|NCT00112489|540473637|FG000|Overall Study|Patient never treated|2|||
149820498|NCT00112489|540473637|FG000|Overall Study|Ineligible|7|||
149820499|NCT04467697|540473639|FG000|Overall Study|Adverse Event|2|||
149820500|NCT04467697|540473639|FG000|Overall Study|Lost to Follow-up|6|||
149820501|NCT04467697|540473639|FG000|Overall Study|Withdrawal by Subject|9|||
149820502|NCT04467697|540473639|FG000|Overall Study|Protocol Violation|3|||
149820503|NCT05751629|540473640|FG000|Overall Study|Withdrawal by Subject|6|||
149820504|NCT05751629|540473640|FG000|Overall Study|Death|25|||
149820505|NCT05751629|540473640|FG000|Overall Study|Study Site Closed|9|||
149820506|NCT05751629|540473640|FG000|Overall Study|Physician Decision|1|||
149820507|NCT01909466|540473641|FG000|Overall Study|Lost to Follow-up|5|||
149820508|NCT01909466|540473642|FG001|Overall Study|Lost to Follow-up|7|||
149820509|NCT01909466|540473641|FG000|Overall Study|Adverse Event|3|||
149820510|NCT01909466|540473642|FG001|Overall Study|Adverse Event|4|||
149820511|NCT01909466|540473641|FG000|Overall Study|Met Withdrawal Criteria|0|||
149820512|NCT01909466|540473642|FG001|Overall Study|Met Withdrawal Criteria|3|||
149820513|NCT01909466|540473641|FG000|Overall Study|Physician Decision|2|||
149820514|NCT01909466|540473642|FG001|Overall Study|Physician Decision|0|||
149820515|NCT01909466|540473641|FG000|Overall Study|Withdrawal by Subject|11|||
149820516|NCT01909466|540473642|FG001|Overall Study|Withdrawal by Subject|9|||
149820517|NCT01909466|540473641|FG000|Overall Study|Lack of Efficacy|1|||
149820518|NCT01909466|540473642|FG001|Overall Study|Lack of Efficacy|0|||
149820519|NCT02231710|540473643|FG000|Overall Study|Physician Decision|1|||
149820520|NCT00673361|540473647|FG000|Overall Study|Screen Failure|2|||
149820521|NCT00124020|540473648|FG000|Overall Study|Death|67|||
149820522|NCT00124020|540473649|FG001|Overall Study|Death|71|||
149820523|NCT00124020|540473648|FG000|Overall Study|Withdrawal by Subject|13|||
149820524|NCT00124020|540473649|FG001|Overall Study|Withdrawal by Subject|11|||
149820525|NCT00124020|540473648|FG000|Overall Study|Lost to Follow-up|5|||
149820526|NCT00124020|540473649|FG001|Overall Study|Lost to Follow-up|8|||
149820527|NCT00124020|540473648|FG000|Overall Study|Other|1|||
149820528|NCT00124020|540473649|FG001|Overall Study|Other|1|||
149820529|NCT00124020|540473648|FG000|Overall Study|Transfer to another hospital|2|||
149820530|NCT00124020|540473649|FG001|Overall Study|Transfer to another hospital|0|||
150272191|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149820531|NCT00268346|540473650|FG000|Overall Study|Adverse Event|0|||
149820532|NCT00268346|540473651|FG001|Overall Study|Adverse Event|1|||
149820533|NCT00268346|540473650|FG000|Overall Study|Death|0|||
149820534|NCT00268346|540473651|FG001|Overall Study|Death|1|||
149820535|NCT00268346|540473650|FG000|Overall Study|Withdrawal by Subject|0|||
149820536|NCT00268346|540473651|FG001|Overall Study|Withdrawal by Subject|1|||
149820537|NCT01799590|540473652|FG000|Overall Study|Adverse Event|13|||
149820538|NCT01799590|540473653|FG001|Overall Study|Adverse Event|7|||
149820539|NCT01799590|540473654|FG002|Overall Study|Adverse Event|5|||
149820540|NCT01799590|540473652|FG000|Overall Study|Pregnancy|2|||
149820541|NCT01799590|540473653|FG001|Overall Study|Pregnancy|0|||
149820542|NCT01799590|540473654|FG002|Overall Study|Pregnancy|0|||
149820543|NCT01799590|540473652|FG000|Overall Study|Lack of Efficacy|3|||
149820544|NCT01799590|540473653|FG001|Overall Study|Lack of Efficacy|1|||
149938231|NCT00784875|540912217|FG001|Period A - Baseline|Sponsor Decision|0|||
149938232|NCT00784875|540912218|FG002|Period A - Baseline|Sponsor Decision|0|||
149938233|NCT00784875|540912219|FG003|Period A - Baseline|Sponsor Decision|113|||
149938234|NCT00784875|540912216|FG000|Period A - Baseline|Lost to Follow-up|0|||
149938235|NCT00784875|540912217|FG001|Period A - Baseline|Lost to Follow-up|0|||
150272192|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272193|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272194|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
150272195|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272196|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272197|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272198|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272199|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
150272200|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272201|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272202|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272203|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
150272204|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272205|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272206|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272207|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272208|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272209|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272210|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
150272211|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272212|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272213|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272214|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272215|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272216|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272217|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
150272218|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272219|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272220|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272221|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
150272222|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272223|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272224|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272225|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272226|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
150272227|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
150272228|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272229|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
150272230|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272231|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272232|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
150272233|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
150272234|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
150272235|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
150272236|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
150272237|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
150272238|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
150272239|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
150272240|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
150272241|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
150272242|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
150272243|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
150272244|NCT04178967|542134859|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272245|NCT04178967|542134860|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272246|NCT04178967|542134861|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272247|NCT04178967|542134862|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
150272248|NCT04178967|542134863|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149938236|NCT00784875|540912218|FG002|Period A - Baseline|Lost to Follow-up|0|||
149938237|NCT00784875|540912219|FG003|Period A - Baseline|Lost to Follow-up|2|||
150031144|NCT01791244|541252564|FG001|Overall Study|Adverse Event|7|||
149820545|NCT01799590|540473654|FG002|Overall Study|Lack of Efficacy|3|||
149820546|NCT01799590|540473652|FG000|Overall Study|Participants convenience|4|||
149820547|NCT01799590|540473653|FG001|Overall Study|Participants convenience|4|||
149820548|NCT01799590|540473654|FG002|Overall Study|Participants convenience|2|||
149820549|NCT01799590|540473652|FG000|Overall Study|Aggravation of complications|0|||
149820550|NCT01799590|540473653|FG001|Overall Study|Aggravation of complications|1|||
150272249|NCT04178967|542134864|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
150272250|NCT04178967|542134865|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
150272251|NCT04178967|542134866|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
150272252|NCT04178967|542134867|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272253|NCT04178967|542134868|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272254|NCT04178967|542134869|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150272255|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272256|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272257|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272258|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272259|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272260|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272261|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272262|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272263|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
150272264|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
150272265|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
150272266|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272267|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272268|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272269|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272270|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272271|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272272|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272273|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
150272274|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
150272275|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
150272276|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
150272277|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272278|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272279|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272280|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272281|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272282|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272283|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272284|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272285|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272286|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
150272287|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
150272288|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272289|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272290|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272291|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272292|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272293|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272294|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272295|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150272296|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
150272297|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
150272298|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
150272299|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272300|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272301|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272302|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272303|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272304|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272305|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272306|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272307|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272308|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
149820551|NCT01799590|540473654|FG002|Overall Study|Aggravation of complications|1|||
150272309|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
150272310|NCT04178967|542134859|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272311|NCT04178967|542134860|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272312|NCT04178967|542134861|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272313|NCT04178967|542134862|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272314|NCT04178967|542134863|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272315|NCT04178967|542134864|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272316|NCT04178967|542134865|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272317|NCT04178967|542134866|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272318|NCT04178967|542134867|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272319|NCT04178967|542134868|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
150272320|NCT04178967|542134869|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
150272321|NCT02608879|542134872|FG000|Overall Study|Lost to Follow-up|1|||
150272322|NCT02608879|542134873|FG001|Overall Study|Lost to Follow-up|0|||
150272323|NCT02608879|542134874|FG002|Overall Study|Lost to Follow-up|0|||
150272324|NCT02608879|542134872|FG000|Overall Study|Did not meet continuation criteria|0|||
150272325|NCT02608879|542134873|FG001|Overall Study|Did not meet continuation criteria|0|||
150272326|NCT02608879|542134874|FG002|Overall Study|Did not meet continuation criteria|3|||
150272327|NCT04409353|542134877|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
150272328|NCT04409353|542134878|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
150272329|NCT04409353|542134879|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
150272330|NCT04409353|542134877|FG000|Overall Study|Lost to Follow-up|6|||
150272331|NCT04409353|542134878|FG001|Overall Study|Lost to Follow-up|8|||
150272332|NCT04409353|542134879|FG002|Overall Study|Lost to Follow-up|7|||
150272333|NCT04409353|542134877|FG000|Overall Study|Major surgery during participation window|4|||
150272334|NCT04409353|542134878|FG001|Overall Study|Major surgery during participation window|3|||
150272335|NCT04409353|542134879|FG002|Overall Study|Major surgery during participation window|3|||
150272336|NCT04409353|542134877|FG000|Overall Study|Life event occurred during participation window|3|||
150272337|NCT04409353|542134878|FG001|Overall Study|Life event occurred during participation window|2|||
150272338|NCT04409353|542134879|FG002|Overall Study|Life event occurred during participation window|4|||
150272339|NCT04409353|542134877|FG000|Overall Study|Lack of Efficacy|4|||
150272340|NCT04409353|542134878|FG001|Overall Study|Lack of Efficacy|1|||
150272341|NCT04409353|542134879|FG002|Overall Study|Lack of Efficacy|3|||
150272342|NCT04409353|542134877|FG000|Overall Study|Adverse Event|2|||
150272343|NCT04409353|542134878|FG001|Overall Study|Adverse Event|1|||
150272344|NCT04409353|542134879|FG002|Overall Study|Adverse Event|1|||
150272345|NCT04409353|542134877|FG000|Overall Study|Disease burden - unable to participate|0|||
150272346|NCT04409353|542134878|FG001|Overall Study|Disease burden - unable to participate|1|||
150272347|NCT04409353|542134879|FG002|Overall Study|Disease burden - unable to participate|1|||
150272348|NCT04409353|542134877|FG000|Overall Study|Intervention too complicated|1|||
150272349|NCT04409353|542134878|FG001|Overall Study|Intervention too complicated|0|||
150272350|NCT04409353|542134879|FG002|Overall Study|Intervention too complicated|1|||
150272351|NCT02499770|542134881|FG000|Overall Study|Death|17|||
150272352|NCT02499770|542134882|FG001|Overall Study|Death|56|||
150272353|NCT02499770|542134881|FG000|Overall Study|Study completion|1|||
150272354|NCT02499770|542134882|FG001|Overall Study|Study completion|10|||
150272355|NCT02499770|542134881|FG000|Overall Study|Withdrawal by Subject|0|||
150272356|NCT02499770|542134882|FG001|Overall Study|Withdrawal by Subject|7|||
150272357|NCT02499770|542134881|FG000|Overall Study|Lost to Follow-up|0|||
150272358|NCT02499770|542134882|FG001|Overall Study|Lost to Follow-up|2|||
150272359|NCT02499770|542134881|FG000|Overall Study|Subject declined further treatment|1|||
150272360|NCT02499770|542134882|FG001|Overall Study|Subject declined further treatment|0|||
150168953|NCT02163915|541752636|FG003|Overall Study|Withdrawal by Subject|2|||
150168954|NCT02163915|541752637|FG004|Overall Study|Withdrawal by Subject|2|||
150168955|NCT02163915|541752633|FG000|Overall Study|Study termination|1|||
150168956|NCT02163915|541752634|FG001|Overall Study|Study termination|0|||
150168957|NCT02163915|541752635|FG002|Overall Study|Study termination|0|||
150168958|NCT02163915|541752636|FG003|Overall Study|Study termination|0|||
150168959|NCT02163915|541752637|FG004|Overall Study|Study termination|2|||
150168960|NCT02163915|541752633|FG000|Overall Study|Physician Decision|0|||
150168961|NCT02163915|541752634|FG001|Overall Study|Physician Decision|0|||
150168962|NCT02163915|541752635|FG002|Overall Study|Physician Decision|0|||
150168963|NCT02163915|541752636|FG003|Overall Study|Physician Decision|1|||
150168964|NCT02163915|541752637|FG004|Overall Study|Physician Decision|0|||
150168965|NCT00603447|541752638|FG000|Overall Study|Adverse Event|0|||
150168966|NCT00603447|541752639|FG001|Overall Study|Adverse Event|1|||
150168967|NCT00603447|541752640|FG002|Overall Study|Adverse Event|1|||
150168968|NCT00603447|541752641|FG003|Overall Study|Adverse Event|2|||
150168969|NCT00603447|541752642|FG004|Overall Study|Adverse Event|1|||
150168970|NCT00603447|541752643|FG005|Overall Study|Adverse Event|2|||
150168971|NCT00603447|541752644|FG006|Overall Study|Adverse Event|10|||
150168972|NCT00603447|541752638|FG000|Overall Study|Other|0|||
149820552|NCT01799590|540473652|FG000|Overall Study|Using drugs with restricted days of use|0|||
149820553|NCT01799590|540473653|FG001|Overall Study|Using drugs with restricted days of use|3|||
150168973|NCT00603447|541752639|FG001|Overall Study|Other|0|||
150168974|NCT00603447|541752640|FG002|Overall Study|Other|1|||
150168975|NCT00603447|541752641|FG003|Overall Study|Other|0|||
150168976|NCT00603447|541752642|FG004|Overall Study|Other|3|||
150168977|NCT00603447|541752643|FG005|Overall Study|Other|0|||
150168978|NCT00603447|541752644|FG006|Overall Study|Other|13|||
150168979|NCT00603447|541752638|FG000|Overall Study|Withdrew Consent|0|||
150168980|NCT00603447|541752639|FG001|Overall Study|Withdrew Consent|2|||
150168981|NCT00603447|541752640|FG002|Overall Study|Withdrew Consent|0|||
150168982|NCT00603447|541752641|FG003|Overall Study|Withdrew Consent|0|||
150168983|NCT00603447|541752642|FG004|Overall Study|Withdrew Consent|1|||
150168984|NCT00603447|541752643|FG005|Overall Study|Withdrew Consent|0|||
150168985|NCT00603447|541752644|FG006|Overall Study|Withdrew Consent|1|||
150168986|NCT00470626|541753929|FG000|Overall Study|Lost to Follow-up|10|||
150168987|NCT00470626|541753929|FG000|Overall Study|Withdrawal by Subject|7|||
150168988|NCT00777556|541753930|FG000|Overall Study|Inappropriate self-selection|34|||
150168989|NCT00777556|541753930|FG000|Overall Study|Dispensed but did not use product|12|||
150168990|NCT00777556|541753930|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
150168991|NCT02689349|541753931|FG000|Overall Study|Not implanted|4|||
150168992|NCT02689349|541753932|FG001|Overall Study|Not implanted|0|||
150168993|NCT02689349|541753931|FG000|Overall Study|Withdrawal by Subject|9|||
150168994|NCT02689349|541753932|FG001|Overall Study|Withdrawal by Subject|0|||
150168995|NCT01185522|541753933|FG000|Overall Study|Lack of Efficacy|28|||
150168996|NCT01185522|541753933|FG000|Overall Study|Lost to Follow-up|19|||
150168997|NCT01185522|541753933|FG000|Overall Study|Withdrawal by Subject|10|||
150168998|NCT01185522|541753933|FG000|Overall Study|Poor tolerance|39|||
150168999|NCT01185522|541753933|FG000|Overall Study|Other reasons|12|||
150169000|NCT02962674|541753934|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
150169001|NCT00364286|541753936|FG000|Overall Study|Withdrawal by Subject|1|||
150169002|NCT00364286|541753936|FG000|Overall Study|Adverse Event|2|||
150169003|NCT01227278|541753939|FG000|Overall Study|Withdrawal by Subject|4|||
150169004|NCT01227278|541753940|FG001|Overall Study|Withdrawal by Subject|4|||
150169005|NCT01227278|541753939|FG000|Overall Study|Death|0|||
150169006|NCT01227278|541753940|FG001|Overall Study|Death|2|||
150169007|NCT01227278|541753939|FG000|Overall Study|Other|1|||
150169008|NCT01227278|541753940|FG001|Overall Study|Other|2|||
150169009|NCT03546907|541753955|FG000|Overall Study|Lack of Efficacy|1|||
150169010|NCT03546907|541753956|FG001|Overall Study|Lack of Efficacy|1|||
150169011|NCT03546907|541753955|FG000|Overall Study|Withdrawal by Subject|8|||
150169012|NCT03546907|541753956|FG001|Overall Study|Withdrawal by Subject|9|||
150169013|NCT03546907|541753955|FG000|Overall Study|Adverse events (AEs)|7|||
150169014|NCT03546907|541753956|FG001|Overall Study|Adverse events (AEs)|10|||
150169015|NCT03546907|541753955|FG000|Overall Study|Other-unspecified|1|||
150169016|NCT03546907|541753956|FG001|Overall Study|Other-unspecified|1|||
150169017|NCT00975806|541753959|FG000|Overall Study|Adverse Event|2|||
150169018|NCT00975806|541753960|FG001|Overall Study|Adverse Event|1|||
150169019|NCT00975806|541753961|FG002|Overall Study|Adverse Event|2|||
150169020|NCT00975806|541753959|FG000|Overall Study|Disease Progression|1|||
150169021|NCT00975806|541753960|FG001|Overall Study|Disease Progression|5|||
150169022|NCT00975806|541753961|FG002|Overall Study|Disease Progression|1|||
150169023|NCT00975806|541753959|FG000|Overall Study|Withdrawal by Subject|1|||
150169024|NCT00975806|541753960|FG001|Overall Study|Withdrawal by Subject|0|||
150169025|NCT00975806|541753961|FG002|Overall Study|Withdrawal by Subject|0|||
150169026|NCT00975806|541753959|FG000|Overall Study|Death|0|||
150169027|NCT00975806|541753960|FG001|Overall Study|Death|1|||
150169028|NCT00975806|541753961|FG002|Overall Study|Death|0|||
150169029|NCT00975806|541753959|FG000|Overall Study|Physician decision and disease related|1|||
150169030|NCT00975806|541753960|FG001|Overall Study|Physician decision and disease related|0|||
150169031|NCT00975806|541753961|FG002|Overall Study|Physician decision and disease related|1|||
150169032|NCT00246012|541753962|FG000|Overall Study|Adverse Event|0|||
150169033|NCT00246012|541753963|FG001|Overall Study|Adverse Event|0|||
150169034|NCT00246012|541753964|FG002|Overall Study|Adverse Event|0|||
150169035|NCT00246012|541753965|FG003|Overall Study|Adverse Event|0|||
150169036|NCT00246012|541753966|FG004|Overall Study|Adverse Event|0|||
150169037|NCT00246012|541753967|FG005|Overall Study|Adverse Event|1|||
150169038|NCT00246012|541753968|FG006|Overall Study|Adverse Event|0|||
150169039|NCT00246012|541753969|FG007|Overall Study|Adverse Event|0|||
150169040|NCT00246012|541753970|FG008|Overall Study|Adverse Event|2|||
150169041|NCT00246012|541753962|FG000|Overall Study|Withdrawal by Subject|0|||
150169042|NCT00246012|541753963|FG001|Overall Study|Withdrawal by Subject|0|||
150169043|NCT00246012|541753964|FG002|Overall Study|Withdrawal by Subject|0|||
150169044|NCT00246012|541753965|FG003|Overall Study|Withdrawal by Subject|0|||
150169045|NCT00246012|541753966|FG004|Overall Study|Withdrawal by Subject|0|||
149820554|NCT01799590|540473654|FG002|Overall Study|Using drugs with restricted days of use|2|||
149820555|NCT01799590|540473652|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
149820556|NCT01799590|540473653|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
149820557|NCT01799590|540473654|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
149820558|NCT01799590|540473652|FG000|Overall Study|Other|3|||
149938238|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
149938239|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
149938240|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
149820559|NCT01799590|540473653|FG001|Overall Study|Other|0|||
149820560|NCT01799590|540473654|FG002|Overall Study|Other|1|||
149820561|NCT00294723|540473657|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
149820562|NCT00294723|540473658|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
149820563|NCT00294723|540473659|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
149820564|NCT00294723|540473657|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
149820565|NCT00294723|540473658|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
149820566|NCT00294723|540473659|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
149820567|NCT00294723|540473657|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
149820568|NCT00294723|540473658|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
149820569|NCT00294723|540473659|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
149820570|NCT00294723|540473657|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
149820571|NCT00294723|540473658|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
149820572|NCT00294723|540473659|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
149820573|NCT00294723|540473657|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
149820574|NCT00294723|540473658|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
149820575|NCT00294723|540473659|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
149820576|NCT00294723|540473657|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
149820577|NCT00294723|540473658|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
149820578|NCT00294723|540473659|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
149820579|NCT00294723|540473657|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
149820580|NCT00294723|540473658|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
149820581|NCT00294723|540473659|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
149820582|NCT00294723|540473657|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
149820583|NCT00294723|540473658|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
149820584|NCT00294723|540473659|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
149820585|NCT00294723|540473657|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
149820586|NCT00294723|540473658|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
149820587|NCT00294723|540473659|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
149820588|NCT00294723|540473657|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
149820589|NCT00294723|540473658|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
149820590|NCT00294723|540473659|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
149820591|NCT00294723|540473657|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
149820592|NCT00294723|540473658|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
149820593|NCT00294723|540473659|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
149820594|NCT00294723|540473657|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
149820595|NCT00294723|540473658|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
149820596|NCT00294723|540473659|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
149820597|NCT03038113|540473664|FG000|Overall Study|Withdrawal by Subject|0|||
149820598|NCT03038113|540473665|FG001|Overall Study|Withdrawal by Subject|0|||
149820599|NCT03038113|540473666|FG002|Overall Study|Withdrawal by Subject|1|||
149820600|NCT03038113|540473667|FG003|Overall Study|Withdrawal by Subject|0|||
149820601|NCT03038113|540473668|FG004|Overall Study|Withdrawal by Subject|0|||
149820602|NCT03038113|540473669|FG005|Overall Study|Withdrawal by Subject|0|||
149820603|NCT03038113|540473670|FG006|Overall Study|Withdrawal by Subject|0|||
149820604|NCT03038113|540473671|FG007|Overall Study|Withdrawal by Subject|0|||
150169046|NCT00246012|541753967|FG005|Overall Study|Withdrawal by Subject|1|||
150169047|NCT00246012|541753968|FG006|Overall Study|Withdrawal by Subject|0|||
150169048|NCT00246012|541753969|FG007|Overall Study|Withdrawal by Subject|0|||
150169049|NCT00246012|541753970|FG008|Overall Study|Withdrawal by Subject|0|||
150169050|NCT00246012|541753962|FG000|Overall Study|Disease progression|3|||
150169051|NCT00246012|541753963|FG001|Overall Study|Disease progression|1|||
150169052|NCT00246012|541753964|FG002|Overall Study|Disease progression|2|||
150169053|NCT00246012|541753965|FG003|Overall Study|Disease progression|3|||
150169054|NCT00246012|541753966|FG004|Overall Study|Disease progression|3|||
150169055|NCT00246012|541753967|FG005|Overall Study|Disease progression|25|||
150169056|NCT00246012|541753968|FG006|Overall Study|Disease progression|30|||
150169057|NCT00246012|541753969|FG007|Overall Study|Disease progression|27|||
149820605|NCT03038113|540473672|FG008|Overall Study|Withdrawal by Subject|0|||
149820606|NCT03038113|540473673|FG009|Overall Study|Withdrawal by Subject|0|||
149820607|NCT03038113|540473674|FG010|Overall Study|Withdrawal by Subject|0|||
150169058|NCT00246012|541753970|FG008|Overall Study|Disease progression|26|||
149938241|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
149938242|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
149938243|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
149938244|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
149938245|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
149938246|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
149938247|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
149938248|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
149938249|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
149938250|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
149938251|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
149938252|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
150272361|NCT02499770|542134881|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
150272362|NCT02499770|542134882|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
150272363|NCT02499770|542134881|FG000|Overall Study|Randomized but not enrolled|0|||
150272364|NCT02499770|542134882|FG001|Overall Study|Randomized but not enrolled|1|||
150272365|NCT03610165|542134885|FG000|Overall Study|Device didn't work|0|||
150272366|NCT03610165|542134886|FG001|Overall Study|Device didn't work|1|||
150272367|NCT00671554|542134893|FG000|Overall Study|Disease progression|3|||
150272368|NCT00977574|542134895|FG000|Overall Study|Never Treated|4|||
150272369|NCT00977574|542134896|FG001|Overall Study|Never Treated|2|||
150272370|NCT00977574|542134897|FG002|Overall Study|Never Treated|4|||
150272371|NCT04223791|542134898|FG000|Overall Study|Lost to Follow-up|0|||
150272372|NCT04223791|542134899|FG001|Overall Study|Lost to Follow-up|4|||
150272373|NCT04223791|542134898|FG000|Overall Study|Physician Decision|5|||
150272374|NCT04223791|542134899|FG001|Overall Study|Physician Decision|1|||
150272375|NCT04223791|542134898|FG000|Overall Study|Protocol Violation|1|||
150272376|NCT04223791|542134899|FG001|Overall Study|Protocol Violation|1|||
150272377|NCT04223791|542134898|FG000|Overall Study|Withdrawal by Subject|10|||
150272378|NCT04223791|542134899|FG001|Overall Study|Withdrawal by Subject|12|||
150272379|NCT04223791|542134898|FG000|Overall Study|Pregnancy|1|||
150272380|NCT04223791|542134899|FG001|Overall Study|Pregnancy|1|||
150272381|NCT04223791|542134898|FG000|Overall Study|Ongoing in Study|305|||
150272382|NCT04223791|542134899|FG001|Overall Study|Ongoing in Study|302|||
150272383|NCT04667247|542134900|FG000|Overall Study|Withdrawal by Subject|0|||
150272384|NCT04667247|542134901|FG001|Overall Study|Withdrawal by Subject|1|||
150272385|NCT05460273|542134902|FG000|Overall Study|Death|43|||
150272386|NCT05460273|542134903|FG001|Overall Study|Death|9|||
150272387|NCT05460273|542134902|FG000|Overall Study|Lost to Follow-up|7|||
150272388|NCT05460273|542134903|FG001|Overall Study|Lost to Follow-up|0|||
150272389|NCT05460273|542134902|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
150272390|NCT05460273|542134903|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
150272391|NCT04124614|542134904|FG000|Placebo Run-in Period|Not Randomized|34|||
150272392|NCT04124614|542134905|FG001|Placebo Run-in Period|Not Randomized|0|||
150272393|NCT04124614|542134906|FG002|Placebo Run-in Period|Not Randomized|0|||
150272394|NCT04124614|542134904|FG000|Double Blind Treatment Period|Adverse Event|0|||
150272395|NCT04124614|542134905|FG001|Double Blind Treatment Period|Adverse Event|7|||
150272396|NCT04124614|542134906|FG002|Double Blind Treatment Period|Adverse Event|22|||
150272397|NCT04124614|542134904|FG000|Double Blind Treatment Period|Death|0|||
150272398|NCT04124614|542134905|FG001|Double Blind Treatment Period|Death|0|||
150272399|NCT04124614|542134906|FG002|Double Blind Treatment Period|Death|1|||
150272400|NCT04124614|542134904|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
150272401|NCT04124614|542134905|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
150272402|NCT04124614|542134906|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
150272403|NCT04124614|542134904|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
150272404|NCT04124614|542134905|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
150272405|NCT04124614|542134906|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
150272406|NCT04124614|542134904|FG000|Double Blind Treatment Period|Physician Decision|0|||
150272407|NCT04124614|542134905|FG001|Double Blind Treatment Period|Physician Decision|0|||
150272408|NCT04124614|542134906|FG002|Double Blind Treatment Period|Physician Decision|3|||
150272409|NCT04124614|542134904|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
150272410|NCT04124614|542134905|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
150272411|NCT04124614|542134906|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
150272412|NCT04124614|542134904|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
150272413|NCT04124614|542134905|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
150272414|NCT04124614|542134906|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
150272415|NCT04124614|542134904|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
150272416|NCT04124614|542134905|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
150272417|NCT04124614|542134906|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
150272418|NCT05749952|542134907|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
150272419|NCT03047551|542136045|FG000|Overall Study|Did not receive TAS|1|||
149938253|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
150272420|NCT03047551|542136046|FG001|Overall Study|Did not receive TAS|0|||
150272421|NCT03047551|542136045|FG000|Overall Study|Physician Decision|1|||
150272422|NCT03047551|542136046|FG001|Overall Study|Physician Decision|0|||
150272423|NCT03047551|542136045|FG000|Overall Study|Withdrawal by Subject|0|||
150272424|NCT03047551|542136046|FG001|Overall Study|Withdrawal by Subject|1|||
150272425|NCT03047551|542136045|FG000|Overall Study|Probe malfunction|0|||
150272426|NCT03047551|542136046|FG001|Overall Study|Probe malfunction|1|||
150272427|NCT03047551|542136045|FG000|Overall Study|Ineligible|0|||
150272428|NCT03047551|542136046|FG001|Overall Study|Ineligible|1|||
150272429|NCT02462928|542136047|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
150272430|NCT02462928|542136048|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
150272431|NCT02462928|542136049|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
150272432|NCT02462928|542136047|FG000|Overall Study|Adverse Event|47|||
150272433|NCT02462928|542136048|FG001|Overall Study|Adverse Event|51|||
150272434|NCT02462928|542136049|FG002|Overall Study|Adverse Event|25|||
150272435|NCT02462928|542136047|FG000|Overall Study|Lack of Efficacy|3|||
150272436|NCT02462928|542136048|FG001|Overall Study|Lack of Efficacy|8|||
150272437|NCT02462928|542136049|FG002|Overall Study|Lack of Efficacy|3|||
150272438|NCT02462928|542136047|FG000|Overall Study|Lost to Follow-up|4|||
150272439|NCT02462928|542136048|FG001|Overall Study|Lost to Follow-up|4|||
150272440|NCT02462928|542136049|FG002|Overall Study|Lost to Follow-up|1|||
150272441|NCT02462928|542136047|FG000|Overall Study|Withdrawal by Patient|31|||
150272442|NCT02462928|542136048|FG001|Overall Study|Withdrawal by Patient|21|||
150272443|NCT02462928|542136049|FG002|Overall Study|Withdrawal by Patient|21|||
150272444|NCT02462928|542136047|FG000|Overall Study|Protocol Violation|0|||
150272445|NCT02462928|542136048|FG001|Overall Study|Protocol Violation|1|||
150272446|NCT02462928|542136049|FG002|Overall Study|Protocol Violation|0|||
150272447|NCT02462928|542136047|FG000|Overall Study|Reason not Specified|4|||
150272448|NCT02462928|542136048|FG001|Overall Study|Reason not Specified|6|||
150272449|NCT02462928|542136049|FG002|Overall Study|Reason not Specified|5|||
150272450|NCT00395863|542136050|FG000|Overall Study|Patients did not complete both exams|2|||
150272451|NCT00395863|542136051|FG001|Overall Study|Patients did not complete both exams|3|||
150272452|NCT03503513|542136052|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
150272453|NCT03503513|542136052|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
149820608|NCT03038113|540473675|FG011|Overall Study|Withdrawal by Subject|0|||
149820609|NCT03038113|540473676|FG012|Overall Study|Withdrawal by Subject|0|||
149820610|NCT03038113|540473677|FG013|Overall Study|Withdrawal by Subject|1|||
150272454|NCT03503513|542136052|FG000|Overall Study|Physician Decision|3|||
150272455|NCT03503513|542136052|FG000|Overall Study|Withdrawal by Subject|2|||
150272456|NCT03503513|542136052|FG000|Overall Study|Lost to Follow-up|1|||
150272457|NCT01170039|542136053|FG000|Overall Study|Withdrawal by Subject|5|||
150272458|NCT01170039|542136054|FG001|Overall Study|Withdrawal by Subject|3|||
150272459|NCT01170039|542136053|FG000|Overall Study|Lack of funding, drug not available|3|||
150272460|NCT01170039|542136054|FG001|Overall Study|Lack of funding, drug not available|3|||
150272461|NCT00727649|542136055|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
150272462|NCT00727649|542136056|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
150272463|NCT00727649|542136055|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
150272464|NCT00727649|542136056|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
150272465|NCT00727649|542136055|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
150272466|NCT00727649|542136056|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
150272467|NCT00727649|542136055|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
150272468|NCT00727649|542136056|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
150272469|NCT00727649|542136055|FG000|Second Intervention (4-weeks)|Death|1|||
150272470|NCT00727649|542136056|FG001|Second Intervention (4-weeks)|Death|0|||
150272471|NCT00727649|542136055|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
150272472|NCT00727649|542136056|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
150272473|NCT00727649|542136055|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
150272474|NCT00727649|542136056|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
150272475|NCT02953639|542136059|FG000|Overall Study|Adverse Event|2|||
150272476|NCT02953639|542136060|FG001|Overall Study|Adverse Event|0|||
150272477|NCT02953639|542136061|FG002|Overall Study|Adverse Event|1|||
150272478|NCT02953639|542136059|FG000|Overall Study|Lost to Follow-up|8|||
150272479|NCT02953639|542136060|FG001|Overall Study|Lost to Follow-up|4|||
150272480|NCT02953639|542136061|FG002|Overall Study|Lost to Follow-up|3|||
150272481|NCT02953639|542136059|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150272482|NCT02953639|542136060|FG001|Overall Study|Non-Compliance With Study Drug|2|||
150272483|NCT02953639|542136061|FG002|Overall Study|Non-Compliance With Study Drug|1|||
150272484|NCT02953639|542136059|FG000|Overall Study|Multiple Reasons|1|||
150272485|NCT02953639|542136060|FG001|Overall Study|Multiple Reasons|0|||
150272486|NCT02953639|542136061|FG002|Overall Study|Multiple Reasons|1|||
150272487|NCT02953639|542136059|FG000|Overall Study|Physician Decision|1|||
149820611|NCT03038113|540473664|FG000|Overall Study|Lost to Follow-up|0|||
149820612|NCT03038113|540473665|FG001|Overall Study|Lost to Follow-up|0|||
150272488|NCT02953639|542136060|FG001|Overall Study|Physician Decision|0|||
149820613|NCT03038113|540473666|FG002|Overall Study|Lost to Follow-up|0|||
149820614|NCT03038113|540473667|FG003|Overall Study|Lost to Follow-up|0|||
149820615|NCT03038113|540473668|FG004|Overall Study|Lost to Follow-up|0|||
149820616|NCT03038113|540473669|FG005|Overall Study|Lost to Follow-up|0|||
149820617|NCT03038113|540473670|FG006|Overall Study|Lost to Follow-up|1|||
149820618|NCT03038113|540473671|FG007|Overall Study|Lost to Follow-up|0|||
149820619|NCT03038113|540473672|FG008|Overall Study|Lost to Follow-up|0|||
149820620|NCT03038113|540473673|FG009|Overall Study|Lost to Follow-up|0|||
149820621|NCT03038113|540473674|FG010|Overall Study|Lost to Follow-up|0|||
149820622|NCT03038113|540473675|FG011|Overall Study|Lost to Follow-up|0|||
149820623|NCT03038113|540473676|FG012|Overall Study|Lost to Follow-up|0|||
149820624|NCT03038113|540473677|FG013|Overall Study|Lost to Follow-up|0|||
149820625|NCT01755858|540473680|FG000|Overall Study|Adverse Event|1|||
149820626|NCT01755858|540473681|FG001|Overall Study|Adverse Event|1|||
149820627|NCT01580020|540473686|FG000|Overall Study|Lack of Efficacy|0|||
149820628|NCT01580020|540473687|FG001|Overall Study|Lack of Efficacy|5|||
149820629|NCT01580020|540473688|FG002|Overall Study|Lack of Efficacy|0|||
149820630|NCT01580020|540473689|FG003|Overall Study|Lack of Efficacy|1|||
149820631|NCT01580020|540473686|FG000|Overall Study|Withdrawal by Subject|0|||
149820632|NCT01580020|540473687|FG001|Overall Study|Withdrawal by Subject|1|||
149938254|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
150272489|NCT02953639|542136061|FG002|Overall Study|Physician Decision|0|||
150272490|NCT02953639|542136059|FG000|Overall Study|Withdrawal by Subject|7|||
150272491|NCT02953639|542136060|FG001|Overall Study|Withdrawal by Subject|8|||
150272492|NCT02953639|542136061|FG002|Overall Study|Withdrawal by Subject|10|||
150272493|NCT02953639|542136059|FG000|Overall Study|Completed or Discontinued information is missing|1|||
150272494|NCT02953639|542136060|FG001|Overall Study|Completed or Discontinued information is missing|0|||
150272495|NCT02953639|542136061|FG002|Overall Study|Completed or Discontinued information is missing|0|||
150272496|NCT01830855|542136062|FG000|Overall Study|Other|7|||
150272497|NCT01830855|542136063|FG001|Overall Study|Other|1|||
150272498|NCT01830855|542136064|FG002|Overall Study|Other|4|||
150272499|NCT01830855|542136065|FG003|Overall Study|Other|4|||
150272500|NCT01830855|542136062|FG000|Overall Study|Medication error without associated AE|1|||
150272501|NCT01830855|542136063|FG001|Overall Study|Medication error without associated AE|0|||
150272502|NCT01830855|542136064|FG002|Overall Study|Medication error without associated AE|0|||
150272503|NCT01830855|542136065|FG003|Overall Study|Medication error without associated AE|1|||
150272504|NCT01830855|542136062|FG000|Overall Study|Pregnancy|3|||
150272505|NCT01830855|542136063|FG001|Overall Study|Pregnancy|1|||
150272506|NCT01830855|542136064|FG002|Overall Study|Pregnancy|2|||
150272507|NCT01830855|542136065|FG003|Overall Study|Pregnancy|1|||
150272508|NCT01830855|542136062|FG000|Overall Study|No longer meets eligibility criteria|11|||
150272509|NCT01830855|542136063|FG001|Overall Study|No longer meets eligibility criteria|2|||
150272510|NCT01830855|542136064|FG002|Overall Study|No longer meets eligibility criteria|3|||
150272511|NCT01830855|542136065|FG003|Overall Study|No longer meets eligibility criteria|5|||
150272512|NCT01830855|542136062|FG000|Overall Study|Adverse Event|11|||
150272513|NCT01830855|542136063|FG001|Overall Study|Adverse Event|5|||
150272514|NCT01830855|542136064|FG002|Overall Study|Adverse Event|6|||
150272515|NCT01830855|542136065|FG003|Overall Study|Adverse Event|3|||
150272516|NCT01830855|542136062|FG000|Overall Study|Protocol deviation|10|||
150272517|NCT01830855|542136063|FG001|Overall Study|Protocol deviation|5|||
150272518|NCT01830855|542136064|FG002|Overall Study|Protocol deviation|6|||
150272519|NCT01830855|542136065|FG003|Overall Study|Protocol deviation|6|||
150272520|NCT01830855|542136062|FG000|Overall Study|Withdrawal by Subject|33|||
150272521|NCT01830855|542136063|FG001|Overall Study|Withdrawal by Subject|14|||
150272522|NCT01830855|542136064|FG002|Overall Study|Withdrawal by Subject|10|||
150272523|NCT01830855|542136065|FG003|Overall Study|Withdrawal by Subject|12|||
150272524|NCT01830855|542136062|FG000|Overall Study|No longer willing to participate|32|||
150272525|NCT01830855|542136063|FG001|Overall Study|No longer willing to participate|13|||
150272526|NCT01830855|542136064|FG002|Overall Study|No longer willing to participate|12|||
150272527|NCT01830855|542136065|FG003|Overall Study|No longer willing to participate|17|||
150272528|NCT01830855|542136062|FG000|Overall Study|Lost to Follow-up|47|||
150272529|NCT01830855|542136063|FG001|Overall Study|Lost to Follow-up|20|||
150272530|NCT01830855|542136064|FG002|Overall Study|Lost to Follow-up|23|||
150272531|NCT01830855|542136065|FG003|Overall Study|Lost to Follow-up|33|||
150272532|NCT00295633|542136068|FG000|Overall Study|Lack of Efficacy|19|||
150272533|NCT00295633|542136069|FG001|Overall Study|Lack of Efficacy|7|||
149820633|NCT01580020|540473688|FG002|Overall Study|Withdrawal by Subject|1|||
149820634|NCT01580020|540473689|FG003|Overall Study|Withdrawal by Subject|0|||
149820635|NCT01580020|540473686|FG000|Overall Study|Adverse Event|1|||
149820636|NCT01580020|540473687|FG001|Overall Study|Adverse Event|1|||
149820637|NCT01580020|540473688|FG002|Overall Study|Adverse Event|1|||
149820638|NCT01580020|540473689|FG003|Overall Study|Adverse Event|1|||
149820639|NCT01580020|540473686|FG000|Overall Study|Administrative Problems|0|||
149820640|NCT01580020|540473687|FG001|Overall Study|Administrative Problems|0|||
149820641|NCT01580020|540473688|FG002|Overall Study|Administrative Problems|1|||
149820642|NCT01580020|540473689|FG003|Overall Study|Administrative Problems|0|||
149938255|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
150272534|NCT00295633|542136070|FG002|Overall Study|Lack of Efficacy|16|||
149820643|NCT01580020|540473686|FG000|Overall Study|Lost to Follow-up|0|||
149820644|NCT01580020|540473687|FG001|Overall Study|Lost to Follow-up|0|||
149820645|NCT01580020|540473688|FG002|Overall Study|Lost to Follow-up|1|||
149820646|NCT01580020|540473689|FG003|Overall Study|Lost to Follow-up|0|||
150272535|NCT00295633|542136068|FG000|Overall Study|Withdrawal of consent by subject|16|||
150272536|NCT00295633|542136069|FG001|Overall Study|Withdrawal of consent by subject|16|||
150272537|NCT00295633|542136070|FG002|Overall Study|Withdrawal of consent by subject|26|||
150272538|NCT00295633|542136068|FG000|Overall Study|Adverse Event|9|||
150272539|NCT00295633|542136069|FG001|Overall Study|Adverse Event|17|||
150272540|NCT00295633|542136070|FG002|Overall Study|Adverse Event|9|||
150272541|NCT00295633|542136068|FG000|Overall Study|Lost to Follow-up|6|||
150272542|NCT00295633|542136069|FG001|Overall Study|Lost to Follow-up|11|||
149820647|NCT01724359|540473690|FG000|Overall Study|Adverse Event|10|||
149820648|NCT01724359|540473690|FG000|Overall Study|Death|1|||
149820649|NCT01724359|540473690|FG000|Overall Study|Other|20|||
149820650|NCT01335464|540473692|FG000|Overall Study|Adverse Event|15|||
149820651|NCT01335464|540473693|FG001|Overall Study|Adverse Event|25|||
149820652|NCT01335464|540473692|FG000|Overall Study|Non compliant with protocol|2|||
149820653|NCT01335464|540473693|FG001|Overall Study|Non compliant with protocol|0|||
149820654|NCT01335464|540473692|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
149820655|NCT01335464|540473693|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
149820656|NCT01335464|540473692|FG000|Overall Study|Not treated|2|||
149820657|NCT01335464|540473693|FG001|Overall Study|Not treated|0|||
150272543|NCT00295633|542136070|FG002|Overall Study|Lost to Follow-up|7|||
150272544|NCT00295633|542136068|FG000|Overall Study|Physician Decision|9|||
150272545|NCT00295633|542136069|FG001|Overall Study|Physician Decision|10|||
150272546|NCT00295633|542136070|FG002|Overall Study|Physician Decision|8|||
150272547|NCT00295633|542136068|FG000|Overall Study|Poor/Noncompliance|2|||
150272548|NCT00295633|542136069|FG001|Overall Study|Poor/Noncompliance|2|||
150272549|NCT00295633|542136070|FG002|Overall Study|Poor/Noncompliance|6|||
150272550|NCT00295633|542136068|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
150272551|NCT00295633|542136069|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
150272552|NCT00295633|542136070|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
150272553|NCT00295633|542136068|FG000|Overall Study|Death|1|||
150272554|NCT00295633|542136069|FG001|Overall Study|Death|1|||
150272555|NCT00295633|542136070|FG002|Overall Study|Death|0|||
149820658|NCT01335464|540473692|FG000|Overall Study|Reason other than those stated above|1|||
149820659|NCT01335464|540473693|FG001|Overall Study|Reason other than those stated above|1|||
149820660|NCT00591253|540473694|FG000|Overall Study|Adverse Event|3|||
149820661|NCT00591253|540473695|FG001|Overall Study|Adverse Event|3|||
149820662|NCT00591253|540473696|FG002|Overall Study|Adverse Event|1|||
149820663|NCT00591253|540473694|FG000|Overall Study|Protocol Violation|2|||
149820664|NCT00591253|540473695|FG001|Overall Study|Protocol Violation|2|||
149820665|NCT00591253|540473696|FG002|Overall Study|Protocol Violation|2|||
149820666|NCT00591253|540473694|FG000|Overall Study|Lost to Follow-up|2|||
149820667|NCT00591253|540473695|FG001|Overall Study|Lost to Follow-up|4|||
149820668|NCT00591253|540473696|FG002|Overall Study|Lost to Follow-up|0|||
149820669|NCT00591253|540473694|FG000|Overall Study|Withdrawal by Subject|1|||
149820670|NCT00591253|540473695|FG001|Overall Study|Withdrawal by Subject|7|||
149820671|NCT00591253|540473696|FG002|Overall Study|Withdrawal by Subject|6|||
149820672|NCT00591253|540473694|FG000|Overall Study|Lack of Efficacy|1|||
149820673|NCT00591253|540473695|FG001|Overall Study|Lack of Efficacy|0|||
149820674|NCT00591253|540473696|FG002|Overall Study|Lack of Efficacy|3|||
149820675|NCT00591253|540473694|FG000|Overall Study|Other|5|||
149820676|NCT00591253|540473695|FG001|Overall Study|Other|5|||
150272556|NCT00295633|542136068|FG000|Overall Study|Administrative reason by sponsor|0|||
150272557|NCT00295633|542136069|FG001|Overall Study|Administrative reason by sponsor|0|||
150272558|NCT00295633|542136070|FG002|Overall Study|Administrative reason by sponsor|1|||
150272559|NCT01798992|542136071|FG000|Overall Study|Administrative withdrawal|0|||
150272560|NCT01798992|542136072|FG001|Overall Study|Administrative withdrawal|1|||
150272561|NCT01798992|542136073|FG002|Overall Study|Administrative withdrawal|0|||
150272562|NCT01798992|542136074|FG003|Overall Study|Administrative withdrawal|1|||
149820677|NCT00591253|540473696|FG002|Overall Study|Other|3|||
149820678|NCT01841359|540473697|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
149820679|NCT01841359|540473697|FG000|Overall Study|Concommitant medical issues|2|||
149820680|NCT01841359|540473697|FG000|Overall Study|Adverse Event|3|||
149820681|NCT01841359|540473697|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
149820682|NCT00871169|540473698|FG000|Overall Study|Protocol Violation|1|||
149820683|NCT00871169|540473698|FG000|Overall Study|Patient did not receive study treatment|2|||
149820684|NCT02168270|540473699|FG000|Overall Study|Lack of Efficacy|4|||
149820685|NCT03493698|540473703|FG000|Treatment Period C|Adverse Event|1|||
149820686|NCT03493698|540473703|FG000|Treatment Period C|Withdrawal by Subject|1|||
149820687|NCT03361956|540473704|FG000|Overall Study|Adverse Event|1|||
149820688|NCT03361956|540473705|FG001|Overall Study|Adverse Event|0|||
149820689|NCT03361956|540473706|FG002|Overall Study|Adverse Event|1|||
150272563|NCT01798992|542136071|FG000|Overall Study|Lost to Follow-up|0|||
150272564|NCT01798992|542136072|FG001|Overall Study|Lost to Follow-up|1|||
150272565|NCT01798992|542136073|FG002|Overall Study|Lost to Follow-up|1|||
149820690|NCT03361956|540473707|FG003|Overall Study|Adverse Event|1|||
149820691|NCT03361956|540473708|FG004|Overall Study|Adverse Event|0|||
149820692|NCT03361956|540473704|FG000|Overall Study|Other|0|||
149820693|NCT03361956|540473705|FG001|Overall Study|Other|0|||
149820694|NCT03361956|540473706|FG002|Overall Study|Other|0|||
149820695|NCT03361956|540473707|FG003|Overall Study|Other|1|||
149820696|NCT03361956|540473708|FG004|Overall Study|Other|0|||
149820697|NCT03361956|540473704|FG000|Overall Study|Withdrawal by Subject|2|||
149820698|NCT03361956|540473705|FG001|Overall Study|Withdrawal by Subject|2|||
149820699|NCT03361956|540473706|FG002|Overall Study|Withdrawal by Subject|2|||
149820700|NCT03361956|540473707|FG003|Overall Study|Withdrawal by Subject|0|||
149820701|NCT03361956|540473708|FG004|Overall Study|Withdrawal by Subject|3|||
149820702|NCT03361956|540473704|FG000|Overall Study|Disease Relapse|0|||
149820703|NCT03361956|540473705|FG001|Overall Study|Disease Relapse|0|||
149820704|NCT03361956|540473706|FG002|Overall Study|Disease Relapse|1|||
149820705|NCT03361956|540473707|FG003|Overall Study|Disease Relapse|0|||
149820706|NCT03361956|540473708|FG004|Overall Study|Disease Relapse|0|||
149820707|NCT03361956|540473704|FG000|Overall Study|Physician Decision|0|||
149820708|NCT03361956|540473705|FG001|Overall Study|Physician Decision|2|||
149820709|NCT03361956|540473706|FG002|Overall Study|Physician Decision|0|||
149820710|NCT03361956|540473707|FG003|Overall Study|Physician Decision|1|||
149820711|NCT03361956|540473708|FG004|Overall Study|Physician Decision|0|||
149820712|NCT03361956|540473704|FG000|Overall Study|Lost to Follow-up|0|||
149820713|NCT03361956|540473705|FG001|Overall Study|Lost to Follow-up|0|||
149820714|NCT03361956|540473706|FG002|Overall Study|Lost to Follow-up|1|||
149820715|NCT03361956|540473707|FG003|Overall Study|Lost to Follow-up|1|||
149820716|NCT03361956|540473708|FG004|Overall Study|Lost to Follow-up|2|||
149820717|NCT00291330|540473711|FG000|Overall Study|Adverse Event|47|||
150272566|NCT01798992|542136074|FG003|Overall Study|Lost to Follow-up|0|||
150272567|NCT01798992|542136071|FG000|Overall Study|Insufficient biopsy tissue|0|||
150272568|NCT01798992|542136072|FG001|Overall Study|Insufficient biopsy tissue|0|||
150272569|NCT01798992|542136073|FG002|Overall Study|Insufficient biopsy tissue|1|||
150272570|NCT01798992|542136074|FG003|Overall Study|Insufficient biopsy tissue|0|||
150272571|NCT02294682|542136075|FG000|Overall Study|Could not swallow pills|1|||
150272572|NCT02294682|542136076|FG001|Overall Study|Could not swallow pills|0|||
150272573|NCT01516970|542136077|FG000|Overall Study|Lost to Follow-up|7|||
150272574|NCT01516970|542136078|FG001|Overall Study|Lost to Follow-up|8|||
150272575|NCT01516970|542136077|FG000|Overall Study|Adverse Event|1|||
150272576|NCT01516970|542136078|FG001|Overall Study|Adverse Event|5|||
150272577|NCT01516970|542136077|FG000|Overall Study|Withdrawal by Subject|1|||
150272578|NCT01516970|542136078|FG001|Overall Study|Withdrawal by Subject|1|||
150272579|NCT01516970|542136077|FG000|Overall Study|Other|9|||
150272580|NCT01516970|542136078|FG001|Overall Study|Other|7|||
150272581|NCT00434421|542136079|FG000|Overall Study|Withdrawal by Subject|1|||
150272582|NCT00434421|542136079|FG000|Overall Study|Non-compliance with study treatment|1|||
150272583|NCT00892177|542136086|FG000|Phase II|Ineligible|0|||
150272584|NCT00892177|542136087|FG001|Phase II|Ineligible|0|||
150272585|NCT00892177|542136088|FG002|Phase II|Ineligible|0|||
150272586|NCT00892177|542136089|FG003|Phase II|Ineligible|0|||
150272587|NCT00892177|542136090|FG004|Phase II|Ineligible|1|||
150272588|NCT00892177|542136091|FG005|Phase II|Ineligible|1|||
150272589|NCT00892177|542136086|FG000|Phase II|Withdrawal by Subject|0|||
150272590|NCT00892177|542136087|FG001|Phase II|Withdrawal by Subject|0|||
150272591|NCT00892177|542136088|FG002|Phase II|Withdrawal by Subject|0|||
150272592|NCT00892177|542136089|FG003|Phase II|Withdrawal by Subject|0|||
150272593|NCT00892177|542136090|FG004|Phase II|Withdrawal by Subject|4|||
150272594|NCT00892177|542136091|FG005|Phase II|Withdrawal by Subject|1|||
150272595|NCT01446016|542136092|FG000|Overall Study|Lost to Follow-up|3|||
150272596|NCT01446016|542136092|FG000|Overall Study|Withdrawal by Subject|1|||
150272597|NCT01446016|542136092|FG000|Overall Study|Toxicity|3|||
150272598|NCT00404066|542136099|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
150272599|NCT00404066|542136099|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
150272600|NCT01296035|542136100|FG000|Overall Study|Withdrawal by Subject|1|||
150272601|NCT01674712|542136101|FG000|Overall Study|Adverse Event|5|||
150272602|NCT01674712|542136102|FG001|Overall Study|Adverse Event|6|||
150272603|NCT01674712|542136103|FG002|Overall Study|Adverse Event|3|||
150272604|NCT01674712|542136104|FG003|Overall Study|Adverse Event|4|||
150272605|NCT01674712|542136105|FG004|Overall Study|Adverse Event|6|||
150272606|NCT01674712|542136101|FG000|Overall Study|Lost to Follow-up|1|||
150272607|NCT01674712|542136102|FG001|Overall Study|Lost to Follow-up|0|||
150272608|NCT01674712|542136103|FG002|Overall Study|Lost to Follow-up|0|||
150272609|NCT01674712|542136104|FG003|Overall Study|Lost to Follow-up|0|||
149820718|NCT00291330|540473712|FG001|Overall Study|Adverse Event|40|||
149820719|NCT00291330|540473711|FG000|Overall Study|Protocol Violation|13|||
149820720|NCT00291330|540473712|FG001|Overall Study|Protocol Violation|20|||
149820721|NCT00291330|540473711|FG000|Overall Study|Lost to Follow-up|16|||
150272610|NCT01674712|542136105|FG004|Overall Study|Lost to Follow-up|0|||
150272611|NCT01674712|542136101|FG000|Overall Study|Protocol Violation|2|||
150272612|NCT01674712|542136102|FG001|Overall Study|Protocol Violation|0|||
150272613|NCT01674712|542136103|FG002|Overall Study|Protocol Violation|0|||
150272614|NCT01674712|542136104|FG003|Overall Study|Protocol Violation|0|||
150272615|NCT01674712|542136105|FG004|Overall Study|Protocol Violation|0|||
150272616|NCT01674712|542136101|FG000|Overall Study|Withdrawal by Subject|2|||
150272617|NCT01674712|542136102|FG001|Overall Study|Withdrawal by Subject|2|||
150272618|NCT01674712|542136103|FG002|Overall Study|Withdrawal by Subject|5|||
150272619|NCT01674712|542136104|FG003|Overall Study|Withdrawal by Subject|4|||
150272620|NCT01674712|542136105|FG004|Overall Study|Withdrawal by Subject|3|||
150272621|NCT01674712|542136101|FG000|Overall Study|Administrative|0|||
150272622|NCT01674712|542136102|FG001|Overall Study|Administrative|1|||
150272623|NCT01674712|542136103|FG002|Overall Study|Administrative|0|||
150272624|NCT01674712|542136104|FG003|Overall Study|Administrative|0|||
150272625|NCT01674712|542136105|FG004|Overall Study|Administrative|1|||
150272626|NCT01674712|542136101|FG000|Overall Study|Lack of Efficacy|0|||
150272627|NCT01674712|542136102|FG001|Overall Study|Lack of Efficacy|0|||
150272628|NCT01674712|542136103|FG002|Overall Study|Lack of Efficacy|1|||
150272629|NCT01674712|542136104|FG003|Overall Study|Lack of Efficacy|0|||
150272630|NCT01674712|542136105|FG004|Overall Study|Lack of Efficacy|1|||
150272631|NCT01186796|542136106|FG000|Overall Study|Adverse Event|3|||
150272632|NCT01186796|542136107|FG001|Overall Study|Adverse Event|0|||
150272633|NCT01186796|542136106|FG000|Overall Study|Withdrawal by Subject|1|||
150272634|NCT01186796|542136107|FG001|Overall Study|Withdrawal by Subject|1|||
150272635|NCT01186796|542136106|FG000|Overall Study|Protocol Violation|0|||
150272636|NCT01186796|542136107|FG001|Overall Study|Protocol Violation|1|||
150272637|NCT01287364|542136109|FG000|Overall Study|Adverse Event|0|||
150272638|NCT01287364|542136110|FG001|Overall Study|Adverse Event|3|||
150272639|NCT01287364|542136109|FG000|Overall Study|Protocol Violation|5|||
150272640|NCT01287364|542136110|FG001|Overall Study|Protocol Violation|5|||
150272641|NCT01287364|542136109|FG000|Overall Study|Other Reason|4|||
150272642|NCT01287364|542136110|FG001|Overall Study|Other Reason|2|||
150272643|NCT05372653|542136119|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
150272644|NCT05372653|542136120|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
150272645|NCT05372653|542136119|FG000|Overall Study|Adverse Event|0|||
150272646|NCT05372653|542136120|FG001|Overall Study|Adverse Event|1|||
150272647|NCT01003990|542136123|FG000|Overall Study|Adverse Event|8|||
150272648|NCT01003990|542136124|FG001|Overall Study|Adverse Event|5|||
150272649|NCT01003990|542136125|FG002|Overall Study|Adverse Event|11|||
150272650|NCT01003990|542136123|FG000|Overall Study|Death|0|||
150272651|NCT01003990|542136124|FG001|Overall Study|Death|8|||
150272652|NCT01003990|542136125|FG002|Overall Study|Death|1|||
150272653|NCT01003990|542136123|FG000|Overall Study|Lack of Efficacy|10|||
150272654|NCT01003990|542136124|FG001|Overall Study|Lack of Efficacy|2|||
150272655|NCT01003990|542136125|FG002|Overall Study|Lack of Efficacy|3|||
150272656|NCT01003990|542136123|FG000|Overall Study|Lost to Follow-up|30|||
150272657|NCT01003990|542136124|FG001|Overall Study|Lost to Follow-up|12|||
150272658|NCT01003990|542136125|FG002|Overall Study|Lost to Follow-up|7|||
150272659|NCT01003990|542136123|FG000|Overall Study|Reasons Not Identified|14|||
150272660|NCT01003990|542136124|FG001|Overall Study|Reasons Not Identified|13|||
150272661|NCT01003990|542136125|FG002|Overall Study|Reasons Not Identified|8|||
150272662|NCT01003990|542136123|FG000|Overall Study|Poor/Non-compliance|4|||
150272663|NCT01003990|542136124|FG001|Overall Study|Poor/Non-compliance|3|||
150272664|NCT01003990|542136125|FG002|Overall Study|Poor/Non-compliance|2|||
150272665|NCT01003990|542136123|FG000|Overall Study|Pregnancy|10|||
150272666|NCT01003990|542136124|FG001|Overall Study|Pregnancy|2|||
150272667|NCT01003990|542136125|FG002|Overall Study|Pregnancy|4|||
150272668|NCT01003990|542136123|FG000|Overall Study|No Longer Met Study Criteria|4|||
150272669|NCT01003990|542136124|FG001|Overall Study|No Longer Met Study Criteria|1|||
150272670|NCT01003990|542136125|FG002|Overall Study|No Longer Met Study Criteria|0|||
150272671|NCT01003990|542136123|FG000|Overall Study|Subject Withdrew Consent|12|||
150272672|NCT01003990|542136124|FG001|Overall Study|Subject Withdrew Consent|5|||
150272673|NCT01003990|542136125|FG002|Overall Study|Subject Withdrew Consent|7|||
150272674|NCT01829425|542136126|FG000|Overall Study|Withdrawal by Subject|4|||
150272675|NCT01829425|542136127|FG001|Overall Study|Withdrawal by Subject|3|||
150272676|NCT01829425|542136126|FG000|Overall Study|Lost to Follow-up|2|||
150272677|NCT01829425|542136127|FG001|Overall Study|Lost to Follow-up|1|||
150272678|NCT05211739|542136128|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
150272679|NCT05211739|542136129|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
150272680|NCT05211739|542136128|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
150272681|NCT05211739|542136129|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
150272682|NCT05211739|542136128|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
150272683|NCT05211739|542136129|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
150272684|NCT05211739|542136128|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
150272685|NCT05211739|542136129|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
150272686|NCT03606980|542136130|FG000|Overall Study|Lost to Follow-up|3|||
150272687|NCT03606980|542136131|FG001|Overall Study|Lost to Follow-up|2|||
150272688|NCT03606980|542136132|FG002|Overall Study|Lost to Follow-up|3|||
150272689|NCT03606980|542136130|FG000|Overall Study|Withdrawal by Subject|1|||
150272690|NCT03606980|542136131|FG001|Overall Study|Withdrawal by Subject|0|||
149820722|NCT00291330|540473712|FG001|Overall Study|Lost to Follow-up|11|||
149820723|NCT00291330|540473711|FG000|Overall Study|Withdrawal by Subject|22|||
149820724|NCT00291330|540473712|FG001|Overall Study|Withdrawal by Subject|25|||
149820725|NCT00291330|540473711|FG000|Overall Study|Other|3|||
149820726|NCT00291330|540473712|FG001|Overall Study|Other|1|||
149820727|NCT01829295|540473713|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
149820728|NCT01829295|540473714|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
149820729|NCT01829295|540473715|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
149820730|NCT01829295|540473716|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
149820731|NCT01829295|540473713|FG000|6-12 Months|Adverse Event|0|||
149820732|NCT01829295|540473714|FG001|6-12 Months|Adverse Event|0|||
149820733|NCT01829295|540473715|FG002|6-12 Months|Adverse Event|3|||
149820734|NCT01829295|540473716|FG003|6-12 Months|Adverse Event|2|||
149820735|NCT01829295|540473713|FG000|6-12 Months|Lost to Follow-up|2|||
149820736|NCT01829295|540473714|FG001|6-12 Months|Lost to Follow-up|0|||
149820737|NCT01829295|540473715|FG002|6-12 Months|Lost to Follow-up|0|||
149820738|NCT01829295|540473716|FG003|6-12 Months|Lost to Follow-up|0|||
149820739|NCT01829295|540473713|FG000|6-12 Months|Withdrawal by Subject|2|||
149820740|NCT01829295|540473714|FG001|6-12 Months|Withdrawal by Subject|2|||
149820741|NCT01829295|540473715|FG002|6-12 Months|Withdrawal by Subject|0|||
149820742|NCT01829295|540473716|FG003|6-12 Months|Withdrawal by Subject|0|||
149820743|NCT02629965|540473719|FG000|Period 1|Adverse Event|1|||
149820744|NCT02629965|540473720|FG001|Period 1|Adverse Event|0|||
149820745|NCT02629965|540473719|FG000|Period 1|Unexpected worsening of disease|2|||
149820746|NCT02629965|540473720|FG001|Period 1|Unexpected worsening of disease|0|||
149820747|NCT02629965|540473719|FG000|Period 1|Other than listed above|1|||
150169059|NCT00246012|541753962|FG000|Overall Study|Other|0|||
149938256|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
149938257|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
149938258|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
149938259|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
149938260|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
149938261|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
150169060|NCT00246012|541753963|FG001|Overall Study|Other|0|||
150169061|NCT00246012|541753964|FG002|Overall Study|Other|0|||
150169062|NCT00246012|541753965|FG003|Overall Study|Other|0|||
150169063|NCT00246012|541753966|FG004|Overall Study|Other|0|||
150169064|NCT00246012|541753967|FG005|Overall Study|Other|0|||
150169065|NCT00246012|541753968|FG006|Overall Study|Other|0|||
150169066|NCT00246012|541753969|FG007|Overall Study|Other|1|||
150169067|NCT00246012|541753970|FG008|Overall Study|Other|0|||
150169068|NCT00246012|541753962|FG000|Overall Study|Randomly assigned but not treated|0|||
150169069|NCT00246012|541753963|FG001|Overall Study|Randomly assigned but not treated|0|||
150169070|NCT00246012|541753964|FG002|Overall Study|Randomly assigned but not treated|0|||
150169071|NCT00246012|541753965|FG003|Overall Study|Randomly assigned but not treated|0|||
150169072|NCT00246012|541753966|FG004|Overall Study|Randomly assigned but not treated|0|||
150169073|NCT00246012|541753967|FG005|Overall Study|Randomly assigned but not treated|1|||
150169074|NCT00246012|541753968|FG006|Overall Study|Randomly assigned but not treated|1|||
150169075|NCT00246012|541753969|FG007|Overall Study|Randomly assigned but not treated|0|||
150169076|NCT00246012|541753970|FG008|Overall Study|Randomly assigned but not treated|0|||
150169077|NCT04889664|541753971|FG000|Screen|Lost to Follow-up|1|||
150169078|NCT04889664|541753971|FG000|Screen|Failed to meet screening criteria|1|||
150169079|NCT04889664|541753971|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
150169080|NCT02469064|541753978|FG000|Overall Study|Request not to receive intervention.|1|||
150169081|NCT02469064|541753979|FG001|Overall Study|Request not to receive intervention.|3|||
150169082|NCT01120275|541753983|FG000|Overall Study|Adverse Event|3|||
150169083|NCT01120275|541753983|FG000|Overall Study|Progression|27|||
150169084|NCT01120275|541753983|FG000|Overall Study|Ineligible|3|||
150169085|NCT01120275|541753983|FG000|Overall Study|Withdrawal by Subject|1|||
150169086|NCT01120275|541753983|FG000|Overall Study|Refusal|1|||
150169087|NCT01120275|541753983|FG000|Overall Study|Not specific|1|||
150169088|NCT01191086|541753984|FG000|Overall Study|Adverse Event|20|||
150169089|NCT01191086|541753984|FG000|Overall Study|Lack of Efficacy|10|||
150169090|NCT01191086|541753984|FG000|Overall Study|Lost to Follow-up|4|||
150169091|NCT01191086|541753984|FG000|Overall Study|Physician Decision|2|||
150169092|NCT01191086|541753984|FG000|Overall Study|Withdrawal by Subject|24|||
150169093|NCT01191086|541753984|FG000|Overall Study|Discontinuation criterion met|1|||
150169094|NCT01191086|541753984|FG000|Overall Study|Other|1|||
150169095|NCT00771849|541753985|FG000|Overall Study|Lost to Follow-up|1|||
150169096|NCT00771849|541753986|FG001|Overall Study|Lost to Follow-up|2|||
150169097|NCT00771849|541753985|FG000|Overall Study|Withdrawal by Subject|1|||
150169098|NCT00771849|541753986|FG001|Overall Study|Withdrawal by Subject|1|||
149820748|NCT02629965|540473720|FG001|Period 1|Other than listed above|2|||
149820749|NCT02629965|540473719|FG000|Period 2|Adverse Event|1|||
149820750|NCT02629965|540473720|FG001|Period 2|Adverse Event|0|||
150169099|NCT00771849|541753985|FG000|Overall Study|Not vaccinated|0|||
149820751|NCT03443869|540473721|FG000|Overall Study|Death|3|||
149820752|NCT03443869|540473722|FG001|Overall Study|Death|3|||
149820753|NCT03443869|540473721|FG000|Overall Study|Withdrawal by Subject|34|||
149820754|NCT03443869|540473722|FG001|Overall Study|Withdrawal by Subject|22|||
149820755|NCT03443869|540473721|FG000|Overall Study|Lost to Follow-up|1|||
149820756|NCT03443869|540473722|FG001|Overall Study|Lost to Follow-up|2|||
149820757|NCT03443869|540473721|FG000|Overall Study|Physician Decision|3|||
149820758|NCT03443869|540473722|FG001|Overall Study|Physician Decision|3|||
149820759|NCT03443869|540473721|FG000|Overall Study|Other|4|||
149820760|NCT03443869|540473722|FG001|Overall Study|Other|4|||
149820761|NCT02390219|540473723|FG000|Overall Study|Death|1|||
149820762|NCT02390219|540473723|FG000|Overall Study|Physician Decision|1|||
149820763|NCT02390219|540473723|FG000|Overall Study|Adverse Event|6|||
149820764|NCT02390219|540473723|FG000|Overall Study|Withdrawal by Subject|1|||
149820765|NCT02390219|540473723|FG000|Overall Study|Lost to Follow-up|2|||
149820766|NCT02390219|540473723|FG000|Overall Study|Other|2|||
149820767|NCT00299728|540473724|FG000|Overall Study|Lost to Follow-up|0|||
149820768|NCT00299728|540473725|FG001|Overall Study|Lost to Follow-up|1|||
149820769|NCT00299728|540473724|FG000|Overall Study|Withdrawal by Subject|0|||
149820770|NCT00299728|540473725|FG001|Overall Study|Withdrawal by Subject|1|||
149820771|NCT00299728|540473724|FG000|Overall Study|Progressive disease|0|||
149820772|NCT00299728|540473725|FG001|Overall Study|Progressive disease|1|||
149820773|NCT02230085|540473726|FG000|Overall Study|Physician Decision|1|||
149820774|NCT02230085|540473726|FG000|Overall Study|Withdrawal by Subject|3|||
149820775|NCT00580983|540473727|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
149820776|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
149820777|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
149820778|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
149820779|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
149820780|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
149820781|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Adverse Event|60|||
149820782|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Adverse Event|0|||
149820783|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Adverse Event|0|||
149820784|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Adverse Event|0|||
149820785|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Adverse Event|0|||
149820786|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
149820787|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
149820788|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
149820789|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
149820790|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
149820791|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Physician Decision|10|||
149820792|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Physician Decision|0|||
149820793|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Physician Decision|0|||
149820794|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Physician Decision|0|||
149820795|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Physician Decision|0|||
149820796|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
149820797|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
149820798|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
149820799|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
149820800|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
149820801|NCT01360632|540473728|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
149820802|NCT01360632|540473729|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
149820803|NCT01360632|540473730|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
149820804|NCT01360632|540473731|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
149820805|NCT01360632|540473732|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
149820806|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
149820807|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
149820808|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
150169100|NCT00771849|541753986|FG001|Overall Study|Not vaccinated|1|||
149820809|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
149820810|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
149820811|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Adverse Event|0|||
149820812|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Adverse Event|3|||
149820813|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Adverse Event|9|||
149820814|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Adverse Event|3|||
149820815|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Adverse Event|0|||
150169101|NCT02736799|541753990|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
150169102|NCT02736799|541753991|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
150169103|NCT02736799|541753992|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
150169104|NCT02736799|541753993|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
150169105|NCT01833832|541753994|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
150169106|NCT01156116|541753995|FG000|Overall Study|Withdrawal by Subject|3|||
150169107|NCT01156116|541753996|FG001|Overall Study|Withdrawal by Subject|1|||
149820816|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149820817|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149820818|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
149820819|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
149820820|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
150272691|NCT03606980|542136132|FG002|Overall Study|Withdrawal by Subject|4|||
150272692|NCT01294150|542136133|FG000|Overall Study|Physician Decision|2|||
150272693|NCT01294150|542136134|FG001|Overall Study|Physician Decision|2|||
150272694|NCT03675776|542136135|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
150272695|NCT03675776|542136136|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
150272696|NCT03675776|542136137|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
150272697|NCT03675776|542136135|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
150272698|NCT03675776|542136136|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
150272699|NCT03675776|542136137|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
150272700|NCT00999713|542136138|FG000|Overall Study|Physician Decision|2|||
150272701|NCT00999713|542136139|FG001|Overall Study|Physician Decision|0|||
150272702|NCT03427125|542136143|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
150272703|NCT03427125|542136144|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
150272704|NCT03427125|542136145|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
150272705|NCT05390580|542136148|FG000|Overall Study|Physician Decision|3|||
150272706|NCT05390580|542136149|FG001|Overall Study|Physician Decision|2|||
150272707|NCT04014361|542136150|FG000|Period 2|Physician Decision|0|||
150272708|NCT04014361|542136151|FG001|Period 2|Physician Decision|0|||
150272709|NCT04014361|542136152|FG002|Period 2|Physician Decision|0|||
150272710|NCT04014361|542136153|FG003|Period 2|Physician Decision|1|||
150272711|NCT04014361|542136154|FG004|Period 2|Physician Decision|0|||
150272712|NCT04014361|542136155|FG005|Period 2|Physician Decision|0|||
150272713|NCT04014361|542136156|FG006|Period 2|Physician Decision|0|||
150272714|NCT04014361|542136157|FG007|Period 2|Physician Decision|0|||
150272715|NCT01130051|542136159|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
150272716|NCT01130051|542136160|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
150272717|NCT01130051|542136159|FG000|Washout Period of 14 Days|Protocol Violation|1|||
150272718|NCT01130051|542136160|FG001|Washout Period of 14 Days|Protocol Violation|1|||
150272719|NCT04252287|542136163|FG000|Overall Study|Death|5|||
150272720|NCT04252287|542136164|FG001|Overall Study|Death|3|||
150272721|NCT04252287|542136163|FG000|Overall Study|Lost to Follow-up|4|||
150272722|NCT04252287|542136164|FG001|Overall Study|Lost to Follow-up|6|||
150272723|NCT04252287|542136163|FG000|Overall Study|Withdrawal by Subject|19|||
150272724|NCT04252287|542136164|FG001|Overall Study|Withdrawal by Subject|16|||
150272725|NCT04252287|542136163|FG000|Overall Study|Protocol Violation|3|||
150272726|NCT04252287|542136164|FG001|Overall Study|Protocol Violation|4|||
150272727|NCT02129205|542136169|FG000|Overall Study|Withdrawal by Subject|0|||
150272728|NCT02129205|542136170|FG001|Overall Study|Withdrawal by Subject|0|||
150272729|NCT02129205|542136171|FG002|Overall Study|Withdrawal by Subject|0|||
150272730|NCT02129205|542136172|FG003|Overall Study|Withdrawal by Subject|0|||
150272731|NCT02129205|542136173|FG004|Overall Study|Withdrawal by Subject|1|||
150272732|NCT02129205|542136174|FG005|Overall Study|Withdrawal by Subject|1|||
150272733|NCT02129205|542136175|FG006|Overall Study|Withdrawal by Subject|1|||
150272734|NCT02129205|542136176|FG007|Overall Study|Withdrawal by Subject|0|||
150272735|NCT02129205|542136177|FG008|Overall Study|Withdrawal by Subject|1|||
150272736|NCT02129205|542136178|FG009|Overall Study|Withdrawal by Subject|0|||
150272737|NCT02129205|542136169|FG000|Overall Study|Other|1|||
150272738|NCT02129205|542136170|FG001|Overall Study|Other|0|||
149820821|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Physician Decision|0|||
149820822|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Physician Decision|0|||
149820823|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Physician Decision|0|||
149938262|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
150272739|NCT02129205|542136171|FG002|Overall Study|Other|0|||
150272740|NCT02129205|542136172|FG003|Overall Study|Other|0|||
150272741|NCT02129205|542136173|FG004|Overall Study|Other|2|||
150272742|NCT02129205|542136174|FG005|Overall Study|Other|3|||
150272743|NCT02129205|542136175|FG006|Overall Study|Other|3|||
150272744|NCT02129205|542136176|FG007|Overall Study|Other|2|||
150272745|NCT02129205|542136177|FG008|Overall Study|Other|1|||
150272746|NCT02129205|542136178|FG009|Overall Study|Other|0|||
150272747|NCT04376060|542136180|FG000|Overall Study|Physician Decision|1|||
150272748|NCT07052682|542136183|FG000|Overall Study|Withdrawal by Subject|4|||
149938263|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
149938264|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
150272749|NCT01310803|542137674|FG000|Overall Study|Subject terminated by Sponsor|1|||
150272750|NCT01310803|542137675|FG001|Overall Study|Subject terminated by Sponsor|0|||
150272751|NCT00332839|542137676|FG000|Core (Months 0 - 12)|Administrative problems|1|||
150272752|NCT00332839|542137677|FG001|Core (Months 0 - 12)|Administrative problems|1|||
149938265|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
150272753|NCT00332839|542137676|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
149820824|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Physician Decision|1|||
149938266|NCT00784875|540912216|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
150272754|NCT00332839|542137677|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
150272755|NCT00332839|542137676|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
150272756|NCT00332839|542137677|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
149938267|NCT00784875|540912217|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
149938268|NCT00784875|540912218|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
149938269|NCT00784875|540912219|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
149938270|NCT00784875|540912216|FG000|Period C|Adverse Event|1|||
149938271|NCT00784875|540912217|FG001|Period C|Adverse Event|0|||
149938272|NCT00784875|540912218|FG002|Period C|Adverse Event|4|||
149938273|NCT00784875|540912219|FG003|Period C|Adverse Event|2|||
149938274|NCT00784875|540912216|FG000|Period C|Protocol Violation|0|||
149938275|NCT00784875|540912217|FG001|Period C|Protocol Violation|0|||
149938276|NCT00784875|540912218|FG002|Period C|Protocol Violation|1|||
149938277|NCT00784875|540912219|FG003|Period C|Protocol Violation|2|||
149938278|NCT00784875|540912216|FG000|Period C|Lack of Efficacy|0|||
150169108|NCT01156116|541753995|FG000|Overall Study|CPAP intolerance|2|||
150169109|NCT01156116|541753996|FG001|Overall Study|CPAP intolerance|0|||
150272757|NCT00332839|542137676|FG000|Core (Months 0 - 12)|Adverse Event|5|||
150169110|NCT00197015|541753997|FG000|Overall Study|Adverse Event|3|||
150169111|NCT00197015|541753998|FG001|Overall Study|Adverse Event|0|||
150169112|NCT00197015|541753999|FG002|Overall Study|Adverse Event|1|||
150169113|NCT00197015|541753997|FG000|Overall Study|Protocol Violation|0|||
150169114|NCT00197015|541753998|FG001|Overall Study|Protocol Violation|3|||
150169115|NCT00197015|541753999|FG002|Overall Study|Protocol Violation|3|||
150169116|NCT00197015|541753997|FG000|Overall Study|Withdrawal by Subject|17|||
150169117|NCT00197015|541753998|FG001|Overall Study|Withdrawal by Subject|37|||
150169118|NCT00197015|541753999|FG002|Overall Study|Withdrawal by Subject|34|||
150169119|NCT00197015|541753997|FG000|Overall Study|Lost to Follow-up|28|||
150169120|NCT00197015|541753998|FG001|Overall Study|Lost to Follow-up|46|||
150169121|NCT00197015|541753999|FG002|Overall Study|Lost to Follow-up|37|||
150169122|NCT00197015|541753997|FG000|Overall Study|Other|2|||
150169123|NCT00197015|541753998|FG001|Overall Study|Other|3|||
150169124|NCT00197015|541753999|FG002|Overall Study|Other|2|||
150169125|NCT04511650|541754002|FG000|Overall Study|Lost to Follow-up|1|||
150169126|NCT04511650|541754003|FG001|Overall Study|Lost to Follow-up|0|||
150169127|NCT04511650|541754004|FG002|Overall Study|Lost to Follow-up|0|||
150169128|NCT04511650|541754002|FG000|Overall Study|Withdrawal by Subject|1|||
150169129|NCT04511650|541754003|FG001|Overall Study|Withdrawal by Subject|0|||
150169130|NCT04511650|541754004|FG002|Overall Study|Withdrawal by Subject|0|||
150169131|NCT04511650|541754002|FG000|Overall Study|reason not provided|0|||
150169132|NCT04511650|541754003|FG001|Overall Study|reason not provided|0|||
150169133|NCT04511650|541754004|FG002|Overall Study|reason not provided|1|||
150169134|NCT04511650|541754002|FG000|Overall Study|Death|1|||
150169135|NCT04511650|541754003|FG001|Overall Study|Death|1|||
150169136|NCT04511650|541754004|FG002|Overall Study|Death|1|||
150169137|NCT00906035|541754006|FG000|Overall Study|Withdrawal by Subject|2|||
150169138|NCT00906035|541754007|FG001|Overall Study|Withdrawal by Subject|3|||
150169139|NCT00906035|541754008|FG002|Overall Study|Withdrawal by Subject|0|||
150169140|NCT03058991|541754011|FG000|Overall Study|Lost to Follow-up|17|||
150169141|NCT03058991|541754012|FG001|Overall Study|Lost to Follow-up|12|||
150169142|NCT03058991|541754013|FG002|Overall Study|Lost to Follow-up|12|||
150169143|NCT03058991|541754011|FG000|Overall Study|Withdrawal by Subject|1|||
150169144|NCT03058991|541754012|FG001|Overall Study|Withdrawal by Subject|0|||
150169145|NCT03058991|541754013|FG002|Overall Study|Withdrawal by Subject|0|||
150169146|NCT01972152|541754014|FG000|First Treatment Visit|Lost to Follow-up|0|||
150169147|NCT01972152|541754015|FG001|First Treatment Visit|Lost to Follow-up|1|||
150169148|NCT01972152|541754016|FG002|First Treatment Visit|Lost to Follow-up|0|||
150169149|NCT01972152|541754017|FG003|First Treatment Visit|Lost to Follow-up|0|||
150169150|NCT01972152|541754018|FG004|First Treatment Visit|Lost to Follow-up|0|||
150169151|NCT01972152|541754019|FG005|First Treatment Visit|Lost to Follow-up|0|||
150169152|NCT01972152|541754014|FG000|Second Treatment Visit|Protocol Violation|0|||
150169153|NCT01972152|541754015|FG001|Second Treatment Visit|Protocol Violation|1|||
150169154|NCT01972152|541754016|FG002|Second Treatment Visit|Protocol Violation|0|||
150169155|NCT01972152|541754017|FG003|Second Treatment Visit|Protocol Violation|0|||
150169156|NCT01972152|541754018|FG004|Second Treatment Visit|Protocol Violation|0|||
150169157|NCT01972152|541754019|FG005|Second Treatment Visit|Protocol Violation|0|||
150169158|NCT01186848|541754020|FG000|Overall Study|Lost to Follow-up|4|||
150169159|NCT01186848|541754020|FG000|Overall Study|Withdrawal by Subject|2|||
150169160|NCT01186848|541754020|FG000|Overall Study|Adverse Event|2|||
150169161|NCT02596035|541754021|FG000|Overall Study|Disease Progression|64|||
150169162|NCT02596035|541754022|FG001|Overall Study|Disease Progression|32|||
150169163|NCT02596035|541754023|FG002|Overall Study|Disease Progression|1|||
150169164|NCT02596035|541754021|FG000|Overall Study|study drug toxicity|12|||
150272758|NCT00332839|542137677|FG001|Core (Months 0 - 12)|Adverse Event|15|||
150169165|NCT02596035|541754022|FG001|Overall Study|study drug toxicity|3|||
150169166|NCT02596035|541754023|FG002|Overall Study|study drug toxicity|0|||
150169167|NCT02596035|541754021|FG000|Overall Study|AE unrelated to study drug|5|||
150169168|NCT02596035|541754022|FG001|Overall Study|AE unrelated to study drug|2|||
150169169|NCT02596035|541754023|FG002|Overall Study|AE unrelated to study drug|0|||
149938279|NCT00784875|540912217|FG001|Period C|Lack of Efficacy|0|||
149938280|NCT00784875|540912218|FG002|Period C|Lack of Efficacy|1|||
149938281|NCT00784875|540912219|FG003|Period C|Lack of Efficacy|0|||
149820825|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Physician Decision|0|||
149820826|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149820827|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
149820828|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
149820829|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
149820830|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149820831|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
150272759|NCT00332839|542137676|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
150272760|NCT00332839|542137677|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
150272761|NCT00332839|542137676|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
150272762|NCT00332839|542137677|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
150272763|NCT00332839|542137676|FG000|Follow-up (Months 12 - 60)|Death|1|||
150272764|NCT00332839|542137677|FG001|Follow-up (Months 12 - 60)|Death|1|||
150272765|NCT00594516|542137682|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
150272766|NCT00594516|542137683|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
150272767|NCT00594516|542137684|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
150272768|NCT00594516|542137682|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
150272769|NCT00594516|542137683|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
150272770|NCT00594516|542137684|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
150272771|NCT00594516|542137682|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
150272772|NCT00594516|542137683|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
149820832|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
149820833|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
149820834|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
149820835|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
149820836|NCT01360632|540473728|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
149820837|NCT01360632|540473729|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
149820838|NCT01360632|540473730|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
149820839|NCT01360632|540473731|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
149820840|NCT01360632|540473732|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
149820841|NCT01360632|540473728|FG000|Phase A+|Lost to Follow-up|0|||
149820842|NCT01360632|540473729|FG001|Phase A+|Lost to Follow-up|0|||
149820843|NCT01360632|540473730|FG002|Phase A+|Lost to Follow-up|0|||
149820844|NCT01360632|540473731|FG003|Phase A+|Lost to Follow-up|0|||
149820845|NCT01360632|540473732|FG004|Phase A+|Lost to Follow-up|2|||
149820846|NCT01360632|540473728|FG000|Phase A+|Adverse Event|0|||
149820847|NCT01360632|540473729|FG001|Phase A+|Adverse Event|0|||
149820848|NCT01360632|540473730|FG002|Phase A+|Adverse Event|0|||
149820849|NCT01360632|540473731|FG003|Phase A+|Adverse Event|0|||
149820850|NCT01360632|540473732|FG004|Phase A+|Adverse Event|2|||
149820851|NCT01360632|540473728|FG000|Phase A+|Met Withdrawal Criteria|0|||
149820852|NCT01360632|540473729|FG001|Phase A+|Met Withdrawal Criteria|0|||
149820853|NCT01360632|540473730|FG002|Phase A+|Met Withdrawal Criteria|0|||
149820854|NCT01360632|540473731|FG003|Phase A+|Met Withdrawal Criteria|0|||
150169170|NCT02596035|541754021|FG000|Overall Study|participant request to discontinue study treatment|2|||
150169171|NCT02596035|541754022|FG001|Overall Study|participant request to discontinue study treatment|0|||
150169172|NCT02596035|541754023|FG002|Overall Study|participant request to discontinue study treatment|0|||
150169173|NCT02596035|541754021|FG000|Overall Study|participant withdrew consent|2|||
150169174|NCT02596035|541754022|FG001|Overall Study|participant withdrew consent|2|||
150169175|NCT02596035|541754023|FG002|Overall Study|participant withdrew consent|0|||
150169176|NCT02596035|541754021|FG000|Overall Study|Poor/Non Comlpiance|0|||
150169177|NCT02596035|541754022|FG001|Overall Study|Poor/Non Comlpiance|1|||
150169178|NCT02596035|541754023|FG002|Overall Study|Poor/Non Comlpiance|0|||
150169179|NCT02596035|541754021|FG000|Overall Study|participant no longer meets study criteria|1|||
150169180|NCT02596035|541754022|FG001|Overall Study|participant no longer meets study criteria|0|||
150169181|NCT02596035|541754023|FG002|Overall Study|participant no longer meets study criteria|0|||
150169182|NCT02596035|541754021|FG000|Overall Study|other reasons|11|||
150169183|NCT02596035|541754022|FG001|Overall Study|other reasons|4|||
150169184|NCT02596035|541754023|FG002|Overall Study|other reasons|0|||
150169185|NCT00509769|541754024|FG000|Overall Study|Progressive disease|77|||
150169186|NCT00509769|541754024|FG000|Overall Study|Adverse Event|4|||
150169187|NCT00509769|541754024|FG000|Overall Study|Patient's decision|1|||
150169188|NCT00509769|541754024|FG000|Overall Study|Physician Decision|8|||
150169189|NCT00509769|541754024|FG000|Overall Study|Use of prohibited therapies during study|1|||
150169190|NCT01194258|541754026|FG000|Titration Period|Withdrawal by Subject|6|||
150169191|NCT01194258|541754027|FG001|Titration Period|Withdrawal by Subject|0|||
150169192|NCT01194258|541754028|FG002|Titration Period|Withdrawal by Subject|0|||
149820855|NCT01360632|540473732|FG004|Phase A+|Met Withdrawal Criteria|7|||
149820856|NCT01360632|540473728|FG000|Phase A+|Physician Decision|0|||
149820857|NCT01360632|540473729|FG001|Phase A+|Physician Decision|0|||
150169193|NCT01194258|541754029|FG003|Titration Period|Withdrawal by Subject|0|||
149820858|NCT01360632|540473730|FG002|Phase A+|Physician Decision|0|||
149820859|NCT01360632|540473731|FG003|Phase A+|Physician Decision|0|||
149820860|NCT01360632|540473732|FG004|Phase A+|Physician Decision|3|||
149820861|NCT01360632|540473728|FG000|Phase A+|Withdrawal by Subject|0|||
150272773|NCT00594516|542137684|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
150272774|NCT00594516|542137682|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
150272775|NCT00594516|542137683|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
150272776|NCT00594516|542137684|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
150272777|NCT00594516|542137682|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
150272778|NCT00594516|542137683|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
150272779|NCT00594516|542137684|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
150272780|NCT00594516|542137682|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
150272781|NCT00594516|542137683|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
150272782|NCT00594516|542137684|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
150272783|NCT00594516|542137682|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
150272784|NCT00594516|542137683|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
150272785|NCT00594516|542137684|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
150272786|NCT00594516|542137682|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
150272787|NCT00594516|542137683|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
150272788|NCT00594516|542137684|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
150272789|NCT00594516|542137682|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
150272790|NCT00594516|542137683|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
150272791|NCT00594516|542137684|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
150272792|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
150272793|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
150272794|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
150272795|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
150272796|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
150272797|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
150272798|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
150272799|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
150272800|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
150272801|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
150272802|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
150272803|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
150272804|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
150272805|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
150272806|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
150272807|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
150272808|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
150272809|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
150272810|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Early termination|0|||
150272811|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Early termination|0|||
150272812|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Early termination|34|||
150272813|NCT01493557|542137685|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
150272814|NCT01493557|542137686|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
150272815|NCT01493557|542137687|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
150272816|NCT01493557|542137685|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
150272817|NCT01493557|542137686|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
150272818|NCT01493557|542137687|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
150272819|NCT01493557|542137685|FG000|Randomized to Management Strategies|Other adverse event|8|||
149820862|NCT01360632|540473729|FG001|Phase A+|Withdrawal by Subject|0|||
149820863|NCT01360632|540473730|FG002|Phase A+|Withdrawal by Subject|0|||
149820864|NCT01360632|540473731|FG003|Phase A+|Withdrawal by Subject|0|||
149820865|NCT01360632|540473732|FG004|Phase A+|Withdrawal by Subject|8|||
149820866|NCT01360632|540473728|FG000|Phase A+|Protocol Deviation|0|||
149820867|NCT01360632|540473729|FG001|Phase A+|Protocol Deviation|0|||
149820868|NCT01360632|540473730|FG002|Phase A+|Protocol Deviation|0|||
149820869|NCT01360632|540473731|FG003|Phase A+|Protocol Deviation|0|||
149820870|NCT01360632|540473732|FG004|Phase A+|Protocol Deviation|3|||
149820871|NCT01298596|540473733|FG000|Overall Study|Withdrawal by Subject|1|||
149820872|NCT01298596|540473734|FG001|Overall Study|Withdrawal by Subject|1|||
149820873|NCT01298596|540473733|FG000|Overall Study|Death|5|||
149938282|NCT00784875|540912216|FG000|Period C|Withdrawal by Subject|1|||
149938283|NCT00784875|540912217|FG001|Period C|Withdrawal by Subject|1|||
149938284|NCT00784875|540912218|FG002|Period C|Withdrawal by Subject|2|||
149820874|NCT01298596|540473734|FG001|Overall Study|Death|3|||
149938285|NCT00784875|540912219|FG003|Period C|Withdrawal by Subject|0|||
149938286|NCT00784875|540912216|FG000|Period C|Physician Decision|0|||
149938287|NCT00784875|540912217|FG001|Period C|Physician Decision|0|||
149820875|NCT01298596|540473733|FG000|Overall Study|Lost to Follow-up|6|||
149820876|NCT01298596|540473734|FG001|Overall Study|Lost to Follow-up|14|||
149820877|NCT01298596|540473733|FG000|Overall Study|Referred for further management|16|||
149820878|NCT01298596|540473734|FG001|Overall Study|Referred for further management|15|||
149820879|NCT04128696|540473735|FG000|Overall Study|Lost to Follow-up|3|||
149820880|NCT04128696|540473736|FG001|Overall Study|Lost to Follow-up|7|||
149820881|NCT04128696|540473735|FG000|Overall Study|Withdrawal by Subject|12|||
149820882|NCT04128696|540473736|FG001|Overall Study|Withdrawal by Subject|11|||
149820883|NCT04128696|540473735|FG000|Overall Study|Study Closed/Terminated|26|||
149820884|NCT04128696|540473736|FG001|Overall Study|Study Closed/Terminated|38|||
149820885|NCT04128696|540473735|FG000|Overall Study|Physician Decision|2|||
149820886|NCT04128696|540473736|FG001|Overall Study|Physician Decision|3|||
149820887|NCT02046369|540473737|FG000|Overall Study|Adverse Event|3|||
149820888|NCT02046369|540473738|FG001|Overall Study|Adverse Event|3|||
149820889|NCT02046369|540473737|FG000|Overall Study|Lack of Efficacy|3|||
149820890|NCT02046369|540473738|FG001|Overall Study|Lack of Efficacy|3|||
149820891|NCT02046369|540473737|FG000|Overall Study|Lost to Follow-up|3|||
149820892|NCT02046369|540473738|FG001|Overall Study|Lost to Follow-up|3|||
149820893|NCT02046369|540473737|FG000|Overall Study|Protocol Violation|1|||
149820894|NCT02046369|540473738|FG001|Overall Study|Protocol Violation|2|||
149820895|NCT02046369|540473737|FG000|Overall Study|Withdrawal by Subject|3|||
149820896|NCT02046369|540473738|FG001|Overall Study|Withdrawal by Subject|6|||
150272820|NCT01493557|542137686|FG001|Randomized to Management Strategies|Other adverse event|5|||
150272821|NCT01493557|542137687|FG002|Randomized to Management Strategies|Other adverse event|0|||
150272822|NCT01493557|542137685|FG000|Randomized to Management Strategies|Protocol Violation|3|||
150272823|NCT01493557|542137686|FG001|Randomized to Management Strategies|Protocol Violation|0|||
150272824|NCT01493557|542137687|FG002|Randomized to Management Strategies|Protocol Violation|0|||
150272825|NCT01493557|542137685|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
150272826|NCT01493557|542137686|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
150272827|NCT01493557|542137687|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
150272828|NCT01493557|542137685|FG000|Randomized to Management Strategies|Other than stated above|1|||
150272829|NCT01493557|542137686|FG001|Randomized to Management Strategies|Other than stated above|3|||
150272830|NCT01493557|542137687|FG002|Randomized to Management Strategies|Other than stated above|0|||
150272831|NCT01493557|542137685|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
150272832|NCT01493557|542137686|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
150272833|NCT01493557|542137687|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
149820897|NCT02046369|540473737|FG000|Overall Study|never received study drug|0|||
149820898|NCT02046369|540473738|FG001|Overall Study|never received study drug|1|||
149820899|NCT02046369|540473737|FG000|Overall Study|non compliance|1|||
149820900|NCT02046369|540473738|FG001|Overall Study|non compliance|0|||
149820901|NCT02196506|540473743|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
149820902|NCT02196506|540473744|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
149820903|NCT02196506|540473745|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
149820904|NCT02196506|540473746|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
149820905|NCT02196506|540473743|FG000|Phase A|Withdrawal by Subject|34|||
149820906|NCT02196506|540473744|FG001|Phase A|Withdrawal by Subject|0|||
149820907|NCT02196506|540473745|FG002|Phase A|Withdrawal by Subject|0|||
149820908|NCT02196506|540473746|FG003|Phase A|Withdrawal by Subject|0|||
149820909|NCT02196506|540473743|FG000|Phase A|Adverse Event|22|||
149820910|NCT02196506|540473744|FG001|Phase A|Adverse Event|0|||
149820911|NCT02196506|540473745|FG002|Phase A|Adverse Event|0|||
149820912|NCT02196506|540473746|FG003|Phase A|Adverse Event|0|||
149820913|NCT02196506|540473743|FG000|Phase A|Lost to Follow-up|9|||
149820914|NCT02196506|540473744|FG001|Phase A|Lost to Follow-up|0|||
149820915|NCT02196506|540473745|FG002|Phase A|Lost to Follow-up|0|||
150272834|NCT01493557|542137685|FG000|Adding the Second Strategy|Other adverse event|1|||
150272835|NCT01493557|542137686|FG001|Adding the Second Strategy|Other adverse event|2|||
150272836|NCT01493557|542137687|FG002|Adding the Second Strategy|Other adverse event|0|||
150272837|NCT01493557|542137685|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
150272838|NCT01493557|542137686|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
150272839|NCT01493557|542137687|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
149820916|NCT02196506|540473746|FG003|Phase A|Lost to Follow-up|0|||
149820917|NCT02196506|540473743|FG000|Phase A|Protocol deviation|12|||
150272840|NCT02592551|542137688|FG000|Overall Study|Not evaluable|1|||
149820918|NCT02196506|540473744|FG001|Phase A|Protocol deviation|0|||
149820919|NCT02196506|540473745|FG002|Phase A|Protocol deviation|0|||
149820920|NCT02196506|540473746|FG003|Phase A|Protocol deviation|0|||
149820921|NCT02196506|540473743|FG000|Phase A|Participant withdrawn by investigator|10|||
149820922|NCT02196506|540473744|FG001|Phase A|Participant withdrawn by investigator|0|||
149820923|NCT02196506|540473745|FG002|Phase A|Participant withdrawn by investigator|0|||
149820924|NCT02196506|540473746|FG003|Phase A|Participant withdrawn by investigator|0|||
149820925|NCT02196506|540473743|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
149820926|NCT02196506|540473744|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
149820927|NCT02196506|540473745|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
149820928|NCT02196506|540473746|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
149820929|NCT02196506|540473743|FG000|Phase B|Lack of Efficacy|0|||
149820930|NCT02196506|540473744|FG001|Phase B|Lack of Efficacy|1|||
150272841|NCT02592551|542137689|FG001|Overall Study|Not evaluable|3|||
149820931|NCT02196506|540473745|FG002|Phase B|Lack of Efficacy|2|||
149820932|NCT02196506|540473746|FG003|Phase B|Lack of Efficacy|0|||
149820933|NCT02196506|540473743|FG000|Phase B|Withdrawal by Participant|0|||
149820934|NCT02196506|540473744|FG001|Phase B|Withdrawal by Participant|8|||
149820935|NCT02196506|540473745|FG002|Phase B|Withdrawal by Participant|1|||
149820936|NCT02196506|540473746|FG003|Phase B|Withdrawal by Participant|0|||
149820937|NCT02196506|540473743|FG000|Phase B|Adverse Event|0|||
149820938|NCT02196506|540473744|FG001|Phase B|Adverse Event|4|||
149820939|NCT02196506|540473745|FG002|Phase B|Adverse Event|1|||
149820940|NCT02196506|540473746|FG003|Phase B|Adverse Event|0|||
149820941|NCT02196506|540473743|FG000|Phase B|Lost to Follow-up|0|||
149820942|NCT02196506|540473744|FG001|Phase B|Lost to Follow-up|2|||
149820943|NCT02196506|540473745|FG002|Phase B|Lost to Follow-up|1|||
149820944|NCT02196506|540473746|FG003|Phase B|Lost to Follow-up|0|||
149820945|NCT02196506|540473743|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
149820946|NCT02196506|540473744|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
149820947|NCT02196506|540473745|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
149820948|NCT02196506|540473746|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
149820949|NCT02196506|540473743|FG000|Phase A+|Withdrawal by Participant|0|||
149820950|NCT02196506|540473744|FG001|Phase A+|Withdrawal by Participant|0|||
149820951|NCT02196506|540473745|FG002|Phase A+|Withdrawal by Participant|0|||
149820952|NCT02196506|540473746|FG003|Phase A+|Withdrawal by Participant|5|||
149820953|NCT02196506|540473743|FG000|Phase A+|Adverse Event|0|||
149820954|NCT02196506|540473744|FG001|Phase A+|Adverse Event|0|||
149820955|NCT02196506|540473745|FG002|Phase A+|Adverse Event|0|||
149820956|NCT02196506|540473746|FG003|Phase A+|Adverse Event|1|||
149820957|NCT02196506|540473743|FG000|Phase A+|Lost to Follow-up|0|||
149820958|NCT02196506|540473744|FG001|Phase A+|Lost to Follow-up|0|||
149820959|NCT02196506|540473745|FG002|Phase A+|Lost to Follow-up|0|||
149820960|NCT02196506|540473746|FG003|Phase A+|Lost to Follow-up|6|||
149820961|NCT02196506|540473743|FG000|Phase A+|Participant withdrawn by investigator|0|||
149820962|NCT02196506|540473744|FG001|Phase A+|Participant withdrawn by investigator|0|||
149820963|NCT02196506|540473745|FG002|Phase A+|Participant withdrawn by investigator|0|||
149820964|NCT02196506|540473746|FG003|Phase A+|Participant withdrawn by investigator|1|||
149820965|NCT03387059|540473747|FG000|Overall Study|Study termination|5|||
149820966|NCT03387059|540473748|FG001|Overall Study|Study termination|4|||
149820967|NCT04578548|540473757|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
149820968|NCT04578548|540473758|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
149820969|NCT04578548|540473757|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
149820970|NCT04578548|540473758|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
149820971|NCT04578548|540473757|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
149820972|NCT04578548|540473758|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
149938288|NCT00784875|540912218|FG002|Period C|Physician Decision|1|||
149938289|NCT00784875|540912219|FG003|Period C|Physician Decision|1|||
149938290|NCT00784875|540912216|FG000|Period C|Sponsor Decision|5|||
149938291|NCT00784875|540912217|FG001|Period C|Sponsor Decision|5|||
150272842|NCT02592551|542137690|FG002|Overall Study|Not evaluable|0|||
150272843|NCT01876251|542137693|FG000|Overall Study|Clinical progression|1|||
150272844|NCT01876251|542137694|FG001|Overall Study|Clinical progression|0|||
150272845|NCT01876251|542137695|FG002|Overall Study|Clinical progression|0|||
150272846|NCT01876251|542137693|FG000|Overall Study|Death|2|||
150272847|NCT01876251|542137694|FG001|Overall Study|Death|0|||
150272848|NCT01876251|542137695|FG002|Overall Study|Death|1|||
150272849|NCT01876251|542137693|FG000|Overall Study|Participant started new treatment|1|||
150272850|NCT01876251|542137694|FG001|Overall Study|Participant started new treatment|0|||
149820973|NCT04578548|540473757|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
149820974|NCT04578548|540473758|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
149820975|NCT04578548|540473757|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
149820976|NCT04578548|540473758|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
149820977|NCT04578548|540473757|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
149820978|NCT04578548|540473758|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
149938292|NCT00784875|540912218|FG002|Period C|Sponsor Decision|4|||
149820979|NCT00395083|540473759|FG000|Overall Study|Withdrawal by Subject|6|||
149820980|NCT00395083|540473760|FG001|Overall Study|Withdrawal by Subject|5|||
149820981|NCT00395083|540473759|FG000|Overall Study|Developed another disease|4|||
149820982|NCT00395083|540473760|FG001|Overall Study|Developed another disease|3|||
149938293|NCT00784875|540912219|FG003|Period C|Sponsor Decision|2|||
149938294|NCT00784875|540912216|FG000|Period D|Adverse Event|0|||
149938295|NCT00784875|540912217|FG001|Period D|Adverse Event|2|||
149938296|NCT00784875|540912218|FG002|Period D|Adverse Event|2|||
149938297|NCT00784875|540912219|FG003|Period D|Adverse Event|0|||
150272851|NCT01876251|542137695|FG002|Overall Study|Participant started new treatment|1|||
150272852|NCT01876251|542137693|FG000|Overall Study|Participant refused further follow-up|0|||
150272853|NCT01876251|542137694|FG001|Overall Study|Participant refused further follow-up|0|||
150272854|NCT01876251|542137695|FG002|Overall Study|Participant refused further follow-up|1|||
150272855|NCT01876251|542137693|FG000|Overall Study|Study terminated|1|||
150272856|NCT01876251|542137694|FG001|Overall Study|Study terminated|0|||
150272857|NCT01876251|542137695|FG002|Overall Study|Study terminated|0|||
150272858|NCT01876251|542137693|FG000|Overall Study|Objective progression or relapse|10|||
150272859|NCT01876251|542137694|FG001|Overall Study|Objective progression or relapse|3|||
150272860|NCT01876251|542137695|FG002|Overall Study|Objective progression or relapse|8|||
150272861|NCT02460497|542137702|FG000|Overall Study|Participant Requested Withdrawal|4|||
150272862|NCT02460497|542137702|FG000|Overall Study|Non-Compliance|1|||
150272863|NCT02460497|542137702|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
150272864|NCT02460497|542137702|FG000|Overall Study|Lost to Follow-up|2|||
150272865|NCT02460497|542137702|FG000|Overall Study|Investigator Decision|1|||
150272866|NCT03876171|542137703|FG000|Overall Study|Withdrawal by Subject|3|||
150272867|NCT03876171|542137704|FG001|Overall Study|Withdrawal by Subject|3|||
150272868|NCT03876171|542137703|FG000|Overall Study|Re-arrest|0|||
150272869|NCT03876171|542137704|FG001|Overall Study|Re-arrest|4|||
150272870|NCT02012296|542137705|FG000|Overall Study|Lack of Efficacy|0|||
150272871|NCT02012296|542137706|FG001|Overall Study|Lack of Efficacy|0|||
150272872|NCT02012296|542137707|FG002|Overall Study|Lack of Efficacy|15|||
150272873|NCT02012296|542137705|FG000|Overall Study|Adverse Event|0|||
150272874|NCT02012296|542137706|FG001|Overall Study|Adverse Event|0|||
150272875|NCT02012296|542137707|FG002|Overall Study|Adverse Event|2|||
150272876|NCT02012296|542137705|FG000|Overall Study|Early study closure|0|||
150272877|NCT02012296|542137706|FG001|Overall Study|Early study closure|0|||
150272878|NCT02012296|542137707|FG002|Overall Study|Early study closure|5|||
150272879|NCT02012296|542137705|FG000|Overall Study|Protocol Violation|0|||
150272880|NCT02012296|542137706|FG001|Overall Study|Protocol Violation|1|||
150272881|NCT02012296|542137707|FG002|Overall Study|Protocol Violation|0|||
150272882|NCT00908583|542137710|FG000|Phase 1|Withdrawal by Subject|1|||
150272883|NCT00908583|542137710|FG000|Phase 1|Adverse Event|4|||
150272884|NCT00908583|542137710|FG000|Phase 2|Physician Decision|1|||
150272885|NCT00908583|542137710|FG000|Phase 2|Adverse Event|1|||
150272886|NCT00908583|542137710|FG000|Phase 3|Adverse Event|2|||
150272887|NCT00908583|542137710|FG000|Phase 4|Adverse Event|1|||
150272888|NCT00908583|542137710|FG000|Phase 4|Physician Decision|1|||
150272889|NCT00908583|542137710|FG000|Phase 5|Adverse Event|3|||
150272890|NCT00993954|542137711|FG000|Overall Study|Protocol Violation|21|||
150272891|NCT00993954|542137712|FG001|Overall Study|Protocol Violation|2|||
150272892|NCT00860951|542137713|FG000|Overall Study|Withdrawal by Subject|2|||
150272893|NCT00860951|542137713|FG000|Overall Study|Lost to Follow-up|5|||
150272894|NCT01667081|542137715|FG000|Overall Study|Death|43|||
150272895|NCT01667081|542137716|FG001|Overall Study|Death|3|||
150272896|NCT01667081|542137715|FG000|Overall Study|Lost to Follow-up|99|||
150272897|NCT01667081|542137716|FG001|Overall Study|Lost to Follow-up|48|||
150272898|NCT01667081|542137715|FG000|Overall Study|Physician Decision|16|||
150272899|NCT01667081|542137716|FG001|Overall Study|Physician Decision|2|||
150272900|NCT01667081|542137715|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
150272901|NCT01667081|542137716|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
150272902|NCT01667081|542137715|FG000|Overall Study|Withdrawal by Subject|90|||
150272903|NCT01667081|542137716|FG001|Overall Study|Withdrawal by Subject|35|||
150272904|NCT03034460|542137717|FG000|Overall Study|Adverse Event|0|||
150272905|NCT03034460|542137718|FG001|Overall Study|Adverse Event|1|||
150272906|NCT03034460|542137717|FG000|Overall Study|Withdrawal by Subject|2|||
150272907|NCT03034460|542137718|FG001|Overall Study|Withdrawal by Subject|2|||
150272908|NCT03034460|542137717|FG000|Overall Study|Personal Reasons|1|||
150272909|NCT03034460|542137718|FG001|Overall Study|Personal Reasons|0|||
150272910|NCT01205438|542137719|FG000|Overall Study|Adverse Event|19|||
150272911|NCT01205438|542137720|FG001|Overall Study|Adverse Event|17|||
150272912|NCT01205438|542137721|FG002|Overall Study|Adverse Event|24|||
150272913|NCT01205438|542137719|FG000|Overall Study|Death|1|||
150272914|NCT01205438|542137720|FG001|Overall Study|Death|1|||
150272915|NCT01205438|542137721|FG002|Overall Study|Death|3|||
150272916|NCT01205438|542137719|FG000|Overall Study|Entry Criteria Not Met|16|||
150272917|NCT01205438|542137720|FG001|Overall Study|Entry Criteria Not Met|15|||
150272918|NCT01205438|542137721|FG002|Overall Study|Entry Criteria Not Met|13|||
150272919|NCT01205438|542137719|FG000|Overall Study|Lack of Efficacy|14|||
150272920|NCT01205438|542137720|FG001|Overall Study|Lack of Efficacy|11|||
150272921|NCT01205438|542137721|FG002|Overall Study|Lack of Efficacy|14|||
150272922|NCT01205438|542137719|FG000|Overall Study|Lost to Follow-up|6|||
150272923|NCT01205438|542137720|FG001|Overall Study|Lost to Follow-up|7|||
150272924|NCT01205438|542137721|FG002|Overall Study|Lost to Follow-up|8|||
150272925|NCT01205438|542137719|FG000|Overall Study|Withdrawal by Subject|19|||
150272926|NCT01205438|542137720|FG001|Overall Study|Withdrawal by Subject|25|||
150272927|NCT01205438|542137721|FG002|Overall Study|Withdrawal by Subject|19|||
150272928|NCT01205438|542137719|FG000|Overall Study|Physician Decision|0|||
150272929|NCT01205438|542137720|FG001|Overall Study|Physician Decision|3|||
149820983|NCT00972153|540473761|FG000|Overall Study|Equipment malfunction during case|0|||
149820984|NCT00972153|540473762|FG001|Overall Study|Equipment malfunction during case|1|||
149820985|NCT00972153|540473763|FG002|Overall Study|Equipment malfunction during case|0|||
149820986|NCT01077713|540473764|FG000|Overall Study|Withdrawal by Subject|1|||
149820987|NCT01077713|540473765|FG001|Overall Study|Withdrawal by Subject|2|||
149820988|NCT01077713|540473764|FG000|Overall Study|Progressive Disease (PD)|0|||
149820989|NCT01077713|540473765|FG001|Overall Study|Progressive Disease (PD)|1|||
149820990|NCT01077713|540473764|FG000|Overall Study|Death|28|||
149820991|NCT01077713|540473765|FG001|Overall Study|Death|29|||
149820992|NCT01077713|540473764|FG000|Overall Study|Lost to Follow-up|1|||
149820993|NCT01077713|540473765|FG001|Overall Study|Lost to Follow-up|1|||
149820994|NCT01077713|540473764|FG000|Overall Study|Adverse Event|2|||
149820995|NCT01077713|540473765|FG001|Overall Study|Adverse Event|1|||
149820996|NCT01077713|540473764|FG000|Overall Study|Other|4|||
149820997|NCT01077713|540473765|FG001|Overall Study|Other|2|||
149820998|NCT02482805|540475614|FG000|Overall Study|Lost to Follow-up|4|||
149820999|NCT02482805|540475615|FG001|Overall Study|Lost to Follow-up|4|||
149821000|NCT02482805|540475616|FG002|Overall Study|Lost to Follow-up|0|||
149938298|NCT00784875|540912216|FG000|Period D|Protocol Violation|1|||
149938299|NCT00784875|540912217|FG001|Period D|Protocol Violation|0|||
149938300|NCT00784875|540912218|FG002|Period D|Protocol Violation|0|||
149938301|NCT00784875|540912219|FG003|Period D|Protocol Violation|0|||
149938302|NCT00784875|540912216|FG000|Period D|Withdrawal by Subject|2|||
149938303|NCT00784875|540912217|FG001|Period D|Withdrawal by Subject|0|||
149938304|NCT00784875|540912218|FG002|Period D|Withdrawal by Subject|2|||
149938305|NCT00784875|540912219|FG003|Period D|Withdrawal by Subject|0|||
149938306|NCT00784875|540912216|FG000|Period D|Physician Decision|0|||
149938307|NCT00784875|540912217|FG001|Period D|Physician Decision|1|||
149938308|NCT00784875|540912218|FG002|Period D|Physician Decision|0|||
149938309|NCT00784875|540912219|FG003|Period D|Physician Decision|0|||
149938310|NCT00784875|540912216|FG000|Period D|Sponsor Decision|1|||
149938311|NCT00784875|540912217|FG001|Period D|Sponsor Decision|1|||
149938312|NCT00784875|540912218|FG002|Period D|Sponsor Decision|1|||
150169194|NCT01194258|541754030|FG004|Titration Period|Withdrawal by Subject|0|||
150169195|NCT01194258|541754026|FG000|Titration Period|Lost to Follow-up|2|||
150169196|NCT01194258|541754027|FG001|Titration Period|Lost to Follow-up|0|||
150169197|NCT01194258|541754028|FG002|Titration Period|Lost to Follow-up|0|||
150169198|NCT01194258|541754029|FG003|Titration Period|Lost to Follow-up|0|||
150169199|NCT01194258|541754030|FG004|Titration Period|Lost to Follow-up|0|||
150169200|NCT01194258|541754026|FG000|Titration Period|Titration failure|3|||
150169201|NCT01194258|541754027|FG001|Titration Period|Titration failure|0|||
150169202|NCT01194258|541754028|FG002|Titration Period|Titration failure|0|||
150169203|NCT01194258|541754029|FG003|Titration Period|Titration failure|0|||
150169204|NCT01194258|541754030|FG004|Titration Period|Titration failure|0|||
150169205|NCT01194258|541754026|FG000|Period 1 (12 Weeks)|Death|0|||
150169206|NCT01194258|541754027|FG001|Period 1 (12 Weeks)|Death|0|||
150169207|NCT01194258|541754028|FG002|Period 1 (12 Weeks)|Death|0|||
150169208|NCT01194258|541754029|FG003|Period 1 (12 Weeks)|Death|0|||
150169209|NCT01194258|541754030|FG004|Period 1 (12 Weeks)|Death|1|||
150169210|NCT01194258|541754026|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
150169211|NCT01194258|541754027|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
150169212|NCT01194258|541754028|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
150169213|NCT01194258|541754029|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
150169214|NCT01194258|541754030|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
150169215|NCT01194258|541754026|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
150169216|NCT01194258|541754027|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
150169217|NCT01194258|541754028|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
150169218|NCT01194258|541754029|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
150169219|NCT01194258|541754030|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
150169220|NCT01194258|541754026|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150169221|NCT01194258|541754027|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150169222|NCT01194258|541754028|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150169223|NCT01194258|541754029|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150169224|NCT01194258|541754030|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150169225|NCT02873754|541754032|FG000|Overall Study|Lost to Follow-up|5|||
149821001|NCT01806597|540475617|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
149821002|NCT01806597|540475618|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
149821003|NCT01806597|540475619|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
149821004|NCT01806597|540475620|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
149938313|NCT00784875|540912219|FG003|Period D|Sponsor Decision|0|||
149938314|NCT00784875|540912216|FG000|Period D|Lost to Follow-up|1|||
149938315|NCT00784875|540912217|FG001|Period D|Lost to Follow-up|0|||
149938316|NCT00784875|540912218|FG002|Period D|Lost to Follow-up|1|||
149938317|NCT00784875|540912219|FG003|Period D|Lost to Follow-up|1|||
149938318|NCT00853385|540912220|FG000|Overall Study|Death|0|||
149938319|NCT00853385|540912221|FG001|Overall Study|Death|0|||
149938320|NCT00853385|540912222|FG002|Overall Study|Death|0|||
149938321|NCT00853385|540912223|FG003|Overall Study|Death|0|||
150169226|NCT02873754|541754032|FG000|Overall Study|Couldn't complete study procedures|1|||
150272930|NCT01205438|542137721|FG002|Overall Study|Physician Decision|2|||
150272931|NCT01205438|542137719|FG000|Overall Study|Protocol Violation|2|||
150272932|NCT01205438|542137720|FG001|Overall Study|Protocol Violation|7|||
150272933|NCT01205438|542137721|FG002|Overall Study|Protocol Violation|4|||
150272934|NCT01205438|542137719|FG000|Overall Study|Sponsor Decision|0|||
150272935|NCT01205438|542137720|FG001|Overall Study|Sponsor Decision|1|||
150272936|NCT01205438|542137721|FG002|Overall Study|Sponsor Decision|1|||
150272937|NCT03823404|542137722|FG000|Overall Study|Lost to Follow-up|1|||
150272938|NCT03823404|542137723|FG001|Overall Study|Lost to Follow-up|2|||
150272939|NCT03823404|542137724|FG002|Overall Study|Lost to Follow-up|3|||
150272940|NCT03823404|542137722|FG000|Overall Study|Protocol Violation|2|||
150272941|NCT03823404|542137723|FG001|Overall Study|Protocol Violation|0|||
150272942|NCT03823404|542137724|FG002|Overall Study|Protocol Violation|2|||
150272943|NCT03823404|542137722|FG000|Overall Study|Adverse Event|35|||
150272944|NCT03823404|542137723|FG001|Overall Study|Adverse Event|38|||
150272945|NCT03823404|542137724|FG002|Overall Study|Adverse Event|8|||
150272946|NCT03823404|542137722|FG000|Overall Study|Withdrawal by Subject|38|||
150272947|NCT03823404|542137723|FG001|Overall Study|Withdrawal by Subject|40|||
150272948|NCT03823404|542137724|FG002|Overall Study|Withdrawal by Subject|35|||
150272949|NCT03823404|542137722|FG000|Overall Study|Death|4|||
150272950|NCT03823404|542137723|FG001|Overall Study|Death|0|||
150272951|NCT03823404|542137724|FG002|Overall Study|Death|0|||
150272952|NCT03823404|542137722|FG000|Overall Study|Other: Various reasons provided|5|||
150272953|NCT03823404|542137723|FG001|Overall Study|Other: Various reasons provided|5|||
150272954|NCT03823404|542137724|FG002|Overall Study|Other: Various reasons provided|6|||
150272955|NCT03631667|542137725|FG000|Overall Study|Withdrawal by Subject|3|||
150272956|NCT01087957|542137726|FG000|Overall Study|Death|2|||
150272957|NCT01087957|542137727|FG001|Overall Study|Death|2|||
150272958|NCT01087957|542137726|FG000|Overall Study|Lost to Follow-up|3|||
150272959|NCT01087957|542137727|FG001|Overall Study|Lost to Follow-up|4|||
150272960|NCT01087957|542137726|FG000|Overall Study|Protocol Violation|13|||
150272961|NCT01087957|542137727|FG001|Overall Study|Protocol Violation|25|||
150272962|NCT01087957|542137726|FG000|Overall Study|Withdrawal by Subject|18|||
150272963|NCT01087957|542137727|FG001|Overall Study|Withdrawal by Subject|15|||
150272964|NCT01087957|542137726|FG000|Overall Study|Physician Decision|5|||
150272965|NCT01087957|542137727|FG001|Overall Study|Physician Decision|9|||
150272966|NCT01399190|542137730|FG000|Overall Study|Not Eligible for Final Analysis|5|||
150272967|NCT01399190|542137730|FG000|Overall Study|Adverse Event|8|||
150272968|NCT01399190|542137730|FG000|Overall Study|Participant's Request|5|||
150272969|NCT01399190|542137730|FG000|Overall Study|Physician Decision|2|||
150272970|NCT01835015|542137732|FG000|Overall Study|Adverse Event|0|||
150272971|NCT01835015|542137733|FG001|Overall Study|Adverse Event|0|||
150272972|NCT01835015|542137734|FG002|Overall Study|Adverse Event|1|||
150272973|NCT01835015|542137735|FG003|Overall Study|Adverse Event|0|||
150272974|NCT01835015|542137736|FG004|Overall Study|Adverse Event|0|||
150272975|NCT03239483|542137737|FG000|Overall Study|Lost to Follow-up|1|||
150272976|NCT03239483|542137738|FG001|Overall Study|Lost to Follow-up|0|||
150272977|NCT03239483|542137737|FG000|Overall Study|Withdrawal by Subject|1|||
150272978|NCT03239483|542137738|FG001|Overall Study|Withdrawal by Subject|0|||
150272979|NCT03678103|542137742|FG000|Overall Study|Withdrawn prior to completion|4|||
149821005|NCT01806597|540475621|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
149821006|NCT01806597|540475622|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
149821007|NCT01806597|540475617|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
149821008|NCT01806597|540475618|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
149821009|NCT01806597|540475619|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
149821010|NCT01806597|540475620|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
149821011|NCT01806597|540475621|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
149821012|NCT01806597|540475622|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
150272980|NCT01241552|542137744|FG000|Overall Study|Lack of Efficacy|1|||
150272981|NCT01241552|542137745|FG001|Overall Study|Lack of Efficacy|0|||
150272982|NCT01241552|542137746|FG002|Overall Study|Lack of Efficacy|0|||
150272983|NCT01241552|542137747|FG003|Overall Study|Lack of Efficacy|0|||
150272984|NCT01241552|542137744|FG000|Overall Study|Death|26|||
150272985|NCT01241552|542137745|FG001|Overall Study|Death|30|||
150272986|NCT01241552|542137746|FG002|Overall Study|Death|20|||
150272987|NCT01241552|542137747|FG003|Overall Study|Death|25|||
150272988|NCT01241552|542137744|FG000|Overall Study|Adverse Event|1|||
150272989|NCT01241552|542137745|FG001|Overall Study|Adverse Event|1|||
150272990|NCT01241552|542137746|FG002|Overall Study|Adverse Event|0|||
150272991|NCT01241552|542137747|FG003|Overall Study|Adverse Event|0|||
150272992|NCT01241552|542137744|FG000|Overall Study|Technical Problems|2|||
150272993|NCT01241552|542137745|FG001|Overall Study|Technical Problems|0|||
150272994|NCT01241552|542137746|FG002|Overall Study|Technical Problems|2|||
150272995|NCT01241552|542137747|FG003|Overall Study|Technical Problems|2|||
149821013|NCT01806597|540475617|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
150272996|NCT01241552|542137744|FG000|Overall Study|Progressive Disease|0|||
150272997|NCT01241552|542137745|FG001|Overall Study|Progressive Disease|0|||
150272998|NCT01241552|542137746|FG002|Overall Study|Progressive Disease|1|||
150272999|NCT01241552|542137747|FG003|Overall Study|Progressive Disease|2|||
149821014|NCT01806597|540475618|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
149821015|NCT01806597|540475619|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
149821016|NCT01806597|540475620|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
149821017|NCT01806597|540475621|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
149821018|NCT01806597|540475622|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
149821019|NCT01806597|540475617|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
149821020|NCT01806597|540475618|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
149821021|NCT01806597|540475619|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
149821022|NCT01806597|540475620|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
149821023|NCT01806597|540475621|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
149821024|NCT01806597|540475622|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
149821025|NCT01806597|540475617|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
149821026|NCT01806597|540475618|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
149821027|NCT01806597|540475619|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
149821028|NCT01806597|540475620|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
149821029|NCT01806597|540475621|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
149821030|NCT01806597|540475622|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
149821031|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
149821032|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
149821033|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
149821034|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
149821035|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
149821036|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
149821037|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
149821038|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
149821039|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
149821040|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
149821041|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
149821042|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
149821043|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
149938322|NCT00853385|540912224|FG004|Overall Study|Death|1|||
149938323|NCT00853385|540912220|FG000|Overall Study|Adverse Event|24|||
149938324|NCT00853385|540912221|FG001|Overall Study|Adverse Event|24|||
149938325|NCT00853385|540912222|FG002|Overall Study|Adverse Event|2|||
149821044|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
149821045|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
149821046|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
149821047|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
149821048|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
149821049|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
149821050|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
149938326|NCT00853385|540912223|FG003|Overall Study|Adverse Event|5|||
150169227|NCT01321606|541754036|FG000|Overall Study|Lost to Follow-up|0|||
150169228|NCT01321606|541754037|FG001|Overall Study|Lost to Follow-up|0|||
150273000|NCT01241552|542137744|FG000|Overall Study|Protocol Violation|0|||
150273001|NCT01241552|542137745|FG001|Overall Study|Protocol Violation|2|||
150273002|NCT01241552|542137746|FG002|Overall Study|Protocol Violation|6|||
150273003|NCT01241552|542137747|FG003|Overall Study|Protocol Violation|1|||
150273004|NCT01241552|542137744|FG000|Overall Study|Withdrawal by Subject|7|||
150273005|NCT01241552|542137745|FG001|Overall Study|Withdrawal by Subject|15|||
150273006|NCT01241552|542137746|FG002|Overall Study|Withdrawal by Subject|14|||
150273007|NCT01241552|542137747|FG003|Overall Study|Withdrawal by Subject|15|||
150273008|NCT01241552|542137744|FG000|Overall Study|Physician Decision|2|||
149938327|NCT00853385|540912224|FG004|Overall Study|Adverse Event|22|||
149938328|NCT00853385|540912220|FG000|Overall Study|Lack of Efficacy|6|||
150169229|NCT01321606|541754038|FG002|Overall Study|Lost to Follow-up|0|||
150169230|NCT01321606|541754039|FG003|Overall Study|Lost to Follow-up|1|||
150169231|NCT03593070|541754040|FG000|Overall Study|administrative withdrawal|1|||
150169232|NCT03593070|541754041|FG001|Overall Study|administrative withdrawal|1|||
150169233|NCT03612804|541754047|FG000|Overall Study|Death|0|||
150169234|NCT03612804|541754048|FG001|Overall Study|Death|7|||
150169235|NCT03612804|541754049|FG002|Overall Study|Death|0|||
150169236|NCT03612804|541754050|FG003|Overall Study|Death|8|||
150169237|NCT03612804|541754047|FG000|Overall Study|Medication copay coverage issues|0|||
150169238|NCT03612804|541754048|FG001|Overall Study|Medication copay coverage issues|0|||
150169239|NCT03612804|541754049|FG002|Overall Study|Medication copay coverage issues|0|||
150169240|NCT03612804|541754050|FG003|Overall Study|Medication copay coverage issues|17|||
150169241|NCT03612804|541754047|FG000|Overall Study|Not current smoker at time of screening|0|||
150169242|NCT03612804|541754048|FG001|Overall Study|Not current smoker at time of screening|1|||
150169243|NCT03612804|541754049|FG002|Overall Study|Not current smoker at time of screening|0|||
150273009|NCT01241552|542137745|FG001|Overall Study|Physician Decision|4|||
150273010|NCT01241552|542137746|FG002|Overall Study|Physician Decision|2|||
150273011|NCT01241552|542137747|FG003|Overall Study|Physician Decision|3|||
150273012|NCT01241552|542137744|FG000|Overall Study|Lost to Follow-up|2|||
150273013|NCT01241552|542137745|FG001|Overall Study|Lost to Follow-up|11|||
150273014|NCT01241552|542137746|FG002|Overall Study|Lost to Follow-up|15|||
150273015|NCT01241552|542137747|FG003|Overall Study|Lost to Follow-up|16|||
150273016|NCT05395104|542137750|FG000|Overall Study|Met Liver Stopping Criteria|1|||
150273017|NCT05395104|542137750|FG000|Overall Study|Withdrawal by Subject|1|||
150273018|NCT00381563|542137751|FG000|Overall Study|Withdrawal by Subject|5|||
150273019|NCT00381563|542137752|FG001|Overall Study|Withdrawal by Subject|5|||
150273020|NCT00381563|542137751|FG000|Overall Study|Lost to Follow-up|2|||
150273021|NCT00381563|542137752|FG001|Overall Study|Lost to Follow-up|0|||
150273022|NCT00381563|542137751|FG000|Overall Study|Protocol Violation|0|||
150273023|NCT00381563|542137752|FG001|Overall Study|Protocol Violation|1|||
150273024|NCT00024167|542137753|FG000|Overall Study|Death|53|||
150273025|NCT00024167|542137754|FG001|Overall Study|Death|47|||
150273026|NCT00770770|542137759|FG000|Overall Study|Lost to Follow-up|1|||
150273027|NCT00770770|542137760|FG001|Overall Study|Lost to Follow-up|0|||
150273028|NCT00770770|542137759|FG000|Overall Study|Withdrawal by Subject|1|||
150273029|NCT00770770|542137760|FG001|Overall Study|Withdrawal by Subject|0|||
150273030|NCT00770770|542137759|FG000|Overall Study|Death|0|||
150273031|NCT00770770|542137760|FG001|Overall Study|Death|1|||
150273032|NCT00770770|542137759|FG000|Overall Study|Study Terminated|8|||
150273033|NCT00770770|542137760|FG001|Overall Study|Study Terminated|0|||
150273034|NCT00117507|542137762|FG000|Overall Study|Adverse Event|4|||
150273035|NCT00117507|542137762|FG000|Overall Study|Abnormal laboratory values|3|||
150273036|NCT00117507|542137762|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150273037|NCT00117507|542137762|FG000|Overall Study|Patient withdrew consent|4|||
150273038|NCT00117507|542137762|FG000|Overall Study|Death|3|||
150273039|NCT01505010|542137763|FG000|Overall Study|Protocol Violation|0|||
150273040|NCT01505010|542137764|FG001|Overall Study|Protocol Violation|1|||
150273041|NCT01505010|542137763|FG000|Overall Study|Lost to Follow-up|0|||
150273042|NCT01505010|542137764|FG001|Overall Study|Lost to Follow-up|1|||
150273043|NCT04513665|542137773|FG000|Overall Study|Adverse Event|2|||
150273044|NCT04513665|542137774|FG001|Overall Study|Adverse Event|0|||
150273045|NCT04513665|542137773|FG000|Overall Study|Lack of Efficacy|14|||
150273046|NCT04513665|542137774|FG001|Overall Study|Lack of Efficacy|0|||
150273047|NCT01368042|542137775|FG000|Overall Study|Death|14|||
150273048|NCT01368042|542137775|FG000|Overall Study|Protocol Violation|11|||
150273049|NCT01368042|542137775|FG000|Overall Study|Lost to Follow-up|4|||
150273050|NCT01368042|542137775|FG000|Overall Study|Transplanted|1|||
150273051|NCT02663271|542137776|FG000|Overall Study|Withdrawal by Subject|5|||
150273052|NCT02663271|542137776|FG000|Overall Study|Lack of Efficacy|1|||
150273053|NCT01572675|542137777|FG000|Overall Study|End of prescribed treatment|140|||
150273054|NCT01572675|542137778|FG001|Overall Study|End of prescribed treatment|118|||
150273055|NCT01572675|542137777|FG000|Overall Study|Recovery|16|||
150273056|NCT01572675|542137778|FG001|Overall Study|Recovery|23|||
150273057|NCT01572675|542137777|FG000|Overall Study|Lack of Efficacy|31|||
150273058|NCT01572675|542137778|FG001|Overall Study|Lack of Efficacy|31|||
150273059|NCT01572675|542137777|FG000|Overall Study|Intolerance|6|||
150273060|NCT01572675|542137778|FG001|Overall Study|Intolerance|5|||
150273061|NCT01572675|542137777|FG000|Overall Study|Improved symptoms|8|||
150273062|NCT01572675|542137778|FG001|Overall Study|Improved symptoms|2|||
150273063|NCT01572675|542137777|FG000|Overall Study|Surgical intervention|3|||
150273064|NCT01572675|542137778|FG001|Overall Study|Surgical intervention|6|||
150273065|NCT01572675|542137777|FG000|Overall Study|Withdrawal by Subject|5|||
150273066|NCT01572675|542137778|FG001|Overall Study|Withdrawal by Subject|1|||
150273067|NCT01572675|542137777|FG000|Overall Study|Physician Decision|2|||
150273068|NCT01572675|542137778|FG001|Overall Study|Physician Decision|2|||
150273069|NCT01572675|542137777|FG000|Overall Study|Death unrelated to coxibs|1|||
150273070|NCT01572675|542137778|FG001|Overall Study|Death unrelated to coxibs|1|||
150273071|NCT01572675|542137777|FG000|Overall Study|Other disease detected|1|||
150273072|NCT01572675|542137778|FG001|Overall Study|Other disease detected|1|||
150273073|NCT01572675|542137777|FG000|Overall Study|Unknown reason|1|||
150273074|NCT01572675|542137778|FG001|Overall Study|Unknown reason|1|||
150273075|NCT01572675|542137777|FG000|Overall Study|Rheumatologist new evaluation|0|||
150273076|NCT01572675|542137778|FG001|Overall Study|Rheumatologist new evaluation|1|||
150273077|NCT01572675|542137777|FG000|Overall Study|Missing data|1|||
150273078|NCT01572675|542137778|FG001|Overall Study|Missing data|4|||
150273079|NCT01572675|542137777|FG000|Overall Study|Lost to Follow-up|22|||
150273080|NCT01572675|542137778|FG001|Overall Study|Lost to Follow-up|27|||
150273081|NCT02966223|542137780|FG000|Overall Study|Physician Decision|3|||
150273082|NCT02966223|542137780|FG000|Overall Study|Withdrawal by Subject|11|||
150273083|NCT02966223|542137780|FG000|Overall Study|Lost to Follow-up|1|||
150273084|NCT01326728|542137781|FG000|Overall Study|Death|13|||
150273085|NCT01326728|542137782|FG001|Overall Study|Death|0|||
150273086|NCT01326728|542137781|FG000|Overall Study|Early closure of study|34|||
150273087|NCT01326728|542137782|FG001|Overall Study|Early closure of study|9|||
150273088|NCT02536755|542137783|FG000|Overall Study|Adverse Event|4|||
149821051|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
149821052|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
149821053|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
149821054|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
149821055|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
149821056|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
149821057|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
149821058|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
149821059|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
149938329|NCT00853385|540912221|FG001|Overall Study|Lack of Efficacy|7|||
149938330|NCT00853385|540912222|FG002|Overall Study|Lack of Efficacy|3|||
149938331|NCT00853385|540912223|FG003|Overall Study|Lack of Efficacy|3|||
149938332|NCT00853385|540912224|FG004|Overall Study|Lack of Efficacy|6|||
149938333|NCT00853385|540912220|FG000|Overall Study|Lost to Follow-up|2|||
149938334|NCT00853385|540912221|FG001|Overall Study|Lost to Follow-up|1|||
149938335|NCT00853385|540912222|FG002|Overall Study|Lost to Follow-up|0|||
149938336|NCT00853385|540912223|FG003|Overall Study|Lost to Follow-up|0|||
149821060|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
149821061|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
149821062|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
149821063|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
149938337|NCT00853385|540912224|FG004|Overall Study|Lost to Follow-up|0|||
149938338|NCT00853385|540912220|FG000|Overall Study|Withdrawal by Subject|4|||
149938339|NCT00853385|540912221|FG001|Overall Study|Withdrawal by Subject|2|||
149938340|NCT00853385|540912222|FG002|Overall Study|Withdrawal by Subject|0|||
149938341|NCT00853385|540912223|FG003|Overall Study|Withdrawal by Subject|1|||
149938342|NCT00853385|540912224|FG004|Overall Study|Withdrawal by Subject|1|||
149938343|NCT00853385|540912220|FG000|Overall Study|Other|18|||
149938344|NCT00853385|540912221|FG001|Overall Study|Other|9|||
149938345|NCT00853385|540912222|FG002|Overall Study|Other|4|||
149938346|NCT00853385|540912223|FG003|Overall Study|Other|4|||
149938347|NCT00853385|540912224|FG004|Overall Study|Other|12|||
149938348|NCT00941928|540912227|FG000|Overall Study|Withdrawal by Subject|1|||
149938349|NCT00941928|540912227|FG000|Overall Study|Disease Progression|1|||
149938350|NCT02300610|540912234|FG000|Overall Study|Withdrawal by Subject|1|||
149938351|NCT02300610|540912235|FG001|Overall Study|Withdrawal by Subject|0|||
149938352|NCT02300610|540912236|FG002|Overall Study|Withdrawal by Subject|1|||
149938353|NCT01829347|540912237|FG000|VTI-210|Death|5|||
149938354|NCT01829347|540912238|FG001|VTI-210|Death|3|||
149938355|NCT01829347|540912237|FG000|VTI-210|Withdrawal by Subject|1|||
149938356|NCT01829347|540912238|FG001|VTI-210|Withdrawal by Subject|0|||
149938357|NCT01829347|540912237|FG000|VTI-210E|Death|2|||
149938358|NCT01829347|540912238|FG001|VTI-210E|Death|1|||
149938359|NCT01829347|540912237|FG000|VTI-210E|Study terminated prematurely|1|||
149938360|NCT01829347|540912238|FG001|VTI-210E|Study terminated prematurely|5|||
149938361|NCT04018066|540912239|FG000|Overall Study|participants started taking medications during the study period|3|||
149938362|NCT04018066|540912239|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
149938363|NCT03530293|540912246|FG000|Pre-randomization|Adverse Event|12|||
149938364|NCT03530293|540912247|FG001|Pre-randomization|Adverse Event|0|||
149938365|NCT03530293|540912248|FG002|Pre-randomization|Adverse Event|0|||
149938366|NCT03530293|540912246|FG000|Pre-randomization|Protocol Violation|2|||
149938367|NCT03530293|540912247|FG001|Pre-randomization|Protocol Violation|0|||
149938368|NCT03530293|540912248|FG002|Pre-randomization|Protocol Violation|0|||
149938369|NCT03530293|540912246|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
150169244|NCT03612804|541754050|FG003|Overall Study|Not current smoker at time of screening|3|||
150169245|NCT03612804|541754047|FG000|Overall Study|Non-veteran status|0|||
150169246|NCT03612804|541754048|FG001|Overall Study|Non-veteran status|1|||
150169247|NCT03612804|541754049|FG002|Overall Study|Non-veteran status|0|||
150169248|NCT03612804|541754050|FG003|Overall Study|Non-veteran status|0|||
150169249|NCT03612804|541754047|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
150169250|NCT03612804|541754048|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
150169251|NCT03612804|541754049|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
150169252|NCT03612804|541754050|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
150169253|NCT03612804|541754047|FG000|Overall Study|Provider retired from VA|0|||
150169254|NCT03612804|541754048|FG001|Overall Study|Provider retired from VA|0|||
150169255|NCT03612804|541754049|FG002|Overall Study|Provider retired from VA|2|||
150169256|NCT03612804|541754050|FG003|Overall Study|Provider retired from VA|0|||
150169257|NCT03612804|541754047|FG000|Overall Study|Withdrawal by Subject|0|||
150169258|NCT03612804|541754048|FG001|Overall Study|Withdrawal by Subject|0|||
149938370|NCT03530293|540912247|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
149938371|NCT03530293|540912248|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
149938372|NCT03530293|540912246|FG000|Pre-randomization|Withdrawal by Subject|5|||
149938373|NCT03530293|540912247|FG001|Pre-randomization|Withdrawal by Subject|0|||
150169259|NCT03612804|541754049|FG002|Overall Study|Withdrawal by Subject|7|||
149938374|NCT03530293|540912248|FG002|Pre-randomization|Withdrawal by Subject|0|||
149938375|NCT03530293|540912246|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
149938376|NCT03530293|540912247|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
149938377|NCT03530293|540912248|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
149938378|NCT03530293|540912246|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
149938379|NCT03530293|540912247|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
149938380|NCT03530293|540912248|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
149938381|NCT03530293|540912246|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
149938382|NCT03530293|540912247|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
149938383|NCT03530293|540912248|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
149938384|NCT03530293|540912246|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
149938385|NCT03530293|540912247|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
149938386|NCT03530293|540912248|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
149938387|NCT03530293|540912246|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
149938388|NCT03530293|540912247|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
149938389|NCT03530293|540912248|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
150169260|NCT03612804|541754050|FG003|Overall Study|Withdrawal by Subject|0|||
150169261|NCT03612804|541754047|FG000|Overall Study|Provider involved with study activities|1|||
150169262|NCT03612804|541754048|FG001|Overall Study|Provider involved with study activities|0|||
150169263|NCT03612804|541754049|FG002|Overall Study|Provider involved with study activities|0|||
150169264|NCT03612804|541754050|FG003|Overall Study|Provider involved with study activities|0|||
150169265|NCT04550039|541754051|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
150169266|NCT04550039|541754052|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
150169267|NCT04550039|541754051|FG000|Overall Study|patient self-withdrew from study|0|||
150169268|NCT04550039|541754052|FG001|Overall Study|patient self-withdrew from study|1|||
150169269|NCT00462943|541754053|FG000|Overall Study|Failure to achieve a response|5|||
150169270|NCT00462943|541754054|FG001|Overall Study|Failure to achieve a response|5|||
150169271|NCT00462943|541754055|FG002|Overall Study|Failure to achieve a response|1|||
150169272|NCT00462943|541754053|FG000|Overall Study|Adverse Event|6|||
150169273|NCT00462943|541754054|FG001|Overall Study|Adverse Event|4|||
150169274|NCT00462943|541754055|FG002|Overall Study|Adverse Event|1|||
150169275|NCT00462943|541754053|FG000|Overall Study|Protocol Violation|1|||
150169276|NCT00462943|541754054|FG001|Overall Study|Protocol Violation|0|||
150169277|NCT00462943|541754055|FG002|Overall Study|Protocol Violation|0|||
150169278|NCT00462943|541754053|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
150169279|NCT00462943|541754054|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
150169280|NCT00462943|541754055|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
150169281|NCT00462943|541754053|FG000|Overall Study|Disease Progression|15|||
150169282|NCT00462943|541754054|FG001|Overall Study|Disease Progression|15|||
150169283|NCT00462943|541754055|FG002|Overall Study|Disease Progression|9|||
150169284|NCT00462943|541754053|FG000|Overall Study|Death|5|||
150169285|NCT00462943|541754054|FG001|Overall Study|Death|2|||
150169286|NCT00462943|541754055|FG002|Overall Study|Death|7|||
150169287|NCT00462943|541754053|FG000|Overall Study|Stem Cell Transplant|1|||
150169288|NCT00462943|541754054|FG001|Overall Study|Stem Cell Transplant|1|||
150169289|NCT00462943|541754055|FG002|Overall Study|Stem Cell Transplant|0|||
150169290|NCT00462943|541754053|FG000|Overall Study|Bone Marrow Transplant|1|||
150169291|NCT00462943|541754054|FG001|Overall Study|Bone Marrow Transplant|0|||
150169292|NCT00462943|541754055|FG002|Overall Study|Bone Marrow Transplant|0|||
150169293|NCT00462943|541754053|FG000|Overall Study|Required Lymphocyte Infusion|1|||
150169294|NCT00462943|541754054|FG001|Overall Study|Required Lymphocyte Infusion|0|||
150169295|NCT00462943|541754055|FG002|Overall Study|Required Lymphocyte Infusion|0|||
150169296|NCT00462943|541754053|FG000|Overall Study|Transplant - not specified|1|||
150169297|NCT00462943|541754054|FG001|Overall Study|Transplant - not specified|0|||
150169298|NCT00462943|541754055|FG002|Overall Study|Transplant - not specified|1|||
150169299|NCT00462943|541754053|FG000|Overall Study|Physician Decision|1|||
150169300|NCT00462943|541754054|FG001|Overall Study|Physician Decision|0|||
150169301|NCT00462943|541754055|FG002|Overall Study|Physician Decision|0|||
150169302|NCT00462943|541754053|FG000|Overall Study|Withdrawal by Subject|0|||
150169303|NCT00462943|541754054|FG001|Overall Study|Withdrawal by Subject|1|||
150169304|NCT00462943|541754055|FG002|Overall Study|Withdrawal by Subject|0|||
150169305|NCT01697319|541754057|FG000|Primary Phase|Withdrawal by Subject|1|||
150169306|NCT01697319|541754057|FG000|Extension Phase|Terminated by Sponsor|15|||
150169307|NCT04222959|541754060|FG000|Overall Study|Lost to Follow-up|76|||
150169308|NCT04222959|541754061|FG001|Overall Study|Lost to Follow-up|28|||
150169309|NCT01543685|541754066|FG000|Overall Study|Lack of Efficacy|1|||
150169310|NCT01543685|541754067|FG001|Overall Study|Lack of Efficacy|2|||
150169311|NCT01543685|541754068|FG002|Overall Study|Lack of Efficacy|2|||
150169312|NCT01543685|541754069|FG003|Overall Study|Lack of Efficacy|0|||
150169313|NCT01543685|541754070|FG004|Overall Study|Lack of Efficacy|2|||
150169314|NCT01543685|541754066|FG000|Overall Study|Adverse Event|2|||
150169315|NCT01543685|541754067|FG001|Overall Study|Adverse Event|1|||
149821064|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
149821065|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
149821066|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
149821067|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
149821068|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
149821069|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
149821070|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
149821071|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
149821072|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
149821073|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
149821074|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
149821075|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
149821076|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
149938390|NCT01663623|540912249|FG000|Overall Study|Adverse Event|3|||
149938391|NCT01663623|540912250|FG001|Overall Study|Adverse Event|7|||
149938392|NCT01663623|540912249|FG000|Overall Study|Lack of Efficacy|5|||
149938393|NCT01663623|540912250|FG001|Overall Study|Lack of Efficacy|6|||
149938394|NCT01663623|540912249|FG000|Overall Study|Protocol Violation|0|||
149938395|NCT01663623|540912250|FG001|Overall Study|Protocol Violation|1|||
149938396|NCT01663623|540912249|FG000|Overall Study|Other-Study closed/terminated|1|||
149938397|NCT01663623|540912250|FG001|Overall Study|Other-Study closed/terminated|1|||
149938398|NCT01663623|540912249|FG000|Overall Study|Physician Decision|1|||
149938399|NCT01663623|540912250|FG001|Overall Study|Physician Decision|4|||
149938400|NCT01663623|540912249|FG000|Overall Study|Withdrawal by Subject|2|||
149938401|NCT01663623|540912250|FG001|Overall Study|Withdrawal by Subject|1|||
149938402|NCT00686972|540912251|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
149938403|NCT04465422|540912264|FG000|Overall Study|Lost to Follow-up|0|||
149938404|NCT04465422|540912265|FG001|Overall Study|Lost to Follow-up|2|||
149938405|NCT05412134|540912270|FG000|Overall Study|Lost to Follow-up|2|||
149938406|NCT05412134|540912271|FG001|Overall Study|Lost to Follow-up|0|||
149938407|NCT01218802|540912273|FG000|Overall Study|Lost to Follow-up|5|||
149938408|NCT01218802|540912274|FG001|Overall Study|Lost to Follow-up|6|||
149938409|NCT01218802|540912273|FG000|Overall Study|Withdrawal by Subject|3|||
149938410|NCT01218802|540912274|FG001|Overall Study|Withdrawal by Subject|10|||
149938411|NCT01218802|540912273|FG000|Overall Study|Adverse Event|0|||
150273089|NCT01667107|542137785|FG000|Overall Study|Adverse Event|4|||
150273090|NCT01667107|542137786|FG001|Overall Study|Adverse Event|3|||
149821077|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
149821078|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
149821079|NCT01806597|540475617|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
149821080|NCT01806597|540475618|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
149821081|NCT01806597|540475619|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
149821082|NCT01806597|540475620|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
149821083|NCT01806597|540475621|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
149821084|NCT01806597|540475622|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
149821085|NCT01806597|540475617|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
149821086|NCT01806597|540475618|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
149821087|NCT01806597|540475619|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
149821088|NCT01806597|540475620|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
149821089|NCT01806597|540475621|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
149821090|NCT01806597|540475622|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
149821091|NCT01806597|540475617|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
149821092|NCT01806597|540475618|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
149821093|NCT01806597|540475619|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
149821094|NCT01806597|540475620|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
149821095|NCT01806597|540475621|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
149821096|NCT01806597|540475622|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
149821097|NCT01806597|540475617|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
149821098|NCT01806597|540475618|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
149821099|NCT01806597|540475619|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
149821100|NCT01806597|540475620|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
149821101|NCT01806597|540475621|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
149938412|NCT01218802|540912274|FG001|Overall Study|Adverse Event|2|||
149938413|NCT01218802|540912273|FG000|Overall Study|Incarcerated|2|||
149938414|NCT01218802|540912274|FG001|Overall Study|Incarcerated|0|||
149938415|NCT01123655|540912275|FG000|Overall Study|Medication for RA had to be changed|1|||
149938416|NCT01123655|540912276|FG001|Overall Study|Medication for RA had to be changed|0|||
150273091|NCT01667107|542137785|FG000|Overall Study|Tolerability issues|0|||
150273092|NCT01667107|542137786|FG001|Overall Study|Tolerability issues|2|||
150273093|NCT01667107|542137785|FG000|Overall Study|Protocol Violation|0|||
150273094|NCT01667107|542137786|FG001|Overall Study|Protocol Violation|1|||
150273095|NCT01667107|542137785|FG000|Overall Study|Lack of Efficacy|0|||
150273096|NCT01667107|542137786|FG001|Overall Study|Lack of Efficacy|1|||
150273097|NCT00972777|542137787|FG000|Overall Study|Adverse Event|3|||
150273098|NCT00972777|542137788|FG001|Overall Study|Adverse Event|2|||
150273099|NCT00972777|542137787|FG000|Overall Study|Lost to Follow-up|0|||
150273100|NCT00972777|542137788|FG001|Overall Study|Lost to Follow-up|4|||
150273101|NCT00972777|542137787|FG000|Overall Study|Withdrawal by Subject|4|||
150273102|NCT00972777|542137788|FG001|Overall Study|Withdrawal by Subject|5|||
150273103|NCT00972777|542137787|FG000|Overall Study|Physician Decision|4|||
150273104|NCT00972777|542137788|FG001|Overall Study|Physician Decision|0|||
150273105|NCT00972777|542137787|FG000|Overall Study|Protocol Violation|0|||
150273106|NCT00972777|542137788|FG001|Overall Study|Protocol Violation|2|||
150273107|NCT00972777|542137787|FG000|Overall Study|Screening Failure|2|||
150273108|NCT00972777|542137788|FG001|Overall Study|Screening Failure|1|||
150273109|NCT00972777|542137787|FG000|Overall Study|Missed visit|1|||
150273110|NCT00972777|542137788|FG001|Overall Study|Missed visit|0|||
150273111|NCT01093326|542137789|FG000|Overall Study|Death|0|||
150273112|NCT01093326|542137790|FG001|Overall Study|Death|1|||
150273113|NCT01093326|542137791|FG002|Overall Study|Death|0|||
150273114|NCT01093326|542137789|FG000|Overall Study|Lack of Efficacy|7|||
150273115|NCT01093326|542137790|FG001|Overall Study|Lack of Efficacy|6|||
150273116|NCT01093326|542137791|FG002|Overall Study|Lack of Efficacy|3|||
150273117|NCT01093326|542137789|FG000|Overall Study|Lost to Follow-up|2|||
150273118|NCT01093326|542137790|FG001|Overall Study|Lost to Follow-up|5|||
150273119|NCT01093326|542137791|FG002|Overall Study|Lost to Follow-up|4|||
150273120|NCT01093326|542137789|FG000|Overall Study|Physician Decision|3|||
150273121|NCT01093326|542137790|FG001|Overall Study|Physician Decision|1|||
150273122|NCT01093326|542137791|FG002|Overall Study|Physician Decision|3|||
150273123|NCT01093326|542137789|FG000|Overall Study|Withdrawal by Subject|30|||
150273124|NCT01093326|542137790|FG001|Overall Study|Withdrawal by Subject|27|||
150273125|NCT01093326|542137791|FG002|Overall Study|Withdrawal by Subject|26|||
150273126|NCT01093326|542137789|FG000|Overall Study|Adverse Event|2|||
150273127|NCT01093326|542137790|FG001|Overall Study|Adverse Event|1|||
150273128|NCT01093326|542137791|FG002|Overall Study|Adverse Event|4|||
150273129|NCT01093326|542137789|FG000|Overall Study|Other|0|||
150273130|NCT01093326|542137790|FG001|Overall Study|Other|0|||
150273131|NCT01093326|542137791|FG002|Overall Study|Other|1|||
150273132|NCT06950879|542137792|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
150273133|NCT05162027|542139459|FG000|Overall Study|Adverse Event|1|||
150273134|NCT05162027|542139460|FG001|Overall Study|Adverse Event|0|||
150273135|NCT02553265|542139461|FG000|Enrollment|Death|0|||
150273136|NCT02553265|542139462|FG001|Enrollment|Death|0|||
150273137|NCT02553265|542139463|FG002|Enrollment|Death|1|||
149938417|NCT01123655|540912277|FG002|Overall Study|Medication for RA had to be changed|0|||
149938418|NCT01123655|540912275|FG000|Overall Study|new illness|0|||
149938419|NCT01123655|540912276|FG001|Overall Study|new illness|1|||
149938420|NCT01123655|540912277|FG002|Overall Study|new illness|0|||
149938421|NCT01123655|540912275|FG000|Overall Study|began prohibitive drug|0|||
149938422|NCT01123655|540912276|FG001|Overall Study|began prohibitive drug|0|||
149938423|NCT01123655|540912277|FG002|Overall Study|began prohibitive drug|1|||
149938424|NCT00062166|540912278|FG000|Overall Study|Withdrawal by Subject|6|||
149938425|NCT01776554|540912284|FG000|Overall Study|Adverse Event|1|||
149938426|NCT01776554|540912285|FG001|Overall Study|Adverse Event|0|||
149938427|NCT01776554|540912284|FG000|Overall Study|Withdrawal by Subject|3|||
149938428|NCT01776554|540912285|FG001|Overall Study|Withdrawal by Subject|8|||
149938429|NCT01776554|540912284|FG000|Overall Study|Lost to Follow-up|6|||
150273138|NCT02553265|542139461|FG000|First Intervention (28 Days)|Adverse Event|1|||
150273139|NCT02553265|542139462|FG001|First Intervention (28 Days)|Adverse Event|0|||
150273140|NCT02553265|542139463|FG002|First Intervention (28 Days)|Adverse Event|0|||
150273141|NCT02553265|542139461|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
150273142|NCT02553265|542139462|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
150273143|NCT02553265|542139463|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
149938430|NCT01776554|540912285|FG001|Overall Study|Lost to Follow-up|9|||
149938431|NCT01776554|540912284|FG000|Overall Study|Administrative Reason|2|||
149938432|NCT01776554|540912285|FG001|Overall Study|Administrative Reason|5|||
150273144|NCT02553265|542139461|FG000|Second Intervention (28 Days)|Adverse Event|1|||
150273145|NCT02553265|542139462|FG001|Second Intervention (28 Days)|Adverse Event|0|||
150273146|NCT02553265|542139463|FG002|Second Intervention (28 Days)|Adverse Event|0|||
150273147|NCT02553265|542139461|FG000|Third Intervention (28 Days)|Adverse Event|1|||
150273148|NCT02553265|542139462|FG001|Third Intervention (28 Days)|Adverse Event|0|||
150273149|NCT02553265|542139463|FG002|Third Intervention (28 Days)|Adverse Event|0|||
149938433|NCT01776554|540912284|FG000|Overall Study|Protocol Violation|1|||
149938434|NCT01776554|540912285|FG001|Overall Study|Protocol Violation|0|||
149938435|NCT01776554|540912284|FG000|Overall Study|Unclassified|4|||
149938436|NCT01776554|540912285|FG001|Overall Study|Unclassified|1|||
150273150|NCT02553265|542139461|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
150273151|NCT02553265|542139462|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
150273152|NCT02553265|542139463|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
150273153|NCT01650285|542139469|FG000|Overall Study|Adverse Event|1|||
150273154|NCT00659529|542139470|FG000|Overall Study|Withdrawal by Subject|4|||
150273155|NCT00659529|542139470|FG000|Overall Study|Protocol Violation|3|||
150273156|NCT00659529|542139470|FG000|Overall Study|Screen failure|9|||
150273157|NCT02023242|542139473|FG000|Overall Study|Lost to Follow-up|3|||
150273158|NCT02023242|542139474|FG001|Overall Study|Lost to Follow-up|1|||
150273159|NCT02023242|542139473|FG000|Overall Study|Death|0|||
150273160|NCT02023242|542139474|FG001|Overall Study|Death|1|||
150273161|NCT01950247|542139475|FG000|Overall Study|Withdrawal by Subject|28|||
150273162|NCT01950247|542139476|FG001|Overall Study|Withdrawal by Subject|13|||
150273163|NCT01950247|542139475|FG000|Overall Study|Lost to Follow-up|18|||
150273164|NCT01950247|542139476|FG001|Overall Study|Lost to Follow-up|16|||
150273165|NCT01950247|542139475|FG000|Overall Study|Physician Decision|3|||
150169316|NCT01543685|541754068|FG002|Overall Study|Adverse Event|0|||
150169317|NCT01543685|541754069|FG003|Overall Study|Adverse Event|0|||
150169318|NCT01543685|541754070|FG004|Overall Study|Adverse Event|2|||
150169319|NCT01838551|541754071|FG000|Overall Study|Adverse Event|16|||
150169320|NCT01838551|541754071|FG000|Overall Study|Death|1|||
150169321|NCT01838551|541754071|FG000|Overall Study|Lack of Efficacy|10|||
150169322|NCT01838551|541754071|FG000|Overall Study|Physician Decision|4|||
150169323|NCT01838551|541754071|FG000|Overall Study|Withdrawal by Subject|10|||
150169324|NCT01838551|541754071|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
150169325|NCT00906282|541754072|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
150169326|NCT00906282|541754072|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
150169327|NCT00906282|541754072|FG000|Preoperative Chemotherapy|Progressive disease|6|||
150169328|NCT00906282|541754072|FG000|Preoperative Chemotherapy|Toxicity|1|||
150169329|NCT02685033|541754075|FG000|Overall Study|Withdrawal of Consent|0|||
150169330|NCT02685033|541754076|FG001|Overall Study|Withdrawal of Consent|1|||
150169331|NCT02685033|541754075|FG000|Overall Study|Lost to Follow-up|2|||
150169332|NCT02685033|541754076|FG001|Overall Study|Lost to Follow-up|1|||
150169333|NCT02685033|541754075|FG000|Overall Study|Adverse Event|1|||
150169334|NCT02685033|541754076|FG001|Overall Study|Adverse Event|0|||
150169335|NCT00708097|541754077|FG000|Period 1|Protocol Violation|0|||
150169336|NCT00708097|541754078|FG001|Period 1|Protocol Violation|1|||
150169337|NCT00708097|541754079|FG002|Period 1|Protocol Violation|0|||
150169338|NCT00708097|541754080|FG003|Period 1|Protocol Violation|2|||
150169339|NCT00708097|541754081|FG004|Period 1|Protocol Violation|0|||
150169340|NCT00708097|541754077|FG000|Period 1|Other Reason|0|||
150169341|NCT00708097|541754078|FG001|Period 1|Other Reason|0|||
150169342|NCT00708097|541754079|FG002|Period 1|Other Reason|0|||
150169343|NCT00708097|541754080|FG003|Period 1|Other Reason|0|||
150169344|NCT00708097|541754081|FG004|Period 1|Other Reason|1|||
150169345|NCT00708097|541754077|FG000|Period 2|Protocol Violation|0|||
150169346|NCT00708097|541754078|FG001|Period 2|Protocol Violation|1|||
150169347|NCT00708097|541754079|FG002|Period 2|Protocol Violation|1|||
150169348|NCT00708097|541754080|FG003|Period 2|Protocol Violation|1|||
150169349|NCT00708097|541754081|FG004|Period 2|Protocol Violation|0|||
150169350|NCT00628862|541755545|FG000|Overall Study|Adverse Event|6|||
150169351|NCT00628862|541755546|FG001|Overall Study|Adverse Event|8|||
150169352|NCT00628862|541755547|FG002|Overall Study|Adverse Event|10|||
150169353|NCT00628862|541755545|FG000|Overall Study|Withdrawal by Subject|4|||
150169354|NCT00628862|541755546|FG001|Overall Study|Withdrawal by Subject|6|||
150169355|NCT00628862|541755547|FG002|Overall Study|Withdrawal by Subject|11|||
150169356|NCT00628862|541755545|FG000|Overall Study|Lost to Follow-up|0|||
150169357|NCT00628862|541755546|FG001|Overall Study|Lost to Follow-up|2|||
150169358|NCT00628862|541755547|FG002|Overall Study|Lost to Follow-up|1|||
150169359|NCT00628862|541755545|FG000|Overall Study|Protocol Violation|1|||
150169360|NCT00628862|541755546|FG001|Overall Study|Protocol Violation|0|||
150169361|NCT00628862|541755547|FG002|Overall Study|Protocol Violation|0|||
150169362|NCT00628862|541755545|FG000|Overall Study|COPD Exacerbation|0|||
150169363|NCT00628862|541755546|FG001|Overall Study|COPD Exacerbation|1|||
150169364|NCT00628862|541755547|FG002|Overall Study|COPD Exacerbation|0|||
150169365|NCT03720210|541755548|FG000|Overall Study|Lost to Follow-up|1|||
150169366|NCT02614560|541755549|FG000|Overall Study|Death|6|||
150169367|NCT02614560|541755550|FG001|Overall Study|Death|2|||
150169368|NCT04033432|541755551|FG000|Overall Study|Progressive Disease|8|||
150169369|NCT04033432|541755551|FG000|Overall Study|Adverse Event|4|||
150273166|NCT01950247|542139476|FG001|Overall Study|Physician Decision|4|||
150273167|NCT01950247|542139475|FG000|Overall Study|Adverse Event|3|||
150169370|NCT04033432|541755551|FG000|Overall Study|Death|1|||
150169371|NCT00738699|541755557|FG000|Overall Study|Withdrawal by Subject|5|||
150169372|NCT00738699|541755558|FG001|Overall Study|Withdrawal by Subject|0|||
150169373|NCT00738699|541755557|FG000|Overall Study|Lost to Follow-up|1|||
150169374|NCT00738699|541755558|FG001|Overall Study|Lost to Follow-up|0|||
150169375|NCT00738699|541755557|FG000|Overall Study|Death|144|||
150273168|NCT01950247|542139476|FG001|Overall Study|Adverse Event|2|||
150273169|NCT01950247|542139475|FG000|Overall Study|Death|1|||
150273170|NCT01950247|542139476|FG001|Overall Study|Death|1|||
150273171|NCT01950247|542139475|FG000|Overall Study|Not Defined|4|||
150273172|NCT01950247|542139476|FG001|Overall Study|Not Defined|10|||
150273173|NCT00763971|542139477|FG000|Overall Study|Adverse Event|5|||
150273174|NCT00763971|542139478|FG001|Overall Study|Adverse Event|2|||
150273175|NCT00763971|542139479|FG002|Overall Study|Adverse Event|4|||
150273176|NCT00763971|542139477|FG000|Overall Study|Protocol Violation|3|||
150273177|NCT00763971|542139478|FG001|Overall Study|Protocol Violation|3|||
150273178|NCT00763971|542139479|FG002|Overall Study|Protocol Violation|2|||
150273179|NCT00763971|542139477|FG000|Overall Study|Withdrawal by Subject|4|||
150273180|NCT00763971|542139478|FG001|Overall Study|Withdrawal by Subject|5|||
150273181|NCT00763971|542139479|FG002|Overall Study|Withdrawal by Subject|5|||
150273182|NCT00763971|542139477|FG000|Overall Study|Lost to Follow-up|0|||
150273183|NCT00763971|542139478|FG001|Overall Study|Lost to Follow-up|1|||
150273184|NCT00763971|542139479|FG002|Overall Study|Lost to Follow-up|0|||
150273185|NCT00763971|542139477|FG000|Overall Study|Lack of Efficacy|11|||
150273186|NCT00763971|542139478|FG001|Overall Study|Lack of Efficacy|22|||
150273187|NCT00763971|542139479|FG002|Overall Study|Lack of Efficacy|54|||
150273188|NCT00763971|542139477|FG000|Overall Study|Unable to swallow capsule|2|||
150273189|NCT00763971|542139478|FG001|Overall Study|Unable to swallow capsule|1|||
150273190|NCT00763971|542139479|FG002|Overall Study|Unable to swallow capsule|1|||
150273191|NCT00763971|542139477|FG000|Overall Study|Personal reason|3|||
150273192|NCT00763971|542139478|FG001|Overall Study|Personal reason|0|||
150273193|NCT00763971|542139479|FG002|Overall Study|Personal reason|0|||
150273194|NCT00763971|542139477|FG000|Overall Study|Exclusion criteria met|1|||
150273195|NCT00763971|542139478|FG001|Overall Study|Exclusion criteria met|0|||
150273196|NCT00763971|542139479|FG002|Overall Study|Exclusion criteria met|0|||
150273197|NCT00763971|542139477|FG000|Overall Study|Sponsor decision|1|||
150273198|NCT00763971|542139478|FG001|Overall Study|Sponsor decision|0|||
150273199|NCT00763971|542139479|FG002|Overall Study|Sponsor decision|0|||
150273200|NCT00763971|542139477|FG000|Overall Study|Due to holiday season|2|||
150273201|NCT00763971|542139478|FG001|Overall Study|Due to holiday season|0|||
150273202|NCT00763971|542139479|FG002|Overall Study|Due to holiday season|1|||
149821102|NCT01806597|540475622|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
149938437|NCT01041859|540912286|FG000|Open-Label Titration|Adverse Event|69|||
149938438|NCT01041859|540912287|FG001|Open-Label Titration|Adverse Event|0|||
149938439|NCT01041859|540912288|FG002|Open-Label Titration|Adverse Event|0|||
149938440|NCT01041859|540912286|FG000|Open-Label Titration|Lack of Efficacy|3|||
149938441|NCT01041859|540912287|FG001|Open-Label Titration|Lack of Efficacy|0|||
149938442|NCT01041859|540912288|FG002|Open-Label Titration|Lack of Efficacy|0|||
149938443|NCT01041859|540912286|FG000|Open-Label Titration|Lost to Follow-up|1|||
149938444|NCT01041859|540912287|FG001|Open-Label Titration|Lost to Follow-up|0|||
149938445|NCT01041859|540912288|FG002|Open-Label Titration|Lost to Follow-up|0|||
149938446|NCT01041859|540912286|FG000|Open-Label Titration|Physician Decision|1|||
149938447|NCT01041859|540912287|FG001|Open-Label Titration|Physician Decision|0|||
149938448|NCT01041859|540912288|FG002|Open-Label Titration|Physician Decision|0|||
149938449|NCT01041859|540912286|FG000|Open-Label Titration|Protocol Violation|1|||
149938450|NCT01041859|540912287|FG001|Open-Label Titration|Protocol Violation|0|||
149938451|NCT01041859|540912288|FG002|Open-Label Titration|Protocol Violation|0|||
149938452|NCT01041859|540912286|FG000|Open-Label Titration|Other|7|||
149938453|NCT01041859|540912287|FG001|Open-Label Titration|Other|0|||
149938454|NCT01041859|540912288|FG002|Open-Label Titration|Other|0|||
149938455|NCT01041859|540912286|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
149938456|NCT01041859|540912287|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
149938457|NCT01041859|540912288|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
149938458|NCT01041859|540912286|FG000|Open-Label Titration|Withdrawal by Subject|11|||
149938459|NCT01041859|540912287|FG001|Open-Label Titration|Withdrawal by Subject|0|||
149938460|NCT01041859|540912288|FG002|Open-Label Titration|Withdrawal by Subject|0|||
149938461|NCT01041859|540912286|FG000|Double-Blind Maintenance|Adverse Event|0|||
149938462|NCT01041859|540912287|FG001|Double-Blind Maintenance|Adverse Event|23|||
149938463|NCT01041859|540912288|FG002|Double-Blind Maintenance|Adverse Event|13|||
149938464|NCT01041859|540912286|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
149938465|NCT01041859|540912287|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
150273203|NCT00763971|542139477|FG000|Overall Study|Randomization error|0|||
150273204|NCT00763971|542139478|FG001|Overall Study|Randomization error|0|||
150273205|NCT00763971|542139479|FG002|Overall Study|Randomization error|1|||
149938466|NCT01041859|540912288|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
149938467|NCT01041859|540912286|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
150273206|NCT00763971|542139477|FG000|Overall Study|Medical monitor decision|0|||
149938468|NCT01041859|540912287|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
149938469|NCT01041859|540912288|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
150273207|NCT00763971|542139478|FG001|Overall Study|Medical monitor decision|0|||
150273208|NCT00763971|542139479|FG002|Overall Study|Medical monitor decision|1|||
150273209|NCT00763971|542139477|FG000|Overall Study|Moved to another country|0|||
150273210|NCT00763971|542139478|FG001|Overall Study|Moved to another country|1|||
149821103|NCT01806597|540475617|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
149821104|NCT01806597|540475618|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
149821105|NCT01806597|540475619|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
149821106|NCT01806597|540475620|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
149821107|NCT01806597|540475621|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
149821108|NCT01806597|540475622|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
149821109|NCT01806597|540475617|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
149821110|NCT01806597|540475618|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
149821111|NCT01806597|540475619|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
149821112|NCT01806597|540475620|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
149821113|NCT01806597|540475621|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
149821114|NCT01806597|540475622|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
149821115|NCT01034137|540475623|FG000|Overall Study|Adverse Event|9|||
149821116|NCT01034137|540475624|FG001|Overall Study|Adverse Event|10|||
149821117|NCT01034137|540475625|FG002|Overall Study|Adverse Event|8|||
149821118|NCT01034137|540475623|FG000|Overall Study|Withdrawal by Subject|4|||
149821119|NCT01034137|540475624|FG001|Overall Study|Withdrawal by Subject|3|||
149821120|NCT01034137|540475625|FG002|Overall Study|Withdrawal by Subject|3|||
149821121|NCT01034137|540475623|FG000|Overall Study|Lack of Efficacy|9|||
149821122|NCT01034137|540475624|FG001|Overall Study|Lack of Efficacy|4|||
149821123|NCT01034137|540475625|FG002|Overall Study|Lack of Efficacy|13|||
149821124|NCT01034137|540475623|FG000|Overall Study|Protocol Violation|2|||
149821125|NCT01034137|540475624|FG001|Overall Study|Protocol Violation|2|||
149821126|NCT01034137|540475625|FG002|Overall Study|Protocol Violation|1|||
149821127|NCT01034137|540475623|FG000|Overall Study|Refused treatment or did not cooperate|2|||
149821128|NCT01034137|540475624|FG001|Overall Study|Refused treatment or did not cooperate|0|||
149821129|NCT01034137|540475625|FG002|Overall Study|Refused treatment or did not cooperate|1|||
150169376|NCT00738699|541755558|FG001|Overall Study|Death|68|||
150169377|NCT00738699|541755557|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
150169378|NCT00738699|541755558|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
150169379|NCT00738699|541755557|FG000|Overall Study|Other|2|||
150169380|NCT00738699|541755558|FG001|Overall Study|Other|0|||
150169381|NCT00549848|541755559|FG000|Overall Study|Death|1|||
150169382|NCT00549848|541755560|FG001|Overall Study|Death|4|||
150169383|NCT00549848|541755561|FG002|Overall Study|Death|13|||
150169384|NCT00549848|541755559|FG000|Overall Study|Physician Decision|0|||
150169385|NCT00549848|541755560|FG001|Overall Study|Physician Decision|0|||
150169386|NCT00549848|541755561|FG002|Overall Study|Physician Decision|4|||
150169387|NCT00549848|541755559|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
150169388|NCT00549848|541755560|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
150169389|NCT00549848|541755561|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
150169390|NCT00549848|541755559|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
150169391|NCT00549848|541755560|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
150169392|NCT00549848|541755561|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
150169393|NCT00549848|541755559|FG000|Overall Study|Participant/Family Withdraw|2|||
150169394|NCT00549848|541755560|FG001|Overall Study|Participant/Family Withdraw|3|||
150169395|NCT00549848|541755561|FG002|Overall Study|Participant/Family Withdraw|5|||
150169396|NCT00549848|541755559|FG000|Overall Study|Second Malignancy|1|||
150169397|NCT00549848|541755560|FG001|Overall Study|Second Malignancy|0|||
150169398|NCT00549848|541755561|FG002|Overall Study|Second Malignancy|0|||
150169399|NCT00549848|541755559|FG000|Overall Study|Transplant|3|||
150169400|NCT00549848|541755560|FG001|Overall Study|Transplant|3|||
150169401|NCT00549848|541755561|FG002|Overall Study|Transplant|18|||
150169402|NCT00549848|541755559|FG000|Overall Study|Unacceptable Toxicity|1|||
150169403|NCT00549848|541755560|FG001|Overall Study|Unacceptable Toxicity|6|||
150169404|NCT00549848|541755561|FG002|Overall Study|Unacceptable Toxicity|6|||
150169405|NCT00868192|541755563|FG000|Overall Study|Ineligible|4|||
150169406|NCT02174562|541755564|FG000|Overall Study|Withdrawal by Subject|7|||
150169407|NCT02174562|541755565|FG001|Overall Study|Withdrawal by Subject|2|||
150169408|NCT02174562|541755564|FG000|Overall Study|Death|2|||
150169409|NCT02174562|541755565|FG001|Overall Study|Death|0|||
150169410|NCT02174562|541755564|FG000|Overall Study|Lost to Follow-up|0|||
150169411|NCT02174562|541755565|FG001|Overall Study|Lost to Follow-up|3|||
150169412|NCT05193318|541755566|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
150169413|NCT05193318|541755566|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
150169414|NCT03201809|541755567|FG000|Overall Study|Lost to Follow-up|2|||
150169415|NCT03201809|541755568|FG001|Overall Study|Lost to Follow-up|0|||
150169416|NCT02046616|541755573|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
150169417|NCT02046616|541755573|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
150169418|NCT02046616|541755573|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
150169419|NCT02046616|541755573|FG000|24-Week Treatment Period|Physician Decision|3|||
150169420|NCT02046616|541755573|FG000|24-Week Treatment Period|Other|1|||
149821130|NCT01034137|540475623|FG000|Overall Study|Administrative or other|2|||
149821131|NCT01034137|540475624|FG001|Overall Study|Administrative or other|3|||
149821132|NCT01034137|540475625|FG002|Overall Study|Administrative or other|4|||
149821133|NCT03572933|540475626|FG000|Overall Study|Adverse Event|4|||
149821134|NCT03572933|540475627|FG001|Overall Study|Adverse Event|1|||
149821135|NCT03572933|540475626|FG000|Overall Study|Withdrawal by Subject|0|||
149821136|NCT03572933|540475627|FG001|Overall Study|Withdrawal by Subject|1|||
149821137|NCT02049359|540475631|FG000|Overall Study|Lost to Follow-up|26|||
149821138|NCT02049359|540475632|FG001|Overall Study|Lost to Follow-up|19|||
149821139|NCT01405950|540475633|FG000|Overall Study|Withdrawal by Subject|1|||
149821140|NCT01405950|540475634|FG001|Overall Study|Withdrawal by Subject|0|||
149821141|NCT01405950|540475635|FG002|Overall Study|Withdrawal by Subject|0|||
149821142|NCT01405950|540475636|FG003|Overall Study|Withdrawal by Subject|0|||
149821143|NCT01381900|540475637|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
149821144|NCT01381900|540475638|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
149821145|NCT01381900|540475639|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
149821146|NCT01381900|540475637|FG000|Overall Study|Adverse Event|4|||
149821147|NCT01381900|540475638|FG001|Overall Study|Adverse Event|6|||
149821148|NCT01381900|540475639|FG002|Overall Study|Adverse Event|7|||
149821149|NCT01381900|540475637|FG000|Overall Study|Noncompliance with study drug|0|||
149821150|NCT01381900|540475638|FG001|Overall Study|Noncompliance with study drug|0|||
149821151|NCT01381900|540475639|FG002|Overall Study|Noncompliance with study drug|1|||
149821152|NCT01381900|540475637|FG000|Overall Study|Physician Decision|0|||
149821153|NCT01381900|540475638|FG001|Overall Study|Physician Decision|1|||
149821154|NCT01381900|540475639|FG002|Overall Study|Physician Decision|1|||
149821155|NCT01381900|540475637|FG000|Overall Study|Protocol Violation|0|||
149821156|NCT01381900|540475638|FG001|Overall Study|Protocol Violation|1|||
149821157|NCT01381900|540475639|FG002|Overall Study|Protocol Violation|1|||
149821158|NCT01381900|540475637|FG000|Overall Study|Withdrawal by Subject|0|||
149938470|NCT01041859|540912286|FG000|Double-Blind Maintenance|Physician Decision|0|||
149938471|NCT01041859|540912287|FG001|Double-Blind Maintenance|Physician Decision|2|||
149938472|NCT01041859|540912288|FG002|Double-Blind Maintenance|Physician Decision|1|||
149938473|NCT01041859|540912286|FG000|Double-Blind Maintenance|Protocol Violation|0|||
149938474|NCT01041859|540912287|FG001|Double-Blind Maintenance|Protocol Violation|1|||
149938475|NCT01041859|540912288|FG002|Double-Blind Maintenance|Protocol Violation|3|||
149938476|NCT01041859|540912286|FG000|Double-Blind Maintenance|Other|0|||
150169421|NCT02046616|541755573|FG000|8-Week FU Period|Lost to Follow-up|1|||
150169422|NCT00130637|541755576|FG000|Overall Study|Adverse Event|2|||
150169423|NCT00130637|541755576|FG000|Overall Study|Withdrawal by Subject|1|||
150169424|NCT01591616|541755578|FG000|Overall Study|Withdrawal by Subject|1|||
150169425|NCT01959412|541755579|FG000|Overall Study|Protocol deviation|1|||
150169426|NCT01959412|541755580|FG001|Overall Study|Protocol deviation|1|||
150169427|NCT01959412|541755581|FG002|Overall Study|Protocol deviation|0|||
150169428|NCT01959412|541755582|FG003|Overall Study|Protocol deviation|1|||
150169429|NCT01959412|541755583|FG004|Overall Study|Protocol deviation|3|||
150169430|NCT01959412|541755584|FG005|Overall Study|Protocol deviation|0|||
150169431|NCT01959412|541755579|FG000|Overall Study|Adverse Event|0|||
150169432|NCT01959412|541755580|FG001|Overall Study|Adverse Event|0|||
150169433|NCT01959412|541755581|FG002|Overall Study|Adverse Event|0|||
150169434|NCT01959412|541755582|FG003|Overall Study|Adverse Event|1|||
150169435|NCT01959412|541755583|FG004|Overall Study|Adverse Event|0|||
150169436|NCT01959412|541755584|FG005|Overall Study|Adverse Event|0|||
150169437|NCT00158054|541755585|FG000|Overall Study|Refused to continue|3|||
150169438|NCT00158054|541755586|FG001|Overall Study|Refused to continue|0|||
150169439|NCT00158054|541755585|FG000|Overall Study|Unavailable for follow up|7|||
150169440|NCT00158054|541755586|FG001|Overall Study|Unavailable for follow up|3|||
150169441|NCT00414648|541755587|FG000|Overall Study|Adverse Event|5|||
150169442|NCT00414648|541755588|FG001|Overall Study|Adverse Event|5|||
150169443|NCT00414648|541755587|FG000|Overall Study|Death|0|||
150169444|NCT00414648|541755588|FG001|Overall Study|Death|1|||
150169445|NCT00414648|541755587|FG000|Overall Study|Lack of Efficacy|0|||
150169446|NCT00414648|541755588|FG001|Overall Study|Lack of Efficacy|2|||
150169447|NCT00414648|541755587|FG000|Overall Study|Withdrawal by Subject|0|||
150169448|NCT00414648|541755588|FG001|Overall Study|Withdrawal by Subject|1|||
150169449|NCT01490580|541755589|FG000|Overall Study|Parents withdrew consent|0|||
150169450|NCT01490580|541755590|FG001|Overall Study|Parents withdrew consent|2|||
150169451|NCT00383188|541755591|FG000|Overall Study|Adverse Event|4|||
150169452|NCT00383188|541755592|FG001|Overall Study|Adverse Event|7|||
150169453|NCT00383188|541755593|FG002|Overall Study|Adverse Event|9|||
150169454|NCT00383188|541755594|FG003|Overall Study|Adverse Event|8|||
150169455|NCT00383188|541755595|FG004|Overall Study|Adverse Event|8|||
150169456|NCT00383188|541755591|FG000|Overall Study|Lack of Efficacy|9|||
149938477|NCT01041859|540912287|FG001|Double-Blind Maintenance|Other|6|||
150169457|NCT00383188|541755592|FG001|Overall Study|Lack of Efficacy|3|||
150169458|NCT00383188|541755593|FG002|Overall Study|Lack of Efficacy|3|||
150169459|NCT00383188|541755594|FG003|Overall Study|Lack of Efficacy|2|||
149821159|NCT01381900|540475638|FG001|Overall Study|Withdrawal by Subject|0|||
150169460|NCT00383188|541755595|FG004|Overall Study|Lack of Efficacy|6|||
149938478|NCT01041859|540912288|FG002|Double-Blind Maintenance|Other|2|||
149938479|NCT01041859|540912286|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
149938480|NCT01041859|540912287|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
149938481|NCT01041859|540912288|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
149938482|NCT01041859|540912286|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
149938483|NCT01041859|540912287|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
149938484|NCT01041859|540912288|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
149938485|NCT01991795|540912291|FG000|Overall Study|Lost to Follow-up|6|||
149938486|NCT01991795|540912292|FG001|Overall Study|Lost to Follow-up|4|||
149938487|NCT01991795|540912291|FG000|Overall Study|Withdrawal by Subject|117|||
149938488|NCT01991795|540912292|FG001|Overall Study|Withdrawal by Subject|94|||
149938489|NCT01991795|540912291|FG000|Overall Study|Site prematurely closed by sponsor|26|||
149938490|NCT01991795|540912292|FG001|Overall Study|Site prematurely closed by sponsor|25|||
149938491|NCT00251758|540912297|FG000|Overall Study|Adverse Event|7|||
149938492|NCT00251758|540912298|FG001|Overall Study|Adverse Event|9|||
149938493|NCT00251758|540912299|FG002|Overall Study|Adverse Event|11|||
149938494|NCT00251758|540912297|FG000|Overall Study|Lost to Follow-up|4|||
149938495|NCT00251758|540912298|FG001|Overall Study|Lost to Follow-up|2|||
149938496|NCT00251758|540912299|FG002|Overall Study|Lost to Follow-up|5|||
149938497|NCT00251758|540912297|FG000|Overall Study|Withdrawal by Subject|13|||
149938498|NCT00251758|540912298|FG001|Overall Study|Withdrawal by Subject|7|||
149938499|NCT00251758|540912299|FG002|Overall Study|Withdrawal by Subject|3|||
149938500|NCT00251758|540912297|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
149821160|NCT01381900|540475639|FG002|Overall Study|Withdrawal by Subject|1|||
149938501|NCT00251758|540912298|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
149938502|NCT00251758|540912299|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
149938503|NCT00251758|540912297|FG000|Overall Study|Lack of Efficacy|3|||
149938504|NCT00251758|540912298|FG001|Overall Study|Lack of Efficacy|0|||
149938505|NCT00251758|540912299|FG002|Overall Study|Lack of Efficacy|0|||
149938506|NCT00251758|540912297|FG000|Overall Study|Noncompliant|0|||
149938507|NCT00251758|540912298|FG001|Overall Study|Noncompliant|2|||
149938508|NCT00251758|540912299|FG002|Overall Study|Noncompliant|2|||
149938509|NCT00251758|540912297|FG000|Overall Study|Pregnancy|0|||
149938510|NCT00251758|540912298|FG001|Overall Study|Pregnancy|1|||
149938511|NCT00251758|540912299|FG002|Overall Study|Pregnancy|0|||
149938512|NCT00251758|540912297|FG000|Overall Study|Per Subject Request|0|||
149938513|NCT00251758|540912298|FG001|Overall Study|Per Subject Request|0|||
149938514|NCT00251758|540912299|FG002|Overall Study|Per Subject Request|1|||
149938515|NCT00251758|540912297|FG000|Overall Study|Per Investigator Request|1|||
149938516|NCT00251758|540912298|FG001|Overall Study|Per Investigator Request|0|||
149938517|NCT00251758|540912299|FG002|Overall Study|Per Investigator Request|0|||
149938518|NCT03641508|540912302|FG000|First Injection|Lost to Follow-up|2|||
149938519|NCT03641508|540912303|FG001|First Injection|Lost to Follow-up|0|||
149938520|NCT02404545|540912304|FG000|Overall Study|Sponsor Termination|6|||
149938521|NCT02404545|540912305|FG001|Overall Study|Sponsor Termination|6|||
149938522|NCT02577029|540912306|FG000|Overall Study|Adverse Event|1|||
149938523|NCT02577029|540912307|FG001|Overall Study|Adverse Event|0|||
149938524|NCT02577029|540912308|FG002|Overall Study|Adverse Event|2|||
149938525|NCT02577029|540912309|FG003|Overall Study|Adverse Event|0|||
149938526|NCT02577029|540912310|FG004|Overall Study|Adverse Event|1|||
149938527|NCT02577029|540912311|FG005|Overall Study|Adverse Event|0|||
149938528|NCT02577029|540912312|FG006|Overall Study|Adverse Event|0|||
149938529|NCT02577029|540912313|FG007|Overall Study|Adverse Event|0|||
149938530|NCT02577029|540912306|FG000|Overall Study|Withdrawal by Subject|0|||
149938531|NCT02577029|540912307|FG001|Overall Study|Withdrawal by Subject|0|||
149938532|NCT02577029|540912308|FG002|Overall Study|Withdrawal by Subject|0|||
149938533|NCT02577029|540912309|FG003|Overall Study|Withdrawal by Subject|0|||
149938534|NCT02577029|540912310|FG004|Overall Study|Withdrawal by Subject|0|||
149938535|NCT02577029|540912311|FG005|Overall Study|Withdrawal by Subject|1|||
149938536|NCT02577029|540912312|FG006|Overall Study|Withdrawal by Subject|0|||
150169461|NCT00383188|541755591|FG000|Overall Study|Other|3|||
150169462|NCT00383188|541755592|FG001|Overall Study|Other|1|||
150169463|NCT00383188|541755593|FG002|Overall Study|Other|0|||
150169464|NCT00383188|541755594|FG003|Overall Study|Other|2|||
150169465|NCT00383188|541755595|FG004|Overall Study|Other|6|||
150169466|NCT00383188|541755591|FG000|Overall Study|No longer willing to participate|1|||
150169467|NCT00383188|541755592|FG001|Overall Study|No longer willing to participate|0|||
150169468|NCT00383188|541755593|FG002|Overall Study|No longer willing to participate|1|||
150169469|NCT00383188|541755594|FG003|Overall Study|No longer willing to participate|0|||
150169470|NCT00383188|541755595|FG004|Overall Study|No longer willing to participate|2|||
150169471|NCT00383188|541755591|FG000|Overall Study|Lost to Follow-up|0|||
150169472|NCT00383188|541755592|FG001|Overall Study|Lost to Follow-up|0|||
150169473|NCT00383188|541755593|FG002|Overall Study|Lost to Follow-up|0|||
150169474|NCT00383188|541755594|FG003|Overall Study|Lost to Follow-up|0|||
150169475|NCT00383188|541755595|FG004|Overall Study|Lost to Follow-up|1|||
149938537|NCT02577029|540912313|FG007|Overall Study|Withdrawal by Subject|0|||
150169476|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
150273211|NCT00763971|542139479|FG002|Overall Study|Moved to another country|0|||
150273212|NCT00763971|542139477|FG000|Overall Study|Subject wanted dose reduction|0|||
150273213|NCT00763971|542139478|FG001|Overall Study|Subject wanted dose reduction|1|||
150273214|NCT00763971|542139479|FG002|Overall Study|Subject wanted dose reduction|0|||
150273215|NCT00763971|542139477|FG000|Overall Study|Lack of availability|0|||
150273216|NCT00763971|542139478|FG001|Overall Study|Lack of availability|1|||
150273217|NCT00763971|542139479|FG002|Overall Study|Lack of availability|0|||
150273218|NCT00763971|542139477|FG000|Overall Study|Performed final visit on phone|0|||
150273219|NCT00763971|542139478|FG001|Overall Study|Performed final visit on phone|1|||
150273220|NCT00763971|542139479|FG002|Overall Study|Performed final visit on phone|0|||
150273221|NCT00763971|542139477|FG000|Overall Study|Participation in 489-326 required|1|||
150273222|NCT00763971|542139478|FG001|Overall Study|Participation in 489-326 required|0|||
150273223|NCT00763971|542139479|FG002|Overall Study|Participation in 489-326 required|0|||
150273224|NCT03383289|542139482|FG000|Overall Study|Death|83|||
150273225|NCT03383289|542139483|FG001|Overall Study|Death|78|||
150273226|NCT03383289|542139482|FG000|Overall Study|discharge from facility|84|||
150273227|NCT03383289|542139483|FG001|Overall Study|discharge from facility|84|||
150273228|NCT03383289|542139482|FG000|Overall Study|Withdrawal by Subject|4|||
150273229|NCT03383289|542139483|FG001|Overall Study|Withdrawal by Subject|1|||
150273230|NCT00832117|542139484|FG000|Overall Study|Death|1|||
150273231|NCT00832117|542139484|FG000|Overall Study|Disease Progression|11|||
150273232|NCT02606461|542139485|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
150273233|NCT02606461|542139486|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
150273234|NCT02606461|542139487|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
150273235|NCT02606461|542139488|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
150273236|NCT02606461|542139489|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
150273237|NCT02606461|542139490|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
150273238|NCT03740997|542139494|FG000|Overall Study|Withdrawal by Subject|1|||
150273239|NCT03740997|542139495|FG001|Overall Study|Withdrawal by Subject|0|||
150273240|NCT03740997|542139494|FG000|Overall Study|Participant was unable to complete study procedures|1|||
150273241|NCT03740997|542139495|FG001|Overall Study|Participant was unable to complete study procedures|0|||
150273242|NCT03681951|542139499|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
150273243|NCT03681951|542139500|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273244|NCT03681951|542139501|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273245|NCT03681951|542139502|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273246|NCT03681951|542139503|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273247|NCT03681951|542139504|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273248|NCT03681951|542139505|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273249|NCT03681951|542139506|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
150273250|NCT03681951|542139499|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
150273251|NCT03681951|542139500|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273252|NCT03681951|542139501|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273253|NCT03681951|542139502|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273254|NCT03681951|542139503|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273255|NCT03681951|542139504|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273256|NCT03681951|542139505|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273257|NCT03681951|542139506|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
150273258|NCT03681951|542139499|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
150273259|NCT03681951|542139500|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273260|NCT03681951|542139501|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273261|NCT03681951|542139502|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273262|NCT03681951|542139503|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273263|NCT03681951|542139504|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273264|NCT03681951|542139505|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273265|NCT03681951|542139506|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
150273266|NCT02187809|542139507|FG000|Overall Study|The study was terminated|3|||
150273267|NCT01020448|542139508|FG000|Pre-assignment|Adverse Event|6|||
150273268|NCT01020448|542139508|FG000|Pre-assignment|Withdrawal by Subject|5|||
150273269|NCT01020448|542139508|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
150273270|NCT01020448|542139508|FG000|Treatment|Adverse Event|11|||
150273271|NCT01020448|542139508|FG000|Treatment|Consent Withdrawn|3|||
150273272|NCT01020448|542139508|FG000|Treatment|Disease Progression|2|||
149938538|NCT02577029|540912306|FG000|Overall Study|Sponsor Termination of the Study|9|||
150273273|NCT01020448|542139508|FG000|Treatment|Lack of Efficacy|8|||
150273274|NCT01020448|542139508|FG000|Treatment|Lost to Follow-up|2|||
150273275|NCT01230554|542139509|FG000|Overall Study|Lost to Follow-up|2|||
150273276|NCT01230554|542139509|FG000|Overall Study|Inability to maintain visit schedule|1|||
149821161|NCT01381900|540475637|FG000|Overall Study|Early withdraw|3|||
149938539|NCT02577029|540912307|FG001|Overall Study|Sponsor Termination of the Study|2|||
150273277|NCT01006265|542139512|FG000|Overall Study|Lost to Follow-up|1|||
150273278|NCT01006265|542139513|FG001|Overall Study|Lost to Follow-up|0|||
150273279|NCT01006265|542139514|FG002|Overall Study|Lost to Follow-up|1|||
150273280|NCT01006265|542139515|FG003|Overall Study|Lost to Follow-up|0|||
150273281|NCT01006265|542139512|FG000|Overall Study|Withdrawal by Subject|4|||
150273282|NCT01006265|542139513|FG001|Overall Study|Withdrawal by Subject|7|||
150273283|NCT01006265|542139514|FG002|Overall Study|Withdrawal by Subject|5|||
150273284|NCT01006265|542139515|FG003|Overall Study|Withdrawal by Subject|5|||
150273285|NCT01006265|542139512|FG000|Overall Study|Administrative reason|1|||
150273286|NCT01006265|542139513|FG001|Overall Study|Administrative reason|2|||
150273287|NCT01006265|542139514|FG002|Overall Study|Administrative reason|3|||
150273288|NCT01006265|542139515|FG003|Overall Study|Administrative reason|0|||
150273289|NCT00307333|542139516|FG000|Overall Study|Lost to Follow-up|11|||
150273290|NCT00307333|542139517|FG001|Overall Study|Lost to Follow-up|3|||
150273291|NCT01245387|542139518|FG000|Overall Study|Lost to Follow-up|106|||
150273292|NCT01245387|542139518|FG000|Overall Study|Lack of Efficacy|195|||
150273293|NCT01245387|542139518|FG000|Overall Study|Adverse Event|9|||
150273294|NCT01245387|542139518|FG000|Overall Study|Death|3|||
150273295|NCT01245387|542139518|FG000|Overall Study|Other|131|||
150273296|NCT01245387|542139518|FG000|Overall Study|Missing discontinuation status|369|||
150273297|NCT02101021|542139521|FG000|Overall Study|Death|4|||
150273298|NCT02101021|542139522|FG001|Overall Study|Death|3|||
150273299|NCT02101021|542139523|FG002|Overall Study|Death|6|||
150273300|NCT02101021|542139524|FG003|Overall Study|Death|0|||
150273301|NCT02101021|542139525|FG004|Overall Study|Death|3|||
150273302|NCT02101021|542139521|FG000|Overall Study|Withdrew Consent from study|1|||
150273303|NCT02101021|542139522|FG001|Overall Study|Withdrew Consent from study|1|||
150273304|NCT02101021|542139523|FG002|Overall Study|Withdrew Consent from study|0|||
150273305|NCT02101021|542139524|FG003|Overall Study|Withdrew Consent from study|2|||
150273306|NCT02101021|542139525|FG004|Overall Study|Withdrew Consent from study|0|||
150273307|NCT02101021|542139521|FG000|Overall Study|Lost to Follow-up|1|||
150273308|NCT02101021|542139522|FG001|Overall Study|Lost to Follow-up|0|||
150273309|NCT02101021|542139523|FG002|Overall Study|Lost to Follow-up|0|||
150273310|NCT02101021|542139524|FG003|Overall Study|Lost to Follow-up|0|||
150273311|NCT02101021|542139525|FG004|Overall Study|Lost to Follow-up|0|||
150273312|NCT02101021|542139521|FG000|Overall Study|Study Terminated by Sponsor|1|||
150273313|NCT02101021|542139522|FG001|Overall Study|Study Terminated by Sponsor|0|||
150273314|NCT02101021|542139523|FG002|Overall Study|Study Terminated by Sponsor|1|||
150273315|NCT02101021|542139524|FG003|Overall Study|Study Terminated by Sponsor|1|||
150273316|NCT02101021|542139525|FG004|Overall Study|Study Terminated by Sponsor|1|||
150273317|NCT01621542|542139526|FG000|Overall Study|Adverse Event|0|||
150273318|NCT01621542|542139527|FG001|Overall Study|Adverse Event|0|||
150273319|NCT01621542|542139528|FG002|Overall Study|Adverse Event|1|||
150273320|NCT01621542|542139529|FG003|Overall Study|Adverse Event|3|||
150273321|NCT01621542|542139530|FG004|Overall Study|Adverse Event|0|||
150273322|NCT01621542|542139531|FG005|Overall Study|Adverse Event|0|||
150273323|NCT01621542|542139526|FG000|Overall Study|Death|0|||
150273324|NCT01621542|542139527|FG001|Overall Study|Death|1|||
150273325|NCT01621542|542139528|FG002|Overall Study|Death|0|||
150273326|NCT01621542|542139529|FG003|Overall Study|Death|0|||
150273327|NCT01621542|542139530|FG004|Overall Study|Death|0|||
150273328|NCT01621542|542139531|FG005|Overall Study|Death|0|||
150273329|NCT01621542|542139526|FG000|Overall Study|Physician Decision|1|||
150273330|NCT01621542|542139527|FG001|Overall Study|Physician Decision|0|||
150273331|NCT01621542|542139528|FG002|Overall Study|Physician Decision|1|||
150273332|NCT01621542|542139529|FG003|Overall Study|Physician Decision|13|||
150273333|NCT01621542|542139530|FG004|Overall Study|Physician Decision|3|||
150273334|NCT01621542|542139531|FG005|Overall Study|Physician Decision|1|||
150273335|NCT01621542|542139526|FG000|Overall Study|Withdrawal by Subject|2|||
150273336|NCT01621542|542139527|FG001|Overall Study|Withdrawal by Subject|0|||
150273337|NCT01621542|542139528|FG002|Overall Study|Withdrawal by Subject|1|||
150273338|NCT01621542|542139529|FG003|Overall Study|Withdrawal by Subject|3|||
150273339|NCT01621542|542139530|FG004|Overall Study|Withdrawal by Subject|3|||
150273340|NCT01621542|542139531|FG005|Overall Study|Withdrawal by Subject|3|||
150273341|NCT01621542|542139526|FG000|Overall Study|progression/treatment failure|2|||
150273342|NCT01621542|542139527|FG001|Overall Study|progression/treatment failure|4|||
150273343|NCT01621542|542139528|FG002|Overall Study|progression/treatment failure|3|||
150273344|NCT01621542|542139529|FG003|Overall Study|progression/treatment failure|7|||
150273345|NCT01621542|542139530|FG004|Overall Study|progression/treatment failure|3|||
150273346|NCT01621542|542139531|FG005|Overall Study|progression/treatment failure|5|||
150273347|NCT01621542|542139526|FG000|Overall Study|Protocol Violation|0|||
149821162|NCT01381900|540475638|FG001|Overall Study|Early withdraw|1|||
149821163|NCT01381900|540475639|FG002|Overall Study|Early withdraw|1|||
150273348|NCT01621542|542139527|FG001|Overall Study|Protocol Violation|0|||
150273349|NCT01621542|542139528|FG002|Overall Study|Protocol Violation|0|||
150273350|NCT01621542|542139529|FG003|Overall Study|Protocol Violation|1|||
150273351|NCT01621542|542139530|FG004|Overall Study|Protocol Violation|0|||
150273352|NCT01621542|542139531|FG005|Overall Study|Protocol Violation|0|||
150273353|NCT01621542|542139526|FG000|Overall Study|study stopped by sponsor|0|||
149938540|NCT02577029|540912308|FG002|Overall Study|Sponsor Termination of the Study|5|||
149938541|NCT02577029|540912309|FG003|Overall Study|Sponsor Termination of the Study|12|||
149938542|NCT02577029|540912310|FG004|Overall Study|Sponsor Termination of the Study|10|||
149938543|NCT02577029|540912311|FG005|Overall Study|Sponsor Termination of the Study|12|||
149938544|NCT02577029|540912312|FG006|Overall Study|Sponsor Termination of the Study|12|||
149938545|NCT02577029|540912313|FG007|Overall Study|Sponsor Termination of the Study|12|||
149938546|NCT01274351|540912315|FG000|Overall Study|Lost to Follow-up|1|||
149938547|NCT01274351|540912315|FG000|Overall Study|patient not compliant with the protocol|1|||
149938548|NCT01274351|540912315|FG000|Overall Study|Pregnancy|1|||
149938549|NCT01274351|540912315|FG000|Overall Study|Death|2|||
149938550|NCT01274351|540912315|FG000|Overall Study|Withdrawal by Subject|3|||
150169477|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
150169478|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
150169479|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
150169480|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
150169481|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
150169482|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
150169483|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
150169484|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
150169485|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
150169486|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
150169487|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
150169488|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Death|7|||
150169489|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Death|4|||
150169490|NCT00410124|541755596|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
150169491|NCT00410124|541755597|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
150169492|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
150169493|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
150169494|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
150169495|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
150169496|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
150169497|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
150169498|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
150169499|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
150169500|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
150169501|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
150169502|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
150169503|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
150169504|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
150169505|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
150169506|NCT00410124|541755596|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
150169507|NCT00410124|541755597|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
150169508|NCT00988637|541755603|FG000|Overall Study|Lost to Follow-up|2|||
150169509|NCT00988637|541755604|FG001|Overall Study|Lost to Follow-up|1|||
150169510|NCT00988637|541755603|FG000|Overall Study|Withdrawal by Subject|1|||
150169511|NCT00988637|541755604|FG001|Overall Study|Withdrawal by Subject|1|||
150169512|NCT00988637|541755603|FG000|Overall Study|non-compliance with study drug|0|||
150169513|NCT00988637|541755604|FG001|Overall Study|non-compliance with study drug|1|||
150169514|NCT03098030|541755605|FG000|Overall Study|Death|10|||
150169515|NCT03098030|541755606|FG001|Overall Study|Death|156|||
150169516|NCT03098030|541755607|FG002|Overall Study|Death|156|||
150169517|NCT03098030|541755608|FG003|Overall Study|Death|82|||
150169518|NCT03098030|541755605|FG000|Overall Study|Withdrawal by Subject|0|||
150169519|NCT03098030|541755606|FG001|Overall Study|Withdrawal by Subject|7|||
150169520|NCT03098030|541755607|FG002|Overall Study|Withdrawal by Subject|8|||
150169521|NCT03098030|541755608|FG003|Overall Study|Withdrawal by Subject|2|||
150169522|NCT03098030|541755605|FG000|Overall Study|Lost to Follow-up|0|||
150169523|NCT03098030|541755606|FG001|Overall Study|Lost to Follow-up|0|||
150169524|NCT03098030|541755607|FG002|Overall Study|Lost to Follow-up|2|||
150169525|NCT03098030|541755608|FG003|Overall Study|Lost to Follow-up|1|||
150169526|NCT03310983|541755609|FG000|Overall Study|Lost to Follow-up|15|||
150169527|NCT03310983|541755610|FG001|Overall Study|Lost to Follow-up|17|||
150169528|NCT03368001|541755611|FG000|Allocation|Lost to Pretest|16|||
150169529|NCT03368001|541755612|FG001|Allocation|Lost to Pretest|25|||
150169530|NCT03368001|541755611|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
150169531|NCT03368001|541755612|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
150169532|NCT03368001|541755611|FG000|Posttest|Lost to Posttest|7|||
150169533|NCT03368001|541755612|FG001|Posttest|Lost to Posttest|11|||
150169534|NCT03368001|541755611|FG000|Posttest|Discontinued Intervention|6|||
149938551|NCT01274351|540912315|FG000|Overall Study|Adverse Event|8|||
149821164|NCT01772368|540475640|FG000|Overall Study|Adverse Event|1|||
150169535|NCT03368001|541755612|FG001|Posttest|Discontinued Intervention|19|||
150169536|NCT03368001|541755611|FG000|Follow-up|Lost to Follow-up|6|||
150169537|NCT03368001|541755612|FG001|Follow-up|Lost to Follow-up|3|||
150169538|NCT01656304|541755613|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
150169539|NCT04391309|541755614|FG000|Overall Study|Death|1|||
150169540|NCT04391309|541755615|FG001|Overall Study|Death|1|||
150169541|NCT04391309|541755614|FG000|Overall Study|Lost to Follow-up|3|||
150169542|NCT04391309|541755615|FG001|Overall Study|Lost to Follow-up|2|||
150169543|NCT04391309|541755614|FG000|Overall Study|Withdrawal by Subject|2|||
150169544|NCT04391309|541755615|FG001|Overall Study|Withdrawal by Subject|2|||
150169545|NCT05826431|541755616|FG000|Overall Study|Withdrawal by Subject|1|||
150169546|NCT00768651|541755621|FG000|Overall Study|Withdrawal by Subject|1|||
150169547|NCT02104765|541755622|FG000|Overall Study|Lost to Follow-up|0|||
150169548|NCT02104765|541755623|FG001|Overall Study|Lost to Follow-up|0|||
150169549|NCT02104765|541755624|FG002|Overall Study|Lost to Follow-up|1|||
150169550|NCT02104765|541755625|FG003|Overall Study|Lost to Follow-up|0|||
150169551|NCT02104765|541755626|FG004|Overall Study|Lost to Follow-up|0|||
150169552|NCT02104765|541755627|FG005|Overall Study|Lost to Follow-up|0|||
150169553|NCT02104765|541755628|FG006|Overall Study|Lost to Follow-up|0|||
150169554|NCT02104765|541755622|FG000|Overall Study|Withdrawal by Subject|0|||
150169555|NCT02104765|541755623|FG001|Overall Study|Withdrawal by Subject|0|||
150169556|NCT02104765|541755624|FG002|Overall Study|Withdrawal by Subject|0|||
150169557|NCT02104765|541755625|FG003|Overall Study|Withdrawal by Subject|1|||
150169558|NCT02104765|541755626|FG004|Overall Study|Withdrawal by Subject|1|||
150169559|NCT02104765|541755627|FG005|Overall Study|Withdrawal by Subject|0|||
150169560|NCT02104765|541755628|FG006|Overall Study|Withdrawal by Subject|1|||
150169561|NCT04771273|541755629|FG000|Dose Escalation Period|Not treated with trial medication|0|||
150169562|NCT04771273|541755630|FG001|Dose Escalation Period|Not treated with trial medication|1|||
150169563|NCT04771273|541755631|FG002|Dose Escalation Period|Not treated with trial medication|1|||
150169564|NCT04771273|541755632|FG003|Dose Escalation Period|Not treated with trial medication|0|||
150169565|NCT04771273|541755629|FG000|Dose Escalation Period|Other reasons than listed|2|||
150169566|NCT04771273|541755630|FG001|Dose Escalation Period|Other reasons than listed|0|||
150169567|NCT04771273|541755631|FG002|Dose Escalation Period|Other reasons than listed|2|||
150169568|NCT04771273|541755632|FG003|Dose Escalation Period|Other reasons than listed|1|||
150169569|NCT04771273|541755629|FG000|Dose Escalation Period|Protocol Violation|0|||
150169570|NCT04771273|541755630|FG001|Dose Escalation Period|Protocol Violation|0|||
150169571|NCT04771273|541755631|FG002|Dose Escalation Period|Protocol Violation|3|||
150169572|NCT04771273|541755632|FG003|Dose Escalation Period|Protocol Violation|1|||
150169573|NCT04771273|541755629|FG000|Dose Escalation Period|Burden of study procedures|1|||
150169574|NCT04771273|541755630|FG001|Dose Escalation Period|Burden of study procedures|0|||
150169575|NCT04771273|541755631|FG002|Dose Escalation Period|Burden of study procedures|0|||
150169576|NCT04771273|541755632|FG003|Dose Escalation Period|Burden of study procedures|0|||
150169577|NCT04771273|541755629|FG000|Dose Escalation Period|Change of residence|0|||
150169578|NCT04771273|541755630|FG001|Dose Escalation Period|Change of residence|0|||
150169579|NCT04771273|541755631|FG002|Dose Escalation Period|Change of residence|0|||
150169580|NCT04771273|541755632|FG003|Dose Escalation Period|Change of residence|1|||
150169581|NCT04771273|541755629|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
150169582|NCT04771273|541755630|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
150169583|NCT04771273|541755631|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
150169584|NCT04771273|541755632|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
150169585|NCT04771273|541755629|FG000|Dose Escalation Period|Adverse Event|8|||
150169586|NCT04771273|541755630|FG001|Dose Escalation Period|Adverse Event|9|||
150169587|NCT04771273|541755631|FG002|Dose Escalation Period|Adverse Event|12|||
150169588|NCT04771273|541755632|FG003|Dose Escalation Period|Adverse Event|2|||
150169589|NCT04771273|541755629|FG000|Maintenance Period|Other than listed|4|||
150169590|NCT04771273|541755630|FG001|Maintenance Period|Other than listed|2|||
150169591|NCT04771273|541755631|FG002|Maintenance Period|Other than listed|0|||
150169592|NCT04771273|541755632|FG003|Maintenance Period|Other than listed|3|||
150169593|NCT04771273|541755629|FG000|Maintenance Period|Burden of study procedures|1|||
150169594|NCT04771273|541755630|FG001|Maintenance Period|Burden of study procedures|0|||
150169595|NCT04771273|541755631|FG002|Maintenance Period|Burden of study procedures|0|||
150169596|NCT04771273|541755632|FG003|Maintenance Period|Burden of study procedures|0|||
150169597|NCT04771273|541755629|FG000|Maintenance Period|Change of residence|0|||
150169598|NCT04771273|541755630|FG001|Maintenance Period|Change of residence|1|||
150169599|NCT04771273|541755631|FG002|Maintenance Period|Change of residence|3|||
150169600|NCT04771273|541755632|FG003|Maintenance Period|Change of residence|0|||
150169601|NCT04771273|541755629|FG000|Maintenance Period|Perceived lack of efficacy|0|||
150169602|NCT04771273|541755630|FG001|Maintenance Period|Perceived lack of efficacy|0|||
150169603|NCT04771273|541755631|FG002|Maintenance Period|Perceived lack of efficacy|0|||
150169604|NCT04771273|541755632|FG003|Maintenance Period|Perceived lack of efficacy|1|||
150169605|NCT04771273|541755629|FG000|Maintenance Period|Adverse Event|4|||
150169606|NCT04771273|541755630|FG001|Maintenance Period|Adverse Event|5|||
150169607|NCT04771273|541755631|FG002|Maintenance Period|Adverse Event|5|||
150169608|NCT04771273|541755632|FG003|Maintenance Period|Adverse Event|0|||
150169609|NCT02357784|541755636|FG000|Overall Study|Withdrawal by Subject|1|||
149938552|NCT01274351|540912315|FG000|Overall Study|progression of disease|3|||
149938553|NCT01274351|540912315|FG000|Overall Study|hospitalization|1|||
149938554|NCT01296412|540912318|FG000|Overall Study|Adverse Event|8|||
149938555|NCT01296412|540912319|FG001|Overall Study|Adverse Event|29|||
149938556|NCT01296412|540912318|FG000|Overall Study|Lack of Efficacy|1|||
149938557|NCT01296412|540912319|FG001|Overall Study|Lack of Efficacy|0|||
149938558|NCT01296412|540912318|FG000|Overall Study|Lost to Follow-up|10|||
149938559|NCT01296412|540912319|FG001|Overall Study|Lost to Follow-up|7|||
149938560|NCT01296412|540912318|FG000|Overall Study|Non-compliance with study drug|1|||
149938561|NCT01296412|540912319|FG001|Overall Study|Non-compliance with study drug|2|||
149938562|NCT01296412|540912318|FG000|Overall Study|Other reason not specified|20|||
149938563|NCT01296412|540912319|FG001|Overall Study|Other reason not specified|15|||
149938564|NCT01296412|540912318|FG000|Overall Study|Physician Decision|1|||
149938565|NCT01296412|540912319|FG001|Overall Study|Physician Decision|3|||
149938566|NCT01296412|540912318|FG000|Overall Study|Pregnancy|0|||
149938567|NCT01296412|540912319|FG001|Overall Study|Pregnancy|1|||
149938568|NCT01296412|540912318|FG000|Overall Study|Withdrawal by Subject|10|||
149938569|NCT01296412|540912319|FG001|Overall Study|Withdrawal by Subject|13|||
149938570|NCT02160626|540912320|FG000|Overall Study|Adverse Event|1|||
149938571|NCT02160626|540912321|FG001|Overall Study|Adverse Event|0|||
149938572|NCT02160626|540912322|FG002|Overall Study|Adverse Event|0|||
149938573|NCT02160626|540912320|FG000|Overall Study|Schedule not conducive to study visits|0|||
149938574|NCT02160626|540912321|FG001|Overall Study|Schedule not conducive to study visits|0|||
149938575|NCT02160626|540912322|FG002|Overall Study|Schedule not conducive to study visits|1|||
149938576|NCT02160626|540912320|FG000|Overall Study|Withdrawal by Subject|0|||
149938577|NCT02160626|540912321|FG001|Overall Study|Withdrawal by Subject|1|||
149938578|NCT02160626|540912322|FG002|Overall Study|Withdrawal by Subject|0|||
149938579|NCT02765035|540913796|FG000|First Intervention (90 Days)|Adverse Event|1|||
149938580|NCT02765035|540913797|FG001|First Intervention (90 Days)|Adverse Event|1|||
149938581|NCT02765035|540913796|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
149938582|NCT02765035|540913797|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
149938583|NCT02732639|540913802|FG000|Overall Study|Lost to Follow-up|1|||
149938584|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
149938585|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
149938586|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
149938587|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
149938588|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
149938589|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
149938590|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
149938591|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
149938592|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
149938593|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
149938594|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
149938595|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
149938596|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
149938597|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
149938598|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
149938599|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
149938600|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
149938601|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
149938602|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
150169610|NCT00995709|541755637|FG000|Overall Study|Adverse Event|4|||
150169611|NCT00995709|541755638|FG001|Overall Study|Adverse Event|2|||
150169612|NCT00995709|541755639|FG002|Overall Study|Adverse Event|0|||
150169613|NCT00995709|541755637|FG000|Overall Study|Lack of Efficacy|0|||
150169614|NCT00995709|541755638|FG001|Overall Study|Lack of Efficacy|1|||
150169615|NCT00995709|541755639|FG002|Overall Study|Lack of Efficacy|4|||
150169616|NCT00995709|541755637|FG000|Overall Study|Withdrawal by Subject|0|||
150169617|NCT00995709|541755638|FG001|Overall Study|Withdrawal by Subject|4|||
150169618|NCT00995709|541755639|FG002|Overall Study|Withdrawal by Subject|1|||
150169619|NCT00995709|541755637|FG000|Overall Study|Lost to Follow-up|1|||
150169620|NCT00995709|541755638|FG001|Overall Study|Lost to Follow-up|0|||
149938603|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
149938604|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
149938605|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
149938606|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
149938607|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
149938608|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
149938609|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
149975584|NCT00114127|541047893|FG001|Overall Study|Withdrawal by Subject|3|||
150169621|NCT00995709|541755639|FG002|Overall Study|Lost to Follow-up|0|||
150169622|NCT00995709|541755637|FG000|Overall Study|Death|0|||
149938610|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
149938611|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
149938612|NCT01668797|540913803|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
149938613|NCT01668797|540913804|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
149938614|NCT01668797|540913805|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
149938615|NCT01668797|540913806|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
149938616|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
149938617|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
149938618|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
149938619|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
149938620|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
149938621|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
149938622|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
149938623|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
149938624|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
149938625|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
149938626|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
149938627|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
149938628|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
149938629|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
149938630|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
149938631|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
149938632|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
149938633|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
149938634|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
149938635|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
149938636|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
149938637|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
149938638|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
149938639|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
149938640|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
149938641|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
149938642|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
149938643|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
149938644|NCT01668797|540913803|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
149938645|NCT01668797|540913804|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
149938646|NCT01668797|540913805|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
149938647|NCT01668797|540913806|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
149938648|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
149938649|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
149938650|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
149938651|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
149938652|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
149938653|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
149938654|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
149938655|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
149938656|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
149938657|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
149938658|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
149938659|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
149938660|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
149938661|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
149938662|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
149938663|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
149938664|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
149938665|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
149938666|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
149938667|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
149938668|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
149938669|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
150169623|NCT00995709|541755638|FG001|Overall Study|Death|1|||
150169624|NCT00995709|541755639|FG002|Overall Study|Death|0|||
149938670|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
149938671|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
150273354|NCT01621542|542139527|FG001|Overall Study|study stopped by sponsor|0|||
150273355|NCT01621542|542139528|FG002|Overall Study|study stopped by sponsor|0|||
150273356|NCT01621542|542139529|FG003|Overall Study|study stopped by sponsor|1|||
150273357|NCT01621542|542139530|FG004|Overall Study|study stopped by sponsor|0|||
150273358|NCT01621542|542139531|FG005|Overall Study|study stopped by sponsor|0|||
150273359|NCT02632721|542139533|FG000|Overall Study|Adverse Event|0|||
150273360|NCT02632721|542139534|FG001|Overall Study|Adverse Event|0|||
150273361|NCT02632721|542139535|FG002|Overall Study|Adverse Event|2|||
150273362|NCT02632721|542139536|FG003|Overall Study|Adverse Event|5|||
150273363|NCT02632721|542139537|FG004|Overall Study|Adverse Event|3|||
150273364|NCT02632721|542139533|FG000|Overall Study|Dose limiting toxicity|0|||
150273365|NCT02632721|542139534|FG001|Overall Study|Dose limiting toxicity|0|||
150273366|NCT02632721|542139535|FG002|Overall Study|Dose limiting toxicity|0|||
150273367|NCT02632721|542139536|FG003|Overall Study|Dose limiting toxicity|1|||
150273368|NCT02632721|542139537|FG004|Overall Study|Dose limiting toxicity|0|||
150273369|NCT02632721|542139533|FG000|Overall Study|Progressive disease|3|||
150273370|NCT02632721|542139534|FG001|Overall Study|Progressive disease|0|||
150273371|NCT02632721|542139535|FG002|Overall Study|Progressive disease|4|||
150273372|NCT02632721|542139536|FG003|Overall Study|Progressive disease|6|||
150273373|NCT02632721|542139537|FG004|Overall Study|Progressive disease|5|||
150273374|NCT02632721|542139533|FG000|Overall Study|Refused to continue taking trial medication|0|||
150273375|NCT02632721|542139534|FG001|Overall Study|Refused to continue taking trial medication|1|||
150273376|NCT02632721|542139535|FG002|Overall Study|Refused to continue taking trial medication|1|||
150273377|NCT02632721|542139536|FG003|Overall Study|Refused to continue taking trial medication|1|||
150273378|NCT02632721|542139537|FG004|Overall Study|Refused to continue taking trial medication|2|||
150273379|NCT02632721|542139533|FG000|Overall Study|Inadequate clinical condition|0|||
150273380|NCT02632721|542139534|FG001|Overall Study|Inadequate clinical condition|0|||
150273381|NCT02632721|542139535|FG002|Overall Study|Inadequate clinical condition|0|||
150273382|NCT02632721|542139536|FG003|Overall Study|Inadequate clinical condition|0|||
150273383|NCT02632721|542139537|FG004|Overall Study|Inadequate clinical condition|1|||
150273384|NCT02632721|542139533|FG000|Overall Study|No meet eligibility|0|||
150273385|NCT02632721|542139534|FG001|Overall Study|No meet eligibility|0|||
150273386|NCT02632721|542139535|FG002|Overall Study|No meet eligibility|0|||
150273387|NCT02632721|542139536|FG003|Overall Study|No meet eligibility|0|||
150273388|NCT02632721|542139537|FG004|Overall Study|No meet eligibility|1|||
150273389|NCT02632721|542139533|FG000|Overall Study|Allergic reaction|0|||
150273390|NCT02632721|542139534|FG001|Overall Study|Allergic reaction|0|||
150273391|NCT02632721|542139535|FG002|Overall Study|Allergic reaction|0|||
150273392|NCT02632721|542139536|FG003|Overall Study|Allergic reaction|1|||
150273393|NCT02632721|542139537|FG004|Overall Study|Allergic reaction|0|||
150273394|NCT02632721|542139533|FG000|Overall Study|Receiving Decitabine locally|0|||
150273395|NCT02632721|542139534|FG001|Overall Study|Receiving Decitabine locally|0|||
150273396|NCT02632721|542139535|FG002|Overall Study|Receiving Decitabine locally|1|||
150273397|NCT02632721|542139536|FG003|Overall Study|Receiving Decitabine locally|0|||
150273398|NCT02632721|542139537|FG004|Overall Study|Receiving Decitabine locally|0|||
150273399|NCT02632721|542139533|FG000|Overall Study|No benefit from study treatment|1|||
150273400|NCT02632721|542139534|FG001|Overall Study|No benefit from study treatment|1|||
150273401|NCT02632721|542139535|FG002|Overall Study|No benefit from study treatment|0|||
150273402|NCT02632721|542139536|FG003|Overall Study|No benefit from study treatment|0|||
150273403|NCT02632721|542139537|FG004|Overall Study|No benefit from study treatment|1|||
150273404|NCT02632721|542139533|FG000|Overall Study|Patient wish for other treatment|0|||
150273405|NCT02632721|542139534|FG001|Overall Study|Patient wish for other treatment|1|||
150273406|NCT02632721|542139535|FG002|Overall Study|Patient wish for other treatment|0|||
150273407|NCT02632721|542139536|FG003|Overall Study|Patient wish for other treatment|0|||
150273408|NCT02632721|542139537|FG004|Overall Study|Patient wish for other treatment|0|||
150273409|NCT02632721|542139533|FG000|Overall Study|Relapsed Pneumonia|0|||
150273410|NCT02632721|542139534|FG001|Overall Study|Relapsed Pneumonia|0|||
150273411|NCT02632721|542139535|FG002|Overall Study|Relapsed Pneumonia|0|||
150273412|NCT02632721|542139536|FG003|Overall Study|Relapsed Pneumonia|0|||
150273413|NCT02632721|542139537|FG004|Overall Study|Relapsed Pneumonia|1|||
150273414|NCT02632721|542139533|FG000|Overall Study|Therapy refractory AML|0|||
150273415|NCT02632721|542139534|FG001|Overall Study|Therapy refractory AML|0|||
150273416|NCT02632721|542139535|FG002|Overall Study|Therapy refractory AML|0|||
150273417|NCT02632721|542139536|FG003|Overall Study|Therapy refractory AML|0|||
150273418|NCT02632721|542139537|FG004|Overall Study|Therapy refractory AML|1|||
150273419|NCT02632721|542139533|FG000|Overall Study|Increase of white blood cell count|0|||
150273420|NCT02632721|542139534|FG001|Overall Study|Increase of white blood cell count|0|||
150273421|NCT02632721|542139535|FG002|Overall Study|Increase of white blood cell count|0|||
150273422|NCT02632721|542139536|FG003|Overall Study|Increase of white blood cell count|0|||
150273423|NCT02632721|542139537|FG004|Overall Study|Increase of white blood cell count|1|||
150273424|NCT02632721|542139533|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
150273425|NCT02632721|542139534|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
150273426|NCT02632721|542139535|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
149938672|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
149938673|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
149938674|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
149938675|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
149938676|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
149938677|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
149938678|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
149938679|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
149938680|NCT01668797|540913803|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
149938681|NCT01668797|540913804|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
149938682|NCT01668797|540913805|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
149938683|NCT01668797|540913806|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
149938684|NCT02515227|540913807|FG000|Overall Study|Adverse Event|0|||
149938685|NCT02515227|540913808|FG001|Overall Study|Adverse Event|2|||
149938686|NCT02515227|540913807|FG000|Overall Study|Progressive disease|2|||
149938687|NCT02515227|540913808|FG001|Overall Study|Progressive disease|9|||
149938688|NCT02834975|540913817|FG000|Overall Study|Physician Decision|2|||
149938689|NCT02834975|540913817|FG000|Overall Study|Adverse Event|1|||
149938690|NCT02834975|540913817|FG000|Overall Study|Withdrawal by Subject|1|||
149938691|NCT02834975|540913817|FG000|Overall Study|Lack of Efficacy|1|||
149938692|NCT03451071|540913818|FG000|First Vaccine|Withdrawal by Subject|1|||
149938693|NCT03451071|540913818|FG000|Second Vaccine|Lost to Follow-up|19|||
149938694|NCT03451071|540913818|FG000|Third Vaccine|Lost to Follow-up|22|||
149938695|NCT03451071|540913818|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
149938696|NCT03482024|540913820|FG000|Overall Study|Physician Decision|1|||
149938697|NCT03482024|540913821|FG001|Overall Study|Physician Decision|0|||
149938698|NCT03482024|540913822|FG002|Overall Study|Physician Decision|0|||
149938699|NCT03482024|540913823|FG003|Overall Study|Physician Decision|0|||
149938700|NCT03482024|540913824|FG004|Overall Study|Physician Decision|0|||
149938701|NCT03363906|540913829|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
149938702|NCT03363906|540913830|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
149938703|NCT03363906|540913829|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
149938704|NCT03363906|540913830|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
149938705|NCT03363906|540913829|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
149938706|NCT03363906|540913830|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
149938707|NCT03363906|540913829|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
149938708|NCT03363906|540913830|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
149938709|NCT00676143|540913831|FG000|Overall Study|Adverse Event|34|||
149938710|NCT00676143|540913832|FG001|Overall Study|Adverse Event|60|||
149938711|NCT00676143|540913831|FG000|Overall Study|Death|4|||
149938712|NCT00676143|540913832|FG001|Overall Study|Death|4|||
149938713|NCT00676143|540913831|FG000|Overall Study|Lack of Efficacy|0|||
149938714|NCT00676143|540913832|FG001|Overall Study|Lack of Efficacy|6|||
149938715|NCT00676143|540913831|FG000|Overall Study|Lost to Follow-up|0|||
149938716|NCT00676143|540913832|FG001|Overall Study|Lost to Follow-up|13|||
149938717|NCT00676143|540913831|FG000|Overall Study|Physician Decision|5|||
149938718|NCT00676143|540913832|FG001|Overall Study|Physician Decision|8|||
149938719|NCT00676143|540913831|FG000|Overall Study|Protocol Violation|4|||
149938720|NCT00676143|540913832|FG001|Overall Study|Protocol Violation|8|||
149938721|NCT00676143|540913831|FG000|Overall Study|Withdrawal by Subject|24|||
149938722|NCT00676143|540913832|FG001|Overall Study|Withdrawal by Subject|42|||
149938723|NCT00676143|540913831|FG000|Overall Study|Discontinuation of study by sponsor|65|||
149938724|NCT00676143|540913832|FG001|Overall Study|Discontinuation of study by sponsor|88|||
149938725|NCT00676143|540913831|FG000|Overall Study|Failed to return|2|||
149938726|NCT00676143|540913832|FG001|Overall Study|Failed to return|1|||
149938727|NCT00676143|540913831|FG000|Overall Study|Loss of caregiver|5|||
149938728|NCT00676143|540913832|FG001|Overall Study|Loss of caregiver|3|||
149938729|NCT00676143|540913831|FG000|Overall Study|Other|11|||
149938730|NCT00676143|540913832|FG001|Overall Study|Other|20|||
149938731|NCT00676143|540913831|FG000|Overall Study|Participant participation unknown|1|||
149938732|NCT00676143|540913832|FG001|Overall Study|Participant participation unknown|4|||
149938733|NCT00676143|540913831|FG000|Overall Study|Vasogenic edema recurrence|1|||
149938734|NCT00676143|540913832|FG001|Overall Study|Vasogenic edema recurrence|3|||
149938735|NCT03937778|540913833|FG000|Overall Study|Withdrawal by Subject|1|||
149938736|NCT03937778|540913833|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
149938737|NCT00929669|540913834|FG000|Overall Study|elevated glucose levels|1|||
149938738|NCT02714153|540913836|FG000|Overall Study|Death|1|||
149938739|NCT01901185|540913837|FG000|Overall Study|Withdrawal by Subject|2|||
149938740|NCT02065557|540913840|FG000|Induction Period|Withdrawal by Subject|2|||
149938741|NCT02065557|540913841|FG001|Induction Period|Withdrawal by Subject|1|||
149938742|NCT02065557|540913842|FG002|Induction Period|Withdrawal by Subject|0|||
149938743|NCT02065557|540913843|FG003|Induction Period|Withdrawal by Subject|0|||
149938744|NCT02065557|540913844|FG004|Induction Period|Withdrawal by Subject|0|||
149938745|NCT02065557|540913845|FG005|Induction Period|Withdrawal by Subject|0|||
149938746|NCT02065557|540913840|FG000|Induction Period|Lack of Efficacy|2|||
149938747|NCT02065557|540913841|FG001|Induction Period|Lack of Efficacy|1|||
149938748|NCT02065557|540913842|FG002|Induction Period|Lack of Efficacy|1|||
149938749|NCT02065557|540913843|FG003|Induction Period|Lack of Efficacy|0|||
149938750|NCT02065557|540913844|FG004|Induction Period|Lack of Efficacy|0|||
149938751|NCT02065557|540913845|FG005|Induction Period|Lack of Efficacy|0|||
149938752|NCT02065557|540913840|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
149938753|NCT02065557|540913841|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
149938754|NCT02065557|540913842|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
150273427|NCT02632721|542139536|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
150273428|NCT02632721|542139537|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
150273429|NCT00544648|542139543|FG000|Overall Study|Withdrawal by Subject|1|||
150273430|NCT00544648|542139544|FG001|Overall Study|Withdrawal by Subject|0|||
150273431|NCT00544648|542139543|FG000|Overall Study|Adverse Event|1|||
150273432|NCT00544648|542139544|FG001|Overall Study|Adverse Event|1|||
150273433|NCT00544648|542139543|FG000|Overall Study|progression of disease|1|||
150273434|NCT00544648|542139544|FG001|Overall Study|progression of disease|0|||
150273435|NCT04166383|542139545|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
150273436|NCT04166383|542139545|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
150273437|NCT04166383|542139545|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
150273438|NCT03346057|542139546|FG000|Overall Study|Death|1|||
150273439|NCT03346057|542139547|FG001|Overall Study|Death|2|||
150273440|NCT03346057|542139548|FG002|Overall Study|Death|0|||
150273441|NCT03346057|542139549|FG003|Overall Study|Death|0|||
150273442|NCT03346057|542139546|FG000|Overall Study|Lost to Follow-up|0|||
150273443|NCT03346057|542139547|FG001|Overall Study|Lost to Follow-up|2|||
150273444|NCT03346057|542139548|FG002|Overall Study|Lost to Follow-up|1|||
150273445|NCT03346057|542139549|FG003|Overall Study|Lost to Follow-up|0|||
150273446|NCT03346057|542139546|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
150273447|NCT03346057|542139547|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
150273448|NCT03346057|542139548|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
150273449|NCT03346057|542139549|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
150273450|NCT03346057|542139546|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
149938755|NCT02065557|540913843|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
149938756|NCT02065557|540913844|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
149938757|NCT02065557|540913845|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
149938758|NCT02065557|540913840|FG000|Induction Period|Non-Responder at Week 8|4|||
149938759|NCT02065557|540913841|FG001|Induction Period|Non-Responder at Week 8|4|||
149938760|NCT02065557|540913842|FG002|Induction Period|Non-Responder at Week 8|0|||
149938761|NCT02065557|540913843|FG003|Induction Period|Non-Responder at Week 8|0|||
149938762|NCT02065557|540913844|FG004|Induction Period|Non-Responder at Week 8|0|||
149938763|NCT02065557|540913845|FG005|Induction Period|Non-Responder at Week 8|0|||
149938764|NCT02065557|540913840|FG000|Induction Period|Adverse Event|1|||
149938765|NCT02065557|540913841|FG001|Induction Period|Adverse Event|1|||
149938766|NCT02065557|540913842|FG002|Induction Period|Adverse Event|0|||
149938767|NCT02065557|540913843|FG003|Induction Period|Adverse Event|0|||
149938768|NCT02065557|540913844|FG004|Induction Period|Adverse Event|0|||
149938769|NCT02065557|540913845|FG005|Induction Period|Adverse Event|0|||
149938770|NCT02065557|540913840|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
149938771|NCT02065557|540913841|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
149938772|NCT02065557|540913842|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
149938773|NCT02065557|540913843|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
149938774|NCT02065557|540913844|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
149938775|NCT02065557|540913845|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
149938776|NCT02065557|540913840|FG000|Maintenance Period|Withdrawal by Subject|0|||
149938777|NCT02065557|540913841|FG001|Maintenance Period|Withdrawal by Subject|0|||
149938778|NCT02065557|540913842|FG002|Maintenance Period|Withdrawal by Subject|0|||
149938779|NCT02065557|540913843|FG003|Maintenance Period|Withdrawal by Subject|0|||
149938780|NCT02065557|540913844|FG004|Maintenance Period|Withdrawal by Subject|2|||
149938781|NCT02065557|540913845|FG005|Maintenance Period|Withdrawal by Subject|1|||
149938782|NCT02065557|540913840|FG000|Maintenance Period|Lack of Efficacy|0|||
150273451|NCT03346057|542139547|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
150273452|NCT03346057|542139548|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
150273453|NCT03346057|542139549|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
150273454|NCT03346057|542139546|FG000|Overall Study|Physician Decision|3|||
150273455|NCT03346057|542139547|FG001|Overall Study|Physician Decision|2|||
150273456|NCT03346057|542139548|FG002|Overall Study|Physician Decision|0|||
149938783|NCT02065557|540913841|FG001|Maintenance Period|Lack of Efficacy|0|||
149938784|NCT02065557|540913842|FG002|Maintenance Period|Lack of Efficacy|0|||
149938785|NCT02065557|540913843|FG003|Maintenance Period|Lack of Efficacy|0|||
149938786|NCT02065557|540913844|FG004|Maintenance Period|Lack of Efficacy|5|||
150273457|NCT03346057|542139549|FG003|Overall Study|Physician Decision|2|||
150273458|NCT03346057|542139546|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
150273459|NCT03346057|542139547|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
150273460|NCT03346057|542139548|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
150273461|NCT03346057|542139549|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
150273462|NCT03346057|542139546|FG000|Overall Study|Withdrawal by Subject|1|||
150273463|NCT03346057|542139547|FG001|Overall Study|Withdrawal by Subject|0|||
150273464|NCT03346057|542139548|FG002|Overall Study|Withdrawal by Subject|0|||
150273465|NCT03346057|542139549|FG003|Overall Study|Withdrawal by Subject|0|||
150273466|NCT01184053|542139550|FG000|Overall Study|progression while on treatment|3|||
150273467|NCT03785678|542139553|FG000|Overall Study|Death|44|||
150273468|NCT03785678|542139554|FG001|Overall Study|Death|42|||
150273469|NCT03785678|542139553|FG000|Overall Study|Lost to Follow-up|4|||
150273470|NCT03785678|542139554|FG001|Overall Study|Lost to Follow-up|2|||
150273471|NCT03785678|542139553|FG000|Overall Study|Physician Decision|0|||
150273472|NCT03785678|542139554|FG001|Overall Study|Physician Decision|2|||
150273473|NCT03785678|542139553|FG000|Overall Study|Withdrawal by Subject|5|||
150273474|NCT03785678|542139554|FG001|Overall Study|Withdrawal by Subject|3|||
150273475|NCT04399122|542139555|FG000|Overall Study|Lost to Follow-up|2|||
150273476|NCT04399122|542139556|FG001|Overall Study|Lost to Follow-up|0|||
150273477|NCT04399122|542139555|FG000|Overall Study|Withdrawal by Subject|1|||
150273478|NCT04399122|542139556|FG001|Overall Study|Withdrawal by Subject|0|||
150273479|NCT01174238|542139561|FG000|Overall Study|Lost to Follow-up|2|||
150273480|NCT02301936|542139562|FG000|Overall Study|Lost to Follow-up|1|||
150273481|NCT02301936|542139563|FG001|Overall Study|Lost to Follow-up|0|||
150273482|NCT02322229|542139564|FG000|Overall Study|Physician Decision|2|||
150273483|NCT00705432|542139565|FG000|Treatment Period|Adverse Event|45|||
150273484|NCT00705432|542139566|FG001|Treatment Period|Adverse Event|37|||
150273485|NCT00705432|542139567|FG002|Treatment Period|Adverse Event|51|||
150273486|NCT00705432|542139568|FG003|Treatment Period|Adverse Event|12|||
150273487|NCT00705432|542139569|FG004|Treatment Period|Adverse Event|8|||
150273488|NCT00705432|542139570|FG005|Treatment Period|Adverse Event|9|||
150273489|NCT00705432|542139565|FG000|Treatment Period|Treatment failure|92|||
150273490|NCT00705432|542139566|FG001|Treatment Period|Treatment failure|42|||
150273491|NCT00705432|542139567|FG002|Treatment Period|Treatment failure|33|||
150273492|NCT00705432|542139568|FG003|Treatment Period|Treatment failure|25|||
150273493|NCT00705432|542139569|FG004|Treatment Period|Treatment failure|13|||
150273494|NCT00705432|542139570|FG005|Treatment Period|Treatment failure|14|||
150273495|NCT00705432|542139565|FG000|Treatment Period|Non medical reason|26|||
150273496|NCT00705432|542139566|FG001|Treatment Period|Non medical reason|32|||
150273497|NCT00705432|542139567|FG002|Treatment Period|Non medical reason|37|||
150273498|NCT00705432|542139568|FG003|Treatment Period|Non medical reason|4|||
150273499|NCT00705432|542139569|FG004|Treatment Period|Non medical reason|7|||
150273500|NCT00705432|542139570|FG005|Treatment Period|Non medical reason|7|||
150273501|NCT00705432|542139565|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
150273502|NCT00705432|542139566|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
150273503|NCT00705432|542139567|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
150273504|NCT00705432|542139568|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
150273505|NCT00705432|542139569|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
150273506|NCT00705432|542139570|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
150273507|NCT00705432|542139565|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
150273508|NCT00705432|542139566|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
150273509|NCT00705432|542139567|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
150273510|NCT00705432|542139568|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
150273511|NCT00705432|542139569|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
150273512|NCT00705432|542139570|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
150273513|NCT01102803|542139571|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
150273514|NCT01102803|542139572|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
150273515|NCT01102803|542139571|FG000|Post to Follow-Up|Lost to Follow-up|1|||
150273516|NCT01102803|542139572|FG001|Post to Follow-Up|Lost to Follow-up|3|||
150273517|NCT00521053|542139573|FG000|Observation Phase|Disease Progression|55|||
150273518|NCT00521053|542139573|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
150273519|NCT00521053|542139573|FG000|Observation Phase|Death|2|||
150273520|NCT00521053|542139573|FG000|Observation Phase|Adverse Event|1|||
150273521|NCT00521053|542139573|FG000|Observation Phase|Other non-study melanoma treatment|1|||
150273522|NCT00521053|542139573|FG000|Observation Phase|Physician Decision|1|||
150273523|NCT00375219|542139574|FG000|Overall Study|Failure to achieve a response|16|||
150273524|NCT00375219|542139575|FG001|Overall Study|Failure to achieve a response|2|||
150273525|NCT00375219|542139576|FG002|Overall Study|Failure to achieve a response|0|||
150273526|NCT00375219|542139574|FG000|Overall Study|Adverse Event|8|||
150273527|NCT00375219|542139575|FG001|Overall Study|Adverse Event|2|||
150273528|NCT00375219|542139576|FG002|Overall Study|Adverse Event|1|||
150273529|NCT00375219|542139574|FG000|Overall Study|Protocol Violation|1|||
150273530|NCT00375219|542139575|FG001|Overall Study|Protocol Violation|0|||
150273531|NCT00375219|542139576|FG002|Overall Study|Protocol Violation|1|||
149938787|NCT02065557|540913845|FG005|Maintenance Period|Lack of Efficacy|2|||
149938788|NCT02065557|540913840|FG000|Maintenance Period|Subject Non-Compliance|0|||
149938789|NCT02065557|540913841|FG001|Maintenance Period|Subject Non-Compliance|0|||
149938790|NCT02065557|540913842|FG002|Maintenance Period|Subject Non-Compliance|0|||
149938791|NCT02065557|540913843|FG003|Maintenance Period|Subject Non-Compliance|0|||
149938792|NCT02065557|540913844|FG004|Maintenance Period|Subject Non-Compliance|0|||
149938793|NCT02065557|540913845|FG005|Maintenance Period|Subject Non-Compliance|1|||
149938794|NCT00250588|540913846|FG000|Overall Study|Withdrawal by Subject|3|||
149938795|NCT00250588|540913847|FG001|Overall Study|Withdrawal by Subject|6|||
149938796|NCT00250588|540913848|FG002|Overall Study|Withdrawal by Subject|0|||
149938797|NCT00250588|540913846|FG000|Overall Study|Lost to Follow-up|6|||
149938798|NCT00250588|540913847|FG001|Overall Study|Lost to Follow-up|13|||
149938799|NCT00250588|540913848|FG002|Overall Study|Lost to Follow-up|13|||
149938800|NCT00706797|540913849|FG000|Overall Study|Lack of Efficacy|3|||
149938801|NCT00706797|540913850|FG001|Overall Study|Lack of Efficacy|0|||
149938802|NCT00706797|540913849|FG000|Overall Study|Adverse Event|0|||
149938803|NCT00706797|540913850|FG001|Overall Study|Adverse Event|3|||
149938804|NCT00706797|540913849|FG000|Overall Study|Withdrawal by Subject|8|||
149938805|NCT00706797|540913850|FG001|Overall Study|Withdrawal by Subject|1|||
149938806|NCT00706797|540913849|FG000|Overall Study|Death|1|||
149938807|NCT00706797|540913850|FG001|Overall Study|Death|0|||
149938808|NCT00706797|540913849|FG000|Overall Study|Discontinuation of study by sponsor|52|||
149938809|NCT00706797|540913850|FG001|Overall Study|Discontinuation of study by sponsor|63|||
149938810|NCT00706797|540913849|FG000|Overall Study|Protocol Violation|3|||
149938811|NCT00706797|540913850|FG001|Overall Study|Protocol Violation|2|||
149938812|NCT00706797|540913849|FG000|Overall Study|Lost to Follow-up|1|||
149938813|NCT00706797|540913850|FG001|Overall Study|Lost to Follow-up|2|||
149938814|NCT00706797|540913849|FG000|Overall Study|Other|1|||
149938815|NCT00706797|540913850|FG001|Overall Study|Other|0|||
149938816|NCT03502798|540913853|FG000|Overall Study|equipment failure|0|||
149938817|NCT03502798|540913854|FG001|Overall Study|equipment failure|7|||
149938818|NCT03307174|540913855|FG000|Overall Study|Unplanned ICU Administrion|5|||
149938819|NCT03307174|540913856|FG001|Overall Study|Unplanned ICU Administrion|3|||
149938820|NCT03307174|540913855|FG000|Overall Study|Aborted Surgery|1|||
149938821|NCT03307174|540913856|FG001|Overall Study|Aborted Surgery|2|||
149938822|NCT03307174|540913855|FG000|Overall Study|Hypotension|6|||
149938823|NCT03307174|540913856|FG001|Overall Study|Hypotension|0|||
149938824|NCT03307174|540913855|FG000|Overall Study|Nonfunctional epidural|1|||
149938825|NCT03307174|540913856|FG001|Overall Study|Nonfunctional epidural|1|||
149938826|NCT03307174|540913855|FG000|Overall Study|Planned epidural removal|1|||
149938827|NCT03307174|540913856|FG001|Overall Study|Planned epidural removal|0|||
149938828|NCT03307174|540913855|FG000|Overall Study|Intrathecal catheter placement|0|||
149938829|NCT03307174|540913856|FG001|Overall Study|Intrathecal catheter placement|1|||
149938830|NCT01192815|540913857|FG000|Overall Study|Withdrawal by Subject|1|||
149938831|NCT01192815|540913857|FG000|Overall Study|Lack of Efficacy|1|||
149938832|NCT03444584|540913858|FG000|Overall Study|Withdrawal by Subject|0|||
149938833|NCT03444584|540913859|FG001|Overall Study|Withdrawal by Subject|1|||
149938834|NCT03444584|540913858|FG000|Overall Study|Other|0|||
149938835|NCT03444584|540913859|FG001|Overall Study|Other|1|||
149938836|NCT00863707|540913860|FG000|Overall Study|Randomized, but drug not received|4|||
149938837|NCT00863707|540913861|FG001|Overall Study|Randomized, but drug not received|3|||
149938838|NCT01142336|540913862|FG000|Overall Study|Adverse Event|1|||
149938839|NCT01142336|540913863|FG001|Overall Study|Adverse Event|1|||
149938840|NCT01142336|540913862|FG000|Overall Study|Lost to Follow-up|0|||
149938841|NCT01142336|540913863|FG001|Overall Study|Lost to Follow-up|1|||
149938842|NCT01704261|540913864|FG000|Overall Study|Withdrawal by Subject|12|||
149938843|NCT01704261|540913865|FG001|Overall Study|Withdrawal by Subject|15|||
149938844|NCT01704261|540913864|FG000|Overall Study|Lost to Follow-up|1|||
149938845|NCT01704261|540913865|FG001|Overall Study|Lost to Follow-up|0|||
150273532|NCT00375219|542139574|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
150273533|NCT00375219|542139575|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
150273534|NCT00375219|542139576|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
150273535|NCT00375219|542139574|FG000|Overall Study|Lost to Follow-up|1|||
150273536|NCT00375219|542139575|FG001|Overall Study|Lost to Follow-up|1|||
150273537|NCT00375219|542139576|FG002|Overall Study|Lost to Follow-up|0|||
149938846|NCT02722967|540913866|FG000|Overall Study|Adverse Event|1|||
149938847|NCT02722967|540913867|FG001|Overall Study|Adverse Event|0|||
149938848|NCT02722967|540913868|FG002|Overall Study|Adverse Event|0|||
149938849|NCT02722967|540913866|FG000|Overall Study|Lost to Follow-up|0|||
149938850|NCT02722967|540913867|FG001|Overall Study|Lost to Follow-up|1|||
149938851|NCT02722967|540913868|FG002|Overall Study|Lost to Follow-up|0|||
149938852|NCT02722967|540913866|FG000|Overall Study|Non-compliance with patch wearing|2|||
149938853|NCT02722967|540913867|FG001|Overall Study|Non-compliance with patch wearing|1|||
149938854|NCT02722967|540913868|FG002|Overall Study|Non-compliance with patch wearing|1|||
149938855|NCT02722967|540913866|FG000|Overall Study|Withdrawal by Subject|1|||
150273538|NCT00375219|542139574|FG000|Overall Study|Disease progression|18|||
150273539|NCT00375219|542139575|FG001|Overall Study|Disease progression|9|||
150273540|NCT00375219|542139576|FG002|Overall Study|Disease progression|12|||
150273541|NCT00375219|542139574|FG000|Overall Study|Death|4|||
150273542|NCT00375219|542139575|FG001|Overall Study|Death|3|||
150273543|NCT00375219|542139576|FG002|Overall Study|Death|7|||
150273544|NCT00375219|542139574|FG000|Overall Study|Hematologic resistance|1|||
150273545|NCT00375219|542139575|FG001|Overall Study|Hematologic resistance|0|||
150273546|NCT00375219|542139576|FG002|Overall Study|Hematologic resistance|0|||
150273547|NCT00375219|542139574|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
150273548|NCT00375219|542139575|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
150273549|NCT00375219|542139576|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
150273550|NCT00375219|542139574|FG000|Overall Study|Allograft|2|||
150273551|NCT00375219|542139575|FG001|Overall Study|Allograft|0|||
150273552|NCT00375219|542139576|FG002|Overall Study|Allograft|0|||
150273553|NCT00375219|542139574|FG000|Overall Study|Cord blood transplantation|1|||
150273554|NCT00375219|542139575|FG001|Overall Study|Cord blood transplantation|0|||
150273555|NCT00375219|542139576|FG002|Overall Study|Cord blood transplantation|0|||
150273556|NCT00375219|542139574|FG000|Overall Study|Withdrawal by Subject|1|||
150273557|NCT00375219|542139575|FG001|Overall Study|Withdrawal by Subject|0|||
150273558|NCT00375219|542139576|FG002|Overall Study|Withdrawal by Subject|0|||
150273559|NCT02281357|542139579|FG000|Overall Study|Adverse Event|2|||
150273560|NCT02281357|542139580|FG001|Overall Study|Adverse Event|1|||
150273561|NCT02281357|542139579|FG000|Overall Study|Lost to Follow-up|1|||
150273562|NCT02281357|542139580|FG001|Overall Study|Lost to Follow-up|0|||
150273563|NCT02281357|542139579|FG000|Overall Study|Withdrawal by Subject|4|||
150273564|NCT02281357|542139580|FG001|Overall Study|Withdrawal by Subject|3|||
150273565|NCT02684279|542139581|FG000|Overall Study|Adverse Event|87|||
150273566|NCT02684279|542139581|FG000|Overall Study|Lack of Efficacy|4|||
150273567|NCT02684279|542139581|FG000|Overall Study|Lost to Follow-up|61|||
150273568|NCT02684279|542139581|FG000|Overall Study|Protocol Violation|6|||
150273569|NCT02684279|542139581|FG000|Overall Study|Pregnancy|8|||
150273570|NCT02684279|542139581|FG000|Overall Study|Withdrawal by Subject|92|||
150273571|NCT02684279|542139581|FG000|Overall Study|non-compliance with study drug|9|||
150273572|NCT02684279|542139581|FG000|Overall Study|non compliance with study visits|2|||
150273573|NCT02684279|542139581|FG000|Overall Study|subject to have surgery|1|||
150273574|NCT02684279|542139581|FG000|Overall Study|family emergency|1|||
150273575|NCT02684279|542139581|FG000|Overall Study|Site closures|7|||
150273576|NCT02684279|542139581|FG000|Overall Study|Physician Decision|1|||
150273577|NCT01162239|542139582|FG000|Treatment Phase|Withdrawal by Subject|1|||
149938856|NCT02722967|540913867|FG001|Overall Study|Withdrawal by Subject|0|||
149938857|NCT02722967|540913868|FG002|Overall Study|Withdrawal by Subject|1|||
149938858|NCT02722967|540913866|FG000|Overall Study|Physician Decision|1|||
150273578|NCT01162239|542139583|FG001|Treatment Phase|Withdrawal by Subject|3|||
150273579|NCT01162239|542139584|FG002|Treatment Phase|Withdrawal by Subject|2|||
150273580|NCT01162239|542139585|FG003|Treatment Phase|Withdrawal by Subject|3|||
150273581|NCT01162239|542139582|FG000|Treatment Phase|Death|0|||
150273582|NCT01162239|542139583|FG001|Treatment Phase|Death|0|||
150273583|NCT01162239|542139584|FG002|Treatment Phase|Death|0|||
150273584|NCT01162239|542139585|FG003|Treatment Phase|Death|1|||
150273585|NCT01162239|542139582|FG000|Treatment Phase|Lost to Follow-up|5|||
150273586|NCT01162239|542139583|FG001|Treatment Phase|Lost to Follow-up|4|||
150273587|NCT01162239|542139584|FG002|Treatment Phase|Lost to Follow-up|2|||
150273588|NCT01162239|542139585|FG003|Treatment Phase|Lost to Follow-up|1|||
150273589|NCT01162239|542139582|FG000|Extended Follow-up|Lost to Follow-up|8|||
150273590|NCT01162239|542139583|FG001|Extended Follow-up|Lost to Follow-up|13|||
150273591|NCT01162239|542139584|FG002|Extended Follow-up|Lost to Follow-up|8|||
150273592|NCT01162239|542139585|FG003|Extended Follow-up|Lost to Follow-up|6|||
150273593|NCT00228566|542139586|FG000|Overall Study|Adverse Event|31|||
150273594|NCT00228566|542139586|FG000|Overall Study|Lack of Efficacy|14|||
150273595|NCT00228566|542139586|FG000|Overall Study|Lost to Follow-up|16|||
150273596|NCT00228566|542139586|FG000|Overall Study|Physician Decision|5|||
150273597|NCT00228566|542139586|FG000|Overall Study|Withdrawal by Subject|4|||
150273598|NCT00228566|542139586|FG000|Overall Study|Miscellaneous|1|||
150273599|NCT04448756|542139589|FG000|Overall Study|Adverse Event|0|||
150273600|NCT04448756|542139590|FG001|Overall Study|Adverse Event|1|||
150273601|NCT04448756|542139591|FG002|Overall Study|Adverse Event|0|||
150273602|NCT04448756|542139589|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
150273603|NCT04448756|542139590|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
150273604|NCT04448756|542139591|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
150273605|NCT04448756|542139589|FG000|Overall Study|Withdrawal by Subject|0|||
150273606|NCT04448756|542139590|FG001|Overall Study|Withdrawal by Subject|3|||
149938859|NCT02722967|540913867|FG001|Overall Study|Physician Decision|0|||
150273607|NCT04448756|542139591|FG002|Overall Study|Withdrawal by Subject|1|||
150273608|NCT04448756|542139589|FG000|Overall Study|Death|2|||
149938860|NCT02722967|540913868|FG002|Overall Study|Physician Decision|0|||
150273609|NCT04448756|542139590|FG001|Overall Study|Death|1|||
150273610|NCT04448756|542139591|FG002|Overall Study|Death|0|||
150273611|NCT02733185|542139592|FG000|Overall Study|Withdrawal by Subject|12|||
150273612|NCT02733185|542139593|FG001|Overall Study|Withdrawal by Subject|10|||
150273613|NCT02733185|542139594|FG002|Overall Study|Withdrawal by Subject|17|||
149938861|NCT02722967|540913866|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
149938862|NCT02722967|540913867|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
149938863|NCT02722967|540913868|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
149938864|NCT02783911|540913875|FG000|Overall Study|Lost to Follow-up|3|||
149938865|NCT02783911|540913876|FG001|Overall Study|Lost to Follow-up|32|||
149938866|NCT00467519|540913879|FG000|Overall Study|Protocol Violation|8|||
149938867|NCT00467519|540913880|FG001|Overall Study|Protocol Violation|4|||
149938868|NCT00467519|540913879|FG000|Overall Study|Lost to Follow-up|2|||
149938869|NCT00467519|540913880|FG001|Overall Study|Lost to Follow-up|9|||
149938870|NCT00467519|540913879|FG000|Overall Study|Withdrawal by Subject|4|||
149938871|NCT00467519|540913880|FG001|Overall Study|Withdrawal by Subject|10|||
149938872|NCT02475369|540913886|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
149938873|NCT02475369|540913887|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
149938874|NCT00885118|540913890|FG000|Overall Study|Adverse Event|1|||
149938875|NCT00885118|540913891|FG001|Overall Study|Adverse Event|0|||
149938876|NCT00885118|540913892|FG002|Overall Study|Adverse Event|0|||
149938877|NCT00885118|540913893|FG003|Overall Study|Adverse Event|0|||
149938878|NCT00885118|540913894|FG004|Overall Study|Adverse Event|0|||
149938879|NCT00885118|540913890|FG000|Overall Study|Withdrawal by Subject|0|||
149938880|NCT00885118|540913891|FG001|Overall Study|Withdrawal by Subject|0|||
149938881|NCT00885118|540913892|FG002|Overall Study|Withdrawal by Subject|0|||
149938882|NCT00885118|540913893|FG003|Overall Study|Withdrawal by Subject|0|||
149938883|NCT00885118|540913894|FG004|Overall Study|Withdrawal by Subject|1|||
149938884|NCT00885118|540913890|FG000|Overall Study|Other reason not defined above|0|||
149938885|NCT00885118|540913891|FG001|Overall Study|Other reason not defined above|0|||
149938886|NCT00885118|540913892|FG002|Overall Study|Other reason not defined above|1|||
149938887|NCT00885118|540913893|FG003|Overall Study|Other reason not defined above|0|||
149938888|NCT00885118|540913894|FG004|Overall Study|Other reason not defined above|0|||
149938889|NCT03642990|540913895|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
149938890|NCT03642990|540913895|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
149938891|NCT00094445|540913896|FG000|Overall Study|Withdrawal by Subject|3|||
149938892|NCT00094445|540913896|FG000|Overall Study|Lost to Follow-up|1|||
149938893|NCT00094445|540913896|FG000|Overall Study|Progressive Disease|2|||
149938894|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
149938895|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
149938896|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
150169625|NCT00995709|541755637|FG000|Overall Study|Protocol Violation|2|||
150169626|NCT00995709|541755638|FG001|Overall Study|Protocol Violation|1|||
150169627|NCT00995709|541755639|FG002|Overall Study|Protocol Violation|0|||
150169628|NCT00604721|541755644|FG000|Overall Study|Physician Decision|1|||
150169629|NCT00604721|541755644|FG000|Overall Study|Withdrawal by Subject|1|||
150169630|NCT04776213|541755645|FG000|Overall Study|Other|1|||
150169631|NCT04776213|541755645|FG000|Overall Study|Withdrawal by Subject|7|||
150169632|NCT04776213|541755645|FG000|Overall Study|Protocol Violation|1|||
150169633|NCT04776213|541755645|FG000|Overall Study|Lost to Follow-up|2|||
150169634|NCT01981356|541755660|FG000|Overall Study|Lost to Follow-up|4|||
150169635|NCT01981356|541755661|FG001|Overall Study|Lost to Follow-up|1|||
150169636|NCT01981356|541755660|FG000|Overall Study|Withdrawal by Subject|1|||
150169637|NCT01981356|541755661|FG001|Overall Study|Withdrawal by Subject|1|||
150169638|NCT01981356|541755660|FG000|Overall Study|Protocol Violation|2|||
150169639|NCT01981356|541755661|FG001|Overall Study|Protocol Violation|0|||
150169640|NCT01751724|541755664|FG000|Overall Study|extubated bef.start assigned treatment|1|||
150169641|NCT01751724|541755665|FG001|Overall Study|extubated bef.start assigned treatment|0|||
150169642|NCT01751724|541755664|FG000|Overall Study|withdrawn by parent|0|||
150169643|NCT01751724|541755665|FG001|Overall Study|withdrawn by parent|2|||
150169644|NCT03395353|541755666|FG000|Overall Study|Adverse Event|20|||
150169645|NCT03395353|541755666|FG000|Overall Study|Protocol Violation|1|||
150169646|NCT03395353|541755666|FG000|Overall Study|Lack of Efficacy|3|||
150169647|NCT03395353|541755666|FG000|Overall Study|Withdrawal by Subject|24|||
150169648|NCT03395353|541755666|FG000|Overall Study|Discontinued visit|1|||
150169649|NCT03395353|541755666|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
150169650|NCT03395353|541755666|FG000|Overall Study|Physician Decision|4|||
150169651|NCT03395353|541755666|FG000|Overall Study|Early termination of overall study|33|||
150169652|NCT01278862|541755671|FG000|Overall Study|Lost to Follow-up|1|||
150169653|NCT01278862|541755672|FG001|Overall Study|Lost to Follow-up|1|||
150169654|NCT00798265|541755673|FG000|Overall Study|Lost to Follow-up|1|||
150169655|NCT00798265|541755674|FG001|Overall Study|Lost to Follow-up|10|||
150169656|NCT00798265|541755673|FG000|Overall Study|Study closing|7|||
150169657|NCT00798265|541755674|FG001|Overall Study|Study closing|6|||
150169658|NCT00798265|541755673|FG000|Overall Study|Withdrawal by Subject|0|||
150169659|NCT00798265|541755674|FG001|Overall Study|Withdrawal by Subject|1|||
150169660|NCT00798265|541755673|FG000|Overall Study|Screen failure|0|||
150169661|NCT00798265|541755674|FG001|Overall Study|Screen failure|1|||
150169662|NCT03425643|541755677|FG000|Overall Study|Withdrawal by Subject|10|||
150169663|NCT03425643|541755678|FG001|Overall Study|Withdrawal by Subject|12|||
150169664|NCT03425643|541755677|FG000|Overall Study|Lost to Follow-up|2|||
150273614|NCT02733185|542139595|FG003|Overall Study|Withdrawal by Subject|21|||
150273615|NCT02733185|542139592|FG000|Overall Study|Death|46|||
150273616|NCT02733185|542139593|FG001|Overall Study|Death|34|||
150273617|NCT02733185|542139594|FG002|Overall Study|Death|35|||
150273618|NCT02733185|542139595|FG003|Overall Study|Death|43|||
150273619|NCT02733185|542139592|FG000|Overall Study|Lost to Follow-up|17|||
150273620|NCT02733185|542139593|FG001|Overall Study|Lost to Follow-up|18|||
150273621|NCT02733185|542139594|FG002|Overall Study|Lost to Follow-up|16|||
150273622|NCT02733185|542139595|FG003|Overall Study|Lost to Follow-up|11|||
150273623|NCT01624259|542139596|FG000|Overall Study|Adverse Event|18|||
150273624|NCT01624259|542139597|FG001|Overall Study|Adverse Event|18|||
150273625|NCT01624259|542139596|FG000|Overall Study|Protocol Violation|1|||
150273626|NCT01624259|542139597|FG001|Overall Study|Protocol Violation|2|||
150273627|NCT01624259|542139596|FG000|Overall Study|Withdrawal by Subject|5|||
150273628|NCT01624259|542139597|FG001|Overall Study|Withdrawal by Subject|7|||
150273629|NCT01624259|542139596|FG000|Overall Study|Physician Decision|1|||
150273630|NCT01624259|542139597|FG001|Overall Study|Physician Decision|1|||
150273631|NCT01624259|542139596|FG000|Overall Study|Lost to Follow-up|2|||
150273632|NCT01624259|542139597|FG001|Overall Study|Lost to Follow-up|3|||
150273633|NCT01624259|542139596|FG000|Overall Study|Abnormal laboratory measure|3|||
150273634|NCT01624259|542139597|FG001|Overall Study|Abnormal laboratory measure|0|||
150273635|NCT01298518|542139598|FG000|Overall Study|Withdrawal by Subject|0|||
150273636|NCT01298518|542139599|FG001|Overall Study|Withdrawal by Subject|0|||
150273637|NCT01298518|542139600|FG002|Overall Study|Withdrawal by Subject|1|||
150273638|NCT02877927|542139604|FG000|Overall Study|Adverse Event|1|||
150273639|NCT02877927|542139605|FG001|Overall Study|Adverse Event|0|||
150273640|NCT02877927|542139604|FG000|Overall Study|Lost to Follow-up|37|||
150273641|NCT02877927|542139605|FG001|Overall Study|Lost to Follow-up|38|||
150273642|NCT02877927|542139604|FG000|Overall Study|Withdrawal by Subject|11|||
150273643|NCT02877927|542139605|FG001|Overall Study|Withdrawal by Subject|12|||
150273644|NCT02877927|542139604|FG000|Overall Study|Physician Decision|0|||
150273645|NCT02877927|542139605|FG001|Overall Study|Physician Decision|1|||
150273646|NCT02877927|542139604|FG000|Overall Study|Missed EOT/PTE Visit|5|||
150273647|NCT02877927|542139605|FG001|Overall Study|Missed EOT/PTE Visit|6|||
150273648|NCT00601250|542139606|FG000|Overall Study|Adverse Event|3|||
150273649|NCT00601250|542139607|FG001|Overall Study|Adverse Event|9|||
150273650|NCT00601250|542139606|FG000|Overall Study|Protocol Violation|3|||
150273651|NCT00601250|542139607|FG001|Overall Study|Protocol Violation|2|||
150273652|NCT00601250|542139606|FG000|Overall Study|Lost to Follow-up|2|||
150273653|NCT00601250|542139607|FG001|Overall Study|Lost to Follow-up|6|||
150273654|NCT00601250|542139606|FG000|Overall Study|Withdrawal by Subject|4|||
150273655|NCT00601250|542139607|FG001|Overall Study|Withdrawal by Subject|13|||
150273656|NCT00601250|542139606|FG000|Overall Study|Other incl. lack of efficacy|2|||
150273657|NCT00601250|542139607|FG001|Overall Study|Other incl. lack of efficacy|9|||
150273658|NCT01810016|542139608|FG000|Overall Study|Progressive disease|1|||
150273659|NCT01810016|542139609|FG001|Overall Study|Progressive disease|1|||
150273660|NCT01810016|542139610|FG002|Overall Study|Progressive disease|0|||
150273661|NCT01810016|542139608|FG000|Overall Study|Death|0|||
150273662|NCT01810016|542139609|FG001|Overall Study|Death|0|||
150273663|NCT01810016|542139610|FG002|Overall Study|Death|1|||
150273664|NCT01791803|542139611|FG000|Overall Study|Withdrawal by Subject|0|||
150273665|NCT01791803|542139612|FG001|Overall Study|Withdrawal by Subject|0|||
150273666|NCT01791803|542139613|FG002|Overall Study|Withdrawal by Subject|0|||
150273667|NCT01791803|542139614|FG003|Overall Study|Withdrawal by Subject|2|||
150273668|NCT01791803|542139611|FG000|Overall Study|Physician Decision|0|||
150273669|NCT01791803|542139612|FG001|Overall Study|Physician Decision|2|||
150273670|NCT01791803|542139613|FG002|Overall Study|Physician Decision|0|||
150273671|NCT01791803|542139614|FG003|Overall Study|Physician Decision|1|||
150273672|NCT01791803|542139611|FG000|Overall Study|Death|0|||
150273673|NCT01791803|542139612|FG001|Overall Study|Death|0|||
150273674|NCT01791803|542139613|FG002|Overall Study|Death|2|||
149938897|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
149938898|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
149938899|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
149938900|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
149938901|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
150273675|NCT01791803|542139614|FG003|Overall Study|Death|2|||
150273676|NCT04572854|542139615|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
150273677|NCT04572854|542139616|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
150273678|NCT04572854|542139617|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
150273679|NCT04572854|542139618|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
150273680|NCT04572854|542139615|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
150273681|NCT04572854|542139616|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
150273682|NCT04572854|542139617|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
150273683|NCT04572854|542139618|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
150273684|NCT02246582|542141443|FG000|Overall Study|Withdrawal by Subject|3|||
150273685|NCT02246582|542141444|FG001|Overall Study|Withdrawal by Subject|4|||
149938902|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
149938903|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
149938904|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
149938905|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
149938906|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
149938907|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
149938908|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
149938909|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
149938910|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
149938911|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
149938912|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
149938913|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
149938914|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
149938915|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
149938916|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
149938917|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
149938918|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
149938919|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
149938920|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
149938921|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
149938922|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
149938923|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
149938924|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
149938925|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
149938926|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
149938927|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
149938928|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
149938929|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
149938930|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
149938931|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
149938932|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
149938933|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
149938934|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
149938935|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
149938936|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
149938937|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
149938938|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
149938939|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
149938940|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
149938941|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
149938942|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
149938943|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
149938944|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
150169665|NCT03425643|541755678|FG001|Overall Study|Lost to Follow-up|0|||
150169666|NCT03425643|541755677|FG000|Overall Study|Death|109|||
150169667|NCT03425643|541755678|FG001|Overall Study|Death|141|||
150273686|NCT02229539|542141445|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
150273687|NCT02229539|542141446|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
150273688|NCT02229539|542141447|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
150273689|NCT02229539|542141445|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
150273690|NCT02229539|542141446|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
150273691|NCT02229539|542141447|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
150273692|NCT02229539|542141445|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
150273693|NCT02229539|542141446|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
150169668|NCT03425643|541755677|FG000|Overall Study|Ongoing in study|276|||
150169669|NCT03425643|541755678|FG001|Overall Study|Ongoing in study|247|||
150169670|NCT03141788|541755679|FG000|Overall Study|Lost to Follow-up|1|||
150169671|NCT03141788|541755679|FG000|Overall Study|Protocol Violation|3|||
150169672|NCT03141788|541755679|FG000|Overall Study|Withdrawal by Subject|4|||
150169673|NCT04133363|541755680|FG000|Overall Study|Lost to Follow-up|2|||
150169674|NCT04133363|541755681|FG001|Overall Study|Lost to Follow-up|1|||
150169675|NCT04133363|541755682|FG002|Overall Study|Lost to Follow-up|4|||
150169676|NCT01838200|541755683|FG000|Overall Study|Adverse Event|0|||
150169677|NCT01838200|541755684|FG001|Overall Study|Adverse Event|2|||
150169678|NCT01838200|541755683|FG000|Overall Study|Progressive disease|3|||
150273694|NCT02229539|542141447|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
149821165|NCT01772368|540475640|FG000|Overall Study|Withdrawal by Subject|3|||
149938945|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
149938946|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
149938947|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
149938948|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
149938949|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
149938950|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
149938951|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
149938952|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
149938953|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
149938954|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
149938955|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
149938956|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
149938957|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
149938958|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
149938959|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
149938960|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
149938961|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
149938962|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
150169679|NCT01838200|541755684|FG001|Overall Study|Progressive disease|0|||
150169680|NCT03354390|541755688|FG000|Level 1|Death|2|||
150169681|NCT03354390|541755689|FG001|Level 1|Death|0|||
150169682|NCT03354390|541755690|FG002|Level 1|Death|0|||
150169683|NCT03354390|541755691|FG003|Level 1|Death|0|||
150169684|NCT03354390|541755688|FG000|Level 1|Physician Decision|1|||
150169685|NCT03354390|541755689|FG001|Level 1|Physician Decision|0|||
150169686|NCT03354390|541755690|FG002|Level 1|Physician Decision|0|||
150169687|NCT03354390|541755691|FG003|Level 1|Physician Decision|0|||
150169688|NCT03354390|541755688|FG000|Level 2|Physician Decision|0|||
150169689|NCT03354390|541755689|FG001|Level 2|Physician Decision|2|||
150169690|NCT03354390|541755690|FG002|Level 2|Physician Decision|0|||
150169691|NCT03354390|541755691|FG003|Level 2|Physician Decision|0|||
150169692|NCT03354390|541755688|FG000|Level 2|Lack of Efficacy|0|||
150169693|NCT03354390|541755689|FG001|Level 2|Lack of Efficacy|1|||
150169694|NCT03354390|541755690|FG002|Level 2|Lack of Efficacy|0|||
150169695|NCT03354390|541755691|FG003|Level 2|Lack of Efficacy|0|||
150169696|NCT03354390|541755688|FG000|Level 2|Lost to Follow-up|0|||
150169697|NCT03354390|541755689|FG001|Level 2|Lost to Follow-up|1|||
150169698|NCT03354390|541755690|FG002|Level 2|Lost to Follow-up|0|||
150169699|NCT03354390|541755691|FG003|Level 2|Lost to Follow-up|0|||
150169700|NCT03354390|541755688|FG000|Level 3|Death|0|||
150169701|NCT03354390|541755689|FG001|Level 3|Death|0|||
150169702|NCT03354390|541755690|FG002|Level 3|Death|1|||
150169703|NCT03354390|541755691|FG003|Level 3|Death|0|||
150169704|NCT03354390|541755688|FG000|Level 3|Physician Decision|0|||
150169705|NCT03354390|541755689|FG001|Level 3|Physician Decision|0|||
150169706|NCT03354390|541755690|FG002|Level 3|Physician Decision|2|||
150169707|NCT03354390|541755691|FG003|Level 3|Physician Decision|0|||
150169708|NCT03354390|541755688|FG000|Level 4|Death|0|||
150169709|NCT03354390|541755689|FG001|Level 4|Death|0|||
150169710|NCT03354390|541755690|FG002|Level 4|Death|0|||
150169711|NCT03354390|541755691|FG003|Level 4|Death|3|||
150169712|NCT00589667|541757131|FG000|Overall Study|Adverse Event|2|||
150169713|NCT00589667|541757131|FG000|Overall Study|Withdrawal by Subject|1|||
150169714|NCT03538041|541757134|FG000|12-Week Treatment Period|Adverse Event|1|||
150169715|NCT03538041|541757135|FG001|12-Week Treatment Period|Adverse Event|1|||
150169716|NCT03538041|541757134|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
150169717|NCT03538041|541757135|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
150169718|NCT03538041|541757134|FG000|Treatment Extension Period|Adverse Event|4|||
150169719|NCT03538041|541757135|FG001|Treatment Extension Period|Adverse Event|1|||
150169720|NCT03538041|541757134|FG000|Treatment Extension Period|Physician Decision|1|||
150169721|NCT03538041|541757135|FG001|Treatment Extension Period|Physician Decision|1|||
150169722|NCT03538041|541757134|FG000|Treatment Extension Period|Lack of Efficacy|1|||
150169723|NCT03538041|541757135|FG001|Treatment Extension Period|Lack of Efficacy|4|||
150169724|NCT03538041|541757134|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
150169725|NCT03538041|541757135|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
150169726|NCT03538041|541757134|FG000|Treatment Extension Period|Death|0|||
150169727|NCT03538041|541757135|FG001|Treatment Extension Period|Death|1|||
150169728|NCT00726596|541757136|FG000|Overall Study|Adverse Event|2|||
150169729|NCT00726596|541757137|FG001|Overall Study|Adverse Event|1|||
150169730|NCT00726596|541757136|FG000|Overall Study|Withdrawal by Subject|3|||
150169731|NCT00726596|541757137|FG001|Overall Study|Withdrawal by Subject|3|||
150169732|NCT02034916|541757149|FG000|Overall Study|Death|39|||
150169733|NCT02034916|541757150|FG001|Overall Study|Death|28|||
150169734|NCT02034916|541757149|FG000|Overall Study|Withdrawal by Subject|2|||
149821166|NCT01772368|540475640|FG000|Overall Study|Protocol Violation|2|||
150273695|NCT02229539|542141445|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
150273696|NCT02229539|542141446|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
150273697|NCT02229539|542141447|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
150273698|NCT02229539|542141445|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
150273699|NCT02229539|542141446|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
150273700|NCT02229539|542141447|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
150273701|NCT02229539|542141445|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
150273702|NCT02229539|542141446|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
150273703|NCT02229539|542141447|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
150273704|NCT02060383|542141449|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
150273705|NCT02060383|542141450|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
150273706|NCT02060383|542141451|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
150273707|NCT02060383|542141452|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
150273708|NCT02060383|542141453|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
150273709|NCT02060383|542141449|FG000|Core Phase|Adverse Event|2|||
150273710|NCT02060383|542141450|FG001|Core Phase|Adverse Event|0|||
150273711|NCT02060383|542141451|FG002|Core Phase|Adverse Event|0|||
150273712|NCT02060383|542141452|FG003|Core Phase|Adverse Event|2|||
150273713|NCT02060383|542141453|FG004|Core Phase|Adverse Event|6|||
150273714|NCT02060383|542141449|FG000|Core Phase|Administrative problems|0|||
150273715|NCT02060383|542141450|FG001|Core Phase|Administrative problems|1|||
150273716|NCT02060383|542141451|FG002|Core Phase|Administrative problems|0|||
150273717|NCT02060383|542141452|FG003|Core Phase|Administrative problems|0|||
150273718|NCT02060383|542141453|FG004|Core Phase|Administrative problems|0|||
150273719|NCT02060383|542141449|FG000|Core Phase|Protocol Violation|0|||
150273720|NCT02060383|542141450|FG001|Core Phase|Protocol Violation|0|||
150273721|NCT02060383|542141451|FG002|Core Phase|Protocol Violation|0|||
150273722|NCT02060383|542141452|FG003|Core Phase|Protocol Violation|1|||
150273723|NCT02060383|542141453|FG004|Core Phase|Protocol Violation|0|||
150273724|NCT02060383|542141449|FG000|Core Phase|Withdrawal by Subject|0|||
150273725|NCT02060383|542141450|FG001|Core Phase|Withdrawal by Subject|0|||
150273726|NCT02060383|542141451|FG002|Core Phase|Withdrawal by Subject|0|||
150273727|NCT02060383|542141452|FG003|Core Phase|Withdrawal by Subject|4|||
149821167|NCT01772368|540475640|FG000|Overall Study|Other|1|||
149938963|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
149938964|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
149938965|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
149938966|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
149938967|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
149938968|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
149938969|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
149938970|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
149938971|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
149938972|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
149938973|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
149938974|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
149938975|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
149938976|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
149938977|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
149938978|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
149938979|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
149938980|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
149938981|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
149938982|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
149938983|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
149938984|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
149938985|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
149938986|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
150273728|NCT02060383|542141453|FG004|Core Phase|Withdrawal by Subject|2|||
150273729|NCT02060383|542141449|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
150273730|NCT02060383|542141450|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
150273731|NCT02060383|542141451|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
150273732|NCT02060383|542141452|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
150273733|NCT02060383|542141453|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
150273734|NCT02060383|542141449|FG000|Extension Phase|Adverse Event|1|||
150273735|NCT02060383|542141450|FG001|Extension Phase|Adverse Event|1|||
149821168|NCT03347695|540475647|FG000|Overall Study|Death|0|||
150273736|NCT02060383|542141451|FG002|Extension Phase|Adverse Event|2|||
150273737|NCT02060383|542141452|FG003|Extension Phase|Adverse Event|0|||
150273738|NCT02060383|542141453|FG004|Extension Phase|Adverse Event|1|||
150273739|NCT02060383|542141449|FG000|Extension Phase|Withdrawal by Subject|0|||
150273740|NCT02060383|542141450|FG001|Extension Phase|Withdrawal by Subject|1|||
150273741|NCT02060383|542141451|FG002|Extension Phase|Withdrawal by Subject|0|||
150273742|NCT02060383|542141452|FG003|Extension Phase|Withdrawal by Subject|0|||
150273743|NCT02060383|542141453|FG004|Extension Phase|Withdrawal by Subject|2|||
150273744|NCT02060383|542141449|FG000|Extension Phase|Administrative problems|1|||
150273745|NCT02060383|542141450|FG001|Extension Phase|Administrative problems|0|||
150273746|NCT02060383|542141451|FG002|Extension Phase|Administrative problems|0|||
150273747|NCT02060383|542141452|FG003|Extension Phase|Administrative problems|0|||
150273748|NCT02060383|542141453|FG004|Extension Phase|Administrative problems|0|||
150273749|NCT02060383|542141449|FG000|Extension Phase|Death|0|||
150273750|NCT02060383|542141450|FG001|Extension Phase|Death|0|||
150273751|NCT02060383|542141451|FG002|Extension Phase|Death|1|||
150273752|NCT02060383|542141452|FG003|Extension Phase|Death|0|||
149938987|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
149938988|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
149938989|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
149938990|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
149938991|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
149938992|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
149938993|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
149938994|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
149938995|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
149938996|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
149938997|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
149938998|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
149938999|NCT02717195|540913897|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
150273753|NCT02060383|542141453|FG004|Extension Phase|Death|1|||
150273754|NCT02060383|542141449|FG000|Extension Phase|Protocol Violation|0|||
150273755|NCT02060383|542141450|FG001|Extension Phase|Protocol Violation|0|||
150273756|NCT02060383|542141451|FG002|Extension Phase|Protocol Violation|0|||
150273757|NCT02060383|542141452|FG003|Extension Phase|Protocol Violation|0|||
150273758|NCT02060383|542141453|FG004|Extension Phase|Protocol Violation|1|||
150273759|NCT03441334|542141454|FG000|Overall Study|Withdrawal by Subject|1|||
150273760|NCT03441334|542141455|FG001|Overall Study|Withdrawal by Subject|0|||
150273761|NCT03426787|542141462|FG000|Overall Study|Withdrawal by Subject|6|||
150273762|NCT03426787|542141462|FG000|Overall Study|Lost to Follow-up|7|||
150273763|NCT03426787|542141462|FG000|Overall Study|Unrelated to intervention death|1|||
150273764|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
150273765|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
150273766|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
150273767|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
150273768|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
150273769|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
150273770|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
150273771|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
150273772|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
150273773|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
150273774|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
150273775|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
150273776|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
150273777|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
150273778|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
150273779|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
150273780|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
150273781|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
150273782|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
150273783|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
150273784|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
150273785|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
150273786|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
149939000|NCT02717195|540913898|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
149939001|NCT02717195|540913899|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
149939002|NCT02717195|540913900|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
150273787|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
150273788|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
149939003|NCT02717195|540913901|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
149939004|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
149939005|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
149939006|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
149939007|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
149939008|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
149939009|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
149939010|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
149939011|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
149939012|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
149939013|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
149939014|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
149939015|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
149939016|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
149939017|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
149939018|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
149939019|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
149939020|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
149939021|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
149939022|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
149939023|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
149939024|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149939025|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149939026|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
149939027|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
149939028|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
149939029|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
149939030|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
149939031|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
149939032|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
149939033|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
149939034|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
149939035|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
149939036|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
149939037|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
149939038|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
149939039|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
149939040|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
149939041|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
149939042|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
149939043|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
149939044|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
149939045|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
149939046|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
149939047|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
149939048|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
149939049|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
149939050|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
149939051|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
150273789|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
149939052|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
149939053|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
149939054|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
149939055|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
150273790|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
150273791|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
150273792|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
149939056|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
150273793|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
150273794|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
150273795|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
150273796|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
150273797|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
149939057|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
149939058|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
149939059|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
149939060|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
149939061|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
149939062|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
149939063|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
149939064|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
149939065|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
149939066|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
149939067|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
149939068|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
149939069|NCT02717195|540913897|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
149939070|NCT02717195|540913898|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
149939071|NCT02717195|540913899|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
149939072|NCT02717195|540913900|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
149939073|NCT02717195|540913901|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
149939074|NCT00855218|540913902|FG000|Overall Study|Adverse Event|43|||
149821169|NCT03347695|540475648|FG001|Overall Study|Death|4|||
150169735|NCT02034916|541757150|FG001|Overall Study|Withdrawal by Subject|1|||
150169736|NCT02034916|541757149|FG000|Overall Study|Lost to Follow-up|4|||
150169737|NCT02034916|541757150|FG001|Overall Study|Lost to Follow-up|1|||
150169738|NCT02034916|541757149|FG000|Overall Study|Study terminated by sponsor|4|||
150169739|NCT02034916|541757150|FG001|Overall Study|Study terminated by sponsor|5|||
150169740|NCT00798096|541757153|FG000|Overall Study|Ongoing|2|||
150169741|NCT03670602|541757154|FG000|Overall Study|Lost to Follow-up|1|||
150169742|NCT03670602|541757155|FG001|Overall Study|Lost to Follow-up|0|||
150169743|NCT03670602|541757154|FG000|Overall Study|Withdrawal by Subject|0|||
150169744|NCT03670602|541757155|FG001|Overall Study|Withdrawal by Subject|3|||
150169745|NCT00864682|541757157|FG000|Overall Study|Protocol Violation|2|||
150169746|NCT00864682|541757158|FG001|Overall Study|Protocol Violation|1|||
150169747|NCT00864682|541757159|FG002|Overall Study|Protocol Violation|2|||
150169748|NCT00957658|541757160|FG000|Overall Study|Death|1|||
150169749|NCT00957658|541757160|FG000|Overall Study|Lost to Follow-up|4|||
150169750|NCT00957658|541757160|FG000|Overall Study|Withdrawal by Subject|12|||
150169751|NCT00957658|541757160|FG000|Overall Study|Revision|1|||
150169752|NCT00957658|541757160|FG000|Overall Study|Incomplete 2 yr data|28|||
150169753|NCT00957658|541757160|FG000|Overall Study|Site termination|10|||
150169754|NCT00957658|541757160|FG000|Overall Study|unwilling/unable to return|2|||
150169755|NCT00957658|541757160|FG000|Overall Study|surgery cancelled|2|||
150169756|NCT00957658|541757160|FG000|Overall Study|Protocol Violation|5|||
150169757|NCT01585038|541757161|FG000|Overall Study|Adverse Event|2|||
150169758|NCT01585038|541757162|FG001|Overall Study|Adverse Event|2|||
150169759|NCT02957539|541757167|FG000|Baseline to Week 16|Lost to Follow-up|8|||
150169760|NCT02957539|541757168|FG001|Baseline to Week 16|Lost to Follow-up|10|||
150169761|NCT02957539|541757169|FG002|Baseline to Week 16|Lost to Follow-up|16|||
150169762|NCT02957539|541757167|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
150169763|NCT02957539|541757168|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
150169764|NCT02957539|541757169|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
150169765|NCT02957539|541757167|FG000|Week 16 to 32|Withdrawal by Subject|3|||
150169766|NCT02957539|541757168|FG001|Week 16 to 32|Withdrawal by Subject|3|||
150169767|NCT02957539|541757169|FG002|Week 16 to 32|Withdrawal by Subject|1|||
150169768|NCT02957539|541757167|FG000|Week 16 to 32|Lost to Follow-up|8|||
150169769|NCT02957539|541757168|FG001|Week 16 to 32|Lost to Follow-up|7|||
150169770|NCT02957539|541757169|FG002|Week 16 to 32|Lost to Follow-up|5|||
150169771|NCT02957539|541757167|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
150169772|NCT02957539|541757168|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
150169773|NCT02957539|541757169|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
150169774|NCT02957539|541757167|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
150169775|NCT02957539|541757168|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
150169776|NCT02957539|541757169|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
150169777|NCT00217672|541757171|FG000|Allocation|Ineligible|2|||
150169778|NCT00217672|541757172|FG001|Allocation|Ineligible|0|||
150169779|NCT00217672|541757171|FG000|Treatment|disease progression|33|||
150169780|NCT00217672|541757172|FG001|Treatment|disease progression|4|||
150169781|NCT00217672|541757171|FG000|Treatment|Adverse Event|18|||
150169782|NCT00217672|541757172|FG001|Treatment|Adverse Event|2|||
150169783|NCT00217672|541757171|FG000|Treatment|reqd treatment not permitted by protocol|6|||
150169784|NCT00217672|541757172|FG001|Treatment|reqd treatment not permitted by protocol|0|||
150169785|NCT00217672|541757171|FG000|Treatment|Physician Decision|6|||
150169786|NCT00217672|541757172|FG001|Treatment|Physician Decision|0|||
150169787|NCT00217672|541757171|FG000|Treatment|insurance issues|1|||
150169788|NCT00217672|541757172|FG001|Treatment|insurance issues|1|||
150169789|NCT00217672|541757171|FG000|Treatment|Death|2|||
149939075|NCT00855218|540913903|FG001|Overall Study|Adverse Event|27|||
149939076|NCT00855218|540913902|FG000|Overall Study|Withdrawal by Subject|10|||
149939077|NCT00855218|540913903|FG001|Overall Study|Withdrawal by Subject|6|||
149939078|NCT00855218|540913902|FG000|Overall Study|Physician Decision|18|||
149939079|NCT00855218|540913903|FG001|Overall Study|Physician Decision|11|||
149939080|NCT00855218|540913902|FG000|Overall Study|Lost to Follow-up|0|||
149939081|NCT00855218|540913903|FG001|Overall Study|Lost to Follow-up|1|||
149939082|NCT00855218|540913902|FG000|Overall Study|Protocol Violation|5|||
149939083|NCT00855218|540913903|FG001|Overall Study|Protocol Violation|9|||
149939084|NCT00855218|540913902|FG000|Overall Study|non-compliant with study drug|3|||
149939085|NCT00855218|540913903|FG001|Overall Study|non-compliant with study drug|1|||
149939086|NCT00855218|540913902|FG000|Overall Study|patient convenience|2|||
149939087|NCT00855218|540913903|FG001|Overall Study|patient convenience|0|||
149939088|NCT00855218|540913902|FG000|Overall Study|technical problems|2|||
149939089|NCT00855218|540913903|FG001|Overall Study|technical problems|1|||
149939090|NCT00855218|540913902|FG000|Overall Study|Still treated with study medication|0|||
149939091|NCT00855218|540913903|FG001|Overall Study|Still treated with study medication|1|||
149939092|NCT00855218|540913902|FG000|Overall Study|Untreatable disease progression|54|||
149939093|NCT00855218|540913903|FG001|Overall Study|Untreatable disease progression|67|||
149939094|NCT00855218|540913902|FG000|Overall Study|Second malignancy|0|||
149939095|NCT00855218|540913903|FG001|Overall Study|Second malignancy|1|||
149939096|NCT00855218|540913902|FG000|Overall Study|Progression measurement proven|7|||
149939097|NCT00855218|540913903|FG001|Overall Study|Progression measurement proven|15|||
149939098|NCT00855218|540913902|FG000|Overall Study|Clinical endpoint reached|10|||
149939099|NCT00855218|540913903|FG001|Overall Study|Clinical endpoint reached|13|||
149939100|NCT00769561|540913905|FG000|Overall Study|Withdrawal by Subject|2|||
149939101|NCT00769561|540913906|FG001|Overall Study|Withdrawal by Subject|2|||
149939102|NCT00769561|540913905|FG000|Overall Study|Lost to Follow-up|1|||
149939103|NCT00769561|540913906|FG001|Overall Study|Lost to Follow-up|3|||
149939104|NCT03824561|540913913|FG000|Overall Study|Protocol Violation|19|||
149939105|NCT03191552|540913914|FG000|Overall Study|Lost to Follow-up|1|||
149939106|NCT03191552|540913915|FG001|Overall Study|Lost to Follow-up|0|||
149939107|NCT03191552|540913916|FG002|Overall Study|Lost to Follow-up|0|||
149939108|NCT03191552|540913914|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
149939109|NCT03191552|540913915|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
149939110|NCT03191552|540913916|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
149939111|NCT02370511|540913919|FG000|Overall Study|Death|10|||
149939112|NCT02370511|540913920|FG001|Overall Study|Death|7|||
149939113|NCT02370511|540913921|FG002|Overall Study|Death|1|||
149939114|NCT02370511|540913919|FG000|Overall Study|Withdrawal by Subject|2|||
149939115|NCT02370511|540913920|FG001|Overall Study|Withdrawal by Subject|0|||
149939116|NCT02370511|540913921|FG002|Overall Study|Withdrawal by Subject|0|||
149939117|NCT02370511|540913919|FG000|Overall Study|Lost to Follow-up|0|||
149939118|NCT02370511|540913920|FG001|Overall Study|Lost to Follow-up|4|||
149939119|NCT02370511|540913921|FG002|Overall Study|Lost to Follow-up|0|||
149939120|NCT03092752|540913924|FG000|Overall Study|Aged <40 years|14209|||
149939121|NCT03092752|540913924|FG000|Overall Study|At least one claim with T2DM|61299|||
149939122|NCT03092752|540913924|FG000|Overall Study|Having no claim of study drugs|29282|||
149939123|NCT03092752|540913924|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
149939124|NCT03092752|540913924|FG000|Overall Study|<6 month history|245900|||
149939125|NCT03882918|540913925|FG000|Overall Study|Study terminated by sponsor|98|||
149939126|NCT03882918|540913925|FG000|Overall Study|Protocol Violation|1|||
149939127|NCT03882918|540913925|FG000|Overall Study|Other|9|||
149939128|NCT03882918|540913925|FG000|Overall Study|Lack of Efficacy|14|||
149939129|NCT03882918|540913925|FG000|Overall Study|Adverse Event|13|||
149939130|NCT03882918|540913925|FG000|Overall Study|Withdrawal by Subject|5|||
149939131|NCT06996301|540913926|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
149939132|NCT06996301|540913927|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
149939133|NCT06996301|540913926|FG000|Overall Study|Patients with discordant diagnostic results|107|||
149939134|NCT06996301|540913927|FG001|Overall Study|Patients with discordant diagnostic results|90|||
149939135|NCT06996301|540913926|FG000|Overall Study|Lost to Follow-up|31|||
149939136|NCT06996301|540913927|FG001|Overall Study|Lost to Follow-up|56|||
149939137|NCT06996301|540913926|FG000|Overall Study|Withdrawal by Subject|12|||
149939138|NCT06996301|540913927|FG001|Overall Study|Withdrawal by Subject|7|||
150273798|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
150273799|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
149939139|NCT04030598|540913928|FG000|Overall Study|Voluntary Withdrawal|0|||
149939140|NCT04030598|540913929|FG001|Overall Study|Voluntary Withdrawal|1|||
149939141|NCT04030598|540913930|FG002|Overall Study|Voluntary Withdrawal|0|||
149939142|NCT03141359|540913933|FG000|Overall Study|Death|32|||
149939143|NCT03141359|540913933|FG000|Overall Study|Still On Study (in follow up)|29|||
149939144|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Other than specified|2|||
149939145|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Other than specified|4|||
149975585|NCT00570713|541047894|FG000|Overall Study|Adverse Event|16|||
149939146|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
149939147|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
149939148|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Pregnancy|0|||
149939149|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Pregnancy|2|||
149939150|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Physician Decision|1|||
149939151|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Physician Decision|1|||
149939152|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
149939153|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
149939154|NCT02003144|540913934|FG000|Open Label Maintenance Phase|Adverse Event|2|||
149939155|NCT02003144|540913935|FG001|Open Label Maintenance Phase|Adverse Event|1|||
149939156|NCT01419535|540913937|FG000|Overall Study|could not maintain iv line|1|||
149939157|NCT01419535|540913938|FG001|Overall Study|could not maintain iv line|1|||
149939158|NCT01419535|540913937|FG000|Overall Study|Withdrawal by Subject|0|||
149939159|NCT01419535|540913938|FG001|Overall Study|Withdrawal by Subject|1|||
149939160|NCT05965752|540913945|FG000|Overall Study|Adverse Event|0|||
149939161|NCT05965752|540913946|FG001|Overall Study|Adverse Event|1|||
149939162|NCT05965752|540913947|FG002|Overall Study|Adverse Event|0|||
150273800|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
150273801|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
150273802|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
149939163|NCT05965752|540913948|FG003|Overall Study|Adverse Event|1|||
149939164|NCT05965752|540913949|FG004|Overall Study|Adverse Event|3|||
149939165|NCT05965752|540913945|FG000|Overall Study|Lost to Follow-up|2|||
149939166|NCT05965752|540913946|FG001|Overall Study|Lost to Follow-up|0|||
149939167|NCT05965752|540913947|FG002|Overall Study|Lost to Follow-up|1|||
149939168|NCT05965752|540913948|FG003|Overall Study|Lost to Follow-up|1|||
149939169|NCT05965752|540913949|FG004|Overall Study|Lost to Follow-up|1|||
149939170|NCT05965752|540913945|FG000|Overall Study|Withdrawal by Subject|2|||
149939171|NCT05965752|540913946|FG001|Overall Study|Withdrawal by Subject|2|||
149939172|NCT05965752|540913947|FG002|Overall Study|Withdrawal by Subject|1|||
149939173|NCT05965752|540913948|FG003|Overall Study|Withdrawal by Subject|5|||
149939174|NCT05965752|540913949|FG004|Overall Study|Withdrawal by Subject|0|||
149939175|NCT05965752|540913945|FG000|Overall Study|Disease Relapse|1|||
149939176|NCT05965752|540913946|FG001|Overall Study|Disease Relapse|0|||
149939177|NCT05965752|540913947|FG002|Overall Study|Disease Relapse|1|||
149939178|NCT05965752|540913948|FG003|Overall Study|Disease Relapse|0|||
149939179|NCT05965752|540913949|FG004|Overall Study|Disease Relapse|0|||
149939180|NCT05965752|540913945|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
149939181|NCT05965752|540913946|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
149939182|NCT05965752|540913947|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
149939183|NCT05965752|540913948|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
149939184|NCT05965752|540913949|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
149939185|NCT05965752|540913945|FG000|Overall Study|Unable to Return for Study Visits|0|||
149939186|NCT05965752|540913946|FG001|Overall Study|Unable to Return for Study Visits|1|||
149939187|NCT05965752|540913947|FG002|Overall Study|Unable to Return for Study Visits|0|||
149939188|NCT05965752|540913948|FG003|Overall Study|Unable to Return for Study Visits|3|||
149939189|NCT05965752|540913949|FG004|Overall Study|Unable to Return for Study Visits|1|||
149939190|NCT05965752|540913945|FG000|Overall Study|Early Termination|0|||
149939191|NCT05965752|540913946|FG001|Overall Study|Early Termination|0|||
149939192|NCT05965752|540913947|FG002|Overall Study|Early Termination|1|||
149939193|NCT05965752|540913948|FG003|Overall Study|Early Termination|0|||
149939194|NCT05965752|540913949|FG004|Overall Study|Early Termination|0|||
149939195|NCT05965752|540913945|FG000|Overall Study|Reported Unwanted Symptoms|0|||
149939196|NCT05965752|540913946|FG001|Overall Study|Reported Unwanted Symptoms|0|||
149939197|NCT05965752|540913947|FG002|Overall Study|Reported Unwanted Symptoms|0|||
149939198|NCT05965752|540913948|FG003|Overall Study|Reported Unwanted Symptoms|0|||
149939199|NCT05965752|540913949|FG004|Overall Study|Reported Unwanted Symptoms|1|||
149939200|NCT05965752|540913945|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
149939201|NCT05965752|540913946|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
149939202|NCT05965752|540913947|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
150273803|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
150273804|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
150273805|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149939203|NCT05965752|540913948|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
149939204|NCT05965752|540913949|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
149939205|NCT02934178|540915808|FG000|Received Vaccination 2|Death|0|||
149939206|NCT02934178|540915809|FG001|Received Vaccination 2|Death|1|||
149939207|NCT02934178|540915808|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
149939208|NCT02934178|540915809|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
149939209|NCT03944616|540915813|FG000|Overall Study|Lost to Follow-up|0|||
149939210|NCT03944616|540915814|FG001|Overall Study|Lost to Follow-up|2|||
149939211|NCT01287936|540915815|FG000|Overall Study|Lost to Follow-up|0|||
150273806|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149939212|NCT01287936|540915816|FG001|Overall Study|Lost to Follow-up|1|||
149939213|NCT01287936|540915817|FG002|Overall Study|Lost to Follow-up|1|||
149939214|NCT00296244|540915818|FG000|Overall Study|Underwent retransplant|0|||
149939215|NCT00296244|540915819|FG001|Overall Study|Underwent retransplant|1|||
149939216|NCT00703534|540915820|FG000|Overall Study|Adverse Event|14|||
150169790|NCT00217672|541757172|FG001|Treatment|Death|0|||
150169791|NCT00217672|541757171|FG000|Treatment|secondary malignancy|1|||
150169792|NCT00217672|541757172|FG001|Treatment|secondary malignancy|0|||
150169793|NCT00217672|541757171|FG000|Follow-up|Withdrawal by Subject|4|||
150169794|NCT00217672|541757172|FG001|Follow-up|Withdrawal by Subject|0|||
150169795|NCT00217672|541757171|FG000|Follow-up|Lost to Follow-up|1|||
150169796|NCT00217672|541757172|FG001|Follow-up|Lost to Follow-up|0|||
150169797|NCT04567888|541757179|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
150169798|NCT04567888|541757180|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
150169799|NCT04567888|541757179|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
150169800|NCT04567888|541757180|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
150169801|NCT04567888|541757179|FG000|Overall Study|Reported Unusual Birth Year|2|||
150169802|NCT04567888|541757180|FG001|Overall Study|Reported Unusual Birth Year|3|||
150169803|NCT04567888|541757179|FG000|Overall Study|Duplicate Responses|0|||
150169804|NCT04567888|541757180|FG001|Overall Study|Duplicate Responses|1|||
150169805|NCT00619645|541757181|FG000|Overall Study|Adverse Event|1|||
150169806|NCT04173572|541757182|FG000|Overall Study|Withdrawal by Subject|1|||
150169807|NCT04173572|541757183|FG001|Overall Study|Withdrawal by Subject|5|||
150169808|NCT04173572|541757182|FG000|Overall Study|Lost to Follow-up|3|||
150169809|NCT04173572|541757183|FG001|Overall Study|Lost to Follow-up|1|||
150169810|NCT02026258|541757184|FG000|Randomized|Did not start treatment|2|||
150169811|NCT02026258|541757185|FG001|Randomized|Did not start treatment|1|||
150169812|NCT02026258|541757184|FG000|Randomized|Change in treatment plan|1|||
150169813|NCT02026258|541757185|FG001|Randomized|Change in treatment plan|0|||
150169814|NCT02026258|541757184|FG000|Randomized|Presence of periodontal disease|1|||
150169815|NCT02026258|541757185|FG001|Randomized|Presence of periodontal disease|1|||
150169816|NCT02026258|541757184|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
150169817|NCT02026258|541757185|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
150169818|NCT02026258|541757184|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
150169819|NCT02026258|541757185|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
150169820|NCT00878722|541757188|FG000|Overall Study|Progressive disease|3|||
150169821|NCT00878722|541757189|FG001|Overall Study|Progressive disease|3|||
150169822|NCT00878722|541757190|FG002|Overall Study|Progressive disease|3|||
150169823|NCT00878722|541757191|FG003|Overall Study|Progressive disease|7|||
150169824|NCT00878722|541757192|FG004|Overall Study|Progressive disease|7|||
150169825|NCT00878722|541757193|FG005|Overall Study|Progressive disease|1|||
150169826|NCT00878722|541757194|FG006|Overall Study|Progressive disease|4|||
150169827|NCT00878722|541757195|FG007|Overall Study|Progressive disease|3|||
150169828|NCT00878722|541757188|FG000|Overall Study|Death|0|||
150169829|NCT00878722|541757189|FG001|Overall Study|Death|0|||
150169830|NCT00878722|541757190|FG002|Overall Study|Death|0|||
150169831|NCT00878722|541757191|FG003|Overall Study|Death|1|||
150169832|NCT00878722|541757192|FG004|Overall Study|Death|0|||
150169833|NCT00878722|541757193|FG005|Overall Study|Death|1|||
150169834|NCT00878722|541757194|FG006|Overall Study|Death|0|||
150169835|NCT00878722|541757195|FG007|Overall Study|Death|2|||
150169836|NCT00878722|541757188|FG000|Overall Study|Adverse Event|0|||
150169837|NCT00878722|541757189|FG001|Overall Study|Adverse Event|0|||
150169838|NCT00878722|541757190|FG002|Overall Study|Adverse Event|0|||
150169839|NCT00878722|541757191|FG003|Overall Study|Adverse Event|0|||
150169840|NCT00878722|541757192|FG004|Overall Study|Adverse Event|0|||
150169841|NCT00878722|541757193|FG005|Overall Study|Adverse Event|0|||
150169842|NCT00878722|541757194|FG006|Overall Study|Adverse Event|2|||
150169843|NCT00878722|541757195|FG007|Overall Study|Adverse Event|0|||
150169844|NCT00878722|541757188|FG000|Overall Study|Withdrawal by Subject|0|||
150169845|NCT00878722|541757189|FG001|Overall Study|Withdrawal by Subject|0|||
150169846|NCT00878722|541757190|FG002|Overall Study|Withdrawal by Subject|0|||
150169847|NCT00878722|541757191|FG003|Overall Study|Withdrawal by Subject|0|||
150169848|NCT00878722|541757192|FG004|Overall Study|Withdrawal by Subject|0|||
150169849|NCT00878722|541757193|FG005|Overall Study|Withdrawal by Subject|0|||
150169850|NCT00878722|541757194|FG006|Overall Study|Withdrawal by Subject|0|||
150169851|NCT00878722|541757195|FG007|Overall Study|Withdrawal by Subject|2|||
149939217|NCT00703534|540915821|FG001|Overall Study|Adverse Event|3|||
150169852|NCT00878722|541757188|FG000|Overall Study|Relapse|0|||
150169853|NCT00878722|541757189|FG001|Overall Study|Relapse|0|||
150169854|NCT00878722|541757190|FG002|Overall Study|Relapse|0|||
150169855|NCT00878722|541757191|FG003|Overall Study|Relapse|1|||
150169856|NCT00878722|541757192|FG004|Overall Study|Relapse|0|||
150169857|NCT00878722|541757193|FG005|Overall Study|Relapse|0|||
150169858|NCT00878722|541757194|FG006|Overall Study|Relapse|0|||
150169859|NCT00878722|541757195|FG007|Overall Study|Relapse|0|||
150169860|NCT02341625|541757200|FG000|Overall Study|Disease Progression|2|||
150169861|NCT02341625|541757201|FG001|Overall Study|Disease Progression|2|||
149939218|NCT00703534|540915820|FG000|Overall Study|Withdrawal by Subject|8|||
149939219|NCT00703534|540915821|FG001|Overall Study|Withdrawal by Subject|7|||
149939220|NCT00703534|540915820|FG000|Overall Study|Incorrect Enrollment|6|||
149939221|NCT00703534|540915821|FG001|Overall Study|Incorrect Enrollment|6|||
149939222|NCT00703534|540915820|FG000|Overall Study|Lost to Follow-up|1|||
149939223|NCT00703534|540915821|FG001|Overall Study|Lost to Follow-up|4|||
149939224|NCT00703534|540915820|FG000|Overall Study|Severe Non Compliance|1|||
149939225|NCT00703534|540915821|FG001|Overall Study|Severe Non Compliance|5|||
149939226|NCT00427934|540915822|FG000|Overall Study|Adverse Event|1|||
149939227|NCT00427934|540915823|FG001|Overall Study|Adverse Event|0|||
149939228|NCT00427934|540915824|FG002|Overall Study|Adverse Event|5|||
149939229|NCT00427934|540915825|FG003|Overall Study|Adverse Event|4|||
149939230|NCT00427934|540915822|FG000|Overall Study|Lack of Efficacy|0|||
149939231|NCT00427934|540915823|FG001|Overall Study|Lack of Efficacy|0|||
149939232|NCT00427934|540915824|FG002|Overall Study|Lack of Efficacy|5|||
149939233|NCT00427934|540915825|FG003|Overall Study|Lack of Efficacy|2|||
149939234|NCT00427934|540915822|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
149939235|NCT00427934|540915823|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
149939236|NCT00427934|540915824|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
149939237|NCT00427934|540915825|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
149939238|NCT00427934|540915822|FG000|Overall Study|Other|0|||
149939239|NCT00427934|540915823|FG001|Overall Study|Other|0|||
149939240|NCT00427934|540915824|FG002|Overall Study|Other|11|||
149939241|NCT00427934|540915825|FG003|Overall Study|Other|5|||
149939242|NCT00427934|540915822|FG000|Overall Study|Withdrawal by Subject|0|||
149939243|NCT00427934|540915823|FG001|Overall Study|Withdrawal by Subject|0|||
149939244|NCT00427934|540915824|FG002|Overall Study|Withdrawal by Subject|1|||
149939245|NCT00427934|540915825|FG003|Overall Study|Withdrawal by Subject|3|||
149939246|NCT00998946|540915828|FG000|Overall Study|Lost to Follow-up|1|||
149939247|NCT00998946|540915828|FG000|Overall Study|Withdrawal by Subject|1|||
149939248|NCT00998946|540915828|FG000|Overall Study|Death|2|||
149939249|NCT00998946|540915828|FG000|Overall Study|Reason Unspecified|3|||
149939250|NCT00998946|540915828|FG000|Overall Study|Enrolled but not Dosed|2|||
149939251|NCT00915525|540915834|FG000|Overall Study|Protocol Violation|9|||
149939252|NCT00915525|540915835|FG001|Overall Study|Protocol Violation|4|||
149939253|NCT00915525|540915834|FG000|Overall Study|Withdrawal by Subject|59|||
149939254|NCT00915525|540915835|FG001|Overall Study|Withdrawal by Subject|21|||
149939255|NCT00915525|540915834|FG000|Overall Study|Lost to Follow-up|27|||
149939256|NCT00915525|540915835|FG001|Overall Study|Lost to Follow-up|16|||
149939257|NCT00915525|540915834|FG000|Overall Study|Pregnancy|2|||
149939258|NCT00915525|540915835|FG001|Overall Study|Pregnancy|0|||
149939259|NCT00915525|540915834|FG000|Overall Study|Lack of Efficacy|15|||
149939260|NCT00915525|540915835|FG001|Overall Study|Lack of Efficacy|32|||
149939261|NCT00915525|540915834|FG000|Overall Study|Adverse Event|29|||
149939262|NCT00915525|540915835|FG001|Overall Study|Adverse Event|13|||
149939263|NCT00915525|540915834|FG000|Overall Study|Missing|12|||
149939264|NCT00915525|540915835|FG001|Overall Study|Missing|1|||
149939265|NCT00915525|540915834|FG000|Overall Study|Other Reason|35|||
149939266|NCT00915525|540915835|FG001|Overall Study|Other Reason|12|||
149939267|NCT00915525|540915834|FG000|Overall Study|Site Closed|27|||
149939268|NCT00915525|540915835|FG001|Overall Study|Site Closed|9|||
149939269|NCT00915525|540915834|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
149939270|NCT00915525|540915835|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
149939271|NCT00915525|540915834|FG000|Overall Study|Study Burden|28|||
149939272|NCT00915525|540915835|FG001|Overall Study|Study Burden|12|||
149939273|NCT00915525|540915834|FG000|Overall Study|Non-Compliance|3|||
149939274|NCT00915525|540915835|FG001|Overall Study|Non-Compliance|1|||
149939275|NCT00915525|540915834|FG000|Overall Study|Patient Moved|15|||
149939276|NCT00915525|540915835|FG001|Overall Study|Patient Moved|9|||
149939277|NCT00485303|540915837|FG000|Overall Study|Adverse Event|5|||
149939278|NCT00485303|540915837|FG000|Overall Study|Progressive Disease|44|||
149939279|NCT00485303|540915837|FG000|Overall Study|Other|3|||
149939280|NCT00485303|540915837|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
149939281|NCT00485303|540915837|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
149939282|NCT00296335|540915846|FG000|Overall Study|Recurrence|3|||
149939283|NCT00296335|540915847|FG001|Overall Study|Recurrence|51|||
149939284|NCT00296335|540915846|FG000|Overall Study|Adverse Event|17|||
149939285|NCT00296335|540915847|FG001|Overall Study|Adverse Event|27|||
149939286|NCT00296335|540915846|FG000|Overall Study|Lost to Follow-up|7|||
150273807|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149939287|NCT00296335|540915847|FG001|Overall Study|Lost to Follow-up|33|||
149939288|NCT00296335|540915846|FG000|Overall Study|Physician Decision|3|||
149939289|NCT00296335|540915847|FG001|Overall Study|Physician Decision|11|||
149939290|NCT01027845|540915848|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
149939291|NCT01027845|540915849|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
149939292|NCT01027845|540915850|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
149939293|NCT01027845|540915851|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
149939294|NCT01027845|540915848|FG000|Primary Vaccination Phase|Adverse Event|1|||
149939295|NCT01027845|540915849|FG001|Primary Vaccination Phase|Adverse Event|0|||
149939296|NCT01027845|540915850|FG002|Primary Vaccination Phase|Adverse Event|0|||
149939297|NCT01027845|540915851|FG003|Primary Vaccination Phase|Adverse Event|0|||
149939298|NCT01027845|540915848|FG000|Primary Vaccination Phase|Protocol Violation|1|||
149939299|NCT01027845|540915849|FG001|Primary Vaccination Phase|Protocol Violation|0|||
149939300|NCT01027845|540915850|FG002|Primary Vaccination Phase|Protocol Violation|0|||
150273808|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
150273809|NCT03627767|542141471|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
150273810|NCT03627767|542141472|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
150273811|NCT03627767|542141473|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
150273812|NCT03627767|542141474|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
150273813|NCT03627767|542141475|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
150273814|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
150273815|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
150273816|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
150273817|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
150273818|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
150273819|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150273820|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150273821|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
150273822|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
150273823|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150273824|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
150273825|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
150273826|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
150273827|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
150273828|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
150273829|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
150273830|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
150273831|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
150273832|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
150273833|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
150273834|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
150273835|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
150273836|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
150273837|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
150273838|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
150273839|NCT03627767|542141471|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
150273840|NCT03627767|542141472|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
150273841|NCT03627767|542141473|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
150273842|NCT03627767|542141474|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
150273843|NCT03627767|542141475|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
150273844|NCT03627767|542141471|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
150273845|NCT03627767|542141472|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
150273846|NCT03627767|542141473|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
150273847|NCT03627767|542141474|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
150273848|NCT03627767|542141475|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
150273849|NCT03627767|542141471|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
150273850|NCT03627767|542141472|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
150273851|NCT03627767|542141473|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
150273852|NCT03627767|542141474|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
150273853|NCT03627767|542141475|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
150273854|NCT03627767|542141471|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
150273855|NCT03627767|542141472|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
150273856|NCT03627767|542141473|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
150273857|NCT03627767|542141474|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
150273858|NCT03627767|542141475|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
150273859|NCT03627767|542141471|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
150273860|NCT03627767|542141472|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
150273861|NCT03627767|542141473|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
150273862|NCT03627767|542141474|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
150273863|NCT03627767|542141475|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
150273864|NCT00907257|542141476|FG000|Overall Study|Adverse Event|0|||
150273865|NCT00907257|542141477|FG001|Overall Study|Adverse Event|4|||
150273866|NCT00907257|542141476|FG000|Overall Study|Protocol Violation|1|||
150273867|NCT00907257|542141477|FG001|Overall Study|Protocol Violation|2|||
149939301|NCT01027845|540915851|FG003|Primary Vaccination Phase|Protocol Violation|0|||
150273868|NCT00907257|542141476|FG000|Overall Study|Lost to Follow-up|3|||
150273869|NCT00907257|542141477|FG001|Overall Study|Lost to Follow-up|3|||
150273870|NCT00907257|542141476|FG000|Overall Study|Withdrawal by Subject|1|||
149939302|NCT01027845|540915848|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
149939303|NCT01027845|540915849|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
149939304|NCT01027845|540915850|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
149939305|NCT01027845|540915851|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
149939306|NCT01027845|540915848|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
149939307|NCT01027845|540915849|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
149939308|NCT01027845|540915850|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
149939309|NCT01027845|540915851|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
149939310|NCT01027845|540915848|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
149939311|NCT01027845|540915849|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
149939312|NCT01027845|540915850|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
149939313|NCT01027845|540915851|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
149939314|NCT01670292|540915853|FG000|Overall Study|Lost to Follow-up|14|||
149939315|NCT01603277|540915856|FG000|Overall Study|Adverse Event|1|||
149939316|NCT01603277|540915857|FG001|Overall Study|Adverse Event|2|||
149939317|NCT01603277|540915856|FG000|Overall Study|Physician Decision|0|||
149939318|NCT01603277|540915857|FG001|Overall Study|Physician Decision|1|||
149939319|NCT01603277|540915856|FG000|Overall Study|Protocol Violation|6|||
149939320|NCT01603277|540915857|FG001|Overall Study|Protocol Violation|10|||
149939321|NCT01603277|540915856|FG000|Overall Study|Withdrawal by Subject|5|||
149939322|NCT01603277|540915857|FG001|Overall Study|Withdrawal by Subject|4|||
149939323|NCT01603277|540915856|FG000|Overall Study|Non-Compliance|2|||
149939324|NCT01603277|540915857|FG001|Overall Study|Non-Compliance|1|||
149939325|NCT00087178|540915858|FG000|Overall Study|No follow up data|5|||
149939326|NCT00087178|540915859|FG001|Overall Study|No follow up data|15|||
149939327|NCT00087178|540915858|FG000|Overall Study|No clinical assessment|1|||
149939328|NCT00087178|540915859|FG001|Overall Study|No clinical assessment|2|||
149939329|NCT00087178|540915858|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
149939330|NCT00087178|540915859|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
149939331|NCT04494646|540915860|FG000|Overall Study|Adverse Event|0|||
149939332|NCT04494646|540915861|FG001|Overall Study|Adverse Event|1|||
149939333|NCT04494646|540915860|FG000|Overall Study|Withdrawal by Subject|0|||
149939334|NCT04494646|540915861|FG001|Overall Study|Withdrawal by Subject|1|||
149939335|NCT01692119|540915862|FG000|Overall Study|Protocol Violation|3|||
149939336|NCT01692119|540915863|FG001|Overall Study|Protocol Violation|1|||
149939337|NCT01692119|540915862|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
149939338|NCT01692119|540915863|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
149939339|NCT05569174|540915864|FG000|Overall Study|Adverse Event|0|||
149939340|NCT05569174|540915865|FG001|Overall Study|Adverse Event|1|||
149939341|NCT05569174|540915864|FG000|Overall Study|Lack of compliance|0|||
149939342|NCT05569174|540915865|FG001|Overall Study|Lack of compliance|1|||
149939343|NCT05569174|540915864|FG000|Overall Study|Withdrawal of consent|0|||
149939344|NCT05569174|540915865|FG001|Overall Study|Withdrawal of consent|1|||
149939345|NCT05569174|540915864|FG000|Overall Study|Participant wish|0|||
149939346|NCT05569174|540915865|FG001|Overall Study|Participant wish|1|||
149939347|NCT05569174|540915864|FG000|Overall Study|Lost to Follow-up|0|||
149939348|NCT05569174|540915865|FG001|Overall Study|Lost to Follow-up|1|||
150273871|NCT00907257|542141477|FG001|Overall Study|Withdrawal by Subject|2|||
150273872|NCT00907257|542141476|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
150273873|NCT00907257|542141477|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
150273874|NCT00907257|542141476|FG000|Overall Study|Moved|1|||
150273875|NCT00907257|542141477|FG001|Overall Study|Moved|0|||
150273876|NCT00907257|542141476|FG000|Overall Study|Personal Reasons|6|||
150273877|NCT00907257|542141477|FG001|Overall Study|Personal Reasons|1|||
149939349|NCT00112957|540915872|FG000|Overall Study|Progressive disease|18|||
150273878|NCT04163900|542141478|FG000|Overall Study|Radiological disease progression|112|||
150273879|NCT04163900|542141479|FG001|Overall Study|Radiological disease progression|127|||
150273880|NCT04163900|542141478|FG000|Overall Study|Study closure|98|||
149939350|NCT00112957|540915872|FG000|Overall Study|Physician Decision|1|||
150273881|NCT04163900|542141479|FG001|Overall Study|Study closure|133|||
149939351|NCT02309359|540915875|FG000|Overall Study|Adverse Event|4|||
149939352|NCT02309359|540915876|FG001|Overall Study|Adverse Event|5|||
149939353|NCT02309359|540915877|FG002|Overall Study|Adverse Event|5|||
149939354|NCT02309359|540915878|FG003|Overall Study|Adverse Event|4|||
149939355|NCT02309359|540915879|FG004|Overall Study|Adverse Event|4|||
149939356|NCT02309359|540915875|FG000|Overall Study|Death|1|||
149939357|NCT02309359|540915876|FG001|Overall Study|Death|0|||
150273882|NCT04163900|542141478|FG000|Overall Study|Adverse Event|78|||
149939358|NCT02309359|540915877|FG002|Overall Study|Death|0|||
149939359|NCT02309359|540915878|FG003|Overall Study|Death|0|||
150273883|NCT04163900|542141479|FG001|Overall Study|Adverse Event|32|||
149939360|NCT02309359|540915879|FG004|Overall Study|Death|0|||
150273884|NCT04163900|542141478|FG000|Overall Study|Withdrawal by Subject|37|||
150273885|NCT04163900|542141479|FG001|Overall Study|Withdrawal by Subject|34|||
150273886|NCT04163900|542141478|FG000|Overall Study|Death|29|||
150273887|NCT04163900|542141479|FG001|Overall Study|Death|16|||
150273888|NCT04163900|542141478|FG000|Overall Study|Physician Decision|17|||
150273889|NCT04163900|542141479|FG001|Overall Study|Physician Decision|25|||
150273890|NCT04163900|542141478|FG000|Overall Study|Clinical disease progression|14|||
150273891|NCT04163900|542141479|FG001|Overall Study|Clinical disease progression|13|||
150273892|NCT04163900|542141478|FG000|Overall Study|Protocol Violation|3|||
150273893|NCT04163900|542141479|FG001|Overall Study|Protocol Violation|4|||
150273894|NCT04163900|542141478|FG000|Overall Study|Lost to Follow-up|0|||
150273895|NCT04163900|542141479|FG001|Overall Study|Lost to Follow-up|1|||
150273896|NCT00283049|542141480|FG000|Overall Study|Adverse Event|6|||
150273897|NCT00283049|542141481|FG001|Overall Study|Adverse Event|1|||
150273898|NCT00283049|542141482|FG002|Overall Study|Adverse Event|4|||
150273899|NCT00283049|542141480|FG000|Overall Study|Protocol Violation|3|||
150273900|NCT00283049|542141481|FG001|Overall Study|Protocol Violation|0|||
150273901|NCT00283049|542141482|FG002|Overall Study|Protocol Violation|3|||
150273902|NCT00283049|542141480|FG000|Overall Study|Death|1|||
150273903|NCT00283049|542141481|FG001|Overall Study|Death|1|||
150273904|NCT00283049|542141482|FG002|Overall Study|Death|1|||
150273905|NCT00283049|542141480|FG000|Overall Study|Lack of Efficacy|0|||
150273906|NCT00283049|542141481|FG001|Overall Study|Lack of Efficacy|1|||
150273907|NCT00283049|542141482|FG002|Overall Study|Lack of Efficacy|1|||
150273908|NCT00283049|542141480|FG000|Overall Study|Lost to Follow-up|4|||
150273909|NCT00283049|542141481|FG001|Overall Study|Lost to Follow-up|2|||
150273910|NCT00283049|542141482|FG002|Overall Study|Lost to Follow-up|5|||
150273911|NCT00283049|542141480|FG000|Overall Study|Withdrawal by Subject|26|||
150273912|NCT00283049|542141481|FG001|Overall Study|Withdrawal by Subject|24|||
150273913|NCT00283049|542141482|FG002|Overall Study|Withdrawal by Subject|19|||
150273914|NCT00283049|542141480|FG000|Overall Study|Discontinuation of Study|18|||
150273915|NCT00283049|542141481|FG001|Overall Study|Discontinuation of Study|16|||
150273916|NCT00283049|542141482|FG002|Overall Study|Discontinuation of Study|20|||
150273917|NCT00283049|542141480|FG000|Overall Study|No longer requires study treatment|0|||
150273918|NCT00283049|542141481|FG001|Overall Study|No longer requires study treatment|0|||
150273919|NCT00283049|542141482|FG002|Overall Study|No longer requires study treatment|1|||
150273920|NCT01628107|542141483|FG000|Overall Study|Withdrawal by Subject|17|||
150273921|NCT01628107|542141483|FG000|Overall Study|Lost to Follow-up|4|||
150273922|NCT01628107|542141483|FG000|Overall Study|Adverse Event|33|||
150273923|NCT01628107|542141483|FG000|Overall Study|Physician Decision|2|||
150273924|NCT01628107|542141483|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
150273925|NCT01628107|542141483|FG000|Overall Study|Non-compliant with Study Procedures|10|||
150273926|NCT01628107|542141483|FG000|Overall Study|Not Treated|8|||
150273927|NCT01628107|542141483|FG000|Overall Study|Sponsor Decision|11|||
150273928|NCT01628107|542141483|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
150273929|NCT01628107|542141483|FG000|Overall Study|Relocated|8|||
150273930|NCT01628107|542141483|FG000|Overall Study|Kidney Transplant|9|||
150273931|NCT01628107|542141483|FG000|Overall Study|Use of Standard of Care|9|||
150273932|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Adverse Event|2|||
150273933|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Adverse Event|2|||
150273934|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Adverse Event|4|||
150273935|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Adverse Event|0|||
150273936|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Adverse Event|0|||
150273937|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Progressive disease|0|||
150273938|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Progressive disease|0|||
150273939|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Progressive disease|1|||
150273940|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Progressive disease|0|||
150273941|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Progressive disease|0|||
150273942|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
150273943|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
150273944|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
150273945|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
150273946|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
149821170|NCT03347695|540475647|FG000|Overall Study|Lost to Follow-up|0|||
149821171|NCT03347695|540475648|FG001|Overall Study|Lost to Follow-up|1|||
149821172|NCT02884206|540475649|FG000|Valsartan Run-in Period|Death|1|||
149821173|NCT02884206|540475650|FG001|Valsartan Run-in Period|Death|0|||
149821174|NCT02884206|540475651|FG002|Valsartan Run-in Period|Death|0|||
149939361|NCT02309359|540915875|FG000|Overall Study|Withdrawal by Subject|2|||
149939362|NCT02309359|540915876|FG001|Overall Study|Withdrawal by Subject|2|||
150273947|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
150273948|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
150273949|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
150273950|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
150273951|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
150273952|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
150273953|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
150273954|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
150273955|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
150273956|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
150273957|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
150273958|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
150273959|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
150273960|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
150273961|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
150273962|NCT03523728|542141484|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
150273963|NCT03523728|542141485|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
150273964|NCT03523728|542141486|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
150273965|NCT03523728|542141487|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
150273966|NCT03523728|542141488|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
150273967|NCT03523728|542141484|FG000|Stage 2 (24 Months)|Adverse Event|0|||
150273968|NCT03523728|542141485|FG001|Stage 2 (24 Months)|Adverse Event|0|||
150273969|NCT03523728|542141486|FG002|Stage 2 (24 Months)|Adverse Event|0|||
150273970|NCT03523728|542141487|FG003|Stage 2 (24 Months)|Adverse Event|1|||
150273971|NCT03523728|542141488|FG004|Stage 2 (24 Months)|Adverse Event|2|||
150273972|NCT03523728|542141484|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
150273973|NCT03523728|542141485|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
150273974|NCT03523728|542141486|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
150273975|NCT03523728|542141487|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
150273976|NCT03523728|542141488|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
150273977|NCT03523728|542141484|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
150273978|NCT03523728|542141485|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
150273979|NCT03523728|542141486|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
150273980|NCT03523728|542141487|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
150273981|NCT03523728|542141488|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
150273982|NCT03523728|542141484|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
150273983|NCT03523728|542141485|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
150273984|NCT03523728|542141486|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
150273985|NCT03523728|542141487|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
150273986|NCT03523728|542141488|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
150273987|NCT03523728|542141484|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
150273988|NCT03523728|542141485|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
150273989|NCT03523728|542141486|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
150273990|NCT03523728|542141487|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
150273991|NCT03523728|542141488|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
150273992|NCT02230254|542141489|FG000|Overall Study|Lost to Follow-up|3|||
150273993|NCT00621751|542141490|FG000|Overall Study|Adverse Event|0|||
150273994|NCT00621751|542141491|FG001|Overall Study|Adverse Event|1|||
150273995|NCT00419120|542141495|FG000|Long Term Follow up Period|study ongoing|10|||
150273996|NCT01069120|542141498|FG000|Overall Study|Study prematurely terminated|27|||
150273997|NCT03349775|542141502|FG000|Overall Study|Side Effects|1|||
150273998|NCT03349775|542141503|FG001|Overall Study|Side Effects|2|||
150273999|NCT03349775|542141502|FG000|Overall Study|Withdrawal by Subject|1|||
150274000|NCT03349775|542141503|FG001|Overall Study|Withdrawal by Subject|1|||
150274001|NCT03349775|542141502|FG000|Overall Study|No primary outcome measurements|0|||
150274002|NCT03349775|542141503|FG001|Overall Study|No primary outcome measurements|1|||
150274003|NCT00884325|542141504|FG000|Overall Study|Lost to Follow-up|1|||
150274004|NCT00884325|542141505|FG001|Overall Study|Lost to Follow-up|2|||
150274005|NCT00884325|542141504|FG000|Overall Study|Lack of Efficacy|0|||
150274006|NCT00884325|542141505|FG001|Overall Study|Lack of Efficacy|1|||
150274007|NCT00884325|542141504|FG000|Overall Study|Withdrawal by Subject|1|||
150274008|NCT00884325|542141505|FG001|Overall Study|Withdrawal by Subject|1|||
150274009|NCT00884325|542141504|FG000|Overall Study|Not provided|1|||
150274010|NCT00884325|542141505|FG001|Overall Study|Not provided|0|||
150274011|NCT04439071|542141506|FG000|Overall Study|Lost to Follow-up|0|||
150274012|NCT04439071|542141507|FG001|Overall Study|Lost to Follow-up|3|||
150274013|NCT04439071|542141506|FG000|Overall Study|Withdrawal by Subject|3|||
150274014|NCT04439071|542141507|FG001|Overall Study|Withdrawal by Subject|8|||
150274015|NCT04439071|542141506|FG000|Overall Study|Death|6|||
150274016|NCT04439071|542141507|FG001|Overall Study|Death|4|||
150274017|NCT04439071|542141506|FG000|Overall Study|Other than specified|3|||
150274018|NCT04439071|542141507|FG001|Overall Study|Other than specified|3|||
150274019|NCT04439071|542141506|FG000|Overall Study|Randomized but not treated|2|||
150274020|NCT04439071|542141507|FG001|Overall Study|Randomized but not treated|0|||
150274021|NCT01186939|542141508|FG000|Overall Study|Death|7|||
150274022|NCT01186939|542141508|FG000|Overall Study|Withdrawal by Subject|2|||
150274023|NCT01186939|542141508|FG000|Overall Study|No longer receiving clinical benefit|17|||
150274024|NCT01186939|542141508|FG000|Overall Study|Program closed|5|||
150274025|NCT01186939|542141508|FG000|Overall Study|Sponsor decision|4|||
150274026|NCT01186939|542141508|FG000|Overall Study|Started additional treatment|1|||
150274027|NCT01186939|542141508|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
150274028|NCT01186939|542141508|FG000|Overall Study|Myocardial infarction|1|||
150274029|NCT01186939|542141508|FG000|Overall Study|Bone marrow transplant|1|||
149821175|NCT02884206|540475649|FG000|Valsartan Run-in Period|Adverse Event|31|||
149939363|NCT02309359|540915877|FG002|Overall Study|Withdrawal by Subject|4|||
149939364|NCT02309359|540915878|FG003|Overall Study|Withdrawal by Subject|4|||
149939365|NCT02309359|540915879|FG004|Overall Study|Withdrawal by Subject|0|||
149939366|NCT02309359|540915875|FG000|Overall Study|Lack of Efficacy|3|||
149939367|NCT02309359|540915876|FG001|Overall Study|Lack of Efficacy|1|||
149939368|NCT02309359|540915877|FG002|Overall Study|Lack of Efficacy|0|||
149939369|NCT02309359|540915878|FG003|Overall Study|Lack of Efficacy|0|||
149939370|NCT02309359|540915879|FG004|Overall Study|Lack of Efficacy|3|||
149939371|NCT02309359|540915875|FG000|Overall Study|Lost to Follow-up|0|||
149939372|NCT02309359|540915876|FG001|Overall Study|Lost to Follow-up|0|||
149939373|NCT02309359|540915877|FG002|Overall Study|Lost to Follow-up|0|||
149939374|NCT02309359|540915878|FG003|Overall Study|Lost to Follow-up|1|||
149939375|NCT02309359|540915879|FG004|Overall Study|Lost to Follow-up|0|||
149939376|NCT02309359|540915875|FG000|Overall Study|Other|2|||
149939377|NCT02309359|540915876|FG001|Overall Study|Other|0|||
149939378|NCT02309359|540915877|FG002|Overall Study|Other|2|||
149939379|NCT02309359|540915878|FG003|Overall Study|Other|3|||
149939380|NCT02309359|540915879|FG004|Overall Study|Other|2|||
149939381|NCT03895086|540915881|FG000|Overall Study|Early termination study|1|||
149939382|NCT03895086|540915882|FG001|Overall Study|Early termination study|0|||
149939383|NCT03451045|540915886|FG000|Overall Study|Lack of Efficacy|3|||
149939384|NCT03451045|540915887|FG001|Overall Study|Lack of Efficacy|2|||
149939385|NCT03451045|540915888|FG002|Overall Study|Lack of Efficacy|2|||
149939386|NCT03451045|540915886|FG000|Overall Study|Physician Decision|1|||
149939387|NCT03451045|540915887|FG001|Overall Study|Physician Decision|1|||
149939388|NCT03451045|540915888|FG002|Overall Study|Physician Decision|1|||
149939389|NCT03451045|540915886|FG000|Overall Study|Withdrawal by Subject|4|||
149939390|NCT03451045|540915887|FG001|Overall Study|Withdrawal by Subject|0|||
149939391|NCT03451045|540915888|FG002|Overall Study|Withdrawal by Subject|5|||
149939392|NCT03451045|540915886|FG000|Overall Study|Pregnancy|0|||
149939393|NCT03451045|540915887|FG001|Overall Study|Pregnancy|0|||
149939394|NCT03451045|540915888|FG002|Overall Study|Pregnancy|2|||
149939395|NCT03451045|540915886|FG000|Overall Study|Adverse Event|7|||
149939396|NCT03451045|540915887|FG001|Overall Study|Adverse Event|1|||
149939397|NCT03451045|540915888|FG002|Overall Study|Adverse Event|3|||
149939398|NCT03451045|540915886|FG000|Overall Study|Non-compliance with study|2|||
149939399|NCT03451045|540915887|FG001|Overall Study|Non-compliance with study|0|||
149939400|NCT03451045|540915888|FG002|Overall Study|Non-compliance with study|1|||
149939401|NCT03451045|540915886|FG000|Overall Study|any other reason|10|||
149939402|NCT03451045|540915887|FG001|Overall Study|any other reason|2|||
149939403|NCT03451045|540915888|FG002|Overall Study|any other reason|13|||
149939404|NCT02391337|540915890|FG000|6 Months Follow-up|Death|5|||
149939405|NCT02391337|540915891|FG001|6 Months Follow-up|Death|4|||
149939406|NCT02391337|540915890|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
149939407|NCT02391337|540915891|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
149939408|NCT02391337|540915890|FG000|12 Months Follow-up|Death|2|||
150169862|NCT02341625|541757202|FG002|Overall Study|Disease Progression|3|||
150169863|NCT02341625|541757203|FG003|Overall Study|Disease Progression|6|||
150169864|NCT02341625|541757204|FG004|Overall Study|Disease Progression|7|||
150169865|NCT02341625|541757205|FG005|Overall Study|Disease Progression|7|||
150169866|NCT02341625|541757206|FG006|Overall Study|Disease Progression|28|||
150169867|NCT02341625|541757207|FG007|Overall Study|Disease Progression|5|||
150169868|NCT02341625|541757208|FG008|Overall Study|Disease Progression|4|||
150169869|NCT02341625|541757209|FG009|Overall Study|Disease Progression|19|||
150169870|NCT02341625|541757200|FG000|Overall Study|Study Drug Toxicity|0|||
150169871|NCT02341625|541757201|FG001|Overall Study|Study Drug Toxicity|0|||
150169872|NCT02341625|541757202|FG002|Overall Study|Study Drug Toxicity|0|||
150169873|NCT02341625|541757203|FG003|Overall Study|Study Drug Toxicity|1|||
150169874|NCT02341625|541757204|FG004|Overall Study|Study Drug Toxicity|0|||
150169875|NCT02341625|541757205|FG005|Overall Study|Study Drug Toxicity|3|||
150169876|NCT02341625|541757206|FG006|Overall Study|Study Drug Toxicity|10|||
150169877|NCT02341625|541757207|FG007|Overall Study|Study Drug Toxicity|0|||
150169878|NCT02341625|541757208|FG008|Overall Study|Study Drug Toxicity|0|||
150169879|NCT02341625|541757209|FG009|Overall Study|Study Drug Toxicity|3|||
150169880|NCT02341625|541757200|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150169881|NCT02341625|541757201|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150169882|NCT02341625|541757202|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149939409|NCT02391337|540915891|FG001|12 Months Follow-up|Death|0|||
149939410|NCT02391337|540915890|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
149939411|NCT02391337|540915891|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
149939412|NCT02391337|540915890|FG000|12 Months Follow-up|Lost to Follow-up|0|||
150274030|NCT01186939|542141508|FG000|Overall Study|Transformation to AML|1|||
150169883|NCT02341625|541757203|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150169884|NCT02341625|541757204|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149939413|NCT02391337|540915891|FG001|12 Months Follow-up|Lost to Follow-up|2|||
149939414|NCT03704064|540915895|FG000|Overall Study|Lost to Follow-up|8|||
149939415|NCT03704064|540915896|FG001|Overall Study|Lost to Follow-up|4|||
150169885|NCT02341625|541757205|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150274031|NCT03945591|542141513|FG000|Overall Study|Participant not transplanted|1|||
150274032|NCT03945591|542141513|FG000|Overall Study|Change in treatment plan|3|||
150274033|NCT03945591|542141513|FG000|Overall Study|Adverse Event|1|||
149939416|NCT03704064|540915895|FG000|Overall Study|Withdrawal by Subject|1|||
149939417|NCT03704064|540915896|FG001|Overall Study|Withdrawal by Subject|1|||
149939418|NCT03704064|540915895|FG000|Overall Study|No longer available for study visits|0|||
149939419|NCT03704064|540915896|FG001|Overall Study|No longer available for study visits|1|||
149939420|NCT03704064|540915895|FG000|Overall Study|Censoring event|1|||
149939421|NCT03704064|540915896|FG001|Overall Study|Censoring event|0|||
149939422|NCT01286129|540915897|FG000|Overall Study|Withdrawal by Subject|4|||
149939423|NCT01286129|540915898|FG001|Overall Study|Withdrawal by Subject|1|||
149939424|NCT01286129|540915897|FG000|Overall Study|Could not comply with study requirements|4|||
149939425|NCT01286129|540915898|FG001|Overall Study|Could not comply with study requirements|4|||
149939426|NCT00830128|540915899|FG000|Overall Study|Adverse Event|5|||
149939427|NCT00830128|540915899|FG000|Overall Study|Lack of Efficacy|7|||
149939428|NCT00830128|540915899|FG000|Overall Study|Protocol Violation|1|||
149939429|NCT00830128|540915899|FG000|Overall Study|Withdrawal by Subject|2|||
149939430|NCT00830128|540915899|FG000|Overall Study|Family obligation|1|||
149939431|NCT00830128|540915899|FG000|Overall Study|Relocation|1|||
149939432|NCT00830128|540915899|FG000|Overall Study|Work obligation|1|||
149939433|NCT00830128|540915899|FG000|Overall Study|Operating a vehicle|1|||
149939434|NCT04142242|540915904|FG000|Stage I|Non-compliance with the protocol|1|||
149939435|NCT04142242|540915905|FG001|Stage I|Non-compliance with the protocol|0|||
149939436|NCT04142242|540915906|FG002|Stage I|Non-compliance with the protocol|0|||
149939437|NCT04142242|540915907|FG003|Stage I|Non-compliance with the protocol|0|||
149939438|NCT04142242|540915908|FG004|Stage I|Non-compliance with the protocol|0|||
149939439|NCT04142242|540915909|FG005|Stage I|Non-compliance with the protocol|1|||
149939440|NCT04142242|540915904|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
149939441|NCT04142242|540915905|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
149939442|NCT04142242|540915906|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
149939443|NCT04142242|540915907|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
149939444|NCT04142242|540915908|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
149939445|NCT04142242|540915909|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
149939446|NCT04142242|540915904|FG000|Stage II|Non-compliance with the protocol|0|||
149939447|NCT04142242|540915905|FG001|Stage II|Non-compliance with the protocol|0|||
149939448|NCT04142242|540915906|FG002|Stage II|Non-compliance with the protocol|0|||
149939449|NCT04142242|540915907|FG003|Stage II|Non-compliance with the protocol|2|||
149939450|NCT04142242|540915908|FG004|Stage II|Non-compliance with the protocol|0|||
149939451|NCT04142242|540915909|FG005|Stage II|Non-compliance with the protocol|0|||
149939452|NCT04142242|540915904|FG000|Stage II|Lost to Follow-up|0|||
149939453|NCT04142242|540915905|FG001|Stage II|Lost to Follow-up|0|||
149939454|NCT04142242|540915906|FG002|Stage II|Lost to Follow-up|1|||
149939455|NCT04142242|540915907|FG003|Stage II|Lost to Follow-up|2|||
149939456|NCT04142242|540915908|FG004|Stage II|Lost to Follow-up|0|||
149939457|NCT04142242|540915909|FG005|Stage II|Lost to Follow-up|0|||
149939458|NCT04142242|540915904|FG000|Stage II|Withdrawal by Subject|0|||
149939459|NCT04142242|540915905|FG001|Stage II|Withdrawal by Subject|0|||
149939460|NCT04142242|540915906|FG002|Stage II|Withdrawal by Subject|5|||
149939461|NCT04142242|540915907|FG003|Stage II|Withdrawal by Subject|9|||
149939462|NCT04142242|540915908|FG004|Stage II|Withdrawal by Subject|0|||
149939463|NCT04142242|540915909|FG005|Stage II|Withdrawal by Subject|0|||
149939464|NCT00846053|540915912|FG000|Overall Study|Physician Decision|3|||
149939465|NCT00846053|540915913|FG001|Overall Study|Physician Decision|0|||
149939466|NCT00111761|540915914|FG000|Part 1|Physician Decision|0|||
149939467|NCT00111761|540915915|FG001|Part 1|Physician Decision|1|||
149939468|NCT00111761|540915914|FG000|Part 1|Death|0|||
149939469|NCT00111761|540915915|FG001|Part 1|Death|2|||
149939470|NCT00111761|540915914|FG000|Part 1|Other|0|||
149939471|NCT00111761|540915915|FG001|Part 1|Other|1|||
149939472|NCT00111761|540915914|FG000|Part 1|Withdrawal by Subject|0|||
149939473|NCT00111761|540915915|FG001|Part 1|Withdrawal by Subject|1|||
149939474|NCT00111761|540915914|FG000|Part 2|Adverse Event|1|||
149939475|NCT00111761|540915915|FG001|Part 2|Adverse Event|0|||
150274034|NCT00698204|542141516|FG000|Overall Study|Withdrawal by Subject|1|||
149939476|NCT00111761|540915914|FG000|Part 2|Physician Decision|1|||
149939477|NCT00111761|540915915|FG001|Part 2|Physician Decision|0|||
149939478|NCT00111761|540915914|FG000|Part 2|Death|1|||
149939479|NCT00111761|540915915|FG001|Part 2|Death|0|||
149939480|NCT00111761|540915914|FG000|Part 2|Disease progression|3|||
149939481|NCT00111761|540915915|FG001|Part 2|Disease progression|0|||
149939482|NCT00111761|540915914|FG000|Part 2|Protocol-specified criteria|1|||
149939483|NCT00111761|540915915|FG001|Part 2|Protocol-specified criteria|0|||
150274035|NCT00698204|542141517|FG001|Overall Study|Withdrawal by Subject|0|||
149939484|NCT00111761|540915914|FG000|Part 2|Other|1|||
149939485|NCT00111761|540915915|FG001|Part 2|Other|0|||
149939486|NCT01604785|540915916|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
149939487|NCT01604785|540915917|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
149939488|NCT04798027|540915920|FG000|Overall Study|Protocol Violation|0|||
149939489|NCT04798027|540915921|FG001|Overall Study|Protocol Violation|0|||
149939490|NCT04798027|540915922|FG002|Overall Study|Protocol Violation|0|||
149939491|NCT04798027|540915923|FG003|Overall Study|Protocol Violation|0|||
149939492|NCT04798027|540915924|FG004|Overall Study|Protocol Violation|1|||
149939493|NCT04798027|540915925|FG005|Overall Study|Protocol Violation|0|||
149939494|NCT04798027|540915926|FG006|Overall Study|Protocol Violation|0|||
149939495|NCT04798027|540915927|FG007|Overall Study|Protocol Violation|1|||
149939496|NCT04798027|540915928|FG008|Overall Study|Protocol Violation|0|||
149939497|NCT04798027|540915920|FG000|Overall Study|Withdrawal by Subject|1|||
149939498|NCT04798027|540915921|FG001|Overall Study|Withdrawal by Subject|0|||
149939499|NCT04798027|540915922|FG002|Overall Study|Withdrawal by Subject|1|||
149939500|NCT04798027|540915923|FG003|Overall Study|Withdrawal by Subject|1|||
149939501|NCT04798027|540915924|FG004|Overall Study|Withdrawal by Subject|1|||
149939502|NCT04798027|540915925|FG005|Overall Study|Withdrawal by Subject|1|||
149939503|NCT04798027|540915926|FG006|Overall Study|Withdrawal by Subject|3|||
149939504|NCT04798027|540915927|FG007|Overall Study|Withdrawal by Subject|2|||
149939505|NCT04798027|540915928|FG008|Overall Study|Withdrawal by Subject|2|||
149939506|NCT04798027|540915920|FG000|Overall Study|Lost to Follow-up|1|||
149939507|NCT04798027|540915921|FG001|Overall Study|Lost to Follow-up|3|||
149939508|NCT04798027|540915922|FG002|Overall Study|Lost to Follow-up|0|||
149939509|NCT04798027|540915923|FG003|Overall Study|Lost to Follow-up|0|||
149939510|NCT04798027|540915924|FG004|Overall Study|Lost to Follow-up|0|||
149939511|NCT04798027|540915925|FG005|Overall Study|Lost to Follow-up|1|||
149939512|NCT04798027|540915926|FG006|Overall Study|Lost to Follow-up|0|||
149939513|NCT04798027|540915927|FG007|Overall Study|Lost to Follow-up|0|||
149939514|NCT04798027|540915928|FG008|Overall Study|Lost to Follow-up|1|||
149939515|NCT04798027|540915920|FG000|Overall Study|Withdrawal by Sponsor|8|||
149939516|NCT04798027|540915921|FG001|Overall Study|Withdrawal by Sponsor|22|||
149939517|NCT04798027|540915922|FG002|Overall Study|Withdrawal by Sponsor|9|||
149939518|NCT04798027|540915923|FG003|Overall Study|Withdrawal by Sponsor|26|||
149939519|NCT04798027|540915924|FG004|Overall Study|Withdrawal by Sponsor|24|||
149939520|NCT04798027|540915925|FG005|Overall Study|Withdrawal by Sponsor|11|||
149939521|NCT04798027|540915926|FG006|Overall Study|Withdrawal by Sponsor|25|||
149939522|NCT04798027|540915927|FG007|Overall Study|Withdrawal by Sponsor|26|||
149939523|NCT04798027|540915928|FG008|Overall Study|Withdrawal by Sponsor|11|||
149939524|NCT02121210|540915929|FG000|Overall Study|Adverse Event|5|||
149939525|NCT02121210|540915930|FG001|Overall Study|Adverse Event|7|||
149939526|NCT02121210|540915929|FG000|Overall Study|Lack of Efficacy|2|||
149939527|NCT02121210|540915930|FG001|Overall Study|Lack of Efficacy|0|||
149939528|NCT02121210|540915929|FG000|Overall Study|Other than specified above|0|||
149939529|NCT02121210|540915930|FG001|Overall Study|Other than specified above|2|||
149939530|NCT04609514|540915931|FG000|Overall Study|Lost to Follow-up|5|||
149939531|NCT04609514|540915932|FG001|Overall Study|Lost to Follow-up|4|||
149939532|NCT04609514|540915931|FG000|Overall Study|Withdrawal by PI|0|||
149939533|NCT04609514|540915932|FG001|Overall Study|Withdrawal by PI|2|||
149939534|NCT01981616|540915940|FG000|Overall Study|Adverse Event|0|||
149939535|NCT01981616|540915941|FG001|Overall Study|Adverse Event|1|||
149939536|NCT01981616|540915940|FG000|Overall Study|Protocol Violation|1|||
149939537|NCT01981616|540915941|FG001|Overall Study|Protocol Violation|0|||
149939538|NCT03225287|540915942|FG000|Overall Study|Adverse Event|0|||
149939539|NCT03225287|540915943|FG001|Overall Study|Adverse Event|0|||
149939540|NCT03225287|540915944|FG002|Overall Study|Adverse Event|1|||
149939541|NCT03225287|540915942|FG000|Overall Study|Protocol non-compliance|0|||
149939542|NCT03225287|540915943|FG001|Overall Study|Protocol non-compliance|0|||
149939543|NCT03225287|540915944|FG002|Overall Study|Protocol non-compliance|1|||
149939544|NCT03225287|540915942|FG000|Overall Study|Subject withdraws consent|3|||
149939545|NCT03225287|540915943|FG001|Overall Study|Subject withdraws consent|0|||
149939546|NCT03225287|540915944|FG002|Overall Study|Subject withdraws consent|0|||
149939547|NCT03225287|540915942|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
149939548|NCT03225287|540915943|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
149939549|NCT03225287|540915944|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
149939550|NCT03225287|540915942|FG000|Overall Study|Trial drug not effective|0|||
149939551|NCT03225287|540915943|FG001|Overall Study|Trial drug not effective|1|||
149939552|NCT03225287|540915944|FG002|Overall Study|Trial drug not effective|0|||
149939553|NCT03225287|540915942|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
149939554|NCT03225287|540915943|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
150169886|NCT02341625|541757206|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
149939555|NCT03225287|540915944|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
149939556|NCT03225287|540915942|FG000|Overall Study|Stem cell transplantation|0|||
149939557|NCT03225287|540915943|FG001|Overall Study|Stem cell transplantation|1|||
149939558|NCT03225287|540915944|FG002|Overall Study|Stem cell transplantation|0|||
149939559|NCT01499810|540915946|FG000|Overall Study|Lost to Follow-up|10|||
149939560|NCT01499810|540915946|FG000|Overall Study|Protocol Violation|1|||
149939561|NCT01499810|540915946|FG000|Overall Study|Withdrawal by Subject|1|||
149939562|NCT05117060|540915947|FG000|Overall Study|Adverse Event|3|||
149939563|NCT05117060|540915948|FG001|Overall Study|Adverse Event|5|||
149939564|NCT05117060|540915949|FG002|Overall Study|Adverse Event|6|||
149939565|NCT05117060|540915950|FG003|Overall Study|Adverse Event|1|||
149939566|NCT05117060|540915947|FG000|Overall Study|Lost to Follow-up|0|||
149939567|NCT05117060|540915948|FG001|Overall Study|Lost to Follow-up|0|||
149939568|NCT05117060|540915949|FG002|Overall Study|Lost to Follow-up|0|||
149939569|NCT05117060|540915950|FG003|Overall Study|Lost to Follow-up|1|||
149939570|NCT05117060|540915947|FG000|Overall Study|Lack of Efficacy|4|||
149939571|NCT05117060|540915948|FG001|Overall Study|Lack of Efficacy|5|||
149939572|NCT05117060|540915949|FG002|Overall Study|Lack of Efficacy|2|||
149939573|NCT05117060|540915950|FG003|Overall Study|Lack of Efficacy|6|||
149939574|NCT05117060|540915947|FG000|Overall Study|Withdrawal by Subject|8|||
149939575|NCT05117060|540915948|FG001|Overall Study|Withdrawal by Subject|5|||
149939576|NCT05117060|540915949|FG002|Overall Study|Withdrawal by Subject|5|||
149939577|NCT05117060|540915950|FG003|Overall Study|Withdrawal by Subject|6|||
149939578|NCT05117060|540915947|FG000|Overall Study|Other|2|||
149939579|NCT05117060|540915948|FG001|Overall Study|Other|1|||
149939580|NCT05117060|540915949|FG002|Overall Study|Other|3|||
149939581|NCT05117060|540915950|FG003|Overall Study|Other|1|||
149939582|NCT05079321|540915951|FG000|Overall Study|Withdrawal by Subject|2|||
149939583|NCT05079321|540915952|FG001|Overall Study|Withdrawal by Subject|2|||
149939584|NCT05079321|540915951|FG000|Overall Study|Lost to Follow-up|0|||
149939585|NCT05079321|540915952|FG001|Overall Study|Lost to Follow-up|1|||
149939586|NCT02074514|540915954|FG000|Overall Study|Lack of Efficacy|3|||
149939587|NCT02074514|540915955|FG001|Overall Study|Lack of Efficacy|2|||
149939588|NCT02074514|540915954|FG000|Overall Study|Lost to Follow-up|0|||
149939589|NCT02074514|540915955|FG001|Overall Study|Lost to Follow-up|1|||
149939590|NCT02074514|540915954|FG000|Overall Study|Withdrew Consent|0|||
149939591|NCT02074514|540915955|FG001|Overall Study|Withdrew Consent|1|||
149939592|NCT04239924|540915958|FG000|Overall Study|Lost to Follow-up|2|||
149939593|NCT00666237|540915959|FG000|Overall Study|Death|5|||
149939594|NCT00666237|540915960|FG001|Overall Study|Death|5|||
149939595|NCT00666237|540915959|FG000|Overall Study|Lost to Follow-up|29|||
149939596|NCT00666237|540915960|FG001|Overall Study|Lost to Follow-up|25|||
149939597|NCT05399680|540917493|FG000|Overall Study|Lost to Follow-up|1|||
149939598|NCT05399680|540917494|FG001|Overall Study|Lost to Follow-up|0|||
149939599|NCT05399680|540917493|FG000|Overall Study|Death|0|||
149939600|NCT05399680|540917494|FG001|Overall Study|Death|1|||
149939601|NCT03370172|540917495|FG000|Overall Study|Withdrawal by Subject|0|||
149939602|NCT03370172|540917496|FG001|Overall Study|Withdrawal by Subject|1|||
149939603|NCT05610605|540917497|FG000|6-month Assessment|Death|1|||
149939604|NCT05610605|540917498|FG001|6-month Assessment|Death|1|||
149939605|NCT05610605|540917497|FG000|6-month Assessment|Lost to Follow-up|20|||
149939606|NCT05610605|540917498|FG001|6-month Assessment|Lost to Follow-up|0|||
149939607|NCT05610605|540917497|FG000|6-month Assessment|Institutionalized|1|||
149939608|NCT05610605|540917498|FG001|6-month Assessment|Institutionalized|2|||
149939609|NCT05610605|540917497|FG000|12-month Assessment|Death|2|||
149939610|NCT05610605|540917498|FG001|12-month Assessment|Death|1|||
149939611|NCT05610605|540917497|FG000|12-month Assessment|Lost to Follow-up|1|||
149939612|NCT05610605|540917498|FG001|12-month Assessment|Lost to Follow-up|4|||
149939613|NCT05610605|540917497|FG000|12-month Assessment|Institutionalized|2|||
149939614|NCT05610605|540917498|FG001|12-month Assessment|Institutionalized|1|||
149939615|NCT00753519|540917500|FG000|Overall Study|Withdrawal by Subject|0|||
149939616|NCT00753519|540917501|FG001|Overall Study|Withdrawal by Subject|2|||
149939617|NCT01171534|540917504|FG000|Overall Study|Lost to Follow-up|0|||
149939618|NCT01171534|540917505|FG001|Overall Study|Lost to Follow-up|2|||
149939619|NCT01171534|540917504|FG000|Overall Study|screen failure|0|||
149939620|NCT01171534|540917505|FG001|Overall Study|screen failure|1|||
149939621|NCT03861039|540917506|FG000|Overall Study|Adverse Event|2|||
149939622|NCT03861039|540917507|FG001|Overall Study|Adverse Event|5|||
149939623|NCT03861039|540917508|FG002|Overall Study|Adverse Event|11|||
149939624|NCT03861039|540917506|FG000|Overall Study|Withdrawal by Subject|1|||
149939625|NCT03861039|540917507|FG001|Overall Study|Withdrawal by Subject|3|||
149939626|NCT03861039|540917508|FG002|Overall Study|Withdrawal by Subject|4|||
150274036|NCT01179672|542141518|FG000|Overall Study|Adverse Event|17|||
150274037|NCT01179672|542141519|FG001|Overall Study|Adverse Event|8|||
150274038|NCT01179672|542141518|FG000|Overall Study|Withdrawal by Subject|10|||
149939627|NCT01113749|540917509|FG000|Overall Study|Lost to Follow-up|1|||
149939628|NCT01113749|540917510|FG001|Overall Study|Lost to Follow-up|2|||
149939629|NCT03427892|540917511|FG000|Overall Study|Lost to Follow-up|2|||
149939630|NCT03255187|540917512|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
149939631|NCT03255187|540917513|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
149939632|NCT03255187|540917512|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
149939633|NCT03255187|540917513|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
149939634|NCT02034006|540917514|FG000|Overall Study|Withdrawal by Subject|7|||
149939635|NCT02034006|540917514|FG000|Overall Study|Lost to Follow-up|5|||
149939636|NCT02034006|540917514|FG000|Overall Study|Death|1|||
149939637|NCT02034006|540917514|FG000|Overall Study|Pregnancy|1|||
149939638|NCT02100631|540917515|FG000|Overall Study|Withdrawal by Subject|1|||
149939639|NCT02100631|540917516|FG001|Overall Study|Withdrawal by Subject|0|||
150274039|NCT01179672|542141519|FG001|Overall Study|Withdrawal by Subject|12|||
149939640|NCT02100631|540917517|FG002|Overall Study|Withdrawal by Subject|0|||
149939641|NCT02100631|540917515|FG000|Overall Study|Lost to Follow-up|3|||
149939642|NCT02100631|540917516|FG001|Overall Study|Lost to Follow-up|4|||
149939643|NCT02100631|540917517|FG002|Overall Study|Lost to Follow-up|0|||
149939644|NCT02100631|540917515|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
149939645|NCT02100631|540917516|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
149939646|NCT02100631|540917517|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
149939647|NCT01125930|540917518|FG000|Overall Study|Adverse Event|0|||
149939648|NCT01125930|540917519|FG001|Overall Study|Adverse Event|1|||
149939649|NCT01125930|540917518|FG000|Overall Study|Withdrawal by Subject|1|||
149939650|NCT01125930|540917519|FG001|Overall Study|Withdrawal by Subject|6|||
149939651|NCT01125930|540917518|FG000|Overall Study|Protocol Violation|0|||
149939652|NCT01125930|540917519|FG001|Overall Study|Protocol Violation|1|||
149939653|NCT01125930|540917518|FG000|Overall Study|Lost to Follow-up|0|||
149939654|NCT01125930|540917519|FG001|Overall Study|Lost to Follow-up|2|||
149939655|NCT03617588|540917522|FG000|Overall Study|Withdrawal by Subject|1|||
149939656|NCT03617588|540917523|FG001|Overall Study|Withdrawal by Subject|0|||
149939657|NCT03261401|540917524|FG000|Overall Study|Withdrawal by Subject|0|||
149939658|NCT03261401|540917525|FG001|Overall Study|Withdrawal by Subject|0|||
149939659|NCT03261401|540917526|FG002|Overall Study|Withdrawal by Subject|0|||
149939660|NCT03261401|540917527|FG003|Overall Study|Withdrawal by Subject|0|||
149939661|NCT03261401|540917528|FG004|Overall Study|Withdrawal by Subject|0|||
149939662|NCT03261401|540917529|FG005|Overall Study|Withdrawal by Subject|1|||
149939663|NCT03261401|540917530|FG006|Overall Study|Withdrawal by Subject|0|||
149939664|NCT03261401|540917531|FG007|Overall Study|Withdrawal by Subject|0|||
149939665|NCT03261401|540917532|FG008|Overall Study|Withdrawal by Subject|0|||
149939666|NCT03261401|540917533|FG009|Overall Study|Withdrawal by Subject|0|||
149939667|NCT03261401|540917534|FG010|Overall Study|Withdrawal by Subject|0|||
149939668|NCT03261401|540917535|FG011|Overall Study|Withdrawal by Subject|0|||
149939669|NCT03261401|540917536|FG012|Overall Study|Withdrawal by Subject|0|||
149939670|NCT03261401|540917524|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
149939671|NCT03261401|540917525|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
149939672|NCT03261401|540917526|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
149939673|NCT03261401|540917527|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
149939674|NCT03261401|540917528|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
149939675|NCT03261401|540917529|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
149939676|NCT03261401|540917530|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
149939677|NCT03261401|540917531|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
149939678|NCT03261401|540917532|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
149939679|NCT03261401|540917533|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
149939680|NCT03261401|540917534|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
149939681|NCT03261401|540917535|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
149939682|NCT03261401|540917536|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
149939683|NCT01715298|540917537|FG000|Overall Study|Lost to Follow-up|0|||
149939684|NCT01715298|540917538|FG001|Overall Study|Lost to Follow-up|2|||
149939685|NCT01715298|540917537|FG000|Overall Study|Patient/guardian decision|7|||
149939686|NCT01715298|540917538|FG001|Overall Study|Patient/guardian decision|9|||
149939687|NCT02058095|540917539|FG000|Overall Study|Adverse Event|1|||
149939688|NCT02058095|540917540|FG001|Overall Study|Adverse Event|0|||
149939689|NCT01499511|540917541|FG000|Overall Study|Death|1|||
149939690|NCT01499511|540917542|FG001|Overall Study|Death|0|||
149939691|NCT02842866|540917544|FG000|Overall Study|Serious Adverse Event|0|||
149939692|NCT02842866|540917545|FG001|Overall Study|Serious Adverse Event|1|||
149939693|NCT02842866|540917544|FG000|Overall Study|Protocol Violation|4|||
149939694|NCT02842866|540917545|FG001|Overall Study|Protocol Violation|2|||
149939695|NCT02842866|540917544|FG000|Overall Study|Lost to Follow-up|2|||
149939696|NCT02842866|540917545|FG001|Overall Study|Lost to Follow-up|0|||
150169887|NCT02341625|541757207|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
150169888|NCT02341625|541757208|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150169889|NCT02341625|541757209|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
150169890|NCT02341625|541757200|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169891|NCT02341625|541757201|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169892|NCT02341625|541757202|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169893|NCT02341625|541757203|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169894|NCT02341625|541757204|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149939697|NCT02842866|540917544|FG000|Overall Study|Withdrawal by Subject|1|||
149939698|NCT02842866|540917545|FG001|Overall Study|Withdrawal by Subject|0|||
149939699|NCT01432327|540917546|FG000|Posttest 3 Months|depression|3|||
149939700|NCT01432327|540917547|FG001|Posttest 3 Months|depression|0|||
149939701|NCT01432327|540917548|FG002|Posttest 3 Months|depression|0|||
150169895|NCT02341625|541757205|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149939702|NCT01432327|540917549|FG003|Posttest 3 Months|depression|0|||
149939703|NCT01432327|540917546|FG000|Posttest 3 Months|Lost to Follow-up|1|||
149939704|NCT01432327|540917547|FG001|Posttest 3 Months|Lost to Follow-up|0|||
149939705|NCT01432327|540917548|FG002|Posttest 3 Months|Lost to Follow-up|2|||
149939706|NCT01432327|540917549|FG003|Posttest 3 Months|Lost to Follow-up|1|||
149939707|NCT01432327|540917546|FG000|Posttest 3 Months|Allergic reaction|0|||
149939708|NCT01432327|540917547|FG001|Posttest 3 Months|Allergic reaction|2|||
149939709|NCT01432327|540917548|FG002|Posttest 3 Months|Allergic reaction|0|||
149939710|NCT01432327|540917549|FG003|Posttest 3 Months|Allergic reaction|0|||
149939711|NCT01432327|540917546|FG000|Posttest 6 Months|Lost to Follow-up|0|||
149939712|NCT01432327|540917547|FG001|Posttest 6 Months|Lost to Follow-up|0|||
149939713|NCT01432327|540917548|FG002|Posttest 6 Months|Lost to Follow-up|3|||
149939714|NCT01432327|540917549|FG003|Posttest 6 Months|Lost to Follow-up|2|||
149939715|NCT01432327|540917546|FG000|Posttest 6 Months|Allergic reaction|0|||
149939716|NCT01432327|540917547|FG001|Posttest 6 Months|Allergic reaction|0|||
149939717|NCT01432327|540917548|FG002|Posttest 6 Months|Allergic reaction|1|||
149939718|NCT01432327|540917549|FG003|Posttest 6 Months|Allergic reaction|0|||
149939719|NCT01432327|540917546|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
149939720|NCT01432327|540917547|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
149939721|NCT01432327|540917548|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
149939722|NCT01432327|540917549|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
149939723|NCT01432327|540917546|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
149939724|NCT01432327|540917547|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
149939725|NCT01432327|540917548|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
149939726|NCT01432327|540917549|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
149939727|NCT01432327|540917546|FG000|Posttest 1 Year|Lost to Follow-up|0|||
149939728|NCT01432327|540917547|FG001|Posttest 1 Year|Lost to Follow-up|0|||
149939729|NCT01432327|540917548|FG002|Posttest 1 Year|Lost to Follow-up|4|||
149939730|NCT01432327|540917549|FG003|Posttest 1 Year|Lost to Follow-up|2|||
149939731|NCT01432327|540917546|FG000|Posttest 1 Year|Allergic reaction|0|||
149939732|NCT01432327|540917547|FG001|Posttest 1 Year|Allergic reaction|0|||
149939733|NCT01432327|540917548|FG002|Posttest 1 Year|Allergic reaction|1|||
149939734|NCT01432327|540917549|FG003|Posttest 1 Year|Allergic reaction|1|||
149939735|NCT03248037|540917550|FG000|Overall Study|Withdrawal by Subject|6|||
149939736|NCT03248037|540917551|FG001|Overall Study|Withdrawal by Subject|9|||
149939737|NCT03248037|540917550|FG000|Overall Study|Adverse Event|15|||
149939738|NCT03248037|540917551|FG001|Overall Study|Adverse Event|0|||
149939739|NCT00577408|540917552|FG000|Overall Study|Stopped attending study visits|9|||
149939740|NCT00577408|540917553|FG001|Overall Study|Stopped attending study visits|11|||
149939741|NCT00577408|540917552|FG000|Overall Study|Continued opioid use|3|||
149939742|NCT00577408|540917553|FG001|Overall Study|Continued opioid use|2|||
149939743|NCT00577408|540917552|FG000|Overall Study|Non-compliance with study meds|0|||
149939744|NCT00577408|540917553|FG001|Overall Study|Non-compliance with study meds|3|||
149939745|NCT00577408|540917552|FG000|Overall Study|Refused Oral Naltrexone|0|||
149939746|NCT00577408|540917553|FG001|Overall Study|Refused Oral Naltrexone|1|||
149939747|NCT00577408|540917552|FG000|Overall Study|Moved out of state|0|||
149939748|NCT00577408|540917553|FG001|Overall Study|Moved out of state|1|||
149939749|NCT00577408|540917552|FG000|Overall Study|Scheduling Issues|0|||
149939750|NCT00577408|540917553|FG001|Overall Study|Scheduling Issues|3|||
149939751|NCT00577408|540917552|FG000|Overall Study|Death|0|||
149939752|NCT00577408|540917553|FG001|Overall Study|Death|1|||
149939753|NCT00577408|540917552|FG000|Overall Study|Psychiatric hospitalization|0|||
149939754|NCT00577408|540917553|FG001|Overall Study|Psychiatric hospitalization|1|||
149939755|NCT02897349|540917557|FG000|Overall Study|Lost to Follow-up|2|||
149939756|NCT02897349|540917558|FG001|Overall Study|Lost to Follow-up|2|||
149939757|NCT02897349|540917557|FG000|Overall Study|Adverse Event|3|||
149939758|NCT02897349|540917558|FG001|Overall Study|Adverse Event|3|||
149939759|NCT02897349|540917557|FG000|Overall Study|Other than listed above|0|||
150169896|NCT02341625|541757206|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
150169897|NCT02341625|541757207|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
150169898|NCT02341625|541757208|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169899|NCT02341625|541757209|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
150169900|NCT02341625|541757200|FG000|Overall Study|Participant Withdrew Consent|0|||
150169901|NCT02341625|541757201|FG001|Overall Study|Participant Withdrew Consent|0|||
150169902|NCT02341625|541757202|FG002|Overall Study|Participant Withdrew Consent|0|||
150169903|NCT02341625|541757203|FG003|Overall Study|Participant Withdrew Consent|1|||
150169904|NCT02341625|541757204|FG004|Overall Study|Participant Withdrew Consent|0|||
149939760|NCT02897349|540917558|FG001|Overall Study|Other than listed above|1|||
149939761|NCT03055013|540917561|FG000|Overall Study|Adverse Event|78|||
149939762|NCT03055013|540917562|FG001|Overall Study|Adverse Event|0|||
149939763|NCT03055013|540917561|FG000|Overall Study|Death|6|||
149939764|NCT03055013|540917562|FG001|Overall Study|Death|0|||
149939765|NCT03055013|540917561|FG000|Overall Study|Disease relapse|33|||
149939766|NCT03055013|540917562|FG001|Overall Study|Disease relapse|0|||
149939767|NCT03055013|540917561|FG000|Overall Study|Withdrawal by Subject|28|||
149939768|NCT03055013|540917562|FG001|Overall Study|Withdrawal by Subject|0|||
149939769|NCT03055013|540917561|FG000|Overall Study|Other complicating disease|5|||
149939770|NCT03055013|540917562|FG001|Overall Study|Other complicating disease|0|||
149939771|NCT03055013|540917561|FG000|Overall Study|Physician Decision|1|||
149939772|NCT03055013|540917562|FG001|Overall Study|Physician Decision|0|||
149939773|NCT03055013|540917561|FG000|Overall Study|Benign mass/non-RCC|4|||
149939774|NCT03055013|540917562|FG001|Overall Study|Benign mass/non-RCC|0|||
149939775|NCT03055013|540917561|FG000|Overall Study|Enrolled in another trial|1|||
149939776|NCT03055013|540917562|FG001|Overall Study|Enrolled in another trial|0|||
149939777|NCT03055013|540917561|FG000|Overall Study|Non-protocol therapy|1|||
149939778|NCT03055013|540917562|FG001|Overall Study|Non-protocol therapy|0|||
149939779|NCT03055013|540917561|FG000|Overall Study|Incompliance|1|||
149939780|NCT03055013|540917562|FG001|Overall Study|Incompliance|0|||
149939781|NCT03055013|540917561|FG000|Overall Study|Insurance issues|1|||
149939782|NCT03055013|540917562|FG001|Overall Study|Insurance issues|0|||
149939783|NCT03055013|540917561|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
149939784|NCT03055013|540917562|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
149939785|NCT03055013|540917561|FG000|Overall Study|Did not receive nivolumab|10|||
149939786|NCT03055013|540917562|FG001|Overall Study|Did not receive nivolumab|0|||
149939787|NCT03055013|540917561|FG000|Overall Study|Did not receive surgery|0|||
149939788|NCT03055013|540917562|FG001|Overall Study|Did not receive surgery|28|||
149939789|NCT03435055|540917563|FG000|Screening|Physician Decision|2|||
149939790|NCT03435055|540917563|FG000|Received Intervention|Did not complete nitrous administration|3|||
149939791|NCT03817528|540917566|FG000|Overall Study|Withdrawal by Subject|1|||
149939792|NCT03817528|540917566|FG000|Overall Study|Adverse Event|2|||
149939793|NCT00827567|540917568|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
149939794|NCT01259245|540917574|FG000|Overall Study|Withdrawal by Subject|27|||
149939795|NCT01259245|540917575|FG001|Overall Study|Withdrawal by Subject|24|||
149939796|NCT01259245|540917574|FG000|Overall Study|Death|1|||
149939797|NCT01259245|540917575|FG001|Overall Study|Death|2|||
149939798|NCT00368550|540917578|FG000|Overall Study|Adverse Event|7|||
149939799|NCT00368550|540917579|FG001|Overall Study|Adverse Event|4|||
149939800|NCT00368550|540917578|FG000|Overall Study|Lack of Efficacy|4|||
149939801|NCT00368550|540917579|FG001|Overall Study|Lack of Efficacy|9|||
149939802|NCT00368550|540917578|FG000|Overall Study|Withdrawal by Subject|17|||
149939803|NCT00368550|540917579|FG001|Overall Study|Withdrawal by Subject|10|||
149939804|NCT02410629|540917581|FG000|Overall Study|Family cannot commit to the study|2|||
149939805|NCT02410629|540917582|FG001|Overall Study|Family cannot commit to the study|1|||
149939806|NCT02410629|540917581|FG000|Overall Study|Subject returned to work|1|||
149939807|NCT02410629|540917582|FG001|Overall Study|Subject returned to work|0|||
149939808|NCT02410629|540917581|FG000|Overall Study|Subject moved back to home country|0|||
149939809|NCT02410629|540917582|FG001|Overall Study|Subject moved back to home country|1|||
149939810|NCT02410629|540917581|FG000|Overall Study|Subject underwent heart surgery|0|||
149939811|NCT02410629|540917582|FG001|Overall Study|Subject underwent heart surgery|1|||
149939812|NCT05282823|540917583|FG000|Overall Study|Withdrawal by Subject|9|||
149939813|NCT05282823|540917583|FG000|Overall Study|Adverse Event|1|||
149939814|NCT05282823|540917583|FG000|Overall Study|did not meet protocol criteria|2|||
149939815|NCT05282823|540917583|FG000|Overall Study|Withdrawal by Subject|7|||
149939816|NCT06129149|540917588|FG000|Overall Study|Death|1|||
149939817|NCT04649359|540917589|FG000|Overall Study|Withdrawal by Subject|7|||
149939818|NCT04649359|540917590|FG001|Overall Study|Withdrawal by Subject|7|||
149939819|NCT04649359|540917589|FG000|Overall Study|Death|41|||
149939820|NCT04649359|540917590|FG001|Overall Study|Death|26|||
149939821|NCT04649359|540917589|FG000|Overall Study|Ongoing in the study|75|||
149939822|NCT04649359|540917590|FG001|Overall Study|Ongoing in the study|31|||
149939823|NCT04656652|540917591|FG000|Overall Study|Lost to Follow-up|2|||
149939824|NCT04656652|540917592|FG001|Overall Study|Lost to Follow-up|2|||
149939825|NCT04656652|540917591|FG000|Overall Study|Death|213|||
149939826|NCT04656652|540917592|FG001|Overall Study|Death|212|||
149939827|NCT04656652|540917591|FG000|Overall Study|Other|1|||
149939828|NCT04656652|540917592|FG001|Overall Study|Other|0|||
149939829|NCT04656652|540917591|FG000|Overall Study|Withdrawal by Subject|15|||
149939830|NCT04656652|540917592|FG001|Overall Study|Withdrawal by Subject|29|||
149939831|NCT05595369|540917593|FG000|Overall Study|Adverse Event|2|||
149939832|NCT05595369|540917594|FG001|Overall Study|Adverse Event|0|||
149939833|NCT05595369|540917595|FG002|Overall Study|Adverse Event|0|||
149939834|NCT05595369|540917593|FG000|Overall Study|Lost to Follow-up|11|||
149939835|NCT05595369|540917594|FG001|Overall Study|Lost to Follow-up|10|||
149939836|NCT05595369|540917595|FG002|Overall Study|Lost to Follow-up|10|||
149939837|NCT05595369|540917593|FG000|Overall Study|Physician Decision|1|||
150274040|NCT01179672|542141518|FG000|Overall Study|Entry Criteria Not Met|0|||
149939838|NCT05595369|540917594|FG001|Overall Study|Physician Decision|0|||
149939839|NCT05595369|540917595|FG002|Overall Study|Physician Decision|0|||
149939840|NCT05595369|540917593|FG000|Overall Study|Withdrawal by Subject|5|||
150274041|NCT01179672|542141519|FG001|Overall Study|Entry Criteria Not Met|2|||
149939841|NCT05595369|540917594|FG001|Overall Study|Withdrawal by Subject|7|||
149939842|NCT05595369|540917595|FG002|Overall Study|Withdrawal by Subject|6|||
150274042|NCT01179672|542141518|FG000|Overall Study|Lost to Follow-up|0|||
150274043|NCT01179672|542141519|FG001|Overall Study|Lost to Follow-up|1|||
150274044|NCT01179672|542141518|FG000|Overall Study|Protocol Violation|2|||
150274045|NCT01179672|542141519|FG001|Overall Study|Protocol Violation|2|||
150274046|NCT01179672|542141518|FG000|Overall Study|Physician Decision|1|||
150274047|NCT01179672|542141519|FG001|Overall Study|Physician Decision|1|||
150274048|NCT01949155|542141520|FG000|Overall Study|Lost to Follow-up|1|||
150274049|NCT01949155|542141521|FG001|Overall Study|Lost to Follow-up|0|||
150274050|NCT01949155|542141520|FG000|Overall Study|Protocol Violation|1|||
150274051|NCT01949155|542141521|FG001|Overall Study|Protocol Violation|0|||
150274052|NCT00314249|542141522|FG000|Overall Study|Adverse Event|73|||
150274053|NCT00314249|542141523|FG001|Overall Study|Adverse Event|94|||
150274054|NCT00314249|542141522|FG000|Overall Study|Lack of Efficacy|33|||
150274055|NCT00314249|542141523|FG001|Overall Study|Lack of Efficacy|24|||
150274056|NCT00314249|542141522|FG000|Overall Study|Withdrawal by Subject|21|||
150274057|NCT00314249|542141523|FG001|Overall Study|Withdrawal by Subject|28|||
150274058|NCT00314249|542141522|FG000|Overall Study|Lost to Follow-up|15|||
150274059|NCT00314249|542141523|FG001|Overall Study|Lost to Follow-up|9|||
150274060|NCT00314249|542141522|FG000|Overall Study|Physician Decision|1|||
150274061|NCT00314249|542141523|FG001|Overall Study|Physician Decision|1|||
150274062|NCT00314249|542141522|FG000|Overall Study|Withdrawn for other reasons|4|||
150274063|NCT00314249|542141523|FG001|Overall Study|Withdrawn for other reasons|1|||
150274064|NCT00314249|542141522|FG000|Overall Study|Non-Compliant|5|||
150274065|NCT00314249|542141523|FG001|Overall Study|Non-Compliant|6|||
150274066|NCT04667377|542141524|FG000|Dose Escalation Period|Other not specified below|3|||
150274067|NCT04667377|542141525|FG001|Dose Escalation Period|Other not specified below|3|||
150274068|NCT04667377|542141526|FG002|Dose Escalation Period|Other not specified below|2|||
150274069|NCT04667377|542141527|FG003|Dose Escalation Period|Other not specified below|1|||
150274070|NCT04667377|542141528|FG004|Dose Escalation Period|Other not specified below|3|||
150274071|NCT04667377|542141524|FG000|Dose Escalation Period|Protocol Violation|2|||
150274072|NCT04667377|542141525|FG001|Dose Escalation Period|Protocol Violation|2|||
150274073|NCT04667377|542141526|FG002|Dose Escalation Period|Protocol Violation|0|||
150274074|NCT04667377|542141527|FG003|Dose Escalation Period|Protocol Violation|2|||
150274075|NCT04667377|542141528|FG004|Dose Escalation Period|Protocol Violation|1|||
150274076|NCT04667377|542141524|FG000|Dose Escalation Period|Burden of study procedures|2|||
150274077|NCT04667377|542141525|FG001|Dose Escalation Period|Burden of study procedures|1|||
150274078|NCT04667377|542141526|FG002|Dose Escalation Period|Burden of study procedures|1|||
150274079|NCT04667377|542141527|FG003|Dose Escalation Period|Burden of study procedures|1|||
150274080|NCT04667377|542141528|FG004|Dose Escalation Period|Burden of study procedures|5|||
150274081|NCT04667377|542141524|FG000|Dose Escalation Period|Change of residence|0|||
150274082|NCT04667377|542141525|FG001|Dose Escalation Period|Change of residence|0|||
150274083|NCT04667377|542141526|FG002|Dose Escalation Period|Change of residence|1|||
150274084|NCT04667377|542141527|FG003|Dose Escalation Period|Change of residence|0|||
150274085|NCT04667377|542141528|FG004|Dose Escalation Period|Change of residence|0|||
150274086|NCT04667377|542141524|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
150274087|NCT04667377|542141525|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
150274088|NCT04667377|542141526|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
149939843|NCT05595369|540917593|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
149939844|NCT05595369|540917594|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
149939845|NCT05595369|540917595|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
149939846|NCT05595369|540917593|FG000|Overall Study|Study Drug Non-compliance|0|||
149939847|NCT05595369|540917594|FG001|Overall Study|Study Drug Non-compliance|1|||
149939848|NCT05595369|540917595|FG002|Overall Study|Study Drug Non-compliance|0|||
150274089|NCT04667377|542141527|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
150274090|NCT04667377|542141528|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
150274091|NCT04667377|542141524|FG000|Dose Escalation Period|Adverse Event|9|||
150274092|NCT04667377|542141525|FG001|Dose Escalation Period|Adverse Event|10|||
150274093|NCT04667377|542141526|FG002|Dose Escalation Period|Adverse Event|12|||
150274094|NCT04667377|542141527|FG003|Dose Escalation Period|Adverse Event|17|||
150274095|NCT04667377|542141528|FG004|Dose Escalation Period|Adverse Event|3|||
150274096|NCT04667377|542141524|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
149939849|NCT05595369|540917593|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
149939850|NCT05595369|540917594|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
150274097|NCT04667377|542141525|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
149939851|NCT05595369|540917595|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
149975586|NCT00570713|541047895|FG001|Overall Study|Adverse Event|9|||
150274098|NCT04667377|542141526|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
150274099|NCT04667377|542141527|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
150274100|NCT04667377|542141528|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
150274101|NCT04667377|542141524|FG000|Dose Escalation Period|Not treated|1|||
150274102|NCT04667377|542141525|FG001|Dose Escalation Period|Not treated|0|||
150274103|NCT04667377|542141526|FG002|Dose Escalation Period|Not treated|0|||
150274104|NCT04667377|542141527|FG003|Dose Escalation Period|Not treated|0|||
150274105|NCT04667377|542141528|FG004|Dose Escalation Period|Not treated|0|||
150274106|NCT04667377|542141524|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
150274107|NCT04667377|542141525|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
150274108|NCT04667377|542141526|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
150274109|NCT04667377|542141527|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
149939852|NCT03040726|540917598|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
149939853|NCT03040726|540917599|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
149939854|NCT03040726|540917598|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
149939855|NCT03040726|540917599|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
149939856|NCT03040726|540917598|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
149939857|NCT03040726|540917599|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
149939858|NCT03040726|540917598|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
149939859|NCT03040726|540917599|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
149939860|NCT03040726|540917598|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
149939861|NCT03040726|540917599|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
149939862|NCT02908347|540917600|FG000|Overall Study|Adverse Event|0|||
149939863|NCT02908347|540917601|FG001|Overall Study|Adverse Event|1|||
149939864|NCT02908347|540917600|FG000|Overall Study|Lost to Follow-up|1|||
149939865|NCT02908347|540917601|FG001|Overall Study|Lost to Follow-up|0|||
149939866|NCT03104374|540917602|FG000|Period 1|Adverse Event|7|||
149939867|NCT03104374|540917603|FG001|Period 1|Adverse Event|7|||
149939868|NCT03104374|540917604|FG002|Period 1|Adverse Event|12|||
149939869|NCT03104374|540917605|FG003|Period 1|Adverse Event|14|||
149939870|NCT03104374|540917602|FG000|Period 1|Withdrawal by Subject|18|||
149939871|NCT03104374|540917603|FG001|Period 1|Withdrawal by Subject|9|||
149939872|NCT03104374|540917604|FG002|Period 1|Withdrawal by Subject|10|||
149939873|NCT03104374|540917605|FG003|Period 1|Withdrawal by Subject|17|||
149939874|NCT03104374|540917602|FG000|Period 1|Lost to Follow-up|4|||
149939875|NCT03104374|540917603|FG001|Period 1|Lost to Follow-up|4|||
149939876|NCT03104374|540917604|FG002|Period 1|Lost to Follow-up|6|||
149939877|NCT03104374|540917605|FG003|Period 1|Lost to Follow-up|8|||
149939878|NCT03104374|540917602|FG000|Period 1|Lack of Efficacy|6|||
149939879|NCT03104374|540917603|FG001|Period 1|Lack of Efficacy|7|||
149939880|NCT03104374|540917604|FG002|Period 1|Lack of Efficacy|12|||
149939881|NCT03104374|540917605|FG003|Period 1|Lack of Efficacy|6|||
149939882|NCT03104374|540917602|FG000|Period 1|Other|2|||
149939883|NCT03104374|540917603|FG001|Period 1|Other|2|||
149939884|NCT03104374|540917604|FG002|Period 1|Other|4|||
149939885|NCT03104374|540917605|FG003|Period 1|Other|7|||
149939886|NCT03104374|540917602|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
149939887|NCT03104374|540917603|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
149939888|NCT03104374|540917604|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
149939889|NCT03104374|540917605|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
149939890|NCT03104374|540917602|FG000|Period 2|Adverse Event|4|||
149939891|NCT03104374|540917603|FG001|Period 2|Adverse Event|7|||
149939892|NCT03104374|540917604|FG002|Period 2|Adverse Event|10|||
149939893|NCT03104374|540917605|FG003|Period 2|Adverse Event|10|||
149939894|NCT03104374|540917602|FG000|Period 2|Withdrawal by Subject|3|||
149939895|NCT03104374|540917603|FG001|Period 2|Withdrawal by Subject|7|||
149939896|NCT03104374|540917604|FG002|Period 2|Withdrawal by Subject|13|||
149939897|NCT03104374|540917605|FG003|Period 2|Withdrawal by Subject|16|||
149939898|NCT03104374|540917602|FG000|Period 2|Lost to Follow-up|2|||
149939899|NCT03104374|540917603|FG001|Period 2|Lost to Follow-up|2|||
149939900|NCT03104374|540917604|FG002|Period 2|Lost to Follow-up|3|||
149939901|NCT03104374|540917605|FG003|Period 2|Lost to Follow-up|5|||
149939902|NCT03104374|540917602|FG000|Period 2|Lack of Efficacy|2|||
149939903|NCT03104374|540917603|FG001|Period 2|Lack of Efficacy|4|||
149939904|NCT03104374|540917604|FG002|Period 2|Lack of Efficacy|7|||
149939905|NCT03104374|540917605|FG003|Period 2|Lack of Efficacy|4|||
149939906|NCT03104374|540917602|FG000|Period 2|COVID-19 Infection|0|||
149939907|NCT03104374|540917603|FG001|Period 2|COVID-19 Infection|0|||
150274110|NCT04667377|542141528|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
150274111|NCT04667377|542141524|FG000|Dose Escalation Period|Lost to Follow-up|0|||
150274112|NCT04667377|542141525|FG001|Dose Escalation Period|Lost to Follow-up|1|||
150274113|NCT04667377|542141526|FG002|Dose Escalation Period|Lost to Follow-up|0|||
149939908|NCT03104374|540917604|FG002|Period 2|COVID-19 Infection|1|||
149939909|NCT03104374|540917605|FG003|Period 2|COVID-19 Infection|0|||
149939910|NCT03104374|540917602|FG000|Period 2|Other|3|||
149939911|NCT03104374|540917603|FG001|Period 2|Other|2|||
149939912|NCT03104374|540917604|FG002|Period 2|Other|2|||
150274114|NCT04667377|542141527|FG003|Dose Escalation Period|Lost to Follow-up|0|||
150274115|NCT04667377|542141528|FG004|Dose Escalation Period|Lost to Follow-up|0|||
149939913|NCT03104374|540917605|FG003|Period 2|Other|4|||
149939914|NCT03210714|540917606|FG000|Overall Study|Adverse Event|6|||
150274116|NCT04667377|542141524|FG000|Maintenance Period|Perceived lack of efficacy|0|||
149939915|NCT03210714|540917606|FG000|Overall Study|Physician Decision|1|||
149939916|NCT03210714|540917606|FG000|Overall Study|Progressive disease|11|||
149939917|NCT03210714|540917606|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
149939918|NCT02867592|540917607|FG000|Overall Study|Adverse Event|3|||
149939919|NCT02867592|540917608|FG001|Overall Study|Adverse Event|0|||
149939920|NCT02867592|540917609|FG002|Overall Study|Adverse Event|2|||
149939921|NCT02867592|540917610|FG003|Overall Study|Adverse Event|1|||
149939922|NCT02867592|540917611|FG004|Overall Study|Adverse Event|1|||
149939923|NCT02867592|540917612|FG005|Overall Study|Adverse Event|5|||
149939924|NCT02867592|540917607|FG000|Overall Study|Death|0|||
149939925|NCT02867592|540917608|FG001|Overall Study|Death|0|||
149939926|NCT02867592|540917609|FG002|Overall Study|Death|0|||
150274117|NCT04667377|542141525|FG001|Maintenance Period|Perceived lack of efficacy|2|||
150274118|NCT04667377|542141526|FG002|Maintenance Period|Perceived lack of efficacy|1|||
150274119|NCT04667377|542141527|FG003|Maintenance Period|Perceived lack of efficacy|0|||
150274120|NCT04667377|542141528|FG004|Maintenance Period|Perceived lack of efficacy|1|||
149939927|NCT02867592|540917610|FG003|Overall Study|Death|1|||
149939928|NCT02867592|540917611|FG004|Overall Study|Death|0|||
149939929|NCT02867592|540917612|FG005|Overall Study|Death|1|||
149939930|NCT02867592|540917607|FG000|Overall Study|Lack of Efficacy|8|||
149939931|NCT02867592|540917608|FG001|Overall Study|Lack of Efficacy|10|||
149939932|NCT02867592|540917609|FG002|Overall Study|Lack of Efficacy|8|||
149939933|NCT02867592|540917610|FG003|Overall Study|Lack of Efficacy|8|||
149939934|NCT02867592|540917611|FG004|Overall Study|Lack of Efficacy|12|||
149939935|NCT02867592|540917612|FG005|Overall Study|Lack of Efficacy|17|||
149939936|NCT02867592|540917607|FG000|Overall Study|Physician Decision|1|||
149939937|NCT02867592|540917608|FG001|Overall Study|Physician Decision|2|||
149939938|NCT02867592|540917609|FG002|Overall Study|Physician Decision|2|||
149939939|NCT02867592|540917610|FG003|Overall Study|Physician Decision|0|||
149939940|NCT02867592|540917611|FG004|Overall Study|Physician Decision|5|||
149939941|NCT02867592|540917612|FG005|Overall Study|Physician Decision|1|||
149939942|NCT02867592|540917607|FG000|Overall Study|Protocol Violation|0|||
149939943|NCT02867592|540917608|FG001|Overall Study|Protocol Violation|0|||
149939944|NCT02867592|540917609|FG002|Overall Study|Protocol Violation|0|||
149939945|NCT02867592|540917610|FG003|Overall Study|Protocol Violation|0|||
149939946|NCT02867592|540917611|FG004|Overall Study|Protocol Violation|1|||
149939947|NCT02867592|540917612|FG005|Overall Study|Protocol Violation|1|||
149939948|NCT02867592|540917607|FG000|Overall Study|Withdrawal by Subject|0|||
149939949|NCT02867592|540917608|FG001|Overall Study|Withdrawal by Subject|1|||
149939950|NCT02867592|540917609|FG002|Overall Study|Withdrawal by Subject|0|||
149939951|NCT02867592|540917610|FG003|Overall Study|Withdrawal by Subject|1|||
149939952|NCT02867592|540917611|FG004|Overall Study|Withdrawal by Subject|3|||
149939953|NCT02867592|540917612|FG005|Overall Study|Withdrawal by Subject|3|||
149939954|NCT02867592|540917607|FG000|Overall Study|Ineligible|1|||
149939955|NCT02867592|540917608|FG001|Overall Study|Ineligible|1|||
149939956|NCT02867592|540917609|FG002|Overall Study|Ineligible|0|||
149939957|NCT02867592|540917610|FG003|Overall Study|Ineligible|0|||
149939958|NCT02867592|540917611|FG004|Overall Study|Ineligible|2|||
149939959|NCT02867592|540917612|FG005|Overall Study|Ineligible|0|||
149939960|NCT02867592|540917607|FG000|Overall Study|No Treatment|1|||
149939961|NCT02867592|540917608|FG001|Overall Study|No Treatment|0|||
149939962|NCT02867592|540917609|FG002|Overall Study|No Treatment|0|||
149939963|NCT02867592|540917610|FG003|Overall Study|No Treatment|0|||
149939964|NCT02867592|540917611|FG004|Overall Study|No Treatment|0|||
149939965|NCT02867592|540917612|FG005|Overall Study|No Treatment|0|||
149939966|NCT02867592|540917607|FG000|Overall Study|Still on Therapy|0|||
149939967|NCT02867592|540917608|FG001|Overall Study|Still on Therapy|0|||
149939968|NCT02867592|540917609|FG002|Overall Study|Still on Therapy|0|||
149939969|NCT02867592|540917610|FG003|Overall Study|Still on Therapy|0|||
149939970|NCT02867592|540917611|FG004|Overall Study|Still on Therapy|1|||
149939971|NCT02867592|540917612|FG005|Overall Study|Still on Therapy|0|||
149939972|NCT02867592|540917607|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
149939973|NCT02867592|540917608|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
149939974|NCT02867592|540917609|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
149939975|NCT02867592|540917610|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
149939976|NCT02867592|540917611|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
149939977|NCT02867592|540917612|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
149939978|NCT02867592|540917607|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
149939979|NCT02867592|540917608|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
149939980|NCT02867592|540917609|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
149939981|NCT02867592|540917610|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
149939982|NCT02867592|540917611|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
150274121|NCT04667377|542141524|FG000|Maintenance Period|Adverse Event|2|||
150274122|NCT04667377|542141525|FG001|Maintenance Period|Adverse Event|8|||
149975587|NCT00570713|541047894|FG000|Overall Study|Death|7|||
150274123|NCT04667377|542141526|FG002|Maintenance Period|Adverse Event|5|||
150274124|NCT04667377|542141527|FG003|Maintenance Period|Adverse Event|4|||
150274125|NCT04667377|542141528|FG004|Maintenance Period|Adverse Event|1|||
150274126|NCT04667377|542141524|FG000|Maintenance Period|Adverse event: COVID infection|0|||
150274127|NCT04667377|542141525|FG001|Maintenance Period|Adverse event: COVID infection|1|||
150274128|NCT04667377|542141526|FG002|Maintenance Period|Adverse event: COVID infection|0|||
150274129|NCT04667377|542141527|FG003|Maintenance Period|Adverse event: COVID infection|0|||
150274130|NCT04667377|542141528|FG004|Maintenance Period|Adverse event: COVID infection|0|||
150274131|NCT04667377|542141524|FG000|Maintenance Period|COVID-related|0|||
150274132|NCT04667377|542141525|FG001|Maintenance Period|COVID-related|0|||
150274133|NCT04667377|542141526|FG002|Maintenance Period|COVID-related|1|||
150274134|NCT04667377|542141527|FG003|Maintenance Period|COVID-related|1|||
150274135|NCT04667377|542141528|FG004|Maintenance Period|COVID-related|0|||
150274136|NCT04667377|542141524|FG000|Maintenance Period|Protocol Violation|1|||
150274137|NCT04667377|542141525|FG001|Maintenance Period|Protocol Violation|0|||
150274138|NCT04667377|542141526|FG002|Maintenance Period|Protocol Violation|0|||
150274139|NCT04667377|542141527|FG003|Maintenance Period|Protocol Violation|0|||
150274140|NCT04667377|542141528|FG004|Maintenance Period|Protocol Violation|1|||
150274141|NCT04667377|542141524|FG000|Maintenance Period|Burden of study procedures|1|||
150274142|NCT04667377|542141525|FG001|Maintenance Period|Burden of study procedures|2|||
150274143|NCT04667377|542141526|FG002|Maintenance Period|Burden of study procedures|0|||
150274144|NCT04667377|542141527|FG003|Maintenance Period|Burden of study procedures|1|||
150274145|NCT04667377|542141528|FG004|Maintenance Period|Burden of study procedures|0|||
150274146|NCT04667377|542141524|FG000|Maintenance Period|Change of residence|0|||
150274147|NCT04667377|542141525|FG001|Maintenance Period|Change of residence|1|||
150274148|NCT04667377|542141526|FG002|Maintenance Period|Change of residence|0|||
150274149|NCT04667377|542141527|FG003|Maintenance Period|Change of residence|0|||
150274150|NCT04667377|542141528|FG004|Maintenance Period|Change of residence|1|||
150274151|NCT04667377|542141524|FG000|Maintenance Period|Missing|1|||
150274152|NCT04667377|542141525|FG001|Maintenance Period|Missing|0|||
150274153|NCT04667377|542141526|FG002|Maintenance Period|Missing|0|||
150274154|NCT04667377|542141527|FG003|Maintenance Period|Missing|0|||
150274155|NCT04667377|542141528|FG004|Maintenance Period|Missing|0|||
150274156|NCT04667377|542141524|FG000|Maintenance Period|Other than listed above|2|||
150274157|NCT04667377|542141525|FG001|Maintenance Period|Other than listed above|0|||
150274158|NCT04667377|542141526|FG002|Maintenance Period|Other than listed above|3|||
149939983|NCT02867592|540917612|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
149939984|NCT00803179|540917613|FG000|Overall Study|Lost to Follow-up|3|||
149939985|NCT04158648|540917614|FG000|Overall Study|Ongoing in the Study|69|||
149939986|NCT04158648|540917614|FG000|Overall Study|Withdrawal by Subject|4|||
149939987|NCT00909870|540917615|FG000|Overall Study|Adverse Event|13|||
149939988|NCT00909870|540917616|FG001|Overall Study|Adverse Event|7|||
149939989|NCT00909870|540917615|FG000|Overall Study|Protocol Violation|1|||
149939990|NCT00909870|540917616|FG001|Overall Study|Protocol Violation|2|||
149939991|NCT00909870|540917615|FG000|Overall Study|Withdrawal by Subject|5|||
149939992|NCT00909870|540917616|FG001|Overall Study|Withdrawal by Subject|8|||
149939993|NCT00909870|540917615|FG000|Overall Study|Lost to Follow-up|3|||
149939994|NCT00909870|540917616|FG001|Overall Study|Lost to Follow-up|3|||
149939995|NCT00909870|540917615|FG000|Overall Study|Physician Decision|0|||
149939996|NCT00909870|540917616|FG001|Overall Study|Physician Decision|2|||
149939997|NCT00909870|540917615|FG000|Overall Study|Other|1|||
149939998|NCT00909870|540917616|FG001|Overall Study|Other|5|||
149939999|NCT01773928|540917617|FG000|Overall Study|Adverse Event|0|||
149940000|NCT01773928|540917618|FG001|Overall Study|Adverse Event|0|||
149940001|NCT01773928|540917619|FG002|Overall Study|Adverse Event|0|||
149940002|NCT01773928|540917620|FG003|Overall Study|Adverse Event|0|||
149940003|NCT01773928|540917621|FG004|Overall Study|Adverse Event|0|||
149940004|NCT01773928|540917622|FG005|Overall Study|Adverse Event|0|||
149940005|NCT01773928|540917623|FG006|Overall Study|Adverse Event|0|||
150274159|NCT04667377|542141527|FG003|Maintenance Period|Other than listed above|2|||
150274160|NCT04667377|542141528|FG004|Maintenance Period|Other than listed above|6|||
150274161|NCT04667377|542141524|FG000|Maintenance Period|Withdrawal by Subject|0|||
149940006|NCT01773928|540917624|FG007|Overall Study|Adverse Event|1|||
150274162|NCT04667377|542141525|FG001|Maintenance Period|Withdrawal by Subject|1|||
150274163|NCT04667377|542141526|FG002|Maintenance Period|Withdrawal by Subject|0|||
149940007|NCT01773928|540917625|FG008|Overall Study|Adverse Event|0|||
149940008|NCT01773928|540917617|FG000|Overall Study|Physician Decision|0|||
149940009|NCT01773928|540917618|FG001|Overall Study|Physician Decision|0|||
149940010|NCT01773928|540917619|FG002|Overall Study|Physician Decision|0|||
150274164|NCT04667377|542141527|FG003|Maintenance Period|Withdrawal by Subject|0|||
150274165|NCT04667377|542141528|FG004|Maintenance Period|Withdrawal by Subject|0|||
150274166|NCT04667377|542141524|FG000|Maintenance Period|Lost to Follow-up|1|||
149940011|NCT01773928|540917620|FG003|Overall Study|Physician Decision|1|||
149940012|NCT01773928|540917621|FG004|Overall Study|Physician Decision|0|||
150274167|NCT04667377|542141525|FG001|Maintenance Period|Lost to Follow-up|0|||
150274168|NCT04667377|542141526|FG002|Maintenance Period|Lost to Follow-up|1|||
150274169|NCT04667377|542141527|FG003|Maintenance Period|Lost to Follow-up|0|||
150274170|NCT04667377|542141528|FG004|Maintenance Period|Lost to Follow-up|1|||
149940013|NCT01773928|540917622|FG005|Overall Study|Physician Decision|0|||
149940014|NCT01773928|540917623|FG006|Overall Study|Physician Decision|0|||
149940015|NCT01773928|540917624|FG007|Overall Study|Physician Decision|0|||
149940016|NCT01773928|540917625|FG008|Overall Study|Physician Decision|0|||
149940017|NCT01773928|540917617|FG000|Overall Study|Withdrawal by Subject|5|||
149940018|NCT01773928|540917618|FG001|Overall Study|Withdrawal by Subject|4|||
149940019|NCT01773928|540917619|FG002|Overall Study|Withdrawal by Subject|4|||
149940020|NCT01773928|540917620|FG003|Overall Study|Withdrawal by Subject|4|||
149940021|NCT01773928|540917621|FG004|Overall Study|Withdrawal by Subject|7|||
149940022|NCT01773928|540917622|FG005|Overall Study|Withdrawal by Subject|1|||
149940023|NCT01773928|540917623|FG006|Overall Study|Withdrawal by Subject|0|||
149940024|NCT01773928|540917624|FG007|Overall Study|Withdrawal by Subject|0|||
149940025|NCT01773928|540917625|FG008|Overall Study|Withdrawal by Subject|1|||
149940026|NCT01773928|540917617|FG000|Overall Study|Lost to Follow-up|0|||
149940027|NCT01773928|540917618|FG001|Overall Study|Lost to Follow-up|0|||
149940028|NCT01773928|540917619|FG002|Overall Study|Lost to Follow-up|0|||
149940029|NCT01773928|540917620|FG003|Overall Study|Lost to Follow-up|0|||
149940030|NCT01773928|540917621|FG004|Overall Study|Lost to Follow-up|0|||
149940031|NCT01773928|540917622|FG005|Overall Study|Lost to Follow-up|1|||
149940032|NCT01773928|540917623|FG006|Overall Study|Lost to Follow-up|0|||
149940033|NCT01773928|540917624|FG007|Overall Study|Lost to Follow-up|0|||
149940034|NCT01773928|540917625|FG008|Overall Study|Lost to Follow-up|0|||
149940035|NCT01773928|540917617|FG000|Overall Study|Subject misrepresented age|0|||
149940036|NCT01773928|540917618|FG001|Overall Study|Subject misrepresented age|1|||
149940037|NCT01773928|540917619|FG002|Overall Study|Subject misrepresented age|0|||
149940038|NCT01773928|540917620|FG003|Overall Study|Subject misrepresented age|0|||
149940039|NCT01773928|540917621|FG004|Overall Study|Subject misrepresented age|0|||
149940040|NCT01773928|540917622|FG005|Overall Study|Subject misrepresented age|0|||
149940041|NCT01773928|540917623|FG006|Overall Study|Subject misrepresented age|0|||
149940042|NCT01773928|540917624|FG007|Overall Study|Subject misrepresented age|0|||
149940043|NCT01773928|540917625|FG008|Overall Study|Subject misrepresented age|0|||
149940044|NCT01773928|540917617|FG000|Overall Study|Subject met exclusion criteria|0|||
149940045|NCT01773928|540917618|FG001|Overall Study|Subject met exclusion criteria|0|||
149940046|NCT01773928|540917619|FG002|Overall Study|Subject met exclusion criteria|0|||
149940047|NCT01773928|540917620|FG003|Overall Study|Subject met exclusion criteria|0|||
149940048|NCT01773928|540917621|FG004|Overall Study|Subject met exclusion criteria|0|||
149940049|NCT01773928|540917622|FG005|Overall Study|Subject met exclusion criteria|0|||
149940050|NCT01773928|540917623|FG006|Overall Study|Subject met exclusion criteria|0|||
149940051|NCT01773928|540917624|FG007|Overall Study|Subject met exclusion criteria|0|||
149940052|NCT01773928|540917625|FG008|Overall Study|Subject met exclusion criteria|1|||
149940053|NCT01773928|540917617|FG000|Overall Study|Randomized, had to leave, never returned|0|||
149940054|NCT01773928|540917618|FG001|Overall Study|Randomized, had to leave, never returned|0|||
149940055|NCT01773928|540917619|FG002|Overall Study|Randomized, had to leave, never returned|0|||
149940056|NCT01773928|540917620|FG003|Overall Study|Randomized, had to leave, never returned|1|||
149940057|NCT01773928|540917621|FG004|Overall Study|Randomized, had to leave, never returned|0|||
149940058|NCT01773928|540917622|FG005|Overall Study|Randomized, had to leave, never returned|0|||
149940059|NCT01773928|540917623|FG006|Overall Study|Randomized, had to leave, never returned|0|||
149940060|NCT01773928|540917624|FG007|Overall Study|Randomized, had to leave, never returned|0|||
149940061|NCT01773928|540917625|FG008|Overall Study|Randomized, had to leave, never returned|0|||
149940062|NCT01773928|540917617|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
149940063|NCT01773928|540917618|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
149940064|NCT01773928|540917619|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
149940065|NCT01773928|540917620|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
149940066|NCT01773928|540917621|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
149940067|NCT01773928|540917622|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
149940068|NCT01773928|540917623|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
149940069|NCT01773928|540917624|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
149940070|NCT01773928|540917625|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
149940071|NCT03054428|540917626|FG000|Overall Study|Physician Decision|0|||
149940072|NCT03054428|540917627|FG001|Overall Study|Physician Decision|1|||
149940073|NCT03054428|540917628|FG002|Overall Study|Physician Decision|1|||
149940074|NCT03054428|540917626|FG000|Overall Study|Lack of Efficacy|3|||
149940075|NCT03054428|540917627|FG001|Overall Study|Lack of Efficacy|1|||
149940076|NCT03054428|540917628|FG002|Overall Study|Lack of Efficacy|0|||
149940077|NCT03054428|540917626|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
149940078|NCT03054428|540917627|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
149940079|NCT03054428|540917628|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
149940080|NCT03054428|540917626|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
149940081|NCT03054428|540917627|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
149940082|NCT03054428|540917628|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
149821176|NCT02884206|540475650|FG001|Valsartan Run-in Period|Adverse Event|0|||
149940083|NCT03054428|540917626|FG000|Overall Study|Transitioned to OLE study|76|||
149940084|NCT03054428|540917627|FG001|Overall Study|Transitioned to OLE study|76|||
149940085|NCT03054428|540917628|FG002|Overall Study|Transitioned to OLE study|73|||
149940086|NCT03054428|540917626|FG000|Overall Study|Withdrawal by Subject|3|||
149940087|NCT03054428|540917627|FG001|Overall Study|Withdrawal by Subject|2|||
149940088|NCT03054428|540917628|FG002|Overall Study|Withdrawal by Subject|3|||
149940089|NCT03054428|540917626|FG000|Overall Study|Lost to Follow-up|0|||
149940090|NCT03054428|540917627|FG001|Overall Study|Lost to Follow-up|0|||
149940091|NCT03054428|540917628|FG002|Overall Study|Lost to Follow-up|1|||
149940092|NCT03759379|540918997|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
149940093|NCT03759379|540918998|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
149940094|NCT03759379|540918997|FG000|Treatment Period|Death|2|||
149940095|NCT03759379|540918998|FG001|Treatment Period|Death|3|||
149940096|NCT03759379|540918997|FG000|Treatment Period|Lost to Follow-up|1|||
149940097|NCT03759379|540918998|FG001|Treatment Period|Lost to Follow-up|0|||
149940098|NCT03759379|540918997|FG000|Treatment Period|Physician Decision|0|||
149940099|NCT03759379|540918998|FG001|Treatment Period|Physician Decision|1|||
149940100|NCT02659865|540918999|FG000|Period 1|Withdrawal by Subject|1|||
149940101|NCT02659865|540919000|FG001|Period 1|Withdrawal by Subject|0|||
149940102|NCT02659865|540919001|FG002|Period 1|Withdrawal by Subject|0|||
149940103|NCT02659865|540919002|FG003|Period 1|Withdrawal by Subject|0|||
149940104|NCT02659865|540919003|FG004|Period 1|Withdrawal by Subject|0|||
149940105|NCT02659865|540918999|FG000|Period 1|Adverse Event|0|||
149940106|NCT02659865|540919000|FG001|Period 1|Adverse Event|0|||
149940107|NCT02659865|540919001|FG002|Period 1|Adverse Event|0|||
149940108|NCT02659865|540919002|FG003|Period 1|Adverse Event|0|||
149940109|NCT02659865|540919003|FG004|Period 1|Adverse Event|1|||
149940110|NCT02325414|540919004|FG000|Overall Study|Withdrawal by Subject|3|||
149940111|NCT02325414|540919005|FG001|Overall Study|Withdrawal by Subject|1|||
149940112|NCT02325414|540919004|FG000|Overall Study|Lost to Follow-up|5|||
149940113|NCT02325414|540919005|FG001|Overall Study|Lost to Follow-up|5|||
149940114|NCT05722522|540919006|FG000|Overall Study|Adverse Event|0|||
149940115|NCT05722522|540919007|FG001|Overall Study|Adverse Event|1|||
149940116|NCT03834961|540919010|FG000|Overall Study|Lack of Efficacy|1|||
149940117|NCT03834961|540919011|FG001|Overall Study|Lack of Efficacy|1|||
149940118|NCT03834961|540919012|FG002|Overall Study|Lack of Efficacy|0|||
149940119|NCT03834961|540919010|FG000|Overall Study|Physician Decision|0|||
149940120|NCT03834961|540919011|FG001|Overall Study|Physician Decision|1|||
149940121|NCT03834961|540919012|FG002|Overall Study|Physician Decision|0|||
149940122|NCT04736199|540919015|FG000|Overall Study|Adverse Event|28|||
149940123|NCT04736199|540919016|FG001|Overall Study|Adverse Event|22|||
149940124|NCT04736199|540919015|FG000|Overall Study|Death|9|||
149940125|NCT04736199|540919016|FG001|Overall Study|Death|3|||
149940126|NCT04736199|540919015|FG000|Overall Study|Lost to Follow-up|4|||
149940127|NCT04736199|540919016|FG001|Overall Study|Lost to Follow-up|1|||
149940128|NCT04736199|540919015|FG000|Overall Study|Physician Decision|5|||
149940129|NCT04736199|540919016|FG001|Overall Study|Physician Decision|9|||
149940130|NCT04736199|540919015|FG000|Overall Study|Withdrawal by Subject|21|||
149940131|NCT04736199|540919016|FG001|Overall Study|Withdrawal by Subject|9|||
149940132|NCT04736199|540919015|FG000|Overall Study|Progressive disease|120|||
149940133|NCT04736199|540919016|FG001|Overall Study|Progressive disease|101|||
149940134|NCT04736199|540919015|FG000|Overall Study|Subject decision|13|||
149940135|NCT04736199|540919016|FG001|Overall Study|Subject decision|13|||
149940136|NCT04736199|540919015|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
149940137|NCT04736199|540919016|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
149940138|NCT04736199|540919015|FG000|Overall Study|Additional primary malignancy|1|||
149940139|NCT04736199|540919016|FG001|Overall Study|Additional primary malignancy|0|||
149940140|NCT04736199|540919015|FG000|Overall Study|Non-compliance with study drug|0|||
149940141|NCT04736199|540919016|FG001|Overall Study|Non-compliance with study drug|1|||
149940142|NCT04736199|540919015|FG000|Overall Study|Other reason|0|||
149940143|NCT04736199|540919016|FG001|Overall Study|Other reason|1|||
149940144|NCT04736199|540919015|FG000|Overall Study|Ongoing with study drug|240|||
149940145|NCT04736199|540919016|FG001|Overall Study|Ongoing with study drug|63|||
149940146|NCT04736199|540919015|FG000|Overall Study|Study drug never administered|3|||
149940147|NCT04736199|540919016|FG001|Overall Study|Study drug never administered|0|||
149940148|NCT02775851|540919017|FG000|Overall Study|Adverse Event|1|||
149940149|NCT02775851|540919018|FG001|Overall Study|Adverse Event|10|||
149940150|NCT02775851|540919017|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
149940151|NCT02775851|540919018|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
149940152|NCT02775851|540919017|FG000|Overall Study|Progression/Relapse|0|||
149940153|NCT02775851|540919018|FG001|Overall Study|Progression/Relapse|4|||
149940154|NCT02775851|540919017|FG000|Overall Study|Other - Not Protocol Specified|0|||
149940155|NCT02775851|540919018|FG001|Overall Study|Other - Not Protocol Specified|7|||
149940156|NCT02775851|540919017|FG000|Overall Study|Withdrawal by Subject|1|||
149940157|NCT02775851|540919018|FG001|Overall Study|Withdrawal by Subject|0|||
149940158|NCT05918055|540919019|FG000|Phase I - Dose Level 1|Ineligible|0|||
149940159|NCT05918055|540919020|FG001|Phase I - Dose Level 1|Ineligible|0|||
149940160|NCT05918055|540919021|FG002|Phase I - Dose Level 1|Ineligible|1|||
149940161|NCT05918055|540919019|FG000|Phase I - Dose Level -1|Physician Decision|1|||
149940162|NCT05918055|540919020|FG001|Phase I - Dose Level -1|Physician Decision|0|||
149940163|NCT05918055|540919021|FG002|Phase I - Dose Level -1|Physician Decision|0|||
149940164|NCT00959751|540919024|FG000|Overall Study|Lost to Follow-up|2|||
149940165|NCT00959751|540919025|FG001|Overall Study|Lost to Follow-up|3|||
149940166|NCT00959751|540919024|FG000|Overall Study|Consent Withdrawn|0|||
149940167|NCT00959751|540919025|FG001|Overall Study|Consent Withdrawn|1|||
149940168|NCT00959751|540919024|FG000|Overall Study|Non-compliance to Study Procedures|0|||
149940169|NCT00959751|540919025|FG001|Overall Study|Non-compliance to Study Procedures|1|||
149940170|NCT00959751|540919024|FG000|Overall Study|No migraine headache without aura|7|||
149940171|NCT00959751|540919025|FG001|Overall Study|No migraine headache without aura|7|||
149940172|NCT01027949|540919035|FG000|Overall Study|Death|174|||
149940173|NCT01027949|540919035|FG000|Overall Study|Progressive Disease|163|||
149940174|NCT01027949|540919035|FG000|Overall Study|Adverse Event|172|||
149940175|NCT01027949|540919035|FG000|Overall Study|Withdrawal by Subject|113|||
149940176|NCT01027949|540919035|FG000|Overall Study|Lost to Follow-up|17|||
149940177|NCT01027949|540919035|FG000|Overall Study|Protocol Violation|13|||
149940178|NCT01027949|540919035|FG000|Overall Study|PI Decision|8|||
149940179|NCT01027949|540919035|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
149821177|NCT02884206|540475651|FG002|Valsartan Run-in Period|Adverse Event|0|||
149940180|NCT01027949|540919035|FG000|Overall Study|Non-compliance with Study Procedures|7|||
149940181|NCT01027949|540919035|FG000|Overall Study|Lung Transplant|5|||
149940182|NCT01027949|540919035|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
149940183|NCT01027949|540919035|FG000|Overall Study|Use of Excluded Medication|2|||
149940184|NCT01027949|540919035|FG000|Overall Study|Patient Self-discontinuation|1|||
149940185|NCT01027949|540919035|FG000|Overall Study|Pregnancy|1|||
149940186|NCT01027949|540919035|FG000|Overall Study|Surgery|1|||
149940187|NCT01712178|540919040|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
149940188|NCT01712178|540919041|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
149940189|NCT01712178|540919040|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
149940190|NCT01712178|540919041|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
149940191|NCT01712178|540919040|FG000|Overall Study|Lost to Follow-up|0|||
149940192|NCT01712178|540919041|FG001|Overall Study|Lost to Follow-up|1|||
149940193|NCT00856180|540919042|FG000|Overall Study|Adverse Event|4|||
149940194|NCT00856180|540919042|FG000|Overall Study|Progressive Disease|16|||
149940195|NCT00671749|540919043|FG000|Overall Study|Adverse Event|2|||
149940196|NCT00671749|540919043|FG000|Overall Study|Withdrawal by Subject|4|||
149940197|NCT00671749|540919043|FG000|Overall Study|Protocol Violation|1|||
149940198|NCT00671749|540919043|FG000|Overall Study|Lost to Follow-up|1|||
149940199|NCT01200355|540919044|FG000|Overall Study|Death|7|||
149940200|NCT01200355|540919045|FG001|Overall Study|Death|2|||
149940201|NCT01281306|540919047|FG000|Overall Study|Lack of Efficacy|0|||
149940202|NCT01281306|540919048|FG001|Overall Study|Lack of Efficacy|1|||
149940203|NCT01281306|540919049|FG002|Overall Study|Lack of Efficacy|3|||
149940204|NCT01281306|540919050|FG003|Overall Study|Lack of Efficacy|0|||
149940205|NCT01281306|540919051|FG004|Overall Study|Lack of Efficacy|2|||
149940206|NCT01281306|540919052|FG005|Overall Study|Lack of Efficacy|0|||
149940207|NCT01281306|540919053|FG006|Overall Study|Lack of Efficacy|1|||
149940208|NCT01281306|540919047|FG000|Overall Study|Withdrawal by Subject|1|||
149940209|NCT01281306|540919048|FG001|Overall Study|Withdrawal by Subject|0|||
149940210|NCT01281306|540919049|FG002|Overall Study|Withdrawal by Subject|2|||
149940211|NCT01281306|540919050|FG003|Overall Study|Withdrawal by Subject|4|||
149940212|NCT01281306|540919051|FG004|Overall Study|Withdrawal by Subject|1|||
149940213|NCT01281306|540919052|FG005|Overall Study|Withdrawal by Subject|3|||
149940214|NCT01281306|540919053|FG006|Overall Study|Withdrawal by Subject|1|||
149940215|NCT01281306|540919047|FG000|Overall Study|Protocol deviation|0|||
149940216|NCT01281306|540919048|FG001|Overall Study|Protocol deviation|1|||
149940217|NCT01281306|540919049|FG002|Overall Study|Protocol deviation|1|||
149940218|NCT01281306|540919050|FG003|Overall Study|Protocol deviation|1|||
149940219|NCT01281306|540919051|FG004|Overall Study|Protocol deviation|1|||
149940220|NCT01281306|540919052|FG005|Overall Study|Protocol deviation|0|||
149940221|NCT01281306|540919053|FG006|Overall Study|Protocol deviation|0|||
149940222|NCT01281306|540919047|FG000|Overall Study|Condition no longer requires study drug|1|||
149940223|NCT01281306|540919048|FG001|Overall Study|Condition no longer requires study drug|0|||
149940224|NCT01281306|540919049|FG002|Overall Study|Condition no longer requires study drug|0|||
149940225|NCT01281306|540919050|FG003|Overall Study|Condition no longer requires study drug|0|||
149940226|NCT01281306|540919051|FG004|Overall Study|Condition no longer requires study drug|0|||
149940227|NCT01281306|540919052|FG005|Overall Study|Condition no longer requires study drug|1|||
149940228|NCT01281306|540919053|FG006|Overall Study|Condition no longer requires study drug|1|||
149940229|NCT01281306|540919047|FG000|Overall Study|Lost to Follow-up|1|||
149940230|NCT01281306|540919048|FG001|Overall Study|Lost to Follow-up|0|||
149940231|NCT01281306|540919049|FG002|Overall Study|Lost to Follow-up|0|||
149940232|NCT01281306|540919050|FG003|Overall Study|Lost to Follow-up|2|||
149940233|NCT01281306|540919051|FG004|Overall Study|Lost to Follow-up|0|||
149940234|NCT01281306|540919052|FG005|Overall Study|Lost to Follow-up|0|||
149821178|NCT02884206|540475649|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
149940235|NCT01281306|540919053|FG006|Overall Study|Lost to Follow-up|1|||
149940236|NCT01281306|540919047|FG000|Overall Study|Death|1|||
149940237|NCT01281306|540919048|FG001|Overall Study|Death|0|||
149940238|NCT01281306|540919049|FG002|Overall Study|Death|0|||
149940239|NCT01281306|540919050|FG003|Overall Study|Death|0|||
149940240|NCT01281306|540919051|FG004|Overall Study|Death|0|||
149940241|NCT01281306|540919052|FG005|Overall Study|Death|0|||
149940242|NCT01281306|540919053|FG006|Overall Study|Death|0|||
149940243|NCT01281306|540919047|FG000|Overall Study|Adverse Event|3|||
149940244|NCT01281306|540919048|FG001|Overall Study|Adverse Event|2|||
149940245|NCT01281306|540919049|FG002|Overall Study|Adverse Event|2|||
149940246|NCT01281306|540919050|FG003|Overall Study|Adverse Event|3|||
149940247|NCT01281306|540919051|FG004|Overall Study|Adverse Event|5|||
149940248|NCT01281306|540919052|FG005|Overall Study|Adverse Event|3|||
149940249|NCT01281306|540919053|FG006|Overall Study|Adverse Event|3|||
149940250|NCT01281306|540919047|FG000|Overall Study|Randomized in error|1|||
149940251|NCT01281306|540919048|FG001|Overall Study|Randomized in error|0|||
149940252|NCT01281306|540919049|FG002|Overall Study|Randomized in error|0|||
149940253|NCT01281306|540919050|FG003|Overall Study|Randomized in error|1|||
149940254|NCT01281306|540919051|FG004|Overall Study|Randomized in error|0|||
149940255|NCT01281306|540919052|FG005|Overall Study|Randomized in error|0|||
149940256|NCT01281306|540919053|FG006|Overall Study|Randomized in error|0|||
149940257|NCT01401322|540919054|FG000|Overall Study|Withdrawal by Subject|1|||
149940258|NCT01401322|540919054|FG000|Overall Study|Physician Decision|1|||
149940259|NCT00486044|540919055|FG000|Overall Study|Withdrawal by Subject|2|||
149940260|NCT00486044|540919056|FG001|Overall Study|Withdrawal by Subject|1|||
149940261|NCT00486044|540919055|FG000|Overall Study|Adverse Event|0|||
149940262|NCT00486044|540919056|FG001|Overall Study|Adverse Event|1|||
149940263|NCT00486044|540919055|FG000|Overall Study|Lost to Follow-up|0|||
149940264|NCT00486044|540919056|FG001|Overall Study|Lost to Follow-up|1|||
149940265|NCT03466346|540919057|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
149940266|NCT03466346|540919058|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
149940267|NCT03466346|540919059|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
149940268|NCT03466346|540919060|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
149940269|NCT03466346|540919061|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
149940270|NCT03466346|540919057|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
149940271|NCT03466346|540919058|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
149940272|NCT03466346|540919059|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
149940273|NCT03466346|540919060|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
149940274|NCT03466346|540919061|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
149940275|NCT03466346|540919057|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
149940276|NCT03466346|540919058|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
149940277|NCT03466346|540919059|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
149940278|NCT03466346|540919060|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
149940279|NCT03466346|540919061|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
149940280|NCT03466346|540919057|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
149940281|NCT03466346|540919058|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
149940282|NCT03466346|540919059|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
149940283|NCT03466346|540919060|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
149940284|NCT03466346|540919061|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
149940285|NCT03466346|540919057|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
149940286|NCT03466346|540919058|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
149940287|NCT03466346|540919059|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
149940288|NCT03466346|540919060|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
149940289|NCT03466346|540919061|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
149940290|NCT03466346|540919057|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
149940291|NCT03466346|540919058|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
149940292|NCT03466346|540919059|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
149940293|NCT03466346|540919060|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
149940294|NCT03466346|540919061|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
149940295|NCT03466346|540919057|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
149940296|NCT03466346|540919058|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
149940297|NCT03466346|540919059|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
149940298|NCT03466346|540919060|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
149940299|NCT03466346|540919061|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
149821179|NCT02884206|540475650|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
149821180|NCT02884206|540475651|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
149821181|NCT02884206|540475649|FG000|Valsartan Run-in Period|Protocol deviation|4|||
149821182|NCT02884206|540475650|FG001|Valsartan Run-in Period|Protocol deviation|0|||
149940300|NCT01206764|540919062|FG000|Overall Study|Adverse Event|20|||
149940301|NCT01206764|540919062|FG000|Overall Study|Abnormal laboratory value|2|||
149940302|NCT01206764|540919062|FG000|Overall Study|Abnormal test procedure result|1|||
149940303|NCT01206764|540919062|FG000|Overall Study|Patient withdrew consent|5|||
149940304|NCT01206764|540919062|FG000|Overall Study|Lost to Follow-up|6|||
149940305|NCT01206764|540919062|FG000|Overall Study|Death|11|||
149940306|NCT01206764|540919062|FG000|Overall Study|New cancer therapy|2|||
149940307|NCT01206764|540919062|FG000|Overall Study|Disease progression|88|||
149940308|NCT01206764|540919062|FG000|Overall Study|Protocol deviation|3|||
149940309|NCT00997893|540919065|FG000|Overall Study|Adverse Event|1|||
149940310|NCT00997893|540919066|FG001|Overall Study|Adverse Event|0|||
149940311|NCT00997893|540919067|FG002|Overall Study|Adverse Event|0|||
149940312|NCT00997893|540919065|FG000|Overall Study|Unable to meet study timelines|1|||
149940313|NCT00997893|540919066|FG001|Overall Study|Unable to meet study timelines|0|||
149940314|NCT00997893|540919067|FG002|Overall Study|Unable to meet study timelines|0|||
149940315|NCT00997893|540919065|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
149940316|NCT00997893|540919066|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
149940317|NCT00997893|540919067|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
149940318|NCT00961415|540919068|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
149940319|NCT00961415|540919069|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
149940320|NCT00961415|540919070|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
149940321|NCT00961415|540919068|FG000|Induction Treatment Phase|Death|77|||
149940322|NCT00961415|540919069|FG001|Induction Treatment Phase|Death|0|||
149940323|NCT00961415|540919070|FG002|Induction Treatment Phase|Death|0|||
149940324|NCT00961415|540919068|FG000|Induction Treatment Phase|Protocol Violation|1|||
149940325|NCT00961415|540919069|FG001|Induction Treatment Phase|Protocol Violation|0|||
149940326|NCT00961415|540919070|FG002|Induction Treatment Phase|Protocol Violation|0|||
149940327|NCT00961415|540919068|FG000|Induction Treatment Phase|Physician Decision|2|||
149940328|NCT00961415|540919069|FG001|Induction Treatment Phase|Physician Decision|0|||
149940329|NCT00961415|540919070|FG002|Induction Treatment Phase|Physician Decision|0|||
149940330|NCT00961415|540919068|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
149940331|NCT00961415|540919069|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
149940332|NCT00961415|540919070|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
149940333|NCT00961415|540919068|FG000|Induction Treatment Phase|Other Reason|5|||
149940334|NCT00961415|540919069|FG001|Induction Treatment Phase|Other Reason|0|||
149940335|NCT00961415|540919070|FG002|Induction Treatment Phase|Other Reason|0|||
149940336|NCT00961415|540919068|FG000|Maintenance Treatment Phase|Death|0|||
149940337|NCT00961415|540919069|FG001|Maintenance Treatment Phase|Death|42|||
149940338|NCT00961415|540919070|FG002|Maintenance Treatment Phase|Death|34|||
149940339|NCT00961415|540919068|FG000|Maintenance Treatment Phase|Investigators decision|0|||
149940340|NCT00961415|540919069|FG001|Maintenance Treatment Phase|Investigators decision|2|||
149940341|NCT00961415|540919070|FG002|Maintenance Treatment Phase|Investigators decision|0|||
149940342|NCT00961415|540919068|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149940343|NCT00961415|540919069|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
149940344|NCT00961415|540919070|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
149940345|NCT00961415|540919068|FG000|Maintenance Treatment Phase|Other reason|0|||
149940346|NCT00961415|540919069|FG001|Maintenance Treatment Phase|Other reason|1|||
149940347|NCT00961415|540919070|FG002|Maintenance Treatment Phase|Other reason|3|||
149940348|NCT00226655|540919071|FG000|Overall Study|Death|13|||
149940349|NCT00226655|540919071|FG000|Overall Study|Withdrawal by Subject|15|||
149940350|NCT00226655|540919071|FG000|Overall Study|Adverse Event|35|||
149940351|NCT00226655|540919071|FG000|Overall Study|Physician Decision|6|||
149940352|NCT00226655|540919071|FG000|Overall Study|Clinical deterioration|10|||
149940353|NCT05911841|540919072|FG000|Induction Period|Study Terminated by Sponsor|2|||
149940354|NCT05911841|540919073|FG001|Induction Period|Study Terminated by Sponsor|0|||
149940355|NCT05911841|540919074|FG002|Induction Period|Study Terminated by Sponsor|14|||
149940356|NCT05911841|540919075|FG003|Induction Period|Study Terminated by Sponsor|6|||
149940357|NCT05911841|540919076|FG004|Induction Period|Study Terminated by Sponsor|0|||
149940358|NCT05911841|540919077|FG005|Induction Period|Study Terminated by Sponsor|0|||
149940359|NCT05911841|540919078|FG006|Induction Period|Study Terminated by Sponsor|0|||
149940360|NCT05911841|540919079|FG007|Induction Period|Study Terminated by Sponsor|0|||
149940361|NCT05911841|540919080|FG008|Induction Period|Study Terminated by Sponsor|0|||
149940362|NCT05911841|540919081|FG009|Induction Period|Study Terminated by Sponsor|0|||
149940363|NCT05911841|540919072|FG000|Induction Period|Withdrawal by Subject|4|||
149940364|NCT05911841|540919073|FG001|Induction Period|Withdrawal by Subject|3|||
149940365|NCT05911841|540919074|FG002|Induction Period|Withdrawal by Subject|4|||
149940366|NCT05911841|540919075|FG003|Induction Period|Withdrawal by Subject|6|||
149940367|NCT05911841|540919076|FG004|Induction Period|Withdrawal by Subject|0|||
149940368|NCT05911841|540919077|FG005|Induction Period|Withdrawal by Subject|0|||
149940369|NCT05911841|540919078|FG006|Induction Period|Withdrawal by Subject|0|||
149940370|NCT05911841|540919079|FG007|Induction Period|Withdrawal by Subject|0|||
149940371|NCT05911841|540919080|FG008|Induction Period|Withdrawal by Subject|0|||
149940372|NCT05911841|540919081|FG009|Induction Period|Withdrawal by Subject|0|||
149940373|NCT05911841|540919072|FG000|Induction Period|Lack of Efficacy|3|||
149940374|NCT05911841|540919073|FG001|Induction Period|Lack of Efficacy|0|||
149940375|NCT05911841|540919074|FG002|Induction Period|Lack of Efficacy|3|||
149940376|NCT05911841|540919075|FG003|Induction Period|Lack of Efficacy|3|||
149940377|NCT05911841|540919076|FG004|Induction Period|Lack of Efficacy|0|||
149940378|NCT05911841|540919077|FG005|Induction Period|Lack of Efficacy|0|||
149940379|NCT05911841|540919078|FG006|Induction Period|Lack of Efficacy|0|||
149940380|NCT05911841|540919079|FG007|Induction Period|Lack of Efficacy|0|||
149940381|NCT05911841|540919080|FG008|Induction Period|Lack of Efficacy|0|||
149940382|NCT05911841|540919081|FG009|Induction Period|Lack of Efficacy|0|||
149940383|NCT05911841|540919072|FG000|Induction Period|Adverse Event|3|||
149940384|NCT05911841|540919073|FG001|Induction Period|Adverse Event|1|||
149940385|NCT05911841|540919074|FG002|Induction Period|Adverse Event|2|||
149940386|NCT05911841|540919075|FG003|Induction Period|Adverse Event|0|||
149940387|NCT05911841|540919076|FG004|Induction Period|Adverse Event|0|||
149940388|NCT05911841|540919077|FG005|Induction Period|Adverse Event|0|||
149940389|NCT05911841|540919078|FG006|Induction Period|Adverse Event|0|||
149940390|NCT05911841|540919079|FG007|Induction Period|Adverse Event|0|||
149940391|NCT05911841|540919080|FG008|Induction Period|Adverse Event|0|||
149940392|NCT05911841|540919081|FG009|Induction Period|Adverse Event|0|||
149940393|NCT05911841|540919072|FG000|Induction Period|Assigned Treatment by Mistake|0|||
149940394|NCT05911841|540919073|FG001|Induction Period|Assigned Treatment by Mistake|1|||
149940395|NCT05911841|540919074|FG002|Induction Period|Assigned Treatment by Mistake|0|||
149940396|NCT05911841|540919075|FG003|Induction Period|Assigned Treatment by Mistake|1|||
149940397|NCT05911841|540919076|FG004|Induction Period|Assigned Treatment by Mistake|0|||
149940398|NCT05911841|540919077|FG005|Induction Period|Assigned Treatment by Mistake|0|||
149940399|NCT05911841|540919078|FG006|Induction Period|Assigned Treatment by Mistake|0|||
149940400|NCT05911841|540919079|FG007|Induction Period|Assigned Treatment by Mistake|0|||
149940401|NCT05911841|540919080|FG008|Induction Period|Assigned Treatment by Mistake|0|||
149940402|NCT05911841|540919081|FG009|Induction Period|Assigned Treatment by Mistake|0|||
149940403|NCT05911841|540919072|FG000|Induction Period|Lost to Follow-up|0|||
149940404|NCT05911841|540919073|FG001|Induction Period|Lost to Follow-up|0|||
149940405|NCT05911841|540919074|FG002|Induction Period|Lost to Follow-up|1|||
149940406|NCT05911841|540919075|FG003|Induction Period|Lost to Follow-up|1|||
149940407|NCT05911841|540919076|FG004|Induction Period|Lost to Follow-up|0|||
149940408|NCT05911841|540919077|FG005|Induction Period|Lost to Follow-up|0|||
149940409|NCT05911841|540919078|FG006|Induction Period|Lost to Follow-up|0|||
149940410|NCT05911841|540919079|FG007|Induction Period|Lost to Follow-up|0|||
149940411|NCT05911841|540919080|FG008|Induction Period|Lost to Follow-up|0|||
149940412|NCT05911841|540919081|FG009|Induction Period|Lost to Follow-up|0|||
149940413|NCT05911841|540919072|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
149940414|NCT05911841|540919073|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
149940415|NCT05911841|540919074|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
149940416|NCT05911841|540919075|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
149940417|NCT05911841|540919076|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
149940418|NCT05911841|540919077|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
149940419|NCT05911841|540919078|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
149940420|NCT05911841|540919079|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
149940421|NCT05911841|540919080|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
149940422|NCT05911841|540919081|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
149940423|NCT05911841|540919072|FG000|Maintenance Period|Lack of Efficacy|0|||
149940424|NCT05911841|540919073|FG001|Maintenance Period|Lack of Efficacy|0|||
149940425|NCT05911841|540919074|FG002|Maintenance Period|Lack of Efficacy|0|||
149940426|NCT05911841|540919075|FG003|Maintenance Period|Lack of Efficacy|0|||
149940427|NCT05911841|540919076|FG004|Maintenance Period|Lack of Efficacy|1|||
149940428|NCT05911841|540919077|FG005|Maintenance Period|Lack of Efficacy|0|||
149940429|NCT05911841|540919078|FG006|Maintenance Period|Lack of Efficacy|1|||
149940430|NCT05911841|540919079|FG007|Maintenance Period|Lack of Efficacy|0|||
149940431|NCT05911841|540919080|FG008|Maintenance Period|Lack of Efficacy|0|||
149940432|NCT05911841|540919081|FG009|Maintenance Period|Lack of Efficacy|0|||
149940433|NCT05911841|540919072|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
149940434|NCT05911841|540919073|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
149940435|NCT05911841|540919074|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
149821183|NCT02884206|540475651|FG002|Valsartan Run-in Period|Protocol deviation|0|||
149940436|NCT05911841|540919075|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
149940437|NCT05911841|540919076|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
149940438|NCT05911841|540919077|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
149940439|NCT05911841|540919078|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
149940440|NCT05911841|540919079|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
149940441|NCT05911841|540919080|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
149940442|NCT05911841|540919081|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
149940443|NCT05911841|540919072|FG000|Maintenance Period|Withdrawal by Subject|0|||
149940444|NCT05911841|540919073|FG001|Maintenance Period|Withdrawal by Subject|0|||
149940445|NCT05911841|540919074|FG002|Maintenance Period|Withdrawal by Subject|0|||
149940446|NCT05911841|540919075|FG003|Maintenance Period|Withdrawal by Subject|0|||
149940447|NCT05911841|540919076|FG004|Maintenance Period|Withdrawal by Subject|0|||
149940448|NCT05911841|540919077|FG005|Maintenance Period|Withdrawal by Subject|1|||
149940449|NCT05911841|540919078|FG006|Maintenance Period|Withdrawal by Subject|0|||
149940450|NCT05911841|540919079|FG007|Maintenance Period|Withdrawal by Subject|1|||
149940451|NCT05911841|540919080|FG008|Maintenance Period|Withdrawal by Subject|0|||
149940452|NCT05911841|540919081|FG009|Maintenance Period|Withdrawal by Subject|0|||
149940453|NCT05911841|540919072|FG000|Maintenance Period|Adverse Event|0|||
149940454|NCT05911841|540919073|FG001|Maintenance Period|Adverse Event|0|||
149940455|NCT05911841|540919074|FG002|Maintenance Period|Adverse Event|0|||
149940456|NCT05911841|540919075|FG003|Maintenance Period|Adverse Event|0|||
149940457|NCT05911841|540919076|FG004|Maintenance Period|Adverse Event|0|||
149940458|NCT05911841|540919077|FG005|Maintenance Period|Adverse Event|0|||
149940459|NCT05911841|540919078|FG006|Maintenance Period|Adverse Event|0|||
149821184|NCT02884206|540475649|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
149940460|NCT05911841|540919079|FG007|Maintenance Period|Adverse Event|1|||
149940461|NCT05911841|540919080|FG008|Maintenance Period|Adverse Event|0|||
149940462|NCT05911841|540919081|FG009|Maintenance Period|Adverse Event|0|||
149940463|NCT05911841|540919072|FG000|Escape Period|Adverse Event|0|||
150169905|NCT02341625|541757205|FG005|Overall Study|Participant Withdrew Consent|0|||
149821185|NCT02884206|540475650|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
149821186|NCT02884206|540475651|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
149821187|NCT02884206|540475649|FG000|Valsartan Run-in Period|Physician Decision|1|||
149821188|NCT02884206|540475650|FG001|Valsartan Run-in Period|Physician Decision|0|||
149821189|NCT02884206|540475651|FG002|Valsartan Run-in Period|Physician Decision|0|||
149821190|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Adverse Event|38|||
149821191|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Adverse Event|0|||
149821192|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Adverse Event|0|||
149821193|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Death|2|||
149821194|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Death|0|||
149821195|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Death|0|||
149821196|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
149821197|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
149821198|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
149821199|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
149821200|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
149821201|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
149821202|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
149821203|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
149821204|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
149821205|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Physician Decision|1|||
149821206|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Physician Decision|0|||
149821207|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Physician Decision|0|||
149821208|NCT02884206|540475649|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
149821209|NCT02884206|540475650|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
149821210|NCT02884206|540475651|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
149821211|NCT02884206|540475649|FG000|Double-Blind Period|Death|0|||
149821212|NCT02884206|540475650|FG001|Double-Blind Period|Death|28|||
149821213|NCT02884206|540475651|FG002|Double-Blind Period|Death|39|||
149821214|NCT02884206|540475649|FG000|Double-Blind Period|Patient/guardian decision|0|||
149821215|NCT02884206|540475650|FG001|Double-Blind Period|Patient/guardian decision|10|||
149821216|NCT02884206|540475651|FG002|Double-Blind Period|Patient/guardian decision|13|||
149821217|NCT02884206|540475649|FG000|Double-Blind Period|Lost to Follow-up|0|||
149821218|NCT02884206|540475650|FG001|Double-Blind Period|Lost to Follow-up|4|||
149821219|NCT02884206|540475651|FG002|Double-Blind Period|Lost to Follow-up|4|||
149821220|NCT02884206|540475649|FG000|Double-Blind Period|Physician Decision|0|||
149821221|NCT02884206|540475650|FG001|Double-Blind Period|Physician Decision|2|||
149821222|NCT02884206|540475651|FG002|Double-Blind Period|Physician Decision|0|||
149821223|NCT02884206|540475649|FG000|Double-Blind Period|Adverse Event|0|||
149821224|NCT02884206|540475650|FG001|Double-Blind Period|Adverse Event|0|||
149821225|NCT02884206|540475651|FG002|Double-Blind Period|Adverse Event|3|||
149821226|NCT02884206|540475649|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
149821227|NCT02884206|540475650|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
149940464|NCT05911841|540919073|FG001|Escape Period|Adverse Event|0|||
149940465|NCT05911841|540919074|FG002|Escape Period|Adverse Event|0|||
149821228|NCT02884206|540475651|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
149821229|NCT03341507|540475654|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
149821230|NCT02927847|540475656|FG000|Overall Study|Lost to Follow-up|1|||
149821231|NCT02927847|540475657|FG001|Overall Study|Lost to Follow-up|0|||
149821232|NCT02927847|540475656|FG000|Overall Study|Withdrawal by Subject|4|||
149940466|NCT05911841|540919075|FG003|Escape Period|Adverse Event|0|||
149940467|NCT05911841|540919076|FG004|Escape Period|Adverse Event|0|||
149940468|NCT05911841|540919077|FG005|Escape Period|Adverse Event|0|||
150169906|NCT02341625|541757206|FG006|Overall Study|Participant Withdrew Consent|0|||
149821233|NCT02927847|540475657|FG001|Overall Study|Withdrawal by Subject|2|||
149940469|NCT05911841|540919078|FG006|Escape Period|Adverse Event|0|||
149940470|NCT05911841|540919079|FG007|Escape Period|Adverse Event|0|||
149940471|NCT05911841|540919080|FG008|Escape Period|Adverse Event|0|||
149940472|NCT05911841|540919081|FG009|Escape Period|Adverse Event|1|||
149940473|NCT05911841|540919072|FG000|Escape Period|Lack of Efficacy|0|||
149940474|NCT05911841|540919073|FG001|Escape Period|Lack of Efficacy|0|||
149940475|NCT05911841|540919074|FG002|Escape Period|Lack of Efficacy|0|||
149940476|NCT05911841|540919075|FG003|Escape Period|Lack of Efficacy|0|||
149940477|NCT05911841|540919076|FG004|Escape Period|Lack of Efficacy|0|||
149940478|NCT05911841|540919077|FG005|Escape Period|Lack of Efficacy|0|||
149940479|NCT05911841|540919078|FG006|Escape Period|Lack of Efficacy|0|||
149940480|NCT05911841|540919079|FG007|Escape Period|Lack of Efficacy|0|||
149940481|NCT05911841|540919080|FG008|Escape Period|Lack of Efficacy|0|||
149940482|NCT05911841|540919081|FG009|Escape Period|Lack of Efficacy|31|||
149940483|NCT05911841|540919072|FG000|Escape Period|Lost to Follow-up|0|||
149940484|NCT05911841|540919073|FG001|Escape Period|Lost to Follow-up|0|||
149940485|NCT05911841|540919074|FG002|Escape Period|Lost to Follow-up|0|||
149940486|NCT05911841|540919075|FG003|Escape Period|Lost to Follow-up|0|||
149940487|NCT05911841|540919076|FG004|Escape Period|Lost to Follow-up|0|||
149940488|NCT05911841|540919077|FG005|Escape Period|Lost to Follow-up|0|||
149940489|NCT05911841|540919078|FG006|Escape Period|Lost to Follow-up|0|||
149940490|NCT05911841|540919079|FG007|Escape Period|Lost to Follow-up|0|||
149940491|NCT05911841|540919080|FG008|Escape Period|Lost to Follow-up|0|||
149940492|NCT05911841|540919081|FG009|Escape Period|Lost to Follow-up|1|||
149940493|NCT05911841|540919072|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940494|NCT05911841|540919073|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940495|NCT05911841|540919074|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940496|NCT05911841|540919075|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940497|NCT05911841|540919076|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940498|NCT05911841|540919077|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940499|NCT05911841|540919078|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940500|NCT05911841|540919079|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940501|NCT05911841|540919080|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149940502|NCT05911841|540919081|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
149940503|NCT05911841|540919072|FG000|Escape Period|Site Terminated by Sponsor|0|||
149940504|NCT05911841|540919073|FG001|Escape Period|Site Terminated by Sponsor|0|||
149940505|NCT05911841|540919074|FG002|Escape Period|Site Terminated by Sponsor|0|||
149940506|NCT05911841|540919075|FG003|Escape Period|Site Terminated by Sponsor|0|||
149940507|NCT05911841|540919076|FG004|Escape Period|Site Terminated by Sponsor|0|||
149940508|NCT05911841|540919077|FG005|Escape Period|Site Terminated by Sponsor|0|||
149940509|NCT05911841|540919078|FG006|Escape Period|Site Terminated by Sponsor|0|||
149940510|NCT05911841|540919079|FG007|Escape Period|Site Terminated by Sponsor|0|||
149940511|NCT05911841|540919080|FG008|Escape Period|Site Terminated by Sponsor|0|||
149940512|NCT05911841|540919081|FG009|Escape Period|Site Terminated by Sponsor|1|||
149940513|NCT05911841|540919072|FG000|Escape Period|Study Terminated by Sponsor|0|||
149940514|NCT05911841|540919073|FG001|Escape Period|Study Terminated by Sponsor|0|||
149940515|NCT05911841|540919074|FG002|Escape Period|Study Terminated by Sponsor|0|||
149940516|NCT05911841|540919075|FG003|Escape Period|Study Terminated by Sponsor|0|||
149940517|NCT05911841|540919076|FG004|Escape Period|Study Terminated by Sponsor|0|||
149940518|NCT05911841|540919077|FG005|Escape Period|Study Terminated by Sponsor|0|||
149940519|NCT05911841|540919078|FG006|Escape Period|Study Terminated by Sponsor|0|||
149940520|NCT05911841|540919079|FG007|Escape Period|Study Terminated by Sponsor|0|||
149940521|NCT05911841|540919080|FG008|Escape Period|Study Terminated by Sponsor|0|||
149940522|NCT05911841|540919081|FG009|Escape Period|Study Terminated by Sponsor|34|||
149940523|NCT05911841|540919072|FG000|Escape Period|Withdrawal by Subject|0|||
149940524|NCT05911841|540919073|FG001|Escape Period|Withdrawal by Subject|0|||
149940525|NCT05911841|540919074|FG002|Escape Period|Withdrawal by Subject|0|||
149940526|NCT05911841|540919075|FG003|Escape Period|Withdrawal by Subject|0|||
149940527|NCT05911841|540919076|FG004|Escape Period|Withdrawal by Subject|0|||
149940528|NCT05911841|540919077|FG005|Escape Period|Withdrawal by Subject|0|||
149940529|NCT05911841|540919078|FG006|Escape Period|Withdrawal by Subject|0|||
149940530|NCT05911841|540919079|FG007|Escape Period|Withdrawal by Subject|0|||
149940531|NCT05911841|540919080|FG008|Escape Period|Withdrawal by Subject|0|||
149940532|NCT05911841|540919081|FG009|Escape Period|Withdrawal by Subject|10|||
149940533|NCT03025035|540919082|FG000|Overall Study|Death|2|||
149940534|NCT03025035|540919082|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
149940535|NCT05063448|540919089|FG000|Overall Study|Withdrawal by Subject|1|||
149940536|NCT04777331|540919091|FG000|DBT Period|Death|2|||
149940537|NCT04777331|540919092|FG001|DBT Period|Death|1|||
149940538|NCT04777331|540919093|FG002|DBT Period|Death|0|||
150169907|NCT02341625|541757207|FG007|Overall Study|Participant Withdrew Consent|0|||
149940539|NCT04777331|540919091|FG000|DBT Period|Reason not Specified|1|||
149940540|NCT04777331|540919092|FG001|DBT Period|Reason not Specified|1|||
149940541|NCT04777331|540919093|FG002|DBT Period|Reason not Specified|0|||
149940542|NCT04777331|540919091|FG000|DBT Period|Physician Decision|4|||
149940543|NCT04777331|540919092|FG001|DBT Period|Physician Decision|0|||
149940544|NCT04777331|540919093|FG002|DBT Period|Physician Decision|0|||
149940545|NCT04777331|540919091|FG000|DBT Period|Withdrawal by Subject|12|||
149940546|NCT04777331|540919092|FG001|DBT Period|Withdrawal by Subject|11|||
149940547|NCT04777331|540919093|FG002|DBT Period|Withdrawal by Subject|0|||
149940548|NCT04777331|540919091|FG000|DBT Period|Randomized but not Treated|1|||
149940549|NCT04777331|540919092|FG001|DBT Period|Randomized but not Treated|3|||
149940550|NCT04777331|540919093|FG002|DBT Period|Randomized but not Treated|0|||
149940551|NCT04777331|540919091|FG000|OLE Period|Ongoing in OLE|0|||
149940552|NCT04777331|540919092|FG001|OLE Period|Ongoing in OLE|0|||
149940553|NCT04777331|540919093|FG002|OLE Period|Ongoing in OLE|534|||
149940554|NCT02642042|540919094|FG000|Overall Study|Adverse Event|22|||
149940555|NCT02642042|540919094|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149940556|NCT02642042|540919094|FG000|Overall Study|Progression/Relapse|28|||
149940557|NCT02642042|540919094|FG000|Overall Study|Death|1|||
149940558|NCT02642042|540919094|FG000|Overall Study|Not Protocol Specified|2|||
149940559|NCT04108468|540919095|FG000|Overall Study|Physician Decision|0|||
149940560|NCT04108468|540919096|FG001|Overall Study|Physician Decision|1|||
149940561|NCT04108468|540919095|FG000|Overall Study|Lost to Follow-up|0|||
149940562|NCT04108468|540919096|FG001|Overall Study|Lost to Follow-up|1|||
149940563|NCT04108468|540919095|FG000|Overall Study|Non-compliance|1|||
149940564|NCT04108468|540919096|FG001|Overall Study|Non-compliance|1|||
149940565|NCT04108468|540919095|FG000|Overall Study|Unable to attend final visit|2|||
149940566|NCT04108468|540919096|FG001|Overall Study|Unable to attend final visit|0|||
149940567|NCT04108468|540919095|FG000|Overall Study|Missed study medication|0|||
149940568|NCT04108468|540919096|FG001|Overall Study|Missed study medication|1|||
149940569|NCT03260023|540919097|FG000|Overall Study|Adverse Event|0|||
149940570|NCT03260023|540919098|FG001|Overall Study|Adverse Event|0|||
149940571|NCT03260023|540919099|FG002|Overall Study|Adverse Event|4|||
149940572|NCT03260023|540919100|FG003|Overall Study|Adverse Event|4|||
149940573|NCT03260023|540919101|FG004|Overall Study|Adverse Event|4|||
149940574|NCT03260023|540919102|FG005|Overall Study|Adverse Event|1|||
149940575|NCT03260023|540919103|FG006|Overall Study|Adverse Event|2|||
149940576|NCT03260023|540919097|FG000|Overall Study|Clinical Progression|0|||
149940577|NCT03260023|540919098|FG001|Overall Study|Clinical Progression|1|||
149940578|NCT03260023|540919099|FG002|Overall Study|Clinical Progression|3|||
149940579|NCT03260023|540919100|FG003|Overall Study|Clinical Progression|1|||
149940580|NCT03260023|540919101|FG004|Overall Study|Clinical Progression|0|||
149940581|NCT03260023|540919102|FG005|Overall Study|Clinical Progression|0|||
149940582|NCT03260023|540919103|FG006|Overall Study|Clinical Progression|0|||
149940583|NCT03260023|540919097|FG000|Overall Study|Physician Decision|0|||
149940584|NCT03260023|540919098|FG001|Overall Study|Physician Decision|0|||
149940585|NCT03260023|540919099|FG002|Overall Study|Physician Decision|0|||
149940586|NCT03260023|540919100|FG003|Overall Study|Physician Decision|1|||
149940587|NCT03260023|540919101|FG004|Overall Study|Physician Decision|1|||
149940588|NCT03260023|540919102|FG005|Overall Study|Physician Decision|0|||
149940589|NCT03260023|540919103|FG006|Overall Study|Physician Decision|0|||
149940590|NCT03260023|540919097|FG000|Overall Study|Withdrawal by Subject|0|||
149940591|NCT03260023|540919098|FG001|Overall Study|Withdrawal by Subject|0|||
149940592|NCT03260023|540919099|FG002|Overall Study|Withdrawal by Subject|0|||
149940593|NCT03260023|540919100|FG003|Overall Study|Withdrawal by Subject|0|||
149940594|NCT03260023|540919101|FG004|Overall Study|Withdrawal by Subject|3|||
149940595|NCT03260023|540919102|FG005|Overall Study|Withdrawal by Subject|0|||
149940596|NCT03260023|540919103|FG006|Overall Study|Withdrawal by Subject|0|||
149940597|NCT03260023|540919097|FG000|Overall Study|Under trial intervention|0|||
149940598|NCT03260023|540919098|FG001|Overall Study|Under trial intervention|0|||
149940599|NCT03260023|540919099|FG002|Overall Study|Under trial intervention|2|||
149940600|NCT03260023|540919100|FG003|Overall Study|Under trial intervention|5|||
149940601|NCT03260023|540919101|FG004|Overall Study|Under trial intervention|3|||
149940602|NCT03260023|540919102|FG005|Overall Study|Under trial intervention|0|||
149940603|NCT03260023|540919103|FG006|Overall Study|Under trial intervention|0|||
149940604|NCT05035407|540919104|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
149940605|NCT05035407|540919105|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
149940606|NCT05035407|540919106|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
149940607|NCT05035407|540919107|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
149940608|NCT05035407|540919108|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
149940609|NCT05035407|540919109|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
149940610|NCT04004000|540919112|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
149940611|NCT06121609|540919113|FG000|Overall Study|Lack of Efficacy|0|||
149940612|NCT06121609|540919114|FG001|Overall Study|Lack of Efficacy|0|||
149940613|NCT06121609|540919115|FG002|Overall Study|Lack of Efficacy|45|||
149940614|NCT06494761|540919116|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
149940615|NCT06494761|540919116|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
149940616|NCT04865289|540919118|FG000|Overall Study|Death|34|||
149940617|NCT04865289|540919119|FG001|Overall Study|Death|25|||
149940618|NCT04865289|540919118|FG000|Overall Study|Physician Decision|27|||
149940619|NCT04865289|540919119|FG001|Overall Study|Physician Decision|27|||
149940620|NCT04865289|540919118|FG000|Overall Study|Sponsor Decision|11|||
149940621|NCT04865289|540919119|FG001|Overall Study|Sponsor Decision|1|||
149940622|NCT04865289|540919118|FG000|Overall Study|Withdrawal by Subject|2|||
149940623|NCT04865289|540919119|FG001|Overall Study|Withdrawal by Subject|3|||
149940624|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
149940625|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
149940626|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940627|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940628|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940629|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940630|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940631|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940632|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940633|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149940634|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
149940635|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
149940636|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940637|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940638|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940639|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940640|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940641|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940642|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940643|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149940644|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
149940645|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940646|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940647|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940648|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940649|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940650|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940651|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940652|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940653|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149940654|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
149940655|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
149940656|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940657|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940658|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940659|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940660|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940661|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940662|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940663|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149940664|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
149940665|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
149940666|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940667|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940668|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940669|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940670|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940671|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940672|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940673|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
149940674|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
149940675|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
149940676|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940677|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940678|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940679|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940680|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940681|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940682|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940683|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
149940684|NCT01232283|540919120|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
149940685|NCT01232283|540919121|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
149940686|NCT01232283|540919122|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940687|NCT01232283|540919123|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940688|NCT01232283|540919124|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940689|NCT01232283|540919125|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940690|NCT01232283|540919126|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940691|NCT01232283|540919127|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940692|NCT01232283|540919128|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940693|NCT01232283|540919129|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
149940694|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940695|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940696|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
149940697|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
149940698|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940699|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940700|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940701|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940702|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940703|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
149940704|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940705|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940706|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
149940707|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
149940708|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940709|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940710|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940711|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940712|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940713|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149940714|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940715|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940716|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
149940717|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940718|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940719|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940720|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940721|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940722|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940723|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
149940724|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940725|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940726|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
149940727|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
149940728|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940729|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940730|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940731|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940732|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940733|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
149940734|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940735|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940736|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
149940737|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
149940738|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940739|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940740|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940741|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940742|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940743|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
149940744|NCT01232283|540919120|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
149940745|NCT01232283|540919121|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
149940746|NCT01232283|540919122|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
150274171|NCT02316340|542141529|FG000|First Progression|Clinical progression|2|||
150274172|NCT02316340|542141530|FG001|First Progression|Clinical progression|1|||
149940747|NCT01232283|540919123|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
149940748|NCT01232283|540919124|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
149940749|NCT01232283|540919125|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
149940750|NCT01232283|540919126|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
149940751|NCT01232283|540919127|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
149940752|NCT01232283|540919128|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
149940753|NCT01232283|540919129|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
149940754|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940755|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940756|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940757|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940758|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
149940759|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
149940760|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940761|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
149940762|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940763|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
149940764|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940765|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940766|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940767|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940768|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
149940769|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940770|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
149940771|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
149940772|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940773|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
149940774|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940775|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940776|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940777|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940778|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
149940779|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
149940780|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
149940781|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
149940782|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940783|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
149940784|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940785|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940786|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940787|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940788|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
149940789|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940790|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
150169908|NCT02341625|541757208|FG008|Overall Study|Participant Withdrew Consent|0|||
149940791|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940792|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940793|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
149940794|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940795|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940796|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940797|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940798|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
149940799|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940800|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
149940801|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
149940802|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940803|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
149940804|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940805|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940806|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940807|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940808|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940809|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
150169909|NCT02341625|541757209|FG009|Overall Study|Participant Withdrew Consent|0|||
149940810|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940811|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
149940812|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940813|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
149940814|NCT01232283|540919120|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940815|NCT01232283|540919121|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149821234|NCT02927847|540475656|FG000|Overall Study|PI withdrawn due to missed visits|1|||
149821235|NCT02927847|540475657|FG001|Overall Study|PI withdrawn due to missed visits|1|||
149821236|NCT03255031|540475661|FG000|Overall Study|Adverse Event|5|||
149821237|NCT03255031|540475662|FG001|Overall Study|Adverse Event|3|||
149821238|NCT03255031|540475661|FG000|Overall Study|Physician Decision|2|||
149821239|NCT03255031|540475662|FG001|Overall Study|Physician Decision|1|||
149940816|NCT01232283|540919122|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940817|NCT01232283|540919123|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940818|NCT01232283|540919124|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940819|NCT01232283|540919125|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
149940820|NCT01232283|540919126|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940821|NCT01232283|540919127|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940822|NCT01232283|540919128|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940823|NCT01232283|540919129|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
149940824|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940825|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940826|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940827|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940828|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940829|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940830|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940831|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
149940832|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
149940833|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
149940834|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940835|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940836|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940837|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940838|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940839|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940840|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940841|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149940842|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
149940843|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
149940844|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940845|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940846|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940847|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940848|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940849|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940850|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940851|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149940852|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
149940853|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
149940854|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940855|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940856|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940857|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940858|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940859|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940860|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940861|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
149940862|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
149940863|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
149940864|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940865|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940866|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940867|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
150031145|NCT01791244|541252563|FG000|Overall Study|Insufficient clinical response|10|||
150031146|NCT01791244|541252564|FG001|Overall Study|Insufficient clinical response|10|||
150031147|NCT01791244|541252563|FG000|Overall Study|Laboratory Abnormality|0|||
150031148|NCT01791244|541252564|FG001|Overall Study|Laboratory Abnormality|1|||
150031149|NCT05468814|541252569|FG000|Overall Study|Lost to Follow-up|5|||
150031150|NCT05468814|541252570|FG001|Overall Study|Lost to Follow-up|6|||
150031151|NCT04716426|541252574|FG000|Overall Study|Vaccination|1|||
150031152|NCT04716426|541252575|FG001|Overall Study|Vaccination|1|||
150031153|NCT04716426|541252574|FG000|Overall Study|Contamination|1|||
150031154|NCT04716426|541252575|FG001|Overall Study|Contamination|0|||
150031155|NCT01046565|541252578|FG000|Overall Study|Adverse Event|2|||
150031156|NCT01046565|541252578|FG000|Overall Study|Withdrawal by Subject|7|||
150031157|NCT01650558|541252579|FG000|Overall Study|Migration out of study area|61|||
150031158|NCT01650558|541252580|FG001|Overall Study|Migration out of study area|71|||
150031159|NCT01650558|541252581|FG002|Overall Study|Migration out of study area|56|||
150031160|NCT01650558|541252579|FG000|Overall Study|Lost to Follow-up|10|||
150031161|NCT01650558|541252580|FG001|Overall Study|Lost to Follow-up|13|||
150031162|NCT01650558|541252581|FG002|Overall Study|Lost to Follow-up|6|||
150031163|NCT01650558|541252579|FG000|Overall Study|Death|10|||
150031164|NCT01650558|541252580|FG001|Overall Study|Death|6|||
150031165|NCT01650558|541252581|FG002|Overall Study|Death|8|||
150031166|NCT01650558|541252579|FG000|Overall Study|Withdrawal by Subject|1|||
150031167|NCT01650558|541252580|FG001|Overall Study|Withdrawal by Subject|1|||
150031168|NCT01650558|541252581|FG002|Overall Study|Withdrawal by Subject|3|||
150031169|NCT01650558|541252579|FG000|Overall Study|Non-compliant participant|1|||
150031170|NCT01650558|541252580|FG001|Overall Study|Non-compliant participant|0|||
150031171|NCT01650558|541252581|FG002|Overall Study|Non-compliant participant|2|||
150031172|NCT01650558|541252579|FG000|Overall Study|Physician Decision|0|||
150031173|NCT01650558|541252580|FG001|Overall Study|Physician Decision|1|||
150031174|NCT01650558|541252581|FG002|Overall Study|Physician Decision|0|||
150031175|NCT02960217|541252582|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
150031176|NCT02960217|541252583|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
150031177|NCT02960217|541252582|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
150031178|NCT02960217|541252583|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
150031179|NCT02960217|541252582|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
150031180|NCT02960217|541252583|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
150031181|NCT02960217|541252582|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
150031182|NCT02960217|541252583|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
150031183|NCT02960217|541252582|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
150031184|NCT02960217|541252583|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
150031185|NCT02960217|541252582|FG000|Open-Label Extension Phase|Adverse Event|1|||
150031186|NCT02960217|541252583|FG001|Open-Label Extension Phase|Adverse Event|0|||
150031187|NCT02960217|541252582|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
150031188|NCT02960217|541252583|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
150031189|NCT02960217|541252582|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
150031190|NCT02960217|541252583|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
150031191|NCT02960217|541252582|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
150031192|NCT02960217|541252583|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
150031193|NCT01069484|541252584|FG000|Overall Study|Death-in-near-family|1|||
150031194|NCT01069484|541252585|FG001|Overall Study|Death-in-near-family|0|||
150031195|NCT01069484|541252584|FG000|Overall Study|No specific reason|8|||
150031196|NCT01069484|541252585|FG001|Overall Study|No specific reason|2|||
150031197|NCT01069484|541252584|FG000|Overall Study|Illness mother or child|3|||
150031198|NCT01069484|541252585|FG001|Overall Study|Illness mother or child|1|||
150031199|NCT02978417|541252588|FG000|Overall Study|Lost to Follow-up|2|||
150031200|NCT02978417|541252589|FG001|Overall Study|Lost to Follow-up|2|||
150031201|NCT05083351|541252590|FG000|Overall Study|Adverse Event|3|||
150169910|NCT02341625|541757200|FG000|Overall Study|Completed Treatment as per Protocol|0|||
150031202|NCT05083351|541252590|FG000|Overall Study|Did not meet data inclusion criteria|8|||
150031203|NCT05083351|541252590|FG000|Overall Study|Did not meet eligibility criteria|19|||
150031204|NCT05083351|541252590|FG000|Overall Study|Study Staff Decision|19|||
150031205|NCT00083889|541252595|FG000|Overall Study|Adverse Event|76|||
150031206|NCT00083889|541252596|FG001|Overall Study|Adverse Event|86|||
150031207|NCT00083889|541252595|FG000|Overall Study|Protocol Violation|2|||
150031208|NCT00083889|541252596|FG001|Overall Study|Protocol Violation|2|||
150031209|NCT00083889|541252595|FG000|Overall Study|Withdrawal by Subject|22|||
150031210|NCT00083889|541252596|FG001|Overall Study|Withdrawal by Subject|24|||
150031211|NCT00083889|541252595|FG000|Overall Study|Lack of Efficacy|240|||
150031212|NCT00083889|541252596|FG001|Overall Study|Lack of Efficacy|219|||
150031213|NCT00083889|541252595|FG000|Overall Study|Decision of sponsor|32|||
150031214|NCT00083889|541252596|FG001|Overall Study|Decision of sponsor|4|||
150031215|NCT00083889|541252595|FG000|Overall Study|Randomized: did not take study drug|0|||
150031216|NCT00083889|541252596|FG001|Overall Study|Randomized: did not take study drug|15|||
150031217|NCT00083889|541252595|FG000|Overall Study|Completed on marketed sunitinub|3|||
150169911|NCT02341625|541757201|FG001|Overall Study|Completed Treatment as per Protocol|0|||
150031218|NCT00083889|541252596|FG001|Overall Study|Completed on marketed sunitinub|0|||
150031219|NCT00083889|541252595|FG000|Overall Study|Crossover to SU011248|0|||
150031220|NCT00083889|541252596|FG001|Overall Study|Crossover to SU011248|25|||
150031221|NCT00960375|541252597|FG000|Overall Study|Lost to Follow-up|20|||
150031222|NCT00960375|541252598|FG001|Overall Study|Lost to Follow-up|22|||
150031223|NCT03019406|541252599|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
150031224|NCT03019406|541252600|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
150031225|NCT03019406|541252601|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
150031226|NCT03019406|541252602|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
150031227|NCT03668873|541252603|FG000|Overall Study|Lost to Follow-up|6|||
150031228|NCT03668873|541252604|FG001|Overall Study|Lost to Follow-up|3|||
150031229|NCT03473236|541252607|FG000|Overall Study|Withdrawal by Subject|0|||
150031230|NCT03473236|541252608|FG001|Overall Study|Withdrawal by Subject|0|||
150031231|NCT03473236|541252609|FG002|Overall Study|Withdrawal by Subject|0|||
150031232|NCT03473236|541252610|FG003|Overall Study|Withdrawal by Subject|0|||
150031233|NCT03473236|541252611|FG004|Overall Study|Withdrawal by Subject|0|||
150031234|NCT03473236|541252612|FG005|Overall Study|Withdrawal by Subject|1|||
150031235|NCT03473236|541252613|FG006|Overall Study|Withdrawal by Subject|0|||
150031236|NCT03473236|541252614|FG007|Overall Study|Withdrawal by Subject|0|||
150031237|NCT03473236|541252615|FG008|Overall Study|Withdrawal by Subject|1|||
149940868|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940869|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940870|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940871|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
149940872|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
149940873|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
149940874|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940875|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940876|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940877|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940878|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940879|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940880|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940881|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940882|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
149940883|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
149940884|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940885|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940886|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940887|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940888|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940889|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940890|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940891|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940892|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
149940893|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
149940894|NCT01232283|540919120|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940895|NCT01232283|540919121|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940896|NCT01232283|540919122|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940897|NCT01232283|540919123|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940898|NCT01232283|540919124|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940899|NCT01232283|540919125|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940900|NCT01232283|540919126|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940901|NCT01232283|540919127|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
149940902|NCT01232283|540919128|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
149940903|NCT01232283|540919129|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
149940904|NCT04589650|540919130|FG000|Overall Study|Subject decision|6|||
149940905|NCT04589650|540919131|FG001|Overall Study|Subject decision|2|||
149940906|NCT04589650|540919132|FG002|Overall Study|Subject decision|2|||
149940907|NCT04589650|540919133|FG003|Overall Study|Subject decision|0|||
149940908|NCT04589650|540919134|FG004|Overall Study|Subject decision|0|||
149940909|NCT04589650|540919135|FG005|Overall Study|Subject decision|0|||
149940910|NCT04589650|540919130|FG000|Overall Study|Adverse Event|3|||
149940911|NCT04589650|540919131|FG001|Overall Study|Adverse Event|1|||
149940912|NCT04589650|540919132|FG002|Overall Study|Adverse Event|1|||
149940913|NCT04589650|540919133|FG003|Overall Study|Adverse Event|1|||
149940914|NCT04589650|540919134|FG004|Overall Study|Adverse Event|0|||
149940915|NCT04589650|540919135|FG005|Overall Study|Adverse Event|1|||
150169912|NCT02341625|541757202|FG002|Overall Study|Completed Treatment as per Protocol|0|||
150169913|NCT02341625|541757203|FG003|Overall Study|Completed Treatment as per Protocol|0|||
150169914|NCT02341625|541757204|FG004|Overall Study|Completed Treatment as per Protocol|0|||
149940916|NCT04589650|540919130|FG000|Overall Study|Physician Decision|1|||
149940917|NCT04589650|540919131|FG001|Overall Study|Physician Decision|1|||
149940918|NCT04589650|540919132|FG002|Overall Study|Physician Decision|0|||
149940919|NCT04589650|540919133|FG003|Overall Study|Physician Decision|0|||
149940920|NCT04589650|540919134|FG004|Overall Study|Physician Decision|0|||
149940921|NCT04589650|540919135|FG005|Overall Study|Physician Decision|0|||
149940922|NCT04589650|540919130|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149940923|NCT04589650|540919131|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149940924|NCT04589650|540919132|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149940925|NCT04589650|540919133|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149940926|NCT04589650|540919134|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
150031238|NCT03473236|541252616|FG009|Overall Study|Withdrawal by Subject|0|||
150031239|NCT03155724|541252621|FG000|Overall Study|Death|3|||
150031240|NCT03155724|541252621|FG000|Overall Study|Physician Decision|1|||
150031241|NCT03155724|541252621|FG000|Overall Study|Study closure|7|||
150031242|NCT00525512|541252622|FG000|Double-Blind Phase|Adverse Event|48|||
150031243|NCT00525512|541252623|FG001|Double-Blind Phase|Adverse Event|28|||
150031244|NCT00525512|541252624|FG002|Double-Blind Phase|Adverse Event|0|||
150031245|NCT00525512|541252625|FG003|Double-Blind Phase|Adverse Event|0|||
150031246|NCT00525512|541252622|FG000|Double-Blind Phase|Protocol Violation|3|||
150031247|NCT00525512|541252623|FG001|Double-Blind Phase|Protocol Violation|1|||
150031248|NCT00525512|541252624|FG002|Double-Blind Phase|Protocol Violation|0|||
150031249|NCT00525512|541252625|FG003|Double-Blind Phase|Protocol Violation|0|||
150031250|NCT00525512|541252622|FG000|Double-Blind Phase|Lost to Follow-up|3|||
150031251|NCT00525512|541252623|FG001|Double-Blind Phase|Lost to Follow-up|7|||
150031252|NCT00525512|541252624|FG002|Double-Blind Phase|Lost to Follow-up|0|||
150031253|NCT00525512|541252625|FG003|Double-Blind Phase|Lost to Follow-up|0|||
150031254|NCT00525512|541252622|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
150031255|NCT00525512|541252623|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
150031256|NCT00525512|541252624|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
150031257|NCT00525512|541252625|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
150031258|NCT00525512|541252622|FG000|Double-Blind Phase|Lack of Efficacy|13|||
150031259|NCT00525512|541252623|FG001|Double-Blind Phase|Lack of Efficacy|5|||
150031260|NCT00525512|541252624|FG002|Double-Blind Phase|Lack of Efficacy|0|||
150031261|NCT00525512|541252625|FG003|Double-Blind Phase|Lack of Efficacy|0|||
150031262|NCT00525512|541252622|FG000|Double-Blind Phase|Other reason (not specified)|12|||
150031263|NCT00525512|541252623|FG001|Double-Blind Phase|Other reason (not specified)|13|||
150031264|NCT00525512|541252624|FG002|Double-Blind Phase|Other reason (not specified)|0|||
150031265|NCT00525512|541252625|FG003|Double-Blind Phase|Other reason (not specified)|0|||
150031266|NCT00525512|541252622|FG000|Open-Label Phase|Adverse Event|0|||
150031267|NCT00525512|541252623|FG001|Open-Label Phase|Adverse Event|0|||
150031268|NCT00525512|541252624|FG002|Open-Label Phase|Adverse Event|1|||
150031269|NCT00525512|541252625|FG003|Open-Label Phase|Adverse Event|0|||
150031270|NCT00525512|541252622|FG000|Open-Label Phase|Lost to Follow-up|0|||
150031271|NCT00525512|541252623|FG001|Open-Label Phase|Lost to Follow-up|0|||
150274173|NCT02316340|542141529|FG000|First Progression|Withdrawal by Subject|1|||
150274174|NCT02316340|542141530|FG001|First Progression|Withdrawal by Subject|0|||
149940927|NCT04589650|540919135|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
149940928|NCT04589650|540919130|FG000|Overall Study|Death|0|||
149940929|NCT04589650|540919131|FG001|Overall Study|Death|0|||
149940930|NCT04589650|540919132|FG002|Overall Study|Death|0|||
149940931|NCT04589650|540919133|FG003|Overall Study|Death|1|||
149940932|NCT04589650|540919134|FG004|Overall Study|Death|0|||
149940933|NCT04589650|540919135|FG005|Overall Study|Death|0|||
149940934|NCT04589650|540919130|FG000|Overall Study|Guardian Decision|0|||
149940935|NCT04589650|540919131|FG001|Overall Study|Guardian Decision|0|||
149940936|NCT04589650|540919132|FG002|Overall Study|Guardian Decision|0|||
149940937|NCT04589650|540919133|FG003|Overall Study|Guardian Decision|1|||
149940938|NCT04589650|540919134|FG004|Overall Study|Guardian Decision|0|||
149940939|NCT04589650|540919135|FG005|Overall Study|Guardian Decision|0|||
149940940|NCT01652690|540919136|FG000|Overall Study|Withdrawal by Subject|16|||
149940941|NCT01652690|540919137|FG001|Overall Study|Withdrawal by Subject|4|||
149940942|NCT01652690|540919136|FG000|Overall Study|Other|8|||
149940943|NCT01652690|540919137|FG001|Overall Study|Other|9|||
150031272|NCT00525512|541252624|FG002|Open-Label Phase|Lost to Follow-up|1|||
150031273|NCT00525512|541252625|FG003|Open-Label Phase|Lost to Follow-up|0|||
150031274|NCT00525512|541252622|FG000|Open-Label Phase|Other reason (not specified)|0|||
150031275|NCT00525512|541252623|FG001|Open-Label Phase|Other reason (not specified)|0|||
150031276|NCT00525512|541252624|FG002|Open-Label Phase|Other reason (not specified)|4|||
150031277|NCT00525512|541252625|FG003|Open-Label Phase|Other reason (not specified)|5|||
150031278|NCT04258423|541252626|FG000|Overall Study|Study Closure|2|||
149940944|NCT01652690|540919136|FG000|Overall Study|Lost to Follow-up|6|||
149940945|NCT01652690|540919137|FG001|Overall Study|Lost to Follow-up|6|||
149940946|NCT01652690|540919136|FG000|Overall Study|Death|5|||
149940947|NCT01652690|540919137|FG001|Overall Study|Death|2|||
149940948|NCT01884597|540919138|FG000|Overall Study|Adverse Event|0|||
149940949|NCT01884597|540919139|FG001|Overall Study|Adverse Event|0|||
150031279|NCT04258423|541252627|FG001|Overall Study|Study Closure|2|||
149940950|NCT01884597|540919140|FG002|Overall Study|Adverse Event|1|||
149940951|NCT01884597|540919138|FG000|Overall Study|Lack of Efficacy|1|||
149940952|NCT01884597|540919139|FG001|Overall Study|Lack of Efficacy|0|||
149940953|NCT01884597|540919140|FG002|Overall Study|Lack of Efficacy|0|||
149940954|NCT01884597|540919138|FG000|Overall Study|Death|0|||
149940955|NCT01884597|540919139|FG001|Overall Study|Death|1|||
149940956|NCT01884597|540919140|FG002|Overall Study|Death|0|||
149940957|NCT02097823|540919141|FG000|Overall Study|Withdrawal by Subject|1|||
149940958|NCT02097823|540919142|FG001|Overall Study|Withdrawal by Subject|1|||
149940959|NCT01081626|540919143|FG000|Overall Study|Dosing error|1|||
149940960|NCT01081626|540919144|FG001|Overall Study|Dosing error|1|||
149940961|NCT01081626|540919143|FG000|Overall Study|Missing Estradiol|25|||
149940962|NCT01081626|540919144|FG001|Overall Study|Missing Estradiol|28|||
149940963|NCT01081626|540919143|FG000|Overall Study|Low antral follicle count|1|||
149940964|NCT01081626|540919144|FG001|Overall Study|Low antral follicle count|0|||
149940965|NCT01081626|540919143|FG000|Overall Study|Overstimulation|0|||
149940966|NCT01081626|540919144|FG001|Overall Study|Overstimulation|1|||
149940967|NCT01081626|540919143|FG000|Overall Study|Lost to Follow-up|0|||
149940968|NCT01081626|540919144|FG001|Overall Study|Lost to Follow-up|1|||
149940969|NCT01081626|540919143|FG000|Overall Study|Other|33|||
149940970|NCT01081626|540919144|FG001|Overall Study|Other|30|||
149940971|NCT04530630|540920303|FG000|Overall Study|Physician Decision|1|||
149940972|NCT03675308|540920304|FG000|Overall Study|Adverse Event|3|||
149940973|NCT03675308|540920305|FG001|Overall Study|Adverse Event|2|||
149940974|NCT03675308|540920304|FG000|Overall Study|Withdrawal by Subject|6|||
149940975|NCT03675308|540920305|FG001|Overall Study|Withdrawal by Subject|4|||
149940976|NCT03675308|540920304|FG000|Overall Study|Lost to Follow-up|3|||
149940977|NCT03675308|540920305|FG001|Overall Study|Lost to Follow-up|0|||
149940978|NCT03675308|540920304|FG000|Overall Study|Lack of Efficacy|1|||
149940979|NCT03675308|540920305|FG001|Overall Study|Lack of Efficacy|1|||
149940980|NCT03675308|540920304|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
149940981|NCT03675308|540920305|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
149940982|NCT03675308|540920304|FG000|Overall Study|Other|0|||
149940983|NCT03675308|540920305|FG001|Overall Study|Other|1|||
149940984|NCT06125964|540920307|FG000|Overall Study|Lost to Follow-up|0|||
149940985|NCT06125964|540920308|FG001|Overall Study|Lost to Follow-up|1|||
149940986|NCT06125964|540920309|FG002|Overall Study|Lost to Follow-up|0|||
149940987|NCT06125964|540920310|FG003|Overall Study|Lost to Follow-up|0|||
149940988|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
149940989|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
149940990|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
149940991|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Death|1|||
149940992|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Death|1|||
149940993|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Death|0|||
149940994|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
149940995|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
149940996|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
149940997|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
149940998|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
149940999|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
149941000|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
149941001|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
149941002|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
149941003|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
149941004|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
149941005|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
149941006|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
149941007|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
149941008|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
149941009|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
149941010|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
149941011|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
149941012|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
149941013|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
149941014|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
149941015|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
149941016|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
149941017|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
149941018|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Other|10|||
149941019|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Other|4|||
149941020|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Other|0|||
149941021|NCT04006457|540920311|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
149975588|NCT00570713|541047895|FG001|Overall Study|Death|7|||
150031280|NCT01601535|541252630|FG000|Phase 1|Adverse Event|1|||
150031281|NCT01601535|541252631|FG001|Phase 1|Adverse Event|0|||
150031282|NCT01601535|541252632|FG002|Phase 1|Adverse Event|2|||
150031283|NCT01601535|541252633|FG003|Phase 1|Adverse Event|1|||
150031284|NCT01601535|541252634|FG004|Phase 1|Adverse Event|0|||
150031285|NCT01601535|541252635|FG005|Phase 1|Adverse Event|0|||
150031286|NCT01601535|541252630|FG000|Phase 1|Withdrawal by Subject|2|||
150031287|NCT01601535|541252631|FG001|Phase 1|Withdrawal by Subject|1|||
150031288|NCT01601535|541252632|FG002|Phase 1|Withdrawal by Subject|1|||
150031289|NCT01601535|541252633|FG003|Phase 1|Withdrawal by Subject|2|||
150031290|NCT01601535|541252634|FG004|Phase 1|Withdrawal by Subject|0|||
150031291|NCT01601535|541252635|FG005|Phase 1|Withdrawal by Subject|0|||
150031292|NCT01601535|541252630|FG000|Phase 1|Progressive Disease|2|||
150031293|NCT01601535|541252631|FG001|Phase 1|Progressive Disease|3|||
150031294|NCT01601535|541252632|FG002|Phase 1|Progressive Disease|2|||
150031295|NCT01601535|541252633|FG003|Phase 1|Progressive Disease|1|||
150031296|NCT01601535|541252634|FG004|Phase 1|Progressive Disease|0|||
150031297|NCT01601535|541252635|FG005|Phase 1|Progressive Disease|0|||
150031298|NCT01601535|541252630|FG000|Phase 1|Started Another Treatment|1|||
150031299|NCT01601535|541252631|FG001|Phase 1|Started Another Treatment|2|||
150031300|NCT01601535|541252632|FG002|Phase 1|Started Another Treatment|0|||
150031301|NCT01601535|541252633|FG003|Phase 1|Started Another Treatment|0|||
150031302|NCT01601535|541252634|FG004|Phase 1|Started Another Treatment|0|||
150031303|NCT01601535|541252635|FG005|Phase 1|Started Another Treatment|0|||
150031304|NCT01601535|541252630|FG000|Phase 2|Adverse Event|0|||
150031305|NCT01601535|541252631|FG001|Phase 2|Adverse Event|0|||
150031306|NCT01601535|541252632|FG002|Phase 2|Adverse Event|0|||
150031307|NCT01601535|541252633|FG003|Phase 2|Adverse Event|0|||
150031308|NCT01601535|541252634|FG004|Phase 2|Adverse Event|5|||
150031309|NCT01601535|541252635|FG005|Phase 2|Adverse Event|1|||
150031310|NCT01601535|541252630|FG000|Phase 2|Withdrawal by Subject|0|||
150031311|NCT01601535|541252631|FG001|Phase 2|Withdrawal by Subject|0|||
150031312|NCT01601535|541252632|FG002|Phase 2|Withdrawal by Subject|0|||
150031313|NCT01601535|541252633|FG003|Phase 2|Withdrawal by Subject|0|||
150031314|NCT01601535|541252634|FG004|Phase 2|Withdrawal by Subject|8|||
150031315|NCT01601535|541252635|FG005|Phase 2|Withdrawal by Subject|2|||
150031316|NCT01601535|541252630|FG000|Phase 2|Progressive Disease|0|||
150031317|NCT01601535|541252631|FG001|Phase 2|Progressive Disease|0|||
150031318|NCT01601535|541252632|FG002|Phase 2|Progressive Disease|0|||
150031319|NCT01601535|541252633|FG003|Phase 2|Progressive Disease|0|||
150031320|NCT01601535|541252634|FG004|Phase 2|Progressive Disease|5|||
150031321|NCT01601535|541252635|FG005|Phase 2|Progressive Disease|7|||
150031322|NCT01601535|541252630|FG000|Phase 2|Started Another Treatment|0|||
150031323|NCT01601535|541252631|FG001|Phase 2|Started Another Treatment|0|||
150031324|NCT01601535|541252632|FG002|Phase 2|Started Another Treatment|0|||
150031325|NCT01601535|541252633|FG003|Phase 2|Started Another Treatment|0|||
150031326|NCT01601535|541252634|FG004|Phase 2|Started Another Treatment|1|||
150031327|NCT01601535|541252635|FG005|Phase 2|Started Another Treatment|2|||
150031328|NCT03309020|541252636|FG000|Overall Study|Death|1|||
150031329|NCT03309020|541252637|FG001|Overall Study|Death|0|||
150031330|NCT03309020|541252636|FG000|Overall Study|Did not undergo surgery|2|||
150031331|NCT03309020|541252637|FG001|Overall Study|Did not undergo surgery|1|||
150031332|NCT00601835|541252638|FG000|Overall Study|Withdrawal by Subject|9|||
150031333|NCT00601835|541252639|FG001|Overall Study|Withdrawal by Subject|6|||
150031334|NCT00601835|541252638|FG000|Overall Study|Physician Decision|1|||
150031335|NCT00601835|541252639|FG001|Overall Study|Physician Decision|0|||
150031336|NCT00601835|541252638|FG000|Overall Study|Lost to Follow-up|37|||
150031337|NCT00601835|541252639|FG001|Overall Study|Lost to Follow-up|5|||
150031338|NCT00601835|541252638|FG000|Overall Study|Adverse Event|1|||
150031339|NCT00601835|541252639|FG001|Overall Study|Adverse Event|1|||
150031340|NCT00601835|541252638|FG000|Overall Study|Relocate|12|||
150031341|NCT00601835|541252639|FG001|Overall Study|Relocate|2|||
150031342|NCT00880620|541252640|FG000|Overall Study|Adverse Event|4|||
150031343|NCT00880620|541252641|FG001|Overall Study|Adverse Event|5|||
150031344|NCT00880620|541252642|FG002|Overall Study|Adverse Event|15|||
150031345|NCT00880620|541252643|FG003|Overall Study|Adverse Event|15|||
150031346|NCT00880620|541252640|FG000|Overall Study|Death|0|||
150031347|NCT00880620|541252641|FG001|Overall Study|Death|0|||
150031348|NCT00880620|541252642|FG002|Overall Study|Death|1|||
150031349|NCT00880620|541252643|FG003|Overall Study|Death|0|||
150031350|NCT00880620|541252640|FG000|Overall Study|Lack of Efficacy|12|||
150031351|NCT00880620|541252641|FG001|Overall Study|Lack of Efficacy|4|||
150031352|NCT00880620|541252642|FG002|Overall Study|Lack of Efficacy|0|||
150031353|NCT00880620|541252643|FG003|Overall Study|Lack of Efficacy|1|||
150031354|NCT00880620|541252640|FG000|Overall Study|Lost to Follow-up|0|||
150031355|NCT00880620|541252641|FG001|Overall Study|Lost to Follow-up|1|||
150031356|NCT00880620|541252642|FG002|Overall Study|Lost to Follow-up|1|||
150031357|NCT00880620|541252643|FG003|Overall Study|Lost to Follow-up|0|||
150031358|NCT00880620|541252640|FG000|Overall Study|Protocol Violation|0|||
150031359|NCT00880620|541252641|FG001|Overall Study|Protocol Violation|1|||
150031360|NCT00880620|541252642|FG002|Overall Study|Protocol Violation|0|||
150031361|NCT00880620|541252643|FG003|Overall Study|Protocol Violation|2|||
150031362|NCT00880620|541252640|FG000|Overall Study|Withdrawal by Subject|4|||
150031363|NCT00880620|541252641|FG001|Overall Study|Withdrawal by Subject|3|||
150031364|NCT00880620|541252642|FG002|Overall Study|Withdrawal by Subject|1|||
150031365|NCT00880620|541252643|FG003|Overall Study|Withdrawal by Subject|3|||
150031366|NCT00880620|541252640|FG000|Overall Study|Noncompliance|0|||
150031367|NCT00880620|541252641|FG001|Overall Study|Noncompliance|0|||
150031368|NCT00880620|541252642|FG002|Overall Study|Noncompliance|1|||
150031369|NCT00880620|541252643|FG003|Overall Study|Noncompliance|1|||
150031370|NCT00880620|541252640|FG000|Overall Study|Other|1|||
150031371|NCT00880620|541252641|FG001|Overall Study|Other|1|||
150031372|NCT00880620|541252642|FG002|Overall Study|Other|2|||
150031373|NCT00880620|541252643|FG003|Overall Study|Other|2|||
149941022|NCT04006457|540920312|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
149941023|NCT04006457|540920313|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
149941024|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
149941025|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
149941026|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
149941027|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
149941028|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
149941029|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
149941030|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
149941031|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
149941032|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
149941033|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
149941034|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
149941035|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
149941036|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
149941037|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
149941038|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
149941039|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Other|2|||
149941040|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Other|3|||
149941041|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Other|0|||
149941042|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
149941043|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
149941044|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
149941045|NCT04006457|540920311|FG000|Main Study: Treatment Period 2|Ongoing|86|||
149941046|NCT04006457|540920312|FG001|Main Study: Treatment Period 2|Ongoing|96|||
149941047|NCT04006457|540920313|FG002|Main Study: Treatment Period 2|Ongoing|0|||
149941048|NCT04006457|540920311|FG000|Main Study Observation Period|Adverse Event|1|||
149941049|NCT04006457|540920312|FG001|Main Study Observation Period|Adverse Event|1|||
149941050|NCT04006457|540920313|FG002|Main Study Observation Period|Adverse Event|0|||
149941051|NCT04006457|540920311|FG000|Main Study Observation Period|Lost to Follow-up|0|||
149941052|NCT04006457|540920312|FG001|Main Study Observation Period|Lost to Follow-up|1|||
149941053|NCT04006457|540920313|FG002|Main Study Observation Period|Lost to Follow-up|0|||
149941054|NCT04006457|540920311|FG000|Main Study Observation Period|Pregnancy|1|||
149941055|NCT04006457|540920312|FG001|Main Study Observation Period|Pregnancy|0|||
149941056|NCT04006457|540920313|FG002|Main Study Observation Period|Pregnancy|0|||
149941057|NCT04006457|540920311|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
149941058|NCT04006457|540920312|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
149941059|NCT04006457|540920313|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
149941060|NCT04006457|540920311|FG000|Main Study Observation Period|Other|8|||
149941061|NCT04006457|540920312|FG001|Main Study Observation Period|Other|16|||
149941062|NCT04006457|540920313|FG002|Main Study Observation Period|Other|0|||
149941063|NCT04006457|540920311|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
149941064|NCT04006457|540920312|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
149941065|NCT04006457|540920313|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
149941066|NCT04006457|540920311|FG000|Main Study Observation Period|Ongoing|2|||
149941067|NCT04006457|540920312|FG001|Main Study Observation Period|Ongoing|1|||
149941068|NCT04006457|540920313|FG002|Main Study Observation Period|Ongoing|0|||
149941069|NCT04006457|540920311|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
149941070|NCT04006457|540920312|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
149941071|NCT04006457|540920313|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
149941072|NCT03729362|540920314|FG000|Overall Study|Withdrawal by Subject|2|||
149941073|NCT03729362|540920315|FG001|Overall Study|Withdrawal by Subject|0|||
149941074|NCT03729362|540920314|FG000|Overall Study|Physician Decision|1|||
149941075|NCT03729362|540920315|FG001|Overall Study|Physician Decision|0|||
150031374|NCT05893862|541252646|FG000|Overall Study|Physician Decision|0|||
150031375|NCT05893862|541252647|FG001|Overall Study|Physician Decision|1|||
150031376|NCT05893862|541252648|FG002|Overall Study|Physician Decision|0|||
150031377|NCT05893862|541252649|FG003|Overall Study|Physician Decision|0|||
150031378|NCT05893862|541252650|FG004|Overall Study|Physician Decision|1|||
150031379|NCT05893862|541252651|FG005|Overall Study|Physician Decision|0|||
150031380|NCT05893862|541252646|FG000|Overall Study|Withdrawal by Subject|1|||
150031381|NCT05893862|541252647|FG001|Overall Study|Withdrawal by Subject|7|||
150031382|NCT05893862|541252648|FG002|Overall Study|Withdrawal by Subject|1|||
150031383|NCT05893862|541252649|FG003|Overall Study|Withdrawal by Subject|3|||
150031384|NCT05893862|541252650|FG004|Overall Study|Withdrawal by Subject|3|||
150031385|NCT05893862|541252651|FG005|Overall Study|Withdrawal by Subject|2|||
150031386|NCT05893862|541252646|FG000|Overall Study|Adverse Event|1|||
150031387|NCT05893862|541252647|FG001|Overall Study|Adverse Event|4|||
150031388|NCT05893862|541252648|FG002|Overall Study|Adverse Event|2|||
150031389|NCT05893862|541252649|FG003|Overall Study|Adverse Event|2|||
150031390|NCT05893862|541252650|FG004|Overall Study|Adverse Event|1|||
150031391|NCT05893862|541252651|FG005|Overall Study|Adverse Event|0|||
150031392|NCT01400698|541252652|FG000|Overall Study|Lost to Follow-up|2|||
150031393|NCT01400698|541252653|FG001|Overall Study|Lost to Follow-up|5|||
150031394|NCT01400698|541252654|FG002|Overall Study|Lost to Follow-up|2|||
150031395|NCT01400698|541252655|FG003|Overall Study|Lost to Follow-up|1|||
150031396|NCT01400698|541252656|FG004|Overall Study|Lost to Follow-up|4|||
150031397|NCT01400698|541252657|FG005|Overall Study|Lost to Follow-up|3|||
150031398|NCT01400698|541252652|FG000|Overall Study|Withdrawal by Subject|8|||
150031399|NCT01400698|541252653|FG001|Overall Study|Withdrawal by Subject|2|||
150031400|NCT01400698|541252654|FG002|Overall Study|Withdrawal by Subject|0|||
150031401|NCT01400698|541252655|FG003|Overall Study|Withdrawal by Subject|4|||
150031402|NCT01400698|541252656|FG004|Overall Study|Withdrawal by Subject|1|||
150031403|NCT01400698|541252657|FG005|Overall Study|Withdrawal by Subject|3|||
150031404|NCT01400698|541252652|FG000|Overall Study|Protocol Violation|0|||
150031405|NCT01400698|541252653|FG001|Overall Study|Protocol Violation|1|||
150031406|NCT01400698|541252654|FG002|Overall Study|Protocol Violation|0|||
150031407|NCT01400698|541252655|FG003|Overall Study|Protocol Violation|0|||
150031408|NCT01400698|541252656|FG004|Overall Study|Protocol Violation|1|||
150031409|NCT01400698|541252657|FG005|Overall Study|Protocol Violation|0|||
150031410|NCT01400698|541252652|FG000|Overall Study|Non-compliance|0|||
150031411|NCT01400698|541252653|FG001|Overall Study|Non-compliance|1|||
150031412|NCT01400698|541252654|FG002|Overall Study|Non-compliance|0|||
150031413|NCT01400698|541252655|FG003|Overall Study|Non-compliance|1|||
150031414|NCT01400698|541252656|FG004|Overall Study|Non-compliance|0|||
150031415|NCT01400698|541252657|FG005|Overall Study|Non-compliance|0|||
150031416|NCT01400698|541252652|FG000|Overall Study|Adverse Event|1|||
150031417|NCT01400698|541252653|FG001|Overall Study|Adverse Event|0|||
150031418|NCT01400698|541252654|FG002|Overall Study|Adverse Event|0|||
150031419|NCT01400698|541252655|FG003|Overall Study|Adverse Event|0|||
150031420|NCT01400698|541252656|FG004|Overall Study|Adverse Event|0|||
150031421|NCT01400698|541252657|FG005|Overall Study|Adverse Event|0|||
150031422|NCT01400698|541252652|FG000|Overall Study|Other|4|||
150031423|NCT01400698|541252653|FG001|Overall Study|Other|2|||
150031424|NCT01400698|541252654|FG002|Overall Study|Other|0|||
150031425|NCT01400698|541252655|FG003|Overall Study|Other|2|||
150031426|NCT01400698|541252656|FG004|Overall Study|Other|1|||
150031427|NCT01400698|541252657|FG005|Overall Study|Other|0|||
150031428|NCT02919761|541252658|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
150031429|NCT02919761|541252659|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
150031430|NCT02919761|541252660|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
150031431|NCT02919761|541252658|FG000|Part 1: Open Label|Adverse Event|1|||
150031432|NCT02919761|541252659|FG001|Part 1: Open Label|Adverse Event|0|||
150031433|NCT02919761|541252660|FG002|Part 1: Open Label|Adverse Event|0|||
150031434|NCT02919761|541252658|FG000|Part 1: Open Label|Lost to Follow-up|1|||
150031435|NCT02919761|541252659|FG001|Part 1: Open Label|Lost to Follow-up|0|||
150031436|NCT02919761|541252660|FG002|Part 1: Open Label|Lost to Follow-up|0|||
150031437|NCT02919761|541252658|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
150031438|NCT02919761|541252659|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
150031439|NCT02919761|541252660|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
150031440|NCT02919761|541252658|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
150031441|NCT02919761|541252659|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
150031442|NCT02919761|541252660|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
150031443|NCT02919761|541252658|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
150031444|NCT02919761|541252659|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
150031445|NCT02919761|541252660|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
150031446|NCT02919761|541252658|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
150031447|NCT02919761|541252659|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
150031448|NCT02919761|541252660|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
150031449|NCT02919761|541252658|FG000|Part 1: Open Label|Termination by Sponsor|1|||
150031450|NCT02919761|541252659|FG001|Part 1: Open Label|Termination by Sponsor|0|||
150031451|NCT02919761|541252660|FG002|Part 1: Open Label|Termination by Sponsor|0|||
150031452|NCT02919761|541252658|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
150031453|NCT02919761|541252659|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
150031454|NCT02919761|541252660|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
150031455|NCT02919761|541252658|FG000|Part 2: Double-blind|Adverse Event|0|||
150031456|NCT02919761|541252659|FG001|Part 2: Double-blind|Adverse Event|1|||
149821240|NCT03255031|540475661|FG000|Overall Study|Withdrawal by Subject|9|||
149821241|NCT03255031|540475662|FG001|Overall Study|Withdrawal by Subject|3|||
149821242|NCT01092702|540475663|FG000|Overall Study|Withdrawal by Subject|7|||
149821243|NCT01092702|540475663|FG000|Overall Study|Lost to Follow-up|2|||
149821244|NCT01107535|540475664|FG000|Overall Study|Death|5|||
149821245|NCT01155583|540475665|FG000|Phase I|Screen failure - did not start treatment|0|||
149821246|NCT01155583|540475666|FG001|Phase I|Screen failure - did not start treatment|0|||
149821247|NCT01155583|540475667|FG002|Phase I|Screen failure - did not start treatment|0|||
149821248|NCT01155583|540475668|FG003|Phase I|Screen failure - did not start treatment|0|||
149821249|NCT01155583|540475669|FG004|Phase I|Screen failure - did not start treatment|1|||
149821250|NCT01155583|540475670|FG005|Phase I|Screen failure - did not start treatment|0|||
149821251|NCT01155583|540475671|FG006|Phase I|Screen failure - did not start treatment|0|||
149821252|NCT01155583|540475672|FG007|Phase I|Screen failure - did not start treatment|2|||
149821253|NCT01155583|540475673|FG008|Phase I|Screen failure - did not start treatment|0|||
149821254|NCT01155583|540475665|FG000|Phase I|Withdrawal by Subject|0|||
149941076|NCT03729362|540920314|FG000|Overall Study|COVID-19 Pandemic|1|||
149941077|NCT03729362|540920315|FG001|Overall Study|COVID-19 Pandemic|0|||
149941078|NCT03729362|540920314|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
149941079|NCT03729362|540920315|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
149941080|NCT03729362|540920314|FG000|Overall Study|Adverse Event|0|||
149941081|NCT03729362|540920315|FG001|Overall Study|Adverse Event|1|||
149941082|NCT03729362|540920314|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
149941083|NCT03729362|540920315|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
149941084|NCT05172609|540920316|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
149941085|NCT05172609|540920317|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
149941086|NCT05172609|540920316|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
149941087|NCT05172609|540920317|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
149941088|NCT05172609|540920316|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
149941089|NCT05172609|540920317|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
149941090|NCT03737994|540920318|FG000|Overall Study|Withdrawal by Subject|0|||
149941091|NCT03737994|540920319|FG001|Overall Study|Withdrawal by Subject|0|||
149941092|NCT03737994|540920320|FG002|Overall Study|Withdrawal by Subject|0|||
149941093|NCT03737994|540920321|FG003|Overall Study|Withdrawal by Subject|0|||
149941094|NCT03737994|540920322|FG004|Overall Study|Withdrawal by Subject|0|||
149941095|NCT03737994|540920323|FG005|Overall Study|Withdrawal by Subject|0|||
149941096|NCT03737994|540920324|FG006|Overall Study|Withdrawal by Subject|1|||
149941097|NCT00042289|540920325|FG000|Overall Study|Lost to Follow-up|3|||
149941098|NCT00042289|540920326|FG001|Overall Study|Lost to Follow-up|0|||
149941099|NCT00042289|540920327|FG002|Overall Study|Lost to Follow-up|0|||
149941100|NCT00042289|540920328|FG003|Overall Study|Lost to Follow-up|1|||
149941101|NCT00042289|540920329|FG004|Overall Study|Lost to Follow-up|3|||
149941102|NCT00042289|540920330|FG005|Overall Study|Lost to Follow-up|3|||
149941103|NCT00042289|540920331|FG006|Overall Study|Lost to Follow-up|6|||
149941104|NCT00042289|540920332|FG007|Overall Study|Lost to Follow-up|1|||
149941105|NCT00042289|540920333|FG008|Overall Study|Lost to Follow-up|1|||
149941106|NCT00042289|540920334|FG009|Overall Study|Lost to Follow-up|0|||
149941107|NCT00042289|540920335|FG010|Overall Study|Lost to Follow-up|0|||
149941108|NCT00042289|540920336|FG011|Overall Study|Lost to Follow-up|0|||
149941109|NCT00042289|540920337|FG012|Overall Study|Lost to Follow-up|0|||
149941110|NCT00042289|540920338|FG013|Overall Study|Lost to Follow-up|0|||
149941111|NCT00042289|540920339|FG014|Overall Study|Lost to Follow-up|0|||
149941112|NCT00042289|540920340|FG015|Overall Study|Lost to Follow-up|1|||
149941113|NCT00042289|540920341|FG016|Overall Study|Lost to Follow-up|1|||
149941114|NCT00042289|540920342|FG017|Overall Study|Lost to Follow-up|0|||
149941115|NCT00042289|540920343|FG018|Overall Study|Lost to Follow-up|3|||
149941116|NCT00042289|540920344|FG019|Overall Study|Lost to Follow-up|2|||
149941117|NCT00042289|540920345|FG020|Overall Study|Lost to Follow-up|0|||
149941118|NCT00042289|540920346|FG021|Overall Study|Lost to Follow-up|0|||
149941119|NCT00042289|540920347|FG022|Overall Study|Lost to Follow-up|0|||
149941120|NCT00042289|540920348|FG023|Overall Study|Lost to Follow-up|0|||
149941121|NCT00042289|540920349|FG024|Overall Study|Lost to Follow-up|0|||
150274175|NCT04004429|542141531|FG000|Overall Study|Protocol Violation|1|||
150274176|NCT04004429|542141532|FG001|Overall Study|Protocol Violation|0|||
150274177|NCT04004429|542141533|FG002|Overall Study|Protocol Violation|0|||
150274178|NCT04004429|542141531|FG000|Overall Study|Physician Decision|0|||
150274179|NCT04004429|542141532|FG001|Overall Study|Physician Decision|1|||
150274180|NCT04004429|542141533|FG002|Overall Study|Physician Decision|1|||
149821255|NCT01155583|540475666|FG001|Phase I|Withdrawal by Subject|0|||
149821256|NCT01155583|540475667|FG002|Phase I|Withdrawal by Subject|0|||
149821257|NCT01155583|540475668|FG003|Phase I|Withdrawal by Subject|0|||
149941122|NCT00042289|540920350|FG025|Overall Study|Lost to Follow-up|0|||
149941123|NCT00042289|540920351|FG026|Overall Study|Lost to Follow-up|2|||
150274181|NCT04004429|542141531|FG000|Overall Study|Withdrawal by Subject|1|||
149821258|NCT01155583|540475669|FG004|Phase I|Withdrawal by Subject|0|||
149821259|NCT01155583|540475670|FG005|Phase I|Withdrawal by Subject|0|||
150031457|NCT02919761|541252660|FG002|Part 2: Double-blind|Adverse Event|0|||
150031458|NCT02919761|541252658|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
150031459|NCT02919761|541252659|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
150031460|NCT02919761|541252660|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
150031461|NCT02919761|541252658|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
150031462|NCT02919761|541252659|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
150274182|NCT04004429|542141532|FG001|Overall Study|Withdrawal by Subject|1|||
150031463|NCT02919761|541252660|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
150031464|NCT02919761|541252658|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
150274183|NCT04004429|542141533|FG002|Overall Study|Withdrawal by Subject|1|||
150274184|NCT02092350|542141534|FG000|Overall Study|Adverse Event|0|||
150274185|NCT02092350|542141535|FG001|Overall Study|Adverse Event|3|||
150274186|NCT02092350|542141534|FG000|Overall Study|Death|2|||
150274187|NCT02092350|542141535|FG001|Overall Study|Death|5|||
150274188|NCT02092350|542141534|FG000|Overall Study|Lost to Follow-up|3|||
150274189|NCT02092350|542141535|FG001|Overall Study|Lost to Follow-up|1|||
150274190|NCT02092350|542141534|FG000|Overall Study|Protocol Violation|1|||
150274191|NCT02092350|542141535|FG001|Overall Study|Protocol Violation|0|||
150274192|NCT02092350|542141534|FG000|Overall Study|Physician Decision|1|||
150274193|NCT02092350|542141535|FG001|Overall Study|Physician Decision|1|||
150274194|NCT02092350|542141534|FG000|Overall Study|Screen Failure|1|||
150274195|NCT02092350|542141535|FG001|Overall Study|Screen Failure|0|||
150274196|NCT02092350|542141534|FG000|Overall Study|Withdrawal by Subject|2|||
150274197|NCT02092350|542141535|FG001|Overall Study|Withdrawal by Subject|2|||
150274198|NCT02448225|542141537|FG000|Overall Study|Withdrawal by Subject|1|||
150274199|NCT02448225|542141537|FG000|Overall Study|Did not get FSPG scan|18|||
150274200|NCT02448225|542141537|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
150274201|NCT00962390|542141542|FG000|Overall Study|Adverse Event|0|||
150274202|NCT00962390|542141543|FG001|Overall Study|Adverse Event|0|||
150274203|NCT00962390|542141544|FG002|Overall Study|Adverse Event|3|||
150274204|NCT00962390|542141545|FG003|Overall Study|Adverse Event|1|||
150274205|NCT00962390|542141542|FG000|Overall Study|Lost to Follow-up|2|||
150274206|NCT00962390|542141543|FG001|Overall Study|Lost to Follow-up|2|||
150274207|NCT00962390|542141544|FG002|Overall Study|Lost to Follow-up|0|||
150274208|NCT00962390|542141545|FG003|Overall Study|Lost to Follow-up|0|||
150274209|NCT00962390|542141542|FG000|Overall Study|Protocol Violation|1|||
150274210|NCT00962390|542141543|FG001|Overall Study|Protocol Violation|0|||
150274211|NCT00962390|542141544|FG002|Overall Study|Protocol Violation|0|||
150274212|NCT00962390|542141545|FG003|Overall Study|Protocol Violation|0|||
150274213|NCT00962390|542141542|FG000|Overall Study|Withdrawal by Subject|1|||
150274214|NCT00962390|542141543|FG001|Overall Study|Withdrawal by Subject|1|||
150274215|NCT00962390|542141544|FG002|Overall Study|Withdrawal by Subject|1|||
150274216|NCT00962390|542141545|FG003|Overall Study|Withdrawal by Subject|0|||
150274217|NCT04422990|542141546|FG000|Overall Study|Withdrawal by Subject|0|||
150274218|NCT04422990|542141547|FG001|Overall Study|Withdrawal by Subject|1|||
150274219|NCT04422990|542141546|FG000|Overall Study|Travel|3|||
150274220|NCT04422990|542141547|FG001|Overall Study|Travel|0|||
150274221|NCT02486653|542141553|FG000|Overall Study|Withdrawal by Subject|1|||
150274222|NCT02486653|542141554|FG001|Overall Study|Withdrawal by Subject|3|||
150274223|NCT02486653|542141553|FG000|Overall Study|Protocol Violation|1|||
150274224|NCT02486653|542141554|FG001|Overall Study|Protocol Violation|0|||
150274225|NCT02486653|542141553|FG000|Overall Study|surgery cancelled|4|||
150274226|NCT02486653|542141554|FG001|Overall Study|surgery cancelled|1|||
150274227|NCT00800436|542141555|FG000|Overall Study|Withdrawal by Subject|0|||
150274228|NCT00800436|542141556|FG001|Overall Study|Withdrawal by Subject|0|||
150274229|NCT00800436|542141557|FG002|Overall Study|Withdrawal by Subject|1|||
150274230|NCT00800436|542141558|FG003|Overall Study|Withdrawal by Subject|1|||
150274231|NCT00800436|542141559|FG004|Overall Study|Withdrawal by Subject|0|||
150274232|NCT00800436|542141560|FG005|Overall Study|Withdrawal by Subject|0|||
150274233|NCT00800436|542141561|FG006|Overall Study|Withdrawal by Subject|0|||
150031465|NCT02919761|541252659|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
150274234|NCT00711529|542141568|FG000|Overall Study|Protocol Violation|2|||
150031466|NCT02919761|541252660|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
150031467|NCT02919761|541252658|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
150274235|NCT00711529|542141569|FG001|Overall Study|Protocol Violation|0|||
150274236|NCT00711529|542141568|FG000|Overall Study|Withdrawal by Subject|2|||
150031468|NCT02919761|541252659|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
150274237|NCT00711529|542141569|FG001|Overall Study|Withdrawal by Subject|6|||
150274238|NCT00698932|542141578|FG000|Overall Study|Adverse Event|0|||
150274239|NCT00698932|542141579|FG001|Overall Study|Adverse Event|2|||
150274240|NCT00698932|542141578|FG000|Overall Study|Incorrect enrollment|0|||
149821260|NCT01155583|540475671|FG006|Phase I|Withdrawal by Subject|0|||
150031469|NCT02919761|541252660|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
150274241|NCT00698932|542141579|FG001|Overall Study|Incorrect enrollment|2|||
150274242|NCT00698932|542141578|FG000|Overall Study|Study specific discontinuation criteria|3|||
150274243|NCT00698932|542141579|FG001|Overall Study|Study specific discontinuation criteria|4|||
150274244|NCT00698932|542141578|FG000|Overall Study|Withdrawal by Subject|11|||
150274245|NCT00698932|542141579|FG001|Overall Study|Withdrawal by Subject|23|||
150274246|NCT00698932|542141578|FG000|Overall Study|Lost to Follow-up|6|||
150274247|NCT00698932|542141579|FG001|Overall Study|Lost to Follow-up|1|||
150274248|NCT00698932|542141578|FG000|Overall Study|Severe non-compliance to protocol|1|||
150274249|NCT00698932|542141579|FG001|Overall Study|Severe non-compliance to protocol|2|||
150274250|NCT00698932|542141578|FG000|Overall Study|Safety reasons|0|||
150274251|NCT00698932|542141579|FG001|Overall Study|Safety reasons|2|||
150274252|NCT00698932|542141578|FG000|Overall Study|Death|1|||
150274253|NCT00698932|542141579|FG001|Overall Study|Death|0|||
150274254|NCT00757003|542141580|FG000|Overall Study|Death|33|||
150274255|NCT00757003|542141580|FG000|Overall Study|Lost to Follow-up|9|||
150274256|NCT00757003|542141580|FG000|Overall Study|Withdrawal by Subject|4|||
150274257|NCT00757003|542141580|FG000|Overall Study|Surgically explanted|2|||
150274258|NCT00757003|542141580|FG000|Overall Study|Not implanted|1|||
150274259|NCT00601705|542141581|FG000|Overall Study|Withdrawal by Subject|1|||
150274260|NCT02146599|542141583|FG000|Overall Study|Failed to meet inclusion criteria|5|||
150274261|NCT04246801|542141584|FG000|Overall Study|Adverse Event|1|||
150274262|NCT04246801|542141585|FG001|Overall Study|Adverse Event|1|||
150274263|NCT04246801|542141584|FG000|Overall Study|Protocol Violation|1|||
150274264|NCT04246801|542141585|FG001|Overall Study|Protocol Violation|1|||
150274265|NCT04246801|542141584|FG000|Overall Study|Lack of Efficacy|0|||
150274266|NCT04246801|542141585|FG001|Overall Study|Lack of Efficacy|2|||
150274267|NCT04246801|542141584|FG000|Overall Study|Lost to Follow-up|1|||
150274268|NCT04246801|542141585|FG001|Overall Study|Lost to Follow-up|1|||
150274269|NCT04246801|542141584|FG000|Overall Study|Withdrawal by Subject|2|||
150274270|NCT04246801|542141585|FG001|Overall Study|Withdrawal by Subject|1|||
150274271|NCT03044886|542141589|FG000|Overall Study|Lost to Follow-up|15|||
150274272|NCT03044886|542141590|FG001|Overall Study|Lost to Follow-up|10|||
150274273|NCT03044886|542141591|FG002|Overall Study|Lost to Follow-up|12|||
150274274|NCT02921269|542141592|FG000|Overall Study|Did not complete DLT period|1|||
150274275|NCT00387764|542141602|FG000|Overall Study|Adverse Event|12|||
150274276|NCT00387764|542141602|FG000|Overall Study|Withdrawal by Subject|8|||
150274277|NCT00387764|542141602|FG000|Overall Study|Sponsor Terminated Study|1|||
150274278|NCT00387764|542141602|FG000|Overall Study|Physician Decision|1|||
150274279|NCT00387764|542141602|FG000|Overall Study|Other|2|||
150274280|NCT00387764|542141602|FG000|Overall Study|Death|7|||
150274281|NCT03065023|542141603|FG000|Overall Study|Progressive Disease|0|||
150274282|NCT03065023|542141604|FG001|Overall Study|Progressive Disease|1|||
150274283|NCT03065023|542141605|FG002|Overall Study|Progressive Disease|0|||
150274284|NCT03065023|542141606|FG003|Overall Study|Progressive Disease|0|||
150274285|NCT03065023|542141607|FG004|Overall Study|Progressive Disease|0|||
150274286|NCT03065023|542141603|FG000|Overall Study|Death|2|||
150274287|NCT03065023|542141604|FG001|Overall Study|Death|0|||
150274288|NCT03065023|542141605|FG002|Overall Study|Death|1|||
150274289|NCT03065023|542141606|FG003|Overall Study|Death|1|||
150274290|NCT03065023|542141607|FG004|Overall Study|Death|0|||
150274291|NCT03065023|542141603|FG000|Overall Study|Lost to Follow-up|0|||
150274292|NCT03065023|542141604|FG001|Overall Study|Lost to Follow-up|1|||
150274293|NCT03065023|542141605|FG002|Overall Study|Lost to Follow-up|0|||
150274294|NCT03065023|542141606|FG003|Overall Study|Lost to Follow-up|0|||
150274295|NCT03065023|542141607|FG004|Overall Study|Lost to Follow-up|0|||
150274296|NCT03065023|542141603|FG000|Overall Study|Participant Decision|0|||
150274297|NCT03065023|542141604|FG001|Overall Study|Participant Decision|0|||
150274298|NCT03065023|542141605|FG002|Overall Study|Participant Decision|0|||
150274299|NCT03065023|542141606|FG003|Overall Study|Participant Decision|1|||
150274300|NCT03065023|542141607|FG004|Overall Study|Participant Decision|0|||
150274301|NCT03065023|542141603|FG000|Overall Study|Withdrawal by Subject|0|||
150274302|NCT03065023|542141604|FG001|Overall Study|Withdrawal by Subject|0|||
150274303|NCT03065023|542141605|FG002|Overall Study|Withdrawal by Subject|0|||
150274304|NCT03065023|542141606|FG003|Overall Study|Withdrawal by Subject|1|||
150274305|NCT03065023|542141607|FG004|Overall Study|Withdrawal by Subject|0|||
150274306|NCT05975840|542141608|FG000|Overall Study|Other|1|||
150274307|NCT05975840|542141609|FG001|Overall Study|Other|0|||
150274308|NCT05975840|542141610|FG002|Overall Study|Other|0|||
150274309|NCT05975840|542141611|FG003|Overall Study|Other|0|||
150274310|NCT05975840|542141612|FG004|Overall Study|Other|1|||
150274311|NCT05975840|542141613|FG005|Overall Study|Other|0|||
150274312|NCT05975840|542141614|FG006|Overall Study|Other|0|||
150274313|NCT05975840|542141615|FG007|Overall Study|Other|0|||
150274314|NCT05975840|542141608|FG000|Overall Study|Lost to Follow-up|3|||
150274315|NCT05975840|542141609|FG001|Overall Study|Lost to Follow-up|6|||
150274316|NCT05975840|542141610|FG002|Overall Study|Lost to Follow-up|3|||
150274317|NCT05975840|542141611|FG003|Overall Study|Lost to Follow-up|1|||
150274318|NCT05975840|542141612|FG004|Overall Study|Lost to Follow-up|4|||
150274319|NCT05975840|542141613|FG005|Overall Study|Lost to Follow-up|1|||
150274320|NCT05975840|542141614|FG006|Overall Study|Lost to Follow-up|2|||
150274321|NCT05975840|542141615|FG007|Overall Study|Lost to Follow-up|4|||
150274322|NCT05975840|542141608|FG000|Overall Study|Migrated/moved from the study area|1|||
150274323|NCT05975840|542141609|FG001|Overall Study|Migrated/moved from the study area|0|||
150274324|NCT05975840|542141610|FG002|Overall Study|Migrated/moved from the study area|0|||
150031470|NCT02919761|541252658|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
150031471|NCT02919761|541252659|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
150031472|NCT02919761|541252660|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
150031473|NCT02919761|541252658|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
150031474|NCT02919761|541252659|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
150031475|NCT02919761|541252660|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
150031476|NCT04972162|541252663|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
150031477|NCT04972162|541252664|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
150031478|NCT01352117|541255346|FG000|Overall Study|Death|15|||
150031479|NCT01352117|541255347|FG001|Overall Study|Death|16|||
150031480|NCT01352117|541255346|FG000|Overall Study|Withdrawal by Subject|1|||
150031481|NCT01352117|541255347|FG001|Overall Study|Withdrawal by Subject|0|||
150031482|NCT01352117|541255346|FG000|Overall Study|Lost to Follow-up|2|||
150031483|NCT01352117|541255347|FG001|Overall Study|Lost to Follow-up|7|||
150031484|NCT01352117|541255346|FG000|Overall Study|Non-adherent to study requirements|1|||
150031485|NCT01352117|541255347|FG001|Overall Study|Non-adherent to study requirements|1|||
150031486|NCT01352117|541255346|FG000|Overall Study|Did not initiate study treatment|1|||
150031487|NCT01352117|541255347|FG001|Overall Study|Did not initiate study treatment|0|||
150031488|NCT01352117|541255346|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
150031489|NCT01352117|541255347|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
150031490|NCT01766050|541255348|FG000|Overall Study|Adverse Event|1|||
150031491|NCT01766050|541255348|FG000|Overall Study|Lost to Follow-up|1|||
150031492|NCT01766050|541255348|FG000|Overall Study|Withdrawal by Subject|2|||
150031493|NCT02081677|541255349|FG000|Overall Study|Adverse Event|0|||
150031494|NCT02081677|541255350|FG001|Overall Study|Adverse Event|0|||
150031495|NCT02081677|541255351|FG002|Overall Study|Adverse Event|1|||
150031496|NCT02081677|541255352|FG003|Overall Study|Adverse Event|0|||
150031497|NCT02081677|541255349|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
150031498|NCT02081677|541255350|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150031499|NCT02081677|541255351|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
150031500|NCT02081677|541255352|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
150031501|NCT02081677|541255349|FG000|Overall Study|Not comfortable with lens care system|1|||
149941124|NCT00042289|540920352|FG027|Overall Study|Lost to Follow-up|2|||
149941125|NCT00042289|540920353|FG028|Overall Study|Lost to Follow-up|2|||
149941126|NCT00042289|540920354|FG029|Overall Study|Lost to Follow-up|0|||
149941127|NCT00042289|540920355|FG030|Overall Study|Lost to Follow-up|0|||
149941128|NCT00042289|540920356|FG031|Overall Study|Lost to Follow-up|2|||
149941129|NCT00042289|540920357|FG032|Overall Study|Lost to Follow-up|1|||
149941130|NCT00042289|540920358|FG033|Overall Study|Lost to Follow-up|1|||
149941131|NCT00042289|540920359|FG034|Overall Study|Lost to Follow-up|1|||
149941132|NCT00042289|540920360|FG035|Overall Study|Lost to Follow-up|2|||
149941133|NCT00042289|540920361|FG036|Overall Study|Lost to Follow-up|1|||
149941134|NCT00042289|540920362|FG037|Overall Study|Lost to Follow-up|1|||
149941135|NCT00042289|540920363|FG038|Overall Study|Lost to Follow-up|0|||
149941136|NCT00042289|540920364|FG039|Overall Study|Lost to Follow-up|5|||
149941137|NCT00042289|540920365|FG040|Overall Study|Lost to Follow-up|0|||
149941138|NCT00042289|540920366|FG041|Overall Study|Lost to Follow-up|2|||
149941139|NCT00042289|540920367|FG042|Overall Study|Lost to Follow-up|2|||
149941140|NCT00042289|540920368|FG043|Overall Study|Lost to Follow-up|0|||
149941141|NCT00042289|540920369|FG044|Overall Study|Lost to Follow-up|0|||
149941142|NCT00042289|540920370|FG045|Overall Study|Lost to Follow-up|1|||
149941143|NCT00042289|540920371|FG046|Overall Study|Lost to Follow-up|0|||
150031502|NCT02081677|541255350|FG001|Overall Study|Not comfortable with lens care system|0|||
150031503|NCT02081677|541255351|FG002|Overall Study|Not comfortable with lens care system|0|||
150031504|NCT02081677|541255352|FG003|Overall Study|Not comfortable with lens care system|0|||
150169915|NCT02341625|541757205|FG005|Overall Study|Completed Treatment as per Protocol|0|||
150169916|NCT02341625|541757206|FG006|Overall Study|Completed Treatment as per Protocol|0|||
150169917|NCT02341625|541757207|FG007|Overall Study|Completed Treatment as per Protocol|0|||
150169918|NCT02341625|541757208|FG008|Overall Study|Completed Treatment as per Protocol|0|||
150169919|NCT02341625|541757209|FG009|Overall Study|Completed Treatment as per Protocol|1|||
150169920|NCT02341625|541757200|FG000|Overall Study|Other Reasons|0|||
150169921|NCT02341625|541757201|FG001|Overall Study|Other Reasons|0|||
150169922|NCT02341625|541757202|FG002|Overall Study|Other Reasons|0|||
150169923|NCT02341625|541757203|FG003|Overall Study|Other Reasons|0|||
150169924|NCT02341625|541757204|FG004|Overall Study|Other Reasons|1|||
150169925|NCT02341625|541757205|FG005|Overall Study|Other Reasons|0|||
149941144|NCT00042289|540920325|FG000|Overall Study|Other reason|0|||
150031505|NCT02081677|541255349|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
150031506|NCT02081677|541255350|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
150031507|NCT02081677|541255351|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
150169926|NCT02341625|541757206|FG006|Overall Study|Other Reasons|5|||
150169927|NCT02341625|541757207|FG007|Overall Study|Other Reasons|0|||
150169928|NCT02341625|541757208|FG008|Overall Study|Other Reasons|0|||
150169929|NCT02341625|541757209|FG009|Overall Study|Other Reasons|2|||
149941145|NCT00042289|540920326|FG001|Overall Study|Other reason|0|||
150031508|NCT02081677|541255352|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
150031509|NCT00385671|541255355|FG000|Overall Study|Adverse Event|14|||
150031510|NCT00385671|541255356|FG001|Overall Study|Adverse Event|27|||
150031511|NCT00385671|541255357|FG002|Overall Study|Adverse Event|18|||
150031512|NCT00385671|541255355|FG000|Overall Study|Lack of Efficacy|5|||
150031513|NCT00385671|541255356|FG001|Overall Study|Lack of Efficacy|9|||
150031514|NCT00385671|541255357|FG002|Overall Study|Lack of Efficacy|5|||
149941146|NCT00042289|540920327|FG002|Overall Study|Other reason|0|||
149941147|NCT00042289|540920328|FG003|Overall Study|Other reason|2|||
149941148|NCT00042289|540920329|FG004|Overall Study|Other reason|0|||
149941149|NCT00042289|540920330|FG005|Overall Study|Other reason|0|||
149941150|NCT00042289|540920331|FG006|Overall Study|Other reason|0|||
149941151|NCT00042289|540920332|FG007|Overall Study|Other reason|0|||
149941152|NCT00042289|540920333|FG008|Overall Study|Other reason|0|||
149941153|NCT00042289|540920334|FG009|Overall Study|Other reason|0|||
149941154|NCT00042289|540920335|FG010|Overall Study|Other reason|0|||
149941155|NCT00042289|540920336|FG011|Overall Study|Other reason|0|||
149941156|NCT00042289|540920337|FG012|Overall Study|Other reason|0|||
150031515|NCT00385671|541255355|FG000|Overall Study|Lost to Follow-up|6|||
150031516|NCT00385671|541255356|FG001|Overall Study|Lost to Follow-up|6|||
150031517|NCT00385671|541255357|FG002|Overall Study|Lost to Follow-up|5|||
149821261|NCT01155583|540475672|FG007|Phase I|Withdrawal by Subject|1|||
150031518|NCT00385671|541255355|FG000|Overall Study|Physician Decision|2|||
150031519|NCT00385671|541255356|FG001|Overall Study|Physician Decision|1|||
150031520|NCT00385671|541255357|FG002|Overall Study|Physician Decision|2|||
149821262|NCT01155583|540475673|FG008|Phase I|Withdrawal by Subject|0|||
149821263|NCT00585351|540475678|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
149821264|NCT00585351|540475679|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
149821265|NCT00585351|540475680|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
149821266|NCT00585351|540475681|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
149821267|NCT00585351|540475682|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
149821268|NCT00585351|540475683|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
149821269|NCT00585351|540475684|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
149821270|NCT00585351|540475685|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
149821271|NCT00585351|540475678|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
149821272|NCT00585351|540475679|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
149821273|NCT00585351|540475680|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
149821274|NCT00585351|540475681|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
149821275|NCT00585351|540475682|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
149821276|NCT00585351|540475683|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
149821277|NCT00585351|540475684|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
149821278|NCT00585351|540475685|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
149821279|NCT00585351|540475678|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
149821280|NCT00585351|540475679|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
149821281|NCT00585351|540475680|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
149821282|NCT00585351|540475681|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
149821283|NCT00585351|540475682|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
149821284|NCT00585351|540475683|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
149821285|NCT00585351|540475684|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
149821286|NCT00585351|540475685|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
149821287|NCT00585351|540475678|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
149821288|NCT00585351|540475679|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
149821289|NCT00585351|540475680|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821290|NCT00585351|540475681|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821291|NCT00585351|540475682|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821292|NCT00585351|540475683|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821293|NCT00585351|540475684|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821294|NCT00585351|540475685|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
149821295|NCT00585351|540475678|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149821296|NCT00585351|540475679|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149821297|NCT00585351|540475680|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149821298|NCT00585351|540475681|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149821299|NCT00585351|540475682|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149941157|NCT00042289|540920338|FG013|Overall Study|Other reason|0|||
150031521|NCT00385671|541255355|FG000|Overall Study|Protocol Violation|5|||
150031522|NCT00385671|541255356|FG001|Overall Study|Protocol Violation|2|||
150031523|NCT00385671|541255357|FG002|Overall Study|Protocol Violation|1|||
150031524|NCT00385671|541255355|FG000|Overall Study|Sponsor Decision|2|||
150031525|NCT00385671|541255356|FG001|Overall Study|Sponsor Decision|2|||
150031526|NCT00385671|541255357|FG002|Overall Study|Sponsor Decision|1|||
149941158|NCT00042289|540920339|FG014|Overall Study|Other reason|0|||
149941159|NCT00042289|540920340|FG015|Overall Study|Other reason|0|||
149941160|NCT00042289|540920341|FG016|Overall Study|Other reason|0|||
149941161|NCT00042289|540920342|FG017|Overall Study|Other reason|0|||
149941162|NCT00042289|540920343|FG018|Overall Study|Other reason|1|||
149941163|NCT00042289|540920344|FG019|Overall Study|Other reason|0|||
149941164|NCT00042289|540920345|FG020|Overall Study|Other reason|0|||
149941165|NCT00042289|540920346|FG021|Overall Study|Other reason|0|||
149941166|NCT00042289|540920347|FG022|Overall Study|Other reason|0|||
149941167|NCT00042289|540920348|FG023|Overall Study|Other reason|1|||
149941168|NCT00042289|540920349|FG024|Overall Study|Other reason|0|||
149941169|NCT00042289|540920350|FG025|Overall Study|Other reason|0|||
149941170|NCT00042289|540920351|FG026|Overall Study|Other reason|1|||
149941171|NCT00042289|540920352|FG027|Overall Study|Other reason|0|||
149941172|NCT00042289|540920353|FG028|Overall Study|Other reason|3|||
149941173|NCT00042289|540920354|FG029|Overall Study|Other reason|0|||
149941174|NCT00042289|540920355|FG030|Overall Study|Other reason|0|||
149941175|NCT00042289|540920356|FG031|Overall Study|Other reason|1|||
149941176|NCT00042289|540920357|FG032|Overall Study|Other reason|0|||
149941177|NCT00042289|540920358|FG033|Overall Study|Other reason|1|||
149941178|NCT00042289|540920359|FG034|Overall Study|Other reason|0|||
149941179|NCT00042289|540920360|FG035|Overall Study|Other reason|2|||
149941180|NCT00042289|540920361|FG036|Overall Study|Other reason|0|||
149941181|NCT00042289|540920362|FG037|Overall Study|Other reason|0|||
149941182|NCT00042289|540920363|FG038|Overall Study|Other reason|0|||
149941183|NCT00042289|540920364|FG039|Overall Study|Other reason|0|||
149941184|NCT00042289|540920365|FG040|Overall Study|Other reason|0|||
149941185|NCT00042289|540920366|FG041|Overall Study|Other reason|0|||
149941186|NCT00042289|540920367|FG042|Overall Study|Other reason|0|||
149941187|NCT00042289|540920368|FG043|Overall Study|Other reason|1|||
149941188|NCT00042289|540920369|FG044|Overall Study|Other reason|0|||
149941189|NCT00042289|540920370|FG045|Overall Study|Other reason|0|||
149941190|NCT00042289|540920371|FG046|Overall Study|Other reason|0|||
149941191|NCT00042289|540920325|FG000|Overall Study|Severe debilitation, unable to continue|0|||
149941192|NCT00042289|540920326|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149941193|NCT00042289|540920327|FG002|Overall Study|Severe debilitation, unable to continue|0|||
149941194|NCT00042289|540920328|FG003|Overall Study|Severe debilitation, unable to continue|0|||
149941195|NCT00042289|540920329|FG004|Overall Study|Severe debilitation, unable to continue|0|||
149941196|NCT00042289|540920330|FG005|Overall Study|Severe debilitation, unable to continue|0|||
149941197|NCT00042289|540920331|FG006|Overall Study|Severe debilitation, unable to continue|0|||
149941198|NCT00042289|540920332|FG007|Overall Study|Severe debilitation, unable to continue|0|||
149941199|NCT00042289|540920333|FG008|Overall Study|Severe debilitation, unable to continue|0|||
149941200|NCT00042289|540920334|FG009|Overall Study|Severe debilitation, unable to continue|0|||
149941201|NCT00042289|540920335|FG010|Overall Study|Severe debilitation, unable to continue|0|||
149941202|NCT00042289|540920336|FG011|Overall Study|Severe debilitation, unable to continue|0|||
149941203|NCT00042289|540920337|FG012|Overall Study|Severe debilitation, unable to continue|0|||
149941204|NCT00042289|540920338|FG013|Overall Study|Severe debilitation, unable to continue|0|||
149941205|NCT00042289|540920339|FG014|Overall Study|Severe debilitation, unable to continue|0|||
149941206|NCT00042289|540920340|FG015|Overall Study|Severe debilitation, unable to continue|0|||
149941207|NCT00042289|540920341|FG016|Overall Study|Severe debilitation, unable to continue|0|||
149941208|NCT00042289|540920342|FG017|Overall Study|Severe debilitation, unable to continue|0|||
149941209|NCT00042289|540920343|FG018|Overall Study|Severe debilitation, unable to continue|0|||
149941210|NCT00042289|540920344|FG019|Overall Study|Severe debilitation, unable to continue|0|||
149941211|NCT00042289|540920345|FG020|Overall Study|Severe debilitation, unable to continue|0|||
149941212|NCT00042289|540920346|FG021|Overall Study|Severe debilitation, unable to continue|1|||
149941213|NCT00042289|540920347|FG022|Overall Study|Severe debilitation, unable to continue|0|||
149941214|NCT00042289|540920348|FG023|Overall Study|Severe debilitation, unable to continue|1|||
149941215|NCT00042289|540920349|FG024|Overall Study|Severe debilitation, unable to continue|0|||
149941216|NCT00042289|540920350|FG025|Overall Study|Severe debilitation, unable to continue|0|||
149941217|NCT00042289|540920351|FG026|Overall Study|Severe debilitation, unable to continue|0|||
149941218|NCT00042289|540920352|FG027|Overall Study|Severe debilitation, unable to continue|1|||
149941219|NCT00042289|540920353|FG028|Overall Study|Severe debilitation, unable to continue|0|||
149941220|NCT00042289|540920354|FG029|Overall Study|Severe debilitation, unable to continue|0|||
149941221|NCT00042289|540920355|FG030|Overall Study|Severe debilitation, unable to continue|0|||
149941222|NCT00042289|540920356|FG031|Overall Study|Severe debilitation, unable to continue|1|||
149941223|NCT00042289|540920357|FG032|Overall Study|Severe debilitation, unable to continue|1|||
149941224|NCT00042289|540920358|FG033|Overall Study|Severe debilitation, unable to continue|0|||
149975589|NCT00570713|541047894|FG000|Overall Study|Lack of Efficacy|40|||
149975590|NCT00570713|541047895|FG001|Overall Study|Lack of Efficacy|49|||
149975591|NCT00570713|541047894|FG000|Overall Study|Physician Decision|2|||
149975592|NCT00570713|541047895|FG001|Overall Study|Physician Decision|2|||
149975593|NCT00570713|541047894|FG000|Overall Study|Withdrawal by Subject|3|||
149975594|NCT00570713|541047895|FG001|Overall Study|Withdrawal by Subject|3|||
149941225|NCT00042289|540920359|FG034|Overall Study|Severe debilitation, unable to continue|0|||
149941226|NCT00042289|540920360|FG035|Overall Study|Severe debilitation, unable to continue|0|||
149941227|NCT00042289|540920361|FG036|Overall Study|Severe debilitation, unable to continue|0|||
149941228|NCT00042289|540920362|FG037|Overall Study|Severe debilitation, unable to continue|0|||
149941229|NCT00042289|540920363|FG038|Overall Study|Severe debilitation, unable to continue|0|||
149941230|NCT00042289|540920364|FG039|Overall Study|Severe debilitation, unable to continue|0|||
149941231|NCT00042289|540920365|FG040|Overall Study|Severe debilitation, unable to continue|0|||
149941232|NCT00042289|540920366|FG041|Overall Study|Severe debilitation, unable to continue|0|||
149941233|NCT00042289|540920367|FG042|Overall Study|Severe debilitation, unable to continue|0|||
149941234|NCT00042289|540920368|FG043|Overall Study|Severe debilitation, unable to continue|0|||
149941235|NCT00042289|540920369|FG044|Overall Study|Severe debilitation, unable to continue|0|||
149941236|NCT00042289|540920370|FG045|Overall Study|Severe debilitation, unable to continue|0|||
149941237|NCT00042289|540920371|FG046|Overall Study|Severe debilitation, unable to continue|0|||
149941238|NCT00042289|540920325|FG000|Overall Study|Site closed|0|||
149941239|NCT00042289|540920326|FG001|Overall Study|Site closed|0|||
149941240|NCT00042289|540920327|FG002|Overall Study|Site closed|0|||
149941241|NCT00042289|540920328|FG003|Overall Study|Site closed|0|||
149941242|NCT00042289|540920329|FG004|Overall Study|Site closed|0|||
149941243|NCT00042289|540920330|FG005|Overall Study|Site closed|0|||
149941244|NCT00042289|540920331|FG006|Overall Study|Site closed|0|||
149941245|NCT00042289|540920332|FG007|Overall Study|Site closed|0|||
149941246|NCT00042289|540920333|FG008|Overall Study|Site closed|0|||
149941247|NCT00042289|540920334|FG009|Overall Study|Site closed|0|||
149941248|NCT00042289|540920335|FG010|Overall Study|Site closed|0|||
149941249|NCT00042289|540920336|FG011|Overall Study|Site closed|0|||
149941250|NCT00042289|540920337|FG012|Overall Study|Site closed|0|||
149941251|NCT00042289|540920338|FG013|Overall Study|Site closed|0|||
149941252|NCT00042289|540920339|FG014|Overall Study|Site closed|0|||
149941253|NCT00042289|540920340|FG015|Overall Study|Site closed|0|||
149941254|NCT00042289|540920341|FG016|Overall Study|Site closed|0|||
149941255|NCT00042289|540920342|FG017|Overall Study|Site closed|0|||
149941256|NCT00042289|540920343|FG018|Overall Study|Site closed|0|||
149941257|NCT00042289|540920344|FG019|Overall Study|Site closed|0|||
149941258|NCT00042289|540920345|FG020|Overall Study|Site closed|0|||
149941259|NCT00042289|540920346|FG021|Overall Study|Site closed|0|||
149941260|NCT00042289|540920347|FG022|Overall Study|Site closed|0|||
149941261|NCT00042289|540920348|FG023|Overall Study|Site closed|0|||
149941262|NCT00042289|540920349|FG024|Overall Study|Site closed|0|||
149941263|NCT00042289|540920350|FG025|Overall Study|Site closed|0|||
149941264|NCT00042289|540920351|FG026|Overall Study|Site closed|0|||
149941265|NCT00042289|540920352|FG027|Overall Study|Site closed|0|||
149941266|NCT00042289|540920353|FG028|Overall Study|Site closed|0|||
149941267|NCT00042289|540920354|FG029|Overall Study|Site closed|0|||
149941268|NCT00042289|540920355|FG030|Overall Study|Site closed|0|||
149941269|NCT00042289|540920356|FG031|Overall Study|Site closed|3|||
149941270|NCT00042289|540920357|FG032|Overall Study|Site closed|0|||
149941271|NCT00042289|540920358|FG033|Overall Study|Site closed|0|||
149941272|NCT00042289|540920359|FG034|Overall Study|Site closed|0|||
149941273|NCT00042289|540920360|FG035|Overall Study|Site closed|0|||
149941274|NCT00042289|540920361|FG036|Overall Study|Site closed|1|||
149941275|NCT00042289|540920362|FG037|Overall Study|Site closed|0|||
149941276|NCT00042289|540920363|FG038|Overall Study|Site closed|0|||
149941277|NCT00042289|540920364|FG039|Overall Study|Site closed|0|||
149941278|NCT00042289|540920365|FG040|Overall Study|Site closed|0|||
149941279|NCT00042289|540920366|FG041|Overall Study|Site closed|0|||
149941280|NCT00042289|540920367|FG042|Overall Study|Site closed|1|||
149941281|NCT00042289|540920368|FG043|Overall Study|Site closed|0|||
149941282|NCT00042289|540920369|FG044|Overall Study|Site closed|0|||
149941283|NCT00042289|540920370|FG045|Overall Study|Site closed|0|||
149941284|NCT00042289|540920371|FG046|Overall Study|Site closed|0|||
149941285|NCT00042289|540920325|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
149941286|NCT00042289|540920326|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
149941287|NCT00042289|540920327|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
149941288|NCT00042289|540920328|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
149941289|NCT00042289|540920329|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
149941290|NCT00042289|540920330|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
149941291|NCT00042289|540920331|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
149941292|NCT00042289|540920332|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
149941293|NCT00042289|540920333|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
149941294|NCT00042289|540920334|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
149941295|NCT00042289|540920335|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
149941296|NCT00042289|540920336|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
149941297|NCT00042289|540920337|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
149941298|NCT00042289|540920338|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
149941299|NCT00042289|540920339|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
149941300|NCT00042289|540920340|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
150169930|NCT02341625|541757200|FG000|Overall Study|Not Reported|0|||
149941301|NCT00042289|540920341|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
149941302|NCT00042289|540920342|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
149941303|NCT00042289|540920343|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
149941304|NCT00042289|540920344|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
149941305|NCT00042289|540920345|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
149941306|NCT00042289|540920346|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
149941307|NCT00042289|540920347|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
149941308|NCT00042289|540920348|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
149941309|NCT00042289|540920349|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
149941310|NCT00042289|540920350|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
149941311|NCT00042289|540920351|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
149941312|NCT00042289|540920352|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
149941313|NCT00042289|540920353|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
149941314|NCT00042289|540920354|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
149941315|NCT00042289|540920355|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
149941316|NCT00042289|540920356|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
149941317|NCT00042289|540920357|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
149941318|NCT00042289|540920358|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
149941319|NCT00042289|540920359|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
149941320|NCT00042289|540920360|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
149941321|NCT00042289|540920361|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
149941322|NCT00042289|540920362|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
149941323|NCT00042289|540920363|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
149941324|NCT00042289|540920364|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
149941325|NCT00042289|540920365|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
149941326|NCT00042289|540920366|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
149941327|NCT00042289|540920367|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
149941328|NCT00042289|540920368|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
149941329|NCT00042289|540920369|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
149941330|NCT00042289|540920370|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
149941331|NCT00042289|540920371|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
149941332|NCT00042289|540920325|FG000|Overall Study|Protocol Violation|0|||
149941333|NCT00042289|540920326|FG001|Overall Study|Protocol Violation|0|||
149941334|NCT00042289|540920327|FG002|Overall Study|Protocol Violation|0|||
149941335|NCT00042289|540920328|FG003|Overall Study|Protocol Violation|0|||
149941336|NCT00042289|540920329|FG004|Overall Study|Protocol Violation|0|||
149941337|NCT00042289|540920330|FG005|Overall Study|Protocol Violation|1|||
149941338|NCT00042289|540920331|FG006|Overall Study|Protocol Violation|0|||
149941339|NCT00042289|540920332|FG007|Overall Study|Protocol Violation|1|||
149941340|NCT00042289|540920333|FG008|Overall Study|Protocol Violation|0|||
149941341|NCT00042289|540920334|FG009|Overall Study|Protocol Violation|0|||
149941342|NCT00042289|540920335|FG010|Overall Study|Protocol Violation|0|||
149941343|NCT00042289|540920336|FG011|Overall Study|Protocol Violation|0|||
149941344|NCT00042289|540920337|FG012|Overall Study|Protocol Violation|0|||
149941345|NCT00042289|540920338|FG013|Overall Study|Protocol Violation|0|||
149941346|NCT00042289|540920339|FG014|Overall Study|Protocol Violation|0|||
149941347|NCT00042289|540920340|FG015|Overall Study|Protocol Violation|0|||
149941348|NCT00042289|540920341|FG016|Overall Study|Protocol Violation|0|||
149941349|NCT00042289|540920342|FG017|Overall Study|Protocol Violation|0|||
149941350|NCT00042289|540920343|FG018|Overall Study|Protocol Violation|0|||
149941351|NCT00042289|540920344|FG019|Overall Study|Protocol Violation|0|||
149941352|NCT00042289|540920345|FG020|Overall Study|Protocol Violation|0|||
149941353|NCT00042289|540920346|FG021|Overall Study|Protocol Violation|0|||
149941354|NCT00042289|540920347|FG022|Overall Study|Protocol Violation|0|||
149941355|NCT00042289|540920348|FG023|Overall Study|Protocol Violation|1|||
149941356|NCT00042289|540920349|FG024|Overall Study|Protocol Violation|1|||
149941357|NCT00042289|540920350|FG025|Overall Study|Protocol Violation|0|||
149941358|NCT00042289|540920351|FG026|Overall Study|Protocol Violation|2|||
149941359|NCT00042289|540920352|FG027|Overall Study|Protocol Violation|0|||
149941360|NCT00042289|540920353|FG028|Overall Study|Protocol Violation|0|||
149941361|NCT00042289|540920354|FG029|Overall Study|Protocol Violation|0|||
149941362|NCT00042289|540920355|FG030|Overall Study|Protocol Violation|1|||
149941363|NCT00042289|540920356|FG031|Overall Study|Protocol Violation|0|||
149941364|NCT00042289|540920357|FG032|Overall Study|Protocol Violation|0|||
149941365|NCT00042289|540920358|FG033|Overall Study|Protocol Violation|0|||
149941366|NCT00042289|540920359|FG034|Overall Study|Protocol Violation|0|||
149941367|NCT00042289|540920360|FG035|Overall Study|Protocol Violation|0|||
149941368|NCT00042289|540920361|FG036|Overall Study|Protocol Violation|0|||
149941369|NCT00042289|540920362|FG037|Overall Study|Protocol Violation|0|||
149941370|NCT00042289|540920363|FG038|Overall Study|Protocol Violation|0|||
149941371|NCT00042289|540920364|FG039|Overall Study|Protocol Violation|0|||
150031527|NCT00385671|541255355|FG000|Overall Study|Withdrawal by Subject|4|||
150031528|NCT00385671|541255356|FG001|Overall Study|Withdrawal by Subject|4|||
150031529|NCT00385671|541255357|FG002|Overall Study|Withdrawal by Subject|4|||
150031530|NCT03037385|541255360|FG000|Overall Study|Adverse Event|0|||
150031531|NCT03037385|541255361|FG001|Overall Study|Adverse Event|0|||
150031532|NCT03037385|541255362|FG002|Overall Study|Adverse Event|1|||
150031533|NCT03037385|541255363|FG003|Overall Study|Adverse Event|0|||
150031534|NCT03037385|541255364|FG004|Overall Study|Adverse Event|0|||
150031535|NCT03037385|541255365|FG005|Overall Study|Adverse Event|0|||
150031536|NCT03037385|541255366|FG006|Overall Study|Adverse Event|0|||
150031537|NCT03037385|541255367|FG007|Overall Study|Adverse Event|0|||
150031538|NCT03037385|541255368|FG008|Overall Study|Adverse Event|0|||
150031539|NCT03037385|541255369|FG009|Overall Study|Adverse Event|6|||
150031540|NCT03037385|541255360|FG000|Overall Study|Death|1|||
150031541|NCT03037385|541255361|FG001|Overall Study|Death|4|||
150031542|NCT03037385|541255362|FG002|Overall Study|Death|2|||
150031543|NCT03037385|541255363|FG003|Overall Study|Death|2|||
150031544|NCT03037385|541255364|FG004|Overall Study|Death|5|||
150031545|NCT03037385|541255365|FG005|Overall Study|Death|2|||
150031546|NCT03037385|541255366|FG006|Overall Study|Death|1|||
150031547|NCT03037385|541255367|FG007|Overall Study|Death|4|||
150031548|NCT03037385|541255368|FG008|Overall Study|Death|3|||
150031549|NCT03037385|541255369|FG009|Overall Study|Death|240|||
150031550|NCT03037385|541255360|FG000|Overall Study|Initiation of Another Therapy|1|||
150031551|NCT03037385|541255361|FG001|Overall Study|Initiation of Another Therapy|0|||
150031552|NCT03037385|541255362|FG002|Overall Study|Initiation of Another Therapy|0|||
150031553|NCT03037385|541255363|FG003|Overall Study|Initiation of Another Therapy|0|||
150031554|NCT03037385|541255364|FG004|Overall Study|Initiation of Another Therapy|0|||
150031555|NCT03037385|541255365|FG005|Overall Study|Initiation of Another Therapy|0|||
150031556|NCT03037385|541255366|FG006|Overall Study|Initiation of Another Therapy|0|||
150031557|NCT03037385|541255367|FG007|Overall Study|Initiation of Another Therapy|1|||
150031558|NCT03037385|541255368|FG008|Overall Study|Initiation of Another Therapy|0|||
150031559|NCT03037385|541255369|FG009|Overall Study|Initiation of Another Therapy|2|||
150031560|NCT03037385|541255360|FG000|Overall Study|Lost to Follow-up|0|||
150031561|NCT03037385|541255361|FG001|Overall Study|Lost to Follow-up|0|||
150031562|NCT03037385|541255362|FG002|Overall Study|Lost to Follow-up|0|||
150031563|NCT03037385|541255363|FG003|Overall Study|Lost to Follow-up|0|||
150031564|NCT03037385|541255364|FG004|Overall Study|Lost to Follow-up|0|||
150031565|NCT03037385|541255365|FG005|Overall Study|Lost to Follow-up|1|||
150031566|NCT03037385|541255366|FG006|Overall Study|Lost to Follow-up|0|||
149821300|NCT00585351|540475683|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
150031567|NCT03037385|541255367|FG007|Overall Study|Lost to Follow-up|0|||
150031568|NCT03037385|541255368|FG008|Overall Study|Lost to Follow-up|0|||
150031569|NCT03037385|541255369|FG009|Overall Study|Lost to Follow-up|16|||
149821301|NCT00585351|540475684|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
149821302|NCT00585351|540475685|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
149821303|NCT00585351|540475678|FG000|Enrollment Period (Intervention)|Death|0|||
149821304|NCT00585351|540475679|FG001|Enrollment Period (Intervention)|Death|0|||
149821305|NCT00585351|540475680|FG002|Enrollment Period (Intervention)|Death|0|||
149821306|NCT00585351|540475681|FG003|Enrollment Period (Intervention)|Death|0|||
149821307|NCT00585351|540475682|FG004|Enrollment Period (Intervention)|Death|1|||
149821308|NCT00585351|540475683|FG005|Enrollment Period (Intervention)|Death|0|||
149821309|NCT00585351|540475684|FG006|Enrollment Period (Intervention)|Death|1|||
149821310|NCT00585351|540475685|FG007|Enrollment Period (Intervention)|Death|0|||
149821311|NCT00585351|540475678|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821312|NCT00585351|540475679|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821313|NCT00585351|540475680|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821314|NCT00585351|540475681|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821315|NCT00585351|540475682|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
149821316|NCT00585351|540475683|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
149821317|NCT00585351|540475684|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821318|NCT00585351|540475685|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
149821319|NCT01001169|540475686|FG000|Overall Study|Withdrawal by Subject|2|||
149821320|NCT01001169|540475687|FG001|Overall Study|Withdrawal by Subject|1|||
150031570|NCT03037385|541255360|FG000|Overall Study|Physician Decision|0|||
150031571|NCT03037385|541255361|FG001|Overall Study|Physician Decision|0|||
149821321|NCT02536378|540475690|FG000|Overall Study|Physician Decision|0|||
150031572|NCT03037385|541255362|FG002|Overall Study|Physician Decision|0|||
150031573|NCT03037385|541255363|FG003|Overall Study|Physician Decision|0|||
150031574|NCT03037385|541255364|FG004|Overall Study|Physician Decision|0|||
150031575|NCT03037385|541255365|FG005|Overall Study|Physician Decision|0|||
150031576|NCT03037385|541255366|FG006|Overall Study|Physician Decision|0|||
150031577|NCT03037385|541255367|FG007|Overall Study|Physician Decision|0|||
150031578|NCT03037385|541255368|FG008|Overall Study|Physician Decision|0|||
150031579|NCT03037385|541255369|FG009|Overall Study|Physician Decision|1|||
150031580|NCT03037385|541255360|FG000|Overall Study|Progressive Disease|0|||
149821322|NCT02536378|540475691|FG001|Overall Study|Physician Decision|2|||
149941372|NCT00042289|540920365|FG040|Overall Study|Protocol Violation|0|||
150031581|NCT03037385|541255361|FG001|Overall Study|Progressive Disease|1|||
150031582|NCT03037385|541255362|FG002|Overall Study|Progressive Disease|1|||
150031583|NCT03037385|541255363|FG003|Overall Study|Progressive Disease|5|||
150031584|NCT03037385|541255364|FG004|Overall Study|Progressive Disease|2|||
150031585|NCT03037385|541255365|FG005|Overall Study|Progressive Disease|0|||
150031586|NCT03037385|541255366|FG006|Overall Study|Progressive Disease|1|||
150031587|NCT03037385|541255367|FG007|Overall Study|Progressive Disease|0|||
150031588|NCT03037385|541255368|FG008|Overall Study|Progressive Disease|0|||
150031589|NCT03037385|541255369|FG009|Overall Study|Progressive Disease|30|||
150031590|NCT03037385|541255360|FG000|Overall Study|Withdrawal by Subject|0|||
150031591|NCT03037385|541255361|FG001|Overall Study|Withdrawal by Subject|0|||
150031592|NCT03037385|541255362|FG002|Overall Study|Withdrawal by Subject|1|||
150031593|NCT03037385|541255363|FG003|Overall Study|Withdrawal by Subject|2|||
150031594|NCT03037385|541255364|FG004|Overall Study|Withdrawal by Subject|1|||
150031595|NCT03037385|541255365|FG005|Overall Study|Withdrawal by Subject|3|||
150031596|NCT03037385|541255366|FG006|Overall Study|Withdrawal by Subject|0|||
150031597|NCT03037385|541255367|FG007|Overall Study|Withdrawal by Subject|0|||
150031598|NCT03037385|541255368|FG008|Overall Study|Withdrawal by Subject|0|||
150031599|NCT03037385|541255369|FG009|Overall Study|Withdrawal by Subject|52|||
150031600|NCT03037385|541255360|FG000|Overall Study|Reason Not Specified|0|||
150031601|NCT03037385|541255361|FG001|Overall Study|Reason Not Specified|1|||
150031602|NCT03037385|541255362|FG002|Overall Study|Reason Not Specified|0|||
150031603|NCT03037385|541255363|FG003|Overall Study|Reason Not Specified|4|||
150031604|NCT03037385|541255364|FG004|Overall Study|Reason Not Specified|3|||
150031605|NCT03037385|541255365|FG005|Overall Study|Reason Not Specified|6|||
150031606|NCT03037385|541255366|FG006|Overall Study|Reason Not Specified|2|||
150031607|NCT03037385|541255367|FG007|Overall Study|Reason Not Specified|0|||
150031608|NCT03037385|541255368|FG008|Overall Study|Reason Not Specified|1|||
150031609|NCT03037385|541255369|FG009|Overall Study|Reason Not Specified|181|||
149941373|NCT00042289|540920366|FG041|Overall Study|Protocol Violation|1|||
149941374|NCT00042289|540920367|FG042|Overall Study|Protocol Violation|1|||
149941375|NCT00042289|540920368|FG043|Overall Study|Protocol Violation|1|||
149941376|NCT00042289|540920369|FG044|Overall Study|Protocol Violation|0|||
149941377|NCT00042289|540920370|FG045|Overall Study|Protocol Violation|0|||
149941378|NCT00042289|540920371|FG046|Overall Study|Protocol Violation|0|||
149941379|NCT00042289|540920325|FG000|Overall Study|Withdrawal by Subject|4|||
149941380|NCT00042289|540920326|FG001|Overall Study|Withdrawal by Subject|1|||
149941381|NCT00042289|540920327|FG002|Overall Study|Withdrawal by Subject|0|||
149941382|NCT00042289|540920328|FG003|Overall Study|Withdrawal by Subject|2|||
149941383|NCT00042289|540920329|FG004|Overall Study|Withdrawal by Subject|0|||
149941384|NCT00042289|540920330|FG005|Overall Study|Withdrawal by Subject|2|||
149941385|NCT00042289|540920331|FG006|Overall Study|Withdrawal by Subject|0|||
149941386|NCT00042289|540920332|FG007|Overall Study|Withdrawal by Subject|0|||
149941387|NCT00042289|540920333|FG008|Overall Study|Withdrawal by Subject|0|||
149941388|NCT00042289|540920334|FG009|Overall Study|Withdrawal by Subject|1|||
149941389|NCT00042289|540920335|FG010|Overall Study|Withdrawal by Subject|0|||
149941390|NCT00042289|540920336|FG011|Overall Study|Withdrawal by Subject|0|||
149941391|NCT00042289|540920337|FG012|Overall Study|Withdrawal by Subject|2|||
149941392|NCT00042289|540920338|FG013|Overall Study|Withdrawal by Subject|0|||
149941393|NCT00042289|540920339|FG014|Overall Study|Withdrawal by Subject|0|||
149941394|NCT00042289|540920340|FG015|Overall Study|Withdrawal by Subject|0|||
149941395|NCT00042289|540920341|FG016|Overall Study|Withdrawal by Subject|0|||
149941396|NCT00042289|540920342|FG017|Overall Study|Withdrawal by Subject|0|||
149941397|NCT00042289|540920343|FG018|Overall Study|Withdrawal by Subject|0|||
149941398|NCT00042289|540920344|FG019|Overall Study|Withdrawal by Subject|0|||
149941399|NCT00042289|540920345|FG020|Overall Study|Withdrawal by Subject|0|||
149941400|NCT00042289|540920346|FG021|Overall Study|Withdrawal by Subject|1|||
149941401|NCT00042289|540920347|FG022|Overall Study|Withdrawal by Subject|1|||
149941402|NCT00042289|540920348|FG023|Overall Study|Withdrawal by Subject|1|||
149941403|NCT00042289|540920349|FG024|Overall Study|Withdrawal by Subject|0|||
150031610|NCT04515771|541255370|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
149941404|NCT00042289|540920350|FG025|Overall Study|Withdrawal by Subject|0|||
150031611|NCT04515771|541255371|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
150031612|NCT04515771|541255370|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
150031613|NCT04515771|541255371|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
149941405|NCT00042289|540920351|FG026|Overall Study|Withdrawal by Subject|1|||
149941406|NCT00042289|540920352|FG027|Overall Study|Withdrawal by Subject|0|||
149941407|NCT00042289|540920353|FG028|Overall Study|Withdrawal by Subject|2|||
150031614|NCT04515771|541255370|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
150169931|NCT02341625|541757201|FG001|Overall Study|Not Reported|0|||
149941408|NCT00042289|540920354|FG029|Overall Study|Withdrawal by Subject|0|||
150169932|NCT02341625|541757202|FG002|Overall Study|Not Reported|0|||
149941409|NCT00042289|540920355|FG030|Overall Study|Withdrawal by Subject|0|||
149941410|NCT00042289|540920356|FG031|Overall Study|Withdrawal by Subject|1|||
150031615|NCT04515771|541255371|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
149941411|NCT00042289|540920357|FG032|Overall Study|Withdrawal by Subject|2|||
149941412|NCT00042289|540920358|FG033|Overall Study|Withdrawal by Subject|1|||
149941413|NCT00042289|540920359|FG034|Overall Study|Withdrawal by Subject|0|||
150031616|NCT01021020|541255373|FG000|Period I|Protocol Violation|1|||
150031617|NCT01021020|541255373|FG000|Period I|Withdrawal by Subject|1|||
150031618|NCT01021020|541255373|FG000|14 Day Washout Period A|Physician Decision|1|||
150031619|NCT05543265|541255377|FG000|Overall Study|Lost to Follow-up|3|||
150031620|NCT05543265|541255378|FG001|Overall Study|Lost to Follow-up|3|||
150031621|NCT05543265|541255377|FG000|Overall Study|Withdrawal by Subject|0|||
150031622|NCT05543265|541255378|FG001|Overall Study|Withdrawal by Subject|1|||
150031623|NCT02766023|541255379|FG000|Overall Study|Lost to Follow-up|23|||
150031624|NCT02766023|541255380|FG001|Overall Study|Lost to Follow-up|11|||
150031625|NCT02766023|541255379|FG000|Overall Study|Pregnancy|1|||
149941414|NCT00042289|540920360|FG035|Overall Study|Withdrawal by Subject|0|||
149941415|NCT00042289|540920361|FG036|Overall Study|Withdrawal by Subject|0|||
149941416|NCT00042289|540920362|FG037|Overall Study|Withdrawal by Subject|1|||
149941417|NCT00042289|540920363|FG038|Overall Study|Withdrawal by Subject|0|||
149941418|NCT00042289|540920364|FG039|Overall Study|Withdrawal by Subject|0|||
149941419|NCT00042289|540920365|FG040|Overall Study|Withdrawal by Subject|0|||
149941420|NCT00042289|540920366|FG041|Overall Study|Withdrawal by Subject|0|||
149941421|NCT00042289|540920367|FG042|Overall Study|Withdrawal by Subject|1|||
149941422|NCT00042289|540920368|FG043|Overall Study|Withdrawal by Subject|0|||
149941423|NCT00042289|540920369|FG044|Overall Study|Withdrawal by Subject|0|||
149941424|NCT00042289|540920370|FG045|Overall Study|Withdrawal by Subject|0|||
149941425|NCT00042289|540920371|FG046|Overall Study|Withdrawal by Subject|0|||
149941426|NCT03973996|540920375|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149941427|NCT03973996|540920376|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149941428|NCT03973996|540920377|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149941429|NCT03973996|540920378|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
149941430|NCT02194465|540920381|FG000|Overall Study|Adverse Event|6|||
149941431|NCT02194465|540920382|FG001|Overall Study|Adverse Event|1|||
149941432|NCT02194465|540920383|FG002|Overall Study|Adverse Event|4|||
149941433|NCT02194465|540920384|FG003|Overall Study|Adverse Event|4|||
149941434|NCT02194465|540920385|FG004|Overall Study|Adverse Event|4|||
149941435|NCT02194465|540920386|FG005|Overall Study|Adverse Event|2|||
149941436|NCT02194465|540920387|FG006|Overall Study|Adverse Event|0|||
149941437|NCT02194465|540920381|FG000|Overall Study|Lost to Follow-up|0|||
149941438|NCT02194465|540920382|FG001|Overall Study|Lost to Follow-up|0|||
149941439|NCT02194465|540920383|FG002|Overall Study|Lost to Follow-up|0|||
149941440|NCT02194465|540920384|FG003|Overall Study|Lost to Follow-up|1|||
149941441|NCT02194465|540920385|FG004|Overall Study|Lost to Follow-up|0|||
149941442|NCT02194465|540920386|FG005|Overall Study|Lost to Follow-up|1|||
149941443|NCT02194465|540920387|FG006|Overall Study|Lost to Follow-up|0|||
149941444|NCT02194465|540920381|FG000|Overall Study|Physician Decision|1|||
149941445|NCT02194465|540920382|FG001|Overall Study|Physician Decision|0|||
149941446|NCT02194465|540920383|FG002|Overall Study|Physician Decision|0|||
149941447|NCT02194465|540920384|FG003|Overall Study|Physician Decision|0|||
149941448|NCT02194465|540920385|FG004|Overall Study|Physician Decision|0|||
149941449|NCT02194465|540920386|FG005|Overall Study|Physician Decision|0|||
149941450|NCT02194465|540920387|FG006|Overall Study|Physician Decision|0|||
149941451|NCT02194465|540920381|FG000|Overall Study|Protocol Violation|1|||
149941452|NCT02194465|540920382|FG001|Overall Study|Protocol Violation|1|||
149941453|NCT02194465|540920383|FG002|Overall Study|Protocol Violation|2|||
149941454|NCT02194465|540920384|FG003|Overall Study|Protocol Violation|1|||
149941455|NCT02194465|540920385|FG004|Overall Study|Protocol Violation|1|||
149941456|NCT02194465|540920386|FG005|Overall Study|Protocol Violation|0|||
149941457|NCT02194465|540920387|FG006|Overall Study|Protocol Violation|0|||
149941458|NCT02194465|540920381|FG000|Overall Study|Withdrawal by Subject|1|||
149941459|NCT02194465|540920382|FG001|Overall Study|Withdrawal by Subject|3|||
149941460|NCT02194465|540920383|FG002|Overall Study|Withdrawal by Subject|1|||
149941461|NCT02194465|540920384|FG003|Overall Study|Withdrawal by Subject|2|||
149941462|NCT02194465|540920385|FG004|Overall Study|Withdrawal by Subject|2|||
150169933|NCT02341625|541757203|FG003|Overall Study|Not Reported|0|||
149941463|NCT02194465|540920386|FG005|Overall Study|Withdrawal by Subject|1|||
149941464|NCT02194465|540920387|FG006|Overall Study|Withdrawal by Subject|2|||
150169934|NCT02341625|541757204|FG004|Overall Study|Not Reported|0|||
149941465|NCT02194465|540920381|FG000|Overall Study|Discontinued follow-up period|0|||
149941466|NCT02194465|540920382|FG001|Overall Study|Discontinued follow-up period|2|||
149941467|NCT02194465|540920383|FG002|Overall Study|Discontinued follow-up period|1|||
149941468|NCT02194465|540920384|FG003|Overall Study|Discontinued follow-up period|0|||
149941469|NCT02194465|540920385|FG004|Overall Study|Discontinued follow-up period|2|||
149941470|NCT02194465|540920386|FG005|Overall Study|Discontinued follow-up period|0|||
150169935|NCT02341625|541757205|FG005|Overall Study|Not Reported|0|||
149941471|NCT02194465|540920387|FG006|Overall Study|Discontinued follow-up period|0|||
149941472|NCT04810962|540920388|FG000|Overall Study|Adverse Event|0|||
149941473|NCT04810962|540920389|FG001|Overall Study|Adverse Event|1|||
149941474|NCT04810962|540920388|FG000|Overall Study|Lost to Follow-up|2|||
149941475|NCT04810962|540920389|FG001|Overall Study|Lost to Follow-up|1|||
149941476|NCT04810962|540920388|FG000|Overall Study|Physician Decision|1|||
149941477|NCT04810962|540920389|FG001|Overall Study|Physician Decision|0|||
149941478|NCT04810962|540920388|FG000|Overall Study|Withdrawal by Subject|1|||
149941479|NCT04810962|540920389|FG001|Overall Study|Withdrawal by Subject|3|||
149941480|NCT04810962|540920388|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
149941481|NCT04810962|540920389|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
149941482|NCT02412657|540920390|FG000|Overall Study|Lost to Follow-up|1|||
149941483|NCT02412657|540920391|FG001|Overall Study|Lost to Follow-up|0|||
149941484|NCT02412657|540920392|FG002|Overall Study|Lost to Follow-up|0|||
149941485|NCT02412657|540920390|FG000|Overall Study|Protocol Violation|0|||
149941486|NCT02412657|540920391|FG001|Overall Study|Protocol Violation|2|||
149941487|NCT02412657|540920392|FG002|Overall Study|Protocol Violation|3|||
149941488|NCT04530552|540920396|FG000|Overall Study|Physician Decision|0|||
149941489|NCT04530552|540920397|FG001|Overall Study|Physician Decision|1|||
149941490|NCT04530552|540920396|FG000|Overall Study|Withdrawal by Subject|0|||
149941491|NCT04530552|540920397|FG001|Overall Study|Withdrawal by Subject|1|||
149941492|NCT04530552|540920396|FG000|Overall Study|Adverse Event|0|||
149941493|NCT04530552|540920397|FG001|Overall Study|Adverse Event|1|||
149941494|NCT04530552|540920396|FG000|Overall Study|No surgery|0|||
149941495|NCT04530552|540920397|FG001|Overall Study|No surgery|1|||
149941496|NCT04220021|540920409|FG000|Overall Study|Withdrawal by Subject|11|||
149941497|NCT04220021|540920409|FG000|Overall Study|Physician Decision|2|||
149941498|NCT04220021|540920409|FG000|Overall Study|Non-study related illness|5|||
149941499|NCT04935879|540920411|FG000|Overall Study|Adverse Event|2|||
149941500|NCT04935879|540920412|FG001|Overall Study|Adverse Event|1|||
149941501|NCT04935879|540920411|FG000|Overall Study|Lost to Follow-up|1|||
149941502|NCT04935879|540920412|FG001|Overall Study|Lost to Follow-up|1|||
149941503|NCT04935879|540920411|FG000|Overall Study|Pregnancy|2|||
149941504|NCT04935879|540920412|FG001|Overall Study|Pregnancy|3|||
150031626|NCT02766023|541255380|FG001|Overall Study|Pregnancy|0|||
150031627|NCT02766023|541255379|FG000|Overall Study|Adverse Event|1|||
150031628|NCT02766023|541255380|FG001|Overall Study|Adverse Event|0|||
149941505|NCT04935879|540920411|FG000|Overall Study|Withdrawal by Subject|8|||
149941506|NCT04935879|540920412|FG001|Overall Study|Withdrawal by Subject|6|||
149941507|NCT04935879|540920411|FG000|Overall Study|Other|3|||
149941508|NCT04935879|540920412|FG001|Overall Study|Other|3|||
149941509|NCT02839707|540920418|FG000|Phase I|Not eligible for analysis|9|||
149941510|NCT02839707|540920419|FG001|Phase I|Not eligible for analysis|0|||
149941511|NCT02839707|540920420|FG002|Phase I|Not eligible for analysis|0|||
149941512|NCT02839707|540920418|FG000|Phase II|Not treated according to protocol|4|||
149941513|NCT02839707|540920419|FG001|Phase II|Not treated according to protocol|0|||
149941514|NCT02839707|540920420|FG002|Phase II|Not treated according to protocol|2|||
149941515|NCT02839707|540920418|FG000|Phase III|Not treated according to protocol|0|||
149941516|NCT02839707|540920419|FG001|Phase III|Not treated according to protocol|0|||
149941517|NCT02839707|540920420|FG002|Phase III|Not treated according to protocol|4|||
149941518|NCT02634710|540920421|FG000|Overall Study|Death|4|||
149941519|NCT00548327|540922072|FG000|Overall Study|Adverse Event|0|||
149941520|NCT00548327|540922073|FG001|Overall Study|Adverse Event|1|||
149941521|NCT01673386|540922074|FG000|Overall Study|Study terminated by sponsor|16|||
149941522|NCT01673386|540922075|FG001|Overall Study|Study terminated by sponsor|22|||
149941523|NCT01673386|540922074|FG000|Overall Study|Adverse Event|5|||
149941524|NCT01673386|540922075|FG001|Overall Study|Adverse Event|2|||
149941525|NCT01673386|540922074|FG000|Overall Study|Progressive disease|4|||
149941526|NCT01673386|540922075|FG001|Overall Study|Progressive disease|1|||
149941527|NCT01673386|540922074|FG000|Overall Study|Withdrawal by Subject|0|||
149941528|NCT01673386|540922075|FG001|Overall Study|Withdrawal by Subject|2|||
149941529|NCT00109343|540922076|FG000|Overall Study|Adverse Event|1|||
149941530|NCT00109343|540922077|FG001|Overall Study|Adverse Event|0|||
149941531|NCT00109343|540922078|FG002|Overall Study|Adverse Event|2|||
149941532|NCT00109343|540922076|FG000|Overall Study|Lack of Efficacy|1|||
149941533|NCT00109343|540922077|FG001|Overall Study|Lack of Efficacy|0|||
149941534|NCT00109343|540922078|FG002|Overall Study|Lack of Efficacy|0|||
150031629|NCT02766023|541255379|FG000|Overall Study|Withdrawal by Subject|4|||
150031630|NCT02766023|541255380|FG001|Overall Study|Withdrawal by Subject|5|||
150031631|NCT02766023|541255379|FG000|Overall Study|Physician Decision|1|||
150169936|NCT02341625|541757206|FG006|Overall Study|Not Reported|0|||
150031632|NCT02766023|541255380|FG001|Overall Study|Physician Decision|0|||
150031633|NCT02766023|541255379|FG000|Overall Study|Not Eligible at Enrollment|0|||
150169937|NCT02341625|541757207|FG007|Overall Study|Not Reported|0|||
150169938|NCT02341625|541757208|FG008|Overall Study|Not Reported|0|||
150169939|NCT02341625|541757209|FG009|Overall Study|Not Reported|3|||
150169940|NCT01839877|541757212|FG000|Overall Study|Protocol Violation|1|||
149941535|NCT00109343|540922076|FG000|Overall Study|Lost to Follow-up|35|||
149941536|NCT00109343|540922077|FG001|Overall Study|Lost to Follow-up|20|||
149941537|NCT00109343|540922078|FG002|Overall Study|Lost to Follow-up|14|||
149941538|NCT00109343|540922076|FG000|Overall Study|Protocol Violation|1|||
149941539|NCT00109343|540922077|FG001|Overall Study|Protocol Violation|2|||
149941540|NCT00109343|540922078|FG002|Overall Study|Protocol Violation|2|||
149941541|NCT00109343|540922076|FG000|Overall Study|Withdrawal by Subject|15|||
149941542|NCT00109343|540922077|FG001|Overall Study|Withdrawal by Subject|11|||
149941543|NCT00109343|540922078|FG002|Overall Study|Withdrawal by Subject|10|||
149941544|NCT00109343|540922076|FG000|Overall Study|Subject Moved|6|||
149941545|NCT00109343|540922077|FG001|Overall Study|Subject Moved|2|||
149941546|NCT00109343|540922078|FG002|Overall Study|Subject Moved|1|||
149941547|NCT00109343|540922076|FG000|Overall Study|Other|5|||
149941548|NCT00109343|540922077|FG001|Overall Study|Other|2|||
149941549|NCT00109343|540922078|FG002|Overall Study|Other|1|||
149941550|NCT01721798|540922079|FG000|Overall Study|Death|0|||
149941551|NCT01721798|540922080|FG001|Overall Study|Death|0|||
149941552|NCT01721798|540922081|FG002|Overall Study|Death|1|||
149941553|NCT01721798|540922082|FG003|Overall Study|Death|1|||
149941554|NCT01721798|540922079|FG000|Overall Study|Lost to Follow-up|2|||
149941555|NCT01721798|540922080|FG001|Overall Study|Lost to Follow-up|2|||
149941556|NCT01721798|540922081|FG002|Overall Study|Lost to Follow-up|9|||
149941557|NCT01721798|540922082|FG003|Overall Study|Lost to Follow-up|9|||
149941558|NCT01721798|540922079|FG000|Overall Study|Pregnancy|0|||
149941559|NCT01721798|540922080|FG001|Overall Study|Pregnancy|0|||
149941560|NCT01721798|540922081|FG002|Overall Study|Pregnancy|1|||
149941561|NCT01721798|540922082|FG003|Overall Study|Pregnancy|1|||
149941562|NCT01721798|540922079|FG000|Overall Study|Withdrawal by Subject|1|||
149941563|NCT01721798|540922080|FG001|Overall Study|Withdrawal by Subject|0|||
149941564|NCT01721798|540922081|FG002|Overall Study|Withdrawal by Subject|2|||
149941565|NCT01721798|540922082|FG003|Overall Study|Withdrawal by Subject|1|||
149941566|NCT01721798|540922079|FG000|Overall Study|Not eligible for 24 month visit|1|||
149941567|NCT01721798|540922080|FG001|Overall Study|Not eligible for 24 month visit|0|||
149941568|NCT01721798|540922081|FG002|Overall Study|Not eligible for 24 month visit|8|||
149941569|NCT01721798|540922082|FG003|Overall Study|Not eligible for 24 month visit|7|||
149941570|NCT00336544|540922083|FG000|Overall Study|Lack of Efficacy|8|||
149941571|NCT00336544|540922084|FG001|Overall Study|Lack of Efficacy|5|||
149941572|NCT00336544|540922083|FG000|Overall Study|Adverse Event|4|||
149941573|NCT00336544|540922084|FG001|Overall Study|Adverse Event|9|||
149941574|NCT00336544|540922083|FG000|Overall Study|Withdrawal by Subject|4|||
149941575|NCT00336544|540922084|FG001|Overall Study|Withdrawal by Subject|3|||
149941576|NCT00336544|540922083|FG000|Overall Study|Other|3|||
149941577|NCT00336544|540922084|FG001|Overall Study|Other|5|||
149941578|NCT01649765|540922085|FG000|Overall Study|Adverse Event|5|||
149941579|NCT01649765|540922086|FG001|Overall Study|Adverse Event|3|||
149941580|NCT01649765|540922085|FG000|Overall Study|Lack of Efficacy|1|||
149941581|NCT01649765|540922086|FG001|Overall Study|Lack of Efficacy|1|||
149941582|NCT01649765|540922085|FG000|Overall Study|Physician Decision|0|||
149941583|NCT01649765|540922086|FG001|Overall Study|Physician Decision|3|||
149941584|NCT01649765|540922085|FG000|Overall Study|Protocol Violation|1|||
149941585|NCT01649765|540922086|FG001|Overall Study|Protocol Violation|0|||
149941586|NCT01649765|540922085|FG000|Overall Study|Withdrawal by Subject|2|||
149941587|NCT01649765|540922086|FG001|Overall Study|Withdrawal by Subject|1|||
149941588|NCT00961064|540922087|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
149941589|NCT00961064|540922087|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
149941590|NCT00961064|540922087|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
149941591|NCT00961064|540922087|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
149941592|NCT00961064|540922087|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
149941593|NCT00961064|540922087|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
149941594|NCT00961064|540922087|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
149941595|NCT00961064|540922087|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
149941596|NCT01408641|540922088|FG000|Overall Study|Physician Decision|1|||
149941597|NCT01408641|540922089|FG001|Overall Study|Physician Decision|0|||
149941598|NCT00715208|540922090|FG000|Overall Study|Withdrawal by Subject|1|||
149941599|NCT00715208|540922091|FG001|Overall Study|Withdrawal by Subject|1|||
149941600|NCT00715208|540922090|FG000|Overall Study|Adverse Event|0|||
149941601|NCT00715208|540922091|FG001|Overall Study|Adverse Event|6|||
149941602|NCT00715208|540922090|FG000|Overall Study|Lack of Efficacy|0|||
149941603|NCT00715208|540922091|FG001|Overall Study|Lack of Efficacy|2|||
149941604|NCT01648764|540922092|FG000|Overall Study|Progressive Disease|0|||
149941605|NCT01648764|540922093|FG001|Overall Study|Progressive Disease|1|||
150169941|NCT00597519|541757215|FG000|Overall Study|Death|1|||
149941606|NCT01648764|540922094|FG002|Overall Study|Progressive Disease|0|||
149941607|NCT01648764|540922095|FG003|Overall Study|Progressive Disease|0|||
149941608|NCT01648764|540922096|FG004|Overall Study|Progressive Disease|0|||
149941609|NCT01648764|540922097|FG005|Overall Study|Progressive Disease|1|||
149941610|NCT01648764|540922098|FG006|Overall Study|Progressive Disease|1|||
149941611|NCT01648764|540922099|FG007|Overall Study|Progressive Disease|0|||
149941612|NCT01648764|540922100|FG008|Overall Study|Progressive Disease|0|||
149941613|NCT01648764|540922101|FG009|Overall Study|Progressive Disease|2|||
149941614|NCT01648764|540922102|FG010|Overall Study|Progressive Disease|0|||
149941615|NCT01648764|540922103|FG011|Overall Study|Progressive Disease|1|||
149941616|NCT01648764|540922104|FG012|Overall Study|Progressive Disease|2|||
149941617|NCT01648764|540922105|FG013|Overall Study|Progressive Disease|1|||
149941618|NCT01648764|540922092|FG000|Overall Study|Adverse Event|0|||
149941619|NCT01648764|540922093|FG001|Overall Study|Adverse Event|0|||
149941620|NCT01648764|540922094|FG002|Overall Study|Adverse Event|0|||
149941621|NCT01648764|540922095|FG003|Overall Study|Adverse Event|0|||
149941622|NCT01648764|540922096|FG004|Overall Study|Adverse Event|0|||
149941623|NCT01648764|540922097|FG005|Overall Study|Adverse Event|1|||
149941624|NCT01648764|540922098|FG006|Overall Study|Adverse Event|0|||
149941625|NCT01648764|540922099|FG007|Overall Study|Adverse Event|0|||
149941626|NCT01648764|540922100|FG008|Overall Study|Adverse Event|0|||
149941627|NCT01648764|540922101|FG009|Overall Study|Adverse Event|1|||
149941628|NCT01648764|540922102|FG010|Overall Study|Adverse Event|0|||
149941629|NCT01648764|540922103|FG011|Overall Study|Adverse Event|3|||
149941630|NCT01648764|540922104|FG012|Overall Study|Adverse Event|1|||
149941631|NCT01648764|540922105|FG013|Overall Study|Adverse Event|1|||
149941632|NCT01648764|540922092|FG000|Overall Study|Death|0|||
149941633|NCT01648764|540922093|FG001|Overall Study|Death|0|||
149941634|NCT01648764|540922094|FG002|Overall Study|Death|0|||
149941635|NCT01648764|540922095|FG003|Overall Study|Death|0|||
149941636|NCT01648764|540922096|FG004|Overall Study|Death|0|||
149941637|NCT01648764|540922097|FG005|Overall Study|Death|0|||
149941638|NCT01648764|540922098|FG006|Overall Study|Death|1|||
149941639|NCT01648764|540922099|FG007|Overall Study|Death|0|||
149941640|NCT01648764|540922100|FG008|Overall Study|Death|0|||
149941641|NCT01648764|540922101|FG009|Overall Study|Death|0|||
149941642|NCT01648764|540922102|FG010|Overall Study|Death|0|||
149941643|NCT01648764|540922103|FG011|Overall Study|Death|0|||
149941644|NCT01648764|540922104|FG012|Overall Study|Death|0|||
149941645|NCT01648764|540922105|FG013|Overall Study|Death|1|||
149941646|NCT01648764|540922092|FG000|Overall Study|Withdrawal by Subject|0|||
149941647|NCT01648764|540922093|FG001|Overall Study|Withdrawal by Subject|0|||
149941648|NCT01648764|540922094|FG002|Overall Study|Withdrawal by Subject|0|||
149941649|NCT01648764|540922095|FG003|Overall Study|Withdrawal by Subject|0|||
149941650|NCT01648764|540922096|FG004|Overall Study|Withdrawal by Subject|0|||
149941651|NCT01648764|540922097|FG005|Overall Study|Withdrawal by Subject|0|||
149941652|NCT01648764|540922098|FG006|Overall Study|Withdrawal by Subject|2|||
149941653|NCT01648764|540922099|FG007|Overall Study|Withdrawal by Subject|0|||
149941654|NCT01648764|540922100|FG008|Overall Study|Withdrawal by Subject|0|||
149941655|NCT01648764|540922101|FG009|Overall Study|Withdrawal by Subject|0|||
149941656|NCT01648764|540922102|FG010|Overall Study|Withdrawal by Subject|0|||
149941657|NCT01648764|540922103|FG011|Overall Study|Withdrawal by Subject|0|||
149941658|NCT01648764|540922104|FG012|Overall Study|Withdrawal by Subject|1|||
149941659|NCT01648764|540922105|FG013|Overall Study|Withdrawal by Subject|0|||
149941660|NCT01648764|540922092|FG000|Overall Study|Investigator Decision|0|||
149941661|NCT01648764|540922093|FG001|Overall Study|Investigator Decision|0|||
149941662|NCT01648764|540922094|FG002|Overall Study|Investigator Decision|0|||
149941663|NCT01648764|540922095|FG003|Overall Study|Investigator Decision|0|||
149941664|NCT01648764|540922096|FG004|Overall Study|Investigator Decision|0|||
149941665|NCT01648764|540922097|FG005|Overall Study|Investigator Decision|0|||
149941666|NCT01648764|540922098|FG006|Overall Study|Investigator Decision|1|||
149941667|NCT01648764|540922099|FG007|Overall Study|Investigator Decision|0|||
149941668|NCT01648764|540922100|FG008|Overall Study|Investigator Decision|0|||
149941669|NCT01648764|540922101|FG009|Overall Study|Investigator Decision|0|||
149941670|NCT01648764|540922102|FG010|Overall Study|Investigator Decision|0|||
149941671|NCT01648764|540922103|FG011|Overall Study|Investigator Decision|1|||
149941672|NCT01648764|540922104|FG012|Overall Study|Investigator Decision|0|||
149941673|NCT01648764|540922105|FG013|Overall Study|Investigator Decision|0|||
149941674|NCT01316614|540922106|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
149941675|NCT01316614|540922106|FG000|Overall Study|Cytology slides not available for review|4|||
149941676|NCT01316614|540922106|FG000|Overall Study|Cystic lesion|5|||
149941677|NCT01316614|540922106|FG000|Overall Study|Inadequate number of passes|2|||
149941678|NCT01316614|540922106|FG000|Overall Study|Medically unstable|1|||
149941679|NCT03427411|540922107|FG000|Overall Study|Screen failure - platelets too low|0|||
149941680|NCT03427411|540922108|FG001|Overall Study|Screen failure - platelets too low|1|||
149941681|NCT00076570|540922109|FG000|Overall Study|Drug intolerance|8|||
149941682|NCT00076570|540922110|FG001|Overall Study|Drug intolerance|8|||
149941683|NCT01294046|540922111|FG000|Overall Study|Infection and surgical explant|1|||
149941684|NCT01294046|540922111|FG000|Overall Study|Eligibility criteria expanded|1|||
149941685|NCT01294046|540922111|FG000|Overall Study|Stimulation response inadqequate|1|||
149941686|NCT00089648|540922112|FG000|Overall Study|Adverse Event|7|||
149941687|NCT00089648|540922112|FG000|Overall Study|Withdrawal by Subject|1|||
149941688|NCT00089648|540922112|FG000|Overall Study|Lack of Efficacy|33|||
149941689|NCT00420745|540922113|FG000|Overall Study|Adverse Event|2|||
149941690|NCT00420745|540922114|FG001|Overall Study|Adverse Event|2|||
149941691|NCT00420745|540922113|FG000|Overall Study|Lost to Follow-up|10|||
149941692|NCT00420745|540922114|FG001|Overall Study|Lost to Follow-up|2|||
149941693|NCT00420745|540922113|FG000|Overall Study|Protocol Violation|1|||
149941694|NCT00420745|540922114|FG001|Overall Study|Protocol Violation|0|||
149941695|NCT00420745|540922113|FG000|Overall Study|Physician Decision|1|||
149941696|NCT00420745|540922114|FG001|Overall Study|Physician Decision|1|||
149941697|NCT00420745|540922113|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
150031634|NCT02766023|541255380|FG001|Overall Study|Not Eligible at Enrollment|1|||
150031635|NCT00286468|541255383|FG000|Overall Study|Hyperglycemic Rescue|28|||
150031636|NCT00286468|541255384|FG001|Overall Study|Hyperglycemic Rescue|30|||
150031637|NCT00286468|541255385|FG002|Overall Study|Hyperglycemic Rescue|31|||
150031638|NCT00286468|541255383|FG000|Overall Study|Adverse Event|2|||
150031639|NCT00286468|541255384|FG001|Overall Study|Adverse Event|6|||
150031640|NCT00286468|541255385|FG002|Overall Study|Adverse Event|4|||
150031641|NCT00286468|541255383|FG000|Overall Study|Protocol Violation|0|||
150031642|NCT00286468|541255384|FG001|Overall Study|Protocol Violation|3|||
150031643|NCT00286468|541255385|FG002|Overall Study|Protocol Violation|1|||
150031644|NCT00286468|541255383|FG000|Overall Study|Lost to Follow-up|1|||
150031645|NCT00286468|541255384|FG001|Overall Study|Lost to Follow-up|1|||
150031646|NCT00286468|541255385|FG002|Overall Study|Lost to Follow-up|2|||
150031647|NCT00286468|541255383|FG000|Overall Study|Withdrawal by Subject|3|||
150031648|NCT00286468|541255384|FG001|Overall Study|Withdrawal by Subject|8|||
150031649|NCT00286468|541255385|FG002|Overall Study|Withdrawal by Subject|11|||
150031650|NCT00286468|541255383|FG000|Overall Study|Physician Decision|3|||
150169942|NCT05484726|541757216|FG000|Overall Study|Protocol Violation|3|||
149941698|NCT00420745|540922114|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
149941699|NCT00420745|540922113|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
149941700|NCT00420745|540922114|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
149941701|NCT00423605|540922115|FG000|Overall Study|Adverse Event|129|||
149941702|NCT00423605|540922115|FG000|Overall Study|Withdrawal by Subject|36|||
149941703|NCT00423605|540922115|FG000|Overall Study|Lost to Follow-up|15|||
149941704|NCT00423605|540922115|FG000|Overall Study|Lack of Efficacy|38|||
149941705|NCT00423605|540922115|FG000|Overall Study|Sponsor Decision|3|||
149941706|NCT00423605|540922115|FG000|Overall Study|Physician Decision|8|||
149941707|NCT00423605|540922115|FG000|Overall Study|Protocol Violation|7|||
149941708|NCT00423605|540922115|FG000|Overall Study|Not one of the pre-specified options|5|||
149941709|NCT03183908|540922119|FG000|Overall Study|Missing Symptom Diary Data|0|||
149941710|NCT03183908|540922120|FG001|Overall Study|Missing Symptom Diary Data|2|||
149941711|NCT03738696|540922121|FG000|Overall Study|Withdrawal by Subject|0|||
149941712|NCT03738696|540922122|FG001|Overall Study|Withdrawal by Subject|1|||
149941713|NCT03738696|540922121|FG000|Overall Study|Lost to Follow-up|8|||
149941714|NCT03738696|540922122|FG001|Overall Study|Lost to Follow-up|14|||
149941715|NCT01588509|540922125|FG000|Overall Study|Lost to Follow-up|1|||
149941716|NCT01588509|540922126|FG001|Overall Study|Lost to Follow-up|0|||
149941717|NCT01983930|540922127|FG000|Overall Study|Withdrawal by Subject|9|||
149941718|NCT01983930|540922128|FG001|Overall Study|Withdrawal by Subject|8|||
149941719|NCT01983930|540922127|FG000|Overall Study|Adverse Event|0|||
149941720|NCT01983930|540922128|FG001|Overall Study|Adverse Event|1|||
149941721|NCT01454284|540922129|FG000|Overall Study|Adverse Event|20|||
149941722|NCT01454284|540922130|FG001|Overall Study|Adverse Event|7|||
149941723|NCT01454284|540922129|FG000|Overall Study|Death|0|||
149941724|NCT01454284|540922130|FG001|Overall Study|Death|3|||
149941725|NCT01454284|540922129|FG000|Overall Study|Lost to Follow-up|13|||
149941726|NCT01454284|540922130|FG001|Overall Study|Lost to Follow-up|8|||
149941727|NCT01454284|540922129|FG000|Overall Study|Protocol Violation|9|||
149941728|NCT01454284|540922130|FG001|Overall Study|Protocol Violation|6|||
149941729|NCT01454284|540922129|FG000|Overall Study|Withdrawal by Subject|58|||
149941730|NCT01454284|540922130|FG001|Overall Study|Withdrawal by Subject|36|||
149941731|NCT01454284|540922129|FG000|Overall Study|Physician Decision|16|||
149941732|NCT01454284|540922130|FG001|Overall Study|Physician Decision|11|||
149941733|NCT01454284|540922129|FG000|Overall Study|Sponsor Decision|0|||
149941734|NCT01454284|540922130|FG001|Overall Study|Sponsor Decision|2|||
149941735|NCT00393367|540922133|FG000|Overall Study|Protocol Violation|2|||
149941736|NCT00393367|540922134|FG001|Overall Study|Protocol Violation|5|||
149941737|NCT00393367|540922133|FG000|Overall Study|Withdrawal by Subject|0|||
149941738|NCT00393367|540922134|FG001|Overall Study|Withdrawal by Subject|2|||
149941739|NCT00091819|540922135|FG000|Overall Study|Adverse Event|1|||
149941740|NCT00091819|540922136|FG001|Overall Study|Adverse Event|1|||
149941741|NCT00091819|540922135|FG000|Overall Study|Death|4|||
149941742|NCT00091819|540922136|FG001|Overall Study|Death|5|||
149941743|NCT00091819|540922135|FG000|Overall Study|Lost to Follow-up|26|||
149941744|NCT00091819|540922136|FG001|Overall Study|Lost to Follow-up|23|||
149941745|NCT00091819|540922135|FG000|Overall Study|Withdrawal by Subject|5|||
149941746|NCT00091819|540922136|FG001|Overall Study|Withdrawal by Subject|8|||
149941747|NCT00091819|540922135|FG000|Overall Study|Protocol Violation|1|||
149941748|NCT00091819|540922136|FG001|Overall Study|Protocol Violation|2|||
149941749|NCT00091819|540922135|FG000|Overall Study|Other|2|||
150031651|NCT00286468|541255384|FG001|Overall Study|Physician Decision|2|||
150031652|NCT00286468|541255385|FG002|Overall Study|Physician Decision|1|||
150031653|NCT02953652|541255386|FG000|Overall Study|Adverse Event|18|||
150031654|NCT02953652|541255386|FG000|Overall Study|Withdrawal by Subject|6|||
150031655|NCT02953652|541255386|FG000|Overall Study|Protocol Violation|1|||
150169943|NCT05484726|541757217|FG001|Overall Study|Protocol Violation|3|||
149941750|NCT00091819|540922136|FG001|Overall Study|Other|3|||
149941751|NCT00091819|540922135|FG000|Overall Study|Never received study treatment|3|||
149941752|NCT00091819|540922136|FG001|Overall Study|Never received study treatment|4|||
149941753|NCT05001620|540922137|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
149941754|NCT05001620|540922138|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
149941755|NCT00481676|540922139|FG000|Overall Study|Adverse Event|0|||
149941756|NCT00481676|540922140|FG001|Overall Study|Adverse Event|1|||
149941757|NCT00481676|540922139|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149941758|NCT00481676|540922140|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
149941759|NCT00481676|540922139|FG000|Overall Study|Administrative problem|1|||
149941760|NCT00481676|540922140|FG001|Overall Study|Administrative problem|0|||
149941761|NCT02911116|540922141|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149941762|NCT02911116|540922142|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149941763|NCT02911116|540922141|FG000|Overall Study|Lost to Follow-up|0|||
149941764|NCT02911116|540922142|FG001|Overall Study|Lost to Follow-up|1|||
149941765|NCT00819039|540922143|FG000|Overall Study|Physician Decision|1|||
149941766|NCT00819039|540922144|FG001|Overall Study|Physician Decision|0|||
149941767|NCT00819039|540922145|FG002|Overall Study|Physician Decision|1|||
149941768|NCT00819039|540922143|FG000|Overall Study|Protocol Violation|1|||
149941769|NCT00819039|540922144|FG001|Overall Study|Protocol Violation|0|||
149941770|NCT00819039|540922145|FG002|Overall Study|Protocol Violation|0|||
149941771|NCT04796415|540922146|FG000|Overall Study|not interested|12|||
149941772|NCT04796415|540922146|FG000|Overall Study|health issue|8|||
149941773|NCT04796415|540922146|FG000|Overall Study|Other|4|||
149941774|NCT04796415|540922146|FG000|Overall Study|discharged from home health service|3|||
149941775|NCT04796415|540922146|FG000|Overall Study|re-hospitalization|2|||
149941776|NCT04796415|540922146|FG000|Overall Study|moving to nursing home|1|||
149941777|NCT04796415|540922146|FG000|Overall Study|lost contact|1|||
149941778|NCT03185208|540922151|FG000|Overall Study|Did not start study medication|0|||
149941779|NCT03185208|540922152|FG001|Overall Study|Did not start study medication|3|||
149941780|NCT01311661|540922157|FG000|Overall Study|Adverse Event|2|||
149941781|NCT01311661|540922157|FG000|Overall Study|Protocol Violation|3|||
149941782|NCT01311661|540922157|FG000|Overall Study|Withdrawal by Subject|2|||
149941783|NCT00701363|540922158|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
149941784|NCT00701363|540922159|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
149941785|NCT00701363|540922160|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
149941786|NCT00701363|540922161|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
149941787|NCT00701363|540922158|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
149941788|NCT00701363|540922159|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
149941789|NCT00701363|540922160|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
149941790|NCT00701363|540922161|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
149941791|NCT00701363|540922158|FG000|Treatment Phase 1|Adverse Event|7|||
149941792|NCT00701363|540922159|FG001|Treatment Phase 1|Adverse Event|0|||
149941793|NCT00701363|540922160|FG002|Treatment Phase 1|Adverse Event|0|||
149941794|NCT00701363|540922161|FG003|Treatment Phase 1|Adverse Event|0|||
149941795|NCT00701363|540922158|FG000|Treatment Phase 1|Protocol Violation|1|||
149941796|NCT00701363|540922159|FG001|Treatment Phase 1|Protocol Violation|0|||
149941797|NCT00701363|540922160|FG002|Treatment Phase 1|Protocol Violation|0|||
149941798|NCT00701363|540922161|FG003|Treatment Phase 1|Protocol Violation|0|||
149941799|NCT00701363|540922158|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
149941800|NCT00701363|540922159|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
149941801|NCT00701363|540922160|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
149941802|NCT00701363|540922161|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
149941803|NCT00701363|540922158|FG000|Treatment Phase 1|Lack of Efficacy|1|||
149941804|NCT00701363|540922159|FG001|Treatment Phase 1|Lack of Efficacy|0|||
149941805|NCT00701363|540922160|FG002|Treatment Phase 1|Lack of Efficacy|0|||
149941806|NCT00701363|540922161|FG003|Treatment Phase 1|Lack of Efficacy|0|||
149941807|NCT00701363|540922158|FG000|Treatment Phase 2|Adverse Event|0|||
149941808|NCT00701363|540922159|FG001|Treatment Phase 2|Adverse Event|0|||
149941809|NCT00701363|540922160|FG002|Treatment Phase 2|Adverse Event|1|||
149941810|NCT00701363|540922161|FG003|Treatment Phase 2|Adverse Event|0|||
149941811|NCT00701363|540922158|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
149941812|NCT00701363|540922159|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
149941813|NCT00701363|540922160|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
149941814|NCT00701363|540922161|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
149941815|NCT04759131|540922162|FG000|Overall Study|Investigator's discretion|1|||
149941816|NCT04759131|540922163|FG001|Overall Study|Investigator's discretion|0|||
149941817|NCT04759131|540922162|FG000|Overall Study|Subject withdrawal|1|||
149941818|NCT04759131|540922163|FG001|Overall Study|Subject withdrawal|0|||
149941819|NCT05144945|540922164|FG000|Overall Study|Withdrawal by Subject|1|||
149941820|NCT05144945|540922165|FG001|Overall Study|Withdrawal by Subject|0|||
149941821|NCT00465179|540922168|FG000|Overall Study|Adverse Event|4|||
149941822|NCT00465179|540922168|FG000|Overall Study|Withdrawal by Subject|2|||
149941823|NCT00465179|540922168|FG000|Overall Study|Progression of Disease|47|||
149941824|NCT00833755|540922172|FG000|Overall Study|Physician Decision|4|||
149941825|NCT00833755|540922173|FG001|Overall Study|Physician Decision|4|||
149941826|NCT00833755|540922174|FG002|Overall Study|Physician Decision|2|||
149941827|NCT00833755|540922175|FG003|Overall Study|Physician Decision|6|||
149941828|NCT00833755|540922172|FG000|Overall Study|Subject had scheduling issues|0|||
149821323|NCT02536378|540475690|FG000|Overall Study|Withdrawal by Subject|0|||
149941829|NCT00833755|540922173|FG001|Overall Study|Subject had scheduling issues|1|||
149941830|NCT00833755|540922174|FG002|Overall Study|Subject had scheduling issues|0|||
149941831|NCT00833755|540922175|FG003|Overall Study|Subject had scheduling issues|0|||
149941832|NCT00560404|540922177|FG000|Overall Study|Adverse Event|2|||
149941833|NCT00560404|540922178|FG001|Overall Study|Adverse Event|3|||
149941834|NCT00560404|540922177|FG000|Overall Study|Death|3|||
149941835|NCT00560404|540922178|FG001|Overall Study|Death|3|||
149941836|NCT00560404|540922177|FG000|Overall Study|Protocol Violation|12|||
150031656|NCT02953652|541255386|FG000|Overall Study|Disease Progression|27|||
150031657|NCT02927301|541255389|FG000|Overall Study|Death|39|||
150031658|NCT02927301|541255389|FG000|Overall Study|Lost to Follow-up|8|||
150031659|NCT02927301|541255389|FG000|Overall Study|Physician Decision|2|||
150031660|NCT02927301|541255389|FG000|Overall Study|Withdrawal by Subject|12|||
150031661|NCT02927301|541255389|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
150031662|NCT04742556|541255390|FG000|Overall Study|Withdrawal by Subject|0|||
150031663|NCT04742556|541255391|FG001|Overall Study|Withdrawal by Subject|1|||
150031664|NCT04742556|541255392|FG002|Overall Study|Withdrawal by Subject|0|||
150031665|NCT04742556|541255390|FG000|Overall Study|Adverse Event|0|||
150169944|NCT05484726|541757216|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
150169945|NCT05484726|541757217|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
150169946|NCT05484726|541757216|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
150169947|NCT05484726|541757217|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
150169948|NCT05484726|541757216|FG000|Overall Study|continued need of mechanical ventilation|2|||
150169949|NCT05484726|541757217|FG001|Overall Study|continued need of mechanical ventilation|3|||
150169950|NCT05484726|541757216|FG000|Overall Study|Withdrawal by Subject|2|||
150169951|NCT05484726|541757217|FG001|Overall Study|Withdrawal by Subject|3|||
150169952|NCT05484726|541757216|FG000|Overall Study|IVH (G III & IV)|2|||
150169953|NCT05484726|541757217|FG001|Overall Study|IVH (G III & IV)|1|||
150169954|NCT05484726|541757216|FG000|Overall Study|NEC (stage II & III)|2|||
150169955|NCT05484726|541757217|FG001|Overall Study|NEC (stage II & III)|3|||
150169956|NCT02781584|541757218|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
150169957|NCT02781584|541757219|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
150169958|NCT02781584|541757220|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
150169959|NCT02781584|541757221|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
150169960|NCT02781584|541757222|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
150169961|NCT02781584|541757223|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
150169962|NCT02781584|541757224|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
150169963|NCT02781584|541757225|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
150169964|NCT02781584|541757226|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
150169965|NCT02781584|541757227|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
150169966|NCT02781584|541757228|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
150169967|NCT02781584|541757229|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
150169968|NCT02781584|541757230|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
150169969|NCT02781584|541757218|FG000|Pre-treatment Phase|Adverse Event|0|||
150169970|NCT02781584|541757219|FG001|Pre-treatment Phase|Adverse Event|0|||
150169971|NCT02781584|541757220|FG002|Pre-treatment Phase|Adverse Event|0|||
150169972|NCT02781584|541757221|FG003|Pre-treatment Phase|Adverse Event|0|||
150169973|NCT02781584|541757222|FG004|Pre-treatment Phase|Adverse Event|0|||
150169974|NCT02781584|541757223|FG005|Pre-treatment Phase|Adverse Event|0|||
150169975|NCT02781584|541757224|FG006|Pre-treatment Phase|Adverse Event|0|||
150169976|NCT02781584|541757225|FG007|Pre-treatment Phase|Adverse Event|0|||
150169977|NCT02781584|541757226|FG008|Pre-treatment Phase|Adverse Event|0|||
150169978|NCT02781584|541757227|FG009|Pre-treatment Phase|Adverse Event|0|||
150169979|NCT02781584|541757228|FG010|Pre-treatment Phase|Adverse Event|0|||
150169980|NCT02781584|541757229|FG011|Pre-treatment Phase|Adverse Event|1|||
150169981|NCT02781584|541757230|FG012|Pre-treatment Phase|Adverse Event|0|||
150169982|NCT02781584|541757218|FG000|Treatment Phase|Withdrew Consent|0|||
150169983|NCT02781584|541757219|FG001|Treatment Phase|Withdrew Consent|0|||
150169984|NCT02781584|541757220|FG002|Treatment Phase|Withdrew Consent|0|||
150169985|NCT02781584|541757221|FG003|Treatment Phase|Withdrew Consent|0|||
150169986|NCT02781584|541757222|FG004|Treatment Phase|Withdrew Consent|0|||
150169987|NCT02781584|541757223|FG005|Treatment Phase|Withdrew Consent|1|||
150169988|NCT02781584|541757224|FG006|Treatment Phase|Withdrew Consent|0|||
149941837|NCT00560404|540922178|FG001|Overall Study|Protocol Violation|7|||
149941838|NCT00560404|540922177|FG000|Overall Study|Administrative Reasons|1|||
149941839|NCT00560404|540922178|FG001|Overall Study|Administrative Reasons|1|||
149941840|NCT00560404|540922177|FG000|Overall Study|Withdrew Consent|4|||
150031666|NCT04742556|541255391|FG001|Overall Study|Adverse Event|0|||
150031667|NCT04742556|541255392|FG002|Overall Study|Adverse Event|2|||
150031668|NCT04742556|541255390|FG000|Overall Study|Clinical disease progression|0|||
149941841|NCT00560404|540922178|FG001|Overall Study|Withdrew Consent|0|||
149941842|NCT00560404|540922177|FG000|Overall Study|Failure to return|1|||
149941843|NCT00560404|540922178|FG001|Overall Study|Failure to return|2|||
149941844|NCT00560404|540922177|FG000|Overall Study|Other withdrawal reason|13|||
149941845|NCT00560404|540922178|FG001|Overall Study|Other withdrawal reason|5|||
149941846|NCT05219162|540922179|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
149941847|NCT05219162|540922179|FG000|Overall Study|Withdrawal by Subject|23|||
149941848|NCT02187783|540922182|FG000|Overall Study|Adverse Event|8|||
149941849|NCT02187783|540922182|FG000|Overall Study|Death|3|||
149941850|NCT02187783|540922182|FG000|Overall Study|Progressive disease|80|||
149941851|NCT02187783|540922182|FG000|Overall Study|Protocol Violation|3|||
149941852|NCT02187783|540922182|FG000|Overall Study|Physician Decision|2|||
149941853|NCT02187783|540922182|FG000|Overall Study|Withdrawal by Subject|9|||
149941854|NCT02187783|540922182|FG000|Overall Study|Study terminated by sponsor|1|||
149941855|NCT00171249|540922183|FG000|Overall Study|Withdrawal by Subject|2|||
149941856|NCT00171249|540922184|FG001|Overall Study|Withdrawal by Subject|0|||
149941857|NCT00171249|540922185|FG002|Overall Study|Withdrawal by Subject|0|||
149941858|NCT00171249|540922186|FG003|Overall Study|Withdrawal by Subject|6|||
149941859|NCT00171249|540922187|FG004|Overall Study|Withdrawal by Subject|0|||
149941860|NCT00171249|540922188|FG005|Overall Study|Withdrawal by Subject|0|||
149941861|NCT00171249|540922189|FG006|Overall Study|Withdrawal by Subject|0|||
149941862|NCT00171249|540922183|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
149941863|NCT00171249|540922184|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149941864|NCT00171249|540922185|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
149941865|NCT00171249|540922186|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
149941866|NCT00171249|540922187|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149941867|NCT00171249|540922188|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
149941868|NCT00171249|540922189|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149941869|NCT00171249|540922183|FG000|Overall Study|Death|7|||
149941870|NCT00171249|540922184|FG001|Overall Study|Death|1|||
149941871|NCT00171249|540922185|FG002|Overall Study|Death|0|||
149941872|NCT00171249|540922186|FG003|Overall Study|Death|4|||
149941873|NCT00171249|540922187|FG004|Overall Study|Death|0|||
149941874|NCT00171249|540922188|FG005|Overall Study|Death|3|||
149941875|NCT00171249|540922189|FG006|Overall Study|Death|1|||
149941876|NCT00171249|540922183|FG000|Overall Study|Other|10|||
149941877|NCT00171249|540922184|FG001|Overall Study|Other|0|||
149941878|NCT00171249|540922185|FG002|Overall Study|Other|0|||
149941879|NCT00171249|540922186|FG003|Overall Study|Other|43|||
149941880|NCT00171249|540922187|FG004|Overall Study|Other|0|||
149941881|NCT00171249|540922188|FG005|Overall Study|Other|2|||
149941882|NCT00171249|540922189|FG006|Overall Study|Other|0|||
149941883|NCT00171249|540922183|FG000|Overall Study|No Longer Requires Study Drug|4|||
149941884|NCT00171249|540922184|FG001|Overall Study|No Longer Requires Study Drug|0|||
149941885|NCT00171249|540922185|FG002|Overall Study|No Longer Requires Study Drug|0|||
149941886|NCT00171249|540922186|FG003|Overall Study|No Longer Requires Study Drug|3|||
149941887|NCT00171249|540922187|FG004|Overall Study|No Longer Requires Study Drug|0|||
149941888|NCT00171249|540922188|FG005|Overall Study|No Longer Requires Study Drug|5|||
149941889|NCT00171249|540922189|FG006|Overall Study|No Longer Requires Study Drug|0|||
149941890|NCT00171249|540922183|FG000|Overall Study|Administrative Problems|1|||
149941891|NCT00171249|540922184|FG001|Overall Study|Administrative Problems|0|||
149941892|NCT00171249|540922185|FG002|Overall Study|Administrative Problems|0|||
149941893|NCT00171249|540922186|FG003|Overall Study|Administrative Problems|2|||
149941894|NCT00171249|540922187|FG004|Overall Study|Administrative Problems|0|||
149941895|NCT00171249|540922188|FG005|Overall Study|Administrative Problems|0|||
149941896|NCT00171249|540922189|FG006|Overall Study|Administrative Problems|0|||
149941897|NCT00171249|540922183|FG000|Overall Study|Adverse Event|3|||
149941898|NCT00171249|540922184|FG001|Overall Study|Adverse Event|1|||
149941899|NCT00171249|540922185|FG002|Overall Study|Adverse Event|0|||
149941900|NCT00171249|540922186|FG003|Overall Study|Adverse Event|15|||
149941901|NCT00171249|540922187|FG004|Overall Study|Adverse Event|0|||
149941902|NCT00171249|540922188|FG005|Overall Study|Adverse Event|2|||
149941903|NCT00171249|540922189|FG006|Overall Study|Adverse Event|0|||
149941904|NCT00171249|540922183|FG000|Overall Study|Lost to Follow-up|5|||
149941905|NCT00171249|540922184|FG001|Overall Study|Lost to Follow-up|0|||
149941906|NCT00171249|540922185|FG002|Overall Study|Lost to Follow-up|0|||
149941907|NCT00171249|540922186|FG003|Overall Study|Lost to Follow-up|9|||
149941908|NCT00171249|540922187|FG004|Overall Study|Lost to Follow-up|0|||
149941909|NCT00171249|540922188|FG005|Overall Study|Lost to Follow-up|0|||
149941910|NCT00171249|540922189|FG006|Overall Study|Lost to Follow-up|0|||
149941911|NCT00471497|540922190|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
149941912|NCT00471497|540922191|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
149941913|NCT00471497|540922192|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
149941914|NCT00471497|540922190|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
149941915|NCT00471497|540922191|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
149941916|NCT00471497|540922192|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
149941917|NCT00471497|540922190|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
149941918|NCT00471497|540922191|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
150031669|NCT04742556|541255391|FG001|Overall Study|Clinical disease progression|1|||
150031670|NCT04742556|541255392|FG002|Overall Study|Clinical disease progression|2|||
150031671|NCT04742556|541255390|FG000|Overall Study|Objective disease progression|3|||
150031672|NCT04742556|541255391|FG001|Overall Study|Objective disease progression|2|||
150031673|NCT04742556|541255392|FG002|Overall Study|Objective disease progression|4|||
150031674|NCT03035032|541255393|FG000|Overall Study|Adverse Event|2|||
150031675|NCT03035032|541255393|FG000|Overall Study|Death|9|||
150031676|NCT03035032|541255393|FG000|Overall Study|Lost to Follow-up|1|||
150031677|NCT03035032|541255393|FG000|Overall Study|Progressive Disease|22|||
150031678|NCT03035032|541255393|FG000|Overall Study|Protocol Violation|2|||
150031679|NCT03035032|541255393|FG000|Overall Study|Withdrawal by Subject|2|||
150031680|NCT03035032|541255393|FG000|Overall Study|Physician Decision|5|||
150031681|NCT03617172|541255410|FG000|Overall Study|Lost to Follow-up|1|||
150031682|NCT03617172|541255411|FG001|Overall Study|Lost to Follow-up|0|||
150031683|NCT03305666|541255412|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
149941919|NCT00471497|540922192|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
149941920|NCT00471497|540922190|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
149941921|NCT00471497|540922191|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
149941922|NCT00471497|540922192|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
149941923|NCT00471497|540922190|FG000|Core Treatment Phase|Lost to Follow-up|6|||
149941924|NCT00471497|540922191|FG001|Core Treatment Phase|Lost to Follow-up|6|||
149941925|NCT00471497|540922192|FG002|Core Treatment Phase|Lost to Follow-up|3|||
149941926|NCT00471497|540922190|FG000|Core Treatment Phase|Death|3|||
149941927|NCT00471497|540922191|FG001|Core Treatment Phase|Death|9|||
149941928|NCT00471497|540922192|FG002|Core Treatment Phase|Death|3|||
149941929|NCT00471497|540922190|FG000|Core Treatment Phase|Disease Progression|10|||
149941930|NCT00471497|540922191|FG001|Core Treatment Phase|Disease Progression|2|||
149941931|NCT00471497|540922192|FG002|Core Treatment Phase|Disease Progression|4|||
149941932|NCT00471497|540922190|FG000|Core Treatment Phase|Protocol Violation|6|||
149941933|NCT00471497|540922191|FG001|Core Treatment Phase|Protocol Violation|15|||
149941934|NCT00471497|540922192|FG002|Core Treatment Phase|Protocol Violation|11|||
149941935|NCT00471497|540922190|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
149941936|NCT00471497|540922191|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
149941937|NCT00471497|540922192|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
149941938|NCT00471497|540922190|FG000|Core Treatment Phase|Administrative problems|14|||
149941939|NCT00471497|540922191|FG001|Core Treatment Phase|Administrative problems|14|||
149941940|NCT00471497|540922192|FG002|Core Treatment Phase|Administrative problems|12|||
149941941|NCT00471497|540922190|FG000|Core Treatment Phase|Adverse Event|43|||
149941942|NCT00471497|540922191|FG001|Core Treatment Phase|Adverse Event|53|||
149941943|NCT00471497|540922192|FG002|Core Treatment Phase|Adverse Event|89|||
149941944|NCT00471497|540922190|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
149941945|NCT00471497|540922191|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
149941946|NCT00471497|540922192|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
149941947|NCT00471497|540922190|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
149941948|NCT00471497|540922191|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
149941949|NCT00471497|540922192|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
149941950|NCT00471497|540922190|FG000|Extension Phase|Adverse Event|9|||
149941951|NCT00471497|540922191|FG001|Extension Phase|Adverse Event|5|||
149941952|NCT00471497|540922192|FG002|Extension Phase|Adverse Event|1|||
149941953|NCT00471497|540922190|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
149941954|NCT00471497|540922191|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
149941955|NCT00471497|540922192|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
149941956|NCT00471497|540922190|FG000|Extension Phase|Withdrawal by Subject|3|||
149941957|NCT00471497|540922191|FG001|Extension Phase|Withdrawal by Subject|1|||
149941958|NCT00471497|540922192|FG002|Extension Phase|Withdrawal by Subject|0|||
149941959|NCT00471497|540922190|FG000|Extension Phase|Lost to Follow-up|2|||
149941960|NCT00471497|540922191|FG001|Extension Phase|Lost to Follow-up|0|||
149941961|NCT00471497|540922192|FG002|Extension Phase|Lost to Follow-up|0|||
149941962|NCT00471497|540922190|FG000|Extension Phase|Death|1|||
149941963|NCT00471497|540922191|FG001|Extension Phase|Death|0|||
149941964|NCT00471497|540922192|FG002|Extension Phase|Death|0|||
149941965|NCT00471497|540922190|FG000|Extension Phase|Disease progression|2|||
149941966|NCT00471497|540922191|FG001|Extension Phase|Disease progression|0|||
150031684|NCT03305666|541255413|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
150031685|NCT02587221|541255417|FG000|Overall Study|Adverse Event|3|||
149941967|NCT00471497|540922192|FG002|Extension Phase|Disease progression|0|||
149941968|NCT00471497|540922190|FG000|Extension Phase|Protocol Violation|2|||
149941969|NCT00471497|540922191|FG001|Extension Phase|Protocol Violation|2|||
149941970|NCT00471497|540922192|FG002|Extension Phase|Protocol Violation|0|||
149941971|NCT01420536|540922198|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
149941972|NCT01420536|540922199|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
150031686|NCT02587221|541255418|FG001|Overall Study|Adverse Event|3|||
150031687|NCT02587221|541255417|FG000|Overall Study|Death|33|||
149941973|NCT04711005|540922200|FG000|Overall Study|Withdrawal by Subject|0|||
149941974|NCT04711005|540922201|FG001|Overall Study|Withdrawal by Subject|0|||
149941975|NCT04711005|540922202|FG002|Overall Study|Withdrawal by Subject|0|||
149941976|NCT04711005|540922203|FG003|Overall Study|Withdrawal by Subject|0|||
149941977|NCT04711005|540922204|FG004|Overall Study|Withdrawal by Subject|0|||
149941978|NCT04711005|540922205|FG005|Overall Study|Withdrawal by Subject|0|||
149941979|NCT04711005|540922206|FG006|Overall Study|Withdrawal by Subject|0|||
149941980|NCT04711005|540922207|FG007|Overall Study|Withdrawal by Subject|1|||
149941981|NCT04711005|540922208|FG008|Overall Study|Withdrawal by Subject|0|||
149941982|NCT04711005|540922209|FG009|Overall Study|Withdrawal by Subject|0|||
149941983|NCT04711005|540922200|FG000|Overall Study|Physician Decision|0|||
149941984|NCT04711005|540922201|FG001|Overall Study|Physician Decision|0|||
149941985|NCT04711005|540922202|FG002|Overall Study|Physician Decision|0|||
149941986|NCT04711005|540922203|FG003|Overall Study|Physician Decision|0|||
149941987|NCT04711005|540922204|FG004|Overall Study|Physician Decision|0|||
150031688|NCT02587221|541255418|FG001|Overall Study|Death|34|||
150031689|NCT02587221|541255417|FG000|Overall Study|Withdrawal by Subject|66|||
150031690|NCT02587221|541255418|FG001|Overall Study|Withdrawal by Subject|61|||
150031691|NCT02587221|541255417|FG000|Overall Study|Lost to Follow-up|21|||
150031692|NCT02587221|541255418|FG001|Overall Study|Lost to Follow-up|19|||
150031693|NCT02587221|541255417|FG000|Overall Study|Protocol Violation|6|||
150031694|NCT02587221|541255418|FG001|Overall Study|Protocol Violation|5|||
150031695|NCT02587221|541255417|FG000|Overall Study|Other Reason or Unspecified|2|||
150031696|NCT02587221|541255418|FG001|Overall Study|Other Reason or Unspecified|1|||
150031697|NCT02546609|541255419|FG000|Overall Study|Withdrawal by Subject|0|||
150031698|NCT02546609|541255420|FG001|Overall Study|Withdrawal by Subject|1|||
150031699|NCT02546609|541255421|FG002|Overall Study|Withdrawal by Subject|2|||
150031700|NCT02546609|541255419|FG000|Overall Study|Adverse Event|0|||
150031701|NCT02546609|541255420|FG001|Overall Study|Adverse Event|6|||
150031702|NCT02546609|541255421|FG002|Overall Study|Adverse Event|1|||
150031703|NCT02546609|541255419|FG000|Overall Study|Protocol Violation|0|||
150031704|NCT02546609|541255420|FG001|Overall Study|Protocol Violation|1|||
150031705|NCT02546609|541255421|FG002|Overall Study|Protocol Violation|1|||
150031706|NCT02546609|541255419|FG000|Overall Study|Lost to Follow-up|2|||
150031707|NCT02546609|541255420|FG001|Overall Study|Lost to Follow-up|3|||
150031708|NCT02546609|541255421|FG002|Overall Study|Lost to Follow-up|1|||
150031709|NCT02546609|541255419|FG000|Overall Study|travel or work schedule restriction|0|||
150031710|NCT02546609|541255420|FG001|Overall Study|travel or work schedule restriction|0|||
150031711|NCT02546609|541255421|FG002|Overall Study|travel or work schedule restriction|2|||
150031712|NCT03780452|541255426|FG000|Overall Study|Screening failure|2|||
150031713|NCT00914849|541255427|FG000|Overall Study|Withdrawal by Subject|1|||
150031714|NCT00914849|541255428|FG001|Overall Study|Withdrawal by Subject|0|||
150031715|NCT00914849|541255427|FG000|Overall Study|Not eligible|0|||
150031716|NCT00914849|541255428|FG001|Overall Study|Not eligible|1|||
150031717|NCT01001221|541255429|FG000|Overall Study|Adverse Event|1|||
150031718|NCT01001221|541255430|FG001|Overall Study|Adverse Event|2|||
150031719|NCT01001221|541255431|FG002|Overall Study|Adverse Event|0|||
150031720|NCT01001221|541255432|FG003|Overall Study|Adverse Event|2|||
150031721|NCT01001221|541255433|FG004|Overall Study|Adverse Event|0|||
150031722|NCT01001221|541255429|FG000|Overall Study|Disease progression|3|||
150031723|NCT01001221|541255430|FG001|Overall Study|Disease progression|2|||
150031724|NCT01001221|541255431|FG002|Overall Study|Disease progression|2|||
150031725|NCT01001221|541255432|FG003|Overall Study|Disease progression|4|||
150031726|NCT01001221|541255433|FG004|Overall Study|Disease progression|0|||
150031727|NCT01001221|541255429|FG000|Overall Study|Other|1|||
150031728|NCT01001221|541255430|FG001|Overall Study|Other|1|||
150031729|NCT01001221|541255431|FG002|Overall Study|Other|0|||
150031730|NCT01001221|541255432|FG003|Overall Study|Other|0|||
150031731|NCT01001221|541255433|FG004|Overall Study|Other|0|||
150274325|NCT05975840|542141611|FG003|Overall Study|Migrated/moved from the study area|0|||
150031732|NCT01001221|541255429|FG000|Overall Study|Not treated; protocol exclusion|0|||
150031733|NCT01001221|541255430|FG001|Overall Study|Not treated; protocol exclusion|0|||
150031734|NCT01001221|541255431|FG002|Overall Study|Not treated; protocol exclusion|1|||
150031735|NCT01001221|541255432|FG003|Overall Study|Not treated; protocol exclusion|0|||
150031736|NCT01001221|541255433|FG004|Overall Study|Not treated; protocol exclusion|0|||
150031737|NCT02388269|541255434|FG000|Overall Study|Adverse Event|2|||
150031738|NCT02388269|541255435|FG001|Overall Study|Adverse Event|0|||
150031739|NCT02388269|541255436|FG002|Overall Study|Adverse Event|0|||
150031740|NCT02388269|541255434|FG000|Overall Study|Withdrawal by Subject|1|||
149941988|NCT04711005|540922205|FG005|Overall Study|Physician Decision|0|||
149941989|NCT04711005|540922206|FG006|Overall Study|Physician Decision|0|||
149941990|NCT04711005|540922207|FG007|Overall Study|Physician Decision|2|||
150031741|NCT02388269|541255435|FG001|Overall Study|Withdrawal by Subject|2|||
150031742|NCT02388269|541255436|FG002|Overall Study|Withdrawal by Subject|0|||
150031743|NCT02388269|541255434|FG000|Overall Study|less than 50% stimulations|1|||
150031744|NCT02388269|541255435|FG001|Overall Study|less than 50% stimulations|0|||
150031745|NCT02388269|541255436|FG002|Overall Study|less than 50% stimulations|0|||
150031746|NCT02388269|541255434|FG000|Overall Study|no diary data|3|||
149941991|NCT04711005|540922208|FG008|Overall Study|Physician Decision|1|||
149941992|NCT04711005|540922209|FG009|Overall Study|Physician Decision|0|||
149941993|NCT00764790|540922210|FG000|Overall Study|Protocol Violation|0|||
149941994|NCT00764790|540922211|FG001|Overall Study|Protocol Violation|0|||
149941995|NCT00764790|540922212|FG002|Overall Study|Protocol Violation|1|||
149941996|NCT00764790|540922210|FG000|Overall Study|Withdrawal by Subject|10|||
149941997|NCT00764790|540922211|FG001|Overall Study|Withdrawal by Subject|12|||
149941998|NCT00764790|540922212|FG002|Overall Study|Withdrawal by Subject|6|||
149941999|NCT00764790|540922210|FG000|Overall Study|Lost to Follow-up|28|||
149942000|NCT00764790|540922211|FG001|Overall Study|Lost to Follow-up|29|||
149942001|NCT00764790|540922212|FG002|Overall Study|Lost to Follow-up|23|||
149942002|NCT03533751|540922213|FG000|Overall Study|Withdrawal by Subject|12|||
149942003|NCT03533751|540922214|FG001|Overall Study|Withdrawal by Subject|6|||
149942004|NCT03533751|540922215|FG002|Overall Study|Withdrawal by Subject|11|||
149942005|NCT03533751|540922216|FG003|Overall Study|Withdrawal by Subject|9|||
149942006|NCT03533751|540922217|FG004|Overall Study|Withdrawal by Subject|10|||
149942007|NCT03533751|540922213|FG000|Overall Study|Adverse Event|4|||
149942008|NCT03533751|540922214|FG001|Overall Study|Adverse Event|7|||
149942009|NCT03533751|540922215|FG002|Overall Study|Adverse Event|2|||
149942010|NCT03533751|540922216|FG003|Overall Study|Adverse Event|4|||
149942011|NCT03533751|540922217|FG004|Overall Study|Adverse Event|5|||
149942012|NCT03533751|540922213|FG000|Overall Study|Physician Decision|0|||
149942013|NCT03533751|540922214|FG001|Overall Study|Physician Decision|2|||
149942014|NCT03533751|540922215|FG002|Overall Study|Physician Decision|1|||
149942015|NCT03533751|540922216|FG003|Overall Study|Physician Decision|2|||
149942016|NCT03533751|540922217|FG004|Overall Study|Physician Decision|1|||
149942017|NCT03533751|540922213|FG000|Overall Study|Sponsor Decision|0|||
149942018|NCT03533751|540922214|FG001|Overall Study|Sponsor Decision|0|||
149942019|NCT03533751|540922215|FG002|Overall Study|Sponsor Decision|1|||
149942020|NCT03533751|540922216|FG003|Overall Study|Sponsor Decision|1|||
149942021|NCT03533751|540922217|FG004|Overall Study|Sponsor Decision|0|||
149942022|NCT03533751|540922213|FG000|Overall Study|Lost to Follow-up|3|||
149942023|NCT03533751|540922214|FG001|Overall Study|Lost to Follow-up|7|||
149942024|NCT03533751|540922215|FG002|Overall Study|Lost to Follow-up|6|||
149942025|NCT03533751|540922216|FG003|Overall Study|Lost to Follow-up|4|||
149942026|NCT03533751|540922217|FG004|Overall Study|Lost to Follow-up|3|||
149942027|NCT03533751|540922213|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
149942028|NCT03533751|540922214|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
149942029|NCT03533751|540922215|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
149942030|NCT03533751|540922216|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
149942031|NCT03533751|540922217|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
149942032|NCT03533751|540922213|FG000|Overall Study|Other|0|||
149942033|NCT03533751|540922214|FG001|Overall Study|Other|2|||
149942034|NCT03533751|540922215|FG002|Overall Study|Other|1|||
149942035|NCT03533751|540922216|FG003|Overall Study|Other|0|||
149942036|NCT03533751|540922217|FG004|Overall Study|Other|3|||
149942037|NCT06070610|540922221|FG000|Washout period|Adverse Event|1|||
149942038|NCT06070610|540922221|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
149942039|NCT02485860|540922223|FG000|Overall Study|Lost to Follow-up|4|||
149942040|NCT02485860|540922224|FG001|Overall Study|Lost to Follow-up|1|||
149942041|NCT02485860|540922223|FG000|Overall Study|Physician Decision|1|||
149942042|NCT02485860|540922224|FG001|Overall Study|Physician Decision|2|||
149942043|NCT02485860|540922223|FG000|Overall Study|Health context (COVID-19)|1|||
149942044|NCT02485860|540922224|FG001|Overall Study|Health context (COVID-19)|0|||
149942045|NCT03586479|540922225|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
149942046|NCT03586479|540922226|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
149942047|NCT03586479|540922227|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
149942048|NCT03586479|540922225|FG000|Overall Study|Protocol Violation|2|||
149942049|NCT03586479|540922226|FG001|Overall Study|Protocol Violation|0|||
149942050|NCT03586479|540922227|FG002|Overall Study|Protocol Violation|0|||
149942051|NCT03586479|540922225|FG000|Overall Study|Lost to Follow-up|1|||
149942052|NCT03586479|540922226|FG001|Overall Study|Lost to Follow-up|1|||
149942053|NCT03586479|540922227|FG002|Overall Study|Lost to Follow-up|2|||
149942054|NCT03586479|540922225|FG000|Overall Study|Behavioral Issues|1|||
149942055|NCT03586479|540922226|FG001|Overall Study|Behavioral Issues|0|||
149821324|NCT02536378|540475691|FG001|Overall Study|Withdrawal by Subject|1|||
149942056|NCT03586479|540922227|FG002|Overall Study|Behavioral Issues|0|||
149942057|NCT00576758|540923652|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
149942058|NCT00576758|540923653|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
149942059|NCT00576758|540923652|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
149942060|NCT00576758|540923653|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
149942061|NCT00576758|540923652|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
149942062|NCT00576758|540923653|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
149942063|NCT00576758|540923652|FG000|Induction Treatment Period|Death|1|||
149942064|NCT00576758|540923653|FG001|Induction Treatment Period|Death|0|||
149942065|NCT00576758|540923652|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
149942066|NCT00576758|540923653|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
149942067|NCT00576758|540923652|FG000|Induction Treatment Period|Withdrew consent|1|||
149942068|NCT00576758|540923653|FG001|Induction Treatment Period|Withdrew consent|0|||
149942069|NCT00576758|540923652|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
149942070|NCT00576758|540923653|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
149942071|NCT00576758|540923652|FG000|Extension Treatment Period|Death|1|||
149942072|NCT00576758|540923653|FG001|Extension Treatment Period|Death|1|||
149942073|NCT00576758|540923652|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
149942074|NCT00576758|540923653|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
149942075|NCT00576758|540923652|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
149942076|NCT00576758|540923653|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
149942077|NCT00576758|540923652|FG000|Extension Treatment Period|Administrative/Other|3|||
149942078|NCT00576758|540923653|FG001|Extension Treatment Period|Administrative/Other|1|||
149942079|NCT00576758|540923652|FG000|Follow-up Period|Administrative/Other|6|||
149942080|NCT00576758|540923653|FG001|Follow-up Period|Administrative/Other|8|||
149942081|NCT00576758|540923652|FG000|Follow-up Period|Death|3|||
149942082|NCT00576758|540923653|FG001|Follow-up Period|Death|3|||
149942083|NCT00576758|540923652|FG000|Follow-up Period|Insufficient therapeutic response|16|||
149942084|NCT00576758|540923653|FG001|Follow-up Period|Insufficient therapeutic response|5|||
149942085|NCT00576758|540923652|FG000|Follow-up Period|Withdrew consent|2|||
149942086|NCT00576758|540923653|FG001|Follow-up Period|Withdrew consent|1|||
149942087|NCT00903968|540923654|FG000|Overall Study|Adverse Event|0|||
149942088|NCT00903968|540923655|FG001|Overall Study|Adverse Event|0|||
149942089|NCT00903968|540923656|FG002|Overall Study|Adverse Event|0|||
149942090|NCT00903968|540923657|FG003|Overall Study|Adverse Event|0|||
149942091|NCT00903968|540923658|FG004|Overall Study|Adverse Event|0|||
149942092|NCT00903968|540923659|FG005|Overall Study|Adverse Event|0|||
149942093|NCT00903968|540923660|FG006|Overall Study|Adverse Event|1|||
149942094|NCT00903968|540923661|FG007|Overall Study|Adverse Event|8|||
149942095|NCT00903968|540923654|FG000|Overall Study|DLT|0|||
149942096|NCT00903968|540923655|FG001|Overall Study|DLT|0|||
149942097|NCT00903968|540923656|FG002|Overall Study|DLT|0|||
149942098|NCT00903968|540923657|FG003|Overall Study|DLT|0|||
149942099|NCT00903968|540923658|FG004|Overall Study|DLT|0|||
149942100|NCT00903968|540923659|FG005|Overall Study|DLT|0|||
149942101|NCT00903968|540923660|FG006|Overall Study|DLT|2|||
149942102|NCT00903968|540923661|FG007|Overall Study|DLT|0|||
149942103|NCT00903968|540923654|FG000|Overall Study|Withdrawal by Subject|1|||
149942104|NCT00903968|540923655|FG001|Overall Study|Withdrawal by Subject|0|||
149942105|NCT00903968|540923656|FG002|Overall Study|Withdrawal by Subject|1|||
149942106|NCT00903968|540923657|FG003|Overall Study|Withdrawal by Subject|0|||
149942107|NCT00903968|540923658|FG004|Overall Study|Withdrawal by Subject|1|||
149942108|NCT00903968|540923659|FG005|Overall Study|Withdrawal by Subject|1|||
149942109|NCT00903968|540923660|FG006|Overall Study|Withdrawal by Subject|0|||
149942110|NCT00903968|540923661|FG007|Overall Study|Withdrawal by Subject|4|||
149942111|NCT00903968|540923654|FG000|Overall Study|Non-Compliance|0|||
149942112|NCT00903968|540923655|FG001|Overall Study|Non-Compliance|0|||
149942113|NCT00903968|540923656|FG002|Overall Study|Non-Compliance|0|||
149942114|NCT00903968|540923657|FG003|Overall Study|Non-Compliance|0|||
149942115|NCT00903968|540923658|FG004|Overall Study|Non-Compliance|0|||
149942116|NCT00903968|540923659|FG005|Overall Study|Non-Compliance|1|||
149942117|NCT00903968|540923660|FG006|Overall Study|Non-Compliance|0|||
149942118|NCT00903968|540923661|FG007|Overall Study|Non-Compliance|0|||
149942119|NCT00903968|540923654|FG000|Overall Study|Physician Decision|0|||
149942120|NCT00903968|540923655|FG001|Overall Study|Physician Decision|0|||
149942121|NCT00903968|540923656|FG002|Overall Study|Physician Decision|0|||
149942122|NCT00903968|540923657|FG003|Overall Study|Physician Decision|0|||
149942123|NCT00903968|540923658|FG004|Overall Study|Physician Decision|0|||
149942124|NCT00903968|540923659|FG005|Overall Study|Physician Decision|1|||
149942125|NCT00903968|540923660|FG006|Overall Study|Physician Decision|0|||
149942126|NCT00903968|540923661|FG007|Overall Study|Physician Decision|0|||
149942127|NCT00903968|540923654|FG000|Overall Study|Progressive Disease|2|||
149942128|NCT00903968|540923655|FG001|Overall Study|Progressive Disease|3|||
149942129|NCT00903968|540923656|FG002|Overall Study|Progressive Disease|2|||
149942130|NCT00903968|540923657|FG003|Overall Study|Progressive Disease|3|||
149942131|NCT00903968|540923658|FG004|Overall Study|Progressive Disease|3|||
149942132|NCT00903968|540923659|FG005|Overall Study|Progressive Disease|3|||
149942133|NCT00903968|540923660|FG006|Overall Study|Progressive Disease|0|||
149942134|NCT00903968|540923661|FG007|Overall Study|Progressive Disease|18|||
149942135|NCT00903968|540923654|FG000|Overall Study|Lack of Efficacy|0|||
149942136|NCT00903968|540923655|FG001|Overall Study|Lack of Efficacy|0|||
149942137|NCT00903968|540923656|FG002|Overall Study|Lack of Efficacy|0|||
149942138|NCT00903968|540923657|FG003|Overall Study|Lack of Efficacy|0|||
149942139|NCT00903968|540923658|FG004|Overall Study|Lack of Efficacy|0|||
149942140|NCT00903968|540923659|FG005|Overall Study|Lack of Efficacy|0|||
149942141|NCT00903968|540923660|FG006|Overall Study|Lack of Efficacy|0|||
149942142|NCT00903968|540923661|FG007|Overall Study|Lack of Efficacy|3|||
149942143|NCT00726453|540923662|FG000|Primary Enrollment Group|Death|18|||
149942144|NCT00726453|540923663|FG001|Primary Enrollment Group|Death|0|||
149942145|NCT00726453|540923662|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
149942146|NCT00726453|540923663|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
149942147|NCT00726453|540923662|FG000|38 mm Length Group|Death|0|||
149942148|NCT00726453|540923663|FG001|38 mm Length Group|Death|3|||
149942149|NCT01513590|540923664|FG000|Overall Study|Adverse Event|2|||
149942150|NCT01513590|540923665|FG001|Overall Study|Adverse Event|3|||
149942151|NCT01513590|540923664|FG000|Overall Study|Withdrawal Criteria|3|||
149942152|NCT01513590|540923665|FG001|Overall Study|Withdrawal Criteria|0|||
149942153|NCT01513590|540923664|FG000|Overall Study|Unclassified|5|||
149942154|NCT01513590|540923665|FG001|Overall Study|Unclassified|10|||
149942155|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
149942156|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
149942157|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
149942158|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
149942159|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
149942160|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
149942161|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
149942162|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
149942163|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
149942164|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
149942165|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Death|3|||
149942166|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Death|1|||
149942167|NCT01056276|540923666|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
149942168|NCT01056276|540923667|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
149942169|NCT01056276|540923666|FG000|Maintenance Therapy|Toxicity|0|||
149942170|NCT01056276|540923667|FG001|Maintenance Therapy|Toxicity|2|||
149942171|NCT01056276|540923666|FG000|Maintenance Therapy|Progressive Disease|0|||
149942172|NCT01056276|540923667|FG001|Maintenance Therapy|Progressive Disease|9|||
149942173|NCT01056276|540923666|FG000|Maintenance Therapy|Physician Decision|0|||
149942174|NCT01056276|540923667|FG001|Maintenance Therapy|Physician Decision|1|||
149942175|NCT01056276|540923666|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
149942176|NCT01056276|540923667|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
149942177|NCT01056276|540923666|FG000|Maintenance Therapy|Intercurrent Illness|0|||
149942178|NCT01056276|540923667|FG001|Maintenance Therapy|Intercurrent Illness|1|||
149942179|NCT01056276|540923666|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
149942180|NCT01056276|540923667|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
149942181|NCT04154956|540923668|FG000|Overall Study|Death|109|||
149942182|NCT04154956|540923669|FG001|Overall Study|Death|110|||
149942183|NCT04154956|540923668|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
149942184|NCT04154956|540923669|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
149942185|NCT04154956|540923668|FG000|Overall Study|Withdrawal by Subject|1|||
149942186|NCT04154956|540923669|FG001|Overall Study|Withdrawal by Subject|7|||
149942187|NCT04154956|540923668|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
149942188|NCT04154956|540923669|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
149942189|NCT00147238|540923670|FG000|Overall Study|Inevaluable|8|||
149942190|NCT04424901|540923671|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
149942191|NCT04424901|540923672|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
149942192|NCT01348269|540923673|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
149942193|NCT01348269|540923674|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
149942194|NCT01348269|540923673|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
149942195|NCT01348269|540923674|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
149942196|NCT01348269|540923673|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
149942197|NCT01348269|540923674|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
149942198|NCT00805532|540923675|FG000|Overall Study|invalid data|0|||
149942199|NCT00805532|540923676|FG001|Overall Study|invalid data|1|||
149942200|NCT01859741|540923677|FG000|Overall Study|Death|3|||
149942201|NCT01859741|540923678|FG001|Overall Study|Death|2|||
150274326|NCT05975840|542141612|FG004|Overall Study|Migrated/moved from the study area|0|||
150274327|NCT05975840|542141613|FG005|Overall Study|Migrated/moved from the study area|0|||
150274328|NCT05975840|542141614|FG006|Overall Study|Migrated/moved from the study area|0|||
150274329|NCT05975840|542141615|FG007|Overall Study|Migrated/moved from the study area|0|||
149942202|NCT01859741|540923679|FG002|Overall Study|Death|4|||
149942203|NCT01859741|540923680|FG003|Overall Study|Death|3|||
149942204|NCT01859741|540923681|FG004|Overall Study|Death|5|||
149942205|NCT01859741|540923682|FG005|Overall Study|Death|4|||
149942206|NCT01859741|540923683|FG006|Overall Study|Death|51|||
150274330|NCT05975840|542141608|FG000|Overall Study|Withdrawal by Subject|0|||
149942207|NCT01859741|540923684|FG007|Overall Study|Death|51|||
149942208|NCT01859741|540923677|FG000|Overall Study|Lost to Follow-up|0|||
149942209|NCT01859741|540923678|FG001|Overall Study|Lost to Follow-up|0|||
149942210|NCT01859741|540923679|FG002|Overall Study|Lost to Follow-up|0|||
149942211|NCT01859741|540923680|FG003|Overall Study|Lost to Follow-up|0|||
150274331|NCT05975840|542141609|FG001|Overall Study|Withdrawal by Subject|5|||
150031747|NCT02388269|541255435|FG001|Overall Study|no diary data|0|||
150031748|NCT02388269|541255436|FG002|Overall Study|no diary data|0|||
150031749|NCT02388269|541255434|FG000|Overall Study|Protocol Violation|2|||
150031750|NCT02388269|541255435|FG001|Overall Study|Protocol Violation|0|||
150031751|NCT02388269|541255436|FG002|Overall Study|Protocol Violation|0|||
150031752|NCT02388269|541255434|FG000|Overall Study|Screen Failure|0|||
150031753|NCT02388269|541255435|FG001|Overall Study|Screen Failure|0|||
150031754|NCT02388269|541255436|FG002|Overall Study|Screen Failure|10|||
150031755|NCT05106959|541255437|FG000|Overall Study|Lost to Follow-up|1|||
150031756|NCT03988400|541255439|FG000|Overall Study|Adverse Event|1|||
150031757|NCT03988400|541255440|FG001|Overall Study|Adverse Event|0|||
150031758|NCT03988400|541255439|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
150031759|NCT03988400|541255440|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
150031760|NCT03988400|541255439|FG000|Overall Study|Lost to Follow-up|0|||
150031761|NCT03988400|541255440|FG001|Overall Study|Lost to Follow-up|1|||
150031762|NCT02542865|541255441|FG000|Overall Study|Identified as screen failure|1|||
150031763|NCT02542865|541255442|FG001|Overall Study|Identified as screen failure|0|||
150031764|NCT02542865|541255441|FG000|Overall Study|Withdrawal by Subject|16|||
150031765|NCT02542865|541255442|FG001|Overall Study|Withdrawal by Subject|0|||
150031766|NCT02240485|541255450|FG000|3 Months Post-admission|Lost to Follow-up|1|||
150031767|NCT02240485|541255451|FG001|3 Months Post-admission|Lost to Follow-up|5|||
150031768|NCT02240485|541255450|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
150031769|NCT02240485|541255451|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
150031770|NCT02240485|541255450|FG000|9 Months Post-admission|Lost to Follow-up|3|||
150031771|NCT02240485|541255451|FG001|9 Months Post-admission|Lost to Follow-up|1|||
150031772|NCT02240485|541255450|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
150031773|NCT02240485|541255451|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
150031774|NCT02240485|541255450|FG000|18 Months Post-admission|Lost to Follow-up|1|||
150031775|NCT02240485|541255451|FG001|18 Months Post-admission|Lost to Follow-up|1|||
150031776|NCT02240485|541255450|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
150031777|NCT02240485|541255451|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
150031778|NCT04038359|541255452|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
150031779|NCT04038359|541255453|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
150031780|NCT04038359|541255452|FG000|Overall Study|Death|8|||
150031781|NCT04038359|541255453|FG001|Overall Study|Death|7|||
150031782|NCT04038359|541255452|FG000|Overall Study|Lost to Follow-up|3|||
150031783|NCT04038359|541255453|FG001|Overall Study|Lost to Follow-up|0|||
150031784|NCT04038359|541255452|FG000|Overall Study|Participant Moved|1|||
150031785|NCT04038359|541255453|FG001|Overall Study|Participant Moved|0|||
150031786|NCT04038359|541255452|FG000|Overall Study|Withdrawal by Subject|4|||
150031787|NCT04038359|541255453|FG001|Overall Study|Withdrawal by Subject|3|||
150031788|NCT04038359|541255452|FG000|Overall Study|Physician Decision|3|||
150031789|NCT04038359|541255453|FG001|Overall Study|Physician Decision|2|||
150031790|NCT04038359|541255452|FG000|Overall Study|Adverse Event|0|||
150031791|NCT04038359|541255453|FG001|Overall Study|Adverse Event|2|||
150031792|NCT04038359|541255452|FG000|Overall Study|Progressive Disease|0|||
150031793|NCT04038359|541255453|FG001|Overall Study|Progressive Disease|1|||
150031794|NCT00703014|541255454|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
150031795|NCT00703014|541255455|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
150031796|NCT00703014|541255456|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
150031797|NCT00703014|541255457|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
150031798|NCT00703014|541255454|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
150031799|NCT00703014|541255455|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
150031800|NCT00703014|541255456|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
150031801|NCT00703014|541255457|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
150031802|NCT02004236|541255458|FG000|Overall Study|Lack of Efficacy|0|||
150031803|NCT02004236|541255459|FG001|Overall Study|Lack of Efficacy|0|||
150031804|NCT02004236|541255460|FG002|Overall Study|Lack of Efficacy|16|||
150031805|NCT04949191|541255461|FG000|Overall Study|Non-compliance with Study Drug|1|||
150031806|NCT04949191|541255462|FG001|Overall Study|Non-compliance with Study Drug|0|||
150031807|NCT04949191|541255463|FG002|Overall Study|Non-compliance with Study Drug|0|||
150031808|NCT04949191|541255464|FG003|Overall Study|Non-compliance with Study Drug|0|||
150031809|NCT04949191|541255461|FG000|Overall Study|Progressive Disease|0|||
150031810|NCT04949191|541255462|FG001|Overall Study|Progressive Disease|1|||
150031811|NCT04949191|541255463|FG002|Overall Study|Progressive Disease|0|||
150031812|NCT04949191|541255464|FG003|Overall Study|Progressive Disease|0|||
150031813|NCT04949191|541255461|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
150031814|NCT04949191|541255462|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
150031815|NCT04949191|541255463|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
150031816|NCT04949191|541255464|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
150031817|NCT04949191|541255461|FG000|Overall Study|Sponsor Terminated Study|0|||
150031818|NCT04949191|541255462|FG001|Overall Study|Sponsor Terminated Study|0|||
149942212|NCT01859741|540923681|FG004|Overall Study|Lost to Follow-up|0|||
149942213|NCT01859741|540923682|FG005|Overall Study|Lost to Follow-up|1|||
149942214|NCT01859741|540923683|FG006|Overall Study|Lost to Follow-up|0|||
149942215|NCT01859741|540923684|FG007|Overall Study|Lost to Follow-up|4|||
149942216|NCT01859741|540923677|FG000|Overall Study|Withdrawal by Subject|0|||
149942217|NCT01859741|540923678|FG001|Overall Study|Withdrawal by Subject|1|||
149942218|NCT01859741|540923679|FG002|Overall Study|Withdrawal by Subject|2|||
149942219|NCT01859741|540923680|FG003|Overall Study|Withdrawal by Subject|0|||
149942220|NCT01859741|540923681|FG004|Overall Study|Withdrawal by Subject|0|||
149942221|NCT01859741|540923682|FG005|Overall Study|Withdrawal by Subject|1|||
149942222|NCT01859741|540923683|FG006|Overall Study|Withdrawal by Subject|1|||
149942223|NCT01859741|540923684|FG007|Overall Study|Withdrawal by Subject|1|||
149942224|NCT01859741|540923677|FG000|Overall Study|Study Terminated by Sponsor|0|||
149942225|NCT01859741|540923678|FG001|Overall Study|Study Terminated by Sponsor|0|||
149942226|NCT01859741|540923679|FG002|Overall Study|Study Terminated by Sponsor|0|||
149942227|NCT01859741|540923680|FG003|Overall Study|Study Terminated by Sponsor|0|||
149942228|NCT01859741|540923681|FG004|Overall Study|Study Terminated by Sponsor|1|||
149942229|NCT01859741|540923682|FG005|Overall Study|Study Terminated by Sponsor|0|||
149942230|NCT01859741|540923683|FG006|Overall Study|Study Terminated by Sponsor|16|||
149942231|NCT01859741|540923684|FG007|Overall Study|Study Terminated by Sponsor|14|||
149942232|NCT01859741|540923677|FG000|Overall Study|Other|0|||
149942233|NCT01859741|540923678|FG001|Overall Study|Other|0|||
149942234|NCT01859741|540923679|FG002|Overall Study|Other|0|||
149942235|NCT01859741|540923680|FG003|Overall Study|Other|0|||
149942236|NCT01859741|540923681|FG004|Overall Study|Other|0|||
149942237|NCT01859741|540923682|FG005|Overall Study|Other|0|||
149942238|NCT01859741|540923683|FG006|Overall Study|Other|2|||
149942239|NCT01859741|540923684|FG007|Overall Study|Other|0|||
149942240|NCT03834350|540923690|FG000|Overall Study|Withdrawal by Subject|1|||
149942241|NCT02701634|540923691|FG000|Overall Study|Adverse Event|2|||
149942242|NCT02701634|540923692|FG001|Overall Study|Adverse Event|3|||
149942243|NCT02701634|540923691|FG000|Overall Study|Death|1|||
149942244|NCT02701634|540923692|FG001|Overall Study|Death|0|||
149942245|NCT02701634|540923691|FG000|Overall Study|Investigator's Discretion|7|||
149942246|NCT02701634|540923692|FG001|Overall Study|Investigator's Discretion|4|||
149942247|NCT02701634|540923691|FG000|Overall Study|Study terminated by Sponsor|15|||
149942248|NCT02701634|540923692|FG001|Overall Study|Study terminated by Sponsor|17|||
149942249|NCT02701634|540923691|FG000|Overall Study|Withdrew Consent|6|||
149942250|NCT02701634|540923692|FG001|Overall Study|Withdrew Consent|7|||
149942251|NCT02701634|540923691|FG000|Overall Study|Randomized but not treated|1|||
149942252|NCT02701634|540923692|FG001|Overall Study|Randomized but not treated|0|||
149942253|NCT00537277|540923693|FG000|Overall Study|Adverse Event|1|||
149942254|NCT00537277|540923693|FG000|Overall Study|Lack of Efficacy|2|||
149942255|NCT00537277|540923693|FG000|Overall Study|Lost to Follow-up|12|||
149942256|NCT00537277|540923693|FG000|Overall Study|Protocol Violation|11|||
149942257|NCT00537277|540923693|FG000|Overall Study|Unclassified|4|||
149942258|NCT00537277|540923693|FG000|Overall Study|Inability to tolerate trial medication|4|||
149942259|NCT00537277|540923693|FG000|Overall Study|Non-compliance with trial procedures|15|||
149942260|NCT03620162|540923694|FG000|Overall Study|Physician Decision|4|||
149942261|NCT03620162|540923695|FG001|Overall Study|Physician Decision|0|||
149942262|NCT03620162|540923696|FG002|Overall Study|Physician Decision|1|||
149942263|NCT03620162|540923697|FG003|Overall Study|Physician Decision|0|||
149942264|NCT03620162|540923698|FG004|Overall Study|Physician Decision|2|||
149942265|NCT03620162|540923694|FG000|Overall Study|Lost to Follow-up|2|||
149942266|NCT03620162|540923695|FG001|Overall Study|Lost to Follow-up|6|||
149942267|NCT03620162|540923696|FG002|Overall Study|Lost to Follow-up|7|||
149942268|NCT03620162|540923697|FG003|Overall Study|Lost to Follow-up|3|||
149942269|NCT03620162|540923698|FG004|Overall Study|Lost to Follow-up|2|||
149942270|NCT03620162|540923694|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
149942271|NCT03620162|540923695|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
149942272|NCT03620162|540923696|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
149942273|NCT03620162|540923697|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
149942274|NCT03620162|540923698|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
149942275|NCT04009837|540923702|FG000|Overall Study|Withdrawal by Subject|5|||
149942276|NCT04009837|540923703|FG001|Overall Study|Withdrawal by Subject|4|||
149942277|NCT04009837|540923702|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
149942278|NCT04009837|540923703|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
149942279|NCT00284856|540923705|FG000|Overall Study|Adverse Event|3|||
150169989|NCT02781584|541757225|FG007|Treatment Phase|Withdrew Consent|0|||
149942280|NCT00284856|540923706|FG001|Overall Study|Adverse Event|3|||
149942281|NCT00284856|540923707|FG002|Overall Study|Adverse Event|3|||
149942282|NCT00284856|540923705|FG000|Overall Study|Lack of Efficacy|2|||
149942283|NCT00284856|540923706|FG001|Overall Study|Lack of Efficacy|1|||
149942284|NCT00284856|540923707|FG002|Overall Study|Lack of Efficacy|8|||
149942285|NCT00284856|540923705|FG000|Overall Study|Lost to Follow-up|25|||
149942286|NCT00284856|540923706|FG001|Overall Study|Lost to Follow-up|21|||
149942287|NCT00284856|540923707|FG002|Overall Study|Lost to Follow-up|22|||
150169990|NCT02781584|541757226|FG008|Treatment Phase|Withdrew Consent|0|||
149942288|NCT00284856|540923705|FG000|Overall Study|Protocol Violation|5|||
149942289|NCT00284856|540923706|FG001|Overall Study|Protocol Violation|4|||
149942290|NCT00284856|540923707|FG002|Overall Study|Protocol Violation|5|||
149942291|NCT00284856|540923705|FG000|Overall Study|Withdrawal by Subject|12|||
149942292|NCT00284856|540923706|FG001|Overall Study|Withdrawal by Subject|16|||
149942293|NCT00284856|540923707|FG002|Overall Study|Withdrawal by Subject|18|||
149942294|NCT00284856|540923705|FG000|Overall Study|Other|4|||
149942295|NCT00284856|540923706|FG001|Overall Study|Other|5|||
149942296|NCT00284856|540923707|FG002|Overall Study|Other|4|||
149942297|NCT05853120|540923708|FG000|Overall Study|Lost to Follow-up|4|||
149942298|NCT05853120|540923709|FG001|Overall Study|Lost to Follow-up|4|||
149942299|NCT05853120|540923708|FG000|Overall Study|Physician Decision|3|||
149942300|NCT05853120|540923709|FG001|Overall Study|Physician Decision|0|||
149942301|NCT05853120|540923708|FG000|Overall Study|Withdrawal by Subject|5|||
149942302|NCT05853120|540923709|FG001|Overall Study|Withdrawal by Subject|2|||
149942303|NCT03692949|540923711|FG000|Overall Study|Lost to Follow-up|0|||
149942304|NCT03692949|540923712|FG001|Overall Study|Lost to Follow-up|0|||
149942305|NCT03692949|540923713|FG002|Overall Study|Lost to Follow-up|0|||
149942306|NCT03692949|540923714|FG003|Overall Study|Lost to Follow-up|0|||
149942307|NCT03692949|540923715|FG004|Overall Study|Lost to Follow-up|0|||
149942308|NCT03692949|540923716|FG005|Overall Study|Lost to Follow-up|0|||
149942309|NCT03692949|540923717|FG006|Overall Study|Lost to Follow-up|0|||
149942310|NCT03692949|540923718|FG007|Overall Study|Lost to Follow-up|1|||
149942311|NCT02592824|540923726|FG000|Overall Study|Protocol Violation|5|||
149942312|NCT02592824|540923727|FG001|Overall Study|Protocol Violation|3|||
149942313|NCT02592824|540923726|FG000|Overall Study|Lost to Follow-up|2|||
149942314|NCT02592824|540923727|FG001|Overall Study|Lost to Follow-up|1|||
149942315|NCT03426878|540923728|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
149942316|NCT03426878|540923728|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
149942317|NCT03426878|540923728|FG000|Overall Study|Declined to receive results|3|||
149942318|NCT03426878|540923728|FG000|Overall Study|Received negative results by mailed letter|65|||
149942319|NCT03426878|540923728|FG000|Overall Study|Lost to Follow-up|177|||
149942320|NCT02855268|540923729|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
149942321|NCT02855268|540923730|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
149942322|NCT02855268|540923729|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
149942323|NCT02855268|540923730|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
149942324|NCT02855268|540923729|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
149942325|NCT02855268|540923730|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
149942326|NCT02855268|540923729|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
149942327|NCT02855268|540923730|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
149942328|NCT02855268|540923729|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
149942329|NCT02855268|540923730|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
149942330|NCT02855268|540923729|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
149942331|NCT02855268|540923730|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
149942332|NCT00465517|540923731|FG000|Overall Study|Adverse Event|7|||
149942333|NCT00465517|540923732|FG001|Overall Study|Adverse Event|3|||
149942334|NCT00465517|540923731|FG000|Overall Study|Lost to Follow-up|1|||
149942335|NCT00465517|540923732|FG001|Overall Study|Lost to Follow-up|0|||
149942336|NCT00465517|540923731|FG000|Overall Study|Withdrawal by Subject|4|||
149942337|NCT00465517|540923732|FG001|Overall Study|Withdrawal by Subject|1|||
149942338|NCT00289276|540923737|FG000|Second Part of FAST Study (Expansion)|Death|0|||
149942339|NCT00289276|540923738|FG001|Second Part of FAST Study (Expansion)|Death|2|||
149942340|NCT00289276|540923737|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
149942341|NCT00289276|540923738|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
149942342|NCT00869960|540923739|FG000|Overall Study|Lost to Follow-up|2|||
149942343|NCT00726609|540923740|FG000|Overall Study|Adverse Event|10|||
149942344|NCT00726609|540923740|FG000|Overall Study|Withdrawal by Subject|2|||
149942345|NCT00726609|540923740|FG000|Overall Study|Lack of Efficacy|25|||
150031819|NCT04949191|541255463|FG002|Overall Study|Sponsor Terminated Study|1|||
150031820|NCT04949191|541255464|FG003|Overall Study|Sponsor Terminated Study|1|||
150031821|NCT05121766|541255465|FG000|Overall Study|Covid reinfection|3|||
149942346|NCT00726609|540923740|FG000|Overall Study|Other|16|||
149942347|NCT00726609|540923740|FG000|Overall Study|Missing|42|||
149942348|NCT00726609|540923740|FG000|Overall Study|Other|3|||
149942349|NCT00746551|540923746|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
149942350|NCT00746551|540923747|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
149942351|NCT00746551|540923746|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
149942352|NCT00746551|540923747|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
149942353|NCT00746551|540923746|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
149942354|NCT00746551|540923747|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
149942355|NCT02029417|540923750|FG000|Overall Study|Death|1|||
149942356|NCT02029417|540923750|FG000|Overall Study|Adverse Event|1|||
149942357|NCT00071981|540923752|FG000|Overall Study|Lack of Efficacy|37|||
149942358|NCT00071981|540923753|FG001|Overall Study|Lack of Efficacy|29|||
149942359|NCT00071981|540923754|FG002|Overall Study|Lack of Efficacy|30|||
149942360|NCT00071981|540923755|FG003|Overall Study|Lack of Efficacy|43|||
150169991|NCT02781584|541757227|FG009|Treatment Phase|Withdrew Consent|0|||
149942361|NCT00071981|540923752|FG000|Overall Study|Adverse Event|4|||
149942362|NCT00071981|540923753|FG001|Overall Study|Adverse Event|4|||
149942363|NCT00071981|540923754|FG002|Overall Study|Adverse Event|3|||
149942364|NCT00071981|540923755|FG003|Overall Study|Adverse Event|1|||
149942365|NCT00071981|540923752|FG000|Overall Study|Death|0|||
149942366|NCT00071981|540923753|FG001|Overall Study|Death|0|||
149942367|NCT00071981|540923754|FG002|Overall Study|Death|1|||
149942368|NCT00071981|540923755|FG003|Overall Study|Death|1|||
149942369|NCT00071981|540923752|FG000|Overall Study|Withdrawal by Subject|3|||
149942370|NCT00071981|540923753|FG001|Overall Study|Withdrawal by Subject|1|||
149942371|NCT00071981|540923754|FG002|Overall Study|Withdrawal by Subject|0|||
149942372|NCT00071981|540923755|FG003|Overall Study|Withdrawal by Subject|0|||
149942373|NCT00071981|540923752|FG000|Overall Study|No protocol therapy|2|||
149942374|NCT00071981|540923753|FG001|Overall Study|No protocol therapy|5|||
149942375|NCT00071981|540923754|FG002|Overall Study|No protocol therapy|1|||
149942376|NCT00071981|540923755|FG003|Overall Study|No protocol therapy|0|||
149942377|NCT00071981|540923752|FG000|Overall Study|others (not specified in the study)|0|||
149942378|NCT00071981|540923753|FG001|Overall Study|others (not specified in the study)|2|||
149942379|NCT00071981|540923754|FG002|Overall Study|others (not specified in the study)|2|||
149942380|NCT00071981|540923755|FG003|Overall Study|others (not specified in the study)|0|||
149942381|NCT00262925|540923756|FG000|Overall Study|Lack of Efficacy|3|||
149942382|NCT00262925|540923756|FG000|Overall Study|Adverse Event|4|||
149942383|NCT00262925|540923756|FG000|Overall Study|Death|2|||
149942384|NCT00262925|540923756|FG000|Overall Study|alternative therapy|1|||
149942385|NCT00262925|540923756|FG000|Overall Study|Other|1|||
149942386|NCT04682301|540923757|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
149942387|NCT04682301|540923757|FG000|Overall Study|Death|2|||
149942388|NCT04513366|540923764|FG000|Treatment Phase|Withdrawal by Subject|6|||
149942389|NCT04513366|540923765|FG001|Treatment Phase|Withdrawal by Subject|8|||
149942390|NCT04513366|540923766|FG002|Treatment Phase|Withdrawal by Subject|3|||
149942391|NCT04513366|540923764|FG000|Treatment Phase|Lost to Follow-up|1|||
149942392|NCT04513366|540923765|FG001|Treatment Phase|Lost to Follow-up|2|||
149942393|NCT04513366|540923766|FG002|Treatment Phase|Lost to Follow-up|5|||
149942394|NCT04513366|540923764|FG000|Treatment Phase|Other than Specified|1|||
149942395|NCT04513366|540923765|FG001|Treatment Phase|Other than Specified|0|||
149942396|NCT04513366|540923766|FG002|Treatment Phase|Other than Specified|2|||
149942397|NCT04513366|540923764|FG000|Treatment Phase|Physician Decision|2|||
149942398|NCT04513366|540923765|FG001|Treatment Phase|Physician Decision|0|||
149942399|NCT04513366|540923766|FG002|Treatment Phase|Physician Decision|0|||
149942400|NCT04513366|540923764|FG000|Treatment Phase|Adverse Event|0|||
149942401|NCT04513366|540923765|FG001|Treatment Phase|Adverse Event|1|||
149942402|NCT04513366|540923766|FG002|Treatment Phase|Adverse Event|1|||
149942403|NCT04513366|540923764|FG000|Extension Phase|Withdrawal by Subject|3|||
149942404|NCT04513366|540923765|FG001|Extension Phase|Withdrawal by Subject|1|||
149942405|NCT04513366|540923766|FG002|Extension Phase|Withdrawal by Subject|1|||
149942406|NCT04513366|540923764|FG000|Extension Phase|Other than Specified|4|||
149942407|NCT04513366|540923765|FG001|Extension Phase|Other than Specified|0|||
149942408|NCT04513366|540923766|FG002|Extension Phase|Other than Specified|1|||
149942409|NCT04513366|540923764|FG000|Extension Phase|Lost to Follow-up|1|||
149942410|NCT04513366|540923765|FG001|Extension Phase|Lost to Follow-up|1|||
149942411|NCT04513366|540923766|FG002|Extension Phase|Lost to Follow-up|1|||
149942412|NCT04513366|540923764|FG000|Extension Phase|Sponsor Decision|0|||
149942413|NCT04513366|540923765|FG001|Extension Phase|Sponsor Decision|1|||
149942414|NCT04513366|540923766|FG002|Extension Phase|Sponsor Decision|0|||
149942415|NCT04513366|540923764|FG000|Extension Phase|Death|0|||
149942416|NCT04513366|540923765|FG001|Extension Phase|Death|1|||
149942417|NCT04513366|540923766|FG002|Extension Phase|Death|0|||
149942418|NCT04513366|540923764|FG000|Extension Phase|Adverse Event|0|||
149942419|NCT04513366|540923765|FG001|Extension Phase|Adverse Event|0|||
149942420|NCT04513366|540923766|FG002|Extension Phase|Adverse Event|1|||
149942421|NCT00392223|540923767|FG000|Overall Study|Adverse Event|5|||
149942422|NCT00392223|540923768|FG001|Overall Study|Adverse Event|4|||
149942423|NCT00392223|540923767|FG000|Overall Study|Lost to Follow-up|1|||
149942424|NCT00392223|540923768|FG001|Overall Study|Lost to Follow-up|4|||
149942425|NCT00392223|540923767|FG000|Overall Study|Protocol Violation|0|||
149942426|NCT00392223|540923768|FG001|Overall Study|Protocol Violation|3|||
149942427|NCT00392223|540923767|FG000|Overall Study|Withdrawal by Subject|3|||
149942428|NCT00392223|540923768|FG001|Overall Study|Withdrawal by Subject|2|||
149942429|NCT03344757|540923770|FG000|Overall Study|Withdrawal by Subject|18|||
149942430|NCT03344757|540923771|FG001|Overall Study|Withdrawal by Subject|16|||
149942431|NCT03344757|540923770|FG000|Overall Study|Lost to Follow-up|0|||
149942432|NCT03344757|540923771|FG001|Overall Study|Lost to Follow-up|2|||
149942433|NCT00269152|540923772|FG000|Overall Study|Adverse Event|9|||
149942434|NCT00269152|540923773|FG001|Overall Study|Adverse Event|3|||
149942435|NCT00269152|540923772|FG000|Overall Study|Withdrawal by Subject|7|||
149942436|NCT00269152|540923773|FG001|Overall Study|Withdrawal by Subject|3|||
149942437|NCT00269152|540923772|FG000|Overall Study|Physician Decision|2|||
149942438|NCT00269152|540923773|FG001|Overall Study|Physician Decision|3|||
149942439|NCT00269152|540923772|FG000|Overall Study|Protocol Violation|0|||
149942440|NCT00269152|540923773|FG001|Overall Study|Protocol Violation|1|||
149942441|NCT02814526|540923776|FG000|Overall Study|Adverse Event|4|||
149942442|NCT02814526|540923777|FG001|Overall Study|Adverse Event|3|||
149942443|NCT02814526|540923776|FG000|Overall Study|Death|1|||
149942444|NCT02814526|540923777|FG001|Overall Study|Death|1|||
149942445|NCT02814526|540923776|FG000|Overall Study|Lost to Follow-up|3|||
149942446|NCT02814526|540923777|FG001|Overall Study|Lost to Follow-up|4|||
149942447|NCT02814526|540923776|FG000|Overall Study|non site physician decision|1|||
149942448|NCT02814526|540923777|FG001|Overall Study|non site physician decision|0|||
149942449|NCT02814526|540923776|FG000|Overall Study|participant noncompliance|1|||
149942450|NCT02814526|540923777|FG001|Overall Study|participant noncompliance|1|||
149942451|NCT02814526|540923776|FG000|Overall Study|Withdrawal by Subject|20|||
149942452|NCT02814526|540923777|FG001|Overall Study|Withdrawal by Subject|14|||
149942453|NCT02814526|540923776|FG000|Overall Study|safety risk|2|||
149942454|NCT02814526|540923777|FG001|Overall Study|safety risk|1|||
149942455|NCT02814526|540923776|FG000|Overall Study|early termination-study terminated|1|||
149942456|NCT02814526|540923777|FG001|Overall Study|early termination-study terminated|2|||
149942457|NCT02814526|540923776|FG000|Overall Study|Other|0|||
149942458|NCT02814526|540923777|FG001|Overall Study|Other|4|||
149942459|NCT03082729|540923780|FG000|Overall Study|Lost to Follow-up|7|||
149942460|NCT03082729|540923780|FG000|Overall Study|Physician Decision|2|||
149942461|NCT03082729|540923780|FG000|Overall Study|Withdrawal by Subject|1|||
149942462|NCT03082729|540923780|FG000|Overall Study|Lack of Efficacy|9|||
149942463|NCT03082729|540923780|FG000|Overall Study|Adverse Event|4|||
149942464|NCT03082729|540923780|FG000|Overall Study|Protocol Violation|6|||
149942465|NCT03082729|540923780|FG000|Overall Study|Fear of study procedure|1|||
149942466|NCT03082729|540923780|FG000|Overall Study|Scheduling conflict|1|||
149942467|NCT03454555|540925399|FG000|Overall Study|Death|6|||
149942468|NCT03454555|540925400|FG001|Overall Study|Death|6|||
149942469|NCT03454555|540925399|FG000|Overall Study|Lost to Follow-up|31|||
149942470|NCT03454555|540925400|FG001|Overall Study|Lost to Follow-up|12|||
149942471|NCT03454555|540925399|FG000|Overall Study|Physician Decision|2|||
149942472|NCT03454555|540925400|FG001|Overall Study|Physician Decision|6|||
149942473|NCT03454555|540925399|FG000|Overall Study|Withdrawal by Subject|34|||
149942474|NCT03454555|540925400|FG001|Overall Study|Withdrawal by Subject|5|||
149942475|NCT03454555|540925399|FG000|Overall Study|Ineligible|1|||
149942476|NCT03454555|540925400|FG001|Overall Study|Ineligible|5|||
149942477|NCT01288430|540925407|FG000|Part 1|Progressive disease|2|||
149942478|NCT01288430|540925408|FG001|Part 1|Progressive disease|1|||
149942479|NCT01288430|540925409|FG002|Part 1|Progressive disease|1|||
149942480|NCT01288430|540925410|FG003|Part 1|Progressive disease|6|||
149942481|NCT01288430|540925411|FG004|Part 1|Progressive disease|2|||
149942482|NCT01288430|540925412|FG005|Part 1|Progressive disease|4|||
149942483|NCT01288430|540925413|FG006|Part 1|Progressive disease|2|||
149942484|NCT01288430|540925414|FG007|Part 1|Progressive disease|0|||
149942485|NCT01288430|540925415|FG008|Part 1|Progressive disease|0|||
149942486|NCT01288430|540925416|FG009|Part 1|Progressive disease|0|||
149942487|NCT01288430|540925407|FG000|Part 1|Clinical disease progression|0|||
149942488|NCT01288430|540925408|FG001|Part 1|Clinical disease progression|0|||
149942489|NCT01288430|540925409|FG002|Part 1|Clinical disease progression|1|||
149942490|NCT01288430|540925410|FG003|Part 1|Clinical disease progression|0|||
149942491|NCT01288430|540925411|FG004|Part 1|Clinical disease progression|0|||
149942492|NCT01288430|540925412|FG005|Part 1|Clinical disease progression|2|||
149942493|NCT01288430|540925413|FG006|Part 1|Clinical disease progression|2|||
149942494|NCT01288430|540925414|FG007|Part 1|Clinical disease progression|0|||
149942495|NCT01288430|540925415|FG008|Part 1|Clinical disease progression|0|||
149942496|NCT01288430|540925416|FG009|Part 1|Clinical disease progression|0|||
149942497|NCT01288430|540925407|FG000|Part 1|Death due to disease progression|0|||
149942498|NCT01288430|540925408|FG001|Part 1|Death due to disease progression|0|||
149942499|NCT01288430|540925409|FG002|Part 1|Death due to disease progression|0|||
149942500|NCT01288430|540925410|FG003|Part 1|Death due to disease progression|0|||
149942501|NCT01288430|540925411|FG004|Part 1|Death due to disease progression|1|||
149942502|NCT01288430|540925412|FG005|Part 1|Death due to disease progression|0|||
149942503|NCT01288430|540925413|FG006|Part 1|Death due to disease progression|0|||
149942504|NCT01288430|540925414|FG007|Part 1|Death due to disease progression|0|||
149942505|NCT01288430|540925415|FG008|Part 1|Death due to disease progression|0|||
149942506|NCT01288430|540925416|FG009|Part 1|Death due to disease progression|0|||
149942507|NCT01288430|540925407|FG000|Part 1|Adverse Event|0|||
149942508|NCT01288430|540925408|FG001|Part 1|Adverse Event|0|||
149942509|NCT01288430|540925409|FG002|Part 1|Adverse Event|3|||
149942510|NCT01288430|540925410|FG003|Part 1|Adverse Event|1|||
149942511|NCT01288430|540925411|FG004|Part 1|Adverse Event|0|||
149942512|NCT01288430|540925412|FG005|Part 1|Adverse Event|0|||
149942513|NCT01288430|540925413|FG006|Part 1|Adverse Event|2|||
149942514|NCT01288430|540925414|FG007|Part 1|Adverse Event|0|||
149942515|NCT01288430|540925415|FG008|Part 1|Adverse Event|0|||
149942516|NCT01288430|540925416|FG009|Part 1|Adverse Event|0|||
149942517|NCT01288430|540925407|FG000|Part 1|Other|0|||
149942518|NCT01288430|540925408|FG001|Part 1|Other|2|||
149942519|NCT01288430|540925409|FG002|Part 1|Other|0|||
149942520|NCT01288430|540925410|FG003|Part 1|Other|0|||
149942521|NCT01288430|540925411|FG004|Part 1|Other|0|||
149942522|NCT01288430|540925412|FG005|Part 1|Other|0|||
149942523|NCT01288430|540925413|FG006|Part 1|Other|1|||
149942524|NCT01288430|540925414|FG007|Part 1|Other|0|||
149942525|NCT01288430|540925415|FG008|Part 1|Other|0|||
149942526|NCT01288430|540925416|FG009|Part 1|Other|0|||
149942527|NCT01288430|540925407|FG000|Part 2|Progressive disease|0|||
149942528|NCT01288430|540925408|FG001|Part 2|Progressive disease|0|||
149942529|NCT01288430|540925409|FG002|Part 2|Progressive disease|0|||
149942530|NCT01288430|540925410|FG003|Part 2|Progressive disease|0|||
149942531|NCT01288430|540925411|FG004|Part 2|Progressive disease|0|||
149942532|NCT01288430|540925412|FG005|Part 2|Progressive disease|0|||
149942533|NCT01288430|540925413|FG006|Part 2|Progressive disease|0|||
149942534|NCT01288430|540925414|FG007|Part 2|Progressive disease|8|||
149942535|NCT01288430|540925415|FG008|Part 2|Progressive disease|7|||
149942536|NCT01288430|540925416|FG009|Part 2|Progressive disease|2|||
149942537|NCT01288430|540925407|FG000|Part 2|Clinical disease progression|0|||
149942538|NCT01288430|540925408|FG001|Part 2|Clinical disease progression|0|||
149942539|NCT01288430|540925409|FG002|Part 2|Clinical disease progression|0|||
149942540|NCT01288430|540925410|FG003|Part 2|Clinical disease progression|0|||
149942541|NCT01288430|540925411|FG004|Part 2|Clinical disease progression|0|||
149942542|NCT01288430|540925412|FG005|Part 2|Clinical disease progression|0|||
149942543|NCT01288430|540925413|FG006|Part 2|Clinical disease progression|0|||
149942544|NCT01288430|540925414|FG007|Part 2|Clinical disease progression|2|||
149942545|NCT01288430|540925415|FG008|Part 2|Clinical disease progression|0|||
149942546|NCT01288430|540925416|FG009|Part 2|Clinical disease progression|0|||
149942547|NCT01288430|540925407|FG000|Part 2|Withdrawal by Subject|0|||
149942548|NCT01288430|540925408|FG001|Part 2|Withdrawal by Subject|0|||
149942549|NCT01288430|540925409|FG002|Part 2|Withdrawal by Subject|0|||
149942550|NCT01288430|540925410|FG003|Part 2|Withdrawal by Subject|0|||
149942551|NCT01288430|540925411|FG004|Part 2|Withdrawal by Subject|0|||
149942552|NCT01288430|540925412|FG005|Part 2|Withdrawal by Subject|0|||
149942553|NCT01288430|540925413|FG006|Part 2|Withdrawal by Subject|0|||
149942554|NCT01288430|540925414|FG007|Part 2|Withdrawal by Subject|1|||
149942555|NCT01288430|540925415|FG008|Part 2|Withdrawal by Subject|4|||
149942556|NCT01288430|540925416|FG009|Part 2|Withdrawal by Subject|0|||
149942557|NCT01288430|540925407|FG000|Part 2|Adverse Event|0|||
149942558|NCT01288430|540925408|FG001|Part 2|Adverse Event|0|||
149942559|NCT01288430|540925409|FG002|Part 2|Adverse Event|0|||
149942560|NCT01288430|540925410|FG003|Part 2|Adverse Event|0|||
149942561|NCT01288430|540925411|FG004|Part 2|Adverse Event|0|||
149942562|NCT01288430|540925412|FG005|Part 2|Adverse Event|0|||
149942563|NCT01288430|540925413|FG006|Part 2|Adverse Event|0|||
149942564|NCT01288430|540925414|FG007|Part 2|Adverse Event|1|||
149942565|NCT01288430|540925415|FG008|Part 2|Adverse Event|1|||
149942566|NCT01288430|540925416|FG009|Part 2|Adverse Event|0|||
149942567|NCT01288430|540925407|FG000|Part 2|Other|0|||
149942568|NCT01288430|540925408|FG001|Part 2|Other|0|||
149942569|NCT01288430|540925409|FG002|Part 2|Other|0|||
149942570|NCT01288430|540925410|FG003|Part 2|Other|0|||
149942571|NCT01288430|540925411|FG004|Part 2|Other|0|||
149942572|NCT01288430|540925412|FG005|Part 2|Other|0|||
149942573|NCT01288430|540925413|FG006|Part 2|Other|0|||
149942574|NCT01288430|540925414|FG007|Part 2|Other|0|||
149942575|NCT01288430|540925415|FG008|Part 2|Other|0|||
149942576|NCT01288430|540925416|FG009|Part 2|Other|1|||
149942577|NCT03405870|540925419|FG000|Overall Study|Withdrawal|1|||
149942578|NCT03405870|540925420|FG001|Overall Study|Withdrawal|0|||
149942579|NCT03405870|540925421|FG002|Overall Study|Withdrawal|1|||
149942580|NCT03405870|540925422|FG003|Overall Study|Withdrawal|0|||
149942581|NCT03405870|540925423|FG004|Overall Study|Withdrawal|0|||
149942582|NCT03405870|540925424|FG005|Overall Study|Withdrawal|0|||
149942583|NCT03405870|540925425|FG006|Overall Study|Withdrawal|1|||
149942584|NCT03405870|540925426|FG007|Overall Study|Withdrawal|0|||
149942585|NCT02807259|540925431|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
149942586|NCT02807259|540925432|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
149942587|NCT02807259|540925431|FG000|Midline (3 Months)|migration, refusal, not available|30|||
149942588|NCT02807259|540925432|FG001|Midline (3 Months)|migration, refusal, not available|34|||
149942589|NCT02807259|540925431|FG000|Endline (3 Months)|migration, refusal, not available|35|||
149942590|NCT02807259|540925432|FG001|Endline (3 Months)|migration, refusal, not available|87|||
149942591|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
149942592|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
149942593|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
149942594|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
149942595|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
149942596|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
149942597|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
149942598|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
149942599|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
149942600|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
150031822|NCT05121766|541255466|FG001|Overall Study|Covid reinfection|0|||
150031823|NCT05121766|541255465|FG000|Overall Study|Withdrawal by Subject|3|||
150031824|NCT05121766|541255466|FG001|Overall Study|Withdrawal by Subject|1|||
149942601|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
149942602|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
149942603|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
150031825|NCT05121766|541255465|FG000|Overall Study|Adverse Event|2|||
150031826|NCT05121766|541255466|FG001|Overall Study|Adverse Event|4|||
150031827|NCT05121766|541255465|FG000|Overall Study|Lost to Follow-up|0|||
150031828|NCT05121766|541255466|FG001|Overall Study|Lost to Follow-up|1|||
150031829|NCT03259230|541255467|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
150031830|NCT03259230|541255468|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
149942604|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
149942605|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
149942606|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
149942607|NCT00849056|540925433|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
149942608|NCT00849056|540925434|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
149942609|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
149942610|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
149942611|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
149942612|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
149942613|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
149942614|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
149942615|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
149942616|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
149942617|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
149942618|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
149942619|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
149942620|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
149942621|NCT00849056|540925433|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
149942622|NCT00849056|540925434|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
149942623|NCT00274456|540925442|FG000|Overall Study|Still on treatment|2|||
149942624|NCT00274456|540925443|FG001|Overall Study|Still on treatment|3|||
149942625|NCT00274456|540925444|FG002|Overall Study|Still on treatment|5|||
149942626|NCT00274456|540925445|FG003|Overall Study|Still on treatment|1|||
149942627|NCT00274456|540925442|FG000|Overall Study|Unacceptable toxicity|10|||
149942628|NCT00274456|540925443|FG001|Overall Study|Unacceptable toxicity|5|||
149942629|NCT00274456|540925444|FG002|Overall Study|Unacceptable toxicity|12|||
149942630|NCT00274456|540925445|FG003|Overall Study|Unacceptable toxicity|16|||
149942631|NCT00274456|540925442|FG000|Overall Study|Adverse Event|0|||
149942632|NCT00274456|540925443|FG001|Overall Study|Adverse Event|1|||
149942633|NCT00274456|540925444|FG002|Overall Study|Adverse Event|2|||
149942634|NCT00274456|540925445|FG003|Overall Study|Adverse Event|2|||
149942635|NCT00274456|540925442|FG000|Overall Study|Physician Decision|7|||
149942636|NCT00274456|540925443|FG001|Overall Study|Physician Decision|5|||
149942637|NCT00274456|540925444|FG002|Overall Study|Physician Decision|6|||
149942638|NCT00274456|540925445|FG003|Overall Study|Physician Decision|13|||
149942639|NCT00274456|540925442|FG000|Overall Study|Lost to Follow-up|0|||
149942640|NCT00274456|540925443|FG001|Overall Study|Lost to Follow-up|0|||
149942641|NCT00274456|540925444|FG002|Overall Study|Lost to Follow-up|1|||
149942642|NCT00274456|540925445|FG003|Overall Study|Lost to Follow-up|0|||
149942643|NCT00274456|540925442|FG000|Overall Study|Withdrawal by Subject|18|||
149942644|NCT00274456|540925443|FG001|Overall Study|Withdrawal by Subject|13|||
149942645|NCT00274456|540925444|FG002|Overall Study|Withdrawal by Subject|9|||
149942646|NCT00274456|540925445|FG003|Overall Study|Withdrawal by Subject|13|||
149942647|NCT00375752|540925446|FG000|Overall Study|Lack of Efficacy|4|||
149942648|NCT00375752|540925447|FG001|Overall Study|Lack of Efficacy|4|||
149942649|NCT00375752|540925446|FG000|Overall Study|Adverse Event|1|||
149942650|NCT00375752|540925447|FG001|Overall Study|Adverse Event|6|||
149942651|NCT00375752|540925446|FG000|Overall Study|Withdrawal by Subject|6|||
149942652|NCT00375752|540925447|FG001|Overall Study|Withdrawal by Subject|1|||
149942653|NCT00375752|540925446|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
150031831|NCT01033240|541255469|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
149942654|NCT00375752|540925447|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
150031832|NCT01033240|541255470|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
150031833|NCT01033240|541255471|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
150031834|NCT01033240|541255469|FG000|Overall Study|Death|2|||
149942655|NCT00375752|540925446|FG000|Overall Study|Protocol Violation|0|||
149942656|NCT00375752|540925447|FG001|Overall Study|Protocol Violation|2|||
149942657|NCT00375752|540925446|FG000|Overall Study|Administrative Problems|0|||
149942658|NCT00375752|540925447|FG001|Overall Study|Administrative Problems|1|||
149942659|NCT01140906|540925454|FG000|Overall Study|Adverse Event|7|||
150031835|NCT01033240|541255470|FG001|Overall Study|Death|0|||
150031836|NCT01033240|541255471|FG002|Overall Study|Death|0|||
150031837|NCT01033240|541255469|FG000|Overall Study|Withdrew Consent|2|||
150031838|NCT01033240|541255470|FG001|Overall Study|Withdrew Consent|9|||
149942660|NCT01140906|540925455|FG001|Overall Study|Adverse Event|10|||
149942661|NCT01140906|540925456|FG002|Overall Study|Adverse Event|17|||
149942662|NCT01140906|540925457|FG003|Overall Study|Adverse Event|7|||
149942663|NCT01140906|540925454|FG000|Overall Study|Lack of Efficacy|6|||
149942664|NCT01140906|540925455|FG001|Overall Study|Lack of Efficacy|8|||
149942665|NCT01140906|540925456|FG002|Overall Study|Lack of Efficacy|2|||
149942666|NCT01140906|540925457|FG003|Overall Study|Lack of Efficacy|1|||
149942667|NCT01140906|540925454|FG000|Overall Study|Non-compliance|0|||
149942668|NCT01140906|540925455|FG001|Overall Study|Non-compliance|1|||
149942669|NCT01140906|540925456|FG002|Overall Study|Non-compliance|0|||
149942670|NCT01140906|540925457|FG003|Overall Study|Non-compliance|1|||
149942671|NCT01140906|540925454|FG000|Overall Study|Protocol Violation|5|||
149942672|NCT01140906|540925455|FG001|Overall Study|Protocol Violation|3|||
149942673|NCT01140906|540925456|FG002|Overall Study|Protocol Violation|2|||
149942674|NCT01140906|540925457|FG003|Overall Study|Protocol Violation|1|||
149942675|NCT01140906|540925454|FG000|Overall Study|Withdrawal of consent|6|||
149942676|NCT01140906|540925455|FG001|Overall Study|Withdrawal of consent|6|||
149942677|NCT01140906|540925456|FG002|Overall Study|Withdrawal of consent|2|||
149942678|NCT01140906|540925457|FG003|Overall Study|Withdrawal of consent|2|||
149942679|NCT01140906|540925454|FG000|Overall Study|Lost to Follow-up|1|||
149942680|NCT01140906|540925455|FG001|Overall Study|Lost to Follow-up|1|||
149942681|NCT01140906|540925456|FG002|Overall Study|Lost to Follow-up|0|||
149942682|NCT01140906|540925457|FG003|Overall Study|Lost to Follow-up|2|||
149942683|NCT01140906|540925454|FG000|Overall Study|Administrative or other reason|0|||
149942684|NCT01140906|540925455|FG001|Overall Study|Administrative or other reason|5|||
149942685|NCT01140906|540925456|FG002|Overall Study|Administrative or other reason|3|||
149942686|NCT01140906|540925457|FG003|Overall Study|Administrative or other reason|2|||
149942687|NCT04889040|540925458|FG000|Overall Study|Withdrawal by Subject|3|||
149942688|NCT04889040|540925459|FG001|Overall Study|Withdrawal by Subject|3|||
149942689|NCT04889040|540925458|FG000|Overall Study|Lost to Follow-up|0|||
149942690|NCT04889040|540925459|FG001|Overall Study|Lost to Follow-up|1|||
149942691|NCT04889040|540925458|FG000|Overall Study|Adverse Event|2|||
149942692|NCT04889040|540925459|FG001|Overall Study|Adverse Event|1|||
149942693|NCT03801252|540925460|FG000|Overall Study|Protocol Violation|1|||
149942694|NCT03801252|540925461|FG001|Overall Study|Protocol Violation|2|||
149942695|NCT02690727|540925462|FG000|Overall Study|Adverse Event|2|||
149942696|NCT02690727|540925463|FG001|Overall Study|Adverse Event|2|||
149942697|NCT05352815|540925468|FG000|Overall Study|Withdrawal by Subject|28|||
149942698|NCT05352815|540925469|FG001|Overall Study|Withdrawal by Subject|24|||
149942699|NCT05352815|540925468|FG000|Overall Study|Lost to Follow-up|4|||
149942700|NCT05352815|540925469|FG001|Overall Study|Lost to Follow-up|7|||
149942701|NCT05352815|540925468|FG000|Overall Study|Death|2|||
149942702|NCT05352815|540925469|FG001|Overall Study|Death|3|||
149942703|NCT05352815|540925468|FG000|Overall Study|Site closure|1|||
149942704|NCT05352815|540925469|FG001|Overall Study|Site closure|0|||
149942705|NCT01316575|540925473|FG000|Overall Study|Withdrawal by Subject|2|||
149942706|NCT01316575|540925474|FG001|Overall Study|Withdrawal by Subject|0|||
149942707|NCT01316575|540925473|FG000|Overall Study|Required alternate treatment|0|||
149942708|NCT01316575|540925474|FG001|Overall Study|Required alternate treatment|1|||
149942709|NCT00402831|540925475|FG000|Overall Study|Lost to Follow-up|1|||
149942710|NCT00402831|540925476|FG001|Overall Study|Lost to Follow-up|2|||
149942711|NCT00402831|540925475|FG000|Overall Study|Non-compliance with protocol|0|||
149942712|NCT00402831|540925476|FG001|Overall Study|Non-compliance with protocol|1|||
149942713|NCT00671788|540925479|FG000|Overall Study|Adverse Event|8|||
149942714|NCT00671788|540925479|FG000|Overall Study|Refused further treatment|3|||
150031839|NCT01033240|541255471|FG002|Overall Study|Withdrew Consent|2|||
150031840|NCT01033240|541255469|FG000|Overall Study|Disease Progression|35|||
150031841|NCT01033240|541255470|FG001|Overall Study|Disease Progression|32|||
149942715|NCT00671788|540925479|FG000|Overall Study|Ineligible|1|||
149942716|NCT00671788|540925479|FG000|Overall Study|MD Decision|1|||
149942717|NCT00671788|540925479|FG000|Overall Study|Other|1|||
149942718|NCT02792504|540925482|FG000|Overall Study|Lost to Follow-up|24|||
149942719|NCT02792504|540925482|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
149942720|NCT01035138|540925483|FG000|Overall Study|Adverse Event|4|||
149942721|NCT01035138|540925484|FG001|Overall Study|Adverse Event|0|||
149942722|NCT01035138|540925485|FG002|Overall Study|Adverse Event|2|||
149942723|NCT01035138|540925483|FG000|Overall Study|Caregiver Decision|2|||
149942724|NCT01035138|540925484|FG001|Overall Study|Caregiver Decision|0|||
149942725|NCT01035138|540925485|FG002|Overall Study|Caregiver Decision|1|||
149942726|NCT01035138|540925483|FG000|Overall Study|Withdrawal by Subject|1|||
149942727|NCT01035138|540925484|FG001|Overall Study|Withdrawal by Subject|0|||
149942728|NCT01035138|540925485|FG002|Overall Study|Withdrawal by Subject|0|||
149942729|NCT01035138|540925483|FG000|Overall Study|Physician Decision|0|||
149942730|NCT01035138|540925484|FG001|Overall Study|Physician Decision|0|||
150031842|NCT01033240|541255471|FG002|Overall Study|Disease Progression|41|||
150031843|NCT01033240|541255469|FG000|Overall Study|Investigator Discretion|0|||
150031844|NCT01033240|541255470|FG001|Overall Study|Investigator Discretion|0|||
150031845|NCT01033240|541255471|FG002|Overall Study|Investigator Discretion|2|||
150031846|NCT01033240|541255469|FG000|Overall Study|Other|0|||
150031847|NCT01033240|541255470|FG001|Overall Study|Other|1|||
150031848|NCT01033240|541255471|FG002|Overall Study|Other|2|||
150031849|NCT02913482|541255472|FG000|Overall Study|Death|0|||
150031850|NCT02913482|541255473|FG001|Overall Study|Death|2|||
150031851|NCT02913482|541255474|FG002|Overall Study|Death|2|||
150031852|NCT02913482|541255472|FG000|Overall Study|Progressive Disease|1|||
150031853|NCT02913482|541255473|FG001|Overall Study|Progressive Disease|1|||
150031854|NCT02913482|541255474|FG002|Overall Study|Progressive Disease|1|||
150031855|NCT02913482|541255472|FG000|Overall Study|Reason not specified|0|||
150031856|NCT02913482|541255473|FG001|Overall Study|Reason not specified|0|||
150031857|NCT02913482|541255474|FG002|Overall Study|Reason not specified|1|||
150031858|NCT02913482|541255472|FG000|Overall Study|Withdrawal by Subject|0|||
150031859|NCT02913482|541255473|FG001|Overall Study|Withdrawal by Subject|1|||
150031860|NCT02913482|541255474|FG002|Overall Study|Withdrawal by Subject|1|||
150031861|NCT00625131|541255476|FG000|Overall Study|Lost to Follow-up|3|||
150031862|NCT00625131|541255477|FG001|Overall Study|Lost to Follow-up|2|||
150031863|NCT00625131|541255478|FG002|Overall Study|Lost to Follow-up|0|||
150031864|NCT00625131|541255476|FG000|Overall Study|Withdrawal by Subject|1|||
150031865|NCT00625131|541255477|FG001|Overall Study|Withdrawal by Subject|0|||
150031866|NCT00625131|541255478|FG002|Overall Study|Withdrawal by Subject|5|||
150031867|NCT00918281|541255481|FG000|Overall Study|Physician Decision|29|||
150031868|NCT03624881|541255482|FG000|Overall Study|Screen Failure|14|||
150031869|NCT03624881|541255483|FG001|Overall Study|Screen Failure|0|||
150031870|NCT03624881|541255482|FG000|Overall Study|No Catheter Inserted|6|||
150031871|NCT03624881|541255483|FG001|Overall Study|No Catheter Inserted|1|||
150031872|NCT03624881|541255482|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
150031873|NCT03624881|541255483|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
150031874|NCT03624881|541255482|FG000|Overall Study|Death|2|||
150031875|NCT03624881|541255483|FG001|Overall Study|Death|0|||
150031876|NCT03624881|541255482|FG000|Overall Study|Lost to Follow-up|10|||
150031877|NCT03624881|541255483|FG001|Overall Study|Lost to Follow-up|4|||
150031878|NCT03624881|541255482|FG000|Overall Study|Withdrawal by Subject|12|||
150031879|NCT03624881|541255483|FG001|Overall Study|Withdrawal by Subject|1|||
150031880|NCT00168844|541255484|FG000|Overall Study|Adverse Event|31|||
150031881|NCT00168844|541255485|FG001|Overall Study|Adverse Event|32|||
150031882|NCT00168844|541255486|FG002|Overall Study|Adverse Event|48|||
150031883|NCT00168844|541255484|FG000|Overall Study|Lost to Follow-up|4|||
150031884|NCT00168844|541255485|FG001|Overall Study|Lost to Follow-up|5|||
150031885|NCT00168844|541255486|FG002|Overall Study|Lost to Follow-up|11|||
150031886|NCT00168844|541255484|FG000|Overall Study|Withdrawal by Subject|12|||
150031887|NCT00168844|541255485|FG001|Overall Study|Withdrawal by Subject|9|||
150169992|NCT02781584|541757228|FG010|Treatment Phase|Withdrew Consent|1|||
149942731|NCT01035138|540925485|FG002|Overall Study|Physician Decision|1|||
149942732|NCT01035138|540925483|FG000|Overall Study|Sponsor Decision|66|||
149942733|NCT01035138|540925484|FG001|Overall Study|Sponsor Decision|60|||
149942734|NCT01035138|540925485|FG002|Overall Study|Sponsor Decision|42|||
149942735|NCT01035138|540925483|FG000|Overall Study|Lost to Follow-up|0|||
149942736|NCT01035138|540925484|FG001|Overall Study|Lost to Follow-up|0|||
149942737|NCT01035138|540925485|FG002|Overall Study|Lost to Follow-up|1|||
149942738|NCT00848497|540925492|FG000|Overall Study|Screen failure|2|||
149942739|NCT00848497|540925493|FG001|Overall Study|Screen failure|0|||
149942740|NCT00848497|540925492|FG000|Overall Study|Withdrawal by Subject|0|||
149942741|NCT00848497|540925493|FG001|Overall Study|Withdrawal by Subject|1|||
149942742|NCT01832766|540925494|FG000|Washout|Lost to Follow-up|0|||
150031888|NCT00168844|541255486|FG002|Overall Study|Withdrawal by Subject|19|||
150031889|NCT00168844|541255484|FG000|Overall Study|Protocol Violation|2|||
150031890|NCT00168844|541255485|FG001|Overall Study|Protocol Violation|2|||
150031891|NCT00168844|541255486|FG002|Overall Study|Protocol Violation|4|||
150031892|NCT00168844|541255484|FG000|Overall Study|Other|6|||
150031893|NCT00168844|541255485|FG001|Overall Study|Other|7|||
150031894|NCT00168844|541255486|FG002|Overall Study|Other|9|||
150031895|NCT03557970|541255489|FG000|Overall Study|Study closure|1|||
150031896|NCT03557970|541255490|FG001|Overall Study|Study closure|0|||
150031897|NCT03557970|541255489|FG000|Overall Study|Physician Decision|0|||
150031898|NCT03557970|541255490|FG001|Overall Study|Physician Decision|1|||
150031899|NCT03557970|541255489|FG000|Overall Study|Death|0|||
150031900|NCT03557970|541255490|FG001|Overall Study|Death|1|||
150031901|NCT02138890|541255493|FG000|Overall Study|Adverse Event|1|||
150031902|NCT02138890|541255494|FG001|Overall Study|Adverse Event|0|||
150031903|NCT00112736|541255495|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
149942743|NCT01832766|540925495|FG001|Washout|Lost to Follow-up|1|||
149942744|NCT01114724|540925498|FG000|Overall Study|Death|8|||
149942745|NCT01114724|540925498|FG000|Overall Study|Lost to Follow-up|1|||
150031904|NCT00112736|541255496|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
150031905|NCT05435339|541255497|FG000|Overall Study|Death|1|||
150031906|NCT05435339|541255498|FG001|Overall Study|Death|0|||
150031907|NCT05435339|541255499|FG002|Overall Study|Death|3|||
149942746|NCT01114724|540925498|FG000|Overall Study|Withdrawal by Subject|1|||
149942747|NCT02966834|540925499|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
149942748|NCT02966834|540925500|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
149942749|NCT02966834|540925501|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
149942750|NCT02966834|540925502|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
149942751|NCT02966834|540925503|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
149942752|NCT02966834|540925504|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
149942753|NCT02966834|540925499|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
149942754|NCT02966834|540925500|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149942755|NCT02966834|540925501|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149942756|NCT02966834|540925502|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149942757|NCT02966834|540925503|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149942758|NCT02966834|540925504|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149942759|NCT02966834|540925499|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
149942760|NCT02966834|540925500|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
149942761|NCT02966834|540925501|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
149942762|NCT02966834|540925502|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
149942763|NCT02966834|540925503|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
149942764|NCT02966834|540925504|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
149942765|NCT02966834|540925499|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
149942766|NCT02966834|540925500|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
149942767|NCT02966834|540925501|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
149942768|NCT02966834|540925502|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
149942769|NCT02966834|540925503|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
149942770|NCT02966834|540925504|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
149942771|NCT02966834|540925499|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
149942772|NCT02966834|540925500|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
149942773|NCT02966834|540925501|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
149942774|NCT02966834|540925502|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
149942775|NCT02966834|540925503|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
149942776|NCT02966834|540925504|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
149942777|NCT02966834|540925499|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
149942778|NCT02966834|540925500|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
149942779|NCT02966834|540925501|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
149942780|NCT02966834|540925502|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
149942781|NCT02966834|540925503|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
149942782|NCT02966834|540925504|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
149942783|NCT04585893|540925509|FG000|Overall Study|Death|1|||
149942784|NCT04585893|540925510|FG001|Overall Study|Death|0|||
149942785|NCT03573297|540925517|FG000|Open Label Treatment Period|Adverse Event|67|||
149942786|NCT03573297|540925518|FG001|Open Label Treatment Period|Adverse Event|0|||
149942787|NCT03573297|540925519|FG002|Open Label Treatment Period|Adverse Event|0|||
149942788|NCT03573297|540925520|FG003|Open Label Treatment Period|Adverse Event|0|||
149942789|NCT03573297|540925517|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
149942790|NCT03573297|540925518|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
149942791|NCT03573297|540925519|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
149942792|NCT03573297|540925520|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
149942793|NCT03573297|540925517|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
149942794|NCT03573297|540925518|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
149942795|NCT03573297|540925519|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
149942796|NCT03573297|540925520|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
149942797|NCT03573297|540925517|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
149942798|NCT03573297|540925518|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
149942799|NCT03573297|540925519|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
149942800|NCT03573297|540925520|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
149942801|NCT03573297|540925517|FG000|Open Label Treatment Period|Pregnancy|1|||
149942802|NCT03573297|540925518|FG001|Open Label Treatment Period|Pregnancy|0|||
149942803|NCT03573297|540925519|FG002|Open Label Treatment Period|Pregnancy|0|||
149942804|NCT03573297|540925520|FG003|Open Label Treatment Period|Pregnancy|0|||
149942805|NCT03573297|540925517|FG000|Open Label Treatment Period|Protocol Violation|17|||
149942806|NCT03573297|540925518|FG001|Open Label Treatment Period|Protocol Violation|0|||
149942807|NCT03573297|540925519|FG002|Open Label Treatment Period|Protocol Violation|0|||
149942808|NCT03573297|540925520|FG003|Open Label Treatment Period|Protocol Violation|0|||
149942809|NCT03573297|540925517|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
149942810|NCT03573297|540925518|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
149942811|NCT03573297|540925519|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
149942812|NCT03573297|540925520|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
149942813|NCT03573297|540925517|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
150031908|NCT05435339|541255500|FG003|Overall Study|Death|1|||
150031909|NCT05435339|541255501|FG004|Overall Study|Death|3|||
150031910|NCT05435339|541255502|FG005|Overall Study|Death|2|||
150031911|NCT05435339|541255503|FG006|Overall Study|Death|4|||
150031912|NCT05435339|541255504|FG007|Overall Study|Death|6|||
150031913|NCT05435339|541255497|FG000|Overall Study|Sponsor Decision|0|||
150031914|NCT05435339|541255498|FG001|Overall Study|Sponsor Decision|1|||
150031915|NCT05435339|541255499|FG002|Overall Study|Sponsor Decision|0|||
150031916|NCT05435339|541255500|FG003|Overall Study|Sponsor Decision|0|||
150031917|NCT05435339|541255501|FG004|Overall Study|Sponsor Decision|2|||
150031918|NCT05435339|541255502|FG005|Overall Study|Sponsor Decision|1|||
150031919|NCT05435339|541255503|FG006|Overall Study|Sponsor Decision|2|||
150031920|NCT05435339|541255504|FG007|Overall Study|Sponsor Decision|2|||
150031921|NCT05435339|541255497|FG000|Overall Study|Withdrawal by Subject|0|||
150031922|NCT05435339|541255498|FG001|Overall Study|Withdrawal by Subject|0|||
150031923|NCT05435339|541255499|FG002|Overall Study|Withdrawal by Subject|0|||
150031924|NCT05435339|541255500|FG003|Overall Study|Withdrawal by Subject|0|||
150031925|NCT05435339|541255501|FG004|Overall Study|Withdrawal by Subject|1|||
150031926|NCT05435339|541255502|FG005|Overall Study|Withdrawal by Subject|0|||
150031927|NCT05435339|541255503|FG006|Overall Study|Withdrawal by Subject|1|||
150031928|NCT05435339|541255504|FG007|Overall Study|Withdrawal by Subject|1|||
150031929|NCT01446159|541255505|FG000|Overall Study|Withdrawal by Subject|1|||
150031930|NCT01446159|541255506|FG001|Overall Study|Withdrawal by Subject|0|||
150031931|NCT01446159|541255507|FG002|Overall Study|Withdrawal by Subject|14|||
150031932|NCT01446159|541255508|FG003|Overall Study|Withdrawal by Subject|11|||
150031933|NCT01446159|541255505|FG000|Overall Study|Lost to Follow-up|0|||
150031934|NCT01446159|541255506|FG001|Overall Study|Lost to Follow-up|0|||
150031935|NCT01446159|541255507|FG002|Overall Study|Lost to Follow-up|1|||
150031936|NCT01446159|541255508|FG003|Overall Study|Lost to Follow-up|2|||
150031937|NCT01446159|541255505|FG000|Overall Study|Death|2|||
150031938|NCT01446159|541255506|FG001|Overall Study|Death|3|||
150031939|NCT01446159|541255507|FG002|Overall Study|Death|43|||
150031940|NCT01446159|541255508|FG003|Overall Study|Death|36|||
150031941|NCT01446159|541255505|FG000|Overall Study|Other|0|||
150031942|NCT01446159|541255506|FG001|Overall Study|Other|0|||
150031943|NCT01446159|541255507|FG002|Overall Study|Other|13|||
150031944|NCT01446159|541255508|FG003|Overall Study|Other|13|||
150031945|NCT00537394|541255509|FG000|First Year of Follow-up|Death|7|||
150031946|NCT00537394|541255510|FG001|First Year of Follow-up|Death|0|||
150031947|NCT00537394|541255511|FG002|First Year of Follow-up|Death|0|||
150031948|NCT00537394|541255509|FG000|First Year of Follow-up|Severe debilitation|1|||
150031949|NCT00537394|541255510|FG001|First Year of Follow-up|Severe debilitation|0|||
150031950|NCT00537394|541255511|FG002|First Year of Follow-up|Severe debilitation|1|||
150031951|NCT00537394|541255509|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
150031952|NCT00537394|541255510|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
150031953|NCT00537394|541255511|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
150031954|NCT00537394|541255509|FG000|First Year of Follow-up|Lost to Follow-up|1|||
150031955|NCT00537394|541255510|FG001|First Year of Follow-up|Lost to Follow-up|5|||
150031956|NCT00537394|541255511|FG002|First Year of Follow-up|Lost to Follow-up|1|||
150031957|NCT00537394|541255509|FG000|2nd Year of Follow-up|Death|4|||
150031958|NCT00537394|541255510|FG001|2nd Year of Follow-up|Death|1|||
150031959|NCT00537394|541255511|FG002|2nd Year of Follow-up|Death|2|||
150031960|NCT00537394|541255509|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
150031961|NCT00537394|541255510|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
150274332|NCT05975840|542141610|FG002|Overall Study|Withdrawal by Subject|2|||
150274333|NCT05975840|542141611|FG003|Overall Study|Withdrawal by Subject|2|||
150031962|NCT00537394|541255511|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
150031963|NCT00537394|541255509|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
150031964|NCT00537394|541255510|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
150031965|NCT00537394|541255511|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
150031966|NCT00537394|541255509|FG000|2nd Year of Follow-up|Clinic site closure|1|||
150031967|NCT00537394|541255510|FG001|2nd Year of Follow-up|Clinic site closure|0|||
150031968|NCT00537394|541255511|FG002|2nd Year of Follow-up|Clinic site closure|0|||
150031969|NCT01283139|541255512|FG000|Overall Study|Lost to Follow-up|5|||
150031970|NCT01283139|541255513|FG001|Overall Study|Lost to Follow-up|2|||
150031971|NCT01283139|541255514|FG002|Overall Study|Lost to Follow-up|3|||
150031972|NCT01283139|541255515|FG003|Overall Study|Lost to Follow-up|1|||
150031973|NCT01283139|541255512|FG000|Overall Study|Withdrawal by Subject|8|||
150031974|NCT01283139|541255513|FG001|Overall Study|Withdrawal by Subject|8|||
150031975|NCT01283139|541255514|FG002|Overall Study|Withdrawal by Subject|6|||
150031976|NCT01283139|541255515|FG003|Overall Study|Withdrawal by Subject|8|||
150031977|NCT01283139|541255512|FG000|Overall Study|Death|2|||
150031978|NCT01283139|541255513|FG001|Overall Study|Death|0|||
150031979|NCT01283139|541255514|FG002|Overall Study|Death|2|||
150031980|NCT01283139|541255515|FG003|Overall Study|Death|2|||
150274334|NCT05975840|542141612|FG004|Overall Study|Withdrawal by Subject|0|||
150031981|NCT01283139|541255512|FG000|Overall Study|Lack of Efficacy|1|||
150031982|NCT01283139|541255513|FG001|Overall Study|Lack of Efficacy|2|||
150031983|NCT01283139|541255514|FG002|Overall Study|Lack of Efficacy|2|||
150031984|NCT01283139|541255515|FG003|Overall Study|Lack of Efficacy|1|||
150031985|NCT01283139|541255512|FG000|Overall Study|Early termination due to AE/SAE|1|||
150031986|NCT01283139|541255513|FG001|Overall Study|Early termination due to AE/SAE|1|||
150031987|NCT01283139|541255514|FG002|Overall Study|Early termination due to AE/SAE|0|||
150031988|NCT01283139|541255515|FG003|Overall Study|Early termination due to AE/SAE|0|||
150031989|NCT01283139|541255512|FG000|Overall Study|Participant's refusal to continue|0|||
150031990|NCT01283139|541255513|FG001|Overall Study|Participant's refusal to continue|3|||
150031991|NCT01283139|541255514|FG002|Overall Study|Participant's refusal to continue|1|||
150031992|NCT01283139|541255515|FG003|Overall Study|Participant's refusal to continue|1|||
150031993|NCT01283139|541255512|FG000|Overall Study|Pregnancy|0|||
150031994|NCT01283139|541255513|FG001|Overall Study|Pregnancy|1|||
150031995|NCT01283139|541255514|FG002|Overall Study|Pregnancy|1|||
150031996|NCT01283139|541255515|FG003|Overall Study|Pregnancy|0|||
150031997|NCT01283139|541255512|FG000|Overall Study|Missed follow-up visit|0|||
150031998|NCT01283139|541255513|FG001|Overall Study|Missed follow-up visit|1|||
150031999|NCT01283139|541255514|FG002|Overall Study|Missed follow-up visit|2|||
150032000|NCT01283139|541255515|FG003|Overall Study|Missed follow-up visit|2|||
150032001|NCT01283139|541255512|FG000|Overall Study|Participant randomized in error|0|||
150274335|NCT05975840|542141613|FG005|Overall Study|Withdrawal by Subject|2|||
150274336|NCT05975840|542141614|FG006|Overall Study|Withdrawal by Subject|2|||
150274337|NCT05975840|542141615|FG007|Overall Study|Withdrawal by Subject|1|||
150274338|NCT05975840|542141608|FG000|Overall Study|Protocol Violation|0|||
150274339|NCT05975840|542141609|FG001|Overall Study|Protocol Violation|1|||
150274340|NCT05975840|542141610|FG002|Overall Study|Protocol Violation|0|||
150274341|NCT05975840|542141611|FG003|Overall Study|Protocol Violation|0|||
150032002|NCT01283139|541255513|FG001|Overall Study|Participant randomized in error|0|||
150032003|NCT01283139|541255514|FG002|Overall Study|Participant randomized in error|1|||
150032004|NCT01283139|541255515|FG003|Overall Study|Participant randomized in error|0|||
150032005|NCT00004563|541255516|FG000|Overall Study|Withdrawal by Subject|20|||
150032006|NCT00004563|541255517|FG001|Overall Study|Withdrawal by Subject|16|||
150274342|NCT05975840|542141612|FG004|Overall Study|Protocol Violation|0|||
150274343|NCT05975840|542141613|FG005|Overall Study|Protocol Violation|0|||
150274344|NCT05975840|542141614|FG006|Overall Study|Protocol Violation|0|||
150274345|NCT05975840|542141615|FG007|Overall Study|Protocol Violation|0|||
150274346|NCT05975840|542141608|FG000|Overall Study|Adverse Event|0|||
150274347|NCT05975840|542141609|FG001|Overall Study|Adverse Event|0|||
150274348|NCT05975840|542141610|FG002|Overall Study|Adverse Event|0|||
150274349|NCT05975840|542141611|FG003|Overall Study|Adverse Event|1|||
150274350|NCT05975840|542141612|FG004|Overall Study|Adverse Event|0|||
150274351|NCT05975840|542141613|FG005|Overall Study|Adverse Event|0|||
150274352|NCT05975840|542141614|FG006|Overall Study|Adverse Event|0|||
149942814|NCT03573297|540925518|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
149942815|NCT03573297|540925519|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
149942816|NCT03573297|540925520|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
149942817|NCT03573297|540925517|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
149942818|NCT03573297|540925518|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
149942819|NCT03573297|540925519|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
149942820|NCT03573297|540925520|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
149942821|NCT03573297|540925517|FG000|Open Label Treatment Period|Other, Not Specified|7|||
149942822|NCT03573297|540925518|FG001|Open Label Treatment Period|Other, Not Specified|0|||
149942823|NCT03573297|540925519|FG002|Open Label Treatment Period|Other, Not Specified|0|||
149942824|NCT03573297|540925520|FG003|Open Label Treatment Period|Other, Not Specified|0|||
149942825|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
149942826|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
149942827|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
149942828|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
149942829|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149942830|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149942831|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Adverse Event|5|||
149942832|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Adverse Event|1|||
149942833|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
149942834|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
149942835|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
150032007|NCT00004563|541255516|FG000|Overall Study|Lack of Efficacy|3|||
150032008|NCT00004563|541255517|FG001|Overall Study|Lack of Efficacy|5|||
150032009|NCT00004563|541255516|FG000|Overall Study|Death|2|||
150032010|NCT00004563|541255517|FG001|Overall Study|Death|3|||
150274353|NCT05975840|542141615|FG007|Overall Study|Adverse Event|0|||
150274354|NCT05975840|542141608|FG000|Overall Study|Death|0|||
150274355|NCT05975840|542141609|FG001|Overall Study|Death|1|||
150274356|NCT05975840|542141610|FG002|Overall Study|Death|0|||
150274357|NCT05975840|542141611|FG003|Overall Study|Death|0|||
150274358|NCT05975840|542141612|FG004|Overall Study|Death|0|||
150274359|NCT05975840|542141613|FG005|Overall Study|Death|0|||
149942836|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
149942837|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149942838|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
149942839|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
149942840|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
149942841|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149942842|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
150032011|NCT00849940|541255521|FG000|Overall Study|Physician Decision|4|||
150032012|NCT02994108|541257097|FG000|Intervention Messages|Withdrawal by Subject|2|||
150032013|NCT02994108|541257098|FG001|Intervention Messages|Withdrawal by Subject|0|||
150032014|NCT02994108|541257097|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
150032015|NCT02994108|541257098|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
150032016|NCT02994108|541257097|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
150032017|NCT02994108|541257098|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
150032018|NCT02994108|541257097|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
150032019|NCT02994108|541257098|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
150032020|NCT00089297|541257099|FG000|Overall Study|Adverse Event|9|||
150032021|NCT00089297|541257099|FG000|Overall Study|Death|1|||
150032022|NCT00089297|541257099|FG000|Overall Study|Withdrawal by Subject|12|||
150032023|NCT00089297|541257099|FG000|Overall Study|Disease progression|2|||
150032024|NCT00089297|541257099|FG000|Overall Study|Ineligible|11|||
150032025|NCT00089297|541257099|FG000|Overall Study|Secondary malignancy|1|||
150032026|NCT00089297|541257099|FG000|Overall Study|IRB approval not ready|1|||
150032027|NCT00089297|541257099|FG000|Overall Study|Non-compliance|1|||
150032028|NCT00904969|541257100|FG000|Overall Study|Lost to Follow-up|4|||
150032029|NCT00904969|541257100|FG000|Overall Study|Withdrawal by Subject|3|||
150032030|NCT00904969|541257100|FG000|Overall Study|Additional Treatments|11|||
150032031|NCT00904969|541257100|FG000|Overall Study|Case Aborted; Subject Exited|1|||
150032032|NCT01097668|541257101|FG000|Overall Study|Withdrawal by Subject|1|||
150032033|NCT01097668|541257102|FG001|Overall Study|Withdrawal by Subject|2|||
150032034|NCT01097668|541257101|FG000|Overall Study|Lost to Follow-up|1|||
150032035|NCT01097668|541257102|FG001|Overall Study|Lost to Follow-up|0|||
150032036|NCT01910298|541257110|FG000|Overall Study|Adverse Event|1|||
150032037|NCT01910298|541257111|FG001|Overall Study|Adverse Event|0|||
150032038|NCT01910298|541257110|FG000|Overall Study|Withdrawal by Subject|2|||
150032039|NCT01910298|541257111|FG001|Overall Study|Withdrawal by Subject|7|||
150032040|NCT01910298|541257110|FG000|Overall Study|Protocol Deviation|0|||
150032041|NCT01910298|541257111|FG001|Overall Study|Protocol Deviation|5|||
150032042|NCT01910298|541257110|FG000|Overall Study|Lost to Follow-up|1|||
150032043|NCT01910298|541257111|FG001|Overall Study|Lost to Follow-up|1|||
150032044|NCT01910298|541257110|FG000|Overall Study|Study Terminated by Sponsor|1|||
150032045|NCT01910298|541257111|FG001|Overall Study|Study Terminated by Sponsor|17|||
150032046|NCT01910298|541257110|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150032047|NCT01910298|541257111|FG001|Overall Study|Other Miscellaneous Reasons|2|||
149942843|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
149942844|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
150032048|NCT00948246|541257112|FG000|Overall Study|Lost to Follow-up|11|||
150032049|NCT00948246|541257112|FG000|Overall Study|Adverse Event|11|||
150274360|NCT05975840|542141614|FG006|Overall Study|Death|0|||
149942845|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
149942846|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
149942847|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
149942848|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
149942849|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
149942850|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
149942851|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
149942852|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
149942853|NCT03573297|540925517|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
149942854|NCT03573297|540925518|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
149942855|NCT03573297|540925519|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
149942856|NCT03573297|540925520|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
149942857|NCT03415178|540925521|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
149942858|NCT03415178|540925522|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
149942859|NCT03415178|540925521|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
150274361|NCT05975840|542141615|FG007|Overall Study|Death|1|||
150032050|NCT00948246|541257112|FG000|Overall Study|Death|1|||
150032051|NCT00948246|541257112|FG000|Overall Study|Withdrawal by Subject|1|||
150032052|NCT00148317|541257113|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
150032053|NCT00148317|541257113|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
150032054|NCT00148317|541257113|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
150032055|NCT04199351|541257114|FG000|Overall Study|Decision by sponsor|0|||
150274362|NCT00088907|542142852|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
150274363|NCT00088907|542142853|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
149942860|NCT03415178|540925522|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
150169993|NCT02781584|541757229|FG011|Treatment Phase|Withdrew Consent|2|||
149942861|NCT01366092|540925523|FG000|Overall Study|Progressive cGVHD|2|||
149942862|NCT01366092|540925523|FG000|Overall Study|Physician Decision|1|||
149942863|NCT01366092|540925523|FG000|Overall Study|Withdrawal by Subject|1|||
149942864|NCT02273167|540925525|FG000|Overall Study|Adverse Event|1|||
149942865|NCT02273167|540925526|FG001|Overall Study|Adverse Event|0|||
149942866|NCT02273167|540925527|FG002|Overall Study|Adverse Event|0|||
149942867|NCT02273167|540925525|FG000|Overall Study|Protocol Violation|3|||
149942868|NCT02273167|540925526|FG001|Overall Study|Protocol Violation|1|||
149942869|NCT02273167|540925527|FG002|Overall Study|Protocol Violation|1|||
149942870|NCT02273167|540925525|FG000|Overall Study|Lost to Follow-up|0|||
149942871|NCT02273167|540925526|FG001|Overall Study|Lost to Follow-up|1|||
149942872|NCT02273167|540925527|FG002|Overall Study|Lost to Follow-up|1|||
149942873|NCT02273167|540925525|FG000|Overall Study|Withdrawal by Subject|10|||
149942874|NCT02273167|540925526|FG001|Overall Study|Withdrawal by Subject|12|||
149942875|NCT02273167|540925527|FG002|Overall Study|Withdrawal by Subject|11|||
149942876|NCT02273167|540925525|FG000|Overall Study|Various|10|||
149942877|NCT02273167|540925526|FG001|Overall Study|Various|9|||
149942878|NCT02273167|540925527|FG002|Overall Study|Various|8|||
149942879|NCT01093846|540925528|FG000|Overall Study|Adverse Event|0|||
149942880|NCT01093846|540925529|FG001|Overall Study|Adverse Event|0|||
149942881|NCT01093846|540925530|FG002|Overall Study|Adverse Event|1|||
149942882|NCT01093846|540925528|FG000|Overall Study|Lack of Efficacy|0|||
149942883|NCT01093846|540925529|FG001|Overall Study|Lack of Efficacy|0|||
149942884|NCT01093846|540925530|FG002|Overall Study|Lack of Efficacy|4|||
149942885|NCT01093846|540925528|FG000|Overall Study|Condition no longer required study drug|1|||
149942886|NCT01093846|540925529|FG001|Overall Study|Condition no longer required study drug|1|||
149942887|NCT01093846|540925530|FG002|Overall Study|Condition no longer required study drug|1|||
149942888|NCT01093846|540925528|FG000|Overall Study|Administrative Problems|18|||
149942889|NCT01093846|540925529|FG001|Overall Study|Administrative Problems|17|||
149942890|NCT01093846|540925530|FG002|Overall Study|Administrative Problems|15|||
149942891|NCT02781324|540925535|FG000|Overall Study|Withdrawal by Subject|1|||
149942892|NCT02781324|540925536|FG001|Overall Study|Withdrawal by Subject|0|||
149942893|NCT02781324|540925535|FG000|Overall Study|Physician Decision|1|||
149942894|NCT02781324|540925536|FG001|Overall Study|Physician Decision|2|||
149942895|NCT00834041|540925537|FG000|Overall Study|Withdrawal by Subject|1|||
149942896|NCT00834041|540925538|FG001|Overall Study|Withdrawal by Subject|0|||
149942897|NCT00834041|540925537|FG000|Overall Study|Lost to Follow-up|0|||
149942898|NCT00834041|540925538|FG001|Overall Study|Lost to Follow-up|1|||
149942899|NCT03074500|540925539|FG000|Overall Study|Lost to Follow-up|1|||
149942900|NCT03074500|540925540|FG001|Overall Study|Lost to Follow-up|0|||
149942901|NCT03074500|540925541|FG002|Overall Study|Lost to Follow-up|0|||
149942902|NCT03074500|540925539|FG000|Overall Study|Lack of Efficacy|0|||
149942903|NCT03074500|540925540|FG001|Overall Study|Lack of Efficacy|1|||
149942904|NCT03074500|540925541|FG002|Overall Study|Lack of Efficacy|0|||
149942905|NCT03074500|540925539|FG000|Overall Study|Adverse Event|0|||
149942906|NCT03074500|540925540|FG001|Overall Study|Adverse Event|0|||
149942907|NCT03074500|540925541|FG002|Overall Study|Adverse Event|1|||
149942908|NCT03321721|540925542|FG000|Overall Study|Lost to Follow-up|4|||
149942909|NCT03321721|540925543|FG001|Overall Study|Lost to Follow-up|8|||
149942910|NCT03321721|540925544|FG002|Overall Study|Lost to Follow-up|11|||
149942911|NCT01416571|540925547|FG000|Overall Study|Lost to Follow-up|2|||
149942912|NCT03608163|540925548|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
149942913|NCT03608163|540925549|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
149942914|NCT03353220|540925550|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
149942915|NCT03353220|540925551|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
149942916|NCT00661388|540925561|FG000|Overall Study|Adverse Event|14|||
149942917|NCT00661388|540925561|FG000|Overall Study|Protocol Violation|7|||
149942918|NCT00661388|540925561|FG000|Overall Study|Renal transplantation|1|||
149942919|NCT00661388|540925561|FG000|Overall Study|Dialysis initiation|1|||
149942920|NCT00661388|540925561|FG000|Overall Study|Administrative reasons|1|||
149942921|NCT04770753|540926434|FG000|Overall Study|Randomized, never treated|1|||
149942922|NCT04770753|540926435|FG001|Overall Study|Randomized, never treated|1|||
149942923|NCT04770753|540926434|FG000|Overall Study|Withdrawal by Subject|3|||
149942924|NCT04770753|540926435|FG001|Overall Study|Withdrawal by Subject|1|||
149942925|NCT04770753|540926434|FG000|Overall Study|Adverse Event|2|||
149942926|NCT04770753|540926435|FG001|Overall Study|Adverse Event|0|||
149942927|NCT04770753|540926434|FG000|Overall Study|Pregnancy|1|||
149942928|NCT04770753|540926435|FG001|Overall Study|Pregnancy|0|||
149942929|NCT04770753|540926434|FG000|Overall Study|Other un-specified|1|||
149942930|NCT04770753|540926435|FG001|Overall Study|Other un-specified|0|||
149942931|NCT04780659|540926436|FG000|Overall Study|Adverse event, serious fatal|3|||
149942932|NCT04780659|540926437|FG001|Overall Study|Adverse event, serious fatal|0|||
149942933|NCT04780659|540926436|FG000|Overall Study|Withdrawal by Subject|3|||
149942934|NCT04780659|540926437|FG001|Overall Study|Withdrawal by Subject|0|||
149942935|NCT04780659|540926436|FG000|Overall Study|Physician Decision|1|||
150032056|NCT04199351|541257115|FG001|Overall Study|Decision by sponsor|0|||
150032057|NCT04199351|541257116|FG002|Overall Study|Decision by sponsor|0|||
150032058|NCT04199351|541257117|FG003|Overall Study|Decision by sponsor|2|||
150032059|NCT04199351|541257118|FG004|Overall Study|Decision by sponsor|0|||
150032060|NCT04199351|541257119|FG005|Overall Study|Decision by sponsor|0|||
150032061|NCT04199351|541257120|FG006|Overall Study|Decision by sponsor|0|||
150032062|NCT04199351|541257121|FG007|Overall Study|Decision by sponsor|0|||
150032063|NCT04199351|541257122|FG008|Overall Study|Decision by sponsor|0|||
150032064|NCT04199351|541257123|FG009|Overall Study|Decision by sponsor|6|||
150032065|NCT04199351|541257114|FG000|Overall Study|Lost to Follow-up|0|||
150032066|NCT04199351|541257115|FG001|Overall Study|Lost to Follow-up|0|||
150032067|NCT04199351|541257116|FG002|Overall Study|Lost to Follow-up|1|||
150032068|NCT04199351|541257117|FG003|Overall Study|Lost to Follow-up|0|||
150032069|NCT04199351|541257118|FG004|Overall Study|Lost to Follow-up|0|||
150032070|NCT04199351|541257119|FG005|Overall Study|Lost to Follow-up|1|||
150032071|NCT04199351|541257120|FG006|Overall Study|Lost to Follow-up|0|||
150032072|NCT04199351|541257121|FG007|Overall Study|Lost to Follow-up|0|||
150032073|NCT04199351|541257122|FG008|Overall Study|Lost to Follow-up|0|||
150032074|NCT04199351|541257123|FG009|Overall Study|Lost to Follow-up|0|||
150032075|NCT04199351|541257114|FG000|Overall Study|Withdrawal by Subject|0|||
150032076|NCT04199351|541257115|FG001|Overall Study|Withdrawal by Subject|1|||
150032077|NCT04199351|541257116|FG002|Overall Study|Withdrawal by Subject|0|||
150032078|NCT04199351|541257117|FG003|Overall Study|Withdrawal by Subject|0|||
150032079|NCT04199351|541257118|FG004|Overall Study|Withdrawal by Subject|1|||
150032080|NCT04199351|541257119|FG005|Overall Study|Withdrawal by Subject|4|||
150032081|NCT04199351|541257120|FG006|Overall Study|Withdrawal by Subject|2|||
150032082|NCT04199351|541257121|FG007|Overall Study|Withdrawal by Subject|0|||
150032083|NCT04199351|541257122|FG008|Overall Study|Withdrawal by Subject|3|||
150032084|NCT04199351|541257123|FG009|Overall Study|Withdrawal by Subject|0|||
150032085|NCT03623243|541257124|FG000|Overall Study|Adverse Event|15|||
150032086|NCT03623243|541257124|FG000|Overall Study|Guardian Decision|1|||
150032087|NCT03623243|541257124|FG000|Overall Study|New Therapy for Study Indication|1|||
150032088|NCT03623243|541257124|FG000|Overall Study|Protocol Deviation|3|||
150032089|NCT03623243|541257124|FG000|Overall Study|Physician Decision|4|||
150032090|NCT03623243|541257124|FG000|Overall Study|Patient Decision|15|||
150032091|NCT03007966|541257125|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
150032092|NCT03007966|541257126|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
150032093|NCT00474487|541257130|FG000|Overall Study|Withdrawal by Subject|6|||
150032094|NCT00474487|541257131|FG001|Overall Study|Withdrawal by Subject|0|||
150032095|NCT00474487|541257132|FG002|Overall Study|Withdrawal by Subject|0|||
150032096|NCT00474487|541257133|FG003|Overall Study|Withdrawal by Subject|0|||
150032097|NCT00474487|541257130|FG000|Overall Study|Lost to Follow-up|20|||
150032098|NCT00474487|541257131|FG001|Overall Study|Lost to Follow-up|1|||
150032099|NCT00474487|541257132|FG002|Overall Study|Lost to Follow-up|7|||
150032100|NCT00474487|541257133|FG003|Overall Study|Lost to Follow-up|0|||
150032101|NCT00474487|541257130|FG000|Overall Study|Inappropriate enrollment|4|||
150032102|NCT00474487|541257131|FG001|Overall Study|Inappropriate enrollment|0|||
150032103|NCT00474487|541257132|FG002|Overall Study|Inappropriate enrollment|7|||
150032104|NCT00474487|541257133|FG003|Overall Study|Inappropriate enrollment|0|||
150032105|NCT00474487|541257130|FG000|Overall Study|Death|0|||
150032106|NCT00474487|541257131|FG001|Overall Study|Death|1|||
150032107|NCT00474487|541257132|FG002|Overall Study|Death|0|||
150032108|NCT00474487|541257133|FG003|Overall Study|Death|0|||
150032109|NCT01428258|541257134|FG000|Intervention 1|Withdrawal by Subject|2|||
150032110|NCT01428258|541257135|FG001|Intervention 1|Withdrawal by Subject|0|||
150032111|NCT00419393|541257136|FG000|Overall Study|Adverse Event|5|||
150032112|NCT00419393|541257136|FG000|Overall Study|Protocol Violation|5|||
150032113|NCT00419393|541257136|FG000|Overall Study|Withdrawal by Subject|7|||
150032114|NCT00419393|541257136|FG000|Overall Study|Other: Sponsor request|3|||
150032115|NCT00419393|541257136|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
150032116|NCT00419393|541257136|FG000|Overall Study|Other: Site closure|1|||
150032117|NCT00419393|541257136|FG000|Overall Study|Other: Other health problems|1|||
150032118|NCT00419393|541257136|FG000|Overall Study|Other: Investigator decision|1|||
150032119|NCT00979901|541257137|FG000|Overall Study|Adverse Event|1|||
150032120|NCT00979901|541257138|FG001|Overall Study|Adverse Event|3|||
150169994|NCT02781584|541757230|FG012|Treatment Phase|Withdrew Consent|0|||
150169995|NCT02781584|541757218|FG000|Treatment Phase|Adverse Event|0|||
150169996|NCT02781584|541757219|FG001|Treatment Phase|Adverse Event|0|||
149821325|NCT02536378|540475690|FG000|Overall Study|Death|1|||
150032121|NCT00979901|541257139|FG002|Overall Study|Adverse Event|9|||
150032122|NCT00979901|541257140|FG003|Overall Study|Adverse Event|2|||
150032123|NCT00979901|541257137|FG000|Overall Study|Lack of Efficacy|8|||
150032124|NCT00979901|541257138|FG001|Overall Study|Lack of Efficacy|4|||
150032125|NCT00979901|541257139|FG002|Overall Study|Lack of Efficacy|9|||
150032126|NCT00979901|541257140|FG003|Overall Study|Lack of Efficacy|0|||
150032127|NCT00979901|541257137|FG000|Overall Study|Lost to Follow-up|1|||
150032128|NCT00979901|541257138|FG001|Overall Study|Lost to Follow-up|1|||
150032129|NCT00979901|541257139|FG002|Overall Study|Lost to Follow-up|2|||
150032130|NCT00979901|541257140|FG003|Overall Study|Lost to Follow-up|0|||
150032131|NCT00979901|541257137|FG000|Overall Study|Protocol Violation|2|||
150032132|NCT00979901|541257138|FG001|Overall Study|Protocol Violation|2|||
150032133|NCT00979901|541257139|FG002|Overall Study|Protocol Violation|7|||
150032134|NCT00979901|541257140|FG003|Overall Study|Protocol Violation|1|||
150032135|NCT00979901|541257137|FG000|Overall Study|Withdrawal by Subject|2|||
150032136|NCT00979901|541257138|FG001|Overall Study|Withdrawal by Subject|1|||
150032137|NCT00979901|541257139|FG002|Overall Study|Withdrawal by Subject|1|||
150032138|NCT00979901|541257140|FG003|Overall Study|Withdrawal by Subject|1|||
150032139|NCT00979901|541257137|FG000|Overall Study|Noncompliance|1|||
150032140|NCT00979901|541257138|FG001|Overall Study|Noncompliance|0|||
150032141|NCT00979901|541257139|FG002|Overall Study|Noncompliance|0|||
150032142|NCT00979901|541257140|FG003|Overall Study|Noncompliance|0|||
150032143|NCT00979901|541257137|FG000|Overall Study|out-of-state|1|||
150032144|NCT00979901|541257138|FG001|Overall Study|out-of-state|0|||
150032145|NCT00979901|541257139|FG002|Overall Study|out-of-state|0|||
150032146|NCT00979901|541257140|FG003|Overall Study|out-of-state|0|||
150032147|NCT00979901|541257137|FG000|Overall Study|vacation|1|||
150032148|NCT00979901|541257138|FG001|Overall Study|vacation|0|||
150032149|NCT00979901|541257139|FG002|Overall Study|vacation|0|||
150032150|NCT00979901|541257140|FG003|Overall Study|vacation|0|||
150032151|NCT00979901|541257137|FG000|Overall Study|elevated lab values pre-randomization|1|||
150032152|NCT00979901|541257138|FG001|Overall Study|elevated lab values pre-randomization|0|||
150032153|NCT00979901|541257139|FG002|Overall Study|elevated lab values pre-randomization|0|||
150032154|NCT00979901|541257140|FG003|Overall Study|elevated lab values pre-randomization|0|||
150032155|NCT00979901|541257137|FG000|Overall Study|Discontinued in Error|0|||
150032156|NCT00979901|541257138|FG001|Overall Study|Discontinued in Error|1|||
150032157|NCT00979901|541257139|FG002|Overall Study|Discontinued in Error|0|||
150032158|NCT00979901|541257140|FG003|Overall Study|Discontinued in Error|0|||
150032159|NCT00979901|541257137|FG000|Overall Study|Left Country|0|||
150032160|NCT00979901|541257138|FG001|Overall Study|Left Country|0|||
150032161|NCT00979901|541257139|FG002|Overall Study|Left Country|1|||
150032162|NCT00979901|541257140|FG003|Overall Study|Left Country|0|||
150032163|NCT00979901|541257137|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
150032164|NCT00979901|541257138|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
150032165|NCT00979901|541257139|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
150032166|NCT00979901|541257140|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
150032167|NCT03924622|541257142|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
150032168|NCT03924622|541257143|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
150032169|NCT03924622|541257144|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
150032170|NCT03924622|541257145|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
150032171|NCT03924622|541257146|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
150032172|NCT03924622|541257147|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
150032173|NCT02814916|541257151|FG000|Overall Study|Withdrawal of consent|0|||
150032174|NCT02814916|541257152|FG001|Overall Study|Withdrawal of consent|2|||
150032175|NCT02814916|541257153|FG002|Overall Study|Withdrawal of consent|0|||
150032176|NCT02814916|541257151|FG000|Overall Study|Lost to Follow-up|0|||
150032177|NCT02814916|541257152|FG001|Overall Study|Lost to Follow-up|1|||
150032178|NCT02814916|541257153|FG002|Overall Study|Lost to Follow-up|0|||
150032179|NCT02814916|541257151|FG000|Overall Study|Other, not specified|0|||
150032180|NCT02814916|541257152|FG001|Overall Study|Other, not specified|1|||
150032181|NCT02814916|541257153|FG002|Overall Study|Other, not specified|0|||
150032182|NCT05316597|541257155|FG000|First Session|Withdrawal by Subject|0|||
150032183|NCT05316597|541257156|FG001|First Session|Withdrawal by Subject|1|||
150032184|NCT05316597|541257155|FG000|Washout Period|Lost to Follow-up|1|||
150032185|NCT05316597|541257156|FG001|Washout Period|Lost to Follow-up|2|||
150032186|NCT05316597|541257155|FG000|Washout Period|Physician Decision|1|||
150032187|NCT05316597|541257156|FG001|Washout Period|Physician Decision|1|||
150032188|NCT05316597|541257155|FG000|Washout Period|Excluded before second session|1|||
150032189|NCT05316597|541257156|FG001|Washout Period|Excluded before second session|1|||
150032190|NCT05316597|541257155|FG000|Washout Period|Withdrawal by Subject|0|||
150169997|NCT02781584|541757220|FG002|Treatment Phase|Adverse Event|0|||
150032191|NCT05316597|541257156|FG001|Washout Period|Withdrawal by Subject|4|||
150032192|NCT03547518|541257157|FG000|Overall Study|Lost to Follow-up|2|||
150032193|NCT03547518|541257158|FG001|Overall Study|Lost to Follow-up|0|||
150032194|NCT04247347|541257160|FG000|Overall Study|Withdrawal by Subject|2|||
150032195|NCT04247347|541257161|FG001|Overall Study|Withdrawal by Subject|3|||
150032196|NCT04247347|541257162|FG002|Overall Study|Withdrawal by Subject|3|||
150032197|NCT04247347|541257160|FG000|Overall Study|Lost to Follow-up|1|||
150032198|NCT04247347|541257161|FG001|Overall Study|Lost to Follow-up|1|||
150032199|NCT04247347|541257162|FG002|Overall Study|Lost to Follow-up|1|||
150032200|NCT02923726|541257163|FG000|Overall Study|Death|196|||
150032201|NCT02923726|541257164|FG001|Overall Study|Death|175|||
150032202|NCT02923726|541257163|FG000|Overall Study|Withdrawal by Subject|337|||
150032203|NCT02923726|541257164|FG001|Overall Study|Withdrawal by Subject|307|||
150032204|NCT00671658|541257168|FG000|Overall Study|Physician Decision|5|||
150032205|NCT01469221|541257170|FG000|Double Blind Phase|Protocol Violation|1|||
150032206|NCT01469221|541257171|FG001|Double Blind Phase|Protocol Violation|0|||
150032207|NCT01469221|541257172|FG002|Double Blind Phase|Protocol Violation|0|||
150032208|NCT01469221|541257170|FG000|Double Blind Phase|Physician Decision|1|||
150032209|NCT01469221|541257171|FG001|Double Blind Phase|Physician Decision|1|||
150032210|NCT01469221|541257172|FG002|Double Blind Phase|Physician Decision|0|||
150032211|NCT01469221|541257170|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
150032212|NCT01469221|541257171|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
150032213|NCT01469221|541257172|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
150032214|NCT02358473|541257178|FG000|Overall Study|Disease Progession|6|||
150032215|NCT02358473|541257178|FG000|Overall Study|Adverse Event|3|||
150032216|NCT02358473|541257178|FG000|Overall Study|Withdrawal by Subject|2|||
150032217|NCT02358473|541257178|FG000|Overall Study|Physician Decision|2|||
150032218|NCT00953667|541257179|FG000|Overall Study|Lost to Follow-up|11|||
150032219|NCT00953667|541257179|FG000|Overall Study|Physician Decision|35|||
150032220|NCT00953667|541257179|FG000|Overall Study|Withdrawal by Subject|63|||
150032221|NCT00953667|541257179|FG000|Overall Study|Adverse Event|10|||
150032222|NCT00953667|541257179|FG000|Overall Study|poor venous access,unable to draw blood|4|||
150032223|NCT00918385|541257183|FG000|Monotherapy|Adverse Event|1|||
150032224|NCT00918385|541257184|FG001|Monotherapy|Adverse Event|6|||
150032225|NCT00918385|541257183|FG000|Monotherapy|Complicating illness|1|||
150032226|NCT00918385|541257184|FG001|Monotherapy|Complicating illness|0|||
150032227|NCT00918385|541257183|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
150032228|NCT00918385|541257184|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
150032229|NCT00918385|541257183|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
150032230|NCT00918385|541257184|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
150032231|NCT00918385|541257183|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
150032232|NCT00918385|541257184|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
149942936|NCT04780659|540926437|FG001|Overall Study|Physician Decision|0|||
149942937|NCT04780659|540926436|FG000|Overall Study|Died in original disease|2|||
149942938|NCT04780659|540926437|FG001|Overall Study|Died in original disease|0|||
149942939|NCT04780659|540926436|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
149942940|NCT04780659|540926437|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
149942941|NCT05507437|540926438|FG000|Overall Study|Withdrawal by Subject|1|||
149942942|NCT05507437|540926439|FG001|Overall Study|Withdrawal by Subject|1|||
149942943|NCT05507437|540926438|FG000|Overall Study|Death|3|||
149942944|NCT05507437|540926439|FG001|Overall Study|Death|0|||
149942945|NCT06583096|540926440|FG000|Overall Study|Lost to Follow-up|4|||
149942946|NCT06583096|540926441|FG001|Overall Study|Lost to Follow-up|10|||
149942947|NCT06583096|540926440|FG000|Overall Study|Withdrawal by Subject|0|||
149942948|NCT06583096|540926441|FG001|Overall Study|Withdrawal by Subject|2|||
149942949|NCT04588259|540926442|FG000|Run-in period|Run-in failure|0|||
149942950|NCT04588259|540926443|FG001|Run-in period|Run-in failure|23|||
149942951|NCT04588259|540926442|FG000|Run-in period|Withdrawn before randomisation|0|||
149942952|NCT04588259|540926443|FG001|Run-in period|Withdrawn before randomisation|8|||
149942953|NCT04588259|540926442|FG000|Treatment period|Withdrawal by Subject|6|||
149942954|NCT04588259|540926443|FG001|Treatment period|Withdrawal by Subject|6|||
149942955|NCT04460885|540926444|FG000|Overall Study|Withdrawal by Subject|6|||
149942956|NCT04460885|540926445|FG001|Overall Study|Withdrawal by Subject|8|||
149942957|NCT04460885|540926444|FG000|Overall Study|Site closure|1|||
149942958|NCT04460885|540926445|FG001|Overall Study|Site closure|0|||
149942959|NCT04460885|540926444|FG000|Overall Study|Death|5|||
149942960|NCT04460885|540926445|FG001|Overall Study|Death|4|||
149942961|NCT04460885|540926444|FG000|Overall Study|Physician Decision|2|||
149942962|NCT04460885|540926445|FG001|Overall Study|Physician Decision|1|||
149942963|NCT04460885|540926444|FG000|Overall Study|Lost to Follow-up|4|||
149942964|NCT04460885|540926445|FG001|Overall Study|Lost to Follow-up|4|||
149942965|NCT02469233|540926449|FG000|Overall Study|Death|1|||
149942966|NCT02469233|540926450|FG001|Overall Study|Death|1|||
149942967|NCT02469233|540926449|FG000|Overall Study|Lost to post or 6 month follow up|7|||
149942968|NCT02469233|540926450|FG001|Overall Study|Lost to post or 6 month follow up|2|||
149942969|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
149942970|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
150032233|NCT00918385|541257183|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
149942971|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
149942972|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
149942973|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
149942974|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
149942975|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
149942976|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
150032234|NCT00918385|541257184|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
150032235|NCT04576988|541257187|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
150032236|NCT04576988|541257188|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
150032237|NCT04576988|541257187|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
150032238|NCT04576988|541257188|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
150032239|NCT04576988|541257187|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
150032240|NCT04576988|541257188|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
150032241|NCT04576988|541257187|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
150032242|NCT04576988|541257188|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
150032243|NCT04576988|541257187|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
149942977|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
149942978|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
149942979|NCT03979313|540926451|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
149942980|NCT03979313|540926452|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
149942981|NCT03979313|540926451|FG000|All Subjects|Any Other Reason|16|||
149942982|NCT03979313|540926452|FG001|All Subjects|Any Other Reason|23|||
149942983|NCT03979313|540926451|FG000|All Subjects|Covid-19|1|||
149942984|NCT03979313|540926452|FG001|All Subjects|Covid-19|3|||
149942985|NCT03979313|540926451|FG000|All Subjects|Withdrawal by Subject|35|||
149942986|NCT03979313|540926452|FG001|All Subjects|Withdrawal by Subject|44|||
149942987|NCT03979313|540926451|FG000|All Subjects|Death|0|||
149942988|NCT03979313|540926452|FG001|All Subjects|Death|5|||
149942989|NCT03979313|540926451|FG000|All Subjects|Lost to Follow-up|28|||
149942990|NCT03979313|540926452|FG001|All Subjects|Lost to Follow-up|61|||
149942991|NCT00656617|540926462|FG000|Overall Study|Adverse Event|1|||
149942992|NCT00656617|540926462|FG000|Overall Study|Death|2|||
149942993|NCT00656617|540926462|FG000|Overall Study|Insurance Issues|2|||
149942994|NCT00656617|540926462|FG000|Overall Study|Move to different clinical trial|2|||
149942995|NCT02030600|540926463|FG000|Treatment Period 1|Adverse Event|5|||
149942996|NCT02030600|540926464|FG001|Treatment Period 1|Adverse Event|7|||
149942997|NCT02030600|540926463|FG000|Treatment Period 1|Lack of Efficacy|0|||
149942998|NCT02030600|540926464|FG001|Treatment Period 1|Lack of Efficacy|1|||
149942999|NCT02030600|540926463|FG000|Treatment Period 1|Lost to Follow-up|11|||
149943000|NCT02030600|540926464|FG001|Treatment Period 1|Lost to Follow-up|3|||
149943001|NCT02030600|540926463|FG000|Treatment Period 1|Protocol Violation|22|||
150274364|NCT00088907|542142852|FG000|Randomized Study (Step 1)|Adverse Event|14|||
150274365|NCT00088907|542142853|FG001|Randomized Study (Step 1)|Adverse Event|19|||
150274366|NCT00088907|542142852|FG000|Randomized Study (Step 1)|Death|11|||
150274367|NCT00088907|542142853|FG001|Randomized Study (Step 1)|Death|12|||
150274368|NCT00088907|542142852|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
150274369|NCT00088907|542142853|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
150274370|NCT00088907|542142852|FG000|Randomized Study (Step 1)|complicating disease|3|||
150274371|NCT00088907|542142853|FG001|Randomized Study (Step 1)|complicating disease|1|||
150274372|NCT00088907|542142852|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
150274373|NCT00088907|542142853|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
150274374|NCT00088907|542142852|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
150274375|NCT00088907|542142853|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
150274376|NCT00088907|542142852|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
150274377|NCT00088907|542142853|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
150274378|NCT00088907|542142852|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
150274379|NCT00088907|542142853|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
150274380|NCT00088907|542142852|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
150274381|NCT00088907|542142853|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
150274382|NCT00088907|542142852|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
150274383|NCT00088907|542142853|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
150274384|NCT00682448|542142854|FG000|Overall Study|Adverse Event|1|||
149943002|NCT02030600|540926464|FG001|Treatment Period 1|Protocol Violation|17|||
149943003|NCT02030600|540926463|FG000|Treatment Period 1|Withdrawal by Subject|13|||
149943004|NCT02030600|540926464|FG001|Treatment Period 1|Withdrawal by Subject|17|||
149943005|NCT02030600|540926463|FG000|Treatment Period 1|Casebook Unsigned|1|||
149943006|NCT02030600|540926464|FG001|Treatment Period 1|Casebook Unsigned|0|||
149943007|NCT02030600|540926463|FG000|Treatment Period 1|Unclassified|1|||
149943008|NCT02030600|540926464|FG001|Treatment Period 1|Unclassified|0|||
149943009|NCT02030600|540926463|FG000|Treatment Period 2|Adverse Event|4|||
149943010|NCT02030600|540926464|FG001|Treatment Period 2|Adverse Event|4|||
149943011|NCT02030600|540926463|FG000|Treatment Period 2|Lack of Efficacy|2|||
149943012|NCT02030600|540926464|FG001|Treatment Period 2|Lack of Efficacy|1|||
149943013|NCT02030600|540926463|FG000|Treatment Period 2|Lost to Follow-up|4|||
150032244|NCT04576988|541257188|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
150032245|NCT04576988|541257187|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
150032246|NCT04576988|541257188|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
150274385|NCT00682448|542142855|FG001|Overall Study|Adverse Event|2|||
150274386|NCT00682448|542142854|FG000|Overall Study|Lack of Efficacy|1|||
149943014|NCT02030600|540926464|FG001|Treatment Period 2|Lost to Follow-up|2|||
150032247|NCT04576988|541257187|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
150032248|NCT04576988|541257188|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
150032249|NCT04576988|541257187|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
150032250|NCT04576988|541257188|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
150032251|NCT04576988|541257187|FG000|Long Term Double Blind (LTDB)|Death|2|||
150032252|NCT04576988|541257188|FG001|Long Term Double Blind (LTDB)|Death|1|||
150032253|NCT04576988|541257187|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
150032254|NCT04576988|541257188|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
150032255|NCT02362724|541257199|FG000|Overall Study|Withdrawal by Subject|3|||
150032256|NCT02362724|541257200|FG001|Overall Study|Withdrawal by Subject|1|||
150032257|NCT02362724|541257199|FG000|Overall Study|Adverse Event|3|||
150032258|NCT02362724|541257200|FG001|Overall Study|Adverse Event|0|||
150032259|NCT02025179|541257201|FG000|Overall Study|Lost to Follow-up|0|||
150032260|NCT02025179|541257202|FG001|Overall Study|Lost to Follow-up|0|||
150032261|NCT02025179|541257203|FG002|Overall Study|Lost to Follow-up|1|||
150032262|NCT00556075|541257204|FG000|Overall Study|Lost to Follow-up|3|||
150032263|NCT00556075|541257205|FG001|Overall Study|Lost to Follow-up|0|||
150032264|NCT00556075|541257206|FG002|Overall Study|Lost to Follow-up|3|||
150032265|NCT00556075|541257204|FG000|Overall Study|Withdrawal by Subject|3|||
150032266|NCT00556075|541257205|FG001|Overall Study|Withdrawal by Subject|3|||
150032267|NCT00556075|541257206|FG002|Overall Study|Withdrawal by Subject|0|||
150032268|NCT00556075|541257204|FG000|Overall Study|Protocol Violation|1|||
150032269|NCT00556075|541257205|FG001|Overall Study|Protocol Violation|1|||
150032270|NCT00556075|541257206|FG002|Overall Study|Protocol Violation|3|||
150032271|NCT00556075|541257204|FG000|Overall Study|Not eligible|1|||
150032272|NCT00556075|541257205|FG001|Overall Study|Not eligible|1|||
150032273|NCT00556075|541257206|FG002|Overall Study|Not eligible|2|||
150032274|NCT00556075|541257204|FG000|Overall Study|Adverse Event|1|||
150032275|NCT00556075|541257205|FG001|Overall Study|Adverse Event|2|||
150032276|NCT00556075|541257206|FG002|Overall Study|Adverse Event|0|||
150032277|NCT00556075|541257204|FG000|Overall Study|Personal issues|4|||
150032278|NCT00556075|541257205|FG001|Overall Study|Personal issues|1|||
150032279|NCT00556075|541257206|FG002|Overall Study|Personal issues|0|||
150032280|NCT00556075|541257204|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
150032281|NCT00556075|541257205|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
150032282|NCT00556075|541257206|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
150032283|NCT02485691|541257209|FG000|Overall Study|Adverse Event|25|||
150032284|NCT02485691|541257210|FG001|Overall Study|Adverse Event|11|||
150032285|NCT02485691|541257209|FG000|Overall Study|Poor compliance to protocol|0|||
150032286|NCT02485691|541257210|FG001|Overall Study|Poor compliance to protocol|1|||
150032287|NCT02485691|541257209|FG000|Overall Study|Disease progression|57|||
149943015|NCT02030600|540926463|FG000|Treatment Period 2|Protocol Violation|1|||
149943016|NCT02030600|540926464|FG001|Treatment Period 2|Protocol Violation|2|||
149943017|NCT02030600|540926463|FG000|Treatment Period 2|Withdrawal by Subject|13|||
149943018|NCT02030600|540926464|FG001|Treatment Period 2|Withdrawal by Subject|9|||
150032288|NCT02485691|541257210|FG001|Overall Study|Disease progression|92|||
150032289|NCT02485691|541257209|FG000|Overall Study|Investigator's decision|23|||
150032290|NCT02485691|541257210|FG001|Overall Study|Investigator's decision|5|||
150032291|NCT02485691|541257209|FG000|Overall Study|Participant's request|13|||
150032292|NCT02485691|541257210|FG001|Overall Study|Participant's request|6|||
150032293|NCT02485691|541257209|FG000|Overall Study|Other reason|8|||
150032294|NCT02485691|541257210|FG001|Overall Study|Other reason|9|||
150032295|NCT02485691|541257209|FG000|Overall Study|Randomized and not treated|3|||
150032296|NCT02485691|541257210|FG001|Overall Study|Randomized and not treated|2|||
149943019|NCT02030600|540926463|FG000|Treatment Period 2|Unclassified|1|||
149943020|NCT02030600|540926464|FG001|Treatment Period 2|Unclassified|0|||
149943021|NCT02736617|540926465|FG000|Treatment|Adverse Event|1|||
149943022|NCT02736617|540926465|FG000|Treatment|Lack of Efficacy|1|||
149943023|NCT02736617|540926465|FG000|Treatment|Withdrawal by Subject|1|||
149943024|NCT02736617|540926465|FG000|Maintenance|Lack of Efficacy|4|||
149943025|NCT02736617|540926465|FG000|Maintenance|Physician Decision|1|||
149943026|NCT01240694|540926468|FG000|Overall Study|Adverse Event|9|||
149943027|NCT01240694|540926468|FG000|Overall Study|Lack of Efficacy|6|||
149943028|NCT01240694|540926468|FG000|Overall Study|Withdrawal by Subject|6|||
150032297|NCT01927497|541257211|FG000|Overall Study|Death|0|||
150169998|NCT02781584|541757221|FG003|Treatment Phase|Adverse Event|0|||
149943029|NCT01240694|540926468|FG000|Overall Study|Protocol Violation|2|||
150169999|NCT02781584|541757222|FG004|Treatment Phase|Adverse Event|0|||
149943030|NCT01240694|540926468|FG000|Overall Study|Lost to Follow-up|2|||
149943031|NCT01240694|540926468|FG000|Overall Study|Other than specified|3|||
150032298|NCT01927497|541257212|FG001|Overall Study|Death|1|||
150032299|NCT01927497|541257211|FG000|Overall Study|Protocol Violation|2|||
150032300|NCT01927497|541257212|FG001|Overall Study|Protocol Violation|0|||
150032301|NCT00395746|541257213|FG000|Overall Study|Adverse Event|5|||
150032302|NCT00395746|541257214|FG001|Overall Study|Adverse Event|2|||
150032303|NCT00395746|541257215|FG002|Overall Study|Adverse Event|2|||
150032304|NCT00395746|541257213|FG000|Overall Study|Protocol Violation|0|||
150032305|NCT00395746|541257214|FG001|Overall Study|Protocol Violation|1|||
149943032|NCT01240694|540926468|FG000|Overall Study|Withdrawn due to early study termination|107|||
150032306|NCT00395746|541257215|FG002|Overall Study|Protocol Violation|0|||
150032307|NCT00395746|541257213|FG000|Overall Study|Lack of Efficacy|2|||
150032308|NCT00395746|541257214|FG001|Overall Study|Lack of Efficacy|0|||
149943033|NCT01881425|540926469|FG000|Overall Study|Death|5|||
149943034|NCT01881425|540926470|FG001|Overall Study|Death|1|||
149943035|NCT01881425|540926469|FG000|Overall Study|Withdrawal by Subject|8|||
149943036|NCT01881425|540926470|FG001|Overall Study|Withdrawal by Subject|3|||
149943037|NCT01881425|540926469|FG000|Overall Study|Physician Decision|2|||
149943038|NCT01881425|540926470|FG001|Overall Study|Physician Decision|1|||
149943039|NCT01881425|540926469|FG000|Overall Study|Adverse Event|3|||
149943040|NCT01881425|540926470|FG001|Overall Study|Adverse Event|0|||
149943041|NCT01881425|540926469|FG000|Overall Study|General Anesthesia panic attack|0|||
149943042|NCT01881425|540926470|FG001|Overall Study|General Anesthesia panic attack|1|||
149943043|NCT01881425|540926469|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
149943044|NCT01881425|540926470|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
149943045|NCT01881425|540926469|FG000|Overall Study|Lost to Follow-up|7|||
149943046|NCT01881425|540926470|FG001|Overall Study|Lost to Follow-up|2|||
149943047|NCT05452239|540926471|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
149943048|NCT05452239|540926472|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
149943049|NCT05452239|540926471|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
149943050|NCT05452239|540926472|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
149943051|NCT05452239|540926471|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
149943052|NCT05452239|540926472|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
149943053|NCT05452239|540926471|FG000|Placebo-controlled Period|Randomized but not treated|2|||
149943054|NCT05452239|540926472|FG001|Placebo-controlled Period|Randomized but not treated|2|||
149943055|NCT05452239|540926471|FG000|Placebo-controlled Period|Other than specified|1|||
149943056|NCT05452239|540926472|FG001|Placebo-controlled Period|Other than specified|1|||
149943057|NCT05452239|540926471|FG000|Open-label Period|Withdrawal by Subject|2|||
149943058|NCT05452239|540926472|FG001|Open-label Period|Withdrawal by Subject|1|||
149943059|NCT05452239|540926471|FG000|Open-label Period|Lost to Follow-up|3|||
149943060|NCT05452239|540926472|FG001|Open-label Period|Lost to Follow-up|0|||
149943061|NCT05452239|540926471|FG000|Open-label Period|Other than specified|1|||
149943062|NCT05452239|540926472|FG001|Open-label Period|Other than specified|2|||
149943063|NCT01385176|540926473|FG000|Randomization Phase|Death|1|||
149943064|NCT01385176|540926474|FG001|Randomization Phase|Death|2|||
149943065|NCT01385176|540926473|FG000|6-18 Month All VNS Active|Death|1|||
149943066|NCT01385176|540926474|FG001|6-18 Month All VNS Active|Death|2|||
149943067|NCT01385176|540926473|FG000|6-18 Month All VNS Active|Physician Decision|0|||
149943068|NCT01385176|540926474|FG001|6-18 Month All VNS Active|Physician Decision|1|||
149943069|NCT01385176|540926473|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
149943070|NCT01385176|540926474|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
149943071|NCT01385176|540926473|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
149943072|NCT01385176|540926474|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
149943073|NCT05082025|540926476|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
149943074|NCT04458922|540926477|FG000|Overall Study|Withdrawal by Subject|1|||
149943075|NCT04458922|540926478|FG001|Overall Study|Withdrawal by Subject|0|||
149943076|NCT04458922|540926479|FG002|Overall Study|Withdrawal by Subject|2|||
149943077|NCT04458922|540926477|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
149943078|NCT04458922|540926478|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
149943079|NCT04458922|540926479|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
149943080|NCT04458922|540926477|FG000|Overall Study|Adverse Event|1|||
149943081|NCT04458922|540926478|FG001|Overall Study|Adverse Event|0|||
149943082|NCT04458922|540926479|FG002|Overall Study|Adverse Event|0|||
149943083|NCT04458922|540926477|FG000|Overall Study|Started new study|0|||
149943084|NCT04458922|540926478|FG001|Overall Study|Started new study|0|||
149943085|NCT04458922|540926479|FG002|Overall Study|Started new study|1|||
149943086|NCT04458922|540926477|FG000|Overall Study|Progressive disease|6|||
150032309|NCT00395746|541257215|FG002|Overall Study|Lack of Efficacy|17|||
150032310|NCT00395746|541257213|FG000|Overall Study|Hypoglycaemia|2|||
150032311|NCT00395746|541257214|FG001|Overall Study|Hypoglycaemia|1|||
150032312|NCT00395746|541257215|FG002|Overall Study|Hypoglycaemia|0|||
149943087|NCT04458922|540926478|FG001|Overall Study|Progressive disease|8|||
149943088|NCT04458922|540926479|FG002|Overall Study|Progressive disease|2|||
149943089|NCT04458922|540926477|FG000|Overall Study|Death|1|||
149943090|NCT04458922|540926478|FG001|Overall Study|Death|0|||
149943091|NCT04458922|540926479|FG002|Overall Study|Death|2|||
149943092|NCT04458922|540926477|FG000|Overall Study|Participant started chemotherapy|0|||
149943093|NCT04458922|540926478|FG001|Overall Study|Participant started chemotherapy|1|||
149943094|NCT04458922|540926479|FG002|Overall Study|Participant started chemotherapy|0|||
150032313|NCT00395746|541257213|FG000|Overall Study|Subject decision|0|||
150032314|NCT00395746|541257214|FG001|Overall Study|Subject decision|0|||
150032315|NCT00395746|541257215|FG002|Overall Study|Subject decision|1|||
150032316|NCT00395746|541257213|FG000|Overall Study|Withdrawal of consent|0|||
149943095|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Adverse Event|6|||
149943096|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Adverse Event|15|||
149943097|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Adverse Event|0|||
149943098|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Death|0|||
149943099|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Death|2|||
149943100|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Death|0|||
149943101|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
149943102|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
149943103|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
149943104|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
149943105|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
149943106|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
149943107|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Physician Decision|1|||
149943108|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Physician Decision|1|||
149943109|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Physician Decision|0|||
149943110|NCT02921256|540926480|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
149943111|NCT02921256|540926481|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
149943112|NCT02921256|540926482|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
149943113|NCT02921256|540926480|FG000|Arm Ib v Arm III|Adverse Event|9|||
149943114|NCT02921256|540926481|FG001|Arm Ib v Arm III|Adverse Event|0|||
149943115|NCT02921256|540926482|FG002|Arm Ib v Arm III|Adverse Event|4|||
149943116|NCT02921256|540926480|FG000|Arm Ib v Arm III|Death|1|||
149943117|NCT02921256|540926481|FG001|Arm Ib v Arm III|Death|0|||
149943118|NCT02921256|540926482|FG002|Arm Ib v Arm III|Death|1|||
149943119|NCT02921256|540926480|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
149943120|NCT02921256|540926481|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
149943121|NCT02921256|540926482|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
149943122|NCT02921256|540926480|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
149943123|NCT02921256|540926481|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
149943124|NCT02921256|540926482|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
149943125|NCT02921256|540926480|FG000|Arm Ib v Arm III|Physician Decision|4|||
149943126|NCT02921256|540926481|FG001|Arm Ib v Arm III|Physician Decision|0|||
149943127|NCT02921256|540926482|FG002|Arm Ib v Arm III|Physician Decision|1|||
149943128|NCT02921256|540926480|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
149943129|NCT02921256|540926481|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
149943130|NCT02921256|540926482|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
149943131|NCT01933594|540926483|FG000|Overall Study|Lost to Follow-up|1|||
149943132|NCT01933594|540926484|FG001|Overall Study|Lost to Follow-up|0|||
149943133|NCT01933594|540926485|FG002|Overall Study|Lost to Follow-up|0|||
149943134|NCT01933594|540926486|FG003|Overall Study|Lost to Follow-up|0|||
149943135|NCT01933594|540926487|FG004|Overall Study|Lost to Follow-up|1|||
149943136|NCT01933594|540926488|FG005|Overall Study|Lost to Follow-up|0|||
149943137|NCT01933594|540926483|FG000|Overall Study|Ineligible for subsequent study step|0|||
149943138|NCT01933594|540926484|FG001|Overall Study|Ineligible for subsequent study step|0|||
149943139|NCT01933594|540926485|FG002|Overall Study|Ineligible for subsequent study step|0|||
149943140|NCT01933594|540926486|FG003|Overall Study|Ineligible for subsequent study step|0|||
149943141|NCT01933594|540926487|FG004|Overall Study|Ineligible for subsequent study step|1|||
149943142|NCT01933594|540926488|FG005|Overall Study|Ineligible for subsequent study step|0|||
149943143|NCT04848480|540926489|FG000|Main Phase (26 Weeks)|Death|1|||
149943144|NCT04848480|540926490|FG001|Main Phase (26 Weeks)|Death|0|||
149943145|NCT04848480|540926489|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
149943146|NCT04848480|540926490|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
149943147|NCT04848480|540926489|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
149943148|NCT04848480|540926490|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
149943149|NCT04848480|540926489|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
149943150|NCT04848480|540926490|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
149943151|NCT04848480|540926489|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
149943152|NCT04848480|540926490|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
149943153|NCT04848480|540926489|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
149943154|NCT04848480|540926490|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
149943155|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
149943156|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
149943157|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Death|1|||
149943158|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Death|3|||
149943159|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
149943160|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
149943161|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
149943162|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
149943163|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
149943164|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
149943165|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
149943166|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
149943167|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
149943168|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
149943169|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
149943170|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
149943171|NCT00362232|540927413|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
149943172|NCT00362232|540927414|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
149943173|NCT00362232|540927413|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
149943174|NCT00362232|540927414|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
149943175|NCT00362232|540927413|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
149943176|NCT00362232|540927414|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
149943177|NCT00362232|540927413|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
149943178|NCT00362232|540927414|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
149943179|NCT00362232|540927413|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
149943180|NCT00362232|540927414|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
149943181|NCT00855582|540927418|FG000|Overall Study|Adverse Event|2|||
149943182|NCT00855582|540927419|FG001|Overall Study|Adverse Event|6|||
149943183|NCT00855582|540927420|FG002|Overall Study|Adverse Event|3|||
149943184|NCT00855582|540927418|FG000|Overall Study|Death|1|||
149943185|NCT00855582|540927419|FG001|Overall Study|Death|0|||
149943186|NCT00855582|540927420|FG002|Overall Study|Death|0|||
149943187|NCT00855582|540927418|FG000|Overall Study|Lack of Efficacy|1|||
149943188|NCT00855582|540927419|FG001|Overall Study|Lack of Efficacy|3|||
149943189|NCT00855582|540927420|FG002|Overall Study|Lack of Efficacy|8|||
149943190|NCT00855582|540927418|FG000|Overall Study|Lost to Follow-up|1|||
149943191|NCT00855582|540927419|FG001|Overall Study|Lost to Follow-up|3|||
149943192|NCT00855582|540927420|FG002|Overall Study|Lost to Follow-up|1|||
149943193|NCT00855582|540927418|FG000|Overall Study|Physician Decision|0|||
149943194|NCT00855582|540927419|FG001|Overall Study|Physician Decision|0|||
149943195|NCT00855582|540927420|FG002|Overall Study|Physician Decision|1|||
149943196|NCT00855582|540927418|FG000|Overall Study|Protocol Violation|6|||
149943197|NCT00855582|540927419|FG001|Overall Study|Protocol Violation|2|||
149943198|NCT00855582|540927420|FG002|Overall Study|Protocol Violation|6|||
149943199|NCT00855582|540927418|FG000|Overall Study|Entry Criteria Not Met|8|||
149943200|NCT00855582|540927419|FG001|Overall Study|Entry Criteria Not Met|6|||
149943201|NCT00855582|540927420|FG002|Overall Study|Entry Criteria Not Met|3|||
149943202|NCT00855582|540927418|FG000|Overall Study|Withdrawal by Subject|7|||
149943203|NCT00855582|540927419|FG001|Overall Study|Withdrawal by Subject|4|||
149943204|NCT00855582|540927420|FG002|Overall Study|Withdrawal by Subject|8|||
149943205|NCT01155323|540927425|FG000|First Intervention|exclusion criteria|1|||
149943206|NCT01155323|540927426|FG001|First Intervention|exclusion criteria|1|||
149943207|NCT01155323|540927425|FG000|Second Intervention|Lost to Follow-up|1|||
149943208|NCT01155323|540927426|FG001|Second Intervention|Lost to Follow-up|1|||
149943209|NCT02606253|540927427|FG000|Overall Study|Adverse Event|2|||
149943210|NCT02606253|540927428|FG001|Overall Study|Adverse Event|0|||
149943211|NCT02606253|540927429|FG002|Overall Study|Adverse Event|0|||
149943212|NCT02606253|540927427|FG000|Overall Study|Protocol Violation|2|||
149943213|NCT02606253|540927428|FG001|Overall Study|Protocol Violation|1|||
149943214|NCT02606253|540927429|FG002|Overall Study|Protocol Violation|0|||
149943215|NCT02606253|540927427|FG000|Overall Study|Physician Decision|1|||
149943216|NCT02606253|540927428|FG001|Overall Study|Physician Decision|1|||
149943217|NCT02606253|540927429|FG002|Overall Study|Physician Decision|0|||
149943218|NCT02765165|540927430|FG000|Treatment Period|Progressive disease|3|||
149943219|NCT02765165|540927431|FG001|Treatment Period|Progressive disease|2|||
149943220|NCT02765165|540927432|FG002|Treatment Period|Progressive disease|3|||
149943221|NCT02765165|540927433|FG003|Treatment Period|Progressive disease|3|||
149943222|NCT02765165|540927434|FG004|Treatment Period|Progressive disease|4|||
149943223|NCT02765165|540927435|FG005|Treatment Period|Progressive disease|2|||
149943224|NCT02765165|540927436|FG006|Treatment Period|Progressive disease|2|||
149943225|NCT02765165|540927430|FG000|Treatment Period|Physician Decision|0|||
149943226|NCT02765165|540927431|FG001|Treatment Period|Physician Decision|1|||
149943227|NCT02765165|540927432|FG002|Treatment Period|Physician Decision|0|||
149943228|NCT02765165|540927433|FG003|Treatment Period|Physician Decision|0|||
149943229|NCT02765165|540927434|FG004|Treatment Period|Physician Decision|0|||
149943230|NCT02765165|540927435|FG005|Treatment Period|Physician Decision|0|||
149943231|NCT02765165|540927436|FG006|Treatment Period|Physician Decision|0|||
149943232|NCT02765165|540927430|FG000|Treatment Period|Adverse Event|0|||
149943233|NCT02765165|540927431|FG001|Treatment Period|Adverse Event|1|||
149943234|NCT02765165|540927432|FG002|Treatment Period|Adverse Event|0|||
149943235|NCT02765165|540927433|FG003|Treatment Period|Adverse Event|0|||
149943236|NCT02765165|540927434|FG004|Treatment Period|Adverse Event|0|||
149943237|NCT02765165|540927435|FG005|Treatment Period|Adverse Event|0|||
149943238|NCT02765165|540927436|FG006|Treatment Period|Adverse Event|0|||
149943239|NCT02765165|540927430|FG000|Treatment Period|Withdrawal by Subject|0|||
149943240|NCT02765165|540927431|FG001|Treatment Period|Withdrawal by Subject|0|||
149943241|NCT02765165|540927432|FG002|Treatment Period|Withdrawal by Subject|0|||
149943242|NCT02765165|540927433|FG003|Treatment Period|Withdrawal by Subject|0|||
149943243|NCT02765165|540927434|FG004|Treatment Period|Withdrawal by Subject|2|||
149943244|NCT02765165|540927435|FG005|Treatment Period|Withdrawal by Subject|0|||
149943245|NCT02765165|540927436|FG006|Treatment Period|Withdrawal by Subject|0|||
149943246|NCT02765165|540927430|FG000|Treatment Period|Study terminated|0|||
149943247|NCT02765165|540927431|FG001|Treatment Period|Study terminated|0|||
149943248|NCT02765165|540927432|FG002|Treatment Period|Study terminated|0|||
149943249|NCT02765165|540927433|FG003|Treatment Period|Study terminated|0|||
149943250|NCT02765165|540927434|FG004|Treatment Period|Study terminated|0|||
149943251|NCT02765165|540927435|FG005|Treatment Period|Study terminated|1|||
149943252|NCT02765165|540927436|FG006|Treatment Period|Study terminated|2|||
149943253|NCT02765165|540927430|FG000|Post-treatment Follow-up|Death|1|||
149943254|NCT02765165|540927431|FG001|Post-treatment Follow-up|Death|2|||
149943255|NCT02765165|540927432|FG002|Post-treatment Follow-up|Death|1|||
149943256|NCT02765165|540927433|FG003|Post-treatment Follow-up|Death|1|||
149943257|NCT02765165|540927434|FG004|Post-treatment Follow-up|Death|1|||
149943258|NCT02765165|540927435|FG005|Post-treatment Follow-up|Death|1|||
149943259|NCT02765165|540927436|FG006|Post-treatment Follow-up|Death|0|||
149943260|NCT02765165|540927430|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
149943261|NCT02765165|540927431|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
149943262|NCT02765165|540927432|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
149943263|NCT02765165|540927433|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
149943264|NCT02765165|540927434|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
149943265|NCT02765165|540927435|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
149943266|NCT02765165|540927436|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
149943267|NCT02765165|540927430|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943268|NCT02765165|540927431|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943269|NCT02765165|540927432|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
149943270|NCT02765165|540927433|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943271|NCT02765165|540927434|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943272|NCT02765165|540927435|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943273|NCT02765165|540927436|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
149943274|NCT02765165|540927430|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
149943275|NCT02765165|540927431|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
149943276|NCT02765165|540927432|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
149943277|NCT02765165|540927433|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
149943278|NCT02765165|540927434|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
149943279|NCT02765165|540927435|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
149943280|NCT02765165|540927436|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
149943281|NCT02765165|540927430|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943282|NCT02765165|540927431|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
149943283|NCT02765165|540927432|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943284|NCT02765165|540927433|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943285|NCT02765165|540927434|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943286|NCT02765165|540927435|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943287|NCT02765165|540927436|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
149943288|NCT02765165|540927430|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
149943289|NCT02765165|540927431|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
149943290|NCT02765165|540927432|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
149943291|NCT02765165|540927433|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
149943292|NCT02765165|540927434|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
149943293|NCT02765165|540927435|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
149943294|NCT02765165|540927436|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
149943295|NCT01189266|540927437|FG000|Overall Study|Adverse Event|1|||
149943296|NCT01189266|540927438|FG001|Overall Study|Adverse Event|0|||
149943297|NCT01189266|540927439|FG002|Overall Study|Adverse Event|5|||
149943298|NCT01189266|540927437|FG000|Overall Study|Death|0|||
149943299|NCT01189266|540927438|FG001|Overall Study|Death|0|||
149943300|NCT01189266|540927439|FG002|Overall Study|Death|5|||
149943301|NCT01189266|540927437|FG000|Overall Study|Lack of Efficacy|4|||
149943302|NCT01189266|540927438|FG001|Overall Study|Lack of Efficacy|5|||
149943303|NCT01189266|540927439|FG002|Overall Study|Lack of Efficacy|44|||
149943304|NCT01189266|540927437|FG000|Overall Study|Physician Decision|0|||
149943305|NCT01189266|540927438|FG001|Overall Study|Physician Decision|0|||
149943306|NCT01189266|540927439|FG002|Overall Study|Physician Decision|1|||
149943307|NCT01189266|540927437|FG000|Overall Study|Protocol Violation|0|||
149943308|NCT01189266|540927438|FG001|Overall Study|Protocol Violation|1|||
149943309|NCT01189266|540927439|FG002|Overall Study|Protocol Violation|1|||
149943310|NCT01189266|540927437|FG000|Overall Study|Withdrawal by Subject|0|||
149943311|NCT01189266|540927438|FG001|Overall Study|Withdrawal by Subject|0|||
149943312|NCT01189266|540927439|FG002|Overall Study|Withdrawal by Subject|1|||
149943313|NCT01189266|540927437|FG000|Overall Study|Patient refuses further therapy|1|||
149943314|NCT01189266|540927438|FG001|Overall Study|Patient refuses further therapy|0|||
149943315|NCT01189266|540927439|FG002|Overall Study|Patient refuses further therapy|7|||
149943316|NCT01189266|540927437|FG000|Overall Study|No treatment|0|||
149943317|NCT01189266|540927438|FG001|Overall Study|No treatment|0|||
149943318|NCT01189266|540927439|FG002|Overall Study|No treatment|1|||
149943319|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
150170000|NCT02781584|541757223|FG005|Treatment Phase|Adverse Event|0|||
149821326|NCT02536378|540475691|FG001|Overall Study|Death|2|||
149821327|NCT02536378|540475690|FG000|Overall Study|Patient refused further follow up|6|||
149821328|NCT02536378|540475691|FG001|Overall Study|Patient refused further follow up|2|||
149821329|NCT00602030|540475692|FG000|Lead-in Phase|Disease Progression|2|||
149943320|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
149943321|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
149943322|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
149943323|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
149943324|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
149943325|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
149943326|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
149943327|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
149943328|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
149943329|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
149943330|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
149943331|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
149943332|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
149943333|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
149943334|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
149943335|NCT00410163|540927440|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
149943336|NCT00410163|540927441|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
149943337|NCT00410163|540927440|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
149943338|NCT00410163|540927441|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
149943339|NCT00410163|540927440|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
149943340|NCT00410163|540927441|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
149943341|NCT00410163|540927440|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
149943342|NCT00410163|540927441|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
149943343|NCT00410163|540927440|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
149943344|NCT00410163|540927441|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
149943345|NCT00410163|540927440|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
149943346|NCT00410163|540927441|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
149943347|NCT04428151|540927442|FG000|Overall Study|Death|100|||
149943348|NCT04428151|540927443|FG001|Overall Study|Death|86|||
149943349|NCT04428151|540927444|FG002|Overall Study|Death|57|||
149943350|NCT04428151|540927442|FG000|Overall Study|Lost to Follow-up|1|||
149943351|NCT04428151|540927443|FG001|Overall Study|Lost to Follow-up|1|||
149943352|NCT04428151|540927444|FG002|Overall Study|Lost to Follow-up|0|||
149943353|NCT04428151|540927442|FG000|Overall Study|Withdrawal by Subject|2|||
149943354|NCT04428151|540927443|FG001|Overall Study|Withdrawal by Subject|2|||
149943355|NCT04428151|540927444|FG002|Overall Study|Withdrawal by Subject|3|||
149943356|NCT04428151|540927442|FG000|Overall Study|Participant Ongoing in Study|41|||
149943357|NCT04428151|540927443|FG001|Overall Study|Participant Ongoing in Study|53|||
149943358|NCT04428151|540927444|FG002|Overall Study|Participant Ongoing in Study|28|||
149943359|NCT02783690|540927445|FG000|Overall Study|Withdrawal by Subject|3|||
149943360|NCT02783690|540927446|FG001|Overall Study|Withdrawal by Subject|3|||
149943361|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
149943362|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
149943363|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
149943364|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
149943365|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Death|38|||
149943366|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Death|10|||
149943367|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
149943368|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
149943369|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
149943370|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
149943371|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
149943372|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
149943373|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
149943374|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
149943375|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
149943376|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
149943377|NCT02421939|540927447|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
149943378|NCT02421939|540927448|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
149943379|NCT02421939|540927447|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
149943380|NCT02421939|540927448|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
149943381|NCT02421939|540927447|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
150032317|NCT00395746|541257214|FG001|Overall Study|Withdrawal of consent|0|||
150032318|NCT00395746|541257215|FG002|Overall Study|Withdrawal of consent|1|||
150032319|NCT00395746|541257213|FG000|Overall Study|Difficultulty in use of device|0|||
150032320|NCT00395746|541257214|FG001|Overall Study|Difficultulty in use of device|0|||
150032321|NCT00395746|541257215|FG002|Overall Study|Difficultulty in use of device|1|||
150032322|NCT00395746|541257213|FG000|Overall Study|Unable to visit site on schedule|1|||
150032323|NCT00395746|541257214|FG001|Overall Study|Unable to visit site on schedule|0|||
150032324|NCT00395746|541257215|FG002|Overall Study|Unable to visit site on schedule|0|||
150032325|NCT04528641|541257216|FG000|Overall Study|Withdrawal by Subject|0|||
150032326|NCT04528641|541257217|FG001|Overall Study|Withdrawal by Subject|0|||
150032327|NCT04528641|541257218|FG002|Overall Study|Withdrawal by Subject|0|||
150032328|NCT04528641|541257219|FG003|Overall Study|Withdrawal by Subject|1|||
150032329|NCT04528641|541257220|FG004|Overall Study|Withdrawal by Subject|0|||
150032330|NCT04528641|541257221|FG005|Overall Study|Withdrawal by Subject|1|||
150032331|NCT00517296|541257222|FG000|Overall Study|Withdrawal by Subject|1|||
150032332|NCT00517296|541257223|FG001|Overall Study|Withdrawal by Subject|0|||
150032333|NCT04764162|541257224|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
150032334|NCT04764162|541257225|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
150032335|NCT03361137|541257226|FG000|Overall Study|Reason not specified|1|||
150032336|NCT03361137|541257227|FG001|Overall Study|Reason not specified|0|||
150032337|NCT03361137|541257228|FG002|Overall Study|Reason not specified|0|||
150032338|NCT03361137|541257229|FG003|Overall Study|Reason not specified|0|||
150032339|NCT03361137|541257230|FG004|Overall Study|Reason not specified|0|||
150032340|NCT00791934|541257231|FG000|Overall Study|Withdrawal by Subject|2|||
150032341|NCT00791934|541257231|FG000|Overall Study|Did not consent for extended follow-up|13|||
150032342|NCT05556265|541257234|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
150032343|NCT05556265|541257235|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
150032344|NCT05556265|541257236|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
150032345|NCT05556265|541257237|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
150032346|NCT05556265|541257238|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
150032347|NCT05556265|541257234|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
150032348|NCT05556265|541257235|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
150032349|NCT05556265|541257236|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
150032350|NCT05556265|541257237|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
150032351|NCT05556265|541257238|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
150032352|NCT05556265|541257234|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
150032353|NCT05556265|541257235|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
150032354|NCT05556265|541257236|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
150032355|NCT05556265|541257237|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
150032356|NCT05556265|541257238|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
150032357|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
150032358|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
150032359|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
150032360|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
150032361|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
150032362|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
150032363|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
150032364|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
150032365|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
150032366|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
150032367|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
150032368|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
150032369|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
150032370|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
150032371|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
150032372|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
150032373|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
150032374|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
150032375|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
150032376|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
150032377|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
150032378|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
150032379|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
150170001|NCT02781584|541757224|FG006|Treatment Phase|Adverse Event|0|||
150032380|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
150032381|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
150032382|NCT05556265|541257234|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
150032383|NCT05556265|541257235|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
150032384|NCT05556265|541257236|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
150032385|NCT05556265|541257237|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
150032386|NCT05556265|541257238|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
150032387|NCT03724942|541257241|FG000|Overall Study|Adverse Event|20|||
150032388|NCT03724942|541257242|FG001|Overall Study|Adverse Event|14|||
150032389|NCT03724942|541257241|FG000|Overall Study|Lack of Efficacy|0|||
150032390|NCT03724942|541257242|FG001|Overall Study|Lack of Efficacy|1|||
150032391|NCT03724942|541257241|FG000|Overall Study|Physician Decision|5|||
150032392|NCT03724942|541257242|FG001|Overall Study|Physician Decision|2|||
150032393|NCT03724942|541257241|FG000|Overall Study|Protocol Violation|1|||
150032394|NCT03724942|541257242|FG001|Overall Study|Protocol Violation|0|||
150032395|NCT03724942|541257241|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
150032396|NCT03724942|541257242|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
150032397|NCT03724942|541257241|FG000|Overall Study|Withdrawal by Legal Representative|3|||
150032398|NCT03724942|541257242|FG001|Overall Study|Withdrawal by Legal Representative|0|||
150032399|NCT02429830|541257243|FG000|Overall Study|Lost to Follow-up|1|||
150032400|NCT02429830|541257243|FG000|Overall Study|Device Explant|2|||
150032401|NCT02608684|541259227|FG000|Overall Study|Physician Decision|2|||
150032402|NCT02608684|541259227|FG000|Overall Study|Withdrawal by Subject|1|||
150032403|NCT01176032|541259232|FG000|Overall Study|Adverse Event|1|||
150032404|NCT01176032|541259233|FG001|Overall Study|Adverse Event|0|||
150032405|NCT01176032|541259232|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150032406|NCT01176032|541259233|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150032407|NCT01176032|541259232|FG000|Overall Study|Protocol Violation|1|||
150032408|NCT01176032|541259233|FG001|Overall Study|Protocol Violation|0|||
150032409|NCT01176032|541259232|FG000|Overall Study|Informed consent withdrawn|3|||
150032410|NCT01176032|541259233|FG001|Overall Study|Informed consent withdrawn|0|||
150032411|NCT01176032|541259232|FG000|Overall Study|Other|1|||
150032412|NCT01176032|541259233|FG001|Overall Study|Other|0|||
150032413|NCT01149096|541259234|FG000|Overall Study|Lost to Follow-up|0|||
150032414|NCT01149096|541259235|FG001|Overall Study|Lost to Follow-up|1|||
150032415|NCT04819945|541259250|FG000|Overall Study|Lost to Follow-up|1|||
150032416|NCT03521570|541259251|FG000|Overall Study|Not eligible|11|||
150032417|NCT00322881|541259252|FG000|Overall Study|Death|2|||
150032418|NCT00322881|541259252|FG000|Overall Study|Adverse Event|1|||
150032419|NCT00322881|541259252|FG000|Overall Study|Disease Progression|2|||
150032420|NCT01667900|541259253|FG000|Part B|Death|0|||
150032421|NCT01667900|541259254|FG001|Part B|Death|0|||
150032422|NCT01667900|541259255|FG002|Part B|Death|0|||
150032423|NCT01667900|541259256|FG003|Part B|Death|0|||
150032424|NCT01667900|541259257|FG004|Part B|Death|0|||
150032425|NCT01667900|541259258|FG005|Part B|Death|0|||
150032426|NCT01667900|541259259|FG006|Part B|Death|0|||
150032427|NCT01667900|541259260|FG007|Part B|Death|0|||
150032428|NCT01667900|541259261|FG008|Part B|Death|0|||
150032429|NCT01667900|541259262|FG009|Part B|Death|0|||
150032430|NCT01667900|541259263|FG010|Part B|Death|0|||
150032431|NCT01667900|541259264|FG011|Part B|Death|0|||
150032432|NCT01667900|541259265|FG012|Part B|Death|0|||
150032433|NCT01667900|541259266|FG013|Part B|Death|0|||
150032434|NCT01667900|541259267|FG014|Part B|Death|0|||
150032435|NCT01667900|541259268|FG015|Part B|Death|0|||
150032436|NCT01667900|541259269|FG016|Part B|Death|1|||
150032437|NCT01667900|541259270|FG017|Part B|Death|0|||
150032438|NCT01667900|541259271|FG018|Part B|Death|0|||
150274387|NCT00682448|542142855|FG001|Overall Study|Lack of Efficacy|0|||
150032439|NCT01667900|541259272|FG019|Part B|Death|0|||
150032440|NCT00468169|541259273|FG000|Overall Study|Withdrawal by Subject|1|||
150032441|NCT00468169|541259274|FG001|Overall Study|Withdrawal by Subject|0|||
150032442|NCT00784563|541259275|FG000|Years 1 & 2|Withdrawal by Subject|3|||
150032443|NCT00784563|541259276|FG001|Years 1 & 2|Withdrawal by Subject|2|||
150032444|NCT00784563|541259277|FG002|Years 1 & 2|Withdrawal by Subject|0|||
150032445|NCT00784563|541259275|FG000|Years 1 & 2|Adverse Event|0|||
150032446|NCT00784563|541259276|FG001|Years 1 & 2|Adverse Event|3|||
150032447|NCT00784563|541259277|FG002|Years 1 & 2|Adverse Event|0|||
150032448|NCT00784563|541259275|FG000|Year 3|Withdrawal by Subject|0|||
150032449|NCT00784563|541259276|FG001|Year 3|Withdrawal by Subject|0|||
150032450|NCT00784563|541259277|FG002|Year 3|Withdrawal by Subject|2|||
150032451|NCT00784563|541259275|FG000|Year 3|Adverse Event|0|||
150032452|NCT00784563|541259276|FG001|Year 3|Adverse Event|0|||
150032453|NCT00784563|541259277|FG002|Year 3|Adverse Event|1|||
150032454|NCT02946580|541259278|FG000|Overall Study|Withdrawal by Subject|1|||
150032455|NCT02946580|541259279|FG001|Overall Study|Withdrawal by Subject|2|||
150032456|NCT02946580|541259278|FG000|Overall Study|Adverse Event|0|||
150032457|NCT02946580|541259279|FG001|Overall Study|Adverse Event|2|||
150032458|NCT02946580|541259278|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
150274388|NCT00682448|542142854|FG000|Overall Study|Lost to Follow-up|1|||
150032459|NCT02946580|541259279|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
150032460|NCT00685165|541259283|FG000|Washout Period of 14 Days|Adverse Event|1|||
150032461|NCT00685165|541259284|FG001|Washout Period of 14 Days|Adverse Event|0|||
150032462|NCT00321789|541259286|FG000|Overall Study|Lost to Follow-up|4|||
150032463|NCT00321789|541259287|FG001|Overall Study|Lost to Follow-up|7|||
150032464|NCT00321789|541259286|FG000|Overall Study|Withdrawal by Subject|6|||
150032465|NCT00321789|541259287|FG001|Overall Study|Withdrawal by Subject|6|||
150032466|NCT00321789|541259286|FG000|Overall Study|Protocol Violation|5|||
150032467|NCT00321789|541259287|FG001|Overall Study|Protocol Violation|3|||
150032468|NCT04292535|541259290|FG000|Overall Study|Withdrawal by Subject|0|||
150032469|NCT04292535|541259291|FG001|Overall Study|Withdrawal by Subject|0|||
150032470|NCT04292535|541259292|FG002|Overall Study|Withdrawal by Subject|0|||
150032471|NCT04292535|541259293|FG003|Overall Study|Withdrawal by Subject|0|||
150032472|NCT04292535|541259294|FG004|Overall Study|Withdrawal by Subject|0|||
150032473|NCT04292535|541259295|FG005|Overall Study|Withdrawal by Subject|0|||
150170002|NCT02781584|541757225|FG007|Treatment Phase|Adverse Event|1|||
149943382|NCT02421939|540927448|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
149943383|NCT02421939|540927447|FG000|Long Term Follow up: up to 3 Years|Death|118|||
149943384|NCT02421939|540927448|FG001|Long Term Follow up: up to 3 Years|Death|65|||
149943385|NCT02421939|540927447|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
149943386|NCT02421939|540927448|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
149943387|NCT04770779|540927450|FG000|Overall Study|Randomized, never treated|0|||
149943388|NCT04770779|540927451|FG001|Overall Study|Randomized, never treated|1|||
149943389|NCT04770779|540927450|FG000|Overall Study|Adverse Event|9|||
149943390|NCT04770779|540927451|FG001|Overall Study|Adverse Event|1|||
149943391|NCT04770779|540927450|FG000|Overall Study|Withdrawal by Subject|7|||
149943392|NCT04770779|540927451|FG001|Overall Study|Withdrawal by Subject|1|||
149943393|NCT04770779|540927450|FG000|Overall Study|Pregnancy|0|||
149943394|NCT04770779|540927451|FG001|Overall Study|Pregnancy|1|||
149943395|NCT02799602|540927452|FG000|Overall Study|Protocol Violation|1|||
149943396|NCT02799602|540927453|FG001|Overall Study|Protocol Violation|0|||
149943397|NCT02799602|540927452|FG000|Overall Study|Physician Decision|5|||
149943398|NCT02799602|540927453|FG001|Overall Study|Physician Decision|6|||
149943399|NCT02799602|540927452|FG000|Overall Study|Lost to Follow-up|4|||
149943400|NCT02799602|540927453|FG001|Overall Study|Lost to Follow-up|2|||
149943401|NCT02799602|540927452|FG000|Overall Study|Additional primary malignancy|11|||
149943402|NCT02799602|540927453|FG001|Overall Study|Additional primary malignancy|6|||
149943403|NCT02799602|540927452|FG000|Overall Study|Non-compliance with study drug|14|||
149943404|NCT02799602|540927453|FG001|Overall Study|Non-compliance with study drug|12|||
149943405|NCT02799602|540927452|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
149943406|NCT02799602|540927453|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
149943407|NCT02799602|540927452|FG000|Overall Study|Withdrawal by Subject|26|||
149943408|NCT02799602|540927453|FG001|Overall Study|Withdrawal by Subject|40|||
149943409|NCT02799602|540927452|FG000|Overall Study|Progressive disease - clinical progression|131|||
149943410|NCT02799602|540927453|FG001|Overall Study|Progressive disease - clinical progression|276|||
149943411|NCT02799602|540927452|FG000|Overall Study|Progressive disease - radiological progression|90|||
149943412|NCT02799602|540927453|FG001|Overall Study|Progressive disease - radiological progression|133|||
149943413|NCT02799602|540927452|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
149943414|NCT02799602|540927453|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
149943415|NCT02799602|540927452|FG000|Overall Study|Death|9|||
149943416|NCT02799602|540927453|FG001|Overall Study|Death|5|||
149943417|NCT02799602|540927452|FG000|Overall Study|Other|287|||
149943418|NCT02799602|540927453|FG001|Overall Study|Other|118|||
149943419|NCT02799602|540927452|FG000|Overall Study|Study drug never administered|0|||
149943420|NCT02799602|540927453|FG001|Overall Study|Study drug never administered|3|||
149943421|NCT05516758|540927463|FG000|Overall Study|Adverse Event|5|||
149943422|NCT05516758|540927464|FG001|Overall Study|Adverse Event|1|||
149943423|NCT05516758|540927465|FG002|Overall Study|Adverse Event|3|||
149943424|NCT05516758|540927466|FG003|Overall Study|Adverse Event|0|||
149943425|NCT05516758|540927467|FG004|Overall Study|Adverse Event|1|||
149943426|NCT05516758|540927468|FG005|Overall Study|Adverse Event|3|||
150032474|NCT04292535|541259296|FG006|Overall Study|Withdrawal by Subject|0|||
150032475|NCT04292535|541259297|FG007|Overall Study|Withdrawal by Subject|1|||
150032476|NCT04292535|541259298|FG008|Overall Study|Withdrawal by Subject|0|||
150032477|NCT04292535|541259299|FG009|Overall Study|Withdrawal by Subject|0|||
150032478|NCT04292535|541259300|FG010|Overall Study|Withdrawal by Subject|0|||
150170003|NCT02781584|541757226|FG008|Treatment Phase|Adverse Event|0|||
150170004|NCT02781584|541757227|FG009|Treatment Phase|Adverse Event|0|||
149943427|NCT05516758|540927469|FG006|Overall Study|Adverse Event|5|||
149943428|NCT05516758|540927463|FG000|Overall Study|Assigned treatment by mistake|1|||
149943429|NCT05516758|540927464|FG001|Overall Study|Assigned treatment by mistake|0|||
149943430|NCT05516758|540927465|FG002|Overall Study|Assigned treatment by mistake|0|||
149943431|NCT05516758|540927466|FG003|Overall Study|Assigned treatment by mistake|0|||
150032479|NCT04292535|541259301|FG011|Overall Study|Withdrawal by Subject|0|||
150032480|NCT04292535|541259302|FG012|Overall Study|Withdrawal by Subject|0|||
150032481|NCT04292535|541259303|FG013|Overall Study|Withdrawal by Subject|0|||
150032482|NCT04292535|541259290|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032483|NCT04292535|541259291|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032484|NCT04292535|541259292|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032485|NCT04292535|541259293|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032486|NCT04292535|541259294|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032487|NCT04292535|541259295|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032488|NCT04292535|541259296|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032489|NCT04292535|541259297|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
150032490|NCT04292535|541259298|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032491|NCT04292535|541259299|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032492|NCT04292535|541259300|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032493|NCT04292535|541259301|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
150032494|NCT04292535|541259302|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
150032495|NCT04292535|541259303|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
150032496|NCT04292535|541259290|FG000|Overall Study|Report of Dizziness|0|||
150032497|NCT04292535|541259291|FG001|Overall Study|Report of Dizziness|0|||
150032498|NCT04292535|541259292|FG002|Overall Study|Report of Dizziness|0|||
150032499|NCT04292535|541259293|FG003|Overall Study|Report of Dizziness|0|||
149943432|NCT05516758|540927467|FG004|Overall Study|Assigned treatment by mistake|1|||
149943433|NCT05516758|540927468|FG005|Overall Study|Assigned treatment by mistake|0|||
150032500|NCT04292535|541259294|FG004|Overall Study|Report of Dizziness|0|||
150032501|NCT04292535|541259295|FG005|Overall Study|Report of Dizziness|0|||
150032502|NCT04292535|541259296|FG006|Overall Study|Report of Dizziness|0|||
149943434|NCT05516758|540927469|FG006|Overall Study|Assigned treatment by mistake|0|||
149943435|NCT05516758|540927463|FG000|Overall Study|Lack of Efficacy|6|||
149943436|NCT05516758|540927464|FG001|Overall Study|Lack of Efficacy|0|||
149943437|NCT05516758|540927465|FG002|Overall Study|Lack of Efficacy|2|||
149943438|NCT05516758|540927466|FG003|Overall Study|Lack of Efficacy|0|||
149943439|NCT05516758|540927467|FG004|Overall Study|Lack of Efficacy|3|||
149943440|NCT05516758|540927468|FG005|Overall Study|Lack of Efficacy|6|||
149943441|NCT05516758|540927469|FG006|Overall Study|Lack of Efficacy|3|||
149943442|NCT05516758|540927463|FG000|Overall Study|Lost to Follow-up|2|||
149943443|NCT05516758|540927464|FG001|Overall Study|Lost to Follow-up|0|||
149943444|NCT05516758|540927465|FG002|Overall Study|Lost to Follow-up|2|||
149943445|NCT05516758|540927466|FG003|Overall Study|Lost to Follow-up|0|||
149943446|NCT05516758|540927467|FG004|Overall Study|Lost to Follow-up|3|||
149943447|NCT05516758|540927468|FG005|Overall Study|Lost to Follow-up|2|||
149943448|NCT05516758|540927469|FG006|Overall Study|Lost to Follow-up|1|||
149943449|NCT05516758|540927463|FG000|Overall Study|Other- As reported by the site|2|||
149943450|NCT05516758|540927464|FG001|Overall Study|Other- As reported by the site|1|||
149943451|NCT05516758|540927465|FG002|Overall Study|Other- As reported by the site|8|||
149943452|NCT05516758|540927466|FG003|Overall Study|Other- As reported by the site|1|||
149943453|NCT05516758|540927467|FG004|Overall Study|Other- As reported by the site|2|||
149943454|NCT05516758|540927468|FG005|Overall Study|Other- As reported by the site|3|||
150032503|NCT04292535|541259297|FG007|Overall Study|Report of Dizziness|0|||
150032504|NCT04292535|541259298|FG008|Overall Study|Report of Dizziness|0|||
150032505|NCT04292535|541259299|FG009|Overall Study|Report of Dizziness|0|||
150032506|NCT04292535|541259300|FG010|Overall Study|Report of Dizziness|0|||
150032507|NCT04292535|541259301|FG011|Overall Study|Report of Dizziness|0|||
150032508|NCT04292535|541259302|FG012|Overall Study|Report of Dizziness|0|||
150032509|NCT04292535|541259303|FG013|Overall Study|Report of Dizziness|1|||
150032510|NCT04292535|541259290|FG000|Overall Study|Equipment Failure|0|||
150032511|NCT04292535|541259291|FG001|Overall Study|Equipment Failure|0|||
149821330|NCT00602030|540475693|FG001|Lead-in Phase|Disease Progression|3|||
149943455|NCT05516758|540927469|FG006|Overall Study|Other- As reported by the site|8|||
149943456|NCT05516758|540927463|FG000|Overall Study|Physician Decision|1|||
149943457|NCT05516758|540927464|FG001|Overall Study|Physician Decision|0|||
149943458|NCT05516758|540927465|FG002|Overall Study|Physician Decision|7|||
149943459|NCT05516758|540927466|FG003|Overall Study|Physician Decision|0|||
150032512|NCT04292535|541259292|FG002|Overall Study|Equipment Failure|0|||
150032513|NCT04292535|541259293|FG003|Overall Study|Equipment Failure|0|||
150032514|NCT04292535|541259294|FG004|Overall Study|Equipment Failure|0|||
150032515|NCT04292535|541259295|FG005|Overall Study|Equipment Failure|0|||
150032516|NCT04292535|541259296|FG006|Overall Study|Equipment Failure|0|||
150032517|NCT04292535|541259297|FG007|Overall Study|Equipment Failure|0|||
150032518|NCT04292535|541259298|FG008|Overall Study|Equipment Failure|0|||
149821331|NCT00602030|540475694|FG002|Lead-in Phase|Disease Progression|0|||
149943460|NCT05516758|540927467|FG004|Overall Study|Physician Decision|1|||
149943461|NCT05516758|540927468|FG005|Overall Study|Physician Decision|1|||
149943462|NCT05516758|540927469|FG006|Overall Study|Physician Decision|2|||
149943463|NCT05516758|540927463|FG000|Overall Study|Protocol Deviation|1|||
149943464|NCT05516758|540927464|FG001|Overall Study|Protocol Deviation|0|||
149943465|NCT05516758|540927465|FG002|Overall Study|Protocol Deviation|0|||
149821332|NCT00602030|540475695|FG003|Lead-in Phase|Disease Progression|0|||
149821333|NCT00602030|540475696|FG004|Lead-in Phase|Disease Progression|0|||
149821334|NCT00602030|540475692|FG000|Lead-in Phase|Adverse Event|0|||
149821335|NCT00602030|540475693|FG001|Lead-in Phase|Adverse Event|2|||
149821336|NCT00602030|540475694|FG002|Lead-in Phase|Adverse Event|0|||
149821337|NCT00602030|540475695|FG003|Lead-in Phase|Adverse Event|0|||
149821338|NCT00602030|540475696|FG004|Lead-in Phase|Adverse Event|0|||
149821339|NCT00602030|540475692|FG000|Double-blind Phase|Disease progression|0|||
149821340|NCT00602030|540475693|FG001|Double-blind Phase|Disease progression|0|||
149821341|NCT00602030|540475694|FG002|Double-blind Phase|Disease progression|33|||
149821342|NCT00602030|540475695|FG003|Double-blind Phase|Disease progression|30|||
149821343|NCT00602030|540475696|FG004|Double-blind Phase|Disease progression|0|||
149821344|NCT00602030|540475692|FG000|Double-blind Phase|Adverse Event|0|||
149821345|NCT00602030|540475693|FG001|Double-blind Phase|Adverse Event|0|||
149821346|NCT00602030|540475694|FG002|Double-blind Phase|Adverse Event|9|||
149821347|NCT00602030|540475695|FG003|Double-blind Phase|Adverse Event|18|||
149821348|NCT00602030|540475696|FG004|Double-blind Phase|Adverse Event|0|||
149821349|NCT00602030|540475692|FG000|Double-blind Phase|Consent withdrawal|0|||
149821350|NCT00602030|540475693|FG001|Double-blind Phase|Consent withdrawal|0|||
149821351|NCT00602030|540475694|FG002|Double-blind Phase|Consent withdrawal|4|||
149821352|NCT00602030|540475695|FG003|Double-blind Phase|Consent withdrawal|3|||
149821353|NCT00602030|540475696|FG004|Double-blind Phase|Consent withdrawal|0|||
149821354|NCT00602030|540475692|FG000|Double-blind Phase|Death|0|||
149821355|NCT00602030|540475693|FG001|Double-blind Phase|Death|0|||
149821356|NCT00602030|540475694|FG002|Double-blind Phase|Death|3|||
149821357|NCT00602030|540475695|FG003|Double-blind Phase|Death|3|||
149821358|NCT00602030|540475696|FG004|Double-blind Phase|Death|0|||
149821359|NCT00602030|540475692|FG000|Double-blind Phase|Administrative decision|0|||
149821360|NCT00602030|540475693|FG001|Double-blind Phase|Administrative decision|0|||
149821361|NCT00602030|540475694|FG002|Double-blind Phase|Administrative decision|0|||
149821362|NCT00602030|540475695|FG003|Double-blind Phase|Administrative decision|2|||
149821363|NCT00602030|540475696|FG004|Double-blind Phase|Administrative decision|0|||
149821364|NCT00602030|540475692|FG000|Double-blind Phase|Ineligibility|0|||
149821365|NCT00602030|540475693|FG001|Double-blind Phase|Ineligibility|0|||
149821366|NCT00602030|540475694|FG002|Double-blind Phase|Ineligibility|0|||
149821367|NCT00602030|540475695|FG003|Double-blind Phase|Ineligibility|1|||
149821368|NCT00602030|540475696|FG004|Double-blind Phase|Ineligibility|0|||
149821369|NCT00602030|540475692|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
149821370|NCT00602030|540475693|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
149821371|NCT00602030|540475694|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
149821372|NCT00602030|540475695|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
149821373|NCT00602030|540475696|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
149821374|NCT00602030|540475692|FG000|Double-blind Phase|Reason not specified|0|||
149821375|NCT00602030|540475693|FG001|Double-blind Phase|Reason not specified|0|||
149821376|NCT00602030|540475694|FG002|Double-blind Phase|Reason not specified|4|||
149821377|NCT00602030|540475695|FG003|Double-blind Phase|Reason not specified|2|||
149821378|NCT00602030|540475696|FG004|Double-blind Phase|Reason not specified|0|||
149821379|NCT00602030|540475692|FG000|Crossover Phase|Disease Progression|0|||
149821380|NCT00602030|540475693|FG001|Crossover Phase|Disease Progression|0|||
149821381|NCT00602030|540475694|FG002|Crossover Phase|Disease Progression|0|||
149821382|NCT00602030|540475695|FG003|Crossover Phase|Disease Progression|0|||
149821383|NCT00602030|540475696|FG004|Crossover Phase|Disease Progression|11|||
149821384|NCT00602030|540475692|FG000|Crossover Phase|Adverse Event|0|||
149821385|NCT00602030|540475693|FG001|Crossover Phase|Adverse Event|0|||
149821386|NCT00602030|540475694|FG002|Crossover Phase|Adverse Event|0|||
149821387|NCT00602030|540475695|FG003|Crossover Phase|Adverse Event|0|||
149821388|NCT00602030|540475696|FG004|Crossover Phase|Adverse Event|3|||
149821389|NCT00602030|540475692|FG000|Crossover Phase|Consent withdrawal|0|||
149821390|NCT00602030|540475693|FG001|Crossover Phase|Consent withdrawal|0|||
149821391|NCT00602030|540475694|FG002|Crossover Phase|Consent withdrawal|0|||
149821392|NCT00602030|540475695|FG003|Crossover Phase|Consent withdrawal|0|||
149821393|NCT00602030|540475696|FG004|Crossover Phase|Consent withdrawal|2|||
149821394|NCT01271933|540475697|FG000|Single-Blind Phase|Lack of Efficacy|37|||
149821395|NCT01271933|540475698|FG001|Single-Blind Phase|Lack of Efficacy|0|||
149821396|NCT01271933|540475699|FG002|Single-Blind Phase|Lack of Efficacy|0|||
149821397|NCT01271933|540475697|FG000|Single-Blind Phase|Lost to Follow-up|10|||
149821398|NCT01271933|540475698|FG001|Single-Blind Phase|Lost to Follow-up|0|||
149821399|NCT01271933|540475699|FG002|Single-Blind Phase|Lost to Follow-up|0|||
149821400|NCT01271933|540475697|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
149821401|NCT01271933|540475698|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
149821402|NCT01271933|540475699|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
149821403|NCT01271933|540475697|FG000|Single-Blind Phase|Protocol Violation|3|||
149821404|NCT01271933|540475698|FG001|Single-Blind Phase|Protocol Violation|0|||
149821405|NCT01271933|540475699|FG002|Single-Blind Phase|Protocol Violation|0|||
149821406|NCT01271933|540475697|FG000|Single-Blind Phase|Adverse Event|52|||
149821407|NCT01271933|540475698|FG001|Single-Blind Phase|Adverse Event|0|||
149821408|NCT01271933|540475699|FG002|Single-Blind Phase|Adverse Event|0|||
150032519|NCT04292535|541259299|FG009|Overall Study|Equipment Failure|0|||
150032520|NCT04292535|541259300|FG010|Overall Study|Equipment Failure|0|||
150032521|NCT04292535|541259301|FG011|Overall Study|Equipment Failure|1|||
150032522|NCT04292535|541259302|FG012|Overall Study|Equipment Failure|0|||
150032523|NCT04292535|541259303|FG013|Overall Study|Equipment Failure|0|||
150032524|NCT01420861|541259308|FG000|Overall Study|Adverse Event|2|||
150032525|NCT01420861|541259308|FG000|Overall Study|Study terminated by Sponsor|7|||
150032526|NCT01420861|541259308|FG000|Overall Study|Screen failure|7|||
150032527|NCT01420861|541259308|FG000|Overall Study|Randomized not Treated|2|||
150032528|NCT03413891|541259310|FG000|Overall Study|Lost to Follow-up|2|||
150032529|NCT03413891|541259311|FG001|Overall Study|Lost to Follow-up|1|||
150032530|NCT03413891|541259310|FG000|Overall Study|Protocol Violation|0|||
150032531|NCT03413891|541259311|FG001|Overall Study|Protocol Violation|1|||
150032532|NCT04905134|541259312|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
150032533|NCT04905134|541259312|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
150032534|NCT03009058|541259313|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
150032535|NCT03137992|541259314|FG000|Washout Period 1|Adverse Event|1|||
150032536|NCT03137992|541259315|FG001|Washout Period 1|Adverse Event|1|||
150032537|NCT03137992|541259316|FG002|Washout Period 1|Adverse Event|0|||
150032538|NCT03137992|541259317|FG003|Washout Period 1|Adverse Event|0|||
150032539|NCT03137992|541259318|FG004|Washout Period 1|Adverse Event|0|||
150032540|NCT03137992|541259319|FG005|Washout Period 1|Adverse Event|1|||
150032541|NCT03137992|541259314|FG000|Washout Period 1|Withdrawal by Subject|0|||
150032542|NCT03137992|541259315|FG001|Washout Period 1|Withdrawal by Subject|1|||
150032543|NCT03137992|541259316|FG002|Washout Period 1|Withdrawal by Subject|1|||
150032544|NCT03137992|541259317|FG003|Washout Period 1|Withdrawal by Subject|0|||
150032545|NCT03137992|541259318|FG004|Washout Period 1|Withdrawal by Subject|0|||
150032546|NCT03137992|541259319|FG005|Washout Period 1|Withdrawal by Subject|0|||
150032547|NCT03137992|541259314|FG000|Washout Period 1|Principal Investigator Discretion|0|||
150032548|NCT03137992|541259315|FG001|Washout Period 1|Principal Investigator Discretion|1|||
150032549|NCT03137992|541259316|FG002|Washout Period 1|Principal Investigator Discretion|0|||
150032550|NCT03137992|541259317|FG003|Washout Period 1|Principal Investigator Discretion|0|||
150032551|NCT03137992|541259318|FG004|Washout Period 1|Principal Investigator Discretion|0|||
150032552|NCT03137992|541259319|FG005|Washout Period 1|Principal Investigator Discretion|0|||
150032553|NCT03137992|541259314|FG000|Washout Period 1|COPD Exacerbation|1|||
150032554|NCT03137992|541259315|FG001|Washout Period 1|COPD Exacerbation|1|||
150032555|NCT03137992|541259316|FG002|Washout Period 1|COPD Exacerbation|1|||
150032556|NCT03137992|541259317|FG003|Washout Period 1|COPD Exacerbation|0|||
150032557|NCT03137992|541259318|FG004|Washout Period 1|COPD Exacerbation|1|||
150032558|NCT03137992|541259319|FG005|Washout Period 1|COPD Exacerbation|1|||
150032559|NCT03137992|541259314|FG000|Washout Period 1|Subject Noncompliance|1|||
150032560|NCT03137992|541259315|FG001|Washout Period 1|Subject Noncompliance|0|||
150032561|NCT03137992|541259316|FG002|Washout Period 1|Subject Noncompliance|0|||
150032562|NCT03137992|541259317|FG003|Washout Period 1|Subject Noncompliance|0|||
150032563|NCT03137992|541259318|FG004|Washout Period 1|Subject Noncompliance|1|||
150032564|NCT03137992|541259319|FG005|Washout Period 1|Subject Noncompliance|0|||
150032565|NCT03137992|541259314|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
150032566|NCT03137992|541259315|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
150032567|NCT03137992|541259316|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
150032568|NCT03137992|541259317|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
150032569|NCT03137992|541259318|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
150032570|NCT03137992|541259319|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
150032571|NCT03137992|541259314|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
150032572|NCT03137992|541259315|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
150032573|NCT03137992|541259316|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
150032574|NCT03137992|541259317|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
150032575|NCT03137992|541259318|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
150032576|NCT03137992|541259319|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
150032577|NCT03137992|541259314|FG000|Period 2 (Visit 3)|Adverse Event|0|||
150032578|NCT03137992|541259315|FG001|Period 2 (Visit 3)|Adverse Event|1|||
150032579|NCT03137992|541259316|FG002|Period 2 (Visit 3)|Adverse Event|0|||
150032580|NCT03137992|541259317|FG003|Period 2 (Visit 3)|Adverse Event|0|||
150032581|NCT03137992|541259318|FG004|Period 2 (Visit 3)|Adverse Event|0|||
150032582|NCT03137992|541259319|FG005|Period 2 (Visit 3)|Adverse Event|0|||
150032583|NCT03137992|541259314|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
150032584|NCT03137992|541259315|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
150032585|NCT03137992|541259316|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
150032586|NCT03137992|541259317|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
150032587|NCT03137992|541259318|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
150032588|NCT03137992|541259319|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
150032589|NCT03137992|541259314|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
150032590|NCT03137992|541259315|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
150032591|NCT03137992|541259316|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
150032592|NCT03137992|541259317|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
149943466|NCT05516758|540927466|FG003|Overall Study|Protocol Deviation|0|||
149943467|NCT05516758|540927467|FG004|Overall Study|Protocol Deviation|0|||
149943468|NCT05516758|540927468|FG005|Overall Study|Protocol Deviation|1|||
149943469|NCT05516758|540927469|FG006|Overall Study|Protocol Deviation|5|||
149943470|NCT05516758|540927463|FG000|Overall Study|Withdrawal by Subject|11|||
149943471|NCT05516758|540927464|FG001|Overall Study|Withdrawal by Subject|1|||
149943472|NCT05516758|540927465|FG002|Overall Study|Withdrawal by Subject|15|||
149943473|NCT05516758|540927466|FG003|Overall Study|Withdrawal by Subject|2|||
149943474|NCT05516758|540927467|FG004|Overall Study|Withdrawal by Subject|7|||
149943475|NCT05516758|540927468|FG005|Overall Study|Withdrawal by Subject|7|||
149943476|NCT05516758|540927469|FG006|Overall Study|Withdrawal by Subject|6|||
149943477|NCT05516758|540927463|FG000|Overall Study|Death|1|||
149943478|NCT05516758|540927464|FG001|Overall Study|Death|0|||
149943479|NCT05516758|540927465|FG002|Overall Study|Death|0|||
149943480|NCT05516758|540927466|FG003|Overall Study|Death|0|||
149943481|NCT05516758|540927467|FG004|Overall Study|Death|0|||
149943482|NCT05516758|540927468|FG005|Overall Study|Death|0|||
149943483|NCT05516758|540927469|FG006|Overall Study|Death|0|||
149943484|NCT05516758|540927463|FG000|Overall Study|Non-compliance With Study Drug|0|||
149943485|NCT05516758|540927464|FG001|Overall Study|Non-compliance With Study Drug|0|||
149943486|NCT05516758|540927465|FG002|Overall Study|Non-compliance With Study Drug|1|||
149943487|NCT05516758|540927466|FG003|Overall Study|Non-compliance With Study Drug|0|||
149943488|NCT05516758|540927467|FG004|Overall Study|Non-compliance With Study Drug|0|||
149943489|NCT05516758|540927468|FG005|Overall Study|Non-compliance With Study Drug|0|||
149943490|NCT05516758|540927469|FG006|Overall Study|Non-compliance With Study Drug|0|||
149943491|NCT05516758|540927463|FG000|Overall Study|Site Terminated by Sponsor|2|||
149943492|NCT05516758|540927464|FG001|Overall Study|Site Terminated by Sponsor|0|||
149943493|NCT05516758|540927465|FG002|Overall Study|Site Terminated by Sponsor|0|||
149943494|NCT05516758|540927466|FG003|Overall Study|Site Terminated by Sponsor|0|||
149943495|NCT05516758|540927467|FG004|Overall Study|Site Terminated by Sponsor|0|||
149943496|NCT05516758|540927468|FG005|Overall Study|Site Terminated by Sponsor|0|||
149943497|NCT05516758|540927469|FG006|Overall Study|Site Terminated by Sponsor|0|||
149943498|NCT05516758|540927463|FG000|Overall Study|Study Terminated by Sponsor|4|||
149943499|NCT05516758|540927464|FG001|Overall Study|Study Terminated by Sponsor|0|||
149943500|NCT05516758|540927465|FG002|Overall Study|Study Terminated by Sponsor|3|||
149943501|NCT05516758|540927466|FG003|Overall Study|Study Terminated by Sponsor|0|||
149943502|NCT05516758|540927467|FG004|Overall Study|Study Terminated by Sponsor|2|||
149943503|NCT05516758|540927468|FG005|Overall Study|Study Terminated by Sponsor|3|||
149943504|NCT05516758|540927469|FG006|Overall Study|Study Terminated by Sponsor|0|||
149943505|NCT05516758|540927463|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
149943506|NCT05516758|540927464|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
149943507|NCT05516758|540927465|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
149943508|NCT05516758|540927466|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
149943509|NCT05516758|540927467|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
149943510|NCT05516758|540927468|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
149943511|NCT05516758|540927469|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
149943512|NCT05516758|540927463|FG000|Overall Study|Other|0|||
149943513|NCT05516758|540927464|FG001|Overall Study|Other|0|||
149943514|NCT05516758|540927465|FG002|Overall Study|Other|0|||
149943515|NCT05516758|540927466|FG003|Overall Study|Other|0|||
149943516|NCT05516758|540927467|FG004|Overall Study|Other|0|||
149943517|NCT05516758|540927468|FG005|Overall Study|Other|0|||
149943518|NCT05516758|540927469|FG006|Overall Study|Other|1|||
149943519|NCT06178991|540927473|FG000|Overall Study|Withdrawal by Subject|2|||
149943520|NCT06178991|540927474|FG001|Overall Study|Withdrawal by Subject|6|||
149943521|NCT06178991|540927475|FG002|Overall Study|Withdrawal by Subject|44|||
149943522|NCT06178991|540927476|FG003|Overall Study|Withdrawal by Subject|23|||
149943523|NCT06178991|540927477|FG004|Overall Study|Withdrawal by Subject|7|||
149943524|NCT06178991|540927478|FG005|Overall Study|Withdrawal by Subject|7|||
149943525|NCT06178991|540927479|FG006|Overall Study|Withdrawal by Subject|7|||
149943526|NCT06178991|540927480|FG007|Overall Study|Withdrawal by Subject|5|||
149943527|NCT06178991|540927473|FG000|Overall Study|Lost to Follow-up|2|||
149943528|NCT06178991|540927474|FG001|Overall Study|Lost to Follow-up|4|||
149943529|NCT06178991|540927475|FG002|Overall Study|Lost to Follow-up|133|||
149943530|NCT06178991|540927476|FG003|Overall Study|Lost to Follow-up|65|||
149943531|NCT06178991|540927477|FG004|Overall Study|Lost to Follow-up|68|||
149943532|NCT06178991|540927478|FG005|Overall Study|Lost to Follow-up|57|||
149943533|NCT06178991|540927479|FG006|Overall Study|Lost to Follow-up|25|||
149943534|NCT06178991|540927480|FG007|Overall Study|Lost to Follow-up|18|||
149943535|NCT06178991|540927473|FG000|Overall Study|Death|1|||
149943536|NCT06178991|540927474|FG001|Overall Study|Death|0|||
149943537|NCT06178991|540927475|FG002|Overall Study|Death|2|||
149943538|NCT06178991|540927476|FG003|Overall Study|Death|1|||
149943539|NCT06178991|540927477|FG004|Overall Study|Death|1|||
150032593|NCT03137992|541259318|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
150032594|NCT03137992|541259319|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
150032595|NCT03137992|541259314|FG000|Washout Period 2|COPD Exacerbation|1|||
150032596|NCT03137992|541259315|FG001|Washout Period 2|COPD Exacerbation|1|||
150032597|NCT03137992|541259316|FG002|Washout Period 2|COPD Exacerbation|0|||
150032598|NCT03137992|541259317|FG003|Washout Period 2|COPD Exacerbation|0|||
150032599|NCT03137992|541259318|FG004|Washout Period 2|COPD Exacerbation|1|||
150032600|NCT03137992|541259319|FG005|Washout Period 2|COPD Exacerbation|0|||
150032601|NCT03137992|541259314|FG000|Washout Period 2|Subject Non-compliance|0|||
150032602|NCT03137992|541259315|FG001|Washout Period 2|Subject Non-compliance|1|||
150032603|NCT03137992|541259316|FG002|Washout Period 2|Subject Non-compliance|0|||
150032604|NCT03137992|541259317|FG003|Washout Period 2|Subject Non-compliance|0|||
149943540|NCT06178991|540927478|FG005|Overall Study|Death|0|||
149943541|NCT06178991|540927479|FG006|Overall Study|Death|1|||
149943542|NCT06178991|540927480|FG007|Overall Study|Death|1|||
149943543|NCT06178991|540927473|FG000|Overall Study|Randomized but not Vaccinated|4|||
149943544|NCT06178991|540927474|FG001|Overall Study|Randomized but not Vaccinated|1|||
149943545|NCT06178991|540927475|FG002|Overall Study|Randomized but not Vaccinated|15|||
149943546|NCT06178991|540927476|FG003|Overall Study|Randomized but not Vaccinated|9|||
149943547|NCT06178991|540927477|FG004|Overall Study|Randomized but not Vaccinated|8|||
149943548|NCT06178991|540927478|FG005|Overall Study|Randomized but not Vaccinated|4|||
149943549|NCT06178991|540927479|FG006|Overall Study|Randomized but not Vaccinated|2|||
149943550|NCT06178991|540927480|FG007|Overall Study|Randomized but not Vaccinated|2|||
149943551|NCT06178991|540927473|FG000|Overall Study|Other: Unspecified|0|||
149943552|NCT06178991|540927474|FG001|Overall Study|Other: Unspecified|1|||
149943553|NCT06178991|540927475|FG002|Overall Study|Other: Unspecified|7|||
149943554|NCT06178991|540927476|FG003|Overall Study|Other: Unspecified|6|||
149943555|NCT06178991|540927477|FG004|Overall Study|Other: Unspecified|1|||
149943556|NCT06178991|540927478|FG005|Overall Study|Other: Unspecified|1|||
149943557|NCT06178991|540927479|FG006|Overall Study|Other: Unspecified|1|||
149943558|NCT06178991|540927480|FG007|Overall Study|Other: Unspecified|0|||
149943559|NCT06178991|540927473|FG000|Overall Study|Physician Decision|0|||
149943560|NCT06178991|540927474|FG001|Overall Study|Physician Decision|0|||
149943561|NCT06178991|540927475|FG002|Overall Study|Physician Decision|2|||
149943562|NCT06178991|540927476|FG003|Overall Study|Physician Decision|0|||
149943563|NCT06178991|540927477|FG004|Overall Study|Physician Decision|2|||
149943564|NCT06178991|540927478|FG005|Overall Study|Physician Decision|1|||
149943565|NCT06178991|540927479|FG006|Overall Study|Physician Decision|0|||
149943566|NCT06178991|540927480|FG007|Overall Study|Physician Decision|0|||
149943567|NCT06178991|540927473|FG000|Overall Study|Protocol Violation|0|||
149943568|NCT06178991|540927474|FG001|Overall Study|Protocol Violation|0|||
149943569|NCT06178991|540927475|FG002|Overall Study|Protocol Violation|1|||
149943570|NCT06178991|540927476|FG003|Overall Study|Protocol Violation|0|||
149943571|NCT06178991|540927477|FG004|Overall Study|Protocol Violation|0|||
149943572|NCT06178991|540927478|FG005|Overall Study|Protocol Violation|0|||
149943573|NCT06178991|540927479|FG006|Overall Study|Protocol Violation|0|||
149943574|NCT06178991|540927480|FG007|Overall Study|Protocol Violation|0|||
149943575|NCT04739800|540927481|FG000|Overall Study|Adverse Event|2|||
149943576|NCT04739800|540927482|FG001|Overall Study|Adverse Event|1|||
149943577|NCT04739800|540927483|FG002|Overall Study|Adverse Event|4|||
149943578|NCT04739800|540927484|FG003|Overall Study|Adverse Event|5|||
149943579|NCT04739800|540927481|FG000|Overall Study|Never Treated|2|||
149943580|NCT04739800|540927482|FG001|Overall Study|Never Treated|0|||
150032605|NCT03137992|541259318|FG004|Washout Period 2|Subject Non-compliance|0|||
150032606|NCT03137992|541259319|FG005|Washout Period 2|Subject Non-compliance|0|||
150032607|NCT03137992|541259314|FG000|Washout Period 2|Adverse Event|0|||
150032608|NCT03137992|541259315|FG001|Washout Period 2|Adverse Event|0|||
150032609|NCT03137992|541259316|FG002|Washout Period 2|Adverse Event|0|||
150032610|NCT03137992|541259317|FG003|Washout Period 2|Adverse Event|1|||
150032611|NCT03137992|541259318|FG004|Washout Period 2|Adverse Event|1|||
150032612|NCT03137992|541259319|FG005|Washout Period 2|Adverse Event|0|||
150032613|NCT03137992|541259314|FG000|Washout Period 2|Withdrawal by Subject|1|||
150032614|NCT03137992|541259315|FG001|Washout Period 2|Withdrawal by Subject|0|||
150032615|NCT03137992|541259316|FG002|Washout Period 2|Withdrawal by Subject|0|||
150032616|NCT03137992|541259317|FG003|Washout Period 2|Withdrawal by Subject|0|||
150032617|NCT03137992|541259318|FG004|Washout Period 2|Withdrawal by Subject|1|||
150032618|NCT03137992|541259319|FG005|Washout Period 2|Withdrawal by Subject|0|||
150032619|NCT03137992|541259314|FG000|Washout Period 2|Sponsor Decision|0|||
150032620|NCT03137992|541259315|FG001|Washout Period 2|Sponsor Decision|0|||
149943581|NCT04739800|540927483|FG002|Overall Study|Never Treated|1|||
149943582|NCT04739800|540927484|FG003|Overall Study|Never Treated|1|||
149943583|NCT04739800|540927481|FG000|Overall Study|On Treatment|5|||
149943584|NCT04739800|540927482|FG001|Overall Study|On Treatment|9|||
149943585|NCT04739800|540927483|FG002|Overall Study|On Treatment|9|||
149943586|NCT04739800|540927484|FG003|Overall Study|On Treatment|9|||
149943587|NCT04739800|540927481|FG000|Overall Study|Symptomatic Deterioration|1|||
149943588|NCT04739800|540927482|FG001|Overall Study|Symptomatic Deterioration|1|||
149943589|NCT04739800|540927483|FG002|Overall Study|Symptomatic Deterioration|3|||
150032621|NCT03137992|541259316|FG002|Washout Period 2|Sponsor Decision|0|||
150032622|NCT03137992|541259317|FG003|Washout Period 2|Sponsor Decision|0|||
150032623|NCT03137992|541259318|FG004|Washout Period 2|Sponsor Decision|0|||
150032624|NCT03137992|541259319|FG005|Washout Period 2|Sponsor Decision|1|||
150032625|NCT03137992|541259314|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
150032626|NCT03137992|541259315|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
150032627|NCT03137992|541259316|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
150032628|NCT03137992|541259317|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
150032629|NCT03137992|541259318|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
150032630|NCT03137992|541259319|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
150032631|NCT03137992|541259314|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
150032632|NCT03137992|541259315|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
150032633|NCT03137992|541259316|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
150032634|NCT03137992|541259317|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
150032635|NCT03137992|541259318|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
150032636|NCT03137992|541259319|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
150032637|NCT03137992|541259314|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
150032638|NCT03137992|541259315|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
150032639|NCT03137992|541259316|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
150032640|NCT03137992|541259317|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
150032641|NCT03137992|541259318|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
150032642|NCT03137992|541259319|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
150032643|NCT03137992|541259314|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
150032644|NCT03137992|541259315|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
150032645|NCT03137992|541259316|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
150032646|NCT03137992|541259317|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
150032647|NCT03137992|541259318|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
150032648|NCT03137992|541259319|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
150032649|NCT03137992|541259314|FG000|Part 2 (Open-label Extension)|Per study team|1|||
150032650|NCT03137992|541259315|FG001|Part 2 (Open-label Extension)|Per study team|0|||
150032651|NCT03137992|541259316|FG002|Part 2 (Open-label Extension)|Per study team|0|||
150032652|NCT03137992|541259317|FG003|Part 2 (Open-label Extension)|Per study team|0|||
150032653|NCT03137992|541259318|FG004|Part 2 (Open-label Extension)|Per study team|0|||
150032654|NCT03137992|541259319|FG005|Part 2 (Open-label Extension)|Per study team|0|||
150032655|NCT03137992|541259314|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
150032656|NCT03137992|541259315|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
150032657|NCT03137992|541259316|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
150032658|NCT03137992|541259317|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
150032659|NCT03137992|541259318|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
150032660|NCT03137992|541259319|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
150032661|NCT03077542|541259322|FG000|Overall Study|Death|4|||
150032662|NCT03077542|541259323|FG001|Overall Study|Death|0|||
150032663|NCT03077542|541259322|FG000|Overall Study|Physician Decision|6|||
150032664|NCT03077542|541259323|FG001|Overall Study|Physician Decision|1|||
150032665|NCT03077542|541259322|FG000|Overall Study|Withdrawal by Subject|0|||
150032666|NCT03077542|541259323|FG001|Overall Study|Withdrawal by Subject|1|||
150032667|NCT03221556|541259326|FG000|Allocation|post-randomization exclusion|0|||
150032668|NCT03221556|541259327|FG001|Allocation|post-randomization exclusion|1|||
150032669|NCT03221556|541259326|FG000|Follow-Up|Withdrawal by Subject|0|||
150032670|NCT03221556|541259327|FG001|Follow-Up|Withdrawal by Subject|1|||
149943590|NCT04739800|540927484|FG003|Overall Study|Symptomatic Deterioration|0|||
149943591|NCT04739800|540927481|FG000|Overall Study|Withdrawal by Subject|1|||
149943592|NCT04739800|540927482|FG001|Overall Study|Withdrawal by Subject|2|||
149943593|NCT04739800|540927483|FG002|Overall Study|Withdrawal by Subject|1|||
149943594|NCT04739800|540927484|FG003|Overall Study|Withdrawal by Subject|3|||
149943595|NCT04739800|540927481|FG000|Overall Study|Other Reason|1|||
149943596|NCT04739800|540927482|FG001|Overall Study|Other Reason|3|||
149943597|NCT04739800|540927483|FG002|Overall Study|Other Reason|5|||
150032671|NCT00795704|541259330|FG000|Overall Study|Withdrawal by Subject|3|||
150032672|NCT00795704|541259331|FG001|Overall Study|Withdrawal by Subject|2|||
150032673|NCT00795704|541259330|FG000|Overall Study|Adverse Event|1|||
150032674|NCT00795704|541259331|FG001|Overall Study|Adverse Event|1|||
150032675|NCT03980730|541259332|FG000|Overall Study|Study Terminated by Sponsor|0|||
149943598|NCT04739800|540927484|FG003|Overall Study|Other Reason|4|||
149943599|NCT03907488|540927487|FG000|Overall Study|Adverse Event|20|||
149943600|NCT03907488|540927488|FG001|Overall Study|Adverse Event|20|||
149943601|NCT03907488|540927487|FG000|Overall Study|Withdrawal by Subject|9|||
150032676|NCT03980730|541259333|FG001|Overall Study|Study Terminated by Sponsor|3|||
150032677|NCT03980730|541259332|FG000|Overall Study|Adverse Event|2|||
150032678|NCT03980730|541259333|FG001|Overall Study|Adverse Event|0|||
150032679|NCT03980730|541259332|FG000|Overall Study|Sponsor Request|0|||
150170005|NCT02781584|541757228|FG010|Treatment Phase|Adverse Event|0|||
149943602|NCT03907488|540927488|FG001|Overall Study|Withdrawal by Subject|13|||
149943603|NCT03907488|540927487|FG000|Overall Study|Lack of Efficacy|0|||
149943604|NCT03907488|540927488|FG001|Overall Study|Lack of Efficacy|9|||
149943605|NCT03907488|540927487|FG000|Overall Study|Death|3|||
149943606|NCT03907488|540927488|FG001|Overall Study|Death|8|||
149943607|NCT03907488|540927487|FG000|Overall Study|not protocol specified|5|||
149943608|NCT03907488|540927488|FG001|Overall Study|not protocol specified|8|||
149943609|NCT03907488|540927487|FG000|Overall Study|Ineligible|9|||
149943610|NCT03907488|540927488|FG001|Overall Study|Ineligible|15|||
149943611|NCT03570892|540927492|FG000|Overall Study|Death|51|||
149943612|NCT03570892|540927493|FG001|Overall Study|Death|45|||
149943613|NCT03570892|540927492|FG000|Overall Study|Subject decision|5|||
149943614|NCT03570892|540927493|FG001|Overall Study|Subject decision|3|||
149943615|NCT03570892|540927492|FG000|Overall Study|Protocol Violation|1|||
149943616|NCT03570892|540927493|FG001|Overall Study|Protocol Violation|4|||
149943617|NCT03570892|540927492|FG000|Overall Study|Physician Decision|0|||
149943618|NCT03570892|540927493|FG001|Overall Study|Physician Decision|2|||
149943619|NCT05493111|540929388|FG000|Overall Study|Adverse Event|3|||
149943620|NCT05493111|540929389|FG001|Overall Study|Adverse Event|4|||
149943621|NCT05493111|540929388|FG000|Overall Study|Withdrawal of Consent|19|||
149943622|NCT05493111|540929389|FG001|Overall Study|Withdrawal of Consent|10|||
149943623|NCT05493111|540929388|FG000|Overall Study|Non-compliance|1|||
149943624|NCT05493111|540929389|FG001|Overall Study|Non-compliance|1|||
149943625|NCT05493111|540929388|FG000|Overall Study|Lost to Follow-up|8|||
149943626|NCT05493111|540929389|FG001|Overall Study|Lost to Follow-up|1|||
149943627|NCT05493111|540929388|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
149943628|NCT05493111|540929389|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
149943629|NCT05493111|540929388|FG000|Overall Study|Withdrawal by Subject|1|||
149943630|NCT05493111|540929389|FG001|Overall Study|Withdrawal by Subject|1|||
149943631|NCT03836053|540929390|FG000|Overall Study|Protocol-specified criteria|0|||
149943632|NCT03836053|540929391|FG001|Overall Study|Protocol-specified criteria|2|||
149943633|NCT03836053|540929392|FG002|Overall Study|Protocol-specified criteria|1|||
149943634|NCT03836053|540929390|FG000|Overall Study|Death|1|||
149943635|NCT03836053|540929391|FG001|Overall Study|Death|6|||
149943636|NCT03836053|540929392|FG002|Overall Study|Death|4|||
149943637|NCT03836053|540929390|FG000|Overall Study|Withdrawal of consent from study|0|||
149943638|NCT03836053|540929391|FG001|Overall Study|Withdrawal of consent from study|0|||
149943639|NCT03836053|540929392|FG002|Overall Study|Withdrawal of consent from study|1|||
149943640|NCT03836053|540929390|FG000|Overall Study|Decision by sponsor|0|||
149943641|NCT03836053|540929391|FG001|Overall Study|Decision by sponsor|2|||
149943642|NCT03836053|540929392|FG002|Overall Study|Decision by sponsor|4|||
149943643|NCT00788671|540929393|FG000|Overall Study|Death|2|||
149943644|NCT00788671|540929393|FG000|Overall Study|Unable to biopsy|1|||
149943645|NCT00788671|540929393|FG000|Overall Study|Withdrawal by Subject|4|||
149943646|NCT00788671|540929393|FG000|Overall Study|IUD expulsed|1|||
149943647|NCT00788671|540929393|FG000|Overall Study|Lost to follow up|2|||
149943648|NCT04486716|540929394|FG000|Core Phase|Subject decision|6|||
149943649|NCT04486716|540929394|FG000|Core Phase|Adverse Event|5|||
149943650|NCT04486716|540929394|FG000|Core Phase|Lost to Follow-up|1|||
149943651|NCT04486716|540929394|FG000|Core Phase|Physician Decision|1|||
149943652|NCT04486716|540929394|FG000|Core Phase|Enrolled subjects not treated|9|||
149943653|NCT03846479|540929395|FG000|Overall Study|Death|8|||
149943654|NCT03846479|540929395|FG000|Overall Study|Lost to Follow-up|1|||
149943655|NCT02332707|540929396|FG000|Overall Study|Adverse Event|0|||
149943656|NCT02332707|540929397|FG001|Overall Study|Adverse Event|0|||
149943657|NCT02332707|540929398|FG002|Overall Study|Adverse Event|0|||
149943658|NCT02332707|540929399|FG003|Overall Study|Adverse Event|0|||
149943659|NCT02332707|540929400|FG004|Overall Study|Adverse Event|0|||
149943660|NCT02332707|540929401|FG005|Overall Study|Adverse Event|0|||
149943661|NCT02332707|540929402|FG006|Overall Study|Adverse Event|0|||
149943662|NCT02332707|540929403|FG007|Overall Study|Adverse Event|0|||
149943663|NCT02332707|540929404|FG008|Overall Study|Adverse Event|0|||
149943664|NCT02332707|540929405|FG009|Overall Study|Adverse Event|0|||
149943665|NCT02332707|540929406|FG010|Overall Study|Adverse Event|0|||
149943666|NCT02332707|540929407|FG011|Overall Study|Adverse Event|0|||
149943667|NCT02332707|540929408|FG012|Overall Study|Adverse Event|1|||
149943668|NCT02332707|540929409|FG013|Overall Study|Adverse Event|0|||
149943669|NCT02332707|540929410|FG014|Overall Study|Adverse Event|0|||
149943670|NCT02332707|540929411|FG015|Overall Study|Adverse Event|0|||
149943671|NCT02332707|540929412|FG016|Overall Study|Adverse Event|0|||
149943672|NCT02332707|540929413|FG017|Overall Study|Adverse Event|0|||
149943673|NCT02332707|540929396|FG000|Overall Study|Lost to Follow-up|0|||
149943674|NCT02332707|540929397|FG001|Overall Study|Lost to Follow-up|0|||
149943675|NCT02332707|540929398|FG002|Overall Study|Lost to Follow-up|0|||
149943676|NCT02332707|540929399|FG003|Overall Study|Lost to Follow-up|0|||
149943677|NCT02332707|540929400|FG004|Overall Study|Lost to Follow-up|0|||
149943678|NCT02332707|540929401|FG005|Overall Study|Lost to Follow-up|1|||
149943679|NCT02332707|540929402|FG006|Overall Study|Lost to Follow-up|0|||
149943680|NCT02332707|540929403|FG007|Overall Study|Lost to Follow-up|0|||
149943681|NCT02332707|540929404|FG008|Overall Study|Lost to Follow-up|0|||
149943682|NCT02332707|540929405|FG009|Overall Study|Lost to Follow-up|0|||
150032680|NCT03980730|541259333|FG001|Overall Study|Sponsor Request|1|||
150032681|NCT01300728|541259334|FG000|Overall Study|Withdrawal by Subject|1|||
150032682|NCT01300728|541259335|FG001|Overall Study|Withdrawal by Subject|1|||
150032683|NCT01300728|541259334|FG000|Overall Study|Physician Decision|1|||
150032684|NCT01300728|541259335|FG001|Overall Study|Physician Decision|0|||
150032685|NCT01486966|541259336|FG000|Overall Study|Adverse Event|0|||
150032686|NCT01486966|541259337|FG001|Overall Study|Adverse Event|1|||
150032687|NCT01486966|541259336|FG000|Overall Study|Withdrawal by Subject|0|||
150032688|NCT01486966|541259337|FG001|Overall Study|Withdrawal by Subject|1|||
150032689|NCT00301808|541259348|FG000|Overall Study|Adverse Event|5|||
150032690|NCT00301808|541259348|FG000|Overall Study|Death|3|||
150032691|NCT00301808|541259348|FG000|Overall Study|Lack of Efficacy|4|||
150032692|NCT02234843|541259349|FG000|Overall Study|Death|1|||
150032693|NCT02234843|541259350|FG001|Overall Study|Death|0|||
150032694|NCT02234843|541259351|FG002|Overall Study|Death|0|||
150032695|NCT02234843|541259352|FG003|Overall Study|Death|0|||
150032696|NCT02234843|541259353|FG004|Overall Study|Death|0|||
150274389|NCT00682448|542142855|FG001|Overall Study|Lost to Follow-up|3|||
149943683|NCT02332707|540929406|FG010|Overall Study|Lost to Follow-up|2|||
149943684|NCT02332707|540929407|FG011|Overall Study|Lost to Follow-up|0|||
149943685|NCT02332707|540929408|FG012|Overall Study|Lost to Follow-up|3|||
149943686|NCT02332707|540929409|FG013|Overall Study|Lost to Follow-up|0|||
149943687|NCT02332707|540929410|FG014|Overall Study|Lost to Follow-up|0|||
149943688|NCT02332707|540929411|FG015|Overall Study|Lost to Follow-up|0|||
149943689|NCT02332707|540929412|FG016|Overall Study|Lost to Follow-up|0|||
149943690|NCT02332707|540929413|FG017|Overall Study|Lost to Follow-up|0|||
149943691|NCT02332707|540929396|FG000|Overall Study|Physician Decision|0|||
149943692|NCT02332707|540929397|FG001|Overall Study|Physician Decision|0|||
149943693|NCT02332707|540929398|FG002|Overall Study|Physician Decision|0|||
149943694|NCT02332707|540929399|FG003|Overall Study|Physician Decision|1|||
149943695|NCT02332707|540929400|FG004|Overall Study|Physician Decision|0|||
149943696|NCT02332707|540929401|FG005|Overall Study|Physician Decision|0|||
149943697|NCT02332707|540929402|FG006|Overall Study|Physician Decision|0|||
149943698|NCT02332707|540929403|FG007|Overall Study|Physician Decision|0|||
149943699|NCT02332707|540929404|FG008|Overall Study|Physician Decision|0|||
149943700|NCT02332707|540929405|FG009|Overall Study|Physician Decision|0|||
149943701|NCT02332707|540929406|FG010|Overall Study|Physician Decision|0|||
149943702|NCT02332707|540929407|FG011|Overall Study|Physician Decision|0|||
149943703|NCT02332707|540929408|FG012|Overall Study|Physician Decision|1|||
149943704|NCT02332707|540929409|FG013|Overall Study|Physician Decision|0|||
149943705|NCT02332707|540929410|FG014|Overall Study|Physician Decision|0|||
149943706|NCT02332707|540929411|FG015|Overall Study|Physician Decision|0|||
149943707|NCT02332707|540929412|FG016|Overall Study|Physician Decision|0|||
149943708|NCT02332707|540929413|FG017|Overall Study|Physician Decision|0|||
149943709|NCT02332707|540929396|FG000|Overall Study|Withdrawal by Subject|0|||
149943710|NCT02332707|540929397|FG001|Overall Study|Withdrawal by Subject|0|||
149943711|NCT02332707|540929398|FG002|Overall Study|Withdrawal by Subject|1|||
149943712|NCT02332707|540929399|FG003|Overall Study|Withdrawal by Subject|0|||
149943713|NCT02332707|540929400|FG004|Overall Study|Withdrawal by Subject|0|||
149943714|NCT02332707|540929401|FG005|Overall Study|Withdrawal by Subject|0|||
149943715|NCT02332707|540929402|FG006|Overall Study|Withdrawal by Subject|0|||
149943716|NCT02332707|540929403|FG007|Overall Study|Withdrawal by Subject|0|||
149943717|NCT02332707|540929404|FG008|Overall Study|Withdrawal by Subject|0|||
149943718|NCT02332707|540929405|FG009|Overall Study|Withdrawal by Subject|3|||
149943719|NCT02332707|540929406|FG010|Overall Study|Withdrawal by Subject|0|||
149943720|NCT02332707|540929407|FG011|Overall Study|Withdrawal by Subject|0|||
149943721|NCT02332707|540929408|FG012|Overall Study|Withdrawal by Subject|0|||
149943722|NCT02332707|540929409|FG013|Overall Study|Withdrawal by Subject|0|||
149943723|NCT02332707|540929410|FG014|Overall Study|Withdrawal by Subject|0|||
150274390|NCT00682448|542142854|FG000|Overall Study|Pregnancy|0|||
150274391|NCT00682448|542142855|FG001|Overall Study|Pregnancy|1|||
149943724|NCT02332707|540929411|FG015|Overall Study|Withdrawal by Subject|0|||
149943725|NCT02332707|540929412|FG016|Overall Study|Withdrawal by Subject|0|||
149943726|NCT02332707|540929413|FG017|Overall Study|Withdrawal by Subject|0|||
149943727|NCT01473134|540929414|FG000|Overall Study|Lost to Follow-up|21|||
150032697|NCT02234843|541259354|FG005|Overall Study|Death|0|||
150032698|NCT02234843|541259355|FG006|Overall Study|Death|0|||
150032699|NCT02234843|541259356|FG007|Overall Study|Death|0|||
150274392|NCT00682448|542142854|FG000|Overall Study|Withdrawal by Subject|2|||
150274393|NCT00682448|542142855|FG001|Overall Study|Withdrawal by Subject|0|||
150032700|NCT02234843|541259357|FG008|Overall Study|Death|0|||
149943728|NCT01473134|540929415|FG001|Overall Study|Lost to Follow-up|13|||
149943729|NCT01473134|540929414|FG000|Overall Study|Protocol Violation|32|||
149943730|NCT01473134|540929415|FG001|Overall Study|Protocol Violation|19|||
149943731|NCT01473134|540929414|FG000|Overall Study|Withdrawal by Subject|1|||
149943732|NCT01473134|540929415|FG001|Overall Study|Withdrawal by Subject|2|||
149943733|NCT01473134|540929414|FG000|Overall Study|Death|0|||
149943734|NCT01473134|540929415|FG001|Overall Study|Death|1|||
150032701|NCT02234843|541259358|FG009|Overall Study|Death|0|||
150032702|NCT02234843|541259349|FG000|Overall Study|Protocol Violation|1|||
150274394|NCT04050670|542142858|FG000|Period 3|Physician Decision|0|||
149943735|NCT01473134|540929414|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
149943736|NCT01473134|540929415|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
149943737|NCT04761822|540929416|FG000|Overall Study|Adverse Event|3|||
149943738|NCT04761822|540929417|FG001|Overall Study|Adverse Event|1|||
149943739|NCT04761822|540929418|FG002|Overall Study|Adverse Event|1|||
149943740|NCT04761822|540929419|FG003|Overall Study|Adverse Event|3|||
149943741|NCT04761822|540929416|FG000|Overall Study|Lost to Follow-up|1|||
149943742|NCT04761822|540929417|FG001|Overall Study|Lost to Follow-up|0|||
149943743|NCT04761822|540929418|FG002|Overall Study|Lost to Follow-up|2|||
149943744|NCT04761822|540929419|FG003|Overall Study|Lost to Follow-up|3|||
149943745|NCT04761822|540929416|FG000|Overall Study|Physician Decision|0|||
149943746|NCT04761822|540929417|FG001|Overall Study|Physician Decision|1|||
149943747|NCT04761822|540929418|FG002|Overall Study|Physician Decision|0|||
149943748|NCT04761822|540929419|FG003|Overall Study|Physician Decision|0|||
149943749|NCT04761822|540929416|FG000|Overall Study|Withdrawal by Subject|3|||
149943750|NCT04761822|540929417|FG001|Overall Study|Withdrawal by Subject|8|||
149943751|NCT04761822|540929418|FG002|Overall Study|Withdrawal by Subject|1|||
149943752|NCT04761822|540929419|FG003|Overall Study|Withdrawal by Subject|11|||
149943753|NCT04761822|540929416|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
149943754|NCT04761822|540929417|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
149943755|NCT04761822|540929418|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
149943756|NCT04761822|540929419|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
149943757|NCT04761822|540929416|FG000|Overall Study|Participant requested unblinding|0|||
149943758|NCT04761822|540929417|FG001|Overall Study|Participant requested unblinding|0|||
149943759|NCT04761822|540929418|FG002|Overall Study|Participant requested unblinding|0|||
149943760|NCT04761822|540929419|FG003|Overall Study|Participant requested unblinding|1|||
149943761|NCT02233413|540929426|FG000|Overall Study|Lost to Follow-up|7|||
149943762|NCT02233413|540929427|FG001|Overall Study|Lost to Follow-up|9|||
149943763|NCT02233413|540929426|FG000|Overall Study|Withdrawal by Subject|4|||
149943764|NCT02233413|540929427|FG001|Overall Study|Withdrawal by Subject|5|||
149943765|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
149943766|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
149943767|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
149943768|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
149943769|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
149943770|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
149943771|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
149943772|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
149943773|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
149943774|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
149943775|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
149943776|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
149943777|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
149943778|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
149943779|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
149943780|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
149943781|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
149943782|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
149943783|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
149943784|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
149943785|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
149943786|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
149943787|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
149943788|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
149943789|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
149943790|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
149943791|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
149943792|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
149943793|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
149943794|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
149943795|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
149943796|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
149943797|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
149943798|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
149943799|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
149943800|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
149943801|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
149943802|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
149943803|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
149943804|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
149943805|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
149943806|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
149943807|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
149943808|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
149943809|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
149943810|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
149943811|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
149943812|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
149943813|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
149943814|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
149943815|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
149943816|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
149943817|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
149943818|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
149943819|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
149943820|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
149943821|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
149943822|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
149943823|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
149943824|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
149943825|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
149943826|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
149943827|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
149943828|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
149943829|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
149943830|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
149943831|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
149943832|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
149943833|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
149943834|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
149943835|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
149943836|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
149943837|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
149943838|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
149943839|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
149943840|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
149943841|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
149943842|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
149943843|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
149943844|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
149943845|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
149943846|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
149943847|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
149943848|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
149943849|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
149943850|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
149943851|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
149943852|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
149943853|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
149943854|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
149943855|NCT00090103|540929428|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
149943856|NCT00090103|540929429|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
149943857|NCT00090103|540929430|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
149943858|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
149943859|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
149943860|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
149943861|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
150032703|NCT02234843|541259350|FG001|Overall Study|Protocol Violation|0|||
150274395|NCT04050670|542142859|FG001|Period 3|Physician Decision|1|||
150274396|NCT04050670|542142860|FG002|Period 3|Physician Decision|0|||
150274397|NCT00268437|542142861|FG000|Overall Study|Ineligible|1|||
150274398|NCT00761306|542142862|FG000|Overall Study|Adverse Event|5|||
150274399|NCT00761306|542142862|FG000|Overall Study|Lack of Efficacy|4|||
150274400|NCT00761306|542142862|FG000|Overall Study|Protocol Violation|2|||
150274401|NCT00761306|542142862|FG000|Overall Study|Withdrawal of Consent|3|||
150274402|NCT00761306|542142862|FG000|Overall Study|Lost to Follow-up|1|||
150274403|NCT00761306|542142862|FG000|Overall Study|Administrative or Other Reasons|5|||
150274404|NCT00525044|542142863|FG000|Overall Study|Lost to Follow-up|0|||
150274405|NCT00525044|542142864|FG001|Overall Study|Lost to Follow-up|1|||
150274406|NCT02982239|542142868|FG000|Overall Study|Lost to Follow-up|3|||
150274407|NCT02982239|542142869|FG001|Overall Study|Lost to Follow-up|2|||
150274408|NCT00880555|542142870|FG000|Overall Study|Physician Decision|0|||
150274409|NCT00880555|542142871|FG001|Overall Study|Physician Decision|8|||
150274410|NCT00880555|542142872|FG002|Overall Study|Physician Decision|0|||
150274411|NCT00880555|542142873|FG003|Overall Study|Physician Decision|2|||
150274412|NCT00880555|542142874|FG004|Overall Study|Physician Decision|1|||
150274413|NCT00880555|542142875|FG005|Overall Study|Physician Decision|0|||
150274414|NCT00880555|542142870|FG000|Overall Study|Withdrawal by Subject|1|||
150274415|NCT00880555|542142871|FG001|Overall Study|Withdrawal by Subject|1|||
150274416|NCT00880555|542142872|FG002|Overall Study|Withdrawal by Subject|0|||
150274417|NCT00880555|542142873|FG003|Overall Study|Withdrawal by Subject|0|||
150274418|NCT00880555|542142874|FG004|Overall Study|Withdrawal by Subject|0|||
150274419|NCT00880555|542142875|FG005|Overall Study|Withdrawal by Subject|0|||
150274420|NCT00880555|542142870|FG000|Overall Study|Lack of resources (hired rater)|9|||
150274421|NCT00880555|542142871|FG001|Overall Study|Lack of resources (hired rater)|7|||
150274422|NCT00880555|542142872|FG002|Overall Study|Lack of resources (hired rater)|5|||
150274423|NCT00880555|542142873|FG003|Overall Study|Lack of resources (hired rater)|0|||
150274424|NCT00880555|542142874|FG004|Overall Study|Lack of resources (hired rater)|0|||
150274425|NCT00880555|542142875|FG005|Overall Study|Lack of resources (hired rater)|0|||
150274426|NCT00880555|542142870|FG000|Overall Study|Death|0|||
150274427|NCT00880555|542142871|FG001|Overall Study|Death|0|||
150274428|NCT00880555|542142872|FG002|Overall Study|Death|0|||
150274429|NCT00880555|542142873|FG003|Overall Study|Death|0|||
150274430|NCT00880555|542142874|FG004|Overall Study|Death|0|||
150274431|NCT00880555|542142875|FG005|Overall Study|Death|1|||
150274432|NCT00880555|542142870|FG000|Overall Study|Lost to Follow-up|0|||
150274433|NCT00880555|542142871|FG001|Overall Study|Lost to Follow-up|1|||
150274434|NCT00880555|542142872|FG002|Overall Study|Lost to Follow-up|0|||
150274435|NCT00880555|542142873|FG003|Overall Study|Lost to Follow-up|0|||
150274436|NCT00880555|542142874|FG004|Overall Study|Lost to Follow-up|0|||
150274437|NCT00880555|542142875|FG005|Overall Study|Lost to Follow-up|0|||
150274438|NCT01873417|542142878|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
150274439|NCT01873417|542142878|FG000|Overall Study|Adverse Event|24|||
150274440|NCT01873417|542142878|FG000|Overall Study|Lost to Follow-up|2|||
149943862|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
149943863|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
149943864|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
150274441|NCT01873417|542142878|FG000|Overall Study|Withdrawal by Subject|2|||
150274442|NCT01873417|542142878|FG000|Overall Study|Physician Decision|3|||
150274443|NCT00785044|542142879|FG000|Overall Study|Dosed at non-participating sites|152|||
150274444|NCT00785044|542142879|FG000|Overall Study|Death|77|||
150274445|NCT00785044|542142879|FG000|Overall Study|Lost to Follow-up|266|||
150274446|NCT00785044|542142879|FG000|Overall Study|Withdrawal by Subject|1|||
150274447|NCT01086410|542142880|FG000|Overall Study|Adverse Event|1|||
150274448|NCT01086410|542142881|FG001|Overall Study|Adverse Event|0|||
150274449|NCT01086410|542142882|FG002|Overall Study|Adverse Event|0|||
150274450|NCT01086410|542142883|FG003|Overall Study|Adverse Event|2|||
150274451|NCT01086410|542142880|FG000|Overall Study|Lack of Efficacy|1|||
150274452|NCT01086410|542142881|FG001|Overall Study|Lack of Efficacy|1|||
150274453|NCT01086410|542142882|FG002|Overall Study|Lack of Efficacy|0|||
150274454|NCT01086410|542142883|FG003|Overall Study|Lack of Efficacy|0|||
149943865|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
149943866|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
150032704|NCT02234843|541259351|FG002|Overall Study|Protocol Violation|1|||
150274455|NCT01086410|542142880|FG000|Overall Study|Protocol Violation|1|||
150274456|NCT01086410|542142881|FG001|Overall Study|Protocol Violation|1|||
150274457|NCT01086410|542142882|FG002|Overall Study|Protocol Violation|0|||
150274458|NCT01086410|542142883|FG003|Overall Study|Protocol Violation|0|||
150274459|NCT01086410|542142880|FG000|Overall Study|Lost to Follow-up|0|||
150274460|NCT01086410|542142881|FG001|Overall Study|Lost to Follow-up|0|||
150274461|NCT01086410|542142882|FG002|Overall Study|Lost to Follow-up|1|||
150274462|NCT01086410|542142883|FG003|Overall Study|Lost to Follow-up|0|||
150274463|NCT04196803|542142884|FG000|Overall Study|Withdrawal by Subject|1|||
150274464|NCT04196803|542142885|FG001|Overall Study|Withdrawal by Subject|3|||
150274465|NCT04196803|542142884|FG000|Overall Study|Adverse Event|4|||
150274466|NCT04196803|542142885|FG001|Overall Study|Adverse Event|2|||
150274467|NCT04196803|542142884|FG000|Overall Study|Lost to Follow-up|0|||
150274468|NCT04196803|542142885|FG001|Overall Study|Lost to Follow-up|1|||
150274469|NCT01022996|542142886|FG000|Overall Study|Adverse Event|14|||
150274470|NCT01022996|542142886|FG000|Overall Study|Withdrawal by Subject|3|||
150274471|NCT01022996|542142886|FG000|Overall Study|Lost to Follow-up|1|||
150274472|NCT01022996|542142886|FG000|Overall Study|Administrative problems|6|||
150274473|NCT01022996|542142886|FG000|Overall Study|Disease Progression|32|||
150274474|NCT01022996|542142886|FG000|Overall Study|Protocol Violation|1|||
150274475|NCT02767323|542142887|FG000|Overall Study|Withdrawal by Subject|17|||
150274476|NCT02767323|542142888|FG001|Overall Study|Withdrawal by Subject|5|||
150032705|NCT02234843|541259352|FG003|Overall Study|Protocol Violation|0|||
150032706|NCT02234843|541259353|FG004|Overall Study|Protocol Violation|0|||
150274477|NCT02767323|542142889|FG002|Overall Study|Withdrawal by Subject|13|||
150274478|NCT02767323|542142890|FG003|Overall Study|Withdrawal by Subject|0|||
150274479|NCT02767323|542142887|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
150274480|NCT02767323|542142888|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
150274481|NCT02767323|542142889|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
150274482|NCT02767323|542142890|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
150274483|NCT00930722|542142891|FG000|Overall Study|Lost to Follow-up|16|||
150274484|NCT00930722|542142891|FG000|Overall Study|No longer willing to participate|9|||
150274485|NCT00930722|542142891|FG000|Overall Study|Study terminated by sponsor|2|||
150274486|NCT00710879|542142892|FG000|Overall Study|Lost to Follow-up|2|||
150274487|NCT00710879|542142893|FG001|Overall Study|Lost to Follow-up|1|||
150274488|NCT00710879|542142892|FG000|Overall Study|Protocol Violation|0|||
150274489|NCT00710879|542142893|FG001|Overall Study|Protocol Violation|3|||
150274490|NCT01809132|542142894|FG000|Overall Study|Withdrawal by Subject|0|||
150274491|NCT01809132|542142895|FG001|Overall Study|Withdrawal by Subject|0|||
150274492|NCT01809132|542142896|FG002|Overall Study|Withdrawal by Subject|1|||
149943867|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
149943868|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
149943869|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
149943870|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
149943871|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
149943872|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
149943873|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
149943874|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
149943875|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
149943876|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
150274493|NCT04854434|542142897|FG000|Overall Study|Death|1|||
150274494|NCT04854434|542142898|FG001|Overall Study|Death|3|||
150274495|NCT04854434|542142899|FG002|Overall Study|Death|4|||
150274496|NCT04854434|542142897|FG000|Overall Study|Study Terminated by Sponsor|2|||
150274497|NCT04854434|542142898|FG001|Overall Study|Study Terminated by Sponsor|0|||
150274498|NCT04854434|542142899|FG002|Overall Study|Study Terminated by Sponsor|0|||
150274499|NCT04854434|542142897|FG000|Overall Study|Other|1|||
150274500|NCT04854434|542142898|FG001|Overall Study|Other|1|||
150274501|NCT04854434|542142899|FG002|Overall Study|Other|0|||
150274502|NCT02667275|542142904|FG000|Overall Study|Protocol Violation|11|||
150274503|NCT02667275|542142905|FG001|Overall Study|Protocol Violation|7|||
150274504|NCT02667275|542142904|FG000|Overall Study|Lost to Follow-up|0|||
150274505|NCT02667275|542142905|FG001|Overall Study|Lost to Follow-up|2|||
150274506|NCT02667275|542142904|FG000|Overall Study|Withdrawal by Subject|0|||
150274507|NCT02667275|542142905|FG001|Overall Study|Withdrawal by Subject|5|||
150274508|NCT02667275|542142904|FG000|Overall Study|Discontinued early without completing|0|||
150274509|NCT02667275|542142905|FG001|Overall Study|Discontinued early without completing|1|||
150274510|NCT01756040|542142906|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
150274511|NCT01756040|542142906|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
150274512|NCT01756040|542142906|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
150274513|NCT01274715|542142907|FG000|Overall Study|Lost to Follow-up|1|||
150274514|NCT01274715|542142907|FG000|Overall Study|After consent, met exclusion criteria.|1|||
150274515|NCT01274715|542142907|FG000|Overall Study|After consent, met exclusion criteria.|1|||
150274516|NCT01274715|542142907|FG000|Overall Study|After consent, met exclusion criteria.|1|||
150274517|NCT04479436|542142908|FG000|Overall Study|Progressive disease|26|||
150274518|NCT04479436|542142909|FG001|Overall Study|Progressive disease|1|||
150274519|NCT04479436|542142908|FG000|Overall Study|Adverse Event|6|||
150032707|NCT02234843|541259354|FG005|Overall Study|Protocol Violation|0|||
150032708|NCT02234843|541259355|FG006|Overall Study|Protocol Violation|0|||
150274520|NCT04479436|542142909|FG001|Overall Study|Adverse Event|0|||
150274521|NCT04479436|542142908|FG000|Overall Study|Withdrawal by Subject|5|||
150274522|NCT04479436|542142909|FG001|Overall Study|Withdrawal by Subject|0|||
150274523|NCT04479436|542142908|FG000|Overall Study|Clinical progression|1|||
150274524|NCT04479436|542142909|FG001|Overall Study|Clinical progression|0|||
150274525|NCT04479436|542142908|FG000|Overall Study|Physician Decision|1|||
150274526|NCT04479436|542142909|FG001|Overall Study|Physician Decision|0|||
149943877|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
150274527|NCT02713542|542142911|FG000|Overall Study|Use of prohibited medication|14|||
150274528|NCT02713542|542142912|FG001|Overall Study|Use of prohibited medication|5|||
150274529|NCT02713542|542142911|FG000|Overall Study|Withdrawal by Subject|4|||
150274530|NCT02713542|542142912|FG001|Overall Study|Withdrawal by Subject|1|||
150274531|NCT02357134|542142913|FG000|Overall Study|Lost to Follow-up|1|||
150274532|NCT02357134|542142914|FG001|Overall Study|Lost to Follow-up|0|||
150274533|NCT02357134|542142915|FG002|Overall Study|Lost to Follow-up|0|||
150274534|NCT02357134|542142916|FG003|Overall Study|Lost to Follow-up|0|||
150274535|NCT03583450|542142917|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
150274536|NCT03583450|542142918|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
150274537|NCT05097716|542142919|FG000|Period 1|Adverse Event|1|||
150274538|NCT05097716|542142919|FG000|Period 1|Close contact with highly-transmissible infection|1|||
150274539|NCT00791258|542142920|FG000|Overall Study|Adverse Event|87|||
150274540|NCT00791258|542142920|FG000|Overall Study|Lost to Follow-up|18|||
150274541|NCT00791258|542142920|FG000|Overall Study|Protocol Violation|109|||
150274542|NCT00791258|542142920|FG000|Overall Study|Withdrawal by Subject|40|||
150274543|NCT00791258|542142920|FG000|Overall Study|Did not take medication for >3 days|1|||
150274544|NCT00791258|542142920|FG000|Overall Study|subject left area|2|||
150274545|NCT00791258|542142920|FG000|Overall Study|non-compliance|3|||
150274546|NCT00791258|542142920|FG000|Overall Study|Subject incarcerated|1|||
150274547|NCT00791258|542142920|FG000|Overall Study|Subject required restricted medication|1|||
150274548|NCT00791258|542142920|FG000|Overall Study|Lack of Efficacy|1|||
150274549|NCT00210184|542142921|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
150274550|NCT01118325|542142926|FG000|Overall Study|Adverse Event|1|||
150274551|NCT01118325|542142927|FG001|Overall Study|Adverse Event|0|||
150274552|NCT01118325|542142928|FG002|Overall Study|Adverse Event|1|||
150274553|NCT03334409|542142929|FG000|Overall Study|Did not meet inclusion criteria|1|||
150274554|NCT03334409|542142930|FG001|Overall Study|Did not meet inclusion criteria|0|||
150274555|NCT00975715|542142931|FG000|Titration Period|Adverse Event|6|||
150274556|NCT00975715|542142932|FG001|Titration Period|Adverse Event|0|||
150274557|NCT00975715|542142931|FG000|Titration Period|Protocol Violation|1|||
150274558|NCT00975715|542142932|FG001|Titration Period|Protocol Violation|0|||
150274559|NCT00975715|542142931|FG000|Maintenance Period|Adverse Event|2|||
150274560|NCT00975715|542142932|FG001|Maintenance Period|Adverse Event|1|||
150274561|NCT05215262|542142942|FG000|Overall Study|Lost to Follow-up|12|||
150274562|NCT05215262|542142943|FG001|Overall Study|Lost to Follow-up|0|||
150274563|NCT00239226|542142949|FG000|Overall Study|permAF during stabilization period|0|||
150274564|NCT00239226|542142950|FG001|Overall Study|permAF during stabilization period|0|||
150274565|NCT00239226|542142951|FG002|Overall Study|permAF during stabilization period|0|||
150274566|NCT00239226|542142952|FG003|Overall Study|permAF during stabilization period|3|||
150274567|NCT00239226|542142949|FG000|Overall Study|Lost to Follow-up|1|||
150274568|NCT00239226|542142950|FG001|Overall Study|Lost to Follow-up|0|||
150274569|NCT00239226|542142951|FG002|Overall Study|Lost to Follow-up|1|||
150274570|NCT00239226|542142952|FG003|Overall Study|Lost to Follow-up|0|||
150274571|NCT00646906|542142953|FG000|Crossover Period 1|Withdrawal by Subject|1|||
150274572|NCT00646906|542142954|FG001|Crossover Period 1|Withdrawal by Subject|0|||
150274573|NCT00646906|542142955|FG002|Crossover Period 1|Withdrawal by Subject|0|||
150274574|NCT00646906|542142956|FG003|Crossover Period 1|Withdrawal by Subject|0|||
150274575|NCT00646906|542142957|FG004|Crossover Period 1|Withdrawal by Subject|0|||
150274576|NCT00646906|542142958|FG005|Crossover Period 1|Withdrawal by Subject|1|||
150274577|NCT00646906|542142959|FG006|Crossover Period 1|Withdrawal by Subject|0|||
150274578|NCT00646906|542142953|FG000|Crossover Period 2|Withdrawal by Subject|0|||
150274579|NCT00646906|542142954|FG001|Crossover Period 2|Withdrawal by Subject|1|||
150274580|NCT00646906|542142955|FG002|Crossover Period 2|Withdrawal by Subject|2|||
150274581|NCT00646906|542142956|FG003|Crossover Period 2|Withdrawal by Subject|1|||
150274582|NCT00646906|542142957|FG004|Crossover Period 2|Withdrawal by Subject|0|||
150274583|NCT00646906|542142958|FG005|Crossover Period 2|Withdrawal by Subject|0|||
150274584|NCT00646906|542142959|FG006|Crossover Period 2|Withdrawal by Subject|0|||
150274585|NCT00646906|542142953|FG000|Crossover Period 2|Physician Decision|0|||
149943878|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
150274586|NCT00646906|542142954|FG001|Crossover Period 2|Physician Decision|0|||
150274587|NCT00646906|542142955|FG002|Crossover Period 2|Physician Decision|0|||
150274588|NCT00646906|542142956|FG003|Crossover Period 2|Physician Decision|0|||
150274589|NCT00646906|542142957|FG004|Crossover Period 2|Physician Decision|0|||
150274590|NCT00646906|542142958|FG005|Crossover Period 2|Physician Decision|0|||
150274591|NCT00646906|542142959|FG006|Crossover Period 2|Physician Decision|1|||
150274592|NCT01303965|542142962|FG000|Overall Study|Adverse Event|1|||
150274593|NCT01303965|542142963|FG001|Overall Study|Adverse Event|1|||
150274594|NCT01303965|542142962|FG000|Overall Study|Death|0|||
150274595|NCT01303965|542142963|FG001|Overall Study|Death|3|||
150274596|NCT01303965|542142962|FG000|Overall Study|Withdrawal by Subject|1|||
150274597|NCT01303965|542142963|FG001|Overall Study|Withdrawal by Subject|0|||
150274598|NCT01303965|542142962|FG000|Overall Study|Disease Progression|1|||
150274599|NCT01303965|542142963|FG001|Overall Study|Disease Progression|6|||
150274600|NCT04060563|542142964|FG000|Overall Study|Lost to Follow-up|1|||
149821409|NCT01271933|540475697|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
149821410|NCT01271933|540475698|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
149821411|NCT01271933|540475699|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
149821412|NCT01271933|540475697|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
149821413|NCT01271933|540475698|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
149821414|NCT01271933|540475699|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
149821415|NCT01271933|540475697|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
149821416|NCT01271933|540475698|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
149821417|NCT01271933|540475699|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
149821418|NCT01271933|540475697|FG000|Double-Blind Phase|Randomized but not treated|0|||
149821419|NCT01271933|540475698|FG001|Double-Blind Phase|Randomized but not treated|0|||
149821420|NCT01271933|540475699|FG002|Double-Blind Phase|Randomized but not treated|1|||
149821421|NCT01271933|540475697|FG000|Double-Blind Phase|Lack of Efficacy|0|||
149821422|NCT01271933|540475698|FG001|Double-Blind Phase|Lack of Efficacy|6|||
149821423|NCT01271933|540475699|FG002|Double-Blind Phase|Lack of Efficacy|9|||
149821424|NCT01271933|540475697|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149821425|NCT01271933|540475698|FG001|Double-Blind Phase|Lost to Follow-up|1|||
150032709|NCT02234843|541259356|FG007|Overall Study|Protocol Violation|0|||
150032710|NCT02234843|541259357|FG008|Overall Study|Protocol Violation|0|||
150032711|NCT02234843|541259358|FG009|Overall Study|Protocol Violation|0|||
150274601|NCT04060563|542142965|FG001|Overall Study|Lost to Follow-up|1|||
150274602|NCT04060563|542142964|FG000|Overall Study|Physician Decision|0|||
150274603|NCT04060563|542142965|FG001|Overall Study|Physician Decision|1|||
149943879|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
149943880|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
149943881|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
149943882|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
149943883|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
149943884|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
149943885|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
149943886|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
149943887|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
149943888|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
149943889|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
149943890|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
149943891|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
149943892|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
149943893|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
149943894|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
149943895|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
149943896|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
149943897|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
149943898|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
149943899|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
149943900|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
149943901|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
149943902|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
149943903|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
149943904|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
149943905|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
149943906|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Death|1|||
149943907|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Death|0|||
149943908|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Death|1|||
149943909|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
149943910|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
149943911|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
149943912|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
149943913|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
149943914|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
149943915|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
149943916|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
149943917|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
149943918|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
149943919|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
149943920|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
150032712|NCT02234843|541259349|FG000|Overall Study|Efficacy outcome reached|2|||
149821426|NCT01271933|540475699|FG002|Double-Blind Phase|Lost to Follow-up|1|||
149821427|NCT01271933|540475697|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149821428|NCT01271933|540475698|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
149821429|NCT01271933|540475699|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
149943921|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
149943922|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
149943923|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
149943924|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
149943925|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
149943926|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
149943927|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
149943928|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
149943929|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
149943930|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Depression|0|||
149943931|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Depression|1|||
149943932|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Depression|0|||
149943933|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
149943934|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
149943935|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
149943936|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Jailed|0|||
149943937|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Jailed|1|||
149943938|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Jailed|0|||
149943939|NCT00090103|540929428|FG000|16-Week Safety Follow-up Period|Other|0|||
149943940|NCT00090103|540929429|FG001|16-Week Safety Follow-up Period|Other|1|||
149943941|NCT00090103|540929430|FG002|16-Week Safety Follow-up Period|Other|0|||
149943942|NCT01799889|540929431|FG000|Overall Study|Adverse Event|4|||
149943943|NCT01799889|540929432|FG001|Overall Study|Adverse Event|4|||
149943944|NCT01799889|540929433|FG002|Overall Study|Adverse Event|5|||
149943945|NCT01799889|540929434|FG003|Overall Study|Adverse Event|1|||
149943946|NCT01799889|540929435|FG004|Overall Study|Adverse Event|11|||
149943947|NCT01799889|540929436|FG005|Overall Study|Adverse Event|1|||
149943948|NCT01799889|540929437|FG006|Overall Study|Adverse Event|5|||
149943949|NCT01799889|540929438|FG007|Overall Study|Adverse Event|2|||
149943950|NCT01799889|540929439|FG008|Overall Study|Adverse Event|3|||
149943951|NCT01799889|540929440|FG009|Overall Study|Adverse Event|1|||
149943952|NCT01799889|540929441|FG010|Overall Study|Adverse Event|1|||
149943953|NCT01799889|540929442|FG011|Overall Study|Adverse Event|0|||
149943954|NCT01799889|540929431|FG000|Overall Study|Death|1|||
149943955|NCT01799889|540929432|FG001|Overall Study|Death|0|||
149943956|NCT01799889|540929433|FG002|Overall Study|Death|5|||
149943957|NCT01799889|540929434|FG003|Overall Study|Death|3|||
149943958|NCT01799889|540929435|FG004|Overall Study|Death|1|||
149943959|NCT01799889|540929436|FG005|Overall Study|Death|0|||
149943960|NCT01799889|540929437|FG006|Overall Study|Death|0|||
149943961|NCT01799889|540929438|FG007|Overall Study|Death|0|||
149943962|NCT01799889|540929439|FG008|Overall Study|Death|1|||
149943963|NCT01799889|540929440|FG009|Overall Study|Death|0|||
149943964|NCT01799889|540929441|FG010|Overall Study|Death|1|||
149943965|NCT01799889|540929442|FG011|Overall Study|Death|0|||
149943966|NCT01799889|540929431|FG000|Overall Study|Lack of Efficacy|1|||
149943967|NCT01799889|540929432|FG001|Overall Study|Lack of Efficacy|1|||
149943968|NCT01799889|540929433|FG002|Overall Study|Lack of Efficacy|0|||
149943969|NCT01799889|540929434|FG003|Overall Study|Lack of Efficacy|1|||
149943970|NCT01799889|540929435|FG004|Overall Study|Lack of Efficacy|2|||
149943971|NCT01799889|540929436|FG005|Overall Study|Lack of Efficacy|2|||
149943972|NCT01799889|540929437|FG006|Overall Study|Lack of Efficacy|0|||
149943973|NCT01799889|540929438|FG007|Overall Study|Lack of Efficacy|0|||
149943974|NCT01799889|540929439|FG008|Overall Study|Lack of Efficacy|2|||
149821430|NCT01271933|540475697|FG000|Double-Blind Phase|Adverse Event|0|||
149821431|NCT01271933|540475698|FG001|Double-Blind Phase|Adverse Event|3|||
149821432|NCT01271933|540475699|FG002|Double-Blind Phase|Adverse Event|0|||
149821433|NCT01271933|540475697|FG000|Double-Blind Phase|Participant request-personal reason|0|||
149943975|NCT01799889|540929440|FG009|Overall Study|Lack of Efficacy|0|||
149943976|NCT01799889|540929441|FG010|Overall Study|Lack of Efficacy|1|||
149943977|NCT01799889|540929442|FG011|Overall Study|Lack of Efficacy|0|||
149943978|NCT01799889|540929431|FG000|Overall Study|Lost to Follow-up|0|||
149943979|NCT01799889|540929432|FG001|Overall Study|Lost to Follow-up|1|||
149943980|NCT01799889|540929433|FG002|Overall Study|Lost to Follow-up|0|||
149943981|NCT01799889|540929434|FG003|Overall Study|Lost to Follow-up|0|||
149943982|NCT01799889|540929435|FG004|Overall Study|Lost to Follow-up|0|||
149943983|NCT01799889|540929436|FG005|Overall Study|Lost to Follow-up|0|||
149943984|NCT01799889|540929437|FG006|Overall Study|Lost to Follow-up|0|||
149943985|NCT01799889|540929438|FG007|Overall Study|Lost to Follow-up|0|||
149943986|NCT01799889|540929439|FG008|Overall Study|Lost to Follow-up|0|||
149943987|NCT01799889|540929440|FG009|Overall Study|Lost to Follow-up|0|||
149943988|NCT01799889|540929441|FG010|Overall Study|Lost to Follow-up|0|||
149943989|NCT01799889|540929442|FG011|Overall Study|Lost to Follow-up|0|||
149943990|NCT01799889|540929431|FG000|Overall Study|Physician Decision|3|||
149943991|NCT01799889|540929432|FG001|Overall Study|Physician Decision|2|||
149943992|NCT01799889|540929433|FG002|Overall Study|Physician Decision|4|||
149943993|NCT01799889|540929434|FG003|Overall Study|Physician Decision|4|||
149943994|NCT01799889|540929435|FG004|Overall Study|Physician Decision|5|||
149943995|NCT01799889|540929436|FG005|Overall Study|Physician Decision|5|||
149943996|NCT01799889|540929437|FG006|Overall Study|Physician Decision|5|||
150032713|NCT02234843|541259350|FG001|Overall Study|Efficacy outcome reached|0|||
150170006|NCT02781584|541757229|FG011|Treatment Phase|Adverse Event|0|||
150170007|NCT02781584|541757230|FG012|Treatment Phase|Adverse Event|0|||
150170008|NCT03396913|541757231|FG000|Overall Study|Lost to Follow-up|0|||
150170009|NCT03396913|541757232|FG001|Overall Study|Lost to Follow-up|6|||
150170010|NCT01093534|541757233|FG000|Overall Study|Adverse Event|2|||
150170011|NCT01093534|541757234|FG001|Overall Study|Adverse Event|5|||
150170012|NCT01093534|541757235|FG002|Overall Study|Adverse Event|2|||
150170013|NCT01093534|541757233|FG000|Overall Study|Lack of Efficacy|2|||
150170014|NCT01093534|541757234|FG001|Overall Study|Lack of Efficacy|1|||
150170015|NCT01093534|541757235|FG002|Overall Study|Lack of Efficacy|1|||
150170016|NCT01093534|541757233|FG000|Overall Study|Withdrawal by Subject|5|||
150170017|NCT01093534|541757234|FG001|Overall Study|Withdrawal by Subject|7|||
150170018|NCT01093534|541757235|FG002|Overall Study|Withdrawal by Subject|2|||
150170019|NCT01093534|541757233|FG000|Overall Study|Other|1|||
150170020|NCT01093534|541757234|FG001|Overall Study|Other|3|||
150170021|NCT01093534|541757235|FG002|Overall Study|Other|4|||
150170022|NCT04436120|541757236|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
150170023|NCT04436120|541757237|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
150170024|NCT04436120|541757238|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
150170025|NCT04436120|541757239|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
150170026|NCT04436120|541757240|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
150170027|NCT04436120|541757241|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
150170028|NCT04436120|541757242|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
150170029|NCT03008915|541757249|FG000|Treatment 1|Withdrawal by Subject|0|||
150170030|NCT03008915|541757250|FG001|Treatment 1|Withdrawal by Subject|1|||
150170031|NCT00712166|541757251|FG000|Overall Study|Noncompliance|0|||
150170032|NCT00712166|541757252|FG001|Overall Study|Noncompliance|1|||
150170033|NCT02289560|541757255|FG000|Overall Study|Lost to Follow-up|6|||
150170034|NCT02289560|541757255|FG000|Overall Study|Alternative Treatment|4|||
150170035|NCT02289560|541757255|FG000|Overall Study|Inadequate Treatment|2|||
150170036|NCT02289560|541757255|FG000|Overall Study|Withdrawal by Subject|23|||
150170037|NCT02540213|541757256|FG000|Overall Study|Death/adverse event|18|||
150170038|NCT02540213|541757256|FG000|Overall Study|Administrative reasons|3|||
150170039|NCT02540213|541757256|FG000|Overall Study|Kidney transplant|3|||
150170040|NCT02540213|541757256|FG000|Overall Study|Lack of Efficacy|6|||
150170041|NCT02540213|541757256|FG000|Overall Study|Consent withdrawn|7|||
150170042|NCT02540213|541757256|FG000|Overall Study|Enrolled but not treated|2|||
150170043|NCT01769391|541757259|FG000|Overall Study|Death|10|||
150170044|NCT01769391|541757260|FG001|Overall Study|Death|1|||
150170045|NCT01769391|541757259|FG000|Overall Study|Adverse Event|0|||
150170046|NCT01769391|541757260|FG001|Overall Study|Adverse Event|3|||
150170047|NCT01769391|541757259|FG000|Overall Study|Progressive Disease|1|||
150170048|NCT01769391|541757260|FG001|Overall Study|Progressive Disease|2|||
150170049|NCT01769391|541757259|FG000|Overall Study|Withdrawal by Subject|4|||
150170050|NCT01769391|541757260|FG001|Overall Study|Withdrawal by Subject|3|||
150170051|NCT01769391|541757259|FG000|Overall Study|Investigator Decision|2|||
150170052|NCT01769391|541757260|FG001|Overall Study|Investigator Decision|0|||
150170053|NCT03386929|541757261|FG000|Overall Study|Death|0|||
150170054|NCT03386929|541757262|FG001|Overall Study|Death|0|||
150170055|NCT03386929|541757263|FG002|Overall Study|Death|1|||
150170056|NCT03386929|541757261|FG000|Overall Study|Withdrawal by Subject|0|||
150170057|NCT03386929|541757262|FG001|Overall Study|Withdrawal by Subject|1|||
150170058|NCT03386929|541757263|FG002|Overall Study|Withdrawal by Subject|0|||
149943997|NCT01799889|540929438|FG007|Overall Study|Physician Decision|2|||
149943998|NCT01799889|540929439|FG008|Overall Study|Physician Decision|6|||
149943999|NCT01799889|540929440|FG009|Overall Study|Physician Decision|0|||
149944000|NCT01799889|540929441|FG010|Overall Study|Physician Decision|0|||
149944001|NCT01799889|540929442|FG011|Overall Study|Physician Decision|1|||
149944002|NCT01799889|540929431|FG000|Overall Study|Progressive Disease|30|||
149944003|NCT01799889|540929432|FG001|Overall Study|Progressive Disease|26|||
149944004|NCT01799889|540929433|FG002|Overall Study|Progressive Disease|25|||
149944005|NCT01799889|540929434|FG003|Overall Study|Progressive Disease|30|||
149944006|NCT01799889|540929435|FG004|Overall Study|Progressive Disease|23|||
149944007|NCT01799889|540929436|FG005|Overall Study|Progressive Disease|9|||
149944008|NCT01799889|540929437|FG006|Overall Study|Progressive Disease|8|||
149944009|NCT01799889|540929438|FG007|Overall Study|Progressive Disease|13|||
149944010|NCT01799889|540929439|FG008|Overall Study|Progressive Disease|18|||
149944011|NCT01799889|540929440|FG009|Overall Study|Progressive Disease|5|||
149944012|NCT01799889|540929441|FG010|Overall Study|Progressive Disease|3|||
149944013|NCT01799889|540929442|FG011|Overall Study|Progressive Disease|1|||
149944014|NCT01799889|540929431|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
149944015|NCT01799889|540929432|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
149944016|NCT01799889|540929433|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
149944017|NCT01799889|540929434|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
149944018|NCT01799889|540929435|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
149944019|NCT01799889|540929436|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
149944020|NCT01799889|540929437|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
149944021|NCT01799889|540929438|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
149944022|NCT01799889|540929439|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
149944023|NCT01799889|540929440|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
149944024|NCT01799889|540929441|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
149944025|NCT01799889|540929442|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
149944026|NCT01799889|540929431|FG000|Overall Study|Study Terminated By Sponsor|1|||
149944027|NCT01799889|540929432|FG001|Overall Study|Study Terminated By Sponsor|0|||
149944028|NCT01799889|540929433|FG002|Overall Study|Study Terminated By Sponsor|0|||
149944029|NCT01799889|540929434|FG003|Overall Study|Study Terminated By Sponsor|0|||
149944030|NCT01799889|540929435|FG004|Overall Study|Study Terminated By Sponsor|2|||
149944031|NCT01799889|540929436|FG005|Overall Study|Study Terminated By Sponsor|1|||
149944032|NCT01799889|540929437|FG006|Overall Study|Study Terminated By Sponsor|0|||
149944033|NCT01799889|540929438|FG007|Overall Study|Study Terminated By Sponsor|2|||
149944034|NCT01799889|540929439|FG008|Overall Study|Study Terminated By Sponsor|1|||
149944035|NCT01799889|540929440|FG009|Overall Study|Study Terminated By Sponsor|1|||
149944036|NCT01799889|540929441|FG010|Overall Study|Study Terminated By Sponsor|0|||
149944037|NCT01799889|540929442|FG011|Overall Study|Study Terminated By Sponsor|0|||
149944038|NCT01799889|540929431|FG000|Overall Study|Withdrawal by Subject|1|||
149944039|NCT01799889|540929432|FG001|Overall Study|Withdrawal by Subject|6|||
149944040|NCT01799889|540929433|FG002|Overall Study|Withdrawal by Subject|4|||
149944041|NCT01799889|540929434|FG003|Overall Study|Withdrawal by Subject|0|||
149944042|NCT01799889|540929435|FG004|Overall Study|Withdrawal by Subject|5|||
149944043|NCT01799889|540929436|FG005|Overall Study|Withdrawal by Subject|1|||
149944044|NCT01799889|540929437|FG006|Overall Study|Withdrawal by Subject|3|||
149944045|NCT01799889|540929438|FG007|Overall Study|Withdrawal by Subject|1|||
149944046|NCT01799889|540929439|FG008|Overall Study|Withdrawal by Subject|2|||
149944047|NCT01799889|540929440|FG009|Overall Study|Withdrawal by Subject|1|||
150170059|NCT03386929|541757261|FG000|Overall Study|Physician Decision|0|||
150170060|NCT03386929|541757262|FG001|Overall Study|Physician Decision|0|||
150170061|NCT03386929|541757263|FG002|Overall Study|Physician Decision|1|||
150170062|NCT03386929|541757261|FG000|Overall Study|Progression|4|||
150170063|NCT03386929|541757262|FG001|Overall Study|Progression|4|||
150170064|NCT03386929|541757263|FG002|Overall Study|Progression|0|||
150170065|NCT03386929|541757261|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
150170066|NCT03386929|541757262|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
150170067|NCT03386929|541757263|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
150170068|NCT03386929|541757261|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
150170069|NCT03386929|541757262|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
150170070|NCT03386929|541757263|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
150170071|NCT00038103|541757265|FG000|Overall Study|Adverse Event|5|||
150170072|NCT00038103|541757266|FG001|Overall Study|Adverse Event|6|||
150170073|NCT00038103|541757265|FG000|Overall Study|Lack of Efficacy|48|||
150170074|NCT00038103|541757266|FG001|Overall Study|Lack of Efficacy|41|||
150170075|NCT00038103|541757265|FG000|Overall Study|Withdrawal by Subject|0|||
150170076|NCT00038103|541757266|FG001|Overall Study|Withdrawal by Subject|3|||
150170077|NCT00038103|541757265|FG000|Overall Study|Lost to Follow-up|0|||
150170078|NCT00038103|541757266|FG001|Overall Study|Lost to Follow-up|3|||
150170079|NCT00038103|541757265|FG000|Overall Study|Protocol Violation|0|||
150170080|NCT00038103|541757266|FG001|Overall Study|Protocol Violation|2|||
150170081|NCT00038103|541757265|FG000|Overall Study|Sponsor Decision|0|||
150170082|NCT00038103|541757266|FG001|Overall Study|Sponsor Decision|1|||
149821434|NCT01271933|540475698|FG001|Double-Blind Phase|Participant request-personal reason|1|||
149821435|NCT01271933|540475699|FG002|Double-Blind Phase|Participant request-personal reason|0|||
149821436|NCT01620983|540475700|FG000|Overall Study|Lost to Follow-up|8|||
149821437|NCT01620983|540475701|FG001|Overall Study|Lost to Follow-up|4|||
149821438|NCT01620983|540475702|FG002|Overall Study|Lost to Follow-up|9|||
149821439|NCT01620983|540475700|FG000|Overall Study|Withdrawal by Subject|6|||
149821440|NCT01620983|540475701|FG001|Overall Study|Withdrawal by Subject|8|||
149821441|NCT01620983|540475702|FG002|Overall Study|Withdrawal by Subject|1|||
149821442|NCT01620983|540475700|FG000|Overall Study|Death|2|||
149821443|NCT01620983|540475701|FG001|Overall Study|Death|0|||
149821444|NCT01620983|540475702|FG002|Overall Study|Death|0|||
149821445|NCT01620983|540475700|FG000|Overall Study|Physician Decision|3|||
149821446|NCT01620983|540475701|FG001|Overall Study|Physician Decision|10|||
149821447|NCT01620983|540475702|FG002|Overall Study|Physician Decision|5|||
149821448|NCT00798889|540475704|FG000|Overall Study|Adverse Event|53|||
149821449|NCT00798889|540475704|FG000|Overall Study|Protocol Violation|2|||
149821450|NCT00798889|540475704|FG000|Overall Study|Withdrawal by Subject|31|||
149821451|NCT00798889|540475704|FG000|Overall Study|Lost to Follow-up|1|||
149821452|NCT00798889|540475704|FG000|Overall Study|Lack of Efficacy|213|||
149821453|NCT00798889|540475704|FG000|Overall Study|Decision of Sponsor|11|||
149821454|NCT00798889|540475704|FG000|Overall Study|Enrolled, Not treated|3|||
149821455|NCT05085964|540475705|FG000|Overall Study|Premature termination of study|21|||
149821456|NCT05085964|540475706|FG001|Overall Study|Premature termination of study|0|||
149821457|NCT00252187|540475712|FG000|Overall Study|Adverse Event|3|||
149821458|NCT00252187|540475713|FG001|Overall Study|Adverse Event|1|||
149821459|NCT00252187|540475712|FG000|Overall Study|Withdrawal by Subject|1|||
149821460|NCT00252187|540475713|FG001|Overall Study|Withdrawal by Subject|0|||
149821461|NCT01102777|540475716|FG000|Overall Study|Death|2|||
149821462|NCT01102777|540475717|FG001|Overall Study|Death|6|||
149821463|NCT01102777|540475716|FG000|Overall Study|Lost to Follow-up|7|||
149821464|NCT01102777|540475717|FG001|Overall Study|Lost to Follow-up|10|||
149821465|NCT01875445|540475718|FG000|Overall Study|Lost to Follow-up|5|||
149821466|NCT01875445|540475719|FG001|Overall Study|Lost to Follow-up|0|||
149821467|NCT01875445|540475718|FG000|Overall Study|Withdrawal by Subject|2|||
149821468|NCT01875445|540475719|FG001|Overall Study|Withdrawal by Subject|0|||
149821469|NCT00593333|540475724|FG000|Overall Study|Lost to Follow-up|10|||
149821470|NCT00593333|540475725|FG001|Overall Study|Lost to Follow-up|11|||
149821471|NCT02175966|540475726|FG000|Follow-up Period|Lack of Efficacy|10|||
149821472|NCT02175966|540475727|FG001|Follow-up Period|Lack of Efficacy|6|||
149821473|NCT01752920|540475728|FG000|Overall Study|Adverse Event|1|||
149821474|NCT01752920|540475729|FG001|Overall Study|Adverse Event|0|||
149821475|NCT01752920|540475730|FG002|Overall Study|Adverse Event|5|||
149821476|NCT01752920|540475731|FG003|Overall Study|Adverse Event|10|||
150274604|NCT00851682|542142966|FG000|Overall Study|screen failure|5|||
150274605|NCT00851682|542142967|FG001|Overall Study|screen failure|0|||
150274606|NCT01379573|542142973|FG000|Overall Study|Lost to Follow-up|1|||
150274607|NCT01379573|542142973|FG000|Overall Study|Screen Failure|10|||
150274608|NCT02871778|542142974|FG000|Part A: Treatment Period 1|Adverse Event|1|||
150274609|NCT02871778|542142975|FG001|Part A: Treatment Period 1|Adverse Event|1|||
150274610|NCT02871778|542142976|FG002|Part A: Treatment Period 1|Adverse Event|1|||
150274611|NCT02871778|542142977|FG003|Part A: Treatment Period 1|Adverse Event|0|||
150274612|NCT02871778|542142978|FG004|Part A: Treatment Period 1|Adverse Event|0|||
150274613|NCT02871778|542142979|FG005|Part A: Treatment Period 1|Adverse Event|0|||
150274614|NCT02871778|542142980|FG006|Part A: Treatment Period 1|Adverse Event|0|||
150274615|NCT02871778|542142981|FG007|Part A: Treatment Period 1|Adverse Event|0|||
150274616|NCT02871778|542142974|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
150274617|NCT02871778|542142975|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
150274618|NCT02871778|542142976|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149821477|NCT01752920|540475728|FG000|Overall Study|Clinical Disease Progression|6|||
149821478|NCT01752920|540475729|FG001|Overall Study|Clinical Disease Progression|4|||
149821479|NCT01752920|540475730|FG002|Overall Study|Clinical Disease Progression|1|||
149944048|NCT01799889|540929441|FG010|Overall Study|Withdrawal by Subject|1|||
149944049|NCT01799889|540929442|FG011|Overall Study|Withdrawal by Subject|1|||
150274619|NCT02871778|542142977|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
150274620|NCT02871778|542142978|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149821480|NCT01752920|540475731|FG003|Overall Study|Clinical Disease Progression|13|||
149821481|NCT01752920|540475728|FG000|Overall Study|Physician Decision|1|||
149821482|NCT01752920|540475729|FG001|Overall Study|Physician Decision|0|||
149821483|NCT01752920|540475730|FG002|Overall Study|Physician Decision|0|||
149821484|NCT01752920|540475731|FG003|Overall Study|Physician Decision|3|||
149821485|NCT01752920|540475728|FG000|Overall Study|Radiographic Disease Progression|20|||
149821486|NCT01752920|540475729|FG001|Overall Study|Radiographic Disease Progression|7|||
149821487|NCT01752920|540475730|FG002|Overall Study|Radiographic Disease Progression|12|||
149821488|NCT01752920|540475731|FG003|Overall Study|Radiographic Disease Progression|29|||
149821489|NCT01752920|540475728|FG000|Overall Study|Study Terminated by Sponsor|0|||
149821490|NCT01752920|540475729|FG001|Overall Study|Study Terminated by Sponsor|0|||
149821491|NCT01752920|540475730|FG002|Overall Study|Study Terminated by Sponsor|0|||
149821492|NCT01752920|540475731|FG003|Overall Study|Study Terminated by Sponsor|1|||
149821493|NCT01752920|540475728|FG000|Overall Study|Withdrawal by Subject|0|||
149821494|NCT01752920|540475729|FG001|Overall Study|Withdrawal by Subject|1|||
149821495|NCT01752920|540475730|FG002|Overall Study|Withdrawal by Subject|0|||
149821496|NCT01752920|540475731|FG003|Overall Study|Withdrawal by Subject|1|||
149821497|NCT01752920|540475728|FG000|Overall Study|Lack of clinical benefit|1|||
149821498|NCT01752920|540475729|FG001|Overall Study|Lack of clinical benefit|1|||
149821499|NCT01752920|540475730|FG002|Overall Study|Lack of clinical benefit|1|||
149821500|NCT01752920|540475731|FG003|Overall Study|Lack of clinical benefit|1|||
149821501|NCT01738581|540475732|FG000|Overall Study|Lost to Follow-up|1|||
149821502|NCT01738581|540475733|FG001|Overall Study|Lost to Follow-up|0|||
149821503|NCT00210626|540475740|FG000|Overall Study|Adverse Event|1|||
149821504|NCT00210626|540475741|FG001|Overall Study|Adverse Event|2|||
149821505|NCT00210626|540475740|FG000|Overall Study|Protocol Violation|1|||
149821506|NCT00210626|540475741|FG001|Overall Study|Protocol Violation|5|||
149821507|NCT00210626|540475740|FG000|Overall Study|Lost to Follow-up|11|||
149821508|NCT00210626|540475741|FG001|Overall Study|Lost to Follow-up|11|||
149821509|NCT00210626|540475740|FG000|Overall Study|Death|1|||
149821510|NCT00210626|540475741|FG001|Overall Study|Death|0|||
149821511|NCT00210626|540475740|FG000|Overall Study|Withdrawal by Subject|29|||
149821512|NCT00210626|540475741|FG001|Overall Study|Withdrawal by Subject|20|||
149821513|NCT00210626|540475740|FG000|Overall Study|Physician Decision|0|||
149821514|NCT00210626|540475741|FG001|Overall Study|Physician Decision|2|||
149821515|NCT00210626|540475740|FG000|Overall Study|Sponser Request|1|||
149821516|NCT00210626|540475741|FG001|Overall Study|Sponser Request|0|||
149821517|NCT00210626|540475740|FG000|Overall Study|Other|4|||
149821518|NCT00210626|540475741|FG001|Overall Study|Other|5|||
149821519|NCT00771901|540475742|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
149821520|NCT00771901|540475743|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
149821521|NCT00771901|540475744|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
149821522|NCT02862535|540475745|FG000|Overall Study|Death|7|||
149821523|NCT02862535|540475746|FG001|Overall Study|Death|3|||
149821524|NCT02862535|540475747|FG002|Overall Study|Death|2|||
149821525|NCT02862535|540475748|FG003|Overall Study|Death|5|||
149821526|NCT02862535|540475745|FG000|Overall Study|Study Terminated by Sponsor|1|||
150274621|NCT02871778|542142979|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
150274622|NCT02871778|542142980|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
150274623|NCT02871778|542142981|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
150274624|NCT02871778|542142974|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274625|NCT02871778|542142975|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274626|NCT02871778|542142976|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
150274627|NCT02871778|542142977|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274628|NCT02871778|542142978|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274629|NCT02871778|542142979|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274630|NCT02871778|542142980|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274631|NCT02871778|542142981|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
150274632|NCT02871778|542142974|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274633|NCT02871778|542142975|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274634|NCT02871778|542142976|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
150274635|NCT02871778|542142977|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274636|NCT02871778|542142978|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274637|NCT02871778|542142979|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274638|NCT02871778|542142980|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274639|NCT02871778|542142981|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
150274640|NCT02871778|542142974|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274641|NCT02871778|542142975|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
150274642|NCT02871778|542142976|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274643|NCT02871778|542142977|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274644|NCT02871778|542142978|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274645|NCT02871778|542142979|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274646|NCT02871778|542142980|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
150274647|NCT02871778|542142981|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
149821527|NCT02862535|540475746|FG001|Overall Study|Study Terminated by Sponsor|3|||
149821528|NCT02862535|540475747|FG002|Overall Study|Study Terminated by Sponsor|8|||
149821529|NCT02862535|540475748|FG003|Overall Study|Study Terminated by Sponsor|5|||
149821530|NCT02862535|540475745|FG000|Overall Study|Enrolled, not Treated|1|||
150274648|NCT02871778|542142974|FG000|Part A: Treatment Period 2|Adverse Event|2|||
149944050|NCT01799889|540929431|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149944051|NCT01799889|540929432|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149944052|NCT01799889|540929433|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149944053|NCT01799889|540929434|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150274649|NCT02871778|542142975|FG001|Part A: Treatment Period 2|Adverse Event|2|||
150274650|NCT02871778|542142976|FG002|Part A: Treatment Period 2|Adverse Event|0|||
150274651|NCT02871778|542142977|FG003|Part A: Treatment Period 2|Adverse Event|0|||
150274652|NCT02871778|542142978|FG004|Part A: Treatment Period 2|Adverse Event|0|||
150274653|NCT02871778|542142979|FG005|Part A: Treatment Period 2|Adverse Event|0|||
150274654|NCT02871778|542142980|FG006|Part A: Treatment Period 2|Adverse Event|0|||
150274655|NCT02871778|542142981|FG007|Part A: Treatment Period 2|Adverse Event|0|||
150274656|NCT02871778|542142974|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274657|NCT02871778|542142975|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274658|NCT02871778|542142976|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274659|NCT02871778|542142977|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
150274660|NCT02871778|542142978|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274661|NCT02871778|542142979|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274662|NCT02871778|542142980|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274663|NCT02871778|542142981|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
150274664|NCT02871778|542142974|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
150274665|NCT02871778|542142975|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274666|NCT02871778|542142976|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
150274667|NCT02871778|542142977|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274668|NCT02871778|542142978|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274669|NCT02871778|542142979|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274670|NCT02871778|542142980|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274671|NCT02871778|542142981|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
150274672|NCT02871778|542142974|FG000|Part B: Treatment Period 3|Adverse Event|0|||
150274673|NCT02871778|542142975|FG001|Part B: Treatment Period 3|Adverse Event|0|||
150274674|NCT02871778|542142976|FG002|Part B: Treatment Period 3|Adverse Event|0|||
150274675|NCT02871778|542142977|FG003|Part B: Treatment Period 3|Adverse Event|0|||
150274676|NCT02871778|542142978|FG004|Part B: Treatment Period 3|Adverse Event|1|||
150274677|NCT02871778|542142979|FG005|Part B: Treatment Period 3|Adverse Event|1|||
150274678|NCT02871778|542142980|FG006|Part B: Treatment Period 3|Adverse Event|1|||
150274679|NCT02871778|542142981|FG007|Part B: Treatment Period 3|Adverse Event|0|||
150274680|NCT02653300|542142983|FG000|Overall Study|Withdrawal by Subject|2|||
150274681|NCT02289352|542142992|FG000|Overall Study|Withdrawal by Subject|1|||
150274682|NCT02289352|542142993|FG001|Overall Study|Withdrawal by Subject|1|||
150274683|NCT02289352|542142994|FG002|Overall Study|Withdrawal by Subject|0|||
150274684|NCT01390272|542142995|FG000|Overall Study|Death|3|||
150274685|NCT01390272|542142996|FG001|Overall Study|Death|2|||
150274686|NCT01390272|542142995|FG000|Overall Study|Withdrawal by Subject|9|||
150274687|NCT01390272|542142996|FG001|Overall Study|Withdrawal by Subject|5|||
150274688|NCT01390272|542142995|FG000|Overall Study|Patient moved, no longer eligible|5|||
150274689|NCT01390272|542142996|FG001|Overall Study|Patient moved, no longer eligible|8|||
149944054|NCT01799889|540929435|FG004|Overall Study|Non-Compliance With Study Drug|0|||
150274690|NCT01177384|542142997|FG000|Overall Study|Adverse Event|6|||
150274691|NCT01177384|542142998|FG001|Overall Study|Adverse Event|4|||
150274692|NCT01177384|542142997|FG000|Overall Study|Lack of Efficacy|0|||
150274693|NCT01177384|542142998|FG001|Overall Study|Lack of Efficacy|1|||
150274694|NCT01177384|542142997|FG000|Overall Study|Lost to Follow-up|3|||
150274695|NCT01177384|542142998|FG001|Overall Study|Lost to Follow-up|4|||
150274696|NCT01177384|542142997|FG000|Overall Study|Physician Decision|0|||
150274697|NCT01177384|542142998|FG001|Overall Study|Physician Decision|3|||
150274698|NCT01177384|542142997|FG000|Overall Study|Protocol Violation|0|||
150274699|NCT01177384|542142998|FG001|Overall Study|Protocol Violation|2|||
150274700|NCT01177384|542142997|FG000|Overall Study|Withdrawal by Subject|5|||
150274701|NCT01177384|542142998|FG001|Overall Study|Withdrawal by Subject|12|||
150274702|NCT01849497|542142999|FG000|Overall Study|Withdrawal by Subject|1|||
149821531|NCT02862535|540475746|FG001|Overall Study|Enrolled, not Treated|0|||
149821532|NCT02862535|540475747|FG002|Overall Study|Enrolled, not Treated|0|||
149821533|NCT02862535|540475748|FG003|Overall Study|Enrolled, not Treated|1|||
149821534|NCT02280356|540475749|FG000|Overall Study|Not Treated|2|||
149821535|NCT02280356|540475749|FG000|Overall Study|Withdrawal by Subject|1|||
149821536|NCT02280356|540475749|FG000|Overall Study|Not evaluable|2|||
149821537|NCT01086215|540475750|FG000|Overall Study|Death|14|||
149821538|NCT01086215|540475751|FG001|Overall Study|Death|8|||
149821539|NCT01086215|540475752|FG002|Overall Study|Death|8|||
149821540|NCT01086215|540475753|FG003|Overall Study|Death|1|||
149821541|NCT01086215|540475750|FG000|Overall Study|Lost to Follow-up|22|||
149821542|NCT01086215|540475751|FG001|Overall Study|Lost to Follow-up|39|||
149821543|NCT01086215|540475752|FG002|Overall Study|Lost to Follow-up|18|||
149821544|NCT01086215|540475753|FG003|Overall Study|Lost to Follow-up|2|||
149821545|NCT01965652|540475754|FG000|Overall Study|Adverse Event|40|||
149821546|NCT01965652|540475755|FG001|Overall Study|Adverse Event|37|||
149821547|NCT01965652|540475754|FG000|Overall Study|Withdrawal by Subject|62|||
149821548|NCT01965652|540475755|FG001|Overall Study|Withdrawal by Subject|69|||
149821549|NCT01965652|540475754|FG000|Overall Study|Lost to Follow-up|53|||
149821550|NCT01965652|540475755|FG001|Overall Study|Lost to Follow-up|40|||
149821551|NCT01965652|540475754|FG000|Overall Study|Protocol Violation|34|||
149821552|NCT01965652|540475755|FG001|Overall Study|Protocol Violation|38|||
149821553|NCT01965652|540475754|FG000|Overall Study|Death|3|||
149821554|NCT01965652|540475755|FG001|Overall Study|Death|4|||
149821555|NCT01965652|540475754|FG000|Overall Study|Other - Miscellaneous|18|||
149821556|NCT01965652|540475755|FG001|Overall Study|Other - Miscellaneous|21|||
149821557|NCT01965652|540475754|FG000|Overall Study|Pregnancy|0|||
149821558|NCT01965652|540475755|FG001|Overall Study|Pregnancy|1|||
149821559|NCT01121900|540475758|FG000|First Intervention Period|Adverse Event|1|||
149821560|NCT01121900|540475759|FG001|First Intervention Period|Adverse Event|1|||
149821561|NCT01121900|540475758|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149821562|NCT01121900|540475759|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149821563|NCT03469271|540475760|FG000|Overall Study|Withdrawal by Subject|2|||
149821564|NCT03469271|540475761|FG001|Overall Study|Withdrawal by Subject|0|||
149821565|NCT03469271|540475762|FG002|Overall Study|Withdrawal by Subject|0|||
149821566|NCT03469271|540475763|FG003|Overall Study|Withdrawal by Subject|1|||
149821567|NCT01328054|540475764|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
149821568|NCT01328054|540475765|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
149821569|NCT01328054|540475764|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
149821570|NCT01328054|540475765|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
149821571|NCT01328054|540475764|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
149821572|NCT01328054|540475765|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
149821573|NCT04147715|540475766|FG000|Overall Study|Adverse Event|0|||
149821574|NCT04147715|540475767|FG001|Overall Study|Adverse Event|0|||
149821575|NCT04147715|540475768|FG002|Overall Study|Adverse Event|0|||
149821576|NCT04147715|540475769|FG003|Overall Study|Adverse Event|0|||
149821577|NCT04147715|540475770|FG004|Overall Study|Adverse Event|0|||
149821578|NCT04147715|540475771|FG005|Overall Study|Adverse Event|0|||
149821579|NCT04147715|540475772|FG006|Overall Study|Adverse Event|0|||
149821580|NCT04147715|540475773|FG007|Overall Study|Adverse Event|2|||
149821581|NCT04147715|540475774|FG008|Overall Study|Adverse Event|1|||
149821582|NCT04147715|540475775|FG009|Overall Study|Adverse Event|0|||
149821583|NCT04147715|540475776|FG010|Overall Study|Adverse Event|0|||
149821584|NCT04147715|540475777|FG011|Overall Study|Adverse Event|0|||
149821585|NCT00616928|540475778|FG000|Overall Study|Adverse Event|6|||
149821586|NCT00616928|540475779|FG001|Overall Study|Adverse Event|3|||
149821587|NCT00616928|540475780|FG002|Overall Study|Adverse Event|2|||
149821588|NCT00616928|540475781|FG003|Overall Study|Adverse Event|2|||
149821589|NCT00616928|540475778|FG000|Overall Study|Other|51|||
149821590|NCT00616928|540475779|FG001|Overall Study|Other|8|||
149821591|NCT00616928|540475780|FG002|Overall Study|Other|15|||
149821592|NCT00616928|540475781|FG003|Overall Study|Other|5|||
149821593|NCT00616928|540475778|FG000|Overall Study|Lost to Follow-up|5|||
149821594|NCT00616928|540475779|FG001|Overall Study|Lost to Follow-up|7|||
149821595|NCT00616928|540475780|FG002|Overall Study|Lost to Follow-up|0|||
149821596|NCT00616928|540475781|FG003|Overall Study|Lost to Follow-up|0|||
149821597|NCT02173301|540475782|FG000|Overall Study|Adverse Event|7|||
149821598|NCT02173301|540475783|FG001|Overall Study|Adverse Event|8|||
150274703|NCT01849497|542143000|FG001|Overall Study|Withdrawal by Subject|2|||
150274704|NCT01849497|542142999|FG000|Overall Study|Sponsor Decision|0|||
149821599|NCT02173301|540475784|FG002|Overall Study|Adverse Event|13|||
149821600|NCT02173301|540475785|FG003|Overall Study|Adverse Event|5|||
149821601|NCT02173301|540475782|FG000|Overall Study|Withdrawal by Subject|8|||
149821602|NCT02173301|540475783|FG001|Overall Study|Withdrawal by Subject|10|||
149944055|NCT01799889|540929436|FG005|Overall Study|Non-Compliance With Study Drug|1|||
149944056|NCT01799889|540929437|FG006|Overall Study|Non-Compliance With Study Drug|0|||
149944057|NCT01799889|540929438|FG007|Overall Study|Non-Compliance With Study Drug|0|||
149944058|NCT01799889|540929439|FG008|Overall Study|Non-Compliance With Study Drug|0|||
149944059|NCT01799889|540929440|FG009|Overall Study|Non-Compliance With Study Drug|0|||
149944060|NCT01799889|540929441|FG010|Overall Study|Non-Compliance With Study Drug|0|||
149944061|NCT01799889|540929442|FG011|Overall Study|Non-Compliance With Study Drug|0|||
150170083|NCT00038103|541757265|FG000|Overall Study|Randomized/never treated|2|||
150170084|NCT00038103|541757266|FG001|Overall Study|Randomized/never treated|0|||
150170085|NCT01144182|541757267|FG000|Overall Study|Death|5|||
149821603|NCT02173301|540475784|FG002|Overall Study|Withdrawal by Subject|4|||
150170086|NCT01144182|541757268|FG001|Overall Study|Death|6|||
150170087|NCT01144182|541757267|FG000|Overall Study|Withdrawal by Subject|3|||
150170088|NCT01144182|541757268|FG001|Overall Study|Withdrawal by Subject|6|||
150170089|NCT01144182|541757267|FG000|Overall Study|Lost to Follow-up|9|||
150170090|NCT01144182|541757268|FG001|Overall Study|Lost to Follow-up|9|||
150170091|NCT02317016|541757269|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
150170092|NCT02317016|541757269|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
150170093|NCT02317016|541757269|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
150170094|NCT02317016|541757269|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
150170095|NCT02317016|541757269|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
150170096|NCT02317016|541757269|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
150170097|NCT02317016|541757269|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
150170098|NCT02013037|541757271|FG000|Overall Study|Death|6|||
150170099|NCT02013037|541757271|FG000|Overall Study|Withdrawal by Subject|1|||
150170100|NCT02013037|541757271|FG000|Overall Study|Awaiting Transplantation|7|||
150170101|NCT02013037|541757271|FG000|Overall Study|Transplanted without DSA|2|||
150170102|NCT02465359|541757272|FG000|Overall Study|Lack of Efficacy|1|||
150170103|NCT02465359|541757272|FG000|Overall Study|Withdrawal by Subject|1|||
150170104|NCT02465359|541757272|FG000|Overall Study|Adverse Event|1|||
150170105|NCT02952261|541757273|FG000|Overall Study|Withdrawal by Subject|4|||
150170106|NCT02952261|541757274|FG001|Overall Study|Withdrawal by Subject|5|||
150170107|NCT02952261|541757273|FG000|Overall Study|Protocol Violation|1|||
150170108|NCT02952261|541757274|FG001|Overall Study|Protocol Violation|0|||
150170109|NCT05052983|541757275|FG000|Overall Study|Lack of Efficacy|3|||
150170110|NCT05052983|541757276|FG001|Overall Study|Lack of Efficacy|12|||
150170111|NCT05052983|541757275|FG000|Overall Study|Adverse Event|1|||
150170112|NCT05052983|541757276|FG001|Overall Study|Adverse Event|0|||
150170113|NCT02812966|541757279|FG000|Overall Study|Death|1|||
150170114|NCT02812966|541757280|FG001|Overall Study|Death|0|||
150170115|NCT01066923|541757281|FG000|Overall Study|Withdrawal by Subject|3|||
150170116|NCT01066923|541757282|FG001|Overall Study|Withdrawal by Subject|3|||
150170117|NCT01066923|541757283|FG002|Overall Study|Withdrawal by Subject|8|||
150170118|NCT01066923|541757284|FG003|Overall Study|Withdrawal by Subject|8|||
150170119|NCT00954707|541758974|FG000|Overall Study|Death|34|||
150170120|NCT00954707|541758974|FG000|Overall Study|Withdrawal by Subject|100|||
150170121|NCT00954707|541758974|FG000|Overall Study|Lost to Follow-up|33|||
150170122|NCT01070888|541758975|FG000|First Intervention (14 Days)|Adverse Event|0|||
150170123|NCT01070888|541758976|FG001|First Intervention (14 Days)|Adverse Event|1|||
150170124|NCT01070888|541758975|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
150170125|NCT01070888|541758976|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
150170126|NCT01070888|541758975|FG000|Washout (14 Days)|Physician Decision|1|||
150170127|NCT01070888|541758976|FG001|Washout (14 Days)|Physician Decision|0|||
150170128|NCT02631148|541758979|FG000|Overall Study|8 were ineligible|8|||
150170129|NCT02631148|541758980|FG001|Overall Study|8 were ineligible|0|||
150170130|NCT02631148|541758979|FG000|Overall Study|Withdrawal by Subject|1|||
150170131|NCT02631148|541758980|FG001|Overall Study|Withdrawal by Subject|0|||
150170132|NCT02631148|541758979|FG000|Overall Study|PAH not available to study participant|1|||
150170133|NCT02631148|541758980|FG001|Overall Study|PAH not available to study participant|0|||
150170134|NCT00357396|541758981|FG000|Overall Study|Adverse Event|1|||
150170135|NCT00357396|541758982|FG001|Overall Study|Adverse Event|0|||
150170136|NCT00487578|541758984|FG000|Overall Study|Adverse Event|1|||
150170137|NCT00487578|541758985|FG001|Overall Study|Adverse Event|2|||
150170138|NCT00487578|541758984|FG000|Overall Study|Lack of Efficacy|0|||
150170139|NCT00487578|541758985|FG001|Overall Study|Lack of Efficacy|1|||
150170140|NCT00487578|541758984|FG000|Overall Study|Lost to Follow-up|0|||
150170141|NCT00487578|541758985|FG001|Overall Study|Lost to Follow-up|1|||
150170142|NCT02525796|541758990|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
150170143|NCT02525796|541758991|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
150170144|NCT02525796|541758992|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
149821604|NCT02173301|540475785|FG003|Overall Study|Withdrawal by Subject|8|||
149821605|NCT02173301|540475782|FG000|Overall Study|Lost to Follow-up|4|||
149821606|NCT02173301|540475783|FG001|Overall Study|Lost to Follow-up|4|||
149821607|NCT02173301|540475784|FG002|Overall Study|Lost to Follow-up|2|||
149821608|NCT02173301|540475785|FG003|Overall Study|Lost to Follow-up|2|||
149821609|NCT02173301|540475782|FG000|Overall Study|Protocol Violation|0|||
149821610|NCT02173301|540475783|FG001|Overall Study|Protocol Violation|1|||
149821611|NCT02173301|540475784|FG002|Overall Study|Protocol Violation|0|||
149821612|NCT02173301|540475785|FG003|Overall Study|Protocol Violation|0|||
149821613|NCT02173301|540475782|FG000|Overall Study|Physician Decision|0|||
149821614|NCT02173301|540475783|FG001|Overall Study|Physician Decision|0|||
149821615|NCT02173301|540475784|FG002|Overall Study|Physician Decision|1|||
149821616|NCT02173301|540475785|FG003|Overall Study|Physician Decision|0|||
149821617|NCT02173301|540475782|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
149821618|NCT02173301|540475783|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
149821619|NCT02173301|540475784|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
150274705|NCT01849497|542143000|FG001|Overall Study|Sponsor Decision|1|||
150274706|NCT01849497|542142999|FG000|Overall Study|Lost to Follow-up|0|||
150274707|NCT01849497|542143000|FG001|Overall Study|Lost to Follow-up|1|||
150274708|NCT01641237|542144470|FG000|Period II|Withdrawal by Subject|1|||
150274709|NCT01641237|542144471|FG001|Period II|Withdrawal by Subject|0|||
150274710|NCT01641237|542144472|FG002|Period II|Withdrawal by Subject|0|||
150274711|NCT01641237|542144473|FG003|Period II|Withdrawal by Subject|0|||
150274712|NCT01641237|542144470|FG000|Period III|Lost to Follow-up|1|||
150274713|NCT01641237|542144471|FG001|Period III|Lost to Follow-up|0|||
150274714|NCT01641237|542144472|FG002|Period III|Lost to Follow-up|0|||
150274715|NCT01641237|542144473|FG003|Period III|Lost to Follow-up|0|||
150274716|NCT01301456|542144474|FG000|Stage 1|Withdrawal by Subject|0|||
150274717|NCT01301456|542144475|FG001|Stage 1|Withdrawal by Subject|0|||
150274718|NCT01301456|542144476|FG002|Stage 1|Withdrawal by Subject|1|||
150274719|NCT01301456|542144477|FG003|Stage 1|Withdrawal by Subject|0|||
150274720|NCT01301456|542144478|FG004|Stage 1|Withdrawal by Subject|1|||
150274721|NCT01301456|542144479|FG005|Stage 1|Withdrawal by Subject|0|||
150274722|NCT01301456|542144480|FG006|Stage 1|Withdrawal by Subject|0|||
150274723|NCT01301456|542144481|FG007|Stage 1|Withdrawal by Subject|0|||
150274724|NCT01301456|542144482|FG008|Stage 1|Withdrawal by Subject|0|||
150274725|NCT01301456|542144483|FG009|Stage 1|Withdrawal by Subject|0|||
150274726|NCT01301456|542144484|FG010|Stage 1|Withdrawal by Subject|0|||
149821620|NCT02173301|540475785|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
149821621|NCT03740100|540475786|FG000|Overall Study|Adverse Event|1|||
149821622|NCT03740100|540475786|FG000|Overall Study|Death|1|||
149821623|NCT03120520|540475787|FG000|Overall Study|Lost to Follow-up|1|||
149821624|NCT03120520|540475788|FG001|Overall Study|Lost to Follow-up|1|||
149821625|NCT03120520|540475789|FG002|Overall Study|Lost to Follow-up|1|||
149821626|NCT03120520|540475790|FG003|Overall Study|Lost to Follow-up|1|||
149821627|NCT03120520|540475787|FG000|Overall Study|Withdrawal by Subject|3|||
149821628|NCT03120520|540475788|FG001|Overall Study|Withdrawal by Subject|2|||
149821629|NCT03120520|540475789|FG002|Overall Study|Withdrawal by Subject|3|||
149821630|NCT03120520|540475790|FG003|Overall Study|Withdrawal by Subject|2|||
149821631|NCT03120520|540475787|FG000|Overall Study|Other|0|||
149821632|NCT03120520|540475788|FG001|Overall Study|Other|1|||
149821633|NCT03120520|540475789|FG002|Overall Study|Other|0|||
149821634|NCT03120520|540475790|FG003|Overall Study|Other|0|||
149821635|NCT02123459|540475794|FG000|Washout Period (1 Day)|Adverse Event|1|||
149821636|NCT02123459|540475795|FG001|Washout Period (1 Day)|Adverse Event|0|||
149821637|NCT01715415|540475801|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
149821638|NCT01715415|540475802|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
149821639|NCT01715415|540475801|FG000|Double-blind Treatment|Adverse Event|3|||
149821640|NCT01715415|540475802|FG001|Double-blind Treatment|Adverse Event|0|||
150274727|NCT01301456|542144485|FG011|Stage 1|Withdrawal by Subject|0|||
150274728|NCT01301456|542144474|FG000|Stage 1|Randomized but not treated|0|||
149821641|NCT01715415|540475801|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
149821642|NCT01715415|540475802|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
149821643|NCT01715415|540475801|FG000|Double-blind Treatment|Other|1|||
149821644|NCT01715415|540475802|FG001|Double-blind Treatment|Other|0|||
149821645|NCT01715415|540475801|FG000|Open-label Treatment|Adverse Event|0|||
150274729|NCT01301456|542144475|FG001|Stage 1|Randomized but not treated|0|||
150274730|NCT01301456|542144476|FG002|Stage 1|Randomized but not treated|0|||
149821646|NCT01715415|540475802|FG001|Open-label Treatment|Adverse Event|1|||
150274731|NCT01301456|542144477|FG003|Stage 1|Randomized but not treated|0|||
150274732|NCT01301456|542144478|FG004|Stage 1|Randomized but not treated|0|||
150274733|NCT01301456|542144479|FG005|Stage 1|Randomized but not treated|0|||
150274734|NCT01301456|542144480|FG006|Stage 1|Randomized but not treated|1|||
150274735|NCT01301456|542144481|FG007|Stage 1|Randomized but not treated|0|||
150274736|NCT01301456|542144482|FG008|Stage 1|Randomized but not treated|0|||
150274737|NCT01301456|542144483|FG009|Stage 1|Randomized but not treated|0|||
150274738|NCT01301456|542144484|FG010|Stage 1|Randomized but not treated|0|||
150274739|NCT01301456|542144485|FG011|Stage 1|Randomized but not treated|0|||
150274740|NCT01301456|542144474|FG000|Stage 2|Adverse Event|0|||
150274741|NCT01301456|542144475|FG001|Stage 2|Adverse Event|0|||
150274742|NCT01301456|542144476|FG002|Stage 2|Adverse Event|0|||
150274743|NCT01301456|542144477|FG003|Stage 2|Adverse Event|0|||
150274744|NCT01301456|542144478|FG004|Stage 2|Adverse Event|0|||
150274745|NCT01301456|542144479|FG005|Stage 2|Adverse Event|0|||
150274746|NCT01301456|542144480|FG006|Stage 2|Adverse Event|0|||
150274747|NCT01301456|542144481|FG007|Stage 2|Adverse Event|0|||
150274748|NCT01301456|542144482|FG008|Stage 2|Adverse Event|0|||
150274749|NCT01301456|542144483|FG009|Stage 2|Adverse Event|0|||
150274750|NCT01301456|542144484|FG010|Stage 2|Adverse Event|1|||
150274751|NCT01301456|542144485|FG011|Stage 2|Adverse Event|0|||
150274752|NCT01383096|542144486|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
150274753|NCT01383096|542144487|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
150274754|NCT01383096|542144488|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
150274755|NCT01383096|542144486|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
150274756|NCT01383096|542144487|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
150274757|NCT01383096|542144488|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
150274758|NCT01383096|542144486|FG000|Third Intervention (8 Days)|Elevated AST|0|||
150274759|NCT01383096|542144487|FG001|Third Intervention (8 Days)|Elevated AST|1|||
150274760|NCT01383096|542144488|FG002|Third Intervention (8 Days)|Elevated AST|0|||
150274761|NCT01383096|542144486|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
150274762|NCT01383096|542144487|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
150274763|NCT01383096|542144488|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
150274764|NCT01383096|542144486|FG000|Third Intervention (8 Days)|Adverse Event|1|||
149821647|NCT01715415|540475801|FG000|Open-label Treatment|Subject Noncompliant|0|||
149944062|NCT04476043|540929445|FG000|Overall Study|Withdrawal by Subject|1|||
149944063|NCT04476043|540929446|FG001|Overall Study|Withdrawal by Subject|3|||
149944064|NCT04476043|540929447|FG002|Overall Study|Withdrawal by Subject|4|||
150170145|NCT02525796|541758990|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
150170146|NCT02525796|541758991|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
150170147|NCT02525796|541758992|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
150170148|NCT02525796|541758990|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
150170149|NCT02525796|541758991|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
150170150|NCT02525796|541758992|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
150170151|NCT02525796|541758990|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
150170152|NCT02525796|541758991|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
150170153|NCT02525796|541758992|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
150170154|NCT02525796|541758990|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
150170155|NCT02525796|541758991|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
150170156|NCT02525796|541758992|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
150170157|NCT00726999|541758993|FG000|Overall Study|Physician Decision|0|||
150170158|NCT00726999|541758994|FG001|Overall Study|Physician Decision|1|||
150170159|NCT00726999|541758993|FG000|Overall Study|Withdrawal by Subject|2|||
150170160|NCT00726999|541758994|FG001|Overall Study|Withdrawal by Subject|0|||
150170161|NCT00726999|541758993|FG000|Overall Study|Protocol Violation|1|||
150170162|NCT00726999|541758994|FG001|Overall Study|Protocol Violation|0|||
150170163|NCT00955825|541758995|FG000|Overall Study|Adverse Event|15|||
150170164|NCT00955825|541758996|FG001|Overall Study|Adverse Event|2|||
150170165|NCT00955825|541758995|FG000|Overall Study|Withdrawal by Subject|4|||
150170166|NCT00955825|541758996|FG001|Overall Study|Withdrawal by Subject|6|||
150170167|NCT00955825|541758995|FG000|Overall Study|Any other reason not above-mentioned|7|||
150170168|NCT00955825|541758996|FG001|Overall Study|Any other reason not above-mentioned|9|||
150170169|NCT02488980|541758997|FG000|Overall Study|Protocol Violation|2|||
150170170|NCT02488980|541758998|FG001|Overall Study|Protocol Violation|2|||
150170171|NCT02488980|541758999|FG002|Overall Study|Protocol Violation|2|||
150170172|NCT02385669|541759001|FG000|Overall Study|Adverse Event|2|||
150170173|NCT02810080|541759002|FG000|Overall Study|Adverse Event|3|||
150170174|NCT02810080|541759003|FG001|Overall Study|Adverse Event|0|||
150170175|NCT02810080|541759002|FG000|Overall Study|Death|0|||
150170176|NCT02810080|541759003|FG001|Overall Study|Death|2|||
150170177|NCT02810080|541759002|FG000|Overall Study|Physician Decision|4|||
150170178|NCT02810080|541759003|FG001|Overall Study|Physician Decision|0|||
150170179|NCT02810080|541759002|FG000|Overall Study|Withdrawal by Subject|0|||
150170180|NCT02810080|541759003|FG001|Overall Study|Withdrawal by Subject|2|||
150274765|NCT01383096|542144487|FG001|Third Intervention (8 Days)|Adverse Event|0|||
150032714|NCT02234843|541259351|FG002|Overall Study|Efficacy outcome reached|0|||
150032715|NCT02234843|541259352|FG003|Overall Study|Efficacy outcome reached|0|||
150032716|NCT02234843|541259353|FG004|Overall Study|Efficacy outcome reached|0|||
150032717|NCT02234843|541259354|FG005|Overall Study|Efficacy outcome reached|2|||
150032718|NCT02234843|541259355|FG006|Overall Study|Efficacy outcome reached|0|||
149821648|NCT01715415|540475802|FG001|Open-label Treatment|Subject Noncompliant|1|||
150032719|NCT02234843|541259356|FG007|Overall Study|Efficacy outcome reached|0|||
150032720|NCT02234843|541259357|FG008|Overall Study|Efficacy outcome reached|0|||
150032721|NCT02234843|541259358|FG009|Overall Study|Efficacy outcome reached|0|||
150032722|NCT02234843|541259349|FG000|Overall Study|Patient convenience|2|||
150032723|NCT02234843|541259350|FG001|Overall Study|Patient convenience|0|||
150032724|NCT02234843|541259351|FG002|Overall Study|Patient convenience|0|||
150032725|NCT02234843|541259352|FG003|Overall Study|Patient convenience|0|||
150032726|NCT02234843|541259353|FG004|Overall Study|Patient convenience|0|||
150032727|NCT02234843|541259354|FG005|Overall Study|Patient convenience|1|||
150032728|NCT02234843|541259355|FG006|Overall Study|Patient convenience|0|||
150170181|NCT05174013|541759009|FG000|Overall Study|Lost to Follow-up|0|||
149821649|NCT04136626|540475803|FG000|Treatment Phase|Withdrawal by Subject|1|||
149821650|NCT04136626|540475804|FG001|Treatment Phase|Withdrawal by Subject|9|||
150170182|NCT05174013|541759010|FG001|Overall Study|Lost to Follow-up|0|||
150170183|NCT05174013|541759011|FG002|Overall Study|Lost to Follow-up|0|||
150170184|NCT05174013|541759012|FG003|Overall Study|Lost to Follow-up|1|||
150170185|NCT05174013|541759013|FG004|Overall Study|Lost to Follow-up|0|||
150170186|NCT05174013|541759014|FG005|Overall Study|Lost to Follow-up|0|||
150170187|NCT05174013|541759009|FG000|Overall Study|Withdrawal by Subject|0|||
150170188|NCT05174013|541759010|FG001|Overall Study|Withdrawal by Subject|0|||
150170189|NCT05174013|541759011|FG002|Overall Study|Withdrawal by Subject|1|||
150170190|NCT05174013|541759012|FG003|Overall Study|Withdrawal by Subject|0|||
150170191|NCT05174013|541759013|FG004|Overall Study|Withdrawal by Subject|0|||
150170192|NCT05174013|541759014|FG005|Overall Study|Withdrawal by Subject|0|||
150170193|NCT00344019|541759016|FG000|Overall Study|did not meet final inclusion criteria|0|||
150170194|NCT00344019|541759017|FG001|Overall Study|did not meet final inclusion criteria|0|||
150170195|NCT00344019|541759018|FG002|Overall Study|did not meet final inclusion criteria|74|||
150170196|NCT02503202|541759019|FG000|Base Study: Up to Month 6|Death|1|||
150170197|NCT02503202|541759020|FG001|Base Study: Up to Month 6|Death|1|||
150170198|NCT02503202|541759021|FG002|Base Study: Up to Month 6|Death|0|||
150170199|NCT02503202|541759022|FG003|Base Study: Up to Month 6|Death|0|||
150170200|NCT02503202|541759023|FG004|Base Study: Up to Month 6|Death|0|||
150170201|NCT02503202|541759019|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
150170202|NCT02503202|541759020|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
150170203|NCT02503202|541759021|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
150170204|NCT02503202|541759022|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
150170205|NCT02503202|541759023|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
150170206|NCT02503202|541759019|FG000|Base Study: Up to Month 6|Physician Decision|0|||
150170207|NCT02503202|541759020|FG001|Base Study: Up to Month 6|Physician Decision|0|||
150170208|NCT02503202|541759021|FG002|Base Study: Up to Month 6|Physician Decision|0|||
150170209|NCT02503202|541759022|FG003|Base Study: Up to Month 6|Physician Decision|0|||
150170210|NCT02503202|541759023|FG004|Base Study: Up to Month 6|Physician Decision|1|||
150170211|NCT02503202|541759019|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
150170212|NCT02503202|541759020|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
150170213|NCT02503202|541759021|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
150170214|NCT02503202|541759022|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
150170215|NCT02503202|541759023|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
150170216|NCT02503202|541759019|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
150170217|NCT02503202|541759020|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
150170218|NCT02503202|541759021|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
150170219|NCT02503202|541759022|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
150170220|NCT02503202|541759023|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
150170221|NCT02503202|541759019|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
150170222|NCT02503202|541759020|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
150170223|NCT02503202|541759021|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
150170224|NCT02503202|541759022|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
150170225|NCT02503202|541759023|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
150170226|NCT02503202|541759019|FG000|Extension: Month 6 to 24|Death|1|||
150170227|NCT02503202|541759020|FG001|Extension: Month 6 to 24|Death|0|||
150170228|NCT02503202|541759021|FG002|Extension: Month 6 to 24|Death|0|||
150170229|NCT02503202|541759022|FG003|Extension: Month 6 to 24|Death|0|||
150170230|NCT02503202|541759023|FG004|Extension: Month 6 to 24|Death|0|||
150170231|NCT02503202|541759019|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
150032729|NCT02234843|541259356|FG007|Overall Study|Patient convenience|0|||
150032730|NCT02234843|541259357|FG008|Overall Study|Patient convenience|0|||
150032731|NCT02234843|541259358|FG009|Overall Study|Patient convenience|0|||
150032732|NCT02234843|541259349|FG000|Overall Study|Withdrawal by Subject|5|||
150032733|NCT02234843|541259350|FG001|Overall Study|Withdrawal by Subject|1|||
149821651|NCT04136626|540475803|FG000|Treatment Phase|Adverse Event|1|||
149821652|NCT04136626|540475804|FG001|Treatment Phase|Adverse Event|0|||
149821653|NCT04136626|540475803|FG000|Treatment Phase|Lost to Follow-up|1|||
149821654|NCT04136626|540475804|FG001|Treatment Phase|Lost to Follow-up|5|||
149821655|NCT04136626|540475803|FG000|12-month Follow-up|Lost to Follow-up|8|||
149821656|NCT04136626|540475804|FG001|12-month Follow-up|Lost to Follow-up|7|||
149821657|NCT00628745|540475805|FG000|Overall Study|Withdrawal by Subject|63|||
149821658|NCT00628745|540475806|FG001|Overall Study|Withdrawal by Subject|3|||
149821659|NCT00628745|540475807|FG002|Overall Study|Withdrawal by Subject|9|||
149821660|NCT00628745|540475808|FG003|Overall Study|Withdrawal by Subject|2|||
149821661|NCT00628745|540475809|FG004|Overall Study|Withdrawal by Subject|69|||
149821662|NCT00628745|540475805|FG000|Overall Study|Does not meet inclusion criteria|0|||
149821663|NCT00628745|540475806|FG001|Overall Study|Does not meet inclusion criteria|12|||
149821664|NCT00628745|540475807|FG002|Overall Study|Does not meet inclusion criteria|0|||
149821665|NCT00628745|540475808|FG003|Overall Study|Does not meet inclusion criteria|0|||
149821666|NCT00628745|540475809|FG004|Overall Study|Does not meet inclusion criteria|18|||
149821667|NCT00628745|540475805|FG000|Overall Study|Participation in an interventional clinical trial|81|||
149821668|NCT00628745|540475806|FG001|Overall Study|Participation in an interventional clinical trial|4|||
149821669|NCT00628745|540475807|FG002|Overall Study|Participation in an interventional clinical trial|7|||
149821670|NCT00628745|540475808|FG003|Overall Study|Participation in an interventional clinical trial|0|||
149821671|NCT00628745|540475809|FG004|Overall Study|Participation in an interventional clinical trial|63|||
149821672|NCT00628745|540475805|FG000|Overall Study|Physician Decision|8|||
149821673|NCT00628745|540475806|FG001|Overall Study|Physician Decision|4|||
149821674|NCT00628745|540475807|FG002|Overall Study|Physician Decision|3|||
149821675|NCT00628745|540475808|FG003|Overall Study|Physician Decision|0|||
149821676|NCT00628745|540475809|FG004|Overall Study|Physician Decision|30|||
149821677|NCT00628745|540475805|FG000|Overall Study|Lost to Follow-up|109|||
149821678|NCT00628745|540475806|FG001|Overall Study|Lost to Follow-up|7|||
149821679|NCT00628745|540475807|FG002|Overall Study|Lost to Follow-up|7|||
149821680|NCT00628745|540475808|FG003|Overall Study|Lost to Follow-up|0|||
149821681|NCT00628745|540475809|FG004|Overall Study|Lost to Follow-up|498|||
149821682|NCT00628745|540475805|FG000|Overall Study|Death|197|||
149821683|NCT00628745|540475806|FG001|Overall Study|Death|81|||
149821684|NCT00628745|540475807|FG002|Overall Study|Death|12|||
149821685|NCT00628745|540475808|FG003|Overall Study|Death|4|||
149821686|NCT00628745|540475809|FG004|Overall Study|Death|939|||
149821687|NCT00628745|540475805|FG000|Overall Study|Participant transferred to another THAOS site|6|||
149821688|NCT00628745|540475806|FG001|Overall Study|Participant transferred to another THAOS site|0|||
149821689|NCT00628745|540475807|FG002|Overall Study|Participant transferred to another THAOS site|0|||
149821690|NCT00628745|540475808|FG003|Overall Study|Participant transferred to another THAOS site|0|||
149821691|NCT00628745|540475809|FG004|Overall Study|Participant transferred to another THAOS site|7|||
149821692|NCT00628745|540475805|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
149821693|NCT00628745|540475806|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
149821694|NCT00628745|540475807|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
149821695|NCT00628745|540475808|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
149821696|NCT00628745|540475809|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
149821697|NCT00628745|540475805|FG000|Overall Study|Site closure|152|||
149821698|NCT00628745|540475806|FG001|Overall Study|Site closure|146|||
149821699|NCT00628745|540475807|FG002|Overall Study|Site closure|6|||
149821700|NCT00628745|540475808|FG003|Overall Study|Site closure|8|||
149821701|NCT00628745|540475809|FG004|Overall Study|Site closure|691|||
149821702|NCT00628745|540475805|FG000|Overall Study|Duplicate participant|0|||
149821703|NCT00628745|540475806|FG001|Overall Study|Duplicate participant|0|||
149821704|NCT00628745|540475807|FG002|Overall Study|Duplicate participant|0|||
149821705|NCT00628745|540475808|FG003|Overall Study|Duplicate participant|0|||
149821706|NCT00628745|540475809|FG004|Overall Study|Duplicate participant|1|||
149821707|NCT00628745|540475805|FG000|Overall Study|Missing|4|||
150032734|NCT02234843|541259351|FG002|Overall Study|Withdrawal by Subject|1|||
150032735|NCT02234843|541259352|FG003|Overall Study|Withdrawal by Subject|0|||
149821708|NCT00628745|540475806|FG001|Overall Study|Missing|3|||
149821709|NCT00628745|540475807|FG002|Overall Study|Missing|0|||
149821710|NCT00628745|540475808|FG003|Overall Study|Missing|0|||
149821711|NCT00628745|540475809|FG004|Overall Study|Missing|10|||
149821712|NCT00628745|540475805|FG000|Overall Study|Othe reasons|987|||
149821713|NCT00628745|540475806|FG001|Overall Study|Othe reasons|373|||
149821714|NCT00628745|540475807|FG002|Overall Study|Othe reasons|105|||
149821715|NCT00628745|540475808|FG003|Overall Study|Othe reasons|1|||
149821716|NCT00628745|540475809|FG004|Overall Study|Othe reasons|1772|||
150032736|NCT02234843|541259353|FG004|Overall Study|Withdrawal by Subject|0|||
150170232|NCT02503202|541759020|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
150170233|NCT02503202|541759021|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
150170234|NCT02503202|541759022|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
150170235|NCT02503202|541759023|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
149821717|NCT00387712|540477254|FG000|Overall Study|Physician Decision|6|||
149821718|NCT00387712|540477255|FG001|Overall Study|Physician Decision|4|||
149821719|NCT00387712|540477254|FG000|Overall Study|Lost to Follow-up|17|||
149821720|NCT00387712|540477255|FG001|Overall Study|Lost to Follow-up|20|||
149821721|NCT00387712|540477254|FG000|Overall Study|Withdrawal by Subject|6|||
149821722|NCT00387712|540477255|FG001|Overall Study|Withdrawal by Subject|12|||
149821723|NCT00671879|540477269|FG000|Overall Study|Withdrawal by Subject|0|||
149821724|NCT00671879|540477270|FG001|Overall Study|Withdrawal by Subject|4|||
149821725|NCT00671879|540477271|FG002|Overall Study|Withdrawal by Subject|6|||
149821726|NCT04633837|540477272|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
149821727|NCT04633837|540477273|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
149821728|NCT02891200|540477274|FG000|Overall Study|Lost to Follow-up|31|||
149821729|NCT02891200|540477275|FG001|Overall Study|Lost to Follow-up|36|||
149821730|NCT02891200|540477274|FG000|Overall Study|Death|10|||
149821731|NCT02891200|540477275|FG001|Overall Study|Death|9|||
149821732|NCT02891200|540477274|FG000|Overall Study|Withdrawal by Subject|1|||
149821733|NCT02891200|540477275|FG001|Overall Study|Withdrawal by Subject|4|||
149821734|NCT03907280|540477276|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
149821735|NCT03907280|540477277|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
149821736|NCT03907280|540477278|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
149821737|NCT04480463|540477281|FG000|Overall Study|Death|0|||
149821738|NCT04480463|540477282|FG001|Overall Study|Death|1|||
149821739|NCT04480463|540477281|FG000|Overall Study|Adverse Event|6|||
149821740|NCT04480463|540477282|FG001|Overall Study|Adverse Event|8|||
149821741|NCT04480463|540477281|FG000|Overall Study|Lost to Follow-up|3|||
149821742|NCT04480463|540477282|FG001|Overall Study|Lost to Follow-up|2|||
149821743|NCT04480463|540477281|FG000|Overall Study|Physician Decision|2|||
149821744|NCT04480463|540477282|FG001|Overall Study|Physician Decision|5|||
149821745|NCT04480463|540477281|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
149821746|NCT04480463|540477282|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
149821747|NCT04480463|540477281|FG000|Overall Study|Protocol Violation|2|||
149821748|NCT04480463|540477282|FG001|Overall Study|Protocol Violation|1|||
149821749|NCT04480463|540477281|FG000|Overall Study|Withdrawal by Subject|6|||
149821750|NCT04480463|540477282|FG001|Overall Study|Withdrawal by Subject|7|||
149821751|NCT04480463|540477281|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
149821752|NCT04480463|540477282|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
149821753|NCT04480463|540477281|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
149821754|NCT04480463|540477282|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
149821755|NCT04480463|540477281|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
149821756|NCT04480463|540477282|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
149821757|NCT04480463|540477281|FG000|Overall Study|Other|6|||
149821758|NCT04480463|540477282|FG001|Overall Study|Other|4|||
149821759|NCT01399723|540477283|FG000|Overall Study|Lost to Follow-up|0|||
149821760|NCT01399723|540477284|FG001|Overall Study|Lost to Follow-up|1|||
149821761|NCT00752791|540477294|FG000|Overall Study|Adverse Event|7|||
149821762|NCT00752791|540477294|FG000|Overall Study|Withdrawal by Subject|1|||
149821763|NCT00752791|540477294|FG000|Overall Study|Physician Decision|1|||
149821764|NCT00752791|540477294|FG000|Overall Study|Death|1|||
149821765|NCT00752791|540477294|FG000|Overall Study|Renal transplant|3|||
149821766|NCT00752791|540477294|FG000|Overall Study|Switched to hemodialysis|2|||
149821767|NCT00752791|540477294|FG000|Overall Study|Protocol deviation|1|||
149821768|NCT01769378|540477297|FG000|Overall Study|Adverse Event|10|||
149821769|NCT01769378|540477298|FG001|Overall Study|Adverse Event|0|||
149821770|NCT01769378|540477297|FG000|Overall Study|Entry criteria not met|1|||
149821771|NCT01769378|540477298|FG001|Overall Study|Entry criteria not met|0|||
149821772|NCT01769378|540477297|FG000|Overall Study|Protocol Violation|1|||
149821773|NCT01769378|540477298|FG001|Overall Study|Protocol Violation|1|||
149821774|NCT01769378|540477297|FG000|Overall Study|Withdrawal by Subject|10|||
149821775|NCT01769378|540477298|FG001|Overall Study|Withdrawal by Subject|3|||
149821776|NCT01769378|540477297|FG000|Overall Study|Sponsor Decision|1|||
149821777|NCT01769378|540477298|FG001|Overall Study|Sponsor Decision|0|||
149944065|NCT04476043|540929448|FG003|Overall Study|Withdrawal by Subject|1|||
149944066|NCT04476043|540929445|FG000|Overall Study|Lost to Follow-up|1|||
149944067|NCT04476043|540929446|FG001|Overall Study|Lost to Follow-up|1|||
149944068|NCT04476043|540929447|FG002|Overall Study|Lost to Follow-up|2|||
149944069|NCT04476043|540929448|FG003|Overall Study|Lost to Follow-up|1|||
149944070|NCT04476043|540929445|FG000|Overall Study|Adverse Event|2|||
149944071|NCT04476043|540929446|FG001|Overall Study|Adverse Event|0|||
149944072|NCT04476043|540929447|FG002|Overall Study|Adverse Event|1|||
149944073|NCT04476043|540929448|FG003|Overall Study|Adverse Event|0|||
149821778|NCT01769378|540477297|FG000|Overall Study|Lost to Follow-up|2|||
149821779|NCT01769378|540477298|FG001|Overall Study|Lost to Follow-up|0|||
149821780|NCT00678392|540477299|FG000|Overall Study|Adverse Event|0|||
149821781|NCT00678392|540477300|FG001|Overall Study|Adverse Event|6|||
149821782|NCT00678392|540477299|FG000|Overall Study|Death|280|||
149821783|NCT00678392|540477300|FG001|Overall Study|Death|269|||
149821784|NCT00678392|540477299|FG000|Overall Study|Lost to Follow-up|15|||
149821785|NCT00678392|540477300|FG001|Overall Study|Lost to Follow-up|13|||
149821786|NCT00678392|540477299|FG000|Overall Study|Objective Progression or Relapse|3|||
149821787|NCT00678392|540477300|FG001|Overall Study|Objective Progression or Relapse|8|||
149821788|NCT00678392|540477299|FG000|Overall Study|Sponsor's Decision|1|||
149821789|NCT00678392|540477300|FG001|Overall Study|Sponsor's Decision|2|||
149821790|NCT00678392|540477299|FG000|Overall Study|Withdrawal by Subject|4|||
149821791|NCT00678392|540477300|FG001|Overall Study|Withdrawal by Subject|4|||
149821792|NCT00678392|540477299|FG000|Overall Study|Randomized But Not Treated|2|||
149821793|NCT00678392|540477300|FG001|Overall Study|Randomized But Not Treated|7|||
149821794|NCT00678392|540477299|FG000|Overall Study|Other|56|||
149821795|NCT00678392|540477300|FG001|Overall Study|Other|53|||
149821796|NCT01958281|540477301|FG000|Overall Study|Lack of Efficacy|5|||
149821797|NCT01958281|540477302|FG001|Overall Study|Lack of Efficacy|2|||
149821798|NCT01958281|540477303|FG002|Overall Study|Lack of Efficacy|0|||
149821799|NCT01958281|540477301|FG000|Overall Study|Adverse Event|0|||
149821800|NCT01958281|540477302|FG001|Overall Study|Adverse Event|2|||
149821801|NCT01958281|540477303|FG002|Overall Study|Adverse Event|0|||
149821802|NCT01958281|540477301|FG000|Overall Study|Withdrew Consent|1|||
149821803|NCT01958281|540477302|FG001|Overall Study|Withdrew Consent|0|||
149821804|NCT01958281|540477303|FG002|Overall Study|Withdrew Consent|0|||
149821805|NCT02784106|540477306|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
149821806|NCT02784106|540477307|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
149821807|NCT02784106|540477308|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
149821808|NCT02784106|540477309|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
149821809|NCT02784106|540477306|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
149821810|NCT02784106|540477307|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
149821811|NCT02784106|540477308|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149821812|NCT02784106|540477309|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149821813|NCT02784106|540477306|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
149821814|NCT02784106|540477307|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
149821815|NCT02784106|540477308|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
149821816|NCT02784106|540477309|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
149821817|NCT02784106|540477306|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
149821818|NCT02784106|540477307|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149821819|NCT02784106|540477308|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149821820|NCT02784106|540477309|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149821821|NCT02784106|540477306|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
149821822|NCT02784106|540477307|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
149821823|NCT02784106|540477308|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
149821824|NCT02784106|540477309|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
149821825|NCT02784106|540477306|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
149821826|NCT02784106|540477307|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
149821827|NCT02784106|540477308|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
149821828|NCT02784106|540477309|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
149821829|NCT00718159|540477310|FG000|Overall Study|Progressive Disease|3|||
149821830|NCT00718159|540477311|FG001|Overall Study|Progressive Disease|3|||
149821831|NCT00718159|540477312|FG002|Overall Study|Progressive Disease|2|||
149821832|NCT00718159|540477313|FG003|Overall Study|Progressive Disease|0|||
149821833|NCT00718159|540477314|FG004|Overall Study|Progressive Disease|6|||
150274766|NCT01383096|542144488|FG002|Third Intervention (8 Days)|Adverse Event|0|||
150274767|NCT01383096|542144486|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
150274768|NCT01383096|542144487|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
150274769|NCT01383096|542144488|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
150274770|NCT01383096|542144486|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
150274771|NCT01383096|542144487|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
150274772|NCT01383096|542144488|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
150274773|NCT01383096|542144486|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
150274774|NCT01383096|542144487|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
150274775|NCT01383096|542144488|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
150274776|NCT01383096|542144486|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
149821834|NCT00718159|540477315|FG005|Overall Study|Progressive Disease|0|||
149821835|NCT00718159|540477316|FG006|Overall Study|Progressive Disease|0|||
149821836|NCT00718159|540477310|FG000|Overall Study|Death due to Adverse Event|0|||
149821837|NCT00718159|540477311|FG001|Overall Study|Death due to Adverse Event|0|||
149821838|NCT00718159|540477312|FG002|Overall Study|Death due to Adverse Event|0|||
149821839|NCT00718159|540477313|FG003|Overall Study|Death due to Adverse Event|2|||
149821840|NCT00718159|540477314|FG004|Overall Study|Death due to Adverse Event|2|||
149821841|NCT00718159|540477315|FG005|Overall Study|Death due to Adverse Event|0|||
149821842|NCT00718159|540477316|FG006|Overall Study|Death due to Adverse Event|0|||
149821843|NCT00718159|540477310|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
149821844|NCT00718159|540477311|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
149821845|NCT00718159|540477312|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
149821846|NCT00718159|540477313|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
149821847|NCT00718159|540477314|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
149821848|NCT00718159|540477315|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
149821849|NCT00718159|540477316|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
149821850|NCT00718159|540477310|FG000|Overall Study|Investigator Decision|0|||
149821851|NCT00718159|540477311|FG001|Overall Study|Investigator Decision|0|||
149821852|NCT00718159|540477312|FG002|Overall Study|Investigator Decision|0|||
149821853|NCT00718159|540477313|FG003|Overall Study|Investigator Decision|0|||
149821854|NCT00718159|540477314|FG004|Overall Study|Investigator Decision|0|||
149821855|NCT00718159|540477315|FG005|Overall Study|Investigator Decision|1|||
149821856|NCT00718159|540477316|FG006|Overall Study|Investigator Decision|1|||
149821857|NCT00175019|540477318|FG000|Overall Study|Adverse Event|54|||
149821858|NCT00175019|540477319|FG001|Overall Study|Adverse Event|22|||
149821859|NCT00175019|540477320|FG002|Overall Study|Adverse Event|2|||
149821860|NCT00175019|540477318|FG000|Overall Study|Protocol Violation|6|||
149821861|NCT00175019|540477319|FG001|Overall Study|Protocol Violation|3|||
149821862|NCT00175019|540477320|FG002|Overall Study|Protocol Violation|3|||
149821863|NCT00175019|540477318|FG000|Overall Study|Lost to Follow-up|42|||
149821864|NCT00175019|540477319|FG001|Overall Study|Lost to Follow-up|39|||
149821865|NCT00175019|540477320|FG002|Overall Study|Lost to Follow-up|9|||
149821866|NCT00175019|540477318|FG000|Overall Study|Did not continue under Amendment 4|1|||
149821867|NCT00175019|540477319|FG001|Overall Study|Did not continue under Amendment 4|1|||
149821868|NCT00175019|540477320|FG002|Overall Study|Did not continue under Amendment 4|2|||
149821869|NCT00175019|540477318|FG000|Overall Study|Personal Reason(s)|39|||
149821870|NCT00175019|540477319|FG001|Overall Study|Personal Reason(s)|31|||
149821871|NCT00175019|540477320|FG002|Overall Study|Personal Reason(s)|8|||
149821872|NCT00175019|540477318|FG000|Overall Study|Therapeutic Failure|10|||
149821873|NCT00175019|540477319|FG001|Overall Study|Therapeutic Failure|38|||
149821874|NCT00175019|540477320|FG002|Overall Study|Therapeutic Failure|22|||
149821875|NCT00175019|540477318|FG000|Overall Study|Gout Flare|2|||
149821876|NCT00175019|540477319|FG001|Overall Study|Gout Flare|3|||
149821877|NCT00175019|540477320|FG002|Overall Study|Gout Flare|0|||
149821878|NCT00175019|540477318|FG000|Overall Study|Reason Not Specified|40|||
149821879|NCT00175019|540477319|FG001|Overall Study|Reason Not Specified|34|||
149821880|NCT00175019|540477320|FG002|Overall Study|Reason Not Specified|11|||
149821881|NCT01405820|540477321|FG000|Randomized Treatment Period|Adverse Event|3|||
149821882|NCT01405820|540477322|FG001|Randomized Treatment Period|Adverse Event|3|||
149821883|NCT01405820|540477323|FG002|Randomized Treatment Period|Adverse Event|3|||
149821884|NCT01405820|540477324|FG003|Randomized Treatment Period|Adverse Event|0|||
149821885|NCT01405820|540477325|FG004|Randomized Treatment Period|Adverse Event|2|||
149821886|NCT01405820|540477326|FG005|Randomized Treatment Period|Adverse Event|1|||
149821887|NCT01405820|540477321|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
149821888|NCT01405820|540477322|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
149821889|NCT01405820|540477323|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
149821890|NCT01405820|540477324|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
149821891|NCT01405820|540477325|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
149821892|NCT01405820|540477326|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
149821893|NCT01405820|540477321|FG000|Randomized Treatment Period|Other|2|||
149821894|NCT01405820|540477322|FG001|Randomized Treatment Period|Other|2|||
150170236|NCT02503202|541759019|FG000|Extension: Month 6 to 24|Physician Decision|1|||
150170237|NCT02503202|541759020|FG001|Extension: Month 6 to 24|Physician Decision|0|||
150170238|NCT02503202|541759021|FG002|Extension: Month 6 to 24|Physician Decision|1|||
150170239|NCT02503202|541759022|FG003|Extension: Month 6 to 24|Physician Decision|3|||
150170240|NCT02503202|541759023|FG004|Extension: Month 6 to 24|Physician Decision|0|||
150170241|NCT02503202|541759019|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
150170242|NCT02503202|541759020|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
150170243|NCT02503202|541759021|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
150170244|NCT02503202|541759022|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
150170245|NCT02503202|541759023|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
150170246|NCT00139737|541759024|FG000|Overall Study|Withdrawal by Subject|190|||
150170247|NCT00139737|541759024|FG000|Overall Study|Adverse Event|58|||
150170248|NCT00139737|541759024|FG000|Overall Study|Lack of Efficacy|40|||
149821895|NCT01405820|540477323|FG002|Randomized Treatment Period|Other|1|||
149821896|NCT01405820|540477324|FG003|Randomized Treatment Period|Other|1|||
149821897|NCT01405820|540477325|FG004|Randomized Treatment Period|Other|0|||
149821898|NCT01405820|540477326|FG005|Randomized Treatment Period|Other|0|||
149821899|NCT01405820|540477321|FG000|Randomized Treatment Period|Physician Decision|0|||
149944074|NCT04476043|540929445|FG000|Overall Study|Protocol Violation|0|||
149821900|NCT01405820|540477322|FG001|Randomized Treatment Period|Physician Decision|2|||
149821901|NCT01405820|540477323|FG002|Randomized Treatment Period|Physician Decision|1|||
149821902|NCT01405820|540477324|FG003|Randomized Treatment Period|Physician Decision|0|||
149821903|NCT01405820|540477325|FG004|Randomized Treatment Period|Physician Decision|0|||
149821904|NCT01405820|540477326|FG005|Randomized Treatment Period|Physician Decision|0|||
149821905|NCT01405820|540477321|FG000|Randomized Treatment Period|Rescue|0|||
149821906|NCT01405820|540477322|FG001|Randomized Treatment Period|Rescue|1|||
149821907|NCT01405820|540477323|FG002|Randomized Treatment Period|Rescue|13|||
149821908|NCT01405820|540477324|FG003|Randomized Treatment Period|Rescue|10|||
149821909|NCT01405820|540477325|FG004|Randomized Treatment Period|Rescue|8|||
149821910|NCT01405820|540477326|FG005|Randomized Treatment Period|Rescue|8|||
149821911|NCT01405820|540477321|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
149821912|NCT01405820|540477322|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
149821913|NCT01405820|540477323|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
149821914|NCT01405820|540477324|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
149821915|NCT01405820|540477325|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
149821916|NCT01405820|540477326|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
149821917|NCT01405820|540477321|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
149821918|NCT01405820|540477322|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
149821919|NCT01405820|540477323|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
149821920|NCT01405820|540477324|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
149821921|NCT01405820|540477325|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
149821922|NCT01405820|540477326|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
149821923|NCT01405820|540477321|FG000|Randomized Treatment Period|Death|0|||
149821924|NCT01405820|540477322|FG001|Randomized Treatment Period|Death|0|||
149821925|NCT01405820|540477323|FG002|Randomized Treatment Period|Death|0|||
149821926|NCT01405820|540477324|FG003|Randomized Treatment Period|Death|1|||
149821927|NCT01405820|540477325|FG004|Randomized Treatment Period|Death|0|||
149821928|NCT01405820|540477326|FG005|Randomized Treatment Period|Death|0|||
149821929|NCT01405820|540477321|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
149821930|NCT01405820|540477322|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
149821931|NCT01405820|540477323|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
149821932|NCT01405820|540477324|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
149821933|NCT01405820|540477325|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
149821934|NCT01405820|540477326|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
149821935|NCT01405820|540477321|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
149821936|NCT01405820|540477322|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
149821937|NCT01405820|540477323|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
149821938|NCT01405820|540477324|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
149821939|NCT01405820|540477325|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
149821940|NCT01405820|540477326|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
149821941|NCT01405820|540477321|FG000|Open-Label Treatment Period|Other|1|||
149821942|NCT01405820|540477322|FG001|Open-Label Treatment Period|Other|1|||
149821943|NCT01405820|540477323|FG002|Open-Label Treatment Period|Other|1|||
149821944|NCT01405820|540477324|FG003|Open-Label Treatment Period|Other|1|||
149821945|NCT01405820|540477325|FG004|Open-Label Treatment Period|Other|1|||
149821946|NCT01405820|540477326|FG005|Open-Label Treatment Period|Other|1|||
149821947|NCT01405820|540477321|FG000|Open-Label Treatment Period|Physician Decision|0|||
149821948|NCT01405820|540477322|FG001|Open-Label Treatment Period|Physician Decision|0|||
149821949|NCT01405820|540477323|FG002|Open-Label Treatment Period|Physician Decision|1|||
149821950|NCT01405820|540477324|FG003|Open-Label Treatment Period|Physician Decision|2|||
149821951|NCT01405820|540477325|FG004|Open-Label Treatment Period|Physician Decision|1|||
149821952|NCT01405820|540477326|FG005|Open-Label Treatment Period|Physician Decision|0|||
149821953|NCT01405820|540477321|FG000|Open-Label Treatment Period|Adverse Event|0|||
149821954|NCT01405820|540477322|FG001|Open-Label Treatment Period|Adverse Event|0|||
149821955|NCT01405820|540477323|FG002|Open-Label Treatment Period|Adverse Event|0|||
149821956|NCT01405820|540477324|FG003|Open-Label Treatment Period|Adverse Event|1|||
149821957|NCT01405820|540477325|FG004|Open-Label Treatment Period|Adverse Event|0|||
149821958|NCT01405820|540477326|FG005|Open-Label Treatment Period|Adverse Event|0|||
149821959|NCT00415532|540477330|FG000|Treatment Period|Adverse Event|2|||
149821960|NCT00415532|540477331|FG001|Treatment Period|Adverse Event|3|||
149821961|NCT00415532|540477330|FG000|Treatment Period|Death|2|||
149821962|NCT00415532|540477331|FG001|Treatment Period|Death|1|||
149821963|NCT00415532|540477330|FG000|Treatment Period|Lost to Follow-up|1|||
149821964|NCT00415532|540477331|FG001|Treatment Period|Lost to Follow-up|1|||
149821965|NCT00415532|540477330|FG000|Treatment Period|Protocol Violation|1|||
150170249|NCT00139737|541759024|FG000|Overall Study|Lost to Follow-up|8|||
149821966|NCT00415532|540477331|FG001|Treatment Period|Protocol Violation|0|||
149821967|NCT00415532|540477330|FG000|Treatment Period|Withdrawal by Subject|6|||
149821968|NCT00415532|540477331|FG001|Treatment Period|Withdrawal by Subject|6|||
149821969|NCT00415532|540477330|FG000|Treatment Period|Other|2|||
149821970|NCT00415532|540477331|FG001|Treatment Period|Other|2|||
149821971|NCT00415532|540477330|FG000|Treatment Period|Ineligibility determined|1|||
150170250|NCT00139737|541759024|FG000|Overall Study|Death|3|||
149821972|NCT00415532|540477331|FG001|Treatment Period|Ineligibility determined|1|||
149821973|NCT00415532|540477330|FG000|Treatment Period|Noncompliance|1|||
149821974|NCT00415532|540477331|FG001|Treatment Period|Noncompliance|1|||
149821975|NCT00415532|540477330|FG000|Treatment Period|Requirement for alternative therapy|1|||
149821976|NCT00415532|540477331|FG001|Treatment Period|Requirement for alternative therapy|0|||
149821977|NCT00415532|540477330|FG000|Safety Follow Up Period|Adverse Event|1|||
149821978|NCT00415532|540477331|FG001|Safety Follow Up Period|Adverse Event|3|||
149821979|NCT00415532|540477330|FG000|Safety Follow Up Period|Death|3|||
149821980|NCT00415532|540477331|FG001|Safety Follow Up Period|Death|0|||
149821981|NCT00415532|540477330|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
149821982|NCT00415532|540477331|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
149821983|NCT00415532|540477330|FG000|Safety Follow Up Period|Other|1|||
149821984|NCT00415532|540477331|FG001|Safety Follow Up Period|Other|4|||
149821985|NCT00415532|540477330|FG000|Safety Follow Up Period|Ineligibility determined|1|||
149821986|NCT00415532|540477331|FG001|Safety Follow Up Period|Ineligibility determined|1|||
149821987|NCT00415532|540477330|FG000|Safety Follow Up Period|Noncompliance|1|||
149821988|NCT00415532|540477331|FG001|Safety Follow Up Period|Noncompliance|0|||
149821989|NCT00415532|540477330|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
149821990|NCT00415532|540477331|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
149821991|NCT01952574|540477332|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
149821992|NCT01952574|540477333|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
149821993|NCT01952574|540477334|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
149821994|NCT01952574|540477335|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
149821995|NCT01952574|540477336|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149821996|NCT01952574|540477337|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149821997|NCT01952574|540477338|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149821998|NCT01952574|540477332|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
149821999|NCT01952574|540477333|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
149822000|NCT01952574|540477334|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
149822001|NCT01952574|540477335|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
149822002|NCT01952574|540477336|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
149822003|NCT01952574|540477337|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
149822004|NCT01952574|540477338|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
149822005|NCT01952574|540477332|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
149822006|NCT01952574|540477333|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
149822007|NCT01952574|540477334|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
149822008|NCT01952574|540477335|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
149822009|NCT01952574|540477336|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
149822010|NCT01952574|540477337|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
149822011|NCT01952574|540477338|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
149822012|NCT01952574|540477332|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822013|NCT01952574|540477333|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822014|NCT01952574|540477334|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822015|NCT01952574|540477335|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822016|NCT01952574|540477336|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
149822017|NCT01952574|540477337|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822018|NCT01952574|540477338|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
149822019|NCT01952574|540477332|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
149822020|NCT01952574|540477333|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
149822021|NCT01952574|540477334|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
149822022|NCT01952574|540477335|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
149822023|NCT01952574|540477336|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
149822024|NCT01952574|540477337|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
149822025|NCT01952574|540477338|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
149822026|NCT01952574|540477332|FG000|Open-label Treatment Phase|Missing|0|||
149822027|NCT01952574|540477333|FG001|Open-label Treatment Phase|Missing|0|||
149822028|NCT01952574|540477334|FG002|Open-label Treatment Phase|Missing|0|||
149822029|NCT01952574|540477335|FG003|Open-label Treatment Phase|Missing|0|||
149822030|NCT01952574|540477336|FG004|Open-label Treatment Phase|Missing|4|||
149944075|NCT04476043|540929446|FG001|Overall Study|Protocol Violation|1|||
149944076|NCT04476043|540929447|FG002|Overall Study|Protocol Violation|0|||
149944077|NCT04476043|540929448|FG003|Overall Study|Protocol Violation|0|||
149822031|NCT01952574|540477337|FG005|Open-label Treatment Phase|Missing|0|||
149822032|NCT01952574|540477338|FG006|Open-label Treatment Phase|Missing|0|||
149822033|NCT01952574|540477332|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
149822034|NCT01952574|540477333|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
149822035|NCT01952574|540477334|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
149822036|NCT01952574|540477335|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
149822037|NCT01952574|540477336|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
149822038|NCT01952574|540477337|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
149822039|NCT01952574|540477338|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
149822040|NCT01952574|540477332|FG000|Open-label Treatment Phase|Death|0|||
149822041|NCT01952574|540477333|FG001|Open-label Treatment Phase|Death|0|||
149822042|NCT01952574|540477334|FG002|Open-label Treatment Phase|Death|0|||
149822043|NCT01952574|540477335|FG003|Open-label Treatment Phase|Death|0|||
149822044|NCT01952574|540477336|FG004|Open-label Treatment Phase|Death|1|||
149822045|NCT01952574|540477337|FG005|Open-label Treatment Phase|Death|0|||
149822046|NCT01952574|540477338|FG006|Open-label Treatment Phase|Death|0|||
149822047|NCT01952574|540477332|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822048|NCT01952574|540477333|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822049|NCT01952574|540477334|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822050|NCT01952574|540477335|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822051|NCT01952574|540477336|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822052|NCT01952574|540477337|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
149822053|NCT01952574|540477338|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149822054|NCT01952574|540477332|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
149822055|NCT01952574|540477333|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
149822056|NCT01952574|540477334|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
149822057|NCT01952574|540477335|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
149822058|NCT01952574|540477336|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
149822059|NCT01952574|540477337|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
149822060|NCT01952574|540477338|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
149822061|NCT00770991|540477342|FG000|Overall Study|Physician Decision|2|||
149822062|NCT00770991|540477343|FG001|Overall Study|Physician Decision|0|||
149822063|NCT00770991|540477342|FG000|Overall Study|Withdrawal by Subject|1|||
149822064|NCT00770991|540477343|FG001|Overall Study|Withdrawal by Subject|0|||
149822065|NCT00770991|540477342|FG000|Overall Study|Adverse Event|1|||
149822066|NCT00770991|540477343|FG001|Overall Study|Adverse Event|5|||
149822067|NCT00770991|540477342|FG000|Overall Study|Pregnancy|1|||
149822068|NCT00770991|540477343|FG001|Overall Study|Pregnancy|0|||
149822069|NCT02087046|540477345|FG000|Overall Study|Adverse Event|4|||
149822070|NCT02087046|540477345|FG000|Overall Study|Death|1|||
149822071|NCT02087046|540477345|FG000|Overall Study|Lost to Follow-up|3|||
149822072|NCT02087046|540477345|FG000|Overall Study|Withdrawal by Subject|2|||
149822073|NCT02087046|540477345|FG000|Overall Study|Physician Decision|1|||
149822074|NCT02444533|540477346|FG000|Overall Study|Not able to complete forms|0|||
149822075|NCT02444533|540477347|FG001|Overall Study|Not able to complete forms|2|||
149822076|NCT02444533|540477346|FG000|Overall Study|Only gave post-procedure complications|2|||
149822077|NCT02444533|540477347|FG001|Overall Study|Only gave post-procedure complications|2|||
149822078|NCT03567057|540477348|FG000|Overall Study|Adverse Event|56|||
149822079|NCT03567057|540477349|FG001|Overall Study|Adverse Event|53|||
149822080|NCT03567057|540477350|FG002|Overall Study|Adverse Event|28|||
149822081|NCT03567057|540477348|FG000|Overall Study|Withdrawal by Subject|22|||
149822082|NCT03567057|540477349|FG001|Overall Study|Withdrawal by Subject|24|||
149822083|NCT03567057|540477350|FG002|Overall Study|Withdrawal by Subject|13|||
149822084|NCT03567057|540477348|FG000|Overall Study|Lost to Follow-up|3|||
149822085|NCT03567057|540477349|FG001|Overall Study|Lost to Follow-up|5|||
149822086|NCT03567057|540477350|FG002|Overall Study|Lost to Follow-up|2|||
149822087|NCT03567057|540477348|FG000|Overall Study|COVID-19 pandemic|4|||
149822088|NCT03567057|540477349|FG001|Overall Study|COVID-19 pandemic|3|||
149822089|NCT03567057|540477350|FG002|Overall Study|COVID-19 pandemic|0|||
149822090|NCT03567057|540477348|FG000|Overall Study|Non-compliance with study drug|4|||
149822091|NCT03567057|540477349|FG001|Overall Study|Non-compliance with study drug|2|||
149822092|NCT03567057|540477350|FG002|Overall Study|Non-compliance with study drug|0|||
149822093|NCT03567057|540477348|FG000|Overall Study|Lack of Efficacy|3|||
150170251|NCT00139737|541759024|FG000|Overall Study|Laboratory Abnormality|2|||
149822094|NCT03567057|540477349|FG001|Overall Study|Lack of Efficacy|0|||
149822095|NCT03567057|540477350|FG002|Overall Study|Lack of Efficacy|1|||
149822096|NCT03567057|540477348|FG000|Overall Study|Death|1|||
149822097|NCT03567057|540477349|FG001|Overall Study|Death|0|||
149822098|NCT03567057|540477350|FG002|Overall Study|Death|0|||
149822099|NCT03567057|540477348|FG000|Overall Study|Physician Decision|1|||
149822100|NCT03567057|540477349|FG001|Overall Study|Physician Decision|0|||
150170252|NCT00139737|541759024|FG000|Overall Study|Protocol Violation|18|||
150170253|NCT00139737|541759024|FG000|Overall Study|Withdrew During Screening Phase|8|||
150170254|NCT00139737|541759024|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
150170255|NCT00139737|541759024|FG000|Overall Study|Screened, Not Treated|13|||
150170256|NCT03525119|541759032|FG000|Overall Study|Adverse Event|0|||
150170257|NCT03525119|541759033|FG001|Overall Study|Adverse Event|1|||
150170258|NCT03525119|541759034|FG002|Overall Study|Adverse Event|0|||
150170259|NCT03525119|541759032|FG000|Overall Study|Lost to Follow-up|32|||
150170260|NCT03525119|541759033|FG001|Overall Study|Lost to Follow-up|33|||
150170261|NCT03525119|541759034|FG002|Overall Study|Lost to Follow-up|37|||
150170262|NCT03525119|541759032|FG000|Overall Study|Withdrawal by Subject|5|||
150170263|NCT03525119|541759033|FG001|Overall Study|Withdrawal by Subject|4|||
149822101|NCT03567057|540477350|FG002|Overall Study|Physician Decision|0|||
149822102|NCT03567057|540477348|FG000|Overall Study|Unstable medical condition|1|||
149822103|NCT03567057|540477349|FG001|Overall Study|Unstable medical condition|0|||
149822104|NCT03567057|540477350|FG002|Overall Study|Unstable medical condition|0|||
149822105|NCT03567057|540477348|FG000|Overall Study|Medical history event|0|||
149822106|NCT03567057|540477349|FG001|Overall Study|Medical history event|0|||
149822107|NCT03567057|540477350|FG002|Overall Study|Medical history event|1|||
149822108|NCT03567057|540477348|FG000|Overall Study|Other|0|||
149822109|NCT03567057|540477349|FG001|Overall Study|Other|0|||
149822110|NCT03567057|540477350|FG002|Overall Study|Other|1|||
149822111|NCT00490061|540477351|FG000|Overall Study|Physician Decision|1|||
149822112|NCT00886483|540477352|FG000|Overall Study|Lost to Follow-up|0|||
149822113|NCT00886483|540477353|FG001|Overall Study|Lost to Follow-up|1|||
149822114|NCT00886483|540477352|FG000|Overall Study|Pursue medications|1|||
149822115|NCT00886483|540477353|FG001|Overall Study|Pursue medications|2|||
149822116|NCT00886483|540477352|FG000|Overall Study|Distance to center, poor grades|1|||
149822117|NCT00886483|540477353|FG001|Overall Study|Distance to center, poor grades|0|||
149822118|NCT00947856|540477356|FG000|Treatment Period|Progressive Disease|33|||
149822119|NCT00947856|540477357|FG001|Treatment Period|Progressive Disease|12|||
149822120|NCT00947856|540477356|FG000|Treatment Period|Adverse Event|15|||
149822121|NCT00947856|540477357|FG001|Treatment Period|Adverse Event|9|||
149822122|NCT00947856|540477356|FG000|Treatment Period|Physician Decision|14|||
149822123|NCT00947856|540477357|FG001|Treatment Period|Physician Decision|6|||
149822124|NCT00947856|540477356|FG000|Treatment Period|Study Stopped by Sponsor|4|||
149822125|NCT00947856|540477357|FG001|Treatment Period|Study Stopped by Sponsor|4|||
149822126|NCT00947856|540477356|FG000|Treatment Period|Withdrawal by Subject|12|||
149822127|NCT00947856|540477357|FG001|Treatment Period|Withdrawal by Subject|1|||
149822128|NCT00947856|540477356|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
149822129|NCT00947856|540477357|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
149822130|NCT00947856|540477356|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
149822131|NCT00947856|540477357|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
149822132|NCT00947856|540477356|FG000|Follow-up Period|Lost to Follow-up|7|||
149822133|NCT00947856|540477357|FG001|Follow-up Period|Lost to Follow-up|0|||
149822134|NCT00947856|540477356|FG000|Follow-up Period|Patient unavailable for site visits|1|||
149822135|NCT00947856|540477357|FG001|Follow-up Period|Patient unavailable for site visits|0|||
149822136|NCT00947856|540477356|FG000|Follow-up Period|Withdrawal by Subject|1|||
149822137|NCT00947856|540477357|FG001|Follow-up Period|Withdrawal by Subject|0|||
149822138|NCT03760510|540477360|FG000|Overall Study|Not ventilated for 24 hours|105|||
149822139|NCT03760510|540477361|FG001|Overall Study|Not ventilated for 24 hours|97|||
149822140|NCT00871728|540477362|FG000|Overall Study|Adverse Event|1|||
149822141|NCT00871728|540477362|FG000|Overall Study|Protocol Violation|7|||
149822142|NCT00871728|540477362|FG000|Overall Study|Lost to Follow-up|2|||
149822143|NCT00871728|540477362|FG000|Overall Study|Failed to Visit Hospital|4|||
149822144|NCT00871728|540477362|FG000|Overall Study|Participant Non-compliance|1|||
149822145|NCT00871728|540477362|FG000|Overall Study|Withdrawal of Informed Consent|5|||
149822146|NCT02418910|540477363|FG000|Overall Study|Lost to Follow-up|3|||
149822147|NCT02418910|540477363|FG000|Overall Study|Withdrawal by Subject|4|||
149822148|NCT02472977|540477369|FG000|Overall Study|Disease progression|4|||
149822149|NCT02472977|540477370|FG001|Overall Study|Disease progression|25|||
149822150|NCT02472977|540477371|FG002|Overall Study|Disease progression|6|||
149822151|NCT02472977|540477369|FG000|Overall Study|Withdrawal by Subject|0|||
149822152|NCT02472977|540477370|FG001|Overall Study|Withdrawal by Subject|1|||
149822153|NCT02472977|540477371|FG002|Overall Study|Withdrawal by Subject|0|||
149822154|NCT02472977|540477369|FG000|Overall Study|Study drug toxicity|2|||
149822155|NCT02472977|540477370|FG001|Overall Study|Study drug toxicity|0|||
149822156|NCT02472977|540477371|FG002|Overall Study|Study drug toxicity|2|||
150032737|NCT02234843|541259354|FG005|Overall Study|Withdrawal by Subject|7|||
149822157|NCT02472977|540477369|FG000|Overall Study|Subject request to discontinue treatment|0|||
149822158|NCT02472977|540477370|FG001|Overall Study|Subject request to discontinue treatment|1|||
149822159|NCT02472977|540477371|FG002|Overall Study|Subject request to discontinue treatment|0|||
149822160|NCT00566709|540477375|FG000|Overall Study|Protocol Violation|5|||
149822161|NCT00566709|540477376|FG001|Overall Study|Protocol Violation|0|||
149822162|NCT02668302|540477379|FG000|Overall Study|Withdrawal by Subject|1|||
149822163|NCT02668302|540477380|FG001|Overall Study|Withdrawal by Subject|0|||
149822164|NCT03775681|540477381|FG000|Overall Study|Physician Decision|3|||
149822165|NCT00895583|540477382|FG000|Overall Study|Adverse Event|28|||
149822166|NCT00895583|540477383|FG001|Overall Study|Adverse Event|4|||
149822167|NCT00895583|540477382|FG000|Overall Study|Death|2|||
149822168|NCT00895583|540477383|FG001|Overall Study|Death|1|||
149822169|NCT00895583|540477382|FG000|Overall Study|Physician Decision|3|||
149822170|NCT00895583|540477383|FG001|Overall Study|Physician Decision|1|||
149822171|NCT00895583|540477382|FG000|Overall Study|Lost to Follow-up|1|||
149822172|NCT00895583|540477383|FG001|Overall Study|Lost to Follow-up|3|||
149822173|NCT00895583|540477382|FG000|Overall Study|Protocol Violation|1|||
149822174|NCT00895583|540477383|FG001|Overall Study|Protocol Violation|0|||
149822175|NCT00895583|540477382|FG000|Overall Study|Withdrawal by Subject|4|||
149822176|NCT00895583|540477383|FG001|Overall Study|Withdrawal by Subject|2|||
149822177|NCT00895583|540477382|FG000|Overall Study|Lack of Efficacy|5|||
149822178|NCT00895583|540477383|FG001|Overall Study|Lack of Efficacy|0|||
149822179|NCT00895583|540477382|FG000|Overall Study|Other|0|||
149822180|NCT00895583|540477383|FG001|Overall Study|Other|1|||
149822181|NCT03558997|540477384|FG000|Overall Study|Adverse Event|0|||
149822182|NCT03558997|540477385|FG001|Overall Study|Adverse Event|2|||
149822183|NCT03558997|540477386|FG002|Overall Study|Adverse Event|5|||
149822184|NCT03558997|540477387|FG003|Overall Study|Adverse Event|1|||
149822185|NCT03558997|540477384|FG000|Overall Study|Physician Decision|0|||
149822186|NCT03558997|540477385|FG001|Overall Study|Physician Decision|0|||
149822187|NCT03558997|540477386|FG002|Overall Study|Physician Decision|1|||
149822188|NCT03558997|540477387|FG003|Overall Study|Physician Decision|0|||
149822189|NCT03558997|540477384|FG000|Overall Study|Withdrawal by Subject|1|||
149822190|NCT03558997|540477385|FG001|Overall Study|Withdrawal by Subject|0|||
149822191|NCT03558997|540477386|FG002|Overall Study|Withdrawal by Subject|1|||
149822192|NCT03558997|540477387|FG003|Overall Study|Withdrawal by Subject|1|||
149822193|NCT03558997|540477384|FG000|Overall Study|Lost to Follow-up|0|||
149822194|NCT03558997|540477385|FG001|Overall Study|Lost to Follow-up|0|||
149822195|NCT03558997|540477386|FG002|Overall Study|Lost to Follow-up|1|||
149822196|NCT03558997|540477387|FG003|Overall Study|Lost to Follow-up|0|||
149822197|NCT03529955|540477390|FG000|Overall Study|Adverse Event|1|||
149822198|NCT03529955|540477390|FG000|Overall Study|Lack of Efficacy|1|||
149822199|NCT03016078|540477396|FG000|Overall Study|Protocol Violation|1|||
149822200|NCT03016078|540477396|FG000|Overall Study|Protocol Violation|1|||
149822201|NCT02378506|540477398|FG000|Overall Study|Lack of Efficacy|3|||
149822202|NCT02378506|540477398|FG000|Overall Study|Withdrawal by Subject|4|||
149822203|NCT02378506|540477398|FG000|Overall Study|Protocol Violation|2|||
149822204|NCT02378506|540477398|FG000|Overall Study|Death|1|||
149822205|NCT02378506|540477398|FG000|Overall Study|Adverse Event|14|||
149822206|NCT02378506|540477398|FG000|Overall Study|Randomized But Not Treated|1|||
149822207|NCT00254397|540477399|FG000|Overall Study|Disease Progression|4|||
149822208|NCT00254397|540477400|FG001|Overall Study|Disease Progression|1|||
149822209|NCT00254397|540477401|FG002|Overall Study|Disease Progression|16|||
149822210|NCT00254397|540477402|FG003|Overall Study|Disease Progression|23|||
150274777|NCT01383096|542144487|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
150274778|NCT01383096|542144488|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
150274779|NCT01383096|542144486|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
150274780|NCT01383096|542144487|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
150274781|NCT01383096|542144488|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
149822211|NCT00254397|540477399|FG000|Overall Study|Non-Compliant|0|||
149822212|NCT00254397|540477400|FG001|Overall Study|Non-Compliant|0|||
149822213|NCT00254397|540477401|FG002|Overall Study|Non-Compliant|0|||
149822214|NCT00254397|540477402|FG003|Overall Study|Non-Compliant|1|||
149822215|NCT00254397|540477399|FG000|Overall Study|Adverse Event|2|||
149822216|NCT00254397|540477400|FG001|Overall Study|Adverse Event|0|||
149822217|NCT00254397|540477401|FG002|Overall Study|Adverse Event|3|||
149822218|NCT00254397|540477402|FG003|Overall Study|Adverse Event|1|||
149822219|NCT01070394|540477403|FG000|Overall Study|Adverse Event|6|||
150032738|NCT02234843|541259355|FG006|Overall Study|Withdrawal by Subject|0|||
149822220|NCT01070394|540477403|FG000|Overall Study|Withdrawal by Subject|1|||
149822221|NCT03586830|540477404|FG000|Overall Study|Site terminated by Sponsor|1|||
149822222|NCT03586830|540477405|FG001|Overall Study|Site terminated by Sponsor|4|||
149822223|NCT03586830|540477406|FG002|Overall Study|Site terminated by Sponsor|3|||
149822224|NCT03586830|540477407|FG003|Overall Study|Site terminated by Sponsor|3|||
149822225|NCT03586830|540477404|FG000|Overall Study|Lost to Follow-up|0|||
149822226|NCT03586830|540477405|FG001|Overall Study|Lost to Follow-up|2|||
149822227|NCT03586830|540477406|FG002|Overall Study|Lost to Follow-up|2|||
149822228|NCT03586830|540477407|FG003|Overall Study|Lost to Follow-up|1|||
149822229|NCT03586830|540477404|FG000|Overall Study|Withdrawal by Subject|1|||
149822230|NCT03586830|540477405|FG001|Overall Study|Withdrawal by Subject|0|||
149822231|NCT03586830|540477406|FG002|Overall Study|Withdrawal by Subject|3|||
149822232|NCT03586830|540477407|FG003|Overall Study|Withdrawal by Subject|1|||
149822233|NCT00458302|540479501|FG000|Overall Study|Adverse Event|4|||
149822234|NCT00458302|540479502|FG001|Overall Study|Adverse Event|14|||
149822235|NCT00458302|540479501|FG000|Overall Study|Pregnancy|2|||
149822236|NCT00458302|540479502|FG001|Overall Study|Pregnancy|1|||
149822237|NCT00458302|540479501|FG000|Overall Study|Protocol Violation|0|||
149822238|NCT00458302|540479502|FG001|Overall Study|Protocol Violation|2|||
149822239|NCT00458302|540479501|FG000|Overall Study|Withdrawal by Subject|6|||
149822240|NCT00458302|540479502|FG001|Overall Study|Withdrawal by Subject|4|||
149944078|NCT06217380|540929449|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
149944079|NCT06217380|540929449|FG000|Overall Study|Physician Decision|1|||
149822241|NCT00458302|540479501|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
150274782|NCT01383096|542144486|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
150274783|NCT01383096|542144487|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
150274784|NCT01383096|542144488|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
150274785|NCT01509079|542144491|FG000|Overall Study|Lack of Efficacy|0|||
150032739|NCT02234843|541259356|FG007|Overall Study|Withdrawal by Subject|0|||
150032740|NCT02234843|541259357|FG008|Overall Study|Withdrawal by Subject|0|||
150032741|NCT02234843|541259358|FG009|Overall Study|Withdrawal by Subject|0|||
150032742|NCT02234843|541259349|FG000|Overall Study|Recovery|1|||
150032743|NCT02234843|541259350|FG001|Overall Study|Recovery|0|||
150032744|NCT02234843|541259351|FG002|Overall Study|Recovery|0|||
150032745|NCT02234843|541259352|FG003|Overall Study|Recovery|0|||
150032746|NCT02234843|541259353|FG004|Overall Study|Recovery|0|||
150032747|NCT02234843|541259354|FG005|Overall Study|Recovery|0|||
150032748|NCT02234843|541259355|FG006|Overall Study|Recovery|0|||
150032749|NCT02234843|541259356|FG007|Overall Study|Recovery|0|||
150032750|NCT02234843|541259357|FG008|Overall Study|Recovery|0|||
150032751|NCT02234843|541259358|FG009|Overall Study|Recovery|0|||
150032752|NCT02234843|541259349|FG000|Overall Study|Other|0|||
150032753|NCT02234843|541259350|FG001|Overall Study|Other|2|||
150032754|NCT02234843|541259351|FG002|Overall Study|Other|0|||
150032755|NCT02234843|541259352|FG003|Overall Study|Other|1|||
150032756|NCT02234843|541259353|FG004|Overall Study|Other|0|||
150032757|NCT02234843|541259354|FG005|Overall Study|Other|1|||
150032758|NCT02234843|541259355|FG006|Overall Study|Other|0|||
150032759|NCT02234843|541259356|FG007|Overall Study|Other|1|||
150032760|NCT02234843|541259357|FG008|Overall Study|Other|0|||
150032761|NCT02234843|541259358|FG009|Overall Study|Other|0|||
150032762|NCT02234843|541259349|FG000|Overall Study|Physician Decision|4|||
150032763|NCT02234843|541259350|FG001|Overall Study|Physician Decision|1|||
150032764|NCT02234843|541259351|FG002|Overall Study|Physician Decision|0|||
150032765|NCT02234843|541259352|FG003|Overall Study|Physician Decision|1|||
150032766|NCT02234843|541259353|FG004|Overall Study|Physician Decision|0|||
150032767|NCT02234843|541259354|FG005|Overall Study|Physician Decision|0|||
150032768|NCT02234843|541259355|FG006|Overall Study|Physician Decision|0|||
150032769|NCT02234843|541259356|FG007|Overall Study|Physician Decision|1|||
150032770|NCT02234843|541259357|FG008|Overall Study|Physician Decision|0|||
150032771|NCT02234843|541259358|FG009|Overall Study|Physician Decision|0|||
150032772|NCT02234843|541259349|FG000|Overall Study|Adverse Event|5|||
150032773|NCT02234843|541259350|FG001|Overall Study|Adverse Event|1|||
150032774|NCT02234843|541259351|FG002|Overall Study|Adverse Event|1|||
150032775|NCT02234843|541259352|FG003|Overall Study|Adverse Event|3|||
150274786|NCT01509079|542144492|FG001|Overall Study|Lack of Efficacy|2|||
150274787|NCT01509079|542144491|FG000|Overall Study|started an excluded medication|0|||
150274788|NCT01509079|542144492|FG001|Overall Study|started an excluded medication|1|||
149944080|NCT06217380|540929449|FG000|Overall Study|Withdrawal by Subject|2|||
149944081|NCT06633965|540929450|FG000|Overall Study|Withdrawal by Subject|0|||
149944082|NCT06633965|540929451|FG001|Overall Study|Withdrawal by Subject|1|||
149944083|NCT00782067|540929452|FG000|Overall Study|Adverse Event|35|||
149944084|NCT00782067|540929452|FG000|Overall Study|Subject withdrew consent|11|||
149944085|NCT00782067|540929452|FG000|Overall Study|Lost to Follow-up|2|||
149944086|NCT00782067|540929452|FG000|Overall Study|Administrative problems|14|||
149944087|NCT00782067|540929452|FG000|Overall Study|Death|9|||
149944088|NCT00782067|540929452|FG000|Overall Study|Disease progression|43|||
149944089|NCT00782067|540929452|FG000|Overall Study|Protocol deviation|2|||
149944090|NCT02471183|540929453|FG000|Main Treatment Period|Adverse Event|1|||
149944091|NCT02471183|540929453|FG000|Main Treatment Period|Withdrawal by Subject|1|||
149944092|NCT02471183|540929453|FG000|Extended Treatment Period|Lack of Efficacy|1|||
149944093|NCT02328105|540929457|FG000|Overall Study|Death|6|||
149944094|NCT02328105|540929457|FG000|Overall Study|Withdrawal by Subject|1|||
149944095|NCT02328105|540929457|FG000|Overall Study|Still On Study in Follow-Up|4|||
150032776|NCT02234843|541259353|FG004|Overall Study|Adverse Event|2|||
150274789|NCT01338415|542144493|FG000|Core + Extension|Adverse Event|8|||
150274790|NCT01338415|542144494|FG001|Core + Extension|Adverse Event|6|||
149944096|NCT00614393|540929458|FG000|Overall Study|Adverse Event|20|||
149944097|NCT00614393|540929459|FG001|Overall Study|Adverse Event|2|||
149944098|NCT00614393|540929460|FG002|Overall Study|Adverse Event|3|||
150032777|NCT02234843|541259354|FG005|Overall Study|Adverse Event|1|||
150032778|NCT02234843|541259355|FG006|Overall Study|Adverse Event|0|||
150032779|NCT02234843|541259356|FG007|Overall Study|Adverse Event|0|||
150032780|NCT02234843|541259357|FG008|Overall Study|Adverse Event|1|||
150032781|NCT02234843|541259358|FG009|Overall Study|Adverse Event|0|||
149944099|NCT00614393|540929461|FG003|Overall Study|Adverse Event|13|||
149944100|NCT00614393|540929462|FG004|Overall Study|Adverse Event|21|||
149944101|NCT00614393|540929458|FG000|Overall Study|Lost to Follow-up|0|||
150032782|NCT02234843|541259349|FG000|Overall Study|Non-compliance with study drug|1|||
150032783|NCT02234843|541259350|FG001|Overall Study|Non-compliance with study drug|0|||
150032784|NCT02234843|541259351|FG002|Overall Study|Non-compliance with study drug|0|||
150032785|NCT02234843|541259352|FG003|Overall Study|Non-compliance with study drug|0|||
150032786|NCT02234843|541259353|FG004|Overall Study|Non-compliance with study drug|0|||
150274791|NCT01338415|542144495|FG002|Core + Extension|Adverse Event|0|||
149944102|NCT00614393|540929459|FG001|Overall Study|Lost to Follow-up|0|||
149944103|NCT00614393|540929460|FG002|Overall Study|Lost to Follow-up|0|||
149944104|NCT00614393|540929461|FG003|Overall Study|Lost to Follow-up|1|||
149944105|NCT00614393|540929462|FG004|Overall Study|Lost to Follow-up|2|||
149944106|NCT00614393|540929458|FG000|Overall Study|Physician Decision|17|||
149944107|NCT00614393|540929459|FG001|Overall Study|Physician Decision|0|||
149944108|NCT00614393|540929460|FG002|Overall Study|Physician Decision|1|||
150274792|NCT01338415|542144493|FG000|Core + Extension|Withdrawal by Subject|1|||
150274793|NCT01338415|542144494|FG001|Core + Extension|Withdrawal by Subject|1|||
150274794|NCT01338415|542144495|FG002|Core + Extension|Withdrawal by Subject|0|||
150274795|NCT01338415|542144493|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
150274796|NCT01338415|542144494|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
150274797|NCT01338415|542144495|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
150274798|NCT01338415|542144493|FG000|Core + Extension|Other (administrative reason)|1|||
150274799|NCT01338415|542144494|FG001|Core + Extension|Other (administrative reason)|0|||
150274800|NCT01338415|542144495|FG002|Core + Extension|Other (administrative reason)|0|||
150274801|NCT01338415|542144493|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
150274802|NCT01338415|542144494|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
150274803|NCT01338415|542144495|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
150274804|NCT01338415|542144493|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
150274805|NCT01338415|542144494|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
150274806|NCT01338415|542144495|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
150274807|NCT01338415|542144493|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
150274808|NCT01338415|542144494|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
150274809|NCT01338415|542144495|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
150274810|NCT01338415|542144493|FG000|Exceptional Use Treatment Period|Death|0|||
150274811|NCT01338415|542144494|FG001|Exceptional Use Treatment Period|Death|0|||
150274812|NCT01338415|542144495|FG002|Exceptional Use Treatment Period|Death|1|||
150274813|NCT00233363|542144498|FG000|Overall Study|Adverse Event|1|||
150274814|NCT00233363|542144499|FG001|Overall Study|Adverse Event|2|||
150274815|NCT00233363|542144498|FG000|Overall Study|Lack of Efficacy|0|||
150274816|NCT00233363|542144499|FG001|Overall Study|Lack of Efficacy|2|||
150274817|NCT00233363|542144498|FG000|Overall Study|Withdrawal by Subject|1|||
150274818|NCT00233363|542144499|FG001|Overall Study|Withdrawal by Subject|1|||
150274819|NCT00233363|542144498|FG000|Overall Study|Aggravation of complication|1|||
150274820|NCT00233363|542144499|FG001|Overall Study|Aggravation of complication|0|||
150274821|NCT00874770|542144500|FG000|Overall Study|Lack of Efficacy|2|||
150274822|NCT00874770|542144501|FG001|Overall Study|Lack of Efficacy|0|||
150274823|NCT00874770|542144502|FG002|Overall Study|Lack of Efficacy|0|||
149944109|NCT00614393|540929461|FG003|Overall Study|Physician Decision|8|||
149944110|NCT00614393|540929462|FG004|Overall Study|Physician Decision|9|||
149944111|NCT00614393|540929458|FG000|Overall Study|Progressive Disease|118|||
149944112|NCT00614393|540929459|FG001|Overall Study|Progressive Disease|5|||
149944113|NCT00614393|540929460|FG002|Overall Study|Progressive Disease|5|||
149944114|NCT00614393|540929461|FG003|Overall Study|Progressive Disease|138|||
149944115|NCT00614393|540929462|FG004|Overall Study|Progressive Disease|130|||
149944116|NCT00614393|540929458|FG000|Overall Study|Protocol Violation|1|||
149944117|NCT00614393|540929459|FG001|Overall Study|Protocol Violation|0|||
149944118|NCT00614393|540929460|FG002|Overall Study|Protocol Violation|0|||
149944119|NCT00614393|540929461|FG003|Overall Study|Protocol Violation|0|||
149944120|NCT00614393|540929462|FG004|Overall Study|Protocol Violation|0|||
149944121|NCT00614393|540929458|FG000|Overall Study|Terminated by Sponsor|0|||
150274824|NCT00874770|542144503|FG003|Overall Study|Lack of Efficacy|2|||
150274825|NCT00874770|542144500|FG000|Overall Study|Adverse Event|1|||
150274826|NCT00874770|542144501|FG001|Overall Study|Adverse Event|1|||
149944122|NCT00614393|540929459|FG001|Overall Study|Terminated by Sponsor|0|||
149944123|NCT00614393|540929460|FG002|Overall Study|Terminated by Sponsor|0|||
149944124|NCT00614393|540929461|FG003|Overall Study|Terminated by Sponsor|0|||
149944125|NCT00614393|540929462|FG004|Overall Study|Terminated by Sponsor|1|||
149944126|NCT00614393|540929458|FG000|Overall Study|Withdrawal by Subject|20|||
150274827|NCT00874770|542144502|FG002|Overall Study|Adverse Event|4|||
149944127|NCT00614393|540929459|FG001|Overall Study|Withdrawal by Subject|1|||
149944128|NCT00614393|540929460|FG002|Overall Study|Withdrawal by Subject|1|||
149822242|NCT00458302|540479502|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
149822243|NCT00458302|540479501|FG000|Overall Study|Study Termination By Sponsor|1|||
149822244|NCT00458302|540479502|FG001|Overall Study|Study Termination By Sponsor|0|||
149822245|NCT00458302|540479501|FG000|Overall Study|Lost to Follow-up|2|||
149822246|NCT00458302|540479502|FG001|Overall Study|Lost to Follow-up|0|||
149822247|NCT00458302|540479501|FG000|Overall Study|Other|4|||
149822248|NCT00458302|540479502|FG001|Overall Study|Other|2|||
149822249|NCT01144663|540479503|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
149822250|NCT01144663|540479504|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
149822251|NCT01144663|540479505|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
149822252|NCT01144663|540479506|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
150032787|NCT02234843|541259354|FG005|Overall Study|Non-compliance with study drug|1|||
149822253|NCT01144663|540479503|FG000|Primary Vaccination Phase|Adverse Event|1|||
149822254|NCT01144663|540479504|FG001|Primary Vaccination Phase|Adverse Event|0|||
149822255|NCT01144663|540479505|FG002|Primary Vaccination Phase|Adverse Event|0|||
149822256|NCT01144663|540479506|FG003|Primary Vaccination Phase|Adverse Event|1|||
149822257|NCT01144663|540479503|FG000|Primary Vaccination Phase|Protocol Violation|2|||
149822258|NCT01144663|540479504|FG001|Primary Vaccination Phase|Protocol Violation|0|||
149822259|NCT01144663|540479505|FG002|Primary Vaccination Phase|Protocol Violation|1|||
149822260|NCT01144663|540479506|FG003|Primary Vaccination Phase|Protocol Violation|0|||
149822261|NCT01144663|540479503|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
149822262|NCT01144663|540479504|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
149822263|NCT01144663|540479505|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
149822264|NCT01144663|540479506|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
149822265|NCT01144663|540479503|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
149822266|NCT01144663|540479504|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
149822267|NCT01144663|540479505|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
149822268|NCT01144663|540479506|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
149822269|NCT01144663|540479503|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
149822270|NCT01144663|540479504|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
149822271|NCT01144663|540479505|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
149822272|NCT01144663|540479506|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
149822273|NCT01144663|540479503|FG000|Primary Vaccination Phase|Other|0|||
149822274|NCT01144663|540479504|FG001|Primary Vaccination Phase|Other|1|||
149822275|NCT01144663|540479505|FG002|Primary Vaccination Phase|Other|0|||
149822276|NCT01144663|540479506|FG003|Primary Vaccination Phase|Other|2|||
149822277|NCT01144663|540479503|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
149822278|NCT01144663|540479504|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
149822279|NCT01144663|540479505|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
149822280|NCT01144663|540479506|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
149822281|NCT01144663|540479503|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
149822282|NCT01144663|540479504|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
149822283|NCT01144663|540479505|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
149822284|NCT01144663|540479506|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
149822285|NCT01144663|540479503|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
149822286|NCT01144663|540479504|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
149822287|NCT01144663|540479505|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
149822288|NCT01144663|540479506|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
149822289|NCT01144663|540479503|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
149822290|NCT01144663|540479504|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
149822291|NCT01144663|540479505|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
149822292|NCT01144663|540479506|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
149822293|NCT01144663|540479503|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
149822294|NCT01144663|540479504|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
149822295|NCT01144663|540479505|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
149822296|NCT01144663|540479506|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
149822297|NCT01144663|540479503|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
149822298|NCT01144663|540479504|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
149822299|NCT01144663|540479505|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
149822300|NCT01144663|540479506|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
149822301|NCT01466686|540479508|FG000|Overall Study|Withdrawal by Subject|1|||
149822302|NCT03273387|540479516|FG000|Overall Study|Death|2|||
149822303|NCT03273387|540479517|FG001|Overall Study|Death|2|||
149822304|NCT03273387|540479516|FG000|Overall Study|Withdrawal by Subject|1|||
149822305|NCT03273387|540479517|FG001|Overall Study|Withdrawal by Subject|1|||
149822306|NCT00658320|540479518|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
149822307|NCT00658320|540479519|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
150032788|NCT02234843|541259355|FG006|Overall Study|Non-compliance with study drug|1|||
150032789|NCT02234843|541259356|FG007|Overall Study|Non-compliance with study drug|0|||
150032790|NCT02234843|541259357|FG008|Overall Study|Non-compliance with study drug|0|||
149822308|NCT00658320|540479518|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
149822309|NCT00658320|540479519|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
149822310|NCT00658320|540479518|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
149822311|NCT00658320|540479519|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
149822312|NCT00658320|540479518|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
149822313|NCT00658320|540479519|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
149822314|NCT01007916|540479529|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
149822315|NCT01007916|540479530|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
149822316|NCT01007916|540479529|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
149822317|NCT01007916|540479530|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
149822318|NCT02040428|540479531|FG000|Overall Study|Death|4|||
149822319|NCT02040428|540479532|FG001|Overall Study|Death|3|||
149822320|NCT02040428|540479531|FG000|Overall Study|Withdrawal by Subject|1|||
149822321|NCT02040428|540479532|FG001|Overall Study|Withdrawal by Subject|1|||
149822322|NCT02058628|540479533|FG000|Overall Study|Adverse Event|1|||
149822323|NCT02058628|540479534|FG001|Overall Study|Adverse Event|0|||
149822324|NCT02058628|540479533|FG000|Overall Study|Withdrawal by Subject|2|||
149822325|NCT02058628|540479534|FG001|Overall Study|Withdrawal by Subject|2|||
149822326|NCT02058628|540479533|FG000|Overall Study|Lost to Follow-up|2|||
149822327|NCT02058628|540479534|FG001|Overall Study|Lost to Follow-up|4|||
149822328|NCT02058628|540479533|FG000|Overall Study|Not in time schedule|0|||
149822329|NCT02058628|540479534|FG001|Overall Study|Not in time schedule|1|||
149822330|NCT02058628|540479533|FG000|Overall Study|The visit date was not in timeline|0|||
149822331|NCT02058628|540479534|FG001|Overall Study|The visit date was not in timeline|1|||
149822332|NCT02058628|540479533|FG000|Overall Study|A lot of time for study for participant|1|||
149822333|NCT02058628|540479534|FG001|Overall Study|A lot of time for study for participant|0|||
149822334|NCT02058628|540479533|FG000|Overall Study|Non compliance|1|||
149822335|NCT02058628|540479534|FG001|Overall Study|Non compliance|0|||
149822336|NCT02961920|540479535|FG000|Overall Study|did not achive stydy protocol schedule|1|||
149822337|NCT02961920|540479536|FG001|Overall Study|did not achive stydy protocol schedule|1|||
149944129|NCT00614393|540929461|FG003|Overall Study|Withdrawal by Subject|16|||
149944130|NCT00614393|540929462|FG004|Overall Study|Withdrawal by Subject|13|||
149944131|NCT00614393|540929458|FG000|Overall Study|Other|4|||
149944132|NCT00614393|540929459|FG001|Overall Study|Other|0|||
149944133|NCT00614393|540929460|FG002|Overall Study|Other|0|||
149944134|NCT00614393|540929461|FG003|Overall Study|Other|4|||
149944135|NCT00614393|540929462|FG004|Overall Study|Other|2|||
149944136|NCT00614393|540929458|FG000|Overall Study|Not Treated|0|||
149944137|NCT00614393|540929459|FG001|Overall Study|Not Treated|0|||
149944138|NCT00614393|540929460|FG002|Overall Study|Not Treated|0|||
149944139|NCT00614393|540929461|FG003|Overall Study|Not Treated|0|||
149944140|NCT00614393|540929462|FG004|Overall Study|Not Treated|2|||
149944141|NCT03345004|540929463|FG000|Overall Study|Physician Decision|1|||
149944142|NCT03345004|540929464|FG001|Overall Study|Physician Decision|0|||
149944143|NCT03345004|540929463|FG000|Overall Study|Withdrawal by Subject|0|||
149944144|NCT03345004|540929464|FG001|Overall Study|Withdrawal by Subject|1|||
149944145|NCT01013753|540929467|FG000|Overall Study|Adverse Event|8|||
149944146|NCT01013753|540929467|FG000|Overall Study|Protocol Violation|3|||
149944147|NCT01013753|540929467|FG000|Overall Study|Lost to Follow-up|1|||
149944148|NCT01013753|540929467|FG000|Overall Study|Withdrawal by Subject|2|||
149944149|NCT01013753|540929467|FG000|Overall Study|Other|2|||
149944150|NCT04757636|540929471|FG000|Overall Study|Adverse Event|25|||
149944151|NCT04757636|540929472|FG001|Overall Study|Adverse Event|8|||
149944152|NCT04757636|540929473|FG002|Overall Study|Adverse Event|11|||
149944153|NCT04757636|540929471|FG000|Overall Study|Death|9|||
149944154|NCT04757636|540929472|FG001|Overall Study|Death|12|||
149944155|NCT04757636|540929473|FG002|Overall Study|Death|6|||
150032791|NCT02234843|541259358|FG009|Overall Study|Non-compliance with study drug|0|||
150032792|NCT02234843|541259349|FG000|Overall Study|Lost to Follow-up|0|||
150032793|NCT02234843|541259350|FG001|Overall Study|Lost to Follow-up|1|||
150032794|NCT02234843|541259351|FG002|Overall Study|Lost to Follow-up|0|||
150032795|NCT02234843|541259352|FG003|Overall Study|Lost to Follow-up|0|||
150032796|NCT02234843|541259353|FG004|Overall Study|Lost to Follow-up|0|||
149822338|NCT01927757|540479539|FG000|Overall Study|Withdrawal by Subject|14|||
149822339|NCT01927757|540479539|FG000|Overall Study|Lost to Follow-up|2|||
149822340|NCT01927757|540479539|FG000|Overall Study|Decision by Sponsor|2|||
149822341|NCT01927757|540479539|FG000|Overall Study|Other|1|||
149822342|NCT01927757|540479539|FG000|Overall Study|Ethical Reasons|4|||
149822343|NCT00444795|540479540|FG000|Overall Study|Not Treated|1|||
149944156|NCT04757636|540929471|FG000|Overall Study|Lack of Efficacy|2|||
149944157|NCT04757636|540929472|FG001|Overall Study|Lack of Efficacy|0|||
149944158|NCT04757636|540929473|FG002|Overall Study|Lack of Efficacy|0|||
149944159|NCT04757636|540929471|FG000|Overall Study|Lost to Follow-up|1|||
149944160|NCT04757636|540929472|FG001|Overall Study|Lost to Follow-up|6|||
149944161|NCT04757636|540929473|FG002|Overall Study|Lost to Follow-up|7|||
149944162|NCT04757636|540929471|FG000|Overall Study|Physician Decision|1|||
149944163|NCT04757636|540929472|FG001|Overall Study|Physician Decision|3|||
150032797|NCT02234843|541259354|FG005|Overall Study|Lost to Follow-up|0|||
149822344|NCT00444795|540479540|FG000|Overall Study|Treated Prior to the Contract Date|2|||
149822345|NCT00988169|540479541|FG000|Overall Study|Withdrawal by Subject|1|||
149822346|NCT02322879|540479543|FG000|First Intervention|Physician Decision|1|||
149822347|NCT02322879|540479544|FG001|First Intervention|Physician Decision|0|||
149822348|NCT00130520|540479545|FG000|Overall Study|Adverse Event|11|||
149822349|NCT00130520|540479545|FG000|Overall Study|Death|1|||
149822350|NCT00130520|540479545|FG000|Overall Study|Physician Decision|1|||
149822351|NCT00130520|540479545|FG000|Overall Study|Withdrawal by Subject|1|||
149822352|NCT00130520|540479545|FG000|Overall Study|Disease Progression|23|||
149822353|NCT00130520|540479545|FG000|Overall Study|Protocol non-compliance|1|||
149822354|NCT00130520|540479545|FG000|Overall Study|Did not meet re-treatment criteria|1|||
149822355|NCT01464827|540479546|FG000|Overall Study|Adverse Event|0|||
149822356|NCT01464827|540479547|FG001|Overall Study|Adverse Event|0|||
149822357|NCT01464827|540479548|FG002|Overall Study|Adverse Event|0|||
149822358|NCT01464827|540479549|FG003|Overall Study|Adverse Event|0|||
149822359|NCT01464827|540479550|FG004|Overall Study|Adverse Event|0|||
149822360|NCT01464827|540479551|FG005|Overall Study|Adverse Event|0|||
149822361|NCT01464827|540479552|FG006|Overall Study|Adverse Event|0|||
149822362|NCT01464827|540479553|FG007|Overall Study|Adverse Event|0|||
149822363|NCT01464827|540479554|FG008|Overall Study|Adverse Event|0|||
149822364|NCT01464827|540479555|FG009|Overall Study|Adverse Event|0|||
149822365|NCT01464827|540479556|FG010|Overall Study|Adverse Event|0|||
149822366|NCT01464827|540479557|FG011|Overall Study|Adverse Event|0|||
149822367|NCT01464827|540479558|FG012|Overall Study|Adverse Event|1|||
149822368|NCT01464827|540479559|FG013|Overall Study|Adverse Event|0|||
149822369|NCT01464827|540479546|FG000|Overall Study|Withdrawal by Subject|1|||
149822370|NCT01464827|540479547|FG001|Overall Study|Withdrawal by Subject|0|||
149822371|NCT01464827|540479548|FG002|Overall Study|Withdrawal by Subject|0|||
149822372|NCT01464827|540479549|FG003|Overall Study|Withdrawal by Subject|0|||
149822373|NCT01464827|540479550|FG004|Overall Study|Withdrawal by Subject|1|||
149822374|NCT01464827|540479551|FG005|Overall Study|Withdrawal by Subject|0|||
149822375|NCT01464827|540479552|FG006|Overall Study|Withdrawal by Subject|0|||
149822376|NCT01464827|540479553|FG007|Overall Study|Withdrawal by Subject|1|||
149822377|NCT01464827|540479554|FG008|Overall Study|Withdrawal by Subject|0|||
149822378|NCT01464827|540479555|FG009|Overall Study|Withdrawal by Subject|0|||
149822379|NCT01464827|540479556|FG010|Overall Study|Withdrawal by Subject|0|||
149822380|NCT01464827|540479557|FG011|Overall Study|Withdrawal by Subject|0|||
149822381|NCT01464827|540479558|FG012|Overall Study|Withdrawal by Subject|0|||
149822382|NCT01464827|540479559|FG013|Overall Study|Withdrawal by Subject|0|||
149822383|NCT01464827|540479546|FG000|Overall Study|Lost to Follow-up|0|||
149822384|NCT01464827|540479547|FG001|Overall Study|Lost to Follow-up|2|||
149822385|NCT01464827|540479548|FG002|Overall Study|Lost to Follow-up|0|||
149822386|NCT01464827|540479549|FG003|Overall Study|Lost to Follow-up|2|||
149822387|NCT01464827|540479550|FG004|Overall Study|Lost to Follow-up|3|||
149822388|NCT01464827|540479551|FG005|Overall Study|Lost to Follow-up|1|||
149944164|NCT04757636|540929473|FG002|Overall Study|Physician Decision|4|||
149944165|NCT04757636|540929471|FG000|Overall Study|Withdrawal by Subject|20|||
149944166|NCT04757636|540929472|FG001|Overall Study|Withdrawal by Subject|23|||
150170264|NCT03525119|541759034|FG002|Overall Study|Withdrawal by Subject|2|||
150170265|NCT03525119|541759032|FG000|Overall Study|Reason not Specified|2|||
150170266|NCT03525119|541759033|FG001|Overall Study|Reason not Specified|1|||
150170267|NCT03525119|541759034|FG002|Overall Study|Reason not Specified|2|||
150170268|NCT03525119|541759032|FG000|Overall Study|Randomized but not Vaccinated|1|||
150170269|NCT03525119|541759033|FG001|Overall Study|Randomized but not Vaccinated|0|||
150170270|NCT03525119|541759034|FG002|Overall Study|Randomized but not Vaccinated|2|||
150170271|NCT03781336|541759035|FG000|Overall Study|Withdrawal by Subject|2|||
150170272|NCT03781336|541759036|FG001|Overall Study|Withdrawal by Subject|2|||
150170273|NCT04379713|541759047|FG000|Overall Study|Adverse Event|2|||
150170274|NCT04379713|541759048|FG001|Overall Study|Adverse Event|0|||
150170275|NCT04379713|541759047|FG000|Overall Study|Physician Decision|2|||
150170276|NCT04379713|541759048|FG001|Overall Study|Physician Decision|1|||
150170277|NCT04379713|541759047|FG000|Overall Study|Protocol Violation|11|||
150170278|NCT04379713|541759048|FG001|Overall Study|Protocol Violation|6|||
150170279|NCT04379713|541759047|FG000|Overall Study|No longer met eligibility criteria|14|||
150170280|NCT04379713|541759048|FG001|Overall Study|No longer met eligibility criteria|11|||
150170281|NCT04379713|541759047|FG000|Overall Study|Withdrawal by parent/guardian|36|||
150170282|NCT04379713|541759048|FG001|Overall Study|Withdrawal by parent/guardian|15|||
150170283|NCT04379713|541759047|FG000|Overall Study|Lost to Follow-up|31|||
150170284|NCT04379713|541759048|FG001|Overall Study|Lost to Follow-up|21|||
150170285|NCT02148133|541759052|FG000|Overall Study|Investigator discretion|1|||
150170286|NCT02148133|541759052|FG000|Overall Study|Lack of Efficacy|1|||
150170287|NCT02148133|541759052|FG000|Overall Study|Protocol deviation|1|||
150170288|NCT02148133|541759052|FG000|Overall Study|Protocol-defined stopping criteria|2|||
149822389|NCT01464827|540479552|FG006|Overall Study|Lost to Follow-up|2|||
149822390|NCT01464827|540479553|FG007|Overall Study|Lost to Follow-up|2|||
149822391|NCT01464827|540479554|FG008|Overall Study|Lost to Follow-up|0|||
149822392|NCT01464827|540479555|FG009|Overall Study|Lost to Follow-up|0|||
149822393|NCT01464827|540479556|FG010|Overall Study|Lost to Follow-up|0|||
149822394|NCT01464827|540479557|FG011|Overall Study|Lost to Follow-up|1|||
149822395|NCT01464827|540479558|FG012|Overall Study|Lost to Follow-up|0|||
149822396|NCT01464827|540479559|FG013|Overall Study|Lost to Follow-up|1|||
149822397|NCT01464827|540479546|FG000|Overall Study|Other|2|||
149822398|NCT01464827|540479547|FG001|Overall Study|Other|3|||
149822399|NCT01464827|540479548|FG002|Overall Study|Other|0|||
149822400|NCT01464827|540479549|FG003|Overall Study|Other|2|||
149822401|NCT01464827|540479550|FG004|Overall Study|Other|3|||
149822402|NCT01464827|540479551|FG005|Overall Study|Other|0|||
149822403|NCT01464827|540479552|FG006|Overall Study|Other|1|||
149822404|NCT01464827|540479553|FG007|Overall Study|Other|0|||
149822405|NCT01464827|540479554|FG008|Overall Study|Other|3|||
149822406|NCT01464827|540479555|FG009|Overall Study|Other|1|||
149822407|NCT01464827|540479556|FG010|Overall Study|Other|2|||
149822408|NCT01464827|540479557|FG011|Overall Study|Other|0|||
149822409|NCT01464827|540479558|FG012|Overall Study|Other|1|||
149822410|NCT01464827|540479559|FG013|Overall Study|Other|0|||
149822411|NCT01464827|540479546|FG000|Overall Study|Not Treated|0|||
149822412|NCT01464827|540479547|FG001|Overall Study|Not Treated|2|||
149822413|NCT01464827|540479548|FG002|Overall Study|Not Treated|0|||
149822414|NCT01464827|540479549|FG003|Overall Study|Not Treated|0|||
149822415|NCT01464827|540479550|FG004|Overall Study|Not Treated|1|||
149822416|NCT01464827|540479551|FG005|Overall Study|Not Treated|0|||
149822417|NCT01464827|540479552|FG006|Overall Study|Not Treated|1|||
149822418|NCT01464827|540479553|FG007|Overall Study|Not Treated|0|||
149822419|NCT01464827|540479554|FG008|Overall Study|Not Treated|0|||
149822420|NCT01464827|540479555|FG009|Overall Study|Not Treated|2|||
149822421|NCT01464827|540479556|FG010|Overall Study|Not Treated|0|||
149822422|NCT01464827|540479557|FG011|Overall Study|Not Treated|1|||
149822423|NCT01464827|540479558|FG012|Overall Study|Not Treated|0|||
149822424|NCT01464827|540479559|FG013|Overall Study|Not Treated|2|||
149822425|NCT03487796|540479560|FG000|Overall Study|Lost to Follow-up|18|||
149822426|NCT03487796|540479561|FG001|Overall Study|Lost to Follow-up|6|||
149822427|NCT00613574|540479562|FG000|Overall Study|Adverse Event|3|||
149822428|NCT00613574|540479562|FG000|Overall Study|Lost to Follow-up|2|||
149822429|NCT00613574|540479562|FG000|Overall Study|Other|1|||
149822430|NCT04604184|540479564|FG000|Overall Study|Adverse Event|5|||
149822431|NCT04604184|540479565|FG001|Overall Study|Adverse Event|5|||
149822432|NCT04604184|540479564|FG000|Overall Study|Death|2|||
149822433|NCT04604184|540479565|FG001|Overall Study|Death|1|||
149822434|NCT04604184|540479564|FG000|Overall Study|Withdrawal by Subject|1|||
149822435|NCT04604184|540479565|FG001|Overall Study|Withdrawal by Subject|3|||
149822436|NCT04604184|540479564|FG000|Overall Study|Not treated|2|||
149822437|NCT04604184|540479565|FG001|Overall Study|Not treated|2|||
149822438|NCT04604184|540479564|FG000|Overall Study|Due to sponsor decision|9|||
149822439|NCT04604184|540479565|FG001|Overall Study|Due to sponsor decision|7|||
149822440|NCT04604184|540479564|FG000|Overall Study|Physician Decision|0|||
149822441|NCT04604184|540479565|FG001|Overall Study|Physician Decision|1|||
149822442|NCT04604184|540479564|FG000|Overall Study|Transfer to healthcare|1|||
149822443|NCT04604184|540479565|FG001|Overall Study|Transfer to healthcare|0|||
149822444|NCT00582036|540479566|FG000|Overall Study|Withdrawal by Subject|0|||
149822445|NCT00582036|540479567|FG001|Overall Study|Withdrawal by Subject|1|||
149822446|NCT02711956|540479568|FG000|Overall Study|Adverse Event|0|||
149822447|NCT02711956|540479569|FG001|Overall Study|Adverse Event|0|||
149822448|NCT02711956|540479570|FG002|Overall Study|Adverse Event|0|||
149822449|NCT02711956|540479571|FG003|Overall Study|Adverse Event|1|||
149822450|NCT02711956|540479572|FG004|Overall Study|Adverse Event|2|||
149822451|NCT02711956|540479573|FG005|Overall Study|Adverse Event|0|||
149822452|NCT02711956|540479574|FG006|Overall Study|Adverse Event|0|||
149822453|NCT02711956|540479575|FG007|Overall Study|Adverse Event|1|||
149822454|NCT02711956|540479576|FG008|Overall Study|Adverse Event|1|||
149822455|NCT02711956|540479577|FG009|Overall Study|Adverse Event|1|||
149822456|NCT02711956|540479578|FG010|Overall Study|Adverse Event|1|||
149822457|NCT02711956|540479579|FG011|Overall Study|Adverse Event|0|||
149822458|NCT02711956|540479580|FG012|Overall Study|Adverse Event|0|||
149822459|NCT02711956|540479581|FG013|Overall Study|Adverse Event|0|||
149822460|NCT02711956|540479582|FG014|Overall Study|Adverse Event|2|||
149822461|NCT02711956|540479568|FG000|Overall Study|Physician Decision|0|||
149822462|NCT02711956|540479569|FG001|Overall Study|Physician Decision|0|||
149822463|NCT02711956|540479570|FG002|Overall Study|Physician Decision|0|||
149822464|NCT02711956|540479571|FG003|Overall Study|Physician Decision|2|||
149822465|NCT02711956|540479572|FG004|Overall Study|Physician Decision|0|||
149822466|NCT02711956|540479573|FG005|Overall Study|Physician Decision|0|||
149822467|NCT02711956|540479574|FG006|Overall Study|Physician Decision|0|||
149822468|NCT02711956|540479575|FG007|Overall Study|Physician Decision|0|||
149822469|NCT02711956|540479576|FG008|Overall Study|Physician Decision|0|||
149822470|NCT02711956|540479577|FG009|Overall Study|Physician Decision|0|||
149822471|NCT02711956|540479578|FG010|Overall Study|Physician Decision|0|||
149822472|NCT02711956|540479579|FG011|Overall Study|Physician Decision|0|||
149822473|NCT02711956|540479580|FG012|Overall Study|Physician Decision|0|||
149822474|NCT02711956|540479581|FG013|Overall Study|Physician Decision|0|||
149822475|NCT02711956|540479582|FG014|Overall Study|Physician Decision|0|||
149822476|NCT02711956|540479568|FG000|Overall Study|Withdrawal by Subject|0|||
149822477|NCT02711956|540479569|FG001|Overall Study|Withdrawal by Subject|0|||
149822478|NCT02711956|540479570|FG002|Overall Study|Withdrawal by Subject|0|||
149822479|NCT02711956|540479571|FG003|Overall Study|Withdrawal by Subject|0|||
149822480|NCT02711956|540479572|FG004|Overall Study|Withdrawal by Subject|0|||
149822481|NCT02711956|540479573|FG005|Overall Study|Withdrawal by Subject|0|||
149822482|NCT02711956|540479574|FG006|Overall Study|Withdrawal by Subject|1|||
149822483|NCT02711956|540479575|FG007|Overall Study|Withdrawal by Subject|0|||
149822484|NCT02711956|540479576|FG008|Overall Study|Withdrawal by Subject|0|||
149822485|NCT02711956|540479577|FG009|Overall Study|Withdrawal by Subject|0|||
149822486|NCT02711956|540479578|FG010|Overall Study|Withdrawal by Subject|0|||
149822487|NCT02711956|540479579|FG011|Overall Study|Withdrawal by Subject|1|||
149822488|NCT02711956|540479580|FG012|Overall Study|Withdrawal by Subject|6|||
149822489|NCT02711956|540479581|FG013|Overall Study|Withdrawal by Subject|0|||
149822490|NCT02711956|540479582|FG014|Overall Study|Withdrawal by Subject|1|||
149822491|NCT02711956|540479568|FG000|Overall Study|Clinical progression|1|||
149822492|NCT02711956|540479569|FG001|Overall Study|Clinical progression|0|||
149822493|NCT02711956|540479570|FG002|Overall Study|Clinical progression|0|||
149822494|NCT02711956|540479571|FG003|Overall Study|Clinical progression|0|||
149822495|NCT02711956|540479572|FG004|Overall Study|Clinical progression|0|||
149822496|NCT02711956|540479573|FG005|Overall Study|Clinical progression|0|||
149822497|NCT02711956|540479574|FG006|Overall Study|Clinical progression|1|||
149822498|NCT02711956|540479575|FG007|Overall Study|Clinical progression|0|||
149822499|NCT02711956|540479576|FG008|Overall Study|Clinical progression|1|||
149822500|NCT02711956|540479577|FG009|Overall Study|Clinical progression|0|||
149822501|NCT02711956|540479578|FG010|Overall Study|Clinical progression|0|||
149822502|NCT02711956|540479579|FG011|Overall Study|Clinical progression|2|||
149822503|NCT02711956|540479580|FG012|Overall Study|Clinical progression|4|||
149822504|NCT02711956|540479581|FG013|Overall Study|Clinical progression|1|||
149822505|NCT02711956|540479582|FG014|Overall Study|Clinical progression|1|||
149822506|NCT02711956|540479568|FG000|Overall Study|Radiographic progression|1|||
149822507|NCT02711956|540479569|FG001|Overall Study|Radiographic progression|1|||
149822508|NCT02711956|540479570|FG002|Overall Study|Radiographic progression|2|||
149822509|NCT02711956|540479571|FG003|Overall Study|Radiographic progression|0|||
149822510|NCT02711956|540479572|FG004|Overall Study|Radiographic progression|1|||
150032798|NCT02234843|541259355|FG006|Overall Study|Lost to Follow-up|1|||
150032799|NCT02234843|541259356|FG007|Overall Study|Lost to Follow-up|0|||
150032800|NCT02234843|541259357|FG008|Overall Study|Lost to Follow-up|0|||
149822511|NCT02711956|540479573|FG005|Overall Study|Radiographic progression|0|||
149822512|NCT02711956|540479574|FG006|Overall Study|Radiographic progression|0|||
149822513|NCT02711956|540479575|FG007|Overall Study|Radiographic progression|0|||
149822514|NCT02711956|540479576|FG008|Overall Study|Radiographic progression|2|||
149822515|NCT02711956|540479577|FG009|Overall Study|Radiographic progression|1|||
149822516|NCT02711956|540479578|FG010|Overall Study|Radiographic progression|0|||
149822517|NCT02711956|540479579|FG011|Overall Study|Radiographic progression|5|||
149822518|NCT02711956|540479580|FG012|Overall Study|Radiographic progression|3|||
149822519|NCT02711956|540479581|FG013|Overall Study|Radiographic progression|0|||
149822520|NCT02711956|540479582|FG014|Overall Study|Radiographic progression|1|||
149822521|NCT02711956|540479568|FG000|Overall Study|PSA progression with clinical progression|0|||
149822522|NCT02711956|540479569|FG001|Overall Study|PSA progression with clinical progression|0|||
149822523|NCT02711956|540479570|FG002|Overall Study|PSA progression with clinical progression|0|||
149822524|NCT02711956|540479571|FG003|Overall Study|PSA progression with clinical progression|0|||
149822525|NCT02711956|540479572|FG004|Overall Study|PSA progression with clinical progression|1|||
149822526|NCT02711956|540479573|FG005|Overall Study|PSA progression with clinical progression|0|||
149822527|NCT02711956|540479574|FG006|Overall Study|PSA progression with clinical progression|0|||
149822528|NCT02711956|540479575|FG007|Overall Study|PSA progression with clinical progression|0|||
149822529|NCT02711956|540479576|FG008|Overall Study|PSA progression with clinical progression|0|||
149822530|NCT02711956|540479577|FG009|Overall Study|PSA progression with clinical progression|0|||
149822531|NCT02711956|540479578|FG010|Overall Study|PSA progression with clinical progression|0|||
149822532|NCT02711956|540479579|FG011|Overall Study|PSA progression with clinical progression|0|||
149822533|NCT02711956|540479580|FG012|Overall Study|PSA progression with clinical progression|1|||
149822534|NCT02711956|540479581|FG013|Overall Study|PSA progression with clinical progression|1|||
149822535|NCT02711956|540479582|FG014|Overall Study|PSA progression with clinical progression|0|||
149822536|NCT02711956|540479568|FG000|Overall Study|PSA progression with radiographic progression|0|||
149822537|NCT02711956|540479569|FG001|Overall Study|PSA progression with radiographic progression|1|||
149822538|NCT02711956|540479570|FG002|Overall Study|PSA progression with radiographic progression|0|||
149822539|NCT02711956|540479571|FG003|Overall Study|PSA progression with radiographic progression|0|||
149822540|NCT02711956|540479572|FG004|Overall Study|PSA progression with radiographic progression|0|||
149822541|NCT02711956|540479573|FG005|Overall Study|PSA progression with radiographic progression|2|||
149822542|NCT02711956|540479574|FG006|Overall Study|PSA progression with radiographic progression|2|||
149822543|NCT02711956|540479575|FG007|Overall Study|PSA progression with radiographic progression|1|||
149822544|NCT02711956|540479576|FG008|Overall Study|PSA progression with radiographic progression|0|||
149822545|NCT02711956|540479577|FG009|Overall Study|PSA progression with radiographic progression|1|||
149822546|NCT02711956|540479578|FG010|Overall Study|PSA progression with radiographic progression|0|||
149822547|NCT02711956|540479579|FG011|Overall Study|PSA progression with radiographic progression|1|||
149822548|NCT02711956|540479580|FG012|Overall Study|PSA progression with radiographic progression|2|||
149822549|NCT02711956|540479581|FG013|Overall Study|PSA progression with radiographic progression|3|||
149822550|NCT02711956|540479582|FG014|Overall Study|PSA progression with radiographic progression|3|||
149822551|NCT05487456|540479583|FG000|Overall Study|Withdrawal by Subject|0|||
149822552|NCT05487456|540479584|FG001|Overall Study|Withdrawal by Subject|0|||
149822553|NCT05487456|540479585|FG002|Overall Study|Withdrawal by Subject|1|||
149822554|NCT05487456|540479586|FG003|Overall Study|Withdrawal by Subject|0|||
149822555|NCT01625377|540479589|FG000|Overall Study|Death|1|||
149822556|NCT01625377|540479590|FG001|Overall Study|Death|1|||
149822557|NCT01625377|540479589|FG000|Overall Study|Administrative Problem|1|||
149822558|NCT01625377|540479590|FG001|Overall Study|Administrative Problem|1|||
149822559|NCT01625377|540479589|FG000|Overall Study|Protocol Violation|0|||
149822560|NCT01625377|540479590|FG001|Overall Study|Protocol Violation|3|||
149822561|NCT01625377|540479589|FG000|Overall Study|Adverse Event|3|||
149822562|NCT01625377|540479590|FG001|Overall Study|Adverse Event|16|||
149822563|NCT01625377|540479589|FG000|Overall Study|Graft loss|1|||
149822564|NCT01625377|540479590|FG001|Overall Study|Graft loss|0|||
150170289|NCT03808883|541759053|FG000|Overall Study|Withdrawal by Subject|2|||
150170290|NCT03808883|541759054|FG001|Overall Study|Withdrawal by Subject|0|||
150170291|NCT03808883|541759053|FG000|Overall Study|Did not complete pre test or post test survey|4|||
150170292|NCT03808883|541759054|FG001|Overall Study|Did not complete pre test or post test survey|3|||
150170293|NCT02613364|541759055|FG000|Overall Study|Other|19|||
150170294|NCT02613364|541759056|FG001|Overall Study|Other|29|||
150170295|NCT02613364|541759057|FG002|Overall Study|Other|17|||
150170296|NCT02613364|541759055|FG000|Overall Study|Too time consuming|21|||
150170297|NCT02613364|541759056|FG001|Overall Study|Too time consuming|26|||
150170298|NCT02613364|541759057|FG002|Overall Study|Too time consuming|26|||
150170299|NCT02613364|541759055|FG000|Overall Study|Withdrawal by Subject|13|||
150170300|NCT02613364|541759056|FG001|Overall Study|Withdrawal by Subject|18|||
150170301|NCT02613364|541759057|FG002|Overall Study|Withdrawal by Subject|17|||
150170302|NCT02613364|541759055|FG000|Overall Study|Medical|12|||
150170303|NCT02613364|541759056|FG001|Overall Study|Medical|13|||
150170304|NCT02613364|541759057|FG002|Overall Study|Medical|9|||
150170305|NCT02613364|541759055|FG000|Overall Study|Disliked Study Procedure|1|||
149822565|NCT01625377|540479589|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149822566|NCT01625377|540479590|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149822567|NCT01625377|540479589|FG000|Overall Study|Abnormal laboratory values|1|||
149944167|NCT04757636|540929473|FG002|Overall Study|Withdrawal by Subject|18|||
149944168|NCT04757636|540929471|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
150274828|NCT00874770|542144503|FG003|Overall Study|Adverse Event|2|||
150274829|NCT00874770|542144500|FG000|Overall Study|Lost to Follow-up|1|||
150274830|NCT00874770|542144501|FG001|Overall Study|Lost to Follow-up|0|||
150274831|NCT00874770|542144502|FG002|Overall Study|Lost to Follow-up|0|||
150274832|NCT00874770|542144503|FG003|Overall Study|Lost to Follow-up|1|||
150274833|NCT00874770|542144500|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
150274834|NCT00874770|542144501|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
150274835|NCT00874770|542144502|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
150274836|NCT00874770|542144503|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
150274837|NCT04880447|542144504|FG000|Overall Study|No vaccination information|1|||
150274838|NCT04880447|542144504|FG000|Overall Study|No adverse event information (missing information)|1|||
150274839|NCT04880447|542144504|FG000|Overall Study|Disease not covered in this study|35|||
150274840|NCT00718549|542144505|FG000|Induction Phase|Disease Progression|1|||
150274841|NCT00718549|542144506|FG001|Induction Phase|Disease Progression|0|||
150274842|NCT00718549|542144507|FG002|Induction Phase|Disease Progression|0|||
150274843|NCT00718549|542144505|FG000|Induction Phase|Eligibility Criteria Violation|2|||
150274844|NCT00718549|542144506|FG001|Induction Phase|Eligibility Criteria Violation|0|||
150274845|NCT00718549|542144507|FG002|Induction Phase|Eligibility Criteria Violation|0|||
150274846|NCT00718549|542144505|FG000|Induction Phase|Early Termination - No Additional Info|59|||
150274847|NCT00718549|542144506|FG001|Induction Phase|Early Termination - No Additional Info|0|||
150274848|NCT00718549|542144507|FG002|Induction Phase|Early Termination - No Additional Info|0|||
150274849|NCT00718549|542144505|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
150274850|NCT00718549|542144506|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
150274851|NCT00718549|542144507|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
150274852|NCT00718549|542144505|FG000|Maintenance/ Observation Phase|Death|0|||
150274853|NCT00718549|542144506|FG001|Maintenance/ Observation Phase|Death|1|||
150274854|NCT00718549|542144507|FG002|Maintenance/ Observation Phase|Death|2|||
150032801|NCT02234843|541259358|FG009|Overall Study|Lost to Follow-up|0|||
150032802|NCT01607957|541259361|FG000|Overall Study|Not treated|1|||
150032803|NCT01607957|541259362|FG001|Overall Study|Not treated|1|||
150032804|NCT01607957|541259361|FG000|Overall Study|Death|367|||
150032805|NCT01607957|541259362|FG001|Overall Study|Death|211|||
150032806|NCT01607957|541259361|FG000|Overall Study|Lost to Follow-up|3|||
150032807|NCT01607957|541259362|FG001|Overall Study|Lost to Follow-up|3|||
150032808|NCT01607957|541259361|FG000|Overall Study|Participant refusal|1|||
150274855|NCT00718549|542144505|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
150274856|NCT00718549|542144506|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
150274857|NCT00718549|542144507|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
150274858|NCT00718549|542144505|FG000|Maintenance/ Observation Phase|Progression|0|||
150274859|NCT00718549|542144506|FG001|Maintenance/ Observation Phase|Progression|5|||
150274860|NCT00718549|542144507|FG002|Maintenance/ Observation Phase|Progression|14|||
150274861|NCT00718549|542144505|FG000|Maintenance/ Observation Phase|Relapse|0|||
149822568|NCT01625377|540479590|FG001|Overall Study|Abnormal laboratory values|0|||
149822569|NCT02043366|540479593|FG000|Overall Study|Lost to Follow-up|2|||
149822570|NCT02043366|540479594|FG001|Overall Study|Lost to Follow-up|2|||
149822571|NCT02043366|540479595|FG002|Overall Study|Lost to Follow-up|2|||
149822572|NCT02043366|540479596|FG003|Overall Study|Lost to Follow-up|2|||
149822573|NCT02043366|540479597|FG004|Overall Study|Lost to Follow-up|2|||
149822574|NCT02043366|540479598|FG005|Overall Study|Lost to Follow-up|2|||
149822575|NCT03294538|540479601|FG000|Overall Study|Adverse Event|0|||
149822576|NCT03294538|540479602|FG001|Overall Study|Adverse Event|1|||
149822577|NCT03294538|540479603|FG002|Overall Study|Adverse Event|1|||
149822578|NCT03294538|540479601|FG000|Overall Study|Lost to Follow-up|1|||
149822579|NCT03294538|540479602|FG001|Overall Study|Lost to Follow-up|0|||
149822580|NCT03294538|540479603|FG002|Overall Study|Lost to Follow-up|0|||
149822581|NCT03294538|540479601|FG000|Overall Study|Outside of Visit Window|4|||
149822582|NCT03294538|540479602|FG001|Overall Study|Outside of Visit Window|4|||
149822583|NCT03294538|540479603|FG002|Overall Study|Outside of Visit Window|1|||
149822584|NCT01489956|540479605|FG000|Overall Study|Lost to Follow-up|1|||
149822585|NCT01489956|540479606|FG001|Overall Study|Lost to Follow-up|0|||
149822586|NCT01489956|540479607|FG002|Overall Study|Lost to Follow-up|0|||
149822587|NCT01489956|540479605|FG000|Overall Study|Withdrawal by Subject|0|||
149822588|NCT01489956|540479606|FG001|Overall Study|Withdrawal by Subject|0|||
149822589|NCT01489956|540479607|FG002|Overall Study|Withdrawal by Subject|1|||
149822590|NCT01090765|540479609|FG000|Overall Study|Patient withdrew consent|0|||
149822591|NCT01090765|540479610|FG001|Overall Study|Patient withdrew consent|0|||
149822592|NCT01090765|540479611|FG002|Overall Study|Patient withdrew consent|0|||
149822593|NCT01090765|540479612|FG003|Overall Study|Patient withdrew consent|0|||
149822594|NCT01090765|540479613|FG004|Overall Study|Patient withdrew consent|1|||
149822595|NCT01090765|540479614|FG005|Overall Study|Patient withdrew consent|1|||
149822596|NCT01090765|540479609|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
149822597|NCT01090765|540479610|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
149822598|NCT01090765|540479611|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
149822599|NCT01090765|540479612|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
149822600|NCT01090765|540479613|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
149822601|NCT01090765|540479614|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
149822602|NCT01090765|540479609|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
149822603|NCT01090765|540479610|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
149822604|NCT01090765|540479611|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
149822605|NCT01090765|540479612|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
149822606|NCT01090765|540479613|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
149822607|NCT01090765|540479614|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
149822608|NCT01977092|540479615|FG000|Overall Study|Death|3|||
149822609|NCT01977092|540479616|FG001|Overall Study|Death|4|||
149822610|NCT01977092|540479615|FG000|Overall Study|Lost to Follow-up|23|||
149822611|NCT01977092|540479616|FG001|Overall Study|Lost to Follow-up|14|||
149822612|NCT01977092|540479615|FG000|Overall Study|Withdrawal by Subject|2|||
149822613|NCT01977092|540479616|FG001|Overall Study|Withdrawal by Subject|1|||
149822614|NCT01977092|540479615|FG000|Overall Study|In prison|3|||
149822615|NCT01977092|540479616|FG001|Overall Study|In prison|11|||
149822616|NCT00782509|540479618|FG000|Overall Study|Adverse Event|20|||
149822617|NCT00782509|540479619|FG001|Overall Study|Adverse Event|10|||
149822618|NCT00782509|540479620|FG002|Overall Study|Adverse Event|20|||
150032809|NCT01607957|541259362|FG001|Overall Study|Participant refusal|0|||
150032810|NCT04972786|541259365|FG000|First Intervention (1 Day)|Adverse Event|1|||
150032811|NCT04972786|541259366|FG001|First Intervention (1 Day)|Adverse Event|0|||
150032812|NCT00844844|541259369|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
149822619|NCT00782509|540479618|FG000|Overall Study|Lost to Follow-up|1|||
149822620|NCT00782509|540479619|FG001|Overall Study|Lost to Follow-up|2|||
149822621|NCT00782509|540479620|FG002|Overall Study|Lost to Follow-up|3|||
149822622|NCT00782509|540479618|FG000|Overall Study|Withdrawal by Subject|3|||
150032813|NCT00844844|541259369|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
149822623|NCT00782509|540479619|FG001|Overall Study|Withdrawal by Subject|5|||
149822624|NCT00782509|540479620|FG002|Overall Study|Withdrawal by Subject|8|||
149822625|NCT00782509|540479618|FG000|Overall Study|Non compliance with protocol|2|||
149822626|NCT00782509|540479619|FG001|Overall Study|Non compliance with protocol|0|||
149822627|NCT00782509|540479620|FG002|Overall Study|Non compliance with protocol|0|||
149822628|NCT00782509|540479618|FG000|Overall Study|Other reasons not stated above|5|||
149822629|NCT00782509|540479619|FG001|Overall Study|Other reasons not stated above|2|||
149822630|NCT00782509|540479620|FG002|Overall Study|Other reasons not stated above|3|||
149822631|NCT00782509|540479618|FG000|Overall Study|Lack of Efficacy|10|||
149822632|NCT00782509|540479619|FG001|Overall Study|Lack of Efficacy|5|||
149822633|NCT00782509|540479620|FG002|Overall Study|Lack of Efficacy|2|||
149822634|NCT03222141|540479630|FG000|Overall Study|Death|15|||
149822635|NCT03222141|540479630|FG000|Overall Study|Lost to Follow-up|3|||
149822636|NCT00441584|540479631|FG000|Overall Study|Lack of Efficacy|79|||
149822637|NCT00441584|540479631|FG000|Overall Study|Withdrawal by Subject|8|||
149822638|NCT00441584|540479631|FG000|Overall Study|Adverse Event|6|||
149822639|NCT00441584|540479631|FG000|Overall Study|Protocol Violation|5|||
149822640|NCT00441584|540479631|FG000|Overall Study|Lost to Follow-up|4|||
149822641|NCT00441584|540479631|FG000|Overall Study|Failure to meet eligibility criteria|3|||
149822642|NCT01418352|540479634|FG000|Overall Study|Lost to Follow-up|2|||
149822643|NCT01418352|540479635|FG001|Overall Study|Lost to Follow-up|0|||
149822644|NCT01418352|540479636|FG002|Overall Study|Lost to Follow-up|0|||
149822645|NCT01418352|540479637|FG003|Overall Study|Lost to Follow-up|0|||
149822646|NCT01418352|540479634|FG000|Overall Study|Adverse Event|0|||
149822647|NCT01418352|540479635|FG001|Overall Study|Adverse Event|1|||
149822648|NCT01418352|540479636|FG002|Overall Study|Adverse Event|0|||
149822649|NCT01418352|540479637|FG003|Overall Study|Adverse Event|0|||
149822650|NCT01418352|540479634|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
149822651|NCT01418352|540479635|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
149822652|NCT01418352|540479636|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
149822653|NCT01418352|540479637|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
149822654|NCT01418352|540479634|FG000|Overall Study|Subject Withdrew Consent|0|||
149822655|NCT01418352|540479635|FG001|Overall Study|Subject Withdrew Consent|1|||
149822656|NCT01418352|540479636|FG002|Overall Study|Subject Withdrew Consent|2|||
149822657|NCT01418352|540479637|FG003|Overall Study|Subject Withdrew Consent|1|||
149822658|NCT01418352|540479634|FG000|Overall Study|Protocol Deviation|0|||
149822659|NCT01418352|540479635|FG001|Overall Study|Protocol Deviation|0|||
149822660|NCT01418352|540479636|FG002|Overall Study|Protocol Deviation|1|||
149822661|NCT01418352|540479637|FG003|Overall Study|Protocol Deviation|0|||
149822662|NCT01418352|540479634|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
149822663|NCT01418352|540479635|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
149822664|NCT01418352|540479636|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
149822665|NCT01418352|540479637|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
149822666|NCT00619619|540479638|FG000|Overall Study|Physician Decision|0|||
149822667|NCT00619619|540479639|FG001|Overall Study|Physician Decision|0|||
149822668|NCT00619619|540479640|FG002|Overall Study|Physician Decision|1|||
149822669|NCT00619619|540479641|FG003|Overall Study|Physician Decision|0|||
149822670|NCT00619619|540479642|FG004|Overall Study|Physician Decision|0|||
149822671|NCT00619619|540479643|FG005|Overall Study|Physician Decision|0|||
149822672|NCT00619619|540479644|FG006|Overall Study|Physician Decision|0|||
149822673|NCT00619619|540479645|FG007|Overall Study|Physician Decision|0|||
149822674|NCT00619619|540479638|FG000|Overall Study|Protocol Violation|0|||
149822675|NCT00619619|540479639|FG001|Overall Study|Protocol Violation|0|||
149822676|NCT00619619|540479640|FG002|Overall Study|Protocol Violation|0|||
149822677|NCT00619619|540479641|FG003|Overall Study|Protocol Violation|1|||
149822678|NCT00619619|540479642|FG004|Overall Study|Protocol Violation|0|||
149822679|NCT00619619|540479643|FG005|Overall Study|Protocol Violation|0|||
149822680|NCT00619619|540479644|FG006|Overall Study|Protocol Violation|1|||
149822681|NCT00619619|540479645|FG007|Overall Study|Protocol Violation|1|||
149822682|NCT00619619|540479638|FG000|Overall Study|Adverse Event|0|||
149822683|NCT00619619|540479639|FG001|Overall Study|Adverse Event|0|||
149822684|NCT00619619|540479640|FG002|Overall Study|Adverse Event|0|||
149822685|NCT00619619|540479641|FG003|Overall Study|Adverse Event|0|||
149822686|NCT00619619|540479642|FG004|Overall Study|Adverse Event|2|||
149822687|NCT00619619|540479643|FG005|Overall Study|Adverse Event|0|||
149822688|NCT00619619|540479644|FG006|Overall Study|Adverse Event|0|||
149822689|NCT00619619|540479645|FG007|Overall Study|Adverse Event|2|||
149822690|NCT01401478|540479647|FG000|Overall Study|Study drug not available|6|||
149822691|NCT01401478|540479647|FG000|Overall Study|Adverse Event|5|||
149822692|NCT01401478|540479647|FG000|Overall Study|Hyperphosphatemia|5|||
149822693|NCT01401478|540479647|FG000|Overall Study|Lost to Follow-up|5|||
149822694|NCT01401478|540479647|FG000|Overall Study|Kidney transplantation|3|||
149822695|NCT01401478|540479647|FG000|Overall Study|Withdrawal by Subject|3|||
149822696|NCT01401478|540479647|FG000|Overall Study|Blood samples not available|1|||
149822697|NCT01401478|540479647|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
149822698|NCT01401478|540479647|FG000|Overall Study|Low intact parathyroid hormone|1|||
149822699|NCT01401478|540479647|FG000|Overall Study|Serious adverse event|1|||
149822700|NCT01814137|540479648|FG000|Overall Study|Adverse Event|0|||
149822701|NCT01814137|540479649|FG001|Overall Study|Adverse Event|1|||
149822702|NCT01814137|540479648|FG000|Overall Study|Withdrawal by Subject|2|||
149822703|NCT01814137|540479649|FG001|Overall Study|Withdrawal by Subject|2|||
149822704|NCT01814137|540479648|FG000|Overall Study|Physician Decision|1|||
149822705|NCT01814137|540479649|FG001|Overall Study|Physician Decision|1|||
149822706|NCT01814137|540479648|FG000|Overall Study|Unclassified|2|||
149822707|NCT01814137|540479649|FG001|Overall Study|Unclassified|1|||
149822708|NCT01798485|540479650|FG000|Overall Study|Adverse Event|32|||
149822709|NCT01798485|540479651|FG001|Overall Study|Adverse Event|40|||
149822710|NCT01798485|540479650|FG000|Overall Study|Withdrawal by Subject|27|||
150032814|NCT00844844|541259369|FG000|Extension Treatment Period|Adverse Event|2|||
150170306|NCT02613364|541759056|FG001|Overall Study|Disliked Study Procedure|1|||
150170307|NCT02613364|541759057|FG002|Overall Study|Disliked Study Procedure|4|||
150170308|NCT02613364|541759055|FG000|Overall Study|Disliked Intervention|0|||
150170309|NCT02613364|541759056|FG001|Overall Study|Disliked Intervention|3|||
150170310|NCT02613364|541759057|FG002|Overall Study|Disliked Intervention|3|||
150170311|NCT01909336|541759058|FG000|Overall Study|Lost to Follow-up|4|||
150170312|NCT01909336|541759059|FG001|Overall Study|Lost to Follow-up|2|||
150170313|NCT01909336|541759060|FG002|Overall Study|Lost to Follow-up|2|||
150170314|NCT01909336|541759058|FG000|Overall Study|Physician Decision|0|||
150170315|NCT01909336|541759059|FG001|Overall Study|Physician Decision|1|||
150170316|NCT01909336|541759060|FG002|Overall Study|Physician Decision|1|||
150170317|NCT01235949|541759061|FG000|Primary Phase|Migrated/moved from study area|1|||
150170318|NCT01235949|541759062|FG001|Primary Phase|Migrated/moved from study area|1|||
150170319|NCT01235949|541759063|FG002|Primary Phase|Migrated/moved from study area|0|||
150170320|NCT01235949|541759064|FG003|Primary Phase|Migrated/moved from study area|0|||
150170321|NCT01235949|541759065|FG004|Primary Phase|Migrated/moved from study area|1|||
150170322|NCT01235949|541759066|FG005|Primary Phase|Migrated/moved from study area|2|||
150170323|NCT01235949|541759067|FG006|Primary Phase|Migrated/moved from study area|0|||
150170324|NCT01235949|541759068|FG007|Primary Phase|Migrated/moved from study area|0|||
150170325|NCT01235949|541759069|FG008|Primary Phase|Migrated/moved from study area|0|||
150170326|NCT01235949|541759070|FG009|Primary Phase|Migrated/moved from study area|0|||
150170327|NCT01235949|541759071|FG010|Primary Phase|Migrated/moved from study area|0|||
149822711|NCT01798485|540479651|FG001|Overall Study|Withdrawal by Subject|31|||
149822712|NCT01798485|540479650|FG000|Overall Study|Lost to Follow-up|0|||
149822713|NCT01798485|540479651|FG001|Overall Study|Lost to Follow-up|3|||
149822714|NCT01798485|540479650|FG000|Overall Study|Physician Decision|14|||
150170328|NCT01235949|541759072|FG011|Primary Phase|Migrated/moved from study area|0|||
149944169|NCT04757636|540929472|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
149944170|NCT04757636|540929473|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
149944171|NCT04757636|540929471|FG000|Overall Study|Study Terminated by Sponsor|103|||
149944172|NCT04757636|540929472|FG001|Overall Study|Study Terminated by Sponsor|104|||
149944173|NCT04757636|540929473|FG002|Overall Study|Study Terminated by Sponsor|114|||
149944174|NCT04757636|540929471|FG000|Overall Study|Sponsor Decision|0|||
149944175|NCT04757636|540929472|FG001|Overall Study|Sponsor Decision|0|||
149822715|NCT01798485|540479651|FG001|Overall Study|Physician Decision|10|||
149944176|NCT04757636|540929473|FG002|Overall Study|Sponsor Decision|1|||
149944177|NCT04757636|540929471|FG000|Overall Study|Randomized in Error|0|||
149944178|NCT04757636|540929472|FG001|Overall Study|Randomized in Error|0|||
149944179|NCT04757636|540929473|FG002|Overall Study|Randomized in Error|2|||
149822716|NCT01798485|540479650|FG000|Overall Study|Objective Disease Progression|152|||
149822717|NCT01798485|540479651|FG001|Overall Study|Objective Disease Progression|106|||
149822718|NCT01798485|540479650|FG000|Overall Study|Death|25|||
149822719|NCT01798485|540479651|FG001|Overall Study|Death|22|||
149822720|NCT01798485|540479650|FG000|Overall Study|Sponsor Decision|61|||
149822721|NCT01798485|540479651|FG001|Overall Study|Sponsor Decision|54|||
149822722|NCT01798485|540479650|FG000|Overall Study|Clinical Progression|35|||
149822723|NCT01798485|540479651|FG001|Overall Study|Clinical Progression|24|||
149822724|NCT03687125|540479652|FG000|Overall Study|Progressive Disease|2|||
149822725|NCT03687125|540479653|FG001|Overall Study|Progressive Disease|1|||
149822726|NCT03687125|540479652|FG000|Overall Study|Protocol Violation|1|||
149822727|NCT03687125|540479653|FG001|Overall Study|Protocol Violation|0|||
150274862|NCT00718549|542144506|FG001|Maintenance/ Observation Phase|Relapse|3|||
150274863|NCT00718549|542144507|FG002|Maintenance/ Observation Phase|Relapse|2|||
150274864|NCT01576172|542144508|FG000|Overall Study|Ineligible|2|||
150274865|NCT01576172|542144509|FG001|Overall Study|Ineligible|1|||
150274866|NCT01576172|542144508|FG000|Overall Study|Withdrawal by Subject|2|||
150274867|NCT01576172|542144509|FG001|Overall Study|Withdrawal by Subject|0|||
150274868|NCT01576172|542144508|FG000|Overall Study|Insurance issue|1|||
150274869|NCT01576172|542144509|FG001|Overall Study|Insurance issue|0|||
150274870|NCT02613884|542144517|FG000|Overall Study|Death|1|||
150274871|NCT02613884|542144517|FG000|Overall Study|Lost to Follow-up|1|||
150274872|NCT00433914|542144518|FG000|Overall Study|Withdrawal by Subject|0|||
150274873|NCT00433914|542144519|FG001|Overall Study|Withdrawal by Subject|2|||
150274874|NCT00433914|542144518|FG000|Overall Study|Lost to Follow-up|0|||
150274875|NCT00433914|542144519|FG001|Overall Study|Lost to Follow-up|1|||
150274876|NCT02844920|542144520|FG000|Overall Study|Lost to Follow-up|2|||
150274877|NCT04534491|542144521|FG000|Overall Study|Not completed end-of-study interview|24|||
150274878|NCT04534491|542144521|FG000|Overall Study|Non-users|70|||
150274879|NCT04534491|542144521|FG000|Overall Study|Non-verifiable users|58|||
150274880|NCT00766090|542144524|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274881|NCT00766090|542144525|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274882|NCT00766090|542144526|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274883|NCT00766090|542144527|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274884|NCT00766090|542144528|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274885|NCT00766090|542144529|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274886|NCT00766090|542144530|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274887|NCT00766090|542144531|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274888|NCT00766090|542144532|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
150274889|NCT00766090|542144533|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274890|NCT00766090|542144534|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274891|NCT00766090|542144535|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150274892|NCT00766090|542144524|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
150274893|NCT00766090|542144525|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274894|NCT00766090|542144526|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274895|NCT00766090|542144527|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274896|NCT00766090|542144528|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274897|NCT00766090|542144529|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274898|NCT00766090|542144530|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274899|NCT00766090|542144531|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274900|NCT00766090|542144532|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274901|NCT00766090|542144533|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274902|NCT00766090|542144534|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274903|NCT00766090|542144535|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
150274904|NCT00766090|542144524|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
150274905|NCT00766090|542144525|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274906|NCT00766090|542144526|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274907|NCT00766090|542144527|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
150274908|NCT00766090|542144528|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274909|NCT00766090|542144529|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274910|NCT00766090|542144530|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274911|NCT00766090|542144531|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274912|NCT00766090|542144532|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274913|NCT00766090|542144533|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274914|NCT00766090|542144534|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274915|NCT00766090|542144535|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150274916|NCT00766090|542144524|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274917|NCT00766090|542144525|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
149822728|NCT01992107|540479654|FG000|Overall Study|Administrative reasons|2|||
150274918|NCT00766090|542144526|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
149822729|NCT01992107|540479655|FG001|Overall Study|Administrative reasons|0|||
149822730|NCT01992107|540479656|FG002|Overall Study|Administrative reasons|0|||
149822731|NCT01992107|540479654|FG000|Overall Study|Adverse Event|0|||
149822732|NCT01992107|540479655|FG001|Overall Study|Adverse Event|1|||
149822733|NCT01992107|540479656|FG002|Overall Study|Adverse Event|0|||
149822734|NCT01992107|540479654|FG000|Overall Study|Lost to Follow-up|46|||
149822735|NCT01992107|540479655|FG001|Overall Study|Lost to Follow-up|22|||
149822736|NCT01992107|540479656|FG002|Overall Study|Lost to Follow-up|26|||
149822737|NCT01992107|540479654|FG000|Overall Study|noncompliance and were unavailable|7|||
149822738|NCT01992107|540479655|FG001|Overall Study|noncompliance and were unavailable|3|||
149822739|NCT01992107|540479656|FG002|Overall Study|noncompliance and were unavailable|2|||
149822740|NCT01992107|540479654|FG000|Overall Study|Withdrawal by Subject|13|||
149822741|NCT01992107|540479655|FG001|Overall Study|Withdrawal by Subject|7|||
149822742|NCT01992107|540479656|FG002|Overall Study|Withdrawal by Subject|8|||
149822743|NCT02022007|540479657|FG000|Overall Study|Withdrawal by Subject|1|||
149822744|NCT02022007|540479658|FG001|Overall Study|Withdrawal by Subject|1|||
149822745|NCT02022007|540479659|FG002|Overall Study|Withdrawal by Subject|1|||
149822746|NCT02022007|540479657|FG000|Overall Study|Noncompliant|0|||
149822747|NCT02022007|540479658|FG001|Overall Study|Noncompliant|0|||
149822748|NCT02022007|540479659|FG002|Overall Study|Noncompliant|1|||
149822749|NCT01214603|540479660|FG000|Overall Study|Adverse Event|0|||
149822750|NCT01214603|540479661|FG001|Overall Study|Adverse Event|0|||
149822751|NCT01214603|540479662|FG002|Overall Study|Adverse Event|1|||
149822752|NCT01214603|540479660|FG000|Overall Study|Death|1|||
149822753|NCT01214603|540479661|FG001|Overall Study|Death|0|||
149822754|NCT01214603|540479662|FG002|Overall Study|Death|0|||
149822755|NCT01214603|540479660|FG000|Overall Study|Progressive Disease|4|||
149822756|NCT01214603|540479661|FG001|Overall Study|Progressive Disease|1|||
149822757|NCT01214603|540479662|FG002|Overall Study|Progressive Disease|3|||
149822758|NCT01507896|540479663|FG000|Overall Study|Withdrawal by Subject|1|||
149822759|NCT01507896|540479663|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
149822760|NCT03156270|540479674|FG000|Overall Study|Failed pre-treatment screening|1|||
149822761|NCT03156270|540479674|FG000|Overall Study|Lost to Follow-up|1|||
149822762|NCT00446654|540479675|FG000|Overall Study|Withdrawal by Subject|1|||
149822763|NCT00446654|540479676|FG001|Overall Study|Withdrawal by Subject|0|||
149822764|NCT00446654|540479675|FG000|Overall Study|Adverse Event|1|||
149822765|NCT00446654|540479676|FG001|Overall Study|Adverse Event|0|||
149822766|NCT02087059|540479677|FG000|Overall Study|Disease Progression|1|||
149822767|NCT02087059|540479677|FG000|Overall Study|Adverse Event|5|||
149822768|NCT02087059|540479677|FG000|Overall Study|Lost to Follow-up|1|||
149822769|NCT01261325|540479678|FG000|Overall Study|Lack of Efficacy|1|||
149822770|NCT01261325|540479679|FG001|Overall Study|Lack of Efficacy|1|||
149822771|NCT01261325|540479680|FG002|Overall Study|Lack of Efficacy|0|||
149822772|NCT01261325|540479678|FG000|Overall Study|Withdrawal by Subject|2|||
149822773|NCT01261325|540479679|FG001|Overall Study|Withdrawal by Subject|2|||
149822774|NCT01261325|540479680|FG002|Overall Study|Withdrawal by Subject|4|||
149822775|NCT01261325|540479678|FG000|Overall Study|SAE, non-fatal|1|||
149822776|NCT01261325|540479679|FG001|Overall Study|SAE, non-fatal|5|||
149822777|NCT01261325|540479680|FG002|Overall Study|SAE, non-fatal|1|||
149822778|NCT01261325|540479678|FG000|Overall Study|AE, non-serious non-fatal|9|||
149822779|NCT01261325|540479679|FG001|Overall Study|AE, non-serious non-fatal|15|||
149822780|NCT01261325|540479680|FG002|Overall Study|AE, non-serious non-fatal|13|||
149822781|NCT01261325|540479678|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
149822782|NCT01261325|540479679|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149822783|NCT01261325|540479680|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149822784|NCT01261325|540479678|FG000|Overall Study|Non Compliance|2|||
149822785|NCT01261325|540479679|FG001|Overall Study|Non Compliance|0|||
149822786|NCT01261325|540479680|FG002|Overall Study|Non Compliance|0|||
149822787|NCT01261325|540479678|FG000|Overall Study|Patient Randomized by Mistake|0|||
149822788|NCT01261325|540479679|FG001|Overall Study|Patient Randomized by Mistake|1|||
149822789|NCT01261325|540479680|FG002|Overall Study|Patient Randomized by Mistake|0|||
150170329|NCT01235949|541759073|FG012|Primary Phase|Migrated/moved from study area|0|||
149822790|NCT01261325|540479678|FG000|Overall Study|Erroneously Randomized|1|||
149822791|NCT01261325|540479679|FG001|Overall Study|Erroneously Randomized|0|||
149822792|NCT01261325|540479680|FG002|Overall Study|Erroneously Randomized|0|||
149822793|NCT01261325|540479678|FG000|Overall Study|Screen Failure|1|||
149822794|NCT01261325|540479679|FG001|Overall Study|Screen Failure|0|||
149822795|NCT01261325|540479680|FG002|Overall Study|Screen Failure|0|||
149822796|NCT01261325|540479678|FG000|Overall Study|Randomized in Error|0|||
149822797|NCT01261325|540479679|FG001|Overall Study|Randomized in Error|0|||
149822798|NCT01261325|540479680|FG002|Overall Study|Randomized in Error|1|||
149822799|NCT01261325|540479678|FG000|Overall Study|Protocol Violation|0|||
149822800|NCT01261325|540479679|FG001|Overall Study|Protocol Violation|3|||
150170330|NCT01235949|541759074|FG013|Primary Phase|Migrated/moved from study area|0|||
149822801|NCT01261325|540479680|FG002|Overall Study|Protocol Violation|1|||
149822802|NCT01261325|540479678|FG000|Overall Study|Lost to Follow-up|0|||
149822803|NCT01261325|540479679|FG001|Overall Study|Lost to Follow-up|1|||
149822804|NCT01261325|540479680|FG002|Overall Study|Lost to Follow-up|3|||
149822805|NCT01261325|540479678|FG000|Overall Study|AE, serious fatal|0|||
150170331|NCT01235949|541759075|FG014|Primary Phase|Migrated/moved from study area|0|||
149822806|NCT01261325|540479679|FG001|Overall Study|AE, serious fatal|0|||
149822807|NCT01261325|540479680|FG002|Overall Study|AE, serious fatal|2|||
149822808|NCT02330081|540479697|FG000|Overall Study|Adverse Event|1|||
149822809|NCT02330081|540479697|FG000|Overall Study|Donation did not meet criteria|1|||
149822810|NCT02330081|540479697|FG000|Overall Study|Protocol Violation|6|||
149822811|NCT01688037|540479703|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
149822812|NCT01688037|540479704|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
149822813|NCT01688037|540479705|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
149822814|NCT01688037|540479703|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
149822815|NCT01688037|540479704|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
149822816|NCT01688037|540479705|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
149822817|NCT01688037|540479703|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
149822818|NCT01688037|540479704|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
149822819|NCT01688037|540479705|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
149822820|NCT01688037|540479703|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
149822821|NCT01688037|540479704|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
149944180|NCT03286504|540929474|FG000|Overall Study|Lost to Follow-up|19|||
149944181|NCT03286504|540929475|FG001|Overall Study|Lost to Follow-up|16|||
149944182|NCT00141921|540929477|FG000|Overall Study|Remain on Study|28|||
149944183|NCT00141921|540929477|FG000|Overall Study|Withdrawal by Subject|42|||
149944184|NCT00141921|540929477|FG000|Overall Study|Lost to Follow-up|19|||
149944185|NCT00141921|540929477|FG000|Overall Study|Noncompliance|17|||
149944186|NCT00141921|540929477|FG000|Overall Study|Disease Progression|7|||
149944187|NCT00141921|540929477|FG000|Overall Study|Protocol Deviation|7|||
149944188|NCT00141921|540929477|FG000|Overall Study|Adverse Event|5|||
149944189|NCT00141921|540929477|FG000|Overall Study|Administrative Decision|2|||
149822822|NCT01688037|540479705|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
149944190|NCT00141921|540929477|FG000|Overall Study|Pregnancy|4|||
149944191|NCT00141921|540929477|FG000|Overall Study|Ineligibility Determined|2|||
149944192|NCT00141921|540929477|FG000|Overall Study|Other|8|||
149944193|NCT03813654|540929480|FG000|Overall Study|Protocol Violation|0|||
149944194|NCT03813654|540929481|FG001|Overall Study|Protocol Violation|1|||
149822823|NCT01688037|540479703|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
149944195|NCT03813654|540929482|FG002|Overall Study|Protocol Violation|2|||
149944196|NCT03813654|540929480|FG000|Overall Study|Withdrawal by Subject|1|||
149944197|NCT03813654|540929481|FG001|Overall Study|Withdrawal by Subject|0|||
149944198|NCT03813654|540929482|FG002|Overall Study|Withdrawal by Subject|0|||
149944199|NCT01732692|540929483|FG000|Overall Study|Adverse Event|0|||
149944200|NCT01732692|540929484|FG001|Overall Study|Adverse Event|1|||
149944201|NCT01208051|540929502|FG000|Total Enrollment|Withdrawal by Subject|0|||
149944202|NCT01208051|540929503|FG001|Total Enrollment|Withdrawal by Subject|1|||
149944203|NCT01208051|540929504|FG002|Total Enrollment|Withdrawal by Subject|0|||
149944204|NCT01208051|540929505|FG003|Total Enrollment|Withdrawal by Subject|0|||
149944205|NCT01208051|540929506|FG004|Total Enrollment|Withdrawal by Subject|2|||
149944206|NCT01208051|540929502|FG000|Total Enrollment|Brain metastases|0|||
149944207|NCT01208051|540929503|FG001|Total Enrollment|Brain metastases|0|||
149944208|NCT01208051|540929504|FG002|Total Enrollment|Brain metastases|1|||
149944209|NCT01208051|540929505|FG003|Total Enrollment|Brain metastases|0|||
149944210|NCT01208051|540929506|FG004|Total Enrollment|Brain metastases|0|||
149944211|NCT02349386|540929508|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
149944212|NCT02349386|540929509|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
149944213|NCT02349386|540929510|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
149944214|NCT02349386|540929511|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
149944215|NCT02349386|540929508|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
149944216|NCT02349386|540929509|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
149944217|NCT02349386|540929510|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
149944218|NCT02349386|540929511|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
149944219|NCT02349386|540929508|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
149944220|NCT02349386|540929509|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
149944221|NCT02349386|540929510|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
149944222|NCT02349386|540929511|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
149944223|NCT02349386|540929508|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
149944224|NCT02349386|540929509|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
149944225|NCT02349386|540929510|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
149944226|NCT02349386|540929511|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
149944227|NCT02349386|540929508|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
149944228|NCT02349386|540929509|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
149944229|NCT02349386|540929510|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
149944230|NCT02349386|540929511|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
149944231|NCT02349386|540929508|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
149944232|NCT02349386|540929509|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
149944233|NCT02349386|540929510|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
149944234|NCT02349386|540929511|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
149944235|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
149944236|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
149944237|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
149944238|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
149944239|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
149944240|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
150170332|NCT01235949|541759076|FG015|Primary Phase|Migrated/moved from study area|0|||
150170333|NCT01235949|541759077|FG016|Primary Phase|Migrated/moved from study area|0|||
150170334|NCT01235949|541759078|FG017|Primary Phase|Migrated/moved from study area|0|||
150170335|NCT01235949|541759061|FG000|Primary Phase|Adverse Event|0|||
150170336|NCT01235949|541759062|FG001|Primary Phase|Adverse Event|0|||
150170337|NCT01235949|541759063|FG002|Primary Phase|Adverse Event|0|||
149822824|NCT01688037|540479704|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
149822825|NCT01688037|540479705|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
149822826|NCT01688037|540479703|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
149822827|NCT01688037|540479704|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
149822828|NCT01688037|540479705|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
149822829|NCT01688037|540479703|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
149822830|NCT01688037|540479704|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
149822831|NCT01688037|540479705|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
149944241|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
150170338|NCT01235949|541759064|FG003|Primary Phase|Adverse Event|1|||
150170339|NCT01235949|541759065|FG004|Primary Phase|Adverse Event|0|||
150170340|NCT01235949|541759066|FG005|Primary Phase|Adverse Event|0|||
149944242|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
149822832|NCT01688037|540479703|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
149822833|NCT01688037|540479704|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
149822834|NCT01688037|540479705|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
149822835|NCT01688037|540479703|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
149822836|NCT01688037|540479704|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
149822837|NCT01688037|540479705|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
149822838|NCT01688037|540479703|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
149822839|NCT01688037|540479704|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
149822840|NCT01688037|540479705|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
149822841|NCT02100956|540479706|FG000|At Least One Week Between Injections|Adverse Event|0|||
149822842|NCT02100956|540479707|FG001|At Least One Week Between Injections|Adverse Event|1|||
149822843|NCT03035227|540479708|FG000|Overall Study|study stopped due to PI leaving institut|1|||
149822844|NCT03035227|540479709|FG001|Overall Study|study stopped due to PI leaving institut|1|||
149822845|NCT04345471|540479714|FG000|Overall Study|Adverse Event|8|||
149822846|NCT04345471|540479715|FG001|Overall Study|Adverse Event|5|||
149822847|NCT04345471|540479716|FG002|Overall Study|Adverse Event|6|||
149822848|NCT04345471|540479714|FG000|Overall Study|Lack of Efficacy|1|||
149822849|NCT04345471|540479715|FG001|Overall Study|Lack of Efficacy|1|||
149822850|NCT04345471|540479716|FG002|Overall Study|Lack of Efficacy|0|||
149822851|NCT04345471|540479714|FG000|Overall Study|Protocol Violation|0|||
149822852|NCT04345471|540479715|FG001|Overall Study|Protocol Violation|1|||
149822853|NCT04345471|540479716|FG002|Overall Study|Protocol Violation|2|||
149822854|NCT04345471|540479714|FG000|Overall Study|Withdrawal by Subject|10|||
149822855|NCT04345471|540479715|FG001|Overall Study|Withdrawal by Subject|5|||
149822856|NCT04345471|540479716|FG002|Overall Study|Withdrawal by Subject|10|||
149822857|NCT01098240|540479717|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
149822858|NCT01098240|540479718|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
149822859|NCT01098240|540479719|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
149944243|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
149944244|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
149975595|NCT00570713|541047894|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
149822860|NCT01098240|540479717|FG000|Open-Label Phase|Protocol Violation|4|||
149822861|NCT01098240|540479718|FG001|Open-Label Phase|Protocol Violation|0|||
149822862|NCT01098240|540479719|FG002|Open-Label Phase|Protocol Violation|0|||
149822863|NCT01098240|540479717|FG000|Open-Label Phase|Lost to Follow-up|13|||
149822864|NCT01098240|540479718|FG001|Open-Label Phase|Lost to Follow-up|0|||
149822865|NCT01098240|540479719|FG002|Open-Label Phase|Lost to Follow-up|0|||
149822866|NCT01098240|540479717|FG000|Open-Label Phase|Other|19|||
149822867|NCT01098240|540479718|FG001|Open-Label Phase|Other|0|||
149822868|NCT01098240|540479719|FG002|Open-Label Phase|Other|0|||
149822869|NCT01098240|540479717|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
149822870|NCT01098240|540479718|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
149822871|NCT01098240|540479719|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
149822872|NCT01098240|540479717|FG000|Open-Label Phase|Pregnancy|1|||
149822873|NCT01098240|540479718|FG001|Open-Label Phase|Pregnancy|0|||
149822874|NCT01098240|540479719|FG002|Open-Label Phase|Pregnancy|0|||
149822875|NCT01098240|540479717|FG000|Open-Label Phase|Withdrawal by Subject|9|||
149822876|NCT01098240|540479718|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149822877|NCT01098240|540479719|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149822878|NCT01098240|540479717|FG000|Open-Label Phase|Adverse Event|12|||
149822879|NCT01098240|540479718|FG001|Open-Label Phase|Adverse Event|0|||
149822880|NCT01098240|540479719|FG002|Open-Label Phase|Adverse Event|0|||
149822881|NCT01098240|540479717|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
149822882|NCT01098240|540479718|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
149822883|NCT01098240|540479719|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
149822884|NCT01098240|540479717|FG000|Double-Blind Phase|Protocol Violation|0|||
149822885|NCT01098240|540479718|FG001|Double-Blind Phase|Protocol Violation|2|||
149822886|NCT01098240|540479719|FG002|Double-Blind Phase|Protocol Violation|4|||
149822887|NCT01098240|540479717|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149822888|NCT01098240|540479718|FG001|Double-Blind Phase|Lost to Follow-up|2|||
149822889|NCT01098240|540479719|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149822890|NCT01098240|540479717|FG000|Double-Blind Phase|Other|0|||
149822891|NCT01098240|540479718|FG001|Double-Blind Phase|Other|2|||
149822892|NCT01098240|540479719|FG002|Double-Blind Phase|Other|2|||
149822893|NCT01098240|540479717|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
149822894|NCT01098240|540479718|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
149822895|NCT01098240|540479719|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
149822896|NCT01098240|540479717|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
149822897|NCT01098240|540479718|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
149822898|NCT01098240|540479719|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
149822899|NCT01098240|540479717|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149822900|NCT01098240|540479718|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
149822901|NCT01098240|540479719|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
149822902|NCT01098240|540479717|FG000|Double-Blind Phase|Adverse Event|0|||
149822903|NCT01098240|540479718|FG001|Double-Blind Phase|Adverse Event|3|||
149822904|NCT01098240|540479719|FG002|Double-Blind Phase|Adverse Event|3|||
149822905|NCT03280537|540479720|FG000|Overall Study|Withdrawal by Subject|2|||
149822906|NCT03280537|540479721|FG001|Overall Study|Withdrawal by Subject|4|||
149822907|NCT01588106|540479722|FG000|Overall Study|Withdrawal by Subject|5|||
149822908|NCT01588106|540479723|FG001|Overall Study|Withdrawal by Subject|4|||
149822909|NCT01015612|540479724|FG000|Overall Study|Death|113|||
149822910|NCT01015612|540479724|FG000|Overall Study|Withdrawal by Subject|40|||
149822911|NCT02034799|540481007|FG000|Overall Study|Withdrawal by Subject|0|||
149822912|NCT02034799|540481008|FG001|Overall Study|Withdrawal by Subject|2|||
149822913|NCT02034799|540481007|FG000|Overall Study|Lost to Follow-up|0|||
149822914|NCT02034799|540481008|FG001|Overall Study|Lost to Follow-up|1|||
149822915|NCT02034799|540481007|FG000|Overall Study|Death|2|||
149822916|NCT02034799|540481008|FG001|Overall Study|Death|1|||
149822917|NCT02224456|540481018|FG000|Overall Study|Lack of Efficacy|1|||
149822918|NCT02224456|540481018|FG000|Overall Study|Lost to Follow-up|15|||
149822919|NCT02224456|540481018|FG000|Overall Study|Withdrawal by Subject|9|||
149822920|NCT02224456|540481018|FG000|Overall Study|Physician Decision|3|||
149822921|NCT02224456|540481018|FG000|Overall Study|Death|2|||
149822922|NCT02224456|540481018|FG000|Overall Study|Pregnancy|4|||
149822923|NCT02224456|540481018|FG000|Overall Study|Protocol Violation|1|||
149822924|NCT02224456|540481018|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
149822925|NCT01241461|540481019|FG000|Overall Study|Progressive Disease|3|||
149822926|NCT01241461|540481020|FG001|Overall Study|Progressive Disease|6|||
149822927|NCT02497391|540481021|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
149822928|NCT02497391|540481022|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
149822929|NCT02497391|540481023|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
149822930|NCT02497391|540481024|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
149822931|NCT02497391|540481025|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
149822932|NCT02497391|540481026|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
149822933|NCT02497391|540481021|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
149822934|NCT02497391|540481022|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
149822935|NCT02497391|540481023|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
149822936|NCT02497391|540481024|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
149822937|NCT02497391|540481025|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
149822938|NCT02497391|540481026|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
149822939|NCT02497391|540481021|FG000|Period 3 (14 Days)|Adverse Event|0|||
149822940|NCT02497391|540481022|FG001|Period 3 (14 Days)|Adverse Event|1|||
149822941|NCT02497391|540481023|FG002|Period 3 (14 Days)|Adverse Event|0|||
149822942|NCT02497391|540481024|FG003|Period 3 (14 Days)|Adverse Event|0|||
149822943|NCT02497391|540481025|FG004|Period 3 (14 Days)|Adverse Event|0|||
149822944|NCT02497391|540481026|FG005|Period 3 (14 Days)|Adverse Event|0|||
149822945|NCT02497391|540481021|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
149822946|NCT02497391|540481022|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
149822947|NCT02497391|540481023|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
149822948|NCT02497391|540481024|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
149822949|NCT02497391|540481025|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
149822950|NCT02497391|540481026|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
149822951|NCT02497391|540481021|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
149822952|NCT02497391|540481022|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
149822953|NCT02497391|540481023|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
149822954|NCT02497391|540481024|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
149822955|NCT02497391|540481025|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
149822956|NCT02497391|540481026|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
149822957|NCT01664052|540481027|FG000|Phase 1|No device placement|6|||
149822958|NCT01664052|540481028|FG001|Phase 1|No device placement|0|||
149822959|NCT01664052|540481027|FG000|Phase 1|No HSG 1 hr post placement|1|||
149822960|NCT01664052|540481028|FG001|Phase 1|No HSG 1 hr post placement|0|||
150274919|NCT00766090|542144527|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
149822961|NCT01664052|540481027|FG000|Phase 2|No device placement|0|||
149822962|NCT01664052|540481028|FG001|Phase 2|No device placement|4|||
149822963|NCT03740698|540481029|FG000|Overall Study|Physician Decision|0|||
149822964|NCT03740698|540481030|FG001|Overall Study|Physician Decision|1|||
149822965|NCT03740698|540481031|FG002|Overall Study|Physician Decision|1|||
149975596|NCT00570713|541047895|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
150274920|NCT00766090|542144528|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274921|NCT00766090|542144529|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274922|NCT00766090|542144530|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
149822966|NCT00633152|540481036|FG000|Overall Study|Adverse Event|1|||
149822967|NCT00633152|540481037|FG001|Overall Study|Adverse Event|0|||
149822968|NCT00633152|540481036|FG000|Overall Study|Randomized, did not receive study drug|5|||
149822969|NCT00633152|540481037|FG001|Overall Study|Randomized, did not receive study drug|2|||
149822970|NCT00633152|540481036|FG000|Overall Study|Withdrawal by Subject|1|||
149822971|NCT00633152|540481037|FG001|Overall Study|Withdrawal by Subject|1|||
149822972|NCT00633152|540481036|FG000|Overall Study|Lost to Follow-up|4|||
149822973|NCT00633152|540481037|FG001|Overall Study|Lost to Follow-up|1|||
149822974|NCT00633152|540481036|FG000|Overall Study|Miscellaneous Other|3|||
149822975|NCT00633152|540481037|FG001|Overall Study|Miscellaneous Other|2|||
149822976|NCT05216978|540481038|FG000|Overall Study|Withdrawal by Subject|3|||
149822977|NCT05216978|540481038|FG000|Overall Study|Lost to Follow-up|5|||
149822978|NCT02410252|540481049|FG000|Overall Study|Withdrawal by Subject|4|||
149822979|NCT02410252|540481049|FG000|Overall Study|Physician Decision|2|||
149822980|NCT03433001|540481052|FG000|Overall Study|Lack of Efficacy|109|||
149822981|NCT03433001|540481052|FG000|Overall Study|Adverse Event|69|||
149822982|NCT03433001|540481052|FG000|Overall Study|Withdrawal by Subject|10|||
149822983|NCT03433001|540481052|FG000|Overall Study|Death|12|||
149822984|NCT03433001|540481052|FG000|Overall Study|Lost to Follow-up|4|||
149822985|NCT03433001|540481052|FG000|Overall Study|Other|25|||
149822986|NCT01162499|540481060|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
149822987|NCT01162499|540481061|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
149822988|NCT01452529|540481062|FG000|Run-in Period|Adverse Event|96|||
149822989|NCT01452529|540481063|FG001|Run-in Period|Adverse Event|0|||
149822990|NCT01452529|540481064|FG002|Run-in Period|Adverse Event|0|||
149822991|NCT01452529|540481062|FG000|Run-in Period|Withdrawal by Subject|49|||
149822992|NCT01452529|540481063|FG001|Run-in Period|Withdrawal by Subject|0|||
149822993|NCT01452529|540481064|FG002|Run-in Period|Withdrawal by Subject|0|||
149822994|NCT01452529|540481062|FG000|Run-in Period|Lost to Follow-up|19|||
149822995|NCT01452529|540481063|FG001|Run-in Period|Lost to Follow-up|0|||
149822996|NCT01452529|540481064|FG002|Run-in Period|Lost to Follow-up|0|||
149822997|NCT01452529|540481062|FG000|Run-in Period|Lack of Efficacy|46|||
149822998|NCT01452529|540481063|FG001|Run-in Period|Lack of Efficacy|0|||
149822999|NCT01452529|540481064|FG002|Run-in Period|Lack of Efficacy|0|||
149823000|NCT01452529|540481062|FG000|Run-in Period|Confirmed or suspected diversion|23|||
149823001|NCT01452529|540481063|FG001|Run-in Period|Confirmed or suspected diversion|0|||
149823002|NCT01452529|540481064|FG002|Run-in Period|Confirmed or suspected diversion|0|||
149823003|NCT01452529|540481062|FG000|Run-in Period|Administrative|21|||
149823004|NCT01452529|540481063|FG001|Run-in Period|Administrative|0|||
149823005|NCT01452529|540481064|FG002|Run-in Period|Administrative|0|||
149823006|NCT01452529|540481062|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
149823007|NCT01452529|540481063|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
149823008|NCT01452529|540481064|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
149823009|NCT01452529|540481062|FG000|Double-blind (DB) Period|Adverse Event|0|||
149823010|NCT01452529|540481063|FG001|Double-blind (DB) Period|Adverse Event|18|||
149823011|NCT01452529|540481064|FG002|Double-blind (DB) Period|Adverse Event|11|||
149823012|NCT01452529|540481062|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
149823013|NCT01452529|540481063|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
149823014|NCT01452529|540481064|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
149823015|NCT01452529|540481062|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
149823016|NCT01452529|540481063|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
149823017|NCT01452529|540481064|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
149823018|NCT01452529|540481062|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
149823019|NCT01452529|540481063|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
149823020|NCT01452529|540481064|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
149823021|NCT01452529|540481062|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
149823022|NCT01452529|540481063|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
149944245|NCT00973973|540929512|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
149944246|NCT00973973|540929513|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
150170341|NCT01235949|541759067|FG006|Primary Phase|Adverse Event|0|||
150170342|NCT01235949|541759068|FG007|Primary Phase|Adverse Event|0|||
150170343|NCT01235949|541759069|FG008|Primary Phase|Adverse Event|0|||
149823023|NCT01452529|540481064|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
149823024|NCT01452529|540481062|FG000|Double-blind (DB) Period|Administrative|0|||
149944247|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
150170344|NCT01235949|541759070|FG009|Primary Phase|Adverse Event|0|||
150170345|NCT01235949|541759071|FG010|Primary Phase|Adverse Event|0|||
150170346|NCT01235949|541759072|FG011|Primary Phase|Adverse Event|0|||
150170347|NCT01235949|541759073|FG012|Primary Phase|Adverse Event|0|||
150170348|NCT01235949|541759074|FG013|Primary Phase|Adverse Event|0|||
150170349|NCT01235949|541759075|FG014|Primary Phase|Adverse Event|0|||
150170350|NCT01235949|541759076|FG015|Primary Phase|Adverse Event|0|||
150170351|NCT01235949|541759077|FG016|Primary Phase|Adverse Event|0|||
150170352|NCT01235949|541759078|FG017|Primary Phase|Adverse Event|0|||
149823025|NCT01452529|540481063|FG001|Double-blind (DB) Period|Administrative|11|||
149823026|NCT01452529|540481064|FG002|Double-blind (DB) Period|Administrative|7|||
149823027|NCT04527471|540481068|FG000|Overall Study|Adverse Event|1|||
149823028|NCT04527471|540481069|FG001|Overall Study|Adverse Event|0|||
149823029|NCT04527471|540481068|FG000|Overall Study|Lost to Follow-up|1|||
150170353|NCT01235949|541759061|FG000|Primary Phase|Withdrawal by Subject|3|||
150170354|NCT01235949|541759062|FG001|Primary Phase|Withdrawal by Subject|2|||
149823030|NCT04527471|540481069|FG001|Overall Study|Lost to Follow-up|0|||
149823031|NCT01628120|540481072|FG000|Overall Study|Withdrawal by Subject|7|||
149823032|NCT01628120|540481072|FG000|Overall Study|Adverse Event|12|||
149823033|NCT01628120|540481072|FG000|Overall Study|Lost to Follow-up|1|||
149823034|NCT01628120|540481072|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
149823035|NCT01628120|540481072|FG000|Overall Study|Non-compliant with Study Procedures|1|||
149823036|NCT01628120|540481072|FG000|Overall Study|Not Treated|3|||
149823037|NCT01628120|540481072|FG000|Overall Study|Sponsor Decision|5|||
149823038|NCT01628120|540481072|FG000|Overall Study|Switched Dialysis Method|2|||
149823039|NCT01628120|540481072|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
149823040|NCT01628120|540481072|FG000|Overall Study|Moved or Relocated|5|||
149823041|NCT01628120|540481072|FG000|Overall Study|Kidney Transplant|2|||
149823042|NCT01628120|540481072|FG000|Overall Study|Use of Standard of Care|1|||
149823043|NCT01165996|540481073|FG000|Overall Study|Death|1|||
149823044|NCT01165996|540481073|FG000|Overall Study|Physician Decision|1|||
149823045|NCT04081337|540481075|FG000|Overall Study|Adverse Event|0|||
149823046|NCT04081337|540481076|FG001|Overall Study|Adverse Event|1|||
149823047|NCT04081337|540481075|FG000|Overall Study|Withdrawal by Subject|2|||
149823048|NCT04081337|540481076|FG001|Overall Study|Withdrawal by Subject|0|||
149823049|NCT04081337|540481075|FG000|Overall Study|Physician Decision|1|||
149823050|NCT04081337|540481076|FG001|Overall Study|Physician Decision|2|||
149823051|NCT04081337|540481075|FG000|Overall Study|Lost to Follow-up|1|||
149823052|NCT04081337|540481076|FG001|Overall Study|Lost to Follow-up|0|||
149823053|NCT02637076|540481077|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
149823054|NCT02637076|540481078|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
149823055|NCT02637076|540481077|FG000|Overall Study|Withdrawal by Subject|0|||
149823056|NCT02637076|540481078|FG001|Overall Study|Withdrawal by Subject|4|||
149823057|NCT02295774|540481080|FG000|Overall Study|Physician Decision|1|||
149823058|NCT02295774|540481080|FG000|Overall Study|Withdrawal by Subject|2|||
149823059|NCT01851590|540481085|FG000|Overall Study|Withdrawal by Subject|0|||
149823060|NCT01851590|540481086|FG001|Overall Study|Withdrawal by Subject|0|||
149823061|NCT01851590|540481087|FG002|Overall Study|Withdrawal by Subject|1|||
149823062|NCT01851590|540481085|FG000|Overall Study|Adverse Event|0|||
149823063|NCT01851590|540481086|FG001|Overall Study|Adverse Event|0|||
149823064|NCT01851590|540481087|FG002|Overall Study|Adverse Event|2|||
149823065|NCT01851590|540481085|FG000|Overall Study|Lack of Efficacy|0|||
149823066|NCT01851590|540481086|FG001|Overall Study|Lack of Efficacy|1|||
149823067|NCT01851590|540481087|FG002|Overall Study|Lack of Efficacy|0|||
149823068|NCT00696709|540481088|FG000|Overall Study|Withdrawal by Subject|1|||
149823069|NCT00696709|540481089|FG001|Overall Study|Withdrawal by Subject|2|||
149823070|NCT00696709|540481090|FG002|Overall Study|Withdrawal by Subject|1|||
149823071|NCT00696709|540481091|FG003|Overall Study|Withdrawal by Subject|4|||
149823072|NCT00696709|540481092|FG004|Overall Study|Withdrawal by Subject|3|||
149823073|NCT00696709|540481088|FG000|Overall Study|Protocol Violation|1|||
149823074|NCT00696709|540481089|FG001|Overall Study|Protocol Violation|0|||
149823075|NCT00696709|540481090|FG002|Overall Study|Protocol Violation|0|||
149823076|NCT00696709|540481091|FG003|Overall Study|Protocol Violation|0|||
149823077|NCT00696709|540481092|FG004|Overall Study|Protocol Violation|0|||
149823078|NCT00696709|540481088|FG000|Overall Study|Lost to Follow-up|1|||
149823079|NCT00696709|540481089|FG001|Overall Study|Lost to Follow-up|1|||
149823080|NCT00696709|540481090|FG002|Overall Study|Lost to Follow-up|0|||
149823081|NCT00696709|540481091|FG003|Overall Study|Lost to Follow-up|0|||
149823082|NCT00696709|540481092|FG004|Overall Study|Lost to Follow-up|0|||
149823083|NCT00696709|540481088|FG000|Overall Study|Adverse Event|0|||
149823084|NCT00696709|540481089|FG001|Overall Study|Adverse Event|0|||
149823085|NCT00696709|540481090|FG002|Overall Study|Adverse Event|0|||
149823086|NCT00696709|540481091|FG003|Overall Study|Adverse Event|1|||
149823087|NCT00696709|540481092|FG004|Overall Study|Adverse Event|0|||
149823088|NCT00310856|540481093|FG000|Overall Study|Withdrawal by Subject|2|||
149823089|NCT00310856|540481094|FG001|Overall Study|Withdrawal by Subject|2|||
149823090|NCT00310856|540481095|FG002|Overall Study|Withdrawal by Subject|2|||
149823091|NCT00310856|540481093|FG000|Overall Study|Lost to Follow-up|1|||
149823092|NCT00310856|540481094|FG001|Overall Study|Lost to Follow-up|2|||
149823093|NCT00310856|540481095|FG002|Overall Study|Lost to Follow-up|6|||
149823094|NCT00310856|540481093|FG000|Overall Study|Inappropriate enrollment|1|||
149823095|NCT00310856|540481094|FG001|Overall Study|Inappropriate enrollment|1|||
149823096|NCT00310856|540481095|FG002|Overall Study|Inappropriate enrollment|0|||
149823097|NCT00310856|540481093|FG000|Overall Study|Unable to classify|1|||
149823098|NCT00310856|540481094|FG001|Overall Study|Unable to classify|0|||
149823099|NCT00310856|540481095|FG002|Overall Study|Unable to classify|0|||
149823100|NCT00321711|540481099|FG000|Part A|Adverse Event|3|||
149823101|NCT00321711|540481100|FG001|Part A|Adverse Event|3|||
149823102|NCT00321711|540481101|FG002|Part A|Adverse Event|2|||
149823103|NCT00321711|540481102|FG003|Part A|Adverse Event|0|||
149823104|NCT00321711|540481103|FG004|Part A|Adverse Event|0|||
149823105|NCT00321711|540481099|FG000|Part A|Withdrawal by Subject|1|||
149823106|NCT00321711|540481100|FG001|Part A|Withdrawal by Subject|1|||
149823107|NCT00321711|540481101|FG002|Part A|Withdrawal by Subject|1|||
150274923|NCT00766090|542144531|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
149944248|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
149944249|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
150274924|NCT00766090|542144532|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274925|NCT00766090|542144533|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274926|NCT00766090|542144534|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274927|NCT00766090|542144535|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
150274928|NCT00766090|542144524|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274929|NCT00766090|542144525|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274930|NCT00766090|542144526|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274931|NCT00766090|542144527|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274932|NCT00766090|542144528|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
150274933|NCT00766090|542144529|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149944250|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
149944251|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
149944252|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
149944253|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
149944254|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
149944255|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
149944256|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
149944257|NCT00973973|540929512|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
149944258|NCT00973973|540929513|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
149944259|NCT02471339|540929514|FG000|Overall Study|Did not provide follow-up data|2|||
149944260|NCT02471339|540929515|FG001|Overall Study|Did not provide follow-up data|0|||
149944261|NCT02567188|540929516|FG000|Overall Study|Death|10|||
149944262|NCT02567188|540929516|FG000|Overall Study|Terminated Mircera Treatment|9|||
149944263|NCT02567188|540929516|FG000|Overall Study|Lost to Follow-up|5|||
149944264|NCT02567188|540929516|FG000|Overall Study|Adverse Event|1|||
149944265|NCT02567188|540929516|FG000|Overall Study|Withdrawal by Subject|1|||
149944266|NCT02567188|540929516|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
149944267|NCT02567188|540929516|FG000|Overall Study|Moved and Changed Clinic|1|||
150274934|NCT00766090|542144530|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149944268|NCT02567188|540929516|FG000|Overall Study|Started Hemodialysis|2|||
149944269|NCT02567188|540929516|FG000|Overall Study|Protocol Violation|5|||
149944270|NCT00655889|540929523|FG000|Overall Study|Inadequate cell growth|1|||
149944271|NCT00655889|540929523|FG000|Overall Study|Protocol Violation|1|||
150274935|NCT00766090|542144531|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274936|NCT00766090|542144532|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274937|NCT00766090|542144533|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274938|NCT00766090|542144534|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274939|NCT00766090|542144535|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150274940|NCT00766090|542144524|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274941|NCT00766090|542144525|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274942|NCT00766090|542144526|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
150274943|NCT00766090|542144527|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274944|NCT00766090|542144528|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274945|NCT00766090|542144529|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274946|NCT00766090|542144530|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274947|NCT00766090|542144531|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274948|NCT00766090|542144532|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274949|NCT00766090|542144533|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274950|NCT00766090|542144534|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274951|NCT00766090|542144535|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
150274952|NCT00766090|542144524|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
150274953|NCT00766090|542144525|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
150274954|NCT00766090|542144526|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
150274955|NCT00766090|542144527|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
150274956|NCT00766090|542144528|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
150274957|NCT00766090|542144529|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
150274958|NCT00766090|542144530|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
150274959|NCT00766090|542144531|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
150274960|NCT00766090|542144532|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
150274961|NCT00766090|542144533|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
150274962|NCT00766090|542144534|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
150274963|NCT00766090|542144535|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
150274964|NCT00766090|542144524|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274965|NCT00766090|542144525|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274966|NCT00766090|542144526|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274967|NCT00766090|542144527|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274968|NCT00766090|542144528|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274969|NCT00766090|542144529|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
150274970|NCT00766090|542144530|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274971|NCT00766090|542144531|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274972|NCT00766090|542144532|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274973|NCT00766090|542144533|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274974|NCT00766090|542144534|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274975|NCT00766090|542144535|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
150274976|NCT00766090|542144524|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274977|NCT00766090|542144525|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
150274978|NCT00766090|542144526|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274979|NCT00766090|542144527|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
150274980|NCT00766090|542144528|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274981|NCT00766090|542144529|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274982|NCT00766090|542144530|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274983|NCT00766090|542144531|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274984|NCT00766090|542144532|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274985|NCT00766090|542144533|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274986|NCT00766090|542144534|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
150274987|NCT00766090|542144535|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
150274988|NCT00766090|542144524|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274989|NCT00766090|542144525|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274990|NCT00766090|542144526|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274991|NCT00766090|542144527|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274992|NCT00766090|542144528|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
150274993|NCT00766090|542144529|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274994|NCT00766090|542144530|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274995|NCT00766090|542144531|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274996|NCT00766090|542144532|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274997|NCT00766090|542144533|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274998|NCT00766090|542144534|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
150274999|NCT00766090|542144535|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149944272|NCT04880850|540929524|FG000|Overall Study|Death|2|||
149823108|NCT00321711|540481102|FG003|Part A|Withdrawal by Subject|0|||
149823109|NCT00321711|540481103|FG004|Part A|Withdrawal by Subject|0|||
149823110|NCT00321711|540481099|FG000|Part A|Disease progression|0|||
149823111|NCT00321711|540481100|FG001|Part A|Disease progression|1|||
149823112|NCT00321711|540481101|FG002|Part A|Disease progression|0|||
149823113|NCT00321711|540481102|FG003|Part A|Disease progression|0|||
149823114|NCT00321711|540481103|FG004|Part A|Disease progression|0|||
149823115|NCT00321711|540481099|FG000|Part A|Requirement for alternative therapy|0|||
149823116|NCT00321711|540481100|FG001|Part A|Requirement for alternative therapy|2|||
149823117|NCT00321711|540481101|FG002|Part A|Requirement for alternative therapy|1|||
149823118|NCT00321711|540481102|FG003|Part A|Requirement for alternative therapy|0|||
149823119|NCT00321711|540481103|FG004|Part A|Requirement for alternative therapy|0|||
149823120|NCT00321711|540481099|FG000|Part A|Physician Decision|0|||
149823121|NCT00321711|540481100|FG001|Part A|Physician Decision|1|||
149823122|NCT00321711|540481101|FG002|Part A|Physician Decision|3|||
149823123|NCT00321711|540481102|FG003|Part A|Physician Decision|0|||
149823124|NCT00321711|540481103|FG004|Part A|Physician Decision|0|||
149823125|NCT00321711|540481099|FG000|Part A|Other|1|||
149823126|NCT00321711|540481100|FG001|Part A|Other|2|||
149823127|NCT00321711|540481101|FG002|Part A|Other|3|||
149823128|NCT00321711|540481102|FG003|Part A|Other|0|||
149823129|NCT00321711|540481103|FG004|Part A|Other|0|||
149823130|NCT00321711|540481099|FG000|Part A|Protocol deviation|0|||
149823131|NCT00321711|540481100|FG001|Part A|Protocol deviation|0|||
149823132|NCT00321711|540481101|FG002|Part A|Protocol deviation|1|||
149823133|NCT00321711|540481102|FG003|Part A|Protocol deviation|0|||
149823134|NCT00321711|540481103|FG004|Part A|Protocol deviation|0|||
149823135|NCT00321711|540481099|FG000|Part B|Noncompliance|0|||
149823136|NCT00321711|540481100|FG001|Part B|Noncompliance|0|||
149823137|NCT00321711|540481101|FG002|Part B|Noncompliance|0|||
149823138|NCT00321711|540481102|FG003|Part B|Noncompliance|0|||
149823139|NCT00321711|540481103|FG004|Part B|Noncompliance|1|||
149823140|NCT00321711|540481099|FG000|Part B|Adverse Event|0|||
149823141|NCT00321711|540481100|FG001|Part B|Adverse Event|0|||
149823142|NCT00321711|540481101|FG002|Part B|Adverse Event|0|||
149823143|NCT00321711|540481102|FG003|Part B|Adverse Event|2|||
149823144|NCT00321711|540481103|FG004|Part B|Adverse Event|1|||
149823145|NCT00321711|540481099|FG000|Part B|Disease progression|0|||
149823146|NCT00321711|540481100|FG001|Part B|Disease progression|0|||
149823147|NCT00321711|540481101|FG002|Part B|Disease progression|0|||
149823148|NCT00321711|540481102|FG003|Part B|Disease progression|1|||
149823149|NCT00321711|540481103|FG004|Part B|Disease progression|0|||
149823150|NCT00321711|540481099|FG000|Part B|Physician Decision|0|||
149823151|NCT00321711|540481100|FG001|Part B|Physician Decision|0|||
149823152|NCT00321711|540481101|FG002|Part B|Physician Decision|0|||
149823153|NCT00321711|540481102|FG003|Part B|Physician Decision|1|||
149823154|NCT00321711|540481103|FG004|Part B|Physician Decision|2|||
149823155|NCT00321711|540481099|FG000|Part B|Death|0|||
149823156|NCT00321711|540481100|FG001|Part B|Death|0|||
149823157|NCT00321711|540481101|FG002|Part B|Death|0|||
149823158|NCT00321711|540481102|FG003|Part B|Death|2|||
149823159|NCT00321711|540481103|FG004|Part B|Death|1|||
149823160|NCT01186978|540481104|FG000|Overall Study|Withdrawal by Subject|1|||
149823161|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
149823162|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
149823163|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
149823164|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
150275000|NCT03024970|542144540|FG000|First Intervention|Adverse Event|1|||
149823165|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
149823166|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
149823167|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
149823168|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
149823169|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
150275001|NCT03024970|542144541|FG001|First Intervention|Adverse Event|0|||
150275002|NCT03024970|542144540|FG000|Second Intervention|Lost to Follow-up|1|||
150275003|NCT03024970|542144541|FG001|Second Intervention|Lost to Follow-up|0|||
150275004|NCT00131469|542144542|FG000|Overall Study|Withdrawal by Subject|3|||
150275005|NCT00131469|542144543|FG001|Overall Study|Withdrawal by Subject|4|||
150275006|NCT00131469|542144542|FG000|Overall Study|Protocol Violation|3|||
149823170|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
149823171|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
149823172|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
149823173|NCT01227668|540481105|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
149823174|NCT01227668|540481106|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
149823175|NCT01227668|540481105|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
149823176|NCT01227668|540481106|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
149823177|NCT01227668|540481105|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
149823178|NCT01227668|540481106|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
149823179|NCT01227668|540481105|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
149823180|NCT01227668|540481106|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
149823181|NCT01227668|540481105|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
149823182|NCT01227668|540481106|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
149823183|NCT01227668|540481105|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
149823184|NCT01227668|540481106|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
149823185|NCT01306253|540481107|FG000|Overall Study|Lost to Follow-up|1|||
149823186|NCT01306253|540481108|FG001|Overall Study|Lost to Follow-up|1|||
149823187|NCT00543439|540481109|FG000|Period 1|Adverse Event|0|||
149823188|NCT00543439|540481110|FG001|Period 1|Adverse Event|2|||
149823189|NCT00543439|540481111|FG002|Period 1|Adverse Event|1|||
149823190|NCT00543439|540481109|FG000|Period 1|Withdrawal by Subject|1|||
149823191|NCT00543439|540481110|FG001|Period 1|Withdrawal by Subject|1|||
149823192|NCT00543439|540481111|FG002|Period 1|Withdrawal by Subject|0|||
149823193|NCT00543439|540481109|FG000|Period 1|Physician Decision|0|||
149823194|NCT00543439|540481110|FG001|Period 1|Physician Decision|0|||
149823195|NCT00543439|540481111|FG002|Period 1|Physician Decision|1|||
149823196|NCT00543439|540481109|FG000|Period 2|Protocol Violation|1|||
149823197|NCT00543439|540481110|FG001|Period 2|Protocol Violation|0|||
149823198|NCT00543439|540481111|FG002|Period 2|Protocol Violation|1|||
149823199|NCT00543439|540481109|FG000|Period 2|Adverse Event|0|||
149823200|NCT00543439|540481110|FG001|Period 2|Adverse Event|1|||
149823201|NCT00543439|540481111|FG002|Period 2|Adverse Event|1|||
149823202|NCT01709383|540481112|FG000|Overall Study|Lost to Follow-up|1|||
149823203|NCT01709383|540481113|FG001|Overall Study|Lost to Follow-up|0|||
149823204|NCT00583596|540481114|FG000|Overall Study|Lost to Follow-up|110|||
149823205|NCT00583596|540481114|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
149823206|NCT00583596|540481114|FG000|Overall Study|Death|2|||
149823207|NCT00583596|540481114|FG000|Overall Study|Withdrawal by Subject|6|||
149823208|NCT00583596|540481114|FG000|Overall Study|Lost to Follow-up|94|||
149823209|NCT00583596|540481114|FG000|Overall Study|Data not complete|1|||
149823210|NCT00583596|540481114|FG000|Overall Study|Not consented|15|||
149823211|NCT00583596|540481114|FG000|Overall Study|Outside f-up window|26|||
149823212|NCT01855126|540481115|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
149823213|NCT01855126|540481116|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
149823214|NCT01855126|540481115|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
149823215|NCT01855126|540481116|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
149823216|NCT00656019|540481117|FG000|Overall Study|Not Eligible|10|||
149823217|NCT00656019|540481118|FG001|Overall Study|Not Eligible|0|||
149823218|NCT00656019|540481119|FG002|Overall Study|Not Eligible|0|||
149823219|NCT00656019|540481120|FG003|Overall Study|Not Eligible|0|||
149823220|NCT00656019|540481117|FG000|Overall Study|Withdrawal by Subject|2|||
149823221|NCT00656019|540481118|FG001|Overall Study|Withdrawal by Subject|0|||
149823222|NCT00656019|540481119|FG002|Overall Study|Withdrawal by Subject|0|||
149823223|NCT00656019|540481120|FG003|Overall Study|Withdrawal by Subject|0|||
149823224|NCT00656019|540481117|FG000|Overall Study|Lost to Follow-up|2|||
149823225|NCT00656019|540481118|FG001|Overall Study|Lost to Follow-up|1|||
149823226|NCT00656019|540481119|FG002|Overall Study|Lost to Follow-up|0|||
149823227|NCT00656019|540481120|FG003|Overall Study|Lost to Follow-up|0|||
149823228|NCT04535583|540481138|FG000|Overall Study|Lost to Follow-up|1|||
149823229|NCT04535583|540481138|FG000|Overall Study|Physician Decision|1|||
149823230|NCT04535583|540481138|FG000|Overall Study|Withdrawal by Subject|1|||
149823231|NCT01078090|540481139|FG000|Overall Study|Lost to Follow-up|2363|||
149823232|NCT01078090|540481139|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
149823233|NCT01078090|540481139|FG000|Overall Study|Lack of Efficacy|1193|||
149823234|NCT01078090|540481139|FG000|Overall Study|ADR and lack of efficacy|61|||
149823235|NCT01078090|540481139|FG000|Overall Study|Other|523|||
149823236|NCT01748890|540481141|FG000|Overall Study|Insufficient recruitment for analysis|4|||
149823237|NCT02669264|540481142|FG000|Overall Study|Death|5|||
149823238|NCT02669264|540481143|FG001|Overall Study|Death|5|||
149823239|NCT02669264|540481144|FG002|Overall Study|Death|3|||
149823240|NCT02669264|540481145|FG003|Overall Study|Death|3|||
150170355|NCT01235949|541759063|FG002|Primary Phase|Withdrawal by Subject|2|||
150170356|NCT01235949|541759064|FG003|Primary Phase|Withdrawal by Subject|0|||
149823241|NCT02669264|540481146|FG004|Overall Study|Death|3|||
149823242|NCT02669264|540481147|FG005|Overall Study|Death|6|||
149823243|NCT02669264|540481148|FG006|Overall Study|Death|3|||
149823244|NCT02669264|540481142|FG000|Overall Study|Withdrawal by Subject|0|||
149823245|NCT02669264|540481143|FG001|Overall Study|Withdrawal by Subject|1|||
149823246|NCT02669264|540481144|FG002|Overall Study|Withdrawal by Subject|0|||
149823247|NCT02669264|540481145|FG003|Overall Study|Withdrawal by Subject|0|||
149823248|NCT02669264|540481146|FG004|Overall Study|Withdrawal by Subject|1|||
149823249|NCT02669264|540481147|FG005|Overall Study|Withdrawal by Subject|0|||
149823250|NCT02669264|540481148|FG006|Overall Study|Withdrawal by Subject|0|||
149823251|NCT02669264|540481142|FG000|Overall Study|Lost to Follow-up|0|||
149823252|NCT02669264|540481143|FG001|Overall Study|Lost to Follow-up|0|||
149823253|NCT02669264|540481144|FG002|Overall Study|Lost to Follow-up|0|||
149823254|NCT02669264|540481145|FG003|Overall Study|Lost to Follow-up|0|||
149823255|NCT02669264|540481146|FG004|Overall Study|Lost to Follow-up|1|||
150275007|NCT00131469|542144543|FG001|Overall Study|Protocol Violation|1|||
149823256|NCT02669264|540481147|FG005|Overall Study|Lost to Follow-up|0|||
149823257|NCT02669264|540481148|FG006|Overall Study|Lost to Follow-up|0|||
149823258|NCT02669264|540481142|FG000|Overall Study|Miscellaneous|0|||
149823259|NCT02669264|540481143|FG001|Overall Study|Miscellaneous|0|||
149823260|NCT02669264|540481144|FG002|Overall Study|Miscellaneous|0|||
149823261|NCT02669264|540481145|FG003|Overall Study|Miscellaneous|0|||
149823262|NCT02669264|540481146|FG004|Overall Study|Miscellaneous|0|||
149823263|NCT02669264|540481147|FG005|Overall Study|Miscellaneous|0|||
149823264|NCT02669264|540481148|FG006|Overall Study|Miscellaneous|2|||
149823265|NCT00526890|540481149|FG000|Overall Study|Adverse Event|2|||
149823266|NCT02220907|540481150|FG000|Overall Study|Adverse Event|7|||
149823267|NCT02220907|540481150|FG000|Overall Study|Physician Decision|1|||
149823268|NCT02220907|540481150|FG000|Overall Study|Withdrawal by Subject|2|||
149823269|NCT02220907|540481150|FG000|Overall Study|Conflict with the stopping criteria|1|||
149823270|NCT02995837|540481151|FG000|Overall Study|Lost to Follow-up|9|||
149823271|NCT02995837|540481152|FG001|Overall Study|Lost to Follow-up|8|||
149823272|NCT01859702|540481153|FG000|Overall Study|Protocol deviation|3|||
149823273|NCT01859702|540481153|FG000|Overall Study|Adverse Event|2|||
149823274|NCT04014959|540482898|FG000|Baseline MRI and Assessments|Physician Decision|2|||
149823275|NCT04014959|540482898|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
149823276|NCT04014959|540482898|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
149823277|NCT02004847|540482900|FG000|Overall Study|Protocol Violation|1|||
149823278|NCT02004847|540482901|FG001|Overall Study|Protocol Violation|1|||
149823279|NCT03381248|540482904|FG000|0-6 Months|Withdrawal by Subject|4|||
149823280|NCT03381248|540482905|FG001|0-6 Months|Withdrawal by Subject|1|||
149823281|NCT03381248|540482904|FG000|0-6 Months|Lost to Follow-up|3|||
149823282|NCT03381248|540482905|FG001|0-6 Months|Lost to Follow-up|2|||
149823283|NCT03381248|540482904|FG000|0-6 Months|Lack of Efficacy|1|||
149823284|NCT03381248|540482905|FG001|0-6 Months|Lack of Efficacy|0|||
149823285|NCT03381248|540482904|FG000|0-6 Months|Adverse Event|1|||
149823286|NCT03381248|540482905|FG001|0-6 Months|Adverse Event|0|||
149823287|NCT03381248|540482904|FG000|0-6 Months|Protocol Violation|2|||
149823288|NCT03381248|540482905|FG001|0-6 Months|Protocol Violation|1|||
149823289|NCT03381248|540482904|FG000|0-6 Months|Physician Decision|1|||
149823290|NCT03381248|540482905|FG001|0-6 Months|Physician Decision|0|||
149823291|NCT03381248|540482904|FG000|0-6 Months|Planning another procedure|1|||
149823292|NCT03381248|540482905|FG001|0-6 Months|Planning another procedure|2|||
149823293|NCT03381248|540482904|FG000|6-12 Months|Withdrawal by Subject|1|||
149823294|NCT03381248|540482905|FG001|6-12 Months|Withdrawal by Subject|3|||
149823295|NCT03381248|540482904|FG000|6-12 Months|Lost to Follow-up|0|||
149823296|NCT03381248|540482905|FG001|6-12 Months|Lost to Follow-up|2|||
149823297|NCT03381248|540482904|FG000|6-12 Months|Protocol Violation|3|||
149823298|NCT03381248|540482905|FG001|6-12 Months|Protocol Violation|2|||
149823299|NCT03381248|540482904|FG000|6-12 Months|Planning another procedure|6|||
149823300|NCT03381248|540482905|FG001|6-12 Months|Planning another procedure|2|||
149823301|NCT03381248|540482904|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
149823302|NCT03381248|540482905|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
149823303|NCT03381248|540482904|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
149823304|NCT03381248|540482905|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
149823305|NCT03381248|540482904|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
149823306|NCT03381248|540482905|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
149823307|NCT05188521|540482906|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
149823308|NCT05188521|540482907|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
149823309|NCT01341639|540482908|FG000|Infant Series|Protocol Violation|1|||
149823310|NCT01341639|540482909|FG001|Infant Series|Protocol Violation|0|||
149823311|NCT01341639|540482908|FG000|Infant Series|Not Vaccinated|0|||
149823312|NCT01341639|540482909|FG001|Infant Series|Not Vaccinated|1|||
149823313|NCT01341639|540482908|FG000|Infant Series|Adverse Event|0|||
149823314|NCT01341639|540482909|FG001|Infant Series|Adverse Event|5|||
149823315|NCT01341639|540482908|FG000|Infant Series|Withdrawal by Subject|11|||
149823316|NCT01341639|540482909|FG001|Infant Series|Withdrawal by Subject|8|||
149823317|NCT01341639|540482908|FG000|Infant Series|Lost to Follow-up|0|||
149823318|NCT01341639|540482909|FG001|Infant Series|Lost to Follow-up|2|||
149823319|NCT01341639|540482908|FG000|Infant Series|Site 0048 Participants|17|||
149823320|NCT01341639|540482909|FG001|Infant Series|Site 0048 Participants|16|||
149823321|NCT01341639|540482908|FG000|Interim Period|Withdrawal by Subject|6|||
149823322|NCT01341639|540482909|FG001|Interim Period|Withdrawal by Subject|7|||
149823323|NCT01341639|540482908|FG000|Interim Period|Lost to Follow-up|2|||
149823324|NCT01341639|540482909|FG001|Interim Period|Lost to Follow-up|0|||
149823325|NCT01341639|540482908|FG000|Interim Period|Physician Decision|0|||
149823326|NCT01341639|540482909|FG001|Interim Period|Physician Decision|1|||
149823327|NCT01341639|540482908|FG000|Interim Period|Protocol Violation|0|||
149823328|NCT01341639|540482909|FG001|Interim Period|Protocol Violation|1|||
149823329|NCT01341639|540482908|FG000|Post-Treatment|Withdrawal by Subject|0|||
149823330|NCT01341639|540482909|FG001|Post-Treatment|Withdrawal by Subject|1|||
149823331|NCT01341639|540482908|FG000|Post-Treatment|Adverse Event|0|||
149823332|NCT01341639|540482909|FG001|Post-Treatment|Adverse Event|2|||
149823333|NCT04582266|540482910|FG000|Overall Study|Lost to Follow-up|7|||
149823334|NCT04582266|540482911|FG001|Overall Study|Lost to Follow-up|5|||
149823335|NCT04582266|540482910|FG000|Overall Study|Withdrawal by Subject|1|||
149823336|NCT04582266|540482911|FG001|Overall Study|Withdrawal by Subject|0|||
149823337|NCT04582266|540482910|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
149823338|NCT04582266|540482911|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
149823339|NCT01379781|540482915|FG000|Overall Study|Lost to Follow-up|11|||
149823340|NCT01379781|540482916|FG001|Overall Study|Lost to Follow-up|8|||
149823341|NCT02247479|540482917|FG000|Overall Study|Adverse Event|8|||
149823342|NCT02247479|540482918|FG001|Overall Study|Adverse Event|9|||
149823343|NCT02247479|540482919|FG002|Overall Study|Adverse Event|8|||
149823344|NCT02247479|540482917|FG000|Overall Study|Death|5|||
149823345|NCT02247479|540482918|FG001|Overall Study|Death|4|||
149823346|NCT02247479|540482919|FG002|Overall Study|Death|6|||
149823347|NCT02247479|540482917|FG000|Overall Study|Lost to Follow-up|3|||
149823348|NCT02247479|540482918|FG001|Overall Study|Lost to Follow-up|3|||
149823349|NCT02247479|540482919|FG002|Overall Study|Lost to Follow-up|1|||
149823350|NCT02247479|540482917|FG000|Overall Study|Non-compliance|0|||
149823351|NCT02247479|540482918|FG001|Overall Study|Non-compliance|0|||
149823352|NCT02247479|540482919|FG002|Overall Study|Non-compliance|1|||
149823353|NCT02247479|540482917|FG000|Overall Study|Withdrawal by Subject|25|||
149823354|NCT02247479|540482918|FG001|Overall Study|Withdrawal by Subject|29|||
149823355|NCT02247479|540482919|FG002|Overall Study|Withdrawal by Subject|24|||
149823356|NCT02247479|540482917|FG000|Overall Study|Study Terminated by Sponsor|98|||
149823357|NCT02247479|540482918|FG001|Overall Study|Study Terminated by Sponsor|88|||
149823358|NCT02247479|540482919|FG002|Overall Study|Study Terminated by Sponsor|94|||
149823359|NCT02247479|540482917|FG000|Overall Study|Physician Decision|1|||
149823360|NCT02247479|540482918|FG001|Overall Study|Physician Decision|0|||
149823361|NCT02247479|540482919|FG002|Overall Study|Physician Decision|2|||
149823362|NCT02247479|540482917|FG000|Overall Study|Unspecified Reason|2|||
149823363|NCT02247479|540482918|FG001|Overall Study|Unspecified Reason|5|||
149823364|NCT02247479|540482919|FG002|Overall Study|Unspecified Reason|2|||
149823365|NCT01132118|540482920|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
149823366|NCT01132118|540482921|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
149823367|NCT01132118|540482920|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
149823368|NCT01132118|540482921|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
149823369|NCT01132118|540482920|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
149823370|NCT01132118|540482921|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
149823371|NCT01299038|540482931|FG000|Overall Study|Withdrawal by Subject|1|||
149823372|NCT01299038|540482932|FG001|Overall Study|Withdrawal by Subject|0|||
149823373|NCT00322556|540482933|FG000|Overall Study|Adverse Event|1|||
149823374|NCT00322556|540482933|FG000|Overall Study|Withdrawal by Subject|1|||
149823375|NCT00322556|540482933|FG000|Overall Study|Lost to Follow-up|3|||
149823376|NCT00322556|540482933|FG000|Overall Study|Other Reason|7|||
149823377|NCT00832078|540482934|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
149823378|NCT00832078|540482935|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
149823379|NCT00832078|540482934|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
149823380|NCT00832078|540482935|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
149823381|NCT03551730|540482936|FG000|Overall Study|Adverse Event|1|||
149823382|NCT03551730|540482937|FG001|Overall Study|Adverse Event|0|||
149944273|NCT04880850|540929525|FG001|Overall Study|Death|1|||
149823383|NCT03551730|540482938|FG002|Overall Study|Adverse Event|0|||
149823384|NCT03551730|540482939|FG003|Overall Study|Adverse Event|0|||
149823385|NCT00096265|540482951|FG000|Overall Study|Ineligible|1|||
149823386|NCT00096265|540482952|FG001|Overall Study|Ineligible|0|||
149823387|NCT00096265|540482953|FG002|Overall Study|Ineligible|0|||
149823388|NCT01506323|540482954|FG000|Overall Study|Lost to Follow-up|5|||
149823389|NCT01506323|540482955|FG001|Overall Study|Lost to Follow-up|4|||
149823390|NCT01506323|540482954|FG000|Overall Study|Withdrawal by Subject|4|||
149823391|NCT01506323|540482955|FG001|Overall Study|Withdrawal by Subject|4|||
149823392|NCT01506323|540482954|FG000|Overall Study|Lack of Efficacy|1|||
149823393|NCT01506323|540482955|FG001|Overall Study|Lack of Efficacy|3|||
149823394|NCT01506323|540482954|FG000|Overall Study|Moved out of area|5|||
149823395|NCT01506323|540482955|FG001|Overall Study|Moved out of area|2|||
149823396|NCT01506323|540482954|FG000|Overall Study|Schedule or Transportation conflict|8|||
149823397|NCT01506323|540482955|FG001|Overall Study|Schedule or Transportation conflict|0|||
149823398|NCT01506323|540482954|FG000|Overall Study|Started another treatment|1|||
149823399|NCT01506323|540482955|FG001|Overall Study|Started another treatment|0|||
149823400|NCT02232074|540482956|FG000|Overall Study|Withdrawal by Subject|5|||
149823401|NCT02232074|540482957|FG001|Overall Study|Withdrawal by Subject|3|||
149823402|NCT02232074|540482956|FG000|Overall Study|No legal concerns at baseline|36|||
149823403|NCT02232074|540482957|FG001|Overall Study|No legal concerns at baseline|41|||
149823404|NCT02232074|540482956|FG000|Overall Study|deemed ineligible|0|||
149823405|NCT02232074|540482957|FG001|Overall Study|deemed ineligible|1|||
149823406|NCT00704418|540482958|FG000|Overall Study|Withdrawal by Subject|2|||
149823407|NCT00704418|540482959|FG001|Overall Study|Withdrawal by Subject|0|||
149823408|NCT00704418|540482958|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
149823409|NCT00704418|540482959|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
149823410|NCT01579474|540482960|FG000|Overall Study|Adverse Event|1|||
149823411|NCT01579474|540482961|FG001|Overall Study|Adverse Event|13|||
149823412|NCT01579474|540482962|FG002|Overall Study|Adverse Event|2|||
149823413|NCT01579474|540482963|FG003|Overall Study|Adverse Event|0|||
149823414|NCT01579474|540482964|FG004|Overall Study|Adverse Event|0|||
149823415|NCT01579474|540482965|FG005|Overall Study|Adverse Event|1|||
149823416|NCT01579474|540482960|FG000|Overall Study|Lack of Efficacy|1|||
149823417|NCT01579474|540482961|FG001|Overall Study|Lack of Efficacy|0|||
149823418|NCT01579474|540482962|FG002|Overall Study|Lack of Efficacy|0|||
149823419|NCT01579474|540482963|FG003|Overall Study|Lack of Efficacy|0|||
149823420|NCT01579474|540482964|FG004|Overall Study|Lack of Efficacy|1|||
149823421|NCT01579474|540482965|FG005|Overall Study|Lack of Efficacy|0|||
149823422|NCT01579474|540482960|FG000|Overall Study|Withdrawal by Subject|1|||
149823423|NCT01579474|540482961|FG001|Overall Study|Withdrawal by Subject|0|||
149823424|NCT01579474|540482962|FG002|Overall Study|Withdrawal by Subject|0|||
149823425|NCT01579474|540482963|FG003|Overall Study|Withdrawal by Subject|0|||
149823426|NCT01579474|540482964|FG004|Overall Study|Withdrawal by Subject|0|||
149823427|NCT01579474|540482965|FG005|Overall Study|Withdrawal by Subject|0|||
149823428|NCT01075763|540482966|FG000|Overall Study|Lost to Follow-up|2|||
149823429|NCT01075763|540482967|FG001|Overall Study|Lost to Follow-up|1|||
149823430|NCT01075763|540482966|FG000|Overall Study|Lack of Efficacy|0|||
149823431|NCT01075763|540482967|FG001|Overall Study|Lack of Efficacy|1|||
149823432|NCT01075763|540482966|FG000|Overall Study|Withdrawal by Subject|2|||
149823433|NCT01075763|540482967|FG001|Overall Study|Withdrawal by Subject|2|||
149823434|NCT00586521|540482968|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
149823435|NCT03083483|540482970|FG000|Overall Study|Adverse Event|1|||
149823436|NCT03083483|540482971|FG001|Overall Study|Adverse Event|1|||
149823437|NCT03083483|540482972|FG002|Overall Study|Adverse Event|1|||
149823438|NCT03083483|540482970|FG000|Overall Study|Lost to Follow-up|2|||
149823439|NCT03083483|540482971|FG001|Overall Study|Lost to Follow-up|1|||
149823440|NCT03083483|540482972|FG002|Overall Study|Lost to Follow-up|1|||
149823441|NCT03083483|540482970|FG000|Overall Study|technological issues|1|||
149823442|NCT03083483|540482971|FG001|Overall Study|technological issues|0|||
149823443|NCT03083483|540482972|FG002|Overall Study|technological issues|1|||
149823444|NCT01751412|540482982|FG000|Overall Study|Disease Progression Before Treatment|1|||
149823445|NCT01673009|540482985|FG000|Overall Study|Physician Decision|5|||
149823446|NCT01673009|540482985|FG000|Overall Study|Withdrawal by Subject|8|||
149823447|NCT01844583|540482986|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
149823448|NCT01844583|540482987|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
149944274|NCT04880850|540929524|FG000|Overall Study|Lost to Follow-up|3|||
149944275|NCT04880850|540929525|FG001|Overall Study|Lost to Follow-up|6|||
149944276|NCT04880850|540929524|FG000|Overall Study|Physician Decision|2|||
149944277|NCT04880850|540929525|FG001|Overall Study|Physician Decision|1|||
149944278|NCT04880850|540929524|FG000|Overall Study|Withdrawal by Subject|9|||
149944279|NCT04880850|540929525|FG001|Overall Study|Withdrawal by Subject|10|||
149944280|NCT04091451|540929526|FG000|Overall Study|Adverse Event|15|||
149944281|NCT04091451|540929527|FG001|Overall Study|Adverse Event|10|||
149944282|NCT04091451|540929526|FG000|Overall Study|Lost to Follow-up|8|||
149944283|NCT04091451|540929527|FG001|Overall Study|Lost to Follow-up|8|||
149944284|NCT04091451|540929526|FG000|Overall Study|Protocol Violation|5|||
149823449|NCT00449072|540482988|FG000|Overall Study|Adverse Event|3|||
149823450|NCT00449072|540482989|FG001|Overall Study|Adverse Event|1|||
149823451|NCT00449072|540482988|FG000|Overall Study|Protocol Violation|14|||
149823452|NCT00449072|540482989|FG001|Overall Study|Protocol Violation|12|||
149823453|NCT00449072|540482988|FG000|Overall Study|Lost to Follow-up|5|||
149944285|NCT04091451|540929527|FG001|Overall Study|Protocol Violation|4|||
149944286|NCT04091451|540929526|FG000|Overall Study|Withdrawal by Subject|21|||
149823454|NCT00449072|540482989|FG001|Overall Study|Lost to Follow-up|7|||
149944287|NCT04091451|540929527|FG001|Overall Study|Withdrawal by Subject|27|||
149944288|NCT04091451|540929526|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
149944289|NCT04091451|540929527|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
149823455|NCT00449072|540482988|FG000|Overall Study|Withdrawal by Subject|11|||
149823456|NCT00449072|540482989|FG001|Overall Study|Withdrawal by Subject|8|||
149823457|NCT00449072|540482988|FG000|Overall Study|Lack of Efficacy|1|||
149823458|NCT00449072|540482989|FG001|Overall Study|Lack of Efficacy|1|||
149823459|NCT00449072|540482988|FG000|Overall Study|Physician Decision|1|||
149823460|NCT00449072|540482989|FG001|Overall Study|Physician Decision|0|||
149823461|NCT00449072|540482988|FG000|Overall Study|Not treated|0|||
149823462|NCT00449072|540482989|FG001|Overall Study|Not treated|1|||
149823463|NCT00449072|540482988|FG000|Overall Study|Excluded medication|0|||
149823464|NCT00449072|540482989|FG001|Overall Study|Excluded medication|2|||
149823465|NCT00449072|540482988|FG000|Overall Study|Non-compliance|2|||
149823466|NCT00449072|540482989|FG001|Overall Study|Non-compliance|5|||
149823467|NCT00449072|540482988|FG000|Overall Study|Sponsor decision|1|||
149823468|NCT00449072|540482989|FG001|Overall Study|Sponsor decision|3|||
149823469|NCT00449072|540482988|FG000|Overall Study|Relocation|3|||
149823470|NCT00449072|540482989|FG001|Overall Study|Relocation|2|||
149823471|NCT02623959|540482990|FG000|Overall Study|Progression|0|||
149823472|NCT02623959|540482991|FG001|Overall Study|Progression|1|||
149823473|NCT01787825|540482992|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
149823474|NCT01787825|540482993|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
149823475|NCT01787825|540482992|FG000|Overall Study|Data Not Analyzable|5|||
149823476|NCT01787825|540482993|FG001|Overall Study|Data Not Analyzable|1|||
149823477|NCT00989261|540482999|FG000|Overall Study|Still in follow up|12|||
149823478|NCT00989261|540483000|FG001|Overall Study|Still in follow up|21|||
149823479|NCT00989261|540482999|FG000|Overall Study|Withdrawal by Subject|0|||
149823480|NCT00989261|540483000|FG001|Overall Study|Withdrawal by Subject|1|||
149823481|NCT00989261|540482999|FG000|Overall Study|Lost to Follow-up|3|||
149823482|NCT00989261|540483000|FG001|Overall Study|Lost to Follow-up|0|||
149823483|NCT00617461|540483003|FG000|First Treatment Intervention Period|Adverse Event|2|||
149823484|NCT00617461|540483004|FG001|First Treatment Intervention Period|Adverse Event|0|||
149823485|NCT00617461|540483003|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
149823486|NCT00617461|540483004|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
149823487|NCT00617461|540483003|FG000|First Treatment Intervention Period|Protocol Violation|2|||
149823488|NCT00617461|540483004|FG001|First Treatment Intervention Period|Protocol Violation|1|||
149823489|NCT00617461|540483003|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
149823490|NCT00617461|540483004|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
149823491|NCT00617461|540483003|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
149823492|NCT00617461|540483004|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
149823493|NCT00617461|540483003|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
149823494|NCT00617461|540483004|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
149823495|NCT00617461|540483003|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
149823496|NCT00617461|540483004|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
149823497|NCT00617461|540483003|FG000|Second Treatment Intervention Period|Adverse Event|0|||
149823498|NCT00617461|540483004|FG001|Second Treatment Intervention Period|Adverse Event|1|||
149823499|NCT00617461|540483003|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
149823500|NCT00617461|540483004|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
149823501|NCT00617461|540483003|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
149823502|NCT00617461|540483004|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
149823503|NCT00617461|540483003|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
149823504|NCT00617461|540483004|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
149823505|NCT01821625|540483005|FG000|Overall Study|Withdrawal by Subject|2|||
149823506|NCT01821625|540483005|FG000|Overall Study|Lack of Efficacy|2|||
149823507|NCT01821625|540483005|FG000|Overall Study|Adverse Event|1|||
149823508|NCT01821625|540483005|FG000|Overall Study|Medical contraindication|1|||
149823509|NCT00457665|540483011|FG000|12 Months|Drug allergy|1|||
149823510|NCT00457665|540483012|FG001|12 Months|Drug allergy|1|||
149823511|NCT00457665|540483011|FG000|12 Months|High HIV viral load|5|||
149823512|NCT00457665|540483012|FG001|12 Months|High HIV viral load|1|||
149823513|NCT00457665|540483011|FG000|12 Months|Lipodystrophy|2|||
149823514|NCT00457665|540483012|FG001|12 Months|Lipodystrophy|0|||
149823515|NCT00457665|540483011|FG000|12 Months|Withdrawal by Subject|0|||
149823516|NCT00457665|540483012|FG001|12 Months|Withdrawal by Subject|2|||
149823517|NCT00457665|540483011|FG000|12 Months|Abnormal Liver function tests|0|||
149823518|NCT00457665|540483012|FG001|12 Months|Abnormal Liver function tests|5|||
149823519|NCT00457665|540483011|FG000|24 Months|Withdrawal by Subject|3|||
149823520|NCT00457665|540483012|FG001|24 Months|Withdrawal by Subject|2|||
149823521|NCT00457665|540483011|FG000|24 Months|Lipodystrophy|1|||
150275008|NCT00131469|542144542|FG000|Overall Study|Death|0|||
150275009|NCT00131469|542144543|FG001|Overall Study|Death|1|||
150275010|NCT00131469|542144542|FG000|Overall Study|Lost to Follow-up|0|||
149823522|NCT00457665|540483012|FG001|24 Months|Lipodystrophy|1|||
149823523|NCT00457665|540483011|FG000|24 Months|Abnormal liver function tests|1|||
149823524|NCT00457665|540483012|FG001|24 Months|Abnormal liver function tests|5|||
149823525|NCT02535000|540483014|FG000|Overall Study|Cancellation of surgery.|1|||
149823526|NCT02535000|540483015|FG001|Overall Study|Cancellation of surgery.|2|||
149823527|NCT01620489|540483020|FG000|Overall Study|Adverse Event|17|||
149944290|NCT04091451|540929526|FG000|Overall Study|Migrated/moved from the study area|3|||
150275011|NCT00131469|542144543|FG001|Overall Study|Lost to Follow-up|1|||
150275012|NCT00131469|542144542|FG000|Overall Study|scan not analyzable|3|||
149823528|NCT01620489|540483021|FG001|Overall Study|Adverse Event|4|||
149823529|NCT01620489|540483020|FG000|Overall Study|Protocol Violation|0|||
149823530|NCT01620489|540483021|FG001|Overall Study|Protocol Violation|3|||
149823531|NCT01620489|540483020|FG000|Overall Study|Withdrawal Criteria|17|||
149823532|NCT01620489|540483021|FG001|Overall Study|Withdrawal Criteria|25|||
149823533|NCT01620489|540483020|FG000|Overall Study|Unclassified|1|||
149823534|NCT01620489|540483021|FG001|Overall Study|Unclassified|2|||
149823535|NCT03264066|540483029|FG000|Overall Study|Adverse Event|1|||
149823536|NCT03264066|540483030|FG001|Overall Study|Adverse Event|1|||
149823537|NCT03264066|540483031|FG002|Overall Study|Adverse Event|0|||
149823538|NCT03264066|540483032|FG003|Overall Study|Adverse Event|0|||
149823539|NCT03264066|540483033|FG004|Overall Study|Adverse Event|0|||
149823540|NCT03264066|540483034|FG005|Overall Study|Adverse Event|0|||
149823541|NCT03264066|540483029|FG000|Overall Study|Death|12|||
149823542|NCT03264066|540483030|FG001|Overall Study|Death|12|||
149823543|NCT03264066|540483031|FG002|Overall Study|Death|8|||
149823544|NCT03264066|540483032|FG003|Overall Study|Death|10|||
149823545|NCT03264066|540483033|FG004|Overall Study|Death|6|||
149823546|NCT03264066|540483034|FG005|Overall Study|Death|1|||
149823547|NCT03264066|540483029|FG000|Overall Study|Lost to Follow-up|1|||
149823548|NCT03264066|540483030|FG001|Overall Study|Lost to Follow-up|0|||
149823549|NCT03264066|540483031|FG002|Overall Study|Lost to Follow-up|0|||
149823550|NCT03264066|540483032|FG003|Overall Study|Lost to Follow-up|0|||
149823551|NCT03264066|540483033|FG004|Overall Study|Lost to Follow-up|0|||
149823552|NCT03264066|540483034|FG005|Overall Study|Lost to Follow-up|0|||
149823553|NCT03264066|540483029|FG000|Overall Study|Progressive Disease|0|||
149823554|NCT03264066|540483030|FG001|Overall Study|Progressive Disease|2|||
149823555|NCT03264066|540483031|FG002|Overall Study|Progressive Disease|1|||
149823556|NCT03264066|540483032|FG003|Overall Study|Progressive Disease|0|||
149823557|NCT03264066|540483033|FG004|Overall Study|Progressive Disease|0|||
149823558|NCT03264066|540483034|FG005|Overall Study|Progressive Disease|0|||
149823559|NCT03264066|540483029|FG000|Overall Study|Study Terminated by Sponsor|5|||
149823560|NCT03264066|540483030|FG001|Overall Study|Study Terminated by Sponsor|5|||
149823561|NCT03264066|540483031|FG002|Overall Study|Study Terminated by Sponsor|8|||
149823562|NCT03264066|540483032|FG003|Overall Study|Study Terminated by Sponsor|5|||
149823563|NCT03264066|540483033|FG004|Overall Study|Study Terminated by Sponsor|1|||
149823564|NCT03264066|540483034|FG005|Overall Study|Study Terminated by Sponsor|2|||
149823565|NCT03264066|540483029|FG000|Overall Study|Withdrawal by Subject|1|||
149823566|NCT03264066|540483030|FG001|Overall Study|Withdrawal by Subject|0|||
149823567|NCT03264066|540483031|FG002|Overall Study|Withdrawal by Subject|0|||
149944291|NCT04091451|540929527|FG001|Overall Study|Migrated/moved from the study area|5|||
149944292|NCT04091451|540929526|FG000|Overall Study|Suspected HZ episode|1|||
149944293|NCT04091451|540929527|FG001|Overall Study|Suspected HZ episode|0|||
149944294|NCT04284774|540929528|FG000|Overall Study|Progressive disease|5|||
149944295|NCT05020015|540930642|FG000|Overall Study|Ongoing on study|1|||
149944296|NCT05020015|540930643|FG001|Overall Study|Ongoing on study|3|||
149944297|NCT05020015|540930644|FG002|Overall Study|Ongoing on study|4|||
149944298|NCT05020015|540930645|FG003|Overall Study|Ongoing on study|7|||
149944299|NCT05020015|540930642|FG000|Overall Study|Death|2|||
149944300|NCT05020015|540930643|FG001|Overall Study|Death|3|||
149944301|NCT05020015|540930644|FG002|Overall Study|Death|4|||
149944302|NCT05020015|540930645|FG003|Overall Study|Death|0|||
149944303|NCT05020015|540930642|FG000|Overall Study|Withdrawal by Subject|0|||
149944304|NCT05020015|540930643|FG001|Overall Study|Withdrawal by Subject|0|||
149944305|NCT05020015|540930644|FG002|Overall Study|Withdrawal by Subject|1|||
149944306|NCT05020015|540930645|FG003|Overall Study|Withdrawal by Subject|0|||
149944307|NCT05020015|540930642|FG000|Overall Study|Reason Not Specified|0|||
149944308|NCT05020015|540930643|FG001|Overall Study|Reason Not Specified|0|||
149944309|NCT05020015|540930644|FG002|Overall Study|Reason Not Specified|2|||
149944310|NCT05020015|540930645|FG003|Overall Study|Reason Not Specified|0|||
149944311|NCT00947544|540930650|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
150275013|NCT00131469|542144543|FG001|Overall Study|scan not analyzable|6|||
150275014|NCT00736034|542144550|FG000|Overall Study|Adverse Event|2|||
150275015|NCT01910116|542144551|FG000|Overall Study|Adverse Event|0|||
150275016|NCT01910116|542144552|FG001|Overall Study|Adverse Event|3|||
150275017|NCT01910116|542144551|FG000|Overall Study|Lack of Efficacy|3|||
150275018|NCT01910116|542144552|FG001|Overall Study|Lack of Efficacy|4|||
150275019|NCT01910116|542144551|FG000|Overall Study|Lost to Follow-up|1|||
150275020|NCT01910116|542144552|FG001|Overall Study|Lost to Follow-up|0|||
149823568|NCT03264066|540483032|FG003|Overall Study|Withdrawal by Subject|5|||
149823569|NCT03264066|540483033|FG004|Overall Study|Withdrawal by Subject|0|||
149823570|NCT03264066|540483034|FG005|Overall Study|Withdrawal by Subject|0|||
149944312|NCT00947544|540930651|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
149944313|NCT00300053|540930652|FG000|Overall Study|Patient/Caregiver Preference|2|||
149944314|NCT00300053|540930653|FG001|Overall Study|Patient/Caregiver Preference|2|||
149944315|NCT00300053|540930654|FG002|Overall Study|Patient/Caregiver Preference|3|||
149823571|NCT01484028|540483035|FG000|Period 1|Lost to Follow-up|0|||
149823572|NCT01484028|540483036|FG001|Period 1|Lost to Follow-up|1|||
149823573|NCT01484028|540483037|FG002|Period 1|Lost to Follow-up|0|||
149823574|NCT01484028|540483038|FG003|Period 1|Lost to Follow-up|0|||
149823575|NCT01484028|540483035|FG000|Period 1|Non-Compliance to Protocol|0|||
149823576|NCT01484028|540483036|FG001|Period 1|Non-Compliance to Protocol|1|||
149823577|NCT01484028|540483037|FG002|Period 1|Non-Compliance to Protocol|0|||
149823578|NCT01484028|540483038|FG003|Period 1|Non-Compliance to Protocol|1|||
149823579|NCT01484028|540483035|FG000|Period 1|Lens Discomfort|0|||
149823580|NCT01484028|540483036|FG001|Period 1|Lens Discomfort|1|||
149823581|NCT01484028|540483037|FG002|Period 1|Lens Discomfort|0|||
149823582|NCT01484028|540483038|FG003|Period 1|Lens Discomfort|0|||
149823583|NCT01193517|540483044|FG000|Overall Study|Early Progression|1|||
149823584|NCT01193517|540483045|FG001|Overall Study|Early Progression|0|||
149823585|NCT01193517|540483046|FG002|Overall Study|Early Progression|0|||
149823586|NCT02115256|540483049|FG000|Overall Study|Withdrawal by Subject|0|||
149823587|NCT02115256|540483050|FG001|Overall Study|Withdrawal by Subject|1|||
149823588|NCT00146770|540483051|FG000|Overall Study|Adverse Event|2|||
149823589|NCT00146770|540483052|FG001|Overall Study|Adverse Event|0|||
149823590|NCT00146770|540483051|FG000|Overall Study|Pregnancy|1|||
149823591|NCT00146770|540483052|FG001|Overall Study|Pregnancy|0|||
149823592|NCT00146770|540483051|FG000|Overall Study|Withdrawal by Subject|2|||
149823593|NCT00146770|540483052|FG001|Overall Study|Withdrawal by Subject|0|||
149823594|NCT01185288|540483053|FG000|Overall Study|Adverse Event|7|||
149823595|NCT01185288|540483054|FG001|Overall Study|Adverse Event|6|||
149823596|NCT01185288|540483053|FG000|Overall Study|Withdrawal by Subject|6|||
149823597|NCT01185288|540483054|FG001|Overall Study|Withdrawal by Subject|4|||
149823598|NCT01185288|540483053|FG000|Overall Study|Lost to Follow-up|2|||
149823599|NCT01185288|540483054|FG001|Overall Study|Lost to Follow-up|5|||
149823600|NCT01185288|540483053|FG000|Overall Study|Lack of Efficacy|2|||
149823601|NCT01185288|540483054|FG001|Overall Study|Lack of Efficacy|0|||
149823602|NCT01185288|540483053|FG000|Overall Study|Investigator discretion|1|||
149823603|NCT01185288|540483054|FG001|Overall Study|Investigator discretion|0|||
149823604|NCT01185288|540483053|FG000|Overall Study|Did not meet inclusion criteria|1|||
149823605|NCT01185288|540483054|FG001|Overall Study|Did not meet inclusion criteria|0|||
149823606|NCT01185288|540483053|FG000|Overall Study|Noncompliance|0|||
149823607|NCT01185288|540483054|FG001|Overall Study|Noncompliance|1|||
149823608|NCT01626859|540483057|FG000|Overall Study|Adverse Event|1|||
149823609|NCT01626859|540483058|FG001|Overall Study|Adverse Event|3|||
149823610|NCT01626859|540483059|FG002|Overall Study|Adverse Event|2|||
149823611|NCT01626859|540483057|FG000|Overall Study|Physician Decision|0|||
149823612|NCT01626859|540483058|FG001|Overall Study|Physician Decision|1|||
149823613|NCT01626859|540483059|FG002|Overall Study|Physician Decision|0|||
149823614|NCT01626859|540483057|FG000|Overall Study|Withdrawal by Subject|1|||
149823615|NCT01626859|540483058|FG001|Overall Study|Withdrawal by Subject|4|||
149823616|NCT01626859|540483059|FG002|Overall Study|Withdrawal by Subject|2|||
149823617|NCT02427607|540483060|FG000|Overall Study|Withdrawal by Subject|1|||
149823618|NCT02277769|540483061|FG000|Overall Study|Protocol Violation|3|||
149823619|NCT02277769|540483062|FG001|Overall Study|Protocol Violation|3|||
149823620|NCT02277769|540483063|FG002|Overall Study|Protocol Violation|5|||
149823621|NCT02277769|540483061|FG000|Overall Study|Lack of Efficacy|17|||
149823622|NCT02277769|540483062|FG001|Overall Study|Lack of Efficacy|0|||
149823623|NCT02277769|540483063|FG002|Overall Study|Lack of Efficacy|4|||
149823624|NCT02277769|540483061|FG000|Overall Study|Adverse Event|14|||
149823625|NCT02277769|540483062|FG001|Overall Study|Adverse Event|2|||
149823626|NCT02277769|540483063|FG002|Overall Study|Adverse Event|4|||
149823627|NCT02277769|540483061|FG000|Overall Study|Other than specified above|12|||
149823628|NCT02277769|540483062|FG001|Overall Study|Other than specified above|8|||
149823629|NCT02277769|540483063|FG002|Overall Study|Other than specified above|5|||
149823630|NCT02826603|540483064|FG000|Overall Study|Adverse Event|17|||
149823631|NCT02826603|540483065|FG001|Overall Study|Adverse Event|9|||
149823632|NCT02826603|540483064|FG000|Overall Study|Lack of Efficacy|4|||
149823633|NCT02826603|540483065|FG001|Overall Study|Lack of Efficacy|9|||
149944316|NCT00300053|540930652|FG000|Overall Study|Death|0|||
149944317|NCT00300053|540930653|FG001|Overall Study|Death|0|||
150170357|NCT01235949|541759065|FG004|Primary Phase|Withdrawal by Subject|0|||
149823634|NCT02826603|540483064|FG000|Overall Study|Lost to Follow-up|13|||
149823635|NCT02826603|540483065|FG001|Overall Study|Lost to Follow-up|12|||
149823636|NCT02826603|540483064|FG000|Overall Study|Noncompliance with treatment|0|||
149823637|NCT02826603|540483065|FG001|Overall Study|Noncompliance with treatment|2|||
149823638|NCT02826603|540483064|FG000|Overall Study|Physician Decision|1|||
149823639|NCT02826603|540483065|FG001|Overall Study|Physician Decision|7|||
149823640|NCT02826603|540483064|FG000|Overall Study|Pregnancy|1|||
149823641|NCT02826603|540483065|FG001|Overall Study|Pregnancy|2|||
149823642|NCT02826603|540483064|FG000|Overall Study|Protocol Violation|3|||
149823643|NCT02826603|540483065|FG001|Overall Study|Protocol Violation|3|||
149823644|NCT02826603|540483064|FG000|Overall Study|Withdrawal by Subject|20|||
150170358|NCT01235949|541759066|FG005|Primary Phase|Withdrawal by Subject|3|||
149823645|NCT02826603|540483065|FG001|Overall Study|Withdrawal by Subject|19|||
149823646|NCT02826603|540483064|FG000|Overall Study|Death|2|||
149823647|NCT02826603|540483065|FG001|Overall Study|Death|0|||
149823648|NCT02826603|540483064|FG000|Overall Study|New therapy for study indication|0|||
149944318|NCT00300053|540930654|FG002|Overall Study|Death|3|||
149823649|NCT02826603|540483065|FG001|Overall Study|New therapy for study indication|1|||
149823650|NCT00905489|540483066|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
149823651|NCT00905489|540483066|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
149823652|NCT00905489|540483066|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
149823653|NCT01626885|540483069|FG000|Overall Study|Adverse Event|8|||
149823654|NCT01626885|540483069|FG000|Overall Study|Withdrawal by Subject|4|||
149823655|NCT00982410|540484474|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
149823656|NCT00982410|540484475|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
149823657|NCT00982410|540484474|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
149823658|NCT00982410|540484475|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
149823659|NCT00982410|540484474|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
149823660|NCT00982410|540484475|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
149823661|NCT00982410|540484474|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
149823662|NCT00982410|540484475|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
149823663|NCT00982410|540484474|FG000|6-month Follow-up Assessment|participant no transportation|1|||
149823664|NCT00982410|540484475|FG001|6-month Follow-up Assessment|participant no transportation|0|||
149823665|NCT00982410|540484474|FG000|6-month Follow-up Assessment|incarceration|0|||
149944319|NCT00300053|540930652|FG000|Overall Study|Lost to Follow-up|0|||
149944320|NCT00300053|540930653|FG001|Overall Study|Lost to Follow-up|1|||
149944321|NCT00300053|540930654|FG002|Overall Study|Lost to Follow-up|0|||
149944322|NCT03095287|540930658|FG000|Overall Study|Treatment Failure|1|||
149944323|NCT03095287|540930658|FG000|Overall Study|Adverse Event|1|||
149944324|NCT01963611|540930661|FG000|Overall Study|Adverse Event|1|||
149944325|NCT01963611|540930662|FG001|Overall Study|Adverse Event|1|||
149944326|NCT01963611|540930663|FG002|Overall Study|Adverse Event|3|||
149944327|NCT01963611|540930664|FG003|Overall Study|Adverse Event|4|||
149944328|NCT01963611|540930665|FG004|Overall Study|Adverse Event|3|||
149944329|NCT01963611|540930661|FG000|Overall Study|Protocol Violation|0|||
149944330|NCT01963611|540930662|FG001|Overall Study|Protocol Violation|0|||
149944331|NCT01963611|540930663|FG002|Overall Study|Protocol Violation|0|||
149944332|NCT01963611|540930664|FG003|Overall Study|Protocol Violation|1|||
149944333|NCT01963611|540930665|FG004|Overall Study|Protocol Violation|0|||
149944334|NCT01963611|540930661|FG000|Overall Study|Lack of Efficacy|0|||
149944335|NCT01963611|540930662|FG001|Overall Study|Lack of Efficacy|0|||
149944336|NCT01963611|540930663|FG002|Overall Study|Lack of Efficacy|0|||
149944337|NCT01963611|540930664|FG003|Overall Study|Lack of Efficacy|1|||
149944338|NCT01963611|540930665|FG004|Overall Study|Lack of Efficacy|0|||
149944339|NCT01963611|540930661|FG000|Overall Study|Withdrawal by Subject|3|||
149944340|NCT01963611|540930662|FG001|Overall Study|Withdrawal by Subject|2|||
149944341|NCT01963611|540930663|FG002|Overall Study|Withdrawal by Subject|1|||
149944342|NCT01963611|540930664|FG003|Overall Study|Withdrawal by Subject|1|||
149944343|NCT01963611|540930665|FG004|Overall Study|Withdrawal by Subject|3|||
149944344|NCT01963611|540930661|FG000|Overall Study|Other|47|||
149944345|NCT01963611|540930662|FG001|Overall Study|Other|46|||
149944346|NCT01963611|540930663|FG002|Overall Study|Other|48|||
149944347|NCT01963611|540930664|FG003|Overall Study|Other|45|||
149944348|NCT01963611|540930665|FG004|Overall Study|Other|45|||
149944349|NCT02394275|540930666|FG000|Overall Study|Adverse Event|22|||
149944350|NCT02394275|540930666|FG000|Overall Study|Lost to Follow-up|7|||
149944351|NCT00984867|540930667|FG000|Overall Study|Adverse Event|3|||
149944352|NCT00984867|540930668|FG001|Overall Study|Adverse Event|7|||
149944353|NCT00984867|540930667|FG000|Overall Study|Death|1|||
150170359|NCT01235949|541759067|FG006|Primary Phase|Withdrawal by Subject|0|||
149823666|NCT00982410|540484475|FG001|6-month Follow-up Assessment|incarceration|2|||
149823667|NCT00982410|540484474|FG000|6-month Follow-up Assessment|patent surgery|0|||
149823668|NCT00982410|540484475|FG001|6-month Follow-up Assessment|patent surgery|1|||
149823669|NCT00982410|540484474|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
149944354|NCT00984867|540930668|FG001|Overall Study|Death|0|||
149944355|NCT00984867|540930667|FG000|Overall Study|Withdrawal by Subject|13|||
149944356|NCT00984867|540930668|FG001|Overall Study|Withdrawal by Subject|4|||
150170360|NCT01235949|541759068|FG007|Primary Phase|Withdrawal by Subject|0|||
150170361|NCT01235949|541759069|FG008|Primary Phase|Withdrawal by Subject|0|||
150170362|NCT01235949|541759070|FG009|Primary Phase|Withdrawal by Subject|0|||
150170363|NCT01235949|541759071|FG010|Primary Phase|Withdrawal by Subject|0|||
149944357|NCT00984867|540930667|FG000|Overall Study|Lost to Follow-up|3|||
149944358|NCT00984867|540930668|FG001|Overall Study|Lost to Follow-up|4|||
149944359|NCT00984867|540930667|FG000|Overall Study|Poor/non-compliance|0|||
149944360|NCT00984867|540930668|FG001|Overall Study|Poor/non-compliance|1|||
149944361|NCT00984867|540930667|FG000|Overall Study|Subject no longer meets study criteria|1|||
149944362|NCT00984867|540930668|FG001|Overall Study|Subject no longer meets study criteria|1|||
149944363|NCT00984867|540930667|FG000|Overall Study|site closing|1|||
149944364|NCT00984867|540930668|FG001|Overall Study|site closing|0|||
149944365|NCT00984867|540930667|FG000|Overall Study|lack of efficacy and subject compliance|1|||
149944366|NCT00984867|540930668|FG001|Overall Study|lack of efficacy and subject compliance|0|||
149944367|NCT01541748|540930669|FG000|Overall Study|Lost to Follow-up|17|||
150170364|NCT01235949|541759072|FG011|Primary Phase|Withdrawal by Subject|0|||
149823670|NCT00982410|540484475|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
149823671|NCT00982410|540484474|FG000|12-month Follow-up Assessment|Death|0|||
149823672|NCT00982410|540484475|FG001|12-month Follow-up Assessment|Death|2|||
149823673|NCT00982410|540484474|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
149823674|NCT00982410|540484475|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
149823675|NCT00982410|540484474|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
149823676|NCT00982410|540484475|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
149823677|NCT00982410|540484474|FG000|12-month Follow-up Assessment|incarceration|2|||
149823678|NCT00982410|540484475|FG001|12-month Follow-up Assessment|incarceration|1|||
149823679|NCT00982410|540484474|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
149823680|NCT00982410|540484475|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
149823681|NCT00759148|540484477|FG000|Overall Study|Adverse Event|1|||
149823682|NCT00759148|540484478|FG001|Overall Study|Adverse Event|6|||
149823683|NCT00759148|540484477|FG000|Overall Study|Withdrawal by Subject|3|||
149823684|NCT00759148|540484478|FG001|Overall Study|Withdrawal by Subject|7|||
149823685|NCT00759148|540484477|FG000|Overall Study|Lost to Follow-up|3|||
149823686|NCT00759148|540484478|FG001|Overall Study|Lost to Follow-up|9|||
149823687|NCT00759148|540484477|FG000|Overall Study|Treatment Failure|6|||
149823688|NCT00759148|540484478|FG001|Overall Study|Treatment Failure|10|||
149823689|NCT00759148|540484477|FG000|Overall Study|Reason not given|1|||
149823690|NCT00759148|540484478|FG001|Overall Study|Reason not given|0|||
149823691|NCT01073020|540484479|FG000|Overall Study|Withdrawal by Subject|6|||
149823692|NCT01073020|540484480|FG001|Overall Study|Withdrawal by Subject|4|||
149823693|NCT01073020|540484481|FG002|Overall Study|Withdrawal by Subject|1|||
149823694|NCT01073020|540484482|FG003|Overall Study|Withdrawal by Subject|2|||
149823695|NCT01073020|540484479|FG000|Overall Study|Physician Decision|1|||
149823696|NCT01073020|540484480|FG001|Overall Study|Physician Decision|0|||
149823697|NCT01073020|540484481|FG002|Overall Study|Physician Decision|2|||
149823698|NCT01073020|540484482|FG003|Overall Study|Physician Decision|0|||
149823699|NCT01073020|540484479|FG000|Overall Study|Death|0|||
149823700|NCT01073020|540484480|FG001|Overall Study|Death|1|||
149823701|NCT01073020|540484481|FG002|Overall Study|Death|0|||
149823702|NCT01073020|540484482|FG003|Overall Study|Death|0|||
149823703|NCT01644890|540484483|FG000|Overall Study|Adverse Event|7|||
149823704|NCT01644890|540484484|FG001|Overall Study|Adverse Event|20|||
149823705|NCT01644890|540484483|FG000|Overall Study|Death|1|||
149823706|NCT01644890|540484484|FG001|Overall Study|Death|3|||
149823707|NCT01644890|540484483|FG000|Overall Study|Physician Decision|3|||
149823708|NCT01644890|540484484|FG001|Overall Study|Physician Decision|9|||
149823709|NCT01644890|540484483|FG000|Overall Study|Protocol Violation|6|||
149823710|NCT01644890|540484484|FG001|Overall Study|Protocol Violation|7|||
149944368|NCT01541748|540930669|FG000|Overall Study|Moved out of state|1|||
149944369|NCT01541748|540930669|FG000|Overall Study|Withdrawal by Subject|7|||
149944370|NCT01541748|540930669|FG000|Overall Study|Screen failure|5|||
149944371|NCT01541748|540930669|FG000|Overall Study|Did not receive study device|1|||
149944372|NCT06057064|540930670|FG000|Overall Study|Death|2|||
149944373|NCT06057064|540930671|FG001|Overall Study|Death|0|||
149944374|NCT06057064|540930670|FG000|Overall Study|Physician Decision|1|||
149944375|NCT06057064|540930671|FG001|Overall Study|Physician Decision|0|||
149944376|NCT06057064|540930670|FG000|Overall Study|Withdrawal by Subject|1|||
149944377|NCT06057064|540930671|FG001|Overall Study|Withdrawal by Subject|1|||
149944378|NCT00785629|540930680|FG000|Overall Study|Adverse Event|2|||
149944379|NCT00785629|540930681|FG001|Overall Study|Adverse Event|1|||
149944380|NCT00785629|540930682|FG002|Overall Study|Adverse Event|1|||
149944381|NCT00785629|540930683|FG003|Overall Study|Adverse Event|5|||
149944382|NCT00785629|540930680|FG000|Overall Study|Protocol Violation|1|||
149944383|NCT00785629|540930681|FG001|Overall Study|Protocol Violation|2|||
149944384|NCT00785629|540930682|FG002|Overall Study|Protocol Violation|4|||
149944385|NCT00785629|540930683|FG003|Overall Study|Protocol Violation|5|||
149944386|NCT00785629|540930680|FG000|Overall Study|administrative decision|5|||
149944387|NCT00785629|540930681|FG001|Overall Study|administrative decision|1|||
149944388|NCT00785629|540930682|FG002|Overall Study|administrative decision|3|||
150170365|NCT01235949|541759073|FG012|Primary Phase|Withdrawal by Subject|0|||
150170366|NCT01235949|541759074|FG013|Primary Phase|Withdrawal by Subject|0|||
149823711|NCT01644890|540484483|FG000|Overall Study|Withdrawal by Subject|19|||
149823712|NCT01644890|540484484|FG001|Overall Study|Withdrawal by Subject|27|||
149823713|NCT01644890|540484483|FG000|Overall Study|Progression Disease|160|||
149823714|NCT01644890|540484484|FG001|Overall Study|Progression Disease|131|||
149823715|NCT01644890|540484483|FG000|Overall Study|Clinical Progression|6|||
149823716|NCT01644890|540484484|FG001|Overall Study|Clinical Progression|6|||
149823717|NCT01644890|540484483|FG000|Overall Study|> 28 days since last dose of study drug|6|||
149944389|NCT00785629|540930683|FG003|Overall Study|administrative decision|4|||
149944390|NCT00785629|540930680|FG000|Overall Study|Withdrawal by Subject|0|||
149944391|NCT00785629|540930681|FG001|Overall Study|Withdrawal by Subject|1|||
149944392|NCT00785629|540930682|FG002|Overall Study|Withdrawal by Subject|2|||
149944393|NCT00785629|540930683|FG003|Overall Study|Withdrawal by Subject|2|||
149944394|NCT00851591|540930684|FG000|Overall Study|Withdrawal by Subject|2|||
150170367|NCT01235949|541759075|FG014|Primary Phase|Withdrawal by Subject|0|||
149823718|NCT01644890|540484484|FG001|Overall Study|> 28 days since last dose of study drug|3|||
149823719|NCT01644890|540484483|FG000|Overall Study|Other|8|||
149823720|NCT01644890|540484484|FG001|Overall Study|Other|9|||
149823721|NCT03031899|540484489|FG000|Overall Study|Protocol Violation|1|||
149823722|NCT03031899|540484489|FG000|Overall Study|lesion disappeared after stopping habit|1|||
149823723|NCT01060670|540484490|FG000|Run In|screen failure|0|||
149823724|NCT01060670|540484491|FG001|Run In|screen failure|238|||
149823725|NCT00094302|540484492|FG000|Overall Study|Lost to Follow-up|43|||
149823726|NCT00094302|540484493|FG001|Overall Study|Lost to Follow-up|41|||
149823727|NCT00094302|540484492|FG000|Overall Study|Physician Decision|5|||
149823728|NCT00094302|540484493|FG001|Overall Study|Physician Decision|8|||
149823729|NCT00094302|540484492|FG000|Overall Study|Withdrawal by Subject|103|||
149823730|NCT00094302|540484493|FG001|Overall Study|Withdrawal by Subject|111|||
149823731|NCT00094302|540484492|FG000|Overall Study|Death|266|||
149823732|NCT00094302|540484493|FG001|Overall Study|Death|246|||
149823733|NCT03705351|540484499|FG000|Overall Study|Study termination|3|||
149823734|NCT03705351|540484499|FG000|Overall Study|Death|1|||
149823735|NCT03705351|540484499|FG000|Overall Study|Lack of Efficacy|2|||
149823736|NCT03705351|540484499|FG000|Overall Study|Withdrawal by Subject|1|||
149823737|NCT02710071|540484504|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
149823738|NCT02710071|540484505|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
149823739|NCT02710071|540484504|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
149823740|NCT02710071|540484505|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
149823741|NCT03734237|540484506|FG000|Overall Study|Lost to Follow-up|1|||
149823742|NCT03734237|540484507|FG001|Overall Study|Lost to Follow-up|3|||
149823743|NCT03734237|540484508|FG002|Overall Study|Lost to Follow-up|0|||
149823744|NCT03734237|540484506|FG000|Overall Study|Withdrawal by Subject|7|||
149823745|NCT03734237|540484507|FG001|Overall Study|Withdrawal by Subject|9|||
149823746|NCT03734237|540484508|FG002|Overall Study|Withdrawal by Subject|10|||
149823747|NCT01238848|540484512|FG000|Overall Study|Physician Decision|13|||
149823748|NCT01238848|540484513|FG001|Overall Study|Physician Decision|5|||
149823749|NCT00576901|540484514|FG000|Overall Study|Withdrawal by Subject|1|||
149823750|NCT00576901|540484514|FG000|Overall Study|Disease course|1|||
149823751|NCT00576901|540484514|FG000|Overall Study|Protocol Violation|1|||
149823752|NCT02398188|540484515|FG000|Overall Study|Adverse Event|2|||
149823753|NCT02398188|540484516|FG001|Overall Study|Adverse Event|3|||
149823754|NCT02398188|540484515|FG000|Overall Study|Lost to Follow-up|5|||
149823755|NCT02398188|540484516|FG001|Overall Study|Lost to Follow-up|0|||
149823756|NCT02398188|540484515|FG000|Overall Study|Non-compliance|4|||
149823757|NCT02398188|540484516|FG001|Overall Study|Non-compliance|4|||
149823758|NCT02398188|540484515|FG000|Overall Study|Protocol Violation|6|||
149944395|NCT00851591|540930685|FG001|Overall Study|Withdrawal by Subject|0|||
149944396|NCT00634504|540930688|FG000|Overall Study|Protocol Violation|1|||
150275021|NCT01910116|542144551|FG000|Overall Study|Protocol Violation|1|||
150275022|NCT01910116|542144552|FG001|Overall Study|Protocol Violation|2|||
150275023|NCT01910116|542144551|FG000|Overall Study|Withdrawal by Subject|8|||
150275024|NCT01910116|542144552|FG001|Overall Study|Withdrawal by Subject|3|||
150275025|NCT01910116|542144551|FG000|Overall Study|uncertain allocation|1|||
150275026|NCT01910116|542144552|FG001|Overall Study|uncertain allocation|3|||
150275027|NCT01910116|542144551|FG000|Overall Study|incomplete data|0|||
150275028|NCT01910116|542144552|FG001|Overall Study|incomplete data|1|||
150275029|NCT00911625|542144557|FG000|Overall Study|Lost to Follow-up|7|||
149944397|NCT00634504|540930689|FG001|Overall Study|Protocol Violation|0|||
149944398|NCT02110693|540930690|FG000|Overall Study|Withdrawal by Subject|6|||
149944399|NCT02110693|540930691|FG001|Overall Study|Withdrawal by Subject|7|||
149944400|NCT02110693|540930690|FG000|Overall Study|skipped assessment|15|||
149944401|NCT02110693|540930691|FG001|Overall Study|skipped assessment|18|||
150275030|NCT00911625|542144558|FG001|Overall Study|Lost to Follow-up|0|||
150275031|NCT00590044|542144559|FG000|Overall Study|Withdrawal by Subject|2|||
150275032|NCT00590044|542144560|FG001|Overall Study|Withdrawal by Subject|2|||
150275033|NCT00590044|542144559|FG000|Overall Study|wrong insulin arm assigned|1|||
150275034|NCT00590044|542144560|FG001|Overall Study|wrong insulin arm assigned|0|||
149823759|NCT02398188|540484516|FG001|Overall Study|Protocol Violation|10|||
149823760|NCT02398188|540484515|FG000|Overall Study|Sponsor Decision|2|||
149823761|NCT02398188|540484516|FG001|Overall Study|Sponsor Decision|1|||
149823762|NCT02398188|540484515|FG000|Overall Study|Pregnancy|1|||
150275035|NCT00590044|542144559|FG000|Overall Study|Protocol Violation|1|||
150275036|NCT00590044|542144560|FG001|Overall Study|Protocol Violation|0|||
150275037|NCT01514136|542144561|FG000|Test Period 1; Test A|Protocol Violation|1|||
149823763|NCT02398188|540484516|FG001|Overall Study|Pregnancy|0|||
149823764|NCT02398188|540484515|FG000|Overall Study|Withdrawal by Subject|7|||
149823765|NCT02398188|540484516|FG001|Overall Study|Withdrawal by Subject|16|||
149944402|NCT02110693|540930690|FG000|Overall Study|technical difficulties|6|||
150275038|NCT01514136|542144562|FG001|Test Period 1; Test A|Protocol Violation|0|||
149823766|NCT01259869|540484517|FG000|Overall Study|Duplicated registration|1|||
149823767|NCT03209570|540484522|FG000|Overall Study|Death|1|||
149823768|NCT03209570|540484523|FG001|Overall Study|Death|0|||
149944403|NCT02110693|540930691|FG001|Overall Study|technical difficulties|4|||
149823769|NCT03209570|540484522|FG000|Overall Study|Incomplete Data|8|||
149944404|NCT02110693|540930690|FG000|Overall Study|Other|1|||
149944405|NCT02110693|540930691|FG001|Overall Study|Other|0|||
149944406|NCT00297167|540930696|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
149944407|NCT00297167|540930697|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
149944408|NCT00297167|540930698|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
149944409|NCT00297167|540930696|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
149944410|NCT00297167|540930697|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
149944411|NCT00297167|540930698|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
149944412|NCT01898130|540930699|FG000|Treatment|Withdrawal by Subject|2|||
149944413|NCT01898130|540930699|FG000|Treatment|Progressive Disease|4|||
149944414|NCT01898130|540930699|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
149944415|NCT00920816|540930700|FG000|Overall Study|Death|116|||
149944416|NCT00920816|540930701|FG001|Overall Study|Death|63|||
149944417|NCT00920816|540930702|FG002|Overall Study|Death|8|||
149944418|NCT00920816|540930703|FG003|Overall Study|Death|3|||
149944419|NCT00920816|540930700|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
149944420|NCT00920816|540930701|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
149944421|NCT00920816|540930702|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
149944422|NCT00920816|540930703|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
149944423|NCT00920816|540930700|FG000|Overall Study|Global deterioration of health status|2|||
149944424|NCT00920816|540930701|FG001|Overall Study|Global deterioration of health status|0|||
149944425|NCT00920816|540930702|FG002|Overall Study|Global deterioration of health status|0|||
149944426|NCT00920816|540930703|FG003|Overall Study|Global deterioration of health status|0|||
149944427|NCT00920816|540930700|FG000|Overall Study|Objective progression or relapse|6|||
149944428|NCT00920816|540930701|FG001|Overall Study|Objective progression or relapse|2|||
149944429|NCT00920816|540930702|FG002|Overall Study|Objective progression or relapse|0|||
149944430|NCT00920816|540930703|FG003|Overall Study|Objective progression or relapse|0|||
149944431|NCT00920816|540930700|FG000|Overall Study|Other|26|||
149944432|NCT00920816|540930701|FG001|Overall Study|Other|15|||
149944433|NCT00920816|540930702|FG002|Overall Study|Other|1|||
149944434|NCT00920816|540930703|FG003|Overall Study|Other|2|||
149944435|NCT00920816|540930700|FG000|Overall Study|Lost to Follow-up|11|||
149944436|NCT00920816|540930701|FG001|Overall Study|Lost to Follow-up|2|||
149944437|NCT00920816|540930702|FG002|Overall Study|Lost to Follow-up|0|||
149944438|NCT00920816|540930703|FG003|Overall Study|Lost to Follow-up|0|||
149944439|NCT00920816|540930700|FG000|Overall Study|Adverse Event|1|||
149944440|NCT00920816|540930701|FG001|Overall Study|Adverse Event|1|||
149944441|NCT00920816|540930702|FG002|Overall Study|Adverse Event|1|||
149944442|NCT00920816|540930703|FG003|Overall Study|Adverse Event|0|||
149944443|NCT00920816|540930700|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
149944444|NCT00920816|540930701|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
149944445|NCT00920816|540930702|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
149944446|NCT00920816|540930703|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
149944447|NCT00920816|540930700|FG000|Overall Study|Randomized but not treated|3|||
149944448|NCT00920816|540930701|FG001|Overall Study|Randomized but not treated|0|||
149944449|NCT00920816|540930702|FG002|Overall Study|Randomized but not treated|0|||
149944450|NCT00920816|540930703|FG003|Overall Study|Randomized but not treated|0|||
149944451|NCT01180777|540930707|FG000|Overall Study|Protocol Violation|6|||
149944452|NCT01180777|540930707|FG000|Overall Study|Poor lens fit|4|||
149944453|NCT01180777|540930707|FG000|Overall Study|Lost to Follow-up|1|||
149944454|NCT01180777|540930707|FG000|Overall Study|Adverse Event|1|||
149944455|NCT04491994|540930708|FG000|Overall Study|Withdrawal by Subject|10|||
149944456|NCT04491994|540930709|FG001|Overall Study|Withdrawal by Subject|5|||
149944457|NCT04491994|540930708|FG000|Overall Study|developed fever > 3 days|4|||
149944458|NCT04491994|540930709|FG001|Overall Study|developed fever > 3 days|1|||
149944459|NCT04491994|540930708|FG000|Overall Study|Protocol Violation|11|||
149944460|NCT04491994|540930709|FG001|Overall Study|Protocol Violation|2|||
149944461|NCT04491994|540930708|FG000|Overall Study|Lost to Follow-up|4|||
149944462|NCT04491994|540930709|FG001|Overall Study|Lost to Follow-up|3|||
149944463|NCT04167462|540930712|FG000|Overall Study|Other reasons|3|||
150275039|NCT01514136|542144563|FG002|Test Period 1; Test A|Protocol Violation|0|||
150275040|NCT01514136|542144564|FG003|Test Period 1; Test A|Protocol Violation|0|||
150275041|NCT01514136|542144565|FG004|Test Period 1; Test A|Protocol Violation|0|||
150275042|NCT01514136|542144566|FG005|Test Period 1; Test A|Protocol Violation|0|||
150275043|NCT01514136|542144567|FG006|Test Period 1; Test A|Protocol Violation|0|||
149944464|NCT04167462|540930713|FG001|Overall Study|Other reasons|2|||
149944465|NCT04167462|540930712|FG000|Overall Study|Withdrawal by Subject|6|||
149944466|NCT04167462|540930713|FG001|Overall Study|Withdrawal by Subject|7|||
149944467|NCT04167462|540930712|FG000|Overall Study|Adverse Event|4|||
149944468|NCT04167462|540930713|FG001|Overall Study|Adverse Event|0|||
149944469|NCT04167462|540930712|FG000|Overall Study|Pregnancy|1|||
149944470|NCT04167462|540930713|FG001|Overall Study|Pregnancy|0|||
150275044|NCT01514136|542144568|FG007|Test Period 1; Test A|Protocol Violation|0|||
150032815|NCT00844844|541259369|FG000|Post Treatment Period|Withdrawal by Subject|1|||
150032816|NCT03905096|541259370|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
150032817|NCT03905096|541259371|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
150032818|NCT02016781|541259373|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
150032819|NCT02016781|541259374|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
150032820|NCT02016781|541259373|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
150032821|NCT02016781|541259374|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
150032822|NCT02016781|541259373|FG000|Final Database Lock|Withdrawal by Subject|2|||
150032823|NCT02016781|541259374|FG001|Final Database Lock|Withdrawal by Subject|1|||
150032824|NCT02016781|541259373|FG000|Final Database Lock|Lost to Follow-up|11|||
150032825|NCT02016781|541259374|FG001|Final Database Lock|Lost to Follow-up|4|||
150032826|NCT02016781|541259373|FG000|Final Database Lock|Missing data|0|||
150032827|NCT02016781|541259374|FG001|Final Database Lock|Missing data|3|||
150032828|NCT00945009|541259377|FG000|Overall Study|Lack of Efficacy|10|||
150032829|NCT00945009|541259378|FG001|Overall Study|Lack of Efficacy|0|||
150032830|NCT00945009|541259379|FG002|Overall Study|Lack of Efficacy|0|||
150032831|NCT00945009|541259377|FG000|Overall Study|Physician Decision|21|||
150032832|NCT00945009|541259378|FG001|Overall Study|Physician Decision|4|||
150032833|NCT00945009|541259379|FG002|Overall Study|Physician Decision|3|||
150032834|NCT00945009|541259377|FG000|Overall Study|Protocol Violation|6|||
150032835|NCT00945009|541259378|FG001|Overall Study|Protocol Violation|1|||
150032836|NCT00945009|541259379|FG002|Overall Study|Protocol Violation|0|||
150032837|NCT00945009|541259377|FG000|Overall Study|Withdrawal by Subject|1|||
150032838|NCT00945009|541259378|FG001|Overall Study|Withdrawal by Subject|0|||
150032839|NCT00945009|541259379|FG002|Overall Study|Withdrawal by Subject|0|||
150032840|NCT00945009|541259377|FG000|Overall Study|Ineligible|6|||
150032841|NCT00945009|541259378|FG001|Overall Study|Ineligible|1|||
150032842|NCT00945009|541259379|FG002|Overall Study|Ineligible|0|||
150032843|NCT00945009|541259377|FG000|Overall Study|Inevaluable|0|||
150032844|NCT00945009|541259378|FG001|Overall Study|Inevaluable|1|||
150032845|NCT00945009|541259379|FG002|Overall Study|Inevaluable|0|||
150032846|NCT00945009|541259377|FG000|Overall Study|Refusal of further protocol|1|||
150032847|NCT00945009|541259378|FG001|Overall Study|Refusal of further protocol|0|||
150032848|NCT00945009|541259379|FG002|Overall Study|Refusal of further protocol|0|||
150032849|NCT04886154|541259380|FG000|Overall Study|Adverse Event|0|||
150032850|NCT04886154|541259381|FG001|Overall Study|Adverse Event|0|||
150032851|NCT04886154|541259382|FG002|Overall Study|Adverse Event|0|||
150032852|NCT04886154|541259383|FG003|Overall Study|Adverse Event|0|||
150032853|NCT04886154|541259384|FG004|Overall Study|Adverse Event|1|||
150032854|NCT04886154|541259385|FG005|Overall Study|Adverse Event|0|||
150032855|NCT04886154|541259386|FG006|Overall Study|Adverse Event|0|||
150032856|NCT04886154|541259387|FG007|Overall Study|Adverse Event|1|||
150032857|NCT04886154|541259388|FG008|Overall Study|Adverse Event|1|||
150032858|NCT04886154|541259389|FG009|Overall Study|Adverse Event|0|||
150032859|NCT04886154|541259390|FG010|Overall Study|Adverse Event|0|||
150032860|NCT04886154|541259391|FG011|Overall Study|Adverse Event|1|||
150032861|NCT04886154|541259392|FG012|Overall Study|Adverse Event|0|||
150032862|NCT04886154|541259393|FG013|Overall Study|Adverse Event|0|||
150032863|NCT04886154|541259394|FG014|Overall Study|Adverse Event|3|||
150032864|NCT04886154|541259380|FG000|Overall Study|Lost to Follow-up|1|||
150032865|NCT04886154|541259381|FG001|Overall Study|Lost to Follow-up|0|||
150032866|NCT04886154|541259382|FG002|Overall Study|Lost to Follow-up|2|||
150032867|NCT04886154|541259383|FG003|Overall Study|Lost to Follow-up|0|||
150032868|NCT04886154|541259384|FG004|Overall Study|Lost to Follow-up|17|||
150032869|NCT04886154|541259385|FG005|Overall Study|Lost to Follow-up|7|||
150032870|NCT04886154|541259386|FG006|Overall Study|Lost to Follow-up|8|||
150032871|NCT04886154|541259387|FG007|Overall Study|Lost to Follow-up|7|||
150032872|NCT04886154|541259388|FG008|Overall Study|Lost to Follow-up|8|||
150032873|NCT04886154|541259389|FG009|Overall Study|Lost to Follow-up|0|||
150032874|NCT04886154|541259390|FG010|Overall Study|Lost to Follow-up|2|||
150032875|NCT04886154|541259391|FG011|Overall Study|Lost to Follow-up|0|||
150032876|NCT04886154|541259392|FG012|Overall Study|Lost to Follow-up|0|||
150032877|NCT04886154|541259393|FG013|Overall Study|Lost to Follow-up|0|||
150032878|NCT04886154|541259394|FG014|Overall Study|Lost to Follow-up|0|||
150032879|NCT04886154|541259380|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032880|NCT04886154|541259381|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032881|NCT04886154|541259382|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032882|NCT04886154|541259383|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032883|NCT04886154|541259384|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032884|NCT04886154|541259385|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032885|NCT04886154|541259386|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
150032886|NCT04886154|541259387|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032887|NCT04886154|541259388|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032888|NCT04886154|541259389|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032889|NCT04886154|541259390|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032890|NCT04886154|541259391|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
149944471|NCT04167462|540930712|FG000|Overall Study|Lack of Efficacy|0|||
149944472|NCT04167462|540930713|FG001|Overall Study|Lack of Efficacy|1|||
149944473|NCT01572792|540930716|FG000|Lead-in Study|Lost to Follow-up|5|||
149944474|NCT01572792|540930717|FG001|Lead-in Study|Lost to Follow-up|9|||
149944475|NCT01572792|540930718|FG002|Lead-in Study|Lost to Follow-up|4|||
149944476|NCT01572792|540930719|FG003|Lead-in Study|Lost to Follow-up|2|||
149944477|NCT01572792|540930720|FG004|Lead-in Study|Lost to Follow-up|4|||
149944478|NCT01572792|540930716|FG000|Lead-in Study|Withdrawal by Subject|22|||
149944479|NCT01572792|540930717|FG001|Lead-in Study|Withdrawal by Subject|11|||
149944480|NCT01572792|540930718|FG002|Lead-in Study|Withdrawal by Subject|12|||
149944481|NCT01572792|540930719|FG003|Lead-in Study|Withdrawal by Subject|24|||
149944482|NCT01572792|540930720|FG004|Lead-in Study|Withdrawal by Subject|11|||
149944483|NCT01572792|540930716|FG000|Lead-in Study|Protocol Violation|19|||
149944484|NCT01572792|540930717|FG001|Lead-in Study|Protocol Violation|10|||
149944485|NCT01572792|540930718|FG002|Lead-in Study|Protocol Violation|12|||
149944486|NCT01572792|540930719|FG003|Lead-in Study|Protocol Violation|13|||
149944487|NCT01572792|540930720|FG004|Lead-in Study|Protocol Violation|21|||
149944488|NCT01572792|540930716|FG000|Lead-in Study|Lack of Efficacy|20|||
149944489|NCT01572792|540930717|FG001|Lead-in Study|Lack of Efficacy|5|||
149944490|NCT01572792|540930718|FG002|Lead-in Study|Lack of Efficacy|4|||
149944491|NCT01572792|540930719|FG003|Lead-in Study|Lack of Efficacy|8|||
149944492|NCT01572792|540930720|FG004|Lead-in Study|Lack of Efficacy|10|||
149944493|NCT01572792|540930716|FG000|Lead-in Study|Adverse Event|21|||
149944494|NCT01572792|540930717|FG001|Lead-in Study|Adverse Event|21|||
149944495|NCT01572792|540930718|FG002|Lead-in Study|Adverse Event|22|||
149944496|NCT01572792|540930719|FG003|Lead-in Study|Adverse Event|16|||
149944497|NCT01572792|540930720|FG004|Lead-in Study|Adverse Event|14|||
149944498|NCT01572792|540930716|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
149944499|NCT01572792|540930717|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
149944500|NCT01572792|540930718|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
149944501|NCT01572792|540930719|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
149944502|NCT01572792|540930720|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
149944503|NCT01572792|540930716|FG000|Extension Study|Lost to Follow-up|6|||
149944504|NCT01572792|540930717|FG001|Extension Study|Lost to Follow-up|2|||
149944505|NCT01572792|540930718|FG002|Extension Study|Lost to Follow-up|0|||
149944506|NCT01572792|540930719|FG003|Extension Study|Lost to Follow-up|3|||
149944507|NCT01572792|540930720|FG004|Extension Study|Lost to Follow-up|3|||
149944508|NCT01572792|540930716|FG000|Extension Study|Withdrawal by Subject|7|||
149944509|NCT01572792|540930717|FG001|Extension Study|Withdrawal by Subject|6|||
149944510|NCT01572792|540930718|FG002|Extension Study|Withdrawal by Subject|11|||
149944511|NCT01572792|540930719|FG003|Extension Study|Withdrawal by Subject|8|||
149944512|NCT01572792|540930720|FG004|Extension Study|Withdrawal by Subject|14|||
149944513|NCT01572792|540930716|FG000|Extension Study|Protocol Violation|0|||
150170368|NCT01235949|541759076|FG015|Primary Phase|Withdrawal by Subject|0|||
149944514|NCT01572792|540930717|FG001|Extension Study|Protocol Violation|4|||
149944515|NCT01572792|540930718|FG002|Extension Study|Protocol Violation|3|||
149944516|NCT01572792|540930719|FG003|Extension Study|Protocol Violation|4|||
149944517|NCT01572792|540930720|FG004|Extension Study|Protocol Violation|3|||
149944518|NCT01572792|540930716|FG000|Extension Study|Lack of Efficacy|2|||
149944519|NCT01572792|540930717|FG001|Extension Study|Lack of Efficacy|3|||
149944520|NCT01572792|540930718|FG002|Extension Study|Lack of Efficacy|3|||
149944521|NCT01572792|540930719|FG003|Extension Study|Lack of Efficacy|2|||
150032891|NCT04886154|541259392|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032892|NCT04886154|541259393|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032893|NCT04886154|541259394|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
150032894|NCT04886154|541259380|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032895|NCT04886154|541259381|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032896|NCT04886154|541259382|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032897|NCT04886154|541259383|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032898|NCT04886154|541259384|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150032899|NCT04886154|541259385|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032900|NCT04886154|541259386|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
150032901|NCT04886154|541259387|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150032902|NCT04886154|541259388|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032903|NCT04886154|541259389|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032904|NCT04886154|541259390|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032905|NCT04886154|541259391|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032906|NCT04886154|541259392|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032907|NCT04886154|541259393|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150032908|NCT04886154|541259394|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150032909|NCT04886154|541259380|FG000|Overall Study|Other, Not Specified|0|||
150032910|NCT04886154|541259381|FG001|Overall Study|Other, Not Specified|0|||
150032911|NCT04886154|541259382|FG002|Overall Study|Other, Not Specified|0|||
150032912|NCT04886154|541259383|FG003|Overall Study|Other, Not Specified|0|||
150032913|NCT04886154|541259384|FG004|Overall Study|Other, Not Specified|11|||
150032914|NCT04886154|541259385|FG005|Overall Study|Other, Not Specified|8|||
150032915|NCT04886154|541259386|FG006|Overall Study|Other, Not Specified|9|||
150032916|NCT04886154|541259387|FG007|Overall Study|Other, Not Specified|10|||
150032917|NCT04886154|541259388|FG008|Overall Study|Other, Not Specified|6|||
150032918|NCT04886154|541259389|FG009|Overall Study|Other, Not Specified|1|||
150032919|NCT04886154|541259390|FG010|Overall Study|Other, Not Specified|1|||
150032920|NCT04886154|541259391|FG011|Overall Study|Other, Not Specified|2|||
150032921|NCT04886154|541259392|FG012|Overall Study|Other, Not Specified|1|||
150032922|NCT04886154|541259393|FG013|Overall Study|Other, Not Specified|2|||
150032923|NCT04886154|541259394|FG014|Overall Study|Other, Not Specified|3|||
150032924|NCT03919773|541259403|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
150032925|NCT03919773|541259404|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
150032926|NCT03919773|541259403|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
150032927|NCT03919773|541259404|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
150032928|NCT04659044|541259407|FG000|Induction|Physician Decision|1|||
150032929|NCT04659044|541259407|FG000|Induction|Adverse Event|2|||
150032930|NCT04966013|541259409|FG000|Overall Study|Withdrawal by Subject|0|||
150032931|NCT04966013|541259410|FG001|Overall Study|Withdrawal by Subject|2|||
150032932|NCT04966013|541259411|FG002|Overall Study|Withdrawal by Subject|1|||
150032933|NCT04966013|541259409|FG000|Overall Study|Adverse Event|2|||
150032934|NCT04966013|541259410|FG001|Overall Study|Adverse Event|1|||
150032935|NCT04966013|541259411|FG002|Overall Study|Adverse Event|1|||
150032936|NCT04875975|541259412|FG000|Overall Study|Adverse Event|1|||
150032937|NCT04875975|541259413|FG001|Overall Study|Adverse Event|2|||
150032938|NCT04875975|541259412|FG000|Overall Study|Lack of Efficacy|2|||
150032939|NCT04875975|541259413|FG001|Overall Study|Lack of Efficacy|2|||
150032940|NCT04875975|541259412|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
150032941|NCT04875975|541259413|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
150032942|NCT04875975|541259412|FG000|Overall Study|Relapse With Insults|0|||
150032943|NCT04875975|541259413|FG001|Overall Study|Relapse With Insults|1|||
150032944|NCT04875975|541259412|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
150032945|NCT04875975|541259413|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
150032946|NCT00781768|541260800|FG000|Overall Study|Not transplanted.|0|||
150032947|NCT00781768|541260801|FG001|Overall Study|Not transplanted.|2|||
150032948|NCT02458313|541260802|FG000|Overall Study|Withdrawal by Subject|6|||
150032949|NCT02458313|541260803|FG001|Overall Study|Withdrawal by Subject|8|||
150032950|NCT02458313|541260802|FG000|Overall Study|Excluded for motion during MRI|1|||
150032951|NCT02458313|541260803|FG001|Overall Study|Excluded for motion during MRI|2|||
150032952|NCT03414983|541260804|FG000|Pre-Treatment|Other reasons|1|||
150032953|NCT03414983|541260805|FG001|Pre-Treatment|Other reasons|0|||
150032954|NCT03414983|541260804|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
150032955|NCT03414983|541260805|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
150032956|NCT03414983|541260804|FG000|Pre-Treatment|Participant withdrew consent|1|||
150032957|NCT03414983|541260805|FG001|Pre-Treatment|Participant withdrew consent|3|||
150032958|NCT03414983|541260804|FG000|Treatment|Participant withdrew consent|4|||
150032959|NCT03414983|541260805|FG001|Treatment|Participant withdrew consent|3|||
150032960|NCT03414983|541260804|FG000|Treatment|Participant request to discontinue study treatment|8|||
150032961|NCT03414983|541260805|FG001|Treatment|Participant request to discontinue study treatment|10|||
150032962|NCT03414983|541260804|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
150032963|NCT03414983|541260805|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
150032964|NCT03414983|541260804|FG000|Treatment|Death|0|||
150032965|NCT03414983|541260805|FG001|Treatment|Death|1|||
150032966|NCT03414983|541260804|FG000|Treatment|Study Drug Toxicity|10|||
150032967|NCT03414983|541260805|FG001|Treatment|Study Drug Toxicity|5|||
150032968|NCT03414983|541260804|FG000|Treatment|Disease Progression|75|||
150032969|NCT03414983|541260805|FG001|Treatment|Disease Progression|29|||
150032970|NCT03414983|541260804|FG000|Treatment|Not reported|1|||
150032971|NCT03414983|541260805|FG001|Treatment|Not reported|0|||
150032972|NCT03414983|541260804|FG000|Treatment|Other reasons|3|||
150032973|NCT03414983|541260805|FG001|Treatment|Other reasons|2|||
150032974|NCT03414983|541260804|FG000|Treatment|Poor/non-compliance|2|||
150032975|NCT03414983|541260805|FG001|Treatment|Poor/non-compliance|0|||
150032976|NCT03414983|541260804|FG000|Treatment|Maximum clinical benefit|5|||
150032977|NCT03414983|541260805|FG001|Treatment|Maximum clinical benefit|9|||
150032978|NCT03414983|541260804|FG000|Treatment|Lost to Follow-up|0|||
150032979|NCT03414983|541260805|FG001|Treatment|Lost to Follow-up|1|||
150032980|NCT03414983|541260804|FG000|Treatment|Administrative reasons by sponsor|1|||
150032981|NCT03414983|541260805|FG001|Treatment|Administrative reasons by sponsor|0|||
150032982|NCT00751296|541260806|FG000|Overall Study|Adverse Event|2|||
150032983|NCT00755183|541260807|FG000|Overall Study|Adverse Event|5|||
150032984|NCT00755183|541260808|FG001|Overall Study|Adverse Event|2|||
149944522|NCT01572792|540930720|FG004|Extension Study|Lack of Efficacy|2|||
149944523|NCT01572792|540930716|FG000|Extension Study|Adverse Event|7|||
149944524|NCT01572792|540930717|FG001|Extension Study|Adverse Event|6|||
149944525|NCT01572792|540930718|FG002|Extension Study|Adverse Event|5|||
149944526|NCT01572792|540930719|FG003|Extension Study|Adverse Event|6|||
149944527|NCT01572792|540930720|FG004|Extension Study|Adverse Event|4|||
149944528|NCT01572792|540930716|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
149944529|NCT01572792|540930717|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
149944530|NCT01572792|540930718|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
149944531|NCT01572792|540930719|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
149944532|NCT01572792|540930720|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
149944533|NCT03530696|540930721|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
149944534|NCT03530696|540930722|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
150032985|NCT00755183|541260807|FG000|Overall Study|Protocol Violation|0|||
149944535|NCT03416179|540930723|FG000|Overall Study|Death|90|||
149944536|NCT03416179|540930724|FG001|Overall Study|Death|87|||
150032986|NCT00755183|541260808|FG001|Overall Study|Protocol Violation|1|||
150032987|NCT00755183|541260807|FG000|Overall Study|Withdrawal by Subject|0|||
149944537|NCT03416179|540930725|FG002|Overall Study|Death|117|||
149944538|NCT03416179|540930726|FG003|Overall Study|Death|113|||
149944539|NCT03416179|540930723|FG000|Overall Study|Withdrawal by Subject|15|||
149944540|NCT03416179|540930724|FG001|Overall Study|Withdrawal by Subject|20|||
149944541|NCT03416179|540930725|FG002|Overall Study|Withdrawal by Subject|6|||
149944542|NCT03416179|540930726|FG003|Overall Study|Withdrawal by Subject|9|||
149944543|NCT03416179|540930723|FG000|Overall Study|Lost to Follow-up|1|||
149944544|NCT03416179|540930724|FG001|Overall Study|Lost to Follow-up|1|||
149944545|NCT03416179|540930725|FG002|Overall Study|Lost to Follow-up|0|||
149944546|NCT03416179|540930726|FG003|Overall Study|Lost to Follow-up|3|||
149944547|NCT03416179|540930723|FG000|Overall Study|Study participation terminated by Sponsor|93|||
149944548|NCT03416179|540930724|FG001|Overall Study|Study participation terminated by Sponsor|91|||
149944549|NCT03416179|540930725|FG002|Overall Study|Study participation terminated by Sponsor|26|||
149944550|NCT03416179|540930726|FG003|Overall Study|Study participation terminated by Sponsor|31|||
149944551|NCT03416179|540930723|FG000|Overall Study|Other|2|||
149944552|NCT03416179|540930724|FG001|Overall Study|Other|3|||
149944553|NCT03416179|540930725|FG002|Overall Study|Other|1|||
149944554|NCT03416179|540930726|FG003|Overall Study|Other|0|||
149944555|NCT01129128|540930727|FG000|Overall Study|Lost to Follow-up|2|||
149944556|NCT01129128|540930728|FG001|Overall Study|Lost to Follow-up|2|||
149944557|NCT01129128|540930729|FG002|Overall Study|Lost to Follow-up|1|||
149944558|NCT01129128|540930727|FG000|Overall Study|Protocol Violation|0|||
149944559|NCT01129128|540930728|FG001|Overall Study|Protocol Violation|1|||
149944560|NCT01129128|540930729|FG002|Overall Study|Protocol Violation|0|||
149944561|NCT01129128|540930727|FG000|Overall Study|Withdrawal by Subject|0|||
149944562|NCT01129128|540930728|FG001|Overall Study|Withdrawal by Subject|1|||
149944563|NCT01129128|540930729|FG002|Overall Study|Withdrawal by Subject|3|||
149944564|NCT01129128|540930727|FG000|Overall Study|Physician Decision|1|||
149944565|NCT01129128|540930728|FG001|Overall Study|Physician Decision|0|||
149944566|NCT01129128|540930729|FG002|Overall Study|Physician Decision|0|||
149944567|NCT06438601|540930730|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
149944568|NCT06438601|540930731|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
149944569|NCT06438601|540930730|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
149944570|NCT06438601|540930731|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
149944571|NCT01900314|540930732|FG000|Overall Study|Lost to Follow-up|1|||
149944572|NCT01900314|540930733|FG001|Overall Study|Lost to Follow-up|0|||
149944573|NCT01900314|540930732|FG000|Overall Study|Protocol Violation|0|||
149944574|NCT01900314|540930733|FG001|Overall Study|Protocol Violation|1|||
149944575|NCT01900314|540930732|FG000|Overall Study|Withdrawal by Subject|3|||
149944576|NCT01900314|540930733|FG001|Overall Study|Withdrawal by Subject|3|||
149975597|NCT02765399|541047896|FG000|Overall Study|Nausea|1|||
149975598|NCT02765399|541047897|FG001|Overall Study|Nausea|0|||
149975599|NCT02103062|541047906|FG000|Overall Study|Adverse Event|1|||
149975600|NCT02103062|541047907|FG001|Overall Study|Adverse Event|2|||
149975601|NCT02103062|541047906|FG000|Overall Study|Progressive Disease|17|||
149975602|NCT02103062|541047907|FG001|Overall Study|Progressive Disease|20|||
149975603|NCT02103062|541047906|FG000|Overall Study|Death|0|||
149944577|NCT03282097|540930735|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
149944578|NCT03282097|540930736|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
149944579|NCT03282097|540930735|FG000|Intervention Visit Complete|Patient Death|13|||
150170369|NCT01235949|541759077|FG016|Primary Phase|Withdrawal by Subject|0|||
150275045|NCT01514136|542144561|FG000|Test Period 1; Test A|Break from study holiday|2|||
150275046|NCT01514136|542144562|FG001|Test Period 1; Test A|Break from study holiday|0|||
150275047|NCT01514136|542144563|FG002|Test Period 1; Test A|Break from study holiday|0|||
150275048|NCT01514136|542144564|FG003|Test Period 1; Test A|Break from study holiday|0|||
150275049|NCT01514136|542144565|FG004|Test Period 1; Test A|Break from study holiday|0|||
150275050|NCT01514136|542144566|FG005|Test Period 1; Test A|Break from study holiday|0|||
150275051|NCT01514136|542144567|FG006|Test Period 1; Test A|Break from study holiday|0|||
150275052|NCT01514136|542144568|FG007|Test Period 1; Test A|Break from study holiday|0|||
150275053|NCT01514136|542144561|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
150275054|NCT01514136|542144562|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
150275055|NCT01514136|542144563|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
150275056|NCT01514136|542144564|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
150275057|NCT01514136|542144565|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
150275058|NCT01514136|542144566|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
150275059|NCT01514136|542144567|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
150275060|NCT01514136|542144568|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
150275061|NCT01514136|542144561|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275062|NCT01514136|542144562|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275063|NCT01514136|542144563|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275064|NCT01514136|542144564|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
150032988|NCT00755183|541260808|FG001|Overall Study|Withdrawal by Subject|2|||
150032989|NCT00755183|541260807|FG000|Overall Study|Administrative|2|||
150032990|NCT00755183|541260808|FG001|Overall Study|Administrative|1|||
150032991|NCT01280903|541260809|FG000|Overall Study|Lost to Follow-up|23|||
150032992|NCT01280903|541260810|FG001|Overall Study|Lost to Follow-up|16|||
150032993|NCT03453164|541260811|FG000|Overall Study|Lack of Efficacy|16|||
150032994|NCT03453164|541260811|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
150032995|NCT02177695|541260814|FG000|ITT Analysis|Ineligible|5|||
150032996|NCT02177695|541260815|FG001|ITT Analysis|Ineligible|5|||
150032997|NCT02177695|541260814|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
150032998|NCT02177695|541260815|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
150032999|NCT02177695|541260814|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
150033000|NCT02177695|541260815|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
150033001|NCT02177695|541260814|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
150033002|NCT02177695|541260815|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
150033003|NCT00248625|541260818|FG000|Overall Study|Withdrawal by Subject|0|||
150033004|NCT00248625|541260819|FG001|Overall Study|Withdrawal by Subject|2|||
150033005|NCT01074502|541260822|FG000|Overall Study|Withdrawal by Subject|1|||
150033006|NCT02220920|541260830|FG000|Overall Study|Adverse Event|1|||
150033007|NCT02220920|541260831|FG001|Overall Study|Adverse Event|0|||
150033008|NCT02220920|541260830|FG000|Overall Study|Lack of Efficacy|0|||
150033009|NCT02220920|541260831|FG001|Overall Study|Lack of Efficacy|1|||
150033010|NCT02220920|541260830|FG000|Overall Study|Withdrawal by Subject|1|||
150033011|NCT02220920|541260831|FG001|Overall Study|Withdrawal by Subject|0|||
150033012|NCT02220920|541260830|FG000|Overall Study|Conflict with the stopping criteria|1|||
150033013|NCT02220920|541260831|FG001|Overall Study|Conflict with the stopping criteria|2|||
150033014|NCT05176314|541260837|FG000|Overall Study|Lost to Follow-up|2|||
150033015|NCT05176314|541260837|FG000|Overall Study|Physician Decision|1|||
150033016|NCT05176314|541260837|FG000|Overall Study|Adverse Event|1|||
150033017|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
150033018|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
150033019|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
150033020|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Death|9|||
150033021|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Death|0|||
150033022|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Death|0|||
150033023|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
150033024|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
150033025|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
150033026|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
150033027|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
150033028|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
150033029|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Other|135|||
150033030|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Other|0|||
150033031|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Other|0|||
150033032|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
150033033|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
150033034|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
150033035|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
150033036|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
150033037|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
150033038|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
150033039|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
150033040|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
150033041|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Other|3|||
150033042|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Other|0|||
150033043|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Other|0|||
150033044|NCT02118584|541260840|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
150033045|NCT02118584|541260841|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
150033046|NCT02118584|541260842|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
150033047|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
150033048|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
150170370|NCT01235949|541759078|FG017|Primary Phase|Withdrawal by Subject|0|||
150033049|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
150033050|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
150033051|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
150033052|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
150033053|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
150170371|NCT01235949|541759061|FG000|Primary Phase|Lost to Follow-up|0|||
150170372|NCT01235949|541759062|FG001|Primary Phase|Lost to Follow-up|0|||
150170373|NCT01235949|541759063|FG002|Primary Phase|Lost to Follow-up|1|||
150170374|NCT01235949|541759064|FG003|Primary Phase|Lost to Follow-up|1|||
150033054|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
150033055|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
150275065|NCT01514136|542144565|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275066|NCT01514136|542144566|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275067|NCT01514136|542144567|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275068|NCT01514136|542144568|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
150275069|NCT01514136|542144561|FG000|Test Period 2; Test A*|Adverse Event|0|||
150275070|NCT01514136|542144562|FG001|Test Period 2; Test A*|Adverse Event|0|||
150275071|NCT01514136|542144563|FG002|Test Period 2; Test A*|Adverse Event|0|||
150275072|NCT01514136|542144564|FG003|Test Period 2; Test A*|Adverse Event|0|||
150275073|NCT01514136|542144565|FG004|Test Period 2; Test A*|Adverse Event|1|||
150275074|NCT01514136|542144566|FG005|Test Period 2; Test A*|Adverse Event|0|||
150275075|NCT01514136|542144567|FG006|Test Period 2; Test A*|Adverse Event|0|||
150275076|NCT01514136|542144568|FG007|Test Period 2; Test A*|Adverse Event|0|||
150275077|NCT01514136|542144561|FG000|Test Period 2; Test A*|Holiday|0|||
150275078|NCT01514136|542144562|FG001|Test Period 2; Test A*|Holiday|0|||
150275079|NCT01514136|542144563|FG002|Test Period 2; Test A*|Holiday|0|||
150275080|NCT01514136|542144564|FG003|Test Period 2; Test A*|Holiday|0|||
150275081|NCT01514136|542144565|FG004|Test Period 2; Test A*|Holiday|1|||
150275082|NCT01514136|542144566|FG005|Test Period 2; Test A*|Holiday|0|||
150275083|NCT01514136|542144567|FG006|Test Period 2; Test A*|Holiday|0|||
150275084|NCT01514136|542144568|FG007|Test Period 2; Test A*|Holiday|0|||
150275085|NCT01514136|542144561|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275086|NCT01514136|542144562|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275087|NCT01514136|542144563|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275088|NCT01514136|542144564|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275089|NCT01514136|542144565|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275090|NCT01514136|542144566|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
150275091|NCT01514136|542144567|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275092|NCT01514136|542144568|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
150275093|NCT01514136|542144561|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275094|NCT01514136|542144562|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275095|NCT01514136|542144563|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275096|NCT01514136|542144564|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275097|NCT01514136|542144565|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275098|NCT01514136|542144566|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275099|NCT01514136|542144567|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
150275100|NCT01514136|542144568|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
150275101|NCT01514136|542144561|FG000|Test Period 2; Test C*|holiday|0|||
150275102|NCT01514136|542144562|FG001|Test Period 2; Test C*|holiday|0|||
150275103|NCT01514136|542144563|FG002|Test Period 2; Test C*|holiday|0|||
150275104|NCT01514136|542144564|FG003|Test Period 2; Test C*|holiday|0|||
150275105|NCT01514136|542144565|FG004|Test Period 2; Test C*|holiday|0|||
150275106|NCT01514136|542144566|FG005|Test Period 2; Test C*|holiday|0|||
150275107|NCT01514136|542144567|FG006|Test Period 2; Test C*|holiday|1|||
150275108|NCT01514136|542144568|FG007|Test Period 2; Test C*|holiday|0|||
150275109|NCT01514136|542144561|FG000|Test Period 2; Test C*|Protocol Violation|0|||
150275110|NCT01514136|542144562|FG001|Test Period 2; Test C*|Protocol Violation|0|||
150275111|NCT01514136|542144563|FG002|Test Period 2; Test C*|Protocol Violation|0|||
150275112|NCT01514136|542144564|FG003|Test Period 2; Test C*|Protocol Violation|0|||
150275113|NCT01514136|542144565|FG004|Test Period 2; Test C*|Protocol Violation|0|||
150275114|NCT01514136|542144566|FG005|Test Period 2; Test C*|Protocol Violation|0|||
150275115|NCT01514136|542144567|FG006|Test Period 2; Test C*|Protocol Violation|1|||
150275116|NCT01514136|542144568|FG007|Test Period 2; Test C*|Protocol Violation|0|||
150275117|NCT00955279|542144584|FG000|Overall Study|Other|0|||
150275118|NCT00955279|542144585|FG001|Overall Study|Other|0|||
150275119|NCT00955279|542144586|FG002|Overall Study|Other|3|||
150275120|NCT00955279|542144584|FG000|Overall Study|Death|1|||
150275121|NCT00955279|542144585|FG001|Overall Study|Death|1|||
150275122|NCT00955279|542144586|FG002|Overall Study|Death|1|||
150275123|NCT00955279|542144584|FG000|Overall Study|Lost to Follow-up|0|||
150275124|NCT00955279|542144585|FG001|Overall Study|Lost to Follow-up|3|||
150275125|NCT00955279|542144586|FG002|Overall Study|Lost to Follow-up|1|||
150275126|NCT00955279|542144584|FG000|Overall Study|Withdrawal by Subject|2|||
150275127|NCT00955279|542144585|FG001|Overall Study|Withdrawal by Subject|0|||
150275128|NCT00955279|542144586|FG002|Overall Study|Withdrawal by Subject|3|||
150275129|NCT01235793|542144587|FG000|Overall Study|Death|6|||
150275130|NCT01159912|542144589|FG000|Overall Study|Adverse Event|2|||
150275131|NCT01159912|542144590|FG001|Overall Study|Adverse Event|2|||
150275132|NCT01159912|542144591|FG002|Overall Study|Adverse Event|3|||
150275133|NCT01159912|542144589|FG000|Overall Study|Lack of Efficacy|23|||
150275134|NCT01159912|542144590|FG001|Overall Study|Lack of Efficacy|15|||
150275135|NCT01159912|542144591|FG002|Overall Study|Lack of Efficacy|14|||
150275136|NCT01159912|542144589|FG000|Overall Study|Protocol Violation|1|||
150033056|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
150033057|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
150033058|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
150033059|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
150033060|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
150033061|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
150033062|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
150033063|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
150033064|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
150033065|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
150033066|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
150275137|NCT01159912|542144590|FG001|Overall Study|Protocol Violation|2|||
150275138|NCT01159912|542144591|FG002|Overall Study|Protocol Violation|3|||
150275139|NCT01159912|542144589|FG000|Overall Study|Lost to Follow-up|4|||
150275140|NCT01159912|542144590|FG001|Overall Study|Lost to Follow-up|0|||
150275141|NCT01159912|542144591|FG002|Overall Study|Lost to Follow-up|0|||
150275142|NCT01159912|542144589|FG000|Overall Study|Physician Decision|0|||
150033067|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
150033068|NCT02118584|541260840|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
150033069|NCT02118584|541260841|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
150033070|NCT02118584|541260842|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
150033071|NCT03103542|541260845|FG000|Overall Study|Physician Decision|2|||
150033072|NCT03103542|541260845|FG000|Overall Study|Adverse Event|2|||
150033073|NCT03103542|541260845|FG000|Overall Study|Other|2|||
150033074|NCT03103542|541260845|FG000|Overall Study|Withdrawal by Subject|1|||
150033075|NCT02939287|541260849|FG000|Overall Study|met exclusion criteria|1|||
150033076|NCT02939287|541260850|FG001|Overall Study|met exclusion criteria|1|||
150033077|NCT02939287|541260851|FG002|Overall Study|met exclusion criteria|1|||
150033078|NCT02939287|541260849|FG000|Overall Study|Did not complete survey|2|||
150033079|NCT02939287|541260850|FG001|Overall Study|Did not complete survey|2|||
150033080|NCT02939287|541260851|FG002|Overall Study|Did not complete survey|0|||
150033081|NCT02939287|541260849|FG000|Overall Study|Withdrawal by Subject|1|||
150033082|NCT02939287|541260850|FG001|Overall Study|Withdrawal by Subject|1|||
150033083|NCT02939287|541260851|FG002|Overall Study|Withdrawal by Subject|0|||
150033084|NCT01680341|541260857|FG000|Overall Study|Adverse Event|3|||
150033085|NCT01680341|541260858|FG001|Overall Study|Adverse Event|2|||
150033086|NCT01680341|541260857|FG000|Overall Study|Unclassified|18|||
150033087|NCT01680341|541260858|FG001|Overall Study|Unclassified|15|||
150033088|NCT00499486|541260860|FG000|Overall Study|Withdrawal by Subject|16|||
150033089|NCT00333775|541260861|FG000|Overall Study|Death|144|||
150033090|NCT00333775|541260862|FG001|Overall Study|Death|149|||
150033091|NCT00333775|541260863|FG002|Overall Study|Death|143|||
150033092|NCT00333775|541260861|FG000|Overall Study|In Follow-up When Study Stopped|87|||
150033093|NCT00333775|541260862|FG001|Overall Study|In Follow-up When Study Stopped|92|||
150033094|NCT00333775|541260863|FG002|Overall Study|In Follow-up When Study Stopped|96|||
150033095|NCT00333775|541260861|FG000|Overall Study|Lost to Follow-up|10|||
150033096|NCT00333775|541260862|FG001|Overall Study|Lost to Follow-up|7|||
150033097|NCT00333775|541260863|FG002|Overall Study|Lost to Follow-up|8|||
150033098|NCT01383928|541260865|FG000|Overall Study|Initiation of ASCT|2|||
150033099|NCT01383928|541260866|FG001|Overall Study|Initiation of ASCT|1|||
150033100|NCT01383928|541260867|FG002|Overall Study|Initiation of ASCT|18|||
150033101|NCT01383928|541260865|FG000|Overall Study|Adverse Event|1|||
150033102|NCT01383928|541260866|FG001|Overall Study|Adverse Event|2|||
150033103|NCT01383928|541260867|FG002|Overall Study|Adverse Event|8|||
150033104|NCT01383928|541260865|FG000|Overall Study|Other|1|||
150033105|NCT01383928|541260866|FG001|Overall Study|Other|3|||
150033106|NCT01383928|541260867|FG002|Overall Study|Other|4|||
150033107|NCT01383928|541260865|FG000|Overall Study|Progressive Disease|1|||
150033108|NCT01383928|541260866|FG001|Overall Study|Progressive Disease|1|||
150033109|NCT01383928|541260867|FG002|Overall Study|Progressive Disease|5|||
150033110|NCT01383928|541260865|FG000|Overall Study|Withdrawal by Subject|0|||
150033111|NCT01383928|541260866|FG001|Overall Study|Withdrawal by Subject|0|||
150275143|NCT01159912|542144590|FG001|Overall Study|Physician Decision|0|||
150275144|NCT01159912|542144591|FG002|Overall Study|Physician Decision|3|||
150275145|NCT01159912|542144589|FG000|Overall Study|Withdrawal by Subject|10|||
150275146|NCT01159912|542144590|FG001|Overall Study|Withdrawal by Subject|3|||
150033112|NCT01383928|541260867|FG002|Overall Study|Withdrawal by Subject|4|||
150033113|NCT01383928|541260865|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
150033114|NCT01383928|541260866|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
150033115|NCT01383928|541260867|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
150033116|NCT04914364|541260869|FG000|Overall Study|No longer eligible for study|1|||
150033117|NCT04914364|541260869|FG000|Overall Study|Lost to Follow-up|2|||
150275147|NCT01159912|542144591|FG002|Overall Study|Withdrawal by Subject|3|||
150275148|NCT02456662|542144594|FG000|Overall Study|Lost to Follow-up|2|||
150275149|NCT02456662|542144595|FG001|Overall Study|Lost to Follow-up|1|||
150033118|NCT01263769|541260870|FG000|Overall Study|Non-Compliant with treatment|1|||
150033119|NCT05058365|541260871|FG000|Overall Study|Migration|1|||
150033120|NCT05058365|541260872|FG001|Overall Study|Migration|1|||
150033121|NCT00702702|541260875|FG000|Overall Study|Study prematurely terminated|56|||
150033122|NCT00551759|541260878|FG000|Overall Study|Adverse Event|7|||
150033123|NCT00551759|541260878|FG000|Overall Study|Death|5|||
150033124|NCT00551759|541260878|FG000|Overall Study|Ineligible|1|||
150033125|NCT03279081|541260879|FG000|Overall Study|Withdrawal by Subject|12|||
150033126|NCT03279081|541260880|FG001|Overall Study|Withdrawal by Subject|20|||
150033127|NCT03279081|541260879|FG000|Overall Study|Physician Decision|4|||
150033128|NCT03279081|541260880|FG001|Overall Study|Physician Decision|1|||
150033129|NCT03279081|541260879|FG000|Overall Study|Lost to Follow-up|8|||
150033130|NCT03279081|541260880|FG001|Overall Study|Lost to Follow-up|8|||
150033131|NCT03279081|541260879|FG000|Overall Study|Death|0|||
150033132|NCT03279081|541260880|FG001|Overall Study|Death|1|||
150033133|NCT03279081|541260879|FG000|Overall Study|Adverse Event|1|||
150033134|NCT03279081|541260880|FG001|Overall Study|Adverse Event|0|||
150033135|NCT03279081|541260879|FG000|Overall Study|Reason not Specified|14|||
150033136|NCT03279081|541260880|FG001|Overall Study|Reason not Specified|4|||
150033137|NCT00762164|541260887|FG000|Overall Study|Lost to Follow-up|1|||
150033138|NCT00762164|541260888|FG001|Overall Study|Lost to Follow-up|1|||
150033139|NCT00762164|541260887|FG000|Overall Study|Discontinued medication|2|||
150033140|NCT00762164|541260888|FG001|Overall Study|Discontinued medication|0|||
150033141|NCT00762164|541260887|FG000|Overall Study|Withdrawal by Subject|0|||
150033142|NCT00762164|541260888|FG001|Overall Study|Withdrawal by Subject|1|||
150033143|NCT02954536|541260889|FG000|Overall Study|Adverse Event|2|||
150033144|NCT02954536|541260889|FG000|Overall Study|Death|12|||
150033145|NCT05135871|541260900|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
150033146|NCT05135871|541260901|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
150033147|NCT05135871|541260902|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
150033148|NCT05135871|541260903|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
150033149|NCT01576341|541260904|FG000|Overall Study|Withdrawal by Subject|24|||
150033150|NCT01576341|541260904|FG000|Overall Study|Adverse Event|10|||
150033151|NCT01576341|541260904|FG000|Overall Study|Death|21|||
150033152|NCT01576341|541260904|FG000|Overall Study|Physician Decision|2|||
150033153|NCT01576341|541260904|FG000|Overall Study|Lost to Follow-up|2|||
150033154|NCT01576341|541260904|FG000|Overall Study|Kidney transplantation|10|||
150033155|NCT01576341|541260904|FG000|Overall Study|Protocol Violation|12|||
150033156|NCT01576341|541260904|FG000|Overall Study|Other|12|||
150033157|NCT00617734|541260905|FG000|Overall Study|Withdrew Consent|2|||
150033158|NCT00617734|541260906|FG001|Overall Study|Withdrew Consent|0|||
150033159|NCT00617734|541260905|FG000|Overall Study|Adverse Event|4|||
150033160|NCT00617734|541260906|FG001|Overall Study|Adverse Event|1|||
150033161|NCT00617734|541260905|FG000|Overall Study|Protocol Violation|1|||
150033162|NCT00617734|541260906|FG001|Overall Study|Protocol Violation|0|||
150033163|NCT00617734|541260905|FG000|Overall Study|Found Ineligible After Randomization|1|||
150033164|NCT00617734|541260906|FG001|Overall Study|Found Ineligible After Randomization|4|||
150033165|NCT00617734|541260905|FG000|Overall Study|Lost to Follow-up|0|||
150033166|NCT00617734|541260906|FG001|Overall Study|Lost to Follow-up|1|||
150033167|NCT01844765|541260907|FG000|Overall Study|Adverse Event|6|||
150033168|NCT01844765|541260908|FG001|Overall Study|Adverse Event|8|||
150033169|NCT01844765|541260907|FG000|Overall Study|Withdrawal by Subject|2|||
150033170|NCT01844765|541260908|FG001|Overall Study|Withdrawal by Subject|3|||
150033171|NCT01844765|541260907|FG000|Overall Study|Disease progression|1|||
150033172|NCT01844765|541260908|FG001|Overall Study|Disease progression|0|||
150033173|NCT01844765|541260907|FG000|Overall Study|Administrative problems|3|||
150033174|NCT01844765|541260908|FG001|Overall Study|Administrative problems|4|||
150033175|NCT01844765|541260907|FG000|Overall Study|Protocol deviation|2|||
150033176|NCT01844765|541260908|FG001|Overall Study|Protocol deviation|0|||
150033177|NCT01844765|541260907|FG000|Overall Study|Untreated|1|||
150033178|NCT01844765|541260908|FG001|Overall Study|Untreated|0|||
150033179|NCT03914417|541260909|FG000|Overall Study|Withdrawal by Subject|2|||
150033180|NCT03836625|541260912|FG000|Overall Study|Lost to Follow-up|9|||
150033181|NCT03836625|541260913|FG001|Overall Study|Lost to Follow-up|9|||
150033182|NCT03836625|541260912|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
150033183|NCT03836625|541260913|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
150033184|NCT03836625|541260912|FG000|Overall Study|Death|0|||
150033185|NCT03836625|541260913|FG001|Overall Study|Death|1|||
150033186|NCT03836625|541260912|FG000|Overall Study|Refused follow-up|0|||
150033187|NCT03836625|541260913|FG001|Overall Study|Refused follow-up|1|||
150033188|NCT01247324|541260916|FG000|Overall Study|Death|6|||
150170375|NCT01235949|541759065|FG004|Primary Phase|Lost to Follow-up|0|||
150170376|NCT01235949|541759066|FG005|Primary Phase|Lost to Follow-up|2|||
150170377|NCT01235949|541759067|FG006|Primary Phase|Lost to Follow-up|0|||
150170378|NCT01235949|541759068|FG007|Primary Phase|Lost to Follow-up|0|||
150170379|NCT01235949|541759069|FG008|Primary Phase|Lost to Follow-up|0|||
149944580|NCT03282097|540930736|FG001|Intervention Visit Complete|Patient Death|15|||
149944581|NCT03282097|540930735|FG000|Intervention Visit Complete|Caregiver Death|0|||
149944582|NCT03282097|540930736|FG001|Intervention Visit Complete|Caregiver Death|3|||
149944583|NCT03282097|540930735|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
149944584|NCT03282097|540930736|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
149944585|NCT03282097|540930735|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
149944586|NCT03282097|540930736|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
150275150|NCT02374021|542144598|FG000|Overall Study|Adverse Event|1|||
149823770|NCT03209570|540484523|FG001|Overall Study|Incomplete Data|10|||
150275151|NCT02374021|542144599|FG001|Overall Study|Adverse Event|0|||
150275152|NCT02374021|542144598|FG000|Overall Study|Lost to Follow-up|3|||
150275153|NCT02374021|542144599|FG001|Overall Study|Lost to Follow-up|2|||
150275154|NCT02374021|542144598|FG000|Overall Study|Physician Decision|0|||
150275155|NCT02374021|542144599|FG001|Overall Study|Physician Decision|3|||
150275156|NCT02374021|542144598|FG000|Overall Study|Withdrawal by Subject|6|||
150275157|NCT02374021|542144599|FG001|Overall Study|Withdrawal by Subject|5|||
150275158|NCT02374021|542144598|FG000|Overall Study|Poor Adherence|0|||
150275159|NCT02374021|542144599|FG001|Overall Study|Poor Adherence|1|||
150275160|NCT02374021|542144598|FG000|Overall Study|Scan protocol not followed|0|||
150275161|NCT02374021|542144599|FG001|Overall Study|Scan protocol not followed|1|||
150275162|NCT02374021|542144598|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
150275163|NCT02374021|542144599|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
150275164|NCT00504153|542144604|FG000|Overall Study|Withdrawal by Subject|1|||
150275165|NCT00504153|542144604|FG000|Overall Study|Adverse Event|4|||
150275166|NCT00504153|542144604|FG000|Overall Study|Death|1|||
150275167|NCT00732251|542144607|FG000|Overall Study|Lost to Follow-up|3|||
150275168|NCT00732251|542144607|FG000|Overall Study|Withdrawal by Subject|3|||
149823771|NCT03209570|540484522|FG000|Overall Study|Protocol Violation|1|||
149823772|NCT03209570|540484523|FG001|Overall Study|Protocol Violation|0|||
149823773|NCT03209570|540484522|FG000|Overall Study|Withdrawal by Subject|0|||
149823774|NCT03209570|540484523|FG001|Overall Study|Withdrawal by Subject|3|||
149823775|NCT00220701|540484525|FG000|Overall Study|Lost to Follow-up|5|||
149823776|NCT00220701|540484526|FG001|Overall Study|Lost to Follow-up|4|||
149823777|NCT00755326|540484528|FG000|Overall Study|Lost to Follow-up|2|||
149823778|NCT00755326|540484529|FG001|Overall Study|Lost to Follow-up|3|||
149823779|NCT00368966|540484536|FG000|Infant Series|Withdrawal by Subject|11|||
149823780|NCT00368966|540484537|FG001|Infant Series|Withdrawal by Subject|6|||
149823781|NCT00368966|540484536|FG000|Infant Series|Protocol Violation|2|||
149823782|NCT00368966|540484537|FG001|Infant Series|Protocol Violation|1|||
149823783|NCT00368966|540484536|FG000|Infant Series|Lost to Follow-up|2|||
149823784|NCT00368966|540484537|FG001|Infant Series|Lost to Follow-up|0|||
149823785|NCT00368966|540484536|FG000|Infant Series|Randomization error|0|||
149823786|NCT00368966|540484537|FG001|Infant Series|Randomization error|1|||
149823787|NCT00368966|540484536|FG000|Infant Series|Failed to meet eligibility criteria|0|||
149823788|NCT00368966|540484537|FG001|Infant Series|Failed to meet eligibility criteria|1|||
149823789|NCT00368966|540484536|FG000|Infant Series|Adverse Event|0|||
149823790|NCT00368966|540484537|FG001|Infant Series|Adverse Event|1|||
149823791|NCT00368966|540484536|FG000|Infant Series|Failed to return|1|||
149823792|NCT00368966|540484537|FG001|Infant Series|Failed to return|0|||
149823793|NCT00368966|540484536|FG000|After Infant|Failed to return|3|||
149823794|NCT00368966|540484537|FG001|After Infant|Failed to return|1|||
149823795|NCT00368966|540484536|FG000|After Infant|Adverse Event|1|||
149823796|NCT00368966|540484537|FG001|After Infant|Adverse Event|2|||
149823797|NCT00368966|540484536|FG000|After Infant|Withdrawal by Subject|1|||
149823798|NCT00368966|540484537|FG001|After Infant|Withdrawal by Subject|1|||
149823799|NCT00368966|540484536|FG000|After Infant|Death|1|||
149823800|NCT00368966|540484537|FG001|After Infant|Death|0|||
149823801|NCT00368966|540484536|FG000|After Infant|Lost to Follow-up|0|||
149823802|NCT00368966|540484537|FG001|After Infant|Lost to Follow-up|1|||
149823803|NCT00368966|540484536|FG000|Toddler Dose|Withdrawal by Subject|1|||
149823804|NCT00368966|540484537|FG001|Toddler Dose|Withdrawal by Subject|1|||
149823805|NCT00368966|540484536|FG000|Toddler Dose|Lost to Follow-up|0|||
149823806|NCT00368966|540484537|FG001|Toddler Dose|Lost to Follow-up|2|||
149823807|NCT01689974|540484538|FG000|Overall Study|Termination of Study|5|||
149823808|NCT01689974|540484539|FG001|Overall Study|Termination of Study|5|||
149823809|NCT01333033|540484543|FG000|Overall Study|Ineligible|0|||
150275169|NCT00732251|542144607|FG000|Overall Study|Early Term due to Site Closure|1|||
150275170|NCT00805025|542144608|FG000|Overall Study|Screened but not enrolled/treated|42|||
150275171|NCT00805025|542144608|FG000|Overall Study|Adverse Event|4|||
149823810|NCT01333033|540484544|FG001|Overall Study|Ineligible|0|||
149823811|NCT01333033|540484545|FG002|Overall Study|Ineligible|0|||
149823812|NCT01333033|540484546|FG003|Overall Study|Ineligible|0|||
149823813|NCT01333033|540484547|FG004|Overall Study|Ineligible|6|||
149823814|NCT01333033|540484548|FG005|Overall Study|Ineligible|8|||
149823815|NCT01333033|540484543|FG000|Overall Study|Withdrawal by Subject|0|||
150275172|NCT00805025|542144608|FG000|Overall Study|Withdrawal by Subject|2|||
150275173|NCT00805025|542144608|FG000|Overall Study|Physician Decision|1|||
150275174|NCT04029961|542144609|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
149823816|NCT01333033|540484544|FG001|Overall Study|Withdrawal by Subject|0|||
149823817|NCT01333033|540484545|FG002|Overall Study|Withdrawal by Subject|0|||
149823818|NCT01333033|540484546|FG003|Overall Study|Withdrawal by Subject|0|||
150275175|NCT04029961|542144610|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
149823819|NCT01333033|540484547|FG004|Overall Study|Withdrawal by Subject|4|||
149823820|NCT01333033|540484548|FG005|Overall Study|Withdrawal by Subject|2|||
149823821|NCT01333033|540484543|FG000|Overall Study|PET inevaluable|0|||
149823822|NCT01333033|540484544|FG001|Overall Study|PET inevaluable|0|||
149823823|NCT01333033|540484545|FG002|Overall Study|PET inevaluable|0|||
149823824|NCT01333033|540484546|FG003|Overall Study|PET inevaluable|0|||
149823825|NCT01333033|540484547|FG004|Overall Study|PET inevaluable|2|||
149823826|NCT01333033|540484548|FG005|Overall Study|PET inevaluable|4|||
149944587|NCT03282097|540930735|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
149944588|NCT03282097|540930736|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
149944589|NCT03282097|540930735|FG000|Primary Outcome Data Collection Complete|Missing|2|||
149944590|NCT03282097|540930736|FG001|Primary Outcome Data Collection Complete|Missing|3|||
149944591|NCT03282097|540930735|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
149944592|NCT03282097|540930736|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
149944593|NCT03282097|540930735|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
149944594|NCT03282097|540930736|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
149944595|NCT03282097|540930735|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
149944596|NCT03282097|540930736|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
149944597|NCT01056536|540930739|FG000|Overall Study|Lost to Follow-up|202|||
149944598|NCT01056536|540930740|FG001|Overall Study|Lost to Follow-up|116|||
149944599|NCT01056536|540930741|FG002|Overall Study|Lost to Follow-up|248|||
149944600|NCT01394276|540930748|FG000|Overall Study|Related Adverse event (AEs)|15|||
150275176|NCT04029961|542144609|FG000|Overall Study|Change in Treatment Course|0|||
150275177|NCT04029961|542144610|FG001|Overall Study|Change in Treatment Course|1|||
150275178|NCT03007979|542144614|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
150275179|NCT00232141|542144615|FG000|Overall Study|Adverse Event|9|||
150275180|NCT00232141|542144616|FG001|Overall Study|Adverse Event|4|||
150275181|NCT00232141|542144615|FG000|Overall Study|Lack of Efficacy|0|||
150275182|NCT00232141|542144616|FG001|Overall Study|Lack of Efficacy|3|||
150275183|NCT00232141|542144615|FG000|Overall Study|Lost to Follow-up|9|||
150275184|NCT00232141|542144616|FG001|Overall Study|Lost to Follow-up|6|||
150275185|NCT00232141|542144615|FG000|Overall Study|Other|8|||
150275186|NCT00232141|542144616|FG001|Overall Study|Other|10|||
150275187|NCT00232141|542144615|FG000|Overall Study|Withdrawal by Subject|5|||
150275188|NCT00232141|542144616|FG001|Overall Study|Withdrawal by Subject|3|||
150275189|NCT02273726|542144617|FG000|Overall Study|Death|70|||
150275190|NCT02273726|542144618|FG001|Overall Study|Death|62|||
150275191|NCT02273726|542144617|FG000|Overall Study|Withdrawal by Subject|41|||
150275192|NCT02273726|542144618|FG001|Overall Study|Withdrawal by Subject|29|||
150275193|NCT02273726|542144617|FG000|Overall Study|Kidney transplant|31|||
150275194|NCT02273726|542144618|FG001|Overall Study|Kidney transplant|39|||
150275195|NCT02273726|542144617|FG000|Overall Study|Physician Decision|30|||
150275196|NCT02273726|542144618|FG001|Overall Study|Physician Decision|15|||
150275197|NCT02273726|542144617|FG000|Overall Study|Adverse Event|27|||
150275198|NCT02273726|542144618|FG001|Overall Study|Adverse Event|9|||
150275199|NCT02273726|542144617|FG000|Overall Study|Lost to Follow-up|6|||
150275200|NCT02273726|542144618|FG001|Overall Study|Lost to Follow-up|3|||
150275201|NCT02273726|542144617|FG000|Overall Study|Lack of Efficacy|6|||
150275202|NCT02273726|542144618|FG001|Overall Study|Lack of Efficacy|1|||
150275203|NCT02273726|542144617|FG000|Overall Study|Protocol Violation|4|||
150275204|NCT02273726|542144618|FG001|Overall Study|Protocol Violation|0|||
150275205|NCT02273726|542144617|FG000|Overall Study|Other than specified|28|||
150275206|NCT02273726|542144618|FG001|Overall Study|Other than specified|30|||
150275207|NCT01479829|542144619|FG000|Overall Study|Withdrawal by Subject|8|||
150275208|NCT01479829|542144620|FG001|Overall Study|Withdrawal by Subject|10|||
150275209|NCT04263896|542144622|FG000|Overall Study|Withdrawal by Subject|2|||
150275210|NCT04263896|542144623|FG001|Overall Study|Withdrawal by Subject|4|||
150275211|NCT04263896|542144622|FG000|Overall Study|converted to open procedure|0|||
150275212|NCT04263896|542144623|FG001|Overall Study|converted to open procedure|1|||
150275213|NCT04263896|542144622|FG000|Overall Study|Lost to Follow-up|9|||
150275214|NCT04263896|542144623|FG001|Overall Study|Lost to Follow-up|11|||
150275215|NCT04263896|542144622|FG000|Overall Study|surveys lost in mail|5|||
150275216|NCT04263896|542144623|FG001|Overall Study|surveys lost in mail|3|||
150275217|NCT04263896|542144622|FG000|Overall Study|excluded from analysis|1|||
150275218|NCT04263896|542144623|FG001|Overall Study|excluded from analysis|0|||
149823827|NCT01333033|540484543|FG000|Overall Study|Adverse Event|0|||
149944601|NCT01394276|540930748|FG000|Overall Study|Not related AEs|9|||
150275219|NCT00257166|542146392|FG000|Overall Study|Adverse Event|18|||
150275220|NCT00257166|542146393|FG001|Overall Study|Adverse Event|13|||
150275221|NCT00257166|542146392|FG000|Overall Study|Laboratory abnormality|1|||
150275222|NCT00257166|542146393|FG001|Overall Study|Laboratory abnormality|0|||
150275223|NCT00257166|542146392|FG000|Overall Study|Lost to Follow-up|8|||
150275224|NCT00257166|542146393|FG001|Overall Study|Lost to Follow-up|1|||
150275225|NCT00257166|542146392|FG000|Overall Study|Withdrawal by Subject|9|||
150275226|NCT00257166|542146393|FG001|Overall Study|Withdrawal by Subject|2|||
149944602|NCT01394276|540930748|FG000|Overall Study|Remission of disease|2|||
149944603|NCT01394276|540930748|FG000|Overall Study|Insufficient therapeutic effect|17|||
149944604|NCT01394276|540930748|FG000|Overall Study|Insufficient compliance|9|||
149944605|NCT01394276|540930748|FG000|Overall Study|Lost to Follow-up|5|||
149944606|NCT01394276|540930748|FG000|Overall Study|Participant moved to another site|1|||
149944607|NCT01394276|540930748|FG000|Overall Study|Pregnancy|1|||
149944608|NCT01394276|540930748|FG000|Overall Study|unavailability of drug at the Hospital|2|||
149944609|NCT01394276|540930748|FG000|Overall Study|Symptoms of concurrent diseases|1|||
149944610|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
149944611|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
149944612|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
149944613|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Death|0|||
149944614|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Death|0|||
149944615|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Death|1|||
149944616|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
149944617|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
149944618|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
149944619|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
149944620|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
149944621|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
149944622|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
149944623|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
149944624|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
149944625|NCT02696798|540930750|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
149944626|NCT02696798|540930751|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
149944627|NCT02696798|540930752|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
149944628|NCT02696798|540930750|FG000|Extended Treatment Period|Adverse Event|1|||
149944629|NCT02696798|540930751|FG001|Extended Treatment Period|Adverse Event|4|||
149944630|NCT02696798|540930752|FG002|Extended Treatment Period|Adverse Event|5|||
149944631|NCT02696798|540930750|FG000|Extended Treatment Period|Lack of Efficacy|7|||
149944632|NCT02696798|540930751|FG001|Extended Treatment Period|Lack of Efficacy|2|||
149944633|NCT02696798|540930752|FG002|Extended Treatment Period|Lack of Efficacy|2|||
149944634|NCT02696798|540930750|FG000|Extended Treatment Period|Lost to Follow-up|1|||
149944635|NCT02696798|540930751|FG001|Extended Treatment Period|Lost to Follow-up|0|||
149944636|NCT02696798|540930752|FG002|Extended Treatment Period|Lost to Follow-up|0|||
149944637|NCT02696798|540930750|FG000|Extended Treatment Period|Physician Decision|0|||
149944638|NCT02696798|540930751|FG001|Extended Treatment Period|Physician Decision|1|||
149944639|NCT02696798|540930752|FG002|Extended Treatment Period|Physician Decision|0|||
149944640|NCT02696798|540930750|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
149944641|NCT02696798|540930751|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
149944642|NCT02696798|540930752|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
149944643|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
149944644|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
149944645|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
149944646|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
149944647|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
149944648|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
149944649|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
149944650|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
149944651|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
149944652|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
149944653|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
149944654|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
149944655|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
149944656|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
149944657|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
149944658|NCT02696798|540930750|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
149944659|NCT02696798|540930751|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
149944660|NCT02696798|540930752|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
149944661|NCT01277861|540930753|FG000|Overall Study|Physician Decision|2|||
149944662|NCT01277861|540930754|FG001|Overall Study|Physician Decision|2|||
149944663|NCT03311555|540930755|FG000|Overall Study|Adverse Event|1|||
149975604|NCT02103062|541047907|FG001|Overall Study|Death|1|||
149975605|NCT00120627|541047908|FG000|Overall Study|Withdrawal by Subject|5|||
149975606|NCT00120627|541047909|FG001|Overall Study|Withdrawal by Subject|5|||
149975607|NCT01182298|541047910|FG000|Overall Study|Lack of Efficacy|4|||
149975608|NCT01182298|541047910|FG000|Overall Study|Withdrawal by Subject|2|||
149975609|NCT04016714|541047911|FG000|Overall Study|Death|1|||
149975610|NCT04016714|541047912|FG001|Overall Study|Death|0|||
149975611|NCT04016714|541047911|FG000|Overall Study|Lost to Follow-up|3|||
149975612|NCT04016714|541047912|FG001|Overall Study|Lost to Follow-up|1|||
149975613|NCT04016714|541047911|FG000|Overall Study|Physician Decision|3|||
149975614|NCT04016714|541047912|FG001|Overall Study|Physician Decision|3|||
149975615|NCT04016714|541047911|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
149975616|NCT04016714|541047912|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
149975617|NCT01677988|541047913|FG000|Overall Study|Lack of Efficacy|2|||
150275227|NCT00257166|542146392|FG000|Overall Study|Other|16|||
150275228|NCT00257166|542146393|FG001|Overall Study|Other|21|||
150275229|NCT00257166|542146392|FG000|Overall Study|Randomized, but not treated|1|||
150275230|NCT00257166|542146393|FG001|Overall Study|Randomized, but not treated|0|||
150275231|NCT02142738|542146394|FG000|Overall Study|Adverse Event|13|||
150275232|NCT02142738|542146395|FG001|Overall Study|Adverse Event|9|||
150275233|NCT02142738|542146394|FG000|Overall Study|Death|92|||
150275234|NCT02142738|542146395|FG001|Overall Study|Death|112|||
150275235|NCT02142738|542146394|FG000|Overall Study|Lost to Follow-up|0|||
150275236|NCT02142738|542146395|FG001|Overall Study|Lost to Follow-up|3|||
150275237|NCT02142738|542146394|FG000|Overall Study|Withdrawal by Subject|6|||
150275238|NCT02142738|542146395|FG001|Overall Study|Withdrawal by Subject|7|||
150275239|NCT02142738|542146394|FG000|Overall Study|Follow up ended by sponsor|43|||
150275240|NCT02142738|542146395|FG001|Overall Study|Follow up ended by sponsor|20|||
150275241|NCT03688880|542146396|FG000|Overall Study|Withdrawal by Subject|0|||
150275242|NCT03688880|542146397|FG001|Overall Study|Withdrawal by Subject|2|||
150275243|NCT03688880|542146396|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
150275244|NCT03688880|542146397|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
150275245|NCT03688880|542146396|FG000|Overall Study|Lost to Follow-up|4|||
150275246|NCT03688880|542146397|FG001|Overall Study|Lost to Follow-up|7|||
150275247|NCT03688880|542146396|FG000|Overall Study|Adverse Event|0|||
150275248|NCT03688880|542146397|FG001|Overall Study|Adverse Event|2|||
150275249|NCT03688880|542146396|FG000|Overall Study|Device deficiencies|0|||
150275250|NCT03688880|542146397|FG001|Overall Study|Device deficiencies|2|||
149975618|NCT00271544|541047914|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
149975619|NCT00271544|541047914|FG000|Overall Study|Model 4196 lead not attempted|9|||
149975620|NCT00271544|541047914|FG000|Overall Study|Implant not attempted|4|||
149975621|NCT01822665|541047915|FG000|Overall Study|Adverse Event|3|||
150275251|NCT03688880|542146396|FG000|Overall Study|Other|10|||
150275252|NCT03688880|542146397|FG001|Overall Study|Other|16|||
149975622|NCT01822665|541047915|FG000|Overall Study|Other Reason|5|||
149975623|NCT00907621|541047919|FG000|Overall Study|Lost to Follow-up|6|||
149975624|NCT00907621|541047920|FG001|Overall Study|Lost to Follow-up|3|||
150033189|NCT01247324|541260917|FG001|Overall Study|Death|10|||
150275253|NCT01704287|542146398|FG000|Initial Treatment Period|Death|139|||
150033190|NCT01247324|541260916|FG000|Overall Study|Physician Decision|2|||
150275254|NCT01704287|542146399|FG001|Initial Treatment Period|Death|129|||
150275255|NCT01704287|542146400|FG002|Initial Treatment Period|Death|71|||
150275256|NCT01704287|542146401|FG003|Initial Treatment Period|Death|0|||
150275257|NCT01704287|542146402|FG004|Initial Treatment Period|Death|0|||
150033191|NCT01247324|541260917|FG001|Overall Study|Physician Decision|3|||
150170380|NCT01235949|541759070|FG009|Primary Phase|Lost to Follow-up|0|||
150170381|NCT01235949|541759071|FG010|Primary Phase|Lost to Follow-up|0|||
150170382|NCT01235949|541759072|FG011|Primary Phase|Lost to Follow-up|0|||
149944664|NCT02566005|540932283|FG000|Overall Study|vaginal bleeding|0|||
149944665|NCT02566005|540932284|FG001|Overall Study|vaginal bleeding|1|||
149944666|NCT02566005|540932283|FG000|Overall Study|received foley|8|||
149944667|NCT02566005|540932284|FG001|Overall Study|received foley|0|||
149944668|NCT02566005|540932283|FG000|Overall Study|did not receive foley|0|||
149944669|NCT02566005|540932284|FG001|Overall Study|did not receive foley|1|||
149944670|NCT02566005|540932283|FG000|Overall Study|labor after randomization|0|||
149944671|NCT02566005|540932284|FG001|Overall Study|labor after randomization|4|||
149944672|NCT01294514|540932285|FG000|Overall Study|Excluded due to Arrhythmia|1|||
149944673|NCT05350423|540932289|FG000|Overall Study|Lost to Follow-up|3|||
149944674|NCT05350423|540932290|FG001|Overall Study|Lost to Follow-up|3|||
149944675|NCT05350423|540932289|FG000|Overall Study|screen failure|5|||
149944676|NCT05350423|540932290|FG001|Overall Study|screen failure|6|||
149944677|NCT02097277|540932291|FG000|Overall Study|Subject no longer meets study criteria|0|||
149944678|NCT02097277|540932292|FG001|Overall Study|Subject no longer meets study criteria|1|||
149944679|NCT02097277|540932293|FG002|Overall Study|Subject no longer meets study criteria|0|||
149944680|NCT02097277|540932294|FG003|Overall Study|Subject no longer meets study criteria|1|||
149944681|NCT02097277|540932295|FG004|Overall Study|Subject no longer meets study criteria|0|||
149944682|NCT02097277|540932291|FG000|Overall Study|Subject request to discontinue treatment|0|||
149944683|NCT02097277|540932292|FG001|Overall Study|Subject request to discontinue treatment|0|||
149944684|NCT02097277|540932293|FG002|Overall Study|Subject request to discontinue treatment|0|||
149944685|NCT02097277|540932294|FG003|Overall Study|Subject request to discontinue treatment|0|||
149944686|NCT02097277|540932295|FG004|Overall Study|Subject request to discontinue treatment|1|||
149944687|NCT02097277|540932291|FG000|Overall Study|Lost to Follow-up|0|||
149944688|NCT02097277|540932292|FG001|Overall Study|Lost to Follow-up|1|||
149944689|NCT02097277|540932293|FG002|Overall Study|Lost to Follow-up|1|||
149944690|NCT02097277|540932294|FG003|Overall Study|Lost to Follow-up|0|||
149944691|NCT02097277|540932295|FG004|Overall Study|Lost to Follow-up|0|||
149944692|NCT02097277|540932291|FG000|Overall Study|Withdrawal by Subject|2|||
149944693|NCT02097277|540932292|FG001|Overall Study|Withdrawal by Subject|1|||
149944694|NCT02097277|540932293|FG002|Overall Study|Withdrawal by Subject|0|||
149944695|NCT02097277|540932294|FG003|Overall Study|Withdrawal by Subject|1|||
149944696|NCT02097277|540932295|FG004|Overall Study|Withdrawal by Subject|0|||
149944697|NCT02097277|540932291|FG000|Overall Study|Adverse Event|0|||
150275258|NCT01704287|542146398|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
150275259|NCT01704287|542146399|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
150275260|NCT01704287|542146400|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
150275261|NCT01704287|542146401|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
150275262|NCT01704287|542146402|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
150275263|NCT01704287|542146398|FG000|Initial Treatment Period|Lost to Follow-up|5|||
150275264|NCT01704287|542146399|FG001|Initial Treatment Period|Lost to Follow-up|3|||
150275265|NCT01704287|542146400|FG002|Initial Treatment Period|Lost to Follow-up|0|||
150275266|NCT01704287|542146401|FG003|Initial Treatment Period|Lost to Follow-up|0|||
150275267|NCT01704287|542146402|FG004|Initial Treatment Period|Lost to Follow-up|0|||
150275268|NCT01704287|542146398|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
150275269|NCT01704287|542146399|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
150275270|NCT01704287|542146400|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
150275271|NCT01704287|542146401|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
150275272|NCT01704287|542146402|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
150275273|NCT01704287|542146398|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
150275274|NCT01704287|542146399|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
150275275|NCT01704287|542146400|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
150275276|NCT01704287|542146401|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
150275277|NCT01704287|542146402|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
150275278|NCT01704287|542146398|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
150275279|NCT01704287|542146399|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
150275280|NCT01704287|542146400|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
150275281|NCT01704287|542146401|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
150275282|NCT01704287|542146402|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
150275283|NCT01704287|542146398|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
150275284|NCT01704287|542146399|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
150275285|NCT01704287|542146400|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
150275286|NCT01704287|542146401|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
150275287|NCT01704287|542146402|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
150275288|NCT03713034|542146403|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
149944698|NCT02097277|540932292|FG001|Overall Study|Adverse Event|0|||
149944699|NCT02097277|540932293|FG002|Overall Study|Adverse Event|1|||
149944700|NCT02097277|540932294|FG003|Overall Study|Adverse Event|2|||
150275289|NCT03713034|542146404|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
149944701|NCT02097277|540932295|FG004|Overall Study|Adverse Event|0|||
149944702|NCT00671060|540932297|FG000|Overall Study|Protocol Violation|1|||
149944703|NCT00671060|540932298|FG001|Overall Study|Protocol Violation|0|||
149944704|NCT00671060|540932297|FG000|Overall Study|Physician Decision|0|||
149944705|NCT00671060|540932298|FG001|Overall Study|Physician Decision|1|||
149944706|NCT00626639|540932299|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
149944707|NCT00626639|540932300|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
149944708|NCT01461551|540932301|FG000|Overall Study|Physician Decision|2|||
149944709|NCT01461551|540932302|FG001|Overall Study|Physician Decision|1|||
149944710|NCT01461551|540932303|FG002|Overall Study|Physician Decision|2|||
149944711|NCT00303186|540932304|FG000|Overall Study|Other|52|||
149944712|NCT03473197|540932305|FG000|Overall Study|Adverse Event|4|||
149944713|NCT03473197|540932305|FG000|Overall Study|Lost to Follow-up|1|||
149944714|NCT03473197|540932305|FG000|Overall Study|Withdrawal by Subject|5|||
149944715|NCT02020941|540932308|FG000|Overall Study|Adverse Event|1|||
149944716|NCT02020941|540932308|FG000|Overall Study|Physician Decision|2|||
149944717|NCT02020941|540932308|FG000|Overall Study|Withdrawal by Subject|1|||
149944718|NCT02020941|540932308|FG000|Overall Study|Disease Progression|4|||
149944719|NCT02832037|540932310|FG000|Overall Study|Administrative reasons|0|||
149944720|NCT02832037|540932311|FG001|Overall Study|Administrative reasons|0|||
149944721|NCT02832037|540932312|FG002|Overall Study|Administrative reasons|1|||
149944722|NCT02832037|540932313|FG003|Overall Study|Administrative reasons|0|||
149944723|NCT02832037|540932314|FG004|Overall Study|Administrative reasons|0|||
149944724|NCT02832037|540932310|FG000|Overall Study|Protocol Violation|3|||
149944725|NCT02832037|540932311|FG001|Overall Study|Protocol Violation|0|||
149944726|NCT02832037|540932312|FG002|Overall Study|Protocol Violation|4|||
149944727|NCT02832037|540932313|FG003|Overall Study|Protocol Violation|1|||
149944728|NCT02832037|540932314|FG004|Overall Study|Protocol Violation|2|||
149944729|NCT02832037|540932310|FG000|Overall Study|Lost to Follow-up|2|||
149944730|NCT02832037|540932311|FG001|Overall Study|Lost to Follow-up|0|||
149944731|NCT02832037|540932312|FG002|Overall Study|Lost to Follow-up|3|||
149944732|NCT02832037|540932313|FG003|Overall Study|Lost to Follow-up|0|||
149944733|NCT02832037|540932314|FG004|Overall Study|Lost to Follow-up|5|||
149944734|NCT02832037|540932310|FG000|Overall Study|Withdrawal by Subject|9|||
149944735|NCT02832037|540932311|FG001|Overall Study|Withdrawal by Subject|8|||
149944736|NCT02832037|540932312|FG002|Overall Study|Withdrawal by Subject|0|||
149944737|NCT02832037|540932313|FG003|Overall Study|Withdrawal by Subject|4|||
149944738|NCT02832037|540932314|FG004|Overall Study|Withdrawal by Subject|8|||
149944739|NCT02832037|540932310|FG000|Overall Study|Adverse Event|5|||
149944740|NCT02832037|540932311|FG001|Overall Study|Adverse Event|4|||
149944741|NCT02832037|540932312|FG002|Overall Study|Adverse Event|0|||
149944742|NCT02832037|540932313|FG003|Overall Study|Adverse Event|2|||
149944743|NCT02832037|540932314|FG004|Overall Study|Adverse Event|4|||
149944744|NCT02326883|540932315|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
149944745|NCT02326883|540932316|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
149944746|NCT02326883|540932317|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
149944747|NCT02107898|540932319|FG000|Overall Study|Adverse Event|4|||
149944748|NCT02107898|540932320|FG001|Overall Study|Adverse Event|7|||
149944749|NCT02107898|540932319|FG000|Overall Study|Poor compliance to protocol|0|||
149944750|NCT02107898|540932320|FG001|Overall Study|Poor compliance to protocol|1|||
149944751|NCT02107898|540932319|FG000|Overall Study|Participant moved|0|||
149944752|NCT02107898|540932320|FG001|Overall Study|Participant moved|2|||
149944753|NCT02107898|540932319|FG000|Overall Study|Consent withdrawn by participant|2|||
149944754|NCT02107898|540932320|FG001|Overall Study|Consent withdrawn by participant|1|||
149944755|NCT02107898|540932319|FG000|Overall Study|Randomized but not treated|0|||
149944756|NCT02107898|540932320|FG001|Overall Study|Randomized but not treated|1|||
149944757|NCT03329989|540932321|FG000|Overall Study|Withdrawal by Subject|9|||
149944758|NCT03329989|540932321|FG000|Overall Study|Lost to Follow-up|8|||
149944759|NCT03329989|540932321|FG000|Overall Study|Adverse Event|5|||
149944760|NCT03329989|540932321|FG000|Overall Study|Protocol Violation|1|||
149944761|NCT01283386|540932330|FG000|Overall Study|Death|2|||
149944762|NCT01283386|540932331|FG001|Overall Study|Death|0|||
149944763|NCT01283386|540932330|FG000|Overall Study|Withdrawal by Subject|2|||
149944764|NCT01283386|540932331|FG001|Overall Study|Withdrawal by Subject|1|||
149944765|NCT01283386|540932330|FG000|Overall Study|Relapse of underlying disease|1|||
149944766|NCT01283386|540932331|FG001|Overall Study|Relapse of underlying disease|3|||
149944767|NCT01283386|540932330|FG000|Overall Study|Progression of underlying disease|2|||
150033192|NCT01247324|541260916|FG000|Overall Study|Non-compliance with study drug|3|||
149944768|NCT01283386|540932331|FG001|Overall Study|Progression of underlying disease|7|||
149944769|NCT01283386|540932330|FG000|Overall Study|Reason not specified|1|||
149944770|NCT01283386|540932331|FG001|Overall Study|Reason not specified|0|||
149944771|NCT01283386|540932330|FG000|Overall Study|Protocol Violation|0|||
150170383|NCT01235949|541759073|FG012|Primary Phase|Lost to Follow-up|0|||
149944772|NCT01283386|540932331|FG001|Overall Study|Protocol Violation|1|||
149944773|NCT02469857|540932332|FG000|Overall Study|Death|24|||
149944774|NCT02469857|540932333|FG001|Overall Study|Death|29|||
150033193|NCT01247324|541260917|FG001|Overall Study|Non-compliance with study drug|0|||
149823828|NCT01333033|540484544|FG001|Overall Study|Adverse Event|0|||
149823829|NCT01333033|540484545|FG002|Overall Study|Adverse Event|0|||
149823830|NCT01333033|540484546|FG003|Overall Study|Adverse Event|0|||
149823831|NCT01333033|540484547|FG004|Overall Study|Adverse Event|2|||
149823832|NCT01333033|540484548|FG005|Overall Study|Adverse Event|1|||
149823833|NCT01333033|540484543|FG000|Overall Study|Progression|0|||
149823834|NCT01333033|540484544|FG001|Overall Study|Progression|0|||
149823835|NCT01333033|540484545|FG002|Overall Study|Progression|0|||
149823836|NCT01333033|540484546|FG003|Overall Study|Progression|0|||
149823837|NCT01333033|540484547|FG004|Overall Study|Progression|0|||
149823838|NCT01333033|540484548|FG005|Overall Study|Progression|1|||
149823839|NCT01333033|540484543|FG000|Overall Study|MD Decision|0|||
149823840|NCT01333033|540484544|FG001|Overall Study|MD Decision|0|||
149823841|NCT01333033|540484545|FG002|Overall Study|MD Decision|0|||
149823842|NCT01333033|540484546|FG003|Overall Study|MD Decision|0|||
149823843|NCT01333033|540484547|FG004|Overall Study|MD Decision|0|||
149823844|NCT01333033|540484548|FG005|Overall Study|MD Decision|2|||
149823845|NCT01388647|540484551|FG000|Overall Study|Adverse Event|1|||
149823846|NCT01388647|540484552|FG001|Overall Study|Adverse Event|2|||
149823847|NCT01006707|540484554|FG000|Study Session 1|Lost to Follow-up|2|||
149823848|NCT01006707|540484555|FG001|Study Session 1|Lost to Follow-up|0|||
149823849|NCT01006707|540484556|FG002|Study Session 1|Lost to Follow-up|0|||
149823850|NCT01006707|540484554|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
149823851|NCT01006707|540484555|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
149823852|NCT01006707|540484556|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
149823853|NCT03361423|540484557|FG000|Overall Study|Withdrawal by Subject|4|||
149823854|NCT03361423|540484558|FG001|Overall Study|Withdrawal by Subject|3|||
149823855|NCT03361423|540484557|FG000|Overall Study|Did not treat|19|||
149823856|NCT03361423|540484558|FG001|Overall Study|Did not treat|18|||
149823857|NCT03361423|540484557|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
149823858|NCT03361423|540484558|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
149823859|NCT03361423|540484557|FG000|Overall Study|Missing data|4|||
149823860|NCT03361423|540484558|FG001|Overall Study|Missing data|1|||
149823861|NCT00818623|540484559|FG000|Overall Study|Adverse Event|1|||
149823862|NCT00818623|540484560|FG001|Overall Study|Adverse Event|0|||
149823863|NCT00818623|540484561|FG002|Overall Study|Adverse Event|1|||
149823864|NCT00818623|540484562|FG003|Overall Study|Adverse Event|0|||
149823865|NCT00818623|540484563|FG004|Overall Study|Adverse Event|0|||
149823866|NCT00818623|540484564|FG005|Overall Study|Adverse Event|1|||
149823867|NCT00818623|540484565|FG006|Overall Study|Adverse Event|0|||
149823868|NCT00818623|540484566|FG007|Overall Study|Adverse Event|0|||
149823869|NCT00818623|540484559|FG000|Overall Study|Bad prostate specific antigen response|0|||
149823870|NCT00818623|540484560|FG001|Overall Study|Bad prostate specific antigen response|3|||
149823871|NCT00818623|540484561|FG002|Overall Study|Bad prostate specific antigen response|2|||
149823872|NCT00818623|540484562|FG003|Overall Study|Bad prostate specific antigen response|5|||
149823873|NCT00818623|540484563|FG004|Overall Study|Bad prostate specific antigen response|0|||
149823874|NCT00818623|540484564|FG005|Overall Study|Bad prostate specific antigen response|1|||
149823875|NCT00818623|540484565|FG006|Overall Study|Bad prostate specific antigen response|0|||
149823876|NCT00818623|540484566|FG007|Overall Study|Bad prostate specific antigen response|0|||
149823877|NCT00818623|540484559|FG000|Overall Study|Withdrawal by Subject|0|||
149823878|NCT00818623|540484560|FG001|Overall Study|Withdrawal by Subject|1|||
149823879|NCT00818623|540484561|FG002|Overall Study|Withdrawal by Subject|1|||
149823880|NCT00818623|540484562|FG003|Overall Study|Withdrawal by Subject|0|||
149823881|NCT00818623|540484563|FG004|Overall Study|Withdrawal by Subject|0|||
149823882|NCT00818623|540484564|FG005|Overall Study|Withdrawal by Subject|1|||
149823883|NCT00818623|540484565|FG006|Overall Study|Withdrawal by Subject|1|||
149823884|NCT00818623|540484566|FG007|Overall Study|Withdrawal by Subject|1|||
149823885|NCT00818623|540484559|FG000|Overall Study|Protocol Violation|1|||
149823886|NCT00818623|540484560|FG001|Overall Study|Protocol Violation|0|||
149823887|NCT00818623|540484561|FG002|Overall Study|Protocol Violation|0|||
149823888|NCT00818623|540484562|FG003|Overall Study|Protocol Violation|0|||
149823889|NCT00818623|540484563|FG004|Overall Study|Protocol Violation|1|||
149823890|NCT00818623|540484564|FG005|Overall Study|Protocol Violation|0|||
149823891|NCT00818623|540484565|FG006|Overall Study|Protocol Violation|1|||
149944775|NCT02469857|540932332|FG000|Overall Study|Discontinuation|1|||
149823892|NCT00818623|540484566|FG007|Overall Study|Protocol Violation|0|||
149823893|NCT00818623|540484559|FG000|Overall Study|Need of additional treatment|0|||
149823894|NCT00818623|540484560|FG001|Overall Study|Need of additional treatment|0|||
149823895|NCT00818623|540484561|FG002|Overall Study|Need of additional treatment|0|||
149823896|NCT00818623|540484562|FG003|Overall Study|Need of additional treatment|0|||
149944776|NCT02469857|540932333|FG001|Overall Study|Discontinuation|3|||
149944777|NCT00937950|540932334|FG000|Overall Study|Withdrawal by Subject|23|||
149944778|NCT00937950|540932334|FG000|Overall Study|Migrated/moved from study area|27|||
149823897|NCT00818623|540484563|FG004|Overall Study|Need of additional treatment|1|||
149944779|NCT00937950|540932334|FG000|Overall Study|Lost to Follow-up|144|||
149944780|NCT00937950|540932334|FG000|Overall Study|Missing confirmed|4|||
149944781|NCT00937950|540932334|FG000|Overall Study|Other|18|||
149823898|NCT00818623|540484564|FG005|Overall Study|Need of additional treatment|0|||
149823899|NCT00818623|540484565|FG006|Overall Study|Need of additional treatment|0|||
149823900|NCT00818623|540484566|FG007|Overall Study|Need of additional treatment|0|||
149823901|NCT00818623|540484559|FG000|Overall Study|Lack of trial drug at site|0|||
149823902|NCT00818623|540484560|FG001|Overall Study|Lack of trial drug at site|0|||
149823903|NCT00818623|540484561|FG002|Overall Study|Lack of trial drug at site|0|||
149823904|NCT00818623|540484562|FG003|Overall Study|Lack of trial drug at site|0|||
149823905|NCT00818623|540484563|FG004|Overall Study|Lack of trial drug at site|2|||
149823906|NCT00818623|540484564|FG005|Overall Study|Lack of trial drug at site|0|||
149823907|NCT00818623|540484565|FG006|Overall Study|Lack of trial drug at site|1|||
149823908|NCT00818623|540484566|FG007|Overall Study|Lack of trial drug at site|0|||
149823909|NCT00818623|540484559|FG000|Overall Study|Disease progression|0|||
149823910|NCT00818623|540484560|FG001|Overall Study|Disease progression|0|||
149823911|NCT00818623|540484561|FG002|Overall Study|Disease progression|0|||
149823912|NCT00818623|540484562|FG003|Overall Study|Disease progression|0|||
149823913|NCT00818623|540484563|FG004|Overall Study|Disease progression|0|||
149823914|NCT00818623|540484564|FG005|Overall Study|Disease progression|0|||
149823915|NCT00818623|540484565|FG006|Overall Study|Disease progression|1|||
149823916|NCT00818623|540484566|FG007|Overall Study|Disease progression|0|||
149823917|NCT00358826|540484567|FG000|Core Study|Adverse Event|1|||
149823918|NCT00358826|540484568|FG001|Core Study|Adverse Event|3|||
149823919|NCT00358826|540484569|FG002|Core Study|Adverse Event|1|||
149823920|NCT00358826|540484570|FG003|Core Study|Adverse Event|1|||
149823921|NCT00358826|540484571|FG004|Core Study|Adverse Event|0|||
149823922|NCT00358826|540484572|FG005|Core Study|Adverse Event|0|||
149823923|NCT00358826|540484573|FG006|Core Study|Adverse Event|0|||
149823924|NCT00358826|540484574|FG007|Core Study|Adverse Event|0|||
149823925|NCT00358826|540484567|FG000|Core Study|Withdrawal by Subject|2|||
149823926|NCT00358826|540484568|FG001|Core Study|Withdrawal by Subject|2|||
149823927|NCT00358826|540484569|FG002|Core Study|Withdrawal by Subject|0|||
149823928|NCT00358826|540484570|FG003|Core Study|Withdrawal by Subject|0|||
149823929|NCT00358826|540484571|FG004|Core Study|Withdrawal by Subject|0|||
149823930|NCT00358826|540484572|FG005|Core Study|Withdrawal by Subject|0|||
149823931|NCT00358826|540484573|FG006|Core Study|Withdrawal by Subject|0|||
149823932|NCT00358826|540484574|FG007|Core Study|Withdrawal by Subject|0|||
149823933|NCT00358826|540484567|FG000|Core Study|Lost to Follow-up|0|||
149823934|NCT00358826|540484568|FG001|Core Study|Lost to Follow-up|0|||
149823935|NCT00358826|540484569|FG002|Core Study|Lost to Follow-up|0|||
149823936|NCT00358826|540484570|FG003|Core Study|Lost to Follow-up|1|||
149823937|NCT00358826|540484571|FG004|Core Study|Lost to Follow-up|0|||
149823938|NCT00358826|540484572|FG005|Core Study|Lost to Follow-up|0|||
149823939|NCT00358826|540484573|FG006|Core Study|Lost to Follow-up|0|||
149823940|NCT00358826|540484574|FG007|Core Study|Lost to Follow-up|0|||
149823941|NCT00358826|540484567|FG000|Core Study|Physician Decision|0|||
149823942|NCT00358826|540484568|FG001|Core Study|Physician Decision|0|||
149823943|NCT00358826|540484569|FG002|Core Study|Physician Decision|1|||
149823944|NCT00358826|540484570|FG003|Core Study|Physician Decision|0|||
149823945|NCT00358826|540484571|FG004|Core Study|Physician Decision|0|||
149823946|NCT00358826|540484572|FG005|Core Study|Physician Decision|0|||
149823947|NCT00358826|540484573|FG006|Core Study|Physician Decision|0|||
149823948|NCT00358826|540484574|FG007|Core Study|Physician Decision|0|||
149823949|NCT00358826|540484567|FG000|MDCT Substudy|Adverse Event|0|||
149823950|NCT00358826|540484568|FG001|MDCT Substudy|Adverse Event|0|||
149823951|NCT00358826|540484569|FG002|MDCT Substudy|Adverse Event|0|||
149823952|NCT00358826|540484570|FG003|MDCT Substudy|Adverse Event|0|||
149823953|NCT00358826|540484571|FG004|MDCT Substudy|Adverse Event|1|||
149823954|NCT00358826|540484572|FG005|MDCT Substudy|Adverse Event|0|||
149823955|NCT00358826|540484573|FG006|MDCT Substudy|Adverse Event|0|||
149823956|NCT00358826|540484574|FG007|MDCT Substudy|Adverse Event|0|||
149823957|NCT00358826|540484567|FG000|MDCT Substudy|Lost to Follow-up|0|||
149823958|NCT00358826|540484568|FG001|MDCT Substudy|Lost to Follow-up|0|||
149823959|NCT00358826|540484569|FG002|MDCT Substudy|Lost to Follow-up|0|||
149823960|NCT00358826|540484570|FG003|MDCT Substudy|Lost to Follow-up|0|||
149823961|NCT00358826|540484571|FG004|MDCT Substudy|Lost to Follow-up|0|||
149823962|NCT00358826|540484572|FG005|MDCT Substudy|Lost to Follow-up|1|||
149944782|NCT01531153|540932335|FG000|Overall Study|Withdrawal by Subject|10|||
149944783|NCT01531153|540932336|FG001|Overall Study|Withdrawal by Subject|9|||
149823963|NCT00358826|540484573|FG006|MDCT Substudy|Lost to Follow-up|0|||
149823964|NCT00358826|540484574|FG007|MDCT Substudy|Lost to Follow-up|0|||
149823965|NCT00358826|540484567|FG000|MDCT Substudy|Withdrawal by Subject|0|||
149823966|NCT00358826|540484568|FG001|MDCT Substudy|Withdrawal by Subject|0|||
149823967|NCT00358826|540484569|FG002|MDCT Substudy|Withdrawal by Subject|0|||
149823968|NCT00358826|540484570|FG003|MDCT Substudy|Withdrawal by Subject|0|||
149823969|NCT00358826|540484571|FG004|MDCT Substudy|Withdrawal by Subject|0|||
149823970|NCT00358826|540484572|FG005|MDCT Substudy|Withdrawal by Subject|1|||
149823971|NCT00358826|540484573|FG006|MDCT Substudy|Withdrawal by Subject|0|||
149823972|NCT00358826|540484574|FG007|MDCT Substudy|Withdrawal by Subject|0|||
149823973|NCT02015793|540484576|FG000|Overall Study|Adverse Event|3|||
149823974|NCT02015793|540484577|FG001|Overall Study|Adverse Event|3|||
149823975|NCT02015793|540484576|FG000|Overall Study|Withdrawal by Subject|1|||
149823976|NCT02015793|540484577|FG001|Overall Study|Withdrawal by Subject|1|||
149823977|NCT04317781|540484578|FG000|Overall Study|Adverse Event|1|||
149823978|NCT04317781|540484578|FG000|Overall Study|Disease relapse|1|||
149823979|NCT04317781|540484578|FG000|Overall Study|Withdrawal by Subject|1|||
149823980|NCT02843074|540484583|FG000|Overall Study|Withdrawal by Subject|5|||
149823981|NCT02843074|540484583|FG000|Overall Study|Progressive disease|1|||
149823982|NCT02843074|540484583|FG000|Overall Study|Physician Decision|1|||
149823983|NCT02843074|540484583|FG000|Overall Study|Lost to Follow-up|1|||
149823984|NCT02843074|540484583|FG000|Overall Study|Death|9|||
149823985|NCT03521999|540484584|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
149823986|NCT03521999|540484585|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
149823987|NCT03521999|540484584|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
149823988|NCT03521999|540484585|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
149823989|NCT03521999|540484584|FG000|Completed 3 Month Follow up|Death|0|||
149823990|NCT03521999|540484585|FG001|Completed 3 Month Follow up|Death|1|||
149823991|NCT03521999|540484584|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
149823992|NCT03521999|540484585|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
149823993|NCT01564758|540484586|FG000|Overall Study|Death|8|||
149823994|NCT01564758|540484586|FG000|Overall Study|Adverse Event|3|||
149823995|NCT01564758|540484586|FG000|Overall Study|Other|3|||
149823996|NCT01211769|540484587|FG000|Overall Study|Lost to Follow-up|7|||
149823997|NCT01211769|540484588|FG001|Overall Study|Lost to Follow-up|9|||
149823998|NCT01211769|540484589|FG002|Overall Study|Lost to Follow-up|5|||
149823999|NCT01211769|540484590|FG003|Overall Study|Lost to Follow-up|9|||
149824000|NCT01211769|540484587|FG000|Overall Study|Physician Decision|2|||
149824001|NCT01211769|540484588|FG001|Overall Study|Physician Decision|0|||
149944784|NCT01531153|540932337|FG002|Overall Study|Withdrawal by Subject|15|||
149944785|NCT03483103|540932338|FG000|Pre-Treatment Phase|Other reasons|1|||
149944786|NCT03483103|540932338|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
149944787|NCT03483103|540932338|FG000|Pre-Treatment Phase|Disease-related complications|1|||
149944788|NCT03483103|540932338|FG000|Pre-Treatment Phase|Death|5|||
149944789|NCT03483103|540932338|FG000|Treatment Phase|Withdrawal by Subject|7|||
149944790|NCT03483103|540932338|FG000|Treatment Phase|Other reasons|1|||
149944791|NCT03483103|540932338|FG000|Treatment Phase|Death|23|||
149944792|NCT03483103|540932338|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
149944793|NCT03483103|540932338|FG000|Treatment Phase|Received nonconforming product|1|||
149944794|NCT00435942|540932339|FG000|Overall Study|Death|17|||
149944795|NCT00435942|540932340|FG001|Overall Study|Death|10|||
149944796|NCT00435942|540932339|FG000|Overall Study|Withdrawal by Subject|2|||
149944797|NCT00435942|540932340|FG001|Overall Study|Withdrawal by Subject|0|||
149944798|NCT00435942|540932339|FG000|Overall Study|Lost to Follow-up|0|||
149944799|NCT00435942|540932340|FG001|Overall Study|Lost to Follow-up|16|||
149944800|NCT00435942|540932339|FG000|Overall Study|Conversion to Open Repair|1|||
149944801|NCT00435942|540932340|FG001|Overall Study|Conversion to Open Repair|0|||
149944802|NCT00435942|540932339|FG000|Overall Study|Technical Failure|3|||
149944803|NCT00435942|540932340|FG001|Overall Study|Technical Failure|0|||
149944804|NCT00435942|540932339|FG000|Overall Study|Other|0|||
149944805|NCT00435942|540932340|FG001|Overall Study|Other|1|||
149944806|NCT04727749|540932341|FG000|Overall Study|Lost to Follow-up|10|||
149944807|NCT04727749|540932342|FG001|Overall Study|Lost to Follow-up|3|||
149944808|NCT02378181|540932343|FG000|Overall Study|Lost to Follow-up|2|||
150275290|NCT02716675|542146409|FG000|Overall Study|Death|2|||
150275291|NCT02716675|542146410|FG001|Overall Study|Death|3|||
150275292|NCT02716675|542146411|FG002|Overall Study|Death|0|||
150275293|NCT02716675|542146409|FG000|Overall Study|Physician Decision|2|||
149824002|NCT01211769|540484589|FG002|Overall Study|Physician Decision|2|||
149944809|NCT02378181|540932344|FG001|Overall Study|Lost to Follow-up|5|||
150275294|NCT02716675|542146410|FG001|Overall Study|Physician Decision|1|||
149824003|NCT01211769|540484590|FG003|Overall Study|Physician Decision|1|||
149824004|NCT01211769|540484587|FG000|Overall Study|Adverse Event|0|||
149824005|NCT01211769|540484588|FG001|Overall Study|Adverse Event|1|||
149944810|NCT02378181|540932343|FG000|Overall Study|Withdrawal by Subject|1|||
149944811|NCT02378181|540932344|FG001|Overall Study|Withdrawal by Subject|1|||
149944812|NCT02378181|540932343|FG000|Overall Study|Incarcerated|0|||
149944813|NCT02378181|540932344|FG001|Overall Study|Incarcerated|1|||
149944814|NCT02320396|540932346|FG000|Overall Study|Adverse Event|2|||
149944815|NCT02320396|540932347|FG001|Overall Study|Adverse Event|2|||
149944816|NCT02320396|540932346|FG000|Overall Study|Pregnancy|0|||
149944817|NCT02320396|540932347|FG001|Overall Study|Pregnancy|1|||
149944818|NCT02320396|540932346|FG000|Overall Study|Protocol Violation|0|||
149944819|NCT02320396|540932347|FG001|Overall Study|Protocol Violation|1|||
149944820|NCT02320396|540932346|FG000|Overall Study|Withdrawal by Subject|2|||
149944821|NCT02320396|540932347|FG001|Overall Study|Withdrawal by Subject|0|||
149824006|NCT01211769|540484589|FG002|Overall Study|Adverse Event|1|||
149824007|NCT01211769|540484590|FG003|Overall Study|Adverse Event|1|||
149824008|NCT01214330|540484591|FG000|Overall Study|Withdrawal by Subject|2|||
149824009|NCT01214330|540484591|FG000|Overall Study|Withdrawal by Subject|2|||
149824010|NCT00947427|540484592|FG000|Overall Study|Withdrawal by Subject|1|||
149944822|NCT03331562|540932348|FG000|Overall Study|Adverse Event|2|||
149824011|NCT00947427|540484593|FG001|Overall Study|Withdrawal by Subject|3|||
149824012|NCT00947427|540484592|FG000|Overall Study|Protocol Violation|0|||
149824013|NCT00947427|540484593|FG001|Overall Study|Protocol Violation|1|||
149824014|NCT01533428|540484594|FG000|Overall Study|Adverse Event|0|||
149824015|NCT01533428|540484595|FG001|Overall Study|Adverse Event|1|||
149824016|NCT01533428|540484594|FG000|Overall Study|Lost to Follow-up|2|||
149824017|NCT01533428|540484595|FG001|Overall Study|Lost to Follow-up|1|||
149824018|NCT01533428|540484594|FG000|Overall Study|Withdrawal by Subject|7|||
149824019|NCT01533428|540484595|FG001|Overall Study|Withdrawal by Subject|6|||
149824020|NCT00859469|540484597|FG000|Overall Study|Adverse Event|2|||
149824021|NCT00859469|540484597|FG000|Overall Study|Lack of Efficacy|9|||
149824022|NCT00859469|540484597|FG000|Overall Study|Withdrawal by Subject|1|||
149824023|NCT00859469|540484597|FG000|Overall Study|Death|16|||
149824024|NCT03896490|540484598|FG000|Overall Study|Withdrawal by Subject|1|||
149824025|NCT03896490|540484599|FG001|Overall Study|Withdrawal by Subject|1|||
149824026|NCT03083132|540484602|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
149824027|NCT03083132|540484603|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
149824028|NCT03083132|540484602|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
149824029|NCT03083132|540484603|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
149824030|NCT03083132|540484602|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
149824031|NCT03083132|540484603|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
149824032|NCT03118739|540484604|FG000|Overall Study|Physician Decision|0|||
149824033|NCT03118739|540484605|FG001|Overall Study|Physician Decision|1|||
149824034|NCT03118739|540484604|FG000|Overall Study|Withdrawal by Subject|5|||
149824035|NCT03118739|540484605|FG001|Overall Study|Withdrawal by Subject|3|||
149824036|NCT03118739|540484604|FG000|Overall Study|Lost to Follow-up|2|||
149824037|NCT03118739|540484605|FG001|Overall Study|Lost to Follow-up|0|||
149824038|NCT00669955|540484606|FG000|Overall Study|Adverse Event|3|||
149824039|NCT00669955|540484607|FG001|Overall Study|Adverse Event|5|||
149824040|NCT00669955|540484606|FG000|Overall Study|Death|0|||
149824041|NCT00669955|540484607|FG001|Overall Study|Death|1|||
149824042|NCT00669955|540484606|FG000|Overall Study|Withdrawal by Subject|2|||
149824043|NCT00669955|540484607|FG001|Overall Study|Withdrawal by Subject|3|||
149824044|NCT00669955|540484606|FG000|Overall Study|Lost to Follow-up|5|||
149824045|NCT00669955|540484607|FG001|Overall Study|Lost to Follow-up|7|||
149824046|NCT00669955|540484606|FG000|Overall Study|Protocol Violation|2|||
149824047|NCT00669955|540484607|FG001|Overall Study|Protocol Violation|7|||
149824048|NCT00669955|540484606|FG000|Overall Study|Investigator Sponsor Judgement|0|||
149824049|NCT00669955|540484607|FG001|Overall Study|Investigator Sponsor Judgement|1|||
149824050|NCT00669955|540484606|FG000|Overall Study|not compliant with study drug/visit|2|||
149824051|NCT00669955|540484607|FG001|Overall Study|not compliant with study drug/visit|3|||
149824052|NCT01893138|540484609|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149824053|NCT01893138|540484610|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149824054|NCT01893138|540484609|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
149824055|NCT01893138|540484610|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
149824056|NCT01893138|540484609|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
149824057|NCT01893138|540484610|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
149824058|NCT01893138|540484609|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
149824059|NCT01893138|540484610|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
149824060|NCT01893138|540484609|FG000|Open Label - Unblinded Period|Adverse Event|1|||
149824061|NCT01893138|540484610|FG001|Open Label - Unblinded Period|Adverse Event|0|||
149824062|NCT01326026|540484617|FG000|Overall Study|Adverse Event|4|||
149824063|NCT01326026|540484618|FG001|Overall Study|Adverse Event|3|||
149824064|NCT01326026|540484617|FG000|Overall Study|Withdrawal Criteria|5|||
149824065|NCT01326026|540484618|FG001|Overall Study|Withdrawal Criteria|7|||
149824066|NCT01326026|540484617|FG000|Overall Study|Other|3|||
149824067|NCT01326026|540484618|FG001|Overall Study|Other|3|||
149824068|NCT04317053|540484622|FG000|Overall Study|Withdrawn (screen failure)|4|||
149824069|NCT04317053|540484623|FG001|Overall Study|Withdrawn (screen failure)|2|||
149824070|NCT04274192|540484624|FG000|Overall Study|Protocol Violation|1|||
149824071|NCT04274192|540484625|FG001|Overall Study|Protocol Violation|0|||
149824072|NCT00289458|540484626|FG000|Overall Study|Death|1|||
149824073|NCT00289458|540484627|FG001|Overall Study|Death|0|||
149824074|NCT00289458|540484628|FG002|Overall Study|Death|0|||
149824075|NCT00289458|540484626|FG000|Overall Study|Physician Decision|3|||
149824076|NCT00289458|540484627|FG001|Overall Study|Physician Decision|4|||
150275295|NCT02716675|542146411|FG002|Overall Study|Physician Decision|1|||
150275296|NCT02716675|542146409|FG000|Overall Study|Lost to Follow-up|100|||
149824077|NCT00289458|540484628|FG002|Overall Study|Physician Decision|2|||
149824078|NCT00289458|540484626|FG000|Overall Study|Withdrawal by Subject|2|||
149824079|NCT00289458|540484627|FG001|Overall Study|Withdrawal by Subject|2|||
149824080|NCT00289458|540484628|FG002|Overall Study|Withdrawal by Subject|4|||
149824081|NCT03507439|540484629|FG000|Overall Study|Other|2|||
149824082|NCT03507439|540484630|FG001|Overall Study|Other|1|||
149824083|NCT03507439|540484629|FG000|Overall Study|Withdrawal by Subject|1|||
149824084|NCT03507439|540484630|FG001|Overall Study|Withdrawal by Subject|0|||
149824085|NCT03507439|540484629|FG000|Overall Study|Death|1|||
149944823|NCT03331562|540932349|FG001|Overall Study|Adverse Event|0|||
149944824|NCT03331562|540932348|FG000|Overall Study|Death|1|||
149944825|NCT03331562|540932349|FG001|Overall Study|Death|0|||
149944826|NCT03718000|540932350|FG000|Overall Study|Relocation|2|||
149944827|NCT03718000|540932351|FG001|Overall Study|Relocation|4|||
149944828|NCT03718000|540932350|FG000|Overall Study|Pregnancy|0|||
149944829|NCT03718000|540932351|FG001|Overall Study|Pregnancy|1|||
149944830|NCT02475213|540932354|FG000|Overall Study|Adverse Event|2|||
149944831|NCT02475213|540932355|FG001|Overall Study|Adverse Event|0|||
149944832|NCT02475213|540932356|FG002|Overall Study|Adverse Event|0|||
149944833|NCT02475213|540932357|FG003|Overall Study|Adverse Event|1|||
149944834|NCT02475213|540932358|FG004|Overall Study|Adverse Event|1|||
149944835|NCT02475213|540932359|FG005|Overall Study|Adverse Event|4|||
149944836|NCT02475213|540932360|FG006|Overall Study|Adverse Event|6|||
149944837|NCT02475213|540932361|FG007|Overall Study|Adverse Event|2|||
149944838|NCT02475213|540932354|FG000|Overall Study|Physician Decision|1|||
149944839|NCT02475213|540932355|FG001|Overall Study|Physician Decision|1|||
149944840|NCT02475213|540932356|FG002|Overall Study|Physician Decision|1|||
149944841|NCT02475213|540932357|FG003|Overall Study|Physician Decision|0|||
149944842|NCT02475213|540932358|FG004|Overall Study|Physician Decision|0|||
149944843|NCT02475213|540932359|FG005|Overall Study|Physician Decision|1|||
149944844|NCT02475213|540932360|FG006|Overall Study|Physician Decision|4|||
149944845|NCT02475213|540932361|FG007|Overall Study|Physician Decision|0|||
149944846|NCT02475213|540932354|FG000|Overall Study|Progressive Disease|3|||
149944847|NCT02475213|540932355|FG001|Overall Study|Progressive Disease|2|||
149944848|NCT02475213|540932356|FG002|Overall Study|Progressive Disease|2|||
149944849|NCT02475213|540932357|FG003|Overall Study|Progressive Disease|13|||
149944850|NCT02475213|540932358|FG004|Overall Study|Progressive Disease|15|||
149944851|NCT02475213|540932359|FG005|Overall Study|Progressive Disease|25|||
149944852|NCT02475213|540932360|FG006|Overall Study|Progressive Disease|30|||
149944853|NCT02475213|540932361|FG007|Overall Study|Progressive Disease|10|||
149944854|NCT02475213|540932354|FG000|Overall Study|Death|0|||
149944855|NCT02475213|540932355|FG001|Overall Study|Death|0|||
149944856|NCT02475213|540932356|FG002|Overall Study|Death|0|||
149944857|NCT02475213|540932357|FG003|Overall Study|Death|0|||
149944858|NCT02475213|540932358|FG004|Overall Study|Death|0|||
149944859|NCT02475213|540932359|FG005|Overall Study|Death|4|||
149944860|NCT02475213|540932360|FG006|Overall Study|Death|1|||
149944861|NCT02475213|540932361|FG007|Overall Study|Death|0|||
149944862|NCT02475213|540932354|FG000|Overall Study|Protocol Violation|0|||
149944863|NCT02475213|540932355|FG001|Overall Study|Protocol Violation|0|||
149944864|NCT02475213|540932356|FG002|Overall Study|Protocol Violation|0|||
149944865|NCT02475213|540932357|FG003|Overall Study|Protocol Violation|0|||
149944866|NCT02475213|540932358|FG004|Overall Study|Protocol Violation|1|||
149944867|NCT02475213|540932359|FG005|Overall Study|Protocol Violation|0|||
149944868|NCT02475213|540932360|FG006|Overall Study|Protocol Violation|0|||
149944869|NCT02475213|540932361|FG007|Overall Study|Protocol Violation|0|||
149944870|NCT02475213|540932354|FG000|Overall Study|Withdrawal by Subject|0|||
149944871|NCT02475213|540932355|FG001|Overall Study|Withdrawal by Subject|0|||
149944872|NCT02475213|540932356|FG002|Overall Study|Withdrawal by Subject|0|||
149944873|NCT02475213|540932357|FG003|Overall Study|Withdrawal by Subject|1|||
149944874|NCT02475213|540932358|FG004|Overall Study|Withdrawal by Subject|0|||
149944875|NCT02475213|540932359|FG005|Overall Study|Withdrawal by Subject|2|||
149944876|NCT02475213|540932360|FG006|Overall Study|Withdrawal by Subject|2|||
149944877|NCT02475213|540932361|FG007|Overall Study|Withdrawal by Subject|0|||
149944878|NCT02475213|540932354|FG000|Overall Study|Other|0|||
149824086|NCT03507439|540484630|FG001|Overall Study|Death|1|||
149824087|NCT00874757|540484631|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
149824088|NCT00313703|540486349|FG000|Overall Study|Lost to Follow-up|11|||
149824089|NCT00313703|540486350|FG001|Overall Study|Lost to Follow-up|2|||
149944879|NCT02475213|540932355|FG001|Overall Study|Other|0|||
149944880|NCT02475213|540932356|FG002|Overall Study|Other|0|||
149944881|NCT02475213|540932357|FG003|Overall Study|Other|1|||
149944882|NCT02475213|540932358|FG004|Overall Study|Other|3|||
149944883|NCT02475213|540932359|FG005|Overall Study|Other|1|||
149944884|NCT02475213|540932360|FG006|Overall Study|Other|0|||
149944885|NCT02475213|540932361|FG007|Overall Study|Other|0|||
149944886|NCT01186770|540932362|FG000|Overall Study|Ineligibility|0|||
149944887|NCT01186770|540932363|FG001|Overall Study|Ineligibility|0|||
149944888|NCT01186770|540932364|FG002|Overall Study|Ineligibility|2|||
149944889|NCT01186770|540932365|FG003|Overall Study|Ineligibility|0|||
149944890|NCT01186770|540932362|FG000|Overall Study|Protocol Violation|7|||
149944891|NCT01186770|540932363|FG001|Overall Study|Protocol Violation|9|||
150033194|NCT01247324|541260916|FG000|Overall Study|Lack of Efficacy|24|||
149944892|NCT01186770|540932364|FG002|Overall Study|Protocol Violation|12|||
149944893|NCT01186770|540932365|FG003|Overall Study|Protocol Violation|14|||
149944894|NCT01186770|540932362|FG000|Overall Study|Adverse Event|2|||
149944895|NCT01186770|540932363|FG001|Overall Study|Adverse Event|9|||
149944896|NCT01186770|540932364|FG002|Overall Study|Adverse Event|7|||
149944897|NCT01186770|540932365|FG003|Overall Study|Adverse Event|9|||
149944898|NCT01186770|540932362|FG000|Overall Study|Withdrawal by Subject|15|||
149944899|NCT01186770|540932363|FG001|Overall Study|Withdrawal by Subject|13|||
149824090|NCT00313703|540486351|FG002|Overall Study|Lost to Follow-up|5|||
149824091|NCT00313703|540486352|FG003|Overall Study|Lost to Follow-up|12|||
149824092|NCT02180061|540486353|FG000|Overall Study|Adverse Event|4|||
149824093|NCT02180061|540486354|FG001|Overall Study|Adverse Event|2|||
149824094|NCT02180061|540486353|FG000|Overall Study|Clinical Progression|5|||
149824095|NCT02180061|540486354|FG001|Overall Study|Clinical Progression|1|||
149824096|NCT02180061|540486353|FG000|Overall Study|Progressive Disease|15|||
149824097|NCT02180061|540486354|FG001|Overall Study|Progressive Disease|5|||
149824098|NCT02180061|540486353|FG000|Overall Study|Physician Decision|1|||
149824099|NCT02180061|540486354|FG001|Overall Study|Physician Decision|0|||
149824100|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
149824101|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
149824102|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
149824103|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
149824104|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
149824105|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
149824106|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
149824107|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
149824108|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
149824109|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
149824110|NCT00056160|540486357|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
149824111|NCT00056160|540486358|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
149824112|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
149824113|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
149824114|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
149824115|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
149824116|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
149824117|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
149824118|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
149824119|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
149824120|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
149824121|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
149824122|NCT00056160|540486357|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
149824123|NCT00056160|540486358|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
149824124|NCT00056160|540486357|FG000|Final Follow-up|Transferred into expanded access study.|3|||
149824125|NCT00056160|540486358|FG001|Final Follow-up|Transferred into expanded access study.|0|||
149824126|NCT00056160|540486357|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
149824127|NCT00056160|540486358|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
149824128|NCT00056160|540486357|FG000|Final Follow-up|Adverse Event|1|||
149824129|NCT00056160|540486358|FG001|Final Follow-up|Adverse Event|0|||
149824130|NCT01469364|540486360|FG000|Overall Study|Adverse Event|1|||
149824131|NCT01469364|540486360|FG000|Overall Study|Withdrawal by Subject|1|||
149824132|NCT02742090|540486361|FG000|Overall Study|Adverse Event|10|||
149824133|NCT02742090|540486361|FG000|Overall Study|Death|3|||
149824134|NCT02742090|540486361|FG000|Overall Study|Disease Progression|25|||
149824135|NCT02742090|540486361|FG000|Overall Study|Investigator's Decision|1|||
149824136|NCT02742090|540486361|FG000|Overall Study|Lost to Follow-up|1|||
149824137|NCT02742090|540486361|FG000|Overall Study|Non-compliance with Study|1|||
149824138|NCT02742090|540486361|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
149824139|NCT02742090|540486361|FG000|Overall Study|Withdrawal by Subject|4|||
149824140|NCT02742090|540486361|FG000|Overall Study|Reason Not Specified|1|||
149824141|NCT01590433|540486362|FG000|Overall Study|Lost to Follow-up|20|||
149824142|NCT01590433|540486363|FG001|Overall Study|Lost to Follow-up|8|||
149824143|NCT01590433|540486362|FG000|Overall Study|Withdrawal by Subject|21|||
149824144|NCT01590433|540486363|FG001|Overall Study|Withdrawal by Subject|11|||
149824145|NCT01590433|540486362|FG000|Overall Study|Adverse Event|11|||
149824146|NCT01590433|540486363|FG001|Overall Study|Adverse Event|3|||
149824147|NCT00555009|540486364|FG000|Overall Study|Withdrawal by Subject|0|||
149824148|NCT00555009|540486365|FG001|Overall Study|Withdrawal by Subject|1|||
149824149|NCT00555009|540486364|FG000|Overall Study|Terminated by Sponsor|2|||
149824150|NCT00555009|540486365|FG001|Overall Study|Terminated by Sponsor|5|||
149824151|NCT01767597|540486366|FG000|Overall Study|Incomplete intervention|3|||
149824152|NCT01767597|540486367|FG001|Overall Study|Incomplete intervention|1|||
149824153|NCT01767597|540486366|FG000|Overall Study|Withdrawal by Subject|1|||
149824154|NCT01767597|540486367|FG001|Overall Study|Withdrawal by Subject|0|||
149824155|NCT03355742|540486368|FG000|Overall Study|Lost to Follow-up|4|||
149824156|NCT03355742|540486368|FG000|Overall Study|Withdrawal by Subject|29|||
149824157|NCT03355742|540486368|FG000|Overall Study|Physician Decision|6|||
149824158|NCT03355742|540486368|FG000|Overall Study|Death|55|||
149824159|NCT03355742|540486368|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
149824160|NCT00836927|540486369|FG000|Overall Study|Progressive disease|2|||
149824161|NCT00836927|540486370|FG001|Overall Study|Progressive disease|0|||
149824162|NCT00836927|540486371|FG002|Overall Study|Progressive disease|0|||
149824163|NCT00836927|540486372|FG003|Overall Study|Progressive disease|1|||
149824164|NCT00836927|540486373|FG004|Overall Study|Progressive disease|1|||
149824165|NCT00836927|540486369|FG000|Overall Study|Withdrawal by Subject|1|||
149824166|NCT00836927|540486370|FG001|Overall Study|Withdrawal by Subject|0|||
149824167|NCT00836927|540486371|FG002|Overall Study|Withdrawal by Subject|0|||
149824168|NCT00836927|540486372|FG003|Overall Study|Withdrawal by Subject|0|||
149824169|NCT00836927|540486373|FG004|Overall Study|Withdrawal by Subject|0|||
149824170|NCT00614055|540486379|FG000|Overall Study|Adverse Event|1|||
149824171|NCT00614055|540486380|FG001|Overall Study|Adverse Event|0|||
149824172|NCT00614055|540486381|FG002|Overall Study|Adverse Event|0|||
149824173|NCT00614055|540486379|FG000|Overall Study|Protocol Violation|2|||
149824174|NCT00614055|540486380|FG001|Overall Study|Protocol Violation|2|||
149824175|NCT00614055|540486381|FG002|Overall Study|Protocol Violation|1|||
149824176|NCT00614055|540486379|FG000|Overall Study|Lack of Efficacy|0|||
149824177|NCT00614055|540486380|FG001|Overall Study|Lack of Efficacy|0|||
149824178|NCT00614055|540486381|FG002|Overall Study|Lack of Efficacy|2|||
149824179|NCT00614055|540486379|FG000|Overall Study|Unclassified|1|||
149824180|NCT00614055|540486380|FG001|Overall Study|Unclassified|4|||
149824181|NCT00614055|540486381|FG002|Overall Study|Unclassified|2|||
149824182|NCT04820842|540486384|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
149824183|NCT04820842|540486385|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
149824184|NCT04820842|540486386|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
149824185|NCT04820842|540486387|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
149824186|NCT04820842|540486388|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
149824187|NCT04820842|540486389|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
149824188|NCT04820842|540486390|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
149824189|NCT04820842|540486384|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
149824190|NCT04820842|540486385|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
149824191|NCT04820842|540486386|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
149824192|NCT04820842|540486387|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824193|NCT04820842|540486388|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824194|NCT04820842|540486389|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824195|NCT04820842|540486390|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824196|NCT04820842|540486384|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824197|NCT04820842|540486385|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
149824198|NCT04820842|540486386|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824199|NCT04820842|540486387|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824200|NCT04820842|540486388|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824201|NCT04820842|540486389|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824202|NCT04820842|540486390|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149824203|NCT04820842|540486384|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824204|NCT04820842|540486385|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824205|NCT04820842|540486386|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824206|NCT04820842|540486387|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
149824207|NCT04820842|540486388|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824208|NCT04820842|540486389|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
149824209|NCT04820842|540486390|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
149824210|NCT01296932|540486391|FG000|Overall Study|Dose limiting toxicity|0|||
149824211|NCT01296932|540486392|FG001|Overall Study|Dose limiting toxicity|0|||
149824212|NCT01296932|540486393|FG002|Overall Study|Dose limiting toxicity|0|||
149824213|NCT01296932|540486394|FG003|Overall Study|Dose limiting toxicity|0|||
149824214|NCT01296932|540486395|FG004|Overall Study|Dose limiting toxicity|0|||
149824215|NCT01296932|540486396|FG005|Overall Study|Dose limiting toxicity|0|||
149824216|NCT01296932|540486397|FG006|Overall Study|Dose limiting toxicity|1|||
149824217|NCT01296932|540486398|FG007|Overall Study|Dose limiting toxicity|0|||
149824218|NCT01296932|540486399|FG008|Overall Study|Dose limiting toxicity|1|||
149824219|NCT01296932|540486391|FG000|Overall Study|Progressive disease|2|||
149824220|NCT01296932|540486392|FG001|Overall Study|Progressive disease|0|||
149824221|NCT01296932|540486393|FG002|Overall Study|Progressive disease|1|||
149824222|NCT01296932|540486394|FG003|Overall Study|Progressive disease|1|||
149824223|NCT01296932|540486395|FG004|Overall Study|Progressive disease|2|||
149944900|NCT01186770|540932364|FG002|Overall Study|Withdrawal by Subject|11|||
149944901|NCT01186770|540932365|FG003|Overall Study|Withdrawal by Subject|17|||
149824224|NCT01296932|540486396|FG005|Overall Study|Progressive disease|3|||
149824225|NCT01296932|540486397|FG006|Overall Study|Progressive disease|1|||
149824226|NCT01296932|540486398|FG007|Overall Study|Progressive disease|0|||
149824227|NCT01296932|540486399|FG008|Overall Study|Progressive disease|0|||
149824228|NCT01296932|540486391|FG000|Overall Study|Withdrawal by Subject|0|||
149824229|NCT01296932|540486392|FG001|Overall Study|Withdrawal by Subject|0|||
149824230|NCT01296932|540486393|FG002|Overall Study|Withdrawal by Subject|1|||
149824231|NCT01296932|540486394|FG003|Overall Study|Withdrawal by Subject|1|||
149824232|NCT01296932|540486395|FG004|Overall Study|Withdrawal by Subject|0|||
149824233|NCT01296932|540486396|FG005|Overall Study|Withdrawal by Subject|0|||
149824234|NCT01296932|540486397|FG006|Overall Study|Withdrawal by Subject|3|||
149824235|NCT01296932|540486398|FG007|Overall Study|Withdrawal by Subject|0|||
149824236|NCT01296932|540486399|FG008|Overall Study|Withdrawal by Subject|0|||
149824237|NCT01296932|540486391|FG000|Overall Study|Adverse Event|1|||
149824238|NCT01296932|540486392|FG001|Overall Study|Adverse Event|1|||
149824239|NCT01296932|540486393|FG002|Overall Study|Adverse Event|1|||
149824240|NCT01296932|540486394|FG003|Overall Study|Adverse Event|2|||
149824241|NCT01296932|540486395|FG004|Overall Study|Adverse Event|1|||
149824242|NCT01296932|540486396|FG005|Overall Study|Adverse Event|0|||
149824243|NCT01296932|540486397|FG006|Overall Study|Adverse Event|0|||
149824244|NCT01296932|540486398|FG007|Overall Study|Adverse Event|0|||
149824245|NCT01296932|540486399|FG008|Overall Study|Adverse Event|1|||
149824246|NCT01296932|540486391|FG000|Overall Study|Investigator decision|0|||
149824247|NCT01296932|540486392|FG001|Overall Study|Investigator decision|1|||
149824248|NCT01296932|540486393|FG002|Overall Study|Investigator decision|0|||
149824249|NCT01296932|540486394|FG003|Overall Study|Investigator decision|1|||
149824250|NCT01296932|540486395|FG004|Overall Study|Investigator decision|0|||
149824251|NCT01296932|540486396|FG005|Overall Study|Investigator decision|0|||
149824252|NCT01296932|540486397|FG006|Overall Study|Investigator decision|1|||
149824253|NCT01296932|540486398|FG007|Overall Study|Investigator decision|0|||
149824254|NCT01296932|540486399|FG008|Overall Study|Investigator decision|1|||
149824255|NCT01296932|540486391|FG000|Overall Study|No clinical benefit anymore|0|||
149824256|NCT01296932|540486392|FG001|Overall Study|No clinical benefit anymore|1|||
149824257|NCT01296932|540486393|FG002|Overall Study|No clinical benefit anymore|0|||
149824258|NCT01296932|540486394|FG003|Overall Study|No clinical benefit anymore|0|||
149824259|NCT01296932|540486395|FG004|Overall Study|No clinical benefit anymore|0|||
149824260|NCT01296932|540486396|FG005|Overall Study|No clinical benefit anymore|0|||
149824261|NCT01296932|540486397|FG006|Overall Study|No clinical benefit anymore|0|||
149824262|NCT01296932|540486398|FG007|Overall Study|No clinical benefit anymore|0|||
149824263|NCT01296932|540486399|FG008|Overall Study|No clinical benefit anymore|0|||
149824264|NCT01296932|540486391|FG000|Overall Study|Physician Decision|0|||
149824265|NCT01296932|540486392|FG001|Overall Study|Physician Decision|0|||
149824266|NCT01296932|540486393|FG002|Overall Study|Physician Decision|1|||
149824267|NCT01296932|540486394|FG003|Overall Study|Physician Decision|0|||
149824268|NCT01296932|540486395|FG004|Overall Study|Physician Decision|0|||
149824269|NCT01296932|540486396|FG005|Overall Study|Physician Decision|0|||
149824270|NCT01296932|540486397|FG006|Overall Study|Physician Decision|0|||
149824271|NCT01296932|540486398|FG007|Overall Study|Physician Decision|0|||
149824272|NCT01296932|540486399|FG008|Overall Study|Physician Decision|0|||
149824273|NCT01296932|540486391|FG000|Overall Study|IV problems, administration not possible|0|||
149824274|NCT01296932|540486392|FG001|Overall Study|IV problems, administration not possible|0|||
149824275|NCT01296932|540486393|FG002|Overall Study|IV problems, administration not possible|1|||
149824276|NCT01296932|540486394|FG003|Overall Study|IV problems, administration not possible|0|||
149824277|NCT01296932|540486395|FG004|Overall Study|IV problems, administration not possible|0|||
149824278|NCT01296932|540486396|FG005|Overall Study|IV problems, administration not possible|0|||
149824279|NCT01296932|540486397|FG006|Overall Study|IV problems, administration not possible|0|||
149824280|NCT01296932|540486398|FG007|Overall Study|IV problems, administration not possible|0|||
149824281|NCT01296932|540486399|FG008|Overall Study|IV problems, administration not possible|0|||
149824282|NCT01296932|540486391|FG000|Overall Study|per protocol|0|||
149824283|NCT01296932|540486392|FG001|Overall Study|per protocol|0|||
149824284|NCT01296932|540486393|FG002|Overall Study|per protocol|1|||
149824285|NCT01296932|540486394|FG003|Overall Study|per protocol|1|||
149824286|NCT01296932|540486395|FG004|Overall Study|per protocol|0|||
149824287|NCT01296932|540486396|FG005|Overall Study|per protocol|0|||
149824288|NCT01296932|540486397|FG006|Overall Study|per protocol|0|||
149824289|NCT01296932|540486398|FG007|Overall Study|per protocol|0|||
149824290|NCT01296932|540486399|FG008|Overall Study|per protocol|0|||
149944902|NCT01186770|540932362|FG000|Overall Study|Lost to Follow-up|10|||
149944903|NCT01186770|540932363|FG001|Overall Study|Lost to Follow-up|6|||
149824291|NCT01296932|540486391|FG000|Overall Study|Low benefit and too many side effects|0|||
149824292|NCT01296932|540486392|FG001|Overall Study|Low benefit and too many side effects|0|||
149824293|NCT01296932|540486393|FG002|Overall Study|Low benefit and too many side effects|0|||
149824294|NCT01296932|540486394|FG003|Overall Study|Low benefit and too many side effects|0|||
149824295|NCT01296932|540486395|FG004|Overall Study|Low benefit and too many side effects|0|||
149824296|NCT01296932|540486396|FG005|Overall Study|Low benefit and too many side effects|0|||
149824297|NCT01296932|540486397|FG006|Overall Study|Low benefit and too many side effects|0|||
149824298|NCT01296932|540486398|FG007|Overall Study|Low benefit and too many side effects|1|||
149824299|NCT01296932|540486399|FG008|Overall Study|Low benefit and too many side effects|0|||
149824300|NCT01296932|540486391|FG000|Overall Study|No adequate treatment response|0|||
149824301|NCT01296932|540486392|FG001|Overall Study|No adequate treatment response|0|||
149824302|NCT01296932|540486393|FG002|Overall Study|No adequate treatment response|0|||
149824303|NCT01296932|540486394|FG003|Overall Study|No adequate treatment response|0|||
149824304|NCT01296932|540486395|FG004|Overall Study|No adequate treatment response|0|||
149824305|NCT01296932|540486396|FG005|Overall Study|No adequate treatment response|0|||
149824306|NCT01296932|540486397|FG006|Overall Study|No adequate treatment response|0|||
149824307|NCT01296932|540486398|FG007|Overall Study|No adequate treatment response|1|||
149824308|NCT01296932|540486399|FG008|Overall Study|No adequate treatment response|0|||
149824309|NCT01296932|540486391|FG000|Overall Study|Dosage already reduced, AE still present|0|||
149824310|NCT01296932|540486392|FG001|Overall Study|Dosage already reduced, AE still present|0|||
149824311|NCT01296932|540486393|FG002|Overall Study|Dosage already reduced, AE still present|0|||
149824312|NCT01296932|540486394|FG003|Overall Study|Dosage already reduced, AE still present|0|||
149824313|NCT01296932|540486395|FG004|Overall Study|Dosage already reduced, AE still present|0|||
149824314|NCT01296932|540486396|FG005|Overall Study|Dosage already reduced, AE still present|0|||
149824315|NCT01296932|540486397|FG006|Overall Study|Dosage already reduced, AE still present|0|||
149824316|NCT01296932|540486398|FG007|Overall Study|Dosage already reduced, AE still present|0|||
149824317|NCT01296932|540486399|FG008|Overall Study|Dosage already reduced, AE still present|1|||
149824318|NCT02637557|540486404|FG000|Overall Study|Adverse Event|3|||
149824319|NCT02637557|540486405|FG001|Overall Study|Adverse Event|1|||
149824320|NCT02637557|540486406|FG002|Overall Study|Adverse Event|3|||
149824321|NCT02637557|540486407|FG003|Overall Study|Adverse Event|3|||
149824322|NCT02637557|540486404|FG000|Overall Study|Lost to Follow-up|1|||
149824323|NCT02637557|540486405|FG001|Overall Study|Lost to Follow-up|1|||
149824324|NCT02637557|540486406|FG002|Overall Study|Lost to Follow-up|0|||
149824325|NCT02637557|540486407|FG003|Overall Study|Lost to Follow-up|1|||
149824326|NCT02637557|540486404|FG000|Overall Study|Physician Decision|1|||
149824327|NCT02637557|540486405|FG001|Overall Study|Physician Decision|0|||
149824328|NCT02637557|540486406|FG002|Overall Study|Physician Decision|0|||
149824329|NCT02637557|540486407|FG003|Overall Study|Physician Decision|0|||
149824330|NCT02637557|540486404|FG000|Overall Study|Protocol Violation|2|||
149824331|NCT02637557|540486405|FG001|Overall Study|Protocol Violation|0|||
149824332|NCT02637557|540486406|FG002|Overall Study|Protocol Violation|2|||
149824333|NCT02637557|540486407|FG003|Overall Study|Protocol Violation|1|||
149824334|NCT02637557|540486404|FG000|Overall Study|Withdrawal by Subject|1|||
149824335|NCT02637557|540486405|FG001|Overall Study|Withdrawal by Subject|3|||
149824336|NCT02637557|540486406|FG002|Overall Study|Withdrawal by Subject|4|||
149824337|NCT02637557|540486407|FG003|Overall Study|Withdrawal by Subject|2|||
149824338|NCT02207621|540486410|FG000|Overall Study|Adverse Event|71|||
149824339|NCT02207621|540486411|FG001|Overall Study|Adverse Event|15|||
149824340|NCT02207621|540486412|FG002|Overall Study|Adverse Event|132|||
149824341|NCT02207621|540486410|FG000|Overall Study|Withdrawal by Subject|9|||
149824342|NCT02207621|540486411|FG001|Overall Study|Withdrawal by Subject|9|||
149824343|NCT02207621|540486412|FG002|Overall Study|Withdrawal by Subject|13|||
149824344|NCT02207621|540486410|FG000|Overall Study|Non-Compliant|3|||
149824345|NCT02207621|540486411|FG001|Overall Study|Non-Compliant|3|||
149824346|NCT02207621|540486412|FG002|Overall Study|Non-Compliant|1|||
149824347|NCT02207621|540486410|FG000|Overall Study|Lost to Follow-up|1|||
149824348|NCT02207621|540486411|FG001|Overall Study|Lost to Follow-up|0|||
149824349|NCT02207621|540486412|FG002|Overall Study|Lost to Follow-up|3|||
149824350|NCT02207621|540486410|FG000|Overall Study|Lack of Efficacy|10|||
149824351|NCT02207621|540486411|FG001|Overall Study|Lack of Efficacy|2|||
149824352|NCT02207621|540486412|FG002|Overall Study|Lack of Efficacy|4|||
149824353|NCT02207621|540486410|FG000|Overall Study|Disallowed Concurrent Medication|2|||
149824354|NCT02207621|540486411|FG001|Overall Study|Disallowed Concurrent Medication|5|||
149824355|NCT02207621|540486412|FG002|Overall Study|Disallowed Concurrent Medication|2|||
149824356|NCT02207621|540486410|FG000|Overall Study|Physician Decision|1|||
149824357|NCT02207621|540486411|FG001|Overall Study|Physician Decision|2|||
149824358|NCT02207621|540486412|FG002|Overall Study|Physician Decision|2|||
149824359|NCT02207621|540486410|FG000|Overall Study|Protocol Violation|4|||
149824360|NCT02207621|540486411|FG001|Overall Study|Protocol Violation|10|||
149824361|NCT02207621|540486412|FG002|Overall Study|Protocol Violation|6|||
149824362|NCT02207621|540486410|FG000|Overall Study|Death|2|||
150033195|NCT01247324|541260917|FG001|Overall Study|Lack of Efficacy|14|||
149824363|NCT02207621|540486411|FG001|Overall Study|Death|0|||
149824364|NCT02207621|540486412|FG002|Overall Study|Death|0|||
149824365|NCT02207621|540486410|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
149824366|NCT02207621|540486411|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
149824367|NCT02207621|540486412|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
149824368|NCT00958256|540486413|FG000|Overall Study|Adverse Event|3|||
149824369|NCT03036579|540486417|FG000|2 Years|Lost to Follow-up|1|||
150170384|NCT01235949|541759074|FG013|Primary Phase|Lost to Follow-up|0|||
149824370|NCT03036579|540486418|FG001|2 Years|Lost to Follow-up|0|||
149824371|NCT03036579|540486417|FG000|3 Years|Lost to Follow-up|0|||
149824372|NCT03036579|540486418|FG001|3 Years|Lost to Follow-up|1|||
149824373|NCT02848599|540486419|FG000|Overall Study|Protocol Violation|7|||
149824374|NCT02848599|540486420|FG001|Overall Study|Protocol Violation|9|||
149824375|NCT00634907|540486422|FG000|Overall Study|Withdrawal by Subject|3|||
149824376|NCT00634907|540486423|FG001|Overall Study|Withdrawal by Subject|0|||
149824377|NCT00634907|540486422|FG000|Overall Study|Physician Decision|3|||
149824378|NCT00634907|540486423|FG001|Overall Study|Physician Decision|9|||
149824379|NCT00634907|540486422|FG000|Overall Study|Withdrawal by Subject|11|||
149824380|NCT00634907|540486423|FG001|Overall Study|Withdrawal by Subject|8|||
149824381|NCT04041570|540486424|FG000|Overall Study|Moved from Area|0|||
149824382|NCT04041570|540486425|FG001|Overall Study|Moved from Area|2|||
149824383|NCT01338636|540486426|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
149824384|NCT02385526|540486427|FG000|Overall Study|Withdrawal by Subject|0|||
149824385|NCT02385526|540486428|FG001|Overall Study|Withdrawal by Subject|2|||
149824386|NCT02385526|540486429|FG002|Overall Study|Withdrawal by Subject|0|||
149824387|NCT02385526|540486427|FG000|Overall Study|Lost to Follow-up|0|||
149824388|NCT02385526|540486428|FG001|Overall Study|Lost to Follow-up|1|||
149824389|NCT02385526|540486429|FG002|Overall Study|Lost to Follow-up|0|||
149824390|NCT02385526|540486427|FG000|Overall Study|Physician Decision|1|||
149824391|NCT02385526|540486428|FG001|Overall Study|Physician Decision|0|||
149824392|NCT02385526|540486429|FG002|Overall Study|Physician Decision|0|||
149824393|NCT02385526|540486427|FG000|Overall Study|Protocol Violation|1|||
149824394|NCT02385526|540486428|FG001|Overall Study|Protocol Violation|0|||
149824395|NCT02385526|540486429|FG002|Overall Study|Protocol Violation|0|||
149824396|NCT03532009|540486432|FG000|Overall Study|Other|1|||
149824397|NCT03532009|540486433|FG001|Overall Study|Other|1|||
149824398|NCT03532009|540486432|FG000|Overall Study|Death|1|||
149824399|NCT03532009|540486433|FG001|Overall Study|Death|1|||
149824400|NCT03532009|540486432|FG000|Overall Study|Withdrawal by Patient|0|||
149824401|NCT03532009|540486433|FG001|Overall Study|Withdrawal by Patient|2|||
149824402|NCT02866175|540486438|FG000|Overall Study|Adverse Event|56|||
149824403|NCT02866175|540486439|FG001|Overall Study|Adverse Event|54|||
149824404|NCT02866175|540486438|FG000|Overall Study|Withdrawal by Subject|31|||
149824405|NCT02866175|540486439|FG001|Overall Study|Withdrawal by Subject|52|||
149824406|NCT02866175|540486438|FG000|Overall Study|Death|30|||
149824407|NCT02866175|540486439|FG001|Overall Study|Death|23|||
149824408|NCT02866175|540486438|FG000|Overall Study|Other|7|||
149824409|NCT02866175|540486439|FG001|Overall Study|Other|14|||
149824410|NCT02866175|540486438|FG000|Overall Study|Progressive disease|1|||
149824411|NCT02866175|540486439|FG001|Overall Study|Progressive disease|1|||
149824412|NCT02866175|540486438|FG000|Overall Study|Lost to Follow-up|2|||
149824413|NCT02866175|540486439|FG001|Overall Study|Lost to Follow-up|0|||
149824414|NCT02866175|540486438|FG000|Overall Study|Lack of Efficacy|0|||
149824415|NCT02866175|540486439|FG001|Overall Study|Lack of Efficacy|1|||
149824416|NCT02866175|540486438|FG000|Overall Study|Physician Decision|3|||
149824417|NCT02866175|540486439|FG001|Overall Study|Physician Decision|15|||
149824418|NCT02866175|540486438|FG000|Overall Study|Did not receive treatment|5|||
149824419|NCT02866175|540486439|FG001|Overall Study|Did not receive treatment|15|||
149824420|NCT01694485|540486440|FG000|Overall Study|Withdrawal by Subject|20|||
149824421|NCT01694485|540486441|FG001|Overall Study|Withdrawal by Subject|6|||
149824422|NCT01694485|540486442|FG002|Overall Study|Withdrawal by Subject|7|||
149824423|NCT01694485|540486443|FG003|Overall Study|Withdrawal by Subject|25|||
149824424|NCT01694485|540486444|FG004|Overall Study|Withdrawal by Subject|18|||
149824425|NCT01694485|540486440|FG000|Overall Study|Sponsor Decision|3|||
149824426|NCT01694485|540486441|FG001|Overall Study|Sponsor Decision|0|||
149824427|NCT01694485|540486442|FG002|Overall Study|Sponsor Decision|0|||
149824428|NCT01694485|540486443|FG003|Overall Study|Sponsor Decision|2|||
149824429|NCT01694485|540486444|FG004|Overall Study|Sponsor Decision|0|||
149824430|NCT01694485|540486440|FG000|Overall Study|Lost to Follow-up|9|||
149824431|NCT01694485|540486441|FG001|Overall Study|Lost to Follow-up|1|||
149824432|NCT01694485|540486442|FG002|Overall Study|Lost to Follow-up|6|||
149824433|NCT01694485|540486443|FG003|Overall Study|Lost to Follow-up|10|||
149824434|NCT01694485|540486444|FG004|Overall Study|Lost to Follow-up|7|||
149824435|NCT01694485|540486440|FG000|Overall Study|Death|1|||
149824436|NCT01694485|540486441|FG001|Overall Study|Death|0|||
149824437|NCT01694485|540486442|FG002|Overall Study|Death|0|||
149824438|NCT01694485|540486443|FG003|Overall Study|Death|1|||
149824439|NCT01694485|540486444|FG004|Overall Study|Death|0|||
149824440|NCT02907203|540486445|FG000|Overall Study|Death|1|||
149824441|NCT02907203|540486445|FG000|Overall Study|Lost to Follow-up|3|||
149824442|NCT02907203|540486445|FG000|Overall Study|Withdrawal by Subject|3|||
149824443|NCT02907203|540486445|FG000|Overall Study|Surgical bypass|1|||
149824444|NCT00681863|540486447|FG000|Overall Study|Adverse Event|1|||
149824445|NCT00681863|540486447|FG000|Overall Study|Lost to Follow-up|2|||
149824446|NCT00681863|540486447|FG000|Overall Study|Lack of Efficacy|2|||
149824447|NCT00681863|540486447|FG000|Overall Study|Other|18|||
149824448|NCT00384033|540486457|FG000|Overall Study|Adverse Event|10|||
149824449|NCT00384033|540486458|FG001|Overall Study|Adverse Event|8|||
149824450|NCT00384033|540486459|FG002|Overall Study|Adverse Event|11|||
149824451|NCT00384033|540486460|FG003|Overall Study|Adverse Event|20|||
149824452|NCT00384033|540486457|FG000|Overall Study|Failed to return|1|||
149824453|NCT00384033|540486458|FG001|Overall Study|Failed to return|3|||
149824454|NCT00384033|540486459|FG002|Overall Study|Failed to return|2|||
149824455|NCT00384033|540486460|FG003|Overall Study|Failed to return|2|||
149824456|NCT00384033|540486457|FG000|Overall Study|Physician Decision|1|||
149824457|NCT00384033|540486458|FG001|Overall Study|Physician Decision|0|||
149824458|NCT00384033|540486459|FG002|Overall Study|Physician Decision|0|||
149824459|NCT00384033|540486460|FG003|Overall Study|Physician Decision|0|||
149824460|NCT00384033|540486457|FG000|Overall Study|Lost to Follow-up|6|||
149824461|NCT00384033|540486458|FG001|Overall Study|Lost to Follow-up|12|||
149824462|NCT00384033|540486459|FG002|Overall Study|Lost to Follow-up|7|||
149824463|NCT00384033|540486460|FG003|Overall Study|Lost to Follow-up|7|||
149824464|NCT00384033|540486457|FG000|Overall Study|Other|2|||
149824465|NCT00384033|540486458|FG001|Overall Study|Other|0|||
149824466|NCT00384033|540486459|FG002|Overall Study|Other|0|||
149824467|NCT00384033|540486460|FG003|Overall Study|Other|0|||
149824468|NCT00384033|540486457|FG000|Overall Study|Protocol Violation|5|||
149824469|NCT00384033|540486458|FG001|Overall Study|Protocol Violation|0|||
149824470|NCT00384033|540486459|FG002|Overall Study|Protocol Violation|5|||
149824471|NCT00384033|540486460|FG003|Overall Study|Protocol Violation|6|||
149824472|NCT00384033|540486457|FG000|Overall Study|Withdrawal by Subject|6|||
149824473|NCT00384033|540486458|FG001|Overall Study|Withdrawal by Subject|2|||
149824474|NCT00384033|540486459|FG002|Overall Study|Withdrawal by Subject|5|||
149824475|NCT00384033|540486460|FG003|Overall Study|Withdrawal by Subject|2|||
149824476|NCT00384033|540486457|FG000|Overall Study|Lack of Efficacy|7|||
149824477|NCT00384033|540486458|FG001|Overall Study|Lack of Efficacy|3|||
149824478|NCT00384033|540486459|FG002|Overall Study|Lack of Efficacy|3|||
149824479|NCT00384033|540486460|FG003|Overall Study|Lack of Efficacy|1|||
149824480|NCT00384033|540486457|FG000|Overall Study|Randomized but not treated|3|||
149824481|NCT00384033|540486458|FG001|Overall Study|Randomized but not treated|7|||
149824482|NCT00384033|540486459|FG002|Overall Study|Randomized but not treated|10|||
149824483|NCT00384033|540486460|FG003|Overall Study|Randomized but not treated|2|||
149824484|NCT00952484|540486461|FG000|Overall Study|Withdrawal by Subject|0|||
149824485|NCT00952484|540486462|FG001|Overall Study|Withdrawal by Subject|1|||
149824486|NCT00952484|540486463|FG002|Overall Study|Withdrawal by Subject|0|||
149824487|NCT02750306|540486465|FG000|Overall Study|Withdrawal by Subject|5|||
149824488|NCT02750306|540486466|FG001|Overall Study|Withdrawal by Subject|2|||
149824489|NCT02750306|540486465|FG000|Overall Study|Protocol Violation|1|||
149824490|NCT02750306|540486466|FG001|Overall Study|Protocol Violation|0|||
149824491|NCT00760383|540486467|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
149824492|NCT00760383|540486468|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
149824493|NCT00192296|540486469|FG000|Overall Study|Withdrawal by Subject|0|||
149824494|NCT00192296|540486470|FG001|Overall Study|Withdrawal by Subject|1|||
149824495|NCT00192296|540486471|FG002|Overall Study|Withdrawal by Subject|0|||
149824496|NCT00192296|540486472|FG003|Overall Study|Withdrawal by Subject|0|||
149824497|NCT01842958|540486474|FG000|Overall Study|Lost to Follow-up|1|||
149824498|NCT01842958|540486475|FG001|Overall Study|Lost to Follow-up|1|||
149824499|NCT01829477|540486476|FG000|Overall Study|Study Terminated by Sponsor|15|||
149824500|NCT01829477|540486477|FG001|Overall Study|Study Terminated by Sponsor|15|||
149824501|NCT01829477|540486476|FG000|Overall Study|Withdrawal by Subject|1|||
149824502|NCT01829477|540486477|FG001|Overall Study|Withdrawal by Subject|0|||
149824503|NCT01336894|540486479|FG000|Follow-up|Study terminated prematurely|2|||
149824504|NCT01336894|540486480|FG001|Follow-up|Study terminated prematurely|7|||
149824505|NCT00299156|540486483|FG000|Period 2 (Randomized)|Screen Failure|0|||
149824506|NCT00299156|540486484|FG001|Period 2 (Randomized)|Screen Failure|1|||
149824507|NCT00299156|540486485|FG002|Period 2 (Randomized)|Screen Failure|0|||
149824508|NCT01725451|540486486|FG000|Period 1|Withdrawal by Subject|1|||
149824509|NCT01725451|540486487|FG001|Period 1|Withdrawal by Subject|0|||
149824510|NCT01725451|540486488|FG002|Period 1|Withdrawal by Subject|0|||
149824511|NCT01725451|540486489|FG003|Period 1|Withdrawal by Subject|0|||
149824512|NCT01725451|540486486|FG000|Washout From Period 3|Protocol Violation|0|||
149944904|NCT01186770|540932364|FG002|Overall Study|Lost to Follow-up|14|||
149944905|NCT01186770|540932365|FG003|Overall Study|Lost to Follow-up|9|||
149824513|NCT01725451|540486487|FG001|Washout From Period 3|Protocol Violation|0|||
149824514|NCT01725451|540486488|FG002|Washout From Period 3|Protocol Violation|1|||
149824515|NCT01725451|540486489|FG003|Washout From Period 3|Protocol Violation|0|||
149824516|NCT01725451|540486486|FG000|Washout From Period 3|Adverse Event|0|||
149824517|NCT01725451|540486487|FG001|Washout From Period 3|Adverse Event|1|||
149824518|NCT01725451|540486488|FG002|Washout From Period 3|Adverse Event|0|||
149824519|NCT01725451|540486489|FG003|Washout From Period 3|Adverse Event|0|||
149824520|NCT01725451|540486486|FG000|Period 4|Adverse Event|0|||
149824521|NCT01725451|540486487|FG001|Period 4|Adverse Event|0|||
149824522|NCT01725451|540486488|FG002|Period 4|Adverse Event|1|||
150170385|NCT01235949|541759075|FG014|Primary Phase|Lost to Follow-up|0|||
149824523|NCT01725451|540486489|FG003|Period 4|Adverse Event|0|||
149824524|NCT00903383|540486496|FG000|Overall Study|Adverse Event|1|||
149824525|NCT00903383|540486497|FG001|Overall Study|Adverse Event|2|||
150033196|NCT01247324|541260916|FG000|Overall Study|Non-compliance|3|||
149944906|NCT01186770|540932362|FG000|Overall Study|Insufficient response to treatment|7|||
149944907|NCT01186770|540932363|FG001|Overall Study|Insufficient response to treatment|8|||
149944908|NCT01186770|540932364|FG002|Overall Study|Insufficient response to treatment|5|||
149944909|NCT01186770|540932365|FG003|Overall Study|Insufficient response to treatment|7|||
149944910|NCT01186770|540932362|FG000|Overall Study|Other than specified|0|||
149944911|NCT01186770|540932363|FG001|Overall Study|Other than specified|1|||
149944912|NCT01186770|540932364|FG002|Overall Study|Other than specified|1|||
149944913|NCT01186770|540932365|FG003|Overall Study|Other than specified|2|||
149944914|NCT00505921|540932366|FG000|Overall Study|Ineligible|1|||
149944915|NCT00505921|540932366|FG000|Overall Study|Failed to Mobilize|8|||
149944916|NCT02441283|540932367|FG000|Overall Study|Withdrew consent|15|||
149944917|NCT02441283|540932367|FG000|Overall Study|Lost to Follow-up|42|||
149944918|NCT02441283|540932367|FG000|Overall Study|Death|1|||
149944919|NCT02441283|540932367|FG000|Overall Study|Other, not specified|32|||
149944920|NCT01033136|540932368|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
149944921|NCT01033136|540932369|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
149944922|NCT00630292|540932370|FG000|Overall Study|Withdrawal by Subject|1|||
149944923|NCT02382939|540932371|FG000|Overall Study|Adverse Event|1|||
149944924|NCT02382939|540932372|FG001|Overall Study|Adverse Event|1|||
149944925|NCT02382939|540932371|FG000|Overall Study|Withdrawal by Subject|2|||
149944926|NCT02382939|540932372|FG001|Overall Study|Withdrawal by Subject|2|||
149944927|NCT00142415|540932375|FG000|Overall Study|Physician Decision|0|||
149944928|NCT00142415|540932376|FG001|Overall Study|Physician Decision|0|||
149944929|NCT00142415|540932377|FG002|Overall Study|Physician Decision|0|||
149944930|NCT00142415|540932378|FG003|Overall Study|Physician Decision|0|||
149944931|NCT00142415|540932379|FG004|Overall Study|Physician Decision|1|||
149944932|NCT00142415|540932380|FG005|Overall Study|Physician Decision|2|||
149944933|NCT05383209|540932381|FG000|Overall Study|Adverse Event: Non-ocular|0|||
149944934|NCT05383209|540932382|FG001|Overall Study|Adverse Event: Non-ocular|1|||
149944935|NCT05383209|540932383|FG002|Overall Study|Adverse Event: Non-ocular|0|||
149944936|NCT05383209|540932381|FG000|Overall Study|Lost to Follow-up|2|||
149944937|NCT05383209|540932382|FG001|Overall Study|Lost to Follow-up|1|||
149944938|NCT05383209|540932383|FG002|Overall Study|Lost to Follow-up|4|||
149944939|NCT05383209|540932381|FG000|Overall Study|Withdrawal by Subject|2|||
149944940|NCT05383209|540932382|FG001|Overall Study|Withdrawal by Subject|0|||
149944941|NCT05383209|540932383|FG002|Overall Study|Withdrawal by Subject|1|||
149944942|NCT05383209|540932381|FG000|Overall Study|Death|1|||
149944943|NCT05383209|540932382|FG001|Overall Study|Death|0|||
149944944|NCT05383209|540932383|FG002|Overall Study|Death|0|||
149944945|NCT05383209|540932381|FG000|Overall Study|Other|0|||
149944946|NCT05383209|540932382|FG001|Overall Study|Other|1|||
149944947|NCT05383209|540932383|FG002|Overall Study|Other|0|||
149944948|NCT00321763|540932385|FG000|Overall Study|Adverse Event|1|||
149944949|NCT00321763|540932386|FG001|Overall Study|Adverse Event|1|||
149944950|NCT00321763|540932387|FG002|Overall Study|Adverse Event|0|||
149944951|NCT00321763|540932388|FG003|Overall Study|Adverse Event|1|||
149944952|NCT00321763|540932385|FG000|Overall Study|Withdrawal by Subject|2|||
149944953|NCT00321763|540932386|FG001|Overall Study|Withdrawal by Subject|0|||
149944954|NCT00321763|540932387|FG002|Overall Study|Withdrawal by Subject|1|||
149944955|NCT00321763|540932388|FG003|Overall Study|Withdrawal by Subject|0|||
149944956|NCT00321763|540932385|FG000|Overall Study|Lost to Follow-up|3|||
149944957|NCT00321763|540932386|FG001|Overall Study|Lost to Follow-up|1|||
149944958|NCT00321763|540932387|FG002|Overall Study|Lost to Follow-up|5|||
149944959|NCT00321763|540932388|FG003|Overall Study|Lost to Follow-up|4|||
149944960|NCT00717886|540932389|FG000|Overall Study|Withdrawal by Subject|3|||
149944961|NCT00717886|540932389|FG000|Overall Study|Treatment Failure|1|||
149944962|NCT00716417|540932390|FG000|Overall Study|Adverse Event|0|||
149944963|NCT00716417|540932391|FG001|Overall Study|Adverse Event|0|||
149944964|NCT00716417|540932392|FG002|Overall Study|Adverse Event|2|||
149944965|NCT00716417|540932393|FG003|Overall Study|Adverse Event|1|||
149944966|NCT00716417|540932394|FG004|Overall Study|Adverse Event|0|||
149944967|NCT00716417|540932395|FG005|Overall Study|Adverse Event|0|||
149944968|NCT00716417|540932396|FG006|Overall Study|Adverse Event|3|||
149944969|NCT00716417|540932397|FG007|Overall Study|Adverse Event|1|||
149944970|NCT00716417|540932398|FG008|Overall Study|Adverse Event|0|||
149944971|NCT00716417|540932399|FG009|Overall Study|Adverse Event|3|||
149944972|NCT00716417|540932390|FG000|Overall Study|Withdrawal by Subject|0|||
149944973|NCT00716417|540932391|FG001|Overall Study|Withdrawal by Subject|1|||
149944974|NCT00716417|540932392|FG002|Overall Study|Withdrawal by Subject|0|||
149944975|NCT00716417|540932393|FG003|Overall Study|Withdrawal by Subject|2|||
149944976|NCT00716417|540932394|FG004|Overall Study|Withdrawal by Subject|0|||
149944977|NCT00716417|540932395|FG005|Overall Study|Withdrawal by Subject|0|||
149944978|NCT00716417|540932396|FG006|Overall Study|Withdrawal by Subject|1|||
149944979|NCT00716417|540932397|FG007|Overall Study|Withdrawal by Subject|0|||
149944980|NCT00716417|540932398|FG008|Overall Study|Withdrawal by Subject|0|||
149944981|NCT00716417|540932399|FG009|Overall Study|Withdrawal by Subject|0|||
149944982|NCT00716417|540932390|FG000|Overall Study|Progressive disease|3|||
149944983|NCT00716417|540932391|FG001|Overall Study|Progressive disease|5|||
149944984|NCT00716417|540932392|FG002|Overall Study|Progressive disease|3|||
149824526|NCT00903383|540486498|FG002|Overall Study|Adverse Event|3|||
149824527|NCT00903383|540486499|FG003|Overall Study|Adverse Event|1|||
149824528|NCT00903383|540486496|FG000|Overall Study|Physician Decision|1|||
149824529|NCT00903383|540486497|FG001|Overall Study|Physician Decision|2|||
149824530|NCT00903383|540486498|FG002|Overall Study|Physician Decision|0|||
149824531|NCT00903383|540486499|FG003|Overall Study|Physician Decision|0|||
149824532|NCT00903383|540486496|FG000|Overall Study|Lost to Follow-up|0|||
149824533|NCT00903383|540486497|FG001|Overall Study|Lost to Follow-up|0|||
149824534|NCT00903383|540486498|FG002|Overall Study|Lost to Follow-up|0|||
149824535|NCT00903383|540486499|FG003|Overall Study|Lost to Follow-up|1|||
149824536|NCT00903383|540486496|FG000|Overall Study|Decision of Sponsor|1|||
149824537|NCT00903383|540486497|FG001|Overall Study|Decision of Sponsor|0|||
149824538|NCT00903383|540486498|FG002|Overall Study|Decision of Sponsor|0|||
149824539|NCT00903383|540486499|FG003|Overall Study|Decision of Sponsor|0|||
149824540|NCT00903383|540486496|FG000|Overall Study|Withdrawal by Subject|4|||
149824541|NCT00903383|540486497|FG001|Overall Study|Withdrawal by Subject|1|||
149824542|NCT00903383|540486498|FG002|Overall Study|Withdrawal by Subject|0|||
149824543|NCT00903383|540486499|FG003|Overall Study|Withdrawal by Subject|2|||
149824544|NCT00903383|540486496|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
149824545|NCT00903383|540486497|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
149824546|NCT00903383|540486498|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
149824547|NCT00903383|540486499|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
149824548|NCT00903383|540486496|FG000|Overall Study|Patient Decision|0|||
149824549|NCT00903383|540486497|FG001|Overall Study|Patient Decision|0|||
149824550|NCT00903383|540486498|FG002|Overall Study|Patient Decision|0|||
149824551|NCT00903383|540486499|FG003|Overall Study|Patient Decision|1|||
149824552|NCT00320593|540486504|FG000|Overall Study|Lost to Follow-up|3|||
149824553|NCT00320593|540486505|FG001|Overall Study|Lost to Follow-up|0|||
149824554|NCT00320593|540486504|FG000|Overall Study|Moved to another state|1|||
149824555|NCT00320593|540486505|FG001|Overall Study|Moved to another state|0|||
149824556|NCT00320593|540486504|FG000|Overall Study|Withdrawal by Subject|2|||
149824557|NCT00320593|540486505|FG001|Overall Study|Withdrawal by Subject|1|||
149824558|NCT00320593|540486504|FG000|Overall Study|Withdrawal by clinical center|1|||
149824559|NCT00320593|540486505|FG001|Overall Study|Withdrawal by clinical center|0|||
149824560|NCT00283686|540486506|FG000|Overall Study|Death|1|||
149824561|NCT00283686|540486507|FG001|Overall Study|Death|1|||
149824562|NCT00283686|540486508|FG002|Overall Study|Death|1|||
149824563|NCT00283686|540486509|FG003|Overall Study|Death|0|||
149824564|NCT00283686|540486506|FG000|Overall Study|Lost to Follow-up|21|||
149824565|NCT00283686|540486507|FG001|Overall Study|Lost to Follow-up|31|||
149824566|NCT00283686|540486508|FG002|Overall Study|Lost to Follow-up|26|||
149824567|NCT00283686|540486509|FG003|Overall Study|Lost to Follow-up|20|||
149824568|NCT00283686|540486506|FG000|Overall Study|Less than full participation|7|||
149824569|NCT00283686|540486507|FG001|Overall Study|Less than full participation|9|||
149824570|NCT00283686|540486508|FG002|Overall Study|Less than full participation|6|||
149824571|NCT00283686|540486509|FG003|Overall Study|Less than full participation|12|||
149824572|NCT01076166|540486510|FG000|Overall Study|Adverse Event|3|||
149824573|NCT01076166|540486510|FG000|Overall Study|Symptoms improved/resolved|6|||
149824574|NCT01716754|540486513|FG000|Overall Study|Death|0|||
149824575|NCT01716754|540486514|FG001|Overall Study|Death|0|||
149824576|NCT01716754|540486515|FG002|Overall Study|Death|0|||
149824577|NCT01716754|540486516|FG003|Overall Study|Death|1|||
149824578|NCT01716754|540486513|FG000|Overall Study|Protocol deviation|0|||
149824579|NCT01716754|540486514|FG001|Overall Study|Protocol deviation|2|||
149824580|NCT01716754|540486515|FG002|Overall Study|Protocol deviation|7|||
149824581|NCT01716754|540486516|FG003|Overall Study|Protocol deviation|2|||
149824582|NCT01716754|540486513|FG000|Overall Study|Non-compliance with study treatment|0|||
149824583|NCT01716754|540486514|FG001|Overall Study|Non-compliance with study treatment|0|||
149824584|NCT01716754|540486515|FG002|Overall Study|Non-compliance with study treatment|1|||
149824585|NCT01716754|540486516|FG003|Overall Study|Non-compliance with study treatment|0|||
149824586|NCT01716754|540486513|FG000|Overall Study|Physician Decision|1|||
149824587|NCT01716754|540486514|FG001|Overall Study|Physician Decision|0|||
149824588|NCT01716754|540486515|FG002|Overall Study|Physician Decision|0|||
149824589|NCT01716754|540486516|FG003|Overall Study|Physician Decision|0|||
149824590|NCT01716754|540486513|FG000|Overall Study|Lost to Follow-up|1|||
149824591|NCT01716754|540486514|FG001|Overall Study|Lost to Follow-up|0|||
149824592|NCT01716754|540486515|FG002|Overall Study|Lost to Follow-up|0|||
149824593|NCT01716754|540486516|FG003|Overall Study|Lost to Follow-up|1|||
149824594|NCT01716754|540486513|FG000|Overall Study|Adverse Event|4|||
149824595|NCT01716754|540486514|FG001|Overall Study|Adverse Event|2|||
149824596|NCT01716754|540486515|FG002|Overall Study|Adverse Event|2|||
149824597|NCT01716754|540486516|FG003|Overall Study|Adverse Event|1|||
149944985|NCT00716417|540932393|FG003|Overall Study|Progressive disease|8|||
149944986|NCT00716417|540932394|FG004|Overall Study|Progressive disease|0|||
149944987|NCT00716417|540932395|FG005|Overall Study|Progressive disease|3|||
149824598|NCT01716754|540486513|FG000|Overall Study|Withdrawal by Subject|5|||
149824599|NCT01716754|540486514|FG001|Overall Study|Withdrawal by Subject|0|||
149824600|NCT01716754|540486515|FG002|Overall Study|Withdrawal by Subject|4|||
149944988|NCT00716417|540932396|FG006|Overall Study|Progressive disease|3|||
149944989|NCT00716417|540932397|FG007|Overall Study|Progressive disease|1|||
149944990|NCT00716417|540932398|FG008|Overall Study|Progressive disease|5|||
149944991|NCT00716417|540932399|FG009|Overall Study|Progressive disease|0|||
149944992|NCT00716417|540932390|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
149944993|NCT00716417|540932391|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
149944994|NCT00716417|540932392|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
149944995|NCT00716417|540932393|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
149944996|NCT00716417|540932394|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
149944997|NCT00716417|540932395|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
149944998|NCT00716417|540932396|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
149944999|NCT00716417|540932397|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
149945000|NCT00716417|540932398|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
149945001|NCT00716417|540932399|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
149945002|NCT00716417|540932390|FG000|Overall Study|On patient request due to toxicities|0|||
149945003|NCT00716417|540932391|FG001|Overall Study|On patient request due to toxicities|0|||
149945004|NCT00716417|540932392|FG002|Overall Study|On patient request due to toxicities|0|||
149945005|NCT00716417|540932393|FG003|Overall Study|On patient request due to toxicities|0|||
149945006|NCT00716417|540932394|FG004|Overall Study|On patient request due to toxicities|0|||
149945007|NCT00716417|540932395|FG005|Overall Study|On patient request due to toxicities|0|||
149945008|NCT00716417|540932396|FG006|Overall Study|On patient request due to toxicities|0|||
149945009|NCT00716417|540932397|FG007|Overall Study|On patient request due to toxicities|1|||
149945010|NCT00716417|540932398|FG008|Overall Study|On patient request due to toxicities|0|||
149945011|NCT00716417|540932399|FG009|Overall Study|On patient request due to toxicities|0|||
149945012|NCT01553851|540932400|FG000|Overall Study|Adverse Event|2|||
149945013|NCT01553851|540932400|FG000|Overall Study|constipation|1|||
149945014|NCT02472353|540932402|FG000|Overall Study|Lost to Follow-up|1|||
149945015|NCT02472353|540932403|FG001|Overall Study|Lost to Follow-up|1|||
149945016|NCT02472353|540932402|FG000|Overall Study|Withdrawal by Subject|2|||
149945017|NCT02472353|540932403|FG001|Overall Study|Withdrawal by Subject|1|||
149945018|NCT02472353|540932402|FG000|Overall Study|Study Termination|1|||
149945019|NCT02472353|540932403|FG001|Overall Study|Study Termination|4|||
149945020|NCT02101294|540932404|FG000|Overall Study|Withdrawal by Subject|5|||
149945021|NCT02101294|540932404|FG000|Overall Study|Lost to Follow-up|6|||
149945022|NCT00797563|540932405|FG000|Overall Study|Adverse Event|1|||
149945023|NCT00688597|540932409|FG000|Overall Study|Adverse Event|2|||
149945024|NCT00688597|540932410|FG001|Overall Study|Adverse Event|0|||
149945025|NCT00688597|540932411|FG002|Overall Study|Adverse Event|0|||
149945026|NCT00688597|540932409|FG000|Overall Study|Physician Decision|1|||
149945027|NCT00688597|540932410|FG001|Overall Study|Physician Decision|0|||
149945028|NCT00688597|540932411|FG002|Overall Study|Physician Decision|0|||
149945029|NCT03822416|540932412|FG000|Overall Study|Lost to Follow-up|1|||
149945030|NCT03822416|540932413|FG001|Overall Study|Lost to Follow-up|0|||
149945031|NCT03822416|540932412|FG000|Overall Study|Withdrawal by Subject|0|||
149945032|NCT03822416|540932413|FG001|Overall Study|Withdrawal by Subject|1|||
149945033|NCT05233761|540932414|FG000|Treatment Period A|Withdrawal by Subject|12|||
149945034|NCT05233761|540932415|FG001|Treatment Period A|Withdrawal by Subject|10|||
149945035|NCT05233761|540932414|FG000|Treatment Period A|Lost to Follow-up|6|||
149945036|NCT05233761|540932415|FG001|Treatment Period A|Lost to Follow-up|12|||
149945037|NCT05233761|540932414|FG000|Treatment Period A|Protocol Violation|8|||
149945038|NCT05233761|540932415|FG001|Treatment Period A|Protocol Violation|15|||
149945039|NCT04058717|540932416|FG000|Randomization Period|Lost to Follow-up|2|||
149945040|NCT04058717|540932417|FG001|Randomization Period|Lost to Follow-up|3|||
149945041|NCT04058717|540932418|FG002|Randomization Period|Lost to Follow-up|4|||
149945042|NCT04058717|540932419|FG003|Randomization Period|Lost to Follow-up|4|||
149945043|NCT04058717|540932416|FG000|Randomization Period|Withdrawal by Subject|1|||
149945044|NCT04058717|540932417|FG001|Randomization Period|Withdrawal by Subject|3|||
149945045|NCT04058717|540932418|FG002|Randomization Period|Withdrawal by Subject|3|||
149945046|NCT04058717|540932419|FG003|Randomization Period|Withdrawal by Subject|3|||
149945047|NCT04058717|540932416|FG000|Randomization Period|PI decision|0|||
149945048|NCT04058717|540932417|FG001|Randomization Period|PI decision|1|||
149945049|NCT04058717|540932418|FG002|Randomization Period|PI decision|0|||
150275297|NCT02716675|542146410|FG001|Overall Study|Lost to Follow-up|87|||
150275298|NCT02716675|542146411|FG002|Overall Study|Lost to Follow-up|99|||
149945050|NCT04058717|540932419|FG003|Randomization Period|PI decision|0|||
149945051|NCT00846365|540932425|FG000|Overall Study|Adverse Event|20|||
149945052|NCT00846365|540932426|FG001|Overall Study|Adverse Event|30|||
149945053|NCT00846365|540932427|FG002|Overall Study|Adverse Event|11|||
149945054|NCT00846365|540932425|FG000|Overall Study|Protocol Violation|5|||
149945055|NCT00846365|540932426|FG001|Overall Study|Protocol Violation|4|||
149945056|NCT00846365|540932427|FG002|Overall Study|Protocol Violation|0|||
149945057|NCT00846365|540932425|FG000|Overall Study|Lost to Follow-up|8|||
149945058|NCT00846365|540932426|FG001|Overall Study|Lost to Follow-up|2|||
149945059|NCT00846365|540932427|FG002|Overall Study|Lost to Follow-up|5|||
149824601|NCT01716754|540486516|FG003|Overall Study|Withdrawal by Subject|3|||
149945060|NCT00846365|540932425|FG000|Overall Study|Withdrawal by Subject|11|||
149824602|NCT00481247|540486517|FG000|Overall Study|Death|0|||
149824603|NCT00481247|540486518|FG001|Overall Study|Death|1|||
149824604|NCT00481247|540486517|FG000|Overall Study|Disease progression|18|||
149824605|NCT00481247|540486518|FG001|Overall Study|Disease progression|22|||
149824606|NCT00481247|540486517|FG000|Overall Study|Intolerance|42|||
149824607|NCT00481247|540486518|FG001|Overall Study|Intolerance|17|||
149824608|NCT00481247|540486517|FG000|Overall Study|Treatment failure|10|||
149824609|NCT00481247|540486518|FG001|Overall Study|Treatment failure|14|||
149824610|NCT00481247|540486517|FG000|Overall Study|AE unrelated to study drug|13|||
149945061|NCT00846365|540932426|FG001|Overall Study|Withdrawal by Subject|11|||
149945062|NCT00846365|540932427|FG002|Overall Study|Withdrawal by Subject|9|||
149945063|NCT00846365|540932425|FG000|Overall Study|Pregnancy|1|||
149945064|NCT00846365|540932426|FG001|Overall Study|Pregnancy|0|||
149945065|NCT00846365|540932427|FG002|Overall Study|Pregnancy|0|||
149945066|NCT00846365|540932425|FG000|Overall Study|Lack of Efficacy|1|||
149945067|NCT00846365|540932426|FG001|Overall Study|Lack of Efficacy|1|||
149945068|NCT00846365|540932427|FG002|Overall Study|Lack of Efficacy|2|||
149945069|NCT00846365|540932425|FG000|Overall Study|Other|9|||
149945070|NCT00846365|540932426|FG001|Overall Study|Other|1|||
149945071|NCT00846365|540932427|FG002|Overall Study|Other|6|||
149945072|NCT01925417|540932439|FG000|Overall Study|Withdrawal by Subject|2|||
149945073|NCT01925417|540932439|FG000|Overall Study|Death|1|||
149945074|NCT01157845|540932447|FG000|Overall Study|Lost to Follow-up|5|||
149945075|NCT01157845|540932447|FG000|Overall Study|Withdrawal by Subject|12|||
149945076|NCT01157845|540932447|FG000|Overall Study|Physician Decision|3|||
149945077|NCT01157845|540932447|FG000|Overall Study|Protocol Violation|13|||
149945078|NCT01157845|540932447|FG000|Overall Study|Study was ended|1|||
149945079|NCT01157845|540932447|FG000|Overall Study|Device malfunction|1|||
149945080|NCT03320369|540933893|FG000|Overall Study|Adverse Event|1|||
149945081|NCT03320369|540933893|FG000|Overall Study|Withdrawal by Subject|2|||
149945082|NCT01155141|540933894|FG000|Overall Study|Withdrawal by Subject|1|||
149945083|NCT01155141|540933894|FG000|Overall Study|Screen Failure|1|||
149945084|NCT00844519|540933895|FG000|Overall Study|Withdrawal by Subject|1|||
149945085|NCT00844519|540933896|FG001|Overall Study|Withdrawal by Subject|1|||
149945086|NCT00844519|540933895|FG000|Overall Study|Adverse Event|1|||
149945087|NCT00844519|540933896|FG001|Overall Study|Adverse Event|0|||
149945088|NCT01303419|540933897|FG000|Overall Study|Discontinuation of study|60|||
149945089|NCT01303419|540933897|FG000|Overall Study|Did not complete both imaging methods|5|||
149945090|NCT01303419|540933897|FG000|Overall Study|Did not meet all I/E after screening|31|||
149945091|NCT02709369|540933899|FG000|Overall Study|Lost to Follow-up|15|||
149945092|NCT02709369|540933899|FG000|Overall Study|Withdrawal by Subject|10|||
149945093|NCT02709369|540933899|FG000|Overall Study|Did not received intervention|2|||
149945094|NCT02755090|540933903|FG000|Overall Study|equipment malfunction|1|||
149945095|NCT02755090|540933904|FG001|Overall Study|equipment malfunction|0|||
149945096|NCT02337829|540933907|FG000|Overall Study|Death|0|||
149945097|NCT02337829|540933908|FG001|Overall Study|Death|1|||
149945098|NCT02337829|540933909|FG002|Overall Study|Death|0|||
149945099|NCT02337829|540933910|FG003|Overall Study|Death|0|||
149945100|NCT02337829|540933907|FG000|Overall Study|Study terminated by sponsor|12|||
149945101|NCT02337829|540933908|FG001|Overall Study|Study terminated by sponsor|10|||
149945102|NCT02337829|540933909|FG002|Overall Study|Study terminated by sponsor|5|||
149945103|NCT02337829|540933910|FG003|Overall Study|Study terminated by sponsor|6|||
149945104|NCT02337829|540933907|FG000|Overall Study|discontinued for other reasons|6|||
149945105|NCT02337829|540933908|FG001|Overall Study|discontinued for other reasons|3|||
149945106|NCT02337829|540933909|FG002|Overall Study|discontinued for other reasons|1|||
149945107|NCT02337829|540933910|FG003|Overall Study|discontinued for other reasons|4|||
149945108|NCT01551173|540933919|FG000|Overall Study|Withdrawal by Subject|11|||
149945109|NCT01551173|540933920|FG001|Overall Study|Withdrawal by Subject|16|||
149945110|NCT01551173|540933919|FG000|Overall Study|Adverse Event|7|||
149945111|NCT01551173|540933920|FG001|Overall Study|Adverse Event|6|||
149945112|NCT01551173|540933919|FG000|Overall Study|Lost to Follow-up|5|||
149824611|NCT00481247|540486518|FG001|Overall Study|AE unrelated to study drug|4|||
149824612|NCT00481247|540486517|FG000|Overall Study|Withdrawal by Subject|8|||
149945113|NCT01551173|540933920|FG001|Overall Study|Lost to Follow-up|7|||
149945114|NCT01551173|540933919|FG000|Overall Study|Other|5|||
149945115|NCT01551173|540933920|FG001|Overall Study|Other|3|||
149945116|NCT04530344|540933921|FG000|Overall Study|Lost to Follow-up|3|||
149945117|NCT04530344|540933922|FG001|Overall Study|Lost to Follow-up|3|||
149945118|NCT04530344|540933923|FG002|Overall Study|Lost to Follow-up|3|||
149945119|NCT04530344|540933924|FG003|Overall Study|Lost to Follow-up|10|||
149945120|NCT04530344|540933921|FG000|Overall Study|Withdrawal by Subject|14|||
149945121|NCT04530344|540933922|FG001|Overall Study|Withdrawal by Subject|5|||
149945122|NCT04530344|540933923|FG002|Overall Study|Withdrawal by Subject|18|||
149945123|NCT04530344|540933924|FG003|Overall Study|Withdrawal by Subject|33|||
149945124|NCT04530344|540933921|FG000|Overall Study|Adverse Event|0|||
149945125|NCT04530344|540933922|FG001|Overall Study|Adverse Event|0|||
149945126|NCT04530344|540933923|FG002|Overall Study|Adverse Event|0|||
149824613|NCT00481247|540486518|FG001|Overall Study|Withdrawal by Subject|13|||
149945127|NCT04530344|540933924|FG003|Overall Study|Adverse Event|1|||
149824614|NCT00481247|540486517|FG000|Overall Study|Pregnancy|2|||
149824615|NCT00481247|540486518|FG001|Overall Study|Pregnancy|1|||
149824616|NCT00481247|540486517|FG000|Overall Study|Lost to Follow-up|1|||
149824617|NCT00481247|540486518|FG001|Overall Study|Lost to Follow-up|2|||
149824618|NCT00481247|540486517|FG000|Overall Study|Poor compliance/noncompliance|1|||
149824619|NCT00481247|540486518|FG001|Overall Study|Poor compliance/noncompliance|7|||
149824620|NCT00481247|540486517|FG000|Overall Study|Administrative reason by sponsor|157|||
149824621|NCT00481247|540486518|FG001|Overall Study|Administrative reason by sponsor|162|||
149824622|NCT00481247|540486517|FG000|Overall Study|Varied|6|||
149824623|NCT00481247|540486518|FG001|Overall Study|Varied|15|||
149824624|NCT00481247|540486517|FG000|Overall Study|Did not receive treatment|1|||
149824625|NCT00481247|540486518|FG001|Overall Study|Did not receive treatment|2|||
149824626|NCT00638157|540486538|FG000|Overall Study|Adverse Event|0|||
149824627|NCT00638157|540486539|FG001|Overall Study|Adverse Event|1|||
149824628|NCT00638157|540486538|FG000|Overall Study|Clinical (symptomatic) failure|1|||
149824629|NCT00638157|540486539|FG001|Overall Study|Clinical (symptomatic) failure|1|||
149945128|NCT04530344|540933921|FG000|Overall Study|Lack of Efficacy|0|||
149945129|NCT04530344|540933922|FG001|Overall Study|Lack of Efficacy|0|||
149945130|NCT04530344|540933923|FG002|Overall Study|Lack of Efficacy|0|||
149945131|NCT04530344|540933924|FG003|Overall Study|Lack of Efficacy|1|||
149945132|NCT04530344|540933921|FG000|Overall Study|Physician Decision|0|||
149945133|NCT04530344|540933922|FG001|Overall Study|Physician Decision|0|||
149945134|NCT04530344|540933923|FG002|Overall Study|Physician Decision|1|||
149945135|NCT04530344|540933924|FG003|Overall Study|Physician Decision|1|||
149945136|NCT04530344|540933921|FG000|Overall Study|Pregnancy|0|||
149945137|NCT04530344|540933922|FG001|Overall Study|Pregnancy|0|||
149945138|NCT04530344|540933923|FG002|Overall Study|Pregnancy|2|||
149945139|NCT04530344|540933924|FG003|Overall Study|Pregnancy|1|||
149945140|NCT04530344|540933921|FG000|Overall Study|Protocol Violation|0|||
149945141|NCT04530344|540933922|FG001|Overall Study|Protocol Violation|0|||
149945142|NCT04530344|540933923|FG002|Overall Study|Protocol Violation|0|||
149945143|NCT04530344|540933924|FG003|Overall Study|Protocol Violation|1|||
149945144|NCT04530344|540933921|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
149945145|NCT04530344|540933922|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
149945146|NCT04530344|540933923|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
149945147|NCT04530344|540933924|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
149945148|NCT04530344|540933921|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
149945149|NCT04530344|540933922|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
149945150|NCT04530344|540933923|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
149945151|NCT04530344|540933924|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
149945152|NCT04530344|540933921|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
149945153|NCT04530344|540933922|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
149945154|NCT04530344|540933923|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
149945155|NCT04530344|540933924|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
149945156|NCT04530344|540933921|FG000|Overall Study|Personal Reasons|0|||
149945157|NCT04530344|540933922|FG001|Overall Study|Personal Reasons|0|||
149945158|NCT04530344|540933923|FG002|Overall Study|Personal Reasons|0|||
149945159|NCT04530344|540933924|FG003|Overall Study|Personal Reasons|1|||
149945160|NCT04530344|540933921|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
149945161|NCT04530344|540933922|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
149945162|NCT04530344|540933923|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
149945163|NCT04530344|540933924|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
149945164|NCT01402700|540933925|FG000|Overall Study|Death|3|||
149945165|NCT01402700|540933925|FG000|Overall Study|Withdrawal by Subject|3|||
149945166|NCT01402700|540933925|FG000|Overall Study|Missed Visit|1|||
149945167|NCT03507790|540933926|FG000|Overall Study|Adverse Event|0|||
149945168|NCT03507790|540933927|FG001|Overall Study|Adverse Event|11|||
149945169|NCT03507790|540933928|FG002|Overall Study|Adverse Event|3|||
149945170|NCT03507790|540933926|FG000|Overall Study|Withdrawal by Subject|2|||
150275299|NCT02716675|542146409|FG000|Overall Study|Withdrawal by Subject|22|||
149824630|NCT00638157|540486538|FG000|Overall Study|Microbiological failure|1|||
149945171|NCT03507790|540933927|FG001|Overall Study|Withdrawal by Subject|0|||
149945172|NCT03507790|540933928|FG002|Overall Study|Withdrawal by Subject|0|||
149945173|NCT03507790|540933926|FG000|Overall Study|Subject moved to another location|1|||
149824631|NCT00638157|540486539|FG001|Overall Study|Microbiological failure|0|||
149824632|NCT00638157|540486538|FG000|Overall Study|Lost to Follow-up|1|||
149824633|NCT00638157|540486539|FG001|Overall Study|Lost to Follow-up|0|||
149824634|NCT00638157|540486538|FG000|Overall Study|Physician Decision|1|||
149945174|NCT03507790|540933927|FG001|Overall Study|Subject moved to another location|2|||
149945175|NCT03507790|540933928|FG002|Overall Study|Subject moved to another location|0|||
149945176|NCT03507790|540933926|FG000|Overall Study|Non-compliance with study drug|0|||
149945177|NCT03507790|540933927|FG001|Overall Study|Non-compliance with study drug|0|||
149824635|NCT00638157|540486539|FG001|Overall Study|Physician Decision|0|||
149824636|NCT00638157|540486538|FG000|Overall Study|Other|1|||
149945178|NCT03507790|540933928|FG002|Overall Study|Non-compliance with study drug|1|||
149945179|NCT03507790|540933926|FG000|Overall Study|COVID 19 Pandemic|0|||
149945180|NCT03507790|540933927|FG001|Overall Study|COVID 19 Pandemic|1|||
149945181|NCT03507790|540933928|FG002|Overall Study|COVID 19 Pandemic|0|||
149945182|NCT03507790|540933926|FG000|Overall Study|Lost to Follow-up|0|||
149945183|NCT03507790|540933927|FG001|Overall Study|Lost to Follow-up|1|||
149945184|NCT03507790|540933928|FG002|Overall Study|Lost to Follow-up|0|||
149945185|NCT03507790|540933926|FG000|Overall Study|Discontinuation of the trial at the site|1|||
149945186|NCT03507790|540933927|FG001|Overall Study|Discontinuation of the trial at the site|1|||
149945187|NCT03507790|540933928|FG002|Overall Study|Discontinuation of the trial at the site|0|||
149945188|NCT03507790|540933926|FG000|Overall Study|Randomized in error|0|||
149945189|NCT03507790|540933927|FG001|Overall Study|Randomized in error|0|||
149824637|NCT00638157|540486539|FG001|Overall Study|Other|2|||
149824638|NCT00638157|540486538|FG000|Overall Study|Randomized, not treated|2|||
149824639|NCT00638157|540486539|FG001|Overall Study|Randomized, not treated|0|||
149824640|NCT02110706|540486540|FG000|Overall Study|Adverse Event|2|||
149824641|NCT02110706|540486541|FG001|Overall Study|Adverse Event|3|||
149824642|NCT02110706|540486540|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
149824643|NCT02110706|540486541|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
149824644|NCT02970669|540486544|FG000|Double-blind Period|Adverse Event|4|||
149824645|NCT02970669|540486545|FG001|Double-blind Period|Adverse Event|0|||
149824646|NCT02970669|540486544|FG000|Double-blind Period|Death|1|||
149824647|NCT02970669|540486545|FG001|Double-blind Period|Death|0|||
149824648|NCT02970669|540486544|FG000|Double-blind Period|Study terminated by sponsor|1|||
149824649|NCT02970669|540486545|FG001|Double-blind Period|Study terminated by sponsor|2|||
149824650|NCT02970669|540486544|FG000|Double-blind Period|Physician Decision|0|||
149824651|NCT02970669|540486545|FG001|Double-blind Period|Physician Decision|2|||
149824652|NCT02970669|540486544|FG000|Double-blind Period|Withdrawal by Subject|2|||
149824653|NCT02970669|540486545|FG001|Double-blind Period|Withdrawal by Subject|2|||
149824654|NCT02970669|540486544|FG000|Open-label Period|Withdrawal by Subject|2|||
149824655|NCT02970669|540486545|FG001|Open-label Period|Withdrawal by Subject|2|||
149824656|NCT02970669|540486544|FG000|Open-label Period|Adverse Event|1|||
149824657|NCT02970669|540486545|FG001|Open-label Period|Adverse Event|0|||
149824658|NCT02970669|540486544|FG000|Open-label Period|Physician Decision|1|||
149824659|NCT02970669|540486545|FG001|Open-label Period|Physician Decision|0|||
149824660|NCT00876733|540486546|FG000|Overall Study|Adverse Event|34|||
149824661|NCT00876733|540486547|FG001|Overall Study|Adverse Event|20|||
149824662|NCT00876733|540486548|FG002|Overall Study|Adverse Event|10|||
149824663|NCT00876733|540486549|FG003|Overall Study|Adverse Event|3|||
149824664|NCT00876733|540486546|FG000|Overall Study|Lack of Efficacy|17|||
149824665|NCT00876733|540486547|FG001|Overall Study|Lack of Efficacy|9|||
149824666|NCT00876733|540486548|FG002|Overall Study|Lack of Efficacy|10|||
149824667|NCT00876733|540486549|FG003|Overall Study|Lack of Efficacy|1|||
149824668|NCT00876733|540486546|FG000|Overall Study|Lost to Follow-up|26|||
149824669|NCT00876733|540486547|FG001|Overall Study|Lost to Follow-up|10|||
149824670|NCT00876733|540486548|FG002|Overall Study|Lost to Follow-up|3|||
149824671|NCT00876733|540486549|FG003|Overall Study|Lost to Follow-up|2|||
149824672|NCT00876733|540486546|FG000|Overall Study|Data not available|14|||
149824673|NCT00876733|540486547|FG001|Overall Study|Data not available|3|||
149945190|NCT03507790|540933928|FG002|Overall Study|Randomized in error|1|||
149945191|NCT00157755|540933930|FG000|Overall Study|Death|2|||
149945192|NCT00157755|540933931|FG001|Overall Study|Death|3|||
149945193|NCT00157755|540933932|FG002|Overall Study|Death|3|||
149945194|NCT00157755|540933933|FG003|Overall Study|Death|2|||
149945195|NCT00157755|540933934|FG004|Overall Study|Death|0|||
149945196|NCT00157755|540933935|FG005|Overall Study|Death|0|||
149945197|NCT00157755|540933930|FG000|Overall Study|Lost to Follow-up|0|||
149945198|NCT00157755|540933931|FG001|Overall Study|Lost to Follow-up|0|||
149945199|NCT00157755|540933932|FG002|Overall Study|Lost to Follow-up|1|||
149945200|NCT00157755|540933933|FG003|Overall Study|Lost to Follow-up|0|||
149945201|NCT00157755|540933934|FG004|Overall Study|Lost to Follow-up|0|||
149945202|NCT00157755|540933935|FG005|Overall Study|Lost to Follow-up|0|||
149945203|NCT00157755|540933930|FG000|Overall Study|Withdrawal by Subject|0|||
149945204|NCT00157755|540933931|FG001|Overall Study|Withdrawal by Subject|0|||
149945205|NCT00157755|540933932|FG002|Overall Study|Withdrawal by Subject|1|||
149945206|NCT00157755|540933933|FG003|Overall Study|Withdrawal by Subject|1|||
149945207|NCT00157755|540933934|FG004|Overall Study|Withdrawal by Subject|1|||
149945208|NCT00157755|540933935|FG005|Overall Study|Withdrawal by Subject|2|||
149945209|NCT00157755|540933930|FG000|Overall Study|Explant due to infection|0|||
149945210|NCT00157755|540933931|FG001|Overall Study|Explant due to infection|0|||
149945211|NCT00157755|540933932|FG002|Overall Study|Explant due to infection|1|||
150170386|NCT01235949|541759076|FG015|Primary Phase|Lost to Follow-up|0|||
150170387|NCT01235949|541759077|FG016|Primary Phase|Lost to Follow-up|0|||
150170388|NCT01235949|541759078|FG017|Primary Phase|Lost to Follow-up|0|||
150170389|NCT01235949|541759061|FG000|Booster Phase|Migrated/moved from study area|0|||
150170390|NCT01235949|541759062|FG001|Booster Phase|Migrated/moved from study area|0|||
150170391|NCT01235949|541759063|FG002|Booster Phase|Migrated/moved from study area|0|||
149824674|NCT00876733|540486548|FG002|Overall Study|Data not available|7|||
150170392|NCT01235949|541759064|FG003|Booster Phase|Migrated/moved from study area|0|||
149945212|NCT00157755|540933933|FG003|Overall Study|Explant due to infection|0|||
149945213|NCT00157755|540933934|FG004|Overall Study|Explant due to infection|0|||
149945214|NCT00157755|540933935|FG005|Overall Study|Explant due to infection|0|||
149945215|NCT00157755|540933930|FG000|Overall Study|Medical reason|0|||
149945216|NCT00157755|540933931|FG001|Overall Study|Medical reason|0|||
149945217|NCT00157755|540933932|FG002|Overall Study|Medical reason|1|||
149945218|NCT00157755|540933933|FG003|Overall Study|Medical reason|1|||
149945219|NCT00157755|540933934|FG004|Overall Study|Medical reason|0|||
149945220|NCT00157755|540933935|FG005|Overall Study|Medical reason|0|||
149945221|NCT00157755|540933930|FG000|Overall Study|Study site closure|0|||
149945222|NCT00157755|540933931|FG001|Overall Study|Study site closure|1|||
149945223|NCT00157755|540933932|FG002|Overall Study|Study site closure|0|||
149945224|NCT00157755|540933933|FG003|Overall Study|Study site closure|0|||
149945225|NCT00157755|540933934|FG004|Overall Study|Study site closure|0|||
149945226|NCT00157755|540933935|FG005|Overall Study|Study site closure|0|||
149945227|NCT00157755|540933930|FG000|Overall Study|Subject non-compliance|0|||
149945228|NCT00157755|540933931|FG001|Overall Study|Subject non-compliance|0|||
149945229|NCT00157755|540933932|FG002|Overall Study|Subject non-compliance|0|||
149945230|NCT00157755|540933933|FG003|Overall Study|Subject non-compliance|0|||
149945231|NCT00157755|540933934|FG004|Overall Study|Subject non-compliance|0|||
149945232|NCT00157755|540933935|FG005|Overall Study|Subject non-compliance|1|||
149945233|NCT00157755|540933930|FG000|Overall Study|Study completion|0|||
149945234|NCT00157755|540933931|FG001|Overall Study|Study completion|0|||
149945235|NCT00157755|540933932|FG002|Overall Study|Study completion|0|||
149945236|NCT00157755|540933933|FG003|Overall Study|Study completion|0|||
149945237|NCT00157755|540933934|FG004|Overall Study|Study completion|1|||
149945238|NCT00157755|540933935|FG005|Overall Study|Study completion|2|||
149945239|NCT03314935|540933943|FG000|Phase 1|Death|4|||
149945240|NCT03314935|540933944|FG001|Phase 1|Death|2|||
149945241|NCT03314935|540933945|FG002|Phase 1|Death|5|||
149945242|NCT03314935|540933946|FG003|Phase 1|Death|4|||
149945243|NCT03314935|540933947|FG004|Phase 1|Death|3|||
149945244|NCT03314935|540933948|FG005|Phase 1|Death|4|||
149945245|NCT03314935|540933949|FG006|Phase 1|Death|5|||
149945246|NCT03314935|540933950|FG007|Phase 1|Death|4|||
149945247|NCT03314935|540933951|FG008|Phase 1|Death|3|||
149945248|NCT03314935|540933952|FG009|Phase 1|Death|0|||
149945249|NCT03314935|540933953|FG010|Phase 1|Death|0|||
149945250|NCT03314935|540933954|FG011|Phase 1|Death|0|||
149945251|NCT03314935|540933955|FG012|Phase 1|Death|0|||
149945252|NCT03314935|540933956|FG013|Phase 1|Death|0|||
149945253|NCT03314935|540933957|FG014|Phase 1|Death|0|||
149945254|NCT03314935|540933943|FG000|Phase 1|Withdrawal by Subject|2|||
149945255|NCT03314935|540933944|FG001|Phase 1|Withdrawal by Subject|1|||
149945256|NCT03314935|540933945|FG002|Phase 1|Withdrawal by Subject|1|||
149945257|NCT03314935|540933946|FG003|Phase 1|Withdrawal by Subject|2|||
149945258|NCT03314935|540933947|FG004|Phase 1|Withdrawal by Subject|1|||
149945259|NCT03314935|540933948|FG005|Phase 1|Withdrawal by Subject|0|||
149945260|NCT03314935|540933949|FG006|Phase 1|Withdrawal by Subject|1|||
149945261|NCT03314935|540933950|FG007|Phase 1|Withdrawal by Subject|0|||
149945262|NCT03314935|540933951|FG008|Phase 1|Withdrawal by Subject|1|||
149945263|NCT03314935|540933952|FG009|Phase 1|Withdrawal by Subject|0|||
149945264|NCT03314935|540933953|FG010|Phase 1|Withdrawal by Subject|0|||
149945265|NCT03314935|540933954|FG011|Phase 1|Withdrawal by Subject|0|||
149945266|NCT03314935|540933955|FG012|Phase 1|Withdrawal by Subject|0|||
149945267|NCT03314935|540933956|FG013|Phase 1|Withdrawal by Subject|0|||
149945268|NCT03314935|540933957|FG014|Phase 1|Withdrawal by Subject|0|||
149945269|NCT03314935|540933943|FG000|Phase 1|Progressive Disease|2|||
149945270|NCT03314935|540933944|FG001|Phase 1|Progressive Disease|0|||
149945271|NCT03314935|540933945|FG002|Phase 1|Progressive Disease|0|||
149945272|NCT03314935|540933946|FG003|Phase 1|Progressive Disease|1|||
149945273|NCT03314935|540933947|FG004|Phase 1|Progressive Disease|0|||
149945274|NCT03314935|540933948|FG005|Phase 1|Progressive Disease|0|||
149945275|NCT03314935|540933949|FG006|Phase 1|Progressive Disease|0|||
149945276|NCT03314935|540933950|FG007|Phase 1|Progressive Disease|0|||
149945277|NCT03314935|540933951|FG008|Phase 1|Progressive Disease|0|||
149945278|NCT03314935|540933952|FG009|Phase 1|Progressive Disease|0|||
149945279|NCT03314935|540933953|FG010|Phase 1|Progressive Disease|0|||
149945280|NCT03314935|540933954|FG011|Phase 1|Progressive Disease|0|||
149945281|NCT03314935|540933955|FG012|Phase 1|Progressive Disease|0|||
149945282|NCT03314935|540933956|FG013|Phase 1|Progressive Disease|0|||
149945283|NCT03314935|540933957|FG014|Phase 1|Progressive Disease|0|||
149945284|NCT03314935|540933943|FG000|Phase 1|Study Terminated by Sponsor|0|||
149945285|NCT03314935|540933944|FG001|Phase 1|Study Terminated by Sponsor|1|||
149945286|NCT03314935|540933945|FG002|Phase 1|Study Terminated by Sponsor|0|||
149945287|NCT03314935|540933946|FG003|Phase 1|Study Terminated by Sponsor|0|||
149945288|NCT03314935|540933947|FG004|Phase 1|Study Terminated by Sponsor|0|||
149945289|NCT03314935|540933948|FG005|Phase 1|Study Terminated by Sponsor|0|||
149945290|NCT03314935|540933949|FG006|Phase 1|Study Terminated by Sponsor|0|||
149945291|NCT03314935|540933950|FG007|Phase 1|Study Terminated by Sponsor|0|||
149945292|NCT03314935|540933951|FG008|Phase 1|Study Terminated by Sponsor|1|||
149945293|NCT03314935|540933952|FG009|Phase 1|Study Terminated by Sponsor|0|||
149945294|NCT03314935|540933953|FG010|Phase 1|Study Terminated by Sponsor|0|||
149945295|NCT03314935|540933954|FG011|Phase 1|Study Terminated by Sponsor|0|||
149945296|NCT03314935|540933955|FG012|Phase 1|Study Terminated by Sponsor|0|||
149945297|NCT03314935|540933956|FG013|Phase 1|Study Terminated by Sponsor|0|||
149945298|NCT03314935|540933957|FG014|Phase 1|Study Terminated by Sponsor|0|||
149945299|NCT03314935|540933943|FG000|Phase 1|"Captured as Other in Database"|0|||
149945300|NCT03314935|540933944|FG001|Phase 1|"Captured as Other in Database"|2|||
149945301|NCT03314935|540933945|FG002|Phase 1|"Captured as Other in Database"|0|||
149945302|NCT03314935|540933946|FG003|Phase 1|"Captured as Other in Database"|0|||
149945303|NCT03314935|540933947|FG004|Phase 1|"Captured as Other in Database"|0|||
149945304|NCT03314935|540933948|FG005|Phase 1|"Captured as Other in Database"|0|||
149945305|NCT03314935|540933949|FG006|Phase 1|"Captured as Other in Database"|1|||
149945306|NCT03314935|540933950|FG007|Phase 1|"Captured as Other in Database"|1|||
149945307|NCT03314935|540933951|FG008|Phase 1|"Captured as Other in Database"|1|||
149945308|NCT03314935|540933952|FG009|Phase 1|"Captured as Other in Database"|0|||
149945309|NCT03314935|540933953|FG010|Phase 1|"Captured as Other in Database"|0|||
149945310|NCT03314935|540933954|FG011|Phase 1|"Captured as Other in Database"|0|||
149945311|NCT03314935|540933955|FG012|Phase 1|"Captured as Other in Database"|0|||
149945312|NCT03314935|540933956|FG013|Phase 1|"Captured as Other in Database"|0|||
149945313|NCT03314935|540933957|FG014|Phase 1|"Captured as Other in Database"|0|||
149945314|NCT03314935|540933943|FG000|Phase 1|Lost to Follow-up|0|||
149945315|NCT03314935|540933944|FG001|Phase 1|Lost to Follow-up|0|||
149945316|NCT03314935|540933945|FG002|Phase 1|Lost to Follow-up|0|||
149945317|NCT03314935|540933946|FG003|Phase 1|Lost to Follow-up|0|||
149945318|NCT03314935|540933947|FG004|Phase 1|Lost to Follow-up|0|||
149945319|NCT03314935|540933948|FG005|Phase 1|Lost to Follow-up|0|||
149945320|NCT03314935|540933949|FG006|Phase 1|Lost to Follow-up|0|||
149945321|NCT03314935|540933950|FG007|Phase 1|Lost to Follow-up|0|||
149945322|NCT03314935|540933951|FG008|Phase 1|Lost to Follow-up|1|||
149945323|NCT03314935|540933952|FG009|Phase 1|Lost to Follow-up|0|||
149945324|NCT03314935|540933953|FG010|Phase 1|Lost to Follow-up|0|||
150170393|NCT01235949|541759065|FG004|Booster Phase|Migrated/moved from study area|0|||
149824675|NCT00876733|540486549|FG003|Overall Study|Data not available|1|||
149824676|NCT02611752|540486552|FG000|Overall Study|Adverse Event|0|||
149824677|NCT02611752|540486553|FG001|Overall Study|Adverse Event|1|||
149824678|NCT00686036|540486556|FG000|Overall Study|Adverse Event|3|||
149824679|NCT00686036|540486557|FG001|Overall Study|Adverse Event|0|||
149824680|NCT00686036|540486556|FG000|Overall Study|Withdrawal by Subject|3|||
149824681|NCT00686036|540486557|FG001|Overall Study|Withdrawal by Subject|1|||
149824682|NCT00686036|540486556|FG000|Overall Study|Study terminated by AstraZeneca|2|||
149824683|NCT00686036|540486557|FG001|Overall Study|Study terminated by AstraZeneca|1|||
149824684|NCT00686036|540486556|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
149824685|NCT00686036|540486557|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
149824686|NCT00686036|540486556|FG000|Overall Study|Other reasons not identified|0|||
149824687|NCT00686036|540486557|FG001|Overall Study|Other reasons not identified|4|||
149824688|NCT01960816|540486559|FG000|Overall Study|Lost to Follow-up|1|||
149824689|NCT03329027|540488564|FG000|Overall Study|Lost to Follow-up|1|||
149824690|NCT03329027|540488565|FG001|Overall Study|Lost to Follow-up|0|||
149824691|NCT03329027|540488566|FG002|Overall Study|Lost to Follow-up|1|||
149824692|NCT03329027|540488564|FG000|Overall Study|Protocol Violation|9|||
149824693|NCT03329027|540488565|FG001|Overall Study|Protocol Violation|5|||
149824694|NCT03329027|540488566|FG002|Overall Study|Protocol Violation|7|||
149824695|NCT04849988|540488567|FG000|Overall Study|Lack of Efficacy|3|||
149824696|NCT04849988|540488568|FG001|Overall Study|Lack of Efficacy|4|||
149824697|NCT04849988|540488569|FG002|Overall Study|Lack of Efficacy|1|||
149824698|NCT04849988|540488570|FG003|Overall Study|Lack of Efficacy|4|||
149824699|NCT04849988|540488567|FG000|Overall Study|Other reasons|1|||
149824700|NCT04849988|540488568|FG001|Overall Study|Other reasons|2|||
149824701|NCT04849988|540488569|FG002|Overall Study|Other reasons|2|||
149824702|NCT04849988|540488570|FG003|Overall Study|Other reasons|1|||
149824703|NCT01691508|540488575|FG000|Overall Study|Adverse Event|3|||
149824704|NCT01691508|540488576|FG001|Overall Study|Adverse Event|3|||
149824705|NCT01691508|540488575|FG000|Overall Study|Withdrawal by Subject|1|||
149824706|NCT01691508|540488576|FG001|Overall Study|Withdrawal by Subject|0|||
149824707|NCT03731182|540488577|FG000|Overall Study|Lost to Follow-up|2|||
149824708|NCT03731182|540488578|FG001|Overall Study|Lost to Follow-up|0|||
149824709|NCT03731182|540488577|FG000|Overall Study|Physician Decision|1|||
149945325|NCT03314935|540933954|FG011|Phase 1|Lost to Follow-up|0|||
149945326|NCT03314935|540933955|FG012|Phase 1|Lost to Follow-up|0|||
150170394|NCT01235949|541759066|FG005|Booster Phase|Migrated/moved from study area|0|||
150170395|NCT01235949|541759067|FG006|Booster Phase|Migrated/moved from study area|0|||
150170396|NCT01235949|541759068|FG007|Booster Phase|Migrated/moved from study area|0|||
150170397|NCT01235949|541759069|FG008|Booster Phase|Migrated/moved from study area|0|||
150170398|NCT01235949|541759070|FG009|Booster Phase|Migrated/moved from study area|0|||
150170399|NCT01235949|541759071|FG010|Booster Phase|Migrated/moved from study area|0|||
150170400|NCT01235949|541759072|FG011|Booster Phase|Migrated/moved from study area|1|||
149945327|NCT03314935|540933956|FG013|Phase 1|Lost to Follow-up|0|||
149824710|NCT03731182|540488578|FG001|Overall Study|Physician Decision|0|||
149945328|NCT03314935|540933957|FG014|Phase 1|Lost to Follow-up|0|||
149945329|NCT03314935|540933943|FG000|Phase 2|Death|0|||
149824711|NCT03731182|540488577|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
149824712|NCT03731182|540488578|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
149824713|NCT02006706|540488579|FG000|Overall Study|Lost to Follow-up|1|||
149824714|NCT04161144|540488580|FG000|Overall Study|Withdrawal by Subject|0|||
149824715|NCT04161144|540488581|FG001|Overall Study|Withdrawal by Subject|1|||
149824716|NCT04161144|540488580|FG000|Overall Study|Protocol Violation|1|||
149824717|NCT04161144|540488581|FG001|Overall Study|Protocol Violation|0|||
149824718|NCT05431153|540488582|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149824719|NCT05431153|540488583|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149824720|NCT05431153|540488584|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149824721|NCT05431153|540488585|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149824722|NCT05431153|540488586|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
149824723|NCT05431153|540488587|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149824724|NCT04828161|540488588|FG000|Overall Study|Withdrawal by Subject|0|||
149824725|NCT04828161|540488589|FG001|Overall Study|Withdrawal by Subject|3|||
149824726|NCT04828161|540488590|FG002|Overall Study|Withdrawal by Subject|3|||
149824727|NCT04828161|540488591|FG003|Overall Study|Withdrawal by Subject|4|||
149824728|NCT04828161|540488588|FG000|Overall Study|Lost to Follow-up|1|||
149824729|NCT04828161|540488589|FG001|Overall Study|Lost to Follow-up|4|||
149824730|NCT04828161|540488590|FG002|Overall Study|Lost to Follow-up|2|||
149824731|NCT04828161|540488591|FG003|Overall Study|Lost to Follow-up|2|||
149824732|NCT04828161|540488588|FG000|Overall Study|Other|2|||
149824733|NCT04828161|540488589|FG001|Overall Study|Other|0|||
149824734|NCT04828161|540488590|FG002|Overall Study|Other|2|||
149824735|NCT04828161|540488591|FG003|Overall Study|Other|0|||
149824736|NCT04828161|540488588|FG000|Overall Study|Death|0|||
149824737|NCT04828161|540488589|FG001|Overall Study|Death|0|||
149824738|NCT04828161|540488590|FG002|Overall Study|Death|0|||
149824739|NCT04828161|540488591|FG003|Overall Study|Death|2|||
149824740|NCT02352337|540488592|FG000|Overall Study|Patients never treated|4|||
149824741|NCT02352337|540488593|FG001|Overall Study|Patients never treated|1|||
149824742|NCT02352337|540488594|FG002|Overall Study|Patients never treated|2|||
149824743|NCT02458638|540488595|FG000|Overall Study|Death|309|||
149824744|NCT02458638|540488595|FG000|Overall Study|End of Cohort/End of Study|67|||
149824745|NCT02458638|540488595|FG000|Overall Study|Lost to Follow-up|31|||
149824746|NCT02458638|540488595|FG000|Overall Study|Other Reasons|4|||
149824747|NCT02458638|540488595|FG000|Overall Study|Physician Decision|1|||
149824748|NCT02458638|540488595|FG000|Overall Study|Withdrawal by Subject|47|||
149824749|NCT00135707|540488606|FG000|Overall Study|Lost to Follow-up|94|||
149824750|NCT00135707|540488607|FG001|Overall Study|Lost to Follow-up|89|||
149824751|NCT00135707|540488606|FG000|Overall Study|Withdrawal by Subject|0|||
149824752|NCT00135707|540488607|FG001|Overall Study|Withdrawal by Subject|1|||
149824753|NCT00135707|540488606|FG000|Overall Study|Institutional review board request|1|||
149824754|NCT00135707|540488607|FG001|Overall Study|Institutional review board request|0|||
149824755|NCT02524379|540488611|FG000|Overall Study|Death|1|||
149824756|NCT01829464|540488612|FG000|Overall Study|Adverse Event|1|||
149824757|NCT01829464|540488613|FG001|Overall Study|Adverse Event|0|||
149824758|NCT01829464|540488614|FG002|Overall Study|Adverse Event|0|||
149824759|NCT01829464|540488612|FG000|Overall Study|Lost to Follow-up|0|||
149824760|NCT01829464|540488613|FG001|Overall Study|Lost to Follow-up|0|||
149824761|NCT01829464|540488614|FG002|Overall Study|Lost to Follow-up|1|||
149824762|NCT01829464|540488612|FG000|Overall Study|Withdrawal by Subject|2|||
149824763|NCT01829464|540488613|FG001|Overall Study|Withdrawal by Subject|0|||
149824764|NCT01829464|540488614|FG002|Overall Study|Withdrawal by Subject|0|||
149824765|NCT01829464|540488612|FG000|Overall Study|Study terminated by sponsor|25|||
149824766|NCT01829464|540488613|FG001|Overall Study|Study terminated by sponsor|28|||
149824767|NCT01829464|540488614|FG002|Overall Study|Study terminated by sponsor|25|||
149824768|NCT01829464|540488612|FG000|Overall Study|Lack of Efficacy|0|||
149824769|NCT01829464|540488613|FG001|Overall Study|Lack of Efficacy|1|||
149824770|NCT01829464|540488614|FG002|Overall Study|Lack of Efficacy|0|||
149824771|NCT03465891|540488621|FG000|Overall Study|Withdrawal by Subject|0|||
149824772|NCT03465891|540488622|FG001|Overall Study|Withdrawal by Subject|1|||
149824773|NCT03465891|540488621|FG000|Overall Study|Disease progression|1|||
149824774|NCT03465891|540488622|FG001|Overall Study|Disease progression|0|||
149824775|NCT02737306|540488624|FG000|Overall Study|Adverse Event|3|||
149824776|NCT02737306|540488625|FG001|Overall Study|Adverse Event|0|||
149824777|NCT02737306|540488624|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
149824778|NCT02737306|540488625|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
149824779|NCT05034731|540488626|FG000|Overall Study|Screen fail|1|||
149824780|NCT05034731|540488627|FG001|Overall Study|Screen fail|1|||
149824781|NCT03937466|540488628|FG000|Overall Study|not eligbile after the 2-week diary|9|||
149824782|NCT03937466|540488628|FG000|Overall Study|never returned their diary|6|||
149824783|NCT03937466|540488628|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
149824784|NCT03937466|540488628|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
149824785|NCT00622908|540488629|FG000|Overall Study|Protocol Violation|1|||
149824786|NCT00622908|540488630|FG001|Overall Study|Protocol Violation|0|||
149824787|NCT00622908|540488629|FG000|Overall Study|Adverse Event|0|||
149824788|NCT00622908|540488630|FG001|Overall Study|Adverse Event|1|||
149824789|NCT00622908|540488629|FG000|Overall Study|Lack of Efficacy|1|||
149945330|NCT03314935|540933944|FG001|Phase 2|Death|0|||
149945331|NCT03314935|540933945|FG002|Phase 2|Death|0|||
149945332|NCT03314935|540933946|FG003|Phase 2|Death|0|||
149945333|NCT03314935|540933947|FG004|Phase 2|Death|0|||
149945334|NCT03314935|540933948|FG005|Phase 2|Death|0|||
149945335|NCT03314935|540933949|FG006|Phase 2|Death|0|||
149945336|NCT03314935|540933950|FG007|Phase 2|Death|0|||
149945337|NCT03314935|540933951|FG008|Phase 2|Death|0|||
149945338|NCT03314935|540933952|FG009|Phase 2|Death|5|||
149945339|NCT03314935|540933953|FG010|Phase 2|Death|20|||
149945340|NCT03314935|540933954|FG011|Phase 2|Death|6|||
149945341|NCT03314935|540933955|FG012|Phase 2|Death|7|||
149945342|NCT03314935|540933956|FG013|Phase 2|Death|6|||
149945343|NCT03314935|540933957|FG014|Phase 2|Death|17|||
149945344|NCT03314935|540933943|FG000|Phase 2|Withdrawal by Subject|0|||
149945345|NCT03314935|540933944|FG001|Phase 2|Withdrawal by Subject|0|||
149945346|NCT03314935|540933945|FG002|Phase 2|Withdrawal by Subject|0|||
149945347|NCT03314935|540933946|FG003|Phase 2|Withdrawal by Subject|0|||
149945348|NCT03314935|540933947|FG004|Phase 2|Withdrawal by Subject|0|||
149945349|NCT03314935|540933948|FG005|Phase 2|Withdrawal by Subject|0|||
149945350|NCT03314935|540933949|FG006|Phase 2|Withdrawal by Subject|0|||
149945351|NCT03314935|540933950|FG007|Phase 2|Withdrawal by Subject|0|||
149945352|NCT03314935|540933951|FG008|Phase 2|Withdrawal by Subject|0|||
149945353|NCT03314935|540933952|FG009|Phase 2|Withdrawal by Subject|1|||
149945354|NCT03314935|540933953|FG010|Phase 2|Withdrawal by Subject|4|||
149945355|NCT03314935|540933954|FG011|Phase 2|Withdrawal by Subject|0|||
149945356|NCT03314935|540933955|FG012|Phase 2|Withdrawal by Subject|1|||
149945357|NCT03314935|540933956|FG013|Phase 2|Withdrawal by Subject|0|||
150170401|NCT01235949|541759073|FG012|Booster Phase|Migrated/moved from study area|1|||
150170402|NCT01235949|541759074|FG013|Booster Phase|Migrated/moved from study area|0|||
149824790|NCT00622908|540488630|FG001|Overall Study|Lack of Efficacy|7|||
149824791|NCT00622908|540488629|FG000|Overall Study|Lost to Follow-up|1|||
149824792|NCT00622908|540488630|FG001|Overall Study|Lost to Follow-up|0|||
149824793|NCT00622908|540488629|FG000|Overall Study|Refusal|0|||
149824794|NCT00622908|540488630|FG001|Overall Study|Refusal|1|||
149824795|NCT00622908|540488629|FG000|Overall Study|Termination by study sponser|0|||
149824796|NCT00622908|540488630|FG001|Overall Study|Termination by study sponser|1|||
149824797|NCT03213210|540488631|FG000|Overall Study|Lost to Follow-up|2|||
149824798|NCT03213210|540488631|FG000|Overall Study|Study termination|3|||
149824799|NCT00684671|540488637|FG000|Overall Study|Adverse Event|1|||
149824800|NCT00684671|540488638|FG001|Overall Study|Adverse Event|0|||
149824801|NCT00684671|540488639|FG002|Overall Study|Adverse Event|0|||
149824802|NCT00684671|540488637|FG000|Overall Study|Lost to Follow-up|1|||
149824803|NCT00684671|540488638|FG001|Overall Study|Lost to Follow-up|0|||
149824804|NCT00684671|540488639|FG002|Overall Study|Lost to Follow-up|0|||
149824805|NCT00684671|540488637|FG000|Overall Study|Alcoholic dependance|1|||
149824806|NCT00684671|540488638|FG001|Overall Study|Alcoholic dependance|0|||
149824807|NCT00684671|540488639|FG002|Overall Study|Alcoholic dependance|0|||
149824808|NCT02649231|540488642|FG000|Overall Study|Adverse Event|0|||
149824809|NCT02649231|540488643|FG001|Overall Study|Adverse Event|0|||
149824810|NCT02649231|540488644|FG002|Overall Study|Adverse Event|0|||
149824811|NCT02649231|540488645|FG003|Overall Study|Adverse Event|1|||
149824812|NCT02649231|540488642|FG000|Overall Study|Lost to Follow-up|2|||
149824813|NCT02649231|540488643|FG001|Overall Study|Lost to Follow-up|1|||
149824814|NCT02649231|540488644|FG002|Overall Study|Lost to Follow-up|1|||
149824815|NCT02649231|540488645|FG003|Overall Study|Lost to Follow-up|0|||
149824816|NCT02649231|540488642|FG000|Overall Study|Withdrawal by Subject|0|||
149824817|NCT02649231|540488643|FG001|Overall Study|Withdrawal by Subject|1|||
149824818|NCT02649231|540488644|FG002|Overall Study|Withdrawal by Subject|0|||
149824819|NCT02649231|540488645|FG003|Overall Study|Withdrawal by Subject|1|||
149824820|NCT02649231|540488642|FG000|Overall Study|Protocol Violation|2|||
149824821|NCT02649231|540488643|FG001|Overall Study|Protocol Violation|1|||
149945358|NCT03314935|540933957|FG014|Phase 2|Withdrawal by Subject|1|||
150033197|NCT01247324|541260917|FG001|Overall Study|Non-compliance|2|||
150170403|NCT01235949|541759075|FG014|Booster Phase|Migrated/moved from study area|0|||
149824822|NCT02649231|540488644|FG002|Overall Study|Protocol Violation|1|||
149824823|NCT02649231|540488645|FG003|Overall Study|Protocol Violation|0|||
149824824|NCT00437281|540488646|FG000|Overall Study|Adverse Event|0|||
149945359|NCT03314935|540933943|FG000|Phase 2|Progressive Disease|0|||
149945360|NCT03314935|540933944|FG001|Phase 2|Progressive Disease|0|||
149945361|NCT03314935|540933945|FG002|Phase 2|Progressive Disease|0|||
149945362|NCT03314935|540933946|FG003|Phase 2|Progressive Disease|0|||
149945363|NCT03314935|540933947|FG004|Phase 2|Progressive Disease|0|||
149945364|NCT03314935|540933948|FG005|Phase 2|Progressive Disease|0|||
149945365|NCT03314935|540933949|FG006|Phase 2|Progressive Disease|0|||
149824825|NCT00437281|540488647|FG001|Overall Study|Adverse Event|0|||
149824826|NCT00437281|540488648|FG002|Overall Study|Adverse Event|0|||
149945366|NCT03314935|540933950|FG007|Phase 2|Progressive Disease|0|||
149945367|NCT03314935|540933951|FG008|Phase 2|Progressive Disease|0|||
149945368|NCT03314935|540933952|FG009|Phase 2|Progressive Disease|1|||
149824827|NCT00437281|540488649|FG003|Overall Study|Adverse Event|1|||
149824828|NCT00437281|540488650|FG004|Overall Study|Adverse Event|0|||
149824829|NCT00437281|540488651|FG005|Overall Study|Adverse Event|1|||
149824830|NCT00437281|540488652|FG006|Overall Study|Adverse Event|0|||
149824831|NCT00437281|540488653|FG007|Overall Study|Adverse Event|0|||
149824832|NCT00437281|540488654|FG008|Overall Study|Adverse Event|0|||
149824833|NCT00437281|540488655|FG009|Overall Study|Adverse Event|1|||
149824834|NCT00437281|540488656|FG010|Overall Study|Adverse Event|0|||
149824835|NCT00437281|540488657|FG011|Overall Study|Adverse Event|0|||
149824836|NCT00437281|540488658|FG012|Overall Study|Adverse Event|0|||
149824837|NCT00437281|540488659|FG013|Overall Study|Adverse Event|1|||
149824838|NCT00437281|540488660|FG014|Overall Study|Adverse Event|1|||
149824839|NCT00437281|540488661|FG015|Overall Study|Adverse Event|0|||
149824840|NCT00437281|540488662|FG016|Overall Study|Adverse Event|0|||
149824841|NCT00437281|540488663|FG017|Overall Study|Adverse Event|0|||
149824842|NCT00437281|540488664|FG018|Overall Study|Adverse Event|1|||
149824843|NCT00437281|540488665|FG019|Overall Study|Adverse Event|0|||
149824844|NCT00437281|540488646|FG000|Overall Study|Lost to Follow-up|0|||
149824845|NCT00437281|540488647|FG001|Overall Study|Lost to Follow-up|0|||
149824846|NCT00437281|540488648|FG002|Overall Study|Lost to Follow-up|0|||
149824847|NCT00437281|540488649|FG003|Overall Study|Lost to Follow-up|0|||
149824848|NCT00437281|540488650|FG004|Overall Study|Lost to Follow-up|0|||
149945369|NCT03314935|540933953|FG010|Phase 2|Progressive Disease|1|||
149945370|NCT03314935|540933954|FG011|Phase 2|Progressive Disease|1|||
149945371|NCT03314935|540933955|FG012|Phase 2|Progressive Disease|2|||
149945372|NCT03314935|540933956|FG013|Phase 2|Progressive Disease|0|||
149945373|NCT03314935|540933957|FG014|Phase 2|Progressive Disease|1|||
149945374|NCT03314935|540933943|FG000|Phase 2|Study Terminated by Sponsor|0|||
149945375|NCT03314935|540933944|FG001|Phase 2|Study Terminated by Sponsor|0|||
149945376|NCT03314935|540933945|FG002|Phase 2|Study Terminated by Sponsor|0|||
149945377|NCT03314935|540933946|FG003|Phase 2|Study Terminated by Sponsor|0|||
149945378|NCT03314935|540933947|FG004|Phase 2|Study Terminated by Sponsor|0|||
149945379|NCT03314935|540933948|FG005|Phase 2|Study Terminated by Sponsor|0|||
149945380|NCT03314935|540933949|FG006|Phase 2|Study Terminated by Sponsor|0|||
149945381|NCT03314935|540933950|FG007|Phase 2|Study Terminated by Sponsor|0|||
149945382|NCT03314935|540933951|FG008|Phase 2|Study Terminated by Sponsor|0|||
149945383|NCT03314935|540933952|FG009|Phase 2|Study Terminated by Sponsor|0|||
149945384|NCT03314935|540933953|FG010|Phase 2|Study Terminated by Sponsor|7|||
149945385|NCT03314935|540933954|FG011|Phase 2|Study Terminated by Sponsor|2|||
149945386|NCT03314935|540933955|FG012|Phase 2|Study Terminated by Sponsor|1|||
149945387|NCT03314935|540933956|FG013|Phase 2|Study Terminated by Sponsor|4|||
149945388|NCT03314935|540933957|FG014|Phase 2|Study Terminated by Sponsor|4|||
149824849|NCT00437281|540488651|FG005|Overall Study|Lost to Follow-up|0|||
149824850|NCT00437281|540488652|FG006|Overall Study|Lost to Follow-up|0|||
149824851|NCT00437281|540488653|FG007|Overall Study|Lost to Follow-up|0|||
149824852|NCT00437281|540488654|FG008|Overall Study|Lost to Follow-up|0|||
149824853|NCT00437281|540488655|FG009|Overall Study|Lost to Follow-up|0|||
149824854|NCT00437281|540488656|FG010|Overall Study|Lost to Follow-up|0|||
149824855|NCT00437281|540488657|FG011|Overall Study|Lost to Follow-up|0|||
149824856|NCT00437281|540488658|FG012|Overall Study|Lost to Follow-up|0|||
149824857|NCT00437281|540488659|FG013|Overall Study|Lost to Follow-up|0|||
150170404|NCT01235949|541759076|FG015|Booster Phase|Migrated/moved from study area|0|||
149824858|NCT00437281|540488660|FG014|Overall Study|Lost to Follow-up|0|||
149824859|NCT00437281|540488661|FG015|Overall Study|Lost to Follow-up|0|||
149824860|NCT00437281|540488662|FG016|Overall Study|Lost to Follow-up|0|||
149824861|NCT00437281|540488663|FG017|Overall Study|Lost to Follow-up|0|||
149824862|NCT00437281|540488664|FG018|Overall Study|Lost to Follow-up|0|||
149824863|NCT00437281|540488665|FG019|Overall Study|Lost to Follow-up|1|||
149824864|NCT03402893|540488669|FG000|Overall Study|Withdrawal by Subject|1|||
149824865|NCT01411995|540488672|FG000|Overall Study|Failed IUD insertion|0|||
149824866|NCT01411995|540488673|FG001|Overall Study|Failed IUD insertion|1|||
149824867|NCT02292238|540488679|FG000|Overall Study|Protocol Violation|1|||
149824868|NCT02292238|540488680|FG001|Overall Study|Protocol Violation|2|||
149824869|NCT02292238|540488679|FG000|Overall Study|Withdrawal by Subject|2|||
149824870|NCT02292238|540488680|FG001|Overall Study|Withdrawal by Subject|1|||
149824871|NCT02292238|540488679|FG000|Overall Study|Lost to Follow-up|1|||
149824872|NCT02292238|540488680|FG001|Overall Study|Lost to Follow-up|0|||
149824873|NCT02292238|540488679|FG000|Overall Study|Physician Decision|0|||
149824874|NCT02292238|540488680|FG001|Overall Study|Physician Decision|1|||
149824875|NCT01754259|540488683|FG000|Overall Study|Withdrawal by Subject|2|||
149824876|NCT01754259|540488684|FG001|Overall Study|Withdrawal by Subject|4|||
149824877|NCT01754259|540488683|FG000|Overall Study|Adverse Event|3|||
149824878|NCT01754259|540488684|FG001|Overall Study|Adverse Event|1|||
149824879|NCT01754259|540488683|FG000|Overall Study|Lost to Follow-up|0|||
149824880|NCT01754259|540488684|FG001|Overall Study|Lost to Follow-up|1|||
149824881|NCT02041702|540488689|FG000|Overall Study|Lost to Follow-up|1|||
149824882|NCT02041702|540488690|FG001|Overall Study|Lost to Follow-up|6|||
149824883|NCT02041702|540488689|FG000|Overall Study|Death|4|||
149824884|NCT02041702|540488690|FG001|Overall Study|Death|0|||
149824885|NCT02041702|540488689|FG000|Overall Study|Withdrawal by Subject|4|||
149824886|NCT02041702|540488690|FG001|Overall Study|Withdrawal by Subject|3|||
149824887|NCT02041702|540488689|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
149824888|NCT02041702|540488690|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
149824889|NCT02041702|540488689|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
149824890|NCT02041702|540488690|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
149824891|NCT00203307|540488691|FG000|First Intervention|Adverse Event|2|||
149824892|NCT00203307|540488692|FG001|First Intervention|Adverse Event|0|||
149824893|NCT01364870|540488697|FG000|Overall Study|Withdrawal by Subject|13|||
149824894|NCT01364870|540488698|FG001|Overall Study|Withdrawal by Subject|24|||
149824895|NCT01364870|540488699|FG002|Overall Study|Withdrawal by Subject|10|||
149824896|NCT01364870|540488697|FG000|Overall Study|Adverse Event|8|||
149824897|NCT01364870|540488698|FG001|Overall Study|Adverse Event|6|||
149824898|NCT01364870|540488699|FG002|Overall Study|Adverse Event|4|||
149824899|NCT01364870|540488697|FG000|Overall Study|Protocol Violation|1|||
149824900|NCT01364870|540488698|FG001|Overall Study|Protocol Violation|0|||
149824901|NCT01364870|540488699|FG002|Overall Study|Protocol Violation|0|||
149824902|NCT01618305|540488700|FG000|Overall Study|Death|0|||
149824903|NCT01618305|540488701|FG001|Overall Study|Death|1|||
149824904|NCT01618305|540488700|FG000|Overall Study|Lost to Follow-up|11|||
149824905|NCT01618305|540488701|FG001|Overall Study|Lost to Follow-up|7|||
149824906|NCT01618305|540488700|FG000|Overall Study|Protocol Violation|1|||
149824907|NCT01618305|540488701|FG001|Overall Study|Protocol Violation|0|||
149824908|NCT01618305|540488700|FG000|Overall Study|Withdrawal by Subject|3|||
149824909|NCT01618305|540488701|FG001|Overall Study|Withdrawal by Subject|2|||
149824910|NCT01309919|540488718|FG000|Overall Study|Did not receive a postpartum IUD|17|||
149824911|NCT01309919|540488719|FG001|Overall Study|Did not receive a postpartum IUD|48|||
149824912|NCT02102490|540488720|FG000|Overall Study|Death|6|||
149824913|NCT02102490|540488720|FG000|Overall Study|Lost to Follow-up|1|||
149824914|NCT00095199|540488721|FG000|Overall Study|Adverse Event|40|||
149824915|NCT00095199|540488722|FG001|Overall Study|Adverse Event|22|||
149824916|NCT00095199|540488723|FG002|Overall Study|Adverse Event|26|||
149824917|NCT00095199|540488724|FG003|Overall Study|Adverse Event|11|||
149824918|NCT00095199|540488721|FG000|Overall Study|Progressive disease|213|||
149824919|NCT00095199|540488722|FG001|Overall Study|Progressive disease|179|||
149824920|NCT00095199|540488723|FG002|Overall Study|Progressive disease|105|||
149824921|NCT00095199|540488724|FG003|Overall Study|Progressive disease|98|||
149824922|NCT00095199|540488721|FG000|Overall Study|Death|10|||
149824923|NCT00095199|540488722|FG001|Overall Study|Death|6|||
149824924|NCT00095199|540488723|FG002|Overall Study|Death|11|||
149824925|NCT00095199|540488724|FG003|Overall Study|Death|9|||
149824926|NCT00095199|540488721|FG000|Overall Study|Withdrawal by Subject|21|||
149824927|NCT00095199|540488722|FG001|Overall Study|Withdrawal by Subject|16|||
149824928|NCT00095199|540488723|FG002|Overall Study|Withdrawal by Subject|13|||
149824929|NCT00095199|540488724|FG003|Overall Study|Withdrawal by Subject|22|||
149824930|NCT00095199|540488721|FG000|Overall Study|Protocol Violation|4|||
149824931|NCT00095199|540488722|FG001|Overall Study|Protocol Violation|4|||
149824932|NCT00095199|540488723|FG002|Overall Study|Protocol Violation|2|||
149824933|NCT00095199|540488724|FG003|Overall Study|Protocol Violation|0|||
149824934|NCT00095199|540488721|FG000|Overall Study|Liver function test results elevated|0|||
149824935|NCT00095199|540488722|FG001|Overall Study|Liver function test results elevated|0|||
149824936|NCT00095199|540488723|FG002|Overall Study|Liver function test results elevated|1|||
149824937|NCT00095199|540488724|FG003|Overall Study|Liver function test results elevated|1|||
149824938|NCT00095199|540488721|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
149824939|NCT00095199|540488722|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
149824940|NCT00095199|540488723|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
149824941|NCT00095199|540488724|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
149824942|NCT00095199|540488721|FG000|Overall Study|Physician Decision|5|||
149824943|NCT00095199|540488722|FG001|Overall Study|Physician Decision|6|||
149824944|NCT00095199|540488723|FG002|Overall Study|Physician Decision|1|||
149824945|NCT00095199|540488724|FG003|Overall Study|Physician Decision|1|||
149824946|NCT00095199|540488721|FG000|Overall Study|Not eligible|1|||
149824947|NCT00095199|540488722|FG001|Overall Study|Not eligible|7|||
149824948|NCT00095199|540488723|FG002|Overall Study|Not eligible|0|||
149824949|NCT00095199|540488724|FG003|Overall Study|Not eligible|1|||
149824950|NCT00095199|540488721|FG000|Overall Study|Started Palliative Radiotherapy|1|||
149824951|NCT00095199|540488722|FG001|Overall Study|Started Palliative Radiotherapy|0|||
149824952|NCT00095199|540488723|FG002|Overall Study|Started Palliative Radiotherapy|0|||
149824953|NCT00095199|540488724|FG003|Overall Study|Started Palliative Radiotherapy|0|||
149824954|NCT00095199|540488721|FG000|Overall Study|Started radiotherapy regimen|0|||
149824955|NCT00095199|540488722|FG001|Overall Study|Started radiotherapy regimen|1|||
149824956|NCT00095199|540488723|FG002|Overall Study|Started radiotherapy regimen|0|||
149824957|NCT00095199|540488724|FG003|Overall Study|Started radiotherapy regimen|0|||
149824958|NCT00095199|540488721|FG000|Overall Study|Primary tumor removed in other surgery|0|||
149824959|NCT00095199|540488722|FG001|Overall Study|Primary tumor removed in other surgery|1|||
149824960|NCT00095199|540488723|FG002|Overall Study|Primary tumor removed in other surgery|0|||
149824961|NCT00095199|540488724|FG003|Overall Study|Primary tumor removed in other surgery|0|||
149824962|NCT00095199|540488721|FG000|Overall Study|Data inadvertently lost by site|1|||
149824963|NCT00095199|540488722|FG001|Overall Study|Data inadvertently lost by site|0|||
149824964|NCT00095199|540488723|FG002|Overall Study|Data inadvertently lost by site|0|||
149824965|NCT00095199|540488724|FG003|Overall Study|Data inadvertently lost by site|0|||
149824966|NCT01736553|540488763|FG000|Overall Study|Death|12|||
149824967|NCT01736553|540488764|FG001|Overall Study|Death|0|||
149824968|NCT01736553|540488763|FG000|Overall Study|Withdrawal by Subject|5|||
149824969|NCT01736553|540488764|FG001|Overall Study|Withdrawal by Subject|2|||
149824970|NCT01736553|540488763|FG000|Overall Study|Lost to Follow-up|2|||
149824971|NCT01736553|540488764|FG001|Overall Study|Lost to Follow-up|2|||
149824972|NCT01896297|540488765|FG000|Overall Study|Died in post treatment phase|1|||
149824973|NCT00003782|540488766|FG000|Overall Study|No follow up data|30|||
149824974|NCT00003782|540488767|FG001|Overall Study|No follow up data|31|||
149824975|NCT00003782|540488768|FG002|Overall Study|No follow up data|26|||
149824976|NCT01890707|540488769|FG000|Overall Study|Lost to Follow-up|1|||
149824977|NCT01890707|540488770|FG001|Overall Study|Lost to Follow-up|1|||
149824978|NCT00385541|540488772|FG000|Overall Study|severe pain, clinician requested unblind|0|||
149824979|NCT00385541|540488773|FG001|Overall Study|severe pain, clinician requested unblind|1|||
149824980|NCT00929708|540488774|FG000|Overall Study|Protocol Violation|2|||
149824981|NCT00929708|540488775|FG001|Overall Study|Protocol Violation|1|||
149824982|NCT00929708|540488776|FG002|Overall Study|Protocol Violation|1|||
149824983|NCT00929708|540488777|FG003|Overall Study|Protocol Violation|1|||
149824984|NCT00929708|540488778|FG004|Overall Study|Protocol Violation|1|||
149824985|NCT00929708|540488774|FG000|Overall Study|Withdrawal by Subject|2|||
149824986|NCT00929708|540488775|FG001|Overall Study|Withdrawal by Subject|0|||
149824987|NCT00929708|540488776|FG002|Overall Study|Withdrawal by Subject|0|||
149824988|NCT00929708|540488777|FG003|Overall Study|Withdrawal by Subject|2|||
149824989|NCT00929708|540488778|FG004|Overall Study|Withdrawal by Subject|1|||
149824990|NCT00929708|540488774|FG000|Overall Study|Adverse Event|0|||
149824991|NCT00929708|540488775|FG001|Overall Study|Adverse Event|0|||
149824992|NCT00929708|540488776|FG002|Overall Study|Adverse Event|0|||
149824993|NCT00929708|540488777|FG003|Overall Study|Adverse Event|0|||
149824994|NCT00929708|540488778|FG004|Overall Study|Adverse Event|3|||
149824995|NCT00929708|540488774|FG000|Overall Study|Physician Decision|0|||
149824996|NCT00929708|540488775|FG001|Overall Study|Physician Decision|2|||
149824997|NCT00929708|540488776|FG002|Overall Study|Physician Decision|2|||
149824998|NCT00929708|540488777|FG003|Overall Study|Physician Decision|2|||
149824999|NCT00929708|540488778|FG004|Overall Study|Physician Decision|1|||
149825000|NCT00929708|540488774|FG000|Overall Study|Lost to Follow-up|0|||
149825001|NCT00929708|540488775|FG001|Overall Study|Lost to Follow-up|0|||
149825002|NCT00929708|540488776|FG002|Overall Study|Lost to Follow-up|0|||
149825003|NCT00929708|540488777|FG003|Overall Study|Lost to Follow-up|1|||
149825004|NCT00929708|540488778|FG004|Overall Study|Lost to Follow-up|0|||
149825005|NCT02154529|540488779|FG000|Overall Study|Death|1|||
149825006|NCT02154529|540488780|FG001|Overall Study|Death|1|||
149825007|NCT02154529|540488781|FG002|Overall Study|Death|5|||
149825008|NCT02154529|540488782|FG003|Overall Study|Death|1|||
149825009|NCT02154529|540488779|FG000|Overall Study|Termination of study by sponsor|2|||
149825010|NCT02154529|540488780|FG001|Overall Study|Termination of study by sponsor|2|||
149825011|NCT02154529|540488781|FG002|Overall Study|Termination of study by sponsor|3|||
149825012|NCT02154529|540488782|FG003|Overall Study|Termination of study by sponsor|1|||
149825013|NCT02154529|540488779|FG000|Overall Study|Lost to Follow-up|1|||
149825014|NCT02154529|540488780|FG001|Overall Study|Lost to Follow-up|0|||
149825015|NCT02154529|540488781|FG002|Overall Study|Lost to Follow-up|0|||
149825016|NCT02154529|540488782|FG003|Overall Study|Lost to Follow-up|0|||
149825017|NCT02761980|540490458|FG000|Overall Study|Adverse Event|4|||
149825018|NCT02761980|540490459|FG001|Overall Study|Adverse Event|6|||
149825019|NCT02761980|540490460|FG002|Overall Study|Adverse Event|5|||
150170405|NCT01235949|541759077|FG016|Booster Phase|Migrated/moved from study area|0|||
150170406|NCT01235949|541759078|FG017|Booster Phase|Migrated/moved from study area|1|||
150170407|NCT01235949|541759061|FG000|Booster Phase|Adverse Event|0|||
149945389|NCT03314935|540933943|FG000|Phase 2|Lost to Follow-up|0|||
149945390|NCT03314935|540933944|FG001|Phase 2|Lost to Follow-up|0|||
150170408|NCT01235949|541759062|FG001|Booster Phase|Adverse Event|0|||
149825020|NCT02761980|540490461|FG003|Overall Study|Adverse Event|6|||
149825021|NCT02761980|540490458|FG000|Overall Study|Withdrawal by Subject|0|||
149825022|NCT02761980|540490459|FG001|Overall Study|Withdrawal by Subject|1|||
149825023|NCT02761980|540490460|FG002|Overall Study|Withdrawal by Subject|0|||
149825024|NCT02761980|540490461|FG003|Overall Study|Withdrawal by Subject|0|||
149825025|NCT02761980|540490458|FG000|Overall Study|Other|0|||
149825026|NCT02761980|540490459|FG001|Overall Study|Other|0|||
149825027|NCT02761980|540490460|FG002|Overall Study|Other|1|||
149825028|NCT02761980|540490461|FG003|Overall Study|Other|0|||
149825029|NCT01907087|540490468|FG000|Overall Study|Withdrawal by Subject|1|||
149825030|NCT03312530|540490469|FG000|Overall Study|Death|5|||
149825031|NCT03312530|540490470|FG001|Overall Study|Death|5|||
149825032|NCT03312530|540490471|FG002|Overall Study|Death|4|||
149825033|NCT03312530|540490472|FG003|Overall Study|Death|10|||
149945391|NCT03314935|540933945|FG002|Phase 2|Lost to Follow-up|0|||
149945392|NCT03314935|540933946|FG003|Phase 2|Lost to Follow-up|0|||
149945393|NCT03314935|540933947|FG004|Phase 2|Lost to Follow-up|0|||
149945394|NCT03314935|540933948|FG005|Phase 2|Lost to Follow-up|0|||
149945395|NCT03314935|540933949|FG006|Phase 2|Lost to Follow-up|0|||
149945396|NCT03314935|540933950|FG007|Phase 2|Lost to Follow-up|0|||
149945397|NCT03314935|540933951|FG008|Phase 2|Lost to Follow-up|0|||
149945398|NCT03314935|540933952|FG009|Phase 2|Lost to Follow-up|1|||
149945399|NCT03314935|540933953|FG010|Phase 2|Lost to Follow-up|0|||
149945400|NCT03314935|540933954|FG011|Phase 2|Lost to Follow-up|0|||
149945401|NCT03314935|540933955|FG012|Phase 2|Lost to Follow-up|0|||
149945402|NCT03314935|540933956|FG013|Phase 2|Lost to Follow-up|0|||
149945403|NCT03314935|540933957|FG014|Phase 2|Lost to Follow-up|1|||
149945404|NCT03314935|540933943|FG000|Phase 2|Physician Decision|0|||
149945405|NCT03314935|540933944|FG001|Phase 2|Physician Decision|0|||
149945406|NCT03314935|540933945|FG002|Phase 2|Physician Decision|0|||
149945407|NCT03314935|540933946|FG003|Phase 2|Physician Decision|0|||
149945408|NCT03314935|540933947|FG004|Phase 2|Physician Decision|0|||
149945409|NCT03314935|540933948|FG005|Phase 2|Physician Decision|0|||
149945410|NCT03314935|540933949|FG006|Phase 2|Physician Decision|0|||
149945411|NCT03314935|540933950|FG007|Phase 2|Physician Decision|0|||
149945412|NCT03314935|540933951|FG008|Phase 2|Physician Decision|0|||
149945413|NCT03314935|540933952|FG009|Phase 2|Physician Decision|0|||
149945414|NCT03314935|540933953|FG010|Phase 2|Physician Decision|1|||
149945415|NCT03314935|540933954|FG011|Phase 2|Physician Decision|0|||
149945416|NCT03314935|540933955|FG012|Phase 2|Physician Decision|0|||
149945417|NCT03314935|540933956|FG013|Phase 2|Physician Decision|0|||
149945418|NCT03314935|540933957|FG014|Phase 2|Physician Decision|0|||
149945419|NCT05352399|540933970|FG000|Overall Study|Discontinued intervention|6|||
149945420|NCT02340949|540933971|FG000|Overall Study|Adverse Event|4|||
149945421|NCT02340949|540933972|FG001|Overall Study|Adverse Event|2|||
149945422|NCT02340949|540933971|FG000|Overall Study|Withdrawal by Subject|2|||
149945423|NCT02340949|540933972|FG001|Overall Study|Withdrawal by Subject|0|||
149945424|NCT02340949|540933971|FG000|Overall Study|Progression disease|6|||
149945425|NCT02340949|540933972|FG001|Overall Study|Progression disease|2|||
149945426|NCT02340949|540933971|FG000|Overall Study|Death|3|||
149945427|NCT02340949|540933972|FG001|Overall Study|Death|0|||
149945428|NCT02340949|540933971|FG000|Overall Study|Physician Decision|1|||
149945429|NCT02340949|540933972|FG001|Overall Study|Physician Decision|0|||
149945430|NCT01192178|540933973|FG000|Overall Study|Withdrawal by Subject|6|||
149945431|NCT01192178|540933974|FG001|Overall Study|Withdrawal by Subject|10|||
149945432|NCT01192178|540933973|FG000|Overall Study|Protocol Violation|10|||
149945433|NCT01192178|540933974|FG001|Overall Study|Protocol Violation|3|||
149945434|NCT01192178|540933973|FG000|Overall Study|Physician Decision|2|||
149945435|NCT01192178|540933974|FG001|Overall Study|Physician Decision|4|||
149945436|NCT01192178|540933973|FG000|Overall Study|Lost to Follow-up|3|||
149945437|NCT01192178|540933974|FG001|Overall Study|Lost to Follow-up|3|||
149945438|NCT01192178|540933973|FG000|Overall Study|Adverse Event|2|||
149945439|NCT01192178|540933974|FG001|Overall Study|Adverse Event|1|||
149945440|NCT01192178|540933973|FG000|Overall Study|Lack of Efficacy|1|||
149945441|NCT01192178|540933974|FG001|Overall Study|Lack of Efficacy|2|||
149945442|NCT01977846|540933977|FG000|Total Study - Prospective|Death|0|||
149945443|NCT01977846|540933978|FG001|Total Study - Prospective|Death|1|||
149945444|NCT01977846|540933977|FG000|Total Study - Prospective|Lost to Follow-up|0|||
149945445|NCT01977846|540933978|FG001|Total Study - Prospective|Lost to Follow-up|8|||
149945446|NCT01977846|540933977|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
149945447|NCT01977846|540933978|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
149945448|NCT01977846|540933977|FG000|Total Study - Prospective|Not available at time of visit|0|||
149945449|NCT01977846|540933978|FG001|Total Study - Prospective|Not available at time of visit|5|||
149945450|NCT01977846|540933977|FG000|Total Study - Prospective|No show|0|||
149945451|NCT01977846|540933978|FG001|Total Study - Prospective|No show|1|||
149945452|NCT01977846|540933977|FG000|Total Study - Prospective|Protocol Violation|0|||
149945453|NCT01977846|540933978|FG001|Total Study - Prospective|Protocol Violation|1|||
149945454|NCT02164916|540933979|FG000|Overall Study|Adverse Event|3|||
149945455|NCT02164916|540933980|FG001|Overall Study|Adverse Event|8|||
149945456|NCT02164916|540933979|FG000|Overall Study|Death|1|||
149945457|NCT02164916|540933980|FG001|Overall Study|Death|1|||
149945458|NCT02164916|540933979|FG000|Overall Study|Refusal unrelated to adverse event|3|||
149945459|NCT02164916|540933980|FG001|Overall Study|Refusal unrelated to adverse event|7|||
149945460|NCT02164916|540933979|FG000|Overall Study|Progression|37|||
149945461|NCT02164916|540933980|FG001|Overall Study|Progression|26|||
149945462|NCT02164916|540933979|FG000|Overall Study|Not protocol specified|5|||
149945463|NCT02164916|540933980|FG001|Overall Study|Not protocol specified|1|||
149825034|NCT03312530|540490473|FG004|Overall Study|Death|8|||
149945464|NCT02164916|540933979|FG000|Overall Study|Reason under review|1|||
149945465|NCT02164916|540933980|FG001|Overall Study|Reason under review|6|||
149945466|NCT02164916|540933979|FG000|Overall Study|Not eligible|2|||
149945467|NCT02164916|540933980|FG001|Overall Study|Not eligible|5|||
149945468|NCT00296517|540933981|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
149945469|NCT00296517|540933982|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
149825035|NCT03312530|540490469|FG000|Overall Study|Lost to Follow-up|0|||
149825036|NCT03312530|540490470|FG001|Overall Study|Lost to Follow-up|0|||
149825037|NCT03312530|540490471|FG002|Overall Study|Lost to Follow-up|0|||
149825038|NCT03312530|540490472|FG003|Overall Study|Lost to Follow-up|1|||
149825039|NCT03312530|540490473|FG004|Overall Study|Lost to Follow-up|0|||
149825040|NCT03312530|540490469|FG000|Overall Study|Participant in another sponsor study.|0|||
149825041|NCT03312530|540490470|FG001|Overall Study|Participant in another sponsor study.|0|||
149825042|NCT03312530|540490471|FG002|Overall Study|Participant in another sponsor study.|0|||
149825043|NCT03312530|540490472|FG003|Overall Study|Participant in another sponsor study.|1|||
149825044|NCT03312530|540490473|FG004|Overall Study|Participant in another sponsor study.|0|||
149825045|NCT03312530|540490469|FG000|Overall Study|Study terminated by sponsor|1|||
149825046|NCT03312530|540490470|FG001|Overall Study|Study terminated by sponsor|0|||
149825047|NCT03312530|540490471|FG002|Overall Study|Study terminated by sponsor|2|||
149825048|NCT03312530|540490472|FG003|Overall Study|Study terminated by sponsor|3|||
149825049|NCT03312530|540490473|FG004|Overall Study|Study terminated by sponsor|7|||
149825050|NCT03312530|540490469|FG000|Overall Study|Withdrawal by Subject|0|||
149825051|NCT03312530|540490470|FG001|Overall Study|Withdrawal by Subject|1|||
149825052|NCT03312530|540490471|FG002|Overall Study|Withdrawal by Subject|0|||
149825053|NCT03312530|540490472|FG003|Overall Study|Withdrawal by Subject|0|||
149825054|NCT03312530|540490473|FG004|Overall Study|Withdrawal by Subject|0|||
149825055|NCT03312530|540490469|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149825056|NCT03312530|540490470|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149825057|NCT03312530|540490471|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149825058|NCT03312530|540490472|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
149825059|NCT03312530|540490473|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149825060|NCT02192905|540490479|FG000|Overall Study|Lost to Follow-up|1|||
149825061|NCT04583579|540490480|FG000|Overall Study|Lost to Follow-up|4|||
149825062|NCT03093454|540490492|FG000|Overall Study|Withdrawal by Subject|1|||
149825063|NCT03093454|540490493|FG001|Overall Study|Withdrawal by Subject|1|||
149825064|NCT03093454|540490492|FG000|Overall Study|Scheduling conflict|3|||
149825065|NCT03093454|540490493|FG001|Overall Study|Scheduling conflict|1|||
149825066|NCT03093454|540490492|FG000|Overall Study|Physician Decision|2|||
149825067|NCT03093454|540490493|FG001|Overall Study|Physician Decision|1|||
149825068|NCT01612000|540490501|FG000|Overall Study|Lost to Follow-up|6|||
149825069|NCT01612000|540490502|FG001|Overall Study|Lost to Follow-up|4|||
149825070|NCT01612000|540490503|FG002|Overall Study|Lost to Follow-up|4|||
149825071|NCT01612000|540490504|FG003|Overall Study|Lost to Follow-up|8|||
149825072|NCT01612000|540490501|FG000|Overall Study|Physician Decision|0|||
149825073|NCT01612000|540490502|FG001|Overall Study|Physician Decision|0|||
149825074|NCT01612000|540490503|FG002|Overall Study|Physician Decision|1|||
149825075|NCT01612000|540490504|FG003|Overall Study|Physician Decision|0|||
149825076|NCT01612000|540490501|FG000|Overall Study|Withdrawal by Subject|3|||
149825077|NCT01612000|540490502|FG001|Overall Study|Withdrawal by Subject|1|||
149825078|NCT01612000|540490503|FG002|Overall Study|Withdrawal by Subject|2|||
149825079|NCT01612000|540490504|FG003|Overall Study|Withdrawal by Subject|2|||
149825080|NCT02173704|540490505|FG000|Overall Study|Adverse Event|1|||
149825081|NCT02173704|540490506|FG001|Overall Study|Adverse Event|0|||
149825082|NCT02173704|540490505|FG000|Overall Study|Lost to Follow-up|1|||
149825083|NCT02173704|540490506|FG001|Overall Study|Lost to Follow-up|0|||
149825084|NCT02173704|540490505|FG000|Overall Study|Other|1|||
149825085|NCT02173704|540490506|FG001|Overall Study|Other|0|||
149825086|NCT02173704|540490505|FG000|Overall Study|Protocol Violation|1|||
149945470|NCT00296517|540933981|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
150170409|NCT01235949|541759063|FG002|Booster Phase|Adverse Event|0|||
150170410|NCT01235949|541759064|FG003|Booster Phase|Adverse Event|0|||
149825087|NCT02173704|540490506|FG001|Overall Study|Protocol Violation|0|||
149825088|NCT02173704|540490505|FG000|Overall Study|Withdrawal by Subject|9|||
149825089|NCT02173704|540490506|FG001|Overall Study|Withdrawal by Subject|4|||
149825090|NCT01180244|540490517|FG000|Overall Study|Lack of Efficacy|0|||
149825091|NCT01180244|540490518|FG001|Overall Study|Lack of Efficacy|7|||
149825092|NCT01180244|540490517|FG000|Overall Study|Physician Decision|3|||
149825093|NCT01180244|540490518|FG001|Overall Study|Physician Decision|0|||
149825094|NCT01180244|540490517|FG000|Overall Study|Adverse Event|1|||
149825095|NCT01180244|540490518|FG001|Overall Study|Adverse Event|0|||
149825096|NCT01180244|540490517|FG000|Overall Study|Withdrawal by Subject|0|||
149825097|NCT01180244|540490518|FG001|Overall Study|Withdrawal by Subject|1|||
149825098|NCT01180244|540490517|FG000|Overall Study|Protocol Violation|1|||
149825099|NCT01180244|540490518|FG001|Overall Study|Protocol Violation|0|||
149825100|NCT01180244|540490517|FG000|Overall Study|Lost to Follow-up|1|||
149825101|NCT01180244|540490518|FG001|Overall Study|Lost to Follow-up|0|||
149825102|NCT00620763|540490521|FG000|Period: First Intervention|Withdrawal by Subject|0|||
149825103|NCT00620763|540490522|FG001|Period: First Intervention|Withdrawal by Subject|2|||
149825104|NCT00620763|540490521|FG000|Period: First Intervention|Protocol Violation|0|||
150170411|NCT01235949|541759065|FG004|Booster Phase|Adverse Event|0|||
149825105|NCT00620763|540490522|FG001|Period: First Intervention|Protocol Violation|3|||
149825106|NCT00620763|540490521|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
149825107|NCT00620763|540490522|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
149825108|NCT01595009|540490523|FG000|Core|Patients completed per protocol|85|||
149825109|NCT01595009|540490524|FG001|Core|Patients completed per protocol|44|||
149825110|NCT01595009|540490525|FG002|Core|Patients completed per protocol|0|||
149825111|NCT01595009|540490526|FG003|Core|Patients completed per protocol|0|||
149825112|NCT01595009|540490523|FG000|Core|Adverse Event|19|||
149825113|NCT01595009|540490524|FG001|Core|Adverse Event|23|||
149825114|NCT01595009|540490525|FG002|Core|Adverse Event|0|||
149825115|NCT01595009|540490526|FG003|Core|Adverse Event|0|||
149825116|NCT01595009|540490523|FG000|Core|Disease progression|14|||
149825117|NCT01595009|540490524|FG001|Core|Disease progression|26|||
149825118|NCT01595009|540490525|FG002|Core|Disease progression|0|||
149825119|NCT01595009|540490526|FG003|Core|Disease progression|0|||
149825120|NCT01595009|540490523|FG000|Core|Withdrawal by Subject|4|||
149825121|NCT01595009|540490524|FG001|Core|Withdrawal by Subject|17|||
149825122|NCT01595009|540490525|FG002|Core|Withdrawal by Subject|0|||
149825123|NCT01595009|540490526|FG003|Core|Withdrawal by Subject|0|||
149825124|NCT01595009|540490523|FG000|Core|Death|3|||
149825125|NCT01595009|540490524|FG001|Core|Death|6|||
149825126|NCT01595009|540490525|FG002|Core|Death|0|||
149825127|NCT01595009|540490526|FG003|Core|Death|0|||
149825128|NCT01595009|540490523|FG000|Core|Lost to Follow-up|1|||
149825129|NCT01595009|540490524|FG001|Core|Lost to Follow-up|2|||
149825130|NCT01595009|540490525|FG002|Core|Lost to Follow-up|0|||
149825131|NCT01595009|540490526|FG003|Core|Lost to Follow-up|0|||
149825132|NCT01595009|540490523|FG000|Core|Protocol deviation|0|||
149825133|NCT01595009|540490524|FG001|Core|Protocol deviation|1|||
149825134|NCT01595009|540490525|FG002|Core|Protocol deviation|0|||
149825135|NCT01595009|540490526|FG003|Core|Protocol deviation|0|||
149825136|NCT01595009|540490523|FG000|Core|Administrative problems|0|||
149825137|NCT01595009|540490524|FG001|Core|Administrative problems|1|||
149825138|NCT01595009|540490525|FG002|Core|Administrative problems|0|||
149825139|NCT01595009|540490526|FG003|Core|Administrative problems|0|||
149825140|NCT01595009|540490523|FG000|Extension|Administrative problems|0|||
149825141|NCT01595009|540490524|FG001|Extension|Administrative problems|0|||
149825142|NCT01595009|540490525|FG002|Extension|Administrative problems|0|||
149825143|NCT01595009|540490526|FG003|Extension|Administrative problems|1|||
149825144|NCT01595009|540490523|FG000|Extension|Patients completed per protocol|0|||
149825145|NCT01595009|540490524|FG001|Extension|Patients completed per protocol|0|||
149825146|NCT01595009|540490525|FG002|Extension|Patients completed per protocol|0|||
149825147|NCT01595009|540490526|FG003|Extension|Patients completed per protocol|2|||
149825148|NCT01595009|540490523|FG000|Extension|Disease progression|0|||
149825149|NCT01595009|540490524|FG001|Extension|Disease progression|0|||
149825150|NCT01595009|540490525|FG002|Extension|Disease progression|4|||
149825151|NCT01595009|540490526|FG003|Extension|Disease progression|7|||
149825152|NCT01595009|540490523|FG000|Extension|Adverse Event|0|||
149825153|NCT01595009|540490524|FG001|Extension|Adverse Event|0|||
149825154|NCT01595009|540490525|FG002|Extension|Adverse Event|0|||
149825155|NCT01595009|540490526|FG003|Extension|Adverse Event|1|||
149825156|NCT04956666|540490528|FG000|Overall Study|Adverse Event|18|||
149825157|NCT04956666|540490528|FG000|Overall Study|Physician Decision|5|||
149825158|NCT00729859|540490529|FG000|Overall Study|Adverse Event|0|||
149825159|NCT00729859|540490530|FG001|Overall Study|Adverse Event|1|||
149825160|NCT00729859|540490531|FG002|Overall Study|Adverse Event|0|||
149825161|NCT00729859|540490529|FG000|Overall Study|Withdrawal by Subject|0|||
149825162|NCT00729859|540490530|FG001|Overall Study|Withdrawal by Subject|1|||
149825163|NCT00729859|540490531|FG002|Overall Study|Withdrawal by Subject|0|||
149825164|NCT02623829|540490538|FG000|Overall Study|Lost to Follow-up|1|||
149825165|NCT02623829|540490539|FG001|Overall Study|Lost to Follow-up|1|||
149825166|NCT00662025|540490540|FG000|Overall Study|Objective progression or relapse|51|||
149825167|NCT00662025|540490540|FG000|Overall Study|Adverse Event|7|||
149825168|NCT00662025|540490540|FG000|Overall Study|Withdrawal by Subject|1|||
149825169|NCT00662025|540490540|FG000|Overall Study|Results of other clinical study|2|||
149825170|NCT00662025|540490540|FG000|Overall Study|Target lesion cannot be evaluated|1|||
149825171|NCT00662025|540490540|FG000|Overall Study|Domestic circumstances|1|||
149825172|NCT01700621|540490541|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
149825173|NCT01700621|540490542|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
149825174|NCT01700621|540490541|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
149825175|NCT01700621|540490542|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
149825176|NCT01700621|540490541|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
149825177|NCT01700621|540490542|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
149825178|NCT02035137|540490545|FG000|Overall Study|Physician Decision|0|||
149825179|NCT02035137|540490546|FG001|Overall Study|Physician Decision|0|||
149825180|NCT02035137|540490547|FG002|Overall Study|Physician Decision|1|||
149825181|NCT02035137|540490545|FG000|Overall Study|Withdrawal by Subject|0|||
149825182|NCT02035137|540490546|FG001|Overall Study|Withdrawal by Subject|1|||
149825183|NCT02035137|540490547|FG002|Overall Study|Withdrawal by Subject|2|||
149825184|NCT02035137|540490545|FG000|Overall Study|Ineligible|0|||
149825185|NCT02035137|540490546|FG001|Overall Study|Ineligible|1|||
149825186|NCT02035137|540490547|FG002|Overall Study|Ineligible|2|||
149825187|NCT02035137|540490545|FG000|Overall Study|Disease progression prior to treatment start|2|||
149825188|NCT02035137|540490546|FG001|Overall Study|Disease progression prior to treatment start|0|||
149825189|NCT02035137|540490547|FG002|Overall Study|Disease progression prior to treatment start|0|||
149825190|NCT03349333|540490554|FG000|Overall Study|Progression of Disease|36|||
149825191|NCT03349333|540490554|FG000|Overall Study|Adverse Event|11|||
149825192|NCT03349333|540490554|FG000|Overall Study|Other|6|||
149825193|NCT03349333|540490554|FG000|Overall Study|Withdrawal by Subject|5|||
149825194|NCT03349333|540490554|FG000|Overall Study|Conditions interfere with participation|2|||
149825195|NCT03349333|540490554|FG000|Overall Study|Physician Decision|2|||
149825196|NCT03349333|540490554|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
149825197|NCT03349333|540490554|FG000|Overall Study|Patients in treatment less than 24 month|8|||
149825198|NCT02985151|540490555|FG000|Original Randomization|Withdrawal by Subject|0|||
149825199|NCT02985151|540490556|FG001|Original Randomization|Withdrawal by Subject|1|||
149825200|NCT00290745|540490557|FG000|Overall Study|Withdrawal by Subject|4|||
149825201|NCT00290745|540490557|FG000|Overall Study|Physician Decision|2|||
149825202|NCT00290745|540490557|FG000|Overall Study|Surgery after 3 months for progression|3|||
149825203|NCT00290745|540490557|FG000|Overall Study|Baseline MRI not available|3|||
149825204|NCT00783796|540490558|FG000|Overall Study|Did not receive any stent|4|||
149825205|NCT00783796|540490558|FG000|Overall Study|Received non-XIENCE V stent|1|||
149825206|NCT00783796|540490558|FG000|Overall Study|Received commercial XIENCE V stent|1|||
149825207|NCT00626925|540490563|FG000|Overall Study|Lost to Follow-up|1|||
149825208|NCT00626925|540490564|FG001|Overall Study|Lost to Follow-up|2|||
149825209|NCT00626925|540490563|FG000|Overall Study|relapse|1|||
149825210|NCT00626925|540490564|FG001|Overall Study|relapse|0|||
149825211|NCT00626925|540490563|FG000|Overall Study|Adverse effect|6|||
149825212|NCT00626925|540490564|FG001|Overall Study|Adverse effect|2|||
149825213|NCT00626925|540490563|FG000|Overall Study|Lack of Efficacy|1|||
149825214|NCT00626925|540490564|FG001|Overall Study|Lack of Efficacy|4|||
149825215|NCT00626925|540490563|FG000|Overall Study|Time constraints|3|||
149825216|NCT00626925|540490564|FG001|Overall Study|Time constraints|1|||
149825217|NCT01215942|540490570|FG000|Treatment Period|Adverse Event|15|||
149825218|NCT01215942|540490571|FG001|Treatment Period|Adverse Event|26|||
149825219|NCT01215942|540490570|FG000|Treatment Period|Death|2|||
149825220|NCT01215942|540490571|FG001|Treatment Period|Death|4|||
149825221|NCT01215942|540490570|FG000|Treatment Period|Lack of Efficacy|23|||
149825222|NCT01215942|540490571|FG001|Treatment Period|Lack of Efficacy|62|||
149825223|NCT01215942|540490570|FG000|Treatment Period|Lost to Follow-up|3|||
149825224|NCT01215942|540490571|FG001|Treatment Period|Lost to Follow-up|4|||
149825225|NCT01215942|540490570|FG000|Treatment Period|Withdrawal by Subject|17|||
149825226|NCT01215942|540490571|FG001|Treatment Period|Withdrawal by Subject|40|||
149825227|NCT01215942|540490570|FG000|Treatment Period|Physician Decision|5|||
149825228|NCT01215942|540490571|FG001|Treatment Period|Physician Decision|5|||
149825229|NCT01215942|540490570|FG000|Treatment Period|Protocol Violation|0|||
149825230|NCT01215942|540490571|FG001|Treatment Period|Protocol Violation|1|||
149825231|NCT01215942|540490570|FG000|Treatment Period|Sponsor Decision|349|||
149825232|NCT01215942|540490571|FG001|Treatment Period|Sponsor Decision|530|||
149825233|NCT01215942|540490570|FG000|Post-Treatment Follow-Up Period|Death|0|||
149825234|NCT01215942|540490571|FG001|Post-Treatment Follow-Up Period|Death|1|||
149825235|NCT01215942|540490570|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
149825236|NCT01215942|540490571|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
149825237|NCT01215942|540490570|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
149825238|NCT01215942|540490571|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
149825239|NCT01215942|540490570|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
149825240|NCT01215942|540490571|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
149825241|NCT01215942|540490570|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
149825242|NCT01215942|540490571|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
150275300|NCT02716675|542146410|FG001|Overall Study|Withdrawal by Subject|25|||
150275301|NCT02716675|542146411|FG002|Overall Study|Withdrawal by Subject|20|||
150275302|NCT02716675|542146409|FG000|Overall Study|Protocol Violation|0|||
150275303|NCT02716675|542146410|FG001|Overall Study|Protocol Violation|3|||
149825243|NCT03305055|540490572|FG000|Overall Study|Withdrawal by Subject|0|||
149825244|NCT03305055|540490573|FG001|Overall Study|Withdrawal by Subject|1|||
149825245|NCT03305055|540490572|FG000|Overall Study|Adverse Event|1|||
149825246|NCT03305055|540490573|FG001|Overall Study|Adverse Event|1|||
150275304|NCT02716675|542146411|FG002|Overall Study|Protocol Violation|1|||
150275305|NCT02716675|542146409|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
149825247|NCT00113490|540490574|FG000|Overall Study|Withdrawal by Subject|1|||
149825248|NCT00113490|540490575|FG001|Overall Study|Withdrawal by Subject|3|||
149825249|NCT00113490|540490574|FG000|Overall Study|Lost to Follow-up|1|||
149825250|NCT00113490|540490575|FG001|Overall Study|Lost to Follow-up|0|||
149825251|NCT01816477|540490576|FG000|Overall Study|Withdrawal by Subject|13|||
149825252|NCT01816477|540490577|FG001|Overall Study|Withdrawal by Subject|1|||
150033198|NCT01247324|541260916|FG000|Overall Study|Pregnancy|5|||
149825253|NCT01816477|540490576|FG000|Overall Study|Unable to tolerate catheter placement|3|||
149825254|NCT01816477|540490577|FG001|Overall Study|Unable to tolerate catheter placement|0|||
149825255|NCT00819247|540490578|FG000|Overall Study|Adverse Event|0|||
149825256|NCT00819247|540490579|FG001|Overall Study|Adverse Event|5|||
149825257|NCT00819247|540490580|FG002|Overall Study|Adverse Event|3|||
149825258|NCT00819247|540490578|FG000|Overall Study|Insufficient testosterone response|5|||
149825259|NCT00819247|540490579|FG001|Overall Study|Insufficient testosterone response|8|||
149825260|NCT00819247|540490580|FG002|Overall Study|Insufficient testosterone response|10|||
149825261|NCT00819247|540490578|FG000|Overall Study|Withdrawal by Subject|1|||
149825262|NCT00819247|540490579|FG001|Overall Study|Withdrawal by Subject|0|||
149825263|NCT00819247|540490580|FG002|Overall Study|Withdrawal by Subject|0|||
149825264|NCT00819247|540490578|FG000|Overall Study|Protocol Violation|1|||
149825265|NCT00819247|540490579|FG001|Overall Study|Protocol Violation|0|||
149825266|NCT00819247|540490580|FG002|Overall Study|Protocol Violation|1|||
149825267|NCT00819247|540490578|FG000|Overall Study|Mistakenly withdrawn|0|||
149825268|NCT00819247|540490579|FG001|Overall Study|Mistakenly withdrawn|1|||
149825269|NCT00819247|540490580|FG002|Overall Study|Mistakenly withdrawn|0|||
149825270|NCT00819247|540490578|FG000|Overall Study|Bad prostate-specific antigen response|3|||
149825271|NCT00819247|540490579|FG001|Overall Study|Bad prostate-specific antigen response|2|||
149825272|NCT00819247|540490580|FG002|Overall Study|Bad prostate-specific antigen response|0|||
149825273|NCT00819247|540490578|FG000|Overall Study|Other|1|||
149825274|NCT00819247|540490579|FG001|Overall Study|Other|0|||
149825275|NCT00819247|540490580|FG002|Overall Study|Other|0|||
149825276|NCT02162758|540490581|FG000|Overall Study|Study termination|0|||
149825277|NCT02162758|540490582|FG001|Overall Study|Study termination|1|||
149825278|NCT04471935|540490583|FG000|Overall Study|Withdrawal by Subject|1|||
149825279|NCT04471935|540490583|FG000|Overall Study|Deemed ineligible to participate|1|||
149825280|NCT02540356|540490586|FG000|Overall Study|Terminated due to disease progression|1|||
149825281|NCT02540356|540490587|FG001|Overall Study|Terminated due to disease progression|0|||
149825282|NCT01166568|540490588|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
149825283|NCT01166568|540490589|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
149825284|NCT01166568|540490590|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
149825285|NCT01166568|540490588|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
149825286|NCT01166568|540490589|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
149825287|NCT01166568|540490590|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
149825288|NCT01166568|540490588|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
149825289|NCT01166568|540490589|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
149825290|NCT01166568|540490590|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
149825291|NCT03335371|540490591|FG000|Overall Study|Lost to Follow-up|0|||
149825292|NCT03335371|540490592|FG001|Overall Study|Lost to Follow-up|0|||
149825293|NCT03335371|540490593|FG002|Overall Study|Lost to Follow-up|0|||
149825294|NCT03335371|540490594|FG003|Overall Study|Lost to Follow-up|0|||
149825295|NCT03335371|540490595|FG004|Overall Study|Lost to Follow-up|1|||
149825296|NCT03335371|540490591|FG000|Overall Study|Withdrawal by Subject|0|||
149825297|NCT03335371|540490592|FG001|Overall Study|Withdrawal by Subject|0|||
149825298|NCT03335371|540490593|FG002|Overall Study|Withdrawal by Subject|0|||
149825299|NCT03335371|540490594|FG003|Overall Study|Withdrawal by Subject|0|||
149825300|NCT03335371|540490595|FG004|Overall Study|Withdrawal by Subject|1|||
149825301|NCT03335371|540490591|FG000|Overall Study|Randomization Error|0|||
149825302|NCT03335371|540490592|FG001|Overall Study|Randomization Error|0|||
149825303|NCT03335371|540490593|FG002|Overall Study|Randomization Error|1|||
149825304|NCT03335371|540490594|FG003|Overall Study|Randomization Error|0|||
149825305|NCT03335371|540490595|FG004|Overall Study|Randomization Error|0|||
149945471|NCT00296517|540933982|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
149945472|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
149945473|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
149945474|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
149945475|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
149945476|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
149825306|NCT00249821|540490598|FG000|Overall Study|Technical problem|0|||
149825307|NCT00249821|540490599|FG001|Overall Study|Technical problem|1|||
149825308|NCT01348542|540490600|FG000|Overall Study|Withdrawal by Subject|3|||
149825309|NCT01348542|540490601|FG001|Overall Study|Withdrawal by Subject|0|||
149825310|NCT00467584|540490602|FG000|Overall Study|Withdrawal by Subject|4|||
149945477|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
149945478|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
149825311|NCT00467584|540490603|FG001|Overall Study|Withdrawal by Subject|5|||
149825312|NCT00467584|540490604|FG002|Overall Study|Withdrawal by Subject|1|||
149825313|NCT00926289|540490605|FG000|Overall Study|Adverse Event|9|||
149825314|NCT00926289|540490606|FG001|Overall Study|Adverse Event|11|||
149825315|NCT00926289|540490605|FG000|Overall Study|Protocol Violation|8|||
149825316|NCT00926289|540490606|FG001|Overall Study|Protocol Violation|12|||
149825317|NCT00926289|540490605|FG000|Overall Study|Lost to Follow-up|3|||
149825318|NCT00926289|540490606|FG001|Overall Study|Lost to Follow-up|6|||
149945479|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
149945480|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
149945481|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
149945482|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
149945483|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
149945484|NCT00296517|540933981|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
149945485|NCT00296517|540933982|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
149945486|NCT01143324|540933985|FG000|Overall Study|Lost to Follow-up|11|||
149945487|NCT01143324|540933985|FG000|Overall Study|Withdrawal by Subject|4|||
149945488|NCT01143324|540933985|FG000|Overall Study|Explant of the device|4|||
149945489|NCT00596635|540933989|FG000|Overall Study|Lost to Follow-up|0|||
149945490|NCT00596635|540933990|FG001|Overall Study|Lost to Follow-up|2|||
149945491|NCT00596635|540933991|FG002|Overall Study|Lost to Follow-up|0|||
149945492|NCT00596635|540933989|FG000|Overall Study|Treatment for symptomatic UTI|4|||
149945493|NCT00596635|540933990|FG001|Overall Study|Treatment for symptomatic UTI|6|||
149945494|NCT00596635|540933991|FG002|Overall Study|Treatment for symptomatic UTI|3|||
149945495|NCT00596635|540933989|FG000|Overall Study|Hip fracture|2|||
149945496|NCT00596635|540933990|FG001|Overall Study|Hip fracture|3|||
149945497|NCT00596635|540933991|FG002|Overall Study|Hip fracture|3|||
149945498|NCT00596635|540933989|FG000|Overall Study|Could not provide urine specimen|1|||
149945499|NCT00596635|540933990|FG001|Overall Study|Could not provide urine specimen|2|||
149945500|NCT00596635|540933991|FG002|Overall Study|Could not provide urine specimen|2|||
149945501|NCT01101178|540933994|FG000|Period 1|Withdrawal by Subject|1|||
149945502|NCT01101178|540933995|FG001|Period 1|Withdrawal by Subject|2|||
149945503|NCT01101178|540933994|FG000|Period 1|Positive drug screen|1|||
149945504|NCT01101178|540933995|FG001|Period 1|Positive drug screen|1|||
149945505|NCT01101178|540933994|FG000|Period 1|Adverse Event|2|||
149945506|NCT01101178|540933995|FG001|Period 1|Adverse Event|1|||
149945507|NCT01101178|540933994|FG000|Period 2|Withdrawal by Subject|0|||
149945508|NCT01101178|540933995|FG001|Period 2|Withdrawal by Subject|1|||
149945509|NCT01850641|540933996|FG000|Overall Study|Physician Decision|1|||
149945510|NCT01850641|540933996|FG000|Overall Study|Decrease in serum phosphorus|1|||
149945511|NCT01850641|540933996|FG000|Overall Study|Decrease in serum calcium|2|||
149945512|NCT01850641|540933996|FG000|Overall Study|Increase in serum ferritin|1|||
149945513|NCT00141817|540933997|FG000|Overall Study|Protocol Violation|0|||
149945514|NCT00141817|540933998|FG001|Overall Study|Protocol Violation|0|||
149945515|NCT00141817|540933999|FG002|Overall Study|Protocol Violation|1|||
149945516|NCT00141817|540934000|FG003|Overall Study|Protocol Violation|0|||
149945517|NCT00141817|540933997|FG000|Overall Study|Parent request|1|||
149945518|NCT00141817|540933998|FG001|Overall Study|Parent request|0|||
149945519|NCT00141817|540933999|FG002|Overall Study|Parent request|0|||
149945520|NCT00141817|540934000|FG003|Overall Study|Parent request|0|||
149945521|NCT00127803|540934003|FG000|Overall Study|Adverse Event|2|||
149945522|NCT00127803|540934004|FG001|Overall Study|Adverse Event|0|||
149945523|NCT00127803|540934005|FG002|Overall Study|Adverse Event|0|||
149945524|NCT00127803|540934006|FG003|Overall Study|Adverse Event|0|||
149945525|NCT00127803|540934003|FG000|Overall Study|Withdrawal by Subject|1|||
149945526|NCT00127803|540934004|FG001|Overall Study|Withdrawal by Subject|0|||
149945527|NCT00127803|540934005|FG002|Overall Study|Withdrawal by Subject|0|||
149945528|NCT00127803|540934006|FG003|Overall Study|Withdrawal by Subject|0|||
149945529|NCT00127803|540934003|FG000|Overall Study|Lost to Follow-up|0|||
149945530|NCT00127803|540934004|FG001|Overall Study|Lost to Follow-up|0|||
149945531|NCT00127803|540934005|FG002|Overall Study|Lost to Follow-up|0|||
149945532|NCT00127803|540934006|FG003|Overall Study|Lost to Follow-up|1|||
149945533|NCT01020123|540934009|FG000|Main Period|Withdrawal by Subject|6|||
149945534|NCT01020123|540934010|FG001|Main Period|Withdrawal by Subject|5|||
149945535|NCT01020123|540934011|FG002|Main Period|Withdrawal by Subject|3|||
149945536|NCT01020123|540934012|FG003|Main Period|Withdrawal by Subject|1|||
149945537|NCT01020123|540934013|FG004|Main Period|Withdrawal by Subject|6|||
149945538|NCT01020123|540934014|FG005|Main Period|Withdrawal by Subject|3|||
149945539|NCT01020123|540934015|FG006|Main Period|Withdrawal by Subject|2|||
149945540|NCT01020123|540934009|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
149945541|NCT01020123|540934010|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
149945542|NCT01020123|540934011|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
149945543|NCT01020123|540934012|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
149945544|NCT01020123|540934013|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
149945545|NCT01020123|540934014|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
149945546|NCT01020123|540934015|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
149945547|NCT01020123|540934009|FG000|Main Period|Adverse Event|5|||
149945548|NCT01020123|540934010|FG001|Main Period|Adverse Event|2|||
149945549|NCT01020123|540934011|FG002|Main Period|Adverse Event|2|||
149945550|NCT01020123|540934012|FG003|Main Period|Adverse Event|1|||
149945551|NCT01020123|540934013|FG004|Main Period|Adverse Event|1|||
149945552|NCT01020123|540934014|FG005|Main Period|Adverse Event|2|||
149945553|NCT01020123|540934015|FG006|Main Period|Adverse Event|1|||
149945554|NCT01020123|540934009|FG000|Main Period|Protocol Violation|4|||
149945555|NCT01020123|540934010|FG001|Main Period|Protocol Violation|4|||
149945556|NCT01020123|540934011|FG002|Main Period|Protocol Violation|2|||
149825319|NCT00926289|540490605|FG000|Overall Study|Withdrawal by Subject|4|||
149825320|NCT00926289|540490606|FG001|Overall Study|Withdrawal by Subject|4|||
149825321|NCT00926289|540490605|FG000|Overall Study|Other|1|||
149825322|NCT00926289|540490606|FG001|Overall Study|Other|3|||
149825323|NCT00319956|540490607|FG000|Overall Study|Death|20|||
149825324|NCT00319956|540490608|FG001|Overall Study|Death|24|||
149825325|NCT00753714|540490609|FG000|Overall Study|Lack of Efficacy|21|||
149825326|NCT00753714|540490610|FG001|Overall Study|Lack of Efficacy|34|||
149825327|NCT00753714|540490609|FG000|Overall Study|Adverse Event|26|||
149945557|NCT01020123|540934012|FG003|Main Period|Protocol Violation|5|||
149945558|NCT01020123|540934013|FG004|Main Period|Protocol Violation|2|||
149945559|NCT01020123|540934014|FG005|Main Period|Protocol Violation|3|||
149945560|NCT01020123|540934015|FG006|Main Period|Protocol Violation|2|||
149945561|NCT01020123|540934009|FG000|Main Period|Lost to Follow-up|0|||
149945562|NCT01020123|540934010|FG001|Main Period|Lost to Follow-up|2|||
149945563|NCT01020123|540934011|FG002|Main Period|Lost to Follow-up|0|||
149945564|NCT01020123|540934012|FG003|Main Period|Lost to Follow-up|0|||
149945565|NCT01020123|540934013|FG004|Main Period|Lost to Follow-up|0|||
149945566|NCT01020123|540934014|FG005|Main Period|Lost to Follow-up|0|||
149945567|NCT01020123|540934015|FG006|Main Period|Lost to Follow-up|0|||
149945568|NCT01020123|540934009|FG000|Main Period|Unclasified|2|||
149945569|NCT01020123|540934010|FG001|Main Period|Unclasified|0|||
149945570|NCT01020123|540934011|FG002|Main Period|Unclasified|1|||
149945571|NCT01020123|540934012|FG003|Main Period|Unclasified|0|||
149945572|NCT01020123|540934013|FG004|Main Period|Unclasified|1|||
149945573|NCT01020123|540934014|FG005|Main Period|Unclasified|3|||
149945574|NCT01020123|540934015|FG006|Main Period|Unclasified|6|||
149945575|NCT01020123|540934009|FG000|Extention Period|Withdrawal by Subject|2|||
149945576|NCT01020123|540934010|FG001|Extention Period|Withdrawal by Subject|1|||
149945577|NCT01020123|540934011|FG002|Extention Period|Withdrawal by Subject|1|||
149945578|NCT01020123|540934012|FG003|Extention Period|Withdrawal by Subject|0|||
149945579|NCT01020123|540934013|FG004|Extention Period|Withdrawal by Subject|0|||
149945580|NCT01020123|540934014|FG005|Extention Period|Withdrawal by Subject|0|||
149945581|NCT01020123|540934015|FG006|Extention Period|Withdrawal by Subject|0|||
149945582|NCT01020123|540934009|FG000|Extention Period|Adverse Event|0|||
149945583|NCT01020123|540934010|FG001|Extention Period|Adverse Event|0|||
149945584|NCT01020123|540934011|FG002|Extention Period|Adverse Event|0|||
149825328|NCT00753714|540490610|FG001|Overall Study|Adverse Event|18|||
149825329|NCT00753714|540490609|FG000|Overall Study|Protocol Violation|1|||
149825330|NCT00753714|540490610|FG001|Overall Study|Protocol Violation|0|||
149825331|NCT00753714|540490609|FG000|Overall Study|Lost to Follow-up|0|||
149825332|NCT00753714|540490610|FG001|Overall Study|Lost to Follow-up|1|||
149825333|NCT00753714|540490609|FG000|Overall Study|Withdrawal by Subject|2|||
149825334|NCT00753714|540490610|FG001|Overall Study|Withdrawal by Subject|1|||
149825335|NCT00753714|540490609|FG000|Overall Study|Death|3|||
149825336|NCT00753714|540490610|FG001|Overall Study|Death|3|||
149825337|NCT00753714|540490609|FG000|Overall Study|Other|7|||
149825338|NCT00753714|540490610|FG001|Overall Study|Other|5|||
149825339|NCT01202747|540490611|FG000|Overall Study|Withdrawal by Subject|1|||
149825340|NCT01446913|540490612|FG000|Overall Study|Significant illness|1|||
149825341|NCT01446913|540490613|FG001|Overall Study|Significant illness|1|||
149825342|NCT01446913|540490614|FG002|Overall Study|Significant illness|1|||
149825343|NCT01446913|540490612|FG000|Overall Study|Withdrawal by Subject|5|||
149825344|NCT01446913|540490613|FG001|Overall Study|Withdrawal by Subject|3|||
149825345|NCT01446913|540490614|FG002|Overall Study|Withdrawal by Subject|5|||
149825346|NCT01446913|540490612|FG000|Overall Study|Physician Decision|0|||
149825347|NCT01446913|540490613|FG001|Overall Study|Physician Decision|0|||
149825348|NCT01446913|540490614|FG002|Overall Study|Physician Decision|2|||
150170412|NCT01235949|541759066|FG005|Booster Phase|Adverse Event|0|||
150170413|NCT01235949|541759067|FG006|Booster Phase|Adverse Event|0|||
150170414|NCT01235949|541759068|FG007|Booster Phase|Adverse Event|0|||
150170415|NCT01235949|541759069|FG008|Booster Phase|Adverse Event|0|||
149825349|NCT01446913|540490612|FG000|Overall Study|Lost to Follow-up|3|||
149825350|NCT01446913|540490613|FG001|Overall Study|Lost to Follow-up|5|||
149825351|NCT01446913|540490614|FG002|Overall Study|Lost to Follow-up|3|||
149825352|NCT04000009|540490615|FG000|Overall Study|Adverse Event|13|||
149825353|NCT04000009|540490615|FG000|Overall Study|Lack of Efficacy|7|||
149825354|NCT04000009|540490615|FG000|Overall Study|Lost to Follow-up|8|||
149825355|NCT04000009|540490615|FG000|Overall Study|Noncompliance with study drug|4|||
149825356|NCT04000009|540490615|FG000|Overall Study|Physician Decision|1|||
149825357|NCT04000009|540490615|FG000|Overall Study|Use of prohibited medication|3|||
149825358|NCT04000009|540490615|FG000|Overall Study|Pregnancy|1|||
149945585|NCT01020123|540934012|FG003|Extention Period|Adverse Event|1|||
150170416|NCT01235949|541759070|FG009|Booster Phase|Adverse Event|0|||
149945586|NCT01020123|540934013|FG004|Extention Period|Adverse Event|0|||
149945587|NCT01020123|540934014|FG005|Extention Period|Adverse Event|0|||
149945588|NCT01020123|540934015|FG006|Extention Period|Adverse Event|0|||
149825359|NCT04000009|540490615|FG000|Overall Study|Withdrawal by Subject|22|||
149825360|NCT04000009|540490615|FG000|Overall Study|Study terminated by sponsor|98|||
149825361|NCT04000009|540490615|FG000|Overall Study|Not further specified|8|||
150170417|NCT01235949|541759071|FG010|Booster Phase|Adverse Event|0|||
150275306|NCT02716675|542146410|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
150275307|NCT02716675|542146411|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
150275308|NCT02716675|542146409|FG000|Overall Study|Other|38|||
150275309|NCT02716675|542146410|FG001|Overall Study|Other|47|||
150275310|NCT02716675|542146411|FG002|Overall Study|Other|48|||
150275311|NCT00616434|542146414|FG000|Overall Study|Adverse Event|5|||
150275312|NCT00616434|542146415|FG001|Overall Study|Adverse Event|2|||
150275313|NCT00616434|542146414|FG000|Overall Study|Physician Decision|0|||
150275314|NCT00616434|542146415|FG001|Overall Study|Physician Decision|4|||
150275315|NCT00616434|542146414|FG000|Overall Study|Withdrawal by Subject|1|||
149945589|NCT01020123|540934009|FG000|Extention Period|Protocol Violation|1|||
149945590|NCT01020123|540934010|FG001|Extention Period|Protocol Violation|1|||
149945591|NCT01020123|540934011|FG002|Extention Period|Protocol Violation|1|||
149945592|NCT01020123|540934012|FG003|Extention Period|Protocol Violation|0|||
149945593|NCT01020123|540934013|FG004|Extention Period|Protocol Violation|0|||
149945594|NCT01020123|540934014|FG005|Extention Period|Protocol Violation|0|||
149945595|NCT01020123|540934015|FG006|Extention Period|Protocol Violation|1|||
149945596|NCT01020123|540934009|FG000|Extention Period|Lost to Follow-up|0|||
149945597|NCT01020123|540934010|FG001|Extention Period|Lost to Follow-up|0|||
149945598|NCT01020123|540934011|FG002|Extention Period|Lost to Follow-up|0|||
149945599|NCT01020123|540934012|FG003|Extention Period|Lost to Follow-up|0|||
149945600|NCT01020123|540934013|FG004|Extention Period|Lost to Follow-up|0|||
149945601|NCT01020123|540934014|FG005|Extention Period|Lost to Follow-up|2|||
149945602|NCT01020123|540934015|FG006|Extention Period|Lost to Follow-up|0|||
149945603|NCT03479905|540934022|FG000|Overall Study|Other airway method used|4|||
149945604|NCT03479905|540934023|FG001|Overall Study|Other airway method used|5|||
149945605|NCT03479905|540934024|FG002|Overall Study|Other airway method used|5|||
149945606|NCT00862992|540934025|FG000|Overall Study|Adverse Event|2|||
149945607|NCT00862992|540934026|FG001|Overall Study|Adverse Event|1|||
149945608|NCT00862992|540934027|FG002|Overall Study|Adverse Event|1|||
149945609|NCT00862992|540934025|FG000|Overall Study|Physician Decision|1|||
149945610|NCT00862992|540934026|FG001|Overall Study|Physician Decision|0|||
149945611|NCT00862992|540934027|FG002|Overall Study|Physician Decision|0|||
149945612|NCT00862992|540934025|FG000|Overall Study|Withdrawal by Subject|0|||
149945613|NCT00862992|540934026|FG001|Overall Study|Withdrawal by Subject|0|||
149945614|NCT00862992|540934027|FG002|Overall Study|Withdrawal by Subject|2|||
149945615|NCT00720759|540934028|FG000|Overall Study|Lost to Follow-up|0|||
149945616|NCT00720759|540934029|FG001|Overall Study|Lost to Follow-up|1|||
149945617|NCT00720759|540934030|FG002|Overall Study|Lost to Follow-up|1|||
149945618|NCT00720759|540934031|FG003|Overall Study|Lost to Follow-up|0|||
149945619|NCT01047319|540934032|FG000|Overall Study|Teva requested participant withdrawal|3|||
149945620|NCT01047319|540934033|FG001|Overall Study|Teva requested participant withdrawal|0|||
149945621|NCT01047319|540934034|FG002|Overall Study|Teva requested participant withdrawal|1|||
149945622|NCT01047319|540934032|FG000|Overall Study|Protocol Violation|3|||
149945623|NCT01047319|540934033|FG001|Overall Study|Protocol Violation|2|||
149945624|NCT01047319|540934034|FG002|Overall Study|Protocol Violation|4|||
149945625|NCT01047319|540934032|FG000|Overall Study|Lack of Efficacy|4|||
149945626|NCT01047319|540934033|FG001|Overall Study|Lack of Efficacy|3|||
149945627|NCT01047319|540934034|FG002|Overall Study|Lack of Efficacy|3|||
149945628|NCT01047319|540934032|FG000|Overall Study|Death|5|||
149945629|NCT01047319|540934033|FG001|Overall Study|Death|1|||
149945630|NCT01047319|540934034|FG002|Overall Study|Death|5|||
150275316|NCT00616434|542146415|FG001|Overall Study|Withdrawal by Subject|1|||
150275317|NCT00616434|542146414|FG000|Overall Study|Protocol deviation|0|||
150275318|NCT00616434|542146415|FG001|Overall Study|Protocol deviation|1|||
150275319|NCT00467779|542146416|FG000|Stage 1|Adverse Event|1|||
149945631|NCT01047319|540934032|FG000|Overall Study|Pregnancy|13|||
149945632|NCT01047319|540934033|FG001|Overall Study|Pregnancy|8|||
149945633|NCT01047319|540934034|FG002|Overall Study|Pregnancy|8|||
149945634|NCT01047319|540934032|FG000|Overall Study|Physician Decision|12|||
149945635|NCT01047319|540934033|FG001|Overall Study|Physician Decision|9|||
149945636|NCT01047319|540934034|FG002|Overall Study|Physician Decision|10|||
149945637|NCT01047319|540934032|FG000|Overall Study|Lost to Follow-up|14|||
149945638|NCT01047319|540934033|FG001|Overall Study|Lost to Follow-up|10|||
149945639|NCT01047319|540934034|FG002|Overall Study|Lost to Follow-up|10|||
149945640|NCT01047319|540934032|FG000|Overall Study|Adverse Event|16|||
149945641|NCT01047319|540934033|FG001|Overall Study|Adverse Event|27|||
149945642|NCT01047319|540934034|FG002|Overall Study|Adverse Event|21|||
149945643|NCT01047319|540934032|FG000|Overall Study|Withdrawal by Subject|77|||
150275320|NCT00467779|542146417|FG001|Stage 1|Adverse Event|0|||
150275321|NCT00467779|542146418|FG002|Stage 1|Adverse Event|0|||
149945644|NCT01047319|540934033|FG001|Overall Study|Withdrawal by Subject|75|||
149945645|NCT01047319|540934034|FG002|Overall Study|Withdrawal by Subject|87|||
149945646|NCT01047319|540934032|FG000|Overall Study|Study terminated by Sponsor|198|||
149945647|NCT01047319|540934033|FG001|Overall Study|Study terminated by Sponsor|215|||
149945648|NCT01047319|540934034|FG002|Overall Study|Study terminated by Sponsor|203|||
149945649|NCT02318940|540934035|FG000|Overall Study|lost the record|1|||
149945650|NCT02318940|540934036|FG001|Overall Study|lost the record|0|||
150275322|NCT00467779|542146419|FG003|Stage 1|Adverse Event|0|||
149825362|NCT02626949|540490616|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
149825363|NCT02626949|540490617|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
149825364|NCT02626949|540490616|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
149825365|NCT02626949|540490617|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
149825366|NCT02626949|540490616|FG000|Enrolled|Lost to Follow-up|7|||
149825367|NCT02626949|540490617|FG001|Enrolled|Lost to Follow-up|6|||
149825368|NCT02626949|540490616|FG000|Enrolled|Withdrawal by Subject|3|||
149825369|NCT02626949|540490617|FG001|Enrolled|Withdrawal by Subject|2|||
149825370|NCT00717756|540490619|FG000|Overall Study|Withdrawal by Subject|1|||
149825371|NCT00673790|540490620|FG000|Overall Study|Adverse Event|23|||
149825372|NCT00673790|540490621|FG001|Overall Study|Adverse Event|14|||
149825373|NCT00673790|540490622|FG002|Overall Study|Adverse Event|2|||
149825374|NCT00673790|540490620|FG000|Overall Study|Lack of Efficacy|2|||
149825375|NCT00673790|540490621|FG001|Overall Study|Lack of Efficacy|2|||
149825376|NCT00673790|540490622|FG002|Overall Study|Lack of Efficacy|2|||
149825377|NCT00673790|540490620|FG000|Overall Study|Protocol Violation|6|||
149825378|NCT00673790|540490621|FG001|Overall Study|Protocol Violation|9|||
149825379|NCT00673790|540490622|FG002|Overall Study|Protocol Violation|1|||
149825380|NCT00673790|540490620|FG000|Overall Study|Withdrawal by Subject|7|||
149825381|NCT00673790|540490621|FG001|Overall Study|Withdrawal by Subject|4|||
149825382|NCT00673790|540490622|FG002|Overall Study|Withdrawal by Subject|1|||
149825383|NCT00673790|540490620|FG000|Overall Study|Lost to Follow-up|6|||
149825384|NCT00673790|540490621|FG001|Overall Study|Lost to Follow-up|6|||
149825385|NCT00673790|540490622|FG002|Overall Study|Lost to Follow-up|5|||
149825386|NCT00673790|540490620|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
149825387|NCT00673790|540490621|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
149825388|NCT00673790|540490622|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
149825389|NCT00673790|540490620|FG000|Overall Study|Poor compliance|1|||
149825390|NCT00673790|540490621|FG001|Overall Study|Poor compliance|0|||
149945651|NCT05032196|540934049|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
149945652|NCT05032196|540934050|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
149945653|NCT05032196|540934051|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
149945654|NCT05032196|540934052|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
149945655|NCT05032196|540934053|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
149945656|NCT05032196|540934054|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
149945657|NCT05032196|540934049|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
149945658|NCT05032196|540934050|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
149945659|NCT05032196|540934051|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
149945660|NCT05032196|540934052|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
149945661|NCT05032196|540934053|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
149945662|NCT05032196|540934054|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
149945663|NCT05032196|540934049|FG000|Period 2 (Multidose)|Physician Decision|0|||
149825391|NCT00673790|540490622|FG002|Overall Study|Poor compliance|0|||
149825392|NCT00673790|540490620|FG000|Overall Study|Participated in two Nebivolol studies|0|||
149825393|NCT00673790|540490621|FG001|Overall Study|Participated in two Nebivolol studies|0|||
149825394|NCT00673790|540490622|FG002|Overall Study|Participated in two Nebivolol studies|1|||
149825395|NCT00673790|540490620|FG000|Overall Study|Unconfirmed pregnancy|0|||
149825396|NCT00673790|540490621|FG001|Overall Study|Unconfirmed pregnancy|1|||
149825397|NCT00673790|540490622|FG002|Overall Study|Unconfirmed pregnancy|0|||
149825398|NCT00673790|540490620|FG000|Overall Study|Randomization criteria not met|0|||
149825399|NCT00673790|540490621|FG001|Overall Study|Randomization criteria not met|1|||
149825400|NCT00673790|540490622|FG002|Overall Study|Randomization criteria not met|0|||
149825401|NCT01873859|540490625|FG000|Overall Study|Withdrawal by Subject|0|||
149825402|NCT01873859|540490626|FG001|Overall Study|Withdrawal by Subject|4|||
149825403|NCT03977584|540490627|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
149825404|NCT03977584|540490628|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
149825405|NCT03977584|540490629|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
149825406|NCT05328375|540492646|FG000|Overall Study|Withdrawal by Subject|0|||
149825407|NCT05328375|540492647|FG001|Overall Study|Withdrawal by Subject|1|||
149825408|NCT00101582|540492651|FG000|Overall Study|Ineligibility determined|0|||
149945664|NCT05032196|540934050|FG001|Period 2 (Multidose)|Physician Decision|0|||
149945665|NCT05032196|540934051|FG002|Period 2 (Multidose)|Physician Decision|0|||
149825409|NCT00101582|540492652|FG001|Overall Study|Ineligibility determined|1|||
149825410|NCT00101582|540492651|FG000|Overall Study|Adverse Event|1|||
149825411|NCT00101582|540492652|FG001|Overall Study|Adverse Event|4|||
149825412|NCT00101582|540492651|FG000|Overall Study|Withdrawal by Subject|6|||
149825413|NCT00101582|540492652|FG001|Overall Study|Withdrawal by Subject|4|||
149825414|NCT00101582|540492651|FG000|Overall Study|Physician Decision|1|||
149825415|NCT00101582|540492652|FG001|Overall Study|Physician Decision|0|||
149825416|NCT00101582|540492651|FG000|Overall Study|Death|3|||
149945666|NCT05032196|540934052|FG003|Period 2 (Multidose)|Physician Decision|0|||
149945667|NCT05032196|540934053|FG004|Period 2 (Multidose)|Physician Decision|1|||
149945668|NCT05032196|540934054|FG005|Period 2 (Multidose)|Physician Decision|0|||
150275323|NCT00467779|542146420|FG004|Stage 1|Adverse Event|0|||
150275324|NCT00467779|542146421|FG005|Stage 1|Adverse Event|1|||
149825417|NCT00101582|540492652|FG001|Overall Study|Death|5|||
149825418|NCT00101582|540492651|FG000|Overall Study|Other|0|||
149825419|NCT00101582|540492652|FG001|Overall Study|Other|1|||
149825420|NCT01919190|540492653|FG000|Overall Study|Intra-op findings, etc.|3|||
149825421|NCT01919190|540492654|FG001|Overall Study|Intra-op findings, etc.|0|||
149825422|NCT02146430|540492655|FG000|Overall Study|Protocol Violation|5|||
149825423|NCT02146430|540492656|FG001|Overall Study|Protocol Violation|4|||
149825424|NCT02146430|540492657|FG002|Overall Study|Protocol Violation|8|||
150275325|NCT00467779|542146422|FG006|Stage 1|Adverse Event|2|||
150275326|NCT00467779|542146423|FG007|Stage 1|Adverse Event|1|||
150275327|NCT00467779|542146424|FG008|Stage 1|Adverse Event|0|||
150275328|NCT00467779|542146425|FG009|Stage 1|Adverse Event|0|||
150275329|NCT00467779|542146426|FG010|Stage 1|Adverse Event|0|||
150275330|NCT00467779|542146427|FG011|Stage 1|Adverse Event|0|||
149825425|NCT02146430|540492658|FG003|Overall Study|Protocol Violation|6|||
149825426|NCT02146430|540492655|FG000|Overall Study|Lack of Efficacy|13|||
149825427|NCT02146430|540492656|FG001|Overall Study|Lack of Efficacy|11|||
149825428|NCT02146430|540492657|FG002|Overall Study|Lack of Efficacy|8|||
149825429|NCT02146430|540492658|FG003|Overall Study|Lack of Efficacy|5|||
149825430|NCT02146430|540492655|FG000|Overall Study|Adverse Event|20|||
149825431|NCT02146430|540492656|FG001|Overall Study|Adverse Event|40|||
149825432|NCT02146430|540492657|FG002|Overall Study|Adverse Event|32|||
149825433|NCT02146430|540492658|FG003|Overall Study|Adverse Event|49|||
149825434|NCT02146430|540492655|FG000|Overall Study|Reason missing or not reported|2|||
149825435|NCT02146430|540492656|FG001|Overall Study|Reason missing or not reported|3|||
149825436|NCT02146430|540492657|FG002|Overall Study|Reason missing or not reported|4|||
149825437|NCT02146430|540492658|FG003|Overall Study|Reason missing or not reported|5|||
149825438|NCT02146430|540492655|FG000|Overall Study|Withdrawal by Subject|27|||
149825439|NCT02146430|540492656|FG001|Overall Study|Withdrawal by Subject|29|||
149825440|NCT02146430|540492657|FG002|Overall Study|Withdrawal by Subject|30|||
149945669|NCT00857389|540934055|FG000|Overall Study|Did not proceed to transplant|2|||
149945670|NCT04817410|540936148|FG000|Overall Study|Withdrawal by Subject|5|||
149945671|NCT04817410|540936148|FG000|Overall Study|Physician Decision|3|||
149945672|NCT03595748|540936149|FG000|Overall Study|Death|11|||
149945673|NCT03595748|540936150|FG001|Overall Study|Death|12|||
149945674|NCT03595748|540936149|FG000|Overall Study|Withdrawal by Subject|28|||
149945675|NCT03595748|540936150|FG001|Overall Study|Withdrawal by Subject|29|||
149945676|NCT03595748|540936149|FG000|Overall Study|Protocol Violation|0|||
149945677|NCT03595748|540936150|FG001|Overall Study|Protocol Violation|1|||
149945678|NCT04809974|540936151|FG000|Lead-in Phase|Withdrawal by Subject|3|||
149945679|NCT04809974|540936152|FG001|Lead-in Phase|Withdrawal by Subject|0|||
149945680|NCT04809974|540936153|FG002|Lead-in Phase|Withdrawal by Subject|0|||
149945681|NCT04809974|540936151|FG000|Lead-in Phase|No longer eligible|11|||
149945682|NCT04809974|540936152|FG001|Lead-in Phase|No longer eligible|0|||
149945683|NCT04809974|540936153|FG002|Lead-in Phase|No longer eligible|0|||
149945684|NCT04809974|540936151|FG000|Randomized Phase|Lost to Follow-up|0|||
149945685|NCT04809974|540936152|FG001|Randomized Phase|Lost to Follow-up|1|||
149945686|NCT04809974|540936153|FG002|Randomized Phase|Lost to Follow-up|5|||
149945687|NCT04809974|540936151|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
149945688|NCT04809974|540936152|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
149945689|NCT04809974|540936153|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
149945690|NCT04809974|540936151|FG000|Randomized Phase|Adverse Event|0|||
149945691|NCT04809974|540936152|FG001|Randomized Phase|Adverse Event|1|||
149945692|NCT04809974|540936153|FG002|Randomized Phase|Adverse Event|4|||
149945693|NCT04809974|540936151|FG000|Randomized Phase|Withdrawal by Subject|0|||
149945694|NCT04809974|540936152|FG001|Randomized Phase|Withdrawal by Subject|0|||
149945695|NCT04809974|540936153|FG002|Randomized Phase|Withdrawal by Subject|5|||
149945696|NCT00549055|540936162|FG000|Overall Study|Adverse Event|4|||
149945697|NCT00549055|540936162|FG000|Overall Study|Lack of Efficacy|18|||
149945698|NCT00549055|540936162|FG000|Overall Study|Stabilization|5|||
149945699|NCT00549055|540936162|FG000|Overall Study|Progression to fibrosis|2|||
149945700|NCT00549055|540936162|FG000|Overall Study|Decrease of size|1|||
149945701|NCT00549055|540936162|FG000|Overall Study|Active choroidal neovascula increased|1|||
149945702|NCT00549055|540936162|FG000|Overall Study|Vitreous hemorrhage|1|||
149945703|NCT00549055|540936162|FG000|Overall Study|Growth choroidal neovascularisation|1|||
149945704|NCT00549055|540936162|FG000|Overall Study|Choroidal neovascularization|1|||
150033199|NCT01247324|541260917|FG001|Overall Study|Pregnancy|10|||
150275331|NCT00467779|542146428|FG012|Stage 1|Adverse Event|0|||
150275332|NCT00467779|542146429|FG013|Stage 1|Adverse Event|0|||
150275333|NCT00467779|542146430|FG014|Stage 1|Adverse Event|0|||
149945705|NCT00549055|540936162|FG000|Overall Study|Very low visual acuity (VA)|1|||
150033200|NCT01247324|541260916|FG000|Overall Study|Protocol Violation|1|||
150275334|NCT00467779|542146416|FG000|Stage 1|Disease Progression|2|||
149825441|NCT02146430|540492658|FG003|Overall Study|Withdrawal by Subject|34|||
149825442|NCT01893905|540492659|FG000|Overall Study|Withdrawal by Subject|1|||
149945706|NCT01134042|540936163|FG000|Overall Study|Adverse Event|3|||
149945707|NCT01134042|540936164|FG001|Overall Study|Adverse Event|7|||
149945708|NCT01134042|540936165|FG002|Overall Study|Adverse Event|2|||
149945709|NCT01134042|540936163|FG000|Overall Study|Lack of Efficacy|21|||
149945710|NCT01134042|540936164|FG001|Overall Study|Lack of Efficacy|6|||
149945711|NCT01134042|540936165|FG002|Overall Study|Lack of Efficacy|18|||
149945712|NCT01134042|540936163|FG000|Overall Study|Protocol Violation|5|||
149945713|NCT01134042|540936164|FG001|Overall Study|Protocol Violation|3|||
149945714|NCT01134042|540936165|FG002|Overall Study|Protocol Violation|5|||
149945715|NCT01134042|540936163|FG000|Overall Study|Lost to Follow-up|2|||
149945716|NCT01134042|540936164|FG001|Overall Study|Lost to Follow-up|0|||
149945717|NCT01134042|540936165|FG002|Overall Study|Lost to Follow-up|1|||
149945718|NCT01134042|540936163|FG000|Overall Study|Physician Decision|4|||
149945719|NCT01134042|540936164|FG001|Overall Study|Physician Decision|8|||
149945720|NCT01134042|540936165|FG002|Overall Study|Physician Decision|1|||
149945721|NCT01134042|540936163|FG000|Overall Study|Withdrawal by Subject|13|||
149945722|NCT01134042|540936164|FG001|Overall Study|Withdrawal by Subject|4|||
149945723|NCT01134042|540936165|FG002|Overall Study|Withdrawal by Subject|7|||
149945724|NCT01091259|540936172|FG000|Overall Study|Adverse Event|3|||
149945725|NCT01091259|540936172|FG000|Overall Study|Lack of Efficacy|2|||
149945726|NCT01137786|540936173|FG000|Overall Study|Lost to Follow-up|0|||
149945727|NCT01137786|540936174|FG001|Overall Study|Lost to Follow-up|2|||
149945728|NCT01137786|540936173|FG000|Overall Study|Withdrawal by Subject|1|||
149945729|NCT01137786|540936174|FG001|Overall Study|Withdrawal by Subject|1|||
149945730|NCT00770367|540936175|FG000|First Intervention|Withdrawal by Subject|0|||
149945731|NCT00770367|540936176|FG001|First Intervention|Withdrawal by Subject|2|||
149945732|NCT00770367|540936175|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
149945733|NCT00770367|540936176|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
149945734|NCT00770367|540936175|FG000|Second Intervention|Lost to Follow-up|2|||
149945735|NCT00770367|540936176|FG001|Second Intervention|Lost to Follow-up|0|||
149945736|NCT03881371|540936180|FG000|Overall Study|Adverse Event|8|||
149945737|NCT03881371|540936181|FG001|Overall Study|Adverse Event|9|||
149945738|NCT03881371|540936180|FG000|Overall Study|Death|1|||
149945739|NCT03881371|540936181|FG001|Overall Study|Death|0|||
149945740|NCT03881371|540936180|FG000|Overall Study|Lost to Follow-up|1|||
149945741|NCT03881371|540936181|FG001|Overall Study|Lost to Follow-up|0|||
149945742|NCT03881371|540936180|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149945743|NCT03881371|540936181|FG001|Overall Study|Non-Compliance with Study Drug|2|||
149945744|NCT03881371|540936180|FG000|Overall Study|Physician Decision|3|||
149945745|NCT03881371|540936181|FG001|Overall Study|Physician Decision|3|||
149945746|NCT03881371|540936180|FG000|Overall Study|Withdrawal by Subject|2|||
149945747|NCT03881371|540936181|FG001|Overall Study|Withdrawal by Subject|10|||
149945748|NCT03881371|540936180|FG000|Overall Study|Discontinuation from Study|1|||
149945749|NCT03881371|540936181|FG001|Overall Study|Discontinuation from Study|0|||
149945750|NCT04666298|540936188|FG000|Overall Study|Subject decision|1|||
149945751|NCT04666298|540936189|FG001|Overall Study|Subject decision|0|||
149945752|NCT04666298|540936190|FG002|Overall Study|Subject decision|0|||
149945753|NCT04666298|540936191|FG003|Overall Study|Subject decision|2|||
149945754|NCT04666298|540936188|FG000|Overall Study|Death|1|||
149945755|NCT04666298|540936189|FG001|Overall Study|Death|0|||
149945756|NCT04666298|540936190|FG002|Overall Study|Death|0|||
149945757|NCT04666298|540936191|FG003|Overall Study|Death|0|||
149945758|NCT04666298|540936188|FG000|Overall Study|Lost to Follow-up|0|||
149945759|NCT04666298|540936189|FG001|Overall Study|Lost to Follow-up|0|||
149945760|NCT04666298|540936190|FG002|Overall Study|Lost to Follow-up|0|||
149945761|NCT04666298|540936191|FG003|Overall Study|Lost to Follow-up|1|||
149945762|NCT04666298|540936188|FG000|Overall Study|Physician Decision|0|||
149945763|NCT04666298|540936189|FG001|Overall Study|Physician Decision|0|||
149945764|NCT04666298|540936190|FG002|Overall Study|Physician Decision|0|||
149945765|NCT04666298|540936191|FG003|Overall Study|Physician Decision|1|||
149945766|NCT04666298|540936188|FG000|Overall Study|Protocol deviation|0|||
149825443|NCT01893905|540492660|FG001|Overall Study|Withdrawal by Subject|0|||
149825444|NCT01893905|540492659|FG000|Overall Study|Adverse Event|9|||
149825445|NCT01893905|540492660|FG001|Overall Study|Adverse Event|3|||
149825446|NCT01893905|540492659|FG000|Overall Study|Lack of Efficacy|5|||
149945767|NCT04666298|540936189|FG001|Overall Study|Protocol deviation|0|||
149945768|NCT04666298|540936190|FG002|Overall Study|Protocol deviation|1|||
149945769|NCT04666298|540936191|FG003|Overall Study|Protocol deviation|0|||
149945770|NCT01995201|540936194|FG000|From Baseline Until Week 24|Adverse Event|4|||
149945771|NCT01995201|540936195|FG001|From Baseline Until Week 24|Adverse Event|15|||
149945772|NCT01995201|540936196|FG002|From Baseline Until Week 24|Adverse Event|0|||
149945773|NCT01995201|540936197|FG003|From Baseline Until Week 24|Adverse Event|0|||
149945774|NCT01995201|540936198|FG004|From Baseline Until Week 24|Adverse Event|0|||
149945775|NCT01995201|540936199|FG005|From Baseline Until Week 24|Adverse Event|0|||
149945776|NCT01995201|540936200|FG006|From Baseline Until Week 24|Adverse Event|0|||
149945777|NCT01995201|540936194|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149945778|NCT01995201|540936195|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
149945779|NCT01995201|540936196|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149825447|NCT01893905|540492660|FG001|Overall Study|Lack of Efficacy|7|||
149825448|NCT01893905|540492659|FG000|Overall Study|Lost to Follow-up|1|||
149825449|NCT01893905|540492660|FG001|Overall Study|Lost to Follow-up|0|||
149825450|NCT01893905|540492659|FG000|Overall Study|Protocol Violation|6|||
149825451|NCT01893905|540492660|FG001|Overall Study|Protocol Violation|1|||
149825452|NCT01893905|540492659|FG000|Overall Study|Lack of adherence to treatment|2|||
149825453|NCT01893905|540492660|FG001|Overall Study|Lack of adherence to treatment|0|||
149825454|NCT01893905|540492659|FG000|Overall Study|Other reason|1|||
149825455|NCT01893905|540492660|FG001|Overall Study|Other reason|3|||
149825456|NCT01768858|540492661|FG000|Overall Study|Lost to Follow-up|9|||
149825457|NCT01768858|540492661|FG000|Overall Study|Lack of Efficacy|8|||
149825458|NCT01768858|540492661|FG000|Overall Study|Serious Adverse Event|1|||
149825459|NCT01768858|540492661|FG000|Overall Study|Participant moved to Germany|1|||
149825460|NCT01768858|540492661|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
149825461|NCT01768858|540492661|FG000|Overall Study|Exanthema|1|||
149825462|NCT01768858|540492661|FG000|Overall Study|Withdrawal by Subject|1|||
149825463|NCT03093324|540492663|FG000|Overall Study|Adverse Event|4|||
149825464|NCT03093324|540492664|FG001|Overall Study|Adverse Event|15|||
149825465|NCT03093324|540492663|FG000|Overall Study|Lost to Follow-up|1|||
149825466|NCT03093324|540492664|FG001|Overall Study|Lost to Follow-up|0|||
149825467|NCT03093324|540492663|FG000|Overall Study|Protocol Deviation|2|||
149825468|NCT03093324|540492664|FG001|Overall Study|Protocol Deviation|2|||
149825469|NCT03093324|540492663|FG000|Overall Study|Withdrawal by Subject|2|||
149825470|NCT03093324|540492664|FG001|Overall Study|Withdrawal by Subject|2|||
149825471|NCT00421174|540492672|FG000|Overall Study|Withdrawal by Subject|0|||
149825472|NCT00421174|540492673|FG001|Overall Study|Withdrawal by Subject|1|||
149825473|NCT00421174|540492672|FG000|Overall Study|Ineligible due to infection|2|||
149825474|NCT00421174|540492673|FG001|Overall Study|Ineligible due to infection|0|||
149825475|NCT00992407|540492674|FG000|Overall Study|Protocol Violation|2|||
149825476|NCT00992407|540492675|FG001|Overall Study|Protocol Violation|1|||
149825477|NCT00992407|540492674|FG000|Overall Study|Lost to Follow-up|3|||
149825478|NCT00992407|540492675|FG001|Overall Study|Lost to Follow-up|3|||
149825479|NCT00992407|540492674|FG000|Overall Study|Adverse Event|3|||
149825480|NCT00992407|540492675|FG001|Overall Study|Adverse Event|2|||
149825481|NCT00992407|540492674|FG000|Overall Study|protocol Violation & Adverse events|2|||
149825482|NCT00992407|540492675|FG001|Overall Study|protocol Violation & Adverse events|4|||
149825483|NCT00992407|540492674|FG000|Overall Study|Other|2|||
149825484|NCT00992407|540492675|FG001|Overall Study|Other|0|||
149825485|NCT00992407|540492674|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
149825486|NCT00992407|540492675|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
149825487|NCT00992407|540492674|FG000|Overall Study|Study medication not administered|17|||
149825488|NCT00992407|540492675|FG001|Overall Study|Study medication not administered|13|||
149825489|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
149825490|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
149825491|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
149825492|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
149825493|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
149825494|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
149825495|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
149825496|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
149825497|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
149825498|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
149825499|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
149825500|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
149825501|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
149825502|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
149825503|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
149825504|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
149825505|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
149825506|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
149825507|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
149825508|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
149825509|NCT04700449|540492676|FG000|Stage 1: Double-Blind Period|Other|0|||
149825510|NCT04700449|540492677|FG001|Stage 1: Double-Blind Period|Other|0|||
149825511|NCT04700449|540492678|FG002|Stage 1: Double-Blind Period|Other|1|||
149825512|NCT04700449|540492679|FG003|Stage 1: Double-Blind Period|Other|0|||
149825513|NCT04700449|540492676|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
149825514|NCT04700449|540492677|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
149825515|NCT04700449|540492678|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
149825516|NCT04700449|540492679|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
149825517|NCT04700449|540492676|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149825518|NCT04700449|540492677|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149825519|NCT04700449|540492678|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149825520|NCT04700449|540492679|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
149825521|NCT04700449|540492676|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
149945780|NCT01995201|540936197|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149945781|NCT01995201|540936198|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149945782|NCT01995201|540936199|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149945783|NCT01995201|540936200|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
149945784|NCT01995201|540936194|FG000|From Baseline Until Week 24|Death|0|||
149945785|NCT01995201|540936195|FG001|From Baseline Until Week 24|Death|1|||
149945786|NCT01995201|540936196|FG002|From Baseline Until Week 24|Death|0|||
149945787|NCT01995201|540936197|FG003|From Baseline Until Week 24|Death|0|||
149945788|NCT01995201|540936198|FG004|From Baseline Until Week 24|Death|0|||
149945789|NCT01995201|540936199|FG005|From Baseline Until Week 24|Death|0|||
149945790|NCT01995201|540936200|FG006|From Baseline Until Week 24|Death|0|||
149945791|NCT01995201|540936194|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
149945792|NCT01995201|540936195|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
149945793|NCT01995201|540936196|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
149945794|NCT01995201|540936197|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
149945795|NCT01995201|540936198|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
149945796|NCT01995201|540936199|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
149945797|NCT01995201|540936200|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
149945798|NCT01995201|540936194|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
149945799|NCT01995201|540936195|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
149945800|NCT01995201|540936196|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
149945801|NCT01995201|540936197|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
149945802|NCT01995201|540936198|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
149945803|NCT01995201|540936199|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
149945804|NCT01995201|540936200|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
149945805|NCT01995201|540936194|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
149945806|NCT01995201|540936195|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
149945807|NCT01995201|540936196|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
149945808|NCT01995201|540936197|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
149945809|NCT01995201|540936198|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
149945810|NCT01995201|540936199|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
149945811|NCT01995201|540936200|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
149945812|NCT01995201|540936194|FG000|From Baseline Until Week 24|Physician Decision|0|||
149945813|NCT01995201|540936195|FG001|From Baseline Until Week 24|Physician Decision|2|||
149945814|NCT01995201|540936196|FG002|From Baseline Until Week 24|Physician Decision|0|||
149945815|NCT01995201|540936197|FG003|From Baseline Until Week 24|Physician Decision|0|||
149945816|NCT01995201|540936198|FG004|From Baseline Until Week 24|Physician Decision|0|||
149945817|NCT01995201|540936199|FG005|From Baseline Until Week 24|Physician Decision|0|||
149945818|NCT01995201|540936200|FG006|From Baseline Until Week 24|Physician Decision|0|||
149945819|NCT01995201|540936194|FG000|From Baseline Until Week 24|Protocol Violation|0|||
149945820|NCT01995201|540936195|FG001|From Baseline Until Week 24|Protocol Violation|9|||
149945821|NCT01995201|540936196|FG002|From Baseline Until Week 24|Protocol Violation|0|||
149945822|NCT01995201|540936197|FG003|From Baseline Until Week 24|Protocol Violation|0|||
149945823|NCT01995201|540936198|FG004|From Baseline Until Week 24|Protocol Violation|0|||
149945824|NCT01995201|540936199|FG005|From Baseline Until Week 24|Protocol Violation|0|||
149945825|NCT01995201|540936200|FG006|From Baseline Until Week 24|Protocol Violation|0|||
149945826|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Adverse Event|0|||
149945827|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Adverse Event|0|||
149945828|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Adverse Event|2|||
149945829|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Adverse Event|1|||
149945830|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Adverse Event|1|||
149945831|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Adverse Event|3|||
149945832|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Adverse Event|1|||
149945833|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Death|0|||
149945834|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Death|0|||
149945835|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Death|0|||
149945836|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Death|0|||
149945837|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Death|0|||
149945838|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Death|2|||
149945839|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Death|0|||
149945840|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
149945841|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
149945842|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
149945843|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
149945844|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
149945845|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
149945846|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
149945847|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
149945848|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
149945849|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
149945850|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
149945851|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
149825522|NCT04700449|540492677|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
149825523|NCT04700449|540492678|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
149825524|NCT04700449|540492679|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
149825525|NCT04700449|540492676|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
149825526|NCT04700449|540492677|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
149825527|NCT04700449|540492678|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
149825528|NCT04700449|540492679|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
149825529|NCT04700449|540492676|FG000|Stage 2 Sub-study 1|Other|1|||
149825530|NCT04700449|540492677|FG001|Stage 2 Sub-study 1|Other|2|||
149825531|NCT04700449|540492678|FG002|Stage 2 Sub-study 1|Other|0|||
149825532|NCT04700449|540492679|FG003|Stage 2 Sub-study 1|Other|0|||
149825533|NCT04700449|540492676|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
149825534|NCT04700449|540492677|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
149825535|NCT04700449|540492678|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
149825536|NCT04700449|540492679|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
149825537|NCT04700449|540492676|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
149825538|NCT04700449|540492677|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
149825539|NCT04700449|540492678|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
149825540|NCT04700449|540492679|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
149825541|NCT04700449|540492676|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
149825542|NCT04700449|540492677|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
149825543|NCT04700449|540492678|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
149825544|NCT04700449|540492679|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
149825545|NCT04700449|540492676|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
149825546|NCT04700449|540492677|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
149825547|NCT04700449|540492678|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
149825548|NCT04700449|540492679|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
149825549|NCT04700449|540492676|FG000|Stage 2 Sub-study 2|Other|0|||
149825550|NCT04700449|540492677|FG001|Stage 2 Sub-study 2|Other|0|||
149825551|NCT04700449|540492678|FG002|Stage 2 Sub-study 2|Other|0|||
149825552|NCT04700449|540492679|FG003|Stage 2 Sub-study 2|Other|5|||
149825553|NCT03738332|540492680|FG000|Overall Study|Withdrawal by Subject|1|||
149825554|NCT02336737|540492681|FG000|Overall Study|Withdrawal by Subject|5|||
149825555|NCT02336737|540492681|FG000|Overall Study|Physician Decision|8|||
149825556|NCT02396381|540492682|FG000|Overall Study|Adverse Event|3|||
149825557|NCT02396381|540492683|FG001|Overall Study|Adverse Event|2|||
149825558|NCT02396381|540492682|FG000|Overall Study|Withdrawal by Subject|33|||
149825559|NCT02396381|540492683|FG001|Overall Study|Withdrawal by Subject|24|||
149825560|NCT02396381|540492682|FG000|Overall Study|Lost to Follow-up|49|||
149825561|NCT02396381|540492683|FG001|Overall Study|Lost to Follow-up|31|||
149825562|NCT02396381|540492682|FG000|Overall Study|Protocol Violation|1|||
149825563|NCT02396381|540492683|FG001|Overall Study|Protocol Violation|0|||
149825564|NCT02396381|540492682|FG000|Overall Study|Site terminated by sponsor|7|||
149825565|NCT02396381|540492683|FG001|Overall Study|Site terminated by sponsor|8|||
149825566|NCT02396381|540492682|FG000|Overall Study|Physician Decision|5|||
149825567|NCT02396381|540492683|FG001|Overall Study|Physician Decision|5|||
149825568|NCT02396381|540492682|FG000|Overall Study|Pregnancy|2|||
149825569|NCT02396381|540492683|FG001|Overall Study|Pregnancy|0|||
149825570|NCT02396381|540492682|FG000|Overall Study|Non-compliance with study procedures|1|||
149825571|NCT02396381|540492683|FG001|Overall Study|Non-compliance with study procedures|0|||
149825572|NCT02396381|540492682|FG000|Overall Study|Moved out of town/state|1|||
149825573|NCT02396381|540492683|FG001|Overall Study|Moved out of town/state|3|||
149825574|NCT02396381|540492682|FG000|Overall Study|Could not complete visit|1|||
149825575|NCT02396381|540492683|FG001|Overall Study|Could not complete visit|0|||
149825576|NCT02396381|540492682|FG000|Overall Study|Possible conflict of interest|1|||
149825577|NCT02396381|540492683|FG001|Overall Study|Possible conflict of interest|0|||
149825578|NCT02396381|540492682|FG000|Overall Study|Randomization/Screening Error|3|||
149825579|NCT02396381|540492683|FG001|Overall Study|Randomization/Screening Error|1|||
149825580|NCT00356200|540492685|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
149825581|NCT00356200|540492686|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
149825582|NCT00356200|540492685|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
149825583|NCT00356200|540492686|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
149825584|NCT00635778|540492687|FG000|Overall Study|Adverse Event|1|||
149825585|NCT00635778|540492688|FG001|Overall Study|Adverse Event|0|||
149825586|NCT00635778|540492689|FG002|Overall Study|Adverse Event|0|||
149825587|NCT00635778|540492690|FG003|Overall Study|Adverse Event|3|||
149825588|NCT00635778|540492691|FG004|Overall Study|Adverse Event|3|||
149825589|NCT00635778|540492692|FG005|Overall Study|Adverse Event|6|||
149825590|NCT00635778|540492693|FG006|Overall Study|Adverse Event|1|||
149825591|NCT00635778|540492687|FG000|Overall Study|Withdrawal by Subject|0|||
149825592|NCT00635778|540492688|FG001|Overall Study|Withdrawal by Subject|0|||
149825593|NCT00635778|540492689|FG002|Overall Study|Withdrawal by Subject|0|||
149825594|NCT00635778|540492690|FG003|Overall Study|Withdrawal by Subject|1|||
149825595|NCT00635778|540492691|FG004|Overall Study|Withdrawal by Subject|0|||
149825596|NCT00635778|540492692|FG005|Overall Study|Withdrawal by Subject|1|||
149825597|NCT00635778|540492693|FG006|Overall Study|Withdrawal by Subject|1|||
149825598|NCT00635778|540492687|FG000|Overall Study|Progressive disease|0|||
149825599|NCT00635778|540492688|FG001|Overall Study|Progressive disease|3|||
149825600|NCT00635778|540492689|FG002|Overall Study|Progressive disease|3|||
149825601|NCT00635778|540492690|FG003|Overall Study|Progressive disease|4|||
149825602|NCT00635778|540492691|FG004|Overall Study|Progressive disease|5|||
149825603|NCT00635778|540492692|FG005|Overall Study|Progressive disease|14|||
149825604|NCT00635778|540492693|FG006|Overall Study|Progressive disease|4|||
149825605|NCT00812253|540492694|FG000|Overall Study|Withdrawal by Subject|3|||
149825606|NCT00812253|540492695|FG001|Overall Study|Withdrawal by Subject|2|||
149825607|NCT00812253|540492694|FG000|Overall Study|Protocol Violation|1|||
149825608|NCT00812253|540492695|FG001|Overall Study|Protocol Violation|1|||
149825609|NCT00812253|540492694|FG000|Overall Study|Lost to Follow-up|2|||
149825610|NCT00812253|540492695|FG001|Overall Study|Lost to Follow-up|0|||
149825611|NCT01884025|540492696|FG000|Overall Study|Lost to Follow-up|3|||
149825612|NCT01884025|540492697|FG001|Overall Study|Lost to Follow-up|4|||
149825613|NCT02655237|540492703|FG000|Overall Study|Adverse Event|10|||
149825614|NCT02655237|540492704|FG001|Overall Study|Adverse Event|7|||
149825615|NCT02655237|540492703|FG000|Overall Study|Protocol Deviation|2|||
149825616|NCT02655237|540492704|FG001|Overall Study|Protocol Deviation|0|||
149825617|NCT02655237|540492703|FG000|Overall Study|Withdrawal by Participant|1|||
149825618|NCT02655237|540492704|FG001|Overall Study|Withdrawal by Participant|2|||
149825619|NCT02655237|540492703|FG000|Overall Study|Lack of Efficacy|0|||
149825620|NCT02655237|540492704|FG001|Overall Study|Lack of Efficacy|1|||
149825621|NCT02655237|540492703|FG000|Overall Study|Recovery Leading to Surgery|2|||
149825622|NCT02655237|540492704|FG001|Overall Study|Recovery Leading to Surgery|1|||
149825623|NCT02655237|540492703|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
149825624|NCT02655237|540492704|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
149825625|NCT02655237|540492703|FG000|Overall Study|Randomized but Not Treated|1|||
149825626|NCT02655237|540492704|FG001|Overall Study|Randomized but Not Treated|0|||
149825627|NCT03679741|540492705|FG000|Period 1|No longer meet eligibility criteria|1|||
149825628|NCT03679741|540492706|FG001|Period 1|No longer meet eligibility criteria|0|||
149825629|NCT03679741|540492705|FG000|Period 1|Lost to Follow-up|0|||
149825630|NCT03679741|540492706|FG001|Period 1|Lost to Follow-up|1|||
149825631|NCT03679741|540492705|FG000|Period 1|Adverse Event|1|||
149825632|NCT03679741|540492706|FG001|Period 1|Adverse Event|1|||
149825633|NCT03679741|540492705|FG000|Period 1|Withdrawal by Subject|0|||
149825634|NCT03679741|540492706|FG001|Period 1|Withdrawal by Subject|1|||
149825635|NCT03679741|540492705|FG000|Period 2|Adverse Event|2|||
149825636|NCT03679741|540492706|FG001|Period 2|Adverse Event|1|||
149825637|NCT03679741|540492705|FG000|Period 2|Withdrawal by Subject|1|||
149825638|NCT03679741|540492706|FG001|Period 2|Withdrawal by Subject|1|||
149945852|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
149945853|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
149945854|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
149945855|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
149945856|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
149945857|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
149945858|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
149945859|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
149945860|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
149945861|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Physician Decision|0|||
149945862|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Physician Decision|0|||
149945863|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Physician Decision|0|||
149945864|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Physician Decision|0|||
149945865|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Physician Decision|1|||
149945866|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Physician Decision|0|||
149945867|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Physician Decision|0|||
149945868|NCT01995201|540936194|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
149945869|NCT01995201|540936195|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
149945870|NCT01995201|540936196|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
149945871|NCT01995201|540936197|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
149945872|NCT01995201|540936198|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
149945873|NCT01995201|540936199|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
149825639|NCT01000337|540492711|FG000|Overall Study|Lost to Follow-up|4|||
149945874|NCT01995201|540936200|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
149945875|NCT03329001|540936201|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
149945876|NCT03329001|540936202|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
149945877|NCT03329001|540936203|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
149825640|NCT01000337|540492712|FG001|Overall Study|Lost to Follow-up|3|||
149825641|NCT02750761|540492713|FG000|Overall Study|Lost to Follow-up|0|||
149825642|NCT02750761|540492714|FG001|Overall Study|Lost to Follow-up|0|||
149825643|NCT02750761|540492715|FG002|Overall Study|Lost to Follow-up|1|||
149825644|NCT02750761|540492716|FG003|Overall Study|Lost to Follow-up|0|||
149825645|NCT02750761|540492717|FG004|Overall Study|Lost to Follow-up|0|||
149825646|NCT02750761|540492718|FG005|Overall Study|Lost to Follow-up|0|||
149825647|NCT02227862|540492719|FG000|Overall Study|Protocol Violation|7|||
149825648|NCT02227862|540492720|FG001|Overall Study|Protocol Violation|9|||
149825649|NCT02227862|540492719|FG000|Overall Study|Other|0|||
149825650|NCT02227862|540492720|FG001|Overall Study|Other|2|||
149825651|NCT02227862|540492719|FG000|Overall Study|Adverse Event|4|||
149825652|NCT02227862|540492720|FG001|Overall Study|Adverse Event|3|||
149825653|NCT02227862|540492719|FG000|Overall Study|Withdrawal by Subject|7|||
149825654|NCT02227862|540492720|FG001|Overall Study|Withdrawal by Subject|6|||
149825655|NCT02227862|540492719|FG000|Overall Study|Lost to Follow-up|1|||
149825656|NCT02227862|540492720|FG001|Overall Study|Lost to Follow-up|2|||
149825657|NCT00419926|540492721|FG000|Overall Study|Withdrawal by Subject|7|||
149825658|NCT00419926|540492722|FG001|Overall Study|Withdrawal by Subject|3|||
149825659|NCT00419926|540492721|FG000|Overall Study|Administrative Problem|4|||
149825660|NCT00419926|540492722|FG001|Overall Study|Administrative Problem|4|||
149825661|NCT00419926|540492721|FG000|Overall Study|Lost to Follow-up|1|||
149825662|NCT00419926|540492722|FG001|Overall Study|Lost to Follow-up|2|||
149825663|NCT00419926|540492721|FG000|Overall Study|Death|2|||
149825664|NCT00419926|540492722|FG001|Overall Study|Death|1|||
149825665|NCT00266409|540492725|FG000|Overall Study|Lack of Efficacy|2|||
149825666|NCT00266409|540492726|FG001|Overall Study|Lack of Efficacy|6|||
149825667|NCT00266409|540492727|FG002|Overall Study|Lack of Efficacy|1|||
149825668|NCT00266409|540492728|FG003|Overall Study|Lack of Efficacy|2|||
149825669|NCT00266409|540492725|FG000|Overall Study|Adverse Event|7|||
149825670|NCT00266409|540492726|FG001|Overall Study|Adverse Event|2|||
149825671|NCT00266409|540492727|FG002|Overall Study|Adverse Event|1|||
149825672|NCT00266409|540492728|FG003|Overall Study|Adverse Event|1|||
149825673|NCT00266409|540492725|FG000|Overall Study|Lost to Follow-up|18|||
149825674|NCT00266409|540492726|FG001|Overall Study|Lost to Follow-up|21|||
149825675|NCT00266409|540492727|FG002|Overall Study|Lost to Follow-up|6|||
149825676|NCT00266409|540492728|FG003|Overall Study|Lost to Follow-up|8|||
149825677|NCT00266409|540492725|FG000|Overall Study|Withdrawal by Subject|6|||
149825678|NCT00266409|540492726|FG001|Overall Study|Withdrawal by Subject|10|||
149825679|NCT00266409|540492727|FG002|Overall Study|Withdrawal by Subject|3|||
149825680|NCT00266409|540492728|FG003|Overall Study|Withdrawal by Subject|9|||
149825681|NCT00266409|540492725|FG000|Overall Study|Protocol Violation|5|||
149825682|NCT00266409|540492726|FG001|Overall Study|Protocol Violation|3|||
149825683|NCT00266409|540492727|FG002|Overall Study|Protocol Violation|4|||
149825684|NCT00266409|540492728|FG003|Overall Study|Protocol Violation|2|||
149825685|NCT00266409|540492725|FG000|Overall Study|Other|7|||
149825686|NCT00266409|540492726|FG001|Overall Study|Other|4|||
149825687|NCT00266409|540492727|FG002|Overall Study|Other|2|||
149825688|NCT00266409|540492728|FG003|Overall Study|Other|0|||
149825689|NCT02116803|540492729|FG000|Overall Study|Adverse Event|2|||
149825690|NCT02116803|540492730|FG001|Overall Study|Adverse Event|1|||
149825691|NCT02116803|540492729|FG000|Overall Study|Physician Decision|1|||
149825692|NCT02116803|540492730|FG001|Overall Study|Physician Decision|0|||
149825693|NCT02116803|540492729|FG000|Overall Study|Progressive disease|4|||
149825694|NCT02116803|540492730|FG001|Overall Study|Progressive disease|0|||
149825695|NCT02116803|540492729|FG000|Overall Study|Study terminated by sponsor|2|||
149825696|NCT02116803|540492730|FG001|Overall Study|Study terminated by sponsor|1|||
149825697|NCT02116803|540492729|FG000|Overall Study|Death|1|||
149825698|NCT02116803|540492730|FG001|Overall Study|Death|0|||
149825699|NCT04128007|540492734|FG000|Overall Study|Withdrawal by Subject|9|||
149825700|NCT04128007|540492735|FG001|Overall Study|Withdrawal by Subject|6|||
149825701|NCT04128007|540492734|FG000|Overall Study|Protocol Violation|1|||
149825702|NCT04128007|540492735|FG001|Overall Study|Protocol Violation|0|||
149825703|NCT04128007|540492734|FG000|Overall Study|Lost to Follow-up|8|||
149825704|NCT04128007|540492735|FG001|Overall Study|Lost to Follow-up|7|||
149825705|NCT04128007|540492734|FG000|Overall Study|Adverse Event|5|||
149825706|NCT04128007|540492735|FG001|Overall Study|Adverse Event|2|||
149825707|NCT04128007|540492734|FG000|Overall Study|Not reported|0|||
149825708|NCT04128007|540492735|FG001|Overall Study|Not reported|2|||
149825709|NCT05476679|540492736|FG000|Overall Study|Withdrawal by Subject|0|||
149825710|NCT05476679|540492737|FG001|Overall Study|Withdrawal by Subject|0|||
149945878|NCT03329001|540936204|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
149825711|NCT05476679|540492738|FG002|Overall Study|Withdrawal by Subject|0|||
149825712|NCT05476679|540492739|FG003|Overall Study|Withdrawal by Subject|1|||
149825713|NCT05476679|540492740|FG004|Overall Study|Withdrawal by Subject|0|||
150275335|NCT00467779|542146417|FG001|Stage 1|Disease Progression|2|||
149825714|NCT05476679|540492736|FG000|Overall Study|Lost to Follow-up|0|||
149825715|NCT05476679|540492737|FG001|Overall Study|Lost to Follow-up|0|||
149945879|NCT03329001|540936205|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
149825716|NCT05476679|540492738|FG002|Overall Study|Lost to Follow-up|0|||
149825717|NCT05476679|540492739|FG003|Overall Study|Lost to Follow-up|1|||
149825718|NCT05476679|540492740|FG004|Overall Study|Lost to Follow-up|0|||
149825719|NCT00601354|540492741|FG000|Overall Study|Lost to Follow-up|4|||
150275336|NCT00467779|542146418|FG002|Stage 1|Disease Progression|2|||
149825720|NCT00601354|540492742|FG001|Overall Study|Lost to Follow-up|5|||
149825721|NCT00278512|540492744|FG000|Overall Study|Death|1|||
149825722|NCT00278512|540492745|FG001|Overall Study|Death|0|||
149825723|NCT01620177|540492746|FG000|Overall Study|Failure at Screening Visit|43|||
149825724|NCT01620177|540492746|FG000|Overall Study|Withdrawal by Subject|26|||
149825725|NCT01620177|540492746|FG000|Overall Study|Lost to Follow-up|7|||
149825726|NCT01620177|540492746|FG000|Overall Study|Physician Decision|2|||
149825727|NCT01620177|540492746|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
149825728|NCT01789320|540492750|FG000|Overall Study|Re-enrolled into study|1|||
149825729|NCT01789320|540492750|FG000|Overall Study|Lost to Follow-up|1|||
149825730|NCT00679783|540492751|FG000|Overall Study|Adverse Event|0|||
149825731|NCT00679783|540492752|FG001|Overall Study|Adverse Event|0|||
149825732|NCT00679783|540492753|FG002|Overall Study|Adverse Event|0|||
149825733|NCT00679783|540492754|FG003|Overall Study|Adverse Event|3|||
149825734|NCT00679783|540492755|FG004|Overall Study|Adverse Event|0|||
149825735|NCT00679783|540492756|FG005|Overall Study|Adverse Event|0|||
149825736|NCT00679783|540492757|FG006|Overall Study|Adverse Event|1|||
149825737|NCT00679783|540492751|FG000|Overall Study|Lack of Efficacy|0|||
149825738|NCT00679783|540492752|FG001|Overall Study|Lack of Efficacy|1|||
149825739|NCT00679783|540492753|FG002|Overall Study|Lack of Efficacy|0|||
149825740|NCT00679783|540492754|FG003|Overall Study|Lack of Efficacy|2|||
149825741|NCT00679783|540492755|FG004|Overall Study|Lack of Efficacy|0|||
149825742|NCT00679783|540492756|FG005|Overall Study|Lack of Efficacy|0|||
149825743|NCT00679783|540492757|FG006|Overall Study|Lack of Efficacy|0|||
149825744|NCT00679783|540492751|FG000|Overall Study|Withdrawal by Subject|0|||
149825745|NCT00679783|540492752|FG001|Overall Study|Withdrawal by Subject|0|||
149825746|NCT00679783|540492753|FG002|Overall Study|Withdrawal by Subject|1|||
149825747|NCT00679783|540492754|FG003|Overall Study|Withdrawal by Subject|1|||
149825748|NCT00679783|540492755|FG004|Overall Study|Withdrawal by Subject|0|||
149825749|NCT00679783|540492756|FG005|Overall Study|Withdrawal by Subject|0|||
149825750|NCT00679783|540492757|FG006|Overall Study|Withdrawal by Subject|0|||
149825751|NCT00679783|540492751|FG000|Overall Study|Not Captured|0|||
149825752|NCT00679783|540492752|FG001|Overall Study|Not Captured|0|||
149825753|NCT00679783|540492753|FG002|Overall Study|Not Captured|0|||
149825754|NCT00679783|540492754|FG003|Overall Study|Not Captured|5|||
149825755|NCT00679783|540492755|FG004|Overall Study|Not Captured|0|||
149825756|NCT00679783|540492756|FG005|Overall Study|Not Captured|0|||
149825757|NCT00679783|540492757|FG006|Overall Study|Not Captured|0|||
149825758|NCT00679783|540492751|FG000|Overall Study|Ongoing at data cut-off|2|||
149825759|NCT00679783|540492752|FG001|Overall Study|Ongoing at data cut-off|2|||
149825760|NCT00679783|540492753|FG002|Overall Study|Ongoing at data cut-off|0|||
149825761|NCT00679783|540492754|FG003|Overall Study|Ongoing at data cut-off|9|||
149825762|NCT00679783|540492755|FG004|Overall Study|Ongoing at data cut-off|1|||
149825763|NCT00679783|540492756|FG005|Overall Study|Ongoing at data cut-off|0|||
149825764|NCT00679783|540492757|FG006|Overall Study|Ongoing at data cut-off|0|||
149825765|NCT00814320|540492762|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
149825766|NCT00814320|540492763|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
149825767|NCT00814320|540492762|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
149825768|NCT00814320|540492763|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
149825769|NCT00814320|540492762|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
149825770|NCT00814320|540492763|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
149825771|NCT00814320|540492762|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
149825772|NCT00814320|540492763|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
149825773|NCT00814320|540492762|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
149825774|NCT00814320|540492763|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
149825775|NCT00814320|540492762|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
149825776|NCT00814320|540492763|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
149825777|NCT00814320|540492762|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
149825778|NCT00814320|540492763|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
149825779|NCT00814320|540492762|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
149825780|NCT00814320|540492763|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
149825781|NCT00814320|540492762|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
149825782|NCT00814320|540492763|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
150275337|NCT00467779|542146419|FG003|Stage 1|Disease Progression|3|||
149825783|NCT00814320|540492762|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
149825784|NCT00814320|540492763|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
149825785|NCT00491504|540492764|FG000|Overall Study|Adverse Event|0|||
149825786|NCT00491504|540492765|FG001|Overall Study|Adverse Event|1|||
149825787|NCT00491504|540492766|FG002|Overall Study|Adverse Event|0|||
149825788|NCT00491504|540492767|FG003|Overall Study|Adverse Event|0|||
150275338|NCT00467779|542146420|FG004|Stage 1|Disease Progression|2|||
150275339|NCT00467779|542146421|FG005|Stage 1|Disease Progression|2|||
149825789|NCT00491504|540492764|FG000|Overall Study|Withdrawal by Subject|0|||
149825790|NCT00491504|540492765|FG001|Overall Study|Withdrawal by Subject|0|||
149825791|NCT00491504|540492766|FG002|Overall Study|Withdrawal by Subject|1|||
149825792|NCT00491504|540492767|FG003|Overall Study|Withdrawal by Subject|2|||
149825793|NCT00491504|540492764|FG000|Overall Study|Protocol Violation|0|||
149825794|NCT00491504|540492765|FG001|Overall Study|Protocol Violation|0|||
149825795|NCT00491504|540492766|FG002|Overall Study|Protocol Violation|3|||
149825796|NCT00491504|540492767|FG003|Overall Study|Protocol Violation|2|||
149825797|NCT00619385|540492768|FG000|Overall Study|Adverse Event|0|||
149825798|NCT00619385|540492769|FG001|Overall Study|Adverse Event|0|||
149825799|NCT00619385|540492770|FG002|Overall Study|Adverse Event|3|||
149825800|NCT00619385|540492768|FG000|Overall Study|Other|1|||
149825801|NCT00619385|540492769|FG001|Overall Study|Other|2|||
149825802|NCT00619385|540492770|FG002|Overall Study|Other|1|||
149825803|NCT03730103|540492771|FG000|Overall Study|Did not meet inclusion criteria|0|||
149825804|NCT03730103|540492772|FG001|Overall Study|Did not meet inclusion criteria|5|||
149825805|NCT02789111|540492773|FG000|Overall Study|Withdrawal by Subject|1|||
149825806|NCT02789111|540492774|FG001|Overall Study|Withdrawal by Subject|4|||
149825807|NCT01488578|540492775|FG000|Overall Study|Protocol Violation|1836|||
149825808|NCT02308111|540492776|FG000|Overall Study|Adverse Event|31|||
149825809|NCT02308111|540492777|FG001|Overall Study|Adverse Event|19|||
149825810|NCT02308111|540492776|FG000|Overall Study|Death|9|||
149825811|NCT02308111|540492777|FG001|Overall Study|Death|6|||
149825812|NCT02308111|540492776|FG000|Overall Study|Lost to Follow-up|2|||
149825813|NCT02308111|540492777|FG001|Overall Study|Lost to Follow-up|7|||
149825814|NCT02308111|540492776|FG000|Overall Study|Physician Decision|6|||
149825815|NCT02308111|540492777|FG001|Overall Study|Physician Decision|17|||
150275340|NCT00467779|542146422|FG006|Stage 1|Disease Progression|4|||
150275341|NCT00467779|542146423|FG007|Stage 1|Disease Progression|5|||
150275342|NCT00467779|542146424|FG008|Stage 1|Disease Progression|0|||
150275343|NCT00467779|542146425|FG009|Stage 1|Disease Progression|0|||
150275344|NCT00467779|542146426|FG010|Stage 1|Disease Progression|0|||
150275345|NCT00467779|542146427|FG011|Stage 1|Disease Progression|0|||
150275346|NCT00467779|542146428|FG012|Stage 1|Disease Progression|0|||
150275347|NCT00467779|542146429|FG013|Stage 1|Disease Progression|0|||
150275348|NCT00467779|542146430|FG014|Stage 1|Disease Progression|0|||
150275349|NCT00467779|542146416|FG000|Stage 1|Unspecified Reason|1|||
150275350|NCT00467779|542146417|FG001|Stage 1|Unspecified Reason|0|||
149825816|NCT02308111|540492776|FG000|Overall Study|Protocol Violation|0|||
149825817|NCT02308111|540492777|FG001|Overall Study|Protocol Violation|1|||
149825818|NCT02308111|540492776|FG000|Overall Study|Withdrawal by Subject|28|||
149825819|NCT02308111|540492777|FG001|Overall Study|Withdrawal by Subject|38|||
149825820|NCT02308111|540492776|FG000|Overall Study|Study Terminated by Sponsor|72|||
149825821|NCT02308111|540492777|FG001|Overall Study|Study Terminated by Sponsor|61|||
149825822|NCT02308111|540492776|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
149825823|NCT02308111|540492777|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
149825824|NCT02308111|540492776|FG000|Overall Study|Site Closure|3|||
149825825|NCT02308111|540492777|FG001|Overall Study|Site Closure|3|||
149825826|NCT02308111|540492776|FG000|Overall Study|Non-compliance with Study Drug|3|||
150275351|NCT00467779|542146418|FG002|Stage 1|Unspecified Reason|1|||
150275352|NCT00467779|542146419|FG003|Stage 1|Unspecified Reason|0|||
150275353|NCT00467779|542146420|FG004|Stage 1|Unspecified Reason|1|||
150275354|NCT00467779|542146421|FG005|Stage 1|Unspecified Reason|2|||
150275355|NCT00467779|542146422|FG006|Stage 1|Unspecified Reason|0|||
150275356|NCT00467779|542146423|FG007|Stage 1|Unspecified Reason|0|||
150275357|NCT00467779|542146424|FG008|Stage 1|Unspecified Reason|0|||
150275358|NCT00467779|542146425|FG009|Stage 1|Unspecified Reason|0|||
150275359|NCT00467779|542146426|FG010|Stage 1|Unspecified Reason|0|||
150275360|NCT00467779|542146427|FG011|Stage 1|Unspecified Reason|0|||
150275361|NCT00467779|542146428|FG012|Stage 1|Unspecified Reason|0|||
150275362|NCT00467779|542146429|FG013|Stage 1|Unspecified Reason|0|||
150275363|NCT00467779|542146430|FG014|Stage 1|Unspecified Reason|0|||
150275364|NCT00467779|542146416|FG000|Stage 1|Physician Decision|0|||
150275365|NCT00467779|542146417|FG001|Stage 1|Physician Decision|1|||
150275366|NCT00467779|542146418|FG002|Stage 1|Physician Decision|0|||
149825827|NCT02308111|540492777|FG001|Overall Study|Non-compliance with Study Drug|1|||
149825828|NCT02308111|540492776|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
149945880|NCT03329001|540936206|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
149945881|NCT03329001|540936207|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
150275367|NCT00467779|542146419|FG003|Stage 1|Physician Decision|0|||
150275368|NCT00467779|542146420|FG004|Stage 1|Physician Decision|0|||
150275369|NCT00467779|542146421|FG005|Stage 1|Physician Decision|0|||
150275370|NCT00467779|542146422|FG006|Stage 1|Physician Decision|0|||
150275371|NCT00467779|542146423|FG007|Stage 1|Physician Decision|0|||
150275372|NCT00467779|542146424|FG008|Stage 1|Physician Decision|0|||
149825829|NCT02308111|540492777|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
149825830|NCT02308111|540492776|FG000|Overall Study|Liver Transplant|3|||
149825831|NCT02308111|540492777|FG001|Overall Study|Liver Transplant|3|||
149825832|NCT02308111|540492776|FG000|Overall Study|Liver Transplant Waitlist|2|||
149825833|NCT02308111|540492777|FG001|Overall Study|Liver Transplant Waitlist|2|||
149825834|NCT02308111|540492776|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
150275373|NCT00467779|542146425|FG009|Stage 1|Physician Decision|0|||
150275374|NCT00467779|542146426|FG010|Stage 1|Physician Decision|0|||
150275375|NCT00467779|542146427|FG011|Stage 1|Physician Decision|0|||
149825835|NCT02308111|540492777|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
149825836|NCT03271528|540492778|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
149825837|NCT03271528|540492779|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
149825838|NCT03271528|540492778|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
149825839|NCT03271528|540492779|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
149825840|NCT03271528|540492778|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
149825841|NCT03271528|540492779|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
149825842|NCT03271528|540492778|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
149825843|NCT03271528|540492779|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
149825844|NCT03271528|540492778|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
149825845|NCT03271528|540492779|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
149825846|NCT03271528|540492778|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
149825847|NCT03271528|540492779|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
149825848|NCT03271528|540492778|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
149825849|NCT03271528|540492779|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
149825850|NCT00306384|540492780|FG000|Overall Study|Adverse Event|103|||
149825851|NCT00306384|540492781|FG001|Overall Study|Adverse Event|87|||
149825852|NCT00306384|540492782|FG002|Overall Study|Adverse Event|40|||
149825853|NCT00306384|540492780|FG000|Overall Study|Major protocol deviation|43|||
149825854|NCT00306384|540492781|FG001|Overall Study|Major protocol deviation|51|||
149825855|NCT00306384|540492782|FG002|Overall Study|Major protocol deviation|18|||
149825856|NCT00306384|540492780|FG000|Overall Study|Lost to Follow-up|57|||
149825857|NCT00306384|540492781|FG001|Overall Study|Lost to Follow-up|41|||
149825858|NCT00306384|540492782|FG002|Overall Study|Lost to Follow-up|35|||
149825859|NCT00306384|540492780|FG000|Overall Study|Voluntary withdrawal|199|||
149825860|NCT00306384|540492781|FG001|Overall Study|Voluntary withdrawal|187|||
149825861|NCT00306384|540492782|FG002|Overall Study|Voluntary withdrawal|91|||
149825862|NCT00306384|540492780|FG000|Overall Study|Study termination|1|||
149825863|NCT00306384|540492781|FG001|Overall Study|Study termination|0|||
149825864|NCT00306384|540492782|FG002|Overall Study|Study termination|1|||
149825865|NCT00306384|540492780|FG000|Overall Study|Pregnancy|3|||
149825866|NCT00306384|540492781|FG001|Overall Study|Pregnancy|1|||
149825867|NCT00306384|540492782|FG002|Overall Study|Pregnancy|1|||
149825868|NCT00306384|540492780|FG000|Overall Study|Lack of Efficacy|26|||
149825869|NCT00306384|540492781|FG001|Overall Study|Lack of Efficacy|40|||
149825870|NCT00306384|540492782|FG002|Overall Study|Lack of Efficacy|38|||
149825871|NCT00306384|540492780|FG000|Overall Study|Investigator discretion|28|||
149825872|NCT00306384|540492781|FG001|Overall Study|Investigator discretion|31|||
149825873|NCT00306384|540492782|FG002|Overall Study|Investigator discretion|21|||
149825874|NCT00306384|540492780|FG000|Overall Study|Other|80|||
149825875|NCT00306384|540492781|FG001|Overall Study|Other|70|||
149825876|NCT00306384|540492782|FG002|Overall Study|Other|32|||
149825877|NCT00306384|540492780|FG000|Overall Study|Site closure|2|||
149825878|NCT00306384|540492781|FG001|Overall Study|Site closure|0|||
149825879|NCT00306384|540492782|FG002|Overall Study|Site closure|0|||
149825880|NCT00745251|540492785|FG000|Overall Study|Adverse Event|1|||
149825881|NCT00745251|540492786|FG001|Overall Study|Adverse Event|2|||
149825882|NCT00745251|540492785|FG000|Overall Study|Withdrawal by Subject|1|||
149825883|NCT00745251|540492786|FG001|Overall Study|Withdrawal by Subject|1|||
149825884|NCT02928848|540492787|FG000|Arm 2|Withdrawal by Subject|1|||
149825885|NCT02928848|540492788|FG001|Arm 2|Withdrawal by Subject|0|||
149825886|NCT02666430|540492789|FG000|Period 1|Lost to Follow-up|1|||
149825887|NCT02666430|540492790|FG001|Period 1|Lost to Follow-up|0|||
149825888|NCT02666430|540492789|FG000|Period 1|Adverse Event|0|||
149825889|NCT02666430|540492790|FG001|Period 1|Adverse Event|1|||
149825890|NCT02666430|540492789|FG000|Period 2|Withdrawal by Subject|1|||
149825891|NCT02666430|540492790|FG001|Period 2|Withdrawal by Subject|4|||
149825892|NCT02666430|540492789|FG000|Period 3|Lost to Follow-up|1|||
149825893|NCT02666430|540492790|FG001|Period 3|Lost to Follow-up|0|||
149825894|NCT03828461|540492791|FG000|Overall Study|Lost to Follow-up|1|||
149825895|NCT03828461|540492791|FG000|Overall Study|Withdrawal by Subject|3|||
149825896|NCT01463683|540492793|FG000|Overall Study|Adverse Event|2|||
149825897|NCT01463683|540492794|FG001|Overall Study|Adverse Event|0|||
149825898|NCT01463683|540492795|FG002|Overall Study|Adverse Event|0|||
149825899|NCT01463683|540492793|FG000|Overall Study|Lost to Follow-up|10|||
149825900|NCT01463683|540492794|FG001|Overall Study|Lost to Follow-up|9|||
149825901|NCT01463683|540492795|FG002|Overall Study|Lost to Follow-up|7|||
149825902|NCT01463683|540492793|FG000|Overall Study|Physician Decision|0|||
149825903|NCT01463683|540492794|FG001|Overall Study|Physician Decision|3|||
149825904|NCT01463683|540492795|FG002|Overall Study|Physician Decision|1|||
149825905|NCT01463683|540492793|FG000|Overall Study|Pregnancy|2|||
149825906|NCT01463683|540492794|FG001|Overall Study|Pregnancy|2|||
149825907|NCT01463683|540492795|FG002|Overall Study|Pregnancy|1|||
149825908|NCT01463683|540492793|FG000|Overall Study|Withdrawal by Subject|5|||
149825909|NCT01463683|540492794|FG001|Overall Study|Withdrawal by Subject|17|||
149825910|NCT01463683|540492795|FG002|Overall Study|Withdrawal by Subject|2|||
149825911|NCT03111147|540492796|FG000|Overall Study|Lost to Follow-up|2|||
149825912|NCT03111147|540492797|FG001|Overall Study|Lost to Follow-up|5|||
149825913|NCT03111147|540492796|FG000|Overall Study|Withdrawal by Subject|4|||
149825914|NCT03111147|540492797|FG001|Overall Study|Withdrawal by Subject|3|||
149825915|NCT03111147|540492796|FG000|Overall Study|Protocol Violation|2|||
149825916|NCT03111147|540492797|FG001|Overall Study|Protocol Violation|1|||
149825917|NCT03111147|540492796|FG000|Overall Study|Death|1|||
149825918|NCT03111147|540492797|FG001|Overall Study|Death|1|||
149825919|NCT01565083|540492798|FG000|Overall Study|Withdrawal by Subject|6|||
149825920|NCT01565083|540492799|FG001|Overall Study|Withdrawal by Subject|4|||
149825921|NCT01565083|540492798|FG000|Overall Study|Lost to Follow-up|2|||
149825922|NCT01565083|540492799|FG001|Overall Study|Lost to Follow-up|7|||
149825923|NCT01565083|540492798|FG000|Overall Study|Death|22|||
149825924|NCT01565083|540492799|FG001|Overall Study|Death|23|||
149825925|NCT01565083|540492798|FG000|Overall Study|Other|3|||
149825926|NCT01565083|540492799|FG001|Overall Study|Other|5|||
149825927|NCT01118728|540492800|FG000|Overall Study|Adverse Event|17|||
149825928|NCT01118728|540492800|FG000|Overall Study|Lack of Efficacy|27|||
149825929|NCT01118728|540492800|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
149825930|NCT01118728|540492800|FG000|Overall Study|Withdrawal by Subject|3|||
149825931|NCT01118728|540492800|FG000|Overall Study|Lost to Follow-up|4|||
149825932|NCT02178709|540494679|FG000|Overall Study|Adverse Event|5|||
149825933|NCT02178709|540494679|FG000|Overall Study|Death|2|||
149825934|NCT02178709|540494679|FG000|Overall Study|Withdrawal by Subject|2|||
149825935|NCT02178709|540494679|FG000|Overall Study|Physician Decision|2|||
149825936|NCT02178709|540494679|FG000|Overall Study|Disease Progression|5|||
149825937|NCT02946385|540494680|FG000|Overall Study|Lost to Follow-up|0|||
149825938|NCT02946385|540494681|FG001|Overall Study|Lost to Follow-up|0|||
149825939|NCT02946385|540494682|FG002|Overall Study|Lost to Follow-up|3|||
149825940|NCT02946385|540494683|FG003|Overall Study|Lost to Follow-up|0|||
149825941|NCT02946385|540494684|FG004|Overall Study|Lost to Follow-up|2|||
149825942|NCT02946385|540494685|FG005|Overall Study|Lost to Follow-up|1|||
149825943|NCT01691859|540494688|FG000|Overall Study|Adverse Event|19|||
149825944|NCT01691859|540494688|FG000|Overall Study|Lack of Efficacy|11|||
149825945|NCT01691859|540494688|FG000|Overall Study|Protocol Violation|4|||
149825946|NCT01691859|540494688|FG000|Overall Study|Product commercially available|221|||
149825947|NCT01691859|540494688|FG000|Overall Study|Study closed/terminated|50|||
149825948|NCT01691859|540494688|FG000|Overall Study|Lost to Follow-up|5|||
149825949|NCT01691859|540494688|FG000|Overall Study|Physician Decision|6|||
149825950|NCT01691859|540494688|FG000|Overall Study|Withdrawal by Subject|31|||
149825951|NCT02688400|540494691|FG000|Overall Study|Protocol Violation|2|||
149825952|NCT02688400|540494692|FG001|Overall Study|Protocol Violation|5|||
149825953|NCT02688400|540494691|FG000|Overall Study|Lack of Efficacy|7|||
149825954|NCT02688400|540494692|FG001|Overall Study|Lack of Efficacy|7|||
149825955|NCT02688400|540494691|FG000|Overall Study|Adverse Event|21|||
149825956|NCT02688400|540494692|FG001|Overall Study|Adverse Event|12|||
149825957|NCT02688400|540494691|FG000|Overall Study|Withdrawal by Subject|15|||
149825958|NCT02688400|540494692|FG001|Overall Study|Withdrawal by Subject|13|||
149825959|NCT02688400|540494691|FG000|Overall Study|No study medication intake|1|||
149825960|NCT02688400|540494692|FG001|Overall Study|No study medication intake|4|||
149825961|NCT02688400|540494691|FG000|Overall Study|Lost to Follow-up|0|||
149825962|NCT02688400|540494692|FG001|Overall Study|Lost to Follow-up|3|||
149825963|NCT03519256|540494696|FG000|Overall Study|Disease recurrence|4|||
149825964|NCT03519256|540494697|FG001|Overall Study|Disease recurrence|4|||
149825965|NCT03519256|540494698|FG002|Overall Study|Disease recurrence|5|||
149825966|NCT03519256|540494699|FG003|Overall Study|Disease recurrence|2|||
149825967|NCT03519256|540494696|FG000|Overall Study|Study drug toxicity|0|||
149825968|NCT03519256|540494697|FG001|Overall Study|Study drug toxicity|2|||
149825969|NCT03519256|540494698|FG002|Overall Study|Study drug toxicity|5|||
149825970|NCT03519256|540494699|FG003|Overall Study|Study drug toxicity|2|||
149825971|NCT03519256|540494696|FG000|Overall Study|Adverse event unrelated to study drug|0|||
149825972|NCT03519256|540494697|FG001|Overall Study|Adverse event unrelated to study drug|1|||
149825973|NCT03519256|540494698|FG002|Overall Study|Adverse event unrelated to study drug|1|||
149825974|NCT03519256|540494699|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149825975|NCT03519256|540494696|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149825976|NCT03519256|540494697|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149825977|NCT03519256|540494698|FG002|Overall Study|Participant request to discontinue study treatment|0|||
149825978|NCT03519256|540494699|FG003|Overall Study|Participant request to discontinue study treatment|2|||
149825979|NCT03519256|540494696|FG000|Overall Study|Other reasons|0|||
149825980|NCT03519256|540494697|FG001|Overall Study|Other reasons|0|||
149825981|NCT03519256|540494698|FG002|Overall Study|Other reasons|2|||
149825982|NCT03519256|540494699|FG003|Overall Study|Other reasons|0|||
149825983|NCT03519256|540494696|FG000|Overall Study|Disease progression|6|||
149825984|NCT03519256|540494697|FG001|Overall Study|Disease progression|3|||
149825985|NCT03519256|540494698|FG002|Overall Study|Disease progression|2|||
149825986|NCT03519256|540494699|FG003|Overall Study|Disease progression|1|||
149825987|NCT03519256|540494696|FG000|Overall Study|Lost to Follow-up|0|||
149825988|NCT03519256|540494697|FG001|Overall Study|Lost to Follow-up|1|||
149825989|NCT03519256|540494698|FG002|Overall Study|Lost to Follow-up|0|||
149825990|NCT03519256|540494699|FG003|Overall Study|Lost to Follow-up|0|||
149825991|NCT00275002|540494700|FG000|Overall Study|Death|1|||
149825992|NCT00275002|540494701|FG001|Overall Study|Death|0|||
149825993|NCT00275002|540494700|FG000|Overall Study|Disease progression|21|||
149825994|NCT00275002|540494701|FG001|Overall Study|Disease progression|15|||
149825995|NCT00275002|540494700|FG000|Overall Study|Adverse Event|0|||
149825996|NCT00275002|540494701|FG001|Overall Study|Adverse Event|1|||
149825997|NCT05456529|540494702|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
149825998|NCT05456529|540494702|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
149825999|NCT05456529|540494702|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
149826000|NCT05456529|540494702|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
149826001|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
149826002|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
150275376|NCT00467779|542146428|FG012|Stage 1|Physician Decision|0|||
150275377|NCT00467779|542146429|FG013|Stage 1|Physician Decision|0|||
150275378|NCT00467779|542146430|FG014|Stage 1|Physician Decision|0|||
150275379|NCT00467779|542146416|FG000|Stage 1|Withdrawal by Subject|0|||
150275380|NCT00467779|542146417|FG001|Stage 1|Withdrawal by Subject|0|||
150275381|NCT00467779|542146418|FG002|Stage 1|Withdrawal by Subject|0|||
149826003|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Physician Decision|2|||
149826004|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
149826005|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
149826006|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
149826007|NCT05456529|540494702|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
149826008|NCT02374918|540494703|FG000|Overall Study|Protocol Violation|2|||
149826009|NCT02374918|540494704|FG001|Overall Study|Protocol Violation|0|||
149826010|NCT02374918|540494705|FG002|Overall Study|Protocol Violation|2|||
149826011|NCT02374918|540494706|FG003|Overall Study|Protocol Violation|1|||
149826012|NCT02374918|540494703|FG000|Overall Study|Withdrawal by Subject|1|||
149826013|NCT02374918|540494704|FG001|Overall Study|Withdrawal by Subject|1|||
149826014|NCT02374918|540494705|FG002|Overall Study|Withdrawal by Subject|1|||
149826015|NCT02374918|540494706|FG003|Overall Study|Withdrawal by Subject|0|||
149826016|NCT02374918|540494703|FG000|Overall Study|Lack of Efficacy|0|||
149826017|NCT02374918|540494704|FG001|Overall Study|Lack of Efficacy|0|||
149826018|NCT02374918|540494705|FG002|Overall Study|Lack of Efficacy|1|||
149826019|NCT02374918|540494706|FG003|Overall Study|Lack of Efficacy|1|||
149826020|NCT01506947|540494707|FG000|Overall Study|Lost to Follow-up|7|||
149826021|NCT01506947|540494707|FG000|Overall Study|Adverse Event|5|||
149826022|NCT01506947|540494707|FG000|Overall Study|Death|1|||
149826023|NCT01506947|540494707|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
149826024|NCT02752776|540494709|FG000|Overall Study|Adverse Event|15|||
149826025|NCT02752776|540494710|FG001|Overall Study|Adverse Event|23|||
149826026|NCT02752776|540494711|FG002|Overall Study|Adverse Event|11|||
149826027|NCT02752776|540494709|FG000|Overall Study|Lack of Efficacy|2|||
149826028|NCT02752776|540494710|FG001|Overall Study|Lack of Efficacy|6|||
149826029|NCT02752776|540494711|FG002|Overall Study|Lack of Efficacy|14|||
149826030|NCT02752776|540494709|FG000|Overall Study|Lost to Follow-up|11|||
149826031|NCT02752776|540494710|FG001|Overall Study|Lost to Follow-up|12|||
149945882|NCT03329001|540936208|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
149945883|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945884|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945885|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945886|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
149945887|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945888|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945889|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945890|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
149945891|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149826032|NCT02752776|540494711|FG002|Overall Study|Lost to Follow-up|4|||
149826033|NCT02752776|540494709|FG000|Overall Study|Non-compliance with study treatment|0|||
149826034|NCT02752776|540494710|FG001|Overall Study|Non-compliance with study treatment|0|||
149945892|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149945893|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149826035|NCT02752776|540494711|FG002|Overall Study|Non-compliance with study treatment|1|||
149945894|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
149945895|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149945896|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
150275382|NCT00467779|542146419|FG003|Stage 1|Withdrawal by Subject|0|||
149826036|NCT02752776|540494709|FG000|Overall Study|Physician Decision|2|||
149826037|NCT02752776|540494710|FG001|Overall Study|Physician Decision|6|||
149826038|NCT02752776|540494711|FG002|Overall Study|Physician Decision|2|||
149826039|NCT02752776|540494709|FG000|Overall Study|Pregnancy|1|||
149826040|NCT02752776|540494710|FG001|Overall Study|Pregnancy|6|||
149826041|NCT02752776|540494711|FG002|Overall Study|Pregnancy|3|||
149826042|NCT02752776|540494709|FG000|Overall Study|Protocol Violation|10|||
149826043|NCT02752776|540494710|FG001|Overall Study|Protocol Violation|13|||
149826044|NCT02752776|540494711|FG002|Overall Study|Protocol Violation|6|||
149826045|NCT02752776|540494709|FG000|Overall Study|Subject/guardian decision|8|||
149826046|NCT02752776|540494710|FG001|Overall Study|Subject/guardian decision|6|||
149826047|NCT02752776|540494711|FG002|Overall Study|Subject/guardian decision|4|||
149826048|NCT02752776|540494709|FG000|Overall Study|Death|0|||
149826049|NCT02752776|540494710|FG001|Overall Study|Death|0|||
149826050|NCT02752776|540494711|FG002|Overall Study|Death|1|||
149826051|NCT02752776|540494709|FG000|Overall Study|Withdrawal by Subject|3|||
150275383|NCT00467779|542146420|FG004|Stage 1|Withdrawal by Subject|0|||
150275384|NCT00467779|542146421|FG005|Stage 1|Withdrawal by Subject|0|||
150275385|NCT00467779|542146422|FG006|Stage 1|Withdrawal by Subject|1|||
150275386|NCT00467779|542146423|FG007|Stage 1|Withdrawal by Subject|1|||
150275387|NCT00467779|542146424|FG008|Stage 1|Withdrawal by Subject|0|||
150275388|NCT00467779|542146425|FG009|Stage 1|Withdrawal by Subject|0|||
150275389|NCT00467779|542146426|FG010|Stage 1|Withdrawal by Subject|0|||
150275390|NCT00467779|542146427|FG011|Stage 1|Withdrawal by Subject|0|||
150275391|NCT00467779|542146428|FG012|Stage 1|Withdrawal by Subject|0|||
150275392|NCT00467779|542146429|FG013|Stage 1|Withdrawal by Subject|0|||
150275393|NCT00467779|542146430|FG014|Stage 1|Withdrawal by Subject|0|||
150275394|NCT00467779|542146416|FG000|Stage 1A|Adverse Event|0|||
150275395|NCT00467779|542146417|FG001|Stage 1A|Adverse Event|0|||
150275396|NCT00467779|542146418|FG002|Stage 1A|Adverse Event|0|||
150275397|NCT00467779|542146419|FG003|Stage 1A|Adverse Event|0|||
150275398|NCT00467779|542146420|FG004|Stage 1A|Adverse Event|0|||
150275399|NCT00467779|542146421|FG005|Stage 1A|Adverse Event|0|||
150275400|NCT00467779|542146422|FG006|Stage 1A|Adverse Event|0|||
150275401|NCT00467779|542146423|FG007|Stage 1A|Adverse Event|0|||
150275402|NCT00467779|542146424|FG008|Stage 1A|Adverse Event|0|||
150275403|NCT00467779|542146425|FG009|Stage 1A|Adverse Event|0|||
150275404|NCT00467779|542146426|FG010|Stage 1A|Adverse Event|0|||
150275405|NCT00467779|542146427|FG011|Stage 1A|Adverse Event|0|||
150275406|NCT00467779|542146428|FG012|Stage 1A|Adverse Event|1|||
150275407|NCT00467779|542146429|FG013|Stage 1A|Adverse Event|0|||
150275408|NCT00467779|542146430|FG014|Stage 1A|Adverse Event|0|||
150275409|NCT00467779|542146416|FG000|Stage 1A|Death|0|||
150275410|NCT00467779|542146417|FG001|Stage 1A|Death|0|||
150275411|NCT00467779|542146418|FG002|Stage 1A|Death|0|||
150275412|NCT00467779|542146419|FG003|Stage 1A|Death|0|||
150275413|NCT00467779|542146420|FG004|Stage 1A|Death|0|||
150275414|NCT00467779|542146421|FG005|Stage 1A|Death|0|||
150275415|NCT00467779|542146422|FG006|Stage 1A|Death|0|||
150275416|NCT00467779|542146423|FG007|Stage 1A|Death|0|||
149826052|NCT02752776|540494710|FG001|Overall Study|Withdrawal by Subject|4|||
149826053|NCT02752776|540494711|FG002|Overall Study|Withdrawal by Subject|2|||
149826054|NCT02492958|540494712|FG000|Overall Study|Withdrawal by Subject|0|||
149826055|NCT02492958|540494713|FG001|Overall Study|Withdrawal by Subject|0|||
149826056|NCT02492958|540494714|FG002|Overall Study|Withdrawal by Subject|1|||
149826057|NCT02492958|540494715|FG003|Overall Study|Withdrawal by Subject|0|||
149826058|NCT02492958|540494712|FG000|Overall Study|Adverse Event|1|||
149826059|NCT02492958|540494713|FG001|Overall Study|Adverse Event|0|||
150275417|NCT00467779|542146424|FG008|Stage 1A|Death|0|||
150275418|NCT00467779|542146425|FG009|Stage 1A|Death|0|||
150275419|NCT00467779|542146426|FG010|Stage 1A|Death|0|||
150275420|NCT00467779|542146427|FG011|Stage 1A|Death|1|||
149826060|NCT02492958|540494714|FG002|Overall Study|Adverse Event|1|||
149826061|NCT02492958|540494715|FG003|Overall Study|Adverse Event|0|||
149826062|NCT00108732|540494716|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
149826063|NCT00108732|540494716|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
149826064|NCT00108732|540494716|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
149826065|NCT00108732|540494716|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
150275421|NCT00467779|542146428|FG012|Stage 1A|Death|1|||
150275422|NCT00467779|542146429|FG013|Stage 1A|Death|0|||
150275423|NCT00467779|542146430|FG014|Stage 1A|Death|0|||
150275424|NCT00467779|542146416|FG000|Stage 1A|Disease Progression|0|||
150275425|NCT00467779|542146417|FG001|Stage 1A|Disease Progression|0|||
150275426|NCT00467779|542146418|FG002|Stage 1A|Disease Progression|0|||
150275427|NCT00467779|542146419|FG003|Stage 1A|Disease Progression|0|||
149826066|NCT00108732|540494716|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
149826067|NCT00108732|540494716|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
149826068|NCT00108732|540494716|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
149826069|NCT01946165|540494718|FG000|Overall Study|Physician Decision|2|||
149826070|NCT01946165|540494719|FG001|Overall Study|Physician Decision|0|||
150275428|NCT00467779|542146420|FG004|Stage 1A|Disease Progression|0|||
150275429|NCT00467779|542146421|FG005|Stage 1A|Disease Progression|0|||
150275430|NCT00467779|542146422|FG006|Stage 1A|Disease Progression|0|||
150275431|NCT00467779|542146423|FG007|Stage 1A|Disease Progression|0|||
150275432|NCT00467779|542146424|FG008|Stage 1A|Disease Progression|0|||
149826071|NCT01946165|540494718|FG000|Overall Study|Withdrawal by Subject|0|||
149826072|NCT01946165|540494719|FG001|Overall Study|Withdrawal by Subject|2|||
149826073|NCT01766921|540494722|FG000|Overall Study|Administrative Reason|5|||
149826074|NCT01766921|540494723|FG001|Overall Study|Administrative Reason|5|||
149826075|NCT01766921|540494722|FG000|Overall Study|Death|1|||
149826076|NCT01766921|540494723|FG001|Overall Study|Death|1|||
149826077|NCT01766921|540494722|FG000|Overall Study|Lost to Follow-up|1|||
149826078|NCT01766921|540494723|FG001|Overall Study|Lost to Follow-up|3|||
149826079|NCT01766921|540494722|FG000|Overall Study|Unclassified|2|||
149826080|NCT01766921|540494723|FG001|Overall Study|Unclassified|2|||
149826081|NCT01766921|540494722|FG000|Overall Study|Protocol Violation|1|||
149826082|NCT01766921|540494723|FG001|Overall Study|Protocol Violation|1|||
149826083|NCT01766921|540494722|FG000|Overall Study|Withdrawal by Subject|14|||
149826084|NCT01766921|540494723|FG001|Overall Study|Withdrawal by Subject|5|||
149826085|NCT01901055|540494724|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
149826086|NCT01901055|540494725|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
149826087|NCT01901055|540494724|FG000|Randomization But Not Titrated|Physician Decision|0|||
149826088|NCT01901055|540494725|FG001|Randomization But Not Titrated|Physician Decision|1|||
149945897|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149945898|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149826089|NCT01901055|540494724|FG000|Started Protocol to Week 6|Physician Decision|2|||
149826090|NCT01901055|540494725|FG001|Started Protocol to Week 6|Physician Decision|1|||
149826091|NCT01901055|540494724|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
149826092|NCT01901055|540494725|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
149826093|NCT01901055|540494724|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
149826094|NCT01901055|540494725|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
149826095|NCT01901055|540494724|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
149826096|NCT01901055|540494725|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
149826097|NCT01901055|540494724|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
149826098|NCT01901055|540494725|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
149826099|NCT01901055|540494724|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
149826100|NCT01901055|540494725|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
149826101|NCT01901055|540494724|FG000|Week 24|Withdrawal by Subject|13|||
149826102|NCT01901055|540494725|FG001|Week 24|Withdrawal by Subject|19|||
149826103|NCT01901055|540494724|FG000|Week 24|Physician Decision|1|||
149826104|NCT01901055|540494725|FG001|Week 24|Physician Decision|0|||
149826105|NCT01901055|540494724|FG000|Week 36|Withdrawal by Subject|0|||
149826106|NCT01901055|540494725|FG001|Week 36|Withdrawal by Subject|5|||
149826107|NCT00708422|540494726|FG000|Overall Study|Adverse Event|3|||
149826108|NCT00708422|540494727|FG001|Overall Study|Adverse Event|1|||
149826109|NCT00708422|540494726|FG000|Overall Study|Withdrawal by Subject|1|||
149826110|NCT00708422|540494727|FG001|Overall Study|Withdrawal by Subject|0|||
149826111|NCT00337571|540494730|FG000|Overall Study|Lack of Efficacy|3|||
149826112|NCT00337571|540494731|FG001|Overall Study|Lack of Efficacy|0|||
149826113|NCT00337571|540494732|FG002|Overall Study|Lack of Efficacy|0|||
149826114|NCT00337571|540494733|FG003|Overall Study|Lack of Efficacy|0|||
149826115|NCT00337571|540494730|FG000|Overall Study|Adverse Event|4|||
149826116|NCT00337571|540494731|FG001|Overall Study|Adverse Event|5|||
149826117|NCT00337571|540494732|FG002|Overall Study|Adverse Event|8|||
149826118|NCT00337571|540494733|FG003|Overall Study|Adverse Event|4|||
149826119|NCT00337571|540494730|FG000|Overall Study|Withdrawal by Subject|2|||
149826120|NCT00337571|540494731|FG001|Overall Study|Withdrawal by Subject|2|||
149945899|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149945900|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149945901|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149945902|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
149945903|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149826121|NCT00337571|540494732|FG002|Overall Study|Withdrawal by Subject|1|||
149826122|NCT00337571|540494733|FG003|Overall Study|Withdrawal by Subject|0|||
149826123|NCT00337571|540494730|FG000|Overall Study|Lost to Follow-up|3|||
149826124|NCT00337571|540494731|FG001|Overall Study|Lost to Follow-up|1|||
149826125|NCT00337571|540494732|FG002|Overall Study|Lost to Follow-up|0|||
149826126|NCT00337571|540494733|FG003|Overall Study|Lost to Follow-up|1|||
149826127|NCT00337571|540494730|FG000|Overall Study|Poor/noncompliance|1|||
149826128|NCT00337571|540494731|FG001|Overall Study|Poor/noncompliance|1|||
149826129|NCT00337571|540494732|FG002|Overall Study|Poor/noncompliance|1|||
149826130|NCT00337571|540494733|FG003|Overall Study|Poor/noncompliance|1|||
149826131|NCT00337571|540494730|FG000|Overall Study|No longer met study criteria|1|||
149826132|NCT00337571|540494731|FG001|Overall Study|No longer met study criteria|0|||
149826133|NCT00337571|540494732|FG002|Overall Study|No longer met study criteria|0|||
149945904|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
150033201|NCT01247324|541260917|FG001|Overall Study|Protocol Violation|1|||
149826134|NCT00337571|540494733|FG003|Overall Study|No longer met study criteria|0|||
149826135|NCT00337571|540494730|FG000|Overall Study|High Potassium level|0|||
149826136|NCT00337571|540494731|FG001|Overall Study|High Potassium level|0|||
149826137|NCT00337571|540494732|FG002|Overall Study|High Potassium level|0|||
149826138|NCT00337571|540494733|FG003|Overall Study|High Potassium level|1|||
149826139|NCT00635154|540494741|FG000|Overall Study|Alternative Treatment|8|||
149826140|NCT00635154|540494741|FG000|Overall Study|Other|4|||
149826141|NCT00635154|540494741|FG000|Overall Study|Still on treatment|21|||
149826142|NCT01399736|540494742|FG000|Overall Study|Withdrawal by Subject|4|||
149826143|NCT01399736|540494743|FG001|Overall Study|Withdrawal by Subject|2|||
149826144|NCT01399736|540494742|FG000|Overall Study|Lost to Follow-up|0|||
149826145|NCT01399736|540494743|FG001|Overall Study|Lost to Follow-up|2|||
149826146|NCT02795104|540494744|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
149826147|NCT02795104|540494745|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
149826148|NCT02795104|540494746|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
149826149|NCT02795104|540494744|FG000|Overall Study|Withdrawal by Subject|0|||
149826150|NCT02795104|540494745|FG001|Overall Study|Withdrawal by Subject|2|||
149826151|NCT02795104|540494746|FG002|Overall Study|Withdrawal by Subject|0|||
149826152|NCT02795104|540494744|FG000|Overall Study|Lost to Follow-up|0|||
149826153|NCT02795104|540494745|FG001|Overall Study|Lost to Follow-up|0|||
149826154|NCT02795104|540494746|FG002|Overall Study|Lost to Follow-up|1|||
149826155|NCT00948675|540494747|FG000|Overall Study|Lost to Follow-up|1|||
149826156|NCT00948675|540494748|FG001|Overall Study|Lost to Follow-up|0|||
149826157|NCT01654380|540494752|FG000|Part B, Period 1|Physician Decision|0|||
149826158|NCT01654380|540494753|FG001|Part B, Period 1|Physician Decision|0|||
149826159|NCT01654380|540494754|FG002|Part B, Period 1|Physician Decision|1|||
149826160|NCT01654380|540494755|FG003|Part B, Period 1|Physician Decision|0|||
149826161|NCT03552757|540494758|FG000|Overall Study|Withdrawal by Subject|10|||
149826162|NCT03552757|540494759|FG001|Overall Study|Withdrawal by Subject|5|||
149826163|NCT03552757|540494760|FG002|Overall Study|Withdrawal by Subject|12|||
149826164|NCT03552757|540494758|FG000|Overall Study|Lost to Follow-up|2|||
149826165|NCT03552757|540494759|FG001|Overall Study|Lost to Follow-up|7|||
149826166|NCT03552757|540494760|FG002|Overall Study|Lost to Follow-up|7|||
149826167|NCT03552757|540494758|FG000|Overall Study|Death|1|||
149826168|NCT03552757|540494759|FG001|Overall Study|Death|1|||
149826169|NCT03552757|540494760|FG002|Overall Study|Death|1|||
149826170|NCT04652453|540494761|FG000|Overall Study|Death|8|||
149826171|NCT04652453|540494762|FG001|Overall Study|Death|2|||
149826172|NCT04652453|540494763|FG002|Overall Study|Death|0|||
149826173|NCT04652453|540494761|FG000|Overall Study|Hospice|5|||
149826174|NCT04652453|540494762|FG001|Overall Study|Hospice|5|||
149826175|NCT04652453|540494763|FG002|Overall Study|Hospice|0|||
149826176|NCT04652453|540494761|FG000|Overall Study|Withdrawal by Subject|2|||
149826177|NCT04652453|540494762|FG001|Overall Study|Withdrawal by Subject|0|||
149826178|NCT04652453|540494763|FG002|Overall Study|Withdrawal by Subject|0|||
149826179|NCT04543136|540494764|FG000|Overall Study|Withdrawal by Subject|0|||
149826180|NCT04543136|540494765|FG001|Overall Study|Withdrawal by Subject|1|||
149826181|NCT04543136|540494766|FG002|Overall Study|Withdrawal by Subject|0|||
149826182|NCT04543136|540494767|FG003|Overall Study|Withdrawal by Subject|1|||
149826183|NCT04543136|540494768|FG004|Overall Study|Withdrawal by Subject|0|||
149826184|NCT04543136|540494769|FG005|Overall Study|Withdrawal by Subject|0|||
149826185|NCT02192099|540494770|FG000|Overall Study|Adverse Event|1|||
149826186|NCT02192099|540494770|FG000|Overall Study|Lost to Follow-up|2|||
149826187|NCT02192099|540494770|FG000|Overall Study|Physician Decision|1|||
149826188|NCT02192099|540494770|FG000|Overall Study|Pregnancy|1|||
149826189|NCT02192099|540494770|FG000|Overall Study|Protocol Violation|8|||
149826190|NCT02192099|540494770|FG000|Overall Study|Study Terminated by Sponsor|32|||
149826191|NCT02192099|540494770|FG000|Overall Study|Withdrawal by Subject|11|||
149826192|NCT02192099|540494770|FG000|Overall Study|Miscellaneous Reasons|5|||
149945905|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149945906|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
149945907|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945908|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
150170418|NCT01235949|541759072|FG011|Booster Phase|Adverse Event|0|||
150170419|NCT01235949|541759073|FG012|Booster Phase|Adverse Event|0|||
149826193|NCT00386009|540494771|FG000|Overall Study|Adverse Event|0|||
149826194|NCT00386009|540494772|FG001|Overall Study|Adverse Event|2|||
150170420|NCT01235949|541759074|FG013|Booster Phase|Adverse Event|0|||
149826195|NCT00386009|540494771|FG000|Overall Study|Death|1|||
149826196|NCT00386009|540494772|FG001|Overall Study|Death|0|||
149826197|NCT00386009|540494771|FG000|Overall Study|Entry Criteria Not Met|0|||
149826198|NCT00386009|540494772|FG001|Overall Study|Entry Criteria Not Met|2|||
150170421|NCT01235949|541759075|FG014|Booster Phase|Adverse Event|0|||
150170422|NCT01235949|541759076|FG015|Booster Phase|Adverse Event|1|||
149826199|NCT00386009|540494771|FG000|Overall Study|Lost to Follow-up|1|||
149826200|NCT00386009|540494772|FG001|Overall Study|Lost to Follow-up|1|||
149826201|NCT00386009|540494771|FG000|Overall Study|Protocol Violation|1|||
149826202|NCT00386009|540494772|FG001|Overall Study|Protocol Violation|0|||
149826203|NCT00386009|540494771|FG000|Overall Study|Sponsor Decision|1|||
149826204|NCT00386009|540494772|FG001|Overall Study|Sponsor Decision|1|||
149826205|NCT00386009|540494771|FG000|Overall Study|Withdrawal by Subject|5|||
149826206|NCT00386009|540494772|FG001|Overall Study|Withdrawal by Subject|4|||
149826207|NCT01862328|540494783|FG000|Overall Study|Progressive Disease|3|||
149826208|NCT01862328|540494784|FG001|Overall Study|Progressive Disease|11|||
149826209|NCT01862328|540494785|FG002|Overall Study|Progressive Disease|5|||
149826210|NCT01862328|540494786|FG003|Overall Study|Progressive Disease|6|||
149826211|NCT01862328|540494787|FG004|Overall Study|Progressive Disease|7|||
149826212|NCT01862328|540494788|FG005|Overall Study|Progressive Disease|4|||
149826213|NCT01862328|540494789|FG006|Overall Study|Progressive Disease|3|||
149826214|NCT01862328|540494783|FG000|Overall Study|Adverse Event|0|||
149826215|NCT01862328|540494784|FG001|Overall Study|Adverse Event|4|||
149826216|NCT01862328|540494785|FG002|Overall Study|Adverse Event|0|||
149826217|NCT01862328|540494786|FG003|Overall Study|Adverse Event|1|||
149826218|NCT01862328|540494787|FG004|Overall Study|Adverse Event|0|||
149826219|NCT01862328|540494788|FG005|Overall Study|Adverse Event|2|||
149826220|NCT01862328|540494789|FG006|Overall Study|Adverse Event|4|||
149826221|NCT01862328|540494783|FG000|Overall Study|Other|0|||
149826222|NCT01862328|540494784|FG001|Overall Study|Other|2|||
149826223|NCT01862328|540494785|FG002|Overall Study|Other|1|||
149826224|NCT01862328|540494786|FG003|Overall Study|Other|0|||
149826225|NCT01862328|540494787|FG004|Overall Study|Other|4|||
149826226|NCT01862328|540494788|FG005|Overall Study|Other|0|||
149826227|NCT01862328|540494789|FG006|Overall Study|Other|1|||
149826228|NCT01862328|540494783|FG000|Overall Study|Withdrawal by Subject|1|||
149826229|NCT01862328|540494784|FG001|Overall Study|Withdrawal by Subject|1|||
149945909|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
149945910|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945911|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945912|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945913|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945914|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149945915|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945916|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945917|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
149945918|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945919|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945920|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945921|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945922|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
149945923|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945924|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945925|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
149945926|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945927|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945928|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945929|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945930|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
149945931|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945932|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945933|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
149945934|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945935|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945936|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149826230|NCT01862328|540494785|FG002|Overall Study|Withdrawal by Subject|0|||
149826231|NCT01862328|540494786|FG003|Overall Study|Withdrawal by Subject|0|||
149826232|NCT01862328|540494787|FG004|Overall Study|Withdrawal by Subject|1|||
149826233|NCT01862328|540494788|FG005|Overall Study|Withdrawal by Subject|1|||
149826234|NCT01862328|540494789|FG006|Overall Study|Withdrawal by Subject|1|||
149826235|NCT01862328|540494783|FG000|Overall Study|Symptomatic Deterioration|0|||
149826236|NCT01862328|540494784|FG001|Overall Study|Symptomatic Deterioration|0|||
149826237|NCT01862328|540494785|FG002|Overall Study|Symptomatic Deterioration|0|||
149826238|NCT01862328|540494786|FG003|Overall Study|Symptomatic Deterioration|0|||
149826239|NCT01862328|540494787|FG004|Overall Study|Symptomatic Deterioration|0|||
149826240|NCT01862328|540494788|FG005|Overall Study|Symptomatic Deterioration|0|||
149826241|NCT01862328|540494789|FG006|Overall Study|Symptomatic Deterioration|1|||
149826242|NCT02482571|540494790|FG000|Overall Study|Adverse Event|1|||
149826243|NCT02482571|540494790|FG000|Overall Study|Scanner or Respiract failure|3|||
149826244|NCT02482571|540494790|FG000|Overall Study|Withdrawal by Subject|4|||
149826245|NCT03922477|540494793|FG000|Overall Study|Death|9|||
149826246|NCT03922477|540494793|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
149826247|NCT03922477|540494793|FG000|Overall Study|Physician Decision|1|||
149826248|NCT03922477|540494793|FG000|Overall Study|Withdrawal by Subject|2|||
149826249|NCT01498484|540494794|FG000|Overall Study|Death|6|||
149826250|NCT01498484|540494795|FG001|Overall Study|Death|3|||
149826251|NCT01498484|540494796|FG002|Overall Study|Death|1|||
149826252|NCT01498484|540494797|FG003|Overall Study|Death|1|||
149826253|NCT01498484|540494798|FG004|Overall Study|Death|0|||
149826254|NCT01498484|540494799|FG005|Overall Study|Death|0|||
149826255|NCT01498484|540494800|FG006|Overall Study|Death|10|||
149826256|NCT01498484|540494801|FG007|Overall Study|Death|1|||
149826257|NCT01498484|540494802|FG008|Overall Study|Death|0|||
149826258|NCT01498484|540494794|FG000|Overall Study|Physician Decision|3|||
149826259|NCT01498484|540494795|FG001|Overall Study|Physician Decision|2|||
149826260|NCT01498484|540494796|FG002|Overall Study|Physician Decision|1|||
149826261|NCT01498484|540494797|FG003|Overall Study|Physician Decision|1|||
149826262|NCT01498484|540494798|FG004|Overall Study|Physician Decision|0|||
149826263|NCT01498484|540494799|FG005|Overall Study|Physician Decision|0|||
149826264|NCT01498484|540494800|FG006|Overall Study|Physician Decision|8|||
149826265|NCT01498484|540494801|FG007|Overall Study|Physician Decision|13|||
149826266|NCT01498484|540494802|FG008|Overall Study|Physician Decision|1|||
149826267|NCT01498484|540494794|FG000|Overall Study|Adverse Event|0|||
149826268|NCT01498484|540494795|FG001|Overall Study|Adverse Event|0|||
149826269|NCT01498484|540494796|FG002|Overall Study|Adverse Event|0|||
149826270|NCT01498484|540494797|FG003|Overall Study|Adverse Event|0|||
149826271|NCT01498484|540494798|FG004|Overall Study|Adverse Event|0|||
149826272|NCT01498484|540494799|FG005|Overall Study|Adverse Event|1|||
149826273|NCT01498484|540494800|FG006|Overall Study|Adverse Event|0|||
149826274|NCT01498484|540494801|FG007|Overall Study|Adverse Event|0|||
149826275|NCT01498484|540494802|FG008|Overall Study|Adverse Event|0|||
149826276|NCT01498484|540494794|FG000|Overall Study|Withdrawal by Subject|0|||
149826277|NCT01498484|540494795|FG001|Overall Study|Withdrawal by Subject|0|||
149826278|NCT01498484|540494796|FG002|Overall Study|Withdrawal by Subject|0|||
149826279|NCT01498484|540494797|FG003|Overall Study|Withdrawal by Subject|1|||
149826280|NCT01498484|540494798|FG004|Overall Study|Withdrawal by Subject|0|||
149826281|NCT01498484|540494799|FG005|Overall Study|Withdrawal by Subject|0|||
149826282|NCT01498484|540494800|FG006|Overall Study|Withdrawal by Subject|1|||
149826283|NCT01498484|540494801|FG007|Overall Study|Withdrawal by Subject|0|||
149826284|NCT01498484|540494802|FG008|Overall Study|Withdrawal by Subject|0|||
149826285|NCT01498484|540494794|FG000|Overall Study|Other|5|||
149945937|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945938|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
149945939|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149945940|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149945941|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
149945942|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
149945943|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149945944|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149945945|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149945946|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
149826286|NCT01498484|540494795|FG001|Overall Study|Other|2|||
149826287|NCT01498484|540494796|FG002|Overall Study|Other|0|||
149826288|NCT01498484|540494797|FG003|Overall Study|Other|0|||
149826289|NCT01498484|540494798|FG004|Overall Study|Other|1|||
149945947|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945948|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945949|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
149826290|NCT01498484|540494799|FG005|Overall Study|Other|0|||
149826291|NCT01498484|540494800|FG006|Overall Study|Other|3|||
149826292|NCT01498484|540494801|FG007|Overall Study|Other|0|||
149826293|NCT01498484|540494802|FG008|Overall Study|Other|1|||
149826294|NCT04104646|540494803|FG000|Overall Study|Withdrawal by Subject|1|||
149826295|NCT04104646|540494804|FG001|Overall Study|Withdrawal by Subject|1|||
149826296|NCT04104646|540494803|FG000|Overall Study|Lost to Follow-up|1|||
149826297|NCT04104646|540494804|FG001|Overall Study|Lost to Follow-up|0|||
149826298|NCT04104646|540494803|FG000|Overall Study|Physician Decision|2|||
149826299|NCT04104646|540494804|FG001|Overall Study|Physician Decision|0|||
149826300|NCT01199601|540494805|FG000|Overall Study|Lost to Follow-up|47|||
149826301|NCT01199601|540494806|FG001|Overall Study|Lost to Follow-up|66|||
149826302|NCT01199601|540494805|FG000|Overall Study|Withdrawal by Subject|15|||
149826303|NCT01199601|540494806|FG001|Overall Study|Withdrawal by Subject|3|||
149826304|NCT01199601|540494805|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
149826305|NCT01199601|540494806|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
149826306|NCT02607800|540494807|FG000|Overall Study|Lost to Follow-up|7|||
149826307|NCT02607800|540494808|FG001|Overall Study|Lost to Follow-up|10|||
149826308|NCT02607800|540494807|FG000|Overall Study|Withdrew Consent|2|||
149826309|NCT02607800|540494808|FG001|Overall Study|Withdrew Consent|0|||
149826310|NCT02607800|540494807|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
149826311|NCT02607800|540494808|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
149826312|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
149826313|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
149826314|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Death|0|||
149826315|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Death|1|||
149826316|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
149826317|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
149826318|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
149826319|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
149826320|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
149826321|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
149826322|NCT01656889|540494809|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
149826323|NCT01656889|540494810|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
149826324|NCT01656889|540494809|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
149826325|NCT01656889|540494810|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
149945950|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945951|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945952|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945953|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149826326|NCT01656889|540494809|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
149826327|NCT01656889|540494810|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
149826328|NCT01656889|540494809|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
149945954|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
149945955|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945956|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945957|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
149945958|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
149945959|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945960|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945961|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945962|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
149945963|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945964|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945965|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
149945966|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
149945967|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945968|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945969|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945970|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
149945971|NCT03329001|540936201|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149945972|NCT03329001|540936202|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149945973|NCT03329001|540936203|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
149945974|NCT03329001|540936204|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
149945975|NCT03329001|540936205|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149945976|NCT03329001|540936206|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149945977|NCT03329001|540936207|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149945978|NCT03329001|540936208|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
149826329|NCT01656889|540494810|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
149826330|NCT01656889|540494809|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
150170423|NCT01235949|541759077|FG016|Booster Phase|Adverse Event|0|||
150170424|NCT01235949|541759078|FG017|Booster Phase|Adverse Event|0|||
150170425|NCT01235949|541759061|FG000|Booster Phase|Withdrawal by Subject|0|||
149826331|NCT01656889|540494810|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
149826332|NCT03387098|540494811|FG000|Overall Study|progressive disease|1|||
149826333|NCT03387098|540494811|FG000|Overall Study|Withdrawal by Subject|2|||
149826334|NCT03387098|540494811|FG000|Overall Study|study terminated by sponsor|1|||
149945979|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945980|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945981|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945982|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
149945983|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945984|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945985|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945986|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
149945987|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945988|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945989|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945990|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
149945991|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945992|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945993|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945994|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
149945995|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149945996|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149945997|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
149945998|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149945999|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149946000|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149946001|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149946002|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
149946003|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946004|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946005|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
149946006|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
149946007|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946008|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946009|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946010|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
149946011|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946012|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946013|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
149946014|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946015|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946016|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946017|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946018|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
149946019|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946020|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946021|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
149946022|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946023|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946024|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946025|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946026|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149946027|NCT03329001|540936201|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946028|NCT03329001|540936202|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946029|NCT03329001|540936203|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946030|NCT03329001|540936204|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
149946031|NCT03329001|540936205|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946032|NCT03329001|540936206|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946033|NCT03329001|540936207|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149946034|NCT03329001|540936208|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
150170426|NCT01235949|541759062|FG001|Booster Phase|Withdrawal by Subject|0|||
150170427|NCT01235949|541759063|FG002|Booster Phase|Withdrawal by Subject|0|||
149826335|NCT02486796|540494812|FG000|Overall Study|Withdrawal by Subject|1|||
149826336|NCT02486796|540494813|FG001|Overall Study|Withdrawal by Subject|1|||
149826337|NCT02486796|540494812|FG000|Overall Study|Physician Decision|1|||
149826338|NCT02486796|540494813|FG001|Overall Study|Physician Decision|0|||
149826339|NCT02974153|540494814|FG000|Overall Study|Adverse Event|6|||
149826340|NCT02974153|540494815|FG001|Overall Study|Adverse Event|0|||
149826341|NCT02974153|540494816|FG002|Overall Study|Adverse Event|1|||
149826342|NCT02974153|540494814|FG000|Overall Study|Lack of Efficacy|6|||
149826343|NCT02974153|540494815|FG001|Overall Study|Lack of Efficacy|5|||
149826344|NCT02974153|540494816|FG002|Overall Study|Lack of Efficacy|10|||
149826345|NCT02974153|540494814|FG000|Overall Study|Lost to Follow-up|9|||
150275433|NCT00467779|542146425|FG009|Stage 1A|Disease Progression|2|||
150275434|NCT00467779|542146426|FG010|Stage 1A|Disease Progression|2|||
150275435|NCT00467779|542146427|FG011|Stage 1A|Disease Progression|5|||
150275436|NCT00467779|542146428|FG012|Stage 1A|Disease Progression|2|||
149826346|NCT02974153|540494815|FG001|Overall Study|Lost to Follow-up|10|||
149826347|NCT02974153|540494816|FG002|Overall Study|Lost to Follow-up|17|||
149826348|NCT02974153|540494814|FG000|Overall Study|Physician Decision|0|||
149826349|NCT02974153|540494815|FG001|Overall Study|Physician Decision|2|||
149826350|NCT02974153|540494816|FG002|Overall Study|Physician Decision|1|||
149826351|NCT02974153|540494814|FG000|Overall Study|Withdrawal by Subject|9|||
149826352|NCT02974153|540494815|FG001|Overall Study|Withdrawal by Subject|16|||
149826353|NCT02974153|540494816|FG002|Overall Study|Withdrawal by Subject|11|||
149826354|NCT02974153|540494814|FG000|Overall Study|Study Burden|8|||
149826355|NCT02974153|540494815|FG001|Overall Study|Study Burden|7|||
149826356|NCT02974153|540494816|FG002|Overall Study|Study Burden|3|||
149826357|NCT02974153|540494814|FG000|Overall Study|Other|14|||
149826358|NCT02974153|540494815|FG001|Overall Study|Other|8|||
149826359|NCT02974153|540494816|FG002|Overall Study|Other|7|||
149826360|NCT02521948|540494817|FG000|Overall Study|Adverse Event|2|||
149826361|NCT02521948|540494817|FG000|Overall Study|Death|4|||
149826362|NCT02521948|540494817|FG000|Overall Study|Lost to Follow-up|1|||
149826363|NCT02521948|540494817|FG000|Overall Study|Did not attend one or both follow-ups|6|||
150275437|NCT00467779|542146429|FG013|Stage 1A|Disease Progression|0|||
150275438|NCT00467779|542146430|FG014|Stage 1A|Disease Progression|0|||
150275439|NCT00467779|542146416|FG000|Stage 1A|Physician Decision|0|||
150275440|NCT00467779|542146417|FG001|Stage 1A|Physician Decision|0|||
150275441|NCT00467779|542146418|FG002|Stage 1A|Physician Decision|0|||
150275442|NCT00467779|542146419|FG003|Stage 1A|Physician Decision|0|||
150275443|NCT00467779|542146420|FG004|Stage 1A|Physician Decision|0|||
150275444|NCT00467779|542146421|FG005|Stage 1A|Physician Decision|0|||
150275445|NCT00467779|542146422|FG006|Stage 1A|Physician Decision|0|||
150275446|NCT00467779|542146423|FG007|Stage 1A|Physician Decision|0|||
150275447|NCT00467779|542146424|FG008|Stage 1A|Physician Decision|0|||
150275448|NCT00467779|542146425|FG009|Stage 1A|Physician Decision|1|||
150275449|NCT00467779|542146426|FG010|Stage 1A|Physician Decision|0|||
150275450|NCT00467779|542146427|FG011|Stage 1A|Physician Decision|0|||
150275451|NCT00467779|542146428|FG012|Stage 1A|Physician Decision|0|||
150275452|NCT00467779|542146429|FG013|Stage 1A|Physician Decision|0|||
150275453|NCT00467779|542146430|FG014|Stage 1A|Physician Decision|0|||
150275454|NCT00467779|542146416|FG000|Stage 1A|Withdrawal by Subject|0|||
150275455|NCT00467779|542146417|FG001|Stage 1A|Withdrawal by Subject|0|||
150275456|NCT00467779|542146418|FG002|Stage 1A|Withdrawal by Subject|0|||
150275457|NCT00467779|542146419|FG003|Stage 1A|Withdrawal by Subject|0|||
150275458|NCT00467779|542146420|FG004|Stage 1A|Withdrawal by Subject|0|||
150275459|NCT00467779|542146421|FG005|Stage 1A|Withdrawal by Subject|0|||
150275460|NCT00467779|542146422|FG006|Stage 1A|Withdrawal by Subject|0|||
149826364|NCT00423800|540494818|FG000|Overall Study|Protocol Violation|0|||
149826365|NCT00423800|540494819|FG001|Overall Study|Protocol Violation|1|||
149826366|NCT00601484|540494824|FG000|Overall Study|Adverse Event|0|||
149826367|NCT00601484|540494825|FG001|Overall Study|Adverse Event|1|||
149826368|NCT00601484|540494824|FG000|Overall Study|Lost to Follow-up|4|||
149946035|NCT03329001|540936201|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946036|NCT03329001|540936202|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946037|NCT03329001|540936203|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946038|NCT03329001|540936204|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149826369|NCT00601484|540494825|FG001|Overall Study|Lost to Follow-up|3|||
149946039|NCT03329001|540936205|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946040|NCT03329001|540936206|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
150275461|NCT00467779|542146423|FG007|Stage 1A|Withdrawal by Subject|0|||
149826370|NCT00601484|540494824|FG000|Overall Study|Lack of Efficacy|0|||
149826371|NCT00601484|540494825|FG001|Overall Study|Lack of Efficacy|2|||
150275462|NCT00467779|542146424|FG008|Stage 1A|Withdrawal by Subject|0|||
150275463|NCT00467779|542146425|FG009|Stage 1A|Withdrawal by Subject|0|||
150275464|NCT00467779|542146426|FG010|Stage 1A|Withdrawal by Subject|1|||
149826372|NCT00601484|540494824|FG000|Overall Study|Withdrawal by Subject|1|||
149826373|NCT00601484|540494825|FG001|Overall Study|Withdrawal by Subject|1|||
150275465|NCT00467779|542146427|FG011|Stage 1A|Withdrawal by Subject|1|||
150275466|NCT00467779|542146428|FG012|Stage 1A|Withdrawal by Subject|1|||
150275467|NCT00467779|542146429|FG013|Stage 1A|Withdrawal by Subject|0|||
149826374|NCT00601484|540494824|FG000|Overall Study|Randomized, but not treated|0|||
149826375|NCT00601484|540494825|FG001|Overall Study|Randomized, but not treated|1|||
149826376|NCT03504852|540494826|FG000|Overall Study|Withdrawal of informed consent|2|||
149826377|NCT03504852|540494827|FG001|Overall Study|Withdrawal of informed consent|1|||
149826378|NCT03504852|540494828|FG002|Overall Study|Withdrawal of informed consent|0|||
149826379|NCT03504852|540494826|FG000|Overall Study|Withdrawal by Subject|5|||
149826380|NCT03504852|540494827|FG001|Overall Study|Withdrawal by Subject|5|||
149826381|NCT03504852|540494828|FG002|Overall Study|Withdrawal by Subject|1|||
149826382|NCT03504852|540494826|FG000|Overall Study|Lost to Follow-up|4|||
149826383|NCT03504852|540494827|FG001|Overall Study|Lost to Follow-up|1|||
149826384|NCT03504852|540494828|FG002|Overall Study|Lost to Follow-up|0|||
149826385|NCT03504852|540494826|FG000|Overall Study|New therapy for study indication|1|||
149826386|NCT03504852|540494827|FG001|Overall Study|New therapy for study indication|0|||
149826387|NCT03504852|540494828|FG002|Overall Study|New therapy for study indication|0|||
149826388|NCT03504852|540494826|FG000|Overall Study|Lack of Efficacy|1|||
149826389|NCT03504852|540494827|FG001|Overall Study|Lack of Efficacy|2|||
149826390|NCT03504852|540494828|FG002|Overall Study|Lack of Efficacy|0|||
149826391|NCT03504852|540494826|FG000|Overall Study|Death|0|||
149826392|NCT03504852|540494827|FG001|Overall Study|Death|1|||
149826393|NCT03504852|540494828|FG002|Overall Study|Death|0|||
149826394|NCT03504852|540494826|FG000|Overall Study|Adverse Event|4|||
149826395|NCT03504852|540494827|FG001|Overall Study|Adverse Event|8|||
149826396|NCT03504852|540494828|FG002|Overall Study|Adverse Event|2|||
149826397|NCT03850509|540494829|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
149826398|NCT03850509|540494830|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
149826399|NCT00969332|540494831|FG000|Overall Study|Physician Decision|8|||
149826400|NCT00969332|540494831|FG000|Overall Study|Withdrawal by Subject|3|||
149826401|NCT00576199|540494832|FG000|Overall Study|Adverse Event|12|||
149826402|NCT00576199|540494832|FG000|Overall Study|Insufficient Therapeutic Response|14|||
149826403|NCT00576199|540494832|FG000|Overall Study|Refused Treatment|2|||
149826404|NCT00576199|540494832|FG000|Overall Study|Reason Unspecified|2|||
149826405|NCT03131999|540494833|FG000|Overall Study|Withdrawal by Subject|0|||
149826406|NCT03131999|540494834|FG001|Overall Study|Withdrawal by Subject|1|||
149826407|NCT03495869|540494835|FG000|Overall Study|Lost to Follow-up|4|||
149826408|NCT03495869|540494836|FG001|Overall Study|Lost to Follow-up|17|||
149826409|NCT03495869|540494837|FG002|Overall Study|Lost to Follow-up|8|||
149826410|NCT03495869|540494838|FG003|Overall Study|Lost to Follow-up|14|||
149826411|NCT03495869|540494835|FG000|Overall Study|Withdrawal by Subject|0|||
149826412|NCT03495869|540494836|FG001|Overall Study|Withdrawal by Subject|3|||
149826413|NCT03495869|540494837|FG002|Overall Study|Withdrawal by Subject|0|||
149826414|NCT03495869|540494838|FG003|Overall Study|Withdrawal by Subject|3|||
149826415|NCT03495869|540494835|FG000|Overall Study|Dropped from study|0|||
149826416|NCT03495869|540494836|FG001|Overall Study|Dropped from study|7|||
149826417|NCT03495869|540494837|FG002|Overall Study|Dropped from study|2|||
149826418|NCT03495869|540494838|FG003|Overall Study|Dropped from study|4|||
149826419|NCT04634409|540494841|FG000|Overall Study|Death|0|||
149826420|NCT04634409|540494842|FG001|Overall Study|Death|0|||
149826421|NCT04634409|540494843|FG002|Overall Study|Death|0|||
149826422|NCT04634409|540494844|FG003|Overall Study|Death|0|||
149826423|NCT04634409|540494845|FG004|Overall Study|Death|0|||
149826424|NCT04634409|540494846|FG005|Overall Study|Death|0|||
149826425|NCT04634409|540494847|FG006|Overall Study|Death|0|||
149826426|NCT04634409|540494848|FG007|Overall Study|Death|0|||
149826427|NCT04634409|540494849|FG008|Overall Study|Death|0|||
149826428|NCT04634409|540494850|FG009|Overall Study|Death|0|||
149826429|NCT04634409|540494851|FG010|Overall Study|Death|1|||
149826430|NCT04634409|540494852|FG011|Overall Study|Death|0|||
149826431|NCT04634409|540494853|FG012|Overall Study|Death|1|||
149826432|NCT04634409|540494854|FG013|Overall Study|Death|0|||
149826433|NCT04634409|540494855|FG014|Overall Study|Death|0|||
149826434|NCT04634409|540494856|FG015|Overall Study|Death|0|||
149826435|NCT04634409|540494857|FG016|Overall Study|Death|0|||
149826436|NCT04634409|540494858|FG017|Overall Study|Death|0|||
149826437|NCT04634409|540494859|FG018|Overall Study|Death|0|||
149826438|NCT04634409|540494860|FG019|Overall Study|Death|0|||
149826439|NCT04634409|540494861|FG020|Overall Study|Death|0|||
149826440|NCT04634409|540494862|FG021|Overall Study|Death|0|||
149826441|NCT04634409|540494863|FG022|Overall Study|Death|0|||
149826442|NCT04634409|540494864|FG023|Overall Study|Death|0|||
149826443|NCT04634409|540494865|FG024|Overall Study|Death|0|||
149826444|NCT04634409|540494866|FG025|Overall Study|Death|0|||
149826445|NCT04634409|540494867|FG026|Overall Study|Death|0|||
149826446|NCT04634409|540494841|FG000|Overall Study|Adverse Event|0|||
149826447|NCT04634409|540494842|FG001|Overall Study|Adverse Event|0|||
149826448|NCT04634409|540494843|FG002|Overall Study|Adverse Event|1|||
149826449|NCT04634409|540494844|FG003|Overall Study|Adverse Event|0|||
149826450|NCT04634409|540494845|FG004|Overall Study|Adverse Event|0|||
149826451|NCT04634409|540494846|FG005|Overall Study|Adverse Event|1|||
149826452|NCT04634409|540494847|FG006|Overall Study|Adverse Event|0|||
149826453|NCT04634409|540494848|FG007|Overall Study|Adverse Event|0|||
149826454|NCT04634409|540494849|FG008|Overall Study|Adverse Event|0|||
149826455|NCT04634409|540494850|FG009|Overall Study|Adverse Event|0|||
149826456|NCT04634409|540494851|FG010|Overall Study|Adverse Event|0|||
149826457|NCT04634409|540494852|FG011|Overall Study|Adverse Event|0|||
149826458|NCT04634409|540494853|FG012|Overall Study|Adverse Event|0|||
149826459|NCT04634409|540494854|FG013|Overall Study|Adverse Event|0|||
149826460|NCT04634409|540494855|FG014|Overall Study|Adverse Event|0|||
149826461|NCT04634409|540494856|FG015|Overall Study|Adverse Event|0|||
149826462|NCT04634409|540494857|FG016|Overall Study|Adverse Event|0|||
149826463|NCT04634409|540494858|FG017|Overall Study|Adverse Event|0|||
149826464|NCT04634409|540494859|FG018|Overall Study|Adverse Event|0|||
149826465|NCT04634409|540494860|FG019|Overall Study|Adverse Event|0|||
149826466|NCT04634409|540494861|FG020|Overall Study|Adverse Event|0|||
149826467|NCT04634409|540494862|FG021|Overall Study|Adverse Event|0|||
149826468|NCT04634409|540494863|FG022|Overall Study|Adverse Event|0|||
149826469|NCT04634409|540494864|FG023|Overall Study|Adverse Event|0|||
149826470|NCT04634409|540494865|FG024|Overall Study|Adverse Event|0|||
149826471|NCT04634409|540494866|FG025|Overall Study|Adverse Event|0|||
149826472|NCT04634409|540494867|FG026|Overall Study|Adverse Event|0|||
149826473|NCT04634409|540494841|FG000|Overall Study|Lost to Follow-up|3|||
149826474|NCT04634409|540494842|FG001|Overall Study|Lost to Follow-up|1|||
149826475|NCT04634409|540494843|FG002|Overall Study|Lost to Follow-up|1|||
149826476|NCT04634409|540494844|FG003|Overall Study|Lost to Follow-up|3|||
149826477|NCT04634409|540494845|FG004|Overall Study|Lost to Follow-up|1|||
149826478|NCT04634409|540494846|FG005|Overall Study|Lost to Follow-up|1|||
149826479|NCT04634409|540494847|FG006|Overall Study|Lost to Follow-up|1|||
149826480|NCT04634409|540494848|FG007|Overall Study|Lost to Follow-up|3|||
149826481|NCT04634409|540494849|FG008|Overall Study|Lost to Follow-up|3|||
149826482|NCT04634409|540494850|FG009|Overall Study|Lost to Follow-up|11|||
149826483|NCT04634409|540494851|FG010|Overall Study|Lost to Follow-up|8|||
149826484|NCT04634409|540494852|FG011|Overall Study|Lost to Follow-up|15|||
149826485|NCT04634409|540494853|FG012|Overall Study|Lost to Follow-up|3|||
149826486|NCT04634409|540494854|FG013|Overall Study|Lost to Follow-up|2|||
149826487|NCT04634409|540494855|FG014|Overall Study|Lost to Follow-up|7|||
149826488|NCT04634409|540494856|FG015|Overall Study|Lost to Follow-up|0|||
149826489|NCT04634409|540494857|FG016|Overall Study|Lost to Follow-up|0|||
149826490|NCT04634409|540494858|FG017|Overall Study|Lost to Follow-up|0|||
149826491|NCT04634409|540494859|FG018|Overall Study|Lost to Follow-up|0|||
149826492|NCT04634409|540494860|FG019|Overall Study|Lost to Follow-up|0|||
149826493|NCT04634409|540494861|FG020|Overall Study|Lost to Follow-up|0|||
149826494|NCT04634409|540494862|FG021|Overall Study|Lost to Follow-up|0|||
149826495|NCT04634409|540494863|FG022|Overall Study|Lost to Follow-up|0|||
149826496|NCT04634409|540494864|FG023|Overall Study|Lost to Follow-up|0|||
149826497|NCT04634409|540494865|FG024|Overall Study|Lost to Follow-up|0|||
149826498|NCT04634409|540494866|FG025|Overall Study|Lost to Follow-up|0|||
149826499|NCT04634409|540494867|FG026|Overall Study|Lost to Follow-up|0|||
149826500|NCT04634409|540494841|FG000|Overall Study|Withdrawal by Subject|3|||
149826501|NCT04634409|540494842|FG001|Overall Study|Withdrawal by Subject|1|||
149826502|NCT04634409|540494843|FG002|Overall Study|Withdrawal by Subject|6|||
149826503|NCT04634409|540494844|FG003|Overall Study|Withdrawal by Subject|4|||
149826504|NCT04634409|540494845|FG004|Overall Study|Withdrawal by Subject|2|||
149826505|NCT04634409|540494846|FG005|Overall Study|Withdrawal by Subject|0|||
149826506|NCT04634409|540494847|FG006|Overall Study|Withdrawal by Subject|0|||
149826507|NCT04634409|540494848|FG007|Overall Study|Withdrawal by Subject|2|||
149826508|NCT04634409|540494849|FG008|Overall Study|Withdrawal by Subject|3|||
149826509|NCT04634409|540494850|FG009|Overall Study|Withdrawal by Subject|2|||
149826510|NCT04634409|540494851|FG010|Overall Study|Withdrawal by Subject|3|||
149826511|NCT04634409|540494852|FG011|Overall Study|Withdrawal by Subject|2|||
149826512|NCT04634409|540494853|FG012|Overall Study|Withdrawal by Subject|2|||
149826513|NCT04634409|540494854|FG013|Overall Study|Withdrawal by Subject|1|||
149826514|NCT04634409|540494855|FG014|Overall Study|Withdrawal by Subject|5|||
149826515|NCT04634409|540494856|FG015|Overall Study|Withdrawal by Subject|0|||
149946041|NCT03329001|540936207|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946042|NCT03329001|540936208|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
149946043|NCT03329001|540936201|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149826516|NCT04634409|540494857|FG016|Overall Study|Withdrawal by Subject|0|||
149826517|NCT04634409|540494858|FG017|Overall Study|Withdrawal by Subject|1|||
149826518|NCT04634409|540494859|FG018|Overall Study|Withdrawal by Subject|0|||
149826519|NCT04634409|540494860|FG019|Overall Study|Withdrawal by Subject|0|||
149826520|NCT04634409|540494861|FG020|Overall Study|Withdrawal by Subject|0|||
149826521|NCT04634409|540494862|FG021|Overall Study|Withdrawal by Subject|0|||
149826522|NCT04634409|540494863|FG022|Overall Study|Withdrawal by Subject|0|||
149826523|NCT04634409|540494864|FG023|Overall Study|Withdrawal by Subject|1|||
149826524|NCT04634409|540494865|FG024|Overall Study|Withdrawal by Subject|0|||
149826525|NCT04634409|540494866|FG025|Overall Study|Withdrawal by Subject|0|||
149826526|NCT04634409|540494867|FG026|Overall Study|Withdrawal by Subject|0|||
149946044|NCT03329001|540936202|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149826527|NCT04634409|540494841|FG000|Overall Study|Other - As reported by Investigator|1|||
149826528|NCT04634409|540494842|FG001|Overall Study|Other - As reported by Investigator|0|||
149826529|NCT04634409|540494843|FG002|Overall Study|Other - As reported by Investigator|0|||
149826530|NCT04634409|540494844|FG003|Overall Study|Other - As reported by Investigator|0|||
149826531|NCT04634409|540494845|FG004|Overall Study|Other - As reported by Investigator|0|||
149826532|NCT04634409|540494846|FG005|Overall Study|Other - As reported by Investigator|0|||
149826533|NCT04634409|540494847|FG006|Overall Study|Other - As reported by Investigator|0|||
149826534|NCT04634409|540494848|FG007|Overall Study|Other - As reported by Investigator|6|||
149826535|NCT04634409|540494849|FG008|Overall Study|Other - As reported by Investigator|4|||
149946045|NCT03329001|540936203|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149946046|NCT03329001|540936204|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149946047|NCT03329001|540936205|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
149946048|NCT03329001|540936206|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149946049|NCT03329001|540936207|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149946050|NCT03329001|540936208|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
149946051|NCT03329001|540936201|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946052|NCT03329001|540936202|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946053|NCT03329001|540936203|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946054|NCT03329001|540936204|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946055|NCT03329001|540936205|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
149946056|NCT03329001|540936206|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
149946057|NCT03329001|540936207|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946058|NCT03329001|540936208|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
149946059|NCT03329001|540936201|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946060|NCT03329001|540936202|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946061|NCT03329001|540936203|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946062|NCT03329001|540936204|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946063|NCT03329001|540936205|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
149946064|NCT03329001|540936206|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946065|NCT03329001|540936207|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946066|NCT03329001|540936208|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
149946067|NCT03329001|540936201|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946068|NCT03329001|540936202|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946069|NCT03329001|540936203|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946070|NCT03329001|540936204|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946071|NCT03329001|540936205|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
149946072|NCT03329001|540936206|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
149946073|NCT03329001|540936207|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946074|NCT03329001|540936208|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
149946075|NCT03329001|540936201|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946076|NCT03329001|540936202|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946077|NCT03329001|540936203|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946078|NCT03329001|540936204|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946079|NCT03329001|540936205|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946080|NCT03329001|540936206|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
149946081|NCT03329001|540936207|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
149946082|NCT03329001|540936208|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
149946083|NCT03329001|540936201|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946084|NCT03329001|540936202|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946085|NCT03329001|540936203|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946086|NCT03329001|540936204|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946087|NCT03329001|540936205|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946088|NCT03329001|540936206|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946089|NCT03329001|540936207|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
149946090|NCT03329001|540936208|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
149946091|NCT03329001|540936201|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
149826536|NCT04634409|540494850|FG009|Overall Study|Other - As reported by Investigator|0|||
149826537|NCT04634409|540494851|FG010|Overall Study|Other - As reported by Investigator|1|||
149826538|NCT04634409|540494852|FG011|Overall Study|Other - As reported by Investigator|2|||
149946092|NCT03329001|540936202|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
149946093|NCT03329001|540936203|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
149946094|NCT03329001|540936204|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
150170428|NCT01235949|541759064|FG003|Booster Phase|Withdrawal by Subject|0|||
149826539|NCT04634409|540494853|FG012|Overall Study|Other - As reported by Investigator|2|||
149826540|NCT04634409|540494854|FG013|Overall Study|Other - As reported by Investigator|1|||
149826541|NCT04634409|540494855|FG014|Overall Study|Other - As reported by Investigator|0|||
149826542|NCT04634409|540494856|FG015|Overall Study|Other - As reported by Investigator|0|||
149826543|NCT04634409|540494857|FG016|Overall Study|Other - As reported by Investigator|0|||
149826544|NCT04634409|540494858|FG017|Overall Study|Other - As reported by Investigator|0|||
149826545|NCT04634409|540494859|FG018|Overall Study|Other - As reported by Investigator|0|||
149826546|NCT04634409|540494860|FG019|Overall Study|Other - As reported by Investigator|0|||
149826547|NCT04634409|540494861|FG020|Overall Study|Other - As reported by Investigator|0|||
149826548|NCT04634409|540494862|FG021|Overall Study|Other - As reported by Investigator|0|||
149826549|NCT04634409|540494863|FG022|Overall Study|Other - As reported by Investigator|0|||
149826550|NCT04634409|540494864|FG023|Overall Study|Other - As reported by Investigator|0|||
149826551|NCT04634409|540494865|FG024|Overall Study|Other - As reported by Investigator|0|||
149826552|NCT04634409|540494866|FG025|Overall Study|Other - As reported by Investigator|0|||
149826553|NCT04634409|540494867|FG026|Overall Study|Other - As reported by Investigator|0|||
149826554|NCT05514119|540496236|FG000|Overall Study|Ineligible due to disease progression|1|||
149826555|NCT00278200|540496237|FG000|Overall Study|Death|1|||
149826556|NCT00278200|540496238|FG001|Overall Study|Death|3|||
149826557|NCT00278200|540496237|FG000|Overall Study|Physician Decision|0|||
149826558|NCT00278200|540496238|FG001|Overall Study|Physician Decision|1|||
149826559|NCT01521559|540496239|FG000|Overall Study|Adverse Event|0|||
149826560|NCT01521559|540496240|FG001|Overall Study|Adverse Event|4|||
149826561|NCT01521559|540496239|FG000|Overall Study|Death|1|||
149826562|NCT01521559|540496240|FG001|Overall Study|Death|0|||
149826563|NCT01521559|540496239|FG000|Overall Study|Withdrawal by Subject|9|||
149826564|NCT01521559|540496240|FG001|Overall Study|Withdrawal by Subject|11|||
149826565|NCT01521559|540496239|FG000|Overall Study|Lost to Follow-up|3|||
149826566|NCT01521559|540496240|FG001|Overall Study|Lost to Follow-up|1|||
149826567|NCT01521559|540496239|FG000|Overall Study|Protocol Violation|1|||
149826568|NCT01521559|540496240|FG001|Overall Study|Protocol Violation|0|||
149826569|NCT01521559|540496239|FG000|Overall Study|Other|1|||
149826570|NCT01521559|540496240|FG001|Overall Study|Other|2|||
149826571|NCT02228382|540496241|FG000|Overall Study|Death|5|||
149826572|NCT02228382|540496242|FG001|Overall Study|Death|7|||
149826573|NCT02228382|540496243|FG002|Overall Study|Death|5|||
149826574|NCT02228382|540496244|FG003|Overall Study|Death|0|||
149826575|NCT02228382|540496245|FG004|Overall Study|Death|2|||
149826576|NCT02228382|540496241|FG000|Overall Study|Participant refused further follow-up|0|||
149826577|NCT02228382|540496242|FG001|Overall Study|Participant refused further follow-up|0|||
149826578|NCT02228382|540496243|FG002|Overall Study|Participant refused further follow-up|1|||
149826579|NCT02228382|540496244|FG003|Overall Study|Participant refused further follow-up|0|||
149826580|NCT02228382|540496245|FG004|Overall Study|Participant refused further follow-up|0|||
149826581|NCT02228382|540496241|FG000|Overall Study|Study terminated by sponsor|3|||
149826582|NCT02228382|540496242|FG001|Overall Study|Study terminated by sponsor|5|||
149826583|NCT02228382|540496243|FG002|Overall Study|Study terminated by sponsor|7|||
149826584|NCT02228382|540496244|FG003|Overall Study|Study terminated by sponsor|0|||
149826585|NCT02228382|540496245|FG004|Overall Study|Study terminated by sponsor|0|||
149826586|NCT02228382|540496241|FG000|Overall Study|Lost to Follow-up|0|||
149826587|NCT02228382|540496242|FG001|Overall Study|Lost to Follow-up|0|||
149826588|NCT02228382|540496243|FG002|Overall Study|Lost to Follow-up|3|||
149826589|NCT02228382|540496244|FG003|Overall Study|Lost to Follow-up|1|||
149826590|NCT02228382|540496245|FG004|Overall Study|Lost to Follow-up|0|||
149826591|NCT02228382|540496241|FG000|Overall Study|Withdrawal by Subject|0|||
149826592|NCT02228382|540496242|FG001|Overall Study|Withdrawal by Subject|3|||
149826593|NCT02228382|540496243|FG002|Overall Study|Withdrawal by Subject|2|||
149826594|NCT02228382|540496244|FG003|Overall Study|Withdrawal by Subject|1|||
149826595|NCT02228382|540496245|FG004|Overall Study|Withdrawal by Subject|0|||
149826596|NCT02228382|540496241|FG000|Overall Study|Other|2|||
149826597|NCT02228382|540496242|FG001|Overall Study|Other|3|||
149826598|NCT02228382|540496243|FG002|Overall Study|Other|3|||
149826599|NCT02228382|540496244|FG003|Overall Study|Other|0|||
149826600|NCT02228382|540496245|FG004|Overall Study|Other|0|||
149826601|NCT02918162|540496247|FG000|Overall Study|Withdrawal by Subject|1|||
149826602|NCT02918162|540496247|FG000|Overall Study|Omental Disease|1|||
149826603|NCT00395226|540496248|FG000|Overall Study|Adverse Event|4|||
149826604|NCT00395226|540496249|FG001|Overall Study|Adverse Event|3|||
149826605|NCT00395226|540496248|FG000|Overall Study|Withdrawal by Subject|0|||
149946095|NCT03329001|540936205|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
149826606|NCT00395226|540496249|FG001|Overall Study|Withdrawal by Subject|1|||
149826607|NCT00395226|540496248|FG000|Overall Study|Lost to Follow-up|0|||
149826608|NCT00395226|540496249|FG001|Overall Study|Lost to Follow-up|1|||
149826609|NCT00576381|540496253|FG000|Overall Study|Reoperation|3|||
149826610|NCT00576381|540496253|FG000|Overall Study|Adverse Event|4|||
149826611|NCT01031537|540496254|FG000|Overall Study|medical reasons not related to study|3|||
149946096|NCT03329001|540936206|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
149946097|NCT03329001|540936207|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
149946098|NCT03329001|540936208|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
149826612|NCT01031537|540496254|FG000|Overall Study|Lack of Efficacy|1|||
149826613|NCT01031537|540496254|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
149826614|NCT01031537|540496254|FG000|Overall Study|moved, met exclusion criteria|10|||
149826615|NCT01031537|540496254|FG000|Overall Study|Withdrawal by Subject|5|||
149826616|NCT01031537|540496254|FG000|Overall Study|PI removal, no longer met eligibility|12|||
149826617|NCT03522948|540496265|FG000|Overall Study|Lost to Follow-up|1|||
149826618|NCT01802879|540496266|FG000|Overall Study|Administrative problems|2|||
149826619|NCT01802879|540496266|FG000|Overall Study|Disease progression|6|||
149826620|NCT00712010|540496269|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
149826621|NCT02187042|540496270|FG000|Overall Study|Death|1|||
149826622|NCT02187042|540496271|FG001|Overall Study|Death|1|||
149826623|NCT02187042|540496270|FG000|Overall Study|Toxicity|6|||
149826624|NCT02187042|540496271|FG001|Overall Study|Toxicity|5|||
149826625|NCT02187042|540496270|FG000|Overall Study|Participant choice|1|||
149826626|NCT02187042|540496271|FG001|Overall Study|Participant choice|0|||
149826627|NCT02187042|540496270|FG000|Overall Study|Doctor choice|1|||
149826628|NCT02187042|540496271|FG001|Overall Study|Doctor choice|0|||
149826629|NCT02187042|540496270|FG000|Overall Study|Progressive disease|4|||
149826630|NCT02187042|540496271|FG001|Overall Study|Progressive disease|8|||
149826631|NCT01659567|540496274|FG000|Overall Study|Lack of Efficacy|22|||
149826632|NCT01659567|540496274|FG000|Overall Study|Switched to Pegferon|6|||
149826633|NCT01659567|540496274|FG000|Overall Study|Adverse Event|12|||
149826634|NCT01659567|540496274|FG000|Overall Study|Good result at early stage of treatment|5|||
149826635|NCT01659567|540496274|FG000|Overall Study|Withdrawal by Subject|64|||
149826636|NCT01659567|540496274|FG000|Overall Study|Progression of the main disease|1|||
149826637|NCT01659567|540496274|FG000|Overall Study|Other|13|||
149826638|NCT03019965|540496275|FG000|Overall Study|Withdrawal by Subject|1|||
149826639|NCT03019965|540496276|FG001|Overall Study|Withdrawal by Subject|0|||
149826640|NCT03019965|540496275|FG000|Overall Study|Protocol Violation|1|||
149826641|NCT03019965|540496276|FG001|Overall Study|Protocol Violation|3|||
149826642|NCT03019965|540496275|FG000|Overall Study|viral or fungal infection|3|||
149826643|NCT03019965|540496276|FG001|Overall Study|viral or fungal infection|4|||
149826644|NCT03019965|540496275|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
149826645|NCT03019965|540496276|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
149826646|NCT03019965|540496275|FG000|Overall Study|Physician Decision|1|||
149826647|NCT03019965|540496276|FG001|Overall Study|Physician Decision|1|||
149826648|NCT01179919|540496279|FG000|Overall Study|Protocol Violation|1|||
149826649|NCT01179919|540496279|FG000|Overall Study|Adverse Event|1|||
149826650|NCT01915732|540496290|FG000|Overall Study|Withdrawal by Subject|18|||
149826651|NCT01915732|540496291|FG001|Overall Study|Withdrawal by Subject|18|||
149826652|NCT01915732|540496290|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
149826653|NCT01915732|540496291|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
149826654|NCT01915732|540496290|FG000|Overall Study|Adverse Event|12|||
149826655|NCT01915732|540496291|FG001|Overall Study|Adverse Event|4|||
149826656|NCT01915732|540496290|FG000|Overall Study|Protocol Violation|5|||
149826657|NCT01915732|540496291|FG001|Overall Study|Protocol Violation|5|||
149826658|NCT01915732|540496290|FG000|Overall Study|Lack of Efficacy|6|||
149826659|NCT01915732|540496291|FG001|Overall Study|Lack of Efficacy|11|||
149826660|NCT01915732|540496290|FG000|Overall Study|Lost to Follow-up|22|||
149826661|NCT01915732|540496291|FG001|Overall Study|Lost to Follow-up|26|||
149826662|NCT01915732|540496290|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
149826663|NCT01915732|540496291|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
149826664|NCT01915732|540496290|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
149826665|NCT01915732|540496291|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
149826666|NCT01915732|540496290|FG000|Overall Study|Drug Release Error|1|||
149826667|NCT01915732|540496291|FG001|Overall Study|Drug Release Error|0|||
149826668|NCT01915732|540496290|FG000|Overall Study|Recovered|1|||
149826669|NCT01915732|540496291|FG001|Overall Study|Recovered|0|||
149826670|NCT01915732|540496290|FG000|Overall Study|Pregnancy|1|||
149826671|NCT01915732|540496291|FG001|Overall Study|Pregnancy|0|||
149826672|NCT01915732|540496290|FG000|Overall Study|Poor Perceived Efficacy|1|||
149826673|NCT01915732|540496291|FG001|Overall Study|Poor Perceived Efficacy|0|||
149826674|NCT01915732|540496290|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
149826675|NCT01915732|540496291|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
149826676|NCT01915732|540496290|FG000|Overall Study|Got Well|0|||
149826677|NCT01915732|540496291|FG001|Overall Study|Got Well|1|||
149826678|NCT01915732|540496290|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
149826679|NCT01915732|540496291|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
149826680|NCT01915732|540496290|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
149826681|NCT01915732|540496291|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
149826682|NCT01915732|540496290|FG000|Overall Study|Job Transfer|0|||
149826683|NCT01915732|540496291|FG001|Overall Study|Job Transfer|1|||
149826684|NCT01915732|540496290|FG000|Overall Study|Improper Facial Procedure|0|||
149826685|NCT01915732|540496291|FG001|Overall Study|Improper Facial Procedure|1|||
149826686|NCT01915732|540496290|FG000|Overall Study|Poor Conscious Effect|0|||
149826687|NCT01915732|540496291|FG001|Overall Study|Poor Conscious Effect|1|||
149826688|NCT01325207|540496292|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
149826689|NCT01325207|540496293|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
149826690|NCT01325207|540496294|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
149826691|NCT01325207|540496295|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
149826692|NCT01325207|540496296|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
149826693|NCT01325207|540496297|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
149826694|NCT01325207|540496292|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
149826695|NCT01325207|540496293|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
149826696|NCT01325207|540496294|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
149826697|NCT01325207|540496295|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
149826698|NCT01325207|540496296|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
149826699|NCT01325207|540496297|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
149826700|NCT01325207|540496292|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149826701|NCT01325207|540496293|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149826702|NCT01325207|540496294|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149826703|NCT01325207|540496295|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149826704|NCT01325207|540496296|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
149826705|NCT01325207|540496297|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
149826706|NCT01325207|540496292|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
149826707|NCT01325207|540496293|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
149826708|NCT01325207|540496294|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
149826709|NCT01325207|540496295|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
149826710|NCT01325207|540496296|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
149826711|NCT01325207|540496297|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
149826712|NCT01325207|540496292|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149826713|NCT01325207|540496293|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149826714|NCT01325207|540496294|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149826715|NCT01325207|540496295|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149826716|NCT01325207|540496296|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149826717|NCT01325207|540496297|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
149826718|NCT01325207|540496292|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
149826719|NCT01325207|540496293|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
149826720|NCT01325207|540496294|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
149826721|NCT01325207|540496295|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
149826722|NCT01325207|540496296|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
149826723|NCT01325207|540496297|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
149826724|NCT01325207|540496292|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
149826725|NCT01325207|540496293|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
149826726|NCT01325207|540496294|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
149826727|NCT01325207|540496295|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
149826728|NCT01325207|540496296|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
149946099|NCT03329001|540936201|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149946100|NCT03329001|540936202|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149946101|NCT03329001|540936203|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149826729|NCT01325207|540496297|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
149826730|NCT00698685|540496298|FG000|Overall Study|Sister withdrew as donor|1|||
149826731|NCT00698685|540496298|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
149946102|NCT03329001|540936204|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149946103|NCT03329001|540936205|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149946104|NCT03329001|540936206|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
149946105|NCT03329001|540936207|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
149946106|NCT03329001|540936208|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
149946107|NCT01138046|540936209|FG000|Overall Study|Withdrawal due to death|6|||
149946108|NCT02178956|540936210|FG000|Overall Study|Lost to Follow-up|4|||
149946109|NCT02178956|540936211|FG001|Overall Study|Lost to Follow-up|4|||
149946110|NCT02178956|540936210|FG000|Overall Study|Sponsor terminated study|49|||
149946111|NCT02178956|540936211|FG001|Overall Study|Sponsor terminated study|58|||
149946112|NCT02178956|540936210|FG000|Overall Study|Withdrawal by Subject|15|||
149946113|NCT02178956|540936211|FG001|Overall Study|Withdrawal by Subject|11|||
149946114|NCT02178956|540936210|FG000|Overall Study|Various Reasons|3|||
149946115|NCT02178956|540936211|FG001|Overall Study|Various Reasons|5|||
149946116|NCT00963235|540936216|FG000|Overall Study|Withdrawal by Subject|22|||
149946117|NCT00963235|540936216|FG000|Overall Study|Lost to Follow-up|14|||
149946118|NCT00963235|540936216|FG000|Overall Study|Failed to return|9|||
149946119|NCT00963235|540936216|FG000|Overall Study|Protocol Violation|7|||
149946120|NCT00963235|540936216|FG000|Overall Study|Adverse Event|5|||
149946121|NCT00963235|540936216|FG000|Overall Study|Physician Decision|2|||
149946122|NCT00963235|540936216|FG000|Overall Study|Other|1|||
149826732|NCT01254409|540496299|FG000|Overall Study|Adverse Event|0|||
149826733|NCT01254409|540496300|FG001|Overall Study|Adverse Event|1|||
149826734|NCT01254409|540496301|FG002|Overall Study|Adverse Event|0|||
149826735|NCT01254409|540496302|FG003|Overall Study|Adverse Event|0|||
149946123|NCT01104766|540936218|FG000|Overall Study|Did not meet inc/exc criteria|1|||
149946124|NCT01104766|540936219|FG001|Overall Study|Did not meet inc/exc criteria|0|||
149946125|NCT01104766|540936220|FG002|Overall Study|Did not meet inc/exc criteria|0|||
149946126|NCT01104766|540936221|FG003|Overall Study|Did not meet inc/exc criteria|0|||
149946127|NCT01104766|540936218|FG000|Overall Study|Adverse Event|17|||
150275468|NCT00467779|542146430|FG014|Stage 1A|Withdrawal by Subject|0|||
150275469|NCT00467779|542146416|FG000|Stage 1A|Unspecified Reason|0|||
150275470|NCT00467779|542146417|FG001|Stage 1A|Unspecified Reason|0|||
150275471|NCT00467779|542146418|FG002|Stage 1A|Unspecified Reason|0|||
150275472|NCT00467779|542146419|FG003|Stage 1A|Unspecified Reason|0|||
150275473|NCT00467779|542146420|FG004|Stage 1A|Unspecified Reason|0|||
150275474|NCT00467779|542146421|FG005|Stage 1A|Unspecified Reason|0|||
150275475|NCT00467779|542146422|FG006|Stage 1A|Unspecified Reason|0|||
150275476|NCT00467779|542146423|FG007|Stage 1A|Unspecified Reason|0|||
150275477|NCT00467779|542146424|FG008|Stage 1A|Unspecified Reason|0|||
150275478|NCT00467779|542146425|FG009|Stage 1A|Unspecified Reason|0|||
150275479|NCT00467779|542146426|FG010|Stage 1A|Unspecified Reason|0|||
150275480|NCT00467779|542146427|FG011|Stage 1A|Unspecified Reason|1|||
150275481|NCT00467779|542146428|FG012|Stage 1A|Unspecified Reason|1|||
150275482|NCT00467779|542146429|FG013|Stage 1A|Unspecified Reason|0|||
150275483|NCT00467779|542146430|FG014|Stage 1A|Unspecified Reason|0|||
150275484|NCT00467779|542146416|FG000|Stage 2|Adverse Event|0|||
150275485|NCT00467779|542146417|FG001|Stage 2|Adverse Event|0|||
150275486|NCT00467779|542146418|FG002|Stage 2|Adverse Event|0|||
150275487|NCT00467779|542146419|FG003|Stage 2|Adverse Event|0|||
150275488|NCT00467779|542146420|FG004|Stage 2|Adverse Event|0|||
150275489|NCT00467779|542146421|FG005|Stage 2|Adverse Event|0|||
150275490|NCT00467779|542146422|FG006|Stage 2|Adverse Event|0|||
150275491|NCT00467779|542146423|FG007|Stage 2|Adverse Event|0|||
150275492|NCT00467779|542146424|FG008|Stage 2|Adverse Event|1|||
150275493|NCT00467779|542146425|FG009|Stage 2|Adverse Event|0|||
150275494|NCT00467779|542146426|FG010|Stage 2|Adverse Event|0|||
150275495|NCT00467779|542146427|FG011|Stage 2|Adverse Event|0|||
150275496|NCT00467779|542146428|FG012|Stage 2|Adverse Event|0|||
150275497|NCT00467779|542146429|FG013|Stage 2|Adverse Event|0|||
150275498|NCT00467779|542146430|FG014|Stage 2|Adverse Event|0|||
149946128|NCT01104766|540936219|FG001|Overall Study|Adverse Event|15|||
149946129|NCT01104766|540936220|FG002|Overall Study|Adverse Event|20|||
149946130|NCT01104766|540936221|FG003|Overall Study|Adverse Event|14|||
149946131|NCT01104766|540936218|FG000|Overall Study|Lack of Efficacy|20|||
149946132|NCT01104766|540936219|FG001|Overall Study|Lack of Efficacy|15|||
149946133|NCT01104766|540936220|FG002|Overall Study|Lack of Efficacy|14|||
149946134|NCT01104766|540936221|FG003|Overall Study|Lack of Efficacy|8|||
149946135|NCT01104766|540936218|FG000|Overall Study|Protocol Violation|2|||
149946136|NCT01104766|540936219|FG001|Overall Study|Protocol Violation|0|||
149946137|NCT01104766|540936220|FG002|Overall Study|Protocol Violation|0|||
149946138|NCT01104766|540936221|FG003|Overall Study|Protocol Violation|0|||
149946139|NCT01104766|540936218|FG000|Overall Study|Withdrawal by Subject|17|||
149946140|NCT01104766|540936219|FG001|Overall Study|Withdrawal by Subject|19|||
149946141|NCT01104766|540936220|FG002|Overall Study|Withdrawal by Subject|25|||
149946142|NCT01104766|540936221|FG003|Overall Study|Withdrawal by Subject|15|||
149946143|NCT01104766|540936218|FG000|Overall Study|Lost to Follow-up|1|||
149946144|NCT01104766|540936219|FG001|Overall Study|Lost to Follow-up|2|||
149946145|NCT01104766|540936220|FG002|Overall Study|Lost to Follow-up|1|||
149946146|NCT01104766|540936221|FG003|Overall Study|Lost to Follow-up|1|||
149946147|NCT01136915|540936222|FG000|Overall Study|Lost to Follow-up|2|||
150275499|NCT00467779|542146416|FG000|Stage 2|Death|0|||
150275500|NCT00467779|542146417|FG001|Stage 2|Death|0|||
150275501|NCT00467779|542146418|FG002|Stage 2|Death|0|||
150275502|NCT00467779|542146419|FG003|Stage 2|Death|0|||
150275503|NCT00467779|542146420|FG004|Stage 2|Death|0|||
149826736|NCT01974895|540496303|FG000|Overall Study|Protocol Violation|1|||
149946148|NCT01136915|540936223|FG001|Overall Study|Lost to Follow-up|0|||
149946149|NCT01136915|540936222|FG000|Overall Study|Exclusion criterion met|0|||
149946150|NCT01136915|540936223|FG001|Overall Study|Exclusion criterion met|1|||
149946151|NCT01756235|540936224|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
149946152|NCT04225832|540936225|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
149946153|NCT04225832|540936226|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
149826737|NCT01974895|540496304|FG001|Overall Study|Protocol Violation|0|||
149826738|NCT01974895|540496303|FG000|Overall Study|Lost to Follow-up|4|||
149946154|NCT04225832|540936225|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
150275504|NCT00467779|542146421|FG005|Stage 2|Death|0|||
150275505|NCT00467779|542146422|FG006|Stage 2|Death|0|||
150275506|NCT00467779|542146423|FG007|Stage 2|Death|0|||
150275507|NCT00467779|542146424|FG008|Stage 2|Death|1|||
150275508|NCT00467779|542146425|FG009|Stage 2|Death|0|||
150275509|NCT00467779|542146426|FG010|Stage 2|Death|0|||
150275510|NCT00467779|542146427|FG011|Stage 2|Death|0|||
149826739|NCT01974895|540496304|FG001|Overall Study|Lost to Follow-up|6|||
149826740|NCT01974895|540496303|FG000|Overall Study|Withdrawal by Subject|0|||
149826741|NCT01974895|540496304|FG001|Overall Study|Withdrawal by Subject|1|||
149826742|NCT01974895|540496303|FG000|Overall Study|Other (Missed Visit)|1|||
149826743|NCT01974895|540496304|FG001|Overall Study|Other (Missed Visit)|0|||
149826744|NCT01974895|540496303|FG000|Overall Study|Other (Reason unknown)|9|||
149826745|NCT01974895|540496304|FG001|Overall Study|Other (Reason unknown)|8|||
149826746|NCT01513148|540496305|FG000|Overall Study|Protocol Violation|2|||
149826747|NCT01513148|540496306|FG001|Overall Study|Protocol Violation|2|||
149826748|NCT03500484|540496307|FG000|Overall Study|Adverse Event|2|||
149826749|NCT03500484|540496308|FG001|Overall Study|Adverse Event|0|||
149826750|NCT03500484|540496307|FG000|Overall Study|Physician Decision|1|||
149826751|NCT03500484|540496308|FG001|Overall Study|Physician Decision|0|||
149826752|NCT03500484|540496307|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
149826753|NCT03500484|540496308|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
149826754|NCT00449150|540496309|FG000|Overall Study|Adverse Event|11|||
149826755|NCT00449150|540496310|FG001|Overall Study|Adverse Event|18|||
149826756|NCT00449150|540496311|FG002|Overall Study|Adverse Event|9|||
149826757|NCT00449150|540496309|FG000|Overall Study|Lack of Efficacy|1|||
149826758|NCT00449150|540496310|FG001|Overall Study|Lack of Efficacy|2|||
150275511|NCT00467779|542146428|FG012|Stage 2|Death|0|||
150275512|NCT00467779|542146429|FG013|Stage 2|Death|0|||
150275513|NCT00467779|542146430|FG014|Stage 2|Death|0|||
150275514|NCT00467779|542146416|FG000|Stage 2|Disease Progression|0|||
150275515|NCT00467779|542146417|FG001|Stage 2|Disease Progression|0|||
150275516|NCT00467779|542146418|FG002|Stage 2|Disease Progression|0|||
150275517|NCT00467779|542146419|FG003|Stage 2|Disease Progression|0|||
150275518|NCT00467779|542146420|FG004|Stage 2|Disease Progression|0|||
150275519|NCT00467779|542146421|FG005|Stage 2|Disease Progression|0|||
150275520|NCT00467779|542146422|FG006|Stage 2|Disease Progression|0|||
150275521|NCT00467779|542146423|FG007|Stage 2|Disease Progression|0|||
150275522|NCT00467779|542146424|FG008|Stage 2|Disease Progression|16|||
150275523|NCT00467779|542146425|FG009|Stage 2|Disease Progression|0|||
150275524|NCT00467779|542146426|FG010|Stage 2|Disease Progression|0|||
150275525|NCT00467779|542146427|FG011|Stage 2|Disease Progression|0|||
150275526|NCT00467779|542146428|FG012|Stage 2|Disease Progression|0|||
150275527|NCT00467779|542146429|FG013|Stage 2|Disease Progression|0|||
150275528|NCT00467779|542146430|FG014|Stage 2|Disease Progression|0|||
150275529|NCT00467779|542146416|FG000|Stage 2|Unspecified Reason|0|||
150275530|NCT00467779|542146417|FG001|Stage 2|Unspecified Reason|0|||
150275531|NCT00467779|542146418|FG002|Stage 2|Unspecified Reason|0|||
150275532|NCT00467779|542146419|FG003|Stage 2|Unspecified Reason|0|||
150275533|NCT00467779|542146420|FG004|Stage 2|Unspecified Reason|0|||
150275534|NCT00467779|542146421|FG005|Stage 2|Unspecified Reason|0|||
150275535|NCT00467779|542146422|FG006|Stage 2|Unspecified Reason|0|||
150275536|NCT00467779|542146423|FG007|Stage 2|Unspecified Reason|0|||
150275537|NCT00467779|542146424|FG008|Stage 2|Unspecified Reason|3|||
150275538|NCT00467779|542146425|FG009|Stage 2|Unspecified Reason|0|||
150275539|NCT00467779|542146426|FG010|Stage 2|Unspecified Reason|0|||
150275540|NCT00467779|542146427|FG011|Stage 2|Unspecified Reason|0|||
150275541|NCT00467779|542146428|FG012|Stage 2|Unspecified Reason|0|||
150275542|NCT00467779|542146429|FG013|Stage 2|Unspecified Reason|0|||
150275543|NCT00467779|542146430|FG014|Stage 2|Unspecified Reason|0|||
150275544|NCT00467779|542146416|FG000|Stage 2A|Adverse Event|0|||
149826759|NCT00449150|540496311|FG002|Overall Study|Lack of Efficacy|2|||
149826760|NCT00449150|540496309|FG000|Overall Study|Other|16|||
149826761|NCT00449150|540496310|FG001|Overall Study|Other|13|||
149826762|NCT00449150|540496311|FG002|Overall Study|Other|14|||
150275545|NCT00467779|542146417|FG001|Stage 2A|Adverse Event|0|||
150275546|NCT00467779|542146418|FG002|Stage 2A|Adverse Event|0|||
150275547|NCT00467779|542146419|FG003|Stage 2A|Adverse Event|0|||
150275548|NCT00467779|542146420|FG004|Stage 2A|Adverse Event|0|||
150275549|NCT00467779|542146421|FG005|Stage 2A|Adverse Event|0|||
150275550|NCT00467779|542146422|FG006|Stage 2A|Adverse Event|0|||
150275551|NCT00467779|542146423|FG007|Stage 2A|Adverse Event|0|||
150275552|NCT00467779|542146424|FG008|Stage 2A|Adverse Event|0|||
150275553|NCT00467779|542146425|FG009|Stage 2A|Adverse Event|0|||
150275554|NCT00467779|542146426|FG010|Stage 2A|Adverse Event|0|||
150275555|NCT00467779|542146427|FG011|Stage 2A|Adverse Event|0|||
149826763|NCT00449150|540496309|FG000|Overall Study|Withdrawal by Subject|17|||
149826764|NCT00449150|540496310|FG001|Overall Study|Withdrawal by Subject|18|||
149826765|NCT00449150|540496311|FG002|Overall Study|Withdrawal by Subject|21|||
149826766|NCT00449150|540496309|FG000|Overall Study|Protocol Violation|1|||
149826767|NCT00449150|540496310|FG001|Overall Study|Protocol Violation|2|||
149826768|NCT00449150|540496311|FG002|Overall Study|Protocol Violation|1|||
149826769|NCT06331156|540496312|FG000|Overall Study|Adverse Event|1|||
150275556|NCT00467779|542146428|FG012|Stage 2A|Adverse Event|0|||
150275557|NCT00467779|542146429|FG013|Stage 2A|Adverse Event|2|||
150275558|NCT00467779|542146430|FG014|Stage 2A|Adverse Event|0|||
150275559|NCT00467779|542146416|FG000|Stage 2A|Death|0|||
150275560|NCT00467779|542146417|FG001|Stage 2A|Death|0|||
150275561|NCT00467779|542146418|FG002|Stage 2A|Death|0|||
149826770|NCT06331156|540496313|FG001|Overall Study|Adverse Event|0|||
149826771|NCT06331156|540496312|FG000|Overall Study|Lost to Follow-up|1|||
149826772|NCT06331156|540496313|FG001|Overall Study|Lost to Follow-up|0|||
149826773|NCT06331156|540496312|FG000|Overall Study|Migrated / Moved from the study area|4|||
149826774|NCT06331156|540496313|FG001|Overall Study|Migrated / Moved from the study area|3|||
149826775|NCT06331156|540496312|FG000|Overall Study|Other|7|||
149826776|NCT06331156|540496313|FG001|Overall Study|Other|0|||
149826777|NCT06331156|540496312|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
149826778|NCT06331156|540496313|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
149826779|NCT02978326|540496317|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
149826780|NCT02978326|540496318|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
149826781|NCT02978326|540496319|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
149826782|NCT02978326|540496317|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
149826783|NCT02978326|540496318|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
149826784|NCT02978326|540496319|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
149826785|NCT02978326|540496317|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
149826786|NCT02978326|540496318|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
149826787|NCT02978326|540496319|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
149826788|NCT02978326|540496317|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
149946155|NCT04225832|540936226|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
149826789|NCT02978326|540496318|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
149826790|NCT02978326|540496319|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
149826791|NCT01265784|540496330|FG000|Overall Study|Lost to Follow-up|5|||
149946156|NCT02327078|540936227|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
149946157|NCT02327078|540936228|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
149946158|NCT02327078|540936229|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
149946159|NCT02327078|540936230|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
149946160|NCT02327078|540936231|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
149946161|NCT02327078|540936232|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
149946162|NCT02327078|540936233|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
149946163|NCT02327078|540936234|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
149946164|NCT02327078|540936235|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
149946165|NCT02327078|540936227|FG000|Overall Study|Death|2|||
149946166|NCT02327078|540936228|FG001|Overall Study|Death|4|||
149946167|NCT02327078|540936229|FG002|Overall Study|Death|10|||
149946168|NCT02327078|540936230|FG003|Overall Study|Death|6|||
149946169|NCT02327078|540936231|FG004|Overall Study|Death|4|||
149946170|NCT02327078|540936232|FG005|Overall Study|Death|3|||
149946171|NCT02327078|540936233|FG006|Overall Study|Death|2|||
149946172|NCT02327078|540936234|FG007|Overall Study|Death|51|||
150170429|NCT01235949|541759065|FG004|Booster Phase|Withdrawal by Subject|0|||
150170430|NCT01235949|541759066|FG005|Booster Phase|Withdrawal by Subject|0|||
150170431|NCT01235949|541759067|FG006|Booster Phase|Withdrawal by Subject|0|||
150170432|NCT01235949|541759068|FG007|Booster Phase|Withdrawal by Subject|1|||
150170433|NCT01235949|541759069|FG008|Booster Phase|Withdrawal by Subject|1|||
150170434|NCT01235949|541759070|FG009|Booster Phase|Withdrawal by Subject|0|||
150170435|NCT01235949|541759071|FG010|Booster Phase|Withdrawal by Subject|1|||
150170436|NCT01235949|541759072|FG011|Booster Phase|Withdrawal by Subject|1|||
150170437|NCT01235949|541759073|FG012|Booster Phase|Withdrawal by Subject|2|||
150170438|NCT01235949|541759074|FG013|Booster Phase|Withdrawal by Subject|0|||
150170439|NCT01235949|541759075|FG014|Booster Phase|Withdrawal by Subject|2|||
150170440|NCT01235949|541759076|FG015|Booster Phase|Withdrawal by Subject|0|||
150170441|NCT01235949|541759077|FG016|Booster Phase|Withdrawal by Subject|0|||
150170442|NCT01235949|541759078|FG017|Booster Phase|Withdrawal by Subject|0|||
150170443|NCT01235949|541759061|FG000|Booster Phase|Lost to Follow-up|0|||
150170444|NCT01235949|541759062|FG001|Booster Phase|Lost to Follow-up|0|||
150170445|NCT01235949|541759063|FG002|Booster Phase|Lost to Follow-up|0|||
150170446|NCT01235949|541759064|FG003|Booster Phase|Lost to Follow-up|0|||
150170447|NCT01235949|541759065|FG004|Booster Phase|Lost to Follow-up|0|||
150170448|NCT01235949|541759066|FG005|Booster Phase|Lost to Follow-up|0|||
150170449|NCT01235949|541759067|FG006|Booster Phase|Lost to Follow-up|0|||
150170450|NCT01235949|541759068|FG007|Booster Phase|Lost to Follow-up|0|||
150170451|NCT01235949|541759069|FG008|Booster Phase|Lost to Follow-up|1|||
150170452|NCT01235949|541759070|FG009|Booster Phase|Lost to Follow-up|1|||
149946173|NCT02327078|540936235|FG008|Overall Study|Death|97|||
149946174|NCT02327078|540936227|FG000|Overall Study|Lost to Follow-up|0|||
149946175|NCT02327078|540936228|FG001|Overall Study|Lost to Follow-up|1|||
149946176|NCT02327078|540936229|FG002|Overall Study|Lost to Follow-up|1|||
150170453|NCT01235949|541759071|FG010|Booster Phase|Lost to Follow-up|1|||
150170454|NCT01235949|541759072|FG011|Booster Phase|Lost to Follow-up|1|||
150170455|NCT01235949|541759073|FG012|Booster Phase|Lost to Follow-up|0|||
150275562|NCT00467779|542146419|FG003|Stage 2A|Death|0|||
149826792|NCT01265784|540496331|FG001|Overall Study|Lost to Follow-up|3|||
149826793|NCT01265784|540496332|FG002|Overall Study|Lost to Follow-up|2|||
149826794|NCT01265784|540496330|FG000|Overall Study|Withdrawal by Subject|0|||
149826795|NCT01265784|540496331|FG001|Overall Study|Withdrawal by Subject|5|||
149826796|NCT01265784|540496332|FG002|Overall Study|Withdrawal by Subject|0|||
149826797|NCT01265784|540496330|FG000|Overall Study|Physician Decision|1|||
149826798|NCT01265784|540496331|FG001|Overall Study|Physician Decision|0|||
149826799|NCT01265784|540496332|FG002|Overall Study|Physician Decision|1|||
149826800|NCT01265784|540496330|FG000|Overall Study|Adverse Event|1|||
149826801|NCT01265784|540496331|FG001|Overall Study|Adverse Event|0|||
149826802|NCT01265784|540496332|FG002|Overall Study|Adverse Event|0|||
149826803|NCT01265784|540496330|FG000|Overall Study|Death|3|||
149826804|NCT01265784|540496331|FG001|Overall Study|Death|0|||
149826805|NCT01265784|540496332|FG002|Overall Study|Death|0|||
149826806|NCT01265784|540496330|FG000|Overall Study|Protocol Violation|2|||
149826807|NCT01265784|540496331|FG001|Overall Study|Protocol Violation|0|||
149826808|NCT01265784|540496332|FG002|Overall Study|Protocol Violation|0|||
150275563|NCT00467779|542146420|FG004|Stage 2A|Death|0|||
150275564|NCT00467779|542146421|FG005|Stage 2A|Death|0|||
150275565|NCT00467779|542146422|FG006|Stage 2A|Death|0|||
150275566|NCT00467779|542146423|FG007|Stage 2A|Death|0|||
150275567|NCT00467779|542146424|FG008|Stage 2A|Death|0|||
150275568|NCT00467779|542146425|FG009|Stage 2A|Death|0|||
150275569|NCT00467779|542146426|FG010|Stage 2A|Death|0|||
150275570|NCT00467779|542146427|FG011|Stage 2A|Death|0|||
150275571|NCT00467779|542146428|FG012|Stage 2A|Death|0|||
150275572|NCT00467779|542146429|FG013|Stage 2A|Death|1|||
150275573|NCT00467779|542146430|FG014|Stage 2A|Death|0|||
150275574|NCT00467779|542146416|FG000|Stage 2A|Disease Progression|0|||
150275575|NCT00467779|542146417|FG001|Stage 2A|Disease Progression|0|||
150275576|NCT00467779|542146418|FG002|Stage 2A|Disease Progression|0|||
150275577|NCT00467779|542146419|FG003|Stage 2A|Disease Progression|0|||
150275578|NCT00467779|542146420|FG004|Stage 2A|Disease Progression|0|||
150275579|NCT00467779|542146421|FG005|Stage 2A|Disease Progression|0|||
150275580|NCT00467779|542146422|FG006|Stage 2A|Disease Progression|0|||
150275581|NCT00467779|542146423|FG007|Stage 2A|Disease Progression|0|||
150275582|NCT00467779|542146424|FG008|Stage 2A|Disease Progression|0|||
150275583|NCT00467779|542146425|FG009|Stage 2A|Disease Progression|0|||
150275584|NCT00467779|542146426|FG010|Stage 2A|Disease Progression|0|||
150275585|NCT00467779|542146427|FG011|Stage 2A|Disease Progression|0|||
150275586|NCT00467779|542146428|FG012|Stage 2A|Disease Progression|0|||
150275587|NCT00467779|542146429|FG013|Stage 2A|Disease Progression|10|||
150275588|NCT00467779|542146430|FG014|Stage 2A|Disease Progression|0|||
150275589|NCT00467779|542146416|FG000|Stage 2A|Unspecified Reason|0|||
150275590|NCT00467779|542146417|FG001|Stage 2A|Unspecified Reason|0|||
150275591|NCT00467779|542146418|FG002|Stage 2A|Unspecified Reason|0|||
150275592|NCT00467779|542146419|FG003|Stage 2A|Unspecified Reason|0|||
150275593|NCT00467779|542146420|FG004|Stage 2A|Unspecified Reason|0|||
150275594|NCT00467779|542146421|FG005|Stage 2A|Unspecified Reason|0|||
150275595|NCT00467779|542146422|FG006|Stage 2A|Unspecified Reason|0|||
150275596|NCT00467779|542146423|FG007|Stage 2A|Unspecified Reason|0|||
150275597|NCT00467779|542146424|FG008|Stage 2A|Unspecified Reason|0|||
150275598|NCT00467779|542146425|FG009|Stage 2A|Unspecified Reason|0|||
150275599|NCT00467779|542146426|FG010|Stage 2A|Unspecified Reason|0|||
150275600|NCT00467779|542146427|FG011|Stage 2A|Unspecified Reason|0|||
150275601|NCT00467779|542146428|FG012|Stage 2A|Unspecified Reason|0|||
150275602|NCT00467779|542146429|FG013|Stage 2A|Unspecified Reason|7|||
149826809|NCT01265784|540496330|FG000|Overall Study|Incorrectly Randomized|0|||
149826810|NCT01265784|540496331|FG001|Overall Study|Incorrectly Randomized|0|||
149826811|NCT01265784|540496332|FG002|Overall Study|Incorrectly Randomized|1|||
149826812|NCT01937364|540496333|FG000|Overall Study|Adverse Event|2|||
149826813|NCT01937364|540496334|FG001|Overall Study|Adverse Event|1|||
150033202|NCT01247324|541260916|FG000|Overall Study|Reason not specified|42|||
150033203|NCT01247324|541260917|FG001|Overall Study|Reason not specified|32|||
150275603|NCT00467779|542146430|FG014|Stage 2A|Unspecified Reason|0|||
150275604|NCT00467779|542146416|FG000|Stage 2A|Withdrawal by Subject|0|||
150275605|NCT00467779|542146417|FG001|Stage 2A|Withdrawal by Subject|0|||
150275606|NCT00467779|542146418|FG002|Stage 2A|Withdrawal by Subject|0|||
150275607|NCT00467779|542146419|FG003|Stage 2A|Withdrawal by Subject|0|||
150275608|NCT00467779|542146420|FG004|Stage 2A|Withdrawal by Subject|0|||
150275609|NCT00467779|542146421|FG005|Stage 2A|Withdrawal by Subject|0|||
150275610|NCT00467779|542146422|FG006|Stage 2A|Withdrawal by Subject|0|||
150275611|NCT00467779|542146423|FG007|Stage 2A|Withdrawal by Subject|0|||
150275612|NCT00467779|542146424|FG008|Stage 2A|Withdrawal by Subject|0|||
150275613|NCT00467779|542146425|FG009|Stage 2A|Withdrawal by Subject|0|||
150275614|NCT00467779|542146426|FG010|Stage 2A|Withdrawal by Subject|0|||
150275615|NCT00467779|542146427|FG011|Stage 2A|Withdrawal by Subject|0|||
150275616|NCT00467779|542146428|FG012|Stage 2A|Withdrawal by Subject|0|||
150275617|NCT00467779|542146429|FG013|Stage 2A|Withdrawal by Subject|1|||
150275618|NCT00467779|542146430|FG014|Stage 2A|Withdrawal by Subject|0|||
150275619|NCT00467779|542146416|FG000|Stage 3|Adverse Event|0|||
150275620|NCT00467779|542146417|FG001|Stage 3|Adverse Event|0|||
150275621|NCT00467779|542146418|FG002|Stage 3|Adverse Event|0|||
150275622|NCT00467779|542146419|FG003|Stage 3|Adverse Event|0|||
150275623|NCT00467779|542146420|FG004|Stage 3|Adverse Event|0|||
149826814|NCT04799158|540496335|FG000|Run-In Period|Adverse Event|6|||
149826815|NCT04799158|540496336|FG001|Run-In Period|Adverse Event|0|||
149826816|NCT04799158|540496337|FG002|Run-In Period|Adverse Event|0|||
149826817|NCT04799158|540496338|FG003|Run-In Period|Adverse Event|0|||
149826818|NCT04799158|540496339|FG004|Run-In Period|Adverse Event|0|||
149826819|NCT04799158|540496335|FG000|Run-In Period|Lost to Follow-up|4|||
149826820|NCT04799158|540496336|FG001|Run-In Period|Lost to Follow-up|0|||
149826821|NCT04799158|540496337|FG002|Run-In Period|Lost to Follow-up|0|||
149826822|NCT04799158|540496338|FG003|Run-In Period|Lost to Follow-up|0|||
149826823|NCT04799158|540496339|FG004|Run-In Period|Lost to Follow-up|0|||
149826824|NCT04799158|540496335|FG000|Run-In Period|Significant Protocol Deviation|1|||
149826825|NCT04799158|540496336|FG001|Run-In Period|Significant Protocol Deviation|0|||
149826826|NCT04799158|540496337|FG002|Run-In Period|Significant Protocol Deviation|0|||
149826827|NCT04799158|540496338|FG003|Run-In Period|Significant Protocol Deviation|0|||
149826828|NCT04799158|540496339|FG004|Run-In Period|Significant Protocol Deviation|0|||
149826829|NCT04799158|540496335|FG000|Run-In Period|Withdrawal by Subject|11|||
149826830|NCT04799158|540496336|FG001|Run-In Period|Withdrawal by Subject|0|||
149826831|NCT04799158|540496337|FG002|Run-In Period|Withdrawal by Subject|0|||
149826832|NCT04799158|540496338|FG003|Run-In Period|Withdrawal by Subject|0|||
149826833|NCT04799158|540496339|FG004|Run-In Period|Withdrawal by Subject|0|||
149826834|NCT04799158|540496335|FG000|Run-In Period|Miscellaneous|3|||
149826835|NCT04799158|540496336|FG001|Run-In Period|Miscellaneous|0|||
149826836|NCT04799158|540496337|FG002|Run-In Period|Miscellaneous|0|||
149826837|NCT04799158|540496338|FG003|Run-In Period|Miscellaneous|0|||
149826838|NCT04799158|540496339|FG004|Run-In Period|Miscellaneous|0|||
149826839|NCT04799158|540496335|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
149826840|NCT04799158|540496336|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
149826841|NCT04799158|540496337|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
149826842|NCT04799158|540496338|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
149826843|NCT04799158|540496339|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
149826844|NCT04799158|540496335|FG000|On-Demand Treatment Period|Adverse Event|0|||
149826845|NCT04799158|540496336|FG001|On-Demand Treatment Period|Adverse Event|1|||
149826846|NCT04799158|540496337|FG002|On-Demand Treatment Period|Adverse Event|0|||
149826847|NCT04799158|540496338|FG003|On-Demand Treatment Period|Adverse Event|0|||
150275624|NCT00467779|542146421|FG005|Stage 3|Adverse Event|0|||
150275625|NCT00467779|542146422|FG006|Stage 3|Adverse Event|0|||
150275626|NCT00467779|542146423|FG007|Stage 3|Adverse Event|0|||
150275627|NCT00467779|542146424|FG008|Stage 3|Adverse Event|0|||
150275628|NCT00467779|542146425|FG009|Stage 3|Adverse Event|0|||
150275629|NCT00467779|542146426|FG010|Stage 3|Adverse Event|0|||
150275630|NCT00467779|542146427|FG011|Stage 3|Adverse Event|0|||
150275631|NCT00467779|542146428|FG012|Stage 3|Adverse Event|0|||
150275632|NCT00467779|542146429|FG013|Stage 3|Adverse Event|0|||
150275633|NCT00467779|542146430|FG014|Stage 3|Adverse Event|2|||
150275634|NCT00467779|542146416|FG000|Stage 3|Death|0|||
150275635|NCT00467779|542146417|FG001|Stage 3|Death|0|||
150275636|NCT00467779|542146418|FG002|Stage 3|Death|0|||
150275637|NCT00467779|542146419|FG003|Stage 3|Death|0|||
150275638|NCT00467779|542146420|FG004|Stage 3|Death|0|||
150275639|NCT00467779|542146421|FG005|Stage 3|Death|0|||
150275640|NCT00467779|542146422|FG006|Stage 3|Death|0|||
149826848|NCT04799158|540496339|FG004|On-Demand Treatment Period|Adverse Event|1|||
149826849|NCT04799158|540496335|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
149826850|NCT04799158|540496336|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
149826851|NCT04799158|540496337|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
149826852|NCT04799158|540496338|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
149826853|NCT04799158|540496339|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
149826854|NCT04799158|540496335|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
149946177|NCT02327078|540936230|FG003|Overall Study|Lost to Follow-up|0|||
149946178|NCT02327078|540936231|FG004|Overall Study|Lost to Follow-up|0|||
149946179|NCT02327078|540936232|FG005|Overall Study|Lost to Follow-up|0|||
149946180|NCT02327078|540936233|FG006|Overall Study|Lost to Follow-up|0|||
149826855|NCT04799158|540496336|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
149946181|NCT02327078|540936234|FG007|Overall Study|Lost to Follow-up|2|||
149946182|NCT02327078|540936235|FG008|Overall Study|Lost to Follow-up|5|||
149946183|NCT02327078|540936227|FG000|Overall Study|Site Terminated by Sponsor|1|||
150275641|NCT00467779|542146423|FG007|Stage 3|Death|0|||
149826856|NCT04799158|540496337|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
149946184|NCT02327078|540936228|FG001|Overall Study|Site Terminated by Sponsor|0|||
150275642|NCT00467779|542146424|FG008|Stage 3|Death|0|||
150275643|NCT00467779|542146425|FG009|Stage 3|Death|0|||
150275644|NCT00467779|542146426|FG010|Stage 3|Death|0|||
150275645|NCT00467779|542146427|FG011|Stage 3|Death|0|||
150275646|NCT00467779|542146428|FG012|Stage 3|Death|0|||
150275647|NCT00467779|542146429|FG013|Stage 3|Death|0|||
150275648|NCT00467779|542146430|FG014|Stage 3|Death|1|||
150275649|NCT00467779|542146416|FG000|Stage 3|Disease Progression|0|||
150275650|NCT00467779|542146417|FG001|Stage 3|Disease Progression|0|||
150275651|NCT00467779|542146418|FG002|Stage 3|Disease Progression|0|||
150275652|NCT00467779|542146419|FG003|Stage 3|Disease Progression|0|||
149826857|NCT04799158|540496338|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
149826858|NCT04799158|540496339|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
149826859|NCT04799158|540496335|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
149826860|NCT04799158|540496336|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
149826861|NCT04799158|540496337|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
149826862|NCT04799158|540496338|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
149826863|NCT04799158|540496339|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
149826864|NCT04799158|540496335|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
149826865|NCT04799158|540496336|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
149826866|NCT04799158|540496337|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
149826867|NCT04799158|540496338|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
149826868|NCT04799158|540496339|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
149826869|NCT04799158|540496335|FG000|On-Demand Treatment Period|Miscellaneous|0|||
149826870|NCT04799158|540496336|FG001|On-Demand Treatment Period|Miscellaneous|0|||
149826871|NCT04799158|540496337|FG002|On-Demand Treatment Period|Miscellaneous|0|||
149826872|NCT04799158|540496338|FG003|On-Demand Treatment Period|Miscellaneous|0|||
149826873|NCT04799158|540496339|FG004|On-Demand Treatment Period|Miscellaneous|1|||
149826874|NCT00936975|540496340|FG000|Overall Study|Withdrawal by Subject|1|||
149826875|NCT00936975|540496340|FG000|Overall Study|Disease progression|3|||
149826876|NCT00936975|540496340|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
149826877|NCT02568384|540496345|FG000|Overall Study|Mobile devices incompatible with App|2|||
149826878|NCT01485536|540496346|FG000|Overall Study|Withdrawal by Subject|3|||
149826879|NCT01485536|540496346|FG000|Overall Study|Adverse Event|1|||
149826880|NCT00329602|540496347|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
149826881|NCT00329602|540496348|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
149826882|NCT00329602|540496349|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
149826883|NCT00329602|540496347|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
149826884|NCT00329602|540496348|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
149826885|NCT00329602|540496349|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
149826886|NCT00329602|540496347|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
149826887|NCT00329602|540496348|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
149826888|NCT00329602|540496349|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
149826889|NCT00329602|540496347|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
149826890|NCT00329602|540496348|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
149826891|NCT00329602|540496349|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
149826892|NCT00329602|540496347|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
149826893|NCT00329602|540496348|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
149826894|NCT00329602|540496349|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
149826895|NCT00329602|540496347|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
149826896|NCT00329602|540496348|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
149826897|NCT00329602|540496349|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
149826898|NCT00510510|540496350|FG000|Overall Study|Adverse Event|4|||
149826899|NCT00510510|540496351|FG001|Overall Study|Adverse Event|3|||
149826900|NCT00510510|540496352|FG002|Overall Study|Adverse Event|6|||
150170456|NCT01235949|541759074|FG013|Booster Phase|Lost to Follow-up|0|||
149826901|NCT00510510|540496350|FG000|Overall Study|Lack of Efficacy|0|||
149826902|NCT00510510|540496351|FG001|Overall Study|Lack of Efficacy|1|||
149826903|NCT00510510|540496352|FG002|Overall Study|Lack of Efficacy|1|||
149826904|NCT00510510|540496350|FG000|Overall Study|Subjects no longer requires study drug|0|||
149826905|NCT00510510|540496351|FG001|Overall Study|Subjects no longer requires study drug|0|||
149826906|NCT00510510|540496352|FG002|Overall Study|Subjects no longer requires study drug|2|||
149826907|NCT00510510|540496350|FG000|Overall Study|Withdrawal by Subject|1|||
149826908|NCT00510510|540496351|FG001|Overall Study|Withdrawal by Subject|2|||
149826909|NCT00510510|540496352|FG002|Overall Study|Withdrawal by Subject|3|||
149826910|NCT00510510|540496350|FG000|Overall Study|Lost to Follow-up|0|||
149826911|NCT00510510|540496351|FG001|Overall Study|Lost to Follow-up|0|||
149826912|NCT00510510|540496352|FG002|Overall Study|Lost to Follow-up|1|||
149826913|NCT00510510|540496350|FG000|Overall Study|Protocol Violation|0|||
149826914|NCT00510510|540496351|FG001|Overall Study|Protocol Violation|3|||
149826915|NCT00510510|540496352|FG002|Overall Study|Protocol Violation|4|||
149826916|NCT01066052|540496353|FG000|Overall Study|Enrolled But Not Treated|3|||
149826917|NCT01066052|540496354|FG001|Overall Study|Enrolled But Not Treated|0|||
149826918|NCT01497938|540496355|FG000|Overall Study|Adverse Event|0|||
149826919|NCT01497938|540496356|FG001|Overall Study|Adverse Event|1|||
149826920|NCT01497938|540496355|FG000|Overall Study|Physician Decision|0|||
149826921|NCT01497938|540496356|FG001|Overall Study|Physician Decision|1|||
149826922|NCT01497938|540496355|FG000|Overall Study|Withdrawal by Subject|4|||
149826923|NCT01497938|540496356|FG001|Overall Study|Withdrawal by Subject|0|||
149826924|NCT01497938|540496355|FG000|Overall Study|Device Violation|1|||
149826925|NCT01497938|540496356|FG001|Overall Study|Device Violation|0|||
149826926|NCT00365352|540496357|FG000|Overall Study|Adverse Event|6|||
149826927|NCT00365352|540496358|FG001|Overall Study|Adverse Event|7|||
149826928|NCT00365352|540496359|FG002|Overall Study|Adverse Event|8|||
149826929|NCT00365352|540496357|FG000|Overall Study|Participant Withdrew Consent|8|||
149826930|NCT00365352|540496358|FG001|Overall Study|Participant Withdrew Consent|3|||
149826931|NCT00365352|540496359|FG002|Overall Study|Participant Withdrew Consent|4|||
149826932|NCT00365352|540496357|FG000|Overall Study|Lack of Efficacy|3|||
149826933|NCT00365352|540496358|FG001|Overall Study|Lack of Efficacy|0|||
149826934|NCT00365352|540496359|FG002|Overall Study|Lack of Efficacy|0|||
149826935|NCT00365352|540496357|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
149826936|NCT00365352|540496358|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
149826937|NCT00365352|540496359|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
149826938|NCT00365352|540496357|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
149826939|NCT00365352|540496358|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
149826940|NCT00365352|540496359|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
149826941|NCT00365352|540496357|FG000|Overall Study|Lost to Follow-up|1|||
149826942|NCT00365352|540496358|FG001|Overall Study|Lost to Follow-up|1|||
149826943|NCT00365352|540496359|FG002|Overall Study|Lost to Follow-up|0|||
149826944|NCT00365352|540496357|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
149826945|NCT00365352|540496358|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
149826946|NCT00365352|540496359|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
149826947|NCT02109133|540496366|FG000|Overall Study|Lost to Follow-up|1|||
149826948|NCT02109133|540496367|FG001|Overall Study|Lost to Follow-up|0|||
149826949|NCT05200858|540496370|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
149826950|NCT05200858|540496371|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
149826951|NCT05200858|540496372|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
149826952|NCT05200858|540496373|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
149826953|NCT02448771|540496374|FG000|Overall Study|Disease Progression|30|||
149826954|NCT02448771|540496374|FG000|Overall Study|Unacceptable Toxicity|1|||
149826955|NCT02448771|540496374|FG000|Overall Study|Physician Decision|3|||
149826956|NCT02448771|540496374|FG000|Overall Study|Started new therapy|2|||
149826957|NCT02683187|540496376|FG000|Overall Study|Failed IV access|3|||
149826958|NCT02683187|540496376|FG000|Overall Study|Withdrawal by Subject|5|||
149826959|NCT01052116|540498196|FG000|Overall Study|Lost to Follow-up|11|||
149826960|NCT01052116|540498197|FG001|Overall Study|Lost to Follow-up|17|||
149826961|NCT01052116|540498196|FG000|Overall Study|Withdrawal by Subject|3|||
149826962|NCT01052116|540498197|FG001|Overall Study|Withdrawal by Subject|6|||
149826963|NCT01052116|540498196|FG000|Overall Study|Spirometry not performed|0|||
149826964|NCT01052116|540498197|FG001|Overall Study|Spirometry not performed|4|||
149826965|NCT00862979|540498199|FG000|Overall Study|Adverse Event|6|||
149826966|NCT00862979|540498200|FG001|Overall Study|Adverse Event|3|||
149826967|NCT00862979|540498199|FG000|Overall Study|Protocol Violation|0|||
149826968|NCT00862979|540498200|FG001|Overall Study|Protocol Violation|1|||
149826969|NCT00862979|540498199|FG000|Overall Study|Patient withdrew consent|2|||
149826970|NCT00862979|540498200|FG001|Overall Study|Patient withdrew consent|1|||
149826971|NCT00862979|540498199|FG000|Overall Study|Administrative problems|0|||
149826972|NCT00862979|540498200|FG001|Overall Study|Administrative problems|1|||
149826973|NCT00862979|540498199|FG000|Overall Study|Death|0|||
149826974|NCT00862979|540498200|FG001|Overall Study|Death|1|||
149826975|NCT01027143|540498201|FG000|Overall Study|Lost to Follow-up|9|||
149826976|NCT01027143|540498202|FG001|Overall Study|Lost to Follow-up|4|||
149826977|NCT01290263|540498203|FG000|Overall Study|Adverse Event|0|||
149826978|NCT01290263|540498204|FG001|Overall Study|Adverse Event|0|||
149826979|NCT01290263|540498205|FG002|Overall Study|Adverse Event|0|||
149826980|NCT01290263|540498206|FG003|Overall Study|Adverse Event|1|||
149826981|NCT01290263|540498207|FG004|Overall Study|Adverse Event|1|||
149826982|NCT01290263|540498203|FG000|Overall Study|Lack of Efficacy|8|||
149826983|NCT01290263|540498204|FG001|Overall Study|Lack of Efficacy|2|||
149826984|NCT01290263|540498205|FG002|Overall Study|Lack of Efficacy|7|||
149826985|NCT01290263|540498206|FG003|Overall Study|Lack of Efficacy|24|||
149946185|NCT02327078|540936229|FG002|Overall Study|Site Terminated by Sponsor|1|||
149946186|NCT02327078|540936230|FG003|Overall Study|Site Terminated by Sponsor|4|||
149946187|NCT02327078|540936231|FG004|Overall Study|Site Terminated by Sponsor|0|||
149946188|NCT02327078|540936232|FG005|Overall Study|Site Terminated by Sponsor|0|||
149946189|NCT02327078|540936233|FG006|Overall Study|Site Terminated by Sponsor|0|||
149946190|NCT02327078|540936234|FG007|Overall Study|Site Terminated by Sponsor|11|||
149946191|NCT02327078|540936235|FG008|Overall Study|Site Terminated by Sponsor|25|||
149826986|NCT01290263|540498207|FG004|Overall Study|Lack of Efficacy|33|||
149826987|NCT01290263|540498203|FG000|Overall Study|Withdrawal by Subject|3|||
149826988|NCT01290263|540498204|FG001|Overall Study|Withdrawal by Subject|1|||
149826989|NCT01290263|540498205|FG002|Overall Study|Withdrawal by Subject|0|||
149826990|NCT01290263|540498206|FG003|Overall Study|Withdrawal by Subject|1|||
149826991|NCT01290263|540498207|FG004|Overall Study|Withdrawal by Subject|2|||
149826992|NCT01290263|540498203|FG000|Overall Study|Participant Non-Compliance|0|||
149826993|NCT01290263|540498204|FG001|Overall Study|Participant Non-Compliance|0|||
149826994|NCT01290263|540498205|FG002|Overall Study|Participant Non-Compliance|0|||
149826995|NCT01290263|540498206|FG003|Overall Study|Participant Non-Compliance|1|||
149826996|NCT01290263|540498207|FG004|Overall Study|Participant Non-Compliance|1|||
150170457|NCT01235949|541759075|FG014|Booster Phase|Lost to Follow-up|0|||
150170458|NCT01235949|541759076|FG015|Booster Phase|Lost to Follow-up|0|||
150170459|NCT01235949|541759077|FG016|Booster Phase|Lost to Follow-up|0|||
150170460|NCT01235949|541759078|FG017|Booster Phase|Lost to Follow-up|1|||
150170461|NCT00754936|541759079|FG000|Overall Study|Lost to Follow-up|3|||
150275653|NCT00467779|542146420|FG004|Stage 3|Disease Progression|0|||
150275654|NCT00467779|542146421|FG005|Stage 3|Disease Progression|0|||
150275655|NCT00467779|542146422|FG006|Stage 3|Disease Progression|0|||
150275656|NCT00467779|542146423|FG007|Stage 3|Disease Progression|0|||
150275657|NCT00467779|542146424|FG008|Stage 3|Disease Progression|0|||
150275658|NCT00467779|542146425|FG009|Stage 3|Disease Progression|0|||
150275659|NCT00467779|542146426|FG010|Stage 3|Disease Progression|0|||
150275660|NCT00467779|542146427|FG011|Stage 3|Disease Progression|0|||
150275661|NCT00467779|542146428|FG012|Stage 3|Disease Progression|0|||
150275662|NCT00467779|542146429|FG013|Stage 3|Disease Progression|0|||
150275663|NCT00467779|542146430|FG014|Stage 3|Disease Progression|9|||
150275664|NCT00467779|542146416|FG000|Stage 3|Unspecified Reason|0|||
150275665|NCT00467779|542146417|FG001|Stage 3|Unspecified Reason|0|||
150275666|NCT00467779|542146418|FG002|Stage 3|Unspecified Reason|0|||
150275667|NCT00467779|542146419|FG003|Stage 3|Unspecified Reason|0|||
150275668|NCT00467779|542146420|FG004|Stage 3|Unspecified Reason|0|||
150275669|NCT00467779|542146421|FG005|Stage 3|Unspecified Reason|0|||
150275670|NCT00467779|542146422|FG006|Stage 3|Unspecified Reason|0|||
150275671|NCT00467779|542146423|FG007|Stage 3|Unspecified Reason|0|||
150275672|NCT00467779|542146424|FG008|Stage 3|Unspecified Reason|0|||
150275673|NCT00467779|542146425|FG009|Stage 3|Unspecified Reason|0|||
150275674|NCT00467779|542146426|FG010|Stage 3|Unspecified Reason|0|||
150275675|NCT00467779|542146427|FG011|Stage 3|Unspecified Reason|0|||
150275676|NCT00467779|542146428|FG012|Stage 3|Unspecified Reason|0|||
150275677|NCT00467779|542146429|FG013|Stage 3|Unspecified Reason|0|||
150275678|NCT00467779|542146430|FG014|Stage 3|Unspecified Reason|5|||
150275679|NCT00436618|542146431|FG000|Overall Study|Withdrawal by Subject|5|||
150275680|NCT00436618|542146432|FG001|Overall Study|Withdrawal by Subject|8|||
150275681|NCT00436618|542146433|FG002|Overall Study|Withdrawal by Subject|11|||
150275682|NCT00436618|542146431|FG000|Overall Study|Adverse Event|8|||
150275683|NCT00436618|542146432|FG001|Overall Study|Adverse Event|8|||
150275684|NCT00436618|542146433|FG002|Overall Study|Adverse Event|9|||
150275685|NCT00436618|542146431|FG000|Overall Study|Alternate Treatment|3|||
150275686|NCT00436618|542146432|FG001|Overall Study|Alternate Treatment|4|||
150275687|NCT00436618|542146433|FG002|Overall Study|Alternate Treatment|12|||
150275688|NCT00436618|542146431|FG000|Overall Study|Other Medical Problems|3|||
150275689|NCT00436618|542146432|FG001|Overall Study|Other Medical Problems|1|||
150275690|NCT00436618|542146433|FG002|Overall Study|Other Medical Problems|7|||
150275691|NCT00436618|542146431|FG000|Overall Study|Death|4|||
150275692|NCT00436618|542146432|FG001|Overall Study|Death|2|||
150275693|NCT00436618|542146433|FG002|Overall Study|Death|3|||
150275694|NCT00436618|542146431|FG000|Overall Study|New Primary or Other Reasons|6|||
150275695|NCT00436618|542146432|FG001|Overall Study|New Primary or Other Reasons|2|||
150275696|NCT00436618|542146433|FG002|Overall Study|New Primary or Other Reasons|12|||
150170462|NCT00754936|541759079|FG000|Overall Study|Physician Decision|1|||
150170463|NCT00754936|541759079|FG000|Overall Study|Withdrawal by Subject|2|||
150170464|NCT00754936|541759079|FG000|Overall Study|Side Effects|3|||
150170465|NCT00754936|541759079|FG000|Overall Study|Inter-current medical events|3|||
150170466|NCT00371566|541759084|FG000|Treatment Phase|Withdrawal by Subject|0|||
150170467|NCT00371566|541759085|FG001|Treatment Phase|Withdrawal by Subject|1|||
150275697|NCT00436618|542146431|FG000|Overall Study|Still on treatment|1|||
150275698|NCT00436618|542146432|FG001|Overall Study|Still on treatment|2|||
150275699|NCT00436618|542146433|FG002|Overall Study|Still on treatment|7|||
150275700|NCT01994382|542146434|FG000|Overall Study|Informed consent withdrawn|0|||
150275701|NCT01994382|542146435|FG001|Overall Study|Informed consent withdrawn|0|||
150275702|NCT01994382|542146436|FG002|Overall Study|Informed consent withdrawn|0|||
150275703|NCT01994382|542146437|FG003|Overall Study|Informed consent withdrawn|0|||
150275704|NCT01994382|542146438|FG004|Overall Study|Informed consent withdrawn|0|||
150275705|NCT01994382|542146439|FG005|Overall Study|Informed consent withdrawn|0|||
150275706|NCT01994382|542146440|FG006|Overall Study|Informed consent withdrawn|1|||
150275707|NCT01994382|542146441|FG007|Overall Study|Informed consent withdrawn|0|||
150275708|NCT01994382|542146442|FG008|Overall Study|Informed consent withdrawn|0|||
150275709|NCT01994382|542146443|FG009|Overall Study|Informed consent withdrawn|0|||
150275710|NCT01994382|542146444|FG010|Overall Study|Informed consent withdrawn|0|||
150275711|NCT01994382|542146445|FG011|Overall Study|Informed consent withdrawn|0|||
150275712|NCT01994382|542146446|FG012|Overall Study|Informed consent withdrawn|0|||
150170468|NCT00371566|541759084|FG000|Treatment Phase|Adverse Event|0|||
150275713|NCT01994382|542146447|FG013|Overall Study|Informed consent withdrawn|0|||
150275714|NCT01994382|542146448|FG014|Overall Study|Informed consent withdrawn|0|||
150275715|NCT01994382|542146449|FG015|Overall Study|Informed consent withdrawn|0|||
150275716|NCT01994382|542146450|FG016|Overall Study|Informed consent withdrawn|0|||
150170469|NCT00371566|541759085|FG001|Treatment Phase|Adverse Event|1|||
150275717|NCT01994382|542146434|FG000|Overall Study|Progressive disease|3|||
150275718|NCT01994382|542146435|FG001|Overall Study|Progressive disease|4|||
150275719|NCT01994382|542146436|FG002|Overall Study|Progressive disease|4|||
150275720|NCT01994382|542146437|FG003|Overall Study|Progressive disease|3|||
150275721|NCT01994382|542146438|FG004|Overall Study|Progressive disease|2|||
150275722|NCT01994382|542146439|FG005|Overall Study|Progressive disease|3|||
150275723|NCT01994382|542146440|FG006|Overall Study|Progressive disease|3|||
150275724|NCT01994382|542146441|FG007|Overall Study|Progressive disease|6|||
150275725|NCT01994382|542146442|FG008|Overall Study|Progressive disease|2|||
150275726|NCT01994382|542146443|FG009|Overall Study|Progressive disease|2|||
150275727|NCT01994382|542146444|FG010|Overall Study|Progressive disease|13|||
150275728|NCT01994382|542146445|FG011|Overall Study|Progressive disease|8|||
150275729|NCT01994382|542146446|FG012|Overall Study|Progressive disease|7|||
150275730|NCT01994382|542146447|FG013|Overall Study|Progressive disease|3|||
149826997|NCT02518113|540498211|FG000|Overall Study|Adverse Event|1|||
149826998|NCT02518113|540498212|FG001|Overall Study|Adverse Event|0|||
149826999|NCT02518113|540498213|FG002|Overall Study|Adverse Event|1|||
149827000|NCT02518113|540498214|FG003|Overall Study|Adverse Event|0|||
149827001|NCT02518113|540498211|FG000|Overall Study|Death|1|||
149827002|NCT02518113|540498212|FG001|Overall Study|Death|2|||
149827003|NCT02518113|540498213|FG002|Overall Study|Death|0|||
149827004|NCT02518113|540498214|FG003|Overall Study|Death|0|||
149827005|NCT02518113|540498211|FG000|Overall Study|Physician Decision|0|||
149827006|NCT02518113|540498212|FG001|Overall Study|Physician Decision|1|||
149827007|NCT02518113|540498213|FG002|Overall Study|Physician Decision|0|||
149827008|NCT02518113|540498214|FG003|Overall Study|Physician Decision|0|||
149827009|NCT02518113|540498211|FG000|Overall Study|Progressive Disease|1|||
149827010|NCT02518113|540498212|FG001|Overall Study|Progressive Disease|2|||
149827011|NCT02518113|540498213|FG002|Overall Study|Progressive Disease|3|||
149827012|NCT02518113|540498214|FG003|Overall Study|Progressive Disease|0|||
149827013|NCT00287118|540498215|FG000|Overall Study|Adverse Event|30|||
149827014|NCT00287118|540498215|FG000|Overall Study|Death|1|||
149827015|NCT00287118|540498215|FG000|Overall Study|Lack of Efficacy|11|||
149827016|NCT00287118|540498215|FG000|Overall Study|Lost to Follow-up|1|||
149827017|NCT00287118|540498215|FG000|Overall Study|Protocol Violation|2|||
149827018|NCT00287118|540498215|FG000|Overall Study|Other|7|||
149827019|NCT02324465|540498216|FG000|Overall Study|device failure|0|||
149827020|NCT02324465|540498217|FG001|Overall Study|device failure|1|||
149827021|NCT01631864|540498218|FG000|Overall Study|Withdrawal by Subject|0|||
149827022|NCT01631864|540498219|FG001|Overall Study|Withdrawal by Subject|1|||
149827023|NCT01631864|540498218|FG000|Overall Study|Adverse Event|2|||
149827024|NCT01631864|540498219|FG001|Overall Study|Adverse Event|3|||
149827025|NCT02132247|540498220|FG000|Overall Study|Protocol Violation|1|||
149827026|NCT02132247|540498221|FG001|Overall Study|Protocol Violation|0|||
149827027|NCT01860976|540498238|FG000|Blinded Treatment|Adverse Event|1|||
149827028|NCT01860976|540498239|FG001|Blinded Treatment|Adverse Event|3|||
149827029|NCT01860976|540498238|FG000|Blinded Treatment|Lack of Efficacy|5|||
149827030|NCT01860976|540498239|FG001|Blinded Treatment|Lack of Efficacy|12|||
149827031|NCT01860976|540498238|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
149827032|NCT01860976|540498239|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
149827033|NCT01860976|540498238|FG000|Blinded Treatment|Withdrawal by Subject|3|||
149827034|NCT01860976|540498239|FG001|Blinded Treatment|Withdrawal by Subject|5|||
149827035|NCT01860976|540498238|FG000|Blinded Treatment|Subject no longer met criteria|1|||
149827036|NCT01860976|540498239|FG001|Blinded Treatment|Subject no longer met criteria|0|||
149827037|NCT01860976|540498238|FG000|Blinded Treatment|Entered Open-Label in error|0|||
149827038|NCT01860976|540498239|FG001|Blinded Treatment|Entered Open-Label in error|1|||
149827039|NCT01860976|540498238|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
149827040|NCT01860976|540498239|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
149827041|NCT01860976|540498238|FG000|Open-Label|Adverse Event|2|||
149827042|NCT01860976|540498239|FG001|Open-Label|Adverse Event|4|||
149827043|NCT01860976|540498238|FG000|Open-Label|Lack of Efficacy|16|||
149827044|NCT01860976|540498239|FG001|Open-Label|Lack of Efficacy|8|||
149827045|NCT01860976|540498238|FG000|Open-Label|Lost to Follow-up|1|||
149827046|NCT01860976|540498239|FG001|Open-Label|Lost to Follow-up|2|||
150275731|NCT01994382|542146448|FG014|Overall Study|Progressive disease|6|||
150275732|NCT01994382|542146449|FG015|Overall Study|Progressive disease|44|||
150275733|NCT01994382|542146450|FG016|Overall Study|Progressive disease|28|||
149827047|NCT01860976|540498238|FG000|Open-Label|Subject request discontinue treatment|4|||
149827048|NCT01860976|540498239|FG001|Open-Label|Subject request discontinue treatment|3|||
149827049|NCT01860976|540498238|FG000|Open-Label|Withdrawal by Subject|4|||
149946192|NCT02327078|540936227|FG000|Overall Study|Physician Decision|0|||
149946193|NCT02327078|540936228|FG001|Overall Study|Physician Decision|0|||
150275734|NCT01994382|542146434|FG000|Overall Study|Physician Decision|0|||
150275735|NCT01994382|542146435|FG001|Overall Study|Physician Decision|1|||
149827050|NCT01860976|540498239|FG001|Open-Label|Withdrawal by Subject|1|||
149827051|NCT01860976|540498238|FG000|Open-Label|Other Reasons|1|||
149827052|NCT01860976|540498239|FG001|Open-Label|Other Reasons|1|||
149946194|NCT02327078|540936229|FG002|Overall Study|Physician Decision|0|||
150275736|NCT01994382|542146436|FG002|Overall Study|Physician Decision|0|||
150170470|NCT00371566|541759084|FG000|Treatment Phase|Protocol Violation|0|||
150170471|NCT00371566|541759085|FG001|Treatment Phase|Protocol Violation|1|||
150170472|NCT00371566|541759084|FG000|Chemoradiation Phase|Physician Decision|2|||
150170473|NCT00371566|541759085|FG001|Chemoradiation Phase|Physician Decision|0|||
150170474|NCT00371566|541759084|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
150170475|NCT00371566|541759085|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
150170476|NCT00371566|541759084|FG000|Chemoradiation Phase|Non compliant|0|||
150170477|NCT00371566|541759085|FG001|Chemoradiation Phase|Non compliant|1|||
150275737|NCT01994382|542146437|FG003|Overall Study|Physician Decision|0|||
149827053|NCT01860976|540498238|FG000|Long Term Extension|Adverse Event|4|||
149827054|NCT01860976|540498239|FG001|Long Term Extension|Adverse Event|0|||
149827055|NCT01860976|540498238|FG000|Long Term Extension|Lack of Efficacy|2|||
149827056|NCT01860976|540498239|FG001|Long Term Extension|Lack of Efficacy|0|||
149827057|NCT01860976|540498238|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
149827058|NCT01860976|540498239|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
149827059|NCT01860976|540498238|FG000|Long Term Extension|Lost to Follow-up|2|||
149827060|NCT01860976|540498239|FG001|Long Term Extension|Lost to Follow-up|0|||
149827061|NCT01860976|540498238|FG000|Long Term Extension|subject withdrew consent|7|||
149827062|NCT01860976|540498239|FG001|Long Term Extension|subject withdrew consent|0|||
149827063|NCT02153398|540498242|FG000|Overall Study|Withdrawal by Subject|1|||
150275738|NCT01994382|542146438|FG004|Overall Study|Physician Decision|0|||
150275739|NCT01994382|542146439|FG005|Overall Study|Physician Decision|0|||
150275740|NCT01994382|542146440|FG006|Overall Study|Physician Decision|0|||
150275741|NCT01994382|542146441|FG007|Overall Study|Physician Decision|0|||
150275742|NCT01994382|542146442|FG008|Overall Study|Physician Decision|0|||
150275743|NCT01994382|542146443|FG009|Overall Study|Physician Decision|0|||
150275744|NCT01994382|542146444|FG010|Overall Study|Physician Decision|3|||
150275745|NCT01994382|542146445|FG011|Overall Study|Physician Decision|1|||
150275746|NCT01994382|542146446|FG012|Overall Study|Physician Decision|1|||
150275747|NCT01994382|542146447|FG013|Overall Study|Physician Decision|0|||
150275748|NCT01994382|542146448|FG014|Overall Study|Physician Decision|1|||
150275749|NCT01994382|542146449|FG015|Overall Study|Physician Decision|4|||
150275750|NCT01994382|542146450|FG016|Overall Study|Physician Decision|2|||
150275751|NCT01994382|542146434|FG000|Overall Study|Death|0|||
150275752|NCT01994382|542146435|FG001|Overall Study|Death|0|||
150275753|NCT01994382|542146436|FG002|Overall Study|Death|0|||
150275754|NCT01994382|542146437|FG003|Overall Study|Death|0|||
150275755|NCT01994382|542146438|FG004|Overall Study|Death|1|||
150275756|NCT01994382|542146439|FG005|Overall Study|Death|0|||
150275757|NCT01994382|542146440|FG006|Overall Study|Death|0|||
150275758|NCT01994382|542146441|FG007|Overall Study|Death|0|||
150275759|NCT01994382|542146442|FG008|Overall Study|Death|1|||
149827064|NCT02153398|540498243|FG001|Overall Study|Withdrawal by Subject|0|||
149946195|NCT02327078|540936230|FG003|Overall Study|Physician Decision|1|||
149946196|NCT02327078|540936231|FG004|Overall Study|Physician Decision|0|||
149946197|NCT02327078|540936232|FG005|Overall Study|Physician Decision|0|||
149946198|NCT02327078|540936233|FG006|Overall Study|Physician Decision|0|||
149946199|NCT02327078|540936234|FG007|Overall Study|Physician Decision|0|||
149946200|NCT02327078|540936235|FG008|Overall Study|Physician Decision|1|||
149946201|NCT02327078|540936227|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
149946202|NCT02327078|540936228|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
149946203|NCT02327078|540936229|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
149946204|NCT02327078|540936230|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
149946205|NCT02327078|540936231|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
149946206|NCT02327078|540936232|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
149946207|NCT02327078|540936233|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
149946208|NCT02327078|540936234|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
149946209|NCT02327078|540936235|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
149946210|NCT02327078|540936227|FG000|Overall Study|Reason not Specified|0|||
149946211|NCT02327078|540936228|FG001|Overall Study|Reason not Specified|0|||
150170478|NCT00371566|541759084|FG000|Chemoradiation Phase|Progressive Disease|1|||
150275760|NCT01994382|542146443|FG009|Overall Study|Death|1|||
150275761|NCT01994382|542146444|FG010|Overall Study|Death|0|||
150275762|NCT01994382|542146445|FG011|Overall Study|Death|0|||
149827065|NCT02153398|540498244|FG002|Overall Study|Withdrawal by Subject|0|||
150275763|NCT01994382|542146446|FG012|Overall Study|Death|0|||
150275764|NCT01994382|542146447|FG013|Overall Study|Death|0|||
149827066|NCT02153398|540498245|FG003|Overall Study|Withdrawal by Subject|0|||
149946212|NCT02327078|540936229|FG002|Overall Study|Reason not Specified|0|||
149946213|NCT02327078|540936230|FG003|Overall Study|Reason not Specified|0|||
149946214|NCT02327078|540936231|FG004|Overall Study|Reason not Specified|0|||
150275765|NCT01994382|542146448|FG014|Overall Study|Death|0|||
150275766|NCT01994382|542146449|FG015|Overall Study|Death|1|||
149946215|NCT02327078|540936232|FG005|Overall Study|Reason not Specified|0|||
149946216|NCT02327078|540936233|FG006|Overall Study|Reason not Specified|0|||
150275767|NCT01994382|542146450|FG016|Overall Study|Death|0|||
150275768|NCT01994382|542146434|FG000|Overall Study|Adverse Event|0|||
149827067|NCT02153398|540498246|FG004|Overall Study|Withdrawal by Subject|0|||
149827068|NCT02153398|540498242|FG000|Overall Study|Adverse Event|0|||
149827069|NCT02153398|540498243|FG001|Overall Study|Adverse Event|0|||
149827070|NCT02153398|540498244|FG002|Overall Study|Adverse Event|1|||
149827071|NCT02153398|540498245|FG003|Overall Study|Adverse Event|1|||
149827072|NCT02153398|540498246|FG004|Overall Study|Adverse Event|0|||
149827073|NCT02204371|540498247|FG000|Overall Study|Adverse Event|1|||
149827074|NCT02246478|540498250|FG000|Multiple-dose Phase|Protocol Violation|1|||
149827075|NCT02246478|540498251|FG001|Multiple-dose Phase|Protocol Violation|0|||
149827076|NCT02246478|540498252|FG002|Multiple-dose Phase|Protocol Violation|0|||
149827077|NCT02246478|540498253|FG003|Multiple-dose Phase|Protocol Violation|1|||
149827078|NCT00865709|540498259|FG000|Treatment|Adverse Event|9|||
149827079|NCT00865709|540498260|FG001|Treatment|Adverse Event|6|||
149827080|NCT00865709|540498259|FG000|Treatment|Withdrawal by Subject|10|||
149827081|NCT00865709|540498260|FG001|Treatment|Withdrawal by Subject|7|||
149827082|NCT00865709|540498259|FG000|Treatment|Physician Decision|3|||
149827083|NCT00865709|540498260|FG001|Treatment|Physician Decision|2|||
149827084|NCT00865709|540498259|FG000|Treatment|Surgery|8|||
149827085|NCT00865709|540498260|FG001|Treatment|Surgery|3|||
149827086|NCT00429923|540498261|FG000|Overall Study|Adverse Event|0|||
149827087|NCT00429923|540498262|FG001|Overall Study|Adverse Event|2|||
149827088|NCT00429923|540498263|FG002|Overall Study|Adverse Event|3|||
149827089|NCT00429923|540498261|FG000|Overall Study|Lack of Efficacy|4|||
149827090|NCT00429923|540498262|FG001|Overall Study|Lack of Efficacy|1|||
149827091|NCT00429923|540498263|FG002|Overall Study|Lack of Efficacy|33|||
149827092|NCT00429923|540498261|FG000|Overall Study|Lost to Follow-up|0|||
149827093|NCT00429923|540498262|FG001|Overall Study|Lost to Follow-up|0|||
149827094|NCT00429923|540498263|FG002|Overall Study|Lost to Follow-up|2|||
149827095|NCT00429923|540498261|FG000|Overall Study|Withdrew Consent|1|||
149827096|NCT00429923|540498262|FG001|Overall Study|Withdrew Consent|0|||
149827097|NCT00429923|540498263|FG002|Overall Study|Withdrew Consent|1|||
149827098|NCT00429923|540498261|FG000|Overall Study|Early Termination|0|||
149827099|NCT00429923|540498262|FG001|Overall Study|Early Termination|1|||
149827100|NCT00429923|540498263|FG002|Overall Study|Early Termination|0|||
149827101|NCT03276975|540498264|FG000|Overall Study|Withdrawal by Subject|1|||
149827102|NCT03276975|540498265|FG001|Overall Study|Withdrawal by Subject|0|||
149827103|NCT00662129|540498266|FG000|Overall Study|Protocol Violation|1|||
149827104|NCT00662129|540498266|FG000|Overall Study|Cancel prior to beginning treatment|1|||
149827105|NCT00662129|540498266|FG000|Overall Study|Ineligible|1|||
149827106|NCT02153736|540498271|FG000|Overall Study|Lost to Follow-up|1|||
149827107|NCT02153736|540498272|FG001|Overall Study|Lost to Follow-up|0|||
149827108|NCT02153736|540498271|FG000|Overall Study|Medical status change made ineligible|1|||
149827109|NCT02153736|540498272|FG001|Overall Study|Medical status change made ineligible|0|||
149827110|NCT02153736|540498271|FG000|Overall Study|Death|0|||
149827111|NCT02153736|540498272|FG001|Overall Study|Death|1|||
149946217|NCT02327078|540936234|FG007|Overall Study|Reason not Specified|5|||
149946218|NCT02327078|540936235|FG008|Overall Study|Reason not Specified|12|||
149946219|NCT04797169|540936239|FG000|Overall Study|Lost to Follow-up|84|||
149946220|NCT04797169|540936240|FG001|Overall Study|Lost to Follow-up|67|||
149946221|NCT04797169|540936239|FG000|Overall Study|Pregnancy|1|||
149946222|NCT04797169|540936240|FG001|Overall Study|Pregnancy|3|||
149946223|NCT04797169|540936239|FG000|Overall Study|Withdrawal by Subject|27|||
149946224|NCT04797169|540936240|FG001|Overall Study|Withdrawal by Subject|35|||
149946225|NCT03839641|540936242|FG000|Overall Study|Withdrawal by Subject|1|||
149946226|NCT03839641|540936243|FG001|Overall Study|Withdrawal by Subject|1|||
149946227|NCT04221490|540936245|FG000|At 30 Days Follow-up|Death|7|||
149946228|NCT04221490|540936245|FG000|At 30 Days Follow-up|Missed Visit|4|||
149946229|NCT04221490|540936245|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
149946230|NCT04221490|540936245|FG000|At 6 Months Follow-up|Death|9|||
149827112|NCT02153736|540498271|FG000|Overall Study|Withdrawal by Subject|0|||
149827113|NCT02153736|540498272|FG001|Overall Study|Withdrawal by Subject|1|||
149827114|NCT00796510|540498281|FG000|Overall Study|Death|1|||
149827115|NCT00796510|540498282|FG001|Overall Study|Death|0|||
149827116|NCT00796510|540498281|FG000|Overall Study|Study Terminated|2|||
149827117|NCT00796510|540498282|FG001|Overall Study|Study Terminated|0|||
149827118|NCT01734772|540498283|FG000|Overall Study|Adverse Event|1|||
149827119|NCT01734772|540498284|FG001|Overall Study|Adverse Event|2|||
149827120|NCT01734772|540498283|FG000|Overall Study|Withdrawal by Subject|0|||
149827121|NCT01734772|540498284|FG001|Overall Study|Withdrawal by Subject|1|||
149827122|NCT05030753|540498285|FG000|9-week|Lost to Follow-up|10|||
149827123|NCT05030753|540498286|FG001|9-week|Lost to Follow-up|7|||
149946231|NCT04221490|540936245|FG000|At 6 Months Follow-up|Physician Decision|1|||
149946232|NCT04221490|540936245|FG000|At 6 Months Follow-up|Missed Visit|8|||
149946233|NCT04221490|540936245|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
149827124|NCT05030753|540498285|FG000|9-week|Withdrawal by Subject|1|||
149827125|NCT05030753|540498286|FG001|9-week|Withdrawal by Subject|0|||
149827126|NCT05030753|540498285|FG000|9-week|Excluded from analysis due to missing covariates|2|||
149827127|NCT05030753|540498286|FG001|9-week|Excluded from analysis due to missing covariates|1|||
149827128|NCT05030753|540498285|FG000|6-month post intervention|Lost to Follow-up|5|||
149827129|NCT05030753|540498286|FG001|6-month post intervention|Lost to Follow-up|4|||
149827130|NCT05030753|540498285|FG000|6-month post intervention|Withdrawal by Subject|4|||
149827131|NCT05030753|540498286|FG001|6-month post intervention|Withdrawal by Subject|0|||
149827132|NCT05030753|540498285|FG000|18-month post intervention|Lost to Follow-up|3|||
149827133|NCT05030753|540498286|FG001|18-month post intervention|Lost to Follow-up|1|||
149827134|NCT00720122|540498295|FG000|Overall Study|Lost to Follow-up|1|||
149827135|NCT00720122|540498295|FG000|Overall Study|Physician Decision|1|||
149827136|NCT00720122|540498295|FG000|Overall Study|Withdrawal by Subject|7|||
149827137|NCT03072459|540498296|FG000|Overall Study|Device revised/removed|1|||
149827138|NCT03072459|540498296|FG000|Overall Study|Subject not able to return|1|||
149827139|NCT02275364|540498297|FG000|Period 1|Withdrawal by Subject|1|||
149827140|NCT02275364|540498298|FG001|Period 1|Withdrawal by Subject|0|||
149827141|NCT02275364|540498297|FG000|Period 1|Other reason|1|||
149827142|NCT02275364|540498298|FG001|Period 1|Other reason|0|||
149827143|NCT03595657|540498303|FG000|Overall Study|Adverse Event|14|||
149827144|NCT03595657|540498303|FG000|Overall Study|Death|1|||
149827145|NCT03595657|540498303|FG000|Overall Study|Lack of Efficacy|40|||
149827146|NCT03595657|540498303|FG000|Overall Study|Withdrawal by Subject|10|||
149827147|NCT03595657|540498303|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
149827148|NCT03595657|540498303|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
149827149|NCT01200394|540498304|FG000|Overall Study|Adverse Event|0|||
149827150|NCT01200394|540498305|FG001|Overall Study|Adverse Event|14|||
149827151|NCT01200394|540498304|FG000|Overall Study|Death|1|||
149827152|NCT01200394|540498305|FG001|Overall Study|Death|0|||
149827153|NCT01200394|540498304|FG000|Overall Study|Lost to Follow-up|0|||
149827154|NCT01200394|540498305|FG001|Overall Study|Lost to Follow-up|1|||
149827155|NCT01200394|540498304|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
149827156|NCT01200394|540498305|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
149827157|NCT01200394|540498304|FG000|Overall Study|Protocol Violation|0|||
149827158|NCT01200394|540498305|FG001|Overall Study|Protocol Violation|3|||
149827159|NCT01200394|540498304|FG000|Overall Study|Withdrawal by Subject|0|||
149827160|NCT01200394|540498305|FG001|Overall Study|Withdrawal by Subject|5|||
149827161|NCT01200394|540498304|FG000|Overall Study|Other|0|||
149827162|NCT01200394|540498305|FG001|Overall Study|Other|1|||
149827163|NCT00663871|540498310|FG000|Overall Study|Lost to Follow-up|5|||
149827164|NCT00663871|540498311|FG001|Overall Study|Lost to Follow-up|5|||
149827165|NCT00663871|540498310|FG000|Overall Study|Withdrawal by Subject|5|||
149827166|NCT00663871|540498311|FG001|Overall Study|Withdrawal by Subject|2|||
149827167|NCT02729896|540498312|FG000|Overall Study|Death|0|||
149827168|NCT02729896|540498313|FG001|Overall Study|Death|2|||
149827169|NCT02729896|540498314|FG002|Overall Study|Death|13|||
149827170|NCT02729896|540498312|FG000|Overall Study|Lost to Follow-up|0|||
149827171|NCT02729896|540498313|FG001|Overall Study|Lost to Follow-up|2|||
149827172|NCT02729896|540498314|FG002|Overall Study|Lost to Follow-up|3|||
149827173|NCT02729896|540498312|FG000|Overall Study|Other|0|||
149827174|NCT02729896|540498313|FG001|Overall Study|Other|2|||
149827175|NCT02729896|540498314|FG002|Overall Study|Other|0|||
149827176|NCT02729896|540498312|FG000|Overall Study|Physician Decision|1|||
149827177|NCT02729896|540498313|FG001|Overall Study|Physician Decision|2|||
149827178|NCT02729896|540498314|FG002|Overall Study|Physician Decision|3|||
149827179|NCT02729896|540498312|FG000|Overall Study|Progressive Disease|0|||
149827180|NCT02729896|540498313|FG001|Overall Study|Progressive Disease|1|||
149827181|NCT02729896|540498314|FG002|Overall Study|Progressive Disease|0|||
149827182|NCT02729896|540498312|FG000|Overall Study|Withdrawal by Subject|1|||
149827183|NCT02729896|540498313|FG001|Overall Study|Withdrawal by Subject|0|||
149827184|NCT02729896|540498314|FG002|Overall Study|Withdrawal by Subject|3|||
149827185|NCT01835145|540498315|FG000|Overall Study|Ineligible prior to treatment|1|||
149827186|NCT01835145|540498316|FG001|Overall Study|Ineligible prior to treatment|0|||
149827187|NCT00582309|540498317|FG000|Overall Study|Protocol Violation|0|||
149827188|NCT00582309|540498318|FG001|Overall Study|Protocol Violation|0|||
149827189|NCT00582309|540498319|FG002|Overall Study|Protocol Violation|2|||
149827190|NCT04094870|540498323|FG000|Overall Study|Lost to Follow-up|1|||
149827191|NCT04094870|540498324|FG001|Overall Study|Lost to Follow-up|1|||
149827192|NCT03384745|540498325|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
149946234|NCT03188822|540936251|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
149946235|NCT03188822|540936251|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
149946236|NCT04537299|540936252|FG000|Overall Study|Withdrawal by Subject|2|||
149946237|NCT04537299|540936253|FG001|Overall Study|Withdrawal by Subject|0|||
149946238|NCT04537299|540936252|FG000|Overall Study|Protocol Violation|1|||
149946239|NCT04537299|540936253|FG001|Overall Study|Protocol Violation|1|||
149827193|NCT03384745|540498326|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
149827194|NCT03384745|540498327|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
149827195|NCT03384745|540498328|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
149827196|NCT03384745|540498329|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
150275769|NCT01994382|542146435|FG001|Overall Study|Adverse Event|1|||
149827197|NCT03384745|540498330|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
149827198|NCT03384745|540498325|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
149827199|NCT03384745|540498326|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
149827200|NCT03384745|540498327|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
149827201|NCT03384745|540498328|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
149827202|NCT03384745|540498329|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
149827203|NCT03384745|540498330|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
149827204|NCT03384745|540498325|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
149827205|NCT03384745|540498326|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
149827206|NCT03384745|540498327|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
149827207|NCT03384745|540498328|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
149827208|NCT03384745|540498329|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
149827209|NCT03384745|540498330|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
149827210|NCT03384745|540498325|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
149827211|NCT03384745|540498326|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
149827212|NCT03384745|540498327|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
149827213|NCT03384745|540498328|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
149827214|NCT03384745|540498329|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
149827215|NCT03384745|540498330|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
149827216|NCT03384745|540498325|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
149827217|NCT03384745|540498326|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
149827218|NCT03384745|540498327|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
149827219|NCT03384745|540498328|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
149827220|NCT03384745|540498329|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
149827221|NCT03384745|540498330|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
149827222|NCT03384745|540498325|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
150275770|NCT01994382|542146436|FG002|Overall Study|Adverse Event|2|||
150275771|NCT01994382|542146437|FG003|Overall Study|Adverse Event|0|||
150275772|NCT01994382|542146438|FG004|Overall Study|Adverse Event|0|||
150275773|NCT01994382|542146439|FG005|Overall Study|Adverse Event|0|||
150275774|NCT01994382|542146440|FG006|Overall Study|Adverse Event|0|||
150275775|NCT01994382|542146441|FG007|Overall Study|Adverse Event|0|||
150275776|NCT01994382|542146442|FG008|Overall Study|Adverse Event|0|||
150275777|NCT01994382|542146443|FG009|Overall Study|Adverse Event|0|||
150275778|NCT01994382|542146444|FG010|Overall Study|Adverse Event|15|||
150275779|NCT01994382|542146445|FG011|Overall Study|Adverse Event|2|||
150275780|NCT01994382|542146446|FG012|Overall Study|Adverse Event|7|||
150275781|NCT01994382|542146447|FG013|Overall Study|Adverse Event|3|||
150275782|NCT01994382|542146448|FG014|Overall Study|Adverse Event|17|||
150275783|NCT01994382|542146449|FG015|Overall Study|Adverse Event|6|||
150275784|NCT01994382|542146450|FG016|Overall Study|Adverse Event|3|||
150275785|NCT01994382|542146434|FG000|Overall Study|Other than specified|0|||
149827223|NCT03384745|540498326|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
149827224|NCT03384745|540498327|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
149827225|NCT03384745|540498328|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
149827226|NCT03384745|540498329|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
149827227|NCT03384745|540498330|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
149827228|NCT03384745|540498325|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
149827229|NCT03384745|540498326|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
149827230|NCT03384745|540498327|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
149827231|NCT03384745|540498328|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
149827232|NCT03384745|540498329|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
149827233|NCT03384745|540498330|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
149827234|NCT03384745|540498325|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
149827235|NCT03384745|540498326|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
149827236|NCT03384745|540498327|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
149827237|NCT03384745|540498328|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
149827238|NCT03384745|540498329|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
149827239|NCT03384745|540498330|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
149827240|NCT03384745|540498325|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
149827241|NCT03384745|540498326|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
149827242|NCT03384745|540498327|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
150275786|NCT01994382|542146435|FG001|Overall Study|Other than specified|0|||
149827243|NCT03384745|540498328|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
149827244|NCT03384745|540498329|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
150275787|NCT01994382|542146436|FG002|Overall Study|Other than specified|0|||
150275788|NCT01994382|542146437|FG003|Overall Study|Other than specified|0|||
150275789|NCT01994382|542146438|FG004|Overall Study|Other than specified|0|||
150275790|NCT01994382|542146439|FG005|Overall Study|Other than specified|0|||
150275791|NCT01994382|542146440|FG006|Overall Study|Other than specified|0|||
150275792|NCT01994382|542146441|FG007|Overall Study|Other than specified|0|||
150275793|NCT01994382|542146442|FG008|Overall Study|Other than specified|0|||
150275794|NCT01994382|542146443|FG009|Overall Study|Other than specified|0|||
150275795|NCT01994382|542146444|FG010|Overall Study|Other than specified|2|||
149827245|NCT03384745|540498330|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
149827246|NCT03384745|540498325|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
149827247|NCT03384745|540498326|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
149827248|NCT03384745|540498327|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
149827249|NCT03384745|540498328|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
149827250|NCT03384745|540498329|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
149827251|NCT03384745|540498330|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
149827252|NCT03384745|540498325|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
149827253|NCT03384745|540498326|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
149827254|NCT03384745|540498327|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
149827255|NCT03384745|540498328|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
149827256|NCT03384745|540498329|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
149827257|NCT03384745|540498330|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
149827258|NCT02708277|540498334|FG000|Overall Study|Lost to Follow-up|7|||
149827259|NCT02708277|540498335|FG001|Overall Study|Lost to Follow-up|4|||
149827260|NCT01058421|540498336|FG000|1 Month Outcomes|Death|10|||
149827261|NCT01058421|540498337|FG001|1 Month Outcomes|Death|6|||
149827262|NCT01058421|540498336|FG000|1 Month Outcomes|Lost to Follow-up|8|||
149827263|NCT01058421|540498337|FG001|1 Month Outcomes|Lost to Follow-up|7|||
150275796|NCT01994382|542146445|FG011|Overall Study|Other than specified|0|||
150275797|NCT01994382|542146446|FG012|Overall Study|Other than specified|2|||
150275798|NCT01994382|542146447|FG013|Overall Study|Other than specified|0|||
150275799|NCT01994382|542146448|FG014|Overall Study|Other than specified|0|||
150275800|NCT01994382|542146449|FG015|Overall Study|Other than specified|4|||
150275801|NCT01994382|542146450|FG016|Overall Study|Other than specified|4|||
150275802|NCT01994382|542146434|FG000|Overall Study|Withdrawal by Subject|0|||
150275803|NCT01994382|542146435|FG001|Overall Study|Withdrawal by Subject|0|||
150275804|NCT01994382|542146436|FG002|Overall Study|Withdrawal by Subject|0|||
150275805|NCT01994382|542146437|FG003|Overall Study|Withdrawal by Subject|0|||
150275806|NCT01994382|542146438|FG004|Overall Study|Withdrawal by Subject|0|||
150275807|NCT01994382|542146439|FG005|Overall Study|Withdrawal by Subject|0|||
150275808|NCT01994382|542146440|FG006|Overall Study|Withdrawal by Subject|0|||
150275809|NCT01994382|542146441|FG007|Overall Study|Withdrawal by Subject|0|||
150275810|NCT01994382|542146442|FG008|Overall Study|Withdrawal by Subject|0|||
150275811|NCT01994382|542146443|FG009|Overall Study|Withdrawal by Subject|0|||
150275812|NCT01994382|542146444|FG010|Overall Study|Withdrawal by Subject|6|||
150275813|NCT01994382|542146445|FG011|Overall Study|Withdrawal by Subject|0|||
150275814|NCT01994382|542146446|FG012|Overall Study|Withdrawal by Subject|2|||
150275815|NCT01994382|542146447|FG013|Overall Study|Withdrawal by Subject|0|||
150275816|NCT01994382|542146448|FG014|Overall Study|Withdrawal by Subject|4|||
150275817|NCT01994382|542146449|FG015|Overall Study|Withdrawal by Subject|3|||
150275818|NCT01994382|542146450|FG016|Overall Study|Withdrawal by Subject|0|||
150275819|NCT01994382|542146434|FG000|Overall Study|Lost to Follow-up|0|||
150275820|NCT01994382|542146435|FG001|Overall Study|Lost to Follow-up|0|||
150275821|NCT01994382|542146436|FG002|Overall Study|Lost to Follow-up|0|||
150275822|NCT01994382|542146437|FG003|Overall Study|Lost to Follow-up|0|||
150275823|NCT01994382|542146438|FG004|Overall Study|Lost to Follow-up|0|||
150275824|NCT01994382|542146439|FG005|Overall Study|Lost to Follow-up|0|||
150275825|NCT01994382|542146440|FG006|Overall Study|Lost to Follow-up|0|||
150275826|NCT01994382|542146441|FG007|Overall Study|Lost to Follow-up|0|||
150275827|NCT01994382|542146442|FG008|Overall Study|Lost to Follow-up|0|||
150275828|NCT01994382|542146443|FG009|Overall Study|Lost to Follow-up|0|||
150275829|NCT01994382|542146444|FG010|Overall Study|Lost to Follow-up|1|||
149827264|NCT01058421|540498336|FG000|1 Month Outcomes|Remained in Hospital|5|||
149827265|NCT01058421|540498337|FG001|1 Month Outcomes|Remained in Hospital|12|||
150275830|NCT01994382|542146445|FG011|Overall Study|Lost to Follow-up|0|||
150275831|NCT01994382|542146446|FG012|Overall Study|Lost to Follow-up|0|||
150275832|NCT01994382|542146447|FG013|Overall Study|Lost to Follow-up|0|||
150275833|NCT01994382|542146448|FG014|Overall Study|Lost to Follow-up|0|||
150275834|NCT01994382|542146449|FG015|Overall Study|Lost to Follow-up|0|||
150275835|NCT01994382|542146450|FG016|Overall Study|Lost to Follow-up|0|||
150275836|NCT01994382|542146434|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275837|NCT01994382|542146435|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149827266|NCT01058421|540498336|FG000|1 Month Outcomes|Remained in Other Facility|16|||
149827267|NCT01058421|540498337|FG001|1 Month Outcomes|Remained in Other Facility|17|||
150275838|NCT01994382|542146436|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275839|NCT01994382|542146437|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275840|NCT01994382|542146438|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275841|NCT01994382|542146439|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275842|NCT01994382|542146440|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275843|NCT01994382|542146441|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275844|NCT01994382|542146442|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275845|NCT01994382|542146443|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275846|NCT01994382|542146444|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
150275847|NCT01994382|542146445|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149827268|NCT01058421|540498336|FG000|3 Month Outcomes|Death|3|||
149827269|NCT01058421|540498337|FG001|3 Month Outcomes|Death|5|||
149827270|NCT01058421|540498336|FG000|3 Month Outcomes|Lost to Follow-up|12|||
149827271|NCT01058421|540498337|FG001|3 Month Outcomes|Lost to Follow-up|11|||
149827272|NCT01058421|540498336|FG000|3 Month Outcomes|Remained in Hospital|0|||
149827273|NCT01058421|540498337|FG001|3 Month Outcomes|Remained in Hospital|2|||
149827274|NCT01058421|540498336|FG000|3 Month Outcomes|Remained in Other Facility|5|||
149827275|NCT01058421|540498337|FG001|3 Month Outcomes|Remained in Other Facility|8|||
149827276|NCT01058421|540498336|FG000|6 Month Outcomes|Death|2|||
149827277|NCT01058421|540498337|FG001|6 Month Outcomes|Death|2|||
149827278|NCT01058421|540498336|FG000|6 Month Outcomes|Lost to Follow-up|16|||
149827279|NCT01058421|540498337|FG001|6 Month Outcomes|Lost to Follow-up|21|||
149827280|NCT01058421|540498336|FG000|6 Month Outcomes|Remained in Other Facility|1|||
149827281|NCT01058421|540498337|FG001|6 Month Outcomes|Remained in Other Facility|3|||
149827282|NCT02984683|540498340|FG000|Overall Study|Adverse Event|3|||
149827283|NCT02984683|540498341|FG001|Overall Study|Adverse Event|3|||
149827284|NCT02984683|540498340|FG000|Overall Study|Withdrawal by Subject|1|||
149827285|NCT02984683|540498341|FG001|Overall Study|Withdrawal by Subject|0|||
149827286|NCT02984683|540498340|FG000|Overall Study|Disease progression|7|||
149827287|NCT02984683|540498341|FG001|Overall Study|Disease progression|9|||
149827288|NCT01592370|540498342|FG000|Overall Study|Disease Progression|62|||
149827289|NCT01592370|540498343|FG001|Overall Study|Disease Progression|16|||
149827290|NCT01592370|540498344|FG002|Overall Study|Disease Progression|52|||
149827291|NCT01592370|540498345|FG003|Overall Study|Disease Progression|3|||
149827292|NCT01592370|540498346|FG004|Overall Study|Disease Progression|3|||
149827293|NCT01592370|540498347|FG005|Overall Study|Disease Progression|31|||
149827294|NCT01592370|540498348|FG006|Overall Study|Disease Progression|14|||
149827295|NCT01592370|540498342|FG000|Overall Study|Study Drug Toxicity|14|||
149827296|NCT01592370|540498343|FG001|Overall Study|Study Drug Toxicity|3|||
149827297|NCT01592370|540498344|FG002|Overall Study|Study Drug Toxicity|0|||
149827298|NCT01592370|540498345|FG003|Overall Study|Study Drug Toxicity|0|||
149827299|NCT01592370|540498346|FG004|Overall Study|Study Drug Toxicity|0|||
149827300|NCT01592370|540498347|FG005|Overall Study|Study Drug Toxicity|0|||
149827301|NCT01592370|540498348|FG006|Overall Study|Study Drug Toxicity|1|||
149827302|NCT01592370|540498342|FG000|Overall Study|AE unrelated to study drug|4|||
149827303|NCT01592370|540498343|FG001|Overall Study|AE unrelated to study drug|3|||
149827304|NCT01592370|540498344|FG002|Overall Study|AE unrelated to study drug|0|||
149827305|NCT01592370|540498345|FG003|Overall Study|AE unrelated to study drug|0|||
149827306|NCT01592370|540498346|FG004|Overall Study|AE unrelated to study drug|0|||
149827307|NCT01592370|540498347|FG005|Overall Study|AE unrelated to study drug|0|||
149827308|NCT01592370|540498348|FG006|Overall Study|AE unrelated to study drug|1|||
149827309|NCT01592370|540498342|FG000|Overall Study|Request to discontinue study treatment|5|||
149827310|NCT01592370|540498343|FG001|Overall Study|Request to discontinue study treatment|0|||
149827311|NCT01592370|540498344|FG002|Overall Study|Request to discontinue study treatment|2|||
149827312|NCT01592370|540498345|FG003|Overall Study|Request to discontinue study treatment|0|||
149827313|NCT01592370|540498346|FG004|Overall Study|Request to discontinue study treatment|1|||
149827314|NCT01592370|540498347|FG005|Overall Study|Request to discontinue study treatment|2|||
149827315|NCT01592370|540498348|FG006|Overall Study|Request to discontinue study treatment|0|||
149827316|NCT01592370|540498342|FG000|Overall Study|Withdrew consent|1|||
149827317|NCT01592370|540498343|FG001|Overall Study|Withdrew consent|2|||
149827318|NCT01592370|540498344|FG002|Overall Study|Withdrew consent|1|||
149827319|NCT01592370|540498345|FG003|Overall Study|Withdrew consent|1|||
149827320|NCT01592370|540498346|FG004|Overall Study|Withdrew consent|0|||
149827321|NCT01592370|540498347|FG005|Overall Study|Withdrew consent|0|||
149827322|NCT01592370|540498348|FG006|Overall Study|Withdrew consent|0|||
149827323|NCT01592370|540498342|FG000|Overall Study|Maximum clinical benefit|11|||
149827324|NCT01592370|540498343|FG001|Overall Study|Maximum clinical benefit|1|||
149827325|NCT01592370|540498344|FG002|Overall Study|Maximum clinical benefit|7|||
149827326|NCT01592370|540498345|FG003|Overall Study|Maximum clinical benefit|1|||
149827327|NCT01592370|540498346|FG004|Overall Study|Maximum clinical benefit|0|||
149827328|NCT01592370|540498347|FG005|Overall Study|Maximum clinical benefit|0|||
149827329|NCT01592370|540498348|FG006|Overall Study|Maximum clinical benefit|0|||
149827330|NCT01592370|540498342|FG000|Overall Study|No longer meets study criteria|1|||
150033204|NCT01247324|541260916|FG000|Overall Study|Consent withdrawn by participant|41|||
150033205|NCT01247324|541260917|FG001|Overall Study|Consent withdrawn by participant|56|||
149827331|NCT01592370|540498343|FG001|Overall Study|No longer meets study criteria|0|||
149827332|NCT01592370|540498344|FG002|Overall Study|No longer meets study criteria|0|||
149827333|NCT01592370|540498345|FG003|Overall Study|No longer meets study criteria|0|||
149827334|NCT01592370|540498346|FG004|Overall Study|No longer meets study criteria|0|||
149827335|NCT01592370|540498347|FG005|Overall Study|No longer meets study criteria|0|||
149827336|NCT01592370|540498348|FG006|Overall Study|No longer meets study criteria|0|||
149827337|NCT01592370|540498342|FG000|Overall Study|Other Reasons|6|||
149827338|NCT01592370|540498343|FG001|Overall Study|Other Reasons|0|||
149827339|NCT01592370|540498344|FG002|Overall Study|Other Reasons|10|||
149827340|NCT01592370|540498345|FG003|Overall Study|Other Reasons|0|||
149827341|NCT01592370|540498346|FG004|Overall Study|Other Reasons|0|||
149827342|NCT01592370|540498347|FG005|Overall Study|Other Reasons|1|||
149827343|NCT01592370|540498348|FG006|Overall Study|Other Reasons|0|||
149827344|NCT01592370|540498342|FG000|Overall Study|Not Treated|0|||
149827345|NCT01592370|540498343|FG001|Overall Study|Not Treated|0|||
149827346|NCT01592370|540498344|FG002|Overall Study|Not Treated|0|||
149827347|NCT01592370|540498345|FG003|Overall Study|Not Treated|0|||
149827348|NCT01592370|540498346|FG004|Overall Study|Not Treated|2|||
149827349|NCT01592370|540498347|FG005|Overall Study|Not Treated|2|||
149827350|NCT01592370|540498348|FG006|Overall Study|Not Treated|0|||
149827351|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
149827352|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
149827353|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
149827354|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
149827355|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
149827356|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
149827357|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
149827358|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
149827359|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
149827360|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
149827361|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
149827362|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
149827363|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
149827364|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
149827365|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
149827366|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
149827367|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
149827368|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
149827369|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
149827370|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
149827371|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
149827372|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
149827373|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
149827374|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
149827375|NCT00455533|540498351|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
149827376|NCT00455533|540498352|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
149827377|NCT00455533|540498353|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
149827378|NCT00455533|540498351|FG000|Period Two: Randomized Period|Death|0|||
149827379|NCT00455533|540498352|FG001|Period Two: Randomized Period|Death|0|||
149827380|NCT00455533|540498353|FG002|Period Two: Randomized Period|Death|3|||
149827381|NCT00455533|540498351|FG000|Period Two: Randomized Period|Disease Progression|0|||
149827382|NCT00455533|540498352|FG001|Period Two: Randomized Period|Disease Progression|1|||
149827383|NCT00455533|540498353|FG002|Period Two: Randomized Period|Disease Progression|1|||
149827384|NCT00455533|540498351|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
149827385|NCT00455533|540498352|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
149827386|NCT00455533|540498353|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
149827387|NCT00455533|540498351|FG000|Period Two: Randomized Period|Other - need reasons|0|||
149827388|NCT00455533|540498352|FG001|Period Two: Randomized Period|Other - need reasons|1|||
149946240|NCT03034967|540936258|FG000|Overall Study|Withdrawal by Subject|9|||
149946241|NCT03034967|540936259|FG001|Overall Study|Withdrawal by Subject|2|||
149946242|NCT03034967|540936260|FG002|Overall Study|Withdrawal by Subject|6|||
149946243|NCT03034967|540936261|FG003|Overall Study|Withdrawal by Subject|6|||
149946244|NCT03034967|540936262|FG004|Overall Study|Withdrawal by Subject|9|||
149946245|NCT03034967|540936263|FG005|Overall Study|Withdrawal by Subject|2|||
149946246|NCT03034967|540936258|FG000|Overall Study|Physician Decision|1|||
149946247|NCT03034967|540936259|FG001|Overall Study|Physician Decision|0|||
149946248|NCT03034967|540936260|FG002|Overall Study|Physician Decision|1|||
149946249|NCT03034967|540936261|FG003|Overall Study|Physician Decision|1|||
149946250|NCT03034967|540936262|FG004|Overall Study|Physician Decision|1|||
149946251|NCT03034967|540936263|FG005|Overall Study|Physician Decision|0|||
149827389|NCT00455533|540498353|FG002|Period Two: Randomized Period|Other - need reasons|0|||
149946252|NCT03034967|540936258|FG000|Overall Study|Lost to Follow-up|0|||
149946253|NCT03034967|540936259|FG001|Overall Study|Lost to Follow-up|0|||
149827390|NCT00455533|540498351|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
149827391|NCT00455533|540498352|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
149827392|NCT00455533|540498353|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
149827393|NCT00455533|540498351|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
149827394|NCT00455533|540498352|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
149827395|NCT00455533|540498353|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
149827396|NCT02415959|540498358|FG000|Overall Study|Adverse Event|0|||
149827397|NCT02415959|540498359|FG001|Overall Study|Adverse Event|1|||
149827398|NCT02415959|540498360|FG002|Overall Study|Adverse Event|0|||
149827399|NCT02415959|540498361|FG003|Overall Study|Adverse Event|0|||
149827400|NCT02415959|540498362|FG004|Overall Study|Adverse Event|0|||
149827401|NCT02415959|540498358|FG000|Overall Study|Protocol Violation|0|||
149827402|NCT02415959|540498359|FG001|Overall Study|Protocol Violation|0|||
149827403|NCT02415959|540498360|FG002|Overall Study|Protocol Violation|0|||
149827404|NCT02415959|540498361|FG003|Overall Study|Protocol Violation|1|||
149827405|NCT02415959|540498362|FG004|Overall Study|Protocol Violation|0|||
149827406|NCT01048333|540498363|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
149827407|NCT01048333|540498364|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
149827408|NCT01048333|540498365|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
149827409|NCT01048333|540498366|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
149827410|NCT01048333|540498367|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
149827411|NCT01048333|540498368|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
149827412|NCT03008460|540498373|FG000|Overall Study|Protocol deviation|0|||
149827413|NCT03008460|540498374|FG001|Overall Study|Protocol deviation|2|||
149827414|NCT03008460|540498373|FG000|Overall Study|Study drug not dispensed|0|||
149827415|NCT03008460|540498374|FG001|Overall Study|Study drug not dispensed|1|||
149827416|NCT03008460|540498373|FG000|Overall Study|Adverse Event|0|||
149827417|NCT03008460|540498374|FG001|Overall Study|Adverse Event|1|||
149827418|NCT03008460|540498373|FG000|Overall Study|Withdrawal by Subject|5|||
149827419|NCT03008460|540498374|FG001|Overall Study|Withdrawal by Subject|6|||
149827420|NCT03008460|540498373|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
149827421|NCT03008460|540498374|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
149827422|NCT03008460|540498373|FG000|Overall Study|End of study visit outside permitted time window|0|||
149827423|NCT03008460|540498374|FG001|Overall Study|End of study visit outside permitted time window|1|||
149827424|NCT03008460|540498373|FG000|Overall Study|Lost to Follow-up|1|||
149827425|NCT03008460|540498374|FG001|Overall Study|Lost to Follow-up|3|||
149827426|NCT02260492|540498377|FG000|Overall Study|Adverse Event|6|||
149827427|NCT02260492|540498378|FG001|Overall Study|Adverse Event|1|||
149827428|NCT02260492|540498379|FG002|Overall Study|Adverse Event|2|||
149827429|NCT02260492|540498377|FG000|Overall Study|Death|0|||
149827430|NCT02260492|540498378|FG001|Overall Study|Death|1|||
149827431|NCT02260492|540498379|FG002|Overall Study|Death|0|||
149827432|NCT02260492|540498377|FG000|Overall Study|Lost to Follow-up|12|||
149827433|NCT02260492|540498378|FG001|Overall Study|Lost to Follow-up|9|||
149827434|NCT02260492|540498379|FG002|Overall Study|Lost to Follow-up|0|||
149827435|NCT02260492|540498377|FG000|Overall Study|Physician Decision|2|||
149827436|NCT02260492|540498378|FG001|Overall Study|Physician Decision|0|||
149827437|NCT02260492|540498379|FG002|Overall Study|Physician Decision|1|||
149827438|NCT02260492|540498377|FG000|Overall Study|Withdrawal by Subject|3|||
149827439|NCT02260492|540498378|FG001|Overall Study|Withdrawal by Subject|2|||
149827440|NCT02260492|540498379|FG002|Overall Study|Withdrawal by Subject|2|||
149827441|NCT00996736|540498380|FG000|Overall Study|Death|1|||
149827442|NCT00996736|540498381|FG001|Overall Study|Death|1|||
149827443|NCT00996736|540498380|FG000|Overall Study|Lost to Follow-up|15|||
149827444|NCT00996736|540498381|FG001|Overall Study|Lost to Follow-up|14|||
149827445|NCT00996736|540498380|FG000|Overall Study|Visit not within 3-month window|5|||
149827446|NCT00996736|540498381|FG001|Overall Study|Visit not within 3-month window|3|||
149827447|NCT02346201|540498383|FG000|Overall Study|Adverse Event|3|||
149827448|NCT02346201|540498384|FG001|Overall Study|Adverse Event|2|||
149827449|NCT02346201|540498383|FG000|Overall Study|Lost to Follow-up|1|||
149827450|NCT02346201|540498384|FG001|Overall Study|Lost to Follow-up|0|||
149827451|NCT02346201|540498383|FG000|Overall Study|Withdrawal by Subject|6|||
149827452|NCT02346201|540498384|FG001|Overall Study|Withdrawal by Subject|3|||
149827453|NCT02346201|540498383|FG000|Overall Study|Unavailable for future follow-up|0|||
149827454|NCT02346201|540498384|FG001|Overall Study|Unavailable for future follow-up|1|||
149827455|NCT02346201|540498383|FG000|Overall Study|Physician Decision|0|||
149827456|NCT02346201|540498384|FG001|Overall Study|Physician Decision|1|||
149827457|NCT02346201|540498383|FG000|Overall Study|Missed final visit|0|||
149827458|NCT02346201|540498384|FG001|Overall Study|Missed final visit|2|||
149827459|NCT03708211|540498385|FG000|Overall Study|Progressive Disease|10|||
149827460|NCT03708211|540498386|FG001|Overall Study|Progressive Disease|7|||
149827461|NCT03708211|540498385|FG000|Overall Study|Withdrawal by Subject|0|||
149946254|NCT03034967|540936260|FG002|Overall Study|Lost to Follow-up|0|||
149946255|NCT03034967|540936261|FG003|Overall Study|Lost to Follow-up|1|||
149946256|NCT03034967|540936262|FG004|Overall Study|Lost to Follow-up|0|||
149827462|NCT03708211|540498386|FG001|Overall Study|Withdrawal by Subject|1|||
149827463|NCT03708211|540498385|FG000|Overall Study|Other|2|||
149827464|NCT03708211|540498386|FG001|Overall Study|Other|0|||
149827465|NCT00462982|540498387|FG000|Overall Study|Adverse Event|1|||
149827466|NCT00462982|540498387|FG000|Overall Study|Patient Not Treated|2|||
149827467|NCT00409578|540498388|FG000|Overall Study|Adverse Event|27|||
149827468|NCT00409578|540498389|FG001|Overall Study|Adverse Event|37|||
149827469|NCT00409578|540498390|FG002|Overall Study|Adverse Event|25|||
149827470|NCT00409578|540498391|FG003|Overall Study|Adverse Event|33|||
149827471|NCT00409578|540498388|FG000|Overall Study|Abnormal laboratory value(s)|2|||
149827472|NCT00409578|540498389|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149827473|NCT00409578|540498390|FG002|Overall Study|Abnormal laboratory value(s)|2|||
149827474|NCT00409578|540498391|FG003|Overall Study|Abnormal laboratory value(s)|4|||
149827475|NCT00409578|540498388|FG000|Overall Study|Lack of Efficacy|0|||
149827476|NCT00409578|540498389|FG001|Overall Study|Lack of Efficacy|0|||
149827477|NCT00409578|540498390|FG002|Overall Study|Lack of Efficacy|0|||
149827478|NCT00409578|540498391|FG003|Overall Study|Lack of Efficacy|2|||
149827479|NCT00409578|540498388|FG000|Overall Study|Subject no longer requires study drug|0|||
149827480|NCT00409578|540498389|FG001|Overall Study|Subject no longer requires study drug|0|||
149827481|NCT00409578|540498390|FG002|Overall Study|Subject no longer requires study drug|0|||
149827482|NCT00409578|540498391|FG003|Overall Study|Subject no longer requires study drug|1|||
149827483|NCT00409578|540498388|FG000|Overall Study|Withdrawal by Subject|8|||
149827484|NCT00409578|540498389|FG001|Overall Study|Withdrawal by Subject|15|||
149827485|NCT00409578|540498390|FG002|Overall Study|Withdrawal by Subject|16|||
149827486|NCT00409578|540498391|FG003|Overall Study|Withdrawal by Subject|17|||
149827487|NCT00409578|540498388|FG000|Overall Study|Lost to Follow-up|2|||
149827488|NCT00409578|540498389|FG001|Overall Study|Lost to Follow-up|0|||
149827489|NCT00409578|540498390|FG002|Overall Study|Lost to Follow-up|2|||
149827490|NCT00409578|540498391|FG003|Overall Study|Lost to Follow-up|2|||
149827491|NCT00409578|540498388|FG000|Overall Study|Administrative problems|8|||
149827492|NCT00409578|540498389|FG001|Overall Study|Administrative problems|9|||
149827493|NCT00409578|540498390|FG002|Overall Study|Administrative problems|2|||
149827494|NCT00409578|540498391|FG003|Overall Study|Administrative problems|4|||
149827495|NCT00409578|540498388|FG000|Overall Study|Death|2|||
149827496|NCT00409578|540498389|FG001|Overall Study|Death|4|||
149827497|NCT00409578|540498390|FG002|Overall Study|Death|4|||
149827498|NCT00409578|540498391|FG003|Overall Study|Death|2|||
149827499|NCT00409578|540498388|FG000|Overall Study|Protocol Violation|3|||
149827500|NCT00409578|540498389|FG001|Overall Study|Protocol Violation|2|||
149827501|NCT00409578|540498390|FG002|Overall Study|Protocol Violation|3|||
149827502|NCT00409578|540498391|FG003|Overall Study|Protocol Violation|1|||
149827503|NCT00409578|540498388|FG000|Overall Study|Missing|0|||
149827504|NCT00409578|540498389|FG001|Overall Study|Missing|1|||
149827505|NCT00409578|540498390|FG002|Overall Study|Missing|0|||
149827506|NCT00409578|540498391|FG003|Overall Study|Missing|1|||
149827507|NCT00770315|540498392|FG000|Overall Study|Adverse Event|11|||
149827508|NCT00770315|540498393|FG001|Overall Study|Adverse Event|17|||
149827509|NCT00770315|540498394|FG002|Overall Study|Adverse Event|16|||
149827510|NCT00770315|540498395|FG003|Overall Study|Adverse Event|6|||
149827511|NCT00770315|540498392|FG000|Overall Study|Lost to Follow-up|9|||
149827512|NCT00770315|540498393|FG001|Overall Study|Lost to Follow-up|5|||
149827513|NCT00770315|540498394|FG002|Overall Study|Lost to Follow-up|10|||
149827514|NCT00770315|540498395|FG003|Overall Study|Lost to Follow-up|3|||
149827515|NCT00770315|540498392|FG000|Overall Study|Withdrawal by Subject|13|||
149827516|NCT00770315|540498393|FG001|Overall Study|Withdrawal by Subject|17|||
149827517|NCT00770315|540498394|FG002|Overall Study|Withdrawal by Subject|24|||
149827518|NCT00770315|540498395|FG003|Overall Study|Withdrawal by Subject|20|||
149827519|NCT00770315|540498392|FG000|Overall Study|Noncompliance with Protocol|7|||
149827520|NCT00770315|540498393|FG001|Overall Study|Noncompliance with Protocol|4|||
149827521|NCT00770315|540498394|FG002|Overall Study|Noncompliance with Protocol|7|||
149827522|NCT00770315|540498395|FG003|Overall Study|Noncompliance with Protocol|9|||
149827523|NCT04256421|540498396|FG000|Overall Study|Death|171|||
149827524|NCT04256421|540498397|FG001|Overall Study|Death|180|||
149827525|NCT04256421|540498396|FG000|Overall Study|Lost to Follow-up|1|||
149827526|NCT04256421|540498397|FG001|Overall Study|Lost to Follow-up|1|||
149827527|NCT04256421|540498396|FG000|Overall Study|Withdrawal by Subject|9|||
149827528|NCT04256421|540498397|FG001|Overall Study|Withdrawal by Subject|10|||
149827529|NCT04256421|540498396|FG000|Overall Study|Ongoing in Study|66|||
149827530|NCT04256421|540498397|FG001|Overall Study|Ongoing in Study|52|||
149827531|NCT02785913|540500261|FG000|Overall Study|Adverse Event|5|||
149827532|NCT02785913|540500261|FG000|Overall Study|Death|2|||
149827533|NCT02785913|540500261|FG000|Overall Study|Progression|18|||
149827534|NCT02785913|540500261|FG000|Overall Study|Not protocol specified|1|||
149827535|NCT02841709|540500262|FG000|5th Intervention|Adverse Event|2|||
149827536|NCT02841709|540500263|FG001|5th Intervention|Adverse Event|0|||
149827537|NCT02841709|540500264|FG002|5th Intervention|Adverse Event|0|||
149827538|NCT02841709|540500265|FG003|5th Intervention|Adverse Event|0|||
149827539|NCT02841709|540500266|FG004|5th Intervention|Adverse Event|2|||
149827540|NCT01929109|540500267|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
149827541|NCT01929109|540500268|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
149827542|NCT01929109|540500269|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
149827543|NCT01929109|540500270|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
149827544|NCT01929109|540500271|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
149827545|NCT01402908|540500272|FG000|Overall Study|Withdrawal by Subject|30|||
149827546|NCT01402908|540500273|FG001|Overall Study|Withdrawal by Subject|17|||
149827547|NCT01402908|540500272|FG000|Overall Study|Lost to Follow-up|3|||
149827548|NCT01402908|540500273|FG001|Overall Study|Lost to Follow-up|1|||
149827549|NCT01402908|540500272|FG000|Overall Study|Physician Decision|1|||
149827550|NCT01402908|540500273|FG001|Overall Study|Physician Decision|0|||
149827551|NCT01739790|540500274|FG000|Overall Study|Early Trial Termination|2|||
149827552|NCT01739790|540500275|FG001|Overall Study|Early Trial Termination|4|||
149827553|NCT02581345|540500276|FG000|Part 1: up to Week 16|Adverse Event|3|||
149827554|NCT02581345|540500277|FG001|Part 1: up to Week 16|Adverse Event|8|||
149827555|NCT02581345|540500278|FG002|Part 1: up to Week 16|Adverse Event|0|||
149827556|NCT02581345|540500279|FG003|Part 1: up to Week 16|Adverse Event|0|||
149827557|NCT02581345|540500276|FG000|Part 1: up to Week 16|Physician Decision|2|||
149827558|NCT02581345|540500277|FG001|Part 1: up to Week 16|Physician Decision|4|||
149827559|NCT02581345|540500278|FG002|Part 1: up to Week 16|Physician Decision|0|||
149827560|NCT02581345|540500279|FG003|Part 1: up to Week 16|Physician Decision|0|||
149827561|NCT02581345|540500276|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
149827562|NCT02581345|540500277|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
149827563|NCT02581345|540500278|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
149827564|NCT02581345|540500279|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
149827565|NCT02581345|540500276|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
149827566|NCT02581345|540500277|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
149827567|NCT02581345|540500278|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
149827568|NCT02581345|540500279|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
149827569|NCT02581345|540500276|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
149827570|NCT02581345|540500277|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
149827571|NCT02581345|540500278|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
149827572|NCT02581345|540500279|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
149827573|NCT02581345|540500276|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
149827574|NCT02581345|540500277|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
149827575|NCT02581345|540500278|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
149827576|NCT02581345|540500279|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
149827577|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
149827578|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
149827579|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
149827580|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
149827581|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
149827582|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
149827583|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
149827584|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
149827585|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
149827586|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
149827587|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
149827588|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
149827589|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
149827590|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
149827591|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
149827592|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
149827593|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
149827594|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
149827595|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
150275848|NCT01994382|542146446|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
150275849|NCT01994382|542146447|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275850|NCT01994382|542146448|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
150275851|NCT01994382|542146449|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
150275852|NCT01994382|542146450|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
149827596|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
149827597|NCT02581345|540500276|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
149827598|NCT02581345|540500277|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
149827599|NCT02581345|540500278|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
149827600|NCT02581345|540500279|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
149827601|NCT03471078|540500286|FG000|Overall Study|Withdrawal by Subject|9|||
149827602|NCT03471078|540500287|FG001|Overall Study|Withdrawal by Subject|1|||
149827603|NCT03471078|540500286|FG000|Overall Study|Adverse Event|4|||
149827604|NCT03471078|540500287|FG001|Overall Study|Adverse Event|1|||
149827605|NCT03471078|540500286|FG000|Overall Study|Physician Decision|3|||
149827606|NCT03471078|540500287|FG001|Overall Study|Physician Decision|2|||
149946257|NCT03034967|540936263|FG005|Overall Study|Lost to Follow-up|2|||
150033206|NCT01247324|541260916|FG000|Overall Study|Adverse Event|49|||
150275853|NCT01994382|542146434|FG000|Overall Study|Protocol violation/noncompliance|0|||
150275854|NCT01994382|542146435|FG001|Overall Study|Protocol violation/noncompliance|0|||
150275855|NCT01994382|542146436|FG002|Overall Study|Protocol violation/noncompliance|0|||
150275856|NCT01994382|542146437|FG003|Overall Study|Protocol violation/noncompliance|0|||
150275857|NCT01994382|542146438|FG004|Overall Study|Protocol violation/noncompliance|0|||
150275858|NCT01994382|542146439|FG005|Overall Study|Protocol violation/noncompliance|0|||
150275859|NCT01994382|542146440|FG006|Overall Study|Protocol violation/noncompliance|0|||
150275860|NCT01994382|542146441|FG007|Overall Study|Protocol violation/noncompliance|0|||
150275861|NCT01994382|542146442|FG008|Overall Study|Protocol violation/noncompliance|0|||
150275862|NCT01994382|542146443|FG009|Overall Study|Protocol violation/noncompliance|0|||
150275863|NCT01994382|542146444|FG010|Overall Study|Protocol violation/noncompliance|0|||
150275864|NCT01994382|542146445|FG011|Overall Study|Protocol violation/noncompliance|1|||
150275865|NCT01994382|542146446|FG012|Overall Study|Protocol violation/noncompliance|0|||
150275866|NCT01994382|542146447|FG013|Overall Study|Protocol violation/noncompliance|0|||
149946258|NCT03034967|540936258|FG000|Overall Study|Liver function test abnormality|0|||
149946259|NCT03034967|540936259|FG001|Overall Study|Liver function test abnormality|0|||
149946260|NCT03034967|540936260|FG002|Overall Study|Liver function test abnormality|1|||
149946261|NCT03034967|540936261|FG003|Overall Study|Liver function test abnormality|0|||
149946262|NCT03034967|540936262|FG004|Overall Study|Liver function test abnormality|0|||
149946263|NCT03034967|540936263|FG005|Overall Study|Liver function test abnormality|0|||
149946264|NCT03034967|540936258|FG000|Overall Study|Protocol Violation|1|||
149946265|NCT03034967|540936259|FG001|Overall Study|Protocol Violation|0|||
149946266|NCT03034967|540936260|FG002|Overall Study|Protocol Violation|0|||
149946267|NCT03034967|540936261|FG003|Overall Study|Protocol Violation|0|||
149946268|NCT03034967|540936262|FG004|Overall Study|Protocol Violation|0|||
149946269|NCT03034967|540936263|FG005|Overall Study|Protocol Violation|2|||
149946270|NCT03034967|540936258|FG000|Overall Study|Lack of Efficacy|0|||
149946271|NCT03034967|540936259|FG001|Overall Study|Lack of Efficacy|1|||
149946272|NCT03034967|540936260|FG002|Overall Study|Lack of Efficacy|2|||
149946273|NCT03034967|540936261|FG003|Overall Study|Lack of Efficacy|1|||
149946274|NCT03034967|540936262|FG004|Overall Study|Lack of Efficacy|1|||
149946275|NCT03034967|540936263|FG005|Overall Study|Lack of Efficacy|0|||
149946276|NCT03034967|540936258|FG000|Overall Study|Adverse Event, non-fatal|3|||
149946277|NCT03034967|540936259|FG001|Overall Study|Adverse Event, non-fatal|1|||
149946278|NCT03034967|540936260|FG002|Overall Study|Adverse Event, non-fatal|2|||
149946279|NCT03034967|540936261|FG003|Overall Study|Adverse Event, non-fatal|0|||
149946280|NCT03034967|540936262|FG004|Overall Study|Adverse Event, non-fatal|2|||
149946281|NCT03034967|540936263|FG005|Overall Study|Adverse Event, non-fatal|8|||
149946282|NCT03034967|540936258|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
149946283|NCT03034967|540936259|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
149946284|NCT03034967|540936260|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
149946285|NCT03034967|540936261|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
149946286|NCT03034967|540936262|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
149946287|NCT03034967|540936263|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
149946288|NCT03806296|540936264|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
149946289|NCT03806296|540936265|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
149946290|NCT03806296|540936266|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
149946291|NCT03806296|540936264|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
149946292|NCT03806296|540936265|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
149946293|NCT03806296|540936266|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
149946294|NCT03806296|540936264|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
149946295|NCT03806296|540936265|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
149946296|NCT03806296|540936266|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
149946297|NCT02763566|540936282|FG000|Overall Study|Lost to Follow-up|1|||
149946298|NCT02763566|540936283|FG001|Overall Study|Lost to Follow-up|4|||
149946299|NCT02763566|540936284|FG002|Overall Study|Lost to Follow-up|0|||
149946300|NCT02763566|540936285|FG003|Overall Study|Lost to Follow-up|1|||
149946301|NCT02763566|540936282|FG000|Overall Study|On study treatment at study conclusion|114|||
149946302|NCT02763566|540936283|FG001|Overall Study|On study treatment at study conclusion|34|||
149946303|NCT02763566|540936284|FG002|Overall Study|On study treatment at study conclusion|54|||
149946304|NCT02763566|540936285|FG003|Overall Study|On study treatment at study conclusion|13|||
149946305|NCT02763566|540936282|FG000|Overall Study|Withdrawal by Subject|3|||
149946306|NCT02763566|540936283|FG001|Overall Study|Withdrawal by Subject|1|||
149946307|NCT02763566|540936284|FG002|Overall Study|Withdrawal by Subject|0|||
149946308|NCT02763566|540936285|FG003|Overall Study|Withdrawal by Subject|0|||
149946309|NCT00790036|540936286|FG000|Overall Study|Abnormal lab values|3|||
149946310|NCT00790036|540936287|FG001|Overall Study|Abnormal lab values|2|||
149946311|NCT00790036|540936286|FG000|Overall Study|Administrative problems|5|||
149946312|NCT00790036|540936287|FG001|Overall Study|Administrative problems|9|||
149946313|NCT00790036|540936286|FG000|Overall Study|Adverse Event|113|||
150033207|NCT01247324|541260917|FG001|Overall Study|Adverse Event|35|||
150275867|NCT01994382|542146448|FG014|Overall Study|Protocol violation/noncompliance|0|||
149827607|NCT03471078|540500286|FG000|Overall Study|Death|2|||
149827608|NCT03471078|540500287|FG001|Overall Study|Death|0|||
149827609|NCT03471078|540500286|FG000|Overall Study|Other|3|||
149827610|NCT03471078|540500287|FG001|Overall Study|Other|2|||
149827611|NCT05568225|540500293|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
149827612|NCT05568225|540500294|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
149827613|NCT05568225|540500295|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
149827614|NCT05568225|540500293|FG000|Primary Treatment Period|Physician Decision|0|||
149827615|NCT05568225|540500294|FG001|Primary Treatment Period|Physician Decision|1|||
149827616|NCT05568225|540500295|FG002|Primary Treatment Period|Physician Decision|0|||
149827617|NCT05568225|540500293|FG000|Primary Treatment Period|Disease progression|0|||
149827618|NCT05568225|540500294|FG001|Primary Treatment Period|Disease progression|1|||
149827619|NCT05568225|540500295|FG002|Primary Treatment Period|Disease progression|0|||
149827620|NCT05568225|540500293|FG000|Primary Treatment Period|Lack of Efficacy|0|||
149827621|NCT05568225|540500294|FG001|Primary Treatment Period|Lack of Efficacy|1|||
149827622|NCT05568225|540500295|FG002|Primary Treatment Period|Lack of Efficacy|0|||
149827623|NCT05568225|540500293|FG000|Primary Treatment Period|Withdrawal of conset|1|||
149827624|NCT05568225|540500294|FG001|Primary Treatment Period|Withdrawal of conset|0|||
149827625|NCT05568225|540500295|FG002|Primary Treatment Period|Withdrawal of conset|4|||
149827626|NCT05568225|540500293|FG000|Primary Treatment Period|Adverse Event|1|||
149827627|NCT05568225|540500294|FG001|Primary Treatment Period|Adverse Event|0|||
149827628|NCT05568225|540500295|FG002|Primary Treatment Period|Adverse Event|0|||
149827629|NCT05568225|540500293|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
149827630|NCT05568225|540500294|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
149827631|NCT05568225|540500295|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
149827632|NCT05568225|540500293|FG000|Extension Treatment Period|Protocol Violation|0|||
149827633|NCT05568225|540500294|FG001|Extension Treatment Period|Protocol Violation|0|||
149827634|NCT05568225|540500295|FG002|Extension Treatment Period|Protocol Violation|1|||
149827635|NCT05568225|540500293|FG000|Extension Treatment Period|Lack of Efficacy|0|||
149827636|NCT05568225|540500294|FG001|Extension Treatment Period|Lack of Efficacy|0|||
149827637|NCT05568225|540500295|FG002|Extension Treatment Period|Lack of Efficacy|1|||
149827638|NCT02309099|540500308|FG000|Overall Study|Adverse Event|2|||
149827639|NCT02309099|540500309|FG001|Overall Study|Adverse Event|0|||
149827640|NCT02819362|540500311|FG000|Overall Study|On-site MRI could not be performed|70|||
149827641|NCT05301751|540500312|FG000|Overall Study|Withdrawal by Subject|0|||
149827642|NCT05301751|540500313|FG001|Overall Study|Withdrawal by Subject|0|||
149827643|NCT05301751|540500314|FG002|Overall Study|Withdrawal by Subject|1|||
149827644|NCT05301751|540500315|FG003|Overall Study|Withdrawal by Subject|0|||
149827645|NCT00797108|540500316|FG000|Overall Study|Adverse Event|1|||
149827646|NCT00797108|540500317|FG001|Overall Study|Adverse Event|0|||
149827647|NCT00797108|540500318|FG002|Overall Study|Adverse Event|3|||
149827648|NCT00797108|540500316|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
149827649|NCT00797108|540500317|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
149827650|NCT00797108|540500318|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
149827651|NCT00797108|540500316|FG000|Overall Study|Global Deterioration of Health Status|0|||
149827652|NCT00797108|540500317|FG001|Overall Study|Global Deterioration of Health Status|1|||
149827653|NCT00797108|540500318|FG002|Overall Study|Global Deterioration of Health Status|0|||
149827654|NCT00797108|540500316|FG000|Overall Study|Lack of Efficacy|1|||
149827655|NCT00797108|540500317|FG001|Overall Study|Lack of Efficacy|0|||
149827656|NCT00797108|540500318|FG002|Overall Study|Lack of Efficacy|1|||
149827657|NCT00797108|540500316|FG000|Overall Study|Other|0|||
149827658|NCT00797108|540500317|FG001|Overall Study|Other|0|||
149827659|NCT00797108|540500318|FG002|Overall Study|Other|2|||
149827660|NCT00797108|540500316|FG000|Overall Study|Randomized but not Treated|2|||
149827661|NCT00797108|540500317|FG001|Overall Study|Randomized but not Treated|0|||
149827662|NCT00797108|540500318|FG002|Overall Study|Randomized but not Treated|0|||
149827663|NCT03803943|540500324|FG000|Overall Study|Withdrawal by Subject|2|||
149827664|NCT03803943|540500325|FG001|Overall Study|Withdrawal by Subject|2|||
149827665|NCT03803943|540500326|FG002|Overall Study|Withdrawal by Subject|2|||
149827666|NCT03803943|540500327|FG003|Overall Study|Withdrawal by Subject|2|||
149827667|NCT01574248|540500328|FG000|Overall Study|Withdrawal by Subject|2|||
149827668|NCT01574248|540500329|FG001|Overall Study|Withdrawal by Subject|0|||
149827669|NCT01574248|540500328|FG000|Overall Study|Missing primary endpoint data|1|||
149827670|NCT01574248|540500329|FG001|Overall Study|Missing primary endpoint data|0|||
149827671|NCT01781286|540500332|FG000|Overall Study|Lost to Follow-up|0|||
149827672|NCT01781286|540500333|FG001|Overall Study|Lost to Follow-up|0|||
149827673|NCT01781286|540500334|FG002|Overall Study|Lost to Follow-up|0|||
149827674|NCT01781286|540500335|FG003|Overall Study|Lost to Follow-up|0|||
149827675|NCT01781286|540500336|FG004|Overall Study|Lost to Follow-up|0|||
149827676|NCT01781286|540500337|FG005|Overall Study|Lost to Follow-up|1|||
149827677|NCT01781286|540500332|FG000|Overall Study|Time Constraints|2|||
149827678|NCT01781286|540500333|FG001|Overall Study|Time Constraints|0|||
149827679|NCT01781286|540500334|FG002|Overall Study|Time Constraints|2|||
149827680|NCT01781286|540500335|FG003|Overall Study|Time Constraints|0|||
149827681|NCT01781286|540500336|FG004|Overall Study|Time Constraints|0|||
149827682|NCT01781286|540500337|FG005|Overall Study|Time Constraints|0|||
149827683|NCT01781286|540500332|FG000|Overall Study|Noncompliance|0|||
149827684|NCT01781286|540500333|FG001|Overall Study|Noncompliance|0|||
149827685|NCT01781286|540500334|FG002|Overall Study|Noncompliance|0|||
149827686|NCT01781286|540500335|FG003|Overall Study|Noncompliance|1|||
149827687|NCT01781286|540500336|FG004|Overall Study|Noncompliance|0|||
149827688|NCT01781286|540500337|FG005|Overall Study|Noncompliance|0|||
149827689|NCT00995410|540500338|FG000|Overall Study|Adverse Event|51|||
149827690|NCT00995410|540500338|FG000|Overall Study|Withdrawal by Subject|7|||
149827691|NCT00995410|540500338|FG000|Overall Study|Lost to Follow-up|2|||
149827692|NCT00995410|540500338|FG000|Overall Study|Misc|28|||
149827693|NCT03594123|540500339|FG000|Overall Study|Lost to Follow-up|0|||
149827694|NCT03594123|540500340|FG001|Overall Study|Lost to Follow-up|1|||
149827695|NCT03594123|540500339|FG000|Overall Study|Adverse Event|8|||
149827696|NCT03594123|540500340|FG001|Overall Study|Adverse Event|5|||
149827697|NCT03594123|540500339|FG000|Overall Study|Site Terminated by Sponsor|4|||
149827698|NCT03594123|540500340|FG001|Overall Study|Site Terminated by Sponsor|1|||
149827699|NCT03594123|540500339|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
149827700|NCT03594123|540500340|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
149827701|NCT03594123|540500339|FG000|Overall Study|Lack of Efficacy|1|||
149827702|NCT03594123|540500340|FG001|Overall Study|Lack of Efficacy|0|||
149827703|NCT03594123|540500339|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
149827704|NCT03594123|540500340|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
149827705|NCT03365375|540500341|FG000|Overall Study|Withdrawal by Subject|0|||
149827706|NCT03365375|540500342|FG001|Overall Study|Withdrawal by Subject|1|||
149827707|NCT03365375|540500341|FG000|Overall Study|Lost to Follow-up|0|||
149827708|NCT03365375|540500342|FG001|Overall Study|Lost to Follow-up|4|||
149827709|NCT02483975|540500343|FG000|Overall Study|Adverse Event|0|||
149827710|NCT02483975|540500344|FG001|Overall Study|Adverse Event|1|||
149827711|NCT02483975|540500343|FG000|Overall Study|Lost to Follow-up|0|||
149827712|NCT02483975|540500344|FG001|Overall Study|Lost to Follow-up|1|||
149827713|NCT02483975|540500343|FG000|Overall Study|Physician Decision|2|||
149827714|NCT02483975|540500344|FG001|Overall Study|Physician Decision|0|||
149827715|NCT00818883|540500345|FG000|Overall Study|Adverse Event|28|||
149827716|NCT00818883|540500346|FG001|Overall Study|Adverse Event|19|||
149827717|NCT00818883|540500345|FG000|Overall Study|Protocol Violation|2|||
149827718|NCT00818883|540500346|FG001|Overall Study|Protocol Violation|2|||
149827719|NCT00818883|540500345|FG000|Overall Study|Lost to Follow-up|3|||
149827720|NCT00818883|540500346|FG001|Overall Study|Lost to Follow-up|2|||
149827721|NCT00818883|540500345|FG000|Overall Study|Withdrawal by Subject|16|||
149827722|NCT00818883|540500346|FG001|Overall Study|Withdrawal by Subject|14|||
149827723|NCT00818883|540500345|FG000|Overall Study|Lack of Efficacy|0|||
149827724|NCT00818883|540500346|FG001|Overall Study|Lack of Efficacy|2|||
149827725|NCT00818883|540500345|FG000|Overall Study|Other|2|||
149827726|NCT00818883|540500346|FG001|Overall Study|Other|7|||
149827727|NCT02166697|540500347|FG000|Overall Study|Protocol Violation|347|||
149827728|NCT01505530|540500351|FG000|Overall Study|Progressive Disease|19|||
149827729|NCT01505530|540500352|FG001|Overall Study|Progressive Disease|17|||
149827730|NCT01505530|540500353|FG002|Overall Study|Progressive Disease|18|||
149827731|NCT01505530|540500351|FG000|Overall Study|Adverse Event|1|||
149827732|NCT01505530|540500352|FG001|Overall Study|Adverse Event|1|||
149827733|NCT01505530|540500353|FG002|Overall Study|Adverse Event|0|||
149827734|NCT01505530|540500351|FG000|Overall Study|Withdrawal by Subject|7|||
149827735|NCT01505530|540500352|FG001|Overall Study|Withdrawal by Subject|8|||
149827736|NCT01505530|540500353|FG002|Overall Study|Withdrawal by Subject|6|||
149827737|NCT01505530|540500351|FG000|Overall Study|Physician Decision|6|||
149827738|NCT01505530|540500352|FG001|Overall Study|Physician Decision|2|||
149827739|NCT01505530|540500353|FG002|Overall Study|Physician Decision|5|||
149946314|NCT00790036|540936287|FG001|Overall Study|Adverse Event|44|||
149946315|NCT00790036|540936286|FG000|Overall Study|Death|1|||
150275868|NCT01994382|542146449|FG015|Overall Study|Protocol violation/noncompliance|0|||
149827740|NCT01505530|540500351|FG000|Overall Study|Sponsor Decision|1|||
149827741|NCT01505530|540500352|FG001|Overall Study|Sponsor Decision|8|||
149827742|NCT01505530|540500353|FG002|Overall Study|Sponsor Decision|7|||
149827743|NCT01505530|540500351|FG000|Overall Study|Death|7|||
149827744|NCT01505530|540500352|FG001|Overall Study|Death|6|||
149827745|NCT01505530|540500353|FG002|Overall Study|Death|5|||
149827746|NCT01505530|540500351|FG000|Overall Study|entry criteria not met|0|||
149827747|NCT01505530|540500352|FG001|Overall Study|entry criteria not met|1|||
149827748|NCT01505530|540500353|FG002|Overall Study|entry criteria not met|0|||
149827749|NCT01618266|540500363|FG000|Overall Study|Lost to Follow-up|9|||
149827750|NCT01618266|540500363|FG000|Overall Study|Treatment satisfaction|10|||
149827751|NCT01618266|540500363|FG000|Overall Study|Other reasons|11|||
149827752|NCT01618266|540500363|FG000|Overall Study|Lack of Efficacy|23|||
149827753|NCT01618266|540500363|FG000|Overall Study|Protocol Violation|43|||
149827754|NCT01966042|540500364|FG000|Overall Study|Death|2|||
149827755|NCT00625807|540500365|FG000|Overall Study|schedule conflict|2|||
149827756|NCT00625807|540500366|FG001|Overall Study|schedule conflict|8|||
149946316|NCT00790036|540936287|FG001|Overall Study|Death|0|||
150275869|NCT01994382|542146450|FG016|Overall Study|Protocol violation/noncompliance|2|||
150275870|NCT01994382|542146434|FG000|Overall Study|Rolled over to Phase 2a|0|||
150275871|NCT01994382|542146435|FG001|Overall Study|Rolled over to Phase 2a|0|||
150275872|NCT01994382|542146436|FG002|Overall Study|Rolled over to Phase 2a|1|||
150275873|NCT01994382|542146437|FG003|Overall Study|Rolled over to Phase 2a|0|||
150275874|NCT01994382|542146438|FG004|Overall Study|Rolled over to Phase 2a|0|||
149827757|NCT03267264|540500367|FG000|Overall Study|Withdrawal by Subject|1|||
149827758|NCT03267264|540500368|FG001|Overall Study|Withdrawal by Subject|0|||
149827759|NCT03267264|540500369|FG002|Overall Study|Withdrawal by Subject|2|||
149827760|NCT03267264|540500370|FG003|Overall Study|Withdrawal by Subject|4|||
149827761|NCT02224391|540500371|FG000|Overall Study|Lost to Follow-up|26|||
149827762|NCT02224391|540500372|FG001|Overall Study|Lost to Follow-up|19|||
149827763|NCT02224391|540500371|FG000|Overall Study|Withdrawal by Subject|6|||
149827764|NCT02224391|540500372|FG001|Overall Study|Withdrawal by Subject|5|||
149827765|NCT00084084|540500373|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
149827766|NCT00084084|540500373|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
149827767|NCT00454636|540500374|FG000|Overall Study|Adverse Event|10|||
149827768|NCT00454636|540500375|FG001|Overall Study|Adverse Event|6|||
149827769|NCT00454636|540500376|FG002|Overall Study|Adverse Event|9|||
149827770|NCT00454636|540500377|FG003|Overall Study|Adverse Event|15|||
149827771|NCT00454636|540500374|FG000|Overall Study|Disease Progression|11|||
149827772|NCT00454636|540500375|FG001|Overall Study|Disease Progression|12|||
149827773|NCT00454636|540500376|FG002|Overall Study|Disease Progression|4|||
149827774|NCT00454636|540500377|FG003|Overall Study|Disease Progression|11|||
149827775|NCT00454636|540500374|FG000|Overall Study|Protocol Violation|3|||
149827776|NCT00454636|540500375|FG001|Overall Study|Protocol Violation|2|||
149827777|NCT00454636|540500376|FG002|Overall Study|Protocol Violation|3|||
149827778|NCT00454636|540500377|FG003|Overall Study|Protocol Violation|3|||
149827779|NCT00454636|540500374|FG000|Overall Study|Death|6|||
149827780|NCT00454636|540500375|FG001|Overall Study|Death|1|||
149827781|NCT00454636|540500376|FG002|Overall Study|Death|1|||
149827782|NCT00454636|540500377|FG003|Overall Study|Death|1|||
149827783|NCT00454636|540500374|FG000|Overall Study|Patient refusal|1|||
149827784|NCT00454636|540500375|FG001|Overall Study|Patient refusal|1|||
149827785|NCT00454636|540500376|FG002|Overall Study|Patient refusal|3|||
149827786|NCT00454636|540500377|FG003|Overall Study|Patient refusal|2|||
149827787|NCT00454636|540500374|FG000|Overall Study|Lost to Follow-up|0|||
149827788|NCT00454636|540500375|FG001|Overall Study|Lost to Follow-up|1|||
149827789|NCT00454636|540500376|FG002|Overall Study|Lost to Follow-up|0|||
149827790|NCT00454636|540500377|FG003|Overall Study|Lost to Follow-up|0|||
149827791|NCT01400113|540500378|FG000|Overall Study|Withdrawal by Subject|1|||
149827792|NCT01400113|540500379|FG001|Overall Study|Withdrawal by Subject|1|||
149827793|NCT02114697|540500380|FG000|Overall Study|Study terminated|5|||
149827794|NCT02114697|540500381|FG001|Overall Study|Study terminated|4|||
149827795|NCT01984242|540500382|FG000|Overall Study|Death|52|||
149827796|NCT01984242|540500383|FG001|Overall Study|Death|50|||
149827797|NCT01984242|540500384|FG002|Overall Study|Death|52|||
149827798|NCT01984242|540500382|FG000|Overall Study|Withdrawal by Subject|5|||
149827799|NCT01984242|540500383|FG001|Overall Study|Withdrawal by Subject|3|||
149827800|NCT01984242|540500384|FG002|Overall Study|Withdrawal by Subject|10|||
149827801|NCT01984242|540500382|FG000|Overall Study|Physician Decision|0|||
149827802|NCT01984242|540500383|FG001|Overall Study|Physician Decision|0|||
149827803|NCT01984242|540500384|FG002|Overall Study|Physician Decision|1|||
149827804|NCT01984242|540500382|FG000|Overall Study|Lost to Follow-up|4|||
149827805|NCT01984242|540500383|FG001|Overall Study|Lost to Follow-up|0|||
149827806|NCT01984242|540500384|FG002|Overall Study|Lost to Follow-up|3|||
149827807|NCT01984242|540500382|FG000|Overall Study|Sponsor Decision|1|||
149827808|NCT01984242|540500383|FG001|Overall Study|Sponsor Decision|0|||
149827809|NCT01984242|540500384|FG002|Overall Study|Sponsor Decision|0|||
149827810|NCT01984242|540500382|FG000|Overall Study|Non-Compliance|1|||
149827811|NCT01984242|540500383|FG001|Overall Study|Non-Compliance|0|||
149827812|NCT01984242|540500384|FG002|Overall Study|Non-Compliance|0|||
149827813|NCT01984242|540500382|FG000|Overall Study|Study terminated by Sponsor|38|||
149827814|NCT01984242|540500383|FG001|Overall Study|Study terminated by Sponsor|50|||
149827815|NCT01984242|540500384|FG002|Overall Study|Study terminated by Sponsor|34|||
149827816|NCT01984242|540500382|FG000|Overall Study|Disease Progression|0|||
149827817|NCT01984242|540500383|FG001|Overall Study|Disease Progression|0|||
149827818|NCT01984242|540500384|FG002|Overall Study|Disease Progression|1|||
149827819|NCT04333095|540500390|FG000|Overall Study|Protocol Violation|4|||
149827820|NCT04333095|540500391|FG001|Overall Study|Protocol Violation|0|||
149827821|NCT04333095|540500390|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
149827822|NCT04333095|540500391|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
149827823|NCT04333095|540500390|FG000|Overall Study|Mini Sternotomy|4|||
149827824|NCT04333095|540500391|FG001|Overall Study|Mini Sternotomy|5|||
149827825|NCT00984295|540500392|FG000|Overall Study|Lost to Follow-up|31|||
150275875|NCT01994382|542146439|FG005|Overall Study|Rolled over to Phase 2a|0|||
150275876|NCT01994382|542146440|FG006|Overall Study|Rolled over to Phase 2a|0|||
149827826|NCT00984295|540500393|FG001|Overall Study|Lost to Follow-up|12|||
149946317|NCT00790036|540936286|FG000|Overall Study|Disease progression|24|||
149946318|NCT00790036|540936287|FG001|Overall Study|Disease progression|48|||
149946319|NCT00790036|540936286|FG000|Overall Study|Lost to Follow-up|1|||
149946320|NCT00790036|540936287|FG001|Overall Study|Lost to Follow-up|2|||
149946321|NCT00790036|540936286|FG000|Overall Study|Protocol Violation|10|||
149946322|NCT00790036|540936287|FG001|Overall Study|Protocol Violation|2|||
149946323|NCT00790036|540936286|FG000|Overall Study|Withdrawal by Subject|18|||
149946324|NCT00790036|540936287|FG001|Overall Study|Withdrawal by Subject|7|||
149946325|NCT00790036|540936286|FG000|Overall Study|Subject/guardian decision|20|||
149946326|NCT00790036|540936287|FG001|Overall Study|Subject/guardian decision|7|||
149946327|NCT03197129|540936288|FG000|Overall Study|did not answer the VPT: shyness|4|||
149946328|NCT03197129|540936289|FG001|Overall Study|did not answer the VPT: shyness|5|||
149946329|NCT02442349|540936290|FG000|Overall Study|Death|95|||
149946330|NCT02442349|540936290|FG000|Overall Study|Withdrawal by Subject|27|||
149946331|NCT02442349|540936290|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
149946332|NCT02442349|540936290|FG000|Overall Study|Lost to Follow-up|1|||
149946333|NCT01285518|540936291|FG000|Overall Study|Lost to Follow-up|0|||
149946334|NCT01285518|540936292|FG001|Overall Study|Lost to Follow-up|0|||
149946335|NCT01285518|540936293|FG002|Overall Study|Lost to Follow-up|0|||
149946336|NCT01285518|540936294|FG003|Overall Study|Lost to Follow-up|0|||
149946337|NCT01285518|540936295|FG004|Overall Study|Lost to Follow-up|0|||
149946338|NCT01285518|540936296|FG005|Overall Study|Lost to Follow-up|1|||
149946339|NCT01285518|540936297|FG006|Overall Study|Lost to Follow-up|0|||
149946340|NCT01285518|540936298|FG007|Overall Study|Lost to Follow-up|0|||
149946341|NCT00879658|540936299|FG000|Overall Study|Abnormal laboratory value(s)|3|||
149946342|NCT00879658|540936300|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149946343|NCT00879658|540936301|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149946344|NCT00879658|540936302|FG003|Overall Study|Abnormal laboratory value(s)|1|||
149946345|NCT00879658|540936303|FG004|Overall Study|Abnormal laboratory value(s)|0|||
149946346|NCT00879658|540936304|FG005|Overall Study|Abnormal laboratory value(s)|0|||
149946347|NCT00879658|540936305|FG006|Overall Study|Abnormal laboratory value(s)|0|||
149946348|NCT00879658|540936299|FG000|Overall Study|Administrative problems|2|||
149946349|NCT00879658|540936300|FG001|Overall Study|Administrative problems|1|||
149946350|NCT00879658|540936301|FG002|Overall Study|Administrative problems|0|||
149946351|NCT00879658|540936302|FG003|Overall Study|Administrative problems|1|||
149946352|NCT00879658|540936303|FG004|Overall Study|Administrative problems|0|||
149946353|NCT00879658|540936304|FG005|Overall Study|Administrative problems|0|||
149946354|NCT00879658|540936305|FG006|Overall Study|Administrative problems|0|||
149946355|NCT00879658|540936299|FG000|Overall Study|Adverse Event|6|||
149946356|NCT00879658|540936300|FG001|Overall Study|Adverse Event|4|||
149946357|NCT00879658|540936301|FG002|Overall Study|Adverse Event|3|||
149946358|NCT00879658|540936302|FG003|Overall Study|Adverse Event|1|||
149946359|NCT00879658|540936303|FG004|Overall Study|Adverse Event|2|||
149946360|NCT00879658|540936304|FG005|Overall Study|Adverse Event|0|||
149946361|NCT00879658|540936305|FG006|Overall Study|Adverse Event|0|||
149946362|NCT00879658|540936299|FG000|Overall Study|Protocol Violation|1|||
149946363|NCT00879658|540936300|FG001|Overall Study|Protocol Violation|0|||
149946364|NCT00879658|540936301|FG002|Overall Study|Protocol Violation|0|||
149946365|NCT00879658|540936302|FG003|Overall Study|Protocol Violation|0|||
149946366|NCT00879658|540936303|FG004|Overall Study|Protocol Violation|0|||
149946367|NCT00879658|540936304|FG005|Overall Study|Protocol Violation|0|||
149946368|NCT00879658|540936305|FG006|Overall Study|Protocol Violation|0|||
149946369|NCT00879658|540936299|FG000|Overall Study|Withdrawal by Subject|3|||
149946370|NCT00879658|540936300|FG001|Overall Study|Withdrawal by Subject|0|||
149946371|NCT00879658|540936301|FG002|Overall Study|Withdrawal by Subject|2|||
149946372|NCT00879658|540936302|FG003|Overall Study|Withdrawal by Subject|0|||
149946373|NCT00879658|540936303|FG004|Overall Study|Withdrawal by Subject|0|||
149946374|NCT00879658|540936304|FG005|Overall Study|Withdrawal by Subject|1|||
149946375|NCT00879658|540936305|FG006|Overall Study|Withdrawal by Subject|0|||
149946376|NCT00879658|540936299|FG000|Overall Study|Lack of Efficacy|0|||
149946377|NCT00879658|540936300|FG001|Overall Study|Lack of Efficacy|0|||
149946378|NCT00879658|540936301|FG002|Overall Study|Lack of Efficacy|2|||
149946379|NCT00879658|540936302|FG003|Overall Study|Lack of Efficacy|0|||
149946380|NCT00879658|540936303|FG004|Overall Study|Lack of Efficacy|0|||
149946381|NCT00879658|540936304|FG005|Overall Study|Lack of Efficacy|0|||
149946382|NCT00879658|540936305|FG006|Overall Study|Lack of Efficacy|0|||
149946383|NCT00879658|540936299|FG000|Overall Study|misrandomized (never received study med)|0|||
149946384|NCT00879658|540936300|FG001|Overall Study|misrandomized (never received study med)|0|||
149946385|NCT00879658|540936301|FG002|Overall Study|misrandomized (never received study med)|0|||
149946386|NCT00879658|540936302|FG003|Overall Study|misrandomized (never received study med)|1|||
149946387|NCT00879658|540936303|FG004|Overall Study|misrandomized (never received study med)|0|||
149946388|NCT00879658|540936304|FG005|Overall Study|misrandomized (never received study med)|0|||
149946389|NCT00879658|540936305|FG006|Overall Study|misrandomized (never received study med)|0|||
149946390|NCT00639509|540936306|FG000|Overall Study|Death|1|||
149946391|NCT01654276|540936309|FG000|Overall Study|Lack of Efficacy|1|||
149827827|NCT00984295|540500394|FG002|Overall Study|Lost to Follow-up|13|||
149827828|NCT00984295|540500392|FG000|Overall Study|Protocol Violation|2|||
149827829|NCT00984295|540500393|FG001|Overall Study|Protocol Violation|1|||
149827830|NCT00984295|540500394|FG002|Overall Study|Protocol Violation|4|||
149827831|NCT00984295|540500392|FG000|Overall Study|Withdrawal by Subject|18|||
149827832|NCT00984295|540500393|FG001|Overall Study|Withdrawal by Subject|9|||
149827833|NCT00984295|540500394|FG002|Overall Study|Withdrawal by Subject|12|||
149827834|NCT00984295|540500392|FG000|Overall Study|CAE - discontinued test vaccine|0|||
149827835|NCT00984295|540500393|FG001|Overall Study|CAE - discontinued test vaccine|1|||
149827836|NCT00984295|540500394|FG002|Overall Study|CAE - discontinued test vaccine|3|||
149827837|NCT00984295|540500392|FG000|Overall Study|Missed one or more blood samplings|3|||
149827838|NCT00984295|540500393|FG001|Overall Study|Missed one or more blood samplings|7|||
149827839|NCT00984295|540500394|FG002|Overall Study|Missed one or more blood samplings|2|||
149827840|NCT00984295|540500392|FG000|Overall Study|Incomplete safety follow-up|11|||
149827841|NCT00984295|540500393|FG001|Overall Study|Incomplete safety follow-up|2|||
149827842|NCT00984295|540500394|FG002|Overall Study|Incomplete safety follow-up|3|||
149827843|NCT03740165|540500395|FG000|Overall Study|Death|232|||
149827844|NCT03740165|540500396|FG001|Overall Study|Death|242|||
149827845|NCT03740165|540500397|FG002|Overall Study|Death|229|||
149827846|NCT03740165|540500395|FG000|Overall Study|Lost to Follow-up|0|||
149827847|NCT03740165|540500396|FG001|Overall Study|Lost to Follow-up|0|||
149827848|NCT03740165|540500397|FG002|Overall Study|Lost to Follow-up|1|||
149827849|NCT03740165|540500395|FG000|Overall Study|Withdrawal by Subject|7|||
149827850|NCT03740165|540500396|FG001|Overall Study|Withdrawal by Subject|4|||
149827851|NCT03740165|540500397|FG002|Overall Study|Withdrawal by Subject|3|||
149827852|NCT03740165|540500395|FG000|Overall Study|Ongoing in Study|216|||
149827853|NCT03740165|540500396|FG001|Overall Study|Ongoing in Study|212|||
149827854|NCT03740165|540500397|FG002|Overall Study|Ongoing in Study|221|||
149827855|NCT03049618|540500398|FG000|Overall Study|Death|1|||
149827856|NCT03049618|540500399|FG001|Overall Study|Death|0|||
149827857|NCT03049618|540500398|FG000|Overall Study|Lack of Efficacy|1|||
149827858|NCT03049618|540500399|FG001|Overall Study|Lack of Efficacy|2|||
149827859|NCT04582539|540500400|FG000|Overall Study|Death|1|||
149827860|NCT04582539|540500401|FG001|Overall Study|Death|1|||
149827861|NCT04582539|540500402|FG002|Overall Study|Death|0|||
149827862|NCT04582539|540500403|FG003|Overall Study|Death|1|||
149827863|NCT04582539|540500404|FG004|Overall Study|Death|0|||
149827864|NCT04582539|540500400|FG000|Overall Study|Lost to Follow-up|1|||
149827865|NCT04582539|540500401|FG001|Overall Study|Lost to Follow-up|0|||
149827866|NCT04582539|540500402|FG002|Overall Study|Lost to Follow-up|0|||
149827867|NCT04582539|540500403|FG003|Overall Study|Lost to Follow-up|0|||
149827868|NCT04582539|540500404|FG004|Overall Study|Lost to Follow-up|0|||
149827869|NCT04582539|540500400|FG000|Overall Study|Study Terminated by Sponsor|1|||
149827870|NCT04582539|540500401|FG001|Overall Study|Study Terminated by Sponsor|3|||
149827871|NCT04582539|540500402|FG002|Overall Study|Study Terminated by Sponsor|2|||
149827872|NCT04582539|540500403|FG003|Overall Study|Study Terminated by Sponsor|2|||
149827873|NCT04582539|540500404|FG004|Overall Study|Study Terminated by Sponsor|3|||
149827874|NCT04582539|540500400|FG000|Overall Study|Physician Decision|0|||
149827875|NCT04582539|540500401|FG001|Overall Study|Physician Decision|1|||
149827876|NCT04582539|540500402|FG002|Overall Study|Physician Decision|0|||
149827877|NCT04582539|540500403|FG003|Overall Study|Physician Decision|0|||
149827878|NCT04582539|540500404|FG004|Overall Study|Physician Decision|0|||
149827879|NCT04582539|540500400|FG000|Overall Study|Withdrawal by Subject|1|||
149827880|NCT04582539|540500401|FG001|Overall Study|Withdrawal by Subject|0|||
149827881|NCT04582539|540500402|FG002|Overall Study|Withdrawal by Subject|2|||
149827882|NCT04582539|540500403|FG003|Overall Study|Withdrawal by Subject|1|||
149827883|NCT04582539|540500404|FG004|Overall Study|Withdrawal by Subject|0|||
149827884|NCT04582539|540500400|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
150275877|NCT01994382|542146441|FG007|Overall Study|Rolled over to Phase 2a|0|||
149827885|NCT04582539|540500401|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
149827886|NCT04582539|540500402|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
149827887|NCT04582539|540500403|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
149827888|NCT04582539|540500404|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
149827889|NCT00788957|540500413|FG000|Part 1|Death|8|||
149827890|NCT00788957|540500414|FG001|Part 1|Death|0|||
149827891|NCT00788957|540500415|FG002|Part 1|Death|0|||
149827892|NCT00788957|540500416|FG003|Part 1|Death|0|||
149827893|NCT00788957|540500417|FG004|Part 1|Death|0|||
149827894|NCT00788957|540500418|FG005|Part 1|Death|0|||
149827895|NCT00788957|540500413|FG000|Part 1|Lost to Follow-up|1|||
149827896|NCT00788957|540500414|FG001|Part 1|Lost to Follow-up|0|||
149827897|NCT00788957|540500415|FG002|Part 1|Lost to Follow-up|0|||
149827898|NCT00788957|540500416|FG003|Part 1|Lost to Follow-up|0|||
150275878|NCT01994382|542146442|FG008|Overall Study|Rolled over to Phase 2a|0|||
149827899|NCT00788957|540500417|FG004|Part 1|Lost to Follow-up|0|||
149827900|NCT00788957|540500418|FG005|Part 1|Lost to Follow-up|0|||
149827901|NCT00788957|540500413|FG000|Part 2|Withdrawal by Subject|0|||
149827902|NCT00788957|540500414|FG001|Part 2|Withdrawal by Subject|9|||
149827903|NCT00788957|540500415|FG002|Part 2|Withdrawal by Subject|5|||
149827904|NCT00788957|540500416|FG003|Part 2|Withdrawal by Subject|3|||
149827905|NCT00788957|540500417|FG004|Part 2|Withdrawal by Subject|0|||
149827906|NCT00788957|540500418|FG005|Part 2|Withdrawal by Subject|0|||
149827907|NCT00788957|540500413|FG000|Part 2|Death|0|||
149827908|NCT00788957|540500414|FG001|Part 2|Death|32|||
149827909|NCT00788957|540500415|FG002|Part 2|Death|35|||
149827910|NCT00788957|540500416|FG003|Part 2|Death|37|||
149827911|NCT00788957|540500417|FG004|Part 2|Death|0|||
149827912|NCT00788957|540500418|FG005|Part 2|Death|0|||
149827913|NCT00788957|540500413|FG000|Part 2|Lost to Follow-up|0|||
149827914|NCT00788957|540500414|FG001|Part 2|Lost to Follow-up|0|||
149827915|NCT00788957|540500415|FG002|Part 2|Lost to Follow-up|3|||
149827916|NCT00788957|540500416|FG003|Part 2|Lost to Follow-up|0|||
149827917|NCT00788957|540500417|FG004|Part 2|Lost to Follow-up|0|||
149827918|NCT00788957|540500418|FG005|Part 2|Lost to Follow-up|0|||
149827919|NCT00788957|540500413|FG000|Part 2|On-study at time of data cut-off|0|||
149827920|NCT00788957|540500414|FG001|Part 2|On-study at time of data cut-off|1|||
149827921|NCT00788957|540500415|FG002|Part 2|On-study at time of data cut-off|1|||
149827922|NCT00788957|540500416|FG003|Part 2|On-study at time of data cut-off|1|||
149827923|NCT00788957|540500417|FG004|Part 2|On-study at time of data cut-off|0|||
149827924|NCT00788957|540500418|FG005|Part 2|On-study at time of data cut-off|0|||
149827925|NCT00788957|540500413|FG000|Part 3|Withdrawal by Subject|0|||
149827926|NCT00788957|540500414|FG001|Part 3|Withdrawal by Subject|0|||
149827927|NCT00788957|540500415|FG002|Part 3|Withdrawal by Subject|0|||
149827928|NCT00788957|540500416|FG003|Part 3|Withdrawal by Subject|0|||
149827929|NCT00788957|540500417|FG004|Part 3|Withdrawal by Subject|0|||
149827930|NCT00788957|540500418|FG005|Part 3|Withdrawal by Subject|2|||
149827931|NCT00788957|540500413|FG000|Part 3|Death|0|||
149827932|NCT00788957|540500414|FG001|Part 3|Death|0|||
149827933|NCT00788957|540500415|FG002|Part 3|Death|0|||
149827934|NCT00788957|540500416|FG003|Part 3|Death|0|||
149827935|NCT00788957|540500417|FG004|Part 3|Death|8|||
149946392|NCT01654276|540936309|FG000|Overall Study|Lost to Follow-up|4|||
149946393|NCT01654276|540936309|FG000|Overall Study|Withdrawal by Subject|1|||
149946394|NCT02657551|540936310|FG000|Overall Study|Adverse Event|2|||
149946395|NCT02657551|540936310|FG000|Overall Study|Withdrawal by Subject|1|||
149946396|NCT02657551|540936310|FG000|Overall Study|Non-Compliance|1|||
149946397|NCT02657551|540936310|FG000|Overall Study|Progression / Relapse|4|||
149946398|NCT04478266|540936311|FG000|Overall Study|Adverse Event|20|||
149946399|NCT04478266|540936312|FG001|Overall Study|Adverse Event|21|||
149946400|NCT04478266|540936311|FG000|Overall Study|Progressive disease|146|||
149946401|NCT04478266|540936312|FG001|Overall Study|Progressive disease|168|||
149946402|NCT04478266|540936311|FG000|Overall Study|Poor compliance to protocol|1|||
149946403|NCT04478266|540936312|FG001|Overall Study|Poor compliance to protocol|0|||
149946404|NCT04478266|540936311|FG000|Overall Study|Withdrawal by Subject|19|||
149946405|NCT04478266|540936312|FG001|Overall Study|Withdrawal by Subject|16|||
149946406|NCT04478266|540936311|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
149946407|NCT04478266|540936312|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
149946408|NCT04478266|540936311|FG000|Overall Study|Study terminated by sponsor|33|||
149946409|NCT04478266|540936312|FG001|Overall Study|Study terminated by sponsor|35|||
149946410|NCT04478266|540936311|FG000|Overall Study|Other: unspecified|5|||
149946411|NCT04478266|540936312|FG001|Overall Study|Other: unspecified|7|||
149946412|NCT04478266|540936311|FG000|Overall Study|Randomized but not treated|1|||
149946413|NCT04478266|540936312|FG001|Overall Study|Randomized but not treated|1|||
149946414|NCT00964782|540936313|FG000|Overall Study|Lost to Follow-up|1|||
149946415|NCT00964782|540936314|FG001|Overall Study|Lost to Follow-up|0|||
149946416|NCT05260008|540936315|FG000|Overall Study|Physician Decision|0|||
149946417|NCT05260008|540936316|FG001|Overall Study|Physician Decision|1|||
149946418|NCT05260008|540936317|FG002|Overall Study|Physician Decision|0|||
149946419|NCT05260008|540936318|FG003|Overall Study|Physician Decision|0|||
149946420|NCT04584788|540936320|FG000|Overall Study|Physician Decision|8|||
149946421|NCT04584788|540936320|FG000|Overall Study|Withdrawal by Subject|1|||
149946422|NCT04584788|540936320|FG000|Overall Study|Adverse Event|3|||
149946423|NCT01240746|540938504|FG000|Overall Study|Adverse Event|2|||
149827936|NCT00788957|540500418|FG005|Part 3|Death|8|||
149827937|NCT00788957|540500413|FG000|Part 3|On-study at time of data cut-off|0|||
149827938|NCT00788957|540500414|FG001|Part 3|On-study at time of data cut-off|0|||
149827939|NCT00788957|540500415|FG002|Part 3|On-study at time of data cut-off|0|||
149827940|NCT00788957|540500416|FG003|Part 3|On-study at time of data cut-off|0|||
149827941|NCT00788957|540500417|FG004|Part 3|On-study at time of data cut-off|1|||
149827942|NCT00788957|540500418|FG005|Part 3|On-study at time of data cut-off|0|||
149827943|NCT02579096|540500421|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
149827944|NCT02579096|540500422|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
149827945|NCT02579096|540500421|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
149946424|NCT01240746|540938505|FG001|Overall Study|Adverse Event|0|||
149827946|NCT02579096|540500422|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
149827947|NCT02579096|540500421|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
149946425|NCT01240746|540938506|FG002|Overall Study|Adverse Event|10|||
149946426|NCT01240746|540938504|FG000|Overall Study|Lost to Follow-up|23|||
149827948|NCT02579096|540500422|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
149827949|NCT02579096|540500421|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
149827950|NCT02579096|540500422|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
149827951|NCT02579096|540500421|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
149827952|NCT02579096|540500422|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
149827953|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Death|2|||
149827954|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Death|4|||
149827955|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
149827956|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
149827957|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
149827958|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
149827959|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
149827960|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
149827961|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
149827962|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
149827963|NCT02579096|540500421|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
149827964|NCT02579096|540500422|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
149827965|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Death|3|||
149827966|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Death|2|||
149827967|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
149827968|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
149827969|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
149827970|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
149827971|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
149827972|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
149827973|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
149827974|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
149827975|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
150170479|NCT00371566|541759085|FG001|Chemoradiation Phase|Progressive Disease|1|||
150170480|NCT00371566|541759084|FG000|Chemoradiation Phase|Death|2|||
150170481|NCT00371566|541759085|FG001|Chemoradiation Phase|Death|0|||
150170482|NCT00371566|541759084|FG000|Follow Up Phase|Death|0|||
150170483|NCT00371566|541759085|FG001|Follow Up Phase|Death|5|||
150170484|NCT00371566|541759084|FG000|Follow Up Phase|Disease progression|1|||
150170485|NCT00371566|541759085|FG001|Follow Up Phase|Disease progression|0|||
150170486|NCT00371566|541759084|FG000|Follow Up Phase|Withdrawal by Subject|0|||
150170487|NCT00371566|541759085|FG001|Follow Up Phase|Withdrawal by Subject|1|||
150170488|NCT00371566|541759084|FG000|Follow Up Phase|Physician Decision|1|||
150170489|NCT00371566|541759085|FG001|Follow Up Phase|Physician Decision|1|||
150170490|NCT00371566|541759084|FG000|Follow Up Phase|Lost to Follow-up|1|||
150170491|NCT00371566|541759085|FG001|Follow Up Phase|Lost to Follow-up|0|||
150170492|NCT00972504|541759086|FG000|Overall Study|Adverse Event|2|||
150170493|NCT00972504|541759086|FG000|Overall Study|Investigator discretion|1|||
150170494|NCT04246762|541759087|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
150170495|NCT02878330|541759088|FG000|Overall Study|Death|3|||
150170496|NCT02878330|541759089|FG001|Overall Study|Death|2|||
150170497|NCT02878330|541759088|FG000|Overall Study|Lost to Follow-up|11|||
150170498|NCT02878330|541759089|FG001|Overall Study|Lost to Follow-up|26|||
150170499|NCT02878330|541759088|FG000|Overall Study|Withdrawal by Subject|11|||
150170500|NCT02878330|541759089|FG001|Overall Study|Withdrawal by Subject|21|||
150170501|NCT02878330|541759088|FG000|Overall Study|Other|4|||
150170502|NCT02878330|541759089|FG001|Overall Study|Other|7|||
150170503|NCT00082810|541759094|FG000|Overall Study|Adverse Event|3|||
150170504|NCT00082810|541759094|FG000|Overall Study|Progressive disease|24|||
150170505|NCT00082810|541759094|FG000|Overall Study|Withdrawal by Subject|4|||
150170506|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
150170507|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
150170508|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
150170509|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
150170510|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
150170511|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
150170512|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
150170513|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
150170514|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
150170515|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
150170516|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
150170517|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
150170518|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
150170519|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
150170520|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
149827976|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
149827977|NCT02579096|540500421|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
149946427|NCT01240746|540938505|FG001|Overall Study|Lost to Follow-up|20|||
149827978|NCT02579096|540500422|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
149827979|NCT02097121|540500423|FG000|Overall Study|Other, not specified|4|||
149827980|NCT02097121|540500424|FG001|Overall Study|Other, not specified|2|||
149827981|NCT02097121|540500425|FG002|Overall Study|Other, not specified|3|||
149827982|NCT02097121|540500423|FG000|Overall Study|Lack of Efficacy|2|||
149827983|NCT02097121|540500424|FG001|Overall Study|Lack of Efficacy|1|||
149827984|NCT02097121|540500425|FG002|Overall Study|Lack of Efficacy|3|||
149827985|NCT02097121|540500423|FG000|Overall Study|Withdrawal by Subject|0|||
149827986|NCT02097121|540500424|FG001|Overall Study|Withdrawal by Subject|1|||
149827987|NCT02097121|540500425|FG002|Overall Study|Withdrawal by Subject|2|||
149827988|NCT02097121|540500423|FG000|Overall Study|Adverse Event|0|||
149827989|NCT02097121|540500424|FG001|Overall Study|Adverse Event|1|||
149827990|NCT02097121|540500425|FG002|Overall Study|Adverse Event|0|||
149827991|NCT02097121|540500423|FG000|Overall Study|Lost to Follow-up|1|||
149827992|NCT02097121|540500424|FG001|Overall Study|Lost to Follow-up|1|||
149827993|NCT02097121|540500425|FG002|Overall Study|Lost to Follow-up|2|||
149827994|NCT00319449|540500426|FG000|Overall Study|Subject did not wish to continue|1|||
149827995|NCT00319449|540500427|FG001|Overall Study|Subject did not wish to continue|0|||
149827996|NCT00319449|540500426|FG000|Overall Study|Noncompliance with the protocol|1|||
149827997|NCT00319449|540500427|FG001|Overall Study|Noncompliance with the protocol|0|||
149827998|NCT02739984|540500428|FG000|Overall Study|Sponsor Decision|1|||
149827999|NCT02739984|540500429|FG001|Overall Study|Sponsor Decision|0|||
149828000|NCT02739984|540500428|FG000|Overall Study|Withdrawal by Subject|1|||
149828001|NCT02739984|540500429|FG001|Overall Study|Withdrawal by Subject|1|||
149828002|NCT02739984|540500428|FG000|Overall Study|Death|0|||
149828003|NCT02739984|540500429|FG001|Overall Study|Death|1|||
149828004|NCT02739984|540500428|FG000|Overall Study|Lost to Follow-up|3|||
149828005|NCT02739984|540500429|FG001|Overall Study|Lost to Follow-up|0|||
149828006|NCT00979628|540500430|FG000|Overall Study|received regimen < 24 hours|7|||
149828007|NCT00979628|540500431|FG001|Overall Study|received regimen < 24 hours|6|||
149828008|NCT00979628|540500432|FG002|Overall Study|received regimen < 24 hours|5|||
149828009|NCT00979628|540500430|FG000|Overall Study|received steroids|1|||
149828010|NCT00979628|540500431|FG001|Overall Study|received steroids|1|||
149946428|NCT01240746|540938506|FG002|Overall Study|Lost to Follow-up|102|||
149946429|NCT01240746|540938504|FG000|Overall Study|Protocol Violation|24|||
149946430|NCT01240746|540938505|FG001|Overall Study|Protocol Violation|15|||
149946431|NCT01240746|540938506|FG002|Overall Study|Protocol Violation|72|||
149946432|NCT01240746|540938504|FG000|Overall Study|Withdrawal by Subject|10|||
149946433|NCT01240746|540938505|FG001|Overall Study|Withdrawal by Subject|13|||
149946434|NCT01240746|540938506|FG002|Overall Study|Withdrawal by Subject|59|||
149946435|NCT02472405|540938507|FG000|Overall Study|Lost to Follow-up|9|||
149946436|NCT02472405|540938507|FG000|Overall Study|Adverse Event|1|||
149946437|NCT01431976|540938508|FG000|Overall Study|Adverse Event|6|||
149946438|NCT01431976|540938508|FG000|Overall Study|Lack of Efficacy|2|||
149946439|NCT01431976|540938508|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
149946440|NCT01431976|540938508|FG000|Overall Study|Physician Decision|1|||
149946441|NCT01431976|540938508|FG000|Overall Study|Withdrawal by Subject|1|||
149946442|NCT01126424|540938516|FG000|Overall Study|Adverse Event|0|||
149946443|NCT01126424|540938517|FG001|Overall Study|Adverse Event|0|||
149946444|NCT01126424|540938518|FG002|Overall Study|Adverse Event|0|||
149946445|NCT01126424|540938519|FG003|Overall Study|Adverse Event|0|||
149946446|NCT01126424|540938520|FG004|Overall Study|Adverse Event|1|||
149946447|NCT01126424|540938521|FG005|Overall Study|Adverse Event|0|||
149946448|NCT01126424|540938516|FG000|Overall Study|Withdrawal by Subject|0|||
149946449|NCT01126424|540938517|FG001|Overall Study|Withdrawal by Subject|0|||
149946450|NCT01126424|540938518|FG002|Overall Study|Withdrawal by Subject|1|||
149946451|NCT01126424|540938519|FG003|Overall Study|Withdrawal by Subject|3|||
149946452|NCT01126424|540938520|FG004|Overall Study|Withdrawal by Subject|1|||
149946453|NCT01126424|540938521|FG005|Overall Study|Withdrawal by Subject|0|||
149946454|NCT02127671|540938522|FG000|Overall Study|Death|2|||
149946455|NCT02127671|540938523|FG001|Overall Study|Death|2|||
149946456|NCT02127671|540938522|FG000|Overall Study|Lost to Follow-up|4|||
149946457|NCT02127671|540938523|FG001|Overall Study|Lost to Follow-up|2|||
149828011|NCT00979628|540500432|FG002|Overall Study|received steroids|0|||
150275879|NCT01994382|542146443|FG009|Overall Study|Rolled over to Phase 2a|2|||
149828012|NCT00979628|540500430|FG000|Overall Study|transferred to ICU|1|||
149828013|NCT00979628|540500431|FG001|Overall Study|transferred to ICU|2|||
149828014|NCT00979628|540500432|FG002|Overall Study|transferred to ICU|1|||
149828015|NCT00911859|540500433|FG000|Treatment Period|Adverse Event|3|||
149828016|NCT00911859|540500434|FG001|Treatment Period|Adverse Event|3|||
149828017|NCT00911859|540500435|FG002|Treatment Period|Adverse Event|7|||
150275880|NCT01994382|542146444|FG010|Overall Study|Rolled over to Phase 2a|0|||
149828018|NCT00911859|540500433|FG000|Treatment Period|Death|1|||
149828019|NCT00911859|540500434|FG001|Treatment Period|Death|3|||
149946458|NCT02127671|540938522|FG000|Overall Study|Physician Decision|1|||
149946459|NCT02127671|540938523|FG001|Overall Study|Physician Decision|0|||
149946460|NCT02127671|540938522|FG000|Overall Study|incarceration|0|||
149946461|NCT02127671|540938523|FG001|Overall Study|incarceration|1|||
150033208|NCT01247324|541260916|FG000|Overall Study|Lost to Follow-up|3|||
149828020|NCT00911859|540500435|FG002|Treatment Period|Death|5|||
149828021|NCT00911859|540500433|FG000|Treatment Period|Lack of Efficacy|1|||
149828022|NCT00911859|540500434|FG001|Treatment Period|Lack of Efficacy|7|||
149828023|NCT00911859|540500435|FG002|Treatment Period|Lack of Efficacy|5|||
149828024|NCT00911859|540500433|FG000|Treatment Period|Physician Decision|3|||
149828025|NCT00911859|540500434|FG001|Treatment Period|Physician Decision|3|||
149828026|NCT00911859|540500435|FG002|Treatment Period|Physician Decision|3|||
149828027|NCT00911859|540500433|FG000|Treatment Period|Withdrawal by Subject|0|||
149828028|NCT00911859|540500434|FG001|Treatment Period|Withdrawal by Subject|4|||
149828029|NCT00911859|540500435|FG002|Treatment Period|Withdrawal by Subject|5|||
149828030|NCT00911859|540500433|FG000|Treatment Period|Did not receive study treatment|0|||
149828031|NCT00911859|540500434|FG001|Treatment Period|Did not receive study treatment|1|||
149828032|NCT00911859|540500435|FG002|Treatment Period|Did not receive study treatment|0|||
149828033|NCT00911859|540500433|FG000|Maintainance Period|Lack of Efficacy|0|||
149828034|NCT00911859|540500434|FG001|Maintainance Period|Lack of Efficacy|0|||
149828035|NCT00911859|540500435|FG002|Maintainance Period|Lack of Efficacy|9|||
149828036|NCT00911859|540500433|FG000|Maintainance Period|Physician Decision|0|||
149828037|NCT00911859|540500434|FG001|Maintainance Period|Physician Decision|0|||
149828038|NCT00911859|540500435|FG002|Maintainance Period|Physician Decision|9|||
149828039|NCT00911859|540500433|FG000|Maintainance Period|Withdrawal by Subject|0|||
149828040|NCT00911859|540500434|FG001|Maintainance Period|Withdrawal by Subject|0|||
149828041|NCT00911859|540500435|FG002|Maintainance Period|Withdrawal by Subject|3|||
149828042|NCT00911859|540500433|FG000|Follow-up Period|Death|5|||
149828043|NCT00911859|540500434|FG001|Follow-up Period|Death|8|||
149828044|NCT00911859|540500435|FG002|Follow-up Period|Death|10|||
150275881|NCT01994382|542146445|FG011|Overall Study|Rolled over to Phase 2a|0|||
150275882|NCT01994382|542146446|FG012|Overall Study|Rolled over to Phase 2a|0|||
149828045|NCT00911859|540500433|FG000|Follow-up Period|Lost to Follow-up|1|||
149828046|NCT00911859|540500434|FG001|Follow-up Period|Lost to Follow-up|1|||
149828047|NCT00911859|540500435|FG002|Follow-up Period|Lost to Follow-up|0|||
149828048|NCT00911859|540500433|FG000|Follow-up Period|Withdrawal by Subject|0|||
149828049|NCT00911859|540500434|FG001|Follow-up Period|Withdrawal by Subject|4|||
149828050|NCT00911859|540500435|FG002|Follow-up Period|Withdrawal by Subject|4|||
149828051|NCT00911859|540500433|FG000|Follow-up Period|Study terminated by sponsor|5|||
149828052|NCT00911859|540500434|FG001|Follow-up Period|Study terminated by sponsor|33|||
149828053|NCT00911859|540500435|FG002|Follow-up Period|Study terminated by sponsor|27|||
149828054|NCT00767325|540500437|FG000|Overall Study|Lack of Efficacy|2|||
149828055|NCT00767325|540500437|FG000|Overall Study|Adverse Event|7|||
149828056|NCT00767325|540500437|FG000|Overall Study|Lost to Follow-up|3|||
149828057|NCT00767325|540500437|FG000|Overall Study|No longer met study criteria|2|||
149828058|NCT00767325|540500437|FG000|Overall Study|Missed visit due to family reasons|1|||
149828059|NCT03538756|540500438|FG000|Long-Term Follow-up|Adverse Event|0|||
149828060|NCT03538756|540500439|FG001|Long-Term Follow-up|Adverse Event|0|||
149828061|NCT03538756|540500440|FG002|Long-Term Follow-up|Adverse Event|6|||
149828062|NCT03538756|540500438|FG000|Long-Term Follow-up|Death|0|||
149828063|NCT03538756|540500439|FG001|Long-Term Follow-up|Death|0|||
149828064|NCT03538756|540500440|FG002|Long-Term Follow-up|Death|1|||
149828065|NCT03538756|540500438|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
149828066|NCT03538756|540500439|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
149828067|NCT03538756|540500440|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
149828068|NCT03538756|540500438|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
149828069|NCT03538756|540500439|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
149828070|NCT03538756|540500440|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
149828071|NCT03538756|540500438|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
149828072|NCT03538756|540500439|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
149828073|NCT03538756|540500440|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
149828074|NCT00752856|540500441|FG000|Overall Study|randomized but did not do viral kinetics|0|||
149828075|NCT00752856|540500442|FG001|Overall Study|randomized but did not do viral kinetics|1|||
149828076|NCT02688608|540500443|FG000|Overall Study|Lost to Follow-up|1|||
149828077|NCT03968224|540500445|FG000|Overall Study|Lost to Follow-up|11|||
149828078|NCT03968224|540500446|FG001|Overall Study|Lost to Follow-up|18|||
149828079|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
149828080|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
149828081|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
149828082|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
149828083|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
149828084|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
149828085|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
149828086|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
150275883|NCT01994382|542146447|FG013|Overall Study|Rolled over to Phase 2a|0|||
149828087|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
149828088|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
149946462|NCT02127671|540938522|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
149828089|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
149828090|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
149828091|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
149828092|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
149828093|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
149828094|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
149828095|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
149828096|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
149828097|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
149828098|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
149828099|NCT02207231|540502560|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
149828100|NCT02207231|540502561|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
149828101|NCT02207231|540502562|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
149828102|NCT02207231|540502563|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
149828103|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
149828104|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
149828105|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
149828106|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
149828107|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
149828108|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
149828109|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
149828110|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
149828111|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
149828112|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
149828113|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
149828114|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
149828115|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
149828116|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
149828117|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
150275884|NCT01994382|542146448|FG014|Overall Study|Rolled over to Phase 2a|0|||
150275885|NCT01994382|542146449|FG015|Overall Study|Rolled over to Phase 2a|0|||
150275886|NCT01994382|542146450|FG016|Overall Study|Rolled over to Phase 2a|0|||
150275887|NCT02428855|542146451|FG000|Overall Study|Withdrawal by Subject|2|||
150275888|NCT02066311|542146452|FG000|Overall Study|Adverse Event|4|||
150275889|NCT02066311|542146452|FG000|Overall Study|Withdrawal by Subject|1|||
150275890|NCT04353596|542146453|FG000|Overall Study|Protocol Violation|4|||
150275891|NCT04353596|542146454|FG001|Overall Study|Protocol Violation|4|||
150275892|NCT04353596|542146453|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
150275893|NCT04353596|542146454|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
150275894|NCT05418673|542146455|FG000|Overall Study|Study Terminated by Sponsor|2|||
150275895|NCT05418673|542146456|FG001|Overall Study|Study Terminated by Sponsor|4|||
150275896|NCT05418673|542146455|FG000|Overall Study|Lost to Follow-up|1|||
150275897|NCT05418673|542146456|FG001|Overall Study|Lost to Follow-up|0|||
150275898|NCT02170779|542146458|FG000|Overall Study|Withdrawal by Subject|1|||
150275899|NCT02170779|542146459|FG001|Overall Study|Withdrawal by Subject|0|||
150275900|NCT02170779|542146458|FG000|Overall Study|Lost to Follow-up|0|||
150275901|NCT02170779|542146459|FG001|Overall Study|Lost to Follow-up|1|||
150275902|NCT00935272|542146460|FG000|Overall Study|Lost to Follow-up|10|||
150275903|NCT00935272|542146461|FG001|Overall Study|Lost to Follow-up|3|||
150275904|NCT00935272|542146460|FG000|Overall Study|Withdrawal by Subject|8|||
149828118|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
149828119|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
149828120|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
150275905|NCT00935272|542146461|FG001|Overall Study|Withdrawal by Subject|2|||
150275906|NCT00935272|542146460|FG000|Overall Study|Physician Decision|1|||
150275907|NCT00935272|542146461|FG001|Overall Study|Physician Decision|0|||
150275908|NCT00935272|542146460|FG000|Overall Study|Protocol Violation|0|||
150275909|NCT00935272|542146461|FG001|Overall Study|Protocol Violation|1|||
150275910|NCT01478360|542146465|FG000|Overall Study|Lost to Follow-up|1|||
149828121|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
149828122|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
149828123|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
149828124|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
149828125|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
150275911|NCT01478360|542146466|FG001|Overall Study|Lost to Follow-up|0|||
150275912|NCT01478360|542146465|FG000|Overall Study|Adverse Event|0|||
150275913|NCT01478360|542146466|FG001|Overall Study|Adverse Event|1|||
150275914|NCT01478360|542146465|FG000|Overall Study|Administrative problems|1|||
150275915|NCT01478360|542146466|FG001|Overall Study|Administrative problems|2|||
150275916|NCT00888381|542146495|FG000|Overall Study|Lost to Follow-up|0|||
150275917|NCT00888381|542146496|FG001|Overall Study|Lost to Follow-up|1|||
150275918|NCT02729740|542146497|FG000|Overall Study|Early Termination|130|||
149828126|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
149828127|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
149828128|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
149828129|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
149828130|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
149828131|NCT02207231|540502560|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
149828132|NCT02207231|540502561|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
149828133|NCT02207231|540502562|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
149828134|NCT02207231|540502563|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
149828135|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
149828136|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
149828137|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
149828138|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
149828139|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
149828140|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
149828141|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
149828142|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
149828143|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
149828144|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
149828145|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
149828146|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
149946463|NCT02127671|540938523|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
149946464|NCT00764517|540938527|FG000|Overall Study|Adverse Event|9|||
149946465|NCT00764517|540938528|FG001|Overall Study|Adverse Event|3|||
149946466|NCT00764517|540938527|FG000|Overall Study|Death|3|||
149946467|NCT00764517|540938528|FG001|Overall Study|Death|11|||
150275919|NCT02729740|542146497|FG000|Overall Study|Other|1|||
150275920|NCT00175877|542146503|FG000|Overall Study|Adverse Event|136|||
150275921|NCT00175877|542146503|FG000|Overall Study|Withdrawal by Subject|141|||
150275922|NCT00175877|542146503|FG000|Overall Study|Lost to Follow-up|9|||
150275923|NCT00175877|542146503|FG000|Overall Study|Lack of Efficacy|26|||
150275924|NCT00175877|542146503|FG000|Overall Study|Protocol Violation|15|||
150275925|NCT00175877|542146503|FG000|Overall Study|Other Reason|20|||
150275926|NCT00175877|542146503|FG000|Overall Study|AE & Other|1|||
150275927|NCT00175877|542146503|FG000|Overall Study|Withdrawal by subject & Other|1|||
150275928|NCT03061175|542146506|FG000|Baseline|Participant was deemed ineligible|1|||
150275929|NCT03061175|542146507|FG001|Baseline|Participant was deemed ineligible|0|||
150275930|NCT03061175|542146506|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
150275931|NCT03061175|542146507|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
150275932|NCT03061175|542146506|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
150275933|NCT03061175|542146507|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
150275934|NCT03061175|542146506|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
150275935|NCT03061175|542146507|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
150275936|NCT03044249|542146512|FG000|Overall Study|Adverse Event|4|||
150275937|NCT03044249|542146513|FG001|Overall Study|Adverse Event|9|||
150275938|NCT03044249|542146512|FG000|Overall Study|Lost to Follow-up|1|||
150275939|NCT03044249|542146513|FG001|Overall Study|Lost to Follow-up|0|||
150275940|NCT03044249|542146512|FG000|Overall Study|Non-compliance with Study Drug|1|||
150275941|NCT03044249|542146513|FG001|Overall Study|Non-compliance with Study Drug|0|||
150275942|NCT03044249|542146512|FG000|Overall Study|Study Terminated by Sponsor|2|||
150275943|NCT03044249|542146513|FG001|Overall Study|Study Terminated by Sponsor|0|||
150275944|NCT03044249|542146512|FG000|Overall Study|Withdrawal by Subject|2|||
150275945|NCT03044249|542146513|FG001|Overall Study|Withdrawal by Subject|5|||
150275946|NCT00760669|542146514|FG000|Overall Study|Not assessed for overall improvement|18|||
149946468|NCT00764517|540938527|FG000|Overall Study|Physician Decision|3|||
149946469|NCT00764517|540938528|FG001|Overall Study|Physician Decision|0|||
149946470|NCT02239328|540938534|FG000|Overall Study|Benign disease noted at time of surgery|6|||
150275947|NCT00760669|542146514|FG000|Overall Study|Participants missing efficacy assessment|6|||
150275948|NCT00760669|542146514|FG000|Overall Study|Participants with overlapping cases|1|||
150275949|NCT00760669|542146514|FG000|Overall Study|Took drug before entering in contract|5|||
150275950|NCT04411628|542146519|FG000|Overall Study|Withdrawal by Subject|1|||
150275951|NCT04411628|542146520|FG001|Overall Study|Withdrawal by Subject|1|||
150275952|NCT04411628|542146521|FG002|Overall Study|Withdrawal by Subject|2|||
150275953|NCT04411628|542146522|FG003|Overall Study|Withdrawal by Subject|0|||
150275954|NCT04411628|542146519|FG000|Overall Study|Lost to Follow-up|0|||
150275955|NCT04411628|542146520|FG001|Overall Study|Lost to Follow-up|1|||
149828147|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
149946471|NCT02239328|540938534|FG000|Overall Study|Equipment or website malfunction|2|||
149946472|NCT00460798|540938535|FG000|Overall Study|Death|59|||
149946473|NCT00460798|540938535|FG000|Overall Study|Adverse Event|27|||
150275956|NCT04411628|542146521|FG002|Overall Study|Lost to Follow-up|0|||
150275957|NCT04411628|542146522|FG003|Overall Study|Lost to Follow-up|0|||
149946474|NCT00460798|540938535|FG000|Overall Study|Lost to Follow-up|19|||
150275958|NCT03734016|542146523|FG000|Overall Study|Sponsor Ended Study|225|||
150275959|NCT03734016|542146524|FG001|Overall Study|Sponsor Ended Study|200|||
150275960|NCT03734016|542146523|FG000|Overall Study|Death|69|||
150275961|NCT03734016|542146524|FG001|Overall Study|Death|83|||
150275962|NCT03734016|542146523|FG000|Overall Study|Withdrawal by Subject|21|||
150275963|NCT03734016|542146524|FG001|Overall Study|Withdrawal by Subject|27|||
150275964|NCT03734016|542146523|FG000|Overall Study|Physician Decision|1|||
150275965|NCT03734016|542146524|FG001|Overall Study|Physician Decision|12|||
150275966|NCT03734016|542146523|FG000|Overall Study|Lost to Follow-up|6|||
150275967|NCT03734016|542146524|FG001|Overall Study|Lost to Follow-up|2|||
150275968|NCT03734016|542146523|FG000|Overall Study|Miscellaneous|5|||
150275969|NCT03734016|542146524|FG001|Overall Study|Miscellaneous|1|||
150275970|NCT01979835|542146525|FG000|Primary Outcome SA Measurment|failed insertion|18|||
150275971|NCT01979835|542146525|FG000|Follow-up|Lost to Follow-up|32|||
150275972|NCT01428661|542146528|FG000|Double-Masked Phase|Protocol Violation|9|||
150275973|NCT01428661|542146529|FG001|Double-Masked Phase|Protocol Violation|4|||
150275974|NCT01428661|542146530|FG002|Double-Masked Phase|Protocol Violation|0|||
150275975|NCT01428661|542146528|FG000|Double-Masked Phase|Adverse Event|13|||
150275976|NCT01428661|542146529|FG001|Double-Masked Phase|Adverse Event|4|||
150275977|NCT01428661|542146530|FG002|Double-Masked Phase|Adverse Event|0|||
150275978|NCT01428661|542146528|FG000|Double-Masked Phase|Lost to Follow-up|14|||
150275979|NCT01428661|542146529|FG001|Double-Masked Phase|Lost to Follow-up|14|||
150275980|NCT01428661|542146530|FG002|Double-Masked Phase|Lost to Follow-up|0|||
150275981|NCT01428661|542146528|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
150275982|NCT01428661|542146529|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
150275983|NCT01428661|542146530|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
150275984|NCT01428661|542146528|FG000|Double-Masked Phase|Lack of Efficacy|2|||
150275985|NCT01428661|542146529|FG001|Double-Masked Phase|Lack of Efficacy|1|||
150275986|NCT01428661|542146530|FG002|Double-Masked Phase|Lack of Efficacy|0|||
150275987|NCT01428661|542146528|FG000|Double-Masked Phase|*Various|1|||
150275988|NCT01428661|542146529|FG001|Double-Masked Phase|*Various|6|||
150275989|NCT01428661|542146530|FG002|Double-Masked Phase|*Various|0|||
150275990|NCT01428661|542146528|FG000|Open Label Extension|Protocol Violation|0|||
150275991|NCT01428661|542146529|FG001|Open Label Extension|Protocol Violation|0|||
150275992|NCT01428661|542146530|FG002|Open Label Extension|Protocol Violation|9|||
150275993|NCT01428661|542146528|FG000|Open Label Extension|Adverse Event|0|||
150275994|NCT01428661|542146529|FG001|Open Label Extension|Adverse Event|0|||
150275995|NCT01428661|542146530|FG002|Open Label Extension|Adverse Event|15|||
150275996|NCT01428661|542146528|FG000|Open Label Extension|Lost to Follow-up|0|||
150275997|NCT01428661|542146529|FG001|Open Label Extension|Lost to Follow-up|0|||
150275998|NCT01428661|542146530|FG002|Open Label Extension|Lost to Follow-up|38|||
150275999|NCT01428661|542146528|FG000|Open Label Extension|Withdrawal by Subject|0|||
150276000|NCT01428661|542146529|FG001|Open Label Extension|Withdrawal by Subject|0|||
150276001|NCT01428661|542146530|FG002|Open Label Extension|Withdrawal by Subject|49|||
150276002|NCT01428661|542146528|FG000|Open Label Extension|Lack of Efficacy|0|||
150276003|NCT01428661|542146529|FG001|Open Label Extension|Lack of Efficacy|0|||
150276004|NCT01428661|542146530|FG002|Open Label Extension|Lack of Efficacy|24|||
150276005|NCT01428661|542146528|FG000|Open Label Extension|**Various|0|||
150276006|NCT01428661|542146529|FG001|Open Label Extension|**Various|0|||
150276007|NCT01428661|542146530|FG002|Open Label Extension|**Various|185|||
150276008|NCT03828292|542146531|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
150276009|NCT03828292|542146532|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
150276010|NCT03828292|542146533|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
150276011|NCT03828292|542146534|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
150276012|NCT03828292|542146535|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
150276013|NCT03828292|542146536|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
150276014|NCT03828292|542146531|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
150276015|NCT03828292|542146532|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
150276016|NCT03828292|542146533|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
150276017|NCT03828292|542146534|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
150276018|NCT03828292|542146535|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
150276019|NCT03828292|542146536|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
150276020|NCT03828292|542146531|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
150276021|NCT03828292|542146532|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
150276022|NCT03828292|542146533|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
150276023|NCT03828292|542146534|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
150276024|NCT03828292|542146535|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
150276025|NCT03828292|542146536|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
150276026|NCT03828292|542146531|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
150276027|NCT03828292|542146532|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
150276028|NCT03828292|542146533|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
150276029|NCT03828292|542146534|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
150276030|NCT03828292|542146535|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
150276031|NCT03828292|542146536|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
150276032|NCT03828292|542146531|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
150276033|NCT03828292|542146532|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149828148|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
149828149|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
149828150|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
149828151|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
149828152|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
149828153|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
149828154|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
149828155|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
149828156|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
149828157|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
149828158|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
149828159|NCT02207231|540502560|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
149828160|NCT02207231|540502561|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
149828161|NCT02207231|540502562|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
149828162|NCT02207231|540502563|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
149828163|NCT00502775|540502567|FG000|Overall Study|Adverse Event|1|||
149828164|NCT00502775|540502568|FG001|Overall Study|Adverse Event|2|||
149828165|NCT00502775|540502569|FG002|Overall Study|Adverse Event|1|||
149828166|NCT00502775|540502567|FG000|Overall Study|Protocol Violation|1|||
149828167|NCT00502775|540502568|FG001|Overall Study|Protocol Violation|5|||
149828168|NCT00502775|540502569|FG002|Overall Study|Protocol Violation|2|||
149828169|NCT00502775|540502567|FG000|Overall Study|Withdrawal by Subject|1|||
149828170|NCT00502775|540502568|FG001|Overall Study|Withdrawal by Subject|1|||
149828171|NCT00502775|540502569|FG002|Overall Study|Withdrawal by Subject|2|||
149828172|NCT00502775|540502567|FG000|Overall Study|Sponsor Terminated Study|1|||
149828173|NCT00502775|540502568|FG001|Overall Study|Sponsor Terminated Study|0|||
149828174|NCT00502775|540502569|FG002|Overall Study|Sponsor Terminated Study|1|||
149828175|NCT00502775|540502567|FG000|Overall Study|Non-compliance with eDiary|4|||
149828176|NCT00502775|540502568|FG001|Overall Study|Non-compliance with eDiary|1|||
149828177|NCT00502775|540502569|FG002|Overall Study|Non-compliance with eDiary|1|||
150276034|NCT03828292|542146533|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
149828178|NCT00502775|540502567|FG000|Overall Study|Subject unable to swallow capsule|1|||
149828179|NCT00502775|540502568|FG001|Overall Study|Subject unable to swallow capsule|0|||
149828180|NCT00502775|540502569|FG002|Overall Study|Subject unable to swallow capsule|1|||
149946475|NCT00460798|540938535|FG000|Overall Study|Progressive Disease|99|||
149946476|NCT00460798|540938535|FG000|Overall Study|Other|27|||
149946477|NCT00460798|540938535|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
149946478|NCT00460798|540938535|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
149946479|NCT04115059|540938536|FG000|Overall Study|Withdrawal by Subject|1|||
149946480|NCT04115059|540938536|FG000|Overall Study|Lack of Efficacy|2|||
149946481|NCT03517137|540938547|FG000|Overall Study|Lack of Efficacy|1|||
149946482|NCT03517137|540938547|FG000|Overall Study|Adverse Event|2|||
149946483|NCT03517137|540938547|FG000|Overall Study|Withdrawal by Subject|2|||
149946484|NCT03517137|540938547|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
149946485|NCT03575364|540938548|FG000|Overall Study|Death|45|||
149946486|NCT03575364|540938548|FG000|Overall Study|Lost to Follow-up|114|||
149946487|NCT03575364|540938548|FG000|Overall Study|Withdrawal by Subject|21|||
149946488|NCT03575364|540938548|FG000|Overall Study|Physician Decision|11|||
149946489|NCT03575364|540938548|FG000|Overall Study|Subject Refused Follow-up|13|||
149946490|NCT03575364|540938548|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
149946491|NCT03575364|540938548|FG000|Overall Study|Patient moved out of the state|1|||
149946492|NCT03575364|540938548|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
149946493|NCT03575364|540938548|FG000|Overall Study|Patient is lost to follow up|1|||
149946494|NCT03575364|540938548|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
149946495|NCT02313155|540938552|FG000|Overall Study|Lost to Follow-up|0|||
149946496|NCT02313155|540938553|FG001|Overall Study|Lost to Follow-up|1|||
149946497|NCT05376358|540938554|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
149946498|NCT05376358|540938555|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
150033209|NCT01247324|541260917|FG001|Overall Study|Lost to Follow-up|6|||
150033210|NCT01247324|541260916|FG000|Overall Study|Study Terminated by Sponsor|4|||
150276035|NCT03828292|542146534|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
150276036|NCT03828292|542146535|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149828181|NCT00502775|540502567|FG000|Overall Study|Logpad compliance <80%|1|||
149828182|NCT00502775|540502568|FG001|Overall Study|Logpad compliance <80%|0|||
149828183|NCT00502775|540502569|FG002|Overall Study|Logpad compliance <80%|0|||
149828184|NCT00502775|540502567|FG000|Overall Study|Randomized in error|0|||
149828185|NCT00502775|540502568|FG001|Overall Study|Randomized in error|1|||
149828186|NCT00502775|540502569|FG002|Overall Study|Randomized in error|1|||
149828187|NCT00502775|540502567|FG000|Overall Study|Non-compliance|0|||
149828188|NCT00502775|540502568|FG001|Overall Study|Non-compliance|2|||
149828189|NCT00502775|540502569|FG002|Overall Study|Non-compliance|2|||
149828190|NCT00502775|540502567|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
149828191|NCT00502775|540502568|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
149828192|NCT00502775|540502569|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
149828193|NCT00502775|540502567|FG000|Overall Study|Declining pollen counts|0|||
149828194|NCT00502775|540502568|FG001|Overall Study|Declining pollen counts|1|||
149828195|NCT00502775|540502569|FG002|Overall Study|Declining pollen counts|1|||
149828196|NCT00502775|540502567|FG000|Overall Study|Subject in jail|0|||
149828197|NCT00502775|540502568|FG001|Overall Study|Subject in jail|1|||
149828198|NCT00502775|540502569|FG002|Overall Study|Subject in jail|0|||
149828199|NCT00502775|540502567|FG000|Overall Study|Subject took disallowed drug|0|||
149828200|NCT00502775|540502568|FG001|Overall Study|Subject took disallowed drug|0|||
149828201|NCT00502775|540502569|FG002|Overall Study|Subject took disallowed drug|1|||
149828202|NCT02016300|540502577|FG000|Overall Study|Lost to Follow-up|0|||
149828203|NCT02016300|540502578|FG001|Overall Study|Lost to Follow-up|3|||
149828204|NCT06165744|540502579|FG000|Overall Study|Non device-related adverse event|1|||
149828205|NCT01545076|540502580|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
149828206|NCT01545076|540502581|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
149828207|NCT01545076|540502582|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
149828208|NCT01545076|540502583|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
149828209|NCT01545076|540502584|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
149828210|NCT01545076|540502580|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
149828211|NCT01545076|540502581|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
149828212|NCT01545076|540502582|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
149828213|NCT01545076|540502583|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
149828214|NCT01545076|540502584|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
149828215|NCT01545076|540502580|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
149828216|NCT01545076|540502581|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
149828217|NCT01545076|540502582|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
149828218|NCT01545076|540502583|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
149828219|NCT01545076|540502584|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
149828220|NCT01545076|540502580|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
149828221|NCT01545076|540502581|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
149828222|NCT01545076|540502582|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
149828223|NCT01545076|540502583|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
149828224|NCT01545076|540502584|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
149828225|NCT01545076|540502580|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
149828226|NCT01545076|540502581|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
149828227|NCT01545076|540502582|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
149828228|NCT01545076|540502583|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
149828229|NCT01545076|540502584|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
149828230|NCT01545076|540502580|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
149828231|NCT01545076|540502581|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
149828232|NCT01545076|540502582|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
149828233|NCT01545076|540502583|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
149828234|NCT01545076|540502584|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
149828235|NCT01545076|540502580|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
149828236|NCT01545076|540502581|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
149828237|NCT01545076|540502582|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
149828238|NCT01545076|540502583|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
149828239|NCT01545076|540502584|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
149828240|NCT01545076|540502580|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
149828241|NCT01545076|540502581|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
149828242|NCT01545076|540502582|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
149946499|NCT05376358|540938554|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
149828243|NCT01545076|540502583|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
149828244|NCT01545076|540502584|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
149828245|NCT01545076|540502580|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
149828246|NCT01545076|540502581|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
149828247|NCT01545076|540502582|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
149828248|NCT01545076|540502583|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
149828249|NCT01545076|540502584|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
149828250|NCT01546987|540502585|FG000|Overall Study|Protocol Violation|3|||
149828251|NCT01546987|540502586|FG001|Overall Study|Protocol Violation|4|||
149828252|NCT05381948|540502591|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
149828253|NCT05381948|540502592|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
149828254|NCT05381948|540502593|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
149828255|NCT05381948|540502591|FG000|Overall Study|Adverse Event: Non-ocular|0|||
149828256|NCT05381948|540502592|FG001|Overall Study|Adverse Event: Non-ocular|1|||
149828257|NCT05381948|540502593|FG002|Overall Study|Adverse Event: Non-ocular|0|||
149828258|NCT05381948|540502591|FG000|Overall Study|Lost to Follow-up|1|||
149828259|NCT05381948|540502592|FG001|Overall Study|Lost to Follow-up|0|||
149828260|NCT05381948|540502593|FG002|Overall Study|Lost to Follow-up|0|||
149828261|NCT05381948|540502591|FG000|Overall Study|Protocol Deviation|0|||
149828262|NCT05381948|540502592|FG001|Overall Study|Protocol Deviation|2|||
149828263|NCT05381948|540502593|FG002|Overall Study|Protocol Deviation|0|||
149828264|NCT05381948|540502591|FG000|Overall Study|Withdrawal by Subject|1|||
149828265|NCT05381948|540502592|FG001|Overall Study|Withdrawal by Subject|0|||
149828266|NCT05381948|540502593|FG002|Overall Study|Withdrawal by Subject|1|||
149828267|NCT05381948|540502591|FG000|Overall Study|Death|0|||
149828268|NCT05381948|540502592|FG001|Overall Study|Death|2|||
149828269|NCT05381948|540502593|FG002|Overall Study|Death|0|||
149828270|NCT05381948|540502591|FG000|Overall Study|Discontinued study without receiving study drug|0|||
149828271|NCT05381948|540502592|FG001|Overall Study|Discontinued study without receiving study drug|0|||
149828272|NCT05381948|540502593|FG002|Overall Study|Discontinued study without receiving study drug|1|||
149828273|NCT04471207|540502594|FG000|Overall Study|Lost to Follow-up|4|||
149828274|NCT04471207|540502595|FG001|Overall Study|Lost to Follow-up|1|||
149828275|NCT04471207|540502594|FG000|Overall Study|Medication Contraindication|0|||
149828276|NCT04471207|540502595|FG001|Overall Study|Medication Contraindication|1|||
149828277|NCT04471207|540502594|FG000|Overall Study|Loss of Interest|2|||
149828278|NCT04471207|540502595|FG001|Overall Study|Loss of Interest|1|||
149828279|NCT04471207|540502594|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
149828280|NCT04471207|540502595|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
149828281|NCT04471207|540502594|FG000|Overall Study|Scheduling Conflicts|3|||
149828282|NCT04471207|540502595|FG001|Overall Study|Scheduling Conflicts|1|||
149828283|NCT04471207|540502594|FG000|Overall Study|Physician Decision|1|||
149828284|NCT04471207|540502595|FG001|Overall Study|Physician Decision|0|||
149828285|NCT04471207|540502594|FG000|Overall Study|Unwilling to Use System|0|||
149828286|NCT04471207|540502595|FG001|Overall Study|Unwilling to Use System|1|||
149828287|NCT00561730|540502602|FG000|Overall Study|Adverse Event|2|||
149828288|NCT00561730|540502602|FG000|Overall Study|Handling of the drug|1|||
149828289|NCT00561730|540502602|FG000|Overall Study|Lost to Follow-up|5|||
149828290|NCT00561730|540502602|FG000|Overall Study|Not specified reasons|1|||
149828291|NCT00520741|540502605|FG000|Overall Study|Adverse Event|16|||
149828292|NCT00520741|540502606|FG001|Overall Study|Adverse Event|56|||
149828293|NCT00520741|540502605|FG000|Overall Study|Lack of Efficacy|11|||
149828294|NCT00520741|540502606|FG001|Overall Study|Lack of Efficacy|30|||
149828295|NCT00520741|540502605|FG000|Overall Study|Withdrawal by Subject|0|||
149828296|NCT00520741|540502606|FG001|Overall Study|Withdrawal by Subject|11|||
149828297|NCT00520741|540502605|FG000|Overall Study|Protocol Violation|2|||
149828298|NCT00520741|540502606|FG001|Overall Study|Protocol Violation|15|||
149828299|NCT00520741|540502605|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
149828300|NCT00520741|540502606|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
149828301|NCT00520741|540502605|FG000|Overall Study|Lost to Follow-up|4|||
149828302|NCT00520741|540502606|FG001|Overall Study|Lost to Follow-up|4|||
149828303|NCT00520741|540502605|FG000|Overall Study|Other reasons for premature termination|0|||
149828304|NCT00520741|540502606|FG001|Overall Study|Other reasons for premature termination|6|||
149828305|NCT04373434|540502607|FG000|Overall Study|Lost to Follow-up|37|||
149828306|NCT04373434|540502608|FG001|Overall Study|Lost to Follow-up|32|||
149828307|NCT04373434|540502607|FG000|Overall Study|Refused at 9 months|1|||
149828308|NCT04373434|540502608|FG001|Overall Study|Refused at 9 months|2|||
149828309|NCT04373434|540502607|FG000|Overall Study|Refused at 4 months|7|||
149828310|NCT04373434|540502608|FG001|Overall Study|Refused at 4 months|3|||
149828311|NCT04373434|540502607|FG000|Overall Study|Excluded|2|||
149828312|NCT04373434|540502608|FG001|Overall Study|Excluded|0|||
149828313|NCT03702621|540502609|FG000|Overall Study|Physician Decision|6|||
149828314|NCT03702621|540502610|FG001|Overall Study|Physician Decision|6|||
149975625|NCT00907621|541047919|FG000|Overall Study|intercurrent febrile illness|1|||
149828315|NCT00527423|540502611|FG000|Overall Study|Protocol Violation|1|||
149828316|NCT00527423|540502611|FG000|Overall Study|Adverse Event|5|||
149828317|NCT00527423|540502611|FG000|Overall Study|Physician Decision|4|||
149828318|NCT00527423|540502611|FG000|Overall Study|Withdrawal by Subject|10|||
149828319|NCT00527423|540502611|FG000|Overall Study|Lost to Follow-up|4|||
149828320|NCT00527423|540502611|FG000|Overall Study|OTHER|4|||
149828321|NCT00527423|540502611|FG000|Overall Study|Death|9|||
149828322|NCT03194464|540502615|FG000|Overall Study|data not usable|2|||
149828323|NCT02446132|540502622|FG000|Overall Study|Adverse Event|10|||
149828324|NCT02446132|540502623|FG001|Overall Study|Adverse Event|27|||
149828325|NCT02446132|540502624|FG002|Overall Study|Adverse Event|27|||
149828326|NCT02446132|540502622|FG000|Overall Study|Death|2|||
150276037|NCT03828292|542146536|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
150276038|NCT01444456|542146537|FG000|Overall Study|Withdrawal by Subject|21|||
150276039|NCT01444456|542146537|FG000|Overall Study|Physician Decision|9|||
149828327|NCT02446132|540502623|FG001|Overall Study|Death|13|||
149828328|NCT02446132|540502624|FG002|Overall Study|Death|10|||
149828329|NCT02446132|540502622|FG000|Overall Study|Lack of Efficacy|1|||
149828330|NCT02446132|540502623|FG001|Overall Study|Lack of Efficacy|10|||
149828331|NCT02446132|540502624|FG002|Overall Study|Lack of Efficacy|6|||
149828332|NCT02446132|540502622|FG000|Overall Study|Lost to Follow-up|2|||
149828333|NCT02446132|540502623|FG001|Overall Study|Lost to Follow-up|4|||
149828334|NCT02446132|540502624|FG002|Overall Study|Lost to Follow-up|5|||
149828335|NCT02446132|540502622|FG000|Overall Study|Non-compliance With Study Drug|2|||
149828336|NCT02446132|540502623|FG001|Overall Study|Non-compliance With Study Drug|2|||
149828337|NCT02446132|540502624|FG002|Overall Study|Non-compliance With Study Drug|3|||
149828338|NCT02446132|540502622|FG000|Overall Study|Physician Decision|1|||
149828339|NCT02446132|540502623|FG001|Overall Study|Physician Decision|8|||
149828340|NCT02446132|540502624|FG002|Overall Study|Physician Decision|13|||
149828341|NCT02446132|540502622|FG000|Overall Study|Protocol Deviation|0|||
149828342|NCT02446132|540502623|FG001|Overall Study|Protocol Deviation|0|||
149828343|NCT02446132|540502624|FG002|Overall Study|Protocol Deviation|1|||
149828344|NCT02446132|540502622|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
149828345|NCT02446132|540502623|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
149828346|NCT02446132|540502624|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
149828347|NCT02446132|540502622|FG000|Overall Study|Study Terminated by Sponsor|4|||
149828348|NCT02446132|540502623|FG001|Overall Study|Study Terminated by Sponsor|35|||
149828349|NCT02446132|540502624|FG002|Overall Study|Study Terminated by Sponsor|58|||
149828350|NCT02446132|540502622|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
149828351|NCT02446132|540502623|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
149828352|NCT02446132|540502624|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
149828353|NCT02446132|540502622|FG000|Overall Study|Withdrawal by Subject|11|||
149828354|NCT02446132|540502623|FG001|Overall Study|Withdrawal by Subject|29|||
149828355|NCT02446132|540502624|FG002|Overall Study|Withdrawal by Subject|25|||
149828356|NCT02446132|540502622|FG000|Overall Study|Reason not Specified|4|||
149828357|NCT02446132|540502623|FG001|Overall Study|Reason not Specified|16|||
149828358|NCT02446132|540502624|FG002|Overall Study|Reason not Specified|10|||
149828359|NCT02446132|540502622|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
149828360|NCT02446132|540502623|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
149828361|NCT02446132|540502624|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
149828362|NCT05526248|540502625|FG000|Overall Study|Lost to Follow-up|1|||
149828363|NCT05526248|540502625|FG000|Overall Study|Adverse Event|2|||
149828364|NCT05526248|540502625|FG000|Overall Study|Withdrawal by Subject|1|||
149828365|NCT03444038|540502626|FG000|Overall Study|Adverse Event|12|||
149828366|NCT03444038|540502626|FG000|Overall Study|Withdrawal by Subject|7|||
149828367|NCT03444038|540502626|FG000|Overall Study|Lost to Follow-up|1|||
149828368|NCT03444038|540502626|FG000|Overall Study|Physician Decision|2|||
149828369|NCT03444038|540502626|FG000|Overall Study|Lack of Efficacy|7|||
149828370|NCT02354586|540502627|FG000|Overall Study|Death|230|||
149828371|NCT02354586|540502627|FG000|Overall Study|Withdrawal by Subject|59|||
149828372|NCT02354586|540502627|FG000|Overall Study|Lost to Follow-up|11|||
149828373|NCT02354586|540502627|FG000|Overall Study|Sponsor decision|51|||
149828374|NCT02354586|540502627|FG000|Overall Study|Site closure|2|||
149828375|NCT02354586|540502627|FG000|Overall Study|Intercurrent illness|1|||
149828376|NCT02354586|540502627|FG000|Overall Study|Protocol Violation|3|||
149828377|NCT02354586|540502627|FG000|Overall Study|Physician Decision|13|||
149828378|NCT02354586|540502627|FG000|Overall Study|Lack of Efficacy|86|||
149828379|NCT02354586|540502627|FG000|Overall Study|Adverse Event|7|||
149828380|NCT00721409|540502631|FG000|Overall Study|Global deterioration of health status|2|||
149828381|NCT00721409|540502632|FG001|Overall Study|Global deterioration of health status|6|||
149828382|NCT00721409|540502633|FG002|Overall Study|Global deterioration of health status|3|||
149828383|NCT00721409|540502631|FG000|Overall Study|Death|0|||
149828384|NCT00721409|540502632|FG001|Overall Study|Death|1|||
149828385|NCT00721409|540502633|FG002|Overall Study|Death|0|||
149828386|NCT00721409|540502631|FG000|Overall Study|Randomized not Treated|0|||
149828387|NCT00721409|540502632|FG001|Overall Study|Randomized not Treated|1|||
149828388|NCT00721409|540502633|FG002|Overall Study|Randomized not Treated|4|||
149975626|NCT00907621|541047920|FG001|Overall Study|intercurrent febrile illness|1|||
150276040|NCT01444456|542146537|FG000|Overall Study|Lost to Follow-up|37|||
149828389|NCT00721409|540502631|FG000|Overall Study|Reason not specified|1|||
149828390|NCT00721409|540502632|FG001|Overall Study|Reason not specified|0|||
149828391|NCT00721409|540502633|FG002|Overall Study|Reason not specified|2|||
149828392|NCT00721409|540502631|FG000|Overall Study|Adverse Event|0|||
149828393|NCT00721409|540502632|FG001|Overall Study|Adverse Event|13|||
149828394|NCT00721409|540502633|FG002|Overall Study|Adverse Event|2|||
149828395|NCT00721409|540502631|FG000|Overall Study|Lost to Follow-up|0|||
150276041|NCT01444456|542146537|FG000|Overall Study|Death|73|||
149828396|NCT00721409|540502632|FG001|Overall Study|Lost to Follow-up|0|||
149828397|NCT00721409|540502633|FG002|Overall Study|Lost to Follow-up|1|||
149828398|NCT00721409|540502631|FG000|Overall Study|Withdrawal by Subject|1|||
149828399|NCT00721409|540502632|FG001|Overall Study|Withdrawal by Subject|6|||
149828400|NCT00721409|540502633|FG002|Overall Study|Withdrawal by Subject|5|||
149828401|NCT00721409|540502631|FG000|Overall Study|Objective progression or relapse|8|||
149828402|NCT00721409|540502632|FG001|Overall Study|Objective progression or relapse|55|||
149828403|NCT00721409|540502633|FG002|Overall Study|Objective progression or relapse|62|||
149828404|NCT02402166|540502634|FG000|Overall Study|Adverse Event|2|||
149828405|NCT02402166|540502634|FG000|Overall Study|Withdrawal by Subject|2|||
149828406|NCT02402166|540502634|FG000|Overall Study|Lost to Follow-up|1|||
149828407|NCT00810368|540502636|FG000|Overall Study|Lost to Follow-up|4|||
149828408|NCT00810368|540502637|FG001|Overall Study|Lost to Follow-up|2|||
149828409|NCT00810368|540502636|FG000|Overall Study|Lack of Efficacy|2|||
149828410|NCT00810368|540502637|FG001|Overall Study|Lack of Efficacy|0|||
149828411|NCT00623103|540502638|FG000|Overall Study|Adverse Event|70|||
149828412|NCT00623103|540502639|FG001|Overall Study|Adverse Event|60|||
149828413|NCT00623103|540502638|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149828414|NCT00623103|540502639|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
149828415|NCT00623103|540502638|FG000|Overall Study|Withdrawal by Subject|18|||
149828416|NCT00623103|540502639|FG001|Overall Study|Withdrawal by Subject|24|||
149828417|NCT00623103|540502638|FG000|Overall Study|Lost to Follow-up|4|||
149828418|NCT00623103|540502639|FG001|Overall Study|Lost to Follow-up|1|||
149828419|NCT00623103|540502638|FG000|Overall Study|Administrative problems|2|||
149828420|NCT00623103|540502639|FG001|Overall Study|Administrative problems|4|||
149828421|NCT00623103|540502638|FG000|Overall Study|Death|11|||
149828422|NCT00623103|540502639|FG001|Overall Study|Death|11|||
149828423|NCT00623103|540502638|FG000|Overall Study|Protocol deviation|2|||
149828424|NCT00623103|540502639|FG001|Overall Study|Protocol deviation|1|||
149828425|NCT01400425|540502640|FG000|Overall Study|Withdrawal by Subject|10|||
149828426|NCT02720510|540502651|FG000|Overall Study|Study Terminated by the sponsor|2|||
149828427|NCT02720510|540502652|FG001|Overall Study|Study Terminated by the sponsor|0|||
149828428|NCT02720510|540502651|FG000|Overall Study|Adverse Event|0|||
149828429|NCT02720510|540502652|FG001|Overall Study|Adverse Event|1|||
149828430|NCT02720510|540502651|FG000|Overall Study|Physician Decision|1|||
149828431|NCT02720510|540502652|FG001|Overall Study|Physician Decision|2|||
149828432|NCT01153984|540502653|FG000|Overall Study|Withdrawal by Subject|1|||
149828433|NCT01153984|540502653|FG000|Overall Study|Adverse Event|1|||
149828434|NCT00973700|540502654|FG000|Overall Study|Withdrawal by Subject|2|||
149828435|NCT00973700|540502655|FG001|Overall Study|Withdrawal by Subject|2|||
149828436|NCT00973700|540502656|FG002|Overall Study|Withdrawal by Subject|8|||
149828437|NCT00973700|540502657|FG003|Overall Study|Withdrawal by Subject|4|||
149828438|NCT00973700|540502658|FG004|Overall Study|Withdrawal by Subject|4|||
149828439|NCT00973700|540502654|FG000|Overall Study|Lost to Follow-up|5|||
149828440|NCT00973700|540502655|FG001|Overall Study|Lost to Follow-up|0|||
149828441|NCT00973700|540502656|FG002|Overall Study|Lost to Follow-up|1|||
149828442|NCT00973700|540502657|FG003|Overall Study|Lost to Follow-up|8|||
149828443|NCT00973700|540502658|FG004|Overall Study|Lost to Follow-up|5|||
149828444|NCT00973700|540502654|FG000|Overall Study|Inappropriate enrolment|0|||
149946500|NCT05376358|540938555|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
149946501|NCT05376358|540938554|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
149946502|NCT05376358|540938555|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
149946503|NCT05376358|540938554|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
150276042|NCT01444456|542146537|FG000|Overall Study|Ineligibility determined|23|||
149946504|NCT05376358|540938555|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
149946505|NCT05376358|540938554|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
149946506|NCT05376358|540938555|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
149946507|NCT05376358|540938554|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
149946508|NCT05376358|540938555|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
149946509|NCT00311168|540938556|FG000|First Intervention|Withdrawal by Subject|2|||
149946510|NCT00311168|540938557|FG001|First Intervention|Withdrawal by Subject|2|||
149946511|NCT00311168|540938556|FG000|First Intervention|Lost to Follow-up|1|||
150276043|NCT01444456|542146537|FG000|Overall Study|Other|18|||
149946512|NCT00311168|540938557|FG001|First Intervention|Lost to Follow-up|1|||
150276044|NCT01444456|542146537|FG000|Overall Study|Not treated|104|||
150276045|NCT00382720|542147901|FG000|Overall Study|Adverse Event|21|||
149828445|NCT00973700|540502655|FG001|Overall Study|Inappropriate enrolment|0|||
149828446|NCT00973700|540502656|FG002|Overall Study|Inappropriate enrolment|0|||
149828447|NCT00973700|540502657|FG003|Overall Study|Inappropriate enrolment|4|||
149828448|NCT00973700|540502658|FG004|Overall Study|Inappropriate enrolment|0|||
149828449|NCT00973700|540502654|FG000|Overall Study|Unable to Classify|0|||
149828450|NCT00973700|540502655|FG001|Overall Study|Unable to Classify|0|||
149828451|NCT00973700|540502656|FG002|Overall Study|Unable to Classify|1|||
149828452|NCT00973700|540502657|FG003|Overall Study|Unable to Classify|2|||
149828453|NCT00973700|540502658|FG004|Overall Study|Unable to Classify|1|||
149828454|NCT03499964|540502661|FG000|Overall Study|Lack of Efficacy|6|||
149828455|NCT03499964|540502662|FG001|Overall Study|Lack of Efficacy|26|||
149828456|NCT03499964|540502661|FG000|Overall Study|Adverse Event|1|||
149828457|NCT03499964|540502662|FG001|Overall Study|Adverse Event|0|||
149828458|NCT03499964|540502661|FG000|Overall Study|Death|1|||
149828459|NCT03499964|540502662|FG001|Overall Study|Death|0|||
149828460|NCT03499964|540502661|FG000|Overall Study|Withdrawal by Subject|2|||
149828461|NCT03499964|540502662|FG001|Overall Study|Withdrawal by Subject|1|||
149828462|NCT03499964|540502661|FG000|Overall Study|Lost to Follow-up|1|||
149828463|NCT03499964|540502662|FG001|Overall Study|Lost to Follow-up|0|||
149828464|NCT01047345|540502668|FG000|Base Study|Adverse Event|3|||
149828465|NCT01047345|540502669|FG001|Base Study|Adverse Event|0|||
149828466|NCT01047345|540502670|FG002|Base Study|Adverse Event|0|||
149828467|NCT01047345|540502668|FG000|Base Study|Lost to Follow-up|4|||
149828468|NCT01047345|540502669|FG001|Base Study|Lost to Follow-up|1|||
149828469|NCT01047345|540502670|FG002|Base Study|Lost to Follow-up|0|||
149828470|NCT01047345|540502668|FG000|Base Study|Protocol Violation|3|||
149828471|NCT01047345|540502669|FG001|Base Study|Protocol Violation|1|||
149828472|NCT01047345|540502670|FG002|Base Study|Protocol Violation|0|||
149828473|NCT01047345|540502668|FG000|Base Study|Withdrawal by Subject|12|||
149828474|NCT01047345|540502669|FG001|Base Study|Withdrawal by Subject|4|||
149828475|NCT01047345|540502670|FG002|Base Study|Withdrawal by Subject|0|||
149828476|NCT01047345|540502668|FG000|Extension|Withdrawal by Subject|0|||
149828477|NCT01047345|540502669|FG001|Extension|Withdrawal by Subject|0|||
149828478|NCT01047345|540502670|FG002|Extension|Withdrawal by Subject|1|||
149828479|NCT01047345|540502668|FG000|Extension|Lost to Follow-up|0|||
149828480|NCT01047345|540502669|FG001|Extension|Lost to Follow-up|0|||
149828481|NCT01047345|540502670|FG002|Extension|Lost to Follow-up|5|||
149828482|NCT00806156|540502671|FG000|Overall Study|Death|35|||
149828483|NCT00806156|540502672|FG001|Overall Study|Death|95|||
149828484|NCT00806156|540502671|FG000|Overall Study|Did not meet eligibility criteria|1|||
149828485|NCT00806156|540502672|FG001|Overall Study|Did not meet eligibility criteria|0|||
149828486|NCT00806156|540502671|FG000|Overall Study|Study terminated by Sponsor|2|||
149828487|NCT00806156|540502672|FG001|Overall Study|Study terminated by Sponsor|40|||
149946513|NCT00311168|540938556|FG000|First Intervention|Protocol Violation|1|||
150276046|NCT00382720|542147902|FG001|Overall Study|Adverse Event|23|||
150276047|NCT00382720|542147903|FG002|Overall Study|Adverse Event|15|||
149828488|NCT00806156|540502671|FG000|Overall Study|Consent withdrawn by subject|1|||
149946514|NCT00311168|540938557|FG001|First Intervention|Protocol Violation|1|||
149946515|NCT00311168|540938556|FG000|First Intervention|Adverse Event|1|||
149946516|NCT00311168|540938557|FG001|First Intervention|Adverse Event|0|||
150276048|NCT00382720|542147901|FG000|Overall Study|Protocol Violation|2|||
150276049|NCT00382720|542147902|FG001|Overall Study|Protocol Violation|5|||
150276050|NCT00382720|542147903|FG002|Overall Study|Protocol Violation|1|||
150276051|NCT00382720|542147901|FG000|Overall Study|Death|0|||
150276052|NCT00382720|542147902|FG001|Overall Study|Death|1|||
150276053|NCT00382720|542147903|FG002|Overall Study|Death|2|||
150276054|NCT00382720|542147901|FG000|Overall Study|Progressive disease|37|||
150276055|NCT00382720|542147902|FG001|Overall Study|Progressive disease|28|||
150276056|NCT00382720|542147903|FG002|Overall Study|Progressive disease|38|||
150276057|NCT00382720|542147901|FG000|Overall Study|Withdrew consent|1|||
150276058|NCT00382720|542147902|FG001|Overall Study|Withdrew consent|1|||
150276059|NCT00382720|542147903|FG002|Overall Study|Withdrew consent|2|||
150276060|NCT00382720|542147901|FG000|Overall Study|Withdrawal by Subject|11|||
150276061|NCT00382720|542147902|FG001|Overall Study|Withdrawal by Subject|20|||
150276062|NCT00382720|542147903|FG002|Overall Study|Withdrawal by Subject|12|||
150276063|NCT00382720|542147901|FG000|Overall Study|Surgery|1|||
150276064|NCT00382720|542147902|FG001|Overall Study|Surgery|1|||
150276065|NCT00382720|542147903|FG002|Overall Study|Surgery|4|||
150276066|NCT00382720|542147901|FG000|Overall Study|Patient did not receive study medication|1|||
150276067|NCT00382720|542147902|FG001|Overall Study|Patient did not receive study medication|1|||
150276068|NCT00382720|542147903|FG002|Overall Study|Patient did not receive study medication|4|||
149828489|NCT00806156|540502672|FG001|Overall Study|Consent withdrawn by subject|3|||
150276069|NCT00382720|542147901|FG000|Overall Study|Clinically progressive disease|0|||
149828490|NCT00806156|540502671|FG000|Overall Study|Lost to Follow-up|0|||
149828491|NCT00806156|540502672|FG001|Overall Study|Lost to Follow-up|1|||
150276070|NCT00382720|542147902|FG001|Overall Study|Clinically progressive disease|1|||
150276071|NCT00382720|542147903|FG002|Overall Study|Clinically progressive disease|0|||
150276072|NCT00382720|542147901|FG000|Overall Study|Good prognosis|0|||
150276073|NCT00382720|542147902|FG001|Overall Study|Good prognosis|1|||
150276074|NCT00382720|542147903|FG002|Overall Study|Good prognosis|0|||
149828492|NCT00282256|540502673|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
149946517|NCT00311168|540938556|FG000|First Intervention|Other|2|||
149828493|NCT00282256|540502673|FG000|Extension Treatment Period|Adverse Event|2|||
149828494|NCT01890915|540502681|FG000|Overall Study|Adverse Event|1|||
149828495|NCT01890915|540502682|FG001|Overall Study|Adverse Event|0|||
149828496|NCT01890915|540502681|FG000|Overall Study|Protocol Violation|2|||
149828497|NCT01890915|540502682|FG001|Overall Study|Protocol Violation|0|||
149828498|NCT01890915|540502681|FG000|Overall Study|Equipment Malfunction|0|||
149828499|NCT01890915|540502682|FG001|Overall Study|Equipment Malfunction|1|||
149828500|NCT00424489|540502683|FG000|Overall Study|Death|3|||
149828501|NCT00536575|540502688|FG000|Overall Study|Withdrawal by Subject|1|||
149828502|NCT00536575|540502688|FG000|Overall Study|Death|1|||
149828503|NCT01089647|540502689|FG000|Overall Study|Lost to Follow-up|2|||
149828504|NCT01089647|540502690|FG001|Overall Study|Lost to Follow-up|2|||
149828505|NCT01089647|540502689|FG000|Overall Study|Withdrawal by Subject|2|||
149828506|NCT01089647|540502690|FG001|Overall Study|Withdrawal by Subject|1|||
149828507|NCT01089647|540502689|FG000|Overall Study|Adverse Event|0|||
149828508|NCT01089647|540502690|FG001|Overall Study|Adverse Event|1|||
149828509|NCT00198029|540502691|FG000|Overall Study|Withdrawal by Subject|4|||
149828510|NCT01626079|540502693|FG000|Overall Study|Death|167|||
149828511|NCT01626079|540502694|FG001|Overall Study|Death|192|||
149828512|NCT01626079|540502695|FG002|Overall Study|Death|39|||
149828513|NCT01626079|540502693|FG000|Overall Study|Withdrawal by Subject|23|||
149828514|NCT01626079|540502694|FG001|Overall Study|Withdrawal by Subject|37|||
149828515|NCT01626079|540502695|FG002|Overall Study|Withdrawal by Subject|5|||
149828516|NCT01626079|540502693|FG000|Overall Study|Lost to Follow-up|7|||
149828517|NCT01626079|540502694|FG001|Overall Study|Lost to Follow-up|4|||
149828518|NCT01626079|540502695|FG002|Overall Study|Lost to Follow-up|2|||
149828519|NCT01626079|540502693|FG000|Overall Study|Missed Visits|1|||
149828520|NCT01626079|540502694|FG001|Overall Study|Missed Visits|4|||
149828521|NCT01626079|540502695|FG002|Overall Study|Missed Visits|6|||
149828522|NCT01457053|540502696|FG000|Overall Study|Unable to undergo selected treatment|1|||
149828523|NCT01457053|540502697|FG001|Overall Study|Unable to undergo selected treatment|1|||
149828524|NCT02430870|540502699|FG000|Part 2|Voluntary Withdrawal|0|||
149828525|NCT02430870|540502700|FG001|Part 2|Voluntary Withdrawal|0|||
149828526|NCT02430870|540502701|FG002|Part 2|Voluntary Withdrawal|0|||
149828527|NCT02430870|540502702|FG003|Part 2|Voluntary Withdrawal|0|||
149828528|NCT02430870|540502703|FG004|Part 2|Voluntary Withdrawal|0|||
149828529|NCT02430870|540502704|FG005|Part 2|Voluntary Withdrawal|0|||
149828530|NCT02430870|540502705|FG006|Part 2|Voluntary Withdrawal|1|||
149828531|NCT02430870|540502706|FG007|Part 2|Voluntary Withdrawal|0|||
149828532|NCT02430870|540502699|FG000|Part 2|Other Reason Not Specified|0|||
149828533|NCT02430870|540502700|FG001|Part 2|Other Reason Not Specified|0|||
149828534|NCT02430870|540502701|FG002|Part 2|Other Reason Not Specified|0|||
149828535|NCT02430870|540502702|FG003|Part 2|Other Reason Not Specified|0|||
149828536|NCT02430870|540502703|FG004|Part 2|Other Reason Not Specified|0|||
149828537|NCT02430870|540502704|FG005|Part 2|Other Reason Not Specified|0|||
149828538|NCT02430870|540502705|FG006|Part 2|Other Reason Not Specified|0|||
149828539|NCT02430870|540502706|FG007|Part 2|Other Reason Not Specified|1|||
149828540|NCT02780687|540502707|FG000|Overall Study|Adverse Event|1|||
149828541|NCT02780687|540502708|FG001|Overall Study|Adverse Event|1|||
149828542|NCT02780687|540502707|FG000|Overall Study|Withdrawal by Subject|2|||
149828543|NCT02780687|540502708|FG001|Overall Study|Withdrawal by Subject|1|||
149828544|NCT02780687|540502707|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
149828545|NCT02780687|540502708|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
149828546|NCT02780687|540502707|FG000|Overall Study|progressive disease|29|||
149828547|NCT02780687|540502708|FG001|Overall Study|progressive disease|6|||
149828548|NCT03982433|540502709|FG000|Overall Study|Lost to Follow-up|1|||
149828549|NCT04257929|540502710|FG000|Overall Study|Adverse Event|1|||
149828550|NCT04257929|540502711|FG001|Overall Study|Adverse Event|0|||
149828551|NCT04257929|540502712|FG002|Overall Study|Adverse Event|1|||
149828552|NCT04257929|540502710|FG000|Overall Study|Withdrawal by Subject|1|||
149828553|NCT04257929|540502711|FG001|Overall Study|Withdrawal by Subject|0|||
149946518|NCT00311168|540938557|FG001|First Intervention|Other|2|||
149946519|NCT00311168|540938556|FG000|Second Intervention|Lost to Follow-up|9|||
149946520|NCT00311168|540938557|FG001|Second Intervention|Lost to Follow-up|2|||
149946521|NCT00311168|540938556|FG000|Second Intervention|Withdrawal by Subject|0|||
149946522|NCT00311168|540938557|FG001|Second Intervention|Withdrawal by Subject|1|||
149946523|NCT00311168|540938556|FG000|Second Intervention|Other|1|||
149946524|NCT00311168|540938557|FG001|Second Intervention|Other|1|||
149946525|NCT03965923|540938560|FG000|Overall Study|Withdrawal by Subject|1|||
149946526|NCT03965923|540938561|FG001|Overall Study|Withdrawal by Subject|2|||
149946527|NCT03965923|540938562|FG002|Overall Study|Withdrawal by Subject|3|||
150170521|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
149946528|NCT03965923|540938563|FG003|Overall Study|Withdrawal by Subject|1|||
149946529|NCT03965923|540938564|FG004|Overall Study|Withdrawal by Subject|2|||
149828554|NCT04257929|540502712|FG002|Overall Study|Withdrawal by Subject|0|||
149828555|NCT04257929|540502710|FG000|Overall Study|COVID-19|0|||
149828556|NCT04257929|540502711|FG001|Overall Study|COVID-19|1|||
149828557|NCT04257929|540502712|FG002|Overall Study|COVID-19|1|||
149828558|NCT04257929|540502710|FG000|Overall Study|Lost to Follow-up|0|||
149828559|NCT04257929|540502711|FG001|Overall Study|Lost to Follow-up|0|||
149828560|NCT04257929|540502712|FG002|Overall Study|Lost to Follow-up|1|||
149828561|NCT05665595|540504281|FG000|Overall Study|Ongoing|692|||
149828562|NCT05665595|540504282|FG001|Overall Study|Ongoing|698|||
149828563|NCT05665595|540504281|FG000|Overall Study|Withdrawal by Subject|2|||
149828564|NCT05665595|540504282|FG001|Overall Study|Withdrawal by Subject|2|||
149828565|NCT05665595|540504281|FG000|Overall Study|Lost to Follow-up|1|||
149828566|NCT05665595|540504282|FG001|Overall Study|Lost to Follow-up|0|||
149828567|NCT05665595|540504281|FG000|Overall Study|Death|6|||
149828568|NCT05665595|540504282|FG001|Overall Study|Death|1|||
149828569|NCT05771428|540504283|FG000|Overall Study|Adverse Event|0|||
149828570|NCT05771428|540504284|FG001|Overall Study|Adverse Event|1|||
149828571|NCT05771428|540504285|FG002|Overall Study|Adverse Event|1|||
149828572|NCT05771428|540504286|FG003|Overall Study|Adverse Event|1|||
149828573|NCT05771428|540504283|FG000|Overall Study|Withdrawal by Subject|3|||
149828574|NCT05771428|540504284|FG001|Overall Study|Withdrawal by Subject|2|||
149828575|NCT05771428|540504285|FG002|Overall Study|Withdrawal by Subject|1|||
149828576|NCT05771428|540504286|FG003|Overall Study|Withdrawal by Subject|4|||
149828577|NCT05771428|540504283|FG000|Overall Study|Other|0|||
149828578|NCT05771428|540504284|FG001|Overall Study|Other|1|||
149828579|NCT05771428|540504285|FG002|Overall Study|Other|2|||
149828580|NCT05771428|540504286|FG003|Overall Study|Other|1|||
149828581|NCT05771428|540504283|FG000|Overall Study|Randomized but Not Treated|0|||
149828582|NCT05771428|540504284|FG001|Overall Study|Randomized but Not Treated|0|||
149828583|NCT05771428|540504285|FG002|Overall Study|Randomized but Not Treated|1|||
149828584|NCT05771428|540504286|FG003|Overall Study|Randomized but Not Treated|0|||
149828585|NCT04025229|540504287|FG000|Overall Study|Adverse Event|1|||
149828586|NCT04025229|540504288|FG001|Overall Study|Adverse Event|0|||
149828587|NCT04025229|540504287|FG000|Overall Study|Withdrawal by Subject|0|||
149828588|NCT04025229|540504288|FG001|Overall Study|Withdrawal by Subject|2|||
149828589|NCT04025229|540504287|FG000|Overall Study|Death|0|||
149828590|NCT04025229|540504288|FG001|Overall Study|Death|1|||
149828591|NCT04025229|540504287|FG000|Overall Study|Physician Decision|0|||
149828592|NCT04025229|540504288|FG001|Overall Study|Physician Decision|1|||
149828593|NCT03815942|540504289|FG000|Overall Study|Withdrawal by Subject|0|||
149828594|NCT03815942|540504290|FG001|Overall Study|Withdrawal by Subject|17|||
149828595|NCT03717064|540504291|FG000|Period 2|Adverse Event|1|||
149828596|NCT01298570|540504292|FG000|Overall Study|Disease progression, relapse during acti|64|||
149828597|NCT01298570|540504293|FG001|Overall Study|Disease progression, relapse during acti|40|||
149828598|NCT01298570|540504292|FG000|Overall Study|Adverse Event|20|||
149828599|NCT01298570|540504293|FG001|Overall Study|Adverse Event|2|||
149828600|NCT01298570|540504292|FG000|Overall Study|Withdrawal by Subject|21|||
149828601|NCT01298570|540504293|FG001|Overall Study|Withdrawal by Subject|6|||
149828602|NCT01298570|540504292|FG000|Overall Study|Treatment delay > 4 weeks|4|||
149828603|NCT01298570|540504293|FG001|Overall Study|Treatment delay > 4 weeks|5|||
149828604|NCT01298570|540504292|FG000|Overall Study|Physician Decision|4|||
149828605|NCT01298570|540504293|FG001|Overall Study|Physician Decision|2|||
149828606|NCT01298570|540504292|FG000|Overall Study|Other complicating disease|2|||
149828607|NCT01298570|540504293|FG001|Overall Study|Other complicating disease|1|||
149828608|NCT01298570|540504292|FG000|Overall Study|Surgery|2|||
149828609|NCT01298570|540504293|FG001|Overall Study|Surgery|1|||
149828610|NCT01298570|540504292|FG000|Overall Study|Symptomatic progression/deterioration|3|||
149828611|NCT01298570|540504293|FG001|Overall Study|Symptomatic progression/deterioration|2|||
150170522|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
150170523|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
149828612|NCT01298570|540504292|FG000|Overall Study|Death|0|||
149828613|NCT01298570|540504293|FG001|Overall Study|Death|1|||
149828614|NCT01298570|540504292|FG000|Overall Study|Ineligibility|0|||
149828615|NCT01298570|540504293|FG001|Overall Study|Ineligibility|1|||
149828616|NCT00076102|540504294|FG000|Overall Study|Clinical progression|1|||
149828617|NCT00076102|540504294|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
149828618|NCT00076102|540504294|FG000|Overall Study|plexiform neurofibroma surgery|1|||
149828619|NCT00076102|540504294|FG000|Overall Study|refusal of further therapy|2|||
149828620|NCT02270736|540504301|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
149828621|NCT02270736|540504302|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
149828622|NCT02270736|540504303|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
149828623|NCT02270736|540504304|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
149828624|NCT02270736|540504305|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
149828625|NCT02270736|540504301|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
150170524|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
150170525|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
150170526|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
150170527|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
150170528|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
150170529|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
150170530|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
149828626|NCT02270736|540504302|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
149828627|NCT02270736|540504303|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
149946530|NCT03965923|540938565|FG005|Overall Study|Withdrawal by Subject|0|||
150170531|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
149828628|NCT02270736|540504304|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
149828629|NCT02270736|540504305|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
149828630|NCT02270736|540504301|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
149828631|NCT02270736|540504302|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
149828632|NCT02270736|540504303|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
149828633|NCT02270736|540504304|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
149828634|NCT02270736|540504305|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
149828635|NCT02270736|540504301|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
149828636|NCT02270736|540504302|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
149828637|NCT02270736|540504303|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
149828638|NCT02270736|540504304|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
149828639|NCT02270736|540504305|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
149828640|NCT02270736|540504301|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
150033211|NCT01247324|541260917|FG001|Overall Study|Study Terminated by Sponsor|1|||
150033212|NCT01247324|541260916|FG000|Overall Study|Missing|2|||
150170532|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
150170533|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
150170534|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
150170535|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
150170536|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
150170537|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
150170538|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
150170539|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170540|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
150170541|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
150170542|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
150170543|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170544|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170545|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170546|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170547|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170548|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170549|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
150170550|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170551|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170552|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170553|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170554|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
150170555|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170556|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170557|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170558|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170559|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170560|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
150170561|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
150170562|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170563|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170564|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170565|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170566|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170567|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170568|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170569|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170570|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170571|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
150170572|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
150170573|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
150170574|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
150170575|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
150170576|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
150170577|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
150170578|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
150170579|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
150170580|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
150170581|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
150170582|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
150170583|NCT02914522|541759095|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170584|NCT02914522|541759096|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
149828641|NCT02270736|540504302|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
149828642|NCT02270736|540504303|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
149828643|NCT02270736|540504304|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
149828644|NCT02270736|540504305|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
149828645|NCT02270736|540504301|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
149828646|NCT02270736|540504302|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
149828647|NCT02270736|540504303|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
149828648|NCT02270736|540504304|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
149828649|NCT02270736|540504305|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
149828650|NCT02270736|540504301|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
149828651|NCT02270736|540504302|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
149828652|NCT02270736|540504303|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
149828653|NCT02270736|540504304|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
149828654|NCT02270736|540504305|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
149828655|NCT02270736|540504301|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
149828656|NCT02270736|540504302|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
149828657|NCT02270736|540504303|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
149828658|NCT02270736|540504304|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
149828659|NCT02270736|540504305|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
149828660|NCT02270736|540504301|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
149828661|NCT02270736|540504302|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
149828662|NCT02270736|540504303|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
149828663|NCT02270736|540504304|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
149828664|NCT02270736|540504305|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
149828665|NCT00262600|540504306|FG000|Overall Study|Lost to Follow-up|17|||
149828666|NCT00262600|540504307|FG001|Overall Study|Lost to Follow-up|31|||
149828667|NCT00262600|540504308|FG002|Overall Study|Lost to Follow-up|41|||
149828668|NCT00262600|540504306|FG000|Overall Study|Withdrawal by Subject|128|||
149828669|NCT00262600|540504307|FG001|Overall Study|Withdrawal by Subject|145|||
149828670|NCT00262600|540504308|FG002|Overall Study|Withdrawal by Subject|139|||
149828671|NCT00262600|540504306|FG000|Overall Study|Not Treated|32|||
149828672|NCT00262600|540504307|FG001|Overall Study|Not Treated|17|||
149828673|NCT00262600|540504308|FG002|Overall Study|Not Treated|24|||
149828674|NCT00262600|540504306|FG000|Overall Study|Other|58|||
149828675|NCT00262600|540504307|FG001|Overall Study|Other|59|||
149828676|NCT00262600|540504308|FG002|Overall Study|Other|62|||
149828677|NCT02710123|540504309|FG000|Overall Study|Lost to Follow-up|3|||
149828678|NCT02710123|540504310|FG001|Overall Study|Lost to Follow-up|4|||
149828679|NCT02710123|540504309|FG000|Overall Study|Withdrawal by Subject|1|||
149828680|NCT02710123|540504310|FG001|Overall Study|Withdrawal by Subject|1|||
149828681|NCT02710123|540504309|FG000|Overall Study|Illness unrelated to study intervention|1|||
149828682|NCT02710123|540504310|FG001|Overall Study|Illness unrelated to study intervention|0|||
149828683|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
149828684|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
149828685|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
149828686|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
149828687|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
149828688|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
149828689|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
149828690|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
149828691|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
149946531|NCT03965923|540938566|FG006|Overall Study|Withdrawal by Subject|4|||
149946532|NCT03965923|540938567|FG007|Overall Study|Withdrawal by Subject|3|||
149946533|NCT03965923|540938568|FG008|Overall Study|Withdrawal by Subject|4|||
149946534|NCT03965923|540938569|FG009|Overall Study|Withdrawal by Subject|0|||
149946535|NCT03965923|540938570|FG010|Overall Study|Withdrawal by Subject|2|||
149946536|NCT03965923|540938571|FG011|Overall Study|Withdrawal by Subject|0|||
149946537|NCT03965923|540938560|FG000|Overall Study|Lost to Follow-up|2|||
149946538|NCT03965923|540938561|FG001|Overall Study|Lost to Follow-up|1|||
149946539|NCT03965923|540938562|FG002|Overall Study|Lost to Follow-up|1|||
149946540|NCT03965923|540938563|FG003|Overall Study|Lost to Follow-up|0|||
149946541|NCT03965923|540938564|FG004|Overall Study|Lost to Follow-up|2|||
149946542|NCT03965923|540938565|FG005|Overall Study|Lost to Follow-up|1|||
149946543|NCT03965923|540938566|FG006|Overall Study|Lost to Follow-up|2|||
149828692|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
149828693|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
149828694|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
149828695|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
149828696|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
149828697|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
149828698|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
149828699|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
149946544|NCT03965923|540938567|FG007|Overall Study|Lost to Follow-up|1|||
149946545|NCT03965923|540938568|FG008|Overall Study|Lost to Follow-up|0|||
150276075|NCT00382720|542147901|FG000|Overall Study|Investigator/Clinical decision|5|||
150276076|NCT00382720|542147902|FG001|Overall Study|Investigator/Clinical decision|6|||
150276077|NCT00382720|542147903|FG002|Overall Study|Investigator/Clinical decision|6|||
150276078|NCT00382720|542147901|FG000|Overall Study|Discontinued at end of study|0|||
150276079|NCT00382720|542147902|FG001|Overall Study|Discontinued at end of study|1|||
150276080|NCT00382720|542147903|FG002|Overall Study|Discontinued at end of study|2|||
150276081|NCT02737852|542147906|FG000|Overall Study|Withdrawal by Subject|2|||
150276082|NCT04042740|542147908|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
150276083|NCT04042740|542147908|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
150276084|NCT04024228|542147910|FG000|Overall Study|Adverse Event|1|||
150276085|NCT04024228|542147911|FG001|Overall Study|Adverse Event|0|||
150276086|NCT04024228|542147910|FG000|Overall Study|Protocol Deviation|0|||
150276087|NCT04024228|542147911|FG001|Overall Study|Protocol Deviation|2|||
150276088|NCT04024228|542147910|FG000|Overall Study|Withdrawal by Subject|3|||
150276089|NCT04024228|542147911|FG001|Overall Study|Withdrawal by Subject|4|||
150276090|NCT02982590|542147912|FG000|Overall Study|Lost to Follow-up|0|||
150276091|NCT02982590|542147913|FG001|Overall Study|Lost to Follow-up|1|||
150276092|NCT02982590|542147912|FG000|Overall Study|Death|4|||
150276093|NCT02982590|542147913|FG001|Overall Study|Death|0|||
150276094|NCT01168973|542147916|FG000|Overall Study|Progressive Disease|341|||
150276095|NCT01168973|542147917|FG001|Overall Study|Progressive Disease|429|||
150276096|NCT01168973|542147916|FG000|Overall Study|Adverse Event|94|||
150276097|NCT01168973|542147917|FG001|Overall Study|Adverse Event|55|||
150276098|NCT01168973|542147916|FG000|Overall Study|Withdrawal by Subject|90|||
150276099|NCT01168973|542147917|FG001|Overall Study|Withdrawal by Subject|53|||
150276100|NCT01168973|542147916|FG000|Overall Study|Death|42|||
150276101|NCT01168973|542147917|FG001|Overall Study|Death|45|||
149946546|NCT03965923|540938569|FG009|Overall Study|Lost to Follow-up|2|||
149946547|NCT03965923|540938570|FG010|Overall Study|Lost to Follow-up|0|||
150276102|NCT01168973|542147916|FG000|Overall Study|Physician Decision|37|||
150276103|NCT01168973|542147917|FG001|Overall Study|Physician Decision|19|||
150276104|NCT01168973|542147916|FG000|Overall Study|Sponsor Decision|2|||
150276105|NCT01168973|542147917|FG001|Overall Study|Sponsor Decision|1|||
150276106|NCT01168973|542147916|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
150276107|NCT01168973|542147917|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
150276108|NCT02163187|542147920|FG000|Overall Study|Device removed|1|||
150276109|NCT02163187|542147921|FG001|Overall Study|Device removed|0|||
150276110|NCT02163187|542147920|FG000|Overall Study|Progressive disease|1|||
150276111|NCT02163187|542147921|FG001|Overall Study|Progressive disease|0|||
150276112|NCT03281668|542147922|FG000|Overall Study|Physician Decision|1|||
150276113|NCT03281668|542147922|FG000|Overall Study|scheduling conflict, family circumstance|2|||
150276114|NCT03281668|542147922|FG000|Overall Study|Withdrawal by Subject|4|||
150276115|NCT03281668|542147922|FG000|Overall Study|Lost to Follow-up|1|||
150276116|NCT00709111|542147928|FG000|Overall Study|Withdrawal by Subject|1|||
150276117|NCT00709111|542147928|FG000|Overall Study|Unable to attend clinic visits|1|||
150276118|NCT00290290|542147933|FG000|Overall Study|Death|3|||
150276119|NCT00290290|542147934|FG001|Overall Study|Death|4|||
150276120|NCT00290290|542147933|FG000|Overall Study|Withdrawal by Subject|2|||
150276121|NCT00290290|542147934|FG001|Overall Study|Withdrawal by Subject|2|||
150276122|NCT00290290|542147933|FG000|Overall Study|Underwent clean surgical procedure|13|||
150276123|NCT00290290|542147934|FG001|Overall Study|Underwent clean surgical procedure|12|||
150276124|NCT03374995|542147937|FG000|Overall Study|Withdrawal by Subject|0|||
150276125|NCT03374995|542147938|FG001|Overall Study|Withdrawal by Subject|1|||
150276126|NCT05111041|542147947|FG000|Overall Study|Lost to Follow-up|6|||
150276127|NCT05111041|542147948|FG001|Overall Study|Lost to Follow-up|7|||
149946548|NCT03965923|540938571|FG011|Overall Study|Lost to Follow-up|0|||
149946549|NCT03965923|540938560|FG000|Overall Study|Death|0|||
149946550|NCT03965923|540938561|FG001|Overall Study|Death|0|||
149946551|NCT03965923|540938562|FG002|Overall Study|Death|0|||
150276128|NCT05111041|542147947|FG000|Overall Study|Withdrawal by Subject|1|||
150276129|NCT05111041|542147948|FG001|Overall Study|Withdrawal by Subject|0|||
150276130|NCT00041080|542147949|FG000|Overall Study|Adverse Event|21|||
150276131|NCT00041080|542147950|FG001|Overall Study|Adverse Event|1|||
150276132|NCT00041080|542147949|FG000|Overall Study|Withdrawal by Subject|6|||
150276133|NCT00041080|542147950|FG001|Overall Study|Withdrawal by Subject|6|||
150276134|NCT00041080|542147949|FG000|Overall Study|Concommitant Illness/Other|1|||
150276135|NCT00041080|542147950|FG001|Overall Study|Concommitant Illness/Other|2|||
150276136|NCT00041080|542147949|FG000|Overall Study|Did not start therapy|1|||
150276137|NCT00041080|542147950|FG001|Overall Study|Did not start therapy|1|||
150276138|NCT00041080|542147949|FG000|Overall Study|Ineligible|1|||
150276139|NCT00041080|542147950|FG001|Overall Study|Ineligible|0|||
149946552|NCT03965923|540938563|FG003|Overall Study|Death|0|||
149946553|NCT03965923|540938564|FG004|Overall Study|Death|0|||
149946554|NCT03965923|540938565|FG005|Overall Study|Death|0|||
149946555|NCT03965923|540938566|FG006|Overall Study|Death|0|||
150276140|NCT01011439|542147951|FG000|Overall Study|Death|37|||
150276141|NCT01011439|542147951|FG000|Overall Study|Lost to Follow-up|4|||
150276142|NCT01011439|542147951|FG000|Overall Study|Withdrawal by Subject|1|||
149828700|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
149828701|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
149828702|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
149828703|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
149828704|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
149828705|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
149828706|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
149828707|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
149828708|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
149828709|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
149828710|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
149828711|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
149828712|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
149828713|NCT01957488|540504313|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
149828714|NCT01957488|540504314|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
149828715|NCT01957488|540504315|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
149828716|NCT01957488|540504316|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
149828717|NCT01957488|540504317|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
149828718|NCT01957488|540504318|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
149828719|NCT01957488|540504313|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
149828720|NCT01957488|540504314|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
149946556|NCT03965923|540938567|FG007|Overall Study|Death|1|||
149946557|NCT03965923|540938568|FG008|Overall Study|Death|4|||
149946558|NCT03965923|540938569|FG009|Overall Study|Death|0|||
149946559|NCT03965923|540938570|FG010|Overall Study|Death|4|||
149946560|NCT03965923|540938571|FG011|Overall Study|Death|0|||
149946561|NCT03965923|540938560|FG000|Overall Study|Other reason|0|||
149946562|NCT03965923|540938561|FG001|Overall Study|Other reason|0|||
149946563|NCT03965923|540938562|FG002|Overall Study|Other reason|0|||
149946564|NCT03965923|540938563|FG003|Overall Study|Other reason|1|||
149946565|NCT03965923|540938564|FG004|Overall Study|Other reason|0|||
149946566|NCT03965923|540938565|FG005|Overall Study|Other reason|0|||
149946567|NCT03965923|540938566|FG006|Overall Study|Other reason|0|||
149946568|NCT03965923|540938567|FG007|Overall Study|Other reason|0|||
149946569|NCT03965923|540938568|FG008|Overall Study|Other reason|0|||
149946570|NCT03965923|540938569|FG009|Overall Study|Other reason|0|||
149946571|NCT03965923|540938570|FG010|Overall Study|Other reason|2|||
149946572|NCT03965923|540938571|FG011|Overall Study|Other reason|0|||
149946573|NCT02452190|540938572|FG000|Overall Study|Withdrawal by Sponsor|1|||
149946574|NCT02452190|540938573|FG001|Overall Study|Withdrawal by Sponsor|3|||
149946575|NCT02452190|540938572|FG000|Overall Study|Pregnancy|1|||
149946576|NCT02452190|540938573|FG001|Overall Study|Pregnancy|0|||
149946577|NCT02452190|540938572|FG000|Overall Study|Investigator's Decision|2|||
149946578|NCT02452190|540938573|FG001|Overall Study|Investigator's Decision|0|||
149946579|NCT02452190|540938572|FG000|Overall Study|Lack of Efficacy|3|||
149946580|NCT02452190|540938573|FG001|Overall Study|Lack of Efficacy|1|||
149946581|NCT02452190|540938572|FG000|Overall Study|Lost to Follow-up|4|||
149946582|NCT02452190|540938573|FG001|Overall Study|Lost to Follow-up|3|||
149946583|NCT02452190|540938572|FG000|Overall Study|Adverse Event|2|||
149946584|NCT02452190|540938573|FG001|Overall Study|Adverse Event|5|||
149946585|NCT02452190|540938572|FG000|Overall Study|Withdrawal by Subject|20|||
149946586|NCT02452190|540938573|FG001|Overall Study|Withdrawal by Subject|11|||
149946587|NCT02452190|540938572|FG000|Overall Study|Noncompliance with study drug|1|||
149946588|NCT02452190|540938573|FG001|Overall Study|Noncompliance with study drug|0|||
149946589|NCT02452190|540938572|FG000|Overall Study|Participant traveled abroad|1|||
149946590|NCT02452190|540938573|FG001|Overall Study|Participant traveled abroad|0|||
149946591|NCT02452190|540938572|FG000|Overall Study|Death|0|||
149946592|NCT02452190|540938573|FG001|Overall Study|Death|1|||
149946593|NCT06001021|540938576|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
149828721|NCT01957488|540504315|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
149828722|NCT01957488|540504316|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
149946594|NCT06001021|540938577|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
149946595|NCT06001021|540938578|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
149946596|NCT06001021|540938579|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
149946597|NCT06001021|540938580|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
149946598|NCT06001021|540938581|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
149946599|NCT06001021|540938582|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
149946600|NCT06001021|540938576|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
149946601|NCT06001021|540938577|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
149828723|NCT01957488|540504317|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
149946602|NCT06001021|540938578|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
149946603|NCT06001021|540938579|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
149946604|NCT06001021|540938580|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
149946605|NCT06001021|540938581|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
149828724|NCT01957488|540504318|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
149828725|NCT01957488|540504313|FG000|Test Period 2 (2 Weeks)|Other|1|||
149828726|NCT01957488|540504314|FG001|Test Period 2 (2 Weeks)|Other|0|||
149828727|NCT01957488|540504315|FG002|Test Period 2 (2 Weeks)|Other|0|||
149828728|NCT01957488|540504316|FG003|Test Period 2 (2 Weeks)|Other|0|||
149828729|NCT01957488|540504317|FG004|Test Period 2 (2 Weeks)|Other|0|||
149828730|NCT01957488|540504318|FG005|Test Period 2 (2 Weeks)|Other|0|||
149828731|NCT01957488|540504313|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
149828732|NCT01957488|540504314|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
149828733|NCT01957488|540504315|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
149828734|NCT01957488|540504316|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
149828735|NCT01957488|540504317|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
149828736|NCT01957488|540504318|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
149828737|NCT01957488|540504313|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
149828738|NCT01957488|540504314|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
149828739|NCT01957488|540504315|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
149828740|NCT01957488|540504316|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
149828741|NCT01957488|540504317|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
149828742|NCT01957488|540504318|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
149828743|NCT01957488|540504313|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149828744|NCT01957488|540504314|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149828745|NCT01957488|540504315|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149828746|NCT01957488|540504316|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149828747|NCT01957488|540504317|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149828748|NCT01957488|540504318|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
149828749|NCT01957488|540504313|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
149828750|NCT01957488|540504314|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
149828751|NCT01957488|540504315|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
149828752|NCT01957488|540504316|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
149828753|NCT01957488|540504317|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
149828754|NCT01957488|540504318|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
149828755|NCT01957488|540504313|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
149828756|NCT01957488|540504314|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
149828757|NCT01957488|540504315|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
149828758|NCT01957488|540504316|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
149828759|NCT01957488|540504317|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
149828760|NCT01957488|540504318|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
149828761|NCT01424722|540504319|FG000|Overall Study|Sponsor terminated investigation|2258|||
149828762|NCT01025037|540504320|FG000|Overall Study|Adverse Event|3|||
149828763|NCT01025037|540504320|FG000|Overall Study|Lost to Follow-up|7|||
149828764|NCT01025037|540504320|FG000|Overall Study|Withdrawal by Subject|1|||
149828765|NCT02674334|540504323|FG000|Overall Study|Lost to Follow-up|5|||
149828766|NCT02674334|540504324|FG001|Overall Study|Lost to Follow-up|3|||
149828767|NCT02674334|540504323|FG000|Overall Study|participant difficulty breathing|1|||
149828768|NCT02674334|540504324|FG001|Overall Study|participant difficulty breathing|0|||
149828769|NCT02674334|540504323|FG000|Overall Study|NIRS not recording|1|||
149828770|NCT02674334|540504324|FG001|Overall Study|NIRS not recording|0|||
149828771|NCT02660242|540504330|FG000|Glucose Tabs|Lost to Follow-up|1|||
149828772|NCT02660242|540504330|FG000|Glucagon Injection|Lost to Follow-up|1|||
149828773|NCT00770510|540504331|FG000|Overall Study|Lost to Follow-up|2|||
149828774|NCT00770510|540504331|FG000|Overall Study|Pregnancy|1|||
149828775|NCT00770510|540504331|FG000|Overall Study|Withdrawal by Subject|2|||
149828776|NCT02796664|540504335|FG000|Overall Study|Withdrawal by Subject|0|||
149828777|NCT02796664|540504336|FG001|Overall Study|Withdrawal by Subject|3|||
149828778|NCT02796664|540504335|FG000|Overall Study|Noncompliance|1|||
149828779|NCT02796664|540504336|FG001|Overall Study|Noncompliance|1|||
149828780|NCT02796664|540504335|FG000|Overall Study|Death|0|||
149828781|NCT02796664|540504336|FG001|Overall Study|Death|1|||
149828782|NCT00995553|540504340|FG000|Overall Study|Withdrawal by Subject|2|||
149828783|NCT00995553|540504341|FG001|Overall Study|Withdrawal by Subject|6|||
149828784|NCT01531205|540504342|FG000|Overall Study|Did not proceed to surgery|1|||
149828785|NCT00927810|540504343|FG000|Overall Study|Withdrawal by Subject|0|||
149828786|NCT00927810|540504344|FG001|Overall Study|Withdrawal by Subject|3|||
149828787|NCT00927810|540504345|FG002|Overall Study|Withdrawal by Subject|0|||
149828788|NCT00927810|540504346|FG003|Overall Study|Withdrawal by Subject|1|||
149828789|NCT00927810|540504343|FG000|Overall Study|Lost to Follow-up|0|||
149828790|NCT00927810|540504344|FG001|Overall Study|Lost to Follow-up|2|||
149828791|NCT00927810|540504345|FG002|Overall Study|Lost to Follow-up|1|||
149828792|NCT00927810|540504346|FG003|Overall Study|Lost to Follow-up|1|||
149828793|NCT00927810|540504343|FG000|Overall Study|Death|0|||
149828794|NCT00927810|540504344|FG001|Overall Study|Death|2|||
149828795|NCT00927810|540504345|FG002|Overall Study|Death|0|||
149828796|NCT00927810|540504346|FG003|Overall Study|Death|0|||
149828797|NCT00927810|540504343|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149828798|NCT00927810|540504344|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149828799|NCT00927810|540504345|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149828800|NCT00927810|540504346|FG003|Overall Study|Abnormal laboratory value(s)|0|||
149828801|NCT02465567|540504349|FG000|Overall Study|Adverse Event|118|||
149828802|NCT02465567|540504350|FG001|Overall Study|Adverse Event|113|||
149828803|NCT02465567|540504351|FG002|Overall Study|Adverse Event|147|||
149828804|NCT02465567|540504352|FG003|Overall Study|Adverse Event|138|||
149828805|NCT02465567|540504349|FG000|Overall Study|Lack of Efficacy|103|||
149828806|NCT02465567|540504350|FG001|Overall Study|Lack of Efficacy|102|||
149828807|NCT02465567|540504351|FG002|Overall Study|Lack of Efficacy|171|||
149828808|NCT02465567|540504352|FG003|Overall Study|Lack of Efficacy|135|||
149828809|NCT02465567|540504349|FG000|Overall Study|Withdrawal by Subject|104|||
149828810|NCT02465567|540504350|FG001|Overall Study|Withdrawal by Subject|94|||
149828811|NCT02465567|540504351|FG002|Overall Study|Withdrawal by Subject|123|||
149828812|NCT02465567|540504352|FG003|Overall Study|Withdrawal by Subject|130|||
149828813|NCT02465567|540504349|FG000|Overall Study|Physician Decision|23|||
149828814|NCT02465567|540504350|FG001|Overall Study|Physician Decision|33|||
149828815|NCT02465567|540504351|FG002|Overall Study|Physician Decision|38|||
149828816|NCT02465567|540504352|FG003|Overall Study|Physician Decision|28|||
149828817|NCT02465567|540504349|FG000|Overall Study|Major Protocol Deviation|24|||
149828818|NCT02465567|540504350|FG001|Overall Study|Major Protocol Deviation|26|||
149828819|NCT02465567|540504351|FG002|Overall Study|Major Protocol Deviation|22|||
149828820|NCT02465567|540504352|FG003|Overall Study|Major Protocol Deviation|25|||
149828821|NCT02465567|540504349|FG000|Overall Study|Lost to Follow-up|25|||
149828822|NCT02465567|540504350|FG001|Overall Study|Lost to Follow-up|21|||
149828823|NCT02465567|540504351|FG002|Overall Study|Lost to Follow-up|19|||
149828824|NCT02465567|540504352|FG003|Overall Study|Lost to Follow-up|15|||
149828825|NCT02465567|540504349|FG000|Overall Study|Protocol Specified Criteria|20|||
149828826|NCT02465567|540504350|FG001|Overall Study|Protocol Specified Criteria|10|||
149828827|NCT02465567|540504351|FG002|Overall Study|Protocol Specified Criteria|9|||
149828828|NCT02465567|540504352|FG003|Overall Study|Protocol Specified Criteria|12|||
149828829|NCT02465567|540504349|FG000|Overall Study|Administrative Reasons|12|||
149828830|NCT02465567|540504350|FG001|Overall Study|Administrative Reasons|9|||
149828831|NCT02465567|540504351|FG002|Overall Study|Administrative Reasons|11|||
149828832|NCT02465567|540504352|FG003|Overall Study|Administrative Reasons|5|||
150033213|NCT01247324|541260917|FG001|Overall Study|Missing|1|||
150033214|NCT00506350|541260918|FG000|Overall Study|Serious Adverse Event|1|||
150033215|NCT00506350|541260919|FG001|Overall Study|Serious Adverse Event|0|||
150033216|NCT00506350|541260920|FG002|Overall Study|Serious Adverse Event|0|||
150033217|NCT00506350|541260921|FG003|Overall Study|Serious Adverse Event|0|||
150033218|NCT00506350|541260922|FG004|Overall Study|Serious Adverse Event|0|||
150033219|NCT00506350|541260923|FG005|Overall Study|Serious Adverse Event|0|||
150033220|NCT00506350|541260924|FG006|Overall Study|Serious Adverse Event|0|||
150033221|NCT00506350|541260925|FG007|Overall Study|Serious Adverse Event|0|||
150033222|NCT00506350|541260926|FG008|Overall Study|Serious Adverse Event|0|||
150033223|NCT00506350|541260918|FG000|Overall Study|Adverse Event|0|||
150033224|NCT00506350|541260919|FG001|Overall Study|Adverse Event|0|||
150033225|NCT00506350|541260920|FG002|Overall Study|Adverse Event|0|||
150033226|NCT00506350|541260921|FG003|Overall Study|Adverse Event|0|||
150033227|NCT00506350|541260922|FG004|Overall Study|Adverse Event|0|||
150033228|NCT00506350|541260923|FG005|Overall Study|Adverse Event|0|||
150033229|NCT00506350|541260924|FG006|Overall Study|Adverse Event|0|||
150033230|NCT00506350|541260925|FG007|Overall Study|Adverse Event|1|||
150033231|NCT00506350|541260926|FG008|Overall Study|Adverse Event|1|||
150033232|NCT00506350|541260918|FG000|Overall Study|Protocol Violation|0|||
150276143|NCT01011439|542147951|FG000|Overall Study|Sponsor's decision|15|||
150276144|NCT00058552|542147952|FG000|Overall Study|Died prior to receiving treatment|4|||
150033233|NCT00506350|541260919|FG001|Overall Study|Protocol Violation|0|||
150033234|NCT00506350|541260920|FG002|Overall Study|Protocol Violation|1|||
150033235|NCT00506350|541260921|FG003|Overall Study|Protocol Violation|0|||
150033236|NCT00506350|541260922|FG004|Overall Study|Protocol Violation|0|||
150033237|NCT00506350|541260923|FG005|Overall Study|Protocol Violation|0|||
150276145|NCT00058552|542147953|FG001|Overall Study|Died prior to receiving treatment|2|||
149828833|NCT02465567|540504349|FG000|Overall Study|Randomized but not treated|1|||
149828834|NCT02465567|540504350|FG001|Overall Study|Randomized but not treated|5|||
149828835|NCT02465567|540504351|FG002|Overall Study|Randomized but not treated|4|||
149828836|NCT02465567|540504352|FG003|Overall Study|Randomized but not treated|5|||
149828837|NCT02465567|540504349|FG000|Overall Study|enrolled in >1 studies|18|||
149828838|NCT02465567|540504350|FG001|Overall Study|enrolled in >1 studies|11|||
149828839|NCT02465567|540504351|FG002|Overall Study|enrolled in >1 studies|19|||
149828840|NCT02465567|540504352|FG003|Overall Study|enrolled in >1 studies|15|||
149828841|NCT02465567|540504349|FG000|Overall Study|missing PI Signature|1|||
149828842|NCT02465567|540504350|FG001|Overall Study|missing PI Signature|0|||
149828843|NCT02465567|540504351|FG002|Overall Study|missing PI Signature|0|||
150033238|NCT00506350|541260924|FG006|Overall Study|Protocol Violation|1|||
150033239|NCT00506350|541260925|FG007|Overall Study|Protocol Violation|0|||
150033240|NCT00506350|541260926|FG008|Overall Study|Protocol Violation|0|||
149828844|NCT02465567|540504352|FG003|Overall Study|missing PI Signature|0|||
150033241|NCT00506350|541260918|FG000|Overall Study|Withdrawal by Subject|0|||
149828845|NCT02001558|540504353|FG000|Overall Study|Lost to Follow-up|8|||
149828846|NCT02001558|540504354|FG001|Overall Study|Lost to Follow-up|14|||
149828847|NCT04117607|540504355|FG000|Overall Study|Early Termination|0|||
149828848|NCT04117607|540504356|FG001|Overall Study|Early Termination|1|||
149828849|NCT04117607|540504357|FG002|Overall Study|Early Termination|0|||
149828850|NCT04117607|540504358|FG003|Overall Study|Early Termination|0|||
149828851|NCT04117607|540504359|FG004|Overall Study|Early Termination|0|||
149828852|NCT04117607|540504360|FG005|Overall Study|Early Termination|0|||
149828853|NCT04117607|540504361|FG006|Overall Study|Early Termination|1|||
149828854|NCT04117607|540504362|FG007|Overall Study|Early Termination|0|||
149828855|NCT04117607|540504363|FG008|Overall Study|Early Termination|0|||
149828856|NCT04117607|540504364|FG009|Overall Study|Early Termination|0|||
149828857|NCT04117607|540504365|FG010|Overall Study|Early Termination|0|||
149828858|NCT04117607|540504366|FG011|Overall Study|Early Termination|0|||
149828859|NCT04117607|540504367|FG012|Overall Study|Early Termination|0|||
149828860|NCT04117607|540504368|FG013|Overall Study|Early Termination|0|||
149828861|NCT00950807|540504371|FG000|Treatment Period 1|Lack of Efficacy|1|||
149828862|NCT00950807|540504372|FG001|Treatment Period 1|Lack of Efficacy|0|||
149828863|NCT00950807|540504373|FG002|Treatment Period 1|Lack of Efficacy|0|||
149828864|NCT00950807|540504374|FG003|Treatment Period 1|Lack of Efficacy|0|||
149828865|NCT00950807|540504375|FG004|Treatment Period 1|Lack of Efficacy|0|||
149828866|NCT00950807|540504376|FG005|Treatment Period 1|Lack of Efficacy|1|||
149828867|NCT00950807|540504377|FG006|Treatment Period 1|Lack of Efficacy|0|||
149828868|NCT00950807|540504378|FG007|Treatment Period 1|Lack of Efficacy|0|||
149828869|NCT00950807|540504379|FG008|Treatment Period 1|Lack of Efficacy|0|||
149828870|NCT00950807|540504380|FG009|Treatment Period 1|Lack of Efficacy|0|||
149828871|NCT00950807|540504371|FG000|Treatment Period 1|Protocol Violation|1|||
149828872|NCT00950807|540504372|FG001|Treatment Period 1|Protocol Violation|0|||
149828873|NCT00950807|540504373|FG002|Treatment Period 1|Protocol Violation|0|||
149828874|NCT00950807|540504374|FG003|Treatment Period 1|Protocol Violation|0|||
149828875|NCT00950807|540504375|FG004|Treatment Period 1|Protocol Violation|0|||
149828876|NCT00950807|540504376|FG005|Treatment Period 1|Protocol Violation|0|||
149828877|NCT00950807|540504377|FG006|Treatment Period 1|Protocol Violation|0|||
149828878|NCT00950807|540504378|FG007|Treatment Period 1|Protocol Violation|0|||
149828879|NCT00950807|540504379|FG008|Treatment Period 1|Protocol Violation|0|||
149828880|NCT00950807|540504380|FG009|Treatment Period 1|Protocol Violation|0|||
149946606|NCT06001021|540938582|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
149946607|NCT06001866|540938583|FG000|Overall Study|Withdrawal by Subject|0|||
149946608|NCT06001866|540938584|FG001|Overall Study|Withdrawal by Subject|2|||
149946609|NCT06001866|540938583|FG000|Overall Study|Protocol Violation|0|||
149946610|NCT06001866|540938584|FG001|Overall Study|Protocol Violation|2|||
149946611|NCT00207740|540938585|FG000|Overall Study|Adverse Event|4|||
149946612|NCT00207740|540938586|FG001|Overall Study|Adverse Event|14|||
149946613|NCT00207740|540938587|FG002|Overall Study|Adverse Event|14|||
149946614|NCT00207740|540938588|FG003|Overall Study|Adverse Event|11|||
149946615|NCT00207740|540938585|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149946616|NCT00207740|540938586|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149946617|NCT00207740|540938587|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149946618|NCT00207740|540938588|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
149946619|NCT00207740|540938585|FG000|Overall Study|Lost to Follow-up|0|||
149946620|NCT00207740|540938586|FG001|Overall Study|Lost to Follow-up|2|||
149946621|NCT00207740|540938587|FG002|Overall Study|Lost to Follow-up|1|||
149946622|NCT00207740|540938588|FG003|Overall Study|Lost to Follow-up|1|||
149946623|NCT00207740|540938585|FG000|Overall Study|Death|0|||
149946624|NCT00207740|540938586|FG001|Overall Study|Death|0|||
149946625|NCT00207740|540938587|FG002|Overall Study|Death|0|||
149946626|NCT00207740|540938588|FG003|Overall Study|Death|1|||
149946627|NCT00207740|540938585|FG000|Overall Study|Sponsor Directive|22|||
149946628|NCT00207740|540938586|FG001|Overall Study|Sponsor Directive|15|||
149946629|NCT00207740|540938587|FG002|Overall Study|Sponsor Directive|16|||
149828881|NCT00950807|540504371|FG000|Treatment Period 1|Lost to Follow-up|0|||
149946630|NCT00207740|540938588|FG003|Overall Study|Sponsor Directive|21|||
149946631|NCT00207740|540938585|FG000|Overall Study|Other|2|||
149828882|NCT00950807|540504372|FG001|Treatment Period 1|Lost to Follow-up|0|||
149828883|NCT00950807|540504373|FG002|Treatment Period 1|Lost to Follow-up|1|||
149828884|NCT00950807|540504374|FG003|Treatment Period 1|Lost to Follow-up|0|||
149828885|NCT00950807|540504375|FG004|Treatment Period 1|Lost to Follow-up|0|||
149946632|NCT00207740|540938586|FG001|Overall Study|Other|10|||
149946633|NCT00207740|540938587|FG002|Overall Study|Other|7|||
149946634|NCT00207740|540938588|FG003|Overall Study|Other|5|||
149828886|NCT00950807|540504376|FG005|Treatment Period 1|Lost to Follow-up|0|||
149828887|NCT00950807|540504377|FG006|Treatment Period 1|Lost to Follow-up|0|||
149828888|NCT00950807|540504378|FG007|Treatment Period 1|Lost to Follow-up|0|||
149828889|NCT00950807|540504379|FG008|Treatment Period 1|Lost to Follow-up|0|||
149828890|NCT00950807|540504380|FG009|Treatment Period 1|Lost to Follow-up|0|||
149828891|NCT00950807|540504371|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149946635|NCT03916926|540938589|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
149946636|NCT03916926|540938590|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
150276146|NCT00058552|542147952|FG000|Overall Study|Disease progression|52|||
150276147|NCT00058552|542147953|FG001|Overall Study|Disease progression|44|||
150276148|NCT00058552|542147952|FG000|Overall Study|Adverse Event|4|||
150276149|NCT00058552|542147953|FG001|Overall Study|Adverse Event|2|||
150276150|NCT00058552|542147952|FG000|Overall Study|Withdrawal by Subject|3|||
150276151|NCT00058552|542147953|FG001|Overall Study|Withdrawal by Subject|5|||
150276152|NCT00058552|542147952|FG000|Overall Study|Physician Decision|2|||
150276153|NCT00058552|542147953|FG001|Overall Study|Physician Decision|5|||
150276154|NCT00058552|542147952|FG000|Overall Study|Clinical disease progression|0|||
150276155|NCT00058552|542147953|FG001|Overall Study|Clinical disease progression|4|||
150276156|NCT00359021|542147954|FG000|Overall Study|Adverse Event|26|||
150276157|NCT00359021|542147955|FG001|Overall Study|Adverse Event|8|||
150276158|NCT00359021|542147954|FG000|Overall Study|Subject Non-Compliant|1|||
150276159|NCT00359021|542147955|FG001|Overall Study|Subject Non-Compliant|2|||
150276160|NCT00359021|542147954|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
150276161|NCT00359021|542147955|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
150276162|NCT00359021|542147954|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
149828892|NCT00950807|540504372|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149828893|NCT00950807|540504373|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149828894|NCT00950807|540504374|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149828895|NCT00950807|540504375|FG004|Treatment Period 1|Withdrawal by Subject|1|||
149828896|NCT00950807|540504376|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149946637|NCT03916926|540938589|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
149946638|NCT03916926|540938590|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
149946639|NCT03916926|540938589|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
149946640|NCT03916926|540938590|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
149828897|NCT00950807|540504377|FG006|Treatment Period 1|Withdrawal by Subject|0|||
149828898|NCT00950807|540504378|FG007|Treatment Period 1|Withdrawal by Subject|0|||
149828899|NCT00950807|540504379|FG008|Treatment Period 1|Withdrawal by Subject|1|||
149828900|NCT00950807|540504380|FG009|Treatment Period 1|Withdrawal by Subject|0|||
149828901|NCT00950807|540504371|FG000|Treatment Period 1|Adverse Event|0|||
149828902|NCT00950807|540504372|FG001|Treatment Period 1|Adverse Event|0|||
149828903|NCT00950807|540504373|FG002|Treatment Period 1|Adverse Event|0|||
149828904|NCT00950807|540504374|FG003|Treatment Period 1|Adverse Event|0|||
149828905|NCT00950807|540504375|FG004|Treatment Period 1|Adverse Event|0|||
149828906|NCT00950807|540504376|FG005|Treatment Period 1|Adverse Event|1|||
149828907|NCT00950807|540504377|FG006|Treatment Period 1|Adverse Event|0|||
149828908|NCT00950807|540504378|FG007|Treatment Period 1|Adverse Event|0|||
149828909|NCT00950807|540504379|FG008|Treatment Period 1|Adverse Event|0|||
149828910|NCT00950807|540504380|FG009|Treatment Period 1|Adverse Event|0|||
149828911|NCT00950807|540504371|FG000|Washout Period 1|Lack of Efficacy|0|||
149828912|NCT00950807|540504372|FG001|Washout Period 1|Lack of Efficacy|0|||
149828913|NCT00950807|540504373|FG002|Washout Period 1|Lack of Efficacy|0|||
149828914|NCT00950807|540504374|FG003|Washout Period 1|Lack of Efficacy|0|||
149828915|NCT00950807|540504375|FG004|Washout Period 1|Lack of Efficacy|0|||
149828916|NCT00950807|540504376|FG005|Washout Period 1|Lack of Efficacy|0|||
149828917|NCT00950807|540504377|FG006|Washout Period 1|Lack of Efficacy|1|||
149828918|NCT00950807|540504378|FG007|Washout Period 1|Lack of Efficacy|0|||
149828919|NCT00950807|540504379|FG008|Washout Period 1|Lack of Efficacy|0|||
149828920|NCT00950807|540504380|FG009|Washout Period 1|Lack of Efficacy|0|||
149828921|NCT00950807|540504371|FG000|Washout Period 1|Withdrawal by Subject|0|||
149828922|NCT00950807|540504372|FG001|Washout Period 1|Withdrawal by Subject|0|||
149828923|NCT00950807|540504373|FG002|Washout Period 1|Withdrawal by Subject|0|||
149828924|NCT00950807|540504374|FG003|Washout Period 1|Withdrawal by Subject|0|||
149828925|NCT00950807|540504375|FG004|Washout Period 1|Withdrawal by Subject|0|||
149828926|NCT00950807|540504376|FG005|Washout Period 1|Withdrawal by Subject|0|||
149828927|NCT00950807|540504377|FG006|Washout Period 1|Withdrawal by Subject|0|||
149828928|NCT00950807|540504378|FG007|Washout Period 1|Withdrawal by Subject|0|||
149828929|NCT00950807|540504379|FG008|Washout Period 1|Withdrawal by Subject|1|||
149828930|NCT00950807|540504380|FG009|Washout Period 1|Withdrawal by Subject|0|||
149828931|NCT00950807|540504371|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
149946641|NCT03916926|540938589|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
149946642|NCT03916926|540938590|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
149946643|NCT02802228|540938594|FG000|Overall Study|Withdrawal by Subject|2|||
150276163|NCT00359021|542147955|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
149828932|NCT00950807|540504372|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828933|NCT00950807|540504373|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828934|NCT00950807|540504374|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828935|NCT00950807|540504375|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828936|NCT00950807|540504376|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828937|NCT00950807|540504377|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
149828938|NCT00950807|540504378|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
149828939|NCT00950807|540504379|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149946644|NCT02802228|540938595|FG001|Overall Study|Withdrawal by Subject|0|||
149828940|NCT00950807|540504380|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
149828941|NCT00950807|540504371|FG000|Washout Period 1|Adverse Event|2|||
149828942|NCT00950807|540504372|FG001|Washout Period 1|Adverse Event|0|||
149828943|NCT00950807|540504373|FG002|Washout Period 1|Adverse Event|0|||
149828944|NCT00950807|540504374|FG003|Washout Period 1|Adverse Event|1|||
149828945|NCT00950807|540504375|FG004|Washout Period 1|Adverse Event|1|||
149828946|NCT00950807|540504376|FG005|Washout Period 1|Adverse Event|0|||
149828947|NCT00950807|540504377|FG006|Washout Period 1|Adverse Event|0|||
149828948|NCT00950807|540504378|FG007|Washout Period 1|Adverse Event|0|||
149828949|NCT00950807|540504379|FG008|Washout Period 1|Adverse Event|0|||
149946645|NCT02802228|540938594|FG000|Overall Study|Lost to Follow-up|1|||
150276164|NCT00359021|542147954|FG000|Overall Study|Withdrawal by Subject|2|||
150276165|NCT00359021|542147955|FG001|Overall Study|Withdrawal by Subject|9|||
150276166|NCT00359021|542147954|FG000|Overall Study|Lost to Follow-up|1|||
150276167|NCT00359021|542147955|FG001|Overall Study|Lost to Follow-up|0|||
150276168|NCT00359021|542147954|FG000|Overall Study|Other|4|||
150276169|NCT00359021|542147955|FG001|Overall Study|Other|1|||
150276170|NCT00359021|542147954|FG000|Overall Study|Pregnancy|1|||
150276171|NCT00359021|542147955|FG001|Overall Study|Pregnancy|0|||
150276172|NCT03861936|542147956|FG000|Overall Study|Withdrawal by Subject|4|||
149946646|NCT02802228|540938595|FG001|Overall Study|Lost to Follow-up|0|||
149946647|NCT02802228|540938594|FG000|Overall Study|Adverse Event|1|||
149946648|NCT02802228|540938595|FG001|Overall Study|Adverse Event|0|||
149946649|NCT02802228|540938594|FG000|Overall Study|Physician Decision|1|||
149946650|NCT02802228|540938595|FG001|Overall Study|Physician Decision|0|||
149946651|NCT01925794|540938598|FG000|180 Days|Death|2|||
149946652|NCT01925794|540938598|FG000|180 Days|Withdrawal by Subject|2|||
149946653|NCT01925794|540938598|FG000|270 Days|Death|2|||
149946654|NCT01925794|540938598|FG000|270 Days|Protocol Violation|3|||
149946655|NCT01901562|540938599|FG000|Overall Study|Protocol Violation|5|||
149946656|NCT01901562|540938599|FG000|Overall Study|Excluded intraoperatively|4|||
149946657|NCT01564407|540938600|FG000|Overall Study|Lost to Follow-up|0|||
149946658|NCT01564407|540938601|FG001|Overall Study|Lost to Follow-up|1|||
149946659|NCT01564407|540938602|FG002|Overall Study|Lost to Follow-up|0|||
149946660|NCT01564407|540938603|FG003|Overall Study|Lost to Follow-up|0|||
149946661|NCT01564407|540938604|FG004|Overall Study|Lost to Follow-up|0|||
149946662|NCT01564407|540938600|FG000|Overall Study|Withdrawal by Subject|0|||
149946663|NCT01564407|540938601|FG001|Overall Study|Withdrawal by Subject|1|||
149946664|NCT01564407|540938602|FG002|Overall Study|Withdrawal by Subject|0|||
149946665|NCT01564407|540938603|FG003|Overall Study|Withdrawal by Subject|0|||
149946666|NCT01564407|540938604|FG004|Overall Study|Withdrawal by Subject|0|||
149946667|NCT01564407|540938600|FG000|Overall Study|funding lost, study ended|0|||
149946668|NCT01564407|540938601|FG001|Overall Study|funding lost, study ended|0|||
149946669|NCT01564407|540938602|FG002|Overall Study|funding lost, study ended|0|||
149946670|NCT01564407|540938603|FG003|Overall Study|funding lost, study ended|1|||
149946671|NCT01564407|540938604|FG004|Overall Study|funding lost, study ended|0|||
149946672|NCT03126110|540938606|FG000|Phase 1|Death|2|||
149946673|NCT03126110|540938607|FG001|Phase 1|Death|2|||
149946674|NCT03126110|540938608|FG002|Phase 1|Death|4|||
149946675|NCT03126110|540938609|FG003|Phase 1|Death|3|||
149946676|NCT03126110|540938610|FG004|Phase 1|Death|4|||
149946677|NCT03126110|540938611|FG005|Phase 1|Death|4|||
149946678|NCT03126110|540938612|FG006|Phase 1|Death|3|||
149946679|NCT03126110|540938613|FG007|Phase 1|Death|4|||
149946680|NCT03126110|540938614|FG008|Phase 1|Death|5|||
149946681|NCT03126110|540938615|FG009|Phase 1|Death|2|||
149946682|NCT03126110|540938616|FG010|Phase 1|Death|6|||
149946683|NCT03126110|540938617|FG011|Phase 1|Death|0|||
149946684|NCT03126110|540938618|FG012|Phase 1|Death|0|||
150276173|NCT03861936|542147957|FG001|Overall Study|Withdrawal by Subject|1|||
150276174|NCT03861936|542147958|FG002|Overall Study|Withdrawal by Subject|3|||
150276175|NCT03861936|542147956|FG000|Overall Study|Lost to Follow-up|5|||
150276176|NCT03861936|542147957|FG001|Overall Study|Lost to Follow-up|3|||
149946685|NCT03126110|540938619|FG013|Phase 1|Death|0|||
149946686|NCT03126110|540938620|FG014|Phase 1|Death|0|||
149946687|NCT03126110|540938621|FG015|Phase 1|Death|0|||
149946688|NCT03126110|540938622|FG016|Phase 1|Death|0|||
149946689|NCT03126110|540938606|FG000|Phase 1|Lost to Follow-up|0|||
149946690|NCT03126110|540938607|FG001|Phase 1|Lost to Follow-up|1|||
149946691|NCT03126110|540938608|FG002|Phase 1|Lost to Follow-up|0|||
150276177|NCT03861936|542147958|FG002|Overall Study|Lost to Follow-up|3|||
150276178|NCT03861936|542147956|FG000|Overall Study|Physician Decision|0|||
150276179|NCT03861936|542147957|FG001|Overall Study|Physician Decision|1|||
150276180|NCT03861936|542147958|FG002|Overall Study|Physician Decision|0|||
150276181|NCT03861936|542147956|FG000|Overall Study|Protocol Deviation|0|||
150276182|NCT03861936|542147957|FG001|Overall Study|Protocol Deviation|0|||
149946692|NCT03126110|540938609|FG003|Phase 1|Lost to Follow-up|0|||
149828950|NCT00950807|540504380|FG009|Washout Period 1|Adverse Event|0|||
149946693|NCT03126110|540938610|FG004|Phase 1|Lost to Follow-up|0|||
149946694|NCT03126110|540938611|FG005|Phase 1|Lost to Follow-up|0|||
149946695|NCT03126110|540938612|FG006|Phase 1|Lost to Follow-up|0|||
149946696|NCT03126110|540938613|FG007|Phase 1|Lost to Follow-up|0|||
149946697|NCT03126110|540938614|FG008|Phase 1|Lost to Follow-up|1|||
149946698|NCT03126110|540938615|FG009|Phase 1|Lost to Follow-up|0|||
149828951|NCT00950807|540504371|FG000|Treatment Period 2|Lack of Efficacy|1|||
149828952|NCT00950807|540504372|FG001|Treatment Period 2|Lack of Efficacy|0|||
149828953|NCT00950807|540504373|FG002|Treatment Period 2|Lack of Efficacy|0|||
149828954|NCT00950807|540504374|FG003|Treatment Period 2|Lack of Efficacy|0|||
149828955|NCT00950807|540504375|FG004|Treatment Period 2|Lack of Efficacy|0|||
149828956|NCT00950807|540504376|FG005|Treatment Period 2|Lack of Efficacy|0|||
149828957|NCT00950807|540504377|FG006|Treatment Period 2|Lack of Efficacy|0|||
149828958|NCT00950807|540504378|FG007|Treatment Period 2|Lack of Efficacy|0|||
149828959|NCT00950807|540504379|FG008|Treatment Period 2|Lack of Efficacy|0|||
149828960|NCT00950807|540504380|FG009|Treatment Period 2|Lack of Efficacy|0|||
149828961|NCT00950807|540504371|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149828962|NCT00950807|540504372|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149828963|NCT00950807|540504373|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149828964|NCT00950807|540504374|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149828965|NCT00950807|540504375|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149828966|NCT00950807|540504376|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149828967|NCT00950807|540504377|FG006|Treatment Period 2|Withdrawal by Subject|1|||
149828968|NCT00950807|540504378|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149828969|NCT00950807|540504379|FG008|Treatment Period 2|Withdrawal by Subject|0|||
149828970|NCT00950807|540504380|FG009|Treatment Period 2|Withdrawal by Subject|0|||
149828971|NCT00950807|540504371|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
149828972|NCT00950807|540504372|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828973|NCT00950807|540504373|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828974|NCT00950807|540504374|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828975|NCT00950807|540504375|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828976|NCT00950807|540504376|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828977|NCT00950807|540504377|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828978|NCT00950807|540504378|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828979|NCT00950807|540504379|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828980|NCT00950807|540504380|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149828981|NCT00950807|540504371|FG000|Treatment Period 2|Adverse Event|0|||
149828982|NCT00950807|540504372|FG001|Treatment Period 2|Adverse Event|1|||
149828983|NCT00950807|540504373|FG002|Treatment Period 2|Adverse Event|0|||
149828984|NCT00950807|540504374|FG003|Treatment Period 2|Adverse Event|1|||
149828985|NCT00950807|540504375|FG004|Treatment Period 2|Adverse Event|0|||
149828986|NCT00950807|540504376|FG005|Treatment Period 2|Adverse Event|1|||
149828987|NCT00950807|540504377|FG006|Treatment Period 2|Adverse Event|0|||
149828988|NCT00950807|540504378|FG007|Treatment Period 2|Adverse Event|1|||
149828989|NCT00950807|540504379|FG008|Treatment Period 2|Adverse Event|0|||
149828990|NCT00950807|540504380|FG009|Treatment Period 2|Adverse Event|0|||
149828991|NCT00950807|540504371|FG000|Washout Period 2|Lack of Efficacy|1|||
149828992|NCT00950807|540504372|FG001|Washout Period 2|Lack of Efficacy|0|||
149828993|NCT00950807|540504373|FG002|Washout Period 2|Lack of Efficacy|0|||
149828994|NCT00950807|540504374|FG003|Washout Period 2|Lack of Efficacy|0|||
149828995|NCT00950807|540504375|FG004|Washout Period 2|Lack of Efficacy|0|||
149828996|NCT00950807|540504376|FG005|Washout Period 2|Lack of Efficacy|0|||
149828997|NCT00950807|540504377|FG006|Washout Period 2|Lack of Efficacy|0|||
149828998|NCT00950807|540504378|FG007|Washout Period 2|Lack of Efficacy|0|||
149828999|NCT00950807|540504379|FG008|Washout Period 2|Lack of Efficacy|0|||
149829000|NCT00950807|540504380|FG009|Washout Period 2|Lack of Efficacy|0|||
149829001|NCT00950807|540504371|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149829002|NCT00950807|540504372|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
149829003|NCT00950807|540504373|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149946699|NCT03126110|540938616|FG010|Phase 1|Lost to Follow-up|0|||
149946700|NCT03126110|540938617|FG011|Phase 1|Lost to Follow-up|0|||
149946701|NCT03126110|540938618|FG012|Phase 1|Lost to Follow-up|0|||
149946702|NCT03126110|540938619|FG013|Phase 1|Lost to Follow-up|0|||
149946703|NCT03126110|540938620|FG014|Phase 1|Lost to Follow-up|0|||
149946704|NCT03126110|540938621|FG015|Phase 1|Lost to Follow-up|0|||
149946705|NCT03126110|540938622|FG016|Phase 1|Lost to Follow-up|0|||
149829004|NCT00950807|540504374|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149946706|NCT03126110|540938606|FG000|Phase 1|Withdrawal by Subject|1|||
149946707|NCT03126110|540938607|FG001|Phase 1|Withdrawal by Subject|0|||
149946708|NCT03126110|540938608|FG002|Phase 1|Withdrawal by Subject|0|||
149829005|NCT00950807|540504375|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
149829006|NCT00950807|540504376|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149829007|NCT00950807|540504377|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
149829008|NCT00950807|540504378|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
149829009|NCT00950807|540504379|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149829010|NCT00950807|540504380|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
149946709|NCT03126110|540938609|FG003|Phase 1|Withdrawal by Subject|1|||
149946710|NCT03126110|540938610|FG004|Phase 1|Withdrawal by Subject|1|||
149946711|NCT03126110|540938611|FG005|Phase 1|Withdrawal by Subject|0|||
149946712|NCT03126110|540938612|FG006|Phase 1|Withdrawal by Subject|0|||
149946713|NCT03126110|540938613|FG007|Phase 1|Withdrawal by Subject|0|||
149829011|NCT00950807|540504371|FG000|Washout Period 2|Adverse Event|3|||
149829012|NCT00950807|540504372|FG001|Washout Period 2|Adverse Event|0|||
149829013|NCT00950807|540504373|FG002|Washout Period 2|Adverse Event|0|||
149829014|NCT00950807|540504374|FG003|Washout Period 2|Adverse Event|1|||
149829015|NCT00950807|540504375|FG004|Washout Period 2|Adverse Event|0|||
149829016|NCT00950807|540504376|FG005|Washout Period 2|Adverse Event|0|||
149829017|NCT00950807|540504377|FG006|Washout Period 2|Adverse Event|0|||
149829018|NCT00950807|540504378|FG007|Washout Period 2|Adverse Event|0|||
149829019|NCT00950807|540504379|FG008|Washout Period 2|Adverse Event|0|||
149829020|NCT00950807|540504380|FG009|Washout Period 2|Adverse Event|0|||
149829021|NCT00950807|540504371|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149829022|NCT00950807|540504372|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149829023|NCT00950807|540504373|FG002|Treatment Period 3|Withdrawal by Subject|0|||
149829024|NCT00950807|540504374|FG003|Treatment Period 3|Withdrawal by Subject|0|||
149829025|NCT00950807|540504375|FG004|Treatment Period 3|Withdrawal by Subject|0|||
149829026|NCT00950807|540504376|FG005|Treatment Period 3|Withdrawal by Subject|0|||
149829027|NCT00950807|540504377|FG006|Treatment Period 3|Withdrawal by Subject|0|||
149829028|NCT00950807|540504378|FG007|Treatment Period 3|Withdrawal by Subject|0|||
149829029|NCT00950807|540504379|FG008|Treatment Period 3|Withdrawal by Subject|0|||
149829030|NCT00950807|540504380|FG009|Treatment Period 3|Withdrawal by Subject|1|||
149829031|NCT00950807|540504371|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
149829032|NCT00950807|540504372|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829033|NCT00950807|540504373|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829034|NCT00950807|540504374|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829035|NCT00950807|540504375|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829036|NCT00950807|540504376|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829037|NCT00950807|540504377|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829038|NCT00950807|540504378|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
149829039|NCT00950807|540504379|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829040|NCT00950807|540504380|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149829041|NCT00950807|540504371|FG000|Treatment Period 3|Adverse Event|0|||
149829042|NCT00950807|540504372|FG001|Treatment Period 3|Adverse Event|0|||
149829043|NCT00950807|540504373|FG002|Treatment Period 3|Adverse Event|0|||
149829044|NCT00950807|540504374|FG003|Treatment Period 3|Adverse Event|0|||
150276183|NCT03861936|542147958|FG002|Overall Study|Protocol Deviation|1|||
150276184|NCT03861936|542147956|FG000|Overall Study|Reason not Specified|5|||
149829045|NCT00950807|540504375|FG004|Treatment Period 3|Adverse Event|0|||
149829046|NCT00950807|540504376|FG005|Treatment Period 3|Adverse Event|0|||
149829047|NCT00950807|540504377|FG006|Treatment Period 3|Adverse Event|1|||
149829048|NCT00950807|540504378|FG007|Treatment Period 3|Adverse Event|0|||
149829049|NCT00950807|540504379|FG008|Treatment Period 3|Adverse Event|0|||
149829050|NCT00950807|540504380|FG009|Treatment Period 3|Adverse Event|0|||
149829051|NCT00337077|540504381|FG000|Overall Study|Progressive disease|25|||
149829052|NCT00337077|540504382|FG001|Overall Study|Progressive disease|37|||
149829053|NCT00337077|540504383|FG002|Overall Study|Progressive disease|19|||
149829054|NCT00337077|540504381|FG000|Overall Study|Adverse Event|7|||
149829055|NCT00337077|540504382|FG001|Overall Study|Adverse Event|7|||
149829056|NCT00337077|540504383|FG002|Overall Study|Adverse Event|1|||
149829057|NCT00337077|540504381|FG000|Overall Study|Death|0|||
149829058|NCT00337077|540504382|FG001|Overall Study|Death|1|||
149829059|NCT00337077|540504383|FG002|Overall Study|Death|0|||
149829060|NCT00337077|540504381|FG000|Overall Study|Withdrawal by Subject|7|||
149829061|NCT00337077|540504382|FG001|Overall Study|Withdrawal by Subject|2|||
149829062|NCT00337077|540504383|FG002|Overall Study|Withdrawal by Subject|2|||
149829063|NCT00337077|540504381|FG000|Overall Study|Alternative therapy|1|||
149829064|NCT00337077|540504382|FG001|Overall Study|Alternative therapy|0|||
149829065|NCT00337077|540504383|FG002|Overall Study|Alternative therapy|0|||
149829066|NCT00337077|540504381|FG000|Overall Study|Physician Decision|1|||
149829067|NCT00337077|540504382|FG001|Overall Study|Physician Decision|4|||
149829068|NCT00337077|540504383|FG002|Overall Study|Physician Decision|2|||
149829069|NCT00337077|540504381|FG000|Overall Study|Never started treatment|1|||
149946714|NCT03126110|540938614|FG008|Phase 1|Withdrawal by Subject|2|||
149829070|NCT00337077|540504382|FG001|Overall Study|Never started treatment|1|||
149946715|NCT03126110|540938615|FG009|Phase 1|Withdrawal by Subject|1|||
149946716|NCT03126110|540938616|FG010|Phase 1|Withdrawal by Subject|0|||
149946717|NCT03126110|540938617|FG011|Phase 1|Withdrawal by Subject|0|||
149946718|NCT03126110|540938618|FG012|Phase 1|Withdrawal by Subject|0|||
149946719|NCT03126110|540938619|FG013|Phase 1|Withdrawal by Subject|0|||
149946720|NCT03126110|540938620|FG014|Phase 1|Withdrawal by Subject|0|||
149829071|NCT00337077|540504383|FG002|Overall Study|Never started treatment|0|||
149829072|NCT00337077|540504381|FG000|Overall Study|Ineligible|1|||
149829073|NCT00337077|540504382|FG001|Overall Study|Ineligible|1|||
149829074|NCT00337077|540504383|FG002|Overall Study|Ineligible|1|||
149829075|NCT06179108|540504384|FG000|Overall Study|Withdrawal by Subject|16|||
149829076|NCT06179108|540504385|FG001|Overall Study|Withdrawal by Subject|19|||
149829077|NCT06179108|540504386|FG002|Overall Study|Withdrawal by Subject|10|||
149829078|NCT06179108|540504387|FG003|Overall Study|Withdrawal by Subject|11|||
150276185|NCT03861936|542147957|FG001|Overall Study|Reason not Specified|5|||
149946721|NCT03126110|540938621|FG015|Phase 1|Withdrawal by Subject|0|||
149946722|NCT03126110|540938622|FG016|Phase 1|Withdrawal by Subject|0|||
149946723|NCT03126110|540938606|FG000|Phase 1|Safety follow-up no longer necessary|1|||
149946724|NCT03126110|540938607|FG001|Phase 1|Safety follow-up no longer necessary|0|||
149946725|NCT03126110|540938608|FG002|Phase 1|Safety follow-up no longer necessary|0|||
149946726|NCT03126110|540938609|FG003|Phase 1|Safety follow-up no longer necessary|0|||
149946727|NCT03126110|540938610|FG004|Phase 1|Safety follow-up no longer necessary|0|||
149946728|NCT03126110|540938611|FG005|Phase 1|Safety follow-up no longer necessary|0|||
149946729|NCT03126110|540938612|FG006|Phase 1|Safety follow-up no longer necessary|0|||
149946730|NCT03126110|540938613|FG007|Phase 1|Safety follow-up no longer necessary|0|||
149946731|NCT03126110|540938614|FG008|Phase 1|Safety follow-up no longer necessary|0|||
149946732|NCT03126110|540938615|FG009|Phase 1|Safety follow-up no longer necessary|0|||
149946733|NCT03126110|540938616|FG010|Phase 1|Safety follow-up no longer necessary|0|||
149946734|NCT03126110|540938617|FG011|Phase 1|Safety follow-up no longer necessary|0|||
149946735|NCT03126110|540938618|FG012|Phase 1|Safety follow-up no longer necessary|0|||
149946736|NCT03126110|540938619|FG013|Phase 1|Safety follow-up no longer necessary|0|||
149946737|NCT03126110|540938620|FG014|Phase 1|Safety follow-up no longer necessary|0|||
149946738|NCT03126110|540938621|FG015|Phase 1|Safety follow-up no longer necessary|0|||
149946739|NCT03126110|540938622|FG016|Phase 1|Safety follow-up no longer necessary|0|||
149946740|NCT03126110|540938606|FG000|Phase 1|Survival follow-up no longer necessary|0|||
149946741|NCT03126110|540938607|FG001|Phase 1|Survival follow-up no longer necessary|0|||
149946742|NCT03126110|540938608|FG002|Phase 1|Survival follow-up no longer necessary|1|||
149946743|NCT03126110|540938609|FG003|Phase 1|Survival follow-up no longer necessary|0|||
149946744|NCT03126110|540938610|FG004|Phase 1|Survival follow-up no longer necessary|0|||
149946745|NCT03126110|540938611|FG005|Phase 1|Survival follow-up no longer necessary|0|||
149946746|NCT03126110|540938612|FG006|Phase 1|Survival follow-up no longer necessary|0|||
149946747|NCT03126110|540938613|FG007|Phase 1|Survival follow-up no longer necessary|0|||
149946748|NCT03126110|540938614|FG008|Phase 1|Survival follow-up no longer necessary|0|||
149946749|NCT03126110|540938615|FG009|Phase 1|Survival follow-up no longer necessary|0|||
149946750|NCT03126110|540938616|FG010|Phase 1|Survival follow-up no longer necessary|0|||
149946751|NCT03126110|540938617|FG011|Phase 1|Survival follow-up no longer necessary|0|||
149946752|NCT03126110|540938618|FG012|Phase 1|Survival follow-up no longer necessary|0|||
149946753|NCT03126110|540938619|FG013|Phase 1|Survival follow-up no longer necessary|0|||
149946754|NCT03126110|540938620|FG014|Phase 1|Survival follow-up no longer necessary|0|||
149946755|NCT03126110|540938621|FG015|Phase 1|Survival follow-up no longer necessary|0|||
149946756|NCT03126110|540938622|FG016|Phase 1|Survival follow-up no longer necessary|0|||
149946757|NCT03126110|540938606|FG000|Phase 2|Study terminated by the sponsor|0|||
149946758|NCT03126110|540938607|FG001|Phase 2|Study terminated by the sponsor|0|||
149946759|NCT03126110|540938608|FG002|Phase 2|Study terminated by the sponsor|0|||
149946760|NCT03126110|540938609|FG003|Phase 2|Study terminated by the sponsor|0|||
149946761|NCT03126110|540938610|FG004|Phase 2|Study terminated by the sponsor|0|||
149946762|NCT03126110|540938611|FG005|Phase 2|Study terminated by the sponsor|0|||
149946763|NCT03126110|540938612|FG006|Phase 2|Study terminated by the sponsor|0|||
149946764|NCT03126110|540938613|FG007|Phase 2|Study terminated by the sponsor|0|||
149946765|NCT03126110|540938614|FG008|Phase 2|Study terminated by the sponsor|0|||
149946766|NCT03126110|540938615|FG009|Phase 2|Study terminated by the sponsor|0|||
149946767|NCT03126110|540938616|FG010|Phase 2|Study terminated by the sponsor|0|||
149946768|NCT03126110|540938617|FG011|Phase 2|Study terminated by the sponsor|0|||
149946769|NCT03126110|540938618|FG012|Phase 2|Study terminated by the sponsor|0|||
149946770|NCT03126110|540938619|FG013|Phase 2|Study terminated by the sponsor|4|||
149946771|NCT03126110|540938620|FG014|Phase 2|Study terminated by the sponsor|0|||
149946772|NCT03126110|540938621|FG015|Phase 2|Study terminated by the sponsor|0|||
149946773|NCT03126110|540938622|FG016|Phase 2|Study terminated by the sponsor|0|||
149946774|NCT03126110|540938606|FG000|Phase 2|Withdrawal by Subject|0|||
149946775|NCT03126110|540938607|FG001|Phase 2|Withdrawal by Subject|0|||
149946776|NCT03126110|540938608|FG002|Phase 2|Withdrawal by Subject|0|||
149946777|NCT03126110|540938609|FG003|Phase 2|Withdrawal by Subject|0|||
149946778|NCT03126110|540938610|FG004|Phase 2|Withdrawal by Subject|0|||
149946779|NCT03126110|540938611|FG005|Phase 2|Withdrawal by Subject|0|||
149946780|NCT03126110|540938612|FG006|Phase 2|Withdrawal by Subject|0|||
149946781|NCT03126110|540938613|FG007|Phase 2|Withdrawal by Subject|0|||
149946782|NCT03126110|540938614|FG008|Phase 2|Withdrawal by Subject|0|||
149946783|NCT03126110|540938615|FG009|Phase 2|Withdrawal by Subject|0|||
149946784|NCT03126110|540938616|FG010|Phase 2|Withdrawal by Subject|0|||
149946785|NCT03126110|540938617|FG011|Phase 2|Withdrawal by Subject|1|||
149946786|NCT03126110|540938618|FG012|Phase 2|Withdrawal by Subject|3|||
149946787|NCT03126110|540938619|FG013|Phase 2|Withdrawal by Subject|3|||
149946788|NCT03126110|540938620|FG014|Phase 2|Withdrawal by Subject|2|||
149946789|NCT03126110|540938621|FG015|Phase 2|Withdrawal by Subject|1|||
149946790|NCT03126110|540938622|FG016|Phase 2|Withdrawal by Subject|0|||
149946791|NCT03126110|540938606|FG000|Phase 2|Lost to Follow-up|0|||
149946792|NCT03126110|540938607|FG001|Phase 2|Lost to Follow-up|0|||
149946793|NCT03126110|540938608|FG002|Phase 2|Lost to Follow-up|0|||
149946794|NCT03126110|540938609|FG003|Phase 2|Lost to Follow-up|0|||
149829079|NCT06179108|540504384|FG000|Overall Study|Lost to Follow-up|12|||
149946795|NCT03126110|540938610|FG004|Phase 2|Lost to Follow-up|0|||
149946796|NCT03126110|540938611|FG005|Phase 2|Lost to Follow-up|0|||
149946797|NCT03126110|540938612|FG006|Phase 2|Lost to Follow-up|0|||
149946798|NCT03126110|540938613|FG007|Phase 2|Lost to Follow-up|0|||
149946799|NCT03126110|540938614|FG008|Phase 2|Lost to Follow-up|0|||
149946800|NCT03126110|540938615|FG009|Phase 2|Lost to Follow-up|0|||
149946801|NCT03126110|540938616|FG010|Phase 2|Lost to Follow-up|0|||
149946802|NCT03126110|540938617|FG011|Phase 2|Lost to Follow-up|1|||
149946803|NCT03126110|540938618|FG012|Phase 2|Lost to Follow-up|1|||
149946804|NCT03126110|540938619|FG013|Phase 2|Lost to Follow-up|1|||
149946805|NCT03126110|540938620|FG014|Phase 2|Lost to Follow-up|2|||
149946806|NCT03126110|540938621|FG015|Phase 2|Lost to Follow-up|0|||
149946807|NCT03126110|540938622|FG016|Phase 2|Lost to Follow-up|0|||
149946808|NCT03126110|540938606|FG000|Phase 2|Death|0|||
149946809|NCT03126110|540938607|FG001|Phase 2|Death|0|||
149946810|NCT03126110|540938608|FG002|Phase 2|Death|0|||
149946811|NCT03126110|540938609|FG003|Phase 2|Death|0|||
149946812|NCT03126110|540938610|FG004|Phase 2|Death|0|||
149946813|NCT03126110|540938611|FG005|Phase 2|Death|0|||
149946814|NCT03126110|540938612|FG006|Phase 2|Death|0|||
149946815|NCT03126110|540938613|FG007|Phase 2|Death|0|||
149946816|NCT03126110|540938614|FG008|Phase 2|Death|0|||
149946817|NCT03126110|540938615|FG009|Phase 2|Death|0|||
149946818|NCT03126110|540938616|FG010|Phase 2|Death|0|||
149946819|NCT03126110|540938617|FG011|Phase 2|Death|6|||
149946820|NCT03126110|540938618|FG012|Phase 2|Death|12|||
149946821|NCT03126110|540938619|FG013|Phase 2|Death|25|||
149946822|NCT03126110|540938620|FG014|Phase 2|Death|11|||
149946823|NCT03126110|540938621|FG015|Phase 2|Death|3|||
149946824|NCT03126110|540938622|FG016|Phase 2|Death|2|||
149946825|NCT03126110|540938606|FG000|Phase 2|Progressive Disease|0|||
149946826|NCT03126110|540938607|FG001|Phase 2|Progressive Disease|0|||
149946827|NCT03126110|540938608|FG002|Phase 2|Progressive Disease|0|||
149946828|NCT03126110|540938609|FG003|Phase 2|Progressive Disease|0|||
149946829|NCT03126110|540938610|FG004|Phase 2|Progressive Disease|0|||
149946830|NCT03126110|540938611|FG005|Phase 2|Progressive Disease|0|||
149946831|NCT03126110|540938612|FG006|Phase 2|Progressive Disease|0|||
149946832|NCT03126110|540938613|FG007|Phase 2|Progressive Disease|0|||
149946833|NCT03126110|540938614|FG008|Phase 2|Progressive Disease|0|||
149946834|NCT03126110|540938615|FG009|Phase 2|Progressive Disease|0|||
149946835|NCT03126110|540938616|FG010|Phase 2|Progressive Disease|0|||
149946836|NCT03126110|540938617|FG011|Phase 2|Progressive Disease|0|||
149946837|NCT03126110|540938618|FG012|Phase 2|Progressive Disease|0|||
149946838|NCT03126110|540938619|FG013|Phase 2|Progressive Disease|1|||
149946839|NCT03126110|540938620|FG014|Phase 2|Progressive Disease|0|||
149946840|NCT03126110|540938621|FG015|Phase 2|Progressive Disease|0|||
149946841|NCT03126110|540938622|FG016|Phase 2|Progressive Disease|0|||
149946842|NCT03126110|540938606|FG000|Phase 2|Started new treatment|0|||
149946843|NCT03126110|540938607|FG001|Phase 2|Started new treatment|0|||
149946844|NCT03126110|540938608|FG002|Phase 2|Started new treatment|0|||
149946845|NCT03126110|540938609|FG003|Phase 2|Started new treatment|0|||
149946846|NCT03126110|540938610|FG004|Phase 2|Started new treatment|0|||
149946847|NCT03126110|540938611|FG005|Phase 2|Started new treatment|0|||
149946848|NCT03126110|540938612|FG006|Phase 2|Started new treatment|0|||
149946849|NCT03126110|540938613|FG007|Phase 2|Started new treatment|0|||
149946850|NCT03126110|540938614|FG008|Phase 2|Started new treatment|0|||
149946851|NCT03126110|540938615|FG009|Phase 2|Started new treatment|0|||
149946852|NCT03126110|540938616|FG010|Phase 2|Started new treatment|0|||
149946853|NCT03126110|540938617|FG011|Phase 2|Started new treatment|0|||
149946854|NCT03126110|540938618|FG012|Phase 2|Started new treatment|0|||
149946855|NCT03126110|540938619|FG013|Phase 2|Started new treatment|0|||
149829080|NCT06179108|540504385|FG001|Overall Study|Lost to Follow-up|4|||
149946856|NCT03126110|540938620|FG014|Phase 2|Started new treatment|1|||
149946857|NCT03126110|540938621|FG015|Phase 2|Started new treatment|0|||
149946858|NCT03126110|540938622|FG016|Phase 2|Started new treatment|0|||
149829081|NCT06179108|540504386|FG002|Overall Study|Lost to Follow-up|1|||
150033242|NCT00506350|541260919|FG001|Overall Study|Withdrawal by Subject|1|||
149946859|NCT00294658|540938623|FG000|Overall Study|Death|0|||
149946860|NCT00294658|540938624|FG001|Overall Study|Death|1|||
149829082|NCT06179108|540504387|FG003|Overall Study|Lost to Follow-up|9|||
149946861|NCT00294658|540938623|FG000|Overall Study|Lost to Follow-up|4|||
149946862|NCT00294658|540938624|FG001|Overall Study|Lost to Follow-up|0|||
149946863|NCT00294658|540938623|FG000|Overall Study|Physician Decision|1|||
149946864|NCT00294658|540938624|FG001|Overall Study|Physician Decision|2|||
149946865|NCT00294658|540938623|FG000|Overall Study|Pregnancy|0|||
149946866|NCT00294658|540938624|FG001|Overall Study|Pregnancy|1|||
149946867|NCT00294658|540938623|FG000|Overall Study|Withdrawal by Subject|0|||
149946868|NCT00294658|540938624|FG001|Overall Study|Withdrawal by Subject|4|||
149829083|NCT06179108|540504384|FG000|Overall Study|Adverse Event|2|||
149946869|NCT00294658|540938623|FG000|Overall Study|Found to have invasive thymoma|1|||
149946870|NCT00294658|540938624|FG001|Overall Study|Found to have invasive thymoma|0|||
149946871|NCT00294658|540938623|FG000|Overall Study|Patient and family were not satisfied|0|||
149946872|NCT00294658|540938624|FG001|Overall Study|Patient and family were not satisfied|1|||
149829084|NCT06179108|540504385|FG001|Overall Study|Adverse Event|3|||
149829085|NCT06179108|540504386|FG002|Overall Study|Adverse Event|3|||
149829086|NCT06179108|540504387|FG003|Overall Study|Adverse Event|2|||
149829087|NCT06179108|540504384|FG000|Overall Study|Protocol Violation|0|||
149829088|NCT06179108|540504385|FG001|Overall Study|Protocol Violation|1|||
149829089|NCT06179108|540504386|FG002|Overall Study|Protocol Violation|0|||
149829090|NCT06179108|540504387|FG003|Overall Study|Protocol Violation|1|||
149829091|NCT06179108|540504384|FG000|Overall Study|Physician Decision|1|||
149829092|NCT06179108|540504385|FG001|Overall Study|Physician Decision|1|||
149829093|NCT06179108|540504386|FG002|Overall Study|Physician Decision|0|||
149829094|NCT06179108|540504387|FG003|Overall Study|Physician Decision|0|||
149829095|NCT06179108|540504384|FG000|Overall Study|Lack of Efficacy|0|||
149829096|NCT06179108|540504385|FG001|Overall Study|Lack of Efficacy|0|||
149829097|NCT06179108|540504386|FG002|Overall Study|Lack of Efficacy|0|||
149829098|NCT06179108|540504387|FG003|Overall Study|Lack of Efficacy|1|||
149829099|NCT06179108|540504384|FG000|Overall Study|Death|0|||
149829100|NCT06179108|540504385|FG001|Overall Study|Death|0|||
149829101|NCT06179108|540504386|FG002|Overall Study|Death|0|||
149829102|NCT06179108|540504387|FG003|Overall Study|Death|1|||
149829103|NCT00814463|540504388|FG000|Overall Study|Lost to Follow-up|1|||
149829104|NCT01370408|540504389|FG000|Overall Study|treatment failure|9|||
149829105|NCT05014412|540504392|FG000|Overall Study|Death|11|||
149829106|NCT05014412|540504393|FG001|Overall Study|Death|7|||
149829107|NCT05014412|540504394|FG002|Overall Study|Death|4|||
149829108|NCT05014412|540504395|FG003|Overall Study|Death|7|||
149829109|NCT05014412|540504392|FG000|Overall Study|Withdrawal by Subject|1|||
149829110|NCT05014412|540504393|FG001|Overall Study|Withdrawal by Subject|1|||
149829111|NCT05014412|540504394|FG002|Overall Study|Withdrawal by Subject|1|||
149829112|NCT05014412|540504395|FG003|Overall Study|Withdrawal by Subject|2|||
149829113|NCT05014412|540504392|FG000|Overall Study|Ongoing|21|||
149829114|NCT05014412|540504393|FG001|Overall Study|Ongoing|4|||
149829115|NCT05014412|540504394|FG002|Overall Study|Ongoing|6|||
149829116|NCT05014412|540504395|FG003|Overall Study|Ongoing|20|||
149946873|NCT00580840|540938625|FG000|Run-in|Adverse Event|17|||
149946874|NCT00580840|540938626|FG001|Run-in|Adverse Event|0|||
149946875|NCT00580840|540938627|FG002|Run-in|Adverse Event|0|||
149946876|NCT00580840|540938628|FG003|Run-in|Adverse Event|0|||
149946877|NCT00580840|540938625|FG000|Run-in|Lack of Efficacy|93|||
149946878|NCT00580840|540938626|FG001|Run-in|Lack of Efficacy|0|||
149946879|NCT00580840|540938627|FG002|Run-in|Lack of Efficacy|0|||
149946880|NCT00580840|540938628|FG003|Run-in|Lack of Efficacy|0|||
149946881|NCT00580840|540938625|FG000|Run-in|Loss of Efficacy|1|||
149946882|NCT00580840|540938626|FG001|Run-in|Loss of Efficacy|0|||
149946883|NCT00580840|540938627|FG002|Run-in|Loss of Efficacy|0|||
149946884|NCT00580840|540938628|FG003|Run-in|Loss of Efficacy|0|||
149946885|NCT00580840|540938625|FG000|Run-in|Lost to Follow-up|4|||
149946886|NCT00580840|540938626|FG001|Run-in|Lost to Follow-up|0|||
149946887|NCT00580840|540938627|FG002|Run-in|Lost to Follow-up|0|||
149946888|NCT00580840|540938628|FG003|Run-in|Lost to Follow-up|0|||
149946889|NCT00580840|540938625|FG000|Run-in|Withdrawal by Subject|5|||
149946890|NCT00580840|540938626|FG001|Run-in|Withdrawal by Subject|0|||
149946891|NCT00580840|540938627|FG002|Run-in|Withdrawal by Subject|0|||
149946892|NCT00580840|540938628|FG003|Run-in|Withdrawal by Subject|0|||
149946893|NCT00580840|540938625|FG000|Run-in|Other: Per Sponsor Request|2|||
149946894|NCT00580840|540938626|FG001|Run-in|Other: Per Sponsor Request|0|||
149946895|NCT00580840|540938627|FG002|Run-in|Other: Per Sponsor Request|0|||
149946896|NCT00580840|540938628|FG003|Run-in|Other: Per Sponsor Request|0|||
149946897|NCT00580840|540938625|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
149946898|NCT00580840|540938626|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
149946899|NCT00580840|540938627|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
149946900|NCT00580840|540938628|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
149946901|NCT00580840|540938625|FG000|Run-in|Other: Exclusionary Lab Value|1|||
149946902|NCT00580840|540938626|FG001|Run-in|Other: Exclusionary Lab Value|0|||
149946903|NCT00580840|540938627|FG002|Run-in|Other: Exclusionary Lab Value|0|||
149829117|NCT02353169|540504396|FG000|Overall Study|QTc > 450 msec|1|||
149829118|NCT02353169|540504397|FG001|Overall Study|QTc > 450 msec|1|||
149829119|NCT02353169|540504398|FG002|Overall Study|QTc > 450 msec|1|||
149829120|NCT02353169|540504399|FG003|Overall Study|QTc > 450 msec|1|||
149829121|NCT02353169|540504396|FG000|Overall Study|OR team declined|2|||
149829122|NCT02353169|540504397|FG001|Overall Study|OR team declined|0|||
149946904|NCT00580840|540938628|FG003|Run-in|Other: Exclusionary Lab Value|0|||
149946905|NCT00580840|540938625|FG000|Double-Blind|Adverse Event|0|||
149946906|NCT00580840|540938626|FG001|Double-Blind|Adverse Event|3|||
149946907|NCT00580840|540938627|FG002|Double-Blind|Adverse Event|4|||
149946908|NCT00580840|540938628|FG003|Double-Blind|Adverse Event|1|||
149946909|NCT00580840|540938625|FG000|Double-Blind|Loss of Efficacy|0|||
149946910|NCT00580840|540938626|FG001|Double-Blind|Loss of Efficacy|1|||
149829123|NCT02353169|540504398|FG002|Overall Study|OR team declined|0|||
149829124|NCT02353169|540504399|FG003|Overall Study|OR team declined|0|||
149946911|NCT00580840|540938627|FG002|Double-Blind|Loss of Efficacy|2|||
149946912|NCT00580840|540938628|FG003|Double-Blind|Loss of Efficacy|10|||
150170585|NCT02914522|541759097|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170586|NCT02914522|541759098|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170587|NCT02914522|541759099|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
150170588|NCT02914522|541759100|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
150170589|NCT02914522|541759101|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170590|NCT02914522|541759102|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170591|NCT02914522|541759103|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170592|NCT02914522|541759104|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170593|NCT02914522|541759105|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
150170594|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
150170595|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
150170596|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
150170597|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
150276186|NCT03861936|542147958|FG002|Overall Study|Reason not Specified|3|||
150276187|NCT03198520|542147965|FG000|Overall Study|Physician Decision|2|||
150276188|NCT03198520|542147965|FG000|Overall Study|Protocol Violation|2|||
150276189|NCT03198520|542147965|FG000|Overall Study|Withdrawal by Subject|1|||
150276190|NCT03198520|542147965|FG000|Overall Study|Study Ended|1|||
150276191|NCT01670539|542147966|FG000|Overall Study|Death|3|||
150276192|NCT01670539|542147967|FG001|Overall Study|Death|5|||
150276193|NCT01670539|542147966|FG000|Overall Study|Withdrawal by Subject|3|||
150276194|NCT01670539|542147967|FG001|Overall Study|Withdrawal by Subject|0|||
150276195|NCT01986920|542147970|FG000|A- 101 25%|Withdrawal by Subject|1|||
150276196|NCT01986920|542147971|FG001|A- 101 25%|Withdrawal by Subject|0|||
150276197|NCT01986920|542147972|FG002|A- 101 25%|Withdrawal by Subject|0|||
150276198|NCT01986920|542147973|FG003|A- 101 25%|Withdrawal by Subject|0|||
150276199|NCT01986920|542147970|FG000|A-101 32.5%|Withdrawal by Subject|0|||
150276200|NCT01986920|542147971|FG001|A-101 32.5%|Withdrawal by Subject|1|||
150276201|NCT01986920|542147972|FG002|A-101 32.5%|Withdrawal by Subject|0|||
150276202|NCT01986920|542147973|FG003|A-101 32.5%|Withdrawal by Subject|0|||
150276203|NCT01986920|542147970|FG000|A-101 40%|Withdrawal by Subject|0|||
150276204|NCT01986920|542147971|FG001|A-101 40%|Withdrawal by Subject|0|||
150276205|NCT01986920|542147972|FG002|A-101 40%|Withdrawal by Subject|1|||
150276206|NCT01986920|542147973|FG003|A-101 40%|Withdrawal by Subject|0|||
150276207|NCT01986920|542147970|FG000|Placebo|Withdrawal by Subject|0|||
150276208|NCT01986920|542147971|FG001|Placebo|Withdrawal by Subject|0|||
150276209|NCT01986920|542147972|FG002|Placebo|Withdrawal by Subject|0|||
150276210|NCT01986920|542147973|FG003|Placebo|Withdrawal by Subject|1|||
150276211|NCT03023059|542147974|FG000|Overall Study|Withdrawal by Subject|5|||
150276212|NCT03781323|542147975|FG000|Overall Study|Withdrawal by Subject|1|||
150276213|NCT01526551|542147979|FG000|Overall Study|Lack of returned parental consent form|424|||
150276214|NCT01353508|542147984|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
150276215|NCT01353508|542147985|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
150276216|NCT01353508|542147986|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
150276217|NCT01353508|542147987|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
150276218|NCT01353508|542147984|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
150276219|NCT01353508|542147985|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
150276220|NCT01353508|542147986|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
150276221|NCT01353508|542147987|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
150276222|NCT00496730|542148002|FG000|Overall Study|Lost to Follow-up|4|||
150276223|NCT00496730|542148003|FG001|Overall Study|Lost to Follow-up|3|||
150276224|NCT00496730|542148002|FG000|Overall Study|Withdrawal by Subject|2|||
150276225|NCT00496730|542148003|FG001|Overall Study|Withdrawal by Subject|2|||
150276226|NCT00113074|542148007|FG000|Overall Study|Lost to Follow-up|10|||
150276227|NCT00113074|542148008|FG001|Overall Study|Lost to Follow-up|10|||
150276228|NCT00113074|542148009|FG002|Overall Study|Lost to Follow-up|14|||
150276229|NCT01106027|542148012|FG000|Overall Study|Lost graft early, discontinued|1|||
150276230|NCT00369785|542148013|FG000|Overall Study|Physician Decision|3|||
150276231|NCT00369785|542148014|FG001|Overall Study|Physician Decision|2|||
150276232|NCT00369785|542148013|FG000|Overall Study|Death|1|||
150276233|NCT00369785|542148014|FG001|Overall Study|Death|2|||
150276234|NCT00369785|542148013|FG000|Overall Study|Withdrawal by Subject|7|||
150276235|NCT00369785|542148014|FG001|Overall Study|Withdrawal by Subject|6|||
150276236|NCT00369785|542148013|FG000|Overall Study|Toxicity|6|||
150276237|NCT00369785|542148014|FG001|Overall Study|Toxicity|4|||
150276238|NCT00369785|542148013|FG000|Overall Study|Never started|0|||
150276239|NCT00369785|542148014|FG001|Overall Study|Never started|2|||
150276240|NCT00369785|542148013|FG000|Overall Study|Progression|4|||
150276241|NCT00369785|542148014|FG001|Overall Study|Progression|4|||
150276242|NCT00369785|542148013|FG000|Overall Study|Multiple reasons|6|||
150276243|NCT00369785|542148014|FG001|Overall Study|Multiple reasons|5|||
150276244|NCT00800683|542148015|FG000|Overall Study|Adverse Event|11|||
150276245|NCT00800683|542148016|FG001|Overall Study|Adverse Event|8|||
150276246|NCT00800683|542148015|FG000|Overall Study|Lost to Follow-up|3|||
149829125|NCT02353169|540504396|FG000|Overall Study|Inhalational induction|0|||
149829126|NCT02353169|540504397|FG001|Overall Study|Inhalational induction|2|||
149829127|NCT02353169|540504398|FG002|Overall Study|Inhalational induction|0|||
149829128|NCT02353169|540504399|FG003|Overall Study|Inhalational induction|0|||
149829129|NCT02353169|540504396|FG000|Overall Study|ECG data error|0|||
149829130|NCT02353169|540504397|FG001|Overall Study|ECG data error|3|||
149829131|NCT02353169|540504398|FG002|Overall Study|ECG data error|2|||
149829132|NCT02353169|540504399|FG003|Overall Study|ECG data error|2|||
149829133|NCT02353169|540504396|FG000|Overall Study|Pre-op medication|0|||
149829134|NCT02353169|540504397|FG001|Overall Study|Pre-op medication|0|||
149829135|NCT02353169|540504398|FG002|Overall Study|Pre-op medication|1|||
149829136|NCT02353169|540504399|FG003|Overall Study|Pre-op medication|0|||
149829137|NCT05049460|540504402|FG000|Overall Study|Withdrawal by Subject|2|||
149829138|NCT05049460|540504403|FG001|Overall Study|Withdrawal by Subject|2|||
149829139|NCT05049460|540504402|FG000|Overall Study|Lost to Follow-up|2|||
149829140|NCT05049460|540504403|FG001|Overall Study|Lost to Follow-up|2|||
149829141|NCT00918567|540504413|FG000|Overall Study|Lack of Efficacy|3|||
149829142|NCT00918567|540504414|FG001|Overall Study|Lack of Efficacy|1|||
149829143|NCT00918567|540504413|FG000|Overall Study|Withdrawal by Subject|1|||
149829144|NCT00918567|540504414|FG001|Overall Study|Withdrawal by Subject|1|||
149829145|NCT00918567|540504413|FG000|Overall Study|Adverse Event|1|||
149829146|NCT00918567|540504414|FG001|Overall Study|Adverse Event|0|||
149829147|NCT03066999|540504415|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
149829148|NCT03066999|540504416|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
149829149|NCT00661999|540504417|FG000|Overall Study|Adverse Event|11|||
149829150|NCT00661999|540504418|FG001|Overall Study|Adverse Event|5|||
149829151|NCT00661999|540504419|FG002|Overall Study|Adverse Event|8|||
149829152|NCT00661999|540504417|FG000|Overall Study|Death|8|||
149829153|NCT00661999|540504418|FG001|Overall Study|Death|6|||
149829154|NCT00661999|540504419|FG002|Overall Study|Death|3|||
149829155|NCT00661999|540504417|FG000|Overall Study|Other Reasons|5|||
149829156|NCT00661999|540504418|FG001|Overall Study|Other Reasons|12|||
149829157|NCT00661999|540504419|FG002|Overall Study|Other Reasons|23|||
149829158|NCT00661999|540504417|FG000|Overall Study|Withdrawal by Subject|30|||
149829159|NCT00661999|540504418|FG001|Overall Study|Withdrawal by Subject|23|||
149829160|NCT00661999|540504419|FG002|Overall Study|Withdrawal by Subject|14|||
149829161|NCT00661999|540504417|FG000|Overall Study|Alternative Treatment|1|||
149829162|NCT00661999|540504418|FG001|Overall Study|Alternative Treatment|0|||
149829163|NCT00661999|540504419|FG002|Overall Study|Alternative Treatment|0|||
149829164|NCT00661999|540504417|FG000|Overall Study|Other Medical Problems|4|||
149829165|NCT00661999|540504418|FG001|Overall Study|Other Medical Problems|4|||
149829166|NCT00661999|540504419|FG002|Overall Study|Other Medical Problems|9|||
149829167|NCT01790568|540504422|FG000|Overall Study|Progression prior to transplant|0|||
149829168|NCT01790568|540504423|FG001|Overall Study|Progression prior to transplant|1|||
149829169|NCT01361126|540504424|FG000|Overall Study|Sponsor decision|0|||
149829170|NCT01361126|540504425|FG001|Overall Study|Sponsor decision|2|||
149829171|NCT02994056|540504426|FG000|Overall Study|Death|8|||
149829172|NCT02994056|540504426|FG000|Overall Study|Withdrew Consent|1|||
149829173|NCT02742181|540504428|FG000|Overall Study|Physician Decision|1|||
149829174|NCT02742181|540504429|FG001|Overall Study|Physician Decision|0|||
149829175|NCT01346410|540504430|FG000|Overall Study|Death|1|||
149829176|NCT02576990|540504431|FG000|Overall Study|Death|29|||
149829177|NCT02576990|540504432|FG001|Overall Study|Death|18|||
149829178|NCT02576990|540504431|FG000|Overall Study|Physician Decision|1|||
149829179|NCT02576990|540504432|FG001|Overall Study|Physician Decision|0|||
149829180|NCT02576990|540504431|FG000|Overall Study|Screen failure|2|||
149829181|NCT02576990|540504432|FG001|Overall Study|Screen failure|0|||
149829182|NCT02576990|540504431|FG000|Overall Study|Sponsor's decision|24|||
149829183|NCT02576990|540504432|FG001|Overall Study|Sponsor's decision|4|||
149829184|NCT02576990|540504431|FG000|Overall Study|Withdrawal by Subject|0|||
149829185|NCT02576990|540504432|FG001|Overall Study|Withdrawal by Subject|2|||
149829186|NCT05905783|540504433|FG000|Overall Study|Lost to Follow-up|12|||
149829187|NCT05905783|540504434|FG001|Overall Study|Lost to Follow-up|18|||
149829188|NCT05905783|540504433|FG000|Overall Study|Withdrawal by Subject|29|||
149829189|NCT05905783|540504434|FG001|Overall Study|Withdrawal by Subject|37|||
149829190|NCT05905783|540504433|FG000|Overall Study|Decision by sponsor|69|||
149829191|NCT05905783|540504434|FG001|Overall Study|Decision by sponsor|65|||
149829192|NCT01575054|540504435|FG000|Overall Study|Other Reasons|5|||
149829193|NCT01575054|540504436|FG001|Overall Study|Other Reasons|3|||
149829194|NCT01575054|540504435|FG000|Overall Study|Protocol Violation|2|||
149829195|NCT01575054|540504436|FG001|Overall Study|Protocol Violation|1|||
149829196|NCT01575054|540504435|FG000|Overall Study|Personal Reasons|10|||
150170598|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
150276247|NCT00800683|542148016|FG001|Overall Study|Lost to Follow-up|1|||
149829197|NCT01575054|540504436|FG001|Overall Study|Personal Reasons|11|||
149829198|NCT01575054|540504435|FG000|Overall Study|Lost to Follow-up|3|||
149829199|NCT01575054|540504436|FG001|Overall Study|Lost to Follow-up|3|||
149829200|NCT01575054|540504435|FG000|Overall Study|Adverse Event|9|||
149829201|NCT01575054|540504436|FG001|Overall Study|Adverse Event|8|||
150276248|NCT00800683|542148015|FG000|Overall Study|Withdrawal by Subject|1|||
150276249|NCT00800683|542148016|FG001|Overall Study|Withdrawal by Subject|7|||
150276250|NCT00800683|542148015|FG000|Overall Study|Lack of Efficacy|1|||
150276251|NCT00800683|542148016|FG001|Overall Study|Lack of Efficacy|1|||
149829202|NCT01508936|540504438|FG000|Overall Study|Adverse Event|11|||
149829203|NCT01508936|540504439|FG001|Overall Study|Adverse Event|32|||
149829204|NCT01508936|540504438|FG000|Overall Study|Lack of Efficacy|0|||
149829205|NCT01508936|540504439|FG001|Overall Study|Lack of Efficacy|1|||
149829206|NCT01508936|540504438|FG000|Overall Study|Withdrawal by Subject|4|||
149829207|NCT01508936|540504439|FG001|Overall Study|Withdrawal by Subject|18|||
149829208|NCT01508936|540504438|FG000|Overall Study|Protocol Violation|2|||
149946913|NCT00580840|540938625|FG000|Double-Blind|Lost to Follow-up|0|||
149946914|NCT00580840|540938626|FG001|Double-Blind|Lost to Follow-up|1|||
149946915|NCT00580840|540938627|FG002|Double-Blind|Lost to Follow-up|0|||
149946916|NCT00580840|540938628|FG003|Double-Blind|Lost to Follow-up|2|||
149946917|NCT00580840|540938625|FG000|Double-Blind|Withdrawal by Subject|0|||
149946918|NCT00580840|540938626|FG001|Double-Blind|Withdrawal by Subject|1|||
149946919|NCT00580840|540938627|FG002|Double-Blind|Withdrawal by Subject|2|||
149946920|NCT00580840|540938628|FG003|Double-Blind|Withdrawal by Subject|2|||
149946921|NCT00580840|540938625|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
149946922|NCT00580840|540938626|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
149946923|NCT00580840|540938627|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
149946924|NCT00580840|540938628|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
149946925|NCT00580840|540938625|FG000|Double-Blind|Other: Forbidden Medication|0|||
149946926|NCT00580840|540938626|FG001|Double-Blind|Other: Forbidden Medication|0|||
149946927|NCT00580840|540938627|FG002|Double-Blind|Other: Forbidden Medication|1|||
149946928|NCT00580840|540938628|FG003|Double-Blind|Other: Forbidden Medication|0|||
149946929|NCT00976027|540938630|FG000|Overall Study|Serious Adverse Event|36|||
149946930|NCT00976027|540938631|FG001|Overall Study|Serious Adverse Event|17|||
149946931|NCT00976027|540938630|FG000|Overall Study|Adverse Event|0|||
149946932|NCT00976027|540938631|FG001|Overall Study|Adverse Event|2|||
149946933|NCT00976027|540938630|FG000|Overall Study|Protocol Violation|60|||
149946934|NCT00976027|540938631|FG001|Overall Study|Protocol Violation|27|||
149946935|NCT00976027|540938630|FG000|Overall Study|Lost to Follow-up|208|||
149946936|NCT00976027|540938631|FG001|Overall Study|Lost to Follow-up|103|||
149946937|NCT00976027|540938630|FG000|Overall Study|Withdrawal by Subject|107|||
149946938|NCT00976027|540938631|FG001|Overall Study|Withdrawal by Subject|66|||
149946939|NCT05049122|540938632|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
149946940|NCT05049122|540938632|FG000|Overall Study|Participant moved|1|||
149946941|NCT05049122|540938632|FG000|Overall Study|At the direction of the doctor|1|||
149946942|NCT01910441|540938633|FG000|Overall Study|Sponsor decision|0|||
149946943|NCT01910441|540938634|FG001|Overall Study|Sponsor decision|2|||
149946944|NCT01910441|540938633|FG000|Overall Study|Lost to Follow-up|6|||
149946945|NCT01910441|540938634|FG001|Overall Study|Lost to Follow-up|5|||
149946946|NCT01910441|540938633|FG000|Overall Study|Withdrawal by Subject|0|||
149946947|NCT01910441|540938634|FG001|Overall Study|Withdrawal by Subject|1|||
149946948|NCT01910441|540938633|FG000|Overall Study|Non-compliance|0|||
149946949|NCT01910441|540938634|FG001|Overall Study|Non-compliance|1|||
149946950|NCT01910441|540938633|FG000|Overall Study|Adverse Event|1|||
149946951|NCT01910441|540938634|FG001|Overall Study|Adverse Event|0|||
149946952|NCT01910441|540938633|FG000|Overall Study|Physician Decision|0|||
149946953|NCT01910441|540938634|FG001|Overall Study|Physician Decision|1|||
149946954|NCT03636477|540938635|FG000|Overall Study|Adverse Event|0|||
149946955|NCT03636477|540938636|FG001|Overall Study|Adverse Event|0|||
149946956|NCT03636477|540938637|FG002|Overall Study|Adverse Event|1|||
149946957|NCT02864992|540938638|FG000|Overall Study|still on treatment|15|||
149946958|NCT02864992|540938639|FG001|Overall Study|still on treatment|1|||
149946959|NCT02864992|540938640|FG002|Overall Study|still on treatment|33|||
149946960|NCT02382380|540938641|FG000|Overall Study|Withdrawal by Subject|2|||
149946961|NCT02382380|540938642|FG001|Overall Study|Withdrawal by Subject|2|||
149946962|NCT02382380|540938641|FG000|Overall Study|Lost to Follow-up|0|||
149946963|NCT02382380|540938642|FG001|Overall Study|Lost to Follow-up|1|||
149946964|NCT05168800|540938643|FG000|Time 1 Survey|Did not start T1 survey|182|||
149946965|NCT05168800|540938644|FG001|Time 1 Survey|Did not start T1 survey|150|||
149946966|NCT05168800|540938645|FG002|Time 1 Survey|Did not start T1 survey|140|||
150276252|NCT00800683|542148015|FG000|Overall Study|Other|1|||
149829209|NCT01508936|540504439|FG001|Overall Study|Protocol Violation|3|||
149829210|NCT01508936|540504438|FG000|Overall Study|Lost to Follow-up|2|||
149946967|NCT05168800|540938643|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
149946968|NCT05168800|540938644|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
149946969|NCT05168800|540938645|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
149946970|NCT05168800|540938643|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
149946971|NCT05168800|540938644|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
149946972|NCT05168800|540938645|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
149946973|NCT05168800|540938643|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
150276253|NCT00800683|542148016|FG001|Overall Study|Other|2|||
150276254|NCT00356889|542148018|FG000|Overall Study|Protocol Violation|2|||
150033243|NCT00506350|541260920|FG002|Overall Study|Withdrawal by Subject|1|||
150033244|NCT00506350|541260921|FG003|Overall Study|Withdrawal by Subject|1|||
150033245|NCT00506350|541260922|FG004|Overall Study|Withdrawal by Subject|4|||
150033246|NCT00506350|541260923|FG005|Overall Study|Withdrawal by Subject|1|||
149946974|NCT05168800|540938644|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
149946975|NCT05168800|540938645|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
149946976|NCT05168800|540938643|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
149946977|NCT05168800|540938644|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
149946978|NCT05168800|540938645|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
149946979|NCT05168800|540938643|FG000|Time 1 Survey|Withdrawal by Subject|6|||
149946980|NCT05168800|540938644|FG001|Time 1 Survey|Withdrawal by Subject|3|||
149946981|NCT05168800|540938645|FG002|Time 1 Survey|Withdrawal by Subject|2|||
149946982|NCT05168800|540938643|FG000|Time 2 Survey|Already excluded at Time 1|228|||
149946983|NCT05168800|540938644|FG001|Time 2 Survey|Already excluded at Time 1|202|||
149946984|NCT05168800|540938645|FG002|Time 2 Survey|Already excluded at Time 1|173|||
149946985|NCT05168800|540938643|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
149946986|NCT05168800|540938644|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
149946987|NCT05168800|540938645|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
149946988|NCT05168800|540938643|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
149946989|NCT05168800|540938644|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
149946990|NCT05168800|540938645|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
149946991|NCT05168800|540938643|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
149946992|NCT05168800|540938644|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
149946993|NCT05168800|540938645|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
149946994|NCT05168800|540938643|FG000|Time 2 Survey|Withdrawal by Subject|1|||
149946995|NCT05168800|540938644|FG001|Time 2 Survey|Withdrawal by Subject|0|||
149946996|NCT05168800|540938645|FG002|Time 2 Survey|Withdrawal by Subject|1|||
149946997|NCT05168800|540938643|FG000|Time 3 Survey|Already excluded at Time 1|228|||
149946998|NCT05168800|540938644|FG001|Time 3 Survey|Already excluded at Time 1|200|||
149946999|NCT05168800|540938645|FG002|Time 3 Survey|Already excluded at Time 1|173|||
149947000|NCT05168800|540938643|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
149947001|NCT05168800|540938644|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
149947002|NCT05168800|540938645|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
149947003|NCT05168800|540938643|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
149947004|NCT05168800|540938644|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
149947005|NCT05168800|540938645|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
149947006|NCT05168800|540938643|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
149947007|NCT05168800|540938644|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
149947008|NCT05168800|540938645|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
149947009|NCT04958707|540938646|FG000|Post Intervention|Withdrawal by Subject|1|||
149947010|NCT04958707|540938647|FG001|Post Intervention|Withdrawal by Subject|0|||
149947011|NCT04958707|540938648|FG002|Post Intervention|Withdrawal by Subject|0|||
149947012|NCT04958707|540938646|FG000|3 Months Follow- up|Lost to Follow-up|0|||
149947013|NCT04958707|540938647|FG001|3 Months Follow- up|Lost to Follow-up|3|||
149947014|NCT04958707|540938648|FG002|3 Months Follow- up|Lost to Follow-up|0|||
149947015|NCT04958707|540938646|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
149947016|NCT04958707|540938647|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
149947017|NCT04958707|540938648|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
149947018|NCT02629159|540938651|FG000|Overall Study|Adverse Event|17|||
149947019|NCT02629159|540938652|FG001|Overall Study|Adverse Event|20|||
149947020|NCT02629159|540938653|FG002|Overall Study|Adverse Event|22|||
149947021|NCT02629159|540938651|FG000|Overall Study|Withdrawal by Subject|22|||
149947022|NCT02629159|540938652|FG001|Overall Study|Withdrawal by Subject|11|||
149947023|NCT02629159|540938653|FG002|Overall Study|Withdrawal by Subject|15|||
149947024|NCT02629159|540938651|FG000|Overall Study|Lost to Follow-up|7|||
149947025|NCT02629159|540938652|FG001|Overall Study|Lost to Follow-up|4|||
149947026|NCT02629159|540938653|FG002|Overall Study|Lost to Follow-up|5|||
149947027|NCT02629159|540938651|FG000|Overall Study|Lack of Efficacy|4|||
149947028|NCT02629159|540938652|FG001|Overall Study|Lack of Efficacy|0|||
149947029|NCT02629159|540938653|FG002|Overall Study|Lack of Efficacy|1|||
149947030|NCT02629159|540938651|FG000|Overall Study|Other|6|||
149947031|NCT02629159|540938652|FG001|Overall Study|Other|4|||
149947032|NCT02629159|540938653|FG002|Overall Study|Other|8|||
149947033|NCT05722015|540938654|FG000|Overall Study|Death|57|||
149947034|NCT05722015|540938655|FG001|Overall Study|Death|37|||
149947035|NCT05722015|540938654|FG000|Overall Study|Lost to Follow-up|1|||
149947036|NCT05722015|540938655|FG001|Overall Study|Lost to Follow-up|0|||
149947037|NCT05722015|540938654|FG000|Overall Study|Withdrawal by Subject|5|||
149947038|NCT05722015|540938655|FG001|Overall Study|Withdrawal by Subject|1|||
149947039|NCT05722015|540938654|FG000|Overall Study|Participants Ongoing|188|||
149947040|NCT05722015|540938655|FG001|Overall Study|Participants Ongoing|88|||
149947041|NCT05523297|540938656|FG000|Overall Study|Death|7|||
149947042|NCT05523297|540938657|FG001|Overall Study|Death|8|||
150033247|NCT00506350|541260924|FG006|Overall Study|Withdrawal by Subject|1|||
150276255|NCT00356889|542148018|FG000|Overall Study|Adverse Event|1|||
149947043|NCT05523297|540938656|FG000|Overall Study|Lost to Follow-up|2|||
149947044|NCT05523297|540938657|FG001|Overall Study|Lost to Follow-up|1|||
149947045|NCT00830765|540938660|FG000|Overall Study|Protocol Violation|3|||
150276256|NCT02678416|542148019|FG000|Part 1|Withdrawal by Subject|1|||
150276257|NCT02678416|542148019|FG000|Part 2|Adverse Event|2|||
150276258|NCT02678416|542148019|FG000|Part 2|Withdrawal by Subject|1|||
150276259|NCT01848353|542148020|FG000|Phase 1|Withdrawal by Subject|3|||
150276260|NCT01848353|542148021|FG001|Phase 1|Withdrawal by Subject|1|||
150276261|NCT01848353|542148022|FG002|Phase 1|Withdrawal by Subject|0|||
149947046|NCT00830765|540938661|FG001|Overall Study|Protocol Violation|2|||
149947047|NCT00315445|540938662|FG000|Overall Study|Adverse Event|7|||
149947048|NCT00315445|540938663|FG001|Overall Study|Adverse Event|12|||
149947049|NCT00315445|540938664|FG002|Overall Study|Adverse Event|15|||
149947050|NCT00315445|540938662|FG000|Overall Study|Lack of Efficacy|16|||
149947051|NCT00315445|540938663|FG001|Overall Study|Lack of Efficacy|1|||
149947052|NCT00315445|540938664|FG002|Overall Study|Lack of Efficacy|7|||
149947053|NCT00315445|540938662|FG000|Overall Study|Lost to Follow-up|1|||
149947054|NCT00315445|540938663|FG001|Overall Study|Lost to Follow-up|0|||
149947055|NCT00315445|540938664|FG002|Overall Study|Lost to Follow-up|1|||
149947056|NCT00315445|540938662|FG000|Overall Study|Protocol Violation|2|||
149947057|NCT00315445|540938663|FG001|Overall Study|Protocol Violation|0|||
149947058|NCT00315445|540938664|FG002|Overall Study|Protocol Violation|1|||
149947059|NCT00315445|540938662|FG000|Overall Study|Other|1|||
149947060|NCT00315445|540938663|FG001|Overall Study|Other|3|||
149947061|NCT00315445|540938664|FG002|Overall Study|Other|0|||
149947062|NCT01299909|540938665|FG000|Overall Study|Lost to Follow-up|22|||
149947063|NCT01299909|540938666|FG001|Overall Study|Lost to Follow-up|18|||
149947064|NCT01299909|540938667|FG002|Overall Study|Lost to Follow-up|17|||
149947065|NCT02460289|540938668|FG000|Overall Study|Adverse Event|1|||
149947066|NCT02460289|540938668|FG000|Overall Study|Withdrawal by Subject|8|||
149947067|NCT02460289|540938668|FG000|Overall Study|Lost to Follow-up|1|||
149947068|NCT01155570|540938669|FG000|Overall Study|Adverse Event|39|||
149947069|NCT01155570|540938669|FG000|Overall Study|Lack of Efficacy|46|||
149947070|NCT01155570|540938669|FG000|Overall Study|Participant's Economic Reasons|17|||
149947071|NCT01155570|540938669|FG000|Overall Study|No Hospital Visits|7|||
149947072|NCT01155570|540938669|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
149947073|NCT01155570|540938669|FG000|Overall Study|Adverse Event + Other Reasons|7|||
149947074|NCT01155570|540938669|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
149947075|NCT01155570|540938669|FG000|Overall Study|Other Reasons|23|||
149947076|NCT02774889|540938679|FG000|Overall Study|Lost to Follow-up|2|||
149947077|NCT02774889|540938680|FG001|Overall Study|Lost to Follow-up|1|||
149947078|NCT00858988|540938681|FG000|Analysis|Lactulose unable to be detected in urine|2|||
149947079|NCT00858988|540938682|FG001|Analysis|Lactulose unable to be detected in urine|1|||
149947080|NCT01349595|540938685|FG000|Overall Study|Lack of funding|2|||
149947081|NCT01349595|540938686|FG001|Overall Study|Lack of funding|2|||
149947082|NCT01706328|540938687|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
149947083|NCT01706328|540938688|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
149947084|NCT01706328|540938689|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
149947085|NCT01706328|540938687|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
149947086|NCT01706328|540938688|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149947087|NCT01706328|540938689|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149947088|NCT01706328|540938687|FG000|2-week Run-in Period|Physician Decision|4|||
149947089|NCT01706328|540938688|FG001|2-week Run-in Period|Physician Decision|0|||
149947090|NCT01706328|540938689|FG002|2-week Run-in Period|Physician Decision|0|||
149947091|NCT01706328|540938687|FG000|2-week Run-in Period|Adverse Event|4|||
149947092|NCT01706328|540938688|FG001|2-week Run-in Period|Adverse Event|0|||
149947093|NCT01706328|540938689|FG002|2-week Run-in Period|Adverse Event|0|||
149947094|NCT01706328|540938687|FG000|2-week Run-in Period|Lost to Follow-up|2|||
149947095|NCT01706328|540938688|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149947096|NCT01706328|540938689|FG002|2-week Run-in Period|Lost to Follow-up|0|||
149947097|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
149947098|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
149947099|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
149947100|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
149947101|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
149947102|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
149947103|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
149947104|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
149947105|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
149947106|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
149947107|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
149975627|NCT00038948|541047922|FG000|Overall Study|Adverse Event|131|||
150276262|NCT01848353|542148023|FG003|Phase 1|Withdrawal by Subject|0|||
150276263|NCT01848353|542148020|FG000|Phase 2|Withdrawal by Subject|3|||
149947108|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
149947109|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
149947110|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
149947111|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
149947112|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
149947113|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
149947114|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
149947115|NCT01706328|540938687|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149947116|NCT01706328|540938688|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
149947117|NCT01706328|540938689|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
149947118|NCT06481579|540938690|FG000|Overall Study|Death|1|||
149947119|NCT06481579|540938691|FG001|Overall Study|Death|0|||
149947120|NCT06481579|540938690|FG000|Overall Study|Withdrawal by Subject|3|||
149947121|NCT06481579|540938691|FG001|Overall Study|Withdrawal by Subject|0|||
149947122|NCT06481579|540938690|FG000|Overall Study|Other|1|||
149947123|NCT06481579|540938691|FG001|Overall Study|Other|1|||
149947124|NCT01369433|540940237|FG000|Overall Study|Adverse Event|31|||
149947125|NCT01369433|540940238|FG001|Overall Study|Adverse Event|1|||
149947126|NCT01369433|540940237|FG000|Overall Study|Required significant surgical procedure|1|||
149947127|NCT01369433|540940238|FG001|Overall Study|Required significant surgical procedure|0|||
149947128|NCT01369433|540940237|FG000|Overall Study|Non-compliance|1|||
149947129|NCT01369433|540940238|FG001|Overall Study|Non-compliance|0|||
149947130|NCT01369433|540940237|FG000|Overall Study|Withdrawal by Subject|5|||
149947131|NCT01369433|540940238|FG001|Overall Study|Withdrawal by Subject|2|||
149947132|NCT01369433|540940237|FG000|Overall Study|Study terminated by Sponsor|67|||
149947133|NCT01369433|540940238|FG001|Overall Study|Study terminated by Sponsor|0|||
149947134|NCT01369433|540940237|FG000|Overall Study|Lost to Follow-up|1|||
149947135|NCT01369433|540940238|FG001|Overall Study|Lost to Follow-up|0|||
149947136|NCT01369433|540940237|FG000|Overall Study|Death|5|||
149947137|NCT01369433|540940238|FG001|Overall Study|Death|0|||
149947138|NCT01369433|540940237|FG000|Overall Study|Investigator discretion|6|||
149947139|NCT01369433|540940238|FG001|Overall Study|Investigator discretion|1|||
149947140|NCT01369433|540940237|FG000|Overall Study|Progressive Disease|92|||
149947141|NCT01369433|540940238|FG001|Overall Study|Progressive Disease|12|||
149947142|NCT00933933|540940243|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
149947143|NCT00933933|540940244|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
149947144|NCT00933933|540940245|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
149947145|NCT00933933|540940243|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
149947146|NCT00933933|540940244|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
149947147|NCT00933933|540940245|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
149947148|NCT01341470|540940246|FG000|Overall Study|Sponsor decision|0|||
149947149|NCT01341470|540940247|FG001|Overall Study|Sponsor decision|0|||
149947150|NCT01341470|540940248|FG002|Overall Study|Sponsor decision|1|||
149947151|NCT01341470|540940249|FG003|Overall Study|Sponsor decision|1|||
149947152|NCT01341470|540940250|FG004|Overall Study|Sponsor decision|0|||
149947153|NCT01341470|540940251|FG005|Overall Study|Sponsor decision|1|||
149947154|NCT03112603|540940259|FG000|End of Randomization Period|Lost to Follow-up|3|||
149947155|NCT03112603|540940260|FG001|End of Randomization Period|Lost to Follow-up|0|||
149947156|NCT03112603|540940261|FG002|End of Randomization Period|Lost to Follow-up|0|||
149947157|NCT03112603|540940259|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
149947158|NCT03112603|540940260|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
149947159|NCT03112603|540940261|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
149947160|NCT03112603|540940259|FG000|End of Randomization Period|Physician Decision|43|||
149947161|NCT03112603|540940260|FG001|End of Randomization Period|Physician Decision|18|||
149947162|NCT03112603|540940261|FG002|End of Randomization Period|Physician Decision|0|||
149947163|NCT03112603|540940259|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
149947164|NCT03112603|540940260|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
149947165|NCT03112603|540940261|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
149947166|NCT03112603|540940259|FG000|End of Randomization Period|Death|10|||
149947167|NCT03112603|540940260|FG001|End of Randomization Period|Death|7|||
149947168|NCT03112603|540940261|FG002|End of Randomization Period|Death|0|||
149947169|NCT03112603|540940259|FG000|End of Randomization Period|Disease Relapse|12|||
149947170|NCT03112603|540940260|FG001|End of Randomization Period|Disease Relapse|7|||
149947171|NCT03112603|540940261|FG002|End of Randomization Period|Disease Relapse|0|||
149947172|NCT03112603|540940259|FG000|End of Randomization Period|Lack of Efficacy|25|||
149947173|NCT03112603|540940260|FG001|End of Randomization Period|Lack of Efficacy|77|||
149947174|NCT03112603|540940261|FG002|End of Randomization Period|Lack of Efficacy|0|||
149947175|NCT03112603|540940259|FG000|End of Randomization Period|Adverse Event|32|||
149947176|NCT03112603|540940260|FG001|End of Randomization Period|Adverse Event|12|||
149947177|NCT03112603|540940261|FG002|End of Randomization Period|Adverse Event|0|||
150177807|NCT03036813|541788209|FG002|Overall Study|Withdrawal by Subject|10|||
149947178|NCT03112603|540940259|FG000|End of Cross Over Period|Death|0|||
149947179|NCT03112603|540940260|FG001|End of Cross Over Period|Death|0|||
149947180|NCT03112603|540940261|FG002|End of Cross Over Period|Death|2|||
149829211|NCT01508936|540504439|FG001|Overall Study|Lost to Follow-up|9|||
149829212|NCT01508936|540504438|FG000|Overall Study|Other|0|||
149829213|NCT01508936|540504439|FG001|Overall Study|Other|5|||
149829214|NCT01508936|540504438|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
149829215|NCT01508936|540504439|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
149829216|NCT00679367|540504440|FG000|Overall Study|Adverse Event|7|||
149829217|NCT00679367|540504440|FG000|Overall Study|inability to swallow oral drugs|1|||
149829218|NCT00679367|540504440|FG000|Overall Study|Lack of Efficacy|3|||
149829219|NCT00679367|540504440|FG000|Overall Study|Withdrawal by Subject|1|||
149829220|NCT03365947|540504441|FG000|Overall Study|Lost to Follow-up|0|||
149829221|NCT03365947|540504442|FG001|Overall Study|Lost to Follow-up|0|||
149829222|NCT03365947|540504443|FG002|Overall Study|Lost to Follow-up|0|||
149829223|NCT03365947|540504444|FG003|Overall Study|Lost to Follow-up|0|||
149829224|NCT03365947|540504445|FG004|Overall Study|Lost to Follow-up|0|||
149829225|NCT03365947|540504446|FG005|Overall Study|Lost to Follow-up|1|||
149829226|NCT03365947|540504447|FG006|Overall Study|Lost to Follow-up|0|||
149829227|NCT03365947|540504448|FG007|Overall Study|Lost to Follow-up|0|||
149829228|NCT03365947|540504449|FG008|Overall Study|Lost to Follow-up|0|||
149829229|NCT03365947|540504450|FG009|Overall Study|Lost to Follow-up|0|||
149829230|NCT03365947|540504451|FG010|Overall Study|Lost to Follow-up|0|||
149829231|NCT03365947|540504452|FG011|Overall Study|Lost to Follow-up|0|||
149829232|NCT03365947|540504453|FG012|Overall Study|Lost to Follow-up|0|||
149829233|NCT03365947|540504454|FG013|Overall Study|Lost to Follow-up|0|||
149829234|NCT03365947|540504455|FG014|Overall Study|Lost to Follow-up|0|||
149829235|NCT03365947|540504456|FG015|Overall Study|Lost to Follow-up|0|||
149829236|NCT03365947|540504457|FG016|Overall Study|Lost to Follow-up|0|||
149829237|NCT03365947|540504458|FG017|Overall Study|Lost to Follow-up|0|||
149829238|NCT03365947|540504459|FG018|Overall Study|Lost to Follow-up|0|||
149829239|NCT02518685|540504460|FG000|Overall Study|Adverse Event|29|||
149829240|NCT02518685|540504461|FG001|Overall Study|Adverse Event|1|||
149829241|NCT02518685|540504460|FG000|Overall Study|Withdrawal by Subject|10|||
149829242|NCT02518685|540504461|FG001|Overall Study|Withdrawal by Subject|3|||
149829243|NCT02518685|540504460|FG000|Overall Study|relocation, study fatigue|7|||
149829244|NCT02518685|540504461|FG001|Overall Study|relocation, study fatigue|2|||
149829245|NCT02518685|540504460|FG000|Overall Study|Pregnancy|1|||
149829246|NCT02518685|540504461|FG001|Overall Study|Pregnancy|0|||
149829247|NCT02518685|540504460|FG000|Overall Study|Physician Decision|1|||
149829248|NCT02518685|540504461|FG001|Overall Study|Physician Decision|0|||
149829249|NCT02518685|540504460|FG000|Overall Study|Lost to Follow-up|1|||
149829250|NCT02518685|540504461|FG001|Overall Study|Lost to Follow-up|4|||
149829251|NCT00336024|540504462|FG000|Overall Study|Death|2|||
149829252|NCT00336024|540504463|FG001|Overall Study|Death|1|||
149829253|NCT00336024|540504462|FG000|Overall Study|Physician Decision|4|||
149829254|NCT00336024|540504463|FG001|Overall Study|Physician Decision|1|||
149829255|NCT00336024|540504462|FG000|Overall Study|Protocol Violation|1|||
149829256|NCT00336024|540504463|FG001|Overall Study|Protocol Violation|0|||
149829257|NCT00336024|540504462|FG000|Overall Study|Withdrawal by Subject|1|||
149829258|NCT00336024|540504463|FG001|Overall Study|Withdrawal by Subject|2|||
149829259|NCT00336024|540504462|FG000|Overall Study|Failure to fulfill consolidation|1|||
149947181|NCT03112603|540940259|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
149947182|NCT03112603|540940260|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
149947183|NCT03112603|540940261|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
149947184|NCT03112603|540940259|FG000|End of Cross Over Period|Physician Decision|0|||
149947185|NCT03112603|540940260|FG001|End of Cross Over Period|Physician Decision|0|||
149947186|NCT03112603|540940261|FG002|End of Cross Over Period|Physician Decision|29|||
149947187|NCT03112603|540940259|FG000|End of Cross Over Period|Lack of Efficacy|0|||
149947188|NCT03112603|540940260|FG001|End of Cross Over Period|Lack of Efficacy|0|||
149947189|NCT03112603|540940261|FG002|End of Cross Over Period|Lack of Efficacy|8|||
149947190|NCT03112603|540940259|FG000|End of Cross Over Period|Adverse Event|0|||
149947191|NCT03112603|540940260|FG001|End of Cross Over Period|Adverse Event|0|||
149947192|NCT03112603|540940261|FG002|End of Cross Over Period|Adverse Event|6|||
149947193|NCT03112603|540940259|FG000|End of Cross Over Period|Disease Relapse|0|||
149947194|NCT03112603|540940260|FG001|End of Cross Over Period|Disease Relapse|0|||
149947195|NCT03112603|540940261|FG002|End of Cross Over Period|Disease Relapse|2|||
150276264|NCT01848353|542148021|FG001|Phase 2|Withdrawal by Subject|2|||
149947196|NCT04725188|540940262|FG000|Overall Study|Death|72|||
149947197|NCT04725188|540940263|FG001|Overall Study|Death|69|||
149947198|NCT04725188|540940264|FG002|Overall Study|Death|76|||
149829260|NCT00336024|540504463|FG001|Overall Study|Failure to fulfill consolidation|1|||
149829261|NCT00336024|540504462|FG000|Overall Study|Progressive Disease|4|||
149829262|NCT00336024|540504463|FG001|Overall Study|Progressive Disease|7|||
149829263|NCT00336024|540504462|FG000|Overall Study|Ineligible|7|||
149947199|NCT04725188|540940262|FG000|Overall Study|Lost to Follow-up|1|||
149829264|NCT00336024|540504463|FG001|Overall Study|Ineligible|7|||
149829265|NCT03946449|540504464|FG000|Treatment Extension II|Rolled over to another study|0|||
150276265|NCT01848353|542148022|FG002|Phase 2|Withdrawal by Subject|0|||
150276266|NCT01848353|542148023|FG003|Phase 2|Withdrawal by Subject|0|||
150276267|NCT01848353|542148020|FG000|Phase 3|Withdrawal by Subject|1|||
150276268|NCT01848353|542148021|FG001|Phase 3|Withdrawal by Subject|1|||
150276269|NCT01848353|542148022|FG002|Phase 3|Withdrawal by Subject|0|||
150276270|NCT01848353|542148023|FG003|Phase 3|Withdrawal by Subject|0|||
150276271|NCT03492554|542148026|FG000|Overall Study|Protocol Violation|0|||
150276272|NCT03492554|542148027|FG001|Overall Study|Protocol Violation|14|||
150276273|NCT01289821|542148028|FG000|Treatment Period|Withdrawal by Subject|1|||
149947200|NCT04725188|540940263|FG001|Overall Study|Lost to Follow-up|0|||
149947201|NCT04725188|540940264|FG002|Overall Study|Lost to Follow-up|1|||
149947202|NCT04725188|540940262|FG000|Overall Study|Withdrawal by Subject|2|||
149947203|NCT04725188|540940263|FG001|Overall Study|Withdrawal by Subject|2|||
149947204|NCT04725188|540940264|FG002|Overall Study|Withdrawal by Subject|1|||
149947205|NCT04725188|540940262|FG000|Overall Study|Sponsor Decision|12|||
149947206|NCT04725188|540940263|FG001|Overall Study|Sponsor Decision|12|||
149947207|NCT04725188|540940264|FG002|Overall Study|Sponsor Decision|7|||
149947208|NCT00390013|540940265|FG000|Phase 1|tired|0|||
149947209|NCT00390013|540940266|FG001|Phase 1|tired|0|||
149947210|NCT00390013|540940267|FG002|Phase 1|tired|0|||
149947211|NCT00390013|540940268|FG003|Phase 1|tired|1|||
149947212|NCT00390013|540940265|FG000|Phase 2 First Treatment|tired|1|||
149947213|NCT00390013|540940266|FG001|Phase 2 First Treatment|tired|0|||
149947214|NCT00390013|540940267|FG002|Phase 2 First Treatment|tired|0|||
149947215|NCT00390013|540940268|FG003|Phase 2 First Treatment|tired|0|||
149947216|NCT00390013|540940265|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
149947217|NCT00390013|540940266|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
149947218|NCT00390013|540940267|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
149947219|NCT00390013|540940268|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
149947220|NCT03765073|540940269|FG000|Stage 1|Lost to Follow-up|1|||
149947221|NCT03765073|540940270|FG001|Stage 1|Lost to Follow-up|0|||
149947222|NCT03765073|540940271|FG002|Stage 1|Lost to Follow-up|0|||
149947223|NCT03765073|540940272|FG003|Stage 1|Lost to Follow-up|0|||
149947224|NCT03765073|540940273|FG004|Stage 1|Lost to Follow-up|0|||
149947225|NCT03765073|540940274|FG005|Stage 1|Lost to Follow-up|0|||
149947226|NCT03765073|540940275|FG006|Stage 1|Lost to Follow-up|0|||
149947227|NCT03765073|540940276|FG007|Stage 1|Lost to Follow-up|0|||
149947228|NCT03765073|540940277|FG008|Stage 1|Lost to Follow-up|0|||
149947229|NCT03765073|540940278|FG009|Stage 1|Lost to Follow-up|0|||
149947230|NCT03765073|540940279|FG010|Stage 1|Lost to Follow-up|0|||
149947231|NCT03765073|540940280|FG011|Stage 1|Lost to Follow-up|0|||
149947232|NCT03765073|540940281|FG012|Stage 1|Lost to Follow-up|0|||
149947233|NCT03765073|540940282|FG013|Stage 1|Lost to Follow-up|0|||
149947234|NCT03765073|540940283|FG014|Stage 1|Lost to Follow-up|0|||
149947235|NCT03765073|540940284|FG015|Stage 1|Lost to Follow-up|0|||
149947236|NCT03765073|540940285|FG016|Stage 1|Lost to Follow-up|0|||
149947237|NCT03765073|540940286|FG017|Stage 1|Lost to Follow-up|0|||
149947238|NCT03765073|540940287|FG018|Stage 1|Lost to Follow-up|0|||
149947239|NCT03765073|540940288|FG019|Stage 1|Lost to Follow-up|0|||
149947240|NCT03765073|540940289|FG020|Stage 1|Lost to Follow-up|0|||
150276274|NCT01289821|542148028|FG000|Treatment Period|Physician Decision|3|||
150276275|NCT01289821|542148028|FG000|Treatment Period|Adverse Event|4|||
150276276|NCT01289821|542148028|FG000|Treatment Period|Radiological Progression|43|||
150276277|NCT01289821|542148028|FG000|Treatment Period|Clinical Progression|2|||
150276278|NCT01289821|542148028|FG000|Treatment Period|Therapeutic procedure required|1|||
149947241|NCT03765073|540940269|FG000|Stage 1|Withdrawal by participant|0|||
149947242|NCT03765073|540940270|FG001|Stage 1|Withdrawal by participant|1|||
149947243|NCT03765073|540940271|FG002|Stage 1|Withdrawal by participant|0|||
149947244|NCT03765073|540940272|FG003|Stage 1|Withdrawal by participant|0|||
149947245|NCT03765073|540940273|FG004|Stage 1|Withdrawal by participant|0|||
149947246|NCT03765073|540940274|FG005|Stage 1|Withdrawal by participant|0|||
149947247|NCT03765073|540940275|FG006|Stage 1|Withdrawal by participant|0|||
149947248|NCT03765073|540940276|FG007|Stage 1|Withdrawal by participant|0|||
149947249|NCT03765073|540940277|FG008|Stage 1|Withdrawal by participant|0|||
149947250|NCT03765073|540940278|FG009|Stage 1|Withdrawal by participant|0|||
149947251|NCT03765073|540940279|FG010|Stage 1|Withdrawal by participant|0|||
149947252|NCT03765073|540940280|FG011|Stage 1|Withdrawal by participant|0|||
149947253|NCT03765073|540940281|FG012|Stage 1|Withdrawal by participant|0|||
149947254|NCT03765073|540940282|FG013|Stage 1|Withdrawal by participant|0|||
149947255|NCT03765073|540940283|FG014|Stage 1|Withdrawal by participant|0|||
149947256|NCT03765073|540940284|FG015|Stage 1|Withdrawal by participant|0|||
149947257|NCT03765073|540940285|FG016|Stage 1|Withdrawal by participant|0|||
150276279|NCT01289821|542148028|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
150276280|NCT01289821|542148028|FG000|Safety Follow-up Period|Protocol Violation|3|||
150276281|NCT01289821|542148028|FG000|Safety Follow-up Period|Unspecified reason|1|||
149947258|NCT03765073|540940286|FG017|Stage 1|Withdrawal by participant|0|||
149947259|NCT03765073|540940287|FG018|Stage 1|Withdrawal by participant|0|||
150276282|NCT01289821|542148028|FG000|Survival Follow-up Period|Protocol Violation|1|||
149947260|NCT03765073|540940288|FG019|Stage 1|Withdrawal by participant|0|||
149947261|NCT03765073|540940289|FG020|Stage 1|Withdrawal by participant|0|||
149947262|NCT03765073|540940269|FG000|Stage 2|Death|0|||
149829266|NCT03946449|540504465|FG001|Treatment Extension II|Rolled over to another study|0|||
149829267|NCT03946449|540504466|FG002|Treatment Extension II|Rolled over to another study|2|||
149829268|NCT03946449|540504464|FG000|Treatment Extension II|Withdrawal by Subject|0|||
149829269|NCT03946449|540504465|FG001|Treatment Extension II|Withdrawal by Subject|0|||
149829270|NCT03946449|540504466|FG002|Treatment Extension II|Withdrawal by Subject|1|||
149829271|NCT05067504|540504468|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
149829272|NCT05067504|540504469|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
149829273|NCT05067504|540504468|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
149829274|NCT05067504|540504469|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
149829275|NCT05067504|540504468|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
149829276|NCT05067504|540504469|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
149829277|NCT04720664|540506370|FG000|Overall Study|Adverse Event|2|||
149829278|NCT04720664|540506370|FG000|Overall Study|Lack of Efficacy|9|||
149829279|NCT02322047|540506371|FG000|Overall Study|Physician Decision|1|||
149829280|NCT02322047|540506372|FG001|Overall Study|Physician Decision|0|||
149829281|NCT02322047|540506373|FG002|Overall Study|Physician Decision|0|||
149829282|NCT02322047|540506374|FG003|Overall Study|Physician Decision|0|||
149829283|NCT02322047|540506371|FG000|Overall Study|Withdrawal by Subject|1|||
149829284|NCT02322047|540506372|FG001|Overall Study|Withdrawal by Subject|0|||
149829285|NCT02322047|540506373|FG002|Overall Study|Withdrawal by Subject|0|||
149829286|NCT02322047|540506374|FG003|Overall Study|Withdrawal by Subject|1|||
149829287|NCT02322047|540506371|FG000|Overall Study|Adverse Event|0|||
149829288|NCT02322047|540506372|FG001|Overall Study|Adverse Event|1|||
149829289|NCT02322047|540506373|FG002|Overall Study|Adverse Event|0|||
149829290|NCT02322047|540506374|FG003|Overall Study|Adverse Event|0|||
149829291|NCT02322047|540506371|FG000|Overall Study|Lost to Follow-up|0|||
149829292|NCT02322047|540506372|FG001|Overall Study|Lost to Follow-up|0|||
149829293|NCT02322047|540506373|FG002|Overall Study|Lost to Follow-up|1|||
149829294|NCT02322047|540506374|FG003|Overall Study|Lost to Follow-up|1|||
149829295|NCT03311646|540506375|FG000|Overall Study|Physician Decision|1|||
149829296|NCT03311646|540506375|FG000|Overall Study|Withdrawal by Subject|5|||
149829297|NCT03311646|540506375|FG000|Overall Study|Lost to Follow-up|5|||
149829298|NCT03311646|540506375|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
149829299|NCT03103100|540506376|FG000|Overall Study|Adverse Event|1|||
149829300|NCT03103100|540506377|FG001|Overall Study|Adverse Event|0|||
149829301|NCT03103100|540506378|FG002|Overall Study|Adverse Event|0|||
149829302|NCT03103100|540506376|FG000|Overall Study|Physician Decision|1|||
149829303|NCT03103100|540506377|FG001|Overall Study|Physician Decision|0|||
149829304|NCT03103100|540506378|FG002|Overall Study|Physician Decision|2|||
149829305|NCT00531206|540506379|FG000|Overall Study|Adverse Event related|5|||
149829306|NCT00531206|540506379|FG000|Overall Study|Lack of Efficacy|2|||
149829307|NCT00531206|540506379|FG000|Overall Study|Lost to Follow-up|5|||
149829308|NCT00531206|540506379|FG000|Overall Study|including non-related adverse events|8|||
149829309|NCT02906709|540506380|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
149829310|NCT02906709|540506381|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
149829311|NCT02906709|540506380|FG000|Phase A (Week 0 to Week 16)|Death|0|||
149829312|NCT02906709|540506381|FG001|Phase A (Week 0 to Week 16)|Death|1|||
149829313|NCT02906709|540506380|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
149829314|NCT02906709|540506381|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
149829315|NCT02906709|540506380|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
149829316|NCT02906709|540506381|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
149829317|NCT00977106|540506383|FG000|Overall Study|Adverse Event|5|||
149829318|NCT00977106|540506384|FG001|Overall Study|Adverse Event|6|||
149829319|NCT00977106|540506383|FG000|Overall Study|Withdrawal by Subject|2|||
149829320|NCT00977106|540506384|FG001|Overall Study|Withdrawal by Subject|2|||
149829321|NCT00977106|540506383|FG000|Overall Study|Lack of Efficacy|2|||
149829322|NCT00977106|540506384|FG001|Overall Study|Lack of Efficacy|2|||
149829323|NCT00977106|540506383|FG000|Overall Study|Protocol Violation|0|||
149829324|NCT00977106|540506384|FG001|Overall Study|Protocol Violation|1|||
149829325|NCT00977106|540506383|FG000|Overall Study|Other|1|||
149829326|NCT00977106|540506384|FG001|Overall Study|Other|0|||
149829327|NCT02419313|540506385|FG000|First Intervention|Lost to Follow-up|2|||
149829328|NCT02419313|540506386|FG001|First Intervention|Lost to Follow-up|0|||
149947263|NCT03765073|540940270|FG001|Stage 2|Death|0|||
149829329|NCT02419313|540506385|FG000|Second Intervention|Lost to Follow-up|1|||
149829330|NCT02419313|540506386|FG001|Second Intervention|Lost to Follow-up|0|||
149829331|NCT00442936|540506390|FG000|Overall Study|Protocol Violation|1|||
149829332|NCT00442936|540506391|FG001|Overall Study|Protocol Violation|0|||
149829333|NCT00442936|540506392|FG002|Overall Study|Protocol Violation|1|||
149829334|NCT00442936|540506393|FG003|Overall Study|Protocol Violation|1|||
149829335|NCT00524459|540506395|FG000|Overall Study|Withdrawal by Subject|1|||
149829336|NCT00524459|540506395|FG000|Overall Study|Other|1|||
149829337|NCT02428699|540506396|FG000|Washout Period 1|Screen Failure|1|||
149829338|NCT02428699|540506397|FG001|Washout Period 1|Screen Failure|2|||
149947264|NCT03765073|540940271|FG002|Stage 2|Death|0|||
149947265|NCT03765073|540940272|FG003|Stage 2|Death|0|||
149829339|NCT02433678|540506398|FG000|Overall Study|Lost to Follow-up|1|||
149947266|NCT03765073|540940273|FG004|Stage 2|Death|0|||
150276283|NCT01289821|542148028|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
150276284|NCT01289821|542148028|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
150276285|NCT01010633|542148032|FG000|Overall Study|Adverse Event|1|||
150276286|NCT01010633|542148033|FG001|Overall Study|Adverse Event|1|||
150276287|NCT01010633|542148032|FG000|Overall Study|Protocol Violation|1|||
150276288|NCT01010633|542148033|FG001|Overall Study|Protocol Violation|2|||
150276289|NCT01010633|542148032|FG000|Overall Study|Withdrawal by Subject|2|||
150276290|NCT01010633|542148033|FG001|Overall Study|Withdrawal by Subject|1|||
150276291|NCT01010633|542148032|FG000|Overall Study|Investigator decision|0|||
150276292|NCT01010633|542148033|FG001|Overall Study|Investigator decision|1|||
150276293|NCT04376827|542148034|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
150276294|NCT04376827|542148035|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
150276295|NCT04376827|542148034|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
150276296|NCT04376827|542148035|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
150276297|NCT04376827|542148034|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
150276298|NCT04376827|542148035|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
150276299|NCT04376827|542148034|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
150276300|NCT04376827|542148035|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
150276301|NCT04376827|542148034|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
150276302|NCT04376827|542148035|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
150276303|NCT02615470|542149912|FG000|Overall Study|Lost to Follow-up|21|||
150276304|NCT02615470|542149913|FG001|Overall Study|Lost to Follow-up|32|||
150276305|NCT01717287|542149917|FG000|Overall Study|Lost to Follow-up|0|||
150276306|NCT01717287|542149918|FG001|Overall Study|Lost to Follow-up|2|||
150276307|NCT01717287|542149917|FG000|Overall Study|Protocol Violation|0|||
150276308|NCT01717287|542149918|FG001|Overall Study|Protocol Violation|1|||
150276309|NCT04490395|542149919|FG000|Overall Study|Lost to Follow-up|0|||
150276310|NCT04490395|542149920|FG001|Overall Study|Lost to Follow-up|1|||
150276311|NCT00388505|542149923|FG000|Overall Study|Adverse Event or Death|43|||
150276312|NCT00388505|542149924|FG001|Overall Study|Adverse Event or Death|17|||
150276313|NCT00388505|542149923|FG000|Overall Study|Withdrawal by Subject|24|||
150276314|NCT00388505|542149924|FG001|Overall Study|Withdrawal by Subject|9|||
150276315|NCT00388505|542149923|FG000|Overall Study|Lost to Follow-up|5|||
150276316|NCT00388505|542149924|FG001|Overall Study|Lost to Follow-up|3|||
150276317|NCT00388505|542149923|FG000|Overall Study|Inappropriate Enrollment|0|||
150276318|NCT00388505|542149924|FG001|Overall Study|Inappropriate Enrollment|1|||
150276319|NCT00388505|542149923|FG000|Overall Study|Administrative Reason|1|||
150276320|NCT00388505|542149924|FG001|Overall Study|Administrative Reason|0|||
150276321|NCT00388505|542149923|FG000|Overall Study|Protocol Violation|6|||
150276322|NCT00388505|542149924|FG001|Overall Study|Protocol Violation|5|||
150276323|NCT00388505|542149923|FG000|Overall Study|Unable to classify|4|||
149947267|NCT03765073|540940274|FG005|Stage 2|Death|0|||
149947268|NCT03765073|540940275|FG006|Stage 2|Death|0|||
149947269|NCT03765073|540940276|FG007|Stage 2|Death|0|||
149947270|NCT03765073|540940277|FG008|Stage 2|Death|0|||
149947271|NCT03765073|540940278|FG009|Stage 2|Death|1|||
149947272|NCT03765073|540940279|FG010|Stage 2|Death|0|||
149947273|NCT03765073|540940280|FG011|Stage 2|Death|1|||
149947274|NCT03765073|540940281|FG012|Stage 2|Death|0|||
149947275|NCT03765073|540940282|FG013|Stage 2|Death|0|||
149947276|NCT03765073|540940283|FG014|Stage 2|Death|0|||
149947277|NCT03765073|540940284|FG015|Stage 2|Death|0|||
149947278|NCT03765073|540940285|FG016|Stage 2|Death|2|||
149947279|NCT03765073|540940286|FG017|Stage 2|Death|0|||
149947280|NCT03765073|540940287|FG018|Stage 2|Death|0|||
149947281|NCT03765073|540940288|FG019|Stage 2|Death|0|||
149947282|NCT03765073|540940289|FG020|Stage 2|Death|0|||
149947283|NCT03765073|540940269|FG000|Stage 2|Lost to Follow-up|0|||
149947284|NCT03765073|540940270|FG001|Stage 2|Lost to Follow-up|0|||
149947285|NCT03765073|540940271|FG002|Stage 2|Lost to Follow-up|0|||
149947286|NCT03765073|540940272|FG003|Stage 2|Lost to Follow-up|5|||
149947287|NCT03765073|540940273|FG004|Stage 2|Lost to Follow-up|1|||
149947288|NCT03765073|540940274|FG005|Stage 2|Lost to Follow-up|0|||
149947289|NCT03765073|540940275|FG006|Stage 2|Lost to Follow-up|3|||
150033248|NCT00506350|541260925|FG007|Overall Study|Withdrawal by Subject|2|||
150276324|NCT00388505|542149924|FG001|Overall Study|Unable to classify|3|||
150276325|NCT05092919|542149925|FG000|Overall Study|Lost to Follow-up|7|||
150276326|NCT05092919|542149925|FG000|Overall Study|Withdrawal by Subject|2|||
150276327|NCT03785925|542149933|FG000|Overall Study|Withdrawal by Subject|15|||
150276328|NCT03785925|542149933|FG000|Overall Study|Lost to Follow-up|1|||
150276329|NCT00677820|542149935|FG000|Overall Study|Lost to Follow-up|1|||
150276330|NCT00677820|542149936|FG001|Overall Study|Lost to Follow-up|0|||
150276331|NCT00915772|542149944|FG000|Overall Study|Adverse Event|12|||
149947290|NCT03765073|540940276|FG007|Stage 2|Lost to Follow-up|3|||
149947291|NCT03765073|540940277|FG008|Stage 2|Lost to Follow-up|1|||
149947292|NCT03765073|540940278|FG009|Stage 2|Lost to Follow-up|6|||
149947293|NCT03765073|540940279|FG010|Stage 2|Lost to Follow-up|5|||
149947294|NCT03765073|540940280|FG011|Stage 2|Lost to Follow-up|1|||
149947295|NCT03765073|540940281|FG012|Stage 2|Lost to Follow-up|1|||
149829340|NCT02433678|540506399|FG001|Overall Study|Lost to Follow-up|2|||
149829341|NCT04424407|540506400|FG000|Overall Study|Withdrawal by Subject|2|||
149829342|NCT04424407|540506400|FG000|Overall Study|Lost to Follow-up|1|||
149829343|NCT02684578|540506401|FG000|Overall Study|Withdrawal by Subject|10|||
149829344|NCT02684578|540506402|FG001|Overall Study|Withdrawal by Subject|7|||
149829345|NCT02684578|540506401|FG000|Overall Study|Lost to Follow-up|0|||
149829346|NCT02684578|540506402|FG001|Overall Study|Lost to Follow-up|3|||
149829347|NCT02684578|540506401|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
149829348|NCT02684578|540506402|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
149829349|NCT02684578|540506401|FG000|Overall Study|Missing follow-up data|0|||
149829350|NCT02684578|540506402|FG001|Overall Study|Missing follow-up data|1|||
149829351|NCT02460159|540506403|FG000|Overall Study|Adverse Event|4|||
149829352|NCT02460159|540506404|FG001|Overall Study|Adverse Event|1|||
149829353|NCT02460159|540506403|FG000|Overall Study|Withdrawal by Subject|2|||
149829354|NCT02460159|540506404|FG001|Overall Study|Withdrawal by Subject|0|||
149829355|NCT01193608|540506405|FG000|Overall Study|Other|0|||
149829356|NCT01193608|540506406|FG001|Overall Study|Other|1|||
149829357|NCT01193608|540506407|FG002|Overall Study|Other|0|||
149829358|NCT01193608|540506408|FG003|Overall Study|Other|0|||
149829359|NCT01193608|540506409|FG004|Overall Study|Other|0|||
149829360|NCT01193608|540506410|FG005|Overall Study|Other|0|||
149829361|NCT01193608|540506405|FG000|Overall Study|Withdrawal by Subject|0|||
149829362|NCT01193608|540506406|FG001|Overall Study|Withdrawal by Subject|1|||
149829363|NCT01193608|540506407|FG002|Overall Study|Withdrawal by Subject|2|||
149829364|NCT01193608|540506408|FG003|Overall Study|Withdrawal by Subject|3|||
149829365|NCT01193608|540506409|FG004|Overall Study|Withdrawal by Subject|3|||
149829366|NCT01193608|540506410|FG005|Overall Study|Withdrawal by Subject|0|||
149829367|NCT01193608|540506405|FG000|Overall Study|Lost to Follow-up|0|||
149829368|NCT01193608|540506406|FG001|Overall Study|Lost to Follow-up|0|||
149829369|NCT01193608|540506407|FG002|Overall Study|Lost to Follow-up|0|||
149829370|NCT01193608|540506408|FG003|Overall Study|Lost to Follow-up|0|||
149829371|NCT01193608|540506409|FG004|Overall Study|Lost to Follow-up|1|||
149829372|NCT01193608|540506410|FG005|Overall Study|Lost to Follow-up|2|||
149829373|NCT01193608|540506405|FG000|Overall Study|Adverse Event|0|||
149829374|NCT01193608|540506406|FG001|Overall Study|Adverse Event|0|||
149829375|NCT01193608|540506407|FG002|Overall Study|Adverse Event|0|||
149829376|NCT01193608|540506408|FG003|Overall Study|Adverse Event|0|||
149829377|NCT01193608|540506409|FG004|Overall Study|Adverse Event|1|||
149829378|NCT01193608|540506410|FG005|Overall Study|Adverse Event|0|||
149829379|NCT01492400|540506418|FG000|Overall Study|Miscellaneous Reasons|2|||
149829380|NCT01492400|540506419|FG001|Overall Study|Miscellaneous Reasons|3|||
149829381|NCT01492400|540506418|FG000|Overall Study|Personal Reasons|0|||
149829382|NCT01492400|540506419|FG001|Overall Study|Personal Reasons|5|||
149829383|NCT01492400|540506418|FG000|Overall Study|Lost to Follow-up|3|||
149829384|NCT01492400|540506419|FG001|Overall Study|Lost to Follow-up|1|||
149829385|NCT01492400|540506418|FG000|Overall Study|Pregnancy|0|||
149829386|NCT01492400|540506419|FG001|Overall Study|Pregnancy|1|||
149829387|NCT01492400|540506418|FG000|Overall Study|Lack of Efficacy|1|||
149829388|NCT01492400|540506419|FG001|Overall Study|Lack of Efficacy|1|||
149829389|NCT01492400|540506418|FG000|Overall Study|Adverse Event|10|||
149947296|NCT03765073|540940282|FG013|Stage 2|Lost to Follow-up|3|||
149829390|NCT01492400|540506419|FG001|Overall Study|Adverse Event|5|||
149829391|NCT00659607|540506420|FG000|Overall Study|No blood pressure recorded|147|||
149829392|NCT00659607|540506420|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
149829393|NCT00659607|540506420|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
149829394|NCT00659607|540506420|FG000|Overall Study|No recorded efficacy data|15|||
149829395|NCT00659607|540506420|FG000|Overall Study|Inconsistent BP measuring date|2|||
149829396|NCT02899338|540506422|FG000|Overall Study|Adverse Event|1|||
149829397|NCT02899338|540506423|FG001|Overall Study|Adverse Event|2|||
149829398|NCT02899338|540506422|FG000|Overall Study|Withdrawal by Subject|2|||
149829399|NCT02899338|540506423|FG001|Overall Study|Withdrawal by Subject|0|||
149829400|NCT00486837|540506424|FG000|Overall Study|Withdrawal by Subject|1|||
149829401|NCT00486837|540506425|FG001|Overall Study|Withdrawal by Subject|0|||
149829402|NCT00486837|540506424|FG000|Overall Study|Adverse Event|1|||
149829403|NCT00486837|540506425|FG001|Overall Study|Adverse Event|1|||
149829404|NCT00486837|540506424|FG000|Overall Study|Protocol Violation|4|||
149829405|NCT00486837|540506425|FG001|Overall Study|Protocol Violation|2|||
149829406|NCT00486837|540506424|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
149829407|NCT00486837|540506425|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
149829408|NCT05694013|540506426|FG000|Overall Study|Death|6|||
149829409|NCT05694013|540506427|FG001|Overall Study|Death|2|||
149829410|NCT05694013|540506426|FG000|Overall Study|Participant Decision|0|||
149829411|NCT05694013|540506427|FG001|Overall Study|Participant Decision|1|||
149829412|NCT05694013|540506426|FG000|Overall Study|Physician Decision|1|||
149829413|NCT05694013|540506427|FG001|Overall Study|Physician Decision|0|||
149829414|NCT05694013|540506426|FG000|Overall Study|Progressive Disease|0|||
149829415|NCT05694013|540506427|FG001|Overall Study|Progressive Disease|1|||
149829416|NCT05694013|540506426|FG000|Overall Study|Study Terminated by Sponsor|12|||
149947297|NCT03765073|540940283|FG014|Stage 2|Lost to Follow-up|3|||
149829417|NCT05694013|540506427|FG001|Overall Study|Study Terminated by Sponsor|17|||
149829418|NCT05694013|540506426|FG000|Overall Study|Withdrawal by Subject|3|||
149829419|NCT05694013|540506427|FG001|Overall Study|Withdrawal by Subject|0|||
149829420|NCT04817891|540506428|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
149829421|NCT04817891|540506428|FG000|Overall Study|Adverse Event|1|||
149829422|NCT04817891|540506428|FG000|Overall Study|Withdrawal by Subject|1|||
149829423|NCT04981912|540506429|FG000|Overall Study|Physician Decision|2|||
149829424|NCT04534283|540506430|FG000|Overall Study|Physician Decision|2|||
149829425|NCT04534283|540506430|FG000|Overall Study|Withdrawal by Subject|1|||
149829426|NCT04534283|540506430|FG000|Overall Study|Disease Progression|12|||
149829427|NCT04534283|540506430|FG000|Overall Study|Adverse Event|1|||
149829428|NCT05630547|540506431|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
149829429|NCT05630547|540506432|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
149829430|NCT05630547|540506433|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
149829431|NCT05630547|540506434|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
149829432|NCT05630547|540506431|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
149829433|NCT05630547|540506432|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
149829434|NCT05630547|540506433|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
149829435|NCT05630547|540506434|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
149829436|NCT05630547|540506431|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
149829437|NCT05630547|540506432|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
149829438|NCT05630547|540506433|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
149829439|NCT05630547|540506434|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
149829440|NCT05630547|540506431|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
149829441|NCT05630547|540506432|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
149829442|NCT05630547|540506433|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
149829443|NCT05630547|540506434|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
149829444|NCT05630547|540506431|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
149829445|NCT05630547|540506432|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
149829446|NCT05630547|540506433|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
149829447|NCT05630547|540506434|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
149829448|NCT05630547|540506431|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
149829449|NCT05630547|540506432|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
149829450|NCT05630547|540506433|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
149829451|NCT05630547|540506434|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
149829452|NCT05630547|540506431|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
149829453|NCT05630547|540506432|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
149829454|NCT05630547|540506433|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
149829455|NCT05630547|540506434|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
149829456|NCT05630547|540506431|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
149829457|NCT05630547|540506432|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
149829458|NCT05630547|540506433|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
149829459|NCT05630547|540506434|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
149829460|NCT05630547|540506431|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
149829461|NCT05630547|540506432|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
149829462|NCT05630547|540506433|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
149829463|NCT05630547|540506434|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
149829464|NCT05630547|540506431|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
149829465|NCT05630547|540506432|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
149829466|NCT05630547|540506433|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
149947298|NCT03765073|540940284|FG015|Stage 2|Lost to Follow-up|1|||
149947299|NCT03765073|540940285|FG016|Stage 2|Lost to Follow-up|6|||
149947300|NCT03765073|540940286|FG017|Stage 2|Lost to Follow-up|0|||
149947301|NCT03765073|540940287|FG018|Stage 2|Lost to Follow-up|0|||
149947302|NCT03765073|540940288|FG019|Stage 2|Lost to Follow-up|0|||
149947303|NCT03765073|540940289|FG020|Stage 2|Lost to Follow-up|0|||
149947304|NCT03765073|540940269|FG000|Stage 2|Other|0|||
149947305|NCT03765073|540940270|FG001|Stage 2|Other|0|||
149947306|NCT03765073|540940271|FG002|Stage 2|Other|0|||
149947307|NCT03765073|540940272|FG003|Stage 2|Other|0|||
149947308|NCT03765073|540940273|FG004|Stage 2|Other|0|||
149947309|NCT03765073|540940274|FG005|Stage 2|Other|0|||
149947310|NCT03765073|540940275|FG006|Stage 2|Other|0|||
149947311|NCT03765073|540940276|FG007|Stage 2|Other|1|||
149947312|NCT03765073|540940277|FG008|Stage 2|Other|1|||
149947313|NCT03765073|540940278|FG009|Stage 2|Other|3|||
149947314|NCT03765073|540940279|FG010|Stage 2|Other|0|||
149947315|NCT03765073|540940280|FG011|Stage 2|Other|0|||
149947316|NCT03765073|540940281|FG012|Stage 2|Other|0|||
149947317|NCT03765073|540940282|FG013|Stage 2|Other|0|||
150170599|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149947318|NCT03765073|540940283|FG014|Stage 2|Other|0|||
149947319|NCT03765073|540940284|FG015|Stage 2|Other|1|||
149947320|NCT03765073|540940285|FG016|Stage 2|Other|2|||
149829467|NCT05630547|540506434|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
149829468|NCT00977470|540506435|FG000|Overall Study|Lack of Efficacy|32|||
149829469|NCT00977470|540506436|FG001|Overall Study|Lack of Efficacy|30|||
149829470|NCT00977470|540506435|FG000|Overall Study|Physician Decision|2|||
149829471|NCT00977470|540506436|FG001|Overall Study|Physician Decision|0|||
149829472|NCT00977470|540506435|FG000|Overall Study|Adverse Event|1|||
149829473|NCT00977470|540506436|FG001|Overall Study|Adverse Event|2|||
149829474|NCT00977470|540506435|FG000|Overall Study|Protocol Violation|1|||
149829475|NCT00977470|540506436|FG001|Overall Study|Protocol Violation|0|||
149829476|NCT00977470|540506435|FG000|Overall Study|Withdrawal by Subject|0|||
149829477|NCT00977470|540506436|FG001|Overall Study|Withdrawal by Subject|2|||
149829478|NCT00977470|540506435|FG000|Overall Study|Death|0|||
149829479|NCT00977470|540506436|FG001|Overall Study|Death|2|||
149829480|NCT00977470|540506435|FG000|Overall Study|clinical decline|0|||
149829481|NCT00977470|540506436|FG001|Overall Study|clinical decline|1|||
149829482|NCT00977470|540506435|FG000|Overall Study|prolonged recovery post-surgery|0|||
149829483|NCT00977470|540506436|FG001|Overall Study|prolonged recovery post-surgery|1|||
149829484|NCT00977470|540506435|FG000|Overall Study|Still on-study|2|||
149829485|NCT00977470|540506436|FG001|Overall Study|Still on-study|0|||
149829486|NCT03257462|540506437|FG000|Cohort A|Lost to Follow-up|1|||
149829487|NCT03257462|540506438|FG001|Cohort A|Lost to Follow-up|0|||
149829488|NCT03257462|540506439|FG002|Cohort A|Lost to Follow-up|0|||
149829489|NCT03257462|540506440|FG003|Cohort A|Lost to Follow-up|0|||
149829490|NCT03257462|540506437|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
149829491|NCT03257462|540506438|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
149829492|NCT03257462|540506439|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
149829493|NCT03257462|540506440|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
149829494|NCT00368277|540506441|FG000|Overall Study|Adverse Event|33|||
149829495|NCT00368277|540506442|FG001|Overall Study|Adverse Event|49|||
149829496|NCT00368277|540506441|FG000|Overall Study|Death|2|||
149829497|NCT00368277|540506442|FG001|Overall Study|Death|1|||
149829498|NCT00368277|540506441|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
149829499|NCT00368277|540506442|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
149829500|NCT00368277|540506441|FG000|Overall Study|Protocol deviation|7|||
149829501|NCT00368277|540506442|FG001|Overall Study|Protocol deviation|0|||
149829502|NCT00368277|540506441|FG000|Overall Study|Patient withdrew consent|32|||
149829503|NCT00368277|540506442|FG001|Overall Study|Patient withdrew consent|28|||
149829504|NCT00368277|540506441|FG000|Overall Study|Lost to Follow-up|8|||
149829505|NCT00368277|540506442|FG001|Overall Study|Lost to Follow-up|6|||
149829506|NCT02364557|540506443|FG000|Overall Study|Protocol Violation|3|||
149829507|NCT02364557|540506444|FG001|Overall Study|Protocol Violation|1|||
149829508|NCT03978624|540506445|FG000|Overall Study|Protocol Violation|1|||
149829509|NCT03978624|540506446|FG001|Overall Study|Protocol Violation|0|||
149829510|NCT04347239|540506447|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
149947321|NCT03765073|540940286|FG017|Stage 2|Other|0|||
149947322|NCT03765073|540940287|FG018|Stage 2|Other|0|||
149947323|NCT03765073|540940288|FG019|Stage 2|Other|0|||
149947324|NCT03765073|540940289|FG020|Stage 2|Other|0|||
149829511|NCT04347239|540506448|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
149947325|NCT03765073|540940269|FG000|Stage 2|Withdrawal by parent/guardian|0|||
149947326|NCT03765073|540940270|FG001|Stage 2|Withdrawal by parent/guardian|0|||
149947327|NCT03765073|540940271|FG002|Stage 2|Withdrawal by parent/guardian|0|||
149947328|NCT03765073|540940272|FG003|Stage 2|Withdrawal by parent/guardian|0|||
149947329|NCT03765073|540940273|FG004|Stage 2|Withdrawal by parent/guardian|0|||
149947330|NCT03765073|540940274|FG005|Stage 2|Withdrawal by parent/guardian|0|||
149947331|NCT03765073|540940275|FG006|Stage 2|Withdrawal by parent/guardian|0|||
150033249|NCT00506350|541260926|FG008|Overall Study|Withdrawal by Subject|0|||
149829512|NCT04347239|540506449|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
149829513|NCT04347239|540506447|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
149829514|NCT04347239|540506448|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
149829515|NCT04347239|540506449|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
149829516|NCT05097989|540506451|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829517|NCT05097989|540506452|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149947332|NCT03765073|540940276|FG007|Stage 2|Withdrawal by parent/guardian|0|||
149947333|NCT03765073|540940277|FG008|Stage 2|Withdrawal by parent/guardian|0|||
149947334|NCT03765073|540940278|FG009|Stage 2|Withdrawal by parent/guardian|0|||
150033250|NCT00506350|541260918|FG000|Overall Study|Lost to Follow-up|1|||
149829518|NCT05097989|540506453|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829519|NCT05097989|540506454|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829520|NCT05097989|540506455|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149947335|NCT03765073|540940279|FG010|Stage 2|Withdrawal by parent/guardian|3|||
149947336|NCT03765073|540940280|FG011|Stage 2|Withdrawal by parent/guardian|3|||
150033251|NCT00506350|541260919|FG001|Overall Study|Lost to Follow-up|1|||
149829521|NCT05097989|540506456|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
149829522|NCT05097989|540506457|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829523|NCT05097989|540506458|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829524|NCT05097989|540506459|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
149829525|NCT05097989|540506451|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
149829526|NCT05097989|540506452|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
149829527|NCT05097989|540506453|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
149829528|NCT05097989|540506454|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
149829529|NCT05097989|540506455|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
149829530|NCT05097989|540506456|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
149829531|NCT05097989|540506457|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
149829532|NCT05097989|540506458|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
149829533|NCT05097989|540506459|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
149829534|NCT05097989|540506451|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829535|NCT05097989|540506452|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829536|NCT05097989|540506453|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829537|NCT05097989|540506454|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829538|NCT05097989|540506455|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829539|NCT05097989|540506456|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
149829540|NCT05097989|540506457|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
149829541|NCT05097989|540506458|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
149829542|NCT05097989|540506459|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
149829543|NCT05097989|540506451|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829544|NCT05097989|540506452|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829545|NCT05097989|540506453|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
149829546|NCT05097989|540506454|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829547|NCT05097989|540506455|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829548|NCT05097989|540506456|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
149829549|NCT05097989|540506457|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829550|NCT05097989|540506458|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
149829551|NCT05097989|540506459|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
149829552|NCT05097989|540506451|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829553|NCT05097989|540506452|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829554|NCT05097989|540506453|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
149829555|NCT05097989|540506454|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829556|NCT05097989|540506455|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829557|NCT05097989|540506456|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829558|NCT05097989|540506457|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829559|NCT05097989|540506458|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149947337|NCT03765073|540940281|FG012|Stage 2|Withdrawal by parent/guardian|3|||
149947338|NCT03765073|540940282|FG013|Stage 2|Withdrawal by parent/guardian|1|||
149947339|NCT03765073|540940283|FG014|Stage 2|Withdrawal by parent/guardian|1|||
149947340|NCT03765073|540940284|FG015|Stage 2|Withdrawal by parent/guardian|0|||
149947341|NCT03765073|540940285|FG016|Stage 2|Withdrawal by parent/guardian|3|||
149947342|NCT03765073|540940286|FG017|Stage 2|Withdrawal by parent/guardian|0|||
149947343|NCT03765073|540940287|FG018|Stage 2|Withdrawal by parent/guardian|0|||
149947344|NCT03765073|540940288|FG019|Stage 2|Withdrawal by parent/guardian|0|||
149947345|NCT03765073|540940289|FG020|Stage 2|Withdrawal by parent/guardian|0|||
149947346|NCT03765073|540940269|FG000|Stage 2|Withdrawal by Subject|0|||
149947347|NCT03765073|540940270|FG001|Stage 2|Withdrawal by Subject|0|||
149947348|NCT03765073|540940271|FG002|Stage 2|Withdrawal by Subject|0|||
149947349|NCT03765073|540940272|FG003|Stage 2|Withdrawal by Subject|3|||
149947350|NCT03765073|540940273|FG004|Stage 2|Withdrawal by Subject|3|||
149947351|NCT03765073|540940274|FG005|Stage 2|Withdrawal by Subject|3|||
149947352|NCT03765073|540940275|FG006|Stage 2|Withdrawal by Subject|0|||
149947353|NCT03765073|540940276|FG007|Stage 2|Withdrawal by Subject|1|||
149947354|NCT03765073|540940277|FG008|Stage 2|Withdrawal by Subject|0|||
149947355|NCT03765073|540940278|FG009|Stage 2|Withdrawal by Subject|5|||
149947356|NCT03765073|540940279|FG010|Stage 2|Withdrawal by Subject|0|||
149947357|NCT03765073|540940280|FG011|Stage 2|Withdrawal by Subject|0|||
149947358|NCT03765073|540940281|FG012|Stage 2|Withdrawal by Subject|0|||
149947359|NCT03765073|540940282|FG013|Stage 2|Withdrawal by Subject|0|||
149947360|NCT03765073|540940283|FG014|Stage 2|Withdrawal by Subject|0|||
149947361|NCT03765073|540940284|FG015|Stage 2|Withdrawal by Subject|0|||
149947362|NCT03765073|540940285|FG016|Stage 2|Withdrawal by Subject|0|||
149947363|NCT03765073|540940286|FG017|Stage 2|Withdrawal by Subject|0|||
149947364|NCT03765073|540940287|FG018|Stage 2|Withdrawal by Subject|0|||
149947365|NCT03765073|540940288|FG019|Stage 2|Withdrawal by Subject|0|||
149947366|NCT03765073|540940289|FG020|Stage 2|Withdrawal by Subject|0|||
149947367|NCT03765073|540940269|FG000|Stage 3|Adverse Event|0|||
149947368|NCT03765073|540940270|FG001|Stage 3|Adverse Event|0|||
149829560|NCT05097989|540506459|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
149829561|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829562|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
149829563|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829564|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829565|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829566|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829567|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829568|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829569|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
149829570|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829571|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829572|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829573|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829574|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149829575|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829576|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829577|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829578|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149829579|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829580|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829581|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829582|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829583|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
149829584|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829585|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829586|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829587|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
149829588|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829589|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149829590|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829591|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149829592|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829593|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829594|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829595|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829596|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149829597|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
149829598|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
149829599|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
149829600|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
149829601|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
149829602|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
149829603|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
149829604|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
149829605|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
149829606|NCT05097989|540506451|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
149829607|NCT05097989|540506452|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
149829608|NCT05097989|540506453|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
149947369|NCT03765073|540940271|FG002|Stage 3|Adverse Event|0|||
149947370|NCT03765073|540940272|FG003|Stage 3|Adverse Event|0|||
149947371|NCT03765073|540940273|FG004|Stage 3|Adverse Event|0|||
149947372|NCT03765073|540940274|FG005|Stage 3|Adverse Event|0|||
149947373|NCT03765073|540940275|FG006|Stage 3|Adverse Event|0|||
149947374|NCT03765073|540940276|FG007|Stage 3|Adverse Event|0|||
149947375|NCT03765073|540940277|FG008|Stage 3|Adverse Event|0|||
149947376|NCT03765073|540940278|FG009|Stage 3|Adverse Event|0|||
150170600|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
150170601|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
150170602|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
150170603|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
150170604|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
150170605|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
150170606|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
150170607|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
150170608|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149829609|NCT05097989|540506454|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
149829610|NCT05097989|540506455|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
149829611|NCT05097989|540506456|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
149829612|NCT05097989|540506457|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
149829613|NCT05097989|540506458|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
149829614|NCT05097989|540506459|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
149829615|NCT05097989|540506451|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829616|NCT05097989|540506452|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829617|NCT05097989|540506453|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829618|NCT05097989|540506454|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829619|NCT05097989|540506455|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
149829620|NCT05097989|540506456|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829621|NCT05097989|540506457|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829622|NCT05097989|540506458|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829623|NCT05097989|540506459|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
149829624|NCT05097989|540506451|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
149829625|NCT05097989|540506452|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
149829626|NCT05097989|540506453|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829627|NCT05097989|540506454|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829628|NCT05097989|540506455|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829629|NCT05097989|540506456|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829630|NCT05097989|540506457|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829631|NCT05097989|540506458|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829632|NCT05097989|540506459|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
149829633|NCT05097989|540506451|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
149829634|NCT05097989|540506452|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
149829635|NCT05097989|540506453|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
149829636|NCT05097989|540506454|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
149829637|NCT05097989|540506455|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
149829638|NCT05097989|540506456|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
149829639|NCT05097989|540506457|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
149829640|NCT05097989|540506458|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
149829641|NCT05097989|540506459|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
149829642|NCT05275998|540506462|FG000|Overall Study|Adverse Event|0|||
149829643|NCT05275998|540506463|FG001|Overall Study|Adverse Event|0|||
149829644|NCT05275998|540506464|FG002|Overall Study|Adverse Event|0|||
149829645|NCT05275998|540506465|FG003|Overall Study|Adverse Event|1|||
149829646|NCT05275998|540506462|FG000|Overall Study|Withdrawal by Subject|0|||
149829647|NCT05275998|540506463|FG001|Overall Study|Withdrawal by Subject|0|||
149829648|NCT05275998|540506464|FG002|Overall Study|Withdrawal by Subject|0|||
149829649|NCT05275998|540506465|FG003|Overall Study|Withdrawal by Subject|1|||
149829650|NCT05275998|540506462|FG000|Overall Study|Physician Decision|0|||
149829651|NCT05275998|540506463|FG001|Overall Study|Physician Decision|0|||
149829652|NCT05275998|540506464|FG002|Overall Study|Physician Decision|0|||
149829653|NCT05275998|540506465|FG003|Overall Study|Physician Decision|1|||
149829654|NCT05275998|540506462|FG000|Overall Study|Protocol Violation|0|||
150170609|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
150170610|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
150170611|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
150170612|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
150170613|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
150170614|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
150170615|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
150170616|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170617|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170618|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170619|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170620|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170621|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170622|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
150170623|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
150170624|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
150170625|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
150170626|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
150170627|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150170628|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150033252|NCT00506350|541260920|FG002|Overall Study|Lost to Follow-up|1|||
150276332|NCT00915772|542149945|FG001|Overall Study|Adverse Event|13|||
150276333|NCT00915772|542149946|FG002|Overall Study|Adverse Event|11|||
150276334|NCT00915772|542149944|FG000|Overall Study|Protocol Violation|4|||
150276335|NCT00915772|542149945|FG001|Overall Study|Protocol Violation|1|||
150276336|NCT00915772|542149946|FG002|Overall Study|Protocol Violation|2|||
150276337|NCT00915772|542149944|FG000|Overall Study|Lost to Follow-up|1|||
150276338|NCT00915772|542149945|FG001|Overall Study|Lost to Follow-up|2|||
150276339|NCT00915772|542149946|FG002|Overall Study|Lost to Follow-up|2|||
150276340|NCT00915772|542149944|FG000|Overall Study|Lack of Efficacy|9|||
150276341|NCT00915772|542149945|FG001|Overall Study|Lack of Efficacy|15|||
150276342|NCT00915772|542149946|FG002|Overall Study|Lack of Efficacy|3|||
150276343|NCT00915772|542149944|FG000|Overall Study|Refused to continue trial medication|6|||
150276344|NCT00915772|542149945|FG001|Overall Study|Refused to continue trial medication|8|||
150276345|NCT00915772|542149946|FG002|Overall Study|Refused to continue trial medication|4|||
150276346|NCT00915772|542149944|FG000|Overall Study|Any other reason|4|||
150276347|NCT00915772|542149945|FG001|Overall Study|Any other reason|7|||
150276348|NCT00915772|542149946|FG002|Overall Study|Any other reason|7|||
150276349|NCT03593850|542149951|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
150276350|NCT03593850|542149952|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
150276351|NCT02490475|542149953|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
150276352|NCT02490475|542149954|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
150276353|NCT02490475|542149955|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
149829655|NCT05275998|540506463|FG001|Overall Study|Protocol Violation|0|||
149829656|NCT05275998|540506464|FG002|Overall Study|Protocol Violation|1|||
149829657|NCT05275998|540506465|FG003|Overall Study|Protocol Violation|0|||
149829658|NCT01867242|540506468|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
149829659|NCT01867242|540506469|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
149829660|NCT01867242|540506470|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
150276354|NCT02490475|542149956|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
150276355|NCT02490475|542149953|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
150276356|NCT02490475|542149954|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
149829661|NCT01139164|540506473|FG000|Overall Study|Withdrawn prior to study start|0|||
149829662|NCT01139164|540506474|FG001|Overall Study|Withdrawn prior to study start|2|||
149829663|NCT01139164|540506475|FG002|Overall Study|Withdrawn prior to study start|0|||
149829664|NCT02719522|540506476|FG000|Overall Study|Implant Failure|4|||
149829665|NCT02719522|540506476|FG000|Overall Study|Death|2|||
149829666|NCT02719522|540506476|FG000|Overall Study|Lost to Follow-up|5|||
149829667|NCT03184441|540506477|FG000|Overall Study|Withdrawal by Subject|1|||
149829668|NCT00264810|540506478|FG000|Baseline|Withdrawal by Subject|10|||
149829669|NCT00264810|540506479|FG001|Baseline|Withdrawal by Subject|10|||
149829670|NCT00264810|540506478|FG000|Baseline|Physician Decision|7|||
149829671|NCT00264810|540506479|FG001|Baseline|Physician Decision|8|||
149829672|NCT00264810|540506478|FG000|Baseline|Subject Compliance Failure|3|||
149829673|NCT00264810|540506479|FG001|Baseline|Subject Compliance Failure|3|||
149829674|NCT00264810|540506478|FG000|Baseline|Insufficient Seizure Frequency|2|||
149829675|NCT00264810|540506479|FG001|Baseline|Insufficient Seizure Frequency|2|||
149829676|NCT00264810|540506478|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
149829677|NCT00264810|540506479|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
149829678|NCT00264810|540506478|FG000|Baseline|Other|0|||
149829679|NCT00264810|540506479|FG001|Baseline|Other|1|||
149829680|NCT00264810|540506478|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
149829681|NCT00264810|540506479|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
149829682|NCT00264810|540506478|FG000|Stimulation Optimization Period|Death|0|||
149829683|NCT00264810|540506479|FG001|Stimulation Optimization Period|Death|1|||
149829684|NCT00264810|540506478|FG000|Blinded Evaluation Period|Explant due to infection|1|||
149829685|NCT00264810|540506479|FG001|Blinded Evaluation Period|Explant due to infection|1|||
149829686|NCT00264810|540506478|FG000|Open Label Evaluation Period|Explant due to infection|1|||
149829687|NCT00264810|540506479|FG001|Open Label Evaluation Period|Explant due to infection|1|||
149829688|NCT00264810|540506478|FG000|Open Label Evaluation Period|Death|3|||
149829689|NCT00264810|540506479|FG001|Open Label Evaluation Period|Death|2|||
149829690|NCT00264810|540506478|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
149829691|NCT00264810|540506479|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
149829692|NCT04803357|540506482|FG000|Overall Study|Withdrawal by Subject|31|||
149829693|NCT04803357|540506483|FG001|Overall Study|Withdrawal by Subject|5|||
149829694|NCT02879643|540506485|FG000|Overall Study|Adverse Event|0|||
149829695|NCT02879643|540506486|FG001|Overall Study|Adverse Event|0|||
149829696|NCT02879643|540506487|FG002|Overall Study|Adverse Event|1|||
149829697|NCT02879643|540506488|FG003|Overall Study|Adverse Event|1|||
149829698|NCT02879643|540506489|FG004|Overall Study|Adverse Event|0|||
149829699|NCT00182091|540506490|FG000|Overall Study|Withdrawal by Subject|1|||
149829700|NCT00182091|540506491|FG001|Overall Study|Withdrawal by Subject|0|||
150276357|NCT02490475|542149955|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
150276358|NCT02490475|542149956|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
149829701|NCT00182091|540506492|FG002|Overall Study|Withdrawal by Subject|0|||
149829702|NCT00182091|540506493|FG003|Overall Study|Withdrawal by Subject|0|||
149829703|NCT02199509|540506494|FG000|Overall Study|Suicidal Ideation|0|||
149829704|NCT02199509|540506495|FG001|Overall Study|Suicidal Ideation|1|||
149829705|NCT02199509|540506494|FG000|Overall Study|Misunderstood titration schedule|1|||
149829706|NCT02199509|540506495|FG001|Overall Study|Misunderstood titration schedule|0|||
149829707|NCT01658943|540506497|FG000|Overall Study|Adverse Event|6|||
149829708|NCT01658943|540506498|FG001|Overall Study|Adverse Event|13|||
149829709|NCT01658943|540506497|FG000|Overall Study|Withdrawal by Subject|9|||
149829710|NCT01658943|540506498|FG001|Overall Study|Withdrawal by Subject|2|||
149829711|NCT01658943|540506497|FG000|Overall Study|Progression/Relapse|39|||
149829712|NCT01658943|540506498|FG001|Overall Study|Progression/Relapse|40|||
149829713|NCT01658943|540506497|FG000|Overall Study|Death|4|||
149829714|NCT01658943|540506498|FG001|Overall Study|Death|2|||
149829715|NCT01658943|540506497|FG000|Overall Study|not protocol specified|4|||
149829716|NCT01658943|540506498|FG001|Overall Study|not protocol specified|1|||
149829717|NCT01658943|540506497|FG000|Overall Study|Not eligible|7|||
149829718|NCT01658943|540506498|FG001|Overall Study|Not eligible|9|||
149829719|NCT01658943|540506497|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
149829720|NCT01658943|540506498|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
149829721|NCT00936390|540506500|FG000|Overall Study|Protocol Violation|21|||
149829722|NCT00936390|540506501|FG001|Overall Study|Protocol Violation|25|||
149829723|NCT02093689|540506502|FG000|Overall Study|Physician Decision|4|||
149829724|NCT02093689|540506503|FG001|Overall Study|Physician Decision|0|||
149829725|NCT02093689|540506504|FG002|Overall Study|Physician Decision|0|||
149829726|NCT00634179|540506508|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
149829727|NCT04947579|540506511|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
149829728|NCT04947579|540506512|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
149829729|NCT04947579|540506513|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
149829730|NCT04947579|540506514|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
149829731|NCT04947579|540506515|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
149829732|NCT04947579|540506516|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
149829733|NCT04947579|540506511|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
149829734|NCT04947579|540506512|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
149829735|NCT04947579|540506513|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
149829736|NCT04947579|540506514|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
149829737|NCT04947579|540506515|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
149829738|NCT04947579|540506516|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
149829739|NCT04947579|540506511|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
149829740|NCT04947579|540506512|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
149829741|NCT04947579|540506513|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
149829742|NCT04947579|540506514|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
149829743|NCT04947579|540506515|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
149829744|NCT04947579|540506516|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
149829745|NCT04947579|540506511|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
149829746|NCT04947579|540506512|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
149829747|NCT04947579|540506513|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
149829748|NCT04947579|540506514|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
149829749|NCT04947579|540506515|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
149829750|NCT04947579|540506516|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
149829751|NCT04947579|540506511|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
149829752|NCT04947579|540506512|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
149829753|NCT04947579|540506513|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
149829754|NCT04947579|540506514|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
149829755|NCT04947579|540506515|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
149829756|NCT04947579|540506516|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
149829757|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
149829758|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
149829759|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
149829760|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
149829761|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
150170629|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150170630|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150170631|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150170632|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
150170633|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
150170634|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
149829762|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
149829763|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
149829764|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
149829765|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
149829766|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
149829767|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
149829768|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
149829769|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
149829770|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
149829771|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
149829772|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
149829773|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
149829774|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
149829775|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
149829776|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
149829777|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
149829778|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
149829779|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
149829780|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
149829781|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
149829782|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
149829783|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
149829784|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
149829785|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
149829786|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
149829787|NCT04947579|540506511|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
149829788|NCT04947579|540506512|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
149829789|NCT04947579|540506513|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
149829790|NCT04947579|540506514|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
149829791|NCT04947579|540506515|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
149829792|NCT04947579|540506516|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
149829793|NCT04272801|540506517|FG000|Overall Study|Withdrawal by Subject|4|||
149829794|NCT04272801|540506517|FG000|Overall Study|Lost to Follow-up|4|||
149829795|NCT04272801|540506517|FG000|Overall Study|Ineligible|1|||
149829796|NCT00475020|540506518|FG000|Overall Study|Physician Decision|3|||
149829797|NCT00475020|540506518|FG000|Overall Study|Insurance Denial|1|||
149829798|NCT00475020|540506518|FG000|Overall Study|Donor not able to donate the last minute|1|||
149829799|NCT03481309|540506519|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
149829800|NCT03481309|540506520|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
149829801|NCT03481309|540506521|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
149829802|NCT03481309|540506522|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
149829803|NCT03481309|540506523|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
149829804|NCT03481309|540506524|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
149829805|NCT02130466|540506525|FG000|Overall Study|Death|4|||
149829806|NCT02130466|540506526|FG001|Overall Study|Death|1|||
149829807|NCT02130466|540506527|FG002|Overall Study|Death|1|||
149829808|NCT02130466|540506528|FG003|Overall Study|Death|3|||
149829809|NCT02130466|540506529|FG004|Overall Study|Death|2|||
149829810|NCT02130466|540506530|FG005|Overall Study|Death|30|||
149829811|NCT02130466|540506531|FG006|Overall Study|Death|45|||
149829812|NCT02130466|540506532|FG007|Overall Study|Death|2|||
149829813|NCT02130466|540506533|FG008|Overall Study|Death|3|||
149829814|NCT02130466|540506534|FG009|Overall Study|Death|4|||
149829815|NCT02130466|540506535|FG010|Overall Study|Death|5|||
149829816|NCT02130466|540506536|FG011|Overall Study|Death|3|||
149829817|NCT02130466|540506537|FG012|Overall Study|Death|11|||
149829818|NCT02130466|540506538|FG013|Overall Study|Death|7|||
149829819|NCT02130466|540506525|FG000|Overall Study|Lost to Follow-up|1|||
149829820|NCT02130466|540506526|FG001|Overall Study|Lost to Follow-up|0|||
149829821|NCT02130466|540506527|FG002|Overall Study|Lost to Follow-up|0|||
149829822|NCT02130466|540506528|FG003|Overall Study|Lost to Follow-up|0|||
149829823|NCT02130466|540506529|FG004|Overall Study|Lost to Follow-up|0|||
149829824|NCT02130466|540506530|FG005|Overall Study|Lost to Follow-up|1|||
149829825|NCT02130466|540506531|FG006|Overall Study|Lost to Follow-up|0|||
149829826|NCT02130466|540506532|FG007|Overall Study|Lost to Follow-up|0|||
149829827|NCT02130466|540506533|FG008|Overall Study|Lost to Follow-up|0|||
149829828|NCT02130466|540506534|FG009|Overall Study|Lost to Follow-up|0|||
149829829|NCT02130466|540506535|FG010|Overall Study|Lost to Follow-up|0|||
149829830|NCT02130466|540506536|FG011|Overall Study|Lost to Follow-up|0|||
149829831|NCT02130466|540506537|FG012|Overall Study|Lost to Follow-up|1|||
149829832|NCT02130466|540506538|FG013|Overall Study|Lost to Follow-up|0|||
149829833|NCT02130466|540506525|FG000|Overall Study|Physician Decision|0|||
149829834|NCT02130466|540506526|FG001|Overall Study|Physician Decision|0|||
150033253|NCT00506350|541260921|FG003|Overall Study|Lost to Follow-up|1|||
150033254|NCT00506350|541260922|FG004|Overall Study|Lost to Follow-up|2|||
149829835|NCT02130466|540506527|FG002|Overall Study|Physician Decision|0|||
149829836|NCT02130466|540506528|FG003|Overall Study|Physician Decision|0|||
149829837|NCT02130466|540506529|FG004|Overall Study|Physician Decision|0|||
149829838|NCT02130466|540506530|FG005|Overall Study|Physician Decision|1|||
149829839|NCT02130466|540506531|FG006|Overall Study|Physician Decision|1|||
149829840|NCT02130466|540506532|FG007|Overall Study|Physician Decision|0|||
149829841|NCT02130466|540506533|FG008|Overall Study|Physician Decision|0|||
149829842|NCT02130466|540506534|FG009|Overall Study|Physician Decision|0|||
149829843|NCT02130466|540506535|FG010|Overall Study|Physician Decision|0|||
149829844|NCT02130466|540506536|FG011|Overall Study|Physician Decision|0|||
149829845|NCT02130466|540506537|FG012|Overall Study|Physician Decision|0|||
149829846|NCT02130466|540506538|FG013|Overall Study|Physician Decision|0|||
149829847|NCT02130466|540506525|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
149829848|NCT02130466|540506526|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
149829849|NCT02130466|540506527|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
149829850|NCT02130466|540506528|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
149829851|NCT02130466|540506529|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
150170635|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
150170636|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
149947377|NCT03765073|540940279|FG010|Stage 3|Adverse Event|0|||
149947378|NCT03765073|540940280|FG011|Stage 3|Adverse Event|0|||
149947379|NCT03765073|540940281|FG012|Stage 3|Adverse Event|0|||
149947380|NCT03765073|540940282|FG013|Stage 3|Adverse Event|0|||
149947381|NCT03765073|540940283|FG014|Stage 3|Adverse Event|0|||
149947382|NCT03765073|540940284|FG015|Stage 3|Adverse Event|0|||
149947383|NCT03765073|540940285|FG016|Stage 3|Adverse Event|0|||
149947384|NCT03765073|540940286|FG017|Stage 3|Adverse Event|0|||
149947385|NCT03765073|540940287|FG018|Stage 3|Adverse Event|1|||
149947386|NCT03765073|540940288|FG019|Stage 3|Adverse Event|0|||
149947387|NCT03765073|540940289|FG020|Stage 3|Adverse Event|0|||
149947388|NCT03765073|540940269|FG000|Stage 3|Death|0|||
149947389|NCT03765073|540940270|FG001|Stage 3|Death|0|||
149947390|NCT03765073|540940271|FG002|Stage 3|Death|0|||
149947391|NCT03765073|540940272|FG003|Stage 3|Death|0|||
149947392|NCT03765073|540940273|FG004|Stage 3|Death|0|||
149947393|NCT03765073|540940274|FG005|Stage 3|Death|0|||
149947394|NCT03765073|540940275|FG006|Stage 3|Death|0|||
149947395|NCT03765073|540940276|FG007|Stage 3|Death|0|||
149947396|NCT03765073|540940277|FG008|Stage 3|Death|0|||
149947397|NCT03765073|540940278|FG009|Stage 3|Death|0|||
149947398|NCT03765073|540940279|FG010|Stage 3|Death|0|||
149947399|NCT03765073|540940280|FG011|Stage 3|Death|0|||
149947400|NCT03765073|540940281|FG012|Stage 3|Death|0|||
149947401|NCT03765073|540940282|FG013|Stage 3|Death|0|||
149947402|NCT03765073|540940283|FG014|Stage 3|Death|0|||
149947403|NCT03765073|540940284|FG015|Stage 3|Death|0|||
149947404|NCT03765073|540940285|FG016|Stage 3|Death|0|||
149947405|NCT03765073|540940286|FG017|Stage 3|Death|0|||
149947406|NCT03765073|540940287|FG018|Stage 3|Death|0|||
149947407|NCT03765073|540940288|FG019|Stage 3|Death|3|||
149947408|NCT03765073|540940289|FG020|Stage 3|Death|2|||
149947409|NCT03765073|540940269|FG000|Stage 3|Lost to Follow-up|0|||
149947410|NCT03765073|540940270|FG001|Stage 3|Lost to Follow-up|0|||
149947411|NCT03765073|540940271|FG002|Stage 3|Lost to Follow-up|0|||
149947412|NCT03765073|540940272|FG003|Stage 3|Lost to Follow-up|0|||
149947413|NCT03765073|540940273|FG004|Stage 3|Lost to Follow-up|0|||
149947414|NCT03765073|540940274|FG005|Stage 3|Lost to Follow-up|0|||
149947415|NCT03765073|540940275|FG006|Stage 3|Lost to Follow-up|0|||
149947416|NCT03765073|540940276|FG007|Stage 3|Lost to Follow-up|0|||
149947417|NCT03765073|540940277|FG008|Stage 3|Lost to Follow-up|0|||
149947418|NCT03765073|540940278|FG009|Stage 3|Lost to Follow-up|0|||
149947419|NCT03765073|540940279|FG010|Stage 3|Lost to Follow-up|0|||
149829852|NCT02130466|540506530|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
149829853|NCT02130466|540506531|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
149829854|NCT02130466|540506532|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
149947420|NCT03765073|540940280|FG011|Stage 3|Lost to Follow-up|0|||
150170637|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
150170638|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
150170639|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
150170640|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
149947421|NCT03765073|540940281|FG012|Stage 3|Lost to Follow-up|0|||
149947422|NCT03765073|540940282|FG013|Stage 3|Lost to Follow-up|0|||
149947423|NCT03765073|540940283|FG014|Stage 3|Lost to Follow-up|0|||
149947424|NCT03765073|540940284|FG015|Stage 3|Lost to Follow-up|0|||
149947425|NCT03765073|540940285|FG016|Stage 3|Lost to Follow-up|0|||
149947426|NCT03765073|540940286|FG017|Stage 3|Lost to Follow-up|8|||
149947427|NCT03765073|540940287|FG018|Stage 3|Lost to Follow-up|5|||
149947428|NCT03765073|540940288|FG019|Stage 3|Lost to Follow-up|7|||
149947429|NCT03765073|540940289|FG020|Stage 3|Lost to Follow-up|4|||
149947430|NCT03765073|540940269|FG000|Stage 3|No longer meets eligibility criteria|0|||
149947431|NCT03765073|540940270|FG001|Stage 3|No longer meets eligibility criteria|0|||
149947432|NCT03765073|540940271|FG002|Stage 3|No longer meets eligibility criteria|0|||
149947433|NCT03765073|540940272|FG003|Stage 3|No longer meets eligibility criteria|0|||
150033255|NCT00506350|541260923|FG005|Overall Study|Lost to Follow-up|1|||
150033256|NCT00506350|541260924|FG006|Overall Study|Lost to Follow-up|0|||
150033257|NCT00506350|541260925|FG007|Overall Study|Lost to Follow-up|0|||
150033258|NCT00506350|541260926|FG008|Overall Study|Lost to Follow-up|2|||
150033259|NCT00506350|541260918|FG000|Overall Study|Medical Reason|0|||
150033260|NCT00506350|541260919|FG001|Overall Study|Medical Reason|0|||
150033261|NCT00506350|541260920|FG002|Overall Study|Medical Reason|0|||
150033262|NCT00506350|541260921|FG003|Overall Study|Medical Reason|0|||
150276359|NCT02490475|542149953|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
150276360|NCT02490475|542149954|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
150033263|NCT00506350|541260922|FG004|Overall Study|Medical Reason|1|||
150033264|NCT00506350|541260923|FG005|Overall Study|Medical Reason|0|||
150033265|NCT00506350|541260924|FG006|Overall Study|Medical Reason|0|||
150033266|NCT00506350|541260925|FG007|Overall Study|Medical Reason|0|||
150033267|NCT00506350|541260926|FG008|Overall Study|Medical Reason|0|||
150033268|NCT00506350|541260918|FG000|Overall Study|Other|1|||
150033269|NCT00506350|541260919|FG001|Overall Study|Other|1|||
150033270|NCT00506350|541260920|FG002|Overall Study|Other|3|||
150033271|NCT00506350|541260921|FG003|Overall Study|Other|0|||
150033272|NCT00506350|541260922|FG004|Overall Study|Other|3|||
150033273|NCT00506350|541260923|FG005|Overall Study|Other|0|||
150033274|NCT00506350|541260924|FG006|Overall Study|Other|0|||
150033275|NCT00506350|541260925|FG007|Overall Study|Other|2|||
150033276|NCT00506350|541260926|FG008|Overall Study|Other|2|||
150033277|NCT03474588|541260927|FG000|Overall Study|Withdrawal by Subject|4|||
150033278|NCT03474588|541260928|FG001|Overall Study|Withdrawal by Subject|3|||
150033279|NCT03474588|541260927|FG000|Overall Study|Death|0|||
150033280|NCT03474588|541260928|FG001|Overall Study|Death|1|||
150033281|NCT01691794|541260930|FG000|Overall Study|Poor/Non-Compliance|1|||
150033282|NCT01691794|541260931|FG001|Overall Study|Poor/Non-Compliance|4|||
150033283|NCT01691794|541260932|FG002|Overall Study|Poor/Non-Compliance|1|||
150033284|NCT01691794|541260930|FG000|Overall Study|Death|0|||
150033285|NCT01691794|541260931|FG001|Overall Study|Death|0|||
150033286|NCT01691794|541260932|FG002|Overall Study|Death|1|||
150033287|NCT01691794|541260930|FG000|Overall Study|Lack of Efficacy|0|||
150033288|NCT01691794|541260931|FG001|Overall Study|Lack of Efficacy|7|||
150033289|NCT01691794|541260932|FG002|Overall Study|Lack of Efficacy|1|||
150033290|NCT01691794|541260930|FG000|Overall Study|Participant request to discontinue|0|||
150033291|NCT01691794|541260931|FG001|Overall Study|Participant request to discontinue|1|||
150033292|NCT01691794|541260932|FG002|Overall Study|Participant request to discontinue|0|||
150033293|NCT01691794|541260930|FG000|Overall Study|Adverse Event|0|||
150033294|NCT01691794|541260931|FG001|Overall Study|Adverse Event|1|||
150033295|NCT01691794|541260932|FG002|Overall Study|Adverse Event|1|||
150033296|NCT01691794|541260930|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
150033297|NCT01691794|541260931|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
150033298|NCT01691794|541260932|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
150033299|NCT01691794|541260930|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
150033300|NCT01691794|541260931|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
150033301|NCT01691794|541260932|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
150033302|NCT02336282|541260939|FG000|Overall Study|Unrelated illness|1|||
150033303|NCT02336282|541260939|FG000|Overall Study|Uncomfortable with technology|1|||
150033304|NCT02336282|541260939|FG000|Overall Study|Lost to Follow-up|1|||
150033305|NCT02336282|541260939|FG000|Overall Study|Not enough time to complete sessions|2|||
150033306|NCT05472090|541260955|FG000|Overall Study|Adverse Event|2|||
150033307|NCT05472090|541260956|FG001|Overall Study|Adverse Event|3|||
150033308|NCT05472090|541260955|FG000|Overall Study|Lack of Efficacy|1|||
150033309|NCT05472090|541260956|FG001|Overall Study|Lack of Efficacy|0|||
150033310|NCT05472090|541260955|FG000|Overall Study|Physician Decision|1|||
150033311|NCT05472090|541260956|FG001|Overall Study|Physician Decision|0|||
150033312|NCT05472090|541260955|FG000|Overall Study|Withdrawal by Subject|2|||
150033313|NCT05472090|541260956|FG001|Overall Study|Withdrawal by Subject|0|||
150033314|NCT05472090|541260955|FG000|Overall Study|Lost to Follow-up|0|||
150033315|NCT05472090|541260956|FG001|Overall Study|Lost to Follow-up|3|||
150033316|NCT00199381|541262751|FG000|Overall Study|Withdrawal by Subject|38|||
150033317|NCT00199381|541262751|FG000|Overall Study|Adverse Event|73|||
150033318|NCT00199381|541262751|FG000|Overall Study|Protocol Violation|6|||
150033319|NCT00199381|541262751|FG000|Overall Study|Lack of Efficacy|27|||
150033320|NCT00199381|541262751|FG000|Overall Study|Not including due to early termination|37|||
150033321|NCT00199381|541262751|FG000|Overall Study|Study termination by Sponsor|323|||
150033322|NCT02892344|541262753|FG000|Overall Study|Protocol deviation|3|||
150033323|NCT02892344|541262754|FG001|Overall Study|Protocol deviation|4|||
150033324|NCT02892344|541262753|FG000|Overall Study|Adverse Event|1|||
150033325|NCT02892344|541262754|FG001|Overall Study|Adverse Event|8|||
150033326|NCT02892344|541262753|FG000|Overall Study|Lost to Follow-up|0|||
150033327|NCT02892344|541262754|FG001|Overall Study|Lost to Follow-up|1|||
150033328|NCT02892344|541262753|FG000|Overall Study|Non-compliance with study treatment|0|||
150033329|NCT02892344|541262754|FG001|Overall Study|Non-compliance with study treatment|1|||
150033330|NCT02892344|541262753|FG000|Overall Study|Physician Decision|0|||
150033331|NCT02892344|541262754|FG001|Overall Study|Physician Decision|2|||
149829855|NCT02130466|540506533|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
149829856|NCT02130466|540506534|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
149829857|NCT02130466|540506535|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
149829858|NCT02130466|540506536|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
149829859|NCT02130466|540506537|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
149829860|NCT02130466|540506538|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
149829861|NCT02130466|540506525|FG000|Overall Study|Withdrawal by Subject|1|||
149829862|NCT02130466|540506526|FG001|Overall Study|Withdrawal by Subject|0|||
149829863|NCT02130466|540506527|FG002|Overall Study|Withdrawal by Subject|0|||
149829864|NCT02130466|540506528|FG003|Overall Study|Withdrawal by Subject|0|||
149829865|NCT02130466|540506529|FG004|Overall Study|Withdrawal by Subject|0|||
149829866|NCT02130466|540506530|FG005|Overall Study|Withdrawal by Subject|1|||
149829867|NCT02130466|540506531|FG006|Overall Study|Withdrawal by Subject|0|||
149829868|NCT02130466|540506532|FG007|Overall Study|Withdrawal by Subject|0|||
149829869|NCT02130466|540506533|FG008|Overall Study|Withdrawal by Subject|1|||
149829870|NCT02130466|540506534|FG009|Overall Study|Withdrawal by Subject|0|||
149829871|NCT02130466|540506535|FG010|Overall Study|Withdrawal by Subject|0|||
149829872|NCT02130466|540506536|FG011|Overall Study|Withdrawal by Subject|0|||
149829873|NCT02130466|540506537|FG012|Overall Study|Withdrawal by Subject|0|||
149829874|NCT02130466|540506538|FG013|Overall Study|Withdrawal by Subject|0|||
149829875|NCT04529109|540506539|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
149829876|NCT04529109|540506540|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
149829877|NCT04603937|540506541|FG000|Overall Study|Adverse Event|9|||
149829878|NCT04603937|540506542|FG001|Overall Study|Adverse Event|10|||
149829879|NCT04603937|540506541|FG000|Overall Study|Withdrawal by Subject|7|||
149829880|NCT04603937|540506542|FG001|Overall Study|Withdrawal by Subject|6|||
149829881|NCT04603937|540506541|FG000|Overall Study|Lost to Follow-up|5|||
149829882|NCT04603937|540506542|FG001|Overall Study|Lost to Follow-up|6|||
149829883|NCT04603937|540506541|FG000|Overall Study|Physician Decision|0|||
149829884|NCT04603937|540506542|FG001|Overall Study|Physician Decision|1|||
149829885|NCT04603937|540506541|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
149829886|NCT04603937|540506542|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
149829887|NCT01922349|540506543|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
149829888|NCT01922349|540506544|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
149829889|NCT01922349|540506545|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
149829890|NCT01922349|540506546|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
149829891|NCT01611090|540506547|FG000|Randomized Period|Lost to Follow-up|8|||
149829892|NCT01611090|540506548|FG001|Randomized Period|Lost to Follow-up|3|||
149829893|NCT01611090|540506549|FG002|Randomized Period|Lost to Follow-up|0|||
149829894|NCT01611090|540506547|FG000|Randomized Period|Withdrawal by Subject|22|||
149829895|NCT01611090|540506548|FG001|Randomized Period|Withdrawal by Subject|26|||
149829896|NCT01611090|540506549|FG002|Randomized Period|Withdrawal by Subject|0|||
149829897|NCT01611090|540506547|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
149829898|NCT01611090|540506548|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
149829899|NCT01611090|540506549|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
149829900|NCT01611090|540506547|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
149829901|NCT01611090|540506548|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
149829902|NCT01611090|540506549|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
149829903|NCT05109234|540506550|FG000|Overall Study|Adverse Event|2|||
149829904|NCT05109234|540506551|FG001|Overall Study|Adverse Event|2|||
149829905|NCT05109234|540506550|FG000|Overall Study|Lack of Efficacy|5|||
149829906|NCT05109234|540506551|FG001|Overall Study|Lack of Efficacy|0|||
149829907|NCT05109234|540506550|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
149829908|NCT05109234|540506551|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
149829909|NCT05109234|540506550|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
149829910|NCT05109234|540506551|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
149829911|NCT05109234|540506550|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
149829912|NCT05109234|540506551|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
149829913|NCT05109234|540506550|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
149829914|NCT05109234|540506551|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
149829915|NCT00993616|540506552|FG000|Overall Study|No tumor at entry|1|||
149829916|NCT00993616|540506552|FG000|Overall Study|Never treated|1|||
149829917|NCT02585258|540506554|FG000|Overall Study|Adverse Event|28|||
149829918|NCT02585258|540506555|FG001|Overall Study|Adverse Event|29|||
149829919|NCT02585258|540506554|FG000|Overall Study|Death|3|||
149829920|NCT02585258|540506555|FG001|Overall Study|Death|2|||
149829921|NCT02585258|540506554|FG000|Overall Study|Lack of Efficacy|7|||
149829922|NCT02585258|540506555|FG001|Overall Study|Lack of Efficacy|9|||
149829923|NCT02585258|540506554|FG000|Overall Study|includes covid-related access problems|42|||
149829924|NCT02585258|540506555|FG001|Overall Study|includes covid-related access problems|46|||
149829925|NCT02585258|540506554|FG000|Overall Study|Lost to Follow-up|5|||
149829926|NCT02585258|540506555|FG001|Overall Study|Lost to Follow-up|2|||
149829927|NCT05125952|540506556|FG000|Overall Study|Physician Decision|1|||
149829928|NCT02180711|540508132|FG000|Overall Study|Death|0|||
149829929|NCT02180711|540508133|FG001|Overall Study|Death|1|||
149829930|NCT02180711|540508134|FG002|Overall Study|Death|0|||
149829931|NCT02180711|540508135|FG003|Overall Study|Death|0|||
149829932|NCT02180711|540508136|FG004|Overall Study|Death|7|||
150276361|NCT02490475|542149955|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
149829933|NCT02180711|540508137|FG005|Overall Study|Death|0|||
149829934|NCT02180711|540508138|FG006|Overall Study|Death|1|||
149829935|NCT02180711|540508139|FG007|Overall Study|Death|3|||
149829936|NCT02180711|540508132|FG000|Overall Study|Lost to Follow-up|0|||
149829937|NCT02180711|540508133|FG001|Overall Study|Lost to Follow-up|1|||
149829938|NCT02180711|540508134|FG002|Overall Study|Lost to Follow-up|0|||
149829939|NCT02180711|540508135|FG003|Overall Study|Lost to Follow-up|0|||
149829940|NCT02180711|540508136|FG004|Overall Study|Lost to Follow-up|1|||
149829941|NCT02180711|540508137|FG005|Overall Study|Lost to Follow-up|1|||
149829942|NCT02180711|540508138|FG006|Overall Study|Lost to Follow-up|0|||
149829943|NCT02180711|540508139|FG007|Overall Study|Lost to Follow-up|3|||
149829944|NCT02180711|540508132|FG000|Overall Study|Withdrawal by Subject|2|||
149829945|NCT02180711|540508133|FG001|Overall Study|Withdrawal by Subject|1|||
149829946|NCT02180711|540508134|FG002|Overall Study|Withdrawal by Subject|0|||
149829947|NCT02180711|540508135|FG003|Overall Study|Withdrawal by Subject|4|||
149829948|NCT02180711|540508136|FG004|Overall Study|Withdrawal by Subject|3|||
149829949|NCT02180711|540508137|FG005|Overall Study|Withdrawal by Subject|0|||
149829950|NCT02180711|540508138|FG006|Overall Study|Withdrawal by Subject|3|||
149829951|NCT02180711|540508139|FG007|Overall Study|Withdrawal by Subject|2|||
149829952|NCT02180711|540508132|FG000|Overall Study|- Disease Progression|0|||
149829953|NCT02180711|540508133|FG001|Overall Study|- Disease Progression|1|||
149829954|NCT02180711|540508134|FG002|Overall Study|- Disease Progression|0|||
149829955|NCT02180711|540508135|FG003|Overall Study|- Disease Progression|0|||
149829956|NCT02180711|540508136|FG004|Overall Study|- Disease Progression|0|||
149829957|NCT02180711|540508137|FG005|Overall Study|- Disease Progression|0|||
149829958|NCT02180711|540508138|FG006|Overall Study|- Disease Progression|0|||
149829959|NCT02180711|540508139|FG007|Overall Study|- Disease Progression|0|||
149829960|NCT02180711|540508132|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
149829961|NCT02180711|540508133|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
149829962|NCT02180711|540508134|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
149829963|NCT02180711|540508135|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
149829964|NCT02180711|540508136|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
149829965|NCT02180711|540508137|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
149829966|NCT02180711|540508138|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
149947434|NCT03765073|540940273|FG004|Stage 3|No longer meets eligibility criteria|0|||
149947435|NCT03765073|540940274|FG005|Stage 3|No longer meets eligibility criteria|0|||
149947436|NCT03765073|540940275|FG006|Stage 3|No longer meets eligibility criteria|0|||
149947437|NCT03765073|540940276|FG007|Stage 3|No longer meets eligibility criteria|0|||
149947438|NCT03765073|540940277|FG008|Stage 3|No longer meets eligibility criteria|0|||
149947439|NCT03765073|540940278|FG009|Stage 3|No longer meets eligibility criteria|0|||
149947440|NCT03765073|540940279|FG010|Stage 3|No longer meets eligibility criteria|0|||
149947441|NCT03765073|540940280|FG011|Stage 3|No longer meets eligibility criteria|0|||
149947442|NCT03765073|540940281|FG012|Stage 3|No longer meets eligibility criteria|0|||
149947443|NCT03765073|540940282|FG013|Stage 3|No longer meets eligibility criteria|0|||
149947444|NCT03765073|540940283|FG014|Stage 3|No longer meets eligibility criteria|0|||
149947445|NCT03765073|540940284|FG015|Stage 3|No longer meets eligibility criteria|0|||
149947446|NCT03765073|540940285|FG016|Stage 3|No longer meets eligibility criteria|0|||
149947447|NCT03765073|540940286|FG017|Stage 3|No longer meets eligibility criteria|0|||
149947448|NCT03765073|540940287|FG018|Stage 3|No longer meets eligibility criteria|1|||
149947449|NCT03765073|540940288|FG019|Stage 3|No longer meets eligibility criteria|0|||
149947450|NCT03765073|540940289|FG020|Stage 3|No longer meets eligibility criteria|1|||
149947451|NCT03765073|540940269|FG000|Stage 3|Other|0|||
149947452|NCT03765073|540940270|FG001|Stage 3|Other|0|||
149947453|NCT03765073|540940271|FG002|Stage 3|Other|0|||
149947454|NCT03765073|540940272|FG003|Stage 3|Other|0|||
149947455|NCT03765073|540940273|FG004|Stage 3|Other|0|||
149947456|NCT03765073|540940274|FG005|Stage 3|Other|0|||
149947457|NCT03765073|540940275|FG006|Stage 3|Other|0|||
149947458|NCT03765073|540940276|FG007|Stage 3|Other|0|||
149947459|NCT03765073|540940277|FG008|Stage 3|Other|0|||
149829967|NCT02180711|540508139|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
149947460|NCT03765073|540940278|FG009|Stage 3|Other|0|||
149947461|NCT03765073|540940279|FG010|Stage 3|Other|0|||
149947462|NCT03765073|540940280|FG011|Stage 3|Other|0|||
149829968|NCT02180711|540508132|FG000|Overall Study|- Study Terminated by Sponsor|2|||
149947463|NCT03765073|540940281|FG012|Stage 3|Other|0|||
149829969|NCT02180711|540508133|FG001|Overall Study|- Study Terminated by Sponsor|3|||
149947464|NCT03765073|540940282|FG013|Stage 3|Other|0|||
149947465|NCT03765073|540940283|FG014|Stage 3|Other|0|||
149829970|NCT02180711|540508134|FG002|Overall Study|- Study Terminated by Sponsor|0|||
149829971|NCT02180711|540508135|FG003|Overall Study|- Study Terminated by Sponsor|5|||
149829972|NCT02180711|540508136|FG004|Overall Study|- Study Terminated by Sponsor|32|||
149829973|NCT02180711|540508137|FG005|Overall Study|- Study Terminated by Sponsor|0|||
149829974|NCT02180711|540508138|FG006|Overall Study|- Study Terminated by Sponsor|4|||
149829975|NCT02180711|540508139|FG007|Overall Study|- Study Terminated by Sponsor|13|||
149829976|NCT02180711|540508132|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
149829977|NCT02180711|540508133|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
149829978|NCT02180711|540508134|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
149829979|NCT02180711|540508135|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
149829980|NCT02180711|540508136|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
149829981|NCT02180711|540508137|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
149829982|NCT02180711|540508138|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
149829983|NCT02180711|540508139|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
149829984|NCT02180711|540508132|FG000|Overall Study|- Other|1|||
149829985|NCT02180711|540508133|FG001|Overall Study|- Other|0|||
149829986|NCT02180711|540508134|FG002|Overall Study|- Other|0|||
149829987|NCT02180711|540508135|FG003|Overall Study|- Other|1|||
150170641|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
150170642|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
149829988|NCT02180711|540508136|FG004|Overall Study|- Other|0|||
149829989|NCT02180711|540508137|FG005|Overall Study|- Other|0|||
149829990|NCT02180711|540508138|FG006|Overall Study|- Other|0|||
149829991|NCT02180711|540508139|FG007|Overall Study|- Other|0|||
149829992|NCT01619800|540508140|FG000|Overall Study|study terminated|2|||
149829993|NCT01619800|540508141|FG001|Overall Study|study terminated|0|||
149829994|NCT02848326|540508142|FG000|Treatment Period|Adverse Event|5|||
149829995|NCT02848326|540508143|FG001|Treatment Period|Adverse Event|4|||
149829996|NCT02848326|540508144|FG002|Treatment Period|Adverse Event|11|||
149829997|NCT02848326|540508145|FG003|Treatment Period|Adverse Event|6|||
149829998|NCT02848326|540508146|FG004|Treatment Period|Adverse Event|5|||
149829999|NCT02848326|540508147|FG005|Treatment Period|Adverse Event|7|||
149830000|NCT02848326|540508142|FG000|Treatment Period|Withdrawal of Consent|20|||
149830001|NCT02848326|540508143|FG001|Treatment Period|Withdrawal of Consent|6|||
149830002|NCT02848326|540508144|FG002|Treatment Period|Withdrawal of Consent|9|||
149830003|NCT02848326|540508145|FG003|Treatment Period|Withdrawal of Consent|6|||
149830004|NCT02848326|540508146|FG004|Treatment Period|Withdrawal of Consent|9|||
149830005|NCT02848326|540508147|FG005|Treatment Period|Withdrawal of Consent|6|||
149830006|NCT02848326|540508142|FG000|Treatment Period|Lost to Follow-up|5|||
149830007|NCT02848326|540508143|FG001|Treatment Period|Lost to Follow-up|1|||
149830008|NCT02848326|540508144|FG002|Treatment Period|Lost to Follow-up|11|||
149830009|NCT02848326|540508145|FG003|Treatment Period|Lost to Follow-up|7|||
149830010|NCT02848326|540508146|FG004|Treatment Period|Lost to Follow-up|2|||
149830011|NCT02848326|540508147|FG005|Treatment Period|Lost to Follow-up|3|||
149947466|NCT03765073|540940284|FG015|Stage 3|Other|0|||
149947467|NCT03765073|540940285|FG016|Stage 3|Other|0|||
149947468|NCT03765073|540940286|FG017|Stage 3|Other|1|||
149947469|NCT03765073|540940287|FG018|Stage 3|Other|2|||
149947470|NCT03765073|540940288|FG019|Stage 3|Other|2|||
149947471|NCT03765073|540940289|FG020|Stage 3|Other|2|||
149947472|NCT03765073|540940269|FG000|Stage 3|Withdrawal by parent/guardian|0|||
149947473|NCT03765073|540940270|FG001|Stage 3|Withdrawal by parent/guardian|0|||
149947474|NCT03765073|540940271|FG002|Stage 3|Withdrawal by parent/guardian|0|||
149947475|NCT03765073|540940272|FG003|Stage 3|Withdrawal by parent/guardian|0|||
149947476|NCT03765073|540940273|FG004|Stage 3|Withdrawal by parent/guardian|0|||
149947477|NCT03765073|540940274|FG005|Stage 3|Withdrawal by parent/guardian|0|||
149947478|NCT03765073|540940275|FG006|Stage 3|Withdrawal by parent/guardian|0|||
149947479|NCT03765073|540940276|FG007|Stage 3|Withdrawal by parent/guardian|0|||
149947480|NCT03765073|540940277|FG008|Stage 3|Withdrawal by parent/guardian|0|||
149947481|NCT03765073|540940278|FG009|Stage 3|Withdrawal by parent/guardian|0|||
149947482|NCT03765073|540940279|FG010|Stage 3|Withdrawal by parent/guardian|0|||
149947483|NCT03765073|540940280|FG011|Stage 3|Withdrawal by parent/guardian|0|||
149947484|NCT03765073|540940281|FG012|Stage 3|Withdrawal by parent/guardian|0|||
149947485|NCT03765073|540940282|FG013|Stage 3|Withdrawal by parent/guardian|0|||
149947486|NCT03765073|540940283|FG014|Stage 3|Withdrawal by parent/guardian|0|||
149947487|NCT03765073|540940284|FG015|Stage 3|Withdrawal by parent/guardian|0|||
149947488|NCT03765073|540940285|FG016|Stage 3|Withdrawal by parent/guardian|0|||
149947489|NCT03765073|540940286|FG017|Stage 3|Withdrawal by parent/guardian|0|||
150170643|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
150170644|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
150170645|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
150170646|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
150170647|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
149830012|NCT02848326|540508142|FG000|Treatment Period|Pregnancy|0|||
149830013|NCT02848326|540508143|FG001|Treatment Period|Pregnancy|0|||
149830014|NCT02848326|540508144|FG002|Treatment Period|Pregnancy|1|||
149830015|NCT02848326|540508145|FG003|Treatment Period|Pregnancy|1|||
150033332|NCT02892344|541262753|FG000|Overall Study|Subject/guardian decision|0|||
150033333|NCT02892344|541262754|FG001|Overall Study|Subject/guardian decision|4|||
150033334|NCT02892344|541262753|FG000|Overall Study|Technical problems|0|||
150033335|NCT02892344|541262754|FG001|Overall Study|Technical problems|1|||
150033336|NCT01295814|541262755|FG000|Overall Study|Lack of Efficacy|0|||
150033337|NCT01295814|541262756|FG001|Overall Study|Lack of Efficacy|2|||
150033338|NCT01295814|541262755|FG000|Overall Study|Withdrawal by Subject|2|||
150033339|NCT01295814|541262756|FG001|Overall Study|Withdrawal by Subject|0|||
150033340|NCT01775501|541262761|FG000|Overall Study|Discontinued prior to treatment|1|||
150033341|NCT02318706|541262762|FG000|Double-blind Phase|Adverse Event|7|||
150033342|NCT02318706|541262763|FG001|Double-blind Phase|Adverse Event|4|||
150033343|NCT02318706|541262764|FG002|Double-blind Phase|Adverse Event|3|||
150033344|NCT02318706|541262765|FG003|Double-blind Phase|Adverse Event|10|||
150033345|NCT02318706|541262766|FG004|Double-blind Phase|Adverse Event|0|||
150033346|NCT02318706|541262762|FG000|Double-blind Phase|Lost to Follow-up|1|||
150033347|NCT02318706|541262763|FG001|Double-blind Phase|Lost to Follow-up|0|||
150033348|NCT02318706|541262764|FG002|Double-blind Phase|Lost to Follow-up|0|||
150033349|NCT02318706|541262765|FG003|Double-blind Phase|Lost to Follow-up|0|||
150033350|NCT02318706|541262766|FG004|Double-blind Phase|Lost to Follow-up|0|||
150033351|NCT02318706|541262762|FG000|Double-blind Phase|Protocol Violation|4|||
149830016|NCT02848326|540508146|FG004|Treatment Period|Pregnancy|0|||
149830017|NCT02848326|540508147|FG005|Treatment Period|Pregnancy|1|||
149830018|NCT02848326|540508142|FG000|Treatment Period|Protocol Violation|4|||
149830019|NCT02848326|540508143|FG001|Treatment Period|Protocol Violation|3|||
149830020|NCT02848326|540508144|FG002|Treatment Period|Protocol Violation|4|||
149830021|NCT02848326|540508145|FG003|Treatment Period|Protocol Violation|2|||
149830022|NCT02848326|540508146|FG004|Treatment Period|Protocol Violation|3|||
149830023|NCT02848326|540508147|FG005|Treatment Period|Protocol Violation|3|||
149830024|NCT02848326|540508142|FG000|Treatment Period|Non-compliance with Study Drug|4|||
149830025|NCT02848326|540508143|FG001|Treatment Period|Non-compliance with Study Drug|0|||
149830026|NCT02848326|540508144|FG002|Treatment Period|Non-compliance with Study Drug|0|||
150033352|NCT02318706|541262763|FG001|Double-blind Phase|Protocol Violation|2|||
150033353|NCT02318706|541262764|FG002|Double-blind Phase|Protocol Violation|4|||
150033354|NCT02318706|541262765|FG003|Double-blind Phase|Protocol Violation|3|||
150033355|NCT02318706|541262766|FG004|Double-blind Phase|Protocol Violation|0|||
150033356|NCT02318706|541262762|FG000|Double-blind Phase|Withdrawal by Subject|9|||
150033357|NCT02318706|541262763|FG001|Double-blind Phase|Withdrawal by Subject|5|||
150033358|NCT02318706|541262764|FG002|Double-blind Phase|Withdrawal by Subject|7|||
150033359|NCT02318706|541262765|FG003|Double-blind Phase|Withdrawal by Subject|10|||
150033360|NCT02318706|541262766|FG004|Double-blind Phase|Withdrawal by Subject|0|||
150033361|NCT02318706|541262762|FG000|Double-blind Phase|Other|4|||
150033362|NCT02318706|541262763|FG001|Double-blind Phase|Other|1|||
150033363|NCT02318706|541262764|FG002|Double-blind Phase|Other|2|||
150033364|NCT02318706|541262765|FG003|Double-blind Phase|Other|1|||
150033365|NCT02318706|541262766|FG004|Double-blind Phase|Other|0|||
150033366|NCT02318706|541262762|FG000|Double-blind Phase|Death|0|||
150033367|NCT02318706|541262763|FG001|Double-blind Phase|Death|0|||
150033368|NCT02318706|541262764|FG002|Double-blind Phase|Death|2|||
150033369|NCT02318706|541262765|FG003|Double-blind Phase|Death|0|||
150033370|NCT02318706|541262766|FG004|Double-blind Phase|Death|0|||
150033371|NCT02318706|541262762|FG000|Open-label Extension Phase|Adverse Event|0|||
149830027|NCT02848326|540508145|FG003|Treatment Period|Non-compliance with Study Drug|1|||
149947490|NCT03765073|540940287|FG018|Stage 3|Withdrawal by parent/guardian|0|||
149947491|NCT03765073|540940288|FG019|Stage 3|Withdrawal by parent/guardian|6|||
149947492|NCT03765073|540940289|FG020|Stage 3|Withdrawal by parent/guardian|9|||
149947493|NCT03765073|540940269|FG000|Stage 3|Withdrawal by Subject|0|||
149947494|NCT03765073|540940270|FG001|Stage 3|Withdrawal by Subject|0|||
149947495|NCT03765073|540940271|FG002|Stage 3|Withdrawal by Subject|0|||
149947496|NCT03765073|540940272|FG003|Stage 3|Withdrawal by Subject|0|||
149947497|NCT03765073|540940273|FG004|Stage 3|Withdrawal by Subject|0|||
149947498|NCT03765073|540940274|FG005|Stage 3|Withdrawal by Subject|0|||
149947499|NCT03765073|540940275|FG006|Stage 3|Withdrawal by Subject|0|||
149947500|NCT03765073|540940276|FG007|Stage 3|Withdrawal by Subject|0|||
149947501|NCT03765073|540940277|FG008|Stage 3|Withdrawal by Subject|0|||
150033372|NCT02318706|541262763|FG001|Open-label Extension Phase|Adverse Event|0|||
150033373|NCT02318706|541262764|FG002|Open-label Extension Phase|Adverse Event|0|||
150033374|NCT02318706|541262765|FG003|Open-label Extension Phase|Adverse Event|0|||
149830028|NCT02848326|540508146|FG004|Treatment Period|Non-compliance with Study Drug|0|||
149947502|NCT03765073|540940278|FG009|Stage 3|Withdrawal by Subject|0|||
150033375|NCT02318706|541262766|FG004|Open-label Extension Phase|Adverse Event|21|||
150033376|NCT02318706|541262762|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
149947503|NCT03765073|540940279|FG010|Stage 3|Withdrawal by Subject|0|||
150033377|NCT02318706|541262763|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
150033378|NCT02318706|541262764|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
150033379|NCT02318706|541262765|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
150033380|NCT02318706|541262766|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
150033381|NCT02318706|541262762|FG000|Open-label Extension Phase|Death|0|||
149947504|NCT03765073|540940280|FG011|Stage 3|Withdrawal by Subject|0|||
149830029|NCT02848326|540508147|FG005|Treatment Period|Non-compliance with Study Drug|0|||
149830030|NCT02848326|540508142|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
149830031|NCT02848326|540508143|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
149830032|NCT02848326|540508144|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
149830033|NCT02848326|540508145|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
149830034|NCT02848326|540508146|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
149830035|NCT02848326|540508147|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
149830036|NCT02848326|540508142|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
149830037|NCT02848326|540508143|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
149830038|NCT02848326|540508144|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
149830039|NCT02848326|540508145|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
149947505|NCT03765073|540940281|FG012|Stage 3|Withdrawal by Subject|0|||
149947506|NCT03765073|540940282|FG013|Stage 3|Withdrawal by Subject|0|||
149947507|NCT03765073|540940283|FG014|Stage 3|Withdrawal by Subject|0|||
149947508|NCT03765073|540940284|FG015|Stage 3|Withdrawal by Subject|0|||
149947509|NCT03765073|540940285|FG016|Stage 3|Withdrawal by Subject|0|||
149947510|NCT03765073|540940286|FG017|Stage 3|Withdrawal by Subject|8|||
149947511|NCT03765073|540940287|FG018|Stage 3|Withdrawal by Subject|11|||
149947512|NCT03765073|540940288|FG019|Stage 3|Withdrawal by Subject|0|||
149947513|NCT03765073|540940289|FG020|Stage 3|Withdrawal by Subject|0|||
149947514|NCT02550795|540940290|FG000|Overall Study|Physician Decision|0|||
149947515|NCT02550795|540940291|FG001|Overall Study|Physician Decision|1|||
149947516|NCT02550795|540940292|FG002|Overall Study|Physician Decision|0|||
149947517|NCT00695019|540940293|FG000|Overall Study|Withdrawal by Subject|8|||
149947518|NCT00695019|540940294|FG001|Overall Study|Withdrawal by Subject|6|||
149947519|NCT00695019|540940295|FG002|Overall Study|Withdrawal by Subject|4|||
149947520|NCT00695019|540940293|FG000|Overall Study|Protocol Violation|1|||
149947521|NCT00695019|540940294|FG001|Overall Study|Protocol Violation|3|||
149947522|NCT00695019|540940295|FG002|Overall Study|Protocol Violation|1|||
149947523|NCT00695019|540940293|FG000|Overall Study|Lack of Efficacy|0|||
149947524|NCT00695019|540940294|FG001|Overall Study|Lack of Efficacy|0|||
149947525|NCT00695019|540940295|FG002|Overall Study|Lack of Efficacy|1|||
149947526|NCT00695019|540940293|FG000|Overall Study|Various|4|||
149947527|NCT00695019|540940294|FG001|Overall Study|Various|5|||
149947528|NCT00695019|540940295|FG002|Overall Study|Various|4|||
149947529|NCT02225587|540940296|FG000|Overall Study|Adverse Event|5|||
149947530|NCT02225587|540940297|FG001|Overall Study|Adverse Event|5|||
149947531|NCT02225587|540940296|FG000|Overall Study|Lost to Follow-up|5|||
149947532|NCT02225587|540940297|FG001|Overall Study|Lost to Follow-up|5|||
149947533|NCT02225587|540940296|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149947534|NCT02225587|540940297|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149947535|NCT02225587|540940296|FG000|Overall Study|Physician Decision|2|||
149947536|NCT02225587|540940297|FG001|Overall Study|Physician Decision|0|||
149947537|NCT02225587|540940296|FG000|Overall Study|Protocol Violation|1|||
149947538|NCT02225587|540940297|FG001|Overall Study|Protocol Violation|0|||
149947539|NCT02225587|540940296|FG000|Overall Study|Participant Moved|1|||
149947540|NCT02225587|540940297|FG001|Overall Study|Participant Moved|0|||
149947541|NCT02225587|540940296|FG000|Overall Study|Withdrawal by Subject|13|||
149947542|NCT02225587|540940297|FG001|Overall Study|Withdrawal by Subject|28|||
149947543|NCT00924898|540940298|FG000|Overall Study|Withdrawal by Subject|2|||
149947544|NCT04896385|540940301|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
149947545|NCT04896385|540940302|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
149947546|NCT04896385|540940303|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
149947547|NCT04896385|540940304|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
149947548|NCT04896385|540940301|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
149947549|NCT04896385|540940302|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
149947550|NCT04896385|540940303|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
149947551|NCT04896385|540940304|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
149947552|NCT04896385|540940301|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
149947553|NCT04896385|540940302|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
149947554|NCT04896385|540940303|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
149947555|NCT04896385|540940304|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
149947556|NCT04896385|540940301|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
149947557|NCT04896385|540940302|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
149947558|NCT04896385|540940303|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
149947559|NCT04896385|540940304|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
149947560|NCT04896385|540940301|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
149947561|NCT04896385|540940302|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
149947562|NCT04896385|540940303|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
149947563|NCT04896385|540940304|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
149947564|NCT04896385|540940301|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
149947565|NCT04896385|540940302|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
149947566|NCT04896385|540940303|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
149947567|NCT04896385|540940304|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
149830040|NCT02848326|540508146|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
149830041|NCT02848326|540508147|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
149830042|NCT00414466|540508149|FG000|Overall Study|Adverse Event|0|||
149830043|NCT00414466|540508150|FG001|Overall Study|Adverse Event|0|||
149830044|NCT00414466|540508151|FG002|Overall Study|Adverse Event|1|||
149947568|NCT05291689|540940308|FG000|Overall Study|Adverse Event|3|||
149947569|NCT05291689|540940308|FG000|Overall Study|Lack of Efficacy|10|||
149947570|NCT05291689|540940308|FG000|Overall Study|Withdrawal by Subject|4|||
149947571|NCT01931098|540940309|FG000|Overall Study|Withdrawal by Subject|0|||
149947572|NCT01931098|540940310|FG001|Overall Study|Withdrawal by Subject|1|||
149947573|NCT01931098|540940309|FG000|Overall Study|Enrolled in different protocol|0|||
149947574|NCT01931098|540940310|FG001|Overall Study|Enrolled in different protocol|1|||
149947575|NCT01931098|540940309|FG000|Overall Study|Unable to begin trmt:active infection|0|||
149947576|NCT01931098|540940310|FG001|Overall Study|Unable to begin trmt:active infection|1|||
149947577|NCT01931098|540940309|FG000|Overall Study|Refused further treatment|0|||
149947578|NCT01931098|540940310|FG001|Overall Study|Refused further treatment|1|||
149947579|NCT02278354|540940314|FG000|Overall Study|Lost to Follow-up|2|||
149947580|NCT02278354|540940315|FG001|Overall Study|Lost to Follow-up|2|||
149947581|NCT02278354|540940314|FG000|Overall Study|Withdrawal by Subject|0|||
149947582|NCT02278354|540940315|FG001|Overall Study|Withdrawal by Subject|1|||
149947583|NCT02278354|540940314|FG000|Overall Study|<10 professional fights|2|||
149947584|NCT02278354|540940315|FG001|Overall Study|<10 professional fights|0|||
149947585|NCT02612155|540940317|FG000|Overall Study|Death|1|||
149947586|NCT02612155|540940318|FG001|Overall Study|Death|1|||
149947587|NCT02612155|540940317|FG000|Overall Study|Lost to Follow-up|2|||
149947588|NCT02612155|540940318|FG001|Overall Study|Lost to Follow-up|2|||
149947589|NCT02879695|540940330|FG000|Overall Study|Did not start study treatment|2|||
149947590|NCT02879695|540940331|FG001|Overall Study|Did not start study treatment|0|||
149947591|NCT02879695|540940332|FG002|Overall Study|Did not start study treatment|3|||
149947592|NCT02879695|540940333|FG003|Overall Study|Did not start study treatment|0|||
149947593|NCT04235374|540940334|FG000|Overall Study|Death|91|||
149947594|NCT04235374|540940335|FG001|Overall Study|Death|91|||
149947595|NCT04235374|540940334|FG000|Overall Study|Refused|2|||
149947596|NCT04235374|540940335|FG001|Overall Study|Refused|2|||
149947597|NCT04235374|540940334|FG000|Overall Study|Unavailable|12|||
149947598|NCT04235374|540940335|FG001|Overall Study|Unavailable|3|||
149947599|NCT04235374|540940334|FG000|Overall Study|Withdrawal by Subject|0|||
149947600|NCT04235374|540940335|FG001|Overall Study|Withdrawal by Subject|1|||
149947601|NCT04235374|540940334|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
149947602|NCT04235374|540940335|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
149947603|NCT00314145|540940336|FG000|Overall Study|Withdrawal by Subject|8|||
149947604|NCT00314145|540940337|FG001|Overall Study|Withdrawal by Subject|10|||
149947605|NCT00314145|540940336|FG000|Overall Study|Lost to Follow-up|5|||
149947606|NCT00314145|540940337|FG001|Overall Study|Lost to Follow-up|12|||
149947607|NCT00314145|540940336|FG000|Overall Study|Physician Decision|3|||
149947608|NCT00314145|540940337|FG001|Overall Study|Physician Decision|4|||
149947609|NCT00314145|540940336|FG000|Overall Study|Adverse Event|0|||
149947610|NCT00314145|540940337|FG001|Overall Study|Adverse Event|3|||
149947611|NCT00314145|540940336|FG000|Overall Study|Protocol Violation|3|||
149947612|NCT00314145|540940337|FG001|Overall Study|Protocol Violation|0|||
149947613|NCT00314145|540940336|FG000|Overall Study|Sponsor Decision|2|||
149947614|NCT00314145|540940337|FG001|Overall Study|Sponsor Decision|0|||
149947615|NCT02572167|540940338|FG000|Overall Study|Withdrawal by Subject|0|||
149947616|NCT02572167|540940339|FG001|Overall Study|Withdrawal by Subject|3|||
149947617|NCT02572167|540940340|FG002|Overall Study|Withdrawal by Subject|0|||
149947618|NCT02572167|540940338|FG000|Overall Study|Lost to Follow-up|2|||
149947619|NCT02572167|540940339|FG001|Overall Study|Lost to Follow-up|5|||
149947620|NCT02572167|540940340|FG002|Overall Study|Lost to Follow-up|3|||
149947621|NCT02572167|540940338|FG000|Overall Study|Death|0|||
149947622|NCT02572167|540940339|FG001|Overall Study|Death|8|||
149947623|NCT02572167|540940340|FG002|Overall Study|Death|3|||
149947624|NCT02572167|540940338|FG000|Overall Study|Did not meet inclusion criteria|0|||
149830045|NCT00414466|540508152|FG003|Overall Study|Adverse Event|1|||
149947625|NCT02572167|540940339|FG001|Overall Study|Did not meet inclusion criteria|0|||
149947626|NCT02572167|540940340|FG002|Overall Study|Did not meet inclusion criteria|1|||
149947627|NCT02572167|540940338|FG000|Overall Study|Study closure by Sponsor|4|||
149947628|NCT02572167|540940339|FG001|Overall Study|Study closure by Sponsor|40|||
149947629|NCT02572167|540940340|FG002|Overall Study|Study closure by Sponsor|24|||
149947630|NCT02296125|540940350|FG000|Overall Study|Withdrawal by Subject|18|||
149947631|NCT02296125|540940351|FG001|Overall Study|Withdrawal by Subject|8|||
149947632|NCT02296125|540940352|FG002|Overall Study|Withdrawal by Subject|6|||
149947633|NCT02296125|540940353|FG003|Overall Study|Withdrawal by Subject|2|||
149947634|NCT02296125|540940350|FG000|Overall Study|Adverse Event|41|||
149947635|NCT02296125|540940351|FG001|Overall Study|Adverse Event|52|||
149947636|NCT02296125|540940352|FG002|Overall Study|Adverse Event|9|||
149947637|NCT02296125|540940353|FG003|Overall Study|Adverse Event|4|||
149947638|NCT02296125|540940350|FG000|Overall Study|Severe non-compliance to protocol|0|||
150276362|NCT02490475|542149956|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
150276363|NCT02490475|542149953|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
150276364|NCT02490475|542149954|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
150276365|NCT02490475|542149955|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
150276366|NCT02490475|542149956|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
150276367|NCT02490475|542149953|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
150276368|NCT02490475|542149954|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
150276369|NCT02490475|542149955|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
150276370|NCT02490475|542149956|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
150276371|NCT02490475|542149953|FG000|Period 2: Extension Phase|Refused Treatment|0|||
150276372|NCT02490475|542149954|FG001|Period 2: Extension Phase|Refused Treatment|0|||
150276373|NCT02490475|542149955|FG002|Period 2: Extension Phase|Refused Treatment|0|||
150276374|NCT02490475|542149956|FG003|Period 2: Extension Phase|Refused Treatment|1|||
150276375|NCT02490475|542149953|FG000|Period 2: Extension Phase|Adverse Event|0|||
150276376|NCT02490475|542149954|FG001|Period 2: Extension Phase|Adverse Event|0|||
150276377|NCT02490475|542149955|FG002|Period 2: Extension Phase|Adverse Event|1|||
150276378|NCT02490475|542149956|FG003|Period 2: Extension Phase|Adverse Event|0|||
150276379|NCT01195090|542149960|FG000|Overall Study|Adverse Event|1|||
150276380|NCT01195090|542149961|FG001|Overall Study|Adverse Event|2|||
150276381|NCT01195090|542149960|FG000|Overall Study|Lost to Follow-up|2|||
150276382|NCT01195090|542149961|FG001|Overall Study|Lost to Follow-up|2|||
150276383|NCT01195090|542149960|FG000|Overall Study|Protocol Violation|3|||
150276384|NCT01195090|542149961|FG001|Overall Study|Protocol Violation|4|||
150276385|NCT04912245|542149962|FG000|Overall Study|Withdrawal by Subject|21|||
150276386|NCT04912245|542149963|FG001|Overall Study|Withdrawal by Subject|4|||
150276387|NCT04912245|542149962|FG000|Overall Study|Lost to Follow-up|5|||
150276388|NCT04912245|542149963|FG001|Overall Study|Lost to Follow-up|11|||
150276389|NCT01205230|542149964|FG000|Overall Study|Adverse Event|4|||
150276390|NCT01205230|542149965|FG001|Overall Study|Adverse Event|0|||
150276391|NCT01205230|542149964|FG000|Overall Study|Physician Decision|1|||
150276392|NCT01205230|542149965|FG001|Overall Study|Physician Decision|0|||
150276393|NCT02319668|542149966|FG000|Overall Study|Other (Not specified)|0|||
150276394|NCT02319668|542149967|FG001|Overall Study|Other (Not specified)|2|||
149947639|NCT02296125|540940351|FG001|Overall Study|Severe non-compliance to protocol|1|||
149947640|NCT02296125|540940352|FG002|Overall Study|Severe non-compliance to protocol|0|||
149947641|NCT02296125|540940353|FG003|Overall Study|Severe non-compliance to protocol|0|||
149947642|NCT02296125|540940350|FG000|Overall Study|Condition under investigation worsened|153|||
149947643|NCT02296125|540940351|FG001|Overall Study|Condition under investigation worsened|199|||
149947644|NCT02296125|540940352|FG002|Overall Study|Condition under investigation worsened|39|||
149947645|NCT02296125|540940353|FG003|Overall Study|Condition under investigation worsened|56|||
149947646|NCT02296125|540940350|FG000|Overall Study|Any reason not specifically recorded|6|||
149947647|NCT02296125|540940351|FG001|Overall Study|Any reason not specifically recorded|4|||
149947648|NCT02296125|540940352|FG002|Overall Study|Any reason not specifically recorded|2|||
149947649|NCT02296125|540940353|FG003|Overall Study|Any reason not specifically recorded|0|||
149947650|NCT05845619|540940355|FG000|Overall Study|duplicate enrollment|2|||
149947651|NCT05845619|540940356|FG001|Overall Study|duplicate enrollment|2|||
149947652|NCT05845619|540940357|FG002|Overall Study|duplicate enrollment|1|||
149947653|NCT04967222|540940358|FG000|Randomized|Lost to Follow-up|0|||
149947654|NCT04967222|540940359|FG001|Randomized|Lost to Follow-up|1|||
149947655|NCT04967222|540940360|FG002|Randomized|Lost to Follow-up|1|||
149947656|NCT04967222|540940358|FG000|Randomized|Physician Decision|0|||
149947657|NCT04967222|540940359|FG001|Randomized|Physician Decision|0|||
149947658|NCT04967222|540940360|FG002|Randomized|Physician Decision|1|||
149947659|NCT04967222|540940358|FG000|Randomized|Withdrawal by Subject|0|||
149947660|NCT04967222|540940359|FG001|Randomized|Withdrawal by Subject|0|||
150276395|NCT01372150|542149968|FG000|Overall Study|Lack of Efficacy|3|||
150276396|NCT01372150|542149969|FG001|Overall Study|Lack of Efficacy|0|||
150276397|NCT01372150|542149970|FG002|Overall Study|Lack of Efficacy|1|||
150276398|NCT01372150|542149968|FG000|Overall Study|Lost to Follow-up|4|||
150276399|NCT01372150|542149969|FG001|Overall Study|Lost to Follow-up|5|||
150276400|NCT01372150|542149970|FG002|Overall Study|Lost to Follow-up|6|||
150276401|NCT01372150|542149968|FG000|Overall Study|Protocol Violation|1|||
150276402|NCT01372150|542149969|FG001|Overall Study|Protocol Violation|0|||
150276403|NCT01372150|542149970|FG002|Overall Study|Protocol Violation|3|||
149947661|NCT04967222|540940360|FG002|Randomized|Withdrawal by Subject|2|||
149947662|NCT04967222|540940358|FG000|Randomized|abnormal finding in MRI|0|||
149947663|NCT04967222|540940359|FG001|Randomized|abnormal finding in MRI|2|||
149947664|NCT04967222|540940360|FG002|Randomized|abnormal finding in MRI|0|||
149947665|NCT01295944|540940361|FG000|Overall Study|Switched to alternative treatment|1|||
149947666|NCT01295944|540940361|FG000|Overall Study|Ineligible|9|||
149947667|NCT01295944|540940361|FG000|Overall Study|Withdrawal by Subject|1|||
149947668|NCT01295944|540940361|FG000|Overall Study|Participant chose to be treated in Peru|1|||
149947669|NCT01295944|540940361|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
149947670|NCT01295944|540940361|FG000|Overall Study|Physician Decision|1|||
149830046|NCT00414466|540508149|FG000|Overall Study|Lack of Efficacy|1|||
149830047|NCT00414466|540508150|FG001|Overall Study|Lack of Efficacy|0|||
149830048|NCT00414466|540508151|FG002|Overall Study|Lack of Efficacy|0|||
149830049|NCT00414466|540508152|FG003|Overall Study|Lack of Efficacy|0|||
149830050|NCT00414466|540508149|FG000|Overall Study|Withdrawn by Sponsor|1|||
149830051|NCT00414466|540508150|FG001|Overall Study|Withdrawn by Sponsor|0|||
149830052|NCT00414466|540508151|FG002|Overall Study|Withdrawn by Sponsor|0|||
149830053|NCT00414466|540508152|FG003|Overall Study|Withdrawn by Sponsor|0|||
149830054|NCT02684344|540508154|FG000|Overall Study|Withdrawal by Subject|0|||
149830055|NCT02684344|540508155|FG001|Overall Study|Withdrawal by Subject|1|||
149830056|NCT01494506|540508160|FG000|Overall Study|Lack of Efficacy|77|||
149830057|NCT01494506|540508161|FG001|Overall Study|Lack of Efficacy|83|||
149830058|NCT01494506|540508162|FG002|Overall Study|Lack of Efficacy|57|||
149947671|NCT01295944|540940361|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
149947672|NCT01295944|540940361|FG000|Overall Study|Disease progression|4|||
149947673|NCT01295944|540940361|FG000|Overall Study|Transferred care before starting new treatment|1|||
149947674|NCT04279522|540940362|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
149947675|NCT04279522|540940363|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
149947676|NCT04279522|540940362|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
149947677|NCT04279522|540940363|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
149947678|NCT04279522|540940362|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
149947679|NCT04279522|540940363|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
149947680|NCT04279522|540940362|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
149947681|NCT04279522|540940363|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
149947682|NCT04279522|540940362|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
149947683|NCT04279522|540940363|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
149947684|NCT04279522|540940362|FG000|Period 2: Open Label Phase|Physician Decision|0|||
149947685|NCT04279522|540940363|FG001|Period 2: Open Label Phase|Physician Decision|3|||
149947686|NCT04279522|540940362|FG000|Period 2: Open Label Phase|Adverse Event|0|||
149947687|NCT04279522|540940363|FG001|Period 2: Open Label Phase|Adverse Event|1|||
149947688|NCT04279522|540940362|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
149947689|NCT04279522|540940363|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
149947690|NCT01802281|540940370|FG000|Overall Study|Death|1|||
149947691|NCT01802281|540940371|FG001|Overall Study|Death|2|||
149947692|NCT01802281|540940370|FG000|Overall Study|Withdrawal by Subject|2|||
149947693|NCT01802281|540940371|FG001|Overall Study|Withdrawal by Subject|1|||
149947694|NCT01802281|540940370|FG000|Overall Study|Ineligible|5|||
149947695|NCT01802281|540940371|FG001|Overall Study|Ineligible|3|||
149947696|NCT02685735|540940372|FG000|Overall Study|Surgery Cancelled|4|||
149947697|NCT02685735|540940373|FG001|Overall Study|Surgery Cancelled|9|||
149947698|NCT02685735|540940372|FG000|Overall Study|Adverse Event|10|||
149947699|NCT02685735|540940373|FG001|Overall Study|Adverse Event|3|||
149947700|NCT02685735|540940372|FG000|Overall Study|Preop testing found to be incomplete|2|||
149947701|NCT02685735|540940373|FG001|Overall Study|Preop testing found to be incomplete|2|||
149947702|NCT02685735|540940372|FG000|Overall Study|Withdrawal by Subject|1|||
149947703|NCT02685735|540940373|FG001|Overall Study|Withdrawal by Subject|2|||
149947704|NCT02685735|540940372|FG000|Overall Study|Death|1|||
149947705|NCT02685735|540940373|FG001|Overall Study|Death|0|||
149947706|NCT02401230|540940374|FG000|Overall Study|Adverse Event|3|||
149947707|NCT02401230|540940375|FG001|Overall Study|Adverse Event|2|||
149947708|NCT02401230|540940376|FG002|Overall Study|Adverse Event|0|||
149947709|NCT02401230|540940374|FG000|Overall Study|Withdrawal by Subject|2|||
149947710|NCT02401230|540940375|FG001|Overall Study|Withdrawal by Subject|1|||
149947711|NCT02401230|540940376|FG002|Overall Study|Withdrawal by Subject|1|||
149947712|NCT02401230|540940374|FG000|Overall Study|Lost to Follow-up|1|||
149947713|NCT02401230|540940375|FG001|Overall Study|Lost to Follow-up|3|||
149947714|NCT02401230|540940376|FG002|Overall Study|Lost to Follow-up|3|||
149947715|NCT00831844|540940382|FG000|Overall Study|Adverse Event|2|||
149947716|NCT00831844|540940383|FG001|Overall Study|Adverse Event|0|||
149947717|NCT00831844|540940384|FG002|Overall Study|Adverse Event|0|||
149947718|NCT00831844|540940385|FG003|Overall Study|Adverse Event|0|||
150170648|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
150170649|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149830059|NCT01494506|540508160|FG000|Overall Study|Adverse Event|17|||
149830060|NCT01494506|540508161|FG001|Overall Study|Adverse Event|10|||
149830061|NCT01494506|540508162|FG002|Overall Study|Adverse Event|11|||
149947719|NCT00831844|540940386|FG004|Overall Study|Adverse Event|1|||
149947720|NCT00831844|540940387|FG005|Overall Study|Adverse Event|1|||
149947721|NCT00831844|540940388|FG006|Overall Study|Adverse Event|2|||
149947722|NCT00831844|540940389|FG007|Overall Study|Adverse Event|0|||
149947723|NCT00831844|540940390|FG008|Overall Study|Adverse Event|0|||
150033382|NCT02318706|541262763|FG001|Open-label Extension Phase|Death|0|||
149830062|NCT01494506|540508160|FG000|Overall Study|Death|9|||
149947724|NCT00831844|540940391|FG009|Overall Study|Adverse Event|0|||
149947725|NCT00831844|540940382|FG000|Overall Study|Death|0|||
149947726|NCT00831844|540940383|FG001|Overall Study|Death|0|||
150033383|NCT02318706|541262764|FG002|Open-label Extension Phase|Death|0|||
150033384|NCT02318706|541262765|FG003|Open-label Extension Phase|Death|0|||
150033385|NCT02318706|541262766|FG004|Open-label Extension Phase|Death|1|||
150033386|NCT02318706|541262762|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
150033387|NCT02318706|541262763|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
150033388|NCT02318706|541262764|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
150033389|NCT02318706|541262765|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
150033390|NCT02318706|541262766|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
150033391|NCT01702311|541262767|FG000|Overall Study|Withdrawal by Subject|3|||
150033392|NCT01702311|541262768|FG001|Overall Study|Withdrawal by Subject|2|||
150033393|NCT01702311|541262767|FG000|Overall Study|Discharge less than 24 hours|10|||
150033394|NCT01702311|541262768|FG001|Overall Study|Discharge less than 24 hours|7|||
150033395|NCT01702311|541262767|FG000|Overall Study|Physician Decision|3|||
150033396|NCT01702311|541262768|FG001|Overall Study|Physician Decision|4|||
150033397|NCT04106557|541262774|FG000|Overall Study|Physician Decision|0|||
150033398|NCT04106557|541262775|FG001|Overall Study|Physician Decision|1|||
150033399|NCT04106557|541262776|FG002|Overall Study|Physician Decision|0|||
150033400|NCT04106557|541262774|FG000|Overall Study|Protocol Violation|0|||
150033401|NCT04106557|541262775|FG001|Overall Study|Protocol Violation|1|||
150033402|NCT04106557|541262776|FG002|Overall Study|Protocol Violation|0|||
150033403|NCT02326155|541262777|FG000|Overall Study|Adverse Event|21|||
150033404|NCT02326155|541262778|FG001|Overall Study|Adverse Event|5|||
150033405|NCT02326155|541262777|FG000|Overall Study|Death|3|||
150033406|NCT02326155|541262778|FG001|Overall Study|Death|0|||
150033407|NCT02326155|541262777|FG000|Overall Study|Lack of Efficacy|49|||
150033408|NCT02326155|541262778|FG001|Overall Study|Lack of Efficacy|5|||
150033409|NCT02326155|541262777|FG000|Overall Study|Lost to Follow-up|14|||
150033410|NCT02326155|541262778|FG001|Overall Study|Lost to Follow-up|3|||
150033411|NCT02326155|541262777|FG000|Overall Study|Protocol Violation|2|||
150033412|NCT02326155|541262778|FG001|Overall Study|Protocol Violation|0|||
150033413|NCT02326155|541262777|FG000|Overall Study|Withdrawal by Subject|34|||
150033414|NCT02326155|541262778|FG001|Overall Study|Withdrawal by Subject|11|||
150033415|NCT02326155|541262777|FG000|Overall Study|Disease progression|37|||
150033416|NCT02326155|541262778|FG001|Overall Study|Disease progression|4|||
150033417|NCT02326155|541262777|FG000|Overall Study|Study close|188|||
150033418|NCT02326155|541262778|FG001|Overall Study|Study close|21|||
150033419|NCT02326155|541262777|FG000|Overall Study|except for study close|46|||
150033420|NCT02326155|541262778|FG001|Overall Study|except for study close|13|||
150033421|NCT05024032|541262779|FG000|Overall Study|Withdrawal by Subject|0|||
150033422|NCT05024032|541262780|FG001|Overall Study|Withdrawal by Subject|3|||
150033423|NCT05024032|541262781|FG002|Overall Study|Withdrawal by Subject|4|||
150033424|NCT05024032|541262779|FG000|Overall Study|Adverse Event|0|||
150033425|NCT05024032|541262780|FG001|Overall Study|Adverse Event|1|||
150033426|NCT05024032|541262781|FG002|Overall Study|Adverse Event|0|||
150033427|NCT05024032|541262779|FG000|Overall Study|Protocol Deviation|1|||
150276404|NCT01372150|542149968|FG000|Overall Study|Withdrawal by Subject|2|||
150276405|NCT01372150|542149969|FG001|Overall Study|Withdrawal by Subject|7|||
150276406|NCT01372150|542149970|FG002|Overall Study|Withdrawal by Subject|2|||
150276407|NCT01372150|542149968|FG000|Overall Study|Other|1|||
150276408|NCT01372150|542149969|FG001|Overall Study|Other|0|||
150276409|NCT01372150|542149970|FG002|Overall Study|Other|2|||
150276410|NCT01372150|542149968|FG000|Overall Study|Adverse Event|2|||
150276411|NCT01372150|542149969|FG001|Overall Study|Adverse Event|1|||
150276412|NCT01372150|542149970|FG002|Overall Study|Adverse Event|2|||
150276413|NCT01372150|542149968|FG000|Overall Study|Randomized but not treated|0|||
150276414|NCT01372150|542149969|FG001|Overall Study|Randomized but not treated|1|||
150276415|NCT01372150|542149970|FG002|Overall Study|Randomized but not treated|0|||
150276416|NCT01236573|542149971|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
150276417|NCT01236573|542149972|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149830063|NCT01494506|540508161|FG001|Overall Study|Death|5|||
149830064|NCT01494506|540508162|FG002|Overall Study|Death|2|||
149830065|NCT01494506|540508160|FG000|Overall Study|Physician Decision|7|||
150276418|NCT01236573|542149973|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
150276419|NCT01236573|542149974|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149830066|NCT01494506|540508161|FG001|Overall Study|Physician Decision|5|||
150033428|NCT05024032|541262780|FG001|Overall Study|Protocol Deviation|0|||
150033429|NCT05024032|541262781|FG002|Overall Study|Protocol Deviation|0|||
150033430|NCT01209689|541262784|FG000|Overall Study|Insufficient Therapeutic Response|7|||
150033431|NCT01209689|541262785|FG001|Overall Study|Insufficient Therapeutic Response|2|||
150033432|NCT01209689|541262784|FG000|Overall Study|Refused Treatment|8|||
150033433|NCT01209689|541262785|FG001|Overall Study|Refused Treatment|3|||
150033434|NCT01209689|541262784|FG000|Overall Study|Adverse Event|4|||
150033435|NCT01209689|541262785|FG001|Overall Study|Adverse Event|0|||
150033436|NCT01209689|541262784|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
150033437|NCT01209689|541262785|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
150033438|NCT01209689|541262784|FG000|Overall Study|Failure to Return|3|||
150276420|NCT01236573|542149975|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149830067|NCT01494506|540508162|FG002|Overall Study|Physician Decision|4|||
149830068|NCT01494506|540508160|FG000|Overall Study|Withdrawal by Subject|17|||
149947727|NCT00831844|540940384|FG002|Overall Study|Death|0|||
149947728|NCT00831844|540940385|FG003|Overall Study|Death|1|||
149947729|NCT00831844|540940386|FG004|Overall Study|Death|0|||
149947730|NCT00831844|540940387|FG005|Overall Study|Death|0|||
149947731|NCT00831844|540940388|FG006|Overall Study|Death|0|||
149947732|NCT00831844|540940389|FG007|Overall Study|Death|0|||
149947733|NCT00831844|540940390|FG008|Overall Study|Death|0|||
149947734|NCT00831844|540940391|FG009|Overall Study|Death|0|||
149947735|NCT00831844|540940382|FG000|Overall Study|Lack of Efficacy|8|||
149947736|NCT00831844|540940383|FG001|Overall Study|Lack of Efficacy|10|||
149947737|NCT00831844|540940384|FG002|Overall Study|Lack of Efficacy|15|||
149947738|NCT00831844|540940385|FG003|Overall Study|Lack of Efficacy|8|||
149947739|NCT00831844|540940386|FG004|Overall Study|Lack of Efficacy|11|||
149947740|NCT00831844|540940387|FG005|Overall Study|Lack of Efficacy|17|||
149947741|NCT00831844|540940388|FG006|Overall Study|Lack of Efficacy|8|||
149947742|NCT00831844|540940389|FG007|Overall Study|Lack of Efficacy|9|||
149947743|NCT00831844|540940390|FG008|Overall Study|Lack of Efficacy|7|||
149947744|NCT00831844|540940391|FG009|Overall Study|Lack of Efficacy|0|||
149947745|NCT00831844|540940382|FG000|Overall Study|Physician Decision|0|||
149947746|NCT00831844|540940383|FG001|Overall Study|Physician Decision|1|||
149947747|NCT00831844|540940384|FG002|Overall Study|Physician Decision|3|||
149947748|NCT00831844|540940385|FG003|Overall Study|Physician Decision|1|||
149947749|NCT00831844|540940386|FG004|Overall Study|Physician Decision|1|||
149947750|NCT00831844|540940387|FG005|Overall Study|Physician Decision|1|||
149947751|NCT00831844|540940388|FG006|Overall Study|Physician Decision|0|||
149947752|NCT00831844|540940389|FG007|Overall Study|Physician Decision|0|||
149830069|NCT01494506|540508161|FG001|Overall Study|Withdrawal by Subject|20|||
149830070|NCT01494506|540508162|FG002|Overall Study|Withdrawal by Subject|14|||
149830071|NCT01494506|540508160|FG000|Overall Study|Clinical Deterioration|21|||
149830072|NCT01494506|540508161|FG001|Overall Study|Clinical Deterioration|17|||
149947753|NCT00831844|540940390|FG008|Overall Study|Physician Decision|1|||
149947754|NCT00831844|540940391|FG009|Overall Study|Physician Decision|0|||
149947755|NCT00831844|540940382|FG000|Overall Study|Withdrawal by Subject|0|||
149947756|NCT00831844|540940383|FG001|Overall Study|Withdrawal by Subject|0|||
149947757|NCT00831844|540940384|FG002|Overall Study|Withdrawal by Subject|1|||
149947758|NCT00831844|540940385|FG003|Overall Study|Withdrawal by Subject|0|||
149947759|NCT00831844|540940386|FG004|Overall Study|Withdrawal by Subject|0|||
149947760|NCT00831844|540940387|FG005|Overall Study|Withdrawal by Subject|0|||
149947761|NCT00831844|540940388|FG006|Overall Study|Withdrawal by Subject|0|||
149947762|NCT00831844|540940389|FG007|Overall Study|Withdrawal by Subject|1|||
149947763|NCT00831844|540940390|FG008|Overall Study|Withdrawal by Subject|1|||
149947764|NCT00831844|540940391|FG009|Overall Study|Withdrawal by Subject|0|||
149947765|NCT00831844|540940382|FG000|Overall Study|Ineligible|0|||
149947766|NCT00831844|540940383|FG001|Overall Study|Ineligible|1|||
149947767|NCT00831844|540940384|FG002|Overall Study|Ineligible|1|||
149947768|NCT00831844|540940385|FG003|Overall Study|Ineligible|0|||
149947769|NCT00831844|540940386|FG004|Overall Study|Ineligible|1|||
149947770|NCT00831844|540940387|FG005|Overall Study|Ineligible|0|||
149947771|NCT00831844|540940388|FG006|Overall Study|Ineligible|0|||
149947772|NCT00831844|540940389|FG007|Overall Study|Ineligible|0|||
149947773|NCT00831844|540940390|FG008|Overall Study|Ineligible|0|||
149947774|NCT00831844|540940391|FG009|Overall Study|Ineligible|0|||
149947775|NCT04133909|540940392|FG000|Overall Study|Death|11|||
149947776|NCT04133909|540940393|FG001|Overall Study|Death|11|||
149947777|NCT04133909|540940392|FG000|Overall Study|Adverse Event|4|||
149947778|NCT04133909|540940393|FG001|Overall Study|Adverse Event|5|||
149947779|NCT04133909|540940392|FG000|Overall Study|Lost to Follow-up|3|||
150033439|NCT01209689|541262785|FG001|Overall Study|Failure to Return|0|||
150033440|NCT01209689|541262784|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
150276421|NCT01236573|542149976|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
150276422|NCT01236573|542149977|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
149947780|NCT04133909|540940393|FG001|Overall Study|Lost to Follow-up|5|||
149947781|NCT04133909|540940392|FG000|Overall Study|Physician Decision|4|||
150276423|NCT01236573|542149978|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149830073|NCT01494506|540508162|FG002|Overall Study|Clinical Deterioration|13|||
149830074|NCT01494506|540508160|FG000|Overall Study|Sponsor Decision|0|||
149947782|NCT04133909|540940393|FG001|Overall Study|Physician Decision|7|||
149830075|NCT01494506|540508161|FG001|Overall Study|Sponsor Decision|0|||
149947783|NCT04133909|540940392|FG000|Overall Study|Withdrawal by Subject|40|||
149947784|NCT04133909|540940393|FG001|Overall Study|Withdrawal by Subject|35|||
149947785|NCT04133909|540940392|FG000|Overall Study|Lack of Efficacy|2|||
149947786|NCT04133909|540940393|FG001|Overall Study|Lack of Efficacy|7|||
149947787|NCT04133909|540940392|FG000|Overall Study|Randomized in error|1|||
149947788|NCT04133909|540940393|FG001|Overall Study|Randomized in error|1|||
149947789|NCT05020743|540940398|FG000|Overall Study|Enrollment in Interventional Study|2|||
149947790|NCT05020743|540940399|FG001|Overall Study|Enrollment in Interventional Study|9|||
149947791|NCT05020743|540940400|FG002|Overall Study|Enrollment in Interventional Study|0|||
149947792|NCT05020743|540940398|FG000|Overall Study|Withdrawal by Subject|0|||
149830076|NCT01494506|540508162|FG002|Overall Study|Sponsor Decision|1|||
149830077|NCT01494506|540508160|FG000|Overall Study|Other|0|||
149830078|NCT01494506|540508161|FG001|Overall Study|Other|3|||
149830079|NCT01494506|540508162|FG002|Overall Study|Other|1|||
149830080|NCT00863746|540508164|FG000|Treatment|Not treated|4|||
149830081|NCT00863746|540508165|FG001|Treatment|Not treated|2|||
149830082|NCT00863746|540508164|FG000|Treatment|Adverse Event|41|||
149830083|NCT00863746|540508165|FG001|Treatment|Adverse Event|16|||
149830084|NCT00863746|540508164|FG000|Treatment|non-compliant with study medication|4|||
149830085|NCT00863746|540508165|FG001|Treatment|non-compliant with study medication|0|||
149830086|NCT00863746|540508164|FG000|Treatment|Consent withdrawn|15|||
149830087|NCT00863746|540508165|FG001|Treatment|Consent withdrawn|14|||
149830088|NCT00863746|540508164|FG000|Treatment|Lost to Follow-up|1|||
149830089|NCT00863746|540508165|FG001|Treatment|Lost to Follow-up|0|||
149830090|NCT00863746|540508164|FG000|Treatment|Protocol Violation|5|||
149830091|NCT00863746|540508165|FG001|Treatment|Protocol Violation|3|||
149830092|NCT00863746|540508164|FG000|Treatment|Other|1|||
149830093|NCT00863746|540508165|FG001|Treatment|Other|0|||
149830094|NCT00863746|540508164|FG000|Survival Follow up|Death|244|||
149830095|NCT00863746|540508165|FG001|Survival Follow up|Death|271|||
149830096|NCT00863746|540508164|FG000|Survival Follow up|Lost to Follow-up|2|||
149830097|NCT00863746|540508165|FG001|Survival Follow up|Lost to Follow-up|1|||
149830098|NCT00863746|540508164|FG000|Survival Follow up|Consent Withdrawn|7|||
149830099|NCT00863746|540508165|FG001|Survival Follow up|Consent Withdrawn|8|||
149830100|NCT02395822|540508166|FG000|Overall Study|Withdrawal by Subject|1|||
149830101|NCT02395822|540508166|FG000|Overall Study|Death|1|||
150033441|NCT01209689|541262785|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
149830102|NCT02127281|540508167|FG000|Overall Study|Lost to Follow-up|1|||
149947793|NCT05020743|540940399|FG001|Overall Study|Withdrawal by Subject|3|||
149947794|NCT05020743|540940400|FG002|Overall Study|Withdrawal by Subject|1|||
149947795|NCT05020743|540940398|FG000|Overall Study|Lost to Follow-up|1|||
149947796|NCT05020743|540940399|FG001|Overall Study|Lost to Follow-up|0|||
149947797|NCT05020743|540940400|FG002|Overall Study|Lost to Follow-up|0|||
149947798|NCT05020743|540940398|FG000|Overall Study|Study Termination by Sponsor|10|||
149947799|NCT05020743|540940399|FG001|Overall Study|Study Termination by Sponsor|11|||
149947800|NCT05020743|540940400|FG002|Overall Study|Study Termination by Sponsor|10|||
149947801|NCT02390284|540940401|FG000|Overall Study|Physician Decision|0|||
149947802|NCT02390284|540940402|FG001|Overall Study|Physician Decision|0|||
149947803|NCT02390284|540940403|FG002|Overall Study|Physician Decision|9|||
149947804|NCT00724945|540940404|FG000|Period 1|non-compliance|1|||
149947805|NCT00724945|540940405|FG001|Period 1|non-compliance|0|||
149947806|NCT00724945|540940404|FG000|Period 1|Adverse Event|1|||
149947807|NCT00724945|540940405|FG001|Period 1|Adverse Event|1|||
149947808|NCT00724945|540940404|FG000|Period 1|Lost to Follow-up|1|||
149947809|NCT00724945|540940405|FG001|Period 1|Lost to Follow-up|0|||
149947810|NCT00724945|540940404|FG000|Period 2|lens comfort issue|3|||
149947811|NCT00724945|540940405|FG001|Period 2|lens comfort issue|0|||
149947812|NCT00724945|540940404|FG000|Period 2|lens physiology issue|1|||
149947813|NCT00724945|540940405|FG001|Period 2|lens physiology issue|0|||
149947814|NCT05166876|540940406|FG000|Overall Study|Withdrawal by Subject|1|||
149947815|NCT05166876|540940407|FG001|Overall Study|Withdrawal by Subject|0|||
149947816|NCT05166876|540940408|FG002|Overall Study|Withdrawal by Subject|0|||
149947817|NCT04409002|540940409|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
149947818|NCT02924376|540940410|FG000|Overall Study|Progressive Disease|4|||
149947819|NCT02924376|540940411|FG001|Overall Study|Progressive Disease|0|||
149947820|NCT02924376|540940412|FG002|Overall Study|Progressive Disease|1|||
149947821|NCT02924376|540940413|FG003|Overall Study|Progressive Disease|0|||
149947822|NCT02924376|540940410|FG000|Overall Study|Death|73|||
149947823|NCT02924376|540940411|FG001|Overall Study|Death|18|||
149947824|NCT02924376|540940412|FG002|Overall Study|Death|15|||
149947825|NCT02924376|540940413|FG003|Overall Study|Death|2|||
149947826|NCT02924376|540940410|FG000|Overall Study|Lost to Follow-up|3|||
149947827|NCT02924376|540940411|FG001|Overall Study|Lost to Follow-up|0|||
149947828|NCT02924376|540940412|FG002|Overall Study|Lost to Follow-up|0|||
149947829|NCT02924376|540940413|FG003|Overall Study|Lost to Follow-up|0|||
149947830|NCT02924376|540940410|FG000|Overall Study|Study Terminated by Sponsor|19|||
149947831|NCT02924376|540940411|FG001|Overall Study|Study Terminated by Sponsor|0|||
149947832|NCT02924376|540940412|FG002|Overall Study|Study Terminated by Sponsor|0|||
149947833|NCT02924376|540940413|FG003|Overall Study|Study Terminated by Sponsor|0|||
149947834|NCT02924376|540940410|FG000|Overall Study|Physician Decision|1|||
150170650|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170651|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149830103|NCT02127281|540508168|FG001|Overall Study|Lost to Follow-up|0|||
149830104|NCT03292653|540508171|FG000|Overall Study|Adverse Event|0|||
149830105|NCT03292653|540508172|FG001|Overall Study|Adverse Event|0|||
149830106|NCT03292653|540508173|FG002|Overall Study|Adverse Event|1|||
149830107|NCT03292653|540508171|FG000|Overall Study|Did not Receive Treatment|1|||
149830108|NCT03292653|540508172|FG001|Overall Study|Did not Receive Treatment|0|||
149947835|NCT02924376|540940411|FG001|Overall Study|Physician Decision|0|||
149947836|NCT02924376|540940412|FG002|Overall Study|Physician Decision|0|||
150276424|NCT01236573|542149979|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
150276425|NCT01236573|542149980|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
150276426|NCT01236573|542149981|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
150276427|NCT01236573|542149971|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276428|NCT01236573|542149972|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276429|NCT01236573|542149973|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149830109|NCT03292653|540508173|FG002|Overall Study|Did not Receive Treatment|0|||
149830110|NCT05037097|540508174|FG000|Overall Study|Withdrawal by Subject|0|||
149830111|NCT05037097|540508175|FG001|Overall Study|Withdrawal by Subject|1|||
149830112|NCT05037097|540508176|FG002|Overall Study|Withdrawal by Subject|0|||
149830113|NCT05037097|540508177|FG003|Overall Study|Withdrawal by Subject|1|||
149830114|NCT05037097|540508178|FG004|Overall Study|Withdrawal by Subject|0|||
149830115|NCT05037097|540508179|FG005|Overall Study|Withdrawal by Subject|2|||
149830116|NCT05037097|540508180|FG006|Overall Study|Withdrawal by Subject|0|||
149830117|NCT05037097|540508181|FG007|Overall Study|Withdrawal by Subject|0|||
149830118|NCT05037097|540508174|FG000|Overall Study|Lost to Follow-up|0|||
149830119|NCT05037097|540508175|FG001|Overall Study|Lost to Follow-up|1|||
149830120|NCT05037097|540508176|FG002|Overall Study|Lost to Follow-up|0|||
149830121|NCT05037097|540508177|FG003|Overall Study|Lost to Follow-up|0|||
149830122|NCT05037097|540508178|FG004|Overall Study|Lost to Follow-up|1|||
149830123|NCT05037097|540508179|FG005|Overall Study|Lost to Follow-up|1|||
149830124|NCT05037097|540508180|FG006|Overall Study|Lost to Follow-up|0|||
149830125|NCT05037097|540508181|FG007|Overall Study|Lost to Follow-up|0|||
149830126|NCT00376220|540508186|FG000|Overall Study|Lost to Follow-up|7|||
149830127|NCT00376220|540508187|FG001|Overall Study|Lost to Follow-up|10|||
149830128|NCT00376220|540508186|FG000|Overall Study|Withdrawal by Subject|3|||
149830129|NCT00376220|540508187|FG001|Overall Study|Withdrawal by Subject|2|||
149830130|NCT00920140|540508188|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
149830131|NCT00920140|540508189|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
149830132|NCT00920140|540508190|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
149830133|NCT00920140|540508191|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
149830134|NCT00920140|540508192|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
149830135|NCT00920140|540508188|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
149830136|NCT00920140|540508189|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
149830137|NCT00920140|540508190|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
149830138|NCT00920140|540508191|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
149830139|NCT00920140|540508192|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
149830140|NCT00920140|540508188|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149830141|NCT00920140|540508189|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
149830142|NCT00920140|540508190|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149830143|NCT00920140|540508191|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149830144|NCT00920140|540508192|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149830145|NCT00920140|540508188|FG000|Phase 2|Adverse Event|0|||
149830146|NCT00920140|540508189|FG001|Phase 2|Adverse Event|0|||
149830147|NCT00920140|540508190|FG002|Phase 2|Adverse Event|14|||
149830148|NCT00920140|540508191|FG003|Phase 2|Adverse Event|2|||
149830149|NCT00920140|540508192|FG004|Phase 2|Adverse Event|3|||
149830150|NCT00920140|540508188|FG000|Phase 2|Lack of Efficacy|0|||
149830151|NCT00920140|540508189|FG001|Phase 2|Lack of Efficacy|0|||
149830152|NCT00920140|540508190|FG002|Phase 2|Lack of Efficacy|29|||
149830153|NCT00920140|540508191|FG003|Phase 2|Lack of Efficacy|14|||
149830154|NCT00920140|540508192|FG004|Phase 2|Lack of Efficacy|5|||
149830155|NCT00920140|540508188|FG000|Phase 2|Lost to Follow-up|0|||
149830156|NCT00920140|540508189|FG001|Phase 2|Lost to Follow-up|0|||
149830157|NCT00920140|540508190|FG002|Phase 2|Lost to Follow-up|0|||
149830158|NCT00920140|540508191|FG003|Phase 2|Lost to Follow-up|1|||
149830159|NCT00920140|540508192|FG004|Phase 2|Lost to Follow-up|0|||
149830160|NCT00920140|540508188|FG000|Phase 2|Physician Decision|0|||
149830161|NCT00920140|540508189|FG001|Phase 2|Physician Decision|0|||
149830162|NCT00920140|540508190|FG002|Phase 2|Physician Decision|3|||
149830163|NCT00920140|540508191|FG003|Phase 2|Physician Decision|3|||
149830164|NCT00920140|540508192|FG004|Phase 2|Physician Decision|2|||
149830165|NCT00920140|540508188|FG000|Phase 2|Withdrawal by Subject|0|||
149830166|NCT00920140|540508189|FG001|Phase 2|Withdrawal by Subject|0|||
149830167|NCT00920140|540508190|FG002|Phase 2|Withdrawal by Subject|4|||
149830168|NCT00920140|540508191|FG003|Phase 2|Withdrawal by Subject|2|||
149830169|NCT00920140|540508192|FG004|Phase 2|Withdrawal by Subject|1|||
149830170|NCT01124149|540508193|FG000|Acute Phase|Withdrawal by Subject|22|||
149830171|NCT01124149|540508193|FG000|Acute Phase|Adverse Event|21|||
149830172|NCT01124149|540508193|FG000|Acute Phase|Lack of Efficacy|17|||
149830173|NCT01124149|540508193|FG000|Acute Phase|Protocol Violation|14|||
149830174|NCT01124149|540508193|FG000|Acute Phase|Lost to Follow-up|2|||
149830175|NCT01124149|540508193|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
149830176|NCT01124149|540508193|FG000|Acute Phase|Sponsor request|1|||
149830177|NCT01124149|540508193|FG000|Acute Phase|UC symptoms not ameliorated|1|||
149830178|NCT01124149|540508193|FG000|Acute Phase|Non-compliance|1|||
149830179|NCT01124149|540508193|FG000|Acute Phase|Low hemoglobin|1|||
149830180|NCT01124149|540508193|FG000|Acute Phase|Travelling to another country|1|||
150033442|NCT03780244|541262786|FG000|Overall Study|Lost to Follow-up|1|||
150033443|NCT03780244|541262787|FG001|Overall Study|Lost to Follow-up|0|||
150033444|NCT03175367|541262788|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
150033445|NCT03175367|541262789|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
150033446|NCT03175367|541262790|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
150033447|NCT03175367|541262791|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
150033448|NCT03175367|541262792|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
150033449|NCT03175367|541262793|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
150033450|NCT03175367|541262794|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
150033451|NCT03175367|541262788|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
150033452|NCT03175367|541262789|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
150033453|NCT03175367|541262790|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
150033454|NCT03175367|541262791|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
150033455|NCT03175367|541262792|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
150033456|NCT03175367|541262793|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
150033457|NCT03175367|541262794|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
150033458|NCT03175367|541262788|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
150033459|NCT03175367|541262789|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
150033460|NCT03175367|541262790|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
150033461|NCT03175367|541262791|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
150033462|NCT03175367|541262792|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
150033463|NCT03175367|541262793|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
150033464|NCT03175367|541262794|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
150033465|NCT03175367|541262788|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
150033466|NCT03175367|541262789|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
150033467|NCT03175367|541262790|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
150033468|NCT03175367|541262791|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
150033469|NCT03175367|541262792|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
150033470|NCT03175367|541262793|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
150033471|NCT03175367|541262794|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
150033472|NCT03175367|541262788|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150033473|NCT03175367|541262789|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150033474|NCT03175367|541262790|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
150033475|NCT03175367|541262791|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150033476|NCT03175367|541262792|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
150033477|NCT03175367|541262793|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150033478|NCT03175367|541262794|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150033479|NCT03175367|541262788|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033480|NCT03175367|541262789|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033481|NCT03175367|541262790|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033482|NCT03175367|541262791|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033483|NCT03175367|541262792|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033484|NCT03175367|541262793|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
150033485|NCT03175367|541262794|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
150033486|NCT03175367|541262788|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
149830181|NCT01124149|540508193|FG000|Acute Phase|Sponsor decision|1|||
149830182|NCT01124149|540508193|FG000|Maintenance Phase|Lack of Efficacy|40|||
149830183|NCT01124149|540508193|FG000|Maintenance Phase|Adverse Event|24|||
149830184|NCT01124149|540508193|FG000|Maintenance Phase|Lost to Follow-up|15|||
149830185|NCT01124149|540508193|FG000|Maintenance Phase|Withdrawal by Subject|10|||
149830186|NCT01124149|540508193|FG000|Maintenance Phase|Protocol Violation|5|||
149830187|NCT01124149|540508193|FG000|Maintenance Phase|Coordinator error|1|||
150033487|NCT03175367|541262789|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150033488|NCT03175367|541262790|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150033489|NCT03175367|541262791|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150033490|NCT03175367|541262792|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150033491|NCT03175367|541262793|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
150033492|NCT03175367|541262794|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
150033493|NCT03714672|541262799|FG000|Overall Study|Adverse Event|0|||
150170652|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149830188|NCT01124149|540508193|FG000|Maintenance Phase|Non-compliance|1|||
149830189|NCT00436007|540508200|FG000|Overall Study|Withdrawal by Subject|5|||
149830190|NCT00436007|540508201|FG001|Overall Study|Withdrawal by Subject|3|||
149830191|NCT00436007|540508202|FG002|Overall Study|Withdrawal by Subject|4|||
149830192|NCT00436007|540508200|FG000|Overall Study|Lost to Follow-up|14|||
149830193|NCT00436007|540508201|FG001|Overall Study|Lost to Follow-up|10|||
149830194|NCT00436007|540508202|FG002|Overall Study|Lost to Follow-up|13|||
149830195|NCT00436007|540508200|FG000|Overall Study|Physician Decision|0|||
149830196|NCT00436007|540508201|FG001|Overall Study|Physician Decision|0|||
149830197|NCT00436007|540508202|FG002|Overall Study|Physician Decision|2|||
149830198|NCT00436007|540508200|FG000|Overall Study|Death|0|||
149830199|NCT00436007|540508201|FG001|Overall Study|Death|1|||
149830200|NCT00436007|540508202|FG002|Overall Study|Death|3|||
149830201|NCT00436007|540508200|FG000|Overall Study|Other|0|||
149830202|NCT00436007|540508201|FG001|Overall Study|Other|0|||
149830203|NCT00436007|540508202|FG002|Overall Study|Other|1|||
149830204|NCT01439165|540508203|FG000|Overall Study|Protocol Violation|3|||
149830205|NCT01439165|540508204|FG001|Overall Study|Protocol Violation|0|||
149830206|NCT01439165|540508203|FG000|Overall Study|Lost to Follow-up|11|||
149830207|NCT01439165|540508204|FG001|Overall Study|Lost to Follow-up|1|||
149830208|NCT01439165|540508203|FG000|Overall Study|Withdrawal by Subject|7|||
149830209|NCT01439165|540508204|FG001|Overall Study|Withdrawal by Subject|1|||
149830210|NCT03331042|540508205|FG000|Overall Study|Protocol Violation|1|||
149947837|NCT02924376|540940413|FG003|Overall Study|Physician Decision|0|||
149947838|NCT02924376|540940410|FG000|Overall Study|Withdrawal by Subject|7|||
149947839|NCT02924376|540940411|FG001|Overall Study|Withdrawal by Subject|2|||
149947840|NCT02924376|540940412|FG002|Overall Study|Withdrawal by Subject|1|||
149830211|NCT03331042|540508206|FG001|Overall Study|Protocol Violation|0|||
149830212|NCT03331042|540508207|FG002|Overall Study|Protocol Violation|0|||
149830213|NCT03331042|540508208|FG003|Overall Study|Protocol Violation|0|||
149947841|NCT02924376|540940413|FG003|Overall Study|Withdrawal by Subject|0|||
149947842|NCT02924376|540940410|FG000|Overall Study|Rolled Over to Another Study|1|||
149947843|NCT02924376|540940411|FG001|Overall Study|Rolled Over to Another Study|0|||
149947844|NCT02924376|540940412|FG002|Overall Study|Rolled Over to Another Study|0|||
149947845|NCT02924376|540940413|FG003|Overall Study|Rolled Over to Another Study|0|||
149947846|NCT00770809|540941948|FG000|Overall Study|Adverse Event|9|||
149947847|NCT00770809|540941949|FG001|Overall Study|Adverse Event|1|||
149947848|NCT00770809|540941950|FG002|Overall Study|Adverse Event|12|||
149947849|NCT00770809|540941948|FG000|Overall Study|Death|1|||
149947850|NCT00770809|540941949|FG001|Overall Study|Death|0|||
149947851|NCT00770809|540941950|FG002|Overall Study|Death|0|||
149947852|NCT00770809|540941948|FG000|Overall Study|Withdrawal by Subject|3|||
149947853|NCT00770809|540941949|FG001|Overall Study|Withdrawal by Subject|3|||
149947854|NCT00770809|540941950|FG002|Overall Study|Withdrawal by Subject|7|||
149947855|NCT00770809|540941948|FG000|Overall Study|Progression|2|||
149947856|NCT00770809|540941949|FG001|Overall Study|Progression|2|||
149947857|NCT00770809|540941950|FG002|Overall Study|Progression|0|||
149947858|NCT00770809|540941948|FG000|Overall Study|Complicating illness|0|||
149947859|NCT00770809|540941949|FG001|Overall Study|Complicating illness|0|||
149947860|NCT00770809|540941950|FG002|Overall Study|Complicating illness|1|||
149947861|NCT00770809|540941948|FG000|Overall Study|Other Medical Reasons|2|||
149947862|NCT00770809|540941949|FG001|Overall Study|Other Medical Reasons|4|||
149947863|NCT00770809|540941950|FG002|Overall Study|Other Medical Reasons|3|||
149947864|NCT01787838|540941951|FG000|Overall Study|refused|1413|||
149947865|NCT05522751|540941957|FG000|Overall Study|Adverse Event|1|||
149947866|NCT06420232|540941958|FG000|Overall Study|Withdrawal by Subject|3|||
149947867|NCT01582451|540941964|FG000|Overall Study|Adverse Event|1|||
149947868|NCT01582451|540941965|FG001|Overall Study|Adverse Event|3|||
149947869|NCT01582451|540941964|FG000|Overall Study|Death|3|||
149947870|NCT01582451|540941965|FG001|Overall Study|Death|3|||
149947871|NCT01582451|540941964|FG000|Overall Study|Lost to Follow-up|0|||
149947872|NCT01582451|540941965|FG001|Overall Study|Lost to Follow-up|2|||
149947873|NCT01582451|540941964|FG000|Overall Study|Protocol Violation|11|||
149947874|NCT01582451|540941965|FG001|Overall Study|Protocol Violation|3|||
149947875|NCT01582451|540941964|FG000|Overall Study|Withdrawal by Subject|13|||
149947876|NCT01582451|540941965|FG001|Overall Study|Withdrawal by Subject|9|||
149947877|NCT01582451|540941964|FG000|Overall Study|Physician Decision|3|||
149947878|NCT01582451|540941965|FG001|Overall Study|Physician Decision|0|||
149947879|NCT01582451|540941964|FG000|Overall Study|Sponsor Decision|1|||
149947880|NCT01582451|540941965|FG001|Overall Study|Sponsor Decision|0|||
149947881|NCT01838876|540941966|FG000|Overall Study|Adverse Event|49|||
149947882|NCT01838876|540941966|FG000|Overall Study|Insufficient Therapeutic Response|10|||
149947883|NCT01838876|540941966|FG000|Overall Study|Protocol Violation|34|||
149947884|NCT01838876|540941966|FG000|Overall Study|Withdrawal of Consent|33|||
149947885|NCT01838876|540941966|FG000|Overall Study|Lost to Follow-up|21|||
149947886|NCT01838876|540941966|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
149947887|NCT01838876|540941966|FG000|Overall Study|Reason not Specified|7|||
149947888|NCT01838876|540941966|FG000|Overall Study|Did not meet eligibility criteria|78|||
149947889|NCT00689936|540941967|FG000|Active Treatment Phase|Adverse Event|68|||
149947890|NCT00689936|540941968|FG001|Active Treatment Phase|Adverse Event|71|||
149947891|NCT00689936|540941969|FG002|Active Treatment Phase|Adverse Event|76|||
149830214|NCT03331042|540508205|FG000|Overall Study|Physician Decision|0|||
149830215|NCT03331042|540508206|FG001|Overall Study|Physician Decision|0|||
149947892|NCT00689936|540941967|FG000|Active Treatment Phase|Disease Progression|273|||
149830216|NCT03331042|540508207|FG002|Overall Study|Physician Decision|1|||
149830217|NCT03331042|540508208|FG003|Overall Study|Physician Decision|0|||
150033494|NCT03714672|541262800|FG001|Overall Study|Adverse Event|0|||
150033495|NCT03714672|541262801|FG002|Overall Study|Adverse Event|3|||
150033496|NCT03714672|541262802|FG003|Overall Study|Adverse Event|0|||
150033497|NCT03714672|541262799|FG000|Overall Study|Physician Decision|0|||
150033498|NCT03714672|541262800|FG001|Overall Study|Physician Decision|1|||
150033499|NCT03714672|541262801|FG002|Overall Study|Physician Decision|0|||
150033500|NCT03714672|541262802|FG003|Overall Study|Physician Decision|0|||
150033501|NCT03714672|541262799|FG000|Overall Study|Other Reason|1|||
150033502|NCT03714672|541262800|FG001|Overall Study|Other Reason|2|||
150033503|NCT03714672|541262801|FG002|Overall Study|Other Reason|1|||
150033504|NCT03714672|541262802|FG003|Overall Study|Other Reason|1|||
150033505|NCT03714672|541262799|FG000|Overall Study|Lost to Follow-up|1|||
150033506|NCT03714672|541262800|FG001|Overall Study|Lost to Follow-up|1|||
150033507|NCT03714672|541262801|FG002|Overall Study|Lost to Follow-up|0|||
150033508|NCT03714672|541262802|FG003|Overall Study|Lost to Follow-up|0|||
150033509|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
150033510|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033511|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033512|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033513|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033514|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033515|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150033516|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
150033517|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033518|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033519|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033520|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033521|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033522|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
150033523|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
150033524|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033525|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033526|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033527|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033528|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033529|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150033530|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
150033531|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033532|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033533|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033534|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033535|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033536|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150033537|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
150033538|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033539|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033540|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033541|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033542|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033543|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
150033544|NCT01054885|541262806|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
150033545|NCT01054885|541262807|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033546|NCT01054885|541262808|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033547|NCT01054885|541262809|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033548|NCT01054885|541262810|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033549|NCT01054885|541262811|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033550|NCT01054885|541262812|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150033551|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
150033552|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
150033553|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
150033554|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
150033555|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
150033556|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
150033557|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
150033558|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150033559|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150276430|NCT01236573|542149974|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150033560|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
150033561|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
150033562|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150033563|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
150033564|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150033565|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
150033566|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
150033567|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
150033568|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
150033569|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
150033570|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
150033571|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
150033572|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
150033573|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
150033574|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
150033575|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
150033576|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
150033577|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
150033578|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
150033579|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
150033580|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
150033581|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
150033582|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
150033583|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
150033584|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
150033585|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
150033586|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
150033587|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
150033588|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
149830218|NCT03331042|540508205|FG000|Overall Study|Lost to Follow-up|0|||
149830219|NCT03331042|540508206|FG001|Overall Study|Lost to Follow-up|0|||
149830220|NCT03331042|540508207|FG002|Overall Study|Lost to Follow-up|0|||
149830221|NCT03331042|540508208|FG003|Overall Study|Lost to Follow-up|1|||
150033589|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
150033590|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
150033591|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
150033592|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
150276431|NCT01236573|542149975|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276432|NCT01236573|542149976|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276433|NCT01236573|542149977|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276434|NCT01236573|542149978|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276435|NCT01236573|542149979|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
150276436|NCT01236573|542149980|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276437|NCT01236573|542149981|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
150276438|NCT01236573|542149971|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276439|NCT01236573|542149972|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276440|NCT01236573|542149973|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276441|NCT01236573|542149974|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276442|NCT01236573|542149975|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276443|NCT01236573|542149976|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276444|NCT01236573|542149977|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276445|NCT01236573|542149978|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276446|NCT01236573|542149979|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276447|NCT01236573|542149980|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
150276448|NCT01236573|542149981|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
149830222|NCT00688064|540508212|FG000|Overall Study|Protocol Violation|0|||
149830223|NCT00688064|540508213|FG001|Overall Study|Protocol Violation|1|||
149830224|NCT00688064|540508212|FG000|Overall Study|Adverse Event|2|||
149830225|NCT00688064|540508213|FG001|Overall Study|Adverse Event|4|||
149830226|NCT00688064|540508212|FG000|Overall Study|Withdrawal by Subject|7|||
149830227|NCT00688064|540508213|FG001|Overall Study|Withdrawal by Subject|7|||
149830228|NCT00688064|540508212|FG000|Overall Study|Lost to Follow-up|10|||
149830229|NCT00688064|540508213|FG001|Overall Study|Lost to Follow-up|10|||
149830230|NCT00688064|540508212|FG000|Overall Study|Lack of Efficacy|0|||
150033593|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150033594|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
150033595|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
150033596|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150033597|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150033598|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
150033599|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
150033600|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
150033601|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
150033602|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
150033603|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
150033604|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
150033605|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
150033606|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
150033607|NCT01054885|541262806|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
150033608|NCT01054885|541262807|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
150033609|NCT01054885|541262808|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
150033610|NCT01054885|541262809|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
150033611|NCT01054885|541262810|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
150033612|NCT01054885|541262811|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
150033613|NCT01054885|541262812|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
150033614|NCT00804908|541262813|FG000|Overall Study|Other|115|||
150033615|NCT00804908|541262814|FG001|Overall Study|Other|116|||
150033616|NCT00804908|541262815|FG002|Overall Study|Other|114|||
150033617|NCT03085095|541262817|FG000|Overall Study|Adverse Event|23|||
150033618|NCT03085095|541262818|FG001|Overall Study|Adverse Event|8|||
150033619|NCT03085095|541262817|FG000|Overall Study|Protocol Violation|0|||
150033620|NCT03085095|541262818|FG001|Overall Study|Protocol Violation|1|||
150033621|NCT03085095|541262817|FG000|Overall Study|Lost to Follow-up|2|||
150033622|NCT03085095|541262818|FG001|Overall Study|Lost to Follow-up|1|||
150033623|NCT03085095|541262817|FG000|Overall Study|Withdrawal by Subject|17|||
150033624|NCT03085095|541262818|FG001|Overall Study|Withdrawal by Subject|6|||
150033625|NCT03085095|541262817|FG000|Overall Study|Physician Decision|9|||
150033626|NCT03085095|541262818|FG001|Overall Study|Physician Decision|3|||
150033627|NCT03085095|541262817|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
150033628|NCT03085095|541262818|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
150033629|NCT03085095|541262817|FG000|Overall Study|Did not Receive Study Drug|2|||
150033630|NCT03085095|541262818|FG001|Overall Study|Did not Receive Study Drug|2|||
150033631|NCT03085095|541262817|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
150033632|NCT03085095|541262818|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
150033633|NCT03459079|541262820|FG000|Overall Study|Adverse Event|4|||
150033634|NCT03459079|541262821|FG001|Overall Study|Adverse Event|2|||
150033635|NCT03459079|541262822|FG002|Overall Study|Adverse Event|0|||
150033636|NCT03459079|541262820|FG000|Overall Study|Withdrawal by Subject|2|||
150033637|NCT03459079|541262821|FG001|Overall Study|Withdrawal by Subject|2|||
150033638|NCT03459079|541262822|FG002|Overall Study|Withdrawal by Subject|0|||
150033639|NCT00674817|541262823|FG000|Period 1|Withdrawal by Subject|2|||
150033640|NCT00674817|541262823|FG000|Period 1|Protocol Violation|1|||
150033641|NCT00674817|541262823|FG000|Period 3|Adverse Event|1|||
150033642|NCT00674817|541262823|FG000|Period 3|Protocol Violation|1|||
150033643|NCT00674817|541262823|FG000|Period 4|Adverse Event|1|||
150033644|NCT02379728|541262824|FG000|Overall Study|Lost to Follow-up|1|||
150033645|NCT02379728|541262825|FG001|Overall Study|Lost to Follow-up|0|||
150033646|NCT02379728|541262826|FG002|Overall Study|Lost to Follow-up|3|||
150033647|NCT02379728|541262827|FG003|Overall Study|Lost to Follow-up|0|||
150033648|NCT02379728|541262824|FG000|Overall Study|Withdrawal by Subject|5|||
150033649|NCT02379728|541262825|FG001|Overall Study|Withdrawal by Subject|0|||
150276449|NCT02665052|542149982|FG000|Overall Study|Lost to Follow-up|1|||
150276450|NCT02665052|542149983|FG001|Overall Study|Lost to Follow-up|0|||
150276451|NCT02665052|542149984|FG002|Overall Study|Lost to Follow-up|0|||
150276452|NCT02665052|542149985|FG003|Overall Study|Lost to Follow-up|0|||
150276453|NCT02665052|542149982|FG000|Overall Study|Withdrawal by Subject|1|||
149947893|NCT00689936|540941968|FG001|Active Treatment Phase|Disease Progression|362|||
149947894|NCT00689936|540941969|FG002|Active Treatment Phase|Disease Progression|339|||
149947895|NCT00689936|540941967|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
149947896|NCT00689936|540941968|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
149947897|NCT00689936|540941969|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
149947898|NCT00689936|540941967|FG000|Active Treatment Phase|Death|60|||
149947899|NCT00689936|540941968|FG001|Active Treatment Phase|Death|28|||
149947900|NCT00689936|540941969|FG002|Active Treatment Phase|Death|37|||
150033650|NCT02379728|541262826|FG002|Overall Study|Withdrawal by Subject|5|||
150276454|NCT02665052|542149983|FG001|Overall Study|Withdrawal by Subject|1|||
149947901|NCT00689936|540941967|FG000|Active Treatment Phase|Lost to Follow-up|0|||
150276455|NCT02665052|542149984|FG002|Overall Study|Withdrawal by Subject|0|||
150276456|NCT02665052|542149985|FG003|Overall Study|Withdrawal by Subject|5|||
150276457|NCT02665052|542149982|FG000|Overall Study|Adverse Event|1|||
150276458|NCT02665052|542149983|FG001|Overall Study|Adverse Event|1|||
150276459|NCT02665052|542149984|FG002|Overall Study|Adverse Event|0|||
150276460|NCT02665052|542149985|FG003|Overall Study|Adverse Event|0|||
150276461|NCT00823823|542149986|FG000|Overall Study|Lost to Follow-up|3|||
150276462|NCT00823823|542149987|FG001|Overall Study|Lost to Follow-up|1|||
150276463|NCT00823823|542149986|FG000|Overall Study|Protocol Violation|5|||
150276464|NCT00823823|542149987|FG001|Overall Study|Protocol Violation|5|||
150276465|NCT02234284|542149988|FG000|Overall Study|Death|4|||
150276466|NCT02234284|542149989|FG001|Overall Study|Death|2|||
150276467|NCT02234284|542149988|FG000|Overall Study|Withdrawal by Subject|1|||
150276468|NCT02234284|542149989|FG001|Overall Study|Withdrawal by Subject|0|||
150276469|NCT02234284|542149988|FG000|Overall Study|Lost to Follow-up|20|||
150276470|NCT02234284|542149989|FG001|Overall Study|Lost to Follow-up|7|||
150276471|NCT00536809|542149990|FG000|Phase II|Adverse Event|1|||
150276472|NCT00536809|542149990|FG000|Phase II|Referred for surgical resection|1|||
150276473|NCT04569032|542149991|FG000|Overall Study|Death|10|||
150276474|NCT04569032|542149992|FG001|Overall Study|Death|13|||
150276475|NCT04569032|542149991|FG000|Overall Study|Withdrawal by Subject|2|||
150276476|NCT04569032|542149992|FG001|Overall Study|Withdrawal by Subject|0|||
150276477|NCT04569032|542149991|FG000|Overall Study|Lost to Follow-up|0|||
150276478|NCT04569032|542149992|FG001|Overall Study|Lost to Follow-up|1|||
150276479|NCT04569032|542149991|FG000|Overall Study|In long term follow up|22|||
150276480|NCT04569032|542149992|FG001|Overall Study|In long term follow up|34|||
150276481|NCT02247960|542150002|FG000|Patient Consent and Randomization|Physician Decision|2|||
150276482|NCT02247960|542150003|FG001|Patient Consent and Randomization|Physician Decision|2|||
150276483|NCT02247960|542150002|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
150276484|NCT02247960|542150003|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
150276485|NCT02247960|542150002|FG000|Catheter Removed|Lost to Follow-up|7|||
150276486|NCT02247960|542150003|FG001|Catheter Removed|Lost to Follow-up|10|||
150276487|NCT03123250|542150007|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
150276488|NCT02361944|542150008|FG000|Overall Study|surgery cancellation|0|||
150276489|NCT02361944|542150009|FG001|Overall Study|surgery cancellation|1|||
150276490|NCT04340557|542150010|FG000|Overall Study|Transferred to ICU and/or death|1|||
149947902|NCT00689936|540941968|FG001|Active Treatment Phase|Lost to Follow-up|2|||
149947903|NCT00689936|540941969|FG002|Active Treatment Phase|Lost to Follow-up|2|||
149947904|NCT00689936|540941967|FG000|Active Treatment Phase|Protocol Violation|2|||
149947905|NCT00689936|540941968|FG001|Active Treatment Phase|Protocol Violation|2|||
149947906|NCT00689936|540941969|FG002|Active Treatment Phase|Protocol Violation|4|||
149947907|NCT00689936|540941967|FG000|Active Treatment Phase|Study Close Out|64|||
149947908|NCT00689936|540941968|FG001|Active Treatment Phase|Study Close Out|26|||
149947909|NCT00689936|540941969|FG002|Active Treatment Phase|Study Close Out|21|||
149947910|NCT00689936|540941967|FG000|Active Treatment Phase|Miscellaneous|52|||
149947911|NCT00689936|540941968|FG001|Active Treatment Phase|Miscellaneous|34|||
149947912|NCT00689936|540941969|FG002|Active Treatment Phase|Miscellaneous|47|||
149947913|NCT00689936|540941967|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
149947914|NCT00689936|540941968|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
149947915|NCT00689936|540941969|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
149947916|NCT01682031|540941970|FG000|Overall Study|Withdrawal by Subject|0|||
149947917|NCT01682031|540941971|FG001|Overall Study|Withdrawal by Subject|1|||
149947918|NCT01682031|540941970|FG000|Overall Study|Adverse Event|0|||
149947919|NCT01682031|540941971|FG001|Overall Study|Adverse Event|2|||
149947920|NCT01682031|540941970|FG000|Overall Study|MRI results indicate increased nodul|0|||
149947921|NCT01682031|540941971|FG001|Overall Study|MRI results indicate increased nodul|1|||
149947922|NCT01682031|540941970|FG000|Overall Study|Patient could not swallow tablets|1|||
149947923|NCT01682031|540941971|FG001|Overall Study|Patient could not swallow tablets|0|||
149947924|NCT01682031|540941970|FG000|Overall Study|Patient stopped selenium on his own|0|||
150276491|NCT04340557|542150011|FG001|Overall Study|Transferred to ICU and/or death|2|||
150276492|NCT00773136|542150012|FG000|Overall Study|Physician Decision|2|||
150276493|NCT02463071|542150016|FG000|Overall Study|Adverse Event|3|||
150276494|NCT02463071|542150017|FG001|Overall Study|Adverse Event|5|||
150276495|NCT02463071|542150018|FG002|Overall Study|Adverse Event|1|||
150276496|NCT02463071|542150016|FG000|Overall Study|Death|1|||
150276497|NCT02463071|542150017|FG001|Overall Study|Death|0|||
150276498|NCT02463071|542150018|FG002|Overall Study|Death|0|||
150276499|NCT02463071|542150016|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
150276500|NCT02463071|542150017|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149830231|NCT00688064|540508213|FG001|Overall Study|Lack of Efficacy|1|||
149947925|NCT01682031|540941971|FG001|Overall Study|Patient stopped selenium on his own|1|||
149947926|NCT04092777|540941974|FG000|Overall Study|Lost to Follow-up|28|||
149947927|NCT04092777|540941975|FG001|Overall Study|Lost to Follow-up|46|||
150276501|NCT02463071|542150018|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
150276502|NCT02463071|542150016|FG000|Overall Study|Reason not specified|7|||
150276503|NCT02463071|542150017|FG001|Overall Study|Reason not specified|9|||
149830232|NCT00688064|540508212|FG000|Overall Study|Pregnancy|1|||
149830233|NCT00688064|540508213|FG001|Overall Study|Pregnancy|0|||
149830234|NCT00688064|540508212|FG000|Overall Study|Any other reasons|1|||
149830235|NCT00688064|540508213|FG001|Overall Study|Any other reasons|3|||
149830236|NCT05518487|540508214|FG000|Overall Study|Withdrawal by Subject|3|||
149830237|NCT02194998|540508219|FG000|On-HCV Treatment|Did not pick up study medication|0|||
149830238|NCT02194998|540508220|FG001|On-HCV Treatment|Did not pick up study medication|1|||
149830239|NCT02194998|540508221|FG002|On-HCV Treatment|Did not pick up study medication|0|||
149830240|NCT02194998|540508222|FG003|On-HCV Treatment|Did not pick up study medication|0|||
149830241|NCT02194998|540508219|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
149830242|NCT02194998|540508220|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
149830243|NCT02194998|540508221|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
149830244|NCT02194998|540508222|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
149830245|NCT01458405|540508223|FG000|Phase 1 (up to 12 Months)|Other|0|||
149830246|NCT01458405|540508224|FG001|Phase 1 (up to 12 Months)|Other|1|||
149830247|NCT01458405|540508225|FG002|Phase 1 (up to 12 Months)|Other|0|||
149830248|NCT01458405|540508226|FG003|Phase 1 (up to 12 Months)|Other|0|||
149830249|NCT01458405|540508223|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
149830250|NCT01458405|540508224|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
149830251|NCT01458405|540508225|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
149830252|NCT01458405|540508226|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
149830253|NCT01458405|540508223|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
149830254|NCT01458405|540508224|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
149830255|NCT01458405|540508225|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
149830256|NCT01458405|540508226|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
149947928|NCT04092777|540941974|FG000|Overall Study|Withdrawal by Subject|8|||
149947929|NCT04092777|540941975|FG001|Overall Study|Withdrawal by Subject|5|||
149947930|NCT03330197|540941978|FG000|Overall Study|Adverse Event|0|||
149947931|NCT03330197|540941979|FG001|Overall Study|Adverse Event|1|||
149947932|NCT03330197|540941978|FG000|Overall Study|Withdrawal by Subject|0|||
149947933|NCT03330197|540941979|FG001|Overall Study|Withdrawal by Subject|1|||
149947934|NCT00876343|540941980|FG000|Overall Study|Adverse Event|7|||
149947935|NCT00876343|540941981|FG001|Overall Study|Adverse Event|8|||
149947936|NCT00876343|540941982|FG002|Overall Study|Adverse Event|2|||
149947937|NCT00876343|540941980|FG000|Overall Study|Withdrawal by Subject|4|||
149947938|NCT00876343|540941981|FG001|Overall Study|Withdrawal by Subject|4|||
149947939|NCT00876343|540941982|FG002|Overall Study|Withdrawal by Subject|3|||
149947940|NCT00876343|540941980|FG000|Overall Study|Lack of Efficacy|0|||
149947941|NCT00876343|540941981|FG001|Overall Study|Lack of Efficacy|0|||
149947942|NCT00876343|540941982|FG002|Overall Study|Lack of Efficacy|1|||
149947943|NCT00876343|540941980|FG000|Overall Study|Protocol Violation|4|||
149947944|NCT00876343|540941981|FG001|Overall Study|Protocol Violation|1|||
149947945|NCT00876343|540941982|FG002|Overall Study|Protocol Violation|1|||
149947946|NCT00876343|540941980|FG000|Overall Study|Physician Decision|0|||
149947947|NCT00876343|540941981|FG001|Overall Study|Physician Decision|1|||
149947948|NCT00876343|540941982|FG002|Overall Study|Physician Decision|1|||
149947949|NCT00876343|540941980|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
149947950|NCT00876343|540941981|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
149947951|NCT00876343|540941982|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
149947952|NCT00876343|540941980|FG000|Overall Study|Change of residence or other commitments|2|||
149947953|NCT00876343|540941981|FG001|Overall Study|Change of residence or other commitments|2|||
149947954|NCT00876343|540941982|FG002|Overall Study|Change of residence or other commitments|3|||
149947955|NCT00005047|540941987|FG000|Overall Study|Withdrawal by Subject|12|||
149947956|NCT00005047|540941988|FG001|Overall Study|Withdrawal by Subject|0|||
149947957|NCT00005047|540941989|FG002|Overall Study|Withdrawal by Subject|0|||
149947958|NCT00005047|540941990|FG003|Overall Study|Withdrawal by Subject|0|||
149947959|NCT00005047|540941987|FG000|Overall Study|Adverse Event|5|||
149947960|NCT00005047|540941988|FG001|Overall Study|Adverse Event|0|||
149947961|NCT00005047|540941989|FG002|Overall Study|Adverse Event|0|||
149947962|NCT00005047|540941990|FG003|Overall Study|Adverse Event|0|||
149947963|NCT00005047|540941987|FG000|Overall Study|Lost to Follow-up|1|||
149947964|NCT00005047|540941988|FG001|Overall Study|Lost to Follow-up|0|||
149947965|NCT00005047|540941989|FG002|Overall Study|Lost to Follow-up|0|||
149830257|NCT01458405|540508223|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
150276504|NCT02463071|542150018|FG002|Overall Study|Reason not specified|4|||
149830258|NCT01458405|540508224|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
149947966|NCT00005047|540941990|FG003|Overall Study|Lost to Follow-up|0|||
149947967|NCT00005047|540941987|FG000|Overall Study|Lack of Efficacy|1|||
149947968|NCT00005047|540941988|FG001|Overall Study|Lack of Efficacy|0|||
149947969|NCT00005047|540941989|FG002|Overall Study|Lack of Efficacy|0|||
149947970|NCT00005047|540941990|FG003|Overall Study|Lack of Efficacy|0|||
149947971|NCT04435626|540941993|FG000|Overall Study|Lost to Follow-up|1|||
149947972|NCT04435626|540941994|FG001|Overall Study|Lost to Follow-up|5|||
149947973|NCT04435626|540941993|FG000|Overall Study|Withdrawal by Subject|6|||
149830259|NCT01458405|540508225|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
149830260|NCT01458405|540508226|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
149830261|NCT02497781|540508227|FG000|Overall Study|Withdrawal by Subject|2|||
149830262|NCT02497781|540508228|FG001|Overall Study|Withdrawal by Subject|0|||
149830263|NCT02497781|540508227|FG000|Overall Study|Lack of Efficacy|0|||
149830264|NCT02497781|540508228|FG001|Overall Study|Lack of Efficacy|1|||
149830265|NCT02497781|540508227|FG000|Overall Study|Randomised but not treated|1|||
149830266|NCT02497781|540508228|FG001|Overall Study|Randomised but not treated|1|||
149830267|NCT02497781|540508227|FG000|Overall Study|Lost to Follow-up|1|||
149830268|NCT02497781|540508228|FG001|Overall Study|Lost to Follow-up|1|||
149830269|NCT02236130|540508229|FG000|Overall Study|Lost to Follow-up|7|||
149830270|NCT02236130|540508230|FG001|Overall Study|Lost to Follow-up|12|||
149830271|NCT00525590|540508231|FG000|Overall Study|Adverse Event|3|||
149830272|NCT00525590|540508231|FG000|Overall Study|Physician Decision|3|||
149830273|NCT00525590|540508231|FG000|Overall Study|Withdrawal by Subject|16|||
149830274|NCT00525590|540508231|FG000|Overall Study|Lost to Follow-up|1|||
149830275|NCT00525590|540508231|FG000|Overall Study|Death|9|||
149830276|NCT00525590|540508231|FG000|Overall Study|Other|13|||
149830277|NCT04276883|540508232|FG000|Overall Study|Withdrawal by Subject|2|||
149830278|NCT04276883|540508233|FG001|Overall Study|Withdrawal by Subject|3|||
150276505|NCT02463071|542150016|FG000|Overall Study|Protocol Violation|0|||
150276506|NCT02463071|542150017|FG001|Overall Study|Protocol Violation|2|||
150276507|NCT02463071|542150018|FG002|Overall Study|Protocol Violation|0|||
150276508|NCT02463071|542150016|FG000|Overall Study|Lost to Follow-up|0|||
150276509|NCT02463071|542150017|FG001|Overall Study|Lost to Follow-up|0|||
150276510|NCT02463071|542150018|FG002|Overall Study|Lost to Follow-up|1|||
150276511|NCT03086057|542150019|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
150276512|NCT03086057|542150020|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
150276513|NCT03086057|542150021|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
150276514|NCT03086057|542150022|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
150276515|NCT03086057|542150019|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
150276516|NCT03086057|542150020|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
149830279|NCT04276883|540508234|FG002|Overall Study|Withdrawal by Subject|6|||
149830280|NCT04276883|540508232|FG000|Overall Study|Lost to Follow-up|1|||
149830281|NCT04276883|540508233|FG001|Overall Study|Lost to Follow-up|3|||
149830282|NCT04276883|540508234|FG002|Overall Study|Lost to Follow-up|0|||
149830283|NCT04276883|540508232|FG000|Overall Study|Adverse Event|0|||
149830284|NCT04276883|540508233|FG001|Overall Study|Adverse Event|1|||
149830285|NCT04276883|540508234|FG002|Overall Study|Adverse Event|0|||
149830286|NCT04276883|540508232|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
149830287|NCT04276883|540508233|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
150276517|NCT03086057|542150021|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
150276518|NCT03086057|542150022|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
150276519|NCT03086057|542150019|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
150276520|NCT03086057|542150020|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
150276521|NCT03086057|542150021|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
150276522|NCT03086057|542150022|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
150276523|NCT03086057|542150019|FG000|Stage 1: PrEP Uptake|Death|1|||
150276524|NCT03086057|542150020|FG001|Stage 1: PrEP Uptake|Death|0|||
150276525|NCT03086057|542150021|FG002|Stage 1: PrEP Uptake|Death|0|||
150276526|NCT03086057|542150022|FG003|Stage 1: PrEP Uptake|Death|0|||
150276527|NCT03086057|542150019|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
150276528|NCT03086057|542150020|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
150276529|NCT03086057|542150021|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
150276530|NCT03086057|542150022|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
150276531|NCT03086057|542150019|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
150276532|NCT03086057|542150020|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
150276533|NCT03086057|542150021|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
149947974|NCT04435626|540941994|FG001|Overall Study|Withdrawal by Subject|7|||
149947975|NCT04435626|540941993|FG000|Overall Study|major GCP violations|8|||
150276534|NCT03086057|542150022|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
150276535|NCT03086057|542150019|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
150276536|NCT03086057|542150020|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
150276537|NCT03086057|542150021|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
150276538|NCT03086057|542150022|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
150276539|NCT02941926|542150023|FG000|Core Phase|Progressive disease|1109|||
150276540|NCT02941926|542150023|FG000|Core Phase|Adverse Event|504|||
150276541|NCT02941926|542150023|FG000|Core Phase|Subject/guardian decision|127|||
150276542|NCT02941926|542150023|FG000|Core Phase|Physician Decision|112|||
150276543|NCT02941926|542150023|FG000|Core Phase|Death|46|||
149830288|NCT04276883|540508234|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
149830289|NCT00320112|540508235|FG000|Overall Study|Lost to Follow-up|3|||
149830290|NCT00320112|540508236|FG001|Overall Study|Lost to Follow-up|4|||
149830291|NCT00320112|540508235|FG000|Overall Study|Withdrawal by Subject|3|||
149830292|NCT00320112|540508236|FG001|Overall Study|Withdrawal by Subject|0|||
149830293|NCT00320112|540508235|FG000|Overall Study|Death|2|||
149830294|NCT00320112|540508236|FG001|Overall Study|Death|1|||
149947976|NCT04435626|540941994|FG001|Overall Study|major GCP violations|7|||
150276544|NCT02941926|542150023|FG000|Core Phase|Protocol deviation|34|||
150276545|NCT02941926|542150023|FG000|Core Phase|Lost to Follow-up|8|||
150276546|NCT02941926|542150023|FG000|Core Phase|Technical problems|5|||
150276547|NCT02941926|542150023|FG000|Extension Phase|Physician Decision|155|||
150276548|NCT02941926|542150023|FG000|Extension Phase|Progressive disease|115|||
150276549|NCT02941926|542150023|FG000|Extension Phase|Adverse Event|13|||
150276550|NCT02941926|542150023|FG000|Extension Phase|Subject/Guardian decision|12|||
150276551|NCT02941926|542150023|FG000|Extension Phase|Death|6|||
150276552|NCT04305275|542150024|FG000|Overall Study|Adverse Event|4|||
150276553|NCT04305275|542150025|FG001|Overall Study|Adverse Event|0|||
150276554|NCT04305275|542150024|FG000|Overall Study|Lost to Follow-up|1|||
150276555|NCT04305275|542150025|FG001|Overall Study|Lost to Follow-up|1|||
150276556|NCT04305275|542150024|FG000|Overall Study|Withdrawal by Participant|8|||
150276557|NCT04305275|542150025|FG001|Overall Study|Withdrawal by Participant|1|||
150276558|NCT00199836|542150027|FG000|Overall Study|Progressive Disease|5|||
150276559|NCT00199836|542150027|FG000|Overall Study|Death|1|||
150276560|NCT02243865|542150028|FG000|Overall Study|Protocol Violation|1|||
150276561|NCT02243865|542150029|FG001|Overall Study|Protocol Violation|3|||
150276562|NCT02243865|542150028|FG000|Overall Study|Lost to Follow-up|1|||
149947977|NCT01771107|540941997|FG000|Overall Study|Adverse Event|1|||
149947978|NCT01771107|540941998|FG001|Overall Study|Adverse Event|3|||
149947979|NCT01771107|540941997|FG000|Overall Study|Withdrawal by Subject|0|||
149947980|NCT01771107|540941998|FG001|Overall Study|Withdrawal by Subject|2|||
149947981|NCT01771107|540941997|FG000|Overall Study|Lost to Follow-up|0|||
149947982|NCT01771107|540941998|FG001|Overall Study|Lost to Follow-up|1|||
149947983|NCT01771107|540941997|FG000|Overall Study|participant moved|0|||
149947984|NCT01771107|540941998|FG001|Overall Study|participant moved|1|||
149947985|NCT01771107|540941997|FG000|Overall Study|Other|0|||
149947986|NCT01771107|540941998|FG001|Overall Study|Other|1|||
149947987|NCT01160614|540942003|FG000|Overall Study|Withdrawal by Subject|0|||
149947988|NCT01160614|540942004|FG001|Overall Study|Withdrawal by Subject|2|||
149947989|NCT03805841|540942005|FG000|Overall Study|Clinical Progression|2|||
149947990|NCT03805841|540942006|FG001|Overall Study|Clinical Progression|0|||
149947991|NCT03805841|540942007|FG002|Overall Study|Clinical Progression|0|||
149947992|NCT03805841|540942005|FG000|Overall Study|Death|0|||
149947993|NCT03805841|540942006|FG001|Overall Study|Death|3|||
149947994|NCT03805841|540942007|FG002|Overall Study|Death|1|||
149947995|NCT03805841|540942005|FG000|Overall Study|Lost to Follow-up|0|||
149947996|NCT03805841|540942006|FG001|Overall Study|Lost to Follow-up|0|||
149947997|NCT03805841|540942007|FG002|Overall Study|Lost to Follow-up|1|||
149947998|NCT03805841|540942005|FG000|Overall Study|Withdrawal by Subject|2|||
149947999|NCT03805841|540942006|FG001|Overall Study|Withdrawal by Subject|3|||
149948000|NCT03805841|540942007|FG002|Overall Study|Withdrawal by Subject|0|||
149948001|NCT03805841|540942005|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
149948002|NCT03805841|540942006|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
149948003|NCT03805841|540942007|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
149948004|NCT05248386|540942008|FG000|Overall Study|Technical problems|0|||
149948005|NCT05248386|540942009|FG001|Overall Study|Technical problems|1|||
149948006|NCT05248386|540942008|FG000|Overall Study|Withdrawal by Subject|15|||
149948007|NCT05248386|540942009|FG001|Overall Study|Withdrawal by Subject|10|||
149948008|NCT05248386|540942008|FG000|Overall Study|Physician Decision|0|||
149948009|NCT05248386|540942009|FG001|Overall Study|Physician Decision|1|||
149948010|NCT05248386|540942008|FG000|Overall Study|Adverse Event|2|||
149948011|NCT05248386|540942009|FG001|Overall Study|Adverse Event|4|||
149948012|NCT05248386|540942008|FG000|Overall Study|Other|1|||
149948013|NCT05248386|540942009|FG001|Overall Study|Other|0|||
149948014|NCT05248386|540942008|FG000|Overall Study|Lack of Efficacy|14|||
149948015|NCT05248386|540942009|FG001|Overall Study|Lack of Efficacy|12|||
149948016|NCT03621592|540942013|FG000|Overall Study|Lost to Follow-up|1|||
150276563|NCT02243865|542150029|FG001|Overall Study|Lost to Follow-up|1|||
149948017|NCT03621592|540942014|FG001|Overall Study|Lost to Follow-up|0|||
149948018|NCT03621592|540942013|FG000|Overall Study|Lack of Improvement|1|||
149948019|NCT03621592|540942014|FG001|Overall Study|Lack of Improvement|0|||
149948020|NCT03621592|540942013|FG000|Overall Study|Preference to receive wound care closer to home|1|||
149948021|NCT03621592|540942014|FG001|Overall Study|Preference to receive wound care closer to home|0|||
150276564|NCT02243865|542150028|FG000|Overall Study|Withdrawal by Subject|1|||
150276565|NCT02243865|542150029|FG001|Overall Study|Withdrawal by Subject|0|||
149948022|NCT03621592|540942013|FG000|Overall Study|Lack of healing|0|||
149948023|NCT03621592|540942014|FG001|Overall Study|Lack of healing|2|||
149948024|NCT03785366|540942023|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
149948025|NCT03785366|540942024|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
149948026|NCT03785366|540942023|FG000|Overall Study|Lost to Follow-up|1|||
150276566|NCT02243865|542150028|FG000|Overall Study|Adverse Event|1|||
149948027|NCT03785366|540942024|FG001|Overall Study|Lost to Follow-up|0|||
149948028|NCT03785366|540942023|FG000|Overall Study|Partial IUD Expulsion|0|||
149948029|NCT03785366|540942024|FG001|Overall Study|Partial IUD Expulsion|2|||
150276567|NCT02243865|542150029|FG001|Overall Study|Adverse Event|1|||
149948030|NCT03785366|540942023|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
150276568|NCT03098836|542150033|FG000|Overall Study|Adverse Event|1|||
150276569|NCT03098836|542150034|FG001|Overall Study|Adverse Event|3|||
150276570|NCT03098836|542150033|FG000|Overall Study|Lack of Efficacy|30|||
150276571|NCT03098836|542150034|FG001|Overall Study|Lack of Efficacy|15|||
150276572|NCT03098836|542150033|FG000|Overall Study|Physician Decision|2|||
150276573|NCT03098836|542150034|FG001|Overall Study|Physician Decision|1|||
150276574|NCT03098836|542150033|FG000|Overall Study|Withdrawal by Subject|3|||
150276575|NCT03098836|542150034|FG001|Overall Study|Withdrawal by Subject|2|||
150276576|NCT03986866|542150035|FG000|Overall Study|Withdrawal by Subject|0|||
149830295|NCT02073643|540508237|FG000|Overall Study|Lost to Follow-up|24|||
149830296|NCT02468778|540508244|FG000|Overall Study|Death|2|||
149830297|NCT02468778|540508245|FG001|Overall Study|Death|1|||
149830298|NCT02468778|540508246|FG002|Overall Study|Death|0|||
149830299|NCT02468778|540508244|FG000|Overall Study|Lost to Follow-up|1|||
149830300|NCT02468778|540508245|FG001|Overall Study|Lost to Follow-up|2|||
149830301|NCT02468778|540508246|FG002|Overall Study|Lost to Follow-up|2|||
149830302|NCT02468778|540508244|FG000|Overall Study|Withdrawal by Subject|0|||
149830303|NCT02468778|540508245|FG001|Overall Study|Withdrawal by Subject|1|||
149830304|NCT02468778|540508246|FG002|Overall Study|Withdrawal by Subject|1|||
149830305|NCT00414765|540508247|FG000|Overall Study|Adverse Event|5|||
149830306|NCT00414765|540508248|FG001|Overall Study|Adverse Event|9|||
149830307|NCT00414765|540508247|FG000|Overall Study|Withdrawal by Subject|1|||
149830308|NCT00414765|540508248|FG001|Overall Study|Withdrawal by Subject|1|||
149830309|NCT00414765|540508247|FG000|Overall Study|Disease Progression|0|||
149830310|NCT00414765|540508248|FG001|Overall Study|Disease Progression|1|||
149830311|NCT05295953|540508250|FG000|Overall Study|Withdrawal by Subject|0|||
149830312|NCT05295953|540508251|FG001|Overall Study|Withdrawal by Subject|1|||
149830313|NCT01199861|540508253|FG000|Overall Study|Administrative problems|1|||
149830314|NCT01199861|540508254|FG001|Overall Study|Administrative problems|0|||
149830315|NCT01199861|540508253|FG000|Overall Study|Adverse Event|1|||
149830316|NCT01199861|540508254|FG001|Overall Study|Adverse Event|0|||
149830317|NCT00661505|540508255|FG000|Overall Study|Adverse Event|3|||
149830318|NCT00661505|540508255|FG000|Overall Study|Protocol Violation|14|||
149830319|NCT00661505|540508255|FG000|Overall Study|Withdrawal by Subject|8|||
149830320|NCT00661505|540508255|FG000|Overall Study|Lost to Follow-up|3|||
149830321|NCT00661505|540508255|FG000|Overall Study|Other|2|||
149830322|NCT00796822|540508256|FG000|Overall Study|Lost to Follow-up|2|||
149830323|NCT00796822|540508257|FG001|Overall Study|Lost to Follow-up|0|||
149830324|NCT00796822|540508256|FG000|Overall Study|Adverse Event|1|||
149830325|NCT00796822|540508257|FG001|Overall Study|Adverse Event|0|||
149830326|NCT03283709|540508267|FG000|Overall Study|trial terminated|0|||
149830327|NCT03283709|540508268|FG001|Overall Study|trial terminated|1|||
149830328|NCT00117949|540508269|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
149830329|NCT00117949|540508270|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
149830330|NCT00117949|540508271|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
149830331|NCT00117949|540508272|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
149830332|NCT00117949|540508269|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
149830333|NCT00117949|540508270|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
149830334|NCT00117949|540508271|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
149830335|NCT00117949|540508272|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
149830336|NCT00117949|540508269|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
149830337|NCT00117949|540508270|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
149830338|NCT00117949|540508271|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
149830339|NCT00117949|540508272|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
149830340|NCT00117949|540508269|FG000|Overall Study|PSA increase >=10ng/mL|0|||
149830341|NCT00117949|540508270|FG001|Overall Study|PSA increase >=10ng/mL|1|||
149830342|NCT00117949|540508271|FG002|Overall Study|PSA increase >=10ng/mL|1|||
149830343|NCT00117949|540508272|FG003|Overall Study|PSA increase >=10ng/mL|0|||
150033651|NCT02379728|541262827|FG003|Overall Study|Withdrawal by Subject|3|||
150033652|NCT02379728|541262824|FG000|Overall Study|Protocol Violation|0|||
150033653|NCT02379728|541262825|FG001|Overall Study|Protocol Violation|0|||
150033654|NCT02379728|541262826|FG002|Overall Study|Protocol Violation|2|||
150276577|NCT03986866|542150036|FG001|Overall Study|Withdrawal by Subject|3|||
150276578|NCT03986866|542150035|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
150276579|NCT03986866|542150036|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
149830344|NCT00117949|540508269|FG000|Overall Study|PSA reduction <=50%|0|||
149830345|NCT00117949|540508270|FG001|Overall Study|PSA reduction <=50%|2|||
149830346|NCT00117949|540508271|FG002|Overall Study|PSA reduction <=50%|2|||
149830347|NCT00117949|540508272|FG003|Overall Study|PSA reduction <=50%|4|||
150033655|NCT02379728|541262827|FG003|Overall Study|Protocol Violation|0|||
149830348|NCT00117949|540508269|FG000|Overall Study|Hepatic abnormalities|0|||
150033656|NCT04945733|541262829|FG000|Overall Study|Physician Decision|1|||
149830349|NCT00117949|540508270|FG001|Overall Study|Hepatic abnormalities|1|||
149830350|NCT00117949|540508271|FG002|Overall Study|Hepatic abnormalities|0|||
149830351|NCT00117949|540508272|FG003|Overall Study|Hepatic abnormalities|1|||
149830352|NCT00406848|540508276|FG000|Overall Study|Withdrawal by Subject|27|||
149830353|NCT00406848|540508277|FG001|Overall Study|Withdrawal by Subject|22|||
149830354|NCT00406848|540508276|FG000|Overall Study|Adverse Event|38|||
149830355|NCT00406848|540508277|FG001|Overall Study|Adverse Event|7|||
149830356|NCT00406848|540508276|FG000|Overall Study|Lack of Efficacy|9|||
149830357|NCT00406848|540508277|FG001|Overall Study|Lack of Efficacy|14|||
149830358|NCT00406848|540508276|FG000|Overall Study|Protocol Violation|10|||
149830359|NCT00406848|540508277|FG001|Overall Study|Protocol Violation|6|||
149830360|NCT00406848|540508276|FG000|Overall Study|Lost to Follow-up|6|||
149830361|NCT00406848|540508277|FG001|Overall Study|Lost to Follow-up|2|||
149830362|NCT00406848|540508276|FG000|Overall Study|Physician Decision|2|||
149830363|NCT00406848|540508277|FG001|Overall Study|Physician Decision|2|||
149830364|NCT00406848|540508276|FG000|Overall Study|Sponsor Decision|1|||
149830365|NCT00406848|540508277|FG001|Overall Study|Sponsor Decision|1|||
149830366|NCT01355081|540508278|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
149830367|NCT01355081|540508279|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
149830368|NCT01355081|540508280|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
149830369|NCT01355081|540508278|FG000|Overall Study|Major Protocol Deviation|0|||
149830370|NCT01355081|540508279|FG001|Overall Study|Major Protocol Deviation|1|||
149830371|NCT01355081|540508280|FG002|Overall Study|Major Protocol Deviation|0|||
149830372|NCT01355081|540508278|FG000|Overall Study|Lost to Follow-up|0|||
149830373|NCT01355081|540508279|FG001|Overall Study|Lost to Follow-up|0|||
149830374|NCT01355081|540508280|FG002|Overall Study|Lost to Follow-up|1|||
149830375|NCT01355081|540508278|FG000|Overall Study|Withdrawal of Consent|2|||
149830376|NCT01355081|540508279|FG001|Overall Study|Withdrawal of Consent|3|||
149830377|NCT01355081|540508280|FG002|Overall Study|Withdrawal of Consent|3|||
149830378|NCT01355081|540508278|FG000|Overall Study|Lack of Efficacy|2|||
149830379|NCT01355081|540508279|FG001|Overall Study|Lack of Efficacy|1|||
149830380|NCT01355081|540508280|FG002|Overall Study|Lack of Efficacy|1|||
149830381|NCT01355081|540508278|FG000|Overall Study|Non Compliance with Study Medication|0|||
149830382|NCT01355081|540508279|FG001|Overall Study|Non Compliance with Study Medication|1|||
149830383|NCT01355081|540508280|FG002|Overall Study|Non Compliance with Study Medication|0|||
149830384|NCT02456909|540508281|FG000|Overall Study|Did not receive allocated intervention|24|||
149830385|NCT02456909|540508282|FG001|Overall Study|Did not receive allocated intervention|26|||
149830386|NCT02456909|540508281|FG000|Overall Study|Did not complete the primary outcome|0|||
149830387|NCT02456909|540508282|FG001|Overall Study|Did not complete the primary outcome|1|||
149830388|NCT03309956|540508285|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
149830389|NCT02768298|540508286|FG000|Overall Study|Adverse Event|1|||
149830390|NCT02768298|540508287|FG001|Overall Study|Adverse Event|4|||
149830391|NCT02768298|540508286|FG000|Overall Study|Death|2|||
149830392|NCT02768298|540508287|FG001|Overall Study|Death|1|||
149830393|NCT02768298|540508286|FG000|Overall Study|Non-compliance with study treatment|0|||
149830394|NCT02768298|540508287|FG001|Overall Study|Non-compliance with study treatment|1|||
149830395|NCT02768298|540508286|FG000|Overall Study|Subject/guardian decision|1|||
149830396|NCT02768298|540508287|FG001|Overall Study|Subject/guardian decision|0|||
149830397|NCT02768298|540508286|FG000|Overall Study|Withdrawal of informed consent|0|||
149830398|NCT02768298|540508287|FG001|Overall Study|Withdrawal of informed consent|1|||
149830399|NCT00922779|540508288|FG000|Overall Study|Adverse Event|67|||
149830400|NCT00922779|540508288|FG000|Overall Study|Pregnancy|7|||
149830401|NCT00922779|540508288|FG000|Overall Study|Withdrawal by Subject|308|||
149830402|NCT00922779|540508288|FG000|Overall Study|Lost to Follow-up|44|||
149830403|NCT00922779|540508288|FG000|Overall Study|Other|27|||
149830404|NCT00922779|540508288|FG000|Overall Study|Missing|1874|||
149830405|NCT01210001|540509766|FG000|Overall Study|Not treated|1|||
149830406|NCT01210001|540509767|FG001|Overall Study|Not treated|0|||
149830407|NCT01210001|540509768|FG002|Overall Study|Not treated|0|||
149830408|NCT01210001|540509766|FG000|Overall Study|Adverse Event|4|||
149830409|NCT01210001|540509767|FG001|Overall Study|Adverse Event|2|||
150276580|NCT02003014|542150039|FG000|Overall Study|Case report forms uncollected|9|||
150276581|NCT02003014|542150039|FG000|Overall Study|Treatment started after contract period|1|||
150276582|NCT02003014|542150039|FG000|Overall Study|Patient did not visit the study site|5|||
150276583|NCT02003014|542150039|FG000|Overall Study|Investigator's transfer|4|||
150276584|NCT01660451|542150040|FG000|Overall Study|Protocol Violation|0|||
149830410|NCT01210001|540509768|FG002|Overall Study|Adverse Event|5|||
149830411|NCT01210001|540509766|FG000|Overall Study|Non compliant with protocol|2|||
149830412|NCT01210001|540509767|FG001|Overall Study|Non compliant with protocol|2|||
149830413|NCT01210001|540509768|FG002|Overall Study|Non compliant with protocol|3|||
149830414|NCT01210001|540509766|FG000|Overall Study|Lost to Follow-up|4|||
149830415|NCT01210001|540509767|FG001|Overall Study|Lost to Follow-up|3|||
149830416|NCT01210001|540509768|FG002|Overall Study|Lost to Follow-up|2|||
149830417|NCT01210001|540509766|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
149830418|NCT01210001|540509767|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
149830419|NCT01210001|540509768|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
149830420|NCT01210001|540509766|FG000|Overall Study|Other reason not defined above|2|||
149830421|NCT01210001|540509767|FG001|Overall Study|Other reason not defined above|2|||
149830422|NCT01210001|540509768|FG002|Overall Study|Other reason not defined above|1|||
149830423|NCT00788125|540509769|FG000|Overall Study|Death|6|||
149830424|NCT00444145|540509773|FG000|Overall Study|Withdrawal by Subject|2|||
149830425|NCT00444145|540509773|FG000|Overall Study|Lost to Follow-up|1|||
149830426|NCT00444145|540509773|FG000|Overall Study|non-compliant|11|||
149830427|NCT00444145|540509773|FG000|Overall Study|Screen Failures|5|||
149830428|NCT01374919|540509774|FG000|Overall Study|Withdrawal by Subject|2|||
149830429|NCT03805438|540509775|FG000|Overall Study|Lack of Efficacy|1|||
149830430|NCT03805438|540509775|FG000|Overall Study|Protocol Violation|1|||
149830431|NCT00366899|540509776|FG000|Infant Series|Withdrawal by Subject|4|||
149830432|NCT00366899|540509777|FG001|Infant Series|Withdrawal by Subject|7|||
149830433|NCT00366899|540509776|FG000|Infant Series|Protocol Violation|2|||
149830434|NCT00366899|540509777|FG001|Infant Series|Protocol Violation|1|||
149830435|NCT00366899|540509776|FG000|Infant Series|Failed to return|1|||
149830436|NCT00366899|540509777|FG001|Infant Series|Failed to return|1|||
149830437|NCT00366899|540509776|FG000|Infant Series|Lost to Follow-up|0|||
149830438|NCT00366899|540509777|FG001|Infant Series|Lost to Follow-up|2|||
149830439|NCT00366899|540509776|FG000|Infant Series|Adverse Event|0|||
149830440|NCT00366899|540509777|FG001|Infant Series|Adverse Event|1|||
149830441|NCT00366899|540509776|FG000|Infant Series|Physician Decision|1|||
149830442|NCT00366899|540509777|FG001|Infant Series|Physician Decision|0|||
149830443|NCT00366899|540509776|FG000|Infant Series|Randomized but not consented|1|||
149830444|NCT00366899|540509777|FG001|Infant Series|Randomized but not consented|0|||
149830445|NCT00366899|540509776|FG000|After Infant Series|Lost to Follow-up|4|||
149830446|NCT00366899|540509777|FG001|After Infant Series|Lost to Follow-up|3|||
149830447|NCT00366899|540509776|FG000|After Infant Series|Withdrawal by Subject|1|||
149830448|NCT00366899|540509777|FG001|After Infant Series|Withdrawal by Subject|4|||
149830449|NCT00366899|540509776|FG000|After Infant Series|Adverse Event|1|||
149830450|NCT00366899|540509777|FG001|After Infant Series|Adverse Event|2|||
149830451|NCT00366899|540509776|FG000|After Infant Series|Protocol Violation|1|||
149830452|NCT00366899|540509777|FG001|After Infant Series|Protocol Violation|0|||
149830453|NCT00366899|540509776|FG000|Toddler Dose|Withdrawal by Subject|1|||
149830454|NCT00366899|540509777|FG001|Toddler Dose|Withdrawal by Subject|1|||
149830455|NCT00366899|540509776|FG000|Toddler Dose|Protocol Violation|1|||
149830456|NCT00366899|540509777|FG001|Toddler Dose|Protocol Violation|0|||
149830457|NCT00419770|540509778|FG000|Overall Study|Withdrawal by Subject|5|||
149830458|NCT00419770|540509779|FG001|Overall Study|Withdrawal by Subject|1|||
149830459|NCT01781637|540509780|FG000|Overall Study|Adverse Event|1|||
149830460|NCT01781637|540509781|FG001|Overall Study|Adverse Event|0|||
149830461|NCT01781637|540509780|FG000|Overall Study|Lack of Efficacy|2|||
149830462|NCT01781637|540509781|FG001|Overall Study|Lack of Efficacy|6|||
149830463|NCT01781637|540509780|FG000|Overall Study|Withdrawal by Subject|1|||
149830464|NCT01781637|540509781|FG001|Overall Study|Withdrawal by Subject|0|||
149830465|NCT02637232|540509782|FG000|Overall Study|Lost to Follow-up|42|||
149830466|NCT02637232|540509782|FG000|Overall Study|Adverse Event|11|||
149830467|NCT02637232|540509782|FG000|Overall Study|patient 's decision|2|||
149830468|NCT02999178|540509783|FG000|Overall Study|Adverse Event|85|||
149830469|NCT02999178|540509784|FG001|Overall Study|Adverse Event|62|||
149830470|NCT02999178|540509783|FG000|Overall Study|Protocol Violation|1|||
149830471|NCT02999178|540509784|FG001|Overall Study|Protocol Violation|2|||
149830472|NCT02999178|540509783|FG000|Overall Study|Lost to Follow-up|0|||
149830473|NCT02999178|540509784|FG001|Overall Study|Lost to Follow-up|2|||
149830474|NCT02999178|540509783|FG000|Overall Study|Withdrawal by Subject|21|||
149830475|NCT02999178|540509784|FG001|Overall Study|Withdrawal by Subject|21|||
149830476|NCT02999178|540509783|FG000|Overall Study|Other reason not defined above|7|||
149830477|NCT02999178|540509784|FG001|Overall Study|Other reason not defined above|13|||
149830478|NCT00090857|540509785|FG000|Overall Study|Lost to Follow-up|0|||
149830479|NCT00090857|540509786|FG001|Overall Study|Lost to Follow-up|1|||
149830480|NCT00090857|540509785|FG000|Overall Study|Withdrawal by Subject|2|||
149830481|NCT00090857|540509786|FG001|Overall Study|Withdrawal by Subject|0|||
149830482|NCT00090857|540509785|FG000|Overall Study|Adverse Event|2|||
149830483|NCT00090857|540509786|FG001|Overall Study|Adverse Event|2|||
149948031|NCT03785366|540942024|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
149830484|NCT05097326|540509787|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
149830485|NCT05097326|540509788|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
149830486|NCT03480425|540509790|FG000|Overall Study|Force transducer technical failure|1|||
149948032|NCT03240874|540942025|FG000|Overall Study|Lost to Follow-up|0|||
149948033|NCT03240874|540942026|FG001|Overall Study|Lost to Follow-up|2|||
149948034|NCT03240874|540942027|FG002|Overall Study|Lost to Follow-up|4|||
149948035|NCT03240874|540942028|FG003|Overall Study|Lost to Follow-up|1|||
149830487|NCT01244126|540509791|FG000|Overall Study|Protocol Violation|3|||
149830488|NCT01244126|540509792|FG001|Overall Study|Protocol Violation|3|||
149830489|NCT01244126|540509793|FG002|Overall Study|Protocol Violation|9|||
149830490|NCT01451762|540509796|FG000|Overall Study|Lost to Follow-up|3|||
149830491|NCT01451762|540509797|FG001|Overall Study|Lost to Follow-up|6|||
149830492|NCT01451762|540509798|FG002|Overall Study|Lost to Follow-up|6|||
149830493|NCT02424188|540509804|FG000|Overall Study|Death|2|||
149830494|NCT02424188|540509805|FG001|Overall Study|Death|2|||
149830495|NCT02424188|540509804|FG000|Overall Study|Lost to Follow-up|1|||
149830496|NCT02424188|540509805|FG001|Overall Study|Lost to Follow-up|3|||
149830497|NCT02424188|540509804|FG000|Overall Study|Incarceration|1|||
149830498|NCT02424188|540509805|FG001|Overall Study|Incarceration|0|||
149830499|NCT00630305|540509806|FG000|Overall Study|Withdrawal by Subject|1|||
149830500|NCT00630305|540509806|FG000|Overall Study|Inability to insert contact lens|1|||
149830501|NCT01085045|540509807|FG000|Part A|Withdrawal by Subject|4|||
149830502|NCT01085045|540509807|FG000|Part A|Adverse Event|6|||
149830503|NCT01085045|540509807|FG000|Part A|Protocol Violation|1|||
149830504|NCT01085045|540509807|FG000|Part A|Protocol Specified Criteria|7|||
149830505|NCT01085045|540509807|FG000|Part B|Withdrawal by Subject|2|||
149830506|NCT01085045|540509807|FG000|Part B|Protocol Specified Criteria|6|||
149830507|NCT01085045|540509807|FG000|Part B|Lost to Follow-up|1|||
149830508|NCT01085045|540509807|FG000|Part B|Adverse Event|6|||
149830509|NCT03601637|540509815|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
149830510|NCT03601637|540509816|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
149830511|NCT03601637|540509815|FG000|Overall Study|Adverse Event|1|||
149830512|NCT03601637|540509816|FG001|Overall Study|Adverse Event|1|||
149830513|NCT03601637|540509815|FG000|Overall Study|Other|0|||
149830514|NCT03601637|540509816|FG001|Overall Study|Other|1|||
149830515|NCT04510857|540509818|FG000|Overall Study|Withdrawal by Subject|1|||
149830516|NCT04510857|540509819|FG001|Overall Study|Withdrawal by Subject|2|||
149830517|NCT02564263|540509822|FG000|Overall Study|Adverse Event|31|||
149830518|NCT02564263|540509823|FG001|Overall Study|Adverse Event|29|||
149830519|NCT02564263|540509822|FG000|Overall Study|Death|270|||
149830520|NCT02564263|540509823|FG001|Overall Study|Death|262|||
149830521|NCT02564263|540509822|FG000|Overall Study|Withdrawal by Subject|4|||
149830522|NCT02564263|540509823|FG001|Overall Study|Withdrawal by Subject|19|||
149830523|NCT02564263|540509822|FG000|Overall Study|Sponsor's decision|9|||
149830524|NCT02564263|540509823|FG001|Overall Study|Sponsor's decision|4|||
149830525|NCT01644500|540509824|FG000|Overall Study|Adverse Event|6|||
149830526|NCT01644500|540509825|FG001|Overall Study|Adverse Event|1|||
149830527|NCT01644500|540509826|FG002|Overall Study|Adverse Event|2|||
149830528|NCT01644500|540509824|FG000|Overall Study|Death|0|||
149830529|NCT01644500|540509825|FG001|Overall Study|Death|1|||
149830530|NCT01644500|540509826|FG002|Overall Study|Death|0|||
149830531|NCT01644500|540509824|FG000|Overall Study|Lost to Follow-up|3|||
149830532|NCT01644500|540509825|FG001|Overall Study|Lost to Follow-up|8|||
149830533|NCT01644500|540509826|FG002|Overall Study|Lost to Follow-up|0|||
149830534|NCT01644500|540509824|FG000|Overall Study|Protocol Violation|1|||
149830535|NCT01644500|540509825|FG001|Overall Study|Protocol Violation|1|||
149830536|NCT01644500|540509826|FG002|Overall Study|Protocol Violation|0|||
149830537|NCT01644500|540509824|FG000|Overall Study|Withdrawal by Subject|11|||
149830538|NCT01644500|540509825|FG001|Overall Study|Withdrawal by Subject|12|||
149830539|NCT01644500|540509826|FG002|Overall Study|Withdrawal by Subject|12|||
149830540|NCT01644500|540509824|FG000|Overall Study|Physician Decision|1|||
149830541|NCT01644500|540509825|FG001|Overall Study|Physician Decision|1|||
149830542|NCT01644500|540509826|FG002|Overall Study|Physician Decision|1|||
149830543|NCT00322491|540509833|FG000|Overall Study|Adverse Event|1|||
149830544|NCT00322491|540509834|FG001|Overall Study|Adverse Event|0|||
149830545|NCT00322491|540509833|FG000|Overall Study|Death|1|||
149830546|NCT00322491|540509834|FG001|Overall Study|Death|2|||
149830547|NCT00720096|540509835|FG000|Overall Study|Withdrawal by Subject|0|||
149830548|NCT00720096|540509836|FG001|Overall Study|Withdrawal by Subject|2|||
149830549|NCT04557124|540509837|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
149830550|NCT04557124|540509838|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
149830551|NCT04557124|540509837|FG000|Mid-point (1 Month)|Missed testing|5|||
149830552|NCT04557124|540509838|FG001|Mid-point (1 Month)|Missed testing|4|||
149830553|NCT04557124|540509837|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
149830554|NCT04557124|540509838|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
149830555|NCT04557124|540509837|FG000|Post-testing (2 Months)|Missed testing|1|||
149830556|NCT04557124|540509838|FG001|Post-testing (2 Months)|Missed testing|5|||
149830557|NCT04557124|540509837|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
149830558|NCT04557124|540509838|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
149830559|NCT04557124|540509837|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
149830560|NCT04557124|540509838|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
149830561|NCT00001849|540509839|FG000|Overall Study|Death|4|||
149830562|NCT00001849|540509839|FG000|Overall Study|Lost to Follow-up|2|||
149830563|NCT00001849|540509839|FG000|Overall Study|Withdrawal by Subject|2|||
149830564|NCT00001849|540509839|FG000|Overall Study|tumor remained occult|6|||
149948036|NCT05252702|540942029|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
149830565|NCT03127137|540509844|FG000|Overall Study|Requested sedation after consent|1|||
149830566|NCT03127137|540509845|FG001|Overall Study|Requested sedation after consent|0|||
149830567|NCT03127137|540509844|FG000|Overall Study|Malfunction in electronic data collection|1|||
149830568|NCT03127137|540509845|FG001|Overall Study|Malfunction in electronic data collection|0|||
149830569|NCT03127137|540509844|FG000|Overall Study|Post procedure testing could not be obtained|0|||
149830570|NCT03127137|540509845|FG001|Overall Study|Post procedure testing could not be obtained|1|||
149830571|NCT02319148|540509848|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
149830572|NCT02319148|540509849|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
149830573|NCT02319148|540509850|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
149830574|NCT02319148|540509851|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
149830575|NCT02319148|540509848|FG000|Second Intervention Period|No longer willing to participate|0|||
149830576|NCT02319148|540509849|FG001|Second Intervention Period|No longer willing to participate|1|||
149830577|NCT02319148|540509850|FG002|Second Intervention Period|No longer willing to participate|0|||
149830578|NCT02319148|540509851|FG003|Second Intervention Period|No longer willing to participate|0|||
149830579|NCT02319148|540509848|FG000|Second Intervention Period|Other|0|||
149830580|NCT02319148|540509849|FG001|Second Intervention Period|Other|0|||
149830581|NCT02319148|540509850|FG002|Second Intervention Period|Other|0|||
149830582|NCT02319148|540509851|FG003|Second Intervention Period|Other|1|||
149830583|NCT00264797|540509852|FG000|Overall Study|Withdrawal by Subject|11|||
149830584|NCT00264797|540509853|FG001|Overall Study|Withdrawal by Subject|11|||
149830585|NCT00264797|540509852|FG000|Overall Study|Lost to Follow-up|9|||
149830586|NCT00264797|540509853|FG001|Overall Study|Lost to Follow-up|17|||
149830587|NCT00264797|540509852|FG000|Overall Study|Moved from area|3|||
149830588|NCT00264797|540509853|FG001|Overall Study|Moved from area|1|||
149830589|NCT00264797|540509852|FG000|Overall Study|Practical Problems|2|||
149830590|NCT00264797|540509853|FG001|Overall Study|Practical Problems|3|||
149830591|NCT00264797|540509852|FG000|Overall Study|Incarceration|4|||
149830592|NCT00264797|540509853|FG001|Overall Study|Incarceration|5|||
149830593|NCT00264797|540509852|FG000|Overall Study|Pressure/advice from Outsiders|1|||
149830594|NCT00264797|540509853|FG001|Overall Study|Pressure/advice from Outsiders|1|||
149830595|NCT00264797|540509852|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
149830596|NCT00264797|540509853|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
149830597|NCT00264797|540509852|FG000|Overall Study|Other|3|||
149830598|NCT00264797|540509853|FG001|Overall Study|Other|4|||
149830599|NCT00048048|540509854|FG000|Core Treatment|Withdrawal by Subject|0|||
149830600|NCT00048048|540509855|FG001|Core Treatment|Withdrawal by Subject|0|||
149830601|NCT00048048|540509856|FG002|Core Treatment|Withdrawal by Subject|1|||
149830602|NCT00048048|540509857|FG003|Core Treatment|Withdrawal by Subject|0|||
149830603|NCT00048048|540509858|FG004|Core Treatment|Withdrawal by Subject|0|||
149830604|NCT00048048|540509859|FG005|Core Treatment|Withdrawal by Subject|0|||
149830605|NCT00048048|540509860|FG006|Core Treatment|Withdrawal by Subject|0|||
149830606|NCT00048048|540509861|FG007|Core Treatment|Withdrawal by Subject|0|||
149830607|NCT00048048|540509862|FG008|Core Treatment|Withdrawal by Subject|0|||
149830608|NCT00048048|540509863|FG009|Core Treatment|Withdrawal by Subject|0|||
149830609|NCT00048048|540509864|FG010|Core Treatment|Withdrawal by Subject|0|||
149830610|NCT00048048|540509865|FG011|Core Treatment|Withdrawal by Subject|0|||
149830611|NCT00048048|540509854|FG000|Core Treatment|Adverse Event|0|||
149830612|NCT00048048|540509855|FG001|Core Treatment|Adverse Event|0|||
149830613|NCT00048048|540509856|FG002|Core Treatment|Adverse Event|0|||
149830614|NCT00048048|540509857|FG003|Core Treatment|Adverse Event|0|||
149830615|NCT00048048|540509858|FG004|Core Treatment|Adverse Event|0|||
149830616|NCT00048048|540509859|FG005|Core Treatment|Adverse Event|0|||
149830617|NCT00048048|540509860|FG006|Core Treatment|Adverse Event|0|||
150033657|NCT04945733|541262830|FG001|Overall Study|Physician Decision|3|||
150033658|NCT04945733|541262831|FG002|Overall Study|Physician Decision|0|||
150033659|NCT04945733|541262829|FG000|Overall Study|Withdrawal by Subject|3|||
150033660|NCT04945733|541262830|FG001|Overall Study|Withdrawal by Subject|3|||
149830618|NCT00048048|540509861|FG007|Core Treatment|Adverse Event|1|||
149830619|NCT00048048|540509862|FG008|Core Treatment|Adverse Event|0|||
149830620|NCT00048048|540509863|FG009|Core Treatment|Adverse Event|0|||
149830621|NCT00048048|540509864|FG010|Core Treatment|Adverse Event|0|||
149830622|NCT00048048|540509865|FG011|Core Treatment|Adverse Event|0|||
149830623|NCT00048048|540509854|FG000|Extension Year 1|Early withdrawals|0|||
149830624|NCT00048048|540509855|FG001|Extension Year 1|Early withdrawals|0|||
149830625|NCT00048048|540509856|FG002|Extension Year 1|Early withdrawals|0|||
149830626|NCT00048048|540509857|FG003|Extension Year 1|Early withdrawals|0|||
149830627|NCT00048048|540509858|FG004|Extension Year 1|Early withdrawals|0|||
149830628|NCT00048048|540509859|FG005|Extension Year 1|Early withdrawals|0|||
149830629|NCT00048048|540509860|FG006|Extension Year 1|Early withdrawals|0|||
149830630|NCT00048048|540509861|FG007|Extension Year 1|Early withdrawals|0|||
150033661|NCT04945733|541262831|FG002|Overall Study|Withdrawal by Subject|0|||
150033662|NCT00726063|541262832|FG000|Overall Study|Adverse Event|9|||
150033663|NCT00726063|541262833|FG001|Overall Study|Adverse Event|7|||
150033664|NCT02007096|541262834|FG000|Overall Study|medication not available|2|||
150033665|NCT02007096|541262835|FG001|Overall Study|medication not available|0|||
150033666|NCT02007096|541262834|FG000|Overall Study|did not inject saline|0|||
149830631|NCT00048048|540509862|FG008|Extension Year 1|Early withdrawals|0|||
149830632|NCT00048048|540509863|FG009|Extension Year 1|Early withdrawals|2|||
149830633|NCT00048048|540509864|FG010|Extension Year 1|Early withdrawals|2|||
149830634|NCT00048048|540509865|FG011|Extension Year 1|Early withdrawals|4|||
149830635|NCT00048048|540509854|FG000|Extension Year 2|Early withdrawals|0|||
150033667|NCT02007096|541262835|FG001|Overall Study|did not inject saline|3|||
149830636|NCT00048048|540509855|FG001|Extension Year 2|Early withdrawals|0|||
149830637|NCT00048048|540509856|FG002|Extension Year 2|Early withdrawals|0|||
149830638|NCT00048048|540509857|FG003|Extension Year 2|Early withdrawals|0|||
149830639|NCT00048048|540509858|FG004|Extension Year 2|Early withdrawals|0|||
149830640|NCT00048048|540509859|FG005|Extension Year 2|Early withdrawals|0|||
149830641|NCT00048048|540509860|FG006|Extension Year 2|Early withdrawals|0|||
149830642|NCT00048048|540509861|FG007|Extension Year 2|Early withdrawals|0|||
149830643|NCT00048048|540509862|FG008|Extension Year 2|Early withdrawals|0|||
149830644|NCT00048048|540509863|FG009|Extension Year 2|Early withdrawals|0|||
149830645|NCT00048048|540509864|FG010|Extension Year 2|Early withdrawals|4|||
149830646|NCT00048048|540509865|FG011|Extension Year 2|Early withdrawals|2|||
149830647|NCT03992196|540509866|FG000|Enrollment|lost to follow-up prior dosing|1|||
149830648|NCT03992196|540509867|FG001|Enrollment|lost to follow-up prior dosing|0|||
149830649|NCT03992196|540509868|FG002|Enrollment|lost to follow-up prior dosing|0|||
149830650|NCT03992196|540509866|FG000|Treatment|Protocol Violation|0|||
149830651|NCT03992196|540509867|FG001|Treatment|Protocol Violation|0|||
149830652|NCT03992196|540509868|FG002|Treatment|Protocol Violation|1|||
149830653|NCT03992196|540509866|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
149830654|NCT03992196|540509867|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
149830655|NCT03992196|540509868|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
149830656|NCT03992196|540509866|FG000|Treatment|Withdrawal due to non-compliance|0|||
149830657|NCT03992196|540509867|FG001|Treatment|Withdrawal due to non-compliance|0|||
149830658|NCT03992196|540509868|FG002|Treatment|Withdrawal due to non-compliance|1|||
149830659|NCT03992196|540509866|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
149830660|NCT03992196|540509867|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
149830661|NCT03992196|540509868|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
149830662|NCT03992196|540509866|FG000|Treatment|Withdrawal by parent/guardian|0|||
149830663|NCT03992196|540509867|FG001|Treatment|Withdrawal by parent/guardian|0|||
149830664|NCT03992196|540509868|FG002|Treatment|Withdrawal by parent/guardian|2|||
149830665|NCT02388763|540509872|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
149830666|NCT02388763|540509873|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
149830667|NCT02388763|540509872|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
149830668|NCT02388763|540509873|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
149830669|NCT01604850|540509874|FG000|Overall Study|Enrolled but never treated|0|||
149830670|NCT01604850|540509875|FG001|Overall Study|Enrolled but never treated|1|||
149830671|NCT01604850|540509874|FG000|Overall Study|Efficacy Failure|50|||
149830672|NCT01604850|540509875|FG001|Overall Study|Efficacy Failure|29|||
149830673|NCT01604850|540509874|FG000|Overall Study|Lost to Follow-up|1|||
149830674|NCT01604850|540509875|FG001|Overall Study|Lost to Follow-up|0|||
149830675|NCT01604850|540509874|FG000|Overall Study|Subject withdrew consent|1|||
149830676|NCT01604850|540509875|FG001|Overall Study|Subject withdrew consent|0|||
149830677|NCT01703832|540509876|FG000|Overall Study|Withdrawal by Subject|1|||
149830678|NCT01703832|540509877|FG001|Overall Study|Withdrawal by Subject|0|||
149830679|NCT00243932|540509878|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
149830680|NCT00243932|540509879|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
149830681|NCT00243932|540509880|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
149830682|NCT00543309|540509881|FG000|Overall Study|Physician Decision|0|||
149830683|NCT00543309|540509882|FG001|Overall Study|Physician Decision|1|||
149830684|NCT00543309|540509883|FG002|Overall Study|Physician Decision|0|||
149830685|NCT01249664|540509885|FG000|Overall Study|Withdrawal by Subject|5|||
149830686|NCT01249664|540509886|FG001|Overall Study|Withdrawal by Subject|0|||
149830687|NCT01249664|540509885|FG000|Overall Study|Adverse Event|1|||
149830688|NCT01249664|540509886|FG001|Overall Study|Adverse Event|0|||
149830689|NCT01345019|540509897|FG000|Blinded Treatment Phase|Death|147|||
149830690|NCT01345019|540509898|FG001|Blinded Treatment Phase|Death|137|||
149830691|NCT01345019|540509897|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
149830692|NCT01345019|540509898|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
149830693|NCT01345019|540509897|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
149830694|NCT01345019|540509898|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
149948037|NCT05252702|540942029|FG000|Overall Study|Death|16|||
149948038|NCT05252702|540942029|FG000|Overall Study|System explant|5|||
149948039|NCT05252702|540942029|FG000|Overall Study|Lost to Follow-up|1|||
149948040|NCT05252702|540942029|FG000|Overall Study|Withdrawn by investigator|1|||
149948041|NCT05252702|540942029|FG000|Overall Study|Visit not due|306|||
149948042|NCT05252702|540942029|FG000|Overall Study|Visit within window but not completed|92|||
149948043|NCT05252702|540942029|FG000|Overall Study|Unsuccessful implant|1|||
149948044|NCT04153864|540942030|FG000|Overall Study|Withdrawal by Subject|21|||
149948045|NCT04153864|540942031|FG001|Overall Study|Withdrawal by Subject|7|||
149948046|NCT04153864|540942032|FG002|Overall Study|Withdrawal by Subject|23|||
149948047|NCT04153864|540942033|FG003|Overall Study|Withdrawal by Subject|2|||
149948048|NCT04153864|540942030|FG000|Overall Study|Lost to Follow-up|4|||
149948049|NCT04153864|540942031|FG001|Overall Study|Lost to Follow-up|0|||
149948050|NCT04153864|540942032|FG002|Overall Study|Lost to Follow-up|3|||
150276585|NCT01660451|542150041|FG001|Overall Study|Protocol Violation|1|||
150276586|NCT01660451|542150042|FG002|Overall Study|Protocol Violation|1|||
150276587|NCT01660451|542150040|FG000|Overall Study|AE not associated with clinical disease progression|13|||
150276588|NCT01660451|542150041|FG001|Overall Study|AE not associated with clinical disease progression|10|||
150276589|NCT01660451|542150042|FG002|Overall Study|AE not associated with clinical disease progression|40|||
150276590|NCT01660451|542150040|FG000|Overall Study|AE associated with clinical disease progression|1|||
150276591|NCT01660451|542150041|FG001|Overall Study|AE associated with clinical disease progression|3|||
150276592|NCT01660451|542150042|FG002|Overall Study|AE associated with clinical disease progression|11|||
150276593|NCT01660451|542150040|FG000|Overall Study|Sponsor Decision|0|||
150276594|NCT01660451|542150041|FG001|Overall Study|Sponsor Decision|0|||
150276595|NCT01660451|542150042|FG002|Overall Study|Sponsor Decision|1|||
150276596|NCT01660451|542150040|FG000|Overall Study|Protocol Deviation|0|||
150276597|NCT01660451|542150041|FG001|Overall Study|Protocol Deviation|0|||
150276598|NCT01660451|542150042|FG002|Overall Study|Protocol Deviation|1|||
150276599|NCT01660451|542150040|FG000|Overall Study|Physician Decision|1|||
150276600|NCT01660451|542150041|FG001|Overall Study|Physician Decision|2|||
150276601|NCT01660451|542150042|FG002|Overall Study|Physician Decision|5|||
150276602|NCT01660451|542150040|FG000|Overall Study|Withdrawal by Subject|1|||
150276603|NCT01660451|542150041|FG001|Overall Study|Withdrawal by Subject|1|||
150276604|NCT01660451|542150042|FG002|Overall Study|Withdrawal by Subject|20|||
150276605|NCT01660451|542150040|FG000|Overall Study|Trial closure.|0|||
150276606|NCT01660451|542150041|FG001|Overall Study|Trial closure.|0|||
150276607|NCT01660451|542150042|FG002|Overall Study|Trial closure.|1|||
150276608|NCT01660451|542150040|FG000|Overall Study|Switching to other therapy|0|||
150276609|NCT01660451|542150041|FG001|Overall Study|Switching to other therapy|1|||
150276610|NCT01660451|542150042|FG002|Overall Study|Switching to other therapy|1|||
150276611|NCT01660451|542150040|FG000|Overall Study|Progressive disease - clinical progression|4|||
150276612|NCT01660451|542150041|FG001|Overall Study|Progressive disease - clinical progression|10|||
150276613|NCT01660451|542150042|FG002|Overall Study|Progressive disease - clinical progression|9|||
150276614|NCT01660451|542150040|FG000|Overall Study|Progressive disease - radiological progression|12|||
150276615|NCT01660451|542150041|FG001|Overall Study|Progressive disease - radiological progression|23|||
150276616|NCT01660451|542150042|FG002|Overall Study|Progressive disease - radiological progression|50|||
150276617|NCT01660451|542150040|FG000|Overall Study|Death|1|||
150276618|NCT01660451|542150041|FG001|Overall Study|Death|0|||
150276619|NCT01660451|542150042|FG002|Overall Study|Death|1|||
150276620|NCT01660451|542150040|FG000|Overall Study|Other|0|||
150276621|NCT01660451|542150041|FG001|Overall Study|Other|0|||
150276622|NCT01660451|542150042|FG002|Overall Study|Other|1|||
150276623|NCT05093322|542150043|FG000|Overall Study|Death|6|||
150276624|NCT05093322|542150044|FG001|Overall Study|Death|2|||
150276625|NCT05093322|542150043|FG000|Overall Study|Other|4|||
150276626|NCT05093322|542150044|FG001|Overall Study|Other|1|||
150276627|NCT00898443|542150045|FG000|Overall Study|Withdrawal by Subject|1|||
150276628|NCT00898443|542150046|FG001|Overall Study|Withdrawal by Subject|0|||
150276629|NCT00074581|542150050|FG000|Overall Study|Death|15|||
150276630|NCT00074581|542150051|FG001|Overall Study|Death|16|||
150276631|NCT00074581|542150050|FG000|Overall Study|Withdrawal by Subject|50|||
150276632|NCT00074581|542150051|FG001|Overall Study|Withdrawal by Subject|49|||
150276633|NCT00074581|542150050|FG000|Overall Study|Unable to adhere to visit schedule|13|||
150276634|NCT00074581|542150051|FG001|Overall Study|Unable to adhere to visit schedule|14|||
150276635|NCT00074581|542150050|FG000|Overall Study|Relocated|14|||
150276636|NCT00074581|542150051|FG001|Overall Study|Relocated|9|||
150276637|NCT00074581|542150050|FG000|Overall Study|Were withdrawn by investigator|5|||
150276638|NCT00074581|542150051|FG001|Overall Study|Were withdrawn by investigator|2|||
150276639|NCT00074581|542150050|FG000|Overall Study|Lost to Follow-up|16|||
150276640|NCT00074581|542150051|FG001|Overall Study|Lost to Follow-up|11|||
150276641|NCT00074581|542150050|FG000|Overall Study|Ended relationship w. index participant|117|||
150276642|NCT00074581|542150051|FG001|Overall Study|Ended relationship w. index participant|106|||
150276643|NCT00074581|542150050|FG000|Overall Study|Other|14|||
150276644|NCT00074581|542150051|FG001|Overall Study|Other|19|||
150276645|NCT01708291|542150053|FG000|Overall Study|fighting|2|||
150276646|NCT01708291|542150054|FG001|Overall Study|fighting|1|||
150276647|NCT00617604|542150055|FG000|Overall Study|Death|2|||
150276648|NCT00617604|542150056|FG001|Overall Study|Death|1|||
150276649|NCT00617604|542150055|FG000|Overall Study|Lost to Follow-up|1|||
150276650|NCT00617604|542150056|FG001|Overall Study|Lost to Follow-up|0|||
150276651|NCT00617604|542150055|FG000|Overall Study|Miscellaneous Reasons|8|||
150276652|NCT00617604|542150056|FG001|Overall Study|Miscellaneous Reasons|10|||
150276653|NCT00617604|542150055|FG000|Overall Study|Withdrawal by Subject|4|||
150276654|NCT00617604|542150056|FG001|Overall Study|Withdrawal by Subject|6|||
150276655|NCT00617604|542150055|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
150276656|NCT00617604|542150056|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
150276657|NCT03250832|542150057|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
150276658|NCT03250832|542150058|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
150276659|NCT03250832|542150059|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
150276660|NCT03250832|542150060|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
149830695|NCT01345019|540509897|FG000|Blinded Treatment Phase|Disease Progression|12|||
149830696|NCT01345019|540509898|FG001|Blinded Treatment Phase|Disease Progression|10|||
149830697|NCT01345019|540509897|FG000|Blinded Treatment Phase|Adverse Event|6|||
149830698|NCT01345019|540509898|FG001|Blinded Treatment Phase|Adverse Event|13|||
149830699|NCT01345019|540509897|FG000|Blinded Treatment Phase|Administrative Decision|10|||
149830700|NCT01345019|540509898|FG001|Blinded Treatment Phase|Administrative Decision|8|||
149830701|NCT01345019|540509897|FG000|Blinded Treatment Phase|Noncompliance|5|||
149830702|NCT01345019|540509898|FG001|Blinded Treatment Phase|Noncompliance|3|||
149830703|NCT01345019|540509897|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
149830704|NCT01345019|540509898|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
149830705|NCT01345019|540509897|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
149830706|NCT01345019|540509898|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
149830707|NCT01345019|540509897|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
149830708|NCT01345019|540509898|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
149830709|NCT01345019|540509897|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
149830710|NCT01345019|540509898|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
149830711|NCT01345019|540509897|FG000|Open Label Treatment Phase|Death|49|||
149830712|NCT01345019|540509898|FG001|Open Label Treatment Phase|Death|48|||
149830713|NCT01345019|540509897|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
149830714|NCT01345019|540509898|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
149830715|NCT01345019|540509897|FG000|Open Label Treatment Phase|Adverse Event|30|||
149830716|NCT01345019|540509898|FG001|Open Label Treatment Phase|Adverse Event|51|||
149830717|NCT01345019|540509897|FG000|Open Label Treatment Phase|Administrative Decision|30|||
149830718|NCT01345019|540509898|FG001|Open Label Treatment Phase|Administrative Decision|15|||
149830719|NCT01345019|540509897|FG000|Open Label Treatment Phase|Disease Progression|17|||
149830720|NCT01345019|540509898|FG001|Open Label Treatment Phase|Disease Progression|18|||
149830721|NCT01345019|540509897|FG000|Open Label Treatment Phase|Noncompliance|5|||
149830722|NCT01345019|540509898|FG001|Open Label Treatment Phase|Noncompliance|4|||
149830723|NCT01345019|540509897|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
149830724|NCT01345019|540509898|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
149830725|NCT01345019|540509897|FG000|Open Label Treatment Phase|Pregnancy|1|||
149830726|NCT01345019|540509898|FG001|Open Label Treatment Phase|Pregnancy|0|||
149830727|NCT01345019|540509897|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
149830728|NCT01345019|540509898|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
149830729|NCT01345019|540509897|FG000|Open Label Treatment Phase|Protocol Violation|0|||
149830730|NCT01345019|540509898|FG001|Open Label Treatment Phase|Protocol Violation|1|||
149830731|NCT03830164|540509899|FG000|Overall Study|Adverse Event|0|||
149830732|NCT03830164|540509900|FG001|Overall Study|Adverse Event|2|||
149830733|NCT03830164|540509901|FG002|Overall Study|Adverse Event|0|||
149830734|NCT03830164|540509899|FG000|Overall Study|Lack of Efficacy|1|||
149830735|NCT03830164|540509900|FG001|Overall Study|Lack of Efficacy|5|||
149830736|NCT03830164|540509901|FG002|Overall Study|Lack of Efficacy|0|||
149830737|NCT03830164|540509899|FG000|Overall Study|Lost to Follow-up|0|||
149830738|NCT03830164|540509900|FG001|Overall Study|Lost to Follow-up|1|||
149830739|NCT03830164|540509901|FG002|Overall Study|Lost to Follow-up|0|||
149830740|NCT03830164|540509899|FG000|Overall Study|Withdrawal by Subject|1|||
149830741|NCT03830164|540509900|FG001|Overall Study|Withdrawal by Subject|0|||
149830742|NCT03830164|540509901|FG002|Overall Study|Withdrawal by Subject|0|||
149830743|NCT00860405|540509902|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
149830744|NCT00860405|540509903|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
149830745|NCT01074554|540509905|FG000|Overall Study|Adverse Event|3|||
149948051|NCT04153864|540942033|FG003|Overall Study|Lost to Follow-up|0|||
149948052|NCT04153864|540942030|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
149948053|NCT04153864|540942031|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
149948054|NCT04153864|540942032|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
149948055|NCT04153864|540942033|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
149948056|NCT03036254|540942036|FG000|Overall Study|Adverse Event|6|||
149948057|NCT03036254|540942037|FG001|Overall Study|Adverse Event|4|||
149948058|NCT03036254|540942036|FG000|Overall Study|Death|3|||
149948059|NCT03036254|540942037|FG001|Overall Study|Death|1|||
149830746|NCT01074554|540509906|FG001|Overall Study|Adverse Event|3|||
149830747|NCT01074554|540509905|FG000|Overall Study|Lost to Follow-up|0|||
149830748|NCT01074554|540509906|FG001|Overall Study|Lost to Follow-up|1|||
149830749|NCT00497796|540509907|FG000|Overall Study|Adverse event (not related)|9|||
149830750|NCT00497796|540509908|FG001|Overall Study|Adverse event (not related)|9|||
149948060|NCT03036254|540942036|FG000|Overall Study|Lack of Efficacy|5|||
149830751|NCT00497796|540509907|FG000|Overall Study|Adverse event (related)|5|||
149830752|NCT00497796|540509908|FG001|Overall Study|Adverse event (related)|4|||
149830753|NCT00497796|540509907|FG000|Overall Study|CMV infection or disease treatment|30|||
150276661|NCT03250832|542150061|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
149830754|NCT00497796|540509908|FG001|Overall Study|CMV infection or disease treatment|4|||
149830755|NCT00497796|540509907|FG000|Overall Study|Consent withdrawn|10|||
149830756|NCT00497796|540509908|FG001|Overall Study|Consent withdrawn|3|||
149830757|NCT00497796|540509907|FG000|Overall Study|Investigator/sponsor discretion|31|||
149830758|NCT00497796|540509908|FG001|Overall Study|Investigator/sponsor discretion|34|||
149830759|NCT00497796|540509907|FG000|Overall Study|Lost to Follow-up|0|||
149830760|NCT00497796|540509908|FG001|Overall Study|Lost to Follow-up|1|||
149830761|NCT00497796|540509907|FG000|Overall Study|Not applicable (randomized not treated)|0|||
149830762|NCT00497796|540509908|FG001|Overall Study|Not applicable (randomized not treated)|4|||
149830763|NCT01004172|540509910|FG000|Overall Study|Progressive Disease in CNS Only|16|||
149830764|NCT01004172|540509910|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
149830765|NCT01004172|540509910|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
149830766|NCT01004172|540509910|FG000|Overall Study|Adverse Event|1|||
149830767|NCT01004172|540509910|FG000|Overall Study|Physician Decision|1|||
149830768|NCT01004172|540509910|FG000|Overall Study|Symptomatic Deterioration|2|||
149830769|NCT04526210|540511299|FG000|Overall Study|Sponsor decision|7|||
149830770|NCT04526210|540511300|FG001|Overall Study|Sponsor decision|5|||
149830771|NCT04526210|540511299|FG000|Overall Study|Withdrawal by Subject|3|||
149830772|NCT04526210|540511300|FG001|Overall Study|Withdrawal by Subject|2|||
149830773|NCT02924038|540511301|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
149830774|NCT02924038|540511302|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
149830775|NCT02473640|540511305|FG000|Treatment Period 1|Adverse Event|1|||
149830776|NCT02777528|540511308|FG000|Overall Study|Still in study|24|||
149830777|NCT02777528|540511309|FG001|Overall Study|Still in study|10|||
149830778|NCT02777528|540511310|FG002|Overall Study|Still in study|1|||
149830779|NCT02777528|540511308|FG000|Overall Study|Study Device Explanted|1|||
149830780|NCT02777528|540511309|FG001|Overall Study|Study Device Explanted|0|||
149830781|NCT02777528|540511310|FG002|Overall Study|Study Device Explanted|0|||
149830782|NCT02777528|540511308|FG000|Overall Study|Death|14|||
149830783|NCT02777528|540511309|FG001|Overall Study|Death|7|||
149830784|NCT02777528|540511310|FG002|Overall Study|Death|1|||
149830785|NCT02777528|540511308|FG000|Overall Study|Withdrawal by Subject|2|||
149830786|NCT02777528|540511309|FG001|Overall Study|Withdrawal by Subject|2|||
149830787|NCT02777528|540511310|FG002|Overall Study|Withdrawal by Subject|1|||
149830788|NCT02777528|540511308|FG000|Overall Study|Physician Decision|2|||
149830789|NCT02777528|540511309|FG001|Overall Study|Physician Decision|1|||
149830790|NCT02777528|540511310|FG002|Overall Study|Physician Decision|0|||
149830791|NCT02777528|540511308|FG000|Overall Study|Lost to Follow-up|2|||
149830792|NCT02777528|540511309|FG001|Overall Study|Lost to Follow-up|0|||
149830793|NCT02777528|540511310|FG002|Overall Study|Lost to Follow-up|0|||
149830794|NCT02777528|540511308|FG000|Overall Study|Discontinued due to Other|1|||
149830795|NCT02777528|540511309|FG001|Overall Study|Discontinued due to Other|0|||
149830796|NCT02777528|540511310|FG002|Overall Study|Discontinued due to Other|0|||
149830797|NCT00453362|540511313|FG000|Overall Study|Adverse Event|5|||
149830798|NCT00453362|540511313|FG000|Overall Study|Death|7|||
149830799|NCT00453362|540511313|FG000|Overall Study|Physician Decision|2|||
149830800|NCT00453362|540511313|FG000|Overall Study|Withdrawal by Subject|3|||
149830801|NCT00453362|540511313|FG000|Overall Study|Progression of disease|56|||
149830802|NCT00453362|540511313|FG000|Overall Study|Screening Failure|14|||
149830803|NCT04885296|540511314|FG000|Period 1|Covid-19 Related|1|||
149830804|NCT04885296|540511315|FG001|Period 1|Covid-19 Related|0|||
149830805|NCT04885296|540511314|FG000|Period 1|Adverse Event|0|||
149830806|NCT04885296|540511315|FG001|Period 1|Adverse Event|1|||
149830807|NCT04885296|540511314|FG000|Period 1|Withdrawal by Subject|1|||
149830808|NCT04885296|540511315|FG001|Period 1|Withdrawal by Subject|1|||
149830809|NCT04885296|540511314|FG000|Period 1|Test Article No Longer Available|1|||
149830810|NCT04885296|540511315|FG001|Period 1|Test Article No Longer Available|0|||
149948061|NCT03036254|540942037|FG001|Overall Study|Lack of Efficacy|1|||
150170653|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170654|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170655|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170656|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
150170657|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
150170658|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170659|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
150170660|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149830811|NCT04885296|540511314|FG000|Period 1|Dispensed Study lens in Error|1|||
149830812|NCT04885296|540511315|FG001|Period 1|Dispensed Study lens in Error|0|||
149830813|NCT04885296|540511314|FG000|Period 1|Lost to Follow-up|1|||
149830814|NCT04885296|540511315|FG001|Period 1|Lost to Follow-up|0|||
149830815|NCT04885296|540511314|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
149830816|NCT04885296|540511315|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
149830817|NCT00433147|540511317|FG000|Overall Study|Adverse Event|0|||
149830818|NCT00433147|540511318|FG001|Overall Study|Adverse Event|1|||
149830819|NCT00433147|540511319|FG002|Overall Study|Adverse Event|0|||
149830820|NCT00433147|540511320|FG003|Overall Study|Adverse Event|0|||
149830821|NCT01882647|540511321|FG000|Overall Study|Lost to Follow-up|2|||
149830822|NCT01882647|540511322|FG001|Overall Study|Lost to Follow-up|2|||
149830823|NCT01882647|540511321|FG000|Overall Study|Withdrawal by Subject|0|||
149830824|NCT01882647|540511322|FG001|Overall Study|Withdrawal by Subject|4|||
149830825|NCT02937701|540511323|FG000|Day 1 to Week 22|Adverse Event|11|||
149830826|NCT02937701|540511324|FG001|Day 1 to Week 22|Adverse Event|14|||
149830827|NCT02937701|540511325|FG002|Day 1 to Week 22|Adverse Event|0|||
149830828|NCT02937701|540511326|FG003|Day 1 to Week 22|Adverse Event|0|||
149830829|NCT02937701|540511327|FG004|Day 1 to Week 22|Adverse Event|0|||
149830830|NCT02937701|540511323|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
149830831|NCT02937701|540511324|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
149830832|NCT02937701|540511325|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
149830833|NCT02937701|540511326|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
149830834|NCT02937701|540511327|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
149830835|NCT02937701|540511323|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
149830836|NCT02937701|540511324|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
149830837|NCT02937701|540511325|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
149830838|NCT02937701|540511326|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
149830839|NCT02937701|540511327|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
149830840|NCT02937701|540511323|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
149830841|NCT02937701|540511324|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
149830842|NCT02937701|540511325|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
149830843|NCT02937701|540511326|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
149830844|NCT02937701|540511327|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
149830845|NCT02937701|540511323|FG000|Day 1 to Week 22|Death|1|||
149830846|NCT02937701|540511324|FG001|Day 1 to Week 22|Death|1|||
149830847|NCT02937701|540511325|FG002|Day 1 to Week 22|Death|0|||
149830848|NCT02937701|540511326|FG003|Day 1 to Week 22|Death|0|||
149830849|NCT02937701|540511327|FG004|Day 1 to Week 22|Death|0|||
149830850|NCT02937701|540511323|FG000|Day 1 to Week 22|Protocol Violation|1|||
149830851|NCT02937701|540511324|FG001|Day 1 to Week 22|Protocol Violation|1|||
149830852|NCT02937701|540511325|FG002|Day 1 to Week 22|Protocol Violation|0|||
149830853|NCT02937701|540511326|FG003|Day 1 to Week 22|Protocol Violation|0|||
149830854|NCT02937701|540511327|FG004|Day 1 to Week 22|Protocol Violation|0|||
149830855|NCT02937701|540511323|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
149830856|NCT02937701|540511324|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
149830857|NCT02937701|540511325|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
149830858|NCT02937701|540511326|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
149830859|NCT02937701|540511327|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
149830860|NCT02937701|540511323|FG000|Day 1 to Week 22|Physician Decision|2|||
149830861|NCT02937701|540511324|FG001|Day 1 to Week 22|Physician Decision|0|||
149830862|NCT02937701|540511325|FG002|Day 1 to Week 22|Physician Decision|0|||
149830863|NCT02937701|540511326|FG003|Day 1 to Week 22|Physician Decision|0|||
149830864|NCT02937701|540511327|FG004|Day 1 to Week 22|Physician Decision|0|||
149830865|NCT02937701|540511323|FG000|Day 1 to Week 22|Other|1|||
149830866|NCT02937701|540511324|FG001|Day 1 to Week 22|Other|0|||
149830867|NCT02937701|540511325|FG002|Day 1 to Week 22|Other|0|||
149830868|NCT02937701|540511326|FG003|Day 1 to Week 22|Other|0|||
149830869|NCT02937701|540511327|FG004|Day 1 to Week 22|Other|0|||
149830870|NCT02937701|540511323|FG000|Week 22 to Week 50|Adverse Event|0|||
149830871|NCT02937701|540511324|FG001|Week 22 to Week 50|Adverse Event|0|||
149830872|NCT02937701|540511325|FG002|Week 22 to Week 50|Adverse Event|10|||
149830873|NCT02937701|540511326|FG003|Week 22 to Week 50|Adverse Event|3|||
149830874|NCT02937701|540511327|FG004|Week 22 to Week 50|Adverse Event|3|||
149830875|NCT02937701|540511323|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
149830876|NCT02937701|540511324|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
149830877|NCT02937701|540511325|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
149830878|NCT02937701|540511326|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
149948062|NCT03036254|540942036|FG000|Overall Study|Withdrawal by Subject|3|||
149948063|NCT03036254|540942037|FG001|Overall Study|Withdrawal by Subject|5|||
149948064|NCT02783274|540942045|FG000|Overall Study|Withdrawal by Subject|16|||
149948065|NCT02783274|540942045|FG000|Overall Study|Physician Decision|6|||
149948066|NCT02783274|540942045|FG000|Overall Study|Death|9|||
150276662|NCT03250832|542150062|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
149948067|NCT02783274|540942045|FG000|Overall Study|Lost to Follow-up|22|||
150276663|NCT03250832|542150063|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
149830879|NCT02937701|540511327|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
149830880|NCT02937701|540511323|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
150276664|NCT03250832|542150064|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
149830881|NCT02937701|540511324|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
149830882|NCT02937701|540511325|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
149830883|NCT02937701|540511326|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
149830884|NCT02937701|540511327|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
149830885|NCT02937701|540511323|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
149830886|NCT02937701|540511324|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
149830887|NCT02937701|540511325|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
149948068|NCT02783274|540942045|FG000|Overall Study|Other|22|||
149948069|NCT04717557|540942046|FG000|Overall Study|Withdrawal by Subject|2|||
150276665|NCT03250832|542150065|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
150276666|NCT03250832|542150066|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
150276667|NCT03250832|542150067|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
150276668|NCT03250832|542150068|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
150276669|NCT03250832|542150057|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
150276670|NCT03250832|542150058|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
150276671|NCT03250832|542150059|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
150276672|NCT03250832|542150060|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
150276673|NCT03250832|542150061|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
150276674|NCT03250832|542150062|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
150276675|NCT03250832|542150063|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
150276676|NCT03250832|542150064|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
150276677|NCT03250832|542150065|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
150276678|NCT03250832|542150066|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
150276679|NCT03250832|542150067|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149830888|NCT02937701|540511326|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
149948070|NCT04717557|540942047|FG001|Overall Study|Withdrawal by Subject|0|||
149948071|NCT04717557|540942046|FG000|Overall Study|Death|1|||
150276680|NCT03250832|542150068|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
150276681|NCT03250832|542150057|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276682|NCT03250832|542150058|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276683|NCT03250832|542150059|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
150276684|NCT03250832|542150060|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276685|NCT03250832|542150061|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276686|NCT03250832|542150062|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276687|NCT03250832|542150063|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276688|NCT03250832|542150064|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276689|NCT03250832|542150065|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276690|NCT03250832|542150066|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276691|NCT03250832|542150067|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276692|NCT03250832|542150068|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
150276693|NCT03250832|542150057|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276694|NCT03250832|542150058|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276695|NCT03250832|542150059|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276696|NCT03250832|542150060|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276697|NCT03250832|542150061|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276698|NCT03250832|542150062|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276699|NCT03250832|542150063|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276700|NCT03250832|542150064|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
150276701|NCT03250832|542150065|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276702|NCT03250832|542150066|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276703|NCT03250832|542150067|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276704|NCT03250832|542150068|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
150276705|NCT03250832|542150057|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276706|NCT03250832|542150058|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276707|NCT03250832|542150059|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276708|NCT03250832|542150060|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276709|NCT03250832|542150061|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276710|NCT03250832|542150062|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276711|NCT03250832|542150063|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276712|NCT03250832|542150064|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
150276713|NCT03250832|542150065|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276714|NCT03250832|542150066|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276715|NCT03250832|542150067|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149948072|NCT04717557|540942047|FG001|Overall Study|Death|0|||
149948073|NCT06354257|540942051|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149948074|NCT06354257|540942051|FG000|Treatment Period 2|Adverse Event|1|||
149948075|NCT03488524|540942052|FG000|Overall Study|Withdrawal by Subject|51|||
149948076|NCT03488524|540942052|FG000|Overall Study|Death|19|||
149948077|NCT03488524|540942052|FG000|Overall Study|Study Sponsor|11|||
149830889|NCT02937701|540511327|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
149830890|NCT02937701|540511323|FG000|Week 22 to Week 50|Physician Decision|0|||
149948078|NCT03488524|540942052|FG000|Overall Study|Physician Decision|4|||
149948079|NCT03488524|540942052|FG000|Overall Study|Lost to Follow-up|3|||
149948080|NCT01811238|540942053|FG000|Overall Study|Withdrawal by Subject|42|||
149830891|NCT02937701|540511324|FG001|Week 22 to Week 50|Physician Decision|0|||
149948081|NCT01811238|540942053|FG000|Overall Study|Adverse Event|25|||
149948082|NCT01811238|540942053|FG000|Overall Study|Protocol Violation|4|||
150276716|NCT03250832|542150068|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
150276717|NCT03250832|542150057|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276718|NCT03250832|542150058|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276719|NCT03250832|542150059|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276720|NCT03250832|542150060|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276721|NCT03250832|542150061|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276722|NCT03250832|542150062|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276723|NCT03250832|542150063|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276724|NCT03250832|542150064|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
150276725|NCT03250832|542150065|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276726|NCT03250832|542150066|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276727|NCT03250832|542150067|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276728|NCT03250832|542150068|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
150276729|NCT03250832|542150057|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276730|NCT03250832|542150058|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276731|NCT03250832|542150059|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276732|NCT03250832|542150060|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276733|NCT03250832|542150061|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276734|NCT03250832|542150062|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276735|NCT03250832|542150063|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276736|NCT03250832|542150064|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
150276737|NCT03250832|542150065|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276738|NCT03250832|542150066|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276739|NCT03250832|542150067|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276740|NCT03250832|542150068|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
150276741|NCT03250832|542150057|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276742|NCT03250832|542150058|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276743|NCT03250832|542150059|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276744|NCT03250832|542150060|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276745|NCT03250832|542150061|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276746|NCT03250832|542150062|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276747|NCT03250832|542150063|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276748|NCT03250832|542150064|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
150276749|NCT03250832|542150065|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276750|NCT03250832|542150066|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276751|NCT03250832|542150067|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276752|NCT03250832|542150068|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
150276753|NCT03250832|542150057|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276754|NCT03250832|542150058|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276755|NCT03250832|542150059|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276756|NCT03250832|542150060|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276757|NCT03250832|542150061|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276758|NCT03250832|542150062|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276759|NCT03250832|542150063|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276760|NCT03250832|542150064|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276761|NCT03250832|542150065|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
150276762|NCT03250832|542150066|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
150276763|NCT03250832|542150067|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276764|NCT03250832|542150068|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
150276765|NCT03250832|542150057|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276766|NCT03250832|542150058|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276767|NCT03250832|542150059|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276768|NCT03250832|542150060|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276769|NCT03250832|542150061|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276770|NCT03250832|542150062|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276771|NCT03250832|542150063|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276772|NCT03250832|542150064|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276773|NCT03250832|542150065|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
150276774|NCT03250832|542150066|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
150276775|NCT03250832|542150067|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276776|NCT03250832|542150068|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
150276777|NCT03250832|542150057|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276778|NCT03250832|542150058|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276779|NCT03250832|542150059|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276780|NCT03250832|542150060|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276781|NCT03250832|542150061|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276782|NCT03250832|542150062|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276783|NCT03250832|542150063|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276784|NCT03250832|542150064|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276785|NCT03250832|542150065|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
150276786|NCT03250832|542150066|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
150276787|NCT03250832|542150067|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276788|NCT03250832|542150068|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
150276789|NCT03250832|542150057|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276790|NCT03250832|542150058|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276791|NCT03250832|542150059|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276792|NCT03250832|542150060|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276793|NCT03250832|542150061|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276794|NCT03250832|542150062|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276795|NCT03250832|542150063|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276796|NCT03250832|542150064|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276797|NCT03250832|542150065|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276798|NCT03250832|542150066|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276799|NCT03250832|542150067|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
150276800|NCT03250832|542150068|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
150276801|NCT02303704|542150069|FG000|Overall Study|Protocol Violation|5|||
150276802|NCT02303704|542150070|FG001|Overall Study|Protocol Violation|9|||
150276803|NCT01034540|542150071|FG000|Overall Study|Adverse Event|0|||
150276804|NCT01034540|542150072|FG001|Overall Study|Adverse Event|1|||
150276805|NCT05293743|542150082|FG000|Overall Study|Withdrawal by Subject|1|||
150276806|NCT05293743|542150083|FG001|Overall Study|Withdrawal by Subject|0|||
150276807|NCT02064920|542150084|FG000|Overall Study|Adverse Event|0|||
150276808|NCT02064920|542150085|FG001|Overall Study|Adverse Event|4|||
150276809|NCT02064920|542150084|FG000|Overall Study|Physician Decision|0|||
150276810|NCT02064920|542150085|FG001|Overall Study|Physician Decision|1|||
150276811|NCT02064920|542150084|FG000|Overall Study|Technical Problems|0|||
150276812|NCT02064920|542150085|FG001|Overall Study|Technical Problems|1|||
150276813|NCT02064920|542150084|FG000|Overall Study|Withdrawal by Subject|1|||
150276814|NCT02064920|542150085|FG001|Overall Study|Withdrawal by Subject|3|||
150276815|NCT00916279|542150086|FG000|Overall Study|Death|2|||
150276816|NCT00916279|542150086|FG000|Overall Study|Lost to Follow-up|2|||
150276817|NCT00310804|542150087|FG000|Overall Study|Lost to Follow-up|2|||
150276818|NCT00310804|542150088|FG001|Overall Study|Lost to Follow-up|0|||
150276819|NCT00310804|542150087|FG000|Overall Study|Withdrawal by Subject|3|||
150276820|NCT00310804|542150088|FG001|Overall Study|Withdrawal by Subject|0|||
150276821|NCT00688155|542150093|FG000|Overall Study|Withdrawal by Subject|2|||
150276822|NCT00688155|542150094|FG001|Overall Study|Withdrawal by Subject|2|||
150276823|NCT00688155|542150095|FG002|Overall Study|Withdrawal by Subject|1|||
150276824|NCT00688155|542150096|FG003|Overall Study|Withdrawal by Subject|1|||
150276825|NCT03697720|542151827|FG000|Overall Study|Lost to Follow-up|7|||
150276826|NCT01183143|542151828|FG000|Overall Study|Protocol Violation|115|||
150276827|NCT01183143|542151828|FG000|Overall Study|Withdrawal by Subject|19|||
150276828|NCT01183143|542151828|FG000|Overall Study|Subject Questionnaires not returned|5|||
150276829|NCT01183143|542151828|FG000|Overall Study|Subjects enrolled, but not treated|11|||
150276830|NCT04096274|542151829|FG000|Phase I|Lost to Follow-up|5|||
149948083|NCT01811238|540942053|FG000|Overall Study|Lack of Efficacy|4|||
149948084|NCT01811238|540942053|FG000|Overall Study|subject refused study medication|6|||
149948085|NCT03980223|540942054|FG000|Overall Study|Lost to Follow-up|3|||
149948086|NCT03980223|540942055|FG001|Overall Study|Lost to Follow-up|7|||
149948087|NCT03980223|540942056|FG002|Overall Study|Lost to Follow-up|10|||
149948088|NCT03980223|540942057|FG003|Overall Study|Lost to Follow-up|8|||
149948089|NCT03980223|540942054|FG000|Overall Study|Withdrawal by Subject|0|||
149948090|NCT03980223|540942055|FG001|Overall Study|Withdrawal by Subject|0|||
149948091|NCT03980223|540942056|FG002|Overall Study|Withdrawal by Subject|1|||
149948092|NCT03980223|540942057|FG003|Overall Study|Withdrawal by Subject|2|||
149948093|NCT03980223|540942054|FG000|Overall Study|Physician Decision|0|||
149948094|NCT03980223|540942055|FG001|Overall Study|Physician Decision|0|||
149948095|NCT03980223|540942056|FG002|Overall Study|Physician Decision|1|||
149948096|NCT03980223|540942057|FG003|Overall Study|Physician Decision|0|||
150276831|NCT04096274|542151830|FG001|Phase I|Lost to Follow-up|5|||
150276832|NCT04096274|542151829|FG000|Phase II|Lost to Follow-up|11|||
150276833|NCT04096274|542151830|FG001|Phase II|Lost to Follow-up|11|||
150276834|NCT01942148|542151831|FG000|Overall Study|Adverse Event|4|||
150276835|NCT01942148|542151831|FG000|Overall Study|Lack of Efficacy|2|||
150276836|NCT01942148|542151831|FG000|Overall Study|Physician Decision|11|||
150276837|NCT01942148|542151831|FG000|Overall Study|Protocol Violation|1|||
150276838|NCT01942148|542151831|FG000|Overall Study|Withdrawal by Subject|8|||
149948097|NCT03980223|540942054|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
149830892|NCT02937701|540511325|FG002|Week 22 to Week 50|Physician Decision|2|||
149830893|NCT02937701|540511326|FG003|Week 22 to Week 50|Physician Decision|0|||
149830894|NCT02937701|540511327|FG004|Week 22 to Week 50|Physician Decision|1|||
149830895|NCT02937701|540511323|FG000|Week 22 to Week 50|Other|0|||
149830896|NCT02937701|540511324|FG001|Week 22 to Week 50|Other|0|||
150170661|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170662|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170663|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170664|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170665|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170666|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170667|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170668|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
150170669|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
150170670|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
150170671|NCT02914522|541759095|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170672|NCT02914522|541759096|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170673|NCT02914522|541759097|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170674|NCT02914522|541759098|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170675|NCT02914522|541759099|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170676|NCT02914522|541759100|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170677|NCT02914522|541759101|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170678|NCT02914522|541759102|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170679|NCT02914522|541759103|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170680|NCT02914522|541759104|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
150170681|NCT02914522|541759105|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
150170682|NCT00177216|541759106|FG000|Overall Study|Withdrawal by Subject|6|||
150170683|NCT00177216|541759107|FG001|Overall Study|Withdrawal by Subject|3|||
150170684|NCT00177216|541759108|FG002|Overall Study|Withdrawal by Subject|1|||
150170685|NCT00811057|541759109|FG000|Overall Study|Protocol Violation|5|||
150170686|NCT00811057|541759110|FG001|Overall Study|Protocol Violation|10|||
150170687|NCT00811057|541759111|FG002|Overall Study|Protocol Violation|10|||
150170688|NCT01773122|541759112|FG000|Overall Study|Due to amended age eligibility criteria|3|||
150170689|NCT01773122|541759113|FG001|Overall Study|Due to amended age eligibility criteria|1|||
150170690|NCT01773122|541759114|FG002|Overall Study|Due to amended age eligibility criteria|0|||
150170691|NCT01773122|541759115|FG003|Overall Study|Due to amended age eligibility criteria|1|||
150170692|NCT01264718|541759116|FG000|Overall Study|Lost to Follow-up|3|||
150170693|NCT01264718|541759117|FG001|Overall Study|Lost to Follow-up|2|||
150170694|NCT01264718|541759116|FG000|Overall Study|Withdrawal by Subject|9|||
150170695|NCT01264718|541759117|FG001|Overall Study|Withdrawal by Subject|15|||
150170696|NCT01264718|541759116|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
150170697|NCT01264718|541759117|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
150170698|NCT03545984|541759120|FG000|Overall Study|CSF cases not present during rotation|11|||
150170699|NCT03545984|541759121|FG001|Overall Study|CSF cases not present during rotation|9|||
150170700|NCT01768676|541759122|FG000|Overall Study|Adverse Event|3|||
150170701|NCT01768676|541759123|FG001|Overall Study|Adverse Event|3|||
150170702|NCT01768676|541759122|FG000|Overall Study|Lost to Follow-up|13|||
150170703|NCT01768676|541759123|FG001|Overall Study|Lost to Follow-up|16|||
150170704|NCT01768676|541759122|FG000|Overall Study|Protocol Violation|1|||
150170705|NCT01768676|541759123|FG001|Overall Study|Protocol Violation|1|||
150170706|NCT01768676|541759122|FG000|Overall Study|Physician Decision|4|||
150170707|NCT01768676|541759123|FG001|Overall Study|Physician Decision|1|||
150170708|NCT01768676|541759122|FG000|Overall Study|Withdrawal by Subject|3|||
150170709|NCT01768676|541759123|FG001|Overall Study|Withdrawal by Subject|10|||
150170710|NCT03121950|541759125|FG000|Overall Study|Withdrawal by Subject|11|||
150170711|NCT03121950|541759126|FG001|Overall Study|Withdrawal by Subject|2|||
150170712|NCT03183518|541759132|FG000|Overall Study|Other (Not specified)|2|||
150170713|NCT03183518|541759132|FG000|Overall Study|Other (Withdrawal of consent)|1|||
150170714|NCT04248829|541759133|FG000|Overall Study|Disease progression|44|||
150170715|NCT04248829|541759134|FG001|Overall Study|Disease progression|109|||
150170716|NCT04248829|541759133|FG000|Overall Study|Adverse Event|19|||
150170717|NCT04248829|541759134|FG001|Overall Study|Adverse Event|18|||
150170718|NCT04248829|541759133|FG000|Overall Study|Withdrawal by Subject|11|||
150170719|NCT04248829|541759134|FG001|Overall Study|Withdrawal by Subject|2|||
150170720|NCT04248829|541759133|FG000|Overall Study|Lost to Follow-up|0|||
149830897|NCT02937701|540511325|FG002|Week 22 to Week 50|Other|0|||
150170721|NCT04248829|541759134|FG001|Overall Study|Lost to Follow-up|1|||
150170722|NCT04248829|541759133|FG000|Overall Study|Death|12|||
150170723|NCT04248829|541759134|FG001|Overall Study|Death|14|||
150170724|NCT04248829|541759133|FG000|Overall Study|Physician Decision|2|||
150170725|NCT04248829|541759134|FG001|Overall Study|Physician Decision|4|||
150170726|NCT04248829|541759133|FG000|Overall Study|Any reason not specifically recorded|0|||
150170727|NCT04248829|541759134|FG001|Overall Study|Any reason not specifically recorded|2|||
150170728|NCT02132702|541759135|FG000|Overall Study|Protocol Violation|2|||
150170729|NCT02132702|541759135|FG000|Overall Study|Adverse Event|3|||
150170730|NCT02132702|541759135|FG000|Overall Study|Withdrawal by Subject|3|||
150170731|NCT01867580|541759137|FG000|Overall Study|Withdrawal by Subject|2|||
150170732|NCT01867580|541759138|FG001|Overall Study|Withdrawal by Subject|3|||
150170733|NCT01867580|541759137|FG000|Overall Study|Physician Decision|17|||
150170734|NCT01867580|541759138|FG001|Overall Study|Physician Decision|12|||
150170735|NCT01867580|541759137|FG000|Overall Study|Lost to Follow-up|3|||
150170736|NCT01867580|541759138|FG001|Overall Study|Lost to Follow-up|5|||
150170737|NCT01867580|541759137|FG000|Overall Study|Sponsor terminated study|1|||
150170738|NCT01867580|541759138|FG001|Overall Study|Sponsor terminated study|0|||
150170739|NCT01867580|541759137|FG000|Overall Study|Missed follow-up assessment|2|||
150170740|NCT01867580|541759138|FG001|Overall Study|Missed follow-up assessment|1|||
150170741|NCT01867580|541759137|FG000|Overall Study|Interruption to therapy|3|||
150170742|NCT01867580|541759138|FG001|Overall Study|Interruption to therapy|0|||
150170743|NCT01867580|541759137|FG000|Overall Study|Osteomyelitis|0|||
150170744|NCT01867580|541759138|FG001|Overall Study|Osteomyelitis|1|||
150170745|NCT01867580|541759137|FG000|Overall Study|Continuation of therapy|0|||
150170746|NCT01867580|541759138|FG001|Overall Study|Continuation of therapy|1|||
150170747|NCT01867580|541759137|FG000|Overall Study|Wound recurrence|0|||
150170748|NCT01867580|541759138|FG001|Overall Study|Wound recurrence|1|||
150170749|NCT01304147|541759139|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
150170750|NCT01304147|541759140|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
150170751|NCT01244828|541759141|FG000|Overall Study|Adverse Event|37|||
150170752|NCT01244828|541759141|FG000|Overall Study|Withdrawal by Subject|31|||
150170753|NCT01244828|541759141|FG000|Overall Study|Lack of Efficacy|7|||
150170754|NCT01244828|541759141|FG000|Overall Study|Lost to Follow-up|2|||
150170755|NCT01244828|541759141|FG000|Overall Study|Other reason (not specified)|1|||
150170756|NCT01198275|541760728|FG000|Overall Study|Adverse Event|2|||
150170757|NCT01198275|541760729|FG001|Overall Study|Adverse Event|3|||
150170758|NCT01198275|541760728|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
150170759|NCT01198275|541760729|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
150170760|NCT00150176|541760730|FG000|Overall Study|Adverse Event|16|||
150170761|NCT00150176|541760731|FG001|Overall Study|Adverse Event|53|||
150170762|NCT00150176|541760730|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
150170763|NCT00150176|541760731|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
150170764|NCT00150176|541760730|FG000|Overall Study|Withdrawal by Subject|19|||
150170765|NCT00150176|541760731|FG001|Overall Study|Withdrawal by Subject|12|||
150170766|NCT00150176|541760730|FG000|Overall Study|Lost to Follow-up|3|||
150170767|NCT00150176|541760731|FG001|Overall Study|Lost to Follow-up|3|||
150170768|NCT00150176|541760730|FG000|Overall Study|OTHER|11|||
150170769|NCT00150176|541760731|FG001|Overall Study|OTHER|13|||
150170770|NCT00393848|541760732|FG000|Overall Study|Surgical schedule|0|||
150170771|NCT00393848|541760733|FG001|Overall Study|Surgical schedule|0|||
150170772|NCT00393848|541760734|FG002|Overall Study|Surgical schedule|0|||
150170773|NCT00393848|541760735|FG003|Overall Study|Surgical schedule|1|||
150170774|NCT00393848|541760732|FG000|Overall Study|Personal reasons|0|||
150170775|NCT00393848|541760733|FG001|Overall Study|Personal reasons|0|||
150170776|NCT00393848|541760734|FG002|Overall Study|Personal reasons|2|||
150170777|NCT00393848|541760735|FG003|Overall Study|Personal reasons|0|||
150170778|NCT02192606|541760736|FG000|Overall Study|surgery type was changed|1|||
150170779|NCT02192606|541760737|FG001|Overall Study|surgery type was changed|1|||
150170780|NCT02192606|541760736|FG000|Overall Study|Physician Decision|1|||
150170781|NCT02192606|541760737|FG001|Overall Study|Physician Decision|2|||
150170782|NCT02192606|541760736|FG000|Overall Study|3D equipment rep unable to join|0|||
150170783|NCT02192606|541760737|FG001|Overall Study|3D equipment rep unable to join|1|||
150170784|NCT01616654|541760744|FG000|Overall Study|Lack of Efficacy|1|||
150276839|NCT01942148|542151831|FG000|Overall Study|Use of the prohibition medicine|1|||
150276840|NCT02248259|542151832|FG000|Treatment Period 1|Adverse Event|0|||
150276841|NCT02248259|542151833|FG001|Treatment Period 1|Adverse Event|0|||
149948098|NCT03980223|540942055|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
150170785|NCT01616654|541760745|FG001|Overall Study|Lack of Efficacy|0|||
150170786|NCT01616654|541760746|FG002|Overall Study|Lack of Efficacy|0|||
150170787|NCT01616654|541760747|FG003|Overall Study|Lack of Efficacy|0|||
149948099|NCT03980223|540942056|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
150170788|NCT01616654|541760748|FG004|Overall Study|Lack of Efficacy|1|||
150170789|NCT01616654|541760744|FG000|Overall Study|Adverse Event|0|||
150170790|NCT01616654|541760745|FG001|Overall Study|Adverse Event|1|||
150170791|NCT01616654|541760746|FG002|Overall Study|Adverse Event|2|||
150170792|NCT01616654|541760747|FG003|Overall Study|Adverse Event|1|||
150170793|NCT01616654|541760748|FG004|Overall Study|Adverse Event|0|||
150170794|NCT01616654|541760744|FG000|Overall Study|Withdrawal by Subject|2|||
150170795|NCT01616654|541760745|FG001|Overall Study|Withdrawal by Subject|2|||
150170796|NCT01616654|541760746|FG002|Overall Study|Withdrawal by Subject|3|||
150170797|NCT01616654|541760747|FG003|Overall Study|Withdrawal by Subject|1|||
150276842|NCT02248259|542151834|FG002|Treatment Period 1|Adverse Event|1|||
150276843|NCT02248259|542151835|FG003|Treatment Period 1|Adverse Event|0|||
150276844|NCT02807480|542151836|FG000|Overall Study|Withdrawal by Subject|14|||
150276845|NCT02807480|542151837|FG001|Overall Study|Withdrawal by Subject|10|||
150276846|NCT02369848|542151838|FG000|Overall Study|Death|1|||
150276847|NCT02369848|542151838|FG000|Overall Study|Withdrawal by Subject|2|||
150276848|NCT02369848|542151838|FG000|Overall Study|Lost to Follow-up|1|||
150276849|NCT00096785|542151842|FG000|Overall Study|Lost to Follow-up|1|||
150276850|NCT00096785|542151843|FG001|Overall Study|Lost to Follow-up|0|||
150276851|NCT00096785|542151842|FG000|Overall Study|Withdrawal by Subject|0|||
150276852|NCT00096785|542151843|FG001|Overall Study|Withdrawal by Subject|1|||
150276853|NCT00096785|542151842|FG000|Overall Study|Relocated|1|||
150276854|NCT00096785|542151843|FG001|Overall Study|Relocated|0|||
150276855|NCT00257725|542151844|FG000|Overall Study|Adverse Event|3|||
150276856|NCT02573870|542151845|FG000|Overall Study|Adverse Event|0|||
150276857|NCT02573870|542151846|FG001|Overall Study|Adverse Event|2|||
150276858|NCT02573870|542151845|FG000|Overall Study|Lack of Efficacy|0|||
150276859|NCT02573870|542151846|FG001|Overall Study|Lack of Efficacy|1|||
150276860|NCT02573870|542151845|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
150276861|NCT02573870|542151846|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
150276862|NCT02573870|542151845|FG000|Overall Study|Lost to Follow-up|0|||
150276863|NCT02573870|542151846|FG001|Overall Study|Lost to Follow-up|1|||
150276864|NCT02573870|542151845|FG000|Overall Study|Other: Fail to Meet Visit|0|||
150276865|NCT02573870|542151846|FG001|Overall Study|Other: Fail to Meet Visit|2|||
150276866|NCT01858532|542151847|FG000|Overall Study|Adverse Event|58|||
150276867|NCT01858532|542151848|FG001|Overall Study|Adverse Event|50|||
150276868|NCT01858532|542151849|FG002|Overall Study|Adverse Event|23|||
150276869|NCT01858532|542151850|FG003|Overall Study|Adverse Event|28|||
150276870|NCT01858532|542151847|FG000|Overall Study|Withdrew consent|71|||
150276871|NCT01858532|542151848|FG001|Overall Study|Withdrew consent|93|||
150276872|NCT01858532|542151849|FG002|Overall Study|Withdrew consent|46|||
150276873|NCT01858532|542151850|FG003|Overall Study|Withdrew consent|27|||
150276874|NCT01858532|542151847|FG000|Overall Study|Lost to Follow-up|17|||
150276875|NCT01858532|542151848|FG001|Overall Study|Lost to Follow-up|26|||
150276876|NCT01858532|542151849|FG002|Overall Study|Lost to Follow-up|11|||
150276877|NCT01858532|542151850|FG003|Overall Study|Lost to Follow-up|14|||
150276878|NCT01858532|542151847|FG000|Overall Study|Deterioration of medical status|3|||
150276879|NCT01858532|542151848|FG001|Overall Study|Deterioration of medical status|4|||
150276880|NCT01858532|542151849|FG002|Overall Study|Deterioration of medical status|3|||
150276881|NCT01858532|542151850|FG003|Overall Study|Deterioration of medical status|7|||
150276882|NCT01858532|542151847|FG000|Overall Study|Investigator request|3|||
150276883|NCT01858532|542151848|FG001|Overall Study|Investigator request|4|||
150276884|NCT01858532|542151849|FG002|Overall Study|Investigator request|2|||
150276885|NCT01858532|542151850|FG003|Overall Study|Investigator request|6|||
150276886|NCT01858532|542151847|FG000|Overall Study|Other, not specified|29|||
150276887|NCT01858532|542151848|FG001|Overall Study|Other, not specified|15|||
150276888|NCT01858532|542151849|FG002|Overall Study|Other, not specified|13|||
150276889|NCT01858532|542151850|FG003|Overall Study|Other, not specified|11|||
150276890|NCT00514514|542151851|FG000|Pre-phase|Death|10|||
150276891|NCT00514514|542151852|FG001|Pre-phase|Death|0|||
150276892|NCT00514514|542151853|FG002|Pre-phase|Death|0|||
150276893|NCT00514514|542151851|FG000|Pre-phase|administrative problems|2|||
150276894|NCT00514514|542151852|FG001|Pre-phase|administrative problems|0|||
150276895|NCT00514514|542151853|FG002|Pre-phase|administrative problems|0|||
150276896|NCT00514514|542151851|FG000|Pre-phase|Protocol Violation|6|||
150276897|NCT00514514|542151852|FG001|Pre-phase|Protocol Violation|0|||
150276898|NCT00514514|542151853|FG002|Pre-phase|Protocol Violation|0|||
150276899|NCT00514514|542151851|FG000|Pre-phase|condition no longer requires study drug|7|||
150276900|NCT00514514|542151852|FG001|Pre-phase|condition no longer requires study drug|0|||
149948100|NCT03980223|540942057|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
149948101|NCT01922934|540942064|FG000|Eligible Patients|Death|0|||
149948102|NCT01922934|540942065|FG001|Eligible Patients|Death|7|||
149948103|NCT01922934|540942064|FG000|Eligible Patients|Physician Decision|17|||
149948104|NCT01922934|540942065|FG001|Eligible Patients|Physician Decision|0|||
149948105|NCT01922934|540942064|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
149948106|NCT01922934|540942065|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
149948107|NCT01922934|540942064|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
149948108|NCT01922934|540942065|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
149948109|NCT01922934|540942064|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
149948110|NCT01922934|540942065|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
149975628|NCT00038948|541047923|FG001|Overall Study|Adverse Event|43|||
150276901|NCT00514514|542151853|FG002|Pre-phase|condition no longer requires study drug|0|||
150276902|NCT00514514|542151851|FG000|Pre-phase|abnormal test procedure results|15|||
150276903|NCT00514514|542151852|FG001|Pre-phase|abnormal test procedure results|0|||
150276904|NCT00514514|542151853|FG002|Pre-phase|abnormal test procedure results|0|||
150276905|NCT00514514|542151851|FG000|Pre-phase|Lost to Follow-up|2|||
150276906|NCT00514514|542151852|FG001|Pre-phase|Lost to Follow-up|0|||
150276907|NCT00514514|542151853|FG002|Pre-phase|Lost to Follow-up|0|||
150276908|NCT00514514|542151851|FG000|Pre-phase|abnormal lab values|23|||
150276909|NCT00514514|542151852|FG001|Pre-phase|abnormal lab values|0|||
150276910|NCT00514514|542151853|FG002|Pre-phase|abnormal lab values|0|||
150276911|NCT00514514|542151851|FG000|Pre-phase|Lack of Efficacy|35|||
150276912|NCT00514514|542151852|FG001|Pre-phase|Lack of Efficacy|0|||
150276913|NCT00514514|542151853|FG002|Pre-phase|Lack of Efficacy|0|||
150276914|NCT00514514|542151851|FG000|Pre-phase|Adverse Event|137|||
150276915|NCT00514514|542151852|FG001|Pre-phase|Adverse Event|0|||
150276916|NCT00514514|542151853|FG002|Pre-phase|Adverse Event|0|||
150276917|NCT00514514|542151851|FG000|Pre-phase|Withdrawal by Subject|66|||
150276918|NCT00514514|542151852|FG001|Pre-phase|Withdrawal by Subject|0|||
150276919|NCT00514514|542151853|FG002|Pre-phase|Withdrawal by Subject|0|||
150276920|NCT00514514|542151851|FG000|Randomized - 9 Month|Death|3|||
150276921|NCT00514514|542151852|FG001|Randomized - 9 Month|Death|2|||
150276922|NCT00514514|542151853|FG002|Randomized - 9 Month|Death|2|||
150276923|NCT00514514|542151851|FG000|Randomized - 9 Month|Administrative problems|1|||
150276924|NCT00514514|542151852|FG001|Randomized - 9 Month|Administrative problems|1|||
150276925|NCT00514514|542151853|FG002|Randomized - 9 Month|Administrative problems|2|||
150276926|NCT00514514|542151851|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
150276927|NCT00514514|542151852|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
150276928|NCT00514514|542151853|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
150276929|NCT00514514|542151851|FG000|Randomized - 9 Month|Protocol Violation|1|||
150276930|NCT00514514|542151852|FG001|Randomized - 9 Month|Protocol Violation|1|||
150276931|NCT00514514|542151853|FG002|Randomized - 9 Month|Protocol Violation|0|||
150276932|NCT00514514|542151851|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
150276933|NCT00514514|542151852|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
150276934|NCT00514514|542151853|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
150276935|NCT00514514|542151851|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
150276936|NCT00514514|542151852|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
150276937|NCT00514514|542151853|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
150276938|NCT00514514|542151851|FG000|Randomized - 9 Month|Adverse Event|25|||
150276939|NCT00514514|542151852|FG001|Randomized - 9 Month|Adverse Event|44|||
150276940|NCT00514514|542151853|FG002|Randomized - 9 Month|Adverse Event|27|||
150276941|NCT00514514|542151851|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
150276942|NCT00514514|542151852|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
150276943|NCT00514514|542151853|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
150276944|NCT00514514|542151851|FG000|Extension - 4 Years|Lost to Follow-up|12|||
150276945|NCT00514514|542151852|FG001|Extension - 4 Years|Lost to Follow-up|10|||
150276946|NCT00514514|542151853|FG002|Extension - 4 Years|Lost to Follow-up|9|||
150276947|NCT00514514|542151851|FG000|Extension - 4 Years|Administrative problems|3|||
150276948|NCT00514514|542151852|FG001|Extension - 4 Years|Administrative problems|1|||
150276949|NCT00514514|542151853|FG002|Extension - 4 Years|Administrative problems|1|||
150276950|NCT00514514|542151851|FG000|Extension - 4 Years|Death|8|||
150276951|NCT00514514|542151852|FG001|Extension - 4 Years|Death|3|||
150276952|NCT00514514|542151853|FG002|Extension - 4 Years|Death|6|||
150276953|NCT00514514|542151851|FG000|Extension - 4 Years|Adverse Event|9|||
150276954|NCT00514514|542151852|FG001|Extension - 4 Years|Adverse Event|6|||
150276955|NCT00514514|542151853|FG002|Extension - 4 Years|Adverse Event|3|||
150276956|NCT00957528|542151859|FG000|Overall Study|Protocol Violation|0|||
150276957|NCT00957528|542151860|FG001|Overall Study|Protocol Violation|1|||
150276958|NCT00957528|542151861|FG002|Overall Study|Protocol Violation|0|||
150276959|NCT00957528|542151859|FG000|Overall Study|Withdrawal by Subject|0|||
150276960|NCT00957528|542151860|FG001|Overall Study|Withdrawal by Subject|0|||
150276961|NCT00957528|542151861|FG002|Overall Study|Withdrawal by Subject|1|||
150276962|NCT02081534|542151866|FG000|Overall Study|Adverse Event|5|||
150276963|NCT02081534|542151867|FG001|Overall Study|Adverse Event|4|||
150276964|NCT02081534|542151868|FG002|Overall Study|Adverse Event|3|||
150276965|NCT02081534|542151869|FG003|Overall Study|Adverse Event|10|||
150276966|NCT02081534|542151870|FG004|Overall Study|Adverse Event|2|||
149830898|NCT02937701|540511326|FG003|Week 22 to Week 50|Other|0|||
149830899|NCT02937701|540511327|FG004|Week 22 to Week 50|Other|1|||
149975629|NCT00038948|541047922|FG000|Overall Study|Lost to Follow-up|4|||
150276967|NCT02081534|542151871|FG005|Overall Study|Adverse Event|8|||
150276968|NCT02081534|542151872|FG006|Overall Study|Adverse Event|2|||
150276969|NCT02081534|542151866|FG000|Overall Study|Withdrawal by Subject|0|||
150276970|NCT02081534|542151867|FG001|Overall Study|Withdrawal by Subject|1|||
150276971|NCT02081534|542151868|FG002|Overall Study|Withdrawal by Subject|1|||
150276972|NCT02081534|542151869|FG003|Overall Study|Withdrawal by Subject|1|||
150276973|NCT02081534|542151870|FG004|Overall Study|Withdrawal by Subject|1|||
150276974|NCT02081534|542151871|FG005|Overall Study|Withdrawal by Subject|0|||
150276975|NCT02081534|542151872|FG006|Overall Study|Withdrawal by Subject|1|||
150276976|NCT02081534|542151866|FG000|Overall Study|Protocol Violation|0|||
150276977|NCT02081534|542151867|FG001|Overall Study|Protocol Violation|3|||
150276978|NCT02081534|542151868|FG002|Overall Study|Protocol Violation|0|||
150276979|NCT02081534|542151869|FG003|Overall Study|Protocol Violation|0|||
149830900|NCT00416520|540511329|FG000|Open-label Period|Adverse Event|28|||
149830901|NCT00416520|540511330|FG001|Open-label Period|Adverse Event|10|||
150276980|NCT02081534|542151870|FG004|Overall Study|Protocol Violation|0|||
150276981|NCT02081534|542151871|FG005|Overall Study|Protocol Violation|0|||
150276982|NCT02081534|542151872|FG006|Overall Study|Protocol Violation|1|||
150276983|NCT02081534|542151866|FG000|Overall Study|Lost to Follow-up|0|||
150276984|NCT02081534|542151867|FG001|Overall Study|Lost to Follow-up|0|||
150276985|NCT02081534|542151868|FG002|Overall Study|Lost to Follow-up|0|||
150276986|NCT02081534|542151869|FG003|Overall Study|Lost to Follow-up|2|||
150276987|NCT02081534|542151870|FG004|Overall Study|Lost to Follow-up|1|||
150276988|NCT02081534|542151871|FG005|Overall Study|Lost to Follow-up|1|||
150276989|NCT02081534|542151872|FG006|Overall Study|Lost to Follow-up|0|||
150276990|NCT00762892|542151873|FG000|Overall Study|Lost to Follow-up|2|||
150276991|NCT00762892|542151874|FG001|Overall Study|Lost to Follow-up|5|||
150276992|NCT00762892|542151873|FG000|Overall Study|Withdrawal by Subject|0|||
150276993|NCT00762892|542151874|FG001|Overall Study|Withdrawal by Subject|1|||
150276994|NCT00762892|542151873|FG000|Overall Study|Death|1|||
150276995|NCT00762892|542151874|FG001|Overall Study|Death|0|||
150276996|NCT00762892|542151873|FG000|Overall Study|Pregnancy|1|||
150276997|NCT00762892|542151874|FG001|Overall Study|Pregnancy|0|||
150276998|NCT00762892|542151873|FG000|Overall Study|Incarceration|1|||
150276999|NCT00762892|542151874|FG001|Overall Study|Incarceration|0|||
150277000|NCT02234479|542151876|FG000|Overall Study|Withdrawal by Subject|1|||
150277001|NCT02234479|542151877|FG001|Overall Study|Withdrawal by Subject|3|||
150277002|NCT01841749|542151881|FG000|Overall Study|Protocol Violation|1|||
150277003|NCT02285920|542151882|FG000|Overall Study|Kidney transplantation|2|||
150277004|NCT02285920|542151883|FG001|Overall Study|Kidney transplantation|2|||
150277005|NCT02285920|542151884|FG002|Overall Study|Kidney transplantation|2|||
150277006|NCT02285920|542151885|FG003|Overall Study|Kidney transplantation|0|||
150277007|NCT02285920|542151882|FG000|Overall Study|Change to peritoneal dialysis|0|||
150277008|NCT02285920|542151883|FG001|Overall Study|Change to peritoneal dialysis|0|||
150277009|NCT02285920|542151884|FG002|Overall Study|Change to peritoneal dialysis|1|||
150277010|NCT02285920|542151885|FG003|Overall Study|Change to peritoneal dialysis|0|||
150277011|NCT02285920|542151882|FG000|Overall Study|Transfer to non-participating unit|0|||
150277012|NCT02285920|542151883|FG001|Overall Study|Transfer to non-participating unit|1|||
150277013|NCT02285920|542151884|FG002|Overall Study|Transfer to non-participating unit|0|||
150277014|NCT02285920|542151885|FG003|Overall Study|Transfer to non-participating unit|0|||
150277015|NCT02285920|542151882|FG000|Overall Study|Dialysis discontinuation|0|||
150277016|NCT02285920|542151883|FG001|Overall Study|Dialysis discontinuation|1|||
150277017|NCT02285920|542151884|FG002|Overall Study|Dialysis discontinuation|0|||
150277018|NCT02285920|542151885|FG003|Overall Study|Dialysis discontinuation|0|||
150277019|NCT02285920|542151882|FG000|Overall Study|Death|2|||
150277020|NCT02285920|542151883|FG001|Overall Study|Death|0|||
150277021|NCT02285920|542151884|FG002|Overall Study|Death|2|||
150277022|NCT02285920|542151885|FG003|Overall Study|Death|1|||
150277023|NCT01480284|542151889|FG000|Overall Study|Withdrawal by Subject|2|||
150277024|NCT01480284|542151890|FG001|Overall Study|Withdrawal by Subject|0|||
150277025|NCT01480284|542151889|FG000|Overall Study|Adverse Event|1|||
150277026|NCT01480284|542151890|FG001|Overall Study|Adverse Event|0|||
150277027|NCT01480284|542151889|FG000|Overall Study|Study closed/terminated|3|||
150277028|NCT01480284|542151890|FG001|Overall Study|Study closed/terminated|0|||
149830902|NCT00416520|540511331|FG002|Open-label Period|Adverse Event|0|||
149830903|NCT00416520|540511332|FG003|Open-label Period|Adverse Event|0|||
149830904|NCT00416520|540511329|FG000|Open-label Period|Death|2|||
149830905|NCT00416520|540511330|FG001|Open-label Period|Death|1|||
150170798|NCT01616654|541760748|FG004|Overall Study|Withdrawal by Subject|5|||
150170799|NCT01616654|541760744|FG000|Overall Study|Protocol Violation|0|||
150170800|NCT01616654|541760745|FG001|Overall Study|Protocol Violation|5|||
150170801|NCT01616654|541760746|FG002|Overall Study|Protocol Violation|2|||
150170802|NCT01616654|541760747|FG003|Overall Study|Protocol Violation|4|||
150170803|NCT01616654|541760748|FG004|Overall Study|Protocol Violation|4|||
150170804|NCT01616654|541760744|FG000|Overall Study|Lost to Follow-up|1|||
150170805|NCT01616654|541760745|FG001|Overall Study|Lost to Follow-up|0|||
150170806|NCT01616654|541760746|FG002|Overall Study|Lost to Follow-up|3|||
150170807|NCT01616654|541760747|FG003|Overall Study|Lost to Follow-up|2|||
150170808|NCT01616654|541760748|FG004|Overall Study|Lost to Follow-up|1|||
150170809|NCT01616654|541760744|FG000|Overall Study|Pregnancy|1|||
150170810|NCT01616654|541760745|FG001|Overall Study|Pregnancy|0|||
150170811|NCT01616654|541760746|FG002|Overall Study|Pregnancy|0|||
150277029|NCT01480284|542151889|FG000|Overall Study|Lost to Follow-up|1|||
150277030|NCT01480284|542151890|FG001|Overall Study|Lost to Follow-up|0|||
150277031|NCT01480284|542151889|FG000|Overall Study|Physician Decision|1|||
150277032|NCT01480284|542151890|FG001|Overall Study|Physician Decision|0|||
150277033|NCT00066742|542151891|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
150277034|NCT00066742|542151891|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
149830906|NCT00416520|540511331|FG002|Open-label Period|Death|0|||
149830907|NCT00416520|540511332|FG003|Open-label Period|Death|0|||
150170812|NCT01616654|541760747|FG003|Overall Study|Pregnancy|0|||
150170813|NCT01616654|541760748|FG004|Overall Study|Pregnancy|1|||
150170814|NCT00753012|541760755|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
150170815|NCT00753012|541760756|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
149830908|NCT00416520|540511329|FG000|Open-label Period|Lack of Efficacy|8|||
149830909|NCT00416520|540511330|FG001|Open-label Period|Lack of Efficacy|1|||
149830910|NCT00416520|540511331|FG002|Open-label Period|Lack of Efficacy|0|||
149830911|NCT00416520|540511332|FG003|Open-label Period|Lack of Efficacy|0|||
149830912|NCT00416520|540511329|FG000|Open-label Period|Protocol Violation|3|||
149830913|NCT00416520|540511330|FG001|Open-label Period|Protocol Violation|3|||
149830914|NCT00416520|540511331|FG002|Open-label Period|Protocol Violation|0|||
149830915|NCT00416520|540511332|FG003|Open-label Period|Protocol Violation|0|||
150170816|NCT00753012|541760755|FG000|Overall Study|Adverse Event|2|||
150170817|NCT00753012|541760756|FG001|Overall Study|Adverse Event|0|||
150170818|NCT00753012|541760755|FG000|Overall Study|Withdrawal by Subject|0|||
150170819|NCT00753012|541760756|FG001|Overall Study|Withdrawal by Subject|1|||
150170820|NCT00753012|541760755|FG000|Overall Study|Lost to Follow-up|4|||
150170821|NCT00753012|541760756|FG001|Overall Study|Lost to Follow-up|0|||
150170822|NCT00753012|541760755|FG000|Overall Study|Confounded endpoint data|1|||
150170823|NCT00753012|541760756|FG001|Overall Study|Confounded endpoint data|0|||
150170824|NCT01027286|541760757|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
150170825|NCT01027286|541760758|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
150170826|NCT01027286|541760757|FG000|Overall Study|Lost to Follow-up|0|||
150170827|NCT01027286|541760758|FG001|Overall Study|Lost to Follow-up|1|||
150170828|NCT00094809|541760759|FG000|Overall Study|Protocol deviation|2|||
150170829|NCT00094809|541760760|FG001|Overall Study|Protocol deviation|2|||
150170830|NCT00094809|541760759|FG000|Overall Study|Noncompliance|1|||
150170831|NCT00094809|541760760|FG001|Overall Study|Noncompliance|0|||
150170832|NCT00094809|541760759|FG000|Overall Study|Adverse Event|3|||
150170833|NCT00094809|541760760|FG001|Overall Study|Adverse Event|1|||
150170834|NCT00094809|541760759|FG000|Overall Study|Withdrawal by Subject|8|||
150170835|NCT00094809|541760760|FG001|Overall Study|Withdrawal by Subject|9|||
150170836|NCT00094809|541760759|FG000|Overall Study|Disease progression|3|||
150170837|NCT00094809|541760760|FG001|Overall Study|Disease progression|3|||
150170838|NCT00094809|541760759|FG000|Overall Study|Physician Decision|3|||
150170839|NCT00094809|541760760|FG001|Overall Study|Physician Decision|5|||
150170840|NCT00094809|541760759|FG000|Overall Study|Lost to Follow-up|6|||
150170841|NCT00094809|541760760|FG001|Overall Study|Lost to Follow-up|6|||
150170842|NCT00094809|541760759|FG000|Overall Study|Death|19|||
150170843|NCT00094809|541760760|FG001|Overall Study|Death|25|||
150170844|NCT00094809|541760759|FG000|Overall Study|Protocol-specified criteria|1|||
150170845|NCT00094809|541760760|FG001|Overall Study|Protocol-specified criteria|1|||
150170846|NCT00094809|541760759|FG000|Overall Study|Other|2|||
150170847|NCT00094809|541760760|FG001|Overall Study|Other|4|||
150170848|NCT00094809|541760759|FG000|Overall Study|Informed consent signed after treatment|1|||
150170849|NCT00094809|541760760|FG001|Overall Study|Informed consent signed after treatment|0|||
150170850|NCT00094809|541760759|FG000|Overall Study|Study drug not received|2|||
150170851|NCT00094809|541760760|FG001|Overall Study|Study drug not received|8|||
150170852|NCT00094809|541760759|FG000|Overall Study|Other|1|||
150170853|NCT00094809|541760760|FG001|Overall Study|Other|1|||
150170854|NCT04842604|541760764|FG000|Overall Study|Death|1|||
150170855|NCT04842604|541760765|FG001|Overall Study|Death|0|||
150170856|NCT04842604|541760764|FG000|Overall Study|Other|4|||
150170857|NCT04842604|541760765|FG001|Overall Study|Other|4|||
150170858|NCT04842604|541760764|FG000|Overall Study|Randomized but not treated|1|||
150170859|NCT04842604|541760765|FG001|Overall Study|Randomized but not treated|0|||
150170860|NCT01191788|541760772|FG000|Overall Study|Lost to Follow-up|21|||
150170861|NCT01191788|541760773|FG001|Overall Study|Lost to Follow-up|22|||
150170862|NCT03939819|541760774|FG000|Overall Study|Death|2|||
150170863|NCT03939819|541760775|FG001|Overall Study|Death|0|||
150170864|NCT01183780|541760779|FG000|Overall Study|Withdrawal by Subject|25|||
150170865|NCT01183780|541760780|FG001|Overall Study|Withdrawal by Subject|14|||
150170866|NCT01183780|541760779|FG000|Overall Study|Lost to Follow-up|6|||
150170867|NCT01183780|541760780|FG001|Overall Study|Lost to Follow-up|11|||
150170868|NCT00855465|541760785|FG000|Treatment Period|Adverse Event|4|||
150170869|NCT00855465|541760786|FG001|Treatment Period|Adverse Event|2|||
150170870|NCT00855465|541760785|FG000|Treatment Period|Death|2|||
150170871|NCT00855465|541760786|FG001|Treatment Period|Death|2|||
150170872|NCT00855465|541760785|FG000|Treatment Period|Lack of Efficacy|2|||
150170873|NCT00855465|541760786|FG001|Treatment Period|Lack of Efficacy|1|||
150170874|NCT00855465|541760785|FG000|Treatment Period|Non-compliance|1|||
150170875|NCT00855465|541760786|FG001|Treatment Period|Non-compliance|0|||
150170876|NCT00855465|541760785|FG000|Treatment Period|Protocol Violation|2|||
150170877|NCT00855465|541760786|FG001|Treatment Period|Protocol Violation|0|||
150170878|NCT00855465|541760785|FG000|Treatment Period|Withdrawal by Subject|2|||
150170879|NCT00855465|541760786|FG001|Treatment Period|Withdrawal by Subject|0|||
150170880|NCT00855465|541760785|FG000|Treatment Period|Not treated|1|||
150170881|NCT00855465|541760786|FG001|Treatment Period|Not treated|0|||
150170882|NCT00855465|541760785|FG000|Follow-up Period (FUP)|Adverse Event|0|||
150170883|NCT00855465|541760786|FG001|Follow-up Period (FUP)|Adverse Event|1|||
150170884|NCT00855465|541760785|FG000|Follow-up Period (FUP)|Death|0|||
150170885|NCT00855465|541760786|FG001|Follow-up Period (FUP)|Death|1|||
150170886|NCT00855465|541760785|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
150033668|NCT02007096|541262834|FG000|Overall Study|did not follow postoperative protocol|8|||
150033669|NCT02007096|541262835|FG001|Overall Study|did not follow postoperative protocol|11|||
150033670|NCT02007096|541262834|FG000|Overall Study|converted to open surgery|1|||
150033671|NCT02007096|541262835|FG001|Overall Study|converted to open surgery|1|||
150033672|NCT02007096|541262834|FG000|Overall Study|no mesh placed|0|||
150033673|NCT02007096|541262835|FG001|Overall Study|no mesh placed|1|||
150033674|NCT01231984|541262836|FG000|Study Period 1|Withdrawal by Subject|0|||
150033675|NCT01231984|541262837|FG001|Study Period 1|Withdrawal by Subject|0|||
150033676|NCT01231984|541262838|FG002|Study Period 1|Withdrawal by Subject|0|||
150033677|NCT01231984|541262839|FG003|Study Period 1|Withdrawal by Subject|1|||
150033678|NCT01231984|541262836|FG000|Study Period 1|Lost to Follow-up|1|||
150033679|NCT01231984|541262837|FG001|Study Period 1|Lost to Follow-up|1|||
150033680|NCT01231984|541262838|FG002|Study Period 1|Lost to Follow-up|1|||
150033681|NCT01231984|541262839|FG003|Study Period 1|Lost to Follow-up|0|||
150033682|NCT01231984|541262836|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
150033683|NCT01231984|541262837|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
150033684|NCT01231984|541262838|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
150033685|NCT01231984|541262839|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
150033686|NCT01231984|541262836|FG000|Study Period 1|Screen Failure|0|||
150033687|NCT01231984|541262837|FG001|Study Period 1|Screen Failure|0|||
150033688|NCT01231984|541262838|FG002|Study Period 1|Screen Failure|0|||
150033689|NCT01231984|541262839|FG003|Study Period 1|Screen Failure|1|||
150033690|NCT01231984|541262836|FG000|Study Period 1|Non-compliance with study requirements|5|||
150033691|NCT01231984|541262837|FG001|Study Period 1|Non-compliance with study requirements|0|||
150033692|NCT01231984|541262838|FG002|Study Period 1|Non-compliance with study requirements|2|||
150033693|NCT01231984|541262839|FG003|Study Period 1|Non-compliance with study requirements|1|||
150033694|NCT01231984|541262836|FG000|Study Period 1|Protocol Violation|3|||
150033695|NCT01231984|541262837|FG001|Study Period 1|Protocol Violation|4|||
150033696|NCT01231984|541262838|FG002|Study Period 1|Protocol Violation|2|||
150033697|NCT01231984|541262839|FG003|Study Period 1|Protocol Violation|3|||
150033698|NCT01231984|541262836|FG000|Study Period 1|Adverse Event|1|||
150033699|NCT01231984|541262837|FG001|Study Period 1|Adverse Event|0|||
150033700|NCT01231984|541262838|FG002|Study Period 1|Adverse Event|0|||
150033701|NCT01231984|541262839|FG003|Study Period 1|Adverse Event|0|||
150033702|NCT01231984|541262836|FG000|Study Period 1|Other|0|||
150033703|NCT01231984|541262837|FG001|Study Period 1|Other|0|||
150033704|NCT01231984|541262838|FG002|Study Period 1|Other|0|||
150033705|NCT01231984|541262839|FG003|Study Period 1|Other|1|||
150277035|NCT00066742|542151891|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
149830916|NCT00416520|540511329|FG000|Open-label Period|Withdrawal by Subject|16|||
149830917|NCT00416520|540511330|FG001|Open-label Period|Withdrawal by Subject|5|||
149830918|NCT00416520|540511331|FG002|Open-label Period|Withdrawal by Subject|0|||
150033706|NCT01231984|541262836|FG000|Study Period 2|Withdrawal by Subject|1|||
150033707|NCT01231984|541262837|FG001|Study Period 2|Withdrawal by Subject|1|||
150033708|NCT01231984|541262838|FG002|Study Period 2|Withdrawal by Subject|0|||
150033709|NCT01231984|541262839|FG003|Study Period 2|Withdrawal by Subject|0|||
150033710|NCT01231984|541262836|FG000|Study Period 2|Lost to Follow-up|1|||
150277036|NCT00066742|542151891|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
150277037|NCT00066742|542151891|FG000|Induction Chemoradiotherapy|Ineligible|3|||
150277038|NCT00066742|542151891|FG000|Consolidation Chemotherapy|not protocol specified|1|||
150277039|NCT00066742|542151891|FG000|Consolidation Chemotherapy|Ineligible|2|||
150277040|NCT01211535|542151894|FG000|Overall Study|Adverse Event|0|||
150277041|NCT01211535|542151895|FG001|Overall Study|Adverse Event|1|||
150277042|NCT00549939|542151898|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
150277043|NCT00549939|542151899|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
150277044|NCT00549939|542151900|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
150277045|NCT00549939|542151898|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
150277046|NCT00549939|542151899|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
150277047|NCT00549939|542151900|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
150277048|NCT00549939|542151898|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
150277049|NCT00549939|542151899|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
150277050|NCT00549939|542151900|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
150277051|NCT00549939|542151898|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
150277052|NCT00549939|542151899|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
150277053|NCT00549939|542151900|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
150277054|NCT00549939|542151898|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
150277055|NCT00549939|542151899|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
150277056|NCT00549939|542151900|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
149830919|NCT00416520|540511332|FG003|Open-label Period|Withdrawal by Subject|0|||
150033711|NCT01231984|541262837|FG001|Study Period 2|Lost to Follow-up|0|||
150033712|NCT01231984|541262838|FG002|Study Period 2|Lost to Follow-up|0|||
150033713|NCT01231984|541262839|FG003|Study Period 2|Lost to Follow-up|3|||
150277057|NCT00549939|542151898|FG000|40-week Open Label Treatment Period|Other|0|||
150277058|NCT00549939|542151899|FG001|40-week Open Label Treatment Period|Other|1|||
150277059|NCT00549939|542151900|FG002|40-week Open Label Treatment Period|Other|4|||
150277060|NCT00003895|542151901|FG000|Overall Study|Adverse Event|4|||
150277061|NCT00003895|542151902|FG001|Overall Study|Adverse Event|0|||
150277062|NCT00003895|542151901|FG000|Overall Study|Lack of Efficacy|1|||
150277063|NCT00003895|542151902|FG001|Overall Study|Lack of Efficacy|1|||
150277064|NCT00003895|542151901|FG000|Overall Study|Patient Vacation|2|||
150277065|NCT00003895|542151902|FG001|Overall Study|Patient Vacation|0|||
150277066|NCT00003895|542151901|FG000|Overall Study|Withdrawal by Subject|0|||
150277067|NCT00003895|542151902|FG001|Overall Study|Withdrawal by Subject|3|||
150277068|NCT01735279|542151905|FG000|Overall Study|Lost to Follow-up|11|||
150277069|NCT01735279|542151906|FG001|Overall Study|Lost to Follow-up|8|||
150277070|NCT01380730|542151907|FG000|Overall Study|Death|0|||
150277071|NCT01380730|542151908|FG001|Overall Study|Death|0|||
150277072|NCT01380730|542151909|FG002|Overall Study|Death|0|||
150277073|NCT01380730|542151910|FG003|Overall Study|Death|0|||
150277074|NCT01380730|542151911|FG004|Overall Study|Death|1|||
150277075|NCT01380730|542151912|FG005|Overall Study|Death|0|||
150277076|NCT01380730|542151913|FG006|Overall Study|Death|0|||
150277077|NCT01380730|542151914|FG007|Overall Study|Death|0|||
150277078|NCT00922480|542151917|FG000|Main Study|Protocol Violation|3|||
150277079|NCT00922480|542151918|FG001|Main Study|Protocol Violation|6|||
150277080|NCT00922480|542151917|FG000|Main Study|Adverse Event|6|||
150277081|NCT00922480|542151918|FG001|Main Study|Adverse Event|7|||
150277082|NCT00922480|542151917|FG000|Main Study|Lack of Efficacy|3|||
150277083|NCT00922480|542151918|FG001|Main Study|Lack of Efficacy|0|||
150277084|NCT00922480|542151917|FG000|Main Study|Withdrawal by Subject|20|||
150277085|NCT00922480|542151918|FG001|Main Study|Withdrawal by Subject|15|||
150277086|NCT00922480|542151917|FG000|Main Study|Lost to Follow-up|5|||
150277087|NCT00922480|542151918|FG001|Main Study|Lost to Follow-up|0|||
150277088|NCT00922480|542151917|FG000|Main Study|Physician Decision|0|||
150277089|NCT00922480|542151918|FG001|Main Study|Physician Decision|1|||
150277090|NCT00922480|542151917|FG000|Extension Study|Protocol Violation|3|||
150277091|NCT00922480|542151918|FG001|Extension Study|Protocol Violation|0|||
150277092|NCT00922480|542151917|FG000|Extension Study|Adverse Event|1|||
150277093|NCT00922480|542151918|FG001|Extension Study|Adverse Event|1|||
150277094|NCT00922480|542151917|FG000|Extension Study|Withdrawal by Subject|1|||
150277095|NCT00922480|542151918|FG001|Extension Study|Withdrawal by Subject|1|||
150277096|NCT00922480|542151917|FG000|Extension Study|Others|0|||
150277097|NCT00922480|542151918|FG001|Extension Study|Others|1|||
150277098|NCT04784897|542151919|FG000|Overall Study|Death|4|||
150277099|NCT04784897|542151920|FG001|Overall Study|Death|2|||
150277100|NCT04784897|542151921|FG002|Overall Study|Death|1|||
150277101|NCT04784897|542151919|FG000|Overall Study|Withdrawal by Subject|0|||
150277102|NCT04784897|542151920|FG001|Overall Study|Withdrawal by Subject|0|||
150277103|NCT04784897|542151921|FG002|Overall Study|Withdrawal by Subject|1|||
150277104|NCT04754802|542151927|FG000|Overall Study|Lost to Follow-up|0|||
150277105|NCT04754802|542151928|FG001|Overall Study|Lost to Follow-up|2|||
150277106|NCT04754802|542151927|FG000|Overall Study|Withdrawal by Subject|2|||
150277107|NCT04754802|542151928|FG001|Overall Study|Withdrawal by Subject|0|||
150033714|NCT01231984|541262836|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
150033715|NCT01231984|541262837|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
150033716|NCT01231984|541262838|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
150033717|NCT01231984|541262839|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
150033718|NCT02182895|541262842|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
150033719|NCT02182895|541262843|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
150170887|NCT00855465|541760786|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
150170888|NCT00855465|541760785|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
150170889|NCT00855465|541760786|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
150170890|NCT00855465|541760785|FG000|Follow-up Period (FUP)|Missing|1|||
150277108|NCT00701090|542151929|FG000|Overall Study|Adverse Event|11|||
150277109|NCT00701090|542151930|FG001|Overall Study|Adverse Event|2|||
150277110|NCT00701090|542151929|FG000|Overall Study|Death|0|||
150277111|NCT00701090|542151930|FG001|Overall Study|Death|1|||
150277112|NCT00701090|542151929|FG000|Overall Study|Lack of Efficacy|5|||
149830920|NCT00416520|540511329|FG000|Open-label Period|Other Reasons|3|||
150170891|NCT00855465|541760786|FG001|Follow-up Period (FUP)|Missing|0|||
150170892|NCT00079183|541760795|FG000|Overall Study|Withdrawal by Subject|4|||
150170893|NCT00079183|541760795|FG000|Overall Study|Study medication non-compliance|2|||
150170894|NCT00079183|541760795|FG000|Overall Study|Specimen collection non-compliance|1|||
150170895|NCT00770965|541760796|FG000|Safety Set|Withdrawal by Subject|0|||
150170896|NCT00770965|541760797|FG001|Safety Set|Withdrawal by Subject|0|||
150170897|NCT00770965|541760798|FG002|Safety Set|Withdrawal by Subject|0|||
150170898|NCT00770965|541760799|FG003|Safety Set|Withdrawal by Subject|1|||
150170899|NCT00770965|541760796|FG000|Safety Set|Protocol deviation|0|||
149830921|NCT00416520|540511330|FG001|Open-label Period|Other Reasons|12|||
150170900|NCT00770965|541760797|FG001|Safety Set|Protocol deviation|0|||
150277113|NCT00701090|542151930|FG001|Overall Study|Lack of Efficacy|4|||
150277114|NCT00701090|542151929|FG000|Overall Study|Lost to Follow-up|9|||
150277115|NCT00701090|542151930|FG001|Overall Study|Lost to Follow-up|9|||
150277116|NCT00701090|542151929|FG000|Overall Study|Physician Decision|3|||
150277117|NCT00701090|542151930|FG001|Overall Study|Physician Decision|4|||
150277118|NCT00701090|542151929|FG000|Overall Study|Protocol Violation|2|||
150277119|NCT00701090|542151930|FG001|Overall Study|Protocol Violation|3|||
150277120|NCT00701090|542151929|FG000|Overall Study|Withdrawal by Subject|11|||
150277121|NCT00701090|542151930|FG001|Overall Study|Withdrawal by Subject|16|||
150277122|NCT00701090|542151929|FG000|Overall Study|Other|7|||
150277123|NCT00701090|542151930|FG001|Overall Study|Other|12|||
150277124|NCT00873366|542151931|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
150277125|NCT00873366|542151931|FG000|Overall Study|Off tamoxifen due to side effects|2|||
150277126|NCT00873366|542151931|FG000|Overall Study|Refused to continue DM-BT testing|3|||
150277127|NCT01970488|542151932|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
150277128|NCT01970488|542151933|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
150277129|NCT01970488|542151934|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
150277130|NCT01970488|542151935|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
150277131|NCT01970488|542151936|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
150277132|NCT01970488|542151932|FG000|Part 1: Through Week 16|Protocol Violation|1|||
150277133|NCT01970488|542151933|FG001|Part 1: Through Week 16|Protocol Violation|2|||
150277134|NCT01970488|542151934|FG002|Part 1: Through Week 16|Protocol Violation|0|||
150277135|NCT01970488|542151935|FG003|Part 1: Through Week 16|Protocol Violation|0|||
150277136|NCT01970488|542151936|FG004|Part 1: Through Week 16|Protocol Violation|0|||
150277137|NCT01970488|542151932|FG000|Part 1: Through Week 16|Adverse Event|6|||
150277138|NCT01970488|542151933|FG001|Part 1: Through Week 16|Adverse Event|5|||
150277139|NCT01970488|542151934|FG002|Part 1: Through Week 16|Adverse Event|0|||
150277140|NCT01970488|542151935|FG003|Part 1: Through Week 16|Adverse Event|0|||
149830922|NCT00416520|540511331|FG002|Open-label Period|Other Reasons|0|||
149830923|NCT00416520|540511332|FG003|Open-label Period|Other Reasons|0|||
149830924|NCT00416520|540511329|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
149830925|NCT00416520|540511330|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
149948111|NCT01922934|540942064|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
149948112|NCT01922934|540942065|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
149948113|NCT02916927|540942066|FG000|Overall Study|Discharged prior to study drug receipt|0|||
149948114|NCT02916927|540942067|FG001|Overall Study|Discharged prior to study drug receipt|2|||
149948115|NCT02916927|540942066|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
149948116|NCT02916927|540942067|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
149948117|NCT02916927|540942066|FG000|Overall Study|Withdrawal before first time point|1|||
149948118|NCT02916927|540942067|FG001|Overall Study|Withdrawal before first time point|0|||
149948119|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
149948120|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
149948121|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
149948122|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
149948123|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
149948124|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
149948125|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
149948126|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
149948127|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
149948128|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
149948129|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
149948130|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
149948131|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
149948132|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
149948133|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
149948134|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
149948135|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
150170901|NCT00770965|541760798|FG002|Safety Set|Protocol deviation|1|||
150170902|NCT00770965|541760799|FG003|Safety Set|Protocol deviation|0|||
150170903|NCT00770965|541760796|FG000|Excluded Set|Administrative problems|14|||
150170904|NCT00770965|541760797|FG001|Excluded Set|Administrative problems|12|||
150170905|NCT00770965|541760798|FG002|Excluded Set|Administrative problems|12|||
150170906|NCT00770965|541760799|FG003|Excluded Set|Administrative problems|10|||
150277141|NCT01970488|542151936|FG004|Part 1: Through Week 16|Adverse Event|0|||
150277142|NCT01970488|542151932|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
149830926|NCT00416520|540511331|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
149948136|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
150170907|NCT00770965|541760796|FG000|Excluded Set|Withdrawal by Subject|1|||
150170908|NCT00770965|541760797|FG001|Excluded Set|Withdrawal by Subject|1|||
150170909|NCT00770965|541760798|FG002|Excluded Set|Withdrawal by Subject|2|||
149830927|NCT00416520|540511332|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
150277143|NCT01970488|542151933|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
150277144|NCT01970488|542151934|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
150277145|NCT01970488|542151935|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
150277146|NCT01970488|542151936|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
150277147|NCT01970488|542151932|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
150277148|NCT01970488|542151933|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
150277149|NCT01970488|542151934|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
150277150|NCT01970488|542151935|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
150277151|NCT01970488|542151936|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
150277152|NCT01970488|542151932|FG000|Part 2: Post Week 16|Physician Decision|0|||
150277153|NCT01970488|542151933|FG001|Part 2: Post Week 16|Physician Decision|0|||
150277154|NCT01970488|542151934|FG002|Part 2: Post Week 16|Physician Decision|0|||
150277155|NCT01970488|542151935|FG003|Part 2: Post Week 16|Physician Decision|0|||
150277156|NCT01970488|542151936|FG004|Part 2: Post Week 16|Physician Decision|1|||
150277157|NCT01970488|542151932|FG000|Part 2: Post Week 16|Non-compliance|0|||
150277158|NCT01970488|542151933|FG001|Part 2: Post Week 16|Non-compliance|0|||
150277159|NCT01970488|542151934|FG002|Part 2: Post Week 16|Non-compliance|1|||
150277160|NCT01970488|542151935|FG003|Part 2: Post Week 16|Non-compliance|0|||
150277161|NCT01970488|542151936|FG004|Part 2: Post Week 16|Non-compliance|0|||
150277162|NCT01970488|542151932|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
150277163|NCT01970488|542151933|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
150277164|NCT01970488|542151934|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
150277165|NCT01970488|542151935|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
150277166|NCT01970488|542151936|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
150277167|NCT01970488|542151932|FG000|Part 2: Post Week 16|Adverse Event|0|||
150277168|NCT01970488|542151933|FG001|Part 2: Post Week 16|Adverse Event|0|||
150277169|NCT01970488|542151934|FG002|Part 2: Post Week 16|Adverse Event|5|||
150277170|NCT01970488|542151935|FG003|Part 2: Post Week 16|Adverse Event|1|||
150277171|NCT01970488|542151936|FG004|Part 2: Post Week 16|Adverse Event|1|||
150277172|NCT01970488|542151932|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
150277173|NCT01970488|542151933|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
150277174|NCT01970488|542151934|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
150277175|NCT01970488|542151935|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
150277176|NCT01970488|542151936|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
150277177|NCT01970488|542151932|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
150277178|NCT01970488|542151933|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
150277179|NCT01970488|542151934|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
150277180|NCT01970488|542151935|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
150277181|NCT01970488|542151936|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
150277182|NCT01490814|542151938|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
150033720|NCT03566511|541262847|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
150033721|NCT03566511|541262848|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
150033722|NCT00981656|541262850|FG000|Overall Study|Protocol Violation|1|||
150033723|NCT00981656|541262850|FG000|Overall Study|Did not start protocol treatment|2|||
150277183|NCT01490814|542151939|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
150277184|NCT01490814|542151938|FG000|Overall Study|Physician Decision|1|||
150277185|NCT01490814|542151939|FG001|Overall Study|Physician Decision|0|||
150277186|NCT01490814|542151938|FG000|Overall Study|Withdrawal by Subject|0|||
150033724|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
150033725|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
150033726|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
150033727|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
150033728|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
150033729|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
150033730|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
150033731|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
150033732|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
150033733|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150033734|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
150277187|NCT01490814|542151939|FG001|Overall Study|Withdrawal by Subject|5|||
150277188|NCT01537198|542151940|FG000|Overall Study|RSV infection|2|||
150277189|NCT01537198|542151940|FG000|Overall Study|Adverse Event|4|||
150277190|NCT01537198|542151940|FG000|Overall Study|No Further Visits to the Clinic|37|||
150277191|NCT01537198|542151940|FG000|Overall Study|Other|111|||
150277192|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
150277193|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
150277194|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
150277195|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
150033735|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150033736|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
150033737|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
150033738|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
150033739|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
149948137|NCT01069939|540942072|FG000|Randomised and Included in the Analyses|Removal|1|||
149948138|NCT01069939|540942073|FG001|Randomised and Included in the Analyses|Removal|0|||
149948139|NCT00658528|540942074|FG000|Overall Study|Adverse Event|5|||
149948140|NCT00658528|540942075|FG001|Overall Study|Adverse Event|7|||
149948141|NCT00658528|540942074|FG000|Overall Study|Lost to Follow-up|14|||
149948142|NCT00658528|540942075|FG001|Overall Study|Lost to Follow-up|22|||
149948143|NCT00658528|540942074|FG000|Overall Study|Withdrawal by Subject|8|||
149948144|NCT00658528|540942075|FG001|Overall Study|Withdrawal by Subject|6|||
149948145|NCT00658528|540942074|FG000|Overall Study|Withdrawal of consent|5|||
149948146|NCT00658528|540942075|FG001|Overall Study|Withdrawal of consent|6|||
150177808|NCT03036813|541788207|FG000|Overall Study|Lost to Follow-up|1|||
150177809|NCT03036813|541788208|FG001|Overall Study|Lost to Follow-up|1|||
149830928|NCT00416520|540511329|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
149948147|NCT00658528|540942074|FG000|Overall Study|Other|8|||
150177810|NCT03036813|541788209|FG002|Overall Study|Lost to Follow-up|0|||
150177811|NCT03036813|541788207|FG000|Overall Study|Physician Decision|2|||
150177812|NCT03036813|541788208|FG001|Overall Study|Physician Decision|1|||
150177813|NCT03036813|541788209|FG002|Overall Study|Physician Decision|1|||
150177814|NCT03036813|541788207|FG000|Overall Study|Non-Compliance|1|||
150177815|NCT03036813|541788208|FG001|Overall Study|Non-Compliance|5|||
150177816|NCT03036813|541788209|FG002|Overall Study|Non-Compliance|3|||
150177817|NCT03036813|541788207|FG000|Overall Study|Pregnancy|0|||
150177818|NCT03036813|541788208|FG001|Overall Study|Pregnancy|0|||
150177819|NCT03036813|541788209|FG002|Overall Study|Pregnancy|1|||
150177820|NCT03036813|541788207|FG000|Overall Study|Other|0|||
150177821|NCT03036813|541788208|FG001|Overall Study|Other|3|||
150177822|NCT03036813|541788209|FG002|Overall Study|Other|5|||
150177823|NCT01943799|541788230|FG000|Overall Study|Lost to Follow-up|0|||
150177824|NCT01943799|541788231|FG001|Overall Study|Lost to Follow-up|1|||
150177825|NCT01943799|541788232|FG002|Overall Study|Lost to Follow-up|1|||
150177826|NCT01943799|541788233|FG003|Overall Study|Lost to Follow-up|0|||
150177827|NCT01943799|541788230|FG000|Overall Study|Protocol Violation|1|||
150177828|NCT01943799|541788231|FG001|Overall Study|Protocol Violation|0|||
150177829|NCT01943799|541788232|FG002|Overall Study|Protocol Violation|0|||
150177830|NCT01943799|541788233|FG003|Overall Study|Protocol Violation|0|||
150177831|NCT01943799|541788230|FG000|Overall Study|Withdrawal by Subject|4|||
150177832|NCT01943799|541788231|FG001|Overall Study|Withdrawal by Subject|2|||
150177833|NCT01943799|541788232|FG002|Overall Study|Withdrawal by Subject|1|||
150177834|NCT01943799|541788233|FG003|Overall Study|Withdrawal by Subject|0|||
150177835|NCT04594759|541788234|FG000|Overall Study|Lost to Follow-up|3|||
150177836|NCT01832480|541788237|FG000|Overall Study|Lost to Follow-up|33|||
150177837|NCT01832480|541788238|FG001|Overall Study|Lost to Follow-up|30|||
150177838|NCT01832480|541788237|FG000|Overall Study|Withdrawal by Subject|0|||
150177839|NCT01832480|541788238|FG001|Overall Study|Withdrawal by Subject|2|||
150177840|NCT01832480|541788237|FG000|Overall Study|post randomization ineligible|8|||
150177841|NCT01832480|541788238|FG001|Overall Study|post randomization ineligible|10|||
150177842|NCT03144674|541788241|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
150177843|NCT03144674|541788242|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
150177844|NCT03144674|541788243|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
150177845|NCT03144674|541788244|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
150177846|NCT03144674|541788241|FG000|Overall Study|Death|3|||
150177847|NCT03144674|541788242|FG001|Overall Study|Death|2|||
150177848|NCT03144674|541788243|FG002|Overall Study|Death|6|||
150177849|NCT03144674|541788244|FG003|Overall Study|Death|24|||
150177850|NCT03144674|541788241|FG000|Overall Study|Lost to Follow-up|0|||
150177851|NCT03144674|541788242|FG001|Overall Study|Lost to Follow-up|1|||
150177852|NCT03144674|541788243|FG002|Overall Study|Lost to Follow-up|0|||
150177853|NCT03144674|541788244|FG003|Overall Study|Lost to Follow-up|4|||
150177854|NCT03144674|541788241|FG000|Overall Study|Withdrawal by Participant|0|||
150177855|NCT03144674|541788242|FG001|Overall Study|Withdrawal by Participant|0|||
150177856|NCT03144674|541788243|FG002|Overall Study|Withdrawal by Participant|2|||
150177857|NCT03144674|541788244|FG003|Overall Study|Withdrawal by Participant|6|||
150177858|NCT03144674|541788241|FG000|Overall Study|Discharged from the Trust|0|||
150177859|NCT03144674|541788242|FG001|Overall Study|Discharged from the Trust|0|||
150177860|NCT03144674|541788243|FG002|Overall Study|Discharged from the Trust|1|||
150177861|NCT03144674|541788244|FG003|Overall Study|Discharged from the Trust|0|||
150177862|NCT03144674|541788241|FG000|Overall Study|Exclusion Criteria Met|0|||
150177863|NCT03144674|541788242|FG001|Overall Study|Exclusion Criteria Met|0|||
150177864|NCT03144674|541788243|FG002|Overall Study|Exclusion Criteria Met|1|||
150177865|NCT03144674|541788244|FG003|Overall Study|Exclusion Criteria Met|0|||
150177866|NCT03144674|541788241|FG000|Overall Study|Changed Physicians|0|||
150177867|NCT03144674|541788242|FG001|Overall Study|Changed Physicians|0|||
150277196|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
150277197|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
150277198|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
150277199|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
150277200|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
150277201|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
150277202|NCT01299376|542151941|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
150277203|NCT01299376|542151942|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
150277204|NCT01299376|542151941|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
150277205|NCT01299376|542151942|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
150277206|NCT01299376|542151941|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
150277207|NCT01299376|542151942|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
150277208|NCT01299376|542151941|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
150277209|NCT01299376|542151942|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
150277210|NCT01299376|542151941|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
150277211|NCT01299376|542151942|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
150277212|NCT01299376|542151941|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
150277213|NCT01299376|542151942|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
150277214|NCT03680911|542151943|FG000|At Home Treatment|Study Termination|3|||
149830929|NCT00416520|540511330|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
149948148|NCT00658528|540942075|FG001|Overall Study|Other|4|||
149948149|NCT02811159|540942084|FG000|Treatment Course 1|Lost to Follow-up|1|||
149948150|NCT04603066|540942086|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
149948151|NCT04603066|540942087|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
149948152|NCT01525589|540942088|FG000|Overall Study|Non-treatment-related AE|1|||
149948153|NCT01525589|540942089|FG001|Overall Study|Non-treatment-related AE|0|||
149948154|NCT01525589|540942090|FG002|Overall Study|Non-treatment-related AE|0|||
149948155|NCT01525589|540942088|FG000|Overall Study|Progressive disease|48|||
149948156|NCT01525589|540942089|FG001|Overall Study|Progressive disease|15|||
149948157|NCT01525589|540942090|FG002|Overall Study|Progressive disease|29|||
149948158|NCT01525589|540942088|FG000|Overall Study|Never treated|2|||
149948159|NCT01525589|540942089|FG001|Overall Study|Never treated|0|||
149948160|NCT01525589|540942090|FG002|Overall Study|Never treated|0|||
149948161|NCT01525589|540942088|FG000|Overall Study|Physician Decision|4|||
149948162|NCT01525589|540942089|FG001|Overall Study|Physician Decision|2|||
149948163|NCT01525589|540942090|FG002|Overall Study|Physician Decision|2|||
149948164|NCT01525589|540942088|FG000|Overall Study|Death|0|||
149948165|NCT01525589|540942089|FG001|Overall Study|Death|0|||
149948166|NCT01525589|540942090|FG002|Overall Study|Death|2|||
149948167|NCT01525589|540942088|FG000|Overall Study|Treatment-related AE|1|||
149948168|NCT01525589|540942089|FG001|Overall Study|Treatment-related AE|1|||
149948169|NCT01525589|540942090|FG002|Overall Study|Treatment-related AE|2|||
149948170|NCT01525589|540942088|FG000|Overall Study|Other reasons|0|||
149948171|NCT01525589|540942089|FG001|Overall Study|Other reasons|1|||
149948172|NCT01525589|540942090|FG002|Overall Study|Other reasons|0|||
149948173|NCT01525589|540942088|FG000|Overall Study|Withdrawal by Subject|0|||
149948174|NCT01525589|540942089|FG001|Overall Study|Withdrawal by Subject|1|||
149948175|NCT01525589|540942090|FG002|Overall Study|Withdrawal by Subject|0|||
149948176|NCT05759338|540942091|FG000|Overall Study|Withdrawal by Subject|3|||
149948177|NCT04835441|540942093|FG000|Overall Study|Physician Decision|4|||
149948178|NCT04835441|540942094|FG001|Overall Study|Physician Decision|4|||
149948179|NCT04835441|540942093|FG000|Overall Study|Other|1|||
149948180|NCT04835441|540942094|FG001|Overall Study|Other|1|||
149948181|NCT04835441|540942093|FG000|Overall Study|Lost to Follow-up|0|||
149948182|NCT04835441|540942094|FG001|Overall Study|Lost to Follow-up|1|||
149948183|NCT04611126|540942095|FG000|Overall Study|TIL expansion unsuccessful|1|||
149948184|NCT04611126|540942096|FG001|Overall Study|TIL expansion unsuccessful|0|||
149948189|NCT02328014|540944693|FG000|Overall Study|Adverse Event|1|||
149948190|NCT02328014|540944694|FG001|Overall Study|Adverse Event|0|||
149948191|NCT02328014|540944695|FG002|Overall Study|Adverse Event|0|||
149948192|NCT02328014|540944696|FG003|Overall Study|Adverse Event|1|||
149948193|NCT02328014|540944693|FG000|Overall Study|Death|0|||
149948194|NCT02328014|540944694|FG001|Overall Study|Death|0|||
149948195|NCT02328014|540944695|FG002|Overall Study|Death|0|||
149948196|NCT02328014|540944696|FG003|Overall Study|Death|4|||
149948197|NCT02328014|540944693|FG000|Overall Study|Physician Decision|0|||
149948198|NCT02328014|540944694|FG001|Overall Study|Physician Decision|0|||
149948199|NCT02328014|540944695|FG002|Overall Study|Physician Decision|0|||
149948200|NCT02328014|540944696|FG003|Overall Study|Physician Decision|1|||
149948201|NCT02328014|540944693|FG000|Overall Study|Disease Progression|1|||
149948202|NCT02328014|540944694|FG001|Overall Study|Disease Progression|0|||
149948203|NCT02328014|540944695|FG002|Overall Study|Disease Progression|1|||
150277215|NCT03680911|542151944|FG001|At Home Treatment|Study Termination|0|||
150277216|NCT03680911|542151943|FG000|At Home Treatment|Lost to Follow-up|0|||
150277217|NCT03680911|542151944|FG001|At Home Treatment|Lost to Follow-up|1|||
150277218|NCT03680911|542151943|FG000|At Home Treatment|Withdrawal by Subject|0|||
150277219|NCT03680911|542151944|FG001|At Home Treatment|Withdrawal by Subject|2|||
150277220|NCT03680911|542151943|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
150277221|NCT03680911|542151944|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
150277222|NCT03962738|542151945|FG000|Overall Study|Protocol Deviation|3|||
150277223|NCT03962738|542151946|FG001|Overall Study|Protocol Deviation|0|||
150277224|NCT03962738|542151947|FG002|Overall Study|Protocol Deviation|1|||
150277225|NCT03962738|542151948|FG003|Overall Study|Protocol Deviation|1|||
150277226|NCT03962738|542151945|FG000|Overall Study|Withdrawal by Subject|4|||
150277227|NCT03962738|542151946|FG001|Overall Study|Withdrawal by Subject|0|||
150277228|NCT03962738|542151947|FG002|Overall Study|Withdrawal by Subject|0|||
150277229|NCT03962738|542151948|FG003|Overall Study|Withdrawal by Subject|0|||
150277230|NCT03962738|542151945|FG000|Overall Study|Lost to Follow-up|0|||
150277231|NCT03962738|542151946|FG001|Overall Study|Lost to Follow-up|0|||
150277232|NCT03962738|542151947|FG002|Overall Study|Lost to Follow-up|1|||
150277233|NCT03962738|542151948|FG003|Overall Study|Lost to Follow-up|0|||
150277234|NCT00574288|542151949|FG000|Overall Study|Adverse Event|2|||
150277235|NCT00574288|542151950|FG001|Overall Study|Adverse Event|0|||
150277236|NCT00574288|542151951|FG002|Overall Study|Adverse Event|0|||
150277237|NCT00574288|542151952|FG003|Overall Study|Adverse Event|0|||
150277238|NCT00574288|542151953|FG004|Overall Study|Adverse Event|1|||
150277239|NCT00574288|542151954|FG005|Overall Study|Adverse Event|0|||
150277240|NCT00574288|542151955|FG006|Overall Study|Adverse Event|0|||
150277241|NCT00574288|542151949|FG000|Overall Study|Death|0|||
150277242|NCT00574288|542151950|FG001|Overall Study|Death|0|||
150277243|NCT00574288|542151951|FG002|Overall Study|Death|0|||
150277244|NCT00574288|542151952|FG003|Overall Study|Death|0|||
150277245|NCT00574288|542151953|FG004|Overall Study|Death|0|||
150277246|NCT00574288|542151954|FG005|Overall Study|Death|25|||
150277247|NCT00574288|542151955|FG006|Overall Study|Death|21|||
150277248|NCT00574288|542151949|FG000|Overall Study|Lost to Follow-up|0|||
150277249|NCT00574288|542151950|FG001|Overall Study|Lost to Follow-up|0|||
150277250|NCT00574288|542151951|FG002|Overall Study|Lost to Follow-up|0|||
150277251|NCT00574288|542151952|FG003|Overall Study|Lost to Follow-up|0|||
150277252|NCT00574288|542151953|FG004|Overall Study|Lost to Follow-up|0|||
150277253|NCT00574288|542151954|FG005|Overall Study|Lost to Follow-up|1|||
150277254|NCT00574288|542151955|FG006|Overall Study|Lost to Follow-up|2|||
150277255|NCT00574288|542151949|FG000|Overall Study|Study Terminated By Sponsor|0|||
150277256|NCT00574288|542151950|FG001|Overall Study|Study Terminated By Sponsor|0|||
150277257|NCT00574288|542151951|FG002|Overall Study|Study Terminated By Sponsor|0|||
150277258|NCT00574288|542151952|FG003|Overall Study|Study Terminated By Sponsor|0|||
150277259|NCT00574288|542151953|FG004|Overall Study|Study Terminated By Sponsor|0|||
150277260|NCT00574288|542151954|FG005|Overall Study|Study Terminated By Sponsor|0|||
150277261|NCT00574288|542151955|FG006|Overall Study|Study Terminated By Sponsor|5|||
150277262|NCT00574288|542151949|FG000|Overall Study|Progressive Disease|17|||
150277263|NCT00574288|542151950|FG001|Overall Study|Progressive Disease|2|||
150277264|NCT00574288|542151951|FG002|Overall Study|Progressive Disease|3|||
150277265|NCT00574288|542151952|FG003|Overall Study|Progressive Disease|2|||
150277266|NCT00574288|542151953|FG004|Overall Study|Progressive Disease|1|||
150277267|NCT00574288|542151954|FG005|Overall Study|Progressive Disease|0|||
150277268|NCT00574288|542151955|FG006|Overall Study|Progressive Disease|0|||
150277269|NCT00574288|542151949|FG000|Overall Study|Other|1|||
150277270|NCT00574288|542151950|FG001|Overall Study|Other|1|||
150277271|NCT00574288|542151951|FG002|Overall Study|Other|0|||
150277272|NCT00574288|542151952|FG003|Overall Study|Other|0|||
150277273|NCT00574288|542151953|FG004|Overall Study|Other|0|||
150277274|NCT00574288|542151954|FG005|Overall Study|Other|0|||
150277275|NCT00574288|542151955|FG006|Overall Study|Other|0|||
150277276|NCT03716050|542151958|FG000|Overall Study|Lost to Follow-up|0|||
150277277|NCT03716050|542151959|FG001|Overall Study|Lost to Follow-up|0|||
150277278|NCT03716050|542151960|FG002|Overall Study|Lost to Follow-up|1|||
150277279|NCT03716050|542151961|FG003|Overall Study|Lost to Follow-up|0|||
150277280|NCT03716050|542151962|FG004|Overall Study|Lost to Follow-up|0|||
150277281|NCT03716050|542151963|FG005|Overall Study|Lost to Follow-up|0|||
150277282|NCT03716050|542151964|FG006|Overall Study|Lost to Follow-up|0|||
150277283|NCT03716050|542151965|FG007|Overall Study|Lost to Follow-up|0|||
150277284|NCT03716050|542151958|FG000|Overall Study|Physician Decision|0|||
150277285|NCT03716050|542151959|FG001|Overall Study|Physician Decision|0|||
149948204|NCT02328014|540944696|FG003|Overall Study|Disease Progression|3|||
150277286|NCT03716050|542151960|FG002|Overall Study|Physician Decision|0|||
150277287|NCT03716050|542151961|FG003|Overall Study|Physician Decision|1|||
150277288|NCT03716050|542151962|FG004|Overall Study|Physician Decision|0|||
150277289|NCT03716050|542151963|FG005|Overall Study|Physician Decision|0|||
150277290|NCT03716050|542151964|FG006|Overall Study|Physician Decision|0|||
150277291|NCT03716050|542151965|FG007|Overall Study|Physician Decision|0|||
150277292|NCT03716050|542151958|FG000|Overall Study|Protocol Violation|0|||
150277293|NCT03716050|542151959|FG001|Overall Study|Protocol Violation|0|||
150277294|NCT03716050|542151960|FG002|Overall Study|Protocol Violation|0|||
150277295|NCT03716050|542151961|FG003|Overall Study|Protocol Violation|1|||
150277296|NCT03716050|542151962|FG004|Overall Study|Protocol Violation|0|||
150277297|NCT03716050|542151963|FG005|Overall Study|Protocol Violation|0|||
150277298|NCT03716050|542151964|FG006|Overall Study|Protocol Violation|0|||
150277299|NCT03716050|542151965|FG007|Overall Study|Protocol Violation|2|||
150277300|NCT01221727|542151966|FG000|Overall Study|Physician Decision|2|||
150277301|NCT01221727|542151967|FG001|Overall Study|Physician Decision|0|||
150277302|NCT01221727|542151966|FG000|Overall Study|Withdrawal by Subject|1|||
150277303|NCT01221727|542151967|FG001|Overall Study|Withdrawal by Subject|1|||
150277304|NCT00529451|542151968|FG000|Overall Study|Subject withdrew consent|16|||
150277305|NCT00529451|542151969|FG001|Overall Study|Subject withdrew consent|21|||
150277306|NCT00529451|542151970|FG002|Overall Study|Subject withdrew consent|13|||
150277307|NCT00529451|542151971|FG003|Overall Study|Subject withdrew consent|12|||
150277308|NCT00529451|542151968|FG000|Overall Study|Adverse Event|9|||
150277309|NCT00529451|542151969|FG001|Overall Study|Adverse Event|16|||
150277310|NCT00529451|542151970|FG002|Overall Study|Adverse Event|14|||
150277311|NCT00529451|542151971|FG003|Overall Study|Adverse Event|8|||
150277312|NCT00529451|542151968|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
150277313|NCT00529451|542151969|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
150277314|NCT00529451|542151970|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
150277315|NCT00529451|542151971|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
150277316|NCT00529451|542151968|FG000|Overall Study|Lost to Follow-up|4|||
150277317|NCT00529451|542151969|FG001|Overall Study|Lost to Follow-up|7|||
150277318|NCT00529451|542151970|FG002|Overall Study|Lost to Follow-up|4|||
150277319|NCT00529451|542151971|FG003|Overall Study|Lost to Follow-up|4|||
150277320|NCT00529451|542151968|FG000|Overall Study|Protocol deviation|1|||
150277321|NCT00529451|542151969|FG001|Overall Study|Protocol deviation|1|||
150277322|NCT00529451|542151970|FG002|Overall Study|Protocol deviation|4|||
150277323|NCT00529451|542151971|FG003|Overall Study|Protocol deviation|1|||
150277324|NCT00529451|542151968|FG000|Overall Study|Administrative problems|1|||
150277325|NCT00529451|542151969|FG001|Overall Study|Administrative problems|1|||
150277326|NCT00529451|542151970|FG002|Overall Study|Administrative problems|0|||
150277327|NCT00529451|542151971|FG003|Overall Study|Administrative problems|2|||
150277328|NCT02566577|542151972|FG000|Overall Study|Withdrawal by Subject|1|||
150277329|NCT02566577|542151973|FG001|Overall Study|Withdrawal by Subject|1|||
150277330|NCT02566577|542151972|FG000|Overall Study|Equipment failure|1|||
150277331|NCT02566577|542151973|FG001|Overall Study|Equipment failure|1|||
150277332|NCT02566577|542151972|FG000|Overall Study|Physical limitation|1|||
150277333|NCT02566577|542151973|FG001|Overall Study|Physical limitation|0|||
150277334|NCT00097773|542151974|FG000|Overall Study|Lost to Follow-up|2|||
150277335|NCT00097773|542151975|FG001|Overall Study|Lost to Follow-up|2|||
150277336|NCT00097773|542151976|FG002|Overall Study|Lost to Follow-up|0|||
150277337|NCT00097773|542151977|FG003|Overall Study|Lost to Follow-up|1|||
150277338|NCT00097773|542151974|FG000|Overall Study|Physician Decision|2|||
150277339|NCT00097773|542151975|FG001|Overall Study|Physician Decision|2|||
150277340|NCT00097773|542151976|FG002|Overall Study|Physician Decision|3|||
150277341|NCT00097773|542151977|FG003|Overall Study|Physician Decision|1|||
150277342|NCT00097773|542151974|FG000|Overall Study|Withdrawal by Subject|3|||
150277343|NCT00097773|542151975|FG001|Overall Study|Withdrawal by Subject|3|||
150277344|NCT00097773|542151976|FG002|Overall Study|Withdrawal by Subject|3|||
150277345|NCT00097773|542151977|FG003|Overall Study|Withdrawal by Subject|1|||
150277346|NCT00097773|542151974|FG000|Overall Study|Adverse Event|0|||
150277347|NCT00097773|542151975|FG001|Overall Study|Adverse Event|1|||
150277348|NCT00097773|542151976|FG002|Overall Study|Adverse Event|0|||
150277349|NCT00097773|542151977|FG003|Overall Study|Adverse Event|0|||
150277350|NCT00097773|542151974|FG000|Overall Study|Other|1|||
150277351|NCT00097773|542151975|FG001|Overall Study|Other|0|||
150277352|NCT00097773|542151976|FG002|Overall Study|Other|2|||
150277353|NCT00097773|542151977|FG003|Overall Study|Other|0|||
150277354|NCT01009034|542151978|FG000|Overall Study|Lost to Follow-up|2|||
150277355|NCT01009034|542151978|FG000|Overall Study|Withdrawal by Subject|2|||
150277356|NCT01494350|542151979|FG000|Overall Study|Worsening of lesion|1|||
149948205|NCT02328014|540944693|FG000|Overall Study|Study Terminated by Sponsor|4|||
149948206|NCT02328014|540944694|FG001|Overall Study|Study Terminated by Sponsor|1|||
149948207|NCT02328014|540944695|FG002|Overall Study|Study Terminated by Sponsor|1|||
149948208|NCT02328014|540944696|FG003|Overall Study|Study Terminated by Sponsor|0|||
149948209|NCT02328014|540944693|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
150277357|NCT01786603|542151980|FG000|Overall Study|Death|5|||
150277358|NCT01786603|542151981|FG001|Overall Study|Death|1|||
150277359|NCT01786603|542151980|FG000|Overall Study|Adverse Event|6|||
150277360|NCT01786603|542151981|FG001|Overall Study|Adverse Event|2|||
150277361|NCT01786603|542151980|FG000|Overall Study|Physician decision to withdraw|6|||
150277362|NCT01786603|542151981|FG001|Overall Study|Physician decision to withdraw|7|||
150277363|NCT01786603|542151980|FG000|Overall Study|Lost to Follow-up|1|||
150277364|NCT01786603|542151981|FG001|Overall Study|Lost to Follow-up|2|||
150277365|NCT03700320|542151982|FG000|Overall Study|Adverse Event|5|||
150277366|NCT03700320|542151983|FG001|Overall Study|Adverse Event|31|||
150277367|NCT03700320|542151982|FG000|Overall Study|Lack of Efficacy|2|||
150277368|NCT03700320|542151983|FG001|Overall Study|Lack of Efficacy|5|||
150277369|NCT03700320|542151982|FG000|Overall Study|Withdrawal by Subject|29|||
150277370|NCT03700320|542151983|FG001|Overall Study|Withdrawal by Subject|75|||
150277371|NCT03700320|542151982|FG000|Overall Study|Lost to Follow-up|16|||
150277372|NCT03700320|542151983|FG001|Overall Study|Lost to Follow-up|23|||
150277373|NCT03700320|542151982|FG000|Overall Study|Pregnancy|2|||
149948210|NCT02328014|540944694|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
149948211|NCT02328014|540944695|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
149948212|NCT02328014|540944696|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
149948213|NCT02328014|540944693|FG000|Overall Study|Withdrawal by Subject|0|||
149948214|NCT02328014|540944694|FG001|Overall Study|Withdrawal by Subject|0|||
149948215|NCT02328014|540944695|FG002|Overall Study|Withdrawal by Subject|0|||
149948216|NCT02328014|540944696|FG003|Overall Study|Withdrawal by Subject|1|||
149948247|NCT04338581|540944714|FG000|Overall Study|Lack of Efficacy|1|||
149948248|NCT04338581|540944715|FG001|Overall Study|Lack of Efficacy|0|||
149948249|NCT04338581|540944714|FG000|Overall Study|Withdrawal by Subject|4|||
149948250|NCT04338581|540944715|FG001|Overall Study|Withdrawal by Subject|4|||
149948251|NCT04338581|540944714|FG000|Overall Study|Prohibited Medication|1|||
149948252|NCT04338581|540944715|FG001|Overall Study|Prohibited Medication|0|||
149948253|NCT05028569|540944719|FG000|Double-Blind Phase|Death|0|||
149948254|NCT05028569|540944720|FG001|Double-Blind Phase|Death|0|||
149948255|NCT05028569|540944721|FG002|Double-Blind Phase|Death|0|||
149948256|NCT05028569|540944722|FG003|Double-Blind Phase|Death|1|||
149948257|NCT05028569|540944723|FG004|Double-Blind Phase|Death|0|||
149948258|NCT05028569|540944724|FG005|Double-Blind Phase|Death|0|||
149948259|NCT05028569|540944725|FG006|Double-Blind Phase|Death|0|||
149948260|NCT05028569|540944719|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149948261|NCT05028569|540944720|FG001|Double-Blind Phase|Lost to Follow-up|6|||
149948262|NCT05028569|540944721|FG002|Double-Blind Phase|Lost to Follow-up|3|||
149948263|NCT05028569|540944722|FG003|Double-Blind Phase|Lost to Follow-up|9|||
149948264|NCT05028569|540944723|FG004|Double-Blind Phase|Lost to Follow-up|0|||
149948265|NCT05028569|540944724|FG005|Double-Blind Phase|Lost to Follow-up|0|||
149948266|NCT05028569|540944725|FG006|Double-Blind Phase|Lost to Follow-up|0|||
149948267|NCT05028569|540944719|FG000|Double-Blind Phase|Protocol Deviation|0|||
149948268|NCT05028569|540944720|FG001|Double-Blind Phase|Protocol Deviation|2|||
149948269|NCT05028569|540944721|FG002|Double-Blind Phase|Protocol Deviation|0|||
149948270|NCT05028569|540944722|FG003|Double-Blind Phase|Protocol Deviation|0|||
149948271|NCT05028569|540944723|FG004|Double-Blind Phase|Protocol Deviation|0|||
149948272|NCT05028569|540944724|FG005|Double-Blind Phase|Protocol Deviation|0|||
149948273|NCT05028569|540944725|FG006|Double-Blind Phase|Protocol Deviation|0|||
149948274|NCT05028569|540944719|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149948275|NCT05028569|540944720|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
149948276|NCT05028569|540944721|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
149948277|NCT05028569|540944722|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
149948278|NCT05028569|540944723|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149948279|NCT05028569|540944724|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
150277374|NCT03700320|542151983|FG001|Overall Study|Pregnancy|4|||
150277375|NCT03700320|542151982|FG000|Overall Study|Protocol Deviation|7|||
149948280|NCT05028569|540944725|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
150033740|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
150033741|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
150033742|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
150033743|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
150033744|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
150033745|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
150033746|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
150033747|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
150033748|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
150033749|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
150033750|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
150033751|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
150033752|NCT04026113|541262851|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
150033753|NCT04026113|541262852|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
150033754|NCT04026113|541262853|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
150033755|NCT04026113|541262854|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
150033756|NCT04026113|541262851|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
150033757|NCT04026113|541262852|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
150033758|NCT04026113|541262853|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
150033759|NCT04026113|541262854|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
150033760|NCT00687596|541262855|FG000|Overall Study|Adverse Event (AE)|10|||
150033761|NCT00687596|541262856|FG001|Overall Study|Adverse Event (AE)|3|||
150033762|NCT00687596|541262855|FG000|Overall Study|Radiological Disease Progression|6|||
150033763|NCT00687596|541262856|FG001|Overall Study|Radiological Disease Progression|2|||
150033764|NCT00687596|541262855|FG000|Overall Study|Clinical Disease Progression|1|||
150033765|NCT00687596|541262856|FG001|Overall Study|Clinical Disease Progression|3|||
150033766|NCT00687596|541262855|FG000|Overall Study|Investigator Discretion|3|||
150033767|NCT00687596|541262856|FG001|Overall Study|Investigator Discretion|1|||
150033768|NCT00687596|541262855|FG000|Overall Study|Sponsor Terminated Study|6|||
150033769|NCT00687596|541262856|FG001|Overall Study|Sponsor Terminated Study|17|||
150033770|NCT04613362|541262857|FG000|3 Month Follow-up|Lost to Follow-up|1|||
150033771|NCT04613362|541262858|FG001|3 Month Follow-up|Lost to Follow-up|2|||
150033772|NCT04613362|541262857|FG000|6 Month Follow-up|Lost to Follow-up|0|||
150033773|NCT04613362|541262858|FG001|6 Month Follow-up|Lost to Follow-up|1|||
150033774|NCT02903771|541262859|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
150033775|NCT02903771|541262860|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
150033776|NCT02903771|541262861|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
150033777|NCT02903771|541262862|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
150033778|NCT02903771|541262863|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
150033779|NCT02903771|541262864|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
150033780|NCT02903771|541262865|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
150033781|NCT02903771|541262859|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033782|NCT02903771|541262860|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
150033783|NCT02903771|541262861|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033784|NCT02903771|541262862|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033785|NCT02903771|541262863|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033786|NCT02903771|541262864|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033787|NCT02903771|541262865|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
150033788|NCT02903771|541262859|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
150033789|NCT02903771|541262860|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
150033790|NCT02903771|541262861|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
150033791|NCT02903771|541262862|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
150033792|NCT02903771|541262863|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
150033793|NCT02903771|541262864|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
150033794|NCT02903771|541262865|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
150033795|NCT02903771|541262859|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033796|NCT02903771|541262860|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033797|NCT02903771|541262861|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033798|NCT02903771|541262862|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033799|NCT02903771|541262863|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
150033800|NCT02903771|541262864|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033801|NCT02903771|541262865|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
150033802|NCT02903771|541262859|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
150033803|NCT02903771|541262860|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
150033804|NCT02903771|541262861|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
150033805|NCT02903771|541262862|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
150170910|NCT00770965|541760799|FG003|Excluded Set|Withdrawal by Subject|3|||
150170911|NCT02371746|541760800|FG000|Overall Study|Consent withdrawn|0|||
150033806|NCT02903771|541262863|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
150033807|NCT02903771|541262864|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
150033808|NCT02903771|541262865|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
150033809|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033810|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033811|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033812|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033813|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
150033814|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033815|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
150033816|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033817|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033818|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033819|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033820|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
150033821|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033822|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
150033823|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150033824|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150033825|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150033826|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150170912|NCT02371746|541760801|FG001|Overall Study|Consent withdrawn|0|||
150170913|NCT02371746|541760802|FG002|Overall Study|Consent withdrawn|0|||
150170914|NCT02371746|541760803|FG003|Overall Study|Consent withdrawn|0|||
150170915|NCT02371746|541760804|FG004|Overall Study|Consent withdrawn|0|||
150170916|NCT02371746|541760805|FG005|Overall Study|Consent withdrawn|0|||
150170917|NCT02371746|541760806|FG006|Overall Study|Consent withdrawn|1|||
150170918|NCT00436644|541760807|FG000|Overall Study|Adverse Event|2|||
150170919|NCT00436644|541760807|FG000|Overall Study|Death|1|||
150170920|NCT04364269|541760808|FG000|Overall Study|Adverse Event|1|||
150170921|NCT04364269|541760809|FG001|Overall Study|Adverse Event|0|||
150170922|NCT04364269|541760810|FG002|Overall Study|Adverse Event|0|||
150170923|NCT04364269|541760808|FG000|Overall Study|Withdrawal by Subject|0|||
150170924|NCT04364269|541760809|FG001|Overall Study|Withdrawal by Subject|1|||
150170925|NCT04364269|541760810|FG002|Overall Study|Withdrawal by Subject|0|||
150170926|NCT01157182|541760811|FG000|Washout of 28 Days|Adverse Event|2|||
150170927|NCT01157182|541760812|FG001|Washout of 28 Days|Adverse Event|0|||
150170928|NCT02534350|541760813|FG000|Overall Study|Randomized But Not Treated|1|||
150170929|NCT02534350|541760814|FG001|Overall Study|Randomized But Not Treated|0|||
150170930|NCT02534350|541760813|FG000|Overall Study|Protocol Violation|1|||
150170931|NCT02534350|541760814|FG001|Overall Study|Protocol Violation|0|||
150170932|NCT02534350|541760813|FG000|Overall Study|Withdrew Consent|2|||
150170933|NCT02534350|541760814|FG001|Overall Study|Withdrew Consent|0|||
150170934|NCT00319436|541760819|FG000|Overall Study|Withdrawal by Subject|6|||
150170935|NCT00319436|541760820|FG001|Overall Study|Withdrawal by Subject|7|||
150170936|NCT00790790|541760821|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
150170937|NCT00790790|541760822|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
150170938|NCT00790790|541760823|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
150170939|NCT00790790|541760821|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
150170940|NCT00790790|541760822|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
150170941|NCT00790790|541760823|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
150170942|NCT00790790|541760821|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
150170943|NCT00790790|541760822|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
150170944|NCT00790790|541760823|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
150170945|NCT00790790|541760821|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
150170946|NCT00790790|541760822|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
150170947|NCT00790790|541760823|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
150170948|NCT00790790|541760821|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
150170949|NCT00790790|541760822|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
150170950|NCT00790790|541760823|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
150170951|NCT01161498|541760826|FG000|Overall Study|Disease Progression|0|||
150170952|NCT01161498|541760827|FG001|Overall Study|Disease Progression|1|||
150170953|NCT02807493|541760828|FG000|Overall Study|Adverse Event|5|||
150170954|NCT02807493|541760829|FG001|Overall Study|Adverse Event|2|||
150170955|NCT02807493|541760828|FG000|Overall Study|Lost to Follow-up|6|||
150170956|NCT02807493|541760829|FG001|Overall Study|Lost to Follow-up|0|||
150170957|NCT02807493|541760828|FG000|Overall Study|Physician Decision|4|||
150170958|NCT02807493|541760829|FG001|Overall Study|Physician Decision|1|||
150170959|NCT02807493|541760828|FG000|Overall Study|Protocol Violation|7|||
150170960|NCT02807493|541760829|FG001|Overall Study|Protocol Violation|0|||
150170961|NCT02807493|541760828|FG000|Overall Study|Withdrawal by Subject|17|||
150170962|NCT02807493|541760829|FG001|Overall Study|Withdrawal by Subject|10|||
150170963|NCT02807493|541760828|FG000|Overall Study|Other withdrawal|17|||
150170964|NCT02807493|541760829|FG001|Overall Study|Other withdrawal|0|||
150277376|NCT03700320|542151983|FG001|Overall Study|Protocol Deviation|31|||
150277377|NCT03700320|542151982|FG000|Overall Study|Non-compliance with Study Drug|1|||
150277378|NCT03700320|542151983|FG001|Overall Study|Non-compliance with Study Drug|3|||
150277379|NCT03700320|542151982|FG000|Overall Study|Reason not Specified|0|||
150277380|NCT03700320|542151983|FG001|Overall Study|Reason not Specified|1|||
150277381|NCT03654976|542151984|FG000|Overall Study|Withdrawal by Subject|12|||
150277382|NCT03654976|542151985|FG001|Overall Study|Withdrawal by Subject|11|||
150277383|NCT03654976|542151984|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
150277384|NCT03654976|542151985|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
150277385|NCT03654976|542151984|FG000|Overall Study|Adverse Event|5|||
150277386|NCT03654976|542151985|FG001|Overall Study|Adverse Event|0|||
150277387|NCT03654976|542151984|FG000|Overall Study|Lost to Follow-up|2|||
150277388|NCT03654976|542151985|FG001|Overall Study|Lost to Follow-up|0|||
150277389|NCT03654976|542151984|FG000|Overall Study|Lack of Efficacy|0|||
150277390|NCT03654976|542151985|FG001|Overall Study|Lack of Efficacy|1|||
150277391|NCT02054325|542151993|FG000|Overall Study|Lost to Follow-up|8|||
150277392|NCT02054325|542151994|FG001|Overall Study|Lost to Follow-up|5|||
150277393|NCT04688775|542151995|FG000|Placebo-controlled Period|Randomized, not treated|1|||
150277394|NCT04688775|542151996|FG001|Placebo-controlled Period|Randomized, not treated|1|||
150277395|NCT04688775|542151997|FG002|Placebo-controlled Period|Randomized, not treated|0|||
150277396|NCT04688775|542151998|FG003|Placebo-controlled Period|Randomized, not treated|0|||
150277397|NCT04688775|542151995|FG000|Placebo-controlled Period|Adverse Event|2|||
150277398|NCT04688775|542151996|FG001|Placebo-controlled Period|Adverse Event|0|||
150277399|NCT04688775|542151997|FG002|Placebo-controlled Period|Adverse Event|0|||
150277400|NCT04688775|542151998|FG003|Placebo-controlled Period|Adverse Event|0|||
150277401|NCT04688775|542151995|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
150277402|NCT04688775|542151996|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
150277403|NCT04688775|542151997|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
150277404|NCT04688775|542151998|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
150277405|NCT04688775|542151995|FG000|Placebo-controlled Period|Protocol Violation|0|||
150277406|NCT04688775|542151996|FG001|Placebo-controlled Period|Protocol Violation|1|||
150277407|NCT04688775|542151997|FG002|Placebo-controlled Period|Protocol Violation|0|||
150277408|NCT04688775|542151998|FG003|Placebo-controlled Period|Protocol Violation|0|||
150277409|NCT04688775|542151995|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
150277410|NCT04688775|542151996|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
150277411|NCT04688775|542151997|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
150277412|NCT04688775|542151998|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
150277413|NCT04688775|542151995|FG000|Placebo-controlled Period|Other reasons|0|||
150277414|NCT04688775|542151996|FG001|Placebo-controlled Period|Other reasons|1|||
150277415|NCT04688775|542151997|FG002|Placebo-controlled Period|Other reasons|0|||
150277416|NCT04688775|542151998|FG003|Placebo-controlled Period|Other reasons|0|||
150277417|NCT04688775|542151995|FG000|Delayed Start Period|Adverse Event|0|||
150277418|NCT04688775|542151996|FG001|Delayed Start Period|Adverse Event|0|||
150277419|NCT04688775|542151997|FG002|Delayed Start Period|Adverse Event|1|||
150277420|NCT04688775|542151998|FG003|Delayed Start Period|Adverse Event|0|||
150277421|NCT04688775|542151995|FG000|Delayed Start Period|Lack of Efficacy|0|||
150277422|NCT04688775|542151996|FG001|Delayed Start Period|Lack of Efficacy|0|||
150277423|NCT04688775|542151997|FG002|Delayed Start Period|Lack of Efficacy|0|||
150277424|NCT04688775|542151998|FG003|Delayed Start Period|Lack of Efficacy|3|||
150277425|NCT04688775|542151995|FG000|Delayed Start Period|Withdrawal by Subject|0|||
150277426|NCT04688775|542151996|FG001|Delayed Start Period|Withdrawal by Subject|0|||
150277427|NCT04688775|542151997|FG002|Delayed Start Period|Withdrawal by Subject|2|||
150277428|NCT04688775|542151998|FG003|Delayed Start Period|Withdrawal by Subject|4|||
150277429|NCT04688775|542151995|FG000|Delayed Start Period|Lost to Follow-up|0|||
150277430|NCT04688775|542151996|FG001|Delayed Start Period|Lost to Follow-up|0|||
150277431|NCT04688775|542151997|FG002|Delayed Start Period|Lost to Follow-up|2|||
150277432|NCT04688775|542151998|FG003|Delayed Start Period|Lost to Follow-up|1|||
150277433|NCT04688775|542151995|FG000|Delayed Start Period|other reasons|0|||
150277434|NCT04688775|542151996|FG001|Delayed Start Period|other reasons|0|||
150277435|NCT04688775|542151997|FG002|Delayed Start Period|other reasons|1|||
150277436|NCT04688775|542151998|FG003|Delayed Start Period|other reasons|0|||
150277437|NCT00932425|542151999|FG000|Overall Study|Lost to Follow-up|0|||
150277438|NCT00932425|542152000|FG001|Overall Study|Lost to Follow-up|1|||
150277439|NCT00932425|542151999|FG000|Overall Study|Withdrawal by Subject|0|||
150277440|NCT00932425|542152000|FG001|Overall Study|Withdrawal by Subject|1|||
150277441|NCT01721876|542152001|FG000|Overall Study|Not treated|1|||
150277442|NCT01721876|542152002|FG001|Overall Study|Not treated|4|||
150277443|NCT01721876|542152001|FG000|Overall Study|Disease progression / relapse|123|||
150277444|NCT01721876|542152002|FG001|Overall Study|Disease progression / relapse|156|||
150277445|NCT01721876|542152001|FG000|Overall Study|Death|6|||
150277446|NCT01721876|542152002|FG001|Overall Study|Death|13|||
150277447|NCT01721876|542152001|FG000|Overall Study|Adverse Event|41|||
150277448|NCT01721876|542152002|FG001|Overall Study|Adverse Event|165|||
150277449|NCT01721876|542152001|FG000|Overall Study|Protocol Violation|2|||
150277450|NCT01721876|542152002|FG001|Overall Study|Protocol Violation|1|||
150277451|NCT01721876|542152001|FG000|Overall Study|Withdrawal by Subject|15|||
150277452|NCT01721876|542152002|FG001|Overall Study|Withdrawal by Subject|38|||
150277453|NCT01721876|542152001|FG000|Overall Study|Reason not listed|34|||
150277454|NCT01721876|542152002|FG001|Overall Study|Reason not listed|63|||
150277455|NCT01721876|542152001|FG000|Overall Study|Sponsor terminated trial|0|||
150277456|NCT01721876|542152002|FG001|Overall Study|Sponsor terminated trial|4|||
150277457|NCT01200238|542152003|FG000|Overall Study|Adverse Event|2|||
150277458|NCT01200238|542152004|FG001|Overall Study|Adverse Event|1|||
150277459|NCT01200238|542152003|FG000|Overall Study|Progressive Disease|5|||
150277460|NCT01200238|542152004|FG001|Overall Study|Progressive Disease|8|||
150277461|NCT01200238|542152003|FG000|Overall Study|Withdrawal by Subject|0|||
150277462|NCT01200238|542152004|FG001|Overall Study|Withdrawal by Subject|1|||
150277463|NCT02717754|542152005|FG000|Overall Study|Incorrect Infusion Duration|0|||
150277464|NCT02717754|542152006|FG001|Overall Study|Incorrect Infusion Duration|0|||
150277465|NCT02717754|542152007|FG002|Overall Study|Incorrect Infusion Duration|0|||
150277466|NCT02717754|542152008|FG003|Overall Study|Incorrect Infusion Duration|10|||
150277467|NCT02717754|542152009|FG004|Overall Study|Incorrect Infusion Duration|20|||
150277468|NCT02717754|542152010|FG005|Overall Study|Incorrect Infusion Duration|20|||
150277469|NCT00482703|542152011|FG000|Overall Study|Poor compliance|1|||
150277470|NCT00482703|542152012|FG001|Overall Study|Poor compliance|0|||
150277471|NCT03677596|542153412|FG000|Overall Study|Adverse Event|0|||
150277472|NCT03677596|542153413|FG001|Overall Study|Adverse Event|1|||
150277473|NCT03677596|542153412|FG000|Overall Study|Death|10|||
150277474|NCT03677596|542153413|FG001|Overall Study|Death|6|||
150277475|NCT03677596|542153412|FG000|Overall Study|Lost to Follow-up|0|||
150277476|NCT03677596|542153413|FG001|Overall Study|Lost to Follow-up|1|||
150277477|NCT03677596|542153412|FG000|Overall Study|Progressive Disease|8|||
150277478|NCT03677596|542153413|FG001|Overall Study|Progressive Disease|8|||
150277479|NCT03677596|542153412|FG000|Overall Study|Withdrawal by Subject|3|||
150277480|NCT03677596|542153413|FG001|Overall Study|Withdrawal by Subject|0|||
150277481|NCT03677596|542153412|FG000|Overall Study|Disease Relapse|2|||
150277482|NCT03677596|542153413|FG001|Overall Study|Disease Relapse|2|||
150277483|NCT03677596|542153412|FG000|Overall Study|Other|0|||
150277484|NCT03677596|542153413|FG001|Overall Study|Other|1|||
150277485|NCT00806195|542153414|FG000|Overall Study|Death|6|||
150277486|NCT00806195|542153415|FG001|Overall Study|Death|0|||
150277487|NCT00806195|542153416|FG002|Overall Study|Death|1|||
150277488|NCT00806195|542153417|FG003|Overall Study|Death|0|||
150277489|NCT00806195|542153414|FG000|Overall Study|Adverse Event|25|||
150277490|NCT00806195|542153415|FG001|Overall Study|Adverse Event|5|||
150277491|NCT00806195|542153416|FG002|Overall Study|Adverse Event|11|||
150277492|NCT00806195|542153417|FG003|Overall Study|Adverse Event|2|||
150277493|NCT00806195|542153414|FG000|Overall Study|Withdrawal by Subject|119|||
150277494|NCT00806195|542153415|FG001|Overall Study|Withdrawal by Subject|31|||
150277495|NCT00806195|542153416|FG002|Overall Study|Withdrawal by Subject|76|||
150277496|NCT00806195|542153417|FG003|Overall Study|Withdrawal by Subject|35|||
150277497|NCT00806195|542153414|FG000|Overall Study|Lost to Follow-up|217|||
150277498|NCT00806195|542153415|FG001|Overall Study|Lost to Follow-up|66|||
150277499|NCT00806195|542153416|FG002|Overall Study|Lost to Follow-up|90|||
150277500|NCT00806195|542153417|FG003|Overall Study|Lost to Follow-up|34|||
150277501|NCT00806195|542153414|FG000|Overall Study|Inappropriate Enrollment|0|||
150277502|NCT00806195|542153415|FG001|Overall Study|Inappropriate Enrollment|1|||
150277503|NCT00806195|542153416|FG002|Overall Study|Inappropriate Enrollment|0|||
150277504|NCT00806195|542153417|FG003|Overall Study|Inappropriate Enrollment|0|||
150277505|NCT00806195|542153414|FG000|Overall Study|Administrative Reason|113|||
150277506|NCT00806195|542153415|FG001|Overall Study|Administrative Reason|35|||
150277507|NCT00806195|542153416|FG002|Overall Study|Administrative Reason|66|||
150277508|NCT00806195|542153417|FG003|Overall Study|Administrative Reason|26|||
150277509|NCT00806195|542153414|FG000|Overall Study|Protocol Violation|34|||
150277510|NCT00806195|542153415|FG001|Overall Study|Protocol Violation|24|||
150277511|NCT00806195|542153416|FG002|Overall Study|Protocol Violation|26|||
150277512|NCT00806195|542153417|FG003|Overall Study|Protocol Violation|9|||
150277513|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
150277514|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
150277515|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
150277516|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
150277517|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
150277518|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
150277519|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
150277520|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
150277521|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
150277522|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
150277523|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
150277524|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
150277525|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
150277526|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
150277527|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
150277528|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
150277529|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
150277530|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
150277531|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
150277532|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
150277533|NCT02752035|542153418|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
150277534|NCT02752035|542153419|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
150277535|NCT02752035|542153420|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
150277536|NCT02752035|542153421|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
150277537|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
150277538|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
150277539|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
150277540|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
150277541|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
150277542|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
150277543|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
150277544|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
150277545|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
150277546|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
150277547|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
150277548|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
150277549|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
150277550|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
150277551|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
150277552|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
150277553|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
150277554|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
150277555|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
150277556|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
150277557|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Death|0|||
150277558|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Death|25|||
150277559|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Death|13|||
150277560|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Death|4|||
150277561|NCT02752035|542153418|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
150277562|NCT02752035|542153419|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
150277563|NCT02752035|542153420|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
150277564|NCT02752035|542153421|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
150277565|NCT02752035|542153418|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
150277566|NCT02752035|542153419|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
150277567|NCT02752035|542153420|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
150277568|NCT02752035|542153421|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
150277569|NCT02752035|542153418|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
150277570|NCT02752035|542153419|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
150277571|NCT02752035|542153420|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
150277572|NCT02752035|542153421|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
150277573|NCT02752035|542153418|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
150277574|NCT02752035|542153419|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
150277575|NCT02752035|542153420|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
150277576|NCT02752035|542153421|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
150277577|NCT02752035|542153418|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
150277578|NCT02752035|542153419|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
150277579|NCT02752035|542153420|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
150277580|NCT02752035|542153421|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
150277581|NCT01161043|542153422|FG000|Overall Study|Withdrawal by Subject|3|||
150277582|NCT01131676|542153427|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
150277583|NCT01131676|542153428|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
149830930|NCT00416520|540511331|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
149830931|NCT00416520|540511332|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
149948281|NCT05028569|540944719|FG000|Double-Blind Phase|Other, not specified|0|||
149948282|NCT05028569|540944720|FG001|Double-Blind Phase|Other, not specified|5|||
150277584|NCT01131676|542153429|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
150277585|NCT01131676|542153427|FG000|Discontinuation From Treatment|Not treated|4|||
150277586|NCT01131676|542153428|FG001|Discontinuation From Treatment|Not treated|2|||
149948283|NCT05028569|540944721|FG002|Double-Blind Phase|Other, not specified|4|||
149948284|NCT05028569|540944722|FG003|Double-Blind Phase|Other, not specified|6|||
149948285|NCT05028569|540944723|FG004|Double-Blind Phase|Other, not specified|0|||
150277587|NCT01131676|542153429|FG002|Discontinuation From Treatment|Not treated|2|||
150277588|NCT01131676|542153427|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
150277589|NCT01131676|542153428|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
150277590|NCT01131676|542153429|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
150277591|NCT01131676|542153427|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
150277592|NCT01131676|542153428|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
150033827|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
150033828|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150033829|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
150033830|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150033831|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150033832|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150277593|NCT01131676|542153429|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
150277594|NCT01131676|542153427|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
150277595|NCT01131676|542153428|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
150277596|NCT01131676|542153429|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
150277597|NCT01131676|542153427|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
150277598|NCT01131676|542153428|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
150277599|NCT01131676|542153429|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
150277600|NCT01131676|542153427|FG000|Discontinuation From Treatment|Other than those specified|162|||
150277601|NCT01131676|542153428|FG001|Discontinuation From Treatment|Other than those specified|142|||
150277602|NCT01131676|542153429|FG002|Discontinuation From Treatment|Other than those specified|125|||
150277603|NCT01131676|542153427|FG000|Discontinuation From Treatment|Adverse Event|303|||
150277604|NCT01131676|542153428|FG001|Discontinuation From Treatment|Adverse Event|267|||
150277605|NCT01131676|542153429|FG002|Discontinuation From Treatment|Adverse Event|273|||
150277606|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
150277607|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
150277608|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
150277609|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
150277610|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
150277611|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
150277612|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
150277613|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
150033833|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150033834|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
150033835|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150033836|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
150033837|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033838|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033839|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033840|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033841|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
150033842|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033843|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
150033844|NCT02903771|541262859|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033845|NCT02903771|541262860|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033846|NCT02903771|541262861|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033847|NCT02903771|541262862|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033848|NCT02903771|541262863|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
150033849|NCT02903771|541262864|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033850|NCT02903771|541262865|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
150033851|NCT02218372|541262866|FG000|Overall Study|Adverse Event|1|||
150033852|NCT02218372|541262867|FG001|Overall Study|Adverse Event|1|||
150033853|NCT02218372|541262866|FG000|Overall Study|Miscellaneous|2|||
150033854|NCT02218372|541262867|FG001|Overall Study|Miscellaneous|1|||
150033855|NCT02218372|541262866|FG000|Overall Study|Randomized but did not receive treatment|2|||
150277614|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
150277615|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
150277616|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
150033856|NCT02218372|541262867|FG001|Overall Study|Randomized but did not receive treatment|3|||
150033857|NCT02218372|541262866|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150033858|NCT02218372|541262867|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150033859|NCT03406780|541262872|FG000|Overall Study|Withdrawal by Subject|1|||
150033860|NCT03406780|541262873|FG001|Overall Study|Withdrawal by Subject|1|||
149830932|NCT00416520|540511329|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
150033861|NCT03406780|541262872|FG000|Overall Study|Other|0|||
150033862|NCT03406780|541262873|FG001|Overall Study|Other|2|||
150033863|NCT01488045|541262878|FG000|Overall Study|Withdrawal by Subject|6|||
150033864|NCT01488045|541262879|FG001|Overall Study|Withdrawal by Subject|11|||
150033865|NCT01488045|541262878|FG000|Overall Study|Failure to present for colonoscopy|3|||
150033866|NCT01488045|541262879|FG001|Overall Study|Failure to present for colonoscopy|6|||
150033867|NCT01488045|541262878|FG000|Overall Study|Failure to report exclusion criteria|0|||
150033868|NCT01488045|541262879|FG001|Overall Study|Failure to report exclusion criteria|1|||
150033869|NCT05365217|541262881|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150033870|NCT05365217|541262882|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150033871|NCT02476617|541262883|FG000|Overall Study|Adverse Event|1|||
150033872|NCT02476617|541262883|FG000|Overall Study|Lost to Follow-up|1|||
150033873|NCT02491684|541262884|FG000|Treatment Phase|Adverse Event|2|||
150033874|NCT02491684|541262885|FG001|Treatment Phase|Adverse Event|2|||
150033875|NCT02491684|541262884|FG000|Treatment Phase|Incorrect randomisation|1|||
150033876|NCT02491684|541262885|FG001|Treatment Phase|Incorrect randomisation|0|||
150033877|NCT02491684|541262884|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
150033878|NCT02491684|541262885|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
150033879|NCT04739982|541262887|FG000|Overall Study|Lost to Follow-up|176|||
150033880|NCT04739982|541262888|FG001|Overall Study|Lost to Follow-up|65|||
150033881|NCT04739982|541262887|FG000|Overall Study|Withdrawal by Subject|19|||
150033882|NCT04739982|541262888|FG001|Overall Study|Withdrawal by Subject|0|||
150033883|NCT04739982|541262887|FG000|Overall Study|Protocol Violation|0|||
150033884|NCT04739982|541262888|FG001|Overall Study|Protocol Violation|5|||
150033885|NCT03651765|541262889|FG000|Overall Study|Adverse Event|6|||
150033886|NCT03651765|541262889|FG000|Overall Study|Lack of Efficacy|18|||
150033887|NCT03651765|541262889|FG000|Overall Study|Lost to Follow-up|5|||
150033888|NCT03651765|541262889|FG000|Overall Study|Non-Compliance with Study Drug|4|||
150033889|NCT03651765|541262889|FG000|Overall Study|Physician Decision|6|||
150033890|NCT03651765|541262889|FG000|Overall Study|Pregnancy|1|||
150033891|NCT03651765|541262889|FG000|Overall Study|Discontinued by Sponsor|40|||
150033892|NCT03651765|541262889|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
150033893|NCT03651765|541262889|FG000|Overall Study|Withdrawal by Subject|24|||
150033894|NCT03651765|541262889|FG000|Overall Study|Miscellaneous|6|||
150033895|NCT01346358|541262890|FG000|Overall Study|Withdrawal by Subject|1|||
150033896|NCT01346358|541262891|FG001|Overall Study|Withdrawal by Subject|0|||
150033897|NCT01346358|541262892|FG002|Overall Study|Withdrawal by Subject|1|||
150033898|NCT01346358|541262893|FG003|Overall Study|Withdrawal by Subject|1|||
150277617|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
150277618|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
150277619|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
150277620|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
150277621|NCT01131676|542153427|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
150277622|NCT01131676|542153428|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
149830933|NCT00416520|540511330|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
149830934|NCT00416520|540511331|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
150033899|NCT01346358|541262894|FG004|Overall Study|Withdrawal by Subject|0|||
150033900|NCT01346358|541262895|FG005|Overall Study|Withdrawal by Subject|2|||
150033901|NCT01346358|541262896|FG006|Overall Study|Withdrawal by Subject|1|||
150033902|NCT01346358|541262897|FG007|Overall Study|Withdrawal by Subject|1|||
150033903|NCT01346358|541262898|FG008|Overall Study|Withdrawal by Subject|1|||
150033904|NCT01346358|541262890|FG000|Overall Study|Adverse Event|1|||
150033905|NCT01346358|541262891|FG001|Overall Study|Adverse Event|0|||
150033906|NCT01346358|541262892|FG002|Overall Study|Adverse Event|0|||
150033907|NCT01346358|541262893|FG003|Overall Study|Adverse Event|0|||
150033908|NCT01346358|541262894|FG004|Overall Study|Adverse Event|1|||
150277623|NCT01131676|542153429|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
149830935|NCT00416520|540511332|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
150033909|NCT01346358|541262895|FG005|Overall Study|Adverse Event|0|||
150033910|NCT01346358|541262896|FG006|Overall Study|Adverse Event|0|||
150033911|NCT01346358|541262897|FG007|Overall Study|Adverse Event|0|||
149830936|NCT00755196|540511336|FG000|Overall Study|Lost to Follow-up|1|||
150033912|NCT01346358|541262898|FG008|Overall Study|Adverse Event|1|||
150033913|NCT01346358|541262890|FG000|Overall Study|Non-Compliance|0|||
150033914|NCT01346358|541262891|FG001|Overall Study|Non-Compliance|0|||
150033915|NCT01346358|541262892|FG002|Overall Study|Non-Compliance|0|||
150033916|NCT01346358|541262893|FG003|Overall Study|Non-Compliance|0|||
150033917|NCT01346358|541262894|FG004|Overall Study|Non-Compliance|0|||
150033918|NCT01346358|541262895|FG005|Overall Study|Non-Compliance|0|||
150033919|NCT01346358|541262896|FG006|Overall Study|Non-Compliance|0|||
150033920|NCT01346358|541262897|FG007|Overall Study|Non-Compliance|2|||
150033921|NCT01346358|541262898|FG008|Overall Study|Non-Compliance|0|||
150033922|NCT01346358|541262890|FG000|Overall Study|Physician Decision|0|||
150277624|NCT01231659|542153430|FG000|Overall Study|Adverse Event|9|||
150277625|NCT01231659|542153430|FG000|Overall Study|Disease Progression|48|||
150277626|NCT01231659|542153430|FG000|Overall Study|Death|2|||
150277627|NCT01231659|542153430|FG000|Overall Study|Patient refused to complete study visit|1|||
150277628|NCT01231659|542153430|FG000|Overall Study|Other protocol defined criteria|12|||
150277629|NCT00509067|542153431|FG000|Overall Study|Lost to Follow-up|1|||
150277630|NCT00509067|542153432|FG001|Overall Study|Lost to Follow-up|1|||
150277631|NCT00509067|542153431|FG000|Overall Study|Adverse Event|3|||
150277632|NCT00509067|542153432|FG001|Overall Study|Adverse Event|1|||
150277633|NCT00509067|542153431|FG000|Overall Study|Protocol Violation|0|||
150277634|NCT00509067|542153432|FG001|Overall Study|Protocol Violation|3|||
150277635|NCT00117598|542153442|FG000|Prior to Treatment Cross Over|Death|40|||
150277636|NCT00117598|542153443|FG001|Prior to Treatment Cross Over|Death|41|||
150277637|NCT00117598|542153444|FG002|Prior to Treatment Cross Over|Death|37|||
149830937|NCT00755196|540511336|FG000|Overall Study|Lack of Efficiency|1|||
149830938|NCT02636907|540511343|FG000|Autoinjector Assessment Period|Adverse Event|2|||
149830939|NCT02636907|540511343|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
149830940|NCT02636907|540511343|FG000|Extension Phase|Adverse Event|2|||
150277638|NCT00117598|542153445|FG003|Prior to Treatment Cross Over|Death|0|||
150277639|NCT00117598|542153446|FG004|Prior to Treatment Cross Over|Death|0|||
150277640|NCT00117598|542153442|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
150277641|NCT00117598|542153443|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
150277642|NCT00117598|542153444|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
150277643|NCT00117598|542153445|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
150277644|NCT00117598|542153446|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
150277645|NCT00117598|542153442|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
150277646|NCT00117598|542153443|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
150277647|NCT00117598|542153444|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
150277648|NCT00117598|542153445|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
150277649|NCT00117598|542153446|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
150277650|NCT00117598|542153442|FG000|Prior to Treatment Cross Over|Other|15|||
150277651|NCT00117598|542153443|FG001|Prior to Treatment Cross Over|Other|9|||
150277652|NCT00117598|542153444|FG002|Prior to Treatment Cross Over|Other|9|||
150277653|NCT00117598|542153445|FG003|Prior to Treatment Cross Over|Other|0|||
150277654|NCT00117598|542153446|FG004|Prior to Treatment Cross Over|Other|0|||
150277655|NCT00117598|542153442|FG000|After Treament Cross Over|Death|0|||
150277656|NCT00117598|542153443|FG001|After Treament Cross Over|Death|0|||
150277657|NCT00117598|542153444|FG002|After Treament Cross Over|Death|0|||
150277658|NCT00117598|542153445|FG003|After Treament Cross Over|Death|1|||
150277659|NCT00117598|542153446|FG004|After Treament Cross Over|Death|2|||
150277660|NCT00117598|542153442|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
150277661|NCT00117598|542153443|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
150277662|NCT00117598|542153444|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
150277663|NCT00117598|542153445|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
150277664|NCT00117598|542153446|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
150277665|NCT00117598|542153442|FG000|After Treament Cross Over|Other|0|||
150277666|NCT00117598|542153443|FG001|After Treament Cross Over|Other|0|||
150277667|NCT00117598|542153444|FG002|After Treament Cross Over|Other|0|||
150277668|NCT00117598|542153445|FG003|After Treament Cross Over|Other|1|||
150277669|NCT00117598|542153446|FG004|After Treament Cross Over|Other|2|||
150277670|NCT00545064|542153447|FG000|Overall Study|Lost to Follow-up|3|||
150277671|NCT00545064|542153447|FG000|Overall Study|Withdrawal by Subject|2|||
150277672|NCT00545064|542153447|FG000|Overall Study|did not complete course of treatment|1|||
150277673|NCT00545064|542153447|FG000|Overall Study|cancel all appointments, no rebooking|1|||
150277674|NCT00545064|542153447|FG000|Overall Study|inclement weather|1|||
150277675|NCT01770912|542153448|FG000|Overall Study|Lost to Follow-up|2|||
150277676|NCT01770912|542153449|FG001|Overall Study|Lost to Follow-up|0|||
150277677|NCT01536951|542153453|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277678|NCT01536951|542153454|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277679|NCT01536951|542153455|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
150277680|NCT01536951|542153456|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277681|NCT01536951|542153457|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149830941|NCT02636907|540511343|FG000|Extension Phase|Withdrawal by Subject|4|||
150277682|NCT01536951|542153458|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277683|NCT01536951|542153459|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277684|NCT01536951|542153460|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277685|NCT01536951|542153461|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
150277686|NCT01536951|542153453|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
150277687|NCT01536951|542153454|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
150277688|NCT01536951|542153455|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
149830942|NCT02636907|540511343|FG000|Extension Phase|Physician Decision|1|||
149830943|NCT02636907|540511343|FG000|Extension Phase|Lost to Follow-up|2|||
150277689|NCT01536951|542153456|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
150277690|NCT01536951|542153457|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
150277691|NCT01536951|542153458|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
150277692|NCT01536951|542153459|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
150277693|NCT01536951|542153460|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
150277694|NCT01536951|542153461|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
150277695|NCT01843972|542153464|FG000|Overall Study|Withdrawal by Subject|0|||
150277696|NCT01843972|542153465|FG001|Overall Study|Withdrawal by Subject|0|||
150277697|NCT01843972|542153466|FG002|Overall Study|Withdrawal by Subject|0|||
150277698|NCT01843972|542153467|FG003|Overall Study|Withdrawal by Subject|0|||
150277699|NCT01843972|542153468|FG004|Overall Study|Withdrawal by Subject|1|||
150277700|NCT01843972|542153469|FG005|Overall Study|Withdrawal by Subject|0|||
150277701|NCT01843972|542153470|FG006|Overall Study|Withdrawal by Subject|0|||
150277702|NCT01843972|542153471|FG007|Overall Study|Withdrawal by Subject|0|||
150277703|NCT01843972|542153472|FG008|Overall Study|Withdrawal by Subject|0|||
150277704|NCT01843972|542153473|FG009|Overall Study|Withdrawal by Subject|0|||
150277705|NCT01854645|542153476|FG000|Overall Study|Protocol-Specified Criteria|13|||
150277706|NCT01854645|542153477|FG001|Overall Study|Protocol-Specified Criteria|10|||
150277707|NCT01854645|542153478|FG002|Overall Study|Protocol-Specified Criteria|8|||
150277708|NCT01854645|542153479|FG003|Overall Study|Protocol-Specified Criteria|5|||
150277709|NCT01854645|542153480|FG004|Overall Study|Protocol-Specified Criteria|7|||
150277710|NCT01854645|542153476|FG000|Overall Study|Administrative Reasons / Missing|0|||
150277711|NCT01854645|542153477|FG001|Overall Study|Administrative Reasons / Missing|0|||
150277712|NCT01854645|542153478|FG002|Overall Study|Administrative Reasons / Missing|0|||
150277713|NCT01854645|542153479|FG003|Overall Study|Administrative Reasons / Missing|1|||
150277714|NCT01854645|542153480|FG004|Overall Study|Administrative Reasons / Missing|1|||
150277715|NCT01854645|542153476|FG000|Overall Study|Protocol Violation|3|||
150277716|NCT01854645|542153477|FG001|Overall Study|Protocol Violation|0|||
150277717|NCT01854645|542153478|FG002|Overall Study|Protocol Violation|5|||
150277718|NCT01854645|542153479|FG003|Overall Study|Protocol Violation|4|||
150277719|NCT01854645|542153480|FG004|Overall Study|Protocol Violation|1|||
150277720|NCT01854645|542153476|FG000|Overall Study|Lost to Follow-up|10|||
150277721|NCT01854645|542153477|FG001|Overall Study|Lost to Follow-up|7|||
150277722|NCT01854645|542153478|FG002|Overall Study|Lost to Follow-up|8|||
150277723|NCT01854645|542153479|FG003|Overall Study|Lost to Follow-up|5|||
150277724|NCT01854645|542153480|FG004|Overall Study|Lost to Follow-up|0|||
150277725|NCT01854645|542153476|FG000|Overall Study|Physician Decision|1|||
150277726|NCT01854645|542153477|FG001|Overall Study|Physician Decision|5|||
150277727|NCT01854645|542153478|FG002|Overall Study|Physician Decision|3|||
150277728|NCT01854645|542153479|FG003|Overall Study|Physician Decision|3|||
150277729|NCT01854645|542153480|FG004|Overall Study|Physician Decision|7|||
150277730|NCT01854645|542153476|FG000|Overall Study|Withdrawal by Subject|31|||
150277731|NCT01854645|542153477|FG001|Overall Study|Withdrawal by Subject|41|||
150277732|NCT01854645|542153478|FG002|Overall Study|Withdrawal by Subject|30|||
150277733|NCT01854645|542153479|FG003|Overall Study|Withdrawal by Subject|21|||
150277734|NCT01854645|542153480|FG004|Overall Study|Withdrawal by Subject|24|||
150277735|NCT01854645|542153476|FG000|Overall Study|Lack of Efficacy|7|||
150277736|NCT01854645|542153477|FG001|Overall Study|Lack of Efficacy|12|||
150277737|NCT01854645|542153478|FG002|Overall Study|Lack of Efficacy|9|||
150277738|NCT01854645|542153479|FG003|Overall Study|Lack of Efficacy|3|||
150277739|NCT01854645|542153480|FG004|Overall Study|Lack of Efficacy|9|||
150277740|NCT01854645|542153476|FG000|Overall Study|Adverse Event|33|||
150277741|NCT01854645|542153477|FG001|Overall Study|Adverse Event|31|||
150277742|NCT01854645|542153478|FG002|Overall Study|Adverse Event|19|||
150277743|NCT01854645|542153479|FG003|Overall Study|Adverse Event|20|||
150277744|NCT01854645|542153480|FG004|Overall Study|Adverse Event|11|||
150277745|NCT00430482|542153486|FG000|Completed Treatment|Insufficient Treatment|7|||
150277746|NCT00430482|542153487|FG001|Completed Treatment|Insufficient Treatment|11|||
150277747|NCT00545402|542153488|FG000|Overall Study|Discontinuation of treatment|17|||
150277748|NCT00545402|542153489|FG001|Overall Study|Discontinuation of treatment|9|||
150277749|NCT00545402|542153488|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
150277750|NCT00545402|542153489|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
150277751|NCT00545402|542153488|FG000|Overall Study|Death|5|||
150277752|NCT00545402|542153489|FG001|Overall Study|Death|7|||
150277753|NCT00545402|542153488|FG000|Overall Study|Graft loss|2|||
150277754|NCT00545402|542153489|FG001|Overall Study|Graft loss|4|||
150033923|NCT01346358|541262891|FG001|Overall Study|Physician Decision|1|||
150277755|NCT00545402|542153488|FG000|Overall Study|Withdrawal by Subject|0|||
150277756|NCT00545402|542153489|FG001|Overall Study|Withdrawal by Subject|1|||
150277757|NCT00545402|542153488|FG000|Overall Study|Protocol Violation|1|||
150277758|NCT00545402|542153489|FG001|Overall Study|Protocol Violation|0|||
150277759|NCT00545402|542153488|FG000|Overall Study|Reason not specified|1|||
150277760|NCT00545402|542153489|FG001|Overall Study|Reason not specified|1|||
150277761|NCT01817751|542153490|FG000|Overall Study|Physician Decision|1|||
150277762|NCT00555477|542153491|FG000|Overall Study|Adverse Event|0|||
150277763|NCT00555477|542153492|FG001|Overall Study|Adverse Event|9|||
149948286|NCT05028569|540944724|FG005|Double-Blind Phase|Other, not specified|0|||
149948287|NCT05028569|540944725|FG006|Double-Blind Phase|Other, not specified|0|||
149948288|NCT05028569|540944719|FG000|Open-Label Phase|Death|0|||
149948289|NCT05028569|540944720|FG001|Open-Label Phase|Death|0|||
149948290|NCT05028569|540944721|FG002|Open-Label Phase|Death|0|||
149948291|NCT05028569|540944722|FG003|Open-Label Phase|Death|0|||
149948292|NCT05028569|540944723|FG004|Open-Label Phase|Death|0|||
149948293|NCT05028569|540944724|FG005|Open-Label Phase|Death|0|||
149948294|NCT05028569|540944725|FG006|Open-Label Phase|Death|1|||
149948295|NCT05028569|540944719|FG000|Open-Label Phase|Lost to Follow-up|0|||
149948296|NCT05028569|540944720|FG001|Open-Label Phase|Lost to Follow-up|0|||
149948297|NCT05028569|540944721|FG002|Open-Label Phase|Lost to Follow-up|0|||
149948298|NCT05028569|540944722|FG003|Open-Label Phase|Lost to Follow-up|0|||
149948299|NCT05028569|540944723|FG004|Open-Label Phase|Lost to Follow-up|5|||
149948300|NCT05028569|540944724|FG005|Open-Label Phase|Lost to Follow-up|5|||
149948301|NCT05028569|540944725|FG006|Open-Label Phase|Lost to Follow-up|4|||
149948302|NCT05028569|540944719|FG000|Open-Label Phase|Protocol Deviation|0|||
149948303|NCT05028569|540944720|FG001|Open-Label Phase|Protocol Deviation|0|||
149948304|NCT05028569|540944721|FG002|Open-Label Phase|Protocol Deviation|0|||
149948305|NCT05028569|540944722|FG003|Open-Label Phase|Protocol Deviation|0|||
149948306|NCT05028569|540944723|FG004|Open-Label Phase|Protocol Deviation|1|||
149948307|NCT05028569|540944724|FG005|Open-Label Phase|Protocol Deviation|0|||
149948308|NCT05028569|540944725|FG006|Open-Label Phase|Protocol Deviation|0|||
149948309|NCT05028569|540944719|FG000|Open-Label Phase|Pregnancy|0|||
149948310|NCT05028569|540944720|FG001|Open-Label Phase|Pregnancy|0|||
149948311|NCT05028569|540944721|FG002|Open-Label Phase|Pregnancy|0|||
149948312|NCT05028569|540944722|FG003|Open-Label Phase|Pregnancy|0|||
149948313|NCT05028569|540944723|FG004|Open-Label Phase|Pregnancy|0|||
149948314|NCT05028569|540944724|FG005|Open-Label Phase|Pregnancy|1|||
149948315|NCT05028569|540944725|FG006|Open-Label Phase|Pregnancy|0|||
150170965|NCT02807493|541760828|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
150170966|NCT02807493|541760829|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
150170967|NCT01493778|541760830|FG000|Overall Study|Withdrawal by Subject|8|||
150170968|NCT01227707|541760831|FG000|Overall Study|Adverse Event|10|||
150170969|NCT01227707|541760831|FG000|Overall Study|Progression of disease|3|||
150170970|NCT01227707|541760831|FG000|Overall Study|Withdrawal by Subject|1|||
150170971|NCT01227707|541760831|FG000|Overall Study|Patient non-compliance|3|||
150170972|NCT01227707|541760831|FG000|Overall Study|Medical decision|6|||
150170973|NCT01227707|541760831|FG000|Overall Study|Death|1|||
150170974|NCT00823979|541760846|FG000|Overall Study|Lack of Efficacy|13|||
150170975|NCT00823979|541760847|FG001|Overall Study|Lack of Efficacy|16|||
150170976|NCT00823979|541760848|FG002|Overall Study|Lack of Efficacy|9|||
150170977|NCT00823979|541760846|FG000|Overall Study|Lost to Follow-up|2|||
150170978|NCT00823979|541760847|FG001|Overall Study|Lost to Follow-up|1|||
150170979|NCT00823979|541760848|FG002|Overall Study|Lost to Follow-up|0|||
150170980|NCT00823979|541760846|FG000|Overall Study|Withdrawal by Subject|2|||
150170981|NCT00823979|541760847|FG001|Overall Study|Withdrawal by Subject|3|||
150170982|NCT00823979|541760848|FG002|Overall Study|Withdrawal by Subject|2|||
150170983|NCT00823979|541760846|FG000|Overall Study|Protocol Violation|1|||
150170984|NCT00823979|541760847|FG001|Overall Study|Protocol Violation|1|||
150170985|NCT00823979|541760848|FG002|Overall Study|Protocol Violation|0|||
150170986|NCT00823979|541760846|FG000|Overall Study|Pregnancy|0|||
150170987|NCT00823979|541760847|FG001|Overall Study|Pregnancy|1|||
150170988|NCT00823979|541760848|FG002|Overall Study|Pregnancy|0|||
150170989|NCT00823979|541760846|FG000|Overall Study|Adverse Event|0|||
150170990|NCT00823979|541760847|FG001|Overall Study|Adverse Event|2|||
150170991|NCT00823979|541760848|FG002|Overall Study|Adverse Event|4|||
150170992|NCT00823979|541760846|FG000|Overall Study|Other|2|||
150170993|NCT00823979|541760847|FG001|Overall Study|Other|0|||
150170994|NCT00823979|541760848|FG002|Overall Study|Other|1|||
150170995|NCT00823979|541760846|FG000|Overall Study|Randomized but not Treated|4|||
150170996|NCT00823979|541760847|FG001|Overall Study|Randomized but not Treated|3|||
150170997|NCT00823979|541760848|FG002|Overall Study|Randomized but not Treated|1|||
150170998|NCT00823979|541760846|FG000|Overall Study|Study Terminated by Sponsor|5|||
150170999|NCT00823979|541760847|FG001|Overall Study|Study Terminated by Sponsor|5|||
150171000|NCT00823979|541760848|FG002|Overall Study|Study Terminated by Sponsor|7|||
150171001|NCT03523091|541760849|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
150171002|NCT03523091|541760850|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
150171003|NCT03523091|541760849|FG000|Overall Study|Withdrawal by Subject|0|||
150171004|NCT03523091|541760850|FG001|Overall Study|Withdrawal by Subject|3|||
150171005|NCT03523091|541760849|FG000|Overall Study|Increase Botox dose|0|||
150171006|NCT03523091|541760850|FG001|Overall Study|Increase Botox dose|1|||
150171007|NCT00741988|541760851|FG000|Overall Study|Adverse Event|2|||
150171008|NCT00741988|541760852|FG001|Overall Study|Adverse Event|4|||
149948316|NCT05028569|540944719|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149948317|NCT05028569|540944720|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149948318|NCT05028569|540944721|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149948319|NCT05028569|540944722|FG003|Open-Label Phase|Withdrawal by Subject|0|||
150171009|NCT00741988|541760851|FG000|Overall Study|Lack of Efficacy|2|||
149830944|NCT02636907|540511343|FG000|Extension Phase|Lack of Efficacy|1|||
149830945|NCT00762086|540511344|FG000|Overall Study|Adverse Event|2|||
150277764|NCT00555477|542153491|FG000|Overall Study|Withdrawal by Subject|1|||
150277765|NCT00555477|542153492|FG001|Overall Study|Withdrawal by Subject|2|||
150277766|NCT00555477|542153491|FG000|Overall Study|Physician Decision|1|||
150277767|NCT00555477|542153492|FG001|Overall Study|Physician Decision|2|||
150277768|NCT00397033|542153493|FG000|Overall Study|Adverse Event|7|||
150277769|NCT00397033|542153494|FG001|Overall Study|Adverse Event|10|||
150277770|NCT00397033|542153495|FG002|Overall Study|Adverse Event|4|||
150277771|NCT00397033|542153493|FG000|Overall Study|Lack of Efficacy|22|||
150277772|NCT00397033|542153494|FG001|Overall Study|Lack of Efficacy|12|||
150277773|NCT00397033|542153495|FG002|Overall Study|Lack of Efficacy|9|||
150277774|NCT00397033|542153493|FG000|Overall Study|Lost to Follow-up|3|||
150277775|NCT00397033|542153494|FG001|Overall Study|Lost to Follow-up|3|||
150277776|NCT00397033|542153495|FG002|Overall Study|Lost to Follow-up|3|||
150277777|NCT00397033|542153493|FG000|Overall Study|Withdrawal by Subject|12|||
150277778|NCT00397033|542153494|FG001|Overall Study|Withdrawal by Subject|7|||
150277779|NCT00397033|542153495|FG002|Overall Study|Withdrawal by Subject|5|||
150277780|NCT00397033|542153493|FG000|Overall Study|Other|0|||
150277781|NCT00397033|542153494|FG001|Overall Study|Other|5|||
150277782|NCT00397033|542153495|FG002|Overall Study|Other|2|||
150277783|NCT03519867|542153496|FG000|Overall Study|Adverse Event|1|||
150277784|NCT03519867|542153497|FG001|Overall Study|Adverse Event|1|||
150277785|NCT03519867|542153498|FG002|Overall Study|Adverse Event|0|||
150277786|NCT03519867|542153499|FG003|Overall Study|Adverse Event|0|||
150277787|NCT03519867|542153500|FG004|Overall Study|Adverse Event|0|||
150277788|NCT03519867|542153501|FG005|Overall Study|Adverse Event|0|||
150277789|NCT03519867|542153502|FG006|Overall Study|Adverse Event|0|||
150277790|NCT03519867|542153503|FG007|Overall Study|Adverse Event|0|||
150277791|NCT03519867|542153504|FG008|Overall Study|Adverse Event|0|||
150277792|NCT03519867|542153505|FG009|Overall Study|Adverse Event|0|||
150277793|NCT03519867|542153496|FG000|Overall Study|Protocol Violation|0|||
150277794|NCT03519867|542153497|FG001|Overall Study|Protocol Violation|0|||
150277795|NCT03519867|542153498|FG002|Overall Study|Protocol Violation|0|||
150277796|NCT03519867|542153499|FG003|Overall Study|Protocol Violation|0|||
150277797|NCT03519867|542153500|FG004|Overall Study|Protocol Violation|0|||
150277798|NCT03519867|542153501|FG005|Overall Study|Protocol Violation|1|||
150277799|NCT03519867|542153502|FG006|Overall Study|Protocol Violation|0|||
150277800|NCT03519867|542153503|FG007|Overall Study|Protocol Violation|0|||
150277801|NCT03519867|542153504|FG008|Overall Study|Protocol Violation|0|||
150277802|NCT03519867|542153505|FG009|Overall Study|Protocol Violation|0|||
150277803|NCT03519867|542153496|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277804|NCT03519867|542153497|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277805|NCT03519867|542153498|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277806|NCT03519867|542153499|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277807|NCT03519867|542153500|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277808|NCT03519867|542153501|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277809|NCT03519867|542153502|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
150277810|NCT03519867|542153503|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277811|NCT03519867|542153504|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277812|NCT03519867|542153505|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
150277813|NCT03519867|542153496|FG000|Overall Study|Admin. of other reversal agent|1|||
150277814|NCT03519867|542153497|FG001|Overall Study|Admin. of other reversal agent|1|||
150277815|NCT03519867|542153498|FG002|Overall Study|Admin. of other reversal agent|0|||
150277816|NCT03519867|542153499|FG003|Overall Study|Admin. of other reversal agent|0|||
150277817|NCT03519867|542153500|FG004|Overall Study|Admin. of other reversal agent|0|||
150277818|NCT03519867|542153501|FG005|Overall Study|Admin. of other reversal agent|1|||
150277819|NCT03519867|542153502|FG006|Overall Study|Admin. of other reversal agent|0|||
150277820|NCT03519867|542153503|FG007|Overall Study|Admin. of other reversal agent|0|||
150277821|NCT03519867|542153504|FG008|Overall Study|Admin. of other reversal agent|0|||
150277822|NCT03519867|542153505|FG009|Overall Study|Admin. of other reversal agent|0|||
150277823|NCT03519867|542153496|FG000|Overall Study|Reason not provided|1|||
149830946|NCT00762086|540511345|FG001|Overall Study|Adverse Event|0|||
149830947|NCT00762086|540511344|FG000|Overall Study|Lost to Follow-up|0|||
149948320|NCT05028569|540944723|FG004|Open-Label Phase|Withdrawal by Subject|15|||
149948321|NCT05028569|540944724|FG005|Open-Label Phase|Withdrawal by Subject|8|||
149948322|NCT05028569|540944725|FG006|Open-Label Phase|Withdrawal by Subject|13|||
149948323|NCT05028569|540944719|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
149948324|NCT05028569|540944720|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
149948325|NCT05028569|540944721|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
150277824|NCT03519867|542153497|FG001|Overall Study|Reason not provided|1|||
150277825|NCT03519867|542153498|FG002|Overall Study|Reason not provided|1|||
150277826|NCT03519867|542153499|FG003|Overall Study|Reason not provided|1|||
150277827|NCT03519867|542153500|FG004|Overall Study|Reason not provided|0|||
149948326|NCT05028569|540944722|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
150277828|NCT03519867|542153501|FG005|Overall Study|Reason not provided|1|||
149948327|NCT05028569|540944723|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
149948328|NCT05028569|540944724|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
149948329|NCT05028569|540944725|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
149948330|NCT05028569|540944719|FG000|Open-Label Phase|Other, not specified|0|||
149948331|NCT05028569|540944720|FG001|Open-Label Phase|Other, not specified|0|||
149948332|NCT05028569|540944721|FG002|Open-Label Phase|Other, not specified|0|||
149948333|NCT05028569|540944722|FG003|Open-Label Phase|Other, not specified|0|||
149948334|NCT05028569|540944723|FG004|Open-Label Phase|Other, not specified|6|||
149948335|NCT05028569|540944724|FG005|Open-Label Phase|Other, not specified|5|||
149948336|NCT05028569|540944725|FG006|Open-Label Phase|Other, not specified|7|||
149948337|NCT05028569|540944719|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948338|NCT05028569|540944720|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948339|NCT05028569|540944721|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948340|NCT05028569|540944722|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948341|NCT05028569|540944723|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948342|NCT05028569|540944724|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
149948343|NCT05028569|540944725|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149948344|NCT05028569|540944719|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948345|NCT05028569|540944720|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948346|NCT05028569|540944721|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948347|NCT05028569|540944722|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948348|NCT05028569|540944723|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948349|NCT05028569|540944724|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149948350|NCT05028569|540944725|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
149948356|NCT04609553|540944732|FG000|Overall Study|Lost to Follow-up|27|||
149948357|NCT04609553|540944733|FG001|Overall Study|Lost to Follow-up|31|||
149948358|NCT04609553|540944734|FG002|Overall Study|Lost to Follow-up|24|||
149948359|NCT04609553|540944732|FG000|Overall Study|Discontinued|12|||
149948360|NCT04609553|540944733|FG001|Overall Study|Discontinued|10|||
149948361|NCT04609553|540944734|FG002|Overall Study|Discontinued|9|||
150277829|NCT03519867|542153502|FG006|Overall Study|Reason not provided|0|||
150033924|NCT01346358|541262892|FG002|Overall Study|Physician Decision|0|||
150033925|NCT01346358|541262893|FG003|Overall Study|Physician Decision|0|||
150033926|NCT01346358|541262894|FG004|Overall Study|Physician Decision|0|||
150033927|NCT01346358|541262895|FG005|Overall Study|Physician Decision|0|||
150033928|NCT01346358|541262896|FG006|Overall Study|Physician Decision|0|||
150033929|NCT01346358|541262897|FG007|Overall Study|Physician Decision|1|||
150033930|NCT01346358|541262898|FG008|Overall Study|Physician Decision|1|||
150033931|NCT00771914|541262902|FG000|Overall Study|Physician Decision|0|||
150033932|NCT00771914|541262903|FG001|Overall Study|Physician Decision|0|||
150033933|NCT00771914|541262904|FG002|Overall Study|Physician Decision|0|||
150033934|NCT00771914|541262905|FG003|Overall Study|Physician Decision|1|||
150033935|NCT00771914|541262902|FG000|Overall Study|Lost to Follow-up|0|||
149830948|NCT00762086|540511345|FG001|Overall Study|Lost to Follow-up|2|||
149830949|NCT00762086|540511344|FG000|Overall Study|Non compliance|1|||
149830950|NCT00762086|540511345|FG001|Overall Study|Non compliance|0|||
149830951|NCT00762086|540511344|FG000|Overall Study|Withdrawal by Subject|2|||
150033936|NCT00771914|541262903|FG001|Overall Study|Lost to Follow-up|0|||
150033937|NCT00771914|541262904|FG002|Overall Study|Lost to Follow-up|0|||
150033938|NCT00771914|541262905|FG003|Overall Study|Lost to Follow-up|1|||
150171010|NCT00741988|541760852|FG001|Overall Study|Lack of Efficacy|0|||
150171011|NCT02685488|541760859|FG000|Overall Study|Withdrawal by Subject|0|||
150171012|NCT02685488|541760860|FG001|Overall Study|Withdrawal by Subject|1|||
150171013|NCT05019729|541760861|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
150171014|NCT05019729|541760862|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
150171015|NCT05019729|541760863|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
150171016|NCT05019729|541760864|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
150171017|NCT05019729|541760865|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
150171018|NCT05019729|541760866|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
150171019|NCT03254394|541760869|FG000|Overall Study|Withdrawal by Subject|0|||
150171020|NCT03254394|541760870|FG001|Overall Study|Withdrawal by Subject|2|||
150171021|NCT00536380|541760871|FG000|Overall Study|Adverse Event|0|||
150171022|NCT00536380|541760872|FG001|Overall Study|Adverse Event|2|||
150171023|NCT00536380|541760873|FG002|Overall Study|Adverse Event|2|||
150171024|NCT00536380|541760871|FG000|Overall Study|Lost to Follow-up|0|||
150171025|NCT00536380|541760872|FG001|Overall Study|Lost to Follow-up|0|||
150171026|NCT00536380|541760873|FG002|Overall Study|Lost to Follow-up|1|||
150171027|NCT00536380|541760871|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
150171028|NCT00536380|541760872|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
150171029|NCT00536380|541760873|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
150171030|NCT00536380|541760871|FG000|Overall Study|Withdrawal related to study drug|7|||
150171031|NCT00536380|541760872|FG001|Overall Study|Withdrawal related to study drug|5|||
150171032|NCT00536380|541760873|FG002|Overall Study|Withdrawal related to study drug|2|||
150171033|NCT00536380|541760871|FG000|Overall Study|Noncompliance with protocol|3|||
150171034|NCT00536380|541760872|FG001|Overall Study|Noncompliance with protocol|2|||
150171035|NCT00536380|541760873|FG002|Overall Study|Noncompliance with protocol|2|||
150171036|NCT00536380|541760871|FG000|Overall Study|Did not meet protocol eligibility|0|||
150171037|NCT00536380|541760872|FG001|Overall Study|Did not meet protocol eligibility|0|||
150171038|NCT00536380|541760873|FG002|Overall Study|Did not meet protocol eligibility|1|||
150171039|NCT00536380|541760871|FG000|Overall Study|Administrative|0|||
150171040|NCT00536380|541760872|FG001|Overall Study|Administrative|0|||
150171041|NCT00536380|541760873|FG002|Overall Study|Administrative|1|||
150171042|NCT00387465|541760874|FG000|Overall Study|Withdrawal by Subject|0|||
150171043|NCT00387465|541760875|FG001|Overall Study|Withdrawal by Subject|1|||
150171044|NCT00387465|541760876|FG002|Overall Study|Withdrawal by Subject|0|||
150171045|NCT03418324|541760877|FG000|Overall Study|Death|0|||
150171046|NCT03418324|541760878|FG001|Overall Study|Death|1|||
150171047|NCT03418324|541760877|FG000|Overall Study|Physician Decision|1|||
150171048|NCT03418324|541760878|FG001|Overall Study|Physician Decision|1|||
150171049|NCT05233085|541760881|FG000|Overall Study|Adverse Event|1|||
150171050|NCT05233085|541760882|FG001|Overall Study|Adverse Event|0|||
150171051|NCT05233085|541760883|FG002|Overall Study|Adverse Event|0|||
150171052|NCT05233085|541760884|FG003|Overall Study|Adverse Event|0|||
150171053|NCT05147233|541763369|FG000|Overall Study|Adverse Event|0|||
150171054|NCT05147233|541763370|FG001|Overall Study|Adverse Event|1|||
150171055|NCT05147233|541763369|FG000|Overall Study|Lost to Follow-up|1|||
150171056|NCT05147233|541763370|FG001|Overall Study|Lost to Follow-up|1|||
150171057|NCT05147233|541763369|FG000|Overall Study|Protocol Violation|0|||
149830952|NCT00762086|540511345|FG001|Overall Study|Withdrawal by Subject|2|||
150033939|NCT01521117|541262910|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
150033940|NCT01521117|541262911|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
150171058|NCT05147233|541763370|FG001|Overall Study|Protocol Violation|1|||
150171059|NCT05147233|541763369|FG000|Overall Study|Withdrawal by Subject|2|||
150171060|NCT05147233|541763370|FG001|Overall Study|Withdrawal by Subject|1|||
150171061|NCT04517864|541763373|FG000|Placebo-Controlled Phase|Adverse Event|1|||
150277830|NCT03519867|542153503|FG007|Overall Study|Reason not provided|1|||
150277831|NCT03519867|542153504|FG008|Overall Study|Reason not provided|1|||
150277832|NCT03519867|542153505|FG009|Overall Study|Reason not provided|0|||
150277833|NCT00382018|542153506|FG000|Overall Study|Progression|0|||
150277834|NCT00382018|542153507|FG001|Overall Study|Progression|136|||
150277835|NCT00382018|542153508|FG002|Overall Study|Progression|51|||
150277836|NCT00382018|542153509|FG003|Overall Study|Progression|43|||
150277837|NCT00382018|542153506|FG000|Overall Study|Death|0|||
150277838|NCT00382018|542153507|FG001|Overall Study|Death|9|||
149830953|NCT00762086|540511344|FG000|Overall Study|Ineligible to participate in the study|1|||
149830954|NCT00762086|540511345|FG001|Overall Study|Ineligible to participate in the study|0|||
149830955|NCT04538170|540511346|FG000|Overall Study|Withdrawal by Subject|104|||
149830956|NCT04538170|540511347|FG001|Overall Study|Withdrawal by Subject|210|||
149830957|NCT01682083|540511352|FG000|Overall Study|Lost to Follow-up|11|||
149830958|NCT01682083|540511353|FG001|Overall Study|Lost to Follow-up|18|||
149830959|NCT01682083|540511352|FG000|Overall Study|Withdrawal by Subject|31|||
149830960|NCT01682083|540511353|FG001|Overall Study|Withdrawal by Subject|40|||
150277839|NCT00382018|542153508|FG002|Overall Study|Death|7|||
150277840|NCT00382018|542153509|FG003|Overall Study|Death|11|||
150277841|NCT00382018|542153506|FG000|Overall Study|Withdrawal by Subject|0|||
150277842|NCT00382018|542153507|FG001|Overall Study|Withdrawal by Subject|4|||
150277843|NCT00382018|542153508|FG002|Overall Study|Withdrawal by Subject|3|||
150277844|NCT00382018|542153509|FG003|Overall Study|Withdrawal by Subject|4|||
150277845|NCT00382018|542153506|FG000|Overall Study|Other, not protocol specified|0|||
150277846|NCT00382018|542153507|FG001|Overall Study|Other, not protocol specified|16|||
150277847|NCT00382018|542153508|FG002|Overall Study|Other, not protocol specified|3|||
150277848|NCT00382018|542153509|FG003|Overall Study|Other, not protocol specified|1|||
150277849|NCT01252810|542153510|FG000|Overall Study|Withdrawal by Subject|4|||
150277850|NCT01252810|542153511|FG001|Overall Study|Withdrawal by Subject|1|||
150277851|NCT01252810|542153510|FG000|Overall Study|Lost to Follow-up|0|||
150277852|NCT01252810|542153511|FG001|Overall Study|Lost to Follow-up|1|||
150277853|NCT01252810|542153510|FG000|Overall Study|Physician Decision|2|||
150277854|NCT01252810|542153511|FG001|Overall Study|Physician Decision|1|||
150277855|NCT01252810|542153510|FG000|Overall Study|Various reasons|8|||
150277856|NCT01252810|542153511|FG001|Overall Study|Various reasons|0|||
150277857|NCT01721057|542153512|FG000|Treatment Period|Withdrawal by Subject|11|||
150277858|NCT01721057|542153513|FG001|Treatment Period|Withdrawal by Subject|5|||
150277859|NCT01721057|542153514|FG002|Treatment Period|Withdrawal by Subject|8|||
150277860|NCT01721057|542153515|FG003|Treatment Period|Withdrawal by Subject|0|||
150277861|NCT01721057|542153516|FG004|Treatment Period|Withdrawal by Subject|0|||
150277862|NCT01721057|542153517|FG005|Treatment Period|Withdrawal by Subject|0|||
150277863|NCT01721057|542153518|FG006|Treatment Period|Withdrawal by Subject|0|||
150277864|NCT01721057|542153512|FG000|Treatment Period|Adverse Event|7|||
150277865|NCT01721057|542153513|FG001|Treatment Period|Adverse Event|10|||
150277866|NCT01721057|542153514|FG002|Treatment Period|Adverse Event|12|||
150277867|NCT01721057|542153515|FG003|Treatment Period|Adverse Event|0|||
150277868|NCT01721057|542153516|FG004|Treatment Period|Adverse Event|0|||
150277869|NCT01721057|542153517|FG005|Treatment Period|Adverse Event|0|||
150277870|NCT01721057|542153518|FG006|Treatment Period|Adverse Event|0|||
150277871|NCT01721057|542153512|FG000|Treatment Period|Lack of Efficacy|7|||
150277872|NCT01721057|542153513|FG001|Treatment Period|Lack of Efficacy|3|||
150277873|NCT01721057|542153514|FG002|Treatment Period|Lack of Efficacy|0|||
150277874|NCT01721057|542153515|FG003|Treatment Period|Lack of Efficacy|0|||
150277875|NCT01721057|542153516|FG004|Treatment Period|Lack of Efficacy|0|||
150277876|NCT01721057|542153517|FG005|Treatment Period|Lack of Efficacy|0|||
150277877|NCT01721057|542153518|FG006|Treatment Period|Lack of Efficacy|0|||
150277878|NCT01721057|542153512|FG000|Treatment Period|Lost to Follow-up|1|||
150277879|NCT01721057|542153513|FG001|Treatment Period|Lost to Follow-up|0|||
150277880|NCT01721057|542153514|FG002|Treatment Period|Lost to Follow-up|0|||
150277881|NCT01721057|542153515|FG003|Treatment Period|Lost to Follow-up|0|||
150277882|NCT01721057|542153516|FG004|Treatment Period|Lost to Follow-up|0|||
149830961|NCT01682083|540511352|FG000|Overall Study|Death|60|||
149830962|NCT01682083|540511353|FG001|Overall Study|Death|93|||
150277883|NCT01721057|542153517|FG005|Treatment Period|Lost to Follow-up|0|||
150277884|NCT01721057|542153518|FG006|Treatment Period|Lost to Follow-up|0|||
150277885|NCT01721057|542153512|FG000|Treatment Period|Physician Decision|0|||
149830963|NCT01682083|540511352|FG000|Overall Study|Physician Decision|5|||
149830964|NCT01682083|540511353|FG001|Overall Study|Physician Decision|4|||
150277886|NCT01721057|542153513|FG001|Treatment Period|Physician Decision|1|||
150277887|NCT01721057|542153514|FG002|Treatment Period|Physician Decision|3|||
150277888|NCT01721057|542153515|FG003|Treatment Period|Physician Decision|0|||
150277889|NCT01721057|542153516|FG004|Treatment Period|Physician Decision|0|||
149830965|NCT00864097|540511354|FG000|Overall Study|Death|0|||
149830966|NCT00864097|540511355|FG001|Overall Study|Death|1|||
150277890|NCT01721057|542153517|FG005|Treatment Period|Physician Decision|0|||
150277891|NCT01721057|542153518|FG006|Treatment Period|Physician Decision|0|||
150033941|NCT01521117|541262910|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
150033942|NCT01521117|541262911|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
150033943|NCT01521117|541262910|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
150033944|NCT01521117|541262911|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
150033945|NCT01056822|541262912|FG000|Overall Study|Adverse Event|0|||
150033946|NCT01056822|541262913|FG001|Overall Study|Adverse Event|1|||
150033947|NCT01056822|541262912|FG000|Overall Study|Protocol Violation|6|||
150033948|NCT01056822|541262913|FG001|Overall Study|Protocol Violation|5|||
150033949|NCT01056822|541262912|FG000|Overall Study|Withdrawal by Subject|1|||
150033950|NCT01056822|541262913|FG001|Overall Study|Withdrawal by Subject|1|||
150033951|NCT01056822|541262912|FG000|Overall Study|Lost to Follow-up|1|||
150033952|NCT01056822|541262913|FG001|Overall Study|Lost to Follow-up|0|||
150033953|NCT01527149|541264663|FG000|Overall Study|Death|2|||
150033954|NCT03331315|541264664|FG000|Overall Study|Physician Decision|18|||
150033955|NCT03331315|541264665|FG001|Overall Study|Physician Decision|14|||
150033956|NCT02230410|541264666|FG000|Overall Study|Screen Failure|3|||
150033957|NCT02992288|541264672|FG000|Overall Study|Adverse Event|8|||
150033958|NCT02992288|541264673|FG001|Overall Study|Adverse Event|2|||
150033959|NCT02992288|541264674|FG002|Overall Study|Adverse Event|2|||
150033960|NCT02992288|541264675|FG003|Overall Study|Adverse Event|2|||
150033961|NCT02992288|541264676|FG004|Overall Study|Adverse Event|2|||
150033962|NCT02992288|541264677|FG005|Overall Study|Adverse Event|7|||
150033963|NCT02992288|541264672|FG000|Overall Study|Non-compliance with study drug|0|||
150033964|NCT02992288|541264673|FG001|Overall Study|Non-compliance with study drug|1|||
150033965|NCT02992288|541264674|FG002|Overall Study|Non-compliance with study drug|1|||
150033966|NCT02992288|541264675|FG003|Overall Study|Non-compliance with study drug|0|||
150033967|NCT02992288|541264676|FG004|Overall Study|Non-compliance with study drug|1|||
150033968|NCT02992288|541264677|FG005|Overall Study|Non-compliance with study drug|0|||
150033969|NCT02992288|541264672|FG000|Overall Study|Physician Decision|3|||
150033970|NCT02992288|541264673|FG001|Overall Study|Physician Decision|0|||
150033971|NCT02992288|541264674|FG002|Overall Study|Physician Decision|1|||
150033972|NCT02992288|541264675|FG003|Overall Study|Physician Decision|0|||
150033973|NCT02992288|541264676|FG004|Overall Study|Physician Decision|0|||
150033974|NCT02992288|541264677|FG005|Overall Study|Physician Decision|1|||
150033975|NCT02992288|541264672|FG000|Overall Study|Death|2|||
150033976|NCT02992288|541264673|FG001|Overall Study|Death|0|||
150033977|NCT02992288|541264674|FG002|Overall Study|Death|2|||
150033978|NCT02992288|541264675|FG003|Overall Study|Death|1|||
150033979|NCT02992288|541264676|FG004|Overall Study|Death|2|||
150033980|NCT02992288|541264677|FG005|Overall Study|Death|0|||
150033981|NCT02992288|541264672|FG000|Overall Study|Lost to Follow-up|0|||
150033982|NCT02992288|541264673|FG001|Overall Study|Lost to Follow-up|0|||
150033983|NCT02992288|541264674|FG002|Overall Study|Lost to Follow-up|0|||
150033984|NCT02992288|541264675|FG003|Overall Study|Lost to Follow-up|1|||
150033985|NCT02992288|541264676|FG004|Overall Study|Lost to Follow-up|0|||
150033986|NCT02992288|541264677|FG005|Overall Study|Lost to Follow-up|0|||
150033987|NCT02992288|541264672|FG000|Overall Study|Protocol Violation|0|||
150033988|NCT02992288|541264673|FG001|Overall Study|Protocol Violation|0|||
150033989|NCT02992288|541264674|FG002|Overall Study|Protocol Violation|0|||
150033990|NCT02992288|541264675|FG003|Overall Study|Protocol Violation|0|||
150033991|NCT02992288|541264676|FG004|Overall Study|Protocol Violation|0|||
150033992|NCT02992288|541264677|FG005|Overall Study|Protocol Violation|1|||
150033993|NCT02992288|541264672|FG000|Overall Study|Withdrawal by Subject|4|||
150033994|NCT02992288|541264673|FG001|Overall Study|Withdrawal by Subject|2|||
150033995|NCT02992288|541264674|FG002|Overall Study|Withdrawal by Subject|1|||
150033996|NCT02992288|541264675|FG003|Overall Study|Withdrawal by Subject|5|||
150033997|NCT02992288|541264676|FG004|Overall Study|Withdrawal by Subject|3|||
150033998|NCT02992288|541264677|FG005|Overall Study|Withdrawal by Subject|4|||
150033999|NCT00656513|541264678|FG000|Overall Study|Protocol Violation|1|||
150171062|NCT04517864|541763374|FG001|Placebo-Controlled Phase|Adverse Event|0|||
150171063|NCT04517864|541763375|FG002|Placebo-Controlled Phase|Adverse Event|0|||
150171064|NCT04517864|541763373|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
150171065|NCT04517864|541763374|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
150171066|NCT04517864|541763375|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
150171067|NCT04517864|541763373|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
150171068|NCT04517864|541763374|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
150171069|NCT04517864|541763375|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
150171070|NCT04517864|541763373|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
150171071|NCT04517864|541763374|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
150277892|NCT01721057|542153512|FG000|Treatment Period|Death|2|||
150034000|NCT00656513|541264679|FG001|Overall Study|Protocol Violation|0|||
150034001|NCT00656513|541264680|FG002|Overall Study|Protocol Violation|2|||
150034002|NCT00656513|541264678|FG000|Overall Study|Withdrawal by Subject|0|||
150034003|NCT00656513|541264679|FG001|Overall Study|Withdrawal by Subject|11|||
150034004|NCT00656513|541264680|FG002|Overall Study|Withdrawal by Subject|4|||
150034005|NCT00656513|541264678|FG000|Overall Study|Death|0|||
150034006|NCT00656513|541264679|FG001|Overall Study|Death|0|||
150171072|NCT04517864|541763375|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
150277893|NCT01721057|542153513|FG001|Treatment Period|Death|0|||
150277894|NCT01721057|542153514|FG002|Treatment Period|Death|0|||
150277895|NCT01721057|542153515|FG003|Treatment Period|Death|0|||
150277896|NCT01721057|542153516|FG004|Treatment Period|Death|0|||
150277897|NCT01721057|542153517|FG005|Treatment Period|Death|0|||
150277898|NCT01721057|542153518|FG006|Treatment Period|Death|0|||
150277899|NCT01721057|542153512|FG000|Rescue Period|Adverse Event|0|||
150277900|NCT01721057|542153513|FG001|Rescue Period|Adverse Event|0|||
150277901|NCT01721057|542153514|FG002|Rescue Period|Adverse Event|0|||
150277902|NCT01721057|542153515|FG003|Rescue Period|Adverse Event|1|||
150277903|NCT01721057|542153516|FG004|Rescue Period|Adverse Event|0|||
150277904|NCT01721057|542153517|FG005|Rescue Period|Adverse Event|0|||
150277905|NCT01721057|542153518|FG006|Rescue Period|Adverse Event|0|||
150277906|NCT01721057|542153512|FG000|Rescue Period|Lack of Efficacy|0|||
150277907|NCT01721057|542153513|FG001|Rescue Period|Lack of Efficacy|0|||
150277908|NCT01721057|542153514|FG002|Rescue Period|Lack of Efficacy|0|||
150277909|NCT01721057|542153515|FG003|Rescue Period|Lack of Efficacy|2|||
150277910|NCT01721057|542153516|FG004|Rescue Period|Lack of Efficacy|0|||
150277911|NCT01721057|542153517|FG005|Rescue Period|Lack of Efficacy|0|||
150277912|NCT01721057|542153518|FG006|Rescue Period|Lack of Efficacy|0|||
150277913|NCT01202279|542153521|FG000|Overall Study|Adverse Event|8|||
150277914|NCT01202279|542153522|FG001|Overall Study|Adverse Event|6|||
150277915|NCT01202279|542153521|FG000|Overall Study|Withdrawal by Subject|13|||
150277916|NCT01202279|542153522|FG001|Overall Study|Withdrawal by Subject|10|||
150277917|NCT01202279|542153521|FG000|Overall Study|Physician Decision|0|||
150277918|NCT01202279|542153522|FG001|Overall Study|Physician Decision|1|||
150277919|NCT01202279|542153521|FG000|Overall Study|Lost to Follow-up|10|||
150277920|NCT01202279|542153522|FG001|Overall Study|Lost to Follow-up|7|||
150277921|NCT01202279|542153521|FG000|Overall Study|Protocol Violation|1|||
150277922|NCT01202279|542153522|FG001|Overall Study|Protocol Violation|1|||
150277923|NCT01202279|542153521|FG000|Overall Study|study compliance|5|||
150277924|NCT01202279|542153522|FG001|Overall Study|study compliance|2|||
150277925|NCT03805750|542153523|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
150277926|NCT03805750|542153524|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
150277927|NCT01984164|542153525|FG000|Overall Study|Withdrawal by Subject|4|||
150277928|NCT01984164|542153526|FG001|Overall Study|Withdrawal by Subject|3|||
150277929|NCT01984164|542153525|FG000|Overall Study|Adverse Event|5|||
150277930|NCT01984164|542153526|FG001|Overall Study|Adverse Event|19|||
150277931|NCT01984164|542153525|FG000|Overall Study|Lost to Follow-up|1|||
150277932|NCT01984164|542153526|FG001|Overall Study|Lost to Follow-up|3|||
150277933|NCT02811549|542153527|FG000|Overall Study|Lost to Follow-up|1|||
150277934|NCT02811549|542153527|FG000|Overall Study|Withdrawal by Subject|3|||
150277935|NCT02811549|542153527|FG000|Overall Study|Subject screen failed|4|||
150277936|NCT02811549|542153527|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
149830967|NCT00864097|540511356|FG002|Overall Study|Death|0|||
150277937|NCT03472924|542153528|FG000|Overall Study|Adverse Event|1|||
150277938|NCT03472924|542153529|FG001|Overall Study|Adverse Event|0|||
150277939|NCT02546765|542153533|FG000|Overall Study|Withdrawal by Subject|0|||
150277940|NCT02546765|542153534|FG001|Overall Study|Withdrawal by Subject|1|||
150277941|NCT02546765|542153535|FG002|Overall Study|Withdrawal by Subject|0|||
150277942|NCT02546765|542153536|FG003|Overall Study|Withdrawal by Subject|0|||
150277943|NCT05082376|542153537|FG000|Overall Study|Lost to Follow-up|2|||
150277944|NCT00493220|542153538|FG000|Third Intervention|Withdrawal by Subject|1|||
150277945|NCT00493220|542153539|FG001|Third Intervention|Withdrawal by Subject|0|||
150277946|NCT00493220|542153540|FG002|Third Intervention|Withdrawal by Subject|0|||
150277947|NCT00493220|542153541|FG003|Third Intervention|Withdrawal by Subject|0|||
150277948|NCT00493220|542153542|FG004|Third Intervention|Withdrawal by Subject|0|||
150277949|NCT00493220|542153543|FG005|Third Intervention|Withdrawal by Subject|0|||
150277950|NCT02109562|542153544|FG000|Overall Study|Insufficient clinical response|2|||
150277951|NCT02109562|542153545|FG001|Overall Study|Insufficient clinical response|0|||
150277952|NCT02109562|542153546|FG002|Overall Study|Insufficient clinical response|4|||
150277953|NCT02109562|542153544|FG000|Overall Study|Adverse Event|0|||
150277954|NCT02109562|542153545|FG001|Overall Study|Adverse Event|2|||
150277955|NCT02109562|542153546|FG002|Overall Study|Adverse Event|3|||
150277956|NCT02109562|542153544|FG000|Overall Study|Lost to Follow-up|1|||
150277957|NCT02109562|542153545|FG001|Overall Study|Lost to Follow-up|0|||
150277958|NCT02109562|542153546|FG002|Overall Study|Lost to Follow-up|1|||
150277959|NCT02109562|542153544|FG000|Overall Study|Protocol Violation|0|||
150277960|NCT02109562|542153545|FG001|Overall Study|Protocol Violation|3|||
150277961|NCT02109562|542153546|FG002|Overall Study|Protocol Violation|1|||
150277962|NCT02109562|542153544|FG000|Overall Study|Withdrawal by Subject|20|||
150277963|NCT02109562|542153545|FG001|Overall Study|Withdrawal by Subject|25|||
150277964|NCT02109562|542153546|FG002|Overall Study|Withdrawal by Subject|21|||
150277965|NCT02109562|542153544|FG000|Overall Study|Physician Decision|3|||
150277966|NCT02109562|542153545|FG001|Overall Study|Physician Decision|4|||
150277967|NCT02109562|542153546|FG002|Overall Study|Physician Decision|5|||
150277968|NCT00445224|542153547|FG000|Specific Exercises|Withdrawal by Subject|3|||
150277969|NCT00445224|542153548|FG001|Specific Exercises|Withdrawal by Subject|3|||
150277970|NCT00445224|542153547|FG000|Specific Exercises|Withdrawal by Subject|1|||
150277971|NCT00445224|542153548|FG001|Specific Exercises|Withdrawal by Subject|0|||
150277972|NCT04136184|542153551|FG000|Overall Study|Lost to Follow-up|0|||
150277973|NCT04136184|542153552|FG001|Overall Study|Lost to Follow-up|3|||
150277974|NCT04136184|542153551|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
150277975|NCT04136184|542153552|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
150277976|NCT03318978|542153556|FG000|Overall Study|Withdrawal by Subject|1|||
150277977|NCT02844816|542153557|FG000|Overall Study|No protocol treatment received|5|||
150277978|NCT02844816|542153558|FG001|Overall Study|No protocol treatment received|1|||
149830968|NCT00864097|540511357|FG003|Overall Study|Death|0|||
150277979|NCT02844816|542153557|FG000|Overall Study|Ineligible|22|||
150277980|NCT02844816|542153558|FG001|Overall Study|Ineligible|15|||
150277981|NCT02844816|542153557|FG000|Overall Study|Participant refusal|5|||
150277982|NCT02844816|542153558|FG001|Overall Study|Participant refusal|5|||
150277983|NCT02844816|542153557|FG000|Overall Study|Adverse Event|5|||
150277984|NCT02844816|542153558|FG001|Overall Study|Adverse Event|4|||
150277985|NCT02844816|542153557|FG000|Overall Study|Death|0|||
150277986|NCT02844816|542153558|FG001|Overall Study|Death|1|||
150277987|NCT02844816|542153557|FG000|Overall Study|Disease progression/recurrence|50|||
150277988|NCT02844816|542153558|FG001|Overall Study|Disease progression/recurrence|24|||
150277989|NCT02844816|542153557|FG000|Overall Study|Physician Decision|1|||
150277990|NCT02844816|542153558|FG001|Overall Study|Physician Decision|1|||
150277991|NCT00667823|542153559|FG000|Overall Study|Lost to Follow-up|5|||
150277992|NCT00667823|542153559|FG000|Overall Study|Adverse Event|7|||
150277993|NCT00667823|542153559|FG000|Overall Study|Death|182|||
150277994|NCT00667823|542153559|FG000|Overall Study|Withdrawal by Subject|12|||
150277995|NCT00667823|542153559|FG000|Overall Study|Other|8|||
150277996|NCT00667823|542153559|FG000|Overall Study|Missing (completion page missing)|2|||
150277997|NCT02592018|542153561|FG000|Overall Study|Adverse Event|1|||
150277998|NCT02592018|542153561|FG000|Overall Study|Lost to Follow-up|1|||
150277999|NCT06156215|542153564|FG000|Overall Study|Withdrawal by Subject|2|||
150278000|NCT06156215|542153565|FG001|Overall Study|Withdrawal by Subject|4|||
150278001|NCT06156215|542153566|FG002|Overall Study|Withdrawal by Subject|4|||
150278002|NCT06156215|542153567|FG003|Overall Study|Withdrawal by Subject|0|||
150278003|NCT06156215|542153568|FG004|Overall Study|Withdrawal by Subject|2|||
150278004|NCT06156215|542153569|FG005|Overall Study|Withdrawal by Subject|2|||
150278005|NCT06156215|542153564|FG000|Overall Study|Left ED without completing study|9|||
150278006|NCT06156215|542153565|FG001|Overall Study|Left ED without completing study|3|||
150278007|NCT06156215|542153566|FG002|Overall Study|Left ED without completing study|9|||
150278008|NCT06156215|542153567|FG003|Overall Study|Left ED without completing study|0|||
150278009|NCT06156215|542153568|FG004|Overall Study|Left ED without completing study|8|||
150278010|NCT06156215|542153569|FG005|Overall Study|Left ED without completing study|16|||
150278011|NCT06156215|542153564|FG000|Overall Study|Physician Decision|1|||
150278012|NCT06156215|542153565|FG001|Overall Study|Physician Decision|0|||
150278013|NCT06156215|542153566|FG002|Overall Study|Physician Decision|0|||
150278014|NCT06156215|542153567|FG003|Overall Study|Physician Decision|0|||
150278015|NCT06156215|542153568|FG004|Overall Study|Physician Decision|0|||
150278016|NCT06156215|542153569|FG005|Overall Study|Physician Decision|0|||
150278017|NCT06156215|542153564|FG000|Overall Study|Became or found ineligible|2|||
150278018|NCT06156215|542153565|FG001|Overall Study|Became or found ineligible|0|||
150278019|NCT06156215|542153566|FG002|Overall Study|Became or found ineligible|2|||
150278020|NCT06156215|542153567|FG003|Overall Study|Became or found ineligible|0|||
150278021|NCT06156215|542153568|FG004|Overall Study|Became or found ineligible|1|||
150278022|NCT06156215|542153569|FG005|Overall Study|Became or found ineligible|2|||
150278023|NCT05050318|542155404|FG000|Overall Study|Protocol Deviation|1|||
150278024|NCT05050318|542155405|FG001|Overall Study|Protocol Deviation|0|||
150278025|NCT05050318|542155406|FG002|Overall Study|Protocol Deviation|0|||
150278026|NCT04360551|542155407|FG000|Overall Study|Withdrawal by Subject|1|||
150278027|NCT04360551|542155408|FG001|Overall Study|Withdrawal by Subject|0|||
150278028|NCT03496012|542155412|FG000|Overall Study|Withdrawal by Subject|2|||
150278029|NCT03496012|542155413|FG001|Overall Study|Withdrawal by Subject|0|||
150278030|NCT03496012|542155414|FG002|Overall Study|Withdrawal by Subject|2|||
150278031|NCT03496012|542155412|FG000|Overall Study|Adverse Event|0|||
150278032|NCT03496012|542155413|FG001|Overall Study|Adverse Event|0|||
150278033|NCT03496012|542155414|FG002|Overall Study|Adverse Event|1|||
150278034|NCT03496012|542155412|FG000|Overall Study|Reason Not Specified|2|||
150278035|NCT03496012|542155413|FG001|Overall Study|Reason Not Specified|0|||
150278036|NCT03496012|542155414|FG002|Overall Study|Reason Not Specified|1|||
150278037|NCT02322125|542155415|FG000|Overall Study|Withdrawal by Subject|2|||
150278038|NCT00766038|542155425|FG000|Overall Study|Lost to Follow-up|15|||
150278039|NCT00766038|542155426|FG001|Overall Study|Lost to Follow-up|14|||
150278040|NCT01524198|542155435|FG000|Overall Study|Protocol Violation|8|||
150278041|NCT01524198|542155436|FG001|Overall Study|Protocol Violation|6|||
150278042|NCT01524198|542155435|FG000|Overall Study|Withdrawal by Subject|15|||
150278043|NCT01524198|542155436|FG001|Overall Study|Withdrawal by Subject|10|||
150278044|NCT02232802|542155437|FG000|Period 1|Sponsor request|1|||
150278045|NCT02232802|542155438|FG001|Period 1|Sponsor request|0|||
150278046|NCT02232802|542155437|FG000|Period 1|Adverse Event|1|||
150278047|NCT02232802|542155438|FG001|Period 1|Adverse Event|1|||
150278048|NCT00885703|542155445|FG000|Overall Study|Death|9|||
150278049|NCT00885703|542155446|FG001|Overall Study|Death|7|||
150278050|NCT00885703|542155447|FG002|Overall Study|Death|8|||
150278051|NCT00885703|542155448|FG003|Overall Study|Death|7|||
150278052|NCT00885703|542155449|FG004|Overall Study|Death|7|||
150278053|NCT00885703|542155450|FG005|Overall Study|Death|8|||
150278054|NCT00885703|542155451|FG006|Overall Study|Death|4|||
150278055|NCT00885703|542155445|FG000|Overall Study|Lost to Follow-up|0|||
150278056|NCT00885703|542155446|FG001|Overall Study|Lost to Follow-up|0|||
150278057|NCT00885703|542155447|FG002|Overall Study|Lost to Follow-up|1|||
150278058|NCT00885703|542155448|FG003|Overall Study|Lost to Follow-up|0|||
150278059|NCT00885703|542155449|FG004|Overall Study|Lost to Follow-up|0|||
150278060|NCT00885703|542155450|FG005|Overall Study|Lost to Follow-up|1|||
150278061|NCT00885703|542155451|FG006|Overall Study|Lost to Follow-up|0|||
150278062|NCT00885703|542155445|FG000|Overall Study|Withdrawal by Subject|0|||
150278063|NCT00885703|542155446|FG001|Overall Study|Withdrawal by Subject|0|||
150278064|NCT00885703|542155447|FG002|Overall Study|Withdrawal by Subject|0|||
150278065|NCT00885703|542155448|FG003|Overall Study|Withdrawal by Subject|1|||
150278066|NCT00885703|542155449|FG004|Overall Study|Withdrawal by Subject|3|||
150278067|NCT00885703|542155450|FG005|Overall Study|Withdrawal by Subject|1|||
150278068|NCT00885703|542155451|FG006|Overall Study|Withdrawal by Subject|1|||
150278069|NCT00885703|542155445|FG000|Overall Study|Ineligible (no CM)|1|||
150278070|NCT00885703|542155446|FG001|Overall Study|Ineligible (no CM)|3|||
150278071|NCT00885703|542155447|FG002|Overall Study|Ineligible (no CM)|2|||
150278072|NCT00885703|542155448|FG003|Overall Study|Ineligible (no CM)|1|||
150278073|NCT00885703|542155449|FG004|Overall Study|Ineligible (no CM)|2|||
150278074|NCT00885703|542155450|FG005|Overall Study|Ineligible (no CM)|3|||
150278075|NCT00885703|542155451|FG006|Overall Study|Ineligible (no CM)|1|||
150278076|NCT01490450|542155454|FG000|Period 1|Lack of Efficacy|2|||
150278077|NCT01490450|542155455|FG001|Period 1|Lack of Efficacy|0|||
150278078|NCT01490450|542155456|FG002|Period 1|Lack of Efficacy|3|||
150278079|NCT01490450|542155457|FG003|Period 1|Lack of Efficacy|0|||
150278080|NCT01490450|542155454|FG000|Period 1|Adverse Event|0|||
150278081|NCT01490450|542155455|FG001|Period 1|Adverse Event|0|||
150278082|NCT01490450|542155456|FG002|Period 1|Adverse Event|0|||
150278083|NCT01490450|542155457|FG003|Period 1|Adverse Event|5|||
150278084|NCT01490450|542155454|FG000|Period 1|Request to discontinue treatment|1|||
150278085|NCT01490450|542155455|FG001|Period 1|Request to discontinue treatment|0|||
150278086|NCT01490450|542155456|FG002|Period 1|Request to discontinue treatment|0|||
150278087|NCT01490450|542155457|FG003|Period 1|Request to discontinue treatment|0|||
150278088|NCT01490450|542155454|FG000|Period 1|Withdrawal by Subject|0|||
150278089|NCT01490450|542155455|FG001|Period 1|Withdrawal by Subject|0|||
150278090|NCT01490450|542155456|FG002|Period 1|Withdrawal by Subject|0|||
150278091|NCT01490450|542155457|FG003|Period 1|Withdrawal by Subject|3|||
150278092|NCT01490450|542155454|FG000|Period 1|No longer met study criteria|0|||
150278093|NCT01490450|542155455|FG001|Period 1|No longer met study criteria|1|||
150278094|NCT01490450|542155456|FG002|Period 1|No longer met study criteria|1|||
150278095|NCT01490450|542155457|FG003|Period 1|No longer met study criteria|0|||
150278096|NCT01490450|542155454|FG000|Period 2|Lack of Efficacy|0|||
150278097|NCT01490450|542155455|FG001|Period 2|Lack of Efficacy|0|||
150278098|NCT01490450|542155456|FG002|Period 2|Lack of Efficacy|0|||
150278099|NCT01490450|542155457|FG003|Period 2|Lack of Efficacy|1|||
150278100|NCT01490450|542155454|FG000|Period 2|Adverse Event|1|||
150278101|NCT01490450|542155455|FG001|Period 2|Adverse Event|1|||
150278102|NCT01490450|542155456|FG002|Period 2|Adverse Event|0|||
150278103|NCT01490450|542155457|FG003|Period 2|Adverse Event|1|||
150278104|NCT01490450|542155454|FG000|Period 2|Withdrawal by Subject|1|||
150278105|NCT01490450|542155455|FG001|Period 2|Withdrawal by Subject|0|||
150278106|NCT01490450|542155456|FG002|Period 2|Withdrawal by Subject|0|||
150278107|NCT01490450|542155457|FG003|Period 2|Withdrawal by Subject|0|||
150278108|NCT01490450|542155454|FG000|Period 2|Lost to Follow-up|0|||
150278109|NCT01490450|542155455|FG001|Period 2|Lost to Follow-up|0|||
150278110|NCT01490450|542155456|FG002|Period 2|Lost to Follow-up|0|||
150278111|NCT01490450|542155457|FG003|Period 2|Lost to Follow-up|2|||
150278112|NCT00404820|542155458|FG000|Overall Study|Adverse Event|4|||
150278113|NCT00404820|542155459|FG001|Overall Study|Adverse Event|16|||
149830969|NCT00864097|540511354|FG000|Overall Study|Adverse Event|6|||
150278114|NCT00404820|542155458|FG000|Overall Study|Withdrawal by Subject|5|||
150278115|NCT00404820|542155459|FG001|Overall Study|Withdrawal by Subject|3|||
150278116|NCT00404820|542155458|FG000|Overall Study|Lost to Follow-up|7|||
150278117|NCT00404820|542155459|FG001|Overall Study|Lost to Follow-up|3|||
150278118|NCT00404820|542155458|FG000|Overall Study|Administrative problems|2|||
150278119|NCT00404820|542155459|FG001|Overall Study|Administrative problems|0|||
150278120|NCT00404820|542155458|FG000|Overall Study|Death|1|||
150278121|NCT00404820|542155459|FG001|Overall Study|Death|0|||
150278122|NCT00404820|542155458|FG000|Overall Study|Other|0|||
150278123|NCT00404820|542155459|FG001|Overall Study|Other|2|||
150278124|NCT00938717|542155460|FG000|Overall Study|Adverse Event|10|||
150278125|NCT00938717|542155461|FG001|Overall Study|Adverse Event|41|||
150278126|NCT00938717|542155460|FG000|Overall Study|Protocol Violation|11|||
150278127|NCT00938717|542155461|FG001|Overall Study|Protocol Violation|8|||
150278128|NCT00938717|542155460|FG000|Overall Study|Withdrawal by Subject|26|||
150278129|NCT00938717|542155461|FG001|Overall Study|Withdrawal by Subject|24|||
150278130|NCT00938717|542155460|FG000|Overall Study|Lost to Follow-up|13|||
150278131|NCT00938717|542155461|FG001|Overall Study|Lost to Follow-up|18|||
150278132|NCT00938717|542155460|FG000|Overall Study|Lack of Efficacy|33|||
150278133|NCT00938717|542155461|FG001|Overall Study|Lack of Efficacy|15|||
150278134|NCT00938717|542155460|FG000|Overall Study|Other reason|5|||
150278135|NCT00938717|542155461|FG001|Overall Study|Other reason|2|||
150278136|NCT01462435|542155463|FG000|Overall Study|Lack of Efficacy|1|||
150278137|NCT01462435|542155464|FG001|Overall Study|Lack of Efficacy|0|||
150278138|NCT01462435|542155465|FG002|Overall Study|Lack of Efficacy|0|||
150278139|NCT01462435|542155466|FG003|Overall Study|Lack of Efficacy|3|||
150278140|NCT01462435|542155463|FG000|Overall Study|Physician Decision|0|||
150278141|NCT01462435|542155464|FG001|Overall Study|Physician Decision|0|||
150278142|NCT01462435|542155465|FG002|Overall Study|Physician Decision|1|||
150278143|NCT01462435|542155466|FG003|Overall Study|Physician Decision|0|||
150278144|NCT01462435|542155463|FG000|Overall Study|Withdrawal by Subject|0|||
150278145|NCT01462435|542155464|FG001|Overall Study|Withdrawal by Subject|0|||
150278146|NCT01462435|542155465|FG002|Overall Study|Withdrawal by Subject|0|||
150278147|NCT01462435|542155466|FG003|Overall Study|Withdrawal by Subject|1|||
150278148|NCT01462435|542155463|FG000|Overall Study|Lost to Follow-up|0|||
150278149|NCT01462435|542155464|FG001|Overall Study|Lost to Follow-up|0|||
150278150|NCT01462435|542155465|FG002|Overall Study|Lost to Follow-up|0|||
150278151|NCT01462435|542155466|FG003|Overall Study|Lost to Follow-up|1|||
150278152|NCT01543152|542155471|FG000|Overall Study|Withdrawal by Subject|0|||
150278153|NCT01543152|542155472|FG001|Overall Study|Withdrawal by Subject|2|||
150278154|NCT01543152|542155473|FG002|Overall Study|Withdrawal by Subject|0|||
150278155|NCT01543152|542155474|FG003|Overall Study|Withdrawal by Subject|0|||
150278156|NCT01543152|542155475|FG004|Overall Study|Withdrawal by Subject|0|||
150278157|NCT02053168|542155478|FG000|Overall Study|Withdrawal by Subject|1|||
150278158|NCT02053168|542155478|FG000|Overall Study|Physician Decision|1|||
150278159|NCT02053168|542155478|FG000|Overall Study|Lost to Follow-up|1|||
150278160|NCT00636675|542155479|FG000|Overall Study|Lost to Follow-up|121|||
150278161|NCT00636675|542155480|FG001|Overall Study|Lost to Follow-up|31|||
150278162|NCT00636675|542155479|FG000|Overall Study|Withdrawal by Subject|19|||
150278163|NCT00636675|542155480|FG001|Overall Study|Withdrawal by Subject|10|||
150278164|NCT02687542|542155482|FG000|Overall Study|Medication error without associated AEs|0|||
150278165|NCT02687542|542155483|FG001|Overall Study|Medication error without associated AEs|0|||
150278166|NCT02687542|542155484|FG002|Overall Study|Medication error without associated AEs|0|||
150278167|NCT02687542|542155485|FG003|Overall Study|Medication error without associated AEs|0|||
150278168|NCT02687542|542155486|FG004|Overall Study|Medication error without associated AEs|1|||
150278169|NCT02687542|542155482|FG000|Overall Study|Lost to Follow-up|0|||
150278170|NCT02687542|542155483|FG001|Overall Study|Lost to Follow-up|0|||
150278171|NCT02687542|542155484|FG002|Overall Study|Lost to Follow-up|0|||
150278172|NCT02687542|542155485|FG003|Overall Study|Lost to Follow-up|0|||
150278173|NCT02687542|542155486|FG004|Overall Study|Lost to Follow-up|1|||
150278174|NCT02687542|542155482|FG000|Overall Study|Protocol Violation|0|||
150278175|NCT02687542|542155483|FG001|Overall Study|Protocol Violation|1|||
150278176|NCT02687542|542155484|FG002|Overall Study|Protocol Violation|0|||
150278177|NCT02687542|542155485|FG003|Overall Study|Protocol Violation|0|||
150278178|NCT02687542|542155486|FG004|Overall Study|Protocol Violation|0|||
150278179|NCT02687542|542155482|FG000|Overall Study|Other|5|||
150278180|NCT02687542|542155483|FG001|Overall Study|Other|9|||
150278181|NCT02687542|542155484|FG002|Overall Study|Other|10|||
150278182|NCT02687542|542155485|FG003|Overall Study|Other|6|||
150278183|NCT02687542|542155486|FG004|Overall Study|Other|5|||
150278184|NCT02687542|542155482|FG000|Overall Study|Adverse Event|3|||
150278185|NCT02687542|542155483|FG001|Overall Study|Adverse Event|1|||
150278186|NCT02687542|542155484|FG002|Overall Study|Adverse Event|3|||
150278187|NCT02687542|542155485|FG003|Overall Study|Adverse Event|2|||
150278188|NCT02687542|542155486|FG004|Overall Study|Adverse Event|9|||
150278189|NCT02687542|542155482|FG000|Overall Study|Withdrawal by Subject|0|||
150278190|NCT02687542|542155483|FG001|Overall Study|Withdrawal by Subject|1|||
150278191|NCT02687542|542155484|FG002|Overall Study|Withdrawal by Subject|1|||
150278192|NCT02687542|542155485|FG003|Overall Study|Withdrawal by Subject|2|||
150278193|NCT02687542|542155486|FG004|Overall Study|Withdrawal by Subject|4|||
150278194|NCT01838616|542155487|FG000|Titration Period|Adverse Event|18|||
150278195|NCT01838616|542155488|FG001|Titration Period|Adverse Event|48|||
150278196|NCT01838616|542155487|FG000|Titration Period|Lack of Efficacy|5|||
150278197|NCT01838616|542155488|FG001|Titration Period|Lack of Efficacy|12|||
150278198|NCT01838616|542155487|FG000|Titration Period|Withdrawal by Subject|5|||
150278199|NCT01838616|542155488|FG001|Titration Period|Withdrawal by Subject|5|||
150278200|NCT01838616|542155487|FG000|Titration Period|Technical problems|1|||
150278201|NCT01838616|542155488|FG001|Titration Period|Technical problems|0|||
150278202|NCT01838616|542155487|FG000|Titration Period|Other|1|||
150278203|NCT01838616|542155488|FG001|Titration Period|Other|0|||
150278204|NCT01838616|542155487|FG000|Titration Period|Protocol Violation|0|||
150278205|NCT01838616|542155488|FG001|Titration Period|Protocol Violation|1|||
150278206|NCT01838616|542155487|FG000|Continuation Period|Lack of Efficacy|3|||
150278207|NCT01838616|542155488|FG001|Continuation Period|Lack of Efficacy|5|||
150278208|NCT01838616|542155487|FG000|Continuation Period|Adverse Event|8|||
150278209|NCT01838616|542155488|FG001|Continuation Period|Adverse Event|4|||
150278210|NCT01838616|542155487|FG000|Continuation Period|Protocol Violation|2|||
150278211|NCT01838616|542155488|FG001|Continuation Period|Protocol Violation|0|||
150278212|NCT01838616|542155487|FG000|Continuation Period|Lost to Follow-up|1|||
150278213|NCT01838616|542155488|FG001|Continuation Period|Lost to Follow-up|0|||
150278214|NCT01838616|542155487|FG000|Continuation Period|Withdrawal by Subject|0|||
150278215|NCT01838616|542155488|FG001|Continuation Period|Withdrawal by Subject|4|||
150278216|NCT01838616|542155487|FG000|Continuation Period|Technical problems|0|||
150278217|NCT01838616|542155488|FG001|Continuation Period|Technical problems|1|||
150278218|NCT01838616|542155487|FG000|Pick-up Arm|Lack of Efficacy|4|||
150278219|NCT01838616|542155488|FG001|Pick-up Arm|Lack of Efficacy|0|||
150278220|NCT01838616|542155487|FG000|Pick-up Arm|Adverse Event|9|||
150278221|NCT01838616|542155488|FG001|Pick-up Arm|Adverse Event|0|||
150278222|NCT01838616|542155487|FG000|Pick-up Arm|Withdrawal by Subject|1|||
150278223|NCT01838616|542155488|FG001|Pick-up Arm|Withdrawal by Subject|0|||
150278224|NCT01838616|542155487|FG000|Pick-up Arm|Technical problems|1|||
150278225|NCT01838616|542155488|FG001|Pick-up Arm|Technical problems|0|||
150278226|NCT01848288|542155489|FG000|Overall Study|Death|1|||
150278227|NCT01848288|542155489|FG000|Overall Study|Protocol Violation|1|||
150278228|NCT01848288|542155489|FG000|Overall Study|Withdrawal by Subject|1|||
150278229|NCT01007032|542155490|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
150278230|NCT01007032|542155491|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
150278231|NCT01007032|542155492|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
150278232|NCT01007032|542155493|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
150278233|NCT01007032|542155490|FG000|Overall Study|Withdrawal by Subject|0|||
150278234|NCT01007032|542155491|FG001|Overall Study|Withdrawal by Subject|0|||
150278235|NCT01007032|542155492|FG002|Overall Study|Withdrawal by Subject|0|||
150278236|NCT01007032|542155493|FG003|Overall Study|Withdrawal by Subject|1|||
150278237|NCT01101438|542155494|FG000|Overall Study|Withdrawal by Subject|8|||
150278238|NCT01101438|542155495|FG001|Overall Study|Withdrawal by Subject|9|||
150278239|NCT00914927|542155512|FG000|Overall Study|Adverse Event|0|||
150278240|NCT00914927|542155513|FG001|Overall Study|Adverse Event|0|||
150278241|NCT00914927|542155514|FG002|Overall Study|Adverse Event|0|||
150278242|NCT00914927|542155515|FG003|Overall Study|Adverse Event|0|||
150278243|NCT00914927|542155516|FG004|Overall Study|Adverse Event|1|||
150278244|NCT00914927|542155517|FG005|Overall Study|Adverse Event|0|||
150278245|NCT00914927|542155518|FG006|Overall Study|Adverse Event|0|||
150278246|NCT00914927|542155512|FG000|Overall Study|Withdrawal by Subject|0|||
150278247|NCT00914927|542155513|FG001|Overall Study|Withdrawal by Subject|1|||
150278248|NCT00914927|542155514|FG002|Overall Study|Withdrawal by Subject|0|||
150278249|NCT00914927|542155515|FG003|Overall Study|Withdrawal by Subject|1|||
150278250|NCT00914927|542155516|FG004|Overall Study|Withdrawal by Subject|0|||
150278251|NCT00914927|542155517|FG005|Overall Study|Withdrawal by Subject|0|||
150278252|NCT00914927|542155518|FG006|Overall Study|Withdrawal by Subject|0|||
150278253|NCT00914927|542155512|FG000|Overall Study|Lost to Follow-up|0|||
150278254|NCT00914927|542155513|FG001|Overall Study|Lost to Follow-up|0|||
150278255|NCT00914927|542155514|FG002|Overall Study|Lost to Follow-up|0|||
150278256|NCT00914927|542155515|FG003|Overall Study|Lost to Follow-up|1|||
150278257|NCT00914927|542155516|FG004|Overall Study|Lost to Follow-up|0|||
150278258|NCT00914927|542155517|FG005|Overall Study|Lost to Follow-up|0|||
150278259|NCT00914927|542155518|FG006|Overall Study|Lost to Follow-up|0|||
150278260|NCT00914927|542155512|FG000|Overall Study|Administrative/Other|2|||
150278261|NCT00914927|542155513|FG001|Overall Study|Administrative/Other|1|||
150278262|NCT00914927|542155514|FG002|Overall Study|Administrative/Other|0|||
150278263|NCT00914927|542155515|FG003|Overall Study|Administrative/Other|0|||
150278264|NCT00914927|542155516|FG004|Overall Study|Administrative/Other|1|||
150278265|NCT00914927|542155517|FG005|Overall Study|Administrative/Other|0|||
150278266|NCT00914927|542155518|FG006|Overall Study|Administrative/Other|0|||
150278267|NCT01519934|542155523|FG000|Overall Study|Lost to Follow-up|3|||
150278268|NCT02164929|542155526|FG000|Overall Study|Converted to open procedure|1|||
150278269|NCT02164929|542155527|FG001|Overall Study|Converted to open procedure|0|||
150278270|NCT02164929|542155528|FG002|Overall Study|Converted to open procedure|0|||
150278271|NCT02164929|542155529|FG003|Overall Study|Converted to open procedure|2|||
150278272|NCT02164929|542155526|FG000|Overall Study|Failed regional block|0|||
150278273|NCT02164929|542155527|FG001|Overall Study|Failed regional block|0|||
150278274|NCT02164929|542155528|FG002|Overall Study|Failed regional block|1|||
150278275|NCT02164929|542155529|FG003|Overall Study|Failed regional block|0|||
150278276|NCT00365456|542155533|FG000|Trial Period I (12 Months)|Adverse Event|84|||
150278277|NCT00365456|542155534|FG001|Trial Period I (12 Months)|Adverse Event|0|||
150278278|NCT00365456|542155533|FG000|Trial Period I (12 Months)|Non-compliance|3|||
150278279|NCT00365456|542155534|FG001|Trial Period I (12 Months)|Non-compliance|0|||
150278280|NCT00365456|542155533|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
150278281|NCT00365456|542155534|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
150278282|NCT00365456|542155533|FG000|Trial Period I (12 Months)|Other|11|||
150278283|NCT00365456|542155534|FG001|Trial Period I (12 Months)|Other|0|||
150278284|NCT00365456|542155533|FG000|Trial Period II (12 Months)|Adverse Event|0|||
150278285|NCT00365456|542155534|FG001|Trial Period II (12 Months)|Adverse Event|6|||
150278286|NCT00365456|542155533|FG000|Trial Period II (12 Months)|Non-compliance|0|||
150278287|NCT00365456|542155534|FG001|Trial Period II (12 Months)|Non-compliance|2|||
150278288|NCT00365456|542155533|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
150278289|NCT00365456|542155534|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
150278290|NCT00365456|542155533|FG000|Trial Period II (12 Months)|Other|0|||
150278291|NCT00365456|542155534|FG001|Trial Period II (12 Months)|Other|1|||
150278292|NCT00365456|542155533|FG000|Trial Period III (12 Months)|Adverse Event|13|||
150278293|NCT00365456|542155534|FG001|Trial Period III (12 Months)|Adverse Event|3|||
150278294|NCT00365456|542155533|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
150278295|NCT00365456|542155534|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
150278296|NCT00365456|542155533|FG000|Trial Period III (12 Months)|Other|1|||
150278297|NCT00365456|542155534|FG001|Trial Period III (12 Months)|Other|1|||
150278298|NCT02161575|542155538|FG000|Overall Study|Protocol Violation|8|||
150278299|NCT02161575|542155538|FG000|Overall Study|Lack of Efficacy|1|||
150278300|NCT02161575|542155538|FG000|Overall Study|Adverse Event|2|||
150278301|NCT00714285|542155539|FG000|Overall Study|Lost to Follow-up|0|||
150278302|NCT00714285|542155540|FG001|Overall Study|Lost to Follow-up|2|||
150278303|NCT00714285|542155541|FG002|Overall Study|Lost to Follow-up|0|||
150278304|NCT00714285|542155542|FG003|Overall Study|Lost to Follow-up|1|||
150278305|NCT00714285|542155539|FG000|Overall Study|Migrated/moved from study area|0|||
150278306|NCT00714285|542155540|FG001|Overall Study|Migrated/moved from study area|1|||
150278307|NCT00714285|542155541|FG002|Overall Study|Migrated/moved from study area|0|||
150278308|NCT00714285|542155542|FG003|Overall Study|Migrated/moved from study area|0|||
150278309|NCT02138617|542155543|FG000|Overall Study|Death|1|||
150278310|NCT02138617|542155544|FG001|Overall Study|Death|2|||
150278311|NCT02138617|542155545|FG002|Overall Study|Death|2|||
150278312|NCT02138617|542155543|FG000|Overall Study|Adverse Event|8|||
150278313|NCT02138617|542155544|FG001|Overall Study|Adverse Event|5|||
150278314|NCT02138617|542155545|FG002|Overall Study|Adverse Event|2|||
150278315|NCT02138617|542155543|FG000|Overall Study|Disease Progression|20|||
150278316|NCT02138617|542155544|FG001|Overall Study|Disease Progression|13|||
150278317|NCT02138617|542155545|FG002|Overall Study|Disease Progression|4|||
150278318|NCT02138617|542155543|FG000|Overall Study|Withdrawal by Subject|7|||
150278319|NCT02138617|542155544|FG001|Overall Study|Withdrawal by Subject|10|||
150278320|NCT02138617|542155545|FG002|Overall Study|Withdrawal by Subject|2|||
150278321|NCT02138617|542155543|FG000|Overall Study|other complicating disease|0|||
150278322|NCT02138617|542155544|FG001|Overall Study|other complicating disease|2|||
150278323|NCT02138617|542155545|FG002|Overall Study|other complicating disease|0|||
150278324|NCT02138617|542155543|FG000|Overall Study|Protocol Violation|1|||
150278325|NCT02138617|542155544|FG001|Overall Study|Protocol Violation|0|||
150278326|NCT02138617|542155545|FG002|Overall Study|Protocol Violation|0|||
150278327|NCT02138617|542155543|FG000|Overall Study|Physician Decision|7|||
150278328|NCT02138617|542155544|FG001|Overall Study|Physician Decision|6|||
150278329|NCT02138617|542155545|FG002|Overall Study|Physician Decision|0|||
150278330|NCT02138617|542155543|FG000|Overall Study|financial reason|0|||
150278331|NCT02138617|542155544|FG001|Overall Study|financial reason|1|||
150278332|NCT02138617|542155545|FG002|Overall Study|financial reason|0|||
150278333|NCT02138617|542155543|FG000|Overall Study|other therapy|3|||
150278334|NCT02138617|542155544|FG001|Overall Study|other therapy|4|||
150278335|NCT02138617|542155545|FG002|Overall Study|other therapy|0|||
150278336|NCT00702325|542155561|FG000|Overall Study|Adverse Event|1|||
150278337|NCT00702325|542155562|FG001|Overall Study|Adverse Event|0|||
150278338|NCT00702325|542155561|FG000|Overall Study|Withdrawal by Subject|7|||
150278339|NCT00702325|542155562|FG001|Overall Study|Withdrawal by Subject|7|||
150278340|NCT00702325|542155561|FG000|Overall Study|Lost to Follow-up|3|||
150278341|NCT00702325|542155562|FG001|Overall Study|Lost to Follow-up|4|||
150278342|NCT00702325|542155561|FG000|Overall Study|Incorrect enrollment|5|||
150278343|NCT00702325|542155562|FG001|Overall Study|Incorrect enrollment|7|||
150278344|NCT00702325|542155561|FG000|Overall Study|Developed study discontinuation criteria|18|||
150278345|NCT00702325|542155562|FG001|Overall Study|Developed study discontinuation criteria|28|||
150278346|NCT00702325|542155561|FG000|Overall Study|Severe noncompliance to protocol|3|||
150171073|NCT04517864|541763373|FG000|Active Therapy Extension Phase|Adverse Event|1|||
150171074|NCT04517864|541763374|FG001|Active Therapy Extension Phase|Adverse Event|0|||
150171075|NCT04517864|541763375|FG002|Active Therapy Extension Phase|Adverse Event|0|||
150171076|NCT04517864|541763373|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
150171077|NCT04517864|541763374|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
150171078|NCT04517864|541763375|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
150171079|NCT04517864|541763373|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
150171080|NCT04517864|541763374|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
150171081|NCT04517864|541763375|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
150171082|NCT04517864|541763373|FG000|Active Therapy Extension Phase|Physician Decision|1|||
150278347|NCT00702325|542155562|FG001|Overall Study|Severe noncompliance to protocol|3|||
150278348|NCT00702325|542155561|FG000|Overall Study|Termination due to lab results|1|||
150278349|NCT00702325|542155562|FG001|Overall Study|Termination due to lab results|0|||
150278350|NCT00702325|542155561|FG000|Overall Study|Didn't follow study medication dosage|0|||
150278351|NCT00702325|542155562|FG001|Overall Study|Didn't follow study medication dosage|2|||
150278352|NCT00702325|542155561|FG000|Overall Study|Withdrew consent|0|||
150278353|NCT00702325|542155562|FG001|Overall Study|Withdrew consent|1|||
150278354|NCT00702325|542155561|FG000|Overall Study|Incorrectly Discontinued|0|||
150278355|NCT00702325|542155562|FG001|Overall Study|Incorrectly Discontinued|1|||
150278356|NCT04556136|542155566|FG000|Overall Study|Lost to Follow-up|6|||
150278357|NCT04556136|542155567|FG001|Overall Study|Lost to Follow-up|6|||
150278358|NCT04556136|542155566|FG000|Overall Study|Physician Decision|2|||
150278359|NCT04556136|542155567|FG001|Overall Study|Physician Decision|1|||
150278360|NCT04556136|542155566|FG000|Overall Study|Withdrawal by Subject|2|||
150278361|NCT04556136|542155567|FG001|Overall Study|Withdrawal by Subject|1|||
150278362|NCT01022502|542155570|FG000|Overall Study|Adverse Event|1|||
150278363|NCT01022502|542155570|FG000|Overall Study|employment related reasons|1|||
150278364|NCT01022502|542155570|FG000|Overall Study|Withdrawal by Subject|1|||
150278365|NCT00073528|542155578|FG000|Overall Study|Death|488|||
150278366|NCT00073528|542155579|FG001|Overall Study|Death|473|||
150278367|NCT00073528|542155578|FG000|Overall Study|Lost to Follow-up|52|||
150278368|NCT00073528|542155579|FG001|Overall Study|Lost to Follow-up|45|||
150278369|NCT00073528|542155578|FG000|Overall Study|Withdrawal by Subject|50|||
150278370|NCT00073528|542155579|FG001|Overall Study|Withdrawal by Subject|45|||
150171083|NCT04517864|541763374|FG001|Active Therapy Extension Phase|Physician Decision|0|||
150171084|NCT04517864|541763375|FG002|Active Therapy Extension Phase|Physician Decision|0|||
150171085|NCT04517864|541763373|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
150171086|NCT04517864|541763374|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
150171087|NCT04517864|541763375|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
150171088|NCT04517864|541763373|FG000|Extension Phase|Adverse Event|0|||
150171089|NCT04517864|541763374|FG001|Extension Phase|Adverse Event|0|||
150171090|NCT04517864|541763375|FG002|Extension Phase|Adverse Event|1|||
150171091|NCT04517864|541763373|FG000|Extension Phase|Lack of Efficacy|0|||
150171092|NCT04517864|541763374|FG001|Extension Phase|Lack of Efficacy|0|||
150171093|NCT04517864|541763375|FG002|Extension Phase|Lack of Efficacy|2|||
150171094|NCT04517864|541763373|FG000|Extension Phase|Study Terminated By Sponsor|0|||
150171095|NCT04517864|541763374|FG001|Extension Phase|Study Terminated By Sponsor|0|||
150171096|NCT04517864|541763375|FG002|Extension Phase|Study Terminated By Sponsor|32|||
150171097|NCT04517864|541763373|FG000|Extension Phase|Withdrawal by Subject|0|||
150171098|NCT04517864|541763374|FG001|Extension Phase|Withdrawal by Subject|0|||
150171099|NCT04517864|541763375|FG002|Extension Phase|Withdrawal by Subject|3|||
150171100|NCT04517864|541763373|FG000|Extension Phase|Approved Drug Available for Indication|0|||
150171101|NCT04517864|541763374|FG001|Extension Phase|Approved Drug Available for Indication|0|||
150171102|NCT04517864|541763375|FG002|Extension Phase|Approved Drug Available for Indication|7|||
150171103|NCT01049503|541763376|FG000|Overall Study|Lost to Follow-up|11|||
150171104|NCT01049503|541763377|FG001|Overall Study|Lost to Follow-up|12|||
150171105|NCT01049503|541763378|FG002|Overall Study|Lost to Follow-up|24|||
150171106|NCT01049503|541763379|FG003|Overall Study|Lost to Follow-up|26|||
150171107|NCT01049503|541763380|FG004|Overall Study|Lost to Follow-up|27|||
150171108|NCT01049503|541763381|FG005|Overall Study|Lost to Follow-up|8|||
150278371|NCT00073528|542155578|FG000|Overall Study|Study terminated by Sponsor|10|||
150278372|NCT00073528|542155579|FG001|Overall Study|Study terminated by Sponsor|29|||
150278373|NCT00073528|542155578|FG000|Overall Study|Other|18|||
150278374|NCT00073528|542155579|FG001|Overall Study|Other|19|||
150171109|NCT03169244|541763382|FG000|Overall Study|Lost to Follow-up|1|||
150171110|NCT03169244|541763383|FG001|Overall Study|Lost to Follow-up|2|||
150278375|NCT00073528|542155578|FG000|Overall Study|Other|9|||
150278376|NCT00073528|542155579|FG001|Overall Study|Other|12|||
150278377|NCT00073528|542155578|FG000|Overall Study|Protocol Violation|3|||
150278378|NCT00073528|542155579|FG001|Overall Study|Protocol Violation|5|||
150278379|NCT00003702|542155582|FG000|Overall Study|Ineligible cell types|2|||
150278380|NCT00003702|542155583|FG001|Overall Study|Ineligible cell types|2|||
150278381|NCT00003702|542155582|FG000|Overall Study|Did not meet criteria for persistence|8|||
150278382|NCT00003702|542155583|FG001|Overall Study|Did not meet criteria for persistence|5|||
150278383|NCT00003702|542155582|FG000|Overall Study|WHO score > 6|2|||
150278384|NCT00003702|542155583|FG001|Overall Study|WHO score > 6|1|||
150278385|NCT00003702|542155582|FG000|Overall Study|Inadequate documentation of disease|1|||
150278386|NCT00003702|542155583|FG001|Overall Study|Inadequate documentation of disease|3|||
150278387|NCT02790138|542155584|FG000|Overall Study|Adverse Event|5|||
150278388|NCT02790138|542155585|FG001|Overall Study|Adverse Event|2|||
150278389|NCT02790138|542155584|FG000|Overall Study|Significant Protocol Deviation|0|||
150278390|NCT02790138|542155585|FG001|Overall Study|Significant Protocol Deviation|1|||
150278391|NCT02790138|542155584|FG000|Overall Study|Lost to Follow-up|1|||
150278392|NCT02790138|542155585|FG001|Overall Study|Lost to Follow-up|0|||
150278393|NCT02790138|542155584|FG000|Overall Study|Voluntary Withdrawal|8|||
150278394|NCT02790138|542155585|FG001|Overall Study|Voluntary Withdrawal|9|||
150278395|NCT02790138|542155584|FG000|Overall Study|Lack of Efficacy|6|||
150278396|NCT02790138|542155585|FG001|Overall Study|Lack of Efficacy|7|||
150278397|NCT02790138|542155584|FG000|Overall Study|Reason not Specified|1|||
150278398|NCT02790138|542155585|FG001|Overall Study|Reason not Specified|0|||
150278399|NCT03199040|542155586|FG000|Overall Study|Lack of Efficacy|2|||
150278400|NCT03199040|542155587|FG001|Overall Study|Lack of Efficacy|0|||
150278401|NCT03199040|542155586|FG000|Overall Study|Withdrawal by Subject|2|||
150278402|NCT03199040|542155587|FG001|Overall Study|Withdrawal by Subject|0|||
150278403|NCT03199040|542155586|FG000|Overall Study|Adverse Event|0|||
150278404|NCT03199040|542155587|FG001|Overall Study|Adverse Event|1|||
150278405|NCT03199040|542155586|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
150278406|NCT03199040|542155587|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
150278407|NCT01226459|542155588|FG000|Overall Study|Adverse Event|2|||
150278408|NCT01226459|542155589|FG001|Overall Study|Adverse Event|8|||
150278409|NCT01226459|542155588|FG000|Overall Study|Protocol Violation|4|||
150278410|NCT01226459|542155589|FG001|Overall Study|Protocol Violation|3|||
150278411|NCT01226459|542155588|FG000|Overall Study|Withdrawal by Subject|10|||
150278412|NCT01226459|542155589|FG001|Overall Study|Withdrawal by Subject|13|||
150278413|NCT01226459|542155588|FG000|Overall Study|Lost to Follow-up|4|||
150278414|NCT01226459|542155589|FG001|Overall Study|Lost to Follow-up|8|||
150278415|NCT01226459|542155588|FG000|Overall Study|Pregnancy|1|||
150278416|NCT01226459|542155589|FG001|Overall Study|Pregnancy|0|||
150278417|NCT00474708|542155590|FG000|Overall Study|Lack of Efficacy|11|||
150278418|NCT00474708|542155591|FG001|Overall Study|Lack of Efficacy|5|||
150278419|NCT00474708|542155590|FG000|Overall Study|Suicide ideation/behavior|0|||
150278420|NCT00474708|542155591|FG001|Overall Study|Suicide ideation/behavior|1|||
150278421|NCT00474708|542155590|FG000|Overall Study|Withdrawal by Subject|7|||
150278422|NCT00474708|542155591|FG001|Overall Study|Withdrawal by Subject|0|||
150278423|NCT00474708|542155590|FG000|Overall Study|Lack of compliance|12|||
150278424|NCT00474708|542155591|FG001|Overall Study|Lack of compliance|4|||
150278425|NCT00474708|542155590|FG000|Overall Study|Lost to Follow-up|18|||
150278426|NCT00474708|542155591|FG001|Overall Study|Lost to Follow-up|9|||
150278427|NCT00474708|542155590|FG000|Overall Study|Physician Decision|9|||
150278428|NCT00474708|542155591|FG001|Overall Study|Physician Decision|6|||
150278429|NCT00698997|542155597|FG000|Overall Study|Lost to Follow-up|3|||
150278430|NCT00698997|542155598|FG001|Overall Study|Lost to Follow-up|0|||
150278431|NCT00698997|542155597|FG000|Overall Study|Withdrawal by Subject|7|||
150278432|NCT00698997|542155598|FG001|Overall Study|Withdrawal by Subject|27|||
150278433|NCT00475722|542155599|FG000|Overall Study|Withdrawal by Subject|12|||
150278434|NCT00475722|542155600|FG001|Overall Study|Withdrawal by Subject|12|||
150278435|NCT00475722|542155599|FG000|Overall Study|Protocol Violation|3|||
150278436|NCT00475722|542155600|FG001|Overall Study|Protocol Violation|0|||
150278437|NCT01889238|542155601|FG000|Overall Study|Death|1|||
150278438|NCT01889238|542155601|FG000|Overall Study|Withdrawal by Subject|1|||
150278439|NCT01889238|542155601|FG000|Overall Study|Adverse Event|6|||
150278440|NCT01889238|542155601|FG000|Overall Study|Disease Progression|104|||
150278441|NCT01889238|542155601|FG000|Overall Study|Other|6|||
150278442|NCT00574145|542157089|FG000|Overall Study|Withdrawal by Subject|2|||
150278443|NCT00574145|542157090|FG001|Overall Study|Withdrawal by Subject|1|||
150278444|NCT03227471|542157091|FG000|Overall Study|Withdrawal by Subject|0|||
150278445|NCT03227471|542157092|FG001|Overall Study|Withdrawal by Subject|0|||
150278446|NCT03227471|542157093|FG002|Overall Study|Withdrawal by Subject|0|||
150278447|NCT03227471|542157094|FG003|Overall Study|Withdrawal by Subject|0|||
149830970|NCT00864097|540511355|FG001|Overall Study|Adverse Event|8|||
150278448|NCT03227471|542157095|FG004|Overall Study|Withdrawal by Subject|1|||
150278449|NCT03227471|542157096|FG005|Overall Study|Withdrawal by Subject|0|||
150278450|NCT03227471|542157097|FG006|Overall Study|Withdrawal by Subject|0|||
150278451|NCT03227471|542157098|FG007|Overall Study|Withdrawal by Subject|0|||
150278452|NCT03227471|542157099|FG008|Overall Study|Withdrawal by Subject|0|||
150278453|NCT03227471|542157100|FG009|Overall Study|Withdrawal by Subject|0|||
150278454|NCT03227471|542157101|FG010|Overall Study|Withdrawal by Subject|0|||
150278455|NCT03227471|542157102|FG011|Overall Study|Withdrawal by Subject|0|||
150278456|NCT03227471|542157103|FG012|Overall Study|Withdrawal by Subject|1|||
150278457|NCT03227471|542157104|FG013|Overall Study|Withdrawal by Subject|0|||
150278458|NCT03227471|542157105|FG014|Overall Study|Withdrawal by Subject|0|||
150278459|NCT03227471|542157091|FG000|Overall Study|Randomized, Never Dosed|0|||
150278460|NCT03227471|542157092|FG001|Overall Study|Randomized, Never Dosed|0|||
150278461|NCT03227471|542157093|FG002|Overall Study|Randomized, Never Dosed|0|||
150278462|NCT03227471|542157094|FG003|Overall Study|Randomized, Never Dosed|0|||
150278463|NCT03227471|542157095|FG004|Overall Study|Randomized, Never Dosed|0|||
150278464|NCT03227471|542157096|FG005|Overall Study|Randomized, Never Dosed|0|||
150278465|NCT03227471|542157097|FG006|Overall Study|Randomized, Never Dosed|0|||
150278466|NCT03227471|542157098|FG007|Overall Study|Randomized, Never Dosed|0|||
150278467|NCT03227471|542157099|FG008|Overall Study|Randomized, Never Dosed|0|||
150278468|NCT03227471|542157100|FG009|Overall Study|Randomized, Never Dosed|0|||
150278469|NCT03227471|542157101|FG010|Overall Study|Randomized, Never Dosed|0|||
150278470|NCT03227471|542157102|FG011|Overall Study|Randomized, Never Dosed|0|||
150278471|NCT03227471|542157103|FG012|Overall Study|Randomized, Never Dosed|0|||
150278472|NCT03227471|542157104|FG013|Overall Study|Randomized, Never Dosed|0|||
150278473|NCT03227471|542157105|FG014|Overall Study|Randomized, Never Dosed|1|||
150278474|NCT00449670|542157106|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
150278475|NCT00449670|542157107|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
150278476|NCT00449670|542157106|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
150278477|NCT00449670|542157107|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
150278478|NCT00449670|542157106|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
150278479|NCT00449670|542157107|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
150278480|NCT00449670|542157106|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
150278481|NCT00449670|542157107|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
150278482|NCT00449670|542157106|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
150278483|NCT00449670|542157107|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
150278484|NCT00449670|542157106|FG000|Booster Phase (Study no.109873)|Other|0|||
150278485|NCT00449670|542157107|FG001|Booster Phase (Study no.109873)|Other|2|||
150278486|NCT04183790|542157108|FG000|Overall Study|Participants did not rollover to Part B|12|||
150278487|NCT04183790|542157109|FG001|Overall Study|Participants did not rollover to Part B|0|||
150278488|NCT04183790|542157108|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
150278489|NCT04183790|542157109|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
150278490|NCT04183790|542157108|FG000|Overall Study|Commercial drug is available for participant|6|||
150278491|NCT04183790|542157109|FG001|Overall Study|Commercial drug is available for participant|0|||
150278492|NCT04183790|542157108|FG000|Overall Study|Adverse Event|1|||
150278493|NCT04183790|542157109|FG001|Overall Study|Adverse Event|0|||
150278494|NCT04183790|542157108|FG000|Overall Study|Not enrolled in 107 study|0|||
150278495|NCT04183790|542157109|FG001|Overall Study|Not enrolled in 107 study|2|||
150278496|NCT01251653|542157110|FG000|Overall Study|Progressive Disease|1|||
150278497|NCT01251653|542157111|FG001|Overall Study|Progressive Disease|7|||
150278498|NCT01251653|542157112|FG002|Overall Study|Progressive Disease|16|||
150278499|NCT01251653|542157113|FG003|Overall Study|Progressive Disease|4|||
150278500|NCT01251653|542157114|FG004|Overall Study|Progressive Disease|0|||
150278501|NCT01251653|542157115|FG005|Overall Study|Progressive Disease|17|||
150278502|NCT01251653|542157116|FG006|Overall Study|Progressive Disease|14|||
150278503|NCT01251653|542157117|FG007|Overall Study|Progressive Disease|7|||
150278504|NCT01251653|542157118|FG008|Overall Study|Progressive Disease|5|||
150278505|NCT01251653|542157110|FG000|Overall Study|Dose-limiting toxicity|0|||
150278506|NCT01251653|542157111|FG001|Overall Study|Dose-limiting toxicity|1|||
150278507|NCT01251653|542157112|FG002|Overall Study|Dose-limiting toxicity|1|||
150278508|NCT01251653|542157113|FG003|Overall Study|Dose-limiting toxicity|1|||
150278509|NCT01251653|542157114|FG004|Overall Study|Dose-limiting toxicity|0|||
150278510|NCT01251653|542157115|FG005|Overall Study|Dose-limiting toxicity|0|||
150278511|NCT01251653|542157116|FG006|Overall Study|Dose-limiting toxicity|2|||
150278512|NCT01251653|542157117|FG007|Overall Study|Dose-limiting toxicity|0|||
150278513|NCT01251653|542157118|FG008|Overall Study|Dose-limiting toxicity|0|||
150278514|NCT01251653|542157110|FG000|Overall Study|Adverse Event|1|||
150278515|NCT01251653|542157111|FG001|Overall Study|Adverse Event|0|||
150278516|NCT01251653|542157112|FG002|Overall Study|Adverse Event|2|||
150278517|NCT01251653|542157113|FG003|Overall Study|Adverse Event|1|||
150278518|NCT01251653|542157114|FG004|Overall Study|Adverse Event|1|||
150034007|NCT00656513|541264680|FG002|Overall Study|Death|1|||
150278519|NCT01251653|542157115|FG005|Overall Study|Adverse Event|0|||
150278520|NCT01251653|542157116|FG006|Overall Study|Adverse Event|2|||
150278521|NCT01251653|542157117|FG007|Overall Study|Adverse Event|2|||
150278522|NCT01251653|542157118|FG008|Overall Study|Adverse Event|1|||
150278523|NCT01251653|542157110|FG000|Overall Study|Withdrawal by Subject|1|||
150278524|NCT01251653|542157111|FG001|Overall Study|Withdrawal by Subject|0|||
150278525|NCT01251653|542157112|FG002|Overall Study|Withdrawal by Subject|1|||
150278526|NCT01251653|542157113|FG003|Overall Study|Withdrawal by Subject|0|||
150278527|NCT01251653|542157114|FG004|Overall Study|Withdrawal by Subject|1|||
150278528|NCT01251653|542157115|FG005|Overall Study|Withdrawal by Subject|1|||
150278529|NCT01251653|542157116|FG006|Overall Study|Withdrawal by Subject|0|||
150278530|NCT01251653|542157117|FG007|Overall Study|Withdrawal by Subject|1|||
150278531|NCT01251653|542157118|FG008|Overall Study|Withdrawal by Subject|0|||
150278532|NCT01251653|542157110|FG000|Overall Study|Other reason not mentioned above|0|||
149830971|NCT00864097|540511356|FG002|Overall Study|Adverse Event|11|||
149830972|NCT00864097|540511357|FG003|Overall Study|Adverse Event|9|||
150278533|NCT01251653|542157111|FG001|Overall Study|Other reason not mentioned above|0|||
150278534|NCT01251653|542157112|FG002|Overall Study|Other reason not mentioned above|0|||
150278535|NCT01251653|542157113|FG003|Overall Study|Other reason not mentioned above|0|||
150278536|NCT01251653|542157114|FG004|Overall Study|Other reason not mentioned above|0|||
150278537|NCT01251653|542157115|FG005|Overall Study|Other reason not mentioned above|0|||
150278538|NCT01251653|542157116|FG006|Overall Study|Other reason not mentioned above|0|||
150278539|NCT01251653|542157117|FG007|Overall Study|Other reason not mentioned above|2|||
150278540|NCT01251653|542157118|FG008|Overall Study|Other reason not mentioned above|0|||
150278541|NCT03197493|542157119|FG000|Overall Study|Withdrawal by Subject|5|||
150278542|NCT00176605|542157122|FG000|Overall Study|Withdrawal by Subject|2|||
150278543|NCT00833053|542157123|FG000|Overall Study|Adverse Event|4|||
150278544|NCT00833053|542157124|FG001|Overall Study|Adverse Event|0|||
150278545|NCT00833053|542157123|FG000|Overall Study|Treatment Failure|3|||
150278546|NCT00833053|542157124|FG001|Overall Study|Treatment Failure|1|||
150278547|NCT00833053|542157123|FG000|Overall Study|Withdrawal by Subject|0|||
150278548|NCT00833053|542157124|FG001|Overall Study|Withdrawal by Subject|1|||
150278549|NCT00833053|542157123|FG000|Overall Study|Protocol Violation|2|||
150278550|NCT00833053|542157124|FG001|Overall Study|Protocol Violation|1|||
150278551|NCT01033734|542157125|FG000|Overall Study|Withdrawal by Subject|1|||
150278552|NCT02865018|542157126|FG000|Overall Study|Withdrawal by Subject|1|||
150278553|NCT00139776|542157127|FG000|Period I|Did not enter Period II|575|||
150278554|NCT00139776|542157128|FG001|Period I|Did not enter Period II|0|||
150278555|NCT00139776|542157129|FG002|Period I|Did not enter Period II|0|||
150278556|NCT00139776|542157130|FG003|Period I|Did not enter Period II|0|||
150278557|NCT00139776|542157127|FG000|Period II|Not Randomized into Period III|0|||
150278558|NCT00139776|542157128|FG001|Period II|Not Randomized into Period III|322|||
150278559|NCT00139776|542157129|FG002|Period II|Not Randomized into Period III|0|||
150278560|NCT00139776|542157130|FG003|Period II|Not Randomized into Period III|0|||
150278561|NCT00139776|542157127|FG000|Period III|Adverse Event|0|||
150278562|NCT00139776|542157128|FG001|Period III|Adverse Event|0|||
150278563|NCT00139776|542157129|FG002|Period III|Adverse Event|22|||
150278564|NCT00139776|542157130|FG003|Period III|Adverse Event|23|||
150278565|NCT00139776|542157127|FG000|Period III|Other|0|||
150278566|NCT00139776|542157128|FG001|Period III|Other|0|||
150278567|NCT00139776|542157129|FG002|Period III|Other|23|||
150278568|NCT00139776|542157130|FG003|Period III|Other|34|||
150278569|NCT00139776|542157127|FG000|Period III|Lack of Efficacy|0|||
150278570|NCT00139776|542157128|FG001|Period III|Lack of Efficacy|0|||
150278571|NCT00139776|542157129|FG002|Period III|Lack of Efficacy|10|||
150278572|NCT00139776|542157130|FG003|Period III|Lack of Efficacy|24|||
150278573|NCT00139776|542157127|FG000|Period III|Lost to Follow-up|0|||
150278574|NCT00139776|542157128|FG001|Period III|Lost to Follow-up|0|||
150278575|NCT00139776|542157129|FG002|Period III|Lost to Follow-up|5|||
150278576|NCT00139776|542157130|FG003|Period III|Lost to Follow-up|4|||
150278577|NCT00139776|542157127|FG000|Period III|Withdrawal by Subject|0|||
150278578|NCT00139776|542157128|FG001|Period III|Withdrawal by Subject|0|||
150278579|NCT00139776|542157129|FG002|Period III|Withdrawal by Subject|16|||
150278580|NCT00139776|542157130|FG003|Period III|Withdrawal by Subject|21|||
150278581|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
150278582|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
150278583|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
150278584|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
149830973|NCT00864097|540511354|FG000|Overall Study|Lack of Efficacy|9|||
150034008|NCT00656513|541264678|FG000|Overall Study|Missing data|0|||
150278585|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
150278586|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
150278587|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
150278588|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
150278589|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
150278590|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
150278591|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
150278592|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
150278593|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
150278594|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
150278595|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
150278596|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
150278597|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
150278598|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
149830974|NCT00864097|540511355|FG001|Overall Study|Lack of Efficacy|3|||
150278599|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
150278600|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
150278601|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
150278602|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
150278603|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
150278604|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
150278605|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
150278606|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
150278607|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
150278608|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
150278609|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
150278610|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
149830975|NCT00864097|540511356|FG002|Overall Study|Lack of Efficacy|7|||
149830976|NCT00864097|540511357|FG003|Overall Study|Lack of Efficacy|2|||
149948540|NCT04190225|540944770|FG000|Overall Study|Lost to Follow-up|2|||
149948541|NCT04190225|540944771|FG001|Overall Study|Lost to Follow-up|3|||
149948542|NCT04190225|540944770|FG000|Overall Study|Withdrawal by Subject|3|||
149948543|NCT04190225|540944771|FG001|Overall Study|Withdrawal by Subject|2|||
149948544|NCT04190225|540944770|FG000|Overall Study|Unrelated health condition|2|||
150278611|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278612|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
150278613|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
150278614|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
150278615|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278616|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
150278617|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
150278618|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
150278619|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
150278620|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
150278621|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
150278622|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
150278623|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
150278624|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
150278625|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
150278626|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
150278627|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
150278628|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
150278629|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
150278630|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
150278631|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
150278632|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
150278633|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
150278634|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
150278635|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
150278636|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
150278637|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
150278638|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
150278639|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
150278640|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
150278641|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
150278642|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
150278643|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
150278644|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
150278645|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
150278646|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
150278647|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
150278648|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
150278649|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
150278650|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
150278651|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
150278652|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
150278653|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
150278654|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
150278655|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
150278656|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
150278657|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
150278658|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
150278659|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
150278660|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
150278661|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
150278662|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
150278663|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
150278664|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
150278665|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
150278666|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149948545|NCT04190225|540944771|FG001|Overall Study|Unrelated health condition|0|||
150278667|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
150278668|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
150278669|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
150278670|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
150278671|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
150278672|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
150278673|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
150278674|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
150278675|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
150278676|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
150278677|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
150278678|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
150278679|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
150278680|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
150278681|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
150278682|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
150278683|NCT00111800|542157134|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
150278684|NCT00111800|542157135|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
150278685|NCT00111800|542157136|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
150278686|NCT00111800|542157137|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
150278687|NCT00111800|542157138|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
150278688|NCT00111800|542157139|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
150278689|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
150278690|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
150278691|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
150278692|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
150278693|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
150278694|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
150278695|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
150278696|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
150278697|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
150278698|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
150278699|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
150278700|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
150278701|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
150278702|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
150278703|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
150278704|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
150278705|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
150278706|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
150278707|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
150278708|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
150278709|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
150278710|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
150278711|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
150278712|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
150278713|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278714|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278715|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
150278716|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278717|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150278718|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
150171111|NCT03169244|541763382|FG000|Overall Study|Adverse Event|1|||
150171112|NCT03169244|541763383|FG001|Overall Study|Adverse Event|0|||
150171113|NCT03169244|541763382|FG000|Overall Study|Withdrawal by Subject|2|||
150171114|NCT03169244|541763383|FG001|Overall Study|Withdrawal by Subject|2|||
150171115|NCT03169244|541763382|FG000|Overall Study|Physician Decision|1|||
150171116|NCT03169244|541763383|FG001|Overall Study|Physician Decision|0|||
150171117|NCT02577523|541763387|FG000|Overall Study|Adverse Event|1|||
150171118|NCT02577523|541763388|FG001|Overall Study|Adverse Event|1|||
150171119|NCT02577523|541763387|FG000|Overall Study|Lack of Efficacy|1|||
150171120|NCT02577523|541763388|FG001|Overall Study|Lack of Efficacy|1|||
150278719|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
150278720|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
150278721|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
150278722|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
150278723|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
150278724|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
150278725|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
150278726|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
150278727|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
150278728|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
150278729|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
150278730|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
150278731|NCT00111800|542157134|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
150278732|NCT00111800|542157135|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
150278733|NCT00111800|542157136|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
150278734|NCT00111800|542157137|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
150278735|NCT00111800|542157138|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
150278736|NCT00111800|542157139|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
150278737|NCT00971178|542157142|FG000|Overall Study|Lost to Follow-up|2|||
150278738|NCT00971178|542157143|FG001|Overall Study|Lost to Follow-up|2|||
150278739|NCT00971178|542157144|FG002|Overall Study|Lost to Follow-up|2|||
150278740|NCT00326209|542157145|FG000|Overall Study|Adverse Event|28|||
150278741|NCT00326209|542157145|FG000|Overall Study|Withdrawal by Subject|22|||
150278742|NCT00326209|542157145|FG000|Overall Study|Lack of Efficacy|31|||
150278743|NCT00326209|542157145|FG000|Overall Study|Lost to Follow-up|18|||
150278744|NCT00326209|542157145|FG000|Overall Study|Participant non-compliant|6|||
150278745|NCT00326209|542157145|FG000|Overall Study|Sponsor closed study|173|||
150278746|NCT00326209|542157145|FG000|Overall Study|Prohibited medication use|1|||
150278747|NCT00326209|542157145|FG000|Overall Study|Violation of entry criteria|1|||
150278748|NCT00326209|542157145|FG000|Overall Study|Withdrawn in error|1|||
150278749|NCT00326209|542157145|FG000|Overall Study|Pregnancy|1|||
150278750|NCT04109222|542157146|FG000|Overall Study|Adverse Event|1|||
150278751|NCT04109222|542157147|FG001|Overall Study|Adverse Event|0|||
150278752|NCT04109222|542157148|FG002|Overall Study|Adverse Event|0|||
150278753|NCT02577406|542157149|FG000|Randomized Period|Death|1|||
150278754|NCT02577406|542157150|FG001|Randomized Period|Death|0|||
150278755|NCT02577406|542157149|FG000|Randomized Period|Other reasons|0|||
150278756|NCT02577406|542157150|FG001|Randomized Period|Other reasons|20|||
150278757|NCT02577406|542157149|FG000|Treatment Period|Death|38|||
150278758|NCT02577406|542157150|FG001|Treatment Period|Death|23|||
150278759|NCT02577406|542157149|FG000|Treatment Period|Adverse Event|17|||
150278760|NCT02577406|542157150|FG001|Treatment Period|Adverse Event|12|||
150278761|NCT02577406|542157149|FG000|Treatment Period|Progressive Disease|53|||
150278762|NCT02577406|542157150|FG001|Treatment Period|Progressive Disease|37|||
150278763|NCT02577406|542157149|FG000|Treatment Period|Withdrawal by Subject|10|||
150278764|NCT02577406|542157150|FG001|Treatment Period|Withdrawal by Subject|24|||
150278765|NCT02577406|542157149|FG000|Treatment Period|Lost to Follow-up|0|||
150278766|NCT02577406|542157150|FG001|Treatment Period|Lost to Follow-up|1|||
150278767|NCT02577406|542157149|FG000|Treatment Period|Transition to commercially available treatment|1|||
150278768|NCT02577406|542157150|FG001|Treatment Period|Transition to commercially available treatment|1|||
150278769|NCT02577406|542157149|FG000|Treatment Period|Physician Decision|1|||
150278770|NCT02577406|542157150|FG001|Treatment Period|Physician Decision|0|||
150278771|NCT02577406|542157149|FG000|Treatment Period|Disease Relapse|28|||
150278772|NCT02577406|542157150|FG001|Treatment Period|Disease Relapse|1|||
150278773|NCT02577406|542157149|FG000|Treatment Period|Protocol Violation|0|||
150278774|NCT02577406|542157150|FG001|Treatment Period|Protocol Violation|1|||
150278775|NCT02577406|542157149|FG000|Treatment Period|Other Reasons|3|||
150278776|NCT02577406|542157150|FG001|Treatment Period|Other Reasons|39|||
150278777|NCT02577406|542157149|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
150278778|NCT02577406|542157150|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
150278779|NCT01111851|542157156|FG000|Overall Study|All planned PET scans were not obtained.|2|||
150278780|NCT01111851|542157157|FG001|Overall Study|All planned PET scans were not obtained.|0|||
150278781|NCT05807464|542157158|FG000|Overall Study|Adverse Event|1|||
150278782|NCT01816061|542157160|FG000|Overall Study|Lost to Follow-up|13|||
150278783|NCT01816061|542157161|FG001|Overall Study|Lost to Follow-up|24|||
150278784|NCT01961349|542157162|FG000|Overall Study|Withdrawal by Subject|1|||
150278785|NCT01961349|542157163|FG001|Overall Study|Withdrawal by Subject|4|||
150278786|NCT01961349|542157164|FG002|Overall Study|Withdrawal by Subject|0|||
150278787|NCT01961349|542157162|FG000|Overall Study|Adverse Event|0|||
150278788|NCT01961349|542157163|FG001|Overall Study|Adverse Event|0|||
150278789|NCT01961349|542157164|FG002|Overall Study|Adverse Event|1|||
150278790|NCT01961349|542157162|FG000|Overall Study|registration error, personal reason etc|2|||
150278791|NCT01961349|542157163|FG001|Overall Study|registration error, personal reason etc|2|||
150278792|NCT01961349|542157164|FG002|Overall Study|registration error, personal reason etc|1|||
150278793|NCT05525689|542157166|FG000|Overall Study|Lost to Follow-up|1|||
150278794|NCT05525689|542157167|FG001|Overall Study|Lost to Follow-up|0|||
150278795|NCT01671111|542157170|FG000|Overall Study|Adverse Event|2|||
150278796|NCT01671111|542157170|FG000|Overall Study|Lack of Efficacy|1|||
150278797|NCT01671111|542157170|FG000|Overall Study|Withdrawal by Subject|2|||
150278798|NCT01671111|542157170|FG000|Overall Study|Physician Decision|1|||
150278799|NCT01671111|542157170|FG000|Overall Study|Other|24|||
150278800|NCT02343159|542157171|FG000|Overall Study|Early Study Termination|16|||
150278801|NCT02343159|542157172|FG001|Overall Study|Early Study Termination|19|||
150278802|NCT02343159|542157173|FG002|Overall Study|Early Study Termination|23|||
150278803|NCT02343159|542157171|FG000|Overall Study|Physician Decision|2|||
150278804|NCT02343159|542157172|FG001|Overall Study|Physician Decision|0|||
150278805|NCT02343159|542157173|FG002|Overall Study|Physician Decision|1|||
150278806|NCT02343159|542157171|FG000|Overall Study|Withdrawal by Subject|3|||
150278807|NCT02343159|542157172|FG001|Overall Study|Withdrawal by Subject|0|||
150278808|NCT02343159|542157173|FG002|Overall Study|Withdrawal by Subject|2|||
150278809|NCT02343159|542157171|FG000|Overall Study|Lost to Follow-up|0|||
150278810|NCT02343159|542157172|FG001|Overall Study|Lost to Follow-up|2|||
150278811|NCT02343159|542157173|FG002|Overall Study|Lost to Follow-up|2|||
150278812|NCT02343159|542157171|FG000|Overall Study|Adverse Event|4|||
150278813|NCT02343159|542157172|FG001|Overall Study|Adverse Event|4|||
150278814|NCT02343159|542157173|FG002|Overall Study|Adverse Event|2|||
150278815|NCT02343159|542157171|FG000|Overall Study|Sponsor Decision|0|||
150278816|NCT02343159|542157172|FG001|Overall Study|Sponsor Decision|1|||
150278817|NCT02343159|542157173|FG002|Overall Study|Sponsor Decision|0|||
150278818|NCT02343159|542157171|FG000|Overall Study|Enrollment Error|1|||
150278819|NCT02343159|542157172|FG001|Overall Study|Enrollment Error|0|||
150278820|NCT02343159|542157173|FG002|Overall Study|Enrollment Error|0|||
150278821|NCT01092143|542157178|FG000|Overall Study|Adverse Event|10|||
150278822|NCT01092143|542157179|FG001|Overall Study|Adverse Event|5|||
150278823|NCT01092143|542157180|FG002|Overall Study|Adverse Event|1|||
150278824|NCT01092143|542157181|FG003|Overall Study|Adverse Event|4|||
150278825|NCT01092143|542157182|FG004|Overall Study|Adverse Event|3|||
150278826|NCT01092143|542157178|FG000|Overall Study|Lost to Follow-up|1|||
150278827|NCT01092143|542157179|FG001|Overall Study|Lost to Follow-up|0|||
150278828|NCT01092143|542157180|FG002|Overall Study|Lost to Follow-up|1|||
150278829|NCT01092143|542157181|FG003|Overall Study|Lost to Follow-up|0|||
150278830|NCT01092143|542157182|FG004|Overall Study|Lost to Follow-up|0|||
150278831|NCT01092143|542157178|FG000|Overall Study|Consent withdrawn|2|||
150278832|NCT01092143|542157179|FG001|Overall Study|Consent withdrawn|1|||
150278833|NCT01092143|542157180|FG002|Overall Study|Consent withdrawn|0|||
150278834|NCT01092143|542157181|FG003|Overall Study|Consent withdrawn|1|||
150278835|NCT01092143|542157182|FG004|Overall Study|Consent withdrawn|3|||
150278836|NCT01092143|542157178|FG000|Overall Study|Not treated|0|||
150278837|NCT01092143|542157179|FG001|Overall Study|Not treated|0|||
150278838|NCT01092143|542157180|FG002|Overall Study|Not treated|1|||
150278839|NCT01092143|542157181|FG003|Overall Study|Not treated|0|||
150278840|NCT01092143|542157182|FG004|Overall Study|Not treated|0|||
150278841|NCT01092143|542157178|FG000|Overall Study|did not reversibility criteria|0|||
150278842|NCT01092143|542157179|FG001|Overall Study|did not reversibility criteria|0|||
150278843|NCT01092143|542157180|FG002|Overall Study|did not reversibility criteria|1|||
150278844|NCT01092143|542157181|FG003|Overall Study|did not reversibility criteria|0|||
150278845|NCT01092143|542157182|FG004|Overall Study|did not reversibility criteria|0|||
150278846|NCT01092143|542157178|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
150278847|NCT01092143|542157179|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
150278848|NCT01092143|542157180|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
150278849|NCT01092143|542157181|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
150278850|NCT01092143|542157182|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
150278851|NCT01092143|542157178|FG000|Overall Study|Ineligible patient|1|||
150278852|NCT01092143|542157179|FG001|Overall Study|Ineligible patient|0|||
150278853|NCT01092143|542157180|FG002|Overall Study|Ineligible patient|0|||
150278854|NCT01092143|542157181|FG003|Overall Study|Ineligible patient|0|||
150278855|NCT01092143|542157182|FG004|Overall Study|Ineligible patient|0|||
150278856|NCT01092143|542157178|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
150278857|NCT01092143|542157179|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
150278858|NCT01092143|542157180|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
150278859|NCT01092143|542157181|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
150278860|NCT01092143|542157182|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
150278861|NCT01092143|542157178|FG000|Overall Study|Patient travel|0|||
150278862|NCT01092143|542157179|FG001|Overall Study|Patient travel|0|||
150278863|NCT01092143|542157180|FG002|Overall Study|Patient travel|0|||
150278864|NCT01092143|542157181|FG003|Overall Study|Patient travel|0|||
150278865|NCT01092143|542157182|FG004|Overall Study|Patient travel|1|||
150278866|NCT01092143|542157178|FG000|Overall Study|Non compliance with study medication|0|||
150278867|NCT01092143|542157179|FG001|Overall Study|Non compliance with study medication|0|||
150278868|NCT01092143|542157180|FG002|Overall Study|Non compliance with study medication|0|||
150278869|NCT01092143|542157181|FG003|Overall Study|Non compliance with study medication|0|||
150278870|NCT01092143|542157182|FG004|Overall Study|Non compliance with study medication|1|||
150278871|NCT01092143|542157178|FG000|Overall Study|Randomized by mistake|0|||
150278872|NCT01092143|542157179|FG001|Overall Study|Randomized by mistake|0|||
150278873|NCT01092143|542157180|FG002|Overall Study|Randomized by mistake|0|||
150278874|NCT01092143|542157181|FG003|Overall Study|Randomized by mistake|1|||
150278875|NCT01092143|542157182|FG004|Overall Study|Randomized by mistake|0|||
150278876|NCT01092143|542157178|FG000|Overall Study|Pregnancy|0|||
150278877|NCT01092143|542157179|FG001|Overall Study|Pregnancy|0|||
150278878|NCT01092143|542157180|FG002|Overall Study|Pregnancy|0|||
150278879|NCT01092143|542157181|FG003|Overall Study|Pregnancy|1|||
150278880|NCT01092143|542157182|FG004|Overall Study|Pregnancy|0|||
150278881|NCT01506960|542157183|FG000|Overall Study|Did not meet angiographic criteria|47|||
150278882|NCT01846624|542157184|FG000|Overall Study|Died during induction, no midostaurin|1|||
150278883|NCT04702737|542157185|FG000|Overall Study|Decision by Sponsor|1|||
150278884|NCT04702737|542157185|FG000|Overall Study|Withdrawal of Consent from Study|3|||
150278885|NCT04702737|542157185|FG000|Overall Study|Lost to Follow-up|1|||
150278886|NCT04702737|542157185|FG000|Overall Study|Death|35|||
150278887|NCT03574753|542157186|FG000|Overall Study|Adverse Event|3|||
150278888|NCT03574753|542157186|FG000|Overall Study|Progression/relapse|19|||
150278889|NCT03574753|542157186|FG000|Overall Study|Death|1|||
150278890|NCT01177683|542157187|FG000|Study Treatment|Disease Progressions during treatment|2|||
150278891|NCT01177683|542157188|FG001|Study Treatment|Disease Progressions during treatment|0|||
150278892|NCT01177683|542157189|FG002|Study Treatment|Disease Progressions during treatment|3|||
150278893|NCT01177683|542157187|FG000|Study Treatment|Adverse Event|0|||
150278894|NCT01177683|542157188|FG001|Study Treatment|Adverse Event|1|||
150278895|NCT01177683|542157189|FG002|Study Treatment|Adverse Event|12|||
150278896|NCT01177683|542157187|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
150278897|NCT01177683|542157188|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
150278898|NCT01177683|542157189|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
150278899|NCT01177683|542157187|FG000|Study Treatment|Alternative therapy|0|||
150278900|NCT01177683|542157188|FG001|Study Treatment|Alternative therapy|0|||
150278901|NCT01177683|542157189|FG002|Study Treatment|Alternative therapy|4|||
150278902|NCT01177683|542157187|FG000|Study Treatment|Physician Decision|1|||
150278903|NCT01177683|542157188|FG001|Study Treatment|Physician Decision|0|||
150278904|NCT01177683|542157189|FG002|Study Treatment|Physician Decision|1|||
150278905|NCT01177683|542157187|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
150278906|NCT01177683|542157188|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
150278907|NCT01177683|542157189|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
150278908|NCT01177683|542157187|FG000|Study Treatment|Symptomatic Deterioration|0|||
150278909|NCT01177683|542157188|FG001|Study Treatment|Symptomatic Deterioration|0|||
150278910|NCT01177683|542157189|FG002|Study Treatment|Symptomatic Deterioration|1|||
150278911|NCT01177683|542157187|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
150278912|NCT01177683|542157188|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
150278913|NCT01177683|542157189|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
150278914|NCT01177683|542157187|FG000|Follow up|Patient lost to follow up|0|||
150278915|NCT01177683|542157188|FG001|Follow up|Patient lost to follow up|0|||
150278916|NCT01177683|542157189|FG002|Follow up|Patient lost to follow up|2|||
150278917|NCT01177683|542157187|FG000|Follow up|Death|2|||
150278918|NCT01177683|542157188|FG001|Follow up|Death|1|||
150278919|NCT01177683|542157189|FG002|Follow up|Death|7|||
150278920|NCT01177683|542157187|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
150278921|NCT01177683|542157188|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
150278922|NCT01177683|542157189|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
150278923|NCT00427349|542157193|FG000|Overall Study|Lack of Efficacy|23|||
150278924|NCT00427349|542157193|FG000|Overall Study|Adverse Event|14|||
150278925|NCT00427349|542157193|FG000|Overall Study|Death|1|||
150278926|NCT00427349|542157193|FG000|Overall Study|Withdrawal by Subject|3|||
150278927|NCT00427349|542157193|FG000|Overall Study|Alternative therapy|1|||
150278928|NCT00427349|542157193|FG000|Overall Study|Other|2|||
150278929|NCT00427349|542157193|FG000|Overall Study|Ineligible|1|||
150278930|NCT00427349|542157193|FG000|Overall Study|Never started therapy|1|||
150278931|NCT01977820|542157196|FG000|Overall Study|Sponsor terminated the study|1|||
150278932|NCT01977820|542157197|FG001|Overall Study|Sponsor terminated the study|1|||
150278933|NCT02568475|542157201|FG000|Overall Study|Lost to Follow-up|40|||
150278934|NCT02568475|542157202|FG001|Overall Study|Lost to Follow-up|39|||
150278935|NCT02568475|542157201|FG000|Overall Study|Withdrawal by Subject|2|||
150278936|NCT02568475|542157202|FG001|Overall Study|Withdrawal by Subject|0|||
150278937|NCT02568475|542157201|FG000|Overall Study|Discharged home|4|||
150278938|NCT02568475|542157202|FG001|Overall Study|Discharged home|4|||
150278939|NCT02568475|542157201|FG000|Overall Study|Short-term: Discharge location unknown|4|||
150278940|NCT02568475|542157202|FG001|Overall Study|Short-term: Discharge location unknown|0|||
150278941|NCT02568475|542157201|FG000|Overall Study|Transferred to another facility|1|||
150278942|NCT02568475|542157202|FG001|Overall Study|Transferred to another facility|0|||
150278943|NCT02625233|542157203|FG000|Overall Study|Adverse Event|2|||
150278944|NCT02625233|542157204|FG001|Overall Study|Adverse Event|0|||
150278945|NCT04425720|542157214|FG000|Overall Study|Withdrawal by Subject|0|||
150278946|NCT04425720|542157215|FG001|Overall Study|Withdrawal by Subject|20|||
150278947|NCT00290186|542157216|FG000|Overall Study|Adverse Event|1|||
150278948|NCT00290186|542157217|FG001|Overall Study|Adverse Event|1|||
150278949|NCT00290186|542157216|FG000|Overall Study|Lost to Follow-up|3|||
150278950|NCT00290186|542157217|FG001|Overall Study|Lost to Follow-up|2|||
150278951|NCT00290186|542157216|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
150278952|NCT00290186|542157217|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
150278953|NCT00290186|542157216|FG000|Overall Study|Withdrawal by Subject|0|||
150278954|NCT00290186|542157217|FG001|Overall Study|Withdrawal by Subject|1|||
150278955|NCT03184077|542157222|FG000|Overall Study|Lost to Follow-up|21|||
150278956|NCT03184077|542157223|FG001|Overall Study|Lost to Follow-up|21|||
150278957|NCT00262522|542157226|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
150278958|NCT00262522|542157227|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
150278959|NCT00262522|542157228|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
150278960|NCT00262522|542157229|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
150278961|NCT00262522|542157226|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
150278962|NCT00262522|542157227|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
150278963|NCT00262522|542157228|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
150278964|NCT00262522|542157229|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
150278965|NCT00262522|542157226|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
150278966|NCT00262522|542157227|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
150278967|NCT00262522|542157228|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
150278968|NCT00262522|542157229|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
150278969|NCT00262522|542157226|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
150278970|NCT00262522|542157227|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
150278971|NCT00262522|542157228|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
150278972|NCT00262522|542157229|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
150278973|NCT00262522|542157226|FG000|Study Start Through 8 Weeks|Death|1|||
150278974|NCT00262522|542157227|FG001|Study Start Through 8 Weeks|Death|0|||
150278975|NCT00262522|542157228|FG002|Study Start Through 8 Weeks|Death|0|||
150278976|NCT00262522|542157229|FG003|Study Start Through 8 Weeks|Death|0|||
150278977|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
150278978|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
150278979|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
150278980|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
149830977|NCT00864097|540511354|FG000|Overall Study|Lost to Follow-up|0|||
150278981|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
150278982|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
150278983|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
150278984|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
150278985|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
150278986|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
150278987|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
150278988|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
150278989|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
150278990|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
150278991|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
150278992|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
149830978|NCT00864097|540511355|FG001|Overall Study|Lost to Follow-up|1|||
149830979|NCT00864097|540511356|FG002|Overall Study|Lost to Follow-up|0|||
150034009|NCT00656513|541264679|FG001|Overall Study|Missing data|11|||
150034010|NCT00656513|541264680|FG002|Overall Study|Missing data|9|||
150034011|NCT00656513|541264678|FG000|Overall Study|Incomplete treatment|3|||
150034012|NCT00656513|541264679|FG001|Overall Study|Incomplete treatment|0|||
150034013|NCT00656513|541264680|FG002|Overall Study|Incomplete treatment|0|||
150034014|NCT00656513|541264678|FG000|Overall Study|Treatment completed outside of timeframe|0|||
150034015|NCT00656513|541264679|FG001|Overall Study|Treatment completed outside of timeframe|3|||
150034016|NCT00656513|541264680|FG002|Overall Study|Treatment completed outside of timeframe|1|||
150034017|NCT00656513|541264678|FG000|Overall Study|Missing baseline form|0|||
150034018|NCT00656513|541264679|FG001|Overall Study|Missing baseline form|5|||
150034019|NCT00656513|541264680|FG002|Overall Study|Missing baseline form|5|||
150034020|NCT04558125|541264681|FG000|Overall Study|Death|1|||
150034021|NCT01748292|541264682|FG000|Overall Study|Adverse Event|2|||
150034022|NCT01748292|541264683|FG001|Overall Study|Adverse Event|4|||
150034023|NCT01748292|541264682|FG000|Overall Study|Lost to Follow-up|0|||
150034024|NCT01748292|541264683|FG001|Overall Study|Lost to Follow-up|3|||
150034025|NCT01748292|541264682|FG000|Overall Study|Death|0|||
150034026|NCT01748292|541264683|FG001|Overall Study|Death|3|||
150034027|NCT01748292|541264682|FG000|Overall Study|Withdrawal by Subject|0|||
150034028|NCT01748292|541264683|FG001|Overall Study|Withdrawal by Subject|2|||
150034029|NCT03199976|541264685|FG000|Overall Study|Lack of Efficacy|3|||
150034030|NCT03199976|541264686|FG001|Overall Study|Lack of Efficacy|6|||
150171121|NCT02577523|541763387|FG000|Overall Study|Withdrawal by Subject|1|||
150171122|NCT02577523|541763388|FG001|Overall Study|Withdrawal by Subject|0|||
150171123|NCT00391846|541763391|FG000|Overall Study|Adverse Event|4|||
150171124|NCT00391846|541763392|FG001|Overall Study|Adverse Event|1|||
150171125|NCT00391846|541763391|FG000|Overall Study|Did not meet the required elig. crit|2|||
150171126|NCT00391846|541763392|FG001|Overall Study|Did not meet the required elig. crit|2|||
150171127|NCT00391846|541763391|FG000|Overall Study|Withdrawal by Subject|2|||
150171128|NCT00391846|541763392|FG001|Overall Study|Withdrawal by Subject|3|||
150171129|NCT00391846|541763391|FG000|Overall Study|Developed study specific DC criteria|0|||
150171130|NCT00391846|541763392|FG001|Overall Study|Developed study specific DC criteria|1|||
150171131|NCT02477670|541763395|FG000|Stage 1|Adverse Event|2|||
150171132|NCT02477670|541763396|FG001|Stage 1|Adverse Event|7|||
150171133|NCT02477670|541763397|FG002|Stage 1|Adverse Event|0|||
150171134|NCT02477670|541763398|FG003|Stage 1|Adverse Event|0|||
150171135|NCT02477670|541763399|FG004|Stage 1|Adverse Event|0|||
150171136|NCT02477670|541763400|FG005|Stage 1|Adverse Event|0|||
150171137|NCT02477670|541763401|FG006|Stage 1|Adverse Event|0|||
150171138|NCT02477670|541763395|FG000|Stage 1|Lost to Follow-up|0|||
150171139|NCT02477670|541763396|FG001|Stage 1|Lost to Follow-up|2|||
150171140|NCT02477670|541763397|FG002|Stage 1|Lost to Follow-up|0|||
150171141|NCT02477670|541763398|FG003|Stage 1|Lost to Follow-up|0|||
150171142|NCT02477670|541763399|FG004|Stage 1|Lost to Follow-up|0|||
150171143|NCT02477670|541763400|FG005|Stage 1|Lost to Follow-up|0|||
150171144|NCT02477670|541763401|FG006|Stage 1|Lost to Follow-up|0|||
150171145|NCT02477670|541763395|FG000|Stage 1|Withdrawal by Subject|1|||
150171146|NCT02477670|541763396|FG001|Stage 1|Withdrawal by Subject|2|||
150171147|NCT02477670|541763397|FG002|Stage 1|Withdrawal by Subject|0|||
150171148|NCT02477670|541763398|FG003|Stage 1|Withdrawal by Subject|0|||
150171149|NCT02477670|541763399|FG004|Stage 1|Withdrawal by Subject|0|||
150171150|NCT02477670|541763400|FG005|Stage 1|Withdrawal by Subject|0|||
150171151|NCT02477670|541763401|FG006|Stage 1|Withdrawal by Subject|0|||
150171152|NCT02477670|541763395|FG000|Stage 1|Non-compliance with Study Drug|1|||
150171153|NCT02477670|541763396|FG001|Stage 1|Non-compliance with Study Drug|2|||
150171154|NCT02477670|541763397|FG002|Stage 1|Non-compliance with Study Drug|0|||
150171155|NCT02477670|541763398|FG003|Stage 1|Non-compliance with Study Drug|0|||
150171156|NCT02477670|541763399|FG004|Stage 1|Non-compliance with Study Drug|0|||
150171157|NCT02477670|541763400|FG005|Stage 1|Non-compliance with Study Drug|0|||
150171158|NCT02477670|541763401|FG006|Stage 1|Non-compliance with Study Drug|0|||
150171159|NCT02477670|541763395|FG000|Stage 2|Adverse Event|0|||
150171160|NCT02477670|541763396|FG001|Stage 2|Adverse Event|0|||
150171161|NCT02477670|541763397|FG002|Stage 2|Adverse Event|1|||
150171162|NCT02477670|541763398|FG003|Stage 2|Adverse Event|0|||
150171163|NCT02477670|541763399|FG004|Stage 2|Adverse Event|0|||
150171164|NCT02477670|541763400|FG005|Stage 2|Adverse Event|0|||
150171165|NCT02477670|541763401|FG006|Stage 2|Adverse Event|0|||
150171166|NCT02477670|541763395|FG000|Stage 2|Antipsychotic Medication Changed|0|||
150171167|NCT02477670|541763396|FG001|Stage 2|Antipsychotic Medication Changed|0|||
150171168|NCT02477670|541763397|FG002|Stage 2|Antipsychotic Medication Changed|1|||
150171169|NCT02477670|541763398|FG003|Stage 2|Antipsychotic Medication Changed|0|||
150171170|NCT02477670|541763399|FG004|Stage 2|Antipsychotic Medication Changed|0|||
150171171|NCT02477670|541763400|FG005|Stage 2|Antipsychotic Medication Changed|0|||
150034031|NCT03199976|541264687|FG002|Overall Study|Lack of Efficacy|13|||
150034032|NCT03199976|541264685|FG000|Overall Study|Withdrawal by Subject|1|||
150034033|NCT03199976|541264686|FG001|Overall Study|Withdrawal by Subject|0|||
150171172|NCT02477670|541763401|FG006|Stage 2|Antipsychotic Medication Changed|0|||
150171173|NCT02477670|541763395|FG000|Stage 2|Withdrawal by Subject|0|||
150171174|NCT02477670|541763396|FG001|Stage 2|Withdrawal by Subject|0|||
150278993|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Death|2|||
150278994|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Death|0|||
150278995|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Death|1|||
150278996|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Death|0|||
150278997|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
150278998|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
150278999|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
150279000|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
150279001|NCT00262522|542157226|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
150279002|NCT00262522|542157227|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
150279003|NCT00262522|542157228|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
150279004|NCT00262522|542157229|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
150279005|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
150279006|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
150279007|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
150279008|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
150279009|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
150279010|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
150279011|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
150279012|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
150279013|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
150279014|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
150279015|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
150279016|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
150279017|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
150279018|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
150279019|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
150279020|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
150279021|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Death|2|||
150279022|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Death|0|||
150279023|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Death|2|||
150279024|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Death|0|||
150279025|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
150279026|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
150279027|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
150279028|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
150279029|NCT00262522|542157226|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
150279030|NCT00262522|542157227|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
150279031|NCT00262522|542157228|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
150279032|NCT00262522|542157229|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
150279033|NCT02269787|542157235|FG000|Overall Study|Lost to Follow-up|20|||
150279034|NCT02269787|542157236|FG001|Overall Study|Lost to Follow-up|6|||
150279035|NCT02269787|542157235|FG000|Overall Study|Death|2|||
150279036|NCT02269787|542157236|FG001|Overall Study|Death|3|||
150279037|NCT02269787|542157235|FG000|Overall Study|Incapacitated|0|||
150279038|NCT02269787|542157236|FG001|Overall Study|Incapacitated|1|||
150279039|NCT00687440|542157237|FG000|Overall Study|Adverse Event|3|||
150279040|NCT00687440|542157237|FG000|Overall Study|Lost to Follow-up|3|||
150279041|NCT00687440|542157237|FG000|Overall Study|Lack of Efficacy|2|||
150279042|NCT00687440|542157237|FG000|Overall Study|Death|2|||
150279043|NCT00687440|542157237|FG000|Overall Study|Other|1|||
150279044|NCT00687440|542157237|FG000|Overall Study|Missing|1|||
150279045|NCT00736255|542158799|FG000|Overall Study|Adverse Event|1|||
150279046|NCT00736255|542158800|FG001|Overall Study|Adverse Event|0|||
150279047|NCT00736255|542158799|FG000|Overall Study|Physician Decision|1|||
150279048|NCT00736255|542158800|FG001|Overall Study|Physician Decision|0|||
150279049|NCT00736255|542158799|FG000|Overall Study|Non-compliance|1|||
150279050|NCT00736255|542158800|FG001|Overall Study|Non-compliance|1|||
150279051|NCT02833974|542158801|FG000|Overall Study|Lost to Follow-up|1|||
150279052|NCT02833974|542158802|FG001|Overall Study|Lost to Follow-up|0|||
150279053|NCT02833974|542158801|FG000|Overall Study|Adverse Event|0|||
150279054|NCT02833974|542158802|FG001|Overall Study|Adverse Event|3|||
150279055|NCT01439282|542158803|FG000|Overall Study|Adverse Event|5|||
150279056|NCT01439282|542158804|FG001|Overall Study|Adverse Event|0|||
150279057|NCT01439282|542158803|FG000|Overall Study|Withdrawal by Subject|2|||
149830980|NCT00864097|540511357|FG003|Overall Study|Lost to Follow-up|1|||
150279058|NCT01439282|542158804|FG001|Overall Study|Withdrawal by Subject|0|||
150279059|NCT01439282|542158803|FG000|Overall Study|Other|1|||
150279060|NCT01439282|542158804|FG001|Overall Study|Other|1|||
150279061|NCT04419610|542158805|FG000|Overall Study|Withdrawal by Subject|3|||
150279062|NCT04419610|542158806|FG001|Overall Study|Withdrawal by Subject|1|||
150279063|NCT04419610|542158805|FG000|Overall Study|Adverse Event|1|||
149830981|NCT00864097|540511354|FG000|Overall Study|Withdrawal by Subject|15|||
150034034|NCT03199976|541264687|FG002|Overall Study|Withdrawal by Subject|0|||
150034035|NCT03199976|541264685|FG000|Overall Study|Lost to Follow-up|0|||
150034036|NCT03199976|541264686|FG001|Overall Study|Lost to Follow-up|1|||
150034037|NCT03199976|541264687|FG002|Overall Study|Lost to Follow-up|1|||
150034038|NCT01761877|541264690|FG000|Overall Study|Adverse Event|7|||
150034039|NCT01761877|541264691|FG001|Overall Study|Adverse Event|0|||
150034040|NCT01761877|541264690|FG000|Overall Study|Withdrawal by Subject|6|||
150034041|NCT01761877|541264691|FG001|Overall Study|Withdrawal by Subject|4|||
150034042|NCT01761877|541264690|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
150034043|NCT01761877|541264691|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
150034044|NCT01761877|541264690|FG000|Overall Study|Death|0|||
150034045|NCT01761877|541264691|FG001|Overall Study|Death|1|||
150034046|NCT01761877|541264690|FG000|Overall Study|MRI intolerant|1|||
150034047|NCT01761877|541264691|FG001|Overall Study|MRI intolerant|6|||
150034048|NCT03962491|541264693|FG000|Overall Study|Lost to Follow-up|4|||
150034049|NCT03962491|541264694|FG001|Overall Study|Lost to Follow-up|5|||
150034050|NCT03697252|541264701|FG000|Overall Study|Adverse Event|3|||
150034051|NCT03697252|541264702|FG001|Overall Study|Adverse Event|2|||
150034052|NCT03697252|541264701|FG000|Overall Study|Withdrawal by Subject|14|||
150034053|NCT03697252|541264702|FG001|Overall Study|Withdrawal by Subject|14|||
150034054|NCT03697252|541264701|FG000|Overall Study|Lost to Follow-up|0|||
150034055|NCT03697252|541264702|FG001|Overall Study|Lost to Follow-up|1|||
150034056|NCT03697252|541264701|FG000|Overall Study|Physician Decision|1|||
150034057|NCT03697252|541264702|FG001|Overall Study|Physician Decision|1|||
150034058|NCT03697252|541264701|FG000|Overall Study|Other|0|||
150034059|NCT03697252|541264702|FG001|Overall Study|Other|1|||
150034060|NCT03796728|541264706|FG000|Overall Study|Lost to Follow-up|8|||
150034061|NCT03796728|541264706|FG000|Overall Study|Reason not Specified|16|||
150034062|NCT05236270|541264709|FG000|Overall Study|Lost to Follow-up|3|||
150034063|NCT05236270|541264710|FG001|Overall Study|Lost to Follow-up|2|||
150034064|NCT05236270|541264711|FG002|Overall Study|Lost to Follow-up|0|||
150034065|NCT05236270|541264712|FG003|Overall Study|Lost to Follow-up|0|||
150034066|NCT05236270|541264713|FG004|Overall Study|Lost to Follow-up|2|||
150034067|NCT05236270|541264714|FG005|Overall Study|Lost to Follow-up|0|||
150034068|NCT05236270|541264715|FG006|Overall Study|Lost to Follow-up|1|||
150034069|NCT05236270|541264716|FG007|Overall Study|Lost to Follow-up|3|||
150034070|NCT01499940|541264719|FG000|Overall Study|Study was withdrawn before completion.|9|||
150034071|NCT03694678|541264720|FG000|Overall Study|Withdrawal by Subject|2|||
150034072|NCT03694678|541264721|FG001|Overall Study|Withdrawal by Subject|0|||
150034073|NCT03694678|541264720|FG000|Overall Study|Lost to Follow-up|2|||
150034074|NCT03694678|541264721|FG001|Overall Study|Lost to Follow-up|3|||
150034075|NCT02435212|541264722|FG000|Core Phase|Adverse Event|8|||
150034076|NCT02435212|541264723|FG001|Core Phase|Adverse Event|5|||
150034077|NCT02435212|541264722|FG000|Core Phase|Withdrawal by Subject|3|||
150034078|NCT02435212|541264723|FG001|Core Phase|Withdrawal by Subject|0|||
150034079|NCT02435212|541264722|FG000|Core Phase|Withdrawal by parent/guardian|9|||
150034080|NCT02435212|541264723|FG001|Core Phase|Withdrawal by parent/guardian|4|||
150034081|NCT02435212|541264722|FG000|Core Phase|Protocol Violation|1|||
150034082|NCT02435212|541264723|FG001|Core Phase|Protocol Violation|2|||
150034083|NCT02435212|541264722|FG000|Core Phase|Physician Decision|3|||
150034084|NCT02435212|541264723|FG001|Core Phase|Physician Decision|0|||
150279064|NCT04419610|542158806|FG001|Overall Study|Adverse Event|0|||
150279065|NCT04419610|542158805|FG000|Overall Study|discharged early|1|||
150279066|NCT04419610|542158806|FG001|Overall Study|discharged early|1|||
150279067|NCT01502709|542158810|FG000|Overall Study|Lost to Follow-up|4|||
150279068|NCT01502709|542158811|FG001|Overall Study|Lost to Follow-up|0|||
150034085|NCT02435212|541264722|FG000|Core Phase|Lost to Follow-up|0|||
150034086|NCT02435212|541264723|FG001|Core Phase|Lost to Follow-up|1|||
150034087|NCT02435212|541264722|FG000|Core Phase|Lack of Efficacy|0|||
150034088|NCT02435212|541264723|FG001|Core Phase|Lack of Efficacy|1|||
150034089|NCT02435212|541264722|FG000|Core Phase|Recovery|1|||
150034090|NCT02435212|541264723|FG001|Core Phase|Recovery|0|||
150034091|NCT02435212|541264722|FG000|Optional Extension Phase|Adverse Event|3|||
150034092|NCT02435212|541264723|FG001|Optional Extension Phase|Adverse Event|9|||
150034093|NCT02435212|541264722|FG000|Optional Extension Phase|Physician Decision|6|||
150034094|NCT02435212|541264723|FG001|Optional Extension Phase|Physician Decision|8|||
150034095|NCT02435212|541264722|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
150034096|NCT02435212|541264723|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
150034097|NCT02435212|541264722|FG000|Optional Extension Phase|Lack of Efficacy|2|||
150034098|NCT02435212|541264723|FG001|Optional Extension Phase|Lack of Efficacy|3|||
150034099|NCT02435212|541264722|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
150034100|NCT02435212|541264723|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
150034101|NCT02435212|541264722|FG000|Optional Extension Phase|Protocol Violation|0|||
150034102|NCT02435212|541264723|FG001|Optional Extension Phase|Protocol Violation|1|||
150034103|NCT02435212|541264722|FG000|Optional Extension Phase|Recovery|1|||
150034104|NCT02435212|541264723|FG001|Optional Extension Phase|Recovery|1|||
150034105|NCT02435212|541264722|FG000|Optional Extension Phase|Death|1|||
150279069|NCT03703882|542158815|FG000|Overall Study|Adverse Event|1|||
150279070|NCT03703882|542158816|FG001|Overall Study|Adverse Event|0|||
150279071|NCT03703882|542158815|FG000|Overall Study|Lost to Follow-up|0|||
150279072|NCT03703882|542158816|FG001|Overall Study|Lost to Follow-up|2|||
150279073|NCT03703882|542158815|FG000|Overall Study|Non-compliance with study drug|0|||
150279074|NCT03703882|542158816|FG001|Overall Study|Non-compliance with study drug|1|||
150279075|NCT03703882|542158815|FG000|Overall Study|Physician Decision|0|||
150279076|NCT03703882|542158816|FG001|Overall Study|Physician Decision|1|||
150279077|NCT03703882|542158815|FG000|Overall Study|Progressive disease|1|||
150279078|NCT03703882|542158816|FG001|Overall Study|Progressive disease|0|||
150279079|NCT03703882|542158815|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150279080|NCT03703882|542158816|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150279081|NCT03703882|542158815|FG000|Overall Study|Starting another treatment|0|||
150279082|NCT03703882|542158816|FG001|Overall Study|Starting another treatment|1|||
150279083|NCT03703882|542158815|FG000|Overall Study|noncompliance with study procedures|0|||
150279084|NCT03703882|542158816|FG001|Overall Study|noncompliance with study procedures|1|||
150279085|NCT00457015|542158822|FG000|Overall Study|Left study site against medical advice|0|||
150279086|NCT00457015|542158823|FG001|Overall Study|Left study site against medical advice|1|||
150279087|NCT03670953|542158824|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
150279088|NCT03670953|542158825|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
150279089|NCT03670953|542158826|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
150279090|NCT03670953|542158827|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
150279091|NCT03670953|542158824|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
150279092|NCT03670953|542158825|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
150279093|NCT03670953|542158826|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
150279094|NCT03670953|542158827|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
150279095|NCT03670953|542158824|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
150279096|NCT03670953|542158825|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
150279097|NCT03670953|542158826|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
150279098|NCT03670953|542158827|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
150279099|NCT03670953|542158824|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
150279100|NCT03670953|542158825|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
150279101|NCT03670953|542158826|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
150279102|NCT03670953|542158827|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
150279103|NCT03670953|542158824|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
150279104|NCT03670953|542158825|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
150279105|NCT03670953|542158826|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
150279106|NCT03670953|542158827|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
150279107|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
150279108|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
150279109|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
150279110|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
150279111|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
150279112|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
150279113|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
150279114|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
150279115|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
150279116|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
150279117|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
150279118|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
150279119|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
150279120|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
150279121|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
150279122|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
150279123|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
150279124|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
150279125|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
150279126|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
150279127|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
150279128|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
150279129|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
150279130|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
150279131|NCT03670953|542158824|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
150279132|NCT03670953|542158825|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
150279133|NCT03670953|542158826|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
150279134|NCT03670953|542158827|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
150279135|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
150279136|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
150279137|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
150279138|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
150279139|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
150034106|NCT02435212|541264723|FG001|Optional Extension Phase|Death|0|||
149830982|NCT00864097|540511355|FG001|Overall Study|Withdrawal by Subject|11|||
149830983|NCT00864097|540511356|FG002|Overall Study|Withdrawal by Subject|11|||
150279140|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
150279141|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
150279142|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
150279143|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
150279144|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
150279145|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
150279146|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
150279147|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
150279148|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
150279149|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
150279150|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
150279151|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
150279152|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
150279153|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
150279154|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
150279155|NCT03670953|542158824|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
150279156|NCT03670953|542158825|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
150279157|NCT03670953|542158826|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
150279158|NCT03670953|542158827|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
150279159|NCT04179734|542158828|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
150279160|NCT04179734|542158829|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
150279161|NCT04179734|542158828|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
150279162|NCT04179734|542158829|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
150279163|NCT00937937|542158831|FG000|Overall Study|Adverse Event|6|||
150279164|NCT00937937|542158831|FG000|Overall Study|Withdrawal by Subject|2|||
150279165|NCT00937937|542158831|FG000|Overall Study|Progression/relapse|61|||
150279166|NCT00937937|542158831|FG000|Overall Study|Death|1|||
150279167|NCT00937937|542158831|FG000|Overall Study|Other|2|||
150279168|NCT02966509|542158832|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
150279169|NCT02966509|542158833|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
150279170|NCT02966509|542158832|FG000|Baseline Satisfaction Survey|Death|0|||
150279171|NCT02966509|542158833|FG001|Baseline Satisfaction Survey|Death|1|||
150279172|NCT02966509|542158832|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
150279173|NCT02966509|542158833|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
150279174|NCT02966509|542158832|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
150279175|NCT02966509|542158833|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
150279176|NCT02966509|542158832|FG000|6 Month Satisfaction Decision Survey|Death|22|||
150279177|NCT02966509|542158833|FG001|6 Month Satisfaction Decision Survey|Death|25|||
150279178|NCT02966509|542158832|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
150279179|NCT02966509|542158833|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
150279180|NCT02966509|542158832|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
150279181|NCT02966509|542158833|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
150279182|NCT02966509|542158832|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
150279183|NCT02966509|542158833|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
150279184|NCT02966509|542158832|FG000|6 Month Satisfaction Survey|Death|36|||
150279185|NCT02966509|542158833|FG001|6 Month Satisfaction Survey|Death|33|||
150279186|NCT02966509|542158832|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
150279187|NCT02966509|542158833|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
150279188|NCT02966509|542158832|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
150279189|NCT02966509|542158833|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
150279190|NCT02966509|542158832|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
150279191|NCT02966509|542158833|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
150279192|NCT02966509|542158832|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
150279193|NCT02966509|542158833|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
150279194|NCT02966509|542158832|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
150171175|NCT02477670|541763397|FG002|Stage 2|Withdrawal by Subject|0|||
150171176|NCT02477670|541763398|FG003|Stage 2|Withdrawal by Subject|1|||
150171177|NCT02477670|541763399|FG004|Stage 2|Withdrawal by Subject|0|||
150171178|NCT02477670|541763400|FG005|Stage 2|Withdrawal by Subject|0|||
150171179|NCT02477670|541763401|FG006|Stage 2|Withdrawal by Subject|0|||
150171180|NCT00970307|541763402|FG000|Overall Study|Serious Adverse Event|1|||
150171181|NCT00970307|541763403|FG001|Overall Study|Serious Adverse Event|0|||
150171182|NCT00970307|541763404|FG002|Overall Study|Serious Adverse Event|0|||
150171183|NCT00970307|541763402|FG000|Overall Study|Withdrawal by Subject|2|||
149830984|NCT00864097|540511357|FG003|Overall Study|Withdrawal by Subject|12|||
149830985|NCT00864097|540511354|FG000|Overall Study|Protocol Violation|2|||
149830986|NCT00864097|540511355|FG001|Overall Study|Protocol Violation|1|||
149830987|NCT00864097|540511356|FG002|Overall Study|Protocol Violation|0|||
149830988|NCT00864097|540511357|FG003|Overall Study|Protocol Violation|1|||
149830989|NCT00864097|540511354|FG000|Overall Study|Terminated by sponsor|105|||
149830990|NCT00864097|540511355|FG001|Overall Study|Terminated by sponsor|112|||
149830991|NCT00864097|540511356|FG002|Overall Study|Terminated by sponsor|102|||
149830992|NCT00864097|540511357|FG003|Overall Study|Terminated by sponsor|99|||
149830993|NCT00864097|540511354|FG000|Overall Study|Randomized but not treated|2|||
149830994|NCT00864097|540511355|FG001|Overall Study|Randomized but not treated|0|||
149830995|NCT00864097|540511356|FG002|Overall Study|Randomized but not treated|1|||
149830996|NCT00864097|540511357|FG003|Overall Study|Randomized but not treated|0|||
149830997|NCT00864097|540511354|FG000|Overall Study|Other|0|||
149830998|NCT00864097|540511355|FG001|Overall Study|Other|0|||
149830999|NCT00864097|540511356|FG002|Overall Study|Other|0|||
149831000|NCT00864097|540511357|FG003|Overall Study|Other|1|||
149831001|NCT01225146|540511364|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
149831002|NCT01225146|540511365|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
149831003|NCT03661528|540511370|FG000|Overall Study|Death|1|||
149831004|NCT03661528|540511371|FG001|Overall Study|Death|0|||
149831005|NCT03661528|540511370|FG000|Overall Study|Physician Decision|3|||
149831006|NCT03661528|540511371|FG001|Overall Study|Physician Decision|1|||
149831007|NCT03661528|540511370|FG000|Overall Study|Other than Specified|5|||
149831008|NCT03661528|540511371|FG001|Overall Study|Other than Specified|2|||
149831009|NCT03661528|540511370|FG000|Overall Study|Withdrawal by Subject|5|||
150279195|NCT02966509|542158833|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
150279196|NCT01227187|542158836|FG000|Overall Study|Physician Decision|0|||
150279197|NCT01227187|542158837|FG001|Overall Study|Physician Decision|0|||
150279198|NCT01227187|542158838|FG002|Overall Study|Physician Decision|0|||
150279199|NCT01227187|542158839|FG003|Overall Study|Physician Decision|1|||
149831010|NCT03661528|540511371|FG001|Overall Study|Withdrawal by Subject|3|||
149831011|NCT03661528|540511370|FG000|Overall Study|Disease Progression|8|||
149831012|NCT03661528|540511371|FG001|Overall Study|Disease Progression|13|||
149831013|NCT03661528|540511370|FG000|Overall Study|Adverse Event|61|||
149831014|NCT03661528|540511371|FG001|Overall Study|Adverse Event|55|||
149831015|NCT02732210|540511372|FG000|Overall Study|Site Closed|0|||
149831016|NCT02732210|540511373|FG001|Overall Study|Site Closed|11|||
149831017|NCT02732210|540511372|FG000|Overall Study|Study Ended|13|||
149831018|NCT02732210|540511373|FG001|Overall Study|Study Ended|13|||
149831019|NCT02732210|540511372|FG000|Overall Study|Withdrawal by Subject|28|||
149831020|NCT02732210|540511373|FG001|Overall Study|Withdrawal by Subject|87|||
150279200|NCT01566773|542158840|FG000|Overall Study|Protocol specified criteria|4|||
150279201|NCT01566773|542158840|FG000|Overall Study|Protocol Violation|4|||
150279202|NCT01566773|542158840|FG000|Overall Study|Withdrawal by Subject|9|||
150279203|NCT01566773|542158840|FG000|Overall Study|Administrative reason|1|||
150279204|NCT01566773|542158840|FG000|Overall Study|Adverse Event|10|||
150279205|NCT01566773|542158840|FG000|Overall Study|Physician Decision|2|||
150279206|NCT02187471|542158841|FG000|Overall Study|Protocol Violation|4|||
150279207|NCT02187471|542158842|FG001|Overall Study|Protocol Violation|5|||
150279208|NCT02187471|542158843|FG002|Overall Study|Protocol Violation|4|||
150279209|NCT02187471|542158844|FG003|Overall Study|Protocol Violation|4|||
150279210|NCT02187471|542158841|FG000|Overall Study|Missing|0|||
150279211|NCT02187471|542158842|FG001|Overall Study|Missing|0|||
150279212|NCT02187471|542158843|FG002|Overall Study|Missing|0|||
150279213|NCT02187471|542158844|FG003|Overall Study|Missing|1|||
150279214|NCT02187471|542158841|FG000|Overall Study|Lack of Efficacy|18|||
150279215|NCT02187471|542158842|FG001|Overall Study|Lack of Efficacy|9|||
150279216|NCT02187471|542158843|FG002|Overall Study|Lack of Efficacy|13|||
150279217|NCT02187471|542158844|FG003|Overall Study|Lack of Efficacy|11|||
150279218|NCT02187471|542158841|FG000|Overall Study|Adverse Event|24|||
150279219|NCT02187471|542158842|FG001|Overall Study|Adverse Event|34|||
149831021|NCT02732210|540511372|FG000|Overall Study|Lost to Follow-up|5|||
149831022|NCT02732210|540511373|FG001|Overall Study|Lost to Follow-up|57|||
149831023|NCT02732210|540511372|FG000|Overall Study|Death|4|||
149831024|NCT02732210|540511373|FG001|Overall Study|Death|15|||
149831025|NCT02732210|540511372|FG000|Overall Study|Other|35|||
149831026|NCT02732210|540511373|FG001|Overall Study|Other|103|||
149831027|NCT02732210|540511372|FG000|Overall Study|Missing|0|||
149831028|NCT02732210|540511373|FG001|Overall Study|Missing|8|||
149831029|NCT03561883|540511381|FG000|Overall Study|Adverse Event|10|||
149831030|NCT03561883|540511382|FG001|Overall Study|Adverse Event|13|||
149831031|NCT03561883|540511381|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149831032|NCT03561883|540511382|FG001|Overall Study|Non-Compliance With Study Drug|2|||
149831033|NCT03561883|540511381|FG000|Overall Study|Protocol Violation|2|||
150279220|NCT02187471|542158843|FG002|Overall Study|Adverse Event|44|||
150279221|NCT02187471|542158844|FG003|Overall Study|Adverse Event|36|||
150279222|NCT02187471|542158841|FG000|Overall Study|Withdrawal by Subject|23|||
150279223|NCT02187471|542158842|FG001|Overall Study|Withdrawal by Subject|29|||
150279224|NCT02187471|542158843|FG002|Overall Study|Withdrawal by Subject|22|||
149831034|NCT03561883|540511382|FG001|Overall Study|Protocol Violation|3|||
149831035|NCT03561883|540511381|FG000|Overall Study|Withdrawal by Subject|14|||
149831036|NCT03561883|540511382|FG001|Overall Study|Withdrawal by Subject|6|||
149831037|NCT03561883|540511381|FG000|Overall Study|Lost to Follow-up|2|||
149831038|NCT03561883|540511382|FG001|Overall Study|Lost to Follow-up|6|||
149831039|NCT03561883|540511381|FG000|Overall Study|Study Terminated by Sponsor|12|||
149831040|NCT03561883|540511382|FG001|Overall Study|Study Terminated by Sponsor|11|||
149831041|NCT03561883|540511381|FG000|Overall Study|Physician Decision|1|||
149831042|NCT03561883|540511382|FG001|Overall Study|Physician Decision|0|||
149831043|NCT03561883|540511381|FG000|Overall Study|Randomized by Mistake|1|||
149831044|NCT03561883|540511382|FG001|Overall Study|Randomized by Mistake|0|||
149831045|NCT03561883|540511381|FG000|Overall Study|Other, Not Specified|3|||
149831046|NCT03561883|540511382|FG001|Overall Study|Other, Not Specified|2|||
149831047|NCT05956665|540511383|FG000|Overall Study|Death|1|||
149831048|NCT05956665|540511383|FG000|Overall Study|Withdrawal by Subject|1|||
149831049|NCT01939197|540511391|FG000|Overall Study|Withdrawal by Subject|1|||
149831050|NCT01939197|540511392|FG001|Overall Study|Withdrawal by Subject|0|||
149831051|NCT01939197|540511393|FG002|Overall Study|Withdrawal by Subject|0|||
149831052|NCT01939197|540511394|FG003|Overall Study|Withdrawal by Subject|0|||
149831053|NCT01939197|540511395|FG004|Overall Study|Withdrawal by Subject|1|||
149831054|NCT01939197|540511396|FG005|Overall Study|Withdrawal by Subject|0|||
149831055|NCT01939197|540511397|FG006|Overall Study|Withdrawal by Subject|0|||
149831056|NCT01939197|540511391|FG000|Overall Study|Lost to Follow-up|0|||
149831057|NCT01939197|540511392|FG001|Overall Study|Lost to Follow-up|1|||
149831058|NCT01939197|540511393|FG002|Overall Study|Lost to Follow-up|0|||
149831059|NCT01939197|540511394|FG003|Overall Study|Lost to Follow-up|1|||
149831060|NCT01939197|540511395|FG004|Overall Study|Lost to Follow-up|3|||
149831061|NCT01939197|540511396|FG005|Overall Study|Lost to Follow-up|1|||
149831062|NCT01939197|540511397|FG006|Overall Study|Lost to Follow-up|2|||
149831063|NCT02545998|540511398|FG000|Overall Study|Lost to Follow-up|12|||
149831064|NCT02545998|540511399|FG001|Overall Study|Lost to Follow-up|3|||
149831065|NCT02545998|540511398|FG000|Overall Study|Withdrawal by Subject|3|||
149831066|NCT02545998|540511399|FG001|Overall Study|Withdrawal by Subject|2|||
149831067|NCT04028843|540511410|FG000|Overall Study|Lost to Follow-up|32|||
149831068|NCT04028843|540511411|FG001|Overall Study|Lost to Follow-up|39|||
150279225|NCT02187471|542158844|FG003|Overall Study|Withdrawal by Subject|24|||
149831069|NCT04028843|540511410|FG000|Overall Study|Adverse Event|1|||
149831070|NCT04028843|540511411|FG001|Overall Study|Adverse Event|0|||
149831071|NCT04028843|540511410|FG000|Overall Study|Non-viable Pregnancy|0|||
150279226|NCT02187471|542158841|FG000|Overall Study|Other|7|||
150279227|NCT02187471|542158842|FG001|Overall Study|Other|5|||
150279228|NCT02187471|542158843|FG002|Overall Study|Other|3|||
150279229|NCT02187471|542158844|FG003|Overall Study|Other|4|||
150279230|NCT02236520|542158845|FG000|Overall Study|Physician Decision|0|||
150279231|NCT02236520|542158846|FG001|Overall Study|Physician Decision|5|||
150279232|NCT02236520|542158847|FG002|Overall Study|Physician Decision|0|||
150279233|NCT02236520|542158848|FG003|Overall Study|Physician Decision|0|||
150279234|NCT02236520|542158845|FG000|Overall Study|Withdrawal by Subject|1|||
150279235|NCT02236520|542158846|FG001|Overall Study|Withdrawal by Subject|0|||
150279236|NCT02236520|542158847|FG002|Overall Study|Withdrawal by Subject|0|||
150279237|NCT02236520|542158848|FG003|Overall Study|Withdrawal by Subject|1|||
150279238|NCT02236520|542158845|FG000|Overall Study|Pregnancy|1|||
150279239|NCT02236520|542158846|FG001|Overall Study|Pregnancy|0|||
150279240|NCT02236520|542158847|FG002|Overall Study|Pregnancy|0|||
150279241|NCT02236520|542158848|FG003|Overall Study|Pregnancy|0|||
150279242|NCT01785160|542158849|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
150279243|NCT01785160|542158849|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
150279244|NCT02318667|542158850|FG000|Overall Study|Adverse Event|1|||
150279245|NCT02318667|542158850|FG000|Overall Study|Lack of Efficacy|6|||
150279246|NCT02318667|542158850|FG000|Overall Study|Protocol Violation|2|||
150279247|NCT01365039|542158855|FG000|Overall Study|Study related symptoms and complaints|1|||
149831072|NCT04028843|540511411|FG001|Overall Study|Non-viable Pregnancy|1|||
149831073|NCT04028843|540511410|FG000|Overall Study|Withdrawal by Subject|4|||
150279248|NCT01365039|542158856|FG001|Overall Study|Study related symptoms and complaints|0|||
150279249|NCT03807349|542158859|FG000|Overall Study|Early Study Termination|9|||
150279250|NCT00294060|542158860|FG000|Overall Study|Death|225|||
150279251|NCT00294060|542158860|FG000|Overall Study|Other|59|||
150279252|NCT00294060|542158860|FG000|Overall Study|Lost to Follow-up|55|||
149831074|NCT04028843|540511411|FG001|Overall Study|Withdrawal by Subject|2|||
149831075|NCT03298451|540511412|FG000|Overall Study|Death|275|||
149831076|NCT03298451|540511413|FG001|Overall Study|Death|260|||
149831077|NCT03298451|540511414|FG002|Overall Study|Death|122|||
149831078|NCT03298451|540511415|FG003|Overall Study|Death|280|||
149831079|NCT03298451|540511412|FG000|Overall Study|Lost to Follow-up|1|||
149831080|NCT03298451|540511413|FG001|Overall Study|Lost to Follow-up|1|||
149831081|NCT03298451|540511414|FG002|Overall Study|Lost to Follow-up|0|||
149831082|NCT03298451|540511415|FG003|Overall Study|Lost to Follow-up|7|||
149831083|NCT03298451|540511412|FG000|Overall Study|Withdrawal by Subject|9|||
149831084|NCT03298451|540511413|FG001|Overall Study|Withdrawal by Subject|7|||
149831085|NCT03298451|540511414|FG002|Overall Study|Withdrawal by Subject|1|||
149831086|NCT03298451|540511415|FG003|Overall Study|Withdrawal by Subject|20|||
149831087|NCT01347710|540511416|FG000|Overall Study|Withdrawal by Subject|2|||
149831088|NCT01347710|540511416|FG000|Overall Study|Adverse Event|4|||
149831089|NCT01347710|540511416|FG000|Overall Study|Angio or SPECT not completed|18|||
149831090|NCT01347710|540511416|FG000|Overall Study|issue with vitals prior to dosing|1|||
149831091|NCT01347710|540511416|FG000|Overall Study|Lost to Follow-up|1|||
149831092|NCT01347710|540511416|FG000|Overall Study|Physician Decision|2|||
149831093|NCT01347710|540511416|FG000|Overall Study|Other|3|||
149831094|NCT04591626|540511418|FG000|Overall Study|Adverse Event|4|||
149831095|NCT04591626|540511419|FG001|Overall Study|Adverse Event|0|||
149831096|NCT04591626|540511418|FG000|Overall Study|Withdrawal by Subject|5|||
149831097|NCT04591626|540511419|FG001|Overall Study|Withdrawal by Subject|3|||
149831098|NCT04591626|540511418|FG000|Overall Study|Physician Decision|0|||
149831099|NCT04591626|540511419|FG001|Overall Study|Physician Decision|1|||
149831100|NCT04591626|540511418|FG000|Overall Study|Death|0|||
149831101|NCT04591626|540511419|FG001|Overall Study|Death|1|||
149831102|NCT04591626|540511418|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149831103|NCT04591626|540511419|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149831104|NCT00950872|540511425|FG000|Overall Study|Withdrawal by Subject|1|||
149831105|NCT00950872|540511425|FG000|Overall Study|Did not have surgery|2|||
149831106|NCT00878995|540511426|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
149831107|NCT00878995|540511427|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
149831108|NCT02480764|540511430|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
149831109|NCT02480764|540511431|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
149831110|NCT02480764|540511432|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
149831111|NCT02480764|540511430|FG000|Overall Study|Major Protocol Deviation|1|||
149831112|NCT02480764|540511431|FG001|Overall Study|Major Protocol Deviation|4|||
149831113|NCT02480764|540511432|FG002|Overall Study|Major Protocol Deviation|3|||
149831114|NCT02480764|540511430|FG000|Overall Study|Lost to Follow-up|0|||
149831115|NCT02480764|540511431|FG001|Overall Study|Lost to Follow-up|1|||
149831116|NCT02480764|540511432|FG002|Overall Study|Lost to Follow-up|2|||
149831117|NCT02480764|540511430|FG000|Overall Study|Voluntary Withdrawal|6|||
149975630|NCT00038948|541047923|FG001|Overall Study|Lost to Follow-up|4|||
150171184|NCT00970307|541763403|FG001|Overall Study|Withdrawal by Subject|3|||
150171185|NCT00970307|541763404|FG002|Overall Study|Withdrawal by Subject|2|||
150171186|NCT01458210|541763405|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
150171187|NCT01458210|541763405|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
150171188|NCT01458210|541763405|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
150171189|NCT01458210|541763405|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
150171190|NCT02224924|541763406|FG000|Overall Study|Withdrawal by Subject|7|||
150171191|NCT02224924|541763407|FG001|Overall Study|Withdrawal by Subject|6|||
150171192|NCT02224924|541763406|FG000|Overall Study|Biopsy cancelled|20|||
150171193|NCT02224924|541763407|FG001|Overall Study|Biopsy cancelled|14|||
150171194|NCT02224924|541763406|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
150171195|NCT02224924|541763407|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
150171196|NCT02224924|541763406|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
150177868|NCT03144674|541788243|FG002|Overall Study|Changed Physicians|0|||
149831118|NCT02480764|540511431|FG001|Overall Study|Voluntary Withdrawal|5|||
149831119|NCT02480764|540511432|FG002|Overall Study|Voluntary Withdrawal|10|||
149831120|NCT02480764|540511430|FG000|Overall Study|Lack of Efficacy|0|||
149831121|NCT02480764|540511431|FG001|Overall Study|Lack of Efficacy|3|||
149831122|NCT02480764|540511432|FG002|Overall Study|Lack of Efficacy|3|||
149831123|NCT02480764|540511430|FG000|Overall Study|Reason not Specified|0|||
149831124|NCT02480764|540511431|FG001|Overall Study|Reason not Specified|1|||
149831125|NCT02480764|540511432|FG002|Overall Study|Reason not Specified|0|||
149831126|NCT02457832|540511433|FG000|Training|Lost to Follow-up|10|||
149831127|NCT02457832|540511434|FG001|Training|Lost to Follow-up|6|||
149831128|NCT02457832|540511435|FG002|Training|Lost to Follow-up|3|||
149831129|NCT02457832|540511433|FG000|One Month Washout|Lost to Follow-up|0|||
149831130|NCT02457832|540511434|FG001|One Month Washout|Lost to Follow-up|1|||
149831131|NCT02457832|540511435|FG002|One Month Washout|Lost to Follow-up|1|||
149831132|NCT01868009|540511438|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
149831133|NCT01868009|540511439|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
149831134|NCT01868009|540511438|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
149831135|NCT01868009|540511439|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
149831136|NCT01868009|540511438|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
149831137|NCT01868009|540511439|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
149831138|NCT00860028|540511443|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
149831139|NCT00860028|540511444|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
149831140|NCT02514174|540511448|FG000|Overall Study|Patient refused to continue medication|1|||
149831141|NCT02514174|540511448|FG000|Overall Study|Adverse Event|2|||
149831142|NCT02514174|540511448|FG000|Overall Study|Study closed by sponsor|9|||
149831143|NCT02514174|540511448|FG000|Overall Study|Progressive disease|11|||
149831144|NCT02514174|540511448|FG000|Overall Study|Treatment change|1|||
149831145|NCT02514174|540511448|FG000|Overall Study|Treated off study with Afatinib.|1|||
149831146|NCT01108094|540513068|FG000|Overall Study|Adverse Event|2|||
149831147|NCT01108094|540513069|FG001|Overall Study|Adverse Event|0|||
149831148|NCT01108094|540513070|FG002|Overall Study|Adverse Event|0|||
149831149|NCT01108094|540513071|FG003|Overall Study|Adverse Event|0|||
149831150|NCT01108094|540513068|FG000|Overall Study|Withdrawal by Subject|1|||
149831151|NCT01108094|540513069|FG001|Overall Study|Withdrawal by Subject|0|||
149831152|NCT01108094|540513070|FG002|Overall Study|Withdrawal by Subject|0|||
149831153|NCT01108094|540513071|FG003|Overall Study|Withdrawal by Subject|0|||
150279253|NCT00294060|542158860|FG000|Overall Study|Withdrawal by Subject|11|||
150279254|NCT00294060|542158860|FG000|Overall Study|Physician Decision|797|||
150279255|NCT00294060|542158860|FG000|Overall Study|Medical condition|3|||
150279256|NCT00294060|542158860|FG000|Overall Study|Device explanted/not replaced|23|||
150279257|NCT00187096|542158861|FG000|Overall Study|unacceptable toxicity|0|||
150279258|NCT00187096|542158862|FG001|Overall Study|unacceptable toxicity|0|||
150279259|NCT00187096|542158863|FG002|Overall Study|unacceptable toxicity|1|||
150279260|NCT01263483|542158868|FG000|Overall Study|Adverse Event|4|||
150279261|NCT01263483|542158869|FG001|Overall Study|Adverse Event|0|||
150279262|NCT01263483|542158870|FG002|Overall Study|Adverse Event|3|||
150279263|NCT01263483|542158868|FG000|Overall Study|Withdrawal by Subject|1|||
150279264|NCT01263483|542158869|FG001|Overall Study|Withdrawal by Subject|0|||
150279265|NCT01263483|542158870|FG002|Overall Study|Withdrawal by Subject|0|||
150279266|NCT01263483|542158868|FG000|Overall Study|Lack of Efficacy|2|||
150279267|NCT01263483|542158869|FG001|Overall Study|Lack of Efficacy|0|||
150279268|NCT01263483|542158870|FG002|Overall Study|Lack of Efficacy|0|||
150279269|NCT01263483|542158868|FG000|Overall Study|Protocol Violation|0|||
150279270|NCT01263483|542158869|FG001|Overall Study|Protocol Violation|1|||
150279271|NCT01263483|542158870|FG002|Overall Study|Protocol Violation|1|||
150279272|NCT01263483|542158868|FG000|Overall Study|Participant Unavailability|0|||
150279273|NCT01263483|542158869|FG001|Overall Study|Participant Unavailability|1|||
150279274|NCT01263483|542158870|FG002|Overall Study|Participant Unavailability|1|||
150279275|NCT05500274|542158871|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
150279276|NCT05500274|542158872|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
149831154|NCT02918877|540513077|FG000|Overall Study|Withdrawal by Subject|2|||
149831155|NCT02918877|540513078|FG001|Overall Study|Withdrawal by Subject|2|||
149831156|NCT02918877|540513077|FG000|Overall Study|Surgery cancelled|1|||
150279277|NCT05500274|542158871|FG000|Overall Study|Lost to Follow-up|76|||
150279278|NCT05500274|542158872|FG001|Overall Study|Lost to Follow-up|51|||
150279279|NCT01555151|542158875|FG000|Overall Study|Withdrawal by Subject|6|||
150279280|NCT01555151|542158876|FG001|Overall Study|Withdrawal by Subject|2|||
150279281|NCT01555151|542158877|FG002|Overall Study|Withdrawal by Subject|0|||
149831157|NCT02918877|540513078|FG001|Overall Study|Surgery cancelled|0|||
149831158|NCT02918877|540513077|FG000|Overall Study|Physician Decision|1|||
149831159|NCT02918877|540513078|FG001|Overall Study|Physician Decision|0|||
149831160|NCT02918877|540513077|FG000|Overall Study|Received intraoperative steroids|1|||
149831161|NCT02918877|540513078|FG001|Overall Study|Received intraoperative steroids|0|||
149831162|NCT02918877|540513077|FG000|Overall Study|Unable to obtain lab samples|1|||
149831163|NCT02918877|540513078|FG001|Overall Study|Unable to obtain lab samples|0|||
149831164|NCT02918877|540513077|FG000|Overall Study|Unsafe to perform BAL|0|||
150279282|NCT01555151|542158878|FG003|Overall Study|Withdrawal by Subject|2|||
150279283|NCT01555151|542158875|FG000|Overall Study|Administrative|3|||
150279284|NCT01555151|542158876|FG001|Overall Study|Administrative|1|||
150279285|NCT01555151|542158877|FG002|Overall Study|Administrative|2|||
150279286|NCT01555151|542158878|FG003|Overall Study|Administrative|0|||
150279287|NCT01555151|542158875|FG000|Overall Study|Protocol Violation|3|||
150279288|NCT01555151|542158876|FG001|Overall Study|Protocol Violation|3|||
150279289|NCT01555151|542158877|FG002|Overall Study|Protocol Violation|3|||
150279290|NCT01555151|542158878|FG003|Overall Study|Protocol Violation|5|||
150279291|NCT01555151|542158875|FG000|Overall Study|Adverse Event|1|||
150279292|NCT01555151|542158876|FG001|Overall Study|Adverse Event|2|||
150279293|NCT01555151|542158877|FG002|Overall Study|Adverse Event|1|||
150279294|NCT01555151|542158878|FG003|Overall Study|Adverse Event|2|||
150279295|NCT01555151|542158875|FG000|Overall Study|Lost to Follow-up|0|||
150279296|NCT01555151|542158876|FG001|Overall Study|Lost to Follow-up|0|||
150279297|NCT01555151|542158877|FG002|Overall Study|Lost to Follow-up|0|||
150279298|NCT01555151|542158878|FG003|Overall Study|Lost to Follow-up|1|||
150279299|NCT03596866|542158879|FG000|Overall Study|Site terminated by Sponsor|64|||
150279300|NCT03596866|542158880|FG001|Overall Study|Site terminated by Sponsor|65|||
150279301|NCT03596866|542158879|FG000|Overall Study|Death|37|||
150279302|NCT03596866|542158880|FG001|Overall Study|Death|24|||
150279303|NCT03596866|542158879|FG000|Overall Study|Withdrawal by Subject|4|||
150279304|NCT03596866|542158880|FG001|Overall Study|Withdrawal by Subject|6|||
150279305|NCT03596866|542158879|FG000|Overall Study|Missing|0|||
150279306|NCT03596866|542158880|FG001|Overall Study|Missing|6|||
150279307|NCT03596866|542158879|FG000|Overall Study|Lost to Follow-up|2|||
150279308|NCT03596866|542158880|FG001|Overall Study|Lost to Follow-up|3|||
150279309|NCT03596866|542158879|FG000|Overall Study|Protocol Violation|1|||
150279310|NCT03596866|542158880|FG001|Overall Study|Protocol Violation|0|||
150279311|NCT03596866|542158879|FG000|Overall Study|Reason Not Specified|14|||
150279312|NCT03596866|542158880|FG001|Overall Study|Reason Not Specified|13|||
150279313|NCT00829179|542158881|FG000|Overall Study|Withdrawal by Subject|1|||
150279314|NCT03000179|542158882|FG000|Overall Study|Lost to Follow-up|2|||
150279315|NCT02047253|542158889|FG000|Overall Study|Lost to Follow-up|8|||
150279316|NCT04085523|542158890|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
150279317|NCT04085523|542158891|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
150279318|NCT04085523|542158892|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
150279319|NCT04085523|542158893|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
150279320|NCT04085523|542158894|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
150279321|NCT04085523|542158895|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
150279322|NCT05318937|542158896|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150279323|NCT05318937|542158897|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150279324|NCT05318937|542158896|FG000|Overall Study|Lost to Follow-up|0|||
150279325|NCT05318937|542158897|FG001|Overall Study|Lost to Follow-up|1|||
150279326|NCT05318937|542158896|FG000|Overall Study|Withdrawal by Subject|0|||
150279327|NCT05318937|542158897|FG001|Overall Study|Withdrawal by Subject|2|||
150279328|NCT05318937|542158896|FG000|Overall Study|Protocol Violation|0|||
150279329|NCT05318937|542158897|FG001|Overall Study|Protocol Violation|1|||
150279330|NCT04722042|542158898|FG000|Overall Study|Withdrawal by Subject|2|||
150279331|NCT04722042|542158899|FG001|Overall Study|Withdrawal by Subject|1|||
150279332|NCT04722042|542158900|FG002|Overall Study|Withdrawal by Subject|0|||
150279333|NCT01877915|542158908|FG000|Overall Study|Lost to Follow-up|10|||
150279334|NCT01877915|542158909|FG001|Overall Study|Lost to Follow-up|9|||
150279335|NCT01877915|542158908|FG000|Overall Study|Withdrawal by Subject|42|||
150279336|NCT01877915|542158909|FG001|Overall Study|Withdrawal by Subject|55|||
150279337|NCT01877915|542158908|FG000|Overall Study|Other|2|||
150279338|NCT01877915|542158909|FG001|Overall Study|Other|4|||
150279339|NCT01449461|542158910|FG000|Overall Study|Adverse Event|0|||
150279340|NCT01449461|542158911|FG001|Overall Study|Adverse Event|3|||
150279341|NCT01449461|542158912|FG002|Overall Study|Adverse Event|2|||
150279342|NCT01449461|542158913|FG003|Overall Study|Adverse Event|3|||
150279343|NCT01449461|542158914|FG004|Overall Study|Adverse Event|4|||
150279344|NCT01449461|542158915|FG005|Overall Study|Adverse Event|4|||
150279345|NCT01449461|542158910|FG000|Overall Study|Death|0|||
150279346|NCT01449461|542158911|FG001|Overall Study|Death|2|||
150279347|NCT01449461|542158912|FG002|Overall Study|Death|0|||
150279348|NCT01449461|542158913|FG003|Overall Study|Death|0|||
150279349|NCT01449461|542158914|FG004|Overall Study|Death|7|||
150279350|NCT01449461|542158915|FG005|Overall Study|Death|1|||
150279351|NCT01449461|542158910|FG000|Overall Study|Physician Decision|0|||
150279352|NCT01449461|542158911|FG001|Overall Study|Physician Decision|1|||
150279353|NCT01449461|542158912|FG002|Overall Study|Physician Decision|0|||
150279354|NCT01449461|542158913|FG003|Overall Study|Physician Decision|4|||
150279355|NCT01449461|542158914|FG004|Overall Study|Physician Decision|1|||
149831165|NCT02918877|540513078|FG001|Overall Study|Unsafe to perform BAL|1|||
149831166|NCT05818137|540513079|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
149831167|NCT05818137|540513079|FG000|Extension Treatment Period|Ongoing participants|44|||
149831168|NCT05346055|540513082|FG000|Overall Study|Withdrawal by Subject|1|||
149831169|NCT05346055|540513082|FG000|Overall Study|Protocol Violation|1|||
149831170|NCT05346055|540513082|FG000|Overall Study|Therapist decision|1|||
149831171|NCT00728949|540513083|FG000|Overall Study|Adverse Event|8|||
149831172|NCT00728949|540513084|FG001|Overall Study|Adverse Event|0|||
149831173|NCT00728949|540513083|FG000|Overall Study|Withdrawal by Subject|2|||
149831174|NCT00728949|540513084|FG001|Overall Study|Withdrawal by Subject|2|||
149831175|NCT00728949|540513083|FG000|Overall Study|Abnormal Lab Results|0|||
149831176|NCT00728949|540513084|FG001|Overall Study|Abnormal Lab Results|2|||
149831177|NCT00728949|540513083|FG000|Overall Study|On treatment at cutoff date|1|||
149831178|NCT00728949|540513084|FG001|Overall Study|On treatment at cutoff date|0|||
150279356|NCT01449461|542158915|FG005|Overall Study|Physician Decision|0|||
150279357|NCT01449461|542158910|FG000|Overall Study|Documented Progressive Disease|4|||
150279358|NCT01449461|542158911|FG001|Overall Study|Documented Progressive Disease|7|||
150279359|NCT01449461|542158912|FG002|Overall Study|Documented Progressive Disease|14|||
150279360|NCT01449461|542158913|FG003|Overall Study|Documented Progressive Disease|15|||
150279361|NCT01449461|542158914|FG004|Overall Study|Documented Progressive Disease|24|||
150279362|NCT01449461|542158915|FG005|Overall Study|Documented Progressive Disease|5|||
150279363|NCT01449461|542158910|FG000|Overall Study|Clinical Progressive Disease|2|||
150279364|NCT01449461|542158911|FG001|Overall Study|Clinical Progressive Disease|2|||
150279365|NCT01449461|542158912|FG002|Overall Study|Clinical Progressive Disease|0|||
150279366|NCT01449461|542158913|FG003|Overall Study|Clinical Progressive Disease|3|||
150279367|NCT01449461|542158914|FG004|Overall Study|Clinical Progressive Disease|4|||
150279368|NCT01449461|542158915|FG005|Overall Study|Clinical Progressive Disease|2|||
150279369|NCT01449461|542158910|FG000|Overall Study|Protocol Violation|0|||
150279370|NCT01449461|542158911|FG001|Overall Study|Protocol Violation|0|||
150279371|NCT01449461|542158912|FG002|Overall Study|Protocol Violation|0|||
150279372|NCT01449461|542158913|FG003|Overall Study|Protocol Violation|1|||
150279373|NCT01449461|542158914|FG004|Overall Study|Protocol Violation|0|||
150279374|NCT01449461|542158915|FG005|Overall Study|Protocol Violation|0|||
150279375|NCT01449461|542158910|FG000|Overall Study|Site Terminated by Sponsor|0|||
150279376|NCT01449461|542158911|FG001|Overall Study|Site Terminated by Sponsor|1|||
150279377|NCT01449461|542158912|FG002|Overall Study|Site Terminated by Sponsor|2|||
150279378|NCT01449461|542158913|FG003|Overall Study|Site Terminated by Sponsor|3|||
150279379|NCT01449461|542158914|FG004|Overall Study|Site Terminated by Sponsor|4|||
150279380|NCT01449461|542158915|FG005|Overall Study|Site Terminated by Sponsor|1|||
150279381|NCT01449461|542158910|FG000|Overall Study|Withdrawal by Subject|0|||
150279382|NCT01449461|542158911|FG001|Overall Study|Withdrawal by Subject|1|||
150279383|NCT01449461|542158912|FG002|Overall Study|Withdrawal by Subject|0|||
150279384|NCT01449461|542158913|FG003|Overall Study|Withdrawal by Subject|0|||
150279385|NCT01449461|542158914|FG004|Overall Study|Withdrawal by Subject|2|||
150279386|NCT01449461|542158915|FG005|Overall Study|Withdrawal by Subject|1|||
150279387|NCT01449461|542158910|FG000|Overall Study|Reason not Specified|0|||
150279388|NCT01449461|542158911|FG001|Overall Study|Reason not Specified|1|||
150279389|NCT01449461|542158912|FG002|Overall Study|Reason not Specified|0|||
150279390|NCT01449461|542158913|FG003|Overall Study|Reason not Specified|3|||
150279391|NCT01449461|542158914|FG004|Overall Study|Reason not Specified|2|||
150279392|NCT01449461|542158915|FG005|Overall Study|Reason not Specified|1|||
150279393|NCT05314517|542158916|FG000|Double-blind Period|Adverse Event|4|||
150279394|NCT05314517|542158917|FG001|Double-blind Period|Adverse Event|0|||
150279395|NCT05314517|542158918|FG002|Double-blind Period|Adverse Event|0|||
150279396|NCT05314517|542158919|FG003|Double-blind Period|Adverse Event|0|||
150279397|NCT05314517|542158916|FG000|Double-blind Period|Noncompliance|0|||
150279398|NCT05314517|542158917|FG001|Double-blind Period|Noncompliance|1|||
150279399|NCT05314517|542158918|FG002|Double-blind Period|Noncompliance|0|||
150279400|NCT05314517|542158919|FG003|Double-blind Period|Noncompliance|0|||
150279401|NCT05314517|542158916|FG000|Double-blind Period|Randomized, not treated|1|||
150279402|NCT05314517|542158917|FG001|Double-blind Period|Randomized, not treated|0|||
150279403|NCT05314517|542158918|FG002|Double-blind Period|Randomized, not treated|0|||
150279404|NCT05314517|542158919|FG003|Double-blind Period|Randomized, not treated|0|||
149831179|NCT01996033|540513085|FG000|Overall Study|Death|1|||
149831180|NCT01996033|540513085|FG000|Overall Study|Physician Decision|1|||
150279405|NCT05314517|542158916|FG000|Open-label Extension|Adverse Event|0|||
150279406|NCT05314517|542158917|FG001|Open-label Extension|Adverse Event|0|||
150279407|NCT05314517|542158918|FG002|Open-label Extension|Adverse Event|1|||
150279408|NCT05314517|542158919|FG003|Open-label Extension|Adverse Event|2|||
150279409|NCT05314517|542158916|FG000|Open-label Extension|Investigator decision|0|||
149831181|NCT01996033|540513085|FG000|Overall Study|Withdrawal by Subject|4|||
149831182|NCT01996033|540513085|FG000|Overall Study|Lost to Follow-up|3|||
149831183|NCT01087970|540513090|FG000|Overall Study|Protocol Violation|2|||
149831184|NCT02143102|540513091|FG000|Overall Study|Lost to Follow-up|11|||
149831185|NCT02143102|540513092|FG001|Overall Study|Lost to Follow-up|0|||
150279410|NCT05314517|542158917|FG001|Open-label Extension|Investigator decision|0|||
149831186|NCT04099888|540513099|FG000|Overall Study|Study terminated by sponsor|9|||
149831187|NCT04099888|540513100|FG001|Overall Study|Study terminated by sponsor|11|||
149831188|NCT04099888|540513099|FG000|Overall Study|Lost to Follow-up|1|||
149831189|NCT04099888|540513100|FG001|Overall Study|Lost to Follow-up|1|||
149831190|NCT04099888|540513099|FG000|Overall Study|Withdrawal by Subject|5|||
149831191|NCT04099888|540513100|FG001|Overall Study|Withdrawal by Subject|6|||
149831192|NCT04099888|540513099|FG000|Overall Study|Death|5|||
149831193|NCT04099888|540513100|FG001|Overall Study|Death|2|||
149831194|NCT04099888|540513099|FG000|Overall Study|Other|1|||
149831195|NCT04099888|540513100|FG001|Overall Study|Other|0|||
149831196|NCT00891293|540513104|FG000|Overall Study|Adverse Event|2|||
149831197|NCT00891293|540513104|FG000|Overall Study|Protocol Violation|2|||
149831198|NCT00891293|540513104|FG000|Overall Study|Laboratory abnormality|4|||
149831199|NCT00891293|540513104|FG000|Overall Study|Lost to Follow-up|7|||
149831200|NCT00891293|540513104|FG000|Overall Study|Subject withdrew consent|7|||
149831201|NCT00891293|540513104|FG000|Overall Study|Sponsor termination|62|||
149831202|NCT01448057|540513105|FG000|Overall Study|Protocol Violation|3|||
149831203|NCT01448057|540513106|FG001|Overall Study|Protocol Violation|2|||
149831204|NCT01448057|540513105|FG000|Overall Study|Lost to Follow-up|3|||
149831205|NCT01448057|540513106|FG001|Overall Study|Lost to Follow-up|0|||
149831206|NCT01448057|540513105|FG000|Overall Study|Adverse Event|0|||
149831207|NCT01448057|540513106|FG001|Overall Study|Adverse Event|2|||
149831208|NCT01448057|540513105|FG000|Overall Study|Withdrawal by Subject|2|||
149831209|NCT01448057|540513106|FG001|Overall Study|Withdrawal by Subject|0|||
149831210|NCT03883906|540513108|FG000|Overall Study|Withdrawal by Subject|2|||
149831211|NCT03883906|540513108|FG000|Overall Study|Physician Decision|5|||
149831212|NCT00874237|540513109|FG000|Overall Study|Physician Decision|0|||
149831213|NCT00874237|540513110|FG001|Overall Study|Physician Decision|1|||
149831214|NCT00874237|540513111|FG002|Overall Study|Physician Decision|0|||
149831215|NCT00874237|540513112|FG003|Overall Study|Physician Decision|0|||
149831216|NCT00874237|540513113|FG004|Overall Study|Physician Decision|0|||
149831217|NCT00874237|540513114|FG005|Overall Study|Physician Decision|0|||
149831218|NCT00874237|540513109|FG000|Overall Study|Withdrawal by Subject|0|||
149831219|NCT00874237|540513110|FG001|Overall Study|Withdrawal by Subject|0|||
149831220|NCT00874237|540513111|FG002|Overall Study|Withdrawal by Subject|1|||
149831221|NCT00874237|540513112|FG003|Overall Study|Withdrawal by Subject|0|||
149831222|NCT00874237|540513113|FG004|Overall Study|Withdrawal by Subject|0|||
149831223|NCT00874237|540513114|FG005|Overall Study|Withdrawal by Subject|0|||
149831224|NCT03912337|540513130|FG000|Overall Study|Withdrawal of Consent From Study|1|||
149831225|NCT03912337|540513131|FG001|Overall Study|Withdrawal of Consent From Study|0|||
149831226|NCT03912337|540513130|FG000|Overall Study|Lost to Follow-up|1|||
149831227|NCT03912337|540513131|FG001|Overall Study|Lost to Follow-up|1|||
149831228|NCT02458469|540513132|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149831229|NCT02458469|540513133|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149975631|NCT00038948|541047922|FG000|Overall Study|Nonmedical event|5|||
149975632|NCT00038948|541047923|FG001|Overall Study|Nonmedical event|7|||
149975633|NCT00038948|541047922|FG000|Overall Study|Withdrawal by Subject|23|||
149975634|NCT00038948|541047923|FG001|Overall Study|Withdrawal by Subject|10|||
149975635|NCT00038948|541047922|FG000|Overall Study|Protocol Violation|3|||
149975636|NCT00038948|541047923|FG001|Overall Study|Protocol Violation|7|||
149975637|NCT00038948|541047922|FG000|Overall Study|Lack of Efficacy|3|||
149975638|NCT00038948|541047923|FG001|Overall Study|Lack of Efficacy|6|||
149975639|NCT03247829|541049387|FG000|Overall Study|Death|3|||
149975640|NCT03247829|541049388|FG001|Overall Study|Death|4|||
149975641|NCT03247829|541049387|FG000|Overall Study|Enter Hospice Care|1|||
149975642|NCT03247829|541049388|FG001|Overall Study|Enter Hospice Care|0|||
149975643|NCT03247829|541049387|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
149975644|NCT03247829|541049388|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
149975645|NCT03247829|541049387|FG000|Overall Study|LVAD Explant|1|||
149975646|NCT03247829|541049388|FG001|Overall Study|LVAD Explant|1|||
149975647|NCT03247829|541049387|FG000|Overall Study|Transplant|1|||
149975648|NCT03247829|541049388|FG001|Overall Study|Transplant|1|||
149975649|NCT01783444|541049389|FG000|Treatment Phase|Adverse Event|9|||
149975650|NCT01783444|541049390|FG001|Treatment Phase|Adverse Event|20|||
149975651|NCT01783444|541049391|FG002|Treatment Phase|Adverse Event|19|||
149975652|NCT01783444|541049389|FG000|Treatment Phase|Disease Progression|76|||
149975653|NCT01783444|541049390|FG001|Treatment Phase|Disease Progression|66|||
149975654|NCT01783444|541049391|FG002|Treatment Phase|Disease Progression|64|||
149975655|NCT01783444|541049389|FG000|Treatment Phase|Death|2|||
149975656|NCT01783444|541049390|FG001|Treatment Phase|Death|2|||
149975657|NCT01783444|541049391|FG002|Treatment Phase|Death|2|||
149975658|NCT01783444|541049389|FG000|Treatment Phase|Protocol Violation|1|||
149975659|NCT01783444|541049390|FG001|Treatment Phase|Protocol Violation|1|||
149975660|NCT01783444|541049391|FG002|Treatment Phase|Protocol Violation|2|||
149975661|NCT01783444|541049389|FG000|Treatment Phase|Withdrawal by Subject|6|||
149975662|NCT01783444|541049390|FG001|Treatment Phase|Withdrawal by Subject|8|||
149975663|NCT01783444|541049391|FG002|Treatment Phase|Withdrawal by Subject|9|||
149975664|NCT01783444|541049389|FG000|Treatment Phase|Administrative problems|2|||
149831230|NCT02458469|540513134|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
149831231|NCT02458469|540513135|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149831232|NCT02458469|540513136|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149831233|NCT02458469|540513137|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149831234|NCT02458469|540513132|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
149831235|NCT02458469|540513133|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
149831236|NCT02458469|540513134|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
149831237|NCT02458469|540513135|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
149831238|NCT02458469|540513136|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
149831239|NCT02458469|540513137|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
149831240|NCT02458469|540513132|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
149831241|NCT02458469|540513133|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
149831242|NCT02458469|540513134|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
149831243|NCT02458469|540513135|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
149831244|NCT02458469|540513136|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
149831245|NCT02458469|540513137|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
149831246|NCT01496183|540513138|FG000|Overall Study|Physician Decision|3|||
149831247|NCT01496183|540513139|FG001|Overall Study|Physician Decision|1|||
149831248|NCT01496183|540513138|FG000|Overall Study|Withdrawal by Subject|0|||
149831249|NCT01496183|540513139|FG001|Overall Study|Withdrawal by Subject|1|||
149831250|NCT03130699|540513140|FG000|Overall Study|Lost to Follow-up|34|||
149831251|NCT03130699|540513141|FG001|Overall Study|Lost to Follow-up|37|||
149831252|NCT03130699|540513142|FG002|Overall Study|Lost to Follow-up|26|||
149831253|NCT03130699|540513140|FG000|Overall Study|Withdrawal by Subject|5|||
149831254|NCT03130699|540513141|FG001|Overall Study|Withdrawal by Subject|1|||
149831255|NCT03130699|540513142|FG002|Overall Study|Withdrawal by Subject|0|||
149831256|NCT03130699|540513140|FG000|Overall Study|Withdrawal by PI|1|||
149831257|NCT03130699|540513141|FG001|Overall Study|Withdrawal by PI|2|||
149831258|NCT03130699|540513142|FG002|Overall Study|Withdrawal by PI|5|||
149831259|NCT03130699|540513140|FG000|Overall Study|Death|0|||
149831260|NCT03130699|540513141|FG001|Overall Study|Death|0|||
149831261|NCT03130699|540513142|FG002|Overall Study|Death|1|||
150177869|NCT03144674|541788244|FG003|Overall Study|Changed Physicians|1|||
149831262|NCT06354270|540513149|FG000|Overall Study|Withdrawal by Subject|1|||
149831263|NCT06354270|540513150|FG001|Overall Study|Withdrawal by Subject|0|||
149831264|NCT00680121|540513151|FG000|Overall Study|Lost to Follow-up|27|||
149831265|NCT00680121|540513152|FG001|Overall Study|Lost to Follow-up|23|||
150177870|NCT03144674|541788241|FG000|Overall Study|Removed for Safety|0|||
150177871|NCT03144674|541788242|FG001|Overall Study|Removed for Safety|0|||
150177872|NCT03144674|541788243|FG002|Overall Study|Removed for Safety|0|||
150177873|NCT03144674|541788244|FG003|Overall Study|Removed for Safety|1|||
150177874|NCT03144674|541788241|FG000|Overall Study|Site Closed|0|||
150177875|NCT03144674|541788242|FG001|Overall Study|Site Closed|0|||
150177876|NCT03144674|541788243|FG002|Overall Study|Site Closed|0|||
150177877|NCT03144674|541788244|FG003|Overall Study|Site Closed|1|||
150177878|NCT03144674|541788241|FG000|Overall Study|Histological Criteria Not Met|0|||
150177879|NCT03144674|541788242|FG001|Overall Study|Histological Criteria Not Met|0|||
150177880|NCT03144674|541788243|FG002|Overall Study|Histological Criteria Not Met|0|||
150177881|NCT03144674|541788244|FG003|Overall Study|Histological Criteria Not Met|1|||
150177882|NCT03144674|541788241|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
150177883|NCT03144674|541788242|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
150177884|NCT03144674|541788243|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
150177885|NCT03144674|541788244|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
150177886|NCT03144674|541788241|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
150177887|NCT03144674|541788242|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
150177888|NCT03144674|541788243|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
150177889|NCT03144674|541788244|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
150177890|NCT01395758|541788247|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
150177891|NCT01395758|541788248|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
150177892|NCT01395758|541788249|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
150177893|NCT03942042|541788254|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
150177894|NCT03942042|541788255|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
150177895|NCT03942042|541788254|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
150177896|NCT03942042|541788255|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
150177897|NCT05135000|541788256|FG000|Overall Study|Adverse Event|2|||
150177898|NCT05135000|541788257|FG001|Overall Study|Adverse Event|0|||
150177899|NCT05135000|541788256|FG000|Overall Study|Lost to Follow-up|1|||
150177900|NCT05135000|541788257|FG001|Overall Study|Lost to Follow-up|0|||
150177901|NCT05135000|541788256|FG000|Overall Study|Study Terminated by Sponsor|6|||
150177902|NCT05135000|541788257|FG001|Overall Study|Study Terminated by Sponsor|3|||
150177903|NCT04411056|541790280|FG000|Overall Study|surgery cancelled|1|||
150177904|NCT04411056|541790281|FG001|Overall Study|surgery cancelled|0|||
150034107|NCT02435212|541264722|FG000|Optional Extension Phase|Technical problems|2|||
150034108|NCT02435212|541264723|FG001|Optional Extension Phase|Technical problems|0|||
150034109|NCT05249582|541264724|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
150034110|NCT05249582|541264725|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
150034111|NCT05249582|541264724|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
150034112|NCT05249582|541264725|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
150034113|NCT05249582|541264724|FG000|Overall Study|Declined to use virtual reality headset|1|||
150034114|NCT05249582|541264725|FG001|Overall Study|Declined to use virtual reality headset|0|||
150034115|NCT03267277|541264726|FG000|Overall Study|Withdrawal by Subject|1|||
150034116|NCT04531176|541264744|FG000|Overall Study|Study was stopped early|24|||
150034117|NCT04531176|541264745|FG001|Overall Study|Study was stopped early|26|||
150034118|NCT04531176|541264746|FG002|Overall Study|Study was stopped early|24|||
150034119|NCT00561652|541264751|FG000|Overall Study|Withdrawal by Subject|0|||
150034120|NCT00561652|541264752|FG001|Overall Study|Withdrawal by Subject|1|||
150034121|NCT04842747|541264753|FG000|Overall Study|Withdrawal by Subject|6|||
150279411|NCT05314517|542158918|FG002|Open-label Extension|Investigator decision|1|||
150279412|NCT05314517|542158919|FG003|Open-label Extension|Investigator decision|0|||
150279413|NCT05314517|542158916|FG000|Open-label Extension|Lost to Follow-up|0|||
150279414|NCT05314517|542158917|FG001|Open-label Extension|Lost to Follow-up|0|||
150279415|NCT05314517|542158918|FG002|Open-label Extension|Lost to Follow-up|0|||
150279416|NCT05314517|542158919|FG003|Open-label Extension|Lost to Follow-up|1|||
150279417|NCT05314517|542158916|FG000|Open-label Extension|Withdrawal by Subject|0|||
150279418|NCT05314517|542158917|FG001|Open-label Extension|Withdrawal by Subject|0|||
150279419|NCT05314517|542158918|FG002|Open-label Extension|Withdrawal by Subject|1|||
150279420|NCT05314517|542158919|FG003|Open-label Extension|Withdrawal by Subject|2|||
150279421|NCT05314517|542158916|FG000|Open-label Extension|Use of prohibited medication|0|||
150279422|NCT05314517|542158917|FG001|Open-label Extension|Use of prohibited medication|0|||
150279423|NCT05314517|542158918|FG002|Open-label Extension|Use of prohibited medication|1|||
150279424|NCT05314517|542158919|FG003|Open-label Extension|Use of prohibited medication|0|||
150279425|NCT05314517|542158916|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
150279426|NCT05314517|542158917|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
150279427|NCT05314517|542158918|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
150279428|NCT05314517|542158919|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
150279429|NCT02710136|542158921|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
150279430|NCT02710136|542158922|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
150279431|NCT00798135|542158925|FG000|Overall Study|Disease progression, relapse|11|||
150279432|NCT00798135|542158925|FG000|Overall Study|Disease progression, refractory|1|||
150279433|NCT00798135|542158925|FG000|Overall Study|Physician Decision|1|||
150279434|NCT02228720|542158926|FG000|Open Label - Day 30|Lost to Follow-up|1|||
150279435|NCT01401842|542158927|FG000|Overall Study|Withdrawal by Subject|3|||
150279436|NCT01401842|542158928|FG001|Overall Study|Withdrawal by Subject|2|||
150279437|NCT01401842|542158927|FG000|Overall Study|academic reason|4|||
150279438|NCT01401842|542158928|FG001|Overall Study|academic reason|1|||
150279439|NCT01401842|542158927|FG000|Overall Study|changed companies|20|||
150279440|NCT01401842|542158928|FG001|Overall Study|changed companies|34|||
150279441|NCT01401842|542158927|FG000|Overall Study|discharged from US Army|3|||
150279442|NCT01401842|542158928|FG001|Overall Study|discharged from US Army|4|||
150279443|NCT01401842|542158927|FG000|Overall Study|invalid follow-up strength data|1|||
150279444|NCT01401842|542158928|FG001|Overall Study|invalid follow-up strength data|4|||
150279445|NCT01401842|542158927|FG000|Overall Study|on profile|9|||
150279446|NCT01401842|542158928|FG001|Overall Study|on profile|5|||
150279447|NCT01401842|542158927|FG000|Overall Study|other/unknown|28|||
150279448|NCT01401842|542158928|FG001|Overall Study|other/unknown|17|||
150279449|NCT03337542|542158929|FG000|Overall Study|Withdrew Consent|17|||
150279450|NCT03337542|542158929|FG000|Overall Study|Allergic Adverse Event|1|||
150279451|NCT03337542|542158929|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
150279452|NCT03337542|542158929|FG000|Overall Study|Lost to Follow-up|1|||
150279453|NCT03337542|542158929|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
150279454|NCT00282295|542158932|FG000|Overall Study|Adverse Event|0|||
150279455|NCT00282295|542158933|FG001|Overall Study|Adverse Event|1|||
150279456|NCT00282295|542158934|FG002|Overall Study|Adverse Event|0|||
150279457|NCT00282295|542158932|FG000|Overall Study|Serious Adverse Events|0|||
150279458|NCT00282295|542158933|FG001|Overall Study|Serious Adverse Events|0|||
150279459|NCT00282295|542158934|FG002|Overall Study|Serious Adverse Events|1|||
150279460|NCT00282295|542158932|FG000|Overall Study|Protocol Violation|0|||
150279461|NCT00282295|542158933|FG001|Overall Study|Protocol Violation|2|||
150279462|NCT00282295|542158934|FG002|Overall Study|Protocol Violation|1|||
150279463|NCT00282295|542158932|FG000|Overall Study|Withdrawal by Subject|2|||
150279464|NCT00282295|542158933|FG001|Overall Study|Withdrawal by Subject|6|||
150034122|NCT04842747|541264754|FG001|Overall Study|Withdrawal by Subject|2|||
150279465|NCT00282295|542158934|FG002|Overall Study|Withdrawal by Subject|4|||
150034123|NCT04842747|541264753|FG000|Overall Study|Lost to Follow-up|1|||
149831266|NCT02603952|540513162|FG000|Overall Study|Withdrawal by Subject|1|||
149831267|NCT02603952|540513163|FG001|Overall Study|Withdrawal by Subject|0|||
149831268|NCT02603952|540513164|FG002|Overall Study|Withdrawal by Subject|0|||
149831269|NCT02603952|540513165|FG003|Overall Study|Withdrawal by Subject|0|||
149831270|NCT02603952|540513162|FG000|Overall Study|Received oseltamivir by error|0|||
149831271|NCT02603952|540513163|FG001|Overall Study|Received oseltamivir by error|0|||
149831272|NCT02603952|540513164|FG002|Overall Study|Received oseltamivir by error|0|||
149831273|NCT02603952|540513165|FG003|Overall Study|Received oseltamivir by error|1|||
149831274|NCT00958243|540513175|FG000|Overall Study|Withdrawal by Subject|0|||
149831275|NCT00958243|540513176|FG001|Overall Study|Withdrawal by Subject|1|||
149831276|NCT00958243|540513177|FG002|Overall Study|Withdrawal by Subject|3|||
149831277|NCT00958243|540513178|FG003|Overall Study|Withdrawal by Subject|1|||
149831278|NCT00958243|540513179|FG004|Overall Study|Withdrawal by Subject|1|||
150279466|NCT00282295|542158932|FG000|Overall Study|Lost to Follow-up|1|||
149831279|NCT00958243|540513180|FG005|Overall Study|Withdrawal by Subject|5|||
149831280|NCT00958243|540513175|FG000|Overall Study|Lost to Follow-up|2|||
149831281|NCT00958243|540513176|FG001|Overall Study|Lost to Follow-up|5|||
149831282|NCT00958243|540513177|FG002|Overall Study|Lost to Follow-up|11|||
149831283|NCT00958243|540513178|FG003|Overall Study|Lost to Follow-up|2|||
150279467|NCT00282295|542158933|FG001|Overall Study|Lost to Follow-up|7|||
150279468|NCT00282295|542158934|FG002|Overall Study|Lost to Follow-up|2|||
150279469|NCT00282295|542158932|FG000|Overall Study|Other|0|||
150279470|NCT00282295|542158933|FG001|Overall Study|Other|1|||
150279471|NCT00282295|542158934|FG002|Overall Study|Other|0|||
150279472|NCT00583024|542158949|FG000|Overall Study|Lost to Follow-up|4|||
150279473|NCT03977974|542158952|FG000|Period 2|Adverse Event|0|||
150279474|NCT03977974|542158953|FG001|Period 2|Adverse Event|0|||
150279475|NCT03977974|542158954|FG002|Period 2|Adverse Event|0|||
150279476|NCT03977974|542158955|FG003|Period 2|Adverse Event|0|||
150279477|NCT03977974|542158956|FG004|Period 2|Adverse Event|1|||
150279478|NCT03977974|542158957|FG005|Period 2|Adverse Event|0|||
150279479|NCT03977974|542158958|FG006|Period 2|Adverse Event|0|||
150279480|NCT03977974|542158959|FG007|Period 2|Adverse Event|0|||
150279481|NCT03977974|542158960|FG008|Period 2|Adverse Event|0|||
150279482|NCT03977974|542158961|FG009|Period 2|Adverse Event|0|||
149831284|NCT00958243|540513179|FG004|Overall Study|Lost to Follow-up|8|||
149831285|NCT00958243|540513180|FG005|Overall Study|Lost to Follow-up|5|||
149831286|NCT04646109|540513181|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
149831287|NCT04646109|540513182|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
149831288|NCT06176768|540513183|FG000|Overall Study|Adverse Event|1|||
149948623|NCT04429971|540944780|FG000|Overall Study|Lost to Follow-up|7|||
149948624|NCT04429971|540944781|FG001|Overall Study|Lost to Follow-up|8|||
150279483|NCT03977974|542158962|FG010|Period 2|Adverse Event|0|||
150279484|NCT03977974|542158963|FG011|Period 2|Adverse Event|0|||
150279485|NCT03977974|542158964|FG012|Period 2|Adverse Event|0|||
150279486|NCT00847145|542160303|FG000|Overall Study|AE or Death|0|||
149831289|NCT06176768|540513184|FG001|Overall Study|Adverse Event|0|||
149831290|NCT06176768|540513183|FG000|Overall Study|Assigned treatment by mistake|1|||
150034124|NCT04842747|541264754|FG001|Overall Study|Lost to Follow-up|2|||
150279487|NCT00847145|542160304|FG001|Overall Study|AE or Death|1|||
150279488|NCT00847145|542160305|FG002|Overall Study|AE or Death|1|||
149831291|NCT06176768|540513184|FG001|Overall Study|Assigned treatment by mistake|0|||
149831292|NCT06176768|540513183|FG000|Overall Study|Lost to Follow-up|0|||
149831293|NCT06176768|540513184|FG001|Overall Study|Lost to Follow-up|3|||
149831294|NCT06176768|540513183|FG000|Overall Study|Physician Decision|1|||
149831295|NCT06176768|540513184|FG001|Overall Study|Physician Decision|0|||
149831296|NCT06176768|540513183|FG000|Overall Study|Protocol deviation|3|||
149831297|NCT06176768|540513184|FG001|Overall Study|Protocol deviation|1|||
149831298|NCT06176768|540513183|FG000|Overall Study|Other|1|||
149831299|NCT06176768|540513184|FG001|Overall Study|Other|0|||
149831300|NCT06176768|540513183|FG000|Overall Study|Withdrawal by Subject|6|||
149831301|NCT06176768|540513184|FG001|Overall Study|Withdrawal by Subject|9|||
149831302|NCT01226797|540513185|FG000|Overall Study|Adverse Event|1|||
149831303|NCT01226797|540513186|FG001|Overall Study|Adverse Event|0|||
149831304|NCT01226797|540513185|FG000|Overall Study|No longer willing to participate|1|||
149831305|NCT01226797|540513186|FG001|Overall Study|No longer willing to participate|0|||
149831306|NCT01226797|540513185|FG000|Overall Study|Protocol Violation|0|||
149831307|NCT01226797|540513186|FG001|Overall Study|Protocol Violation|1|||
149831308|NCT00577460|540513189|FG000|Overall Study|Adverse Event|11|||
149831309|NCT00577460|540513190|FG001|Overall Study|Adverse Event|7|||
149831310|NCT00577460|540513191|FG002|Overall Study|Adverse Event|14|||
149831311|NCT00577460|540513189|FG000|Overall Study|Protocol Violation|0|||
149831312|NCT00577460|540513190|FG001|Overall Study|Protocol Violation|1|||
149831313|NCT00577460|540513191|FG002|Overall Study|Protocol Violation|1|||
149948644|NCT04044690|540944790|FG000|Period 1|Lack of Efficacy|1|||
149948645|NCT04044690|540944791|FG001|Period 1|Lack of Efficacy|1|||
149948646|NCT04044690|540944790|FG000|Period 1|Adverse Event|4|||
149948647|NCT04044690|540944791|FG001|Period 1|Adverse Event|2|||
149948648|NCT04044690|540944790|FG000|Period 1|Physician Decision|0|||
149948649|NCT04044690|540944791|FG001|Period 1|Physician Decision|1|||
149948650|NCT04044690|540944790|FG000|Period 1|Withdrawal by Subject|2|||
149948651|NCT04044690|540944791|FG001|Period 1|Withdrawal by Subject|5|||
149948652|NCT04044690|540944790|FG000|Period 1|Protocol Deviation|2|||
149948653|NCT04044690|540944791|FG001|Period 1|Protocol Deviation|0|||
149948654|NCT04044690|540944790|FG000|Period 1|Site Terminated by Sponsor|0|||
149948655|NCT04044690|540944791|FG001|Period 1|Site Terminated by Sponsor|1|||
149948656|NCT04044690|540944790|FG000|Period 1|Study Terminated by Sponsor|0|||
150171197|NCT02224924|541763407|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
150171198|NCT00545844|541763409|FG000|Overall Study|Lost to Follow-up|9|||
149948657|NCT04044690|540944791|FG001|Period 1|Study Terminated by Sponsor|1|||
149948658|NCT04044690|540944790|FG000|Period 1|Death|1|||
149948659|NCT04044690|540944791|FG001|Period 1|Death|1|||
149948660|NCT04044690|540944790|FG000|Period 1|Other: Unspecified|1|||
149948661|NCT04044690|540944791|FG001|Period 1|Other: Unspecified|0|||
149948662|NCT04044690|540944790|FG000|Period 2|Lack of Efficacy|0|||
149948663|NCT04044690|540944791|FG001|Period 2|Lack of Efficacy|1|||
149948664|NCT04044690|540944790|FG000|Period 2|Adverse Event|0|||
149948665|NCT04044690|540944791|FG001|Period 2|Adverse Event|1|||
149948666|NCT04044690|540944790|FG000|Period 2|Physician Decision|0|||
149948667|NCT04044690|540944791|FG001|Period 2|Physician Decision|2|||
149948668|NCT04044690|540944790|FG000|Period 2|Withdrawal by Subject|5|||
149948669|NCT04044690|540944791|FG001|Period 2|Withdrawal by Subject|5|||
149948670|NCT04044690|540944790|FG000|Period 2|Lost to Follow-up|0|||
149948671|NCT04044690|540944791|FG001|Period 2|Lost to Follow-up|1|||
149948672|NCT04044690|540944790|FG000|Period 2|Site Terminated by Sponsor|1|||
149948673|NCT04044690|540944791|FG001|Period 2|Site Terminated by Sponsor|3|||
149948674|NCT04044690|540944790|FG000|Period 2|Study Terminated by Sponsor|8|||
149948675|NCT04044690|540944791|FG001|Period 2|Study Terminated by Sponsor|3|||
149948676|NCT04044690|540944790|FG000|Period 2|Death|1|||
150171199|NCT00545844|541763409|FG000|Overall Study|Protocol Violation|1|||
150171200|NCT00545844|541763409|FG000|Overall Study|Withdrawal by Subject|2|||
150171201|NCT01329328|541763410|FG000|Overall Study|Withdrawal by Subject|2|||
150171202|NCT01329328|541763411|FG001|Overall Study|Withdrawal by Subject|4|||
150171203|NCT01329328|541763412|FG002|Overall Study|Withdrawal by Subject|3|||
150171204|NCT02506257|541763421|FG000|Overall Study|Adverse Event|0|||
150171205|NCT02506257|541763422|FG001|Overall Study|Adverse Event|2|||
150171206|NCT02506257|541763423|FG002|Overall Study|Adverse Event|3|||
150171207|NCT02506257|541763424|FG003|Overall Study|Adverse Event|0|||
150171208|NCT02506257|541763421|FG000|Overall Study|Protocol Violation|0|||
150171209|NCT02506257|541763422|FG001|Overall Study|Protocol Violation|0|||
149831314|NCT00577460|540513189|FG000|Overall Study|Lost to Follow-up|0|||
150279489|NCT00847145|542160306|FG003|Overall Study|AE or Death|0|||
150279490|NCT00847145|542160307|FG004|Overall Study|AE or Death|0|||
150279491|NCT00847145|542160308|FG005|Overall Study|AE or Death|0|||
150279492|NCT00847145|542160309|FG006|Overall Study|AE or Death|0|||
150279493|NCT00847145|542160310|FG007|Overall Study|AE or Death|0|||
150279494|NCT00847145|542160303|FG000|Overall Study|Withdrawal by Subject|3|||
150279495|NCT00847145|542160304|FG001|Overall Study|Withdrawal by Subject|4|||
150279496|NCT00847145|542160305|FG002|Overall Study|Withdrawal by Subject|6|||
150279497|NCT00847145|542160306|FG003|Overall Study|Withdrawal by Subject|1|||
150279498|NCT00847145|542160307|FG004|Overall Study|Withdrawal by Subject|0|||
150279499|NCT00847145|542160308|FG005|Overall Study|Withdrawal by Subject|0|||
150279500|NCT00847145|542160309|FG006|Overall Study|Withdrawal by Subject|1|||
150279501|NCT00847145|542160310|FG007|Overall Study|Withdrawal by Subject|1|||
150279502|NCT00847145|542160303|FG000|Overall Study|Lost to Follow-up|3|||
150279503|NCT00847145|542160304|FG001|Overall Study|Lost to Follow-up|1|||
150279504|NCT00847145|542160305|FG002|Overall Study|Lost to Follow-up|1|||
150279505|NCT00847145|542160306|FG003|Overall Study|Lost to Follow-up|0|||
150279506|NCT00847145|542160307|FG004|Overall Study|Lost to Follow-up|4|||
150279507|NCT00847145|542160308|FG005|Overall Study|Lost to Follow-up|4|||
150279508|NCT00847145|542160309|FG006|Overall Study|Lost to Follow-up|8|||
150279509|NCT00847145|542160310|FG007|Overall Study|Lost to Follow-up|2|||
150279510|NCT00847145|542160303|FG000|Overall Study|Inappropriate enrollment|0|||
150279511|NCT00847145|542160304|FG001|Overall Study|Inappropriate enrollment|0|||
150279512|NCT00847145|542160305|FG002|Overall Study|Inappropriate enrollment|0|||
150279513|NCT00847145|542160306|FG003|Overall Study|Inappropriate enrollment|0|||
150279514|NCT00847145|542160307|FG004|Overall Study|Inappropriate enrollment|1|||
150279515|NCT00847145|542160308|FG005|Overall Study|Inappropriate enrollment|0|||
150279516|NCT00847145|542160309|FG006|Overall Study|Inappropriate enrollment|0|||
150279517|NCT00847145|542160310|FG007|Overall Study|Inappropriate enrollment|0|||
150279518|NCT00847145|542160303|FG000|Overall Study|Protocol Violation|0|||
150279519|NCT00847145|542160304|FG001|Overall Study|Protocol Violation|0|||
150279520|NCT00847145|542160305|FG002|Overall Study|Protocol Violation|3|||
150279521|NCT00847145|542160306|FG003|Overall Study|Protocol Violation|0|||
150279522|NCT00847145|542160307|FG004|Overall Study|Protocol Violation|1|||
150279523|NCT00847145|542160308|FG005|Overall Study|Protocol Violation|0|||
150279524|NCT00847145|542160309|FG006|Overall Study|Protocol Violation|0|||
150279525|NCT00847145|542160310|FG007|Overall Study|Protocol Violation|1|||
150279526|NCT00307151|542160311|FG000|Overall Study|Death|4|||
150279527|NCT00307151|542160312|FG001|Overall Study|Death|3|||
150279528|NCT00307151|542160313|FG002|Overall Study|Death|10|||
150279529|NCT00307151|542160314|FG003|Overall Study|Death|3|||
150279530|NCT00307151|542160311|FG000|Overall Study|Severe debilitation, unable to continue|1|||
150279531|NCT00307151|542160312|FG001|Overall Study|Severe debilitation, unable to continue|0|||
150279532|NCT00307151|542160313|FG002|Overall Study|Severe debilitation, unable to continue|0|||
150279533|NCT00307151|542160314|FG003|Overall Study|Severe debilitation, unable to continue|0|||
150279534|NCT00307151|542160311|FG000|Overall Study|Subject unable to get to clinic|1|||
150279535|NCT00307151|542160312|FG001|Overall Study|Subject unable to get to clinic|0|||
150279536|NCT00307151|542160313|FG002|Overall Study|Subject unable to get to clinic|6|||
150279537|NCT00307151|542160314|FG003|Overall Study|Subject unable to get to clinic|2|||
150279538|NCT00307151|542160311|FG000|Overall Study|Withdrew consent|0|||
150279539|NCT00307151|542160312|FG001|Overall Study|Withdrew consent|1|||
150279540|NCT00307151|542160313|FG002|Overall Study|Withdrew consent|1|||
150279541|NCT00307151|542160314|FG003|Overall Study|Withdrew consent|3|||
150279542|NCT00307151|542160311|FG000|Overall Study|Not willing to adhere to study reqs|2|||
150279543|NCT00307151|542160312|FG001|Overall Study|Not willing to adhere to study reqs|0|||
150279544|NCT00307151|542160313|FG002|Overall Study|Not willing to adhere to study reqs|2|||
149948677|NCT04044690|540944791|FG001|Period 2|Death|0|||
149948678|NCT04044690|540944790|FG000|Period 2|Other: Unspecified|1|||
149948679|NCT04044690|540944791|FG001|Period 2|Other: Unspecified|1|||
149948680|NCT04044690|540944790|FG000|Period 3|Site Terminated by Sponsor|1|||
149948681|NCT04044690|540944791|FG001|Period 3|Site Terminated by Sponsor|2|||
149948682|NCT04044690|540944790|FG000|Period 3|Study Terminated by Sponsor|24|||
149948683|NCT04044690|540944791|FG001|Period 3|Study Terminated by Sponsor|18|||
149948684|NCT04044690|540944790|FG000|Period 3|Missing|0|||
149948685|NCT04044690|540944791|FG001|Period 3|Missing|2|||
150034125|NCT04842747|541264753|FG000|Overall Study|Physician Decision|1|||
150279545|NCT00307151|542160314|FG003|Overall Study|Not willing to adhere to study reqs|2|||
150279546|NCT00307151|542160311|FG000|Overall Study|Clinic unable to contact subject|3|||
150279547|NCT00307151|542160312|FG001|Overall Study|Clinic unable to contact subject|3|||
150279548|NCT00307151|542160313|FG002|Overall Study|Clinic unable to contact subject|1|||
150279549|NCT00307151|542160314|FG003|Overall Study|Clinic unable to contact subject|1|||
150279550|NCT00346073|542160315|FG000|Overall Study|Serious Adverse Event|2|||
150279551|NCT00346073|542160316|FG001|Overall Study|Serious Adverse Event|0|||
149831315|NCT00577460|540513190|FG001|Overall Study|Lost to Follow-up|3|||
149831316|NCT00577460|540513191|FG002|Overall Study|Lost to Follow-up|4|||
149831317|NCT00577460|540513189|FG000|Overall Study|Withdrawal by Subject|5|||
149831318|NCT00577460|540513190|FG001|Overall Study|Withdrawal by Subject|5|||
149831319|NCT00577460|540513191|FG002|Overall Study|Withdrawal by Subject|6|||
149831320|NCT00577460|540513189|FG000|Overall Study|Other|0|||
149831321|NCT00577460|540513190|FG001|Overall Study|Other|3|||
149831322|NCT00577460|540513191|FG002|Overall Study|Other|2|||
149831323|NCT01936948|540513195|FG000|Overall Study|no 30-day follow-up data|0|||
149831324|NCT01936948|540513196|FG001|Overall Study|no 30-day follow-up data|3|||
149831325|NCT01936948|540513197|FG002|Overall Study|no 30-day follow-up data|3|||
149831326|NCT01936948|540513198|FG003|Overall Study|no 30-day follow-up data|3|||
149831327|NCT02365207|540513199|FG000|Overall Study|Withdrawal by Subject|1|||
149831328|NCT02365207|540513199|FG000|Overall Study|Physician Decision|1|||
149831329|NCT01318499|540513202|FG000|Overall Study|Adverse Event|16|||
149831330|NCT01318499|540513203|FG001|Overall Study|Adverse Event|11|||
149831331|NCT01318499|540513204|FG002|Overall Study|Adverse Event|6|||
149831332|NCT01318499|540513202|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
149831333|NCT01318499|540513203|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
149831334|NCT01318499|540513204|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
149831335|NCT01318499|540513202|FG000|Overall Study|Noncompliance|2|||
149831336|NCT01318499|540513203|FG001|Overall Study|Noncompliance|3|||
149831337|NCT01318499|540513204|FG002|Overall Study|Noncompliance|0|||
149831338|NCT01318499|540513202|FG000|Overall Study|Treatment Failure|19|||
149831339|NCT01318499|540513203|FG001|Overall Study|Treatment Failure|19|||
149831340|NCT01318499|540513204|FG002|Overall Study|Treatment Failure|101|||
149831341|NCT01318499|540513202|FG000|Overall Study|Protocol Violation|2|||
149831342|NCT01318499|540513203|FG001|Overall Study|Protocol Violation|4|||
149831343|NCT01318499|540513204|FG002|Overall Study|Protocol Violation|2|||
149831344|NCT01318499|540513202|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
149831345|NCT01318499|540513203|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
149831346|NCT01318499|540513204|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
149831347|NCT01318499|540513202|FG000|Overall Study|Other|7|||
149831348|NCT01318499|540513203|FG001|Overall Study|Other|10|||
149831349|NCT01318499|540513204|FG002|Overall Study|Other|22|||
149831350|NCT01395030|540513205|FG000|Overall Study|Did not complete FCH PET/CT|7|||
149831351|NCT01974141|540513209|FG000|Overall Study|Other Reasons|28|||
149831352|NCT01974141|540513210|FG001|Overall Study|Other Reasons|18|||
149831353|NCT01974141|540513209|FG000|Overall Study|Protocol Violation|2|||
149831354|NCT01974141|540513210|FG001|Overall Study|Protocol Violation|6|||
149831355|NCT01974141|540513209|FG000|Overall Study|Personal Reasons|21|||
149831356|NCT01974141|540513210|FG001|Overall Study|Personal Reasons|20|||
149831357|NCT01974141|540513209|FG000|Overall Study|Lost to Follow-up|38|||
149831358|NCT01974141|540513210|FG001|Overall Study|Lost to Follow-up|29|||
149831359|NCT01974141|540513209|FG000|Overall Study|Pregnancy|3|||
149831360|NCT01974141|540513210|FG001|Overall Study|Pregnancy|3|||
149831361|NCT01974141|540513209|FG000|Overall Study|Lack of Efficacy|0|||
149831362|NCT01974141|540513210|FG001|Overall Study|Lack of Efficacy|1|||
149831363|NCT01974141|540513209|FG000|Overall Study|Adverse Event|4|||
149831364|NCT01974141|540513210|FG001|Overall Study|Adverse Event|5|||
149831365|NCT04977336|540513213|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
149831366|NCT04977336|540513214|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
149831367|NCT04977336|540513215|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
149831368|NCT04977336|540513216|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
149831369|NCT04977336|540513217|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
149831370|NCT04977336|540513213|FG000|Overall Study|Lost to Follow-up|0|||
149831371|NCT04977336|540513214|FG001|Overall Study|Lost to Follow-up|0|||
149831372|NCT04977336|540513215|FG002|Overall Study|Lost to Follow-up|1|||
149831373|NCT04977336|540513216|FG003|Overall Study|Lost to Follow-up|0|||
149831374|NCT04977336|540513217|FG004|Overall Study|Lost to Follow-up|0|||
149831375|NCT01606306|540513220|FG000|Overall Study|Lack of Efficacy|2|||
149831376|NCT01606306|540513221|FG001|Overall Study|Lack of Efficacy|1|||
149831377|NCT01606306|540513222|FG002|Overall Study|Lack of Efficacy|4|||
150171210|NCT02506257|541763423|FG002|Overall Study|Protocol Violation|1|||
149831378|NCT01606306|540513223|FG003|Overall Study|Lack of Efficacy|4|||
149831379|NCT01606306|540513224|FG004|Overall Study|Lack of Efficacy|1|||
149831380|NCT01606306|540513225|FG005|Overall Study|Lack of Efficacy|2|||
149831381|NCT01606306|540513220|FG000|Overall Study|Adverse Event|1|||
149831382|NCT01606306|540513221|FG001|Overall Study|Adverse Event|0|||
149831383|NCT01606306|540513222|FG002|Overall Study|Adverse Event|1|||
149831384|NCT01606306|540513223|FG003|Overall Study|Adverse Event|1|||
149831385|NCT01606306|540513224|FG004|Overall Study|Adverse Event|2|||
149831386|NCT01606306|540513225|FG005|Overall Study|Adverse Event|0|||
149831387|NCT01606306|540513220|FG000|Overall Study|Lost to Follow-up|7|||
149831388|NCT01606306|540513221|FG001|Overall Study|Lost to Follow-up|4|||
150171211|NCT02506257|541763424|FG003|Overall Study|Protocol Violation|0|||
149831389|NCT01606306|540513222|FG002|Overall Study|Lost to Follow-up|5|||
149831390|NCT01606306|540513223|FG003|Overall Study|Lost to Follow-up|4|||
150279552|NCT00346073|542160315|FG000|Overall Study|Lost to Follow-up|39|||
150279553|NCT00346073|542160316|FG001|Overall Study|Lost to Follow-up|24|||
150279554|NCT00980200|542160321|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
150279555|NCT00980200|542160322|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
150279556|NCT00980200|542160323|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
150279557|NCT00980200|542160324|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
150279558|NCT00980200|542160325|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
150279559|NCT00980200|542160321|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
150279560|NCT00980200|542160322|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
150279561|NCT00980200|542160323|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
150279562|NCT00980200|542160324|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
150279563|NCT00980200|542160325|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
150279564|NCT01617460|542160326|FG000|Overall Study|Adverse Event|10|||
150279565|NCT01617460|542160326|FG000|Overall Study|Physician Decision|16|||
150279566|NCT01617460|542160326|FG000|Overall Study|Protocol Violation|5|||
150279567|NCT01617460|542160326|FG000|Overall Study|Withdrawal by Subject|9|||
150279568|NCT00054704|542160328|FG000|Overall Study|Lack of Efficacy|2|||
150279569|NCT00054704|542160329|FG001|Overall Study|Lack of Efficacy|3|||
150279570|NCT00054704|542160328|FG000|Overall Study|Adverse Event|3|||
150279571|NCT00054704|542160329|FG001|Overall Study|Adverse Event|1|||
150279572|NCT00054704|542160328|FG000|Overall Study|Lost to Follow-up|0|||
150279573|NCT00054704|542160329|FG001|Overall Study|Lost to Follow-up|1|||
150279574|NCT00362414|542160330|FG000|Overall Study|Death|2|||
150279575|NCT00362414|542160330|FG000|Overall Study|Adverse Event|1|||
150279576|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
150279577|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
150279578|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
150279579|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
150279580|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
150279581|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
150279582|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Death|2|||
150279583|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Death|0|||
150279584|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
150279585|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
150279586|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
150279587|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
150279588|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
150279589|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
150279590|NCT02603120|542160331|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
150279591|NCT02603120|542160332|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
150279592|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
150279593|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
150279594|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
150279595|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
150279596|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
150279597|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
150279598|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
150279599|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
150279600|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
150279601|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
150279602|NCT02603120|542160331|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
150279603|NCT02603120|542160332|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
150279604|NCT01469182|542160335|FG000|Overall Study|Adverse Event|21|||
150279605|NCT01469182|542160336|FG001|Overall Study|Adverse Event|3|||
150279606|NCT01469182|542160335|FG000|Overall Study|Lost to Follow-up|3|||
150279607|NCT01469182|542160336|FG001|Overall Study|Lost to Follow-up|0|||
150279608|NCT01469182|542160335|FG000|Overall Study|Withdrawal by Subject|4|||
150279609|NCT01469182|542160336|FG001|Overall Study|Withdrawal by Subject|1|||
150279610|NCT01469182|542160335|FG000|Overall Study|Protocol Violation|4|||
150279611|NCT01469182|542160336|FG001|Overall Study|Protocol Violation|2|||
150279612|NCT01469182|542160335|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
150279613|NCT01469182|542160336|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
150279614|NCT01321710|542160339|FG000|Overall Study|Lost to Follow-up|4|||
150279615|NCT01321710|542160340|FG001|Overall Study|Lost to Follow-up|5|||
150279616|NCT01321710|542160341|FG002|Overall Study|Lost to Follow-up|0|||
150279617|NCT01761292|542160343|FG000|Part 1|Adverse Event|1|||
150279618|NCT01761292|542160343|FG000|Part 1|not receiving treatment in Part 1|1|||
149831391|NCT01606306|540513224|FG004|Overall Study|Lost to Follow-up|3|||
150279619|NCT01761292|542160343|FG000|Extension 1|Withdrawal by Subject|1|||
150279620|NCT00916357|542160344|FG000|Period 1|Withdrawal by Subject|1|||
150279621|NCT00916357|542160345|FG001|Period 1|Withdrawal by Subject|0|||
150279622|NCT00916357|542160346|FG002|Period 1|Withdrawal by Subject|0|||
150279623|NCT00916357|542160347|FG003|Period 1|Withdrawal by Subject|0|||
149831392|NCT01606306|540513225|FG005|Overall Study|Lost to Follow-up|5|||
149831393|NCT01606306|540513220|FG000|Overall Study|Withdrawal by Subject|4|||
149831394|NCT01606306|540513221|FG001|Overall Study|Withdrawal by Subject|3|||
149831395|NCT01606306|540513222|FG002|Overall Study|Withdrawal by Subject|4|||
149831396|NCT01606306|540513223|FG003|Overall Study|Withdrawal by Subject|4|||
149831397|NCT01606306|540513224|FG004|Overall Study|Withdrawal by Subject|5|||
149831398|NCT01606306|540513225|FG005|Overall Study|Withdrawal by Subject|4|||
149831399|NCT01606306|540513220|FG000|Overall Study|Physician Decision|1|||
149831400|NCT01606306|540513221|FG001|Overall Study|Physician Decision|2|||
149831401|NCT01606306|540513222|FG002|Overall Study|Physician Decision|0|||
149831402|NCT01606306|540513223|FG003|Overall Study|Physician Decision|0|||
149831403|NCT01606306|540513224|FG004|Overall Study|Physician Decision|0|||
149831404|NCT01606306|540513225|FG005|Overall Study|Physician Decision|0|||
149831405|NCT01759290|540513226|FG000|Overall Study|Subjects withdrawn consent|5|||
149831406|NCT01759290|540513226|FG000|Overall Study|Physician Decision|2|||
149831407|NCT01759290|540513226|FG000|Overall Study|Death|17|||
149831408|NCT01759290|540513226|FG000|Overall Study|Lost to Follow-up|53|||
149831409|NCT01759290|540513226|FG000|Overall Study|Unknown reason|4|||
149831410|NCT03629249|540513227|FG000|Overall Study|Study terminated by sponsor|197|||
149831411|NCT03629249|540513228|FG001|Overall Study|Study terminated by sponsor|197|||
149831412|NCT03629249|540513229|FG002|Overall Study|Study terminated by sponsor|194|||
149831413|NCT03629249|540513227|FG000|Overall Study|Protocol deviation|0|||
149831414|NCT03629249|540513228|FG001|Overall Study|Protocol deviation|2|||
149831415|NCT03629249|540513229|FG002|Overall Study|Protocol deviation|5|||
149831416|NCT03629249|540513227|FG000|Overall Study|Subject decision|1|||
149831417|NCT03629249|540513228|FG001|Overall Study|Subject decision|1|||
149831418|NCT03629249|540513229|FG002|Overall Study|Subject decision|3|||
149831419|NCT03629249|540513227|FG000|Overall Study|Adverse Event|1|||
149831420|NCT03629249|540513228|FG001|Overall Study|Adverse Event|1|||
149831421|NCT03629249|540513229|FG002|Overall Study|Adverse Event|0|||
149831422|NCT03629249|540513227|FG000|Overall Study|Death|1|||
149831423|NCT03629249|540513228|FG001|Overall Study|Death|0|||
149831424|NCT03629249|540513229|FG002|Overall Study|Death|0|||
149831425|NCT03629249|540513227|FG000|Overall Study|Physician Decision|1|||
149831426|NCT03629249|540513228|FG001|Overall Study|Physician Decision|0|||
149831427|NCT03629249|540513229|FG002|Overall Study|Physician Decision|0|||
149831428|NCT00352690|540513230|FG000|Overall Study|Determined to be ineligible|2|||
149831429|NCT00352690|540513231|FG001|Overall Study|Determined to be ineligible|0|||
149831430|NCT01475474|540513232|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
149831431|NCT01475474|540513232|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
149831432|NCT06096168|540513233|FG000|Overall Study|Death|30|||
149831433|NCT06096168|540513233|FG000|Overall Study|Revision|2|||
149831434|NCT01471522|540513240|FG000|Overall Study|Withdrawal by Subject|28|||
149831435|NCT01471522|540513241|FG001|Overall Study|Withdrawal by Subject|22|||
149831436|NCT01471522|540513240|FG000|Overall Study|Lost to Follow-up|36|||
149831437|NCT01471522|540513241|FG001|Overall Study|Lost to Follow-up|26|||
149831438|NCT01691248|540513242|FG000|Overall Study|Protocol Violation|43|||
149831439|NCT01691248|540513243|FG001|Overall Study|Protocol Violation|27|||
149831440|NCT01691248|540513242|FG000|Overall Study|Adverse Event|24|||
149831441|NCT01691248|540513243|FG001|Overall Study|Adverse Event|22|||
149831442|NCT01691248|540513242|FG000|Overall Study|Withdrawal by Subject|20|||
149831443|NCT01691248|540513243|FG001|Overall Study|Withdrawal by Subject|18|||
149831444|NCT01691248|540513242|FG000|Overall Study|Confirmed CDAD|14|||
149831445|NCT01691248|540513243|FG001|Overall Study|Confirmed CDAD|31|||
149831446|NCT01691248|540513242|FG000|Overall Study|Lost to Follow-up|2|||
149831447|NCT01691248|540513243|FG001|Overall Study|Lost to Follow-up|5|||
149831448|NCT01691248|540513242|FG000|Overall Study|Reason not provided|4|||
149831449|NCT01691248|540513243|FG001|Overall Study|Reason not provided|4|||
149831450|NCT01691248|540513242|FG000|Overall Study|Not Treated|4|||
150279624|NCT00916357|542160348|FG004|Period 1|Withdrawal by Subject|0|||
150279625|NCT00916357|542160349|FG005|Period 1|Withdrawal by Subject|0|||
150279626|NCT00916357|542160344|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
150034126|NCT04842747|541264754|FG001|Overall Study|Physician Decision|0|||
150051992|NCT00717236|541332848|FG001|Double-Blind Period|Other: Site withdrew|0|||
150279627|NCT00916357|542160345|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
150279628|NCT00916357|542160346|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
150279629|NCT00916357|542160347|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
149831451|NCT01691248|540513243|FG001|Overall Study|Not Treated|7|||
150279630|NCT00916357|542160348|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
149831452|NCT02863575|540513244|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
150279631|NCT00916357|542160349|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
150279632|NCT03577730|542160350|FG000|Overall Study|Physician Decision|3|||
149831453|NCT02863575|540513245|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
149831454|NCT02863575|540513246|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
149831455|NCT02863575|540513244|FG000|Overall Study|Withdrawal by Subject|0|||
149831456|NCT02863575|540513245|FG001|Overall Study|Withdrawal by Subject|1|||
149831457|NCT02863575|540513246|FG002|Overall Study|Withdrawal by Subject|1|||
149831458|NCT02863575|540513244|FG000|Overall Study|Adverse Event|0|||
149831459|NCT02863575|540513245|FG001|Overall Study|Adverse Event|1|||
149831460|NCT02863575|540513246|FG002|Overall Study|Adverse Event|0|||
149831461|NCT04349917|540514896|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
149831462|NCT04349917|540514897|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
149831463|NCT04349917|540514896|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
149831464|NCT04349917|540514897|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
149831465|NCT05628675|540514908|FG000|Overall Study|Lost to Follow-up|2|||
149831466|NCT05628675|540514908|FG000|Overall Study|Withdrawal by Subject|1|||
149831467|NCT00088829|540514911|FG000|Overall Study|PI left institution and study was close|22|||
149831468|NCT01367275|540514912|FG000|Overall Study|Ineligible|1|||
149831469|NCT01367275|540514912|FG000|Overall Study|Disease Progression|2|||
149831470|NCT01648166|540514913|FG000|Overall Study|inadequate toenail samples|53|||
149831471|NCT01648166|540514914|FG001|Overall Study|inadequate toenail samples|100|||
149831472|NCT00883090|540514915|FG000|Overall Study|Sponsor's decision|1|||
149831473|NCT00883090|540514915|FG000|Overall Study|Withdrawal by Subject|1|||
149831474|NCT02532764|540514916|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831475|NCT02532764|540514917|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831476|NCT02532764|540514918|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831477|NCT02532764|540514919|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831478|NCT02532764|540514920|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831479|NCT02532764|540514921|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831480|NCT02532764|540514922|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
149831481|NCT02532764|540514923|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
149831482|NCT02532764|540514924|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
149831483|NCT02532764|540514925|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
149831484|NCT01475838|540514926|FG000|Randomized Phase|Randomized but Not Treated|0|||
150279633|NCT03577730|542160351|FG001|Overall Study|Physician Decision|1|||
150279634|NCT03577730|542160350|FG000|Overall Study|Did not receive allocated intervention|1|||
150279635|NCT03577730|542160351|FG001|Overall Study|Did not receive allocated intervention|0|||
150279636|NCT00003535|542160352|FG000|Overall Study|Not evaluable|5|||
150279637|NCT02289742|542160353|FG000|First Wear Period|Adverse event prior to treatment|0|||
150279638|NCT02289742|542160354|FG001|First Wear Period|Adverse event prior to treatment|1|||
150279639|NCT02289742|542160355|FG002|First Wear Period|Adverse event prior to treatment|0|||
150279640|NCT02289742|542160356|FG003|First Wear Period|Adverse event prior to treatment|0|||
150279641|NCT02289742|542160353|FG000|First Wear Period|Adverse Event|0|||
150279642|NCT02289742|542160354|FG001|First Wear Period|Adverse Event|0|||
150279643|NCT02289742|542160355|FG002|First Wear Period|Adverse Event|1|||
150279644|NCT02289742|542160356|FG003|First Wear Period|Adverse Event|0|||
150279645|NCT02289742|542160353|FG000|First Wear Period|Other prior to treatment|0|||
150279646|NCT02289742|542160354|FG001|First Wear Period|Other prior to treatment|0|||
150279647|NCT02289742|542160355|FG002|First Wear Period|Other prior to treatment|0|||
150279648|NCT02289742|542160356|FG003|First Wear Period|Other prior to treatment|1|||
150279649|NCT02289742|542160353|FG000|Third Wear Period|Adverse Event|0|||
150279650|NCT02289742|542160354|FG001|Third Wear Period|Adverse Event|1|||
150279651|NCT02289742|542160355|FG002|Third Wear Period|Adverse Event|0|||
150279652|NCT02289742|542160356|FG003|Third Wear Period|Adverse Event|0|||
150279653|NCT02289742|542160353|FG000|Third Wear Period|Reason not given|0|||
150279654|NCT02289742|542160354|FG001|Third Wear Period|Reason not given|0|||
150279655|NCT02289742|542160355|FG002|Third Wear Period|Reason not given|0|||
150279656|NCT02289742|542160356|FG003|Third Wear Period|Reason not given|1|||
150279657|NCT01360554|542160357|FG000|Overall Study|Death|359|||
150279658|NCT01360554|542160358|FG001|Overall Study|Death|371|||
150279659|NCT01360554|542160357|FG000|Overall Study|Lost to Follow-up|4|||
150279660|NCT01360554|542160358|FG001|Overall Study|Lost to Follow-up|4|||
150279661|NCT01360554|542160357|FG000|Overall Study|Withdrawal by Subject|23|||
149831485|NCT01475838|540514927|FG001|Randomized Phase|Randomized but Not Treated|5|||
149831486|NCT01475838|540514926|FG000|Randomized Phase|Adverse Event|6|||
149831487|NCT01475838|540514927|FG001|Randomized Phase|Adverse Event|1|||
150279662|NCT01360554|542160358|FG001|Overall Study|Withdrawal by Subject|24|||
150279663|NCT01360554|542160357|FG000|Overall Study|Study terminated by sponsor|49|||
150279664|NCT01360554|542160358|FG001|Overall Study|Study terminated by sponsor|37|||
150279665|NCT01360554|542160357|FG000|Overall Study|Other, not specified|1|||
150279666|NCT01360554|542160358|FG001|Overall Study|Other, not specified|0|||
150279667|NCT01360554|542160357|FG000|Overall Study|Randomized but not treated.|3|||
150279668|NCT01360554|542160358|FG001|Overall Study|Randomized but not treated.|3|||
150279669|NCT01911442|542160359|FG000|Overall Study|Adverse Event|2|||
150279670|NCT01911442|542160360|FG001|Overall Study|Adverse Event|2|||
149831488|NCT01475838|540514926|FG000|Randomized Phase|Pregnancy|0|||
149831489|NCT01475838|540514927|FG001|Randomized Phase|Pregnancy|1|||
149831490|NCT01475838|540514926|FG000|Randomized Phase|Investigators Discretion|1|||
149831491|NCT01475838|540514927|FG001|Randomized Phase|Investigators Discretion|2|||
149831492|NCT01475838|540514926|FG000|Randomized Phase|Withdrew Consent|10|||
149831493|NCT01475838|540514927|FG001|Randomized Phase|Withdrew Consent|14|||
149831494|NCT01475838|540514926|FG000|Randomized Phase|Lost to Follow-up|3|||
149831495|NCT01475838|540514927|FG001|Randomized Phase|Lost to Follow-up|4|||
149831496|NCT01475838|540514926|FG000|Randomized Phase|Participant Noncompliance|1|||
149831497|NCT01475838|540514927|FG001|Randomized Phase|Participant Noncompliance|5|||
149831498|NCT01475838|540514926|FG000|Randomized Phase|Protocol Violation|9|||
149831499|NCT01475838|540514927|FG001|Randomized Phase|Protocol Violation|4|||
149831500|NCT01475838|540514926|FG000|Extension Phase|Participant Noncompliance|1|||
149831501|NCT01475838|540514927|FG001|Extension Phase|Participant Noncompliance|0|||
149831502|NCT01717976|540514928|FG000|Overall Study|Protocol Violation|0|||
149831503|NCT01717976|540514929|FG001|Overall Study|Protocol Violation|1|||
149831504|NCT02932878|540514949|FG000|Overall Study|Due to Lab Results|2|||
150279671|NCT01911442|542160361|FG002|Overall Study|Adverse Event|4|||
150279672|NCT01911442|542160359|FG000|Overall Study|Lack of Efficacy|1|||
150279673|NCT01911442|542160360|FG001|Overall Study|Lack of Efficacy|1|||
150279674|NCT01911442|542160361|FG002|Overall Study|Lack of Efficacy|1|||
150279675|NCT01911442|542160359|FG000|Overall Study|Lost to Follow-up|2|||
150279676|NCT01911442|542160360|FG001|Overall Study|Lost to Follow-up|0|||
150279677|NCT01911442|542160361|FG002|Overall Study|Lost to Follow-up|1|||
150279678|NCT01911442|542160359|FG000|Overall Study|Withdrawal by Subject|1|||
150279679|NCT01911442|542160360|FG001|Overall Study|Withdrawal by Subject|0|||
150279680|NCT01911442|542160361|FG002|Overall Study|Withdrawal by Subject|6|||
150279681|NCT01911442|542160359|FG000|Overall Study|Mother's Work Schedule|0|||
150279682|NCT01911442|542160360|FG001|Overall Study|Mother's Work Schedule|1|||
150279683|NCT01911442|542160361|FG002|Overall Study|Mother's Work Schedule|0|||
150279684|NCT03668600|542160368|FG000|Overall Study|Study Terminated by the Sponsor|157|||
150279685|NCT03668600|542160368|FG000|Overall Study|Protocol Violation|1|||
150279686|NCT03668600|542160368|FG000|Overall Study|Pregnancy|1|||
150279687|NCT03668600|542160368|FG000|Overall Study|Lost to Follow-up|7|||
150279688|NCT03668600|542160368|FG000|Overall Study|Withdrawal by Subject|56|||
150279689|NCT03668600|542160368|FG000|Overall Study|Lack of Efficacy|7|||
150279690|NCT03668600|542160368|FG000|Overall Study|Adverse Event|1|||
150279691|NCT00424749|542160370|FG000|Overall Study|Withdrawal by Subject|1|||
150279692|NCT04451161|542160371|FG000|Overall Study|Lost to Follow-up|28|||
150279693|NCT04451161|542160372|FG001|Overall Study|Lost to Follow-up|37|||
150279694|NCT04451161|542160373|FG002|Overall Study|Lost to Follow-up|22|||
150279695|NCT04451161|542160374|FG003|Overall Study|Lost to Follow-up|13|||
150279696|NCT04451161|542160375|FG004|Overall Study|Lost to Follow-up|11|||
150279697|NCT04451161|542160376|FG005|Overall Study|Lost to Follow-up|14|||
150279698|NCT04451161|542160371|FG000|Overall Study|Withdrawal by Subject|3|||
150279699|NCT04451161|542160372|FG001|Overall Study|Withdrawal by Subject|0|||
150279700|NCT04451161|542160373|FG002|Overall Study|Withdrawal by Subject|0|||
150279701|NCT04451161|542160374|FG003|Overall Study|Withdrawal by Subject|0|||
150279702|NCT04451161|542160375|FG004|Overall Study|Withdrawal by Subject|2|||
150279703|NCT04451161|542160376|FG005|Overall Study|Withdrawal by Subject|4|||
150279704|NCT00454857|542160377|FG000|Overall Study|Withdrawal by Subject|15|||
150279705|NCT00454857|542160377|FG000|Overall Study|Lost to Follow-up|16|||
150279706|NCT00454857|542160377|FG000|Overall Study|Noncompliance|6|||
150279707|NCT00454857|542160377|FG000|Overall Study|Death|5|||
150279708|NCT00454857|542160377|FG000|Overall Study|Other|11|||
150279709|NCT00454857|542160377|FG000|Overall Study|Reason unknown|1|||
150279710|NCT00596947|542160378|FG000|Overall Study|study halted due to low enrollment|5|||
150279711|NCT00596947|542160379|FG001|Overall Study|study halted due to low enrollment|3|||
150279712|NCT00596947|542160378|FG000|Overall Study|Lost to Follow-up|1|||
150279713|NCT00596947|542160379|FG001|Overall Study|Lost to Follow-up|0|||
150279714|NCT02114268|542160380|FG000|Overall Study|Lost to Follow-up|4|||
150279715|NCT02114268|542160381|FG001|Overall Study|Lost to Follow-up|1|||
150279716|NCT02114268|542160382|FG002|Overall Study|Lost to Follow-up|1|||
150279717|NCT02114268|542160383|FG003|Overall Study|Lost to Follow-up|0|||
150279718|NCT02114268|542160384|FG004|Overall Study|Lost to Follow-up|0|||
150279719|NCT02114268|542160385|FG005|Overall Study|Lost to Follow-up|2|||
150279720|NCT02114268|542160380|FG000|Overall Study|Withdrawal by Subject|1|||
150279721|NCT02114268|542160381|FG001|Overall Study|Withdrawal by Subject|0|||
149831505|NCT02932878|540514950|FG001|Overall Study|Due to Lab Results|1|||
150279722|NCT02114268|542160382|FG002|Overall Study|Withdrawal by Subject|0|||
150279723|NCT02114268|542160383|FG003|Overall Study|Withdrawal by Subject|0|||
150279724|NCT02114268|542160384|FG004|Overall Study|Withdrawal by Subject|0|||
150279725|NCT02114268|542160385|FG005|Overall Study|Withdrawal by Subject|1|||
150279726|NCT02114268|542160380|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
150279727|NCT02114268|542160381|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
150279728|NCT02114268|542160382|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
150279729|NCT02114268|542160383|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
150279730|NCT02114268|542160384|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
149831506|NCT00262223|540514951|FG000|Treatment Phase|Withdrawal by Subject|3|||
149831507|NCT00262223|540514952|FG001|Treatment Phase|Withdrawal by Subject|6|||
150279731|NCT02114268|542160385|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
149831508|NCT00262223|540514951|FG000|Treatment Phase|Adverse Event|1|||
149831509|NCT00262223|540514952|FG001|Treatment Phase|Adverse Event|2|||
149831510|NCT00262223|540514951|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
149831511|NCT00262223|540514952|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
149831512|NCT00262223|540514951|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
149831513|NCT00262223|540514952|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
149831514|NCT00262223|540514951|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
149831515|NCT00262223|540514952|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
149831516|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
149831517|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
149831518|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
149831519|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
149831520|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
149831521|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
149831522|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
149831523|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
149831524|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
149831525|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
149831526|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
149831527|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
149831528|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
149831529|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
149831530|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
149831531|NCT00437658|540514953|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
149831532|NCT00437658|540514954|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
149831533|NCT00437658|540514955|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
149831534|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
149831535|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
149831536|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
149831537|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
149831538|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
149831539|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
149831540|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
149831541|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
149831542|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
149831543|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
149831544|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
149831545|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
149831546|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
149831547|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
149831548|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
150279732|NCT01075412|542160389|FG000|Overall Study|Withdrawal by Subject|0|||
150279733|NCT01075412|542160390|FG001|Overall Study|Withdrawal by Subject|1|||
150279734|NCT00865904|542160391|FG000|Overall Study|Randomized but not Treated|2|||
150279735|NCT00865904|542160392|FG001|Overall Study|Randomized but not Treated|0|||
150279736|NCT00865904|542160393|FG002|Overall Study|Randomized but not Treated|0|||
150279737|NCT00865904|542160394|FG003|Overall Study|Randomized but not Treated|1|||
150279738|NCT00865904|542160395|FG004|Overall Study|Randomized but not Treated|1|||
150279739|NCT01431274|542160396|FG000|Overall Study|Adverse Event|51|||
150279740|NCT01431274|542160397|FG001|Overall Study|Adverse Event|37|||
149831549|NCT00437658|540514953|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
149831550|NCT00437658|540514954|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
149831551|NCT00437658|540514955|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
149831552|NCT03952143|540514956|FG000|Lead-In Period|Adverse Event|2|||
149831553|NCT03952143|540514957|FG001|Lead-In Period|Adverse Event|0|||
150279741|NCT01431274|542160398|FG002|Overall Study|Adverse Event|43|||
150279742|NCT01431274|542160399|FG003|Overall Study|Adverse Event|30|||
150279743|NCT01431274|542160400|FG004|Overall Study|Adverse Event|37|||
150279744|NCT01431274|542160396|FG000|Overall Study|Consent withdrawn not due to AE|29|||
150279745|NCT01431274|542160397|FG001|Overall Study|Consent withdrawn not due to AE|20|||
150279746|NCT01431274|542160398|FG002|Overall Study|Consent withdrawn not due to AE|17|||
150279747|NCT01431274|542160399|FG003|Overall Study|Consent withdrawn not due to AE|20|||
150279748|NCT01431274|542160400|FG004|Overall Study|Consent withdrawn not due to AE|11|||
150279749|NCT01431274|542160396|FG000|Overall Study|Non compliant with protocol|5|||
150279750|NCT01431274|542160397|FG001|Overall Study|Non compliant with protocol|8|||
150279751|NCT01431274|542160398|FG002|Overall Study|Non compliant with protocol|4|||
150279752|NCT01431274|542160399|FG003|Overall Study|Non compliant with protocol|4|||
150279753|NCT01431274|542160400|FG004|Overall Study|Non compliant with protocol|4|||
150279754|NCT01431274|542160396|FG000|Overall Study|Lost to Follow-up|6|||
150279755|NCT01431274|542160397|FG001|Overall Study|Lost to Follow-up|7|||
150279756|NCT01431274|542160398|FG002|Overall Study|Lost to Follow-up|1|||
150279757|NCT01431274|542160399|FG003|Overall Study|Lost to Follow-up|4|||
150279758|NCT01431274|542160400|FG004|Overall Study|Lost to Follow-up|0|||
150279759|NCT01431274|542160396|FG000|Overall Study|Other reason not stated above|6|||
150279760|NCT01431274|542160397|FG001|Overall Study|Other reason not stated above|5|||
150279761|NCT01431274|542160398|FG002|Overall Study|Other reason not stated above|7|||
150279762|NCT01431274|542160399|FG003|Overall Study|Other reason not stated above|2|||
150279763|NCT01431274|542160400|FG004|Overall Study|Other reason not stated above|4|||
150279764|NCT01378858|542160401|FG000|Overall Study|Withdrawal by Subject|4|||
150279765|NCT01378858|542160402|FG001|Overall Study|Withdrawal by Subject|4|||
150279766|NCT02664272|542160403|FG000|Overall Study|Fluoroscopic images not made available|2|||
150279767|NCT03073980|542160404|FG000|Overall Study|Lost to Follow-up|10|||
150279768|NCT03073980|542160405|FG001|Overall Study|Lost to Follow-up|2|||
150279769|NCT03073980|542160406|FG002|Overall Study|Lost to Follow-up|9|||
150279770|NCT03073980|542160404|FG000|Overall Study|No post-procedure data|0|||
150279771|NCT03073980|542160405|FG001|Overall Study|No post-procedure data|0|||
150279772|NCT03073980|542160406|FG002|Overall Study|No post-procedure data|2|||
150279773|NCT01358760|542160407|FG000|Overall Study|Adverse Event|3|||
150279774|NCT01358760|542160408|FG001|Overall Study|Adverse Event|4|||
150279775|NCT01358760|542160409|FG002|Overall Study|Adverse Event|3|||
150279776|NCT01358760|542160407|FG000|Overall Study|Lost to Follow-up|1|||
150279777|NCT01358760|542160408|FG001|Overall Study|Lost to Follow-up|1|||
150279778|NCT01358760|542160409|FG002|Overall Study|Lost to Follow-up|3|||
150279779|NCT01358760|542160407|FG000|Overall Study|Withdrawal by Subject|5|||
150279780|NCT01358760|542160408|FG001|Overall Study|Withdrawal by Subject|3|||
150279781|NCT01358760|542160409|FG002|Overall Study|Withdrawal by Subject|2|||
150279782|NCT01358760|542160407|FG000|Overall Study|Physician Decision|1|||
150279783|NCT01358760|542160408|FG001|Overall Study|Physician Decision|0|||
150279784|NCT01358760|542160409|FG002|Overall Study|Physician Decision|1|||
150279785|NCT01358760|542160407|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
150279786|NCT01358760|542160408|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
150279787|NCT01358760|542160409|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
150279788|NCT00789880|542160414|FG000|Overall Study|Adverse Event|0|||
150279789|NCT00789880|542160415|FG001|Overall Study|Adverse Event|0|||
150279790|NCT00789880|542160416|FG002|Overall Study|Adverse Event|0|||
150279791|NCT00789880|542160417|FG003|Overall Study|Adverse Event|0|||
150279792|NCT00789880|542160418|FG004|Overall Study|Adverse Event|1|||
150279793|NCT00789880|542160419|FG005|Overall Study|Adverse Event|0|||
150279794|NCT00789880|542160414|FG000|Overall Study|Protocol Violation|0|||
150279795|NCT00789880|542160415|FG001|Overall Study|Protocol Violation|1|||
150279796|NCT00789880|542160416|FG002|Overall Study|Protocol Violation|0|||
150279797|NCT00789880|542160417|FG003|Overall Study|Protocol Violation|1|||
150279798|NCT00789880|542160418|FG004|Overall Study|Protocol Violation|0|||
150279799|NCT00789880|542160419|FG005|Overall Study|Protocol Violation|0|||
150279800|NCT00789880|542160414|FG000|Overall Study|Withdrawal by Subject|1|||
150279801|NCT00789880|542160415|FG001|Overall Study|Withdrawal by Subject|0|||
150279802|NCT00789880|542160416|FG002|Overall Study|Withdrawal by Subject|0|||
150034127|NCT04842747|541264753|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
150034128|NCT04842747|541264754|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
150279803|NCT00789880|542160417|FG003|Overall Study|Withdrawal by Subject|0|||
150279804|NCT00789880|542160418|FG004|Overall Study|Withdrawal by Subject|2|||
150279805|NCT00789880|542160419|FG005|Overall Study|Withdrawal by Subject|0|||
150279806|NCT00609986|542160423|FG000|Overall Study|Did not receive transplant or treatment|8|||
150279807|NCT00609986|542160424|FG001|Overall Study|Did not receive transplant or treatment|3|||
150279808|NCT03159091|542160425|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
150279809|NCT03159091|542160426|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
150279810|NCT03159091|542160425|FG000|Overall Study|Patient has taken no dose of study drug|0|||
150279811|NCT03159091|542160426|FG001|Overall Study|Patient has taken no dose of study drug|1|||
150279812|NCT04814823|542160427|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
150279813|NCT02044133|542160428|FG000|Overall Study|Lost to Follow-up|1|||
150279814|NCT02044133|542160429|FG001|Overall Study|Lost to Follow-up|1|||
150279815|NCT02044133|542160428|FG000|Overall Study|Death|1|||
150279816|NCT02044133|542160429|FG001|Overall Study|Death|0|||
149831554|NCT03952143|540514958|FG002|Lead-In Period|Adverse Event|0|||
149831555|NCT03952143|540514956|FG000|Lead-In Period|Lack of Efficacy|2|||
149831556|NCT03952143|540514957|FG001|Lead-In Period|Lack of Efficacy|0|||
149831557|NCT03952143|540514958|FG002|Lead-In Period|Lack of Efficacy|0|||
149831558|NCT03952143|540514956|FG000|Lead-In Period|Physician Decision|5|||
149831559|NCT03952143|540514957|FG001|Lead-In Period|Physician Decision|0|||
149831560|NCT03952143|540514958|FG002|Lead-In Period|Physician Decision|0|||
149831561|NCT03952143|540514956|FG000|Lead-In Period|Protocol Violation|5|||
149831562|NCT03952143|540514957|FG001|Lead-In Period|Protocol Violation|0|||
149831563|NCT03952143|540514958|FG002|Lead-In Period|Protocol Violation|0|||
149831564|NCT03952143|540514956|FG000|Lead-In Period|Withdrawal by Subject|19|||
149831565|NCT03952143|540514957|FG001|Lead-In Period|Withdrawal by Subject|0|||
149831566|NCT03952143|540514958|FG002|Lead-In Period|Withdrawal by Subject|0|||
149831567|NCT03952143|540514956|FG000|Treatment Period|Adverse Event|0|||
149831568|NCT03952143|540514957|FG001|Treatment Period|Adverse Event|0|||
149831569|NCT03952143|540514958|FG002|Treatment Period|Adverse Event|1|||
149831570|NCT03952143|540514956|FG000|Treatment Period|Lost to Follow-up|0|||
149831571|NCT03952143|540514957|FG001|Treatment Period|Lost to Follow-up|2|||
149831572|NCT03952143|540514958|FG002|Treatment Period|Lost to Follow-up|0|||
149831573|NCT03952143|540514956|FG000|Treatment Period|Physician Decision|0|||
149831574|NCT03952143|540514957|FG001|Treatment Period|Physician Decision|0|||
149831575|NCT03952143|540514958|FG002|Treatment Period|Physician Decision|2|||
149831576|NCT03952143|540514956|FG000|Treatment Period|Protocol Violation|0|||
149831577|NCT03952143|540514957|FG001|Treatment Period|Protocol Violation|0|||
149831578|NCT03952143|540514958|FG002|Treatment Period|Protocol Violation|1|||
149831579|NCT03952143|540514956|FG000|Treatment Period|Withdrawal by Subject|0|||
149831580|NCT03952143|540514957|FG001|Treatment Period|Withdrawal by Subject|5|||
149831581|NCT03952143|540514958|FG002|Treatment Period|Withdrawal by Subject|26|||
149831582|NCT03952143|540514956|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
149831583|NCT03952143|540514957|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
149831584|NCT03952143|540514958|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
149831585|NCT03952143|540514956|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
149831586|NCT03952143|540514957|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
149831587|NCT03952143|540514958|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
149831588|NCT02152566|540514959|FG000|Overall Study|Lost to Follow-up|1|||
149831589|NCT02152566|540514959|FG000|Overall Study|Withdrawal by Subject|2|||
149831590|NCT01866319|540514960|FG000|Overall Study|Adverse Event|12|||
149831591|NCT01866319|540514961|FG001|Overall Study|Adverse Event|5|||
149831592|NCT01866319|540514962|FG002|Overall Study|Adverse Event|9|||
149831593|NCT01866319|540514960|FG000|Overall Study|Clinical progression|3|||
149831594|NCT01866319|540514961|FG001|Overall Study|Clinical progression|2|||
149831595|NCT01866319|540514962|FG002|Overall Study|Clinical progression|2|||
149831596|NCT01866319|540514960|FG000|Overall Study|Death|153|||
149831597|NCT01866319|540514961|FG001|Overall Study|Death|154|||
149831598|NCT01866319|540514962|FG002|Overall Study|Death|147|||
149831599|NCT01866319|540514960|FG000|Overall Study|Lost to Follow-up|6|||
149831600|NCT01866319|540514961|FG001|Overall Study|Lost to Follow-up|3|||
149831601|NCT01866319|540514962|FG002|Overall Study|Lost to Follow-up|8|||
149831602|NCT01866319|540514960|FG000|Overall Study|Physician Decision|1|||
149831603|NCT01866319|540514961|FG001|Overall Study|Physician Decision|0|||
149831604|NCT01866319|540514962|FG002|Overall Study|Physician Decision|1|||
149831605|NCT01866319|540514960|FG000|Overall Study|Protocol Violation|0|||
149831606|NCT01866319|540514961|FG001|Overall Study|Protocol Violation|0|||
150279817|NCT02044133|542160428|FG000|Overall Study|Release|3|||
150279818|NCT02044133|542160429|FG001|Overall Study|Release|4|||
149831607|NCT01866319|540514962|FG002|Overall Study|Protocol Violation|1|||
149831608|NCT01866319|540514960|FG000|Overall Study|Withdrawal by Subject|32|||
149831609|NCT01866319|540514961|FG001|Overall Study|Withdrawal by Subject|14|||
149831610|NCT01866319|540514962|FG002|Overall Study|Withdrawal by Subject|12|||
149831611|NCT02731157|540514963|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
149831612|NCT00623779|540514965|FG000|Overall Study|Adverse Event|1|||
149831613|NCT00623779|540514966|FG001|Overall Study|Adverse Event|3|||
149831614|NCT00623779|540514967|FG002|Overall Study|Adverse Event|0|||
149831615|NCT00623779|540514965|FG000|Overall Study|Criteria from CSR|2|||
149831616|NCT00623779|540514966|FG001|Overall Study|Criteria from CSR|0|||
149831617|NCT00623779|540514967|FG002|Overall Study|Criteria from CSR|1|||
149831618|NCT01856309|540514968|FG000|Overall Study|Death|4|||
150279819|NCT02044133|542160428|FG000|Overall Study|Transfer|1|||
149831619|NCT01856309|540514969|FG001|Overall Study|Death|6|||
149831620|NCT01856309|540514970|FG002|Overall Study|Death|11|||
149831621|NCT01856309|540514971|FG003|Overall Study|Death|6|||
149831622|NCT01856309|540514968|FG000|Overall Study|Lost to Follow-up|6|||
149831623|NCT01856309|540514969|FG001|Overall Study|Lost to Follow-up|2|||
149831624|NCT01856309|540514970|FG002|Overall Study|Lost to Follow-up|4|||
149831625|NCT01856309|540514971|FG003|Overall Study|Lost to Follow-up|8|||
149831626|NCT01856309|540514968|FG000|Overall Study|Withdrawal by Subject|11|||
149831627|NCT01856309|540514969|FG001|Overall Study|Withdrawal by Subject|13|||
149831628|NCT01856309|540514970|FG002|Overall Study|Withdrawal by Subject|28|||
149831629|NCT01856309|540514971|FG003|Overall Study|Withdrawal by Subject|26|||
149831630|NCT01856309|540514968|FG000|Overall Study|Other|227|||
149831631|NCT01856309|540514969|FG001|Overall Study|Other|225|||
149831632|NCT01856309|540514970|FG002|Overall Study|Other|447|||
149831633|NCT01856309|540514971|FG003|Overall Study|Other|469|||
149831634|NCT01856309|540514968|FG000|Overall Study|Lack of Efficacy|14|||
149831635|NCT01856309|540514969|FG001|Overall Study|Lack of Efficacy|9|||
149831636|NCT01856309|540514970|FG002|Overall Study|Lack of Efficacy|40|||
149831637|NCT01856309|540514971|FG003|Overall Study|Lack of Efficacy|25|||
149831638|NCT01856309|540514968|FG000|Overall Study|Adverse Event|31|||
149831639|NCT01856309|540514969|FG001|Overall Study|Adverse Event|31|||
149831640|NCT01856309|540514970|FG002|Overall Study|Adverse Event|55|||
149831641|NCT01856309|540514971|FG003|Overall Study|Adverse Event|65|||
149831642|NCT01856309|540514968|FG000|Overall Study|Pregnancy|0|||
149831643|NCT01856309|540514969|FG001|Overall Study|Pregnancy|0|||
149831644|NCT01856309|540514970|FG002|Overall Study|Pregnancy|0|||
149831645|NCT01856309|540514971|FG003|Overall Study|Pregnancy|1|||
149831646|NCT01856309|540514968|FG000|Overall Study|Physician Decision|6|||
149831647|NCT01856309|540514969|FG001|Overall Study|Physician Decision|1|||
149831648|NCT01856309|540514970|FG002|Overall Study|Physician Decision|6|||
149831649|NCT01856309|540514971|FG003|Overall Study|Physician Decision|8|||
149831650|NCT01856309|540514968|FG000|Overall Study|Noncompliance With Study Drug|0|||
149831651|NCT01856309|540514969|FG001|Overall Study|Noncompliance With Study Drug|1|||
149831652|NCT01856309|540514970|FG002|Overall Study|Noncompliance With Study Drug|4|||
149831653|NCT01856309|540514971|FG003|Overall Study|Noncompliance With Study Drug|1|||
149831654|NCT00220337|540514972|FG000|Overall Study|Adverse Event|70|||
149831655|NCT00220337|540514972|FG000|Overall Study|Lack of Efficacy|17|||
149831656|NCT00220337|540514972|FG000|Overall Study|Withdrawal by Subject|68|||
149831657|NCT00220337|540514972|FG000|Overall Study|Protocol Violation|2|||
149831658|NCT00220337|540514972|FG000|Overall Study|Lost to Follow-up|5|||
149831659|NCT00220337|540514972|FG000|Overall Study|Other|12|||
149831660|NCT00220337|540514972|FG000|Overall Study|Unsatisfactory compliance|5|||
149831661|NCT00832377|540514973|FG000|Overall Study|Protocol Violation|1|||
149831662|NCT01273181|540514974|FG000|Phase I, Dose 1|Study termination|1|||
149831663|NCT01273181|540514975|FG001|Phase I, Dose 1|Study termination|0|||
149831664|NCT01273181|540514976|FG002|Phase I, Dose 1|Study termination|0|||
149831665|NCT01273181|540514977|FG003|Phase I, Dose 1|Study termination|0|||
149831666|NCT01273181|540514974|FG000|Phase I, Dose 2|Death during treatment|0|||
149831667|NCT01273181|540514975|FG001|Phase I, Dose 2|Death during treatment|1|||
149831668|NCT01273181|540514976|FG002|Phase I, Dose 2|Death during treatment|0|||
149831669|NCT01273181|540514977|FG003|Phase I, Dose 2|Death during treatment|0|||
149831670|NCT01273181|540514974|FG000|Phase 2, Dose 1|Study termination|0|||
149831671|NCT01273181|540514975|FG001|Phase 2, Dose 1|Study termination|0|||
149831672|NCT01273181|540514976|FG002|Phase 2, Dose 1|Study termination|1|||
149831673|NCT01273181|540514977|FG003|Phase 2, Dose 1|Study termination|0|||
150279820|NCT02044133|542160429|FG001|Overall Study|Transfer|0|||
150279821|NCT02044133|542160428|FG000|Overall Study|refusal of blood sampling|0|||
150279822|NCT02044133|542160429|FG001|Overall Study|refusal of blood sampling|1|||
150279823|NCT05678257|542160434|FG000|Overall Study|Withdrawal by Subject|2|||
150279824|NCT05678257|542160435|FG001|Overall Study|Withdrawal by Subject|0|||
150279825|NCT05678257|542160436|FG002|Overall Study|Withdrawal by Subject|5|||
150279826|NCT05678257|542160434|FG000|Overall Study|Physician Decision|1|||
149831674|NCT01273181|540514974|FG000|Phase 2, Dose 2|Death during treatment|0|||
149831675|NCT01273181|540514975|FG001|Phase 2, Dose 2|Death during treatment|0|||
149831676|NCT01273181|540514976|FG002|Phase 2, Dose 2|Death during treatment|0|||
149831677|NCT01273181|540514977|FG003|Phase 2, Dose 2|Death during treatment|1|||
149831678|NCT00944697|540514978|FG000|Overall Study|Withdrawal by Subject|1|||
149831679|NCT00944697|540514979|FG001|Overall Study|Withdrawal by Subject|1|||
149831680|NCT00944697|540514978|FG000|Overall Study|Adverse Event|0|||
149831681|NCT00944697|540514979|FG001|Overall Study|Adverse Event|3|||
149831682|NCT00944697|540514978|FG000|Overall Study|Administrative|1|||
149831683|NCT00944697|540514979|FG001|Overall Study|Administrative|1|||
149831684|NCT01876706|540514982|FG000|Overall Study|BPH Intervention|9|||
149831685|NCT01876706|540514982|FG000|Overall Study|Lost to Follow-up|7|||
149831686|NCT01876706|540514982|FG000|Overall Study|Withdrawals|6|||
149831687|NCT01876706|540514982|FG000|Overall Study|Death|3|||
150279827|NCT05678257|542160435|FG001|Overall Study|Physician Decision|0|||
149831688|NCT00604500|540514983|FG000|Overall Study|Adverse Event|2|||
149831689|NCT00604500|540514983|FG000|Overall Study|Protocol Violation|2|||
149831690|NCT00604500|540514983|FG000|Overall Study|Treatment Failure|1|||
149831691|NCT00604500|540514983|FG000|Overall Study|Withdrawal by Subject|4|||
149831692|NCT00604500|540514983|FG000|Overall Study|Administrative|1|||
149831693|NCT00604500|540514983|FG000|Overall Study|Did not meet protocol eligibility|1|||
149831694|NCT02191891|540514985|FG000|Overall Study|Withdrawal by Subject|0|||
149831695|NCT02191891|540514986|FG001|Overall Study|Withdrawal by Subject|1|||
149831696|NCT02191891|540514987|FG002|Overall Study|Withdrawal by Subject|0|||
149831697|NCT02191891|540514988|FG003|Overall Study|Withdrawal by Subject|0|||
149831698|NCT02191891|540514989|FG004|Overall Study|Withdrawal by Subject|1|||
149831699|NCT02191891|540514985|FG000|Overall Study|Adverse Event|0|||
149831700|NCT02191891|540514986|FG001|Overall Study|Adverse Event|1|||
149831701|NCT02191891|540514987|FG002|Overall Study|Adverse Event|0|||
149831702|NCT02191891|540514988|FG003|Overall Study|Adverse Event|0|||
149831703|NCT02191891|540514989|FG004|Overall Study|Adverse Event|2|||
149831704|NCT02191891|540514985|FG000|Overall Study|Disease Progression|4|||
149831705|NCT02191891|540514986|FG001|Overall Study|Disease Progression|10|||
149831706|NCT02191891|540514987|FG002|Overall Study|Disease Progression|4|||
149831707|NCT02191891|540514988|FG003|Overall Study|Disease Progression|2|||
149831708|NCT02191891|540514989|FG004|Overall Study|Disease Progression|7|||
149831709|NCT01062256|540514993|FG000|Overall Study|Adverse Event|1|||
149831710|NCT01062256|540514994|FG001|Overall Study|Adverse Event|0|||
149831711|NCT01062256|540514995|FG002|Overall Study|Adverse Event|0|||
149831712|NCT01062256|540514993|FG000|Overall Study|Withdrawal by Subject|1|||
149831713|NCT01062256|540514994|FG001|Overall Study|Withdrawal by Subject|1|||
150279828|NCT05678257|542160436|FG002|Overall Study|Physician Decision|1|||
150279829|NCT05678257|542160434|FG000|Overall Study|Adverse Event|1|||
150279830|NCT05678257|542160435|FG001|Overall Study|Adverse Event|3|||
150279831|NCT05678257|542160436|FG002|Overall Study|Adverse Event|1|||
150279832|NCT05678257|542160434|FG000|Overall Study|Progressive disease|11|||
150279833|NCT05678257|542160435|FG001|Overall Study|Progressive disease|18|||
150279834|NCT05678257|542160436|FG002|Overall Study|Progressive disease|7|||
150279835|NCT05678257|542160434|FG000|Overall Study|No longer clinically benefitting|2|||
150279836|NCT05678257|542160435|FG001|Overall Study|No longer clinically benefitting|1|||
150279837|NCT05678257|542160436|FG002|Overall Study|No longer clinically benefitting|0|||
150279838|NCT05678257|542160434|FG000|Overall Study|Sponsor decision|5|||
150279839|NCT05678257|542160435|FG001|Overall Study|Sponsor decision|9|||
150279840|NCT05678257|542160436|FG002|Overall Study|Sponsor decision|8|||
150279841|NCT05678257|542160434|FG000|Overall Study|Protocol Violation|0|||
150279842|NCT05678257|542160435|FG001|Overall Study|Protocol Violation|0|||
150279843|NCT05678257|542160436|FG002|Overall Study|Protocol Violation|1|||
150279844|NCT05678257|542160434|FG000|Overall Study|Patient non-compliance|0|||
150279845|NCT05678257|542160435|FG001|Overall Study|Patient non-compliance|0|||
150279846|NCT05678257|542160436|FG002|Overall Study|Patient non-compliance|3|||
150279847|NCT02046096|542160437|FG000|Overall Study|Death|28|||
150279848|NCT02046096|542160438|FG001|Overall Study|Death|45|||
150279849|NCT02046096|542160437|FG000|Overall Study|Lost to Follow-up|9|||
150279850|NCT02046096|542160438|FG001|Overall Study|Lost to Follow-up|20|||
150279851|NCT02046096|542160437|FG000|Overall Study|Withdrawal by Subject|5|||
150279852|NCT02046096|542160438|FG001|Overall Study|Withdrawal by Subject|17|||
149831714|NCT01062256|540514995|FG002|Overall Study|Withdrawal by Subject|1|||
149831715|NCT01062256|540514993|FG000|Overall Study|Ineligible|1|||
150279853|NCT02046096|542160437|FG000|Overall Study|Other endpoint|2|||
150279854|NCT02046096|542160438|FG001|Overall Study|Other endpoint|19|||
150279855|NCT03520959|542160439|FG000|Overall Study|Study terminated by Sponsor|0|||
150279856|NCT03520959|542160440|FG001|Overall Study|Study terminated by Sponsor|1|||
150279857|NCT04969276|542160442|FG000|Overall Study|Protocol Deviation|0|||
150279858|NCT04969276|542160443|FG001|Overall Study|Protocol Deviation|1|||
150279859|NCT04969276|542160444|FG002|Overall Study|Protocol Deviation|0|||
150279860|NCT04969276|542160442|FG000|Overall Study|Withdrawal by Subject|1|||
150279861|NCT04969276|542160443|FG001|Overall Study|Withdrawal by Subject|10|||
150279862|NCT04969276|542160444|FG002|Overall Study|Withdrawal by Subject|0|||
150279863|NCT04969276|542160442|FG000|Overall Study|Lost to Follow-up|0|||
150279864|NCT04969276|542160443|FG001|Overall Study|Lost to Follow-up|1|||
150279865|NCT04969276|542160444|FG002|Overall Study|Lost to Follow-up|0|||
150279866|NCT00943579|542160449|FG000|Overall Study|Adverse Event|4|||
150279867|NCT00943579|542160450|FG001|Overall Study|Adverse Event|3|||
150279868|NCT00943579|542160449|FG000|Overall Study|Lack of Efficacy|2|||
149831716|NCT01062256|540514994|FG001|Overall Study|Ineligible|4|||
149831717|NCT01062256|540514995|FG002|Overall Study|Ineligible|3|||
149831718|NCT01062256|540514993|FG000|Overall Study|Administrative|0|||
149831719|NCT01062256|540514994|FG001|Overall Study|Administrative|2|||
149831720|NCT01062256|540514995|FG002|Overall Study|Administrative|0|||
149831721|NCT03049488|540514996|FG000|Overall Study|Lost to Follow-up|1|||
149831722|NCT03049488|540514997|FG001|Overall Study|Lost to Follow-up|1|||
149831723|NCT03049488|540514998|FG002|Overall Study|Lost to Follow-up|0|||
150279869|NCT00943579|542160450|FG001|Overall Study|Lack of Efficacy|2|||
150279870|NCT00418665|542160453|FG000|Treatment Period|Ineligibility determined|1|||
149831724|NCT03049488|540514999|FG003|Overall Study|Lost to Follow-up|0|||
149831725|NCT03049488|540515000|FG004|Overall Study|Lost to Follow-up|0|||
149831726|NCT03049488|540515001|FG005|Overall Study|Lost to Follow-up|0|||
149831727|NCT03049488|540514996|FG000|Overall Study|Moved from Area|1|||
149831728|NCT03049488|540514997|FG001|Overall Study|Moved from Area|0|||
149831729|NCT03049488|540514998|FG002|Overall Study|Moved from Area|0|||
149831730|NCT03049488|540514999|FG003|Overall Study|Moved from Area|1|||
149831731|NCT03049488|540515000|FG004|Overall Study|Moved from Area|1|||
149831732|NCT03049488|540515001|FG005|Overall Study|Moved from Area|0|||
149831733|NCT03049488|540514996|FG000|Overall Study|Physician Decision|0|||
149831734|NCT03049488|540514997|FG001|Overall Study|Physician Decision|1|||
149831735|NCT03049488|540514998|FG002|Overall Study|Physician Decision|0|||
149831736|NCT03049488|540514999|FG003|Overall Study|Physician Decision|0|||
149831737|NCT03049488|540515000|FG004|Overall Study|Physician Decision|0|||
149831738|NCT03049488|540515001|FG005|Overall Study|Physician Decision|0|||
149831739|NCT03049488|540514996|FG000|Overall Study|Withdrawal by Subject|0|||
149831740|NCT03049488|540514997|FG001|Overall Study|Withdrawal by Subject|0|||
149831741|NCT03049488|540514998|FG002|Overall Study|Withdrawal by Subject|0|||
149831742|NCT03049488|540514999|FG003|Overall Study|Withdrawal by Subject|1|||
149831743|NCT03049488|540515000|FG004|Overall Study|Withdrawal by Subject|1|||
149831744|NCT03049488|540515001|FG005|Overall Study|Withdrawal by Subject|0|||
149831745|NCT00537030|540515006|FG000|Overall Study|Physician Decision|2|||
149831746|NCT00537030|540515006|FG000|Overall Study|Withdrawal by Subject|2|||
149831747|NCT00537030|540515006|FG000|Overall Study|≥ Grade 2 allergy|7|||
149831748|NCT00537030|540515006|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
149831749|NCT00537030|540515006|FG000|Overall Study|Ineligible|2|||
149831750|NCT00537030|540515006|FG000|Overall Study|Inevaluable|2|||
149831751|NCT00669864|540515008|FG000|Overall Study|Lost to Follow-up|2|||
149831752|NCT00669864|540515008|FG000|Overall Study|Protocol Violation|2|||
149831753|NCT00669864|540515008|FG000|Overall Study|Withdrawal by Subject|3|||
149831754|NCT00669864|540515008|FG000|Overall Study|Other|2|||
149831755|NCT00162123|540515009|FG000|Overall Study|Disease progression|27|||
149831756|NCT00162123|540515010|FG001|Overall Study|Disease progression|19|||
149831757|NCT00162123|540515011|FG002|Overall Study|Disease progression|10|||
149831758|NCT00162123|540515012|FG003|Overall Study|Disease progression|4|||
149831759|NCT00162123|540515013|FG004|Overall Study|Disease progression|8|||
149831760|NCT00162123|540515014|FG005|Overall Study|Disease progression|3|||
149831761|NCT00162123|540515015|FG006|Overall Study|Disease progression|1|||
149831762|NCT00162123|540515016|FG007|Overall Study|Disease progression|0|||
149831763|NCT00162123|540515009|FG000|Overall Study|Study drug toxicity|6|||
149831764|NCT00162123|540515010|FG001|Overall Study|Study drug toxicity|1|||
149831765|NCT00162123|540515011|FG002|Overall Study|Study drug toxicity|5|||
149831766|NCT00162123|540515012|FG003|Overall Study|Study drug toxicity|0|||
149831767|NCT00162123|540515013|FG004|Overall Study|Study drug toxicity|4|||
149831768|NCT00162123|540515014|FG005|Overall Study|Study drug toxicity|1|||
149831769|NCT00162123|540515015|FG006|Overall Study|Study drug toxicity|1|||
149831770|NCT00162123|540515016|FG007|Overall Study|Study drug toxicity|0|||
149831771|NCT00162123|540515009|FG000|Overall Study|Death|3|||
149831772|NCT00162123|540515010|FG001|Overall Study|Death|3|||
149831773|NCT00162123|540515011|FG002|Overall Study|Death|1|||
149831774|NCT00162123|540515012|FG003|Overall Study|Death|1|||
149831775|NCT00162123|540515013|FG004|Overall Study|Death|1|||
149831776|NCT00162123|540515014|FG005|Overall Study|Death|1|||
149831777|NCT00162123|540515015|FG006|Overall Study|Death|0|||
149831778|NCT00162123|540515016|FG007|Overall Study|Death|0|||
149831779|NCT00162123|540515009|FG000|Overall Study|Withdrawal by Subject|2|||
149831780|NCT00162123|540515010|FG001|Overall Study|Withdrawal by Subject|0|||
149831781|NCT00162123|540515011|FG002|Overall Study|Withdrawal by Subject|2|||
149831782|NCT00162123|540515012|FG003|Overall Study|Withdrawal by Subject|1|||
149831783|NCT00162123|540515013|FG004|Overall Study|Withdrawal by Subject|1|||
149831784|NCT00162123|540515014|FG005|Overall Study|Withdrawal by Subject|2|||
149831785|NCT00162123|540515015|FG006|Overall Study|Withdrawal by Subject|1|||
149831786|NCT00162123|540515016|FG007|Overall Study|Withdrawal by Subject|0|||
149831787|NCT00162123|540515009|FG000|Overall Study|Deterioration without progression|2|||
149831788|NCT00162123|540515010|FG001|Overall Study|Deterioration without progression|2|||
149831789|NCT00162123|540515011|FG002|Overall Study|Deterioration without progression|3|||
149831790|NCT00162123|540515012|FG003|Overall Study|Deterioration without progression|0|||
149831791|NCT00162123|540515013|FG004|Overall Study|Deterioration without progression|1|||
149831792|NCT00162123|540515014|FG005|Overall Study|Deterioration without progression|0|||
149831793|NCT00162123|540515015|FG006|Overall Study|Deterioration without progression|0|||
149831794|NCT00162123|540515016|FG007|Overall Study|Deterioration without progression|0|||
149831795|NCT00162123|540515009|FG000|Overall Study|Adverse Event|1|||
149831796|NCT00162123|540515010|FG001|Overall Study|Adverse Event|2|||
149831797|NCT00162123|540515011|FG002|Overall Study|Adverse Event|0|||
149831798|NCT00162123|540515012|FG003|Overall Study|Adverse Event|2|||
149831799|NCT00162123|540515013|FG004|Overall Study|Adverse Event|1|||
149831800|NCT00162123|540515014|FG005|Overall Study|Adverse Event|0|||
149831801|NCT00162123|540515015|FG006|Overall Study|Adverse Event|0|||
149831802|NCT00162123|540515016|FG007|Overall Study|Adverse Event|0|||
149831803|NCT00162123|540515009|FG000|Overall Study|Not specified (before treatment)|2|||
149831804|NCT00162123|540515010|FG001|Overall Study|Not specified (before treatment)|0|||
149831805|NCT00162123|540515011|FG002|Overall Study|Not specified (before treatment)|0|||
149831806|NCT00162123|540515012|FG003|Overall Study|Not specified (before treatment)|0|||
149831807|NCT00162123|540515013|FG004|Overall Study|Not specified (before treatment)|12|||
149831808|NCT00162123|540515014|FG005|Overall Study|Not specified (before treatment)|1|||
149831809|NCT00162123|540515015|FG006|Overall Study|Not specified (before treatment)|0|||
149831810|NCT00162123|540515016|FG007|Overall Study|Not specified (before treatment)|0|||
149831811|NCT00162123|540515009|FG000|Overall Study|Not specified (after start of treatment)|0|||
149831812|NCT00162123|540515010|FG001|Overall Study|Not specified (after start of treatment)|0|||
149831813|NCT00162123|540515011|FG002|Overall Study|Not specified (after start of treatment)|0|||
149831814|NCT00162123|540515012|FG003|Overall Study|Not specified (after start of treatment)|0|||
149831815|NCT00162123|540515013|FG004|Overall Study|Not specified (after start of treatment)|3|||
149831816|NCT00162123|540515014|FG005|Overall Study|Not specified (after start of treatment)|0|||
149831817|NCT00162123|540515015|FG006|Overall Study|Not specified (after start of treatment)|0|||
149831818|NCT00162123|540515016|FG007|Overall Study|Not specified (after start of treatment)|0|||
149831819|NCT00162123|540515009|FG000|Overall Study|Physician Decision|1|||
149831820|NCT00162123|540515010|FG001|Overall Study|Physician Decision|2|||
149831821|NCT00162123|540515011|FG002|Overall Study|Physician Decision|0|||
149831822|NCT00162123|540515012|FG003|Overall Study|Physician Decision|0|||
149831823|NCT00162123|540515013|FG004|Overall Study|Physician Decision|0|||
149831824|NCT00162123|540515014|FG005|Overall Study|Physician Decision|1|||
149831825|NCT00162123|540515015|FG006|Overall Study|Physician Decision|1|||
149831826|NCT00162123|540515016|FG007|Overall Study|Physician Decision|0|||
149831827|NCT00162123|540515009|FG000|Overall Study|Tumor assessment only (not treated)|0|||
149831828|NCT00162123|540515010|FG001|Overall Study|Tumor assessment only (not treated)|0|||
149831829|NCT00162123|540515011|FG002|Overall Study|Tumor assessment only (not treated)|0|||
149831830|NCT00162123|540515012|FG003|Overall Study|Tumor assessment only (not treated)|0|||
149831831|NCT00162123|540515013|FG004|Overall Study|Tumor assessment only (not treated)|0|||
149831832|NCT00162123|540515014|FG005|Overall Study|Tumor assessment only (not treated)|0|||
149831833|NCT00162123|540515015|FG006|Overall Study|Tumor assessment only (not treated)|0|||
149831834|NCT00162123|540515016|FG007|Overall Study|Tumor assessment only (not treated)|1|||
149831835|NCT00162123|540515009|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
149831836|NCT00162123|540515010|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
149831837|NCT00162123|540515011|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
149831838|NCT00162123|540515012|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
149831839|NCT00162123|540515013|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
149831840|NCT00162123|540515014|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
149831841|NCT00162123|540515015|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
149831842|NCT00162123|540515016|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
149831843|NCT02016170|540515017|FG000|Overall Study|Adverse Event|1|||
149831844|NCT02016170|540515018|FG001|Overall Study|Adverse Event|1|||
149831845|NCT02016170|540515019|FG002|Overall Study|Adverse Event|0|||
149831846|NCT02016170|540515017|FG000|Overall Study|Protocol Violation|1|||
149831847|NCT02016170|540515018|FG001|Overall Study|Protocol Violation|0|||
149831848|NCT02016170|540515019|FG002|Overall Study|Protocol Violation|0|||
149831849|NCT02327130|540515020|FG000|Overall Study|Discharged in less than 5 days|5|||
149831850|NCT02327130|540515020|FG000|Overall Study|Physician Decision|2|||
149831851|NCT02327130|540515020|FG000|Overall Study|Unable to provide breath sample|1|||
149831852|NCT02327130|540515020|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
149831853|NCT02327130|540515020|FG000|Overall Study|Met exclusion criteria|3|||
149831854|NCT02672553|540515022|FG000|Overall Study|Death|3|||
149831855|NCT02672553|540515023|FG001|Overall Study|Death|5|||
150279871|NCT00418665|542160454|FG001|Treatment Period|Ineligibility determined|1|||
150279872|NCT00418665|542160455|FG002|Treatment Period|Ineligibility determined|0|||
150279873|NCT00418665|542160453|FG000|Treatment Period|Adverse Event|2|||
150279874|NCT00418665|542160454|FG001|Treatment Period|Adverse Event|2|||
150279875|NCT00418665|542160455|FG002|Treatment Period|Adverse Event|0|||
149831856|NCT02672553|540515022|FG000|Overall Study|Valve Explant|1|||
149831857|NCT02672553|540515023|FG001|Overall Study|Valve Explant|0|||
149831858|NCT02672553|540515022|FG000|Overall Study|Conversion to Commercial Valve|3|||
149831859|NCT02672553|540515023|FG001|Overall Study|Conversion to Commercial Valve|0|||
149831860|NCT02672553|540515022|FG000|Overall Study|Withdrawal by Subject|3|||
149831861|NCT02672553|540515023|FG001|Overall Study|Withdrawal by Subject|3|||
150279876|NCT00418665|542160453|FG000|Treatment Period|Withdrawal by Subject|0|||
149831862|NCT02672553|540515022|FG000|Overall Study|Intraoperative screen failure|2|||
149831863|NCT02672553|540515023|FG001|Overall Study|Intraoperative screen failure|0|||
149831864|NCT00408902|540515024|FG000|Overall Study|Lack of Efficacy|7|||
149831865|NCT00408902|540515024|FG000|Overall Study|Adverse Event|3|||
149831866|NCT00970281|540515025|FG000|Overall Study|Lack of Efficacy|1|||
149831867|NCT00970281|540515026|FG001|Overall Study|Lack of Efficacy|14|||
149831868|NCT00970281|540515025|FG000|Overall Study|Withdrawal by Subject|0|||
149831869|NCT00970281|540515026|FG001|Overall Study|Withdrawal by Subject|1|||
149831870|NCT00970281|540515025|FG000|Overall Study|Physician Decision|1|||
149831871|NCT00970281|540515026|FG001|Overall Study|Physician Decision|1|||
149831872|NCT02003183|540515029|FG000|Overall Study|Lost to Follow-up|0|||
149831873|NCT02003183|540515030|FG001|Overall Study|Lost to Follow-up|2|||
149831874|NCT00841100|540515033|FG000|Phase 1 (28 Days)|Adverse Event|1|||
149831875|NCT00841100|540515033|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
149831876|NCT03338972|540515034|FG000|Overall Study|Death|1|||
149831877|NCT03338972|540515035|FG001|Overall Study|Death|1|||
149831878|NCT03338972|540515036|FG002|Overall Study|Death|0|||
149831879|NCT03338972|540515037|FG003|Overall Study|Death|0|||
149831880|NCT03338972|540515034|FG000|Overall Study|Withdrawal by Subject|1|||
149831881|NCT03338972|540515035|FG001|Overall Study|Withdrawal by Subject|0|||
149831882|NCT03338972|540515036|FG002|Overall Study|Withdrawal by Subject|0|||
149831883|NCT03338972|540515037|FG003|Overall Study|Withdrawal by Subject|0|||
149831884|NCT03633721|540515042|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
149831885|NCT03633721|540515043|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
149831886|NCT03633721|540515044|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
149831887|NCT03633721|540515045|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
149831888|NCT02343120|540515049|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
149831889|NCT02343120|540515050|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
149831890|NCT02343120|540515051|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
149831891|NCT02343120|540515052|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
149831892|NCT02343120|540515053|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
149831893|NCT02343120|540515049|FG000|Part 1: Dose Escalation|Death|1|||
149831894|NCT02343120|540515050|FG001|Part 1: Dose Escalation|Death|2|||
149831895|NCT02343120|540515051|FG002|Part 1: Dose Escalation|Death|2|||
149831896|NCT02343120|540515052|FG003|Part 1: Dose Escalation|Death|2|||
149831897|NCT02343120|540515053|FG004|Part 1: Dose Escalation|Death|1|||
149831898|NCT02343120|540515049|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
149831899|NCT02343120|540515050|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
149831900|NCT02343120|540515051|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
149831901|NCT02343120|540515052|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
149831902|NCT02343120|540515053|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
149831903|NCT02343120|540515049|FG000|Part 2: Expansion|Sponsor decision|0|||
149831904|NCT02343120|540515050|FG001|Part 2: Expansion|Sponsor decision|0|||
149831905|NCT02343120|540515051|FG002|Part 2: Expansion|Sponsor decision|0|||
149831906|NCT02343120|540515052|FG003|Part 2: Expansion|Sponsor decision|165|||
149831907|NCT02343120|540515053|FG004|Part 2: Expansion|Sponsor decision|67|||
149831908|NCT02343120|540515049|FG000|Part 2: Expansion|Death|0|||
149831909|NCT02343120|540515050|FG001|Part 2: Expansion|Death|0|||
149831910|NCT02343120|540515051|FG002|Part 2: Expansion|Death|0|||
149831911|NCT02343120|540515052|FG003|Part 2: Expansion|Death|74|||
149831912|NCT02343120|540515053|FG004|Part 2: Expansion|Death|17|||
149831913|NCT02343120|540515049|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
149831914|NCT02343120|540515050|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
150034129|NCT01743469|541264755|FG000|Active Treatment Phase|Adverse Event|10|||
150034130|NCT01743469|541264756|FG001|Active Treatment Phase|Adverse Event|5|||
150034131|NCT01743469|541264757|FG002|Active Treatment Phase|Adverse Event|8|||
150034132|NCT01743469|541264758|FG003|Active Treatment Phase|Adverse Event|1|||
150034133|NCT01743469|541264755|FG000|Active Treatment Phase|Disease Progression|40|||
150034134|NCT01743469|541264756|FG001|Active Treatment Phase|Disease Progression|47|||
150034135|NCT01743469|541264757|FG002|Active Treatment Phase|Disease Progression|30|||
150034136|NCT01743469|541264758|FG003|Active Treatment Phase|Disease Progression|20|||
150034137|NCT01743469|541264755|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
150034138|NCT01743469|541264756|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
150171212|NCT00964366|541763425|FG000|Overall Study|Did not qualify at Day 1|1|||
150171213|NCT00964366|541763426|FG001|Overall Study|Did not qualify at Day 1|0|||
149831915|NCT02343120|540515051|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
149831916|NCT02343120|540515052|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
149831917|NCT02343120|540515053|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
149831918|NCT02343120|540515049|FG000|Part 2: Expansion|Lost to Follow-up|0|||
150171214|NCT00964366|541763425|FG000|Overall Study|Withdrawal by Subject|0|||
150171215|NCT00964366|541763426|FG001|Overall Study|Withdrawal by Subject|1|||
150171216|NCT01370694|541763427|FG000|Overall Study|Switched to rituximab|4|||
149831919|NCT02343120|540515050|FG001|Part 2: Expansion|Lost to Follow-up|0|||
149831920|NCT02343120|540515051|FG002|Part 2: Expansion|Lost to Follow-up|0|||
150171217|NCT01370694|541763427|FG000|Overall Study|Progressive disease|2|||
149831921|NCT02343120|540515052|FG003|Part 2: Expansion|Lost to Follow-up|5|||
149831922|NCT02343120|540515053|FG004|Part 2: Expansion|Lost to Follow-up|2|||
149831923|NCT02343120|540515049|FG000|Part 2: Expansion|Other|0|||
149831924|NCT02343120|540515050|FG001|Part 2: Expansion|Other|0|||
149831925|NCT02343120|540515051|FG002|Part 2: Expansion|Other|0|||
149831926|NCT02343120|540515052|FG003|Part 2: Expansion|Other|1|||
149831927|NCT02343120|540515053|FG004|Part 2: Expansion|Other|5|||
149831928|NCT02343120|540515049|FG000|Part 2: Expansion|Adverse Event|0|||
149831929|NCT02343120|540515050|FG001|Part 2: Expansion|Adverse Event|0|||
149831930|NCT02343120|540515051|FG002|Part 2: Expansion|Adverse Event|0|||
149831931|NCT02343120|540515052|FG003|Part 2: Expansion|Adverse Event|1|||
149831932|NCT02343120|540515053|FG004|Part 2: Expansion|Adverse Event|1|||
149831933|NCT05277389|540515054|FG000|Overall Study|Lost to Follow-up|1|||
149831934|NCT05277389|540515055|FG001|Overall Study|Lost to Follow-up|4|||
149831935|NCT03069937|540515056|FG000|Overall Study|Second primary malignancy noted|1|||
149831936|NCT01046253|540515057|FG000|Second Intervention|Adverse Event|0|||
149831937|NCT01046253|540515058|FG001|Second Intervention|Adverse Event|1|||
149831938|NCT01046253|540515057|FG000|Second Intervention|Protocol Violation|0|||
149831939|NCT01046253|540515058|FG001|Second Intervention|Protocol Violation|1|||
149831940|NCT02339909|540515059|FG000|Overall Study|Became ineligible after randomisation|89|||
149831941|NCT02339909|540515060|FG001|Overall Study|Became ineligible after randomisation|63|||
149831942|NCT02339909|540515061|FG002|Overall Study|Became ineligible after randomisation|71|||
149831943|NCT01766778|540515067|FG000|Overall Study|Adverse Event|4|||
149831944|NCT01766778|540515068|FG001|Overall Study|Adverse Event|4|||
149831945|NCT01766778|540515067|FG000|Overall Study|Withdrawal by Subject|1|||
149831946|NCT01766778|540515068|FG001|Overall Study|Withdrawal by Subject|0|||
149831947|NCT01054599|540515069|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
149831948|NCT01054599|540515070|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
149831949|NCT01054599|540515069|FG000|Overall Study|Protocol Violation|1|||
149831950|NCT01054599|540515070|FG001|Overall Study|Protocol Violation|0|||
149831951|NCT01054599|540515069|FG000|Overall Study|Spells/seizure-like episodes|1|||
149831952|NCT01054599|540515070|FG001|Overall Study|Spells/seizure-like episodes|1|||
149831953|NCT01054599|540515069|FG000|Overall Study|Timing/scheduling difficulties|1|||
149831954|NCT01054599|540515070|FG001|Overall Study|Timing/scheduling difficulties|1|||
149831955|NCT01054599|540515069|FG000|Overall Study|Visual impairment, WTAR <80|0|||
149831956|NCT01054599|540515070|FG001|Overall Study|Visual impairment, WTAR <80|1|||
149831957|NCT01054599|540515069|FG000|Overall Study|Lost to Follow-up|0|||
149831958|NCT01054599|540515070|FG001|Overall Study|Lost to Follow-up|2|||
149831959|NCT01054599|540515069|FG000|Overall Study|Adverse Event|0|||
149831960|NCT01054599|540515070|FG001|Overall Study|Adverse Event|1|||
149831961|NCT01054599|540515069|FG000|Overall Study|Withdrawal by Subject|0|||
149831962|NCT01054599|540515070|FG001|Overall Study|Withdrawal by Subject|1|||
149831963|NCT00743197|540515071|FG000|Overall Study|Study terminated due to departure of PI.|1|||
149831964|NCT00743197|540515072|FG001|Overall Study|Study terminated due to departure of PI.|2|||
149831965|NCT01104662|540515073|FG000|Overall Study|Adverse Event|2|||
149831966|NCT01104662|540515074|FG001|Overall Study|Adverse Event|2|||
149831967|NCT01104662|540515075|FG002|Overall Study|Adverse Event|0|||
149831968|NCT01104662|540515076|FG003|Overall Study|Adverse Event|1|||
149831969|NCT01104662|540515077|FG004|Overall Study|Adverse Event|1|||
149831970|NCT01104662|540515078|FG005|Overall Study|Adverse Event|1|||
149831971|NCT01104662|540515079|FG006|Overall Study|Adverse Event|0|||
149831972|NCT01104662|540515080|FG007|Overall Study|Adverse Event|0|||
149831973|NCT01104662|540515073|FG000|Overall Study|Clinical Failure|1|||
149831974|NCT01104662|540515074|FG001|Overall Study|Clinical Failure|0|||
149831975|NCT01104662|540515075|FG002|Overall Study|Clinical Failure|0|||
149831976|NCT01104662|540515076|FG003|Overall Study|Clinical Failure|0|||
149831977|NCT01104662|540515077|FG004|Overall Study|Clinical Failure|0|||
149831978|NCT01104662|540515078|FG005|Overall Study|Clinical Failure|1|||
149831979|NCT01104662|540515079|FG006|Overall Study|Clinical Failure|0|||
149831980|NCT01104662|540515080|FG007|Overall Study|Clinical Failure|0|||
149831981|NCT01104662|540515073|FG000|Overall Study|Participant left investigator's care|1|||
149831982|NCT01104662|540515074|FG001|Overall Study|Participant left investigator's care|1|||
149831983|NCT01104662|540515075|FG002|Overall Study|Participant left investigator's care|0|||
149831984|NCT01104662|540515076|FG003|Overall Study|Participant left investigator's care|0|||
149831985|NCT01104662|540515077|FG004|Overall Study|Participant left investigator's care|0|||
149831986|NCT01104662|540515078|FG005|Overall Study|Participant left investigator's care|0|||
149831987|NCT01104662|540515079|FG006|Overall Study|Participant left investigator's care|0|||
149831988|NCT01104662|540515080|FG007|Overall Study|Participant left investigator's care|0|||
149831989|NCT01104662|540515073|FG000|Overall Study|Reason not specified|3|||
149831990|NCT01104662|540515074|FG001|Overall Study|Reason not specified|3|||
149831991|NCT01104662|540515075|FG002|Overall Study|Reason not specified|0|||
149831992|NCT01104662|540515076|FG003|Overall Study|Reason not specified|0|||
149831993|NCT01104662|540515077|FG004|Overall Study|Reason not specified|0|||
149831994|NCT01104662|540515078|FG005|Overall Study|Reason not specified|1|||
149831995|NCT01104662|540515079|FG006|Overall Study|Reason not specified|0|||
149831996|NCT01104662|540515080|FG007|Overall Study|Reason not specified|0|||
149831997|NCT01104662|540515073|FG000|Overall Study|Randomized but not treated|3|||
149831998|NCT01104662|540515074|FG001|Overall Study|Randomized but not treated|4|||
149831999|NCT01104662|540515075|FG002|Overall Study|Randomized but not treated|1|||
149832000|NCT01104662|540515076|FG003|Overall Study|Randomized but not treated|0|||
149832001|NCT01104662|540515077|FG004|Overall Study|Randomized but not treated|0|||
149832002|NCT01104662|540515078|FG005|Overall Study|Randomized but not treated|1|||
149832003|NCT01104662|540515079|FG006|Overall Study|Randomized but not treated|0|||
149832004|NCT01104662|540515080|FG007|Overall Study|Randomized but not treated|0|||
150279877|NCT00418665|542160454|FG001|Treatment Period|Withdrawal by Subject|3|||
150279878|NCT00418665|542160455|FG002|Treatment Period|Withdrawal by Subject|1|||
150279879|NCT00418665|542160453|FG000|Treatment Period|Requirement for alternative therapy|1|||
150279880|NCT00418665|542160454|FG001|Treatment Period|Requirement for alternative therapy|0|||
150279881|NCT00418665|542160455|FG002|Treatment Period|Requirement for alternative therapy|0|||
150279882|NCT00418665|542160453|FG000|Treatment Period|Physician Decision|1|||
150279883|NCT00418665|542160454|FG001|Treatment Period|Physician Decision|0|||
149948778|NCT05472142|540944824|FG000|Total Participants|Lost to Follow-up|312|||
149948779|NCT05472142|540944825|FG001|Total Participants|Lost to Follow-up|0|||
149948780|NCT05472142|540944824|FG000|Clinic Patients|Lost to Follow-up|312|||
149948781|NCT05472142|540944825|FG001|Clinic Patients|Lost to Follow-up|0|||
150279884|NCT00418665|542160455|FG002|Treatment Period|Physician Decision|3|||
150279885|NCT00418665|542160453|FG000|Treatment Extension|Adverse Event|1|||
149832005|NCT04188106|540516721|FG000|Overall Study|Lost to Follow-up|5|||
149832006|NCT04188106|540516721|FG000|Overall Study|Non-Compliance|1|||
149832007|NCT01507051|540516722|FG000|Overall Study|Withdrawal by Subject|1|||
149832008|NCT01507051|540516723|FG001|Overall Study|Withdrawal by Subject|3|||
149832009|NCT01507051|540516724|FG002|Overall Study|Withdrawal by Subject|1|||
149832010|NCT01507051|540516725|FG003|Overall Study|Withdrawal by Subject|6|||
149832011|NCT01507051|540516722|FG000|Overall Study|Physician Decision|0|||
149832012|NCT01507051|540516723|FG001|Overall Study|Physician Decision|0|||
149832013|NCT01507051|540516724|FG002|Overall Study|Physician Decision|0|||
149832014|NCT01507051|540516725|FG003|Overall Study|Physician Decision|1|||
149832015|NCT01507051|540516722|FG000|Overall Study|Adverse Event|1|||
149832016|NCT01507051|540516723|FG001|Overall Study|Adverse Event|0|||
149832017|NCT01507051|540516724|FG002|Overall Study|Adverse Event|0|||
149832018|NCT01507051|540516725|FG003|Overall Study|Adverse Event|0|||
149832019|NCT01519661|540516726|FG000|Overall Study|Protocol deviation|6|||
149832020|NCT01519661|540516726|FG000|Overall Study|Lost to Follow-up|3|||
149832021|NCT01519661|540516726|FG000|Overall Study|Withdrawal by Subject|17|||
149832022|NCT01519661|540516726|FG000|Overall Study|Lack of Efficacy|6|||
149832023|NCT01519661|540516726|FG000|Overall Study|Adverse Event|29|||
149832024|NCT00420303|540516727|FG000|Overall Study|Serious Adverse Event|1|||
149832025|NCT00420303|540516728|FG001|Overall Study|Serious Adverse Event|0|||
149832026|NCT00420303|540516727|FG000|Overall Study|Lack of Efficacy|0|||
149832027|NCT00420303|540516728|FG001|Overall Study|Lack of Efficacy|3|||
149832028|NCT00420303|540516727|FG000|Overall Study|Physician Decision|0|||
149832029|NCT00420303|540516728|FG001|Overall Study|Physician Decision|1|||
149832030|NCT02311361|540516729|FG000|Overall Study|Did not receive treatment|0|||
149832031|NCT02311361|540516730|FG001|Overall Study|Did not receive treatment|1|||
149832032|NCT02311361|540516731|FG002|Overall Study|Did not receive treatment|0|||
149832033|NCT02311361|540516732|FG003|Overall Study|Did not receive treatment|1|||
149832034|NCT00745420|540516734|FG000|Overall Study|Ineligible|1|||
149832035|NCT01941095|540516735|FG000|Overall Study|Insufficient therapeutic response|13|||
149832036|NCT01941095|540516735|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
149832037|NCT01941095|540516735|FG000|Overall Study|Adverse Event|11|||
149832038|NCT01941095|540516735|FG000|Overall Study|Physician Decision|3|||
149832039|NCT01941095|540516735|FG000|Overall Study|Withdrawal by Subject|17|||
149832040|NCT01941095|540516735|FG000|Overall Study|Lost to Follow-up|10|||
149832041|NCT04455633|540516743|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
149832042|NCT04455633|540516744|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
149832043|NCT04455633|540516745|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
149832044|NCT04455633|540516743|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
149832045|NCT04455633|540516744|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
149832046|NCT04455633|540516745|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
149832047|NCT04455633|540516743|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
149832048|NCT04455633|540516744|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
149832049|NCT04455633|540516745|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
149832050|NCT04455633|540516743|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
149832051|NCT04455633|540516744|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
149832052|NCT04455633|540516745|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
149832053|NCT03527745|540516746|FG000|Overall Study|Lost to Follow-up|3|||
149832054|NCT03527745|540516747|FG001|Overall Study|Lost to Follow-up|6|||
150279886|NCT00418665|542160454|FG001|Treatment Extension|Adverse Event|0|||
150279887|NCT00418665|542160455|FG002|Treatment Extension|Adverse Event|0|||
150279888|NCT00418665|542160453|FG000|Treatment Extension|Withdrawal by Subject|1|||
150279889|NCT00418665|542160454|FG001|Treatment Extension|Withdrawal by Subject|0|||
150279890|NCT00418665|542160455|FG002|Treatment Extension|Withdrawal by Subject|0|||
150279891|NCT00418665|542160453|FG000|Treatment Extension|Requirement for alternative therapy|2|||
149832055|NCT03527745|540516748|FG002|Overall Study|Lost to Follow-up|7|||
149832056|NCT03527745|540516749|FG003|Overall Study|Lost to Follow-up|9|||
149832057|NCT03527745|540516750|FG004|Overall Study|Lost to Follow-up|0|||
149832058|NCT03527745|540516751|FG005|Overall Study|Lost to Follow-up|2|||
149832059|NCT03527745|540516752|FG006|Overall Study|Lost to Follow-up|3|||
149832060|NCT03527745|540516753|FG007|Overall Study|Lost to Follow-up|2|||
149832061|NCT03527745|540516754|FG008|Overall Study|Lost to Follow-up|3|||
149832062|NCT03527745|540516755|FG009|Overall Study|Lost to Follow-up|2|||
149832063|NCT03527745|540516756|FG010|Overall Study|Lost to Follow-up|1|||
149832064|NCT03527745|540516757|FG011|Overall Study|Lost to Follow-up|1|||
149832065|NCT03527745|540516758|FG012|Overall Study|Lost to Follow-up|0|||
149832066|NCT03527745|540516759|FG013|Overall Study|Lost to Follow-up|0|||
149832067|NCT03527745|540516760|FG014|Overall Study|Lost to Follow-up|0|||
149832068|NCT03527745|540516761|FG015|Overall Study|Lost to Follow-up|0|||
149832069|NCT03527745|540516762|FG016|Overall Study|Lost to Follow-up|1|||
149832070|NCT03527745|540516763|FG017|Overall Study|Lost to Follow-up|0|||
149832071|NCT03527745|540516764|FG018|Overall Study|Lost to Follow-up|0|||
149832072|NCT03527745|540516765|FG019|Overall Study|Lost to Follow-up|1|||
150279892|NCT00418665|542160454|FG001|Treatment Extension|Requirement for alternative therapy|2|||
149832073|NCT03527745|540516766|FG020|Overall Study|Lost to Follow-up|1|||
149832074|NCT03527745|540516767|FG021|Overall Study|Lost to Follow-up|5|||
149832075|NCT03527745|540516768|FG022|Overall Study|Lost to Follow-up|6|||
149832076|NCT03527745|540516769|FG023|Overall Study|Lost to Follow-up|8|||
149832077|NCT03527745|540516770|FG024|Overall Study|Lost to Follow-up|1|||
150279893|NCT00418665|542160455|FG002|Treatment Extension|Requirement for alternative therapy|0|||
150279894|NCT00418665|542160453|FG000|Treatment Extension|Physician Decision|2|||
150279895|NCT00418665|542160454|FG001|Treatment Extension|Physician Decision|2|||
150279896|NCT00418665|542160455|FG002|Treatment Extension|Physician Decision|1|||
150279897|NCT00418665|542160453|FG000|Treatment Extension|Death|0|||
150279898|NCT00418665|542160454|FG001|Treatment Extension|Death|0|||
150279899|NCT00418665|542160455|FG002|Treatment Extension|Death|1|||
150279900|NCT00840086|542161987|FG000|Overall Study|Adverse Event|1|||
150279901|NCT00840086|542161987|FG000|Overall Study|Protocol Violation|2|||
150279902|NCT00840086|542161987|FG000|Overall Study|Lost to Follow-up|1|||
150279903|NCT03332498|542161988|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
149832078|NCT03527745|540516771|FG025|Overall Study|Lost to Follow-up|3|||
149832079|NCT00048568|540516780|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
149832080|NCT00048568|540516781|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
149832081|NCT00048568|540516782|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
149832082|NCT00048568|540516780|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
149832083|NCT00048568|540516781|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
149832084|NCT00048568|540516782|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
149832085|NCT00048568|540516780|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
149832086|NCT00048568|540516781|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
149832087|NCT00048568|540516782|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
149832088|NCT00048568|540516780|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
149832089|NCT00048568|540516781|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
149832090|NCT00048568|540516782|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
149832091|NCT00048568|540516780|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
149832092|NCT00048568|540516781|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
149832093|NCT00048568|540516782|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
149832094|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Death|1|||
149832095|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Death|1|||
149832096|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Death|0|||
149832097|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
149832098|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
149832099|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
149832100|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
149832101|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
149832102|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
149832103|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
149832104|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
149832105|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
149832106|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
149832107|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
149832108|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
149832109|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
149832110|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
149832111|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
149832112|NCT00048568|540516780|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
149832113|NCT00048568|540516781|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
149832114|NCT00048568|540516782|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
149832115|NCT00048568|540516780|FG000|Open-Label Period|Death|0|||
149832116|NCT00048568|540516781|FG001|Open-Label Period|Death|0|||
149832117|NCT00048568|540516782|FG002|Open-Label Period|Death|13|||
149832118|NCT00048568|540516780|FG000|Open-Label Period|Adverse Event|0|||
149948785|NCT04703192|540944832|FG000|Overall Study|Withdrawal by Subject|2|||
150279904|NCT03332498|542161989|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
150279905|NCT03332498|542161990|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
149832119|NCT00048568|540516781|FG001|Open-Label Period|Adverse Event|0|||
149832120|NCT00048568|540516782|FG002|Open-Label Period|Adverse Event|49|||
149948786|NCT04703192|540944833|FG001|Overall Study|Withdrawal by Subject|0|||
149948787|NCT04703192|540944832|FG000|Overall Study|Death|3|||
150279906|NCT02554019|542161991|FG000|Overall Study|Withdrawal by Subject|1|||
149832121|NCT00048568|540516780|FG000|Open-Label Period|Lack of Efficacy|0|||
149832122|NCT00048568|540516781|FG001|Open-Label Period|Lack of Efficacy|0|||
149832123|NCT00048568|540516782|FG002|Open-Label Period|Lack of Efficacy|32|||
149832124|NCT00048568|540516780|FG000|Open-Label Period|Withdrawal by Subject|0|||
149948788|NCT04703192|540944833|FG001|Overall Study|Death|1|||
150279907|NCT02554019|542161992|FG001|Overall Study|Withdrawal by Subject|0|||
149832125|NCT00048568|540516781|FG001|Open-Label Period|Withdrawal by Subject|0|||
149832126|NCT00048568|540516782|FG002|Open-Label Period|Withdrawal by Subject|26|||
149832127|NCT00048568|540516780|FG000|Open-Label Period|Pregnancy|0|||
149832128|NCT00048568|540516781|FG001|Open-Label Period|Pregnancy|0|||
149832129|NCT00048568|540516782|FG002|Open-Label Period|Pregnancy|5|||
149832130|NCT00048568|540516780|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
149832131|NCT00048568|540516781|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
149832132|NCT00048568|540516782|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
149832133|NCT00048568|540516780|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
149832134|NCT00048568|540516781|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
149832135|NCT00048568|540516782|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
149832136|NCT00048568|540516780|FG000|Open-Label Period|Unknown Reasons|0|||
149832137|NCT00048568|540516781|FG001|Open-Label Period|Unknown Reasons|0|||
149832138|NCT00048568|540516782|FG002|Open-Label Period|Unknown Reasons|25|||
149832139|NCT00048568|540516780|FG000|Open-Label Period|Lost to Follow-up|0|||
149832140|NCT00048568|540516781|FG001|Open-Label Period|Lost to Follow-up|0|||
149832141|NCT00048568|540516782|FG002|Open-Label Period|Lost to Follow-up|7|||
149832142|NCT03831048|540516783|FG000|Overall Study|Protocol Violation|9|||
149832143|NCT03831048|540516784|FG001|Overall Study|Protocol Violation|3|||
149832144|NCT03831048|540516783|FG000|Overall Study|Death|4|||
149832145|NCT03831048|540516784|FG001|Overall Study|Death|9|||
149832146|NCT03831048|540516783|FG000|Overall Study|Re-transplant|0|||
149832147|NCT03831048|540516784|FG001|Overall Study|Re-transplant|2|||
149832148|NCT03831048|540516783|FG000|Overall Study|Protocol violation and death|1|||
149832149|NCT03831048|540516784|FG001|Overall Study|Protocol violation and death|1|||
149832150|NCT01315249|540516787|FG000|Overall Study|Adverse Event|22|||
149832151|NCT01315249|540516788|FG001|Overall Study|Adverse Event|26|||
149832152|NCT01315249|540516787|FG000|Overall Study|Withdrawal by Subject|11|||
149832153|NCT01315249|540516788|FG001|Overall Study|Withdrawal by Subject|10|||
149832154|NCT01315249|540516787|FG000|Overall Study|Protocol Violation|8|||
149832155|NCT01315249|540516788|FG001|Overall Study|Protocol Violation|5|||
149832156|NCT01315249|540516787|FG000|Overall Study|Abnormal test results|1|||
149832157|NCT01315249|540516788|FG001|Overall Study|Abnormal test results|2|||
149832158|NCT01315249|540516787|FG000|Overall Study|Administrative problems|1|||
149832159|NCT01315249|540516788|FG001|Overall Study|Administrative problems|0|||
149832160|NCT01315249|540516787|FG000|Overall Study|inability to use device|1|||
149832161|NCT01315249|540516788|FG001|Overall Study|inability to use device|0|||
149832162|NCT01315249|540516787|FG000|Overall Study|Lack of Efficacy|0|||
149832163|NCT01315249|540516788|FG001|Overall Study|Lack of Efficacy|1|||
149832164|NCT01315249|540516787|FG000|Overall Study|Lost to Follow-up|0|||
149832165|NCT01315249|540516788|FG001|Overall Study|Lost to Follow-up|2|||
149832166|NCT01315249|540516787|FG000|Overall Study|Death|0|||
149832167|NCT01315249|540516788|FG001|Overall Study|Death|1|||
149832168|NCT03227445|540516789|FG000|Period 1 (28 Days)|Adverse Event|1|||
149832169|NCT03227445|540516790|FG001|Period 1 (28 Days)|Adverse Event|2|||
149832170|NCT03227445|540516791|FG002|Period 1 (28 Days)|Adverse Event|0|||
149832171|NCT03227445|540516792|FG003|Period 1 (28 Days)|Adverse Event|1|||
149832172|NCT03227445|540516789|FG000|Period 1 (28 Days)|Protocol Violation|1|||
149832173|NCT03227445|540516790|FG001|Period 1 (28 Days)|Protocol Violation|0|||
149832174|NCT03227445|540516791|FG002|Period 1 (28 Days)|Protocol Violation|0|||
149832175|NCT03227445|540516792|FG003|Period 1 (28 Days)|Protocol Violation|0|||
149832176|NCT03227445|540516789|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
149832177|NCT03227445|540516790|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
149832178|NCT03227445|540516791|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
149832179|NCT03227445|540516792|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
149832180|NCT03227445|540516789|FG000|Period 2 (28 Days)|Adverse Event|1|||
150279908|NCT02554019|542161993|FG002|Overall Study|Withdrawal by Subject|2|||
150279909|NCT02554019|542161991|FG000|Overall Study|Adverse Event|1|||
150279910|NCT02554019|542161992|FG001|Overall Study|Adverse Event|0|||
150279911|NCT02554019|542161993|FG002|Overall Study|Adverse Event|0|||
150279912|NCT02463409|542161994|FG000|Overall Study|Withdrawal by Subject|1|||
150279913|NCT02463409|542161994|FG000|Overall Study|Screen failure|1|||
149832181|NCT03227445|540516790|FG001|Period 2 (28 Days)|Adverse Event|0|||
149832182|NCT03227445|540516791|FG002|Period 2 (28 Days)|Adverse Event|2|||
149832183|NCT03227445|540516792|FG003|Period 2 (28 Days)|Adverse Event|1|||
149832184|NCT03227445|540516789|FG000|Period 2 (28 Days)|Protocol Violation|0|||
149832185|NCT03227445|540516790|FG001|Period 2 (28 Days)|Protocol Violation|0|||
150279914|NCT02634151|542161996|FG000|Overall Study|Withdrawal by Subject|1|||
149832186|NCT03227445|540516791|FG002|Period 2 (28 Days)|Protocol Violation|0|||
149832187|NCT03227445|540516792|FG003|Period 2 (28 Days)|Protocol Violation|1|||
149832188|NCT03227445|540516789|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
149832189|NCT03227445|540516790|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
149832190|NCT03227445|540516791|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
150279915|NCT02634151|542161997|FG001|Overall Study|Withdrawal by Subject|0|||
149832191|NCT03227445|540516792|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
149832192|NCT03164772|540516794|FG000|Overall Study|Death|4|||
149832193|NCT03164772|540516795|FG001|Overall Study|Death|2|||
150279916|NCT02634151|542161996|FG000|Overall Study|Non-Compliance|0|||
149832194|NCT03164772|540516794|FG000|Overall Study|Adverse Event|1|||
149832195|NCT03164772|540516795|FG001|Overall Study|Adverse Event|4|||
149832196|NCT03164772|540516794|FG000|Overall Study|Progressive Disease|11|||
149832197|NCT03164772|540516795|FG001|Overall Study|Progressive Disease|21|||
149832198|NCT03164772|540516794|FG000|Overall Study|Physician Decision|2|||
149832199|NCT03164772|540516795|FG001|Overall Study|Physician Decision|0|||
149832200|NCT03164772|540516794|FG000|Overall Study|Withdrawal by Subject|0|||
149832201|NCT03164772|540516795|FG001|Overall Study|Withdrawal by Subject|4|||
149832202|NCT01029353|540516796|FG000|Overall Study|Lost to Follow-up|4|||
149832203|NCT01029353|540516797|FG001|Overall Study|Lost to Follow-up|5|||
149832204|NCT01029353|540516798|FG002|Overall Study|Lost to Follow-up|5|||
149832205|NCT01029353|540516799|FG003|Overall Study|Lost to Follow-up|4|||
149832206|NCT01029353|540516796|FG000|Overall Study|Consent Withdrawn|2|||
149832207|NCT01029353|540516797|FG001|Overall Study|Consent Withdrawn|0|||
149832208|NCT01029353|540516798|FG002|Overall Study|Consent Withdrawn|0|||
149832209|NCT01029353|540516799|FG003|Overall Study|Consent Withdrawn|0|||
149832210|NCT01029353|540516796|FG000|Overall Study|Primary Outcome Indeterminate|1|||
149832211|NCT01029353|540516797|FG001|Overall Study|Primary Outcome Indeterminate|3|||
149832212|NCT01029353|540516798|FG002|Overall Study|Primary Outcome Indeterminate|2|||
149832213|NCT01029353|540516799|FG003|Overall Study|Primary Outcome Indeterminate|0|||
149832214|NCT00849901|540516802|FG000|Acute Treatment Phase|Adverse Event|9|||
149832215|NCT00849901|540516803|FG001|Acute Treatment Phase|Adverse Event|1|||
149832216|NCT00849901|540516804|FG002|Acute Treatment Phase|Adverse Event|3|||
149832217|NCT00849901|540516802|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
149832218|NCT00849901|540516803|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
149832219|NCT00849901|540516804|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
149832220|NCT00849901|540516802|FG000|Acute Treatment Phase|Protocol Violation|0|||
149832221|NCT00849901|540516803|FG001|Acute Treatment Phase|Protocol Violation|2|||
149832222|NCT00849901|540516804|FG002|Acute Treatment Phase|Protocol Violation|1|||
149832223|NCT00849901|540516802|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
149832224|NCT00849901|540516803|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
149832225|NCT00849901|540516804|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
149832226|NCT00849901|540516802|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
149832227|NCT00849901|540516803|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
149832228|NCT00849901|540516804|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
149832229|NCT00849901|540516802|FG000|Acute Treatment Phase|Physician Decision|1|||
149832230|NCT00849901|540516803|FG001|Acute Treatment Phase|Physician Decision|1|||
149832231|NCT00849901|540516804|FG002|Acute Treatment Phase|Physician Decision|1|||
149832232|NCT00849901|540516802|FG000|Acute Treatment Phase|Sponsor Decision|1|||
149832233|NCT00849901|540516803|FG001|Acute Treatment Phase|Sponsor Decision|0|||
149832234|NCT00849901|540516804|FG002|Acute Treatment Phase|Sponsor Decision|0|||
149832235|NCT00849901|540516802|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
149832236|NCT00849901|540516803|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
149832237|NCT00849901|540516804|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
149832238|NCT00849901|540516802|FG000|Extension Phase|Adverse Event|2|||
149832239|NCT00849901|540516803|FG001|Extension Phase|Adverse Event|8|||
149832240|NCT00849901|540516804|FG002|Extension Phase|Adverse Event|4|||
149832241|NCT00849901|540516802|FG000|Extension Phase|Lost to Follow-up|3|||
149832242|NCT00849901|540516803|FG001|Extension Phase|Lost to Follow-up|0|||
149832243|NCT00849901|540516804|FG002|Extension Phase|Lost to Follow-up|1|||
149832244|NCT00849901|540516802|FG000|Extension Phase|Protocol Violation|2|||
149832245|NCT00849901|540516803|FG001|Extension Phase|Protocol Violation|2|||
149832246|NCT00849901|540516804|FG002|Extension Phase|Protocol Violation|4|||
149832247|NCT00849901|540516802|FG000|Extension Phase|Withdrawal by Subject|7|||
149832248|NCT00849901|540516803|FG001|Extension Phase|Withdrawal by Subject|6|||
149832249|NCT00849901|540516804|FG002|Extension Phase|Withdrawal by Subject|3|||
149832250|NCT00849901|540516802|FG000|Extension Phase|Parent or Caregiver Decision|10|||
149832251|NCT00849901|540516803|FG001|Extension Phase|Parent or Caregiver Decision|4|||
149832252|NCT00849901|540516804|FG002|Extension Phase|Parent or Caregiver Decision|4|||
149832253|NCT00849901|540516802|FG000|Extension Phase|Physician Decision|1|||
149832254|NCT00849901|540516803|FG001|Extension Phase|Physician Decision|2|||
149832255|NCT00849901|540516804|FG002|Extension Phase|Physician Decision|0|||
149832256|NCT00849901|540516802|FG000|Extension Phase|Lack of Efficacy|2|||
149832257|NCT00849901|540516803|FG001|Extension Phase|Lack of Efficacy|4|||
149832258|NCT00849901|540516804|FG002|Extension Phase|Lack of Efficacy|1|||
149832259|NCT05214560|540516808|FG000|Overall Study|Screening Failure|1|||
149832260|NCT05214560|540516808|FG000|Overall Study|Physician Decision|4|||
149832261|NCT05214560|540516808|FG000|Overall Study|Withdrawal by Subject|1|||
149832262|NCT05214560|540516808|FG000|Overall Study|Lost to Follow-up|2|||
149832263|NCT05214560|540516808|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
149832264|NCT05214560|540516808|FG000|Overall Study|Study physician not available for the anesthesia|3|||
149948789|NCT04703192|540944832|FG000|Overall Study|Adverse Event|13|||
149948790|NCT04703192|540944833|FG001|Overall Study|Adverse Event|2|||
149948791|NCT04703192|540944832|FG000|Overall Study|Progressive or Relapsed Disease|46|||
149948792|NCT04703192|540944833|FG001|Overall Study|Progressive or Relapsed Disease|7|||
149832265|NCT05214560|540516808|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
149832266|NCT05214560|540516808|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
149832267|NCT05214560|540516808|FG000|Overall Study|Surgery not performed|3|||
149832268|NCT01030965|540516812|FG000|Overall Study|Lack of Efficacy|3|||
149832269|NCT01030965|540516813|FG001|Overall Study|Lack of Efficacy|2|||
149832270|NCT01030965|540516814|FG002|Overall Study|Lack of Efficacy|0|||
149832271|NCT01030965|540516815|FG003|Overall Study|Lack of Efficacy|3|||
149832272|NCT01030965|540516812|FG000|Overall Study|Protocol Violation|1|||
149832273|NCT01030965|540516813|FG001|Overall Study|Protocol Violation|1|||
149832274|NCT01030965|540516814|FG002|Overall Study|Protocol Violation|1|||
149832275|NCT01030965|540516815|FG003|Overall Study|Protocol Violation|1|||
149832276|NCT01030965|540516812|FG000|Overall Study|Adverse Event|0|||
149832277|NCT01030965|540516813|FG001|Overall Study|Adverse Event|1|||
149832278|NCT01030965|540516814|FG002|Overall Study|Adverse Event|2|||
149832279|NCT01030965|540516815|FG003|Overall Study|Adverse Event|1|||
149832280|NCT01030965|540516812|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
149832281|NCT01030965|540516813|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
149832282|NCT01030965|540516814|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
149832283|NCT01030965|540516815|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
149832284|NCT01030965|540516812|FG000|Overall Study|Withdrawal by Subject|0|||
149832285|NCT01030965|540516813|FG001|Overall Study|Withdrawal by Subject|1|||
149832286|NCT01030965|540516814|FG002|Overall Study|Withdrawal by Subject|0|||
149832287|NCT01030965|540516815|FG003|Overall Study|Withdrawal by Subject|2|||
149832288|NCT02097290|540516816|FG000|Overall Study|Death|6|||
149832289|NCT02097290|540516816|FG000|Overall Study|Total Withdrawals|3|||
149832290|NCT02097290|540516816|FG000|Overall Study|Attempt|8|||
149832291|NCT02534493|540516817|FG000|Overall Study|Lost to Follow-up|1|||
149832292|NCT02534493|540516817|FG000|Overall Study|Withdrawal by Subject|1|||
149832293|NCT03144687|540516820|FG000|Overall Study|Death|0|||
149832294|NCT03144687|540516821|FG001|Overall Study|Death|2|||
149832295|NCT03144687|540516820|FG000|Overall Study|Lost to Follow-up|0|||
149832296|NCT03144687|540516821|FG001|Overall Study|Lost to Follow-up|1|||
149832297|NCT03144687|540516820|FG000|Overall Study|Physician Decision|0|||
149832298|NCT03144687|540516821|FG001|Overall Study|Physician Decision|1|||
149832299|NCT03144687|540516820|FG000|Overall Study|Withdrawal by Subject|1|||
149832300|NCT03144687|540516821|FG001|Overall Study|Withdrawal by Subject|3|||
149832301|NCT03144687|540516820|FG000|Overall Study|Not Reported|2|||
149832302|NCT03144687|540516821|FG001|Overall Study|Not Reported|0|||
149832303|NCT01478620|540516822|FG000|Overall Study|Lost to Follow-up|6|||
149832304|NCT02888171|540516829|FG000|Overall Study|Lost to Follow-up|2|||
149832305|NCT02888171|540516830|FG001|Overall Study|Lost to Follow-up|1|||
149832306|NCT02888171|540516829|FG000|Overall Study|Withdrawal by Subject|3|||
149832307|NCT02888171|540516830|FG001|Overall Study|Withdrawal by Subject|2|||
149832308|NCT02888171|540516829|FG000|Overall Study|Adverse Event|0|||
149832309|NCT02888171|540516830|FG001|Overall Study|Adverse Event|1|||
150279917|NCT02634151|542161997|FG001|Overall Study|Non-Compliance|1|||
150279918|NCT02634151|542161996|FG000|Overall Study|Other|0|||
150279919|NCT02634151|542161997|FG001|Overall Study|Other|1|||
150279920|NCT02347098|542161998|FG000|Overall Study|Death|1|||
150279921|NCT02347098|542161999|FG001|Overall Study|Death|0|||
150279922|NCT02347098|542161998|FG000|Overall Study|Withdrawal by Subject|1|||
150279923|NCT02347098|542161999|FG001|Overall Study|Withdrawal by Subject|0|||
150279924|NCT02347098|542161998|FG000|Overall Study|Lost to Follow-up|2|||
150279925|NCT02347098|542161999|FG001|Overall Study|Lost to Follow-up|2|||
150279926|NCT02347098|542161998|FG000|Overall Study|Refuse Follow-up Visit|1|||
150279927|NCT02347098|542161999|FG001|Overall Study|Refuse Follow-up Visit|5|||
150279928|NCT02347098|542161998|FG000|Overall Study|no visit due to illness|2|||
150279929|NCT02347098|542161999|FG001|Overall Study|no visit due to illness|1|||
150279930|NCT01444742|542162000|FG000|Overall Study|Death|1|||
150279931|NCT02187172|542162001|FG000|Overall Study|Lost to Follow-up|1|||
150279932|NCT02187172|542162002|FG001|Overall Study|Lost to Follow-up|2|||
150279933|NCT02187172|542162001|FG000|Overall Study|Lack of Efficacy|1|||
150279934|NCT02187172|542162002|FG001|Overall Study|Lack of Efficacy|2|||
150279935|NCT02187172|542162001|FG000|Overall Study|Adverse Event|0|||
150279936|NCT02187172|542162002|FG001|Overall Study|Adverse Event|1|||
149832310|NCT01411332|540516831|FG000|Enrollment|Protocol Violation|0|||
149832311|NCT01411332|540516832|FG001|Enrollment|Protocol Violation|1|||
149832312|NCT01411332|540516831|FG000|Enrollment|Withdrawal by Subject|0|||
149832313|NCT01411332|540516832|FG001|Enrollment|Withdrawal by Subject|1|||
149832314|NCT01411332|540516831|FG000|Treatment|Lost to Follow-up|1|||
149832315|NCT01411332|540516832|FG001|Treatment|Lost to Follow-up|0|||
149832316|NCT02170688|540516833|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
149832317|NCT02170688|540516834|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
149832318|NCT02170688|540516835|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
149832319|NCT02170688|540516836|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
149832320|NCT02170688|540516837|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
150279937|NCT02187172|542162001|FG000|Overall Study|Physician Decision|1|||
150279938|NCT02187172|542162002|FG001|Overall Study|Physician Decision|1|||
149832321|NCT02170688|540516833|FG000|Overall Study|Full dose not received|0|||
149832322|NCT02170688|540516834|FG001|Overall Study|Full dose not received|1|||
149832323|NCT02170688|540516835|FG002|Overall Study|Full dose not received|0|||
149832324|NCT02170688|540516836|FG003|Overall Study|Full dose not received|0|||
149832325|NCT02170688|540516837|FG004|Overall Study|Full dose not received|0|||
149832326|NCT02170688|540516833|FG000|Overall Study|Physician Decision|0|||
149832327|NCT02170688|540516834|FG001|Overall Study|Physician Decision|0|||
149832328|NCT02170688|540516835|FG002|Overall Study|Physician Decision|1|||
149832329|NCT02170688|540516836|FG003|Overall Study|Physician Decision|0|||
149832330|NCT02170688|540516837|FG004|Overall Study|Physician Decision|0|||
149832331|NCT02079532|540516840|FG000|Overall Study|Adverse Event|7|||
149832332|NCT02079532|540516840|FG000|Overall Study|Additional or changed therapy|2|||
149832333|NCT02079532|540516840|FG000|Overall Study|Lack of Efficacy|9|||
149832334|NCT02079532|540516840|FG000|Overall Study|Protocol Violation|3|||
149832335|NCT02079532|540516840|FG000|Overall Study|Withdrawal by Subject|1|||
149832336|NCT02079532|540516840|FG000|Overall Study|Administrative problems|1|||
149832337|NCT02079532|540516840|FG000|Overall Study|Inclusion into ReFIRST|3|||
149832338|NCT02079532|540516840|FG000|Overall Study|Other|3|||
149832339|NCT01402947|540516841|FG000|First Intervention|Adverse Event|0|||
149832340|NCT01402947|540516842|FG001|First Intervention|Adverse Event|1|||
149832341|NCT00591630|540516843|FG000|Overall Study|Death|0|||
149832342|NCT00591630|540516844|FG001|Overall Study|Death|0|||
149832343|NCT00591630|540516845|FG002|Overall Study|Death|1|||
149832344|NCT00591630|540516846|FG003|Overall Study|Death|0|||
149832345|NCT01432171|540516851|FG000|Overall Study|Death|1|||
150034139|NCT01743469|541264757|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
150034140|NCT01743469|541264758|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
150034141|NCT01743469|541264755|FG000|Active Treatment Phase|Missing|1|||
150034142|NCT01743469|541264756|FG001|Active Treatment Phase|Missing|0|||
150034143|NCT01743469|541264757|FG002|Active Treatment Phase|Missing|0|||
150034144|NCT01743469|541264758|FG003|Active Treatment Phase|Missing|0|||
150034145|NCT01743469|541264755|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
150034146|NCT01743469|541264756|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
150034147|NCT01743469|541264757|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
150034148|NCT01743469|541264758|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
150034149|NCT01743469|541264755|FG000|Follow-up Period - Post-Treatment|Death|43|||
150034150|NCT01743469|541264756|FG001|Follow-up Period - Post-Treatment|Death|47|||
150034151|NCT01743469|541264757|FG002|Follow-up Period - Post-Treatment|Death|22|||
150034152|NCT01743469|541264758|FG003|Follow-up Period - Post-Treatment|Death|16|||
150034153|NCT01743469|541264755|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
150034154|NCT01743469|541264756|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
150034155|NCT01743469|541264757|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
150034156|NCT01743469|541264758|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
150034157|NCT00317473|541264759|FG000|Overall Study|Withdrawal by Subject|2|||
150034158|NCT00317473|541264760|FG001|Overall Study|Withdrawal by Subject|1|||
150034159|NCT00317473|541264761|FG002|Overall Study|Withdrawal by Subject|2|||
150034160|NCT00317473|541264762|FG003|Overall Study|Withdrawal by Subject|1|||
150034161|NCT00317473|541264763|FG004|Overall Study|Withdrawal by Subject|3|||
150034162|NCT00317473|541264764|FG005|Overall Study|Withdrawal by Subject|1|||
150034163|NCT00317473|541264759|FG000|Overall Study|Relocation|1|||
150034164|NCT00317473|541264760|FG001|Overall Study|Relocation|0|||
150034165|NCT00317473|541264761|FG002|Overall Study|Relocation|1|||
150034166|NCT00317473|541264762|FG003|Overall Study|Relocation|1|||
150034167|NCT00317473|541264763|FG004|Overall Study|Relocation|5|||
150034168|NCT00317473|541264764|FG005|Overall Study|Relocation|2|||
150034169|NCT00317473|541264759|FG000|Overall Study|Death|1|||
150034170|NCT00317473|541264760|FG001|Overall Study|Death|0|||
149832346|NCT01432171|540516852|FG001|Overall Study|Death|2|||
149832347|NCT01432171|540516851|FG000|Overall Study|Lost to Follow-up|6|||
149832348|NCT01432171|540516852|FG001|Overall Study|Lost to Follow-up|5|||
150034171|NCT00317473|541264761|FG002|Overall Study|Death|0|||
150034172|NCT00317473|541264762|FG003|Overall Study|Death|0|||
150034173|NCT00317473|541264763|FG004|Overall Study|Death|0|||
150034174|NCT00317473|541264764|FG005|Overall Study|Death|0|||
150034175|NCT00317473|541264759|FG000|Overall Study|Other|0|||
150034176|NCT00317473|541264760|FG001|Overall Study|Other|2|||
150034177|NCT00317473|541264761|FG002|Overall Study|Other|0|||
149832349|NCT01432171|540516851|FG000|Overall Study|Withdrawal by Subject|3|||
149832350|NCT01432171|540516852|FG001|Overall Study|Withdrawal by Subject|1|||
150034178|NCT00317473|541264762|FG003|Overall Study|Other|0|||
150034179|NCT00317473|541264763|FG004|Overall Study|Other|0|||
150034180|NCT00317473|541264764|FG005|Overall Study|Other|0|||
150034181|NCT02285855|541264765|FG000|Overall Study|Withdrawal by Subject|2|||
150034182|NCT02285855|541264766|FG001|Overall Study|Withdrawal by Subject|1|||
149832351|NCT01432171|540516851|FG000|Overall Study|Noncompliance|2|||
149832352|NCT01432171|540516852|FG001|Overall Study|Noncompliance|3|||
149832353|NCT01432171|540516851|FG000|Overall Study|Insurance denial trial coverage|1|||
149832354|NCT01432171|540516852|FG001|Overall Study|Insurance denial trial coverage|0|||
149832355|NCT01432171|540516851|FG000|Overall Study|Patient moved to palliative care|1|||
149832356|NCT01432171|540516852|FG001|Overall Study|Patient moved to palliative care|0|||
149832357|NCT01706926|540516853|FG000|Overall Study|Lost to Follow-up|0|||
149832358|NCT01706926|540516854|FG001|Overall Study|Lost to Follow-up|0|||
149832359|NCT01706926|540516855|FG002|Overall Study|Lost to Follow-up|1|||
149832360|NCT01706926|540516856|FG003|Overall Study|Lost to Follow-up|0|||
149832361|NCT01706926|540516853|FG000|Overall Study|Withdrawal by Subject|2|||
149832362|NCT01706926|540516854|FG001|Overall Study|Withdrawal by Subject|0|||
149832363|NCT01706926|540516855|FG002|Overall Study|Withdrawal by Subject|1|||
149832364|NCT01706926|540516856|FG003|Overall Study|Withdrawal by Subject|2|||
149832365|NCT01706926|540516853|FG000|Overall Study|Other|4|||
149832366|NCT01706926|540516854|FG001|Overall Study|Other|4|||
149832367|NCT01706926|540516855|FG002|Overall Study|Other|4|||
149832368|NCT01706926|540516856|FG003|Overall Study|Other|3|||
149832369|NCT01387737|540518581|FG000|Overall Study|Adverse Event|20|||
149832370|NCT01387737|540518582|FG001|Overall Study|Adverse Event|30|||
149832371|NCT01387737|540518581|FG000|Overall Study|Lack of Efficacy|1|||
149832372|NCT01387737|540518582|FG001|Overall Study|Lack of Efficacy|0|||
149832373|NCT01387737|540518581|FG000|Overall Study|Physician Decision|3|||
149832374|NCT01387737|540518582|FG001|Overall Study|Physician Decision|10|||
149832375|NCT01387737|540518581|FG000|Overall Study|Withdrawal by Subject|27|||
149832376|NCT01387737|540518582|FG001|Overall Study|Withdrawal by Subject|31|||
149832377|NCT01387737|540518581|FG000|Overall Study|Clearly not eligible for the study|1|||
150279939|NCT02181816|542162003|FG000|Overall Study|Case Report Forms Uncollected|38|||
150279940|NCT02181816|542162003|FG000|Overall Study|Protocol Deviation|21|||
150279941|NCT02830880|542162004|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
150279942|NCT02830880|542162004|FG000|Overall Study|Death|1|||
150279943|NCT02830880|542162004|FG000|Overall Study|Physician Decision|1|||
150279944|NCT02349048|542162009|FG000|Overall Study|Withdrawal by Subject|4|||
150279945|NCT02349048|542162010|FG001|Overall Study|Withdrawal by Subject|0|||
150279946|NCT02349048|542162009|FG000|Overall Study|Lost to Follow-up|1|||
150279947|NCT02349048|542162010|FG001|Overall Study|Lost to Follow-up|0|||
150279948|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
150279949|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
150279950|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
150279951|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
150279952|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
150279953|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
150279954|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
150279955|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
150279956|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
150279957|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
150279958|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
150279959|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
150279960|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
150279961|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
150279962|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
150279963|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
150279964|NCT00094770|542162013|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
150279965|NCT00094770|542162014|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
150279966|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
150279967|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
150279968|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
150279969|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
150279970|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
150279971|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
150279972|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
150279973|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
150279974|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
150279975|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
150279976|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
150279977|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
150279978|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
150279979|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
150279980|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
150279981|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
149832378|NCT01387737|540518582|FG001|Overall Study|Clearly not eligible for the study|3|||
150034183|NCT04484961|541264769|FG000|Overall Study|Lost to Follow-up|9|||
150279982|NCT00094770|542162013|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
150279983|NCT00094770|542162014|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
150279984|NCT00253643|542162017|FG000|Overall Study|Withdrawal by Subject|0|||
149832379|NCT00441467|540518583|FG000|Overall Study|Adverse Event|6|||
149832380|NCT00441467|540518583|FG000|Overall Study|Withdrawal by Subject|3|||
149832381|NCT00441467|540518583|FG000|Overall Study|Progressive disease|9|||
149832382|NCT02289963|540518584|FG000|Overall Study|Adverse Event|1|||
149832383|NCT02289963|540518585|FG001|Overall Study|Adverse Event|2|||
150279985|NCT00253643|542162018|FG001|Overall Study|Withdrawal by Subject|0|||
150279986|NCT00253643|542162019|FG002|Overall Study|Withdrawal by Subject|1|||
150279987|NCT00253643|542162020|FG003|Overall Study|Withdrawal by Subject|1|||
150279988|NCT00253643|542162017|FG000|Overall Study|Non-Compliance|0|||
150279989|NCT00253643|542162018|FG001|Overall Study|Non-Compliance|0|||
150279990|NCT00253643|542162019|FG002|Overall Study|Non-Compliance|0|||
150279991|NCT00253643|542162020|FG003|Overall Study|Non-Compliance|2|||
150279992|NCT01368536|542162024|FG000|Overall Study|Adverse Event|5|||
150279993|NCT01368536|542162025|FG001|Overall Study|Adverse Event|6|||
150279994|NCT01368536|542162026|FG002|Overall Study|Adverse Event|8|||
150279995|NCT01368536|542162024|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150279996|NCT01368536|542162025|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150279997|NCT01368536|542162026|FG002|Overall Study|Abnormal laboratory value(s)|2|||
150279998|NCT01368536|542162024|FG000|Overall Study|Abnormal test procedure result(s)|0|||
150279999|NCT01368536|542162025|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150280000|NCT01368536|542162026|FG002|Overall Study|Abnormal test procedure result(s)|1|||
150280001|NCT01368536|542162024|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
150280002|NCT01368536|542162025|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150280003|NCT01368536|542162026|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
150280004|NCT01368536|542162024|FG000|Overall Study|No longer required study medication|0|||
150280005|NCT01368536|542162025|FG001|Overall Study|No longer required study medication|0|||
150280006|NCT01368536|542162026|FG002|Overall Study|No longer required study medication|1|||
150280007|NCT01368536|542162024|FG000|Overall Study|Withdrawal by Subject|2|||
150280008|NCT01368536|542162025|FG001|Overall Study|Withdrawal by Subject|5|||
150280009|NCT01368536|542162026|FG002|Overall Study|Withdrawal by Subject|4|||
150280010|NCT01368536|542162024|FG000|Overall Study|Lost to Follow-up|3|||
150280011|NCT01368536|542162025|FG001|Overall Study|Lost to Follow-up|3|||
150280012|NCT01368536|542162026|FG002|Overall Study|Lost to Follow-up|5|||
150280013|NCT01368536|542162024|FG000|Overall Study|Administrative problems|34|||
150280014|NCT01368536|542162025|FG001|Overall Study|Administrative problems|39|||
150280015|NCT01368536|542162026|FG002|Overall Study|Administrative problems|35|||
150280016|NCT01368536|542162024|FG000|Overall Study|Protocol deviation|0|||
150280017|NCT01368536|542162025|FG001|Overall Study|Protocol deviation|3|||
150280018|NCT01368536|542162026|FG002|Overall Study|Protocol deviation|1|||
150280019|NCT00383084|542162029|FG000|Overall Study|Withdrawal by Subject|12|||
150280020|NCT00383084|542162030|FG001|Overall Study|Withdrawal by Subject|10|||
150280021|NCT02113436|542162031|FG000|Period 1: 8 Weeks|Adverse Event|1|||
150280022|NCT02113436|542162032|FG001|Period 1: 8 Weeks|Adverse Event|0|||
150280023|NCT02113436|542162033|FG002|Period 1: 8 Weeks|Adverse Event|0|||
150280024|NCT02113436|542162034|FG003|Period 1: 8 Weeks|Adverse Event|0|||
150280025|NCT02113436|542162031|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
150280026|NCT02113436|542162032|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
150280027|NCT02113436|542162033|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
150280028|NCT02113436|542162034|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
150280029|NCT02113436|542162031|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
150280030|NCT02113436|542162032|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
150280031|NCT02113436|542162033|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
150280032|NCT02113436|542162034|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
150280033|NCT02113436|542162031|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
150280034|NCT02113436|542162032|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
150280035|NCT02113436|542162033|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
150280036|NCT02113436|542162034|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
150280037|NCT02113436|542162031|FG000|Period 2: 16 Weeks|Adverse Event|0|||
150280038|NCT02113436|542162032|FG001|Period 2: 16 Weeks|Adverse Event|0|||
150280039|NCT02113436|542162033|FG002|Period 2: 16 Weeks|Adverse Event|4|||
150280040|NCT02113436|542162034|FG003|Period 2: 16 Weeks|Adverse Event|5|||
150280041|NCT02113436|542162031|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
150280042|NCT02113436|542162032|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
150280043|NCT02113436|542162033|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
150280044|NCT02113436|542162034|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
150280045|NCT02113436|542162031|FG000|Period 2: 16 Weeks|Physician Decision|0|||
150280046|NCT02113436|542162032|FG001|Period 2: 16 Weeks|Physician Decision|0|||
150280047|NCT02113436|542162033|FG002|Period 2: 16 Weeks|Physician Decision|2|||
150280048|NCT02113436|542162034|FG003|Period 2: 16 Weeks|Physician Decision|0|||
150280049|NCT02113436|542162031|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
150280050|NCT02113436|542162032|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
150280051|NCT02113436|542162033|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
150280052|NCT02113436|542162034|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
150280053|NCT01648790|542162035|FG000|Treatment 3|Withdrawal by Subject|0|||
150280054|NCT01648790|542162036|FG001|Treatment 3|Withdrawal by Subject|0|||
150280055|NCT01648790|542162037|FG002|Treatment 3|Withdrawal by Subject|0|||
150280056|NCT01648790|542162038|FG003|Treatment 3|Withdrawal by Subject|1|||
150280057|NCT01648790|542162039|FG004|Treatment 3|Withdrawal by Subject|0|||
150280058|NCT01486927|542162040|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
150280059|NCT01486927|542162040|FG000|Overall Study|Physician Decision|1|||
149832384|NCT02289963|540518584|FG000|Overall Study|Poor compliance to protocol|1|||
150171218|NCT02393716|541763428|FG000|Overall Study|Death|29|||
150171219|NCT02393716|541763428|FG000|Overall Study|Withdrawal by Subject|8|||
150171220|NCT02393716|541763428|FG000|Overall Study|Device Explanted|8|||
150171221|NCT02393716|541763428|FG000|Overall Study|Missed visit|16|||
150171222|NCT01924767|541763431|FG000|Overall Study|Adverse Event|1|||
150171223|NCT01924767|541763432|FG001|Overall Study|Adverse Event|0|||
150171224|NCT01924767|541763433|FG002|Overall Study|Adverse Event|1|||
150171225|NCT01924767|541763434|FG003|Overall Study|Adverse Event|0|||
150171226|NCT01924767|541763435|FG004|Overall Study|Adverse Event|0|||
150171227|NCT01193153|541763436|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
150171228|NCT01193153|541763437|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
150171229|NCT01193153|541763436|FG000|Open-label Lead in Period|Pregnancy|1|||
150171230|NCT01193153|541763437|FG001|Open-label Lead in Period|Pregnancy|0|||
150171231|NCT01193153|541763436|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
150171232|NCT01193153|541763437|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
150171233|NCT01193153|541763436|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
150171234|NCT01193153|541763437|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
150171235|NCT01193153|541763436|FG000|Open-label Lead in Period|Other|14|||
150171236|NCT01193153|541763437|FG001|Open-label Lead in Period|Other|0|||
150171237|NCT01193153|541763436|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
150171238|NCT01193153|541763437|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
150171239|NCT01193153|541763436|FG000|Open-label Lead in Period|Adverse Event|41|||
150171240|NCT01193153|541763437|FG001|Open-label Lead in Period|Adverse Event|0|||
150171241|NCT01193153|541763436|FG000|Open-label Lead in Period|Death|1|||
150171242|NCT01193153|541763437|FG001|Open-label Lead in Period|Death|0|||
150171243|NCT01193153|541763436|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
150171244|NCT01193153|541763437|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
150171245|NCT01193153|541763436|FG000|Open-label Stabilization Period|Adverse Event|9|||
150171246|NCT01193153|541763437|FG001|Open-label Stabilization Period|Adverse Event|0|||
150171247|NCT01193153|541763436|FG000|Open-label Stabilization Period|Death|2|||
150171248|NCT01193153|541763437|FG001|Open-label Stabilization Period|Death|0|||
150171249|NCT01193153|541763436|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
150171250|NCT01193153|541763437|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
150171251|NCT01193153|541763436|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
150171252|NCT01193153|541763437|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
150171253|NCT01193153|541763436|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
150171254|NCT01193153|541763437|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
150171255|NCT01193153|541763436|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
150171256|NCT01193153|541763437|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
150171257|NCT01193153|541763436|FG000|Open-label Stabilization Period|Other|8|||
150171258|NCT01193153|541763437|FG001|Open-label Stabilization Period|Other|0|||
150171259|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Other|2|||
150171260|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Other|3|||
150171261|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
150171262|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
150171263|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Death|2|||
150171264|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Death|0|||
150171265|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
150171266|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
150171267|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
150171268|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
150171269|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
150171270|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
150171271|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
150171272|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
150171273|NCT01193153|541763436|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
150171274|NCT01193153|541763437|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
150171275|NCT01648140|541763438|FG000|Overall Study|Physician Decision|1|||
150171276|NCT01648140|541763439|FG001|Overall Study|Physician Decision|0|||
150171277|NCT01648140|541763440|FG002|Overall Study|Physician Decision|0|||
150171278|NCT01648140|541763441|FG003|Overall Study|Physician Decision|0|||
150171279|NCT01648140|541763438|FG000|Overall Study|Lack of Efficacy|4|||
150171280|NCT01648140|541763439|FG001|Overall Study|Lack of Efficacy|7|||
150171281|NCT01648140|541763440|FG002|Overall Study|Lack of Efficacy|1|||
150171282|NCT01648140|541763441|FG003|Overall Study|Lack of Efficacy|0|||
150171283|NCT01648140|541763438|FG000|Overall Study|Adverse Event|3|||
150171284|NCT01648140|541763439|FG001|Overall Study|Adverse Event|1|||
150171285|NCT01648140|541763440|FG002|Overall Study|Adverse Event|2|||
150171286|NCT01648140|541763441|FG003|Overall Study|Adverse Event|0|||
150171287|NCT01648140|541763438|FG000|Overall Study|Withdrawal by Subject|2|||
150280060|NCT01486927|542162040|FG000|Overall Study|50 Exposure days not reached|2|||
150280061|NCT01486927|542162040|FG000|Overall Study|Withdrawal by Subject|8|||
150280062|NCT01486927|542162040|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
150280063|NCT02159729|542162044|FG000|Overall Study|Adverse Event|0|||
150280064|NCT02159729|542162045|FG001|Overall Study|Adverse Event|1|||
150280065|NCT02159729|542162044|FG000|Overall Study|Subject's Request|13|||
150280066|NCT02159729|542162045|FG001|Overall Study|Subject's Request|10|||
150280067|NCT02159729|542162044|FG000|Overall Study|Lost to Follow-up|24|||
150280068|NCT02159729|542162045|FG001|Overall Study|Lost to Follow-up|9|||
150280069|NCT02159729|542162044|FG000|Overall Study|Non compliance|2|||
150280070|NCT02159729|542162045|FG001|Overall Study|Non compliance|0|||
150280071|NCT02159729|542162044|FG000|Overall Study|Other Unspecified|3|||
150280072|NCT02159729|542162045|FG001|Overall Study|Other Unspecified|1|||
150280073|NCT02636582|542162046|FG000|Overall Study|Surgical Pathology|1|||
150280074|NCT02636582|542162047|FG001|Overall Study|Surgical Pathology|0|||
150280075|NCT00573430|542162048|FG000|Overall Study|Incorrect enrollment of randomization|0|||
150280076|NCT00573430|542162049|FG001|Overall Study|Incorrect enrollment of randomization|4|||
150280077|NCT00573430|542162050|FG002|Overall Study|Incorrect enrollment of randomization|3|||
150280078|NCT00573430|542162048|FG000|Overall Study|Adverse Event|0|||
150280079|NCT00573430|542162049|FG001|Overall Study|Adverse Event|0|||
150280080|NCT00573430|542162050|FG002|Overall Study|Adverse Event|2|||
150280081|NCT00573430|542162048|FG000|Overall Study|Withdrawal by Subject|1|||
150280082|NCT00573430|542162049|FG001|Overall Study|Withdrawal by Subject|0|||
150280083|NCT00573430|542162050|FG002|Overall Study|Withdrawal by Subject|1|||
150280084|NCT00573430|542162048|FG000|Overall Study|Protocol Violation|0|||
150280085|NCT00573430|542162049|FG001|Overall Study|Protocol Violation|1|||
150280086|NCT00573430|542162050|FG002|Overall Study|Protocol Violation|1|||
150280087|NCT00573430|542162048|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150280088|NCT00573430|542162049|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150280089|NCT00573430|542162050|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
150280090|NCT01278745|542162051|FG000|Overall Study|Death|2|||
150280091|NCT01278745|542162052|FG001|Overall Study|Death|5|||
150280092|NCT01278745|542162053|FG002|Overall Study|Death|7|||
149832385|NCT02289963|540518585|FG001|Overall Study|Poor compliance to protocol|0|||
149832386|NCT02289963|540518584|FG000|Overall Study|Withdrawal by Subject|1|||
149832387|NCT02289963|540518585|FG001|Overall Study|Withdrawal by Subject|0|||
149832388|NCT02289963|540518584|FG000|Overall Study|Last injection missed|2|||
149832389|NCT02289963|540518585|FG001|Overall Study|Last injection missed|2|||
149832390|NCT02289963|540518584|FG000|Overall Study|End treatment visit outside visit window|0|||
149832391|NCT02289963|540518585|FG001|Overall Study|End treatment visit outside visit window|4|||
149832392|NCT02289963|540518584|FG000|Overall Study|Other than specified above|0|||
149832393|NCT02289963|540518585|FG001|Overall Study|Other than specified above|2|||
149832394|NCT01042522|540518587|FG000|Overall Study|Adverse Event|1|||
149832395|NCT01042522|540518588|FG001|Overall Study|Adverse Event|2|||
149832396|NCT01042522|540518587|FG000|Overall Study|Disease Progression|5|||
149832397|NCT01042522|540518588|FG001|Overall Study|Disease Progression|0|||
149832398|NCT01042522|540518587|FG000|Overall Study|Death|1|||
149832399|NCT01042522|540518588|FG001|Overall Study|Death|0|||
149832400|NCT01042522|540518587|FG000|Overall Study|Patient Refused|0|||
149832401|NCT01042522|540518588|FG001|Overall Study|Patient Refused|3|||
149832402|NCT01042522|540518587|FG000|Overall Study|Withdrawal by Subject|1|||
149832403|NCT01042522|540518588|FG001|Overall Study|Withdrawal by Subject|1|||
149832404|NCT01746017|540518591|FG000|Period 1|Withdrawal by Subject|0|||
149832405|NCT01746017|540518592|FG001|Period 1|Withdrawal by Subject|0|||
149832406|NCT01746017|540518593|FG002|Period 1|Withdrawal by Subject|0|||
149832407|NCT01746017|540518594|FG003|Period 1|Withdrawal by Subject|0|||
149832408|NCT01746017|540518595|FG004|Period 1|Withdrawal by Subject|0|||
149832409|NCT01746017|540518596|FG005|Period 1|Withdrawal by Subject|0|||
149832410|NCT01746017|540518597|FG006|Period 1|Withdrawal by Subject|1|||
149832411|NCT01746017|540518598|FG007|Period 1|Withdrawal by Subject|0|||
149832412|NCT01746017|540518599|FG008|Period 1|Withdrawal by Subject|0|||
149832413|NCT01746017|540518600|FG009|Period 1|Withdrawal by Subject|0|||
149832414|NCT01746017|540518601|FG010|Period 1|Withdrawal by Subject|0|||
149832415|NCT01746017|540518591|FG000|Period 3|Withdrawal by Subject|0|||
149832416|NCT01746017|540518592|FG001|Period 3|Withdrawal by Subject|0|||
149832417|NCT01746017|540518593|FG002|Period 3|Withdrawal by Subject|0|||
149832418|NCT01746017|540518594|FG003|Period 3|Withdrawal by Subject|0|||
149832419|NCT01746017|540518595|FG004|Period 3|Withdrawal by Subject|0|||
149832420|NCT01746017|540518596|FG005|Period 3|Withdrawal by Subject|1|||
149832421|NCT01746017|540518597|FG006|Period 3|Withdrawal by Subject|0|||
149832422|NCT01746017|540518598|FG007|Period 3|Withdrawal by Subject|0|||
149832423|NCT01746017|540518599|FG008|Period 3|Withdrawal by Subject|0|||
149832424|NCT01746017|540518600|FG009|Period 3|Withdrawal by Subject|0|||
150280093|NCT01278745|542162054|FG003|Overall Study|Death|0|||
150280094|NCT01278745|542162051|FG000|Overall Study|Physician Decision|1|||
149832425|NCT01746017|540518601|FG010|Period 3|Withdrawal by Subject|0|||
150280095|NCT01278745|542162052|FG001|Overall Study|Physician Decision|0|||
150280096|NCT01278745|542162053|FG002|Overall Study|Physician Decision|0|||
150280097|NCT01278745|542162054|FG003|Overall Study|Physician Decision|9|||
150280098|NCT01278745|542162051|FG000|Overall Study|Withdrawal by Subject|1|||
149832426|NCT01675622|540518605|FG000|Overall Study|Withdrawal by Subject|2|||
149832427|NCT01675622|540518606|FG001|Overall Study|Withdrawal by Subject|2|||
149832428|NCT01675622|540518605|FG000|Overall Study|Adverse Event|12|||
149832429|NCT01675622|540518606|FG001|Overall Study|Adverse Event|10|||
149832430|NCT01675622|540518605|FG000|Overall Study|Protocol Violation|4|||
149832431|NCT01675622|540518606|FG001|Overall Study|Protocol Violation|1|||
149832432|NCT01675622|540518605|FG000|Overall Study|Lack of Efficacy|2|||
149832433|NCT01675622|540518606|FG001|Overall Study|Lack of Efficacy|4|||
149832434|NCT01675622|540518605|FG000|Overall Study|Lost to Follow-up|1|||
149832435|NCT01675622|540518606|FG001|Overall Study|Lost to Follow-up|3|||
149832436|NCT01675622|540518605|FG000|Overall Study|Other|5|||
149832437|NCT01675622|540518606|FG001|Overall Study|Other|4|||
149832438|NCT01101022|540518607|FG000|Overall Study|Adverse Event|6|||
149832439|NCT01101022|540518608|FG001|Overall Study|Adverse Event|2|||
149832440|NCT01101022|540518607|FG000|Overall Study|Protocol Violation|4|||
149832441|NCT01101022|540518608|FG001|Overall Study|Protocol Violation|3|||
149832442|NCT01101022|540518607|FG000|Overall Study|Withdrawal by Subject|3|||
149832443|NCT01101022|540518608|FG001|Overall Study|Withdrawal by Subject|8|||
149832444|NCT01101022|540518607|FG000|Overall Study|Lost to Follow-up|1|||
149832445|NCT01101022|540518608|FG001|Overall Study|Lost to Follow-up|4|||
149832446|NCT01101022|540518607|FG000|Overall Study|Lack of Efficacy|0|||
149832447|NCT01101022|540518608|FG001|Overall Study|Lack of Efficacy|7|||
149832448|NCT01101022|540518607|FG000|Overall Study|Sponsor decision|1|||
149832449|NCT01101022|540518608|FG001|Overall Study|Sponsor decision|1|||
149832450|NCT01101022|540518607|FG000|Overall Study|Non-compliance|1|||
149832451|NCT01101022|540518608|FG001|Overall Study|Non-compliance|0|||
149832452|NCT01101022|540518607|FG000|Overall Study|Work schedule|1|||
149832453|NCT01101022|540518608|FG001|Overall Study|Work schedule|1|||
149832454|NCT01101022|540518607|FG000|Overall Study|Vacation|0|||
149832455|NCT01101022|540518608|FG001|Overall Study|Vacation|1|||
149832456|NCT03075761|540518609|FG000|Overall Study|Lost to Follow-up|1|||
149832457|NCT03075761|540518610|FG001|Overall Study|Lost to Follow-up|6|||
149832458|NCT01139047|540518611|FG000|Overall Study|Withdrawal by Subject|1|||
149832459|NCT00485472|540518612|FG000|Overall Study|Adverse Event|8|||
149832460|NCT00485472|540518613|FG001|Overall Study|Adverse Event|5|||
149832461|NCT00485472|540518612|FG000|Overall Study|Lack of Efficacy|5|||
149832462|NCT00485472|540518613|FG001|Overall Study|Lack of Efficacy|4|||
149832463|NCT00485472|540518612|FG000|Overall Study|Withdrawal by Subject|1|||
149832464|NCT00485472|540518613|FG001|Overall Study|Withdrawal by Subject|0|||
149832465|NCT00485472|540518612|FG000|Overall Study|Protocol Violation|0|||
149832466|NCT00485472|540518613|FG001|Overall Study|Protocol Violation|1|||
149832467|NCT00485472|540518612|FG000|Overall Study|Other|2|||
149832468|NCT00485472|540518613|FG001|Overall Study|Other|1|||
149832469|NCT00485472|540518612|FG000|Overall Study|Lost to Follow-up|0|||
149832470|NCT00485472|540518613|FG001|Overall Study|Lost to Follow-up|1|||
149832471|NCT01492361|540518614|FG000|Overall Study|Withdrawal by Subject|281|||
149832472|NCT01492361|540518615|FG001|Overall Study|Withdrawal by Subject|297|||
149832473|NCT01492361|540518614|FG000|Overall Study|Physician Decision|12|||
149832474|NCT01492361|540518615|FG001|Overall Study|Physician Decision|12|||
149832475|NCT01492361|540518614|FG000|Overall Study|Lost to Follow-up|6|||
149832476|NCT01492361|540518615|FG001|Overall Study|Lost to Follow-up|13|||
149832477|NCT01492361|540518614|FG000|Overall Study|Other than specified above|106|||
149832478|NCT01492361|540518615|FG001|Overall Study|Other than specified above|138|||
149832479|NCT00560235|540518619|FG000|Phase 1|Discontinued|8|||
149832480|NCT00560235|540518620|FG001|Phase 1|Discontinued|0|||
149832481|NCT00560235|540518621|FG002|Phase 1|Discontinued|0|||
149832482|NCT00560235|540518619|FG000|Phase 1B|Discontinued|0|||
149832483|NCT00560235|540518620|FG001|Phase 1B|Discontinued|19|||
149832484|NCT00560235|540518621|FG002|Phase 1B|Discontinued|0|||
149832485|NCT00560235|540518619|FG000|Phase 2|Discontinued|0|||
149832486|NCT00560235|540518620|FG001|Phase 2|Discontinued|0|||
149832487|NCT00560235|540518621|FG002|Phase 2|Discontinued|96|||
150171288|NCT01648140|541763439|FG001|Overall Study|Withdrawal by Subject|3|||
149832488|NCT00560235|540518619|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
149832489|NCT00560235|540518620|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
149832490|NCT00560235|540518621|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
150171289|NCT01648140|541763440|FG002|Overall Study|Withdrawal by Subject|3|||
150171290|NCT01648140|541763441|FG003|Overall Study|Withdrawal by Subject|2|||
149832491|NCT04015232|540518623|FG000|Overall Study|Withdrawal by Subject|7|||
149832492|NCT04015232|540518624|FG001|Overall Study|Withdrawal by Subject|4|||
149832493|NCT04015232|540518623|FG000|Overall Study|Protocol Violation|1|||
149832494|NCT04015232|540518624|FG001|Overall Study|Protocol Violation|0|||
149832495|NCT04015232|540518623|FG000|Overall Study|Medical Grounds|3|||
149832496|NCT04015232|540518624|FG001|Overall Study|Medical Grounds|3|||
149832497|NCT00365300|540518627|FG000|Open-label Phase|Adverse Event|4|||
149832498|NCT00365300|540518628|FG001|Open-label Phase|Adverse Event|0|||
149832499|NCT00365300|540518627|FG000|Open-label Phase|Failed to Return|1|||
149832500|NCT00365300|540518628|FG001|Open-label Phase|Failed to Return|0|||
149832501|NCT00365300|540518627|FG000|Open-label Phase|Physician Decision|1|||
149832502|NCT00365300|540518628|FG001|Open-label Phase|Physician Decision|0|||
149832503|NCT00365300|540518627|FG000|Open-label Phase|Noncompliance|9|||
149832504|NCT00365300|540518628|FG001|Open-label Phase|Noncompliance|0|||
149832505|NCT00365300|540518627|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
149832506|NCT00365300|540518628|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
149832507|NCT00365300|540518627|FG000|Open-label Phase|Protocol Violation|1|||
149832508|NCT00365300|540518628|FG001|Open-label Phase|Protocol Violation|0|||
149832509|NCT00365300|540518627|FG000|Open-label Phase|Lack of Efficacy|1|||
149832510|NCT00365300|540518628|FG001|Open-label Phase|Lack of Efficacy|0|||
149832511|NCT00365300|540518627|FG000|Open-label Phase|Patient skipped open label phase|1|||
149832512|NCT00365300|540518628|FG001|Open-label Phase|Patient skipped open label phase|0|||
149832513|NCT00365300|540518627|FG000|Double-blind Phase|Failed to return|1|||
149832514|NCT00365300|540518628|FG001|Double-blind Phase|Failed to return|0|||
149832515|NCT00365300|540518627|FG000|Double-blind Phase|Noncompliance|1|||
149832516|NCT00365300|540518628|FG001|Double-blind Phase|Noncompliance|1|||
149832517|NCT00365300|540518627|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149832518|NCT00365300|540518628|FG001|Double-blind Phase|Withdrawal by Subject|1|||
149832519|NCT00365300|540518627|FG000|Double-blind Phase|Protocol Violation|3|||
149832520|NCT00365300|540518628|FG001|Double-blind Phase|Protocol Violation|1|||
149832521|NCT00365300|540518627|FG000|Double-blind Phase|Lack of Efficacy|6|||
149832522|NCT00365300|540518628|FG001|Double-blind Phase|Lack of Efficacy|6|||
149832523|NCT01991470|540518629|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
149832524|NCT01991470|540518629|FG000|Enlite 1 Period|Adverse Event|1|||
149832525|NCT01991470|540518629|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
149832526|NCT01991470|540518629|FG000|Enlite 3 Period|Lost to Follow-up|1|||
149832527|NCT01991470|540518629|FG000|Enlite 3 Period|Physician Decision|2|||
149832528|NCT01991470|540518629|FG000|Enlite 3 Period|Physician Decision|8|||
149832529|NCT01991470|540518629|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
149832530|NCT02896361|540518630|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
149832531|NCT02896361|540518631|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
149832532|NCT02896361|540518632|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
149832533|NCT02896361|540518630|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
149832534|NCT02896361|540518631|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
149832535|NCT02896361|540518632|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
149832536|NCT00496964|540518641|FG000|Overall Study|Withdrawal by Subject|0|||
149832537|NCT00496964|540518642|FG001|Overall Study|Withdrawal by Subject|1|||
149832538|NCT02942264|540518643|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832539|NCT02942264|540518644|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
149832540|NCT02942264|540518645|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832541|NCT02942264|540518646|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832542|NCT02942264|540518647|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832543|NCT02942264|540518648|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832544|NCT02942264|540518649|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
149832545|NCT02942264|540518650|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832546|NCT02942264|540518651|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
149832547|NCT02942264|540518643|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832548|NCT02942264|540518644|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832549|NCT02942264|540518645|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832550|NCT02942264|540518646|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832551|NCT02942264|540518647|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832552|NCT02942264|540518648|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832553|NCT02942264|540518649|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832554|NCT02942264|540518650|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
149832555|NCT02942264|540518651|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
149948793|NCT04703192|540944832|FG000|Overall Study|Clinical Progression|19|||
149948794|NCT04703192|540944833|FG001|Overall Study|Clinical Progression|8|||
149948795|NCT04703192|540944832|FG000|Overall Study|Lost to Follow-up|1|||
149948796|NCT04703192|540944833|FG001|Overall Study|Lost to Follow-up|0|||
149948797|NCT04703192|540944832|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
149948798|NCT04703192|540944833|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
149948799|NCT04703192|540944832|FG000|Overall Study|Other|5|||
149948800|NCT04703192|540944833|FG001|Overall Study|Other|1|||
150034184|NCT04484961|541264770|FG001|Overall Study|Lost to Follow-up|9|||
150171291|NCT01648140|541763438|FG000|Overall Study|Lost to Follow-up|2|||
150171292|NCT01648140|541763439|FG001|Overall Study|Lost to Follow-up|1|||
150171293|NCT01648140|541763440|FG002|Overall Study|Lost to Follow-up|2|||
150171294|NCT01648140|541763441|FG003|Overall Study|Lost to Follow-up|0|||
150171295|NCT01563354|541763444|FG000|Core Phase|Adverse Event|5|||
149832556|NCT01328093|540518652|FG000|Double-Blind Phase|Adverse Event|78|||
150171296|NCT01563354|541763445|FG001|Core Phase|Adverse Event|15|||
150280099|NCT01278745|542162052|FG001|Overall Study|Withdrawal by Subject|1|||
150280100|NCT01278745|542162053|FG002|Overall Study|Withdrawal by Subject|5|||
150280101|NCT01278745|542162054|FG003|Overall Study|Withdrawal by Subject|1|||
150280102|NCT01278745|542162051|FG000|Overall Study|Sponsor Decision|1|||
150280103|NCT01278745|542162052|FG001|Overall Study|Sponsor Decision|0|||
150280104|NCT01278745|542162053|FG002|Overall Study|Sponsor Decision|62|||
150280105|NCT01278745|542162054|FG003|Overall Study|Sponsor Decision|6|||
150280106|NCT01278745|542162051|FG000|Overall Study|Ineligible|0|||
150280107|NCT01278745|542162052|FG001|Overall Study|Ineligible|0|||
150280108|NCT01278745|542162053|FG002|Overall Study|Ineligible|42|||
150280109|NCT01278745|542162054|FG003|Overall Study|Ineligible|61|||
150280110|NCT01278745|542162051|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
150280111|NCT01278745|542162052|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
150280112|NCT01278745|542162053|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
150280113|NCT01278745|542162054|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
150280114|NCT01148537|542162055|FG000|Overall Study|Withdrawal by Subject|1|||
150280115|NCT01148537|542162056|FG001|Overall Study|Withdrawal by Subject|0|||
150280116|NCT01148537|542162057|FG002|Overall Study|Withdrawal by Subject|2|||
150280117|NCT01148537|542162055|FG000|Overall Study|Adverse Event|2|||
150280118|NCT01148537|542162056|FG001|Overall Study|Adverse Event|0|||
150280119|NCT01148537|542162057|FG002|Overall Study|Adverse Event|1|||
150280120|NCT01843842|542162060|FG000|Overall Study|Do not meet inclusion criteria|1|||
150280121|NCT01843842|542162061|FG001|Overall Study|Do not meet inclusion criteria|1|||
150280122|NCT02953340|542162062|FG000|Overall Study|Death|0|||
150280123|NCT02953340|542162063|FG001|Overall Study|Death|1|||
150280124|NCT02953340|542162062|FG000|Overall Study|Investigator Decision|3|||
150280125|NCT02953340|542162063|FG001|Overall Study|Investigator Decision|3|||
150280126|NCT02953340|542162062|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
150280127|NCT02953340|542162063|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
150280128|NCT02953340|542162062|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
150280129|NCT02953340|542162063|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
150280130|NCT02953340|542162062|FG000|Overall Study|Withdrawal by Subject|9|||
150280131|NCT02953340|542162063|FG001|Overall Study|Withdrawal by Subject|9|||
150280132|NCT02953340|542162062|FG000|Overall Study|Sponsor decision|0|||
150280133|NCT02953340|542162063|FG001|Overall Study|Sponsor decision|2|||
150280134|NCT02953340|542162062|FG000|Overall Study|Lost to Follow-up|3|||
150280135|NCT02953340|542162063|FG001|Overall Study|Lost to Follow-up|2|||
150280136|NCT02953340|542162062|FG000|Overall Study|Reason not specified|2|||
150280137|NCT02953340|542162063|FG001|Overall Study|Reason not specified|2|||
150280138|NCT01376778|542162064|FG000|Overall Study|Lost to Follow-up|3|||
150280139|NCT01376778|542162065|FG001|Overall Study|Lost to Follow-up|2|||
150280140|NCT01197521|542162066|FG000|Overall Study|Not reported|24|||
150280141|NCT01197521|542162067|FG001|Overall Study|Not reported|25|||
150280142|NCT01197521|542162068|FG002|Overall Study|Not reported|21|||
150280143|NCT01197521|542162066|FG000|Overall Study|Enrolment in long term extension|42|||
150280144|NCT01197521|542162067|FG001|Overall Study|Enrolment in long term extension|36|||
150280145|NCT01197521|542162068|FG002|Overall Study|Enrolment in long term extension|87|||
150280146|NCT01197521|542162066|FG000|Overall Study|Severe non-compliance to protocol|1|||
150280147|NCT01197521|542162067|FG001|Overall Study|Severe non-compliance to protocol|3|||
150280148|NCT01197521|542162068|FG002|Overall Study|Severe non-compliance to protocol|3|||
150280149|NCT01197521|542162066|FG000|Overall Study|Lack of therapeutic response|2|||
150280150|NCT01197521|542162067|FG001|Overall Study|Lack of therapeutic response|3|||
150280151|NCT01197521|542162068|FG002|Overall Study|Lack of therapeutic response|4|||
150280152|NCT01197521|542162066|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
150280153|NCT01197521|542162067|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
150280154|NCT01197521|542162068|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
150280155|NCT01197521|542162066|FG000|Overall Study|Lost to Follow-up|3|||
150280156|NCT01197521|542162067|FG001|Overall Study|Lost to Follow-up|2|||
150280157|NCT01197521|542162068|FG002|Overall Study|Lost to Follow-up|2|||
150280158|NCT01197521|542162066|FG000|Overall Study|Adverse Event|25|||
150280159|NCT01197521|542162067|FG001|Overall Study|Adverse Event|28|||
150280160|NCT01197521|542162068|FG002|Overall Study|Adverse Event|24|||
149832557|NCT01328093|540518653|FG001|Double-Blind Phase|Adverse Event|15|||
150034185|NCT00388349|541264771|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
150280161|NCT01543828|542162069|FG000|Treatment 2|Lost to Follow-up|1|||
150280162|NCT01543828|542162070|FG001|Treatment 2|Lost to Follow-up|0|||
150280163|NCT01069172|542162071|FG000|Overall Study|Withdrawal by Subject|1|||
150280164|NCT01069172|542162072|FG001|Overall Study|Withdrawal by Subject|0|||
150280165|NCT00827606|542162073|FG000|Overall Study|Protocol Violation|4|||
150280166|NCT00827606|542162074|FG001|Overall Study|Protocol Violation|3|||
150280167|NCT00827606|542162073|FG000|Overall Study|Lost to Follow-up|3|||
150280168|NCT00827606|542162074|FG001|Overall Study|Lost to Follow-up|1|||
150280169|NCT00827606|542162073|FG000|Overall Study|Withdrawal by Subject|7|||
150280170|NCT00827606|542162074|FG001|Overall Study|Withdrawal by Subject|6|||
150280171|NCT00827606|542162073|FG000|Overall Study|Pregnancy|0|||
150280172|NCT00827606|542162074|FG001|Overall Study|Pregnancy|1|||
149832558|NCT01328093|540518652|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
149832559|NCT01328093|540518653|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
149832560|NCT01328093|540518652|FG000|Double-Blind Phase|Lost to Follow-up|39|||
149832561|NCT01328093|540518653|FG001|Double-Blind Phase|Lost to Follow-up|14|||
149832562|NCT01328093|540518652|FG000|Double-Blind Phase|Protocol Violation|30|||
149832563|NCT01328093|540518653|FG001|Double-Blind Phase|Protocol Violation|10|||
149832564|NCT01328093|540518652|FG000|Double-Blind Phase|Lack of Efficacy|55|||
149832565|NCT01328093|540518653|FG001|Double-Blind Phase|Lack of Efficacy|13|||
149832566|NCT01328093|540518652|FG000|Double-Blind Phase|Sponsor Decision|17|||
149832567|NCT01328093|540518653|FG001|Double-Blind Phase|Sponsor Decision|3|||
149832568|NCT01328093|540518652|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
149832569|NCT01328093|540518653|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
149832570|NCT01328093|540518652|FG000|Double-Blind Phase|Scheduling conflict|8|||
149832571|NCT01328093|540518653|FG001|Double-Blind Phase|Scheduling conflict|3|||
149832572|NCT01328093|540518652|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
149832573|NCT01328093|540518653|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
149832574|NCT01328093|540518652|FG000|Double-Blind Phase|Death|1|||
149832575|NCT01328093|540518653|FG001|Double-Blind Phase|Death|0|||
149832576|NCT01328093|540518652|FG000|Open-Label Phase|Sponsor Decision|98|||
149832577|NCT01328093|540518653|FG001|Open-Label Phase|Sponsor Decision|34|||
149832578|NCT01328093|540518652|FG000|Open-Label Phase|Protocol Violation|8|||
149832579|NCT01328093|540518653|FG001|Open-Label Phase|Protocol Violation|3|||
149832580|NCT01328093|540518652|FG000|Open-Label Phase|Lost to Follow-up|10|||
149832581|NCT01328093|540518653|FG001|Open-Label Phase|Lost to Follow-up|1|||
149832582|NCT01328093|540518652|FG000|Open-Label Phase|Adverse Event|10|||
149832583|NCT01328093|540518653|FG001|Open-Label Phase|Adverse Event|4|||
149832584|NCT01328093|540518652|FG000|Open-Label Phase|Lack of Efficacy|5|||
149832585|NCT01328093|540518653|FG001|Open-Label Phase|Lack of Efficacy|6|||
149832586|NCT01328093|540518652|FG000|Open-Label Phase|Withdrawal by Subject|4|||
149832587|NCT01328093|540518653|FG001|Open-Label Phase|Withdrawal by Subject|1|||
149832588|NCT01328093|540518652|FG000|Open-Label Phase|Scheduling conflict|2|||
149832589|NCT01328093|540518653|FG001|Open-Label Phase|Scheduling conflict|1|||
149832590|NCT01328093|540518652|FG000|Open-Label Phase|Subject is moving or has moved|2|||
149832591|NCT01328093|540518653|FG001|Open-Label Phase|Subject is moving or has moved|0|||
149832592|NCT01328093|540518652|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
149832593|NCT01328093|540518653|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
149832594|NCT03980483|540518656|FG000|Overall Study|Adverse Event|13|||
149832595|NCT03980483|540518657|FG001|Overall Study|Adverse Event|29|||
149832596|NCT03980483|540518658|FG002|Overall Study|Adverse Event|11|||
149832597|NCT03980483|540518659|FG003|Overall Study|Adverse Event|2|||
150034186|NCT00388349|541264772|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
149832598|NCT03980483|540518660|FG004|Overall Study|Adverse Event|2|||
149832599|NCT03980483|540518661|FG005|Overall Study|Adverse Event|2|||
149832600|NCT03980483|540518656|FG000|Overall Study|Lack of Efficacy|7|||
149832601|NCT03980483|540518657|FG001|Overall Study|Lack of Efficacy|6|||
149832602|NCT03980483|540518658|FG002|Overall Study|Lack of Efficacy|0|||
149832603|NCT03980483|540518659|FG003|Overall Study|Lack of Efficacy|3|||
149832604|NCT03980483|540518660|FG004|Overall Study|Lack of Efficacy|1|||
149832605|NCT03980483|540518661|FG005|Overall Study|Lack of Efficacy|1|||
149832606|NCT03980483|540518656|FG000|Overall Study|Lost to Follow-up|2|||
149832607|NCT03980483|540518657|FG001|Overall Study|Lost to Follow-up|4|||
149832608|NCT03980483|540518658|FG002|Overall Study|Lost to Follow-up|2|||
149832609|NCT03980483|540518659|FG003|Overall Study|Lost to Follow-up|1|||
149832610|NCT03980483|540518660|FG004|Overall Study|Lost to Follow-up|2|||
150034187|NCT01345240|541264773|FG000|Overall Study|Adverse Event|3|||
150034188|NCT01345240|541264774|FG001|Overall Study|Adverse Event|5|||
150034189|NCT01345240|541264775|FG002|Overall Study|Adverse Event|4|||
150034190|NCT01345240|541264776|FG003|Overall Study|Adverse Event|2|||
150034191|NCT01345240|541264777|FG004|Overall Study|Adverse Event|1|||
149832611|NCT03980483|540518661|FG005|Overall Study|Lost to Follow-up|0|||
149832612|NCT03980483|540518656|FG000|Overall Study|Protocol Violation|4|||
149832613|NCT03980483|540518657|FG001|Overall Study|Protocol Violation|2|||
149832614|NCT03980483|540518658|FG002|Overall Study|Protocol Violation|1|||
150034192|NCT01345240|541264773|FG000|Overall Study|Lost to Follow-up|8|||
150034193|NCT01345240|541264774|FG001|Overall Study|Lost to Follow-up|9|||
150034194|NCT01345240|541264775|FG002|Overall Study|Lost to Follow-up|14|||
150280173|NCT00827606|542162073|FG000|Overall Study|Other|5|||
150280174|NCT00827606|542162074|FG001|Overall Study|Other|13|||
149832615|NCT03980483|540518659|FG003|Overall Study|Protocol Violation|1|||
149832616|NCT03980483|540518660|FG004|Overall Study|Protocol Violation|0|||
149832617|NCT03980483|540518661|FG005|Overall Study|Protocol Violation|0|||
149832618|NCT03980483|540518656|FG000|Overall Study|Physician Decision|14|||
149832619|NCT03980483|540518657|FG001|Overall Study|Physician Decision|10|||
149832620|NCT03980483|540518658|FG002|Overall Study|Physician Decision|7|||
149832621|NCT03980483|540518659|FG003|Overall Study|Physician Decision|4|||
149832622|NCT03980483|540518660|FG004|Overall Study|Physician Decision|4|||
149832623|NCT03980483|540518661|FG005|Overall Study|Physician Decision|2|||
149832624|NCT03980483|540518656|FG000|Overall Study|Withdrawal by Subject|38|||
150280175|NCT00827606|542162073|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
149832625|NCT03980483|540518657|FG001|Overall Study|Withdrawal by Subject|21|||
149832626|NCT03980483|540518658|FG002|Overall Study|Withdrawal by Subject|15|||
149832627|NCT03980483|540518659|FG003|Overall Study|Withdrawal by Subject|5|||
149832628|NCT03980483|540518660|FG004|Overall Study|Withdrawal by Subject|3|||
149832629|NCT03980483|540518661|FG005|Overall Study|Withdrawal by Subject|4|||
149832630|NCT03980483|540518656|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
149832631|NCT03980483|540518657|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149832632|NCT03980483|540518658|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
150034195|NCT01345240|541264776|FG003|Overall Study|Lost to Follow-up|7|||
150034196|NCT01345240|541264777|FG004|Overall Study|Lost to Follow-up|9|||
150034197|NCT04011540|541264778|FG000|Overall Study|Lost to Follow-up|9|||
150034198|NCT04011540|541264779|FG001|Overall Study|Lost to Follow-up|6|||
150034199|NCT01339832|541264784|FG000|Overall Study|Lost to Follow-up|3|||
150034200|NCT01339832|541264784|FG000|Overall Study|Death|11|||
150034201|NCT00774046|541264785|FG000|Screening|Not eligible|56|||
150034202|NCT00774046|541264785|FG000|Enrollment|Desired other therapy/refused|28|||
150034203|NCT00774046|541264785|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
150034204|NCT01126749|541264786|FG000|Phase 1b|Other|0|||
150034205|NCT01126749|541264787|FG001|Phase 1b|Other|1|||
150034206|NCT01126749|541264788|FG002|Phase 1b|Other|0|||
150034207|NCT01126749|541264789|FG003|Phase 1b|Other|0|||
150034208|NCT01126749|541264786|FG000|Phase 1b|Withdrawal by Subject|0|||
150034209|NCT01126749|541264787|FG001|Phase 1b|Withdrawal by Subject|1|||
150034210|NCT01126749|541264788|FG002|Phase 1b|Withdrawal by Subject|0|||
150034211|NCT01126749|541264789|FG003|Phase 1b|Withdrawal by Subject|0|||
150034212|NCT01126749|541264786|FG000|Phase 1b|Death|3|||
150034213|NCT01126749|541264787|FG001|Phase 1b|Death|4|||
150034214|NCT01126749|541264788|FG002|Phase 1b|Death|0|||
150034215|NCT01126749|541264789|FG003|Phase 1b|Death|0|||
150034216|NCT01126749|541264786|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
150034217|NCT01126749|541264787|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
150034218|NCT01126749|541264788|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
150034219|NCT01126749|541264789|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
150034220|NCT01126749|541264786|FG000|Phase 2|Study Termination by Sponsor|0|||
150034221|NCT01126749|541264787|FG001|Phase 2|Study Termination by Sponsor|0|||
150034222|NCT01126749|541264788|FG002|Phase 2|Study Termination by Sponsor|12|||
150034223|NCT01126749|541264789|FG003|Phase 2|Study Termination by Sponsor|6|||
150034224|NCT01126749|541264786|FG000|Phase 2|Other|0|||
150034225|NCT01126749|541264787|FG001|Phase 2|Other|0|||
150034226|NCT01126749|541264788|FG002|Phase 2|Other|4|||
150034227|NCT01126749|541264789|FG003|Phase 2|Other|2|||
150034228|NCT01126749|541264786|FG000|Phase 2|Withdrawal by Subject|0|||
150034229|NCT01126749|541264787|FG001|Phase 2|Withdrawal by Subject|0|||
150034230|NCT01126749|541264788|FG002|Phase 2|Withdrawal by Subject|0|||
150034231|NCT01126749|541264789|FG003|Phase 2|Withdrawal by Subject|2|||
150034232|NCT01126749|541264786|FG000|Phase 2|Lost to Follow-up|0|||
150034233|NCT01126749|541264787|FG001|Phase 2|Lost to Follow-up|0|||
150034234|NCT01126749|541264788|FG002|Phase 2|Lost to Follow-up|0|||
149832633|NCT03980483|540518659|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149832634|NCT03980483|540518660|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
150171297|NCT01563354|541763446|FG002|Core Phase|Adverse Event|13|||
150034235|NCT01126749|541264789|FG003|Phase 2|Lost to Follow-up|1|||
150034236|NCT01126749|541264786|FG000|Phase 2|Death|0|||
150034237|NCT01126749|541264787|FG001|Phase 2|Death|0|||
150034238|NCT01126749|541264788|FG002|Phase 2|Death|22|||
150034239|NCT01126749|541264789|FG003|Phase 2|Death|22|||
150171298|NCT01563354|541763444|FG000|Core Phase|Withdrawal by Subject|1|||
149832635|NCT03980483|540518661|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
150034240|NCT01126749|541264786|FG000|Phase 2|Adverse Event|0|||
150034241|NCT01126749|541264787|FG001|Phase 2|Adverse Event|0|||
150034242|NCT01126749|541264788|FG002|Phase 2|Adverse Event|0|||
150034243|NCT01126749|541264789|FG003|Phase 2|Adverse Event|1|||
150034244|NCT00976274|541264791|FG000|Overall Study|Lost to Follow-up|5|||
149832636|NCT03980483|540518656|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
149832637|NCT03980483|540518657|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
149832638|NCT03980483|540518658|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
149832639|NCT03980483|540518659|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
149832640|NCT03980483|540518660|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
149832641|NCT03980483|540518661|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
149832642|NCT03980483|540518656|FG000|Overall Study|Other|0|||
149832643|NCT03980483|540518657|FG001|Overall Study|Other|1|||
149832644|NCT03980483|540518658|FG002|Overall Study|Other|0|||
149832645|NCT03980483|540518659|FG003|Overall Study|Other|0|||
149832646|NCT03980483|540518660|FG004|Overall Study|Other|0|||
149832647|NCT03980483|540518661|FG005|Overall Study|Other|0|||
149832648|NCT00760266|540518666|FG000|Overall Study|Adverse Event|13|||
149832649|NCT00760266|540518667|FG001|Overall Study|Adverse Event|7|||
149832650|NCT00760266|540518666|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149832651|NCT00760266|540518667|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149832652|NCT00760266|540518666|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149832653|NCT00760266|540518667|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149832654|NCT00760266|540518666|FG000|Overall Study|Lack of Efficacy|2|||
149832655|NCT00760266|540518667|FG001|Overall Study|Lack of Efficacy|2|||
149832656|NCT00760266|540518666|FG000|Overall Study|Protocol deviation|2|||
149832657|NCT00760266|540518667|FG001|Overall Study|Protocol deviation|4|||
149832658|NCT00760266|540518666|FG000|Overall Study|Patient withdrew consent|3|||
149832659|NCT00760266|540518667|FG001|Overall Study|Patient withdrew consent|3|||
149832660|NCT00760266|540518666|FG000|Overall Study|Lost to Follow-up|2|||
149832661|NCT00760266|540518667|FG001|Overall Study|Lost to Follow-up|1|||
149832662|NCT00760266|540518666|FG000|Overall Study|Administrative Problems|0|||
149832663|NCT00760266|540518667|FG001|Overall Study|Administrative Problems|1|||
149832664|NCT05150964|540518668|FG000|Overall Study|Lost to Follow-up|2|||
149832665|NCT01239121|540518669|FG000|Overall Study|Withdrawal by Subject|2|||
149832666|NCT01239121|540518670|FG001|Overall Study|Withdrawal by Subject|4|||
149832667|NCT01239121|540518671|FG002|Overall Study|Withdrawal by Subject|0|||
149832668|NCT03657160|540518672|FG000|Overall Study|Adverse Event|5|||
149832669|NCT03657160|540518673|FG001|Overall Study|Adverse Event|6|||
149832670|NCT03657160|540518672|FG000|Overall Study|Protocol Deviation|3|||
149832671|NCT03657160|540518673|FG001|Overall Study|Protocol Deviation|0|||
149832672|NCT03657160|540518672|FG000|Overall Study|Withdrawal by Subject|18|||
149832673|NCT03657160|540518673|FG001|Overall Study|Withdrawal by Subject|16|||
149832674|NCT03657160|540518672|FG000|Overall Study|Site Termination|1|||
149832675|NCT03657160|540518673|FG001|Overall Study|Site Termination|0|||
149832676|NCT03657160|540518672|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
149832677|NCT03657160|540518673|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
149832678|NCT03657160|540518672|FG000|Overall Study|Death|33|||
149832679|NCT03657160|540518673|FG001|Overall Study|Death|26|||
149832680|NCT03657160|540518672|FG000|Overall Study|Death (COVID-19-Related)|1|||
149832681|NCT03657160|540518673|FG001|Overall Study|Death (COVID-19-Related)|0|||
149832682|NCT03657160|540518672|FG000|Overall Study|Reason Not Specified|5|||
149832683|NCT03657160|540518673|FG001|Overall Study|Reason Not Specified|5|||
149832684|NCT03657160|540518672|FG000|Overall Study|Other (COVID-19-Related)|0|||
149832685|NCT03657160|540518673|FG001|Overall Study|Other (COVID-19-Related)|1|||
149832686|NCT00686959|540518675|FG000|Overall Study|Participants censored (no death events)|124|||
149832687|NCT00686959|540518676|FG001|Overall Study|Participants censored (no death events)|117|||
149832688|NCT02178722|540518677|FG000|Overall Study|Withdrawal by Subject|0|||
149832689|NCT02178722|540518678|FG001|Overall Study|Withdrawal by Subject|0|||
149832690|NCT02178722|540518679|FG002|Overall Study|Withdrawal by Subject|0|||
149832691|NCT02178722|540518680|FG003|Overall Study|Withdrawal by Subject|2|||
149832692|NCT02178722|540518681|FG004|Overall Study|Withdrawal by Subject|33|||
149832693|NCT02178722|540518677|FG000|Overall Study|Death|2|||
149832694|NCT02178722|540518678|FG001|Overall Study|Death|13|||
149832695|NCT02178722|540518679|FG002|Overall Study|Death|12|||
149832696|NCT02178722|540518680|FG003|Overall Study|Death|12|||
149832697|NCT02178722|540518681|FG004|Overall Study|Death|205|||
149832698|NCT02178722|540518677|FG000|Overall Study|Lost to Follow-up|0|||
149832699|NCT02178722|540518678|FG001|Overall Study|Lost to Follow-up|0|||
149832700|NCT02178722|540518679|FG002|Overall Study|Lost to Follow-up|0|||
149832701|NCT02178722|540518680|FG003|Overall Study|Lost to Follow-up|2|||
149832702|NCT02178722|540518681|FG004|Overall Study|Lost to Follow-up|11|||
149832703|NCT02178722|540518677|FG000|Overall Study|Study terminated by Sponsor|2|||
149832704|NCT02178722|540518678|FG001|Overall Study|Study terminated by Sponsor|7|||
149832705|NCT02178722|540518679|FG002|Overall Study|Study terminated by Sponsor|6|||
149832706|NCT02178722|540518680|FG003|Overall Study|Study terminated by Sponsor|4|||
149832707|NCT02178722|540518681|FG004|Overall Study|Study terminated by Sponsor|128|||
149832708|NCT02178722|540518677|FG000|Overall Study|Physician Decision|0|||
149832709|NCT02178722|540518678|FG001|Overall Study|Physician Decision|0|||
149832710|NCT02178722|540518679|FG002|Overall Study|Physician Decision|0|||
149832711|NCT02178722|540518680|FG003|Overall Study|Physician Decision|0|||
149832712|NCT02178722|540518681|FG004|Overall Study|Physician Decision|3|||
149832713|NCT02178722|540518677|FG000|Overall Study|Other|0|||
149832714|NCT02178722|540518678|FG001|Overall Study|Other|0|||
149832715|NCT02178722|540518679|FG002|Overall Study|Other|0|||
149832716|NCT02178722|540518680|FG003|Overall Study|Other|0|||
149832717|NCT02178722|540518681|FG004|Overall Study|Other|2|||
149832718|NCT00440557|540518682|FG000|Overall Study|Withdrawal by Subject|10|||
149832719|NCT00440557|540518683|FG001|Overall Study|Withdrawal by Subject|5|||
149832720|NCT00440557|540518684|FG002|Overall Study|Withdrawal by Subject|11|||
149832721|NCT00440557|540518682|FG000|Overall Study|Lost to Follow-up|1|||
149832722|NCT00440557|540518683|FG001|Overall Study|Lost to Follow-up|2|||
149832723|NCT00440557|540518684|FG002|Overall Study|Lost to Follow-up|6|||
149832724|NCT00440557|540518682|FG000|Overall Study|Adverse Event|3|||
149832725|NCT00440557|540518683|FG001|Overall Study|Adverse Event|3|||
149832726|NCT00440557|540518684|FG002|Overall Study|Adverse Event|5|||
149832727|NCT00440557|540518682|FG000|Overall Study|Death|2|||
149832728|NCT00440557|540518683|FG001|Overall Study|Death|6|||
149832729|NCT00440557|540518684|FG002|Overall Study|Death|3|||
149832730|NCT00440557|540518682|FG000|Overall Study|Began Dialysis|4|||
149832731|NCT00440557|540518683|FG001|Overall Study|Began Dialysis|1|||
149832732|NCT00440557|540518684|FG002|Overall Study|Began Dialysis|4|||
149832733|NCT00440557|540518682|FG000|Overall Study|Principal Investigator decision|0|||
149832734|NCT00440557|540518683|FG001|Overall Study|Principal Investigator decision|3|||
149832735|NCT00440557|540518684|FG002|Overall Study|Principal Investigator decision|1|||
149832736|NCT00440557|540518682|FG000|Overall Study|Patient moved|1|||
149832737|NCT00440557|540518683|FG001|Overall Study|Patient moved|2|||
149832738|NCT00440557|540518684|FG002|Overall Study|Patient moved|1|||
149832739|NCT00440557|540518682|FG000|Overall Study|Principal Investigator's office closed|3|||
149832740|NCT00440557|540518683|FG001|Overall Study|Principal Investigator's office closed|6|||
149832741|NCT00440557|540518684|FG002|Overall Study|Principal Investigator's office closed|4|||
149832742|NCT00440557|540518682|FG000|Overall Study|Patient transferred to nursing home|0|||
149832743|NCT00440557|540518683|FG001|Overall Study|Patient transferred to nursing home|1|||
149832744|NCT00440557|540518684|FG002|Overall Study|Patient transferred to nursing home|0|||
149832745|NCT00440557|540518682|FG000|Overall Study|Patient had surgery|1|||
149832746|NCT00440557|540518683|FG001|Overall Study|Patient had surgery|0|||
149832747|NCT00440557|540518684|FG002|Overall Study|Patient had surgery|0|||
149832748|NCT01572948|540518685|FG000|Overall Study|Lost to Follow-up|1|||
149832749|NCT01572948|540518686|FG001|Overall Study|Lost to Follow-up|0|||
149832750|NCT01572948|540518685|FG000|Overall Study|unable to contact|0|||
149832751|NCT01572948|540518686|FG001|Overall Study|unable to contact|1|||
149832752|NCT01126736|540518692|FG000|Overall Study|Death|2|||
149832753|NCT01126736|540518693|FG001|Overall Study|Death|2|||
149832754|NCT01126736|540518694|FG002|Overall Study|Death|1|||
149832755|NCT01126736|540518695|FG003|Overall Study|Death|19|||
149832756|NCT01126736|540518696|FG004|Overall Study|Death|19|||
149832757|NCT01126736|540518692|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
149832758|NCT01126736|540518693|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
149832759|NCT01126736|540518694|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
149832760|NCT01126736|540518695|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
149832761|NCT01126736|540518696|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
149832762|NCT01126736|540518692|FG000|Overall Study|Lost to Follow-up|0|||
149832763|NCT01126736|540518693|FG001|Overall Study|Lost to Follow-up|0|||
150280176|NCT00827606|542162074|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
150280177|NCT00827606|542162073|FG000|Overall Study|Adverse Event|4|||
150280178|NCT00827606|542162074|FG001|Overall Study|Adverse Event|2|||
150280179|NCT00243386|542162077|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
150280180|NCT00243386|542162078|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
150280181|NCT00243386|542162079|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
150280182|NCT00243386|542162077|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
150280183|NCT00243386|542162078|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
150280184|NCT00243386|542162079|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
149832764|NCT01126736|540518694|FG002|Overall Study|Lost to Follow-up|0|||
149832765|NCT01126736|540518695|FG003|Overall Study|Lost to Follow-up|1|||
149832766|NCT01126736|540518696|FG004|Overall Study|Lost to Follow-up|1|||
149832767|NCT01126736|540518692|FG000|Overall Study|Administrative reasons|0|||
149832768|NCT01126736|540518693|FG001|Overall Study|Administrative reasons|0|||
149832769|NCT01126736|540518694|FG002|Overall Study|Administrative reasons|0|||
149832770|NCT01126736|540518695|FG003|Overall Study|Administrative reasons|0|||
149832771|NCT01126736|540518696|FG004|Overall Study|Administrative reasons|1|||
149832772|NCT01126736|540518692|FG000|Overall Study|Progressive disease|0|||
150280185|NCT00243386|542162077|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
150280186|NCT00243386|542162078|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
149832773|NCT01126736|540518693|FG001|Overall Study|Progressive disease|0|||
149832774|NCT01126736|540518694|FG002|Overall Study|Progressive disease|0|||
149832775|NCT01126736|540518695|FG003|Overall Study|Progressive disease|2|||
149832776|NCT01126736|540518696|FG004|Overall Study|Progressive disease|1|||
149832777|NCT01126736|540518692|FG000|Overall Study|Withdrawal by Subject|0|||
149832778|NCT01126736|540518693|FG001|Overall Study|Withdrawal by Subject|0|||
149832779|NCT01126736|540518694|FG002|Overall Study|Withdrawal by Subject|0|||
149832780|NCT01126736|540518695|FG003|Overall Study|Withdrawal by Subject|1|||
149832781|NCT01126736|540518696|FG004|Overall Study|Withdrawal by Subject|1|||
149832782|NCT01126736|540518692|FG000|Overall Study|Other|2|||
149832783|NCT01126736|540518693|FG001|Overall Study|Other|4|||
149832784|NCT01126736|540518694|FG002|Overall Study|Other|4|||
149832785|NCT01126736|540518695|FG003|Overall Study|Other|16|||
149832786|NCT01126736|540518696|FG004|Overall Study|Other|15|||
149832787|NCT01720264|540518701|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
149832788|NCT01720264|540518701|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
149832789|NCT01720264|540518701|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
149832790|NCT01479439|540518704|FG000|Overall Study|Adverse Event|1|||
149832791|NCT01479439|540518705|FG001|Overall Study|Adverse Event|0|||
149832792|NCT01479439|540518706|FG002|Overall Study|Adverse Event|0|||
149832793|NCT01479439|540518704|FG000|Overall Study|Lost to Follow-up|0|||
149832794|NCT01479439|540518705|FG001|Overall Study|Lost to Follow-up|1|||
149832795|NCT01479439|540518706|FG002|Overall Study|Lost to Follow-up|0|||
149832796|NCT01479439|540518704|FG000|Overall Study|Protocol Violation|0|||
149832797|NCT01479439|540518705|FG001|Overall Study|Protocol Violation|0|||
149832798|NCT01479439|540518706|FG002|Overall Study|Protocol Violation|2|||
149832799|NCT02079766|540518707|FG000|Overall Study|Physician Decision|1|||
149832800|NCT02079766|540518708|FG001|Overall Study|Physician Decision|0|||
149832801|NCT02079766|540518707|FG000|Overall Study|Withdrawal by Subject|1|||
149832802|NCT02079766|540518708|FG001|Overall Study|Withdrawal by Subject|0|||
149832803|NCT03018249|540518713|FG000|Overall Study|Withdrawal by Subject|2|||
149832804|NCT03018249|540518714|FG001|Overall Study|Withdrawal by Subject|2|||
149832805|NCT00824265|540518717|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
150280187|NCT00243386|542162079|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
150280188|NCT00243386|542162077|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
150280189|NCT00243386|542162078|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
150280190|NCT00243386|542162079|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
150280191|NCT00243386|542162077|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
150280192|NCT00243386|542162078|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
150280193|NCT00243386|542162079|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
150280194|NCT00243386|542162077|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
150280195|NCT00243386|542162078|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
150280196|NCT00243386|542162079|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
150280197|NCT00243386|542162077|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
150280198|NCT00243386|542162078|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
150280199|NCT00243386|542162079|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
150280200|NCT00243386|542162077|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
150280201|NCT00243386|542162078|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
150280202|NCT00243386|542162079|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
150280203|NCT04037748|542162080|FG000|Treatment Period 1|Withdrawal by Subject|3|||
150280204|NCT04037748|542162081|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150280205|NCT04037748|542162080|FG000|Treatment Period 1|Adverse Event|1|||
150280206|NCT04037748|542162081|FG001|Treatment Period 1|Adverse Event|1|||
150280207|NCT04037748|542162080|FG000|Treatment Period 1|Protocol Violation|4|||
150280208|NCT04037748|542162081|FG001|Treatment Period 1|Protocol Violation|5|||
150280209|NCT04037748|542162080|FG000|Treatment Period 2|Adverse Event|0|||
150280210|NCT04037748|542162081|FG001|Treatment Period 2|Adverse Event|1|||
150280211|NCT04037748|542162080|FG000|Treatment Period 2|Protocol Violation|2|||
150280212|NCT04037748|542162081|FG001|Treatment Period 2|Protocol Violation|0|||
150280213|NCT04995055|542162082|FG000|Period 1|COVID-19 Related|1|||
149832806|NCT00824265|540518718|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
149832807|NCT00824265|540518717|FG000|Treatment Phase|Protocol Violation|1|||
149832808|NCT00824265|540518718|FG001|Treatment Phase|Protocol Violation|0|||
149832809|NCT00824265|540518717|FG000|Treatment Phase|Lost to Follow-up|1|||
149832810|NCT00824265|540518718|FG001|Treatment Phase|Lost to Follow-up|1|||
149832811|NCT00824265|540518717|FG000|Treatment Phase|Physician Decision|6|||
149832812|NCT00824265|540518718|FG001|Treatment Phase|Physician Decision|12|||
149832813|NCT00824265|540518717|FG000|Treatment Phase|Withdrawal by Subject|6|||
149832814|NCT00824265|540518718|FG001|Treatment Phase|Withdrawal by Subject|15|||
149832815|NCT00824265|540518717|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
149832816|NCT00824265|540518718|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
149832817|NCT00824265|540518717|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
149832818|NCT00824265|540518718|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
149832819|NCT01248247|540520087|FG000|Overall Study|Adverse Event|2|||
149832820|NCT01248247|540520088|FG001|Overall Study|Adverse Event|4|||
150280214|NCT04995055|542162083|FG001|Period 1|COVID-19 Related|0|||
150280215|NCT04995055|542162082|FG000|Period 1|Withdrawal by Subject|0|||
149832821|NCT01248247|540520089|FG002|Overall Study|Adverse Event|4|||
149832822|NCT01248247|540520090|FG003|Overall Study|Adverse Event|2|||
149832823|NCT01248247|540520087|FG000|Overall Study|Death|0|||
149832824|NCT01248247|540520088|FG001|Overall Study|Death|1|||
149832825|NCT01248247|540520089|FG002|Overall Study|Death|4|||
149832826|NCT01248247|540520090|FG003|Overall Study|Death|7|||
149832827|NCT01248247|540520087|FG000|Overall Study|Lost to Follow-up|0|||
149832828|NCT01248247|540520088|FG001|Overall Study|Lost to Follow-up|1|||
149832829|NCT01248247|540520089|FG002|Overall Study|Lost to Follow-up|1|||
149832830|NCT01248247|540520090|FG003|Overall Study|Lost to Follow-up|0|||
149832831|NCT01248247|540520087|FG000|Overall Study|Alternative treatment|0|||
149832832|NCT01248247|540520088|FG001|Overall Study|Alternative treatment|1|||
149832833|NCT01248247|540520089|FG002|Overall Study|Alternative treatment|0|||
149832834|NCT01248247|540520090|FG003|Overall Study|Alternative treatment|0|||
149832835|NCT01248247|540520087|FG000|Overall Study|Other|2|||
149832836|NCT01248247|540520088|FG001|Overall Study|Other|8|||
149832837|NCT01248247|540520089|FG002|Overall Study|Other|8|||
149832838|NCT01248247|540520090|FG003|Overall Study|Other|5|||
149832839|NCT01248247|540520087|FG000|Overall Study|Progression|18|||
149832840|NCT01248247|540520088|FG001|Overall Study|Progression|27|||
149832841|NCT01248247|540520089|FG002|Overall Study|Progression|56|||
149832842|NCT01248247|540520090|FG003|Overall Study|Progression|44|||
149832843|NCT01248247|540520087|FG000|Overall Study|Refuse further treatment|0|||
149832844|NCT01248247|540520088|FG001|Overall Study|Refuse further treatment|0|||
149832845|NCT01248247|540520089|FG002|Overall Study|Refuse further treatment|1|||
149832846|NCT01248247|540520090|FG003|Overall Study|Refuse further treatment|2|||
149832847|NCT01248247|540520087|FG000|Overall Study|Complicating disease|0|||
149832848|NCT01248247|540520088|FG001|Overall Study|Complicating disease|0|||
149832849|NCT01248247|540520089|FG002|Overall Study|Complicating disease|1|||
149832850|NCT01248247|540520090|FG003|Overall Study|Complicating disease|1|||
149832851|NCT01900730|540520092|FG000|Overall Study|Withdrawal by Subject|1|||
149832852|NCT01900730|540520093|FG001|Overall Study|Withdrawal by Subject|0|||
149832853|NCT01900730|540520092|FG000|Overall Study|Screen Failure|1|||
149832854|NCT01900730|540520093|FG001|Overall Study|Screen Failure|0|||
149832855|NCT02109042|540520094|FG000|Overall Study|Sponsor Decision|15|||
149832856|NCT00324168|540520099|FG000|Overall Study|Lost to Follow-up|19|||
149832857|NCT00324168|540520100|FG001|Overall Study|Lost to Follow-up|18|||
149832858|NCT00324168|540520099|FG000|Overall Study|Death|3|||
149832859|NCT00324168|540520100|FG001|Overall Study|Death|3|||
149832860|NCT00324168|540520099|FG000|Overall Study|Patient did not visit in f/u window|6|||
149832861|NCT00324168|540520100|FG001|Overall Study|Patient did not visit in f/u window|9|||
149832862|NCT00274937|540520101|FG000|Overall Study|Physician Decision|10|||
149832863|NCT00274937|540520101|FG000|Overall Study|Withdrawal by Subject|6|||
149832864|NCT00274937|540520101|FG000|Overall Study|Progressive Disease|4|||
149832865|NCT02189941|540520102|FG000|Overall Study|Non-compliance|0|||
149832866|NCT02189941|540520103|FG001|Overall Study|Non-compliance|0|||
149832867|NCT02189941|540520104|FG002|Overall Study|Non-compliance|1|||
149832868|NCT03478397|540520105|FG000|Overall Study|Refused to participate|31|||
149832869|NCT03478397|540520106|FG001|Overall Study|Refused to participate|7|||
149832870|NCT02017964|540520112|FG000|Overall Study|Patient deemed ineligible|1|||
149832871|NCT01434693|540520114|FG000|Overall Study|Adverse Event|1|||
149832872|NCT01434693|540520115|FG001|Overall Study|Adverse Event|0|||
149832873|NCT01434693|540520116|FG002|Overall Study|Adverse Event|0|||
149832874|NCT01434693|540520117|FG003|Overall Study|Adverse Event|0|||
150171299|NCT01563354|541763445|FG001|Core Phase|Withdrawal by Subject|0|||
150171300|NCT01563354|541763446|FG002|Core Phase|Withdrawal by Subject|3|||
150171301|NCT01563354|541763444|FG000|Core Phase|Lost to Follow-up|1|||
150171302|NCT01563354|541763445|FG001|Core Phase|Lost to Follow-up|0|||
150171303|NCT01563354|541763446|FG002|Core Phase|Lost to Follow-up|0|||
150171304|NCT01563354|541763444|FG000|Core Phase|Death|1|||
150171305|NCT01563354|541763445|FG001|Core Phase|Death|5|||
150171306|NCT01563354|541763446|FG002|Core Phase|Death|2|||
150171307|NCT01563354|541763444|FG000|Core Phase|Diseasse progression|18|||
150171308|NCT01563354|541763445|FG001|Core Phase|Diseasse progression|7|||
150171309|NCT01563354|541763446|FG002|Core Phase|Diseasse progression|8|||
150171310|NCT01563354|541763444|FG000|Core Phase|Protocol deviation|2|||
150171311|NCT01563354|541763445|FG001|Core Phase|Protocol deviation|0|||
150171312|NCT01563354|541763446|FG002|Core Phase|Protocol deviation|0|||
150171313|NCT01563354|541763444|FG000|Core Phase|PI decision - did not enter extension|0|||
150171314|NCT01563354|541763445|FG001|Core Phase|PI decision - did not enter extension|1|||
150171315|NCT01563354|541763446|FG002|Core Phase|PI decision - did not enter extension|0|||
150171316|NCT01563354|541763444|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
150171317|NCT01563354|541763445|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
150171318|NCT01563354|541763446|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
150171319|NCT01563354|541763444|FG000|Extension Phase|Adverse Event|0|||
150171320|NCT01563354|541763445|FG001|Extension Phase|Adverse Event|3|||
149832875|NCT01434693|540520114|FG000|Overall Study|Withdrawal by Subject|1|||
149832876|NCT01434693|540520115|FG001|Overall Study|Withdrawal by Subject|0|||
149832877|NCT01434693|540520116|FG002|Overall Study|Withdrawal by Subject|1|||
149832878|NCT01434693|540520117|FG003|Overall Study|Withdrawal by Subject|1|||
149832879|NCT01434693|540520114|FG000|Overall Study|Lost to Follow-up|1|||
149832880|NCT01434693|540520115|FG001|Overall Study|Lost to Follow-up|0|||
149832881|NCT01434693|540520116|FG002|Overall Study|Lost to Follow-up|0|||
149832882|NCT01434693|540520117|FG003|Overall Study|Lost to Follow-up|0|||
149832883|NCT04006171|540520118|FG000|Overall Study|Withdrawal by Subject|8|||
149832884|NCT04006171|540520119|FG001|Overall Study|Withdrawal by Subject|7|||
149832885|NCT04006171|540520118|FG000|Overall Study|missing serum samples|2|||
149832886|NCT04006171|540520119|FG001|Overall Study|missing serum samples|2|||
149832887|NCT04006171|540520118|FG000|Overall Study|insufficient sample volume|2|||
149832888|NCT04006171|540520119|FG001|Overall Study|insufficient sample volume|3|||
149832889|NCT00912288|540520120|FG000|Overall Study|Death|0|||
149832890|NCT00912288|540520121|FG001|Overall Study|Death|1|||
149832891|NCT00912288|540520120|FG000|Overall Study|Adverse Event|1|||
149832892|NCT00912288|540520121|FG001|Overall Study|Adverse Event|1|||
149832893|NCT00912288|540520120|FG000|Overall Study|Lost to Follow-up|1|||
149832894|NCT00912288|540520121|FG001|Overall Study|Lost to Follow-up|0|||
149832895|NCT00912288|540520120|FG000|Overall Study|Protocol Violation|1|||
150280216|NCT04995055|542162083|FG001|Period 1|Withdrawal by Subject|1|||
150280217|NCT04995055|542162082|FG000|Period 1|Subject discontinued due to timing|4|||
149832896|NCT00912288|540520121|FG001|Overall Study|Protocol Violation|0|||
149832897|NCT00912288|540520120|FG000|Overall Study|Withdrawal by Subject|3|||
149832898|NCT00912288|540520121|FG001|Overall Study|Withdrawal by Subject|3|||
149832899|NCT00912288|540520120|FG000|Overall Study|Study terminated by sponsor|34|||
149832900|NCT00912288|540520121|FG001|Overall Study|Study terminated by sponsor|35|||
149832901|NCT00912288|540520120|FG000|Overall Study|Other|1|||
149832902|NCT00912288|540520121|FG001|Overall Study|Other|0|||
149832903|NCT01440283|540520124|FG000|Overall Study|Death|3|||
149832904|NCT01440283|540520124|FG000|Overall Study|Withdrawal by Subject|4|||
149832905|NCT01440283|540520124|FG000|Overall Study|Physician Decision|3|||
149832906|NCT01449630|540520125|FG000|Period 1|Physician Decision|1|||
149832907|NCT01449630|540520126|FG001|Period 1|Physician Decision|0|||
149832908|NCT01449630|540520127|FG002|Period 1|Physician Decision|0|||
149832909|NCT01449630|540520128|FG003|Period 1|Physician Decision|1|||
149832910|NCT01449630|540520129|FG004|Period 1|Physician Decision|0|||
149832911|NCT01449630|540520130|FG005|Period 1|Physician Decision|0|||
149832912|NCT01449630|540520131|FG006|Period 1|Physician Decision|0|||
149832913|NCT01449630|540520132|FG007|Period 1|Physician Decision|0|||
149832914|NCT01449630|540520133|FG008|Period 1|Physician Decision|0|||
149832915|NCT01449630|540520125|FG000|Period 1|Sponsor Decision|0|||
149832916|NCT01449630|540520126|FG001|Period 1|Sponsor Decision|0|||
149832917|NCT01449630|540520127|FG002|Period 1|Sponsor Decision|0|||
149832918|NCT01449630|540520128|FG003|Period 1|Sponsor Decision|0|||
150280218|NCT04995055|542162083|FG001|Period 1|Subject discontinued due to timing|4|||
150280219|NCT04695392|542162085|FG000|Overall Study|Withdrawn by parent/guardian|0|||
150280220|NCT04695392|542162086|FG001|Overall Study|Withdrawn by parent/guardian|1|||
149832919|NCT01449630|540520129|FG004|Period 1|Sponsor Decision|0|||
149832920|NCT01449630|540520130|FG005|Period 1|Sponsor Decision|1|||
149832921|NCT01449630|540520131|FG006|Period 1|Sponsor Decision|0|||
149832922|NCT01449630|540520132|FG007|Period 1|Sponsor Decision|0|||
149832923|NCT01449630|540520133|FG008|Period 1|Sponsor Decision|0|||
149832924|NCT01449630|540520125|FG000|Period 2|Sponsor Decision|0|||
149832925|NCT01449630|540520126|FG001|Period 2|Sponsor Decision|0|||
149832926|NCT01449630|540520127|FG002|Period 2|Sponsor Decision|0|||
149832927|NCT01449630|540520128|FG003|Period 2|Sponsor Decision|0|||
149832928|NCT01449630|540520129|FG004|Period 2|Sponsor Decision|0|||
149832929|NCT01449630|540520130|FG005|Period 2|Sponsor Decision|0|||
150171321|NCT01563354|541763446|FG002|Extension Phase|Adverse Event|2|||
150171322|NCT01563354|541763444|FG000|Extension Phase|Withdrawal by Subject|0|||
150171323|NCT01563354|541763445|FG001|Extension Phase|Withdrawal by Subject|1|||
150171324|NCT01563354|541763446|FG002|Extension Phase|Withdrawal by Subject|0|||
150171325|NCT01563354|541763444|FG000|Extension Phase|Administration problems|3|||
150171326|NCT01563354|541763445|FG001|Extension Phase|Administration problems|2|||
150171327|NCT01563354|541763446|FG002|Extension Phase|Administration problems|3|||
150171328|NCT01563354|541763444|FG000|Extension Phase|Disease progression|9|||
150171329|NCT01563354|541763445|FG001|Extension Phase|Disease progression|8|||
150171330|NCT01563354|541763446|FG002|Extension Phase|Disease progression|10|||
150171331|NCT01565928|541763447|FG000|Overall Study|Adverse Event|3|||
150171332|NCT01565928|541763447|FG000|Overall Study|Other|3|||
150171333|NCT01565928|541763447|FG000|Overall Study|Progressive Disease|13|||
150171334|NCT01565928|541763447|FG000|Overall Study|Withdrawal by Subject|1|||
150171335|NCT01565928|541763447|FG000|Overall Study|Death|2|||
150171336|NCT01119950|541763448|FG000|Overall Study|Adverse Event|25|||
150171337|NCT01119950|541763448|FG000|Overall Study|Withdrawal by Subject|9|||
150171338|NCT01119950|541763448|FG000|Overall Study|Protocol Violation|5|||
150171339|NCT01119950|541763448|FG000|Overall Study|Lost to Follow-up|4|||
150171340|NCT01119950|541763448|FG000|Overall Study|Administrative|2|||
150280221|NCT04695392|542162085|FG000|Overall Study|Withdrawn by physician|0|||
149832930|NCT01449630|540520131|FG006|Period 2|Sponsor Decision|1|||
149832931|NCT01449630|540520132|FG007|Period 2|Sponsor Decision|0|||
149832932|NCT01449630|540520133|FG008|Period 2|Sponsor Decision|0|||
149832933|NCT02087904|540520139|FG000|Overall Study|Did Not Receive Study Drug|0|||
149832934|NCT02087904|540520140|FG001|Overall Study|Did Not Receive Study Drug|0|||
149832935|NCT02087904|540520141|FG002|Overall Study|Did Not Receive Study Drug|2|||
149832936|NCT02087904|540520142|FG003|Overall Study|Did Not Receive Study Drug|1|||
149832937|NCT02087904|540520139|FG000|Overall Study|Adverse Event|8|||
149832938|NCT02087904|540520140|FG001|Overall Study|Adverse Event|4|||
149832939|NCT02087904|540520141|FG002|Overall Study|Adverse Event|4|||
149832940|NCT02087904|540520142|FG003|Overall Study|Adverse Event|12|||
149832941|NCT02087904|540520139|FG000|Overall Study|Lack of Efficacy|3|||
149832942|NCT02087904|540520140|FG001|Overall Study|Lack of Efficacy|6|||
149832943|NCT02087904|540520141|FG002|Overall Study|Lack of Efficacy|3|||
149832944|NCT02087904|540520142|FG003|Overall Study|Lack of Efficacy|2|||
149832945|NCT02087904|540520139|FG000|Overall Study|Other|6|||
149832946|NCT02087904|540520140|FG001|Overall Study|Other|2|||
149832947|NCT02087904|540520141|FG002|Overall Study|Other|4|||
149832948|NCT02087904|540520142|FG003|Overall Study|Other|4|||
149832949|NCT02087904|540520139|FG000|Overall Study|Withdrawal by Subject|8|||
149832950|NCT02087904|540520140|FG001|Overall Study|Withdrawal by Subject|3|||
149832951|NCT02087904|540520141|FG002|Overall Study|Withdrawal by Subject|7|||
149832952|NCT02087904|540520142|FG003|Overall Study|Withdrawal by Subject|4|||
149832953|NCT02087904|540520139|FG000|Overall Study|Lost to Follow-up|0|||
149832954|NCT02087904|540520140|FG001|Overall Study|Lost to Follow-up|4|||
149832955|NCT02087904|540520141|FG002|Overall Study|Lost to Follow-up|2|||
149832956|NCT02087904|540520142|FG003|Overall Study|Lost to Follow-up|2|||
149832957|NCT01735630|540520143|FG000|Overall Study|Adverse Event|8|||
149832958|NCT01735630|540520144|FG001|Overall Study|Adverse Event|7|||
149832959|NCT01735630|540520143|FG000|Overall Study|Lost to Follow-up|1|||
149832960|NCT01735630|540520144|FG001|Overall Study|Lost to Follow-up|0|||
149832961|NCT01735630|540520143|FG000|Overall Study|Physician Decision|0|||
149832962|NCT01735630|540520144|FG001|Overall Study|Physician Decision|1|||
149832963|NCT01735630|540520143|FG000|Overall Study|Sponsor Decision|2|||
149832964|NCT01735630|540520144|FG001|Overall Study|Sponsor Decision|1|||
149832965|NCT01735630|540520143|FG000|Overall Study|Withdrawal by Subject|7|||
149832966|NCT01735630|540520144|FG001|Overall Study|Withdrawal by Subject|9|||
149832967|NCT03099538|540520146|FG000|Overall Study|Lack of Efficacy|3|||
149832968|NCT01196052|540520147|FG000|Overall Study|Adverse Event|9|||
149832969|NCT01196052|540520147|FG000|Overall Study|Lost to Follow-up|1|||
149832970|NCT01196052|540520147|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
149832971|NCT01196052|540520147|FG000|Overall Study|Reason not Specified|5|||
149832972|NCT01196052|540520147|FG000|Overall Study|Withdrawal by Subject|6|||
149832973|NCT04625114|540520161|FG000|Overall Study|Adverse Event|3|||
149832974|NCT04625114|540520162|FG001|Overall Study|Adverse Event|1|||
149832975|NCT04625114|540520161|FG000|Overall Study|Withdrawal by Subject|2|||
149832976|NCT04625114|540520162|FG001|Overall Study|Withdrawal by Subject|0|||
149832977|NCT01629381|540520163|FG000|Overall Study|Withdrawal by Subject|2|||
149832978|NCT01629381|540520164|FG001|Overall Study|Withdrawal by Subject|5|||
149832979|NCT00906347|540520167|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
149832980|NCT00906347|540520168|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
149832981|NCT00906347|540520167|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
149832982|NCT00906347|540520168|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
149832983|NCT00906347|540520167|FG000|Received Study Drug|Refused study drug|1|||
149832984|NCT00906347|540520168|FG001|Received Study Drug|Refused study drug|0|||
149832985|NCT00906347|540520167|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
149832986|NCT00906347|540520168|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
149832987|NCT02849652|540520176|FG000|Overall Study|Lost to Follow-up|104|||
149832988|NCT02849652|540520177|FG001|Overall Study|Lost to Follow-up|35|||
149832989|NCT02849652|540520178|FG002|Overall Study|Lost to Follow-up|116|||
149832990|NCT02849652|540520179|FG003|Overall Study|Lost to Follow-up|22|||
150280222|NCT04695392|542162086|FG001|Overall Study|Withdrawn by physician|1|||
150280223|NCT00450723|542162088|FG000|Overall Study|Physician Decision|5|||
150280224|NCT01987960|542162089|FG000|Period 1|Adverse Event|24|||
150280225|NCT01987960|542162090|FG001|Period 1|Adverse Event|0|||
150280226|NCT01987960|542162091|FG002|Period 1|Adverse Event|0|||
149832991|NCT02849652|540520176|FG000|Overall Study|Withdrawal by Subject|10|||
149832992|NCT02849652|540520177|FG001|Overall Study|Withdrawal by Subject|2|||
149832993|NCT02849652|540520178|FG002|Overall Study|Withdrawal by Subject|8|||
150280227|NCT01987960|542162092|FG003|Period 1|Adverse Event|0|||
150280228|NCT01987960|542162089|FG000|Period 1|Lack of Efficacy|4|||
149832994|NCT02849652|540520179|FG003|Overall Study|Withdrawal by Subject|4|||
149832995|NCT00472290|540520180|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
149832996|NCT00472290|540520180|FG000|Overall Study|Protocol Specified Criteria|7|||
149832997|NCT00472290|540520180|FG000|Overall Study|Administrative Decision|37|||
149832998|NCT00472290|540520180|FG000|Overall Study|Death|3|||
149832999|NCT00472290|540520180|FG000|Overall Study|Lost to Follow-up|1|||
149833000|NCT00472290|540520180|FG000|Overall Study|Lack of Efficacy|1|||
150280229|NCT01987960|542162090|FG001|Period 1|Lack of Efficacy|0|||
150280230|NCT01987960|542162091|FG002|Period 1|Lack of Efficacy|0|||
149833001|NCT00472290|540520180|FG000|Overall Study|Disease Progression|4|||
149833002|NCT00472290|540520180|FG000|Overall Study|Withdrawal by Subject|5|||
149833003|NCT00472290|540520180|FG000|Overall Study|Adverse Event|6|||
149833004|NCT00472290|540520180|FG000|Overall Study|Requirement for alternative therapy|7|||
149833005|NCT00777829|540520181|FG000|Overall Study|Withdrawal by Subject|0|||
149833006|NCT00777829|540520182|FG001|Overall Study|Withdrawal by Subject|2|||
149833007|NCT00854308|540520191|FG000|Overall Study|Disease progression|42|||
149833008|NCT00854308|540520192|FG001|Overall Study|Disease progression|50|||
149833009|NCT00854308|540520191|FG000|Overall Study|Adverse Event|8|||
149833010|NCT00854308|540520192|FG001|Overall Study|Adverse Event|3|||
149833011|NCT00854308|540520191|FG000|Overall Study|Death|2|||
149833012|NCT00854308|540520192|FG001|Overall Study|Death|5|||
149833013|NCT00854308|540520191|FG000|Overall Study|Physician Decision|6|||
149833014|NCT00854308|540520192|FG001|Overall Study|Physician Decision|6|||
149833015|NCT00854308|540520191|FG000|Overall Study|Withdrawal by Subject|4|||
149833016|NCT00854308|540520192|FG001|Overall Study|Withdrawal by Subject|2|||
149833017|NCT00854308|540520191|FG000|Overall Study|Sponsor's decision to terminate study|0|||
149833018|NCT00854308|540520192|FG001|Overall Study|Sponsor's decision to terminate study|1|||
149833019|NCT01390844|540520193|FG000|Treatment Phase|Adverse Event|12|||
149833020|NCT01390844|540520194|FG001|Treatment Phase|Adverse Event|2|||
149833021|NCT01390844|540520195|FG002|Treatment Phase|Adverse Event|3|||
149833022|NCT01390844|540520196|FG003|Treatment Phase|Adverse Event|2|||
149833023|NCT01390844|540520193|FG000|Treatment Phase|Treatment Failure|23|||
149833024|NCT01390844|540520194|FG001|Treatment Phase|Treatment Failure|25|||
149833025|NCT01390844|540520195|FG002|Treatment Phase|Treatment Failure|10|||
149833026|NCT01390844|540520196|FG003|Treatment Phase|Treatment Failure|13|||
149833027|NCT01390844|540520193|FG000|Treatment Phase|Non-Medical Reasons|5|||
149833028|NCT01390844|540520194|FG001|Treatment Phase|Non-Medical Reasons|1|||
149833029|NCT01390844|540520195|FG002|Treatment Phase|Non-Medical Reasons|8|||
149833030|NCT01390844|540520196|FG003|Treatment Phase|Non-Medical Reasons|1|||
149833031|NCT01390844|540520193|FG000|Treatment Phase|Non-GCP Compliant|0|||
149833032|NCT01390844|540520194|FG001|Treatment Phase|Non-GCP Compliant|0|||
149833033|NCT01390844|540520195|FG002|Treatment Phase|Non-GCP Compliant|10|||
149833034|NCT01390844|540520196|FG003|Treatment Phase|Non-GCP Compliant|3|||
149833035|NCT01390844|540520193|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
149833036|NCT01390844|540520194|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
149833037|NCT01390844|540520195|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
149833038|NCT01390844|540520196|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
149833039|NCT00745095|540520197|FG000|Overall Study|Declined to participate|1|||
149833040|NCT00745095|540520198|FG001|Overall Study|Declined to participate|0|||
149833041|NCT00745095|540520199|FG002|Overall Study|Declined to participate|0|||
149833042|NCT00745095|540520200|FG003|Overall Study|Declined to participate|0|||
149833043|NCT00745095|540520201|FG004|Overall Study|Declined to participate|92|||
149833044|NCT00745095|540520202|FG005|Overall Study|Declined to participate|95|||
149833045|NCT00745095|540520197|FG000|Overall Study|Ineligible due to GFR criteria|0|||
149833046|NCT00745095|540520198|FG001|Overall Study|Ineligible due to GFR criteria|2|||
149833047|NCT00745095|540520199|FG002|Overall Study|Ineligible due to GFR criteria|3|||
149833048|NCT00745095|540520200|FG003|Overall Study|Ineligible due to GFR criteria|3|||
149833049|NCT00745095|540520201|FG004|Overall Study|Ineligible due to GFR criteria|30|||
149833050|NCT00745095|540520202|FG005|Overall Study|Ineligible due to GFR criteria|28|||
149833051|NCT00304083|540520212|FG000|Overall Study|Withdrawal by Subject|4|||
149833052|NCT00304083|540520213|FG001|Overall Study|Withdrawal by Subject|2|||
149833053|NCT00304083|540520212|FG000|Overall Study|Physician Decision|8|||
149833054|NCT00304083|540520213|FG001|Overall Study|Physician Decision|3|||
149833055|NCT00304083|540520212|FG000|Overall Study|Disease Progression|5|||
149833056|NCT00304083|540520213|FG001|Overall Study|Disease Progression|1|||
149833057|NCT00304083|540520212|FG000|Overall Study|Other|5|||
149833058|NCT00304083|540520213|FG001|Overall Study|Other|2|||
149833059|NCT01044732|540520214|FG000|Overall Study|Lost to Follow-up|2|||
149833060|NCT01044732|540520215|FG001|Overall Study|Lost to Follow-up|1|||
149833061|NCT01044732|540520214|FG000|Overall Study|Physician Decision|5|||
149833062|NCT01044732|540520215|FG001|Overall Study|Physician Decision|3|||
149833063|NCT01044732|540520214|FG000|Overall Study|Protocol Violation|11|||
149833064|NCT01044732|540520215|FG001|Overall Study|Protocol Violation|12|||
149833065|NCT01044732|540520214|FG000|Overall Study|Withdrawal by Subject|0|||
149833066|NCT01044732|540520215|FG001|Overall Study|Withdrawal by Subject|1|||
149833067|NCT01044732|540520214|FG000|Overall Study|Inadequate bowel preparation|11|||
149833068|NCT01044732|540520215|FG001|Overall Study|Inadequate bowel preparation|17|||
149833069|NCT01044732|540520214|FG000|Overall Study|Inability to reach cecum|5|||
149833070|NCT01044732|540520215|FG001|Overall Study|Inability to reach cecum|2|||
149833071|NCT01044732|540520214|FG000|Overall Study|Technical error or malfunction|15|||
149833072|NCT01044732|540520215|FG001|Overall Study|Technical error or malfunction|14|||
149833073|NCT03991494|540520220|FG000|Overall Study|Progressive Disease|4|||
149833074|NCT00683293|540520226|FG000|Overall Study|Withdrawal by Subject|2|||
150171341|NCT01119950|541763448|FG000|Overall Study|Abnormal lab value|1|||
150171342|NCT01119950|541763448|FG000|Overall Study|Death|1|||
150171343|NCT01988233|541763455|FG000|Overall Study|Lost to Follow-up|64|||
150171344|NCT01988233|541763456|FG001|Overall Study|Lost to Follow-up|51|||
150171345|NCT01713530|541763464|FG000|Overall Study|Adverse Event|0|||
150171346|NCT01713530|541763465|FG001|Overall Study|Adverse Event|5|||
150171347|NCT01713530|541763464|FG000|Overall Study|Withdrawal criteria|21|||
150171348|NCT01713530|541763465|FG001|Overall Study|Withdrawal criteria|12|||
150171349|NCT01713530|541763464|FG000|Overall Study|Unclassified|4|||
150171350|NCT01713530|541763465|FG001|Overall Study|Unclassified|2|||
150171351|NCT03743246|541763466|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
150171352|NCT03743246|541763467|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
150171353|NCT03743246|541763468|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
150171354|NCT03743246|541763469|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
150171355|NCT03743246|541763466|FG000|Pre-Treatment Period|Death|0|||
150171356|NCT03743246|541763467|FG001|Pre-Treatment Period|Death|1|||
150171357|NCT03743246|541763468|FG002|Pre-Treatment Period|Death|0|||
150171358|NCT03743246|541763469|FG003|Pre-Treatment Period|Death|1|||
150171359|NCT03743246|541763466|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
150171360|NCT03743246|541763467|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
150171361|NCT03743246|541763468|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
150171362|NCT03743246|541763469|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
150171363|NCT03743246|541763466|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
150171364|NCT03743246|541763467|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
150171365|NCT03743246|541763468|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
150171366|NCT03743246|541763469|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
150171367|NCT03743246|541763466|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
150171368|NCT03743246|541763467|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
150171369|NCT03743246|541763468|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
150171370|NCT03743246|541763469|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
150171371|NCT03743246|541763466|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
150171372|NCT03743246|541763467|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
150171373|NCT03743246|541763468|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
150171374|NCT03743246|541763469|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
150171375|NCT03743246|541763466|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
150171376|NCT03743246|541763467|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
150171377|NCT03743246|541763468|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
150171378|NCT03743246|541763469|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
150171379|NCT03743246|541763466|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
150171380|NCT03743246|541763467|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
150171381|NCT03743246|541763468|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
150171382|NCT03743246|541763469|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
150171383|NCT03743246|541763466|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
150171384|NCT03743246|541763467|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
150171385|NCT03743246|541763468|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
150171386|NCT03743246|541763469|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
150171387|NCT01184508|541763472|FG000|Overall Study|Adverse Event|4|||
150171388|NCT01184508|541763473|FG001|Overall Study|Adverse Event|6|||
150171389|NCT01184508|541763472|FG000|Overall Study|Lack of Efficacy|1|||
150171390|NCT01184508|541763473|FG001|Overall Study|Lack of Efficacy|1|||
150171391|NCT01184508|541763472|FG000|Overall Study|Lost to Follow-up|1|||
150171392|NCT01184508|541763473|FG001|Overall Study|Lost to Follow-up|1|||
150171393|NCT01184508|541763472|FG000|Overall Study|Physician Decision|1|||
150171394|NCT01184508|541763473|FG001|Overall Study|Physician Decision|0|||
150171395|NCT01184508|541763472|FG000|Overall Study|Protocol Violation|3|||
150171396|NCT01184508|541763473|FG001|Overall Study|Protocol Violation|1|||
150171397|NCT01184508|541763472|FG000|Overall Study|Sponsor Decision|5|||
150171398|NCT01184508|541763473|FG001|Overall Study|Sponsor Decision|2|||
150171399|NCT01184508|541763472|FG000|Overall Study|Withdrawal by Subject|1|||
150171400|NCT01184508|541763473|FG001|Overall Study|Withdrawal by Subject|3|||
150171401|NCT01184508|541763472|FG000|Overall Study|Randomized, Not Treated|0|||
150171402|NCT01184508|541763473|FG001|Overall Study|Randomized, Not Treated|1|||
150171403|NCT00756730|541763479|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
150171404|NCT00756730|541763480|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
150171405|NCT00756730|541763479|FG000|Overall Study|persistent low-level viremmia|0|||
150171406|NCT00756730|541763480|FG001|Overall Study|persistent low-level viremmia|1|||
150171407|NCT00639002|541763483|FG000|Overall Study|Death|1|||
149833075|NCT00683293|540520227|FG001|Overall Study|Withdrawal by Subject|3|||
149833076|NCT02920996|540520230|FG000|Overall Study|Adverse Event|8|||
149833077|NCT02920996|540520231|FG001|Overall Study|Adverse Event|0|||
149833078|NCT02920996|540520230|FG000|Overall Study|Physician Decision|1|||
149833079|NCT02920996|540520231|FG001|Overall Study|Physician Decision|0|||
149833080|NCT02920996|540520230|FG000|Overall Study|Death|1|||
149833081|NCT02920996|540520231|FG001|Overall Study|Death|0|||
149833082|NCT02920996|540520230|FG000|Overall Study|Missing|1|||
149833083|NCT02920996|540520231|FG001|Overall Study|Missing|0|||
149833084|NCT02920996|540520230|FG000|Overall Study|Subject Non-Compliance|1|||
149833085|NCT02920996|540520231|FG001|Overall Study|Subject Non-Compliance|0|||
149833086|NCT02507375|540520232|FG000|Overall Study|Progressive Disease|4|||
149833087|NCT02507375|540520233|FG001|Overall Study|Progressive Disease|5|||
149833088|NCT02507375|540520232|FG000|Overall Study|Death|0|||
149833089|NCT02507375|540520233|FG001|Overall Study|Death|1|||
149833090|NCT02507375|540520232|FG000|Overall Study|Refused treatment|0|||
149833091|NCT02507375|540520233|FG001|Overall Study|Refused treatment|1|||
149833092|NCT02507375|540520232|FG000|Overall Study|Adverse Event|0|||
149833093|NCT02507375|540520233|FG001|Overall Study|Adverse Event|1|||
149833094|NCT02158936|540520234|FG000|Overall Study|Study closed/ terminated|57|||
149833095|NCT02158936|540520235|FG001|Overall Study|Study closed/ terminated|77|||
149833096|NCT02158936|540520234|FG000|Overall Study|Azacitidine tx discontinued|53|||
149833097|NCT02158936|540520235|FG001|Overall Study|Azacitidine tx discontinued|46|||
149833098|NCT02158936|540520234|FG000|Overall Study|Adverse Event|39|||
149833099|NCT02158936|540520235|FG001|Overall Study|Adverse Event|24|||
149833100|NCT02158936|540520234|FG000|Overall Study|Withdrawal by Subject|15|||
149833101|NCT02158936|540520235|FG001|Overall Study|Withdrawal by Subject|16|||
149833102|NCT02158936|540520234|FG000|Overall Study|Physician Decision|15|||
149833103|NCT02158936|540520235|FG001|Overall Study|Physician Decision|13|||
149833104|NCT02158936|540520234|FG000|Overall Study|Lost to Follow-up|0|||
149833105|NCT02158936|540520235|FG001|Overall Study|Lost to Follow-up|1|||
149833106|NCT00522457|540520236|FG000|Overall Study|Due to disease progression|16|||
149833107|NCT00522457|540520236|FG000|Overall Study|Adverse Event|2|||
149833108|NCT02817841|540521551|FG000|Overall Study|Lost to Follow-up|287|||
149833109|NCT02817841|540521551|FG000|Overall Study|Withdrawal by Subject|183|||
149833110|NCT02817841|540521551|FG000|Overall Study|Adverse event not related to bleeding|131|||
149833111|NCT02817841|540521551|FG000|Overall Study|Adverse event related to bleeding|51|||
149833112|NCT02817841|540521551|FG000|Overall Study|Pregnancy|32|||
149833113|NCT02817841|540521551|FG000|Overall Study|Pregnancy wish|17|||
149833114|NCT02817841|540521551|FG000|Overall Study|Other reasons|53|||
149833115|NCT02817841|540521551|FG000|Overall Study|Protocol Violation|94|||
149833116|NCT00705536|540521552|FG000|Start Period 1|Withdrawal by Subject|0|||
149833117|NCT00705536|540521553|FG001|Start Period 1|Withdrawal by Subject|0|||
149833118|NCT00705536|540521554|FG002|Start Period 1|Withdrawal by Subject|0|||
149833119|NCT00705536|540521555|FG003|Start Period 1|Withdrawal by Subject|1|||
149833120|NCT00549718|540521556|FG000|Overall Study|Insufficient clinical response|20|||
149833121|NCT00549718|540521557|FG001|Overall Study|Insufficient clinical response|7|||
149833122|NCT00549718|540521558|FG002|Overall Study|Insufficient clinical response|18|||
149833123|NCT00549718|540521559|FG003|Overall Study|Insufficient clinical response|32|||
149833124|NCT00549718|540521556|FG000|Overall Study|Adverse Event|6|||
149833125|NCT00549718|540521557|FG001|Overall Study|Adverse Event|8|||
149833126|NCT00549718|540521558|FG002|Overall Study|Adverse Event|7|||
149833127|NCT00549718|540521559|FG003|Overall Study|Adverse Event|3|||
149833128|NCT00549718|540521556|FG000|Overall Study|Lost to Follow-up|4|||
149833129|NCT00549718|540521557|FG001|Overall Study|Lost to Follow-up|2|||
149833130|NCT00549718|540521558|FG002|Overall Study|Lost to Follow-up|0|||
150034245|NCT00976274|541264792|FG001|Overall Study|Lost to Follow-up|5|||
150034246|NCT00976274|541264791|FG000|Overall Study|Withdrawal by Subject|1|||
150034247|NCT00976274|541264792|FG001|Overall Study|Withdrawal by Subject|1|||
150034248|NCT00976274|541264791|FG000|Overall Study|Physician Decision|1|||
150171408|NCT00639002|541763483|FG000|Overall Study|Adverse Event|1|||
150171409|NCT00639002|541763483|FG000|Overall Study|Protocol Violation|1|||
149833131|NCT00549718|540521559|FG003|Overall Study|Lost to Follow-up|6|||
149833132|NCT00549718|540521556|FG000|Overall Study|Withdrawal by Subject|9|||
149833133|NCT00549718|540521557|FG001|Overall Study|Withdrawal by Subject|18|||
149833134|NCT00549718|540521558|FG002|Overall Study|Withdrawal by Subject|12|||
149833135|NCT00549718|540521559|FG003|Overall Study|Withdrawal by Subject|13|||
149833136|NCT00549718|540521556|FG000|Overall Study|Administrative|2|||
149833137|NCT00549718|540521557|FG001|Overall Study|Administrative|2|||
149833138|NCT00549718|540521558|FG002|Overall Study|Administrative|2|||
150034249|NCT00976274|541264792|FG001|Overall Study|Physician Decision|2|||
150034250|NCT02183675|541264793|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
149833139|NCT00549718|540521559|FG003|Overall Study|Administrative|1|||
149833140|NCT00397488|540521560|FG000|Overall Study|Withdrawal by Subject|3|||
149833141|NCT00397488|540521560|FG000|Overall Study|Adverse Event|3|||
150171410|NCT00639002|541763483|FG000|Overall Study|Disease progression|3|||
150171411|NCT00639002|541763483|FG000|Overall Study|Physician Decision|6|||
150171412|NCT00639002|541763483|FG000|Overall Study|Lack of Efficacy|1|||
150171413|NCT04210180|541763489|FG000|Overall Study|Withdrawal by Subject|2|||
149833142|NCT00397488|540521560|FG000|Overall Study|Death|1|||
149833143|NCT04032977|540521565|FG000|Overall Study|Withdrawal by Subject|6|||
149833144|NCT04032977|540521566|FG001|Overall Study|Withdrawal by Subject|1|||
149833145|NCT04032977|540521565|FG000|Overall Study|Lost to Follow-up|2|||
149833146|NCT04032977|540521566|FG001|Overall Study|Lost to Follow-up|7|||
149833147|NCT04032977|540521565|FG000|Overall Study|Pregnancy|1|||
149833148|NCT04032977|540521566|FG001|Overall Study|Pregnancy|0|||
149833149|NCT02880761|540521568|FG000|Overall Study|Death|6|||
149833150|NCT02880761|540521569|FG001|Overall Study|Death|8|||
149833151|NCT02880761|540521568|FG000|Overall Study|Withdrawal by Subject|3|||
149833152|NCT02880761|540521569|FG001|Overall Study|Withdrawal by Subject|6|||
149833153|NCT02880761|540521568|FG000|Overall Study|Protocol Violation|4|||
149833154|NCT02880761|540521569|FG001|Overall Study|Protocol Violation|3|||
149833155|NCT02880761|540521568|FG000|Overall Study|Lost to Follow-up|3|||
149833156|NCT02880761|540521569|FG001|Overall Study|Lost to Follow-up|4|||
149833157|NCT03597256|540521570|FG000|Overall Study|Lost to Follow-up|3|||
149833158|NCT03597256|540521571|FG001|Overall Study|Lost to Follow-up|1|||
149833159|NCT03597256|540521570|FG000|Overall Study|Withdrawal by Subject|0|||
149833160|NCT03597256|540521571|FG001|Overall Study|Withdrawal by Subject|1|||
149833161|NCT03597256|540521570|FG000|Overall Study|Could not return for treatment|0|||
149833162|NCT03597256|540521571|FG001|Overall Study|Could not return for treatment|1|||
149833163|NCT03597256|540521570|FG000|Overall Study|Moved from location|0|||
149833164|NCT03597256|540521571|FG001|Overall Study|Moved from location|1|||
149833165|NCT03597256|540521570|FG000|Overall Study|Not accepted the treatment|0|||
149833166|NCT03597256|540521571|FG001|Overall Study|Not accepted the treatment|1|||
149833167|NCT02106156|540521572|FG000|Overall Study|Patient Died|19|||
149833168|NCT02106156|540521573|FG001|Overall Study|Patient Died|0|||
149833169|NCT02106156|540521574|FG002|Overall Study|Patient Died|0|||
149833170|NCT02106156|540521572|FG000|Overall Study|Lack of Tolerability|305|||
149833171|NCT02106156|540521573|FG001|Overall Study|Lack of Tolerability|3|||
149833172|NCT02106156|540521574|FG002|Overall Study|Lack of Tolerability|0|||
149833173|NCT02106156|540521572|FG000|Overall Study|Lack of Virological Response|1044|||
149833174|NCT02106156|540521573|FG001|Overall Study|Lack of Virological Response|8|||
149833175|NCT02106156|540521574|FG002|Overall Study|Lack of Virological Response|0|||
149833176|NCT02106156|540521572|FG000|Overall Study|Concomitant Disease|74|||
149833177|NCT02106156|540521573|FG001|Overall Study|Concomitant Disease|2|||
149833178|NCT02106156|540521574|FG002|Overall Study|Concomitant Disease|0|||
149833179|NCT02106156|540521572|FG000|Overall Study|Lack of Compliance|211|||
149833180|NCT02106156|540521573|FG001|Overall Study|Lack of Compliance|7|||
149833181|NCT02106156|540521574|FG002|Overall Study|Lack of Compliance|0|||
149833182|NCT02106156|540521572|FG000|Overall Study|Patients Request|307|||
149833183|NCT02106156|540521573|FG001|Overall Study|Patients Request|9|||
149833184|NCT02106156|540521574|FG002|Overall Study|Patients Request|0|||
149833185|NCT02106156|540521572|FG000|Overall Study|Lost to Follow-up|451|||
149833186|NCT02106156|540521573|FG001|Overall Study|Lost to Follow-up|8|||
149833187|NCT02106156|540521574|FG002|Overall Study|Lost to Follow-up|0|||
149833188|NCT02106156|540521572|FG000|Overall Study|Unplanned Event|82|||
149833189|NCT02106156|540521573|FG001|Overall Study|Unplanned Event|2|||
149833190|NCT02106156|540521574|FG002|Overall Study|Unplanned Event|0|||
149833191|NCT02106156|540521572|FG000|Overall Study|Change of Laboratory Parameter|10|||
149833192|NCT02106156|540521573|FG001|Overall Study|Change of Laboratory Parameter|0|||
149833193|NCT02106156|540521574|FG002|Overall Study|Change of Laboratory Parameter|0|||
149833194|NCT02106156|540521572|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
149833195|NCT02106156|540521573|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
149833196|NCT02106156|540521574|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
149833197|NCT02106156|540521572|FG000|Overall Study|Relocation/Change of Physician|40|||
149833198|NCT02106156|540521573|FG001|Overall Study|Relocation/Change of Physician|1|||
149833199|NCT02106156|540521574|FG002|Overall Study|Relocation/Change of Physician|0|||
149833200|NCT00840632|540521585|FG000|First Intervention|Withdrawal by Subject|0|||
149833201|NCT00840632|540521586|FG001|First Intervention|Withdrawal by Subject|1|||
149833202|NCT00840632|540521585|FG000|Washout|Withdrawal by Subject|1|||
149833203|NCT00840632|540521586|FG001|Washout|Withdrawal by Subject|1|||
149833204|NCT01725529|540521587|FG000|Overall Study|Adverse Event|1|||
149833205|NCT01725529|540521588|FG001|Overall Study|Adverse Event|0|||
149833206|NCT01725529|540521589|FG002|Overall Study|Adverse Event|0|||
149833207|NCT01725529|540521587|FG000|Overall Study|Lost to Follow-up|2|||
149833208|NCT01725529|540521588|FG001|Overall Study|Lost to Follow-up|1|||
149833209|NCT01725529|540521589|FG002|Overall Study|Lost to Follow-up|1|||
149833210|NCT01725529|540521587|FG000|Overall Study|Protocol Violation|0|||
149833211|NCT01725529|540521588|FG001|Overall Study|Protocol Violation|1|||
149833212|NCT01725529|540521589|FG002|Overall Study|Protocol Violation|1|||
149833213|NCT01725529|540521587|FG000|Overall Study|Withdrawal by Subject|12|||
149833214|NCT01725529|540521588|FG001|Overall Study|Withdrawal by Subject|14|||
149833215|NCT01725529|540521589|FG002|Overall Study|Withdrawal by Subject|8|||
149833216|NCT00051025|540521596|FG000|Overall Study|Progressive Disease|1|||
149833217|NCT00051025|540521597|FG001|Overall Study|Progressive Disease|1|||
149833218|NCT00051025|540521596|FG000|Overall Study|Adverse Event|1|||
149833219|NCT00051025|540521597|FG001|Overall Study|Adverse Event|1|||
149833220|NCT00051025|540521596|FG000|Overall Study|Withdrawal by Subject|0|||
149833221|NCT00051025|540521597|FG001|Overall Study|Withdrawal by Subject|1|||
149833222|NCT00051025|540521596|FG000|Overall Study|Death|0|||
149833223|NCT00051025|540521597|FG001|Overall Study|Death|1|||
149833224|NCT01179048|540521598|FG000|Overall Study|Withdrawn - does not allow contact|4|||
149833225|NCT01179048|540521599|FG001|Overall Study|Withdrawn - does not allow contact|8|||
149833226|NCT01179048|540521598|FG000|Overall Study|Lost to Follow-up|8|||
149833227|NCT01179048|540521599|FG001|Overall Study|Lost to Follow-up|9|||
149833228|NCT01179048|540521598|FG000|Overall Study|Alive|127|||
149833229|NCT01179048|540521599|FG001|Overall Study|Alive|142|||
149833230|NCT03203447|540521600|FG000|Overall Study|Withdrawal by Subject|2|||
149833231|NCT03203447|540521601|FG001|Overall Study|Withdrawal by Subject|1|||
149833232|NCT03203447|540521600|FG000|Overall Study|Lost to Follow-up|1|||
149833233|NCT03203447|540521601|FG001|Overall Study|Lost to Follow-up|10|||
149833234|NCT03203447|540521600|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
149833235|NCT03203447|540521601|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
149833236|NCT01203878|540521602|FG000|Overall Study|Withdrawal by Subject|0|||
149833237|NCT01203878|540521603|FG001|Overall Study|Withdrawal by Subject|0|||
150171414|NCT05190419|541763490|FG000|Overall Study|Lack of Efficacy|8|||
150171415|NCT05190419|541763491|FG001|Overall Study|Lack of Efficacy|0|||
150171416|NCT05190419|541763492|FG002|Overall Study|Lack of Efficacy|1|||
150171417|NCT05190419|541763493|FG003|Overall Study|Lack of Efficacy|0|||
150171418|NCT05190419|541763490|FG000|Overall Study|Withdrawal by Subject|7|||
150171419|NCT05190419|541763491|FG001|Overall Study|Withdrawal by Subject|1|||
150171420|NCT05190419|541763492|FG002|Overall Study|Withdrawal by Subject|2|||
150171421|NCT05190419|541763493|FG003|Overall Study|Withdrawal by Subject|2|||
150171422|NCT05190419|541763490|FG000|Overall Study|Adverse Event|2|||
150171423|NCT05190419|541763491|FG001|Overall Study|Adverse Event|10|||
150171424|NCT05190419|541763492|FG002|Overall Study|Adverse Event|11|||
150171425|NCT05190419|541763493|FG003|Overall Study|Adverse Event|21|||
149833238|NCT01203878|540521604|FG002|Overall Study|Withdrawal by Subject|1|||
149833239|NCT01203878|540521602|FG000|Overall Study|Adverse Event|0|||
149833240|NCT01203878|540521603|FG001|Overall Study|Adverse Event|0|||
149833241|NCT01203878|540521604|FG002|Overall Study|Adverse Event|2|||
149833242|NCT00445003|540521605|FG000|Overall Study|Death|1|||
149833243|NCT00445003|540521606|FG001|Overall Study|Death|2|||
149833244|NCT00445003|540521607|FG002|Overall Study|Death|1|||
149833245|NCT00445003|540521605|FG000|Overall Study|Missed Visit|3|||
149833246|NCT00445003|540521606|FG001|Overall Study|Missed Visit|5|||
149833247|NCT00445003|540521607|FG002|Overall Study|Missed Visit|1|||
149833248|NCT00445003|540521605|FG000|Overall Study|Dropped|1|||
149833249|NCT00445003|540521606|FG001|Overall Study|Dropped|3|||
149833250|NCT00445003|540521607|FG002|Overall Study|Dropped|2|||
149833251|NCT00528606|540521608|FG000|Overall Study|Withdrew consent|4|||
149833252|NCT00528606|540521609|FG001|Overall Study|Withdrew consent|3|||
149833253|NCT00528606|540521608|FG000|Overall Study|Lost to Follow-up|4|||
149833254|NCT00528606|540521609|FG001|Overall Study|Lost to Follow-up|1|||
149833255|NCT00528606|540521608|FG000|Overall Study|Adverse Event|3|||
149833256|NCT00528606|540521609|FG001|Overall Study|Adverse Event|0|||
149833257|NCT00528606|540521608|FG000|Overall Study|Other|2|||
149833258|NCT00528606|540521609|FG001|Overall Study|Other|0|||
149833259|NCT02475954|540521610|FG000|Overall Study|Withdrawal by Subject|2|||
149833260|NCT02475954|540521611|FG001|Overall Study|Withdrawal by Subject|2|||
149833261|NCT02475954|540521610|FG000|Overall Study|Lost to Follow-up|11|||
149833262|NCT02475954|540521611|FG001|Overall Study|Lost to Follow-up|9|||
149833263|NCT02475954|540521610|FG000|Overall Study|Death|1|||
149833264|NCT02475954|540521611|FG001|Overall Study|Death|1|||
149833265|NCT01918397|540521616|FG000|Overall Study|Never started treatment|2|||
149833266|NCT01918397|540521617|FG001|Overall Study|Never started treatment|1|||
149833267|NCT01918397|540521618|FG002|Overall Study|Never started treatment|0|||
149833268|NCT01918397|540521619|FG003|Overall Study|Never started treatment|0|||
149833269|NCT01918397|540521616|FG000|Overall Study|Adverse Event|1|||
149833270|NCT01918397|540521617|FG001|Overall Study|Adverse Event|1|||
149833271|NCT01918397|540521618|FG002|Overall Study|Adverse Event|1|||
149833272|NCT01918397|540521619|FG003|Overall Study|Adverse Event|0|||
149833273|NCT01918397|540521616|FG000|Overall Study|Lack of compliance|2|||
149833274|NCT01918397|540521617|FG001|Overall Study|Lack of compliance|2|||
149833275|NCT01918397|540521618|FG002|Overall Study|Lack of compliance|3|||
149833276|NCT01918397|540521619|FG003|Overall Study|Lack of compliance|0|||
149833277|NCT01918397|540521616|FG000|Overall Study|Pregnancy|0|||
149833278|NCT01918397|540521617|FG001|Overall Study|Pregnancy|1|||
149833279|NCT01918397|540521618|FG002|Overall Study|Pregnancy|0|||
149833280|NCT01918397|540521619|FG003|Overall Study|Pregnancy|0|||
149833281|NCT01918397|540521616|FG000|Overall Study|Rifampin susceptible|0|||
149833282|NCT01918397|540521617|FG001|Overall Study|Rifampin susceptible|0|||
149833283|NCT01918397|540521618|FG002|Overall Study|Rifampin susceptible|0|||
149833284|NCT01918397|540521619|FG003|Overall Study|Rifampin susceptible|2|||
149833285|NCT01918397|540521616|FG000|Overall Study|Treatment failure|0|||
149833286|NCT01918397|540521617|FG001|Overall Study|Treatment failure|0|||
149833287|NCT01918397|540521618|FG002|Overall Study|Treatment failure|0|||
149833288|NCT01918397|540521619|FG003|Overall Study|Treatment failure|1|||
149833289|NCT01918397|540521616|FG000|Overall Study|Withdrawal by Subject|3|||
149833290|NCT01918397|540521617|FG001|Overall Study|Withdrawal by Subject|2|||
149833291|NCT01918397|540521618|FG002|Overall Study|Withdrawal by Subject|1|||
149833292|NCT01918397|540521619|FG003|Overall Study|Withdrawal by Subject|1|||
149833293|NCT01918397|540521616|FG000|Overall Study|XDR at baseline|0|||
149833294|NCT01918397|540521617|FG001|Overall Study|XDR at baseline|0|||
149833295|NCT01918397|540521618|FG002|Overall Study|XDR at baseline|1|||
150280231|NCT01987960|542162092|FG003|Period 1|Lack of Efficacy|0|||
150280232|NCT01987960|542162089|FG000|Period 1|Non-compliance with IMP|6|||
150280233|NCT01987960|542162090|FG001|Period 1|Non-compliance with IMP|0|||
150280234|NCT01987960|542162091|FG002|Period 1|Non-compliance with IMP|0|||
149833296|NCT01918397|540521619|FG003|Overall Study|XDR at baseline|0|||
149833297|NCT01918397|540521616|FG000|Overall Study|Lost to Follow-up|2|||
149833298|NCT01918397|540521617|FG001|Overall Study|Lost to Follow-up|1|||
149833299|NCT01918397|540521618|FG002|Overall Study|Lost to Follow-up|1|||
149833300|NCT01918397|540521619|FG003|Overall Study|Lost to Follow-up|1|||
149833301|NCT01918397|540521616|FG000|Overall Study|Increased QTc|1|||
149833302|NCT01918397|540521617|FG001|Overall Study|Increased QTc|0|||
149833303|NCT01918397|540521618|FG002|Overall Study|Increased QTc|0|||
149833304|NCT01918397|540521619|FG003|Overall Study|Increased QTc|1|||
149833305|NCT01918397|540521616|FG000|Overall Study|Death|0|||
150034251|NCT02183675|541264794|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
150280235|NCT01987960|542162092|FG003|Period 1|Non-compliance with IMP|0|||
150280236|NCT01987960|542162089|FG000|Period 1|Protocol Violation|12|||
149833306|NCT01918397|540521617|FG001|Overall Study|Death|0|||
149833307|NCT01918397|540521618|FG002|Overall Study|Death|1|||
149833308|NCT01918397|540521619|FG003|Overall Study|Death|0|||
149833309|NCT01918397|540521616|FG000|Overall Study|Involved in another investigative trial|0|||
149833310|NCT01918397|540521617|FG001|Overall Study|Involved in another investigative trial|0|||
150280237|NCT01987960|542162090|FG001|Period 1|Protocol Violation|0|||
149833311|NCT01918397|540521618|FG002|Overall Study|Involved in another investigative trial|0|||
149833312|NCT01918397|540521619|FG003|Overall Study|Involved in another investigative trial|1|||
149833313|NCT00880568|540521620|FG000|Overall Study|Disease progression|3|||
149833314|NCT00880568|540521621|FG001|Overall Study|Disease progression|3|||
149833315|NCT00880568|540521622|FG002|Overall Study|Disease progression|3|||
149833316|NCT00880568|540521623|FG003|Overall Study|Disease progression|1|||
149833317|NCT00880568|540521624|FG004|Overall Study|Disease progression|3|||
149833318|NCT00880568|540521625|FG005|Overall Study|Disease progression|3|||
149833319|NCT00880568|540521626|FG006|Overall Study|Disease progression|5|||
149833320|NCT00880568|540521627|FG007|Overall Study|Disease progression|0|||
149833321|NCT00880568|540521628|FG008|Overall Study|Disease progression|3|||
149833322|NCT00880568|540521620|FG000|Overall Study|Adverse Event|0|||
149833323|NCT00880568|540521621|FG001|Overall Study|Adverse Event|0|||
149833324|NCT00880568|540521622|FG002|Overall Study|Adverse Event|0|||
149833325|NCT00880568|540521623|FG003|Overall Study|Adverse Event|0|||
149833326|NCT00880568|540521624|FG004|Overall Study|Adverse Event|0|||
149833327|NCT00880568|540521625|FG005|Overall Study|Adverse Event|0|||
149833328|NCT00880568|540521626|FG006|Overall Study|Adverse Event|1|||
149833329|NCT00880568|540521627|FG007|Overall Study|Adverse Event|1|||
149833330|NCT00880568|540521628|FG008|Overall Study|Adverse Event|0|||
149833331|NCT00880568|540521620|FG000|Overall Study|Withdrawal by Subject|0|||
149833332|NCT00880568|540521621|FG001|Overall Study|Withdrawal by Subject|0|||
149833333|NCT00880568|540521622|FG002|Overall Study|Withdrawal by Subject|0|||
149833334|NCT00880568|540521623|FG003|Overall Study|Withdrawal by Subject|0|||
149833335|NCT00880568|540521624|FG004|Overall Study|Withdrawal by Subject|0|||
149833336|NCT00880568|540521625|FG005|Overall Study|Withdrawal by Subject|0|||
149833337|NCT00880568|540521626|FG006|Overall Study|Withdrawal by Subject|0|||
149833338|NCT00880568|540521627|FG007|Overall Study|Withdrawal by Subject|1|||
149833339|NCT00880568|540521628|FG008|Overall Study|Withdrawal by Subject|0|||
149833340|NCT00620022|540521629|FG000|Treatment Period 1|Adverse Event|4|||
149833341|NCT00620022|540521630|FG001|Treatment Period 1|Adverse Event|6|||
149833342|NCT00620022|540521629|FG000|Treatment Period 1|Subject withdrew consent|1|||
149833343|NCT00620022|540521630|FG001|Treatment Period 1|Subject withdrew consent|0|||
149833344|NCT00620022|540521629|FG000|Treatment Period 2|Adverse Event|2|||
149833345|NCT00620022|540521630|FG001|Treatment Period 2|Adverse Event|2|||
149833346|NCT01617668|540521633|FG000|Overall Study|Adverse Event|7|||
149833347|NCT01617668|540521634|FG001|Overall Study|Adverse Event|0|||
149833348|NCT01617668|540521635|FG002|Overall Study|Adverse Event|12|||
149833349|NCT01617668|540521636|FG003|Overall Study|Adverse Event|5|||
149833350|NCT01617668|540521633|FG000|Overall Study|Physician Decision|1|||
149833351|NCT01617668|540521634|FG001|Overall Study|Physician Decision|2|||
149833352|NCT01617668|540521635|FG002|Overall Study|Physician Decision|3|||
149833353|NCT01617668|540521636|FG003|Overall Study|Physician Decision|0|||
149833354|NCT01617668|540521633|FG000|Overall Study|Progressive Disease|4|||
149833355|NCT01617668|540521634|FG001|Overall Study|Progressive Disease|4|||
149833356|NCT01617668|540521635|FG002|Overall Study|Progressive Disease|6|||
149833357|NCT01617668|540521636|FG003|Overall Study|Progressive Disease|9|||
149833358|NCT01617668|540521633|FG000|Overall Study|Subject/guardian decision|1|||
149833359|NCT01617668|540521634|FG001|Overall Study|Subject/guardian decision|3|||
149833360|NCT01617668|540521635|FG002|Overall Study|Subject/guardian decision|2|||
149833361|NCT01617668|540521636|FG003|Overall Study|Subject/guardian decision|1|||
149833362|NCT00925769|540521637|FG000|Overall Study|Major toxicity|1|||
149833363|NCT00925769|540521638|FG001|Overall Study|Major toxicity|0|||
149833364|NCT00925769|540521639|FG002|Overall Study|Major toxicity|1|||
149833365|NCT00925769|540521640|FG003|Overall Study|Major toxicity|1|||
149833366|NCT00925769|540521641|FG004|Overall Study|Major toxicity|0|||
149833367|NCT00925769|540521642|FG005|Overall Study|Major toxicity|0|||
149833368|NCT00925769|540521637|FG000|Overall Study|Disease progression|4|||
149833369|NCT00925769|540521638|FG001|Overall Study|Disease progression|5|||
149833370|NCT00925769|540521639|FG002|Overall Study|Disease progression|3|||
149833371|NCT00925769|540521640|FG003|Overall Study|Disease progression|4|||
149833372|NCT00925769|540521641|FG004|Overall Study|Disease progression|2|||
149833373|NCT00925769|540521642|FG005|Overall Study|Disease progression|3|||
149833374|NCT00925769|540521637|FG000|Overall Study|Death|0|||
149833375|NCT00925769|540521638|FG001|Overall Study|Death|0|||
149833376|NCT00925769|540521639|FG002|Overall Study|Death|1|||
149833377|NCT00925769|540521640|FG003|Overall Study|Death|0|||
149833378|NCT00925769|540521641|FG004|Overall Study|Death|0|||
149833379|NCT00925769|540521642|FG005|Overall Study|Death|0|||
149833380|NCT00925769|540521637|FG000|Overall Study|Physician Decision|1|||
149833381|NCT00925769|540521638|FG001|Overall Study|Physician Decision|0|||
149833382|NCT00925769|540521639|FG002|Overall Study|Physician Decision|0|||
149833383|NCT00925769|540521640|FG003|Overall Study|Physician Decision|0|||
149833384|NCT00925769|540521641|FG004|Overall Study|Physician Decision|0|||
149833385|NCT00925769|540521642|FG005|Overall Study|Physician Decision|0|||
149833386|NCT00925769|540521637|FG000|Overall Study|Missing documentation|0|||
149833387|NCT00925769|540521638|FG001|Overall Study|Missing documentation|1|||
150171426|NCT05190419|541763490|FG000|Overall Study|Lost to Follow-up|1|||
150171427|NCT05190419|541763491|FG001|Overall Study|Lost to Follow-up|2|||
150171428|NCT05190419|541763492|FG002|Overall Study|Lost to Follow-up|3|||
149833388|NCT00925769|540521639|FG002|Overall Study|Missing documentation|0|||
149833389|NCT00925769|540521640|FG003|Overall Study|Missing documentation|0|||
149833390|NCT00925769|540521641|FG004|Overall Study|Missing documentation|0|||
149833391|NCT00925769|540521642|FG005|Overall Study|Missing documentation|0|||
149833392|NCT00925769|540521637|FG000|Overall Study|End of study visit not done|0|||
149833393|NCT00925769|540521638|FG001|Overall Study|End of study visit not done|0|||
149833394|NCT00925769|540521639|FG002|Overall Study|End of study visit not done|1|||
149833395|NCT00925769|540521640|FG003|Overall Study|End of study visit not done|0|||
149833396|NCT00925769|540521641|FG004|Overall Study|End of study visit not done|0|||
149833397|NCT00925769|540521642|FG005|Overall Study|End of study visit not done|0|||
149833398|NCT00925769|540521637|FG000|Overall Study|Participant is unable to swallow drug|0|||
149833399|NCT00925769|540521638|FG001|Overall Study|Participant is unable to swallow drug|0|||
149833400|NCT00925769|540521639|FG002|Overall Study|Participant is unable to swallow drug|0|||
149833401|NCT00925769|540521640|FG003|Overall Study|Participant is unable to swallow drug|1|||
149833402|NCT00925769|540521641|FG004|Overall Study|Participant is unable to swallow drug|0|||
149833403|NCT00925769|540521642|FG005|Overall Study|Participant is unable to swallow drug|0|||
149833404|NCT00925769|540521637|FG000|Overall Study|Adverse Event|0|||
149833405|NCT00925769|540521638|FG001|Overall Study|Adverse Event|0|||
149833406|NCT00925769|540521639|FG002|Overall Study|Adverse Event|0|||
149833407|NCT00925769|540521640|FG003|Overall Study|Adverse Event|0|||
149833408|NCT00925769|540521641|FG004|Overall Study|Adverse Event|1|||
149833409|NCT00925769|540521642|FG005|Overall Study|Adverse Event|0|||
149833410|NCT01038856|540521645|FG000|Overall Study|Adverse Event|2|||
149833411|NCT02300103|540521648|FG000|Overall Study|Lack of Efficacy|3|||
149833412|NCT02300103|540521648|FG000|Overall Study|Protocol Violation|1|||
150034252|NCT02183675|541264795|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
150034253|NCT02183675|541264796|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
150034254|NCT02183675|541264797|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
150034255|NCT02183675|541264798|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
150034256|NCT00627393|541264799|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
150034257|NCT00627393|541264800|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
150034258|NCT00627393|541264799|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
150034259|NCT00627393|541264800|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
150034260|NCT00627393|541264799|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
150034261|NCT00627393|541264800|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
150034262|NCT00627393|541264799|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
150034263|NCT00627393|541264800|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
150034264|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
150034265|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
150034266|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
150034267|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
150034268|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
150034269|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
150034270|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
150034271|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
150034272|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
150034273|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
150034274|NCT01668784|541264802|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
150034275|NCT01668784|541264803|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
150034276|NCT01668784|541264802|FG000|Treatment Period|Disease Progression|316|||
150034277|NCT01668784|541264803|FG001|Treatment Period|Disease Progression|293|||
150034278|NCT01668784|541264802|FG000|Treatment Period|Study Drug Toxicity|46|||
150034279|NCT01668784|541264803|FG001|Treatment Period|Study Drug Toxicity|53|||
150034280|NCT01668784|541264802|FG000|Treatment Period|Death|1|||
150034281|NCT01668784|541264803|FG001|Treatment Period|Death|1|||
150034282|NCT01668784|541264802|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
150034283|NCT01668784|541264803|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
150280238|NCT01987960|542162091|FG002|Period 1|Protocol Violation|0|||
150034284|NCT01668784|541264802|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
150034285|NCT01668784|541264803|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
150034286|NCT01668784|541264802|FG000|Treatment Period|Withdrawal by Subject|5|||
150034287|NCT01668784|541264803|FG001|Treatment Period|Withdrawal by Subject|3|||
150280239|NCT01987960|542162092|FG003|Period 1|Protocol Violation|0|||
150280240|NCT01987960|542162089|FG000|Period 1|Withdrawal by Subject|21|||
150280241|NCT01987960|542162090|FG001|Period 1|Withdrawal by Subject|0|||
150280242|NCT01987960|542162091|FG002|Period 1|Withdrawal by Subject|0|||
149833413|NCT02300103|540521648|FG000|Overall Study|Withdrew Consent|2|||
149833414|NCT04091971|540521649|FG000|Overall Study|Withdrawal by Subject|1|||
149833415|NCT04091971|540521649|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
149833416|NCT04091971|540521649|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
149833417|NCT03340727|540521650|FG000|Overall Study|Death|1|||
149833418|NCT03340727|540521651|FG001|Overall Study|Death|0|||
149833419|NCT03340727|540521650|FG000|Overall Study|Lost to Follow-up|31|||
149833420|NCT03340727|540521651|FG001|Overall Study|Lost to Follow-up|35|||
149833421|NCT03340727|540521650|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
149833422|NCT03340727|540521651|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
149833423|NCT03340727|540521650|FG000|Overall Study|Transferred to another facility|10|||
149833424|NCT03340727|540521651|FG001|Overall Study|Transferred to another facility|7|||
149833425|NCT03340727|540521650|FG000|Overall Study|Withdrawal by Subject|28|||
149833426|NCT03340727|540521651|FG001|Overall Study|Withdrawal by Subject|17|||
149833427|NCT00877032|540521652|FG000|Overall Study|Did not meet entrance criteria|0|||
149833428|NCT00877032|540521653|FG001|Overall Study|Did not meet entrance criteria|0|||
149833429|NCT00877032|540521654|FG002|Overall Study|Did not meet entrance criteria|0|||
149833430|NCT00877032|540521655|FG003|Overall Study|Did not meet entrance criteria|1|||
149833431|NCT00877032|540521656|FG004|Overall Study|Did not meet entrance criteria|0|||
149833432|NCT00877032|540521657|FG005|Overall Study|Did not meet entrance criteria|0|||
149833433|NCT00877032|540521658|FG006|Overall Study|Did not meet entrance criteria|2|||
149833434|NCT00669942|540521659|FG000|Parts 2 and 3|Adverse Event|0|||
149833435|NCT00669942|540521660|FG001|Parts 2 and 3|Adverse Event|0|||
149833436|NCT00669942|540521661|FG002|Parts 2 and 3|Adverse Event|0|||
149833437|NCT00669942|540521662|FG003|Parts 2 and 3|Adverse Event|0|||
149833438|NCT00669942|540521663|FG004|Parts 2 and 3|Adverse Event|0|||
149833439|NCT00669942|540521664|FG005|Parts 2 and 3|Adverse Event|0|||
149833440|NCT00669942|540521665|FG006|Parts 2 and 3|Adverse Event|0|||
149833441|NCT00669942|540521666|FG007|Parts 2 and 3|Adverse Event|2|||
149833442|NCT00669942|540521667|FG008|Parts 2 and 3|Adverse Event|1|||
149833443|NCT00669942|540521668|FG009|Parts 2 and 3|Adverse Event|0|||
149833444|NCT00669942|540521669|FG010|Parts 2 and 3|Adverse Event|0|||
149833445|NCT00669942|540521670|FG011|Parts 2 and 3|Adverse Event|0|||
149833446|NCT00669942|540521659|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
149833447|NCT00669942|540521660|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
149833448|NCT00669942|540521661|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
149833449|NCT00669942|540521662|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
149833450|NCT00669942|540521663|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
149833451|NCT00669942|540521664|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
149833452|NCT00669942|540521665|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
149833453|NCT00669942|540521666|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
149833454|NCT00669942|540521667|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
149833455|NCT00669942|540521668|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
149833456|NCT00669942|540521669|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
149833457|NCT00669942|540521670|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
149833458|NCT00669942|540521659|FG000|Parts 2 and 3|Protocol Violation|0|||
149833459|NCT00669942|540521660|FG001|Parts 2 and 3|Protocol Violation|0|||
149833460|NCT00669942|540521661|FG002|Parts 2 and 3|Protocol Violation|0|||
149833461|NCT00669942|540521662|FG003|Parts 2 and 3|Protocol Violation|0|||
149833462|NCT00669942|540521663|FG004|Parts 2 and 3|Protocol Violation|0|||
149833463|NCT00669942|540521664|FG005|Parts 2 and 3|Protocol Violation|1|||
149833464|NCT00669942|540521665|FG006|Parts 2 and 3|Protocol Violation|0|||
149833465|NCT00669942|540521666|FG007|Parts 2 and 3|Protocol Violation|0|||
149833466|NCT00669942|540521667|FG008|Parts 2 and 3|Protocol Violation|0|||
149833467|NCT00669942|540521668|FG009|Parts 2 and 3|Protocol Violation|0|||
149833468|NCT00669942|540521669|FG010|Parts 2 and 3|Protocol Violation|0|||
149833469|NCT00669942|540521670|FG011|Parts 2 and 3|Protocol Violation|0|||
149833470|NCT03752528|540521671|FG000|Part A|Lost to Follow-up|1|||
149833471|NCT03752528|540521671|FG000|Part A|Protocol Violation|1|||
149833472|NCT03752528|540521671|FG000|Part B|Protocol Violation|1|||
149833473|NCT03752528|540521671|FG000|Part B|Study terminated by sponsor|3|||
149833474|NCT00282048|540521673|FG000|Overall Study|Lack of Efficacy|30|||
149833475|NCT00282048|540521673|FG000|Overall Study|Adverse Event|22|||
149833476|NCT00282048|540521673|FG000|Overall Study|Withdrawal by Subject|1|||
149833477|NCT00282048|540521673|FG000|Overall Study|Other|8|||
149833478|NCT00282048|540521673|FG000|Overall Study|Ongoing|1|||
149833479|NCT02107092|540521674|FG000|Overall Study|Miscellaneous|3|||
149833480|NCT02107092|540521674|FG000|Overall Study|Subject compliance|3|||
149833481|NCT02107092|540521674|FG000|Overall Study|Hypo-or hyperkalemia|2|||
149833482|NCT02107092|540521674|FG000|Overall Study|Met ECG withdrawal criteria|3|||
149833483|NCT02107092|540521674|FG000|Overall Study|Physician Decision|3|||
149833484|NCT02107092|540521674|FG000|Overall Study|Lost to Follow-up|2|||
149833485|NCT02107092|540521674|FG000|Overall Study|Withdrawal by Subject|9|||
149833486|NCT02107092|540521674|FG000|Overall Study|Adverse Event|7|||
149833487|NCT02107092|540521674|FG000|Overall Study|Expected progression of CKD|12|||
149833488|NCT00259012|540521676|FG000|Overall Study|Adverse Event|0|||
149833489|NCT00259012|540521677|FG001|Overall Study|Adverse Event|1|||
150280243|NCT01987960|542162092|FG003|Period 1|Withdrawal by Subject|0|||
150280244|NCT01987960|542162089|FG000|Period 1|Lost to Follow-up|40|||
150280245|NCT01987960|542162090|FG001|Period 1|Lost to Follow-up|0|||
150280246|NCT01987960|542162091|FG002|Period 1|Lost to Follow-up|0|||
150280247|NCT01987960|542162092|FG003|Period 1|Lost to Follow-up|0|||
150280248|NCT01987960|542162089|FG000|Period 1|administrative or other reason|75|||
150280249|NCT01987960|542162090|FG001|Period 1|administrative or other reason|0|||
150280250|NCT01987960|542162091|FG002|Period 1|administrative or other reason|0|||
150280251|NCT01987960|542162092|FG003|Period 1|administrative or other reason|0|||
150280252|NCT01987960|542162089|FG000|Period 1|Withdrawal of consent before treatment|4|||
150280253|NCT01987960|542162090|FG001|Period 1|Withdrawal of consent before treatment|0|||
150280254|NCT01987960|542162091|FG002|Period 1|Withdrawal of consent before treatment|0|||
150280255|NCT01987960|542162092|FG003|Period 1|Withdrawal of consent before treatment|0|||
150280256|NCT01987960|542162089|FG000|Period 2|Adverse Event|0|||
150280257|NCT01987960|542162090|FG001|Period 2|Adverse Event|0|||
150280258|NCT01987960|542162091|FG002|Period 2|Adverse Event|1|||
150280259|NCT01987960|542162092|FG003|Period 2|Adverse Event|0|||
150280260|NCT01987960|542162089|FG000|Period 2|Withdrawal by Subject|0|||
150280261|NCT01987960|542162090|FG001|Period 2|Withdrawal by Subject|0|||
150280262|NCT01987960|542162091|FG002|Period 2|Withdrawal by Subject|1|||
150280263|NCT01987960|542162092|FG003|Period 2|Withdrawal by Subject|0|||
150280264|NCT01987960|542162089|FG000|Period 2|Administrative or other reason|0|||
150280265|NCT01987960|542162090|FG001|Period 2|Administrative or other reason|5|||
150280266|NCT01987960|542162091|FG002|Period 2|Administrative or other reason|7|||
150280267|NCT01987960|542162092|FG003|Period 2|Administrative or other reason|0|||
150280268|NCT01987960|542162089|FG000|Period 3|Adverse Event|0|||
150280269|NCT01987960|542162090|FG001|Period 3|Adverse Event|0|||
150280270|NCT01987960|542162091|FG002|Period 3|Adverse Event|0|||
150280271|NCT01987960|542162092|FG003|Period 3|Adverse Event|7|||
150280272|NCT01987960|542162089|FG000|Period 3|Non-compliance with IMP|0|||
150280273|NCT01987960|542162090|FG001|Period 3|Non-compliance with IMP|0|||
150280274|NCT01987960|542162091|FG002|Period 3|Non-compliance with IMP|0|||
150280275|NCT01987960|542162092|FG003|Period 3|Non-compliance with IMP|1|||
150280276|NCT01987960|542162089|FG000|Period 3|Protocol Violation|0|||
150280277|NCT01987960|542162090|FG001|Period 3|Protocol Violation|0|||
150280278|NCT01987960|542162091|FG002|Period 3|Protocol Violation|0|||
150280279|NCT01987960|542162092|FG003|Period 3|Protocol Violation|6|||
150280280|NCT01987960|542162089|FG000|Period 3|Withdrawal by Subject|0|||
150280281|NCT01987960|542162090|FG001|Period 3|Withdrawal by Subject|0|||
150280282|NCT01987960|542162091|FG002|Period 3|Withdrawal by Subject|0|||
150280283|NCT01987960|542162092|FG003|Period 3|Withdrawal by Subject|9|||
150280284|NCT01987960|542162089|FG000|Period 3|Lost to Follow-up|0|||
150280285|NCT01987960|542162090|FG001|Period 3|Lost to Follow-up|0|||
150280286|NCT01987960|542162091|FG002|Period 3|Lost to Follow-up|0|||
150280287|NCT01987960|542162092|FG003|Period 3|Lost to Follow-up|5|||
150280288|NCT01987960|542162089|FG000|Period 3|Administrative or other reason|0|||
150280289|NCT01987960|542162090|FG001|Period 3|Administrative or other reason|0|||
150280290|NCT01987960|542162091|FG002|Period 3|Administrative or other reason|0|||
150280291|NCT01987960|542162092|FG003|Period 3|Administrative or other reason|43|||
150280292|NCT00807742|542162093|FG000|Overall Study|Death|9|||
150280293|NCT00807742|542162094|FG001|Overall Study|Death|2|||
150280294|NCT00807742|542162093|FG000|Overall Study|Withdrawal by Subject|2|||
149833490|NCT00259012|540521676|FG000|Overall Study|Withdrawal by Subject|1|||
149833491|NCT00259012|540521677|FG001|Overall Study|Withdrawal by Subject|0|||
150280295|NCT00807742|542162094|FG001|Overall Study|Withdrawal by Subject|1|||
150280296|NCT00807742|542162093|FG000|Overall Study|Lost to Follow-up|35|||
150280297|NCT00807742|542162094|FG001|Overall Study|Lost to Follow-up|51|||
150280298|NCT03834519|542162095|FG000|Overall Study|Lost to Follow-up|2|||
150280299|NCT03834519|542162096|FG001|Overall Study|Lost to Follow-up|1|||
150280300|NCT03834519|542162095|FG000|Overall Study|Withdrawal by Subject|5|||
150280301|NCT03834519|542162096|FG001|Overall Study|Withdrawal by Subject|8|||
150280302|NCT03834519|542162095|FG000|Overall Study|Death|368|||
150280303|NCT03834519|542162096|FG001|Overall Study|Death|174|||
150280304|NCT03834519|542162095|FG000|Overall Study|Physician Decision|5|||
150280305|NCT03834519|542162096|FG001|Overall Study|Physician Decision|1|||
150280306|NCT03834519|542162095|FG000|Overall Study|Sponsor decision|149|||
150280307|NCT03834519|542162096|FG001|Overall Study|Sponsor decision|80|||
150280308|NCT04655144|542162097|FG000|Overall Study|Consumed THC|1|||
150280309|NCT04655144|542162098|FG001|Overall Study|Consumed THC|0|||
150280310|NCT04655144|542162097|FG000|Overall Study|Unilateral embolization|0|||
150280311|NCT04655144|542162098|FG001|Overall Study|Unilateral embolization|1|||
150280312|NCT01484977|542162099|FG000|Overall Study|Adverse Event|8|||
150280313|NCT01484977|542162099|FG000|Overall Study|Lack of Efficacy|4|||
150280314|NCT01484977|542162099|FG000|Overall Study|Protocol Violation|6|||
150280315|NCT01484977|542162099|FG000|Overall Study|Lost to Follow-up|1|||
149833492|NCT00259012|540521676|FG000|Overall Study|Physician Decision|0|||
150280316|NCT01484977|542162099|FG000|Overall Study|Withdrawal by Subject|4|||
150280317|NCT01484977|542162099|FG000|Overall Study|Subject Protocol Non-compliant|1|||
150280318|NCT01484977|542162099|FG000|Overall Study|Moving Overseas|1|||
149833493|NCT00259012|540521677|FG001|Overall Study|Physician Decision|1|||
149833494|NCT00259012|540521676|FG000|Overall Study|Lost to Follow-up|0|||
149833495|NCT00259012|540521677|FG001|Overall Study|Lost to Follow-up|1|||
149833496|NCT00259012|540521676|FG000|Overall Study|Protocol Violation|1|||
149833497|NCT00259012|540521677|FG001|Overall Study|Protocol Violation|1|||
149833498|NCT04213326|540521682|FG000|Overall Study|Consent withdrawn|51|||
149833499|NCT04213326|540521683|FG001|Overall Study|Consent withdrawn|241|||
149833500|NCT04213326|540521682|FG000|Overall Study|Lost to Follow-up|50|||
149833501|NCT04213326|540521683|FG001|Overall Study|Lost to Follow-up|902|||
149833502|NCT04213326|540521682|FG000|Overall Study|Protocol Violation|3|||
149833503|NCT04213326|540521683|FG001|Overall Study|Protocol Violation|25|||
149833504|NCT04213326|540521682|FG000|Overall Study|Participant eligibility changed|106|||
149833505|NCT04213326|540521683|FG001|Overall Study|Participant eligibility changed|19|||
149833506|NCT04213326|540521682|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
149833507|NCT04213326|540521683|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
149833508|NCT04213326|540521682|FG000|Overall Study|Incomplete study visit|0|||
149833509|NCT04213326|540521683|FG001|Overall Study|Incomplete study visit|367|||
149833510|NCT02549092|540521684|FG000|Treatment Period|Adverse Event|2|||
149833511|NCT02549092|540521685|FG001|Treatment Period|Adverse Event|2|||
149833512|NCT02549092|540521684|FG000|Treatment Period|Withdrawal by Subject|1|||
149833513|NCT02549092|540521685|FG001|Treatment Period|Withdrawal by Subject|3|||
149833514|NCT02549092|540521684|FG000|Treatment Period|Lack of Efficacy|0|||
149833515|NCT02549092|540521685|FG001|Treatment Period|Lack of Efficacy|2|||
149833516|NCT02549092|540521684|FG000|Extension/Transition Period|Adverse Event|1|||
149833517|NCT02549092|540521685|FG001|Extension/Transition Period|Adverse Event|1|||
149833518|NCT02549092|540521684|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
149833519|NCT02549092|540521685|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
149833520|NCT02549092|540521684|FG000|Extension/Transition Period|Other, Not Specified|4|||
149833521|NCT02549092|540521685|FG001|Extension/Transition Period|Other, Not Specified|2|||
149833522|NCT03002077|540521687|FG000|Overall Study|Non-compliance with Study Drug|4|||
149833523|NCT03002077|540521687|FG000|Overall Study|Non-compliance w/Background ADT|1|||
149833524|NCT03002077|540521687|FG000|Overall Study|Study Terminated by Sponsor|257|||
149833525|NCT03002077|540521687|FG000|Overall Study|Site Terminated by Sponsor|5|||
149833526|NCT03002077|540521687|FG000|Overall Study|Miscellaneous Reasons|10|||
149833527|NCT03002077|540521687|FG000|Overall Study|Adverse Event|23|||
149833528|NCT03002077|540521687|FG000|Overall Study|Lack of Efficacy|20|||
149833529|NCT03002077|540521687|FG000|Overall Study|Withdrawal by Subject|72|||
149833530|NCT03002077|540521687|FG000|Overall Study|Lost to Follow-up|21|||
149833531|NCT03002077|540521687|FG000|Overall Study|Pregnancy|4|||
149833532|NCT03002077|540521687|FG000|Overall Study|Protocol Violation|21|||
149833533|NCT03048500|540521690|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
149833534|NCT03048500|540521690|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
149833535|NCT03048500|540521690|FG000|Reached 1st Response/Continued Treatment|Death|1|||
149833536|NCT03048500|540521690|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
149833537|NCT03048500|540521690|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
149833538|NCT03048500|540521690|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
149833539|NCT03048500|540521690|FG000|Follow up for 3 Years|Death|12|||
149833540|NCT01941030|540521693|FG000|Overall Study|Death|3|||
149833541|NCT01941030|540521694|FG001|Overall Study|Death|2|||
149833542|NCT01941030|540521693|FG000|Overall Study|Lost to Follow-up|6|||
149833543|NCT01941030|540521694|FG001|Overall Study|Lost to Follow-up|5|||
149833544|NCT01941030|540521693|FG000|Overall Study|Withdrawal by Subject|4|||
149833545|NCT01941030|540521694|FG001|Overall Study|Withdrawal by Subject|6|||
149833546|NCT00585689|540521695|FG000|Overall Study|Received different ABI-007 schedule|3|||
149833547|NCT00585689|540521695|FG000|Overall Study|Adverse Event|1|||
150280319|NCT01484977|542162099|FG000|Overall Study|Low White Blood Cell Count|1|||
150280320|NCT01484977|542162099|FG000|Overall Study|Lack of Compliance|1|||
150280321|NCT00853749|542162100|FG000|Overall Study|Lost to Follow-up|0|||
150280322|NCT00853749|542162101|FG001|Overall Study|Lost to Follow-up|1|||
150280323|NCT00591214|542162102|FG000|Overall Study|Physician Decision|7|||
150280324|NCT00591214|542162102|FG000|Overall Study|Withdrawal by Subject|1|||
149833548|NCT00585689|540521695|FG000|Overall Study|Patient Declined Surgery|1|||
150280325|NCT04857996|542162105|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
149833549|NCT00585689|540521695|FG000|Overall Study|Patient had unresectable disease|1|||
149833550|NCT00585689|540521695|FG000|Overall Study|Death|1|||
149833551|NCT02781727|540521698|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
149833552|NCT02781727|540521699|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
149833553|NCT02781727|540521698|FG000|Treatment Period|Withdrawal by Subject|1|||
149833554|NCT02781727|540521699|FG001|Treatment Period|Withdrawal by Subject|0|||
149833555|NCT02781727|540521698|FG000|Treatment Period|Lost to Follow-up|0|||
149833556|NCT02781727|540521699|FG001|Treatment Period|Lost to Follow-up|1|||
149833557|NCT01378975|540521700|FG000|Overall Study|Death|77|||
149833558|NCT01378975|540521701|FG001|Overall Study|Death|46|||
149833559|NCT01378975|540521700|FG000|Overall Study|Investigator Request|1|||
149833560|NCT01378975|540521701|FG001|Overall Study|Investigator Request|0|||
149833561|NCT01378975|540521700|FG000|Overall Study|Lost to Follow-up|4|||
149833562|NCT01378975|540521701|FG001|Overall Study|Lost to Follow-up|1|||
149833563|NCT01378975|540521700|FG000|Overall Study|Withdrew Consent|4|||
149833564|NCT01378975|540521701|FG001|Overall Study|Withdrew Consent|3|||
149833565|NCT00694551|540521705|FG000|Overall Study|Disease Progression|1|||
149833566|NCT00694551|540521706|FG001|Overall Study|Disease Progression|0|||
149833567|NCT00694551|540521707|FG002|Overall Study|Disease Progression|1|||
149833568|NCT02424097|540523616|FG000|Overall Study|Lost to Follow-up|1|||
149833569|NCT02424097|540523617|FG001|Overall Study|Lost to Follow-up|2|||
149833570|NCT01215981|540523618|FG000|Overall Study|Physician Decision|0|||
149833571|NCT01215981|540523619|FG001|Overall Study|Physician Decision|1|||
149833572|NCT01215981|540523618|FG000|Overall Study|Protocol Violation|1|||
149833573|NCT01215981|540523619|FG001|Overall Study|Protocol Violation|0|||
149833574|NCT01215981|540523618|FG000|Overall Study|Withdrawal by Subject|1|||
149833575|NCT01215981|540523619|FG001|Overall Study|Withdrawal by Subject|0|||
149833576|NCT02943447|540523620|FG000|Blinded Study Phase|Withdrew Consent|1|||
149833577|NCT02943447|540523621|FG001|Blinded Study Phase|Withdrew Consent|2|||
149833578|NCT02943447|540523622|FG002|Blinded Study Phase|Withdrew Consent|1|||
149833579|NCT02943447|540523620|FG000|Blinded Study Phase|Adverse Event|3|||
149833580|NCT02943447|540523621|FG001|Blinded Study Phase|Adverse Event|0|||
149833581|NCT02943447|540523622|FG002|Blinded Study Phase|Adverse Event|0|||
149833582|NCT02943447|540523620|FG000|Blinded Study Phase|Investigator's discretion|1|||
149833583|NCT02943447|540523621|FG001|Blinded Study Phase|Investigator's discretion|0|||
149833584|NCT02943447|540523622|FG002|Blinded Study Phase|Investigator's discretion|0|||
149833585|NCT02943447|540523620|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
149833586|NCT02943447|540523621|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
149833587|NCT02943447|540523622|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
149833588|NCT02943447|540523620|FG000|Open-Label Extension Phase|Adverse Event|4|||
149833589|NCT02943447|540523621|FG001|Open-Label Extension Phase|Adverse Event|7|||
149833590|NCT02943447|540523622|FG002|Open-Label Extension Phase|Adverse Event|3|||
149833591|NCT02943447|540523620|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
149833592|NCT02943447|540523621|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
149833593|NCT02943447|540523622|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
149833594|NCT02943447|540523620|FG000|Open-Label Extension Phase|Withdrew consent|1|||
149833595|NCT02943447|540523621|FG001|Open-Label Extension Phase|Withdrew consent|1|||
149833596|NCT02943447|540523622|FG002|Open-Label Extension Phase|Withdrew consent|1|||
149833597|NCT02943447|540523620|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
149833598|NCT02943447|540523621|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
149833599|NCT02943447|540523622|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
149833600|NCT05017480|540523623|FG000|Stage 1 Study|Withdrawal by Subject|8|||
149833601|NCT05017480|540523624|FG001|Stage 1 Study|Withdrawal by Subject|6|||
149833602|NCT05017480|540523625|FG002|Stage 1 Study|Withdrawal by Subject|0|||
149833603|NCT05017480|540523626|FG003|Stage 1 Study|Withdrawal by Subject|0|||
149833604|NCT05017480|540523627|FG004|Stage 1 Study|Withdrawal by Subject|0|||
149833605|NCT05017480|540523623|FG000|Stage 1 Study|Adverse Event|1|||
149833606|NCT05017480|540523624|FG001|Stage 1 Study|Adverse Event|1|||
149833607|NCT05017480|540523625|FG002|Stage 1 Study|Adverse Event|0|||
149833608|NCT05017480|540523626|FG003|Stage 1 Study|Adverse Event|0|||
149833609|NCT05017480|540523627|FG004|Stage 1 Study|Adverse Event|0|||
149833610|NCT05017480|540523623|FG000|Stage 1 Study|Poor Compliance|1|||
149833611|NCT05017480|540523624|FG001|Stage 1 Study|Poor Compliance|1|||
149833612|NCT05017480|540523625|FG002|Stage 1 Study|Poor Compliance|0|||
150034288|NCT01668784|541264802|FG000|Treatment Period|Maximal Clinical Benefit|3|||
150034289|NCT01668784|541264803|FG001|Treatment Period|Maximal Clinical Benefit|3|||
150034290|NCT01668784|541264802|FG000|Treatment Period|Other|2|||
150034291|NCT01668784|541264803|FG001|Treatment Period|Other|8|||
150034292|NCT01668784|541264802|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
150034293|NCT01668784|541264803|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
149833613|NCT05017480|540523626|FG003|Stage 1 Study|Poor Compliance|0|||
149833614|NCT05017480|540523627|FG004|Stage 1 Study|Poor Compliance|0|||
149833615|NCT05017480|540523623|FG000|Stage 1 Study|Physician Decision|0|||
149833616|NCT05017480|540523624|FG001|Stage 1 Study|Physician Decision|1|||
149833617|NCT05017480|540523625|FG002|Stage 1 Study|Physician Decision|0|||
149833618|NCT05017480|540523626|FG003|Stage 1 Study|Physician Decision|0|||
149833619|NCT05017480|540523627|FG004|Stage 1 Study|Physician Decision|0|||
149833620|NCT05017480|540523623|FG000|Stage 2 Study|Withdrawal by Subject|0|||
149833621|NCT05017480|540523624|FG001|Stage 2 Study|Withdrawal by Subject|0|||
149833622|NCT05017480|540523625|FG002|Stage 2 Study|Withdrawal by Subject|6|||
150171429|NCT05190419|541763493|FG003|Overall Study|Lost to Follow-up|1|||
150171430|NCT05190419|541763490|FG000|Overall Study|Other|1|||
150171431|NCT05190419|541763491|FG001|Overall Study|Other|1|||
150171432|NCT05190419|541763492|FG002|Overall Study|Other|0|||
149833623|NCT05017480|540523626|FG003|Stage 2 Study|Withdrawal by Subject|9|||
149833624|NCT05017480|540523627|FG004|Stage 2 Study|Withdrawal by Subject|11|||
149833625|NCT05017480|540523623|FG000|Stage 2 Study|Lost to Follow-up|0|||
149833626|NCT05017480|540523624|FG001|Stage 2 Study|Lost to Follow-up|0|||
149833627|NCT05017480|540523625|FG002|Stage 2 Study|Lost to Follow-up|0|||
149833628|NCT05017480|540523626|FG003|Stage 2 Study|Lost to Follow-up|2|||
149833629|NCT05017480|540523627|FG004|Stage 2 Study|Lost to Follow-up|1|||
149833630|NCT05017480|540523623|FG000|Stage 2 Study|Adverse Event|0|||
149833631|NCT05017480|540523624|FG001|Stage 2 Study|Adverse Event|0|||
149833632|NCT05017480|540523625|FG002|Stage 2 Study|Adverse Event|0|||
149833633|NCT05017480|540523626|FG003|Stage 2 Study|Adverse Event|1|||
149833634|NCT05017480|540523627|FG004|Stage 2 Study|Adverse Event|0|||
149833635|NCT05017480|540523623|FG000|Stage 2 Study|COVID-19|0|||
149833636|NCT05017480|540523624|FG001|Stage 2 Study|COVID-19|0|||
149833637|NCT05017480|540523625|FG002|Stage 2 Study|COVID-19|0|||
149833638|NCT05017480|540523626|FG003|Stage 2 Study|COVID-19|1|||
149833639|NCT05017480|540523627|FG004|Stage 2 Study|COVID-19|0|||
149833640|NCT05017480|540523623|FG000|Stage 2 Study|Pregnancy|0|||
149833641|NCT05017480|540523624|FG001|Stage 2 Study|Pregnancy|0|||
149833642|NCT05017480|540523625|FG002|Stage 2 Study|Pregnancy|0|||
149833643|NCT05017480|540523626|FG003|Stage 2 Study|Pregnancy|0|||
149833644|NCT05017480|540523627|FG004|Stage 2 Study|Pregnancy|1|||
149833645|NCT01136382|540523632|FG000|Overall Study|Other|8|||
149833646|NCT01136382|540523633|FG001|Overall Study|Other|3|||
150280326|NCT04857996|542162106|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
150280327|NCT04857996|542162105|FG000|Overall Study|Lost to Follow-up|1|||
150280328|NCT04857996|542162106|FG001|Overall Study|Lost to Follow-up|3|||
150280329|NCT04857996|542162105|FG000|Overall Study|Site Closure|1|||
150280330|NCT04857996|542162106|FG001|Overall Study|Site Closure|0|||
150280331|NCT04857996|542162105|FG000|Overall Study|Withdrawal by Subject|1|||
149833647|NCT01136382|540523632|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
149833648|NCT01136382|540523633|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
149833649|NCT01136382|540523632|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
149833650|NCT01136382|540523633|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149833651|NCT01136382|540523632|FG000|Overall Study|Withdrawal by Subject|4|||
149833652|NCT01136382|540523633|FG001|Overall Study|Withdrawal by Subject|1|||
149833653|NCT02653664|540523639|FG000|Post-Treatment|Withdrawal by Subject|6|||
149833654|NCT02653664|540523640|FG001|Post-Treatment|Withdrawal by Subject|5|||
149833655|NCT02653664|540523641|FG002|Post-Treatment|Withdrawal by Subject|7|||
149833656|NCT02653664|540523639|FG000|Post-Treatment|Lost to Follow-up|8|||
149833657|NCT02653664|540523640|FG001|Post-Treatment|Lost to Follow-up|1|||
149833658|NCT02653664|540523641|FG002|Post-Treatment|Lost to Follow-up|7|||
149833659|NCT02653664|540523639|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
149833660|NCT02653664|540523640|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
149833661|NCT02653664|540523641|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
149833662|NCT02653664|540523639|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
149833663|NCT02653664|540523640|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
149833664|NCT02653664|540523641|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
149833665|NCT02653664|540523639|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
149833666|NCT02653664|540523640|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
149833667|NCT02653664|540523641|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
149833668|NCT02653664|540523639|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
149833669|NCT02653664|540523640|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
149833670|NCT02653664|540523641|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
150280332|NCT04857996|542162106|FG001|Overall Study|Withdrawal by Subject|0|||
150280333|NCT01129921|542162107|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
150280334|NCT01129921|542162108|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
149833671|NCT02653664|540523639|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
149833672|NCT02653664|540523640|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
149833673|NCT02653664|540523641|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
149833674|NCT02653664|540523639|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
149833675|NCT02653664|540523640|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
150280335|NCT01129921|542162107|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
150280336|NCT01129921|542162108|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
149833676|NCT02653664|540523641|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
149833677|NCT02653664|540523639|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
149833678|NCT02653664|540523640|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
149833679|NCT02653664|540523641|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
149833680|NCT02653664|540523639|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
149833681|NCT02653664|540523640|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
149833682|NCT02653664|540523641|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
149833683|NCT00727571|540523644|FG000|Overall Study|Ineligibility determined|1|||
149833684|NCT00727571|540523645|FG001|Overall Study|Ineligibility determined|1|||
149833685|NCT00727571|540523646|FG002|Overall Study|Ineligibility determined|1|||
149833686|NCT00727571|540523647|FG003|Overall Study|Ineligibility determined|0|||
149833687|NCT00727571|540523644|FG000|Overall Study|Death|0|||
149833688|NCT00727571|540523645|FG001|Overall Study|Death|19|||
149833689|NCT00727571|540523646|FG002|Overall Study|Death|5|||
149833690|NCT00727571|540523647|FG003|Overall Study|Death|1|||
149833691|NCT00727571|540523644|FG000|Overall Study|Physician Decision|0|||
149833692|NCT00727571|540523645|FG001|Overall Study|Physician Decision|5|||
149833693|NCT00727571|540523646|FG002|Overall Study|Physician Decision|0|||
149833694|NCT00727571|540523647|FG003|Overall Study|Physician Decision|0|||
149833695|NCT00727571|540523644|FG000|Overall Study|Withdrawal by Subject|0|||
149833696|NCT00727571|540523645|FG001|Overall Study|Withdrawal by Subject|10|||
149833697|NCT00727571|540523646|FG002|Overall Study|Withdrawal by Subject|11|||
149833698|NCT00727571|540523647|FG003|Overall Study|Withdrawal by Subject|0|||
149833699|NCT00727571|540523644|FG000|Overall Study|Subject Non Compliance|0|||
149833700|NCT00727571|540523645|FG001|Overall Study|Subject Non Compliance|6|||
149833701|NCT00727571|540523646|FG002|Overall Study|Subject Non Compliance|0|||
149833702|NCT00727571|540523647|FG003|Overall Study|Subject Non Compliance|4|||
149833703|NCT00727571|540523644|FG000|Overall Study|Dismissed from nursing home|0|||
149833704|NCT00727571|540523645|FG001|Overall Study|Dismissed from nursing home|9|||
149833705|NCT00727571|540523646|FG002|Overall Study|Dismissed from nursing home|5|||
149833706|NCT00727571|540523647|FG003|Overall Study|Dismissed from nursing home|0|||
149833707|NCT00727571|540523644|FG000|Overall Study|Hospitalization|0|||
149833708|NCT00727571|540523645|FG001|Overall Study|Hospitalization|1|||
149833709|NCT00727571|540523646|FG002|Overall Study|Hospitalization|0|||
149833710|NCT00727571|540523647|FG003|Overall Study|Hospitalization|1|||
149833711|NCT00727571|540523644|FG000|Overall Study|AE not leading to hospitalization|0|||
149833712|NCT00727571|540523645|FG001|Overall Study|AE not leading to hospitalization|0|||
149833713|NCT00727571|540523646|FG002|Overall Study|AE not leading to hospitalization|2|||
149833714|NCT00727571|540523647|FG003|Overall Study|AE not leading to hospitalization|0|||
149833715|NCT00727571|540523644|FG000|Overall Study|Other|0|||
149833716|NCT00727571|540523645|FG001|Overall Study|Other|4|||
149833717|NCT00727571|540523646|FG002|Overall Study|Other|6|||
149833718|NCT00727571|540523647|FG003|Overall Study|Other|0|||
149833719|NCT03247556|540523648|FG000|Overall Study|Adverse Event|1|||
149833720|NCT03247556|540523649|FG001|Overall Study|Adverse Event|4|||
149833721|NCT03247556|540523650|FG002|Overall Study|Adverse Event|5|||
149833722|NCT03247556|540523648|FG000|Overall Study|Lost to Follow-up|5|||
149833723|NCT03247556|540523649|FG001|Overall Study|Lost to Follow-up|5|||
149833724|NCT03247556|540523650|FG002|Overall Study|Lost to Follow-up|4|||
149833725|NCT03247556|540523648|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
149833726|NCT03247556|540523649|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
149833727|NCT03247556|540523650|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
149833728|NCT03247556|540523648|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
149833729|NCT03247556|540523649|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
149833730|NCT03247556|540523650|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
149833731|NCT03247556|540523648|FG000|Overall Study|Protocol Violation|2|||
149833732|NCT03247556|540523649|FG001|Overall Study|Protocol Violation|0|||
149833733|NCT03247556|540523650|FG002|Overall Study|Protocol Violation|1|||
149833734|NCT03247556|540523648|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
149833735|NCT03247556|540523649|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
150280337|NCT01129921|542162107|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
150280338|NCT01129921|542162108|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
150280339|NCT01129921|542162107|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
150280340|NCT01129921|542162108|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
150280341|NCT01392677|542162109|FG000|Overall Study|Adverse Event|3|||
150280342|NCT01392677|542162110|FG001|Overall Study|Adverse Event|1|||
150280343|NCT01392677|542162109|FG000|Overall Study|Withdrawal by Subject|0|||
150280344|NCT01392677|542162110|FG001|Overall Study|Withdrawal by Subject|2|||
149833736|NCT03247556|540523650|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
149833737|NCT00358449|540523651|FG000|Overall Study|Adverse Event|1|||
150280345|NCT01392677|542162109|FG000|Overall Study|Incorrect enrollment|2|||
150280346|NCT01392677|542162110|FG001|Overall Study|Incorrect enrollment|3|||
149833738|NCT00358449|540523652|FG001|Overall Study|Adverse Event|0|||
149833739|NCT00358449|540523653|FG002|Overall Study|Adverse Event|1|||
149833740|NCT00358449|540523651|FG000|Overall Study|Lost to Follow-up|1|||
149833741|NCT00358449|540523652|FG001|Overall Study|Lost to Follow-up|0|||
149833742|NCT00358449|540523653|FG002|Overall Study|Lost to Follow-up|0|||
149833743|NCT00358449|540523651|FG000|Overall Study|Withdrawal by Subject|2|||
149833744|NCT00358449|540523652|FG001|Overall Study|Withdrawal by Subject|0|||
149833745|NCT00358449|540523653|FG002|Overall Study|Withdrawal by Subject|0|||
149833746|NCT00358449|540523651|FG000|Overall Study|Lack of Efficacy|0|||
149833747|NCT00358449|540523652|FG001|Overall Study|Lack of Efficacy|1|||
149833748|NCT00358449|540523653|FG002|Overall Study|Lack of Efficacy|0|||
149833749|NCT00358449|540523651|FG000|Overall Study|Steriod Inhaler was Increased|0|||
149833750|NCT00358449|540523652|FG001|Overall Study|Steriod Inhaler was Increased|0|||
149833751|NCT00358449|540523653|FG002|Overall Study|Steriod Inhaler was Increased|1|||
149833752|NCT01804270|540523654|FG000|Overall Study|Withdrawal by Subject|1|||
149833753|NCT01804270|540523655|FG001|Overall Study|Withdrawal by Subject|1|||
149833754|NCT02188303|540523661|FG000|Overall Study|Adverse Event|0|||
149833755|NCT02188303|540523662|FG001|Overall Study|Adverse Event|0|||
149833756|NCT02188303|540523663|FG002|Overall Study|Adverse Event|0|||
149833757|NCT02188303|540523664|FG003|Overall Study|Adverse Event|0|||
149833758|NCT02188303|540523665|FG004|Overall Study|Adverse Event|0|||
149833759|NCT02188303|540523666|FG005|Overall Study|Adverse Event|2|||
149833760|NCT02188303|540523667|FG006|Overall Study|Adverse Event|0|||
149833761|NCT02188303|540523668|FG007|Overall Study|Adverse Event|2|||
149833762|NCT02188303|540523661|FG000|Overall Study|Dose Termination Criteria Met|0|||
149833763|NCT02188303|540523662|FG001|Overall Study|Dose Termination Criteria Met|0|||
149833764|NCT02188303|540523663|FG002|Overall Study|Dose Termination Criteria Met|0|||
149833765|NCT02188303|540523664|FG003|Overall Study|Dose Termination Criteria Met|0|||
149833766|NCT02188303|540523665|FG004|Overall Study|Dose Termination Criteria Met|0|||
149833767|NCT02188303|540523666|FG005|Overall Study|Dose Termination Criteria Met|0|||
149833768|NCT02188303|540523667|FG006|Overall Study|Dose Termination Criteria Met|2|||
149833769|NCT02188303|540523668|FG007|Overall Study|Dose Termination Criteria Met|4|||
149833770|NCT04206332|540523670|FG000|Part A|Lost to Follow-up|0|||
149833771|NCT04206332|540523671|FG001|Part A|Lost to Follow-up|1|||
149833772|NCT04206332|540523672|FG002|Part A|Lost to Follow-up|0|||
149833773|NCT04206332|540523673|FG003|Part A|Lost to Follow-up|0|||
149833774|NCT04206332|540523674|FG004|Part A|Lost to Follow-up|0|||
149833775|NCT04206332|540523675|FG005|Part A|Lost to Follow-up|0|||
149833776|NCT04206332|540523676|FG006|Part A|Lost to Follow-up|0|||
149833777|NCT04206332|540523677|FG007|Part A|Lost to Follow-up|0|||
149833778|NCT04206332|540523678|FG008|Part A|Lost to Follow-up|0|||
149833779|NCT04206332|540523679|FG009|Part A|Lost to Follow-up|0|||
149833780|NCT04206332|540523680|FG010|Part A|Lost to Follow-up|0|||
149833781|NCT04206332|540523681|FG011|Part A|Lost to Follow-up|0|||
149833782|NCT04206332|540523682|FG012|Part A|Lost to Follow-up|0|||
149833783|NCT04206332|540523683|FG013|Part A|Lost to Follow-up|0|||
149833784|NCT04206332|540523684|FG014|Part A|Lost to Follow-up|0|||
149833785|NCT04206332|540523685|FG015|Part A|Lost to Follow-up|0|||
149833786|NCT04206332|540523686|FG016|Part A|Lost to Follow-up|0|||
149833787|NCT04206332|540523670|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833788|NCT04206332|540523671|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833789|NCT04206332|540523672|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833790|NCT04206332|540523673|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
150171433|NCT05190419|541763493|FG003|Overall Study|Other|3|||
150171434|NCT03210402|541763494|FG000|Overall Study|Withdrawal by Subject|0|||
150171435|NCT03210402|541763495|FG001|Overall Study|Withdrawal by Subject|1|||
150171436|NCT02517307|541763510|FG000|Overall Study|Withdrawal by Subject|1|||
150171437|NCT02517307|541763511|FG001|Overall Study|Withdrawal by Subject|0|||
150171438|NCT02517307|541763512|FG002|Overall Study|Withdrawal by Subject|1|||
150171439|NCT02517307|541763513|FG003|Overall Study|Withdrawal by Subject|0|||
150171440|NCT02517307|541763510|FG000|Overall Study|Protocol Violation|0|||
150171441|NCT02517307|541763511|FG001|Overall Study|Protocol Violation|0|||
150171442|NCT02517307|541763512|FG002|Overall Study|Protocol Violation|1|||
150171443|NCT02517307|541763513|FG003|Overall Study|Protocol Violation|1|||
150171444|NCT03863834|541763514|FG000|Overall Study|Lost to Follow-up|3|||
150171445|NCT02770248|541763515|FG000|Overall Study|Adverse Event|0|||
150171446|NCT02770248|541763516|FG001|Overall Study|Adverse Event|1|||
150171447|NCT02770248|541763515|FG000|Overall Study|Randomized in error, prior to treatment|0|||
150171448|NCT02770248|541763516|FG001|Overall Study|Randomized in error, prior to treatment|1|||
150171449|NCT03538054|541763519|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
150171450|NCT03538054|541763519|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
150171451|NCT03538054|541763519|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
150171452|NCT02351180|541763522|FG000|Overall Study|Withdrawal by Subject|1|||
150171453|NCT02351180|541763523|FG001|Overall Study|Withdrawal by Subject|0|||
150171454|NCT00208767|541763524|FG000|Overall Study|Adverse Event|9|||
150171455|NCT00208767|541763525|FG001|Overall Study|Adverse Event|1|||
150171456|NCT00208767|541763524|FG000|Overall Study|Withdrawal by Subject|14|||
150171457|NCT00208767|541763525|FG001|Overall Study|Withdrawal by Subject|3|||
150171458|NCT00208767|541763524|FG000|Overall Study|Death|1|||
150171459|NCT00208767|541763525|FG001|Overall Study|Death|0|||
150171460|NCT00208767|541763524|FG000|Overall Study|Lost to Follow-up|3|||
149833791|NCT04206332|540523674|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833792|NCT04206332|540523675|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
149833793|NCT04206332|540523676|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833794|NCT04206332|540523677|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833795|NCT04206332|540523678|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833796|NCT04206332|540523679|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833797|NCT04206332|540523680|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833798|NCT04206332|540523681|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833799|NCT04206332|540523682|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833800|NCT04206332|540523683|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833801|NCT04206332|540523684|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833802|NCT04206332|540523685|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833803|NCT04206332|540523686|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
149833804|NCT04206332|540523670|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833805|NCT04206332|540523671|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833806|NCT04206332|540523672|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833807|NCT04206332|540523673|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833808|NCT04206332|540523674|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833809|NCT04206332|540523675|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833810|NCT04206332|540523676|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833811|NCT04206332|540523677|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
149833812|NCT04206332|540523678|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833813|NCT04206332|540523679|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833814|NCT04206332|540523680|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
149833815|NCT04206332|540523681|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833816|NCT04206332|540523682|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833817|NCT04206332|540523683|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833818|NCT04206332|540523684|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833819|NCT04206332|540523685|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833820|NCT04206332|540523686|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833821|NCT04206332|540523670|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833822|NCT04206332|540523671|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833823|NCT04206332|540523672|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833824|NCT04206332|540523673|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833825|NCT04206332|540523674|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833826|NCT04206332|540523675|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833827|NCT04206332|540523676|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833828|NCT04206332|540523677|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833829|NCT04206332|540523678|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833830|NCT04206332|540523679|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833831|NCT04206332|540523680|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833832|NCT04206332|540523681|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833833|NCT04206332|540523682|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833834|NCT04206332|540523683|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833835|NCT04206332|540523684|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
149833836|NCT04206332|540523685|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
150280347|NCT01392677|542162109|FG000|Overall Study|Other reason|3|||
150280348|NCT01392677|542162110|FG001|Overall Study|Other reason|2|||
150280349|NCT01380379|542162115|FG000|Overall Study|Pregnancy|1|||
150280350|NCT01538628|542162118|FG000|Overall Study|Withdrawal by Subject|1|||
150280351|NCT01538628|542162119|FG001|Overall Study|Withdrawal by Subject|1|||
149833837|NCT04206332|540523686|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
149833838|NCT04206332|540523670|FG000|Part C|Withdrawal by Subject|0|||
149833839|NCT04206332|540523671|FG001|Part C|Withdrawal by Subject|0|||
149833840|NCT04206332|540523672|FG002|Part C|Withdrawal by Subject|0|||
149833841|NCT04206332|540523673|FG003|Part C|Withdrawal by Subject|0|||
149833842|NCT04206332|540523674|FG004|Part C|Withdrawal by Subject|0|||
149833843|NCT04206332|540523675|FG005|Part C|Withdrawal by Subject|0|||
149833844|NCT04206332|540523676|FG006|Part C|Withdrawal by Subject|0|||
149833845|NCT04206332|540523677|FG007|Part C|Withdrawal by Subject|0|||
149833846|NCT04206332|540523678|FG008|Part C|Withdrawal by Subject|0|||
149833847|NCT04206332|540523679|FG009|Part C|Withdrawal by Subject|0|||
149833848|NCT04206332|540523680|FG010|Part C|Withdrawal by Subject|0|||
149833849|NCT04206332|540523681|FG011|Part C|Withdrawal by Subject|0|||
149833850|NCT04206332|540523682|FG012|Part C|Withdrawal by Subject|0|||
149833851|NCT04206332|540523683|FG013|Part C|Withdrawal by Subject|0|||
149833852|NCT04206332|540523684|FG014|Part C|Withdrawal by Subject|2|||
149833853|NCT04206332|540523685|FG015|Part C|Withdrawal by Subject|0|||
149833854|NCT04206332|540523686|FG016|Part C|Withdrawal by Subject|0|||
149833855|NCT02334722|540523687|FG000|Overall Study|Lost to Follow-up|4|||
149833856|NCT02334722|540523688|FG001|Overall Study|Lost to Follow-up|0|||
149833857|NCT02334722|540523687|FG000|Overall Study|6 week questionnaire not completed|2|||
149833858|NCT02334722|540523688|FG001|Overall Study|6 week questionnaire not completed|0|||
149833859|NCT02334722|540523687|FG000|Overall Study|Unable to obtain medication|1|||
149833860|NCT02334722|540523688|FG001|Overall Study|Unable to obtain medication|1|||
149833861|NCT02334722|540523687|FG000|Overall Study|Withdrawal by Subject|0|||
149833862|NCT02334722|540523688|FG001|Overall Study|Withdrawal by Subject|3|||
149833863|NCT02334722|540523687|FG000|Overall Study|Adverse Event|0|||
149833864|NCT02334722|540523688|FG001|Overall Study|Adverse Event|2|||
149833865|NCT02334722|540523687|FG000|Overall Study|Physician Decision|0|||
149833866|NCT02334722|540523688|FG001|Overall Study|Physician Decision|1|||
149833867|NCT05612724|540523690|FG000|Overall Study|Lost to Follow-up|4|||
149833868|NCT04000815|540523697|FG000|Overall Study|Lost to Follow-up|9|||
149833869|NCT04000815|540523698|FG001|Overall Study|Lost to Follow-up|2|||
149833870|NCT04000815|540523699|FG002|Overall Study|Lost to Follow-up|3|||
149833871|NCT04000815|540523697|FG000|Overall Study|Withdrawal by Subject|4|||
150280352|NCT01538628|542162118|FG000|Overall Study|Lost to Follow-up|0|||
150280353|NCT01538628|542162119|FG001|Overall Study|Lost to Follow-up|1|||
150280354|NCT01357577|542162120|FG000|Overall Study|Lost to Follow-up|20|||
150280355|NCT01357577|542162121|FG001|Overall Study|Lost to Follow-up|16|||
150280356|NCT01357577|542162120|FG000|Overall Study|Withdrawal by Subject|16|||
150280357|NCT01357577|542162121|FG001|Overall Study|Withdrawal by Subject|8|||
150280358|NCT01357577|542162120|FG000|Overall Study|look at data in database?|1|||
150280359|NCT01357577|542162121|FG001|Overall Study|look at data in database?|2|||
150280360|NCT00909181|542163450|FG000|Overall Study|Lost to Follow-up|39|||
150280361|NCT00909181|542163451|FG001|Overall Study|Lost to Follow-up|18|||
150280362|NCT00909181|542163452|FG002|Overall Study|Lost to Follow-up|33|||
150280363|NCT02375724|542163456|FG000|Overall Study|Lack of Efficacy|1|||
150280364|NCT02375724|542163457|FG001|Overall Study|Lack of Efficacy|1|||
150280365|NCT02375724|542163456|FG000|Overall Study|Withdrawal by Subject|1|||
150280366|NCT02375724|542163457|FG001|Overall Study|Withdrawal by Subject|1|||
150280367|NCT02375724|542163456|FG000|Overall Study|Lost to Follow-up|1|||
150280368|NCT02375724|542163457|FG001|Overall Study|Lost to Follow-up|0|||
150280369|NCT02375724|542163456|FG000|Overall Study|Protocol Violation|1|||
150280370|NCT02375724|542163457|FG001|Overall Study|Protocol Violation|0|||
150280371|NCT02375724|542163456|FG000|Overall Study|Adverse Event|2|||
150280372|NCT02375724|542163457|FG001|Overall Study|Adverse Event|4|||
150280373|NCT04712110|542163458|FG000|Overall Study|Lost to Follow-up|0|||
150280374|NCT04712110|542163459|FG001|Overall Study|Lost to Follow-up|1|||
150280375|NCT04712110|542163458|FG000|Overall Study|Withdrawal by Subject|0|||
149833872|NCT04000815|540523698|FG001|Overall Study|Withdrawal by Subject|3|||
150280376|NCT04712110|542163459|FG001|Overall Study|Withdrawal by Subject|4|||
149833873|NCT04000815|540523699|FG002|Overall Study|Withdrawal by Subject|2|||
149833874|NCT04000815|540523697|FG000|Overall Study|Right ovarian cyst occured|1|||
149833875|NCT04000815|540523698|FG001|Overall Study|Right ovarian cyst occured|0|||
149833876|NCT04000815|540523699|FG002|Overall Study|Right ovarian cyst occured|0|||
149833877|NCT04000815|540523697|FG000|Overall Study|Hypertension occured on follow up|0|||
149833878|NCT04000815|540523698|FG001|Overall Study|Hypertension occured on follow up|0|||
149833879|NCT04000815|540523699|FG002|Overall Study|Hypertension occured on follow up|2|||
150280377|NCT04712110|542163458|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
150280378|NCT04712110|542163459|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
149833880|NCT00239577|540523700|FG000|Primary Phase|Adverse Event|0|||
149833881|NCT00239577|540523701|FG001|Primary Phase|Adverse Event|0|||
149833882|NCT00239577|540523702|FG002|Primary Phase|Adverse Event|1|||
149833883|NCT00239577|540523703|FG003|Primary Phase|Adverse Event|0|||
150280379|NCT01517893|542163460|FG000|Overall Study|Withdrawal by Subject|3|||
149833884|NCT00239577|540523700|FG000|Primary Phase|Other|5|||
150280380|NCT01517893|542163461|FG001|Overall Study|Withdrawal by Subject|0|||
150280381|NCT03462576|542163462|FG000|Overall Study|Protocol Violation|5|||
149833885|NCT00239577|540523701|FG001|Primary Phase|Other|3|||
149833886|NCT00239577|540523702|FG002|Primary Phase|Other|2|||
149833887|NCT00239577|540523703|FG003|Primary Phase|Other|0|||
149833888|NCT02422264|540523706|FG000|Overall Study|Serious Adverse Event|1|||
149833889|NCT02422264|540523707|FG001|Overall Study|Serious Adverse Event|0|||
149833890|NCT02422264|540523706|FG000|Overall Study|Withdrawal by Subject|1|||
149833891|NCT02422264|540523707|FG001|Overall Study|Withdrawal by Subject|2|||
149833892|NCT02422264|540523706|FG000|Overall Study|Migrated/moved from study area|3|||
149833893|NCT02422264|540523707|FG001|Overall Study|Migrated/moved from study area|1|||
149833894|NCT02422264|540523706|FG000|Overall Study|Subject vaccinated outside of the study|0|||
149833895|NCT02422264|540523707|FG001|Overall Study|Subject vaccinated outside of the study|1|||
149833896|NCT03988803|540523708|FG000|Period 2|Prematurely discontinued from medication|2|||
149833897|NCT03988803|540523708|FG000|Period 2|Adverse Event|1|||
149833898|NCT03021018|540523710|FG000|Overall Study|Adverse Event|1|||
149833899|NCT03021018|540523711|FG001|Overall Study|Adverse Event|0|||
149833900|NCT03021018|540523712|FG002|Overall Study|Adverse Event|0|||
149833901|NCT03021018|540523710|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
149833902|NCT03021018|540523711|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
149833903|NCT03021018|540523712|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
149833904|NCT00856388|540523715|FG000|Overall Study|Other|1|||
149833905|NCT00150462|540523716|FG000|Overall Study|Disease Progression or Relapse|3|||
149833906|NCT00150462|540523717|FG001|Overall Study|Disease Progression or Relapse|1|||
149833907|NCT00150462|540523718|FG002|Overall Study|Disease Progression or Relapse|2|||
149833908|NCT00150462|540523719|FG003|Overall Study|Disease Progression or Relapse|1|||
149833909|NCT00150462|540523720|FG004|Overall Study|Disease Progression or Relapse|2|||
149833910|NCT00150462|540523721|FG005|Overall Study|Disease Progression or Relapse|2|||
150171461|NCT00208767|541763525|FG001|Overall Study|Lost to Follow-up|3|||
149833911|NCT00150462|540523722|FG006|Overall Study|Disease Progression or Relapse|3|||
149833912|NCT00150462|540523723|FG007|Overall Study|Disease Progression or Relapse|5|||
149948915|NCT03483584|540944877|FG000|Overall Study|Lost to Follow-up|40|||
149948916|NCT03483584|540944878|FG001|Overall Study|Lost to Follow-up|7|||
149948917|NCT03483584|540944877|FG000|Overall Study|Withdrawal by Subject|4|||
149948918|NCT03483584|540944878|FG001|Overall Study|Withdrawal by Subject|1|||
149948937|NCT04063163|540944882|FG000|Overall Study|Death|281|||
149948938|NCT04063163|540944883|FG001|Overall Study|Death|166|||
150171462|NCT00605033|541763532|FG000|Overall Study|Adverse Event|2|||
150171463|NCT00605033|541763533|FG001|Overall Study|Adverse Event|2|||
149833913|NCT00150462|540523724|FG008|Overall Study|Disease Progression or Relapse|5|||
149833914|NCT00150462|540523725|FG009|Overall Study|Disease Progression or Relapse|3|||
149833915|NCT00150462|540523726|FG010|Overall Study|Disease Progression or Relapse|2|||
149833916|NCT00150462|540523716|FG000|Overall Study|Withdrawal by Subject|0|||
149948939|NCT04063163|540944882|FG000|Overall Study|Lost to Follow-up|12|||
149948940|NCT04063163|540944883|FG001|Overall Study|Lost to Follow-up|8|||
149948941|NCT04063163|540944882|FG000|Overall Study|Withdrawal by Subject|19|||
150034294|NCT02657889|541264804|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
150034295|NCT02657889|541264805|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
150034296|NCT02657889|541264806|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
150034297|NCT02657889|541264807|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
150034298|NCT02657889|541264804|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
150034299|NCT02657889|541264805|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
150034300|NCT02657889|541264806|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
150034301|NCT02657889|541264807|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
150034302|NCT02657889|541264804|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
150034303|NCT02657889|541264805|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
150034304|NCT02657889|541264806|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
150034305|NCT02657889|541264807|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
150034306|NCT02657889|541264804|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
150034307|NCT02657889|541264805|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
150034308|NCT02657889|541264806|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
150034309|NCT02657889|541264807|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
150034310|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
150034311|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
149833917|NCT00150462|540523717|FG001|Overall Study|Withdrawal by Subject|1|||
149833918|NCT00150462|540523718|FG002|Overall Study|Withdrawal by Subject|1|||
149833919|NCT00150462|540523719|FG003|Overall Study|Withdrawal by Subject|0|||
149833920|NCT00150462|540523720|FG004|Overall Study|Withdrawal by Subject|1|||
149833921|NCT00150462|540523721|FG005|Overall Study|Withdrawal by Subject|2|||
149833922|NCT00150462|540523722|FG006|Overall Study|Withdrawal by Subject|0|||
149833923|NCT00150462|540523723|FG007|Overall Study|Withdrawal by Subject|1|||
149833924|NCT00150462|540523724|FG008|Overall Study|Withdrawal by Subject|0|||
149833925|NCT00150462|540523725|FG009|Overall Study|Withdrawal by Subject|1|||
149833926|NCT00150462|540523726|FG010|Overall Study|Withdrawal by Subject|0|||
149833927|NCT00150462|540523716|FG000|Overall Study|Death|0|||
149833928|NCT00150462|540523717|FG001|Overall Study|Death|1|||
149833929|NCT00150462|540523718|FG002|Overall Study|Death|0|||
149833930|NCT00150462|540523719|FG003|Overall Study|Death|0|||
149833931|NCT00150462|540523720|FG004|Overall Study|Death|0|||
149833932|NCT00150462|540523721|FG005|Overall Study|Death|0|||
149833933|NCT00150462|540523722|FG006|Overall Study|Death|0|||
150034312|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
150034313|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
150034314|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
150034315|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
150034316|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
150034317|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
150034318|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
150034319|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
150034320|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
150034321|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
150034322|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
150034323|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
150034324|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
150034325|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
150034326|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
150034327|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
150034328|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
150034329|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
150034330|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
150034331|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
150171464|NCT00605033|541763532|FG000|Overall Study|Lost to Follow-up|1|||
150171465|NCT00605033|541763533|FG001|Overall Study|Lost to Follow-up|1|||
150171466|NCT00605033|541763532|FG000|Overall Study|Withdrawal by Subject|3|||
150171467|NCT00605033|541763533|FG001|Overall Study|Withdrawal by Subject|4|||
149833934|NCT00150462|540523723|FG007|Overall Study|Death|0|||
149833935|NCT00150462|540523724|FG008|Overall Study|Death|1|||
150171468|NCT00605033|541763532|FG000|Overall Study|Protocol Violation|1|||
150171469|NCT00605033|541763533|FG001|Overall Study|Protocol Violation|1|||
149833936|NCT00150462|540523725|FG009|Overall Study|Death|0|||
150171470|NCT02299336|541763538|FG000|Overall Study|Withdrawal by Subject|11|||
149833937|NCT00150462|540523726|FG010|Overall Study|Death|0|||
149833938|NCT00150462|540523716|FG000|Overall Study|Adverse Event|0|||
149833939|NCT00150462|540523717|FG001|Overall Study|Adverse Event|0|||
149833940|NCT00150462|540523718|FG002|Overall Study|Adverse Event|0|||
149833941|NCT00150462|540523719|FG003|Overall Study|Adverse Event|1|||
149833942|NCT00150462|540523720|FG004|Overall Study|Adverse Event|0|||
149833943|NCT00150462|540523721|FG005|Overall Study|Adverse Event|0|||
149833944|NCT00150462|540523722|FG006|Overall Study|Adverse Event|0|||
149833945|NCT00150462|540523723|FG007|Overall Study|Adverse Event|2|||
149833946|NCT00150462|540523724|FG008|Overall Study|Adverse Event|0|||
149833947|NCT00150462|540523725|FG009|Overall Study|Adverse Event|1|||
149833948|NCT00150462|540523726|FG010|Overall Study|Adverse Event|0|||
149833949|NCT00150462|540523716|FG000|Overall Study|Physician Decision|0|||
149833950|NCT00150462|540523717|FG001|Overall Study|Physician Decision|0|||
149833951|NCT00150462|540523718|FG002|Overall Study|Physician Decision|1|||
149833952|NCT00150462|540523719|FG003|Overall Study|Physician Decision|1|||
149833953|NCT00150462|540523720|FG004|Overall Study|Physician Decision|0|||
149833954|NCT00150462|540523721|FG005|Overall Study|Physician Decision|0|||
149833955|NCT00150462|540523722|FG006|Overall Study|Physician Decision|0|||
149833956|NCT00150462|540523723|FG007|Overall Study|Physician Decision|0|||
149833957|NCT00150462|540523724|FG008|Overall Study|Physician Decision|0|||
149833958|NCT00150462|540523725|FG009|Overall Study|Physician Decision|0|||
149833959|NCT00150462|540523726|FG010|Overall Study|Physician Decision|0|||
149833960|NCT00150462|540523716|FG000|Overall Study|Other|0|||
149833961|NCT00150462|540523717|FG001|Overall Study|Other|0|||
149833962|NCT00150462|540523718|FG002|Overall Study|Other|0|||
149833963|NCT00150462|540523719|FG003|Overall Study|Other|0|||
149833964|NCT00150462|540523720|FG004|Overall Study|Other|0|||
149833965|NCT00150462|540523721|FG005|Overall Study|Other|0|||
149833966|NCT00150462|540523722|FG006|Overall Study|Other|0|||
149833967|NCT00150462|540523723|FG007|Overall Study|Other|0|||
149833968|NCT00150462|540523724|FG008|Overall Study|Other|0|||
149833969|NCT00150462|540523725|FG009|Overall Study|Other|1|||
149833970|NCT00150462|540523726|FG010|Overall Study|Other|1|||
149833971|NCT00569374|540523729|FG000|Overall Study|Withdrawal by Subject|4|||
149833972|NCT01666730|540523730|FG000|Overall Study|Adverse Event|16|||
149833973|NCT01666730|540523730|FG000|Overall Study|Death|2|||
149833974|NCT01666730|540523730|FG000|Overall Study|Physician Decision|5|||
149833975|NCT01666730|540523730|FG000|Overall Study|Withdrawal by Subject|9|||
149833976|NCT01666730|540523730|FG000|Overall Study|Disease progression/relapse|18|||
149833977|NCT04638153|540523731|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149833978|NCT04638153|540523732|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149833979|NCT04638153|540523733|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149833980|NCT04638153|540523731|FG000|Overall Study|Study terminated by sponsor|4|||
149833981|NCT04638153|540523732|FG001|Overall Study|Study terminated by sponsor|2|||
149833982|NCT04638153|540523733|FG002|Overall Study|Study terminated by sponsor|14|||
149833983|NCT03553823|540523738|FG000|Overall Study|Physician Decision|0|||
149833984|NCT03553823|540523739|FG001|Overall Study|Physician Decision|1|||
149833985|NCT03603314|540523740|FG000|Overall Study|Lost to Follow-up|0|||
149833986|NCT03603314|540523741|FG001|Overall Study|Lost to Follow-up|3|||
149833987|NCT03603314|540523742|FG002|Overall Study|Lost to Follow-up|0|||
149833988|NCT03603314|540523740|FG000|Overall Study|Protocol Violation|0|||
149833989|NCT03603314|540523741|FG001|Overall Study|Protocol Violation|1|||
149833990|NCT03603314|540523742|FG002|Overall Study|Protocol Violation|0|||
149833991|NCT03603314|540523740|FG000|Overall Study|Adverse Event|2|||
149833992|NCT03603314|540523741|FG001|Overall Study|Adverse Event|0|||
149833993|NCT03603314|540523742|FG002|Overall Study|Adverse Event|0|||
149833994|NCT03603314|540523740|FG000|Overall Study|Physician Decision|1|||
149833995|NCT03603314|540523741|FG001|Overall Study|Physician Decision|1|||
149833996|NCT03603314|540523742|FG002|Overall Study|Physician Decision|0|||
149833997|NCT03603314|540523740|FG000|Overall Study|Withdrawal by Subject|4|||
149833998|NCT03603314|540523741|FG001|Overall Study|Withdrawal by Subject|5|||
149833999|NCT03603314|540523742|FG002|Overall Study|Withdrawal by Subject|3|||
149834000|NCT03603314|540523740|FG000|Overall Study|Other|0|||
150280382|NCT03462576|542163463|FG001|Overall Study|Protocol Violation|11|||
149834001|NCT03603314|540523741|FG001|Overall Study|Other|1|||
149834002|NCT03603314|540523742|FG002|Overall Study|Other|0|||
149834003|NCT01389102|540523743|FG000|Overall Study|Adverse Event|1|||
149834004|NCT01389102|540523744|FG001|Overall Study|Adverse Event|3|||
149834005|NCT01389102|540523745|FG002|Overall Study|Adverse Event|2|||
149834006|NCT01389102|540523746|FG003|Overall Study|Adverse Event|2|||
149834007|NCT01389102|540523747|FG004|Overall Study|Adverse Event|2|||
149834008|NCT01389102|540523748|FG005|Overall Study|Adverse Event|2|||
149834009|NCT01389102|540523743|FG000|Overall Study|Hurricane Katrina|4|||
149834010|NCT01389102|540523744|FG001|Overall Study|Hurricane Katrina|2|||
149834011|NCT01389102|540523745|FG002|Overall Study|Hurricane Katrina|3|||
149834012|NCT01389102|540523746|FG003|Overall Study|Hurricane Katrina|0|||
149834013|NCT01389102|540523747|FG004|Overall Study|Hurricane Katrina|3|||
149834014|NCT01389102|540523748|FG005|Overall Study|Hurricane Katrina|1|||
149834015|NCT01389102|540523743|FG000|Overall Study|Lost to Follow-up|4|||
149834016|NCT01389102|540523744|FG001|Overall Study|Lost to Follow-up|1|||
149834017|NCT01389102|540523745|FG002|Overall Study|Lost to Follow-up|1|||
149834018|NCT01389102|540523746|FG003|Overall Study|Lost to Follow-up|2|||
149834019|NCT01389102|540523747|FG004|Overall Study|Lost to Follow-up|4|||
149834020|NCT01389102|540523748|FG005|Overall Study|Lost to Follow-up|1|||
149834021|NCT01389102|540523743|FG000|Overall Study|Protocol Violation|0|||
149834022|NCT01389102|540523744|FG001|Overall Study|Protocol Violation|0|||
150280383|NCT03462576|542163464|FG002|Overall Study|Protocol Violation|7|||
150280384|NCT03462576|542163462|FG000|Overall Study|Device Malfunction|0|||
150280385|NCT03462576|542163463|FG001|Overall Study|Device Malfunction|0|||
150280386|NCT03462576|542163464|FG002|Overall Study|Device Malfunction|1|||
150280387|NCT00271596|542163465|FG000|Overall Study|Protocol Violation|1|||
150280388|NCT00271596|542163466|FG001|Overall Study|Protocol Violation|0|||
150280389|NCT00271596|542163465|FG000|Overall Study|Withdrawal by Subject|0|||
150280390|NCT00271596|542163466|FG001|Overall Study|Withdrawal by Subject|1|||
150280391|NCT04206605|542163479|FG000|Overall Study|Adverse Event|0|||
150280392|NCT04206605|542163480|FG001|Overall Study|Adverse Event|1|||
150280393|NCT04206605|542163479|FG000|Overall Study|Withdrawal by Subject|1|||
150280394|NCT04206605|542163480|FG001|Overall Study|Withdrawal by Subject|0|||
150280395|NCT05879107|542163486|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
150280396|NCT05879107|542163487|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
150280397|NCT05879107|542163486|FG000|Overall Study|Migrated / moved from the study area|1|||
150280398|NCT05879107|542163487|FG001|Overall Study|Migrated / moved from the study area|1|||
150280399|NCT05879107|542163486|FG000|Overall Study|Lost to Follow-up|8|||
150280400|NCT05879107|542163487|FG001|Overall Study|Lost to Follow-up|13|||
150280401|NCT05879107|542163486|FG000|Overall Study|Death|0|||
150280402|NCT05879107|542163487|FG001|Overall Study|Death|2|||
150280403|NCT05879107|542163486|FG000|Overall Study|Other|0|||
150280404|NCT05879107|542163487|FG001|Overall Study|Other|3|||
150280405|NCT03901079|542163488|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
150280406|NCT00589420|542163491|FG000|Overall Study|screen failure|1|||
150280407|NCT00133991|542163492|FG000|Overall Study|Death|4|||
150280408|NCT00942175|542163498|FG000|Overall Study|Adverse Event|2|||
150280409|NCT00942175|542163499|FG001|Overall Study|Adverse Event|1|||
150280410|NCT00942175|542163500|FG002|Overall Study|Adverse Event|0|||
150280411|NCT00942175|542163501|FG003|Overall Study|Adverse Event|0|||
150280412|NCT00942175|542163498|FG000|Overall Study|Protocol Violation|0|||
150280413|NCT00942175|542163499|FG001|Overall Study|Protocol Violation|1|||
150280414|NCT00942175|542163500|FG002|Overall Study|Protocol Violation|2|||
150280415|NCT00942175|542163501|FG003|Overall Study|Protocol Violation|0|||
150280416|NCT00942175|542163498|FG000|Overall Study|Pregnancy|0|||
150280417|NCT00942175|542163499|FG001|Overall Study|Pregnancy|0|||
150280418|NCT00942175|542163500|FG002|Overall Study|Pregnancy|0|||
150280419|NCT00942175|542163501|FG003|Overall Study|Pregnancy|1|||
150280420|NCT00942175|542163498|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
150280421|NCT00942175|542163499|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
150280422|NCT00942175|542163500|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
150280423|NCT00942175|542163501|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
150280424|NCT00942175|542163498|FG000|Overall Study|Low Platelet Count|0|||
150280425|NCT00942175|542163499|FG001|Overall Study|Low Platelet Count|2|||
150280426|NCT00942175|542163500|FG002|Overall Study|Low Platelet Count|0|||
150280427|NCT00942175|542163501|FG003|Overall Study|Low Platelet Count|0|||
150280428|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
150280429|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
150280430|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
150280431|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
150280432|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
150280433|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
150280434|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
150280435|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
150280436|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
150280437|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
150280438|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
150280439|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
150280440|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
150280441|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
150280442|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
150280443|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
149834023|NCT01389102|540523745|FG002|Overall Study|Protocol Violation|3|||
149834024|NCT01389102|540523746|FG003|Overall Study|Protocol Violation|0|||
149834025|NCT01389102|540523747|FG004|Overall Study|Protocol Violation|1|||
149834026|NCT01389102|540523748|FG005|Overall Study|Protocol Violation|1|||
149834027|NCT01389102|540523743|FG000|Overall Study|Withdrawal by Subject|7|||
149834028|NCT01389102|540523744|FG001|Overall Study|Withdrawal by Subject|4|||
149834029|NCT01389102|540523745|FG002|Overall Study|Withdrawal by Subject|9|||
149834030|NCT01389102|540523746|FG003|Overall Study|Withdrawal by Subject|2|||
149834031|NCT01389102|540523747|FG004|Overall Study|Withdrawal by Subject|3|||
149834032|NCT01389102|540523748|FG005|Overall Study|Withdrawal by Subject|3|||
149834033|NCT01389102|540523743|FG000|Overall Study|Subject Traveling Out of Country|0|||
150280444|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
150280445|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
150280446|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
149834034|NCT01389102|540523744|FG001|Overall Study|Subject Traveling Out of Country|0|||
149834035|NCT01389102|540523745|FG002|Overall Study|Subject Traveling Out of Country|0|||
149834036|NCT01389102|540523746|FG003|Overall Study|Subject Traveling Out of Country|1|||
149834037|NCT01389102|540523747|FG004|Overall Study|Subject Traveling Out of Country|0|||
149834038|NCT01389102|540523748|FG005|Overall Study|Subject Traveling Out of Country|0|||
149834039|NCT01389102|540523743|FG000|Overall Study|Subject Moved|2|||
149834040|NCT01389102|540523744|FG001|Overall Study|Subject Moved|0|||
149834041|NCT01389102|540523745|FG002|Overall Study|Subject Moved|1|||
149834042|NCT01389102|540523746|FG003|Overall Study|Subject Moved|0|||
149834043|NCT01389102|540523747|FG004|Overall Study|Subject Moved|0|||
149834044|NCT01389102|540523748|FG005|Overall Study|Subject Moved|0|||
149834045|NCT01389102|540523743|FG000|Overall Study|Unavailable due to husband's illness|0|||
149834046|NCT01389102|540523744|FG001|Overall Study|Unavailable due to husband's illness|1|||
149834047|NCT01389102|540523745|FG002|Overall Study|Unavailable due to husband's illness|0|||
149834048|NCT01389102|540523746|FG003|Overall Study|Unavailable due to husband's illness|0|||
149834049|NCT01389102|540523747|FG004|Overall Study|Unavailable due to husband's illness|0|||
149834050|NCT01389102|540523748|FG005|Overall Study|Unavailable due to husband's illness|0|||
149834051|NCT01389102|540523743|FG000|Overall Study|Investigator Judgement|0|||
149834052|NCT01389102|540523744|FG001|Overall Study|Investigator Judgement|1|||
149834053|NCT01389102|540523745|FG002|Overall Study|Investigator Judgement|0|||
149834054|NCT01389102|540523746|FG003|Overall Study|Investigator Judgement|0|||
149834055|NCT01389102|540523747|FG004|Overall Study|Investigator Judgement|0|||
149834056|NCT01389102|540523748|FG005|Overall Study|Investigator Judgement|0|||
149834057|NCT03450070|540523749|FG000|Overall Study|Withdrawal by Subject|8|||
149834058|NCT00050778|540523750|FG000|Overall Study|Adverse Event|13|||
149834059|NCT00050778|540523751|FG001|Overall Study|Adverse Event|3|||
149834060|NCT00050778|540523752|FG002|Overall Study|Adverse Event|2|||
149834061|NCT00050778|540523750|FG000|Overall Study|Death|0|||
149834062|NCT00050778|540523751|FG001|Overall Study|Death|1|||
149834063|NCT00050778|540523752|FG002|Overall Study|Death|1|||
149834064|NCT00050778|540523750|FG000|Overall Study|Lack of Efficacy|16|||
149834065|NCT00050778|540523751|FG001|Overall Study|Lack of Efficacy|2|||
149834066|NCT00050778|540523752|FG002|Overall Study|Lack of Efficacy|2|||
149834067|NCT00050778|540523750|FG000|Overall Study|Lost to Follow-up|0|||
149834068|NCT00050778|540523751|FG001|Overall Study|Lost to Follow-up|2|||
149834069|NCT00050778|540523752|FG002|Overall Study|Lost to Follow-up|4|||
149834070|NCT00050778|540523750|FG000|Overall Study|Physician Decision|3|||
149834071|NCT00050778|540523751|FG001|Overall Study|Physician Decision|0|||
149834072|NCT00050778|540523752|FG002|Overall Study|Physician Decision|2|||
149834073|NCT00050778|540523750|FG000|Overall Study|Protocol Violation|2|||
149834074|NCT00050778|540523751|FG001|Overall Study|Protocol Violation|0|||
149834075|NCT00050778|540523752|FG002|Overall Study|Protocol Violation|1|||
149834076|NCT00050778|540523750|FG000|Overall Study|Withdrawal by Subject|6|||
149834077|NCT00050778|540523751|FG001|Overall Study|Withdrawal by Subject|8|||
149834078|NCT00050778|540523752|FG002|Overall Study|Withdrawal by Subject|4|||
149834079|NCT00050778|540523750|FG000|Overall Study|Randomized but not treated|4|||
149834080|NCT00050778|540523751|FG001|Overall Study|Randomized but not treated|5|||
149834081|NCT00050778|540523752|FG002|Overall Study|Randomized but not treated|2|||
149834082|NCT00050778|540523750|FG000|Overall Study|Familial and personal reasons|1|||
149834083|NCT00050778|540523751|FG001|Overall Study|Familial and personal reasons|0|||
149834084|NCT00050778|540523752|FG002|Overall Study|Familial and personal reasons|0|||
149834085|NCT02015390|540523753|FG000|Overall Study|Lost to Follow-up|1|||
149834086|NCT02015390|540523754|FG001|Overall Study|Lost to Follow-up|0|||
149834087|NCT02015390|540523753|FG000|Overall Study|Adverse Event|0|||
149834088|NCT02015390|540523754|FG001|Overall Study|Adverse Event|3|||
149834089|NCT02015390|540523753|FG000|Overall Study|Physician Decision|0|||
149834090|NCT02015390|540523754|FG001|Overall Study|Physician Decision|1|||
149834091|NCT01661686|540523760|FG000|Overall Study|Lost to Follow-up|2|||
149834092|NCT01661686|540523761|FG001|Overall Study|Lost to Follow-up|1|||
149834093|NCT01661686|540523760|FG000|Overall Study|did not receive allocated intervention|0|||
149834094|NCT01661686|540523761|FG001|Overall Study|did not receive allocated intervention|1|||
150171471|NCT02299336|541763538|FG000|Overall Study|Adverse Event|1|||
149834095|NCT04869787|540523764|FG000|Screening|Physician Decision|1|||
149834096|NCT04869787|540523764|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
149834097|NCT00813293|540523765|FG000|Overall Study|Intercurrent illness|1|||
149834098|NCT00813293|540523766|FG001|Overall Study|Intercurrent illness|0|||
149834099|NCT00813293|540523765|FG000|Overall Study|Adverse Event|0|||
149834100|NCT00813293|540523766|FG001|Overall Study|Adverse Event|1|||
149834101|NCT00533273|540523767|FG000|Double-blind|Withdrew consent|0|||
149834102|NCT00533273|540523768|FG001|Double-blind|Withdrew consent|2|||
149834103|NCT00533273|540523767|FG000|Open-label|Withdrawal by Subject|6|||
149834104|NCT00533273|540523768|FG001|Open-label|Withdrawal by Subject|0|||
149834105|NCT02794974|540523769|FG000|Overall Study|Physician Decision|0|||
149834106|NCT02794974|540523770|FG001|Overall Study|Physician Decision|1|||
149834107|NCT01873586|540523772|FG000|Overall Study|Lost to Follow-up|3|||
149834108|NCT00454909|540523773|FG000|Overall Study|Withdrawal by Subject|1|||
149834109|NCT00454909|540523774|FG001|Overall Study|Withdrawal by Subject|0|||
149834110|NCT00454909|540523775|FG002|Overall Study|Withdrawal by Subject|0|||
149834111|NCT00454909|540523773|FG000|Overall Study|Migrated/moved from study area|0|||
149834112|NCT00454909|540523774|FG001|Overall Study|Migrated/moved from study area|0|||
149834113|NCT00454909|540523775|FG002|Overall Study|Migrated/moved from study area|1|||
149834114|NCT00454909|540523773|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
149834115|NCT00454909|540523774|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
149834116|NCT00454909|540523775|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
149834117|NCT00454909|540523773|FG000|Overall Study|Others|1|||
149834118|NCT00454909|540523774|FG001|Overall Study|Others|0|||
149834119|NCT00454909|540523775|FG002|Overall Study|Others|0|||
149834120|NCT00870870|540523776|FG000|Overall Study|Withdrawal by Subject|0|||
149834121|NCT00870870|540523777|FG001|Overall Study|Withdrawal by Subject|1|||
149834122|NCT00870870|540523778|FG002|Overall Study|Withdrawal by Subject|1|||
149834123|NCT00870870|540523779|FG003|Overall Study|Withdrawal by Subject|3|||
149834124|NCT00870870|540523776|FG000|Overall Study|Adverse Event|0|||
149834125|NCT00870870|540523777|FG001|Overall Study|Adverse Event|0|||
149834126|NCT00870870|540523778|FG002|Overall Study|Adverse Event|2|||
149834127|NCT00870870|540523779|FG003|Overall Study|Adverse Event|2|||
149834128|NCT03639311|540523785|FG000|Maintenance Phase|Lost to Follow-up|1|||
149834129|NCT03639311|540523786|FG001|Maintenance Phase|Lost to Follow-up|0|||
149834130|NCT03639311|540523787|FG002|Maintenance Phase|Lost to Follow-up|0|||
149834131|NCT03639311|540523785|FG000|Maintenance Phase|Adverse Event|1|||
149834132|NCT03639311|540523786|FG001|Maintenance Phase|Adverse Event|0|||
149834133|NCT03639311|540523787|FG002|Maintenance Phase|Adverse Event|0|||
149834134|NCT03639311|540523785|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
150280447|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
150280448|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
149834135|NCT03639311|540523786|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
149834136|NCT03639311|540523787|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
149834137|NCT03639311|540523785|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
149834138|NCT03639311|540523786|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
149834139|NCT03639311|540523787|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
149834140|NCT03639311|540523785|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
149834141|NCT03639311|540523786|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
149834142|NCT03639311|540523787|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
149834143|NCT03639311|540523785|FG000|Maintenance Phase|Lack of Efficacy|1|||
149834144|NCT03639311|540523786|FG001|Maintenance Phase|Lack of Efficacy|0|||
149834145|NCT03639311|540523787|FG002|Maintenance Phase|Lack of Efficacy|0|||
149834146|NCT00822926|540523788|FG000|Second Injection Visit|Lost to Follow-up|1|||
149834147|NCT00822926|540523789|FG001|Second Injection Visit|Lost to Follow-up|0|||
149834148|NCT00822926|540523788|FG000|Second Injection Visit|Withdrawal by Subject|0|||
149834149|NCT00822926|540523789|FG001|Second Injection Visit|Withdrawal by Subject|1|||
149834150|NCT03125200|540523791|FG000|Overall Study|Study Termination|0|||
149834151|NCT03125200|540523792|FG001|Overall Study|Study Termination|0|||
149834152|NCT03125200|540523793|FG002|Overall Study|Study Termination|0|||
149834153|NCT03125200|540523794|FG003|Overall Study|Study Termination|1|||
149834154|NCT03125200|540523795|FG004|Overall Study|Study Termination|1|||
149834155|NCT03125200|540523796|FG005|Overall Study|Study Termination|2|||
149834156|NCT03125200|540523797|FG006|Overall Study|Study Termination|1|||
149834157|NCT03125200|540523791|FG000|Overall Study|Clinical Progression|0|||
149834158|NCT03125200|540523792|FG001|Overall Study|Clinical Progression|0|||
149834159|NCT03125200|540523793|FG002|Overall Study|Clinical Progression|0|||
149834160|NCT03125200|540523794|FG003|Overall Study|Clinical Progression|1|||
149834161|NCT03125200|540523795|FG004|Overall Study|Clinical Progression|0|||
149834162|NCT03125200|540523796|FG005|Overall Study|Clinical Progression|1|||
149834163|NCT03125200|540523797|FG006|Overall Study|Clinical Progression|0|||
149834164|NCT03125200|540523791|FG000|Overall Study|Progressive Disease|2|||
149834165|NCT03125200|540523792|FG001|Overall Study|Progressive Disease|1|||
149834166|NCT03125200|540523793|FG002|Overall Study|Progressive Disease|2|||
149834167|NCT03125200|540523794|FG003|Overall Study|Progressive Disease|1|||
149834168|NCT03125200|540523795|FG004|Overall Study|Progressive Disease|2|||
149834169|NCT03125200|540523796|FG005|Overall Study|Progressive Disease|0|||
150280449|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
149834170|NCT03125200|540523797|FG006|Overall Study|Progressive Disease|1|||
149834171|NCT03125200|540523791|FG000|Overall Study|Lack of Efficacy|0|||
150280450|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
150280451|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
150280452|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Death|2|||
149834172|NCT03125200|540523792|FG001|Overall Study|Lack of Efficacy|0|||
149834173|NCT03125200|540523793|FG002|Overall Study|Lack of Efficacy|0|||
149834174|NCT03125200|540523794|FG003|Overall Study|Lack of Efficacy|1|||
150280453|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Death|1|||
149834175|NCT03125200|540523795|FG004|Overall Study|Lack of Efficacy|0|||
149834176|NCT03125200|540523796|FG005|Overall Study|Lack of Efficacy|0|||
149834177|NCT03125200|540523797|FG006|Overall Study|Lack of Efficacy|0|||
149834178|NCT03125200|540523791|FG000|Overall Study|Toxicity|0|||
149834179|NCT03125200|540523792|FG001|Overall Study|Toxicity|0|||
149834180|NCT03125200|540523793|FG002|Overall Study|Toxicity|0|||
149834181|NCT03125200|540523794|FG003|Overall Study|Toxicity|1|||
149834182|NCT03125200|540523795|FG004|Overall Study|Toxicity|0|||
149834183|NCT03125200|540523796|FG005|Overall Study|Toxicity|0|||
149834184|NCT03125200|540523797|FG006|Overall Study|Toxicity|0|||
149834185|NCT03125200|540523791|FG000|Overall Study|Consent Withdrawn by Subject|0|||
149834186|NCT03125200|540523792|FG001|Overall Study|Consent Withdrawn by Subject|1|||
149834187|NCT03125200|540523793|FG002|Overall Study|Consent Withdrawn by Subject|0|||
149834188|NCT03125200|540523794|FG003|Overall Study|Consent Withdrawn by Subject|0|||
149834189|NCT03125200|540523795|FG004|Overall Study|Consent Withdrawn by Subject|1|||
149834190|NCT03125200|540523796|FG005|Overall Study|Consent Withdrawn by Subject|0|||
149834191|NCT03125200|540523797|FG006|Overall Study|Consent Withdrawn by Subject|1|||
149834192|NCT01937390|540523803|FG000|Overall Study|Death|2|||
149834193|NCT01937390|540523803|FG000|Overall Study|Lost to Follow-up|7|||
149834194|NCT01937390|540523803|FG000|Overall Study|Withdrawal by Subject|5|||
149834195|NCT01937390|540523803|FG000|Overall Study|Fail to return|21|||
149834196|NCT03544138|540523806|FG000|Overall Study|Lost to Follow-up|29|||
149834197|NCT04657770|540525464|FG000|Overall Study|Withdrawal by Subject|3|||
149834198|NCT04657770|540525464|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
149834199|NCT00746798|540525465|FG000|Overall Study|Protocol Violation|0|||
149834200|NCT00746798|540525466|FG001|Overall Study|Protocol Violation|1|||
149834201|NCT00746798|540525467|FG002|Overall Study|Protocol Violation|0|||
149834202|NCT00746798|540525468|FG003|Overall Study|Protocol Violation|0|||
149834203|NCT00746798|540525465|FG000|Overall Study|Withdrawal by Subject|0|||
149834204|NCT00746798|540525466|FG001|Overall Study|Withdrawal by Subject|1|||
149834205|NCT00746798|540525467|FG002|Overall Study|Withdrawal by Subject|1|||
149834206|NCT00746798|540525468|FG003|Overall Study|Withdrawal by Subject|0|||
149834207|NCT00746798|540525465|FG000|Overall Study|Death|0|||
149834208|NCT00746798|540525466|FG001|Overall Study|Death|0|||
149834209|NCT00746798|540525467|FG002|Overall Study|Death|2|||
149834210|NCT00746798|540525468|FG003|Overall Study|Death|0|||
149834211|NCT00746798|540525465|FG000|Overall Study|Participant unable to return for visit|1|||
149834212|NCT00746798|540525466|FG001|Overall Study|Participant unable to return for visit|0|||
149834213|NCT00746798|540525467|FG002|Overall Study|Participant unable to return for visit|0|||
149834214|NCT00746798|540525468|FG003|Overall Study|Participant unable to return for visit|0|||
149834215|NCT00633594|540525471|FG000|Overall Study|Adverse Event|0|||
149834216|NCT00633594|540525472|FG001|Overall Study|Adverse Event|4|||
149834217|NCT00633594|540525473|FG002|Overall Study|Adverse Event|7|||
149834218|NCT00633594|540525471|FG000|Overall Study|Death|0|||
149834219|NCT00633594|540525472|FG001|Overall Study|Death|1|||
149834220|NCT00633594|540525473|FG002|Overall Study|Death|2|||
149834221|NCT00633594|540525471|FG000|Overall Study|Disease Progression|0|||
149834222|NCT00633594|540525472|FG001|Overall Study|Disease Progression|0|||
149834223|NCT00633594|540525473|FG002|Overall Study|Disease Progression|1|||
149834224|NCT02028715|540525474|FG000|Overall Study|Adverse Event|2|||
149834225|NCT02028715|540525475|FG001|Overall Study|Adverse Event|2|||
149834226|NCT02028715|540525474|FG000|Overall Study|Physician Decision|1|||
149834227|NCT02028715|540525475|FG001|Overall Study|Physician Decision|0|||
149834228|NCT02028715|540525474|FG000|Overall Study|Did not complete satisfaction surveys|2|||
149834229|NCT02028715|540525475|FG001|Overall Study|Did not complete satisfaction surveys|2|||
149834230|NCT01287013|540525476|FG000|Overall Study|Non-evaluable|3|||
150171472|NCT02299336|541763538|FG000|Overall Study|Death|1|||
149834231|NCT01287013|540525477|FG001|Overall Study|Non-evaluable|5|||
149834232|NCT01287013|540525478|FG002|Overall Study|Non-evaluable|21|||
149834233|NCT01471093|540525479|FG000|Overall Study|Adverse Event|1|||
149834234|NCT01471093|540525480|FG001|Overall Study|Adverse Event|0|||
149834235|NCT01471093|540525481|FG002|Overall Study|Adverse Event|0|||
149834236|NCT01471093|540525482|FG003|Overall Study|Adverse Event|0|||
149834237|NCT01710657|540525485|FG000|Overall Study|Lost to Follow-up|2|||
149834238|NCT01710657|540525486|FG001|Overall Study|Lost to Follow-up|0|||
149834239|NCT01710657|540525487|FG002|Overall Study|Lost to Follow-up|1|||
149834240|NCT01710657|540525485|FG000|Overall Study|Protocol Violation|2|||
149834241|NCT01710657|540525486|FG001|Overall Study|Protocol Violation|2|||
149834242|NCT01710657|540525487|FG002|Overall Study|Protocol Violation|0|||
149834243|NCT01710657|540525485|FG000|Overall Study|Adverse Event|14|||
149834244|NCT01710657|540525486|FG001|Overall Study|Adverse Event|8|||
149834245|NCT01710657|540525487|FG002|Overall Study|Adverse Event|28|||
150171473|NCT02299336|541763538|FG000|Overall Study|Lost to Follow-up|1|||
150171474|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
150171475|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
150171476|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
150171477|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150171478|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150171479|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150171480|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150034332|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
150034333|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
150034334|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
150034335|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
150034336|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
150034337|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
150034338|NCT02657889|541264804|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
150034339|NCT02657889|541264805|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
150034340|NCT02657889|541264806|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
150034341|NCT02657889|541264807|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
150034342|NCT00795535|541264808|FG000|Overall Study|incomplete data and technical problems|20|||
150034343|NCT00374140|541264811|FG000|Overall Study|Lost to Follow-up|1|||
150034344|NCT00374140|541264811|FG000|Overall Study|Protocol Violation|1|||
150034345|NCT00604565|541264812|FG000|Overall Study|Study terminated|0|||
150034346|NCT00604565|541264813|FG001|Overall Study|Study terminated|3|||
150034347|NCT03341299|541264815|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
150034348|NCT03341299|541264816|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
150034349|NCT03341299|541264817|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
150034350|NCT03341299|541264818|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
150034351|NCT04609319|541264819|FG000|Overall Study|Death|64|||
150034352|NCT04609319|541264820|FG001|Overall Study|Death|49|||
150034353|NCT04609319|541264821|FG002|Overall Study|Death|1|||
150034354|NCT04609319|541264819|FG000|Overall Study|Withdrawal of consent|15|||
150034355|NCT04609319|541264820|FG001|Overall Study|Withdrawal of consent|3|||
150034356|NCT04609319|541264821|FG002|Overall Study|Withdrawal of consent|0|||
150034357|NCT04609319|541264819|FG000|Overall Study|Lost to Follow-up|20|||
150034358|NCT04609319|541264820|FG001|Overall Study|Lost to Follow-up|33|||
150034359|NCT04609319|541264821|FG002|Overall Study|Lost to Follow-up|0|||
150034360|NCT04609319|541264819|FG000|Overall Study|Alive until end of follow-up|60|||
150034361|NCT04609319|541264820|FG001|Overall Study|Alive until end of follow-up|53|||
150034362|NCT04609319|541264821|FG002|Overall Study|Alive until end of follow-up|1|||
150034363|NCT03804528|541264822|FG000|Overall Study|Time Commitment|18|||
150034364|NCT03804528|541264822|FG000|Overall Study|Health Reasons|5|||
150034365|NCT04607005|541264823|FG000|Overall Study|Adverse Event|0|||
150034366|NCT04607005|541264824|FG001|Overall Study|Adverse Event|1|||
150034367|NCT04607005|541264823|FG000|Overall Study|Lack of Efficacy|1|||
150034368|NCT04607005|541264824|FG001|Overall Study|Lack of Efficacy|6|||
150034369|NCT04607005|541264823|FG000|Overall Study|Withdrawal by Subject|4|||
150034370|NCT04607005|541264824|FG001|Overall Study|Withdrawal by Subject|9|||
150034371|NCT04607005|541264823|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
150034372|NCT04607005|541264824|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
150034373|NCT04825574|541264825|FG000|Overall Study|Commercial treatment became available|1|||
150034374|NCT04825574|541264825|FG000|Overall Study|Disease progression|1|||
150034375|NCT03518086|541264826|FG000|Overall Study|Adverse Event|23|||
150034376|NCT03518086|541264827|FG001|Overall Study|Adverse Event|15|||
150034377|NCT03518086|541264828|FG002|Overall Study|Adverse Event|3|||
150034378|NCT03518086|541264829|FG003|Overall Study|Adverse Event|2|||
150034379|NCT03518086|541264826|FG000|Overall Study|Withdrawal by Subject|8|||
150034380|NCT03518086|541264827|FG001|Overall Study|Withdrawal by Subject|5|||
150034381|NCT03518086|541264828|FG002|Overall Study|Withdrawal by Subject|1|||
150034382|NCT03518086|541264829|FG003|Overall Study|Withdrawal by Subject|0|||
150034383|NCT03518086|541264826|FG000|Overall Study|Lack of Efficacy|5|||
150034384|NCT03518086|541264827|FG001|Overall Study|Lack of Efficacy|5|||
150034385|NCT03518086|541264828|FG002|Overall Study|Lack of Efficacy|0|||
150034386|NCT03518086|541264829|FG003|Overall Study|Lack of Efficacy|2|||
150034387|NCT03518086|541264826|FG000|Overall Study|Protocol Violation|1|||
150034388|NCT03518086|541264827|FG001|Overall Study|Protocol Violation|5|||
150034389|NCT03518086|541264828|FG002|Overall Study|Protocol Violation|1|||
150034390|NCT03518086|541264829|FG003|Overall Study|Protocol Violation|3|||
150034391|NCT03518086|541264826|FG000|Overall Study|Lost to Follow-up|0|||
150034392|NCT03518086|541264827|FG001|Overall Study|Lost to Follow-up|3|||
150034393|NCT03518086|541264828|FG002|Overall Study|Lost to Follow-up|0|||
150034394|NCT03518086|541264829|FG003|Overall Study|Lost to Follow-up|0|||
150034395|NCT03518086|541264826|FG000|Overall Study|Insufficient Diary Data|0|||
150034396|NCT03518086|541264827|FG001|Overall Study|Insufficient Diary Data|2|||
150034397|NCT03518086|541264828|FG002|Overall Study|Insufficient Diary Data|0|||
150034398|NCT03518086|541264829|FG003|Overall Study|Insufficient Diary Data|0|||
150034399|NCT03518086|541264826|FG000|Overall Study|Non- compliance to Protocol|0|||
150034400|NCT03518086|541264827|FG001|Overall Study|Non- compliance to Protocol|1|||
150034401|NCT03518086|541264828|FG002|Overall Study|Non- compliance to Protocol|0|||
150034402|NCT03518086|541264829|FG003|Overall Study|Non- compliance to Protocol|0|||
150034403|NCT03518086|541264826|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
150034404|NCT03518086|541264827|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
149834246|NCT01710657|540525485|FG000|Overall Study|Withdrawal by Subject|0|||
149834247|NCT01710657|540525486|FG001|Overall Study|Withdrawal by Subject|1|||
149834248|NCT01710657|540525487|FG002|Overall Study|Withdrawal by Subject|2|||
149834249|NCT01710657|540525485|FG000|Overall Study|Lack of Efficacy|0|||
149834250|NCT01710657|540525486|FG001|Overall Study|Lack of Efficacy|1|||
149834251|NCT01710657|540525487|FG002|Overall Study|Lack of Efficacy|1|||
149834252|NCT04407806|540525489|FG000|Overall Study|Withdrawal by Subject|1|||
149834253|NCT04407806|540525490|FG001|Overall Study|Withdrawal by Subject|2|||
149834254|NCT02058498|540525491|FG000|Overall Study|Withdrawal by Subject|4|||
149834255|NCT05327491|540525492|FG000|Periods 1 & 2|Miscellaneous|0|||
149834256|NCT05327491|540525493|FG001|Periods 1 & 2|Miscellaneous|1|||
149834257|NCT05327491|540525494|FG002|Periods 1 & 2|Miscellaneous|0|||
149834258|NCT05327491|540525495|FG003|Periods 1 & 2|Miscellaneous|0|||
149834259|NCT05327491|540525492|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
149834260|NCT05327491|540525493|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
149834261|NCT05327491|540525494|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
149834262|NCT05327491|540525495|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
149834263|NCT01035060|540525501|FG000|Overall Study|Lost to Follow-up|0|||
149834264|NCT01035060|540525502|FG001|Overall Study|Lost to Follow-up|7|||
149834265|NCT01035060|540525501|FG000|Overall Study|Did not quality after 2nd screening|14|||
149834266|NCT01035060|540525502|FG001|Overall Study|Did not quality after 2nd screening|1|||
149834267|NCT01035060|540525501|FG000|Overall Study|Withdrawal by Subject|8|||
149834268|NCT01035060|540525502|FG001|Overall Study|Withdrawal by Subject|6|||
149834269|NCT01035060|540525501|FG000|Overall Study|Physician Decision|2|||
149834270|NCT01035060|540525502|FG001|Overall Study|Physician Decision|0|||
149834271|NCT00064753|540525510|FG000|Overall Study|Death|251|||
149834272|NCT00064753|540525511|FG001|Overall Study|Death|242|||
149834273|NCT00064753|540525510|FG000|Overall Study|Withdrawal by Subject|198|||
149834274|NCT00064753|540525511|FG001|Overall Study|Withdrawal by Subject|171|||
149834275|NCT00064753|540525510|FG000|Overall Study|Lost to Follow-up|225|||
149834276|NCT00064753|540525511|FG001|Overall Study|Lost to Follow-up|235|||
149834277|NCT02193880|540525512|FG000|Overall Study|patients did not collect enough HPC|3|||
149834278|NCT02202850|540525513|FG000|Overall Study|Other|2|||
149834279|NCT02202850|540525514|FG001|Overall Study|Other|2|||
149834280|NCT02202850|540525513|FG000|Overall Study|Enbrel treatment discontinued|15|||
149834281|NCT02202850|540525514|FG001|Overall Study|Enbrel treatment discontinued|3|||
149834282|NCT02202850|540525513|FG000|Overall Study|Lost to Follow-up|7|||
149834283|NCT02202850|540525514|FG001|Overall Study|Lost to Follow-up|1|||
149834284|NCT00615069|540525515|FG000|Overall Study|Death|10|||
149834285|NCT00615069|540525515|FG000|Overall Study|Physician Decision|2|||
149834286|NCT00615069|540525515|FG000|Overall Study|Withdrawal by Subject|4|||
149834287|NCT02996682|540525516|FG000|Overall Study|Death|0|||
149834288|NCT02996682|540525517|FG001|Overall Study|Death|3|||
149834289|NCT01981720|540525518|FG000|Overall Study|Adverse Event|1|||
149834290|NCT01981720|540525518|FG000|Overall Study|Withdrawal by Subject|3|||
149834291|NCT01981720|540525518|FG000|Overall Study|Pregnancy|1|||
149834292|NCT03522675|540525519|FG000|Overall Study|Screen fail|1|||
149834293|NCT03522675|540525519|FG000|Overall Study|Non-reactive to histamine|1|||
149834294|NCT00707161|540525520|FG000|Overall Study|Physician Decision|6|||
149834295|NCT02674477|540525521|FG000|Overall Study|Protocol Violation|8|||
149834296|NCT02674477|540525522|FG001|Overall Study|Protocol Violation|2|||
149834297|NCT02511782|540525523|FG000|Overall Study|Withdrawal by Subject|1|||
149834298|NCT02511782|540525524|FG001|Overall Study|Withdrawal by Subject|0|||
149834299|NCT02511782|540525525|FG002|Overall Study|Withdrawal by Subject|0|||
149834300|NCT00834756|540525526|FG000|First Intervention|Adverse Event|1|||
149948942|NCT04063163|540944883|FG001|Overall Study|Withdrawal by Subject|10|||
149834301|NCT00834756|540525527|FG001|First Intervention|Adverse Event|0|||
149834302|NCT00834756|540525526|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
149834303|NCT00834756|540525527|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
149834304|NCT01173692|540525528|FG000|Overall Study|Adverse Event|1|||
149834305|NCT01173692|540525529|FG001|Overall Study|Adverse Event|2|||
149834306|NCT01173692|540525528|FG000|Overall Study|Withdrawal by Subject|1|||
149834307|NCT01173692|540525529|FG001|Overall Study|Withdrawal by Subject|3|||
149834308|NCT01472341|540525530|FG000|Overall Study|Started insulin therapy|55|||
149834309|NCT01472341|540525530|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
149834310|NCT01472341|540525530|FG000|Overall Study|Withdrawal by Subject|39|||
149834311|NCT01472341|540525530|FG000|Overall Study|Lost to Follow-up|52|||
149834312|NCT01472341|540525530|FG000|Overall Study|Laboratory parameters unavailable|25|||
149834313|NCT01472341|540525530|FG000|Overall Study|Death|9|||
149834314|NCT00579670|540525531|FG000|Overall Study|Death|1|||
149834315|NCT00579670|540525532|FG001|Overall Study|Death|0|||
149834316|NCT00579670|540525533|FG002|Overall Study|Death|0|||
149834317|NCT00579670|540525534|FG003|Overall Study|Death|0|||
149834318|NCT00579670|540525535|FG004|Overall Study|Death|0|||
149834319|NCT00579670|540525531|FG000|Overall Study|Adverse Event|1|||
149834320|NCT00579670|540525532|FG001|Overall Study|Adverse Event|0|||
150280454|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Death|0|||
150280455|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Death|0|||
150280456|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
149834321|NCT00579670|540525533|FG002|Overall Study|Adverse Event|1|||
149834322|NCT00579670|540525534|FG003|Overall Study|Adverse Event|2|||
149834323|NCT00579670|540525535|FG004|Overall Study|Adverse Event|0|||
150280457|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
150280458|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
150280459|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
150280460|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
150280461|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
150280462|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
150280463|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
150280464|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
150280465|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
150280466|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
150280467|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
150280468|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
150280469|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
150280470|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
150280471|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
150280472|NCT01940471|542163504|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
150280473|NCT01940471|542163505|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
150280474|NCT01940471|542163506|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
150280475|NCT01940471|542163507|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
150280476|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
150280477|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
150280478|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
150280479|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
150280480|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
150280481|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
150280482|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
150280483|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
150280484|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
150280485|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
150280486|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
150280487|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
150280488|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
150280489|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
150280490|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
150280491|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
150280492|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
150280493|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
150280494|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
150280495|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
150280496|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
150280497|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
150280498|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
150280499|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
150280500|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
150280501|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
150280502|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
150280503|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
150280504|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
150280505|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
150280506|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
150280507|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
150280508|NCT01940471|542163504|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
150280509|NCT01940471|542163505|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
150280510|NCT01940471|542163506|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
149834324|NCT00579670|540525531|FG000|Overall Study|Lack of Efficacy|0|||
149834325|NCT00579670|540525532|FG001|Overall Study|Lack of Efficacy|0|||
149834326|NCT00579670|540525533|FG002|Overall Study|Lack of Efficacy|1|||
149834327|NCT00579670|540525534|FG003|Overall Study|Lack of Efficacy|14|||
149834328|NCT00579670|540525535|FG004|Overall Study|Lack of Efficacy|0|||
149834329|NCT00579670|540525531|FG000|Overall Study|Lost to Follow-up|0|||
149834330|NCT00579670|540525532|FG001|Overall Study|Lost to Follow-up|1|||
149834331|NCT00579670|540525533|FG002|Overall Study|Lost to Follow-up|0|||
149834332|NCT00579670|540525534|FG003|Overall Study|Lost to Follow-up|4|||
149834333|NCT00579670|540525535|FG004|Overall Study|Lost to Follow-up|0|||
149834334|NCT00579670|540525531|FG000|Overall Study|Other|0|||
149834335|NCT00579670|540525532|FG001|Overall Study|Other|0|||
149834336|NCT00579670|540525533|FG002|Overall Study|Other|1|||
149834337|NCT00579670|540525534|FG003|Overall Study|Other|2|||
149834338|NCT00579670|540525535|FG004|Overall Study|Other|0|||
149834339|NCT00579670|540525531|FG000|Overall Study|Withdrawal by Subject|0|||
149834340|NCT00579670|540525532|FG001|Overall Study|Withdrawal by Subject|0|||
149834341|NCT00579670|540525533|FG002|Overall Study|Withdrawal by Subject|1|||
149834342|NCT00579670|540525534|FG003|Overall Study|Withdrawal by Subject|0|||
149834343|NCT00579670|540525535|FG004|Overall Study|Withdrawal by Subject|0|||
149834344|NCT00296647|540525539|FG000|Overall Study|Death|4|||
149834345|NCT00296647|540525540|FG001|Overall Study|Death|1|||
149834346|NCT00296647|540525541|FG002|Overall Study|Death|2|||
149834347|NCT00296647|540525542|FG003|Overall Study|Death|1|||
149834348|NCT00296647|540525543|FG004|Overall Study|Death|1|||
149834349|NCT00296647|540525539|FG000|Overall Study|Withdrawal by Subject|28|||
149834350|NCT00296647|540525540|FG001|Overall Study|Withdrawal by Subject|27|||
149834351|NCT00296647|540525541|FG002|Overall Study|Withdrawal by Subject|32|||
149834352|NCT00296647|540525542|FG003|Overall Study|Withdrawal by Subject|16|||
149834353|NCT00296647|540525543|FG004|Overall Study|Withdrawal by Subject|19|||
149834354|NCT00986245|540525544|FG000|First Intervention|Poor compliance|8|||
149834355|NCT00986245|540525545|FG001|First Intervention|Poor compliance|4|||
149834356|NCT00986245|540525544|FG000|First Intervention|Lack of Efficacy|1|||
149834357|NCT00986245|540525545|FG001|First Intervention|Lack of Efficacy|2|||
149834358|NCT00986245|540525544|FG000|First Intervention|Withdrawal by Subject|0|||
149834359|NCT00986245|540525545|FG001|First Intervention|Withdrawal by Subject|1|||
149834360|NCT00986245|540525544|FG000|First Intervention|Protocol Violation|0|||
149834361|NCT00986245|540525545|FG001|First Intervention|Protocol Violation|1|||
149834362|NCT00986245|540525544|FG000|First Intervention|Out of indication|1|||
149834363|NCT00986245|540525545|FG001|First Intervention|Out of indication|0|||
149834364|NCT00986245|540525544|FG000|Second Intervention|Poor compliance|1|||
149834365|NCT00986245|540525545|FG001|Second Intervention|Poor compliance|0|||
149834366|NCT00986245|540525544|FG000|Second Intervention|Lost to Follow-up|1|||
149834367|NCT00986245|540525545|FG001|Second Intervention|Lost to Follow-up|0|||
149834368|NCT00986245|540525544|FG000|Second Intervention|Protocol Violation|0|||
149834369|NCT00986245|540525545|FG001|Second Intervention|Protocol Violation|1|||
149834370|NCT05093205|540525547|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
150280511|NCT01940471|542163507|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
150280512|NCT02973087|542163508|FG000|Overall Study|Withdrawal by Subject|2|||
150280513|NCT02973087|542163509|FG001|Overall Study|Withdrawal by Subject|1|||
150280514|NCT02973087|542163508|FG000|Overall Study|Adverse Event|1|||
150280515|NCT02973087|542163509|FG001|Overall Study|Adverse Event|0|||
150280516|NCT02973087|542163508|FG000|Overall Study|other|1|||
150280517|NCT02973087|542163509|FG001|Overall Study|other|1|||
150280518|NCT03710486|542163512|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
150280519|NCT03710486|542163513|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
150280520|NCT03710486|542163512|FG000|Overall Study|Missing|0|||
150280521|NCT03710486|542163513|FG001|Overall Study|Missing|2|||
150280522|NCT01279850|542163518|FG000|Overall Study|Protocol Violation|50|||
150280523|NCT01279850|542163518|FG000|Overall Study|No Drug Administration Information|7|||
150280524|NCT01279850|542163518|FG000|Overall Study|No Visit After Treatment|34|||
150280525|NCT01131520|542163519|FG000|Overall Study|Computer problem|1|||
150280526|NCT01131520|542163520|FG001|Overall Study|Computer problem|0|||
150280527|NCT01131520|542163519|FG000|Overall Study|Counselor not available|0|||
149834371|NCT05093205|540525548|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
149834372|NCT05093205|540525549|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
149834373|NCT05093205|540525550|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
149834374|NCT05093205|540525551|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
149834375|NCT05093205|540525552|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
149834376|NCT05093205|540525553|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
149834377|NCT05093205|540525554|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
149834378|NCT05093205|540525555|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
149834379|NCT05093205|540525556|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
149834380|NCT05093205|540525557|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
149834381|NCT05093205|540525558|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
150280528|NCT01131520|542163520|FG001|Overall Study|Counselor not available|3|||
150280529|NCT01131520|542163519|FG000|Overall Study|Subject changed history after enrollment|0|||
150280530|NCT01131520|542163520|FG001|Overall Study|Subject changed history after enrollment|1|||
150280531|NCT01147744|542163521|FG000|Overall Study|Protocol Violation|1|||
150280532|NCT01147744|542163522|FG001|Overall Study|Protocol Violation|0|||
150280533|NCT01147744|542163523|FG002|Overall Study|Protocol Violation|1|||
150280534|NCT01147744|542163524|FG003|Overall Study|Protocol Violation|0|||
150280535|NCT01147744|542163525|FG004|Overall Study|Protocol Violation|1|||
150280536|NCT01147744|542163526|FG005|Overall Study|Protocol Violation|3|||
150280537|NCT01147744|542163527|FG006|Overall Study|Protocol Violation|1|||
150280538|NCT01147744|542163521|FG000|Overall Study|Physician Decision|0|||
150280539|NCT01147744|542163522|FG001|Overall Study|Physician Decision|1|||
150280540|NCT01147744|542163523|FG002|Overall Study|Physician Decision|1|||
150280541|NCT01147744|542163524|FG003|Overall Study|Physician Decision|0|||
150280542|NCT01147744|542163525|FG004|Overall Study|Physician Decision|0|||
150280543|NCT01147744|542163526|FG005|Overall Study|Physician Decision|0|||
150280544|NCT01147744|542163527|FG006|Overall Study|Physician Decision|1|||
150280545|NCT01147744|542163521|FG000|Overall Study|Lack of Efficacy|11|||
150280546|NCT01147744|542163522|FG001|Overall Study|Lack of Efficacy|11|||
150280547|NCT01147744|542163523|FG002|Overall Study|Lack of Efficacy|9|||
150280548|NCT01147744|542163524|FG003|Overall Study|Lack of Efficacy|11|||
150280549|NCT01147744|542163525|FG004|Overall Study|Lack of Efficacy|13|||
150280550|NCT01147744|542163526|FG005|Overall Study|Lack of Efficacy|8|||
150280551|NCT01147744|542163527|FG006|Overall Study|Lack of Efficacy|7|||
150280552|NCT01147744|542163521|FG000|Overall Study|Adverse Event|1|||
150280553|NCT01147744|542163522|FG001|Overall Study|Adverse Event|2|||
150280554|NCT01147744|542163523|FG002|Overall Study|Adverse Event|3|||
150280555|NCT01147744|542163524|FG003|Overall Study|Adverse Event|0|||
150280556|NCT01147744|542163525|FG004|Overall Study|Adverse Event|2|||
150280557|NCT01147744|542163526|FG005|Overall Study|Adverse Event|1|||
150280558|NCT01147744|542163527|FG006|Overall Study|Adverse Event|2|||
150280559|NCT01147744|542163521|FG000|Overall Study|Withdrawal by Subject|8|||
150280560|NCT01147744|542163522|FG001|Overall Study|Withdrawal by Subject|4|||
150280561|NCT01147744|542163523|FG002|Overall Study|Withdrawal by Subject|2|||
150280562|NCT01147744|542163524|FG003|Overall Study|Withdrawal by Subject|2|||
150280563|NCT01147744|542163525|FG004|Overall Study|Withdrawal by Subject|2|||
150280564|NCT01147744|542163526|FG005|Overall Study|Withdrawal by Subject|5|||
150280565|NCT01147744|542163527|FG006|Overall Study|Withdrawal by Subject|2|||
150280566|NCT01147744|542163521|FG000|Overall Study|Lost to Follow-up|0|||
150280567|NCT01147744|542163522|FG001|Overall Study|Lost to Follow-up|1|||
150280568|NCT01147744|542163523|FG002|Overall Study|Lost to Follow-up|0|||
150280569|NCT01147744|542163524|FG003|Overall Study|Lost to Follow-up|0|||
150280570|NCT01147744|542163525|FG004|Overall Study|Lost to Follow-up|0|||
150280571|NCT01147744|542163526|FG005|Overall Study|Lost to Follow-up|0|||
150280572|NCT01147744|542163527|FG006|Overall Study|Lost to Follow-up|0|||
150280573|NCT01147744|542163521|FG000|Overall Study|Sponsor decision to amend protocol|7|||
150280574|NCT01147744|542163522|FG001|Overall Study|Sponsor decision to amend protocol|4|||
150280575|NCT01147744|542163523|FG002|Overall Study|Sponsor decision to amend protocol|2|||
150280576|NCT01147744|542163524|FG003|Overall Study|Sponsor decision to amend protocol|5|||
150280577|NCT01147744|542163525|FG004|Overall Study|Sponsor decision to amend protocol|7|||
150280578|NCT01147744|542163526|FG005|Overall Study|Sponsor decision to amend protocol|2|||
150280579|NCT01147744|542163527|FG006|Overall Study|Sponsor decision to amend protocol|6|||
150280580|NCT01147744|542163521|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
150280581|NCT01147744|542163522|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150280582|NCT01147744|542163523|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150280583|NCT01147744|542163524|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150280584|NCT01147744|542163525|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150280585|NCT01147744|542163526|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
150280586|NCT01147744|542163527|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150280587|NCT01436084|542163535|FG000|Overall Study|Disease Progression|2|||
150280588|NCT01436084|542163535|FG000|Overall Study|Withdrawal by Subject|1|||
150280589|NCT01436084|542163535|FG000|Overall Study|Early Closure of Study|1|||
150280590|NCT01744665|542163537|FG000|Monitoring Phase|Adverse Event|4|||
150280591|NCT01744665|542163537|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
150280592|NCT01744665|542163537|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
150280593|NCT01744665|542163537|FG000|Monitoring Phase|Withdrawal by Subject|5|||
150280594|NCT01744665|542163537|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
150280595|NCT01744665|542163537|FG000|Consolidation Phase|Adverse Event|2|||
150280596|NCT01744665|542163537|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
150280597|NCT01744665|542163537|FG000|Consolidation Phase|Withdrawal by Subject|4|||
150280598|NCT01744665|542163537|FG000|Consolidation Phase|Administrative problems|9|||
150280599|NCT01744665|542163537|FG000|Re-initiation Phase|Administrative problems|10|||
150280600|NCT01744665|542163537|FG000|Re-initiation Phase|Adverse Event|1|||
150280601|NCT01744665|542163537|FG000|Re-initiation Phase|No longer required treatment|1|||
150280602|NCT01744665|542163537|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
150280603|NCT03803059|542163538|FG000|Overall Study|Protocol Violation|2|||
150280604|NCT03803059|542163538|FG000|Overall Study|Lost to Follow-up|1|||
150280605|NCT02090413|542163543|FG000|Overall Study|Adverse Event|11|||
150280606|NCT02090413|542163544|FG001|Overall Study|Adverse Event|15|||
150280607|NCT02090413|542163545|FG002|Overall Study|Adverse Event|20|||
149834382|NCT05093205|540525559|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
149834383|NCT05093205|540525547|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834384|NCT05093205|540525548|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834385|NCT05093205|540525549|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
149834386|NCT05093205|540525550|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834387|NCT05093205|540525551|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834388|NCT05093205|540525552|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834389|NCT05093205|540525553|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834390|NCT05093205|540525554|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834391|NCT05093205|540525555|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834392|NCT05093205|540525556|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834393|NCT05093205|540525557|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834394|NCT05093205|540525558|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834395|NCT05093205|540525559|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
149834396|NCT05093205|540525547|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
149834397|NCT05093205|540525548|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
149834398|NCT05093205|540525549|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
149834399|NCT05093205|540525550|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
149834400|NCT05093205|540525551|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
149834401|NCT05093205|540525552|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
149834402|NCT05093205|540525553|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
149834403|NCT05093205|540525554|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
149834404|NCT05093205|540525555|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
149834405|NCT05093205|540525556|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
149834406|NCT05093205|540525557|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
149834407|NCT05093205|540525558|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
150280608|NCT02090413|542163543|FG000|Overall Study|Flushing event|2|||
150280609|NCT02090413|542163544|FG001|Overall Study|Flushing event|0|||
150280610|NCT02090413|542163545|FG002|Overall Study|Flushing event|1|||
150280611|NCT02090413|542163543|FG000|Overall Study|Withdrawal by Subject|2|||
150280612|NCT02090413|542163544|FG001|Overall Study|Withdrawal by Subject|2|||
150280613|NCT02090413|542163545|FG002|Overall Study|Withdrawal by Subject|2|||
150280614|NCT02090413|542163543|FG000|Overall Study|Investigator Decision|1|||
150280615|NCT02090413|542163544|FG001|Overall Study|Investigator Decision|1|||
150280616|NCT02090413|542163545|FG002|Overall Study|Investigator Decision|0|||
150280617|NCT02090413|542163543|FG000|Overall Study|Other|2|||
150280618|NCT02090413|542163544|FG001|Overall Study|Other|1|||
150280619|NCT02090413|542163545|FG002|Overall Study|Other|0|||
150280620|NCT02090413|542163543|FG000|Overall Study|Lost to Follow-up|1|||
150280621|NCT02090413|542163544|FG001|Overall Study|Lost to Follow-up|1|||
150280622|NCT02090413|542163545|FG002|Overall Study|Lost to Follow-up|0|||
150280623|NCT01045798|542163546|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
150280624|NCT01045798|542163547|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
150280625|NCT01045798|542163546|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
150280626|NCT01045798|542163547|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
150280627|NCT01045798|542163546|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
150280628|NCT01045798|542163547|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
150280629|NCT01045798|542163546|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
150280630|NCT01045798|542163547|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
150280631|NCT05419128|542163548|FG000|Overall Study|Withdrawal by Subject|1|||
150280632|NCT05419128|542163549|FG001|Overall Study|Withdrawal by Subject|1|||
150280633|NCT05419128|542163550|FG002|Overall Study|Withdrawal by Subject|0|||
150280634|NCT05419128|542163551|FG003|Overall Study|Withdrawal by Subject|1|||
150280635|NCT05419128|542163552|FG004|Overall Study|Withdrawal by Subject|1|||
150280636|NCT05419128|542163553|FG005|Overall Study|Withdrawal by Subject|0|||
150280637|NCT05419128|542163548|FG000|Overall Study|Lost to Follow-up|0|||
150280638|NCT05419128|542163549|FG001|Overall Study|Lost to Follow-up|0|||
150280639|NCT05419128|542163550|FG002|Overall Study|Lost to Follow-up|1|||
149834408|NCT05093205|540525559|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
149834409|NCT05093205|540525547|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
149949021|NCT00984399|540944914|FG000|Overall Study|Adverse Event|0|||
149949022|NCT00984399|540944915|FG001|Overall Study|Adverse Event|1|||
149834410|NCT05093205|540525548|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
149834411|NCT05093205|540525549|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
149834412|NCT05093205|540525550|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
149834413|NCT05093205|540525551|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
149949023|NCT00984399|540944914|FG000|Overall Study|Physician Decision|1|||
149949024|NCT00984399|540944915|FG001|Overall Study|Physician Decision|0|||
150280640|NCT05419128|542163551|FG003|Overall Study|Lost to Follow-up|0|||
150280641|NCT05419128|542163552|FG004|Overall Study|Lost to Follow-up|0|||
150280642|NCT05419128|542163553|FG005|Overall Study|Lost to Follow-up|1|||
150280643|NCT05248295|542163554|FG000|Overall Study|found ineligible|4|||
150280644|NCT05248295|542163555|FG001|Overall Study|found ineligible|1|||
150034405|NCT03518086|541264828|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
150034406|NCT03518086|541264829|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
150034407|NCT03518086|541264826|FG000|Overall Study|Site Terminated by Sponsor|0|||
150034408|NCT03518086|541264827|FG001|Overall Study|Site Terminated by Sponsor|1|||
150034409|NCT03518086|541264828|FG002|Overall Study|Site Terminated by Sponsor|0|||
150034410|NCT03518086|541264829|FG003|Overall Study|Site Terminated by Sponsor|0|||
150034411|NCT03518086|541264826|FG000|Overall Study|Pregnancy|0|||
150034412|NCT03518086|541264827|FG001|Overall Study|Pregnancy|0|||
150034413|NCT03518086|541264828|FG002|Overall Study|Pregnancy|0|||
150034414|NCT03518086|541264829|FG003|Overall Study|Pregnancy|2|||
150034415|NCT00668148|541264830|FG000|Overall Study|Adverse Event|5|||
150034416|NCT00668148|541264830|FG000|Overall Study|Subject Non-compliance|1|||
150034417|NCT00668148|541264830|FG000|Overall Study|Progressive Disease Before Treatment|2|||
150034418|NCT00668148|541264830|FG000|Overall Study|Withdrawal of Consent|2|||
150034419|NCT02702492|541264831|FG000|Overall Study|Disease progression|3|||
150034420|NCT02702492|541264832|FG001|Overall Study|Disease progression|3|||
150034421|NCT02702492|541264833|FG002|Overall Study|Disease progression|2|||
150034422|NCT02702492|541264834|FG003|Overall Study|Disease progression|4|||
150034423|NCT02702492|541264835|FG004|Overall Study|Disease progression|4|||
150034424|NCT02702492|541264836|FG005|Overall Study|Disease progression|1|||
150034425|NCT02702492|541264837|FG006|Overall Study|Disease progression|2|||
150034426|NCT02702492|541264838|FG007|Overall Study|Disease progression|8|||
150034427|NCT02702492|541264839|FG008|Overall Study|Disease progression|5|||
150034428|NCT02702492|541264840|FG009|Overall Study|Disease progression|1|||
150034429|NCT02702492|541264841|FG010|Overall Study|Disease progression|0|||
150034430|NCT02702492|541264842|FG011|Overall Study|Disease progression|3|||
150034431|NCT02702492|541264843|FG012|Overall Study|Disease progression|2|||
150034432|NCT02702492|541264831|FG000|Overall Study|Clinical progression|0|||
150034433|NCT02702492|541264832|FG001|Overall Study|Clinical progression|0|||
150034434|NCT02702492|541264833|FG002|Overall Study|Clinical progression|2|||
150034435|NCT02702492|541264834|FG003|Overall Study|Clinical progression|1|||
150034436|NCT02702492|541264835|FG004|Overall Study|Clinical progression|0|||
150034437|NCT02702492|541264836|FG005|Overall Study|Clinical progression|2|||
150034438|NCT02702492|541264837|FG006|Overall Study|Clinical progression|1|||
150034439|NCT02702492|541264838|FG007|Overall Study|Clinical progression|4|||
150034440|NCT02702492|541264839|FG008|Overall Study|Clinical progression|0|||
150034441|NCT02702492|541264840|FG009|Overall Study|Clinical progression|0|||
150034442|NCT02702492|541264841|FG010|Overall Study|Clinical progression|1|||
150034443|NCT02702492|541264842|FG011|Overall Study|Clinical progression|2|||
150034444|NCT02702492|541264843|FG012|Overall Study|Clinical progression|0|||
150034445|NCT02702492|541264831|FG000|Overall Study|Adverse Event|0|||
150034446|NCT02702492|541264832|FG001|Overall Study|Adverse Event|0|||
150034447|NCT02702492|541264833|FG002|Overall Study|Adverse Event|1|||
150034448|NCT02702492|541264834|FG003|Overall Study|Adverse Event|2|||
150034449|NCT02702492|541264835|FG004|Overall Study|Adverse Event|1|||
150034450|NCT02702492|541264836|FG005|Overall Study|Adverse Event|0|||
150034451|NCT02702492|541264837|FG006|Overall Study|Adverse Event|1|||
150034452|NCT02702492|541264838|FG007|Overall Study|Adverse Event|0|||
150034453|NCT02702492|541264839|FG008|Overall Study|Adverse Event|2|||
150034454|NCT02702492|541264840|FG009|Overall Study|Adverse Event|0|||
150034455|NCT02702492|541264841|FG010|Overall Study|Adverse Event|0|||
150034456|NCT02702492|541264842|FG011|Overall Study|Adverse Event|0|||
150034457|NCT02702492|541264843|FG012|Overall Study|Adverse Event|1|||
150034458|NCT02702492|541264831|FG000|Overall Study|Other|0|||
150034459|NCT02702492|541264832|FG001|Overall Study|Other|0|||
150034460|NCT02702492|541264833|FG002|Overall Study|Other|0|||
150034461|NCT02702492|541264834|FG003|Overall Study|Other|0|||
150034462|NCT02702492|541264835|FG004|Overall Study|Other|0|||
150034463|NCT02702492|541264836|FG005|Overall Study|Other|0|||
150034464|NCT02702492|541264837|FG006|Overall Study|Other|0|||
150034465|NCT02702492|541264838|FG007|Overall Study|Other|0|||
150034466|NCT02702492|541264839|FG008|Overall Study|Other|0|||
150034467|NCT02702492|541264840|FG009|Overall Study|Other|0|||
150034468|NCT02702492|541264841|FG010|Overall Study|Other|0|||
150034469|NCT02702492|541264842|FG011|Overall Study|Other|0|||
150034470|NCT02702492|541264843|FG012|Overall Study|Other|1|||
150034471|NCT04944992|541266423|FG000|Overall Study|Lost to Follow-up|1|||
150034472|NCT04944992|541266424|FG001|Overall Study|Lost to Follow-up|1|||
150034473|NCT04944992|541266423|FG000|Overall Study|Physician Decision|1|||
150034474|NCT04944992|541266424|FG001|Overall Study|Physician Decision|0|||
150034475|NCT04944992|541266423|FG000|Overall Study|Withdrawal by Subject|6|||
150171481|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150171482|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150171483|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
150171484|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
150171485|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
150171486|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150171487|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150280645|NCT05248295|542163554|FG000|Overall Study|Withdrawal by Subject|0|||
150280646|NCT05248295|542163555|FG001|Overall Study|Withdrawal by Subject|1|||
150280647|NCT05248295|542163554|FG000|Overall Study|Data loss: audio recording error|1|||
150280648|NCT05248295|542163555|FG001|Overall Study|Data loss: audio recording error|1|||
150280649|NCT04066491|542163556|FG000|Overall Study|Randomized, not treated|0|||
150280650|NCT04066491|542163557|FG001|Overall Study|Randomized, not treated|0|||
150280651|NCT04066491|542163558|FG002|Overall Study|Randomized, not treated|2|||
149834414|NCT05093205|540525552|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
149834415|NCT05093205|540525553|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
149834416|NCT05093205|540525554|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
149834417|NCT05093205|540525555|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
149834418|NCT05093205|540525556|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
149834419|NCT05093205|540525557|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
149834420|NCT05093205|540525558|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
149834421|NCT05093205|540525559|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
149834422|NCT05093205|540525547|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
149834423|NCT05093205|540525548|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
149834424|NCT05093205|540525549|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
149834425|NCT05093205|540525550|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
149949025|NCT00984399|540944914|FG000|Overall Study|Withdrawal by Subject|1|||
149949026|NCT00984399|540944915|FG001|Overall Study|Withdrawal by Subject|1|||
149949027|NCT00984399|540944914|FG000|Overall Study|Protocol Violation|0|||
149949028|NCT00984399|540944915|FG001|Overall Study|Protocol Violation|1|||
149949029|NCT00984399|540944914|FG000|Overall Study|Pts did not start treatment|2|||
149949030|NCT00984399|540944915|FG001|Overall Study|Pts did not start treatment|2|||
149949031|NCT01723774|540944917|FG000|Neoadjuvant|Ki67 > 10%|4|||
149949032|NCT01723774|540944918|FG001|Neoadjuvant|Ki67 > 10%|0|||
149949033|NCT01723774|540944919|FG002|Neoadjuvant|Ki67 > 10%|10|||
149949034|NCT01723774|540944920|FG003|Neoadjuvant|Ki67 > 10%|0|||
149949035|NCT01723774|540944917|FG000|Neoadjuvant|Withdrawal by Subject|3|||
149949036|NCT01723774|540944918|FG001|Neoadjuvant|Withdrawal by Subject|1|||
149949037|NCT01723774|540944919|FG002|Neoadjuvant|Withdrawal by Subject|0|||
149949038|NCT01723774|540944920|FG003|Neoadjuvant|Withdrawal by Subject|0|||
149949039|NCT01723774|540944917|FG000|Neoadjuvant|Disease progression|0|||
149949040|NCT01723774|540944918|FG001|Neoadjuvant|Disease progression|1|||
149949041|NCT01723774|540944919|FG002|Neoadjuvant|Disease progression|1|||
149949042|NCT01723774|540944920|FG003|Neoadjuvant|Disease progression|0|||
149949043|NCT01723774|540944917|FG000|Neoadjuvant|Adverse Event|0|||
149949044|NCT01723774|540944918|FG001|Neoadjuvant|Adverse Event|1|||
149949045|NCT01723774|540944919|FG002|Neoadjuvant|Adverse Event|2|||
149949046|NCT01723774|540944920|FG003|Neoadjuvant|Adverse Event|0|||
149949047|NCT01723774|540944917|FG000|Neoadjuvant|High estradiol|0|||
149949048|NCT01723774|540944918|FG001|Neoadjuvant|High estradiol|1|||
149949049|NCT01723774|540944919|FG002|Neoadjuvant|High estradiol|0|||
149949050|NCT01723774|540944920|FG003|Neoadjuvant|High estradiol|0|||
149949053|NCT02964182|540944922|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949054|NCT02964182|540944923|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
149949055|NCT02964182|540944924|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949056|NCT02964182|540944925|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949057|NCT02964182|540944926|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949058|NCT02964182|540944927|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
149949059|NCT02964182|540944928|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949060|NCT02964182|540944929|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149949061|NCT02964182|540944922|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949062|NCT02964182|540944923|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949063|NCT02964182|540944924|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949064|NCT02964182|540944925|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949065|NCT02964182|540944926|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949066|NCT02964182|540944927|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
149949067|NCT02964182|540944928|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949068|NCT02964182|540944929|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149949069|NCT02964182|540944922|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149834426|NCT05093205|540525551|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
149834427|NCT05093205|540525552|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
149834428|NCT05093205|540525553|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
149949070|NCT02964182|540944923|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
149949071|NCT02964182|540944924|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149949072|NCT02964182|540944925|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149949073|NCT02964182|540944926|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149949074|NCT02964182|540944927|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
149949075|NCT02964182|540944928|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149949076|NCT02964182|540944929|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149949077|NCT02964182|540944922|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149949078|NCT02964182|540944923|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149949079|NCT02964182|540944924|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
150280652|NCT04490018|542163559|FG000|Overall Study|Protocol Violation|0|||
150280653|NCT04490018|542163560|FG001|Overall Study|Protocol Violation|2|||
150280654|NCT04490018|542163561|FG002|Overall Study|Protocol Violation|1|||
150280655|NCT04490018|542163559|FG000|Overall Study|Lost to Follow-up|2|||
150280656|NCT04490018|542163560|FG001|Overall Study|Lost to Follow-up|2|||
150280657|NCT04490018|542163561|FG002|Overall Study|Lost to Follow-up|0|||
150280658|NCT04490018|542163559|FG000|Overall Study|Withdrawal by Subject|2|||
150280659|NCT04490018|542163560|FG001|Overall Study|Withdrawal by Subject|1|||
150280660|NCT04490018|542163561|FG002|Overall Study|Withdrawal by Subject|0|||
150280661|NCT04490018|542163559|FG000|Overall Study|Withdrawal by parent/guardian|2|||
150280662|NCT04490018|542163560|FG001|Overall Study|Withdrawal by parent/guardian|3|||
150280663|NCT04490018|542163561|FG002|Overall Study|Withdrawal by parent/guardian|0|||
150280664|NCT02321930|542163564|FG000|Overall Study|Lost to Follow-up|1|||
150280665|NCT01293968|542163565|FG000|Overall Study|non-cooperation|3|||
150280666|NCT01293968|542163566|FG001|Overall Study|non-cooperation|3|||
150280667|NCT01133379|542163567|FG000|Overall Study|Withdrawal by Subject|0|||
150280668|NCT01133379|542163568|FG001|Overall Study|Withdrawal by Subject|1|||
150280669|NCT01133379|542163569|FG002|Overall Study|Withdrawal by Subject|1|||
150280670|NCT01133379|542163567|FG000|Overall Study|Lost to Follow-up|1|||
150280671|NCT01133379|542163568|FG001|Overall Study|Lost to Follow-up|1|||
150280672|NCT01133379|542163569|FG002|Overall Study|Lost to Follow-up|1|||
150280673|NCT00121108|542163572|FG000|Overall Study|Lost to Follow-up|10|||
150280674|NCT00121108|542163573|FG001|Overall Study|Lost to Follow-up|22|||
150280675|NCT00121108|542163572|FG000|Overall Study|Withdrawal by Subject|106|||
150280676|NCT00121108|542163573|FG001|Overall Study|Withdrawal by Subject|195|||
149949080|NCT02964182|540944925|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
150280677|NCT00121108|542163572|FG000|Overall Study|Death|5|||
150280678|NCT00121108|542163573|FG001|Overall Study|Death|8|||
150280679|NCT03080883|542163574|FG000|Overall Study|Withdrawal by Subject|11|||
150280680|NCT03080883|542163575|FG001|Overall Study|Withdrawal by Subject|15|||
150280681|NCT03080883|542163574|FG000|Overall Study|Adverse Event|22|||
150280682|NCT03080883|542163575|FG001|Overall Study|Adverse Event|22|||
150280683|NCT03080883|542163574|FG000|Overall Study|Alternative Therapy|0|||
150280684|NCT03080883|542163575|FG001|Overall Study|Alternative Therapy|3|||
150280685|NCT03080883|542163574|FG000|Overall Study|Other Complicating Disease|9|||
150280686|NCT03080883|542163575|FG001|Overall Study|Other Complicating Disease|5|||
150280687|NCT03080883|542163574|FG000|Overall Study|Death|21|||
150280688|NCT03080883|542163575|FG001|Overall Study|Death|16|||
150280689|NCT03080883|542163574|FG000|Overall Study|Physician Decision|2|||
150280690|NCT03080883|542163575|FG001|Overall Study|Physician Decision|2|||
150280691|NCT03080883|542163574|FG000|Overall Study|Disease Progression|2|||
150280692|NCT03080883|542163575|FG001|Overall Study|Disease Progression|8|||
149949081|NCT02964182|540944926|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149949082|NCT02964182|540944927|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149949083|NCT02964182|540944928|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
150171488|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150171489|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150171490|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150171491|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150171492|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
150171493|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
150171494|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
150171495|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171496|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171497|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171498|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171499|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171500|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150171501|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
150171502|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171503|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
150171504|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171505|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171506|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171507|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171508|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171509|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
150171510|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
150171511|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
150171512|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
150171513|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150171514|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150280693|NCT03080883|542163574|FG000|Overall Study|Lost to Follow-up|1|||
150280694|NCT03080883|542163575|FG001|Overall Study|Lost to Follow-up|1|||
150280695|NCT00388973|542165114|FG000|Overall Study|Adverse Event|16|||
150280696|NCT00388973|542165115|FG001|Overall Study|Adverse Event|6|||
150280697|NCT00388973|542165114|FG000|Overall Study|Lack of Efficacy|1|||
150280698|NCT00388973|542165115|FG001|Overall Study|Lack of Efficacy|12|||
150280699|NCT00388973|542165114|FG000|Overall Study|Protocol Violation|3|||
150280700|NCT00388973|542165115|FG001|Overall Study|Protocol Violation|0|||
150280701|NCT00388973|542165114|FG000|Overall Study|Withdrawal by Subject|14|||
150280702|NCT00388973|542165115|FG001|Overall Study|Withdrawal by Subject|17|||
150280703|NCT00388973|542165114|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
150280704|NCT00388973|542165115|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
150280705|NCT00388973|542165114|FG000|Overall Study|Did not complete 61 days of treatment|5|||
150280706|NCT00388973|542165115|FG001|Overall Study|Did not complete 61 days of treatment|4|||
150280707|NCT00388973|542165114|FG000|Overall Study|Left region|0|||
150280708|NCT00388973|542165115|FG001|Overall Study|Left region|1|||
150280709|NCT00388973|542165114|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
150280710|NCT00388973|542165115|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
150280711|NCT00075400|542165128|FG000|Overall Study|Ineligible: wrong primary|1|||
150280712|NCT00075400|542165128|FG000|Overall Study|Never treated|2|||
150280713|NCT01652885|542165129|FG000|Overall Study|Adverse Event|1|||
150280714|NCT03723707|542165131|FG000|Overall Study|Death|32|||
150280715|NCT03723707|542165132|FG001|Overall Study|Death|32|||
150280716|NCT03723707|542165131|FG000|Overall Study|Admitted to long term care|12|||
150280717|NCT03723707|542165132|FG001|Overall Study|Admitted to long term care|12|||
149949084|NCT02964182|540944929|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
150280718|NCT03723707|542165131|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
150280719|NCT03723707|542165132|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
150280720|NCT03723707|542165131|FG000|Overall Study|Lost to Follow-up|40|||
150280721|NCT03723707|542165132|FG001|Overall Study|Lost to Follow-up|22|||
150280722|NCT03723707|542165131|FG000|Overall Study|Discontinued after study closure|24|||
150280723|NCT03723707|542165132|FG001|Overall Study|Discontinued after study closure|12|||
150280724|NCT00075023|542165133|FG000|Pilot Study|Physician Decision|1|||
150280725|NCT00075023|542165134|FG001|Pilot Study|Physician Decision|2|||
150280726|NCT00075023|542165133|FG000|Pilot Study|Withdrawal by Subject|1|||
150280727|NCT00075023|542165134|FG001|Pilot Study|Withdrawal by Subject|0|||
150280728|NCT04342871|542165135|FG000|Overall Study|Death|4|||
150280729|NCT04342871|542165135|FG000|Overall Study|Clinical deterioration/illness progression|2|||
150280730|NCT04342871|542165135|FG000|Overall Study|Did not complete baseline assessments|5|||
150280731|NCT04342871|542165135|FG000|Overall Study|Lost to Follow-up|13|||
149949085|NCT02964182|540944922|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149949086|NCT02964182|540944923|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149949087|NCT02964182|540944924|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
149949088|NCT02964182|540944925|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
149949089|NCT02964182|540944926|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
150280732|NCT00666458|542165137|FG000|Overall Study|Adverse Event|8|||
150280733|NCT00666458|542165138|FG001|Overall Study|Adverse Event|7|||
150280734|NCT00666458|542165137|FG000|Overall Study|Withdrawal by Subject|5|||
150280735|NCT00666458|542165138|FG001|Overall Study|Withdrawal by Subject|4|||
150280736|NCT00666458|542165137|FG000|Overall Study|Lost to Follow-up|0|||
150280737|NCT00666458|542165138|FG001|Overall Study|Lost to Follow-up|3|||
150280738|NCT00666458|542165137|FG000|Overall Study|Administrative reason by sponsor|1|||
150280739|NCT00666458|542165138|FG001|Overall Study|Administrative reason by sponsor|1|||
150280740|NCT00666458|542165137|FG000|Overall Study|Incorrect enrollment|7|||
150280741|NCT00666458|542165138|FG001|Overall Study|Incorrect enrollment|1|||
150280742|NCT00666458|542165137|FG000|Overall Study|Study specific discontinuation criteria|14|||
150280743|NCT00666458|542165138|FG001|Overall Study|Study specific discontinuation criteria|7|||
150280744|NCT00666458|542165137|FG000|Overall Study|Severe non-compliance to the protocol|1|||
150280745|NCT00666458|542165138|FG001|Overall Study|Severe non-compliance to the protocol|1|||
150280746|NCT00666458|542165137|FG000|Overall Study|Safety reasons|1|||
150280747|NCT00666458|542165138|FG001|Overall Study|Safety reasons|0|||
150280748|NCT00666458|542165137|FG000|Overall Study|Medical history of anemia|1|||
150280749|NCT00666458|542165138|FG001|Overall Study|Medical history of anemia|0|||
150280750|NCT04682405|542165140|FG000|Overall Study|Adverse Event|0|||
150280751|NCT04682405|542165141|FG001|Overall Study|Adverse Event|1|||
149949090|NCT02964182|540944927|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
150034476|NCT04944992|541266424|FG001|Overall Study|Withdrawal by Subject|1|||
150280752|NCT02982954|542165142|FG000|Overall Study|Death|55|||
150034477|NCT00303069|541266425|FG000|Overall Study|Lost to Follow-up|1|||
150280753|NCT02982954|542165143|FG001|Overall Study|Death|29|||
150280754|NCT02982954|542165144|FG002|Overall Study|Death|15|||
150280755|NCT02982954|542165145|FG003|Overall Study|Death|20|||
150280756|NCT02982954|542165142|FG000|Overall Study|Lost to Follow-up|2|||
150280757|NCT02982954|542165143|FG001|Overall Study|Lost to Follow-up|1|||
149949091|NCT02964182|540944928|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149949092|NCT02964182|540944929|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
149834429|NCT05093205|540525554|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
149834430|NCT05093205|540525555|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
149834431|NCT05093205|540525556|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
149834432|NCT05093205|540525557|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
149834433|NCT05093205|540525558|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
149834434|NCT05093205|540525559|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
149834435|NCT05093205|540525547|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
149834436|NCT05093205|540525548|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
149834437|NCT05093205|540525549|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
149834438|NCT05093205|540525550|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
149834439|NCT05093205|540525551|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
149834440|NCT05093205|540525552|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
149834441|NCT05093205|540525553|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
149834442|NCT05093205|540525554|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
149834443|NCT05093205|540525555|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
149834444|NCT05093205|540525556|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
149834445|NCT05093205|540525557|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
149834446|NCT05093205|540525558|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
149834447|NCT05093205|540525559|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
149834448|NCT05093205|540525547|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
149834449|NCT05093205|540525548|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
149834450|NCT05093205|540525549|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
149834451|NCT05093205|540525550|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
149834452|NCT05093205|540525551|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
149834453|NCT05093205|540525552|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
149834454|NCT05093205|540525553|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
149834455|NCT05093205|540525554|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
149834456|NCT05093205|540525555|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
149834457|NCT05093205|540525556|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
149834458|NCT05093205|540525557|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
149834459|NCT05093205|540525558|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
149834460|NCT05093205|540525559|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
149834461|NCT05093205|540525547|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
149834462|NCT05093205|540525548|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
149834463|NCT05093205|540525549|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
149834464|NCT05093205|540525550|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
149834465|NCT05093205|540525551|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
149834466|NCT05093205|540525552|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
149834467|NCT05093205|540525553|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
149834468|NCT05093205|540525554|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
149834469|NCT05093205|540525555|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
149834470|NCT05093205|540525556|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
149834471|NCT05093205|540525557|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
149834472|NCT05093205|540525558|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
149834473|NCT05093205|540525559|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
149834474|NCT05093205|540525547|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834475|NCT05093205|540525548|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834476|NCT05093205|540525549|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834477|NCT05093205|540525550|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834478|NCT05093205|540525551|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834479|NCT05093205|540525552|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834480|NCT05093205|540525553|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834481|NCT05093205|540525554|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834482|NCT05093205|540525555|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834483|NCT05093205|540525556|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
149834484|NCT05093205|540525557|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834485|NCT05093205|540525558|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834486|NCT05093205|540525559|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
149834487|NCT05093205|540525547|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
149834488|NCT05093205|540525548|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
149834489|NCT05093205|540525549|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
149834490|NCT05093205|540525550|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
149834491|NCT05093205|540525551|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
149949093|NCT02964182|540944922|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149949094|NCT02964182|540944923|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149949095|NCT02964182|540944924|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
149834492|NCT05093205|540525552|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
149834493|NCT05093205|540525553|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
149834494|NCT05093205|540525554|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
149834495|NCT05093205|540525555|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
149834496|NCT05093205|540525556|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
149834497|NCT05093205|540525557|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
149834498|NCT05093205|540525558|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
149834499|NCT05093205|540525559|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
149834500|NCT05093205|540525547|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834501|NCT05093205|540525548|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834502|NCT05093205|540525549|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834503|NCT05093205|540525550|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834504|NCT05093205|540525551|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834505|NCT05093205|540525552|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834506|NCT05093205|540525553|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834507|NCT05093205|540525554|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834508|NCT05093205|540525555|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834509|NCT05093205|540525556|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834510|NCT05093205|540525557|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
149834511|NCT05093205|540525558|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834512|NCT05093205|540525559|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
149834513|NCT05093205|540525547|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834514|NCT05093205|540525548|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834515|NCT05093205|540525549|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834516|NCT05093205|540525550|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834517|NCT05093205|540525551|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834518|NCT05093205|540525552|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834519|NCT05093205|540525553|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834520|NCT05093205|540525554|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834521|NCT05093205|540525555|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834522|NCT05093205|540525556|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834523|NCT05093205|540525557|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834524|NCT05093205|540525558|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
149834525|NCT05093205|540525559|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
149834526|NCT05093205|540525547|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
149834527|NCT05093205|540525548|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
149834528|NCT05093205|540525549|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
149834529|NCT05093205|540525550|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
149834530|NCT05093205|540525551|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
149834531|NCT05093205|540525552|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
149834532|NCT05093205|540525553|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
149834533|NCT05093205|540525554|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
149834534|NCT05093205|540525555|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
149834535|NCT05093205|540525556|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
149834536|NCT05093205|540525557|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
149834537|NCT05093205|540525558|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
149834538|NCT05093205|540525559|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
149834539|NCT05093205|540525547|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834540|NCT05093205|540525548|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834541|NCT05093205|540525549|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834542|NCT05093205|540525550|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834543|NCT05093205|540525551|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834544|NCT05093205|540525552|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834545|NCT05093205|540525553|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834546|NCT05093205|540525554|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834547|NCT05093205|540525555|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834548|NCT05093205|540525556|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834549|NCT05093205|540525557|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834550|NCT05093205|540525558|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
149834551|NCT05093205|540525559|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
149834552|NCT03693430|540525565|FG000|Overall Study|Lost to Follow-up|3|||
149834553|NCT03693430|540525566|FG001|Overall Study|Lost to Follow-up|14|||
149834554|NCT03693430|540525565|FG000|Overall Study|Death|1|||
149834555|NCT03693430|540525566|FG001|Overall Study|Death|0|||
149834556|NCT03693430|540525565|FG000|Overall Study|Withdrawal by Subject|0|||
149834557|NCT03693430|540525566|FG001|Overall Study|Withdrawal by Subject|4|||
149834558|NCT02930005|540525568|FG000|Overall Study|Lost to Follow-up|1|||
149834559|NCT02930005|540525569|FG001|Overall Study|Lost to Follow-up|5|||
149834560|NCT02373098|540525570|FG000|Overall Study|Lost to Follow-up|1|||
149834561|NCT02373098|540525571|FG001|Overall Study|Lost to Follow-up|0|||
149834562|NCT02373098|540525570|FG000|Overall Study|Protocol Violation|3|||
149834563|NCT02373098|540525571|FG001|Overall Study|Protocol Violation|0|||
149834564|NCT02373098|540525570|FG000|Overall Study|Withdrawal by Subject|5|||
149949096|NCT02964182|540944925|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
149949097|NCT02964182|540944926|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149949098|NCT02964182|540944927|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149834565|NCT02373098|540525571|FG001|Overall Study|Withdrawal by Subject|0|||
149834566|NCT02373098|540525570|FG000|Overall Study|Adverse Event|3|||
149949099|NCT02964182|540944928|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149949100|NCT02964182|540944929|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149834567|NCT02373098|540525571|FG001|Overall Study|Adverse Event|0|||
149834568|NCT05067647|540525577|FG000|Overall Study|Lost to Follow-up|1|||
149834569|NCT00855738|540525584|FG000|Overall Study|Lost to Follow-up|2|||
149834570|NCT00855738|540525584|FG000|Overall Study|Adverse Event|1|||
149834571|NCT00855738|540525584|FG000|Overall Study|Subject Defaulted|1|||
149834572|NCT00855738|540525584|FG000|Overall Study|Death|1|||
149834573|NCT03929393|540525589|FG000|Overall Study|Death|1|||
149834574|NCT03929393|540525590|FG001|Overall Study|Death|0|||
149834575|NCT03929393|540525589|FG000|Overall Study|Time Commitment|2|||
149834576|NCT03929393|540525590|FG001|Overall Study|Time Commitment|5|||
149834577|NCT03929393|540525589|FG000|Overall Study|Motor Vehicle Accident|0|||
149834578|NCT03929393|540525590|FG001|Overall Study|Motor Vehicle Accident|1|||
149834579|NCT03929393|540525589|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
149834580|NCT03929393|540525590|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
149834581|NCT03929393|540525589|FG000|Overall Study|Other|1|||
149834582|NCT03929393|540525590|FG001|Overall Study|Other|3|||
149834583|NCT00119379|540525600|FG000|Overall Study|Adverse Event|4|||
149834584|NCT00119379|540525601|FG001|Overall Study|Adverse Event|1|||
149834585|NCT01706536|540525603|FG000|Overall Study|Withdrawal by Subject|1|||
149834586|NCT01706536|540525604|FG001|Overall Study|Withdrawal by Subject|0|||
149834587|NCT01706536|540525605|FG002|Overall Study|Withdrawal by Subject|1|||
149834588|NCT01706536|540525606|FG003|Overall Study|Withdrawal by Subject|0|||
149834589|NCT01706536|540525607|FG004|Overall Study|Withdrawal by Subject|0|||
149834590|NCT01706536|540525603|FG000|Overall Study|Adverse Event|2|||
149834591|NCT01706536|540525604|FG001|Overall Study|Adverse Event|3|||
149834592|NCT01706536|540525605|FG002|Overall Study|Adverse Event|4|||
149834593|NCT01706536|540525606|FG003|Overall Study|Adverse Event|3|||
149834594|NCT01706536|540525607|FG004|Overall Study|Adverse Event|2|||
149834595|NCT01706536|540525603|FG000|Overall Study|Lack of Efficacy|1|||
149834596|NCT01706536|540525604|FG001|Overall Study|Lack of Efficacy|0|||
149834597|NCT01706536|540525605|FG002|Overall Study|Lack of Efficacy|0|||
149834598|NCT01706536|540525606|FG003|Overall Study|Lack of Efficacy|1|||
149834599|NCT01706536|540525607|FG004|Overall Study|Lack of Efficacy|0|||
149834600|NCT01706536|540525603|FG000|Overall Study|non compliance|0|||
149834601|NCT01706536|540525604|FG001|Overall Study|non compliance|1|||
149834602|NCT01706536|540525605|FG002|Overall Study|non compliance|0|||
149834603|NCT01706536|540525606|FG003|Overall Study|non compliance|0|||
149834604|NCT01706536|540525607|FG004|Overall Study|non compliance|0|||
149834605|NCT03262012|540525608|FG000|Overall Study|Withdrawal by Subject|15|||
149949101|NCT02964182|540944922|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149949102|NCT02964182|540944923|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149949103|NCT02964182|540944924|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
149949104|NCT02964182|540944925|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
149949105|NCT02964182|540944926|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149949106|NCT02964182|540944927|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149949107|NCT02964182|540944928|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
149949108|NCT02964182|540944929|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
150280758|NCT02982954|542165144|FG002|Overall Study|Lost to Follow-up|0|||
150280759|NCT02982954|542165145|FG003|Overall Study|Lost to Follow-up|0|||
150280760|NCT02982954|542165142|FG000|Overall Study|Participant withdrew consent|7|||
150280761|NCT02982954|542165143|FG001|Overall Study|Participant withdrew consent|5|||
150280762|NCT02982954|542165144|FG002|Overall Study|Participant withdrew consent|1|||
150280763|NCT02982954|542165145|FG003|Overall Study|Participant withdrew consent|1|||
150034478|NCT00303069|541266426|FG001|Overall Study|Lost to Follow-up|0|||
150280764|NCT02982954|542165142|FG000|Overall Study|Other reasons|42|||
150280765|NCT02982954|542165143|FG001|Overall Study|Other reasons|17|||
149834606|NCT03262012|540525609|FG001|Overall Study|Withdrawal by Subject|13|||
149834607|NCT03262012|540525610|FG002|Overall Study|Withdrawal by Subject|8|||
149834608|NCT03262012|540525611|FG003|Overall Study|Withdrawal by Subject|7|||
149834609|NCT03262012|540525608|FG000|Overall Study|Adverse Event|10|||
149834610|NCT03262012|540525609|FG001|Overall Study|Adverse Event|12|||
149834611|NCT03262012|540525610|FG002|Overall Study|Adverse Event|4|||
149834612|NCT03262012|540525611|FG003|Overall Study|Adverse Event|6|||
149834613|NCT03262012|540525608|FG000|Overall Study|Physician Decision|2|||
149834614|NCT03262012|540525609|FG001|Overall Study|Physician Decision|5|||
149834615|NCT03262012|540525610|FG002|Overall Study|Physician Decision|1|||
149834616|NCT03262012|540525611|FG003|Overall Study|Physician Decision|0|||
149834617|NCT03262012|540525608|FG000|Overall Study|Lack of Efficacy|0|||
149834618|NCT03262012|540525609|FG001|Overall Study|Lack of Efficacy|5|||
149834619|NCT03262012|540525610|FG002|Overall Study|Lack of Efficacy|1|||
149834620|NCT03262012|540525611|FG003|Overall Study|Lack of Efficacy|2|||
149834621|NCT03262012|540525608|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
149834622|NCT03262012|540525609|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
149834623|NCT03262012|540525610|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
149834624|NCT03262012|540525611|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
149834625|NCT00154102|540525612|FG000|Overall Study|investigational study phase ongoing|7|||
149834626|NCT00154102|540525613|FG001|Overall Study|investigational study phase ongoing|2|||
149834627|NCT04915755|540527334|FG000|Overall Study|Physician Decision|3|||
149834628|NCT04915755|540527335|FG001|Overall Study|Physician Decision|2|||
149834629|NCT04915755|540527334|FG000|Overall Study|Withdrawal by Subject|1|||
149834630|NCT04915755|540527335|FG001|Overall Study|Withdrawal by Subject|1|||
149834631|NCT04915755|540527334|FG000|Overall Study|Ongoing for PACT|3|||
149834632|NCT04915755|540527335|FG001|Overall Study|Ongoing for PACT|2|||
149834633|NCT04915755|540527334|FG000|Overall Study|Other|7|||
149834634|NCT04915755|540527335|FG001|Overall Study|Other|11|||
149834635|NCT03655106|540527336|FG000|Overall Study|Withdrawal by Subject|3|||
149834636|NCT03655106|540527337|FG001|Overall Study|Withdrawal by Subject|2|||
149834637|NCT03655106|540527336|FG000|Overall Study|Lost to Follow-up|2|||
149834638|NCT03655106|540527337|FG001|Overall Study|Lost to Follow-up|1|||
149834639|NCT03655106|540527336|FG000|Overall Study|Duplicate Enrollment|1|||
149834640|NCT03655106|540527337|FG001|Overall Study|Duplicate Enrollment|1|||
149834641|NCT03655106|540527336|FG000|Overall Study|Protocol Violation|3|||
149834642|NCT03655106|540527337|FG001|Overall Study|Protocol Violation|0|||
149834643|NCT02495857|540527348|FG000|Overall Study|Adverse Event|5|||
149834644|NCT02495857|540527349|FG001|Overall Study|Adverse Event|0|||
149834645|NCT02495857|540527350|FG002|Overall Study|Adverse Event|1|||
149834646|NCT02495857|540527348|FG000|Overall Study|Withdrawal by Subject|9|||
149834647|NCT02495857|540527349|FG001|Overall Study|Withdrawal by Subject|6|||
149834648|NCT02495857|540527350|FG002|Overall Study|Withdrawal by Subject|10|||
149834649|NCT02495857|540527348|FG000|Overall Study|Physician Decision|0|||
149834650|NCT02495857|540527349|FG001|Overall Study|Physician Decision|1|||
149834651|NCT02495857|540527350|FG002|Overall Study|Physician Decision|0|||
149834652|NCT02495857|540527348|FG000|Overall Study|Protocol Violation|1|||
149834653|NCT02495857|540527349|FG001|Overall Study|Protocol Violation|1|||
149834654|NCT02495857|540527350|FG002|Overall Study|Protocol Violation|2|||
149834655|NCT02495857|540527348|FG000|Overall Study|Lost to Follow-up|4|||
149834656|NCT02495857|540527349|FG001|Overall Study|Lost to Follow-up|5|||
149834657|NCT02495857|540527350|FG002|Overall Study|Lost to Follow-up|3|||
149834658|NCT02495857|540527348|FG000|Overall Study|Other|3|||
149834659|NCT02495857|540527349|FG001|Overall Study|Other|3|||
149834660|NCT02495857|540527350|FG002|Overall Study|Other|2|||
149834661|NCT01367457|540527351|FG000|Overall Study|Death|2|||
149834662|NCT01367457|540527352|FG001|Overall Study|Death|0|||
149834663|NCT01367457|540527353|FG002|Overall Study|Death|0|||
149834664|NCT01367457|540527351|FG000|Overall Study|Investigator's decision|2|||
149834665|NCT01367457|540527352|FG001|Overall Study|Investigator's decision|0|||
149834666|NCT01367457|540527353|FG002|Overall Study|Investigator's decision|0|||
149834667|NCT01367457|540527351|FG000|Overall Study|Clinical decline (CD)|2|||
149834668|NCT01367457|540527352|FG001|Overall Study|Clinical decline (CD)|0|||
149834669|NCT01367457|540527353|FG002|Overall Study|Clinical decline (CD)|0|||
149834670|NCT01367457|540527351|FG000|Overall Study|Progression and death|8|||
149834671|NCT01367457|540527352|FG001|Overall Study|Progression and death|0|||
149834672|NCT01367457|540527353|FG002|Overall Study|Progression and death|0|||
149834673|NCT01367457|540527351|FG000|Overall Study|Toxicity|16|||
149834674|NCT01367457|540527352|FG001|Overall Study|Toxicity|0|||
149834675|NCT01367457|540527353|FG002|Overall Study|Toxicity|0|||
149834676|NCT01367457|540527351|FG000|Overall Study|Progression|137|||
149834677|NCT01367457|540527352|FG001|Overall Study|Progression|0|||
149834678|NCT01367457|540527353|FG002|Overall Study|Progression|0|||
149834679|NCT01367457|540527351|FG000|Overall Study|Patient asks for rest + slow progression|1|||
149834680|NCT01367457|540527352|FG001|Overall Study|Patient asks for rest + slow progression|0|||
149834681|NCT01367457|540527353|FG002|Overall Study|Patient asks for rest + slow progression|0|||
149834682|NCT01367457|540527351|FG000|Overall Study|Investigator's opinion, stable disease|1|||
149834683|NCT01367457|540527352|FG001|Overall Study|Investigator's opinion, stable disease|0|||
149834684|NCT01367457|540527353|FG002|Overall Study|Investigator's opinion, stable disease|0|||
150034479|NCT00303069|541266427|FG002|Overall Study|Lost to Follow-up|0|||
150171515|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150171516|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150171517|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150171518|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150171519|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150171520|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
150171521|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
150171522|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150171523|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150171524|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150171525|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150171526|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149834685|NCT01367457|540527351|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
149834686|NCT01367457|540527352|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
149834687|NCT01367457|540527353|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
149834688|NCT01367457|540527351|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
149834689|NCT01367457|540527352|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
149834690|NCT01367457|540527353|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
149834691|NCT01367457|540527351|FG000|Overall Study|low grade toxicities + stable disease|1|||
149834692|NCT01367457|540527352|FG001|Overall Study|low grade toxicities + stable disease|0|||
149834693|NCT01367457|540527353|FG002|Overall Study|low grade toxicities + stable disease|0|||
149834694|NCT01367457|540527351|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
149834695|NCT01367457|540527352|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
149834696|NCT01367457|540527353|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
149834697|NCT01367457|540527351|FG000|Overall Study|Withdrawal by Subject|1|||
149834698|NCT01367457|540527352|FG001|Overall Study|Withdrawal by Subject|0|||
149834699|NCT01367457|540527353|FG002|Overall Study|Withdrawal by Subject|0|||
149834700|NCT01367457|540527351|FG000|Overall Study|CD, associated leukaemia|1|||
149834701|NCT01367457|540527352|FG001|Overall Study|CD, associated leukaemia|0|||
149834702|NCT01367457|540527353|FG002|Overall Study|CD, associated leukaemia|0|||
149834703|NCT01367457|540527351|FG000|Overall Study|Uncontrolled pain|1|||
149834704|NCT01367457|540527352|FG001|Overall Study|Uncontrolled pain|0|||
149834705|NCT01367457|540527353|FG002|Overall Study|Uncontrolled pain|0|||
149834706|NCT01367457|540527351|FG000|Overall Study|Overall status worsens to grade 4|1|||
149834707|NCT01367457|540527352|FG001|Overall Study|Overall status worsens to grade 4|0|||
149834708|NCT01367457|540527353|FG002|Overall Study|Overall status worsens to grade 4|0|||
149834709|NCT01367457|540527351|FG000|Overall Study|Stabilisation + frequent infections|1|||
149834710|NCT01367457|540527352|FG001|Overall Study|Stabilisation + frequent infections|0|||
149834711|NCT01367457|540527353|FG002|Overall Study|Stabilisation + frequent infections|0|||
149834712|NCT01367457|540527351|FG000|Overall Study|No clinical benefit|1|||
149834713|NCT01367457|540527352|FG001|Overall Study|No clinical benefit|0|||
149834714|NCT01367457|540527353|FG002|Overall Study|No clinical benefit|0|||
149834715|NCT01367457|540527351|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
149834716|NCT01367457|540527352|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
149834717|NCT01367457|540527353|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
149834718|NCT01367457|540527351|FG000|Overall Study|Overall decline|1|||
149834719|NCT01367457|540527352|FG001|Overall Study|Overall decline|0|||
149834720|NCT01367457|540527353|FG002|Overall Study|Overall decline|0|||
149834721|NCT01367457|540527351|FG000|Overall Study|Rejection of treatment|1|||
149834722|NCT01367457|540527352|FG001|Overall Study|Rejection of treatment|0|||
149834723|NCT01367457|540527353|FG002|Overall Study|Rejection of treatment|0|||
149834724|NCT01367457|540527351|FG000|Overall Study|Lost to Follow-up|1|||
149834725|NCT01367457|540527352|FG001|Overall Study|Lost to Follow-up|0|||
149834726|NCT01367457|540527353|FG002|Overall Study|Lost to Follow-up|0|||
149834727|NCT01367457|540527351|FG000|Overall Study|Death from septic shock|1|||
149834728|NCT01367457|540527352|FG001|Overall Study|Death from septic shock|0|||
149834729|NCT01367457|540527353|FG002|Overall Study|Death from septic shock|0|||
149834730|NCT01367457|540527351|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
149834731|NCT01367457|540527352|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
149834732|NCT01367457|540527353|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
149834733|NCT01367457|540527351|FG000|Overall Study|Patient's Wish|1|||
149834734|NCT01367457|540527352|FG001|Overall Study|Patient's Wish|0|||
149834735|NCT01367457|540527353|FG002|Overall Study|Patient's Wish|0|||
150034480|NCT00303069|541266428|FG003|Overall Study|Lost to Follow-up|2|||
150280766|NCT02982954|542165144|FG002|Overall Study|Other reasons|12|||
150280767|NCT02982954|542165145|FG003|Overall Study|Other reasons|3|||
150280768|NCT02982954|542165142|FG000|Overall Study|Premature site closure|0|||
150280769|NCT02982954|542165143|FG001|Overall Study|Premature site closure|0|||
150280770|NCT02982954|542165144|FG002|Overall Study|Premature site closure|0|||
150280771|NCT02982954|542165145|FG003|Overall Study|Premature site closure|1|||
150280772|NCT01429584|542165146|FG000|Overall Study|Withdrawal by Subject|1|||
150280773|NCT01429584|542165147|FG001|Overall Study|Withdrawal by Subject|0|||
150280774|NCT01429584|542165146|FG000|Overall Study|Protocol Violation|0|||
149834736|NCT01367457|540527351|FG000|Overall Study|Palliative. Overall decline|1|||
149834737|NCT01367457|540527352|FG001|Overall Study|Palliative. Overall decline|0|||
149834738|NCT01367457|540527353|FG002|Overall Study|Palliative. Overall decline|0|||
149834739|NCT01367457|540527351|FG000|Overall Study|Suspected DP/suspected active infection|1|||
149834740|NCT01367457|540527352|FG001|Overall Study|Suspected DP/suspected active infection|0|||
149834741|NCT01367457|540527353|FG002|Overall Study|Suspected DP/suspected active infection|0|||
149834742|NCT03447262|540527354|FG000|Overall Study|Adverse Event|7|||
149834743|NCT03447262|540527354|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
149834744|NCT03447262|540527354|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
149834745|NCT03447262|540527354|FG000|Overall Study|Death|2|||
149834746|NCT03447262|540527354|FG000|Overall Study|Study Termination by Sponsor|455|||
149834747|NCT03447262|540527354|FG000|Overall Study|Other|4|||
149834748|NCT05038293|540527363|FG000|Overall Study|device was not operating properly for one subject.|1|||
149834749|NCT05038293|540527364|FG001|Overall Study|device was not operating properly for one subject.|0|||
149834750|NCT05038293|540527363|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
149834751|NCT05038293|540527364|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
149834752|NCT01838941|540527365|FG000|Overall Study|Adverse Event|1|||
149834753|NCT01838941|540527365|FG000|Overall Study|Withdrawal by Subject|1|||
149834754|NCT02822235|540527366|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
149834755|NCT02822235|540527367|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
149834756|NCT02822235|540527366|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
149834757|NCT02822235|540527367|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
149834758|NCT02822235|540527366|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
149834759|NCT02822235|540527367|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
149834760|NCT02822235|540527366|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
149834761|NCT02822235|540527367|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
149834762|NCT02822235|540527366|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
149834763|NCT02822235|540527367|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
149834764|NCT02822235|540527366|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
149834765|NCT02822235|540527367|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
149834766|NCT02910037|540527368|FG000|Overall Study|Withdrawal by Subject|4|||
149834767|NCT02910037|540527368|FG000|Overall Study|Lost to Follow-up|6|||
149834768|NCT00436553|540527371|FG000|Overall Study|Adverse Event|4|||
149834769|NCT00436553|540527372|FG001|Overall Study|Adverse Event|3|||
149834770|NCT00436553|540527373|FG002|Overall Study|Adverse Event|4|||
149834771|NCT00436553|540527371|FG000|Overall Study|Death|3|||
149834772|NCT00436553|540527372|FG001|Overall Study|Death|1|||
149834773|NCT00436553|540527373|FG002|Overall Study|Death|3|||
149834774|NCT00436553|540527371|FG000|Overall Study|Lost to Follow-up|0|||
149834775|NCT00436553|540527372|FG001|Overall Study|Lost to Follow-up|2|||
149834776|NCT00436553|540527373|FG002|Overall Study|Lost to Follow-up|0|||
149834777|NCT00436553|540527371|FG000|Overall Study|Protocol Violation|1|||
149834778|NCT00436553|540527372|FG001|Overall Study|Protocol Violation|0|||
149834779|NCT00436553|540527373|FG002|Overall Study|Protocol Violation|0|||
149834780|NCT00436553|540527371|FG000|Overall Study|Withdrawal by Subject|5|||
149834781|NCT00436553|540527372|FG001|Overall Study|Withdrawal by Subject|6|||
149834782|NCT00436553|540527373|FG002|Overall Study|Withdrawal by Subject|3|||
149834783|NCT02457520|540527374|FG000|Active Treatment Phase|Adverse Event|10|||
149834784|NCT02457520|540527374|FG000|Active Treatment Phase|Lost to Follow-up|8|||
149834785|NCT02457520|540527374|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
149834786|NCT02457520|540527374|FG000|Active Treatment Phase|other|4|||
149834787|NCT02457520|540527374|FG000|Active Treatment Phase|Physician Decision|1|||
149834788|NCT02457520|540527374|FG000|Active Treatment Phase|Protocol Violation|1|||
149834789|NCT02457520|540527374|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
149834790|NCT02457520|540527374|FG000|Post-treatment Period|Other: Retreatment Required|7|||
149834791|NCT02457520|540527374|FG000|Post-treatment Period|Lost to Follow-up|23|||
149834792|NCT02457520|540527374|FG000|Post-treatment Period|Other|3|||
149834793|NCT02457520|540527374|FG000|Post-treatment Period|Physician Decision|1|||
149834794|NCT02457520|540527374|FG000|Post-treatment Period|Withdrawal by Subject|14|||
149834795|NCT01772537|540527375|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
149834796|NCT01772537|540527376|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
149834797|NCT01772537|540527377|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
149834798|NCT00450190|540527378|FG000|Overall Study|Withdrawal by Subject|2|||
149834799|NCT01536574|540527379|FG000|Overall Study|Adverse Event|4|||
149834800|NCT01536574|540527380|FG001|Overall Study|Adverse Event|5|||
149834801|NCT01536574|540527379|FG000|Overall Study|Withdrawal by Subject|1|||
149834802|NCT01536574|540527380|FG001|Overall Study|Withdrawal by Subject|2|||
149834803|NCT01536574|540527379|FG000|Overall Study|Lack of Efficacy|1|||
149834804|NCT01536574|540527380|FG001|Overall Study|Lack of Efficacy|0|||
149834805|NCT01376167|540527381|FG000|Overall Study|Lost to Follow-up|2|||
149834806|NCT01376167|540527382|FG001|Overall Study|Lost to Follow-up|4|||
149834807|NCT01376167|540527383|FG002|Overall Study|Lost to Follow-up|2|||
149834808|NCT01376167|540527381|FG000|Overall Study|Physician Decision|1|||
149834809|NCT01376167|540527382|FG001|Overall Study|Physician Decision|1|||
149834810|NCT01376167|540527383|FG002|Overall Study|Physician Decision|0|||
149834811|NCT01376167|540527381|FG000|Overall Study|Withdrawal by Subject|1|||
149834812|NCT01376167|540527382|FG001|Overall Study|Withdrawal by Subject|5|||
149834813|NCT01376167|540527383|FG002|Overall Study|Withdrawal by Subject|4|||
149834814|NCT02193165|540527386|FG000|4 Week Product Use|Lost to Follow-up|1|||
149834815|NCT02193165|540527387|FG001|4 Week Product Use|Lost to Follow-up|1|||
149834816|NCT02193165|540527388|FG002|4 Week Product Use|Lost to Follow-up|1|||
149834817|NCT02193165|540527386|FG000|6 Week Product Use|Lost to Follow-up|0|||
149834818|NCT02193165|540527387|FG001|6 Week Product Use|Lost to Follow-up|1|||
149834819|NCT02193165|540527388|FG002|6 Week Product Use|Lost to Follow-up|0|||
149834820|NCT04239872|540527389|FG000|Overall Study|Lost to Follow-up|0|||
149834821|NCT04239872|540527390|FG001|Overall Study|Lost to Follow-up|1|||
149834822|NCT00112463|540527394|FG000|Overall Study|Physician Decision|1|||
149834823|NCT00112463|540527394|FG000|Overall Study|Progression|30|||
149834824|NCT00112463|540527394|FG000|Overall Study|Second Primary|1|||
149834825|NCT00112463|540527394|FG000|Overall Study|Toxicity|3|||
149834826|NCT00112463|540527394|FG000|Overall Study|Withdrawal by Subject|2|||
149834827|NCT00112463|540527394|FG000|Overall Study|Never started treatment|2|||
149834828|NCT01214850|540527395|FG000|Overall Study|Withdrawal by Subject|38|||
149834829|NCT01214850|540527396|FG001|Overall Study|Withdrawal by Subject|31|||
149834830|NCT01214850|540527397|FG002|Overall Study|Withdrawal by Subject|28|||
149834831|NCT01214850|540527395|FG000|Overall Study|Lost to Follow-up|124|||
149834832|NCT01214850|540527396|FG001|Overall Study|Lost to Follow-up|98|||
149834833|NCT01214850|540527397|FG002|Overall Study|Lost to Follow-up|123|||
150034481|NCT00303069|541266425|FG000|Overall Study|subject moved|1|||
150280775|NCT01429584|542165147|FG001|Overall Study|Protocol Violation|1|||
150280776|NCT00747643|542165151|FG000|Overall Study|Withdrawal by Subject|36|||
150280777|NCT00747643|542165152|FG001|Overall Study|Withdrawal by Subject|27|||
150280778|NCT00750698|542165153|FG000|Overall Study|Withdrawal by Subject|1|||
150280779|NCT00750698|542165154|FG001|Overall Study|Withdrawal by Subject|0|||
150280780|NCT00750698|542165153|FG000|Overall Study|Progressive disease|5|||
150280781|NCT00750698|542165154|FG001|Overall Study|Progressive disease|2|||
150280782|NCT00516048|542165155|FG000|Overall Study|Death|0|||
150280783|NCT00516048|542165156|FG001|Overall Study|Death|0|||
150280784|NCT00516048|542165157|FG002|Overall Study|Death|1|||
150280785|NCT00516048|542165155|FG000|Overall Study|Subject Decision|0|||
150280786|NCT00516048|542165156|FG001|Overall Study|Subject Decision|2|||
150280787|NCT00516048|542165157|FG002|Overall Study|Subject Decision|0|||
150280788|NCT02263079|542165158|FG000|Overall Study|Physician Decision|1|||
150280789|NCT02263079|542165159|FG001|Overall Study|Physician Decision|0|||
150280790|NCT02263079|542165160|FG002|Overall Study|Physician Decision|0|||
150280791|NCT02263079|542165158|FG000|Overall Study|Withdrawal by Subject|2|||
150280792|NCT02263079|542165159|FG001|Overall Study|Withdrawal by Subject|8|||
150280793|NCT02263079|542165160|FG002|Overall Study|Withdrawal by Subject|0|||
150280794|NCT03557281|542165161|FG000|Overall Study|Investigator discretion|0|||
150280795|NCT03557281|542165162|FG001|Overall Study|Investigator discretion|0|||
150280796|NCT03557281|542165163|FG002|Overall Study|Investigator discretion|1|||
150280797|NCT03557281|542165164|FG003|Overall Study|Investigator discretion|0|||
150280798|NCT03557281|542165165|FG004|Overall Study|Investigator discretion|0|||
150280799|NCT03557281|542165161|FG000|Overall Study|Withdrawal by Subject|0|||
150280800|NCT03557281|542165162|FG001|Overall Study|Withdrawal by Subject|1|||
150280801|NCT03557281|542165163|FG002|Overall Study|Withdrawal by Subject|1|||
150280802|NCT03557281|542165164|FG003|Overall Study|Withdrawal by Subject|1|||
150280803|NCT03557281|542165165|FG004|Overall Study|Withdrawal by Subject|2|||
150280804|NCT03557281|542165161|FG000|Overall Study|Randomized, but did not receive treatment|0|||
150280805|NCT03557281|542165162|FG001|Overall Study|Randomized, but did not receive treatment|0|||
150280806|NCT03557281|542165163|FG002|Overall Study|Randomized, but did not receive treatment|0|||
150280807|NCT03557281|542165164|FG003|Overall Study|Randomized, but did not receive treatment|0|||
150280808|NCT03557281|542165165|FG004|Overall Study|Randomized, but did not receive treatment|1|||
150280809|NCT00402649|542165166|FG000|Overall Study|Lost to Follow-up|1|||
149834834|NCT01214850|540527395|FG000|Overall Study|Protocol Violation|5|||
150280810|NCT00402649|542165166|FG000|Overall Study|Withdrawal by Subject|1|||
150280811|NCT01999465|542165167|FG000|Overall Study|Lost to Follow-up|0|||
149834835|NCT01214850|540527396|FG001|Overall Study|Protocol Violation|5|||
149834836|NCT01214850|540527397|FG002|Overall Study|Protocol Violation|6|||
150280812|NCT01999465|542165168|FG001|Overall Study|Lost to Follow-up|2|||
150280813|NCT01999465|542165167|FG000|Overall Study|Protocol Violation|0|||
150280814|NCT01999465|542165168|FG001|Overall Study|Protocol Violation|1|||
149834837|NCT01214850|540527395|FG000|Overall Study|Adverse event or death|11|||
149834838|NCT01214850|540527396|FG001|Overall Study|Adverse event or death|8|||
149834839|NCT01214850|540527397|FG002|Overall Study|Adverse event or death|3|||
149834840|NCT01214850|540527395|FG000|Overall Study|Inappropriate enrollment|2|||
149834841|NCT01214850|540527396|FG001|Overall Study|Inappropriate enrollment|1|||
149834842|NCT01214850|540527397|FG002|Overall Study|Inappropriate enrollment|0|||
149834843|NCT01214850|540527395|FG000|Overall Study|Administrative reason|1|||
149834844|NCT01214850|540527396|FG001|Overall Study|Administrative reason|0|||
149834845|NCT01214850|540527397|FG002|Overall Study|Administrative reason|0|||
149834846|NCT01214850|540527395|FG000|Overall Study|Unable to classify|2|||
149834847|NCT01214850|540527396|FG001|Overall Study|Unable to classify|1|||
149834848|NCT01214850|540527397|FG002|Overall Study|Unable to classify|1|||
149834849|NCT00565448|540527398|FG000|Overall Study|Adverse Event|1|||
149834850|NCT00565448|540527399|FG001|Overall Study|Adverse Event|2|||
149834851|NCT00565448|540527398|FG000|Overall Study|Disease progression|1|||
149834852|NCT00565448|540527399|FG001|Overall Study|Disease progression|0|||
149834853|NCT00565448|540527398|FG000|Overall Study|Withdrawal by Subject|1|||
149834854|NCT00565448|540527399|FG001|Overall Study|Withdrawal by Subject|0|||
149834855|NCT01863745|540527400|FG000|Overall Study|Disease Progression|9|||
149834856|NCT01863745|540527400|FG000|Overall Study|Adverse Event|2|||
149834857|NCT01863745|540527400|FG000|Overall Study|Death|1|||
149834858|NCT01863745|540527400|FG000|Overall Study|Withdrawal by Subject|1|||
149834859|NCT00193609|540527401|FG000|Overall Study|Lack of Efficacy|2|||
149834860|NCT00193609|540527401|FG000|Overall Study|Adverse Event|2|||
149834861|NCT00735904|540527402|FG000|Overall Study|Adverse Event|3|||
149834862|NCT00735904|540527402|FG000|Overall Study|Death|20|||
149834863|NCT00735904|540527402|FG000|Overall Study|Protocol Violation|1|||
149949136|NCT01964404|540944933|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
149949137|NCT01964404|540944934|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
149949138|NCT01964404|540944935|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
149949139|NCT01964404|540944936|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
149949140|NCT01964404|540944937|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
149949141|NCT01964404|540944938|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
149949142|NCT01964404|540944939|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
149949143|NCT01964404|540944940|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
149949144|NCT01964404|540944941|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
149949145|NCT01964404|540944942|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
149949146|NCT01964404|540944933|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
149949147|NCT01964404|540944934|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
149949148|NCT01964404|540944935|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149949149|NCT01964404|540944936|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149949150|NCT01964404|540944937|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949151|NCT01964404|540944938|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949152|NCT01964404|540944939|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949153|NCT01964404|540944940|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949154|NCT01964404|540944941|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949155|NCT01964404|540944942|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949156|NCT01964404|540944933|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149949157|NCT01964404|540944934|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
149949158|NCT01964404|540944935|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949159|NCT01964404|540944936|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
149949160|NCT01964404|540944937|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949161|NCT01964404|540944938|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949162|NCT01964404|540944939|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949163|NCT01964404|540944940|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949164|NCT01964404|540944941|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949165|NCT01964404|540944942|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149949166|NCT05528510|540944944|FG000|Overall Study|Death|1|||
149949167|NCT05528510|540944945|FG001|Overall Study|Death|0|||
149949168|NCT05528510|540944946|FG002|Overall Study|Death|0|||
149949169|NCT05528510|540944944|FG000|Overall Study|Lost to Follow-up|1|||
149949170|NCT05528510|540944945|FG001|Overall Study|Lost to Follow-up|0|||
149949171|NCT05528510|540944946|FG002|Overall Study|Lost to Follow-up|0|||
149949172|NCT05528510|540944944|FG000|Overall Study|Withdrawal by Subject|4|||
149834864|NCT00735904|540527402|FG000|Overall Study|Withdrawal by Subject|1|||
149834865|NCT00735904|540527402|FG000|Overall Study|Study Terminated by Sponsor|5|||
149834866|NCT00735904|540527402|FG000|Overall Study|Other|8|||
149834867|NCT00610363|540527406|FG000|Overall Study|Non-compliance with protocol|0|||
149834868|NCT00610363|540527407|FG001|Overall Study|Non-compliance with protocol|1|||
149834869|NCT00610363|540527406|FG000|Overall Study|Adverse Event|3|||
149834870|NCT00610363|540527407|FG001|Overall Study|Adverse Event|1|||
149949173|NCT05528510|540944945|FG001|Overall Study|Withdrawal by Subject|1|||
149949174|NCT05528510|540944946|FG002|Overall Study|Withdrawal by Subject|3|||
149949175|NCT05528510|540944944|FG000|Overall Study|Other|2|||
149949176|NCT05528510|540944945|FG001|Overall Study|Other|2|||
149834871|NCT00610363|540527406|FG000|Overall Study|Lack of Efficacy|2|||
149834872|NCT00610363|540527407|FG001|Overall Study|Lack of Efficacy|0|||
149834873|NCT00610363|540527406|FG000|Overall Study|Lost to Follow-up|4|||
149834874|NCT00610363|540527407|FG001|Overall Study|Lost to Follow-up|0|||
149834875|NCT00610363|540527406|FG000|Overall Study|Withdrawal by Subject|1|||
149834876|NCT00610363|540527407|FG001|Overall Study|Withdrawal by Subject|0|||
149834877|NCT00610363|540527406|FG000|Overall Study|Other than specified above|1|||
149834878|NCT00610363|540527407|FG001|Overall Study|Other than specified above|1|||
149834879|NCT03204539|540527408|FG000|Overall Study|Loss of funding|0|||
149834880|NCT03204539|540527409|FG001|Overall Study|Loss of funding|1|||
149834881|NCT01171963|540527410|FG000|Overall Study|Adverse Event|10|||
149834882|NCT01171963|540527411|FG001|Overall Study|Adverse Event|15|||
149834883|NCT01171963|540527410|FG000|Overall Study|Lost to Follow-up|23|||
149834884|NCT01171963|540527411|FG001|Overall Study|Lost to Follow-up|24|||
149834885|NCT01171963|540527410|FG000|Overall Study|Other - diarrhoea|1|||
149834886|NCT01171963|540527411|FG001|Overall Study|Other - diarrhoea|0|||
149834887|NCT01171963|540527410|FG000|Overall Study|Withdrawal by Subject|114|||
149834888|NCT01171963|540527411|FG001|Overall Study|Withdrawal by Subject|129|||
149834889|NCT03361228|540527423|FG000|Overall Study|Other|1|||
149834890|NCT03361228|540527424|FG001|Overall Study|Other|1|||
149834891|NCT03361228|540527423|FG000|Overall Study|Death|3|||
149834892|NCT03361228|540527424|FG001|Overall Study|Death|0|||
149834893|NCT00302952|540527425|FG000|Overall Study|Physician Decision|1|||
149834894|NCT00302952|540527426|FG001|Overall Study|Physician Decision|1|||
149834895|NCT00302952|540527425|FG000|Overall Study|Withdrawal by Subject|2|||
149834896|NCT00302952|540527426|FG001|Overall Study|Withdrawal by Subject|3|||
149834897|NCT00302952|540527425|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
149834898|NCT00302952|540527426|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
149834899|NCT02979353|540527434|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
149834900|NCT02979353|540527435|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
149834901|NCT02979353|540527434|FG000|Overall Study|Withdrawal by Subject|16|||
149834902|NCT02979353|540527435|FG001|Overall Study|Withdrawal by Subject|12|||
149834903|NCT02979353|540527434|FG000|Overall Study|Death|10|||
149834904|NCT02979353|540527435|FG001|Overall Study|Death|11|||
149834905|NCT02979353|540527434|FG000|Overall Study|Transfer to Hospice Care|19|||
149834906|NCT02979353|540527435|FG001|Overall Study|Transfer to Hospice Care|14|||
149834907|NCT02979353|540527434|FG000|Overall Study|Lost to Follow-up|1|||
149834908|NCT02979353|540527435|FG001|Overall Study|Lost to Follow-up|5|||
149834909|NCT01722877|540527439|FG000|Overall Study|Death|1|||
149834910|NCT01722877|540527439|FG000|Overall Study|Lost to Follow-up|1|||
149834911|NCT03897088|540527440|FG000|Overall Study|Withdrawal by Subject|12|||
149834912|NCT03897088|540527441|FG001|Overall Study|Withdrawal by Subject|12|||
149834913|NCT03897088|540527440|FG000|Overall Study|Lost to Follow-up|7|||
149834914|NCT03897088|540527441|FG001|Overall Study|Lost to Follow-up|15|||
149834915|NCT03897088|540527440|FG000|Overall Study|Sponsor Decision|1|||
149834916|NCT03897088|540527441|FG001|Overall Study|Sponsor Decision|2|||
149834917|NCT03897088|540527440|FG000|Overall Study|COVID-19|2|||
149834918|NCT03897088|540527441|FG001|Overall Study|COVID-19|0|||
149834919|NCT03897088|540527440|FG000|Overall Study|Other|3|||
149834920|NCT03897088|540527441|FG001|Overall Study|Other|0|||
149834921|NCT03897088|540527440|FG000|Overall Study|Non-compliance with Study Drug|1|||
149834922|NCT03897088|540527441|FG001|Overall Study|Non-compliance with Study Drug|1|||
149834923|NCT03897088|540527440|FG000|Overall Study|Pregnancy|0|||
149834924|NCT03897088|540527441|FG001|Overall Study|Pregnancy|1|||
149834925|NCT04320849|540527450|FG000|Overall Study|Withdrawal by Subject|4|||
149834926|NCT04320849|540527450|FG000|Overall Study|Imaging data unavailable|2|||
149834927|NCT04320849|540527450|FG000|Overall Study|Incomplete imaging|2|||
149834928|NCT00319735|540527453|FG000|Overall Study|Death|2|||
149949177|NCT05528510|540944946|FG002|Overall Study|Other|1|||
150171527|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149834929|NCT01569152|540527464|FG000|Phase IIa, Period 1|Early Escape|5|||
149834930|NCT01569152|540527465|FG001|Phase IIa, Period 1|Early Escape|22|||
149834931|NCT01569152|540527466|FG002|Phase IIa, Period 1|Early Escape|0|||
149834932|NCT01569152|540527464|FG000|Phase IIa, Period 1|Adverse Event|4|||
149834933|NCT01569152|540527465|FG001|Phase IIa, Period 1|Adverse Event|0|||
149834934|NCT01569152|540527466|FG002|Phase IIa, Period 1|Adverse Event|0|||
149834935|NCT01569152|540527464|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
149834936|NCT01569152|540527465|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
149834937|NCT01569152|540527466|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
149834938|NCT01569152|540527464|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
149834939|NCT01569152|540527465|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
150171528|NCT01212757|541763542|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
149834940|NCT01569152|540527466|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
149834941|NCT01569152|540527464|FG000|Phase IIa, Period 1|Protocol Violation|0|||
149834942|NCT01569152|540527465|FG001|Phase IIa, Period 1|Protocol Violation|1|||
149834943|NCT01569152|540527466|FG002|Phase IIa, Period 1|Protocol Violation|0|||
149834944|NCT01569152|540527464|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
149834945|NCT01569152|540527465|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
149834946|NCT01569152|540527466|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
149834947|NCT01569152|540527464|FG000|Safety Extension, Period 3|Adverse Event|0|||
149834948|NCT01569152|540527465|FG001|Safety Extension, Period 3|Adverse Event|0|||
149834949|NCT01569152|540527466|FG002|Safety Extension, Period 3|Adverse Event|4|||
149834950|NCT01569152|540527464|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
149834951|NCT01569152|540527465|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
149834952|NCT01569152|540527466|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
149834953|NCT01569152|540527464|FG000|Safety Extension, Period 3|Physician Decision|0|||
149834954|NCT01569152|540527465|FG001|Safety Extension, Period 3|Physician Decision|0|||
149834955|NCT01569152|540527466|FG002|Safety Extension, Period 3|Physician Decision|2|||
149834956|NCT01569152|540527464|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
149834957|NCT01569152|540527465|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
149834958|NCT01569152|540527466|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
149834959|NCT01469546|540527469|FG000|Received 5 mg Dose|Adverse Event|13|||
149834960|NCT01469546|540527469|FG000|Received 5 mg Dose|Death|2|||
149834961|NCT01469546|540527469|FG000|Received 5 mg Dose|Protocol Violation|2|||
149834962|NCT01469546|540527469|FG000|Received 5 mg Dose|Progressive Disease|3|||
149834963|NCT01469546|540527469|FG000|Received 5 mg Dose|Physician Decision|3|||
149834964|NCT00385684|540527472|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
149834965|NCT00385684|540527473|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
149834966|NCT00385684|540527472|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
149834967|NCT00385684|540527473|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
149834968|NCT00385684|540527472|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
149834969|NCT00385684|540527473|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
149834970|NCT02801877|540527474|FG000|Overall Study|Lost to Follow-up|1|||
149834971|NCT02801877|540527475|FG001|Overall Study|Lost to Follow-up|1|||
149834972|NCT02801877|540527476|FG002|Overall Study|Lost to Follow-up|2|||
149834973|NCT02801877|540527477|FG003|Overall Study|Lost to Follow-up|0|||
149834974|NCT02801877|540527474|FG000|Overall Study|Never Started Treatment|2|||
149834975|NCT02801877|540527475|FG001|Overall Study|Never Started Treatment|0|||
149834976|NCT02801877|540527476|FG002|Overall Study|Never Started Treatment|4|||
149834977|NCT02801877|540527477|FG003|Overall Study|Never Started Treatment|0|||
149834978|NCT00463606|540527478|FG000|Overall Study|Adverse Event|21|||
149834979|NCT00463606|540527479|FG001|Overall Study|Adverse Event|18|||
149834980|NCT00463606|540527480|FG002|Overall Study|Adverse Event|11|||
149834981|NCT00463606|540527478|FG000|Overall Study|Withdrawal by Subject|11|||
149834982|NCT00463606|540527479|FG001|Overall Study|Withdrawal by Subject|11|||
149834983|NCT00463606|540527480|FG002|Overall Study|Withdrawal by Subject|5|||
149834984|NCT00463606|540527478|FG000|Overall Study|Lost to Follow-up|2|||
149834985|NCT00463606|540527479|FG001|Overall Study|Lost to Follow-up|2|||
149834986|NCT00463606|540527480|FG002|Overall Study|Lost to Follow-up|3|||
149834987|NCT00463606|540527478|FG000|Overall Study|Subject noncompliance|1|||
149834988|NCT00463606|540527479|FG001|Overall Study|Subject noncompliance|1|||
149834989|NCT00463606|540527480|FG002|Overall Study|Subject noncompliance|0|||
149834990|NCT00463606|540527478|FG000|Overall Study|Subject moved out of town|1|||
149834991|NCT00463606|540527479|FG001|Overall Study|Subject moved out of town|0|||
149834992|NCT00463606|540527480|FG002|Overall Study|Subject moved out of town|0|||
149834993|NCT00463606|540527478|FG000|Overall Study|Physician Decision|0|||
149834994|NCT00463606|540527479|FG001|Overall Study|Physician Decision|1|||
149834995|NCT00463606|540527480|FG002|Overall Study|Physician Decision|0|||
149834996|NCT00463606|540527478|FG000|Overall Study|Sponsor request|0|||
149834997|NCT00463606|540527479|FG001|Overall Study|Sponsor request|1|||
150280815|NCT04329702|542165181|FG000|Overall Study|illness|3|||
149834998|NCT00463606|540527480|FG002|Overall Study|Sponsor request|0|||
149834999|NCT00463606|540527478|FG000|Overall Study|Exclusion criteria violation|2|||
149835000|NCT00463606|540527479|FG001|Overall Study|Exclusion criteria violation|0|||
149835001|NCT00463606|540527480|FG002|Overall Study|Exclusion criteria violation|0|||
149835002|NCT00463606|540527478|FG000|Overall Study|Coordinator error|1|||
149835003|NCT00463606|540527479|FG001|Overall Study|Coordinator error|0|||
149835004|NCT00463606|540527480|FG002|Overall Study|Coordinator error|0|||
149835005|NCT00463606|540527478|FG000|Overall Study|Patient randomized in error|1|||
149835006|NCT00463606|540527479|FG001|Overall Study|Patient randomized in error|0|||
149835007|NCT00463606|540527480|FG002|Overall Study|Patient randomized in error|0|||
149835008|NCT00463606|540527478|FG000|Overall Study|Participation in another ABT-335 trial|1|||
149835009|NCT00463606|540527479|FG001|Overall Study|Participation in another ABT-335 trial|0|||
149835010|NCT00463606|540527480|FG002|Overall Study|Participation in another ABT-335 trial|0|||
149835011|NCT00463606|540527478|FG000|Overall Study|Protocol Violation|0|||
150280816|NCT04329702|542165182|FG001|Overall Study|illness|4|||
149835012|NCT00463606|540527479|FG001|Overall Study|Protocol Violation|0|||
149835013|NCT00463606|540527480|FG002|Overall Study|Protocol Violation|1|||
149835014|NCT01223365|540527482|FG000|Open-label Titration Period|Enrolled but not treated|1|||
149835015|NCT01223365|540527482|FG000|Open-label Titration Period|Adverse Event|23|||
149835016|NCT01223365|540527482|FG000|Open-label Titration Period|Lack of Efficacy|3|||
149835017|NCT01223365|540527482|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
149835018|NCT01223365|540527482|FG000|Open-label Titration Period|Protocol Violation|1|||
149835019|NCT01223365|540527482|FG000|Open-label Titration Period|Lost to Follow-up|2|||
149835020|NCT01223365|540527482|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
149835021|NCT01223365|540527482|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
149835022|NCT01223365|540527482|FG000|Open-label Titration Period|Starting physical therapy|1|||
149835023|NCT01223365|540527482|FG000|Open-label Treatment Period|Adverse Event|39|||
149835024|NCT01223365|540527482|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
149835025|NCT01223365|540527482|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
149835026|NCT01223365|540527482|FG000|Open-label Treatment Period|Protocol Violation|15|||
149835027|NCT01223365|540527482|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
149835028|NCT01223365|540527482|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
149835029|NCT01223365|540527482|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
149835030|NCT01223365|540527482|FG000|Open-label Treatment Period|Moved out of area|2|||
149835031|NCT01223365|540527482|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
149835032|NCT01223365|540527482|FG000|Open-label Treatment Period|"Out of window"|1|||
149835033|NCT01223365|540527482|FG000|Open-label Treatment Period|Starting physical therapy|1|||
149835034|NCT01223365|540527482|FG000|Open-label Treatment Period|Physician Decision|2|||
149835035|NCT02682602|540527483|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
149835036|NCT02682602|540527484|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
149835037|NCT02682602|540527483|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
149835038|NCT02682602|540527484|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
149835039|NCT02140060|540527485|FG000|Overall Study|Adverse Event|0|||
149835040|NCT02140060|540527486|FG001|Overall Study|Adverse Event|0|||
149835041|NCT02140060|540527487|FG002|Overall Study|Adverse Event|0|||
149835042|NCT02140060|540527488|FG003|Overall Study|Adverse Event|1|||
149835043|NCT02140060|540527489|FG004|Overall Study|Adverse Event|1|||
149835044|NCT02140060|540527490|FG005|Overall Study|Adverse Event|1|||
149835045|NCT02140060|540527485|FG000|Overall Study|Lack of Efficacy|0|||
149835046|NCT02140060|540527486|FG001|Overall Study|Lack of Efficacy|0|||
149835047|NCT02140060|540527487|FG002|Overall Study|Lack of Efficacy|0|||
149835048|NCT02140060|540527488|FG003|Overall Study|Lack of Efficacy|1|||
150280817|NCT04329702|542165183|FG002|Overall Study|illness|0|||
150280818|NCT04329702|542165181|FG000|Overall Study|Lost to Follow-up|0|||
150280819|NCT04329702|542165182|FG001|Overall Study|Lost to Follow-up|0|||
150280820|NCT04329702|542165183|FG002|Overall Study|Lost to Follow-up|2|||
150280821|NCT04329702|542165181|FG000|Overall Study|Death|0|||
150280822|NCT04329702|542165182|FG001|Overall Study|Death|2|||
150280823|NCT04329702|542165183|FG002|Overall Study|Death|0|||
150280824|NCT00766532|542165184|FG000|Overall Study|Protocol Violation|2|||
150280825|NCT01438489|542165185|FG000|Overall Study|Lost to Follow-up|4|||
150280826|NCT01438489|542165186|FG001|Overall Study|Lost to Follow-up|2|||
149835049|NCT02140060|540527489|FG004|Overall Study|Lack of Efficacy|0|||
149835050|NCT02140060|540527490|FG005|Overall Study|Lack of Efficacy|0|||
149835051|NCT06358820|540529194|FG000|Overall Study|Adverse Event|11|||
149835052|NCT06358820|540529194|FG000|Overall Study|kidney transplantation|3|||
149835053|NCT06358820|540529194|FG000|Overall Study|patient voluntary withdrawal|6|||
149835054|NCT06358820|540529194|FG000|Overall Study|Physician Decision|1|||
149835055|NCT01811953|540529197|FG000|Overall Study|Adverse Event|0|||
149835056|NCT01811953|540529198|FG001|Overall Study|Adverse Event|0|||
149835057|NCT01811953|540529199|FG002|Overall Study|Adverse Event|0|||
149835058|NCT01811953|540529200|FG003|Overall Study|Adverse Event|1|||
149835059|NCT01811953|540529201|FG004|Overall Study|Adverse Event|0|||
149835060|NCT01811953|540529202|FG005|Overall Study|Adverse Event|1|||
149835061|NCT01811953|540529197|FG000|Overall Study|Protocol Violation|0|||
149835062|NCT01811953|540529198|FG001|Overall Study|Protocol Violation|0|||
149835063|NCT01811953|540529199|FG002|Overall Study|Protocol Violation|0|||
149835064|NCT01811953|540529200|FG003|Overall Study|Protocol Violation|0|||
149835065|NCT01811953|540529201|FG004|Overall Study|Protocol Violation|1|||
149835066|NCT01811953|540529202|FG005|Overall Study|Protocol Violation|0|||
149835067|NCT00070291|540529204|FG000|Step 1|Withdrawal by Subject|1|||
149835068|NCT00070291|540529204|FG000|Step 1|Adverse Event|1|||
149835069|NCT00070291|540529204|FG000|Step 2|Adverse Event|1|||
149835070|NCT00520130|540529205|FG000|Overall Study|Disease progression on study|4|||
149835071|NCT00520130|540529206|FG001|Overall Study|Disease progression on study|0|||
149835072|NCT00520130|540529205|FG000|Overall Study|Physician Decision|1|||
149835073|NCT00520130|540529206|FG001|Overall Study|Physician Decision|1|||
149835074|NCT02533258|540529207|FG000|Overall Study|Adverse Event|1|||
149835075|NCT02533258|540529207|FG000|Overall Study|Death|2|||
149835076|NCT02533258|540529207|FG000|Overall Study|Other|1|||
149835077|NCT02533258|540529207|FG000|Overall Study|Economic factor|1|||
149835078|NCT02533258|540529207|FG000|Overall Study|Progression of pleural effusion|1|||
149835079|NCT02533258|540529207|FG000|Overall Study|Lack of Efficacy|2|||
149835080|NCT03497897|540529208|FG000|Overall Study|Adverse Event|1|||
149835081|NCT03497897|540529209|FG001|Overall Study|Adverse Event|1|||
149835082|NCT03497897|540529210|FG002|Overall Study|Adverse Event|1|||
149835083|NCT03497897|540529208|FG000|Overall Study|Lost to Follow-up|2|||
149835084|NCT03497897|540529209|FG001|Overall Study|Lost to Follow-up|0|||
149835085|NCT03497897|540529210|FG002|Overall Study|Lost to Follow-up|2|||
149835086|NCT03497897|540529208|FG000|Overall Study|Physician Decision|1|||
150171529|NCT01212757|541763543|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
150171530|NCT01212757|541763544|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171531|NCT01212757|541763545|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171532|NCT01212757|541763546|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171533|NCT01212757|541763547|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171534|NCT01212757|541763548|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171535|NCT01212757|541763549|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171536|NCT01212757|541763550|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
150171537|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
150171538|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
150171539|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
150171540|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
150171541|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
150171542|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
150171543|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
150171544|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
150171545|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
150171546|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
150171547|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
150171548|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
150171549|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
150171550|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
150171551|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
150171552|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
150171553|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
150171554|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
150171555|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171556|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171557|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
150171558|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171559|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171560|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171561|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171562|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171563|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
150171564|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
150171565|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
150171566|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
150171567|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
150171568|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
150171569|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
150171570|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
150171571|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
150171572|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
150171573|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171574|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
150171575|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171576|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171577|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
150171578|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171579|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171580|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171581|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
150171582|NCT01212757|541763542|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171583|NCT01212757|541763543|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
150171584|NCT01212757|541763544|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
150280827|NCT01438489|542165187|FG002|Overall Study|Lost to Follow-up|2|||
150280828|NCT01438489|542165185|FG000|Overall Study|Withdrawal by Subject|11|||
150280829|NCT01438489|542165186|FG001|Overall Study|Withdrawal by Subject|3|||
150280830|NCT01438489|542165187|FG002|Overall Study|Withdrawal by Subject|8|||
150280831|NCT01438489|542165185|FG000|Overall Study|Death|0|||
150280832|NCT01438489|542165186|FG001|Overall Study|Death|0|||
150280833|NCT01438489|542165187|FG002|Overall Study|Death|1|||
150280834|NCT01438489|542165185|FG000|Overall Study|Sponsor decision|4|||
150280835|NCT01438489|542165186|FG001|Overall Study|Sponsor decision|1|||
150280836|NCT01438489|542165187|FG002|Overall Study|Sponsor decision|4|||
150280837|NCT01438489|542165185|FG000|Overall Study|Subject choice/Subject moved|2|||
150280838|NCT01438489|542165186|FG001|Overall Study|Subject choice/Subject moved|1|||
150280839|NCT01438489|542165187|FG002|Overall Study|Subject choice/Subject moved|1|||
150280840|NCT01438489|542165185|FG000|Overall Study|Investigator decision|0|||
150280841|NCT01438489|542165186|FG001|Overall Study|Investigator decision|1|||
150280842|NCT01438489|542165187|FG002|Overall Study|Investigator decision|0|||
149949189|NCT05567172|540946015|FG000|Overall Study|Death|3|||
150171585|NCT01212757|541763545|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171586|NCT01212757|541763546|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171587|NCT01212757|541763547|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171588|NCT01212757|541763548|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171589|NCT01212757|541763549|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171590|NCT01212757|541763550|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
150171591|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171592|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171593|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171594|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171595|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171596|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171597|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171598|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
150171599|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
150171600|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
150171601|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
150171602|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
150171603|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
150171604|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
150171605|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
150171606|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
150171607|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
150171608|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
150171609|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171610|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
150171611|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
150171612|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171613|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171614|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171615|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171616|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
150171617|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
150171618|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150171619|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
150171620|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
150171621|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150280843|NCT01438489|542165185|FG000|Overall Study|AE/SAEs|2|||
150280844|NCT01438489|542165186|FG001|Overall Study|AE/SAEs|1|||
150280845|NCT01438489|542165187|FG002|Overall Study|AE/SAEs|1|||
150280846|NCT01438489|542165185|FG000|Overall Study|Received prohibited medication|1|||
150280847|NCT01438489|542165186|FG001|Overall Study|Received prohibited medication|0|||
150280848|NCT01438489|542165187|FG002|Overall Study|Received prohibited medication|0|||
150280849|NCT01438489|542165185|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
150280850|NCT01438489|542165186|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
150280851|NCT01438489|542165187|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
150280852|NCT01438489|542165185|FG000|Overall Study|Inadequate venous access|0|||
149835087|NCT03497897|540529209|FG001|Overall Study|Physician Decision|0|||
149835088|NCT03497897|540529210|FG002|Overall Study|Physician Decision|0|||
149835089|NCT03497897|540529208|FG000|Overall Study|Subject/Guardian Decision|2|||
149835090|NCT03497897|540529209|FG001|Overall Study|Subject/Guardian Decision|1|||
149835091|NCT03497897|540529210|FG002|Overall Study|Subject/Guardian Decision|3|||
149835092|NCT00723528|540529211|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835093|NCT00723528|540529212|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835094|NCT00723528|540529213|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
149835095|NCT00723528|540529214|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835096|NCT00723528|540529215|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835097|NCT00723528|540529216|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835098|NCT00723528|540529217|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
149835099|NCT00723528|540529211|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
149835100|NCT00723528|540529212|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835101|NCT00723528|540529213|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835102|NCT00723528|540529214|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835103|NCT00723528|540529215|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835104|NCT00723528|540529216|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835105|NCT00723528|540529217|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
149835106|NCT00723528|540529211|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
149835107|NCT00723528|540529212|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
149835108|NCT00723528|540529213|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
149835109|NCT00723528|540529214|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
149835110|NCT00723528|540529215|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
149835111|NCT00723528|540529216|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
150171622|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150171623|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149835112|NCT00723528|540529217|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
149835113|NCT00723528|540529211|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835114|NCT00723528|540529212|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835115|NCT00723528|540529213|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
149835116|NCT00723528|540529214|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835117|NCT00723528|540529215|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835118|NCT00723528|540529216|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835119|NCT00723528|540529217|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
149835120|NCT00723528|540529211|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
149835121|NCT00723528|540529212|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
149835122|NCT00723528|540529213|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
149835123|NCT00723528|540529214|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
149835124|NCT00723528|540529215|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
149835125|NCT00723528|540529216|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
149835126|NCT00723528|540529217|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
149835127|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
149835128|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
149835129|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
149835130|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
149835131|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
149835132|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
149835133|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
149835134|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835135|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835136|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835137|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835138|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835139|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
149835140|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
149835141|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Other|0|||
149835142|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Other|0|||
149835143|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Other|0|||
150171624|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150171625|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
150171626|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
150171627|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171628|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171629|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
150171630|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171631|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171632|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171633|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171634|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171635|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
150171636|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171637|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
150171638|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
150171639|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171640|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171641|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171642|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171643|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
150171644|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
150171645|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
150171646|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
150171647|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
150171648|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
150171649|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
150171650|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
150171651|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
150171652|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
150171653|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
150171654|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171655|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171656|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
150171657|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171658|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171659|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171660|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171661|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171662|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
150171663|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150171664|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
150171665|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
150171666|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150171667|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150171668|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150171669|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150171670|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
150171671|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
150171672|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171673|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171674|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171675|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171676|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171677|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171678|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
150171679|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149835144|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Other|0|||
149835145|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Other|1|||
149835146|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Other|4|||
149835147|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Other|0|||
149835148|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Adverse Event|0|||
149835149|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Adverse Event|0|||
149835150|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Adverse Event|0|||
149835151|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Adverse Event|0|||
149835152|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Adverse Event|1|||
149835153|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Adverse Event|0|||
150171680|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
150171681|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
150171682|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
150171683|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149835154|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Adverse Event|1|||
149835155|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835156|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835157|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835158|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835159|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835160|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
149835161|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
149835162|NCT00723528|540529211|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835163|NCT00723528|540529212|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835164|NCT00723528|540529213|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835165|NCT00723528|540529214|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835166|NCT00723528|540529215|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835167|NCT00723528|540529216|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
149835168|NCT00723528|540529217|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
149835169|NCT01993030|540529219|FG000|Overall Study|Adverse Event|0|||
149835170|NCT01993030|540529220|FG001|Overall Study|Adverse Event|4|||
149835171|NCT01591785|540529223|FG000|Overall Study|worsening condition|1|||
149835172|NCT01591785|540529224|FG001|Overall Study|worsening condition|2|||
149835173|NCT01591785|540529223|FG000|Overall Study|Protocol Violation|2|||
149835174|NCT01591785|540529224|FG001|Overall Study|Protocol Violation|0|||
149835175|NCT01591785|540529223|FG000|Overall Study|Lost to Follow-up|1|||
149835176|NCT01591785|540529224|FG001|Overall Study|Lost to Follow-up|0|||
149835177|NCT00667862|540529225|FG000|Overall Study|Adverse Event|9|||
149835178|NCT00667862|540529225|FG000|Overall Study|Death|1|||
149835179|NCT00667862|540529225|FG000|Overall Study|Disease Progression|22|||
149835180|NCT00667862|540529225|FG000|Overall Study|Withdrawal by Subject|3|||
149835181|NCT01049334|540529226|FG000|Overall Study|Withdrawal by Subject|5|||
149835182|NCT01049334|540529227|FG001|Overall Study|Withdrawal by Subject|3|||
149835183|NCT01049334|540529226|FG000|Overall Study|Adverse Event|2|||
149835184|NCT01049334|540529227|FG001|Overall Study|Adverse Event|3|||
149835185|NCT01049334|540529226|FG000|Overall Study|Physician Decision|2|||
149835186|NCT01049334|540529227|FG001|Overall Study|Physician Decision|0|||
149835187|NCT01049334|540529226|FG000|Overall Study|Protocol Violation|0|||
149835188|NCT01049334|540529227|FG001|Overall Study|Protocol Violation|1|||
149835189|NCT04123548|540529231|FG000|Overall Study|Withdrawal by Subject|1|||
149835190|NCT04123548|540529231|FG000|Overall Study|Lost to Follow-up|8|||
149835191|NCT04123548|540529231|FG000|Overall Study|Death|4|||
149835192|NCT04123548|540529231|FG000|Overall Study|Reason Not Specified|1|||
149835193|NCT01171989|540529232|FG000|Overall Study|Lost to Follow-up|0|||
149835194|NCT01171989|540529233|FG001|Overall Study|Lost to Follow-up|0|||
149835195|NCT01171989|540529234|FG002|Overall Study|Lost to Follow-up|1|||
149835196|NCT01247701|540529237|FG000|Overall Study|Death|2|||
149835197|NCT01247701|540529237|FG000|Overall Study|Relapsed|8|||
149835198|NCT04166630|540529238|FG000|Overall Study|Withdrawal by Subject|0|||
149835199|NCT04166630|540529239|FG001|Overall Study|Withdrawal by Subject|1|||
149835200|NCT01034358|540529240|FG000|Overall Study|Withdrawal by Subject|1|||
149835201|NCT01034358|540529240|FG000|Overall Study|Protocol Violation|1|||
149835202|NCT01534663|540529243|FG000|Overall Study|Lost to Follow-up|0|||
149835203|NCT01534663|540529244|FG001|Overall Study|Lost to Follow-up|2|||
149835204|NCT01534663|540529243|FG000|Overall Study|Adverse Event|2|||
149835205|NCT01534663|540529244|FG001|Overall Study|Adverse Event|1|||
149835206|NCT00627016|540529245|FG000|Overall Study|Adverse Event|1|||
149835207|NCT00627016|540529246|FG001|Overall Study|Adverse Event|1|||
149835208|NCT00627016|540529245|FG000|Overall Study|Protocol Violation|0|||
149835209|NCT00627016|540529246|FG001|Overall Study|Protocol Violation|2|||
149835210|NCT00627016|540529245|FG000|Overall Study|Lost to Follow-up|0|||
149835211|NCT00627016|540529246|FG001|Overall Study|Lost to Follow-up|1|||
149835212|NCT00627016|540529245|FG000|Overall Study|Withdrawal by Subject|2|||
149835213|NCT00627016|540529246|FG001|Overall Study|Withdrawal by Subject|1|||
149835214|NCT00627016|540529245|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
149835215|NCT00627016|540529246|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
149835216|NCT00627016|540529245|FG000|Overall Study|Lack of Efficacy|1|||
149835217|NCT00627016|540529246|FG001|Overall Study|Lack of Efficacy|0|||
149835218|NCT00627016|540529245|FG000|Overall Study|Placed on Excluded Drugs|1|||
149835219|NCT00627016|540529246|FG001|Overall Study|Placed on Excluded Drugs|0|||
149835220|NCT00627016|540529245|FG000|Overall Study|Pregnancy|1|||
149835221|NCT00627016|540529246|FG001|Overall Study|Pregnancy|0|||
149835222|NCT04088760|540529249|FG000|Overall Study|Physician Decision|1|||
149835223|NCT00377260|540529250|FG000|Overall Study|Lost to Follow-up|0|||
149835224|NCT00377260|540529251|FG001|Overall Study|Lost to Follow-up|1|||
149835225|NCT00377260|540529250|FG000|Overall Study|Withdrawal by Subject|2|||
149835226|NCT00377260|540529251|FG001|Overall Study|Withdrawal by Subject|4|||
149835227|NCT00829530|540529252|FG000|First Intervention|Adverse Event|0|||
149835228|NCT00829530|540529253|FG001|First Intervention|Adverse Event|1|||
149835229|NCT00829530|540529252|FG000|First Intervention|Intolerance to Venopuncture|0|||
149835230|NCT00829530|540529253|FG001|First Intervention|Intolerance to Venopuncture|1|||
149835231|NCT00829530|540529252|FG000|Second Intervention|Intolerance to Venopuncture|1|||
149835232|NCT00829530|540529253|FG001|Second Intervention|Intolerance to Venopuncture|0|||
149835233|NCT01391793|540529254|FG000|Overall Study|Ineligible|3|||
149835234|NCT01391793|540529255|FG001|Overall Study|Ineligible|0|||
149835235|NCT01391793|540529254|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
149835236|NCT01391793|540529255|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
149835237|NCT01391793|540529254|FG000|Overall Study|No DMSA|73|||
149835238|NCT01391793|540529255|FG001|Overall Study|No DMSA|57|||
149835239|NCT01015625|540529256|FG000|Overall Study|Lost to Follow-up|3|||
149835240|NCT01015625|540529257|FG001|Overall Study|Lost to Follow-up|1|||
149835241|NCT01015625|540529256|FG000|Overall Study|Withdrawal by Subject|2|||
149835242|NCT01015625|540529257|FG001|Overall Study|Withdrawal by Subject|3|||
149835243|NCT01015625|540529256|FG000|Overall Study|Physician Decision|2|||
149835244|NCT01015625|540529257|FG001|Overall Study|Physician Decision|0|||
149835245|NCT01015625|540529256|FG000|Overall Study|Death|30|||
149835246|NCT01015625|540529257|FG001|Overall Study|Death|22|||
149835247|NCT04466111|540529260|FG000|Prior to Trial Phase|Physician Decision|1|||
149835248|NCT00105196|540529261|FG000|Overall Study|Lack of Efficacy|2|||
149835249|NCT00105196|540529262|FG001|Overall Study|Lack of Efficacy|3|||
149835250|NCT00105196|540529261|FG000|Overall Study|Adverse Event|11|||
149835251|NCT00105196|540529262|FG001|Overall Study|Adverse Event|3|||
149835252|NCT00105196|540529261|FG000|Overall Study|Withdrawal by Subject|6|||
149835253|NCT00105196|540529262|FG001|Overall Study|Withdrawal by Subject|6|||
149835254|NCT00105196|540529261|FG000|Overall Study|Lost to Follow-up|3|||
149835255|NCT00105196|540529262|FG001|Overall Study|Lost to Follow-up|2|||
149835256|NCT00105196|540529261|FG000|Overall Study|Poor/noncompliance|3|||
149835257|NCT00105196|540529262|FG001|Overall Study|Poor/noncompliance|4|||
149835258|NCT00105196|540529261|FG000|Overall Study|Protocol Violation|5|||
149835259|NCT00105196|540529262|FG001|Overall Study|Protocol Violation|2|||
149835260|NCT00105196|540529261|FG000|Overall Study|pending surgery|0|||
149835261|NCT00105196|540529262|FG001|Overall Study|pending surgery|1|||
149835262|NCT00105196|540529261|FG000|Overall Study|marijuana use|0|||
149835263|NCT00105196|540529262|FG001|Overall Study|marijuana use|1|||
149835264|NCT00105196|540529261|FG000|Overall Study|Subject became unblinded|0|||
149835265|NCT00105196|540529262|FG001|Overall Study|Subject became unblinded|1|||
149835266|NCT00893464|540529263|FG000|Overall Study|Did not complete therapy/experience PD|0|||
149835267|NCT00893464|540529264|FG001|Overall Study|Did not complete therapy/experience PD|0|||
149835268|NCT00893464|540529265|FG002|Overall Study|Did not complete therapy/experience PD|0|||
149835269|NCT00893464|540529266|FG003|Overall Study|Did not complete therapy/experience PD|0|||
149835270|NCT00893464|540529267|FG004|Overall Study|Did not complete therapy/experience PD|0|||
149835271|NCT00893464|540529268|FG005|Overall Study|Did not complete therapy/experience PD|0|||
149835272|NCT00893464|540529269|FG006|Overall Study|Did not complete therapy/experience PD|2|||
149835273|NCT00893464|540529270|FG007|Overall Study|Did not complete therapy/experience PD|2|||
149835274|NCT00286754|540529271|FG000|Overall Study|Adverse Event|2|||
149835275|NCT00286754|540529272|FG001|Overall Study|Adverse Event|2|||
149835276|NCT00286754|540529273|FG002|Overall Study|Adverse Event|3|||
149835277|NCT00286754|540529271|FG000|Overall Study|Withdrawal by Subject|6|||
149835278|NCT00286754|540529272|FG001|Overall Study|Withdrawal by Subject|2|||
149835279|NCT00286754|540529273|FG002|Overall Study|Withdrawal by Subject|0|||
149835280|NCT00286754|540529271|FG000|Overall Study|Lost to Follow-up|12|||
149835281|NCT00286754|540529272|FG001|Overall Study|Lost to Follow-up|14|||
149835282|NCT00286754|540529273|FG002|Overall Study|Lost to Follow-up|6|||
149835283|NCT00286754|540529271|FG000|Overall Study|Moved out of state|0|||
149835284|NCT00286754|540529272|FG001|Overall Study|Moved out of state|0|||
149835285|NCT00286754|540529273|FG002|Overall Study|Moved out of state|1|||
149835286|NCT00910663|540529274|FG000|Period 1|Withdrawal by Subject|0|||
149835287|NCT00910663|540529275|FG001|Period 1|Withdrawal by Subject|1|||
149835288|NCT01844375|540529279|FG000|Overall Study|Protocol Violation|1|||
149835289|NCT01844375|540529280|FG001|Overall Study|Protocol Violation|1|||
149835290|NCT03627091|540529281|FG000|Overall Study|Adverse Event|0|||
149835291|NCT03627091|540529282|FG001|Overall Study|Adverse Event|0|||
149835292|NCT03627091|540529283|FG002|Overall Study|Adverse Event|2|||
149835293|NCT03627091|540529281|FG000|Overall Study|Withdrawal by Subject|2|||
149835294|NCT03627091|540529282|FG001|Overall Study|Withdrawal by Subject|0|||
149835295|NCT03627091|540529283|FG002|Overall Study|Withdrawal by Subject|2|||
149835296|NCT03627091|540529281|FG000|Overall Study|Physician Decision|2|||
149835297|NCT03627091|540529282|FG001|Overall Study|Physician Decision|0|||
149835298|NCT03627091|540529283|FG002|Overall Study|Physician Decision|0|||
149835299|NCT03627091|540529281|FG000|Overall Study|Site terminated by sponsor|0|||
149835300|NCT03627091|540529282|FG001|Overall Study|Site terminated by sponsor|1|||
149835301|NCT03627091|540529283|FG002|Overall Study|Site terminated by sponsor|0|||
149835302|NCT03627091|540529281|FG000|Overall Study|Disease relapse|7|||
149835303|NCT03627091|540529282|FG001|Overall Study|Disease relapse|5|||
149835304|NCT03627091|540529283|FG002|Overall Study|Disease relapse|1|||
149835305|NCT03627091|540529281|FG000|Overall Study|Other|1|||
149835306|NCT03627091|540529282|FG001|Overall Study|Other|0|||
149835307|NCT03627091|540529283|FG002|Overall Study|Other|0|||
149835308|NCT01498120|540529284|FG000|Overall Study|Lost to Follow-up|1|||
149835309|NCT01498120|540529284|FG000|Overall Study|Withdrawal by Subject|5|||
149835310|NCT01498120|540529284|FG000|Overall Study|AE, non-serious non-fatal|3|||
149835311|NCT01498120|540529284|FG000|Overall Study|Other|4|||
149835312|NCT00678639|540529287|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
149835313|NCT00678639|540529288|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
149835314|NCT01546545|540529291|FG000|Overall Study|Withdrawal by Subject|1|||
149835315|NCT04060147|540529292|FG000|Overall Study|Withdrew consent|1|||
149835316|NCT00336479|540529293|FG000|Overall Study|Adverse Event|8|||
149835317|NCT00336479|540529294|FG001|Overall Study|Adverse Event|11|||
149835318|NCT00336479|540529295|FG002|Overall Study|Adverse Event|18|||
149835319|NCT00336479|540529296|FG003|Overall Study|Adverse Event|4|||
149835320|NCT00336479|540529293|FG000|Overall Study|Noncompliant|1|||
149835321|NCT00336479|540529294|FG001|Overall Study|Noncompliant|7|||
149835322|NCT00336479|540529295|FG002|Overall Study|Noncompliant|3|||
149835323|NCT00336479|540529296|FG003|Overall Study|Noncompliant|0|||
149835324|NCT00336479|540529293|FG000|Overall Study|Physician Decision|2|||
149835325|NCT00336479|540529294|FG001|Overall Study|Physician Decision|3|||
149835326|NCT00336479|540529295|FG002|Overall Study|Physician Decision|1|||
149835327|NCT00336479|540529296|FG003|Overall Study|Physician Decision|0|||
149835328|NCT00336479|540529293|FG000|Overall Study|Lost to Follow-up|3|||
149835329|NCT00336479|540529294|FG001|Overall Study|Lost to Follow-up|2|||
149835330|NCT00336479|540529295|FG002|Overall Study|Lost to Follow-up|0|||
149835331|NCT00336479|540529296|FG003|Overall Study|Lost to Follow-up|0|||
149835332|NCT00336479|540529293|FG000|Overall Study|Withdrawal by Subject|3|||
149835333|NCT00336479|540529294|FG001|Overall Study|Withdrawal by Subject|2|||
149835334|NCT00336479|540529295|FG002|Overall Study|Withdrawal by Subject|3|||
149835335|NCT00336479|540529296|FG003|Overall Study|Withdrawal by Subject|0|||
149835336|NCT00336479|540529293|FG000|Overall Study|Other|0|||
149835337|NCT00336479|540529294|FG001|Overall Study|Other|0|||
149835338|NCT00336479|540529295|FG002|Overall Study|Other|1|||
149835339|NCT00336479|540529296|FG003|Overall Study|Other|0|||
149835340|NCT00336479|540529293|FG000|Overall Study|Virologic Stopping Rule|20|||
149835341|NCT00336479|540529294|FG001|Overall Study|Virologic Stopping Rule|0|||
149835342|NCT00336479|540529295|FG002|Overall Study|Virologic Stopping Rule|0|||
149835343|NCT00336479|540529296|FG003|Overall Study|Virologic Stopping Rule|0|||
149835344|NCT00550537|540529297|FG000|Overall Study|Death|18|||
149835345|NCT00550537|540529297|FG000|Overall Study|Adverse Event|20|||
149835346|NCT00550537|540529297|FG000|Overall Study|Disease progression before|46|||
149835347|NCT00550537|540529297|FG000|Overall Study|Withdrawal by Subject|7|||
149835348|NCT00550537|540529297|FG000|Overall Study|Change in treatment plan|4|||
149835349|NCT00550537|540529297|FG000|Overall Study|Other complicating ilness|3|||
149835350|NCT00550537|540529297|FG000|Overall Study|Declining performance status|2|||
149835351|NCT00550537|540529297|FG000|Overall Study|Treated closer to home|4|||
149835352|NCT02008565|540529298|FG000|Overall Study|Protocol Violation|1|||
149835353|NCT02008565|540529299|FG001|Overall Study|Protocol Violation|1|||
149835354|NCT02008565|540529300|FG002|Overall Study|Protocol Violation|2|||
149835355|NCT02008565|540529301|FG003|Overall Study|Protocol Violation|0|||
149835356|NCT00268905|540529302|FG000|Overall Study|Adverse Event|3|||
149835357|NCT00268905|540529303|FG001|Overall Study|Adverse Event|0|||
149835358|NCT00268905|540529304|FG002|Overall Study|Adverse Event|4|||
149835359|NCT00268905|540529302|FG000|Overall Study|Lost to Follow-up|0|||
149835360|NCT00268905|540529303|FG001|Overall Study|Lost to Follow-up|1|||
149835361|NCT00268905|540529304|FG002|Overall Study|Lost to Follow-up|0|||
149835362|NCT00268905|540529302|FG000|Overall Study|Withdrawal by Subject|0|||
149835363|NCT00268905|540529303|FG001|Overall Study|Withdrawal by Subject|0|||
149835364|NCT00268905|540529304|FG002|Overall Study|Withdrawal by Subject|3|||
149835365|NCT00268905|540529302|FG000|Overall Study|Progressive Disease|28|||
149835366|NCT00268905|540529303|FG001|Overall Study|Progressive Disease|4|||
149835367|NCT00268905|540529304|FG002|Overall Study|Progressive Disease|3|||
149835368|NCT00268905|540529302|FG000|Overall Study|Physician Decision|3|||
149835369|NCT00268905|540529303|FG001|Overall Study|Physician Decision|0|||
149835370|NCT00268905|540529304|FG002|Overall Study|Physician Decision|1|||
149835371|NCT00268905|540529302|FG000|Overall Study|Clinical Progression|9|||
149835372|NCT00268905|540529303|FG001|Overall Study|Clinical Progression|4|||
149835373|NCT00268905|540529304|FG002|Overall Study|Clinical Progression|1|||
149835374|NCT00617305|540529305|FG000|Overall Study|Adverse Event|4|||
149835375|NCT00617305|540529306|FG001|Overall Study|Adverse Event|0|||
149835376|NCT00617305|540529307|FG002|Overall Study|Adverse Event|0|||
149835377|NCT00617305|540529305|FG000|Overall Study|Death|1|||
149835378|NCT00617305|540529306|FG001|Overall Study|Death|0|||
149835379|NCT00617305|540529307|FG002|Overall Study|Death|0|||
149835380|NCT00617305|540529305|FG000|Overall Study|Physician Decision|1|||
149835381|NCT00617305|540529306|FG001|Overall Study|Physician Decision|0|||
149835382|NCT00617305|540529307|FG002|Overall Study|Physician Decision|0|||
149835383|NCT00617305|540529305|FG000|Overall Study|Protocol Violation|1|||
149835384|NCT00617305|540529306|FG001|Overall Study|Protocol Violation|0|||
149835385|NCT00617305|540529307|FG002|Overall Study|Protocol Violation|1|||
149835386|NCT00617305|540529305|FG000|Overall Study|Withdrawal by Subject|1|||
149835387|NCT00617305|540529306|FG001|Overall Study|Withdrawal by Subject|0|||
149835388|NCT00617305|540529307|FG002|Overall Study|Withdrawal by Subject|0|||
149835389|NCT02193178|540529308|FG000|Overall Study|Lost to Follow-up|1|||
149835390|NCT02193178|540529308|FG000|Overall Study|Dry eyes|1|||
149835391|NCT03435081|540529309|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
149835392|NCT03435081|540529310|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
149835393|NCT03435081|540529311|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
149835394|NCT03435081|540529309|FG000|Week 0 to Week 16|Adverse Event|2|||
149835395|NCT03435081|540529310|FG001|Week 0 to Week 16|Adverse Event|2|||
149835396|NCT03435081|540529311|FG002|Week 0 to Week 16|Adverse Event|2|||
149835397|NCT03435081|540529309|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
149835398|NCT03435081|540529310|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
149835399|NCT03435081|540529311|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
149835400|NCT03435081|540529309|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
149835401|NCT03435081|540529310|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
149835402|NCT03435081|540529311|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
149835403|NCT03435081|540529309|FG000|Week 0 to Week 16|Pregnancy|1|||
149835404|NCT03435081|540529310|FG001|Week 0 to Week 16|Pregnancy|0|||
149835405|NCT03435081|540529311|FG002|Week 0 to Week 16|Pregnancy|0|||
149835406|NCT03435081|540529309|FG000|Week 0 to Week 16|Non-compliance|1|||
149835407|NCT03435081|540529310|FG001|Week 0 to Week 16|Non-compliance|0|||
149835408|NCT03435081|540529311|FG002|Week 0 to Week 16|Non-compliance|2|||
149835409|NCT03435081|540529309|FG000|Week 0 to Week 16|Inadequate Response|0|||
149835410|NCT03435081|540529310|FG001|Week 0 to Week 16|Inadequate Response|1|||
149835411|NCT03435081|540529311|FG002|Week 0 to Week 16|Inadequate Response|0|||
149835412|NCT03435081|540529309|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
149835413|NCT03435081|540529310|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
149835414|NCT03435081|540529311|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
149835415|NCT03435081|540529309|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
149835416|NCT03435081|540529310|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
149835417|NCT03435081|540529311|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
149835418|NCT03435081|540529309|FG000|Week 16 to Week 104|Adverse Event|1|||
149835419|NCT03435081|540529310|FG001|Week 16 to Week 104|Adverse Event|0|||
149835420|NCT03435081|540529311|FG002|Week 16 to Week 104|Adverse Event|2|||
149835421|NCT03435081|540529309|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
149835422|NCT03435081|540529310|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
149835423|NCT03435081|540529311|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
149835424|NCT03435081|540529309|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
149835425|NCT03435081|540529310|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
149835426|NCT03435081|540529311|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
149835427|NCT03435081|540529309|FG000|Week 16 to Week 104|Non--Compliance|0|||
149835428|NCT03435081|540529310|FG001|Week 16 to Week 104|Non--Compliance|0|||
149835429|NCT03435081|540529311|FG002|Week 16 to Week 104|Non--Compliance|1|||
149835430|NCT00420238|540529312|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
149835431|NCT00420238|540529313|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
149835432|NCT00420238|540529312|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
149835433|NCT00420238|540529313|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
149835434|NCT00420238|540529312|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
149835435|NCT00420238|540529313|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
149835436|NCT00420238|540529312|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
149835437|NCT00420238|540529313|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
149835438|NCT00420238|540529312|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
149835439|NCT00420238|540529313|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
149835440|NCT00420238|540529312|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
149835441|NCT00420238|540529313|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
149835442|NCT00048581|540529314|FG000|Double-Blind Period|Adverse Event|9|||
149835443|NCT00048581|540529315|FG001|Double-Blind Period|Adverse Event|5|||
149835444|NCT00048581|540529316|FG002|Double-Blind Period|Adverse Event|0|||
149835445|NCT00048581|540529314|FG000|Double-Blind Period|Lack of Efficacy|14|||
149835446|NCT00048581|540529315|FG001|Double-Blind Period|Lack of Efficacy|27|||
149835447|NCT00048581|540529316|FG002|Double-Blind Period|Lack of Efficacy|0|||
149835448|NCT00048581|540529314|FG000|Double-Blind Period|Lost to Follow-up|5|||
149835449|NCT00048581|540529315|FG001|Double-Blind Period|Lost to Follow-up|0|||
149835450|NCT00048581|540529316|FG002|Double-Blind Period|Lost to Follow-up|0|||
149835451|NCT00048581|540529314|FG000|Double-Blind Period|Withdrawal by Subject|5|||
149835452|NCT00048581|540529315|FG001|Double-Blind Period|Withdrawal by Subject|2|||
149835453|NCT00048581|540529316|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149835454|NCT00048581|540529314|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
149835455|NCT00048581|540529315|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
149835456|NCT00048581|540529316|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
149835457|NCT00048581|540529314|FG000|Double-Blind Period|Investigator Decision|1|||
149835458|NCT00048581|540529315|FG001|Double-Blind Period|Investigator Decision|0|||
149835459|NCT00048581|540529316|FG002|Double-Blind Period|Investigator Decision|0|||
149835460|NCT00048581|540529314|FG000|Open-Label Period|Death|0|||
149835461|NCT00048581|540529315|FG001|Open-Label Period|Death|0|||
149835462|NCT00048581|540529316|FG002|Open-Label Period|Death|4|||
149835463|NCT00048581|540529314|FG000|Open-Label Period|Adverse Event|0|||
149835464|NCT00048581|540529315|FG001|Open-Label Period|Adverse Event|0|||
149835465|NCT00048581|540529316|FG002|Open-Label Period|Adverse Event|37|||
149835466|NCT00048581|540529314|FG000|Open-Label Period|Lack of Efficacy|0|||
149835467|NCT00048581|540529315|FG001|Open-Label Period|Lack of Efficacy|0|||
149835468|NCT00048581|540529316|FG002|Open-Label Period|Lack of Efficacy|69|||
149835469|NCT00048581|540529314|FG000|Open-Label Period|Lost to Follow-up|0|||
149835470|NCT00048581|540529315|FG001|Open-Label Period|Lost to Follow-up|0|||
149835471|NCT00048581|540529316|FG002|Open-Label Period|Lost to Follow-up|14|||
149835472|NCT00048581|540529314|FG000|Open-Label Period|Withdrawal by Subject|0|||
149835473|NCT00048581|540529315|FG001|Open-Label Period|Withdrawal by Subject|0|||
149835474|NCT00048581|540529316|FG002|Open-Label Period|Withdrawal by Subject|20|||
149835475|NCT00048581|540529314|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
149835476|NCT00048581|540529315|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
149835477|NCT00048581|540529316|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
149835478|NCT00048581|540529314|FG000|Open-Label Period|Poor/Non-compliance|0|||
149835479|NCT00048581|540529315|FG001|Open-Label Period|Poor/Non-compliance|0|||
149835480|NCT00048581|540529316|FG002|Open-Label Period|Poor/Non-compliance|5|||
149835481|NCT00048581|540529314|FG000|Open-Label Period|Pregnancy|0|||
149835482|NCT00048581|540529315|FG001|Open-Label Period|Pregnancy|0|||
149835483|NCT00048581|540529316|FG002|Open-Label Period|Pregnancy|7|||
149835484|NCT00048581|540529314|FG000|Open-Label Period|Study Site Closure|0|||
149835485|NCT00048581|540529315|FG001|Open-Label Period|Study Site Closure|0|||
149835486|NCT00048581|540529316|FG002|Open-Label Period|Study Site Closure|2|||
149835487|NCT00048581|540529314|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
149835488|NCT00048581|540529315|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
149835489|NCT00048581|540529316|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
149835490|NCT00048581|540529314|FG000|Open-Label Period|Problem With Transportation To Site|0|||
149835491|NCT00048581|540529315|FG001|Open-Label Period|Problem With Transportation To Site|0|||
149835492|NCT00048581|540529316|FG002|Open-Label Period|Problem With Transportation To Site|1|||
149835493|NCT00048581|540529314|FG000|Open-Label Period|Primary Investigator Retired|0|||
149835494|NCT00048581|540529315|FG001|Open-Label Period|Primary Investigator Retired|0|||
149835495|NCT00048581|540529316|FG002|Open-Label Period|Primary Investigator Retired|2|||
149835496|NCT00048581|540529314|FG000|Open-Label Period|Study Ended By Sponsor|0|||
149835497|NCT00048581|540529315|FG001|Open-Label Period|Study Ended By Sponsor|0|||
149835498|NCT00048581|540529316|FG002|Open-Label Period|Study Ended By Sponsor|1|||
149835499|NCT01406795|540529317|FG000|Overall Study|Withdrawal by Subject|1|||
149835500|NCT03966365|540529318|FG000|Overall Study|Protocol Violation|1|||
149835501|NCT03966365|540529319|FG001|Overall Study|Protocol Violation|0|||
149835502|NCT04753437|540529320|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149835503|NCT04753437|540529321|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
149835504|NCT04753437|540529320|FG000|Overall Study|Liver Function Test Abnormalities|2|||
149835505|NCT04753437|540529321|FG001|Overall Study|Liver Function Test Abnormalities|4|||
149835506|NCT03567174|540529322|FG000|Overall Study|Death|24|||
149835507|NCT03567174|540529323|FG001|Overall Study|Death|31|||
149835508|NCT03567174|540529322|FG000|Overall Study|Lost to Follow-up|165|||
149835509|NCT03567174|540529323|FG001|Overall Study|Lost to Follow-up|174|||
149835510|NCT02865122|540529324|FG000|Overall Study|Adverse Event|1|||
149835511|NCT02865122|540529325|FG001|Overall Study|Adverse Event|0|||
149835512|NCT02865122|540529326|FG002|Overall Study|Adverse Event|0|||
149835513|NCT05376319|540531250|FG000|Overall Study|Funding termination|2|||
149835514|NCT05376319|540531251|FG001|Overall Study|Funding termination|4|||
149835515|NCT01124175|540531252|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
149835516|NCT01124175|540531253|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
149835517|NCT00942968|540531254|FG000|Overall Study|Adverse Event|60|||
149835518|NCT00942968|540531254|FG000|Overall Study|Death|76|||
149835519|NCT00942968|540531254|FG000|Overall Study|Protocol Violation|9|||
149835520|NCT00942968|540531254|FG000|Overall Study|Lost to Follow-up|4|||
149835521|NCT00942968|540531254|FG000|Overall Study|Withdrawal by Subject|44|||
149835522|NCT00942968|540531254|FG000|Overall Study|Sponsor request|5|||
149835523|NCT00942968|540531254|FG000|Overall Study|Physician Decision|11|||
149835524|NCT00942968|540531254|FG000|Overall Study|Progression of disease|12|||
149835525|NCT00942968|540531254|FG000|Overall Study|Inferior vena cava filter placement|4|||
149835526|NCT00942968|540531254|FG000|Overall Study|Pulmonary embolism (PE)|1|||
149835527|NCT00942968|540531254|FG000|Overall Study|Participant required pancreatic biopsy|1|||
149835528|NCT00942968|540531254|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
149835529|NCT01340495|540531257|FG000|Overall Study|Withdrawal by Subject|1|||
149835530|NCT02262377|540531258|FG000|Overall Study|Lost to Follow-up|5|||
149835531|NCT02262377|540531259|FG001|Overall Study|Lost to Follow-up|6|||
149835532|NCT02262377|540531258|FG000|Overall Study|Found ineligible after enrollment|3|||
149835533|NCT02262377|540531259|FG001|Overall Study|Found ineligible after enrollment|0|||
149835534|NCT02262377|540531258|FG000|Overall Study|Withdrawal by Subject|4|||
149835535|NCT02262377|540531259|FG001|Overall Study|Withdrawal by Subject|0|||
149835536|NCT01045096|540531260|FG000|Overall Study|Withdrawal by Subject|2|||
149835537|NCT01045096|540531261|FG001|Overall Study|Withdrawal by Subject|0|||
149835538|NCT01045096|540531262|FG002|Overall Study|Withdrawal by Subject|0|||
149835539|NCT01045096|540531260|FG000|Overall Study|Other|1|||
149835540|NCT01045096|540531261|FG001|Overall Study|Other|0|||
149835541|NCT01045096|540531262|FG002|Overall Study|Other|0|||
149835542|NCT01511939|540531264|FG000|Overall Study|Withdrawal by Subject|2|||
149835543|NCT01511939|540531265|FG001|Overall Study|Withdrawal by Subject|1|||
149835544|NCT01511939|540531266|FG002|Overall Study|Withdrawal by Subject|0|||
149835545|NCT02883452|540531273|FG000|Overall Study|Withdrawal by Subject|1|||
149835546|NCT02883452|540531274|FG001|Overall Study|Withdrawal by Subject|1|||
149835547|NCT02883452|540531275|FG002|Overall Study|Withdrawal by Subject|3|||
149835548|NCT02883452|540531276|FG003|Overall Study|Withdrawal by Subject|0|||
149835549|NCT02883452|540531277|FG004|Overall Study|Withdrawal by Subject|2|||
149835550|NCT02883452|540531278|FG005|Overall Study|Withdrawal by Subject|5|||
149835551|NCT02883452|540531273|FG000|Overall Study|Disease progression|1|||
149835552|NCT02883452|540531274|FG001|Overall Study|Disease progression|0|||
149835553|NCT02883452|540531275|FG002|Overall Study|Disease progression|0|||
149835554|NCT02883452|540531276|FG003|Overall Study|Disease progression|1|||
149835555|NCT02883452|540531277|FG004|Overall Study|Disease progression|4|||
149835556|NCT02883452|540531278|FG005|Overall Study|Disease progression|5|||
149835557|NCT02883452|540531273|FG000|Overall Study|Adverse Event|2|||
149835558|NCT02883452|540531274|FG001|Overall Study|Adverse Event|1|||
149835559|NCT02883452|540531275|FG002|Overall Study|Adverse Event|1|||
149835560|NCT02883452|540531276|FG003|Overall Study|Adverse Event|1|||
149835561|NCT02883452|540531277|FG004|Overall Study|Adverse Event|1|||
149835562|NCT02883452|540531278|FG005|Overall Study|Adverse Event|3|||
149835563|NCT02883452|540531273|FG000|Overall Study|Physician Decision|0|||
149835564|NCT02883452|540531274|FG001|Overall Study|Physician Decision|0|||
149835565|NCT02883452|540531275|FG002|Overall Study|Physician Decision|0|||
149835566|NCT02883452|540531276|FG003|Overall Study|Physician Decision|0|||
149835567|NCT02883452|540531277|FG004|Overall Study|Physician Decision|4|||
149835568|NCT02883452|540531278|FG005|Overall Study|Physician Decision|1|||
149835569|NCT02883452|540531273|FG000|Overall Study|Death|1|||
149835570|NCT02883452|540531274|FG001|Overall Study|Death|0|||
149835571|NCT02883452|540531275|FG002|Overall Study|Death|1|||
149835572|NCT02883452|540531276|FG003|Overall Study|Death|0|||
149835573|NCT02883452|540531277|FG004|Overall Study|Death|0|||
149835574|NCT02883452|540531278|FG005|Overall Study|Death|0|||
149835575|NCT02883452|540531273|FG000|Overall Study|Other|0|||
149835576|NCT02883452|540531274|FG001|Overall Study|Other|0|||
149835577|NCT02883452|540531275|FG002|Overall Study|Other|0|||
149835578|NCT02883452|540531276|FG003|Overall Study|Other|0|||
149835579|NCT02883452|540531277|FG004|Overall Study|Other|0|||
149835580|NCT02883452|540531278|FG005|Overall Study|Other|1|||
149835581|NCT00667095|540531288|FG000|Overall Study|Withdrawal by Subject|0|||
149835582|NCT00667095|540531289|FG001|Overall Study|Withdrawal by Subject|1|||
149835583|NCT01520909|540531290|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
149835584|NCT01520909|540531291|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
149835585|NCT01520909|540531292|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
149835586|NCT01520909|540531290|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
149835587|NCT01520909|540531291|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
149835588|NCT01520909|540531292|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
149835589|NCT01520909|540531290|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
149835590|NCT01520909|540531291|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
149835591|NCT01520909|540531292|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
149835592|NCT01520909|540531290|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
149835593|NCT01520909|540531291|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
149835594|NCT01520909|540531292|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
149835595|NCT01882257|540531294|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
149835596|NCT01882257|540531295|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
149835597|NCT01882257|540531296|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
149835598|NCT01882257|540531294|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
149835599|NCT01882257|540531295|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
149835600|NCT01882257|540531296|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
149835601|NCT00830206|540531297|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
149835602|NCT00830206|540531298|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
149835603|NCT01900691|540531299|FG000|Overall Study|Death|7|||
149835604|NCT01900691|540531299|FG000|Overall Study|Lost to Follow-up|4|||
149835605|NCT01900691|540531299|FG000|Overall Study|Study Device Not Placed|3|||
149835606|NCT01900691|540531299|FG000|Overall Study|Non study stent placed|2|||
149835607|NCT01900691|540531299|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
149835608|NCT01900691|540531299|FG000|Overall Study|Complete stent migration through digestive tract|1|||
149835609|NCT02736721|540531304|FG000|Overall Study|Adverse Event|8|||
149835610|NCT02736721|540531304|FG000|Overall Study|Lost to Follow-up|3|||
149835611|NCT02736721|540531304|FG000|Overall Study|Other|5|||
149835612|NCT04112823|540531307|FG000|Overall Study|Lost to Follow-up|2|||
149835613|NCT04112823|540531308|FG001|Overall Study|Lost to Follow-up|3|||
149835614|NCT00625443|540531309|FG000|Overall Study|Adverse Event|1|||
149835615|NCT00625443|540531310|FG001|Overall Study|Adverse Event|4|||
149835616|NCT00625443|540531311|FG002|Overall Study|Adverse Event|0|||
149835617|NCT00625443|540531309|FG000|Overall Study|Non-compliance with protocol|0|||
149835618|NCT00625443|540531310|FG001|Overall Study|Non-compliance with protocol|1|||
149835619|NCT00625443|540531311|FG002|Overall Study|Non-compliance with protocol|0|||
149835620|NCT00625443|540531309|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
149835621|NCT00625443|540531310|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
149835622|NCT00625443|540531311|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
149835623|NCT00625443|540531309|FG000|Overall Study|Withdrawal by Subject|0|||
149835624|NCT00625443|540531310|FG001|Overall Study|Withdrawal by Subject|1|||
149835625|NCT00625443|540531311|FG002|Overall Study|Withdrawal by Subject|2|||
149835626|NCT00625443|540531309|FG000|Overall Study|Physician Decision|0|||
149835627|NCT00625443|540531310|FG001|Overall Study|Physician Decision|4|||
149835628|NCT00625443|540531311|FG002|Overall Study|Physician Decision|2|||
149835629|NCT00625443|540531309|FG000|Overall Study|Other|0|||
149835630|NCT00625443|540531310|FG001|Overall Study|Other|1|||
149835631|NCT00625443|540531311|FG002|Overall Study|Other|1|||
149835632|NCT03136380|540531312|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149835633|NCT03136380|540531313|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
149835634|NCT03136380|540531314|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149835635|NCT03136380|540531315|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149835636|NCT03136380|540531316|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149835637|NCT02728102|540531317|FG000|Overall Study|Death|3|||
149835638|NCT02728102|540531318|FG001|Overall Study|Death|0|||
149835639|NCT02728102|540531319|FG002|Overall Study|Death|1|||
149835640|NCT02728102|540531317|FG000|Overall Study|Withdrawal by Subject|0|||
149835641|NCT02728102|540531318|FG001|Overall Study|Withdrawal by Subject|2|||
149835642|NCT02728102|540531319|FG002|Overall Study|Withdrawal by Subject|3|||
149835643|NCT02728102|540531317|FG000|Overall Study|Physician Decision|1|||
149835644|NCT02728102|540531318|FG001|Overall Study|Physician Decision|1|||
149835645|NCT02728102|540531319|FG002|Overall Study|Physician Decision|0|||
149835646|NCT02728102|540531317|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
149835647|NCT02728102|540531318|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
149835648|NCT02728102|540531319|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
149835649|NCT02728102|540531317|FG000|Overall Study|Covid|0|||
149835650|NCT02728102|540531318|FG001|Overall Study|Covid|0|||
149835651|NCT02728102|540531319|FG002|Overall Study|Covid|1|||
149835652|NCT02419937|540531323|FG000|Overall Study|Lost to Follow-up|1|||
149835653|NCT02419937|540531324|FG001|Overall Study|Lost to Follow-up|0|||
149835654|NCT00553280|540531325|FG000|Overall Study|Adverse Event|19|||
149835655|NCT00553280|540531325|FG000|Overall Study|Lack of Efficacy|3|||
149835656|NCT00553280|540531325|FG000|Overall Study|Withdrawal by Subject|3|||
149835657|NCT00553280|540531325|FG000|Overall Study|Physician Decision|1|||
149835658|NCT01182415|540531326|FG000|Overall Study|Lost to Follow-up|1|||
149835659|NCT01544127|540531327|FG000|Overall Study|Lost to Follow-up|4|||
149835660|NCT01544127|540531328|FG001|Overall Study|Lost to Follow-up|2|||
149835661|NCT01544127|540531329|FG002|Overall Study|Lost to Follow-up|9|||
149835662|NCT01544127|540531327|FG000|Overall Study|Withdrawal by Subject|2|||
149835663|NCT01544127|540531328|FG001|Overall Study|Withdrawal by Subject|2|||
149835664|NCT01544127|540531329|FG002|Overall Study|Withdrawal by Subject|1|||
149835665|NCT01544127|540531327|FG000|Overall Study|Discharged out of catchment area|1|||
149835666|NCT01544127|540531328|FG001|Overall Study|Discharged out of catchment area|1|||
149835667|NCT01544127|540531329|FG002|Overall Study|Discharged out of catchment area|1|||
149835668|NCT01544127|540531327|FG000|Overall Study|Death|1|||
149835669|NCT01544127|540531328|FG001|Overall Study|Death|0|||
149835670|NCT01544127|540531329|FG002|Overall Study|Death|0|||
149835671|NCT01544127|540531327|FG000|Overall Study|Jail or Prison|1|||
149835672|NCT01544127|540531328|FG001|Overall Study|Jail or Prison|1|||
149835673|NCT01544127|540531329|FG002|Overall Study|Jail or Prison|2|||
149835674|NCT01544127|540531327|FG000|Overall Study|Became Psychotic|1|||
149835675|NCT01544127|540531328|FG001|Overall Study|Became Psychotic|0|||
149835676|NCT01544127|540531329|FG002|Overall Study|Became Psychotic|0|||
149835677|NCT01544127|540531327|FG000|Overall Study|Researcher withdrew|1|||
149835678|NCT01544127|540531328|FG001|Overall Study|Researcher withdrew|0|||
149835679|NCT01544127|540531329|FG002|Overall Study|Researcher withdrew|0|||
149835680|NCT01544127|540531327|FG000|Overall Study|Went active duty|0|||
149835681|NCT01544127|540531328|FG001|Overall Study|Went active duty|0|||
149835682|NCT01544127|540531329|FG002|Overall Study|Went active duty|1|||
149835683|NCT01256684|540531332|FG000|Overall Study|Adverse Event|1|||
149835684|NCT01256684|540531333|FG001|Overall Study|Adverse Event|4|||
149835685|NCT01256684|540531334|FG002|Overall Study|Adverse Event|2|||
149835686|NCT01256684|540531332|FG000|Overall Study|Withdrawal by Subject|4|||
149835687|NCT01256684|540531333|FG001|Overall Study|Withdrawal by Subject|0|||
149835688|NCT01256684|540531334|FG002|Overall Study|Withdrawal by Subject|2|||
150171684|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
150171685|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
150171686|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
150171687|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149835689|NCT01256684|540531332|FG000|Overall Study|Physician Decision|0|||
149835690|NCT01256684|540531333|FG001|Overall Study|Physician Decision|1|||
149835691|NCT01256684|540531334|FG002|Overall Study|Physician Decision|0|||
149835692|NCT01256684|540531332|FG000|Overall Study|Lack of Efficacy|0|||
149835693|NCT01256684|540531333|FG001|Overall Study|Lack of Efficacy|1|||
150171688|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149835694|NCT01256684|540531334|FG002|Overall Study|Lack of Efficacy|1|||
149835695|NCT01256684|540531332|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
149835696|NCT01256684|540531333|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
149835697|NCT01256684|540531334|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
149835698|NCT02914600|540531335|FG000|Overall Study|Adverse Event|298|||
149835699|NCT02914600|540531336|FG001|Overall Study|Adverse Event|35|||
149835700|NCT02914600|540531337|FG002|Overall Study|Adverse Event|25|||
149835701|NCT02914600|540531335|FG000|Overall Study|Sponsors decision|287|||
150171689|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149835702|NCT02914600|540531336|FG001|Overall Study|Sponsors decision|41|||
149835703|NCT02914600|540531337|FG002|Overall Study|Sponsors decision|12|||
149835704|NCT02914600|540531335|FG000|Overall Study|Withdrawal by Subject|158|||
149835705|NCT02914600|540531336|FG001|Overall Study|Withdrawal by Subject|20|||
149835706|NCT02914600|540531337|FG002|Overall Study|Withdrawal by Subject|18|||
149835707|NCT02914600|540531335|FG000|Overall Study|Investigators discretion|169|||
149835708|NCT02914600|540531336|FG001|Overall Study|Investigators discretion|14|||
149835709|NCT02914600|540531337|FG002|Overall Study|Investigators discretion|13|||
149835710|NCT02914600|540531335|FG000|Overall Study|Lost to Follow-up|10|||
149835711|NCT02914600|540531336|FG001|Overall Study|Lost to Follow-up|4|||
149835712|NCT02914600|540531337|FG002|Overall Study|Lost to Follow-up|0|||
149835713|NCT02914600|540531335|FG000|Overall Study|Pregnancy|8|||
149835714|NCT02914600|540531336|FG001|Overall Study|Pregnancy|0|||
149835715|NCT02914600|540531337|FG002|Overall Study|Pregnancy|0|||
149835716|NCT02914600|540531335|FG000|Overall Study|Protocol Violation|5|||
149835717|NCT02914600|540531336|FG001|Overall Study|Protocol Violation|3|||
149835718|NCT02914600|540531337|FG002|Overall Study|Protocol Violation|0|||
149835719|NCT02914600|540531335|FG000|Overall Study|Non-compliance with study drug|6|||
149835720|NCT02914600|540531336|FG001|Overall Study|Non-compliance with study drug|1|||
149835721|NCT02914600|540531337|FG002|Overall Study|Non-compliance with study drug|0|||
149835722|NCT02914600|540531335|FG000|Overall Study|Death|3|||
149835723|NCT02914600|540531336|FG001|Overall Study|Death|1|||
149835724|NCT02914600|540531337|FG002|Overall Study|Death|1|||
149835725|NCT02914600|540531335|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
149835726|NCT02914600|540531336|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
149835727|NCT02914600|540531337|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
149835728|NCT02914600|540531335|FG000|Overall Study|Enrolled but not treated|1|||
149835729|NCT02914600|540531336|FG001|Overall Study|Enrolled but not treated|0|||
149835730|NCT02914600|540531337|FG002|Overall Study|Enrolled but not treated|0|||
149835731|NCT01185548|540531339|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
149835732|NCT01422538|540531344|FG000|Overall Study|Lost to Follow-up|0|||
149835733|NCT01422538|540531345|FG001|Overall Study|Lost to Follow-up|1|||
149835734|NCT01422538|540531346|FG002|Overall Study|Lost to Follow-up|1|||
149835735|NCT01422538|540531344|FG000|Overall Study|Missed visit|0|||
149835736|NCT01422538|540531345|FG001|Overall Study|Missed visit|1|||
149835737|NCT01422538|540531346|FG002|Overall Study|Missed visit|1|||
149835738|NCT00184600|540531347|FG000|Overall Study|Adverse Event|9|||
149835739|NCT00184600|540531348|FG001|Overall Study|Adverse Event|0|||
149835740|NCT00184600|540531349|FG002|Overall Study|Adverse Event|5|||
149835741|NCT00184600|540531347|FG000|Overall Study|Death|3|||
149835742|NCT00184600|540531348|FG001|Overall Study|Death|9|||
149835743|NCT00184600|540531349|FG002|Overall Study|Death|7|||
149835744|NCT00184600|540531347|FG000|Overall Study|Lack of Efficacy|3|||
149835745|NCT00184600|540531348|FG001|Overall Study|Lack of Efficacy|1|||
149835746|NCT00184600|540531349|FG002|Overall Study|Lack of Efficacy|3|||
149835747|NCT00184600|540531347|FG000|Overall Study|Lost to Follow-up|4|||
149835748|NCT00184600|540531348|FG001|Overall Study|Lost to Follow-up|6|||
149835749|NCT00184600|540531349|FG002|Overall Study|Lost to Follow-up|1|||
149835750|NCT00184600|540531347|FG000|Overall Study|Protocol Violation|2|||
149835751|NCT00184600|540531348|FG001|Overall Study|Protocol Violation|2|||
149835752|NCT00184600|540531349|FG002|Overall Study|Protocol Violation|3|||
149835753|NCT00184600|540531347|FG000|Overall Study|Withdrawal by Subject|20|||
149835754|NCT00184600|540531348|FG001|Overall Study|Withdrawal by Subject|28|||
149835755|NCT00184600|540531349|FG002|Overall Study|Withdrawal by Subject|12|||
149835756|NCT00184600|540531347|FG000|Overall Study|Unclassified|4|||
149835757|NCT00184600|540531348|FG001|Overall Study|Unclassified|5|||
149835758|NCT00184600|540531349|FG002|Overall Study|Unclassified|3|||
149835759|NCT00696020|540531352|FG000|Overall Study|Adverse Event|3|||
149835760|NCT00696020|540531353|FG001|Overall Study|Adverse Event|1|||
149835761|NCT00696020|540531354|FG002|Overall Study|Adverse Event|2|||
149835762|NCT00696020|540531355|FG003|Overall Study|Adverse Event|1|||
149835763|NCT00696020|540531352|FG000|Overall Study|Lack of Efficacy|1|||
149835764|NCT00696020|540531353|FG001|Overall Study|Lack of Efficacy|0|||
149835765|NCT00696020|540531354|FG002|Overall Study|Lack of Efficacy|0|||
149835766|NCT00696020|540531355|FG003|Overall Study|Lack of Efficacy|0|||
149835767|NCT00696020|540531352|FG000|Overall Study|Protocol Violation|0|||
149835768|NCT00696020|540531353|FG001|Overall Study|Protocol Violation|0|||
149835769|NCT00696020|540531354|FG002|Overall Study|Protocol Violation|0|||
149835770|NCT00696020|540531355|FG003|Overall Study|Protocol Violation|1|||
149835771|NCT00696020|540531352|FG000|Overall Study|Withdrawal by Subject|0|||
149835772|NCT00696020|540531353|FG001|Overall Study|Withdrawal by Subject|1|||
149835773|NCT00696020|540531354|FG002|Overall Study|Withdrawal by Subject|0|||
149835774|NCT00696020|540531355|FG003|Overall Study|Withdrawal by Subject|1|||
149835775|NCT00696020|540531352|FG000|Overall Study|Other not stated above|0|||
149835776|NCT00696020|540531353|FG001|Overall Study|Other not stated above|0|||
149835777|NCT00696020|540531354|FG002|Overall Study|Other not stated above|1|||
149835778|NCT00696020|540531355|FG003|Overall Study|Other not stated above|1|||
149835779|NCT00624065|540531356|FG000|Overall Study|Adverse Event|5|||
149835780|NCT00624065|540531357|FG001|Overall Study|Adverse Event|6|||
149835781|NCT00624065|540531356|FG000|Overall Study|Lost to Follow-up|4|||
149835782|NCT00624065|540531357|FG001|Overall Study|Lost to Follow-up|1|||
149835783|NCT00624065|540531356|FG000|Overall Study|Consent withdrawn|6|||
149835784|NCT00624065|540531357|FG001|Overall Study|Consent withdrawn|5|||
149835785|NCT00624065|540531356|FG000|Overall Study|Lack of Efficacy|0|||
149835786|NCT00624065|540531357|FG001|Overall Study|Lack of Efficacy|3|||
149835787|NCT00624065|540531356|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
149835788|NCT00624065|540531357|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
149835789|NCT01387022|540531358|FG000|Overall Study|Death|1|||
149835790|NCT01387022|540531359|FG001|Overall Study|Death|1|||
149835791|NCT01387022|540531358|FG000|Overall Study|Lost to Follow-up|0|||
149835792|NCT01387022|540531359|FG001|Overall Study|Lost to Follow-up|3|||
149835793|NCT02076022|540531363|FG000|Overall Study|Withdrawal by Subject|2|||
149835794|NCT02076022|540531364|FG001|Overall Study|Withdrawal by Subject|0|||
149835795|NCT01536405|540531368|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
149835796|NCT01536405|540531369|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
149835797|NCT01536405|540531368|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
149835798|NCT01536405|540531369|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
149835799|NCT01536405|540531368|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
149835800|NCT01536405|540531369|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
149835801|NCT01536405|540531368|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
149835802|NCT01536405|540531369|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
149835803|NCT01536405|540531368|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
149835804|NCT01536405|540531369|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
149835805|NCT01536405|540531368|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
149835806|NCT01536405|540531369|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
149835807|NCT01536405|540531368|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
149835808|NCT01536405|540531369|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
149835809|NCT01536405|540531368|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
149835810|NCT01536405|540531369|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
149835811|NCT01536405|540531368|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
149835812|NCT01536405|540531369|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
149835813|NCT01536405|540531368|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
149835814|NCT01536405|540531369|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
149835815|NCT01536405|540531368|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
149835816|NCT01536405|540531369|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
149835817|NCT01536405|540531368|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
149835818|NCT01536405|540531369|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
149835819|NCT01536405|540531368|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
149835820|NCT01536405|540531369|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
149835821|NCT02661295|540531370|FG000|Overall Study|Death|1|||
149835822|NCT02661295|540531370|FG000|Overall Study|Transferred Out|1|||
149835823|NCT02661295|540531370|FG000|Overall Study|Kidney Transplant|1|||
149835824|NCT02661295|540531370|FG000|Overall Study|Withdrawn due to side effects|8|||
149835825|NCT02661295|540531370|FG000|Overall Study|Withdrawn due to access type|1|||
149835826|NCT02661295|540531370|FG000|Overall Study|Withdrawn due to allergies|1|||
149835827|NCT02661295|540531370|FG000|Overall Study|Withdrawn due to non-compliance|1|||
149835828|NCT02661295|540531370|FG000|Overall Study|Withdrawal by Subject|3|||
149835829|NCT02661295|540531370|FG000|Overall Study|Failed screening|2|||
149835830|NCT02336165|540531371|FG000|Overall Study|Death|3|||
149835831|NCT02336165|540531372|FG001|Overall Study|Death|0|||
149835832|NCT02336165|540531373|FG002|Overall Study|Death|0|||
149835833|NCT02336165|540531374|FG003|Overall Study|Death|0|||
149835834|NCT02336165|540531375|FG004|Overall Study|Death|1|||
149835835|NCT02336165|540531371|FG000|Overall Study|Physician Decision|2|||
149835836|NCT02336165|540531372|FG001|Overall Study|Physician Decision|2|||
149835837|NCT02336165|540531373|FG002|Overall Study|Physician Decision|1|||
149835838|NCT02336165|540531374|FG003|Overall Study|Physician Decision|1|||
149835839|NCT02336165|540531375|FG004|Overall Study|Physician Decision|0|||
149835840|NCT02336165|540531371|FG000|Overall Study|Withdrawal by Subject|0|||
149835841|NCT02336165|540531372|FG001|Overall Study|Withdrawal by Subject|0|||
149835842|NCT02336165|540531373|FG002|Overall Study|Withdrawal by Subject|1|||
149835843|NCT02336165|540531374|FG003|Overall Study|Withdrawal by Subject|0|||
149835844|NCT02336165|540531375|FG004|Overall Study|Withdrawal by Subject|1|||
149835845|NCT02336165|540531371|FG000|Overall Study|Adverse Event|4|||
149835846|NCT02336165|540531372|FG001|Overall Study|Adverse Event|1|||
149835847|NCT02336165|540531373|FG002|Overall Study|Adverse Event|2|||
149835848|NCT02336165|540531374|FG003|Overall Study|Adverse Event|4|||
149835849|NCT02336165|540531375|FG004|Overall Study|Adverse Event|1|||
149835850|NCT02336165|540531371|FG000|Overall Study|Progressive disease|23|||
149835851|NCT02336165|540531372|FG001|Overall Study|Progressive disease|22|||
149835852|NCT02336165|540531373|FG002|Overall Study|Progressive disease|27|||
149835853|NCT02336165|540531374|FG003|Overall Study|Progressive disease|24|||
149835854|NCT02336165|540531375|FG004|Overall Study|Progressive disease|19|||
149835855|NCT02336165|540531371|FG000|Overall Study|Non-compliance|1|||
149835856|NCT02336165|540531372|FG001|Overall Study|Non-compliance|0|||
149835857|NCT02336165|540531373|FG002|Overall Study|Non-compliance|0|||
149835858|NCT02336165|540531374|FG003|Overall Study|Non-compliance|1|||
149835859|NCT02336165|540531375|FG004|Overall Study|Non-compliance|0|||
149835860|NCT02336165|540531371|FG000|Overall Study|Other|1|||
149835861|NCT02336165|540531372|FG001|Overall Study|Other|0|||
149835862|NCT02336165|540531373|FG002|Overall Study|Other|0|||
149835863|NCT02336165|540531374|FG003|Overall Study|Other|1|||
149835864|NCT02336165|540531375|FG004|Overall Study|Other|0|||
149835865|NCT02726581|540531378|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
149835866|NCT02726581|540531379|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
149835867|NCT02726581|540531380|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
149835868|NCT02726581|540531378|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
149835869|NCT02726581|540531379|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
149835870|NCT02726581|540531380|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
149835871|NCT02726581|540531378|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149835872|NCT02726581|540531379|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149835873|NCT02726581|540531380|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149835874|NCT02726581|540531378|FG000|Treatment Period|Disease progression|47|||
149835875|NCT02726581|540531379|FG001|Treatment Period|Disease progression|50|||
149835876|NCT02726581|540531380|FG002|Treatment Period|Disease progression|16|||
149835877|NCT02726581|540531378|FG000|Treatment Period|Other reasons|9|||
149835878|NCT02726581|540531379|FG001|Treatment Period|Other reasons|8|||
149835879|NCT02726581|540531380|FG002|Treatment Period|Other reasons|2|||
149835880|NCT02726581|540531378|FG000|Treatment Period|Study drug toxicity|6|||
149835881|NCT02726581|540531379|FG001|Treatment Period|Study drug toxicity|3|||
149835882|NCT02726581|540531380|FG002|Treatment Period|Study drug toxicity|2|||
149835883|NCT02726581|540531378|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
149835884|NCT02726581|540531379|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
149835885|NCT02726581|540531380|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
149835886|NCT02726581|540531378|FG000|Treatment Period|Participant withdrew consent|3|||
149835887|NCT02726581|540531379|FG001|Treatment Period|Participant withdrew consent|1|||
149835888|NCT02726581|540531380|FG002|Treatment Period|Participant withdrew consent|1|||
149835889|NCT02726581|540531378|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
149835890|NCT02726581|540531379|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
149835891|NCT02726581|540531380|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
149835892|NCT02726581|540531378|FG000|Treatment Period|Maximum clinical benefit|0|||
149835893|NCT02726581|540531379|FG001|Treatment Period|Maximum clinical benefit|2|||
149835894|NCT02726581|540531380|FG002|Treatment Period|Maximum clinical benefit|0|||
149835895|NCT02726581|540531378|FG000|Treatment Period|Death|1|||
149835896|NCT02726581|540531379|FG001|Treatment Period|Death|0|||
149835897|NCT02726581|540531380|FG002|Treatment Period|Death|0|||
149835898|NCT02726581|540531378|FG000|Treatment Period|Poor/non-compliance|1|||
149835899|NCT02726581|540531379|FG001|Treatment Period|Poor/non-compliance|0|||
149835900|NCT02726581|540531380|FG002|Treatment Period|Poor/non-compliance|0|||
149835901|NCT02726581|540531378|FG000|Treatment Period|Participant no longer meets study criteria|0|||
149835902|NCT02726581|540531379|FG001|Treatment Period|Participant no longer meets study criteria|1|||
149835903|NCT02726581|540531380|FG002|Treatment Period|Participant no longer meets study criteria|0|||
149835904|NCT02865850|540531381|FG000|Overall Study|Death|15|||
149835905|NCT02865850|540531382|FG001|Overall Study|Death|19|||
149835906|NCT02865850|540531381|FG000|Overall Study|Withdrawal by Subject|3|||
149835907|NCT02865850|540531382|FG001|Overall Study|Withdrawal by Subject|2|||
149835908|NCT02865850|540531381|FG000|Overall Study|Lost to Follow-up|3|||
149835909|NCT02865850|540531382|FG001|Overall Study|Lost to Follow-up|2|||
150171690|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171691|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171692|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
150171693|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171694|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171695|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171696|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171697|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
150171698|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
150171699|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171700|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
150171701|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171702|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171703|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171704|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171705|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149835910|NCT00772941|540531384|FG000|Overall Study|CRFs not available|195|||
149835911|NCT00772941|540531384|FG000|Overall Study|Study not completed|16|||
150171706|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
150171707|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
150171708|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
150171709|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
150171710|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
150280853|NCT01438489|542165186|FG001|Overall Study|Inadequate venous access|2|||
150280854|NCT01438489|542165187|FG002|Overall Study|Inadequate venous access|0|||
150280855|NCT03719690|542165193|FG000|Overall Study|Withdrawal by Subject|5|||
150280856|NCT03719690|542165194|FG001|Overall Study|Withdrawal by Subject|10|||
150280857|NCT03719690|542165193|FG000|Overall Study|Death|40|||
149835912|NCT00772941|540531384|FG000|Overall Study|Missed Visits|374|||
149835913|NCT00772941|540531384|FG000|Overall Study|Poor Compliance|7|||
149835914|NCT00772941|540531384|FG000|Overall Study|GPSP Violation|90|||
149835915|NCT02255097|540531385|FG000|Overall Study|Death|151|||
149835916|NCT02255097|540531385|FG000|Overall Study|Lost to Follow-up|5|||
149835917|NCT02255097|540531385|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
150280858|NCT03719690|542165194|FG001|Overall Study|Death|149|||
150280859|NCT03719690|542165193|FG000|Overall Study|Miscellaneous|12|||
149835918|NCT02255097|540531385|FG000|Overall Study|Withdrawal by Subject|7|||
149835919|NCT02255097|540531385|FG000|Overall Study|Allocated but not treated|1|||
149835920|NCT02514122|540531386|FG000|Overall Study|Withdrawal by Subject|2|||
149835921|NCT02514122|540531387|FG001|Overall Study|Withdrawal by Subject|0|||
149835922|NCT01010542|540531388|FG000|Overall Study|Adverse Event|0|||
149835923|NCT01010542|540531389|FG001|Overall Study|Adverse Event|1|||
150280860|NCT03719690|542165194|FG001|Overall Study|Miscellaneous|56|||
149835924|NCT01010542|540531390|FG002|Overall Study|Adverse Event|0|||
149835925|NCT01010542|540531388|FG000|Overall Study|Lost to Follow-up|0|||
150280861|NCT03719690|542165193|FG000|Overall Study|Lost to Follow-up|2|||
150280862|NCT03719690|542165194|FG001|Overall Study|Lost to Follow-up|18|||
150280863|NCT03719690|542165193|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
149835926|NCT01010542|540531389|FG001|Overall Study|Lost to Follow-up|1|||
149835927|NCT01010542|540531390|FG002|Overall Study|Lost to Follow-up|0|||
149835928|NCT01010542|540531388|FG000|Overall Study|Withdrawal by Subject|0|||
149835929|NCT01010542|540531389|FG001|Overall Study|Withdrawal by Subject|3|||
149835930|NCT01010542|540531390|FG002|Overall Study|Withdrawal by Subject|2|||
149835931|NCT01118312|540531391|FG000|Overall Study|Lost to Follow-up|33|||
149835932|NCT01118312|540531392|FG001|Overall Study|Lost to Follow-up|32|||
149835933|NCT01118312|540531391|FG000|Overall Study|Withdrawal by Subject|1|||
150280864|NCT03719690|542165194|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
150280865|NCT01471015|542165195|FG000|Overall Study|Death|0|||
150280866|NCT01471015|542165196|FG001|Overall Study|Death|1|||
149835934|NCT01118312|540531392|FG001|Overall Study|Withdrawal by Subject|3|||
149835935|NCT04510285|540531395|FG000|Overall Study|Death|1|||
150280867|NCT01471015|542165197|FG002|Overall Study|Death|1|||
150280868|NCT00928889|542165202|FG000|Overall Study|Lost to Follow-up|3|||
149835936|NCT03555305|540531396|FG000|Period 1|Physician Decision|0|||
150280869|NCT00928889|542165203|FG001|Overall Study|Lost to Follow-up|1|||
149835937|NCT03555305|540531397|FG001|Period 1|Physician Decision|1|||
149835938|NCT03555305|540531396|FG000|Period 1|Adverse Event|0|||
149835939|NCT03555305|540531397|FG001|Period 1|Adverse Event|1|||
149835940|NCT03135834|540531403|FG000|Stage 1|Adverse Event|1|||
149835941|NCT03135834|540531404|FG001|Stage 1|Adverse Event|2|||
149835942|NCT03135834|540531405|FG002|Stage 1|Adverse Event|2|||
149835943|NCT03135834|540531406|FG003|Stage 1|Adverse Event|1|||
149835944|NCT03135834|540531403|FG000|Stage 1|Death|1|||
149835945|NCT03135834|540531404|FG001|Stage 1|Death|0|||
149835946|NCT03135834|540531405|FG002|Stage 1|Death|0|||
149835947|NCT03135834|540531406|FG003|Stage 1|Death|0|||
149835948|NCT03135834|540531403|FG000|Stage 1|Lost to Follow-up|17|||
149835949|NCT03135834|540531404|FG001|Stage 1|Lost to Follow-up|24|||
149835950|NCT03135834|540531405|FG002|Stage 1|Lost to Follow-up|21|||
149835951|NCT03135834|540531406|FG003|Stage 1|Lost to Follow-up|38|||
149835952|NCT03135834|540531403|FG000|Stage 1|No longer met eligibility criteria|1|||
149835953|NCT03135834|540531404|FG001|Stage 1|No longer met eligibility criteria|6|||
149835954|NCT03135834|540531405|FG002|Stage 1|No longer met eligibility criteria|2|||
149835955|NCT03135834|540531406|FG003|Stage 1|No longer met eligibility criteria|5|||
149835956|NCT03135834|540531403|FG000|Stage 1|Other|0|||
149835957|NCT03135834|540531404|FG001|Stage 1|Other|2|||
149835958|NCT03135834|540531405|FG002|Stage 1|Other|1|||
149835959|NCT03135834|540531406|FG003|Stage 1|Other|0|||
149835960|NCT03135834|540531403|FG000|Stage 1|Physician Decision|0|||
149835961|NCT03135834|540531404|FG001|Stage 1|Physician Decision|1|||
149835962|NCT03135834|540531405|FG002|Stage 1|Physician Decision|0|||
149835963|NCT03135834|540531406|FG003|Stage 1|Physician Decision|0|||
149835964|NCT03135834|540531403|FG000|Stage 1|Pregnancy|0|||
149835965|NCT03135834|540531404|FG001|Stage 1|Pregnancy|4|||
149835966|NCT03135834|540531405|FG002|Stage 1|Pregnancy|2|||
149835967|NCT03135834|540531406|FG003|Stage 1|Pregnancy|4|||
149835968|NCT03135834|540531403|FG000|Stage 1|Protocol Violation|1|||
149835969|NCT03135834|540531404|FG001|Stage 1|Protocol Violation|1|||
149835970|NCT03135834|540531405|FG002|Stage 1|Protocol Violation|2|||
149835971|NCT03135834|540531406|FG003|Stage 1|Protocol Violation|1|||
149835972|NCT03135834|540531403|FG000|Stage 1|Withdrawal by parent/guardian|2|||
149835973|NCT03135834|540531404|FG001|Stage 1|Withdrawal by parent/guardian|10|||
149835974|NCT03135834|540531405|FG002|Stage 1|Withdrawal by parent/guardian|2|||
149835975|NCT03135834|540531406|FG003|Stage 1|Withdrawal by parent/guardian|1|||
149835976|NCT03135834|540531403|FG000|Stage 1|Withdrawal by Subject|16|||
149835977|NCT03135834|540531404|FG001|Stage 1|Withdrawal by Subject|22|||
149835978|NCT03135834|540531405|FG002|Stage 1|Withdrawal by Subject|7|||
149835979|NCT03135834|540531406|FG003|Stage 1|Withdrawal by Subject|10|||
149835980|NCT03135834|540531403|FG000|Stage 1|Randomized but not Vaccinated|0|||
149835981|NCT03135834|540531404|FG001|Stage 1|Randomized but not Vaccinated|3|||
149835982|NCT03135834|540531405|FG002|Stage 1|Randomized but not Vaccinated|1|||
149835983|NCT03135834|540531406|FG003|Stage 1|Randomized but not Vaccinated|6|||
149835984|NCT03135834|540531403|FG000|Stage 2|Lost to Follow-up|0|||
149835985|NCT03135834|540531404|FG001|Stage 2|Lost to Follow-up|1|||
149835986|NCT03135834|540531405|FG002|Stage 2|Lost to Follow-up|0|||
149835987|NCT03135834|540531406|FG003|Stage 2|Lost to Follow-up|0|||
149835988|NCT03135834|540531403|FG000|Stage 2|Withdrawal by Subject|0|||
149835989|NCT03135834|540531404|FG001|Stage 2|Withdrawal by Subject|1|||
149835990|NCT03135834|540531405|FG002|Stage 2|Withdrawal by Subject|0|||
149835991|NCT03135834|540531406|FG003|Stage 2|Withdrawal by Subject|0|||
149835992|NCT03135834|540531403|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
149835993|NCT03135834|540531404|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
149835994|NCT03135834|540531405|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
149835995|NCT03135834|540531406|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
149949276|NCT04707469|540946042|FG000|Overall Study|Site closure|0|||
149949277|NCT04707469|540946043|FG001|Overall Study|Site closure|2|||
149949278|NCT04707469|540946044|FG002|Overall Study|Site closure|0|||
149949279|NCT04707469|540946042|FG000|Overall Study|Physician Decision|2|||
149949280|NCT04707469|540946043|FG001|Overall Study|Physician Decision|2|||
149949281|NCT04707469|540946044|FG002|Overall Study|Physician Decision|2|||
149949282|NCT04707469|540946042|FG000|Overall Study|Death|1|||
149949283|NCT04707469|540946043|FG001|Overall Study|Death|6|||
149949284|NCT04707469|540946044|FG002|Overall Study|Death|2|||
149949285|NCT04707469|540946042|FG000|Overall Study|Lost to Follow-up|9|||
149835996|NCT03135834|540531403|FG000|Stage 2|Did not receive Booster Vaccination|1|||
149835997|NCT03135834|540531404|FG001|Stage 2|Did not receive Booster Vaccination|1|||
149835998|NCT03135834|540531405|FG002|Stage 2|Did not receive Booster Vaccination|0|||
149835999|NCT03135834|540531406|FG003|Stage 2|Did not receive Booster Vaccination|0|||
149949286|NCT04707469|540946043|FG001|Overall Study|Lost to Follow-up|19|||
149836000|NCT02100228|540531407|FG000|Overall Study|Other|19|||
149836001|NCT02100228|540531408|FG001|Overall Study|Other|19|||
149949287|NCT04707469|540946044|FG002|Overall Study|Lost to Follow-up|14|||
149949288|NCT04707469|540946042|FG000|Overall Study|Withdrawal by Subject|17|||
149836002|NCT02100228|540531407|FG000|Overall Study|Administrative reason|0|||
149836003|NCT02100228|540531408|FG001|Overall Study|Administrative reason|1|||
149949289|NCT04707469|540946043|FG001|Overall Study|Withdrawal by Subject|16|||
149836004|NCT02100228|540531407|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
150280870|NCT00928889|542165202|FG000|Overall Study|Protocol Violation|0|||
149836005|NCT02100228|540531408|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
149836006|NCT02100228|540531407|FG000|Overall Study|Non-compliance|0|||
149836007|NCT02100228|540531408|FG001|Overall Study|Non-compliance|3|||
149836008|NCT02100228|540531407|FG000|Overall Study|Lost to Follow-up|0|||
149836009|NCT02100228|540531408|FG001|Overall Study|Lost to Follow-up|1|||
149836010|NCT02100228|540531407|FG000|Overall Study|Withdrawal by Subject|27|||
149836011|NCT02100228|540531408|FG001|Overall Study|Withdrawal by Subject|37|||
149836012|NCT02100228|540531407|FG000|Overall Study|Adverse Event|16|||
149836013|NCT02100228|540531408|FG001|Overall Study|Adverse Event|12|||
149836014|NCT02100228|540531407|FG000|Overall Study|Death|1|||
149836015|NCT02100228|540531408|FG001|Overall Study|Death|1|||
149836016|NCT00214422|540531409|FG000|Overall Study|Physician Decision|2|||
149836017|NCT00214422|540531410|FG001|Overall Study|Physician Decision|0|||
149836018|NCT00214422|540531411|FG002|Overall Study|Physician Decision|0|||
149836019|NCT00214422|540531409|FG000|Overall Study|Developed esophageal ca|1|||
149836020|NCT00214422|540531410|FG001|Overall Study|Developed esophageal ca|0|||
149836021|NCT00214422|540531411|FG002|Overall Study|Developed esophageal ca|0|||
149836022|NCT00214422|540531409|FG000|Overall Study|Pt taken off study|1|||
149836023|NCT00214422|540531410|FG001|Overall Study|Pt taken off study|1|||
149836024|NCT00214422|540531411|FG002|Overall Study|Pt taken off study|0|||
149836025|NCT00214422|540531409|FG000|Overall Study|Disease progression on study|1|||
149836026|NCT00214422|540531410|FG001|Overall Study|Disease progression on study|0|||
149836027|NCT00214422|540531411|FG002|Overall Study|Disease progression on study|0|||
149836028|NCT00214422|540531409|FG000|Overall Study|Unable to make a radiation treatment|0|||
149836029|NCT00214422|540531410|FG001|Overall Study|Unable to make a radiation treatment|0|||
149836030|NCT00214422|540531411|FG002|Overall Study|Unable to make a radiation treatment|1|||
149836031|NCT02421952|540531414|FG000|Overall Study|Diary Not Returned|93|||
149836032|NCT02421952|540531414|FG000|Overall Study|Failed seriation task|13|||
149836033|NCT02421952|540531414|FG000|Overall Study|Subject uncooperative for baseline test|2|||
149836034|NCT02421952|540531414|FG000|Overall Study|Surgery cancelled|1|||
149836035|NCT00854100|540531415|FG000|Overall Study|Inability to complete the study visits|0|||
149836036|NCT00854100|540531416|FG001|Overall Study|Inability to complete the study visits|0|||
149836037|NCT00854100|540531417|FG002|Overall Study|Inability to complete the study visits|1|||
149836038|NCT00854100|540531415|FG000|Overall Study|Lost to Follow-up|2|||
149836039|NCT00854100|540531416|FG001|Overall Study|Lost to Follow-up|0|||
149836040|NCT00854100|540531417|FG002|Overall Study|Lost to Follow-up|3|||
149836041|NCT00854100|540531415|FG000|Overall Study|Withdrawal by Subject|3|||
149836042|NCT00854100|540531416|FG001|Overall Study|Withdrawal by Subject|1|||
149836043|NCT00854100|540531417|FG002|Overall Study|Withdrawal by Subject|2|||
149836044|NCT00854100|540531415|FG000|Overall Study|Protocol Violation|2|||
149836045|NCT00854100|540531416|FG001|Overall Study|Protocol Violation|4|||
149836046|NCT00854100|540531417|FG002|Overall Study|Protocol Violation|3|||
149836047|NCT00854100|540531415|FG000|Overall Study|Adverse Event|2|||
149836048|NCT00854100|540531416|FG001|Overall Study|Adverse Event|1|||
149836049|NCT00854100|540531417|FG002|Overall Study|Adverse Event|2|||
149836050|NCT02216071|540531420|FG000|Overall Study|Withdrawal by Subject|7|||
149836051|NCT02216071|540531421|FG001|Overall Study|Withdrawal by Subject|2|||
149836052|NCT02216071|540531420|FG000|Overall Study|Lost to Follow-up|3|||
149836053|NCT02216071|540531421|FG001|Overall Study|Lost to Follow-up|3|||
149836054|NCT02216071|540531420|FG000|Overall Study|Protocol Violation|3|||
149836055|NCT02216071|540531421|FG001|Overall Study|Protocol Violation|5|||
149836056|NCT02216071|540531420|FG000|Overall Study|Other|2|||
149836057|NCT02216071|540531421|FG001|Overall Study|Other|2|||
149836058|NCT01066143|540533029|FG000|Overall Study|ineligible for the study|8|||
149836059|NCT01294787|540533030|FG000|Period 1|Adverse Event|0|||
149836060|NCT01294787|540533031|FG001|Period 1|Adverse Event|0|||
149836061|NCT01294787|540533032|FG002|Period 1|Adverse Event|0|||
149949290|NCT04707469|540946044|FG002|Overall Study|Withdrawal by Subject|12|||
150280871|NCT00928889|542165203|FG001|Overall Study|Protocol Violation|1|||
149836062|NCT01294787|540533033|FG003|Period 1|Adverse Event|0|||
149836063|NCT01294787|540533034|FG004|Period 1|Adverse Event|1|||
149836064|NCT01294787|540533035|FG005|Period 1|Adverse Event|0|||
149836065|NCT01294787|540533030|FG000|Period 1|Withdrawal by Subject|0|||
150280872|NCT00928889|542165202|FG000|Overall Study|Adverse Event|1|||
149836066|NCT01294787|540533031|FG001|Period 1|Withdrawal by Subject|0|||
149836067|NCT01294787|540533032|FG002|Period 1|Withdrawal by Subject|0|||
149836068|NCT01294787|540533033|FG003|Period 1|Withdrawal by Subject|1|||
149836069|NCT01294787|540533034|FG004|Period 1|Withdrawal by Subject|1|||
149836070|NCT01294787|540533035|FG005|Period 1|Withdrawal by Subject|1|||
149836071|NCT01294787|540533030|FG000|Period 1|Administrative problem|0|||
149836072|NCT01294787|540533031|FG001|Period 1|Administrative problem|0|||
149836073|NCT01294787|540533032|FG002|Period 1|Administrative problem|1|||
149836074|NCT01294787|540533033|FG003|Period 1|Administrative problem|0|||
149836075|NCT01294787|540533034|FG004|Period 1|Administrative problem|0|||
149836076|NCT01294787|540533035|FG005|Period 1|Administrative problem|1|||
149836077|NCT01294787|540533030|FG000|Period 2|Adverse Event|0|||
149836078|NCT01294787|540533031|FG001|Period 2|Adverse Event|3|||
149836079|NCT01294787|540533032|FG002|Period 2|Adverse Event|0|||
149836080|NCT01294787|540533033|FG003|Period 2|Adverse Event|1|||
149836081|NCT01294787|540533034|FG004|Period 2|Adverse Event|0|||
149836082|NCT01294787|540533035|FG005|Period 2|Adverse Event|0|||
149836083|NCT01294787|540533030|FG000|Period 2|No longer needs study drug|0|||
149836084|NCT01294787|540533031|FG001|Period 2|No longer needs study drug|0|||
149836085|NCT01294787|540533032|FG002|Period 2|No longer needs study drug|0|||
149836086|NCT01294787|540533033|FG003|Period 2|No longer needs study drug|1|||
149836087|NCT01294787|540533034|FG004|Period 2|No longer needs study drug|0|||
149836088|NCT01294787|540533035|FG005|Period 2|No longer needs study drug|0|||
149836089|NCT01294787|540533030|FG000|Period 3|Adverse Event|0|||
149836090|NCT01294787|540533031|FG001|Period 3|Adverse Event|0|||
149836091|NCT01294787|540533032|FG002|Period 3|Adverse Event|0|||
149836092|NCT01294787|540533033|FG003|Period 3|Adverse Event|0|||
149836093|NCT01294787|540533034|FG004|Period 3|Adverse Event|1|||
149836094|NCT01294787|540533035|FG005|Period 3|Adverse Event|0|||
149836095|NCT01948258|540533036|FG000|Overall Study|Pregnancy|41|||
149836096|NCT01948258|540533036|FG000|Overall Study|Did not complete by cut-off date|35|||
149836097|NCT01948258|540533036|FG000|Overall Study|Lost to Follow-up|27|||
149836098|NCT01948258|540533036|FG000|Overall Study|Withdrawal by SPD|8|||
149836099|NCT01948258|540533036|FG000|Overall Study|Withdrawal by Subject|6|||
149836100|NCT01948258|540533036|FG000|Overall Study|Health Care Professional|43|||
149836101|NCT01948258|540533036|FG000|Overall Study|Removed from statistical analysis|2|||
149836102|NCT03785548|540533042|FG000|Overall Study|age > 80|1|||
149836103|NCT03785548|540533043|FG001|Overall Study|age > 80|0|||
149836104|NCT03785548|540533042|FG000|Overall Study|no Postop queries|1|||
149836105|NCT03785548|540533043|FG001|Overall Study|no Postop queries|0|||
149836106|NCT00396279|540533044|FG000|Overall Study|Ongoing in study|26|||
149836107|NCT00396279|540533044|FG000|Overall Study|Disease progression|2|||
149836108|NCT00396279|540533044|FG000|Overall Study|Withdrawal by Subject|1|||
149836109|NCT00396279|540533044|FG000|Overall Study|Physician Decision|1|||
149836110|NCT00905346|540533052|FG000|Period 1|Withdrawal by Subject|1|||
149836111|NCT00905346|540533053|FG001|Period 1|Withdrawal by Subject|0|||
149836112|NCT01435265|540533054|FG000|Overall Study|Lost to Follow-up|0|||
149836113|NCT01435265|540533055|FG001|Overall Study|Lost to Follow-up|1|||
149836114|NCT03351335|540533056|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
149836115|NCT03351335|540533057|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
149836116|NCT03351335|540533058|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
149836117|NCT04605094|540533059|FG000|Overall Study|Adverse Event|2|||
149836118|NCT04605094|540533060|FG001|Overall Study|Adverse Event|2|||
149836119|NCT04605094|540533059|FG000|Overall Study|Lost to Follow-up|1|||
149836120|NCT04605094|540533060|FG001|Overall Study|Lost to Follow-up|4|||
149836121|NCT04605094|540533059|FG000|Overall Study|Physician Decision|2|||
150171711|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149836122|NCT04605094|540533060|FG001|Overall Study|Physician Decision|2|||
149836123|NCT04605094|540533059|FG000|Overall Study|Study terminated by Sponsor|31|||
149836124|NCT04605094|540533060|FG001|Overall Study|Study terminated by Sponsor|33|||
149836125|NCT04605094|540533059|FG000|Overall Study|Withdrawal by Subject|22|||
149836126|NCT04605094|540533060|FG001|Overall Study|Withdrawal by Subject|19|||
149836127|NCT04605094|540533059|FG000|Overall Study|Other|1|||
149836128|NCT04605094|540533060|FG001|Overall Study|Other|1|||
149836129|NCT02724462|540533061|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
149836130|NCT02724462|540533062|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
149836131|NCT02724462|540533061|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
149836132|NCT02724462|540533062|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
149836133|NCT02724462|540533061|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
149836134|NCT02724462|540533062|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
149836135|NCT02724462|540533061|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
149836136|NCT02724462|540533062|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
149836137|NCT02724462|540533061|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
149836138|NCT02724462|540533062|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
149836139|NCT02724462|540533061|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
149836140|NCT02724462|540533062|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
149836141|NCT00469417|540533065|FG000|Overall Study|Treatment failure all lesions|18|||
149836142|NCT00469417|540533066|FG001|Overall Study|Treatment failure all lesions|11|||
149836143|NCT00469417|540533065|FG000|Overall Study|Consent withdrawn|1|||
149836144|NCT00469417|540533066|FG001|Overall Study|Consent withdrawn|1|||
149836145|NCT00469417|540533065|FG000|Overall Study|Adverse Event|8|||
149836146|NCT00469417|540533066|FG001|Overall Study|Adverse Event|2|||
149836147|NCT00469417|540533065|FG000|Overall Study|Lost to Follow-up|1|||
149836148|NCT00469417|540533066|FG001|Overall Study|Lost to Follow-up|2|||
149836149|NCT00469417|540533065|FG000|Overall Study|Intercurrent disease|0|||
149836150|NCT00469417|540533066|FG001|Overall Study|Intercurrent disease|1|||
149836151|NCT00469417|540533065|FG000|Overall Study|Randomized but not treated|2|||
149836152|NCT00469417|540533066|FG001|Overall Study|Randomized but not treated|0|||
149836153|NCT01954394|540533069|FG000|Overall Study|Enrolled but not treated|1|||
149836154|NCT01954394|540533070|FG001|Overall Study|Enrolled but not treated|0|||
149836155|NCT01954394|540533069|FG000|Overall Study|Adverse Event|10|||
149836156|NCT01954394|540533070|FG001|Overall Study|Adverse Event|23|||
149836157|NCT01954394|540533069|FG000|Overall Study|Poor compliance to protocol|7|||
149836158|NCT01954394|540533070|FG001|Overall Study|Poor compliance to protocol|7|||
149836159|NCT01954394|540533069|FG000|Overall Study|Participant Moved|0|||
149836160|NCT01954394|540533070|FG001|Overall Study|Participant Moved|4|||
149836161|NCT01954394|540533069|FG000|Overall Study|Related to Study Drug administration|2|||
149836162|NCT01954394|540533070|FG001|Overall Study|Related to Study Drug administration|2|||
149836163|NCT01954394|540533069|FG000|Overall Study|Other than specified above|10|||
149836164|NCT01954394|540533070|FG001|Overall Study|Other than specified above|21|||
149836165|NCT00909610|540533071|FG000|Period: First Intervention|Adverse Event|0|||
149836166|NCT00909610|540533072|FG001|Period: First Intervention|Adverse Event|1|||
149836167|NCT00909610|540533071|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
149836168|NCT00909610|540533072|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
149836169|NCT00909610|540533071|FG000|Period: Second Intervention|Adverse Event|1|||
149836170|NCT00909610|540533072|FG001|Period: Second Intervention|Adverse Event|0|||
149836171|NCT04089735|540533075|FG000|Overall Study|Adverse Event|1|||
149836172|NCT04089735|540533076|FG001|Overall Study|Adverse Event|0|||
149836173|NCT04089735|540533077|FG002|Overall Study|Adverse Event|1|||
149836174|NCT04089735|540533078|FG003|Overall Study|Adverse Event|1|||
149836175|NCT04089735|540533079|FG004|Overall Study|Adverse Event|0|||
149836176|NCT04089735|540533080|FG005|Overall Study|Adverse Event|0|||
149836177|NCT04089735|540533075|FG000|Overall Study|Physician Decision|0|||
149836178|NCT04089735|540533076|FG001|Overall Study|Physician Decision|3|||
149836179|NCT04089735|540533077|FG002|Overall Study|Physician Decision|0|||
149836180|NCT04089735|540533078|FG003|Overall Study|Physician Decision|0|||
149836181|NCT04089735|540533079|FG004|Overall Study|Physician Decision|0|||
149836182|NCT04089735|540533080|FG005|Overall Study|Physician Decision|0|||
149836183|NCT04089735|540533075|FG000|Overall Study|Withdrawal by Subject|0|||
149836184|NCT04089735|540533076|FG001|Overall Study|Withdrawal by Subject|0|||
149836185|NCT04089735|540533077|FG002|Overall Study|Withdrawal by Subject|1|||
149836186|NCT04089735|540533078|FG003|Overall Study|Withdrawal by Subject|0|||
149836187|NCT04089735|540533079|FG004|Overall Study|Withdrawal by Subject|0|||
149836188|NCT04089735|540533080|FG005|Overall Study|Withdrawal by Subject|0|||
149836189|NCT04089735|540533075|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
149836190|NCT04089735|540533076|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
149836191|NCT04089735|540533077|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
149836192|NCT04089735|540533078|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
150171712|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
150171713|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
150171714|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149836193|NCT04089735|540533079|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
149836194|NCT04089735|540533080|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
149836195|NCT02128997|540533087|FG000|Overall Study|Lost to Follow-up|6|||
149836196|NCT02128997|540533088|FG001|Overall Study|Lost to Follow-up|11|||
149836197|NCT00418184|540533093|FG000|Double-blind Phase|Withdrawal by Subject|22|||
149836198|NCT00418184|540533094|FG001|Double-blind Phase|Withdrawal by Subject|9|||
149836199|NCT00418184|540533093|FG000|Double-blind Phase|Adverse Event|2|||
149836200|NCT00418184|540533094|FG001|Double-blind Phase|Adverse Event|1|||
149836201|NCT00418184|540533093|FG000|Double-blind Phase|Poor compliance|3|||
149836202|NCT00418184|540533094|FG001|Double-blind Phase|Poor compliance|1|||
149836203|NCT03107091|540533099|FG000|Overall Study|Physician Decision|1|||
149836204|NCT03025880|540533104|FG000|Overall Study|Adverse Event|1|||
149836205|NCT03025880|540533105|FG001|Overall Study|Adverse Event|0|||
149836206|NCT03025880|540533104|FG000|Overall Study|Death|1|||
149836207|NCT03025880|540533105|FG001|Overall Study|Death|1|||
149836208|NCT03025880|540533104|FG000|Overall Study|Withdrawal by Subject|0|||
149836209|NCT03025880|540533105|FG001|Overall Study|Withdrawal by Subject|1|||
149836210|NCT03025880|540533104|FG000|Overall Study|Physician Decision|0|||
149836211|NCT03025880|540533105|FG001|Overall Study|Physician Decision|1|||
149836212|NCT03025880|540533104|FG000|Overall Study|Progressive Disease|12|||
149836213|NCT03025880|540533105|FG001|Overall Study|Progressive Disease|19|||
149836214|NCT02924883|540533108|FG000|Overall Study|Death|39|||
149836215|NCT02924883|540533109|FG001|Overall Study|Death|20|||
149836216|NCT02924883|540533108|FG000|Overall Study|Lost to Follow-up|1|||
149836217|NCT02924883|540533109|FG001|Overall Study|Lost to Follow-up|0|||
149836218|NCT02924883|540533108|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
149836219|NCT02924883|540533109|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
149836220|NCT02924883|540533108|FG000|Overall Study|Protocol Violation|1|||
149836221|NCT02924883|540533109|FG001|Overall Study|Protocol Violation|0|||
149836222|NCT02924883|540533108|FG000|Overall Study|Withdrawal by Subject|22|||
149836223|NCT02924883|540533109|FG001|Overall Study|Withdrawal by Subject|16|||
149836224|NCT02924883|540533108|FG000|Overall Study|Progressive Disease|1|||
149836225|NCT02924883|540533109|FG001|Overall Study|Progressive Disease|0|||
149836226|NCT02924883|540533108|FG000|Overall Study|Study Terminated by Sponsor|69|||
149836227|NCT02924883|540533109|FG001|Overall Study|Study Terminated by Sponsor|32|||
149836228|NCT02587962|540533112|FG000|Overall Study|Adverse Event|0|||
149836229|NCT02587962|540533113|FG001|Overall Study|Adverse Event|0|||
149836230|NCT02587962|540533114|FG002|Overall Study|Adverse Event|1|||
149836231|NCT02587962|540533115|FG003|Overall Study|Adverse Event|0|||
149836232|NCT02587962|540533116|FG004|Overall Study|Adverse Event|0|||
149836233|NCT02587962|540533112|FG000|Overall Study|Withdrawal by Subject|0|||
149836234|NCT02587962|540533113|FG001|Overall Study|Withdrawal by Subject|0|||
149836235|NCT02587962|540533114|FG002|Overall Study|Withdrawal by Subject|1|||
149836236|NCT02587962|540533115|FG003|Overall Study|Withdrawal by Subject|1|||
149836237|NCT02587962|540533116|FG004|Overall Study|Withdrawal by Subject|4|||
149836238|NCT02587962|540533112|FG000|Overall Study|Radiological progression|2|||
149836239|NCT02587962|540533113|FG001|Overall Study|Radiological progression|2|||
149836240|NCT02587962|540533114|FG002|Overall Study|Radiological progression|2|||
149836241|NCT02587962|540533115|FG003|Overall Study|Radiological progression|5|||
149836242|NCT02587962|540533116|FG004|Overall Study|Radiological progression|10|||
149836243|NCT02587962|540533112|FG000|Overall Study|Clinical progression|0|||
149836244|NCT02587962|540533113|FG001|Overall Study|Clinical progression|1|||
149836245|NCT02587962|540533114|FG002|Overall Study|Clinical progression|2|||
149836246|NCT02587962|540533115|FG003|Overall Study|Clinical progression|0|||
149836247|NCT02587962|540533116|FG004|Overall Study|Clinical progression|1|||
150280873|NCT00928889|542165203|FG001|Overall Study|Adverse Event|0|||
150280874|NCT00928889|542165202|FG000|Overall Study|Other|1|||
150280875|NCT00928889|542165203|FG001|Overall Study|Other|0|||
149836248|NCT00312663|540533117|FG000|Immunization Phase|Adverse Event|0|||
149836249|NCT00312663|540533118|FG001|Immunization Phase|Adverse Event|1|||
149836250|NCT00312663|540533119|FG002|Immunization Phase|Adverse Event|0|||
149836251|NCT02098876|540533124|FG000|Overall Study|Withdrawal by Subject|5|||
149836252|NCT02098876|540533125|FG001|Overall Study|Withdrawal by Subject|5|||
149836253|NCT01263704|540533126|FG000|Overall Study|Progressive disease|18|||
149836254|NCT01263704|540533126|FG000|Overall Study|Adverse Event|3|||
150280876|NCT00632099|542165204|FG000|Overall Study|Lost to Follow-up|3|||
149836255|NCT01263704|540533126|FG000|Overall Study|Death|2|||
149836256|NCT01263704|540533126|FG000|Overall Study|Patient withdrew consent|2|||
149836257|NCT01263704|540533126|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
149836258|NCT01263704|540533126|FG000|Overall Study|Lost to Follow-up|1|||
149836259|NCT01263704|540533126|FG000|Overall Study|Colon metastases|1|||
149836260|NCT01263704|540533126|FG000|Overall Study|Principal Investigator (PI) decision|1|||
149836261|NCT01061866|540533127|FG000|Overall Study|Adverse Event|2|||
149836262|NCT00102440|540533128|FG000|Overall Study|Lost to Follow-up|25|||
149836263|NCT00102440|540533129|FG001|Overall Study|Lost to Follow-up|18|||
149836264|NCT00102440|540533130|FG002|Overall Study|Lost to Follow-up|21|||
149836265|NCT00102440|540533128|FG000|Overall Study|Adverse Event|16|||
149836266|NCT00102440|540533129|FG001|Overall Study|Adverse Event|23|||
149836267|NCT00102440|540533130|FG002|Overall Study|Adverse Event|8|||
149836268|NCT00102440|540533128|FG000|Overall Study|Gout Flare|10|||
149836269|NCT00102440|540533129|FG001|Overall Study|Gout Flare|28|||
149836270|NCT00102440|540533130|FG002|Overall Study|Gout Flare|9|||
149836271|NCT00102440|540533128|FG000|Overall Study|Personal Reason(s)|19|||
149836272|NCT00102440|540533129|FG001|Overall Study|Personal Reason(s)|13|||
149836273|NCT00102440|540533130|FG002|Overall Study|Personal Reason(s)|13|||
149836274|NCT00102440|540533128|FG000|Overall Study|Other|11|||
149836275|NCT00102440|540533129|FG001|Overall Study|Other|14|||
149836276|NCT00102440|540533130|FG002|Overall Study|Other|14|||
149836277|NCT00102440|540533128|FG000|Overall Study|Protocol Violation|7|||
149836278|NCT00102440|540533129|FG001|Overall Study|Protocol Violation|2|||
149836279|NCT00102440|540533130|FG002|Overall Study|Protocol Violation|1|||
149836280|NCT04786184|540533132|FG000|Overall Study|Adverse Event|4|||
149836281|NCT04786184|540533133|FG001|Overall Study|Adverse Event|0|||
149836282|NCT04786184|540533132|FG000|Overall Study|Withdrawal by Subject|3|||
149836283|NCT04786184|540533133|FG001|Overall Study|Withdrawal by Subject|1|||
149836284|NCT04786184|540533132|FG000|Overall Study|Lost to Follow-up|4|||
149836285|NCT04786184|540533133|FG001|Overall Study|Lost to Follow-up|2|||
149836286|NCT03965091|540533135|FG000|Overall Study|Adverse Event|0|||
149836287|NCT03965091|540533136|FG001|Overall Study|Adverse Event|2|||
149836288|NCT03965091|540533137|FG002|Overall Study|Adverse Event|3|||
149836289|NCT03965091|540533135|FG000|Overall Study|Withdrawal by Subject|11|||
149836290|NCT03965091|540533136|FG001|Overall Study|Withdrawal by Subject|3|||
149836291|NCT03965091|540533137|FG002|Overall Study|Withdrawal by Subject|5|||
149836292|NCT03965091|540533135|FG000|Overall Study|Non-compliance with study drug|0|||
149836293|NCT03965091|540533136|FG001|Overall Study|Non-compliance with study drug|0|||
149836294|NCT03965091|540533137|FG002|Overall Study|Non-compliance with study drug|1|||
149836295|NCT03965091|540533135|FG000|Overall Study|Lost to Follow-up|1|||
149836296|NCT03965091|540533136|FG001|Overall Study|Lost to Follow-up|1|||
149836297|NCT03965091|540533137|FG002|Overall Study|Lost to Follow-up|1|||
149836298|NCT03965091|540533135|FG000|Overall Study|Lack of Efficacy|2|||
149836299|NCT03965091|540533136|FG001|Overall Study|Lack of Efficacy|0|||
149836300|NCT03965091|540533137|FG002|Overall Study|Lack of Efficacy|0|||
149836301|NCT03965091|540533135|FG000|Overall Study|Other than specified|9|||
149836302|NCT03965091|540533136|FG001|Overall Study|Other than specified|11|||
149836303|NCT03965091|540533137|FG002|Overall Study|Other than specified|8|||
149836304|NCT01534520|540533139|FG000|Overall Study|Adverse Event|0|||
149836305|NCT01534520|540533140|FG001|Overall Study|Adverse Event|1|||
149836306|NCT00857623|540533143|FG000|Overall Study|Adverse Event|5|||
149836307|NCT00857623|540533144|FG001|Overall Study|Adverse Event|2|||
149836308|NCT00857623|540533143|FG000|Overall Study|Study-specific discontinuation criteria|5|||
149836309|NCT00857623|540533144|FG001|Overall Study|Study-specific discontinuation criteria|3|||
149836310|NCT00857623|540533143|FG000|Overall Study|Withdrawal by Subject|2|||
149836311|NCT00857623|540533144|FG001|Overall Study|Withdrawal by Subject|1|||
149836312|NCT00857623|540533143|FG000|Overall Study|Lack of Efficacy|1|||
149836313|NCT00857623|540533144|FG001|Overall Study|Lack of Efficacy|1|||
149836314|NCT00857623|540533143|FG000|Overall Study|Severe non-compliance to protocol|1|||
149836315|NCT00857623|540533144|FG001|Overall Study|Severe non-compliance to protocol|1|||
149836316|NCT00857623|540533143|FG000|Overall Study|Intake of prohibited medication|0|||
149836317|NCT00857623|540533144|FG001|Overall Study|Intake of prohibited medication|1|||
149836318|NCT00857623|540533143|FG000|Overall Study|Positive for HEP C|0|||
149836319|NCT00857623|540533144|FG001|Overall Study|Positive for HEP C|1|||
149836320|NCT04185909|540533145|FG000|Overall Study|Lost to Follow-up|1|||
149836321|NCT02601560|540533146|FG000|Overall Study|Other|0|||
149836322|NCT02601560|540533147|FG001|Overall Study|Other|0|||
149836323|NCT02601560|540533148|FG002|Overall Study|Other|0|||
149836324|NCT02601560|540533149|FG003|Overall Study|Other|0|||
149836325|NCT02601560|540533150|FG004|Overall Study|Other|0|||
149836326|NCT02601560|540533151|FG005|Overall Study|Other|0|||
149836327|NCT02601560|540533152|FG006|Overall Study|Other|1|||
149836328|NCT02601560|540533153|FG007|Overall Study|Other|0|||
149836329|NCT01417078|540533154|FG000|Overall Study|Withdrawal by Subject|1|||
149836330|NCT00626548|540533155|FG000|Overall Study|Adverse Event|164|||
149836331|NCT00626548|540533156|FG001|Overall Study|Adverse Event|44|||
149836332|NCT00626548|540533155|FG000|Overall Study|Withdrawal by Subject|42|||
149836333|NCT00626548|540533156|FG001|Overall Study|Withdrawal by Subject|46|||
149836334|NCT00626548|540533155|FG000|Overall Study|Protocol Violation|4|||
149836335|NCT00626548|540533156|FG001|Overall Study|Protocol Violation|11|||
149836336|NCT00626548|540533155|FG000|Overall Study|Lost to Follow-up|2|||
149836337|NCT00626548|540533156|FG001|Overall Study|Lost to Follow-up|2|||
149836338|NCT00626548|540533155|FG000|Overall Study|Other termination reason|493|||
149836339|NCT00626548|540533156|FG001|Overall Study|Other termination reason|613|||
149836340|NCT01059903|540533160|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
149836341|NCT01059903|540533161|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
149836342|NCT00385593|540533164|FG000|Overall Study|Adverse Event|3|||
149836343|NCT00385593|540533165|FG001|Overall Study|Adverse Event|2|||
149836344|NCT00385593|540533164|FG000|Overall Study|Withdrawal by Subject|17|||
149836345|NCT00385593|540533165|FG001|Overall Study|Withdrawal by Subject|7|||
149836346|NCT00385593|540533164|FG000|Overall Study|Lost to Follow-up|12|||
149836347|NCT00385593|540533165|FG001|Overall Study|Lost to Follow-up|8|||
149836348|NCT00385593|540533164|FG000|Overall Study|Protocol Violation|7|||
149836349|NCT00385593|540533165|FG001|Overall Study|Protocol Violation|4|||
149836350|NCT00385593|540533164|FG000|Overall Study|Several reasons|17|||
149836351|NCT00385593|540533165|FG001|Overall Study|Several reasons|15|||
149836352|NCT00385593|540533164|FG000|Overall Study|Incorrect inclusion|2|||
149836353|NCT00385593|540533165|FG001|Overall Study|Incorrect inclusion|0|||
149836354|NCT00385593|540533164|FG000|Overall Study|Incorrect randomization|0|||
149836355|NCT00385593|540533165|FG001|Overall Study|Incorrect randomization|1|||
149836356|NCT04384978|540533166|FG000|Overall Study|Withdrawal by Subject|4|||
149836357|NCT04384978|540533167|FG001|Overall Study|Withdrawal by Subject|0|||
149836358|NCT03586726|540533168|FG000|Overall Study|Withdrawal by Subject|1|||
149836359|NCT02612337|540533170|FG000|Overall Study|Lack of Efficacy|1|||
149836360|NCT02612337|540533171|FG001|Overall Study|Lack of Efficacy|0|||
149836361|NCT02612337|540533170|FG000|Overall Study|Withdrawal by Subject|2|||
149836362|NCT02612337|540533171|FG001|Overall Study|Withdrawal by Subject|2|||
149836363|NCT02612337|540533170|FG000|Overall Study|Did not receive study drug|0|||
149836364|NCT02612337|540533171|FG001|Overall Study|Did not receive study drug|1|||
149836365|NCT00389064|540533177|FG000|Overall Study|Adverse Event|11|||
149836366|NCT00389064|540533178|FG001|Overall Study|Adverse Event|3|||
149836367|NCT00389064|540533177|FG000|Overall Study|Lack of Efficacy|3|||
149836368|NCT00389064|540533178|FG001|Overall Study|Lack of Efficacy|14|||
149836369|NCT00389064|540533177|FG000|Overall Study|Withdrawal by Subject|17|||
149836370|NCT00389064|540533178|FG001|Overall Study|Withdrawal by Subject|27|||
149836371|NCT00389064|540533177|FG000|Overall Study|Physician Decision|2|||
149836372|NCT00389064|540533178|FG001|Overall Study|Physician Decision|2|||
149836373|NCT00389064|540533177|FG000|Overall Study|Lost to Follow-up|1|||
149836374|NCT00389064|540533178|FG001|Overall Study|Lost to Follow-up|2|||
149836375|NCT00389064|540533177|FG000|Overall Study|Protocol Violation|2|||
149836376|NCT00389064|540533178|FG001|Overall Study|Protocol Violation|0|||
149836377|NCT00389064|540533177|FG000|Overall Study|Multiple Reasons|9|||
149836378|NCT00389064|540533178|FG001|Overall Study|Multiple Reasons|11|||
149836379|NCT02963259|540533179|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
149836380|NCT02963259|540533179|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
149836381|NCT02963259|540533179|FG000|Overall Study|Death|1|||
149836382|NCT02963259|540533179|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
149836383|NCT05369208|540534274|FG000|Core Phase|Prohibited Medication Required|2|||
149836384|NCT05369208|540534274|FG000|Core Phase|Adverse Event|1|||
149836385|NCT05369208|540534274|FG000|Core Phase|Lack of Efficacy|1|||
149836386|NCT04934722|540534275|FG000|Overall Study|Death|4|||
149836387|NCT04934722|540534276|FG001|Overall Study|Death|3|||
149836388|NCT04934722|540534275|FG000|Overall Study|Participants Ongoing|88|||
149836389|NCT04934722|540534276|FG001|Overall Study|Participants Ongoing|91|||
149836390|NCT00371839|540534277|FG000|Overall Study|Death|4|||
149836391|NCT00371839|540534278|FG001|Overall Study|Death|0|||
149836392|NCT00371839|540534279|FG002|Overall Study|Death|0|||
149836393|NCT00371839|540534277|FG000|Overall Study|Withdrawal by Subject|7|||
149836394|NCT00371839|540534278|FG001|Overall Study|Withdrawal by Subject|4|||
149836395|NCT00371839|540534279|FG002|Overall Study|Withdrawal by Subject|0|||
149836396|NCT00371839|540534277|FG000|Overall Study|Lost to Follow-up|6|||
149836397|NCT00371839|540534278|FG001|Overall Study|Lost to Follow-up|3|||
149836398|NCT00371839|540534279|FG002|Overall Study|Lost to Follow-up|2|||
149836399|NCT01149473|540534280|FG000|First Intervention|Adverse Event|1|||
149836400|NCT01149473|540534281|FG001|First Intervention|Adverse Event|1|||
149836401|NCT01149473|540534280|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149836402|NCT01149473|540534281|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
149836403|NCT00834249|540534285|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
149836404|NCT00834249|540534286|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
149836405|NCT00834249|540534285|FG000|Second Intervention|Adverse Event|1|||
149836406|NCT00834249|540534286|FG001|Second Intervention|Adverse Event|0|||
149836407|NCT00851877|540534287|FG000|Phase I-1|Death|1|||
149836408|NCT00851877|540534288|FG001|Phase I-1|Death|0|||
149836409|NCT00851877|540534289|FG002|Phase I-1|Death|0|||
149836410|NCT00851877|540534287|FG000|Phase II|Withdrawal by Subject|0|||
149836411|NCT00851877|540534288|FG001|Phase II|Withdrawal by Subject|0|||
149836412|NCT00851877|540534289|FG002|Phase II|Withdrawal by Subject|3|||
149836413|NCT00620074|540534290|FG000|Overall Study|Adverse Event|1|||
150280877|NCT00632099|542165205|FG001|Overall Study|Lost to Follow-up|3|||
150280878|NCT04707157|542165223|FG000|Overall Study|Adverse Event|12|||
150280879|NCT04707157|542165224|FG001|Overall Study|Adverse Event|3|||
150280880|NCT04707157|542165223|FG000|Overall Study|Lost to Follow-up|2|||
150280881|NCT04707157|542165224|FG001|Overall Study|Lost to Follow-up|0|||
150280882|NCT04707157|542165223|FG000|Overall Study|Sponsor's decision|1|||
150280883|NCT04707157|542165224|FG001|Overall Study|Sponsor's decision|0|||
150280884|NCT04707157|542165223|FG000|Overall Study|Physician Decision|8|||
150280885|NCT04707157|542165224|FG001|Overall Study|Physician Decision|5|||
150280886|NCT04707157|542165223|FG000|Overall Study|Protocol Deviation|1|||
150280887|NCT04707157|542165224|FG001|Overall Study|Protocol Deviation|0|||
150280888|NCT04707157|542165223|FG000|Overall Study|Withdrawal by Subject|1|||
150280889|NCT04707157|542165224|FG001|Overall Study|Withdrawal by Subject|1|||
150280890|NCT03625687|542165226|FG000|Overall Study|Death|1|||
150280891|NCT00711425|542165227|FG000|Overall Study|Protocol Violation|1|||
150280892|NCT00711425|542165227|FG000|Overall Study|Death|2|||
150280893|NCT00711425|542165227|FG000|Overall Study|Lost to Follow-up|1|||
150280894|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
150280895|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
150280896|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Death|0|||
150280897|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Death|1|||
150280898|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
150280899|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
150280900|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
150280901|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
150280902|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
150280903|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
150280904|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
150280905|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
150280906|NCT00843518|542165228|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
150280907|NCT00843518|542165229|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
150280908|NCT01342484|542165233|FG000|Overall Study|Other Reasons|1|||
150280909|NCT01342484|542165234|FG001|Overall Study|Other Reasons|0|||
150280910|NCT01342484|542165235|FG002|Overall Study|Other Reasons|0|||
150280911|NCT01342484|542165233|FG000|Overall Study|Protocol Violation|0|||
150280912|NCT01342484|542165234|FG001|Overall Study|Protocol Violation|0|||
150280913|NCT01342484|542165235|FG002|Overall Study|Protocol Violation|1|||
150280914|NCT01342484|542165233|FG000|Overall Study|Withdrawal by Subject|1|||
150280915|NCT01342484|542165234|FG001|Overall Study|Withdrawal by Subject|0|||
150280916|NCT01342484|542165235|FG002|Overall Study|Withdrawal by Subject|0|||
150280917|NCT01840579|542165236|FG000|Overall Study|Status not recorded|0|||
150280918|NCT01840579|542165237|FG001|Overall Study|Status not recorded|0|||
150280919|NCT01840579|542165238|FG002|Overall Study|Status not recorded|2|||
150280920|NCT01840579|542165239|FG003|Overall Study|Status not recorded|3|||
150280921|NCT01840579|542165240|FG004|Overall Study|Status not recorded|4|||
150280922|NCT01840579|542165241|FG005|Overall Study|Status not recorded|3|||
150280923|NCT01840579|542165242|FG006|Overall Study|Status not recorded|0|||
150280924|NCT01840579|542165243|FG007|Overall Study|Status not recorded|3|||
150280925|NCT01840579|542165244|FG008|Overall Study|Status not recorded|3|||
150280926|NCT01840579|542165245|FG009|Overall Study|Status not recorded|3|||
150280927|NCT01840579|542165236|FG000|Overall Study|Progressive disease|3|||
150280928|NCT01840579|542165237|FG001|Overall Study|Progressive disease|5|||
150280929|NCT01840579|542165238|FG002|Overall Study|Progressive disease|0|||
150280930|NCT01840579|542165239|FG003|Overall Study|Progressive disease|0|||
150280931|NCT01840579|542165240|FG004|Overall Study|Progressive disease|0|||
150280932|NCT01840579|542165241|FG005|Overall Study|Progressive disease|0|||
150280933|NCT01840579|542165242|FG006|Overall Study|Progressive disease|0|||
150280934|NCT01840579|542165243|FG007|Overall Study|Progressive disease|0|||
150280935|NCT01840579|542165244|FG008|Overall Study|Progressive disease|0|||
150280936|NCT01840579|542165245|FG009|Overall Study|Progressive disease|0|||
150280937|NCT01840579|542165236|FG000|Overall Study|Ongoing in study|0|||
150280938|NCT01840579|542165237|FG001|Overall Study|Ongoing in study|1|||
150280939|NCT01840579|542165238|FG002|Overall Study|Ongoing in study|0|||
150280940|NCT01840579|542165239|FG003|Overall Study|Ongoing in study|0|||
150280941|NCT01840579|542165240|FG004|Overall Study|Ongoing in study|0|||
150280942|NCT01840579|542165241|FG005|Overall Study|Ongoing in study|0|||
150280943|NCT01840579|542165242|FG006|Overall Study|Ongoing in study|0|||
150280944|NCT01840579|542165243|FG007|Overall Study|Ongoing in study|0|||
150280945|NCT01840579|542165244|FG008|Overall Study|Ongoing in study|0|||
150280946|NCT01840579|542165245|FG009|Overall Study|Ongoing in study|0|||
150280947|NCT01840579|542165236|FG000|Overall Study|Death|0|||
150280948|NCT01840579|542165237|FG001|Overall Study|Death|0|||
150280949|NCT01840579|542165238|FG002|Overall Study|Death|0|||
150280950|NCT01840579|542165239|FG003|Overall Study|Death|0|||
150280951|NCT01840579|542165240|FG004|Overall Study|Death|0|||
150280952|NCT01840579|542165241|FG005|Overall Study|Death|1|||
150280953|NCT01840579|542165242|FG006|Overall Study|Death|0|||
150280954|NCT01840579|542165243|FG007|Overall Study|Death|0|||
149836414|NCT00829673|540534291|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149836415|NCT00829673|540534292|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149836416|NCT00096447|540534293|FG000|Overall Study|Never treated|1|||
149836417|NCT00573066|540534294|FG000|Overall Study|Exclusion criteria|18|||
149836418|NCT00573066|540534294|FG000|Overall Study|IV malfunction|1|||
149836419|NCT00573066|540534294|FG000|Overall Study|Postoperative bleeding|1|||
149836420|NCT02246166|540534297|FG000|Overall Study|Protocol Violation|1|||
149836421|NCT02246166|540534298|FG001|Overall Study|Protocol Violation|0|||
149836422|NCT00834743|540534299|FG000|Second Intervention|Withdrawal by Subject|1|||
149836423|NCT00834743|540534300|FG001|Second Intervention|Withdrawal by Subject|0|||
149836424|NCT00086996|540534301|FG000|Overall Study|Adverse Event|29|||
149836425|NCT00086996|540534301|FG000|Overall Study|Death|4|||
149836426|NCT00086996|540534301|FG000|Overall Study|progression/relapse|7|||
149836427|NCT00086996|540534301|FG000|Overall Study|Withdrawal by Subject|13|||
149836428|NCT00086996|540534301|FG000|Overall Study|Other|6|||
149836429|NCT00086996|540534301|FG000|Overall Study|not eligible|5|||
149836430|NCT02770820|540534302|FG000|Overall Study|Death|1|||
149836431|NCT02770820|540534302|FG000|Overall Study|Physician Decision|2|||
149836432|NCT02331394|540534303|FG000|Overall Study|Disease progression|1|||
149836433|NCT01313273|540534306|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
149836434|NCT01313273|540534307|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
149836435|NCT01313273|540534306|FG000|Overall Study|Withdrawal by Subject|1|||
149836436|NCT01313273|540534307|FG001|Overall Study|Withdrawal by Subject|0|||
149836437|NCT01313273|540534306|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
149836438|NCT01313273|540534307|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
149836439|NCT00552669|540534308|FG000|Overall Study|Death|3|||
149836440|NCT00552669|540534309|FG001|Overall Study|Death|7|||
149836441|NCT03687736|540534310|FG000|Overall Study|Lost to Follow-up|7|||
149836442|NCT03687736|540534310|FG000|Overall Study|Withdrawal by Subject|3|||
149836443|NCT03195491|540534313|FG000|Overall Study|Study drug toxicity|25|||
149836444|NCT03195491|540534314|FG001|Overall Study|Study drug toxicity|3|||
149836445|NCT03195491|540534313|FG000|Overall Study|Maximum clinical benefit|5|||
149836446|NCT03195491|540534314|FG001|Overall Study|Maximum clinical benefit|0|||
149836447|NCT03195491|540534313|FG000|Overall Study|Lost to Follow-up|1|||
149836448|NCT03195491|540534314|FG001|Overall Study|Lost to Follow-up|0|||
149836449|NCT03195491|540534313|FG000|Overall Study|Death|3|||
149836450|NCT03195491|540534314|FG001|Overall Study|Death|0|||
149836451|NCT03195491|540534313|FG000|Overall Study|Adverse event unrelated to study drug|19|||
149836452|NCT03195491|540534314|FG001|Overall Study|Adverse event unrelated to study drug|2|||
149836453|NCT03195491|540534313|FG000|Overall Study|Disease progression|266|||
149836454|NCT03195491|540534314|FG001|Overall Study|Disease progression|8|||
149836455|NCT03195491|540534313|FG000|Overall Study|Other reasons|10|||
149836456|NCT03195491|540534314|FG001|Overall Study|Other reasons|0|||
149836457|NCT03195491|540534313|FG000|Overall Study|Participant withdrew consent|8|||
149836458|NCT03195491|540534314|FG001|Overall Study|Participant withdrew consent|1|||
149836459|NCT03195491|540534313|FG000|Overall Study|Participant no longer meets study criteria|0|||
149836460|NCT03195491|540534314|FG001|Overall Study|Participant no longer meets study criteria|1|||
149836461|NCT03195491|540534313|FG000|Overall Study|Participant request to discontinue study treatment|10|||
149836462|NCT03195491|540534314|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149836463|NCT01270503|540534315|FG000|Overall Study|Lost to Follow-up|1|||
149836464|NCT02459951|540534316|FG000|Overall Study|Unable to meet holding requirement|1|||
149836465|NCT00252720|540534318|FG000|Overall Study|Withdrawal by Subject|95|||
149836466|NCT00252720|540534319|FG001|Overall Study|Withdrawal by Subject|97|||
149836467|NCT00252720|540534318|FG000|Overall Study|Death|7|||
150280955|NCT01840579|542165244|FG008|Overall Study|Death|0|||
150280956|NCT01840579|542165245|FG009|Overall Study|Death|0|||
150034482|NCT00303069|541266426|FG001|Overall Study|subject moved|0|||
149836468|NCT00252720|540534319|FG001|Overall Study|Death|8|||
149836469|NCT00252720|540534318|FG000|Overall Study|Moving|23|||
149836470|NCT00252720|540534319|FG001|Overall Study|Moving|42|||
149836471|NCT00252720|540534318|FG000|Overall Study|Mainly patients lost to follow-up|7|||
149836472|NCT00252720|540534319|FG001|Overall Study|Mainly patients lost to follow-up|18|||
149836473|NCT01792635|540534320|FG000|Part B|Adverse Event|0|||
149836474|NCT01792635|540534321|FG001|Part B|Adverse Event|0|||
149836475|NCT01792635|540534322|FG002|Part B|Adverse Event|1|||
149836476|NCT01792635|540534320|FG000|Part B|Study terminated|0|||
149836477|NCT01792635|540534321|FG001|Part B|Study terminated|4|||
149836478|NCT01792635|540534322|FG002|Part B|Study terminated|3|||
149836479|NCT01745120|540534323|FG000|Overall Study|Investigator decision|1|||
149836480|NCT01745120|540534324|FG001|Overall Study|Investigator decision|0|||
149836481|NCT02017223|540534328|FG000|Overall Study|Algorithm problems|2|||
149836482|NCT01401647|540534329|FG000|Overall Study|Withdrawal by Subject|1|||
149836483|NCT01401647|540534330|FG001|Overall Study|Withdrawal by Subject|5|||
149836484|NCT01401647|540534331|FG002|Overall Study|Withdrawal by Subject|2|||
149836485|NCT01401647|540534329|FG000|Overall Study|Lost to Follow-up|3|||
149836486|NCT01401647|540534330|FG001|Overall Study|Lost to Follow-up|3|||
149836487|NCT01401647|540534331|FG002|Overall Study|Lost to Follow-up|1|||
149836488|NCT01675765|540534332|FG000|Overall Study|Progressive disease|4|||
149836489|NCT01675765|540534333|FG001|Overall Study|Progressive disease|4|||
149836490|NCT01675765|540534332|FG000|Overall Study|Adverse Event|1|||
149836491|NCT01675765|540534333|FG001|Overall Study|Adverse Event|2|||
149836492|NCT01675765|540534332|FG000|Overall Study|Withdrawal by Subject|2|||
149836493|NCT01675765|540534333|FG001|Overall Study|Withdrawal by Subject|0|||
149836494|NCT01675765|540534332|FG000|Overall Study|Death|1|||
149836495|NCT01675765|540534333|FG001|Overall Study|Death|0|||
149836496|NCT01675765|540534332|FG000|Overall Study|Clinical progression|3|||
149836497|NCT01675765|540534333|FG001|Overall Study|Clinical progression|2|||
149836498|NCT01185821|540534336|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149836499|NCT01185821|540534337|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149836500|NCT01185821|540534338|FG002|Overall Study|Abnormal laboratory value(s)|1|||
149836501|NCT01185821|540534339|FG003|Overall Study|Abnormal laboratory value(s)|0|||
149836502|NCT01185821|540534340|FG004|Overall Study|Abnormal laboratory value(s)|0|||
149836503|NCT01185821|540534336|FG000|Overall Study|Protocol Violation|0|||
149836504|NCT01185821|540534337|FG001|Overall Study|Protocol Violation|0|||
149836505|NCT01185821|540534338|FG002|Overall Study|Protocol Violation|0|||
149836506|NCT01185821|540534339|FG003|Overall Study|Protocol Violation|1|||
149836507|NCT01185821|540534340|FG004|Overall Study|Protocol Violation|1|||
149836508|NCT01185821|540534336|FG000|Overall Study|Abnormal test procedure result|0|||
149836509|NCT01185821|540534337|FG001|Overall Study|Abnormal test procedure result|0|||
149836510|NCT01185821|540534338|FG002|Overall Study|Abnormal test procedure result|0|||
149836511|NCT01185821|540534339|FG003|Overall Study|Abnormal test procedure result|0|||
149836512|NCT01185821|540534340|FG004|Overall Study|Abnormal test procedure result|1|||
149836513|NCT01185821|540534336|FG000|Overall Study|Death|0|||
149836514|NCT01185821|540534337|FG001|Overall Study|Death|1|||
149836515|NCT01185821|540534338|FG002|Overall Study|Death|0|||
149836516|NCT01185821|540534339|FG003|Overall Study|Death|0|||
149836517|NCT01185821|540534340|FG004|Overall Study|Death|0|||
149836518|NCT01185821|540534336|FG000|Overall Study|Condition no longer required study drug|0|||
149836519|NCT01185821|540534337|FG001|Overall Study|Condition no longer required study drug|0|||
149836520|NCT01185821|540534338|FG002|Overall Study|Condition no longer required study drug|0|||
149836521|NCT01185821|540534339|FG003|Overall Study|Condition no longer required study drug|0|||
149836522|NCT01185821|540534340|FG004|Overall Study|Condition no longer required study drug|1|||
149836523|NCT01185821|540534336|FG000|Overall Study|Adverse Event|2|||
149836524|NCT01185821|540534337|FG001|Overall Study|Adverse Event|3|||
149836525|NCT01185821|540534338|FG002|Overall Study|Adverse Event|1|||
149836526|NCT01185821|540534339|FG003|Overall Study|Adverse Event|2|||
149836527|NCT01185821|540534340|FG004|Overall Study|Adverse Event|5|||
149836528|NCT01185821|540534336|FG000|Overall Study|Lack of Efficacy|0|||
149836529|NCT01185821|540534337|FG001|Overall Study|Lack of Efficacy|0|||
149836530|NCT01185821|540534338|FG002|Overall Study|Lack of Efficacy|3|||
149836531|NCT01185821|540534339|FG003|Overall Study|Lack of Efficacy|0|||
149836532|NCT01185821|540534340|FG004|Overall Study|Lack of Efficacy|9|||
149836533|NCT01185821|540534336|FG000|Overall Study|Withdrawal by Subject|3|||
149836534|NCT01185821|540534337|FG001|Overall Study|Withdrawal by Subject|2|||
149836535|NCT01185821|540534338|FG002|Overall Study|Withdrawal by Subject|2|||
149836536|NCT01185821|540534339|FG003|Overall Study|Withdrawal by Subject|1|||
149836537|NCT01185821|540534340|FG004|Overall Study|Withdrawal by Subject|3|||
149836538|NCT01185821|540534336|FG000|Overall Study|Lost to Follow-up|1|||
149836539|NCT01185821|540534337|FG001|Overall Study|Lost to Follow-up|1|||
149836540|NCT01185821|540534338|FG002|Overall Study|Lost to Follow-up|2|||
149836541|NCT01185821|540534339|FG003|Overall Study|Lost to Follow-up|1|||
149836542|NCT01185821|540534340|FG004|Overall Study|Lost to Follow-up|2|||
149836543|NCT01185821|540534336|FG000|Overall Study|Administrative problems|0|||
149836544|NCT01185821|540534337|FG001|Overall Study|Administrative problems|0|||
149836545|NCT01185821|540534338|FG002|Overall Study|Administrative problems|1|||
149836546|NCT01185821|540534339|FG003|Overall Study|Administrative problems|1|||
150034483|NCT00303069|541266427|FG002|Overall Study|subject moved|0|||
150034484|NCT00303069|541266428|FG003|Overall Study|subject moved|0|||
150034485|NCT00303069|541266425|FG000|Overall Study|Recruitment into Army Reserves|0|||
150034486|NCT00303069|541266426|FG001|Overall Study|Recruitment into Army Reserves|0|||
150034487|NCT00303069|541266427|FG002|Overall Study|Recruitment into Army Reserves|1|||
150034488|NCT00303069|541266428|FG003|Overall Study|Recruitment into Army Reserves|0|||
150034489|NCT04328077|541266432|FG000|Overall Study|Lost to Follow-up|0|||
150034490|NCT04328077|541266433|FG001|Overall Study|Lost to Follow-up|1|||
150034491|NCT04328077|541266434|FG002|Overall Study|Lost to Follow-up|0|||
150034492|NCT04328077|541266435|FG003|Overall Study|Lost to Follow-up|0|||
150034493|NCT04328077|541266432|FG000|Overall Study|Withdrawal by Subject|0|||
150034494|NCT04328077|541266433|FG001|Overall Study|Withdrawal by Subject|1|||
150171715|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
150171716|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
149836547|NCT01185821|540534340|FG004|Overall Study|Administrative problems|2|||
150034495|NCT04328077|541266434|FG002|Overall Study|Withdrawal by Subject|1|||
150034496|NCT04328077|541266435|FG003|Overall Study|Withdrawal by Subject|3|||
150171717|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
150171718|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
150171719|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
150171720|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
150171721|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
150171722|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
150171723|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
150171724|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
150171725|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
150171726|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150171727|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
150171728|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
150171729|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150171730|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150171731|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150171732|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150171733|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
150171734|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
150171735|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
150171736|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
150171737|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
150171738|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
150171739|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
150171740|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
150171741|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
150171742|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
150171743|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
150171744|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171745|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171746|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171747|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171748|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171749|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171750|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171751|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
150171752|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
150171753|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150171754|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
150171755|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
150171756|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150171757|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150171758|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150171759|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150171760|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
150171761|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
150171762|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171763|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
150171764|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
150171765|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171766|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171767|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171768|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171769|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
150280957|NCT01840579|542165236|FG000|Overall Study|Adverse Event|0|||
149836548|NCT00846495|540534346|FG000|Overall Study|Lost to Follow-up|1|||
149836549|NCT00846495|540534347|FG001|Overall Study|Lost to Follow-up|0|||
149836550|NCT00846495|540534346|FG000|Overall Study|Adverse Event|5|||
149836551|NCT00846495|540534347|FG001|Overall Study|Adverse Event|1|||
149836552|NCT00846495|540534346|FG000|Overall Study|Lack of Efficacy|1|||
149836553|NCT00846495|540534347|FG001|Overall Study|Lack of Efficacy|2|||
149836554|NCT00846495|540534346|FG000|Overall Study|Physician Decision|1|||
149836555|NCT00846495|540534347|FG001|Overall Study|Physician Decision|0|||
149836556|NCT01265056|540534348|FG000|Initial Study Period|Withdrawal by Subject|1|||
149836557|NCT01265056|540534349|FG001|Initial Study Period|Withdrawal by Subject|1|||
149836558|NCT01265056|540534348|FG000|Initial Study Period|Withdrawal by Subject|1|||
149836559|NCT01265056|540534349|FG001|Initial Study Period|Withdrawal by Subject|1|||
149836560|NCT01265056|540534348|FG000|Follow up|Lost to Follow-up|7|||
149836561|NCT01265056|540534349|FG001|Follow up|Lost to Follow-up|3|||
149836562|NCT00537979|540534355|FG000|Overall Study|Adverse Event|2|||
149836563|NCT00537979|540534356|FG001|Overall Study|Adverse Event|2|||
149836564|NCT00537979|540534355|FG000|Overall Study|Withdrawal by Subject|1|||
149836565|NCT00537979|540534356|FG001|Overall Study|Withdrawal by Subject|4|||
149836566|NCT00537979|540534355|FG000|Overall Study|Lost to Follow-up|1|||
149836567|NCT00537979|540534356|FG001|Overall Study|Lost to Follow-up|4|||
149836568|NCT00537979|540534355|FG000|Overall Study|Lack of Efficacy|0|||
149836569|NCT00537979|540534356|FG001|Overall Study|Lack of Efficacy|1|||
149836570|NCT00537979|540534355|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
149836571|NCT00537979|540534356|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
149836572|NCT00537979|540534355|FG000|Overall Study|Death|0|||
149836573|NCT00537979|540534356|FG001|Overall Study|Death|3|||
149836574|NCT00537979|540534355|FG000|Overall Study|Kidney transplant|0|||
149836575|NCT00537979|540534356|FG001|Overall Study|Kidney transplant|3|||
149836576|NCT00537979|540534355|FG000|Overall Study|Heart failure|0|||
149836577|NCT00537979|540534356|FG001|Overall Study|Heart failure|1|||
149836578|NCT03459807|540534360|FG000|Overall Study|Withdrawal due to transplant|0|||
149836579|NCT03459807|540534361|FG001|Overall Study|Withdrawal due to transplant|1|||
149836580|NCT02392000|540534362|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
149836581|NCT02392000|540534362|FG000|Overall Study|Withdrawal by Subject|1|||
149836582|NCT02392000|540534362|FG000|Overall Study|Lost to Follow-up|8|||
149836583|NCT00965185|540534367|FG000|Overall Study|Lost to Follow-up|2|||
149836584|NCT00965185|540534368|FG001|Overall Study|Lost to Follow-up|0|||
149836585|NCT00965185|540534367|FG000|Overall Study|Withdrawal by Subject|0|||
149836586|NCT00965185|540534368|FG001|Overall Study|Withdrawal by Subject|1|||
149836587|NCT03197883|540534369|FG000|Overall Study|Adverse Event|1|||
149836588|NCT03197883|540534370|FG001|Overall Study|Adverse Event|1|||
149836589|NCT03197883|540534369|FG000|Overall Study|Lost to Follow-up|1|||
149836590|NCT03197883|540534370|FG001|Overall Study|Lost to Follow-up|0|||
149836591|NCT03197883|540534369|FG000|Overall Study|Protocol Violation|1|||
149836592|NCT03197883|540534370|FG001|Overall Study|Protocol Violation|0|||
149836593|NCT03197883|540534369|FG000|Overall Study|Other (Not Specified)|0|||
149836594|NCT03197883|540534370|FG001|Overall Study|Other (Not Specified)|5|||
149836595|NCT00858845|540534372|FG000|Overall Study|Patient underwent heart transplant.|0|||
149836596|NCT00858845|540534373|FG001|Overall Study|Patient underwent heart transplant.|1|||
149836597|NCT03243630|540534382|FG000|Overall Study|Protocol Violation|1|||
149836598|NCT03243630|540534382|FG000|Overall Study|Physician Decision|1|||
149836599|NCT00939003|540534383|FG000|Double-blind Treatment Period|Adverse Event|1|||
149836600|NCT00939003|540534384|FG001|Double-blind Treatment Period|Adverse Event|1|||
149836601|NCT00939003|540534383|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
149836602|NCT00939003|540534384|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
149836603|NCT00939003|540534383|FG000|Double-blind Treatment Period|Pregnancy|0|||
149836604|NCT00939003|540534384|FG001|Double-blind Treatment Period|Pregnancy|1|||
149836605|NCT00939003|540534383|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
149836606|NCT00939003|540534384|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
149836607|NCT00939003|540534383|FG000|Open-label Treatment Period|Adverse Event|4|||
149836608|NCT00939003|540534384|FG001|Open-label Treatment Period|Adverse Event|8|||
149836609|NCT00939003|540534383|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
149836610|NCT00939003|540534384|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
149836611|NCT00939003|540534383|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
149836612|NCT00939003|540534384|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
149836613|NCT00939003|540534383|FG000|Open-label Treatment Period|Pregnancy|1|||
149836614|NCT00939003|540534384|FG001|Open-label Treatment Period|Pregnancy|1|||
149836615|NCT00939003|540534383|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
149836616|NCT00939003|540534384|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
149836617|NCT00939003|540534383|FG000|Open-label Treatment Period|Site Closure|3|||
149836618|NCT00939003|540534384|FG001|Open-label Treatment Period|Site Closure|4|||
149836619|NCT02131129|540534385|FG000|Overall Study|Withdrawal by Subject|1|||
149836620|NCT02131129|540534386|FG001|Overall Study|Withdrawal by Subject|0|||
149836621|NCT03707912|540534387|FG000|Overall Study|Violation of inclusion criteria|1|||
149836622|NCT03707912|540534388|FG001|Overall Study|Violation of inclusion criteria|0|||
149836623|NCT01466166|540535921|FG000|Overall Study|Death|1|||
149836624|NCT01466166|540535921|FG000|Overall Study|Lost to Follow-up|7|||
149836625|NCT01466166|540535921|FG000|Overall Study|Infusion Reaction (IR)|27|||
149836626|NCT01466166|540535921|FG000|Overall Study|Adverse Event (Other than IR)|11|||
149836627|NCT01466166|540535921|FG000|Overall Study|Elevated Serum Uric Acid|78|||
149836628|NCT01466166|540535921|FG000|Overall Study|Withdrawal by Subject|13|||
149836629|NCT01466166|540535921|FG000|Overall Study|Sponsor Decision|4|||
149836630|NCT01466166|540535921|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
149836631|NCT01466166|540535921|FG000|Overall Study|Other|20|||
149836632|NCT00328926|540535922|FG000|Overall Study|Pregnancy|2|||
149836633|NCT00328926|540535923|FG001|Overall Study|Pregnancy|1|||
149836634|NCT00328926|540535924|FG002|Overall Study|Pregnancy|0|||
149836635|NCT00328926|540535922|FG000|Overall Study|Lost to Follow-up|0|||
149836636|NCT00328926|540535923|FG001|Overall Study|Lost to Follow-up|1|||
149836637|NCT00328926|540535924|FG002|Overall Study|Lost to Follow-up|0|||
149836638|NCT00328926|540535922|FG000|Overall Study|Death|0|||
149836639|NCT00328926|540535923|FG001|Overall Study|Death|0|||
149836640|NCT00328926|540535924|FG002|Overall Study|Death|1|||
149836641|NCT00328926|540535922|FG000|Overall Study|In vitro fertilization treatment|0|||
149836642|NCT00328926|540535923|FG001|Overall Study|In vitro fertilization treatment|0|||
149836643|NCT00328926|540535924|FG002|Overall Study|In vitro fertilization treatment|1|||
149836644|NCT00328926|540535922|FG000|Overall Study|Lack of ovarian response|0|||
149836645|NCT00328926|540535923|FG001|Overall Study|Lack of ovarian response|1|||
149836646|NCT00328926|540535924|FG002|Overall Study|Lack of ovarian response|0|||
149836647|NCT02269657|540535925|FG000|Overall Study|Protocol Violation|3|||
149836648|NCT00272779|540535928|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
149836649|NCT00272779|540535929|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
149836650|NCT00272779|540535928|FG000|Baseline Through Week 48|Death before Week 48|4|||
149836651|NCT00272779|540535929|FG001|Baseline Through Week 48|Death before Week 48|4|||
149836652|NCT00272779|540535928|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
149836653|NCT00272779|540535929|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
149836654|NCT00272779|540535928|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
149836655|NCT00272779|540535929|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
149836656|NCT00272779|540535928|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
149836657|NCT00272779|540535929|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
150034497|NCT01456039|541266436|FG000|Phase 1 (First Step)|Disease Progression|1|||
150034498|NCT01456039|541266437|FG001|Phase 1 (First Step)|Disease Progression|1|||
150034499|NCT01456039|541266438|FG002|Phase 1 (First Step)|Disease Progression|0|||
150034500|NCT01456039|541266436|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
150171770|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
150171771|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
150171772|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
150171773|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
150171774|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
150171775|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149836658|NCT00272779|540535928|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
149836659|NCT00272779|540535929|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
149836660|NCT00272779|540535928|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
150171776|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
150171777|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
150171778|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
149836661|NCT00272779|540535929|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
149836662|NCT00272779|540535928|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
149836663|NCT00272779|540535929|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
149836664|NCT00272779|540535928|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
149836665|NCT00272779|540535929|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
149836666|NCT00272779|540535928|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
149836667|NCT00272779|540535929|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
149836668|NCT00272779|540535928|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
149836669|NCT00272779|540535929|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
149836670|NCT00272779|540535928|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
149836671|NCT00272779|540535929|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
149836672|NCT00272779|540535928|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
149836673|NCT00272779|540535929|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
149836674|NCT00272779|540535928|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
149836675|NCT00272779|540535929|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
149836676|NCT00272779|540535928|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
149836677|NCT00272779|540535929|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
149836678|NCT00272779|540535928|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
149836679|NCT00272779|540535929|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
149836680|NCT00272779|540535928|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
149836681|NCT00272779|540535929|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
149836682|NCT00272779|540535928|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
149836683|NCT00272779|540535929|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
149836684|NCT00272779|540535928|FG000|Baseline Through Week 48|Continuing treatment|385|||
149836685|NCT00272779|540535929|FG001|Baseline Through Week 48|Continuing treatment|368|||
149836686|NCT00272779|540535928|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
149836687|NCT00272779|540535929|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
149836688|NCT00272779|540535928|FG000|Baseline Through Week 48|Never treated|2|||
149836689|NCT00272779|540535929|FG001|Baseline Through Week 48|Never treated|3|||
149836690|NCT00272779|540535928|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
149836691|NCT00272779|540535929|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
149836692|NCT00272779|540535928|FG000|Baseline Through Week 96|Death before Week 96|6|||
149836693|NCT00272779|540535929|FG001|Baseline Through Week 96|Death before Week 96|5|||
149836694|NCT00272779|540535928|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
149836695|NCT00272779|540535929|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
149836696|NCT00272779|540535928|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
149836697|NCT00272779|540535929|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
149836698|NCT00272779|540535928|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
149836699|NCT00272779|540535929|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
149836700|NCT00272779|540535928|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
149836701|NCT00272779|540535929|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
149836702|NCT00272779|540535928|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
149836703|NCT00272779|540535929|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
149836704|NCT00272779|540535928|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
149836705|NCT00272779|540535929|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
149836706|NCT00272779|540535928|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
149836707|NCT00272779|540535929|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
149836708|NCT00272779|540535928|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
149836709|NCT00272779|540535929|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
149836710|NCT00272779|540535928|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
149836711|NCT00272779|540535929|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
150171779|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
150171780|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171781|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
150171782|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171783|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171784|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171785|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171786|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171787|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149836712|NCT00272779|540535928|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
149836713|NCT00272779|540535929|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
149836714|NCT00272779|540535928|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
149836715|NCT00272779|540535929|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
149836716|NCT00272779|540535928|FG000|Baseline Through Week 96|Never treated|2|||
149836717|NCT00272779|540535929|FG001|Baseline Through Week 96|Never treated|3|||
149836718|NCT00272779|540535928|FG000|Baseline Through Week 96|Continuing on treatment|61|||
149836719|NCT00272779|540535929|FG001|Baseline Through Week 96|Continuing on treatment|38|||
149836720|NCT02440711|540535930|FG000|Second Intervention|Lost to Follow-up|1|||
149836721|NCT02440711|540535931|FG001|Second Intervention|Lost to Follow-up|0|||
149836722|NCT03450057|540535934|FG000|Overall Study|Death|17|||
149836723|NCT03450057|540535934|FG000|Overall Study|ICF withdrawal|4|||
149836724|NCT03450057|540535934|FG000|Overall Study|Lost to Follow-up|2|||
149836725|NCT05755282|540535935|FG000|Overall Study|Protocol Violation|0|||
149836726|NCT05755282|540535936|FG001|Overall Study|Protocol Violation|1|||
149836727|NCT00829790|540535938|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
149836728|NCT00829790|540535939|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
149836729|NCT03214952|540535940|FG000|Overall Study|Protocol Deviation|45|||
149836730|NCT03214952|540535940|FG000|Overall Study|Case Report Forms Uncollected|13|||
149836731|NCT03769896|540535941|FG000|Open-label Phase|Lack of Efficacy|5|||
149836732|NCT03769896|540535942|FG001|Open-label Phase|Lack of Efficacy|0|||
149836733|NCT03769896|540535941|FG000|Open-label Phase|Adverse Event|3|||
149836734|NCT03769896|540535942|FG001|Open-label Phase|Adverse Event|0|||
149836735|NCT03769896|540535941|FG000|Open-label Phase|Withdrawal by Subject|1|||
149836736|NCT03769896|540535942|FG001|Open-label Phase|Withdrawal by Subject|0|||
149836737|NCT01015703|540535943|FG000|Overall Study|Withdrawal by Subject|0|||
149836738|NCT01015703|540535944|FG001|Overall Study|Withdrawal by Subject|1|||
149836739|NCT01015703|540535945|FG002|Overall Study|Withdrawal by Subject|0|||
149836740|NCT01015703|540535946|FG003|Overall Study|Withdrawal by Subject|0|||
149836741|NCT01015703|540535947|FG004|Overall Study|Withdrawal by Subject|0|||
149836742|NCT01015703|540535943|FG000|Overall Study|Adverse Event|1|||
149836743|NCT01015703|540535944|FG001|Overall Study|Adverse Event|0|||
149836744|NCT01015703|540535945|FG002|Overall Study|Adverse Event|0|||
149836745|NCT01015703|540535946|FG003|Overall Study|Adverse Event|0|||
149836746|NCT01015703|540535947|FG004|Overall Study|Adverse Event|0|||
149836747|NCT01015703|540535943|FG000|Overall Study|Protocol Violation|1|||
149836748|NCT01015703|540535944|FG001|Overall Study|Protocol Violation|0|||
149836749|NCT01015703|540535945|FG002|Overall Study|Protocol Violation|0|||
149836750|NCT01015703|540535946|FG003|Overall Study|Protocol Violation|0|||
149836751|NCT01015703|540535947|FG004|Overall Study|Protocol Violation|0|||
149836752|NCT01083693|540535948|FG000|Overall Study|Adverse Event|1|||
149836753|NCT01083693|540535949|FG001|Overall Study|Adverse Event|1|||
149836754|NCT01083693|540535950|FG002|Overall Study|Adverse Event|0|||
149836755|NCT01083693|540535948|FG000|Overall Study|Lost to Follow-up|2|||
149836756|NCT01083693|540535949|FG001|Overall Study|Lost to Follow-up|0|||
149836757|NCT01083693|540535950|FG002|Overall Study|Lost to Follow-up|2|||
149836758|NCT01083693|540535948|FG000|Overall Study|Lack of effectiveness|13|||
149836759|NCT01083693|540535949|FG001|Overall Study|Lack of effectiveness|2|||
149836760|NCT01083693|540535950|FG002|Overall Study|Lack of effectiveness|2|||
149836761|NCT01083693|540535948|FG000|Overall Study|Patient Moved|0|||
149836762|NCT01083693|540535949|FG001|Overall Study|Patient Moved|1|||
149836763|NCT01083693|540535950|FG002|Overall Study|Patient Moved|0|||
149836764|NCT01083693|540535948|FG000|Overall Study|Complete remission|0|||
149836765|NCT01083693|540535949|FG001|Overall Study|Complete remission|1|||
149836766|NCT01083693|540535950|FG002|Overall Study|Complete remission|0|||
149836767|NCT01083693|540535948|FG000|Overall Study|Other medical condition/surgery|1|||
149836768|NCT01083693|540535949|FG001|Overall Study|Other medical condition/surgery|1|||
149836769|NCT01083693|540535950|FG002|Overall Study|Other medical condition/surgery|0|||
149836770|NCT01083693|540535948|FG000|Overall Study|Withdrawal by Subject|3|||
149836771|NCT01083693|540535949|FG001|Overall Study|Withdrawal by Subject|0|||
149836772|NCT01083693|540535950|FG002|Overall Study|Withdrawal by Subject|2|||
149836773|NCT01083693|540535948|FG000|Overall Study|Reason unknown|0|||
149836774|NCT01083693|540535949|FG001|Overall Study|Reason unknown|0|||
149836775|NCT01083693|540535950|FG002|Overall Study|Reason unknown|1|||
149836776|NCT01693523|540535951|FG000|Overall Study|Adverse Event|2|||
149836777|NCT01693523|540535952|FG001|Overall Study|Adverse Event|1|||
149836778|NCT01693523|540535953|FG002|Overall Study|Adverse Event|0|||
149836779|NCT01693523|540535951|FG000|Overall Study|Death|0|||
149836780|NCT01693523|540535952|FG001|Overall Study|Death|1|||
149836781|NCT01693523|540535953|FG002|Overall Study|Death|1|||
149836782|NCT01693523|540535951|FG000|Overall Study|Lost to Follow-up|0|||
149836783|NCT01693523|540535952|FG001|Overall Study|Lost to Follow-up|0|||
149836784|NCT01693523|540535953|FG002|Overall Study|Lost to Follow-up|4|||
149836785|NCT01693523|540535951|FG000|Overall Study|Physician Decision|0|||
149836786|NCT01693523|540535952|FG001|Overall Study|Physician Decision|0|||
149836787|NCT01693523|540535953|FG002|Overall Study|Physician Decision|1|||
149836788|NCT01693523|540535951|FG000|Overall Study|Withdrawal by Subject|1|||
149836789|NCT01693523|540535952|FG001|Overall Study|Withdrawal by Subject|2|||
149836790|NCT01693523|540535953|FG002|Overall Study|Withdrawal by Subject|2|||
149836791|NCT01693523|540535951|FG000|Overall Study|Lack of compliance study medication|1|||
149836792|NCT01693523|540535952|FG001|Overall Study|Lack of compliance study medication|2|||
149836793|NCT01693523|540535953|FG002|Overall Study|Lack of compliance study medication|0|||
149836794|NCT01693523|540535951|FG000|Overall Study|Chemotherapy was held|1|||
149836795|NCT01693523|540535952|FG001|Overall Study|Chemotherapy was held|2|||
149836796|NCT01693523|540535953|FG002|Overall Study|Chemotherapy was held|0|||
149836797|NCT00834418|540535954|FG000|Overall Study|Adverse Event|0|||
149836798|NCT00834418|540535955|FG001|Overall Study|Adverse Event|2|||
149836799|NCT04567186|540535957|FG000|Period 1|COVID-19 related|1|||
149836800|NCT04567186|540535958|FG001|Period 1|COVID-19 related|0|||
149836801|NCT04567186|540535957|FG000|Period 1|Protocol Violation|0|||
149836802|NCT04567186|540535958|FG001|Period 1|Protocol Violation|1|||
149836803|NCT04567186|540535957|FG000|Period 1|Adverse Event|0|||
149836804|NCT04567186|540535958|FG001|Period 1|Adverse Event|2|||
149836805|NCT04567186|540535957|FG000|Period 2|COVID-19 Related|0|||
149836806|NCT04567186|540535958|FG001|Period 2|COVID-19 Related|1|||
149836807|NCT04567186|540535957|FG000|Period 2|Protocol Violation|0|||
149836808|NCT04567186|540535958|FG001|Period 2|Protocol Violation|1|||
149836809|NCT04567186|540535957|FG000|Period 2|Lost to Follow-up|0|||
149836810|NCT04567186|540535958|FG001|Period 2|Lost to Follow-up|1|||
149836811|NCT04567186|540535957|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
149836812|NCT04567186|540535958|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
149836813|NCT00004562|540535959|FG000|Overall Study|Lost to Follow-up|102|||
149836814|NCT00004562|540535960|FG001|Overall Study|Lost to Follow-up|91|||
149836815|NCT00376623|540535963|FG000|Overall Study|Progressive disease|35|||
149836816|NCT00376623|540535964|FG001|Overall Study|Progressive disease|22|||
149836817|NCT00376623|540535965|FG002|Overall Study|Progressive disease|17|||
149836818|NCT00376623|540535963|FG000|Overall Study|Lost to Follow-up|0|||
149836819|NCT00376623|540535964|FG001|Overall Study|Lost to Follow-up|1|||
149836820|NCT00376623|540535965|FG002|Overall Study|Lost to Follow-up|0|||
149836821|NCT00376623|540535963|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
149836822|NCT00376623|540535964|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
149836823|NCT00376623|540535965|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
149836824|NCT00376623|540535963|FG000|Overall Study|Not treated with BI 2536|1|||
149836825|NCT00376623|540535964|FG001|Overall Study|Not treated with BI 2536|0|||
149836826|NCT00376623|540535965|FG002|Overall Study|Not treated with BI 2536|0|||
149836827|NCT00376623|540535963|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
149836828|NCT00376623|540535964|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
149836829|NCT00376623|540535965|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
150171788|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
150171789|NCT01212757|541763542|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171790|NCT01212757|541763543|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
150171791|NCT01212757|541763544|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
150171792|NCT01212757|541763545|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171793|NCT01212757|541763546|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171794|NCT01212757|541763547|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171795|NCT01212757|541763548|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171796|NCT01212757|541763549|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171797|NCT01212757|541763550|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
150171798|NCT00573833|541763551|FG000|Overall Study|Not Treated|2|||
150171799|NCT04493242|541763552|FG000|Overall Study|Death|10|||
150171800|NCT04493242|541763553|FG001|Overall Study|Death|14|||
150171801|NCT04493242|541763554|FG002|Overall Study|Death|16|||
150171802|NCT04493242|541763552|FG000|Overall Study|Lost to Follow-up|1|||
150171803|NCT04493242|541763553|FG001|Overall Study|Lost to Follow-up|1|||
150280958|NCT01840579|542165237|FG001|Overall Study|Adverse Event|1|||
150280959|NCT01840579|542165238|FG002|Overall Study|Adverse Event|0|||
150280960|NCT01840579|542165239|FG003|Overall Study|Adverse Event|0|||
150280961|NCT01840579|542165240|FG004|Overall Study|Adverse Event|0|||
150280962|NCT01840579|542165241|FG005|Overall Study|Adverse Event|0|||
150280963|NCT01840579|542165242|FG006|Overall Study|Adverse Event|0|||
150280964|NCT01840579|542165243|FG007|Overall Study|Adverse Event|0|||
150280965|NCT01840579|542165244|FG008|Overall Study|Adverse Event|0|||
150280966|NCT01840579|542165245|FG009|Overall Study|Adverse Event|0|||
150280967|NCT01840579|542165236|FG000|Overall Study|Follow-up ended by Sponsor|0|||
150280968|NCT01840579|542165237|FG001|Overall Study|Follow-up ended by Sponsor|0|||
150280969|NCT01840579|542165238|FG002|Overall Study|Follow-up ended by Sponsor|0|||
150280970|NCT01840579|542165239|FG003|Overall Study|Follow-up ended by Sponsor|0|||
150280971|NCT01840579|542165240|FG004|Overall Study|Follow-up ended by Sponsor|0|||
150280972|NCT01840579|542165241|FG005|Overall Study|Follow-up ended by Sponsor|0|||
149836830|NCT00376623|540535963|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
149836831|NCT00376623|540535964|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
149836832|NCT00376623|540535965|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
149836833|NCT00376623|540535963|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
149836834|NCT00376623|540535964|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
149836835|NCT00376623|540535965|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
150280973|NCT01840579|542165242|FG006|Overall Study|Follow-up ended by Sponsor|2|||
150280974|NCT01840579|542165243|FG007|Overall Study|Follow-up ended by Sponsor|0|||
150280975|NCT01840579|542165244|FG008|Overall Study|Follow-up ended by Sponsor|0|||
150280976|NCT01840579|542165245|FG009|Overall Study|Follow-up ended by Sponsor|0|||
150280977|NCT03302975|542165247|FG000|Overall Study|Lost to Follow-up|4|||
150280978|NCT04506086|542165248|FG000|Overall Study|Withdrawal by Subject|2|||
150280979|NCT03996876|542165252|FG000|Overall Study|Incomplete Data|2|||
150280980|NCT03996876|542165253|FG001|Overall Study|Incomplete Data|4|||
150280981|NCT00597753|542165258|FG000|Overall Study|Adverse Event|6|||
149836836|NCT00376623|540535963|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
149836837|NCT00376623|540535964|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
150280982|NCT00597753|542165259|FG001|Overall Study|Adverse Event|2|||
150280983|NCT00597753|542165258|FG000|Overall Study|Death|55|||
150280984|NCT00597753|542165259|FG001|Overall Study|Death|29|||
150280985|NCT00597753|542165258|FG000|Overall Study|Lack of Efficacy|2|||
150280986|NCT00597753|542165259|FG001|Overall Study|Lack of Efficacy|0|||
150280987|NCT00597753|542165258|FG000|Overall Study|Lost to Follow-up|10|||
150280988|NCT00597753|542165259|FG001|Overall Study|Lost to Follow-up|3|||
150280989|NCT00597753|542165258|FG000|Overall Study|Physician Decision|5|||
150280990|NCT00597753|542165259|FG001|Overall Study|Physician Decision|1|||
150280991|NCT00597753|542165258|FG000|Overall Study|Pregnancy|1|||
150280992|NCT00597753|542165259|FG001|Overall Study|Pregnancy|0|||
150280993|NCT00597753|542165258|FG000|Overall Study|Withdrawal by Subject|35|||
150280994|NCT00597753|542165259|FG001|Overall Study|Withdrawal by Subject|12|||
150280995|NCT00597753|542165258|FG000|Overall Study|Discontinued Dialysis|0|||
150280996|NCT00597753|542165259|FG001|Overall Study|Discontinued Dialysis|1|||
150280997|NCT00597753|542165258|FG000|Overall Study|Never dosed|2|||
150280998|NCT00597753|542165259|FG001|Overall Study|Never dosed|0|||
150280999|NCT00597753|542165258|FG000|Overall Study|Noncompliance|2|||
150281000|NCT00597753|542165259|FG001|Overall Study|Noncompliance|1|||
150281001|NCT00597753|542165258|FG000|Overall Study|Relocation|17|||
150281002|NCT00597753|542165259|FG001|Overall Study|Relocation|6|||
150281003|NCT00597753|542165258|FG000|Overall Study|Renal transplant|10|||
150281004|NCT00597753|542165259|FG001|Overall Study|Renal transplant|3|||
149836838|NCT00376623|540535965|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
149836839|NCT00376623|540535963|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
150281005|NCT00597753|542165258|FG000|Overall Study|Site closed by sponsor|19|||
149836840|NCT00376623|540535964|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
149836841|NCT00376623|540535965|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
149836842|NCT00376623|540535963|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
149836843|NCT00376623|540535964|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
149836844|NCT00376623|540535965|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
149836845|NCT00376623|540535963|FG000|Overall Study|Increase of tumour markers|0|||
150281006|NCT00597753|542165259|FG001|Overall Study|Site closed by sponsor|7|||
150281007|NCT00597753|542165258|FG000|Overall Study|Site elected to close|2|||
150281008|NCT00597753|542165259|FG001|Overall Study|Site elected to close|4|||
150281009|NCT02222207|542167062|FG000|Overall Study|Death|1|||
150281010|NCT02222207|542167062|FG000|Overall Study|Other reasons|2|||
150281011|NCT02222207|542167062|FG000|Overall Study|Adverse Event|1|||
150281012|NCT01199042|542167063|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
150281013|NCT01199042|542167063|FG000|At Home (3 Months)|Lost to Follow-up|1|||
150281014|NCT01308008|542167070|FG000|4 Weeks|Illness, disinterest, time|9|||
150281015|NCT01308008|542167071|FG001|4 Weeks|Illness, disinterest, time|2|||
150281016|NCT01239342|542167072|FG000|Overall Study|Adverse Event|1|||
150281017|NCT01239342|542167073|FG001|Overall Study|Adverse Event|0|||
150281018|NCT01239342|542167072|FG000|Overall Study|Withdrawal by Subject|1|||
150281019|NCT01239342|542167073|FG001|Overall Study|Withdrawal by Subject|5|||
150281020|NCT01239342|542167072|FG000|Overall Study|Reason Unknown|1|||
150281021|NCT01239342|542167073|FG001|Overall Study|Reason Unknown|1|||
150281022|NCT02325219|542167074|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
150281023|NCT02325219|542167075|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
150281024|NCT02325219|542167076|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
150281025|NCT02325219|542167077|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
150281026|NCT02325219|542167078|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
150281027|NCT02325219|542167074|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
150281028|NCT02325219|542167075|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
150281029|NCT02325219|542167076|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150281030|NCT02325219|542167077|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150281031|NCT02325219|542167078|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150281032|NCT02325219|542167074|FG000|Controlled Period (Week 0 - 16)|Other|0|||
150281033|NCT02325219|542167075|FG001|Controlled Period (Week 0 - 16)|Other|0|||
150281034|NCT02325219|542167076|FG002|Controlled Period (Week 0 - 16)|Other|1|||
150281035|NCT02325219|542167077|FG003|Controlled Period (Week 0 - 16)|Other|0|||
150281036|NCT02325219|542167078|FG004|Controlled Period (Week 0 - 16)|Other|0|||
150281037|NCT02325219|542167074|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
150281038|NCT02325219|542167075|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149836846|NCT00376623|540535964|FG001|Overall Study|Increase of tumour markers|1|||
149836847|NCT00376623|540535965|FG002|Overall Study|Increase of tumour markers|0|||
150034501|NCT01456039|541266437|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
150034502|NCT01456039|541266438|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
150034503|NCT01456039|541266436|FG000|Phase 1 (First Step)|Adverse Event|0|||
150034504|NCT01456039|541266437|FG001|Phase 1 (First Step)|Adverse Event|3|||
150034505|NCT01456039|541266438|FG002|Phase 1 (First Step)|Adverse Event|0|||
150034506|NCT01456039|541266436|FG000|Phase 1 (First Step)|Other|0|||
150034507|NCT01456039|541266437|FG001|Phase 1 (First Step)|Other|1|||
150034508|NCT01456039|541266438|FG002|Phase 1 (First Step)|Other|0|||
150034509|NCT01456039|541266436|FG000|Phase 2 (Second Step)|Disease Progression|0|||
150034510|NCT01456039|541266437|FG001|Phase 2 (Second Step)|Disease Progression|0|||
150034511|NCT01456039|541266438|FG002|Phase 2 (Second Step)|Disease Progression|17|||
149836848|NCT00376623|540535963|FG000|Overall Study|Bone metastasis|1|||
149836849|NCT00376623|540535964|FG001|Overall Study|Bone metastasis|0|||
149836850|NCT00376623|540535965|FG002|Overall Study|Bone metastasis|0|||
149836851|NCT00301366|540535966|FG000|Overall Study|Adverse Event|1|||
150034512|NCT01456039|541266436|FG000|Phase 2 (Second Step)|Adverse Event|0|||
150281039|NCT02325219|542167076|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
150281040|NCT02325219|542167077|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
150281041|NCT02325219|542167078|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
150281042|NCT02325219|542167074|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
149836852|NCT04247282|540535967|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
149836853|NCT04247282|540535968|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
149836854|NCT04247282|540535969|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
149836855|NCT04247282|540535970|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
149836856|NCT04247282|540535967|FG000|Overall Study|Refused further treatment|0|||
149836857|NCT04247282|540535968|FG001|Overall Study|Refused further treatment|1|||
149836858|NCT04247282|540535969|FG002|Overall Study|Refused further treatment|0|||
149836859|NCT04247282|540535970|FG003|Overall Study|Refused further treatment|0|||
149836860|NCT01602419|540535974|FG000|Overall Study|Not treated with Wilate|9|||
149836861|NCT01602419|540535974|FG000|Overall Study|Adverse Drug Reaction|4|||
149836862|NCT01602419|540535974|FG000|Overall Study|Insurance issues|3|||
149836863|NCT01602419|540535974|FG000|Overall Study|Changed treatment centre|1|||
149836864|NCT01602419|540535974|FG000|Overall Study|Treatment centre closed|1|||
149836865|NCT01602419|540535974|FG000|Overall Study|Withdrawal by Subject|5|||
149836866|NCT01602419|540535974|FG000|Overall Study|Lost to Follow-up|6|||
149836867|NCT03956862|540535978|FG000|Overall Study|Lost to Follow-up|1|||
149836868|NCT03956862|540535979|FG001|Overall Study|Lost to Follow-up|1|||
149836869|NCT03956862|540535978|FG000|Overall Study|Withdrawal by Subject|1|||
149836870|NCT03956862|540535979|FG001|Overall Study|Withdrawal by Subject|1|||
149836871|NCT02714062|540535980|FG000|Overall Study|Adverse Event|0|||
149836872|NCT02714062|540535981|FG001|Overall Study|Adverse Event|0|||
149836873|NCT02714062|540535982|FG002|Overall Study|Adverse Event|2|||
149836874|NCT02714062|540535980|FG000|Overall Study|Withdrawal by Subject|1|||
149836875|NCT02714062|540535981|FG001|Overall Study|Withdrawal by Subject|0|||
149836876|NCT02714062|540535982|FG002|Overall Study|Withdrawal by Subject|1|||
149836877|NCT02714062|540535980|FG000|Overall Study|Protocol Violation|0|||
149836878|NCT02714062|540535981|FG001|Overall Study|Protocol Violation|1|||
149949435|NCT04364646|540947738|FG000|Overall Study|Lost to Follow-up|1|||
149949436|NCT04364646|540947739|FG001|Overall Study|Lost to Follow-up|0|||
149949437|NCT04364646|540947738|FG000|Overall Study|Withdrawal by Subject|7|||
149949438|NCT04364646|540947739|FG001|Overall Study|Withdrawal by Subject|14|||
149949439|NCT04364646|540947738|FG000|Overall Study|Protocol Violation|4|||
149949440|NCT04364646|540947739|FG001|Overall Study|Protocol Violation|5|||
149836879|NCT02714062|540535982|FG002|Overall Study|Protocol Violation|0|||
149836880|NCT02294604|540535983|FG000|Overall Study|Did not provide samples for culture|0|||
149836881|NCT02294604|540535984|FG001|Overall Study|Did not provide samples for culture|1|||
149836882|NCT02294604|540535985|FG002|Overall Study|Did not provide samples for culture|0|||
149836883|NCT02294604|540535983|FG000|Overall Study|Culture contamination|1|||
149836884|NCT02294604|540535984|FG001|Overall Study|Culture contamination|2|||
150281043|NCT02325219|542167075|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
150281044|NCT02325219|542167076|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
150281045|NCT02325219|542167077|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
150281046|NCT02325219|542167078|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
150281047|NCT02325219|542167074|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150281048|NCT02325219|542167075|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
150281049|NCT02325219|542167076|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150281050|NCT02325219|542167077|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150281051|NCT02325219|542167078|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150281052|NCT04036708|542167079|FG000|Overall Study|Lost to Follow-up|14|||
150281053|NCT04036708|542167080|FG001|Overall Study|Lost to Follow-up|4|||
150281054|NCT04036708|542167081|FG002|Overall Study|Lost to Follow-up|14|||
150281055|NCT04036708|542167082|FG003|Overall Study|Lost to Follow-up|4|||
150281056|NCT02918864|542167083|FG000|Overall Study|Withdrawal by Subject|1|||
150281057|NCT02918864|542167084|FG001|Overall Study|Withdrawal by Subject|1|||
150281058|NCT02918864|542167083|FG000|Overall Study|Lost to Follow-up|3|||
150281059|NCT02918864|542167084|FG001|Overall Study|Lost to Follow-up|2|||
150281060|NCT02257372|542167088|FG000|Overall Study|Adverse Event|3|||
150281061|NCT02257372|542167089|FG001|Overall Study|Adverse Event|7|||
150281062|NCT02257372|542167088|FG000|Overall Study|Lack of Efficacy|2|||
149836885|NCT02294604|540535985|FG002|Overall Study|Culture contamination|0|||
149836886|NCT01513174|540535991|FG000|Overall Study|Inclusion Error|1|||
149836887|NCT01513174|540535992|FG001|Overall Study|Inclusion Error|7|||
149836888|NCT01513174|540535991|FG000|Overall Study|Not receive study treatment|3|||
149836889|NCT01513174|540535992|FG001|Overall Study|Not receive study treatment|1|||
149836890|NCT00850174|540535993|FG000|Washout: One Week|Withdrawal by Subject|0|||
149836891|NCT00850174|540535994|FG001|Washout: One Week|Withdrawal by Subject|2|||
149836892|NCT00850174|540535993|FG000|Second Intervention|Withdrawal by Subject|1|||
149836893|NCT00850174|540535994|FG001|Second Intervention|Withdrawal by Subject|0|||
149836894|NCT01363765|540535997|FG000|Overall Study|non-diagnostic|2621|||
150281063|NCT02257372|542167089|FG001|Overall Study|Lack of Efficacy|1|||
150281064|NCT02257372|542167088|FG000|Overall Study|Protocol Violation|1|||
150281065|NCT02257372|542167089|FG001|Overall Study|Protocol Violation|1|||
150281066|NCT02257372|542167088|FG000|Overall Study|Lost to Follow-up|0|||
150281067|NCT02257372|542167089|FG001|Overall Study|Lost to Follow-up|1|||
150281068|NCT02257372|542167088|FG000|Overall Study|Withdrew consent|1|||
150281069|NCT02257372|542167089|FG001|Overall Study|Withdrew consent|0|||
150281070|NCT01849874|542167091|FG000|Overall Study|Death|89|||
150281071|NCT01849874|542167092|FG001|Overall Study|Death|42|||
150281072|NCT01849874|542167091|FG000|Overall Study|Withdrawal by Subject|17|||
150281073|NCT01849874|542167092|FG001|Overall Study|Withdrawal by Subject|16|||
150281074|NCT01849874|542167091|FG000|Overall Study|Lost to Follow-up|3|||
150281075|NCT01849874|542167092|FG001|Overall Study|Lost to Follow-up|2|||
150281076|NCT01849874|542167091|FG000|Overall Study|Study Termination By Sponsor|93|||
150281077|NCT01849874|542167092|FG001|Overall Study|Study Termination By Sponsor|48|||
150281078|NCT01849874|542167091|FG000|Overall Study|Completed as per protocol amendment 6|3|||
150281079|NCT01849874|542167092|FG001|Overall Study|Completed as per protocol amendment 6|0|||
150281080|NCT01849874|542167091|FG000|Overall Study|Physician Decision|7|||
150281081|NCT01849874|542167092|FG001|Overall Study|Physician Decision|1|||
150281082|NCT01849874|542167091|FG000|Overall Study|Other|16|||
149836895|NCT01363765|540535998|FG001|Overall Study|non-diagnostic|1124|||
149949479|NCT02003924|540947752|FG000|Double-blind Phase|Lost to Follow-up|2|||
150281083|NCT01849874|542167092|FG001|Overall Study|Other|4|||
149949480|NCT02003924|540947753|FG001|Double-blind Phase|Lost to Follow-up|1|||
149836896|NCT01363765|540535997|FG000|Overall Study|duplicate records|736|||
149836897|NCT01363765|540535998|FG001|Overall Study|duplicate records|3177|||
149836898|NCT01363765|540535997|FG000|Overall Study|non-resident|156|||
149836899|NCT01363765|540535998|FG001|Overall Study|non-resident|76|||
149836900|NCT01363765|540535997|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
149836901|NCT01363765|540535998|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
149836902|NCT01363765|540535997|FG000|Overall Study|smear during intervention|2170|||
149836903|NCT01363765|540535998|FG001|Overall Study|smear during intervention|0|||
149836904|NCT01900626|540535999|FG000|Overall Study|study was closed due to low enrollment|1|||
149836905|NCT01900626|540536000|FG001|Overall Study|study was closed due to low enrollment|1|||
149836906|NCT02682784|540536005|FG000|Overall Study|Withdrawal by Subject|0|||
149836907|NCT02682784|540536006|FG001|Overall Study|Withdrawal by Subject|2|||
149836908|NCT02682784|540536007|FG002|Overall Study|Withdrawal by Subject|1|||
149836909|NCT02682784|540536008|FG003|Overall Study|Withdrawal by Subject|2|||
149836910|NCT02682784|540536005|FG000|Overall Study|Physician Decision|1|||
149836911|NCT02682784|540536006|FG001|Overall Study|Physician Decision|0|||
149836912|NCT02682784|540536007|FG002|Overall Study|Physician Decision|1|||
149836913|NCT02682784|540536008|FG003|Overall Study|Physician Decision|1|||
149836914|NCT01702987|540536009|FG000|Overall Study|Withdrawal by Subject|1|||
149836915|NCT01702987|540536010|FG001|Overall Study|Withdrawal by Subject|0|||
149836916|NCT00365846|540536015|FG000|Overall Study|Lost to Follow-up|1|||
149836917|NCT02057458|540536017|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
149836918|NCT02057458|540536018|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
149836919|NCT02057458|540536019|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
149836920|NCT02057458|540536017|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
149836921|NCT02057458|540536018|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
149836922|NCT02057458|540536019|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
149836923|NCT02057458|540536017|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
149836924|NCT02057458|540536018|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
149949481|NCT02003924|540947754|FG002|Double-blind Phase|Lost to Follow-up|0|||
149949482|NCT02003924|540947752|FG000|Double-blind Phase|Protocol Violation|1|||
149949483|NCT02003924|540947753|FG001|Double-blind Phase|Protocol Violation|2|||
149949484|NCT02003924|540947754|FG002|Double-blind Phase|Protocol Violation|0|||
149949485|NCT02003924|540947752|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
149949486|NCT02003924|540947753|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
149949487|NCT02003924|540947754|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
149949488|NCT02003924|540947752|FG000|Double-blind Phase|Disease Progression|229|||
149949489|NCT02003924|540947753|FG001|Double-blind Phase|Disease Progression|247|||
149949490|NCT02003924|540947754|FG002|Double-blind Phase|Disease Progression|0|||
149949491|NCT02003924|540947752|FG000|Double-blind Phase|Adverse Event|120|||
149949492|NCT02003924|540947753|FG001|Double-blind Phase|Adverse Event|31|||
149949493|NCT02003924|540947754|FG002|Double-blind Phase|Adverse Event|0|||
149949494|NCT02003924|540947752|FG000|Double-blind Phase|Randomized But not Treated|3|||
149949495|NCT02003924|540947753|FG001|Double-blind Phase|Randomized But not Treated|3|||
149949496|NCT02003924|540947754|FG002|Double-blind Phase|Randomized But not Treated|0|||
149949497|NCT02003924|540947752|FG000|Double-blind Phase|Other|29|||
149949498|NCT02003924|540947753|FG001|Double-blind Phase|Other|50|||
149949499|NCT02003924|540947754|FG002|Double-blind Phase|Other|0|||
149949500|NCT02003924|540947752|FG000|Open-label Phase|Lost to Follow-up|0|||
149949501|NCT02003924|540947753|FG001|Open-label Phase|Lost to Follow-up|0|||
149949502|NCT02003924|540947754|FG002|Open-label Phase|Lost to Follow-up|1|||
149949503|NCT02003924|540947752|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
149949504|NCT02003924|540947753|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
149949505|NCT02003924|540947754|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
149949506|NCT02003924|540947752|FG000|Open-label Phase|Disease Progression|59|||
149949507|NCT02003924|540947753|FG001|Open-label Phase|Disease Progression|0|||
149949508|NCT02003924|540947754|FG002|Open-label Phase|Disease Progression|5|||
149949509|NCT02003924|540947752|FG000|Open-label Phase|Adverse Event|25|||
149949510|NCT02003924|540947753|FG001|Open-label Phase|Adverse Event|0|||
149949511|NCT02003924|540947754|FG002|Open-label Phase|Adverse Event|10|||
149949512|NCT02003924|540947752|FG000|Open-label Phase|Other|7|||
149949513|NCT02003924|540947753|FG001|Open-label Phase|Other|0|||
149949514|NCT02003924|540947754|FG002|Open-label Phase|Other|0|||
149949515|NCT02003924|540947752|FG000|Long-term Follow-up Phase|Death|288|||
149949516|NCT02003924|540947753|FG001|Long-term Follow-up Phase|Death|174|||
149949517|NCT02003924|540947754|FG002|Long-term Follow-up Phase|Death|4|||
149949518|NCT02003924|540947752|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
149949519|NCT02003924|540947753|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
150171804|NCT04493242|541763554|FG002|Overall Study|Lost to Follow-up|0|||
150171805|NCT04493242|541763552|FG000|Overall Study|Withdrawal by Subject|1|||
149836925|NCT02057458|540536019|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
150171806|NCT04493242|541763553|FG001|Overall Study|Withdrawal by Subject|0|||
150171807|NCT04493242|541763554|FG002|Overall Study|Withdrawal by Subject|0|||
150171808|NCT04493242|541763552|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
150171809|NCT04493242|541763553|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
150171810|NCT04493242|541763554|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
149836926|NCT04263649|540536020|FG000|Overall Study|Adverse Event|53|||
149836927|NCT04263649|540536020|FG000|Overall Study|Lost to Follow-up|3|||
149836928|NCT04263649|540536020|FG000|Overall Study|Death|29|||
149836929|NCT04263649|540536020|FG000|Overall Study|Device deficiency|19|||
149836930|NCT04263649|540536020|FG000|Overall Study|other reasons|11|||
149836931|NCT00836056|540536029|FG000|First Intervention|Adverse Event|1|||
150281084|NCT02104583|542167093|FG000|Overall Study|New ICD or CRT-D implanted|2|||
150281085|NCT02104583|542167094|FG001|Overall Study|New ICD or CRT-D implanted|0|||
150281086|NCT02104583|542167095|FG002|Overall Study|New ICD or CRT-D implanted|1|||
150281087|NCT02104583|542167096|FG003|Overall Study|New ICD or CRT-D implanted|0|||
150281088|NCT02104583|542167097|FG004|Overall Study|New ICD or CRT-D implanted|0|||
150281089|NCT02104583|542167093|FG000|Overall Study|Death|2|||
150281090|NCT02104583|542167094|FG001|Overall Study|Death|1|||
150281091|NCT02104583|542167095|FG002|Overall Study|Death|3|||
150281092|NCT02104583|542167096|FG003|Overall Study|Death|3|||
149836932|NCT00836056|540536030|FG001|First Intervention|Adverse Event|0|||
149836933|NCT02711852|540536031|FG000|Overall Study|Death|5|||
149836934|NCT02711852|540536031|FG000|Overall Study|Lost to Follow-up|1|||
149836935|NCT02711852|540536031|FG000|Overall Study|Completed follow-up|3|||
150034513|NCT01456039|541266437|FG001|Phase 2 (Second Step)|Adverse Event|0|||
150034514|NCT01456039|541266438|FG002|Phase 2 (Second Step)|Adverse Event|10|||
150034515|NCT01456039|541266436|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
150034516|NCT01456039|541266437|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
150034517|NCT01456039|541266438|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
150034518|NCT01456039|541266436|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
150034519|NCT01456039|541266437|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
150034520|NCT01456039|541266438|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
150034521|NCT01456039|541266436|FG000|Phase 2 (Second Step)|Other|0|||
150034522|NCT01456039|541266437|FG001|Phase 2 (Second Step)|Other|0|||
150034523|NCT01456039|541266438|FG002|Phase 2 (Second Step)|Other|1|||
150034524|NCT00335777|541266441|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
150034525|NCT00335777|541266441|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
150281093|NCT02104583|542167097|FG004|Overall Study|Death|5|||
150281094|NCT02104583|542167093|FG000|Overall Study|Subject required cardiac ablation|6|||
149836936|NCT02711852|540536031|FG000|Overall Study|Withdrawal by Subject|1|||
149836937|NCT00576056|540536032|FG000|Overall Study|Adverse Event|1|||
149949520|NCT02003924|540947754|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
149949521|NCT02003924|540947752|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
149949522|NCT02003924|540947753|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
149949523|NCT02003924|540947754|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
149949524|NCT02003924|540947752|FG000|Long-term Follow-up Phase|Other|5|||
149949525|NCT02003924|540947753|FG001|Long-term Follow-up Phase|Other|2|||
149949526|NCT02003924|540947754|FG002|Long-term Follow-up Phase|Other|1|||
150034526|NCT00335777|541266441|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
150034527|NCT00335777|541266441|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
150281095|NCT02104583|542167094|FG001|Overall Study|Subject required cardiac ablation|4|||
150281096|NCT02104583|542167095|FG002|Overall Study|Subject required cardiac ablation|4|||
150281097|NCT02104583|542167096|FG003|Overall Study|Subject required cardiac ablation|5|||
149836938|NCT00576056|540536032|FG000|Overall Study|Death|1|||
149836939|NCT00576056|540536032|FG000|Overall Study|Lack of Efficacy|1|||
150281098|NCT02104583|542167097|FG004|Overall Study|Subject required cardiac ablation|4|||
150281099|NCT02104583|542167093|FG000|Overall Study|Subject required prohibited medication|0|||
150281100|NCT02104583|542167094|FG001|Overall Study|Subject required prohibited medication|1|||
150281101|NCT02104583|542167095|FG002|Overall Study|Subject required prohibited medication|1|||
150281102|NCT02104583|542167096|FG003|Overall Study|Subject required prohibited medication|0|||
150281103|NCT02104583|542167097|FG004|Overall Study|Subject required prohibited medication|1|||
150281104|NCT02104583|542167093|FG000|Overall Study|Withdrew Consent|3|||
150281105|NCT02104583|542167094|FG001|Overall Study|Withdrew Consent|2|||
150281106|NCT02104583|542167095|FG002|Overall Study|Withdrew Consent|0|||
150281107|NCT02104583|542167096|FG003|Overall Study|Withdrew Consent|2|||
150281108|NCT02104583|542167097|FG004|Overall Study|Withdrew Consent|1|||
150281109|NCT02104583|542167093|FG000|Overall Study|Investigator's Discretion|1|||
150281110|NCT02104583|542167094|FG001|Overall Study|Investigator's Discretion|0|||
150281111|NCT02104583|542167095|FG002|Overall Study|Investigator's Discretion|0|||
150281112|NCT02104583|542167096|FG003|Overall Study|Investigator's Discretion|0|||
150281113|NCT02104583|542167097|FG004|Overall Study|Investigator's Discretion|0|||
150281114|NCT02104583|542167093|FG000|Overall Study|Protocol Violation|0|||
150281115|NCT02104583|542167094|FG001|Overall Study|Protocol Violation|0|||
150281116|NCT02104583|542167095|FG002|Overall Study|Protocol Violation|1|||
150281117|NCT02104583|542167096|FG003|Overall Study|Protocol Violation|0|||
150281118|NCT02104583|542167097|FG004|Overall Study|Protocol Violation|0|||
150281119|NCT02104583|542167093|FG000|Overall Study|Adverse Event|3|||
150281120|NCT02104583|542167094|FG001|Overall Study|Adverse Event|3|||
150281121|NCT02104583|542167095|FG002|Overall Study|Adverse Event|6|||
150281122|NCT02104583|542167096|FG003|Overall Study|Adverse Event|6|||
150281123|NCT02104583|542167097|FG004|Overall Study|Adverse Event|1|||
150281124|NCT02104583|542167093|FG000|Overall Study|Lost to Follow-up|1|||
150281125|NCT02104583|542167094|FG001|Overall Study|Lost to Follow-up|0|||
150281126|NCT02104583|542167095|FG002|Overall Study|Lost to Follow-up|0|||
150281127|NCT02104583|542167096|FG003|Overall Study|Lost to Follow-up|0|||
150281128|NCT02104583|542167097|FG004|Overall Study|Lost to Follow-up|0|||
150281129|NCT02104583|542167093|FG000|Overall Study|Randomized but Never Treated|0|||
150281130|NCT02104583|542167094|FG001|Overall Study|Randomized but Never Treated|0|||
150281131|NCT02104583|542167095|FG002|Overall Study|Randomized but Never Treated|0|||
150281132|NCT02104583|542167096|FG003|Overall Study|Randomized but Never Treated|1|||
150281133|NCT02104583|542167097|FG004|Overall Study|Randomized but Never Treated|0|||
150281134|NCT04640272|542167098|FG000|Overall Study|Subject moved out of area|1|||
150281135|NCT00880399|542167102|FG000|Overall Study|Adverse Event|4|||
150281136|NCT00880399|542167103|FG001|Overall Study|Adverse Event|6|||
150281137|NCT00880399|542167104|FG002|Overall Study|Adverse Event|5|||
150281138|NCT00880399|542167102|FG000|Overall Study|Lack of Efficacy|1|||
150281139|NCT00880399|542167103|FG001|Overall Study|Lack of Efficacy|4|||
150281140|NCT00880399|542167104|FG002|Overall Study|Lack of Efficacy|2|||
149836940|NCT00576056|540536032|FG000|Overall Study|Withdrawal by Subject|2|||
149836941|NCT00576056|540536032|FG000|Overall Study|did not meet eligibility criteria|8|||
149836942|NCT00576056|540536032|FG000|Overall Study|Physician Decision|1|||
149836943|NCT03420300|540536035|FG000|Overall Study|Death|2|||
149836944|NCT05275205|540536043|FG000|Overall Study|Adverse Event|1|||
149836945|NCT05275205|540536044|FG001|Overall Study|Adverse Event|2|||
149836946|NCT05275205|540536043|FG000|Overall Study|Physician Decision|1|||
149836947|NCT05275205|540536044|FG001|Overall Study|Physician Decision|1|||
149836948|NCT05275205|540536043|FG000|Overall Study|Withdrawal by Subject|2|||
149836949|NCT05275205|540536044|FG001|Overall Study|Withdrawal by Subject|3|||
149836950|NCT05275205|540536043|FG000|Overall Study|Death|1|||
149836951|NCT05275205|540536044|FG001|Overall Study|Death|0|||
149836952|NCT05275205|540536043|FG000|Overall Study|Patient unable to attend visits|1|||
149836953|NCT05275205|540536044|FG001|Overall Study|Patient unable to attend visits|0|||
149836954|NCT03041025|540536046|FG000|Overall Study|Adverse Event|0|||
149836955|NCT03041025|540536047|FG001|Overall Study|Adverse Event|0|||
149836956|NCT03041025|540536048|FG002|Overall Study|Adverse Event|1|||
149836957|NCT03041025|540536046|FG000|Overall Study|Lost to Follow-up|1|||
150281141|NCT00880399|542167102|FG000|Overall Study|Protocol Violation|4|||
149836958|NCT03041025|540536047|FG001|Overall Study|Lost to Follow-up|0|||
149836959|NCT03041025|540536048|FG002|Overall Study|Lost to Follow-up|0|||
149836960|NCT03041025|540536046|FG000|Overall Study|Withdrawal by Subject|0|||
150281142|NCT00880399|542167103|FG001|Overall Study|Protocol Violation|4|||
150281143|NCT00880399|542167104|FG002|Overall Study|Protocol Violation|6|||
150281144|NCT00880399|542167102|FG000|Overall Study|Study closed/terminated|3|||
150281145|NCT00880399|542167103|FG001|Overall Study|Study closed/terminated|7|||
150281146|NCT00880399|542167104|FG002|Overall Study|Study closed/terminated|4|||
150281147|NCT00880399|542167102|FG000|Overall Study|Lost to Follow-up|8|||
150281148|NCT00880399|542167103|FG001|Overall Study|Lost to Follow-up|5|||
149836961|NCT03041025|540536047|FG001|Overall Study|Withdrawal by Subject|0|||
149836962|NCT03041025|540536048|FG002|Overall Study|Withdrawal by Subject|1|||
149836963|NCT03880266|540536051|FG000|Overall Study|Withdrawal by Subject|0|||
149836964|NCT03880266|540536052|FG001|Overall Study|Withdrawal by Subject|1|||
149836965|NCT03880266|540536053|FG002|Overall Study|Withdrawal by Subject|1|||
149836966|NCT03880266|540536054|FG003|Overall Study|Withdrawal by Subject|0|||
150281149|NCT00880399|542167104|FG002|Overall Study|Lost to Follow-up|3|||
150281150|NCT00880399|542167102|FG000|Overall Study|Physician Decision|5|||
150281151|NCT00880399|542167103|FG001|Overall Study|Physician Decision|0|||
150281152|NCT00880399|542167104|FG002|Overall Study|Physician Decision|3|||
150281153|NCT00880399|542167102|FG000|Overall Study|Withdrawal by Subject|6|||
150281154|NCT00880399|542167103|FG001|Overall Study|Withdrawal by Subject|3|||
150281155|NCT00880399|542167104|FG002|Overall Study|Withdrawal by Subject|3|||
150281156|NCT03709654|542167110|FG000|Overall Study|Lost to Follow-up|1|||
150281157|NCT03709654|542167111|FG001|Overall Study|Lost to Follow-up|1|||
150281158|NCT03709654|542167110|FG000|Overall Study|Withdrawal by Subject|1|||
150281159|NCT03709654|542167111|FG001|Overall Study|Withdrawal by Subject|1|||
150281160|NCT03709654|542167110|FG000|Overall Study|Adverse Event|1|||
150281161|NCT03709654|542167111|FG001|Overall Study|Adverse Event|0|||
150281162|NCT01902966|542167112|FG000|Overall Study|Death|1|||
150281163|NCT01902966|542167112|FG000|Overall Study|Physician Decision|1|||
150281164|NCT01902966|542167112|FG000|Overall Study|Withdrawal by Subject|1|||
150281165|NCT01549275|542167113|FG000|Overall Study|Lost to Follow-up|1|||
150281166|NCT01549275|542167114|FG001|Overall Study|Lost to Follow-up|0|||
150281167|NCT04773106|542167117|FG000|Overall Study|Withdrawal by Subject|3|||
150281168|NCT04773106|542167117|FG000|Overall Study|Death|1|||
150281169|NCT02819635|542167125|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
150281170|NCT02819635|542167126|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
150281171|NCT02819635|542167127|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
150281172|NCT02819635|542167128|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
149836967|NCT03880266|540536055|FG004|Overall Study|Withdrawal by Subject|0|||
149836968|NCT03880266|540536056|FG005|Overall Study|Withdrawal by Subject|0|||
149836969|NCT03880266|540536057|FG006|Overall Study|Withdrawal by Subject|0|||
149836970|NCT03880266|540536058|FG007|Overall Study|Withdrawal by Subject|0|||
149836971|NCT01577381|540536062|FG000|Overall Study|Discontinued|2|||
149836972|NCT01577381|540536063|FG001|Overall Study|Discontinued|1|||
149836973|NCT01577381|540536064|FG002|Overall Study|Discontinued|2|||
149836974|NCT01577381|540536065|FG003|Overall Study|Discontinued|2|||
149836975|NCT01577381|540536062|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
149836976|NCT01577381|540536063|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
150281173|NCT02819635|542167129|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
150281174|NCT02819635|542167130|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
150281175|NCT02819635|542167131|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
150281176|NCT02819635|542167132|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
150281177|NCT02819635|542167133|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
150281178|NCT02819635|542167134|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
150281179|NCT02819635|542167135|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149836977|NCT01577381|540536064|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
149836978|NCT01577381|540536065|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
149836979|NCT01313780|540536066|FG000|Overall Study|Lack of Efficacy|4|||
149836980|NCT01313780|540536067|FG001|Overall Study|Lack of Efficacy|2|||
149836981|NCT01313780|540536066|FG000|Overall Study|Adverse Event|6|||
150034528|NCT00335777|541266441|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
150034529|NCT00939393|541266449|FG000|Overall Study|Withdrawal by Subject|1|||
150034530|NCT00939393|541266450|FG001|Overall Study|Withdrawal by Subject|0|||
150034531|NCT00939393|541266449|FG000|Overall Study|Lost to Follow-up|3|||
150034532|NCT00939393|541266450|FG001|Overall Study|Lost to Follow-up|0|||
150034533|NCT02851615|541266451|FG000|Overall Study|Cognitive Issue|1|||
150281180|NCT02819635|542167136|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
150281181|NCT02819635|542167125|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281182|NCT02819635|542167126|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281183|NCT02819635|542167127|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281184|NCT02819635|542167128|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281185|NCT02819635|542167129|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
150281186|NCT02819635|542167130|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
150281187|NCT02819635|542167131|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
150281188|NCT02819635|542167132|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281189|NCT02819635|542167133|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281190|NCT02819635|542167134|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149836982|NCT01313780|540536067|FG001|Overall Study|Adverse Event|11|||
149836983|NCT01313780|540536066|FG000|Overall Study|Withdrawal by Subject|2|||
150281191|NCT02819635|542167135|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
150281192|NCT02819635|542167136|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149836984|NCT01313780|540536067|FG001|Overall Study|Withdrawal by Subject|8|||
149836985|NCT01313780|540536066|FG000|Overall Study|Protocol Violation|10|||
150034534|NCT02851615|541266452|FG001|Overall Study|Cognitive Issue|0|||
150034535|NCT02851615|541266451|FG000|Overall Study|Lost to Follow-up|0|||
149836986|NCT01313780|540536067|FG001|Overall Study|Protocol Violation|4|||
149836987|NCT01313780|540536066|FG000|Overall Study|missing data|3|||
150281193|NCT02819635|542167125|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281194|NCT02819635|542167126|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281195|NCT02819635|542167127|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281196|NCT02819635|542167128|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281197|NCT02819635|542167129|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281198|NCT02819635|542167130|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
150281199|NCT02819635|542167131|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
150281200|NCT02819635|542167132|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281201|NCT02819635|542167133|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281202|NCT02819635|542167134|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281203|NCT02819635|542167135|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281204|NCT02819635|542167136|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
150281205|NCT02819635|542167125|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281206|NCT02819635|542167126|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281207|NCT02819635|542167127|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281208|NCT02819635|542167128|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281209|NCT02819635|542167129|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281210|NCT02819635|542167130|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281211|NCT02819635|542167131|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
150281212|NCT02819635|542167132|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281213|NCT02819635|542167133|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281214|NCT02819635|542167134|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281215|NCT02819635|542167135|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281216|NCT02819635|542167136|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
150281217|NCT02819635|542167125|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
150281218|NCT02819635|542167126|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
150281219|NCT02819635|542167127|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
150281220|NCT02819635|542167128|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
150281221|NCT02819635|542167129|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
150281222|NCT02819635|542167130|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
150281223|NCT02819635|542167131|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
150281224|NCT02819635|542167132|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
150281225|NCT02819635|542167133|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
150281226|NCT02819635|542167134|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
150281227|NCT02819635|542167135|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
150281228|NCT02819635|542167136|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
150281229|NCT02819635|542167125|FG000|Substudy 2, Part 2|Adverse Event|0|||
150281230|NCT02819635|542167126|FG001|Substudy 2, Part 2|Adverse Event|0|||
150281231|NCT02819635|542167127|FG002|Substudy 2, Part 2|Adverse Event|0|||
150281232|NCT02819635|542167128|FG003|Substudy 2, Part 2|Adverse Event|0|||
150281233|NCT02819635|542167129|FG004|Substudy 2, Part 2|Adverse Event|0|||
150281234|NCT02819635|542167130|FG005|Substudy 2, Part 2|Adverse Event|4|||
150281235|NCT02819635|542167131|FG006|Substudy 2, Part 2|Adverse Event|0|||
150281236|NCT02819635|542167132|FG007|Substudy 2, Part 2|Adverse Event|0|||
150281237|NCT02819635|542167133|FG008|Substudy 2, Part 2|Adverse Event|0|||
150281238|NCT02819635|542167134|FG009|Substudy 2, Part 2|Adverse Event|0|||
150281239|NCT02819635|542167135|FG010|Substudy 2, Part 2|Adverse Event|0|||
150281240|NCT02819635|542167136|FG011|Substudy 2, Part 2|Adverse Event|0|||
150281241|NCT02819635|542167125|FG000|Substudy 2, Part 2|Withdrew consent|0|||
150281242|NCT02819635|542167126|FG001|Substudy 2, Part 2|Withdrew consent|0|||
150281243|NCT02819635|542167127|FG002|Substudy 2, Part 2|Withdrew consent|0|||
150281244|NCT02819635|542167128|FG003|Substudy 2, Part 2|Withdrew consent|0|||
150281245|NCT02819635|542167129|FG004|Substudy 2, Part 2|Withdrew consent|0|||
150281246|NCT02819635|542167130|FG005|Substudy 2, Part 2|Withdrew consent|3|||
150281247|NCT02819635|542167131|FG006|Substudy 2, Part 2|Withdrew consent|1|||
150281248|NCT02819635|542167132|FG007|Substudy 2, Part 2|Withdrew consent|0|||
150281249|NCT02819635|542167133|FG008|Substudy 2, Part 2|Withdrew consent|0|||
150281250|NCT02819635|542167134|FG009|Substudy 2, Part 2|Withdrew consent|0|||
150281251|NCT02819635|542167135|FG010|Substudy 2, Part 2|Withdrew consent|0|||
150281252|NCT02819635|542167136|FG011|Substudy 2, Part 2|Withdrew consent|0|||
150281253|NCT02819635|542167125|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
150281254|NCT02819635|542167126|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
150281255|NCT02819635|542167127|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
150281256|NCT02819635|542167128|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
150281257|NCT02819635|542167129|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
150281258|NCT02819635|542167130|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
150281259|NCT02819635|542167131|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
150281260|NCT02819635|542167132|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
149836988|NCT01313780|540536067|FG001|Overall Study|missing data|3|||
149836989|NCT00467896|540537692|FG000|Overall Study|Consent Withdrawal|18|||
150034536|NCT02851615|541266452|FG001|Overall Study|Lost to Follow-up|4|||
150171811|NCT04493242|541763552|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
150171812|NCT04493242|541763553|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
150171813|NCT04493242|541763554|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
150171814|NCT00849147|541763555|FG000|Overall Study|Withdrawal by Subject|1|||
150171815|NCT00849147|541763555|FG000|Overall Study|Protocol Violation|2|||
150171816|NCT00849147|541763555|FG000|Overall Study|Disease Relapse/Progression|2|||
150177905|NCT04411056|541790280|FG000|Overall Study|Equipment problem during intubation|0|||
150177906|NCT04411056|541790281|FG001|Overall Study|Equipment problem during intubation|1|||
150177907|NCT05985044|541790292|FG000|Overall Study|Death|6|||
150177908|NCT05985044|541790292|FG000|Overall Study|Lost to Follow-up|4|||
150177909|NCT05985044|541790292|FG000|Overall Study|Incapacitation|3|||
150177910|NCT05985044|541790292|FG000|Overall Study|Withdrawal by Subject|2|||
150177911|NCT02279095|541790298|FG000|Overall Study|Non-Compliance|1|||
150177912|NCT02279095|541790298|FG000|Overall Study|Withdrawal by Subject|8|||
150177913|NCT02279095|541790298|FG000|Overall Study|Adverse Event|2|||
150177914|NCT02279095|541790298|FG000|Overall Study|Other|7|||
150177915|NCT02279095|541790298|FG000|Overall Study|Lost to Follow-up|1|||
150177916|NCT05938413|541790299|FG000|Overall Study|Lost to Follow-up|1|||
150177917|NCT05938413|541790300|FG001|Overall Study|Lost to Follow-up|7|||
150177918|NCT05938413|541790299|FG000|Overall Study|Withdrawal by Subject|1|||
150177919|NCT05938413|541790300|FG001|Overall Study|Withdrawal by Subject|1|||
150177920|NCT04922021|541790301|FG000|Overall Study|Withdrawal by Subject|4|||
150177921|NCT04922021|541790302|FG001|Overall Study|Withdrawal by Subject|10|||
150177922|NCT04922021|541790301|FG000|Overall Study|Adverse Event|2|||
150177923|NCT04922021|541790302|FG001|Overall Study|Adverse Event|2|||
150177924|NCT04922021|541790301|FG000|Overall Study|Lack of Efficacy|0|||
150177925|NCT04922021|541790302|FG001|Overall Study|Lack of Efficacy|1|||
150177926|NCT04922021|541790301|FG000|Overall Study|Multiple reasons|1|||
150177927|NCT04922021|541790302|FG001|Overall Study|Multiple reasons|0|||
150177928|NCT04300647|541790305|FG000|Pre-Crossover|Death|19|||
150177929|NCT04300647|541790306|FG001|Pre-Crossover|Death|58|||
150177930|NCT04300647|541790307|FG002|Pre-Crossover|Death|0|||
150177931|NCT04300647|541790305|FG000|Pre-Crossover|Lost to Follow-up|0|||
150177932|NCT04300647|541790306|FG001|Pre-Crossover|Lost to Follow-up|3|||
150177933|NCT04300647|541790307|FG002|Pre-Crossover|Lost to Follow-up|0|||
150177934|NCT04300647|541790305|FG000|Pre-Crossover|Withdrawal by Subject|2|||
150177935|NCT04300647|541790306|FG001|Pre-Crossover|Withdrawal by Subject|4|||
150177936|NCT04300647|541790307|FG002|Pre-Crossover|Withdrawal by Subject|0|||
150177937|NCT04300647|541790305|FG000|Pre-Crossover|On-going in Study|24|||
150177938|NCT04300647|541790306|FG001|Pre-Crossover|On-going in Study|61|||
150177939|NCT04300647|541790307|FG002|Pre-Crossover|On-going in Study|0|||
150177940|NCT04300647|541790305|FG000|Post-Crossover|Death|0|||
150177941|NCT04300647|541790306|FG001|Post-Crossover|Death|0|||
150177942|NCT04300647|541790307|FG002|Post-Crossover|Death|3|||
150177943|NCT04300647|541790305|FG000|Post-Crossover|Lost to Follow-up|0|||
150177944|NCT04300647|541790306|FG001|Post-Crossover|Lost to Follow-up|0|||
150177945|NCT04300647|541790307|FG002|Post-Crossover|Lost to Follow-up|1|||
150177946|NCT04300647|541790305|FG000|Post-Crossover|Withdrawal by Subject|0|||
150177947|NCT04300647|541790306|FG001|Post-Crossover|Withdrawal by Subject|0|||
150177948|NCT04300647|541790307|FG002|Post-Crossover|Withdrawal by Subject|1|||
150177949|NCT04300647|541790305|FG000|Post-Crossover|On-going in Study|0|||
150177950|NCT04300647|541790306|FG001|Post-Crossover|On-going in Study|0|||
150177951|NCT04300647|541790307|FG002|Post-Crossover|On-going in Study|8|||
150177952|NCT04714320|541790309|FG000|Overall Study|Voluntary Withdrawal|4|||
150177953|NCT04714320|541790310|FG001|Overall Study|Voluntary Withdrawal|1|||
150177954|NCT04714320|541790311|FG002|Overall Study|Voluntary Withdrawal|2|||
150177955|NCT04714320|541790309|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
150177956|NCT04714320|541790310|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
150177957|NCT04714320|541790311|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
150177958|NCT04714320|541790309|FG000|Overall Study|Reason Not Specified|1|||
150177959|NCT04714320|541790310|FG001|Overall Study|Reason Not Specified|3|||
150177960|NCT04714320|541790311|FG002|Overall Study|Reason Not Specified|3|||
150177961|NCT04755660|541790316|FG000|Overall Study|Lost to Follow-up|1|||
150177962|NCT04755660|541790317|FG001|Overall Study|Lost to Follow-up|1|||
150177963|NCT04755660|541790318|FG002|Overall Study|Lost to Follow-up|0|||
150177964|NCT04755660|541790316|FG000|Overall Study|Withdrawal by Subject|0|||
150177965|NCT04755660|541790317|FG001|Overall Study|Withdrawal by Subject|1|||
150177966|NCT04755660|541790318|FG002|Overall Study|Withdrawal by Subject|1|||
150177967|NCT04755660|541790316|FG000|Overall Study|Physician Decision|0|||
150177968|NCT04755660|541790317|FG001|Overall Study|Physician Decision|0|||
150177969|NCT04755660|541790318|FG002|Overall Study|Physician Decision|1|||
150177970|NCT02824029|541790320|FG000|Overall Study|Didn't receive treatment|2|||
150177971|NCT02824029|541790320|FG000|Overall Study|Patient decision to discontinue treatment|3|||
150177972|NCT02824029|541790320|FG000|Overall Study|Non-compliant|5|||
150177973|NCT02824029|541790320|FG000|Overall Study|Progression of disease|15|||
150281261|NCT02819635|542167133|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
150281262|NCT02819635|542167134|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
150281263|NCT02819635|542167135|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
150281264|NCT02819635|542167136|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
150281265|NCT02819635|542167125|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281266|NCT02819635|542167126|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281267|NCT02819635|542167127|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281268|NCT02819635|542167128|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281269|NCT02819635|542167129|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281270|NCT02819635|542167130|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281271|NCT02819635|542167131|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
150281272|NCT02819635|542167132|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281273|NCT02819635|542167133|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281274|NCT02819635|542167134|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281275|NCT02819635|542167135|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281276|NCT02819635|542167136|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
150281277|NCT02819635|542167125|FG000|Substudy 2, Part 2|Other, not specified|0|||
150281278|NCT02819635|542167126|FG001|Substudy 2, Part 2|Other, not specified|0|||
150281279|NCT02819635|542167127|FG002|Substudy 2, Part 2|Other, not specified|0|||
149949586|NCT06081829|540947770|FG000|Overall Study|Participants still on-study|8|||
149949587|NCT06081829|540947770|FG000|Overall Study|Death|4|||
150281280|NCT02819635|542167128|FG003|Substudy 2, Part 2|Other, not specified|0|||
149949605|NCT03608033|540947784|FG000|Treatment Period|Death|0|||
149949606|NCT03608033|540947785|FG001|Treatment Period|Death|1|||
149949607|NCT03608033|540947784|FG000|Treatment Period|Adverse Event|1|||
149949608|NCT03608033|540947785|FG001|Treatment Period|Adverse Event|5|||
150281281|NCT02819635|542167129|FG004|Substudy 2, Part 2|Other, not specified|0|||
150281282|NCT02819635|542167130|FG005|Substudy 2, Part 2|Other, not specified|4|||
150281283|NCT02819635|542167131|FG006|Substudy 2, Part 2|Other, not specified|8|||
150281284|NCT02819635|542167132|FG007|Substudy 2, Part 2|Other, not specified|0|||
150281285|NCT02819635|542167133|FG008|Substudy 2, Part 2|Other, not specified|0|||
150281286|NCT02819635|542167134|FG009|Substudy 2, Part 2|Other, not specified|0|||
150281287|NCT02819635|542167135|FG010|Substudy 2, Part 2|Other, not specified|0|||
150281288|NCT02819635|542167136|FG011|Substudy 2, Part 2|Other, not specified|0|||
150281289|NCT02819635|542167125|FG000|Substudy 3|Adverse Event|0|||
150281290|NCT02819635|542167126|FG001|Substudy 3|Adverse Event|0|||
150281291|NCT02819635|542167127|FG002|Substudy 3|Adverse Event|0|||
150281292|NCT02819635|542167128|FG003|Substudy 3|Adverse Event|0|||
150281293|NCT02819635|542167129|FG004|Substudy 3|Adverse Event|0|||
150281294|NCT02819635|542167130|FG005|Substudy 3|Adverse Event|0|||
150281295|NCT02819635|542167131|FG006|Substudy 3|Adverse Event|0|||
150281296|NCT02819635|542167132|FG007|Substudy 3|Adverse Event|0|||
150281297|NCT02819635|542167133|FG008|Substudy 3|Adverse Event|32|||
150281298|NCT02819635|542167134|FG009|Substudy 3|Adverse Event|3|||
150281299|NCT02819635|542167135|FG010|Substudy 3|Adverse Event|12|||
150281300|NCT02819635|542167136|FG011|Substudy 3|Adverse Event|18|||
150281301|NCT02819635|542167125|FG000|Substudy 3|Withdrew consent|0|||
150281302|NCT02819635|542167126|FG001|Substudy 3|Withdrew consent|0|||
150281303|NCT02819635|542167127|FG002|Substudy 3|Withdrew consent|0|||
150281304|NCT02819635|542167128|FG003|Substudy 3|Withdrew consent|0|||
150281305|NCT02819635|542167129|FG004|Substudy 3|Withdrew consent|0|||
150281306|NCT02819635|542167130|FG005|Substudy 3|Withdrew consent|0|||
150281307|NCT02819635|542167131|FG006|Substudy 3|Withdrew consent|0|||
150281308|NCT02819635|542167132|FG007|Substudy 3|Withdrew consent|0|||
150281309|NCT02819635|542167133|FG008|Substudy 3|Withdrew consent|11|||
150281310|NCT02819635|542167134|FG009|Substudy 3|Withdrew consent|1|||
150281311|NCT02819635|542167135|FG010|Substudy 3|Withdrew consent|4|||
150281312|NCT02819635|542167136|FG011|Substudy 3|Withdrew consent|9|||
150281313|NCT02819635|542167125|FG000|Substudy 3|Lost to Follow-up|0|||
150281314|NCT02819635|542167126|FG001|Substudy 3|Lost to Follow-up|0|||
150281315|NCT02819635|542167127|FG002|Substudy 3|Lost to Follow-up|0|||
150281316|NCT02819635|542167128|FG003|Substudy 3|Lost to Follow-up|0|||
150281317|NCT02819635|542167129|FG004|Substudy 3|Lost to Follow-up|0|||
150281318|NCT02819635|542167130|FG005|Substudy 3|Lost to Follow-up|0|||
150281319|NCT02819635|542167131|FG006|Substudy 3|Lost to Follow-up|0|||
150281320|NCT02819635|542167132|FG007|Substudy 3|Lost to Follow-up|0|||
150281321|NCT02819635|542167133|FG008|Substudy 3|Lost to Follow-up|1|||
150281322|NCT02819635|542167134|FG009|Substudy 3|Lost to Follow-up|0|||
150281323|NCT02819635|542167135|FG010|Substudy 3|Lost to Follow-up|1|||
150281324|NCT02819635|542167136|FG011|Substudy 3|Lost to Follow-up|1|||
150281325|NCT02819635|542167125|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281326|NCT02819635|542167126|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281327|NCT02819635|542167127|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281328|NCT02819635|542167128|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281329|NCT02819635|542167129|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281330|NCT02819635|542167130|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281331|NCT02819635|542167131|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281332|NCT02819635|542167132|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281333|NCT02819635|542167133|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281334|NCT02819635|542167134|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281335|NCT02819635|542167135|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
150281336|NCT02819635|542167136|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
150281337|NCT02819635|542167125|FG000|Substudy 3|Other, not specified|0|||
149949609|NCT03608033|540947784|FG000|Treatment Period|Lack of Efficacy|4|||
150281338|NCT02819635|542167126|FG001|Substudy 3|Other, not specified|0|||
150281339|NCT02819635|542167127|FG002|Substudy 3|Other, not specified|0|||
150281340|NCT02819635|542167128|FG003|Substudy 3|Other, not specified|0|||
150281341|NCT02819635|542167129|FG004|Substudy 3|Other, not specified|0|||
150281342|NCT02819635|542167130|FG005|Substudy 3|Other, not specified|0|||
149949610|NCT03608033|540947785|FG001|Treatment Period|Lack of Efficacy|3|||
149949611|NCT03608033|540947784|FG000|Treatment Period|Lost to Follow-up|2|||
149949612|NCT03608033|540947785|FG001|Treatment Period|Lost to Follow-up|6|||
149949613|NCT03608033|540947784|FG000|Treatment Period|Physician Decision|6|||
149949614|NCT03608033|540947785|FG001|Treatment Period|Physician Decision|10|||
149949615|NCT03608033|540947784|FG000|Treatment Period|Pregnancy|1|||
149949616|NCT03608033|540947785|FG001|Treatment Period|Pregnancy|0|||
149949617|NCT03608033|540947784|FG000|Treatment Period|Protocol Violation|1|||
149949618|NCT03608033|540947785|FG001|Treatment Period|Protocol Violation|2|||
150281343|NCT02819635|542167131|FG006|Substudy 3|Other, not specified|0|||
150281344|NCT02819635|542167132|FG007|Substudy 3|Other, not specified|0|||
150281345|NCT02819635|542167133|FG008|Substudy 3|Other, not specified|202|||
150281346|NCT02819635|542167134|FG009|Substudy 3|Other, not specified|5|||
150281347|NCT02819635|542167135|FG010|Substudy 3|Other, not specified|89|||
150281348|NCT02819635|542167136|FG011|Substudy 3|Other, not specified|39|||
150281349|NCT03179891|542167138|FG000|First Intervention|Withdrawal by Subject|1|||
149949619|NCT03608033|540947784|FG000|Treatment Period|Withdrawal by Subject|46|||
150281350|NCT03179891|542167139|FG001|First Intervention|Withdrawal by Subject|1|||
150281351|NCT03179891|542167138|FG000|First Intervention|Unspecified reason|1|||
150281352|NCT03179891|542167139|FG001|First Intervention|Unspecified reason|0|||
150281353|NCT03179891|542167138|FG000|First Intervention|Protocol Violation|0|||
150281354|NCT03179891|542167139|FG001|First Intervention|Protocol Violation|1|||
150281355|NCT00530894|542167141|FG000|Overall Study|Death|84|||
150281356|NCT00530894|542167142|FG001|Overall Study|Death|89|||
150281357|NCT00530894|542167143|FG002|Overall Study|Death|55|||
150281358|NCT00530894|542167144|FG003|Overall Study|Death|89|||
150281359|NCT00530894|542167141|FG000|Overall Study|Lost to Follow-up|1|||
150281360|NCT00530894|542167142|FG001|Overall Study|Lost to Follow-up|3|||
150281361|NCT00530894|542167143|FG002|Overall Study|Lost to Follow-up|0|||
150281362|NCT00530894|542167144|FG003|Overall Study|Lost to Follow-up|0|||
150281363|NCT00530894|542167141|FG000|Overall Study|Withdrawal by Subject|1|||
150281364|NCT00530894|542167142|FG001|Overall Study|Withdrawal by Subject|23|||
150281365|NCT00530894|542167143|FG002|Overall Study|Withdrawal by Subject|0|||
150281366|NCT00530894|542167144|FG003|Overall Study|Withdrawal by Subject|5|||
150281367|NCT00530894|542167141|FG000|Overall Study|Alive and censored prior to 1 year|2|||
150281368|NCT00530894|542167142|FG001|Overall Study|Alive and censored prior to 1 year|0|||
150281369|NCT00530894|542167143|FG002|Overall Study|Alive and censored prior to 1 year|0|||
150281370|NCT00530894|542167144|FG003|Overall Study|Alive and censored prior to 1 year|0|||
150281371|NCT01349465|542167145|FG000|Overall Study|Adverse Event|1|||
150281372|NCT01349465|542167146|FG001|Overall Study|Adverse Event|0|||
150281373|NCT01349465|542167145|FG000|Overall Study|Death|3|||
150281374|NCT01349465|542167146|FG001|Overall Study|Death|0|||
150281375|NCT01349465|542167145|FG000|Overall Study|Lost to Follow-up|10|||
150281376|NCT01349465|542167146|FG001|Overall Study|Lost to Follow-up|1|||
150281377|NCT01349465|542167145|FG000|Overall Study|Withdrawal by Subject|4|||
150281378|NCT01349465|542167146|FG001|Overall Study|Withdrawal by Subject|2|||
150281379|NCT01349465|542167145|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
150281380|NCT01349465|542167146|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
150281381|NCT02969187|542167147|FG000|Overall Study|Physician Decision|12|||
150281382|NCT02969187|542167148|FG001|Overall Study|Physician Decision|13|||
150281383|NCT01372384|542167149|FG000|Overall Study|Progression of disease|3|||
150281384|NCT02576444|542167153|FG000|Overall Study|Death|1|||
150281385|NCT02576444|542167154|FG001|Overall Study|Death|1|||
150281386|NCT02576444|542167155|FG002|Overall Study|Death|0|||
150281387|NCT02576444|542167156|FG003|Overall Study|Death|0|||
150281388|NCT02576444|542167153|FG000|Overall Study|Withdrawal by Subject|0|||
150281389|NCT02576444|542167154|FG001|Overall Study|Withdrawal by Subject|0|||
150281390|NCT02576444|542167155|FG002|Overall Study|Withdrawal by Subject|2|||
150281391|NCT02576444|542167156|FG003|Overall Study|Withdrawal by Subject|0|||
150281392|NCT02576444|542167153|FG000|Overall Study|Adverse Event|0|||
150281393|NCT02576444|542167154|FG001|Overall Study|Adverse Event|0|||
150281394|NCT02576444|542167155|FG002|Overall Study|Adverse Event|1|||
150281395|NCT02576444|542167156|FG003|Overall Study|Adverse Event|0|||
150281396|NCT02576444|542167153|FG000|Overall Study|Physician Decision|0|||
150281397|NCT02576444|542167154|FG001|Overall Study|Physician Decision|0|||
150281398|NCT02576444|542167155|FG002|Overall Study|Physician Decision|1|||
150281399|NCT02576444|542167156|FG003|Overall Study|Physician Decision|0|||
150281400|NCT03370120|542167160|FG000|Overall Study|Adverse event, non-fatal|24|||
150281401|NCT03370120|542167160|FG000|Overall Study|Withdrawal by Subject|6|||
150281402|NCT03370120|542167160|FG000|Overall Study|Lost to Follow-up|1|||
150281403|NCT03370120|542167160|FG000|Overall Study|Lack of Efficacy|37|||
149949620|NCT03608033|540947785|FG001|Treatment Period|Withdrawal by Subject|45|||
149949621|NCT03608033|540947784|FG000|Treatment Period|Study terminated by sponsor|82|||
149949622|NCT03608033|540947785|FG001|Treatment Period|Study terminated by sponsor|68|||
149949623|NCT03608033|540947784|FG000|Treatment Period|Site Terminated by Sponsor|1|||
149949624|NCT03608033|540947785|FG001|Treatment Period|Site Terminated by Sponsor|0|||
149949625|NCT03608033|540947784|FG000|Open-Label Period: OMS721|Adverse Event|1|||
149949626|NCT03608033|540947785|FG001|Open-Label Period: OMS721|Adverse Event|0|||
149949627|NCT03608033|540947784|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
149949628|NCT03608033|540947785|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
149949629|NCT03608033|540947784|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
149949630|NCT03608033|540947785|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
149949631|NCT03608033|540947784|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
149949632|NCT03608033|540947785|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
149949633|NCT03608033|540947784|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
149949634|NCT03608033|540947785|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
150281404|NCT03370120|542167160|FG000|Overall Study|Per sponsor's instructions|1|||
150281405|NCT03370120|542167160|FG000|Overall Study|Study was terminated by parent company UCB|2|||
150281406|NCT03370120|542167160|FG000|Overall Study|The study was ended by the promoter|3|||
150281407|NCT03370120|542167160|FG000|Overall Study|Discontinuation of drug development|3|||
150281408|NCT03370120|542167160|FG000|Overall Study|End of project|2|||
150281409|NCT03370120|542167160|FG000|Overall Study|Premature study closure|2|||
150281410|NCT03370120|542167160|FG000|Overall Study|Premature program termination|1|||
150281411|NCT03370120|542167160|FG000|Overall Study|Premature study termination|7|||
150281412|NCT03370120|542167160|FG000|Overall Study|Trial terminated by sponsor|2|||
150281413|NCT03370120|542167160|FG000|Overall Study|Trial discontinued by sponsor|2|||
150281414|NCT03370120|542167160|FG000|Overall Study|Study ended|15|||
150281415|NCT03370120|542167160|FG000|Overall Study|Clinical trial has been cancelled|1|||
150281416|NCT03370120|542167160|FG000|Overall Study|End of study per sponsor decision|2|||
150281417|NCT03370120|542167160|FG000|Overall Study|Promoter's decision|2|||
150281418|NCT03370120|542167160|FG000|Overall Study|The trial has been suspended|3|||
150281419|NCT03370120|542167160|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
150281420|NCT03370120|542167160|FG000|Overall Study|Early termination by order of sponsor|2|||
150281421|NCT03370120|542167160|FG000|Overall Study|Discontinuation of the study|5|||
150281422|NCT03370120|542167160|FG000|Overall Study|End of clinical trial discontinuation|1|||
150281423|NCT03370120|542167160|FG000|Overall Study|Because the clinical trial ended halfway|4|||
150281424|NCT03370120|542167160|FG000|Overall Study|Development discontinued|5|||
150281425|NCT03370120|542167160|FG000|Overall Study|Padsenovil program closed|3|||
150281426|NCT03370120|542167160|FG000|Overall Study|End of project|2|||
150281427|NCT03370120|542167160|FG000|Overall Study|Termination of project|1|||
150281428|NCT03370120|542167160|FG000|Overall Study|The study was interrupted by sponsor|4|||
150281429|NCT03370120|542167160|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
150281430|NCT03370120|542167160|FG000|Overall Study|End of sponsor decision|1|||
150281431|NCT03370120|542167160|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
150281432|NCT03370120|542167160|FG000|Overall Study|Early termination of studies|5|||
150281433|NCT03370120|542167160|FG000|Overall Study|This study is ended early|1|||
150281434|NCT03370120|542167160|FG000|Overall Study|End of padsevonil program|2|||
150281435|NCT03370120|542167160|FG000|Overall Study|Decision of sponsor|6|||
150281436|NCT03370120|542167160|FG000|Overall Study|Asked by the sponsor|3|||
150281437|NCT03370120|542167160|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
150281438|NCT03370120|542167160|FG000|Overall Study|PI decision poor compliance from participant|1|||
150281439|NCT03370120|542167160|FG000|Overall Study|Promoter ended the study|3|||
150281440|NCT03370120|542167160|FG000|Overall Study|Premature study close by sponsor's decision|4|||
150281441|NCT03370120|542167160|FG000|Overall Study|Study terminated by sponsor|33|||
150281442|NCT03370120|542167160|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
150281443|NCT03370120|542167160|FG000|Overall Study|Sponsor decision to terminate study|63|||
150281444|NCT03370120|542167160|FG000|Overall Study|Program closure|3|||
150281445|NCT03370120|542167160|FG000|Overall Study|Study ended prematurely|1|||
150281446|NCT03370120|542167160|FG000|Overall Study|Study stopped by sponsor|2|||
150281447|NCT03370120|542167160|FG000|Overall Study|Program termination|55|||
150281448|NCT03370120|542167160|FG000|Overall Study|Sponsor decision|62|||
150281449|NCT03370120|542167160|FG000|Overall Study|Sponsor study closure|10|||
150281450|NCT04962022|542167161|FG000|Period 1|Withdrawal by Subject|1|||
150281451|NCT04962022|542167162|FG001|Period 1|Withdrawal by Subject|0|||
150281452|NCT04416555|542167165|FG000|Overall Study|Withdrawal by Subject|0|||
150281453|NCT04416555|542167166|FG001|Overall Study|Withdrawal by Subject|3|||
150281454|NCT03972969|542167167|FG000|3-month Follow-up|Death|1|||
150281455|NCT03972969|542167168|FG001|3-month Follow-up|Death|1|||
150281456|NCT03972969|542167169|FG002|3-month Follow-up|Death|0|||
150281457|NCT03972969|542167167|FG000|6-month Follow-up|Death|1|||
150281458|NCT03972969|542167168|FG001|6-month Follow-up|Death|1|||
150281459|NCT03972969|542167169|FG002|6-month Follow-up|Death|1|||
150281460|NCT03972969|542167167|FG000|6-month Follow-up|Lost to Follow-up|2|||
150281461|NCT03972969|542167168|FG001|6-month Follow-up|Lost to Follow-up|2|||
150281462|NCT03972969|542167169|FG002|6-month Follow-up|Lost to Follow-up|2|||
150281463|NCT04251910|542167172|FG000|Overall Study|Covid 19 lockdown|0|||
150281464|NCT04251910|542167173|FG001|Overall Study|Covid 19 lockdown|5|||
150281465|NCT04251910|542167174|FG002|Overall Study|Covid 19 lockdown|0|||
150281466|NCT04251910|542167175|FG003|Overall Study|Covid 19 lockdown|4|||
150281467|NCT04251910|542167176|FG004|Overall Study|Covid 19 lockdown|0|||
150281468|NCT04251910|542167177|FG005|Overall Study|Covid 19 lockdown|0|||
150281469|NCT04251910|542167172|FG000|Overall Study|Assisted living facility was closed|0|||
150281470|NCT04251910|542167173|FG001|Overall Study|Assisted living facility was closed|0|||
150281471|NCT04251910|542167174|FG002|Overall Study|Assisted living facility was closed|0|||
150281472|NCT04251910|542167175|FG003|Overall Study|Assisted living facility was closed|0|||
150281473|NCT04251910|542167176|FG004|Overall Study|Assisted living facility was closed|1|||
149836990|NCT00467896|540537692|FG000|Overall Study|Adverse Event|7|||
149836991|NCT00467896|540537692|FG000|Overall Study|Serious Adverse Event|13|||
149836992|NCT00467896|540537692|FG000|Overall Study|Non-compliance|3|||
149836993|NCT00467896|540537692|FG000|Overall Study|Changed therapy|2|||
149836994|NCT00467896|540537692|FG000|Overall Study|Patient received transplant|2|||
149836995|NCT00467896|540537692|FG000|Overall Study|Patient had atrial septostomy|1|||
149836996|NCT00467896|540537692|FG000|Overall Study|Patient weaned off iloprost|1|||
149836997|NCT00467896|540537692|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
150281474|NCT04251910|542167177|FG005|Overall Study|Assisted living facility was closed|0|||
149836998|NCT00467896|540537692|FG000|Overall Study|Started intravenous prostacyclin|1|||
149836999|NCT00467896|540537692|FG000|Overall Study|Started inhaled Remodulin|1|||
149837000|NCT00467896|540537692|FG000|Overall Study|Patient had no improvement|1|||
149837001|NCT03772522|540537693|FG000|Pre-intervention|Withdrawal by Subject|3|||
149837002|NCT03772522|540537694|FG001|Pre-intervention|Withdrawal by Subject|4|||
149837003|NCT03772522|540537693|FG000|Intervention|Withdrawal by Subject|1|||
149837004|NCT03772522|540537694|FG001|Intervention|Withdrawal by Subject|0|||
149837005|NCT03772522|540537693|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
149837006|NCT03772522|540537694|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
149837007|NCT03818581|540537695|FG000|Overall Study|Adverse Event|1|||
149837008|NCT03818581|540537696|FG001|Overall Study|Adverse Event|0|||
149837009|NCT03818581|540537697|FG002|Overall Study|Adverse Event|0|||
149837010|NCT03818581|540537698|FG003|Overall Study|Adverse Event|0|||
149837011|NCT03818581|540537699|FG004|Overall Study|Adverse Event|0|||
149837012|NCT03818581|540537695|FG000|Overall Study|Covid-19|2|||
149837013|NCT03818581|540537696|FG001|Overall Study|Covid-19|0|||
149837014|NCT03818581|540537697|FG002|Overall Study|Covid-19|0|||
149837015|NCT03818581|540537698|FG003|Overall Study|Covid-19|0|||
149837016|NCT03818581|540537699|FG004|Overall Study|Covid-19|1|||
149837017|NCT03818581|540537695|FG000|Overall Study|Withdrawal by Subject|0|||
149837018|NCT03818581|540537696|FG001|Overall Study|Withdrawal by Subject|0|||
149837019|NCT03818581|540537697|FG002|Overall Study|Withdrawal by Subject|0|||
150171817|NCT04722003|541765785|FG000|Overall Study|Lost to Follow-up|2|||
150171818|NCT04722003|541765786|FG001|Overall Study|Lost to Follow-up|0|||
150171819|NCT04722003|541765785|FG000|Overall Study|Physician Decision|1|||
150171820|NCT04722003|541765786|FG001|Overall Study|Physician Decision|0|||
150171821|NCT00028769|541765787|FG000|Overall Study|Adverse Event|2|||
150171822|NCT00028769|541765787|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
149837020|NCT03818581|540537698|FG003|Overall Study|Withdrawal by Subject|0|||
149837021|NCT03818581|540537699|FG004|Overall Study|Withdrawal by Subject|1|||
150171823|NCT00028769|541765787|FG000|Overall Study|Progression or Death|31|||
150171824|NCT00028769|541765787|FG000|Overall Study|Other - Not Protocol Specified|1|||
150171825|NCT00028769|541765787|FG000|Overall Study|Ineligible|5|||
150171826|NCT00028769|541765787|FG000|Overall Study|Not Analyzable|1|||
150171827|NCT01499134|541765788|FG000|Overall Study|Withdrawal by Subject|0|||
150171828|NCT01499134|541765789|FG001|Overall Study|Withdrawal by Subject|1|||
150171829|NCT04035668|541765791|FG000|Overall Study|Adverse Event|3|||
150171830|NCT04035668|541765792|FG001|Overall Study|Adverse Event|4|||
150171831|NCT04035668|541765793|FG002|Overall Study|Adverse Event|2|||
150171832|NCT04035668|541765791|FG000|Overall Study|Lost to Follow-up|0|||
150171833|NCT04035668|541765792|FG001|Overall Study|Lost to Follow-up|1|||
150171834|NCT04035668|541765793|FG002|Overall Study|Lost to Follow-up|0|||
150171835|NCT04035668|541765791|FG000|Overall Study|Physician Decision|2|||
150171836|NCT04035668|541765792|FG001|Overall Study|Physician Decision|1|||
150171837|NCT04035668|541765793|FG002|Overall Study|Physician Decision|1|||
150171838|NCT04035668|541765791|FG000|Overall Study|Subject Decision|2|||
150171839|NCT04035668|541765792|FG001|Overall Study|Subject Decision|2|||
150171840|NCT04035668|541765793|FG002|Overall Study|Subject Decision|0|||
150171841|NCT02937831|541765794|FG000|Overall Study|Protocol Violation|4|||
150171842|NCT02027558|541765799|FG000|Overall Study|Death|0|||
150171843|NCT02027558|541765800|FG001|Overall Study|Death|1|||
150171844|NCT02027558|541765799|FG000|Overall Study|Withdrawal by Subject|2|||
150171845|NCT02027558|541765800|FG001|Overall Study|Withdrawal by Subject|0|||
150171846|NCT02027558|541765799|FG000|Overall Study|Lost to Follow-up|4|||
150171847|NCT02027558|541765800|FG001|Overall Study|Lost to Follow-up|1|||
150171848|NCT02027558|541765799|FG000|Overall Study|Refused assessment|3|||
150171849|NCT02027558|541765800|FG001|Overall Study|Refused assessment|0|||
150171850|NCT00114244|541765805|FG000|Overall Study|Adverse Event|2|||
149837022|NCT03818581|540537695|FG000|Overall Study|No longer met study criteria|0|||
149837023|NCT03818581|540537696|FG001|Overall Study|No longer met study criteria|0|||
149837024|NCT03818581|540537697|FG002|Overall Study|No longer met study criteria|0|||
149837025|NCT03818581|540537698|FG003|Overall Study|No longer met study criteria|0|||
149837026|NCT03818581|540537699|FG004|Overall Study|No longer met study criteria|1|||
149837027|NCT02096211|540537702|FG000|Overall Study|Death|2|||
149837028|NCT02096211|540537702|FG000|Overall Study|Withdrawal by Subject|8|||
150171851|NCT00114244|541765806|FG001|Overall Study|Adverse Event|5|||
149837029|NCT02096211|540537702|FG000|Overall Study|Revision of implant|7|||
149837030|NCT02096211|540537702|FG000|Overall Study|Lost to Follow-up|43|||
149837031|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
149837032|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
149837033|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Death|2|||
149837034|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Death|1|||
149837035|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
149837036|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
149837037|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
149837038|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
149837039|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Other|8|||
150171852|NCT00114244|541765805|FG000|Overall Study|Withdrawal by Subject|0|||
150281475|NCT04607148|542167178|FG000|Overall Study|Withdrawal by Subject|0|||
150281476|NCT04607148|542167179|FG001|Overall Study|Withdrawal by Subject|4|||
150281477|NCT04607148|542167180|FG002|Overall Study|Withdrawal by Subject|2|||
150281478|NCT04607148|542167181|FG003|Overall Study|Withdrawal by Subject|8|||
150281479|NCT04607148|542167178|FG000|Overall Study|Study Terminated by Sponsor|14|||
150281480|NCT04607148|542167179|FG001|Overall Study|Study Terminated by Sponsor|59|||
150281481|NCT04607148|542167180|FG002|Overall Study|Study Terminated by Sponsor|9|||
150281482|NCT04607148|542167181|FG003|Overall Study|Study Terminated by Sponsor|39|||
150281483|NCT04607148|542167178|FG000|Overall Study|Sponsor Decision|0|||
150281484|NCT04607148|542167179|FG001|Overall Study|Sponsor Decision|0|||
150281485|NCT04607148|542167180|FG002|Overall Study|Sponsor Decision|1|||
150281486|NCT04607148|542167181|FG003|Overall Study|Sponsor Decision|0|||
150281487|NCT04607148|542167178|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150281488|NCT04607148|542167179|FG001|Overall Study|Non-Compliance With Study Drug|1|||
150281489|NCT04607148|542167180|FG002|Overall Study|Non-Compliance With Study Drug|0|||
150281490|NCT04607148|542167181|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150281491|NCT04607148|542167178|FG000|Overall Study|Lost to Follow-up|0|||
150281492|NCT04607148|542167179|FG001|Overall Study|Lost to Follow-up|2|||
149837040|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Other|13|||
149837041|NCT01439880|540537708|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
149837042|NCT01439880|540537709|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
149837043|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
149837044|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
149837045|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
149837046|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
149837047|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Death|3|||
149837048|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Death|13|||
149837049|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
149837050|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
149837051|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Other|14|||
149837052|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Other|31|||
149837053|NCT01439880|540537708|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
149837054|NCT01439880|540537709|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
149837055|NCT02956460|540537710|FG000|Lens 1|Lost to Follow-up|1|||
149837056|NCT02956460|540537711|FG001|Lens 1|Lost to Follow-up|0|||
150281493|NCT04607148|542167180|FG002|Overall Study|Lost to Follow-up|0|||
150281494|NCT04607148|542167181|FG003|Overall Study|Lost to Follow-up|0|||
150281495|NCT04607148|542167178|FG000|Overall Study|Death|0|||
150281496|NCT04607148|542167179|FG001|Overall Study|Death|3|||
150281497|NCT04607148|542167180|FG002|Overall Study|Death|0|||
150281498|NCT04607148|542167181|FG003|Overall Study|Death|1|||
150281499|NCT04607148|542167178|FG000|Overall Study|Adverse Event|0|||
150281500|NCT04607148|542167179|FG001|Overall Study|Adverse Event|1|||
150281501|NCT04607148|542167180|FG002|Overall Study|Adverse Event|0|||
150281502|NCT04607148|542167181|FG003|Overall Study|Adverse Event|0|||
150281503|NCT00804570|542167182|FG000|Overall Study|Adverse Event|14|||
150281504|NCT00804570|542167183|FG001|Overall Study|Adverse Event|7|||
150281505|NCT00804570|542167182|FG000|Overall Study|Lack of Efficacy|0|||
150281506|NCT00804570|542167183|FG001|Overall Study|Lack of Efficacy|1|||
150281507|NCT00804570|542167182|FG000|Overall Study|Lost to Follow-up|18|||
150281508|NCT00804570|542167183|FG001|Overall Study|Lost to Follow-up|21|||
150281509|NCT00804570|542167182|FG000|Overall Study|Entry criteria not met|5|||
150281510|NCT00804570|542167183|FG001|Overall Study|Entry criteria not met|5|||
150281511|NCT00804570|542167182|FG000|Overall Study|Protocol Violation|12|||
150281512|NCT00804570|542167183|FG001|Overall Study|Protocol Violation|16|||
150281513|NCT00804570|542167182|FG000|Overall Study|Physician Decision|1|||
150281514|NCT00804570|542167183|FG001|Overall Study|Physician Decision|2|||
150281515|NCT00804570|542167182|FG000|Overall Study|Sponsor decision|1|||
150281516|NCT00804570|542167183|FG001|Overall Study|Sponsor decision|4|||
150281517|NCT00804570|542167182|FG000|Overall Study|Withdrawal by Subject|21|||
150281518|NCT00804570|542167183|FG001|Overall Study|Withdrawal by Subject|38|||
150281519|NCT00290342|542167184|FG000|Overall Study|Other|0|||
149837057|NCT02378935|540537712|FG000|Overall Study|Lack of Efficacy|10|||
150281520|NCT00290342|542167185|FG001|Overall Study|Other|1|||
150281521|NCT00290342|542167184|FG000|Overall Study|Withdrawal by Subject|6|||
149837058|NCT02378935|540537713|FG001|Overall Study|Lack of Efficacy|0|||
149837059|NCT02378935|540537714|FG002|Overall Study|Lack of Efficacy|2|||
149837060|NCT02378935|540537715|FG003|Overall Study|Lack of Efficacy|6|||
150281522|NCT00290342|542167185|FG001|Overall Study|Withdrawal by Subject|4|||
150281523|NCT00290342|542167184|FG000|Overall Study|Lost to Follow-up|1|||
150281524|NCT00290342|542167185|FG001|Overall Study|Lost to Follow-up|0|||
150281525|NCT00916149|542167186|FG000|Overall Study|Lost to Follow-up|3|||
150281526|NCT00916149|542167187|FG001|Overall Study|Lost to Follow-up|2|||
150281527|NCT00916149|542167188|FG002|Overall Study|Lost to Follow-up|0|||
150281528|NCT00916149|542167186|FG000|Overall Study|Unable to place scalp EEG leads|1|||
150281529|NCT00916149|542167187|FG001|Overall Study|Unable to place scalp EEG leads|0|||
150281530|NCT00916149|542167188|FG002|Overall Study|Unable to place scalp EEG leads|0|||
150281531|NCT00912028|542167191|FG000|Overall Study|Lost to Follow-up|2|||
150281532|NCT00912028|542167192|FG001|Overall Study|Lost to Follow-up|3|||
150281533|NCT00912028|542167193|FG002|Overall Study|Lost to Follow-up|0|||
150281534|NCT00912028|542167194|FG003|Overall Study|Lost to Follow-up|1|||
150281535|NCT00912028|542167195|FG004|Overall Study|Lost to Follow-up|3|||
150281536|NCT00912028|542167191|FG000|Overall Study|Withdrawal by Subject|3|||
150281537|NCT00912028|542167192|FG001|Overall Study|Withdrawal by Subject|0|||
150281538|NCT00912028|542167193|FG002|Overall Study|Withdrawal by Subject|0|||
150281539|NCT00912028|542167194|FG003|Overall Study|Withdrawal by Subject|0|||
150281540|NCT00912028|542167195|FG004|Overall Study|Withdrawal by Subject|0|||
150281541|NCT00841568|542167196|FG000|Overall Study|Adverse Event|1|||
150281542|NCT00841568|542167196|FG000|Overall Study|Death|1|||
150281543|NCT00841568|542167196|FG000|Overall Study|Withdrawal by Subject|2|||
150281544|NCT00841568|542167196|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
150281545|NCT03002155|542167197|FG000|Overall Study|Lost to Follow-up|1|||
150281546|NCT03002155|542167198|FG001|Overall Study|Lost to Follow-up|2|||
150281547|NCT03002155|542167197|FG000|Overall Study|Withdrawal by Subject|1|||
150281548|NCT03002155|542167198|FG001|Overall Study|Withdrawal by Subject|0|||
150281549|NCT03002155|542167197|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
150281550|NCT03002155|542167198|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
150281551|NCT00978029|542167199|FG000|Overall Study|Adverse Event|1|||
150281552|NCT00978029|542167200|FG001|Overall Study|Adverse Event|2|||
150281553|NCT00978029|542167201|FG002|Overall Study|Adverse Event|5|||
150281554|NCT00978029|542167199|FG000|Overall Study|Withdrawal by Subject|0|||
150281555|NCT00978029|542167200|FG001|Overall Study|Withdrawal by Subject|0|||
150281556|NCT00978029|542167201|FG002|Overall Study|Withdrawal by Subject|1|||
150281557|NCT00978029|542167199|FG000|Overall Study|Protocol Violation|0|||
150281558|NCT00978029|542167200|FG001|Overall Study|Protocol Violation|1|||
150281559|NCT00978029|542167201|FG002|Overall Study|Protocol Violation|0|||
150281560|NCT02830776|542167202|FG000|Overall Study|Lost to Follow-up|1|||
150281561|NCT01820364|542167205|FG000|Part I: LGX818|Death|1|||
150281562|NCT01820364|542167206|FG001|Part I: LGX818|Death|0|||
150281563|NCT01820364|542167205|FG000|Part I: LGX818|Administrative Problems|3|||
150281564|NCT01820364|542167206|FG001|Part I: LGX818|Administrative Problems|0|||
150281565|NCT01820364|542167205|FG000|Part I: LGX818|Adverse Event|6|||
150281566|NCT01820364|542167206|FG001|Part I: LGX818|Adverse Event|0|||
150281567|NCT01820364|542167205|FG000|Part I: LGX818|Disease Progression|4|||
150281568|NCT01820364|542167206|FG001|Part I: LGX818|Disease Progression|0|||
150281569|NCT01820364|542167205|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
150281570|NCT01820364|542167206|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
150281571|NCT01793142|542167207|FG000|Overall Study|Randomized not treated|7|||
150281572|NCT03451084|542167208|FG000|Overall Study|Withdrawal by Subject|2|||
150281573|NCT03451084|542167209|FG001|Overall Study|Withdrawal by Subject|1|||
150281574|NCT03451084|542167210|FG002|Overall Study|Withdrawal by Subject|2|||
150281575|NCT03451084|542167211|FG003|Overall Study|Withdrawal by Subject|1|||
150281576|NCT03451084|542167208|FG000|Overall Study|Disease recurrence|0|||
150281577|NCT03451084|542167209|FG001|Overall Study|Disease recurrence|2|||
150281578|NCT03451084|542167210|FG002|Overall Study|Disease recurrence|0|||
150281579|NCT03451084|542167211|FG003|Overall Study|Disease recurrence|0|||
150281580|NCT03451084|542167208|FG000|Overall Study|Lack of Efficacy|0|||
150281581|NCT03451084|542167209|FG001|Overall Study|Lack of Efficacy|3|||
150281582|NCT03451084|542167210|FG002|Overall Study|Lack of Efficacy|0|||
150281583|NCT03451084|542167211|FG003|Overall Study|Lack of Efficacy|1|||
150281584|NCT03451084|542167208|FG000|Overall Study|Death|1|||
150281585|NCT03451084|542167209|FG001|Overall Study|Death|0|||
150281586|NCT03451084|542167210|FG002|Overall Study|Death|2|||
150281587|NCT03451084|542167211|FG003|Overall Study|Death|0|||
150281588|NCT03451084|542167208|FG000|Overall Study|Physician Decision|0|||
150281589|NCT03451084|542167209|FG001|Overall Study|Physician Decision|0|||
150281590|NCT03451084|542167210|FG002|Overall Study|Physician Decision|2|||
150281591|NCT03451084|542167211|FG003|Overall Study|Physician Decision|2|||
150281592|NCT03451084|542167208|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
150281593|NCT03451084|542167209|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
150281594|NCT03451084|542167210|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
150281595|NCT03451084|542167211|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
150281596|NCT01087775|542167212|FG000|Overall Study|failed inclusion criteria|2|||
150281597|NCT03418129|542167213|FG000|Overall Study|Lost to Follow-up|11|||
150281598|NCT03418129|542167214|FG001|Overall Study|Lost to Follow-up|20|||
150281599|NCT03418129|542167215|FG002|Overall Study|Lost to Follow-up|15|||
150281600|NCT03418129|542167213|FG000|Overall Study|Withdrawal by Subject|3|||
150281601|NCT03418129|542167214|FG001|Overall Study|Withdrawal by Subject|6|||
150281602|NCT03418129|542167215|FG002|Overall Study|Withdrawal by Subject|4|||
150281603|NCT01066585|542167218|FG000|Overall Study|Protocol Violation|1|||
150281604|NCT01066585|542167219|FG001|Overall Study|Protocol Violation|0|||
150281605|NCT01066585|542167218|FG000|Overall Study|Withdrawal by Subject|0|||
150281606|NCT01066585|542167219|FG001|Overall Study|Withdrawal by Subject|3|||
150281607|NCT00884273|542167220|FG000|Overall Study|Adverse Event|0|||
150281608|NCT00884273|542167221|FG001|Overall Study|Adverse Event|2|||
150281609|NCT00884273|542167220|FG000|Overall Study|Protocol Violation|1|||
150281610|NCT00884273|542167221|FG001|Overall Study|Protocol Violation|3|||
150281611|NCT00884273|542167220|FG000|Overall Study|Practical reasons|1|||
150281612|NCT00884273|542167221|FG001|Overall Study|Practical reasons|0|||
150281613|NCT00258674|542167222|FG000|Overall Study|Death|32|||
150281614|NCT00258674|542167223|FG001|Overall Study|Death|53|||
150281615|NCT00258674|542167224|FG002|Overall Study|Death|34|||
150281616|NCT03715153|542167225|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
150281617|NCT03715153|542167226|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
150281618|NCT03715153|542167225|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
150281619|NCT03715153|542167226|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
150281620|NCT03715153|542167225|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
150281621|NCT03715153|542167226|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
150281622|NCT03715153|542167225|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
150281623|NCT03715153|542167226|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
150281624|NCT03715153|542167225|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
150281625|NCT03715153|542167226|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
150281626|NCT03715153|542167225|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
150281627|NCT03715153|542167226|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
150281628|NCT00432042|542167230|FG000|Overall Study|Protocol Violation|2|||
150281629|NCT00432042|542167231|FG001|Overall Study|Protocol Violation|0|||
150281630|NCT00432042|542167232|FG002|Overall Study|Protocol Violation|0|||
149837061|NCT02378935|540537716|FG004|Overall Study|Lack of Efficacy|0|||
149837062|NCT02378935|540537717|FG005|Overall Study|Lack of Efficacy|0|||
149837063|NCT02378935|540537718|FG006|Overall Study|Lack of Efficacy|0|||
149837064|NCT02378935|540537712|FG000|Overall Study|Death|0|||
149837065|NCT02378935|540537713|FG001|Overall Study|Death|0|||
149837066|NCT02378935|540537714|FG002|Overall Study|Death|1|||
149837067|NCT02378935|540537715|FG003|Overall Study|Death|0|||
149837068|NCT02378935|540537716|FG004|Overall Study|Death|0|||
149837069|NCT02378935|540537717|FG005|Overall Study|Death|0|||
149837070|NCT02378935|540537718|FG006|Overall Study|Death|0|||
149837071|NCT04129346|540537723|FG000|Overall Study|Death|1|||
149837072|NCT04129346|540537724|FG001|Overall Study|Death|0|||
149837073|NCT03935880|540537725|FG000|Overall Study|Lost to Follow-up|0|||
149837074|NCT03935880|540537726|FG001|Overall Study|Lost to Follow-up|1|||
149837075|NCT02476994|540537727|FG000|Overall Study|Based on feedback from FDA|1|||
149837076|NCT02476994|540537728|FG001|Overall Study|Based on feedback from FDA|0|||
149837077|NCT02563561|540537729|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
149837078|NCT02563561|540537730|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
149837079|NCT02563561|540537731|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
149837080|NCT02563561|540537729|FG000|Overall Study|Withdrew of Consent|1|||
149837081|NCT02563561|540537730|FG001|Overall Study|Withdrew of Consent|1|||
149837082|NCT02563561|540537731|FG002|Overall Study|Withdrew of Consent|2|||
149837083|NCT02563561|540537729|FG000|Overall Study|Lost to Follow-up|1|||
149837084|NCT02563561|540537730|FG001|Overall Study|Lost to Follow-up|1|||
149837085|NCT02563561|540537731|FG002|Overall Study|Lost to Follow-up|0|||
149837086|NCT02563561|540537729|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
149837087|NCT02563561|540537730|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
149837088|NCT02563561|540537731|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
149837089|NCT02563561|540537729|FG000|Overall Study|Investigator Decision|3|||
150281631|NCT00432042|542167230|FG000|Overall Study|Withdrawal by Subject|0|||
150281632|NCT00432042|542167231|FG001|Overall Study|Withdrawal by Subject|0|||
150281633|NCT00432042|542167232|FG002|Overall Study|Withdrawal by Subject|2|||
150281634|NCT00432042|542167230|FG000|Overall Study|Lost to Follow-up|5|||
150281635|NCT00432042|542167231|FG001|Overall Study|Lost to Follow-up|1|||
150281636|NCT00432042|542167232|FG002|Overall Study|Lost to Follow-up|0|||
150281637|NCT00492752|542167233|FG000|Double Blind Treatment|Death|13|||
149837090|NCT02563561|540537730|FG001|Overall Study|Investigator Decision|4|||
149837091|NCT02563561|540537731|FG002|Overall Study|Investigator Decision|2|||
149949639|NCT03483012|540947788|FG000|Overall Study|Lack of Efficacy|6|||
150281638|NCT00492752|542167234|FG001|Double Blind Treatment|Death|0|||
150281639|NCT00492752|542167235|FG002|Double Blind Treatment|Death|2|||
149837092|NCT02563561|540537729|FG000|Overall Study|Sponsor Decision|5|||
149837093|NCT02563561|540537730|FG001|Overall Study|Sponsor Decision|2|||
149837094|NCT02563561|540537731|FG002|Overall Study|Sponsor Decision|4|||
149837095|NCT02563561|540537729|FG000|Overall Study|Other|1|||
150281640|NCT00492752|542167236|FG003|Double Blind Treatment|Death|0|||
150281641|NCT00492752|542167233|FG000|Double Blind Treatment|Adverse Event|1|||
150281642|NCT00492752|542167234|FG001|Double Blind Treatment|Adverse Event|0|||
150281643|NCT00492752|542167235|FG002|Double Blind Treatment|Adverse Event|0|||
150281644|NCT00492752|542167236|FG003|Double Blind Treatment|Adverse Event|0|||
150281645|NCT00492752|542167233|FG000|Double Blind Treatment|Protocol Violation|0|||
150281646|NCT00492752|542167234|FG001|Double Blind Treatment|Protocol Violation|0|||
150281647|NCT00492752|542167235|FG002|Double Blind Treatment|Protocol Violation|1|||
150281648|NCT00492752|542167236|FG003|Double Blind Treatment|Protocol Violation|0|||
150281649|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
150281650|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
150281651|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
150281652|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
150281653|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
150281654|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
150281655|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
150281656|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
150281657|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
150281658|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
150281659|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
150281660|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
150281661|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
150281662|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
150281663|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
150281664|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
150281665|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
150281666|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
150281667|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
150281668|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
150281669|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
150281670|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
150281671|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
150281672|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
150281673|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
150281674|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
150281675|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
150281676|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
150281677|NCT00492752|542167233|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
150281678|NCT00492752|542167234|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
150281679|NCT00492752|542167235|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
150281680|NCT00492752|542167236|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
150281681|NCT01357655|542167237|FG000|Overall Study|Administrative Reason by Sponsor|45|||
150281682|NCT01357655|542167238|FG001|Overall Study|Administrative Reason by Sponsor|0|||
150281683|NCT01357655|542167237|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
150281684|NCT01357655|542167238|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
150281685|NCT01357655|542167237|FG000|Overall Study|Disease Progression|1|||
150281686|NCT01357655|542167238|FG001|Overall Study|Disease Progression|0|||
150281687|NCT01357655|542167237|FG000|Overall Study|Lost to Follow-up|2|||
150281688|NCT01357655|542167238|FG001|Overall Study|Lost to Follow-up|0|||
150281689|NCT01357655|542167237|FG000|Overall Study|Maximum Clinical Benefit|2|||
150281690|NCT01357655|542167238|FG001|Overall Study|Maximum Clinical Benefit|0|||
150281691|NCT01357655|542167237|FG000|Overall Study|Reason Unspecified|1|||
150281692|NCT01357655|542167238|FG001|Overall Study|Reason Unspecified|0|||
150281693|NCT01357655|542167237|FG000|Overall Study|Study Drug Toxicity|11|||
150281694|NCT01357655|542167238|FG001|Overall Study|Study Drug Toxicity|0|||
150281695|NCT01357655|542167237|FG000|Overall Study|Subject Withdrew Consent|1|||
150281696|NCT01357655|542167238|FG001|Overall Study|Subject Withdrew Consent|0|||
150281697|NCT05003622|542167239|FG000|Overall Study|Progressive disease|2|||
150281698|NCT05003622|542167239|FG000|Overall Study|Withdrawal by Subject|1|||
150281699|NCT00390546|542168697|FG000|Overall Study|Renal impairment|1|||
150281700|NCT00390546|542168698|FG001|Overall Study|Renal impairment|0|||
150034537|NCT00313014|541266453|FG000|Overall Study|Withdrawal by Subject|11|||
150034538|NCT00313014|541266454|FG001|Overall Study|Withdrawal by Subject|7|||
150281701|NCT00390546|542168697|FG000|Overall Study|Physician Decision|5|||
150281702|NCT00390546|542168698|FG001|Overall Study|Physician Decision|5|||
150281703|NCT03357731|542168699|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
150281704|NCT03357731|542168700|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
150281705|NCT03357731|542168701|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
150281706|NCT03357731|542168702|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
150034539|NCT00313014|541266455|FG002|Overall Study|Withdrawal by Subject|5|||
149837096|NCT02563561|540537730|FG001|Overall Study|Other|5|||
149837097|NCT02563561|540537731|FG002|Overall Study|Other|2|||
150281707|NCT03357731|542168703|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
150281708|NCT03357731|542168704|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
149837098|NCT03154047|540537732|FG000|Overall Study|Death|1|||
149837099|NCT03154047|540537732|FG000|Overall Study|Study terminated by sponsor|76|||
149837100|NCT03154047|540537732|FG000|Overall Study|Withdrawal by Subject|3|||
150281709|NCT03357731|542168699|FG000|Overall Study|Acute bradycardia and hypotension|0|||
150281710|NCT03357731|542168700|FG001|Overall Study|Acute bradycardia and hypotension|0|||
150281711|NCT03357731|542168701|FG002|Overall Study|Acute bradycardia and hypotension|0|||
150281712|NCT03357731|542168702|FG003|Overall Study|Acute bradycardia and hypotension|1|||
150281713|NCT03357731|542168703|FG004|Overall Study|Acute bradycardia and hypotension|0|||
150281714|NCT03357731|542168704|FG005|Overall Study|Acute bradycardia and hypotension|0|||
150281715|NCT03357731|542168699|FG000|Overall Study|Adverse Event|0|||
150281716|NCT03357731|542168700|FG001|Overall Study|Adverse Event|0|||
150281717|NCT03357731|542168701|FG002|Overall Study|Adverse Event|0|||
150281718|NCT03357731|542168702|FG003|Overall Study|Adverse Event|0|||
150281719|NCT03357731|542168703|FG004|Overall Study|Adverse Event|0|||
150281720|NCT03357731|542168704|FG005|Overall Study|Adverse Event|1|||
150281721|NCT03357731|542168699|FG000|Overall Study|Hypotension|0|||
150281722|NCT03357731|542168700|FG001|Overall Study|Hypotension|0|||
150281723|NCT03357731|542168701|FG002|Overall Study|Hypotension|1|||
150281724|NCT03357731|542168702|FG003|Overall Study|Hypotension|1|||
150281725|NCT03357731|542168703|FG004|Overall Study|Hypotension|0|||
150281726|NCT03357731|542168704|FG005|Overall Study|Hypotension|0|||
150281727|NCT03357731|542168699|FG000|Overall Study|Lost to Follow-up|0|||
150281728|NCT03357731|542168700|FG001|Overall Study|Lost to Follow-up|0|||
150281729|NCT03357731|542168701|FG002|Overall Study|Lost to Follow-up|0|||
150281730|NCT03357731|542168702|FG003|Overall Study|Lost to Follow-up|1|||
150281731|NCT03357731|542168703|FG004|Overall Study|Lost to Follow-up|0|||
150281732|NCT03357731|542168704|FG005|Overall Study|Lost to Follow-up|0|||
150281733|NCT01417195|542168705|FG000|Overall Study|Stimulation failure|1|||
150281734|NCT01417195|542168706|FG001|Overall Study|Stimulation failure|0|||
150281735|NCT01417195|542168705|FG000|Overall Study|No embryos for transfer|0|||
150281736|NCT01417195|542168706|FG001|Overall Study|No embryos for transfer|1|||
150281737|NCT01417195|542168705|FG000|Overall Study|No transfer due to risk of OHSS|1|||
150281738|NCT01417195|542168706|FG001|Overall Study|No transfer due to risk of OHSS|0|||
150281739|NCT01417195|542168705|FG000|Overall Study|No transfer due to elevated progesterone|1|||
150281740|NCT01417195|542168706|FG001|Overall Study|No transfer due to elevated progesterone|0|||
150281741|NCT01773109|542168707|FG000|Overall Study|Symptomatic Progression|2|||
150281742|NCT01773109|542168707|FG000|Overall Study|Death|1|||
150281743|NCT04766021|542168710|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
150281744|NCT04766021|542168710|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
150281745|NCT02535715|542168714|FG000|Overall Study|Withdrawal by Subject|0|||
149837101|NCT00365365|540537733|FG000|Overall Study|Randomized but not treated|0|||
149837102|NCT00365365|540537734|FG001|Overall Study|Randomized but not treated|2|||
149837103|NCT00365365|540537735|FG002|Overall Study|Randomized but not treated|0|||
149837104|NCT00365365|540537733|FG000|Overall Study|Poor compliance to protocol|0|||
149837105|NCT00365365|540537734|FG001|Overall Study|Poor compliance to protocol|1|||
149837106|NCT00365365|540537735|FG002|Overall Study|Poor compliance to protocol|0|||
149837107|NCT00365365|540537733|FG000|Overall Study|Lost to Follow-up|3|||
149837108|NCT00365365|540537734|FG001|Overall Study|Lost to Follow-up|3|||
149837109|NCT00365365|540537735|FG002|Overall Study|Lost to Follow-up|3|||
149837110|NCT00365365|540537733|FG000|Overall Study|Death|1|||
149837111|NCT00365365|540537734|FG001|Overall Study|Death|3|||
149837112|NCT00365365|540537735|FG002|Overall Study|Death|0|||
149837113|NCT00365365|540537733|FG000|Overall Study|Subject's request|11|||
149837114|NCT00365365|540537734|FG001|Overall Study|Subject's request|13|||
149837115|NCT00365365|540537735|FG002|Overall Study|Subject's request|1|||
149837116|NCT00365365|540537733|FG000|Overall Study|Disease progression/relapse|9|||
149837117|NCT00365365|540537734|FG001|Overall Study|Disease progression/relapse|6|||
149837118|NCT00365365|540537735|FG002|Overall Study|Disease progression/relapse|7|||
149837119|NCT00365365|540537733|FG000|Overall Study|Adverse Event|6|||
149837120|NCT00365365|540537734|FG001|Overall Study|Adverse Event|6|||
150281746|NCT02535715|542168715|FG001|Overall Study|Withdrawal by Subject|0|||
150281747|NCT02535715|542168716|FG002|Overall Study|Withdrawal by Subject|1|||
150281748|NCT04353284|542168717|FG000|Overall Study|Adverse Event|1|||
150281749|NCT04353284|542168718|FG001|Overall Study|Adverse Event|1|||
150281750|NCT04353284|542168717|FG000|Overall Study|Lost to Follow-up|1|||
150281751|NCT04353284|542168718|FG001|Overall Study|Lost to Follow-up|0|||
150281752|NCT01040351|542168719|FG000|Overall Study|poor ovarian response|1|||
150281753|NCT01040351|542168720|FG001|Overall Study|poor ovarian response|2|||
150281754|NCT01230307|542168721|FG000|Overall Study|LVAD Placement|0|||
149837121|NCT00365365|540537735|FG002|Overall Study|Adverse Event|3|||
149837122|NCT00365365|540537733|FG000|Overall Study|Moved|2|||
149837123|NCT00365365|540537734|FG001|Overall Study|Moved|0|||
149837124|NCT00365365|540537735|FG002|Overall Study|Moved|0|||
149837125|NCT00365365|540537733|FG000|Overall Study|New cancer|1|||
149837126|NCT00365365|540537734|FG001|Overall Study|New cancer|0|||
149837127|NCT00365365|540537735|FG002|Overall Study|New cancer|0|||
149837128|NCT00365365|540537733|FG000|Overall Study|Withdrew consent|1|||
149837129|NCT00365365|540537734|FG001|Overall Study|Withdrew consent|1|||
149837130|NCT00365365|540537735|FG002|Overall Study|Withdrew consent|0|||
149837131|NCT00365365|540537733|FG000|Overall Study|Second malignancy|0|||
149837132|NCT00365365|540537734|FG001|Overall Study|Second malignancy|1|||
149837133|NCT00365365|540537735|FG002|Overall Study|Second malignancy|0|||
149837134|NCT00365365|540537733|FG000|Overall Study|Patient/physician decision|0|||
149837135|NCT00365365|540537734|FG001|Overall Study|Patient/physician decision|0|||
149837136|NCT00365365|540537735|FG002|Overall Study|Patient/physician decision|1|||
149837137|NCT01796171|540537736|FG000|Enrolled|Death|0|||
149837138|NCT01796171|540537737|FG001|Enrolled|Death|0|||
149837139|NCT01796171|540537738|FG002|Enrolled|Death|0|||
149837140|NCT01796171|540537739|FG003|Enrolled|Death|0|||
149837141|NCT01796171|540537740|FG004|Enrolled|Death|0|||
149837142|NCT01796171|540537741|FG005|Enrolled|Death|0|||
149837143|NCT01796171|540537742|FG006|Enrolled|Death|0|||
149837144|NCT01796171|540537743|FG007|Enrolled|Death|0|||
149837145|NCT01796171|540537744|FG008|Enrolled|Death|0|||
149837146|NCT01796171|540537745|FG009|Enrolled|Death|0|||
149837147|NCT01796171|540537746|FG010|Enrolled|Death|0|||
149837148|NCT01796171|540537747|FG011|Enrolled|Death|0|||
149837149|NCT01796171|540537748|FG012|Enrolled|Death|0|||
149837150|NCT01796171|540537749|FG013|Enrolled|Death|0|||
149837151|NCT01796171|540537750|FG014|Enrolled|Death|1|||
149837152|NCT01796171|540537736|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
149837153|NCT01796171|540537737|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
149837154|NCT01796171|540537738|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
149837155|NCT01796171|540537739|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
149837156|NCT01796171|540537740|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
149837157|NCT01796171|540537741|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
150034540|NCT00313014|541266453|FG000|Overall Study|Adverse Event|14|||
150034541|NCT00313014|541266454|FG001|Overall Study|Adverse Event|29|||
150171853|NCT00114244|541765806|FG001|Overall Study|Withdrawal by Subject|2|||
150171854|NCT02694978|541765807|FG000|Overall Study|Adverse Event|10|||
150171855|NCT02694978|541765808|FG001|Overall Study|Adverse Event|9|||
150171856|NCT02694978|541765807|FG000|Overall Study|Withdrawal by Subject|22|||
150171857|NCT02694978|541765808|FG001|Overall Study|Withdrawal by Subject|19|||
150171858|NCT02694978|541765807|FG000|Overall Study|Lost to Follow-up|14|||
150171859|NCT02694978|541765808|FG001|Overall Study|Lost to Follow-up|17|||
150171860|NCT02694978|541765807|FG000|Overall Study|Death|4|||
150171861|NCT02694978|541765808|FG001|Overall Study|Death|1|||
150171862|NCT02694978|541765807|FG000|Overall Study|Other-Decision of Participant|6|||
150171863|NCT02694978|541765808|FG001|Overall Study|Other-Decision of Participant|1|||
150171864|NCT02694978|541765807|FG000|Overall Study|Other-Investigator's decision|1|||
150171865|NCT02694978|541765808|FG001|Overall Study|Other-Investigator's decision|0|||
150171866|NCT02694978|541765807|FG000|Overall Study|Other-Unable to be reached|0|||
150171867|NCT02694978|541765808|FG001|Overall Study|Other-Unable to be reached|1|||
150171868|NCT02694978|541765807|FG000|Overall Study|Other-Protocol noncompliant|2|||
150171869|NCT02694978|541765808|FG001|Overall Study|Other-Protocol noncompliant|1|||
150171870|NCT02694978|541765807|FG000|Overall Study|Other-Personal reasons|3|||
150171871|NCT02694978|541765808|FG001|Overall Study|Other-Personal reasons|3|||
150171872|NCT02694978|541765807|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
150171873|NCT02694978|541765808|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
150171874|NCT01376089|541765810|FG000|Overall Study|Patient received no contrast media|3|||
150171875|NCT01376089|541765811|FG001|Overall Study|Patient received no contrast media|4|||
150171876|NCT00419094|541765814|FG000|Overall Study|Adverse Event|3|||
150171877|NCT00419094|541765815|FG001|Overall Study|Adverse Event|7|||
150171878|NCT00419094|541765814|FG000|Overall Study|Lack of Efficacy|1|||
150171879|NCT00419094|541765815|FG001|Overall Study|Lack of Efficacy|0|||
150171880|NCT00419094|541765814|FG000|Overall Study|Lost to Follow-up|0|||
150171881|NCT00419094|541765815|FG001|Overall Study|Lost to Follow-up|2|||
150171882|NCT00419094|541765814|FG000|Overall Study|Protocol Violation|1|||
150171883|NCT00419094|541765815|FG001|Overall Study|Protocol Violation|14|||
150171884|NCT00419094|541765814|FG000|Overall Study|Withdrawal of consent|1|||
150171885|NCT00419094|541765815|FG001|Overall Study|Withdrawal of consent|5|||
150171886|NCT00419094|541765814|FG000|Overall Study|Other: Error determining exit criteria|1|||
150171887|NCT00419094|541765815|FG001|Overall Study|Other: Error determining exit criteria|0|||
150171888|NCT00419094|541765814|FG000|Overall Study|Other: Patient non-compliant|0|||
150171889|NCT00419094|541765815|FG001|Overall Study|Other: Patient non-compliant|1|||
150171890|NCT00419094|541765814|FG000|Overall Study|Other: No contact for extended period|0|||
150171891|NCT00419094|541765815|FG001|Overall Study|Other: No contact for extended period|1|||
150171892|NCT01811706|541765816|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
150171893|NCT01811706|541765817|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
149837158|NCT01796171|540537742|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
149837159|NCT01796171|540537743|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
149837160|NCT01796171|540537744|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
149837161|NCT01796171|540537745|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
149837162|NCT01796171|540537746|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
149837163|NCT01796171|540537747|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
149837164|NCT01796171|540537748|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
149837165|NCT01796171|540537749|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
150034542|NCT00313014|541266455|FG002|Overall Study|Adverse Event|16|||
150034543|NCT00313014|541266453|FG000|Overall Study|Lost to Follow-up|7|||
150034544|NCT00313014|541266454|FG001|Overall Study|Lost to Follow-up|6|||
150034545|NCT00313014|541266455|FG002|Overall Study|Lost to Follow-up|10|||
149837166|NCT01796171|540537750|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
149949656|NCT02900976|540947795|FG000|Overall Study|Adverse Event|0|||
149949657|NCT02900976|540947796|FG001|Overall Study|Adverse Event|1|||
149949658|NCT02900976|540947795|FG000|Overall Study|Physician Decision|0|||
149949659|NCT02900976|540947796|FG001|Overall Study|Physician Decision|2|||
149949660|NCT02900976|540947795|FG000|Overall Study|Progressive disease|0|||
149949661|NCT02900976|540947796|FG001|Overall Study|Progressive disease|6|||
150034546|NCT00313014|541266453|FG000|Overall Study|Administrative|9|||
150171894|NCT03020745|541765820|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
149949666|NCT02360579|540947800|FG000|Initial|Death|16|||
149949667|NCT02360579|540947801|FG001|Initial|Death|49|||
149949668|NCT02360579|540947802|FG002|Initial|Death|0|||
149949669|NCT02360579|540947803|FG003|Initial|Death|71|||
149949670|NCT02360579|540947800|FG000|Initial|Lost to Follow-up|0|||
149949671|NCT02360579|540947801|FG001|Initial|Lost to Follow-up|4|||
150034547|NCT00313014|541266454|FG001|Overall Study|Administrative|6|||
150034548|NCT00313014|541266455|FG002|Overall Study|Administrative|14|||
150034549|NCT00313014|541266453|FG000|Overall Study|Lack of Efficacy|52|||
150171895|NCT03020745|541765821|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171896|NCT03020745|541765822|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171897|NCT03020745|541765823|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171898|NCT03020745|541765824|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171899|NCT03020745|541765825|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171900|NCT03020745|541765826|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171901|NCT03020745|541765827|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171902|NCT03020745|541765828|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
150171903|NCT03020745|541765829|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
150171904|NCT03020745|541765820|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171905|NCT03020745|541765821|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171906|NCT03020745|541765822|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171907|NCT03020745|541765823|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171908|NCT03020745|541765824|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171909|NCT03020745|541765825|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171910|NCT03020745|541765826|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171911|NCT03020745|541765827|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
150171912|NCT03020745|541765828|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171913|NCT03020745|541765829|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
150171914|NCT03020745|541765820|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171915|NCT03020745|541765821|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171916|NCT03020745|541765822|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171917|NCT03020745|541765823|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171918|NCT03020745|541765824|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171919|NCT03020745|541765825|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
150171920|NCT03020745|541765826|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171921|NCT03020745|541765827|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171922|NCT03020745|541765828|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
150171923|NCT03020745|541765829|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
150171924|NCT03020745|541765820|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171925|NCT03020745|541765821|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171926|NCT03020745|541765822|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150281755|NCT01230307|542168722|FG001|Overall Study|LVAD Placement|2|||
150281756|NCT00122681|542168726|FG000|Overall Study|Adverse Event|20|||
150281757|NCT00122681|542168727|FG001|Overall Study|Adverse Event|16|||
150281758|NCT00122681|542168726|FG000|Overall Study|Lost to Follow-up|1080|||
150281759|NCT00122681|542168727|FG001|Overall Study|Lost to Follow-up|1097|||
150281760|NCT00122681|542168726|FG000|Overall Study|Protocol Violation|7|||
150281761|NCT00122681|542168727|FG001|Overall Study|Protocol Violation|10|||
150281762|NCT00122681|542168726|FG000|Overall Study|Withdrawal by Subject|257|||
150281763|NCT00122681|542168727|FG001|Overall Study|Withdrawal by Subject|251|||
150281764|NCT00122681|542168726|FG000|Overall Study|Personal reasons|150|||
150281765|NCT00122681|542168727|FG001|Overall Study|Personal reasons|147|||
150281766|NCT02256540|542168729|FG000|Overall Study|Withdrawal by Subject|0|||
150281767|NCT02256540|542168730|FG001|Overall Study|Withdrawal by Subject|1|||
150281768|NCT02256540|542168731|FG002|Overall Study|Withdrawal by Subject|1|||
150281769|NCT02256540|542168729|FG000|Overall Study|Back pain preventing exercise|0|||
150281770|NCT02256540|542168730|FG001|Overall Study|Back pain preventing exercise|0|||
150281771|NCT02256540|542168731|FG002|Overall Study|Back pain preventing exercise|1|||
150281772|NCT01230242|542168732|FG000|Overall Study|Physician Decision|2|||
150281773|NCT01230242|542168732|FG000|Overall Study|Withdrawal by Subject|1|||
150281774|NCT03923426|542168735|FG000|Overall Study|Other|19|||
150281775|NCT03923426|542168735|FG000|Overall Study|Lost to Follow-up|16|||
150281776|NCT03923426|542168735|FG000|Overall Study|Death|107|||
150281777|NCT03923426|542168735|FG000|Overall Study|Incomplete response to question|13|||
150281778|NCT01476475|542168736|FG000|Overall Study|Adverse Event|6|||
150281779|NCT01476475|542168737|FG001|Overall Study|Adverse Event|0|||
150281780|NCT01476475|542168736|FG000|Overall Study|Poor compliance to protocol|1|||
150281781|NCT01476475|542168737|FG001|Overall Study|Poor compliance to protocol|1|||
150281782|NCT01476475|542168736|FG000|Overall Study|Other reasons|4|||
150281783|NCT01476475|542168737|FG001|Overall Study|Other reasons|2|||
150281784|NCT00751400|542168738|FG000|Overall Study|Lost to Follow-up|10|||
150281785|NCT01918007|542168742|FG000|Overall Study|Baseline oximetry not acceptable|11|||
150281786|NCT01918007|542168743|FG001|Overall Study|Baseline oximetry not acceptable|7|||
150281787|NCT01918007|542168742|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
150281788|NCT01918007|542168743|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
150281789|NCT01918007|542168742|FG000|Overall Study|Lost to Follow-up|4|||
150281790|NCT01918007|542168743|FG001|Overall Study|Lost to Follow-up|7|||
150281791|NCT00441974|542168745|FG000|Overall Study|Adverse Event|6|||
150281792|NCT00441974|542168745|FG000|Overall Study|Consent Withdrawn|35|||
150281793|NCT00441974|542168745|FG000|Overall Study|Lost to Follow-up|80|||
150281794|NCT00441974|542168745|FG000|Overall Study|Protocol Violation|7|||
150281795|NCT04206020|542168748|FG000|Overall Study|Adverse Event|1|||
150281796|NCT04206020|542168749|FG001|Overall Study|Adverse Event|4|||
150281797|NCT04206020|542168748|FG000|Overall Study|Protocol Violation|2|||
150281798|NCT04206020|542168749|FG001|Overall Study|Protocol Violation|0|||
150281799|NCT04206020|542168748|FG000|Overall Study|Withdrawal by Subject|2|||
150281800|NCT04206020|542168749|FG001|Overall Study|Withdrawal by Subject|0|||
150281801|NCT04206020|542168748|FG000|Overall Study|Lost to Follow-up|2|||
150281802|NCT04206020|542168749|FG001|Overall Study|Lost to Follow-up|0|||
150281803|NCT04206020|542168748|FG000|Overall Study|Pregnancy|0|||
150281804|NCT04206020|542168749|FG001|Overall Study|Pregnancy|1|||
150281805|NCT04206020|542168748|FG000|Overall Study|Unable to attend visits|1|||
150281806|NCT04206020|542168749|FG001|Overall Study|Unable to attend visits|2|||
150281807|NCT02700412|542168750|FG000|Overall Study|Adverse Event|6|||
150281808|NCT02700412|542168750|FG000|Overall Study|Death|1|||
150281809|NCT02700412|542168750|FG000|Overall Study|Lack of Efficacy|19|||
150281810|NCT02700412|542168750|FG000|Overall Study|Protocol Violation|5|||
150281811|NCT02700412|542168750|FG000|Overall Study|Withdrawal by Subject|2|||
150281812|NCT00530270|542168752|FG000|Overall Study|Protocol Violation|1|||
150281813|NCT00530270|542168753|FG001|Overall Study|Protocol Violation|0|||
150281814|NCT01923285|542168756|FG000|Overall Study|Withdrawal by Subject|7|||
150281815|NCT01923285|542168757|FG001|Overall Study|Withdrawal by Subject|6|||
150281816|NCT03374189|542168759|FG000|Overall Study|Lost to Follow-up|1|||
150281817|NCT03374189|542168760|FG001|Overall Study|Lost to Follow-up|0|||
150281818|NCT01356407|542168763|FG000|Overall Study|Lost to Follow-up|2|||
150281819|NCT01356407|542168764|FG001|Overall Study|Lost to Follow-up|0|||
150281820|NCT01356407|542168763|FG000|Overall Study|Patient Withdrew Consent|2|||
150281821|NCT01356407|542168764|FG001|Overall Study|Patient Withdrew Consent|1|||
150281822|NCT01356407|542168763|FG000|Overall Study|Could not afford IMP administration|0|||
150281823|NCT01356407|542168764|FG001|Overall Study|Could not afford IMP administration|1|||
150281824|NCT01356407|542168763|FG000|Overall Study|Not complete Endoscopy|2|||
150281825|NCT01356407|542168764|FG001|Overall Study|Not complete Endoscopy|2|||
150281826|NCT01309659|542168767|FG000|Overall Study|Protocol Violation|0|||
150281827|NCT01309659|542168768|FG001|Overall Study|Protocol Violation|1|||
150281828|NCT02018822|542168769|FG000|Overall Study|filling replaced by crown|0|||
150281829|NCT02018822|542168770|FG001|Overall Study|filling replaced by crown|1|||
150281830|NCT02018822|542168771|FG002|Overall Study|filling replaced by crown|0|||
150281831|NCT02018822|542168769|FG000|Overall Study|Physician Decision|0|||
150281832|NCT02018822|542168770|FG001|Overall Study|Physician Decision|1|||
150281833|NCT02018822|542168771|FG002|Overall Study|Physician Decision|1|||
150281834|NCT02018822|542168769|FG000|Overall Study|Lost to Follow-up|6|||
150281835|NCT02018822|542168770|FG001|Overall Study|Lost to Follow-up|6|||
150281836|NCT02018822|542168771|FG002|Overall Study|Lost to Follow-up|5|||
150281837|NCT02285777|542168772|FG000|Overall Study|Withdrawal by Subject|1|||
150281838|NCT02285777|542168773|FG001|Overall Study|Withdrawal by Subject|1|||
150281839|NCT02285777|542168772|FG000|Overall Study|Lost to Follow-up|4|||
150281840|NCT02285777|542168773|FG001|Overall Study|Lost to Follow-up|2|||
150281841|NCT03201458|542168774|FG000|Overall Study|No longer eligible|2|||
150281842|NCT03201458|542168775|FG001|Overall Study|No longer eligible|5|||
150281843|NCT03201458|542168774|FG000|Overall Study|Health event before starting|1|||
150281844|NCT03201458|542168775|FG001|Overall Study|Health event before starting|0|||
150281845|NCT03201458|542168774|FG000|Overall Study|Physician Decision|1|||
150281846|NCT03201458|542168775|FG001|Overall Study|Physician Decision|0|||
150281847|NCT00715026|542168778|FG000|Overall Study|Withdrawal by Subject|5|||
150281848|NCT00715026|542168778|FG000|Overall Study|Lost to Follow-up|3|||
150281849|NCT00715026|542168778|FG000|Overall Study|Protocol Violation|1|||
150281850|NCT00715026|542168778|FG000|Overall Study|Surgery done on non-study consented hip|1|||
150281851|NCT00552175|542168779|FG000|Overall Study|Lack of Efficacy|2|||
150281852|NCT00552175|542168780|FG001|Overall Study|Lack of Efficacy|0|||
150281853|NCT00552175|542168781|FG002|Overall Study|Lack of Efficacy|1|||
150281854|NCT00552175|542168779|FG000|Overall Study|Adverse Event|9|||
150281855|NCT00552175|542168780|FG001|Overall Study|Adverse Event|9|||
150281856|NCT00552175|542168781|FG002|Overall Study|Adverse Event|10|||
150281857|NCT00552175|542168779|FG000|Overall Study|Withdrawal by Subject|2|||
150281858|NCT00552175|542168780|FG001|Overall Study|Withdrawal by Subject|2|||
150281859|NCT00552175|542168781|FG002|Overall Study|Withdrawal by Subject|1|||
150281860|NCT00552175|542168779|FG000|Overall Study|Lost to Follow-up|0|||
150281861|NCT00552175|542168780|FG001|Overall Study|Lost to Follow-up|0|||
150281862|NCT00552175|542168781|FG002|Overall Study|Lost to Follow-up|1|||
150281863|NCT00552175|542168779|FG000|Overall Study|Entry Criteria Not Met|1|||
150281864|NCT00552175|542168780|FG001|Overall Study|Entry Criteria Not Met|1|||
150281865|NCT00552175|542168781|FG002|Overall Study|Entry Criteria Not Met|0|||
150281866|NCT00552175|542168779|FG000|Overall Study|Reason Not Specified|3|||
150281867|NCT00552175|542168780|FG001|Overall Study|Reason Not Specified|1|||
150281868|NCT00552175|542168781|FG002|Overall Study|Reason Not Specified|1|||
150281869|NCT00750737|542168782|FG000|Overall Study|Withdrawal by Subject|3|||
150281870|NCT00750737|542168783|FG001|Overall Study|Withdrawal by Subject|3|||
150281871|NCT01389752|542168785|FG000|Study Period 1|Sponsor decision|0|||
150281872|NCT01389752|542168786|FG001|Study Period 1|Sponsor decision|2|||
150281873|NCT01389752|542168785|FG000|Study Period 2|Sponsor decision|1|||
150281874|NCT01389752|542168786|FG001|Study Period 2|Sponsor decision|0|||
150281875|NCT03259074|542168787|FG000|Overall Study|Adverse Event|9|||
150281876|NCT03259074|542168788|FG001|Overall Study|Adverse Event|12|||
150281877|NCT03259074|542168789|FG002|Overall Study|Adverse Event|8|||
150281878|NCT03259074|542168787|FG000|Overall Study|Death|1|||
150281879|NCT03259074|542168788|FG001|Overall Study|Death|1|||
150281880|NCT03259074|542168789|FG002|Overall Study|Death|3|||
150281881|NCT03259074|542168787|FG000|Overall Study|Lost to Follow-up|2|||
150281882|NCT03259074|542168788|FG001|Overall Study|Lost to Follow-up|4|||
150281883|NCT03259074|542168789|FG002|Overall Study|Lost to Follow-up|3|||
150281884|NCT03259074|542168787|FG000|Overall Study|New Therapy For Study Indication|1|||
150281885|NCT03259074|542168788|FG001|Overall Study|New Therapy For Study Indication|2|||
150281886|NCT03259074|542168789|FG002|Overall Study|New Therapy For Study Indication|2|||
150281887|NCT03259074|542168787|FG000|Overall Study|Physician Decision|4|||
150281888|NCT03259074|542168788|FG001|Overall Study|Physician Decision|12|||
150281889|NCT03259074|542168789|FG002|Overall Study|Physician Decision|10|||
150281890|NCT03259074|542168787|FG000|Overall Study|Pregnancy|1|||
150281891|NCT03259074|542168788|FG001|Overall Study|Pregnancy|1|||
150281892|NCT03259074|542168789|FG002|Overall Study|Pregnancy|0|||
150281893|NCT03259074|542168787|FG000|Overall Study|Progressive Disease|1|||
149949672|NCT02360579|540947802|FG002|Initial|Lost to Follow-up|0|||
149949673|NCT02360579|540947803|FG003|Initial|Lost to Follow-up|1|||
150281894|NCT03259074|542168788|FG001|Overall Study|Progressive Disease|0|||
150281895|NCT03259074|542168789|FG002|Overall Study|Progressive Disease|0|||
150281896|NCT03259074|542168787|FG000|Overall Study|Protocol Deviation|1|||
150281897|NCT03259074|542168788|FG001|Overall Study|Protocol Deviation|1|||
150281898|NCT03259074|542168789|FG002|Overall Study|Protocol Deviation|3|||
150281899|NCT03259074|542168787|FG000|Overall Study|Subject/Guardian Decision|13|||
150281900|NCT03259074|542168788|FG001|Overall Study|Subject/Guardian Decision|16|||
150281901|NCT03259074|542168789|FG002|Overall Study|Subject/Guardian Decision|14|||
150281902|NCT02184195|542168790|FG000|Overall Study|Patient decision|5|||
150281903|NCT02184195|542168791|FG001|Overall Study|Patient decision|2|||
150281904|NCT02184195|542168790|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150281905|NCT02184195|542168791|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
150281906|NCT02184195|542168790|FG000|Overall Study|Death|67|||
150281907|NCT02184195|542168791|FG001|Overall Study|Death|44|||
150281908|NCT02184195|542168790|FG000|Overall Study|Lost to Follow-up|1|||
150281909|NCT02184195|542168791|FG001|Overall Study|Lost to Follow-up|5|||
150281910|NCT02184195|542168790|FG000|Overall Study|Other|0|||
150281911|NCT02184195|542168791|FG001|Overall Study|Other|3|||
150281912|NCT01056510|542168794|FG000|Overall Study|Dropout Before Start of Treatment|1|||
150281913|NCT01056510|542168795|FG001|Overall Study|Dropout Before Start of Treatment|1|||
150281914|NCT01056510|542168794|FG000|Overall Study|Withdrawal by Subject|4|||
150281915|NCT01056510|542168795|FG001|Overall Study|Withdrawal by Subject|2|||
150281916|NCT01056510|542168794|FG000|Overall Study|Death|29|||
150281917|NCT01056510|542168795|FG001|Overall Study|Death|34|||
150281918|NCT01056510|542168794|FG000|Overall Study|Noncompliance|1|||
150281919|NCT01056510|542168795|FG001|Overall Study|Noncompliance|3|||
150281920|NCT01056510|542168794|FG000|Overall Study|Physician Decision|4|||
150281921|NCT01056510|542168795|FG001|Overall Study|Physician Decision|5|||
150281922|NCT01056510|542168794|FG000|Overall Study|Lost to Follow-up|5|||
150281923|NCT01056510|542168795|FG001|Overall Study|Lost to Follow-up|6|||
150281924|NCT01056510|542168794|FG000|Overall Study|Other|10|||
150281925|NCT01056510|542168795|FG001|Overall Study|Other|12|||
150281926|NCT01056510|542168794|FG000|Overall Study|Missing|0|||
150281927|NCT01056510|542168795|FG001|Overall Study|Missing|1|||
150281928|NCT02285998|542168796|FG000|Overall Study|Adverse Event|9|||
150281929|NCT02285998|542168797|FG001|Overall Study|Adverse Event|8|||
150281930|NCT02285998|542168796|FG000|Overall Study|Physician Decision|1|||
150281931|NCT02285998|542168797|FG001|Overall Study|Physician Decision|2|||
150281932|NCT02285998|542168796|FG000|Overall Study|Lost to Follow-up|176|||
150281933|NCT02285998|542168797|FG001|Overall Study|Lost to Follow-up|172|||
150281934|NCT02285998|542168796|FG000|Overall Study|Withdrawal by Subject|53|||
150281935|NCT02285998|542168797|FG001|Overall Study|Withdrawal by Subject|61|||
150281936|NCT02285998|542168796|FG000|Overall Study|Other Reasons|7|||
150281937|NCT02285998|542168797|FG001|Overall Study|Other Reasons|10|||
150281938|NCT00545298|542168798|FG000|Overall Study|Issues with Standard of Care|2|||
150281939|NCT00545298|542168799|FG001|Overall Study|Issues with Standard of Care|0|||
150281940|NCT00545298|542168800|FG002|Overall Study|Issues with Standard of Care|1|||
150281941|NCT03029143|542168806|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
150281942|NCT03029143|542168807|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
150281943|NCT03029143|542168808|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
150281944|NCT03029143|542168806|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
150281945|NCT03029143|542168807|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
150281946|NCT03029143|542168808|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
150281947|NCT03029143|542168806|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
150281948|NCT03029143|542168807|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
150281949|NCT03029143|542168808|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
150281950|NCT03029143|542168806|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
150281951|NCT03029143|542168807|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
150281952|NCT03029143|542168808|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
150281953|NCT03029143|542168806|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
150281954|NCT03029143|542168807|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
150281955|NCT03029143|542168808|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
150281956|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
150281957|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
150281958|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
150281959|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
150281960|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
150281961|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
150281962|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
150281963|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
150281964|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
150281965|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
149837167|NCT01796171|540537736|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
150281966|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
150281967|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
150281968|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
150281969|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
149837168|NCT01796171|540537737|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837169|NCT01796171|540537738|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
150281970|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
150281971|NCT03029143|542168806|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
150281972|NCT03029143|542168807|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
149837170|NCT01796171|540537739|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837171|NCT01796171|540537740|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837172|NCT01796171|540537741|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837173|NCT01796171|540537742|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837174|NCT01796171|540537743|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
150281973|NCT03029143|542168808|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
150281974|NCT00974675|542168811|FG000|Overall Study|Adverse Event|2|||
150281975|NCT00974675|542168812|FG001|Overall Study|Adverse Event|1|||
150281976|NCT00974675|542168813|FG002|Overall Study|Adverse Event|1|||
150281977|NCT00974675|542168814|FG003|Overall Study|Adverse Event|1|||
150281978|NCT00974675|542168811|FG000|Overall Study|Physician Decision|0|||
150281979|NCT00974675|542168812|FG001|Overall Study|Physician Decision|0|||
150281980|NCT00974675|542168813|FG002|Overall Study|Physician Decision|1|||
150281981|NCT00974675|542168814|FG003|Overall Study|Physician Decision|0|||
150034550|NCT00313014|541266454|FG001|Overall Study|Lack of Efficacy|25|||
150034551|NCT00313014|541266455|FG002|Overall Study|Lack of Efficacy|16|||
150171927|NCT03020745|541765823|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150281982|NCT00974675|542168811|FG000|Overall Study|Participant on holiday; unable to attend|0|||
150281983|NCT00974675|542168812|FG001|Overall Study|Participant on holiday; unable to attend|0|||
150281984|NCT00974675|542168813|FG002|Overall Study|Participant on holiday; unable to attend|0|||
150281985|NCT00974675|542168814|FG003|Overall Study|Participant on holiday; unable to attend|1|||
150281986|NCT01394627|542168815|FG000|First Intervention (1 Day)|poor intravenous access|0|||
150281987|NCT01394627|542168816|FG001|First Intervention (1 Day)|poor intravenous access|1|||
150281988|NCT01394627|542168815|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
150281989|NCT01394627|542168816|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
150281990|NCT04744207|542168817|FG000|Treatment|Withdrawal by Subject|2|||
150281991|NCT04744207|542168818|FG001|Treatment|Withdrawal by Subject|0|||
150281992|NCT04744207|542168817|FG000|Treatment|Adverse Event|1|||
150281993|NCT04744207|542168818|FG001|Treatment|Adverse Event|2|||
150281994|NCT01617070|542168819|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
150281995|NCT04544475|542168825|FG000|Overall Study|Withdrawal by Subject|1|||
150281996|NCT04544475|542168826|FG001|Overall Study|Withdrawal by Subject|3|||
150281997|NCT00808236|542168827|FG000|Overall Study|Was not resuscitated|50|||
150281998|NCT00808236|542168828|FG001|Overall Study|Was not resuscitated|56|||
150281999|NCT00808236|542168827|FG000|Overall Study|Pre-defined exclusion|13|||
150282000|NCT00808236|542168828|FG001|Overall Study|Pre-defined exclusion|3|||
150282001|NCT00808236|542168827|FG000|Overall Study|Lost to Follow-up|1|||
150282002|NCT00808236|542168828|FG001|Overall Study|Lost to Follow-up|1|||
150282003|NCT00808236|542168827|FG000|Overall Study|Physician Decision|0|||
150282004|NCT00808236|542168828|FG001|Overall Study|Physician Decision|1|||
150282005|NCT00808236|542168827|FG000|Overall Study|Death|18|||
150282006|NCT00808236|542168828|FG001|Overall Study|Death|30|||
150282007|NCT00777101|542168829|FG000|Overall Study|Death|48|||
150282008|NCT00777101|542168830|FG001|Overall Study|Death|43|||
150282009|NCT00777101|542168829|FG000|Overall Study|Withdrawal by Subject|11|||
150282010|NCT00777101|542168830|FG001|Overall Study|Withdrawal by Subject|6|||
149949674|NCT02360579|540947800|FG000|Initial|Withdrawal by Subject|0|||
149949675|NCT02360579|540947801|FG001|Initial|Withdrawal by Subject|0|||
149949676|NCT02360579|540947802|FG002|Initial|Withdrawal by Subject|0|||
149949677|NCT02360579|540947803|FG003|Initial|Withdrawal by Subject|3|||
149949678|NCT02360579|540947800|FG000|Initial|Other|7|||
149949679|NCT02360579|540947801|FG001|Initial|Other|0|||
149949680|NCT02360579|540947802|FG002|Initial|Other|0|||
149949681|NCT02360579|540947803|FG003|Initial|Other|0|||
149949682|NCT02360579|540947800|FG000|Initial|Did not receive TIL|8|||
149949683|NCT02360579|540947801|FG001|Initial|Did not receive TIL|11|||
149949684|NCT02360579|540947802|FG002|Initial|Did not receive TIL|0|||
149949685|NCT02360579|540947803|FG003|Initial|Did not receive TIL|22|||
149949686|NCT02360579|540947800|FG000|Retreatment|Death|0|||
149949687|NCT02360579|540947801|FG001|Retreatment|Death|0|||
149949688|NCT02360579|540947802|FG002|Retreatment|Death|11|||
149949689|NCT02360579|540947803|FG003|Retreatment|Death|0|||
150034552|NCT00371150|541266457|FG000|Overall Study|Lost to Follow-up|3|||
150171928|NCT03020745|541765824|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171929|NCT03020745|541765825|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171930|NCT03020745|541765826|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171931|NCT03020745|541765827|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171932|NCT03020745|541765828|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
150171933|NCT03020745|541765829|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
150171934|NCT00743444|541765830|FG000|First Intervention|Catheter placement problems|0|||
150171935|NCT00743444|541765831|FG001|First Intervention|Catheter placement problems|1|||
150171936|NCT00743444|541765830|FG000|Washout Period|Adverse Event|0|||
150171937|NCT00743444|541765831|FG001|Washout Period|Adverse Event|1|||
150171938|NCT00807144|541765834|FG000|Overall Study|Lost to Follow-up|0|||
150171939|NCT00807144|541765835|FG001|Overall Study|Lost to Follow-up|1|||
150171940|NCT02567656|541765839|FG000|Overall Study|Premature discontinuation due to PD|1|||
150171941|NCT02567656|541765840|FG001|Overall Study|Premature discontinuation due to PD|1|||
150171942|NCT02567656|541765841|FG002|Overall Study|Premature discontinuation due to PD|2|||
150171943|NCT02567656|541765842|FG003|Overall Study|Premature discontinuation due to PD|0|||
150171944|NCT02567656|541765843|FG004|Overall Study|Premature discontinuation due to PD|0|||
150282011|NCT00777101|542168829|FG000|Overall Study|Lost to Follow-up|2|||
150282012|NCT00777101|542168830|FG001|Overall Study|Lost to Follow-up|1|||
150282013|NCT00777101|542168829|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
150282014|NCT00777101|542168830|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
150282015|NCT00777101|542168829|FG000|Overall Study|Failed to Return|0|||
150282016|NCT00777101|542168830|FG001|Overall Study|Failed to Return|1|||
150282017|NCT00961220|542168831|FG000|Overall Study|Adverse Event|3|||
150282018|NCT00961220|542168831|FG000|Overall Study|Lack of Efficacy|1|||
150282019|NCT00961220|542168831|FG000|Overall Study|No IV access for O6BG|1|||
150282020|NCT00961220|542168831|FG000|Overall Study|O6BG no longer supplied|1|||
150282021|NCT00961220|542168831|FG000|Overall Study|Complete Response prior to 12 courses|1|||
150282022|NCT05376215|542168832|FG000|Overall Study|Withdrawal by Subject|2|||
150282023|NCT05376215|542168833|FG001|Overall Study|Withdrawal by Subject|1|||
150282024|NCT05376215|542168832|FG000|Overall Study|Lost to Follow-up|0|||
150282025|NCT05376215|542168833|FG001|Overall Study|Lost to Follow-up|1|||
150282026|NCT00282334|542168836|FG000|Overall Study|Withdrawal by Subject|8|||
150282027|NCT00282334|542168837|FG001|Overall Study|Withdrawal by Subject|5|||
150282028|NCT01301950|542168842|FG000|Overall Study|Surgery was cancelled by patient|0|||
150282029|NCT01301950|542168843|FG001|Overall Study|Surgery was cancelled by patient|1|||
150282030|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
150282031|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
150282032|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
150282033|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
150282034|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
150282035|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
150282036|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
150282037|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
150282038|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
150282039|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
150282040|NCT04041284|542168844|FG000|DB Phase (12 Weeks)|Other than specified|1|||
150282041|NCT04041284|542168845|FG001|DB Phase (12 Weeks)|Other than specified|0|||
150282042|NCT04041284|542168844|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
150282043|NCT04041284|542168845|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
150282044|NCT04041284|542168844|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
150282045|NCT04041284|542168845|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
150282046|NCT04041284|542168844|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
150282047|NCT04041284|542168845|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
150282048|NCT04041284|542168844|FG000|OL Phase (12 Weeks)|Other than specified|6|||
150282049|NCT04041284|542168845|FG001|OL Phase (12 Weeks)|Other than specified|2|||
150282050|NCT00825162|542168846|FG000|Overall Study|Withdrawal by Subject|11|||
150282051|NCT00825162|542168847|FG001|Overall Study|Withdrawal by Subject|13|||
150282052|NCT00825162|542168848|FG002|Overall Study|Withdrawal by Subject|3|||
150282053|NCT00825162|542168846|FG000|Overall Study|Lost to Follow-up|9|||
150282054|NCT00825162|542168847|FG001|Overall Study|Lost to Follow-up|6|||
150282055|NCT00825162|542168848|FG002|Overall Study|Lost to Follow-up|3|||
150282056|NCT00825162|542168846|FG000|Overall Study|Physician Decision|2|||
150282057|NCT00825162|542168847|FG001|Overall Study|Physician Decision|0|||
150282058|NCT00825162|542168848|FG002|Overall Study|Physician Decision|0|||
150282059|NCT00825162|542168846|FG000|Overall Study|Move away from the study area|1|||
150282060|NCT00825162|542168847|FG001|Overall Study|Move away from the study area|0|||
150282061|NCT00825162|542168848|FG002|Overall Study|Move away from the study area|0|||
150282062|NCT00825162|542168846|FG000|Overall Study|Unable to attend the study visit|5|||
150282063|NCT00825162|542168847|FG001|Overall Study|Unable to attend the study visit|2|||
150282064|NCT00825162|542168848|FG002|Overall Study|Unable to attend the study visit|0|||
150282065|NCT02037295|542170300|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
150282066|NCT02037295|542170301|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
150282067|NCT02037295|542170302|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
150282068|NCT02037295|542170303|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
150282069|NCT01140451|542170304|FG000|Overall Study|Withdrawal by Subject|26|||
150282070|NCT01140451|542170305|FG001|Overall Study|Withdrawal by Subject|33|||
150282071|NCT01140451|542170304|FG000|Overall Study|Adverse Event|2|||
150282072|NCT01140451|542170305|FG001|Overall Study|Adverse Event|6|||
150282073|NCT01140451|542170304|FG000|Overall Study|Physician Decision|5|||
150282074|NCT01140451|542170305|FG001|Overall Study|Physician Decision|3|||
150282075|NCT01140451|542170304|FG000|Overall Study|Lost to Follow-up|2|||
150282076|NCT01140451|542170305|FG001|Overall Study|Lost to Follow-up|0|||
150282077|NCT01140451|542170304|FG000|Overall Study|Participants Planning Pregnancy|3|||
150282078|NCT01140451|542170305|FG001|Overall Study|Participants Planning Pregnancy|0|||
150282079|NCT00661531|542170311|FG000|Overall Study|Withdrawal by Subject|3|||
150282080|NCT03134599|542170312|FG000|Week 1|Lost to Follow-up|0|||
150282081|NCT03134599|542170313|FG001|Week 1|Lost to Follow-up|0|||
150282082|NCT03134599|542170314|FG002|Week 1|Lost to Follow-up|0|||
150282083|NCT03134599|542170315|FG003|Week 1|Lost to Follow-up|0|||
150282084|NCT03134599|542170316|FG004|Week 1|Lost to Follow-up|1|||
150282085|NCT03134599|542170317|FG005|Week 1|Lost to Follow-up|0|||
150282086|NCT03134599|542170312|FG000|Week 2|Lost to Follow-up|1|||
150282087|NCT03134599|542170313|FG001|Week 2|Lost to Follow-up|0|||
150282088|NCT03134599|542170314|FG002|Week 2|Lost to Follow-up|0|||
150282089|NCT03134599|542170315|FG003|Week 2|Lost to Follow-up|1|||
150282090|NCT03134599|542170316|FG004|Week 2|Lost to Follow-up|1|||
150282091|NCT03134599|542170317|FG005|Week 2|Lost to Follow-up|0|||
150282092|NCT03134599|542170312|FG000|Week 3|Lost to Follow-up|0|||
150282093|NCT03134599|542170313|FG001|Week 3|Lost to Follow-up|0|||
150282094|NCT03134599|542170314|FG002|Week 3|Lost to Follow-up|0|||
150282095|NCT03134599|542170315|FG003|Week 3|Lost to Follow-up|1|||
150282096|NCT03134599|542170316|FG004|Week 3|Lost to Follow-up|0|||
150282097|NCT03134599|542170317|FG005|Week 3|Lost to Follow-up|1|||
150282098|NCT03962101|542170329|FG000|Overall Study|Adverse Event|1|||
150282099|NCT03962101|542170329|FG000|Overall Study|Physician Decision|2|||
150282100|NCT03962101|542170329|FG000|Overall Study|Not related to medical events|1|||
150282101|NCT02614859|542170330|FG000|Overall Study|Physician Decision|0|||
150282102|NCT02614859|542170331|FG001|Overall Study|Physician Decision|1|||
150282103|NCT00732303|542170332|FG000|Overall Study|Study Terminated|2|||
150282104|NCT01399788|542170341|FG000|First Intervention Period|Adverse Event|1|||
150282105|NCT01399788|542170342|FG001|First Intervention Period|Adverse Event|0|||
150282106|NCT02919436|542170344|FG000|Overall Study|Did not undergo surgery|16|||
150282107|NCT02919436|542170345|FG001|Overall Study|Did not undergo surgery|20|||
150282108|NCT02919436|542170344|FG000|Overall Study|Enrolled before trial registration|44|||
150282109|NCT02919436|542170345|FG001|Overall Study|Enrolled before trial registration|33|||
150282110|NCT00283595|542170346|FG000|Overall Study|Withdrawal by Subject|1|||
150282111|NCT00283595|542170347|FG001|Overall Study|Withdrawal by Subject|2|||
150282112|NCT03699007|542170351|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
150282113|NCT03699007|542170352|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
150282114|NCT03699007|542170351|FG000|6-month Follow Up|Lost to Follow-up|2|||
150282115|NCT03699007|542170352|FG001|6-month Follow Up|Lost to Follow-up|3|||
150282116|NCT04718974|542170353|FG000|Overall Study|Death|0|||
150282117|NCT04718974|542170354|FG001|Overall Study|Death|2|||
150282118|NCT04718974|542170353|FG000|Overall Study|Lost to Follow-up|10|||
150282119|NCT04718974|542170354|FG001|Overall Study|Lost to Follow-up|20|||
150282120|NCT04718974|542170353|FG000|Overall Study|Transferred out|2|||
150282121|NCT04718974|542170354|FG001|Overall Study|Transferred out|4|||
150282122|NCT00053417|542170365|FG000|Overall Study|Adverse Event|1|||
150282123|NCT00053417|542170366|FG001|Overall Study|Adverse Event|0|||
150282124|NCT00053417|542170367|FG002|Overall Study|Adverse Event|1|||
150282125|NCT00053417|542170368|FG003|Overall Study|Adverse Event|5|||
150282126|NCT00053417|542170365|FG000|Overall Study|Non-Compliance|0|||
150282127|NCT00053417|542170366|FG001|Overall Study|Non-Compliance|0|||
150282128|NCT00053417|542170367|FG002|Overall Study|Non-Compliance|0|||
149837175|NCT01796171|540537744|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
150282129|NCT00053417|542170368|FG003|Overall Study|Non-Compliance|1|||
150282130|NCT00053417|542170365|FG000|Overall Study|Withdrawal by Subject|0|||
150282131|NCT00053417|542170366|FG001|Overall Study|Withdrawal by Subject|1|||
150282132|NCT00053417|542170367|FG002|Overall Study|Withdrawal by Subject|0|||
150282133|NCT00053417|542170368|FG003|Overall Study|Withdrawal by Subject|0|||
150282134|NCT00053417|542170365|FG000|Overall Study|Lost to Follow-up|1|||
150282135|NCT00053417|542170366|FG001|Overall Study|Lost to Follow-up|1|||
150282136|NCT00053417|542170367|FG002|Overall Study|Lost to Follow-up|0|||
150282137|NCT00053417|542170368|FG003|Overall Study|Lost to Follow-up|0|||
150282138|NCT02409290|542170369|FG000|Overall Study|Protocol Violation|3|||
150282139|NCT02409290|542170370|FG001|Overall Study|Protocol Violation|6|||
150282140|NCT02409290|542170371|FG002|Overall Study|Protocol Violation|9|||
150282141|NCT02409290|542170372|FG003|Overall Study|Protocol Violation|4|||
149837176|NCT01796171|540537745|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837177|NCT01796171|540537746|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837178|NCT01796171|540537747|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837179|NCT01796171|540537748|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837180|NCT01796171|540537749|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
150282142|NCT02409290|542170369|FG000|Overall Study|No positive culture/no baseline sample|3|||
150282143|NCT02409290|542170370|FG001|Overall Study|No positive culture/no baseline sample|9|||
149837181|NCT01796171|540537750|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
149837182|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Progressive disease|0|||
149837183|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Progressive disease|1|||
149837184|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Progressive disease|0|||
150282144|NCT02409290|542170371|FG002|Overall Study|No positive culture/no baseline sample|6|||
150282145|NCT02409290|542170372|FG003|Overall Study|No positive culture/no baseline sample|5|||
150282146|NCT02409290|542170369|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
150282147|NCT02409290|542170370|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
150282148|NCT02409290|542170371|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
150282149|NCT02409290|542170372|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
150282150|NCT00705783|542170375|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
150282151|NCT00705783|542170376|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
150282152|NCT00705783|542170377|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
149837185|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Progressive disease|0|||
150282153|NCT00705783|542170375|FG000|Conversion Phase|Lost to Follow-up|13|||
150282154|NCT00705783|542170376|FG001|Conversion Phase|Lost to Follow-up|0|||
150282155|NCT00705783|542170377|FG002|Conversion Phase|Lost to Follow-up|0|||
150282156|NCT00705783|542170375|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
150282157|NCT00705783|542170376|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
150282158|NCT00705783|542170377|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
150282159|NCT00705783|542170375|FG000|Conversion Phase|Withdrawn by Investigator|4|||
150282160|NCT00705783|542170376|FG001|Conversion Phase|Withdrawn by Investigator|0|||
150282161|NCT00705783|542170377|FG002|Conversion Phase|Withdrawn by Investigator|0|||
150282162|NCT00705783|542170375|FG000|Conversion Phase|Withdrew Consent|24|||
150282163|NCT00705783|542170376|FG001|Conversion Phase|Withdrew Consent|0|||
150282164|NCT00705783|542170377|FG002|Conversion Phase|Withdrew Consent|0|||
150282165|NCT00705783|542170375|FG000|Conversion Phase|Protocol Deviation|2|||
150282166|NCT00705783|542170376|FG001|Conversion Phase|Protocol Deviation|0|||
150282167|NCT00705783|542170377|FG002|Conversion Phase|Protocol Deviation|0|||
150282168|NCT00705783|542170375|FG000|Conversion Phase|Adverse Event|11|||
150282169|NCT00705783|542170376|FG001|Conversion Phase|Adverse Event|0|||
150282170|NCT00705783|542170377|FG002|Conversion Phase|Adverse Event|0|||
150282171|NCT00705783|542170375|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
150282172|NCT00705783|542170376|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
150282173|NCT00705783|542170377|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
150282174|NCT00705783|542170375|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
150282175|NCT00705783|542170376|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
150282176|NCT00705783|542170377|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
150282177|NCT00705783|542170375|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
150282178|NCT00705783|542170376|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
150282179|NCT00705783|542170377|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
150282180|NCT00705783|542170375|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
150282181|NCT00705783|542170376|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
150282182|NCT00705783|542170377|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
150282183|NCT00705783|542170375|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
150282184|NCT00705783|542170376|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
150282185|NCT00705783|542170377|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
150282186|NCT00705783|542170375|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
150282187|NCT00705783|542170376|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
150282188|NCT00705783|542170377|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
150282189|NCT00705783|542170375|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
150282190|NCT00705783|542170376|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
150282191|NCT00705783|542170377|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
150282192|NCT00705783|542170375|FG000|Oral Stabilization Phase|Adverse Event|14|||
150282193|NCT00705783|542170376|FG001|Oral Stabilization Phase|Adverse Event|0|||
150282194|NCT00705783|542170377|FG002|Oral Stabilization Phase|Adverse Event|0|||
150282195|NCT00705783|542170375|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
150282196|NCT00705783|542170376|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150282197|NCT00705783|542170377|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150282198|NCT00705783|542170375|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
150282199|NCT00705783|542170376|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150282200|NCT00705783|542170377|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150282201|NCT00705783|542170375|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
150282202|NCT00705783|542170376|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
150282203|NCT00705783|542170377|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
150282204|NCT00705783|542170375|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
150282205|NCT00705783|542170376|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
150282206|NCT00705783|542170377|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
150282207|NCT00705783|542170375|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
150282208|NCT00705783|542170376|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
150282209|NCT00705783|542170377|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
150282210|NCT00705783|542170375|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
150282211|NCT00705783|542170376|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
150282212|NCT00705783|542170377|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
150282213|NCT00705783|542170375|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
150282214|NCT00705783|542170376|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
150282215|NCT00705783|542170377|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
150282216|NCT00705783|542170375|FG000|Depot Stabilization Phase|Adverse Event|17|||
150282217|NCT00705783|542170376|FG001|Depot Stabilization Phase|Adverse Event|0|||
150282218|NCT00705783|542170377|FG002|Depot Stabilization Phase|Adverse Event|0|||
150282219|NCT00705783|542170375|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
150282220|NCT00705783|542170376|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150282221|NCT00705783|542170377|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150282222|NCT00705783|542170375|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
150282223|NCT00705783|542170376|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150282224|NCT00705783|542170377|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150282225|NCT00705783|542170375|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
150282226|NCT00705783|542170376|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
149837186|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Progressive disease|0|||
149837187|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Progressive disease|0|||
149837188|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Progressive disease|0|||
149837189|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Progressive disease|0|||
149837190|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Progressive disease|0|||
149837191|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Progressive disease|0|||
149837192|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Progressive disease|0|||
149837193|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Progressive disease|0|||
149837194|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Progressive disease|0|||
149837195|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Progressive disease|0|||
149837196|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Progressive disease|0|||
149837197|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837198|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837199|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837200|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837201|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837202|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837203|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837204|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837205|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
149837206|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837207|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
149837208|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
149837209|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
150282227|NCT00705783|542170377|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
150282228|NCT00705783|542170375|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
150282229|NCT00705783|542170376|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
150282230|NCT00705783|542170377|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
150282231|NCT00705783|542170375|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
150282232|NCT00705783|542170376|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
150282233|NCT00705783|542170377|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
150282234|NCT00705783|542170375|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
150282235|NCT00705783|542170376|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
150282236|NCT00705783|542170377|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
150282237|NCT00705783|542170375|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
150282238|NCT00705783|542170376|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
150282239|NCT00705783|542170377|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
150282240|NCT00705783|542170375|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
150282241|NCT00705783|542170376|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
150282242|NCT00705783|542170377|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
150282243|NCT00705783|542170375|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
150282244|NCT00705783|542170376|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
150282245|NCT00705783|542170377|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
150282246|NCT00705783|542170375|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
150282247|NCT00705783|542170376|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
150282248|NCT00705783|542170377|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
150282249|NCT00705783|542170375|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
149837210|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837211|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
149837212|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Physician Decision|0|||
150282250|NCT00705783|542170376|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
150282251|NCT00705783|542170377|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
150282252|NCT02121262|542170381|FG000|Overall Study|Adverse Event|6|||
150282253|NCT02121262|542170382|FG001|Overall Study|Adverse Event|3|||
149837213|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Physician Decision|0|||
149837214|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Physician Decision|0|||
149837215|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Physician Decision|0|||
149837216|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Physician Decision|0|||
149837217|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Physician Decision|0|||
149837218|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Physician Decision|0|||
149837219|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Physician Decision|0|||
149837220|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Physician Decision|0|||
149837221|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Physician Decision|0|||
149837222|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Physician Decision|5|||
149837223|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Physician Decision|1|||
149837224|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Physician Decision|1|||
149837225|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Physician Decision|0|||
149837226|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Physician Decision|0|||
149837227|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Death|0|||
149837228|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Death|0|||
149837229|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Death|0|||
149837230|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Death|0|||
149837231|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Death|0|||
149837232|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Death|0|||
149837233|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Death|0|||
149837234|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Death|0|||
149837235|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Death|0|||
149837236|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Death|0|||
149837237|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Death|2|||
149837238|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Death|0|||
149837239|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Death|0|||
149837240|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Death|0|||
149837241|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Death|0|||
149837242|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
149837243|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
149837244|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
149837245|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
149837246|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
149837247|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
149837248|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
149837249|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
149837250|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
149837251|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
149837252|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
149837253|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
149837254|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
149837255|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
150034553|NCT00371150|541266458|FG001|Overall Study|Lost to Follow-up|2|||
150034554|NCT02345070|541266459|FG000|Overall Study|Adverse Event|12|||
150034555|NCT02345070|541266460|FG001|Overall Study|Adverse Event|8|||
150034556|NCT02345070|541266461|FG002|Overall Study|Adverse Event|16|||
150034557|NCT02345070|541266459|FG000|Overall Study|Poor compliance to protocol|2|||
150034558|NCT02345070|541266460|FG001|Overall Study|Poor compliance to protocol|0|||
150034559|NCT02345070|541266461|FG002|Overall Study|Poor compliance to protocol|0|||
150282254|NCT02121262|542170381|FG000|Overall Study|Lack of Efficacy|3|||
150282255|NCT02121262|542170382|FG001|Overall Study|Lack of Efficacy|0|||
150282256|NCT02121262|542170381|FG000|Overall Study|Personal Reasons|19|||
150034560|NCT02345070|541266459|FG000|Overall Study|Other than specified above|6|||
150034561|NCT02345070|541266460|FG001|Overall Study|Other than specified above|3|||
150282257|NCT02121262|542170382|FG001|Overall Study|Personal Reasons|5|||
150282258|NCT02121262|542170381|FG000|Overall Study|Protocol Violation|1|||
150282259|NCT02121262|542170382|FG001|Overall Study|Protocol Violation|1|||
149837256|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
149837257|NCT01796171|540537736|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837258|NCT01796171|540537737|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
150034562|NCT02345070|541266461|FG002|Overall Study|Other than specified above|7|||
149837259|NCT01796171|540537738|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837260|NCT01796171|540537739|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837261|NCT01796171|540537740|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837262|NCT01796171|540537741|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837263|NCT01796171|540537742|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837264|NCT01796171|540537743|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837265|NCT01796171|540537744|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837266|NCT01796171|540537745|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837267|NCT01796171|540537746|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
149837268|NCT01796171|540537747|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
149837269|NCT01796171|540537748|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837270|NCT01796171|540537749|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837271|NCT01796171|540537750|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
149837272|NCT01796171|540537736|FG000|Follow-up Period|Start of further anticancer therapy|4|||
149837273|NCT01796171|540537737|FG001|Follow-up Period|Start of further anticancer therapy|25|||
149837274|NCT01796171|540537738|FG002|Follow-up Period|Start of further anticancer therapy|2|||
149837275|NCT01796171|540537739|FG003|Follow-up Period|Start of further anticancer therapy|1|||
149837276|NCT01796171|540537740|FG004|Follow-up Period|Start of further anticancer therapy|2|||
149837277|NCT01796171|540537741|FG005|Follow-up Period|Start of further anticancer therapy|2|||
149837278|NCT01796171|540537742|FG006|Follow-up Period|Start of further anticancer therapy|1|||
149837279|NCT01796171|540537743|FG007|Follow-up Period|Start of further anticancer therapy|15|||
149837280|NCT01796171|540537744|FG008|Follow-up Period|Start of further anticancer therapy|2|||
149837281|NCT01796171|540537745|FG009|Follow-up Period|Start of further anticancer therapy|0|||
149837282|NCT01796171|540537746|FG010|Follow-up Period|Start of further anticancer therapy|0|||
149837283|NCT01796171|540537747|FG011|Follow-up Period|Start of further anticancer therapy|0|||
149837284|NCT01796171|540537748|FG012|Follow-up Period|Start of further anticancer therapy|0|||
149837285|NCT01796171|540537749|FG013|Follow-up Period|Start of further anticancer therapy|0|||
150282260|NCT02121262|542170381|FG000|Overall Study|Participant Dropped-out|0|||
150282261|NCT02121262|542170382|FG001|Overall Study|Participant Dropped-out|1|||
150282262|NCT02121262|542170381|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
150282263|NCT02121262|542170382|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
150282264|NCT02121262|542170381|FG000|Overall Study|Consent Withdrawn|1|||
150282265|NCT02121262|542170382|FG001|Overall Study|Consent Withdrawn|0|||
150282266|NCT01553188|542170385|FG000|Overall Study|Patient choice|1|||
150282267|NCT01553188|542170386|FG001|Overall Study|Patient choice|0|||
150282268|NCT01553188|542170387|FG002|Overall Study|Patient choice|0|||
150282269|NCT01553188|542170388|FG003|Overall Study|Patient choice|0|||
150282270|NCT01553188|542170385|FG000|Overall Study|Intercurrent illness and adverse event|0|||
150282271|NCT01553188|542170386|FG001|Overall Study|Intercurrent illness and adverse event|1|||
150282272|NCT01553188|542170387|FG002|Overall Study|Intercurrent illness and adverse event|2|||
149949717|NCT03682848|540947816|FG000|Overall Study|Withdrawal by Subject|3|||
149949718|NCT03682848|540947816|FG000|Overall Study|Site closed|5|||
149949719|NCT03682848|540947816|FG000|Overall Study|Protocol Deviation|1|||
150282273|NCT01553188|542170388|FG003|Overall Study|Intercurrent illness and adverse event|0|||
150282274|NCT02829138|542170390|FG000|Overall Study|Withdrawal by Subject|1|||
150282275|NCT02829138|542170391|FG001|Overall Study|Withdrawal by Subject|0|||
150282276|NCT05289570|542170398|FG000|Overall Study|Physician Decision|1|||
150282277|NCT03223428|542170399|FG000|Overall Study|No longer taking Xermelo|27|||
150282278|NCT03223428|542170399|FG000|Overall Study|Declined Consent|1|||
150282279|NCT03223428|542170399|FG000|Overall Study|Non-responders|56|||
149949720|NCT03682848|540947816|FG000|Overall Study|Adverse Event|2|||
149949721|NCT03682848|540947816|FG000|Overall Study|Lack of Efficacy|1|||
150282280|NCT03223428|542170399|FG000|Overall Study|Withdrawal by Subject|14|||
150282281|NCT02230384|542170401|FG000|Phase 1|Lost to Follow-up|1|||
150282282|NCT02230384|542170402|FG001|Phase 1|Lost to Follow-up|0|||
150282283|NCT02230384|542170401|FG000|Phase 1|Physician Decision|0|||
150282284|NCT02230384|542170402|FG001|Phase 1|Physician Decision|1|||
150282285|NCT02230384|542170401|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
149837286|NCT01796171|540537750|FG014|Follow-up Period|Start of further anticancer therapy|0|||
149837287|NCT01796171|540537736|FG000|Follow-up Period|Progressive disease|0|||
149837288|NCT01796171|540537737|FG001|Follow-up Period|Progressive disease|1|||
149837289|NCT01796171|540537738|FG002|Follow-up Period|Progressive disease|0|||
149837290|NCT01796171|540537739|FG003|Follow-up Period|Progressive disease|0|||
149837291|NCT01796171|540537740|FG004|Follow-up Period|Progressive disease|0|||
149837292|NCT01796171|540537741|FG005|Follow-up Period|Progressive disease|0|||
149837293|NCT01796171|540537742|FG006|Follow-up Period|Progressive disease|0|||
149837294|NCT01796171|540537743|FG007|Follow-up Period|Progressive disease|3|||
149837295|NCT01796171|540537744|FG008|Follow-up Period|Progressive disease|0|||
149837296|NCT01796171|540537745|FG009|Follow-up Period|Progressive disease|0|||
149837297|NCT01796171|540537746|FG010|Follow-up Period|Progressive disease|0|||
149837298|NCT01796171|540537747|FG011|Follow-up Period|Progressive disease|0|||
149837299|NCT01796171|540537748|FG012|Follow-up Period|Progressive disease|0|||
149837300|NCT01796171|540537749|FG013|Follow-up Period|Progressive disease|0|||
149837301|NCT01796171|540537750|FG014|Follow-up Period|Progressive disease|0|||
149837302|NCT01796171|540537736|FG000|Follow-up Period|Physician Decision|0|||
149837303|NCT01796171|540537737|FG001|Follow-up Period|Physician Decision|2|||
149837304|NCT01796171|540537738|FG002|Follow-up Period|Physician Decision|0|||
149837305|NCT01796171|540537739|FG003|Follow-up Period|Physician Decision|0|||
149837306|NCT01796171|540537740|FG004|Follow-up Period|Physician Decision|0|||
149837307|NCT01796171|540537741|FG005|Follow-up Period|Physician Decision|0|||
149837308|NCT01796171|540537742|FG006|Follow-up Period|Physician Decision|0|||
149837309|NCT01796171|540537743|FG007|Follow-up Period|Physician Decision|0|||
149837310|NCT01796171|540537744|FG008|Follow-up Period|Physician Decision|0|||
149837311|NCT01796171|540537745|FG009|Follow-up Period|Physician Decision|0|||
149837312|NCT01796171|540537746|FG010|Follow-up Period|Physician Decision|5|||
149837313|NCT01796171|540537747|FG011|Follow-up Period|Physician Decision|0|||
149837314|NCT01796171|540537748|FG012|Follow-up Period|Physician Decision|0|||
149837315|NCT01796171|540537749|FG013|Follow-up Period|Physician Decision|0|||
149837316|NCT01796171|540537750|FG014|Follow-up Period|Physician Decision|0|||
149837317|NCT01796171|540537736|FG000|Follow-up Period|Withdrawal by Subject|0|||
149837318|NCT01796171|540537737|FG001|Follow-up Period|Withdrawal by Subject|1|||
149837319|NCT01796171|540537738|FG002|Follow-up Period|Withdrawal by Subject|0|||
149837320|NCT01796171|540537739|FG003|Follow-up Period|Withdrawal by Subject|0|||
149837321|NCT01796171|540537740|FG004|Follow-up Period|Withdrawal by Subject|0|||
149837322|NCT01796171|540537741|FG005|Follow-up Period|Withdrawal by Subject|1|||
149837323|NCT01796171|540537742|FG006|Follow-up Period|Withdrawal by Subject|0|||
149837324|NCT01796171|540537743|FG007|Follow-up Period|Withdrawal by Subject|0|||
149837325|NCT01796171|540537744|FG008|Follow-up Period|Withdrawal by Subject|0|||
149837326|NCT01796171|540537745|FG009|Follow-up Period|Withdrawal by Subject|0|||
149837327|NCT01796171|540537746|FG010|Follow-up Period|Withdrawal by Subject|3|||
149837328|NCT01796171|540537747|FG011|Follow-up Period|Withdrawal by Subject|1|||
149837329|NCT01796171|540537748|FG012|Follow-up Period|Withdrawal by Subject|0|||
149837330|NCT01796171|540537749|FG013|Follow-up Period|Withdrawal by Subject|0|||
149837331|NCT01796171|540537750|FG014|Follow-up Period|Withdrawal by Subject|0|||
149837332|NCT01796171|540537736|FG000|Follow-up Period|Death|0|||
149837333|NCT01796171|540537737|FG001|Follow-up Period|Death|0|||
149837334|NCT01796171|540537738|FG002|Follow-up Period|Death|0|||
149837335|NCT01796171|540537739|FG003|Follow-up Period|Death|0|||
149837336|NCT01796171|540537740|FG004|Follow-up Period|Death|0|||
149837337|NCT01796171|540537741|FG005|Follow-up Period|Death|0|||
149837338|NCT01796171|540537742|FG006|Follow-up Period|Death|1|||
149837339|NCT01796171|540537743|FG007|Follow-up Period|Death|0|||
149837340|NCT01796171|540537744|FG008|Follow-up Period|Death|0|||
149837341|NCT01796171|540537745|FG009|Follow-up Period|Death|0|||
149837342|NCT01796171|540537746|FG010|Follow-up Period|Death|17|||
149837343|NCT01796171|540537747|FG011|Follow-up Period|Death|9|||
149837344|NCT01796171|540537748|FG012|Follow-up Period|Death|1|||
149837345|NCT01796171|540537749|FG013|Follow-up Period|Death|0|||
149837346|NCT01796171|540537750|FG014|Follow-up Period|Death|0|||
149837347|NCT01796171|540537736|FG000|Follow-up Period|Patient transferred to other hospital|0|||
149837348|NCT01796171|540537737|FG001|Follow-up Period|Patient transferred to other hospital|1|||
149837349|NCT01796171|540537738|FG002|Follow-up Period|Patient transferred to other hospital|0|||
149837350|NCT01796171|540537739|FG003|Follow-up Period|Patient transferred to other hospital|0|||
149837351|NCT01796171|540537740|FG004|Follow-up Period|Patient transferred to other hospital|0|||
149837352|NCT01796171|540537741|FG005|Follow-up Period|Patient transferred to other hospital|0|||
149837353|NCT01796171|540537742|FG006|Follow-up Period|Patient transferred to other hospital|0|||
149837354|NCT01796171|540537743|FG007|Follow-up Period|Patient transferred to other hospital|0|||
149837355|NCT01796171|540537744|FG008|Follow-up Period|Patient transferred to other hospital|0|||
149837356|NCT01796171|540537745|FG009|Follow-up Period|Patient transferred to other hospital|0|||
149837357|NCT01796171|540537746|FG010|Follow-up Period|Patient transferred to other hospital|0|||
149837358|NCT01796171|540537747|FG011|Follow-up Period|Patient transferred to other hospital|0|||
149837359|NCT01796171|540537748|FG012|Follow-up Period|Patient transferred to other hospital|0|||
149837360|NCT01796171|540537749|FG013|Follow-up Period|Patient transferred to other hospital|0|||
149837361|NCT01796171|540537750|FG014|Follow-up Period|Patient transferred to other hospital|0|||
149837362|NCT01796171|540537736|FG000|Follow-up Period|Sponsor Decision|0|||
149837363|NCT01796171|540537737|FG001|Follow-up Period|Sponsor Decision|0|||
149837364|NCT01796171|540537738|FG002|Follow-up Period|Sponsor Decision|0|||
149837365|NCT01796171|540537739|FG003|Follow-up Period|Sponsor Decision|0|||
149837366|NCT01796171|540537740|FG004|Follow-up Period|Sponsor Decision|0|||
149837367|NCT01796171|540537741|FG005|Follow-up Period|Sponsor Decision|0|||
149837368|NCT01796171|540537742|FG006|Follow-up Period|Sponsor Decision|0|||
149837369|NCT01796171|540537743|FG007|Follow-up Period|Sponsor Decision|0|||
149837370|NCT01796171|540537744|FG008|Follow-up Period|Sponsor Decision|0|||
149837371|NCT01796171|540537745|FG009|Follow-up Period|Sponsor Decision|0|||
149837372|NCT01796171|540537746|FG010|Follow-up Period|Sponsor Decision|40|||
149837373|NCT01796171|540537747|FG011|Follow-up Period|Sponsor Decision|15|||
149837374|NCT01796171|540537748|FG012|Follow-up Period|Sponsor Decision|7|||
149837375|NCT01796171|540537749|FG013|Follow-up Period|Sponsor Decision|0|||
149837376|NCT01796171|540537750|FG014|Follow-up Period|Sponsor Decision|0|||
149837377|NCT00418561|540537751|FG000|Overall Study|Participant's (guardian's) decision|0|||
149837378|NCT00418561|540537752|FG001|Overall Study|Participant's (guardian's) decision|1|||
149837379|NCT00418561|540537753|FG002|Overall Study|Participant's (guardian's) decision|0|||
149837380|NCT04274686|540537758|FG000|Overall Study|Physician Decision|1|||
149837381|NCT04274686|540537759|FG001|Overall Study|Physician Decision|0|||
149837382|NCT03496623|540537762|FG000|Run-In Period (2 Weeks)|Death|1|||
149837383|NCT03496623|540537763|FG001|Run-In Period (2 Weeks)|Death|0|||
149837384|NCT03496623|540537764|FG002|Run-In Period (2 Weeks)|Death|0|||
149837385|NCT03496623|540537765|FG003|Run-In Period (2 Weeks)|Death|0|||
149837386|NCT03496623|540537766|FG004|Run-In Period (2 Weeks)|Death|0|||
149837387|NCT03496623|540537762|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
149837388|NCT03496623|540537763|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
149837389|NCT03496623|540537764|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
149837390|NCT03496623|540537765|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
149837391|NCT03496623|540537766|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
149837392|NCT03496623|540537762|FG000|Period 1 (12 Weeks)|Death|0|||
149837393|NCT03496623|540537763|FG001|Period 1 (12 Weeks)|Death|3|||
149837394|NCT03496623|540537764|FG002|Period 1 (12 Weeks)|Death|0|||
149837395|NCT03496623|540537765|FG003|Period 1 (12 Weeks)|Death|0|||
149837396|NCT03496623|540537766|FG004|Period 1 (12 Weeks)|Death|0|||
149837397|NCT03496623|540537762|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
149837398|NCT03496623|540537763|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
149837399|NCT03496623|540537764|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
149837400|NCT03496623|540537765|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
149837401|NCT03496623|540537766|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
149837402|NCT03496623|540537762|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149837403|NCT03496623|540537763|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
149837404|NCT03496623|540537764|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
149837405|NCT03496623|540537765|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149837406|NCT03496623|540537766|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149837407|NCT03496623|540537762|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
149837408|NCT03496623|540537763|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
149837409|NCT03496623|540537764|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
149837410|NCT03496623|540537765|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
149837411|NCT03496623|540537766|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
149837412|NCT03496623|540537762|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149837413|NCT03496623|540537763|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149837414|NCT03496623|540537764|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
149837415|NCT03496623|540537765|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
150282286|NCT02230384|542170402|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
150282287|NCT02230384|542170401|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
149837416|NCT03496623|540537766|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149837417|NCT03496623|540537762|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
149837418|NCT03496623|540537763|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
149837419|NCT03496623|540537764|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
149837420|NCT03496623|540537765|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
150282288|NCT02230384|542170402|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
149837421|NCT03496623|540537766|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
149837422|NCT03496623|540537762|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149837423|NCT03496623|540537763|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
149837424|NCT03496623|540537764|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149837425|NCT03496623|540537765|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149837426|NCT03496623|540537766|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149837427|NCT02543203|540537767|FG000|Overall Study|Unpalatable Fragrance|2|||
149837428|NCT02543203|540537768|FG001|Overall Study|Unpalatable Fragrance|2|||
149837429|NCT02543203|540537767|FG000|Overall Study|Lost to Follow-up|1|||
149837430|NCT02543203|540537768|FG001|Overall Study|Lost to Follow-up|0|||
149837431|NCT02543203|540537767|FG000|Overall Study|Increased Irritability|1|||
149837432|NCT02543203|540537768|FG001|Overall Study|Increased Irritability|0|||
149837433|NCT02543203|540537767|FG000|Overall Study|Family|1|||
149837434|NCT02543203|540537768|FG001|Overall Study|Family|2|||
149837435|NCT02543203|540537767|FG000|Overall Study|Negative Behavior|1|||
149837436|NCT02543203|540537768|FG001|Overall Study|Negative Behavior|0|||
149837437|NCT02543203|540537767|FG000|Overall Study|Withdrawal by Subject|0|||
149837438|NCT02543203|540537768|FG001|Overall Study|Withdrawal by Subject|1|||
149837439|NCT03020615|540537769|FG000|Overall Study|Physician Decision|3|||
149837440|NCT03020615|540537770|FG001|Overall Study|Physician Decision|1|||
149837441|NCT03020615|540537771|FG002|Overall Study|Physician Decision|2|||
149837442|NCT03020615|540537769|FG000|Overall Study|Parent/guardian/patient choice|3|||
149837443|NCT03020615|540537770|FG001|Overall Study|Parent/guardian/patient choice|0|||
149837444|NCT03020615|540537771|FG002|Overall Study|Parent/guardian/patient choice|4|||
149837445|NCT03020615|540537769|FG000|Overall Study|Screen failure|0|||
149837446|NCT03020615|540537770|FG001|Overall Study|Screen failure|0|||
149837447|NCT03020615|540537771|FG002|Overall Study|Screen failure|1|||
149837448|NCT03020615|540537769|FG000|Overall Study|Death|1|||
149837449|NCT03020615|540537770|FG001|Overall Study|Death|0|||
149837450|NCT03020615|540537771|FG002|Overall Study|Death|0|||
149837451|NCT03020615|540537769|FG000|Overall Study|Lost to Follow-up|0|||
149837452|NCT03020615|540537770|FG001|Overall Study|Lost to Follow-up|1|||
149837453|NCT03020615|540537771|FG002|Overall Study|Lost to Follow-up|0|||
149837454|NCT00089661|540537772|FG000|Overall Study|Adverse Event|0|||
149837455|NCT00089661|540537773|FG001|Overall Study|Adverse Event|2|||
149837456|NCT00089661|540537772|FG000|Overall Study|Death|1|||
149837457|NCT00089661|540537773|FG001|Overall Study|Death|0|||
149837458|NCT00089661|540537772|FG000|Overall Study|Lost to Follow-up|0|||
149837459|NCT00089661|540537773|FG001|Overall Study|Lost to Follow-up|3|||
149837460|NCT00089661|540537772|FG000|Overall Study|Withdrawal by Subject|11|||
149837461|NCT00089661|540537773|FG001|Overall Study|Withdrawal by Subject|9|||
149837462|NCT00089661|540537772|FG000|Overall Study|Disease progression|1|||
149837463|NCT00089661|540537773|FG001|Overall Study|Disease progression|3|||
149837464|NCT00089661|540537772|FG000|Overall Study|Ineligibility determined|4|||
149837465|NCT00089661|540537773|FG001|Overall Study|Ineligibility determined|4|||
149837466|NCT00089661|540537772|FG000|Overall Study|Noncompliance|2|||
149837467|NCT00089661|540537773|FG001|Overall Study|Noncompliance|4|||
149837468|NCT00089661|540537772|FG000|Overall Study|Other|2|||
150034563|NCT05660577|541266464|FG000|Overall Study|Discontinued|9|||
150034564|NCT03363841|541266470|FG000|Overall Study|Adverse Event|1|||
150034565|NCT03363841|541266470|FG000|Overall Study|Withdrawal by Subject|1|||
150034566|NCT03363841|541266470|FG000|Overall Study|Death|7|||
149837469|NCT00089661|540537773|FG001|Overall Study|Other|1|||
150034567|NCT03363841|541266470|FG000|Overall Study|Physician Decision|1|||
150034568|NCT02156076|541266471|FG000|Treatment Period|no longer meets study criteria|0|||
150034569|NCT02156076|541266472|FG001|Treatment Period|no longer meets study criteria|0|||
150034570|NCT02156076|541266473|FG002|Treatment Period|no longer meets study criteria|1|||
150034571|NCT02156076|541266474|FG003|Treatment Period|no longer meets study criteria|0|||
150034572|NCT02156076|541266471|FG000|Treatment Period|Poor/non-compliance|0|||
150034573|NCT02156076|541266472|FG001|Treatment Period|Poor/non-compliance|1|||
150034574|NCT02156076|541266473|FG002|Treatment Period|Poor/non-compliance|0|||
150171945|NCT02567656|541765844|FG005|Overall Study|Premature discontinuation due to PD|0|||
149837470|NCT02077465|540537776|FG000|Overall Study|Withdrew Consent|0|||
149837471|NCT02077465|540537777|FG001|Overall Study|Withdrew Consent|1|||
149837472|NCT02077465|540537776|FG000|Overall Study|Lost to Follow-up|1|||
149837473|NCT02077465|540537777|FG001|Overall Study|Lost to Follow-up|0|||
149837474|NCT02481830|540537779|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
149837475|NCT02481830|540537780|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
149837476|NCT02481830|540537779|FG000|Pre-treatment|Withdrawal by Subject|0|||
149837477|NCT02481830|540537780|FG001|Pre-treatment|Withdrawal by Subject|10|||
150034575|NCT02156076|541266474|FG003|Treatment Period|Poor/non-compliance|0|||
150034576|NCT02156076|541266471|FG000|Treatment Period|Lost to Follow-up|0|||
150034577|NCT02156076|541266472|FG001|Treatment Period|Lost to Follow-up|0|||
150171946|NCT03287622|541765846|FG000|Overall Study|Withdrawal by Subject|1|||
149837478|NCT02481830|540537779|FG000|Pre-treatment|Disease Progression|1|||
149837479|NCT02481830|540537780|FG001|Pre-treatment|Disease Progression|1|||
149837480|NCT02481830|540537779|FG000|Pre-treatment|Other reasons|0|||
149837481|NCT02481830|540537780|FG001|Pre-treatment|Other reasons|1|||
149837482|NCT02481830|540537779|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
149837483|NCT02481830|540537780|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
149837484|NCT02481830|540537779|FG000|Treatment|Disease Progression|233|||
149837485|NCT02481830|540537780|FG001|Treatment|Disease Progression|171|||
149837486|NCT02481830|540537779|FG000|Treatment|Study drug toxicity|18|||
149837487|NCT02481830|540537780|FG001|Treatment|Study drug toxicity|38|||
149837488|NCT02481830|540537779|FG000|Treatment|Death|1|||
149837489|NCT02481830|540537780|FG001|Treatment|Death|1|||
149837490|NCT02481830|540537779|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
149837491|NCT02481830|540537780|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
149837492|NCT02481830|540537779|FG000|Treatment|Participants request to discontinue Study treatment|6|||
149837493|NCT02481830|540537780|FG001|Treatment|Participants request to discontinue Study treatment|34|||
149837494|NCT02481830|540537779|FG000|Treatment|Withdrawal by Subject|2|||
149837495|NCT02481830|540537780|FG001|Treatment|Withdrawal by Subject|3|||
149837496|NCT02481830|540537779|FG000|Treatment|Lost to Follow-up|1|||
149837497|NCT02481830|540537780|FG001|Treatment|Lost to Follow-up|0|||
149837498|NCT02481830|540537779|FG000|Treatment|Maximum Clinical Benefit|0|||
149837499|NCT02481830|540537780|FG001|Treatment|Maximum Clinical Benefit|5|||
149837500|NCT02481830|540537779|FG000|Treatment|Administrative reason by sponsor|1|||
149837501|NCT02481830|540537780|FG001|Treatment|Administrative reason by sponsor|1|||
149837502|NCT02481830|540537779|FG000|Treatment|Other reasons|6|||
149837503|NCT02481830|540537780|FG001|Treatment|Other reasons|1|||
149837504|NCT04627038|540537781|FG000|Overall Study|Adverse Event|36|||
149837505|NCT04627038|540537782|FG001|Overall Study|Adverse Event|8|||
149837506|NCT04627038|540537781|FG000|Overall Study|Lost to Follow-up|1|||
149837507|NCT04627038|540537782|FG001|Overall Study|Lost to Follow-up|0|||
149837508|NCT04627038|540537781|FG000|Overall Study|Physician Decision|0|||
149837509|NCT04627038|540537782|FG001|Overall Study|Physician Decision|1|||
149837510|NCT04627038|540537781|FG000|Overall Study|Protocol Violation|3|||
149837511|NCT04627038|540537782|FG001|Overall Study|Protocol Violation|1|||
149837512|NCT04627038|540537781|FG000|Overall Study|Withdrawal by Subject|13|||
149837513|NCT04627038|540537782|FG001|Overall Study|Withdrawal by Subject|3|||
149837514|NCT04627038|540537781|FG000|Overall Study|Non-compliance with study drug|0|||
149837515|NCT04627038|540537782|FG001|Overall Study|Non-compliance with study drug|1|||
149837516|NCT04627038|540537781|FG000|Overall Study|Prohibited Concomitant Medication|1|||
149837517|NCT04627038|540537782|FG001|Overall Study|Prohibited Concomitant Medication|0|||
149837518|NCT00794963|540537783|FG000|Overall Study|Withdrawal by Subject|1|||
149837519|NCT00794963|540537784|FG001|Overall Study|Withdrawal by Subject|4|||
149837520|NCT01827163|540537785|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
149837521|NCT01827163|540537785|FG000|Overall Study|Adverse Event|9|||
149837522|NCT03375463|540537786|FG000|Period 1|Lost to Follow-up|0|||
149837523|NCT03375463|540537787|FG001|Period 1|Lost to Follow-up|0|||
149837524|NCT03375463|540537788|FG002|Period 1|Lost to Follow-up|1|||
149837525|NCT03375463|540537789|FG003|Period 1|Lost to Follow-up|0|||
149837526|NCT03375463|540537790|FG004|Period 1|Lost to Follow-up|0|||
149837527|NCT03375463|540537791|FG005|Period 1|Lost to Follow-up|0|||
149837528|NCT03375463|540537786|FG000|Period 1|Adverse Event|0|||
149837529|NCT03375463|540537787|FG001|Period 1|Adverse Event|0|||
149837530|NCT03375463|540537788|FG002|Period 1|Adverse Event|0|||
149837531|NCT03375463|540537789|FG003|Period 1|Adverse Event|0|||
149837532|NCT03375463|540537790|FG004|Period 1|Adverse Event|1|||
149837533|NCT03375463|540537791|FG005|Period 1|Adverse Event|0|||
149837534|NCT03375463|540537786|FG000|Period 2|Lost to Follow-up|1|||
149837535|NCT03375463|540537787|FG001|Period 2|Lost to Follow-up|1|||
149837536|NCT03375463|540537788|FG002|Period 2|Lost to Follow-up|0|||
149837537|NCT03375463|540537789|FG003|Period 2|Lost to Follow-up|0|||
150034578|NCT02156076|541266473|FG002|Treatment Period|Lost to Follow-up|0|||
150034579|NCT02156076|541266474|FG003|Treatment Period|Lost to Follow-up|1|||
150034580|NCT02156076|541266471|FG000|Treatment Period|Withdrawal by Subject|0|||
150034581|NCT02156076|541266472|FG001|Treatment Period|Withdrawal by Subject|0|||
150034582|NCT02156076|541266473|FG002|Treatment Period|Withdrawal by Subject|1|||
149837538|NCT03375463|540537790|FG004|Period 2|Lost to Follow-up|0|||
149837539|NCT03375463|540537791|FG005|Period 2|Lost to Follow-up|0|||
149837540|NCT01037114|540537792|FG000|Year 20|Others|1|||
149837541|NCT03620747|540537794|FG000|Overall Study|Participant decision|7|||
149837542|NCT03620747|540537794|FG000|Overall Study|Adverse Event|6|||
149837543|NCT03620747|540537794|FG000|Overall Study|Lack of Efficacy|1|||
149837544|NCT03620747|540537794|FG000|Overall Study|Poor compliance to protocol|2|||
149837545|NCT03620747|540537794|FG000|Overall Study|Other-unspecified|3|||
149837546|NCT00635492|540537806|FG000|Overall Study|Death|12|||
149837547|NCT00635492|540537807|FG001|Overall Study|Death|40|||
150034583|NCT02156076|541266474|FG003|Treatment Period|Withdrawal by Subject|0|||
149837548|NCT00635492|540537806|FG000|Overall Study|Lost to Follow-up|151|||
149837549|NCT00635492|540537807|FG001|Overall Study|Lost to Follow-up|172|||
149837550|NCT00635492|540537806|FG000|Overall Study|Physician Decision|32|||
149837551|NCT00635492|540537807|FG001|Overall Study|Physician Decision|22|||
149837552|NCT00635492|540537806|FG000|Overall Study|Sponsor decision|2|||
149837553|NCT00635492|540537807|FG001|Overall Study|Sponsor decision|3|||
150282289|NCT02230384|542170401|FG000|Phase 2 - Switch|Adverse Event|2|||
150282290|NCT02230384|542170402|FG001|Phase 2 - Switch|Adverse Event|0|||
150282291|NCT00964743|542170410|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
150282292|NCT03317795|542170411|FG000|Overall Study|IUD Expulsion|1|||
150282293|NCT03317795|542170412|FG001|Overall Study|IUD Expulsion|0|||
149837554|NCT00635492|540537806|FG000|Overall Study|Withdrawal by Subject|82|||
149837555|NCT00635492|540537807|FG001|Overall Study|Withdrawal by Subject|45|||
149837556|NCT00467363|540537813|FG000|Overall Study|Lost to Follow-up|80|||
149837557|NCT00467363|540537814|FG001|Overall Study|Lost to Follow-up|70|||
149837558|NCT05169710|540537820|FG000|Overall Study|Adverse Event|1|||
149837559|NCT05169710|540537821|FG001|Overall Study|Adverse Event|2|||
149837560|NCT05169710|540537822|FG002|Overall Study|Adverse Event|2|||
149837561|NCT05169710|540537820|FG000|Overall Study|Lost to Follow-up|0|||
149837562|NCT05169710|540537821|FG001|Overall Study|Lost to Follow-up|0|||
149837563|NCT05169710|540537822|FG002|Overall Study|Lost to Follow-up|1|||
149837564|NCT05169710|540537820|FG000|Overall Study|Withdrawal by Subject|2|||
149837565|NCT05169710|540537821|FG001|Overall Study|Withdrawal by Subject|1|||
149837566|NCT05169710|540537822|FG002|Overall Study|Withdrawal by Subject|0|||
149837567|NCT05169710|540537820|FG000|Overall Study|Other Study Discontinuation Reason|0|||
149837568|NCT05169710|540537821|FG001|Overall Study|Other Study Discontinuation Reason|2|||
149837569|NCT05169710|540537822|FG002|Overall Study|Other Study Discontinuation Reason|0|||
149837570|NCT04400890|540537823|FG000|Overall Study|Withdrawal by Subject|3|||
149837571|NCT04400890|540537824|FG001|Overall Study|Withdrawal by Subject|2|||
149837572|NCT05615935|540537825|FG000|Overall Study|Lost to Follow-up|1|||
149837573|NCT05615935|540537826|FG001|Overall Study|Lost to Follow-up|1|||
149837574|NCT01079988|540537829|FG000|Overall Study|Lost to Follow-up|0|||
149837575|NCT01079988|540537830|FG001|Overall Study|Lost to Follow-up|0|||
149837576|NCT01079988|540537831|FG002|Overall Study|Lost to Follow-up|0|||
149837577|NCT01079988|540537832|FG003|Overall Study|Lost to Follow-up|1|||
149837578|NCT01079988|540537833|FG004|Overall Study|Lost to Follow-up|0|||
149949757|NCT02483429|540947827|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
149949758|NCT02483429|540947828|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
149837579|NCT01079988|540537829|FG000|Overall Study|Lack of Efficacy|1|||
149837580|NCT01079988|540537830|FG001|Overall Study|Lack of Efficacy|0|||
149837581|NCT01079988|540537831|FG002|Overall Study|Lack of Efficacy|0|||
149837582|NCT01079988|540537832|FG003|Overall Study|Lack of Efficacy|0|||
149837583|NCT01079988|540537833|FG004|Overall Study|Lack of Efficacy|0|||
149837584|NCT01079988|540537829|FG000|Overall Study|Other|0|||
149837585|NCT01079988|540537830|FG001|Overall Study|Other|0|||
149837586|NCT01079988|540537831|FG002|Overall Study|Other|0|||
149837587|NCT01079988|540537832|FG003|Overall Study|Other|2|||
149837588|NCT01079988|540537833|FG004|Overall Study|Other|1|||
149837589|NCT02158663|540537834|FG000|Overall Study|Withdrawal by Subject|5|||
149837590|NCT02158663|540537835|FG001|Overall Study|Withdrawal by Subject|4|||
149837591|NCT03273153|540537843|FG000|Overall Study|Adverse Event|1|||
149837592|NCT03273153|540537844|FG001|Overall Study|Adverse Event|2|||
149837593|NCT03273153|540537843|FG000|Overall Study|Missing|0|||
149837594|NCT03273153|540537844|FG001|Overall Study|Missing|2|||
149837595|NCT03273153|540537843|FG000|Overall Study|Other|3|||
149837596|NCT03273153|540537844|FG001|Overall Study|Other|2|||
149837597|NCT03273153|540537843|FG000|Overall Study|Symptomatic Deterioration|0|||
149837598|NCT03273153|540537844|FG001|Overall Study|Symptomatic Deterioration|1|||
149837599|NCT03273153|540537843|FG000|Overall Study|Progressive Disease|6|||
149837600|NCT03273153|540537844|FG001|Overall Study|Progressive Disease|5|||
149837601|NCT03273153|540537843|FG000|Overall Study|Physician Decision|1|||
149837602|NCT03273153|540537844|FG001|Overall Study|Physician Decision|3|||
149837603|NCT03273153|540537843|FG000|Overall Study|Study Terminated by Sponsor|112|||
149837604|NCT03273153|540537844|FG001|Overall Study|Study Terminated by Sponsor|102|||
149837605|NCT03273153|540537843|FG000|Overall Study|Withdrawal by Subject|26|||
149837606|NCT03273153|540537844|FG001|Overall Study|Withdrawal by Subject|25|||
149837607|NCT03273153|540537843|FG000|Overall Study|Protocol Deviation|3|||
149837608|NCT03273153|540537844|FG001|Overall Study|Protocol Deviation|0|||
149837609|NCT03273153|540537843|FG000|Overall Study|Lost to Follow-up|6|||
149837610|NCT03273153|540537844|FG001|Overall Study|Lost to Follow-up|11|||
149837611|NCT03273153|540537843|FG000|Overall Study|Death|66|||
149837612|NCT03273153|540537844|FG001|Overall Study|Death|69|||
149837613|NCT00838539|540537847|FG000|Overall Study|Disease Progression|2|||
149837614|NCT00838539|540537848|FG001|Overall Study|Disease Progression|4|||
149837615|NCT00838539|540537849|FG002|Overall Study|Disease Progression|3|||
149837616|NCT00838539|540537850|FG003|Overall Study|Disease Progression|2|||
149837617|NCT00838539|540537851|FG004|Overall Study|Disease Progression|4|||
149837618|NCT00838539|540537852|FG005|Overall Study|Disease Progression|2|||
149837619|NCT00838539|540537853|FG006|Overall Study|Disease Progression|3|||
150034584|NCT02156076|541266471|FG000|Treatment Period|Subject request to discontinue treatment|0|||
150034585|NCT02156076|541266472|FG001|Treatment Period|Subject request to discontinue treatment|1|||
150171947|NCT03287622|541765847|FG001|Overall Study|Withdrawal by Subject|0|||
149837620|NCT00838539|540537854|FG007|Overall Study|Disease Progression|4|||
149837621|NCT00838539|540537855|FG008|Overall Study|Disease Progression|4|||
149837622|NCT00838539|540537856|FG009|Overall Study|Disease Progression|5|||
149837623|NCT00838539|540537857|FG010|Overall Study|Disease Progression|1|||
149837624|NCT00838539|540537858|FG011|Overall Study|Disease Progression|4|||
149837625|NCT00838539|540537847|FG000|Overall Study|Adverse Event|1|||
149837626|NCT00838539|540537848|FG001|Overall Study|Adverse Event|1|||
150171948|NCT03287622|541765846|FG000|Overall Study|Lost to Follow-up|27|||
149837627|NCT00838539|540537849|FG002|Overall Study|Adverse Event|1|||
149837628|NCT00838539|540537850|FG003|Overall Study|Adverse Event|1|||
150171949|NCT03287622|541765847|FG001|Overall Study|Lost to Follow-up|15|||
149837629|NCT00838539|540537851|FG004|Overall Study|Adverse Event|2|||
149837630|NCT00838539|540537852|FG005|Overall Study|Adverse Event|1|||
150282294|NCT03317795|542170411|FG000|Overall Study|Lost to Follow-up|1|||
150282295|NCT03317795|542170412|FG001|Overall Study|Lost to Follow-up|3|||
150282296|NCT03317795|542170411|FG000|Overall Study|Treatment change|0|||
150282297|NCT03317795|542170412|FG001|Overall Study|Treatment change|3|||
150282298|NCT03317795|542170411|FG000|Overall Study|Intolerance of medication|0|||
150282299|NCT03317795|542170412|FG001|Overall Study|Intolerance of medication|1|||
150282300|NCT00939783|542170413|FG000|Overall Study|Death|6|||
150282301|NCT00939783|542170413|FG000|Overall Study|Adverse Event|39|||
150282302|NCT00939783|542170413|FG000|Overall Study|Study Terminated by Sponsor|498|||
150282303|NCT00939783|542170413|FG000|Overall Study|Withdrawal by Subject|78|||
150282304|NCT00939783|542170413|FG000|Overall Study|Other|16|||
150282305|NCT00939783|542170413|FG000|Overall Study|Lost to Follow-up|8|||
150282306|NCT00939783|542170413|FG000|Overall Study|Protocol Violation|3|||
150282307|NCT00939783|542170413|FG000|Overall Study|Enrolled but not treated|1|||
150282308|NCT03631732|542170420|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
150282309|NCT03631732|542170421|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
150282310|NCT03631732|542170420|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
150282311|NCT03631732|542170421|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
150282312|NCT03631732|542170420|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
150282313|NCT03631732|542170421|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
150282314|NCT03631732|542170420|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
150282315|NCT03631732|542170421|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
150282316|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
149837631|NCT00838539|540537853|FG006|Overall Study|Adverse Event|0|||
149837632|NCT00838539|540537854|FG007|Overall Study|Adverse Event|2|||
149837633|NCT00838539|540537855|FG008|Overall Study|Adverse Event|0|||
149837634|NCT00838539|540537856|FG009|Overall Study|Adverse Event|1|||
149837635|NCT00838539|540537857|FG010|Overall Study|Adverse Event|2|||
149837636|NCT00838539|540537858|FG011|Overall Study|Adverse Event|0|||
149837637|NCT00838539|540537847|FG000|Overall Study|Withdrawal by Subject|0|||
149837638|NCT00838539|540537848|FG001|Overall Study|Withdrawal by Subject|1|||
149837639|NCT00838539|540537849|FG002|Overall Study|Withdrawal by Subject|0|||
149837640|NCT00838539|540537850|FG003|Overall Study|Withdrawal by Subject|0|||
149837641|NCT00838539|540537851|FG004|Overall Study|Withdrawal by Subject|0|||
149837642|NCT00838539|540537852|FG005|Overall Study|Withdrawal by Subject|0|||
149837643|NCT00838539|540537853|FG006|Overall Study|Withdrawal by Subject|0|||
149837644|NCT00838539|540537854|FG007|Overall Study|Withdrawal by Subject|0|||
149837645|NCT00838539|540537855|FG008|Overall Study|Withdrawal by Subject|0|||
149837646|NCT00838539|540537856|FG009|Overall Study|Withdrawal by Subject|1|||
149837647|NCT00838539|540537857|FG010|Overall Study|Withdrawal by Subject|2|||
149837648|NCT00838539|540537858|FG011|Overall Study|Withdrawal by Subject|0|||
149837649|NCT00838539|540537847|FG000|Overall Study|Death|0|||
149837650|NCT00838539|540537848|FG001|Overall Study|Death|0|||
149837651|NCT00838539|540537849|FG002|Overall Study|Death|0|||
149837652|NCT00838539|540537850|FG003|Overall Study|Death|0|||
149837653|NCT00838539|540537851|FG004|Overall Study|Death|0|||
149837654|NCT00838539|540537852|FG005|Overall Study|Death|0|||
149837655|NCT00838539|540537853|FG006|Overall Study|Death|1|||
149837656|NCT00838539|540537854|FG007|Overall Study|Death|0|||
149837657|NCT00838539|540537855|FG008|Overall Study|Death|0|||
149837658|NCT00838539|540537856|FG009|Overall Study|Death|0|||
149837659|NCT00838539|540537857|FG010|Overall Study|Death|0|||
149837660|NCT00838539|540537858|FG011|Overall Study|Death|0|||
149837661|NCT00838539|540537847|FG000|Overall Study|Physician Decision|0|||
149837662|NCT00838539|540537848|FG001|Overall Study|Physician Decision|0|||
149837663|NCT00838539|540537849|FG002|Overall Study|Physician Decision|0|||
149837664|NCT00838539|540537850|FG003|Overall Study|Physician Decision|0|||
149837665|NCT00838539|540537851|FG004|Overall Study|Physician Decision|0|||
149837666|NCT00838539|540537852|FG005|Overall Study|Physician Decision|0|||
149837667|NCT00838539|540537853|FG006|Overall Study|Physician Decision|0|||
149837668|NCT00838539|540537854|FG007|Overall Study|Physician Decision|0|||
149837669|NCT00838539|540537855|FG008|Overall Study|Physician Decision|1|||
149837670|NCT00838539|540537856|FG009|Overall Study|Physician Decision|0|||
149837671|NCT00838539|540537857|FG010|Overall Study|Physician Decision|0|||
149837672|NCT00838539|540537858|FG011|Overall Study|Physician Decision|0|||
149837673|NCT00838539|540537847|FG000|Overall Study|Clinical Progression|0|||
149837674|NCT00838539|540537848|FG001|Overall Study|Clinical Progression|0|||
149837675|NCT00838539|540537849|FG002|Overall Study|Clinical Progression|0|||
149837676|NCT00838539|540537850|FG003|Overall Study|Clinical Progression|0|||
149837677|NCT00838539|540537851|FG004|Overall Study|Clinical Progression|0|||
149837678|NCT00838539|540537852|FG005|Overall Study|Clinical Progression|0|||
149837679|NCT00838539|540537853|FG006|Overall Study|Clinical Progression|1|||
149837680|NCT00838539|540537854|FG007|Overall Study|Clinical Progression|0|||
149837681|NCT00838539|540537855|FG008|Overall Study|Clinical Progression|0|||
149837682|NCT00838539|540537856|FG009|Overall Study|Clinical Progression|0|||
149837683|NCT00838539|540537857|FG010|Overall Study|Clinical Progression|0|||
149837684|NCT00838539|540537858|FG011|Overall Study|Clinical Progression|0|||
149837685|NCT00838539|540537847|FG000|Overall Study|Symptomatic Deterioration|0|||
149837686|NCT00838539|540537848|FG001|Overall Study|Symptomatic Deterioration|0|||
149837687|NCT00838539|540537849|FG002|Overall Study|Symptomatic Deterioration|1|||
149837688|NCT00838539|540537850|FG003|Overall Study|Symptomatic Deterioration|1|||
149837689|NCT00838539|540537851|FG004|Overall Study|Symptomatic Deterioration|0|||
149837690|NCT00838539|540537852|FG005|Overall Study|Symptomatic Deterioration|1|||
149837691|NCT00838539|540537853|FG006|Overall Study|Symptomatic Deterioration|0|||
149837692|NCT00838539|540537854|FG007|Overall Study|Symptomatic Deterioration|0|||
149837693|NCT00838539|540537855|FG008|Overall Study|Symptomatic Deterioration|0|||
149837694|NCT00838539|540537856|FG009|Overall Study|Symptomatic Deterioration|1|||
149837695|NCT00838539|540537857|FG010|Overall Study|Symptomatic Deterioration|0|||
149837696|NCT00838539|540537858|FG011|Overall Study|Symptomatic Deterioration|0|||
149837697|NCT01908205|540537859|FG000|Overall Study|Lost to Follow-up|2|||
149837698|NCT01908205|540537860|FG001|Overall Study|Lost to Follow-up|0|||
149837699|NCT01908205|540537859|FG000|Overall Study|Withdrawal by Subject|3|||
149837700|NCT01908205|540537860|FG001|Overall Study|Withdrawal by Subject|1|||
149837701|NCT03500692|540537862|FG000|Overall Study|Death|163|||
149837702|NCT03500692|540537862|FG000|Overall Study|Lost to Follow-up|75|||
150034586|NCT02156076|541266473|FG002|Treatment Period|Subject request to discontinue treatment|0|||
149837703|NCT03500692|540537862|FG000|Overall Study|Termination Reasons|3|||
149837704|NCT04149964|540537863|FG000|Overall Study|Lost to Follow-up|19|||
149837705|NCT04149964|540537864|FG001|Overall Study|Lost to Follow-up|18|||
149837706|NCT01697696|540537867|FG000|Overall Study|Study terminated by sponsor|0|||
149837707|NCT01697696|540537868|FG001|Overall Study|Study terminated by sponsor|3|||
149837708|NCT01697696|540537867|FG000|Overall Study|Protocol deviation|1|||
149837709|NCT01697696|540537868|FG001|Overall Study|Protocol deviation|0|||
149837710|NCT01697696|540537867|FG000|Overall Study|Physician Decision|1|||
149837711|NCT01697696|540537868|FG001|Overall Study|Physician Decision|0|||
149837712|NCT01697696|540537867|FG000|Overall Study|Death|4|||
149837713|NCT01697696|540537868|FG001|Overall Study|Death|2|||
149837714|NCT01697696|540537867|FG000|Overall Study|Lost to Follow-up|10|||
149837715|NCT01697696|540537868|FG001|Overall Study|Lost to Follow-up|7|||
149837716|NCT01697696|540537867|FG000|Overall Study|Subject/guardian decision|31|||
149837717|NCT01697696|540537868|FG001|Overall Study|Subject/guardian decision|35|||
149837718|NCT01424644|540537869|FG000|Overall Study|Adverse Event|2|||
149837719|NCT01424644|540537870|FG001|Overall Study|Adverse Event|0|||
149837720|NCT01424644|540537869|FG000|Overall Study|Withdrawal by Subject|9|||
149837721|NCT01424644|540537870|FG001|Overall Study|Withdrawal by Subject|12|||
149837722|NCT01424644|540537869|FG000|Overall Study|Lost to Follow-up|16|||
149837723|NCT01424644|540537870|FG001|Overall Study|Lost to Follow-up|12|||
149837724|NCT01424644|540537869|FG000|Overall Study|Protocol Violation|4|||
149837725|NCT01424644|540537870|FG001|Overall Study|Protocol Violation|3|||
149837726|NCT01424644|540537869|FG000|Overall Study|Administrative Reason|1|||
149837727|NCT01424644|540537870|FG001|Overall Study|Administrative Reason|0|||
149837728|NCT01424644|540537869|FG000|Overall Study|Unable to Classify|1|||
149837729|NCT01424644|540537870|FG001|Overall Study|Unable to Classify|0|||
149837730|NCT03616106|540537871|FG000|Overall Study|Removed by PI|6|||
149837731|NCT03616106|540537872|FG001|Overall Study|Removed by PI|0|||
149837732|NCT03616106|540537871|FG000|Overall Study|Withdrawal by Subject|1|||
149837733|NCT03616106|540537872|FG001|Overall Study|Withdrawal by Subject|1|||
149837734|NCT03616106|540537871|FG000|Overall Study|Lost to Follow-up|7|||
149837735|NCT03616106|540537872|FG001|Overall Study|Lost to Follow-up|0|||
149837736|NCT01880593|540537873|FG000|Overall Study|Adverse Event|1|||
149837737|NCT01880593|540537874|FG001|Overall Study|Adverse Event|0|||
149837738|NCT01880593|540537873|FG000|Overall Study|Lack of Efficacy|1|||
149837739|NCT01880593|540537874|FG001|Overall Study|Lack of Efficacy|5|||
149837740|NCT01880593|540537873|FG000|Overall Study|Withdrawal by Subject|6|||
149837741|NCT01880593|540537874|FG001|Overall Study|Withdrawal by Subject|1|||
149837742|NCT02272777|540537875|FG000|Overall Study|Adverse Event|0|||
149837743|NCT02272777|540537876|FG001|Overall Study|Adverse Event|1|||
149837744|NCT02272777|540537875|FG000|Overall Study|Withdrawal by Subject|0|||
149837745|NCT02272777|540537876|FG001|Overall Study|Withdrawal by Subject|3|||
149837746|NCT02272777|540537875|FG000|Overall Study|Lost to Follow-up|2|||
149837747|NCT02272777|540537876|FG001|Overall Study|Lost to Follow-up|0|||
149837748|NCT02272777|540537875|FG000|Overall Study|Other|2|||
149837749|NCT02272777|540537876|FG001|Overall Study|Other|0|||
149837750|NCT00440297|540537880|FG000|Overall Study|Adverse Event|8|||
149837751|NCT00440297|540537881|FG001|Overall Study|Adverse Event|5|||
149837752|NCT00440297|540537880|FG000|Overall Study|Lost to Follow-up|1|||
149837753|NCT00440297|540537881|FG001|Overall Study|Lost to Follow-up|0|||
149837754|NCT00440297|540537880|FG000|Overall Study|Physician Decision|1|||
149837755|NCT00440297|540537881|FG001|Overall Study|Physician Decision|0|||
149837756|NCT00440297|540537880|FG000|Overall Study|Protocol Violation|11|||
149837757|NCT00440297|540537881|FG001|Overall Study|Protocol Violation|7|||
149837758|NCT00440297|540537880|FG000|Overall Study|Withdrawal by Subject|1|||
149837759|NCT00440297|540537881|FG001|Overall Study|Withdrawal by Subject|6|||
149837760|NCT00440297|540537880|FG000|Overall Study|Randomized by mistake|1|||
149837761|NCT00440297|540537881|FG001|Overall Study|Randomized by mistake|0|||
149837762|NCT02445339|540537882|FG000|Overall Study|Physician Decision|1|||
149837763|NCT02445339|540537883|FG001|Overall Study|Physician Decision|0|||
149837764|NCT02445339|540537882|FG000|Overall Study|Lost to Follow-up|11|||
149837765|NCT02445339|540537883|FG001|Overall Study|Lost to Follow-up|15|||
149837766|NCT03206177|540537884|FG000|Overall Study|Withdrawal by Subject|1|||
149837767|NCT02024932|540537885|FG000|Overall Study|Adverse Event|2|||
149837768|NCT02024932|540537886|FG001|Overall Study|Adverse Event|3|||
149837769|NCT02024932|540537887|FG002|Overall Study|Adverse Event|0|||
149837770|NCT02024932|540537888|FG003|Overall Study|Adverse Event|0|||
149837771|NCT02024932|540537889|FG004|Overall Study|Adverse Event|2|||
149837772|NCT02024932|540537890|FG005|Overall Study|Adverse Event|0|||
149837773|NCT02024932|540537885|FG000|Overall Study|Abnormal laboratory value|0|||
149837774|NCT02024932|540537886|FG001|Overall Study|Abnormal laboratory value|0|||
149837775|NCT02024932|540537887|FG002|Overall Study|Abnormal laboratory value|0|||
149837776|NCT02024932|540537888|FG003|Overall Study|Abnormal laboratory value|2|||
149837777|NCT02024932|540537889|FG004|Overall Study|Abnormal laboratory value|0|||
149837778|NCT02024932|540537890|FG005|Overall Study|Abnormal laboratory value|0|||
149837779|NCT00727961|540537891|FG000|Overall Study|Lost to Follow-up|1|||
149837780|NCT00727961|540537891|FG000|Overall Study|Adverse Event|4|||
149837781|NCT00727961|540537891|FG000|Overall Study|Patient's refusal|2|||
149837782|NCT00727961|540537891|FG000|Overall Study|Progression|30|||
149837783|NCT02186821|540537892|FG000|Overall Study|Adverse Event|9|||
149837784|NCT02186821|540537892|FG000|Overall Study|Death|2|||
149837785|NCT02186821|540537892|FG000|Overall Study|Disease progression|32|||
149837786|NCT02186821|540537892|FG000|Overall Study|Protocol Violation|1|||
149837787|NCT02186821|540537892|FG000|Overall Study|Physician Decision|1|||
149837788|NCT02186821|540537892|FG000|Overall Study|Study terminated by sponsor|2|||
149837789|NCT05472038|540539648|FG000|Overall Study|Adverse Event|0|||
149837790|NCT05472038|540539649|FG001|Overall Study|Adverse Event|0|||
149837791|NCT05472038|540539650|FG002|Overall Study|Adverse Event|1|||
149837792|NCT05472038|540539651|FG003|Overall Study|Adverse Event|0|||
149837793|NCT05472038|540539652|FG004|Overall Study|Adverse Event|0|||
149837794|NCT05472038|540539653|FG005|Overall Study|Adverse Event|0|||
149837795|NCT05472038|540539654|FG006|Overall Study|Adverse Event|0|||
149837796|NCT05472038|540539655|FG007|Overall Study|Adverse Event|0|||
149837797|NCT05472038|540539656|FG008|Overall Study|Adverse Event|0|||
149837798|NCT05472038|540539657|FG009|Overall Study|Adverse Event|0|||
149837799|NCT05472038|540539658|FG010|Overall Study|Adverse Event|0|||
149837800|NCT05472038|540539659|FG011|Overall Study|Adverse Event|0|||
149837801|NCT05472038|540539648|FG000|Overall Study|Death|0|||
149837802|NCT05472038|540539649|FG001|Overall Study|Death|0|||
149837803|NCT05472038|540539650|FG002|Overall Study|Death|0|||
149837804|NCT05472038|540539651|FG003|Overall Study|Death|0|||
149837805|NCT05472038|540539652|FG004|Overall Study|Death|0|||
149837806|NCT05472038|540539653|FG005|Overall Study|Death|1|||
149837807|NCT05472038|540539654|FG006|Overall Study|Death|0|||
149837808|NCT05472038|540539655|FG007|Overall Study|Death|0|||
149837809|NCT05472038|540539656|FG008|Overall Study|Death|0|||
149837810|NCT05472038|540539657|FG009|Overall Study|Death|0|||
149837811|NCT05472038|540539658|FG010|Overall Study|Death|0|||
149837812|NCT05472038|540539659|FG011|Overall Study|Death|0|||
149837813|NCT05472038|540539648|FG000|Overall Study|Lost to Follow-up|1|||
149837814|NCT05472038|540539649|FG001|Overall Study|Lost to Follow-up|3|||
149837815|NCT05472038|540539650|FG002|Overall Study|Lost to Follow-up|3|||
149837816|NCT05472038|540539651|FG003|Overall Study|Lost to Follow-up|9|||
149837817|NCT05472038|540539652|FG004|Overall Study|Lost to Follow-up|2|||
149837818|NCT05472038|540539653|FG005|Overall Study|Lost to Follow-up|2|||
149837819|NCT05472038|540539654|FG006|Overall Study|Lost to Follow-up|1|||
149837820|NCT05472038|540539655|FG007|Overall Study|Lost to Follow-up|0|||
149837821|NCT05472038|540539656|FG008|Overall Study|Lost to Follow-up|1|||
149837822|NCT05472038|540539657|FG009|Overall Study|Lost to Follow-up|0|||
149837823|NCT05472038|540539658|FG010|Overall Study|Lost to Follow-up|2|||
149837824|NCT05472038|540539659|FG011|Overall Study|Lost to Follow-up|1|||
149837825|NCT05472038|540539648|FG000|Overall Study|Physician Decision|0|||
149837826|NCT05472038|540539649|FG001|Overall Study|Physician Decision|0|||
149837827|NCT05472038|540539650|FG002|Overall Study|Physician Decision|0|||
149837828|NCT05472038|540539651|FG003|Overall Study|Physician Decision|0|||
149837829|NCT05472038|540539652|FG004|Overall Study|Physician Decision|1|||
149837830|NCT05472038|540539653|FG005|Overall Study|Physician Decision|0|||
149837831|NCT05472038|540539654|FG006|Overall Study|Physician Decision|0|||
149837832|NCT05472038|540539655|FG007|Overall Study|Physician Decision|0|||
149837833|NCT05472038|540539656|FG008|Overall Study|Physician Decision|0|||
149837834|NCT05472038|540539657|FG009|Overall Study|Physician Decision|0|||
149837835|NCT05472038|540539658|FG010|Overall Study|Physician Decision|0|||
149837836|NCT05472038|540539659|FG011|Overall Study|Physician Decision|0|||
149837837|NCT05472038|540539648|FG000|Overall Study|Withdrawal by Subject|1|||
149837838|NCT05472038|540539649|FG001|Overall Study|Withdrawal by Subject|3|||
149837839|NCT05472038|540539650|FG002|Overall Study|Withdrawal by Subject|1|||
149837840|NCT05472038|540539651|FG003|Overall Study|Withdrawal by Subject|6|||
149837841|NCT05472038|540539652|FG004|Overall Study|Withdrawal by Subject|1|||
149837842|NCT05472038|540539653|FG005|Overall Study|Withdrawal by Subject|3|||
149837843|NCT05472038|540539654|FG006|Overall Study|Withdrawal by Subject|0|||
149837844|NCT05472038|540539655|FG007|Overall Study|Withdrawal by Subject|2|||
149837845|NCT05472038|540539656|FG008|Overall Study|Withdrawal by Subject|3|||
149837846|NCT05472038|540539657|FG009|Overall Study|Withdrawal by Subject|1|||
149837847|NCT05472038|540539658|FG010|Overall Study|Withdrawal by Subject|2|||
149837848|NCT05472038|540539659|FG011|Overall Study|Withdrawal by Subject|2|||
149837849|NCT05472038|540539648|FG000|Overall Study|Protocol Violation|0|||
149837850|NCT05472038|540539649|FG001|Overall Study|Protocol Violation|0|||
149837851|NCT05472038|540539650|FG002|Overall Study|Protocol Violation|0|||
149837852|NCT05472038|540539651|FG003|Overall Study|Protocol Violation|0|||
149837853|NCT05472038|540539652|FG004|Overall Study|Protocol Violation|0|||
149837854|NCT05472038|540539653|FG005|Overall Study|Protocol Violation|0|||
149837855|NCT05472038|540539654|FG006|Overall Study|Protocol Violation|0|||
149837856|NCT05472038|540539655|FG007|Overall Study|Protocol Violation|1|||
149837857|NCT05472038|540539656|FG008|Overall Study|Protocol Violation|1|||
149837858|NCT05472038|540539657|FG009|Overall Study|Protocol Violation|1|||
150034587|NCT02156076|541266474|FG003|Treatment Period|Subject request to discontinue treatment|0|||
150034588|NCT02156076|541266471|FG000|Treatment Period|Adverse Event|0|||
150034589|NCT02156076|541266472|FG001|Treatment Period|Adverse Event|0|||
150034590|NCT02156076|541266473|FG002|Treatment Period|Adverse Event|0|||
149837859|NCT05472038|540539658|FG010|Overall Study|Protocol Violation|1|||
149837860|NCT05472038|540539659|FG011|Overall Study|Protocol Violation|1|||
149837861|NCT05472038|540539648|FG000|Overall Study|Not vaccinated|0|||
149837862|NCT05472038|540539649|FG001|Overall Study|Not vaccinated|0|||
149837863|NCT05472038|540539650|FG002|Overall Study|Not vaccinated|0|||
149837864|NCT05472038|540539651|FG003|Overall Study|Not vaccinated|1|||
149837865|NCT05472038|540539652|FG004|Overall Study|Not vaccinated|0|||
149837866|NCT05472038|540539653|FG005|Overall Study|Not vaccinated|0|||
149837867|NCT05472038|540539654|FG006|Overall Study|Not vaccinated|0|||
150034591|NCT02156076|541266474|FG003|Treatment Period|Adverse Event|1|||
150034592|NCT02156076|541266471|FG000|Follow-up Period|Withdrawal by Subject|1|||
149837868|NCT05472038|540539655|FG007|Overall Study|Not vaccinated|0|||
149837869|NCT05472038|540539656|FG008|Overall Study|Not vaccinated|0|||
149837870|NCT05472038|540539657|FG009|Overall Study|Not vaccinated|0|||
149837871|NCT05472038|540539658|FG010|Overall Study|Not vaccinated|0|||
149837872|NCT05472038|540539659|FG011|Overall Study|Not vaccinated|0|||
149837873|NCT03235739|540539662|FG000|Overall Study|Withdrawal by Subject|2|||
149837874|NCT03235739|540539663|FG001|Overall Study|Withdrawal by Subject|2|||
149837875|NCT03235739|540539662|FG000|Overall Study|Physician Decision|0|||
149837876|NCT03235739|540539663|FG001|Overall Study|Physician Decision|1|||
149837877|NCT02847650|540539664|FG000|Overall Study|Adverse Event|2|||
149837878|NCT02847650|540539665|FG001|Overall Study|Adverse Event|4|||
149837879|NCT02847650|540539664|FG000|Overall Study|Lost to Follow-up|1|||
149837880|NCT02847650|540539665|FG001|Overall Study|Lost to Follow-up|0|||
149837881|NCT02847650|540539664|FG000|Overall Study|Protocol Violation|0|||
149837882|NCT02847650|540539665|FG001|Overall Study|Protocol Violation|1|||
149837883|NCT02847650|540539664|FG000|Overall Study|Withdrawal by Subject|1|||
149837884|NCT02847650|540539665|FG001|Overall Study|Withdrawal by Subject|1|||
149837885|NCT00218257|540539666|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
149837886|NCT00218257|540539667|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
149837887|NCT02175095|540539670|FG000|Overall Study|Withdrawal by Subject|3|||
149837888|NCT00462345|540539671|FG000|Overall Study|Withdrawal by Subject|2|||
149837889|NCT00462345|540539671|FG000|Overall Study|Did not complete second course|1|||
149837890|NCT03255733|540539675|FG000|Overall Study|Lost to Follow-up|4|||
149837891|NCT02146105|540539676|FG000|Overall Study|Adverse Event|1|||
149837892|NCT02146105|540539676|FG000|Overall Study|Withdrawal by Subject|5|||
149837893|NCT03122535|540539679|FG000|Overall Study|Lost to Follow-up|68|||
149837894|NCT03122535|540539680|FG001|Overall Study|Lost to Follow-up|68|||
149837895|NCT03122535|540539679|FG000|Overall Study|Physician Decision|3|||
149837896|NCT03122535|540539680|FG001|Overall Study|Physician Decision|3|||
149837897|NCT03122535|540539679|FG000|Overall Study|Withdrawal by Subject|2|||
149837898|NCT03122535|540539680|FG001|Overall Study|Withdrawal by Subject|2|||
149837899|NCT02718326|540539681|FG000|Overall Study|Adverse Event|4|||
150034593|NCT02156076|541266472|FG001|Follow-up Period|Withdrawal by Subject|0|||
150282317|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
149837900|NCT02718326|540539682|FG001|Overall Study|Adverse Event|9|||
149837901|NCT02718326|540539683|FG002|Overall Study|Adverse Event|0|||
149837902|NCT02718326|540539681|FG000|Overall Study|Death|8|||
149837903|NCT02718326|540539682|FG001|Overall Study|Death|1|||
149837904|NCT02718326|540539683|FG002|Overall Study|Death|2|||
149837905|NCT02718326|540539681|FG000|Overall Study|Withdrawal by Subject|4|||
149837906|NCT02718326|540539682|FG001|Overall Study|Withdrawal by Subject|9|||
149837907|NCT02718326|540539683|FG002|Overall Study|Withdrawal by Subject|6|||
149837908|NCT02718326|540539681|FG000|Overall Study|Lost to Follow-up|18|||
149837909|NCT02718326|540539682|FG001|Overall Study|Lost to Follow-up|5|||
149837910|NCT02718326|540539683|FG002|Overall Study|Lost to Follow-up|14|||
149837911|NCT02718326|540539681|FG000|Overall Study|Protocol Deviation|1|||
149837912|NCT02718326|540539682|FG001|Overall Study|Protocol Deviation|0|||
149837913|NCT02718326|540539683|FG002|Overall Study|Protocol Deviation|0|||
149837914|NCT02718326|540539681|FG000|Overall Study|Pregnancy|1|||
149837915|NCT02718326|540539682|FG001|Overall Study|Pregnancy|0|||
149837916|NCT02718326|540539683|FG002|Overall Study|Pregnancy|0|||
149837917|NCT02646124|540539684|FG000|Overall Study|Lost to Follow-up|0|||
149837918|NCT02646124|540539685|FG001|Overall Study|Lost to Follow-up|2|||
149837919|NCT00857454|540539689|FG000|Overall Study|Withdrawal by Subject|2|||
149837920|NCT00857454|540539689|FG000|Overall Study|Lost to Follow-up|1|||
149837921|NCT00857454|540539689|FG000|Overall Study|Adverse Event|2|||
149837922|NCT00857454|540539689|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
149837923|NCT00857454|540539689|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
149837924|NCT00857454|540539689|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
149837925|NCT00984022|540539690|FG000|Overall Study|Lost to Follow-up|10|||
149837926|NCT00984022|540539691|FG001|Overall Study|Lost to Follow-up|14|||
149837927|NCT00573443|540539695|FG000|Double-Blind Phase|Lost to Follow-up|1|||
149837928|NCT00573443|540539696|FG001|Double-Blind Phase|Lost to Follow-up|3|||
149837929|NCT00573443|540539697|FG002|Double-Blind Phase|Lost to Follow-up|2|||
149837930|NCT00573443|540539695|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
149837931|NCT00573443|540539696|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
149837932|NCT00573443|540539697|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
149837933|NCT00573443|540539695|FG000|Double-Blind Phase|Adverse Event|1|||
149837934|NCT00573443|540539696|FG001|Double-Blind Phase|Adverse Event|5|||
149837935|NCT00573443|540539697|FG002|Double-Blind Phase|Adverse Event|0|||
149837936|NCT00573443|540539695|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
149837937|NCT00573443|540539696|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
149837938|NCT00573443|540539697|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
149837939|NCT00573443|540539695|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
149837940|NCT00573443|540539696|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
149837941|NCT00573443|540539697|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
149837942|NCT00573443|540539695|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
149837943|NCT00573443|540539696|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
149837944|NCT00573443|540539697|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
149837945|NCT00573443|540539695|FG000|Double-Blind Phase|Protocol Violation|0|||
149837946|NCT00573443|540539696|FG001|Double-Blind Phase|Protocol Violation|2|||
149837947|NCT00573443|540539697|FG002|Double-Blind Phase|Protocol Violation|1|||
149837948|NCT00573443|540539695|FG000|Double-Blind Phase|Other|0|||
149837949|NCT00573443|540539696|FG001|Double-Blind Phase|Other|2|||
149837950|NCT00573443|540539697|FG002|Double-Blind Phase|Other|3|||
149837951|NCT00573443|540539695|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
149837952|NCT00573443|540539696|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
149837953|NCT00573443|540539697|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
149837954|NCT00573443|540539695|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
149837955|NCT00573443|540539696|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
149837956|NCT00573443|540539697|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
149837957|NCT00573443|540539695|FG000|Open-Label Extension Phase|Adverse Event|3|||
150171950|NCT03287622|541765846|FG000|Overall Study|No prescripion after surgery|28|||
150171951|NCT03287622|541765847|FG001|Overall Study|No prescripion after surgery|31|||
149837958|NCT00573443|540539696|FG001|Open-Label Extension Phase|Adverse Event|0|||
149837959|NCT00573443|540539697|FG002|Open-Label Extension Phase|Adverse Event|0|||
149837960|NCT00573443|540539695|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
149837961|NCT00573443|540539696|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
149837962|NCT00573443|540539697|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
149837963|NCT00573443|540539695|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
149837964|NCT00573443|540539696|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
149837965|NCT00573443|540539697|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
149837966|NCT00573443|540539695|FG000|Open-Label Extension Phase|Protocol Violation|2|||
149837967|NCT00573443|540539696|FG001|Open-Label Extension Phase|Protocol Violation|0|||
149837968|NCT00573443|540539697|FG002|Open-Label Extension Phase|Protocol Violation|0|||
149837969|NCT00573443|540539695|FG000|Open-Label Extension Phase|Other|2|||
149837970|NCT00573443|540539696|FG001|Open-Label Extension Phase|Other|0|||
149837971|NCT00573443|540539697|FG002|Open-Label Extension Phase|Other|0|||
149837972|NCT02472366|540539700|FG000|Overall Study|Lost to Follow-up|1|||
149837973|NCT02472366|540539701|FG001|Overall Study|Lost to Follow-up|0|||
149837974|NCT03699020|540539704|FG000|Overall Study|Withdrawal by Subject|3|||
149837975|NCT03699020|540539705|FG001|Overall Study|Withdrawal by Subject|2|||
149837976|NCT00448019|540539707|FG000|Overall Study|Withdrawal by Subject|3|||
149837977|NCT00448019|540539707|FG000|Overall Study|Disease progression|1|||
149837978|NCT00448019|540539707|FG000|Overall Study|Death|2|||
149837979|NCT00448019|540539707|FG000|Overall Study|Insurance Issues|1|||
149837980|NCT01273805|540539708|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
149837981|NCT01273805|540539709|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
149837982|NCT02647944|540539710|FG000|Overall Study|Withdrawal by Subject|0|||
149837983|NCT02647944|540539711|FG001|Overall Study|Withdrawal by Subject|3|||
149837984|NCT02647944|540539710|FG000|Overall Study|Adverse Event|2|||
149837985|NCT02647944|540539711|FG001|Overall Study|Adverse Event|0|||
149837986|NCT02760368|540539716|FG000|Overall Study|Withdrawal by Subject|8|||
149837987|NCT02760368|540539717|FG001|Overall Study|Withdrawal by Subject|12|||
149837988|NCT02760368|540539718|FG002|Overall Study|Withdrawal by Subject|9|||
149837989|NCT02760368|540539716|FG000|Overall Study|Screen Failure|0|||
149837990|NCT02760368|540539717|FG001|Overall Study|Screen Failure|0|||
149837991|NCT02760368|540539718|FG002|Overall Study|Screen Failure|1|||
149837992|NCT02760368|540539716|FG000|Overall Study|Death|0|||
149837993|NCT02760368|540539717|FG001|Overall Study|Death|1|||
149837994|NCT02760368|540539718|FG002|Overall Study|Death|0|||
149837995|NCT02760368|540539716|FG000|Overall Study|Withdrawal by Sponsor|0|||
149837996|NCT02760368|540539717|FG001|Overall Study|Withdrawal by Sponsor|0|||
149837997|NCT02760368|540539718|FG002|Overall Study|Withdrawal by Sponsor|1|||
149837998|NCT04533594|540539724|FG000|Overall Study|Death|26|||
149837999|NCT00473330|540539728|FG000|Core Study|Adverse Event|4|||
149838000|NCT00473330|540539729|FG001|Core Study|Adverse Event|4|||
149838001|NCT00473330|540539730|FG002|Core Study|Adverse Event|1|||
149838002|NCT00473330|540539728|FG000|Core Study|Death|6|||
149838003|NCT00473330|540539729|FG001|Core Study|Death|4|||
149838004|NCT00473330|540539730|FG002|Core Study|Death|4|||
149838005|NCT00473330|540539728|FG000|Core Study|Lost to Follow-up|5|||
149838006|NCT00473330|540539729|FG001|Core Study|Lost to Follow-up|5|||
149838007|NCT00473330|540539730|FG002|Core Study|Lost to Follow-up|10|||
149838008|NCT00473330|540539728|FG000|Core Study|Physician Decision|2|||
149838009|NCT00473330|540539729|FG001|Core Study|Physician Decision|1|||
149838010|NCT00473330|540539730|FG002|Core Study|Physician Decision|3|||
149838011|NCT00473330|540539728|FG000|Core Study|Subject Non-compliance|1|||
149838012|NCT00473330|540539729|FG001|Core Study|Subject Non-compliance|2|||
149838013|NCT00473330|540539730|FG002|Core Study|Subject Non-compliance|1|||
149838014|NCT00473330|540539728|FG000|Core Study|Subject Required Other Therapy|0|||
149838015|NCT00473330|540539729|FG001|Core Study|Subject Required Other Therapy|1|||
149838016|NCT00473330|540539730|FG002|Core Study|Subject Required Other Therapy|3|||
149838017|NCT00473330|540539728|FG000|Core Study|Subject's Decision|9|||
149838018|NCT00473330|540539729|FG001|Core Study|Subject's Decision|8|||
149838019|NCT00473330|540539730|FG002|Core Study|Subject's Decision|19|||
149838020|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
149838021|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
149838022|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
149838023|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Death|2|||
150282318|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
150282319|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
150282320|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
150282321|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
149838024|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Death|0|||
149838025|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Death|0|||
149838026|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
149838027|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
149838028|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
149838029|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
149838030|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
149838031|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
149838032|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
149838033|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
149838034|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
149838035|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
149838036|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
149838037|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
149838038|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
149838039|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
150282322|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
150282323|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
150282324|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
150282325|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
150282326|NCT03631732|542170420|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
150282327|NCT03631732|542170421|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
150282328|NCT00501007|542170422|FG000|Overall Study|Inclusion criteria not met.|29|||
150282329|NCT00501007|542170423|FG001|Overall Study|Inclusion criteria not met.|25|||
150282330|NCT03917823|542170424|FG000|Overall Study|Lost to Follow-up|1|||
150282331|NCT03917823|542170425|FG001|Overall Study|Lost to Follow-up|1|||
150282332|NCT03917823|542170424|FG000|Overall Study|Withdrawal by Subject|0|||
150282333|NCT03917823|542170425|FG001|Overall Study|Withdrawal by Subject|1|||
150282334|NCT00135668|542170426|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
150282335|NCT00135668|542170427|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
150282336|NCT00135668|542170428|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
150282337|NCT00135668|542170429|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
150282338|NCT02424253|542170430|FG000|Overall Study|Other, unspecified|1|||
150282339|NCT02424253|542170431|FG001|Overall Study|Other, unspecified|0|||
149838040|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
149838041|NCT00473330|540539728|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
149838042|NCT00473330|540539729|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
149838043|NCT00473330|540539730|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
149838044|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
149838045|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
149838046|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
149838047|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Death|2|||
149838048|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Death|2|||
149838049|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Death|1|||
149838050|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
149838051|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
149838052|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
149838053|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
149838054|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
149838055|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
149838056|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
149838057|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
149838058|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
149838059|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
149838060|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
149838061|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
149838062|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
149838063|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
149838064|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
149838065|NCT00473330|540539728|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
149838066|NCT00473330|540539729|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
149838067|NCT00473330|540539730|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
149838068|NCT01975948|540539731|FG000|Overall Study|Withdrawal by Subject|17|||
149838069|NCT01975948|540539732|FG001|Overall Study|Withdrawal by Subject|21|||
149838070|NCT01975948|540539733|FG002|Overall Study|Withdrawal by Subject|7|||
149838071|NCT01975948|540539734|FG003|Overall Study|Withdrawal by Subject|6|||
149838072|NCT02937870|540539735|FG000|Overall Study|Adverse Event|1|||
149838073|NCT02937870|540539735|FG000|Overall Study|Protocol Deviation|2|||
149838074|NCT00609674|540539739|FG000|Overall Study|Adverse Event|1|||
149838075|NCT00609674|540539740|FG001|Overall Study|Adverse Event|1|||
149838076|NCT00609674|540539739|FG000|Overall Study|Protocol Violation|3|||
149838077|NCT00609674|540539740|FG001|Overall Study|Protocol Violation|5|||
149838078|NCT00609674|540539739|FG000|Overall Study|Lost to Follow-up|1|||
149838079|NCT00609674|540539740|FG001|Overall Study|Lost to Follow-up|0|||
149838080|NCT00609674|540539739|FG000|Overall Study|Withdrew consent|2|||
149838081|NCT00609674|540539740|FG001|Overall Study|Withdrew consent|1|||
149838082|NCT03098394|540539741|FG000|Overall Study|Pregnancy|0|||
149838083|NCT03098394|540539742|FG001|Overall Study|Pregnancy|1|||
149838084|NCT00244764|540539746|FG000|Overall Study|Adverse Event|37|||
149838085|NCT00244764|540539746|FG000|Overall Study|Lost to Follow-up|23|||
149838086|NCT00244764|540539746|FG000|Overall Study|Withdrawal by Subject|12|||
149838087|NCT00244764|540539746|FG000|Overall Study|Disease Progression|13|||
149838088|NCT00244764|540539746|FG000|Overall Study|Protocol Violation|2|||
149838089|NCT00244764|540539746|FG000|Overall Study|Death|1|||
149838090|NCT00244764|540539746|FG000|Overall Study|Off Study Medication for >21 Days|1|||
150282340|NCT02424253|542170430|FG000|Overall Study|Compliance problems|1|||
149975665|NCT01783444|541049390|FG001|Treatment Phase|Administrative problems|0|||
149975666|NCT01783444|541049391|FG002|Treatment Phase|Administrative problems|1|||
149975667|NCT01783444|541049389|FG000|Treatment Phase|Physician Decision|8|||
149975668|NCT01783444|541049390|FG001|Treatment Phase|Physician Decision|6|||
149975669|NCT01783444|541049391|FG002|Treatment Phase|Physician Decision|5|||
149975670|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
149975671|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
149975672|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
149975673|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
149975674|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
149975675|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
149975676|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
150282341|NCT02424253|542170431|FG001|Overall Study|Compliance problems|0|||
150282342|NCT02424253|542170430|FG000|Overall Study|Physician Decision|2|||
150282343|NCT02424253|542170431|FG001|Overall Study|Physician Decision|0|||
150282344|NCT02424253|542170430|FG000|Overall Study|Lack of Efficacy|0|||
150282345|NCT02424253|542170431|FG001|Overall Study|Lack of Efficacy|7|||
150282346|NCT02424253|542170430|FG000|Overall Study|Adverse Event|2|||
150282347|NCT02424253|542170431|FG001|Overall Study|Adverse Event|0|||
150282348|NCT02424253|542170430|FG000|Overall Study|Consent withdrawn by subject|4|||
150282349|NCT02424253|542170431|FG001|Overall Study|Consent withdrawn by subject|1|||
150282350|NCT02424253|542170430|FG000|Overall Study|Lost to Follow-up|1|||
149975677|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
149975678|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
149975679|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
149975680|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
149975681|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
149975682|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
149975683|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
149975684|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
149975685|NCT01783444|541049389|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
149975686|NCT01783444|541049390|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
149975687|NCT01783444|541049391|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
149975688|NCT00272792|541049393|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
149975689|NCT00272792|541049394|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
149975690|NCT00272792|541049393|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
149975691|NCT00272792|541049394|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
149975692|NCT00272792|541049393|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
149975693|NCT00272792|541049394|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
149975694|NCT00272792|541049393|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
149975695|NCT00272792|541049394|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
149975696|NCT00288015|541049397|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
149975697|NCT00288015|541049397|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
149975698|NCT00288015|541049397|FG000|First Response Assessment|Withdrawal by Subject|1|||
149975699|NCT00288015|541049397|FG000|First Response Assessment|Death|1|||
149975700|NCT00288015|541049397|FG000|First Response Assessment|Physician Decision|2|||
149975701|NCT00288015|541049397|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
149975702|NCT00288015|541049397|FG000|Follow up for Survival x 2 Years|Death|13|||
149975703|NCT00288015|541049397|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
149975704|NCT00288015|541049397|FG000|Follow up for Survival x 2 Years|Other|9|||
149975705|NCT00443703|541049398|FG000|Overall Study|Never Treated|3|||
149975706|NCT00443703|541049399|FG001|Overall Study|Never Treated|1|||
149975707|NCT00443703|541049398|FG000|Overall Study|Adverse Event|7|||
150282351|NCT02424253|542170431|FG001|Overall Study|Lost to Follow-up|1|||
149838091|NCT00244764|540539746|FG000|Overall Study|Declining Performance Status|1|||
149838092|NCT00244764|540539746|FG000|Overall Study|Participant was Hospitalized until Death|1|||
149838093|NCT00244764|540539746|FG000|Overall Study|Primary Investigator Discretion|2|||
149838094|NCT00244764|540539746|FG000|Overall Study|Sponsor Terminated Study|2|||
149838095|NCT00244764|540539746|FG000|Overall Study|Developed Secondary Malignancy|1|||
149838096|NCT01001208|540539749|FG000|Overall Study|Adverse Event|10|||
149838097|NCT01001208|540539750|FG001|Overall Study|Adverse Event|5|||
149838098|NCT01001208|540539749|FG000|Overall Study|Lost to Follow-up|5|||
149838099|NCT01001208|540539750|FG001|Overall Study|Lost to Follow-up|9|||
149838100|NCT01001208|540539749|FG000|Overall Study|Physician Decision|1|||
149838101|NCT01001208|540539750|FG001|Overall Study|Physician Decision|0|||
149838102|NCT01001208|540539749|FG000|Overall Study|Withdrawal by Subject|4|||
149838103|NCT01001208|540539750|FG001|Overall Study|Withdrawal by Subject|5|||
149838104|NCT01001208|540539749|FG000|Overall Study|Ineligibility Determined|4|||
149838105|NCT01001208|540539750|FG001|Overall Study|Ineligibility Determined|2|||
149838106|NCT01001208|540539749|FG000|Overall Study|Noncompliance|4|||
149838107|NCT01001208|540539750|FG001|Overall Study|Noncompliance|7|||
149838108|NCT01001208|540539749|FG000|Overall Study|Disease Progression|0|||
149838109|NCT01001208|540539750|FG001|Overall Study|Disease Progression|3|||
149838110|NCT01001208|540539749|FG000|Overall Study|Other|0|||
149838111|NCT01001208|540539750|FG001|Overall Study|Other|2|||
149838112|NCT03546842|540539751|FG000|Overall Study|Protocol Violation|1|||
149838113|NCT03546842|540539751|FG000|Overall Study|Withdrawal by Subject|2|||
149838114|NCT01723397|540539752|FG000|Study Period 1|Protocol Violation|0|||
149838115|NCT01723397|540539753|FG001|Study Period 1|Protocol Violation|1|||
149838116|NCT01723397|540539752|FG000|Study Period 2|Protocol Violation|0|||
149838117|NCT01723397|540539753|FG001|Study Period 2|Protocol Violation|1|||
149838118|NCT00833937|540539759|FG000|Washout|Withdrawal by Subject|1|||
149838119|NCT00833937|540539760|FG001|Washout|Withdrawal by Subject|0|||
149838120|NCT03031847|540539761|FG000|Overall Study|Death|1|||
149838121|NCT03031847|540539762|FG001|Overall Study|Death|1|||
149838122|NCT03031847|540539763|FG002|Overall Study|Death|2|||
149838123|NCT03031847|540539764|FG003|Overall Study|Death|3|||
149838124|NCT03031847|540539761|FG000|Overall Study|Lost to Follow-up|1|||
149838125|NCT03031847|540539762|FG001|Overall Study|Lost to Follow-up|1|||
149838126|NCT03031847|540539763|FG002|Overall Study|Lost to Follow-up|2|||
149838127|NCT03031847|540539764|FG003|Overall Study|Lost to Follow-up|3|||
149838128|NCT01353664|540539765|FG000|Overall Study|Other|3|||
149838129|NCT01353664|540539765|FG000|Overall Study|Disease Progression|16|||
149838130|NCT01237054|540539766|FG000|Overall Study|imaging 10C0096|1|||
149838131|NCT05323396|540539767|FG000|Overall Study|Lost to Follow-up|1|||
149838132|NCT05323396|540539768|FG001|Overall Study|Lost to Follow-up|35|||
149838133|NCT05323396|540539767|FG000|Overall Study|Pregnancy|1|||
149838134|NCT05323396|540539768|FG001|Overall Study|Pregnancy|0|||
149838135|NCT00095212|540539777|FG000|Overall Study|Withdrawal by Subject|1|||
149838136|NCT00095212|540539778|FG001|Overall Study|Withdrawal by Subject|3|||
149838137|NCT02242201|540539781|FG000|Overall Study|preoperative identified neuropathy|2|||
149838138|NCT02242201|540539782|FG001|Overall Study|preoperative identified neuropathy|0|||
149838139|NCT02242201|540539783|FG002|Overall Study|preoperative identified neuropathy|0|||
149838140|NCT02242201|540539781|FG000|Overall Study|planned post-op anticoagulation|1|||
149838141|NCT02242201|540539782|FG001|Overall Study|planned post-op anticoagulation|0|||
149838142|NCT02242201|540539783|FG002|Overall Study|planned post-op anticoagulation|0|||
149838143|NCT02242201|540539781|FG000|Overall Study|changed surgical procedure|1|||
149838144|NCT02242201|540539782|FG001|Overall Study|changed surgical procedure|0|||
149838145|NCT02242201|540539783|FG002|Overall Study|changed surgical procedure|0|||
149949983|NCT00177671|540949129|FG000|Overall Study|Withdrawal by Subject|5|||
149949984|NCT00177671|540949130|FG001|Overall Study|Withdrawal by Subject|6|||
149838146|NCT02242201|540539781|FG000|Overall Study|postponed surgery|0|||
149838147|NCT02242201|540539782|FG001|Overall Study|postponed surgery|0|||
149838148|NCT02242201|540539783|FG002|Overall Study|postponed surgery|1|||
149838149|NCT02242201|540539781|FG000|Overall Study|preoperative opioid consumption|0|||
149838150|NCT02242201|540539782|FG001|Overall Study|preoperative opioid consumption|1|||
149838151|NCT02242201|540539783|FG002|Overall Study|preoperative opioid consumption|0|||
149949985|NCT00177671|540949129|FG000|Overall Study|medical complications|2|||
149949986|NCT00177671|540949130|FG001|Overall Study|medical complications|0|||
149949987|NCT00177671|540949129|FG000|Overall Study|Adverse Event|6|||
149949988|NCT00177671|540949130|FG001|Overall Study|Adverse Event|0|||
149838152|NCT03681470|540539784|FG000|Overall Study|Lack of Efficacy|3|||
149838153|NCT03681470|540539784|FG000|Overall Study|Lost to Follow-up|1|||
149838154|NCT03681470|540539784|FG000|Overall Study|Protocol Violation|3|||
149838155|NCT03681470|540539784|FG000|Overall Study|Withdrawal by Subject|1|||
149838156|NCT05593965|540539785|FG000|1st Intervention (1 Day)|Technical error|1|||
149838157|NCT05593965|540539786|FG001|1st Intervention (1 Day)|Technical error|0|||
149838158|NCT02066922|540539787|FG000|Overall Study|Adverse Event|1|||
149838159|NCT03020641|540539788|FG000|Overall Study|Lost to Follow-up|0|||
149838160|NCT03020641|540539789|FG001|Overall Study|Lost to Follow-up|1|||
149838161|NCT03020641|540539788|FG000|Overall Study|Converted to open surgery|2|||
149838162|NCT03020641|540539789|FG001|Overall Study|Converted to open surgery|1|||
149838163|NCT03020641|540539788|FG000|Overall Study|for surgery not performed|0|||
149838164|NCT03020641|540539789|FG001|Overall Study|for surgery not performed|1|||
149838165|NCT04611789|540539790|FG000|Overall Study|Lost to Follow-up|1|||
149838166|NCT04611789|540539791|FG001|Overall Study|Lost to Follow-up|0|||
149838167|NCT04611789|540539792|FG002|Overall Study|Lost to Follow-up|0|||
149838168|NCT03238781|540539794|FG000|Overall Study|Adverse Event|1|||
149838169|NCT03238781|540539795|FG001|Overall Study|Adverse Event|1|||
149838170|NCT03238781|540539796|FG002|Overall Study|Adverse Event|2|||
149838171|NCT03238781|540539794|FG000|Overall Study|Lost to Follow-up|2|||
149838172|NCT03238781|540539795|FG001|Overall Study|Lost to Follow-up|1|||
149838173|NCT03238781|540539796|FG002|Overall Study|Lost to Follow-up|2|||
149838174|NCT03238781|540539794|FG000|Overall Study|Withdrawal by Subject|23|||
149838175|NCT03238781|540539795|FG001|Overall Study|Withdrawal by Subject|14|||
149838176|NCT03238781|540539796|FG002|Overall Study|Withdrawal by Subject|16|||
149838177|NCT03238781|540539794|FG000|Overall Study|Decision by sponsor|0|||
149838178|NCT03238781|540539795|FG001|Overall Study|Decision by sponsor|1|||
149838179|NCT03238781|540539796|FG002|Overall Study|Decision by sponsor|0|||
149838180|NCT03161405|540539797|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
149838181|NCT00837486|540539798|FG000|Blinded-treatment Phase|Physician Decision|1|||
149838182|NCT00837486|540539799|FG001|Blinded-treatment Phase|Physician Decision|0|||
149838183|NCT00837486|540539798|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
149838184|NCT00837486|540539799|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
149838185|NCT00837486|540539798|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
149838186|NCT00837486|540539799|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
149838187|NCT00837486|540539798|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
149838188|NCT00837486|540539799|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
149838189|NCT02655679|540539800|FG000|Overall Study|Adverse Event|0|||
149838190|NCT02655679|540539801|FG001|Overall Study|Adverse Event|1|||
149838191|NCT02655679|540539802|FG002|Overall Study|Adverse Event|0|||
149838192|NCT02655679|540539803|FG003|Overall Study|Adverse Event|0|||
149838193|NCT02655679|540539804|FG004|Overall Study|Adverse Event|0|||
149838194|NCT02655679|540539800|FG000|Overall Study|Withdrawal by Subject|1|||
149838195|NCT02655679|540539801|FG001|Overall Study|Withdrawal by Subject|1|||
149838196|NCT02655679|540539802|FG002|Overall Study|Withdrawal by Subject|0|||
149838197|NCT02655679|540539803|FG003|Overall Study|Withdrawal by Subject|3|||
149838198|NCT02655679|540539804|FG004|Overall Study|Withdrawal by Subject|1|||
149838199|NCT02655679|540539800|FG000|Overall Study|Inability to Comply with the Protocol|1|||
149838200|NCT02655679|540539801|FG001|Overall Study|Inability to Comply with the Protocol|0|||
149838201|NCT02655679|540539802|FG002|Overall Study|Inability to Comply with the Protocol|0|||
149838202|NCT02655679|540539803|FG003|Overall Study|Inability to Comply with the Protocol|0|||
149838203|NCT02655679|540539804|FG004|Overall Study|Inability to Comply with the Protocol|0|||
149838204|NCT02655679|540539800|FG000|Overall Study|Lost to Follow-up|0|||
149838205|NCT02655679|540539801|FG001|Overall Study|Lost to Follow-up|1|||
149838206|NCT02655679|540539802|FG002|Overall Study|Lost to Follow-up|1|||
149838207|NCT02655679|540539803|FG003|Overall Study|Lost to Follow-up|1|||
149838208|NCT02655679|540539804|FG004|Overall Study|Lost to Follow-up|0|||
149838209|NCT02655679|540539800|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149838210|NCT02655679|540539801|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149838211|NCT02655679|540539802|FG002|Overall Study|Other Miscellaneous Reasons|0|||
149838212|NCT02655679|540539803|FG003|Overall Study|Other Miscellaneous Reasons|0|||
149838213|NCT02655679|540539804|FG004|Overall Study|Other Miscellaneous Reasons|0|||
149838214|NCT02039908|540539805|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
149838215|NCT02039908|540539806|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
149838216|NCT02039908|540539807|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
149838217|NCT02039908|540539808|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
149838218|NCT02039908|540539805|FG000|Phase 1-Summer|Protocol Violation|6|||
149838219|NCT02039908|540539806|FG001|Phase 1-Summer|Protocol Violation|0|||
149838220|NCT02039908|540539807|FG002|Phase 1-Summer|Protocol Violation|0|||
149838221|NCT02039908|540539808|FG003|Phase 1-Summer|Protocol Violation|0|||
149838222|NCT02039908|540539805|FG000|Phase 2-School Year|Lost to Follow-up|0|||
149838223|NCT02039908|540539806|FG001|Phase 2-School Year|Lost to Follow-up|0|||
149838224|NCT02039908|540539807|FG002|Phase 2-School Year|Lost to Follow-up|1|||
149838225|NCT02039908|540539808|FG003|Phase 2-School Year|Lost to Follow-up|3|||
149949989|NCT00177671|540949129|FG000|Overall Study|Physician Decision|12|||
149838226|NCT02039908|540539805|FG000|Phase 2-School Year|Protocol Violation|0|||
149838227|NCT02039908|540539806|FG001|Phase 2-School Year|Protocol Violation|0|||
149838228|NCT02039908|540539807|FG002|Phase 2-School Year|Protocol Violation|3|||
149838229|NCT02039908|540539808|FG003|Phase 2-School Year|Protocol Violation|0|||
149838230|NCT02039908|540539805|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
149838231|NCT02039908|540539806|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
149838232|NCT02039908|540539807|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
149838233|NCT02039908|540539808|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
149949990|NCT00177671|540949130|FG001|Overall Study|Physician Decision|8|||
149975708|NCT00443703|541049399|FG001|Overall Study|Adverse Event|3|||
149838234|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
149838235|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
149838236|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
149838237|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
149838238|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838239|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838240|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838241|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838242|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838243|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838244|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838245|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838246|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838247|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838248|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838249|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838250|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838251|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838252|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838253|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838254|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
149838255|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
149838256|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
149838257|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
149838258|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
149838259|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838260|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838261|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838262|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838263|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838264|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838265|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838266|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838267|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838268|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838269|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838270|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838271|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838272|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838273|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838274|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838275|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
149838276|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
149838277|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
149838278|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
149838279|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
149838280|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838281|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838282|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838283|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838284|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838285|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838286|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838287|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838288|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149949991|NCT02293499|540949131|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
149949992|NCT02293499|540949132|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
149949993|NCT02293499|540949133|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
149949994|NCT02293499|540949131|FG000|Intervention - Camp|Withdrawal by Subject|3|||
149949995|NCT02293499|540949132|FG001|Intervention - Camp|Withdrawal by Subject|6|||
149949996|NCT02293499|540949133|FG002|Intervention - Camp|Withdrawal by Subject|2|||
149838289|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838290|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838291|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838292|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149949997|NCT02293499|540949131|FG000|Intervention - Camp|these are those not showing up at camp|24|||
149838293|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838294|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838295|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838296|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
149838297|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
149838298|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
149838299|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
149838300|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838301|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838302|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838303|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838304|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838305|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838306|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838307|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838308|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838309|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838310|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838311|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838312|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838313|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838314|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838315|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838316|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838317|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
149838318|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
149838319|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838320|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838321|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
149838322|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838323|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838324|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838325|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838326|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838327|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838328|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838329|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838330|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838331|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838332|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838333|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838334|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838335|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838336|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838337|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838338|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
149838339|NCT01597245|540539809|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
149838340|NCT01597245|540539810|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
149838341|NCT01597245|540539811|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
149838342|NCT01597245|540539812|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838343|NCT01597245|540539813|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838344|NCT01597245|540539814|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838345|NCT01597245|540539815|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838346|NCT01597245|540539816|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838347|NCT01597245|540539817|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838348|NCT01597245|540539818|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838349|NCT01597245|540539819|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838350|NCT01597245|540539820|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
150171952|NCT03287622|541765846|FG000|Overall Study|prolonged Length of stay|2|||
150171953|NCT03287622|541765847|FG001|Overall Study|prolonged Length of stay|0|||
149838351|NCT01597245|540539821|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838352|NCT01597245|540539822|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838353|NCT01597245|540539823|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
150171954|NCT03287622|541765846|FG000|Overall Study|surgery related|0|||
149838354|NCT01597245|540539824|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
150171955|NCT03287622|541765847|FG001|Overall Study|surgery related|2|||
149838355|NCT01597245|540539825|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838356|NCT01597245|540539826|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838357|NCT01597245|540539827|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149949998|NCT02293499|540949132|FG001|Intervention - Camp|these are those not showing up at camp|28|||
149949999|NCT02293499|540949133|FG002|Intervention - Camp|these are those not showing up at camp|4|||
149838358|NCT01597245|540539828|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149838359|NCT01597245|540539829|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
149950000|NCT02293499|540949131|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
149950001|NCT02293499|540949132|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
149950002|NCT02293499|540949133|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
149950003|NCT02293499|540949131|FG000|3 Month Follow Up|Lost to Follow-up|14|||
149950004|NCT02293499|540949132|FG001|3 Month Follow Up|Lost to Follow-up|15|||
149950005|NCT02293499|540949133|FG002|3 Month Follow Up|Lost to Follow-up|6|||
149950006|NCT02293499|540949131|FG000|6 Month Follow Up|Lost to Follow-up|17|||
149950007|NCT02293499|540949132|FG001|6 Month Follow Up|Lost to Follow-up|27|||
149950008|NCT02293499|540949133|FG002|6 Month Follow Up|Lost to Follow-up|6|||
149950009|NCT02293499|540949131|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
149950010|NCT02293499|540949132|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
149950011|NCT02293499|540949133|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
149950012|NCT02293499|540949131|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
149950013|NCT02293499|540949132|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
149950014|NCT02293499|540949133|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
149950015|NCT02293499|540949131|FG000|9 Month Follow Up|Lost to Follow-up|24|||
149950016|NCT02293499|540949132|FG001|9 Month Follow Up|Lost to Follow-up|28|||
149950017|NCT02293499|540949133|FG002|9 Month Follow Up|Lost to Follow-up|4|||
149950018|NCT02293499|540949131|FG000|12 Month Follow Up|Lost to Follow-up|26|||
149950019|NCT02293499|540949132|FG001|12 Month Follow Up|Lost to Follow-up|25|||
149950020|NCT02293499|540949133|FG002|12 Month Follow Up|Lost to Follow-up|6|||
149950021|NCT02293499|540949131|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
149838360|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838361|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838362|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838363|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838364|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149950022|NCT02293499|540949132|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
150282352|NCT02370615|542170434|FG000|Overall Study|Adverse Event|1|||
149838365|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
149838366|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
150282353|NCT02370615|542170435|FG001|Overall Study|Adverse Event|0|||
150282354|NCT00455013|542170438|FG000|Short Term Period|Adverse Event|2|||
150282355|NCT00455013|542170439|FG001|Short Term Period|Adverse Event|5|||
150282356|NCT00455013|542170440|FG002|Short Term Period|Adverse Event|0|||
150282357|NCT00455013|542170438|FG000|Short Term Period|Withdrawal by Subject|0|||
149838367|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838368|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838369|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838370|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838371|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838372|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838373|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838374|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838375|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838376|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838377|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838378|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838379|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149838380|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
149950023|NCT02293499|540949133|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
149950024|NCT02293499|540949131|FG000|15 Month Follow Up|Lost to Follow-up|22|||
150282358|NCT00455013|542170439|FG001|Short Term Period|Withdrawal by Subject|0|||
150282359|NCT00455013|542170440|FG002|Short Term Period|Withdrawal by Subject|1|||
150282360|NCT00455013|542170438|FG000|Short Term Period|Lack of Efficacy|4|||
150282361|NCT00455013|542170439|FG001|Short Term Period|Lack of Efficacy|0|||
150282362|NCT00455013|542170440|FG002|Short Term Period|Lack of Efficacy|0|||
150282363|NCT00455013|542170438|FG000|Short Term Period|Other|0|||
150282364|NCT00455013|542170439|FG001|Short Term Period|Other|0|||
150282365|NCT00455013|542170440|FG002|Short Term Period|Other|1|||
150282366|NCT00455013|542170438|FG000|Long Term Extension (LTE)|Adverse Event|0|||
150282367|NCT00455013|542170439|FG001|Long Term Extension (LTE)|Adverse Event|1|||
150282368|NCT00455013|542170440|FG002|Long Term Extension (LTE)|Adverse Event|1|||
149838381|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838382|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838383|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838384|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838385|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
149838386|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
149838387|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
149838388|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
149838389|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
150282369|NCT00455013|542170438|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
150282370|NCT00455013|542170439|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
150282371|NCT00455013|542170440|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
150282372|NCT00455013|542170438|FG000|Long Term Extension (LTE)|Death|1|||
150282373|NCT00455013|542170439|FG001|Long Term Extension (LTE)|Death|1|||
150282374|NCT00455013|542170440|FG002|Long Term Extension (LTE)|Death|0|||
150282375|NCT00455013|542170438|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
149838390|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
149838391|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838392|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838393|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838394|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838395|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838396|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838397|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838398|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838399|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838400|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838401|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
149838402|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838403|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838404|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838405|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838406|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
150282376|NCT00455013|542170439|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
150282377|NCT00455013|542170440|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
150282378|NCT00455013|542170438|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
150282379|NCT00455013|542170439|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
150282380|NCT00455013|542170440|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
150282381|NCT00455013|542170438|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
149838407|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
149838408|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838409|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838410|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
149838411|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149950025|NCT02293499|540949132|FG001|15 Month Follow Up|Lost to Follow-up|22|||
149950026|NCT02293499|540949133|FG002|15 Month Follow Up|Lost to Follow-up|7|||
149950027|NCT00690898|540949134|FG000|SCREENING|Screen failure|18|||
149950028|NCT00690898|540949134|FG000|TREATMENT|Adverse Event|3|||
149950029|NCT00690898|540949134|FG000|TREATMENT|Lack of Efficacy|18|||
149950030|NCT00690898|540949134|FG000|TREATMENT|Withdrawal by Subject|4|||
149950031|NCT00690898|540949134|FG000|TREATMENT|Other (not otherwise specified)|1|||
149950032|NCT05977868|540949135|FG000|Overall Study|Withdrawal by Subject|1|||
149950033|NCT05977868|540949136|FG001|Overall Study|Withdrawal by Subject|2|||
149950034|NCT05977868|540949135|FG000|Overall Study|Transitioned to comfort care|1|||
149950035|NCT05977868|540949136|FG001|Overall Study|Transitioned to comfort care|0|||
149950036|NCT01991314|540949145|FG000|Overall Study|Adverse Event|5|||
149950037|NCT01991314|540949146|FG001|Overall Study|Adverse Event|1|||
150282382|NCT00455013|542170439|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
150282383|NCT00455013|542170440|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
150282384|NCT00455013|542170438|FG000|Long Term Extension (LTE)|non-specified|0|||
149838412|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
149950038|NCT01991314|540949145|FG000|Overall Study|Lost to Follow-up|6|||
150282385|NCT00455013|542170439|FG001|Long Term Extension (LTE)|non-specified|0|||
150282386|NCT00455013|542170440|FG002|Long Term Extension (LTE)|non-specified|1|||
150282387|NCT01445951|542170441|FG000|Overall Study|Adverse Event|16|||
150282388|NCT01445951|542170442|FG001|Overall Study|Adverse Event|9|||
150282389|NCT01445951|542170443|FG002|Overall Study|Adverse Event|0|||
150282390|NCT01445951|542170441|FG000|Overall Study|Protocol Violation|2|||
150282391|NCT01445951|542170442|FG001|Overall Study|Protocol Violation|2|||
150282392|NCT01445951|542170443|FG002|Overall Study|Protocol Violation|2|||
149950039|NCT01991314|540949146|FG001|Overall Study|Lost to Follow-up|10|||
149950040|NCT01136954|540949147|FG000|Overall Study|Adverse Event|3|||
149838413|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
149838414|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
149838415|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838416|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838417|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838418|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838419|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838420|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838421|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838422|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
149838423|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838424|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838425|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838426|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838427|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
149838428|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
149838429|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
149838430|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
149838431|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
149838432|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
149838433|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
149838434|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
149838435|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
149838436|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838437|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838438|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838439|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838440|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838441|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838442|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838443|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
149838444|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838445|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838446|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838447|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838448|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
149838449|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
149838450|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
149838451|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838452|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
149838453|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
149838454|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
149838455|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
149838456|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
149838457|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838458|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838459|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838460|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838461|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838462|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838463|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
149838464|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
150171956|NCT02057692|541765851|FG000|Overall Study|Adverse Event|1|||
150171957|NCT02057692|541765852|FG001|Overall Study|Adverse Event|0|||
150171958|NCT02057692|541765853|FG002|Overall Study|Adverse Event|0|||
150171959|NCT02057692|541765854|FG003|Overall Study|Adverse Event|0|||
150171960|NCT02057692|541765851|FG000|Overall Study|Lost to Follow-up|0|||
150171961|NCT02057692|541765852|FG001|Overall Study|Lost to Follow-up|0|||
150171962|NCT02057692|541765853|FG002|Overall Study|Lost to Follow-up|0|||
150171963|NCT02057692|541765854|FG003|Overall Study|Lost to Follow-up|1|||
150171964|NCT03923491|541765855|FG000|Overall Study|Lost to Follow-up|5|||
150171965|NCT03923491|541765856|FG001|Overall Study|Lost to Follow-up|8|||
150171966|NCT03923491|541765855|FG000|Overall Study|Withdrawal by Subject|4|||
150171967|NCT03923491|541765856|FG001|Overall Study|Withdrawal by Subject|6|||
150171968|NCT03823300|541765863|FG000|Overall Study|Withdrawal by Subject|16|||
150171969|NCT03823300|541765864|FG001|Overall Study|Withdrawal by Subject|22|||
149838465|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838466|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838467|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838468|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838469|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
149838470|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838471|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838472|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838473|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
149838474|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
149838475|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
149838476|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838477|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
149838478|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838479|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838480|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838481|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838482|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838483|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838484|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838485|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
149838486|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838487|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838488|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838489|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838490|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
149838491|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
149838492|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
149838493|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838494|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
149838495|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
149838496|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
149838497|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
149838498|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
149838499|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838500|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838501|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838502|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838503|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838504|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838505|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838506|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
149838507|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838508|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838509|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838510|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838511|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149950041|NCT01136954|540949148|FG001|Overall Study|Adverse Event|2|||
149950042|NCT01136954|540949147|FG000|Overall Study|Withdrawal by Subject|6|||
149950043|NCT01136954|540949148|FG001|Overall Study|Withdrawal by Subject|2|||
149950044|NCT01136954|540949147|FG000|Overall Study|Lack of Efficacy|14|||
149950045|NCT01136954|540949148|FG001|Overall Study|Lack of Efficacy|13|||
149950046|NCT01136954|540949147|FG000|Overall Study|Physician Decision|0|||
149950047|NCT01136954|540949148|FG001|Overall Study|Physician Decision|1|||
149950048|NCT01136954|540949147|FG000|Overall Study|Other|1|||
149950049|NCT01136954|540949148|FG001|Overall Study|Other|3|||
149950050|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
149950051|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
149950052|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
149950053|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
149950054|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
149950055|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
149950056|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
149950057|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
149950058|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
149950059|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
149838512|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
149838513|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838514|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838515|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
149838516|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
149838517|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
149838518|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
149838519|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838520|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838521|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838522|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838523|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838524|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838525|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838526|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838527|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149838528|NCT01597245|540539809|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838529|NCT01597245|540539810|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838530|NCT01597245|540539811|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838531|NCT01597245|540539812|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838532|NCT01597245|540539813|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838533|NCT01597245|540539814|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838534|NCT01597245|540539815|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838535|NCT01597245|540539816|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838536|NCT01597245|540539817|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838537|NCT01597245|540539818|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838538|NCT01597245|540539819|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
149838539|NCT01597245|540539820|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838540|NCT01597245|540539821|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838541|NCT01597245|540539822|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838542|NCT01597245|540539823|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838543|NCT01597245|540539824|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838544|NCT01597245|540539825|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838545|NCT01597245|540539826|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838546|NCT01597245|540539827|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838547|NCT01597245|540539828|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838548|NCT01597245|540539829|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
149838549|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838550|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838551|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838552|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838553|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838554|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838555|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838556|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838557|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838558|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838559|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838560|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838561|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838562|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
149838563|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
149838564|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
149838565|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838566|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838567|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838568|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838569|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
149838570|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838571|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838572|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838573|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838574|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838575|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838576|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838577|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838578|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838579|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838580|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838581|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838582|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838583|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
149838584|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
149838585|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
149838586|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838587|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838588|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838589|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838590|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
149838591|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838592|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838593|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838594|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838595|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838596|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838597|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838598|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838599|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838600|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838601|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838602|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838603|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838604|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838605|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
149838606|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
149838607|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838608|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838609|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838610|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838611|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
149838612|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838613|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838614|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838615|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838616|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838617|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838618|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838619|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838620|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838621|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838622|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838623|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838624|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838625|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838626|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
149838627|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
149838628|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838629|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149950060|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Death|0|||
149950061|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Death|0|||
149950062|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Death|1|||
149950063|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Death|0|||
149950064|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Death|0|||
149950065|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
149950066|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
149950067|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
149950068|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
149950069|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
149950070|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Other|2|||
149950071|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Other|1|||
149950072|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Other|0|||
149838630|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838631|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838632|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
149838633|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838634|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838635|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838636|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838637|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838638|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838639|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838640|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838641|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838642|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838643|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838644|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838645|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838646|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
149838647|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
149838648|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
149838649|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838650|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838651|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838652|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149838653|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
149950073|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Other|0|||
149950074|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Other|0|||
149950075|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
150282393|NCT01445951|542170441|FG000|Overall Study|Withdrawal by Subject|21|||
150282394|NCT01445951|542170442|FG001|Overall Study|Withdrawal by Subject|16|||
150282395|NCT01445951|542170443|FG002|Overall Study|Withdrawal by Subject|8|||
149950076|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
149950077|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
149950078|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
149950079|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
149950080|NCT03317496|540949149|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
149950081|NCT03317496|540949150|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
149950082|NCT03317496|540949151|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
149950083|NCT03317496|540949152|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
149950084|NCT03317496|540949153|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
149950085|NCT03317496|540949149|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
149950086|NCT03317496|540949150|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
149950087|NCT03317496|540949151|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
149950088|NCT03317496|540949152|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
149950089|NCT03317496|540949153|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
149950090|NCT03317496|540949149|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
149950091|NCT03317496|540949150|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
149950092|NCT03317496|540949151|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
149950093|NCT03317496|540949152|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
149950094|NCT03317496|540949153|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
149950095|NCT03317496|540949149|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
149950096|NCT03317496|540949150|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
149950097|NCT03317496|540949151|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
149950098|NCT03317496|540949152|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
149950099|NCT03317496|540949153|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
149950100|NCT03317496|540949149|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
149950101|NCT03317496|540949150|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
149950102|NCT03317496|540949151|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
149950103|NCT03317496|540949152|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
149950104|NCT03317496|540949153|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
149950105|NCT03317496|540949149|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
149950106|NCT03317496|540949150|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
149950107|NCT03317496|540949151|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
149975709|NCT00443703|541049398|FG000|Overall Study|Lack of Efficacy|3|||
149975710|NCT00443703|541049399|FG001|Overall Study|Lack of Efficacy|1|||
149975711|NCT00443703|541049398|FG000|Overall Study|Lost to Follow-up|0|||
149975712|NCT00443703|541049399|FG001|Overall Study|Lost to Follow-up|4|||
149838654|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838655|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838656|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838657|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838658|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838659|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838660|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838661|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838662|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838663|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838664|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838665|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838666|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838667|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838668|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
149838669|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
149838670|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838671|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838672|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838673|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838674|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
149838675|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838676|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838677|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838678|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838679|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838680|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838681|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838682|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838683|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838684|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838685|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838686|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838687|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838688|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838689|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
149838690|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
149838691|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838692|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838693|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838694|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838695|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
149838696|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838697|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
150282396|NCT01445951|542170441|FG000|Overall Study|Physician Decision|3|||
150282397|NCT01445951|542170442|FG001|Overall Study|Physician Decision|1|||
149838698|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838699|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838700|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838701|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838702|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838703|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838704|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838705|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838706|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838707|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838708|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149950108|NCT03317496|540949152|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
149950109|NCT03317496|540949153|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
149950110|NCT03317496|540949149|FG000|Phase 2: Treatment|Adverse Event|0|||
150282398|NCT01445951|542170443|FG002|Overall Study|Physician Decision|0|||
150282399|NCT01445951|542170441|FG000|Overall Study|Lost to Follow-up|1|||
150282400|NCT01445951|542170442|FG001|Overall Study|Lost to Follow-up|2|||
150282401|NCT01445951|542170443|FG002|Overall Study|Lost to Follow-up|4|||
150282402|NCT01445951|542170441|FG000|Overall Study|Pregnancy|0|||
150282403|NCT01445951|542170442|FG001|Overall Study|Pregnancy|1|||
150282404|NCT01445951|542170443|FG002|Overall Study|Pregnancy|4|||
150282405|NCT01445951|542170441|FG000|Overall Study|Death|0|||
150282406|NCT01445951|542170442|FG001|Overall Study|Death|0|||
150282407|NCT01445951|542170443|FG002|Overall Study|Death|1|||
150282408|NCT01445951|542170441|FG000|Overall Study|Non-compliance with study drug|1|||
149950111|NCT03317496|540949150|FG001|Phase 2: Treatment|Adverse Event|0|||
149950112|NCT03317496|540949151|FG002|Phase 2: Treatment|Adverse Event|0|||
149950113|NCT03317496|540949152|FG003|Phase 2: Treatment|Adverse Event|0|||
149950114|NCT03317496|540949153|FG004|Phase 2: Treatment|Adverse Event|6|||
149838709|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838710|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
149838711|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
149838712|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838713|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838714|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838715|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838716|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
149838717|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838718|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838719|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838720|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838721|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838722|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838723|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838724|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838725|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838726|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838727|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838728|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838729|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838730|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838731|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
149838732|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
149838733|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838734|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838735|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838736|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838737|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
149838738|NCT01597245|540539809|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838739|NCT01597245|540539810|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838740|NCT01597245|540539811|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838741|NCT01597245|540539812|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838742|NCT01597245|540539813|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838743|NCT01597245|540539814|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838744|NCT01597245|540539815|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838745|NCT01597245|540539816|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838746|NCT01597245|540539817|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838747|NCT01597245|540539818|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838748|NCT01597245|540539819|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838749|NCT01597245|540539820|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838750|NCT01597245|540539821|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838751|NCT01597245|540539822|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
149838752|NCT01597245|540539823|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838753|NCT01597245|540539824|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838754|NCT01597245|540539825|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838755|NCT01597245|540539826|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838756|NCT01597245|540539827|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149950115|NCT03317496|540949149|FG000|Phase 2: Treatment|Progressive disease|0|||
149950116|NCT03317496|540949150|FG001|Phase 2: Treatment|Progressive disease|0|||
149950117|NCT03317496|540949151|FG002|Phase 2: Treatment|Progressive disease|0|||
149950118|NCT03317496|540949152|FG003|Phase 2: Treatment|Progressive disease|0|||
149950119|NCT03317496|540949153|FG004|Phase 2: Treatment|Progressive disease|22|||
149950120|NCT03317496|540949149|FG000|Phase 2: Treatment|Other|0|||
149950121|NCT03317496|540949150|FG001|Phase 2: Treatment|Other|0|||
149950122|NCT03317496|540949151|FG002|Phase 2: Treatment|Other|0|||
149950123|NCT03317496|540949152|FG003|Phase 2: Treatment|Other|0|||
149950124|NCT03317496|540949153|FG004|Phase 2: Treatment|Other|4|||
150282409|NCT01445951|542170442|FG001|Overall Study|Non-compliance with study drug|2|||
150282410|NCT01445951|542170443|FG002|Overall Study|Non-compliance with study drug|0|||
150282411|NCT01445951|542170441|FG000|Overall Study|Non-compliance with protocol|0|||
149838757|NCT01597245|540539828|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149838758|NCT01597245|540539829|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
149950125|NCT03317496|540949149|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
149950126|NCT03317496|540949150|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
149950127|NCT03317496|540949151|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
149950128|NCT03317496|540949152|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
149950129|NCT03317496|540949153|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
149950130|NCT03317496|540949149|FG000|Phase 2: Treatment|Physician Decision|0|||
149838759|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838760|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838761|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838762|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838763|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838764|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838765|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838766|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838767|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838768|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838769|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838770|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838771|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838772|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838773|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838774|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
149838775|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
149838776|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
149838777|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
149950131|NCT03317496|540949150|FG001|Phase 2: Treatment|Physician Decision|0|||
149950132|NCT03317496|540949151|FG002|Phase 2: Treatment|Physician Decision|0|||
149950133|NCT03317496|540949152|FG003|Phase 2: Treatment|Physician Decision|0|||
149950134|NCT03317496|540949153|FG004|Phase 2: Treatment|Physician Decision|1|||
149950135|NCT03317496|540949149|FG000|Phase 2: Treatment|Death|0|||
149950136|NCT03317496|540949150|FG001|Phase 2: Treatment|Death|0|||
149950137|NCT03317496|540949151|FG002|Phase 2: Treatment|Death|0|||
149950138|NCT03317496|540949152|FG003|Phase 2: Treatment|Death|0|||
149950139|NCT03317496|540949153|FG004|Phase 2: Treatment|Death|1|||
149950140|NCT03317496|540949149|FG000|Phase 2: Follow-up|Death|0|||
149838778|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
149950141|NCT03317496|540949150|FG001|Phase 2: Follow-up|Death|0|||
149838779|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
149838780|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838781|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838782|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838783|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149950142|NCT03317496|540949151|FG002|Phase 2: Follow-up|Death|0|||
149950143|NCT03317496|540949152|FG003|Phase 2: Follow-up|Death|0|||
149950144|NCT03317496|540949153|FG004|Phase 2: Follow-up|Death|24|||
149950145|NCT03317496|540949149|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
149950146|NCT03317496|540949150|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
149950147|NCT03317496|540949151|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
149950148|NCT03317496|540949152|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
149950149|NCT03317496|540949153|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
149950150|NCT03317496|540949149|FG000|Phase 2: Follow-up|Other|0|||
149950151|NCT03317496|540949150|FG001|Phase 2: Follow-up|Other|0|||
149950152|NCT03317496|540949151|FG002|Phase 2: Follow-up|Other|0|||
149950153|NCT03317496|540949152|FG003|Phase 2: Follow-up|Other|0|||
149950154|NCT03317496|540949153|FG004|Phase 2: Follow-up|Other|1|||
149950155|NCT03317496|540949149|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
149950156|NCT03317496|540949150|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
149950157|NCT03317496|540949151|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
149950158|NCT03317496|540949152|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
149950159|NCT03317496|540949153|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
149950160|NCT02696616|540949168|FG000|Overall Study|Adverse Event|0|||
149950161|NCT02696616|540949169|FG001|Overall Study|Adverse Event|1|||
149950162|NCT02696616|540949170|FG002|Overall Study|Adverse Event|0|||
150034594|NCT02156076|541266473|FG002|Follow-up Period|Withdrawal by Subject|0|||
149950163|NCT02696616|540949171|FG003|Overall Study|Adverse Event|0|||
149950164|NCT02696616|540949172|FG004|Overall Study|Adverse Event|0|||
149950165|NCT02696616|540949173|FG005|Overall Study|Adverse Event|0|||
149950166|NCT02696616|540949174|FG006|Overall Study|Adverse Event|0|||
149950167|NCT01732783|540949177|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
149950168|NCT01732783|540949178|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
149950169|NCT01732783|540949179|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
149838784|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838785|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838786|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838787|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838788|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838789|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838790|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838791|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838792|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838793|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838794|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838795|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838796|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
149838797|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
149950170|NCT01732783|540949177|FG000|Overall Study|Death|13|||
149950171|NCT01732783|540949178|FG001|Overall Study|Death|4|||
149838798|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
149838799|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
149838800|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
149838801|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149950172|NCT01732783|540949179|FG002|Overall Study|Death|1|||
149950173|NCT01732783|540949177|FG000|Overall Study|Lost to Follow-up|7|||
149950174|NCT01732783|540949178|FG001|Overall Study|Lost to Follow-up|1|||
149950175|NCT01732783|540949179|FG002|Overall Study|Lost to Follow-up|1|||
149950176|NCT01732783|540949177|FG000|Overall Study|Administrative Decision|8|||
149950177|NCT01732783|540949178|FG001|Overall Study|Administrative Decision|2|||
149950178|NCT01732783|540949179|FG002|Overall Study|Administrative Decision|1|||
149950179|NCT01732783|540949177|FG000|Overall Study|Withdrawal by Subject|1|||
149950180|NCT01732783|540949178|FG001|Overall Study|Withdrawal by Subject|0|||
149950181|NCT01732783|540949179|FG002|Overall Study|Withdrawal by Subject|0|||
149950182|NCT01970371|540949180|FG000|Overall Study|Death|8|||
149950183|NCT01970371|540949181|FG001|Overall Study|Death|13|||
149950184|NCT01970371|540949182|FG002|Overall Study|Death|12|||
149950185|NCT01970371|540949180|FG000|Overall Study|Lost to Follow-up|0|||
149950186|NCT01970371|540949181|FG001|Overall Study|Lost to Follow-up|0|||
149950187|NCT01970371|540949182|FG002|Overall Study|Lost to Follow-up|1|||
149950188|NCT01481779|540949183|FG000|Overall Study|Adverse Event|23|||
149950189|NCT01481779|540949184|FG001|Overall Study|Adverse Event|5|||
149950190|NCT01481779|540949183|FG000|Overall Study|Lost to Follow-up|3|||
149950191|NCT01481779|540949184|FG001|Overall Study|Lost to Follow-up|2|||
149950192|NCT01481779|540949183|FG000|Overall Study|Protocol Violation|2|||
149950193|NCT01481779|540949184|FG001|Overall Study|Protocol Violation|3|||
149950194|NCT01481779|540949183|FG000|Overall Study|Withdrawal by Subject|26|||
149950195|NCT01481779|540949184|FG001|Overall Study|Withdrawal by Subject|13|||
149950196|NCT01481779|540949183|FG000|Overall Study|Physician Decision|13|||
149950197|NCT01481779|540949184|FG001|Overall Study|Physician Decision|4|||
149950198|NCT01481779|540949183|FG000|Overall Study|Sponsor Decision|3|||
149950199|NCT01481779|540949184|FG001|Overall Study|Sponsor Decision|1|||
149950200|NCT00487188|540949190|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
149950201|NCT00487188|540949191|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
149950202|NCT00487188|540949192|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
149950203|NCT00487188|540949190|FG000|Induction Phase|Adverse Event|5|||
149950204|NCT00487188|540949191|FG001|Induction Phase|Adverse Event|0|||
149950205|NCT00487188|540949192|FG002|Induction Phase|Adverse Event|0|||
149950206|NCT00487188|540949190|FG000|Induction Phase|Lack of Efficacy|0|||
149950207|NCT00487188|540949191|FG001|Induction Phase|Lack of Efficacy|1|||
149950208|NCT00487188|540949192|FG002|Induction Phase|Lack of Efficacy|0|||
149950209|NCT00487188|540949190|FG000|Induction Phase|Protocol Violation|1|||
149950210|NCT00487188|540949191|FG001|Induction Phase|Protocol Violation|0|||
149950211|NCT00487188|540949192|FG002|Induction Phase|Protocol Violation|0|||
149950212|NCT00487188|540949190|FG000|Induction Phase|Refused Treatment|1|||
149950213|NCT00487188|540949191|FG001|Induction Phase|Refused Treatment|2|||
149950214|NCT00487188|540949192|FG002|Induction Phase|Refused Treatment|0|||
149950215|NCT00487188|540949190|FG000|Induction Phase|Lost to Follow-up|2|||
149950216|NCT00487188|540949191|FG001|Induction Phase|Lost to Follow-up|2|||
149950217|NCT00487188|540949192|FG002|Induction Phase|Lost to Follow-up|0|||
149950218|NCT00487188|540949190|FG000|Induction Phase|Administrative|0|||
149950219|NCT00487188|540949191|FG001|Induction Phase|Administrative|1|||
149950220|NCT00487188|540949192|FG002|Induction Phase|Administrative|0|||
149950221|NCT00487188|540949190|FG000|Maintenance Phase|Adverse Event|1|||
149950222|NCT00487188|540949191|FG001|Maintenance Phase|Adverse Event|0|||
149950223|NCT00487188|540949192|FG002|Maintenance Phase|Adverse Event|0|||
149950224|NCT00487188|540949190|FG000|Maintenance Phase|Death|1|||
149950225|NCT00487188|540949191|FG001|Maintenance Phase|Death|0|||
149950226|NCT00487188|540949192|FG002|Maintenance Phase|Death|0|||
149838802|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838803|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838804|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838805|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838806|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838807|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838808|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838809|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838810|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838811|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838812|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838813|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149950227|NCT00487188|540949190|FG000|Maintenance Phase|Lost to Follow-up|1|||
149950228|NCT00487188|540949191|FG001|Maintenance Phase|Lost to Follow-up|0|||
149950229|NCT00487188|540949192|FG002|Maintenance Phase|Lost to Follow-up|0|||
149950230|NCT00487188|540949190|FG000|Maintenance Phase|Administrative|0|||
149950231|NCT00487188|540949191|FG001|Maintenance Phase|Administrative|0|||
149950232|NCT00487188|540949192|FG002|Maintenance Phase|Administrative|1|||
149950233|NCT04132050|540949193|FG000|Period I (Double-blind Period)|Adverse Event|3|||
149950234|NCT04132050|540949194|FG001|Period I (Double-blind Period)|Adverse Event|0|||
149950235|NCT04132050|540949193|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
149950236|NCT04132050|540949194|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
149950237|NCT04132050|540949193|FG000|R788 Treatment Period|Adverse Event|5|||
149950238|NCT04132050|540949194|FG001|R788 Treatment Period|Adverse Event|0|||
149950239|NCT04132050|540949193|FG000|R788 Treatment Period|Lack of Efficacy|5|||
149950240|NCT04132050|540949194|FG001|R788 Treatment Period|Lack of Efficacy|0|||
149950241|NCT04132050|540949193|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
149950242|NCT04132050|540949194|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
149950243|NCT03168672|540949197|FG000|Overall Study|Withdrawal by Subject|13|||
149950244|NCT03168672|540949197|FG000|Overall Study|Death|3|||
149950245|NCT03168672|540949197|FG000|Overall Study|Investigator's Decision|137|||
149950246|NCT03168672|540949197|FG000|Overall Study|Adverse Event|1|||
149950247|NCT03168672|540949197|FG000|Overall Study|Other|2|||
149950248|NCT03168672|540949197|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
149950249|NCT00927472|540949198|FG000|Overall Study|Withdrawal by Subject|10|||
149950250|NCT00927472|540949199|FG001|Overall Study|Withdrawal by Subject|11|||
149950251|NCT00927472|540949198|FG000|Overall Study|Lost to Follow-up|1|||
149950252|NCT00927472|540949199|FG001|Overall Study|Lost to Follow-up|6|||
149950253|NCT00927472|540949198|FG000|Overall Study|Protocol Violation|0|||
149950254|NCT00927472|540949199|FG001|Overall Study|Protocol Violation|1|||
149950255|NCT00927472|540949198|FG000|Overall Study|Post treatment Assessment out of window|0|||
149950256|NCT00927472|540949199|FG001|Overall Study|Post treatment Assessment out of window|4|||
149950257|NCT00433537|540949200|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
149950258|NCT00433537|540949201|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
149950259|NCT00433537|540949202|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
149950260|NCT00433537|540949200|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
149950261|NCT00433537|540949201|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
149838814|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838815|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838816|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838817|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
149838818|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838819|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
149838820|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
149838821|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
149838822|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838823|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838824|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838825|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838826|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838827|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838828|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838829|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838830|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838831|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838832|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149950262|NCT00433537|540949202|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
149950263|NCT00433537|540949200|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
150282412|NCT01445951|542170442|FG001|Overall Study|Non-compliance with protocol|1|||
149838833|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838834|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838835|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838836|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838837|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838838|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838839|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
149838840|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
149838841|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
149838842|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
149838843|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838844|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838845|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149950264|NCT00433537|540949201|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
149950265|NCT00433537|540949202|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
149950266|NCT00433537|540949200|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
149950267|NCT00433537|540949201|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
149950268|NCT00433537|540949202|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
149950269|NCT00433537|540949200|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
149950270|NCT00433537|540949201|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
149950271|NCT00433537|540949202|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
149950272|NCT00433537|540949200|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
149950273|NCT00433537|540949201|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
149950274|NCT00433537|540949202|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
149950275|NCT00433537|540949200|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
149950276|NCT00433537|540949201|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
149950277|NCT00433537|540949202|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
149950278|NCT00433537|540949200|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
149950279|NCT00433537|540949201|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
149950280|NCT00433537|540949202|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
149950281|NCT00433537|540949200|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
149950282|NCT00433537|540949201|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
149950283|NCT00433537|540949202|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
149950284|NCT05436613|540949203|FG000|Overall Study|Lost to Follow-up|9|||
149950285|NCT05436613|540949203|FG000|Overall Study|Withdrawal by Subject|3|||
149950286|NCT05317546|540949206|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
149950287|NCT05317546|540949207|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
149950288|NCT05350202|540949208|FG000|Visit 1 - Baseline|Not-treated|18|||
149950289|NCT05350202|540949209|FG001|Visit 1 - Baseline|Not-treated|0|||
149950290|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
149950291|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
149950292|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
149950293|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
149950294|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
149950295|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
149950296|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
149950297|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
149950298|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
149950299|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
149950300|NCT05350202|540949208|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
149950301|NCT05350202|540949209|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
149950302|NCT01063114|540949210|FG000|Overall Study|Lost to Follow-up|1|||
149950303|NCT04635423|540949223|FG000|Overall Study|Ongoing|493|||
149950304|NCT04635423|540949224|FG001|Overall Study|Ongoing|501|||
150171970|NCT03823300|541765863|FG000|Overall Study|Death|10|||
150171971|NCT03823300|541765864|FG001|Overall Study|Death|14|||
150171972|NCT03823300|541765863|FG000|Overall Study|Adverse Event|3|||
150171973|NCT03823300|541765864|FG001|Overall Study|Adverse Event|5|||
150171974|NCT03823300|541765863|FG000|Overall Study|Physician Decision|1|||
150171975|NCT03823300|541765864|FG001|Overall Study|Physician Decision|7|||
150171976|NCT03823300|541765863|FG000|Overall Study|Lost to Follow-up|1|||
150171977|NCT03823300|541765864|FG001|Overall Study|Lost to Follow-up|3|||
150171978|NCT03823300|541765863|FG000|Overall Study|Protocol Violation|1|||
150171979|NCT03823300|541765864|FG001|Overall Study|Protocol Violation|1|||
150171980|NCT03823300|541765863|FG000|Overall Study|Lack of Efficacy|1|||
150171981|NCT03823300|541765864|FG001|Overall Study|Lack of Efficacy|1|||
150171982|NCT03823300|541765863|FG000|Overall Study|Not Eligible|0|||
150171983|NCT03823300|541765864|FG001|Overall Study|Not Eligible|1|||
150171984|NCT03823300|541765863|FG000|Overall Study|Other|1|||
149950305|NCT04635423|540949223|FG000|Overall Study|Withdrawal by Subject|36|||
149950306|NCT04635423|540949224|FG001|Overall Study|Withdrawal by Subject|29|||
149950307|NCT05556057|540949225|FG000|Overall Study|Lost to Follow-up|5|||
149950308|NCT05556057|540949226|FG001|Overall Study|Lost to Follow-up|4|||
149950309|NCT05556057|540949225|FG000|Overall Study|Withdrawal by Subject|0|||
149950310|NCT05556057|540949226|FG001|Overall Study|Withdrawal by Subject|2|||
149950311|NCT01147458|540949232|FG000|First Intervention|Study terminated by sponsor|8|||
149950312|NCT01147458|540949233|FG001|First Intervention|Study terminated by sponsor|8|||
149950313|NCT01147458|540949234|FG002|First Intervention|Study terminated by sponsor|7|||
149950314|NCT01147458|540949235|FG003|First Intervention|Study terminated by sponsor|8|||
149950315|NCT01147458|540949232|FG000|First Intervention|Protocol Violation|2|||
149950316|NCT01147458|540949233|FG001|First Intervention|Protocol Violation|3|||
149950317|NCT01147458|540949234|FG002|First Intervention|Protocol Violation|2|||
149950318|NCT01147458|540949235|FG003|First Intervention|Protocol Violation|3|||
149950319|NCT01147458|540949232|FG000|First Intervention|Withdrawal by Subject|3|||
149950320|NCT01147458|540949233|FG001|First Intervention|Withdrawal by Subject|0|||
149950321|NCT01147458|540949234|FG002|First Intervention|Withdrawal by Subject|1|||
149950322|NCT01147458|540949235|FG003|First Intervention|Withdrawal by Subject|0|||
149950323|NCT01147458|540949232|FG000|First Intervention|Adverse Event|0|||
149950324|NCT01147458|540949233|FG001|First Intervention|Adverse Event|3|||
149950325|NCT01147458|540949234|FG002|First Intervention|Adverse Event|2|||
149950326|NCT01147458|540949235|FG003|First Intervention|Adverse Event|3|||
149950327|NCT01147458|540949232|FG000|First Intervention|Other|1|||
149950328|NCT01147458|540949233|FG001|First Intervention|Other|2|||
149950329|NCT01147458|540949234|FG002|First Intervention|Other|0|||
149950330|NCT01147458|540949235|FG003|First Intervention|Other|0|||
150282413|NCT01445951|542170443|FG002|Overall Study|Non-compliance with protocol|0|||
150282414|NCT01445951|542170441|FG000|Overall Study|Sponsor decision - subject travel|0|||
150282415|NCT01445951|542170442|FG001|Overall Study|Sponsor decision - subject travel|1|||
150282416|NCT01445951|542170443|FG002|Overall Study|Sponsor decision - subject travel|0|||
150282417|NCT01445951|542170441|FG000|Overall Study|Cough|0|||
150282418|NCT01445951|542170442|FG001|Overall Study|Cough|1|||
150282419|NCT01445951|542170443|FG002|Overall Study|Cough|0|||
150282420|NCT04126083|542170447|FG000|Overall Study|Withdrawal by Subject|1|||
150282421|NCT00578136|542170448|FG000|Overall Study|Not given intervention|1|||
150282422|NCT00578136|542170449|FG001|Overall Study|Not given intervention|1|||
150282423|NCT00754793|542170450|FG000|Overall Study|voluntary withdrawn from study|0|||
150282424|NCT00754793|542170451|FG001|Overall Study|voluntary withdrawn from study|1|||
150282425|NCT01585272|542170452|FG000|Overall Study|Adverse Event|22|||
150282426|NCT01585272|542170452|FG000|Overall Study|Protocol Violation|7|||
150282427|NCT01585272|542170452|FG000|Overall Study|Withdrawal by Subject|10|||
150282428|NCT00781911|542170453|FG000|Overall Study|Adverse Event|4|||
150282429|NCT00781911|542170454|FG001|Overall Study|Adverse Event|4|||
150282430|NCT00781911|542170453|FG000|Overall Study|Withdrawal by Subject|1|||
150282431|NCT00781911|542170454|FG001|Overall Study|Withdrawal by Subject|2|||
150282432|NCT00781911|542170453|FG000|Overall Study|Physician Decision|0|||
150282433|NCT00781911|542170454|FG001|Overall Study|Physician Decision|2|||
150282434|NCT00781911|542170453|FG000|Overall Study|Sponsor Decision|1|||
150282435|NCT00781911|542170454|FG001|Overall Study|Sponsor Decision|0|||
150282436|NCT00361270|542170458|FG000|Overall Study|Death|0|||
150282437|NCT00361270|542170459|FG001|Overall Study|Death|0|||
150282438|NCT00361270|542170460|FG002|Overall Study|Death|0|||
149838846|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838847|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838848|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838849|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838850|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838851|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838852|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149950331|NCT01147458|540949232|FG000|Second Intervention|Study terminated by sponsor|7|||
149950332|NCT01147458|540949233|FG001|Second Intervention|Study terminated by sponsor|5|||
149950333|NCT01147458|540949234|FG002|Second Intervention|Study terminated by sponsor|5|||
149950334|NCT01147458|540949235|FG003|Second Intervention|Study terminated by sponsor|3|||
150282439|NCT00361270|542170461|FG003|Overall Study|Death|2|||
150282440|NCT00361270|542170458|FG000|Overall Study|Lost to Follow-up|4|||
149950335|NCT01147458|540949232|FG000|Second Intervention|Protocol Violation|0|||
149838853|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149950336|NCT01147458|540949233|FG001|Second Intervention|Protocol Violation|1|||
149950337|NCT01147458|540949234|FG002|Second Intervention|Protocol Violation|1|||
149950338|NCT01147458|540949235|FG003|Second Intervention|Protocol Violation|0|||
149950339|NCT01147458|540949232|FG000|Second Intervention|Withdrawal by Subject|0|||
150282441|NCT00361270|542170459|FG001|Overall Study|Lost to Follow-up|1|||
150282442|NCT00361270|542170460|FG002|Overall Study|Lost to Follow-up|0|||
150282443|NCT00361270|542170461|FG003|Overall Study|Lost to Follow-up|0|||
150282444|NCT00361270|542170458|FG000|Overall Study|Physician Decision|0|||
149838854|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838855|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838856|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838857|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838858|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838859|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
149838860|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838861|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
149838862|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
149838863|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
149838864|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838865|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149950340|NCT01147458|540949233|FG001|Second Intervention|Withdrawal by Subject|1|||
149950341|NCT01147458|540949234|FG002|Second Intervention|Withdrawal by Subject|0|||
149950342|NCT01147458|540949235|FG003|Second Intervention|Withdrawal by Subject|0|||
149950343|NCT01147458|540949232|FG000|Second Intervention|Adverse Event|2|||
149950344|NCT01147458|540949233|FG001|Second Intervention|Adverse Event|0|||
149950345|NCT01147458|540949234|FG002|Second Intervention|Adverse Event|1|||
149950346|NCT01147458|540949235|FG003|Second Intervention|Adverse Event|1|||
149950347|NCT01147458|540949232|FG000|Second Intervention|Other|0|||
149950348|NCT01147458|540949233|FG001|Second Intervention|Other|0|||
149950349|NCT01147458|540949234|FG002|Second Intervention|Other|1|||
149950350|NCT01147458|540949235|FG003|Second Intervention|Other|0|||
149950351|NCT00832975|540949243|FG000|Overall Study|Lost to Follow-up|7|||
149950352|NCT00832975|540949243|FG000|Overall Study|Protocol Violation|6|||
149950353|NCT00832975|540949243|FG000|Overall Study|Death|5|||
149950354|NCT00832975|540949243|FG000|Overall Study|Physician Decision|4|||
149950355|NCT00832975|540949243|FG000|Overall Study|Withdrawal by Subject|3|||
149950356|NCT00832975|540949243|FG000|Overall Study|Other reasons|14|||
149950357|NCT05253807|540949244|FG000|Overall Study|Death|1|||
149950358|NCT05253807|540949245|FG001|Overall Study|Death|4|||
149950359|NCT05253807|540949244|FG000|Overall Study|Withdrawal by Subject|1|||
149950360|NCT05253807|540949245|FG001|Overall Study|Withdrawal by Subject|0|||
149950361|NCT05253807|540949244|FG000|Overall Study|Study Terminated by Sponsor|1|||
149950362|NCT05253807|540949245|FG001|Overall Study|Study Terminated by Sponsor|1|||
149950363|NCT06717399|540949246|FG000|Overall Study|Death|1|||
149950364|NCT01793935|540950323|FG000|Overall Study|Pregnancy|1|||
149950365|NCT01793935|540950324|FG001|Overall Study|Pregnancy|0|||
149950366|NCT01793935|540950323|FG000|Overall Study|Protocol Violation|2|||
149950367|NCT01793935|540950324|FG001|Overall Study|Protocol Violation|1|||
149950368|NCT01793935|540950323|FG000|Overall Study|Adverse Event|2|||
149950369|NCT01793935|540950324|FG001|Overall Study|Adverse Event|0|||
149950370|NCT01793935|540950323|FG000|Overall Study|Patient did not take study medication|1|||
149950371|NCT01793935|540950324|FG001|Overall Study|Patient did not take study medication|1|||
149950372|NCT01793935|540950323|FG000|Overall Study|Lost to Follow-up|0|||
149950373|NCT01793935|540950324|FG001|Overall Study|Lost to Follow-up|1|||
149950374|NCT01121926|540950325|FG000|First Intervention Period|Adverse Event|1|||
149950375|NCT01121926|540950326|FG001|First Intervention Period|Adverse Event|0|||
149950376|NCT01121926|540950325|FG000|Washout Period|Adverse Event|0|||
149950377|NCT01121926|540950326|FG001|Washout Period|Adverse Event|1|||
149950378|NCT01121926|540950325|FG000|Washout Period|Positive pregnancy test|0|||
149950379|NCT01121926|540950326|FG001|Washout Period|Positive pregnancy test|1|||
149950380|NCT02782468|540950327|FG000|Overall Study|Progressive Disease|2|||
149950381|NCT02782468|540950328|FG001|Overall Study|Progressive Disease|5|||
149950382|NCT02782468|540950329|FG002|Overall Study|Progressive Disease|0|||
149950383|NCT02782468|540950330|FG003|Overall Study|Progressive Disease|4|||
150171985|NCT03823300|541765864|FG001|Overall Study|Other|0|||
150171986|NCT03622580|541765867|FG000|Overall Study|Death|16|||
150171987|NCT03622580|541765868|FG001|Overall Study|Death|21|||
149838866|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838867|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838868|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149950384|NCT02782468|540950327|FG000|Overall Study|Adverse Event|0|||
149950385|NCT02782468|540950328|FG001|Overall Study|Adverse Event|2|||
149950386|NCT02782468|540950329|FG002|Overall Study|Adverse Event|2|||
149950387|NCT02782468|540950330|FG003|Overall Study|Adverse Event|3|||
149950388|NCT02782468|540950327|FG000|Overall Study|Other|0|||
149950389|NCT02782468|540950328|FG001|Overall Study|Other|0|||
149950390|NCT02782468|540950329|FG002|Overall Study|Other|1|||
149950391|NCT02782468|540950330|FG003|Overall Study|Other|1|||
149950392|NCT02782468|540950327|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
149950393|NCT02782468|540950328|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
149950394|NCT02782468|540950329|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
150034595|NCT02156076|541266474|FG003|Follow-up Period|Withdrawal by Subject|0|||
150171988|NCT03622580|541765869|FG002|Overall Study|Death|13|||
149950395|NCT02782468|540950330|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
149950396|NCT02782468|540950327|FG000|Overall Study|Symptomatic Deterioration|0|||
149950397|NCT02782468|540950328|FG001|Overall Study|Symptomatic Deterioration|0|||
150282445|NCT00361270|542170459|FG001|Overall Study|Physician Decision|0|||
150282446|NCT00361270|542170460|FG002|Overall Study|Physician Decision|1|||
150282447|NCT00361270|542170461|FG003|Overall Study|Physician Decision|0|||
150282448|NCT00361270|542170458|FG000|Overall Study|Protocol Violation|9|||
150282449|NCT00361270|542170459|FG001|Overall Study|Protocol Violation|4|||
150282450|NCT00361270|542170460|FG002|Overall Study|Protocol Violation|5|||
150282451|NCT00361270|542170461|FG003|Overall Study|Protocol Violation|4|||
150282452|NCT00361270|542170458|FG000|Overall Study|Withdrawal by Subject|6|||
150282453|NCT00361270|542170459|FG001|Overall Study|Withdrawal by Subject|6|||
150282454|NCT00361270|542170460|FG002|Overall Study|Withdrawal by Subject|3|||
150282455|NCT00361270|542170461|FG003|Overall Study|Withdrawal by Subject|7|||
150282456|NCT00361270|542170458|FG000|Overall Study|Afraid of Hypnosis|1|||
150282457|NCT00361270|542170459|FG001|Overall Study|Afraid of Hypnosis|2|||
149838869|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838870|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838871|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838872|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
150282458|NCT00361270|542170460|FG002|Overall Study|Afraid of Hypnosis|0|||
150282459|NCT00361270|542170461|FG003|Overall Study|Afraid of Hypnosis|0|||
150282460|NCT00361270|542170458|FG000|Overall Study|Problems with Transportation|4|||
150282461|NCT00361270|542170459|FG001|Overall Study|Problems with Transportation|0|||
150282462|NCT00361270|542170460|FG002|Overall Study|Problems with Transportation|0|||
150282463|NCT00361270|542170461|FG003|Overall Study|Problems with Transportation|0|||
150282464|NCT00361270|542170458|FG000|Overall Study|Adverse Event|0|||
150282465|NCT00361270|542170459|FG001|Overall Study|Adverse Event|1|||
150282466|NCT00361270|542170460|FG002|Overall Study|Adverse Event|1|||
150282467|NCT00361270|542170461|FG003|Overall Study|Adverse Event|0|||
150282468|NCT00820950|542170464|FG000|Overall Study|Scheduling Conflict|0|||
150282469|NCT00820950|542170465|FG001|Overall Study|Scheduling Conflict|0|||
150282470|NCT00820950|542170466|FG002|Overall Study|Scheduling Conflict|0|||
150282471|NCT00820950|542170467|FG003|Overall Study|Scheduling Conflict|0|||
150282472|NCT00820950|542170468|FG004|Overall Study|Scheduling Conflict|0|||
150282473|NCT00820950|542170469|FG005|Overall Study|Scheduling Conflict|0|||
150282474|NCT00820950|542170470|FG006|Overall Study|Scheduling Conflict|1|||
150282475|NCT00820950|542170471|FG007|Overall Study|Scheduling Conflict|1|||
149838873|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838874|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838875|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838876|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838877|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838878|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838879|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838880|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
149838881|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838882|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
149838883|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
149838884|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
149838885|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838886|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838887|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838888|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838889|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838890|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838891|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838892|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838893|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838894|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838895|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838896|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838897|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838898|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838899|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838900|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838901|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
149838902|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838903|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838904|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
149838905|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
149838906|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838907|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838908|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838909|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149950398|NCT02782468|540950329|FG002|Overall Study|Symptomatic Deterioration|0|||
149950399|NCT02782468|540950330|FG003|Overall Study|Symptomatic Deterioration|1|||
149950400|NCT02782468|540950327|FG000|Overall Study|Withdrawal by Subject|1|||
149950401|NCT02782468|540950328|FG001|Overall Study|Withdrawal by Subject|0|||
149950402|NCT02782468|540950329|FG002|Overall Study|Withdrawal by Subject|0|||
149950403|NCT02782468|540950330|FG003|Overall Study|Withdrawal by Subject|0|||
149950404|NCT00356590|540950337|FG000|Overall Study|Adverse Event|54|||
149950405|NCT00356590|540950337|FG000|Overall Study|Death|10|||
149950406|NCT00356590|540950337|FG000|Overall Study|Lost to Follow-up|35|||
149950407|NCT00356590|540950337|FG000|Overall Study|Physician Decision|46|||
149950408|NCT00356590|540950337|FG000|Overall Study|Withdrawal by Subject|41|||
149950409|NCT00356590|540950337|FG000|Overall Study|Completed month 12 only|2|||
149950410|NCT00356590|540950337|FG000|Overall Study|Protocol issues|6|||
149950411|NCT00356590|540950337|FG000|Overall Study|Response status|28|||
149950412|NCT00356590|540950337|FG000|Overall Study|Other|52|||
149950413|NCT00817063|540950344|FG000|Overall Study|Adverse Event|32|||
149950414|NCT00817063|540950345|FG001|Overall Study|Adverse Event|13|||
149950415|NCT00817063|540950344|FG000|Overall Study|Death|1|||
149950416|NCT00817063|540950345|FG001|Overall Study|Death|1|||
149950417|NCT00817063|540950344|FG000|Overall Study|Lack of Efficacy|33|||
149950418|NCT00817063|540950345|FG001|Overall Study|Lack of Efficacy|86|||
149950419|NCT00817063|540950344|FG000|Overall Study|Failure to Return|13|||
149950420|NCT00817063|540950345|FG001|Overall Study|Failure to Return|12|||
149950421|NCT00817063|540950344|FG000|Overall Study|Violation of Selection at Entry|7|||
149950422|NCT00817063|540950345|FG001|Overall Study|Violation of Selection at Entry|4|||
149950423|NCT00817063|540950344|FG000|Overall Study|Protocol Violation|3|||
149950424|NCT00817063|540950345|FG001|Overall Study|Protocol Violation|8|||
149950425|NCT00817063|540950344|FG000|Overall Study|Withdrawal by Subject|17|||
149950426|NCT00817063|540950345|FG001|Overall Study|Withdrawal by Subject|37|||
149950427|NCT00817063|540950344|FG000|Overall Study|Early Improvement|19|||
149950428|NCT00817063|540950345|FG001|Overall Study|Early Improvement|4|||
149950429|NCT00817063|540950344|FG000|Overall Study|Administrative|10|||
149950430|NCT00817063|540950345|FG001|Overall Study|Administrative|4|||
149950431|NCT00817063|540950344|FG000|Overall Study|Abnormality of Laboratory Test|2|||
149950432|NCT00817063|540950345|FG001|Overall Study|Abnormality of Laboratory Test|1|||
149950433|NCT01496456|540950346|FG000|Overall Study|Protocol Violation|1|||
149950434|NCT01496456|540950346|FG000|Overall Study|Lost to Follow-up|7|||
149950435|NCT04919161|540950347|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
149950436|NCT04919161|540950348|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
149950437|NCT04919161|540950347|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
149950438|NCT04919161|540950348|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
149950439|NCT04919161|540950347|FG000|Overall Study|Acute ankle sprain after session 1|0|||
149950440|NCT04919161|540950348|FG001|Overall Study|Acute ankle sprain after session 1|1|||
149950441|NCT02489773|540950349|FG000|Overall Study|Lost to Follow-up|4|||
149950442|NCT02489773|540950350|FG001|Overall Study|Lost to Follow-up|1|||
149950443|NCT02489773|540950349|FG000|Overall Study|Physician Decision|1|||
149950444|NCT02489773|540950350|FG001|Overall Study|Physician Decision|0|||
149950445|NCT02489773|540950349|FG000|Overall Study|Withdrawal by Subject|1|||
149950446|NCT02489773|540950350|FG001|Overall Study|Withdrawal by Subject|0|||
149950447|NCT02489773|540950349|FG000|Overall Study|Leave the country or the state|1|||
149950448|NCT02489773|540950350|FG001|Overall Study|Leave the country or the state|1|||
149950449|NCT02362451|540950352|FG000|Overall Study|Withdrawal by Subject|0|||
149950450|NCT02362451|540950353|FG001|Overall Study|Withdrawal by Subject|1|||
149950451|NCT02362451|540950352|FG000|Overall Study|Lack of Efficacy|2|||
149950452|NCT02362451|540950353|FG001|Overall Study|Lack of Efficacy|0|||
149950453|NCT02362451|540950352|FG000|Overall Study|Progression|1|||
149950454|NCT02362451|540950353|FG001|Overall Study|Progression|0|||
149950455|NCT02362451|540950352|FG000|Overall Study|Participant chose other therapy.|1|||
149950456|NCT02362451|540950353|FG001|Overall Study|Participant chose other therapy.|0|||
149838910|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149950457|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
149950458|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
149950459|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
149950460|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
149950461|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
149950462|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
149950463|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
149950464|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
149950465|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
149950466|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
149950467|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
149950468|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
149950469|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
149950470|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
149950471|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
149950472|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
149950473|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
149950474|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
149950475|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
149950476|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
149950477|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
149950478|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
149950479|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
149950480|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
149950481|NCT00620542|540950354|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
149950482|NCT00620542|540950355|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
149950483|NCT00620542|540950356|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
149950484|NCT00620542|540950357|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
149950485|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
149950486|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
149950487|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
149950488|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
149950489|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
149950490|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
149950491|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
149950492|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
149950493|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
149950494|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
149950495|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
149950496|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
149950497|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
149950498|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
149950499|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
149950500|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
149950501|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
149950502|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
149950503|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
149950504|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
149950505|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
149950506|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
149950507|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
149950508|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
149950509|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
149950510|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
149950511|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
149950512|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
149950513|NCT00620542|540950354|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
149950514|NCT00620542|540950355|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
149950515|NCT00620542|540950356|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
149950516|NCT00620542|540950357|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
149950517|NCT01500083|540950358|FG000|Overall Study|Adverse Event|4|||
149950518|NCT01500083|540950359|FG001|Overall Study|Adverse Event|17|||
149950519|NCT01500083|540950358|FG000|Overall Study|Death|0|||
149950520|NCT01500083|540950359|FG001|Overall Study|Death|2|||
149950521|NCT01500083|540950358|FG000|Overall Study|Lost to Follow-up|1|||
149950522|NCT01500083|540950359|FG001|Overall Study|Lost to Follow-up|0|||
149950523|NCT01500083|540950358|FG000|Overall Study|Withdrawal of Consent|0|||
149950524|NCT01500083|540950359|FG001|Overall Study|Withdrawal of Consent|1|||
150171989|NCT03622580|541765867|FG000|Overall Study|Adverse Event|6|||
149950525|NCT01500083|540950358|FG000|Overall Study|Disease Progression|2|||
149950526|NCT01500083|540950359|FG001|Overall Study|Disease Progression|10|||
149950527|NCT01500083|540950358|FG000|Overall Study|Investigator Discretion|3|||
149950528|NCT01500083|540950359|FG001|Overall Study|Investigator Discretion|8|||
149950529|NCT01500083|540950358|FG000|Overall Study|Other Reasons|2|||
149950530|NCT01500083|540950359|FG001|Overall Study|Other Reasons|5|||
149950531|NCT01555931|540950360|FG000|Overall Study|Lost to Follow-up|2|||
149950532|NCT01555931|540950361|FG001|Overall Study|Lost to Follow-up|5|||
149975713|NCT00443703|541049398|FG000|Overall Study|Physician Decision|4|||
149975714|NCT00443703|541049399|FG001|Overall Study|Physician Decision|2|||
149975715|NCT00443703|541049398|FG000|Overall Study|Protocol Violation|1|||
149975716|NCT00443703|541049399|FG001|Overall Study|Protocol Violation|1|||
149838911|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838912|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838913|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838914|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
150034596|NCT06271993|541266477|FG000|Overall Study|Not reactive to histamine|5|||
150034597|NCT06271993|541266478|FG001|Overall Study|Not reactive to histamine|5|||
150034598|NCT06271993|541266479|FG002|Overall Study|Not reactive to histamine|5|||
150034599|NCT00481832|541266480|FG000|Enrollment|Physician Decision|8|||
150034600|NCT00481832|541266480|FG000|Enrollment|Unable to collect enough stem cells|2|||
150034601|NCT00481832|541266480|FG000|Inter-transplant Period|Adverse Event|4|||
150034602|NCT00481832|541266480|FG000|Inter-transplant Period|Death|3|||
150034603|NCT00481832|541266480|FG000|Inter-transplant Period|Physician Decision|4|||
150034604|NCT00481832|541266480|FG000|Inter-transplant Period|Disease relapse|11|||
150034605|NCT00481832|541266480|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
150034606|NCT02558894|541266481|FG000|Overall Study|Death; any cause, entire study duration|28|||
150034607|NCT02558894|541266482|FG001|Overall Study|Death; any cause, entire study duration|31|||
149838915|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838916|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838917|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838918|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838919|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838920|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838921|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838922|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
149838923|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838924|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838925|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
149838926|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
149838927|NCT01597245|540539809|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838928|NCT01597245|540539810|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838929|NCT01597245|540539811|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838930|NCT01597245|540539812|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838931|NCT01597245|540539813|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838932|NCT01597245|540539814|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838933|NCT01597245|540539815|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838934|NCT01597245|540539816|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838935|NCT01597245|540539817|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838936|NCT01597245|540539818|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838937|NCT01597245|540539819|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838938|NCT01597245|540539820|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838939|NCT01597245|540539821|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838940|NCT01597245|540539822|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838941|NCT01597245|540539823|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838942|NCT01597245|540539824|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838943|NCT01597245|540539825|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838944|NCT01597245|540539826|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838945|NCT01597245|540539827|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838946|NCT01597245|540539828|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
149838947|NCT01597245|540539829|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
149838948|NCT00731783|540539830|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
149838949|NCT00731783|540539831|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
149838950|NCT00731783|540539830|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
149838951|NCT00731783|540539831|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
149838952|NCT00731783|540539830|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
149838953|NCT00731783|540539831|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
149838954|NCT00731783|540539830|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
149838955|NCT00731783|540539831|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
149838956|NCT02674152|540541259|FG000|Overall Study|Personal Reasons|1|||
149838957|NCT02674152|540541260|FG001|Overall Study|Personal Reasons|0|||
149838958|NCT02674152|540541261|FG002|Overall Study|Personal Reasons|0|||
149838959|NCT02674152|540541262|FG003|Overall Study|Personal Reasons|1|||
149838960|NCT02674152|540541263|FG004|Overall Study|Personal Reasons|1|||
149838961|NCT02674152|540541259|FG000|Overall Study|Other adverse event or clinical progression|0|||
149838962|NCT02674152|540541260|FG001|Overall Study|Other adverse event or clinical progression|1|||
149838963|NCT02674152|540541261|FG002|Overall Study|Other adverse event or clinical progression|0|||
149838964|NCT02674152|540541262|FG003|Overall Study|Other adverse event or clinical progression|3|||
149838965|NCT02674152|540541263|FG004|Overall Study|Other adverse event or clinical progression|0|||
149838966|NCT02674152|540541259|FG000|Overall Study|Dose-limiting toxicity|0|||
149838967|NCT02674152|540541260|FG001|Overall Study|Dose-limiting toxicity|0|||
149950533|NCT05696847|540950364|FG000|Overall Study|Withdrawal by Subject|1|||
149950534|NCT05696847|540950365|FG001|Overall Study|Withdrawal by Subject|0|||
149950535|NCT05696847|540950366|FG002|Overall Study|Withdrawal by Subject|0|||
149950536|NCT05696847|540950367|FG003|Overall Study|Withdrawal by Subject|0|||
149950537|NCT05696847|540950368|FG004|Overall Study|Withdrawal by Subject|0|||
149950538|NCT05696847|540950369|FG005|Overall Study|Withdrawal by Subject|0|||
149950539|NCT05696847|540950364|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149950540|NCT05696847|540950365|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149950541|NCT05696847|540950366|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149950542|NCT05696847|540950367|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149950543|NCT05696847|540950368|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149950544|NCT05696847|540950369|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149950545|NCT05696847|540950364|FG000|Overall Study|Adverse Event|0|||
149950546|NCT05696847|540950365|FG001|Overall Study|Adverse Event|0|||
149838968|NCT02674152|540541261|FG002|Overall Study|Dose-limiting toxicity|0|||
149838969|NCT02674152|540541262|FG003|Overall Study|Dose-limiting toxicity|0|||
149838970|NCT02674152|540541263|FG004|Overall Study|Dose-limiting toxicity|1|||
149838971|NCT02674152|540541259|FG000|Overall Study|Progressive Disease|2|||
149838972|NCT02674152|540541260|FG001|Overall Study|Progressive Disease|1|||
149838973|NCT02674152|540541261|FG002|Overall Study|Progressive Disease|1|||
149838974|NCT02674152|540541262|FG003|Overall Study|Progressive Disease|13|||
149838975|NCT02674152|540541263|FG004|Overall Study|Progressive Disease|2|||
149838976|NCT02674152|540541259|FG000|Overall Study|Adverse Event|0|||
149838977|NCT02674152|540541260|FG001|Overall Study|Adverse Event|0|||
149950547|NCT05696847|540950366|FG002|Overall Study|Adverse Event|0|||
149950548|NCT05696847|540950367|FG003|Overall Study|Adverse Event|0|||
149950549|NCT05696847|540950368|FG004|Overall Study|Adverse Event|0|||
149950550|NCT05696847|540950369|FG005|Overall Study|Adverse Event|1|||
149950551|NCT05696847|540950364|FG000|Overall Study|Sponsor Decision|0|||
149950552|NCT05696847|540950365|FG001|Overall Study|Sponsor Decision|0|||
149950553|NCT05696847|540950366|FG002|Overall Study|Sponsor Decision|0|||
149950554|NCT05696847|540950367|FG003|Overall Study|Sponsor Decision|1|||
149950555|NCT05696847|540950368|FG004|Overall Study|Sponsor Decision|0|||
149950556|NCT05696847|540950369|FG005|Overall Study|Sponsor Decision|0|||
149950557|NCT01697579|540950370|FG000|Base Study-Cycle 1|Adverse Event|1|||
149950558|NCT01697579|540950371|FG001|Base Study-Cycle 1|Adverse Event|0|||
149950559|NCT01697579|540950372|FG002|Base Study-Cycle 1|Adverse Event|0|||
149950560|NCT01697579|540950373|FG003|Base Study-Cycle 1|Adverse Event|0|||
149950561|NCT01697579|540950374|FG004|Base Study-Cycle 1|Adverse Event|0|||
149950562|NCT01697579|540950375|FG005|Base Study-Cycle 1|Adverse Event|0|||
149950563|NCT01697579|540950376|FG006|Base Study-Cycle 1|Adverse Event|0|||
149950564|NCT01697579|540950370|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
149950565|NCT01697579|540950371|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950566|NCT01697579|540950372|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950567|NCT01697579|540950373|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950568|NCT01697579|540950374|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950569|NCT01697579|540950375|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950570|NCT01697579|540950376|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
149950571|NCT01697579|540950370|FG000|Base Study-Cycle 1|Protocol Violation|0|||
149950572|NCT01697579|540950371|FG001|Base Study-Cycle 1|Protocol Violation|0|||
149950573|NCT01697579|540950372|FG002|Base Study-Cycle 1|Protocol Violation|0|||
149950574|NCT01697579|540950373|FG003|Base Study-Cycle 1|Protocol Violation|0|||
149950575|NCT01697579|540950374|FG004|Base Study-Cycle 1|Protocol Violation|3|||
149950576|NCT01697579|540950375|FG005|Base Study-Cycle 1|Protocol Violation|0|||
149950577|NCT01697579|540950376|FG006|Base Study-Cycle 1|Protocol Violation|0|||
149950578|NCT01697579|540950370|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950579|NCT01697579|540950371|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
149950580|NCT01697579|540950372|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950581|NCT01697579|540950373|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950582|NCT01697579|540950374|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950583|NCT01697579|540950375|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950584|NCT01697579|540950376|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
149950585|NCT01697579|540950370|FG000|Base Study-Cycle 1|Technical Problems|0|||
149950586|NCT01697579|540950371|FG001|Base Study-Cycle 1|Technical Problems|0|||
149950587|NCT01697579|540950372|FG002|Base Study-Cycle 1|Technical Problems|1|||
149950588|NCT01697579|540950373|FG003|Base Study-Cycle 1|Technical Problems|1|||
149950589|NCT01697579|540950374|FG004|Base Study-Cycle 1|Technical Problems|0|||
149950590|NCT01697579|540950375|FG005|Base Study-Cycle 1|Technical Problems|0|||
149950591|NCT01697579|540950376|FG006|Base Study-Cycle 1|Technical Problems|0|||
149838978|NCT02674152|540541261|FG002|Overall Study|Adverse Event|1|||
149838979|NCT02674152|540541262|FG003|Overall Study|Adverse Event|0|||
149950592|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Death|0|||
149950593|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Death|0|||
150282476|NCT00820950|542170472|FG008|Overall Study|Scheduling Conflict|0|||
149950594|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Death|0|||
149950595|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Death|0|||
149950596|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Death|0|||
149950597|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Death|0|||
150282477|NCT00820950|542170473|FG009|Overall Study|Scheduling Conflict|0|||
150282478|NCT00820950|542170464|FG000|Overall Study|Protocol Violation|1|||
150282479|NCT00820950|542170465|FG001|Overall Study|Protocol Violation|1|||
150282480|NCT00820950|542170466|FG002|Overall Study|Protocol Violation|0|||
150282481|NCT00820950|542170467|FG003|Overall Study|Protocol Violation|0|||
150282482|NCT00820950|542170468|FG004|Overall Study|Protocol Violation|0|||
149838980|NCT02674152|540541263|FG004|Overall Study|Adverse Event|1|||
149838981|NCT00579345|540541264|FG000|Overall Study|Withdrawal by Subject|2|||
149838982|NCT00579345|540541265|FG001|Overall Study|Withdrawal by Subject|0|||
149838983|NCT00579345|540541266|FG002|Overall Study|Withdrawal by Subject|0|||
149838984|NCT00579345|540541267|FG003|Overall Study|Withdrawal by Subject|0|||
149838985|NCT00579345|540541268|FG004|Overall Study|Withdrawal by Subject|0|||
149838986|NCT00579345|540541269|FG005|Overall Study|Withdrawal by Subject|0|||
149950598|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Death|2|||
149950599|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149950600|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149950601|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149950602|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149950603|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149950604|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
149950605|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
149950606|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
149950607|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
149950608|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
149950609|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
149950610|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
149950611|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
149950612|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
149950613|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950614|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950615|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950616|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950617|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950618|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
149950619|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
149950620|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
149950621|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
149950622|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
149950623|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
149950624|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
149950625|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
149950626|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
149950627|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950628|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950629|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950630|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950631|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950632|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
149950633|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
149950634|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
149950635|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
149950636|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
150034608|NCT02558894|541266481|FG000|Overall Study|Withdrawal by Subject|2|||
150034609|NCT02558894|541266482|FG001|Overall Study|Withdrawal by Subject|1|||
150034610|NCT02558894|541266481|FG000|Overall Study|Closure of Part A|2|||
150282483|NCT00820950|542170469|FG005|Overall Study|Protocol Violation|0|||
150282484|NCT00820950|542170470|FG006|Overall Study|Protocol Violation|0|||
149838987|NCT00579345|540541270|FG006|Overall Study|Withdrawal by Subject|0|||
149950637|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
149950638|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
149950639|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
149950640|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
149950641|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
150034611|NCT02558894|541266482|FG001|Overall Study|Closure of Part A|1|||
149838988|NCT00579345|540541271|FG007|Overall Study|Withdrawal by Subject|1|||
149838989|NCT00579345|540541264|FG000|Overall Study|Lost to Follow-up|1|||
149838990|NCT00579345|540541265|FG001|Overall Study|Lost to Follow-up|0|||
149838991|NCT00579345|540541266|FG002|Overall Study|Lost to Follow-up|0|||
149838992|NCT00579345|540541267|FG003|Overall Study|Lost to Follow-up|0|||
149838993|NCT00579345|540541268|FG004|Overall Study|Lost to Follow-up|0|||
149838994|NCT00579345|540541269|FG005|Overall Study|Lost to Follow-up|0|||
149838995|NCT00579345|540541270|FG006|Overall Study|Lost to Follow-up|0|||
149838996|NCT00579345|540541271|FG007|Overall Study|Lost to Follow-up|0|||
149838997|NCT00579345|540541264|FG000|Overall Study|Adverse Event|0|||
149838998|NCT00579345|540541265|FG001|Overall Study|Adverse Event|0|||
149838999|NCT00579345|540541266|FG002|Overall Study|Adverse Event|1|||
149839000|NCT00579345|540541267|FG003|Overall Study|Adverse Event|0|||
149839001|NCT00579345|540541268|FG004|Overall Study|Adverse Event|0|||
149839002|NCT00579345|540541269|FG005|Overall Study|Adverse Event|0|||
149839003|NCT00579345|540541270|FG006|Overall Study|Adverse Event|0|||
149839004|NCT00579345|540541271|FG007|Overall Study|Adverse Event|0|||
149839005|NCT00579345|540541264|FG000|Overall Study|Protocol Violation|1|||
149839006|NCT00579345|540541265|FG001|Overall Study|Protocol Violation|0|||
149839007|NCT00579345|540541266|FG002|Overall Study|Protocol Violation|0|||
149839008|NCT00579345|540541267|FG003|Overall Study|Protocol Violation|0|||
149839009|NCT00579345|540541268|FG004|Overall Study|Protocol Violation|0|||
149839010|NCT00579345|540541269|FG005|Overall Study|Protocol Violation|0|||
149839011|NCT00579345|540541270|FG006|Overall Study|Protocol Violation|0|||
149839012|NCT00579345|540541271|FG007|Overall Study|Protocol Violation|1|||
149839013|NCT00579345|540541264|FG000|Overall Study|Death|1|||
149839014|NCT00579345|540541265|FG001|Overall Study|Death|1|||
149839015|NCT00579345|540541266|FG002|Overall Study|Death|1|||
149839016|NCT00579345|540541267|FG003|Overall Study|Death|1|||
149839017|NCT00579345|540541268|FG004|Overall Study|Death|0|||
149839018|NCT00579345|540541269|FG005|Overall Study|Death|0|||
149839019|NCT00579345|540541270|FG006|Overall Study|Death|0|||
149839020|NCT00579345|540541271|FG007|Overall Study|Death|0|||
149950642|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
149950643|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
149950644|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
149950645|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
149950646|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
149950647|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
149950648|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950649|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950650|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950651|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950652|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950653|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
149950654|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
149950655|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950656|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950657|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950658|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950659|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950660|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
149950661|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
149950662|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950663|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950664|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950665|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950666|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950667|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
149950668|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
149950669|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
149950670|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
149950671|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
149839021|NCT02267187|540541275|FG000|Overall Study|Physician Decision|2|||
149950672|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
150282485|NCT00820950|542170471|FG007|Overall Study|Protocol Violation|0|||
149839022|NCT02267187|540541275|FG000|Overall Study|Screen fail|3|||
149839023|NCT02222818|540541276|FG000|Period 1|Eligibility criteria not met|0|||
149839024|NCT02222818|540541277|FG001|Period 1|Eligibility criteria not met|3|||
149839025|NCT00508651|540541278|FG000|Overall Study|Lost to Follow-up|3|||
149839026|NCT00508651|540541279|FG001|Overall Study|Lost to Follow-up|1|||
149839027|NCT00508651|540541278|FG000|Overall Study|Withdrawal by Subject|1|||
149839028|NCT00508651|540541279|FG001|Overall Study|Withdrawal by Subject|1|||
149839029|NCT03874715|540541285|FG000|Overall Study|Adverse Event|2|||
149839030|NCT03874715|540541286|FG001|Overall Study|Adverse Event|0|||
149839031|NCT03874715|540541285|FG000|Overall Study|Poor compliance to protocol|5|||
149839032|NCT03874715|540541286|FG001|Overall Study|Poor compliance to protocol|1|||
149839033|NCT03874715|540541285|FG000|Overall Study|Withdrawal by Subject|1|||
149839034|NCT03874715|540541286|FG001|Overall Study|Withdrawal by Subject|0|||
149950673|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
149950674|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
149950675|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
149950676|NCT01697579|540950370|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
150282486|NCT00820950|542170472|FG008|Overall Study|Protocol Violation|0|||
150282487|NCT00820950|542170473|FG009|Overall Study|Protocol Violation|0|||
150282488|NCT02581202|542170476|FG000|Overall Study|Lack of Efficacy|2|||
150282489|NCT02581202|542170476|FG000|Overall Study|Withdrawal by Subject|4|||
150282490|NCT02581202|542170476|FG000|Overall Study|Lost to Follow-up|5|||
150282491|NCT02581202|542170476|FG000|Overall Study|Pregnancy|3|||
150282492|NCT04050982|542170477|FG000|Overall Study|Did not meet eligibility criteria|0|||
150282493|NCT04050982|542170478|FG001|Overall Study|Did not meet eligibility criteria|1|||
150282494|NCT04050982|542170479|FG002|Overall Study|Did not meet eligibility criteria|0|||
150282495|NCT04050982|542170477|FG000|Overall Study|Withdrawal by Subject|1|||
150282496|NCT04050982|542170478|FG001|Overall Study|Withdrawal by Subject|0|||
150282497|NCT04050982|542170479|FG002|Overall Study|Withdrawal by Subject|0|||
150282498|NCT04050982|542170477|FG000|Overall Study|Unable to enroll on platform|1|||
150282499|NCT04050982|542170478|FG001|Overall Study|Unable to enroll on platform|0|||
150282500|NCT04050982|542170479|FG002|Overall Study|Unable to enroll on platform|0|||
150282501|NCT05264740|542170480|FG000|Baseline|Withdrawal by Subject|0|||
150282502|NCT05264740|542170481|FG001|Baseline|Withdrawal by Subject|1|||
150282503|NCT05264740|542170480|FG000|Follow Up 1|Lost to Follow-up|1|||
150282504|NCT05264740|542170481|FG001|Follow Up 1|Lost to Follow-up|1|||
149839035|NCT03874715|540541285|FG000|Overall Study|Other-unspecified|1|||
149839036|NCT03874715|540541286|FG001|Overall Study|Other-unspecified|0|||
149839037|NCT00461786|540541287|FG000|Overall Study|Entry Criteria Not Met|2|||
149950677|NCT01697579|540950371|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
149950678|NCT01697579|540950372|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
149950679|NCT01697579|540950373|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
149950680|NCT01697579|540950374|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
149950681|NCT01697579|540950375|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
149950682|NCT01697579|540950376|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
149950683|NCT01044498|540950377|FG000|Overall Study|Withdrew consent|1|||
149950684|NCT01044498|540950378|FG001|Overall Study|Withdrew consent|1|||
149950685|NCT01044498|540950377|FG000|Overall Study|Adverse Event|1|||
149950686|NCT01044498|540950378|FG001|Overall Study|Adverse Event|1|||
149950687|NCT01044498|540950377|FG000|Overall Study|Other|1|||
149950688|NCT01044498|540950378|FG001|Overall Study|Other|0|||
149950689|NCT05513950|540950381|FG000|Overall Study|Not treated due to technical reasons|0|||
149950690|NCT05513950|540950382|FG001|Overall Study|Not treated due to technical reasons|0|||
149950691|NCT05513950|540950383|FG002|Overall Study|Not treated due to technical reasons|1|||
149950692|NCT05513950|540950384|FG003|Overall Study|Not treated due to technical reasons|0|||
149950693|NCT02903914|540950385|FG000|Overall Study|Adverse Event|0|||
149950694|NCT02903914|540950386|FG001|Overall Study|Adverse Event|0|||
149950695|NCT02903914|540950387|FG002|Overall Study|Adverse Event|1|||
149950696|NCT02903914|540950388|FG003|Overall Study|Adverse Event|0|||
149950697|NCT02903914|540950389|FG004|Overall Study|Adverse Event|0|||
149950698|NCT02903914|540950390|FG005|Overall Study|Adverse Event|0|||
149950699|NCT02903914|540950391|FG006|Overall Study|Adverse Event|2|||
149950700|NCT02903914|540950392|FG007|Overall Study|Adverse Event|0|||
149950701|NCT02903914|540950385|FG000|Overall Study|Withdrawal by Subject|3|||
149950702|NCT02903914|540950386|FG001|Overall Study|Withdrawal by Subject|1|||
150282505|NCT05264740|542170480|FG000|Follow Up 1|Withdrawal by Subject|0|||
150282506|NCT05264740|542170481|FG001|Follow Up 1|Withdrawal by Subject|1|||
150282507|NCT05264740|542170480|FG000|Follow Up 2|Lost to Follow-up|1|||
150282508|NCT05264740|542170481|FG001|Follow Up 2|Lost to Follow-up|4|||
150282509|NCT05264740|542170480|FG000|Follow Up 3|Lost to Follow-up|7|||
150282510|NCT05264740|542170481|FG001|Follow Up 3|Lost to Follow-up|4|||
150282511|NCT05885737|542170482|FG000|DB Period|Adverse Event|4|||
149950703|NCT02903914|540950387|FG002|Overall Study|Withdrawal by Subject|28|||
149950704|NCT02903914|540950388|FG003|Overall Study|Withdrawal by Subject|0|||
149839038|NCT00461786|540541287|FG000|Overall Study|Inevaluable (Never Treated)|1|||
149950705|NCT02903914|540950389|FG004|Overall Study|Withdrawal by Subject|1|||
149950706|NCT02903914|540950390|FG005|Overall Study|Withdrawal by Subject|2|||
150034612|NCT00581308|541266483|FG000|Pre Discharge|Lost to Follow-up|1|||
149950707|NCT02903914|540950391|FG006|Overall Study|Withdrawal by Subject|12|||
149950708|NCT02903914|540950392|FG007|Overall Study|Withdrawal by Subject|0|||
150282512|NCT05885737|542170483|FG001|DB Period|Adverse Event|4|||
149839039|NCT00934050|540541288|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
150282513|NCT05885737|542170482|FG000|DB Period|Lost to Follow-up|0|||
150282514|NCT05885737|542170483|FG001|DB Period|Lost to Follow-up|1|||
150282515|NCT05885737|542170482|FG000|DB Period|Physician Decision|2|||
149839040|NCT00934050|540541289|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
149839041|NCT00934050|540541290|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
149839042|NCT00934050|540541291|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
149839043|NCT00934050|540541292|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
149839044|NCT00934050|540541293|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
149839045|NCT00934050|540541288|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
149839046|NCT00934050|540541289|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
149839047|NCT00934050|540541290|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
149839048|NCT00934050|540541291|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
149839049|NCT00934050|540541292|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
149839050|NCT00934050|540541293|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
149839051|NCT00934050|540541288|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
149839052|NCT00934050|540541289|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
149839053|NCT00934050|540541290|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
149839054|NCT00934050|540541291|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
149950709|NCT02903914|540950385|FG000|Overall Study|Progressive Disease|1|||
149950710|NCT02903914|540950386|FG001|Overall Study|Progressive Disease|0|||
149950711|NCT02903914|540950387|FG002|Overall Study|Progressive Disease|4|||
149839055|NCT00934050|540541292|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
149839056|NCT00934050|540541293|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
149839057|NCT00934050|540541288|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
149839058|NCT00934050|540541289|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
149839059|NCT00934050|540541290|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
149950712|NCT02903914|540950388|FG003|Overall Study|Progressive Disease|0|||
149950713|NCT02903914|540950389|FG004|Overall Study|Progressive Disease|0|||
149950714|NCT02903914|540950390|FG005|Overall Study|Progressive Disease|0|||
149950715|NCT02903914|540950391|FG006|Overall Study|Progressive Disease|2|||
149950716|NCT02903914|540950392|FG007|Overall Study|Progressive Disease|0|||
149950717|NCT02903914|540950385|FG000|Overall Study|Death|0|||
149950718|NCT02903914|540950386|FG001|Overall Study|Death|0|||
149839060|NCT00934050|540541291|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
149839061|NCT00934050|540541292|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
149839062|NCT00934050|540541293|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
149839063|NCT00934050|540541288|FG000|Enrolled After 15 Dec 2009|Death|0|||
149839064|NCT00934050|540541289|FG001|Enrolled After 15 Dec 2009|Death|0|||
149839065|NCT00934050|540541290|FG002|Enrolled After 15 Dec 2009|Death|0|||
149839066|NCT00934050|540541291|FG003|Enrolled After 15 Dec 2009|Death|0|||
149950719|NCT02903914|540950387|FG002|Overall Study|Death|9|||
149950720|NCT02903914|540950388|FG003|Overall Study|Death|0|||
149950721|NCT02903914|540950389|FG004|Overall Study|Death|1|||
149950722|NCT02903914|540950390|FG005|Overall Study|Death|3|||
149950723|NCT02903914|540950391|FG006|Overall Study|Death|24|||
149950724|NCT02903914|540950392|FG007|Overall Study|Death|2|||
149950725|NCT02903914|540950385|FG000|Overall Study|Lost to Follow-up|0|||
149950726|NCT02903914|540950386|FG001|Overall Study|Lost to Follow-up|1|||
149950727|NCT02903914|540950387|FG002|Overall Study|Lost to Follow-up|0|||
149950728|NCT02903914|540950388|FG003|Overall Study|Lost to Follow-up|0|||
149950729|NCT02903914|540950389|FG004|Overall Study|Lost to Follow-up|2|||
149950730|NCT02903914|540950390|FG005|Overall Study|Lost to Follow-up|0|||
149950731|NCT02903914|540950391|FG006|Overall Study|Lost to Follow-up|1|||
149950732|NCT02903914|540950392|FG007|Overall Study|Lost to Follow-up|0|||
149950733|NCT02903914|540950385|FG000|Overall Study|Physician Decision|0|||
149950734|NCT02903914|540950386|FG001|Overall Study|Physician Decision|0|||
149950735|NCT02903914|540950387|FG002|Overall Study|Physician Decision|1|||
149950736|NCT02903914|540950388|FG003|Overall Study|Physician Decision|0|||
149950737|NCT02903914|540950389|FG004|Overall Study|Physician Decision|0|||
149950738|NCT02903914|540950390|FG005|Overall Study|Physician Decision|0|||
149950739|NCT02903914|540950391|FG006|Overall Study|Physician Decision|1|||
149950740|NCT02903914|540950392|FG007|Overall Study|Physician Decision|0|||
149950741|NCT02903914|540950385|FG000|Overall Study|Symptomatic Deterioration|0|||
149950742|NCT02903914|540950386|FG001|Overall Study|Symptomatic Deterioration|0|||
149950743|NCT02903914|540950387|FG002|Overall Study|Symptomatic Deterioration|1|||
149950744|NCT02903914|540950388|FG003|Overall Study|Symptomatic Deterioration|0|||
149950745|NCT02903914|540950389|FG004|Overall Study|Symptomatic Deterioration|0|||
149950746|NCT02903914|540950390|FG005|Overall Study|Symptomatic Deterioration|0|||
149950747|NCT02903914|540950391|FG006|Overall Study|Symptomatic Deterioration|0|||
149950748|NCT02903914|540950392|FG007|Overall Study|Symptomatic Deterioration|0|||
149950749|NCT02903914|540950385|FG000|Overall Study|New Cancer Therapy|2|||
149950750|NCT02903914|540950386|FG001|Overall Study|New Cancer Therapy|2|||
149950751|NCT02903914|540950387|FG002|Overall Study|New Cancer Therapy|21|||
149950752|NCT02903914|540950388|FG003|Overall Study|New Cancer Therapy|4|||
149950753|NCT02903914|540950389|FG004|Overall Study|New Cancer Therapy|3|||
149950754|NCT02903914|540950390|FG005|Overall Study|New Cancer Therapy|6|||
149950755|NCT02903914|540950391|FG006|Overall Study|New Cancer Therapy|56|||
149950756|NCT02903914|540950392|FG007|Overall Study|New Cancer Therapy|3|||
149950757|NCT02903914|540950385|FG000|Overall Study|Didn't Return to Site|1|||
149950758|NCT02903914|540950386|FG001|Overall Study|Didn't Return to Site|0|||
149950759|NCT02903914|540950387|FG002|Overall Study|Didn't Return to Site|1|||
149950760|NCT02903914|540950388|FG003|Overall Study|Didn't Return to Site|1|||
149950761|NCT02903914|540950389|FG004|Overall Study|Didn't Return to Site|0|||
149950762|NCT02903914|540950390|FG005|Overall Study|Didn't Return to Site|0|||
149950763|NCT02903914|540950391|FG006|Overall Study|Didn't Return to Site|2|||
149950764|NCT02903914|540950392|FG007|Overall Study|Didn't Return to Site|0|||
149950765|NCT02903914|540950385|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
149950766|NCT02903914|540950386|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
149950767|NCT02903914|540950387|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
149950768|NCT02903914|540950388|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
149950769|NCT02903914|540950389|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
149950770|NCT02903914|540950390|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
149950771|NCT02903914|540950391|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
149950772|NCT02903914|540950392|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
149950773|NCT02903914|540950385|FG000|Overall Study|Follow-up Did Not Occur|0|||
149950774|NCT02903914|540950386|FG001|Overall Study|Follow-up Did Not Occur|1|||
149950775|NCT02903914|540950387|FG002|Overall Study|Follow-up Did Not Occur|1|||
149950776|NCT02903914|540950388|FG003|Overall Study|Follow-up Did Not Occur|0|||
149950777|NCT02903914|540950389|FG004|Overall Study|Follow-up Did Not Occur|2|||
149950778|NCT02903914|540950390|FG005|Overall Study|Follow-up Did Not Occur|0|||
149950779|NCT02903914|540950391|FG006|Overall Study|Follow-up Did Not Occur|8|||
149839067|NCT00934050|540541292|FG004|Enrolled After 15 Dec 2009|Death|0|||
149839068|NCT00934050|540541293|FG005|Enrolled After 15 Dec 2009|Death|1|||
149950780|NCT02903914|540950392|FG007|Overall Study|Follow-up Did Not Occur|0|||
149950781|NCT02903914|540950385|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
149950782|NCT02903914|540950386|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
149950783|NCT02903914|540950387|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
149950784|NCT02903914|540950388|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
149950785|NCT02903914|540950389|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
149950786|NCT02903914|540950390|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
149950787|NCT02903914|540950391|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
149950788|NCT02903914|540950392|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
149950789|NCT02903914|540950385|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950790|NCT02903914|540950386|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950791|NCT02903914|540950387|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
149950792|NCT02903914|540950388|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950793|NCT02903914|540950389|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950794|NCT02903914|540950390|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
149950795|NCT02903914|540950391|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950796|NCT02903914|540950392|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
149950797|NCT02903914|540950385|FG000|Overall Study|Clinical Disease Progression|0|||
150282516|NCT05885737|542170483|FG001|DB Period|Physician Decision|0|||
149839069|NCT00934050|540541288|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
149839070|NCT00934050|540541289|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
149839071|NCT00934050|540541290|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
149839072|NCT00934050|540541291|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
149839073|NCT00934050|540541292|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
149839074|NCT00934050|540541293|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
149839075|NCT00934050|540541288|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
149839076|NCT00934050|540541289|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
149839077|NCT00934050|540541290|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
149839078|NCT00934050|540541291|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
149839079|NCT00934050|540541292|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
149839080|NCT00934050|540541293|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
149839081|NCT00835991|540541296|FG000|First Intervention|Adverse Event|0|||
149839082|NCT00835991|540541297|FG001|First Intervention|Adverse Event|1|||
149839083|NCT00835991|540541296|FG000|Washout|Protocol Violation|0|||
149839084|NCT00835991|540541297|FG001|Washout|Protocol Violation|2|||
149839085|NCT00835991|540541296|FG000|Washout|Withdrawal by Subject|3|||
149839086|NCT00835991|540541297|FG001|Washout|Withdrawal by Subject|1|||
149839087|NCT00829309|540541298|FG000|Washout: 7 Days|Protocol Violation|1|||
149839088|NCT00829309|540541299|FG001|Washout: 7 Days|Protocol Violation|0|||
149839089|NCT01705574|540541300|FG000|Double-Blind Phase|Lost to Follow-up|12|||
149839090|NCT01705574|540541301|FG001|Double-Blind Phase|Lost to Follow-up|16|||
149839091|NCT01705574|540541302|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149839092|NCT01705574|540541303|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149839093|NCT01705574|540541300|FG000|Double-Blind Phase|Adverse Event|3|||
149839094|NCT01705574|540541301|FG001|Double-Blind Phase|Adverse Event|10|||
149839095|NCT01705574|540541302|FG002|Double-Blind Phase|Adverse Event|0|||
149839096|NCT01705574|540541303|FG003|Double-Blind Phase|Adverse Event|0|||
149950798|NCT02903914|540950386|FG001|Overall Study|Clinical Disease Progression|0|||
149950799|NCT02903914|540950387|FG002|Overall Study|Clinical Disease Progression|2|||
150034613|NCT00581308|541266483|FG000|Pre Discharge|Device Removed|1|||
150034614|NCT00581308|541266483|FG000|Month 1|Lost to Follow-up|3|||
150034615|NCT00581308|541266483|FG000|Month 1|Withdrawal by Subject|2|||
150034616|NCT00581308|541266483|FG000|Month 1|Device Removed|2|||
150034617|NCT00581308|541266483|FG000|Month 1|Uknown|1|||
150034618|NCT00581308|541266483|FG000|Month 6|Lost to Follow-up|1|||
150034619|NCT00581308|541266483|FG000|Month 6|Withdrawal by Subject|2|||
150034620|NCT00581308|541266483|FG000|Month 12|Death|1|||
150034621|NCT00581308|541266483|FG000|Month 12|Lost to Follow-up|14|||
150034622|NCT00581308|541266483|FG000|Month 12|Withdrawal by Subject|3|||
150034623|NCT00581308|541266483|FG000|Month 12|Device Removed|1|||
150034624|NCT00581308|541266483|FG000|Month 12|Other|1|||
150034625|NCT03379818|541266484|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
150034626|NCT03379818|541266485|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
150034627|NCT03379818|541266484|FG000|Overall Study|Withdrawal by Subject|2|||
150034628|NCT03379818|541266485|FG001|Overall Study|Withdrawal by Subject|3|||
150034629|NCT03379818|541266484|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
150034630|NCT03379818|541266485|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
150034631|NCT01310777|541266486|FG000|Overall Study|Adverse Event|23|||
150034632|NCT01310777|541266487|FG001|Overall Study|Adverse Event|1|||
150034633|NCT01310777|541266488|FG002|Overall Study|Adverse Event|15|||
150034634|NCT01310777|541266486|FG000|Overall Study|Lost to Follow-up|0|||
150034635|NCT01310777|541266487|FG001|Overall Study|Lost to Follow-up|4|||
150034636|NCT01310777|541266488|FG002|Overall Study|Lost to Follow-up|1|||
150034637|NCT01310777|541266486|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
150034638|NCT01310777|541266487|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
150034639|NCT01310777|541266488|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
150034640|NCT01310777|541266486|FG000|Overall Study|Inadequate Control of IOP|5|||
150034641|NCT01310777|541266487|FG001|Overall Study|Inadequate Control of IOP|7|||
150034642|NCT01310777|541266488|FG002|Overall Study|Inadequate Control of IOP|10|||
150034643|NCT01310777|541266486|FG000|Overall Study|Other|4|||
150034644|NCT01310777|541266487|FG001|Overall Study|Other|1|||
150034645|NCT01310777|541266488|FG002|Overall Study|Other|2|||
150034646|NCT00003475|541266489|FG000|Overall Study|Not evaluable|13|||
150034647|NCT00106704|541266490|FG000|Overall Study|Adverse Event|10|||
149950800|NCT02903914|540950388|FG003|Overall Study|Clinical Disease Progression|0|||
149950801|NCT02903914|540950389|FG004|Overall Study|Clinical Disease Progression|0|||
149950802|NCT02903914|540950390|FG005|Overall Study|Clinical Disease Progression|0|||
149950803|NCT02903914|540950391|FG006|Overall Study|Clinical Disease Progression|0|||
149950804|NCT02903914|540950392|FG007|Overall Study|Clinical Disease Progression|0|||
149950805|NCT02903914|540950385|FG000|Overall Study|Completed Follow-up Period|0|||
149950806|NCT02903914|540950386|FG001|Overall Study|Completed Follow-up Period|0|||
149950807|NCT02903914|540950387|FG002|Overall Study|Completed Follow-up Period|6|||
149950808|NCT02903914|540950388|FG003|Overall Study|Completed Follow-up Period|2|||
149950809|NCT02903914|540950389|FG004|Overall Study|Completed Follow-up Period|1|||
149950810|NCT02903914|540950390|FG005|Overall Study|Completed Follow-up Period|0|||
149950811|NCT02903914|540950391|FG006|Overall Study|Completed Follow-up Period|9|||
149950812|NCT02903914|540950392|FG007|Overall Study|Completed Follow-up Period|1|||
149950813|NCT02903914|540950385|FG000|Overall Study|Taken off Treatment per Protocol|0|||
149950814|NCT02903914|540950386|FG001|Overall Study|Taken off Treatment per Protocol|0|||
149950815|NCT02903914|540950387|FG002|Overall Study|Taken off Treatment per Protocol|0|||
149950816|NCT02903914|540950388|FG003|Overall Study|Taken off Treatment per Protocol|0|||
149950817|NCT02903914|540950389|FG004|Overall Study|Taken off Treatment per Protocol|0|||
149950818|NCT02903914|540950390|FG005|Overall Study|Taken off Treatment per Protocol|1|||
149950819|NCT02903914|540950391|FG006|Overall Study|Taken off Treatment per Protocol|0|||
149950820|NCT02903914|540950392|FG007|Overall Study|Taken off Treatment per Protocol|0|||
149950821|NCT02903914|540950385|FG000|Overall Study|Refused Further Treatment/Contact|0|||
149950822|NCT02903914|540950386|FG001|Overall Study|Refused Further Treatment/Contact|0|||
149950823|NCT02903914|540950387|FG002|Overall Study|Refused Further Treatment/Contact|0|||
150034648|NCT00106704|541266491|FG001|Overall Study|Adverse Event|7|||
150034649|NCT00106704|541266490|FG000|Overall Study|Death|2|||
150034650|NCT00106704|541266491|FG001|Overall Study|Death|1|||
150034651|NCT00106704|541266490|FG000|Overall Study|Lack of Efficacy|67|||
150034652|NCT00106704|541266491|FG001|Overall Study|Lack of Efficacy|69|||
150034653|NCT00106704|541266490|FG000|Overall Study|Lost to Follow-up|7|||
150034654|NCT00106704|541266491|FG001|Overall Study|Lost to Follow-up|3|||
149950824|NCT02903914|540950388|FG003|Overall Study|Refused Further Treatment/Contact|0|||
149950825|NCT02903914|540950389|FG004|Overall Study|Refused Further Treatment/Contact|0|||
149950826|NCT02903914|540950390|FG005|Overall Study|Refused Further Treatment/Contact|0|||
150034655|NCT00106704|541266490|FG000|Overall Study|Pregnancy|1|||
150034656|NCT00106704|541266491|FG001|Overall Study|Pregnancy|0|||
150034657|NCT00106704|541266490|FG000|Overall Study|Protocol Violation|4|||
150034658|NCT00106704|541266491|FG001|Overall Study|Protocol Violation|7|||
150034659|NCT00106704|541266490|FG000|Overall Study|Withdrawal by Subject|14|||
149950827|NCT02903914|540950391|FG006|Overall Study|Refused Further Treatment/Contact|1|||
149950828|NCT02903914|540950392|FG007|Overall Study|Refused Further Treatment/Contact|0|||
149950829|NCT02903914|540950385|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950830|NCT02903914|540950386|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950831|NCT02903914|540950387|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950832|NCT02903914|540950388|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950833|NCT02903914|540950389|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
150282517|NCT05885737|542170482|FG000|DB Period|Withdrawal by Subject|12|||
150282518|NCT05885737|542170483|FG001|DB Period|Withdrawal by Subject|6|||
150282519|NCT05885737|542170482|FG000|DB Period|Other: Unspecified|2|||
150282520|NCT05885737|542170483|FG001|DB Period|Other: Unspecified|2|||
150282521|NCT05885737|542170482|FG000|OLE Period|Adverse Event|3|||
150282522|NCT05885737|542170483|FG001|OLE Period|Adverse Event|2|||
150282523|NCT05885737|542170482|FG000|OLE Period|Physician Decision|1|||
150282524|NCT05885737|542170483|FG001|OLE Period|Physician Decision|0|||
150282525|NCT05885737|542170482|FG000|OLE Period|Withdrawal by Subject|5|||
149839097|NCT01705574|540541300|FG000|Double-Blind Phase|Withdrew Consent|8|||
150282526|NCT05885737|542170483|FG001|OLE Period|Withdrawal by Subject|5|||
150282527|NCT05885737|542170482|FG000|OLE Period|Other: Unspecified|2|||
149839098|NCT01705574|540541301|FG001|Double-Blind Phase|Withdrew Consent|5|||
149839099|NCT01705574|540541302|FG002|Double-Blind Phase|Withdrew Consent|0|||
149839100|NCT01705574|540541303|FG003|Double-Blind Phase|Withdrew Consent|0|||
149839101|NCT01705574|540541300|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
149839102|NCT01705574|540541301|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
149839103|NCT01705574|540541302|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
149839104|NCT01705574|540541303|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
149839105|NCT01705574|540541300|FG000|Double-Blind Phase|Pregnancy|1|||
149839106|NCT01705574|540541301|FG001|Double-Blind Phase|Pregnancy|1|||
149839107|NCT01705574|540541302|FG002|Double-Blind Phase|Pregnancy|0|||
149839108|NCT01705574|540541303|FG003|Double-Blind Phase|Pregnancy|0|||
149839109|NCT01705574|540541300|FG000|Double-Blind Phase|Protocol Violation|1|||
149839110|NCT01705574|540541301|FG001|Double-Blind Phase|Protocol Violation|0|||
149839111|NCT01705574|540541302|FG002|Double-Blind Phase|Protocol Violation|0|||
149839112|NCT01705574|540541303|FG003|Double-Blind Phase|Protocol Violation|0|||
149839113|NCT01705574|540541300|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
150282528|NCT05885737|542170483|FG001|OLE Period|Other: Unspecified|1|||
150282529|NCT00609791|542171905|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
150282530|NCT04218201|542171906|FG000|Overall Study|Death|0|||
149950834|NCT02903914|540950390|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950835|NCT02903914|540950391|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
149950836|NCT02903914|540950392|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
149950837|NCT04225039|540950396|FG000|Overall Study|Withdrawal by Subject|1|||
149950838|NCT04225039|540950397|FG001|Overall Study|Withdrawal by Subject|0|||
149950839|NCT04225039|540950398|FG002|Overall Study|Withdrawal by Subject|0|||
149950840|NCT04225039|540950399|FG003|Overall Study|Withdrawal by Subject|1|||
149950841|NCT04225039|540950396|FG000|Overall Study|Currently active on study treatment|0|||
149950842|NCT04225039|540950397|FG001|Overall Study|Currently active on study treatment|1|||
149950843|NCT04225039|540950398|FG002|Overall Study|Currently active on study treatment|0|||
149950844|NCT04225039|540950399|FG003|Overall Study|Currently active on study treatment|0|||
149950845|NCT04225039|540950396|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
149950846|NCT04225039|540950397|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
149950847|NCT04225039|540950398|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
149950848|NCT04225039|540950399|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
149950849|NCT04225039|540950396|FG000|Overall Study|Ineligible for treatment|0|||
149950850|NCT04225039|540950397|FG001|Overall Study|Ineligible for treatment|0|||
149950851|NCT04225039|540950398|FG002|Overall Study|Ineligible for treatment|0|||
149950852|NCT04225039|540950399|FG003|Overall Study|Ineligible for treatment|4|||
149950853|NCT00975923|540950402|FG000|Overall Study|Withdrawal by Subject|0|||
149950854|NCT00975923|540950403|FG001|Overall Study|Withdrawal by Subject|1|||
149950855|NCT00088153|540950404|FG000|Overall Study|Physician Decision|3|||
149950856|NCT00088153|540950405|FG001|Overall Study|Physician Decision|3|||
149950857|NCT00088153|540950404|FG000|Overall Study|Withdrawal by Subject|10|||
149950858|NCT00088153|540950405|FG001|Overall Study|Withdrawal by Subject|10|||
150282531|NCT04218201|542171907|FG001|Overall Study|Death|0|||
149950859|NCT00088153|540950404|FG000|Overall Study|Lost to Follow-up|11|||
149950860|NCT00088153|540950405|FG001|Overall Study|Lost to Follow-up|12|||
149950861|NCT02246777|540950408|FG000|Overall Study|Adverse Event|2|||
150282532|NCT04218201|542171908|FG002|Overall Study|Death|2|||
150282533|NCT04218201|542171909|FG003|Overall Study|Death|0|||
150282534|NCT04218201|542171906|FG000|Overall Study|Unable to contact participant|4|||
150282535|NCT04218201|542171907|FG001|Overall Study|Unable to contact participant|0|||
149839114|NCT01705574|540541301|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
149839115|NCT01705574|540541302|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
149950862|NCT02246777|540950408|FG000|Overall Study|Change of residence|1|||
149950863|NCT03331250|540950414|FG000|Overall Study|Withdrawal by Subject|1|||
149950864|NCT03069989|540950424|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
149950865|NCT03069989|540950425|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
149950866|NCT02145390|540950426|FG000|Overall Study|Withdrawal by Subject|1|||
149950867|NCT00143507|540951236|FG000|Overall Study|Death|572|||
150171990|NCT03622580|541765868|FG001|Overall Study|Adverse Event|6|||
149950868|NCT00143507|540951237|FG001|Overall Study|Death|547|||
149950869|NCT00143507|540951236|FG000|Overall Study|Withdrawal by Subject|114|||
149950870|NCT00143507|540951237|FG001|Overall Study|Withdrawal by Subject|102|||
149950871|NCT00143507|540951236|FG000|Overall Study|Lost to Follow-up|1|||
149950872|NCT00143507|540951237|FG001|Overall Study|Lost to Follow-up|0|||
149950873|NCT00143507|540951236|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
149950874|NCT00143507|540951237|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
149950875|NCT00876395|540951238|FG000|Overall Study|Untreated|8|||
149950876|NCT00876395|540951239|FG001|Overall Study|Untreated|1|||
149950877|NCT00876395|540951238|FG000|Overall Study|Adverse Event|63|||
149950878|NCT00876395|540951239|FG001|Overall Study|Adverse Event|11|||
149950879|NCT00876395|540951238|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149950880|NCT00876395|540951239|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149950881|NCT00876395|540951238|FG000|Overall Study|Disease progression|259|||
149950882|NCT00876395|540951239|FG001|Overall Study|Disease progression|162|||
149950883|NCT00876395|540951238|FG000|Overall Study|New cancer therapy|25|||
149950884|NCT00876395|540951239|FG001|Overall Study|New cancer therapy|7|||
149950885|NCT00876395|540951238|FG000|Overall Study|Protocol Violation|5|||
149950886|NCT00876395|540951239|FG001|Overall Study|Protocol Violation|2|||
149950887|NCT00876395|540951238|FG000|Overall Study|Withdrawal by Subject|66|||
149950888|NCT00876395|540951239|FG001|Overall Study|Withdrawal by Subject|33|||
149950889|NCT00876395|540951238|FG000|Overall Study|Lost to Follow-up|2|||
149950890|NCT00876395|540951239|FG001|Overall Study|Lost to Follow-up|0|||
149950891|NCT00876395|540951238|FG000|Overall Study|Administrative problems|39|||
149950892|NCT00876395|540951239|FG001|Overall Study|Administrative problems|23|||
149950893|NCT00876395|540951238|FG000|Overall Study|Death|12|||
149950894|NCT00876395|540951239|FG001|Overall Study|Death|0|||
149950895|NCT00970944|540951243|FG000|Overall Study|Death|1|||
149950896|NCT00970944|540951244|FG001|Overall Study|Death|0|||
149950897|NCT00970944|540951243|FG000|Overall Study|Physician Decision|0|||
149950898|NCT00970944|540951244|FG001|Overall Study|Physician Decision|2|||
149950899|NCT00972738|540951245|FG000|Overall Study|Adverse Event|7|||
149950900|NCT00972738|540951246|FG001|Overall Study|Adverse Event|1|||
149950901|NCT00972738|540951247|FG002|Overall Study|Adverse Event|8|||
149950902|NCT00972738|540951245|FG000|Overall Study|Protocol Violation|2|||
149950903|NCT00972738|540951246|FG001|Overall Study|Protocol Violation|1|||
149950904|NCT00972738|540951247|FG002|Overall Study|Protocol Violation|3|||
149950905|NCT00972738|540951245|FG000|Overall Study|Lost to Follow-up|1|||
149950906|NCT00972738|540951246|FG001|Overall Study|Lost to Follow-up|0|||
149950907|NCT00972738|540951247|FG002|Overall Study|Lost to Follow-up|1|||
149950908|NCT00972738|540951245|FG000|Overall Study|Lack of Efficacy|5|||
149950909|NCT00972738|540951246|FG001|Overall Study|Lack of Efficacy|1|||
149950910|NCT00972738|540951247|FG002|Overall Study|Lack of Efficacy|11|||
149950911|NCT00972738|540951245|FG000|Overall Study|Withdrawal by Subject|5|||
149950912|NCT00972738|540951246|FG001|Overall Study|Withdrawal by Subject|1|||
149950913|NCT00972738|540951247|FG002|Overall Study|Withdrawal by Subject|4|||
149950914|NCT00972738|540951245|FG000|Overall Study|Moved|0|||
149950915|NCT00972738|540951246|FG001|Overall Study|Moved|0|||
149950916|NCT00972738|540951247|FG002|Overall Study|Moved|1|||
149950917|NCT00972738|540951245|FG000|Overall Study|Other|1|||
149950918|NCT00972738|540951246|FG001|Overall Study|Other|2|||
149950919|NCT00972738|540951247|FG002|Overall Study|Other|1|||
149950920|NCT03915067|540951248|FG000|Overall Study|Adverse Event|0|||
149950921|NCT03915067|540951249|FG001|Overall Study|Adverse Event|0|||
149950922|NCT03915067|540951250|FG002|Overall Study|Adverse Event|1|||
150171991|NCT03622580|541765869|FG002|Overall Study|Adverse Event|5|||
150171992|NCT03622580|541765867|FG000|Overall Study|Withdrawal by Subject|12|||
150171993|NCT03622580|541765868|FG001|Overall Study|Withdrawal by Subject|7|||
150171994|NCT03622580|541765869|FG002|Overall Study|Withdrawal by Subject|19|||
150171995|NCT03622580|541765867|FG000|Overall Study|Lost to Follow-up|12|||
150171996|NCT03622580|541765868|FG001|Overall Study|Lost to Follow-up|9|||
150171997|NCT03622580|541765869|FG002|Overall Study|Lost to Follow-up|9|||
150171998|NCT03622580|541765867|FG000|Overall Study|Protocol Violation|1|||
150171999|NCT03622580|541765868|FG001|Overall Study|Protocol Violation|0|||
150172000|NCT03622580|541765869|FG002|Overall Study|Protocol Violation|1|||
150172001|NCT03622580|541765867|FG000|Overall Study|Physician Decision|3|||
150172002|NCT03622580|541765868|FG001|Overall Study|Physician Decision|0|||
150172003|NCT03622580|541765869|FG002|Overall Study|Physician Decision|1|||
150172004|NCT03622580|541765867|FG000|Overall Study|Pregnancy|0|||
150172005|NCT03622580|541765868|FG001|Overall Study|Pregnancy|1|||
150172006|NCT03622580|541765869|FG002|Overall Study|Pregnancy|0|||
150172007|NCT03622580|541765867|FG000|Overall Study|Lack of Efficacy|0|||
150172008|NCT03622580|541765868|FG001|Overall Study|Lack of Efficacy|0|||
150282536|NCT04218201|542171908|FG002|Overall Study|Unable to contact participant|3|||
150282537|NCT04218201|542171909|FG003|Overall Study|Unable to contact participant|0|||
150282538|NCT04218201|542171906|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
150282539|NCT04218201|542171907|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
150282540|NCT04218201|542171908|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
150282541|NCT04218201|542171909|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
150282542|NCT04218201|542171906|FG000|Overall Study|Withdrawal by Subject|2|||
150282543|NCT04218201|542171907|FG001|Overall Study|Withdrawal by Subject|0|||
150282544|NCT04218201|542171908|FG002|Overall Study|Withdrawal by Subject|0|||
149950923|NCT03915067|540951248|FG000|Overall Study|Withdrawal by Subject|4|||
150282545|NCT04218201|542171909|FG003|Overall Study|Withdrawal by Subject|0|||
150282546|NCT04218201|542171906|FG000|Overall Study|PCP plans to leave practice|0|||
150282547|NCT04218201|542171907|FG001|Overall Study|PCP plans to leave practice|8|||
150282548|NCT04218201|542171908|FG002|Overall Study|PCP plans to leave practice|0|||
150282549|NCT04218201|542171909|FG003|Overall Study|PCP plans to leave practice|5|||
150282550|NCT04218201|542171906|FG000|Overall Study|Reduced panel|0|||
150282551|NCT04218201|542171907|FG001|Overall Study|Reduced panel|0|||
150282552|NCT04218201|542171908|FG002|Overall Study|Reduced panel|0|||
150282553|NCT04218201|542171909|FG003|Overall Study|Reduced panel|1|||
150282554|NCT04218201|542171906|FG000|Overall Study|No longer interested in participating|0|||
150282555|NCT04218201|542171907|FG001|Overall Study|No longer interested in participating|1|||
150282556|NCT04218201|542171908|FG002|Overall Study|No longer interested in participating|0|||
150282557|NCT04218201|542171909|FG003|Overall Study|No longer interested in participating|0|||
150282558|NCT01265615|542171910|FG000|Overall Study|Protocol Violation|2|||
150282559|NCT01265615|542171911|FG001|Overall Study|Protocol Violation|2|||
150282560|NCT01265615|542171912|FG002|Overall Study|Protocol Violation|4|||
150282561|NCT01265615|542171913|FG003|Overall Study|Protocol Violation|3|||
150282562|NCT03548935|542171916|FG000|Overall Study|Withdrawal by Subject|26|||
150282563|NCT03548935|542171917|FG001|Overall Study|Withdrawal by Subject|17|||
150282564|NCT03548935|542171916|FG000|Overall Study|Lost to Follow-up|39|||
150282565|NCT03548935|542171917|FG001|Overall Study|Lost to Follow-up|28|||
150282566|NCT03548935|542171916|FG000|Overall Study|Death|1|||
150282567|NCT03548935|542171917|FG001|Overall Study|Death|1|||
150282568|NCT04677959|542171918|FG000|Overall Study|Adverse Event|1|||
150282569|NCT04677959|542171919|FG001|Overall Study|Adverse Event|9|||
149950924|NCT03915067|540951249|FG001|Overall Study|Withdrawal by Subject|3|||
149950925|NCT03915067|540951250|FG002|Overall Study|Withdrawal by Subject|0|||
149950926|NCT03915067|540951248|FG000|Overall Study|Lost to Follow-up|3|||
149950927|NCT03915067|540951249|FG001|Overall Study|Lost to Follow-up|2|||
149950928|NCT03915067|540951250|FG002|Overall Study|Lost to Follow-up|0|||
149950929|NCT03915067|540951248|FG000|Overall Study|Protocol Deviation|0|||
149950930|NCT03915067|540951249|FG001|Overall Study|Protocol Deviation|0|||
149950931|NCT03915067|540951250|FG002|Overall Study|Protocol Deviation|1|||
149950932|NCT03915067|540951248|FG000|Overall Study|Covid-19 Related Issues|2|||
149950933|NCT03915067|540951249|FG001|Overall Study|Covid-19 Related Issues|4|||
149950934|NCT03915067|540951250|FG002|Overall Study|Covid-19 Related Issues|4|||
149950935|NCT03915067|540951248|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
149950936|NCT03915067|540951249|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
149950937|NCT03915067|540951250|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
149950938|NCT02034591|540951253|FG000|Overall Study|Withdrawal by Subject|0|||
149950939|NCT02034591|540951254|FG001|Overall Study|Withdrawal by Subject|0|||
149950940|NCT02034591|540951255|FG002|Overall Study|Withdrawal by Subject|0|||
149950941|NCT02034591|540951256|FG003|Overall Study|Withdrawal by Subject|0|||
149950942|NCT02034591|540951257|FG004|Overall Study|Withdrawal by Subject|1|||
149950943|NCT02034591|540951258|FG005|Overall Study|Withdrawal by Subject|0|||
149950944|NCT00599313|540951261|FG000|Overall Study|Adverse Event|19|||
149950945|NCT00599313|540951261|FG000|Overall Study|Disease Progression|12|||
149950946|NCT00599313|540951261|FG000|Overall Study|Patient Request|4|||
149950947|NCT00599313|540951261|FG000|Overall Study|Ineligible|1|||
149950948|NCT00712920|540951262|FG000|Overall Study|Adverse Event|3|||
149950949|NCT00712920|540951263|FG001|Overall Study|Adverse Event|4|||
149950950|NCT00712920|540951264|FG002|Overall Study|Adverse Event|7|||
150034660|NCT00106704|541266491|FG001|Overall Study|Withdrawal by Subject|21|||
150034661|NCT00106704|541266490|FG000|Overall Study|Patient moved|1|||
150034662|NCT00106704|541266491|FG001|Overall Study|Patient moved|0|||
150282570|NCT04677959|542171918|FG000|Overall Study|Withdrawal by Subject|2|||
150282571|NCT04677959|542171919|FG001|Overall Study|Withdrawal by Subject|15|||
150282572|NCT04677959|542171918|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150282573|NCT04677959|542171919|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149950951|NCT00712920|540951262|FG000|Overall Study|Withdrawal by Subject|4|||
149950952|NCT00712920|540951263|FG001|Overall Study|Withdrawal by Subject|2|||
149950953|NCT00712920|540951264|FG002|Overall Study|Withdrawal by Subject|1|||
149950954|NCT00712920|540951262|FG000|Overall Study|Lost to Follow-up|1|||
149950955|NCT00712920|540951263|FG001|Overall Study|Lost to Follow-up|4|||
149950956|NCT00712920|540951264|FG002|Overall Study|Lost to Follow-up|0|||
149950957|NCT00712920|540951262|FG000|Overall Study|Lack of Efficacy|1|||
149950958|NCT00712920|540951263|FG001|Overall Study|Lack of Efficacy|0|||
149950959|NCT00712920|540951264|FG002|Overall Study|Lack of Efficacy|1|||
149950960|NCT00712920|540951262|FG000|Overall Study|Other|5|||
149950961|NCT00712920|540951263|FG001|Overall Study|Other|7|||
149950962|NCT00712920|540951264|FG002|Overall Study|Other|3|||
149950963|NCT00712920|540951262|FG000|Overall Study|Non-compliance|3|||
149950964|NCT00712920|540951263|FG001|Overall Study|Non-compliance|0|||
149950965|NCT00712920|540951264|FG002|Overall Study|Non-compliance|0|||
149950966|NCT04398134|540951267|FG000|Overall Study|Adverse Event|0|||
150034663|NCT00106704|541266490|FG000|Overall Study|Site terminated|0|||
150034664|NCT00106704|541266491|FG001|Overall Study|Site terminated|1|||
150034665|NCT00106704|541266490|FG000|Overall Study|Planned major surgery|1|||
150034666|NCT00106704|541266491|FG001|Overall Study|Planned major surgery|0|||
150034667|NCT00106704|541266490|FG000|Overall Study|Patient Received Glycemic Medication|22|||
150034668|NCT00106704|541266491|FG001|Overall Study|Patient Received Glycemic Medication|41|||
150034669|NCT00106704|541266490|FG000|Overall Study|Unable to re-enter US|1|||
150034670|NCT00106704|541266491|FG001|Overall Study|Unable to re-enter US|0|||
150034671|NCT00106704|541266490|FG000|Overall Study|Laboratory test|1|||
150034672|NCT00106704|541266491|FG001|Overall Study|Laboratory test|1|||
150034673|NCT01780506|541266492|FG000|Double-Blind Phase|Randomized but not Treated|3|||
150034674|NCT01780506|541266493|FG001|Double-Blind Phase|Randomized but not Treated|2|||
150034675|NCT01780506|541266492|FG000|Double-Blind Phase|Adverse Event|4|||
150034676|NCT01780506|541266493|FG001|Double-Blind Phase|Adverse Event|14|||
150034677|NCT01780506|541266492|FG000|Double-Blind Phase|Death|1|||
150034678|NCT01780506|541266493|FG001|Double-Blind Phase|Death|2|||
150034679|NCT01780506|541266492|FG000|Double-Blind Phase|Pregnancy|2|||
150034680|NCT01780506|541266493|FG001|Double-Blind Phase|Pregnancy|1|||
150034681|NCT01780506|541266492|FG000|Double-Blind Phase|Lack of Efficacy|1|||
150034682|NCT01780506|541266493|FG001|Double-Blind Phase|Lack of Efficacy|1|||
149950967|NCT04398134|540951268|FG001|Overall Study|Adverse Event|0|||
149950968|NCT04398134|540951269|FG002|Overall Study|Adverse Event|1|||
149950969|NCT04398134|540951270|FG003|Overall Study|Adverse Event|0|||
149950970|NCT04398134|540951267|FG000|Overall Study|Withdrawal by Subject|2|||
149950971|NCT04398134|540951268|FG001|Overall Study|Withdrawal by Subject|0|||
149950972|NCT04398134|540951269|FG002|Overall Study|Withdrawal by Subject|0|||
150034683|NCT01780506|541266492|FG000|Double-Blind Phase|Investigator's Discretion|5|||
150034684|NCT01780506|541266493|FG001|Double-Blind Phase|Investigator's Discretion|2|||
150034685|NCT01780506|541266492|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
150034686|NCT01780506|541266493|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
150034687|NCT01780506|541266492|FG000|Double-Blind Phase|Protocol Violation|4|||
150034688|NCT01780506|541266493|FG001|Double-Blind Phase|Protocol Violation|3|||
150034689|NCT01780506|541266492|FG000|Double-Blind Phase|Withdrew Consent|23|||
150034690|NCT01780506|541266493|FG001|Double-Blind Phase|Withdrew Consent|24|||
150172009|NCT03622580|541765869|FG002|Overall Study|Lack of Efficacy|1|||
149950973|NCT04398134|540951270|FG003|Overall Study|Withdrawal by Subject|1|||
149950974|NCT04398134|540951267|FG000|Overall Study|Study Terminated by Sponsor|30|||
149950975|NCT04398134|540951268|FG001|Overall Study|Study Terminated by Sponsor|11|||
149950976|NCT04398134|540951269|FG002|Overall Study|Study Terminated by Sponsor|32|||
150172010|NCT03622580|541765867|FG000|Overall Study|Other|2|||
149950977|NCT04398134|540951270|FG003|Overall Study|Study Terminated by Sponsor|11|||
150034691|NCT01780506|541266492|FG000|Double-Blind Phase|Lost to Follow-up|23|||
150034692|NCT01780506|541266493|FG001|Double-Blind Phase|Lost to Follow-up|26|||
150034693|NCT01780506|541266492|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
150034694|NCT01780506|541266493|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
150034695|NCT01867671|541266497|FG000|Overall Study|Adverse Event|5|||
150034696|NCT01867671|541266498|FG001|Overall Study|Adverse Event|3|||
150172011|NCT03622580|541765868|FG001|Overall Study|Other|0|||
150172012|NCT03622580|541765869|FG002|Overall Study|Other|3|||
150172013|NCT01930045|541765871|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
150172014|NCT01930045|541765872|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
150172015|NCT01930045|541765873|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
150172016|NCT01930045|541765874|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
150172017|NCT01930045|541765875|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
150172018|NCT01930045|541765876|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
150172019|NCT01930045|541765871|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
150172020|NCT01930045|541765872|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
150172021|NCT01930045|541765873|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
150172022|NCT01930045|541765874|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
150172023|NCT01930045|541765875|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
150172024|NCT01930045|541765876|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
150172025|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
150172026|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
150172027|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
150172028|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
150172029|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
149950978|NCT04556097|540951279|FG000|Overall Study|Death|0|||
149950979|NCT04556097|540951280|FG001|Overall Study|Death|5|||
149950980|NCT04556097|540951281|FG002|Overall Study|Death|0|||
149950981|NCT04556097|540951282|FG003|Overall Study|Death|0|||
149950982|NCT04556097|540951279|FG000|Overall Study|No caregiver|43|||
149950983|NCT04556097|540951280|FG001|Overall Study|No caregiver|53|||
149950984|NCT04556097|540951281|FG002|Overall Study|No caregiver|0|||
149950985|NCT04556097|540951282|FG003|Overall Study|No caregiver|0|||
149950986|NCT04556097|540951279|FG000|Overall Study|Ineligible, SNF|2|||
149950987|NCT04556097|540951280|FG001|Overall Study|Ineligible, SNF|2|||
149950988|NCT04556097|540951281|FG002|Overall Study|Ineligible, SNF|0|||
149950989|NCT04556097|540951282|FG003|Overall Study|Ineligible, SNF|0|||
149950990|NCT04556097|540951279|FG000|Overall Study|Ineligible, health|3|||
149950991|NCT04556097|540951280|FG001|Overall Study|Ineligible, health|4|||
149950992|NCT04556097|540951281|FG002|Overall Study|Ineligible, health|0|||
149950993|NCT04556097|540951282|FG003|Overall Study|Ineligible, health|0|||
149950994|NCT04556097|540951279|FG000|Overall Study|Ineligible, language|0|||
149950995|NCT04556097|540951280|FG001|Overall Study|Ineligible, language|1|||
149950996|NCT04556097|540951281|FG002|Overall Study|Ineligible, language|0|||
149950997|NCT04556097|540951282|FG003|Overall Study|Ineligible, language|0|||
149950998|NCT04556097|540951279|FG000|Overall Study|Ineligible, no longer in care management|0|||
149950999|NCT04556097|540951280|FG001|Overall Study|Ineligible, no longer in care management|2|||
149951000|NCT04556097|540951281|FG002|Overall Study|Ineligible, no longer in care management|1|||
149951001|NCT04556097|540951282|FG003|Overall Study|Ineligible, no longer in care management|0|||
149951002|NCT04556097|540951279|FG000|Overall Study|No dementia|13|||
149951003|NCT04556097|540951280|FG001|Overall Study|No dementia|3|||
149951004|NCT04556097|540951281|FG002|Overall Study|No dementia|0|||
149951005|NCT04556097|540951282|FG003|Overall Study|No dementia|0|||
149951006|NCT04556097|540951279|FG000|Overall Study|Missing identifier|2|||
149951007|NCT04556097|540951280|FG001|Overall Study|Missing identifier|4|||
149951008|NCT04556097|540951281|FG002|Overall Study|Missing identifier|0|||
149951009|NCT04556097|540951282|FG003|Overall Study|Missing identifier|0|||
149951010|NCT04556097|540951279|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
149951011|NCT04556097|540951280|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
149951012|NCT04556097|540951281|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
149951013|NCT04556097|540951282|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
149951014|NCT06455111|540951294|FG000|Overall Study|Withdrawal by Subject|11|||
149951015|NCT06455111|540951295|FG001|Overall Study|Withdrawal by Subject|4|||
149951016|NCT02337686|540951304|FG000|Overall Study|Adverse Event|1|||
149951017|NCT02008370|540952810|FG000|Overall Study|Lost to Follow-up|7|||
149951018|NCT00662259|540952811|FG000|Overall Study|Adverse Event|2|||
149951019|NCT00662259|540952812|FG001|Overall Study|Adverse Event|0|||
149951020|NCT02693418|540952814|FG000|Overall Study|Lost to Follow-up|1|||
149951021|NCT02693418|540952815|FG001|Overall Study|Lost to Follow-up|2|||
149951022|NCT02693418|540952816|FG002|Overall Study|Lost to Follow-up|0|||
149951023|NCT02693418|540952817|FG003|Overall Study|Lost to Follow-up|0|||
149951024|NCT02693418|540952818|FG004|Overall Study|Lost to Follow-up|0|||
149951025|NCT02693418|540952814|FG000|Overall Study|Menses during study period|0|||
149951026|NCT02693418|540952815|FG001|Overall Study|Menses during study period|0|||
149951027|NCT02693418|540952816|FG002|Overall Study|Menses during study period|2|||
149951028|NCT02693418|540952817|FG003|Overall Study|Menses during study period|0|||
149951029|NCT02693418|540952818|FG004|Overall Study|Menses during study period|0|||
149951030|NCT01750346|540952820|FG000|Overall Study|Adverse Event|1|||
149951031|NCT01750346|540952821|FG001|Overall Study|Adverse Event|0|||
149951032|NCT01750346|540952822|FG002|Overall Study|Adverse Event|0|||
149951033|NCT01001104|540952823|FG000|Overall Study|Adverse Event|2|||
149951034|NCT01001104|540952824|FG001|Overall Study|Adverse Event|1|||
149951035|NCT01001104|540952825|FG002|Overall Study|Adverse Event|0|||
149951036|NCT01001104|540952826|FG003|Overall Study|Adverse Event|0|||
149951037|NCT01001104|540952823|FG000|Overall Study|Lost to Follow-up|0|||
149951038|NCT01001104|540952824|FG001|Overall Study|Lost to Follow-up|0|||
149951039|NCT01001104|540952825|FG002|Overall Study|Lost to Follow-up|1|||
149951040|NCT01001104|540952826|FG003|Overall Study|Lost to Follow-up|0|||
149951041|NCT01001104|540952823|FG000|Overall Study|Entry Criteria Not Met|0|||
149951042|NCT01001104|540952824|FG001|Overall Study|Entry Criteria Not Met|0|||
149951043|NCT01001104|540952825|FG002|Overall Study|Entry Criteria Not Met|0|||
149951044|NCT01001104|540952826|FG003|Overall Study|Entry Criteria Not Met|1|||
149951045|NCT01001104|540952823|FG000|Overall Study|Withdrawal by Subject|0|||
149951046|NCT01001104|540952824|FG001|Overall Study|Withdrawal by Subject|0|||
149951047|NCT01001104|540952825|FG002|Overall Study|Withdrawal by Subject|0|||
149951048|NCT01001104|540952826|FG003|Overall Study|Withdrawal by Subject|2|||
149951049|NCT03439514|540952827|FG000|Double-Blind Treatment Period|Other|4|||
149951050|NCT03439514|540952828|FG001|Double-Blind Treatment Period|Other|1|||
149951051|NCT03439514|540952827|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
149951052|NCT03439514|540952828|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149951053|NCT03439514|540952827|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
149951054|NCT03439514|540952828|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
149951055|NCT03439514|540952827|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
149951056|NCT03439514|540952828|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
149951057|NCT03439514|540952827|FG000|Double-Blind Treatment Period|Death|1|||
149951058|NCT03439514|540952828|FG001|Double-Blind Treatment Period|Death|2|||
149951059|NCT02175758|540952829|FG000|Treatment Phase|Lost to Follow-up|0|||
149951060|NCT02175758|540952830|FG001|Treatment Phase|Lost to Follow-up|1|||
149951061|NCT02175758|540952831|FG002|Treatment Phase|Lost to Follow-up|0|||
149951062|NCT02175758|540952832|FG003|Treatment Phase|Lost to Follow-up|0|||
149951063|NCT02175758|540952833|FG004|Treatment Phase|Lost to Follow-up|0|||
149951064|NCT02175758|540952834|FG005|Treatment Phase|Lost to Follow-up|0|||
149951065|NCT02175758|540952829|FG000|Treatment Phase|Adverse Event|0|||
149951066|NCT02175758|540952830|FG001|Treatment Phase|Adverse Event|0|||
149951067|NCT02175758|540952831|FG002|Treatment Phase|Adverse Event|0|||
149951068|NCT02175758|540952832|FG003|Treatment Phase|Adverse Event|0|||
149951069|NCT02175758|540952833|FG004|Treatment Phase|Adverse Event|1|||
149951070|NCT02175758|540952834|FG005|Treatment Phase|Adverse Event|0|||
149951071|NCT02299167|540952837|FG000|Overall Study|patients were excluded from the study|11|||
149951072|NCT03600428|540952838|FG000|Overall Study|Not eligible|0|||
149951073|NCT03600428|540952839|FG001|Overall Study|Not eligible|1|||
149951074|NCT03600428|540952838|FG000|Overall Study|Lost to Follow-up|5|||
149951075|NCT03600428|540952839|FG001|Overall Study|Lost to Follow-up|4|||
149951076|NCT03506477|540952848|FG000|Overall Study|Withdrawal by Subject|1|||
149951077|NCT03506477|540952849|FG001|Overall Study|Withdrawal by Subject|0|||
149951078|NCT03462680|540952850|FG000|Overall Study|Withdrawal by Subject|3|||
149951079|NCT03462680|540952851|FG001|Overall Study|Withdrawal by Subject|5|||
149951080|NCT01757847|540952852|FG000|Overall Study|Withdrawal by Subject|3|||
149951081|NCT01757847|540952853|FG001|Overall Study|Withdrawal by Subject|4|||
149951082|NCT02516241|540952854|FG000|Overall Study|Death|255|||
149951083|NCT02516241|540952855|FG001|Overall Study|Death|262|||
149951084|NCT02516241|540952856|FG002|Overall Study|Death|270|||
149951085|NCT02516241|540952854|FG000|Overall Study|Lost to Follow-up|1|||
149951086|NCT02516241|540952855|FG001|Overall Study|Lost to Follow-up|1|||
149951087|NCT02516241|540952856|FG002|Overall Study|Lost to Follow-up|3|||
149951088|NCT02516241|540952854|FG000|Overall Study|Withdrawal by Subject|2|||
149951089|NCT02516241|540952855|FG001|Overall Study|Withdrawal by Subject|7|||
149951090|NCT02516241|540952856|FG002|Overall Study|Withdrawal by Subject|12|||
149951091|NCT02516241|540952854|FG000|Overall Study|participants ongoing at data cut-off|84|||
149951092|NCT02516241|540952855|FG001|Overall Study|participants ongoing at data cut-off|76|||
149951093|NCT02516241|540952856|FG002|Overall Study|participants ongoing at data cut-off|59|||
149951094|NCT04057365|540952857|FG000|Overall Study|Withdrawal by Subject|2|||
149951095|NCT04057365|540952858|FG001|Overall Study|Withdrawal by Subject|0|||
149951096|NCT04738487|540952859|FG000|Overall Study|Participant Ongoing in Study|298|||
149951097|NCT04738487|540952860|FG001|Overall Study|Participant Ongoing in Study|297|||
149951098|NCT04738487|540952859|FG000|Overall Study|Withdrawal by Subject|7|||
149951099|NCT04738487|540952860|FG001|Overall Study|Withdrawal by Subject|9|||
149951100|NCT04738487|540952859|FG000|Overall Study|Lost to Follow-up|2|||
149951101|NCT04738487|540952860|FG001|Overall Study|Lost to Follow-up|0|||
149951102|NCT04738487|540952859|FG000|Overall Study|Death|287|||
149951103|NCT04738487|540952860|FG001|Overall Study|Death|306|||
149951104|NCT00325416|540952864|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
149951105|NCT00325416|540952865|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
149951106|NCT00325416|540952864|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
149951107|NCT00325416|540952865|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
149951108|NCT00325416|540952864|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
149951109|NCT00325416|540952865|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
149951110|NCT00325416|540952864|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
149951111|NCT00325416|540952865|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
149951112|NCT00325416|540952864|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
149951113|NCT00325416|540952865|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
149951114|NCT00325416|540952864|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
149951115|NCT00325416|540952865|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
149951116|NCT06239610|540952866|FG000|Overall Study|no usable migration data for minimum of one day|11|||
149951117|NCT01260948|540952869|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
149951118|NCT01260948|540952870|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
149951119|NCT01260948|540952869|FG000|Second Intervention|Emesis|0|||
149951120|NCT01260948|540952870|FG001|Second Intervention|Emesis|1|||
149951121|NCT00462462|540952871|FG000|Overall Study|Physician Decision|0|||
150034697|NCT01867671|541266497|FG000|Overall Study|Anaphylaxis|0|||
149951122|NCT00462462|540952872|FG001|Overall Study|Physician Decision|1|||
149951123|NCT02555878|540952873|FG000|Overall Study|Lost to Follow-up|2|||
149951124|NCT02555878|540952874|FG001|Overall Study|Lost to Follow-up|3|||
149951125|NCT02555878|540952873|FG000|Overall Study|Withdrawal by Subject|48|||
149951126|NCT02555878|540952874|FG001|Overall Study|Withdrawal by Subject|48|||
149951127|NCT02555878|540952873|FG000|Overall Study|Adverse Event|12|||
149951128|NCT02555878|540952874|FG001|Overall Study|Adverse Event|8|||
149951129|NCT02555878|540952873|FG000|Overall Study|Death|74|||
149951130|NCT02555878|540952874|FG001|Overall Study|Death|59|||
149951131|NCT02555878|540952873|FG000|Overall Study|Protocol Violation|1|||
149951132|NCT02555878|540952874|FG001|Overall Study|Protocol Violation|2|||
149951133|NCT02555878|540952873|FG000|Overall Study|Physician Decision|12|||
149951134|NCT02555878|540952874|FG001|Overall Study|Physician Decision|13|||
149951135|NCT02555878|540952873|FG000|Overall Study|Other|17|||
149951136|NCT02555878|540952874|FG001|Overall Study|Other|17|||
149951137|NCT00765076|540952875|FG000|Overall Study|Adverse Event|1|||
149951138|NCT00765076|540952876|FG001|Overall Study|Adverse Event|0|||
149951139|NCT00765076|540952877|FG002|Overall Study|Adverse Event|0|||
149951140|NCT00765076|540952875|FG000|Overall Study|Withdrawal by Subject|0|||
150034698|NCT01867671|541266498|FG001|Overall Study|Anaphylaxis|1|||
150034699|NCT01867671|541266497|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
150034700|NCT01867671|541266498|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
150034701|NCT01867671|541266497|FG000|Overall Study|Lost to Follow-up|0|||
150034702|NCT01867671|541266498|FG001|Overall Study|Lost to Follow-up|1|||
150034703|NCT01867671|541266497|FG000|Overall Study|Non-compliance with Study Drug|1|||
150034704|NCT01867671|541266498|FG001|Overall Study|Non-compliance with Study Drug|2|||
150034705|NCT01867671|541266497|FG000|Overall Study|Withdrawal by Subject|21|||
150034706|NCT01867671|541266498|FG001|Overall Study|Withdrawal by Subject|21|||
150034707|NCT03486912|541266502|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
150034708|NCT03486912|541266503|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
150034709|NCT03486912|541266504|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
150034710|NCT03486912|541266505|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
150034711|NCT03486912|541266502|FG000|Treatment Period|Withdrawal by Subject|3|||
149951141|NCT00765076|540952876|FG001|Overall Study|Withdrawal by Subject|0|||
149951142|NCT00765076|540952877|FG002|Overall Study|Withdrawal by Subject|1|||
150034712|NCT03486912|541266503|FG001|Treatment Period|Withdrawal by Subject|3|||
150034713|NCT03486912|541266504|FG002|Treatment Period|Withdrawal by Subject|3|||
150034714|NCT03486912|541266505|FG003|Treatment Period|Withdrawal by Subject|2|||
150034715|NCT03486912|541266502|FG000|Treatment Period|Other Reasons|0|||
150034716|NCT03486912|541266503|FG001|Treatment Period|Other Reasons|2|||
150034717|NCT03486912|541266504|FG002|Treatment Period|Other Reasons|1|||
150034718|NCT03486912|541266505|FG003|Treatment Period|Other Reasons|1|||
150034719|NCT03486912|541266502|FG000|Treatment Period|Adverse Event|0|||
150034720|NCT03486912|541266503|FG001|Treatment Period|Adverse Event|1|||
150034721|NCT03486912|541266504|FG002|Treatment Period|Adverse Event|1|||
150034722|NCT03486912|541266505|FG003|Treatment Period|Adverse Event|0|||
150034723|NCT03486912|541266502|FG000|Treatment Period|Lost to Follow-up|1|||
150034724|NCT03486912|541266503|FG001|Treatment Period|Lost to Follow-up|0|||
150034725|NCT03486912|541266504|FG002|Treatment Period|Lost to Follow-up|0|||
150034726|NCT03486912|541266505|FG003|Treatment Period|Lost to Follow-up|2|||
150034727|NCT00412984|541266506|FG000|Overall Study|Death|331|||
150034728|NCT00412984|541266507|FG001|Overall Study|Death|349|||
150034729|NCT00412984|541266506|FG000|Overall Study|Adverse Event|679|||
150034730|NCT00412984|541266507|FG001|Overall Study|Adverse Event|738|||
150034731|NCT00412984|541266506|FG000|Overall Study|Withdrawal by Subject|921|||
150034732|NCT00412984|541266507|FG001|Overall Study|Withdrawal by Subject|989|||
150034733|NCT00412984|541266506|FG000|Overall Study|Lost to Follow-up|51|||
150034734|NCT00412984|541266507|FG001|Overall Study|Lost to Follow-up|39|||
150034735|NCT00412984|541266506|FG000|Overall Study|Poor/Noncompliance|57|||
150034736|NCT00412984|541266507|FG001|Overall Study|Poor/Noncompliance|77|||
150034737|NCT00412984|541266506|FG000|Overall Study|Pregnancy|1|||
150034738|NCT00412984|541266507|FG001|Overall Study|Pregnancy|0|||
149951143|NCT01163617|540952878|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951144|NCT01163617|540952879|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
149951145|NCT01163617|540952880|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951146|NCT01163617|540952881|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951147|NCT01163617|540952882|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951148|NCT01163617|540952883|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951149|NCT01163617|540952884|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
149951150|NCT01163617|540952885|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
150034739|NCT00412984|541266506|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
150034740|NCT00412984|541266507|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
150034741|NCT00412984|541266506|FG000|Overall Study|Administrative Reason by Sponsor|11|||
150034742|NCT00412984|541266507|FG001|Overall Study|Administrative Reason by Sponsor|8|||
150034743|NCT00412984|541266506|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
150034744|NCT00412984|541266507|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
150034745|NCT00412984|541266506|FG000|Overall Study|Other Reason|80|||
150034746|NCT00412984|541266507|FG001|Overall Study|Other Reason|92|||
150034747|NCT00412984|541266506|FG000|Overall Study|Not Reported|11|||
149951151|NCT01163617|540952878|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
150034748|NCT00412984|541266507|FG001|Overall Study|Not Reported|12|||
149951152|NCT01163617|540952879|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
149951153|NCT01163617|540952880|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
150034749|NCT04097678|541266509|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
149951154|NCT01163617|540952881|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
149951155|NCT01163617|540952882|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
149951156|NCT01163617|540952883|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
149951157|NCT01163617|540952884|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
149951158|NCT01163617|540952885|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
149951159|NCT01163617|540952878|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951160|NCT01163617|540952879|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951161|NCT01163617|540952880|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
149951162|NCT01163617|540952881|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951163|NCT01163617|540952882|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951164|NCT01163617|540952883|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951165|NCT01163617|540952884|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951166|NCT01163617|540952885|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
149951167|NCT02875080|540952886|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
149951168|NCT02875080|540952887|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
149951169|NCT02875080|540952888|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
149951170|NCT02394756|540952889|FG000|Period 1|Lens Discomfort|0|||
149951171|NCT02394756|540952890|FG001|Period 1|Lens Discomfort|0|||
149951172|NCT02394756|540952891|FG002|Period 1|Lens Discomfort|0|||
149951173|NCT02394756|540952892|FG003|Period 1|Lens Discomfort|0|||
149951174|NCT02394756|540952893|FG004|Period 1|Lens Discomfort|0|||
149951175|NCT02394756|540952894|FG005|Period 1|Lens Discomfort|1|||
149951176|NCT02394756|540952889|FG000|Period 1|Withdrawal by Subject|0|||
149951177|NCT02394756|540952890|FG001|Period 1|Withdrawal by Subject|1|||
149951178|NCT02394756|540952891|FG002|Period 1|Withdrawal by Subject|1|||
149951179|NCT02394756|540952892|FG003|Period 1|Withdrawal by Subject|1|||
149951180|NCT02394756|540952893|FG004|Period 1|Withdrawal by Subject|0|||
149951181|NCT02394756|540952894|FG005|Period 1|Withdrawal by Subject|0|||
149951182|NCT02394756|540952889|FG000|Period 2|Unsatisfactory Visual Response|0|||
149951183|NCT02394756|540952890|FG001|Period 2|Unsatisfactory Visual Response|0|||
149951184|NCT02394756|540952891|FG002|Period 2|Unsatisfactory Visual Response|0|||
149951185|NCT02394756|540952892|FG003|Period 2|Unsatisfactory Visual Response|0|||
149951186|NCT02394756|540952893|FG004|Period 2|Unsatisfactory Visual Response|1|||
149951187|NCT02394756|540952894|FG005|Period 2|Unsatisfactory Visual Response|0|||
149951188|NCT00768053|540952895|FG000|Overall Study|Adverse Event|10|||
149951189|NCT00768053|540952895|FG000|Overall Study|Lost to Follow-up|1|||
149951190|NCT01164475|540952896|FG000|Overall Study|Lack of Efficacy|1|||
149951191|NCT01164475|540952897|FG001|Overall Study|Lack of Efficacy|0|||
149951192|NCT01164475|540952896|FG000|Overall Study|Other|0|||
149951193|NCT01164475|540952897|FG001|Overall Study|Other|1|||
149951194|NCT01164475|540952896|FG000|Overall Study|Progressive disease|0|||
149951195|NCT01164475|540952897|FG001|Overall Study|Progressive disease|1|||
149951196|NCT01164475|540952896|FG000|Overall Study|Protocol Violation|1|||
149951197|NCT01164475|540952897|FG001|Overall Study|Protocol Violation|0|||
149951198|NCT02335944|540952898|FG000|Treatment Phase|Progressive Disease|2|||
149951199|NCT02335944|540952899|FG001|Treatment Phase|Progressive Disease|5|||
149951200|NCT02335944|540952900|FG002|Treatment Phase|Progressive Disease|2|||
149951201|NCT02335944|540952901|FG003|Treatment Phase|Progressive Disease|11|||
149951202|NCT02335944|540952902|FG004|Treatment Phase|Progressive Disease|4|||
149951203|NCT02335944|540952903|FG005|Treatment Phase|Progressive Disease|25|||
149951204|NCT02335944|540952904|FG006|Treatment Phase|Progressive Disease|2|||
149951205|NCT02335944|540952905|FG007|Treatment Phase|Progressive Disease|30|||
149951206|NCT02335944|540952906|FG008|Treatment Phase|Progressive Disease|27|||
149951207|NCT02335944|540952907|FG009|Treatment Phase|Progressive Disease|0|||
149951208|NCT02335944|540952898|FG000|Treatment Phase|Adverse Event|2|||
149951209|NCT02335944|540952899|FG001|Treatment Phase|Adverse Event|0|||
149951210|NCT02335944|540952900|FG002|Treatment Phase|Adverse Event|0|||
149951211|NCT02335944|540952901|FG003|Treatment Phase|Adverse Event|2|||
149951212|NCT02335944|540952902|FG004|Treatment Phase|Adverse Event|1|||
149951213|NCT02335944|540952903|FG005|Treatment Phase|Adverse Event|15|||
149951214|NCT02335944|540952904|FG006|Treatment Phase|Adverse Event|0|||
149951215|NCT02335944|540952905|FG007|Treatment Phase|Adverse Event|5|||
149951216|NCT02335944|540952906|FG008|Treatment Phase|Adverse Event|7|||
149951217|NCT02335944|540952907|FG009|Treatment Phase|Adverse Event|0|||
149951218|NCT02335944|540952898|FG000|Treatment Phase|Physician Decision|0|||
149951219|NCT02335944|540952899|FG001|Treatment Phase|Physician Decision|0|||
149951220|NCT02335944|540952900|FG002|Treatment Phase|Physician Decision|0|||
149951221|NCT02335944|540952901|FG003|Treatment Phase|Physician Decision|1|||
150034750|NCT04097678|541266510|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
150034751|NCT04711850|541266514|FG000|Overall Study|Graft loss|2|||
150034752|NCT04711850|541266515|FG001|Overall Study|Graft loss|1|||
150034753|NCT04711850|541266514|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
150034754|NCT04711850|541266515|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
150034755|NCT04711850|541266514|FG000|Overall Study|Study terminated by sponsor|5|||
150034756|NCT04711850|541266515|FG001|Overall Study|Study terminated by sponsor|3|||
150034757|NCT04711850|541266514|FG000|Overall Study|Sponsor decision|0|||
150034758|NCT04711850|541266515|FG001|Overall Study|Sponsor decision|2|||
150034759|NCT02718898|541266526|FG000|Blinded Treatment Period|Adverse Event|5|||
150034760|NCT02718898|541266527|FG001|Blinded Treatment Period|Adverse Event|1|||
150034761|NCT02718898|541266528|FG002|Blinded Treatment Period|Adverse Event|0|||
150034762|NCT02718898|541266529|FG003|Blinded Treatment Period|Adverse Event|0|||
150034763|NCT02718898|541266530|FG004|Blinded Treatment Period|Adverse Event|0|||
150034764|NCT02718898|541266531|FG005|Blinded Treatment Period|Adverse Event|0|||
150034765|NCT02718898|541266532|FG006|Blinded Treatment Period|Adverse Event|0|||
150034766|NCT02718898|541266526|FG000|Blinded Treatment Period|Physician Decision|1|||
150034767|NCT02718898|541266527|FG001|Blinded Treatment Period|Physician Decision|0|||
150034768|NCT02718898|541266528|FG002|Blinded Treatment Period|Physician Decision|0|||
150034769|NCT02718898|541266529|FG003|Blinded Treatment Period|Physician Decision|0|||
150034770|NCT02718898|541266530|FG004|Blinded Treatment Period|Physician Decision|0|||
150034771|NCT02718898|541266531|FG005|Blinded Treatment Period|Physician Decision|0|||
150034772|NCT02718898|541266532|FG006|Blinded Treatment Period|Physician Decision|0|||
150034773|NCT02718898|541266526|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
150034774|NCT02718898|541266527|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
150034775|NCT02718898|541266528|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
150034776|NCT02718898|541266529|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
150034777|NCT02718898|541266530|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
150034778|NCT02718898|541266531|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
150034779|NCT02718898|541266532|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
150034780|NCT02718898|541266526|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
150034781|NCT02718898|541266527|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
150034782|NCT02718898|541266528|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
150034783|NCT02718898|541266529|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
150034784|NCT02718898|541266530|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
150034785|NCT02718898|541266531|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
150034786|NCT02718898|541266532|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
150034787|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
149951222|NCT02335944|540952902|FG004|Treatment Phase|Physician Decision|0|||
149951223|NCT02335944|540952903|FG005|Treatment Phase|Physician Decision|6|||
149951224|NCT02335944|540952904|FG006|Treatment Phase|Physician Decision|1|||
149951225|NCT02335944|540952905|FG007|Treatment Phase|Physician Decision|2|||
149951226|NCT02335944|540952906|FG008|Treatment Phase|Physician Decision|1|||
149951227|NCT02335944|540952907|FG009|Treatment Phase|Physician Decision|0|||
149951228|NCT02335944|540952898|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
149951229|NCT02335944|540952899|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
150034788|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
150034789|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
149951230|NCT02335944|540952900|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
149951231|NCT02335944|540952901|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
149951232|NCT02335944|540952902|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
149951233|NCT02335944|540952903|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
149951234|NCT02335944|540952904|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
149951235|NCT02335944|540952905|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
149951236|NCT02335944|540952906|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
149951237|NCT02335944|540952907|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
149951238|NCT02335944|540952898|FG000|Treatment Phase|Subject/Guardian Decision|0|||
149951239|NCT02335944|540952899|FG001|Treatment Phase|Subject/Guardian Decision|0|||
149951240|NCT02335944|540952900|FG002|Treatment Phase|Subject/Guardian Decision|1|||
149951241|NCT02335944|540952901|FG003|Treatment Phase|Subject/Guardian Decision|0|||
150034790|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
150034791|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
150034792|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
150034793|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
150034794|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
150034795|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
150034796|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
149951242|NCT02335944|540952902|FG004|Treatment Phase|Subject/Guardian Decision|0|||
149951243|NCT02335944|540952903|FG005|Treatment Phase|Subject/Guardian Decision|1|||
149951244|NCT02335944|540952904|FG006|Treatment Phase|Subject/Guardian Decision|0|||
150034797|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
150034798|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
149951245|NCT02335944|540952905|FG007|Treatment Phase|Subject/Guardian Decision|4|||
149951246|NCT02335944|540952906|FG008|Treatment Phase|Subject/Guardian Decision|0|||
149951247|NCT02335944|540952907|FG009|Treatment Phase|Subject/Guardian Decision|0|||
149951248|NCT02335944|540952898|FG000|Post-treatment Follow-up|Progressive Disease|0|||
149951249|NCT02335944|540952899|FG001|Post-treatment Follow-up|Progressive Disease|0|||
149951250|NCT02335944|540952900|FG002|Post-treatment Follow-up|Progressive Disease|0|||
149951251|NCT02335944|540952901|FG003|Post-treatment Follow-up|Progressive Disease|1|||
149951252|NCT02335944|540952902|FG004|Post-treatment Follow-up|Progressive Disease|0|||
149951253|NCT02335944|540952903|FG005|Post-treatment Follow-up|Progressive Disease|9|||
149951254|NCT02335944|540952904|FG006|Post-treatment Follow-up|Progressive Disease|0|||
149951255|NCT02335944|540952905|FG007|Post-treatment Follow-up|Progressive Disease|2|||
149951256|NCT02335944|540952906|FG008|Post-treatment Follow-up|Progressive Disease|3|||
149951257|NCT02335944|540952907|FG009|Post-treatment Follow-up|Progressive Disease|0|||
149951258|NCT02335944|540952898|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951259|NCT02335944|540952899|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951260|NCT02335944|540952900|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951261|NCT02335944|540952901|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951262|NCT02335944|540952902|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951263|NCT02335944|540952903|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
149951264|NCT02335944|540952904|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951265|NCT02335944|540952905|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951266|NCT02335944|540952906|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951267|NCT02335944|540952907|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
149951268|NCT02335944|540952898|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951269|NCT02335944|540952899|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951270|NCT02335944|540952900|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951271|NCT02335944|540952901|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951272|NCT02335944|540952902|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951273|NCT02335944|540952903|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951274|NCT02335944|540952904|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951275|NCT02335944|540952905|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
149951276|NCT02335944|540952906|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951277|NCT02335944|540952907|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
149951278|NCT02335944|540952898|FG000|Post-treatment Follow-up|Adverse Event|0|||
149951279|NCT02335944|540952899|FG001|Post-treatment Follow-up|Adverse Event|0|||
149951280|NCT02335944|540952900|FG002|Post-treatment Follow-up|Adverse Event|0|||
149951281|NCT02335944|540952901|FG003|Post-treatment Follow-up|Adverse Event|0|||
149951282|NCT02335944|540952902|FG004|Post-treatment Follow-up|Adverse Event|0|||
149951283|NCT02335944|540952903|FG005|Post-treatment Follow-up|Adverse Event|1|||
149951284|NCT02335944|540952904|FG006|Post-treatment Follow-up|Adverse Event|0|||
149951285|NCT02335944|540952905|FG007|Post-treatment Follow-up|Adverse Event|0|||
149951286|NCT02335944|540952906|FG008|Post-treatment Follow-up|Adverse Event|0|||
149951287|NCT02335944|540952907|FG009|Post-treatment Follow-up|Adverse Event|0|||
149951288|NCT02335944|540952898|FG000|Post-treatment Follow-up|Death|0|||
149951289|NCT02335944|540952899|FG001|Post-treatment Follow-up|Death|0|||
149951290|NCT02335944|540952900|FG002|Post-treatment Follow-up|Death|0|||
149951291|NCT02335944|540952901|FG003|Post-treatment Follow-up|Death|1|||
149951292|NCT02335944|540952902|FG004|Post-treatment Follow-up|Death|0|||
149951293|NCT02335944|540952903|FG005|Post-treatment Follow-up|Death|1|||
149951294|NCT02335944|540952904|FG006|Post-treatment Follow-up|Death|0|||
149951295|NCT02335944|540952905|FG007|Post-treatment Follow-up|Death|0|||
149951296|NCT02335944|540952906|FG008|Post-treatment Follow-up|Death|0|||
149951297|NCT02335944|540952907|FG009|Post-treatment Follow-up|Death|0|||
149951298|NCT02335944|540952898|FG000|Post-treatment Follow-up|Physician Decision|1|||
149951299|NCT02335944|540952899|FG001|Post-treatment Follow-up|Physician Decision|0|||
149951300|NCT02335944|540952900|FG002|Post-treatment Follow-up|Physician Decision|0|||
149951301|NCT02335944|540952901|FG003|Post-treatment Follow-up|Physician Decision|0|||
150034799|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
150034800|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
150034801|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
149951302|NCT02335944|540952902|FG004|Post-treatment Follow-up|Physician Decision|0|||
149951303|NCT02335944|540952903|FG005|Post-treatment Follow-up|Physician Decision|0|||
149951304|NCT02335944|540952904|FG006|Post-treatment Follow-up|Physician Decision|0|||
149951305|NCT02335944|540952905|FG007|Post-treatment Follow-up|Physician Decision|1|||
150034802|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150034803|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
149951306|NCT02335944|540952906|FG008|Post-treatment Follow-up|Physician Decision|0|||
149951307|NCT02335944|540952907|FG009|Post-treatment Follow-up|Physician Decision|0|||
149951308|NCT02830087|540952912|FG000|Overall Study|No study staff to follow-up patients|4|||
149951309|NCT02830087|540952913|FG001|Overall Study|No study staff to follow-up patients|4|||
149951310|NCT02830087|540952914|FG002|Overall Study|No study staff to follow-up patients|4|||
149951311|NCT02830087|540952915|FG003|Overall Study|No study staff to follow-up patients|3|||
149951312|NCT02830087|540952916|FG004|Overall Study|No study staff to follow-up patients|3|||
149951313|NCT02830087|540952917|FG005|Overall Study|No study staff to follow-up patients|3|||
149951314|NCT02916771|540952918|FG000|Overall Study|Withdrawal by Subject|9|||
149951315|NCT02916771|540952918|FG000|Overall Study|Physician Decision|1|||
149951316|NCT02916771|540952918|FG000|Overall Study|Began treatment for another active malignancy|1|||
149951317|NCT01018979|540953774|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
149951318|NCT01018979|540953775|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
149951319|NCT01018979|540953774|FG000|Overall Study|Not received at least one dose|0|||
149951320|NCT01018979|540953775|FG001|Overall Study|Not received at least one dose|1|||
149951321|NCT01695746|540953776|FG000|Overall Study|Adverse Event|1|||
149951322|NCT01695746|540953776|FG000|Overall Study|Non-compliance by the participant|3|||
149951323|NCT01695746|540953776|FG000|Overall Study|Protocol Violation|5|||
149951324|NCT01695746|540953776|FG000|Overall Study|Participant not willing to participate|3|||
149951325|NCT02324153|540953777|FG000|Overall Study|Withdrawal by Subject|4|||
149951326|NCT02324153|540953778|FG001|Overall Study|Withdrawal by Subject|1|||
149951327|NCT02324153|540953777|FG000|Overall Study|Surgery postponed after randomization|3|||
149951328|NCT02324153|540953778|FG001|Overall Study|Surgery postponed after randomization|0|||
149951329|NCT02324153|540953777|FG000|Overall Study|Developed delirium preoperatively|1|||
149951330|NCT02324153|540953778|FG001|Overall Study|Developed delirium preoperatively|0|||
149951331|NCT01937299|540953779|FG000|Overall Study|Adverse Event|13|||
149951332|NCT01937299|540953780|FG001|Overall Study|Adverse Event|0|||
149951333|NCT01937299|540953779|FG000|Overall Study|Lack of Efficacy|0|||
149951334|NCT01937299|540953780|FG001|Overall Study|Lack of Efficacy|4|||
149951335|NCT01937299|540953779|FG000|Overall Study|Withdrawal by Subject|1|||
149951336|NCT01937299|540953780|FG001|Overall Study|Withdrawal by Subject|0|||
149951337|NCT03018938|540953781|FG000|Overall Study|Death|0|||
149951338|NCT03018938|540953782|FG001|Overall Study|Death|1|||
149951339|NCT03018938|540953781|FG000|Overall Study|Lost to Follow-up|21|||
149951340|NCT03018938|540953782|FG001|Overall Study|Lost to Follow-up|32|||
149951341|NCT03018938|540953781|FG000|Overall Study|Withdrawal by Subject|38|||
149951342|NCT03018938|540953782|FG001|Overall Study|Withdrawal by Subject|45|||
149951343|NCT03018938|540953781|FG000|Overall Study|Physician Decision|3|||
149951344|NCT03018938|540953782|FG001|Overall Study|Physician Decision|2|||
149951345|NCT03018938|540953781|FG000|Overall Study|Sponsor Decision|0|||
149951346|NCT03018938|540953782|FG001|Overall Study|Sponsor Decision|1|||
149951347|NCT03018938|540953781|FG000|Overall Study|Screen failure-After randomization|4|||
149951348|NCT03018938|540953782|FG001|Overall Study|Screen failure-After randomization|2|||
149951349|NCT03018938|540953781|FG000|Overall Study|Not recorded|0|||
149951350|NCT03018938|540953782|FG001|Overall Study|Not recorded|2|||
149951351|NCT01202591|540953783|FG000|Overall Study|Adverse Event|2|||
149951352|NCT01202591|540953784|FG001|Overall Study|Adverse Event|1|||
149951353|NCT01202591|540953785|FG002|Overall Study|Adverse Event|4|||
149951354|NCT01202591|540953786|FG003|Overall Study|Adverse Event|4|||
149951355|NCT01202591|540953787|FG004|Overall Study|Adverse Event|0|||
149951356|NCT01202591|540953788|FG005|Overall Study|Adverse Event|0|||
149951357|NCT01202591|540953783|FG000|Overall Study|Other reason as per investigator|3|||
149951358|NCT01202591|540953784|FG001|Overall Study|Other reason as per investigator|4|||
149951359|NCT01202591|540953785|FG002|Overall Study|Other reason as per investigator|7|||
149951360|NCT01202591|540953786|FG003|Overall Study|Other reason as per investigator|3|||
149951361|NCT01202591|540953787|FG004|Overall Study|Other reason as per investigator|1|||
149951362|NCT01202591|540953788|FG005|Overall Study|Other reason as per investigator|3|||
149951363|NCT01202591|540953783|FG000|Overall Study|Withdrawal by Subject|0|||
149951364|NCT01202591|540953784|FG001|Overall Study|Withdrawal by Subject|0|||
149951365|NCT01202591|540953785|FG002|Overall Study|Withdrawal by Subject|0|||
149951366|NCT01202591|540953786|FG003|Overall Study|Withdrawal by Subject|0|||
149951367|NCT01202591|540953787|FG004|Overall Study|Withdrawal by Subject|2|||
149951368|NCT01202591|540953788|FG005|Overall Study|Withdrawal by Subject|1|||
149951369|NCT01202591|540953783|FG000|Overall Study|Objective Disease Progression|0|||
149951370|NCT01202591|540953784|FG001|Overall Study|Objective Disease Progression|0|||
149951371|NCT01202591|540953785|FG002|Overall Study|Objective Disease Progression|0|||
149951372|NCT01202591|540953786|FG003|Overall Study|Objective Disease Progression|0|||
149951373|NCT01202591|540953787|FG004|Overall Study|Objective Disease Progression|2|||
149951374|NCT01202591|540953788|FG005|Overall Study|Objective Disease Progression|0|||
149951375|NCT00191100|540953789|FG000|Overall Study|Adverse Event|18|||
149951376|NCT00191100|540953790|FG001|Overall Study|Adverse Event|1|||
149951377|NCT00191100|540953789|FG000|Overall Study|Lost to Follow-up|2|||
149951378|NCT00191100|540953790|FG001|Overall Study|Lost to Follow-up|0|||
149951379|NCT00191100|540953789|FG000|Overall Study|Patient Moved|0|||
149951380|NCT00191100|540953790|FG001|Overall Study|Patient Moved|1|||
149951381|NCT00191100|540953789|FG000|Overall Study|Withdrawal by Subject|9|||
149951382|NCT00191100|540953790|FG001|Overall Study|Withdrawal by Subject|3|||
149951383|NCT00191100|540953789|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
149951384|NCT00191100|540953790|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
149951385|NCT00191100|540953789|FG000|Overall Study|Clinical Relapse|2|||
149951386|NCT00191100|540953790|FG001|Overall Study|Clinical Relapse|1|||
149951387|NCT00191100|540953789|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
149951388|NCT00191100|540953790|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
149951389|NCT00191100|540953789|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
149951390|NCT00191100|540953790|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
149951391|NCT00191100|540953789|FG000|Overall Study|Physician Decision|3|||
149951392|NCT00191100|540953790|FG001|Overall Study|Physician Decision|1|||
149951393|NCT00191100|540953789|FG000|Overall Study|Death from Study Drug Toxicity|2|||
149951394|NCT00191100|540953790|FG001|Overall Study|Death from Study Drug Toxicity|0|||
149951395|NCT00191100|540953789|FG000|Overall Study|Protocol Violation|1|||
149951396|NCT00191100|540953790|FG001|Overall Study|Protocol Violation|1|||
149951397|NCT00191100|540953789|FG000|Overall Study|Death from Other Cause|1|||
149951398|NCT00191100|540953790|FG001|Overall Study|Death from Other Cause|0|||
149951399|NCT00191100|540953789|FG000|Overall Study|Reason Not Specified|0|||
149951400|NCT00191100|540953790|FG001|Overall Study|Reason Not Specified|1|||
149951401|NCT02406612|540953793|FG000|Overall Study|Screening Failure|3|||
149951402|NCT02406612|540953794|FG001|Overall Study|Screening Failure|0|||
149951403|NCT02406612|540953793|FG000|Overall Study|Intra-procedural Exclusion|1|||
149951404|NCT02406612|540953794|FG001|Overall Study|Intra-procedural Exclusion|3|||
149951405|NCT02406612|540953793|FG000|Overall Study|Guidewire Failure|0|||
149951406|NCT02406612|540953794|FG001|Overall Study|Guidewire Failure|1|||
149951407|NCT03611946|540953799|FG000|Overall Study|Withdrawal by Subject|0|||
149951408|NCT03611946|540953800|FG001|Overall Study|Withdrawal by Subject|0|||
149951409|NCT03611946|540953801|FG002|Overall Study|Withdrawal by Subject|1|||
149951410|NCT03611946|540953802|FG003|Overall Study|Withdrawal by Subject|0|||
149951411|NCT00632359|540953809|FG000|Overall Study|Withdrawal by Subject|2|||
149951412|NCT02872714|540953810|FG000|Overall Study|Progressive Disease|1|||
149951413|NCT02872714|540953811|FG001|Overall Study|Progressive Disease|2|||
149951414|NCT02872714|540953812|FG002|Overall Study|Progressive Disease|0|||
149951415|NCT02872714|540953813|FG003|Overall Study|Progressive Disease|0|||
149951416|NCT02872714|540953814|FG004|Overall Study|Progressive Disease|0|||
149951417|NCT02872714|540953810|FG000|Overall Study|Death|87|||
149951418|NCT02872714|540953811|FG001|Overall Study|Death|36|||
149951419|NCT02872714|540953812|FG002|Overall Study|Death|8|||
149951420|NCT02872714|540953813|FG003|Overall Study|Death|81|||
149951421|NCT02872714|540953814|FG004|Overall Study|Death|2|||
149951422|NCT02872714|540953810|FG000|Overall Study|Lost to Follow-up|2|||
149951423|NCT02872714|540953811|FG001|Overall Study|Lost to Follow-up|1|||
149951424|NCT02872714|540953812|FG002|Overall Study|Lost to Follow-up|0|||
149951425|NCT02872714|540953813|FG003|Overall Study|Lost to Follow-up|3|||
150172030|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
150172031|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
150172032|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
150172033|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
150172034|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
150172035|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
150172036|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
150172037|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
150172038|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
150172039|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
150172040|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
150172041|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
150172042|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
150172043|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
150172044|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
150172045|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
150172046|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
150172047|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
150172048|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
150172049|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
150172050|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
149951426|NCT02872714|540953814|FG004|Overall Study|Lost to Follow-up|0|||
149951427|NCT02872714|540953810|FG000|Overall Study|Physician Decision|0|||
149951428|NCT02872714|540953811|FG001|Overall Study|Physician Decision|0|||
149951429|NCT02872714|540953812|FG002|Overall Study|Physician Decision|0|||
149951430|NCT02872714|540953813|FG003|Overall Study|Physician Decision|1|||
149951431|NCT02872714|540953814|FG004|Overall Study|Physician Decision|0|||
149951432|NCT02872714|540953810|FG000|Overall Study|Withdrawal by Subject|1|||
149951433|NCT02872714|540953811|FG001|Overall Study|Withdrawal by Subject|3|||
149951434|NCT02872714|540953812|FG002|Overall Study|Withdrawal by Subject|0|||
149951435|NCT02872714|540953813|FG003|Overall Study|Withdrawal by Subject|2|||
149951436|NCT02872714|540953814|FG004|Overall Study|Withdrawal by Subject|0|||
149951437|NCT02872714|540953810|FG000|Overall Study|Captured as Other|2|||
149951438|NCT02872714|540953811|FG001|Overall Study|Captured as Other|0|||
149951439|NCT02872714|540953812|FG002|Overall Study|Captured as Other|0|||
150034804|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
150034805|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150034806|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150034807|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
150034808|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
150034809|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
150034810|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
150034811|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
150034812|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
150034813|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
150034814|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
150034815|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
150034816|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
150034817|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
150034818|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
150034819|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
150034820|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
149951440|NCT02872714|540953813|FG003|Overall Study|Captured as Other|1|||
149951441|NCT02872714|540953814|FG004|Overall Study|Captured as Other|0|||
149951442|NCT03043573|540953821|FG000|Overall Study|Lost to Follow-up|3|||
150034821|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
150282574|NCT04677959|542171918|FG000|Overall Study|Non-compliance with study drug|0|||
150282575|NCT04677959|542171919|FG001|Overall Study|Non-compliance with study drug|2|||
149951443|NCT03043573|540953822|FG001|Overall Study|Lost to Follow-up|3|||
149951444|NCT03043573|540953821|FG000|Overall Study|Physician Decision|0|||
149951445|NCT03043573|540953822|FG001|Overall Study|Physician Decision|5|||
149951446|NCT03043573|540953821|FG000|Overall Study|Withdrawal by Subject|0|||
149951447|NCT03043573|540953822|FG001|Overall Study|Withdrawal by Subject|4|||
149951448|NCT05578872|540953827|FG000|Overall Study|Withdrawal by Subject|2|||
149951449|NCT05578872|540953828|FG001|Overall Study|Withdrawal by Subject|1|||
149951450|NCT05578872|540953827|FG000|Overall Study|Adverse Event|1|||
149951451|NCT05578872|540953828|FG001|Overall Study|Adverse Event|1|||
149951452|NCT05578872|540953827|FG000|Overall Study|Physician Decision|1|||
149951453|NCT05578872|540953828|FG001|Overall Study|Physician Decision|2|||
149951454|NCT05578872|540953827|FG000|Overall Study|Progressive disease|10|||
149951455|NCT05578872|540953828|FG001|Overall Study|Progressive disease|9|||
149951456|NCT05578872|540953827|FG000|Overall Study|Sponsor decision|0|||
149951457|NCT05578872|540953828|FG001|Overall Study|Sponsor decision|1|||
149951458|NCT05578872|540953827|FG000|Overall Study|Toxicity and Patient's decision|0|||
149951459|NCT05578872|540953828|FG001|Overall Study|Toxicity and Patient's decision|1|||
149951460|NCT00479232|540955007|FG000|Overall Study|Adverse Event|0|||
149951461|NCT00479232|540955008|FG001|Overall Study|Adverse Event|0|||
149951462|NCT00479232|540955009|FG002|Overall Study|Adverse Event|5|||
149951463|NCT00479232|540955010|FG003|Overall Study|Adverse Event|0|||
149951464|NCT00479232|540955011|FG004|Overall Study|Adverse Event|0|||
149951465|NCT00479232|540955012|FG005|Overall Study|Adverse Event|10|||
149951466|NCT00479232|540955007|FG000|Overall Study|Deviation from Protocol|0|||
149951467|NCT00479232|540955008|FG001|Overall Study|Deviation from Protocol|0|||
149951468|NCT00479232|540955009|FG002|Overall Study|Deviation from Protocol|1|||
149951469|NCT00479232|540955010|FG003|Overall Study|Deviation from Protocol|0|||
149951470|NCT00479232|540955011|FG004|Overall Study|Deviation from Protocol|0|||
149951471|NCT00479232|540955012|FG005|Overall Study|Deviation from Protocol|0|||
150282576|NCT04677959|542171918|FG000|Overall Study|Protocol deviation|0|||
150282577|NCT04677959|542171919|FG001|Overall Study|Protocol deviation|11|||
150282578|NCT04677959|542171918|FG000|Overall Study|Lost to Follow-up|9|||
150282579|NCT04677959|542171919|FG001|Overall Study|Lost to Follow-up|13|||
150282580|NCT04677959|542171918|FG000|Overall Study|Other than specified|0|||
150282581|NCT04677959|542171919|FG001|Overall Study|Other than specified|8|||
150282582|NCT02716987|542171922|FG000|Overall Study|Ligand synthesis failure|0|||
150282583|NCT02716987|542171923|FG001|Overall Study|Ligand synthesis failure|0|||
150282584|NCT02716987|542171924|FG002|Overall Study|Ligand synthesis failure|1|||
150282585|NCT02716987|542171925|FG003|Overall Study|Ligand synthesis failure|0|||
150282586|NCT02716987|542171926|FG004|Overall Study|Ligand synthesis failure|0|||
150282587|NCT02716987|542171927|FG005|Overall Study|Ligand synthesis failure|0|||
150282588|NCT02716987|542171922|FG000|Overall Study|Withdrawal by Subject|0|||
150282589|NCT02716987|542171923|FG001|Overall Study|Withdrawal by Subject|0|||
150282590|NCT02716987|542171924|FG002|Overall Study|Withdrawal by Subject|0|||
150282591|NCT02716987|542171925|FG003|Overall Study|Withdrawal by Subject|0|||
150282592|NCT02716987|542171926|FG004|Overall Study|Withdrawal by Subject|1|||
150282593|NCT02716987|542171927|FG005|Overall Study|Withdrawal by Subject|1|||
150282594|NCT01549002|542171936|FG000|Overall Study|Excessive pain|0|||
150282595|NCT01549002|542171937|FG001|Overall Study|Excessive pain|2|||
149951472|NCT00479232|540955007|FG000|Overall Study|Lack of Efficacy|0|||
149951473|NCT00479232|540955008|FG001|Overall Study|Lack of Efficacy|0|||
150282596|NCT01549002|542171936|FG000|Overall Study|Moderate sedation required|0|||
150282597|NCT01549002|542171937|FG001|Overall Study|Moderate sedation required|2|||
150282598|NCT00886600|542171938|FG000|Double-blind Monotherapy|Adverse Event|1|||
150282599|NCT00886600|542171939|FG001|Double-blind Monotherapy|Adverse Event|1|||
150282600|NCT00886600|542171940|FG002|Double-blind Monotherapy|Adverse Event|1|||
150282601|NCT00886600|542171941|FG003|Double-blind Monotherapy|Adverse Event|1|||
150282602|NCT00886600|542171938|FG000|Double-blind Monotherapy|Protocol Violation|0|||
150282603|NCT00886600|542171939|FG001|Double-blind Monotherapy|Protocol Violation|0|||
150282604|NCT00886600|542171940|FG002|Double-blind Monotherapy|Protocol Violation|0|||
150282605|NCT00886600|542171941|FG003|Double-blind Monotherapy|Protocol Violation|1|||
150282606|NCT00886600|542171938|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
150282607|NCT00886600|542171939|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
150282608|NCT00886600|542171940|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
150282609|NCT00886600|542171941|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
150282610|NCT00886600|542171938|FG000|Combination Therapy Period|Adverse Event|0|||
150282611|NCT00886600|542171939|FG001|Combination Therapy Period|Adverse Event|0|||
150282612|NCT00886600|542171940|FG002|Combination Therapy Period|Adverse Event|1|||
150282613|NCT00886600|542171941|FG003|Combination Therapy Period|Adverse Event|0|||
150282614|NCT00886600|542171938|FG000|Combination Therapy Period|Protocol Violation|0|||
150282615|NCT00886600|542171939|FG001|Combination Therapy Period|Protocol Violation|0|||
150282616|NCT00886600|542171940|FG002|Combination Therapy Period|Protocol Violation|1|||
150282617|NCT00886600|542171941|FG003|Combination Therapy Period|Protocol Violation|0|||
150282618|NCT01251367|542171942|FG000|Overall Study|Protocol Violation|1|||
150282619|NCT01251367|542171942|FG000|Overall Study|Lack of Efficacy|2|||
150282620|NCT01251367|542171942|FG000|Overall Study|Adverse Event|19|||
150282621|NCT01251367|542171942|FG000|Overall Study|Withdrawal by Subject|36|||
150282622|NCT01251367|542171942|FG000|Overall Study|Lost to Follow-up|5|||
150282623|NCT01251367|542171942|FG000|Overall Study|Subject Required Alternative Treatment|7|||
150282624|NCT01251367|542171942|FG000|Overall Study|No Study Drug Available|1|||
150282625|NCT01251367|542171942|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
150282626|NCT01251367|542171942|FG000|Overall Study|End of Study Visit Performed in Error|1|||
150282627|NCT02255409|542171943|FG000|Overall Study|Administrative Reason|3|||
150282628|NCT02255409|542171944|FG001|Overall Study|Administrative Reason|7|||
150282629|NCT02255409|542171943|FG000|Overall Study|Withdrawal by Subject|1|||
150282630|NCT02255409|542171944|FG001|Overall Study|Withdrawal by Subject|5|||
150282631|NCT02255409|542171943|FG000|Overall Study|Lost to Follow-up|10|||
150282632|NCT02255409|542171944|FG001|Overall Study|Lost to Follow-up|19|||
150282633|NCT02290873|542171948|FG000|Overall Study|Withdrawal by Subject|0|||
150282634|NCT02290873|542171949|FG001|Overall Study|Withdrawal by Subject|1|||
150282635|NCT02290873|542171950|FG002|Overall Study|Withdrawal by Subject|1|||
150282636|NCT02290873|542171948|FG000|Overall Study|Nellcor device error|1|||
150282637|NCT02290873|542171949|FG001|Overall Study|Nellcor device error|0|||
150282638|NCT02290873|542171950|FG002|Overall Study|Nellcor device error|0|||
150282639|NCT02290873|542171948|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
150282640|NCT02290873|542171949|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
150282641|NCT02290873|542171950|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
150282642|NCT02290873|542171948|FG000|Overall Study|Protocol Violation|0|||
150282643|NCT02290873|542171949|FG001|Overall Study|Protocol Violation|0|||
150282644|NCT02290873|542171950|FG002|Overall Study|Protocol Violation|1|||
150282645|NCT01378104|542171951|FG000|Overall Study|Adverse Event|8|||
150282646|NCT01378104|542171952|FG001|Overall Study|Adverse Event|8|||
150282647|NCT01378104|542171951|FG000|Overall Study|Lack of Efficacy|7|||
150282648|NCT01378104|542171952|FG001|Overall Study|Lack of Efficacy|5|||
150282649|NCT01378104|542171951|FG000|Overall Study|Withdrawal by Subject|12|||
150282650|NCT01378104|542171952|FG001|Overall Study|Withdrawal by Subject|13|||
150282651|NCT00506883|542171953|FG000|Overall Study|Lost to Follow-up|1|||
150282652|NCT00506883|542171954|FG001|Overall Study|Lost to Follow-up|1|||
149951474|NCT00479232|540955009|FG002|Overall Study|Lack of Efficacy|2|||
149951475|NCT00479232|540955010|FG003|Overall Study|Lack of Efficacy|0|||
149951476|NCT00479232|540955011|FG004|Overall Study|Lack of Efficacy|0|||
149951477|NCT00479232|540955012|FG005|Overall Study|Lack of Efficacy|4|||
149951478|NCT00479232|540955007|FG000|Overall Study|Physician Decision|0|||
149951479|NCT00479232|540955008|FG001|Overall Study|Physician Decision|0|||
150282653|NCT00506883|542171955|FG002|Overall Study|Lost to Follow-up|1|||
149951480|NCT00479232|540955009|FG002|Overall Study|Physician Decision|2|||
150282654|NCT00506883|542171953|FG000|Overall Study|Withdrawal by Subject|1|||
150282655|NCT00506883|542171954|FG001|Overall Study|Withdrawal by Subject|0|||
150282656|NCT00506883|542171955|FG002|Overall Study|Withdrawal by Subject|1|||
150282657|NCT00506883|542171953|FG000|Overall Study|Lack of Efficacy|0|||
150282658|NCT00506883|542171954|FG001|Overall Study|Lack of Efficacy|1|||
150282659|NCT00506883|542171955|FG002|Overall Study|Lack of Efficacy|1|||
150282660|NCT00506883|542171953|FG000|Overall Study|Other|5|||
150282661|NCT00506883|542171954|FG001|Overall Study|Other|1|||
149951481|NCT00479232|540955010|FG003|Overall Study|Physician Decision|0|||
149951482|NCT00479232|540955011|FG004|Overall Study|Physician Decision|0|||
149951483|NCT00479232|540955012|FG005|Overall Study|Physician Decision|1|||
150282662|NCT00506883|542171955|FG002|Overall Study|Other|1|||
150282663|NCT00078325|542171959|FG000|Overall Study|Adverse Event|15|||
150282664|NCT00078325|542171960|FG001|Overall Study|Adverse Event|10|||
150282665|NCT00078325|542171961|FG002|Overall Study|Adverse Event|5|||
150282666|NCT00078325|542171959|FG000|Overall Study|Protocol Violation|2|||
150282667|NCT00078325|542171960|FG001|Overall Study|Protocol Violation|2|||
150282668|NCT00078325|542171961|FG002|Overall Study|Protocol Violation|0|||
150282669|NCT00078325|542171959|FG000|Overall Study|Withdrawal by Subject|1|||
150282670|NCT00078325|542171960|FG001|Overall Study|Withdrawal by Subject|5|||
150282671|NCT00078325|542171961|FG002|Overall Study|Withdrawal by Subject|3|||
150282672|NCT00078325|542171959|FG000|Overall Study|Lost to Follow-up|0|||
150282673|NCT00078325|542171960|FG001|Overall Study|Lost to Follow-up|1|||
150282674|NCT00078325|542171961|FG002|Overall Study|Lost to Follow-up|1|||
150282675|NCT00078325|542171959|FG000|Overall Study|Physician Decision|2|||
150282676|NCT00078325|542171960|FG001|Overall Study|Physician Decision|0|||
150282677|NCT00078325|542171961|FG002|Overall Study|Physician Decision|1|||
150282678|NCT00078325|542171959|FG000|Overall Study|Miscellaneous|1|||
150282679|NCT00078325|542171960|FG001|Overall Study|Miscellaneous|1|||
150282680|NCT00078325|542171961|FG002|Overall Study|Miscellaneous|1|||
150282681|NCT01519765|542171962|FG000|Overall Study|Adverse Event|0|||
150282682|NCT01519765|542171963|FG001|Overall Study|Adverse Event|1|||
150282683|NCT01519765|542171962|FG000|Overall Study|Lack of Efficacy|2|||
150282684|NCT01519765|542171963|FG001|Overall Study|Lack of Efficacy|0|||
150282685|NCT01519765|542171962|FG000|Overall Study|Protocol Violation|1|||
149951484|NCT00479232|540955007|FG000|Overall Study|Progressive Disease|3|||
149951485|NCT00479232|540955008|FG001|Overall Study|Progressive Disease|1|||
149951486|NCT00479232|540955009|FG002|Overall Study|Progressive Disease|12|||
149951487|NCT00479232|540955010|FG003|Overall Study|Progressive Disease|3|||
149951488|NCT00479232|540955011|FG004|Overall Study|Progressive Disease|3|||
149951489|NCT00479232|540955012|FG005|Overall Study|Progressive Disease|12|||
149951490|NCT00479232|540955007|FG000|Overall Study|Withdrew Consent|0|||
149951491|NCT00479232|540955008|FG001|Overall Study|Withdrew Consent|2|||
149951492|NCT00479232|540955009|FG002|Overall Study|Withdrew Consent|6|||
149951493|NCT00479232|540955010|FG003|Overall Study|Withdrew Consent|0|||
149951494|NCT00479232|540955011|FG004|Overall Study|Withdrew Consent|1|||
149951495|NCT00479232|540955012|FG005|Overall Study|Withdrew Consent|3|||
149951496|NCT05399771|540955013|FG000|Overall Study|Physician Decision|3|||
149951497|NCT05399771|540955013|FG000|Overall Study|Adverse Event|1|||
149951498|NCT00484159|540955017|FG000|Overall Study|Lost to Follow-up|1|||
149951499|NCT00484159|540955018|FG001|Overall Study|Lost to Follow-up|1|||
149951500|NCT00484159|540955019|FG002|Overall Study|Lost to Follow-up|0|||
149951501|NCT04766333|540955020|FG000|Overall Study|Lost to Follow-up|40|||
149951502|NCT04766333|540955021|FG001|Overall Study|Lost to Follow-up|826|||
149951503|NCT01239680|540955024|FG000|Overall Study|Withdrawal by Subject|2|||
149951504|NCT01239680|540955025|FG001|Overall Study|Withdrawal by Subject|0|||
149951505|NCT03033901|540955026|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
149951506|NCT03033901|540955026|FG000|Overall Study|Refused PSG|23|||
149951507|NCT03033901|540955026|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
149951508|NCT03033901|540955026|FG000|Overall Study|Missing Oximetry Data|3|||
149951509|NCT01797185|540955027|FG000|Overall Study|Adverse Event|5|||
149951510|NCT01797185|540955028|FG001|Overall Study|Adverse Event|15|||
149951511|NCT01797185|540955029|FG002|Overall Study|Adverse Event|6|||
149951512|NCT01797185|540955027|FG000|Overall Study|Withdrawal by Subject|6|||
149951513|NCT01797185|540955028|FG001|Overall Study|Withdrawal by Subject|9|||
149951514|NCT01797185|540955029|FG002|Overall Study|Withdrawal by Subject|5|||
149951515|NCT01797185|540955027|FG000|Overall Study|Site terminated|8|||
149951516|NCT01797185|540955028|FG001|Overall Study|Site terminated|4|||
149951517|NCT01797185|540955029|FG002|Overall Study|Site terminated|0|||
149951518|NCT01797185|540955027|FG000|Overall Study|Lost to Follow-up|2|||
149951519|NCT01797185|540955028|FG001|Overall Study|Lost to Follow-up|6|||
149951520|NCT01797185|540955029|FG002|Overall Study|Lost to Follow-up|1|||
149951521|NCT01797185|540955027|FG000|Overall Study|Withdrawn per sponsor|5|||
149951522|NCT01797185|540955028|FG001|Overall Study|Withdrawn per sponsor|0|||
149951523|NCT01797185|540955029|FG002|Overall Study|Withdrawn per sponsor|0|||
149951524|NCT01797185|540955027|FG000|Overall Study|Physician Decision|1|||
149951525|NCT01797185|540955028|FG001|Overall Study|Physician Decision|3|||
149951526|NCT01797185|540955029|FG002|Overall Study|Physician Decision|0|||
149951527|NCT01797185|540955027|FG000|Overall Study|Protocol Violation|1|||
149951528|NCT01797185|540955028|FG001|Overall Study|Protocol Violation|1|||
149951529|NCT01797185|540955029|FG002|Overall Study|Protocol Violation|0|||
149951530|NCT00729586|540955030|FG000|Overall Study|Ineligible|0|||
149951531|NCT00729586|540955031|FG001|Overall Study|Ineligible|1|||
149951532|NCT00729586|540955030|FG000|Overall Study|never treated|1|||
149951533|NCT00729586|540955031|FG001|Overall Study|never treated|0|||
149951534|NCT05177094|540955034|FG000|Overall Study|Adverse Event|5|||
149951535|NCT05177094|540955035|FG001|Overall Study|Adverse Event|5|||
150282686|NCT01519765|542171963|FG001|Overall Study|Protocol Violation|0|||
150282687|NCT01519765|542171962|FG000|Overall Study|Withdrawal by Subject|0|||
150282688|NCT01519765|542171963|FG001|Overall Study|Withdrawal by Subject|1|||
150282689|NCT01473563|542171964|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
149951536|NCT05177094|540955034|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
149951537|NCT05177094|540955035|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
149951538|NCT05177094|540955034|FG000|Overall Study|Protocol Deviation|3|||
149951539|NCT05177094|540955035|FG001|Overall Study|Protocol Deviation|0|||
149951540|NCT05177094|540955034|FG000|Overall Study|Withdrawal by Subject|6|||
149951541|NCT05177094|540955035|FG001|Overall Study|Withdrawal by Subject|3|||
149951542|NCT05177094|540955034|FG000|Overall Study|Participant could not tolerate long study visits|1|||
149951543|NCT05177094|540955035|FG001|Overall Study|Participant could not tolerate long study visits|0|||
149951544|NCT01033942|540955036|FG000|Overall Study|Withdrawal by Subject|1|||
149951545|NCT01033942|540955037|FG001|Overall Study|Withdrawal by Subject|1|||
149951546|NCT01033942|540955038|FG002|Overall Study|Withdrawal by Subject|1|||
149951547|NCT01033942|540955036|FG000|Overall Study|Lost to Follow-up|1|||
149951548|NCT01033942|540955037|FG001|Overall Study|Lost to Follow-up|0|||
149951549|NCT01033942|540955038|FG002|Overall Study|Lost to Follow-up|0|||
149951550|NCT01033942|540955036|FG000|Overall Study|Enrolled in Extension Study|0|||
149951551|NCT01033942|540955037|FG001|Overall Study|Enrolled in Extension Study|3|||
149951552|NCT01033942|540955038|FG002|Overall Study|Enrolled in Extension Study|0|||
149951553|NCT02737618|540955039|FG000|Overall Study|Withdrawal by Subject|9|||
149951554|NCT02397837|540955040|FG000|Overall Study|Withdrawal by Subject|6|||
149951555|NCT02397837|540955041|FG001|Overall Study|Withdrawal by Subject|5|||
149951556|NCT02397837|540955040|FG000|Overall Study|Physician Decision|1|||
149951557|NCT02397837|540955041|FG001|Overall Study|Physician Decision|1|||
149951558|NCT00407511|540955047|FG000|Overall Study|Adverse Event|9|||
149951559|NCT00407511|540955047|FG000|Overall Study|Lost to Follow-up|4|||
149951560|NCT00407511|540955047|FG000|Overall Study|Other|5|||
149951561|NCT00407511|540955047|FG000|Overall Study|Withdrawal by Subject|4|||
149951562|NCT02493855|540955048|FG000|Overall Study|Non-compliance|1|||
149951563|NCT02493855|540955049|FG001|Overall Study|Non-compliance|0|||
149951564|NCT02493855|540955050|FG002|Overall Study|Non-compliance|0|||
149951565|NCT02493855|540955048|FG000|Overall Study|Adverse Event|0|||
149951566|NCT02493855|540955049|FG001|Overall Study|Adverse Event|1|||
149951567|NCT02493855|540955050|FG002|Overall Study|Adverse Event|0|||
149951568|NCT02493855|540955048|FG000|Overall Study|Withdrawal by Subject|1|||
149951569|NCT02493855|540955049|FG001|Overall Study|Withdrawal by Subject|0|||
149951570|NCT02493855|540955050|FG002|Overall Study|Withdrawal by Subject|0|||
149951571|NCT03086343|540955051|FG000|Period 1|Adverse Event|7|||
149951572|NCT03086343|540955052|FG001|Period 1|Adverse Event|7|||
149951573|NCT03086343|540955053|FG002|Period 1|Adverse Event|0|||
149951574|NCT03086343|540955054|FG003|Period 1|Adverse Event|1|||
149951575|NCT03086343|540955051|FG000|Period 1|Withdrawal by Subject|6|||
149951576|NCT03086343|540955052|FG001|Period 1|Withdrawal by Subject|10|||
149951577|NCT03086343|540955053|FG002|Period 1|Withdrawal by Subject|0|||
149951578|NCT03086343|540955054|FG003|Period 1|Withdrawal by Subject|0|||
149951579|NCT03086343|540955051|FG000|Period 1|Lost to Follow-up|1|||
149951580|NCT03086343|540955052|FG001|Period 1|Lost to Follow-up|3|||
149951581|NCT03086343|540955053|FG002|Period 1|Lost to Follow-up|1|||
149951582|NCT03086343|540955054|FG003|Period 1|Lost to Follow-up|0|||
149951583|NCT03086343|540955051|FG000|Period 1|Other, Not Specified|10|||
149951584|NCT03086343|540955052|FG001|Period 1|Other, Not Specified|12|||
149951585|NCT03086343|540955053|FG002|Period 1|Other, Not Specified|2|||
149951586|NCT03086343|540955054|FG003|Period 1|Other, Not Specified|1|||
149951587|NCT03086343|540955051|FG000|Period 1|Missing|1|||
149951588|NCT03086343|540955052|FG001|Period 1|Missing|0|||
149951589|NCT03086343|540955053|FG002|Period 1|Missing|0|||
149951590|NCT03086343|540955054|FG003|Period 1|Missing|0|||
149951591|NCT03086343|540955051|FG000|Period 2|Adverse Event|20|||
149951592|NCT03086343|540955052|FG001|Period 2|Adverse Event|11|||
149951593|NCT03086343|540955053|FG002|Period 2|Adverse Event|1|||
149951594|NCT03086343|540955054|FG003|Period 2|Adverse Event|2|||
149951595|NCT03086343|540955051|FG000|Period 2|Withdrawal by Subject|15|||
149951596|NCT03086343|540955052|FG001|Period 2|Withdrawal by Subject|25|||
149951597|NCT03086343|540955053|FG002|Period 2|Withdrawal by Subject|2|||
149951598|NCT03086343|540955054|FG003|Period 2|Withdrawal by Subject|2|||
149951599|NCT03086343|540955051|FG000|Period 2|Lost to Follow-up|6|||
150034822|NCT02718898|541266526|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
149951600|NCT03086343|540955052|FG001|Period 2|Lost to Follow-up|11|||
149951601|NCT03086343|540955053|FG002|Period 2|Lost to Follow-up|1|||
149951602|NCT03086343|540955054|FG003|Period 2|Lost to Follow-up|0|||
149951603|NCT03086343|540955051|FG000|Period 2|COVID-19 Infection|5|||
149951604|NCT03086343|540955052|FG001|Period 2|COVID-19 Infection|0|||
149951605|NCT03086343|540955053|FG002|Period 2|COVID-19 Infection|0|||
149951606|NCT03086343|540955054|FG003|Period 2|COVID-19 Infection|0|||
149951607|NCT03086343|540955051|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
149951608|NCT03086343|540955052|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
149951609|NCT03086343|540955053|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
149951610|NCT03086343|540955054|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
149951611|NCT03086343|540955051|FG000|Period 2|Other, Not Specified|23|||
149951612|NCT03086343|540955052|FG001|Period 2|Other, Not Specified|22|||
149951613|NCT03086343|540955053|FG002|Period 2|Other, Not Specified|2|||
149951614|NCT03086343|540955054|FG003|Period 2|Other, Not Specified|4|||
149951615|NCT00741611|540955056|FG000|Overall Study|Death|0|||
149951616|NCT00741611|540955057|FG001|Overall Study|Death|0|||
149951617|NCT00741611|540955058|FG002|Overall Study|Death|1|||
150282690|NCT02739620|542171965|FG000|Overall Study|Lost to Follow-up|3|||
150282691|NCT02739620|542171966|FG001|Overall Study|Lost to Follow-up|1|||
149951618|NCT00741611|540955056|FG000|Overall Study|Withdrawal by Subject|0|||
149951619|NCT00741611|540955057|FG001|Overall Study|Withdrawal by Subject|2|||
149951620|NCT00741611|540955058|FG002|Overall Study|Withdrawal by Subject|2|||
149951621|NCT01922011|540955061|FG000|Overall Study|Protocol Violation|0|||
149951622|NCT01922011|540955062|FG001|Overall Study|Protocol Violation|1|||
149951623|NCT01922011|540955061|FG000|Overall Study|Physician Decision|0|||
149951624|NCT01922011|540955062|FG001|Overall Study|Physician Decision|1|||
149951625|NCT01922011|540955061|FG000|Overall Study|Parent/Guardian Decision|3|||
149951626|NCT01922011|540955062|FG001|Overall Study|Parent/Guardian Decision|0|||
149951627|NCT01922011|540955061|FG000|Overall Study|Lost to Follow-up|0|||
149951628|NCT01922011|540955062|FG001|Overall Study|Lost to Follow-up|1|||
149951629|NCT01922011|540955061|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
149951630|NCT01922011|540955062|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
149951631|NCT01922011|540955061|FG000|Overall Study|Not Treated|1|||
149951632|NCT01922011|540955062|FG001|Overall Study|Not Treated|0|||
149951633|NCT01922011|540955061|FG000|Overall Study|Lack of willing home health agency|1|||
149951634|NCT01922011|540955062|FG001|Overall Study|Lack of willing home health agency|0|||
149951635|NCT01922011|540955061|FG000|Overall Study|Randomized in error|1|||
149951636|NCT01922011|540955062|FG001|Overall Study|Randomized in error|0|||
149951637|NCT01510756|540955063|FG000|Overall Study|Death|1|||
149951638|NCT01510756|540955063|FG000|Overall Study|Lack of Efficacy|2|||
149951639|NCT01510756|540955063|FG000|Overall Study|Physician Decision|1|||
149951640|NCT00549328|540955068|FG000|Overall Study|Adverse Event|2|||
149951641|NCT00549328|540955068|FG000|Overall Study|Disease Progression|10|||
149951642|NCT00549328|540955068|FG000|Overall Study|Death|1|||
149951643|NCT00549328|540955068|FG000|Overall Study|Use of Prohibited Medication|1|||
149951644|NCT00770484|540955069|FG000|Overall Study|Withdrawal by Subject|1|||
149951645|NCT00770484|540955070|FG001|Overall Study|Withdrawal by Subject|0|||
149951646|NCT03384966|540955074|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
149951647|NCT03384966|540955075|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
149951648|NCT03384966|540955076|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
149951649|NCT03384966|540955074|FG000|Follow-up Period|Adverse Event|1|||
149951650|NCT03384966|540955075|FG001|Follow-up Period|Adverse Event|0|||
149951651|NCT03384966|540955076|FG002|Follow-up Period|Adverse Event|0|||
149951652|NCT02202616|540955077|FG000|Overall Study|Screen failed|24|||
149951653|NCT02202616|540955077|FG000|Overall Study|Adverse Event|32|||
149951654|NCT02202616|540955077|FG000|Overall Study|Protocol deviation|18|||
149951655|NCT02202616|540955077|FG000|Overall Study|Patient withdrew consent|12|||
149951656|NCT02202616|540955077|FG000|Overall Study|Lost to Follow-up|6|||
149951657|NCT02202616|540955077|FG000|Overall Study|Administrative problems|6|||
149951658|NCT02202616|540955077|FG000|Overall Study|Abnormal test procedure result|1|||
149951659|NCT02202616|540955077|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149951660|NCT00367458|540955078|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
149951661|NCT00367458|540955079|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
149951662|NCT04327271|540955084|FG000|Overall Study|Death|1|||
149951663|NCT04327271|540955085|FG001|Overall Study|Death|0|||
149951664|NCT04327271|540955084|FG000|Overall Study|Withdrawal by Subject|1|||
149951665|NCT04327271|540955085|FG001|Overall Study|Withdrawal by Subject|0|||
149951666|NCT04327271|540955084|FG000|Overall Study|randomization error (data capture)|4|||
149951667|NCT04327271|540955085|FG001|Overall Study|randomization error (data capture)|3|||
149951668|NCT04339972|540955086|FG000|Overall Study|Scheduling Issues|3|||
149951669|NCT04339972|540955087|FG001|Overall Study|Scheduling Issues|3|||
149951670|NCT04339972|540955086|FG000|Overall Study|dropout|1|||
149951671|NCT04339972|540955087|FG001|Overall Study|dropout|1|||
149951672|NCT04339972|540955086|FG000|Overall Study|Technical issues|1|||
149951673|NCT04339972|540955087|FG001|Overall Study|Technical issues|0|||
149951674|NCT04339972|540955086|FG000|Overall Study|Claustraphobia|0|||
149951675|NCT04339972|540955087|FG001|Overall Study|Claustraphobia|1|||
149951676|NCT00776997|540955088|FG000|Overall Study|Adverse Event|2|||
149951677|NCT02403271|540955089|FG000|Period 1|Other varied reasons|1|||
149951678|NCT02403271|540955090|FG001|Period 1|Other varied reasons|0|||
149951679|NCT02403271|540955089|FG000|Period 2|Withdrawal by Subject|0|||
149951680|NCT02403271|540955090|FG001|Period 2|Withdrawal by Subject|14|||
149951681|NCT02403271|540955089|FG000|Period 2|Death|0|||
149951682|NCT02403271|540955090|FG001|Period 2|Death|84|||
149951683|NCT02403271|540955089|FG000|Period 2|Lost to Follow-up|0|||
149951684|NCT02403271|540955090|FG001|Period 2|Lost to Follow-up|2|||
149951685|NCT02403271|540955089|FG000|Period 2|Study Terminated by Sponsor|0|||
149951686|NCT02403271|540955090|FG001|Period 2|Study Terminated by Sponsor|14|||
150282692|NCT02739620|542171965|FG000|Overall Study|Adverse Event|0|||
149951687|NCT02403271|540955089|FG000|Period 2|Other varied reasons|0|||
149951688|NCT02403271|540955090|FG001|Period 2|Other varied reasons|10|||
149951689|NCT05221866|540955093|FG000|Overall Study|Withdrawal by Subject|5|||
150282693|NCT02739620|542171966|FG001|Overall Study|Adverse Event|1|||
150282694|NCT02354222|542171967|FG000|Overall Study|Adverse Event|0|||
150282695|NCT02354222|542171968|FG001|Overall Study|Adverse Event|3|||
149951690|NCT05221866|540955094|FG001|Overall Study|Withdrawal by Subject|7|||
149951691|NCT05221866|540955095|FG002|Overall Study|Withdrawal by Subject|6|||
149951692|NCT05221866|540955096|FG003|Overall Study|Withdrawal by Subject|4|||
149951693|NCT05221866|540955093|FG000|Overall Study|Physician Decision|3|||
149951694|NCT05221866|540955094|FG001|Overall Study|Physician Decision|2|||
149951695|NCT05221866|540955095|FG002|Overall Study|Physician Decision|1|||
149951696|NCT05221866|540955096|FG003|Overall Study|Physician Decision|4|||
149951697|NCT05221866|540955093|FG000|Overall Study|Lost to Follow-up|12|||
149951698|NCT05221866|540955094|FG001|Overall Study|Lost to Follow-up|17|||
149951699|NCT05221866|540955095|FG002|Overall Study|Lost to Follow-up|14|||
149951700|NCT05221866|540955096|FG003|Overall Study|Lost to Follow-up|14|||
149951701|NCT05221866|540955093|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
149951702|NCT05221866|540955094|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
149951703|NCT05221866|540955095|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
149951704|NCT05221866|540955096|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
149951705|NCT03487445|540955097|FG000|Randomization|Not treated for administrative reasons|1|||
149951706|NCT03487445|540955098|FG001|Randomization|Not treated for administrative reasons|0|||
149951707|NCT00221104|540955099|FG000|Overall Study|Adverse Event|1|||
149951708|NCT00221104|540955100|FG001|Overall Study|Adverse Event|0|||
149951709|NCT00221104|540955099|FG000|Overall Study|Physician Decision|1|||
149951710|NCT00221104|540955100|FG001|Overall Study|Physician Decision|0|||
149951711|NCT00221104|540955099|FG000|Overall Study|Protocol Violation|2|||
149951712|NCT00221104|540955100|FG001|Overall Study|Protocol Violation|0|||
149951713|NCT00221104|540955099|FG000|Overall Study|Withdrawal by Subject|42|||
149951714|NCT00221104|540955100|FG001|Overall Study|Withdrawal by Subject|29|||
149951715|NCT00221104|540955099|FG000|Overall Study|Others|37|||
149951716|NCT00221104|540955100|FG001|Overall Study|Others|47|||
149951717|NCT02989389|540955101|FG000|Period 1|Lost to Follow-up|0|||
149951718|NCT02989389|540955102|FG001|Period 1|Lost to Follow-up|1|||
149951719|NCT02989389|540955103|FG002|Period 1|Lost to Follow-up|0|||
149951720|NCT02989389|540955104|FG003|Period 1|Lost to Follow-up|0|||
149951721|NCT02989389|540955105|FG004|Period 1|Lost to Follow-up|0|||
149951722|NCT02989389|540955106|FG005|Period 1|Lost to Follow-up|0|||
149951723|NCT02989389|540955107|FG006|Period 1|Lost to Follow-up|0|||
149951724|NCT02989389|540955108|FG007|Period 1|Lost to Follow-up|0|||
149951725|NCT02989389|540955109|FG008|Period 1|Lost to Follow-up|0|||
149951726|NCT02989389|540955110|FG009|Period 1|Lost to Follow-up|0|||
149951727|NCT02989389|540955101|FG000|Period 1|Physician Decision|0|||
149951728|NCT02989389|540955102|FG001|Period 1|Physician Decision|0|||
149951729|NCT02989389|540955103|FG002|Period 1|Physician Decision|0|||
149951730|NCT02989389|540955104|FG003|Period 1|Physician Decision|0|||
149951731|NCT02989389|540955105|FG004|Period 1|Physician Decision|0|||
149951732|NCT02989389|540955106|FG005|Period 1|Physician Decision|0|||
149951733|NCT02989389|540955107|FG006|Period 1|Physician Decision|0|||
149951734|NCT02989389|540955108|FG007|Period 1|Physician Decision|0|||
149951735|NCT02989389|540955109|FG008|Period 1|Physician Decision|1|||
149951736|NCT02989389|540955110|FG009|Period 1|Physician Decision|0|||
149951737|NCT01666652|540955111|FG000|Overall Study|Serious Adverse Event|0|||
149951738|NCT01666652|540955112|FG001|Overall Study|Serious Adverse Event|0|||
149951739|NCT01666652|540955113|FG002|Overall Study|Serious Adverse Event|0|||
149951740|NCT01666652|540955114|FG003|Overall Study|Serious Adverse Event|1|||
149951741|NCT01666652|540955115|FG004|Overall Study|Serious Adverse Event|0|||
149951742|NCT01666652|540955111|FG000|Overall Study|Withdrawal by Subject|0|||
149951743|NCT01666652|540955112|FG001|Overall Study|Withdrawal by Subject|0|||
149951744|NCT01666652|540955113|FG002|Overall Study|Withdrawal by Subject|0|||
149951745|NCT01666652|540955114|FG003|Overall Study|Withdrawal by Subject|0|||
149951746|NCT01666652|540955115|FG004|Overall Study|Withdrawal by Subject|1|||
149951747|NCT01666652|540955111|FG000|Overall Study|Moved from study area|1|||
149951748|NCT01666652|540955112|FG001|Overall Study|Moved from study area|0|||
150282696|NCT02354222|542171967|FG000|Overall Study|Physician Decision|1|||
150282697|NCT02354222|542171968|FG001|Overall Study|Physician Decision|1|||
149951749|NCT01666652|540955113|FG002|Overall Study|Moved from study area|0|||
149951750|NCT01666652|540955114|FG003|Overall Study|Moved from study area|2|||
149951751|NCT01666652|540955115|FG004|Overall Study|Moved from study area|0|||
149951752|NCT01666652|540955111|FG000|Overall Study|Lost to Follow-up|1|||
149951753|NCT01666652|540955112|FG001|Overall Study|Lost to Follow-up|1|||
149951754|NCT01666652|540955113|FG002|Overall Study|Lost to Follow-up|1|||
149951755|NCT01666652|540955114|FG003|Overall Study|Lost to Follow-up|1|||
149951756|NCT01666652|540955115|FG004|Overall Study|Lost to Follow-up|0|||
149951757|NCT04470427|540955116|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
150034823|NCT02718898|541266527|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
149951758|NCT04470427|540955117|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
149951759|NCT04470427|540955118|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
149951760|NCT04470427|540955119|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
149951761|NCT04470427|540955120|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
149951762|NCT04470427|540955121|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
149951763|NCT04470427|540955116|FG000|Part B :Open-label|Other than specified|0|||
149951764|NCT04470427|540955117|FG001|Part B :Open-label|Other than specified|0|||
149951765|NCT04470427|540955118|FG002|Part B :Open-label|Other than specified|788|||
149951766|NCT04470427|540955119|FG003|Part B :Open-label|Other than specified|0|||
149951767|NCT04470427|540955120|FG004|Part B :Open-label|Other than specified|523|||
149951768|NCT04470427|540955121|FG005|Part B :Open-label|Other than specified|0|||
149951769|NCT04470427|540955116|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
149951770|NCT04470427|540955117|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
149951771|NCT04470427|540955118|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
149951772|NCT04470427|540955119|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
149951773|NCT04470427|540955120|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
149951774|NCT04470427|540955121|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
149951775|NCT04470427|540955116|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
149951776|NCT04470427|540955117|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
149951777|NCT04470427|540955118|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
149951778|NCT04470427|540955119|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
149951779|NCT04470427|540955120|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
149951780|NCT04470427|540955121|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
149951781|NCT06170827|540955125|FG000|Overall Study|Withdrawal by Subject|1|||
149951782|NCT06170827|540955126|FG001|Overall Study|Withdrawal by Subject|1|||
149951783|NCT03599713|540955127|FG000|Overall Study|Death|38|||
149951784|NCT03599713|540955128|FG001|Overall Study|Death|3|||
149951785|NCT03599713|540955127|FG000|Overall Study|Withdrawal by Subject|17|||
149951786|NCT03599713|540955128|FG001|Overall Study|Withdrawal by Subject|0|||
149951787|NCT03599713|540955127|FG000|Overall Study|Lost to Follow-up|4|||
149951788|NCT03599713|540955128|FG001|Overall Study|Lost to Follow-up|0|||
149951789|NCT03599713|540955127|FG000|Overall Study|Discontinued Due to End of Study|42|||
149951790|NCT03599713|540955128|FG001|Overall Study|Discontinued Due to End of Study|3|||
149951791|NCT03641924|540956679|FG000|Overall Study|Withdrawal by Subject|26|||
149951792|NCT03641924|540956679|FG000|Overall Study|Lost to Follow-up|16|||
149951793|NCT03641924|540956679|FG000|Overall Study|Protocol Violation|10|||
149951794|NCT04333498|540956680|FG000|Overall Study|Lost to Follow-up|1|||
150051993|NCT00717236|541332847|FG000|Double-Blind Period|Other: Screening failure|1|||
150282698|NCT02354222|542171967|FG000|Overall Study|Pregnancy|1|||
150282699|NCT02354222|542171968|FG001|Overall Study|Pregnancy|0|||
150282700|NCT02354222|542171967|FG000|Overall Study|Withdrawal by Subject|2|||
150282701|NCT02354222|542171968|FG001|Overall Study|Withdrawal by Subject|3|||
150282702|NCT02354222|542171967|FG000|Overall Study|Conflict with the stopping criteria|0|||
150282703|NCT02354222|542171968|FG001|Overall Study|Conflict with the stopping criteria|4|||
150282704|NCT02437864|542171980|FG000|Overall Study|Protocol Violation|4|||
150282705|NCT02437864|542171981|FG001|Overall Study|Protocol Violation|0|||
150282706|NCT01892163|542171982|FG000|Overall Study|Death|1|||
150282707|NCT01892163|542171983|FG001|Overall Study|Death|1|||
150282708|NCT01892163|542171982|FG000|Overall Study|Lost to Follow-up|1|||
150282709|NCT01892163|542171983|FG001|Overall Study|Lost to Follow-up|0|||
150282710|NCT00645593|542171986|FG000|Overall Study|Later found to be ineligible|1|||
150282711|NCT00645593|542171987|FG001|Overall Study|Later found to be ineligible|0|||
150282712|NCT00993265|542171992|FG000|Overall Study|Adverse Event|1|||
150282713|NCT00993265|542171993|FG001|Overall Study|Adverse Event|0|||
150282714|NCT00993265|542171992|FG000|Overall Study|Changed dose of concomitant drug|2|||
150282715|NCT00993265|542171993|FG001|Overall Study|Changed dose of concomitant drug|0|||
150282716|NCT00993265|542171992|FG000|Overall Study|Non-compliant with study medication|1|||
150282717|NCT00993265|542171993|FG001|Overall Study|Non-compliant with study medication|0|||
150282718|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
150282719|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
150282720|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
150282721|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
150282722|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
150282723|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
149951795|NCT04333498|540956681|FG001|Overall Study|Lost to Follow-up|0|||
149951796|NCT04333498|540956680|FG000|Overall Study|Lost to Follow-up|0|||
149951797|NCT04333498|540956681|FG001|Overall Study|Lost to Follow-up|1|||
149951798|NCT01565694|540956682|FG000|Dose-Titration Period|Adverse Event|4|||
149951799|NCT01565694|540956682|FG000|Dose-Titration Period|Protocol Violation|10|||
149951800|NCT01565694|540956682|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
150282724|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
150282725|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
149951801|NCT01373229|540956683|FG000|Overall Study|Death|3|||
149951802|NCT01373229|540956683|FG000|Overall Study|Physician Decision|3|||
149951803|NCT00587457|540956685|FG000|Overall Study|Adverse Event|1|||
149951804|NCT00587457|540956686|FG001|Overall Study|Adverse Event|2|||
149951805|NCT00587457|540956687|FG002|Overall Study|Adverse Event|1|||
149951806|NCT00587457|540956685|FG000|Overall Study|Disease progression|2|||
149951807|NCT00587457|540956686|FG001|Overall Study|Disease progression|0|||
149951808|NCT00587457|540956687|FG002|Overall Study|Disease progression|2|||
149951809|NCT00587457|540956685|FG000|Overall Study|Initiation of alternative therapy|0|||
149951810|NCT00587457|540956686|FG001|Overall Study|Initiation of alternative therapy|1|||
149951811|NCT00587457|540956687|FG002|Overall Study|Initiation of alternative therapy|0|||
149951812|NCT00587457|540956685|FG000|Overall Study|Undefined|0|||
149951813|NCT00587457|540956686|FG001|Overall Study|Undefined|0|||
149951814|NCT00587457|540956687|FG002|Overall Study|Undefined|1|||
149951815|NCT00587457|540956685|FG000|Overall Study|Development of neutralizing Abs|0|||
149951816|NCT00587457|540956686|FG001|Overall Study|Development of neutralizing Abs|0|||
149951817|NCT00587457|540956687|FG002|Overall Study|Development of neutralizing Abs|1|||
149951818|NCT03234881|540956688|FG000|Overall Study|Lost to Follow-up|9|||
149951819|NCT03234881|540956689|FG001|Overall Study|Lost to Follow-up|3|||
149951820|NCT00541229|540956690|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
149951821|NCT00541229|540956691|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
149951822|NCT00541229|540956692|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
149951823|NCT00541229|540956693|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
149951824|NCT00541229|540956694|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
149951825|NCT00541229|540956695|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
149951826|NCT00541229|540956690|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
149951827|NCT00541229|540956691|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
149951828|NCT00541229|540956692|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
149951829|NCT00541229|540956693|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
149951830|NCT00541229|540956694|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
149951831|NCT00541229|540956695|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
149951832|NCT00541229|540956690|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
149951833|NCT00541229|540956691|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
149951834|NCT00541229|540956692|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
149951835|NCT00541229|540956693|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
149951836|NCT00541229|540956694|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
149951837|NCT00541229|540956695|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
149951838|NCT00541229|540956690|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
149951839|NCT00541229|540956691|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
149951840|NCT00541229|540956692|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
149951841|NCT00541229|540956693|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
149951842|NCT00541229|540956694|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
149951843|NCT00541229|540956695|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
150034824|NCT02718898|541266528|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
150282726|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to death|4|||
150282727|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to death|3|||
150282728|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
150282729|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
150282730|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
150282731|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
150282732|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
150282733|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
150282734|NCT02258451|542171997|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
150282735|NCT02258451|542171998|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
150282736|NCT02258451|542171997|FG000|Overall Study|Other reason|1|||
150282737|NCT02258451|542171998|FG001|Overall Study|Other reason|1|||
150282738|NCT02258451|542171997|FG000|Overall Study|Never treated|2|||
150282739|NCT02258451|542171998|FG001|Overall Study|Never treated|3|||
150282740|NCT00517751|542172008|FG000|Overall Study|Death|3|||
150282741|NCT00517751|542172008|FG000|Overall Study|Withdrawal by Subject|37|||
150282742|NCT00517751|542172008|FG000|Overall Study|Lost to Follow-up|4|||
150282743|NCT00517751|542172008|FG000|Overall Study|patient not over due|6|||
150282744|NCT00517751|542172008|FG000|Overall Study|Patient not due for visit|76|||
149951844|NCT00541229|540956690|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
149951845|NCT00541229|540956691|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
149951846|NCT00541229|540956692|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
149951847|NCT00541229|540956693|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
150282745|NCT00517751|542172008|FG000|Overall Study|Missing|3|||
150282746|NCT03021499|542172009|FG000|Overall Study|Adverse Event|1|||
150282747|NCT03021499|542172010|FG001|Overall Study|Adverse Event|0|||
150282748|NCT03021499|542172009|FG000|Overall Study|Death|1|||
150282749|NCT03021499|542172010|FG001|Overall Study|Death|5|||
150282750|NCT03021499|542172009|FG000|Overall Study|Lack of Efficacy|0|||
150282751|NCT03021499|542172010|FG001|Overall Study|Lack of Efficacy|1|||
150282752|NCT03021499|542172009|FG000|Overall Study|Lost to Follow-up|1|||
150282753|NCT03021499|542172010|FG001|Overall Study|Lost to Follow-up|3|||
149839116|NCT01705574|540541303|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
149839117|NCT01705574|540541300|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
149839118|NCT01705574|540541301|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
149839119|NCT01705574|540541302|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
149951848|NCT00541229|540956694|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
149951849|NCT00541229|540956695|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
149951850|NCT00541229|540956690|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
149951851|NCT00541229|540956691|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
149951852|NCT00541229|540956692|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
149951853|NCT00541229|540956693|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
149951854|NCT00541229|540956694|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
149951855|NCT00541229|540956695|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
149951856|NCT00541229|540956690|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
149951857|NCT00541229|540956691|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
149951858|NCT00541229|540956692|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
149951859|NCT00541229|540956693|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
149951860|NCT00541229|540956694|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
149951861|NCT00541229|540956695|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
149951862|NCT00541229|540956690|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
149951863|NCT00541229|540956691|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
149951864|NCT00541229|540956692|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
149951865|NCT00541229|540956693|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
149951866|NCT00541229|540956694|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
149951867|NCT00541229|540956695|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
149951868|NCT00541229|540956690|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
149951869|NCT00541229|540956691|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
149951870|NCT00541229|540956692|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
149951871|NCT00541229|540956693|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
149951872|NCT00541229|540956694|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
149951873|NCT00541229|540956695|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
149951874|NCT00541229|540956690|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
149951875|NCT00541229|540956691|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
149951876|NCT00541229|540956692|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
149951877|NCT00541229|540956693|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
149951878|NCT00541229|540956694|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
149951879|NCT00541229|540956695|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
149951880|NCT00541229|540956690|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
149951881|NCT00541229|540956691|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
149951882|NCT00541229|540956692|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
149951883|NCT00541229|540956693|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
149951884|NCT00541229|540956694|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
149951885|NCT00541229|540956695|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
149951886|NCT00541229|540956690|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
149951887|NCT00541229|540956691|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
149951888|NCT00541229|540956692|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
149951889|NCT00541229|540956693|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
149951890|NCT00541229|540956694|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
149951891|NCT00541229|540956695|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
149951892|NCT00541229|540956690|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
149951893|NCT00541229|540956691|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
149951894|NCT00541229|540956692|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
149951895|NCT00541229|540956693|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
149951896|NCT00541229|540956694|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
149951897|NCT00541229|540956695|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
149839120|NCT01705574|540541303|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
149839121|NCT01705574|540541300|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
149839122|NCT01705574|540541301|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
149839123|NCT01705574|540541302|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
149951898|NCT00541229|540956690|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
150282754|NCT03021499|542172009|FG000|Overall Study|Physician Decision|2|||
150282755|NCT03021499|542172010|FG001|Overall Study|Physician Decision|3|||
150282756|NCT03021499|542172009|FG000|Overall Study|Pregnancy|1|||
150282757|NCT03021499|542172010|FG001|Overall Study|Pregnancy|0|||
150282758|NCT03021499|542172009|FG000|Overall Study|Withdrawal by Subject|7|||
150282759|NCT03021499|542172010|FG001|Overall Study|Withdrawal by Subject|14|||
150282760|NCT03021499|542172009|FG000|Overall Study|Prohibited medication required|1|||
150282761|NCT03021499|542172010|FG001|Overall Study|Prohibited medication required|0|||
150282762|NCT03021499|542172009|FG000|Overall Study|Protocol non-compliance|1|||
149951899|NCT00541229|540956691|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
149951900|NCT00541229|540956692|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
149951901|NCT00541229|540956693|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
149951902|NCT00541229|540956694|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
149951903|NCT00541229|540956695|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
149951904|NCT00541229|540956690|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
149951905|NCT00541229|540956691|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
149951906|NCT00541229|540956692|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
149951907|NCT00541229|540956693|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
149951908|NCT00541229|540956694|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
149951909|NCT00541229|540956695|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
149951910|NCT00541229|540956690|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
149951911|NCT00541229|540956691|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
149951912|NCT00541229|540956692|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
149951913|NCT00541229|540956693|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
149951914|NCT00541229|540956694|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
149951915|NCT00541229|540956695|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
149951916|NCT03720847|540956696|FG000|Washout|Physician Decision|1|||
149951917|NCT03720847|540956697|FG001|Washout|Physician Decision|2|||
149951918|NCT02513199|540956700|FG000|Treatment|Death|1|||
149951919|NCT02513199|540956700|FG000|Treatment|Lost to Follow-up|1|||
149951920|NCT02513199|540956700|FG000|Follow-Up|Death|11|||
149951921|NCT02260986|540956708|FG000|Overall Study|Adverse Event|24|||
149951922|NCT02260986|540956709|FG001|Overall Study|Adverse Event|0|||
149951923|NCT02260986|540956710|FG002|Overall Study|Adverse Event|11|||
149951924|NCT02260986|540956708|FG000|Overall Study|Lack of Efficacy|27|||
149951925|NCT02260986|540956709|FG001|Overall Study|Lack of Efficacy|3|||
149951926|NCT02260986|540956710|FG002|Overall Study|Lack of Efficacy|0|||
149951927|NCT02260986|540956708|FG000|Overall Study|Protocol Violation|14|||
149951928|NCT02260986|540956709|FG001|Overall Study|Protocol Violation|5|||
149951929|NCT02260986|540956710|FG002|Overall Study|Protocol Violation|16|||
149951930|NCT02260986|540956708|FG000|Overall Study|Car accident|0|||
149951931|NCT02260986|540956709|FG001|Overall Study|Car accident|0|||
149951932|NCT02260986|540956710|FG002|Overall Study|Car accident|1|||
149951933|NCT02260986|540956708|FG000|Overall Study|Withdrawal by Subject|17|||
149951934|NCT02260986|540956709|FG001|Overall Study|Withdrawal by Subject|4|||
149951935|NCT02260986|540956710|FG002|Overall Study|Withdrawal by Subject|9|||
149951936|NCT02260986|540956708|FG000|Overall Study|Incorrect randomization|0|||
149951937|NCT02260986|540956709|FG001|Overall Study|Incorrect randomization|1|||
149951938|NCT02260986|540956710|FG002|Overall Study|Incorrect randomization|0|||
149951939|NCT02260986|540956708|FG000|Overall Study|Lack of investigation product supply|2|||
149951940|NCT02260986|540956709|FG001|Overall Study|Lack of investigation product supply|0|||
149951941|NCT02260986|540956710|FG002|Overall Study|Lack of investigation product supply|1|||
149951942|NCT02260986|540956708|FG000|Overall Study|Lost to Follow-up|4|||
149951943|NCT02260986|540956709|FG001|Overall Study|Lost to Follow-up|0|||
149951944|NCT02260986|540956710|FG002|Overall Study|Lost to Follow-up|3|||
149951945|NCT02260986|540956708|FG000|Overall Study|Pregnancy|2|||
149951946|NCT02260986|540956709|FG001|Overall Study|Pregnancy|0|||
149951947|NCT02260986|540956710|FG002|Overall Study|Pregnancy|0|||
149951948|NCT00313170|540956712|FG000|Overall Study|Death|2|||
149951949|NCT00313170|540956713|FG001|Overall Study|Death|4|||
149951950|NCT00313170|540956714|FG002|Overall Study|Death|2|||
149951951|NCT00313170|540956712|FG000|Overall Study|Adverse Event|1|||
149951952|NCT00313170|540956713|FG001|Overall Study|Adverse Event|2|||
149951953|NCT00313170|540956714|FG002|Overall Study|Adverse Event|0|||
149951954|NCT00313170|540956712|FG000|Overall Study|Disease progression|31|||
149951955|NCT00313170|540956713|FG001|Overall Study|Disease progression|26|||
149951956|NCT00313170|540956714|FG002|Overall Study|Disease progression|27|||
149951957|NCT00313170|540956712|FG000|Overall Study|Withdrawal by Subject|1|||
149951958|NCT00313170|540956713|FG001|Overall Study|Withdrawal by Subject|0|||
149951959|NCT00313170|540956714|FG002|Overall Study|Withdrawal by Subject|1|||
150282763|NCT03021499|542172010|FG001|Overall Study|Protocol non-compliance|1|||
149951960|NCT00313170|540956712|FG000|Overall Study|Incorrect enrollment|0|||
149951961|NCT00313170|540956713|FG001|Overall Study|Incorrect enrollment|2|||
149951962|NCT00313170|540956714|FG002|Overall Study|Incorrect enrollment|1|||
149951963|NCT00313170|540956712|FG000|Overall Study|Lost to Follow-up|0|||
150051994|NCT00717236|541332848|FG001|Double-Blind Period|Other: Screening failure|0|||
150282764|NCT03021499|542172009|FG000|Overall Study|None of the above|0|||
149951964|NCT00313170|540956713|FG001|Overall Study|Lost to Follow-up|0|||
149951965|NCT00313170|540956714|FG002|Overall Study|Lost to Follow-up|1|||
149951966|NCT00313170|540956712|FG000|Overall Study|Progression (investigators opinion)|1|||
149951967|NCT00313170|540956713|FG001|Overall Study|Progression (investigators opinion)|0|||
149951968|NCT00313170|540956714|FG002|Overall Study|Progression (investigators opinion)|0|||
149951969|NCT05276804|540956715|FG000|Overall Study|screen failure|23|||
149951970|NCT05276804|540956716|FG001|Overall Study|screen failure|0|||
149951971|NCT02827708|540956718|FG000|Overall Study|Lost to Follow-up|3|||
149951972|NCT02827708|540956719|FG001|Overall Study|Lost to Follow-up|1|||
149951973|NCT02827708|540956718|FG000|Overall Study|Withdrawal by Subject|1|||
149951974|NCT02827708|540956719|FG001|Overall Study|Withdrawal by Subject|2|||
149951975|NCT02827708|540956718|FG000|Overall Study|Death|1|||
149951976|NCT02827708|540956719|FG001|Overall Study|Death|2|||
149951977|NCT00898807|540956725|FG000|Overall Study|Withdrawal by Subject|5|||
149951978|NCT00898807|540956726|FG001|Overall Study|Withdrawal by Subject|3|||
149951979|NCT00898807|540956725|FG000|Overall Study|Family pressure to discontinue|2|||
149951980|NCT00898807|540956726|FG001|Overall Study|Family pressure to discontinue|2|||
149951981|NCT00898807|540956725|FG000|Overall Study|Lost to Follow-up|1|||
149951982|NCT00898807|540956726|FG001|Overall Study|Lost to Follow-up|3|||
149951983|NCT00898807|540956725|FG000|Overall Study|Death|0|||
149951984|NCT00898807|540956726|FG001|Overall Study|Death|1|||
149951985|NCT00529035|540956727|FG000|Overall Study|Withdrawal by Subject|1|||
149951986|NCT01521364|540956728|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
149951987|NCT01521364|540956728|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
149951988|NCT02636283|540956729|FG000|Overall Study|Adverse Event|2|||
149951989|NCT02636283|540956730|FG001|Overall Study|Adverse Event|0|||
149951990|NCT02636283|540956729|FG000|Overall Study|Trial Terminated Prematurely|0|||
149951991|NCT02636283|540956730|FG001|Overall Study|Trial Terminated Prematurely|3|||
149951992|NCT03418675|540956731|FG000|Overall Study|Lost to Follow-up|13|||
149951993|NCT03418675|540956732|FG001|Overall Study|Lost to Follow-up|10|||
149951994|NCT03418675|540956731|FG000|Overall Study|Adverse Event|2|||
149951995|NCT03418675|540956732|FG001|Overall Study|Adverse Event|0|||
149951996|NCT01879852|540956733|FG000|Overall Study|Withdrawal by Subject|2|||
149951997|NCT01879852|540956734|FG001|Overall Study|Withdrawal by Subject|0|||
149951998|NCT02115386|540956735|FG000|Overall Study|Protocol Violation|1|||
149951999|NCT02115386|540956735|FG000|Overall Study|Administrative - trial was terminated|6|||
149952000|NCT02453048|540956738|FG000|Overall Study|Only part of initial 6 mo. study|0|||
149952001|NCT02453048|540956739|FG001|Overall Study|Only part of initial 6 mo. study|0|||
149952002|NCT02453048|540956740|FG002|Overall Study|Only part of initial 6 mo. study|0|||
149952003|NCT02453048|540956741|FG003|Overall Study|Only part of initial 6 mo. study|0|||
149952004|NCT02453048|540956742|FG004|Overall Study|Only part of initial 6 mo. study|6|||
149952005|NCT02453048|540956738|FG000|Overall Study|Lost to Follow-up|0|||
149952006|NCT02453048|540956739|FG001|Overall Study|Lost to Follow-up|1|||
149952007|NCT02453048|540956740|FG002|Overall Study|Lost to Follow-up|2|||
149952008|NCT02453048|540956741|FG003|Overall Study|Lost to Follow-up|0|||
149952009|NCT02453048|540956742|FG004|Overall Study|Lost to Follow-up|0|||
149952010|NCT01482221|540956744|FG000|Overall Study|Lack of Efficacy|1|||
149952011|NCT01482221|540956745|FG001|Overall Study|Lack of Efficacy|0|||
149952012|NCT01482221|540956746|FG002|Overall Study|Lack of Efficacy|1|||
149952013|NCT01482221|540956744|FG000|Overall Study|Lost to Follow-up|3|||
149952014|NCT01482221|540956745|FG001|Overall Study|Lost to Follow-up|2|||
149952015|NCT01482221|540956746|FG002|Overall Study|Lost to Follow-up|1|||
149952016|NCT01482221|540956744|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
149952017|NCT01482221|540956745|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
149952018|NCT01482221|540956746|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
149952019|NCT01482221|540956744|FG000|Overall Study|Condition under Investigation Worsened|3|||
149952020|NCT01482221|540956745|FG001|Overall Study|Condition under Investigation Worsened|2|||
149952021|NCT01482221|540956746|FG002|Overall Study|Condition under Investigation Worsened|4|||
149952022|NCT01482221|540956744|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
149952023|NCT01482221|540956745|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
149952024|NCT01482221|540956746|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
149952025|NCT01482221|540956744|FG000|Overall Study|Adverse Event|1|||
149952026|NCT01482221|540956745|FG001|Overall Study|Adverse Event|7|||
149952027|NCT01482221|540956746|FG002|Overall Study|Adverse Event|3|||
150034825|NCT02718898|541266529|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
149952028|NCT01482221|540956744|FG000|Overall Study|Withdrawal by Subject|10|||
149952029|NCT01482221|540956745|FG001|Overall Study|Withdrawal by Subject|7|||
149952030|NCT01482221|540956746|FG002|Overall Study|Withdrawal by Subject|12|||
149952031|NCT01482221|540956744|FG000|Overall Study|Incorrect randomization|0|||
149952032|NCT01482221|540956745|FG001|Overall Study|Incorrect randomization|1|||
149952033|NCT01482221|540956746|FG002|Overall Study|Incorrect randomization|0|||
149952034|NCT01482221|540956744|FG000|Overall Study|Physician Decision|0|||
149952035|NCT01482221|540956745|FG001|Overall Study|Physician Decision|1|||
149952036|NCT01482221|540956746|FG002|Overall Study|Physician Decision|0|||
149952037|NCT04900272|540956747|FG000|Overall Study|Lost to Follow-up|2|||
150034826|NCT02718898|541266530|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
150034827|NCT02718898|541266531|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
150034828|NCT02718898|541266532|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
150034829|NCT02718898|541266526|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
150034830|NCT02718898|541266527|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
150034831|NCT02718898|541266528|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
150034832|NCT02718898|541266529|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
150034833|NCT02718898|541266530|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
150034834|NCT02718898|541266531|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
150034835|NCT02718898|541266532|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
150034836|NCT02718898|541266526|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
150034837|NCT02718898|541266527|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
150034838|NCT02718898|541266528|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
150034839|NCT02718898|541266529|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
150034840|NCT02718898|541266530|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
150034841|NCT02718898|541266531|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
150034842|NCT02718898|541266532|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
150034843|NCT02718898|541266526|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150034844|NCT02718898|541266527|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150034845|NCT02718898|541266528|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150034846|NCT02718898|541266529|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150034847|NCT02718898|541266530|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
150034848|NCT02718898|541266531|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
150034849|NCT02718898|541266532|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
150034850|NCT01451606|541266533|FG000|Overall Study|Withdrawal by Subject|4|||
150034851|NCT01451606|541266534|FG001|Overall Study|Withdrawal by Subject|3|||
150034852|NCT01502293|541266539|FG000|Overall Study|Progressive Disease|20|||
150034853|NCT01502293|541266540|FG001|Overall Study|Progressive Disease|12|||
150034854|NCT01502293|541266541|FG002|Overall Study|Progressive Disease|2|||
150034855|NCT01502293|541266539|FG000|Overall Study|Withdrawal by Subject|3|||
150034856|NCT01502293|541266540|FG001|Overall Study|Withdrawal by Subject|3|||
150034857|NCT01502293|541266541|FG002|Overall Study|Withdrawal by Subject|1|||
150034858|NCT01502293|541266539|FG000|Overall Study|Adverse Event|0|||
150034859|NCT01502293|541266540|FG001|Overall Study|Adverse Event|2|||
150034860|NCT01502293|541266541|FG002|Overall Study|Adverse Event|0|||
150034861|NCT01502293|541266539|FG000|Overall Study|Reason Not Specified|2|||
150034862|NCT01502293|541266540|FG001|Overall Study|Reason Not Specified|0|||
150034863|NCT01502293|541266541|FG002|Overall Study|Reason Not Specified|0|||
150034864|NCT01502293|541266539|FG000|Overall Study|Physician Decision|0|||
150034865|NCT01502293|541266540|FG001|Overall Study|Physician Decision|0|||
150034866|NCT01502293|541266541|FG002|Overall Study|Physician Decision|1|||
150034867|NCT00231816|541266544|FG000|Overall Study|Adverse Event|1|||
150034868|NCT00231816|541266545|FG001|Overall Study|Adverse Event|0|||
150034869|NCT00231816|541266544|FG000|Overall Study|Lost to Follow-up|8|||
150034870|NCT00231816|541266545|FG001|Overall Study|Lost to Follow-up|5|||
150034871|NCT00231816|541266544|FG000|Overall Study|Protocol Violation|2|||
150034872|NCT00231816|541266545|FG001|Overall Study|Protocol Violation|3|||
150034873|NCT00231816|541266544|FG000|Overall Study|Withdrawal by Subject|3|||
150034874|NCT00231816|541266545|FG001|Overall Study|Withdrawal by Subject|3|||
150034875|NCT00231816|541266544|FG000|Overall Study|Other|2|||
150034876|NCT00231816|541266545|FG001|Overall Study|Other|1|||
150034877|NCT01075243|541266546|FG000|Overall Study|Lost to Follow-up|5|||
150034878|NCT01075243|541266547|FG001|Overall Study|Lost to Follow-up|2|||
150034879|NCT01075243|541266548|FG002|Overall Study|Lost to Follow-up|0|||
150034880|NCT01075243|541266546|FG000|Overall Study|Withdrawal by Subject|1|||
150034881|NCT01075243|541266547|FG001|Overall Study|Withdrawal by Subject|1|||
150034882|NCT01075243|541266548|FG002|Overall Study|Withdrawal by Subject|0|||
150034883|NCT03337308|541266549|FG000|Overall Study|Adverse Event|2|||
150034884|NCT03337308|541266550|FG001|Overall Study|Adverse Event|3|||
150034885|NCT03337308|541266551|FG002|Overall Study|Adverse Event|3|||
150034886|NCT03337308|541266552|FG003|Overall Study|Adverse Event|1|||
150034887|NCT03337308|541266549|FG000|Overall Study|Lost to Follow-up|1|||
150034888|NCT03337308|541266550|FG001|Overall Study|Lost to Follow-up|2|||
150034889|NCT03337308|541266551|FG002|Overall Study|Lost to Follow-up|0|||
150034890|NCT03337308|541266552|FG003|Overall Study|Lost to Follow-up|0|||
150034891|NCT03337308|541266549|FG000|Overall Study|Withdrawal by Subject|2|||
150034892|NCT03337308|541266550|FG001|Overall Study|Withdrawal by Subject|1|||
150034893|NCT03337308|541266551|FG002|Overall Study|Withdrawal by Subject|2|||
150034894|NCT03337308|541266552|FG003|Overall Study|Withdrawal by Subject|1|||
150172051|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
150172052|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
150034895|NCT03337308|541266549|FG000|Overall Study|Protocol Violation|0|||
150034896|NCT03337308|541266550|FG001|Overall Study|Protocol Violation|1|||
150034897|NCT03337308|541266551|FG002|Overall Study|Protocol Violation|0|||
149839124|NCT01705574|540541303|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
149839125|NCT01705574|540541300|FG000|Open-Label Extension Phase|Adverse Event|3|||
149839126|NCT01705574|540541301|FG001|Open-Label Extension Phase|Adverse Event|0|||
149839127|NCT01705574|540541302|FG002|Open-Label Extension Phase|Adverse Event|0|||
149839128|NCT01705574|540541303|FG003|Open-Label Extension Phase|Adverse Event|1|||
149952038|NCT04900272|540956747|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
149952039|NCT04900272|540956747|FG000|Overall Study|Withdrawal by Subject|1|||
149952040|NCT05059080|540956748|FG000|Overall Study|Withdrawal by Subject|3|||
149952041|NCT05059080|540956748|FG000|Overall Study|Study Terminated by Sponsor|64|||
149952042|NCT01047501|540956749|FG000|Overall Study|Adverse Event|7|||
149952043|NCT01047501|540956750|FG001|Overall Study|Adverse Event|8|||
149952044|NCT01047501|540956751|FG002|Overall Study|Adverse Event|5|||
149952045|NCT01047501|540956749|FG000|Overall Study|Withdrew Consent|6|||
149952046|NCT01047501|540956750|FG001|Overall Study|Withdrew Consent|2|||
149952047|NCT01047501|540956751|FG002|Overall Study|Withdrew Consent|4|||
149952048|NCT01047501|540956749|FG000|Overall Study|Lost to Follow-up|0|||
149952049|NCT01047501|540956750|FG001|Overall Study|Lost to Follow-up|1|||
149952050|NCT01047501|540956751|FG002|Overall Study|Lost to Follow-up|1|||
149952051|NCT01047501|540956749|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
149952052|NCT01047501|540956750|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
149952053|NCT01047501|540956751|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
149952054|NCT01047501|540956749|FG000|Overall Study|Death|1|||
149952055|NCT01047501|540956750|FG001|Overall Study|Death|0|||
149952056|NCT01047501|540956751|FG002|Overall Study|Death|0|||
149952057|NCT01047501|540956749|FG000|Overall Study|Other discontinuation|1|||
149952058|NCT01047501|540956750|FG001|Overall Study|Other discontinuation|0|||
149952059|NCT01047501|540956751|FG002|Overall Study|Other discontinuation|1|||
149952060|NCT01047501|540956749|FG000|Overall Study|Investigator judgement|0|||
149952061|NCT01047501|540956750|FG001|Overall Study|Investigator judgement|0|||
149952062|NCT01047501|540956751|FG002|Overall Study|Investigator judgement|1|||
149952063|NCT04602000|540956752|FG000|Overall Study|Withdrawal by Subject|3|||
149952064|NCT04602000|540956753|FG001|Overall Study|Withdrawal by Subject|6|||
149952065|NCT04602000|540956754|FG002|Overall Study|Withdrawal by Subject|3|||
149952066|NCT04602000|540956755|FG003|Overall Study|Withdrawal by Subject|27|||
149952067|NCT04602000|540956756|FG004|Overall Study|Withdrawal by Subject|39|||
149952068|NCT04602000|540956752|FG000|Overall Study|Physician Decision|1|||
149952069|NCT04602000|540956753|FG001|Overall Study|Physician Decision|0|||
149952070|NCT04602000|540956754|FG002|Overall Study|Physician Decision|0|||
149952071|NCT04602000|540956755|FG003|Overall Study|Physician Decision|2|||
149952072|NCT04602000|540956756|FG004|Overall Study|Physician Decision|2|||
149952073|NCT04602000|540956752|FG000|Overall Study|Death|0|||
149952074|NCT04602000|540956753|FG001|Overall Study|Death|1|||
149952075|NCT04602000|540956754|FG002|Overall Study|Death|0|||
149952076|NCT04602000|540956755|FG003|Overall Study|Death|1|||
149952077|NCT04602000|540956756|FG004|Overall Study|Death|2|||
149952078|NCT04602000|540956752|FG000|Overall Study|Lost to Follow-up|0|||
149952079|NCT04602000|540956753|FG001|Overall Study|Lost to Follow-up|0|||
149952080|NCT04602000|540956754|FG002|Overall Study|Lost to Follow-up|0|||
149839129|NCT01705574|540541300|FG000|Open-Label Extension Phase|Death|2|||
149839130|NCT01705574|540541301|FG001|Open-Label Extension Phase|Death|0|||
149839131|NCT01705574|540541302|FG002|Open-Label Extension Phase|Death|1|||
149839132|NCT01705574|540541303|FG003|Open-Label Extension Phase|Death|0|||
149839133|NCT01705574|540541300|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
149839134|NCT01705574|540541301|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
149839135|NCT01705574|540541302|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
149839136|NCT01705574|540541303|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
149839137|NCT01705574|540541300|FG000|Open-Label Extension Phase|Physician Decision|0|||
149839138|NCT01705574|540541301|FG001|Open-Label Extension Phase|Physician Decision|0|||
149839139|NCT01705574|540541302|FG002|Open-Label Extension Phase|Physician Decision|2|||
149839140|NCT01705574|540541303|FG003|Open-Label Extension Phase|Physician Decision|0|||
149839141|NCT01705574|540541300|FG000|Open-Label Extension Phase|Pregnancy|0|||
149839142|NCT01705574|540541301|FG001|Open-Label Extension Phase|Pregnancy|0|||
149839143|NCT01705574|540541302|FG002|Open-Label Extension Phase|Pregnancy|1|||
149839144|NCT01705574|540541303|FG003|Open-Label Extension Phase|Pregnancy|1|||
149839145|NCT00777023|540541304|FG000|Overall Study|Adverse Event|15|||
149839146|NCT00777023|540541305|FG001|Overall Study|Adverse Event|21|||
149839147|NCT00777023|540541306|FG002|Overall Study|Adverse Event|8|||
149839148|NCT00777023|540541304|FG000|Overall Study|Lack of Efficacy|1|||
149839149|NCT00777023|540541305|FG001|Overall Study|Lack of Efficacy|0|||
149839150|NCT00777023|540541306|FG002|Overall Study|Lack of Efficacy|14|||
149839151|NCT00777023|540541304|FG000|Overall Study|Protocol Violation|2|||
149839152|NCT00777023|540541305|FG001|Overall Study|Protocol Violation|1|||
149839153|NCT00777023|540541306|FG002|Overall Study|Protocol Violation|1|||
149839154|NCT00777023|540541304|FG000|Overall Study|Lost to Follow-up|2|||
149839155|NCT00777023|540541305|FG001|Overall Study|Lost to Follow-up|3|||
149952081|NCT04602000|540956755|FG003|Overall Study|Lost to Follow-up|3|||
149952082|NCT04602000|540956756|FG004|Overall Study|Lost to Follow-up|4|||
149952083|NCT04602000|540956752|FG000|Overall Study|Other|4|||
150034898|NCT03337308|541266552|FG003|Overall Study|Protocol Violation|0|||
150034899|NCT01614249|541266555|FG000|Overall Study|Lost to Follow-up|11|||
150034900|NCT01614249|541266556|FG001|Overall Study|Lost to Follow-up|23|||
150034901|NCT05498649|541266557|FG000|Overall Study|Lost to Follow-up|1|||
150034902|NCT02761330|541266569|FG000|Treatment Week 1|Withdrawal by Subject|0|||
150034903|NCT02761330|541266570|FG001|Treatment Week 1|Withdrawal by Subject|0|||
150034904|NCT02761330|541266571|FG002|Treatment Week 1|Withdrawal by Subject|0|||
150034905|NCT02761330|541266572|FG003|Treatment Week 1|Withdrawal by Subject|1|||
150034906|NCT02761330|541266573|FG004|Treatment Week 1|Withdrawal by Subject|0|||
150034907|NCT02761330|541266574|FG005|Treatment Week 1|Withdrawal by Subject|1|||
150034908|NCT00888134|541266575|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
150034909|NCT00888134|541266575|FG000|Follow-up|being followed for long-term survival|1|||
150034910|NCT03043313|541266578|FG000|Overall Study|Withdrawal by Subject|5|||
150034911|NCT03043313|541266579|FG001|Overall Study|Withdrawal by Subject|1|||
150034912|NCT03043313|541266580|FG002|Overall Study|Withdrawal by Subject|1|||
150034913|NCT03043313|541266578|FG000|Overall Study|Lost to Follow-up|1|||
150034914|NCT03043313|541266579|FG001|Overall Study|Lost to Follow-up|1|||
150034915|NCT03043313|541266580|FG002|Overall Study|Lost to Follow-up|0|||
150034916|NCT03043313|541266578|FG000|Overall Study|Death|28|||
150034917|NCT03043313|541266579|FG001|Overall Study|Death|26|||
150034918|NCT03043313|541266580|FG002|Overall Study|Death|17|||
150034919|NCT03043313|541266578|FG000|Overall Study|Participation terminated by sponsor|11|||
150034920|NCT03043313|541266579|FG001|Overall Study|Participation terminated by sponsor|13|||
150034921|NCT03043313|541266580|FG002|Overall Study|Participation terminated by sponsor|13|||
150034922|NCT03050801|541266583|FG000|Experiment 1|Lost to Follow-up|0|||
150034923|NCT03050801|541266584|FG001|Experiment 1|Lost to Follow-up|1|||
150034924|NCT03050801|541266585|FG002|Experiment 1|Lost to Follow-up|0|||
150034925|NCT03050801|541266586|FG003|Experiment 1|Lost to Follow-up|0|||
150034926|NCT03050801|541266587|FG004|Experiment 1|Lost to Follow-up|0|||
150034927|NCT03050801|541266588|FG005|Experiment 1|Lost to Follow-up|0|||
150034928|NCT03050801|541266583|FG000|Experiment 1|Physician Decision|0|||
150034929|NCT03050801|541266584|FG001|Experiment 1|Physician Decision|3|||
150034930|NCT03050801|541266585|FG002|Experiment 1|Physician Decision|0|||
150034931|NCT03050801|541266586|FG003|Experiment 1|Physician Decision|0|||
150034932|NCT03050801|541266587|FG004|Experiment 1|Physician Decision|0|||
150034933|NCT03050801|541266588|FG005|Experiment 1|Physician Decision|0|||
150034934|NCT03050801|541266583|FG000|Experiment 1|Change of experimental design|0|||
150034935|NCT03050801|541266584|FG001|Experiment 1|Change of experimental design|3|||
150034936|NCT03050801|541266585|FG002|Experiment 1|Change of experimental design|0|||
150034937|NCT03050801|541266586|FG003|Experiment 1|Change of experimental design|0|||
150034938|NCT03050801|541266587|FG004|Experiment 1|Change of experimental design|0|||
150034939|NCT03050801|541266588|FG005|Experiment 1|Change of experimental design|0|||
150034940|NCT03050801|541266583|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
150034941|NCT03050801|541266584|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
150034942|NCT03050801|541266585|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
150034943|NCT03050801|541266586|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
150034944|NCT03050801|541266587|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
150034945|NCT03050801|541266588|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
150034946|NCT03050801|541266583|FG000|Experiment 2|Lost to Follow-up|0|||
150034947|NCT03050801|541266584|FG001|Experiment 2|Lost to Follow-up|0|||
150034948|NCT03050801|541266585|FG002|Experiment 2|Lost to Follow-up|0|||
150034949|NCT03050801|541266586|FG003|Experiment 2|Lost to Follow-up|1|||
150034950|NCT03050801|541266587|FG004|Experiment 2|Lost to Follow-up|1|||
150034951|NCT03050801|541266588|FG005|Experiment 2|Lost to Follow-up|0|||
150034952|NCT03050801|541266583|FG000|Experiment 2|Physician Decision|0|||
150034953|NCT03050801|541266584|FG001|Experiment 2|Physician Decision|0|||
150034954|NCT03050801|541266585|FG002|Experiment 2|Physician Decision|0|||
150034955|NCT03050801|541266586|FG003|Experiment 2|Physician Decision|0|||
150034956|NCT03050801|541266587|FG004|Experiment 2|Physician Decision|1|||
150034957|NCT03050801|541266588|FG005|Experiment 2|Physician Decision|0|||
150034958|NCT03050801|541266583|FG000|Experiment 2|Pregnancy|0|||
150034959|NCT03050801|541266584|FG001|Experiment 2|Pregnancy|0|||
150172053|NCT00241644|541765877|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
150034960|NCT03050801|541266585|FG002|Experiment 2|Pregnancy|0|||
150034961|NCT03050801|541266586|FG003|Experiment 2|Pregnancy|0|||
150034962|NCT03050801|541266587|FG004|Experiment 2|Pregnancy|1|||
150034963|NCT03050801|541266588|FG005|Experiment 2|Pregnancy|0|||
150034964|NCT03050801|541266583|FG000|Experiment 2|Withdrawal by Subject|0|||
150034965|NCT03050801|541266584|FG001|Experiment 2|Withdrawal by Subject|0|||
150172054|NCT00241644|541765878|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
150034966|NCT03050801|541266585|FG002|Experiment 2|Withdrawal by Subject|0|||
150034967|NCT03050801|541266586|FG003|Experiment 2|Withdrawal by Subject|1|||
150034968|NCT03050801|541266587|FG004|Experiment 2|Withdrawal by Subject|0|||
150034969|NCT03050801|541266588|FG005|Experiment 2|Withdrawal by Subject|0|||
150034970|NCT03050801|541266583|FG000|Experiment 2|Poor data quality|0|||
150034971|NCT03050801|541266584|FG001|Experiment 2|Poor data quality|0|||
150034972|NCT03050801|541266585|FG002|Experiment 2|Poor data quality|0|||
149952084|NCT04602000|540956753|FG001|Overall Study|Other|1|||
149952085|NCT04602000|540956754|FG002|Overall Study|Other|2|||
149952086|NCT04602000|540956755|FG003|Overall Study|Other|5|||
149952087|NCT04602000|540956756|FG004|Overall Study|Other|4|||
149952088|NCT04602000|540956752|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
149952089|NCT04602000|540956753|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
149952090|NCT04602000|540956754|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
149952091|NCT04602000|540956755|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
149952092|NCT04602000|540956756|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
149952093|NCT05607043|540956757|FG000|Overall Study|Lost to Follow-up|2|||
149952094|NCT04871113|540956762|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952095|NCT04871113|540956763|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952096|NCT04871113|540956764|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952097|NCT04871113|540956765|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952098|NCT04871113|540956766|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952099|NCT04871113|540956767|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
149952100|NCT04871113|540956768|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952101|NCT04871113|540956769|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952102|NCT04871113|540956770|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952103|NCT04871113|540956771|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
149952104|NCT04871113|540956762|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952105|NCT04871113|540956763|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952106|NCT04871113|540956764|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952107|NCT04871113|540956765|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952108|NCT04871113|540956766|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952109|NCT04871113|540956767|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952110|NCT04871113|540956768|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
149952111|NCT04871113|540956769|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
149952112|NCT04871113|540956770|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952113|NCT04871113|540956771|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
149952114|NCT02447029|540956772|FG000|Overall Study|Withdrawal by Subject|3|||
149952115|NCT02447029|540956773|FG001|Overall Study|Withdrawal by Subject|2|||
149952116|NCT01239745|540956774|FG000|Overall Study|Study terminated by sponsor|45|||
149952117|NCT01239745|540956774|FG000|Overall Study|Adverse Event|1|||
149952118|NCT01257542|540956775|FG000|Overall Study|Protocol Violation|3|||
149952119|NCT01257542|540956776|FG001|Overall Study|Protocol Violation|5|||
149952120|NCT01257542|540956775|FG000|Overall Study|Withdrawal by Subject|0|||
149952121|NCT01257542|540956776|FG001|Overall Study|Withdrawal by Subject|2|||
149952122|NCT00081458|540956777|FG000|Overall Study|Adverse Event|1|||
149952123|NCT00081458|540956778|FG001|Overall Study|Adverse Event|5|||
149952124|NCT00081458|540956779|FG002|Overall Study|Adverse Event|2|||
149952125|NCT00081458|540956777|FG000|Overall Study|Withdrawal by Subject|0|||
149952126|NCT00081458|540956778|FG001|Overall Study|Withdrawal by Subject|3|||
149952127|NCT00081458|540956779|FG002|Overall Study|Withdrawal by Subject|1|||
149952128|NCT00081458|540956777|FG000|Overall Study|Randomized but not dosed|0|||
149952129|NCT00081458|540956778|FG001|Overall Study|Randomized but not dosed|0|||
149952130|NCT00081458|540956779|FG002|Overall Study|Randomized but not dosed|1|||
149952131|NCT03097315|540956782|FG000|Overall Study|Withdrawal by Subject|1|||
149952132|NCT00153920|540956783|FG000|Overall Study|Adverse Event|9|||
149952133|NCT00153920|540956783|FG000|Overall Study|Progressive Disease|9|||
149952134|NCT00153920|540956783|FG000|Overall Study|Physician Decision|3|||
149952135|NCT00153920|540956783|FG000|Overall Study|Lack of Response|3|||
149952136|NCT00153920|540956783|FG000|Overall Study|Death|2|||
149952137|NCT00153920|540956783|FG000|Overall Study|Withdrawal by Subject|1|||
149952138|NCT00153920|540956783|FG000|Overall Study|Non-Protocol Therapy|1|||
149952139|NCT00153920|540956783|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
149952140|NCT00153920|540956783|FG000|Overall Study|Progressive Disease before Trt|1|||
149952141|NCT02948400|540956786|FG000|Overall Study|Withdrawal by Subject|17|||
149952142|NCT02948400|540956787|FG001|Overall Study|Withdrawal by Subject|10|||
149952143|NCT02948400|540956786|FG000|Overall Study|failed to attend appointments|47|||
149952144|NCT02948400|540956787|FG001|Overall Study|failed to attend appointments|34|||
149952145|NCT02948400|540956786|FG000|Overall Study|COVID-related closure|6|||
149952146|NCT02948400|540956787|FG001|Overall Study|COVID-related closure|2|||
149952147|NCT02948400|540956786|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
149952148|NCT02948400|540956787|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
149952149|NCT02948400|540956786|FG000|Overall Study|motion sickness in virtual reality|2|||
150034973|NCT03050801|541266586|FG003|Experiment 2|Poor data quality|4|||
149952150|NCT02948400|540956787|FG001|Overall Study|motion sickness in virtual reality|0|||
149952151|NCT01716156|540956788|FG000|Overall Study|Protocol Violation|1|||
149952152|NCT01716156|540956789|FG001|Overall Study|Protocol Violation|0|||
150034974|NCT03050801|541266587|FG004|Experiment 2|Poor data quality|1|||
150034975|NCT03050801|541266588|FG005|Experiment 2|Poor data quality|0|||
150034976|NCT03050801|541266583|FG000|Experiment 2|Discomfort during stimulation|0|||
150034977|NCT03050801|541266584|FG001|Experiment 2|Discomfort during stimulation|0|||
150034978|NCT03050801|541266585|FG002|Experiment 2|Discomfort during stimulation|0|||
150034979|NCT03050801|541266586|FG003|Experiment 2|Discomfort during stimulation|0|||
150034980|NCT03050801|541266587|FG004|Experiment 2|Discomfort during stimulation|0|||
150034981|NCT03050801|541266588|FG005|Experiment 2|Discomfort during stimulation|2|||
150034982|NCT03204188|541266599|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
150034983|NCT03204188|541266599|FG000|Immunotherapy Phase (1 Year)|Death|1|||
150034984|NCT03204188|541266599|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
150034985|NCT03204188|541266599|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
150034986|NCT01972217|541268858|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
150034987|NCT01972217|541268859|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
150034988|NCT01972217|541268860|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
150034989|NCT01972217|541268861|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
150034990|NCT01972217|541268858|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
150034991|NCT01972217|541268859|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
150034992|NCT01972217|541268860|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
150034993|NCT01972217|541268861|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
150034994|NCT01972217|541268858|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
150034995|NCT01972217|541268859|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
150034996|NCT01972217|541268860|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
150034997|NCT01972217|541268861|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
150034998|NCT01972217|541268858|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
150034999|NCT01972217|541268859|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
150035000|NCT01972217|541268860|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
150035001|NCT01972217|541268861|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
150035002|NCT01972217|541268858|FG000|Part B Double-blind, Randomised Period|Death|0|||
150035003|NCT01972217|541268859|FG001|Part B Double-blind, Randomised Period|Death|0|||
150035004|NCT01972217|541268860|FG002|Part B Double-blind, Randomised Period|Death|43|||
150035005|NCT01972217|541268861|FG003|Part B Double-blind, Randomised Period|Death|44|||
150035006|NCT01972217|541268858|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
150035007|NCT01972217|541268859|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
150035008|NCT01972217|541268860|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
150035009|NCT01972217|541268861|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
150035010|NCT01972217|541268858|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
150035011|NCT01972217|541268859|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
150035012|NCT01972217|541268860|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
150035013|NCT01972217|541268861|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
150035014|NCT01972217|541268858|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
150035015|NCT01972217|541268859|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
150035016|NCT01972217|541268860|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
150035017|NCT01972217|541268861|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
150035018|NCT01972217|541268858|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
150035019|NCT01972217|541268859|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
150035020|NCT01972217|541268860|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
150035021|NCT01972217|541268861|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
149839156|NCT00777023|540541306|FG002|Overall Study|Lost to Follow-up|3|||
150035022|NCT03829228|541268862|FG000|Overall Study|Protocol Violation|1|||
150035023|NCT02443688|541268865|FG000|Overall Study|Adverse Event|2|||
150035024|NCT02443688|541268866|FG001|Overall Study|Adverse Event|3|||
150035025|NCT02443688|541268867|FG002|Overall Study|Adverse Event|2|||
150035026|NCT02443688|541268865|FG000|Overall Study|Lost to Follow-up|1|||
150035027|NCT02443688|541268866|FG001|Overall Study|Lost to Follow-up|0|||
150035028|NCT02443688|541268867|FG002|Overall Study|Lost to Follow-up|0|||
150035029|NCT02443688|541268865|FG000|Overall Study|Physician Decision|3|||
150035030|NCT02443688|541268866|FG001|Overall Study|Physician Decision|0|||
150035031|NCT02443688|541268867|FG002|Overall Study|Physician Decision|1|||
150035032|NCT02443688|541268865|FG000|Overall Study|Pregnancy|0|||
150035033|NCT02443688|541268866|FG001|Overall Study|Pregnancy|0|||
150035034|NCT02443688|541268867|FG002|Overall Study|Pregnancy|1|||
150035035|NCT02443688|541268865|FG000|Overall Study|Withdrawal by Subject|3|||
150035036|NCT02443688|541268866|FG001|Overall Study|Withdrawal by Subject|3|||
150035037|NCT02443688|541268867|FG002|Overall Study|Withdrawal by Subject|4|||
150035038|NCT02443688|541268865|FG000|Overall Study|Non-compliance with study drug|1|||
150035039|NCT02443688|541268866|FG001|Overall Study|Non-compliance with study drug|2|||
150035040|NCT02443688|541268867|FG002|Overall Study|Non-compliance with study drug|4|||
150282765|NCT03021499|542172010|FG001|Overall Study|None of the above|4|||
150035041|NCT02443688|541268865|FG000|Overall Study|Sponsor Request|2|||
150035042|NCT02443688|541268866|FG001|Overall Study|Sponsor Request|1|||
150035043|NCT02443688|541268867|FG002|Overall Study|Sponsor Request|0|||
150035044|NCT01112917|541268869|FG000|Overall Study|Death|2|||
150035045|NCT01112917|541268870|FG001|Overall Study|Death|11|||
150035046|NCT01112917|541268869|FG000|Overall Study|Lost to Follow-up|1|||
150035047|NCT01112917|541268870|FG001|Overall Study|Lost to Follow-up|1|||
150035048|NCT01112917|541268869|FG000|Overall Study|Withdrawal by Subject|1|||
150035049|NCT01112917|541268870|FG001|Overall Study|Withdrawal by Subject|3|||
150035050|NCT01112917|541268869|FG000|Overall Study|Unable to Convert Filter|3|||
150035051|NCT01112917|541268870|FG001|Overall Study|Unable to Convert Filter|0|||
150035052|NCT05101122|541268871|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
150035053|NCT05101122|541268871|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
150035054|NCT05101122|541268871|FG000|AD313 80/5|Withdrawal by Subject|1|||
150035055|NCT05101122|541268871|FG000|AD313 80/10|Physician Decision|1|||
150035056|NCT00616759|541268874|FG000|Overall Study|Physician Decision|2|||
150035057|NCT00616759|541268875|FG001|Overall Study|Physician Decision|0|||
150035058|NCT00616759|541268874|FG000|Overall Study|Withdrawal by Subject|1|||
150035059|NCT00616759|541268875|FG001|Overall Study|Withdrawal by Subject|2|||
150035060|NCT02177123|541268876|FG000|Overall Study|Lost to Follow-up|6|||
150035061|NCT02177123|541268876|FG000|Overall Study|Withdrawal by Subject|4|||
150035062|NCT02177123|541268876|FG000|Overall Study|Adverse Event|4|||
150035063|NCT02177123|541268876|FG000|Overall Study|Physician Decision|3|||
150035064|NCT02177123|541268876|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
150035065|NCT02177123|541268876|FG000|Overall Study|Excluded for medical reasons|2|||
150035066|NCT02177123|541268876|FG000|Overall Study|Death|1|||
150035067|NCT02177123|541268876|FG000|Overall Study|Other|1|||
150035068|NCT02177123|541268876|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
150035069|NCT00837434|541268887|FG000|Overall Study|Physician Decision|3|||
150035070|NCT00837434|541268888|FG001|Overall Study|Physician Decision|0|||
150035071|NCT00837434|541268887|FG000|Overall Study|Lost to Follow-up|1|||
150035072|NCT00837434|541268888|FG001|Overall Study|Lost to Follow-up|1|||
150035073|NCT00837434|541268887|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
150035074|NCT00837434|541268888|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
150035075|NCT00837434|541268887|FG000|Overall Study|Noncompliant|2|||
150035076|NCT00837434|541268888|FG001|Overall Study|Noncompliant|0|||
150035077|NCT00837434|541268887|FG000|Overall Study|Baseline assessments not done in time|1|||
150035078|NCT00837434|541268888|FG001|Overall Study|Baseline assessments not done in time|0|||
150035079|NCT00837434|541268887|FG000|Overall Study|Unable to obtain study drug|1|||
150035080|NCT00837434|541268888|FG001|Overall Study|Unable to obtain study drug|0|||
150035081|NCT01709721|541268889|FG000|Open Label Phase|Withdrawal by Subject|0|||
150035082|NCT01709721|541268890|FG001|Open Label Phase|Withdrawal by Subject|0|||
150035083|NCT01709721|541268891|FG002|Open Label Phase|Withdrawal by Subject|5|||
150035084|NCT01709721|541268889|FG000|Open Label Phase|Adverse Event|0|||
150035085|NCT01709721|541268890|FG001|Open Label Phase|Adverse Event|0|||
150035086|NCT01709721|541268891|FG002|Open Label Phase|Adverse Event|8|||
150035087|NCT01709721|541268889|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
150035088|NCT01709721|541268890|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
150035089|NCT01709721|541268891|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
150035090|NCT01709721|541268889|FG000|Open Label Phase|Investigator Decision|0|||
150035091|NCT01709721|541268890|FG001|Open Label Phase|Investigator Decision|0|||
150035092|NCT01709721|541268891|FG002|Open Label Phase|Investigator Decision|1|||
150035093|NCT01709721|541268889|FG000|Open Label Phase|Sponsor Decision|0|||
150035094|NCT01709721|541268890|FG001|Open Label Phase|Sponsor Decision|0|||
150172055|NCT00241644|541765879|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
150282766|NCT03021499|542172009|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
150282767|NCT03021499|542172010|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
149839157|NCT00777023|540541304|FG000|Overall Study|Death|0|||
150035095|NCT01709721|541268891|FG002|Open Label Phase|Sponsor Decision|2|||
150035096|NCT01709721|541268889|FG000|Open Label Phase|Protocol Violation|0|||
150035097|NCT01709721|541268890|FG001|Open Label Phase|Protocol Violation|0|||
150035098|NCT01709721|541268891|FG002|Open Label Phase|Protocol Violation|1|||
150035099|NCT01709721|541268889|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
150035100|NCT01709721|541268890|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
150035101|NCT01709721|541268891|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
150035102|NCT01709721|541268889|FG000|Open Label Phase|Inadequate Pain Control|0|||
150035103|NCT01709721|541268890|FG001|Open Label Phase|Inadequate Pain Control|0|||
150172056|NCT00241644|541765880|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
150172057|NCT00241644|541765877|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
150172058|NCT00241644|541765878|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
150172059|NCT00241644|541765879|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
150172060|NCT00241644|541765880|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
150172061|NCT00241644|541765877|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
149952153|NCT01716156|540956790|FG002|Overall Study|Protocol Violation|0|||
149952154|NCT01716156|540956788|FG000|Overall Study|Withdrawal by Subject|0|||
149952155|NCT01716156|540956789|FG001|Overall Study|Withdrawal by Subject|1|||
149952156|NCT01716156|540956790|FG002|Overall Study|Withdrawal by Subject|2|||
149952157|NCT01716156|540956788|FG000|Overall Study|Lost to Follow-up|1|||
149952158|NCT01716156|540956789|FG001|Overall Study|Lost to Follow-up|0|||
149952159|NCT01716156|540956790|FG002|Overall Study|Lost to Follow-up|0|||
149952160|NCT04822194|540956791|FG000|Overall Study|Withdrawal by Subject|5|||
149952161|NCT04822194|540956792|FG001|Overall Study|Withdrawal by Subject|4|||
149952162|NCT04822194|540956791|FG000|Overall Study|Technical issues with MR scanner|1|||
149952163|NCT04822194|540956792|FG001|Overall Study|Technical issues with MR scanner|0|||
149952164|NCT04822194|540956791|FG000|Overall Study|Lost to Follow-up|5|||
149952165|NCT04822194|540956792|FG001|Overall Study|Lost to Follow-up|7|||
149952166|NCT03976375|540956793|FG000|Overall Study|Death|158|||
149952167|NCT03976375|540956794|FG001|Overall Study|Death|160|||
149952168|NCT03976375|540956795|FG002|Overall Study|Death|42|||
149952169|NCT03976375|540956793|FG000|Overall Study|Lost to Follow-up|2|||
149952170|NCT03976375|540956794|FG001|Overall Study|Lost to Follow-up|1|||
149952171|NCT03976375|540956795|FG002|Overall Study|Lost to Follow-up|1|||
149952172|NCT03976375|540956793|FG000|Overall Study|Withdrawal by Subject|5|||
149952173|NCT03976375|540956794|FG001|Overall Study|Withdrawal by Subject|9|||
149952174|NCT03976375|540956795|FG002|Overall Study|Withdrawal by Subject|4|||
149952175|NCT03976375|540956793|FG000|Overall Study|Sponsor decision|20|||
149952176|NCT03976375|540956794|FG001|Overall Study|Sponsor decision|19|||
149952177|NCT03976375|540956795|FG002|Overall Study|Sponsor decision|1|||
149952178|NCT02717611|540956796|FG000|Overall Study|Death|13|||
149952179|NCT02717611|540956796|FG000|Overall Study|Withdrawal by Subject|6|||
149952180|NCT02717611|540956796|FG000|Overall Study|Active, not recruiting|40|||
149952181|NCT02717611|540956796|FG000|Overall Study|Complicating disease|1|||
149952182|NCT04598828|540956797|FG000|Overall Study|Physician Decision|1|||
149952183|NCT04598828|540956798|FG001|Overall Study|Physician Decision|0|||
149952184|NCT04598828|540956797|FG000|Overall Study|Withdrawal by Subject|0|||
149952185|NCT04598828|540956798|FG001|Overall Study|Withdrawal by Subject|1|||
149952186|NCT04598828|540956797|FG000|Overall Study|Withdrawal by Subject|0|||
149952187|NCT04598828|540956798|FG001|Overall Study|Withdrawal by Subject|1|||
149952188|NCT04818112|540956799|FG000|Overall Study|Withdrawal by Subject|54|||
149952189|NCT04818112|540956800|FG001|Overall Study|Withdrawal by Subject|12|||
149952190|NCT04818112|540956799|FG000|Overall Study|Lost to Follow-up|38|||
149952191|NCT04818112|540956800|FG001|Overall Study|Lost to Follow-up|10|||
149952192|NCT02676973|540956801|FG000|Overall Study|Withdrawal by Subject|9|||
149952193|NCT02676973|540956802|FG001|Overall Study|Withdrawal by Subject|8|||
150282768|NCT01210690|542172011|FG000|Overall Study|Adverse Event|7|||
149952194|NCT02676973|540956803|FG002|Overall Study|Withdrawal by Subject|11|||
149952195|NCT02676973|540956801|FG000|Overall Study|Lost to Follow-up|8|||
149952196|NCT02676973|540956802|FG001|Overall Study|Lost to Follow-up|12|||
149952197|NCT02676973|540956803|FG002|Overall Study|Lost to Follow-up|8|||
149952198|NCT02676973|540956801|FG000|Overall Study|Death|2|||
149952199|NCT02676973|540956802|FG001|Overall Study|Death|1|||
149952200|NCT02676973|540956803|FG002|Overall Study|Death|5|||
149952201|NCT01078662|540956805|FG000|Overall Study|Death|41|||
149952202|NCT01078662|540956806|FG001|Overall Study|Death|103|||
149952203|NCT01078662|540956807|FG002|Overall Study|Death|18|||
149952204|NCT01078662|540956808|FG003|Overall Study|Death|5|||
149952205|NCT01078662|540956809|FG004|Overall Study|Death|8|||
149952206|NCT01078662|540956805|FG000|Overall Study|Patients reached data cut-off|12|||
149952207|NCT01078662|540956806|FG001|Overall Study|Patients reached data cut-off|53|||
149952208|NCT01078662|540956807|FG002|Overall Study|Patients reached data cut-off|2|||
149952209|NCT01078662|540956808|FG003|Overall Study|Patients reached data cut-off|2|||
149952210|NCT01078662|540956809|FG004|Overall Study|Patients reached data cut-off|3|||
149952211|NCT01078662|540956805|FG000|Overall Study|Withdrawal by Subject|4|||
149952212|NCT01078662|540956806|FG001|Overall Study|Withdrawal by Subject|11|||
149952213|NCT01078662|540956807|FG002|Overall Study|Withdrawal by Subject|1|||
149952214|NCT01078662|540956808|FG003|Overall Study|Withdrawal by Subject|0|||
149952215|NCT01078662|540956809|FG004|Overall Study|Withdrawal by Subject|0|||
149952216|NCT01078662|540956805|FG000|Overall Study|Protocol Violation|0|||
150035104|NCT01709721|541268891|FG002|Open Label Phase|Inadequate Pain Control|37|||
149952217|NCT01078662|540956806|FG001|Overall Study|Protocol Violation|1|||
149952218|NCT01078662|540956807|FG002|Overall Study|Protocol Violation|0|||
149952219|NCT01078662|540956808|FG003|Overall Study|Protocol Violation|0|||
149952220|NCT01078662|540956809|FG004|Overall Study|Protocol Violation|0|||
149952221|NCT01078662|540956805|FG000|Overall Study|Lost to Follow-up|1|||
149952222|NCT01078662|540956806|FG001|Overall Study|Lost to Follow-up|0|||
149952223|NCT01078662|540956807|FG002|Overall Study|Lost to Follow-up|0|||
149952224|NCT01078662|540956808|FG003|Overall Study|Lost to Follow-up|0|||
149952225|NCT01078662|540956809|FG004|Overall Study|Lost to Follow-up|0|||
149952226|NCT01913353|540956811|FG000|Overall Study|Adverse Event|2|||
149952227|NCT01913353|540956812|FG001|Overall Study|Adverse Event|0|||
149952228|NCT01913353|540956811|FG000|Overall Study|Physician Decision|0|||
149952229|NCT01913353|540956812|FG001|Overall Study|Physician Decision|2|||
149839158|NCT00777023|540541305|FG001|Overall Study|Death|1|||
149839159|NCT00777023|540541306|FG002|Overall Study|Death|0|||
149839160|NCT00777023|540541304|FG000|Overall Study|Withdrawal by Subject|7|||
149839161|NCT00777023|540541305|FG001|Overall Study|Withdrawal by Subject|7|||
149839162|NCT00777023|540541306|FG002|Overall Study|Withdrawal by Subject|8|||
149839163|NCT00777023|540541304|FG000|Overall Study|Missing data|1|||
149839164|NCT00777023|540541305|FG001|Overall Study|Missing data|1|||
149839165|NCT00777023|540541306|FG002|Overall Study|Missing data|0|||
149839166|NCT00777023|540541304|FG000|Overall Study|Reasons not specified|4|||
149839167|NCT00777023|540541305|FG001|Overall Study|Reasons not specified|4|||
149839168|NCT00777023|540541306|FG002|Overall Study|Reasons not specified|2|||
149952230|NCT01913353|540956811|FG000|Overall Study|Withdrawal by Subject|20|||
149952231|NCT01913353|540956812|FG001|Overall Study|Withdrawal by Subject|6|||
149952232|NCT01913353|540956811|FG000|Overall Study|multiple reasons|10|||
149952233|NCT01913353|540956812|FG001|Overall Study|multiple reasons|7|||
149952234|NCT00385840|540956813|FG000|Overall Study|Adverse Event|1|||
149839169|NCT00777023|540541304|FG000|Overall Study|Last dose date unknown|3|||
149839170|NCT00777023|540541305|FG001|Overall Study|Last dose date unknown|3|||
149839171|NCT00777023|540541306|FG002|Overall Study|Last dose date unknown|1|||
149952235|NCT00385840|540956814|FG001|Overall Study|Adverse Event|1|||
149952236|NCT00385840|540956813|FG000|Overall Study|Lost to Follow-up|3|||
149952237|NCT00385840|540956814|FG001|Overall Study|Lost to Follow-up|13|||
149952238|NCT04017962|540956815|FG000|Overall Study|Death|2|||
149952239|NCT04017962|540956816|FG001|Overall Study|Death|0|||
149839172|NCT02659150|540541307|FG000|Subject Enrollment|Physician Decision|3|||
149839173|NCT02659150|540541307|FG000|Subject Enrollment|Withdrawal by Subject|2|||
149952240|NCT04017962|540956815|FG000|Overall Study|Lost to Follow-up|2|||
149952241|NCT04017962|540956816|FG001|Overall Study|Lost to Follow-up|0|||
149952242|NCT04017962|540956815|FG000|Overall Study|Physician Decision|1|||
149952243|NCT04017962|540956816|FG001|Overall Study|Physician Decision|0|||
149952244|NCT04017962|540956815|FG000|Overall Study|Discontinued LTV|5|||
149952245|NCT04017962|540956816|FG001|Overall Study|Discontinued LTV|0|||
149952246|NCT00700635|540956817|FG000|Overall Study|Adverse Event|1|||
149952247|NCT00700635|540956818|FG001|Overall Study|Adverse Event|0|||
149952248|NCT00700635|540956819|FG002|Overall Study|Adverse Event|0|||
149952249|NCT00700635|540956817|FG000|Overall Study|Lost to Follow-up|1|||
149952250|NCT00700635|540956818|FG001|Overall Study|Lost to Follow-up|3|||
149952251|NCT00700635|540956819|FG002|Overall Study|Lost to Follow-up|0|||
149952252|NCT00700635|540956817|FG000|Overall Study|Protocol Violation|2|||
149952253|NCT00700635|540956818|FG001|Overall Study|Protocol Violation|2|||
149952254|NCT00700635|540956819|FG002|Overall Study|Protocol Violation|0|||
149952255|NCT00700635|540956817|FG000|Overall Study|Withdrawal by Subject|7|||
149952256|NCT00700635|540956818|FG001|Overall Study|Withdrawal by Subject|3|||
149952257|NCT00700635|540956819|FG002|Overall Study|Withdrawal by Subject|1|||
149952258|NCT03580928|540956822|FG000|Overall Study|Death|0|||
149952259|NCT03580928|540956823|FG001|Overall Study|Death|3|||
149952260|NCT03580928|540956822|FG000|Overall Study|Withdrawal by Subject|2|||
149952261|NCT03580928|540956823|FG001|Overall Study|Withdrawal by Subject|1|||
149952262|NCT03580928|540956822|FG000|Overall Study|Lost to Follow-up|2|||
149952263|NCT03580928|540956823|FG001|Overall Study|Lost to Follow-up|0|||
149952264|NCT03580928|540956822|FG000|Overall Study|Progressive Disease|0|||
149952265|NCT03580928|540956823|FG001|Overall Study|Progressive Disease|1|||
149952266|NCT03807843|540957766|FG000|Overall Study|Lost to Follow-up|1|||
149952267|NCT03807843|540957767|FG001|Overall Study|Lost to Follow-up|0|||
149952268|NCT01312129|540957768|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
149952269|NCT01312129|540957769|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
149952270|NCT00924651|540957772|FG000|Overall Study|Chemo started too soon|2|||
149952271|NCT00924651|540957773|FG001|Overall Study|Chemo started too soon|3|||
149952272|NCT00924651|540957772|FG000|Overall Study|No Reason|3|||
149952273|NCT00924651|540957773|FG001|Overall Study|No Reason|7|||
149952274|NCT00924651|540957772|FG000|Overall Study|Overwhelmed|6|||
150172062|NCT00241644|541765878|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
150172063|NCT00241644|541765879|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
150172064|NCT00241644|541765880|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
149952275|NCT00924651|540957773|FG001|Overall Study|Overwhelmed|6|||
149952276|NCT00924651|540957772|FG000|Overall Study|Noncompliant|1|||
149952277|NCT00924651|540957773|FG001|Overall Study|Noncompliant|4|||
150172065|NCT00241644|541765877|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
150172066|NCT00241644|541765878|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
150172067|NCT00241644|541765879|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
150172068|NCT00241644|541765880|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
149952278|NCT00924651|540957772|FG000|Overall Study|Medical|1|||
149952279|NCT00924651|540957773|FG001|Overall Study|Medical|3|||
149952280|NCT00924651|540957772|FG000|Overall Study|Changed Mind|10|||
149952281|NCT00924651|540957773|FG001|Overall Study|Changed Mind|1|||
149952282|NCT00924651|540957772|FG000|Overall Study|Incomplete Form|2|||
149952283|NCT00924651|540957773|FG001|Overall Study|Incomplete Form|1|||
149952284|NCT02506036|540957775|FG000|First Intervention (4-6 Weeks)|Death|1|||
150282769|NCT01210690|542172011|FG000|Overall Study|Lack of Efficacy|12|||
150282770|NCT01210690|542172011|FG000|Overall Study|Lost to Follow-up|3|||
150282771|NCT01210690|542172011|FG000|Overall Study|Disease Remission|1|||
150282772|NCT01210690|542172011|FG000|Overall Study|Withdrawal by Subject|1|||
150282773|NCT01210690|542172011|FG000|Overall Study|Patient refused to swallow|1|||
150282774|NCT01210690|542172011|FG000|Overall Study|Patient could not take glucose|1|||
150282775|NCT00495820|542172012|FG000|Overall Study|Adverse Event|1|||
150282776|NCT00495820|542172013|FG001|Overall Study|Adverse Event|1|||
150282777|NCT00470054|542172014|FG000|Overall Study|Ineligible|1|||
150282778|NCT00528021|542172017|FG000|Overall Study|Lack of Efficacy|17|||
150282779|NCT00528021|542172018|FG001|Overall Study|Lack of Efficacy|13|||
150282780|NCT00528021|542172019|FG002|Overall Study|Lack of Efficacy|7|||
150282781|NCT00528021|542172020|FG003|Overall Study|Lack of Efficacy|9|||
150282782|NCT01246583|542172021|FG000|Overall Study|Lost to Follow-up|0|||
150282783|NCT01246583|542172022|FG001|Overall Study|Lost to Follow-up|0|||
150282784|NCT01246583|542172023|FG002|Overall Study|Lost to Follow-up|0|||
150282785|NCT01246583|542172024|FG003|Overall Study|Lost to Follow-up|1|||
150282786|NCT01246583|542172021|FG000|Overall Study|Protocol Violation|0|||
150282787|NCT01246583|542172022|FG001|Overall Study|Protocol Violation|0|||
150282788|NCT01246583|542172023|FG002|Overall Study|Protocol Violation|1|||
150282789|NCT01246583|542172024|FG003|Overall Study|Protocol Violation|0|||
150282790|NCT01246583|542172021|FG000|Overall Study|Withdrawal by Subject|1|||
150282791|NCT01246583|542172022|FG001|Overall Study|Withdrawal by Subject|0|||
150282792|NCT01246583|542172023|FG002|Overall Study|Withdrawal by Subject|0|||
150282793|NCT01246583|542172024|FG003|Overall Study|Withdrawal by Subject|0|||
150282794|NCT01423851|542172025|FG000|Whole Study|Disease progression|2|||
150282795|NCT01423851|542172026|FG001|Whole Study|Disease progression|1|||
150282796|NCT01423851|542172027|FG002|Whole Study|Disease progression|1|||
150282797|NCT01423851|542172028|FG003|Whole Study|Disease progression|4|||
150282798|NCT01423851|542172029|FG004|Whole Study|Disease progression|1|||
150282799|NCT01423851|542172030|FG005|Whole Study|Disease progression|3|||
150282800|NCT01423851|542172031|FG006|Whole Study|Disease progression|1|||
150282801|NCT01423851|542172032|FG007|Whole Study|Disease progression|4|||
150282802|NCT01423851|542172033|FG008|Whole Study|Disease progression|0|||
150282803|NCT01423851|542172034|FG009|Whole Study|Disease progression|2|||
150282804|NCT01423851|542172035|FG010|Whole Study|Disease progression|10|||
150282805|NCT01423851|542172025|FG000|Whole Study|Physician Decision|0|||
150282806|NCT01423851|542172026|FG001|Whole Study|Physician Decision|1|||
150282807|NCT01423851|542172027|FG002|Whole Study|Physician Decision|2|||
150282808|NCT01423851|542172028|FG003|Whole Study|Physician Decision|0|||
150282809|NCT01423851|542172029|FG004|Whole Study|Physician Decision|2|||
150282810|NCT01423851|542172030|FG005|Whole Study|Physician Decision|0|||
150282811|NCT01423851|542172031|FG006|Whole Study|Physician Decision|2|||
150282812|NCT01423851|542172032|FG007|Whole Study|Physician Decision|1|||
150282813|NCT01423851|542172033|FG008|Whole Study|Physician Decision|3|||
150282814|NCT01423851|542172034|FG009|Whole Study|Physician Decision|4|||
150282815|NCT01423851|542172035|FG010|Whole Study|Physician Decision|12|||
150282816|NCT01423851|542172025|FG000|Whole Study|Withdrawal by Subject|1|||
150282817|NCT01423851|542172026|FG001|Whole Study|Withdrawal by Subject|1|||
150282818|NCT01423851|542172027|FG002|Whole Study|Withdrawal by Subject|0|||
150282819|NCT01423851|542172028|FG003|Whole Study|Withdrawal by Subject|0|||
150282820|NCT01423851|542172029|FG004|Whole Study|Withdrawal by Subject|0|||
150282821|NCT01423851|542172030|FG005|Whole Study|Withdrawal by Subject|0|||
150282822|NCT01423851|542172031|FG006|Whole Study|Withdrawal by Subject|0|||
150282823|NCT01423851|542172032|FG007|Whole Study|Withdrawal by Subject|0|||
150282824|NCT01423851|542172033|FG008|Whole Study|Withdrawal by Subject|2|||
150282825|NCT01423851|542172034|FG009|Whole Study|Withdrawal by Subject|0|||
150282826|NCT01423851|542172035|FG010|Whole Study|Withdrawal by Subject|4|||
150282827|NCT01423851|542172025|FG000|Whole Study|Adverse Event|0|||
150282828|NCT01423851|542172026|FG001|Whole Study|Adverse Event|0|||
150282829|NCT01423851|542172027|FG002|Whole Study|Adverse Event|0|||
150282830|NCT01423851|542172028|FG003|Whole Study|Adverse Event|2|||
150282831|NCT01423851|542172029|FG004|Whole Study|Adverse Event|0|||
150282832|NCT01423851|542172030|FG005|Whole Study|Adverse Event|0|||
150282833|NCT01423851|542172031|FG006|Whole Study|Adverse Event|0|||
150282834|NCT01423851|542172032|FG007|Whole Study|Adverse Event|3|||
150282835|NCT01423851|542172033|FG008|Whole Study|Adverse Event|3|||
150282836|NCT01423851|542172034|FG009|Whole Study|Adverse Event|2|||
150282837|NCT01423851|542172035|FG010|Whole Study|Adverse Event|3|||
150282838|NCT02004262|542173296|FG000|Overall Study|Death|67|||
150282839|NCT02004262|542173297|FG001|Overall Study|Death|64|||
150282840|NCT02004262|542173298|FG002|Overall Study|Death|66|||
150282841|NCT02004262|542173299|FG003|Overall Study|Death|28|||
150282842|NCT02004262|542173300|FG004|Overall Study|Death|29|||
150282843|NCT02004262|542173301|FG005|Overall Study|Death|22|||
150282844|NCT02004262|542173296|FG000|Overall Study|Withdrawal by Subject|1|||
150282845|NCT02004262|542173297|FG001|Overall Study|Withdrawal by Subject|0|||
150282846|NCT02004262|542173298|FG002|Overall Study|Withdrawal by Subject|4|||
150282847|NCT02004262|542173299|FG003|Overall Study|Withdrawal by Subject|0|||
150282848|NCT02004262|542173300|FG004|Overall Study|Withdrawal by Subject|1|||
150282849|NCT02004262|542173301|FG005|Overall Study|Withdrawal by Subject|3|||
150282850|NCT02004262|542173296|FG000|Overall Study|Lost to Follow-up|1|||
149839174|NCT02659150|540541307|FG000|Baseline Imaging|Withdrawal by Subject|1|||
149839175|NCT02659150|540541307|FG000|Baseline Imaging|Physician Decision|1|||
149839176|NCT02659150|540541307|FG000|Study Drug Dosing|Adverse Event|1|||
149839177|NCT01200810|540541313|FG000|Overall Study|Physician Decision|1|||
149839178|NCT01200810|540541314|FG001|Overall Study|Physician Decision|0|||
149839179|NCT01200810|540541313|FG000|Overall Study|Withdrawal by Subject|1|||
149839180|NCT01200810|540541314|FG001|Overall Study|Withdrawal by Subject|2|||
149839181|NCT01200810|540541313|FG000|Overall Study|Sponsor stopped making study drug|3|||
149839182|NCT01200810|540541314|FG001|Overall Study|Sponsor stopped making study drug|3|||
149839183|NCT00904215|540541316|FG000|Overall Study|Adverse Event|25|||
149839184|NCT00904215|540541316|FG000|Overall Study|Protocol Violation|10|||
149839185|NCT00904215|540541316|FG000|Overall Study|Lost to Follow-up|63|||
149839186|NCT00904215|540541316|FG000|Overall Study|Withdrawal by Subject|9|||
149839187|NCT00904215|540541316|FG000|Overall Study|Other|28|||
149839188|NCT00640562|540541317|FG000|Overall Study|Adverse Event|8|||
149839189|NCT00640562|540541318|FG001|Overall Study|Adverse Event|5|||
149839190|NCT00640562|540541317|FG000|Overall Study|Lack of Efficacy|1|||
150035105|NCT01709721|541268889|FG000|Open Label Phase|Other, Specify in text field in database|0|||
150035106|NCT01709721|541268890|FG001|Open Label Phase|Other, Specify in text field in database|0|||
150035107|NCT01709721|541268891|FG002|Open Label Phase|Other, Specify in text field in database|14|||
150035108|NCT01709721|541268889|FG000|Randomized Phase|Adverse Event|0|||
150035109|NCT01709721|541268890|FG001|Randomized Phase|Adverse Event|1|||
150035110|NCT01709721|541268891|FG002|Randomized Phase|Adverse Event|0|||
150035111|NCT01709721|541268889|FG000|Randomized Phase|Lost to Follow-up|1|||
150035112|NCT01709721|541268890|FG001|Randomized Phase|Lost to Follow-up|0|||
150035113|NCT01709721|541268891|FG002|Randomized Phase|Lost to Follow-up|0|||
150035114|NCT01709721|541268889|FG000|Randomized Phase|Inadequate Pain Control|1|||
150035115|NCT01709721|541268890|FG001|Randomized Phase|Inadequate Pain Control|2|||
150035116|NCT01709721|541268891|FG002|Randomized Phase|Inadequate Pain Control|0|||
150035117|NCT01709721|541268889|FG000|Randomized Phase|Other, Specify text field in database|1|||
150035118|NCT01709721|541268890|FG001|Randomized Phase|Other, Specify text field in database|3|||
150035119|NCT01709721|541268891|FG002|Randomized Phase|Other, Specify text field in database|0|||
150035120|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
150035121|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
150035122|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
150035123|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
150035124|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
150035125|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
150035126|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
150035127|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
150035128|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
150035129|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
150035130|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
150035131|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
150035132|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
150035133|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
150035134|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
150035135|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Other|1|||
150035136|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Other|5|||
150035137|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Other|0|||
150035138|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Other|2|||
150035139|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Other|3|||
150035140|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
150035141|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
150282851|NCT02004262|542173297|FG001|Overall Study|Lost to Follow-up|1|||
150282852|NCT02004262|542173298|FG002|Overall Study|Lost to Follow-up|0|||
150282853|NCT02004262|542173299|FG003|Overall Study|Lost to Follow-up|0|||
150282854|NCT02004262|542173300|FG004|Overall Study|Lost to Follow-up|0|||
149839191|NCT00640562|540541318|FG001|Overall Study|Lack of Efficacy|4|||
149839192|NCT00640562|540541317|FG000|Overall Study|Protocol Violation|2|||
149839193|NCT00640562|540541318|FG001|Overall Study|Protocol Violation|4|||
149839194|NCT00640562|540541317|FG000|Overall Study|Withdrawal by Subject|6|||
149839195|NCT00640562|540541318|FG001|Overall Study|Withdrawal by Subject|10|||
149839196|NCT00640562|540541317|FG000|Overall Study|Known risperidone intolerance|0|||
149839197|NCT00640562|540541318|FG001|Overall Study|Known risperidone intolerance|1|||
150035142|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
150035143|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
150035144|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
150035145|NCT02006472|541268892|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
150035146|NCT02006472|541268893|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
150035147|NCT02006472|541268894|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
150035148|NCT02006472|541268895|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
149839198|NCT00640562|540541317|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
149839199|NCT00640562|540541318|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
149839200|NCT00640562|540541317|FG000|Overall Study|Low study drug dose|0|||
149839201|NCT00640562|540541318|FG001|Overall Study|Low study drug dose|1|||
149839202|NCT00640562|540541317|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
149839203|NCT00640562|540541318|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
149839204|NCT00448591|540541319|FG000|Overall Study|Withdrawal by Subject|178|||
149839205|NCT00448591|540541319|FG000|Overall Study|Progressive Disease|1382|||
150282855|NCT02004262|542173301|FG005|Overall Study|Lost to Follow-up|0|||
150282856|NCT02004262|542173296|FG000|Overall Study|Study Terminated by Sponsor|4|||
149839206|NCT00448591|540541319|FG000|Overall Study|Adverse Event|382|||
149839207|NCT00448591|540541319|FG000|Overall Study|Protocol Violation|41|||
150282857|NCT02004262|542173297|FG001|Overall Study|Study Terminated by Sponsor|3|||
150282858|NCT02004262|542173298|FG002|Overall Study|Study Terminated by Sponsor|2|||
150282859|NCT02004262|542173299|FG003|Overall Study|Study Terminated by Sponsor|1|||
150282860|NCT02004262|542173300|FG004|Overall Study|Study Terminated by Sponsor|1|||
150282861|NCT02004262|542173301|FG005|Overall Study|Study Terminated by Sponsor|5|||
150282862|NCT01146873|542173302|FG000|Overall Study|Transfer out|0|||
150282863|NCT01146873|542173303|FG001|Overall Study|Transfer out|6|||
150282864|NCT03200366|542173306|FG000|Patient Navigation Intervention Given|Death|0|||
150282865|NCT03200366|542173307|FG001|Patient Navigation Intervention Given|Death|2|||
150282866|NCT03200366|542173308|FG002|Patient Navigation Intervention Given|Death|0|||
150282867|NCT03200366|542173306|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
150282868|NCT03200366|542173307|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
150282869|NCT03200366|542173308|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
150282870|NCT03200366|542173306|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
150282871|NCT03200366|542173307|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
150282872|NCT03200366|542173308|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
150282873|NCT03200366|542173306|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
150282874|NCT03200366|542173307|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
150282875|NCT03200366|542173308|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
150282876|NCT03200366|542173306|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
150282877|NCT03200366|542173307|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
150282878|NCT03200366|542173308|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
150282879|NCT03200366|542173306|FG000|6 Month Post-Baseline Interview|Death|1|||
150282880|NCT03200366|542173307|FG001|6 Month Post-Baseline Interview|Death|1|||
150282881|NCT03200366|542173308|FG002|6 Month Post-Baseline Interview|Death|1|||
150282882|NCT03200366|542173306|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
150282883|NCT03200366|542173307|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
150282884|NCT03200366|542173308|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
150282885|NCT03200366|542173306|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
150282886|NCT03200366|542173307|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
150282887|NCT03200366|542173308|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
150282888|NCT03200366|542173306|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
150282889|NCT03200366|542173307|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
150282890|NCT03200366|542173308|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
150282891|NCT03200366|542173306|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
150282892|NCT03200366|542173307|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
150282893|NCT03200366|542173308|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
150282894|NCT03200366|542173306|FG000|9 Month Post-Baseline Interview|Death|1|||
150282895|NCT03200366|542173307|FG001|9 Month Post-Baseline Interview|Death|1|||
150282896|NCT03200366|542173308|FG002|9 Month Post-Baseline Interview|Death|1|||
150282897|NCT03200366|542173306|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
150282898|NCT03200366|542173307|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
150282899|NCT03200366|542173308|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
150282900|NCT03200366|542173306|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
150282901|NCT03200366|542173307|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
150282902|NCT03200366|542173308|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
150282903|NCT03200366|542173306|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
150282904|NCT03200366|542173307|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
149839208|NCT00448591|540541319|FG000|Overall Study|Lost to Follow-up|19|||
149839209|NCT00448591|540541319|FG000|Overall Study|Treatment Regimen Completed|70|||
149839210|NCT00448591|540541319|FG000|Overall Study|Other|154|||
149839211|NCT00448591|540541319|FG000|Overall Study|Termination of Study|70|||
149839212|NCT00003659|540541320|FG000|Overall Study|Withdrawal by Subject|3|||
149839213|NCT03925532|540541321|FG000|Overall Study|Lost to Follow-up|1|||
149839214|NCT05446870|540541322|FG000|Overall Study|Death|6|||
150282905|NCT03200366|542173308|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
150282906|NCT00405067|542173309|FG000|Overall Study|Adverse Event|4|||
150282907|NCT00405067|542173310|FG001|Overall Study|Adverse Event|9|||
150282908|NCT00405067|542173311|FG002|Overall Study|Adverse Event|4|||
149839215|NCT05446870|540541323|FG001|Overall Study|Death|5|||
150282909|NCT00405067|542173309|FG000|Overall Study|Lost to Follow-up|0|||
150282910|NCT00405067|542173310|FG001|Overall Study|Lost to Follow-up|0|||
150282911|NCT00405067|542173311|FG002|Overall Study|Lost to Follow-up|1|||
149839216|NCT05446870|540541322|FG000|Overall Study|Lost to Follow-up|0|||
149839217|NCT05446870|540541323|FG001|Overall Study|Lost to Follow-up|1|||
149839218|NCT05446870|540541322|FG000|Overall Study|Physician Decision|52|||
149839219|NCT05446870|540541323|FG001|Overall Study|Physician Decision|53|||
149839220|NCT05446870|540541322|FG000|Overall Study|Withdrawal by Subject|3|||
150282912|NCT02055820|542173313|FG000|Phase I: Dose-Finding|Death|1|||
150282913|NCT02055820|542173314|FG001|Phase I: Dose-Finding|Death|0|||
149839221|NCT05446870|540541323|FG001|Overall Study|Withdrawal by Subject|3|||
149839222|NCT02689505|540541325|FG000|Overall Study|Progressive disease|2|||
149839223|NCT02689505|540541326|FG001|Overall Study|Progressive disease|2|||
149839224|NCT02689505|540541327|FG002|Overall Study|Progressive disease|3|||
149839225|NCT02689505|540541328|FG003|Overall Study|Progressive disease|9|||
149839226|NCT02689505|540541329|FG004|Overall Study|Progressive disease|1|||
150282914|NCT02055820|542173315|FG002|Phase I: Dose-Finding|Death|1|||
150282915|NCT02055820|542173316|FG003|Phase I: Dose-Finding|Death|2|||
149839227|NCT02689505|540541325|FG000|Overall Study|Dose Limiting Toxicity|0|||
149839228|NCT02689505|540541326|FG001|Overall Study|Dose Limiting Toxicity|1|||
149839229|NCT02689505|540541327|FG002|Overall Study|Dose Limiting Toxicity|0|||
149839230|NCT02689505|540541328|FG003|Overall Study|Dose Limiting Toxicity|0|||
150282916|NCT02055820|542173317|FG004|Phase I: Dose-Finding|Death|0|||
150282917|NCT02055820|542173318|FG005|Phase I: Dose-Finding|Death|1|||
150282918|NCT02055820|542173319|FG006|Phase I: Dose-Finding|Death|1|||
150282919|NCT02055820|542173320|FG007|Phase I: Dose-Finding|Death|0|||
150282920|NCT02055820|542173321|FG008|Phase I: Dose-Finding|Death|0|||
150282921|NCT02055820|542173322|FG009|Phase I: Dose-Finding|Death|0|||
150282922|NCT02055820|542173313|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282923|NCT02055820|542173314|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149839231|NCT02689505|540541329|FG004|Overall Study|Dose Limiting Toxicity|2|||
150035149|NCT02006472|541268896|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
150282924|NCT02055820|542173315|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282925|NCT02055820|542173316|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282926|NCT02055820|542173317|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282927|NCT02055820|542173318|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
150282928|NCT02055820|542173319|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282929|NCT02055820|542173320|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282930|NCT02055820|542173321|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282931|NCT02055820|542173322|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
150282932|NCT02055820|542173313|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282933|NCT02055820|542173314|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282934|NCT02055820|542173315|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282935|NCT02055820|542173316|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
150282936|NCT02055820|542173317|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282937|NCT02055820|542173318|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282938|NCT02055820|542173319|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
150282939|NCT02055820|542173320|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282940|NCT02055820|542173321|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282941|NCT02055820|542173322|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
150282942|NCT02055820|542173313|FG000|Phase II: Expansion|Death|0|||
150282943|NCT02055820|542173314|FG001|Phase II: Expansion|Death|0|||
150282944|NCT02055820|542173315|FG002|Phase II: Expansion|Death|0|||
150282945|NCT02055820|542173316|FG003|Phase II: Expansion|Death|0|||
150282946|NCT02055820|542173317|FG004|Phase II: Expansion|Death|33|||
150282947|NCT02055820|542173318|FG005|Phase II: Expansion|Death|0|||
150282948|NCT02055820|542173319|FG006|Phase II: Expansion|Death|0|||
150282949|NCT02055820|542173320|FG007|Phase II: Expansion|Death|0|||
150282950|NCT02055820|542173321|FG008|Phase II: Expansion|Death|0|||
150282951|NCT02055820|542173322|FG009|Phase II: Expansion|Death|0|||
150282952|NCT02055820|542173313|FG000|Phase II: Expansion|Lost to Follow-up|0|||
150282953|NCT02055820|542173314|FG001|Phase II: Expansion|Lost to Follow-up|0|||
150282954|NCT02055820|542173315|FG002|Phase II: Expansion|Lost to Follow-up|0|||
150282955|NCT02055820|542173316|FG003|Phase II: Expansion|Lost to Follow-up|0|||
150282956|NCT02055820|542173317|FG004|Phase II: Expansion|Lost to Follow-up|4|||
150282957|NCT02055820|542173318|FG005|Phase II: Expansion|Lost to Follow-up|0|||
150282958|NCT02055820|542173319|FG006|Phase II: Expansion|Lost to Follow-up|0|||
150282959|NCT02055820|542173320|FG007|Phase II: Expansion|Lost to Follow-up|0|||
150282960|NCT02055820|542173321|FG008|Phase II: Expansion|Lost to Follow-up|0|||
150282961|NCT02055820|542173322|FG009|Phase II: Expansion|Lost to Follow-up|0|||
150282962|NCT02055820|542173313|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
150282963|NCT02055820|542173314|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
150282964|NCT02055820|542173315|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
150282965|NCT02055820|542173316|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
150282966|NCT02055820|542173317|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
149839232|NCT02689505|540541325|FG000|Overall Study|Other AE or clinical progression|0|||
149839233|NCT02689505|540541326|FG001|Overall Study|Other AE or clinical progression|2|||
150282967|NCT02055820|542173318|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
150282968|NCT02055820|542173319|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
150282969|NCT02055820|542173320|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
150282970|NCT02055820|542173321|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
150282971|NCT02055820|542173322|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
150282972|NCT00930761|542173325|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
150282973|NCT00930761|542173326|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
150282974|NCT00930761|542173325|FG000|Overall Study|less than 3 music therapy sessions|0|||
150282975|NCT00930761|542173326|FG001|Overall Study|less than 3 music therapy sessions|3|||
150282976|NCT00631020|542173327|FG000|Overall Study|Lost to Follow-up|7|||
150282977|NCT00631020|542173327|FG000|Overall Study|Incarcerated|1|||
150282978|NCT03571646|542173329|FG000|Overall Study|Adverse Event|1|||
150282979|NCT03571646|542173330|FG001|Overall Study|Adverse Event|0|||
150282980|NCT03571646|542173329|FG000|Overall Study|Withdrawal by Subject|1|||
150282981|NCT03571646|542173330|FG001|Overall Study|Withdrawal by Subject|1|||
150282982|NCT01074190|542173331|FG000|Overall Study|Emergency Cesarean Delivery|1|||
150282983|NCT01074190|542173332|FG001|Overall Study|Emergency Cesarean Delivery|2|||
150282984|NCT01074190|542173333|FG002|Overall Study|Emergency Cesarean Delivery|1|||
150282985|NCT01074190|542173331|FG000|Overall Study|Protocol Violation|2|||
150282986|NCT01074190|542173332|FG001|Overall Study|Protocol Violation|1|||
150282987|NCT01074190|542173333|FG002|Overall Study|Protocol Violation|0|||
150282988|NCT01074190|542173331|FG000|Overall Study|Delivered in under 90 minutes|0|||
150282989|NCT01074190|542173332|FG001|Overall Study|Delivered in under 90 minutes|2|||
150282990|NCT01074190|542173333|FG002|Overall Study|Delivered in under 90 minutes|1|||
150282991|NCT01074190|542173331|FG000|Overall Study|Subject withdrew consent|1|||
150282992|NCT01074190|542173332|FG001|Overall Study|Subject withdrew consent|1|||
150282993|NCT01074190|542173333|FG002|Overall Study|Subject withdrew consent|1|||
150282994|NCT00264875|542173334|FG000|Overall Study|Adverse Event|6|||
150282995|NCT00264875|542173334|FG000|Overall Study|Lost to Follow-up|6|||
150282996|NCT00264875|542173334|FG000|Overall Study|Protocol Violation|11|||
150282997|NCT00264875|542173334|FG000|Overall Study|Withdrawal by Subject|7|||
150282998|NCT01500278|542173335|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
150282999|NCT01500278|542173336|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
150283000|NCT01500278|542173335|FG000|Week 0 - Week 12|Protocol Violation|10|||
150283001|NCT01500278|542173336|FG001|Week 0 - Week 12|Protocol Violation|16|||
150283002|NCT01500278|542173335|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
150283003|NCT01500278|542173336|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
150283004|NCT01500278|542173335|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
150283005|NCT01500278|542173336|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
150283006|NCT01500278|542173335|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
150283007|NCT01500278|542173336|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
150283008|NCT01500278|542173335|FG000|Week 0 - Week 12|Patient decision|1|||
150283009|NCT01500278|542173336|FG001|Week 0 - Week 12|Patient decision|0|||
150283010|NCT01500278|542173335|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
150283011|NCT01500278|542173336|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
150283012|NCT01500278|542173335|FG000|Week 0 - Week 12|Investigator decision|1|||
150283013|NCT01500278|542173336|FG001|Week 0 - Week 12|Investigator decision|0|||
150283014|NCT01500278|542173335|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
150283015|NCT01500278|542173336|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
150283016|NCT01500278|542173335|FG000|Week 0 - Week 12|Sponsor decision|1|||
150283017|NCT01500278|542173336|FG001|Week 0 - Week 12|Sponsor decision|0|||
150283018|NCT01500278|542173335|FG000|Week 0 - Week 12|Personal reason|0|||
150283019|NCT01500278|542173336|FG001|Week 0 - Week 12|Personal reason|1|||
150283020|NCT01500278|542173335|FG000|Week 0 - Week 12|Other serious disease|0|||
150283021|NCT01500278|542173336|FG001|Week 0 - Week 12|Other serious disease|1|||
149839234|NCT02689505|540541327|FG002|Overall Study|Other AE or clinical progression|0|||
149839235|NCT02689505|540541328|FG003|Overall Study|Other AE or clinical progression|2|||
149839236|NCT02689505|540541329|FG004|Overall Study|Other AE or clinical progression|0|||
149839237|NCT04405570|540541333|FG000|Overall Study|Adverse Event|0|||
149839238|NCT04405570|540541334|FG001|Overall Study|Adverse Event|1|||
149839239|NCT04405570|540541335|FG002|Overall Study|Adverse Event|1|||
149839240|NCT04405570|540541336|FG003|Overall Study|Adverse Event|1|||
149839241|NCT04405570|540541333|FG000|Overall Study|Lost to Follow-up|0|||
149839242|NCT04405570|540541334|FG001|Overall Study|Lost to Follow-up|1|||
149839243|NCT04405570|540541335|FG002|Overall Study|Lost to Follow-up|0|||
149839244|NCT04405570|540541336|FG003|Overall Study|Lost to Follow-up|0|||
149839245|NCT04405570|540541333|FG000|Overall Study|Physician Decision|0|||
149839246|NCT04405570|540541334|FG001|Overall Study|Physician Decision|0|||
149839247|NCT04405570|540541335|FG002|Overall Study|Physician Decision|1|||
149839248|NCT04405570|540541336|FG003|Overall Study|Physician Decision|0|||
149839249|NCT04405570|540541333|FG000|Overall Study|Withdrawal by Subject|0|||
150283022|NCT01500278|542173335|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
150283023|NCT01500278|542173336|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
150283024|NCT01500278|542173335|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
150283025|NCT01500278|542173336|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
150283026|NCT01500278|542173335|FG000|Week 13 - Week 104|Protocol Violation|6|||
150283027|NCT01500278|542173336|FG001|Week 13 - Week 104|Protocol Violation|6|||
150283028|NCT01500278|542173335|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
150283029|NCT01500278|542173336|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
150283030|NCT01500278|542173335|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
150283031|NCT01500278|542173336|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
150283032|NCT01500278|542173335|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
150283033|NCT01500278|542173336|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
150283034|NCT01500278|542173335|FG000|Week 13 - Week 104|Non/bad compliance|7|||
150283035|NCT01500278|542173336|FG001|Week 13 - Week 104|Non/bad compliance|5|||
150283036|NCT01500278|542173335|FG000|Week 13 - Week 104|Recurrent infections|1|||
150283037|NCT01500278|542173336|FG001|Week 13 - Week 104|Recurrent infections|0|||
150283038|NCT01500278|542173335|FG000|Week 13 - Week 104|False positive test|1|||
150283039|NCT01500278|542173336|FG001|Week 13 - Week 104|False positive test|2|||
150283040|NCT01500278|542173335|FG000|Week 13 - Week 104|Sponsor request|4|||
150283041|NCT01500278|542173336|FG001|Week 13 - Week 104|Sponsor request|0|||
150283042|NCT01500278|542173335|FG000|Week 13 - Week 104|Withdrawn in error|1|||
150283043|NCT01500278|542173336|FG001|Week 13 - Week 104|Withdrawn in error|0|||
150283044|NCT01500278|542173335|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
150283045|NCT01500278|542173336|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
150283046|NCT01500278|542173335|FG000|Week 13 - Week 104|Protocol deviation|1|||
150283047|NCT01500278|542173336|FG001|Week 13 - Week 104|Protocol deviation|0|||
150283048|NCT01500278|542173335|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
150283049|NCT01500278|542173336|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
150283050|NCT01500278|542173335|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
150283051|NCT01500278|542173336|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
150283052|NCT01500278|542173335|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
150283053|NCT01500278|542173336|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
150283054|NCT01500278|542173335|FG000|Week 13 - Week 104|Relocation|0|||
150283055|NCT01500278|542173336|FG001|Week 13 - Week 104|Relocation|1|||
150283056|NCT01500278|542173335|FG000|Week 13 - Week 104|Sponsor decision|0|||
150283057|NCT01500278|542173336|FG001|Week 13 - Week 104|Sponsor decision|2|||
150283058|NCT01500278|542173335|FG000|Week 13 - Week 104|Medical monitor decision|0|||
150283059|NCT01500278|542173336|FG001|Week 13 - Week 104|Medical monitor decision|2|||
150283060|NCT01500278|542173335|FG000|Week 13 - Week 104|Personal reason|0|||
150283061|NCT01500278|542173336|FG001|Week 13 - Week 104|Personal reason|1|||
150283062|NCT01500278|542173335|FG000|Week 13 - Week 104|Not completed|0|||
150283063|NCT01500278|542173336|FG001|Week 13 - Week 104|Not completed|1|||
150283064|NCT01500278|542173335|FG000|Week 13 - Week 104|Death|2|||
150283065|NCT01500278|542173336|FG001|Week 13 - Week 104|Death|4|||
150283066|NCT01500278|542173335|FG000|Week 13 - Week 104|Adverse Event|54|||
150283067|NCT01500278|542173336|FG001|Week 13 - Week 104|Adverse Event|54|||
150283068|NCT00845728|542173339|FG000|Overall Study|Abnormal laboratory value (s)|2|||
150283069|NCT00845728|542173340|FG001|Overall Study|Abnormal laboratory value (s)|2|||
150283070|NCT00845728|542173339|FG000|Overall Study|Patient's inability to use the device|4|||
150283071|NCT00845728|542173340|FG001|Overall Study|Patient's inability to use the device|6|||
149839250|NCT04405570|540541334|FG001|Overall Study|Withdrawal by Subject|1|||
149839251|NCT04405570|540541335|FG002|Overall Study|Withdrawal by Subject|1|||
149839252|NCT04405570|540541336|FG003|Overall Study|Withdrawal by Subject|0|||
149839253|NCT04405570|540541333|FG000|Overall Study|Randomized not dosed|0|||
149839254|NCT04405570|540541334|FG001|Overall Study|Randomized not dosed|2|||
149839255|NCT04405570|540541335|FG002|Overall Study|Randomized not dosed|0|||
149952285|NCT02506036|540957776|FG001|First Intervention (4-6 Weeks)|Death|0|||
149952286|NCT02506036|540957775|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
149952287|NCT02506036|540957776|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
150283072|NCT00845728|542173339|FG000|Overall Study|Abnormal test procedure result (s)|7|||
150283073|NCT00845728|542173340|FG001|Overall Study|Abnormal test procedure result (s)|2|||
150283074|NCT00845728|542173339|FG000|Overall Study|Lost to Follow-up|22|||
150283075|NCT00845728|542173340|FG001|Overall Study|Lost to Follow-up|13|||
150283076|NCT00845728|542173339|FG000|Overall Study|Death|24|||
150283077|NCT00845728|542173340|FG001|Overall Study|Death|26|||
150283078|NCT00845728|542173339|FG000|Overall Study|Administrative Problems|34|||
150283079|NCT00845728|542173340|FG001|Overall Study|Administrative Problems|26|||
150283080|NCT00845728|542173339|FG000|Overall Study|Protocol Violation|36|||
150283081|NCT00845728|542173340|FG001|Overall Study|Protocol Violation|24|||
150283082|NCT00845728|542173339|FG000|Overall Study|Lack of Efficacy|51|||
150283083|NCT00845728|542173340|FG001|Overall Study|Lack of Efficacy|39|||
150283084|NCT00845728|542173339|FG000|Overall Study|Adverse Event|101|||
150283085|NCT00845728|542173340|FG001|Overall Study|Adverse Event|96|||
150283086|NCT00845728|542173339|FG000|Overall Study|Withdrawal by Subject|105|||
150283087|NCT00845728|542173340|FG001|Overall Study|Withdrawal by Subject|108|||
150283088|NCT01157364|542173341|FG000|Overall Study|Other Reasons|1|||
149839256|NCT04405570|540541336|FG003|Overall Study|Randomized not dosed|0|||
149839257|NCT04499963|540541337|FG000|Overall Study|Adverse Event|3|||
149839258|NCT04499963|540541338|FG001|Overall Study|Adverse Event|0|||
149952288|NCT02506036|540957775|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
150283089|NCT01157364|542173342|FG001|Overall Study|Other Reasons|1|||
150283090|NCT01157364|542173343|FG002|Overall Study|Other Reasons|2|||
150283091|NCT01157364|542173344|FG003|Overall Study|Other Reasons|1|||
150283092|NCT01157364|542173345|FG004|Overall Study|Other Reasons|0|||
150283093|NCT01157364|542173346|FG005|Overall Study|Other Reasons|0|||
150283094|NCT01157364|542173341|FG000|Overall Study|Personal Reasons|0|||
150283095|NCT01157364|542173342|FG001|Overall Study|Personal Reasons|2|||
150283096|NCT01157364|542173343|FG002|Overall Study|Personal Reasons|0|||
150283097|NCT01157364|542173344|FG003|Overall Study|Personal Reasons|0|||
150283098|NCT01157364|542173345|FG004|Overall Study|Personal Reasons|1|||
150283099|NCT01157364|542173346|FG005|Overall Study|Personal Reasons|1|||
150283100|NCT01157364|542173341|FG000|Overall Study|Lost to Follow-up|1|||
150283101|NCT01157364|542173342|FG001|Overall Study|Lost to Follow-up|0|||
150283102|NCT01157364|542173343|FG002|Overall Study|Lost to Follow-up|1|||
150283103|NCT01157364|542173344|FG003|Overall Study|Lost to Follow-up|0|||
150283104|NCT01157364|542173345|FG004|Overall Study|Lost to Follow-up|0|||
150283105|NCT01157364|542173346|FG005|Overall Study|Lost to Follow-up|0|||
150283106|NCT01157364|542173341|FG000|Overall Study|Lack of Efficacy|0|||
150283107|NCT01157364|542173342|FG001|Overall Study|Lack of Efficacy|0|||
150283108|NCT01157364|542173343|FG002|Overall Study|Lack of Efficacy|0|||
150283109|NCT01157364|542173344|FG003|Overall Study|Lack of Efficacy|1|||
150283110|NCT01157364|542173345|FG004|Overall Study|Lack of Efficacy|0|||
150283111|NCT01157364|542173346|FG005|Overall Study|Lack of Efficacy|0|||
150283112|NCT01157364|542173341|FG000|Overall Study|Adverse Event|0|||
150283113|NCT01157364|542173342|FG001|Overall Study|Adverse Event|1|||
150283114|NCT01157364|542173343|FG002|Overall Study|Adverse Event|1|||
150283115|NCT01157364|542173344|FG003|Overall Study|Adverse Event|0|||
150283116|NCT01157364|542173345|FG004|Overall Study|Adverse Event|1|||
150283117|NCT01157364|542173346|FG005|Overall Study|Adverse Event|0|||
150283118|NCT01709435|542173347|FG000|Overall Study|Adverse Event|1|||
150283119|NCT01709435|542173348|FG001|Overall Study|Adverse Event|1|||
150283120|NCT01709435|542173349|FG002|Overall Study|Adverse Event|1|||
150283121|NCT01709435|542173350|FG003|Overall Study|Adverse Event|0|||
150283122|NCT01709435|542173351|FG004|Overall Study|Adverse Event|0|||
150283123|NCT01709435|542173352|FG005|Overall Study|Adverse Event|1|||
150283124|NCT01709435|542173347|FG000|Overall Study|Lack of Efficacy|5|||
150283125|NCT01709435|542173348|FG001|Overall Study|Lack of Efficacy|7|||
150283126|NCT01709435|542173349|FG002|Overall Study|Lack of Efficacy|2|||
150283127|NCT01709435|542173350|FG003|Overall Study|Lack of Efficacy|2|||
150283128|NCT01709435|542173351|FG004|Overall Study|Lack of Efficacy|6|||
150283129|NCT01709435|542173352|FG005|Overall Study|Lack of Efficacy|3|||
150283130|NCT01709435|542173347|FG000|Overall Study|Physician Decision|0|||
150035150|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
150035151|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
150035152|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
150035153|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
150035154|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
150035155|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
150035156|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
150283131|NCT01709435|542173348|FG001|Overall Study|Physician Decision|1|||
150283132|NCT01709435|542173349|FG002|Overall Study|Physician Decision|0|||
150283133|NCT01709435|542173350|FG003|Overall Study|Physician Decision|1|||
150283134|NCT01709435|542173351|FG004|Overall Study|Physician Decision|2|||
150283135|NCT01709435|542173352|FG005|Overall Study|Physician Decision|0|||
150283136|NCT01709435|542173347|FG000|Overall Study|Withdrawal by Subject|0|||
150283137|NCT01709435|542173348|FG001|Overall Study|Withdrawal by Subject|0|||
150283138|NCT01709435|542173349|FG002|Overall Study|Withdrawal by Subject|3|||
150283139|NCT01709435|542173350|FG003|Overall Study|Withdrawal by Subject|0|||
150035157|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
150035158|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
150283140|NCT01709435|542173351|FG004|Overall Study|Withdrawal by Subject|2|||
150283141|NCT01709435|542173352|FG005|Overall Study|Withdrawal by Subject|2|||
150283142|NCT01263639|542173353|FG000|Overall Study|Lost to Follow-up|66|||
150283143|NCT01263639|542173354|FG001|Overall Study|Lost to Follow-up|70|||
150283144|NCT01263639|542173353|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
150283145|NCT01263639|542173354|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
150283146|NCT01576549|542173355|FG000|Overall Study|Sponsor Decision|2|||
150283147|NCT04081363|542173358|FG000|Overall Study|Withdrawal by Subject|1|||
150283148|NCT04081363|542173359|FG001|Overall Study|Withdrawal by Subject|0|||
150283149|NCT00586495|542173360|FG000|Treatment Period|Adverse Event|11|||
150283150|NCT00586495|542173360|FG000|Treatment Period|Death|1|||
150283151|NCT00586495|542173360|FG000|Treatment Period|Protocol Violation|1|||
150283152|NCT00586495|542173360|FG000|Treatment Period|Withdrawal by Subject|1|||
150283153|NCT00586495|542173360|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
150035159|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
149839259|NCT04499963|540541337|FG000|Overall Study|Death|3|||
150283154|NCT00586495|542173360|FG000|Treatment Period|Switch to commercial drug|10|||
150283155|NCT00586495|542173360|FG000|Follow-up|Death|40|||
150283156|NCT00586495|542173360|FG000|Follow-up|Lost to Follow-up|1|||
150283157|NCT00586495|542173360|FG000|Follow-up|Withdrawal by Subject|4|||
150283158|NCT00586495|542173360|FG000|Follow-up|Protocol driven decision point|37|||
150283159|NCT00586495|542173360|FG000|Follow-up|Switch to commercial drug|10|||
150283160|NCT01765920|542173363|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
150283161|NCT01765920|542173364|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
150283162|NCT01765920|542173363|FG000|Overall Study|Patient code disclosure|0|||
150283163|NCT01765920|542173364|FG001|Overall Study|Patient code disclosure|1|||
150283164|NCT01081249|542173365|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
150283165|NCT01081249|542173366|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
150283166|NCT02025907|542173367|FG000|Overall Study|Lack of Efficacy|1|||
150283167|NCT02025907|542173368|FG001|Overall Study|Lack of Efficacy|0|||
150283168|NCT02025907|542173367|FG000|Overall Study|Withdrawal by Subject|15|||
150283169|NCT02025907|542173368|FG001|Overall Study|Withdrawal by Subject|8|||
150283170|NCT02025907|542173367|FG000|Overall Study|Protocol Violation|2|||
150283171|NCT02025907|542173368|FG001|Overall Study|Protocol Violation|0|||
150283172|NCT02025907|542173367|FG000|Overall Study|Physician Decision|2|||
150283173|NCT02025907|542173368|FG001|Overall Study|Physician Decision|0|||
150283174|NCT02025907|542173367|FG000|Overall Study|Lost to Follow-up|2|||
150283175|NCT02025907|542173368|FG001|Overall Study|Lost to Follow-up|2|||
150283176|NCT02025907|542173367|FG000|Overall Study|Adverse Event|3|||
150283177|NCT02025907|542173368|FG001|Overall Study|Adverse Event|1|||
150283178|NCT02025907|542173367|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
150283179|NCT02025907|542173368|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
150283180|NCT02411539|542173374|FG000|Overall Study|Lost to Follow-up|2|||
150283181|NCT02411539|542173375|FG001|Overall Study|Lost to Follow-up|0|||
150283182|NCT02411539|542173374|FG000|Overall Study|Confounding medical condition|0|||
150283183|NCT02411539|542173375|FG001|Overall Study|Confounding medical condition|1|||
150283184|NCT03775421|542173378|FG000|Overall Study|Lost to Follow-up|2|||
150283185|NCT03775421|542173378|FG000|Overall Study|Withdrawal by Subject|10|||
150283186|NCT03775421|542173378|FG000|Overall Study|Physician Decision|3|||
150283187|NCT03775421|542173378|FG000|Overall Study|Death|1|||
150283188|NCT03775421|542173378|FG000|Overall Study|Study Terminated by Sponsor|94|||
150283189|NCT02016820|542173379|FG000|Overall Study|Lost to Follow-up|2|||
150283190|NCT02016820|542173380|FG001|Overall Study|Lost to Follow-up|4|||
150283191|NCT00473343|542173381|FG000|Overall Study|Adverse Event|9|||
150283192|NCT00473343|542173381|FG000|Overall Study|Lost to Follow-up|8|||
150283193|NCT00473343|542173381|FG000|Overall Study|Treatment failure|27|||
150283194|NCT00473343|542173381|FG000|Overall Study|Withdrew consent|3|||
150283195|NCT00473343|542173381|FG000|Overall Study|Other un-specified reason|3|||
150283196|NCT02287623|542173387|FG000|Overall Study|Protocol Violation|0|||
150283197|NCT02287623|542173388|FG001|Overall Study|Protocol Violation|1|||
150283198|NCT02700997|542173389|FG000|Overall Study|Did not undergo CT imaging|1|||
150283199|NCT02700997|542173389|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
150283200|NCT03610724|542173394|FG000|Overall Study|Death|17|||
149839260|NCT04499963|540541338|FG001|Overall Study|Death|0|||
149839261|NCT04499963|540541337|FG000|Overall Study|Lack of Efficacy|7|||
149839262|NCT04499963|540541338|FG001|Overall Study|Lack of Efficacy|0|||
149839263|NCT04499963|540541337|FG000|Overall Study|Lost to Follow-up|2|||
150283201|NCT03610724|542173394|FG000|Overall Study|Lost to Follow-up|1|||
150283202|NCT03610724|542173394|FG000|Overall Study|Physician Decision|1|||
150283203|NCT03610724|542173394|FG000|Overall Study|Died prior to infusion|1|||
150283204|NCT00786565|542173395|FG000|Enrollment Prior to Surgery|Site Closed|3|||
150283205|NCT00786565|542173395|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
150283206|NCT00786565|542173395|FG000|Post Surgery|Abnormal macular pucker|1|||
150283207|NCT00786565|542173395|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
150283208|NCT02943564|542173398|FG000|Overall Study|Miscellaneous Reasons|0|||
150283209|NCT02943564|542173399|FG001|Overall Study|Miscellaneous Reasons|0|||
150283210|NCT02943564|542173400|FG002|Overall Study|Miscellaneous Reasons|3|||
150283211|NCT02943564|542173398|FG000|Overall Study|Site terminated by sponsor|0|||
150283212|NCT02943564|542173399|FG001|Overall Study|Site terminated by sponsor|1|||
150283213|NCT02943564|542173400|FG002|Overall Study|Site terminated by sponsor|0|||
150283214|NCT02943564|542173398|FG000|Overall Study|Non-compliance with study drug|0|||
150283215|NCT02943564|542173399|FG001|Overall Study|Non-compliance with study drug|1|||
150283216|NCT02943564|542173400|FG002|Overall Study|Non-compliance with study drug|0|||
150283217|NCT02943564|542173398|FG000|Overall Study|Pregnancy|0|||
149839264|NCT04499963|540541338|FG001|Overall Study|Lost to Follow-up|0|||
149839265|NCT01005745|540541339|FG000|Overall Study|No TIL growth|1|||
149839266|NCT01005745|540541339|FG000|Overall Study|Disease progressed during TIL growth|3|||
149839267|NCT01005745|540541339|FG000|Overall Study|Death prior to treatment|1|||
149839268|NCT01005745|540541339|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
149839269|NCT01208337|540541345|FG000|Overall Study|Death|3|||
149839270|NCT00984126|540541349|FG000|Overall Study|Protocol Violation|0|||
149839271|NCT00984126|540541350|FG001|Overall Study|Protocol Violation|0|||
149839272|NCT00984126|540541351|FG002|Overall Study|Protocol Violation|1|||
149839273|NCT00984126|540541352|FG003|Overall Study|Protocol Violation|2|||
149839274|NCT00984126|540541349|FG000|Overall Study|Adverse Event|0|||
149839275|NCT00984126|540541350|FG001|Overall Study|Adverse Event|0|||
150283218|NCT02943564|542173399|FG001|Overall Study|Pregnancy|1|||
150283219|NCT02943564|542173400|FG002|Overall Study|Pregnancy|1|||
150283220|NCT02943564|542173398|FG000|Overall Study|Protocol Violation|2|||
150283221|NCT02943564|542173399|FG001|Overall Study|Protocol Violation|2|||
150283222|NCT02943564|542173400|FG002|Overall Study|Protocol Violation|2|||
150283223|NCT02943564|542173398|FG000|Overall Study|Lost to Follow-up|1|||
150283224|NCT02943564|542173399|FG001|Overall Study|Lost to Follow-up|0|||
150283225|NCT02943564|542173400|FG002|Overall Study|Lost to Follow-up|0|||
150283226|NCT02943564|542173398|FG000|Overall Study|Withdrawal by Subject|6|||
150283227|NCT02943564|542173399|FG001|Overall Study|Withdrawal by Subject|5|||
150283228|NCT02943564|542173400|FG002|Overall Study|Withdrawal by Subject|2|||
150283229|NCT02943564|542173398|FG000|Overall Study|Adverse Event|1|||
150283230|NCT02943564|542173399|FG001|Overall Study|Adverse Event|2|||
150283231|NCT02943564|542173400|FG002|Overall Study|Adverse Event|1|||
150283232|NCT02943564|542173398|FG000|Overall Study|Lack of Efficacy|0|||
150283233|NCT02943564|542173399|FG001|Overall Study|Lack of Efficacy|1|||
150283234|NCT02943564|542173400|FG002|Overall Study|Lack of Efficacy|0|||
150283235|NCT00932360|542173401|FG000|Washout (One Week)|Withdrawal by Subject|0|||
150283236|NCT00932360|542173402|FG001|Washout (One Week)|Withdrawal by Subject|0|||
150283237|NCT00932360|542173403|FG002|Washout (One Week)|Withdrawal by Subject|0|||
150283238|NCT00932360|542173404|FG003|Washout (One Week)|Withdrawal by Subject|0|||
150283239|NCT00932360|542173405|FG004|Washout (One Week)|Withdrawal by Subject|2|||
150283240|NCT00932360|542173406|FG005|Washout (One Week)|Withdrawal by Subject|0|||
150283241|NCT02536313|542173407|FG000|Overall Study|Lack of Efficacy|0|||
150283242|NCT02536313|542173408|FG001|Overall Study|Lack of Efficacy|1|||
150283243|NCT01924182|542173409|FG000|Overall Study|Withdrawal by Subject|1|||
150283244|NCT01924182|542173410|FG001|Overall Study|Withdrawal by Subject|0|||
150283245|NCT04143009|542173411|FG000|Pilot Trial|Lost to Follow-up|0|||
150283246|NCT04143009|542173412|FG001|Pilot Trial|Lost to Follow-up|1|||
150283247|NCT04143009|542173413|FG002|Pilot Trial|Lost to Follow-up|1|||
150283248|NCT02577146|542173414|FG000|Overall Study|Lost to Follow-up|8|||
150283249|NCT02577146|542173414|FG000|Overall Study|Physician Decision|3|||
150035160|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
150035161|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
150035162|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
150035163|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
150035164|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
150035165|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Other|0|||
150035166|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Other|1|||
150035167|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Other|0|||
150035168|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Other|1|||
150035169|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Other|0|||
150035170|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Not treated|0|||
150283250|NCT02577146|542173414|FG000|Overall Study|Screen Failure|17|||
150283251|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
150283252|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
150283253|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
150283254|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
150283255|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
150283256|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
150283257|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
150283258|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
150283259|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
150283260|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
150283261|NCT00219284|542173415|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
150283262|NCT00219284|542173416|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
150283263|NCT00219284|542173415|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
149952289|NCT02506036|540957776|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
149952290|NCT01410604|540957778|FG000|Overall Study|Adverse Event|2|||
149952291|NCT01410604|540957779|FG001|Overall Study|Adverse Event|1|||
149952292|NCT01410604|540957778|FG000|Overall Study|Lost to Follow-up|1|||
149952293|NCT01410604|540957779|FG001|Overall Study|Lost to Follow-up|0|||
149952294|NCT01410604|540957778|FG000|Overall Study|Physician Decision|0|||
149952295|NCT01410604|540957779|FG001|Overall Study|Physician Decision|1|||
149952296|NCT01178411|540957780|FG000|Overall Study|Adverse Event|5|||
149952297|NCT01178411|540957780|FG000|Overall Study|Withdrawal by Subject|4|||
149952298|NCT01178411|540957780|FG000|Overall Study|Protocol Violation|1|||
150035171|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Not treated|0|||
150035172|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Not treated|2|||
150035173|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Not treated|0|||
150035174|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Not treated|0|||
150283264|NCT00219284|542173416|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
150283265|NCT00219284|542173415|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
149952299|NCT01178411|540957780|FG000|Overall Study|Progressive disease per RECIST|32|||
149952300|NCT01178411|540957780|FG000|Overall Study|Progressive disease per clinician|9|||
150035175|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
150283266|NCT00219284|542173416|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
150283267|NCT00219284|542173415|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
150283268|NCT00219284|542173416|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
150283269|NCT04013529|542173420|FG000|Overall Study|Withdrawal by Subject|1|||
149952301|NCT01178411|540957780|FG000|Overall Study|Physician Decision|6|||
149952302|NCT01178411|540957780|FG000|Overall Study|Death|1|||
149952303|NCT01178411|540957780|FG000|Overall Study|No reason provided|1|||
149952304|NCT01178411|540957780|FG000|Overall Study|Drug manufacturing ended|1|||
149952305|NCT02383173|540957784|FG000|Overall Study|Palliative Care Team withdrew|0|||
149952306|NCT02383173|540957785|FG001|Overall Study|Palliative Care Team withdrew|2|||
149952307|NCT01625182|540957786|FG000|Overall Study|Administrative problems|1|||
149952308|NCT01625182|540957787|FG001|Overall Study|Administrative problems|0|||
149952309|NCT01625182|540957786|FG000|Overall Study|Protocol deviation|0|||
149952310|NCT01625182|540957787|FG001|Overall Study|Protocol deviation|2|||
149952311|NCT01625182|540957786|FG000|Overall Study|Adverse Event|2|||
149952312|NCT01625182|540957787|FG001|Overall Study|Adverse Event|0|||
149952313|NCT01625182|540957786|FG000|Overall Study|Withdrawal by Subject|5|||
149952314|NCT01625182|540957787|FG001|Overall Study|Withdrawal by Subject|1|||
149952315|NCT01625182|540957786|FG000|Overall Study|Lack of Efficacy|12|||
149952316|NCT01625182|540957787|FG001|Overall Study|Lack of Efficacy|8|||
149952317|NCT00263562|540957788|FG000|Overall Study|Protocol Violation|3|||
149952318|NCT00263562|540957789|FG001|Overall Study|Protocol Violation|0|||
149952319|NCT00429299|540957792|FG000|Overall Study|Disease Progression|1|||
149952320|NCT00429299|540957793|FG001|Overall Study|Disease Progression|1|||
149952321|NCT00429299|540957794|FG002|Overall Study|Disease Progression|0|||
149952322|NCT00429299|540957792|FG000|Overall Study|Adverse Event|2|||
149952323|NCT00429299|540957793|FG001|Overall Study|Adverse Event|5|||
149952324|NCT00429299|540957794|FG002|Overall Study|Adverse Event|1|||
149952325|NCT00429299|540957792|FG000|Overall Study|Protocol Violation|1|||
149952326|NCT00429299|540957793|FG001|Overall Study|Protocol Violation|0|||
149952327|NCT00429299|540957794|FG002|Overall Study|Protocol Violation|0|||
149952328|NCT00429299|540957792|FG000|Overall Study|Withdrawal by Subject|0|||
150172069|NCT00241644|541765877|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
150172070|NCT00241644|541765878|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
150172071|NCT00241644|541765879|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
150172072|NCT00241644|541765880|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
150172073|NCT00241644|541765877|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
150172074|NCT00241644|541765878|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
150172075|NCT00241644|541765879|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
150172076|NCT00241644|541765880|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
150172077|NCT00943735|541765881|FG000|Overall Study|Adverse Event|12|||
150172078|NCT00943735|541765881|FG000|Overall Study|Withdrawal by Subject|8|||
150172079|NCT00943735|541765881|FG000|Overall Study|Death|1|||
150172080|NCT00943735|541765881|FG000|Overall Study|Other|8|||
150172081|NCT00943735|541765881|FG000|Overall Study|Other|3|||
150172082|NCT00486330|541765882|FG000|Overall Study|Adverse Event|2|||
150172083|NCT03804918|541765883|FG000|Overall Study|Participant did not use the app|1|||
150172084|NCT01087762|541765884|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
150172085|NCT01087762|541765885|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
150172086|NCT01087762|541765886|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
150172087|NCT01087762|541765887|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
150172088|NCT01087762|541765888|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
150172089|NCT01087762|541765884|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
150172090|NCT01087762|541765885|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
150172091|NCT01087762|541765886|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
150172092|NCT01087762|541765887|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
150172093|NCT01087762|541765888|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
150172094|NCT01087762|541765884|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
150172095|NCT01087762|541765885|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
150172096|NCT01087762|541765886|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
150172097|NCT01087762|541765887|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
150172098|NCT01087762|541765888|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
150172099|NCT01087762|541765884|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
150172100|NCT01087762|541765885|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
150172101|NCT01087762|541765886|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
150172102|NCT01087762|541765887|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
150172103|NCT01087762|541765888|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
150172104|NCT01087762|541765884|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
150172105|NCT01087762|541765885|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
150172106|NCT01087762|541765886|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
150172107|NCT01087762|541765887|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
150172108|NCT01087762|541765888|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
150172109|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
150283270|NCT04013529|542173421|FG001|Overall Study|Withdrawal by Subject|1|||
150283271|NCT02116777|542173429|FG000|Overall Study|Adverse Event|0|||
150283272|NCT02116777|542173430|FG001|Overall Study|Adverse Event|0|||
150283273|NCT02116777|542173431|FG002|Overall Study|Adverse Event|0|||
150283274|NCT02116777|542173432|FG003|Overall Study|Adverse Event|0|||
150283275|NCT02116777|542173433|FG004|Overall Study|Adverse Event|2|||
150283276|NCT02116777|542173434|FG005|Overall Study|Adverse Event|2|||
150283277|NCT02116777|542173435|FG006|Overall Study|Adverse Event|0|||
150283278|NCT02116777|542173429|FG000|Overall Study|Death|0|||
150283279|NCT02116777|542173430|FG001|Overall Study|Death|0|||
150283280|NCT02116777|542173431|FG002|Overall Study|Death|0|||
150283281|NCT02116777|542173432|FG003|Overall Study|Death|1|||
150283282|NCT02116777|542173433|FG004|Overall Study|Death|0|||
150283283|NCT02116777|542173434|FG005|Overall Study|Death|0|||
150283284|NCT02116777|542173435|FG006|Overall Study|Death|0|||
150283285|NCT02116777|542173429|FG000|Overall Study|Lack of Efficacy|3|||
150283286|NCT02116777|542173430|FG001|Overall Study|Lack of Efficacy|3|||
150283287|NCT02116777|542173431|FG002|Overall Study|Lack of Efficacy|3|||
150283288|NCT02116777|542173432|FG003|Overall Study|Lack of Efficacy|8|||
150283289|NCT02116777|542173433|FG004|Overall Study|Lack of Efficacy|4|||
150283290|NCT02116777|542173434|FG005|Overall Study|Lack of Efficacy|1|||
150283291|NCT02116777|542173435|FG006|Overall Study|Lack of Efficacy|9|||
150283292|NCT02116777|542173429|FG000|Overall Study|Physician Decision|0|||
150283293|NCT02116777|542173430|FG001|Overall Study|Physician Decision|0|||
150283294|NCT02116777|542173431|FG002|Overall Study|Physician Decision|0|||
150283295|NCT02116777|542173432|FG003|Overall Study|Physician Decision|2|||
150283296|NCT02116777|542173433|FG004|Overall Study|Physician Decision|0|||
150283297|NCT02116777|542173434|FG005|Overall Study|Physician Decision|0|||
150283298|NCT02116777|542173435|FG006|Overall Study|Physician Decision|0|||
150283299|NCT02116777|542173429|FG000|Overall Study|Protocol Violation|0|||
150283300|NCT02116777|542173430|FG001|Overall Study|Protocol Violation|0|||
150283301|NCT02116777|542173431|FG002|Overall Study|Protocol Violation|0|||
150283302|NCT02116777|542173432|FG003|Overall Study|Protocol Violation|1|||
150283303|NCT02116777|542173433|FG004|Overall Study|Protocol Violation|0|||
150283304|NCT02116777|542173434|FG005|Overall Study|Protocol Violation|0|||
150283305|NCT02116777|542173435|FG006|Overall Study|Protocol Violation|0|||
150283306|NCT02116777|542173429|FG000|Overall Study|Withdrawal by Subject|0|||
150283307|NCT02116777|542173430|FG001|Overall Study|Withdrawal by Subject|0|||
150283308|NCT02116777|542173431|FG002|Overall Study|Withdrawal by Subject|0|||
150283309|NCT02116777|542173432|FG003|Overall Study|Withdrawal by Subject|1|||
150283310|NCT02116777|542173433|FG004|Overall Study|Withdrawal by Subject|0|||
150283311|NCT02116777|542173434|FG005|Overall Study|Withdrawal by Subject|0|||
150283312|NCT02116777|542173435|FG006|Overall Study|Withdrawal by Subject|0|||
150283313|NCT00733954|542173436|FG000|Overall Study|Lost to Follow-up|5|||
150283314|NCT00733954|542173437|FG001|Overall Study|Lost to Follow-up|2|||
149952329|NCT00429299|540957793|FG001|Overall Study|Withdrawal by Subject|1|||
149952330|NCT00429299|540957794|FG002|Overall Study|Withdrawal by Subject|3|||
149952331|NCT01946802|540957804|FG000|Overall Study|Death|1|||
150283315|NCT00733954|542173436|FG000|Overall Study|Protocol Violation|1|||
150283316|NCT00733954|542173437|FG001|Overall Study|Protocol Violation|0|||
150283317|NCT00733954|542173436|FG000|Overall Study|Withdrawal by Subject|2|||
150283318|NCT00733954|542173437|FG001|Overall Study|Withdrawal by Subject|0|||
150283319|NCT02663453|542173438|FG000|Overall Study|Death|4|||
150283320|NCT02663453|542173439|FG001|Overall Study|Death|4|||
150283321|NCT02663453|542173438|FG000|Overall Study|Withdrawal by Subject|1|||
150283322|NCT02663453|542173439|FG001|Overall Study|Withdrawal by Subject|0|||
150283323|NCT03416153|542173440|FG000|Overall Study|Physician Decision|1|||
150283324|NCT03416153|542173441|FG001|Overall Study|Physician Decision|1|||
150283325|NCT03416153|542173440|FG000|Overall Study|Withdrawal by Subject|1|||
150283326|NCT03416153|542173441|FG001|Overall Study|Withdrawal by Subject|0|||
150283327|NCT04649255|542174700|FG000|Overall Study|Death|9|||
150283328|NCT04649255|542174700|FG000|Overall Study|Withdrawal by Subject|1|||
150283329|NCT02484911|542174701|FG000|Overall Study|Withdrawal by Subject|2|||
150283330|NCT02484911|542174702|FG001|Overall Study|Withdrawal by Subject|1|||
150283331|NCT02484911|542174701|FG000|Overall Study|Protocol Violation|2|||
150283332|NCT02484911|542174702|FG001|Overall Study|Protocol Violation|1|||
150283333|NCT04129528|542174706|FG000|Overall Study|Adverse Event|1|||
150283334|NCT04129528|542174707|FG001|Overall Study|Adverse Event|0|||
150283335|NCT04129528|542174706|FG000|Overall Study|Physician Decision|1|||
150283336|NCT04129528|542174707|FG001|Overall Study|Physician Decision|1|||
150283337|NCT04129528|542174706|FG000|Overall Study|Withdrawal by Subject|1|||
150283338|NCT04129528|542174707|FG001|Overall Study|Withdrawal by Subject|1|||
150283339|NCT00490568|542174713|FG000|Overall Study|Adverse Event|116|||
150283340|NCT00490568|542174713|FG000|Overall Study|Lost to Follow-up|13|||
150283341|NCT00490568|542174713|FG000|Overall Study|Protocol Violation|45|||
150283342|NCT00490568|542174713|FG000|Overall Study|Withdrawal by Subject|135|||
150283343|NCT00490568|542174713|FG000|Overall Study|Still in the study at termination|974|||
150283344|NCT00490568|542174713|FG000|Overall Study|Other|1|||
149952332|NCT01946802|540957804|FG000|Overall Study|Withdrawal by Subject|2|||
150283345|NCT00490568|542174713|FG000|Overall Study|Exclusion criteria met|1|||
150283346|NCT00490568|542174713|FG000|Overall Study|Caregiver related|20|||
150283347|NCT00490568|542174713|FG000|Overall Study|Abnormal ECG|25|||
150283348|NCT00490568|542174713|FG000|Overall Study|Participant refused follow-up|9|||
150283349|NCT00490568|542174713|FG000|Overall Study|Legal representative withdrew consent|1|||
150283350|NCT00490568|542174713|FG000|Overall Study|Disease progression|4|||
150283351|NCT00490568|542174713|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
150283352|NCT00490568|542174713|FG000|Overall Study|Investigator decision|3|||
150283353|NCT00490568|542174713|FG000|Overall Study|Non-Compliance|7|||
150283354|NCT00490568|542174713|FG000|Overall Study|Efficacy related|3|||
150283355|NCT00490568|542174713|FG000|Overall Study|Participant died|1|||
150283356|NCT00490568|542174713|FG000|Overall Study|Participant withdrawal due to surgery|1|||
150283357|NCT01395394|542174714|FG000|Baseline Study Visit|Protocol Violation|1|||
150283358|NCT01395394|542174715|FG001|Baseline Study Visit|Protocol Violation|0|||
150283359|NCT01395394|542174716|FG002|Baseline Study Visit|Protocol Violation|0|||
150283360|NCT01157078|542174719|FG000|Overall Study|Withdrawal by Subject|12|||
150283361|NCT01157078|542174720|FG001|Overall Study|Withdrawal by Subject|14|||
150283362|NCT01157078|542174719|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
150283363|NCT01157078|542174720|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150283364|NCT01157078|542174719|FG000|Overall Study|Adverse Event|6|||
150283365|NCT01157078|542174720|FG001|Overall Study|Adverse Event|6|||
150283366|NCT01157078|542174719|FG000|Overall Study|Severe non-compliance to protocol|2|||
150283367|NCT01157078|542174720|FG001|Overall Study|Severe non-compliance to protocol|4|||
150283368|NCT01157078|542174719|FG000|Overall Study|Condition under investigation worsened|0|||
149839276|NCT00984126|540541351|FG002|Overall Study|Adverse Event|0|||
149839277|NCT00984126|540541352|FG003|Overall Study|Adverse Event|2|||
149839278|NCT00984126|540541349|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
149839279|NCT00984126|540541350|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
149839280|NCT00984126|540541351|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
149839281|NCT00984126|540541352|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
149839282|NCT00984126|540541349|FG000|Overall Study|Withdrawal criteria|0|||
149839283|NCT00984126|540541350|FG001|Overall Study|Withdrawal criteria|1|||
149839284|NCT00984126|540541351|FG002|Overall Study|Withdrawal criteria|3|||
149839285|NCT00984126|540541352|FG003|Overall Study|Withdrawal criteria|9|||
149839286|NCT02739997|540541359|FG000|Overall Study|Death|1|||
149839287|NCT02739997|540541359|FG000|Overall Study|Withdrawal by Subject|1|||
149839288|NCT02196675|540541360|FG000|Overall Study|Withdrawal by Subject|1|||
149839289|NCT02196675|540541361|FG001|Overall Study|Withdrawal by Subject|0|||
150283369|NCT01157078|542174720|FG001|Overall Study|Condition under investigation worsened|1|||
150283370|NCT01157078|542174719|FG000|Overall Study|Lack of Efficacy|2|||
150283371|NCT01157078|542174720|FG001|Overall Study|Lack of Efficacy|0|||
150283372|NCT01157078|542174719|FG000|Overall Study|Study-specific withdrawal criteria|2|||
150283373|NCT01157078|542174720|FG001|Overall Study|Study-specific withdrawal criteria|2|||
150283374|NCT01157078|542174719|FG000|Overall Study|Lost to Follow-up|7|||
150283375|NCT01157078|542174720|FG001|Overall Study|Lost to Follow-up|5|||
149839290|NCT02196675|540541362|FG002|Overall Study|Withdrawal by Subject|0|||
149839291|NCT02196675|540541360|FG000|Overall Study|Intra-operative surgical exclusion|1|||
149839292|NCT02196675|540541361|FG001|Overall Study|Intra-operative surgical exclusion|1|||
149839293|NCT02196675|540541362|FG002|Overall Study|Intra-operative surgical exclusion|0|||
149839294|NCT02196675|540541360|FG000|Overall Study|Protocol Violation|0|||
149839295|NCT02196675|540541361|FG001|Overall Study|Protocol Violation|1|||
150283376|NCT01157078|542174719|FG000|Overall Study|Other|2|||
150283377|NCT01157078|542174720|FG001|Overall Study|Other|4|||
150283378|NCT00789529|542174723|FG000|Overall Study|Withdrawal by Subject|0|||
150283379|NCT00789529|542174724|FG001|Overall Study|Withdrawal by Subject|1|||
150283380|NCT00789529|542174723|FG000|Overall Study|Other Reason|1|||
150283381|NCT00789529|542174724|FG001|Overall Study|Other Reason|0|||
149839296|NCT02196675|540541362|FG002|Overall Study|Protocol Violation|0|||
149839297|NCT02196675|540541360|FG000|Overall Study|Death|0|||
149839298|NCT02196675|540541361|FG001|Overall Study|Death|0|||
150035176|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
150035177|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
150035178|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
150283382|NCT00129766|542174725|FG000|Overall Study|Death|3|||
150283383|NCT00129766|542174726|FG001|Overall Study|Death|8|||
150283384|NCT00129766|542174725|FG000|Overall Study|Withdrawal of consent|31|||
150283385|NCT00129766|542174726|FG001|Overall Study|Withdrawal of consent|30|||
150283386|NCT00129766|542174725|FG000|Overall Study|Lost to Follow-up|26|||
150283387|NCT00129766|542174726|FG001|Overall Study|Lost to Follow-up|21|||
150283388|NCT01081912|542174727|FG000|Conversion/Titration|Adverse Event|47|||
150283389|NCT01081912|542174728|FG001|Conversion/Titration|Adverse Event|0|||
150283390|NCT01081912|542174729|FG002|Conversion/Titration|Adverse Event|0|||
150283391|NCT01081912|542174727|FG000|Conversion/Titration|Lack of Efficacy|17|||
150283392|NCT01081912|542174728|FG001|Conversion/Titration|Lack of Efficacy|0|||
149839299|NCT02196675|540541362|FG002|Overall Study|Death|1|||
149839300|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
150283393|NCT01081912|542174729|FG002|Conversion/Titration|Lack of Efficacy|0|||
150283394|NCT01081912|542174727|FG000|Conversion/Titration|Lost to Follow-up|5|||
150283395|NCT01081912|542174728|FG001|Conversion/Titration|Lost to Follow-up|0|||
150283396|NCT01081912|542174729|FG002|Conversion/Titration|Lost to Follow-up|0|||
150283397|NCT01081912|542174727|FG000|Conversion/Titration|Physician Decision|2|||
150283398|NCT01081912|542174728|FG001|Conversion/Titration|Physician Decision|0|||
150283399|NCT01081912|542174729|FG002|Conversion/Titration|Physician Decision|0|||
150283400|NCT01081912|542174727|FG000|Conversion/Titration|Protocol Violation|67|||
150283401|NCT01081912|542174728|FG001|Conversion/Titration|Protocol Violation|0|||
150283402|NCT01081912|542174729|FG002|Conversion/Titration|Protocol Violation|0|||
150283403|NCT01081912|542174727|FG000|Conversion/Titration|Withdrawal by Subject|23|||
150283404|NCT01081912|542174728|FG001|Conversion/Titration|Withdrawal by Subject|0|||
150283405|NCT01081912|542174729|FG002|Conversion/Titration|Withdrawal by Subject|0|||
150283406|NCT01081912|542174727|FG000|Conversion/Titration|Non-Compliance|47|||
150283407|NCT01081912|542174728|FG001|Conversion/Titration|Non-Compliance|0|||
150283408|NCT01081912|542174729|FG002|Conversion/Titration|Non-Compliance|0|||
150283409|NCT01081912|542174727|FG000|Maintenance Treatment|Adverse Event|0|||
150283410|NCT01081912|542174728|FG001|Maintenance Treatment|Adverse Event|2|||
150283411|NCT01081912|542174729|FG002|Maintenance Treatment|Adverse Event|12|||
150283412|NCT01081912|542174727|FG000|Maintenance Treatment|Lack of Efficacy|0|||
150283413|NCT01081912|542174728|FG001|Maintenance Treatment|Lack of Efficacy|14|||
150283414|NCT01081912|542174729|FG002|Maintenance Treatment|Lack of Efficacy|64|||
150283415|NCT01081912|542174727|FG000|Maintenance Treatment|Lost to Follow-up|0|||
150283416|NCT01081912|542174728|FG001|Maintenance Treatment|Lost to Follow-up|1|||
150283417|NCT01081912|542174729|FG002|Maintenance Treatment|Lost to Follow-up|0|||
150283418|NCT01081912|542174727|FG000|Maintenance Treatment|Physician Decision|0|||
150283419|NCT01081912|542174728|FG001|Maintenance Treatment|Physician Decision|0|||
150283420|NCT01081912|542174729|FG002|Maintenance Treatment|Physician Decision|1|||
150283421|NCT01081912|542174727|FG000|Maintenance Treatment|Protocol Violation|0|||
150283422|NCT01081912|542174728|FG001|Maintenance Treatment|Protocol Violation|1|||
150283423|NCT01081912|542174729|FG002|Maintenance Treatment|Protocol Violation|2|||
150283424|NCT01081912|542174727|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
150283425|NCT01081912|542174728|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
150283426|NCT01081912|542174729|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
150283427|NCT01081912|542174727|FG000|Maintenance Treatment|Non-Compliance|0|||
150283428|NCT01081912|542174728|FG001|Maintenance Treatment|Non-Compliance|4|||
150283429|NCT01081912|542174729|FG002|Maintenance Treatment|Non-Compliance|7|||
150283430|NCT01081912|542174727|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
150283431|NCT01081912|542174728|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
150283432|NCT01081912|542174729|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
150283433|NCT02770547|542174730|FG000|Overall Study|Patient non-compliant|1|||
150283434|NCT02770547|542174731|FG001|Overall Study|Patient non-compliant|0|||
150283435|NCT02770547|542174730|FG000|Overall Study|Adverse Event|0|||
150283436|NCT02770547|542174731|FG001|Overall Study|Adverse Event|1|||
150283437|NCT01324232|542174732|FG000|Overall Study|Protocol Violation|0|||
150283438|NCT01324232|542174733|FG001|Overall Study|Protocol Violation|0|||
150283439|NCT01324232|542174734|FG002|Overall Study|Protocol Violation|0|||
150283440|NCT01324232|542174735|FG003|Overall Study|Protocol Violation|2|||
150283441|NCT01324232|542174732|FG000|Overall Study|Missing|0|||
150283442|NCT01324232|542174733|FG001|Overall Study|Missing|0|||
150283443|NCT01324232|542174734|FG002|Overall Study|Missing|1|||
150283444|NCT01324232|542174735|FG003|Overall Study|Missing|0|||
150283445|NCT01324232|542174732|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
149839301|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
149839302|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
149839303|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
149839304|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
149839305|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
149839306|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
149839307|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
149839308|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
149839309|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
149839310|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
149839311|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
149839312|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
149839313|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
149839314|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
149839315|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
149839316|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
149839317|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
149839318|NCT02009163|540541363|FG000|Open-label Period (Non-randomized)|Other|13|||
149839319|NCT02009163|540541364|FG001|Open-label Period (Non-randomized)|Other|0|||
150283446|NCT01324232|542174733|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
150283447|NCT01324232|542174734|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
150283448|NCT01324232|542174735|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
150283449|NCT01324232|542174732|FG000|Overall Study|Lack of Efficacy|2|||
150283450|NCT01324232|542174733|FG001|Overall Study|Lack of Efficacy|1|||
150283451|NCT01324232|542174734|FG002|Overall Study|Lack of Efficacy|2|||
150283452|NCT01324232|542174735|FG003|Overall Study|Lack of Efficacy|2|||
150283453|NCT01324232|542174732|FG000|Overall Study|Participant Refused Medication|0|||
150283454|NCT01324232|542174733|FG001|Overall Study|Participant Refused Medication|1|||
150283455|NCT01324232|542174734|FG002|Overall Study|Participant Refused Medication|0|||
150283456|NCT01324232|542174735|FG003|Overall Study|Participant Refused Medication|0|||
150283457|NCT01324232|542174732|FG000|Overall Study|Intercurrent illness|0|||
150283458|NCT01324232|542174733|FG001|Overall Study|Intercurrent illness|0|||
150283459|NCT01324232|542174734|FG002|Overall Study|Intercurrent illness|0|||
150283460|NCT01324232|542174735|FG003|Overall Study|Intercurrent illness|1|||
150283461|NCT01324232|542174732|FG000|Overall Study|Adverse Event|2|||
149839320|NCT02009163|540541365|FG002|Open-label Period (Non-randomized)|Other|0|||
149839321|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
149839322|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
150283462|NCT01324232|542174733|FG001|Overall Study|Adverse Event|5|||
149839323|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
150283463|NCT01324232|542174734|FG002|Overall Study|Adverse Event|6|||
150283464|NCT01324232|542174735|FG003|Overall Study|Adverse Event|6|||
150283465|NCT01324232|542174732|FG000|Overall Study|Withdrawal by Subject|0|||
150283466|NCT01324232|542174733|FG001|Overall Study|Withdrawal by Subject|3|||
150283467|NCT01324232|542174734|FG002|Overall Study|Withdrawal by Subject|4|||
150283468|NCT01324232|542174735|FG003|Overall Study|Withdrawal by Subject|0|||
150283469|NCT01324232|542174732|FG000|Overall Study|Lost to Follow-up|1|||
150283470|NCT01324232|542174733|FG001|Overall Study|Lost to Follow-up|0|||
150283471|NCT01324232|542174734|FG002|Overall Study|Lost to Follow-up|0|||
150283472|NCT01324232|542174735|FG003|Overall Study|Lost to Follow-up|0|||
150283473|NCT05440539|542174736|FG000|Overall Study|Lost to Follow-up|4|||
150283474|NCT05440539|542174737|FG001|Overall Study|Lost to Follow-up|4|||
150283475|NCT05440539|542174736|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
150283476|NCT05440539|542174737|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
150283477|NCT00393887|542174738|FG000|Overall Study|Physician Decision|5|||
150283478|NCT00393887|542174739|FG001|Overall Study|Physician Decision|0|||
150283479|NCT00393887|542174738|FG000|Overall Study|Lost to Follow-up|11|||
150283480|NCT00393887|542174739|FG001|Overall Study|Lost to Follow-up|9|||
150283481|NCT01732796|542174740|FG000|Overall Study|Adverse Event|16|||
150283482|NCT01732796|542174741|FG001|Overall Study|Adverse Event|16|||
150283483|NCT01732796|542174742|FG002|Overall Study|Adverse Event|4|||
150283484|NCT01732796|542174740|FG000|Overall Study|Lack of Efficacy|21|||
150283485|NCT01732796|542174741|FG001|Overall Study|Lack of Efficacy|18|||
150283486|NCT01732796|542174742|FG002|Overall Study|Lack of Efficacy|5|||
150283487|NCT01732796|542174740|FG000|Overall Study|Lost to Follow-up|2|||
150283488|NCT01732796|542174741|FG001|Overall Study|Lost to Follow-up|0|||
150283489|NCT01732796|542174742|FG002|Overall Study|Lost to Follow-up|0|||
150283490|NCT01732796|542174740|FG000|Overall Study|Withdrawal by Subject|6|||
150283491|NCT01732796|542174741|FG001|Overall Study|Withdrawal by Subject|8|||
150283492|NCT01732796|542174742|FG002|Overall Study|Withdrawal by Subject|2|||
150283493|NCT01732796|542174740|FG000|Overall Study|Other reason not defined above|1|||
150283494|NCT01732796|542174741|FG001|Overall Study|Other reason not defined above|0|||
150283495|NCT01732796|542174742|FG002|Overall Study|Other reason not defined above|2|||
150283496|NCT00876187|542174748|FG000|Overall Study|Adverse Event|14|||
150283497|NCT00876187|542174749|FG001|Overall Study|Adverse Event|12|||
149839324|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
149839325|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
149839326|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
149839327|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Adverse Event|0|||
149839328|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Adverse Event|0|||
149839329|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Adverse Event|6|||
149839330|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
149839331|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
149839332|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
149839333|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
149839334|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
149952333|NCT01946802|540957804|FG000|Overall Study|Combined septic shock|1|||
149839335|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
149952334|NCT01946802|540957804|FG000|Overall Study|Protocol Violation|1|||
150283498|NCT00876187|542174750|FG002|Overall Study|Adverse Event|19|||
150283499|NCT00876187|542174751|FG003|Overall Study|Adverse Event|29|||
150283500|NCT00876187|542174752|FG004|Overall Study|Adverse Event|10|||
150283501|NCT00876187|542174748|FG000|Overall Study|Lack of Efficacy|59|||
150283502|NCT00876187|542174749|FG001|Overall Study|Lack of Efficacy|34|||
150283503|NCT00876187|542174750|FG002|Overall Study|Lack of Efficacy|45|||
150283504|NCT00876187|542174751|FG003|Overall Study|Lack of Efficacy|34|||
149952335|NCT00195429|540957805|FG000|Overall Study|Adverse Event|2|||
149952336|NCT00195429|540957806|FG001|Overall Study|Adverse Event|4|||
149952337|NCT00195429|540957805|FG000|Overall Study|Lack of Efficacy|2|||
149952338|NCT00195429|540957806|FG001|Overall Study|Lack of Efficacy|1|||
149952339|NCT00195429|540957805|FG000|Overall Study|Lost to Follow-up|1|||
149952340|NCT00195429|540957806|FG001|Overall Study|Lost to Follow-up|0|||
149952341|NCT02143778|540957807|FG000|Overall Study|Withdrawal by Subject|2|||
149952342|NCT02143778|540957807|FG000|Overall Study|Device malfunction|1|||
149952343|NCT01334515|540957808|FG000|Overall Study|Adverse Event|1|||
149952344|NCT01334515|540957809|FG001|Overall Study|Adverse Event|6|||
149952345|NCT01334515|540957808|FG000|Overall Study|Death|1|||
149952346|NCT01334515|540957809|FG001|Overall Study|Death|0|||
149952347|NCT01334515|540957808|FG000|Overall Study|Lack of Efficacy|8|||
149952348|NCT01334515|540957809|FG001|Overall Study|Lack of Efficacy|21|||
149952349|NCT01334515|540957808|FG000|Overall Study|Physician Decision|1|||
149952350|NCT01334515|540957809|FG001|Overall Study|Physician Decision|1|||
149952351|NCT01334515|540957808|FG000|Overall Study|Withdrawal by Subject|1|||
149952352|NCT01334515|540957809|FG001|Overall Study|Withdrawal by Subject|1|||
149952353|NCT03637374|540957810|FG000|Overall Study|Death|2|||
149952354|NCT03637374|540957811|FG001|Overall Study|Death|0|||
149952355|NCT05561140|540957813|FG000|Randomized Treatment Period|Adverse Event|1|||
149952356|NCT05561140|540957814|FG001|Randomized Treatment Period|Adverse Event|0|||
149952357|NCT05561140|540957813|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
149952358|NCT05561140|540957814|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
149952359|NCT05561140|540957813|FG000|Open Label Treatment Period|Adverse Event|6|||
149952360|NCT05561140|540957814|FG001|Open Label Treatment Period|Adverse Event|4|||
149952361|NCT05561140|540957813|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
149952362|NCT05561140|540957814|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
150283505|NCT00876187|542174752|FG004|Overall Study|Lack of Efficacy|59|||
150283506|NCT00876187|542174748|FG000|Overall Study|Lost to Follow-up|9|||
150283507|NCT00876187|542174749|FG001|Overall Study|Lost to Follow-up|10|||
150283508|NCT00876187|542174750|FG002|Overall Study|Lost to Follow-up|8|||
150283509|NCT00876187|542174751|FG003|Overall Study|Lost to Follow-up|8|||
150283510|NCT00876187|542174752|FG004|Overall Study|Lost to Follow-up|11|||
150283511|NCT00876187|542174748|FG000|Overall Study|Protocol Violation|6|||
150283512|NCT00876187|542174749|FG001|Overall Study|Protocol Violation|7|||
150283513|NCT00876187|542174750|FG002|Overall Study|Protocol Violation|7|||
150283514|NCT00876187|542174751|FG003|Overall Study|Protocol Violation|6|||
149839336|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Pregnancy|0|||
149839337|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Pregnancy|0|||
149839338|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Pregnancy|2|||
149839339|NCT02009163|540541363|FG000|Randomized-withdrawal Period|Other|0|||
149839340|NCT02009163|540541364|FG001|Randomized-withdrawal Period|Other|9|||
149839341|NCT02009163|540541365|FG002|Randomized-withdrawal Period|Other|5|||
149839342|NCT00359281|540541366|FG000|Overall Study|Adverse Event|1|||
149952363|NCT05561140|540957813|FG000|Open Label Treatment Period|Physician Decision|0|||
150283515|NCT00876187|542174752|FG004|Overall Study|Protocol Violation|3|||
150283516|NCT00876187|542174748|FG000|Overall Study|Withdrawal by Subject|16|||
150283517|NCT00876187|542174749|FG001|Overall Study|Withdrawal by Subject|26|||
150283518|NCT00876187|542174750|FG002|Overall Study|Withdrawal by Subject|32|||
150283519|NCT00876187|542174751|FG003|Overall Study|Withdrawal by Subject|38|||
150283520|NCT00876187|542174752|FG004|Overall Study|Withdrawal by Subject|37|||
150283521|NCT00876187|542174748|FG000|Overall Study|Entered extension study|101|||
150283522|NCT00876187|542174749|FG001|Overall Study|Entered extension study|120|||
150283523|NCT00876187|542174750|FG002|Overall Study|Entered extension study|156|||
150283524|NCT00876187|542174751|FG003|Overall Study|Entered extension study|151|||
150283525|NCT00876187|542174752|FG004|Overall Study|Entered extension study|144|||
150283526|NCT00876187|542174748|FG000|Overall Study|Randomized but not treated|3|||
150283527|NCT00876187|542174749|FG001|Overall Study|Randomized but not treated|1|||
150283528|NCT00876187|542174750|FG002|Overall Study|Randomized but not treated|3|||
150283529|NCT00876187|542174751|FG003|Overall Study|Randomized but not treated|2|||
150283530|NCT00876187|542174752|FG004|Overall Study|Randomized but not treated|3|||
150283531|NCT00876187|542174748|FG000|Overall Study|Other|2|||
150283532|NCT00876187|542174749|FG001|Overall Study|Other|5|||
150283533|NCT00876187|542174750|FG002|Overall Study|Other|9|||
150283534|NCT00876187|542174751|FG003|Overall Study|Other|7|||
150283535|NCT00876187|542174752|FG004|Overall Study|Other|4|||
149839343|NCT00359281|540541367|FG001|Overall Study|Adverse Event|0|||
149952364|NCT05561140|540957814|FG001|Open Label Treatment Period|Physician Decision|1|||
149952365|NCT05561140|540957813|FG000|Open Label Treatment Period|Pregnancy|1|||
149952366|NCT05561140|540957814|FG001|Open Label Treatment Period|Pregnancy|0|||
149952367|NCT05561140|540957813|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
149952368|NCT05561140|540957814|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
149952369|NCT05561140|540957813|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
149952370|NCT05561140|540957814|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
149952371|NCT05561140|540957813|FG000|Open Label Treatment Period|Other|1|||
150283536|NCT01967628|542174753|FG000|Overall Study|Withdrawal by Subject|2|||
150283537|NCT01967628|542174754|FG001|Overall Study|Withdrawal by Subject|0|||
150283538|NCT01967628|542174753|FG000|Overall Study|Unable to complete bronchoscopy|4|||
150283539|NCT01967628|542174754|FG001|Overall Study|Unable to complete bronchoscopy|6|||
150283540|NCT01967628|542174753|FG000|Overall Study|Lost to Follow-up|1|||
150283541|NCT01967628|542174754|FG001|Overall Study|Lost to Follow-up|0|||
150283542|NCT01967628|542174753|FG000|Overall Study|Low protein concentration in sample|20|||
150283543|NCT01967628|542174754|FG001|Overall Study|Low protein concentration in sample|25|||
150283544|NCT00838331|542174755|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
150283545|NCT01379274|542174756|FG000|Overall Study|funding withdrawn|1|||
150283546|NCT03287219|542174757|FG000|Overall Study|Protocol Violation|0|||
150283547|NCT03287219|542174758|FG001|Overall Study|Protocol Violation|2|||
150283548|NCT01970995|542174761|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
150283549|NCT01970995|542174762|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
150283550|NCT01970995|542174763|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
150283551|NCT01970995|542174761|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
150283552|NCT01970995|542174762|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
150283553|NCT01970995|542174763|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
150283554|NCT01780662|542174764|FG000|Overall Study|Adverse Event|1|||
150283555|NCT01780662|542174765|FG001|Overall Study|Adverse Event|0|||
150283556|NCT01780662|542174766|FG002|Overall Study|Adverse Event|2|||
150283557|NCT01780662|542174764|FG000|Overall Study|Physician Decision|0|||
150283558|NCT01780662|542174765|FG001|Overall Study|Physician Decision|5|||
150283559|NCT01780662|542174766|FG002|Overall Study|Physician Decision|7|||
150283560|NCT01780662|542174764|FG000|Overall Study|Protocol Violation|0|||
150283561|NCT01780662|542174765|FG001|Overall Study|Protocol Violation|1|||
150283562|NCT01780662|542174766|FG002|Overall Study|Protocol Violation|0|||
150283563|NCT01780662|542174764|FG000|Overall Study|Ineligible|0|||
150283564|NCT01780662|542174765|FG001|Overall Study|Ineligible|0|||
150283565|NCT01780662|542174766|FG002|Overall Study|Ineligible|1|||
150283566|NCT02182687|542174769|FG000|Overall Study|Withdrawal by Subject|4|||
150283567|NCT02182687|542174770|FG001|Overall Study|Withdrawal by Subject|0|||
150283568|NCT02182687|542174769|FG000|Overall Study|Adverse Event|1|||
150283569|NCT02182687|542174770|FG001|Overall Study|Adverse Event|0|||
150283570|NCT02182687|542174769|FG000|Overall Study|Lost to Follow-up|0|||
150283571|NCT02182687|542174770|FG001|Overall Study|Lost to Follow-up|1|||
150283572|NCT00794677|542174771|FG000|First Intervention|Withdrawal by Subject|2|||
150283573|NCT00794677|542174772|FG001|First Intervention|Withdrawal by Subject|0|||
150283574|NCT05513625|542174785|FG000|Overall Study|Withdrawal by Subject|1|||
150283575|NCT01073267|542174786|FG000|Overall Study|Disease Progression|3|||
150283576|NCT02039375|542174791|FG000|Overall Study|Lost to Follow-up|2|||
150283577|NCT03765138|542174792|FG000|Overall Study|Lost to Follow-up|1|||
150283578|NCT01624662|542174795|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
150283579|NCT01624662|542174796|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
150283580|NCT01624662|542174797|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
150283581|NCT01624662|542174798|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
150283582|NCT01624662|542174795|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
150283583|NCT01624662|542174796|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
150283584|NCT01624662|542174797|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
150283585|NCT01624662|542174798|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
150283586|NCT01624662|542174795|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
150283587|NCT01624662|542174796|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
150283588|NCT01624662|542174797|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
150283589|NCT01624662|542174798|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
150283590|NCT01624662|542174795|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
150283591|NCT01624662|542174796|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
150283592|NCT01624662|542174797|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
150283593|NCT01624662|542174798|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
150283594|NCT01624662|542174795|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
150283595|NCT01624662|542174796|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
150283596|NCT01624662|542174797|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
150283597|NCT01624662|542174798|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
150283598|NCT01624662|542174795|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
150283599|NCT01624662|542174796|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
150283600|NCT01624662|542174797|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
150283601|NCT01624662|542174798|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
150283602|NCT01624662|542174795|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
150283603|NCT01624662|542174796|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
150283604|NCT01624662|542174797|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
150283605|NCT01624662|542174798|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
150283606|NCT01714687|542174801|FG000|Overall Study|Withdrawal by Subject|1|||
150283607|NCT01714687|542174802|FG001|Overall Study|Withdrawal by Subject|0|||
150283608|NCT01714687|542174801|FG000|Overall Study|Lost to Follow-up|2|||
150283609|NCT01714687|542174802|FG001|Overall Study|Lost to Follow-up|4|||
150283610|NCT03116698|542174803|FG000|Overall Study|Adverse Event|1|||
150283611|NCT03116698|542174804|FG001|Overall Study|Adverse Event|1|||
150283612|NCT03116698|542174805|FG002|Overall Study|Adverse Event|1|||
150283613|NCT03116698|542174806|FG003|Overall Study|Adverse Event|0|||
150283614|NCT03116698|542174803|FG000|Overall Study|Withdrawal by Subject|1|||
150283615|NCT03116698|542174804|FG001|Overall Study|Withdrawal by Subject|4|||
150283616|NCT03116698|542174805|FG002|Overall Study|Withdrawal by Subject|5|||
150283617|NCT03116698|542174806|FG003|Overall Study|Withdrawal by Subject|2|||
150283618|NCT03116698|542174803|FG000|Overall Study|Lost to Follow-up|2|||
150283619|NCT03116698|542174804|FG001|Overall Study|Lost to Follow-up|0|||
150283620|NCT03116698|542174805|FG002|Overall Study|Lost to Follow-up|0|||
150283621|NCT03116698|542174806|FG003|Overall Study|Lost to Follow-up|0|||
150283622|NCT03116698|542174803|FG000|Overall Study|Physician Decision|1|||
150283623|NCT03116698|542174804|FG001|Overall Study|Physician Decision|1|||
150283624|NCT03116698|542174805|FG002|Overall Study|Physician Decision|0|||
150283625|NCT03116698|542174806|FG003|Overall Study|Physician Decision|0|||
150283626|NCT03116698|542174803|FG000|Overall Study|Protocol Violation|1|||
150283627|NCT03116698|542174804|FG001|Overall Study|Protocol Violation|0|||
150283628|NCT03116698|542174805|FG002|Overall Study|Protocol Violation|0|||
150283629|NCT03116698|542174806|FG003|Overall Study|Protocol Violation|0|||
149952372|NCT05561140|540957814|FG001|Open Label Treatment Period|Other|0|||
149952373|NCT02949934|540957819|FG000|Natural Drinking Period|Adverse Event|1|||
149952374|NCT02949934|540957820|FG001|Natural Drinking Period|Adverse Event|0|||
149952375|NCT02949934|540957821|FG002|Natural Drinking Period|Adverse Event|0|||
149952376|NCT02949934|540957822|FG003|Natural Drinking Period|Adverse Event|1|||
149952377|NCT02949934|540957823|FG004|Natural Drinking Period|Adverse Event|0|||
149952378|NCT02949934|540957824|FG005|Natural Drinking Period|Adverse Event|0|||
149952379|NCT02949934|540957819|FG000|Natural Drinking Period|Lost to Follow-up|0|||
149952380|NCT02949934|540957820|FG001|Natural Drinking Period|Lost to Follow-up|0|||
149952381|NCT02949934|540957821|FG002|Natural Drinking Period|Lost to Follow-up|0|||
149952382|NCT02949934|540957822|FG003|Natural Drinking Period|Lost to Follow-up|0|||
149952383|NCT02949934|540957823|FG004|Natural Drinking Period|Lost to Follow-up|1|||
149952384|NCT02949934|540957824|FG005|Natural Drinking Period|Lost to Follow-up|0|||
149952385|NCT02949934|540957819|FG000|Neuroimaging|Protocol Violation|2|||
149952386|NCT02949934|540957820|FG001|Neuroimaging|Protocol Violation|0|||
149952387|NCT02949934|540957821|FG002|Neuroimaging|Protocol Violation|0|||
149952388|NCT02949934|540957822|FG003|Neuroimaging|Protocol Violation|0|||
149952389|NCT02949934|540957823|FG004|Neuroimaging|Protocol Violation|1|||
149952390|NCT02949934|540957824|FG005|Neuroimaging|Protocol Violation|0|||
149952391|NCT02949934|540957819|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
149952392|NCT02949934|540957820|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
149952393|NCT02949934|540957821|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
149952394|NCT02949934|540957822|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
149952395|NCT02949934|540957823|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
149952396|NCT02949934|540957824|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
149952397|NCT02949934|540957819|FG000|Neuroimaging|Not scanned|0|||
149952398|NCT02949934|540957820|FG001|Neuroimaging|Not scanned|0|||
149952399|NCT02949934|540957821|FG002|Neuroimaging|Not scanned|1|||
149952400|NCT02949934|540957822|FG003|Neuroimaging|Not scanned|0|||
149952401|NCT02949934|540957823|FG004|Neuroimaging|Not scanned|0|||
149952402|NCT02949934|540957824|FG005|Neuroimaging|Not scanned|2|||
149952403|NCT02949934|540957819|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
149952404|NCT02949934|540957820|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
149952405|NCT02949934|540957821|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
149952406|NCT02949934|540957822|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
149952407|NCT02949934|540957823|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
149952408|NCT02949934|540957824|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
149952409|NCT02949934|540957819|FG000|Bar Laboratory|Adverse Event|1|||
149952410|NCT02949934|540957820|FG001|Bar Laboratory|Adverse Event|0|||
149952411|NCT02949934|540957821|FG002|Bar Laboratory|Adverse Event|2|||
149952412|NCT02949934|540957822|FG003|Bar Laboratory|Adverse Event|0|||
149952413|NCT02949934|540957823|FG004|Bar Laboratory|Adverse Event|1|||
149952414|NCT02949934|540957824|FG005|Bar Laboratory|Adverse Event|0|||
149952415|NCT02949934|540957819|FG000|Bar Laboratory|Protocol Violation|0|||
149952416|NCT02949934|540957820|FG001|Bar Laboratory|Protocol Violation|0|||
150283630|NCT03116698|542174803|FG000|Overall Study|Death|0|||
149952417|NCT02949934|540957821|FG002|Bar Laboratory|Protocol Violation|0|||
149952418|NCT02949934|540957822|FG003|Bar Laboratory|Protocol Violation|1|||
149952419|NCT02949934|540957823|FG004|Bar Laboratory|Protocol Violation|0|||
149952420|NCT02949934|540957824|FG005|Bar Laboratory|Protocol Violation|0|||
149952421|NCT04069520|540957828|FG000|Overall Study|Lost to Follow-up|0|||
149952422|NCT04069520|540957829|FG001|Overall Study|Lost to Follow-up|2|||
149952423|NCT04069520|540957828|FG000|Overall Study|Withdrawal by Subject|0|||
149952424|NCT04069520|540957829|FG001|Overall Study|Withdrawal by Subject|1|||
149952425|NCT04069520|540957828|FG000|Overall Study|Prior Injury|1|||
150283631|NCT03116698|542174804|FG001|Overall Study|Death|0|||
150283632|NCT03116698|542174805|FG002|Overall Study|Death|2|||
150283633|NCT03116698|542174806|FG003|Overall Study|Death|0|||
150283634|NCT00788372|542174807|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
150283635|NCT00788372|542174807|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
150283636|NCT00788372|542174807|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
150283637|NCT00788372|542174807|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
150283638|NCT00788372|542174807|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
150283639|NCT00788372|542174807|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
150283640|NCT00788372|542174807|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
150283641|NCT03099187|542174812|FG000|Double-blind Treatment|Adverse Event|19|||
150283642|NCT03099187|542174813|FG001|Double-blind Treatment|Adverse Event|1|||
150283643|NCT03099187|542174814|FG002|Double-blind Treatment|Adverse Event|0|||
150283644|NCT03099187|542174815|FG003|Double-blind Treatment|Adverse Event|0|||
150283645|NCT03099187|542174812|FG000|Double-blind Treatment|Death|1|||
150283646|NCT03099187|542174813|FG001|Double-blind Treatment|Death|3|||
150283647|NCT03099187|542174814|FG002|Double-blind Treatment|Death|0|||
150283648|NCT03099187|542174815|FG003|Double-blind Treatment|Death|0|||
150283649|NCT03099187|542174812|FG000|Double-blind Treatment|Lack of Efficacy|1|||
150283650|NCT03099187|542174813|FG001|Double-blind Treatment|Lack of Efficacy|0|||
150283651|NCT03099187|542174814|FG002|Double-blind Treatment|Lack of Efficacy|0|||
150283652|NCT03099187|542174815|FG003|Double-blind Treatment|Lack of Efficacy|0|||
150283653|NCT03099187|542174812|FG000|Double-blind Treatment|Physician Decision|2|||
150283654|NCT03099187|542174813|FG001|Double-blind Treatment|Physician Decision|1|||
150283655|NCT03099187|542174814|FG002|Double-blind Treatment|Physician Decision|0|||
150283656|NCT03099187|542174815|FG003|Double-blind Treatment|Physician Decision|0|||
150283657|NCT03099187|542174812|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
150283658|NCT03099187|542174813|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
150283659|NCT03099187|542174814|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
150283660|NCT03099187|542174815|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
150283661|NCT03099187|542174812|FG000|Double-blind Treatment|Lung transplantation|0|||
150283662|NCT03099187|542174813|FG001|Double-blind Treatment|Lung transplantation|1|||
150283663|NCT03099187|542174814|FG002|Double-blind Treatment|Lung transplantation|0|||
150283664|NCT03099187|542174815|FG003|Double-blind Treatment|Lung transplantation|0|||
150283665|NCT03099187|542174812|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
150283666|NCT03099187|542174813|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
150283667|NCT03099187|542174814|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
150283668|NCT03099187|542174815|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
150283669|NCT03099187|542174812|FG000|Double-blind Treatment|Disease progression|0|||
150283670|NCT03099187|542174813|FG001|Double-blind Treatment|Disease progression|1|||
150283671|NCT03099187|542174814|FG002|Double-blind Treatment|Disease progression|0|||
150283672|NCT03099187|542174815|FG003|Double-blind Treatment|Disease progression|0|||
150283673|NCT03099187|542174812|FG000|Double-blind Treatment|Randomization error|0|||
150283674|NCT03099187|542174813|FG001|Double-blind Treatment|Randomization error|2|||
150283675|NCT03099187|542174814|FG002|Double-blind Treatment|Randomization error|0|||
150283676|NCT03099187|542174815|FG003|Double-blind Treatment|Randomization error|0|||
150283677|NCT03099187|542174812|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
150283678|NCT03099187|542174813|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
150283679|NCT03099187|542174814|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
150283680|NCT03099187|542174815|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
150283681|NCT03099187|542174812|FG000|12-month Safety Follow-up|Adverse Event|0|||
150283682|NCT03099187|542174813|FG001|12-month Safety Follow-up|Adverse Event|0|||
150283683|NCT03099187|542174814|FG002|12-month Safety Follow-up|Adverse Event|5|||
150283684|NCT03099187|542174815|FG003|12-month Safety Follow-up|Adverse Event|12|||
150283685|NCT03099187|542174812|FG000|12-month Safety Follow-up|Death|0|||
150283686|NCT03099187|542174813|FG001|12-month Safety Follow-up|Death|0|||
150283687|NCT03099187|542174814|FG002|12-month Safety Follow-up|Death|7|||
150283688|NCT03099187|542174815|FG003|12-month Safety Follow-up|Death|9|||
150283689|NCT03099187|542174812|FG000|12-month Safety Follow-up|Lung transplantation|0|||
150283690|NCT03099187|542174813|FG001|12-month Safety Follow-up|Lung transplantation|0|||
150283691|NCT03099187|542174814|FG002|12-month Safety Follow-up|Lung transplantation|2|||
150283692|NCT03099187|542174815|FG003|12-month Safety Follow-up|Lung transplantation|1|||
150283693|NCT03099187|542174812|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
150283694|NCT03099187|542174813|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
150283695|NCT03099187|542174814|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
150283696|NCT03099187|542174815|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
150283697|NCT03099187|542174812|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
150283698|NCT03099187|542174813|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
150283699|NCT03099187|542174814|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
150283700|NCT03099187|542174815|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
150283701|NCT03099187|542174812|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
150283702|NCT03099187|542174813|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
150283703|NCT03099187|542174814|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
150283704|NCT03099187|542174815|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
150283705|NCT03099187|542174812|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
150283706|NCT03099187|542174813|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
150283707|NCT03099187|542174814|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
150283708|NCT03099187|542174815|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
150283709|NCT01439555|542174816|FG000|Overall Study|Protocol Violation|1|||
150283710|NCT04869345|542174822|FG000|Overall Study|Lost to Follow-up|8|||
150283711|NCT04869345|542174823|FG001|Overall Study|Lost to Follow-up|3|||
150283712|NCT03921424|542174832|FG000|Overall Study|Lost to Follow-up|0|||
150283713|NCT03921424|542174833|FG001|Overall Study|Lost to Follow-up|1|||
150283714|NCT03921424|542174832|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
150283715|NCT03921424|542174833|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
150283716|NCT05121480|542176248|FG000|Overall Study|Lack of Efficacy|2|||
150283717|NCT05121480|542176249|FG001|Overall Study|Lack of Efficacy|2|||
150283718|NCT05121480|542176250|FG002|Overall Study|Lack of Efficacy|1|||
150283719|NCT05121480|542176251|FG003|Overall Study|Lack of Efficacy|4|||
150283720|NCT05121480|542176252|FG004|Overall Study|Lack of Efficacy|0|||
150283721|NCT05121480|542176253|FG005|Overall Study|Lack of Efficacy|1|||
150283722|NCT05121480|542176254|FG006|Overall Study|Lack of Efficacy|0|||
150283723|NCT05121480|542176255|FG007|Overall Study|Lack of Efficacy|2|||
150283724|NCT05121480|542176248|FG000|Overall Study|Treatment Failure|0|||
150283725|NCT05121480|542176249|FG001|Overall Study|Treatment Failure|2|||
150283726|NCT05121480|542176250|FG002|Overall Study|Treatment Failure|0|||
150283727|NCT05121480|542176251|FG003|Overall Study|Treatment Failure|1|||
150283728|NCT05121480|542176252|FG004|Overall Study|Treatment Failure|0|||
150283729|NCT05121480|542176253|FG005|Overall Study|Treatment Failure|0|||
150283730|NCT05121480|542176254|FG006|Overall Study|Treatment Failure|0|||
150283731|NCT05121480|542176255|FG007|Overall Study|Treatment Failure|0|||
150283732|NCT05121480|542176248|FG000|Overall Study|Adverse Event|0|||
150283733|NCT05121480|542176249|FG001|Overall Study|Adverse Event|1|||
150283734|NCT05121480|542176250|FG002|Overall Study|Adverse Event|0|||
150283735|NCT05121480|542176251|FG003|Overall Study|Adverse Event|5|||
150283736|NCT05121480|542176252|FG004|Overall Study|Adverse Event|3|||
150283737|NCT05121480|542176253|FG005|Overall Study|Adverse Event|2|||
150283738|NCT05121480|542176254|FG006|Overall Study|Adverse Event|0|||
150283739|NCT05121480|542176255|FG007|Overall Study|Adverse Event|4|||
150283740|NCT05121480|542176248|FG000|Overall Study|Withdrawal by Subject|4|||
150283741|NCT05121480|542176249|FG001|Overall Study|Withdrawal by Subject|9|||
150283742|NCT05121480|542176250|FG002|Overall Study|Withdrawal by Subject|1|||
150283743|NCT05121480|542176251|FG003|Overall Study|Withdrawal by Subject|8|||
150283744|NCT05121480|542176252|FG004|Overall Study|Withdrawal by Subject|0|||
150283745|NCT05121480|542176253|FG005|Overall Study|Withdrawal by Subject|9|||
150283746|NCT05121480|542176254|FG006|Overall Study|Withdrawal by Subject|0|||
150283747|NCT05121480|542176255|FG007|Overall Study|Withdrawal by Subject|4|||
150283748|NCT05121480|542176248|FG000|Overall Study|Non-compliance with the protocol|0|||
150283749|NCT05121480|542176249|FG001|Overall Study|Non-compliance with the protocol|0|||
150283750|NCT05121480|542176250|FG002|Overall Study|Non-compliance with the protocol|0|||
150283751|NCT05121480|542176251|FG003|Overall Study|Non-compliance with the protocol|0|||
150283752|NCT05121480|542176252|FG004|Overall Study|Non-compliance with the protocol|1|||
150283753|NCT05121480|542176253|FG005|Overall Study|Non-compliance with the protocol|6|||
150283754|NCT05121480|542176254|FG006|Overall Study|Non-compliance with the protocol|0|||
150283755|NCT05121480|542176255|FG007|Overall Study|Non-compliance with the protocol|1|||
150283756|NCT05121480|542176248|FG000|Overall Study|Lost to Follow-up|0|||
150283757|NCT05121480|542176249|FG001|Overall Study|Lost to Follow-up|4|||
150283758|NCT05121480|542176250|FG002|Overall Study|Lost to Follow-up|1|||
150283759|NCT05121480|542176251|FG003|Overall Study|Lost to Follow-up|3|||
150283760|NCT05121480|542176252|FG004|Overall Study|Lost to Follow-up|1|||
150283761|NCT05121480|542176253|FG005|Overall Study|Lost to Follow-up|1|||
150283762|NCT05121480|542176254|FG006|Overall Study|Lost to Follow-up|1|||
150283763|NCT05121480|542176255|FG007|Overall Study|Lost to Follow-up|4|||
150283764|NCT05121480|542176248|FG000|Overall Study|Physician Decision|0|||
150283765|NCT05121480|542176249|FG001|Overall Study|Physician Decision|0|||
150283766|NCT05121480|542176250|FG002|Overall Study|Physician Decision|0|||
150283767|NCT05121480|542176251|FG003|Overall Study|Physician Decision|0|||
150283768|NCT05121480|542176252|FG004|Overall Study|Physician Decision|0|||
150283769|NCT05121480|542176253|FG005|Overall Study|Physician Decision|1|||
150283770|NCT05121480|542176254|FG006|Overall Study|Physician Decision|0|||
150283771|NCT05121480|542176255|FG007|Overall Study|Physician Decision|1|||
150283772|NCT05121480|542176248|FG000|Overall Study|Other Reason|0|||
150283773|NCT05121480|542176249|FG001|Overall Study|Other Reason|0|||
150283774|NCT05121480|542176250|FG002|Overall Study|Other Reason|0|||
150283775|NCT05121480|542176251|FG003|Overall Study|Other Reason|0|||
150283776|NCT05121480|542176252|FG004|Overall Study|Other Reason|0|||
150283777|NCT05121480|542176253|FG005|Overall Study|Other Reason|1|||
150283778|NCT05121480|542176254|FG006|Overall Study|Other Reason|1|||
150283779|NCT05121480|542176255|FG007|Overall Study|Other Reason|1|||
150283780|NCT02356562|542176256|FG000|Overall Study|Withdrawal by Subject|0|||
150283781|NCT02356562|542176257|FG001|Overall Study|Withdrawal by Subject|1|||
150283782|NCT02356562|542176256|FG000|Overall Study|Re-entered treatment in a previous study|1|||
150283783|NCT02356562|542176257|FG001|Overall Study|Re-entered treatment in a previous study|0|||
150283784|NCT02356562|542176256|FG000|Overall Study|site closure|1|||
150283785|NCT02356562|542176257|FG001|Overall Study|site closure|0|||
150283786|NCT00412750|542176258|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150283787|NCT00412750|542176259|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150283788|NCT00412750|542176260|FG002|Overall Study|Abnormal laboratory value(s)|0|||
150283789|NCT00412750|542176258|FG000|Overall Study|Administrative problems|21|||
150283790|NCT00412750|542176259|FG001|Overall Study|Administrative problems|17|||
150283791|NCT00412750|542176260|FG002|Overall Study|Administrative problems|14|||
150283792|NCT00412750|542176258|FG000|Overall Study|Adverse Event|8|||
150283793|NCT00412750|542176259|FG001|Overall Study|Adverse Event|3|||
150283794|NCT00412750|542176260|FG002|Overall Study|Adverse Event|3|||
150283795|NCT00412750|542176258|FG000|Overall Study|Lost to Follow-up|1|||
150283796|NCT00412750|542176259|FG001|Overall Study|Lost to Follow-up|0|||
150283797|NCT00412750|542176260|FG002|Overall Study|Lost to Follow-up|1|||
150283798|NCT00412750|542176258|FG000|Overall Study|Withdrawal by Subject|0|||
150283799|NCT00412750|542176259|FG001|Overall Study|Withdrawal by Subject|1|||
150283800|NCT00412750|542176260|FG002|Overall Study|Withdrawal by Subject|2|||
150283801|NCT00412750|542176258|FG000|Overall Study|Lack of Efficacy|0|||
150283802|NCT00412750|542176259|FG001|Overall Study|Lack of Efficacy|0|||
150283803|NCT00412750|542176260|FG002|Overall Study|Lack of Efficacy|3|||
150283804|NCT00105443|542176267|FG000|Double-Blind Treatment|Adverse Event|1|||
150283805|NCT00105443|542176268|FG001|Double-Blind Treatment|Adverse Event|0|||
150283806|NCT00105443|542176269|FG002|Double-Blind Treatment|Adverse Event|0|||
150283807|NCT00105443|542176270|FG003|Double-Blind Treatment|Adverse Event|0|||
150283808|NCT00105443|542176267|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
150283809|NCT00105443|542176268|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
150283810|NCT00105443|542176269|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
150283811|NCT00105443|542176270|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
150283812|NCT00105443|542176267|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
150283813|NCT00105443|542176268|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
150283814|NCT00105443|542176269|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
150283815|NCT00105443|542176270|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
150283816|NCT00105443|542176267|FG000|Double-Blind Treatment|Physician Decision|1|||
150283817|NCT00105443|542176268|FG001|Double-Blind Treatment|Physician Decision|0|||
150283818|NCT00105443|542176269|FG002|Double-Blind Treatment|Physician Decision|2|||
150283819|NCT00105443|542176270|FG003|Double-Blind Treatment|Physician Decision|0|||
150283820|NCT00105443|542176267|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
150283821|NCT00105443|542176268|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
150283822|NCT00105443|542176269|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
150283823|NCT00105443|542176270|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
150283824|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
150283825|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
150283826|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
150283827|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
150283828|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
150283829|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
150283830|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
150283831|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
150283832|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
150283833|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
150283834|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
149839344|NCT00359281|540541368|FG002|Overall Study|Adverse Event|0|||
149839345|NCT00359281|540541369|FG003|Overall Study|Adverse Event|0|||
149839346|NCT00359281|540541370|FG004|Overall Study|Adverse Event|0|||
149839347|NCT00359281|540541371|FG005|Overall Study|Adverse Event|0|||
149839348|NCT00359281|540541372|FG006|Overall Study|Adverse Event|1|||
149839349|NCT00359281|540541373|FG007|Overall Study|Adverse Event|0|||
149839350|NCT00359281|540541374|FG008|Overall Study|Adverse Event|0|||
149839351|NCT00359281|540541366|FG000|Overall Study|Withdrawal by Subject|0|||
149839352|NCT00359281|540541367|FG001|Overall Study|Withdrawal by Subject|0|||
149839353|NCT00359281|540541368|FG002|Overall Study|Withdrawal by Subject|0|||
149839354|NCT00359281|540541369|FG003|Overall Study|Withdrawal by Subject|0|||
149839355|NCT00359281|540541370|FG004|Overall Study|Withdrawal by Subject|0|||
149839356|NCT00359281|540541371|FG005|Overall Study|Withdrawal by Subject|0|||
149839357|NCT00359281|540541372|FG006|Overall Study|Withdrawal by Subject|1|||
149839358|NCT00359281|540541373|FG007|Overall Study|Withdrawal by Subject|0|||
149839359|NCT00359281|540541374|FG008|Overall Study|Withdrawal by Subject|0|||
149839360|NCT01474551|540541375|FG000|Overall Study|Death|1|||
149839361|NCT03686033|540541388|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
149839362|NCT03686033|540541389|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
149839363|NCT03686033|540541390|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
149839364|NCT03686033|540541391|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
150283835|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
150283836|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
150283837|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
150283838|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
150283839|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
150283840|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
150283841|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
150283842|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
150283843|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
150283844|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
150283845|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
150283846|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
150283847|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
150283848|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
150283849|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
149952426|NCT04069520|540957829|FG001|Overall Study|Prior Injury|0|||
149952427|NCT04069520|540957828|FG000|Overall Study|Orthodontia|1|||
149952428|NCT04069520|540957829|FG001|Overall Study|Orthodontia|0|||
149952429|NCT04069520|540957828|FG000|Overall Study|Cut from team|0|||
149952430|NCT04069520|540957829|FG001|Overall Study|Cut from team|2|||
149952431|NCT00849472|540957830|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
149952432|NCT00849472|540957830|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
149952433|NCT00849472|540957830|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
149952434|NCT00849472|540957830|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
149952435|NCT00849472|540957830|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
149952436|NCT00849472|540957830|FG000|Weekly Paclitaxel|Disease Progression|1|||
149952437|NCT00849472|540957830|FG000|Weekly Paclitaxel|Adverse Event|11|||
149952438|NCT00849472|540957830|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
149952439|NCT00849472|540957830|FG000|Weekly Paclitaxel|Physician Decision|3|||
149952440|NCT00849472|540957830|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
149952441|NCT00849472|540957830|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
149952442|NCT00849472|540957830|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
149952443|NCT00849472|540957830|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
149952444|NCT00849472|540957830|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
149952445|NCT00849472|540957830|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
149952446|NCT00849472|540957830|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
149952447|NCT00849472|540957830|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
149952448|NCT00825175|540957831|FG000|Overall Study|Withdrawal by Subject|0|||
149952449|NCT00825175|540957832|FG001|Overall Study|Withdrawal by Subject|5|||
149952450|NCT04615507|540957833|FG000|Period 1|Covid-19 exposure|2|||
149952451|NCT04615507|540957834|FG001|Period 1|Covid-19 exposure|1|||
149952452|NCT04615507|540957833|FG000|Period 2|Covid-19 exposure|0|||
149952453|NCT04615507|540957834|FG001|Period 2|Covid-19 exposure|1|||
149952454|NCT04615507|540957833|FG000|Period 2|Protocol Violation|1|||
149952455|NCT04615507|540957834|FG001|Period 2|Protocol Violation|0|||
149952456|NCT04615507|540957833|FG000|Period 2|Withdrawal by Subject|1|||
149952457|NCT04615507|540957834|FG001|Period 2|Withdrawal by Subject|0|||
149952458|NCT04615507|540957833|FG000|Period 2|Adverse Event|0|||
149952459|NCT04615507|540957834|FG001|Period 2|Adverse Event|1|||
149952460|NCT04615507|540957833|FG000|Period 3|Covid-19 exposure|0|||
149952461|NCT04615507|540957834|FG001|Period 3|Covid-19 exposure|1|||
149952462|NCT00118287|540957837|FG000|Overall Study|Intracranial haemorrhage|1|||
149952463|NCT00118287|540957837|FG000|Overall Study|Muscle pain|1|||
149952464|NCT03091439|540957842|FG000|Overall Study|Study Terminated by the Sponsor|1|||
149952465|NCT03091439|540957843|FG001|Overall Study|Study Terminated by the Sponsor|0|||
149952466|NCT03122106|540957844|FG000|Overall Study|Not enough tissue|1|||
149952467|NCT03122106|540957844|FG000|Overall Study|Disease progression during screening|2|||
149952468|NCT03122106|540957844|FG000|Overall Study|Poor RNA quality for vaccine|1|||
149952469|NCT05172570|540957845|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
149952470|NCT05172570|540957846|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
149952471|NCT05172570|540957847|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
149952472|NCT05172570|540957845|FG000|Overall Study|PI Decision due to equipment shortages|0|||
149952473|NCT05172570|540957846|FG001|Overall Study|PI Decision due to equipment shortages|0|||
149952474|NCT05172570|540957847|FG002|Overall Study|PI Decision due to equipment shortages|1|||
149952475|NCT00640289|540957848|FG000|Overall Study|Death|3|||
149952476|NCT00640289|540957848|FG000|Overall Study|Withdrawal by Subject|1|||
149952477|NCT00640289|540957848|FG000|Overall Study|Lost to Follow-up|1|||
149952478|NCT00640289|540957848|FG000|Overall Study|Data collected under different amendment|2|||
149952479|NCT00640289|540957848|FG000|Overall Study|Transferred to another center|1|||
149952480|NCT00640289|540957848|FG000|Overall Study|Missing status|5|||
150283850|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
150283851|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
150283852|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
150283853|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
150283854|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
150283855|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
150283856|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
150283857|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
150283858|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
150283859|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
150283860|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
150283861|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
150283862|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
150283863|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
150283864|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
150283865|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
150283866|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
150283867|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
150283868|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
150283869|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
150283870|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
150283871|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
150283872|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
150283873|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
150283874|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
150283875|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
150283876|NCT00105443|542176267|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
150283877|NCT00105443|542176268|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
150283878|NCT00105443|542176269|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
150283879|NCT00105443|542176270|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
150283880|NCT02135692|542176271|FG000|Overall Study|Adverse Event|3|||
150283881|NCT02135692|542176271|FG000|Overall Study|Lack of Efficacy|2|||
150283882|NCT02135692|542176271|FG000|Overall Study|Protocol Violation|2|||
150283883|NCT02135692|542176271|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
150283884|NCT02135692|542176271|FG000|Overall Study|Product commercially available|159|||
150283885|NCT02135692|542176271|FG000|Overall Study|Study closed/terminated|153|||
150283886|NCT02135692|542176271|FG000|Overall Study|Lost to Follow-up|4|||
150283887|NCT02135692|542176271|FG000|Overall Study|Withdrawal by Subject|15|||
150283888|NCT01623271|542176274|FG000|Overall Study|Withdrawal by Subject|2|||
150283889|NCT01611974|542176275|FG000|Overall Study|Death|10|||
150283890|NCT01611974|542176276|FG001|Overall Study|Death|12|||
150283891|NCT01611974|542176277|FG002|Overall Study|Death|10|||
150283892|NCT01611974|542176275|FG000|Overall Study|Lost to Follow-up|0|||
150283893|NCT01611974|542176276|FG001|Overall Study|Lost to Follow-up|1|||
150283894|NCT01611974|542176277|FG002|Overall Study|Lost to Follow-up|0|||
150283895|NCT01611974|542176275|FG000|Overall Study|Physician Decision|5|||
150283896|NCT01611974|542176276|FG001|Overall Study|Physician Decision|1|||
150283897|NCT01611974|542176277|FG002|Overall Study|Physician Decision|2|||
150283898|NCT01611974|542176275|FG000|Overall Study|Withdrawal by Subject|0|||
150283899|NCT01611974|542176276|FG001|Overall Study|Withdrawal by Subject|1|||
150283900|NCT01611974|542176277|FG002|Overall Study|Withdrawal by Subject|4|||
150283901|NCT01097746|542176278|FG000|Overall Study|Adverse Event|4|||
150283902|NCT01097746|542176278|FG000|Overall Study|taken off study before any treatment given|1|||
150283903|NCT00522431|542176279|FG000|Overall Study|Adverse Event|5|||
150283904|NCT00522431|542176279|FG000|Overall Study|Protocol Violation|2|||
150283905|NCT00522431|542176279|FG000|Overall Study|Withdrawal by Subject|2|||
150283906|NCT00522431|542176279|FG000|Overall Study|Subject non-compliance|1|||
150283907|NCT00522431|542176279|FG000|Overall Study|Other/unknown|1|||
150283908|NCT00772954|542176280|FG000|Overall Study|Adverse Event|0|||
150283909|NCT00772954|542176281|FG001|Overall Study|Adverse Event|0|||
150283910|NCT00772954|542176282|FG002|Overall Study|Adverse Event|1|||
150283911|NCT02495844|542176286|FG000|Overall Study|Lack of Efficacy|1|||
150283912|NCT02495844|542176287|FG001|Overall Study|Lack of Efficacy|2|||
150283913|NCT02495844|542176286|FG000|Overall Study|AE, non-fatal|0|||
150283914|NCT02495844|542176287|FG001|Overall Study|AE, non-fatal|1|||
150283915|NCT02495844|542176286|FG000|Overall Study|Hepatitis Positivity|0|||
150283916|NCT02495844|542176287|FG001|Overall Study|Hepatitis Positivity|1|||
149952481|NCT03550209|540957849|FG000|Overall Study|Lost to Follow-up|1|||
150283917|NCT03927105|542176288|FG000|Overall Study|Death|1|||
150283918|NCT03927105|542176288|FG000|Overall Study|In observation for potential re-treatment|2|||
150283919|NCT03927105|542176288|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
150283920|NCT01135498|542176289|FG000|Overall Study|Adverse Event|20|||
150283921|NCT01135498|542176289|FG000|Overall Study|Progressive disease|38|||
150283922|NCT01135498|542176289|FG000|Overall Study|Investigator judgement|25|||
150283923|NCT01135498|542176289|FG000|Overall Study|Withdrawal by Subject|4|||
150283924|NCT01135498|542176289|FG000|Overall Study|Death|1|||
150283925|NCT01135498|542176289|FG000|Overall Study|Ongoing at time of analysis|2|||
150283926|NCT02513329|542176291|FG000|Overall Study|Lost to Follow-up|5|||
150283927|NCT02513329|542176292|FG001|Overall Study|Lost to Follow-up|2|||
150283928|NCT02083380|542176295|FG000|Overall Study|Lack of Efficacy|68|||
150283929|NCT02083380|542176296|FG001|Overall Study|Lack of Efficacy|79|||
150283930|NCT02083380|542176297|FG002|Overall Study|Lack of Efficacy|64|||
150283931|NCT02083380|542176295|FG000|Overall Study|Withdrawal by Subject|9|||
150283932|NCT02083380|542176296|FG001|Overall Study|Withdrawal by Subject|3|||
150283933|NCT02083380|542176297|FG002|Overall Study|Withdrawal by Subject|7|||
150283934|NCT02083380|542176295|FG000|Overall Study|Physician Decision|1|||
150283935|NCT02083380|542176296|FG001|Overall Study|Physician Decision|6|||
150283936|NCT02083380|542176297|FG002|Overall Study|Physician Decision|3|||
150283937|NCT02083380|542176295|FG000|Overall Study|Adverse Event|0|||
150283938|NCT02083380|542176296|FG001|Overall Study|Adverse Event|0|||
150283939|NCT02083380|542176297|FG002|Overall Study|Adverse Event|1|||
150283940|NCT02083380|542176295|FG000|Overall Study|Lost to Follow-up|5|||
150283941|NCT02083380|542176296|FG001|Overall Study|Lost to Follow-up|3|||
150283942|NCT02083380|542176297|FG002|Overall Study|Lost to Follow-up|3|||
150283943|NCT02083380|542176295|FG000|Overall Study|Other|8|||
150283944|NCT02083380|542176296|FG001|Overall Study|Other|4|||
150283945|NCT02083380|542176297|FG002|Overall Study|Other|6|||
150283946|NCT04091087|542176298|FG000|Overall Study|Not treated|1|||
150283947|NCT04091087|542176299|FG001|Overall Study|Not treated|0|||
150283948|NCT04091087|542176298|FG000|Overall Study|Adverse Event|4|||
150283949|NCT04091087|542176299|FG001|Overall Study|Adverse Event|4|||
150283950|NCT04091087|542176298|FG000|Overall Study|Protocol Violation|0|||
150283951|NCT04091087|542176299|FG001|Overall Study|Protocol Violation|1|||
149952482|NCT03550209|540957850|FG001|Overall Study|Lost to Follow-up|0|||
149952483|NCT03550209|540957851|FG002|Overall Study|Lost to Follow-up|1|||
149952484|NCT03550209|540957852|FG003|Overall Study|Lost to Follow-up|0|||
149952485|NCT03550209|540957849|FG000|Overall Study|Withdrawal by Subject|0|||
149952486|NCT03550209|540957850|FG001|Overall Study|Withdrawal by Subject|3|||
149952487|NCT03550209|540957851|FG002|Overall Study|Withdrawal by Subject|1|||
149952488|NCT03550209|540957852|FG003|Overall Study|Withdrawal by Subject|2|||
149952489|NCT03550209|540957849|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
149952490|NCT03550209|540957850|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
149952491|NCT03550209|540957851|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
149952492|NCT03550209|540957852|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
149952493|NCT02347787|540957855|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
149952494|NCT02347787|540957856|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
149952495|NCT02347787|540957855|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
149952496|NCT02347787|540957856|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
149952497|NCT02347787|540957855|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
149952498|NCT02347787|540957856|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
149952499|NCT02347787|540957855|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
149952500|NCT02347787|540957856|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
149952501|NCT03244189|540957864|FG000|Overall Study|Death|0|||
149952502|NCT03244189|540957865|FG001|Overall Study|Death|2|||
149952503|NCT03244189|540957864|FG000|Overall Study|Lost to Follow-up|92|||
149952504|NCT03244189|540957865|FG001|Overall Study|Lost to Follow-up|107|||
149952505|NCT03244189|540957864|FG000|Overall Study|Physician Decision|4|||
150283952|NCT04091087|542176298|FG000|Overall Study|Withdrawal by Subject|5|||
150283953|NCT04091087|542176299|FG001|Overall Study|Withdrawal by Subject|2|||
150283954|NCT03703102|542176300|FG000|Overall Study|Adverse Event|4|||
150283955|NCT03703102|542176301|FG001|Overall Study|Adverse Event|3|||
150283956|NCT03703102|542176302|FG002|Overall Study|Adverse Event|7|||
150283957|NCT03703102|542176303|FG003|Overall Study|Adverse Event|3|||
150283958|NCT03703102|542176304|FG004|Overall Study|Adverse Event|13|||
150283959|NCT03703102|542176300|FG000|Overall Study|Lack of Efficacy|4|||
150283960|NCT03703102|542176301|FG001|Overall Study|Lack of Efficacy|0|||
150283961|NCT03703102|542176302|FG002|Overall Study|Lack of Efficacy|1|||
150283962|NCT03703102|542176303|FG003|Overall Study|Lack of Efficacy|4|||
150283963|NCT03703102|542176304|FG004|Overall Study|Lack of Efficacy|1|||
150283964|NCT03703102|542176300|FG000|Overall Study|Lost to Follow-up|0|||
149952506|NCT03244189|540957865|FG001|Overall Study|Physician Decision|2|||
149952507|NCT03244189|540957864|FG000|Overall Study|Pregnancy|7|||
149952508|NCT03244189|540957865|FG001|Overall Study|Pregnancy|5|||
149952509|NCT03244189|540957864|FG000|Overall Study|Protocol Violation|0|||
149952510|NCT03244189|540957865|FG001|Overall Study|Protocol Violation|2|||
150283965|NCT03703102|542176301|FG001|Overall Study|Lost to Follow-up|0|||
150283966|NCT03703102|542176302|FG002|Overall Study|Lost to Follow-up|1|||
150283967|NCT03703102|542176303|FG003|Overall Study|Lost to Follow-up|2|||
150283968|NCT03703102|542176304|FG004|Overall Study|Lost to Follow-up|2|||
150283969|NCT03703102|542176300|FG000|Overall Study|Physician Decision|2|||
150283970|NCT03703102|542176301|FG001|Overall Study|Physician Decision|2|||
150283971|NCT03703102|542176302|FG002|Overall Study|Physician Decision|2|||
150283972|NCT03703102|542176303|FG003|Overall Study|Physician Decision|2|||
150283973|NCT03703102|542176304|FG004|Overall Study|Physician Decision|4|||
150283974|NCT03703102|542176300|FG000|Overall Study|Withdrawal by Subject|7|||
150283975|NCT03703102|542176301|FG001|Overall Study|Withdrawal by Subject|5|||
150283976|NCT03703102|542176302|FG002|Overall Study|Withdrawal by Subject|5|||
150283977|NCT03703102|542176303|FG003|Overall Study|Withdrawal by Subject|5|||
150283978|NCT03703102|542176304|FG004|Overall Study|Withdrawal by Subject|9|||
150283979|NCT03703102|542176300|FG000|Overall Study|Ineligibility|0|||
150283980|NCT03703102|542176301|FG001|Overall Study|Ineligibility|0|||
150283981|NCT03703102|542176302|FG002|Overall Study|Ineligibility|1|||
150283982|NCT03703102|542176303|FG003|Overall Study|Ineligibility|0|||
150283983|NCT03703102|542176304|FG004|Overall Study|Ineligibility|0|||
150283984|NCT03703102|542176300|FG000|Overall Study|Protocol Deviation|4|||
150283985|NCT03703102|542176301|FG001|Overall Study|Protocol Deviation|4|||
150283986|NCT03703102|542176302|FG002|Overall Study|Protocol Deviation|3|||
150283987|NCT03703102|542176303|FG003|Overall Study|Protocol Deviation|0|||
150283988|NCT03703102|542176304|FG004|Overall Study|Protocol Deviation|0|||
150283989|NCT03703102|542176300|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150283990|NCT03703102|542176301|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150283991|NCT03703102|542176302|FG002|Overall Study|Non-Compliance with Study Drug|2|||
150283992|NCT03703102|542176303|FG003|Overall Study|Non-Compliance with Study Drug|1|||
150283993|NCT03703102|542176304|FG004|Overall Study|Non-Compliance with Study Drug|4|||
150283994|NCT00957008|542176305|FG000|Overall Study|Withdrawal by Subject|13|||
150283995|NCT00957008|542176306|FG001|Overall Study|Withdrawal by Subject|10|||
150283996|NCT00957008|542176307|FG002|Overall Study|Withdrawal by Subject|12|||
150283997|NCT00957008|542176308|FG003|Overall Study|Withdrawal by Subject|16|||
150283998|NCT00957008|542176305|FG000|Overall Study|Lost to Follow-up|3|||
150283999|NCT00957008|542176306|FG001|Overall Study|Lost to Follow-up|1|||
150284000|NCT00957008|542176307|FG002|Overall Study|Lost to Follow-up|3|||
150284001|NCT00957008|542176308|FG003|Overall Study|Lost to Follow-up|4|||
150284002|NCT00957008|542176305|FG000|Overall Study|Physician Decision|1|||
150284003|NCT00957008|542176306|FG001|Overall Study|Physician Decision|0|||
150284004|NCT00957008|542176307|FG002|Overall Study|Physician Decision|1|||
150284005|NCT00957008|542176308|FG003|Overall Study|Physician Decision|1|||
150284006|NCT00957008|542176305|FG000|Overall Study|Relocated; Family conflict|4|||
150284007|NCT00957008|542176306|FG001|Overall Study|Relocated; Family conflict|1|||
150284008|NCT00957008|542176307|FG002|Overall Study|Relocated; Family conflict|1|||
149952511|NCT03244189|540957864|FG000|Overall Study|Withdrawal by Subject|45|||
149952512|NCT03244189|540957865|FG001|Overall Study|Withdrawal by Subject|23|||
149952513|NCT03244189|540957864|FG000|Overall Study|Technical Problems|2|||
149952514|NCT03244189|540957865|FG001|Overall Study|Technical Problems|0|||
149952515|NCT02850406|540957866|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
149952516|NCT02850406|540957867|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
149952517|NCT02850406|540957868|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
149952518|NCT02850406|540957869|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
149952519|NCT02850406|540957870|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
150284009|NCT00957008|542176308|FG003|Overall Study|Relocated; Family conflict|3|||
150284010|NCT01118351|542176309|FG000|Overall Study|Adverse Event|3|||
150284011|NCT01118351|542176309|FG000|Overall Study|Withdrawal by Subject|1|||
150284012|NCT02797808|542176310|FG000|Overall Study|Withdrawal by Subject|1|||
150284013|NCT02797808|542176311|FG001|Overall Study|Withdrawal by Subject|1|||
150284014|NCT02797808|542176310|FG000|Overall Study|Physician Decision|6|||
150284015|NCT02797808|542176311|FG001|Overall Study|Physician Decision|2|||
150284016|NCT02192827|542176318|FG000|Overall Study|Lost to Follow-up|25|||
150284017|NCT02192827|542176319|FG001|Overall Study|Lost to Follow-up|27|||
150284018|NCT02192827|542176318|FG000|Overall Study|Given additional steroids with admission|13|||
150284019|NCT02192827|542176319|FG001|Overall Study|Given additional steroids with admission|11|||
150284020|NCT00708500|542176321|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
150284021|NCT00708500|542176322|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
150284022|NCT00708500|542176323|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
150284023|NCT00708500|542176321|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
149952520|NCT02850406|540957871|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
150284024|NCT00708500|542176322|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
150284025|NCT00708500|542176323|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
150284026|NCT00708500|542176321|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
149952521|NCT02850406|540957872|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
149952522|NCT02850406|540957873|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
150284027|NCT00708500|542176322|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
150284028|NCT00708500|542176323|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
150284029|NCT00708500|542176321|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
150284030|NCT00708500|542176322|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
150284031|NCT00708500|542176323|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
150284032|NCT00708500|542176321|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
150284033|NCT00708500|542176322|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
150284034|NCT00708500|542176323|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
150284035|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
150284036|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
150284037|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
150284038|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
150284039|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
150284040|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
150284041|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
150284042|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
150284043|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
150284044|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
150284045|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
150284046|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
150284047|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
150284048|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
150284049|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
150284050|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
150284051|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
150284052|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
150284053|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
150284054|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
150284055|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
150284056|NCT00708500|542176321|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
150284057|NCT00708500|542176322|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
150284058|NCT00708500|542176323|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
150284059|NCT00708500|542176321|FG000|FOLLOWUP|Adverse Event|0|||
150284060|NCT00708500|542176322|FG001|FOLLOWUP|Adverse Event|1|||
150284061|NCT00708500|542176323|FG002|FOLLOWUP|Adverse Event|0|||
150284062|NCT00708500|542176321|FG000|FOLLOWUP|Lost to Follow-up|1|||
150284063|NCT00708500|542176322|FG001|FOLLOWUP|Lost to Follow-up|6|||
150284064|NCT00708500|542176323|FG002|FOLLOWUP|Lost to Follow-up|4|||
150284065|NCT00708500|542176321|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
150284066|NCT00708500|542176322|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
150284067|NCT00708500|542176323|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
150284068|NCT00708500|542176321|FG000|FOLLOWUP|Subject withdrew consent|31|||
150284069|NCT00708500|542176322|FG001|FOLLOWUP|Subject withdrew consent|4|||
150284070|NCT00708500|542176323|FG002|FOLLOWUP|Subject withdrew consent|5|||
150284071|NCT00708500|542176321|FG000|FOLLOWUP|Non-compliance with protocol|5|||
150284072|NCT00708500|542176322|FG001|FOLLOWUP|Non-compliance with protocol|0|||
150284073|NCT00708500|542176323|FG002|FOLLOWUP|Non-compliance with protocol|1|||
150284074|NCT03975920|542176324|FG000|Overall Study|Lost to Follow-up|1|||
150284075|NCT03975920|542176325|FG001|Overall Study|Lost to Follow-up|2|||
150284076|NCT03975920|542176324|FG000|Overall Study|Protocol Violation|1|||
150284077|NCT03975920|542176325|FG001|Overall Study|Protocol Violation|1|||
150284078|NCT03975920|542176324|FG000|Overall Study|Did not complete survey|2|||
150284079|NCT03975920|542176325|FG001|Overall Study|Did not complete survey|1|||
150284080|NCT02863809|542176331|FG000|Overall Study|Adverse Event|8|||
149952523|NCT02850406|540957866|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952524|NCT02850406|540957867|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952525|NCT02850406|540957868|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
149952526|NCT02850406|540957869|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
150284081|NCT02863809|542176332|FG001|Overall Study|Adverse Event|8|||
150284082|NCT02863809|542176331|FG000|Overall Study|Withdrawal by Subject|0|||
150284083|NCT02863809|542176332|FG001|Overall Study|Withdrawal by Subject|1|||
150284084|NCT02863809|542176331|FG000|Overall Study|Lost to Follow-up|1|||
149952527|NCT02850406|540957870|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952528|NCT02850406|540957871|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952529|NCT02850406|540957872|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952530|NCT02850406|540957873|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
149952531|NCT02850406|540957866|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
150284085|NCT02863809|542176332|FG001|Overall Study|Lost to Follow-up|1|||
150284086|NCT02863809|542176331|FG000|Overall Study|Death|1|||
150284087|NCT02863809|542176332|FG001|Overall Study|Death|0|||
150284088|NCT01439204|542176333|FG000|Overall Study|Withdrawal by Subject|0|||
150284089|NCT01439204|542176334|FG001|Overall Study|Withdrawal by Subject|1|||
150284090|NCT01439204|542176333|FG000|Overall Study|Lost to Follow-up|0|||
150284091|NCT01439204|542176334|FG001|Overall Study|Lost to Follow-up|2|||
150284092|NCT01439204|542176333|FG000|Overall Study|No longer meets study criteria|1|||
150284093|NCT01439204|542176334|FG001|Overall Study|No longer meets study criteria|0|||
150284094|NCT01439204|542176333|FG000|Overall Study|poor/non-compliance|3|||
150284095|NCT01439204|542176334|FG001|Overall Study|poor/non-compliance|0|||
150284096|NCT01227044|542176338|FG000|Overall Study|Lost to Follow-up|5|||
150284097|NCT01227044|542176339|FG001|Overall Study|Lost to Follow-up|7|||
150284098|NCT01227044|542176338|FG000|Overall Study|Discontinued Intervention|1|||
150284099|NCT01227044|542176339|FG001|Overall Study|Discontinued Intervention|2|||
150284100|NCT04247061|542176340|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
150284101|NCT04247061|542176340|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
150284102|NCT04247061|542176340|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
150284103|NCT00205855|542176351|FG000|Overall Study|Only received temporary implants|16|||
150284104|NCT00205855|542176351|FG000|Overall Study|Withdrawal by Subject|5|||
150284105|NCT00917150|542176352|FG000|Overall Study|Adverse Event|12|||
150284106|NCT00917150|542176353|FG001|Overall Study|Adverse Event|7|||
150284107|NCT00917150|542176354|FG002|Overall Study|Adverse Event|12|||
150284108|NCT00917150|542176355|FG003|Overall Study|Adverse Event|11|||
150284109|NCT00917150|542176352|FG000|Overall Study|Death|1|||
150284110|NCT00917150|542176353|FG001|Overall Study|Death|4|||
150284111|NCT00917150|542176354|FG002|Overall Study|Death|3|||
150284112|NCT00917150|542176355|FG003|Overall Study|Death|2|||
150284113|NCT00917150|542176352|FG000|Overall Study|Lost to Follow-up|1|||
150284114|NCT00917150|542176353|FG001|Overall Study|Lost to Follow-up|0|||
150284115|NCT00917150|542176354|FG002|Overall Study|Lost to Follow-up|4|||
150284116|NCT00917150|542176355|FG003|Overall Study|Lost to Follow-up|2|||
150284117|NCT00917150|542176352|FG000|Overall Study|Physician Decision|0|||
150284118|NCT00917150|542176353|FG001|Overall Study|Physician Decision|2|||
150284119|NCT00917150|542176354|FG002|Overall Study|Physician Decision|0|||
150284120|NCT00917150|542176355|FG003|Overall Study|Physician Decision|1|||
150284121|NCT00917150|542176352|FG000|Overall Study|Protocol Violation|5|||
150284122|NCT00917150|542176353|FG001|Overall Study|Protocol Violation|5|||
150284123|NCT00917150|542176354|FG002|Overall Study|Protocol Violation|3|||
150284124|NCT00917150|542176355|FG003|Overall Study|Protocol Violation|5|||
150284125|NCT00917150|542176352|FG000|Overall Study|Withdrawal by Subject|15|||
150284126|NCT00917150|542176353|FG001|Overall Study|Withdrawal by Subject|16|||
150284127|NCT00917150|542176354|FG002|Overall Study|Withdrawal by Subject|18|||
150284128|NCT00917150|542176355|FG003|Overall Study|Withdrawal by Subject|11|||
150284129|NCT00917150|542176352|FG000|Overall Study|Other than specified|3|||
150284130|NCT00917150|542176353|FG001|Overall Study|Other than specified|3|||
150284131|NCT00917150|542176354|FG002|Overall Study|Other than specified|2|||
150284132|NCT00917150|542176355|FG003|Overall Study|Other than specified|2|||
150284133|NCT03891264|542176356|FG000|Overall Study|Adverse Event|1|||
150284134|NCT03891264|542176356|FG000|Overall Study|Withdrawal by Subject|2|||
150284135|NCT03891264|542176356|FG000|Overall Study|Physician Decision|2|||
150284136|NCT01505634|542176357|FG000|Overall Study|Withdrawal by Subject|2|||
150284137|NCT01505634|542176358|FG001|Overall Study|Withdrawal by Subject|5|||
150284138|NCT01505634|542176359|FG002|Overall Study|Withdrawal by Subject|1|||
149952532|NCT02850406|540957867|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952533|NCT02850406|540957868|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
149952534|NCT02850406|540957869|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952535|NCT02850406|540957870|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952536|NCT02850406|540957871|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952537|NCT02850406|540957872|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952538|NCT02850406|540957873|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
149952539|NCT02850406|540957866|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
149952540|NCT02850406|540957867|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
149952541|NCT02850406|540957868|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
149952542|NCT02850406|540957869|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
149952543|NCT02850406|540957870|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
150284139|NCT01505634|542176357|FG000|Overall Study|Physician Decision|1|||
150284140|NCT01505634|542176358|FG001|Overall Study|Physician Decision|1|||
150284141|NCT01505634|542176359|FG002|Overall Study|Physician Decision|0|||
150284142|NCT01505634|542176357|FG000|Overall Study|Adverse Event|1|||
149952544|NCT02850406|540957871|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
149952545|NCT02850406|540957872|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
150035179|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
150284143|NCT01505634|542176358|FG001|Overall Study|Adverse Event|0|||
150284144|NCT01505634|542176359|FG002|Overall Study|Adverse Event|0|||
150284145|NCT01505634|542176357|FG000|Overall Study|Insufficient supply of drug at site|1|||
150284146|NCT01505634|542176358|FG001|Overall Study|Insufficient supply of drug at site|0|||
150284147|NCT01505634|542176359|FG002|Overall Study|Insufficient supply of drug at site|0|||
150284148|NCT01505634|542176357|FG000|Overall Study|Protocol Violation|2|||
150284149|NCT01505634|542176358|FG001|Overall Study|Protocol Violation|0|||
150284150|NCT01505634|542176359|FG002|Overall Study|Protocol Violation|0|||
150284151|NCT01505634|542176357|FG000|Overall Study|Lost to Follow-up|1|||
150284152|NCT01505634|542176358|FG001|Overall Study|Lost to Follow-up|4|||
150284153|NCT01505634|542176359|FG002|Overall Study|Lost to Follow-up|4|||
150284154|NCT01505634|542176357|FG000|Overall Study|Death|1|||
150284155|NCT01505634|542176358|FG001|Overall Study|Death|0|||
150284156|NCT01505634|542176359|FG002|Overall Study|Death|0|||
150284157|NCT01505634|542176357|FG000|Overall Study|In a conflict zone|0|||
150284158|NCT01505634|542176358|FG001|Overall Study|In a conflict zone|0|||
150284159|NCT01505634|542176359|FG002|Overall Study|In a conflict zone|1|||
150284160|NCT04294719|542176361|FG000|Overall Study|Withdrawal by Subject|1|||
150284161|NCT01934556|542176374|FG000|Overall Study|Withdrawal by Subject|0|||
150284162|NCT01934556|542176375|FG001|Overall Study|Withdrawal by Subject|1|||
150284163|NCT01934556|542176376|FG002|Overall Study|Withdrawal by Subject|1|||
150284164|NCT01934556|542176374|FG000|Overall Study|Lost to Follow-up|4|||
150284165|NCT01934556|542176375|FG001|Overall Study|Lost to Follow-up|10|||
150284166|NCT01934556|542176376|FG002|Overall Study|Lost to Follow-up|7|||
150284167|NCT01934556|542176374|FG000|Overall Study|Death|1|||
150284168|NCT01934556|542176375|FG001|Overall Study|Death|5|||
150284169|NCT01934556|542176376|FG002|Overall Study|Death|2|||
150284170|NCT00102960|542176379|FG000|Overall Study|Death|23|||
150284171|NCT00102960|542176380|FG001|Overall Study|Death|11|||
150284172|NCT00102960|542176381|FG002|Overall Study|Death|11|||
150284173|NCT00102960|542176379|FG000|Overall Study|Lost to Follow-up|6|||
150284174|NCT00102960|542176380|FG001|Overall Study|Lost to Follow-up|12|||
150284175|NCT00102960|542176381|FG002|Overall Study|Lost to Follow-up|16|||
150284176|NCT00102960|542176379|FG000|Overall Study|Withdrawal by Subject|1|||
150284177|NCT00102960|542176380|FG001|Overall Study|Withdrawal by Subject|0|||
150284178|NCT00102960|542176381|FG002|Overall Study|Withdrawal by Subject|1|||
150284179|NCT05038020|542176383|FG000|Overall Study|Early Termination|3|||
150284180|NCT05038020|542176384|FG001|Overall Study|Early Termination|0|||
150284181|NCT03770260|542178666|FG000|Overall Study|Disease progression|0|||
150284182|NCT03770260|542178667|FG001|Overall Study|Disease progression|1|||
150284183|NCT03770260|542178668|FG002|Overall Study|Disease progression|0|||
150284184|NCT03770260|542178669|FG003|Overall Study|Disease progression|0|||
150284185|NCT01394939|542178672|FG000|Overall Study|Adverse Event|1|||
150284186|NCT01394939|542178673|FG001|Overall Study|Adverse Event|3|||
150284187|NCT01394939|542178674|FG002|Overall Study|Adverse Event|0|||
150284188|NCT01394939|542178675|FG003|Overall Study|Adverse Event|2|||
150284189|NCT01394939|542178672|FG000|Overall Study|Death|0|||
150284190|NCT01394939|542178673|FG001|Overall Study|Death|2|||
150284191|NCT01394939|542178674|FG002|Overall Study|Death|0|||
150284192|NCT01394939|542178675|FG003|Overall Study|Death|0|||
150284193|NCT01394939|542178672|FG000|Overall Study|Physician Decision|0|||
150284194|NCT01394939|542178673|FG001|Overall Study|Physician Decision|1|||
149952546|NCT02850406|540957873|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
149952547|NCT02850406|540957866|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
149952548|NCT02850406|540957867|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
149952549|NCT02850406|540957868|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
149952550|NCT02850406|540957869|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
149952551|NCT02850406|540957870|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
149952552|NCT02850406|540957871|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
149952553|NCT02850406|540957872|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
149952554|NCT02850406|540957873|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
150284195|NCT01394939|542178674|FG002|Overall Study|Physician Decision|0|||
150284196|NCT01394939|542178675|FG003|Overall Study|Physician Decision|0|||
150284197|NCT01394939|542178672|FG000|Overall Study|Withdrawal by Subject|0|||
150284198|NCT01394939|542178673|FG001|Overall Study|Withdrawal by Subject|2|||
150284199|NCT01394939|542178674|FG002|Overall Study|Withdrawal by Subject|0|||
150284200|NCT01394939|542178675|FG003|Overall Study|Withdrawal by Subject|2|||
150284201|NCT01394939|542178672|FG000|Overall Study|Others|0|||
150284202|NCT01394939|542178673|FG001|Overall Study|Others|2|||
150284203|NCT01394939|542178674|FG002|Overall Study|Others|0|||
150284204|NCT01394939|542178675|FG003|Overall Study|Others|3|||
150284205|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
150284206|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
150284207|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
150284208|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
150284209|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
150284210|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
150284211|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
149952555|NCT02850406|540957866|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952556|NCT02850406|540957867|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
150284212|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
150284213|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
150284214|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
150284215|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
150284216|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
150284217|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
150284218|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
150284219|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
150284220|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
150284221|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
150284222|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
150284223|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
150284224|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
150284225|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
150284226|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
150284227|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
150284228|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
150284229|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
150284230|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
150284231|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
150284232|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
150284233|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
150284234|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
150284235|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
150284236|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
150284237|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
150284238|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
150284239|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
150284240|NCT02831673|542178676|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
150284241|NCT02831673|542178677|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
150284242|NCT02831673|542178678|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
149952557|NCT02850406|540957868|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952558|NCT02850406|540957869|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952559|NCT02850406|540957870|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
149952560|NCT02850406|540957871|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
149952561|NCT02850406|540957872|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952562|NCT02850406|540957873|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952563|NCT02850406|540957866|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952564|NCT02850406|540957867|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952565|NCT02850406|540957868|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952566|NCT02850406|540957869|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952567|NCT02850406|540957870|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
149952568|NCT02850406|540957871|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952569|NCT02850406|540957872|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952570|NCT02850406|540957873|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
149952571|NCT02850406|540957866|FG000|Part C (Up to 52 Weeks)|Other|0|||
149952572|NCT02850406|540957867|FG001|Part C (Up to 52 Weeks)|Other|0|||
149952573|NCT02850406|540957868|FG002|Part C (Up to 52 Weeks)|Other|0|||
149952574|NCT02850406|540957869|FG003|Part C (Up to 52 Weeks)|Other|0|||
149952575|NCT02850406|540957870|FG004|Part C (Up to 52 Weeks)|Other|1|||
149952576|NCT02850406|540957871|FG005|Part C (Up to 52 Weeks)|Other|3|||
149952577|NCT02850406|540957872|FG006|Part C (Up to 52 Weeks)|Other|0|||
149952578|NCT02850406|540957873|FG007|Part C (Up to 52 Weeks)|Other|0|||
149952579|NCT02850406|540957866|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952580|NCT02850406|540957867|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952581|NCT02850406|540957868|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952582|NCT02850406|540957869|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952583|NCT02850406|540957870|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952584|NCT02850406|540957871|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952585|NCT02850406|540957872|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
149952586|NCT02850406|540957873|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
149952587|NCT02850406|540957866|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952588|NCT02850406|540957867|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952589|NCT02850406|540957868|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952590|NCT02850406|540957869|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952591|NCT02850406|540957870|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952592|NCT02850406|540957871|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
150035180|NCT02006472|541268892|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
150035181|NCT02006472|541268893|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
149952593|NCT02850406|540957872|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
149952594|NCT02850406|540957873|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
149952595|NCT02850406|540957866|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
149952596|NCT02850406|540957867|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
149952597|NCT02850406|540957868|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
149952598|NCT02850406|540957869|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
149952599|NCT02850406|540957870|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
150284243|NCT02831673|542178679|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
150284244|NCT02831673|542178680|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
150284245|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150284246|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150284247|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
150284248|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
150284249|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150284250|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150284251|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150284252|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
150284253|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
150284254|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150284255|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150284256|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150284257|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150284258|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
150284259|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150284260|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
150284261|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
150284262|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
150284263|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
150284264|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
150284265|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150284266|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150284267|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
150284268|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
150284269|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150284270|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150284271|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150284272|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
150284273|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
150284274|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150284275|NCT02831673|542178676|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150284276|NCT02831673|542178677|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150284277|NCT02831673|542178678|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
150284278|NCT02831673|542178679|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
150284279|NCT02831673|542178680|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150284280|NCT02831673|542178676|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
150284281|NCT02831673|542178677|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
150284282|NCT02831673|542178678|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
150284283|NCT02831673|542178679|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
150284284|NCT02831673|542178680|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
150284285|NCT02831673|542178676|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150284286|NCT02831673|542178677|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150284287|NCT02831673|542178678|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150284288|NCT02831673|542178679|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150284289|NCT02831673|542178680|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
150284290|NCT02831673|542178676|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150284291|NCT02831673|542178677|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150284292|NCT02831673|542178678|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150284293|NCT02831673|542178679|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150284294|NCT02831673|542178680|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
150284295|NCT02831673|542178676|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150284296|NCT02831673|542178677|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150284297|NCT02831673|542178678|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150284298|NCT02831673|542178679|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150284299|NCT02831673|542178680|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
150284300|NCT02831673|542178676|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150284301|NCT02831673|542178677|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150284302|NCT02831673|542178678|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150284303|NCT02831673|542178679|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150284304|NCT02831673|542178680|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
150284305|NCT00150592|542178681|FG000|Overall Study|Adverse Event|4|||
150284306|NCT00150592|542178682|FG001|Overall Study|Adverse Event|1|||
150284307|NCT00150592|542178681|FG000|Overall Study|Protocol Violation|1|||
150284308|NCT00150592|542178682|FG001|Overall Study|Protocol Violation|0|||
150284309|NCT00150592|542178681|FG000|Overall Study|Withdrawal by Subject|1|||
150035182|NCT02006472|541268894|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
150035183|NCT02006472|541268895|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
150035184|NCT02006472|541268896|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
150035185|NCT00886379|541268897|FG000|Overall Study|Transferred Schools|0|||
150284310|NCT00150592|542178682|FG001|Overall Study|Withdrawal by Subject|2|||
150284311|NCT00150592|542178681|FG000|Overall Study|Non-compliance|1|||
150284312|NCT00150592|542178682|FG001|Overall Study|Non-compliance|0|||
150284313|NCT00874120|542178683|FG000|First Intervention|Adverse Event|0|||
150284314|NCT00874120|542178684|FG001|First Intervention|Adverse Event|1|||
150284315|NCT00874120|542178683|FG000|First Intervention|Withdrawal by Subject|2|||
150284316|NCT00874120|542178684|FG001|First Intervention|Withdrawal by Subject|0|||
150284317|NCT00874120|542178683|FG000|First Intervention|Lost to Follow-up|0|||
150284318|NCT00874120|542178684|FG001|First Intervention|Lost to Follow-up|1|||
150284319|NCT00874120|542178683|FG000|First Intervention|Protocol Violation|3|||
150284320|NCT00874120|542178684|FG001|First Intervention|Protocol Violation|0|||
150284321|NCT00874120|542178683|FG000|First Intervention|positive drug test|1|||
150284322|NCT00874120|542178684|FG001|First Intervention|positive drug test|0|||
150284323|NCT00874120|542178683|FG000|Second Intervention|Withdrawal by Subject|1|||
150284324|NCT00874120|542178684|FG001|Second Intervention|Withdrawal by Subject|0|||
150284325|NCT00874120|542178683|FG000|Second Intervention|Protocol Violation|1|||
150284326|NCT00874120|542178684|FG001|Second Intervention|Protocol Violation|0|||
150284327|NCT00477165|542178685|FG000|Overall Study|Adverse Event|7|||
150284328|NCT00477165|542178686|FG001|Overall Study|Adverse Event|2|||
150284329|NCT01823679|542178687|FG000|Overall Study|Death|1|||
150284330|NCT01659320|542178693|FG000|Overall Study|Withdrawal by Subject|2|||
150284331|NCT01659320|542178693|FG000|Overall Study|Physician Decision|1|||
150284332|NCT01870401|542178694|FG000|Overall Study|Death|48|||
150284333|NCT01870401|542178695|FG001|Overall Study|Death|24|||
150284334|NCT01870401|542178694|FG000|Overall Study|Withdrawal by Subject|39|||
150284335|NCT01870401|542178695|FG001|Overall Study|Withdrawal by Subject|26|||
150284336|NCT01870401|542178694|FG000|Overall Study|Lost to Follow-up|19|||
150284337|NCT01870401|542178695|FG001|Overall Study|Lost to Follow-up|14|||
150284338|NCT01870401|542178694|FG000|Overall Study|Other|9|||
150284339|NCT01870401|542178695|FG001|Overall Study|Other|7|||
150284340|NCT01870401|542178694|FG000|Overall Study|On-going in the Study|35|||
150284341|NCT01870401|542178695|FG001|Overall Study|On-going in the Study|25|||
150284342|NCT05634577|542178698|FG000|Overall Study|Lost to Follow-up|1|||
150284343|NCT05634577|542178698|FG000|Overall Study|Withdrawal by Subject|1|||
150284344|NCT01192022|542178699|FG000|Overall Study|Withdrawal of Consent|3|||
150284345|NCT01192022|542178700|FG001|Overall Study|Withdrawal of Consent|1|||
150284346|NCT01192022|542178701|FG002|Overall Study|Withdrawal of Consent|0|||
150284347|NCT01192022|542178702|FG003|Overall Study|Withdrawal of Consent|0|||
150284348|NCT01192022|542178703|FG004|Overall Study|Withdrawal of Consent|0|||
150284349|NCT01192022|542178699|FG000|Overall Study|Lost to Follow-up|4|||
150284350|NCT01192022|542178700|FG001|Overall Study|Lost to Follow-up|2|||
150284351|NCT01192022|542178701|FG002|Overall Study|Lost to Follow-up|1|||
150284352|NCT01192022|542178702|FG003|Overall Study|Lost to Follow-up|1|||
150284353|NCT01192022|542178703|FG004|Overall Study|Lost to Follow-up|0|||
150284354|NCT01192022|542178699|FG000|Overall Study|Adverse Event|1|||
150284355|NCT01192022|542178700|FG001|Overall Study|Adverse Event|0|||
150284356|NCT01192022|542178701|FG002|Overall Study|Adverse Event|0|||
150284357|NCT01192022|542178702|FG003|Overall Study|Adverse Event|0|||
150284358|NCT01192022|542178703|FG004|Overall Study|Adverse Event|0|||
150284359|NCT01192022|542178699|FG000|Overall Study|Fatal Adverse Event|4|||
150284360|NCT01192022|542178700|FG001|Overall Study|Fatal Adverse Event|6|||
150035186|NCT00886379|541268898|FG001|Overall Study|Transferred Schools|0|||
150035187|NCT00886379|541268899|FG002|Overall Study|Transferred Schools|2|||
150035188|NCT00886379|541268900|FG003|Overall Study|Transferred Schools|1|||
150284361|NCT01192022|542178701|FG002|Overall Study|Fatal Adverse Event|0|||
150284362|NCT01192022|542178702|FG003|Overall Study|Fatal Adverse Event|0|||
150284363|NCT01192022|542178703|FG004|Overall Study|Fatal Adverse Event|1|||
150284364|NCT01192022|542178699|FG000|Overall Study|Physician withdrew-patient hardship|1|||
150284365|NCT01192022|542178700|FG001|Overall Study|Physician withdrew-patient hardship|0|||
150284366|NCT01192022|542178701|FG002|Overall Study|Physician withdrew-patient hardship|0|||
150284367|NCT01192022|542178702|FG003|Overall Study|Physician withdrew-patient hardship|0|||
150284368|NCT01192022|542178703|FG004|Overall Study|Physician withdrew-patient hardship|0|||
150284369|NCT01192022|542178699|FG000|Overall Study|Patient too sick from chemotherapy|0|||
150284370|NCT01192022|542178700|FG001|Overall Study|Patient too sick from chemotherapy|1|||
150284371|NCT01192022|542178701|FG002|Overall Study|Patient too sick from chemotherapy|0|||
150284372|NCT01192022|542178702|FG003|Overall Study|Patient too sick from chemotherapy|0|||
150284373|NCT01192022|542178703|FG004|Overall Study|Patient too sick from chemotherapy|0|||
150284374|NCT01192022|542178699|FG000|Overall Study|Patient needed surgery|0|||
150284375|NCT01192022|542178700|FG001|Overall Study|Patient needed surgery|1|||
150284376|NCT01192022|542178701|FG002|Overall Study|Patient needed surgery|0|||
150284377|NCT01192022|542178702|FG003|Overall Study|Patient needed surgery|0|||
150284378|NCT01192022|542178703|FG004|Overall Study|Patient needed surgery|0|||
150284379|NCT01192022|542178699|FG000|Overall Study|Parents did not allow all follow up|0|||
150284380|NCT01192022|542178700|FG001|Overall Study|Parents did not allow all follow up|0|||
150284381|NCT01192022|542178701|FG002|Overall Study|Parents did not allow all follow up|0|||
150284382|NCT01192022|542178702|FG003|Overall Study|Parents did not allow all follow up|1|||
150284383|NCT01192022|542178703|FG004|Overall Study|Parents did not allow all follow up|0|||
150284384|NCT01351389|542178704|FG000|Overall Study|Withdrawal by Subject|7|||
150284385|NCT01351389|542178705|FG001|Overall Study|Withdrawal by Subject|0|||
150284386|NCT01351389|542178704|FG000|Overall Study|did not complete intervention|23|||
150284387|NCT01351389|542178705|FG001|Overall Study|did not complete intervention|15|||
150284388|NCT04839978|542178706|FG000|Overall Study|Lost to Follow-up|135|||
150284389|NCT04839978|542178707|FG001|Overall Study|Lost to Follow-up|147|||
150284390|NCT00623480|542178709|FG000|Overall Study|Lost to Follow-up|0|||
150284391|NCT00623480|542178710|FG001|Overall Study|Lost to Follow-up|1|||
150284392|NCT00623480|542178709|FG000|Overall Study|Withdrawal by Subject|2|||
150284393|NCT00623480|542178710|FG001|Overall Study|Withdrawal by Subject|4|||
150284394|NCT00623480|542178709|FG000|Overall Study|Lack of Efficacy|1|||
150284395|NCT00623480|542178710|FG001|Overall Study|Lack of Efficacy|0|||
150284396|NCT00623480|542178709|FG000|Overall Study|Non-compliant with study medication|4|||
150284397|NCT00623480|542178710|FG001|Overall Study|Non-compliant with study medication|0|||
150284398|NCT00623480|542178709|FG000|Overall Study|Protocol Violation|0|||
150284399|NCT00623480|542178710|FG001|Overall Study|Protocol Violation|1|||
150284400|NCT00623480|542178709|FG000|Overall Study|Site closed by sponsor|0|||
150284401|NCT00623480|542178710|FG001|Overall Study|Site closed by sponsor|1|||
150284402|NCT03551509|542178711|FG000|Overall Study|Lost to Follow-up|0|||
150284403|NCT03551509|542178712|FG001|Overall Study|Lost to Follow-up|1|||
150284404|NCT03551509|542178713|FG002|Overall Study|Lost to Follow-up|0|||
150284405|NCT01594853|542178714|FG000|Overall Study|Withdrawal by Subject|1|||
150284406|NCT01594853|542178715|FG001|Overall Study|Withdrawal by Subject|1|||
150284407|NCT01594853|542178714|FG000|Overall Study|Lost to Follow-up|1|||
150284408|NCT01594853|542178715|FG001|Overall Study|Lost to Follow-up|1|||
150284409|NCT01594853|542178714|FG000|Overall Study|noncompliance with exercise|0|||
150284410|NCT01594853|542178715|FG001|Overall Study|noncompliance with exercise|1|||
150284411|NCT00769002|542178718|FG000|Overall Study|Study was not completed, no data|9|||
150284412|NCT00769002|542178719|FG001|Overall Study|Study was not completed, no data|9|||
150284413|NCT03776175|542178721|FG000|Treatment Period (42 Days)|Adverse Event|0|||
150284414|NCT03776175|542178722|FG001|Treatment Period (42 Days)|Adverse Event|1|||
150284415|NCT03776175|542178723|FG002|Treatment Period (42 Days)|Adverse Event|1|||
150284416|NCT03776175|542178724|FG003|Treatment Period (42 Days)|Adverse Event|0|||
150284417|NCT03776175|542178721|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
150284418|NCT03776175|542178722|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
150284419|NCT03776175|542178723|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
150284420|NCT03776175|542178724|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
150284421|NCT03776175|542178721|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
150284422|NCT03776175|542178722|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
150284423|NCT03776175|542178723|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
150284424|NCT03776175|542178724|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
150284425|NCT03776175|542178721|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
150284426|NCT03776175|542178722|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
150284427|NCT03776175|542178723|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
149839365|NCT03686033|540541392|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
149839366|NCT03686033|540541393|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
150284428|NCT03776175|542178724|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
150284429|NCT03776175|542178721|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
150284430|NCT03776175|542178722|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
150284431|NCT03776175|542178723|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
150284432|NCT03776175|542178724|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
150284433|NCT03776175|542178721|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
150284434|NCT03776175|542178722|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
150284435|NCT03776175|542178723|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
150284436|NCT03776175|542178724|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
150284437|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
149839367|NCT01854047|540541394|FG000|Overall Study|Lack of Efficacy|1|||
149839368|NCT01854047|540541395|FG001|Overall Study|Lack of Efficacy|0|||
149839369|NCT01854047|540541396|FG002|Overall Study|Lack of Efficacy|0|||
149839370|NCT01854047|540541397|FG003|Overall Study|Lack of Efficacy|0|||
149839371|NCT01854047|540541398|FG004|Overall Study|Lack of Efficacy|0|||
150284438|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
149839372|NCT01854047|540541394|FG000|Overall Study|Poor compliance to protocol|3|||
149839373|NCT01854047|540541395|FG001|Overall Study|Poor compliance to protocol|0|||
150284439|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
149839374|NCT01854047|540541396|FG002|Overall Study|Poor compliance to protocol|2|||
149839375|NCT01854047|540541397|FG003|Overall Study|Poor compliance to protocol|0|||
149839376|NCT01854047|540541398|FG004|Overall Study|Poor compliance to protocol|0|||
149839377|NCT01854047|540541394|FG000|Overall Study|Adverse Event|5|||
149839378|NCT01854047|540541395|FG001|Overall Study|Adverse Event|4|||
149839379|NCT01854047|540541396|FG002|Overall Study|Adverse Event|6|||
149839380|NCT01854047|540541397|FG003|Overall Study|Adverse Event|10|||
149839381|NCT01854047|540541398|FG004|Overall Study|Adverse Event|7|||
149839382|NCT01854047|540541394|FG000|Overall Study|Randomized but not treated|0|||
149952600|NCT02850406|540957871|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
149952601|NCT02850406|540957872|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
150284440|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
150284441|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
150284442|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
150284443|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
150284444|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
150284445|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
150284446|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
150284447|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
150284448|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
150284449|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
150284450|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
150284451|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
150284452|NCT00960661|542178725|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
150284453|NCT00960661|542178726|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
150284454|NCT00960661|542178727|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
150284455|NCT00960661|542178725|FG000|Interventional Phase|Adverse Event|0|||
150284456|NCT00960661|542178726|FG001|Interventional Phase|Adverse Event|17|||
150284457|NCT00960661|542178727|FG002|Interventional Phase|Adverse Event|8|||
150284458|NCT00960661|542178725|FG000|Interventional Phase|Death|0|||
150284459|NCT00960661|542178726|FG001|Interventional Phase|Death|1|||
150284460|NCT00960661|542178727|FG002|Interventional Phase|Death|0|||
150284461|NCT00960661|542178725|FG000|Interventional Phase|Lost to Follow-up|0|||
150284462|NCT00960661|542178726|FG001|Interventional Phase|Lost to Follow-up|0|||
150284463|NCT00960661|542178727|FG002|Interventional Phase|Lost to Follow-up|2|||
150284464|NCT00960661|542178725|FG000|Interventional Phase|entry criteria not met|0|||
150284465|NCT00960661|542178726|FG001|Interventional Phase|entry criteria not met|3|||
150284466|NCT00960661|542178727|FG002|Interventional Phase|entry criteria not met|0|||
150284467|NCT00960661|542178725|FG000|Interventional Phase|Protocol Violation|0|||
150284468|NCT00960661|542178726|FG001|Interventional Phase|Protocol Violation|7|||
150284469|NCT00960661|542178727|FG002|Interventional Phase|Protocol Violation|2|||
150284470|NCT00960661|542178725|FG000|Interventional Phase|Withdrawal by Subject|0|||
150284471|NCT00960661|542178726|FG001|Interventional Phase|Withdrawal by Subject|18|||
150284472|NCT00960661|542178727|FG002|Interventional Phase|Withdrawal by Subject|29|||
150284473|NCT00960661|542178725|FG000|Interventional Phase|Physician Decision|0|||
150284474|NCT00960661|542178726|FG001|Interventional Phase|Physician Decision|3|||
150284475|NCT00960661|542178727|FG002|Interventional Phase|Physician Decision|5|||
150284476|NCT00960661|542178725|FG000|Interventional Phase|sponsor decision|0|||
150284477|NCT00960661|542178726|FG001|Interventional Phase|sponsor decision|1|||
150284478|NCT00960661|542178727|FG002|Interventional Phase|sponsor decision|0|||
150284479|NCT00960661|542178725|FG000|Interventional Phase|Lack of Efficacy|0|||
150284480|NCT00960661|542178726|FG001|Interventional Phase|Lack of Efficacy|2|||
149952602|NCT02850406|540957873|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
150284481|NCT00960661|542178727|FG002|Interventional Phase|Lack of Efficacy|0|||
150284482|NCT02699892|542178728|FG000|Overall Study|Other|36|||
150284483|NCT04677712|542178730|FG000|Overall Study|Lost to Follow-up|0|||
150284484|NCT04677712|542178731|FG001|Overall Study|Lost to Follow-up|1|||
150284485|NCT04677712|542178732|FG002|Overall Study|Lost to Follow-up|0|||
150284486|NCT04677712|542178733|FG003|Overall Study|Lost to Follow-up|0|||
150284487|NCT04677712|542178734|FG004|Overall Study|Lost to Follow-up|0|||
150284488|NCT04677712|542178735|FG005|Overall Study|Lost to Follow-up|0|||
150284489|NCT00711100|542178736|FG000|Overall Study|Lack of Efficacy|5|||
150284490|NCT00711100|542178736|FG000|Overall Study|Withdrawal by Subject|8|||
150284491|NCT00847912|542178737|FG000|Overall Study|Protocol Violation|6|||
150284492|NCT00847912|542178738|FG001|Overall Study|Protocol Violation|7|||
149952603|NCT02850406|540957866|FG000|Part D (Up to 52 Weeks)|Other|0|||
150284493|NCT00847912|542178737|FG000|Overall Study|Withdrawal by Subject|3|||
150284494|NCT00847912|542178738|FG001|Overall Study|Withdrawal by Subject|6|||
150284495|NCT00783094|542178739|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
150284496|NCT00783094|542178740|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
150284497|NCT00783094|542178741|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
149839383|NCT01854047|540541395|FG001|Overall Study|Randomized but not treated|1|||
149952604|NCT02850406|540957867|FG001|Part D (Up to 52 Weeks)|Other|0|||
150284498|NCT00783094|542178739|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
150284499|NCT00783094|542178740|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
150284500|NCT00783094|542178741|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
150284501|NCT00783094|542178739|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
150284502|NCT00783094|542178740|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
150284503|NCT00783094|542178741|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
150284504|NCT00783094|542178739|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
150284505|NCT00783094|542178740|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
150284506|NCT00783094|542178741|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
150284507|NCT00783094|542178739|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
150284508|NCT00783094|542178740|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
150284509|NCT00783094|542178741|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
150284510|NCT00783094|542178739|FG000|Open-Label Extension Period|Adverse Event|12|||
150284511|NCT00783094|542178740|FG001|Open-Label Extension Period|Adverse Event|7|||
150284512|NCT00783094|542178741|FG002|Open-Label Extension Period|Adverse Event|16|||
150284513|NCT00783094|542178739|FG000|Open-Label Extension Period|Death|0|||
150284514|NCT00783094|542178740|FG001|Open-Label Extension Period|Death|0|||
150284515|NCT00783094|542178741|FG002|Open-Label Extension Period|Death|1|||
150284516|NCT00783094|542178739|FG000|Open-Label Extension Period|Protocol Violation|4|||
150284517|NCT00783094|542178740|FG001|Open-Label Extension Period|Protocol Violation|5|||
150284518|NCT00783094|542178741|FG002|Open-Label Extension Period|Protocol Violation|7|||
150284519|NCT00783094|542178739|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
150284520|NCT00783094|542178740|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
150284521|NCT00783094|542178741|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
150284522|NCT00783094|542178739|FG000|Open-Label Extension Period|Physician Decision|4|||
150284523|NCT00783094|542178740|FG001|Open-Label Extension Period|Physician Decision|2|||
150284524|NCT00783094|542178741|FG002|Open-Label Extension Period|Physician Decision|3|||
150284525|NCT00783094|542178739|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
150284526|NCT00783094|542178740|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
150284527|NCT00783094|542178741|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
150284528|NCT03808077|542178742|FG000|Overall Study|Physician Decision|2|||
150284529|NCT03808077|542178743|FG001|Overall Study|Physician Decision|3|||
150284530|NCT03808077|542178742|FG000|Overall Study|Withdrawal by Subject|1|||
150284531|NCT03808077|542178743|FG001|Overall Study|Withdrawal by Subject|0|||
150284532|NCT03808077|542178742|FG000|Overall Study|Equipment Issues|2|||
150284533|NCT03808077|542178743|FG001|Overall Study|Equipment Issues|1|||
150284534|NCT00001379|542178744|FG000|Initial Treatment|Disease progression|21|||
150284535|NCT00001379|542178745|FG001|Initial Treatment|Disease progression|3|||
150284536|NCT00001379|542178746|FG002|Initial Treatment|Disease progression|0|||
150284537|NCT00001379|542178747|FG003|Initial Treatment|Disease progression|0|||
150284538|NCT00001379|542178744|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
150284539|NCT00001379|542178745|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
150284540|NCT00001379|542178746|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
150284541|NCT00001379|542178747|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
150284542|NCT00001379|542178744|FG000|Initial Treatment|Received alternative treatment|2|||
150284543|NCT00001379|542178745|FG001|Initial Treatment|Received alternative treatment|1|||
150284544|NCT00001379|542178746|FG002|Initial Treatment|Received alternative treatment|0|||
150284545|NCT00001379|542178747|FG003|Initial Treatment|Received alternative treatment|0|||
150284546|NCT00001379|542178744|FG000|Initial Treatment|Refused further treatment|2|||
150284547|NCT00001379|542178745|FG001|Initial Treatment|Refused further treatment|0|||
150284548|NCT00001379|542178746|FG002|Initial Treatment|Refused further treatment|0|||
150284549|NCT00001379|542178747|FG003|Initial Treatment|Refused further treatment|0|||
150284550|NCT00001379|542178744|FG000|Initial Treatment|Did not receive protocol treatment|0|||
150284551|NCT00001379|542178745|FG001|Initial Treatment|Did not receive protocol treatment|0|||
150284552|NCT00001379|542178746|FG002|Initial Treatment|Did not receive protocol treatment|5|||
150284553|NCT00001379|542178747|FG003|Initial Treatment|Did not receive protocol treatment|0|||
150284554|NCT00001379|542178744|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
150284555|NCT00001379|542178745|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
150284556|NCT00001379|542178746|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
150284557|NCT00001379|542178747|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
150284558|NCT00001379|542178744|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
150284559|NCT00001379|542178745|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
150284560|NCT00001379|542178746|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
150284561|NCT00001379|542178747|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
150284562|NCT00001379|542178744|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
150284563|NCT00001379|542178745|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
150284564|NCT00001379|542178746|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
150284565|NCT00001379|542178747|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
150284566|NCT00001379|542178744|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
150284567|NCT00001379|542178745|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
150284568|NCT00001379|542178746|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
150284569|NCT00001379|542178747|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
150284570|NCT00001379|542178744|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
150284571|NCT00001379|542178745|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
150284572|NCT00001379|542178746|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
150284573|NCT00001379|542178747|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
150284574|NCT02311153|542178750|FG000|Overall Study|Lost to Follow-up|5|||
150284575|NCT02311153|542178751|FG001|Overall Study|Lost to Follow-up|7|||
150284576|NCT01650636|542178756|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
150284577|NCT01650636|542178757|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
150284578|NCT01650636|542178756|FG000|Washout up to 5 Months|Physician Decision|2|||
150284579|NCT01650636|542178757|FG001|Washout up to 5 Months|Physician Decision|2|||
150284580|NCT01650636|542178756|FG000|Washout up to 5 Months|Death|1|||
150284581|NCT01650636|542178757|FG001|Washout up to 5 Months|Death|0|||
150284582|NCT01650636|542178756|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
150284583|NCT01650636|542178757|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
150284584|NCT01650636|542178756|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
150284585|NCT01650636|542178757|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
150284586|NCT01650636|542178756|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
150284587|NCT01650636|542178757|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
150284588|NCT01560780|542178758|FG000|Overall Study|Death|2|||
150284589|NCT01560780|542178759|FG001|Overall Study|Death|1|||
150284590|NCT01560780|542178758|FG000|Overall Study|Patient Preference|11|||
149952605|NCT02850406|540957868|FG002|Part D (Up to 52 Weeks)|Other|0|||
149952606|NCT02850406|540957869|FG003|Part D (Up to 52 Weeks)|Other|0|||
149952607|NCT02850406|540957870|FG004|Part D (Up to 52 Weeks)|Other|0|||
149952608|NCT02850406|540957871|FG005|Part D (Up to 52 Weeks)|Other|0|||
149952609|NCT02850406|540957872|FG006|Part D (Up to 52 Weeks)|Other|0|||
149952610|NCT02850406|540957873|FG007|Part D (Up to 52 Weeks)|Other|1|||
149952611|NCT04633447|540958628|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
149952612|NCT04633447|540958629|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
149952613|NCT04633447|540958628|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
149952614|NCT04633447|540958629|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
149952615|NCT04633447|540958628|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
149952616|NCT04633447|540958629|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
149952617|NCT04633447|540958628|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
149952618|NCT04633447|540958629|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
149952619|NCT04633447|540958628|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
149952620|NCT04633447|540958629|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
149952621|NCT04633447|540958628|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
149952622|NCT04633447|540958629|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
149952623|NCT00639379|540958634|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
149952624|NCT00639379|540958635|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
149952625|NCT00639379|540958634|FG000|Period 1 - 2 Weeks|lens issue|3|||
149952626|NCT00639379|540958635|FG001|Period 1 - 2 Weeks|lens issue|0|||
149952627|NCT05630755|540958638|FG000|Overall Study|Lost to Follow-up|7|||
149952628|NCT05630755|540958639|FG001|Overall Study|Lost to Follow-up|0|||
149952629|NCT05630755|540958638|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
149952630|NCT05630755|540958639|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
149952631|NCT05630755|540958638|FG000|Overall Study|Withdrawal by Subject|9|||
149952632|NCT05630755|540958639|FG001|Overall Study|Withdrawal by Subject|3|||
149952633|NCT05630755|540958638|FG000|Overall Study|Participant moved away from trial site|0|||
149952634|NCT05630755|540958639|FG001|Overall Study|Participant moved away from trial site|1|||
149952635|NCT05630755|540958638|FG000|Overall Study|Status not Recorded|316|||
149952636|NCT05630755|540958639|FG001|Overall Study|Status not Recorded|161|||
149952637|NCT04868682|540958640|FG000|Post-treatment|Lost to Follow-up|1|||
149952638|NCT04868682|540958641|FG001|Post-treatment|Lost to Follow-up|1|||
150284591|NCT01560780|542178759|FG001|Overall Study|Patient Preference|11|||
150284592|NCT01577186|542178760|FG000|Overall Study|Adverse Event|23|||
150284593|NCT01577186|542178760|FG000|Overall Study|Death|1|||
150284594|NCT01577186|542178760|FG000|Overall Study|Lost to Follow-up|28|||
149952639|NCT04868682|540958640|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
150035189|NCT00886379|541268901|FG004|Overall Study|Transferred Schools|1|||
149952640|NCT04868682|540958641|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
149952641|NCT04868682|540958640|FG000|Six-month Assessment|Lost to Follow-up|1|||
149952642|NCT04868682|540958641|FG001|Six-month Assessment|Lost to Follow-up|0|||
150284595|NCT01577186|542178760|FG000|Overall Study|Withdrawal by Subject|35|||
150284596|NCT01577186|542178760|FG000|Overall Study|Insufficient Response|18|||
150284597|NCT01577186|542178760|FG000|Overall Study|Ineligible to Continue|15|||
150284598|NCT01577186|542178760|FG000|Overall Study|Non-Compliant|8|||
150284599|NCT01577186|542178760|FG000|Overall Study|Other|2|||
150284600|NCT00811135|542178761|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
150284601|NCT00811135|542178761|FG000|Overall Study|Death|3|||
150284602|NCT00811135|542178761|FG000|Overall Study|Protocol Violation|2|||
150284603|NCT00811135|542178761|FG000|Overall Study|Violation of Selection Criteria|1|||
150284604|NCT00811135|542178761|FG000|Overall Study|Refused Treatment|1|||
150284605|NCT00811135|542178761|FG000|Overall Study|Withdrawal by Subject|3|||
150284606|NCT00811135|542178761|FG000|Overall Study|Administrative/Other Unspecified|11|||
150284607|NCT00811135|542178761|FG000|Overall Study|Ongoing|59|||
150284608|NCT00414453|542178765|FG000|Overall Study|Abnormal lab work|16|||
150284609|NCT01780831|542178768|FG000|Overall Study|Withdrawal by Subject|0|||
150284610|NCT01780831|542178769|FG001|Overall Study|Withdrawal by Subject|0|||
150284611|NCT01780831|542178770|FG002|Overall Study|Withdrawal by Subject|4|||
150284612|NCT01780831|542178771|FG003|Overall Study|Withdrawal by Subject|0|||
150284613|NCT01780831|542178768|FG000|Overall Study|Lost to Follow-up|0|||
150284614|NCT01780831|542178769|FG001|Overall Study|Lost to Follow-up|0|||
150284615|NCT01780831|542178770|FG002|Overall Study|Lost to Follow-up|0|||
150284616|NCT01780831|542178771|FG003|Overall Study|Lost to Follow-up|1|||
150284617|NCT00183274|542178772|FG000|Phase 1: Open-Label|Adverse Event|31|||
150284618|NCT00183274|542178773|FG001|Phase 1: Open-Label|Adverse Event|0|||
150284619|NCT00183274|542178774|FG002|Phase 1: Open-Label|Adverse Event|0|||
150284620|NCT00183274|542178775|FG003|Phase 1: Open-Label|Adverse Event|0|||
150284621|NCT00183274|542178776|FG004|Phase 1: Open-Label|Adverse Event|0|||
150284622|NCT00183274|542178777|FG005|Phase 1: Open-Label|Adverse Event|0|||
150284623|NCT00183274|542178772|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
150284624|NCT00183274|542178773|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
150284625|NCT00183274|542178774|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
150284626|NCT00183274|542178775|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
150284627|NCT00183274|542178776|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
150284628|NCT00183274|542178777|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
150284629|NCT00183274|542178772|FG000|Phase 1: Open-Label|Protocol Violation|11|||
150284630|NCT00183274|542178773|FG001|Phase 1: Open-Label|Protocol Violation|0|||
150284631|NCT00183274|542178774|FG002|Phase 1: Open-Label|Protocol Violation|0|||
150284632|NCT00183274|542178775|FG003|Phase 1: Open-Label|Protocol Violation|0|||
150284633|NCT00183274|542178776|FG004|Phase 1: Open-Label|Protocol Violation|0|||
150284634|NCT00183274|542178777|FG005|Phase 1: Open-Label|Protocol Violation|0|||
150284635|NCT00183274|542178772|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
150284636|NCT00183274|542178773|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
150284637|NCT00183274|542178774|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
150284638|NCT00183274|542178775|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
150284639|NCT00183274|542178776|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
150284640|NCT00183274|542178777|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
150284641|NCT00183274|542178772|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
150284642|NCT00183274|542178773|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
150284643|NCT00183274|542178774|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
150284644|NCT00183274|542178775|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
150284645|NCT00183274|542178776|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
150284646|NCT00183274|542178777|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
150284647|NCT00183274|542178772|FG000|Phase 1: Open-Label|Other|9|||
150284648|NCT00183274|542178773|FG001|Phase 1: Open-Label|Other|0|||
150284649|NCT00183274|542178774|FG002|Phase 1: Open-Label|Other|0|||
150284650|NCT00183274|542178775|FG003|Phase 1: Open-Label|Other|0|||
150284651|NCT00183274|542178776|FG004|Phase 1: Open-Label|Other|0|||
150284652|NCT00183274|542178777|FG005|Phase 1: Open-Label|Other|0|||
150284653|NCT00183274|542178772|FG000|Phase 2: Double-Blind|Relapsed|0|||
150284654|NCT00183274|542178773|FG001|Phase 2: Double-Blind|Relapsed|8|||
150284655|NCT00183274|542178774|FG002|Phase 2: Double-Blind|Relapsed|29|||
150284656|NCT00183274|542178775|FG003|Phase 2: Double-Blind|Relapsed|0|||
150284657|NCT00183274|542178776|FG004|Phase 2: Double-Blind|Relapsed|0|||
150284658|NCT00183274|542178777|FG005|Phase 2: Double-Blind|Relapsed|0|||
150284659|NCT00183274|542178772|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
150284660|NCT00183274|542178773|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
150284661|NCT00183274|542178774|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
150284662|NCT00183274|542178775|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
150284663|NCT00183274|542178776|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
150284664|NCT00183274|542178777|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
150284665|NCT00183274|542178772|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
150284666|NCT00183274|542178773|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
150284667|NCT00183274|542178774|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
150284668|NCT00183274|542178775|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
150284669|NCT00183274|542178776|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
150284670|NCT00183274|542178777|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
149952643|NCT04868682|540958640|FG000|Six-month Assessment|Death|1|||
150284671|NCT00183274|542178772|FG000|Phase 3: Double-Blind|Relapsed|0|||
150284672|NCT00183274|542178773|FG001|Phase 3: Double-Blind|Relapsed|0|||
150284673|NCT00183274|542178774|FG002|Phase 3: Double-Blind|Relapsed|0|||
149952644|NCT04868682|540958641|FG001|Six-month Assessment|Death|0|||
149952645|NCT04868682|540958640|FG000|Six-month Assessment|Refused|0|||
149952646|NCT04868682|540958641|FG001|Six-month Assessment|Refused|1|||
150284674|NCT00183274|542178775|FG003|Phase 3: Double-Blind|Relapsed|1|||
150284675|NCT00183274|542178776|FG004|Phase 3: Double-Blind|Relapsed|11|||
150284676|NCT00183274|542178777|FG005|Phase 3: Double-Blind|Relapsed|2|||
150284677|NCT03882970|542178789|FG000|Overall Study|Adverse Event|5|||
150284678|NCT03882970|542178790|FG001|Overall Study|Adverse Event|7|||
150284679|NCT03882970|542178791|FG002|Overall Study|Adverse Event|3|||
150284680|NCT03882970|542178792|FG003|Overall Study|Adverse Event|1|||
150284681|NCT03882970|542178789|FG000|Overall Study|Death|1|||
150284682|NCT03882970|542178790|FG001|Overall Study|Death|2|||
150284683|NCT03882970|542178791|FG002|Overall Study|Death|1|||
150284684|NCT03882970|542178792|FG003|Overall Study|Death|1|||
150284685|NCT03882970|542178789|FG000|Overall Study|Lost to Follow-up|8|||
150284686|NCT03882970|542178790|FG001|Overall Study|Lost to Follow-up|9|||
150284687|NCT03882970|542178791|FG002|Overall Study|Lost to Follow-up|5|||
150284688|NCT03882970|542178792|FG003|Overall Study|Lost to Follow-up|5|||
150284689|NCT03882970|542178789|FG000|Overall Study|Physician Decision|0|||
150284690|NCT03882970|542178790|FG001|Overall Study|Physician Decision|2|||
150284691|NCT03882970|542178791|FG002|Overall Study|Physician Decision|2|||
150284692|NCT03882970|542178792|FG003|Overall Study|Physician Decision|2|||
150284693|NCT03882970|542178789|FG000|Overall Study|Protocol Violation|2|||
150284694|NCT03882970|542178790|FG001|Overall Study|Protocol Violation|0|||
150284695|NCT03882970|542178791|FG002|Overall Study|Protocol Violation|0|||
150284696|NCT03882970|542178792|FG003|Overall Study|Protocol Violation|0|||
150284697|NCT03882970|542178789|FG000|Overall Study|Withdrawal by Subject|8|||
150284698|NCT03882970|542178790|FG001|Overall Study|Withdrawal by Subject|17|||
150284699|NCT03882970|542178791|FG002|Overall Study|Withdrawal by Subject|7|||
150284700|NCT03882970|542178792|FG003|Overall Study|Withdrawal by Subject|22|||
150284701|NCT03882970|542178789|FG000|Overall Study|Personal Reason|2|||
150284702|NCT03882970|542178790|FG001|Overall Study|Personal Reason|3|||
150284703|NCT03882970|542178791|FG002|Overall Study|Personal Reason|1|||
150284704|NCT03882970|542178792|FG003|Overall Study|Personal Reason|3|||
150284705|NCT00607386|542178793|FG000|Overall Study|Physician Decision|1|||
150284706|NCT01265797|542178800|FG000|Run-in Month|Withdrawal by Subject|0|||
150284707|NCT01265797|542178801|FG001|Run-in Month|Withdrawal by Subject|4|||
150284708|NCT01265797|542178800|FG000|Run-in Month|1st seizure during run-in month|0|||
150284709|NCT01265797|542178801|FG001|Run-in Month|1st seizure during run-in month|1|||
150284710|NCT01265797|542178800|FG000|Blinded Month|Lack of Efficacy|5|||
150284711|NCT01265797|542178801|FG001|Blinded Month|Lack of Efficacy|0|||
150284712|NCT01265797|542178800|FG000|Blinded Month|Lost to Follow-up|1|||
150284713|NCT01265797|542178801|FG001|Blinded Month|Lost to Follow-up|0|||
150284714|NCT01265797|542178800|FG000|Blinded Month|Protocol Violation|2|||
150284715|NCT01265797|542178801|FG001|Blinded Month|Protocol Violation|1|||
150284716|NCT01265797|542178800|FG000|Blinded Month|Adverse Event|2|||
150284717|NCT01265797|542178801|FG001|Blinded Month|Adverse Event|0|||
150284718|NCT01265797|542178800|FG000|Blinded Month|Diary data incomplete|0|||
150284719|NCT01265797|542178801|FG001|Blinded Month|Diary data incomplete|1|||
150284720|NCT01265797|542178800|FG000|Open Label Month|Lost to Follow-up|0|||
150284721|NCT01265797|542178801|FG001|Open Label Month|Lost to Follow-up|1|||
150284722|NCT01422915|542178802|FG000|Overall Study|Adverse Event|1|||
150284723|NCT02980224|542178803|FG000|Overall Study|Adverse Event|4|||
150284724|NCT02980224|542178804|FG001|Overall Study|Adverse Event|1|||
150284725|NCT02980224|542178803|FG000|Overall Study|Withdrawal by Subject|0|||
150284726|NCT02980224|542178804|FG001|Overall Study|Withdrawal by Subject|2|||
150284727|NCT00583362|542178805|FG000|Overall Study|Adverse Event|44|||
150284728|NCT00583362|542178805|FG000|Overall Study|Lack of Efficacy|22|||
149952647|NCT04868682|540958640|FG000|12-month Assessment|Lost to Follow-up|2|||
150284729|NCT00583362|542178805|FG000|Overall Study|Lost to Follow-up|4|||
150284730|NCT00583362|542178805|FG000|Overall Study|Non-compliance with study drug|28|||
150284731|NCT00583362|542178805|FG000|Overall Study|Pregnancy|7|||
150284732|NCT00583362|542178805|FG000|Overall Study|Miscommunication of visit window|5|||
149952648|NCT04868682|540958641|FG001|12-month Assessment|Lost to Follow-up|1|||
150284733|NCT00583362|542178805|FG000|Overall Study|Current site closed|7|||
150284734|NCT00583362|542178805|FG000|Overall Study|Subject not dosed in LBSL99|1|||
150284735|NCT00583362|542178805|FG000|Overall Study|Subject moved out of the country/state|2|||
150284736|NCT00583362|542178805|FG000|Overall Study|Missed visits due to staff changes|1|||
150284737|NCT00583362|542178805|FG000|Overall Study|Misunderstanding of protocol|1|||
150284738|NCT00583362|542178805|FG000|Overall Study|Behavioral problems and non-compliance|1|||
150284739|NCT00583362|542178805|FG000|Overall Study|Sponsor request due to missed doses|1|||
150284740|NCT00583362|542178805|FG000|Overall Study|Physician Decision|19|||
150284741|NCT00583362|542178805|FG000|Overall Study|Protocol Violation|2|||
149952649|NCT04868682|540958640|FG000|12-month Assessment|Death|0|||
150284742|NCT00583362|542178805|FG000|Overall Study|Withdrawal by Subject|57|||
150284743|NCT00577642|542178809|FG000|Overall Study|Clinical Disease Progression|1|||
150284744|NCT04770389|542178810|FG000|Overall Study|Adverse Event|1|||
150284745|NCT04770389|542178811|FG001|Overall Study|Adverse Event|2|||
150284746|NCT04770389|542178812|FG002|Overall Study|Adverse Event|0|||
150284747|NCT04770389|542178813|FG003|Overall Study|Adverse Event|1|||
150284748|NCT04770389|542178810|FG000|Overall Study|Withdrawal by Subject|0|||
150284749|NCT04770389|542178811|FG001|Overall Study|Withdrawal by Subject|2|||
150284750|NCT04770389|542178812|FG002|Overall Study|Withdrawal by Subject|1|||
150284751|NCT04770389|542178813|FG003|Overall Study|Withdrawal by Subject|0|||
150284752|NCT04770389|542178810|FG000|Overall Study|Failed attempt to draw blood|1|||
150284753|NCT04770389|542178811|FG001|Overall Study|Failed attempt to draw blood|0|||
150284754|NCT04770389|542178812|FG002|Overall Study|Failed attempt to draw blood|0|||
150284755|NCT04770389|542178813|FG003|Overall Study|Failed attempt to draw blood|0|||
150284756|NCT04770389|542178810|FG000|Overall Study|Left the country|0|||
150284757|NCT04770389|542178811|FG001|Overall Study|Left the country|0|||
150284758|NCT04770389|542178812|FG002|Overall Study|Left the country|1|||
149952650|NCT04868682|540958641|FG001|12-month Assessment|Death|1|||
149952651|NCT03880565|540958642|FG000|Overall Study|Withdrawal by Subject|1|||
149952652|NCT03880565|540958643|FG001|Overall Study|Withdrawal by Subject|0|||
149952653|NCT04795323|540958647|FG000|Overall Study|Did not interact with TARA|1|||
149952654|NCT04795323|540958648|FG001|Overall Study|Did not interact with TARA|0|||
149952655|NCT01479530|540958649|FG000|Overall Study|Adverse Event|5|||
149952656|NCT01479530|540958650|FG001|Overall Study|Adverse Event|6|||
149952657|NCT01479530|540958649|FG000|Overall Study|Lack of Efficacy|0|||
149952658|NCT01479530|540958650|FG001|Overall Study|Lack of Efficacy|1|||
150284759|NCT04770389|542178813|FG003|Overall Study|Left the country|2|||
150284760|NCT04770389|542178810|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
150284761|NCT04770389|542178811|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
150284762|NCT04770389|542178812|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
150284763|NCT04770389|542178813|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
150284764|NCT04770389|542178810|FG000|Overall Study|Lost to Follow-up|0|||
150284765|NCT04770389|542178811|FG001|Overall Study|Lost to Follow-up|0|||
150284766|NCT04770389|542178812|FG002|Overall Study|Lost to Follow-up|0|||
150284767|NCT04770389|542178813|FG003|Overall Study|Lost to Follow-up|1|||
150284768|NCT04770389|542178810|FG000|Overall Study|Moved away from study site|0|||
150284769|NCT04770389|542178811|FG001|Overall Study|Moved away from study site|1|||
150284770|NCT04770389|542178812|FG002|Overall Study|Moved away from study site|0|||
150284771|NCT04770389|542178813|FG003|Overall Study|Moved away from study site|0|||
150284772|NCT00794157|542178814|FG000|Overall Study|Adverse Event|4|||
150284773|NCT00794157|542178815|FG001|Overall Study|Adverse Event|1|||
150284774|NCT00794157|542178816|FG002|Overall Study|Adverse Event|8|||
150284775|NCT00794157|542178814|FG000|Overall Study|Subject withdrew consent|2|||
150284776|NCT00794157|542178815|FG001|Overall Study|Subject withdrew consent|0|||
150284777|NCT00794157|542178816|FG002|Overall Study|Subject withdrew consent|3|||
150284778|NCT00794157|542178814|FG000|Overall Study|Lost to Follow-up|2|||
150284779|NCT00794157|542178815|FG001|Overall Study|Lost to Follow-up|0|||
150284780|NCT00794157|542178816|FG002|Overall Study|Lost to Follow-up|1|||
150284781|NCT00794157|542178814|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150284782|NCT00794157|542178815|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150284783|NCT00794157|542178816|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
150284784|NCT00794157|542178814|FG000|Overall Study|Administrative problems|1|||
150284785|NCT00794157|542178815|FG001|Overall Study|Administrative problems|7|||
150284786|NCT00794157|542178816|FG002|Overall Study|Administrative problems|4|||
150284787|NCT00794157|542178814|FG000|Overall Study|Abnormal test procedure result(s)|0|||
150284788|NCT00794157|542178815|FG001|Overall Study|Abnormal test procedure result(s)|1|||
150284789|NCT00794157|542178816|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149952659|NCT01479530|540958649|FG000|Overall Study|Protocol Violation|2|||
149952660|NCT01479530|540958650|FG001|Overall Study|Protocol Violation|3|||
150284790|NCT00794157|542178814|FG000|Overall Study|Protocol deviation|0|||
150284791|NCT00794157|542178815|FG001|Overall Study|Protocol deviation|1|||
150284792|NCT00794157|542178816|FG002|Overall Study|Protocol deviation|1|||
150284793|NCT01692275|542178817|FG000|Overall Study|Lost to Follow-up|57|||
150284794|NCT01692275|542178818|FG001|Overall Study|Lost to Follow-up|48|||
150284795|NCT01692275|542178817|FG000|Overall Study|Withdrawal by Subject|9|||
150284796|NCT01692275|542178818|FG001|Overall Study|Withdrawal by Subject|11|||
150284797|NCT00401375|542178821|FG000|Overall Study|Protocol Violation|2|||
150284798|NCT00401375|542178822|FG001|Overall Study|Protocol Violation|2|||
150284799|NCT00401375|542178823|FG002|Overall Study|Protocol Violation|1|||
150284800|NCT00401375|542178821|FG000|Overall Study|Adverse Event|6|||
150284801|NCT00401375|542178822|FG001|Overall Study|Adverse Event|11|||
149952661|NCT01479530|540958649|FG000|Overall Study|Withdrawal of Consent|3|||
149952662|NCT01479530|540958650|FG001|Overall Study|Withdrawal of Consent|2|||
149952663|NCT02836769|540958651|FG000|Overall Study|Lost to Follow-up|10|||
150284802|NCT00401375|542178823|FG002|Overall Study|Adverse Event|10|||
150284803|NCT00401375|542178821|FG000|Overall Study|Withdrawal by Subject|9|||
150284804|NCT00401375|542178822|FG001|Overall Study|Withdrawal by Subject|7|||
150284805|NCT00401375|542178823|FG002|Overall Study|Withdrawal by Subject|7|||
150284806|NCT00401375|542178821|FG000|Overall Study|Lost to Follow-up|0|||
150284807|NCT00401375|542178822|FG001|Overall Study|Lost to Follow-up|1|||
150284808|NCT00401375|542178823|FG002|Overall Study|Lost to Follow-up|1|||
150284809|NCT00401375|542178821|FG000|Overall Study|Other than specified|2|||
150284810|NCT00401375|542178822|FG001|Overall Study|Other than specified|1|||
150284811|NCT00401375|542178823|FG002|Overall Study|Other than specified|3|||
150284812|NCT00401375|542178821|FG000|Overall Study|Randomized but not treated|3|||
150284813|NCT00401375|542178822|FG001|Overall Study|Randomized but not treated|3|||
150284814|NCT00401375|542178823|FG002|Overall Study|Randomized but not treated|3|||
150284815|NCT02821715|542178824|FG000|Overall Study|Protocol Violation|1|||
150284816|NCT02821715|542178825|FG001|Overall Study|Protocol Violation|0|||
150284817|NCT02821715|542178826|FG002|Overall Study|Protocol Violation|0|||
150284818|NCT02821715|542178827|FG003|Overall Study|Protocol Violation|0|||
150284819|NCT02821715|542178828|FG004|Overall Study|Protocol Violation|0|||
150284820|NCT02821715|542178829|FG005|Overall Study|Protocol Violation|0|||
150284821|NCT00677014|542178830|FG000|Overall Study|Lost to Follow-up|20|||
150284822|NCT00677014|542178831|FG001|Overall Study|Lost to Follow-up|12|||
150284823|NCT00677014|542178832|FG002|Overall Study|Lost to Follow-up|24|||
150284824|NCT00677014|542178830|FG000|Overall Study|Death|6|||
150284825|NCT00677014|542178831|FG001|Overall Study|Death|15|||
150284826|NCT00677014|542178832|FG002|Overall Study|Death|7|||
150284827|NCT00677014|542178830|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
150284828|NCT00677014|542178831|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
150284829|NCT00677014|542178832|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
150284830|NCT00640328|542178833|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
150284831|NCT00640328|542178834|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
150284832|NCT00640328|542178835|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
150284833|NCT00640328|542178836|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
150284834|NCT00640328|542178837|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
150284835|NCT00640328|542178838|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
150284836|NCT00640328|542178833|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
150284837|NCT00640328|542178834|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
150284838|NCT00640328|542178835|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
150284839|NCT00640328|542178836|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
150284840|NCT00640328|542178837|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
150284841|NCT00640328|542178838|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
150284842|NCT00640328|542178833|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
150284843|NCT00640328|542178834|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
150284844|NCT00640328|542178835|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
150284845|NCT00640328|542178836|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
150284846|NCT00640328|542178837|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
150284847|NCT00640328|542178838|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
150284848|NCT00640328|542178833|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
150284849|NCT00640328|542178834|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
150284850|NCT00640328|542178835|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
150284851|NCT00640328|542178836|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
150284852|NCT00640328|542178837|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
150284853|NCT00640328|542178838|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
150284854|NCT02374099|542178839|FG000|Overall Study|Adverse Event|1|||
150284855|NCT02374099|542178840|FG001|Overall Study|Adverse Event|0|||
150284856|NCT02374099|542178839|FG000|Overall Study|Progressive Disease|35|||
150284857|NCT02374099|542178840|FG001|Overall Study|Progressive Disease|40|||
150284858|NCT02374099|542178839|FG000|Overall Study|Withdrawal by Subject|5|||
150284859|NCT02374099|542178840|FG001|Overall Study|Withdrawal by Subject|1|||
150284860|NCT02374099|542178839|FG000|Overall Study|Miscellaneous|2|||
150284861|NCT02374099|542178840|FG001|Overall Study|Miscellaneous|3|||
150284862|NCT02374099|542178839|FG000|Overall Study|Randomized, but not treated|2|||
150284863|NCT02374099|542178840|FG001|Overall Study|Randomized, but not treated|1|||
150284864|NCT02374099|542178839|FG000|Overall Study|Study Terminated by Sponsor|3|||
150284865|NCT02374099|542178840|FG001|Overall Study|Study Terminated by Sponsor|4|||
150284866|NCT01033825|542178841|FG000|Overall Study|Withdrawal by Subject|2|||
150284867|NCT01033825|542178842|FG001|Overall Study|Withdrawal by Subject|3|||
150284868|NCT01033825|542178843|FG002|Overall Study|Withdrawal by Subject|2|||
150284869|NCT01033825|542178844|FG003|Overall Study|Withdrawal by Subject|1|||
150284870|NCT01033825|542178845|FG004|Overall Study|Withdrawal by Subject|1|||
150284871|NCT01033825|542178846|FG005|Overall Study|Withdrawal by Subject|0|||
150284872|NCT01033825|542178847|FG006|Overall Study|Withdrawal by Subject|0|||
150284873|NCT01033825|542178841|FG000|Overall Study|Adverse Event|0|||
150284874|NCT01033825|542178842|FG001|Overall Study|Adverse Event|0|||
150284875|NCT01033825|542178843|FG002|Overall Study|Adverse Event|0|||
150284876|NCT01033825|542178844|FG003|Overall Study|Adverse Event|1|||
150284877|NCT01033825|542178845|FG004|Overall Study|Adverse Event|0|||
150284878|NCT01033825|542178846|FG005|Overall Study|Adverse Event|0|||
150284879|NCT01033825|542178847|FG006|Overall Study|Adverse Event|0|||
150284880|NCT01033825|542178841|FG000|Overall Study|Protocol Violation|1|||
150284881|NCT01033825|542178842|FG001|Overall Study|Protocol Violation|0|||
150284882|NCT01033825|542178843|FG002|Overall Study|Protocol Violation|0|||
150284883|NCT01033825|542178844|FG003|Overall Study|Protocol Violation|0|||
150284884|NCT01033825|542178845|FG004|Overall Study|Protocol Violation|0|||
150284885|NCT01033825|542178846|FG005|Overall Study|Protocol Violation|0|||
150284886|NCT01033825|542178847|FG006|Overall Study|Protocol Violation|0|||
150284887|NCT01033825|542178841|FG000|Overall Study|Other|0|||
150284888|NCT01033825|542178842|FG001|Overall Study|Other|0|||
150284889|NCT01033825|542178843|FG002|Overall Study|Other|0|||
150284890|NCT01033825|542178844|FG003|Overall Study|Other|0|||
150284891|NCT01033825|542178845|FG004|Overall Study|Other|1|||
150284892|NCT01033825|542178846|FG005|Overall Study|Other|0|||
150284893|NCT01033825|542178847|FG006|Overall Study|Other|0|||
150284894|NCT03885089|542178848|FG000|Overall Study|No informed consent for publication of study results|2|||
150284895|NCT03349099|542178851|FG000|Overall Study|Physician Decision|3|||
150284896|NCT03349099|542178852|FG001|Overall Study|Physician Decision|4|||
150284897|NCT03349099|542178851|FG000|Overall Study|Stone migrated from the kidney|1|||
150284898|NCT03349099|542178852|FG001|Overall Study|Stone migrated from the kidney|0|||
150284899|NCT00278993|542178853|FG000|Overall Study|Adverse Event|24|||
150284900|NCT00278993|542178853|FG000|Overall Study|Withdrawal by Subject|5|||
150284901|NCT00278993|542178853|FG000|Overall Study|Progressive Disease|65|||
150284902|NCT00278993|542178853|FG000|Overall Study|Physician Decision|9|||
150284903|NCT00278993|542178853|FG000|Overall Study|Not Otherwise Specified|4|||
150284904|NCT03077685|542178857|FG000|Overall Study|Lost to Follow-up|0|||
150284905|NCT03077685|542178858|FG001|Overall Study|Lost to Follow-up|0|||
150284906|NCT03077685|542178859|FG002|Overall Study|Lost to Follow-up|0|||
150284907|NCT03077685|542178860|FG003|Overall Study|Lost to Follow-up|0|||
150284908|NCT03077685|542178861|FG004|Overall Study|Lost to Follow-up|1|||
150284909|NCT03077685|542178857|FG000|Overall Study|Death|0|||
150284910|NCT03077685|542178858|FG001|Overall Study|Death|0|||
150284911|NCT03077685|542178859|FG002|Overall Study|Death|1|||
150284912|NCT03077685|542178860|FG003|Overall Study|Death|1|||
150284913|NCT03077685|542178861|FG004|Overall Study|Death|3|||
150284914|NCT03077685|542178857|FG000|Overall Study|Withdrawal by Subject|0|||
150284915|NCT03077685|542178858|FG001|Overall Study|Withdrawal by Subject|0|||
150284916|NCT03077685|542178859|FG002|Overall Study|Withdrawal by Subject|0|||
150284917|NCT03077685|542178860|FG003|Overall Study|Withdrawal by Subject|2|||
150284918|NCT03077685|542178861|FG004|Overall Study|Withdrawal by Subject|1|||
150284919|NCT03077685|542178857|FG000|Overall Study|Physician Decision|0|||
150284920|NCT03077685|542178858|FG001|Overall Study|Physician Decision|0|||
150284921|NCT03077685|542178859|FG002|Overall Study|Physician Decision|1|||
150284922|NCT03077685|542178860|FG003|Overall Study|Physician Decision|0|||
150284923|NCT03077685|542178861|FG004|Overall Study|Physician Decision|3|||
150284924|NCT03077685|542178857|FG000|Overall Study|Disease Progression|1|||
150284925|NCT03077685|542178858|FG001|Overall Study|Disease Progression|0|||
150284926|NCT03077685|542178859|FG002|Overall Study|Disease Progression|0|||
150284927|NCT03077685|542178860|FG003|Overall Study|Disease Progression|2|||
150284928|NCT03077685|542178861|FG004|Overall Study|Disease Progression|1|||
150284929|NCT03077685|542178857|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
150284930|NCT03077685|542178858|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
150284931|NCT03077685|542178859|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
150284932|NCT03077685|542178860|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
150284933|NCT03077685|542178861|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
150284934|NCT03077685|542178857|FG000|Overall Study|Subject entered hospice care|0|||
149952664|NCT02836769|540958651|FG000|Overall Study|Medical withdrawal|2|||
149952665|NCT02836769|540958651|FG000|Overall Study|Withdrawal by Subject|3|||
149952666|NCT00303628|540958656|FG000|Overall Study|Disease progression|0|||
149952667|NCT00303628|540958657|FG001|Overall Study|Disease progression|1|||
149952668|NCT00303628|540958656|FG000|Overall Study|Adverse Event|26|||
149952669|NCT00303628|540958657|FG001|Overall Study|Adverse Event|36|||
149952670|NCT00303628|540958656|FG000|Overall Study|Death|0|||
149952671|NCT00303628|540958657|FG001|Overall Study|Death|1|||
149952672|NCT00303628|540958656|FG000|Overall Study|Withdrawal by Subject|11|||
149952673|NCT00303628|540958657|FG001|Overall Study|Withdrawal by Subject|20|||
150284935|NCT03077685|542178858|FG001|Overall Study|Subject entered hospice care|0|||
150284936|NCT03077685|542178859|FG002|Overall Study|Subject entered hospice care|0|||
149952674|NCT00303628|540958656|FG000|Overall Study|Alternative therapy|2|||
149952675|NCT00303628|540958657|FG001|Overall Study|Alternative therapy|0|||
150284937|NCT03077685|542178860|FG003|Overall Study|Subject entered hospice care|0|||
150284938|NCT03077685|542178861|FG004|Overall Study|Subject entered hospice care|1|||
150284939|NCT01979536|542178862|FG000|Overall Study|Physician Decision|2|||
150284940|NCT01979536|542178863|FG001|Overall Study|Physician Decision|3|||
150284941|NCT01979536|542178862|FG000|Overall Study|Withdrawal by Subject|0|||
150284942|NCT01979536|542178863|FG001|Overall Study|Withdrawal by Subject|1|||
150284943|NCT01979536|542178862|FG000|Overall Study|Refusal|0|||
150284944|NCT01979536|542178863|FG001|Overall Study|Refusal|1|||
150284945|NCT01979536|542178862|FG000|Overall Study|Relapse|0|||
150284946|NCT01979536|542178863|FG001|Overall Study|Relapse|1|||
150284947|NCT01979536|542178862|FG000|Overall Study|Study terminated by Sponsor|0|||
150284948|NCT01979536|542178863|FG001|Overall Study|Study terminated by Sponsor|1|||
150284949|NCT01979536|542178862|FG000|Overall Study|Did not start treatment|0|||
150284950|NCT01979536|542178863|FG001|Overall Study|Did not start treatment|1|||
150284951|NCT04194528|542178865|FG000|Overall Study|Adverse Event|1|||
150172110|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
149952676|NCT00303628|540958656|FG000|Overall Study|Other complicating disease|0|||
149952677|NCT00303628|540958657|FG001|Overall Study|Other complicating disease|1|||
150172111|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
150172112|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
149952678|NCT00303628|540958656|FG000|Overall Study|Not start protocol therapy|3|||
149952679|NCT00303628|540958657|FG001|Overall Study|Not start protocol therapy|5|||
150172113|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
150172114|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
150172115|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
150172116|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
150172117|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
150172118|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
150172119|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
150172120|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
150172121|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
150172122|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
150172123|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
150172124|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
150172125|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
150172126|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
150172127|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
150172128|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
150172129|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
150172130|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
150172131|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
150172132|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
150172133|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
150172134|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
150172135|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
150172136|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
150172137|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
150172138|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
150172139|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
150172140|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
150172141|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
150172142|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
150172143|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
150172144|NCT01087762|541765884|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
150172145|NCT01087762|541765885|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
150172146|NCT01087762|541765886|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
150172147|NCT01087762|541765887|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
150172148|NCT01087762|541765888|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
150172149|NCT00813904|541765889|FG000|Overall Study|Death|1|||
150172150|NCT01405924|541765890|FG000|Overall Study|Protocol Violation|8|||
150172151|NCT01405924|541765890|FG000|Overall Study|Missing/Incomplete Data|2|||
150172152|NCT03621761|541765893|FG000|Overall Study|Lost to Follow-up|1|||
150172153|NCT03621761|541765894|FG001|Overall Study|Lost to Follow-up|1|||
150172154|NCT03621761|541765895|FG002|Overall Study|Lost to Follow-up|2|||
150172155|NCT03621761|541765893|FG000|Overall Study|Withdrawal by Subject|2|||
150172156|NCT03621761|541765894|FG001|Overall Study|Withdrawal by Subject|1|||
150172157|NCT03621761|541765895|FG002|Overall Study|Withdrawal by Subject|1|||
150172158|NCT03621761|541765893|FG000|Overall Study|Became Ineligible|0|||
150172159|NCT03621761|541765894|FG001|Overall Study|Became Ineligible|2|||
150172160|NCT03621761|541765895|FG002|Overall Study|Became Ineligible|0|||
150172161|NCT01050569|541765896|FG000|Overall Study|Lost to Follow-up|20|||
150172162|NCT01050569|541765897|FG001|Overall Study|Lost to Follow-up|14|||
150172163|NCT01050569|541765898|FG002|Overall Study|Lost to Follow-up|16|||
150172164|NCT01050569|541765896|FG000|Overall Study|Withdrawal by Subject|9|||
150172165|NCT01050569|541765897|FG001|Overall Study|Withdrawal by Subject|3|||
150284952|NCT05054114|542178869|FG000|Overall Study|Protocol Violation|13|||
150284953|NCT05054114|542178870|FG001|Overall Study|Protocol Violation|1|||
150284954|NCT05054114|542178869|FG000|Overall Study|Pregnancy|0|||
150284955|NCT05054114|542178870|FG001|Overall Study|Pregnancy|1|||
150284956|NCT01806779|542178871|FG000|Overall Study|Physician Decision|2|||
150284957|NCT01806779|542178872|FG001|Overall Study|Physician Decision|0|||
150284958|NCT01806779|542178873|FG002|Overall Study|Physician Decision|1|||
150284959|NCT01806779|542178871|FG000|Overall Study|Lack of Efficacy|1|||
150284960|NCT01806779|542178872|FG001|Overall Study|Lack of Efficacy|1|||
150284961|NCT01806779|542178873|FG002|Overall Study|Lack of Efficacy|0|||
150284962|NCT01806779|542178871|FG000|Overall Study|Lost to Follow-up|19|||
150284963|NCT01806779|542178872|FG001|Overall Study|Lost to Follow-up|20|||
150284964|NCT01806779|542178873|FG002|Overall Study|Lost to Follow-up|0|||
150284965|NCT01806779|542178871|FG000|Overall Study|Withdrawal by Subject|20|||
150284966|NCT01806779|542178872|FG001|Overall Study|Withdrawal by Subject|23|||
150284967|NCT01806779|542178873|FG002|Overall Study|Withdrawal by Subject|22|||
150284968|NCT02595450|542178876|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
150284969|NCT02595450|542178876|FG000|Overall Study|Enrolled, but not treated|8|||
150284970|NCT04294901|542178877|FG000|Overall Study|Death|86|||
150284971|NCT04294901|542178878|FG001|Overall Study|Death|110|||
150284972|NCT04294901|542178877|FG000|Overall Study|Provider did not have historical control patients|581|||
150284973|NCT04294901|542178878|FG001|Overall Study|Provider did not have historical control patients|0|||
150284974|NCT04294901|542178877|FG000|Overall Study|Provider did not have intervention patients|0|||
150284975|NCT04294901|542178878|FG001|Overall Study|Provider did not have intervention patients|98|||
150284976|NCT01964352|542180460|FG000|Overall Study|Adverse Event|13|||
149839384|NCT01854047|540541396|FG002|Overall Study|Randomized but not treated|2|||
149839385|NCT01854047|540541397|FG003|Overall Study|Randomized but not treated|0|||
149839386|NCT01854047|540541398|FG004|Overall Study|Randomized but not treated|4|||
149839387|NCT01854047|540541394|FG000|Overall Study|Other than specified above|3|||
149839388|NCT01854047|540541395|FG001|Overall Study|Other than specified above|3|||
149839389|NCT01854047|540541396|FG002|Overall Study|Other than specified above|3|||
149839390|NCT01854047|540541397|FG003|Overall Study|Other than specified above|5|||
149839391|NCT01854047|540541398|FG004|Overall Study|Other than specified above|8|||
149839392|NCT01302548|540541399|FG000|Overall Study|Lost to Follow-up|2|||
149839393|NCT01302548|540541400|FG001|Overall Study|Lost to Follow-up|1|||
149839394|NCT03134222|540541401|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
149839395|NCT03134222|540541402|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
149839396|NCT03134222|540541403|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
149839397|NCT03134222|540541404|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
149839398|NCT03134222|540541405|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
149839399|NCT03134222|540541401|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
149839400|NCT03134222|540541402|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
149839401|NCT03134222|540541403|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
149839402|NCT03134222|540541404|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
149839403|NCT03134222|540541405|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
149839404|NCT03134222|540541401|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
149839405|NCT03134222|540541402|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
149839406|NCT03134222|540541403|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
149839407|NCT03134222|540541404|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
149839408|NCT03134222|540541405|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
149839409|NCT03134222|540541401|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
149839410|NCT03134222|540541402|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
149839411|NCT03134222|540541403|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
149839412|NCT03134222|540541404|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
149839413|NCT03134222|540541405|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
149839414|NCT03134222|540541401|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
149839415|NCT03134222|540541402|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
149839416|NCT03134222|540541403|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
149839417|NCT03134222|540541404|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
149839418|NCT03134222|540541405|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
149839419|NCT03134222|540541401|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
149839420|NCT03134222|540541402|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
149952680|NCT00303628|540958656|FG000|Overall Study|Other|8|||
149952681|NCT00303628|540958657|FG001|Overall Study|Other|9|||
149952682|NCT04925934|540958658|FG000|Overall Study|Adverse Event|1|||
150284977|NCT01964352|542180461|FG001|Overall Study|Adverse Event|3|||
149839421|NCT03134222|540541403|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
149952683|NCT04925934|540958659|FG001|Overall Study|Adverse Event|0|||
149952684|NCT04925934|540958660|FG002|Overall Study|Adverse Event|0|||
150284978|NCT01964352|542180462|FG002|Overall Study|Adverse Event|4|||
150284979|NCT01964352|542180463|FG003|Overall Study|Adverse Event|3|||
150284980|NCT01964352|542180460|FG000|Overall Study|Lack of Efficacy|6|||
150284981|NCT01964352|542180461|FG001|Overall Study|Lack of Efficacy|0|||
150284982|NCT01964352|542180462|FG002|Overall Study|Lack of Efficacy|0|||
149839422|NCT03134222|540541404|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
149839423|NCT03134222|540541405|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
149839424|NCT03134222|540541401|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
149839425|NCT03134222|540541402|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
149839426|NCT03134222|540541403|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
149839427|NCT03134222|540541404|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
149839428|NCT03134222|540541405|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
149839429|NCT03134222|540541401|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
149839430|NCT03134222|540541402|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
149839431|NCT03134222|540541403|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
149839432|NCT03134222|540541404|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
150284983|NCT01964352|542180463|FG003|Overall Study|Lack of Efficacy|0|||
150284984|NCT01964352|542180460|FG000|Overall Study|Protocol Violation|2|||
150284985|NCT01964352|542180461|FG001|Overall Study|Protocol Violation|4|||
150284986|NCT01964352|542180462|FG002|Overall Study|Protocol Violation|0|||
150284987|NCT01964352|542180463|FG003|Overall Study|Protocol Violation|2|||
150284988|NCT01964352|542180460|FG000|Overall Study|Lost to Follow-up|1|||
150284989|NCT01964352|542180461|FG001|Overall Study|Lost to Follow-up|0|||
150284990|NCT01964352|542180462|FG002|Overall Study|Lost to Follow-up|0|||
150284991|NCT01964352|542180463|FG003|Overall Study|Lost to Follow-up|1|||
150284992|NCT01964352|542180460|FG000|Overall Study|Withdrawal by Subject|4|||
150284993|NCT01964352|542180461|FG001|Overall Study|Withdrawal by Subject|2|||
150284994|NCT01964352|542180462|FG002|Overall Study|Withdrawal by Subject|1|||
150284995|NCT01964352|542180463|FG003|Overall Study|Withdrawal by Subject|0|||
150284996|NCT01964352|542180460|FG000|Overall Study|Other than stated above|0|||
150284997|NCT01964352|542180461|FG001|Overall Study|Other than stated above|2|||
150284998|NCT01964352|542180462|FG002|Overall Study|Other than stated above|1|||
150284999|NCT01964352|542180463|FG003|Overall Study|Other than stated above|2|||
150285000|NCT01908101|542180464|FG000|Overall Study|Physician Decision|1|||
150285001|NCT01908101|542180464|FG000|Overall Study|Withdrawal by Subject|1|||
150285002|NCT01908101|542180464|FG000|Overall Study|Incorrect Diagnosis|2|||
150285003|NCT01908101|542180464|FG000|Overall Study|Incorrect Starting Dose|1|||
150285004|NCT01908101|542180464|FG000|Overall Study|Did not complete the first cycle|4|||
150285005|NCT00631371|542180477|FG000|Overall Study|Lost to Follow-up|24|||
150285006|NCT00631371|542180478|FG001|Overall Study|Lost to Follow-up|19|||
150285007|NCT00631371|542180477|FG000|Overall Study|Other reason|5|||
150285008|NCT00631371|542180478|FG001|Overall Study|Other reason|12|||
150285009|NCT00631371|542180477|FG000|Overall Study|subject request|38|||
150285010|NCT00631371|542180478|FG001|Overall Study|subject request|45|||
150285011|NCT00631371|542180477|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
150285012|NCT00631371|542180478|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
150285013|NCT00631371|542180477|FG000|Overall Study|Death|263|||
150285014|NCT00631371|542180478|FG001|Overall Study|Death|239|||
150285015|NCT00590590|542180481|FG000|Overall Study|Lack of Efficacy|1|||
150285016|NCT00590590|542180482|FG001|Overall Study|Lack of Efficacy|2|||
149839433|NCT03134222|540541405|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
149839434|NCT03482882|540541406|FG000|Overall Study|Adverse Event|3|||
149839435|NCT03482882|540541406|FG000|Overall Study|Lost to Follow-up|1|||
150285017|NCT00590590|542180483|FG002|Overall Study|Lack of Efficacy|0|||
150285018|NCT00590590|542180481|FG000|Overall Study|Adverse Event|1|||
149839436|NCT03482882|540541406|FG000|Overall Study|Protocol Violation|2|||
149839437|NCT03482882|540541406|FG000|Overall Study|Not further specified|1|||
149839438|NCT04659603|540541414|FG000|Overall Study|Study terminated by sponsor|0|||
149839439|NCT04659603|540541415|FG001|Overall Study|Study terminated by sponsor|0|||
149839440|NCT04659603|540541416|FG002|Overall Study|Study terminated by sponsor|2|||
149839441|NCT04659603|540541414|FG000|Overall Study|Withdrawal by Subject|0|||
149839442|NCT04659603|540541415|FG001|Overall Study|Withdrawal by Subject|5|||
149839443|NCT04659603|540541416|FG002|Overall Study|Withdrawal by Subject|0|||
149952685|NCT04925934|540958658|FG000|Overall Study|Lost to Follow-up|2|||
149952686|NCT04925934|540958659|FG001|Overall Study|Lost to Follow-up|0|||
149952687|NCT04925934|540958660|FG002|Overall Study|Lost to Follow-up|1|||
150285019|NCT00590590|542180482|FG001|Overall Study|Adverse Event|0|||
149839444|NCT04659603|540541414|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
149839445|NCT04659603|540541415|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
149952688|NCT04925934|540958658|FG000|Overall Study|Death|0|||
149952689|NCT04925934|540958659|FG001|Overall Study|Death|1|||
149952690|NCT04925934|540958660|FG002|Overall Study|Death|0|||
150285020|NCT00590590|542180483|FG002|Overall Study|Adverse Event|0|||
150285021|NCT00590590|542180481|FG000|Overall Study|Protocol Violation|0|||
150285022|NCT00590590|542180482|FG001|Overall Study|Protocol Violation|0|||
150285023|NCT00590590|542180483|FG002|Overall Study|Protocol Violation|2|||
150285024|NCT00590590|542180481|FG000|Overall Study|Lost to Follow-up|4|||
150285025|NCT00590590|542180482|FG001|Overall Study|Lost to Follow-up|1|||
150285026|NCT00590590|542180483|FG002|Overall Study|Lost to Follow-up|2|||
150285027|NCT00590590|542180481|FG000|Overall Study|Withdrawal by Subject|0|||
150285028|NCT00590590|542180482|FG001|Overall Study|Withdrawal by Subject|1|||
149839446|NCT04659603|540541416|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
149839447|NCT02089997|540541421|FG000|Overall Study|Case report forms uncollected|99|||
149839448|NCT02089997|540541421|FG000|Overall Study|Protocol Violation|147|||
149839449|NCT02374853|540541425|FG000|Overall Study|Surgery Cancelled|5|||
149839450|NCT02374853|540541426|FG001|Overall Study|Surgery Cancelled|11|||
149839451|NCT02281084|540541427|FG000|Overall Study|Death|21|||
149839452|NCT02281084|540541428|FG001|Overall Study|Death|18|||
149839453|NCT02281084|540541429|FG002|Overall Study|Death|3|||
149839454|NCT02281084|540541430|FG003|Overall Study|Death|5|||
149839455|NCT02281084|540541427|FG000|Overall Study|Adverse Event|1|||
149839456|NCT02281084|540541428|FG001|Overall Study|Adverse Event|0|||
149839457|NCT02281084|540541429|FG002|Overall Study|Adverse Event|0|||
149839458|NCT02281084|540541430|FG003|Overall Study|Adverse Event|0|||
149839459|NCT02281084|540541427|FG000|Overall Study|Withdrawal by Subject|2|||
149839460|NCT02281084|540541428|FG001|Overall Study|Withdrawal by Subject|2|||
149839461|NCT02281084|540541429|FG002|Overall Study|Withdrawal by Subject|0|||
149839462|NCT02281084|540541430|FG003|Overall Study|Withdrawal by Subject|0|||
149839463|NCT02281084|540541427|FG000|Overall Study|Site Closure by Sponsor|5|||
149839464|NCT02281084|540541428|FG001|Overall Study|Site Closure by Sponsor|1|||
150035190|NCT00886379|541268897|FG000|Overall Study|Final blood draw not obtained|3|||
150035191|NCT00886379|541268898|FG001|Overall Study|Final blood draw not obtained|3|||
150035192|NCT00886379|541268899|FG002|Overall Study|Final blood draw not obtained|4|||
150035193|NCT00886379|541268900|FG003|Overall Study|Final blood draw not obtained|2|||
149839465|NCT02281084|540541429|FG002|Overall Study|Site Closure by Sponsor|2|||
150035194|NCT00886379|541268901|FG004|Overall Study|Final blood draw not obtained|2|||
150035195|NCT03137381|541268902|FG000|Overall Study|Adverse Event|3|||
150035196|NCT03137381|541268903|FG001|Overall Study|Adverse Event|0|||
150035197|NCT03137381|541268904|FG002|Overall Study|Adverse Event|2|||
150035198|NCT03137381|541268905|FG003|Overall Study|Adverse Event|0|||
150035199|NCT03137381|541268902|FG000|Overall Study|Lost to Follow-up|2|||
150035200|NCT03137381|541268903|FG001|Overall Study|Lost to Follow-up|1|||
150035201|NCT03137381|541268904|FG002|Overall Study|Lost to Follow-up|1|||
150035202|NCT03137381|541268905|FG003|Overall Study|Lost to Follow-up|0|||
150035203|NCT03137381|541268902|FG000|Overall Study|Protocol deviation|1|||
150035204|NCT03137381|541268903|FG001|Overall Study|Protocol deviation|1|||
150035205|NCT03137381|541268904|FG002|Overall Study|Protocol deviation|0|||
150035206|NCT03137381|541268905|FG003|Overall Study|Protocol deviation|1|||
150035207|NCT03137381|541268902|FG000|Overall Study|Withdrawal by Investigator|0|||
149839466|NCT02281084|540541430|FG003|Overall Study|Site Closure by Sponsor|0|||
149839467|NCT02335658|540541431|FG000|Overall Study|Adverse Event|18|||
150035208|NCT03137381|541268903|FG001|Overall Study|Withdrawal by Investigator|1|||
150035209|NCT03137381|541268904|FG002|Overall Study|Withdrawal by Investigator|1|||
150172166|NCT01050569|541765898|FG002|Overall Study|Withdrawal by Subject|11|||
150035210|NCT03137381|541268905|FG003|Overall Study|Withdrawal by Investigator|0|||
150035211|NCT03137381|541268902|FG000|Overall Study|Withdrawal by Subject|3|||
150035212|NCT03137381|541268903|FG001|Overall Study|Withdrawal by Subject|4|||
150172167|NCT01050569|541765896|FG000|Overall Study|Lack of Efficacy|5|||
150172168|NCT01050569|541765897|FG001|Overall Study|Lack of Efficacy|4|||
150172169|NCT01050569|541765898|FG002|Overall Study|Lack of Efficacy|3|||
150172170|NCT01050569|541765896|FG000|Overall Study|Adverse Event|1|||
150172171|NCT01050569|541765897|FG001|Overall Study|Adverse Event|0|||
150172172|NCT01050569|541765898|FG002|Overall Study|Adverse Event|0|||
150172173|NCT01050569|541765896|FG000|Overall Study|Physician Decision|3|||
150172174|NCT01050569|541765897|FG001|Overall Study|Physician Decision|3|||
150172175|NCT01050569|541765898|FG002|Overall Study|Physician Decision|3|||
150172176|NCT00758602|541765901|FG000|Overall Study|Adverse Event|11|||
150172177|NCT00758602|541765902|FG001|Overall Study|Adverse Event|10|||
150172178|NCT00758602|541765901|FG000|Overall Study|Lost to Follow-up|4|||
150172179|NCT00758602|541765902|FG001|Overall Study|Lost to Follow-up|3|||
150172180|NCT00758602|541765901|FG000|Overall Study|Withdrawal by Subject|1|||
150172181|NCT00758602|541765902|FG001|Overall Study|Withdrawal by Subject|3|||
150172182|NCT00758602|541765901|FG000|Overall Study|Protocol Violation|0|||
150172183|NCT00758602|541765902|FG001|Overall Study|Protocol Violation|2|||
150172184|NCT00758602|541765901|FG000|Overall Study|Death|0|||
150172185|NCT00758602|541765902|FG001|Overall Study|Death|1|||
150172186|NCT00758602|541765901|FG000|Overall Study|Reason not specified|3|||
150172187|NCT00758602|541765902|FG001|Overall Study|Reason not specified|3|||
150172188|NCT05046132|541765903|FG000|Overall Study|Adverse Event|4|||
150172189|NCT05046132|541765904|FG001|Overall Study|Adverse Event|0|||
150172190|NCT05046132|541765905|FG002|Overall Study|Adverse Event|0|||
150172191|NCT05046132|541765903|FG000|Overall Study|Withdrawal by Subject|3|||
150172192|NCT05046132|541765904|FG001|Overall Study|Withdrawal by Subject|0|||
150172193|NCT05046132|541765905|FG002|Overall Study|Withdrawal by Subject|0|||
150172194|NCT05046132|541765903|FG000|Overall Study|Positive Covid19 Result.|0|||
150172195|NCT05046132|541765904|FG001|Overall Study|Positive Covid19 Result.|1|||
150172196|NCT05046132|541765905|FG002|Overall Study|Positive Covid19 Result.|0|||
150172197|NCT03987451|541765906|FG000|Overall Study|Lost to Follow-up|1|||
149839468|NCT02335658|540541432|FG001|Overall Study|Adverse Event|12|||
149839469|NCT02335658|540541431|FG000|Overall Study|Lack of Efficacy|4|||
150172198|NCT03987451|541765907|FG001|Overall Study|Lost to Follow-up|0|||
149839470|NCT02335658|540541432|FG001|Overall Study|Lack of Efficacy|5|||
150172199|NCT03987451|541765906|FG000|Overall Study|Withdrawal by Subject|1|||
150172200|NCT03987451|541765907|FG001|Overall Study|Withdrawal by Subject|1|||
150172201|NCT02441036|541765908|FG000|Overall Study|No tissue resected|0|||
150172202|NCT02441036|541765909|FG001|Overall Study|No tissue resected|1|||
150172203|NCT02441036|541765910|FG002|Overall Study|No tissue resected|0|||
150172204|NCT02441036|541765911|FG003|Overall Study|No tissue resected|1|||
150172205|NCT02441036|541765912|FG004|Overall Study|No tissue resected|0|||
150172206|NCT00612586|541765915|FG000|Overall Study|Adverse Event|6|||
150172207|NCT00612586|541765916|FG001|Overall Study|Adverse Event|2|||
150172208|NCT00612586|541765915|FG000|Overall Study|Death|1|||
150172209|NCT00612586|541765916|FG001|Overall Study|Death|0|||
150172210|NCT00612586|541765915|FG000|Overall Study|Entry Criteria Not Met|0|||
150172211|NCT00612586|541765916|FG001|Overall Study|Entry Criteria Not Met|2|||
150172212|NCT00612586|541765915|FG000|Overall Study|Withdrawal by Subject|7|||
150172213|NCT00612586|541765916|FG001|Overall Study|Withdrawal by Subject|9|||
150172214|NCT00612586|541765915|FG000|Overall Study|Physician Decision|1|||
150172215|NCT00612586|541765916|FG001|Overall Study|Physician Decision|2|||
150172216|NCT00612586|541765915|FG000|Overall Study|Sponsor Decision|1|||
150172217|NCT00612586|541765916|FG001|Overall Study|Sponsor Decision|1|||
150172218|NCT00612586|541765915|FG000|Overall Study|Progressive Disease|26|||
150172219|NCT00612586|541765916|FG001|Overall Study|Progressive Disease|24|||
150172220|NCT00612586|541765915|FG000|Overall Study|Randomized and Not Treated|1|||
150172221|NCT00612586|541765916|FG001|Overall Study|Randomized and Not Treated|1|||
150172222|NCT00395018|541765917|FG000|On-Treatment|Death|4|||
150172223|NCT00395018|541765917|FG000|On-Treatment|Other Reason|2|||
150172224|NCT00395018|541765917|FG000|On-Treatment|Poor/non-compliance|2|||
150172225|NCT00395018|541765917|FG000|On-Treatment|Subject no longer meets study criteria|2|||
150172226|NCT00395018|541765917|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
150172227|NCT00395018|541765917|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
150172228|NCT00395018|541765917|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
150172229|NCT00530842|541765918|FG000|Overall Study|Adverse Event|10|||
150172230|NCT00530842|541765919|FG001|Overall Study|Adverse Event|6|||
150172231|NCT00530842|541765918|FG000|Overall Study|Lack of Efficacy|2|||
150172232|NCT00530842|541765919|FG001|Overall Study|Lack of Efficacy|1|||
150172233|NCT00530842|541765918|FG000|Overall Study|Lost to Follow-up|0|||
150172234|NCT00530842|541765919|FG001|Overall Study|Lost to Follow-up|4|||
150172235|NCT00530842|541765918|FG000|Overall Study|Protocol Violation|3|||
150172236|NCT00530842|541765919|FG001|Overall Study|Protocol Violation|2|||
150172237|NCT00530842|541765918|FG000|Overall Study|Withdrawal by Subject|4|||
150172238|NCT00530842|541765919|FG001|Overall Study|Withdrawal by Subject|5|||
150172239|NCT00530842|541765918|FG000|Overall Study|Individual different reasons|4|||
150172240|NCT00530842|541765919|FG001|Overall Study|Individual different reasons|3|||
150172241|NCT00530842|541765918|FG000|Period 1|Adverse Event|7|||
150172242|NCT00530842|541765919|FG001|Period 1|Adverse Event|3|||
150172243|NCT00530842|541765918|FG000|Period 1|Lack of Efficacy|1|||
150172244|NCT00530842|541765919|FG001|Period 1|Lack of Efficacy|1|||
150172245|NCT00530842|541765918|FG000|Period 1|Protocol Violation|2|||
150172246|NCT00530842|541765919|FG001|Period 1|Protocol Violation|1|||
150172247|NCT00530842|541765918|FG000|Period 1|Withdrawal by Subject|2|||
150172248|NCT00530842|541765919|FG001|Period 1|Withdrawal by Subject|3|||
150172249|NCT00530842|541765918|FG000|Period 1|Individual different reasons|2|||
150172250|NCT00530842|541765919|FG001|Period 1|Individual different reasons|3|||
150172251|NCT00530842|541765918|FG000|Period 2|Adverse Event|3|||
150172252|NCT00530842|541765919|FG001|Period 2|Adverse Event|3|||
150172253|NCT00530842|541765918|FG000|Period 2|Lack of Efficacy|1|||
150172254|NCT00530842|541765919|FG001|Period 2|Lack of Efficacy|0|||
150172255|NCT00530842|541765918|FG000|Period 2|Lost to Follow-up|0|||
150172256|NCT00530842|541765919|FG001|Period 2|Lost to Follow-up|4|||
150172257|NCT00530842|541765918|FG000|Period 2|Protocol Violation|1|||
150172258|NCT00530842|541765919|FG001|Period 2|Protocol Violation|0|||
150172259|NCT00530842|541765918|FG000|Period 2|Withdrawal by Subject|1|||
150172260|NCT00530842|541765919|FG001|Period 2|Withdrawal by Subject|2|||
150172261|NCT00530842|541765918|FG000|Period 2|Individual different reasons|2|||
150172262|NCT00530842|541765919|FG001|Period 2|Individual different reasons|0|||
150172263|NCT03257813|541765935|FG000|Overall Study|Protocol Violation|6|||
150172264|NCT03257813|541765936|FG001|Overall Study|Protocol Violation|3|||
150172265|NCT03478696|541765937|FG000|Overall Study|Adverse Event|1|||
150172266|NCT03478696|541765938|FG001|Overall Study|Adverse Event|5|||
150172267|NCT03478696|541765937|FG000|Overall Study|Lost to Follow-up|1|||
150172268|NCT03478696|541765938|FG001|Overall Study|Lost to Follow-up|0|||
150172269|NCT03478696|541765937|FG000|Overall Study|Physician Decision|6|||
150172270|NCT03478696|541765938|FG001|Overall Study|Physician Decision|3|||
150172271|NCT03478696|541765937|FG000|Overall Study|Withdrawal by Subject|9|||
150285029|NCT00590590|542180483|FG002|Overall Study|Withdrawal by Subject|1|||
150285030|NCT00590590|542180481|FG000|Overall Study|Did not complete due to study closure|1|||
150285031|NCT00590590|542180482|FG001|Overall Study|Did not complete due to study closure|1|||
150285032|NCT00590590|542180483|FG002|Overall Study|Did not complete due to study closure|1|||
150285033|NCT00590590|542180481|FG000|Overall Study|Did not complete study|0|||
150285034|NCT00590590|542180482|FG001|Overall Study|Did not complete study|1|||
150285035|NCT00590590|542180483|FG002|Overall Study|Did not complete study|0|||
150285036|NCT02145741|542180484|FG000|Overall Study|Progressive disease|3|||
150285037|NCT02145741|542180485|FG001|Overall Study|Progressive disease|6|||
150285038|NCT02145741|542180486|FG002|Overall Study|Progressive disease|6|||
150285039|NCT02145741|542180484|FG000|Overall Study|quality issue with the administered drug|3|||
150285040|NCT02145741|542180485|FG001|Overall Study|quality issue with the administered drug|0|||
150285041|NCT02145741|542180486|FG002|Overall Study|quality issue with the administered drug|0|||
150285042|NCT03865706|542180487|FG000|Overall Study|Death|0|||
150285043|NCT03865706|542180488|FG001|Overall Study|Death|3|||
150285044|NCT03865706|542180489|FG002|Overall Study|Death|1|||
150285045|NCT02646982|542180490|FG000|Overall Study|Adverse Event|1|||
150285046|NCT02646982|542180491|FG001|Overall Study|Adverse Event|1|||
150285047|NCT02646982|542180490|FG000|Overall Study|Withdrawal by Subject|2|||
150285048|NCT02646982|542180491|FG001|Overall Study|Withdrawal by Subject|1|||
150285049|NCT02095535|542180492|FG000|Recruitment|Protocol Violation|2|||
150285050|NCT00713700|542180493|FG000|Overall Study|Lost to Follow-up|3|||
150285051|NCT00713700|542180493|FG000|Overall Study|Withdrawal by Subject|1|||
150285052|NCT00781456|542180494|FG000|Overall Study|Adverse Event|3|||
150285053|NCT00781456|542180495|FG001|Overall Study|Adverse Event|3|||
150285054|NCT00781456|542180494|FG000|Overall Study|Withdrawal by Subject|3|||
150285055|NCT00781456|542180495|FG001|Overall Study|Withdrawal by Subject|5|||
150285056|NCT00781456|542180494|FG000|Overall Study|Protocol Violation|4|||
150285057|NCT00781456|542180495|FG001|Overall Study|Protocol Violation|1|||
150285058|NCT00781456|542180494|FG000|Overall Study|Noncompliance With Protocol|1|||
150285059|NCT00781456|542180495|FG001|Overall Study|Noncompliance With Protocol|1|||
150285060|NCT00781456|542180494|FG000|Overall Study|Lost to Follow-up|10|||
150285061|NCT00781456|542180495|FG001|Overall Study|Lost to Follow-up|5|||
150285062|NCT00781456|542180494|FG000|Overall Study|Other Reason, Unknown|0|||
150285063|NCT00781456|542180495|FG001|Overall Study|Other Reason, Unknown|1|||
150285064|NCT02631200|542180496|FG000|First Period|Death|1|||
150285065|NCT02631200|542180497|FG001|First Period|Death|2|||
150285066|NCT02631200|542180496|FG000|First Period|Patient ill-health|2|||
150285067|NCT02631200|542180497|FG001|First Period|Patient ill-health|4|||
150285068|NCT02631200|542180496|FG000|First Period|Withdrawal by Subject|4|||
149839471|NCT02335658|540541431|FG000|Overall Study|Pregnancy|1|||
149839472|NCT02335658|540541432|FG001|Overall Study|Pregnancy|0|||
149839473|NCT02335658|540541431|FG000|Overall Study|Withdrawal by Subject|13|||
149839474|NCT02335658|540541432|FG001|Overall Study|Withdrawal by Subject|21|||
149839475|NCT02335658|540541431|FG000|Overall Study|non-compliance|2|||
149839476|NCT02335658|540541432|FG001|Overall Study|non-compliance|3|||
149839477|NCT02335658|540541431|FG000|Overall Study|other reason|2|||
149839478|NCT02335658|540541432|FG001|Overall Study|other reason|3|||
149839479|NCT02305758|540541433|FG000|Overall Study|Death|27|||
149839480|NCT02305758|540541434|FG001|Overall Study|Death|27|||
149839481|NCT02305758|540541433|FG000|Overall Study|Withdrew consent|9|||
149839482|NCT02305758|540541434|FG001|Overall Study|Withdrew consent|2|||
149839483|NCT02305758|540541433|FG000|Overall Study|Lost to Follow-up|6|||
150035213|NCT03137381|541268904|FG002|Overall Study|Withdrawal by Subject|3|||
150035214|NCT03137381|541268905|FG003|Overall Study|Withdrawal by Subject|0|||
150035215|NCT03137381|541268902|FG000|Overall Study|Pregnancy|0|||
150035216|NCT03137381|541268903|FG001|Overall Study|Pregnancy|0|||
150035217|NCT03137381|541268904|FG002|Overall Study|Pregnancy|1|||
150035218|NCT03137381|541268905|FG003|Overall Study|Pregnancy|0|||
150035219|NCT01980017|541268910|FG000|Overall Study|Lost to Follow-up|30|||
150035220|NCT01980017|541268911|FG001|Overall Study|Lost to Follow-up|21|||
150035221|NCT01980017|541268910|FG000|Overall Study|Death|0|||
149839484|NCT02305758|540541434|FG001|Overall Study|Lost to Follow-up|1|||
149839485|NCT02305758|540541433|FG000|Overall Study|Study Terminated by Sponsor|21|||
149839486|NCT02305758|540541434|FG001|Overall Study|Study Terminated by Sponsor|34|||
149839487|NCT02305758|540541433|FG000|Overall Study|Other, not specified|2|||
149839488|NCT02305758|540541434|FG001|Overall Study|Other, not specified|1|||
149839489|NCT02032888|540541435|FG000|Treatment Period|Poor compliance/noncompliance|1|||
149839490|NCT02032888|540541436|FG001|Treatment Period|Poor compliance/noncompliance|1|||
150035222|NCT01980017|541268911|FG001|Overall Study|Death|1|||
150035223|NCT03044106|541268912|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
150035224|NCT03044106|541268913|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
150285069|NCT02631200|542180497|FG001|First Period|Withdrawal by Subject|1|||
150285070|NCT02631200|542180496|FG000|Deferred Period|Death|0|||
150285071|NCT02631200|542180497|FG001|Deferred Period|Death|1|||
150285072|NCT02631200|542180496|FG000|Deferred Period|Received kidney transplant|0|||
150285073|NCT02631200|542180497|FG001|Deferred Period|Received kidney transplant|1|||
150285074|NCT02631200|542180496|FG000|Deferred Period|Withdrawal by Subject|0|||
150285075|NCT02631200|542180497|FG001|Deferred Period|Withdrawal by Subject|2|||
150285076|NCT02631200|542180496|FG000|Deferred Period|Lost to Follow-up|0|||
149839491|NCT02032888|540541437|FG002|Treatment Period|Poor compliance/noncompliance|0|||
149839492|NCT02032888|540541435|FG000|Treatment Period|Other|1|||
149839493|NCT02032888|540541436|FG001|Treatment Period|Other|1|||
149839494|NCT02032888|540541437|FG002|Treatment Period|Other|0|||
149839495|NCT02032888|540541435|FG000|Follow-up Period|Lost to Follow-up|1|||
149839496|NCT02032888|540541436|FG001|Follow-up Period|Lost to Follow-up|1|||
149839497|NCT02032888|540541437|FG002|Follow-up Period|Lost to Follow-up|0|||
149839498|NCT02032888|540541435|FG000|Follow-up Period|Death|1|||
149839499|NCT02032888|540541436|FG001|Follow-up Period|Death|1|||
149839500|NCT02032888|540541437|FG002|Follow-up Period|Death|0|||
149839501|NCT02032888|540541435|FG000|Follow-up Period|Other|1|||
149839502|NCT02032888|540541436|FG001|Follow-up Period|Other|0|||
149839503|NCT02032888|540541437|FG002|Follow-up Period|Other|0|||
149839504|NCT01421277|540541440|FG000|Overall Study|Lack of qualifying event|0|||
149839505|NCT01421277|540541441|FG001|Overall Study|Lack of qualifying event|61|||
149839506|NCT01421277|540541440|FG000|Overall Study|Incomplete baseline data|0|||
149839507|NCT01421277|540541441|FG001|Overall Study|Incomplete baseline data|31|||
149839508|NCT00811655|540541442|FG000|Overall Study|Physician Decision|1|||
149839509|NCT02820350|540541443|FG000|Overall Study|Withdrawal by Subject|3|||
149839510|NCT02820350|540541443|FG000|Overall Study|Death|4|||
149839511|NCT01754597|540541444|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
149839512|NCT01754597|540541445|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
149839513|NCT02149420|540542493|FG000|Core Study|Administrative problems|0|||
150285077|NCT02631200|542180497|FG001|Deferred Period|Lost to Follow-up|1|||
150285078|NCT01877187|542180499|FG000|Overall Study|Death|2|||
150285079|NCT01877187|542180499|FG000|Overall Study|Withdrawal by Subject|4|||
150285080|NCT01877187|542180499|FG000|Overall Study|Lost to Follow-up|3|||
150285081|NCT01877187|542180499|FG000|Overall Study|Declining clinical status|11|||
150285082|NCT01877187|542180499|FG000|Overall Study|Liver transplant|2|||
150285083|NCT03273166|542180502|FG000|Overall Study|Withdrawn prior to Completion|31|||
150285084|NCT01294670|542180503|FG000|Overall Study|Not treated|1|||
150285085|NCT01294670|542180504|FG001|Overall Study|Not treated|0|||
150285086|NCT01294670|542180505|FG002|Overall Study|Not treated|0|||
150285087|NCT01294670|542180506|FG003|Overall Study|Not treated|0|||
150285088|NCT01294670|542180507|FG004|Overall Study|Not treated|0|||
150285089|NCT04152161|542180508|FG000|Overall Study|Death|0|||
150285090|NCT04152161|542180509|FG001|Overall Study|Death|1|||
150285091|NCT04152161|542180508|FG000|Overall Study|Physician Decision|0|||
150285092|NCT04152161|542180509|FG001|Overall Study|Physician Decision|1|||
150285093|NCT04152161|542180508|FG000|Overall Study|Lost to Follow-up|9|||
150285094|NCT04152161|542180509|FG001|Overall Study|Lost to Follow-up|3|||
150285095|NCT04152161|542180508|FG000|Overall Study|Protocol Violation|1|||
150285096|NCT04152161|542180509|FG001|Overall Study|Protocol Violation|0|||
150285097|NCT04152161|542180508|FG000|Overall Study|Withdrawal by Subject|29|||
150285098|NCT04152161|542180509|FG001|Overall Study|Withdrawal by Subject|28|||
150285099|NCT04152161|542180508|FG000|Overall Study|Sponsor termination of study|750|||
150285100|NCT04152161|542180509|FG001|Overall Study|Sponsor termination of study|755|||
150285101|NCT04152161|542180508|FG000|Overall Study|Other|20|||
150285102|NCT04152161|542180509|FG001|Overall Study|Other|18|||
150285103|NCT02412787|542180510|FG000|Overall Study|Withdrawal by Subject|9|||
150285104|NCT02412787|542180510|FG000|Overall Study|Participation Terminated by Investigator|1|||
150285105|NCT02412787|542180510|FG000|Overall Study|Site Terminated by Sponsor|21|||
150285106|NCT02412787|542180510|FG000|Overall Study|Technical Problems|1|||
150285107|NCT02412787|542180510|FG000|Overall Study|Reason Not Specified|1|||
150285108|NCT03246958|542180511|FG000|Overall Study|Withdrawal by Subject|0|||
150285109|NCT03246958|542180512|FG001|Overall Study|Withdrawal by Subject|1|||
150285110|NCT03246958|542180513|FG002|Overall Study|Withdrawal by Subject|0|||
150285111|NCT03246958|542180514|FG003|Overall Study|Withdrawal by Subject|0|||
150285112|NCT03246958|542180515|FG004|Overall Study|Withdrawal by Subject|0|||
150285113|NCT03246958|542180516|FG005|Overall Study|Withdrawal by Subject|1|||
150285114|NCT03246958|542180517|FG006|Overall Study|Withdrawal by Subject|0|||
150285115|NCT03246958|542180511|FG000|Overall Study|Progression|13|||
150285116|NCT03246958|542180512|FG001|Overall Study|Progression|9|||
150285117|NCT03246958|542180513|FG002|Overall Study|Progression|3|||
149839514|NCT02149420|540542494|FG001|Core Study|Administrative problems|1|||
149839515|NCT02149420|540542495|FG002|Core Study|Administrative problems|2|||
149839516|NCT02149420|540542493|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
149839517|NCT02149420|540542494|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
149839518|NCT02149420|540542495|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
149839519|NCT00834067|540542498|FG000|Washout of 21 Days|Protocol Violation|0|||
150285118|NCT03246958|542180514|FG003|Overall Study|Progression|2|||
150285119|NCT03246958|542180515|FG004|Overall Study|Progression|1|||
150285120|NCT03246958|542180516|FG005|Overall Study|Progression|2|||
150285121|NCT03246958|542180517|FG006|Overall Study|Progression|1|||
150285122|NCT03246958|542180511|FG000|Overall Study|Adverse Event|2|||
150285123|NCT03246958|542180512|FG001|Overall Study|Adverse Event|2|||
149952691|NCT04925934|540958658|FG000|Overall Study|Withdrawal by Subject|8|||
149952692|NCT04925934|540958659|FG001|Overall Study|Withdrawal by Subject|5|||
149952693|NCT04925934|540958660|FG002|Overall Study|Withdrawal by Subject|9|||
149952694|NCT04925934|540958658|FG000|Overall Study|Other|2|||
150172272|NCT03478696|541765938|FG001|Overall Study|Withdrawal by Subject|4|||
149952695|NCT04925934|540958659|FG001|Overall Study|Other|2|||
150172273|NCT03615924|541765939|FG000|Overall Study|Withdrawal by Subject|2|||
150172274|NCT03615924|541765940|FG001|Overall Study|Withdrawal by Subject|5|||
150172275|NCT03615924|541765939|FG000|Overall Study|Death|3|||
150172276|NCT03615924|541765940|FG001|Overall Study|Death|1|||
150172277|NCT03615924|541765939|FG000|Overall Study|Lost to Follow-up|1|||
150172278|NCT03615924|541765940|FG001|Overall Study|Lost to Follow-up|0|||
150172279|NCT03615924|541765939|FG000|Overall Study|Randomized in error|1|||
150172280|NCT03615924|541765940|FG001|Overall Study|Randomized in error|0|||
150172281|NCT03615924|541765939|FG000|Overall Study|Study termination by Sponsor|94|||
150172282|NCT03615924|541765940|FG001|Overall Study|Study termination by Sponsor|86|||
150172283|NCT00716144|541765941|FG000|Overall Study|Withdrawal by Subject|4|||
150172284|NCT00716144|541765942|FG001|Overall Study|Withdrawal by Subject|2|||
150172285|NCT00716144|541765943|FG002|Overall Study|Withdrawal by Subject|6|||
150172286|NCT00716144|541765944|FG003|Overall Study|Withdrawal by Subject|6|||
150172287|NCT00716144|541765941|FG000|Overall Study|Lost to Follow-up|2|||
150172288|NCT00716144|541765942|FG001|Overall Study|Lost to Follow-up|2|||
150172289|NCT00716144|541765943|FG002|Overall Study|Lost to Follow-up|1|||
150172290|NCT00716144|541765944|FG003|Overall Study|Lost to Follow-up|2|||
150172291|NCT00716144|541765941|FG000|Overall Study|Adverse Event|0|||
150172292|NCT00716144|541765942|FG001|Overall Study|Adverse Event|0|||
150172293|NCT00716144|541765943|FG002|Overall Study|Adverse Event|0|||
150172294|NCT00716144|541765944|FG003|Overall Study|Adverse Event|2|||
150172295|NCT00716144|541765941|FG000|Overall Study|Non-compliance|1|||
150172296|NCT00716144|541765942|FG001|Overall Study|Non-compliance|0|||
150172297|NCT00716144|541765943|FG002|Overall Study|Non-compliance|0|||
150172298|NCT00716144|541765944|FG003|Overall Study|Non-compliance|0|||
150172299|NCT00716144|541765941|FG000|Overall Study|Protocol Violation|2|||
150172300|NCT00716144|541765942|FG001|Overall Study|Protocol Violation|0|||
150172301|NCT00716144|541765943|FG002|Overall Study|Protocol Violation|1|||
150172302|NCT00716144|541765944|FG003|Overall Study|Protocol Violation|0|||
150172303|NCT00716144|541765941|FG000|Overall Study|Physician Decision|0|||
150172304|NCT00716144|541765942|FG001|Overall Study|Physician Decision|1|||
150172305|NCT00716144|541765943|FG002|Overall Study|Physician Decision|2|||
150172306|NCT00716144|541765944|FG003|Overall Study|Physician Decision|2|||
150172307|NCT00716144|541765941|FG000|Overall Study|Intercurrent illness|0|||
150172308|NCT00716144|541765942|FG001|Overall Study|Intercurrent illness|0|||
150172309|NCT00716144|541765943|FG002|Overall Study|Intercurrent illness|1|||
150172310|NCT00716144|541765944|FG003|Overall Study|Intercurrent illness|0|||
150172311|NCT00716144|541765941|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
150172312|NCT00716144|541765942|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
150172313|NCT00716144|541765943|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
150172314|NCT00716144|541765944|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
150172315|NCT00716144|541765941|FG000|Overall Study|Adverse event: left foot pain|0|||
150172316|NCT00716144|541765942|FG001|Overall Study|Adverse event: left foot pain|1|||
150172317|NCT00716144|541765943|FG002|Overall Study|Adverse event: left foot pain|0|||
150172318|NCT00716144|541765944|FG003|Overall Study|Adverse event: left foot pain|0|||
150172319|NCT00716144|541765941|FG000|Overall Study|Clinical Depression|0|||
150172320|NCT00716144|541765942|FG001|Overall Study|Clinical Depression|1|||
150172321|NCT00716144|541765943|FG002|Overall Study|Clinical Depression|0|||
150172322|NCT00716144|541765944|FG003|Overall Study|Clinical Depression|0|||
150172323|NCT00880048|541765945|FG000|Overall Study|Adverse Event|2|||
150172324|NCT00880048|541765946|FG001|Overall Study|Adverse Event|3|||
150172325|NCT00880048|541765947|FG002|Overall Study|Adverse Event|5|||
150172326|NCT00880048|541765945|FG000|Overall Study|Lack of Efficacy|1|||
150172327|NCT00880048|541765946|FG001|Overall Study|Lack of Efficacy|2|||
150172328|NCT00880048|541765947|FG002|Overall Study|Lack of Efficacy|2|||
150172329|NCT00880048|541765945|FG000|Overall Study|Protocol Violation|4|||
150172330|NCT00880048|541765946|FG001|Overall Study|Protocol Violation|6|||
150172331|NCT00880048|541765947|FG002|Overall Study|Protocol Violation|5|||
150172332|NCT00880048|541765945|FG000|Overall Study|Lost to Follow-up|6|||
150172333|NCT00880048|541765946|FG001|Overall Study|Lost to Follow-up|6|||
150172334|NCT00880048|541765947|FG002|Overall Study|Lost to Follow-up|5|||
150172335|NCT00880048|541765945|FG000|Overall Study|Physician Decision|1|||
150172336|NCT00880048|541765946|FG001|Overall Study|Physician Decision|1|||
150172337|NCT00880048|541765947|FG002|Overall Study|Physician Decision|7|||
150172338|NCT00880048|541765945|FG000|Overall Study|Withdrawal by Subject|5|||
150172339|NCT00880048|541765946|FG001|Overall Study|Withdrawal by Subject|8|||
150172340|NCT00880048|541765947|FG002|Overall Study|Withdrawal by Subject|5|||
150172341|NCT00880048|541765945|FG000|Overall Study|Study closed/terminated|9|||
150172342|NCT00880048|541765946|FG001|Overall Study|Study closed/terminated|7|||
150285124|NCT03246958|542180513|FG002|Overall Study|Adverse Event|0|||
150285125|NCT03246958|542180514|FG003|Overall Study|Adverse Event|1|||
150285126|NCT03246958|542180515|FG004|Overall Study|Adverse Event|1|||
150285127|NCT03246958|542180516|FG005|Overall Study|Adverse Event|0|||
150285128|NCT03246958|542180517|FG006|Overall Study|Adverse Event|2|||
150285129|NCT03246958|542180511|FG000|Overall Study|Death|0|||
150285130|NCT03246958|542180512|FG001|Overall Study|Death|1|||
150285131|NCT03246958|542180513|FG002|Overall Study|Death|0|||
150285132|NCT03246958|542180514|FG003|Overall Study|Death|0|||
150285133|NCT03246958|542180515|FG004|Overall Study|Death|0|||
150285134|NCT03246958|542180516|FG005|Overall Study|Death|0|||
150285135|NCT03246958|542180517|FG006|Overall Study|Death|0|||
150285136|NCT03246958|542180511|FG000|Overall Study|Physician Decision|0|||
150285137|NCT03246958|542180512|FG001|Overall Study|Physician Decision|0|||
150285138|NCT03246958|542180513|FG002|Overall Study|Physician Decision|0|||
150285139|NCT03246958|542180514|FG003|Overall Study|Physician Decision|1|||
150285140|NCT03246958|542180515|FG004|Overall Study|Physician Decision|0|||
150285141|NCT03246958|542180516|FG005|Overall Study|Physician Decision|0|||
150285142|NCT03246958|542180517|FG006|Overall Study|Physician Decision|0|||
150285143|NCT03246958|542180511|FG000|Overall Study|Never start treatment|1|||
150285144|NCT03246958|542180512|FG001|Overall Study|Never start treatment|0|||
150285145|NCT03246958|542180513|FG002|Overall Study|Never start treatment|0|||
150285146|NCT03246958|542180514|FG003|Overall Study|Never start treatment|0|||
150285147|NCT03246958|542180515|FG004|Overall Study|Never start treatment|0|||
150285148|NCT03246958|542180516|FG005|Overall Study|Never start treatment|0|||
150285149|NCT03246958|542180517|FG006|Overall Study|Never start treatment|0|||
150285150|NCT03246958|542180511|FG000|Overall Study|Over enrollment|0|||
150285151|NCT03246958|542180512|FG001|Overall Study|Over enrollment|2|||
150285152|NCT03246958|542180513|FG002|Overall Study|Over enrollment|0|||
150285153|NCT03246958|542180514|FG003|Overall Study|Over enrollment|0|||
150285154|NCT03246958|542180515|FG004|Overall Study|Over enrollment|0|||
150285155|NCT03246958|542180516|FG005|Overall Study|Over enrollment|0|||
150285156|NCT03246958|542180517|FG006|Overall Study|Over enrollment|0|||
150285157|NCT01032915|542180521|FG000|Overall Study|Adverse Event|2|||
150285158|NCT01032915|542180522|FG001|Overall Study|Adverse Event|2|||
150285159|NCT01032915|542180523|FG002|Overall Study|Adverse Event|1|||
150285160|NCT01032915|542180524|FG003|Overall Study|Adverse Event|1|||
150285161|NCT01032915|542180521|FG000|Overall Study|Abnormal test procedure result|0|||
150285162|NCT01032915|542180522|FG001|Overall Study|Abnormal test procedure result|0|||
150285163|NCT01032915|542180523|FG002|Overall Study|Abnormal test procedure result|1|||
150285164|NCT01032915|542180524|FG003|Overall Study|Abnormal test procedure result|0|||
150285165|NCT01032915|542180521|FG000|Overall Study|Withdrawal by Subject|0|||
150285166|NCT01032915|542180522|FG001|Overall Study|Withdrawal by Subject|3|||
150285167|NCT01032915|542180523|FG002|Overall Study|Withdrawal by Subject|1|||
150285168|NCT01032915|542180524|FG003|Overall Study|Withdrawal by Subject|1|||
150285169|NCT01032915|542180521|FG000|Overall Study|Administrative reasons|5|||
150285170|NCT01032915|542180522|FG001|Overall Study|Administrative reasons|6|||
150285171|NCT01032915|542180523|FG002|Overall Study|Administrative reasons|4|||
150285172|NCT01032915|542180524|FG003|Overall Study|Administrative reasons|4|||
150285173|NCT01032915|542180521|FG000|Overall Study|Protocol Violation|1|||
150285174|NCT01032915|542180522|FG001|Overall Study|Protocol Violation|0|||
150285175|NCT01032915|542180523|FG002|Overall Study|Protocol Violation|0|||
150285176|NCT01032915|542180524|FG003|Overall Study|Protocol Violation|1|||
149839520|NCT00834067|540542499|FG001|Washout of 21 Days|Protocol Violation|1|||
149839521|NCT00440518|540542500|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
150285177|NCT03363321|542180525|FG000|Overall Study|Withdrawal by Subject|0|||
150285178|NCT03363321|542180526|FG001|Overall Study|Withdrawal by Subject|1|||
150285179|NCT03363321|542180527|FG002|Overall Study|Withdrawal by Subject|0|||
150285180|NCT03363321|542180528|FG003|Overall Study|Withdrawal by Subject|1|||
150285181|NCT03363321|542180529|FG004|Overall Study|Withdrawal by Subject|0|||
149839522|NCT00440518|540542501|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
149839523|NCT00440518|540542502|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
149839524|NCT00440518|540542500|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
149952696|NCT04925934|540958660|FG002|Overall Study|Other|2|||
150285182|NCT00382993|542180535|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
150285183|NCT00382993|542180536|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
150285184|NCT00382993|542180535|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
150285185|NCT00382993|542180536|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
149839525|NCT00440518|540542501|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
149839526|NCT00440518|540542502|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
149839527|NCT00440518|540542500|FG000|Randomized /Titration Period|Protocol Deviation|1|||
149839528|NCT00440518|540542501|FG001|Randomized /Titration Period|Protocol Deviation|0|||
149839529|NCT00440518|540542502|FG002|Randomized /Titration Period|Protocol Deviation|0|||
149839530|NCT00440518|540542500|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
150285186|NCT00382993|542180535|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
150285187|NCT00382993|542180536|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
149839531|NCT00440518|540542501|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
149839532|NCT00440518|540542502|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
149839533|NCT00440518|540542500|FG000|Randomized /Titration Period|Other|1|||
149839534|NCT00440518|540542501|FG001|Randomized /Titration Period|Other|0|||
149839535|NCT00440518|540542502|FG002|Randomized /Titration Period|Other|0|||
150285188|NCT00382993|542180535|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
150285189|NCT00382993|542180536|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
150285190|NCT00382993|542180535|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
150285191|NCT00382993|542180536|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
150285192|NCT00382993|542180535|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
150285193|NCT00382993|542180536|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
150285194|NCT00382993|542180535|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
150285195|NCT00382993|542180536|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
150285196|NCT00382993|542180535|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
150285197|NCT00382993|542180536|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
150285198|NCT00382993|542180535|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
150285199|NCT00382993|542180536|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
150285200|NCT00382993|542180535|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
150285201|NCT00382993|542180536|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
150285202|NCT02941627|542180553|FG000|Overall Study|Death|1|||
150285203|NCT02941627|542180553|FG000|Overall Study|Surgical failure|1|||
150285204|NCT02941627|542180553|FG000|Overall Study|cholesteatoma prevented implantation|1|||
150285205|NCT00606320|542180554|FG000|Overall Study|Adverse Event|3|||
150285206|NCT00606320|542180554|FG000|Overall Study|Lack of Efficacy|5|||
150285207|NCT00606320|542180554|FG000|Overall Study|Physician Decision|7|||
150285208|NCT00606320|542180554|FG000|Overall Study|Protocol Violation|8|||
150285209|NCT00606320|542180554|FG000|Overall Study|Withdrawal by Subject|10|||
150285210|NCT00606320|542180554|FG000|Overall Study|Progression to depressive phase|4|||
150285211|NCT00563186|542180555|FG000|Overall Study|LOS<48 hours|97|||
150285212|NCT00563186|542180556|FG001|Overall Study|LOS<48 hours|74|||
150285213|NCT00563186|542180555|FG000|Overall Study|Incomplete data|1|||
150285214|NCT00563186|542180556|FG001|Overall Study|Incomplete data|1|||
150285215|NCT04839380|542180557|FG000|Overall Study|Withdrawal by Subject|2|||
150285216|NCT04839380|542180557|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
150285217|NCT00879645|542180558|FG000|Overall Study|Adverse Event|1|||
150285218|NCT00879645|542180559|FG001|Overall Study|Adverse Event|0|||
149839536|NCT00440518|540542500|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
149839537|NCT00440518|540542501|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
149839538|NCT00440518|540542502|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
149839539|NCT00440518|540542500|FG000|Randomized /Titration Period|Adverse Event|2|||
149839540|NCT00440518|540542501|FG001|Randomized /Titration Period|Adverse Event|3|||
149839541|NCT00440518|540542502|FG002|Randomized /Titration Period|Adverse Event|0|||
149839542|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
149839543|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
149839544|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
149839545|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
149839546|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
149839547|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
149839548|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
149839549|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
149952697|NCT04925934|540958658|FG000|Overall Study|Eastern European Conflict|7|||
149839550|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
149839551|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
149839552|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
149839553|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
149839554|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
149839555|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
149839556|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
149839557|NCT00440518|540542500|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
149839558|NCT00440518|540542501|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
149839559|NCT00440518|540542502|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
149839560|NCT02246920|540542503|FG000|Overall Study|Adverse Event|3|||
149839561|NCT02246920|540542504|FG001|Overall Study|Adverse Event|1|||
149839562|NCT02246920|540542505|FG002|Overall Study|Adverse Event|1|||
149839563|NCT02246920|540542503|FG000|Overall Study|Lost to Follow-up|2|||
149839564|NCT02246920|540542504|FG001|Overall Study|Lost to Follow-up|1|||
149839565|NCT02246920|540542505|FG002|Overall Study|Lost to Follow-up|0|||
149952698|NCT04925934|540958659|FG001|Overall Study|Eastern European Conflict|3|||
149952699|NCT04925934|540958660|FG002|Overall Study|Eastern European Conflict|2|||
149839566|NCT02246920|540542503|FG000|Overall Study|Protocol Violation|2|||
149839567|NCT02246920|540542504|FG001|Overall Study|Protocol Violation|5|||
150285219|NCT00879645|542180560|FG002|Overall Study|Adverse Event|0|||
150285220|NCT00879645|542180561|FG003|Overall Study|Adverse Event|0|||
150285221|NCT00513500|542180562|FG000|Overall Study|Lost to Follow-up|35|||
150285222|NCT00513500|542180563|FG001|Overall Study|Lost to Follow-up|39|||
150285223|NCT00513500|542180562|FG000|Overall Study|Death|2|||
150285224|NCT00513500|542180563|FG001|Overall Study|Death|1|||
149839568|NCT02246920|540542505|FG002|Overall Study|Protocol Violation|1|||
149839569|NCT02246920|540542503|FG000|Overall Study|Withdrawal by Subject|0|||
149839570|NCT02246920|540542504|FG001|Overall Study|Withdrawal by Subject|0|||
149839571|NCT02246920|540542505|FG002|Overall Study|Withdrawal by Subject|1|||
149839572|NCT02678286|540542506|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
149839573|NCT02678286|540542507|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
149839574|NCT02678286|540542506|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
149839575|NCT02678286|540542507|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
149839576|NCT02678286|540542506|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
149839577|NCT02678286|540542507|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
149839578|NCT02678286|540542506|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
149839579|NCT02678286|540542507|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
149839580|NCT02678286|540542506|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
149839581|NCT02678286|540542507|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
149839582|NCT02902211|540542513|FG000|First Three Months|Withdrawal by Subject|7|||
149839583|NCT02902211|540542514|FG001|First Three Months|Withdrawal by Subject|3|||
149839584|NCT03247972|540542518|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
149839585|NCT03247972|540542518|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
149839586|NCT03500341|540542519|FG000|Overall Study|Withdrawn prior to Completion|2|||
149839587|NCT02576938|540542520|FG000|Overall Study|Adverse Event|5|||
149839588|NCT02576938|540542521|FG001|Overall Study|Adverse Event|3|||
149839589|NCT02576938|540542522|FG002|Overall Study|Adverse Event|6|||
149839590|NCT02576938|540542520|FG000|Overall Study|Protocol Violation|1|||
149839591|NCT02576938|540542521|FG001|Overall Study|Protocol Violation|1|||
149839592|NCT02576938|540542522|FG002|Overall Study|Protocol Violation|1|||
149839593|NCT02576938|540542520|FG000|Overall Study|Withdrawal by Subject|3|||
149839594|NCT02576938|540542521|FG001|Overall Study|Withdrawal by Subject|2|||
149839595|NCT02576938|540542522|FG002|Overall Study|Withdrawal by Subject|4|||
149839596|NCT02576938|540542520|FG000|Overall Study|Lack of Efficacy|9|||
149839597|NCT02576938|540542521|FG001|Overall Study|Lack of Efficacy|4|||
149839598|NCT02576938|540542522|FG002|Overall Study|Lack of Efficacy|0|||
149839599|NCT02576938|540542520|FG000|Overall Study|Lost to Follow-up|2|||
149839600|NCT02576938|540542521|FG001|Overall Study|Lost to Follow-up|0|||
149839601|NCT02576938|540542522|FG002|Overall Study|Lost to Follow-up|1|||
149839602|NCT02576938|540542520|FG000|Overall Study|Physician Decision|0|||
149839603|NCT02576938|540542521|FG001|Overall Study|Physician Decision|1|||
149839604|NCT02576938|540542522|FG002|Overall Study|Physician Decision|0|||
149839605|NCT02576938|540542520|FG000|Overall Study|Met Exclusion Criteria|0|||
149839606|NCT02576938|540542521|FG001|Overall Study|Met Exclusion Criteria|1|||
149839607|NCT02576938|540542522|FG002|Overall Study|Met Exclusion Criteria|0|||
149839608|NCT00968812|540542525|FG000|Overall Study|Adverse Event|30|||
149839609|NCT00968812|540542526|FG001|Overall Study|Adverse Event|46|||
149839610|NCT00968812|540542527|FG002|Overall Study|Adverse Event|33|||
149839611|NCT00968812|540542525|FG000|Overall Study|Death|2|||
149839612|NCT00968812|540542526|FG001|Overall Study|Death|2|||
149839613|NCT00968812|540542527|FG002|Overall Study|Death|1|||
149839614|NCT00968812|540542525|FG000|Overall Study|Lack of Efficacy|9|||
149839615|NCT00968812|540542526|FG001|Overall Study|Lack of Efficacy|7|||
149839616|NCT00968812|540542527|FG002|Overall Study|Lack of Efficacy|16|||
149839617|NCT00968812|540542525|FG000|Overall Study|Lost to Follow-up|17|||
149839618|NCT00968812|540542526|FG001|Overall Study|Lost to Follow-up|12|||
149839619|NCT00968812|540542527|FG002|Overall Study|Lost to Follow-up|11|||
149839620|NCT00968812|540542525|FG000|Overall Study|Physician Decision|8|||
149839621|NCT00968812|540542526|FG001|Overall Study|Physician Decision|5|||
149839622|NCT00968812|540542527|FG002|Overall Study|Physician Decision|9|||
149839623|NCT00968812|540542525|FG000|Overall Study|Protocol Violation|7|||
149839624|NCT00968812|540542526|FG001|Overall Study|Protocol Violation|4|||
149839625|NCT00968812|540542527|FG002|Overall Study|Protocol Violation|3|||
149952700|NCT00376506|540958661|FG000|Overall Study|Death|0|||
149952701|NCT00376506|540958662|FG001|Overall Study|Death|2|||
150285225|NCT00513500|542180562|FG000|Overall Study|Hospitalized|4|||
149839626|NCT00968812|540542525|FG000|Overall Study|Withdrawal by Subject|17|||
149839627|NCT00968812|540542526|FG001|Overall Study|Withdrawal by Subject|23|||
149839628|NCT00968812|540542527|FG002|Overall Study|Withdrawal by Subject|25|||
149839629|NCT00968812|540542525|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
149839630|NCT00968812|540542526|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
149952702|NCT03158688|540958663|FG000|Overall Study|Withdrawal by Subject|14|||
150285226|NCT00513500|542180563|FG001|Overall Study|Hospitalized|14|||
150285227|NCT00749996|542180564|FG000|Overall Study|Lost to Follow-up|7|||
149839631|NCT00968812|540542527|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
149839632|NCT00968812|540542525|FG000|Overall Study|Noncompliance with study drug|4|||
149839633|NCT00968812|540542526|FG001|Overall Study|Noncompliance with study drug|1|||
149839634|NCT00968812|540542527|FG002|Overall Study|Noncompliance with study drug|6|||
149839635|NCT00968812|540542525|FG000|Overall Study|Unable to take rescue therapy|12|||
149839636|NCT00968812|540542526|FG001|Overall Study|Unable to take rescue therapy|12|||
149839637|NCT00968812|540542527|FG002|Overall Study|Unable to take rescue therapy|17|||
149839638|NCT00968812|540542525|FG000|Overall Study|Other|25|||
149839639|NCT00968812|540542526|FG001|Overall Study|Other|37|||
149839640|NCT00968812|540542527|FG002|Overall Study|Other|40|||
149839641|NCT00838630|540542530|FG000|First Intervention|Adverse Event|1|||
149839642|NCT00838630|540542531|FG001|First Intervention|Adverse Event|0|||
149839643|NCT00838630|540542530|FG000|Washout: 7 Days|Protocol Violation|1|||
149839644|NCT00838630|540542531|FG001|Washout: 7 Days|Protocol Violation|0|||
149839645|NCT00571064|540542532|FG000|Overall Study|Adverse Event|13|||
149839646|NCT00571064|540542532|FG000|Overall Study|Protocol Violation|4|||
149839647|NCT00571064|540542532|FG000|Overall Study|Withdrawal by Subject|2|||
149839648|NCT00571064|540542532|FG000|Overall Study|Other|2|||
149839649|NCT04022954|540542533|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
149839650|NCT04022954|540542533|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
149839651|NCT04022954|540542533|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
149839652|NCT03017885|540542534|FG000|Overall Study|Adverse Event|2|||
149839653|NCT03017885|540542535|FG001|Overall Study|Adverse Event|0|||
149839654|NCT03017885|540542536|FG002|Overall Study|Adverse Event|0|||
149839655|NCT03017885|540542537|FG003|Overall Study|Adverse Event|0|||
149839656|NCT03017885|540542538|FG004|Overall Study|Adverse Event|0|||
149839657|NCT03017885|540542539|FG005|Overall Study|Adverse Event|0|||
149839658|NCT03017885|540542534|FG000|Overall Study|Progression of disease|4|||
149839659|NCT03017885|540542535|FG001|Overall Study|Progression of disease|3|||
149839660|NCT03017885|540542536|FG002|Overall Study|Progression of disease|4|||
149839661|NCT03017885|540542537|FG003|Overall Study|Progression of disease|0|||
149839662|NCT03017885|540542538|FG004|Overall Study|Progression of disease|0|||
149839663|NCT03017885|540542539|FG005|Overall Study|Progression of disease|0|||
149839664|NCT03017885|540542534|FG000|Overall Study|Other than listed|1|||
149839665|NCT03017885|540542535|FG001|Overall Study|Other than listed|2|||
149839666|NCT03017885|540542536|FG002|Overall Study|Other than listed|1|||
149839667|NCT03017885|540542537|FG003|Overall Study|Other than listed|0|||
149839668|NCT03017885|540542538|FG004|Overall Study|Other than listed|0|||
149839669|NCT03017885|540542539|FG005|Overall Study|Other than listed|0|||
149839670|NCT03017885|540542534|FG000|Overall Study|Lost to Follow-up|2|||
149839671|NCT03017885|540542535|FG001|Overall Study|Lost to Follow-up|0|||
149839672|NCT03017885|540542536|FG002|Overall Study|Lost to Follow-up|3|||
149839673|NCT03017885|540542537|FG003|Overall Study|Lost to Follow-up|0|||
149839674|NCT03017885|540542538|FG004|Overall Study|Lost to Follow-up|0|||
149839675|NCT03017885|540542539|FG005|Overall Study|Lost to Follow-up|0|||
149839676|NCT03017885|540542534|FG000|Overall Study|Change to other anti-cancer therapy|0|||
149839677|NCT03017885|540542535|FG001|Overall Study|Change to other anti-cancer therapy|0|||
149839678|NCT03017885|540542536|FG002|Overall Study|Change to other anti-cancer therapy|1|||
149839679|NCT03017885|540542537|FG003|Overall Study|Change to other anti-cancer therapy|0|||
149839680|NCT03017885|540542538|FG004|Overall Study|Change to other anti-cancer therapy|0|||
149839681|NCT03017885|540542539|FG005|Overall Study|Change to other anti-cancer therapy|0|||
149839682|NCT02648438|540542544|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149839683|NCT02648438|540542545|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
149839684|NCT02648438|540542546|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
149839685|NCT02648438|540542544|FG000|Overall Study|Protocol Violation|2|||
149839686|NCT02648438|540542545|FG001|Overall Study|Protocol Violation|0|||
149839687|NCT02648438|540542546|FG002|Overall Study|Protocol Violation|0|||
149839688|NCT02648438|540542544|FG000|Overall Study|Withdrawal by Subject|1|||
149839689|NCT02648438|540542545|FG001|Overall Study|Withdrawal by Subject|1|||
149839690|NCT02648438|540542546|FG002|Overall Study|Withdrawal by Subject|0|||
149839691|NCT03138967|540542547|FG000|Overall Study|Death|0|||
149839692|NCT03138967|540542548|FG001|Overall Study|Death|1|||
149839693|NCT03138967|540542547|FG000|Overall Study|Physician Decision|1|||
149839694|NCT03138967|540542548|FG001|Overall Study|Physician Decision|3|||
149839695|NCT04604275|540542549|FG000|Washout-1 Week|Withdrawal by Subject|1|||
149839696|NCT04604275|540542550|FG001|Washout-1 Week|Withdrawal by Subject|0|||
149839697|NCT02258074|540542551|FG000|Overall Study|Withdrawal by Subject|1|||
149839698|NCT02258074|540542552|FG001|Overall Study|Withdrawal by Subject|0|||
149839699|NCT02258074|540542553|FG002|Overall Study|Withdrawal by Subject|0|||
149839700|NCT02258074|540542554|FG003|Overall Study|Withdrawal by Subject|0|||
149839701|NCT00723710|540542555|FG000|Overall Study|Disease progression|48|||
149839702|NCT00723710|540542555|FG000|Overall Study|Adverse Event|88|||
150035225|NCT01207414|541268915|FG000|Overall Study|Adverse Event|25|||
150285228|NCT00749996|542180565|FG001|Overall Study|Lost to Follow-up|4|||
149839703|NCT00723710|540542555|FG000|Overall Study|Withdrawal by Subject|36|||
149839704|NCT00723710|540542555|FG000|Overall Study|Physician Decision|2|||
149839705|NCT01615198|540542558|FG000|Overall Study|Withdrawal by Subject|5|||
149839706|NCT01615198|540542559|FG001|Overall Study|Withdrawal by Subject|5|||
149839707|NCT01615198|540542558|FG000|Overall Study|Protocol deviation|1|||
149839708|NCT01615198|540542559|FG001|Overall Study|Protocol deviation|1|||
149839709|NCT01615198|540542558|FG000|Overall Study|Physician Decision|5|||
149839710|NCT01615198|540542559|FG001|Overall Study|Physician Decision|1|||
149839711|NCT01615198|540542558|FG000|Overall Study|Lost to Follow-up|1|||
149839712|NCT01615198|540542559|FG001|Overall Study|Lost to Follow-up|1|||
149839713|NCT01615198|540542558|FG000|Overall Study|Lack of Efficacy|1|||
149839714|NCT01615198|540542559|FG001|Overall Study|Lack of Efficacy|6|||
149839715|NCT01615198|540542558|FG000|Overall Study|Adverse Event|11|||
149839716|NCT01615198|540542559|FG001|Overall Study|Adverse Event|5|||
149839717|NCT01686438|540542560|FG000|Overall Study|Lost to Follow-up|8|||
149839718|NCT01686438|540542561|FG001|Overall Study|Lost to Follow-up|9|||
149839719|NCT01686438|540542562|FG002|Overall Study|Lost to Follow-up|10|||
149839720|NCT01686438|540542560|FG000|Overall Study|Adverse Event|0|||
149839721|NCT01686438|540542561|FG001|Overall Study|Adverse Event|0|||
149839722|NCT01686438|540542562|FG002|Overall Study|Adverse Event|1|||
149839723|NCT01686438|540542560|FG000|Overall Study|Protocol Violation|0|||
149839724|NCT01686438|540542561|FG001|Overall Study|Protocol Violation|0|||
149839725|NCT01686438|540542562|FG002|Overall Study|Protocol Violation|1|||
149839726|NCT01686438|540542560|FG000|Overall Study|Withdrawal by Subject|0|||
149839727|NCT01686438|540542561|FG001|Overall Study|Withdrawal by Subject|0|||
149839728|NCT01686438|540542562|FG002|Overall Study|Withdrawal by Subject|1|||
149839729|NCT01029340|540542563|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
149839730|NCT01029340|540542564|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
149839731|NCT01029340|540542565|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
149839732|NCT01029340|540542566|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
149839733|NCT01029340|540542567|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
149839734|NCT01029340|540542568|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
149839735|NCT01029340|540542563|FG000|Part B Treatment Period|Protocol Violation|0|||
149839736|NCT01029340|540542564|FG001|Part B Treatment Period|Protocol Violation|0|||
149839737|NCT01029340|540542565|FG002|Part B Treatment Period|Protocol Violation|1|||
149839738|NCT01029340|540542566|FG003|Part B Treatment Period|Protocol Violation|0|||
150035226|NCT01207414|541268916|FG001|Overall Study|Adverse Event|39|||
150035227|NCT01207414|541268915|FG000|Overall Study|Abnormal test procedure results|0|||
150035228|NCT01207414|541268916|FG001|Overall Study|Abnormal test procedure results|1|||
150035229|NCT01207414|541268915|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
150035230|NCT01207414|541268916|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
149839739|NCT01029340|540542567|FG004|Part B Treatment Period|Protocol Violation|0|||
150035231|NCT01207414|541268915|FG000|Overall Study|Patient withdrew consent|14|||
150035232|NCT01207414|541268916|FG001|Overall Study|Patient withdrew consent|11|||
150035233|NCT01207414|541268915|FG000|Overall Study|Lost to Follow-up|15|||
150035234|NCT01207414|541268916|FG001|Overall Study|Lost to Follow-up|17|||
150035235|NCT01207414|541268915|FG000|Overall Study|Administrative problems|1|||
150035236|NCT01207414|541268916|FG001|Overall Study|Administrative problems|1|||
150035237|NCT01207414|541268915|FG000|Overall Study|Protocol deviation|12|||
150035238|NCT01207414|541268916|FG001|Overall Study|Protocol deviation|9|||
150035239|NCT01207414|541268915|FG000|Overall Study|Randomized in error|1|||
150035240|NCT01207414|541268916|FG001|Overall Study|Randomized in error|0|||
150035241|NCT02057250|541268917|FG000|AID Assessment Phase|Adverse Event|3|||
150035242|NCT02057250|541268918|FG001|AID Assessment Phase|Adverse Event|2|||
150035243|NCT02057250|541268919|FG002|AID Assessment Phase|Adverse Event|6|||
150035244|NCT02057250|541268920|FG003|AID Assessment Phase|Adverse Event|1|||
150035245|NCT02057250|541268921|FG004|AID Assessment Phase|Adverse Event|0|||
150035246|NCT02057250|541268917|FG000|AID Assessment Phase|Other than specified above|1|||
150035247|NCT02057250|541268918|FG001|AID Assessment Phase|Other than specified above|1|||
150035248|NCT02057250|541268919|FG002|AID Assessment Phase|Other than specified above|1|||
150285229|NCT00749996|542180564|FG000|Overall Study|Withdrawal by Subject|5|||
150285230|NCT00749996|542180565|FG001|Overall Study|Withdrawal by Subject|4|||
149839740|NCT01029340|540542568|FG005|Part B Treatment Period|Protocol Violation|0|||
149839741|NCT01029340|540542563|FG000|Extension Period|Adverse Event|0|||
149839742|NCT01029340|540542564|FG001|Extension Period|Adverse Event|0|||
149839743|NCT01029340|540542565|FG002|Extension Period|Adverse Event|0|||
149839744|NCT01029340|540542566|FG003|Extension Period|Adverse Event|0|||
149839745|NCT01029340|540542567|FG004|Extension Period|Adverse Event|0|||
149839746|NCT01029340|540542568|FG005|Extension Period|Adverse Event|1|||
149839747|NCT01029340|540542563|FG000|Extension Period|starting another study|0|||
149839748|NCT01029340|540542564|FG001|Extension Period|starting another study|0|||
149839749|NCT01029340|540542565|FG002|Extension Period|starting another study|0|||
149839750|NCT01029340|540542566|FG003|Extension Period|starting another study|0|||
150035249|NCT02057250|541268920|FG003|AID Assessment Phase|Other than specified above|1|||
149839751|NCT01029340|540542567|FG004|Extension Period|starting another study|0|||
149839752|NCT01029340|540542568|FG005|Extension Period|starting another study|8|||
150035250|NCT02057250|541268921|FG004|AID Assessment Phase|Other than specified above|0|||
150035251|NCT02057250|541268917|FG000|Extension Phase|Adverse Event|0|||
150035252|NCT02057250|541268918|FG001|Extension Phase|Adverse Event|0|||
149839753|NCT01029340|540542563|FG000|Extension Period|non-compliance|0|||
149839754|NCT01029340|540542564|FG001|Extension Period|non-compliance|0|||
149839755|NCT01029340|540542565|FG002|Extension Period|non-compliance|0|||
149839756|NCT01029340|540542566|FG003|Extension Period|non-compliance|0|||
149839757|NCT01029340|540542567|FG004|Extension Period|non-compliance|0|||
149839758|NCT01029340|540542568|FG005|Extension Period|non-compliance|1|||
149839759|NCT01029340|540542563|FG000|Extension Period|Withdrawal by Subject|0|||
149839760|NCT01029340|540542564|FG001|Extension Period|Withdrawal by Subject|0|||
149839761|NCT01029340|540542565|FG002|Extension Period|Withdrawal by Subject|0|||
149839762|NCT01029340|540542566|FG003|Extension Period|Withdrawal by Subject|0|||
149839763|NCT01029340|540542567|FG004|Extension Period|Withdrawal by Subject|0|||
149839764|NCT01029340|540542568|FG005|Extension Period|Withdrawal by Subject|1|||
149839765|NCT01029340|540542563|FG000|Extension Period|Physician Decision|0|||
149839766|NCT01029340|540542564|FG001|Extension Period|Physician Decision|0|||
149839767|NCT01029340|540542565|FG002|Extension Period|Physician Decision|0|||
149839768|NCT01029340|540542566|FG003|Extension Period|Physician Decision|0|||
149839769|NCT01029340|540542567|FG004|Extension Period|Physician Decision|0|||
149839770|NCT01029340|540542568|FG005|Extension Period|Physician Decision|1|||
149839771|NCT01864174|540542569|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
149839772|NCT01864174|540542570|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
149839773|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
149839774|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
149839775|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
149839776|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
149839777|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
149839778|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
149839779|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Death|1|||
149839780|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Death|0|||
149839781|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
149839782|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
149839783|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
149839784|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
149839785|NCT01864174|540542569|FG000|Double Blind - Compliant Randomized|Other|6|||
149839786|NCT01864174|540542570|FG001|Double Blind - Compliant Randomized|Other|10|||
149839787|NCT01864174|540542569|FG000|Off Treatment Follow-Up|Other|2|||
149839788|NCT01864174|540542570|FG001|Off Treatment Follow-Up|Other|0|||
149839789|NCT01864174|540542569|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
149839790|NCT01864174|540542570|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
149839791|NCT02648347|540542571|FG000|Overall Study|Death|174|||
149839792|NCT02648347|540542572|FG001|Overall Study|Death|167|||
149839793|NCT02648347|540542571|FG000|Overall Study|Withdrawal by Subject|16|||
149839794|NCT02648347|540542572|FG001|Overall Study|Withdrawal by Subject|9|||
149839795|NCT02648347|540542571|FG000|Overall Study|Lost to Follow-up|18|||
150285231|NCT00749996|542180564|FG000|Overall Study|Protocol Violation|2|||
150285232|NCT00749996|542180565|FG001|Overall Study|Protocol Violation|3|||
150285233|NCT00749996|542180564|FG000|Overall Study|Physician Decision|2|||
150285234|NCT00749996|542180565|FG001|Overall Study|Physician Decision|0|||
150285235|NCT00749996|542180564|FG000|Overall Study|Pregnancy|0|||
150285236|NCT00749996|542180565|FG001|Overall Study|Pregnancy|2|||
150285237|NCT00749996|542180564|FG000|Overall Study|Adverse Event|1|||
150285238|NCT00749996|542180565|FG001|Overall Study|Adverse Event|0|||
150285239|NCT00749996|542180564|FG000|Overall Study|Death|1|||
150285240|NCT00749996|542180565|FG001|Overall Study|Death|0|||
150285241|NCT01225731|542180572|FG000|Part 1|Did not meet eligibility criteria|1|||
150285242|NCT01225731|542180573|FG001|Part 1|Did not meet eligibility criteria|0|||
150285243|NCT01225731|542180574|FG002|Part 1|Did not meet eligibility criteria|0|||
150285244|NCT01225731|542180575|FG003|Part 1|Did not meet eligibility criteria|0|||
150285245|NCT01225731|542180576|FG004|Part 1|Did not meet eligibility criteria|1|||
150285246|NCT01225731|542180577|FG005|Part 1|Did not meet eligibility criteria|0|||
150285247|NCT01225731|542180578|FG006|Part 1|Did not meet eligibility criteria|0|||
150285248|NCT01225731|542180579|FG007|Part 1|Did not meet eligibility criteria|0|||
150285249|NCT01225731|542180580|FG008|Part 1|Did not meet eligibility criteria|0|||
150285250|NCT01225731|542180581|FG009|Part 1|Did not meet eligibility criteria|0|||
150285251|NCT01225731|542180582|FG010|Part 1|Did not meet eligibility criteria|0|||
150285252|NCT01225731|542180583|FG011|Part 1|Did not meet eligibility criteria|0|||
150285253|NCT01225731|542180584|FG012|Part 1|Did not meet eligibility criteria|0|||
150285254|NCT01225731|542180572|FG000|Part 1|Adverse Event|1|||
150285255|NCT01225731|542180573|FG001|Part 1|Adverse Event|2|||
149839796|NCT02648347|540542572|FG001|Overall Study|Lost to Follow-up|21|||
150285256|NCT01225731|542180574|FG002|Part 1|Adverse Event|1|||
150285257|NCT01225731|542180575|FG003|Part 1|Adverse Event|1|||
150285258|NCT01225731|542180576|FG004|Part 1|Adverse Event|1|||
150285259|NCT01225731|542180577|FG005|Part 1|Adverse Event|0|||
150285260|NCT01225731|542180578|FG006|Part 1|Adverse Event|0|||
149839797|NCT02648347|540542571|FG000|Overall Study|Missing|1|||
149839798|NCT02648347|540542572|FG001|Overall Study|Missing|0|||
149839799|NCT00468286|540542577|FG000|Overall Study|Adverse Event|1|||
149839800|NCT00468286|540542578|FG001|Overall Study|Adverse Event|6|||
149839801|NCT00468286|540542577|FG000|Overall Study|Protocol Violation|2|||
149839802|NCT00468286|540542578|FG001|Overall Study|Protocol Violation|2|||
149839803|NCT00468286|540542577|FG000|Overall Study|Withdrawal by Subject|4|||
149839804|NCT00468286|540542578|FG001|Overall Study|Withdrawal by Subject|3|||
149839805|NCT00468286|540542577|FG000|Overall Study|Physician Decision|0|||
149839806|NCT00468286|540542578|FG001|Overall Study|Physician Decision|1|||
149839807|NCT01415986|540542582|FG000|Overall Study|Lost to Follow-up|1|||
149839808|NCT04419311|540542586|FG000|Overall Study|Lost to Follow-up|1|||
149839809|NCT04419311|540542587|FG001|Overall Study|Lost to Follow-up|0|||
149839810|NCT03122457|540542588|FG000|Overall Study|Withdrawal by Subject|6|||
149839811|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
149839812|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
149839813|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
149839814|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
149839815|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
149839816|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
149839817|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
149839818|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
149839819|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
149839820|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
149839821|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
149839822|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
149839823|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
149839824|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
149839825|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
149839826|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
149839827|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
149839828|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
149839829|NCT01045161|540542589|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
149839830|NCT01045161|540542590|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
149839831|NCT01045161|540542591|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
149839832|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
149839833|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
149839834|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
149839835|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
149839836|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
149839837|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
149839838|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
149839839|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
149839840|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
149839841|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
149839842|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
149839843|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
149839844|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
149839845|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
149839846|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
149839847|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
149839848|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
149839849|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
149839850|NCT01045161|540542589|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
149839851|NCT01045161|540542590|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
149839852|NCT01045161|540542591|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
149839853|NCT00819741|540542597|FG000|Overall Study|Adverse Event|5|||
149839854|NCT00819741|540542598|FG001|Overall Study|Adverse Event|2|||
149839855|NCT00819741|540542597|FG000|Overall Study|Lack of Efficacy|0|||
149839856|NCT00819741|540542598|FG001|Overall Study|Lack of Efficacy|2|||
149839857|NCT00819741|540542597|FG000|Overall Study|Lost to Follow-up|3|||
149839858|NCT00819741|540542598|FG001|Overall Study|Lost to Follow-up|1|||
149839859|NCT00819741|540542597|FG000|Overall Study|Protocol Violation|3|||
149839860|NCT00819741|540542598|FG001|Overall Study|Protocol Violation|4|||
149952703|NCT03158688|540958664|FG001|Overall Study|Withdrawal by Subject|28|||
149952704|NCT03158688|540958663|FG000|Overall Study|Decision by sponsor|13|||
149952705|NCT03158688|540958664|FG001|Overall Study|Decision by sponsor|37|||
149952706|NCT03158688|540958663|FG000|Overall Study|Lost to Follow-up|4|||
149952707|NCT03158688|540958664|FG001|Overall Study|Lost to Follow-up|3|||
150035253|NCT02057250|541268919|FG002|Extension Phase|Adverse Event|0|||
149839861|NCT00819741|540542597|FG000|Overall Study|Withdrawal by Subject|2|||
149839862|NCT00819741|540542598|FG001|Overall Study|Withdrawal by Subject|2|||
149839863|NCT00819741|540542597|FG000|Overall Study|Unclassified|6|||
149839864|NCT00819741|540542598|FG001|Overall Study|Unclassified|0|||
149839865|NCT00819741|540542597|FG000|Overall Study|Reasons unknown|3|||
149839866|NCT00819741|540542598|FG001|Overall Study|Reasons unknown|3|||
149839867|NCT01802320|540542599|FG000|Overall Study|Death|1|||
149839868|NCT01802320|540542599|FG000|Overall Study|Withdrawal by Subject|1|||
149839869|NCT04115293|540544503|FG000|Overall Study|Adverse Event|0|||
149839870|NCT04115293|540544504|FG001|Overall Study|Adverse Event|2|||
149839871|NCT04115293|540544503|FG000|Overall Study|Withdrawal by Subject|2|||
149839872|NCT04115293|540544504|FG001|Overall Study|Withdrawal by Subject|1|||
149839873|NCT04115293|540544503|FG000|Overall Study|Physician Decision|1|||
149839874|NCT04115293|540544504|FG001|Overall Study|Physician Decision|0|||
149839875|NCT04115293|540544503|FG000|Overall Study|Death|1|||
149839876|NCT04115293|540544504|FG001|Overall Study|Death|1|||
149839877|NCT02571907|540544505|FG000|Overall Study|Death|4|||
149839878|NCT02571907|540544505|FG000|Overall Study|Lost to Follow-up|3|||
149839879|NCT02571907|540544505|FG000|Overall Study|Withdrawal by Subject|3|||
149839880|NCT05265624|540544506|FG000|Overall Study|Lost to Follow-up|3|||
149839881|NCT05265624|540544507|FG001|Overall Study|Lost to Follow-up|0|||
149839882|NCT05265624|540544506|FG000|Overall Study|Withdrawal by Subject|1|||
149839883|NCT05265624|540544507|FG001|Overall Study|Withdrawal by Subject|0|||
149839884|NCT00001703|540544508|FG000|Overall Study|progressed disease|2|||
149839885|NCT00001703|540544508|FG000|Overall Study|No evidence of disease|1|||
149839886|NCT00001703|540544508|FG000|Overall Study|recurrent disease|2|||
149839887|NCT03071575|540544509|FG000|Overall Study|Death|0|||
149839888|NCT03071575|540544510|FG001|Overall Study|Death|1|||
149839889|NCT03071575|540544509|FG000|Overall Study|Lost to Follow-up|5|||
149839890|NCT03071575|540544510|FG001|Overall Study|Lost to Follow-up|11|||
149839891|NCT03071575|540544509|FG000|Overall Study|Withdrawal by Subject|4|||
149839892|NCT03071575|540544510|FG001|Overall Study|Withdrawal by Subject|2|||
149952708|NCT03158688|540958663|FG000|Overall Study|Death|74|||
149952709|NCT03158688|540958664|FG001|Overall Study|Death|142|||
149952710|NCT03301714|540958671|FG000|Overall Study|Lost to Follow-up|10|||
149952711|NCT03301714|540958672|FG001|Overall Study|Lost to Follow-up|4|||
149952712|NCT03301714|540958673|FG002|Overall Study|Lost to Follow-up|4|||
149952713|NCT03301714|540958671|FG000|Overall Study|Did not receive allocated intervention|0|||
149952714|NCT03301714|540958672|FG001|Overall Study|Did not receive allocated intervention|2|||
150285261|NCT01225731|542180579|FG007|Part 1|Adverse Event|0|||
150285262|NCT01225731|542180580|FG008|Part 1|Adverse Event|0|||
150285263|NCT01225731|542180581|FG009|Part 1|Adverse Event|0|||
150285264|NCT01225731|542180582|FG010|Part 1|Adverse Event|0|||
150285265|NCT01225731|542180583|FG011|Part 1|Adverse Event|0|||
150285266|NCT01225731|542180584|FG012|Part 1|Adverse Event|0|||
150285267|NCT01225731|542180572|FG000|Part 1|Withdrawal by Subject|0|||
150285268|NCT01225731|542180573|FG001|Part 1|Withdrawal by Subject|3|||
150285269|NCT01225731|542180574|FG002|Part 1|Withdrawal by Subject|0|||
150285270|NCT01225731|542180575|FG003|Part 1|Withdrawal by Subject|0|||
150285271|NCT01225731|542180576|FG004|Part 1|Withdrawal by Subject|4|||
150285272|NCT01225731|542180577|FG005|Part 1|Withdrawal by Subject|0|||
150285273|NCT01225731|542180578|FG006|Part 1|Withdrawal by Subject|0|||
150285274|NCT01225731|542180579|FG007|Part 1|Withdrawal by Subject|0|||
149839893|NCT00834795|540544515|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
149839894|NCT00834795|540544516|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
149839895|NCT00834795|540544515|FG000|Second Intervention|Adverse Event|1|||
149839896|NCT00834795|540544516|FG001|Second Intervention|Adverse Event|0|||
149839897|NCT03447353|540544517|FG000|Overall Study|Failure at Screening Visit|2|||
149839898|NCT03447353|540544517|FG000|Overall Study|Lost to Follow-up|4|||
149839899|NCT03447353|540544517|FG000|Overall Study|Scheduling Conflicts|3|||
149839900|NCT03447353|540544517|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
149839901|NCT01376037|540544518|FG000|Overall Study|Lost to Follow-up|0|||
149952715|NCT03301714|540958673|FG002|Overall Study|Did not receive allocated intervention|3|||
149952716|NCT02112552|540958676|FG000|Overall Study|Withdrawal by Subject|1|||
149839902|NCT01376037|540544519|FG001|Overall Study|Lost to Follow-up|2|||
149839903|NCT00561015|540544520|FG000|Overall Study|Adverse Event|0|||
149839904|NCT00561015|540544521|FG001|Overall Study|Adverse Event|0|||
149839905|NCT00561015|540544522|FG002|Overall Study|Adverse Event|0|||
149839906|NCT00561015|540544523|FG003|Overall Study|Adverse Event|0|||
149839907|NCT00561015|540544524|FG004|Overall Study|Adverse Event|1|||
149839908|NCT00561015|540544525|FG005|Overall Study|Adverse Event|0|||
149839909|NCT00561015|540544520|FG000|Overall Study|Lost to Follow-up|2|||
149839910|NCT00561015|540544521|FG001|Overall Study|Lost to Follow-up|0|||
149839911|NCT00561015|540544522|FG002|Overall Study|Lost to Follow-up|0|||
149952717|NCT02112552|540958676|FG000|Overall Study|Adverse Event|1|||
149952718|NCT03349515|540958678|FG000|Overall Study|Lack of Efficacy|2|||
150285275|NCT01225731|542180580|FG008|Part 1|Withdrawal by Subject|0|||
150285276|NCT01225731|542180581|FG009|Part 1|Withdrawal by Subject|0|||
149839912|NCT00561015|540544523|FG003|Overall Study|Lost to Follow-up|1|||
149839913|NCT00561015|540544524|FG004|Overall Study|Lost to Follow-up|0|||
149839914|NCT00561015|540544525|FG005|Overall Study|Lost to Follow-up|3|||
149839915|NCT00561015|540544520|FG000|Overall Study|Participant non-compliance|2|||
149839916|NCT00561015|540544521|FG001|Overall Study|Participant non-compliance|0|||
149839917|NCT00561015|540544522|FG002|Overall Study|Participant non-compliance|0|||
149839918|NCT00561015|540544523|FG003|Overall Study|Participant non-compliance|0|||
149839919|NCT00561015|540544524|FG004|Overall Study|Participant non-compliance|0|||
149839920|NCT00561015|540544525|FG005|Overall Study|Participant non-compliance|0|||
149839921|NCT03570749|540544526|FG000|Overall Study|Ongoing|26|||
150285277|NCT01225731|542180582|FG010|Part 1|Withdrawal by Subject|0|||
150285278|NCT01225731|542180583|FG011|Part 1|Withdrawal by Subject|0|||
150285279|NCT01225731|542180584|FG012|Part 1|Withdrawal by Subject|0|||
149839922|NCT03570749|540544527|FG001|Overall Study|Ongoing|25|||
149839923|NCT03570749|540544528|FG002|Overall Study|Ongoing|25|||
149839924|NCT03570749|540544529|FG003|Overall Study|Ongoing|26|||
149839925|NCT03570749|540544530|FG004|Overall Study|Ongoing|140|||
149839926|NCT03570749|540544531|FG005|Overall Study|Ongoing|142|||
149839927|NCT03570749|540544532|FG006|Overall Study|Ongoing|220|||
149839928|NCT03570749|540544526|FG000|Overall Study|Adverse Event|0|||
149839929|NCT03570749|540544527|FG001|Overall Study|Adverse Event|0|||
149839930|NCT03570749|540544528|FG002|Overall Study|Adverse Event|0|||
149839931|NCT03570749|540544529|FG003|Overall Study|Adverse Event|0|||
149839932|NCT03570749|540544530|FG004|Overall Study|Adverse Event|2|||
149839933|NCT03570749|540544531|FG005|Overall Study|Adverse Event|3|||
149839934|NCT03570749|540544532|FG006|Overall Study|Adverse Event|6|||
149839935|NCT03570749|540544526|FG000|Overall Study|Lack of Efficacy|0|||
149839936|NCT03570749|540544527|FG001|Overall Study|Lack of Efficacy|0|||
149839937|NCT03570749|540544528|FG002|Overall Study|Lack of Efficacy|0|||
149839938|NCT03570749|540544529|FG003|Overall Study|Lack of Efficacy|0|||
149839939|NCT03570749|540544530|FG004|Overall Study|Lack of Efficacy|8|||
149839940|NCT03570749|540544531|FG005|Overall Study|Lack of Efficacy|2|||
149839941|NCT03570749|540544532|FG006|Overall Study|Lack of Efficacy|7|||
149839942|NCT03570749|540544526|FG000|Overall Study|Lost to Follow-up|0|||
149839943|NCT03570749|540544527|FG001|Overall Study|Lost to Follow-up|0|||
149839944|NCT03570749|540544528|FG002|Overall Study|Lost to Follow-up|0|||
149839945|NCT03570749|540544529|FG003|Overall Study|Lost to Follow-up|0|||
149839946|NCT03570749|540544530|FG004|Overall Study|Lost to Follow-up|5|||
149839947|NCT03570749|540544531|FG005|Overall Study|Lost to Follow-up|10|||
149839948|NCT03570749|540544532|FG006|Overall Study|Lost to Follow-up|10|||
149839949|NCT03570749|540544526|FG000|Overall Study|Pregnancy|0|||
149839950|NCT03570749|540544527|FG001|Overall Study|Pregnancy|0|||
149839951|NCT03570749|540544528|FG002|Overall Study|Pregnancy|0|||
149839952|NCT03570749|540544529|FG003|Overall Study|Pregnancy|0|||
149839953|NCT03570749|540544530|FG004|Overall Study|Pregnancy|0|||
149839954|NCT03570749|540544531|FG005|Overall Study|Pregnancy|1|||
149839955|NCT03570749|540544532|FG006|Overall Study|Pregnancy|1|||
149839956|NCT03570749|540544526|FG000|Overall Study|Screen Fail|0|||
149839957|NCT03570749|540544527|FG001|Overall Study|Screen Fail|0|||
149839958|NCT03570749|540544528|FG002|Overall Study|Screen Fail|0|||
149839959|NCT03570749|540544529|FG003|Overall Study|Screen Fail|0|||
149839960|NCT03570749|540544530|FG004|Overall Study|Screen Fail|0|||
149839961|NCT03570749|540544531|FG005|Overall Study|Screen Fail|0|||
149839962|NCT03570749|540544532|FG006|Overall Study|Screen Fail|1|||
149839963|NCT03570749|540544526|FG000|Overall Study|Withdrawal by Subject|2|||
149839964|NCT03570749|540544527|FG001|Overall Study|Withdrawal by Subject|3|||
149839965|NCT03570749|540544528|FG002|Overall Study|Withdrawal by Subject|2|||
149839966|NCT03570749|540544529|FG003|Overall Study|Withdrawal by Subject|1|||
149952719|NCT03349515|540958679|FG001|Overall Study|Lack of Efficacy|0|||
149839967|NCT03570749|540544530|FG004|Overall Study|Withdrawal by Subject|17|||
149839968|NCT03570749|540544531|FG005|Overall Study|Withdrawal by Subject|12|||
149952720|NCT03349515|540958678|FG000|Overall Study|Physician Decision|3|||
149952721|NCT03349515|540958679|FG001|Overall Study|Physician Decision|1|||
149952722|NCT02503865|540958688|FG000|Overall Study|Moved out of area|1|||
149952723|NCT02503865|540958689|FG001|Overall Study|Moved out of area|8|||
149952724|NCT02503865|540958690|FG002|Overall Study|Moved out of area|0|||
149952725|NCT02503865|540958688|FG000|Overall Study|Refused treatment|4|||
149839969|NCT03570749|540544532|FG006|Overall Study|Withdrawal by Subject|15|||
149839970|NCT03570749|540544526|FG000|Overall Study|Other|0|||
149839971|NCT03570749|540544527|FG001|Overall Study|Other|0|||
149839972|NCT03570749|540544528|FG002|Overall Study|Other|0|||
149839973|NCT03570749|540544529|FG003|Overall Study|Other|0|||
149952726|NCT02503865|540958689|FG001|Overall Study|Refused treatment|39|||
149839974|NCT03570749|540544530|FG004|Overall Study|Other|17|||
149839975|NCT03570749|540544531|FG005|Overall Study|Other|14|||
149839976|NCT03570749|540544532|FG006|Overall Study|Other|21|||
149839977|NCT03616535|540544533|FG000|Overall Study|Death|2|||
149839978|NCT03616535|540544534|FG001|Overall Study|Death|0|||
149839979|NCT03616535|540544535|FG002|Overall Study|Death|0|||
149839980|NCT03616535|540544536|FG003|Overall Study|Death|1|||
149952727|NCT02503865|540958690|FG002|Overall Study|Refused treatment|2|||
149952728|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
150285280|NCT01225731|542180572|FG000|Part 1|Protocol Violation|0|||
149839981|NCT03616535|540544533|FG000|Overall Study|Lost to Follow-up|2|||
149839982|NCT03616535|540544534|FG001|Overall Study|Lost to Follow-up|1|||
149839983|NCT03616535|540544535|FG002|Overall Study|Lost to Follow-up|0|||
149839984|NCT03616535|540544536|FG003|Overall Study|Lost to Follow-up|2|||
149839985|NCT03616535|540544533|FG000|Overall Study|Withdrawal by Subject|1|||
149839986|NCT03616535|540544534|FG001|Overall Study|Withdrawal by Subject|2|||
149839987|NCT03616535|540544535|FG002|Overall Study|Withdrawal by Subject|5|||
149839988|NCT03616535|540544536|FG003|Overall Study|Withdrawal by Subject|1|||
149839989|NCT03616535|540544533|FG000|Overall Study|Not specified or change in eligibility|2|||
149839990|NCT03616535|540544534|FG001|Overall Study|Not specified or change in eligibility|3|||
149839991|NCT03616535|540544535|FG002|Overall Study|Not specified or change in eligibility|3|||
149839992|NCT03616535|540544536|FG003|Overall Study|Not specified or change in eligibility|1|||
149839993|NCT00583453|540544539|FG000|Overall Study|discontinued intervention|0|||
149839994|NCT00583453|540544540|FG001|Overall Study|discontinued intervention|2|||
149839995|NCT02436005|540544541|FG000|Second Intervention|Adverse Event|0|||
149839996|NCT02436005|540544542|FG001|Second Intervention|Adverse Event|1|||
149839997|NCT00905606|540544543|FG000|Period 1|Adverse Event|0|||
149839998|NCT00905606|540544544|FG001|Period 1|Adverse Event|1|||
149839999|NCT00905606|540544543|FG000|Washout|Withdrawal by Subject|1|||
149840000|NCT00905606|540544544|FG001|Washout|Withdrawal by Subject|0|||
149840001|NCT03635320|540544545|FG000|Overall Study|not implanted the device|1|||
149840002|NCT03635320|540544546|FG001|Overall Study|not implanted the device|2|||
149840003|NCT03635320|540544545|FG000|Overall Study|Withdrawal by Subject|11|||
149840004|NCT03635320|540544546|FG001|Overall Study|Withdrawal by Subject|6|||
149840005|NCT00804856|540544549|FG000|Overall Study|Progressive Disease|3|||
149840006|NCT00804856|540544550|FG001|Overall Study|Progressive Disease|2|||
149840007|NCT00804856|540544551|FG002|Overall Study|Progressive Disease|4|||
149840008|NCT00804856|540544552|FG003|Overall Study|Progressive Disease|6|||
149840009|NCT00804856|540544553|FG004|Overall Study|Progressive Disease|4|||
149840010|NCT00804856|540544554|FG005|Overall Study|Progressive Disease|1|||
149840011|NCT00804856|540544555|FG006|Overall Study|Progressive Disease|8|||
149840012|NCT00804856|540544556|FG007|Overall Study|Progressive Disease|2|||
149840013|NCT00804856|540544557|FG008|Overall Study|Progressive Disease|4|||
149840014|NCT00804856|540544558|FG009|Overall Study|Progressive Disease|5|||
149840015|NCT00804856|540544559|FG010|Overall Study|Progressive Disease|12|||
149840016|NCT00804856|540544560|FG011|Overall Study|Progressive Disease|2|||
149840017|NCT00804856|540544561|FG012|Overall Study|Progressive Disease|2|||
149840018|NCT00804856|540544562|FG013|Overall Study|Progressive Disease|26|||
149840019|NCT00804856|540544563|FG014|Overall Study|Progressive Disease|20|||
149840020|NCT00804856|540544549|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840021|NCT00804856|540544550|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840022|NCT00804856|540544551|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840023|NCT00804856|540544552|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840024|NCT00804856|540544553|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149840025|NCT00804856|540544554|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840026|NCT00804856|540544555|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840027|NCT00804856|540544556|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840028|NCT00804856|540544557|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840029|NCT00804856|540544558|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840030|NCT00804856|540544559|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840031|NCT00804856|540544560|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840032|NCT00804856|540544561|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840033|NCT00804856|540544562|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149840034|NCT00804856|540544563|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149840035|NCT00804856|540544549|FG000|Overall Study|Other Adverse Event|1|||
149840036|NCT00804856|540544550|FG001|Overall Study|Other Adverse Event|1|||
149840037|NCT00804856|540544551|FG002|Overall Study|Other Adverse Event|1|||
149840038|NCT00804856|540544552|FG003|Overall Study|Other Adverse Event|2|||
149840039|NCT00804856|540544553|FG004|Overall Study|Other Adverse Event|2|||
149840040|NCT00804856|540544554|FG005|Overall Study|Other Adverse Event|1|||
149840041|NCT00804856|540544555|FG006|Overall Study|Other Adverse Event|3|||
149840042|NCT00804856|540544556|FG007|Overall Study|Other Adverse Event|0|||
149840043|NCT00804856|540544557|FG008|Overall Study|Other Adverse Event|0|||
149952729|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
150172343|NCT00880048|541765947|FG002|Overall Study|Study closed/terminated|6|||
149840044|NCT00804856|540544558|FG009|Overall Study|Other Adverse Event|1|||
149840045|NCT00804856|540544559|FG010|Overall Study|Other Adverse Event|5|||
149840046|NCT00804856|540544560|FG011|Overall Study|Other Adverse Event|2|||
149840047|NCT00804856|540544561|FG012|Overall Study|Other Adverse Event|0|||
149840048|NCT00804856|540544562|FG013|Overall Study|Other Adverse Event|6|||
149840049|NCT00804856|540544563|FG014|Overall Study|Other Adverse Event|13|||
149840050|NCT00804856|540544549|FG000|Overall Study|Non compliance with protocol|0|||
149840051|NCT00804856|540544550|FG001|Overall Study|Non compliance with protocol|0|||
149840052|NCT00804856|540544551|FG002|Overall Study|Non compliance with protocol|0|||
149840053|NCT00804856|540544552|FG003|Overall Study|Non compliance with protocol|0|||
150035254|NCT02057250|541268920|FG003|Extension Phase|Adverse Event|0|||
149840054|NCT00804856|540544553|FG004|Overall Study|Non compliance with protocol|0|||
149840055|NCT00804856|540544554|FG005|Overall Study|Non compliance with protocol|0|||
149840056|NCT00804856|540544555|FG006|Overall Study|Non compliance with protocol|0|||
149840057|NCT00804856|540544556|FG007|Overall Study|Non compliance with protocol|0|||
149840058|NCT00804856|540544557|FG008|Overall Study|Non compliance with protocol|0|||
149840059|NCT00804856|540544558|FG009|Overall Study|Non compliance with protocol|0|||
149840060|NCT00804856|540544559|FG010|Overall Study|Non compliance with protocol|0|||
149840061|NCT00804856|540544560|FG011|Overall Study|Non compliance with protocol|0|||
149840062|NCT00804856|540544561|FG012|Overall Study|Non compliance with protocol|0|||
149840063|NCT00804856|540544562|FG013|Overall Study|Non compliance with protocol|2|||
149840064|NCT00804856|540544563|FG014|Overall Study|Non compliance with protocol|0|||
149840065|NCT00804856|540544549|FG000|Overall Study|Refused to continue medication|0|||
149840066|NCT00804856|540544550|FG001|Overall Study|Refused to continue medication|0|||
149840067|NCT00804856|540544551|FG002|Overall Study|Refused to continue medication|0|||
149840068|NCT00804856|540544552|FG003|Overall Study|Refused to continue medication|1|||
149840069|NCT00804856|540544553|FG004|Overall Study|Refused to continue medication|1|||
149840070|NCT00804856|540544554|FG005|Overall Study|Refused to continue medication|0|||
149840071|NCT00804856|540544555|FG006|Overall Study|Refused to continue medication|0|||
149840072|NCT00804856|540544556|FG007|Overall Study|Refused to continue medication|0|||
149840073|NCT00804856|540544557|FG008|Overall Study|Refused to continue medication|0|||
149840074|NCT00804856|540544558|FG009|Overall Study|Refused to continue medication|0|||
149840075|NCT00804856|540544559|FG010|Overall Study|Refused to continue medication|3|||
149840076|NCT00804856|540544560|FG011|Overall Study|Refused to continue medication|0|||
149840077|NCT00804856|540544561|FG012|Overall Study|Refused to continue medication|1|||
149840078|NCT00804856|540544562|FG013|Overall Study|Refused to continue medication|1|||
149840079|NCT00804856|540544563|FG014|Overall Study|Refused to continue medication|5|||
149840080|NCT00804856|540544549|FG000|Overall Study|Other reason than listed above|0|||
149840081|NCT00804856|540544550|FG001|Overall Study|Other reason than listed above|0|||
149840082|NCT00804856|540544551|FG002|Overall Study|Other reason than listed above|0|||
149840083|NCT00804856|540544552|FG003|Overall Study|Other reason than listed above|0|||
149840084|NCT00804856|540544553|FG004|Overall Study|Other reason than listed above|0|||
149840085|NCT00804856|540544554|FG005|Overall Study|Other reason than listed above|1|||
149840086|NCT00804856|540544555|FG006|Overall Study|Other reason than listed above|0|||
149840087|NCT00804856|540544556|FG007|Overall Study|Other reason than listed above|0|||
149840088|NCT00804856|540544557|FG008|Overall Study|Other reason than listed above|1|||
149840089|NCT00804856|540544558|FG009|Overall Study|Other reason than listed above|0|||
149840090|NCT00804856|540544559|FG010|Overall Study|Other reason than listed above|3|||
150035255|NCT02057250|541268921|FG004|Extension Phase|Adverse Event|15|||
150035256|NCT02057250|541268917|FG000|Extension Phase|Lack of Efficacy|0|||
150035257|NCT02057250|541268918|FG001|Extension Phase|Lack of Efficacy|0|||
150035258|NCT02057250|541268919|FG002|Extension Phase|Lack of Efficacy|0|||
150035259|NCT02057250|541268920|FG003|Extension Phase|Lack of Efficacy|0|||
150035260|NCT02057250|541268921|FG004|Extension Phase|Lack of Efficacy|10|||
150035261|NCT02057250|541268917|FG000|Extension Phase|Entered in this period but not treated|0|||
150035262|NCT02057250|541268918|FG001|Extension Phase|Entered in this period but not treated|0|||
150035263|NCT02057250|541268919|FG002|Extension Phase|Entered in this period but not treated|0|||
149840091|NCT00804856|540544560|FG011|Overall Study|Other reason than listed above|1|||
149840092|NCT00804856|540544561|FG012|Overall Study|Other reason than listed above|1|||
149840093|NCT00804856|540544562|FG013|Overall Study|Other reason than listed above|10|||
150035264|NCT02057250|541268920|FG003|Extension Phase|Entered in this period but not treated|0|||
150035265|NCT02057250|541268921|FG004|Extension Phase|Entered in this period but not treated|4|||
150035266|NCT02057250|541268917|FG000|Extension Phase|Other than specified above|0|||
150035267|NCT02057250|541268918|FG001|Extension Phase|Other than specified above|0|||
149840094|NCT00804856|540544563|FG014|Overall Study|Other reason than listed above|3|||
149840095|NCT01558635|540544564|FG000|Overall Study|Death|1|||
149840096|NCT01558635|540544564|FG000|Overall Study|Withdrawal by Subject|2|||
149840097|NCT01558635|540544564|FG000|Overall Study|Physician Decision|1|||
149840098|NCT01558635|540544564|FG000|Overall Study|Subject received other treatment|1|||
150035268|NCT02057250|541268919|FG002|Extension Phase|Other than specified above|0|||
150035269|NCT02057250|541268920|FG003|Extension Phase|Other than specified above|0|||
150035270|NCT02057250|541268921|FG004|Extension Phase|Other than specified above|7|||
150035271|NCT01435382|541268924|FG000|Overall Study|Lost to Follow-up|1|||
150285281|NCT01225731|542180573|FG001|Part 1|Protocol Violation|0|||
150285282|NCT01225731|542180574|FG002|Part 1|Protocol Violation|0|||
149840099|NCT01558635|540544564|FG000|Overall Study|Reveal XT was explanted|1|||
149840100|NCT00455312|540544565|FG000|Overall Study|Death|0|||
149840101|NCT00455312|540544566|FG001|Overall Study|Death|1|||
150035272|NCT01435382|541268925|FG001|Overall Study|Lost to Follow-up|0|||
150035273|NCT01435382|541268926|FG002|Overall Study|Lost to Follow-up|1|||
149840102|NCT03868891|540544567|FG000|Overall Study|Adverse Event|1|||
150035274|NCT01435382|541268927|FG003|Overall Study|Lost to Follow-up|0|||
150035275|NCT01435382|541268924|FG000|Overall Study|Withdrawal by Subject|0|||
150285283|NCT01225731|542180575|FG003|Part 1|Protocol Violation|1|||
149840103|NCT03868891|540544568|FG001|Overall Study|Adverse Event|0|||
149840104|NCT03868891|540544567|FG000|Overall Study|Lost to Follow-up|2|||
149840105|NCT03868891|540544568|FG001|Overall Study|Lost to Follow-up|1|||
149840106|NCT03868891|540544567|FG000|Overall Study|COVID-19 Restrictions|1|||
149840107|NCT03868891|540544568|FG001|Overall Study|COVID-19 Restrictions|2|||
149840108|NCT00905840|540544571|FG000|Overall Study|Lost to Follow-up|11|||
149840109|NCT00905840|540544571|FG000|Overall Study|Death|3|||
149840110|NCT00905840|540544571|FG000|Overall Study|Withdrawal by Subject|1|||
149840111|NCT00905840|540544571|FG000|Overall Study|Adverse Event|1|||
149840112|NCT03181594|540544572|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
149840113|NCT03181594|540544572|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
149840114|NCT03181594|540544572|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
149840115|NCT03181594|540544572|FG000|Initial Study Protocol (12-month FU)|Death|1|||
149840116|NCT03181594|540544572|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
149840117|NCT03181594|540544572|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
149840118|NCT00960297|540544575|FG000|Overall Study|Physician Decision|1|||
149840119|NCT00960297|540544575|FG000|Overall Study|Venous port infection|1|||
149840120|NCT00960297|540544575|FG000|Overall Study|Disease progression|1|||
149840121|NCT01518972|540544585|FG000|Overall Study|Lost to Follow-up|2|||
149840122|NCT01518972|540544586|FG001|Overall Study|Lost to Follow-up|1|||
149840123|NCT01518972|540544585|FG000|Overall Study|Withdrawal by Subject|1|||
149840124|NCT01518972|540544586|FG001|Overall Study|Withdrawal by Subject|0|||
149840125|NCT01518972|540544585|FG000|Overall Study|Moved from area|1|||
149840126|NCT01518972|540544586|FG001|Overall Study|Moved from area|0|||
149840127|NCT01518972|540544585|FG000|Overall Study|Transportation problems|1|||
149840128|NCT01518972|540544586|FG001|Overall Study|Transportation problems|0|||
149840129|NCT01518972|540544585|FG000|Overall Study|Exclusionary medical condition|1|||
149840130|NCT01518972|540544586|FG001|Overall Study|Exclusionary medical condition|0|||
149840131|NCT01518972|540544585|FG000|Overall Study|Missed safety visits|0|||
149840132|NCT01518972|540544586|FG001|Overall Study|Missed safety visits|1|||
149840133|NCT01518972|540544585|FG000|Overall Study|Exclusionary medication|0|||
149840134|NCT01518972|540544586|FG001|Overall Study|Exclusionary medication|1|||
149840135|NCT01518972|540544585|FG000|Overall Study|Declined medication starting on day 12|0|||
149840136|NCT01518972|540544586|FG001|Overall Study|Declined medication starting on day 12|1|||
149840137|NCT02159950|540544599|FG000|Overall Study|Adverse Event|0|||
149840138|NCT02159950|540544600|FG001|Overall Study|Adverse Event|1|||
149840139|NCT02159950|540544599|FG000|Overall Study|Progression|0|||
149840140|NCT02159950|540544600|FG001|Overall Study|Progression|1|||
149840141|NCT03872128|540544604|FG000|Overall Study|Dropped out before treatment|1|||
149840142|NCT03872128|540544605|FG001|Overall Study|Dropped out before treatment|0|||
149840143|NCT03872128|540544606|FG002|Overall Study|Dropped out before treatment|4|||
149840144|NCT03872128|540544604|FG000|Overall Study|Lost to Follow-up|2|||
149840145|NCT03872128|540544605|FG001|Overall Study|Lost to Follow-up|5|||
149840146|NCT03872128|540544606|FG002|Overall Study|Lost to Follow-up|8|||
149840147|NCT04108858|540544616|FG000|Overall Study|Adverse Event|1|||
149840148|NCT03663179|540544617|FG000|Overall Study|Withdrawal by Subject|2|||
149840149|NCT03663179|540544618|FG001|Overall Study|Withdrawal by Subject|0|||
149840150|NCT03663179|540544617|FG000|Overall Study|Lost to Follow-up|1|||
149840151|NCT03663179|540544618|FG001|Overall Study|Lost to Follow-up|1|||
149840152|NCT03663179|540544617|FG000|Overall Study|Revealed exclusionary condition|1|||
149840153|NCT03663179|540544618|FG001|Overall Study|Revealed exclusionary condition|0|||
149840154|NCT02453386|540544621|FG000|Overall Study|Adverse Event|22|||
149840155|NCT02453386|540544622|FG001|Overall Study|Adverse Event|30|||
149840156|NCT02453386|540544623|FG002|Overall Study|Adverse Event|15|||
149840157|NCT02453386|540544621|FG000|Overall Study|Protocol Violation|1|||
149840158|NCT02453386|540544622|FG001|Overall Study|Protocol Violation|0|||
149840159|NCT02453386|540544623|FG002|Overall Study|Protocol Violation|1|||
149840160|NCT02453386|540544621|FG000|Overall Study|Withdrawal by Subject|10|||
149840161|NCT02453386|540544622|FG001|Overall Study|Withdrawal by Subject|9|||
149840162|NCT02453386|540544623|FG002|Overall Study|Withdrawal by Subject|9|||
149840163|NCT02453386|540544621|FG000|Overall Study|Sponsor Terminated Study|14|||
149840164|NCT02453386|540544622|FG001|Overall Study|Sponsor Terminated Study|8|||
149840165|NCT02453386|540544623|FG002|Overall Study|Sponsor Terminated Study|11|||
149840166|NCT02453386|540544621|FG000|Overall Study|Subject Terminated by Sponsor|1|||
149840167|NCT02453386|540544622|FG001|Overall Study|Subject Terminated by Sponsor|1|||
149840168|NCT02453386|540544623|FG002|Overall Study|Subject Terminated by Sponsor|1|||
149840169|NCT02453386|540544621|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
149840170|NCT02453386|540544622|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
149840171|NCT02453386|540544623|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
149840172|NCT02453386|540544621|FG000|Overall Study|Lost to Follow-up|0|||
149840173|NCT02453386|540544622|FG001|Overall Study|Lost to Follow-up|0|||
150172344|NCT01069341|541765948|FG000|Overall Study|Lost to Follow-up|1|||
150285284|NCT01225731|542180576|FG004|Part 1|Protocol Violation|0|||
149840174|NCT02453386|540544623|FG002|Overall Study|Lost to Follow-up|1|||
149840175|NCT02453386|540544621|FG000|Overall Study|Other|1|||
149840176|NCT02453386|540544622|FG001|Overall Study|Other|0|||
149840177|NCT02453386|540544623|FG002|Overall Study|Other|1|||
149840178|NCT02601625|540544624|FG000|Overall Study|Lost to Follow-up|0|||
149840179|NCT02601625|540544625|FG001|Overall Study|Lost to Follow-up|0|||
149840180|NCT02601625|540544626|FG002|Overall Study|Lost to Follow-up|1|||
149840181|NCT02601625|540544627|FG003|Overall Study|Lost to Follow-up|1|||
149840182|NCT01289262|540544630|FG000|Overall Study|Lost to Follow-up|29|||
149840183|NCT01289262|540544631|FG001|Overall Study|Lost to Follow-up|16|||
149840184|NCT01289262|540544630|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
149840185|NCT01289262|540544631|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
149840186|NCT00838279|540544634|FG000|Washout|Protocol Violation|1|||
149840187|NCT00838279|540544635|FG001|Washout|Protocol Violation|0|||
149840188|NCT00838279|540544634|FG000|Washout|Withdrawal by Subject|0|||
149840189|NCT00838279|540544635|FG001|Washout|Withdrawal by Subject|1|||
149840190|NCT04608188|540544636|FG000|Overall Study|Withdrawal by Subject|4|||
149840191|NCT04608188|540544637|FG001|Overall Study|Withdrawal by Subject|8|||
149840192|NCT05646251|540544641|FG000|Overall Study|Physician Decision|1|||
149840193|NCT05646251|540544642|FG001|Overall Study|Physician Decision|0|||
149840194|NCT05646251|540544643|FG002|Overall Study|Physician Decision|2|||
149840195|NCT03792477|540544644|FG000|Overall Study|Adverse Event|0|||
149840196|NCT03792477|540544645|FG001|Overall Study|Adverse Event|0|||
149840197|NCT03792477|540544646|FG002|Overall Study|Adverse Event|0|||
149840198|NCT03792477|540544647|FG003|Overall Study|Adverse Event|1|||
149840199|NCT03792477|540544648|FG004|Overall Study|Adverse Event|0|||
149840200|NCT03792477|540544644|FG000|Overall Study|Lost to Follow-up|0|||
149840201|NCT03792477|540544645|FG001|Overall Study|Lost to Follow-up|0|||
149840202|NCT03792477|540544646|FG002|Overall Study|Lost to Follow-up|2|||
149840203|NCT03792477|540544647|FG003|Overall Study|Lost to Follow-up|0|||
149840204|NCT03792477|540544648|FG004|Overall Study|Lost to Follow-up|0|||
149840205|NCT03792477|540544644|FG000|Overall Study|Other|0|||
149840206|NCT03792477|540544645|FG001|Overall Study|Other|0|||
149840207|NCT03792477|540544646|FG002|Overall Study|Other|0|||
149840208|NCT03792477|540544647|FG003|Overall Study|Other|0|||
149840209|NCT03792477|540544648|FG004|Overall Study|Other|1|||
149840210|NCT00840411|540544649|FG000|First Intervention|Adverse Event|1|||
149840211|NCT00840411|540544650|FG001|First Intervention|Adverse Event|0|||
150285285|NCT01225731|542180577|FG005|Part 1|Protocol Violation|0|||
150285286|NCT01225731|542180578|FG006|Part 1|Protocol Violation|0|||
150285287|NCT01225731|542180579|FG007|Part 1|Protocol Violation|0|||
150285288|NCT01225731|542180580|FG008|Part 1|Protocol Violation|0|||
150285289|NCT01225731|542180581|FG009|Part 1|Protocol Violation|0|||
150285290|NCT01225731|542180582|FG010|Part 1|Protocol Violation|0|||
150285291|NCT01225731|542180583|FG011|Part 1|Protocol Violation|0|||
150285292|NCT01225731|542180584|FG012|Part 1|Protocol Violation|0|||
150285293|NCT01225731|542180572|FG000|Part 2|Protocol Violation|0|||
149840212|NCT00840411|540544649|FG000|Washout|Withdrawal by Subject|1|||
149840213|NCT00840411|540544650|FG001|Washout|Withdrawal by Subject|0|||
149840214|NCT03173547|540544652|FG000|Overall Study|Adverse Event|2|||
149840215|NCT03173547|540544653|FG001|Overall Study|Adverse Event|0|||
149840216|NCT03173547|540544652|FG000|Overall Study|Withdrawal by Subject|2|||
149840217|NCT03173547|540544653|FG001|Overall Study|Withdrawal by Subject|2|||
149840218|NCT00657553|540544654|FG000|Overall Study|low accrual, no analysis run|5|||
149952730|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
149952731|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Death|1|||
149952732|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Death|0|||
149952733|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Death|0|||
149952734|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
149952735|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
149952736|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
149952737|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
149952738|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
149952739|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
149952740|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
149952741|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
149952742|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
149952743|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
149952744|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
150172345|NCT00290706|541765949|FG000|Overall Study|Withdrawal by Subject|2|||
150285294|NCT01225731|542180573|FG001|Part 2|Protocol Violation|0|||
150285295|NCT01225731|542180574|FG002|Part 2|Protocol Violation|0|||
149840219|NCT00657553|540544655|FG001|Overall Study|low accrual, no analysis run|5|||
149840220|NCT00446563|540544656|FG000|Overall Study|Adverse Event|4|||
149840221|NCT00446563|540544657|FG001|Overall Study|Adverse Event|3|||
149840222|NCT00446563|540544656|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149952745|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
149952746|NCT05073315|540958691|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
150285296|NCT01225731|542180575|FG003|Part 2|Protocol Violation|0|||
150285297|NCT01225731|542180576|FG004|Part 2|Protocol Violation|0|||
150285298|NCT01225731|542180577|FG005|Part 2|Protocol Violation|1|||
150285299|NCT01225731|542180578|FG006|Part 2|Protocol Violation|0|||
149840223|NCT00446563|540544657|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149840224|NCT00446563|540544656|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149840225|NCT00446563|540544657|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149840226|NCT00446563|540544656|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149840227|NCT00446563|540544657|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149840228|NCT00446563|540544656|FG000|Overall Study|Withdrawal by Subject|2|||
149840229|NCT00446563|540544657|FG001|Overall Study|Withdrawal by Subject|1|||
149840230|NCT00446563|540544656|FG000|Overall Study|Administrative problems|0|||
149840231|NCT00446563|540544657|FG001|Overall Study|Administrative problems|1|||
149840232|NCT01169558|540544658|FG000|Overall Study|Disease progression|98|||
149840233|NCT01169558|540544658|FG000|Overall Study|Adverse Event|25|||
149840234|NCT01169558|540544658|FG000|Overall Study|Withdrawal of Consent|8|||
149840235|NCT01169558|540544658|FG000|Overall Study|Medical Decision|7|||
149840236|NCT01169558|540544658|FG000|Overall Study|Stable Disease|4|||
149840237|NCT01169558|540544658|FG000|Overall Study|Lost to Follow-up|4|||
149840238|NCT01169558|540544658|FG000|Overall Study|Need for Surgery|4|||
149840239|NCT01169558|540544658|FG000|Overall Study|Non-compliance|2|||
149840240|NCT01169558|540544658|FG000|Overall Study|Protocol Violation|2|||
149840241|NCT01169558|540544658|FG000|Overall Study|Partial response|2|||
149840242|NCT02911701|540544659|FG000|Overall Study|Withdrawal by Subject|2|||
149840243|NCT02911701|540544660|FG001|Overall Study|Withdrawal by Subject|4|||
150035276|NCT01435382|541268925|FG001|Overall Study|Withdrawal by Subject|2|||
150035277|NCT01435382|541268926|FG002|Overall Study|Withdrawal by Subject|0|||
150035278|NCT01435382|541268927|FG003|Overall Study|Withdrawal by Subject|1|||
150035279|NCT03367793|541268928|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
150035280|NCT03367793|541268929|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
150035281|NCT03367793|541268930|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
150035282|NCT03367793|541268931|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
150035283|NCT03367793|541268932|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
149840244|NCT02911701|540544659|FG000|Overall Study|Adverse Event|1|||
149840245|NCT02911701|540544660|FG001|Overall Study|Adverse Event|0|||
149840246|NCT02409355|540544663|FG000|Overall Study|Withdrawal by Subject|1|||
149840247|NCT02409355|540544664|FG001|Overall Study|Withdrawal by Subject|0|||
149840248|NCT02409355|540544663|FG000|Overall Study|Death|1|||
149840249|NCT02409355|540544664|FG001|Overall Study|Death|1|||
149840250|NCT02409355|540544663|FG000|Overall Study|Study terminated by Sponsor|2|||
149840251|NCT02409355|540544664|FG001|Overall Study|Study terminated by Sponsor|3|||
149840252|NCT02605928|540544669|FG000|Overall Study|Model tuning phase|28|||
149840253|NCT02605928|540544669|FG000|Overall Study|Lack of Efficacy|5|||
149840254|NCT02530905|540544672|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
149840255|NCT02530905|540544673|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
149840256|NCT02530905|540544674|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
149840257|NCT01231906|540544676|FG000|Overall Study|Lack of Efficacy|75|||
149840258|NCT01231906|540544677|FG001|Overall Study|Lack of Efficacy|68|||
149840259|NCT01231906|540544676|FG000|Overall Study|Lost to Follow-up|1|||
149840260|NCT01231906|540544677|FG001|Overall Study|Lost to Follow-up|0|||
149840261|NCT01231906|540544676|FG000|Overall Study|Physician Decision|34|||
149840262|NCT01231906|540544677|FG001|Overall Study|Physician Decision|24|||
149840263|NCT01231906|540544676|FG000|Overall Study|Withdrawal by Subject|0|||
149840264|NCT01231906|540544677|FG001|Overall Study|Withdrawal by Subject|4|||
149840265|NCT01231906|540544676|FG000|Overall Study|Ineligible|10|||
149840266|NCT01231906|540544677|FG001|Overall Study|Ineligible|3|||
149840267|NCT01231906|540544676|FG000|Overall Study|No treatment|1|||
149840268|NCT01231906|540544677|FG001|Overall Study|No treatment|2|||
149840269|NCT01110005|540544678|FG000|Overall Study|ineligible|1|||
149840270|NCT01110005|540544679|FG001|Overall Study|ineligible|2|||
149840271|NCT01110005|540544678|FG000|Overall Study|missing consent|3|||
149840272|NCT01110005|540544679|FG001|Overall Study|missing consent|2|||
149840273|NCT01110005|540544678|FG000|Overall Study|Withdrawal by Subject|0|||
149840274|NCT01110005|540544679|FG001|Overall Study|Withdrawal by Subject|1|||
149840275|NCT04646213|540544680|FG000|Overall Study|Physician Decision|3|||
149840276|NCT04646213|540544680|FG000|Overall Study|Withdrawal by Subject|2|||
149840277|NCT02441309|540544681|FG000|Overall Study|Disease progression|2|||
150035284|NCT03367793|541268933|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
150285300|NCT01225731|542180579|FG007|Part 2|Protocol Violation|0|||
149840278|NCT02441309|540544682|FG001|Overall Study|Disease progression|1|||
149840279|NCT02441309|540544683|FG002|Overall Study|Disease progression|2|||
149840280|NCT02441309|540544681|FG000|Overall Study|Adverse Event|0|||
149840281|NCT02441309|540544682|FG001|Overall Study|Adverse Event|1|||
149840282|NCT02441309|540544683|FG002|Overall Study|Adverse Event|0|||
149840283|NCT02441309|540544681|FG000|Overall Study|Withdrawal by Subject|1|||
149840284|NCT02441309|540544682|FG001|Overall Study|Withdrawal by Subject|0|||
149840285|NCT02441309|540544683|FG002|Overall Study|Withdrawal by Subject|1|||
150172346|NCT00290706|541765950|FG001|Overall Study|Withdrawal by Subject|0|||
149840286|NCT00415363|540544684|FG000|Overall Study|Withdrawal by Subject|4|||
150035285|NCT00423579|541268934|FG000|Overall Study|Lost to Follow-up|3|||
150285301|NCT01225731|542180580|FG008|Part 2|Protocol Violation|1|||
149840287|NCT00415363|540544685|FG001|Overall Study|Withdrawal by Subject|4|||
149840288|NCT00415363|540544684|FG000|Overall Study|Adverse Event|4|||
149840289|NCT00415363|540544685|FG001|Overall Study|Adverse Event|4|||
149840290|NCT00415363|540544684|FG000|Overall Study|Lost to Follow-up|2|||
149840291|NCT00415363|540544685|FG001|Overall Study|Lost to Follow-up|1|||
149840292|NCT00415363|540544684|FG000|Overall Study|Physician Decision|3|||
149840293|NCT00415363|540544685|FG001|Overall Study|Physician Decision|1|||
149840294|NCT00415363|540544684|FG000|Overall Study|Death|16|||
149840295|NCT00415363|540544685|FG001|Overall Study|Death|12|||
149840296|NCT00415363|540544684|FG000|Overall Study|Progressive disease|26|||
149840297|NCT00415363|540544685|FG001|Overall Study|Progressive disease|32|||
149840298|NCT01136174|540544698|FG000|Overall Study|Adverse Event|0|||
149840299|NCT01136174|540544699|FG001|Overall Study|Adverse Event|0|||
149840300|NCT01136174|540544700|FG002|Overall Study|Adverse Event|0|||
149840301|NCT01136174|540544701|FG003|Overall Study|Adverse Event|4|||
149840302|NCT00119015|540544704|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
149840303|NCT00119015|540544705|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
149840304|NCT00119015|540544706|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
149840305|NCT02286739|540546216|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
149840306|NCT02286739|540546217|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
149840307|NCT02286739|540546216|FG000|Overall Study|No Verasense type documented|0|||
149840308|NCT02286739|540546217|FG001|Overall Study|No Verasense type documented|23|||
149840309|NCT02286739|540546216|FG000|Overall Study|Adverse Event|1|||
149840310|NCT02286739|540546217|FG001|Overall Study|Adverse Event|2|||
149840311|NCT02286739|540546216|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
149840312|NCT02286739|540546217|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
149840313|NCT02057835|540546218|FG000|Overall Study|Withdrawal by Subject|0|||
149840314|NCT02057835|540546219|FG001|Overall Study|Withdrawal by Subject|2|||
149840315|NCT02057835|540546220|FG002|Overall Study|Withdrawal by Subject|0|||
149840316|NCT02057835|540546221|FG003|Overall Study|Withdrawal by Subject|0|||
149840317|NCT02057835|540546222|FG004|Overall Study|Withdrawal by Subject|0|||
149840318|NCT02057835|540546223|FG005|Overall Study|Withdrawal by Subject|0|||
149840319|NCT02057835|540546224|FG006|Overall Study|Withdrawal by Subject|0|||
149840320|NCT02057835|540546225|FG007|Overall Study|Withdrawal by Subject|0|||
149840321|NCT02057835|540546226|FG008|Overall Study|Withdrawal by Subject|0|||
149840322|NCT02057835|540546227|FG009|Overall Study|Withdrawal by Subject|0|||
149840323|NCT04299087|540546228|FG000|Overall Study|Lost to Follow-up|2|||
149840324|NCT04299087|540546229|FG001|Overall Study|Lost to Follow-up|1|||
149840325|NCT03025087|540546230|FG000|Overall Study|Physician Decision|3|||
149840326|NCT03025087|540546231|FG001|Overall Study|Physician Decision|3|||
149840327|NCT03025087|540546232|FG002|Overall Study|Physician Decision|0|||
149840328|NCT03025087|540546233|FG003|Overall Study|Physician Decision|0|||
149840329|NCT03025087|540546234|FG004|Overall Study|Physician Decision|0|||
149840330|NCT03025087|540546230|FG000|Overall Study|Withdrawal by Subject|1|||
149840331|NCT03025087|540546231|FG001|Overall Study|Withdrawal by Subject|1|||
149840332|NCT03025087|540546232|FG002|Overall Study|Withdrawal by Subject|0|||
149840333|NCT03025087|540546233|FG003|Overall Study|Withdrawal by Subject|0|||
149840334|NCT03025087|540546234|FG004|Overall Study|Withdrawal by Subject|0|||
149840335|NCT03025087|540546230|FG000|Overall Study|Unable to complete MRI|2|||
149840336|NCT03025087|540546231|FG001|Overall Study|Unable to complete MRI|2|||
149840337|NCT03025087|540546232|FG002|Overall Study|Unable to complete MRI|0|||
149840338|NCT03025087|540546233|FG003|Overall Study|Unable to complete MRI|0|||
149840339|NCT03025087|540546234|FG004|Overall Study|Unable to complete MRI|0|||
149840340|NCT05604170|540546235|FG000|Overall Study|Lack of Efficacy|5|||
149840341|NCT05604170|540546235|FG000|Overall Study|Adverse Event|6|||
149840342|NCT05604170|540546235|FG000|Overall Study|Physician Decision|6|||
149840343|NCT05604170|540546235|FG000|Overall Study|Lost to Follow-up|6|||
149840344|NCT05604170|540546235|FG000|Overall Study|Withdrawal by Subject|11|||
149840345|NCT05604170|540546235|FG000|Overall Study|Early study termination by sponsor|77|||
149840346|NCT05604170|540546235|FG000|Overall Study|Other|6|||
149840347|NCT03697109|540546236|FG000|Open-label (OL) Phase|Adverse Event|24|||
149840348|NCT03697109|540546237|FG001|Open-label (OL) Phase|Adverse Event|0|||
149840349|NCT03697109|540546238|FG002|Open-label (OL) Phase|Adverse Event|0|||
149840350|NCT03697109|540546236|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
149840351|NCT03697109|540546237|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
149840352|NCT03697109|540546238|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
149840353|NCT03697109|540546236|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
149840354|NCT03697109|540546237|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
149840355|NCT03697109|540546238|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
149840356|NCT03697109|540546236|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
149840357|NCT03697109|540546237|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
149840358|NCT03697109|540546238|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
149840359|NCT03697109|540546236|FG000|Open-label (OL) Phase|Physician Decision|2|||
149840360|NCT03697109|540546237|FG001|Open-label (OL) Phase|Physician Decision|0|||
149840361|NCT03697109|540546238|FG002|Open-label (OL) Phase|Physician Decision|0|||
149840362|NCT03697109|540546236|FG000|Open-label (OL) Phase|Death|2|||
149840363|NCT03697109|540546237|FG001|Open-label (OL) Phase|Death|0|||
149840364|NCT03697109|540546238|FG002|Open-label (OL) Phase|Death|0|||
149840365|NCT03697109|540546236|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
149840366|NCT03697109|540546237|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
149840367|NCT03697109|540546238|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
149840368|NCT03697109|540546236|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
149840369|NCT03697109|540546237|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
149840370|NCT03697109|540546238|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
149840371|NCT03697109|540546236|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
149840372|NCT03697109|540546237|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
149840373|NCT03697109|540546238|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
149840374|NCT03032172|540546239|FG000|Treatment Period|Adverse Event|0|||
149840375|NCT03032172|540546240|FG001|Treatment Period|Adverse Event|1|||
149840376|NCT03032172|540546241|FG002|Treatment Period|Adverse Event|0|||
149840377|NCT03032172|540546242|FG003|Treatment Period|Adverse Event|0|||
149840378|NCT03032172|540546243|FG004|Treatment Period|Adverse Event|0|||
149840379|NCT03032172|540546244|FG005|Treatment Period|Adverse Event|0|||
149840380|NCT03032172|540546245|FG006|Treatment Period|Adverse Event|0|||
149840381|NCT03032172|540546246|FG007|Treatment Period|Adverse Event|0|||
149840382|NCT03032172|540546239|FG000|Treatment Period|Lack of Efficacy|0|||
149840383|NCT03032172|540546240|FG001|Treatment Period|Lack of Efficacy|1|||
149840384|NCT03032172|540546241|FG002|Treatment Period|Lack of Efficacy|0|||
149840385|NCT03032172|540546242|FG003|Treatment Period|Lack of Efficacy|0|||
149840386|NCT03032172|540546243|FG004|Treatment Period|Lack of Efficacy|0|||
149840387|NCT03032172|540546244|FG005|Treatment Period|Lack of Efficacy|0|||
149840388|NCT03032172|540546245|FG006|Treatment Period|Lack of Efficacy|0|||
149840389|NCT03032172|540546246|FG007|Treatment Period|Lack of Efficacy|0|||
149840390|NCT03032172|540546239|FG000|Treatment Period|Non-compliance With Study Drug|0|||
149840391|NCT03032172|540546240|FG001|Treatment Period|Non-compliance With Study Drug|1|||
149840392|NCT03032172|540546241|FG002|Treatment Period|Non-compliance With Study Drug|0|||
149840393|NCT03032172|540546242|FG003|Treatment Period|Non-compliance With Study Drug|0|||
149840394|NCT03032172|540546243|FG004|Treatment Period|Non-compliance With Study Drug|0|||
149840395|NCT03032172|540546244|FG005|Treatment Period|Non-compliance With Study Drug|0|||
149840396|NCT03032172|540546245|FG006|Treatment Period|Non-compliance With Study Drug|0|||
149840397|NCT03032172|540546246|FG007|Treatment Period|Non-compliance With Study Drug|0|||
149840398|NCT03032172|540546239|FG000|Treatment Period|Reason Not Specified|0|||
149840399|NCT03032172|540546240|FG001|Treatment Period|Reason Not Specified|4|||
149840400|NCT03032172|540546241|FG002|Treatment Period|Reason Not Specified|1|||
149840401|NCT03032172|540546242|FG003|Treatment Period|Reason Not Specified|0|||
149840402|NCT03032172|540546243|FG004|Treatment Period|Reason Not Specified|0|||
149840403|NCT03032172|540546244|FG005|Treatment Period|Reason Not Specified|0|||
149840404|NCT03032172|540546245|FG006|Treatment Period|Reason Not Specified|0|||
149840405|NCT03032172|540546246|FG007|Treatment Period|Reason Not Specified|0|||
149840406|NCT03032172|540546239|FG000|Treatment Period|Physician Decision|0|||
149840407|NCT03032172|540546240|FG001|Treatment Period|Physician Decision|2|||
149840408|NCT03032172|540546241|FG002|Treatment Period|Physician Decision|1|||
149840409|NCT03032172|540546242|FG003|Treatment Period|Physician Decision|0|||
149840410|NCT03032172|540546243|FG004|Treatment Period|Physician Decision|0|||
149840411|NCT03032172|540546244|FG005|Treatment Period|Physician Decision|0|||
149840412|NCT03032172|540546245|FG006|Treatment Period|Physician Decision|0|||
150035286|NCT00423579|541268935|FG001|Overall Study|Lost to Follow-up|0|||
150035287|NCT00423579|541268934|FG000|Overall Study|Protocol Violation|1|||
150285302|NCT01225731|542180581|FG009|Part 2|Protocol Violation|0|||
150285303|NCT01225731|542180582|FG010|Part 2|Protocol Violation|0|||
150285304|NCT01225731|542180583|FG011|Part 2|Protocol Violation|0|||
150285305|NCT01225731|542180584|FG012|Part 2|Protocol Violation|0|||
150285306|NCT01225731|542180572|FG000|Part 2|Adverse Event|0|||
150285307|NCT01225731|542180573|FG001|Part 2|Adverse Event|0|||
149840413|NCT03032172|540546246|FG007|Treatment Period|Physician Decision|0|||
149840414|NCT03032172|540546239|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
149840415|NCT03032172|540546240|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
149840416|NCT03032172|540546241|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
149840417|NCT03032172|540546242|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
149840418|NCT03032172|540546243|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
149840419|NCT03032172|540546244|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
149840420|NCT03032172|540546245|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
149840421|NCT03032172|540546246|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
149840422|NCT03032172|540546239|FG000|Treatment Period|Withdrawal by Subject|2|||
150285308|NCT01225731|542180574|FG002|Part 2|Adverse Event|0|||
150285309|NCT01225731|542180575|FG003|Part 2|Adverse Event|0|||
150285310|NCT01225731|542180576|FG004|Part 2|Adverse Event|0|||
150285311|NCT01225731|542180577|FG005|Part 2|Adverse Event|0|||
149840423|NCT03032172|540546240|FG001|Treatment Period|Withdrawal by Subject|0|||
149840424|NCT03032172|540546241|FG002|Treatment Period|Withdrawal by Subject|3|||
149840425|NCT03032172|540546242|FG003|Treatment Period|Withdrawal by Subject|0|||
149840426|NCT03032172|540546243|FG004|Treatment Period|Withdrawal by Subject|0|||
149840427|NCT03032172|540546244|FG005|Treatment Period|Withdrawal by Subject|0|||
149840428|NCT03032172|540546245|FG006|Treatment Period|Withdrawal by Subject|0|||
149840429|NCT03032172|540546246|FG007|Treatment Period|Withdrawal by Subject|0|||
149840430|NCT03032172|540546239|FG000|Open-label Extension Period|Death|0|||
149840431|NCT03032172|540546240|FG001|Open-label Extension Period|Death|0|||
149840432|NCT03032172|540546241|FG002|Open-label Extension Period|Death|0|||
149840433|NCT03032172|540546242|FG003|Open-label Extension Period|Death|0|||
149840434|NCT03032172|540546243|FG004|Open-label Extension Period|Death|0|||
149840435|NCT03032172|540546244|FG005|Open-label Extension Period|Death|0|||
149840436|NCT03032172|540546245|FG006|Open-label Extension Period|Death|0|||
149840437|NCT03032172|540546246|FG007|Open-label Extension Period|Death|2|||
149840438|NCT03032172|540546239|FG000|Open-label Extension Period|Reason Not Specified|0|||
149840439|NCT03032172|540546240|FG001|Open-label Extension Period|Reason Not Specified|0|||
149840440|NCT03032172|540546241|FG002|Open-label Extension Period|Reason Not Specified|0|||
149840441|NCT03032172|540546242|FG003|Open-label Extension Period|Reason Not Specified|0|||
149840442|NCT03032172|540546243|FG004|Open-label Extension Period|Reason Not Specified|0|||
149840443|NCT03032172|540546244|FG005|Open-label Extension Period|Reason Not Specified|5|||
149840444|NCT03032172|540546245|FG006|Open-label Extension Period|Reason Not Specified|3|||
149840445|NCT03032172|540546246|FG007|Open-label Extension Period|Reason Not Specified|0|||
149840446|NCT03032172|540546239|FG000|Open-label Extension Period|Pregnancy|0|||
149840447|NCT03032172|540546240|FG001|Open-label Extension Period|Pregnancy|0|||
149840448|NCT03032172|540546241|FG002|Open-label Extension Period|Pregnancy|0|||
149840449|NCT03032172|540546242|FG003|Open-label Extension Period|Pregnancy|0|||
149840450|NCT03032172|540546243|FG004|Open-label Extension Period|Pregnancy|0|||
149840451|NCT03032172|540546244|FG005|Open-label Extension Period|Pregnancy|0|||
149840452|NCT03032172|540546245|FG006|Open-label Extension Period|Pregnancy|1|||
149840453|NCT03032172|540546246|FG007|Open-label Extension Period|Pregnancy|0|||
149840454|NCT03032172|540546239|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
149840455|NCT03032172|540546240|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
149840456|NCT03032172|540546241|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
149840457|NCT03032172|540546242|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
149840458|NCT03032172|540546243|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
149840459|NCT03032172|540546244|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
149840460|NCT03032172|540546245|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
149840461|NCT03032172|540546246|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
149840462|NCT06284525|540546247|FG000|Overall Study|Withdrawal by Subject|1|||
149840463|NCT01111461|540546248|FG000|Overall Study|Adverse Event|32|||
149840464|NCT01111461|540546248|FG000|Overall Study|Participant choice|11|||
149840465|NCT01111461|540546248|FG000|Overall Study|Lost to Follow-up|1|||
149840466|NCT01111461|540546248|FG000|Overall Study|Withdrawal by Subject|1|||
149840467|NCT01111461|540546248|FG000|Overall Study|Other|6|||
149840468|NCT02545283|540546250|FG000|Overall Study|Lost to Follow-up|2|||
149840469|NCT02545283|540546251|FG001|Overall Study|Lost to Follow-up|4|||
149840470|NCT02545283|540546250|FG000|Overall Study|Withdrawal by Subject|5|||
149840471|NCT02545283|540546251|FG001|Overall Study|Withdrawal by Subject|9|||
149840472|NCT02545283|540546250|FG000|Overall Study|Death|109|||
149840473|NCT02545283|540546251|FG001|Overall Study|Death|211|||
149840474|NCT02545283|540546250|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
149840475|NCT02545283|540546251|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
150285312|NCT01225731|542180578|FG006|Part 2|Adverse Event|4|||
149840476|NCT02545283|540546250|FG000|Overall Study|Study Terminated By Sponsor|33|||
149952747|NCT05073315|540958692|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
149952748|NCT05073315|540958693|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
149952749|NCT05073315|540958691|FG000|Period 2|Adverse Event|0|||
149952750|NCT05073315|540958692|FG001|Period 2|Adverse Event|3|||
149952751|NCT05073315|540958693|FG002|Period 2|Adverse Event|6|||
149952752|NCT05073315|540958691|FG000|Period 2|Lost to Follow-up|0|||
149952753|NCT05073315|540958692|FG001|Period 2|Lost to Follow-up|5|||
149952754|NCT05073315|540958693|FG002|Period 2|Lost to Follow-up|5|||
150285313|NCT01225731|542180579|FG007|Part 2|Adverse Event|4|||
150285314|NCT01225731|542180580|FG008|Part 2|Adverse Event|2|||
150285315|NCT01225731|542180581|FG009|Part 2|Adverse Event|0|||
149840477|NCT02545283|540546251|FG001|Overall Study|Study Terminated By Sponsor|71|||
149840478|NCT03343535|540546253|FG000|Overall Study|Lost to Follow-up|1|||
149840479|NCT03343535|540546253|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
149840480|NCT03343535|540546253|FG000|Overall Study|Death|12|||
149952755|NCT05073315|540958691|FG000|Period 2|Withdrawal by Subject|0|||
149952756|NCT05073315|540958692|FG001|Period 2|Withdrawal by Subject|4|||
150035288|NCT00423579|541268935|FG001|Overall Study|Protocol Violation|3|||
150285316|NCT01225731|542180582|FG010|Part 2|Adverse Event|0|||
149952757|NCT05073315|540958693|FG002|Period 2|Withdrawal by Subject|9|||
150035289|NCT00423579|541268934|FG000|Overall Study|Diagnosis of diabetes|0|||
149840481|NCT01158118|540546254|FG000|Overall Study|Screen failure|1|||
149840482|NCT01158118|540546255|FG001|Overall Study|Screen failure|0|||
149840483|NCT01158118|540546254|FG000|Overall Study|Donor match was a screen failure|0|||
149840484|NCT01158118|540546255|FG001|Overall Study|Donor match was a screen failure|1|||
149840485|NCT01158118|540546254|FG000|Overall Study|Suffered stroke prior to transplant|0|||
149840486|NCT01158118|540546255|FG001|Overall Study|Suffered stroke prior to transplant|1|||
149840487|NCT01158118|540546254|FG000|Overall Study|Death|0|||
149840488|NCT01158118|540546255|FG001|Overall Study|Death|1|||
149840489|NCT04994535|540546256|FG000|Overall Study|Lost to Follow-up|7|||
149840490|NCT04994535|540546257|FG001|Overall Study|Lost to Follow-up|7|||
149840491|NCT04994535|540546256|FG000|Overall Study|Withdrawal by Subject|10|||
149840492|NCT04994535|540546257|FG001|Overall Study|Withdrawal by Subject|7|||
149840493|NCT04994535|540546256|FG000|Overall Study|Other|1|||
149840494|NCT04994535|540546257|FG001|Overall Study|Other|1|||
149840495|NCT02909907|540546258|FG000|Overall Study|Withdrawal by Subject|0|||
149840496|NCT02909907|540546259|FG001|Overall Study|Withdrawal by Subject|1|||
149840497|NCT02699866|540546260|FG000|Overall Study|Withdrawal by Subject|3|||
149840498|NCT02699866|540546260|FG000|Overall Study|Physician Decision|2|||
149840499|NCT02699866|540546260|FG000|Overall Study|Adverse Event|3|||
149840500|NCT04238754|540546262|FG000|Washout - 1 Week|Lost to Follow-up|1|||
149840501|NCT04238754|540546263|FG001|Washout - 1 Week|Lost to Follow-up|0|||
149840502|NCT01294917|540546266|FG000|Overall Study|Relocation|5|||
149840503|NCT01294917|540546266|FG000|Overall Study|Inconvenience|1|||
149840504|NCT03285594|540546267|FG000|Overall Study|At the Participant's Own Request|10|||
149840505|NCT03285594|540546268|FG001|Overall Study|At the Participant's Own Request|5|||
149840506|NCT03285594|540546269|FG002|Overall Study|At the Participant's Own Request|21|||
149840507|NCT03285594|540546267|FG000|Overall Study|Adverse Event|2|||
149840508|NCT03285594|540546268|FG001|Overall Study|Adverse Event|2|||
149840509|NCT03285594|540546269|FG002|Overall Study|Adverse Event|6|||
149840510|NCT03285594|540546267|FG000|Overall Study|Poor Compliance to Protocol|0|||
149840511|NCT03285594|540546268|FG001|Overall Study|Poor Compliance to Protocol|0|||
149840512|NCT03285594|540546269|FG002|Overall Study|Poor Compliance to Protocol|1|||
149840513|NCT03285594|540546267|FG000|Overall Study|Lost to Follow-up|0|||
149840514|NCT03285594|540546268|FG001|Overall Study|Lost to Follow-up|0|||
149840515|NCT03285594|540546269|FG002|Overall Study|Lost to Follow-up|1|||
149840516|NCT03285594|540546267|FG000|Overall Study|Reason Not Specified|3|||
149840517|NCT03285594|540546268|FG001|Overall Study|Reason Not Specified|4|||
149840518|NCT03285594|540546269|FG002|Overall Study|Reason Not Specified|8|||
149840519|NCT02558491|540546270|FG000|First Invention|Withdrawal by Subject|3|||
149840520|NCT02558491|540546271|FG001|First Invention|Withdrawal by Subject|1|||
149840521|NCT02558491|540546270|FG000|First Invention|Data collection issues|1|||
149840522|NCT02558491|540546271|FG001|First Invention|Data collection issues|0|||
149840523|NCT02558491|540546270|FG000|First Invention|Stopping criteria|0|||
149840524|NCT02558491|540546271|FG001|First Invention|Stopping criteria|1|||
149840525|NCT02558491|540546270|FG000|First Invention|Changed parameters during trial|1|||
149840526|NCT02558491|540546271|FG001|First Invention|Changed parameters during trial|0|||
149840527|NCT02558491|540546270|FG000|Second Intervention|Withdrawal by Subject|1|||
149840528|NCT02558491|540546271|FG001|Second Intervention|Withdrawal by Subject|0|||
149840529|NCT02558491|540546270|FG000|Second Intervention|Stopping Criteria|1|||
149840530|NCT02558491|540546271|FG001|Second Intervention|Stopping Criteria|0|||
149840531|NCT00834431|540546272|FG000|First Intervention|Adverse Event|0|||
149840532|NCT00834431|540546273|FG001|First Intervention|Adverse Event|1|||
149840533|NCT00834431|540546272|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
149840534|NCT00834431|540546273|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
149840535|NCT03733444|540546276|FG000|Overall Study|Adverse Event|8|||
149840536|NCT03733444|540546277|FG001|Overall Study|Adverse Event|10|||
149840537|NCT03733444|540546278|FG002|Overall Study|Adverse Event|5|||
149840538|NCT03733444|540546276|FG000|Overall Study|Death|20|||
149840539|NCT03733444|540546277|FG001|Overall Study|Death|19|||
149840540|NCT03733444|540546278|FG002|Overall Study|Death|11|||
149840541|NCT03733444|540546276|FG000|Overall Study|Lost to Follow-up|3|||
149840542|NCT03733444|540546277|FG001|Overall Study|Lost to Follow-up|0|||
149840543|NCT03733444|540546278|FG002|Overall Study|Lost to Follow-up|1|||
149840544|NCT03733444|540546276|FG000|Overall Study|Lack of Efficacy|0|||
149840545|NCT03733444|540546277|FG001|Overall Study|Lack of Efficacy|1|||
149840546|NCT03733444|540546278|FG002|Overall Study|Lack of Efficacy|1|||
149840547|NCT03733444|540546276|FG000|Overall Study|Physician Decision|2|||
149840548|NCT03733444|540546277|FG001|Overall Study|Physician Decision|1|||
149840549|NCT03733444|540546278|FG002|Overall Study|Physician Decision|0|||
149840550|NCT03733444|540546276|FG000|Overall Study|Protocol Violation|2|||
149840551|NCT03733444|540546277|FG001|Overall Study|Protocol Violation|1|||
149840552|NCT03733444|540546278|FG002|Overall Study|Protocol Violation|0|||
149840553|NCT03733444|540546276|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
149840554|NCT03733444|540546277|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
149840555|NCT03733444|540546278|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
149840556|NCT03733444|540546276|FG000|Overall Study|Study Terminated by Sponsor|203|||
149840557|NCT03733444|540546277|FG001|Overall Study|Study Terminated by Sponsor|209|||
149840558|NCT03733444|540546278|FG002|Overall Study|Study Terminated by Sponsor|221|||
149840559|NCT03733444|540546276|FG000|Overall Study|Withdrawal by Subject|19|||
149840560|NCT03733444|540546277|FG001|Overall Study|Withdrawal by Subject|18|||
149840561|NCT03733444|540546278|FG002|Overall Study|Withdrawal by Subject|16|||
149840562|NCT03733444|540546276|FG000|Overall Study|Miscellaneous|1|||
149840563|NCT03733444|540546277|FG001|Overall Study|Miscellaneous|0|||
149840564|NCT03733444|540546278|FG002|Overall Study|Miscellaneous|1|||
149840565|NCT03733444|540546276|FG000|Overall Study|Not Treated|1|||
149840566|NCT03733444|540546277|FG001|Overall Study|Not Treated|2|||
149840567|NCT03733444|540546278|FG002|Overall Study|Not Treated|1|||
149840568|NCT03637764|540546279|FG000|Overall Study|Adverse Event|2|||
149840569|NCT03637764|540546280|FG001|Overall Study|Adverse Event|0|||
149840570|NCT03637764|540546281|FG002|Overall Study|Adverse Event|0|||
149840571|NCT03637764|540546282|FG003|Overall Study|Adverse Event|1|||
149840572|NCT03637764|540546279|FG000|Overall Study|Progressive Disease|23|||
149840573|NCT03637764|540546280|FG001|Overall Study|Progressive Disease|23|||
149840574|NCT03637764|540546281|FG002|Overall Study|Progressive Disease|18|||
149840575|NCT03637764|540546282|FG003|Overall Study|Progressive Disease|31|||
149840576|NCT03637764|540546279|FG000|Overall Study|Withdrawal by Subject|1|||
149840577|NCT03637764|540546280|FG001|Overall Study|Withdrawal by Subject|3|||
149840578|NCT03637764|540546281|FG002|Overall Study|Withdrawal by Subject|0|||
149840579|NCT03637764|540546282|FG003|Overall Study|Withdrawal by Subject|1|||
149840580|NCT01218867|540546283|FG000|Overall Study|Death during treatment|0|||
149840581|NCT01218867|540546284|FG001|Overall Study|Death during treatment|0|||
149840582|NCT01218867|540546285|FG002|Overall Study|Death during treatment|0|||
149840583|NCT01218867|540546286|FG003|Overall Study|Death during treatment|0|||
149840584|NCT01218867|540546287|FG004|Overall Study|Death during treatment|0|||
149840585|NCT01218867|540546288|FG005|Overall Study|Death during treatment|0|||
149840586|NCT01218867|540546289|FG006|Overall Study|Death during treatment|1|||
149840587|NCT01218867|540546290|FG007|Overall Study|Death during treatment|0|||
149840588|NCT01218867|540546291|FG008|Overall Study|Death during treatment|0|||
149840589|NCT01218867|540546292|FG009|Overall Study|Death during treatment|0|||
149840590|NCT01218867|540546293|FG010|Overall Study|Death during treatment|0|||
149840591|NCT01576042|540546298|FG000|Overall Study|Physician Decision|2|||
149840592|NCT01576042|540546299|FG001|Overall Study|Physician Decision|0|||
149840593|NCT00465270|540546300|FG000|Overall Study|Death|7|||
149840594|NCT00465270|540546301|FG001|Overall Study|Death|11|||
149840595|NCT00465270|540546300|FG000|Overall Study|Withdrawal by Subject|34|||
149840596|NCT00465270|540546301|FG001|Overall Study|Withdrawal by Subject|78|||
149840597|NCT00465270|540546300|FG000|Overall Study|Lost to Follow-up|60|||
149840598|NCT00465270|540546301|FG001|Overall Study|Lost to Follow-up|67|||
149840599|NCT00465270|540546300|FG000|Overall Study|Investigator request|3|||
149840600|NCT00465270|540546301|FG001|Overall Study|Investigator request|4|||
149840601|NCT03233724|540546302|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
149840602|NCT03233724|540546303|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
149840603|NCT03233724|540546304|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
149840604|NCT03233724|540546305|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
149840605|NCT03233724|540546306|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
149840606|NCT03233724|540546302|FG000|Phase I Dose Escalation|Best interest of participant|1|||
149840607|NCT03233724|540546303|FG001|Phase I Dose Escalation|Best interest of participant|1|||
149840608|NCT03233724|540546304|FG002|Phase I Dose Escalation|Best interest of participant|1|||
149840609|NCT03233724|540546305|FG003|Phase I Dose Escalation|Best interest of participant|0|||
149840610|NCT03233724|540546306|FG004|Phase I Dose Escalation|Best interest of participant|0|||
149840611|NCT03233724|540546302|FG000|Phase I Dose Escalation|Physician Decision|0|||
149840612|NCT03233724|540546303|FG001|Phase I Dose Escalation|Physician Decision|0|||
149840613|NCT03233724|540546304|FG002|Phase I Dose Escalation|Physician Decision|1|||
149840614|NCT03233724|540546305|FG003|Phase I Dose Escalation|Physician Decision|0|||
149840615|NCT03233724|540546306|FG004|Phase I Dose Escalation|Physician Decision|0|||
149840616|NCT03233724|540546302|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
149840617|NCT03233724|540546303|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
149840618|NCT03233724|540546304|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
149840619|NCT03233724|540546305|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
149840620|NCT03233724|540546306|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
149840621|NCT00651820|540546309|FG000|Overall Study|Lost to Follow-up|2|||
149840622|NCT02388191|540546310|FG000|Overall Study|Patient did not receive IUD|1|||
149840623|NCT02388191|540546311|FG001|Overall Study|Patient did not receive IUD|0|||
149840624|NCT01921062|540546312|FG000|Overall Study|Withdrawal by Subject|0|||
149840625|NCT01921062|540546313|FG001|Overall Study|Withdrawal by Subject|7|||
149840626|NCT01921062|540546312|FG000|Overall Study|Adverse Event|5|||
149840627|NCT01921062|540546313|FG001|Overall Study|Adverse Event|6|||
149840628|NCT01921062|540546312|FG000|Overall Study|Protocol Violation|0|||
150035290|NCT00423579|541268935|FG001|Overall Study|Diagnosis of diabetes|1|||
150035291|NCT00260533|541268936|FG000|Overall Study|Other|3|||
149840629|NCT01921062|540546313|FG001|Overall Study|Protocol Violation|1|||
149840630|NCT01921062|540546312|FG000|Overall Study|VMIQ score > 72|4|||
149840631|NCT01921062|540546313|FG001|Overall Study|VMIQ score > 72|1|||
149840632|NCT01921062|540546312|FG000|Overall Study|Logistic error|0|||
149840633|NCT01921062|540546313|FG001|Overall Study|Logistic error|1|||
149840634|NCT01911676|540546314|FG000|Period 1 of Study|Withdrawal by Subject|4|||
149840635|NCT01911676|540546315|FG001|Period 1 of Study|Withdrawal by Subject|2|||
149840636|NCT01911676|540546316|FG002|Period 1 of Study|Withdrawal by Subject|1|||
149840637|NCT01911676|540546317|FG003|Period 1 of Study|Withdrawal by Subject|2|||
149840638|NCT01911676|540546314|FG000|Period 1 of Study|Physician Decision|2|||
149840639|NCT01911676|540546315|FG001|Period 1 of Study|Physician Decision|0|||
149840640|NCT01911676|540546316|FG002|Period 1 of Study|Physician Decision|0|||
149840641|NCT01911676|540546317|FG003|Period 1 of Study|Physician Decision|1|||
149840642|NCT01911676|540546314|FG000|Period 2 of Study|Physician Decision|2|||
149840643|NCT01911676|540546315|FG001|Period 2 of Study|Physician Decision|0|||
149840644|NCT01911676|540546316|FG002|Period 2 of Study|Physician Decision|0|||
149840645|NCT01911676|540546317|FG003|Period 2 of Study|Physician Decision|1|||
149840646|NCT01911676|540546314|FG000|Period 2 of Study|Lost to Follow-up|0|||
149840647|NCT01911676|540546315|FG001|Period 2 of Study|Lost to Follow-up|0|||
149840648|NCT01911676|540546316|FG002|Period 2 of Study|Lost to Follow-up|0|||
149840649|NCT01911676|540546317|FG003|Period 2 of Study|Lost to Follow-up|1|||
149840650|NCT00773253|540546320|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
149840651|NCT00773253|540546321|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
149840652|NCT01566721|540546325|FG000|Treatment Period|Withdrawal by Subject|35|||
149840653|NCT01566721|540546326|FG001|Treatment Period|Withdrawal by Subject|9|||
149840654|NCT01566721|540546325|FG000|Treatment Period|Disease Progression/Recurrence|37|||
149840655|NCT01566721|540546326|FG001|Treatment Period|Disease Progression/Recurrence|13|||
149840656|NCT01566721|540546325|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
149840657|NCT01566721|540546326|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
149840658|NCT01566721|540546325|FG000|Treatment Period|Other|13|||
149840659|NCT01566721|540546326|FG001|Treatment Period|Other|2|||
149840660|NCT01566721|540546325|FG000|Treatment Period|Lack of Compliance|5|||
149840661|NCT01566721|540546326|FG001|Treatment Period|Lack of Compliance|1|||
149840662|NCT01566721|540546325|FG000|Treatment Period|Adverse Event|100|||
149840663|NCT01566721|540546326|FG001|Treatment Period|Adverse Event|30|||
149840664|NCT01566721|540546325|FG000|Treatment Period|Pregnancy|1|||
149840665|NCT01566721|540546326|FG001|Treatment Period|Pregnancy|0|||
149840666|NCT01566721|540546325|FG000|Safety Follow-up|Physician Decision|6|||
149840667|NCT01566721|540546326|FG001|Safety Follow-up|Physician Decision|4|||
149840668|NCT01566721|540546325|FG000|Safety Follow-up|Lost to Follow-up|101|||
149840669|NCT01566721|540546326|FG001|Safety Follow-up|Lost to Follow-up|48|||
149840670|NCT01566721|540546325|FG000|Safety Follow-up|Withdrawal by Subject|155|||
149840671|NCT01566721|540546326|FG001|Safety Follow-up|Withdrawal by Subject|49|||
149840672|NCT01566721|540546325|FG000|Safety Follow-up|Death|28|||
149840673|NCT01566721|540546326|FG001|Safety Follow-up|Death|4|||
149840674|NCT01566721|540546325|FG000|Safety Follow-up|Non-compliance|7|||
149840675|NCT01566721|540546326|FG001|Safety Follow-up|Non-compliance|3|||
149840676|NCT01566721|540546325|FG000|Safety Follow-up|Protocol Violation|7|||
149840677|NCT01566721|540546326|FG001|Safety Follow-up|Protocol Violation|0|||
149840678|NCT01566721|540546325|FG000|Safety Follow-up|Site closure|2|||
149840679|NCT01566721|540546326|FG001|Safety Follow-up|Site closure|3|||
149840680|NCT01566721|540546325|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
149840681|NCT01566721|540546326|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
149840682|NCT01566721|540546325|FG000|Safety Follow-up|Missing|7|||
149840683|NCT01566721|540546326|FG001|Safety Follow-up|Missing|2|||
149840684|NCT01566721|540546325|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
149840685|NCT01566721|540546326|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
149840686|NCT01566721|540546325|FG000|Safety Follow-up|Sponsor decision|1|||
149840687|NCT01566721|540546326|FG001|Safety Follow-up|Sponsor decision|0|||
149840688|NCT01566721|540546325|FG000|Safety Follow-up|Adverse Event|8|||
149840689|NCT01566721|540546326|FG001|Safety Follow-up|Adverse Event|4|||
149840690|NCT03769025|540546327|FG000|Overall Study|Withdrawal by Subject|1|||
149840691|NCT03769025|540546328|FG001|Overall Study|Withdrawal by Subject|1|||
149952758|NCT05073315|540958691|FG000|Period 2|Protocol Violation|0|||
150285317|NCT01225731|542180583|FG011|Part 2|Adverse Event|0|||
149840692|NCT03769025|540546327|FG000|Overall Study|Lost to Follow-up|4|||
149952759|NCT05073315|540958692|FG001|Period 2|Protocol Violation|0|||
149840693|NCT03769025|540546328|FG001|Overall Study|Lost to Follow-up|3|||
149840694|NCT03123471|540546333|FG000|Placebo-controlled Phase|Adverse Event|3|||
149840695|NCT03123471|540546334|FG001|Placebo-controlled Phase|Adverse Event|8|||
149840696|NCT03123471|540546333|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
149840697|NCT03123471|540546334|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
149840698|NCT03123471|540546333|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
149840699|NCT03123471|540546334|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
149840700|NCT03123471|540546333|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
149952760|NCT05073315|540958693|FG002|Period 2|Protocol Violation|1|||
149840701|NCT03123471|540546334|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
149840702|NCT03123471|540546333|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
149840703|NCT03123471|540546334|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
149840704|NCT03123471|540546333|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
149840705|NCT03123471|540546334|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
149840706|NCT03123471|540546333|FG000|Placebo-controlled Phase|Miscellaneous|0|||
149840707|NCT03123471|540546334|FG001|Placebo-controlled Phase|Miscellaneous|1|||
149840708|NCT03123471|540546333|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
149840709|NCT03123471|540546334|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
149840710|NCT03123471|540546333|FG000|Apremilast Extension Phase|Adverse Event|1|||
149952761|NCT01529268|540958694|FG000|Overall Study|Lost to Follow-up|9|||
149952762|NCT01529268|540958695|FG001|Overall Study|Lost to Follow-up|3|||
149952763|NCT01529268|540958694|FG000|Overall Study|Moved|3|||
149952764|NCT01529268|540958695|FG001|Overall Study|Moved|0|||
149952765|NCT00303953|540958696|FG000|Overall Study|Ineligible|1|||
149840711|NCT03123471|540546334|FG001|Apremilast Extension Phase|Adverse Event|5|||
149840712|NCT03123471|540546333|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
149840713|NCT03123471|540546334|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
149840714|NCT03123471|540546333|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
149840715|NCT03123471|540546334|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
149840716|NCT05341622|540546336|FG000|Overall Study|Death|0|||
149840717|NCT05341622|540546337|FG001|Overall Study|Death|0|||
149840718|NCT05341622|540546338|FG002|Overall Study|Death|0|||
149840719|NCT05341622|540546339|FG003|Overall Study|Death|0|||
149840720|NCT05341622|540546340|FG004|Overall Study|Death|1|||
149840721|NCT05341622|540546341|FG005|Overall Study|Death|0|||
149840722|NCT05341622|540546342|FG006|Overall Study|Death|0|||
149952766|NCT00303953|540958696|FG000|Overall Study|Death|1|||
149840723|NCT05341622|540546343|FG007|Overall Study|Death|1|||
149840724|NCT05341622|540546336|FG000|Overall Study|Invalid Address|0|||
149840725|NCT05341622|540546337|FG001|Overall Study|Invalid Address|1|||
149840726|NCT05341622|540546338|FG002|Overall Study|Invalid Address|0|||
149840727|NCT05341622|540546339|FG003|Overall Study|Invalid Address|0|||
149840728|NCT05341622|540546340|FG004|Overall Study|Invalid Address|0|||
149840729|NCT05341622|540546341|FG005|Overall Study|Invalid Address|0|||
149840730|NCT05341622|540546342|FG006|Overall Study|Invalid Address|0|||
149840731|NCT05341622|540546343|FG007|Overall Study|Invalid Address|0|||
149840732|NCT05341622|540546336|FG000|Overall Study|Ineligible|26|||
149840733|NCT05341622|540546337|FG001|Overall Study|Ineligible|21|||
149840734|NCT05341622|540546338|FG002|Overall Study|Ineligible|28|||
149840735|NCT05341622|540546339|FG003|Overall Study|Ineligible|24|||
149840736|NCT05341622|540546340|FG004|Overall Study|Ineligible|29|||
149840737|NCT05341622|540546341|FG005|Overall Study|Ineligible|31|||
149840738|NCT05341622|540546342|FG006|Overall Study|Ineligible|28|||
149840739|NCT05341622|540546343|FG007|Overall Study|Ineligible|26|||
149840740|NCT02658084|540546348|FG000|Overall Study|Withdrawal by Subject|1|||
149840741|NCT02658084|540546349|FG001|Overall Study|Withdrawal by Subject|0|||
149840742|NCT02658084|540546348|FG000|Overall Study|Study Termination|1|||
149840743|NCT02658084|540546349|FG001|Overall Study|Study Termination|0|||
149840744|NCT03290781|540546351|FG000|Overall Study|Adverse Event|5|||
149840745|NCT03290781|540546352|FG001|Overall Study|Adverse Event|7|||
149840746|NCT03290781|540546353|FG002|Overall Study|Adverse Event|4|||
149840747|NCT03290781|540546354|FG003|Overall Study|Adverse Event|1|||
149840748|NCT03290781|540546355|FG004|Overall Study|Adverse Event|0|||
149840749|NCT03290781|540546356|FG005|Overall Study|Adverse Event|0|||
150285318|NCT01225731|542180584|FG012|Part 2|Adverse Event|0|||
150285319|NCT01225731|542180572|FG000|Part 2|Lack of Efficacy|0|||
150285320|NCT01225731|542180573|FG001|Part 2|Lack of Efficacy|0|||
150285321|NCT01225731|542180574|FG002|Part 2|Lack of Efficacy|0|||
150285322|NCT01225731|542180575|FG003|Part 2|Lack of Efficacy|0|||
150285323|NCT01225731|542180576|FG004|Part 2|Lack of Efficacy|0|||
150285324|NCT01225731|542180577|FG005|Part 2|Lack of Efficacy|1|||
150285325|NCT01225731|542180578|FG006|Part 2|Lack of Efficacy|0|||
150285326|NCT01225731|542180579|FG007|Part 2|Lack of Efficacy|12|||
149952767|NCT00303953|540958696|FG000|Overall Study|Adverse Event|4|||
149840750|NCT03290781|540546357|FG006|Overall Study|Adverse Event|0|||
149840751|NCT03290781|540546351|FG000|Overall Study|Death|0|||
149840752|NCT03290781|540546352|FG001|Overall Study|Death|0|||
149952768|NCT00303953|540958696|FG000|Overall Study|Lack of Efficacy|12|||
149952769|NCT00303953|540958696|FG000|Overall Study|Physician Decision|1|||
150285327|NCT01225731|542180580|FG008|Part 2|Lack of Efficacy|3|||
150285328|NCT01225731|542180581|FG009|Part 2|Lack of Efficacy|0|||
150285329|NCT01225731|542180582|FG010|Part 2|Lack of Efficacy|0|||
149840753|NCT03290781|540546353|FG002|Overall Study|Death|1|||
149840754|NCT03290781|540546354|FG003|Overall Study|Death|0|||
149840755|NCT03290781|540546355|FG004|Overall Study|Death|1|||
149840756|NCT03290781|540546356|FG005|Overall Study|Death|0|||
149952770|NCT01132755|540958697|FG000|Overall Study|Procedure not done due to medical reason|23|||
149952771|NCT01132755|540958697|FG000|Overall Study|Protocol Violation|15|||
149952772|NCT01132755|540958697|FG000|Overall Study|Withdrawal by Subject|4|||
150285330|NCT01225731|542180583|FG011|Part 2|Lack of Efficacy|0|||
150285331|NCT01225731|542180584|FG012|Part 2|Lack of Efficacy|0|||
149840757|NCT03290781|540546357|FG006|Overall Study|Death|0|||
149840758|NCT03290781|540546351|FG000|Overall Study|Withdrawal by Subject|6|||
149840759|NCT03290781|540546352|FG001|Overall Study|Withdrawal by Subject|5|||
149840760|NCT03290781|540546353|FG002|Overall Study|Withdrawal by Subject|9|||
149840761|NCT03290781|540546354|FG003|Overall Study|Withdrawal by Subject|10|||
149840762|NCT03290781|540546355|FG004|Overall Study|Withdrawal by Subject|1|||
149840763|NCT03290781|540546356|FG005|Overall Study|Withdrawal by Subject|2|||
149840764|NCT03290781|540546357|FG006|Overall Study|Withdrawal by Subject|0|||
149840765|NCT03290781|540546351|FG000|Overall Study|Physician Decision|0|||
149840766|NCT03290781|540546352|FG001|Overall Study|Physician Decision|1|||
149840767|NCT03290781|540546353|FG002|Overall Study|Physician Decision|0|||
149840768|NCT03290781|540546354|FG003|Overall Study|Physician Decision|0|||
149840769|NCT03290781|540546355|FG004|Overall Study|Physician Decision|0|||
149840770|NCT03290781|540546356|FG005|Overall Study|Physician Decision|0|||
149840771|NCT03290781|540546357|FG006|Overall Study|Physician Decision|0|||
149840772|NCT03290781|540546351|FG000|Overall Study|Site Terminated by Sponsor|1|||
149840773|NCT03290781|540546352|FG001|Overall Study|Site Terminated by Sponsor|0|||
149840774|NCT03290781|540546353|FG002|Overall Study|Site Terminated by Sponsor|2|||
149840775|NCT03290781|540546354|FG003|Overall Study|Site Terminated by Sponsor|1|||
149840776|NCT03290781|540546355|FG004|Overall Study|Site Terminated by Sponsor|0|||
149840777|NCT03290781|540546356|FG005|Overall Study|Site Terminated by Sponsor|0|||
149840778|NCT03290781|540546357|FG006|Overall Study|Site Terminated by Sponsor|0|||
149840779|NCT03290781|540546351|FG000|Overall Study|Lost to Follow-up|0|||
149840780|NCT03290781|540546352|FG001|Overall Study|Lost to Follow-up|0|||
149840781|NCT03290781|540546353|FG002|Overall Study|Lost to Follow-up|0|||
149840782|NCT03290781|540546354|FG003|Overall Study|Lost to Follow-up|1|||
149840783|NCT03290781|540546355|FG004|Overall Study|Lost to Follow-up|0|||
149840784|NCT03290781|540546356|FG005|Overall Study|Lost to Follow-up|0|||
149840785|NCT03290781|540546357|FG006|Overall Study|Lost to Follow-up|0|||
149840786|NCT03290781|540546351|FG000|Overall Study|Protocol Deviation|2|||
149840787|NCT03290781|540546352|FG001|Overall Study|Protocol Deviation|0|||
149840788|NCT03290781|540546353|FG002|Overall Study|Protocol Deviation|0|||
149840789|NCT03290781|540546354|FG003|Overall Study|Protocol Deviation|1|||
149840790|NCT03290781|540546355|FG004|Overall Study|Protocol Deviation|0|||
149840791|NCT03290781|540546356|FG005|Overall Study|Protocol Deviation|0|||
149840792|NCT03290781|540546357|FG006|Overall Study|Protocol Deviation|0|||
149840793|NCT03290781|540546351|FG000|Overall Study|Disease Relapse|32|||
149840794|NCT03290781|540546352|FG001|Overall Study|Disease Relapse|5|||
149840795|NCT03290781|540546353|FG002|Overall Study|Disease Relapse|38|||
149840796|NCT03290781|540546354|FG003|Overall Study|Disease Relapse|7|||
149840797|NCT03290781|540546355|FG004|Overall Study|Disease Relapse|3|||
149840798|NCT03290781|540546356|FG005|Overall Study|Disease Relapse|1|||
149840799|NCT03290781|540546357|FG006|Overall Study|Disease Relapse|4|||
149840800|NCT03290781|540546351|FG000|Overall Study|Other|3|||
149840801|NCT03290781|540546352|FG001|Overall Study|Other|0|||
149840802|NCT03290781|540546353|FG002|Overall Study|Other|2|||
149840803|NCT03290781|540546354|FG003|Overall Study|Other|2|||
149840804|NCT03290781|540546355|FG004|Overall Study|Other|0|||
149840805|NCT03290781|540546356|FG005|Overall Study|Other|0|||
149840806|NCT03290781|540546357|FG006|Overall Study|Other|0|||
149840807|NCT02957942|540546358|FG000|Overall Study|Withdrawal by Subject|0|||
149840808|NCT02957942|540546359|FG001|Overall Study|Withdrawal by Subject|1|||
149840809|NCT02957942|540546358|FG000|Overall Study|Practicing experiment protocol|0|||
149840810|NCT02957942|540546359|FG001|Overall Study|Practicing experiment protocol|6|||
149840811|NCT01249651|540546362|FG000|Overall Study|Withdrawal by Subject|4|||
149840812|NCT01249651|540546362|FG000|Overall Study|Adverse Event|1|||
149840813|NCT01249651|540546362|FG000|Overall Study|Protocol Violation|1|||
149840814|NCT01249651|540546362|FG000|Overall Study|Sponsor Decision|1|||
149840815|NCT03801707|540546371|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
149840816|NCT01588236|540546376|FG000|Overall Study|Adverse Event|5|||
149840817|NCT01588236|540546377|FG001|Overall Study|Adverse Event|4|||
149840818|NCT01588236|540546378|FG002|Overall Study|Adverse Event|1|||
149840819|NCT01588236|540546376|FG000|Overall Study|Lost to Follow-up|8|||
149840820|NCT01588236|540546377|FG001|Overall Study|Lost to Follow-up|13|||
149840821|NCT01588236|540546378|FG002|Overall Study|Lost to Follow-up|6|||
149840822|NCT01588236|540546376|FG000|Overall Study|Physician Decision|1|||
149840823|NCT01588236|540546377|FG001|Overall Study|Physician Decision|2|||
149840824|NCT01588236|540546378|FG002|Overall Study|Physician Decision|0|||
149840825|NCT01588236|540546376|FG000|Overall Study|Protocol Violation|0|||
149840826|NCT01588236|540546377|FG001|Overall Study|Protocol Violation|1|||
149840827|NCT01588236|540546378|FG002|Overall Study|Protocol Violation|1|||
149840828|NCT01588236|540546376|FG000|Overall Study|Withdrawal by Subject|14|||
149952773|NCT02393755|540958698|FG000|Overall Study|Withdrawal by Subject|0|||
149952774|NCT02393755|540958699|FG001|Overall Study|Withdrawal by Subject|3|||
149840829|NCT01588236|540546377|FG001|Overall Study|Withdrawal by Subject|16|||
149840830|NCT01588236|540546378|FG002|Overall Study|Withdrawal by Subject|18|||
149840831|NCT01588236|540546376|FG000|Overall Study|Exclusion Criteria met during study|2|||
149840832|NCT01588236|540546377|FG001|Overall Study|Exclusion Criteria met during study|1|||
149952775|NCT02393755|540958698|FG000|Overall Study|Adverse Event|0|||
149840833|NCT01588236|540546378|FG002|Overall Study|Exclusion Criteria met during study|0|||
149840834|NCT01588236|540546376|FG000|Overall Study|sponsor decision|1|||
149840835|NCT01588236|540546377|FG001|Overall Study|sponsor decision|6|||
149840836|NCT01588236|540546378|FG002|Overall Study|sponsor decision|2|||
149840837|NCT03761173|540546385|FG000|Overall Study|Lost to Follow-up|93|||
149840838|NCT03761173|540546385|FG000|Overall Study|Withdrawal by Subject|74|||
149840839|NCT03761173|540546385|FG000|Overall Study|Death|45|||
149840840|NCT03761173|540546385|FG000|Overall Study|Withdrawal for Other Reasons|29|||
149840841|NCT03761173|540546385|FG000|Overall Study|Protocol Violation|1|||
149840842|NCT00316186|540546386|FG000|Overall Study|Adverse Event|6|||
149840843|NCT00316186|540546386|FG000|Overall Study|Disease Progression|4|||
149840844|NCT00316186|540546386|FG000|Overall Study|Lost to Follow-up|1|||
149840845|NCT00316186|540546386|FG000|Overall Study|Other|1|||
149840846|NCT02635750|540548097|FG000|Part 1, Period 2|Adverse Event|1|||
149840847|NCT02635750|540548098|FG001|Part 1, Period 2|Adverse Event|0|||
149840848|NCT02635750|540548099|FG002|Part 1, Period 2|Adverse Event|0|||
149840849|NCT02642653|540548102|FG000|Overall Study|Adverse Event|2|||
149840850|NCT02642653|540548103|FG001|Overall Study|Adverse Event|0|||
149840851|NCT02875392|540548104|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
149840852|NCT02875392|540548105|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
149840853|NCT00834717|540548109|FG000|First Intervention|Adverse Event|1|||
149840854|NCT00834717|540548110|FG001|First Intervention|Adverse Event|0|||
149840855|NCT00834717|540548109|FG000|First Intervention|Withdrawal by Subject|0|||
149840856|NCT00834717|540548110|FG001|First Intervention|Withdrawal by Subject|1|||
149840857|NCT00594035|540548113|FG000|Overall Study|Lost to Follow-up|1|||
149840858|NCT00594035|540548114|FG001|Overall Study|Lost to Follow-up|1|||
149840859|NCT00594035|540548113|FG000|Overall Study|Withdrawal by Subject|1|||
149840860|NCT00594035|540548114|FG001|Overall Study|Withdrawal by Subject|0|||
149840861|NCT00594035|540548113|FG000|Overall Study|Subject transferred to nursing home|0|||
149840862|NCT00594035|540548114|FG001|Overall Study|Subject transferred to nursing home|1|||
149840863|NCT00594035|540548113|FG000|Overall Study|Subject couldn't return due to job|0|||
149840864|NCT00594035|540548114|FG001|Overall Study|Subject couldn't return due to job|1|||
149840865|NCT00795821|540548115|FG000|Acute Treatment Phase|Adverse Event|23|||
149840866|NCT00795821|540548116|FG001|Acute Treatment Phase|Adverse Event|4|||
149840867|NCT00795821|540548115|FG000|Acute Treatment Phase|Death|1|||
149840868|NCT00795821|540548116|FG001|Acute Treatment Phase|Death|0|||
149840869|NCT00795821|540548115|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
149840870|NCT00795821|540548116|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
149840871|NCT00795821|540548115|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
149840872|NCT00795821|540548116|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
149840873|NCT00795821|540548115|FG000|Acute Treatment Phase|Physician Decision|1|||
149840874|NCT00795821|540548116|FG001|Acute Treatment Phase|Physician Decision|1|||
149840875|NCT00795821|540548115|FG000|Acute Treatment Phase|Protocol Violation|1|||
149840876|NCT00795821|540548116|FG001|Acute Treatment Phase|Protocol Violation|2|||
149840877|NCT00795821|540548115|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
149840878|NCT00795821|540548116|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
149840879|NCT00795821|540548115|FG000|Long-term Extension Phase|Adverse Event|25|||
149840880|NCT00795821|540548116|FG001|Long-term Extension Phase|Adverse Event|32|||
149840881|NCT00795821|540548115|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
149840882|NCT00795821|540548116|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
149840883|NCT00795821|540548115|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
149840884|NCT00795821|540548116|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
149840885|NCT00795821|540548115|FG000|Long-term Extension Phase|Physician Decision|1|||
149840886|NCT00795821|540548116|FG001|Long-term Extension Phase|Physician Decision|2|||
149840887|NCT00795821|540548115|FG000|Long-term Extension Phase|Protocol Violation|3|||
149840888|NCT00795821|540548116|FG001|Long-term Extension Phase|Protocol Violation|5|||
149840889|NCT00795821|540548115|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
149840890|NCT00795821|540548116|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
149840891|NCT00795821|540548115|FG000|Taper Phase|Adverse Event|2|||
149840892|NCT00795821|540548116|FG001|Taper Phase|Adverse Event|0|||
149840893|NCT00795821|540548115|FG000|Taper Phase|Lost to Follow-up|1|||
149840894|NCT00795821|540548116|FG001|Taper Phase|Lost to Follow-up|0|||
149840895|NCT00795821|540548115|FG000|Taper Phase|Physician Decision|2|||
149840896|NCT00795821|540548116|FG001|Taper Phase|Physician Decision|0|||
149840897|NCT00795821|540548115|FG000|Taper Phase|Withdrawal by Subject|4|||
149840898|NCT00795821|540548116|FG001|Taper Phase|Withdrawal by Subject|0|||
149840899|NCT00712959|540548121|FG000|Overall Study|Protocol Violation|3|||
149840900|NCT00712959|540548122|FG001|Overall Study|Protocol Violation|1|||
149840901|NCT00712959|540548121|FG000|Overall Study|Lost to Follow-up|13|||
149840902|NCT00712959|540548122|FG001|Overall Study|Lost to Follow-up|2|||
149840903|NCT00712959|540548121|FG000|Overall Study|Withdrawal by Subject|3|||
149840904|NCT00712959|540548122|FG001|Overall Study|Withdrawal by Subject|0|||
149840905|NCT04516967|540548126|FG000|Core Phase|Adverse Event|2|||
149840906|NCT04516967|540548127|FG001|Core Phase|Adverse Event|1|||
149840907|NCT04516967|540548128|FG002|Core Phase|Adverse Event|0|||
149840908|NCT04516967|540548126|FG000|Core Phase|Physician Decision|1|||
149840909|NCT04516967|540548127|FG001|Core Phase|Physician Decision|1|||
149840910|NCT04516967|540548128|FG002|Core Phase|Physician Decision|0|||
149840911|NCT04516967|540548126|FG000|Core Phase|Lack of Efficacy|7|||
149840912|NCT04516967|540548127|FG001|Core Phase|Lack of Efficacy|18|||
149840913|NCT04516967|540548128|FG002|Core Phase|Lack of Efficacy|0|||
149840914|NCT03165994|540548129|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
149840915|NCT03165994|540548129|FG000|Overall Study|Death|2|||
149840916|NCT03165994|540548129|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
149840917|NCT03165994|540548129|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
149840918|NCT03165994|540548129|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
149840919|NCT03165994|540548129|FG000|Overall Study|Miscellaneous|1|||
149840920|NCT00163657|540548132|FG000|Overall Study|Death|12|||
149840921|NCT00163657|540548133|FG001|Overall Study|Death|14|||
149840922|NCT00163657|540548134|FG002|Overall Study|Death|19|||
149840923|NCT00163657|540548132|FG000|Overall Study|graft loss|4|||
149840924|NCT00163657|540548133|FG001|Overall Study|graft loss|1|||
149840925|NCT00163657|540548134|FG002|Overall Study|graft loss|2|||
149840926|NCT00163657|540548132|FG000|Overall Study|Withdrawal by Subject|2|||
149840927|NCT00163657|540548133|FG001|Overall Study|Withdrawal by Subject|3|||
149840928|NCT00163657|540548134|FG002|Overall Study|Withdrawal by Subject|2|||
149840929|NCT00163657|540548132|FG000|Overall Study|Physician Decision|0|||
149840930|NCT00163657|540548133|FG001|Overall Study|Physician Decision|1|||
149840931|NCT00163657|540548134|FG002|Overall Study|Physician Decision|1|||
149840932|NCT00163657|540548132|FG000|Overall Study|Non Compliance|1|||
149840933|NCT00163657|540548133|FG001|Overall Study|Non Compliance|0|||
149840934|NCT00163657|540548134|FG002|Overall Study|Non Compliance|0|||
149840935|NCT00163657|540548132|FG000|Overall Study|Lost to Follow-up|1|||
149840936|NCT00163657|540548133|FG001|Overall Study|Lost to Follow-up|3|||
149840937|NCT00163657|540548134|FG002|Overall Study|Lost to Follow-up|10|||
149840938|NCT00163657|540548132|FG000|Overall Study|Other reason|0|||
149840939|NCT00163657|540548133|FG001|Overall Study|Other reason|1|||
149840940|NCT00163657|540548134|FG002|Overall Study|Other reason|3|||
149840941|NCT03086460|540548139|FG000|Study Participants|Lost to Follow-up|2|||
149840942|NCT03086460|540548139|FG000|Study Participants|Protocol Violation|1|||
149840943|NCT03086460|540548139|FG000|Study Participants|Withdrawal by Subject|6|||
149840944|NCT03086460|540548139|FG000|Treatment A|Lost to Follow-up|1|||
149840945|NCT03086460|540548139|FG000|Treatment A|Protocol Violation|1|||
149840946|NCT03086460|540548139|FG000|Treatment A|Withdrawal by Subject|2|||
149840947|NCT03086460|540548139|FG000|Treatment C|Withdrawal by Subject|2|||
149840948|NCT03086460|540548139|FG000|Treatment E|Lost to Follow-up|1|||
149840949|NCT03086460|540548139|FG000|Treatment E|Withdrawal by Subject|3|||
149840950|NCT03600805|540548140|FG000|Overall Study|Adverse Event|2|||
149840951|NCT03600805|540548141|FG001|Overall Study|Adverse Event|1|||
149840952|NCT03600805|540548142|FG002|Overall Study|Adverse Event|1|||
149840953|NCT03600805|540548143|FG003|Overall Study|Adverse Event|7|||
149840954|NCT03600805|540548140|FG000|Overall Study|Lack of Efficacy|2|||
149840955|NCT03600805|540548141|FG001|Overall Study|Lack of Efficacy|1|||
149840956|NCT03600805|540548142|FG002|Overall Study|Lack of Efficacy|0|||
149840957|NCT03600805|540548143|FG003|Overall Study|Lack of Efficacy|0|||
149840958|NCT03600805|540548140|FG000|Overall Study|Withdrawal by Subject|1|||
149840959|NCT03600805|540548141|FG001|Overall Study|Withdrawal by Subject|0|||
149840960|NCT03600805|540548142|FG002|Overall Study|Withdrawal by Subject|0|||
149840961|NCT03600805|540548143|FG003|Overall Study|Withdrawal by Subject|1|||
149840962|NCT03600805|540548140|FG000|Overall Study|Other unspecified|14|||
149840963|NCT03600805|540548141|FG001|Overall Study|Other unspecified|6|||
149840964|NCT03600805|540548142|FG002|Overall Study|Other unspecified|7|||
149840965|NCT03600805|540548143|FG003|Overall Study|Other unspecified|11|||
149840966|NCT06195579|540548144|FG000|Overall Study|Withdrawal by Subject|1|||
149840967|NCT01735994|540548145|FG000|Overall Study|Withdrawal by Subject|6|||
149840968|NCT01735994|540548146|FG001|Overall Study|Withdrawal by Subject|4|||
149840969|NCT01735994|540548145|FG000|Overall Study|Injury|2|||
149840970|NCT01735994|540548146|FG001|Overall Study|Injury|0|||
149840971|NCT01735994|540548145|FG000|Overall Study|Kicked off team|5|||
149840972|NCT01735994|540548146|FG001|Overall Study|Kicked off team|0|||
149840973|NCT01735994|540548145|FG000|Overall Study|Lost to Follow-up|50|||
149840974|NCT01735994|540548146|FG001|Overall Study|Lost to Follow-up|62|||
149840975|NCT03123094|540548147|FG000|Overall Study|Withdrawal by Subject|0|||
149840976|NCT03123094|540548148|FG001|Overall Study|Withdrawal by Subject|2|||
149840977|NCT03123094|540548149|FG002|Overall Study|Withdrawal by Subject|1|||
149840978|NCT03123094|540548150|FG003|Overall Study|Withdrawal by Subject|0|||
149840979|NCT03123094|540548151|FG004|Overall Study|Withdrawal by Subject|1|||
149840980|NCT00604162|540548152|FG000|Overall Study|Physician Decision|3|||
149840981|NCT00604162|540548152|FG000|Overall Study|Withdrawal by Subject|1|||
149840982|NCT00736190|540548154|FG000|Overall Study|Pregnancy|1|||
149840983|NCT00736190|540548154|FG000|Overall Study|Withdrawal by Subject|1|||
149840984|NCT00736190|540548154|FG000|Overall Study|Adverse Event|1|||
149840985|NCT03128723|540548158|FG000|Overall Study|Withdrawal by Subject|2|||
149840986|NCT02849457|540548164|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
149840987|NCT02849457|540548165|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
149840988|NCT02849457|540548166|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
149840989|NCT02849457|540548167|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
149840990|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
149840991|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
149840992|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
149840993|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
149840994|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
149840995|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
149840996|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
150035292|NCT00260533|541268937|FG001|Overall Study|Other|3|||
150035293|NCT04682366|541268938|FG000|Overall Study|Lost to Follow-up|1|||
150035294|NCT04682366|541268939|FG001|Overall Study|Lost to Follow-up|1|||
150035295|NCT03125395|541268940|FG000|Overall Study|Adverse Event|2|||
150285332|NCT01225731|542180572|FG000|Part 2|Pregnancy|0|||
150285333|NCT01225731|542180573|FG001|Part 2|Pregnancy|0|||
150285334|NCT01225731|542180574|FG002|Part 2|Pregnancy|0|||
150285335|NCT01225731|542180575|FG003|Part 2|Pregnancy|0|||
150285336|NCT01225731|542180576|FG004|Part 2|Pregnancy|0|||
150285337|NCT01225731|542180577|FG005|Part 2|Pregnancy|0|||
149840997|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
149840998|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
149840999|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
149841000|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
149841001|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
149841002|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
149841003|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
149841004|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
149841005|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
149841006|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
149841007|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
149841008|NCT01667679|540548168|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
149841009|NCT01667679|540548169|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
149841010|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
149841011|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
149841012|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
149841013|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
149841014|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
149841015|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
149841016|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
149841017|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
149841018|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
149841019|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
149841020|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
149841021|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
149841022|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
149841023|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
149841024|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
149841025|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
149841026|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
149841027|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
149841028|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
149841029|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
149841030|NCT01667679|540548168|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
149841031|NCT01667679|540548169|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
149841032|NCT01175018|540548170|FG000|Overall Study|Adverse Event|3|||
149841033|NCT01175018|540548171|FG001|Overall Study|Adverse Event|1|||
149841034|NCT00835263|540548173|FG000|Second Intervention|Adverse Event|1|||
149841035|NCT00835263|540548174|FG001|Second Intervention|Adverse Event|0|||
150035296|NCT03125395|541268940|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
150035297|NCT03125395|541268940|FG000|Overall Study|Physician Decision|2|||
150035298|NCT03125395|541268940|FG000|Overall Study|Commercial drug is available|5|||
150285338|NCT01225731|542180578|FG006|Part 2|Pregnancy|1|||
150285339|NCT01225731|542180579|FG007|Part 2|Pregnancy|0|||
150285340|NCT01225731|542180580|FG008|Part 2|Pregnancy|1|||
150285341|NCT01225731|542180581|FG009|Part 2|Pregnancy|0|||
149841036|NCT01020474|540548175|FG000|Overall Study|Adverse Event|4|||
149841037|NCT01020474|540548176|FG001|Overall Study|Adverse Event|4|||
149841038|NCT01020474|540548175|FG000|Overall Study|Protocol Violation|0|||
149841039|NCT01020474|540548176|FG001|Overall Study|Protocol Violation|2|||
149841040|NCT01020474|540548175|FG000|Overall Study|Withdrawal by Subject|5|||
149841041|NCT01020474|540548176|FG001|Overall Study|Withdrawal by Subject|7|||
149841042|NCT01020474|540548175|FG000|Overall Study|Other Reasons|1|||
149841043|NCT01020474|540548176|FG001|Overall Study|Other Reasons|1|||
149841044|NCT01020474|540548175|FG000|Overall Study|Insufficient Clinical Response|0|||
149841045|NCT01020474|540548176|FG001|Overall Study|Insufficient Clinical Response|3|||
149841046|NCT03987191|540548177|FG000|Overall Study|COVID-19 related research disruption|0|||
149841047|NCT03987191|540548178|FG001|Overall Study|COVID-19 related research disruption|2|||
149841048|NCT03406156|540548179|FG000|Overall Study|Death|9|||
149841049|NCT03406156|540548180|FG001|Overall Study|Death|3|||
149841050|NCT03406156|540548179|FG000|Overall Study|Withdrawal by Subject|1|||
149841051|NCT03406156|540548180|FG001|Overall Study|Withdrawal by Subject|2|||
149841052|NCT03406156|540548179|FG000|Overall Study|COVID-19 infection|1|||
149841053|NCT03406156|540548180|FG001|Overall Study|COVID-19 infection|0|||
149841054|NCT03406156|540548179|FG000|Overall Study|Non-compliance with study procedures|1|||
149841055|NCT03406156|540548180|FG001|Overall Study|Non-compliance with study procedures|1|||
149841056|NCT03406156|540548179|FG000|Overall Study|Lost to Follow-up|0|||
149841057|NCT03406156|540548180|FG001|Overall Study|Lost to Follow-up|2|||
149841058|NCT03406156|540548179|FG000|Overall Study|Other, not specified|72|||
149841059|NCT03406156|540548180|FG001|Overall Study|Other, not specified|28|||
149841060|NCT02838420|540548182|FG000|Overall Study|Ongoing in Study|113|||
149841061|NCT02838420|540548183|FG001|Overall Study|Ongoing in Study|45|||
149841062|NCT02838420|540548182|FG000|Overall Study|Lost to Follow-up|1|||
149841063|NCT02838420|540548183|FG001|Overall Study|Lost to Follow-up|0|||
149841064|NCT02838420|540548182|FG000|Overall Study|Withdrawal by Subject|3|||
149841065|NCT02838420|540548183|FG001|Overall Study|Withdrawal by Subject|4|||
149841066|NCT02838420|540548182|FG000|Overall Study|Death|8|||
149841067|NCT02838420|540548183|FG001|Overall Study|Death|13|||
149841068|NCT03419403|540548184|FG000|Overall Study|Withdrawal by Subject|5|||
149841069|NCT03419403|540548185|FG001|Overall Study|Withdrawal by Subject|2|||
149841070|NCT03419403|540548186|FG002|Overall Study|Withdrawal by Subject|5|||
149841071|NCT03419403|540548187|FG003|Overall Study|Withdrawal by Subject|1|||
149841072|NCT03419403|540548184|FG000|Overall Study|Progressive disease (per protocol)|0|||
149841073|NCT03419403|540548185|FG001|Overall Study|Progressive disease (per protocol)|2|||
149841074|NCT03419403|540548186|FG002|Overall Study|Progressive disease (per protocol)|2|||
149841075|NCT03419403|540548187|FG003|Overall Study|Progressive disease (per protocol)|0|||
149841076|NCT03419403|540548184|FG000|Overall Study|Other, not specified|6|||
149841077|NCT03419403|540548185|FG001|Overall Study|Other, not specified|4|||
149841078|NCT03419403|540548186|FG002|Overall Study|Other, not specified|5|||
149841079|NCT03419403|540548187|FG003|Overall Study|Other, not specified|1|||
149841080|NCT03419403|540548184|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
149841081|NCT03419403|540548185|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
149841082|NCT03419403|540548186|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
149841083|NCT03419403|540548187|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
149841084|NCT00796653|540548188|FG000|Overall Study|Adverse Event|19|||
149841085|NCT00796653|540548189|FG001|Overall Study|Adverse Event|16|||
149841086|NCT00796653|540548190|FG002|Overall Study|Adverse Event|16|||
149841087|NCT00796653|540548191|FG003|Overall Study|Adverse Event|16|||
149841088|NCT00796653|540548188|FG000|Overall Study|Lost to Follow-up|2|||
149841089|NCT00796653|540548189|FG001|Overall Study|Lost to Follow-up|1|||
149841090|NCT00796653|540548190|FG002|Overall Study|Lost to Follow-up|2|||
150285342|NCT01225731|542180582|FG010|Part 2|Pregnancy|0|||
150285343|NCT01225731|542180583|FG011|Part 2|Pregnancy|0|||
150285344|NCT01225731|542180584|FG012|Part 2|Pregnancy|0|||
149841091|NCT00796653|540548191|FG003|Overall Study|Lost to Follow-up|3|||
149952776|NCT02393755|540958699|FG001|Overall Study|Adverse Event|2|||
149841092|NCT00796653|540548188|FG000|Overall Study|Withdrawal by Subject|16|||
149841093|NCT00796653|540548189|FG001|Overall Study|Withdrawal by Subject|8|||
149952777|NCT02393755|540958698|FG000|Overall Study|Physician Decision|0|||
150285345|NCT01225731|542180572|FG000|Part 2|Lost to Follow-up|0|||
149841094|NCT00796653|540548190|FG002|Overall Study|Withdrawal by Subject|8|||
149841095|NCT00796653|540548191|FG003|Overall Study|Withdrawal by Subject|13|||
149841096|NCT00796653|540548188|FG000|Overall Study|Lack of Efficacy|8|||
149841097|NCT00796653|540548189|FG001|Overall Study|Lack of Efficacy|1|||
149841098|NCT00796653|540548190|FG002|Overall Study|Lack of Efficacy|3|||
149841099|NCT00796653|540548191|FG003|Overall Study|Lack of Efficacy|2|||
149841100|NCT00796653|540548188|FG000|Overall Study|Non compliance with protocol|2|||
149841101|NCT00796653|540548189|FG001|Overall Study|Non compliance with protocol|2|||
150285346|NCT01225731|542180573|FG001|Part 2|Lost to Follow-up|0|||
149841102|NCT00796653|540548190|FG002|Overall Study|Non compliance with protocol|0|||
149841103|NCT00796653|540548191|FG003|Overall Study|Non compliance with protocol|2|||
149841104|NCT00796653|540548188|FG000|Overall Study|Other reason not described above|4|||
150285347|NCT01225731|542180574|FG002|Part 2|Lost to Follow-up|0|||
149841105|NCT00796653|540548189|FG001|Overall Study|Other reason not described above|9|||
149841106|NCT00796653|540548190|FG002|Overall Study|Other reason not described above|7|||
149841107|NCT00796653|540548191|FG003|Overall Study|Other reason not described above|4|||
149841108|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
149841109|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
149841110|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
149841111|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
149841112|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
149841113|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
149841114|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149841115|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149841116|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
149841117|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
149841118|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
149841119|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
149841120|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
149841121|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
149841122|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
149841123|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
149841124|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
149841125|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
149841126|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
149841127|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
149841128|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Death|0|||
149841129|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Death|1|||
149841130|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Death|0|||
149841131|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Death|0|||
149841132|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
149841133|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
149841134|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
149841135|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
149952778|NCT02393755|540958699|FG001|Overall Study|Physician Decision|2|||
149952779|NCT02207608|540958700|FG000|Overall Study|Adverse Event|1|||
149952780|NCT02207608|540958701|FG001|Overall Study|Adverse Event|0|||
149952781|NCT05800145|540958702|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
149952782|NCT05800145|540958703|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
149952783|NCT05800145|540958704|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
149952784|NCT05800145|540958705|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
149952785|NCT05800145|540958706|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
149952786|NCT05800145|540958707|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
149952787|NCT05800145|540958702|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
149952788|NCT05800145|540958703|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
149952789|NCT05800145|540958704|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
149952790|NCT05800145|540958705|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
149952791|NCT05800145|540958706|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
149952792|NCT05800145|540958707|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
149952793|NCT05800145|540958702|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
149952794|NCT05800145|540958703|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
149952795|NCT05800145|540958704|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
149952796|NCT05800145|540958705|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
149841136|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
149841137|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
149841138|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
149841139|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
149841140|NCT01940341|540548196|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149952797|NCT05800145|540958706|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
149952798|NCT05800145|540958707|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
149952799|NCT05643794|540960124|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
149952800|NCT05643794|540960125|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149952801|NCT05643794|540960126|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
149952802|NCT05643794|540960124|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
149952803|NCT05643794|540960125|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149952804|NCT05643794|540960126|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149841141|NCT01940341|540548197|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
149952805|NCT05643794|540960124|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
149952806|NCT05643794|540960125|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
149841142|NCT01940341|540548198|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149841143|NCT01940341|540548199|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149841144|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
149841145|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
149841146|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
149841147|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
150035299|NCT02383576|541268941|FG000|Overall Study|Death|53|||
149841148|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
149841149|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
150035300|NCT02383576|541268942|FG001|Overall Study|Death|33|||
150035301|NCT02383576|541268941|FG000|Overall Study|Lost to Follow-up|7|||
150035302|NCT02383576|541268942|FG001|Overall Study|Lost to Follow-up|1|||
150035303|NCT02383576|541268941|FG000|Overall Study|Withdrew Consent|1|||
150035304|NCT02383576|541268942|FG001|Overall Study|Withdrew Consent|6|||
150035305|NCT02383576|541268941|FG000|Overall Study|Investigator's Decision|0|||
150035306|NCT02383576|541268942|FG001|Overall Study|Investigator's Decision|1|||
150035307|NCT02383576|541268941|FG000|Overall Study|Administrative/Other|2|||
150035308|NCT02383576|541268942|FG001|Overall Study|Administrative/Other|4|||
150035309|NCT04218240|541268943|FG000|Overall Study|Withdrawal by Subject|6|||
150035310|NCT04218240|541268944|FG001|Overall Study|Withdrawal by Subject|0|||
150035311|NCT04218240|541268943|FG000|Overall Study|Lack of Efficacy|24|||
149841150|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
149841151|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
149841152|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
149952807|NCT05643794|540960126|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
149952808|NCT05643794|540960124|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149952809|NCT05643794|540960125|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149952810|NCT05643794|540960126|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149952811|NCT05643794|540960124|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
149952812|NCT05643794|540960125|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
149952813|NCT05643794|540960126|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
149952814|NCT05643794|540960124|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
149952815|NCT05643794|540960125|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
149952816|NCT05643794|540960126|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
149952817|NCT04167670|540960129|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
149952818|NCT04167670|540960130|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
149952819|NCT04167670|540960131|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
149952820|NCT04167670|540960129|FG000|Overall Study|Significant protocol deviation|3|||
149952821|NCT04167670|540960130|FG001|Overall Study|Significant protocol deviation|1|||
149952822|NCT04167670|540960131|FG002|Overall Study|Significant protocol deviation|0|||
149952823|NCT04167670|540960129|FG000|Overall Study|Lost to Follow-up|0|||
149952824|NCT04167670|540960130|FG001|Overall Study|Lost to Follow-up|3|||
149952825|NCT04167670|540960131|FG002|Overall Study|Lost to Follow-up|3|||
149952826|NCT04167670|540960129|FG000|Overall Study|Voluntary Withdrawal|0|||
149952827|NCT04167670|540960130|FG001|Overall Study|Voluntary Withdrawal|1|||
149952828|NCT04167670|540960131|FG002|Overall Study|Voluntary Withdrawal|1|||
149952829|NCT04167670|540960129|FG000|Overall Study|Withdrawal of Consent|4|||
149952830|NCT04167670|540960130|FG001|Overall Study|Withdrawal of Consent|1|||
149952831|NCT04167670|540960131|FG002|Overall Study|Withdrawal of Consent|3|||
149952832|NCT04167670|540960129|FG000|Overall Study|Miscellaneous|7|||
149952833|NCT04167670|540960130|FG001|Overall Study|Miscellaneous|5|||
149952834|NCT04167670|540960131|FG002|Overall Study|Miscellaneous|3|||
149952835|NCT01127061|540960134|FG000|Overall Study|Lost to Follow-up|7|||
149952836|NCT01127061|540960135|FG001|Overall Study|Lost to Follow-up|10|||
149952837|NCT01127061|540960134|FG000|Overall Study|Physician Decision|3|||
149952838|NCT01127061|540960135|FG001|Overall Study|Physician Decision|3|||
149952839|NCT04827446|540960136|FG000|Overall Study|Lost to Follow-up|1|||
149952840|NCT04827446|540960137|FG001|Overall Study|Lost to Follow-up|1|||
149952841|NCT04827446|540960136|FG000|Overall Study|Death|2|||
149952842|NCT04827446|540960137|FG001|Overall Study|Death|0|||
149952843|NCT04827446|540960136|FG000|Overall Study|Withdrawal by Subject|2|||
149952844|NCT04827446|540960137|FG001|Overall Study|Withdrawal by Subject|2|||
149952845|NCT03921541|540960140|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
149952846|NCT03921541|540960141|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
149952847|NCT04706403|540960142|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
149952848|NCT04706403|540960143|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
150035312|NCT04218240|541268944|FG001|Overall Study|Lack of Efficacy|19|||
150035313|NCT04218240|541268943|FG000|Overall Study|Physician Decision|0|||
150035314|NCT04218240|541268944|FG001|Overall Study|Physician Decision|1|||
150035315|NCT04218240|541268943|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
149841153|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
149841154|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
149841155|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
149841156|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
149841157|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
149841158|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
149841159|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
149841160|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
149841161|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
149841162|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
149841163|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
149841164|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
149952849|NCT04706403|540960144|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
149952850|NCT04706403|540960145|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
149952851|NCT04706403|540960146|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
149952852|NCT00182637|540960147|FG000|Overall Study|Adverse Event|2|||
149952853|NCT00182637|540960147|FG000|Overall Study|Disease Progression|1|||
149952854|NCT04941898|540960148|FG000|Overall Study|Protocol Violation|1|||
149952855|NCT01112267|540960149|FG000|Overall Study|Adverse Event|24|||
149841165|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
149841166|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
149841167|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
149841168|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149841169|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149952856|NCT01112267|540960150|FG001|Overall Study|Adverse Event|6|||
149952857|NCT01112267|540960149|FG000|Overall Study|Withdrawal by Subject|3|||
149952858|NCT01112267|540960150|FG001|Overall Study|Withdrawal by Subject|5|||
149952859|NCT01112267|540960149|FG000|Overall Study|Protocol Violation|5|||
149952860|NCT01112267|540960150|FG001|Overall Study|Protocol Violation|3|||
149952861|NCT01112267|540960149|FG000|Overall Study|Participants not compliant|1|||
149952862|NCT01112267|540960150|FG001|Overall Study|Participants not compliant|2|||
149952863|NCT01112267|540960149|FG000|Overall Study|Participants not receive any study drug|1|||
149952864|NCT01112267|540960150|FG001|Overall Study|Participants not receive any study drug|2|||
149952865|NCT00003456|540960151|FG000|Overall Study|Not evaluable|8|||
149952866|NCT00420407|540960152|FG000|Overall Study|Lost to Follow-up|0|||
149952867|NCT00420407|540960153|FG001|Overall Study|Lost to Follow-up|3|||
149952868|NCT00420407|540960152|FG000|Overall Study|Physician Decision|2|||
149952869|NCT00420407|540960153|FG001|Overall Study|Physician Decision|1|||
149952870|NCT00420407|540960152|FG000|Overall Study|subject identified as detainee|1|||
149952871|NCT00420407|540960153|FG001|Overall Study|subject identified as detainee|0|||
149952872|NCT00420407|540960152|FG000|Overall Study|subject identified as Jehovah's witness|1|||
149952873|NCT00420407|540960153|FG001|Overall Study|subject identified as Jehovah's witness|0|||
149952874|NCT00420407|540960152|FG000|Overall Study|Withdrawal by Subject|0|||
149952875|NCT00420407|540960153|FG001|Overall Study|Withdrawal by Subject|2|||
149952876|NCT05417113|540960157|FG000|Overall Study|Lost to Follow-up|2|||
149952877|NCT05417113|540960158|FG001|Overall Study|Lost to Follow-up|2|||
149952878|NCT00134719|540960159|FG000|Primary Vaccination Phase|Adverse Event|4|||
149952879|NCT00134719|540960160|FG001|Primary Vaccination Phase|Adverse Event|0|||
149952880|NCT00134719|540960161|FG002|Primary Vaccination Phase|Adverse Event|0|||
149952881|NCT00134719|540960159|FG000|Primary Vaccination Phase|Protocol Violation|1|||
149952882|NCT00134719|540960160|FG001|Primary Vaccination Phase|Protocol Violation|0|||
149952883|NCT00134719|540960161|FG002|Primary Vaccination Phase|Protocol Violation|0|||
149952884|NCT00134719|540960159|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
149952885|NCT00134719|540960160|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
149952886|NCT00134719|540960161|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
149952887|NCT00134719|540960159|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
149952888|NCT00134719|540960160|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
149952889|NCT00134719|540960161|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
149952890|NCT00134719|540960159|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
149952891|NCT00134719|540960160|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
149952892|NCT00134719|540960161|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
149952893|NCT00134719|540960159|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
149952894|NCT00134719|540960160|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
149952895|NCT00134719|540960161|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
149952896|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
149952897|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
149952898|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
149952899|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
150285348|NCT01225731|542180575|FG003|Part 2|Lost to Follow-up|0|||
150285349|NCT01225731|542180576|FG004|Part 2|Lost to Follow-up|0|||
150285350|NCT01225731|542180577|FG005|Part 2|Lost to Follow-up|0|||
150285351|NCT01225731|542180578|FG006|Part 2|Lost to Follow-up|0|||
150285352|NCT01225731|542180579|FG007|Part 2|Lost to Follow-up|3|||
149841170|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
149841171|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149841172|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
149841173|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
149841174|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
149841175|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
149841176|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149841177|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149841178|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149841179|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
149841180|NCT01940341|540548196|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
149841181|NCT01940341|540548197|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
149841182|NCT01940341|540548198|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
149841183|NCT01940341|540548199|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
149841184|NCT03552393|540548200|FG000|Core Period|Kidney Transplant|1|||
149841185|NCT03552393|540548200|FG000|Core Period|Prohibited Medication|1|||
149841186|NCT03552393|540548200|FG000|Safety Extension Period|Kidney Transplant|4|||
149841187|NCT02414152|540548201|FG000|Overall Study|Withdrawal by Subject|1|||
149841188|NCT02414152|540548201|FG000|Overall Study|Lack of Efficacy|1|||
149841189|NCT04887415|540548205|FG000|Overall Study|Lost to Follow-up|2|||
149841190|NCT01250912|540548208|FG000|Overall Study|Lost to Follow-up|1|||
149841191|NCT00787254|540548221|FG000|Overall Study|Adverse Event|24|||
149841192|NCT00787254|540548222|FG001|Overall Study|Adverse Event|23|||
149841193|NCT00787254|540548221|FG000|Overall Study|Protocol Violation|26|||
149841194|NCT00787254|540548222|FG001|Overall Study|Protocol Violation|23|||
149841195|NCT00787254|540548221|FG000|Overall Study|Withdrawal by Subject|16|||
149841196|NCT00787254|540548222|FG001|Overall Study|Withdrawal by Subject|11|||
149841197|NCT00787254|540548221|FG000|Overall Study|Lack of Efficacy|4|||
149841198|NCT00787254|540548222|FG001|Overall Study|Lack of Efficacy|15|||
149841199|NCT00787254|540548221|FG000|Overall Study|NSAIDs discontinuation|1|||
149841200|NCT00787254|540548222|FG001|Overall Study|NSAIDs discontinuation|2|||
149841201|NCT00787254|540548221|FG000|Overall Study|Institution closed|1|||
149841202|NCT00787254|540548222|FG001|Overall Study|Institution closed|0|||
149841203|NCT00787254|540548221|FG000|Overall Study|Physician Decision|4|||
149841204|NCT00787254|540548222|FG001|Overall Study|Physician Decision|8|||
149841205|NCT01660243|540550069|FG000|Overall Study|Adverse Event|1|||
149841206|NCT01660243|540550070|FG001|Overall Study|Adverse Event|0|||
149841207|NCT01660243|540550071|FG002|Overall Study|Adverse Event|1|||
149841208|NCT01660243|540550072|FG003|Overall Study|Adverse Event|0|||
149841209|NCT01660243|540550069|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
149841210|NCT01660243|540550070|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
149841211|NCT01660243|540550071|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
149841212|NCT01660243|540550072|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
149841213|NCT01660243|540550069|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
149841214|NCT01660243|540550070|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
149841215|NCT01660243|540550071|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
149841216|NCT01660243|540550072|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
149841217|NCT01660243|540550069|FG000|Overall Study|Randomization error|0|||
149841218|NCT01660243|540550070|FG001|Overall Study|Randomization error|0|||
149841219|NCT01660243|540550071|FG002|Overall Study|Randomization error|0|||
149841220|NCT01660243|540550072|FG003|Overall Study|Randomization error|1|||
149952900|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
149952901|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
149952902|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
149952903|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
149952904|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
150172347|NCT00290706|541765951|FG002|Overall Study|Withdrawal by Subject|0|||
150285353|NCT01225731|542180580|FG008|Part 2|Lost to Follow-up|1|||
150285354|NCT01225731|542180581|FG009|Part 2|Lost to Follow-up|0|||
150285355|NCT01225731|542180582|FG010|Part 2|Lost to Follow-up|0|||
149841221|NCT02255149|540550075|FG000|Overall Study|Lost to Follow-up|2|||
149841222|NCT02255149|540550075|FG000|Overall Study|Withdrawal by Subject|1|||
149841223|NCT02255149|540550075|FG000|Overall Study|Withdrawal by PI|1|||
149841224|NCT02255149|540550075|FG000|Overall Study|Implant Failure|1|||
150285356|NCT01225731|542180583|FG011|Part 2|Lost to Follow-up|0|||
149841225|NCT01701674|540550076|FG000|Overall Study|Unable to safely complete treatment|1|||
149841226|NCT00834522|540550085|FG000|Washout|Adverse Event|1|||
149841227|NCT00834522|540550086|FG001|Washout|Adverse Event|0|||
149841228|NCT00834522|540550085|FG000|Washout|Withdrawal by Subject|2|||
149841229|NCT00834522|540550086|FG001|Washout|Withdrawal by Subject|1|||
149841230|NCT00519194|540550087|FG000|Overall Study|Withdrawal by Subject|9|||
149841231|NCT00519194|540550087|FG000|Overall Study|Death|9|||
149841232|NCT00519194|540550087|FG000|Overall Study|Lost to Follow-up|3|||
149841233|NCT02301975|540550088|FG000|Overall Study|Adverse Event|8|||
149841234|NCT02301975|540550089|FG001|Overall Study|Adverse Event|3|||
149841235|NCT02301975|540550090|FG002|Overall Study|Adverse Event|2|||
149841236|NCT02301975|540550088|FG000|Overall Study|Lack of Efficacy|1|||
149841237|NCT02301975|540550089|FG001|Overall Study|Lack of Efficacy|1|||
149841238|NCT02301975|540550090|FG002|Overall Study|Lack of Efficacy|1|||
149841239|NCT02301975|540550088|FG000|Overall Study|Protocol Violation|3|||
149841240|NCT02301975|540550089|FG001|Overall Study|Protocol Violation|5|||
149841241|NCT02301975|540550090|FG002|Overall Study|Protocol Violation|3|||
149841242|NCT02301975|540550088|FG000|Overall Study|Lost to Follow-up|0|||
149841243|NCT02301975|540550089|FG001|Overall Study|Lost to Follow-up|2|||
149841244|NCT02301975|540550090|FG002|Overall Study|Lost to Follow-up|2|||
149841245|NCT02301975|540550088|FG000|Overall Study|Physician Decision|4|||
149841246|NCT02301975|540550089|FG001|Overall Study|Physician Decision|2|||
149841247|NCT02301975|540550090|FG002|Overall Study|Physician Decision|3|||
149841248|NCT02301975|540550088|FG000|Overall Study|Withdrawal by Subject|15|||
149841249|NCT02301975|540550089|FG001|Overall Study|Withdrawal by Subject|12|||
149841250|NCT02301975|540550090|FG002|Overall Study|Withdrawal by Subject|11|||
149841251|NCT04278560|540550092|FG000|Overall Study|Adverse Event|1|||
149841252|NCT04278560|540550093|FG001|Overall Study|Adverse Event|2|||
149952905|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
149952906|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
149952907|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
149952908|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
149952909|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
149952910|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952911|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952912|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
149952913|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952914|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952915|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952916|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
149952917|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
150285357|NCT01225731|542180584|FG012|Part 2|Lost to Follow-up|0|||
149841253|NCT04278560|540550092|FG000|Overall Study|Withdrawal by Subject|0|||
149841254|NCT04278560|540550093|FG001|Overall Study|Withdrawal by Subject|1|||
149841255|NCT01319383|540550094|FG000|Overall Study|No ex vivo or in vivo response|4|||
149841256|NCT01319383|540550095|FG001|Overall Study|No ex vivo or in vivo response|0|||
149841257|NCT01319383|540550094|FG000|Overall Study|Physician Decision|3|||
149841258|NCT01319383|540550095|FG001|Overall Study|Physician Decision|0|||
149841259|NCT01319383|540550094|FG000|Overall Study|Lack of Efficacy|5|||
149841260|NCT01319383|540550095|FG001|Overall Study|Lack of Efficacy|9|||
149841261|NCT01319383|540550094|FG000|Overall Study|No in vivo response to interval doses|0|||
149841262|NCT01319383|540550095|FG001|Overall Study|No in vivo response to interval doses|1|||
149841263|NCT01531894|540550096|FG000|Overall Study|Physician Decision|8|||
149841264|NCT01531894|540550096|FG000|Overall Study|Death|1|||
149841265|NCT00834340|540550109|FG000|Washout|Adverse Event|1|||
149841266|NCT00834340|540550110|FG001|Washout|Adverse Event|0|||
149841267|NCT00834340|540550109|FG000|Washout|Withdrawal by Subject|1|||
149841268|NCT00834340|540550110|FG001|Washout|Withdrawal by Subject|0|||
149841269|NCT00395694|540550111|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
149841270|NCT00395694|540550112|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
149841271|NCT00395694|540550111|FG000|Continuation Phase|Adverse Event|1|||
149841272|NCT00395694|540550112|FG001|Continuation Phase|Adverse Event|0|||
149841273|NCT00395694|540550111|FG000|Continuation Phase|Lack of Efficacy|12|||
149841274|NCT00395694|540550112|FG001|Continuation Phase|Lack of Efficacy|11|||
149841275|NCT00395694|540550111|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
149841276|NCT00395694|540550112|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
149841277|NCT00395694|540550111|FG000|Continuation Phase|Poor Compliance|1|||
149841278|NCT00395694|540550112|FG001|Continuation Phase|Poor Compliance|0|||
149841279|NCT00395694|540550111|FG000|Continuation Phase|Withdrawal by Subject|0|||
149841280|NCT00395694|540550112|FG001|Continuation Phase|Withdrawal by Subject|2|||
149841281|NCT00392665|540550115|FG000|Overall Study|Death|16|||
149841282|NCT00392665|540550116|FG001|Overall Study|Death|14|||
149841283|NCT00392665|540550115|FG000|Overall Study|Lost to Follow-up|1|||
149841284|NCT00392665|540550116|FG001|Overall Study|Lost to Follow-up|1|||
149841285|NCT03673670|540550120|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
149841286|NCT03673670|540550121|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
150285358|NCT01225731|542180572|FG000|Part 2|Physician Decision|0|||
150285359|NCT01225731|542180573|FG001|Part 2|Physician Decision|0|||
150285360|NCT01225731|542180574|FG002|Part 2|Physician Decision|0|||
150285361|NCT01225731|542180575|FG003|Part 2|Physician Decision|0|||
150285362|NCT01225731|542180576|FG004|Part 2|Physician Decision|0|||
150285363|NCT01225731|542180577|FG005|Part 2|Physician Decision|0|||
150285364|NCT01225731|542180578|FG006|Part 2|Physician Decision|0|||
150285365|NCT01225731|542180579|FG007|Part 2|Physician Decision|2|||
150285366|NCT01225731|542180580|FG008|Part 2|Physician Decision|2|||
150285367|NCT01225731|542180581|FG009|Part 2|Physician Decision|0|||
150285368|NCT01225731|542180582|FG010|Part 2|Physician Decision|0|||
150285369|NCT01225731|542180583|FG011|Part 2|Physician Decision|0|||
150285370|NCT01225731|542180584|FG012|Part 2|Physician Decision|0|||
150285371|NCT01225731|542180572|FG000|Part 2|Withdrawal by Subject|0|||
150285372|NCT01225731|542180573|FG001|Part 2|Withdrawal by Subject|0|||
150285373|NCT01225731|542180574|FG002|Part 2|Withdrawal by Subject|0|||
150285374|NCT01225731|542180575|FG003|Part 2|Withdrawal by Subject|0|||
150285375|NCT01225731|542180576|FG004|Part 2|Withdrawal by Subject|0|||
150285376|NCT01225731|542180577|FG005|Part 2|Withdrawal by Subject|1|||
150285377|NCT01225731|542180578|FG006|Part 2|Withdrawal by Subject|3|||
150285378|NCT01225731|542180579|FG007|Part 2|Withdrawal by Subject|4|||
150285379|NCT01225731|542180580|FG008|Part 2|Withdrawal by Subject|1|||
150285380|NCT01225731|542180581|FG009|Part 2|Withdrawal by Subject|0|||
150285381|NCT01225731|542180582|FG010|Part 2|Withdrawal by Subject|0|||
150285382|NCT01225731|542180583|FG011|Part 2|Withdrawal by Subject|0|||
150285383|NCT01225731|542180584|FG012|Part 2|Withdrawal by Subject|0|||
150285384|NCT01225731|542180572|FG000|Part 3|Adverse Event|0|||
150285385|NCT01225731|542180573|FG001|Part 3|Adverse Event|0|||
150285386|NCT01225731|542180574|FG002|Part 3|Adverse Event|0|||
150285387|NCT01225731|542180575|FG003|Part 3|Adverse Event|0|||
150285388|NCT01225731|542180576|FG004|Part 3|Adverse Event|0|||
150285389|NCT01225731|542180577|FG005|Part 3|Adverse Event|0|||
150285390|NCT01225731|542180578|FG006|Part 3|Adverse Event|0|||
150285391|NCT01225731|542180579|FG007|Part 3|Adverse Event|0|||
150285392|NCT01225731|542180580|FG008|Part 3|Adverse Event|0|||
150285393|NCT01225731|542180581|FG009|Part 3|Adverse Event|0|||
150285394|NCT01225731|542180582|FG010|Part 3|Adverse Event|1|||
150285395|NCT01225731|542180583|FG011|Part 3|Adverse Event|1|||
150285396|NCT01225731|542180584|FG012|Part 3|Adverse Event|0|||
150285397|NCT01225731|542180572|FG000|Part 3|Lost to Follow-up|0|||
150285398|NCT01225731|542180573|FG001|Part 3|Lost to Follow-up|0|||
150285399|NCT01225731|542180574|FG002|Part 3|Lost to Follow-up|0|||
150285400|NCT01225731|542180575|FG003|Part 3|Lost to Follow-up|0|||
150285401|NCT01225731|542180576|FG004|Part 3|Lost to Follow-up|0|||
150285402|NCT01225731|542180577|FG005|Part 3|Lost to Follow-up|0|||
150285403|NCT01225731|542180578|FG006|Part 3|Lost to Follow-up|0|||
149952918|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952919|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952920|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952921|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952922|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952923|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
149952924|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
149952925|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
149952926|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
149952927|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
150172348|NCT00290706|541765952|FG003|Overall Study|Withdrawal by Subject|0|||
150285404|NCT01225731|542180579|FG007|Part 3|Lost to Follow-up|0|||
150285405|NCT01225731|542180580|FG008|Part 3|Lost to Follow-up|0|||
150285406|NCT01225731|542180581|FG009|Part 3|Lost to Follow-up|0|||
150285407|NCT01225731|542180582|FG010|Part 3|Lost to Follow-up|1|||
150285408|NCT01225731|542180583|FG011|Part 3|Lost to Follow-up|2|||
150285409|NCT01225731|542180584|FG012|Part 3|Lost to Follow-up|1|||
150285410|NCT01225731|542180572|FG000|Part 3|Physician Decision|0|||
150285411|NCT01225731|542180573|FG001|Part 3|Physician Decision|0|||
150285412|NCT01225731|542180574|FG002|Part 3|Physician Decision|0|||
150285413|NCT01225731|542180575|FG003|Part 3|Physician Decision|0|||
150285414|NCT01225731|542180576|FG004|Part 3|Physician Decision|0|||
150285415|NCT01225731|542180577|FG005|Part 3|Physician Decision|0|||
150285416|NCT01225731|542180578|FG006|Part 3|Physician Decision|0|||
150285417|NCT01225731|542180579|FG007|Part 3|Physician Decision|0|||
150285418|NCT01225731|542180580|FG008|Part 3|Physician Decision|0|||
150285419|NCT01225731|542180581|FG009|Part 3|Physician Decision|0|||
150285420|NCT01225731|542180582|FG010|Part 3|Physician Decision|0|||
150285421|NCT01225731|542180583|FG011|Part 3|Physician Decision|1|||
150285422|NCT01225731|542180584|FG012|Part 3|Physician Decision|2|||
150285423|NCT01225731|542180572|FG000|Part 3|Withdrawal by Subject|0|||
150285424|NCT01225731|542180573|FG001|Part 3|Withdrawal by Subject|0|||
150285425|NCT01225731|542180574|FG002|Part 3|Withdrawal by Subject|0|||
150285426|NCT01225731|542180575|FG003|Part 3|Withdrawal by Subject|0|||
150285427|NCT01225731|542180576|FG004|Part 3|Withdrawal by Subject|0|||
150285428|NCT01225731|542180577|FG005|Part 3|Withdrawal by Subject|0|||
150285429|NCT01225731|542180578|FG006|Part 3|Withdrawal by Subject|0|||
150285430|NCT01225731|542180579|FG007|Part 3|Withdrawal by Subject|0|||
149841287|NCT03673670|540550122|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
149841288|NCT03673670|540550123|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
149841289|NCT03673670|540550124|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
149841290|NCT03673670|540550125|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
150035316|NCT04218240|541268944|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
150035317|NCT04852302|541268953|FG000|Overall Study|Withdrawal by Subject|2|||
150035318|NCT04852302|541268953|FG000|Overall Study|Did not complete CALM therapy.|2|||
150035319|NCT02163538|541268955|FG000|Overall Study|Protocol Violation|1|||
150035320|NCT02163538|541268956|FG001|Overall Study|Protocol Violation|0|||
150035321|NCT02163538|541268955|FG000|Overall Study|Physician Decision|0|||
150035322|NCT02163538|541268956|FG001|Overall Study|Physician Decision|1|||
150035323|NCT03094416|541268961|FG000|Run-in|Screening failure|8|||
150035324|NCT03094416|541268961|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
150035325|NCT03094416|541268961|FG000|Run-in|Withdrawal by Subject|3|||
150035326|NCT03094416|541268961|FG000|Treatment Period|Withdrawal by Subject|2|||
150035327|NCT02158442|541268964|FG000|Overall Study|Withdrawal by Subject|1|||
150035328|NCT02158442|541268965|FG001|Overall Study|Withdrawal by Subject|0|||
150035329|NCT02158442|541268964|FG000|Overall Study|Perfusion staff not available|1|||
150035330|NCT02158442|541268965|FG001|Overall Study|Perfusion staff not available|0|||
150035331|NCT05386329|541268966|FG000|Overall Study|Lost to Follow-up|3|||
150035332|NCT03600909|541268967|FG000|Overall Study|Not treated|0|||
150035333|NCT03600909|541268968|FG001|Overall Study|Not treated|3|||
150035334|NCT03600909|541268969|FG002|Overall Study|Not treated|0|||
150035335|NCT02651675|541268970|FG000|Overall Study|Death|0|||
150035336|NCT02651675|541268971|FG001|Overall Study|Death|0|||
150035337|NCT02651675|541268972|FG002|Overall Study|Death|1|||
150035338|NCT05712460|541268974|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035339|NCT05712460|541268975|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035340|NCT05712460|541268976|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035341|NCT05712460|541268977|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035342|NCT05712460|541268978|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035343|NCT05712460|541268979|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035344|NCT05712460|541268980|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035345|NCT05712460|541268981|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
150035346|NCT05712460|541268982|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035347|NCT05712460|541268983|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035348|NCT05712460|541268984|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035349|NCT05712460|541268985|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
150035350|NCT05135767|541268986|FG000|Baseline|Lost to Follow-up|1|||
150035351|NCT05135767|541268987|FG001|Baseline|Lost to Follow-up|1|||
150035352|NCT05135767|541268986|FG000|Baseline|Withdrawal by Subject|0|||
150035353|NCT05135767|541268987|FG001|Baseline|Withdrawal by Subject|2|||
150035354|NCT05135767|541268986|FG000|Active Study Phase|Lost to Follow-up|2|||
150035355|NCT05135767|541268987|FG001|Active Study Phase|Lost to Follow-up|0|||
150035356|NCT04363320|541268988|FG000|Overall Study|Lost to Follow-up|43|||
150035357|NCT04363320|541268989|FG001|Overall Study|Lost to Follow-up|42|||
150035358|NCT04363320|541268990|FG002|Overall Study|Lost to Follow-up|24|||
150035359|NCT04363320|541268991|FG003|Overall Study|Lost to Follow-up|29|||
150035360|NCT04363320|541268988|FG000|Overall Study|Death|0|||
150035361|NCT04363320|541268989|FG001|Overall Study|Death|0|||
150035362|NCT04363320|541268990|FG002|Overall Study|Death|1|||
150172349|NCT00290706|541765949|FG000|Overall Study|Progressive Disease|3|||
150172350|NCT00290706|541765950|FG001|Overall Study|Progressive Disease|5|||
150172351|NCT00290706|541765951|FG002|Overall Study|Progressive Disease|4|||
150172352|NCT00290706|541765952|FG003|Overall Study|Progressive Disease|10|||
150172353|NCT00290706|541765949|FG000|Overall Study|Adverse Event|0|||
150172354|NCT00290706|541765950|FG001|Overall Study|Adverse Event|1|||
150285431|NCT01225731|542180580|FG008|Part 3|Withdrawal by Subject|0|||
150285432|NCT01225731|542180581|FG009|Part 3|Withdrawal by Subject|0|||
150285433|NCT01225731|542180582|FG010|Part 3|Withdrawal by Subject|4|||
150285434|NCT01225731|542180583|FG011|Part 3|Withdrawal by Subject|6|||
149841291|NCT03673670|540550120|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
149841292|NCT03673670|540550121|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
149841293|NCT03673670|540550122|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
149841294|NCT03673670|540550123|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
150035363|NCT04363320|541268991|FG003|Overall Study|Death|0|||
150035364|NCT02260934|541268992|FG000|Overall Study|Lost to Follow-up|2|||
150035365|NCT02260934|541268993|FG001|Overall Study|Lost to Follow-up|1|||
150035366|NCT02260934|541268992|FG000|Overall Study|Withdrawal by Subject|0|||
150035367|NCT02260934|541268993|FG001|Overall Study|Withdrawal by Subject|2|||
150035368|NCT02260934|541268992|FG000|Overall Study|Participant Relocated|1|||
150035369|NCT02260934|541268993|FG001|Overall Study|Participant Relocated|0|||
150035370|NCT02260934|541268992|FG000|Overall Study|Site error|0|||
150035371|NCT02260934|541268993|FG001|Overall Study|Site error|1|||
150035372|NCT05194124|541269000|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150285435|NCT01225731|542180584|FG012|Part 3|Withdrawal by Subject|4|||
150285436|NCT03873714|542180595|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
150285437|NCT01970501|542180596|FG000|Overall Study|Discontinuation of study by sponsor|16|||
150285438|NCT01970501|542180597|FG001|Overall Study|Discontinuation of study by sponsor|14|||
150285439|NCT01970501|542180596|FG000|Overall Study|Withdrawal by Subject|6|||
150285440|NCT01970501|542180597|FG001|Overall Study|Withdrawal by Subject|7|||
150285441|NCT01970501|542180596|FG000|Overall Study|Adverse Event|2|||
150285442|NCT01970501|542180597|FG001|Overall Study|Adverse Event|4|||
150285443|NCT01970501|542180596|FG000|Overall Study|Death|1|||
150285444|NCT01970501|542180597|FG001|Overall Study|Death|3|||
150285445|NCT01970501|542180596|FG000|Overall Study|Physician Decision|2|||
150285446|NCT01970501|542180597|FG001|Overall Study|Physician Decision|0|||
150285447|NCT04486950|542180600|FG000|Overall Study|Lost to Follow-up|0|||
150285448|NCT04486950|542180601|FG001|Overall Study|Lost to Follow-up|0|||
150285449|NCT04486950|542180602|FG002|Overall Study|Lost to Follow-up|0|||
150285450|NCT04486950|542180603|FG003|Overall Study|Lost to Follow-up|0|||
150285451|NCT04486950|542180604|FG004|Overall Study|Lost to Follow-up|0|||
150285452|NCT04486950|542180605|FG005|Overall Study|Lost to Follow-up|1|||
150285453|NCT04486950|542180606|FG006|Overall Study|Lost to Follow-up|0|||
150285454|NCT00950664|542180607|FG000|First Intervention|Lost to Follow-up|1|||
150285455|NCT00950664|542180608|FG001|First Intervention|Lost to Follow-up|3|||
150035373|NCT05194124|541269001|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150285456|NCT00950664|542180607|FG000|First Intervention|Withdrawal by Subject|2|||
150285457|NCT00950664|542180608|FG001|First Intervention|Withdrawal by Subject|2|||
150285458|NCT01326546|542180611|FG000|Overall Study|Lost to Follow-up|8|||
150285459|NCT01326546|542180612|FG001|Overall Study|Lost to Follow-up|7|||
150285460|NCT01326546|542180611|FG000|Overall Study|Protocol Violation|3|||
150285461|NCT01326546|542180612|FG001|Overall Study|Protocol Violation|4|||
150285462|NCT01326546|542180611|FG000|Overall Study|Pregnancy|0|||
150285463|NCT01326546|542180612|FG001|Overall Study|Pregnancy|1|||
150285464|NCT01326546|542180611|FG000|Overall Study|Adverse Event|1|||
150285465|NCT01326546|542180612|FG001|Overall Study|Adverse Event|0|||
150285466|NCT01326546|542180611|FG000|Overall Study|Withdrawal by Subject|5|||
150285467|NCT01326546|542180612|FG001|Overall Study|Withdrawal by Subject|1|||
150285468|NCT03152019|542180613|FG000|Overall Study|Adverse Event|0|||
150285469|NCT03152019|542180614|FG001|Overall Study|Adverse Event|1|||
150285470|NCT00081159|542180618|FG000|Overall Study|Withdrawal by Subject|0|||
150285471|NCT00081159|542180619|FG001|Overall Study|Withdrawal by Subject|3|||
150285472|NCT00081159|542180618|FG000|Overall Study|Myelosuppression prior to treatment|0|||
150285473|NCT00081159|542180619|FG001|Overall Study|Myelosuppression prior to treatment|1|||
150285474|NCT00081159|542180618|FG000|Overall Study|Lost to Follow-up|2|||
150285475|NCT00081159|542180619|FG001|Overall Study|Lost to Follow-up|1|||
150285476|NCT00923130|542180622|FG000|Overall Study|Stopped treatment due to progression|17|||
150285477|NCT00923130|542180622|FG000|Overall Study|Death|1|||
150285478|NCT00923130|542180622|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
150285479|NCT00923130|542180622|FG000|Overall Study|Switched to alternative treatment|2|||
150285480|NCT00923130|542180622|FG000|Overall Study|Refused further treatment|2|||
150285481|NCT03693625|542180623|FG000|Overall Study|Adverse Event|2|||
150285482|NCT03693625|542180624|FG001|Overall Study|Adverse Event|0|||
150285483|NCT03693625|542180623|FG000|Overall Study|Study Terminated By Sponsor|20|||
150285484|NCT03693625|542180624|FG001|Overall Study|Study Terminated By Sponsor|7|||
150285485|NCT03693625|542180623|FG000|Overall Study|Withdrawal by Subject|1|||
150285486|NCT03693625|542180624|FG001|Overall Study|Withdrawal by Subject|1|||
150285487|NCT01464307|542180626|FG000|Main Period|Death|0|||
150285488|NCT01464307|542180627|FG001|Main Period|Death|1|||
150285489|NCT01464307|542180626|FG000|Main Period|Adverse Event|6|||
150285490|NCT01464307|542180627|FG001|Main Period|Adverse Event|1|||
150285491|NCT01464307|542180626|FG000|Main Period|Lack of Efficacy|2|||
149841295|NCT03673670|540550124|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
150172355|NCT00290706|541765951|FG002|Overall Study|Adverse Event|2|||
150285492|NCT01464307|542180627|FG001|Main Period|Lack of Efficacy|0|||
150285493|NCT01464307|542180626|FG000|Main Period|Withdrawal by Subject|5|||
150285494|NCT01464307|542180627|FG001|Main Period|Withdrawal by Subject|2|||
150285495|NCT01464307|542180626|FG000|Main Period|Predefined discontinuation criteria|2|||
150285496|NCT01464307|542180627|FG001|Main Period|Predefined discontinuation criteria|1|||
150285497|NCT01464307|542180626|FG000|Open-Label Extension Period|Adverse Event|15|||
150285498|NCT01464307|542180627|FG001|Open-Label Extension Period|Adverse Event|0|||
150285499|NCT01464307|542180626|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
150285500|NCT01464307|542180627|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
150285501|NCT01464307|542180626|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
150285502|NCT01464307|542180627|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
150285503|NCT01464307|542180626|FG000|Open-Label Extension Period|Death|1|||
150285504|NCT01464307|542180627|FG001|Open-Label Extension Period|Death|0|||
150285505|NCT01464307|542180626|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
150285506|NCT01464307|542180627|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
150285507|NCT01464307|542180626|FG000|Open-Label Extension Period|Non-compliance|9|||
150285508|NCT01464307|542180627|FG001|Open-Label Extension Period|Non-compliance|0|||
150285509|NCT01464307|542180626|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
150285510|NCT01464307|542180627|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
150285511|NCT02457637|542180632|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
150285512|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Death|3|||
150285513|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Death|0|||
150285514|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Adverse Event|12|||
150285515|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Adverse Event|6|||
150285516|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
150285517|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
150285518|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
150285519|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
150285520|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
150285521|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
150285522|NCT00159861|542180633|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
150285523|NCT00159861|542180634|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
150285524|NCT00159861|542180633|FG000|Extension Study - up to 3 Years|Death|24|||
150285525|NCT00159861|542180634|FG001|Extension Study - up to 3 Years|Death|28|||
150285526|NCT00159861|542180633|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
150285527|NCT00159861|542180634|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
150285528|NCT00159861|542180633|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
150285529|NCT00159861|542180634|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
150285530|NCT00159861|542180633|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
150285531|NCT00159861|542180634|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
150285532|NCT00159861|542180633|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
150285533|NCT00159861|542180634|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
149841296|NCT03673670|540550125|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
149841297|NCT03673670|540550120|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
149841298|NCT03673670|540550121|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
149841299|NCT03673670|540550122|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
149841300|NCT03673670|540550123|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
149841301|NCT03673670|540550124|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
149841302|NCT03673670|540550125|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
149841303|NCT03673670|540550120|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
149841304|NCT03673670|540550121|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
149841305|NCT03673670|540550122|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
149952928|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
149952929|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
149952930|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
149952931|NCT01807520|540960162|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
149952932|NCT01807520|540960163|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
150035374|NCT05194124|541269002|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035375|NCT05194124|541269003|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
150035376|NCT05194124|541269004|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035377|NCT05194124|541269005|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
150035378|NCT05194124|541269006|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035379|NCT05194124|541269007|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035380|NCT05194124|541269008|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035381|NCT05194124|541269009|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
150035382|NCT05194124|541269000|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035383|NCT05194124|541269001|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035384|NCT05194124|541269002|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035385|NCT05194124|541269003|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035386|NCT05194124|541269004|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035387|NCT05194124|541269005|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035388|NCT05194124|541269006|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035389|NCT05194124|541269007|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035390|NCT05194124|541269008|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
150035391|NCT05194124|541269009|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
150035392|NCT03642873|541269010|FG000|Third Intervention (1 Day)|Screen failure|0|||
150035393|NCT03642873|541269011|FG001|Third Intervention (1 Day)|Screen failure|0|||
150035394|NCT03642873|541269012|FG002|Third Intervention (1 Day)|Screen failure|0|||
150035395|NCT03642873|541269013|FG003|Third Intervention (1 Day)|Screen failure|0|||
150035396|NCT03642873|541269014|FG004|Third Intervention (1 Day)|Screen failure|1|||
150172356|NCT00290706|541765952|FG003|Overall Study|Adverse Event|0|||
150285534|NCT04311502|542182533|FG000|Overall Study|Death|1|||
149841306|NCT03673670|540550123|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
149841307|NCT03673670|540550124|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
149841308|NCT03673670|540550125|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
149841309|NCT03673670|540550120|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
149841310|NCT03673670|540550121|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
149841311|NCT03673670|540550122|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
149841312|NCT03673670|540550123|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
149841313|NCT03673670|540550124|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
149841314|NCT03673670|540550125|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
149841315|NCT03673670|540550120|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
149841316|NCT03673670|540550121|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
149841317|NCT03673670|540550122|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
149952933|NCT01807520|540960164|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
149952934|NCT01807520|540960165|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
149952935|NCT01807520|540960166|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
149952936|NCT01807520|540960167|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
149952937|NCT01807520|540960168|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
149952938|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
149952939|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
149952940|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
149952941|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
149952942|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
149952943|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
149952944|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
149952945|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
150172357|NCT00290706|541765949|FG000|Overall Study|Receive auto transplant or radiation|0|||
150172358|NCT00290706|541765950|FG001|Overall Study|Receive auto transplant or radiation|0|||
150172359|NCT00290706|541765951|FG002|Overall Study|Receive auto transplant or radiation|0|||
150172360|NCT00290706|541765952|FG003|Overall Study|Receive auto transplant or radiation|1|||
150172361|NCT00290706|541765949|FG000|Overall Study|Physician Decision|0|||
150172362|NCT00290706|541765950|FG001|Overall Study|Physician Decision|0|||
150285535|NCT04311502|542182534|FG001|Overall Study|Death|1|||
149841318|NCT03673670|540550123|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
149841319|NCT03673670|540550124|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
149952946|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
149952947|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
150035397|NCT03642873|541269015|FG005|Third Intervention (1 Day)|Screen failure|0|||
150035398|NCT02532517|541269020|FG000|Overall Study|Did not complete 24-Month visit|4|||
150172363|NCT00290706|541765951|FG002|Overall Study|Physician Decision|0|||
150172364|NCT00290706|541765952|FG003|Overall Study|Physician Decision|1|||
150172365|NCT01196429|541765954|FG000|Overall Study|Ineligible - inadequate pathology|1|||
150172366|NCT01196429|541765955|FG001|Overall Study|Ineligible - inadequate pathology|0|||
150172367|NCT01196429|541765954|FG000|Overall Study|Ineligible - wrong cell type|1|||
150172368|NCT01196429|541765955|FG001|Overall Study|Ineligible - wrong cell type|0|||
150172369|NCT01196429|541765954|FG000|Overall Study|Refused - Never Treated|1|||
150172370|NCT01196429|541765955|FG001|Overall Study|Refused - Never Treated|0|||
150172371|NCT03768206|541765956|FG000|Overall Study|Lost to Follow-up|2|||
150172372|NCT03768206|541765957|FG001|Overall Study|Lost to Follow-up|1|||
150172373|NCT03768206|541765956|FG000|Overall Study|Withdrawal by Subject|0|||
150172374|NCT03768206|541765957|FG001|Overall Study|Withdrawal by Subject|1|||
150172375|NCT05328297|541767924|FG000|Overall Study|Adverse Event|5|||
150172376|NCT05328297|541767925|FG001|Overall Study|Adverse Event|7|||
150172377|NCT05328297|541767924|FG000|Overall Study|Withdrawal by Subject|4|||
150172378|NCT05328297|541767925|FG001|Overall Study|Withdrawal by Subject|3|||
150172379|NCT05328297|541767924|FG000|Overall Study|Lack of Efficacy|1|||
150172380|NCT05328297|541767925|FG001|Overall Study|Lack of Efficacy|0|||
150172381|NCT05328297|541767924|FG000|Overall Study|Lost to Follow-up|1|||
149841320|NCT03673670|540550125|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
149841321|NCT03673670|540550120|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
149841322|NCT03673670|540550121|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
149952948|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
149952949|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
149952950|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
149952951|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
149952952|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
149952953|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952954|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952955|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952956|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952957|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952958|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
149952959|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952960|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
149952961|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952962|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952963|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952964|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952965|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
149952966|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
149952967|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
149952968|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
149952969|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
149952970|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
149952971|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
149952972|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
149952973|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
149952974|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
149952975|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
149952976|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
149952977|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
150172382|NCT05328297|541767925|FG001|Overall Study|Lost to Follow-up|0|||
150172383|NCT05328297|541767924|FG000|Overall Study|Protocol Violation|1|||
149841323|NCT03673670|540550122|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
149841324|NCT03673670|540550123|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
149841325|NCT03673670|540550124|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
149841326|NCT03673670|540550125|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
149841327|NCT04408794|540550126|FG000|Overall Study|Adverse Event|43|||
149841328|NCT04408794|540550126|FG000|Overall Study|Infrequent study drug usage|43|||
149841329|NCT04408794|540550126|FG000|Overall Study|Lack of Efficacy|61|||
149841330|NCT04408794|540550126|FG000|Overall Study|Lost to Follow-up|33|||
149841331|NCT04408794|540550126|FG000|Overall Study|Non-compliance|6|||
149841332|NCT04408794|540550126|FG000|Overall Study|Physician Decision|1|||
149841333|NCT04408794|540550126|FG000|Overall Study|Pregnancy|6|||
149841334|NCT04408794|540550126|FG000|Overall Study|Protocol Deviation|9|||
150172384|NCT05328297|541767925|FG001|Overall Study|Protocol Violation|0|||
150172385|NCT05328297|541767924|FG000|Overall Study|Randomized but not treated|1|||
150172386|NCT05328297|541767925|FG001|Overall Study|Randomized but not treated|1|||
150172387|NCT04513522|541767926|FG000|Overall Study|Other reasons|1|||
149841335|NCT04408794|540550126|FG000|Overall Study|Sheehan-STS Result|1|||
150285536|NCT04311502|542182535|FG002|Overall Study|Death|1|||
150285537|NCT04311502|542182533|FG000|Overall Study|Lost to Follow-up|2|||
150285538|NCT04311502|542182534|FG001|Overall Study|Lost to Follow-up|3|||
150285539|NCT04311502|542182535|FG002|Overall Study|Lost to Follow-up|0|||
150285540|NCT04311502|542182533|FG000|Overall Study|Participant is in prison|1|||
150285541|NCT04311502|542182534|FG001|Overall Study|Participant is in prison|0|||
150285542|NCT04311502|542182535|FG002|Overall Study|Participant is in prison|0|||
150285543|NCT04311502|542182533|FG000|Overall Study|Participant moved out of country|1|||
150285544|NCT04311502|542182534|FG001|Overall Study|Participant moved out of country|0|||
150285545|NCT04311502|542182535|FG002|Overall Study|Participant moved out of country|0|||
150285546|NCT04311502|542182533|FG000|Overall Study|Withdrawal by Subject|2|||
150285547|NCT04311502|542182534|FG001|Overall Study|Withdrawal by Subject|0|||
150285548|NCT04311502|542182535|FG002|Overall Study|Withdrawal by Subject|0|||
150285549|NCT04311502|542182533|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
150285550|NCT04311502|542182534|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
150285551|NCT04311502|542182535|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
150285552|NCT01661140|542182546|FG000|Open-Label Period|Adverse Event|44|||
150285553|NCT01661140|542182547|FG001|Open-Label Period|Adverse Event|0|||
150285554|NCT01661140|542182548|FG002|Open-Label Period|Adverse Event|0|||
149841336|NCT04408794|540550126|FG000|Overall Study|Withdrawal by Subject|57|||
149841337|NCT04408794|540550126|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
149841338|NCT04408794|540550126|FG000|Overall Study|Never Treated Migraine|5|||
149841339|NCT03437265|540550129|FG000|Overall Study|Protocol Violation|6|||
149841340|NCT02294786|540550132|FG000|Overall Study|Withdrawal by Subject|0|||
150285555|NCT01661140|542182546|FG000|Open-Label Period|Protocol Violation|3|||
150285556|NCT01661140|542182547|FG001|Open-Label Period|Protocol Violation|0|||
150285557|NCT01661140|542182548|FG002|Open-Label Period|Protocol Violation|0|||
150285558|NCT01661140|542182546|FG000|Open-Label Period|Withdrawal by Subject|5|||
150285559|NCT01661140|542182547|FG001|Open-Label Period|Withdrawal by Subject|0|||
150285560|NCT01661140|542182548|FG002|Open-Label Period|Withdrawal by Subject|0|||
150285561|NCT01661140|542182546|FG000|Open-Label Period|Investigator Decision|3|||
150285562|NCT01661140|542182547|FG001|Open-Label Period|Investigator Decision|0|||
150285563|NCT01661140|542182548|FG002|Open-Label Period|Investigator Decision|0|||
150285564|NCT01661140|542182546|FG000|Open-Label Period|Death|1|||
150285565|NCT01661140|542182547|FG001|Open-Label Period|Death|0|||
150285566|NCT01661140|542182548|FG002|Open-Label Period|Death|0|||
150285567|NCT01661140|542182546|FG000|Open-Label Period|Administrative/Other|1|||
150285568|NCT01661140|542182547|FG001|Open-Label Period|Administrative/Other|0|||
150285569|NCT01661140|542182548|FG002|Open-Label Period|Administrative/Other|0|||
150285570|NCT01661140|542182546|FG000|Open-Label Period|Sponsor termination|16|||
150285571|NCT01661140|542182547|FG001|Open-Label Period|Sponsor termination|0|||
150285572|NCT01661140|542182548|FG002|Open-Label Period|Sponsor termination|0|||
150285573|NCT01661140|542182546|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
150285574|NCT01661140|542182547|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
150285575|NCT01661140|542182548|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
150285576|NCT01661140|542182546|FG000|Open-Label Period|Lost to Follow-up|2|||
150285577|NCT01661140|542182547|FG001|Open-Label Period|Lost to Follow-up|0|||
150285578|NCT01661140|542182548|FG002|Open-Label Period|Lost to Follow-up|0|||
150285579|NCT01661140|542182546|FG000|Double-Blind Period|Refused Treatment|0|||
150285580|NCT01661140|542182547|FG001|Double-Blind Period|Refused Treatment|0|||
150285581|NCT01661140|542182548|FG002|Double-Blind Period|Refused Treatment|1|||
150285582|NCT01661140|542182546|FG000|Double-Blind Period|Adverse Event|0|||
150285583|NCT01661140|542182547|FG001|Double-Blind Period|Adverse Event|16|||
150285584|NCT01661140|542182548|FG002|Double-Blind Period|Adverse Event|18|||
150285585|NCT01661140|542182546|FG000|Double-Blind Period|Protocol Violation|0|||
150285586|NCT01661140|542182547|FG001|Double-Blind Period|Protocol Violation|2|||
150285587|NCT01661140|542182548|FG002|Double-Blind Period|Protocol Violation|3|||
150285588|NCT01661140|542182546|FG000|Double-Blind Period|Withdrawal by Subject|0|||
150285589|NCT01661140|542182547|FG001|Double-Blind Period|Withdrawal by Subject|1|||
150285590|NCT01661140|542182548|FG002|Double-Blind Period|Withdrawal by Subject|3|||
150285591|NCT01661140|542182546|FG000|Double-Blind Period|Investigator's Decision|0|||
149841341|NCT02294786|540550133|FG001|Overall Study|Withdrawal by Subject|1|||
149841342|NCT02294786|540550132|FG000|Overall Study|Physician Decision|6|||
150285592|NCT01661140|542182547|FG001|Double-Blind Period|Investigator's Decision|1|||
150285593|NCT01661140|542182548|FG002|Double-Blind Period|Investigator's Decision|2|||
149841343|NCT02294786|540550133|FG001|Overall Study|Physician Decision|7|||
149841344|NCT02294786|540550132|FG000|Overall Study|Lost to Follow-up|1|||
149841345|NCT02294786|540550133|FG001|Overall Study|Lost to Follow-up|2|||
150035399|NCT02532517|541269020|FG000|Overall Study|Failed Angiographic eligibility|1|||
149841346|NCT02294786|540550132|FG000|Overall Study|Protocol Violation|1|||
150035400|NCT02532517|541269020|FG000|Overall Study|Lost to Follow-up|4|||
150285594|NCT01661140|542182546|FG000|Double-Blind Period|Sponsor Termination|0|||
150285595|NCT01661140|542182547|FG001|Double-Blind Period|Sponsor Termination|14|||
150285596|NCT01661140|542182548|FG002|Double-Blind Period|Sponsor Termination|17|||
150285597|NCT01661140|542182546|FG000|Double-Blind Period|Administrative/Other|0|||
149841347|NCT02294786|540550133|FG001|Overall Study|Protocol Violation|0|||
149841348|NCT02294786|540550132|FG000|Overall Study|Adverse Event|1|||
149841349|NCT02294786|540550133|FG001|Overall Study|Adverse Event|1|||
149841350|NCT02294786|540550132|FG000|Overall Study|Death|2|||
149952978|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
149952979|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
149952980|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
149952981|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
149952982|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
149952983|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
149952984|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
149952985|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
149952986|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
149952987|NCT01807520|540960162|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
149952988|NCT01807520|540960163|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
149952989|NCT01807520|540960164|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
149952990|NCT01807520|540960165|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
149952991|NCT01807520|540960166|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
149952992|NCT01807520|540960167|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
149952993|NCT01807520|540960168|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
149952994|NCT01807520|540960162|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149952995|NCT01807520|540960163|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149952996|NCT01807520|540960164|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149952997|NCT01807520|540960165|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149952998|NCT01807520|540960166|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149952999|NCT01807520|540960167|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
149953000|NCT01807520|540960168|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
149953001|NCT01807520|540960162|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953002|NCT01807520|540960163|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953003|NCT01807520|540960164|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953004|NCT01807520|540960165|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953005|NCT01807520|540960166|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953006|NCT01807520|540960167|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
149953007|NCT01807520|540960168|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
149953008|NCT01807520|540960162|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
149953009|NCT01807520|540960163|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
149953010|NCT01807520|540960164|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
149953011|NCT01807520|540960165|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
149953012|NCT01807520|540960166|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
149953013|NCT01807520|540960167|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
149953014|NCT01807520|540960168|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
149841351|NCT02294786|540550133|FG001|Overall Study|Death|3|||
149841352|NCT01778010|540550134|FG000|Overall Study|Withdrawal by Subject|2|||
149841353|NCT01778010|540550134|FG000|Overall Study|abnormal ECG before meds|1|||
149841354|NCT01778010|540550134|FG000|Overall Study|Arrested|1|||
149841355|NCT01778010|540550134|FG000|Overall Study|rash while on placebo|1|||
149841356|NCT01244620|540550148|FG000|Overall Study|Study terminated|4|||
149841357|NCT01244620|540550149|FG001|Overall Study|Study terminated|4|||
149841358|NCT01244620|540550150|FG002|Overall Study|Study terminated|4|||
149841359|NCT01244620|540550151|FG003|Overall Study|Study terminated|4|||
149841360|NCT00840073|540550152|FG000|Second Intervention|Missed 72 hour blood draw|1|||
149841361|NCT00840073|540550153|FG001|Second Intervention|Missed 72 hour blood draw|1|||
149841362|NCT02321098|540550154|FG000|12 Weeks Treament|Lost to Follow-up|1|||
149841363|NCT02321098|540550155|FG001|12 Weeks Treament|Lost to Follow-up|1|||
149841364|NCT02321098|540550156|FG002|12 Weeks Treament|Lost to Follow-up|0|||
149841365|NCT02321098|540550154|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
149841366|NCT02321098|540550155|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
149841367|NCT02321098|540550156|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
149841368|NCT02321098|540550154|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
149841369|NCT02321098|540550155|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
149841370|NCT02321098|540550156|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
149841371|NCT02321098|540550154|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
149841372|NCT02321098|540550155|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
149841373|NCT02321098|540550156|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
149841374|NCT01663233|540550157|FG000|Overall Study|Withdrawal by Subject|3|||
149841375|NCT01663233|540550158|FG001|Overall Study|Withdrawal by Subject|2|||
149841376|NCT01663233|540550157|FG000|Overall Study|Protocol Deviation|1|||
149841377|NCT01663233|540550158|FG001|Overall Study|Protocol Deviation|4|||
149841378|NCT01663233|540550157|FG000|Overall Study|Lost to Follow-up|0|||
149841379|NCT01663233|540550158|FG001|Overall Study|Lost to Follow-up|1|||
149841380|NCT01788423|540550159|FG000|Overall Study|See Comments in Completed (above)|0|||
150035401|NCT02532517|541269020|FG000|Overall Study|Withdrawal by Subject|4|||
150035402|NCT02532517|541269020|FG000|Overall Study|Death|4|||
150035403|NCT03312231|541269021|FG000|Overall Study|Lost to Follow-up|2|||
150035404|NCT03312231|541269022|FG001|Overall Study|Lost to Follow-up|6|||
150035405|NCT03312231|541269023|FG002|Overall Study|Lost to Follow-up|1|||
150035406|NCT03312231|541269024|FG003|Overall Study|Lost to Follow-up|3|||
150035407|NCT03312231|541269025|FG004|Overall Study|Lost to Follow-up|1|||
150035408|NCT03312231|541269021|FG000|Overall Study|Withdrawal by Subject|0|||
150035409|NCT03312231|541269022|FG001|Overall Study|Withdrawal by Subject|3|||
150035410|NCT03312231|541269023|FG002|Overall Study|Withdrawal by Subject|1|||
150035411|NCT03312231|541269024|FG003|Overall Study|Withdrawal by Subject|0|||
150035412|NCT03312231|541269025|FG004|Overall Study|Withdrawal by Subject|0|||
150035413|NCT03312231|541269021|FG000|Overall Study|Death|0|||
150035414|NCT03312231|541269022|FG001|Overall Study|Death|1|||
150035415|NCT03312231|541269023|FG002|Overall Study|Death|1|||
150035416|NCT03312231|541269024|FG003|Overall Study|Death|0|||
150035417|NCT03312231|541269025|FG004|Overall Study|Death|0|||
150035418|NCT03312231|541269021|FG000|Overall Study|Study Vaccination not Received|1|||
150035419|NCT03312231|541269022|FG001|Overall Study|Study Vaccination not Received|1|||
150035420|NCT03312231|541269023|FG002|Overall Study|Study Vaccination not Received|1|||
150035421|NCT03312231|541269024|FG003|Overall Study|Study Vaccination not Received|0|||
150035422|NCT03312231|541269025|FG004|Overall Study|Study Vaccination not Received|0|||
150035423|NCT03157830|541269030|FG000|Overall Study|Lost to Follow-up|1|||
150035424|NCT03157830|541269030|FG000|Overall Study|Withdrawal by Subject|1|||
150035425|NCT03694353|541269031|FG000|Overall Study|Withdrawal by Subject|1|||
150035426|NCT03694353|541269031|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
150035427|NCT05138653|541269034|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
150035428|NCT05138653|541269035|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035429|NCT05138653|541269036|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035430|NCT05138653|541269037|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035431|NCT05138653|541269038|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035432|NCT05138653|541269039|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035433|NCT05138653|541269040|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035434|NCT05138653|541269041|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035435|NCT05138653|541269042|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035436|NCT05138653|541269043|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035437|NCT05138653|541269044|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035438|NCT05138653|541269045|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035439|NCT05138653|541269046|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035440|NCT05138653|541269047|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035441|NCT05138653|541269048|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035442|NCT05138653|541269049|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
150035443|NCT05138653|541269034|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035444|NCT05138653|541269035|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
150035445|NCT05138653|541269036|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035446|NCT05138653|541269037|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035447|NCT05138653|541269038|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035448|NCT05138653|541269039|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035449|NCT05138653|541269040|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035450|NCT05138653|541269041|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035451|NCT05138653|541269042|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
150035452|NCT05138653|541269043|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035453|NCT05138653|541269044|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035454|NCT05138653|541269045|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035455|NCT05138653|541269046|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035456|NCT05138653|541269047|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035457|NCT05138653|541269048|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035458|NCT05138653|541269049|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
150035459|NCT05138653|541269034|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035460|NCT05138653|541269035|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
150035461|NCT05138653|541269036|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035462|NCT05138653|541269037|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150285598|NCT01661140|542182547|FG001|Double-Blind Period|Administrative/Other|7|||
150285599|NCT01661140|542182548|FG002|Double-Blind Period|Administrative/Other|6|||
150035463|NCT05138653|541269038|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
150035464|NCT05138653|541269039|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035465|NCT05138653|541269040|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150285600|NCT00513409|542182549|FG000|Overall Study|Adverse Event|0|||
150285601|NCT00513409|542182550|FG001|Overall Study|Adverse Event|1|||
149841381|NCT01788423|540550160|FG001|Overall Study|See Comments in Completed (above)|4|||
149841382|NCT01788423|540550161|FG002|Overall Study|See Comments in Completed (above)|5|||
149841383|NCT01913405|540550162|FG000|Overall Study|Withdrawal by Subject|1|||
149841384|NCT01913405|540550162|FG000|Overall Study|Adverse Event|1|||
149841385|NCT03261167|540550165|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
149841386|NCT03261167|540550166|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
149841387|NCT03261167|540550165|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
149841388|NCT03261167|540550166|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
149841389|NCT03261167|540550165|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
149841390|NCT03261167|540550166|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
149841391|NCT03261167|540550165|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
149841392|NCT03261167|540550166|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
149841393|NCT03261167|540550165|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
149841394|NCT03261167|540550166|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
149841395|NCT00705666|540550171|FG000|Overall Study|No post-treatment questionnaire|279|||
149841396|NCT00705666|540550171|FG000|Overall Study|Withdrawal by Subject|21|||
149841397|NCT00705666|540550171|FG000|Overall Study|Physician Decision|7|||
149841398|NCT00705666|540550171|FG000|Overall Study|Lost to Follow-up|5|||
149841399|NCT00705666|540550171|FG000|Overall Study|Death|1|||
149841400|NCT00705666|540550171|FG000|Overall Study|Adverse Event|4|||
149841401|NCT00705666|540550171|FG000|Overall Study|Other|12|||
149841402|NCT00705666|540550171|FG000|Overall Study|Other|2|||
149841403|NCT00705666|540550171|FG000|Overall Study|Lack of data|3|||
149841404|NCT00705666|540550171|FG000|Overall Study|Untreated|5|||
149841405|NCT02105272|540550179|FG000|Overall Study|Adverse Event|1|||
149953015|NCT01847209|540960174|FG000|Overall Study|Withdrawal by Subject|1|||
149953016|NCT01847209|540960174|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
150172388|NCT04513522|541767926|FG000|Overall Study|Adverse event unrelated to study drug|9|||
149841406|NCT02105272|540550180|FG001|Overall Study|Adverse Event|2|||
149953017|NCT03298061|540960175|FG000|Overall Study|Adverse Event|3|||
149953018|NCT03298061|540960175|FG000|Overall Study|Lack of Efficacy|6|||
150172389|NCT04513522|541767926|FG000|Overall Study|Study drug toxicity|14|||
150172390|NCT04513522|541767926|FG000|Overall Study|Disease progression|39|||
150172391|NCT04513522|541767926|FG000|Overall Study|Participants withdrew consent|2|||
149841407|NCT02105272|540550179|FG000|Overall Study|Physician Decision|0|||
149841408|NCT02105272|540550180|FG001|Overall Study|Physician Decision|1|||
149841409|NCT02105272|540550179|FG000|Overall Study|Protocol Violation|2|||
150172392|NCT03351075|541767929|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
150172393|NCT03351075|541767930|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
150172394|NCT03351075|541767929|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
150172395|NCT03351075|541767930|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
150172396|NCT03351075|541767929|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
150172397|NCT03351075|541767930|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
150172398|NCT03351075|541767929|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
150172399|NCT03351075|541767930|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
150172400|NCT05219253|541767940|FG000|Overall Study|Withdrawal by Subject|1|||
150172401|NCT05219253|541767941|FG001|Overall Study|Withdrawal by Subject|2|||
150172402|NCT03086369|541767942|FG000|Overall Study|Lost to Follow-up|1|||
150172403|NCT03086369|541767943|FG001|Overall Study|Lost to Follow-up|0|||
150172404|NCT03086369|541767944|FG002|Overall Study|Lost to Follow-up|0|||
150172405|NCT03086369|541767945|FG003|Overall Study|Lost to Follow-up|2|||
150172406|NCT03086369|541767946|FG004|Overall Study|Lost to Follow-up|1|||
150172407|NCT03086369|541767942|FG000|Overall Study|Physician Decision|0|||
150172408|NCT03086369|541767943|FG001|Overall Study|Physician Decision|0|||
150172409|NCT03086369|541767944|FG002|Overall Study|Physician Decision|0|||
150172410|NCT03086369|541767945|FG003|Overall Study|Physician Decision|1|||
150172411|NCT03086369|541767946|FG004|Overall Study|Physician Decision|2|||
150172412|NCT03086369|541767942|FG000|Overall Study|Withdrawal by Subject|0|||
150172413|NCT03086369|541767943|FG001|Overall Study|Withdrawal by Subject|0|||
150172414|NCT03086369|541767944|FG002|Overall Study|Withdrawal by Subject|0|||
150172415|NCT03086369|541767945|FG003|Overall Study|Withdrawal by Subject|5|||
150172416|NCT03086369|541767946|FG004|Overall Study|Withdrawal by Subject|3|||
150172417|NCT03086369|541767942|FG000|Overall Study|Progressive Disease|0|||
150172418|NCT03086369|541767943|FG001|Overall Study|Progressive Disease|0|||
150172419|NCT03086369|541767944|FG002|Overall Study|Progressive Disease|0|||
150172420|NCT03086369|541767945|FG003|Overall Study|Progressive Disease|1|||
150172421|NCT03086369|541767946|FG004|Overall Study|Progressive Disease|1|||
150172422|NCT03175172|541767947|FG000|Overall Study|Death|3|||
150172423|NCT03175172|541767947|FG000|Overall Study|Withdrawal by Subject|3|||
150172424|NCT03175172|541767947|FG000|Overall Study|Lost to Follow-up|1|||
150172425|NCT03175172|541767947|FG000|Overall Study|Study Terminated by Sponsor|3|||
150172426|NCT02974634|541767948|FG000|Overall Study|Advanced disease|12|||
150172427|NCT02974634|541767949|FG001|Overall Study|Advanced disease|3|||
149953019|NCT03298061|540960175|FG000|Overall Study|Protocol Violation|1|||
149953020|NCT03298061|540960175|FG000|Overall Study|Physician Decision|7|||
149953021|NCT03298061|540960175|FG000|Overall Study|Withdrawal by Subject|10|||
149953022|NCT04307394|540960178|FG000|Overall Study|Lost to Follow-up|3|||
149953023|NCT04307394|540960178|FG000|Overall Study|Withdrawal by Subject|2|||
149953024|NCT02536794|540960183|FG000|Reached 1st Response Assessment|Adverse Event|2|||
149953025|NCT02536794|540960183|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
149953026|NCT02536794|540960183|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
149953027|NCT02536794|540960183|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
149953028|NCT02536794|540960183|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
149953029|NCT02536794|540960183|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
149953030|NCT00416949|540960184|FG000|Overall Study|Patients refused to participate|5|||
149953031|NCT01471574|540960187|FG000|Treatment Period|Lack of Efficacy|12|||
149953032|NCT01471574|540960188|FG001|Treatment Period|Lack of Efficacy|4|||
149953033|NCT01471574|540960189|FG002|Treatment Period|Lack of Efficacy|14|||
149953034|NCT01471574|540960190|FG003|Treatment Period|Lack of Efficacy|1|||
149953035|NCT01471574|540960187|FG000|Treatment Period|Adverse Event|7|||
149953036|NCT01471574|540960188|FG001|Treatment Period|Adverse Event|3|||
149953037|NCT01471574|540960189|FG002|Treatment Period|Adverse Event|6|||
149953038|NCT01471574|540960190|FG003|Treatment Period|Adverse Event|1|||
149953039|NCT01471574|540960187|FG000|Treatment Period|Withdrawal by Subject|5|||
149953040|NCT01471574|540960188|FG001|Treatment Period|Withdrawal by Subject|1|||
149953041|NCT01471574|540960189|FG002|Treatment Period|Withdrawal by Subject|1|||
149953042|NCT01471574|540960190|FG003|Treatment Period|Withdrawal by Subject|0|||
149953043|NCT01471574|540960187|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
149953044|NCT01471574|540960188|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
149953045|NCT01471574|540960189|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
149953046|NCT01471574|540960190|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
149953047|NCT01471574|540960187|FG000|Treatment Period|Lost to Follow-up|1|||
149953048|NCT01471574|540960188|FG001|Treatment Period|Lost to Follow-up|2|||
149953049|NCT01471574|540960189|FG002|Treatment Period|Lost to Follow-up|2|||
150172428|NCT02974634|541767948|FG000|Overall Study|Noncompliance|3|||
150172429|NCT02974634|541767949|FG001|Overall Study|Noncompliance|7|||
150172430|NCT02974634|541767948|FG000|Overall Study|intervention technology related issues|5|||
150172431|NCT02974634|541767949|FG001|Overall Study|intervention technology related issues|0|||
150172432|NCT02974634|541767948|FG000|Overall Study|Death|8|||
150172433|NCT02974634|541767949|FG001|Overall Study|Death|11|||
150172434|NCT04668339|541767952|FG000|Overall Study|Physician Decision|1|||
150172435|NCT04668339|541767953|FG001|Overall Study|Physician Decision|0|||
150172436|NCT04668339|541767954|FG002|Overall Study|Physician Decision|1|||
150172437|NCT04668339|541767955|FG003|Overall Study|Physician Decision|1|||
150172438|NCT04668339|541767952|FG000|Overall Study|Lost to Follow-up|14|||
150172439|NCT04668339|541767953|FG001|Overall Study|Lost to Follow-up|12|||
150172440|NCT04668339|541767954|FG002|Overall Study|Lost to Follow-up|8|||
150172441|NCT04668339|541767955|FG003|Overall Study|Lost to Follow-up|5|||
150172442|NCT04668339|541767952|FG000|Overall Study|Adverse Event|0|||
150172443|NCT04668339|541767953|FG001|Overall Study|Adverse Event|0|||
150172444|NCT04668339|541767954|FG002|Overall Study|Adverse Event|1|||
150172445|NCT04668339|541767955|FG003|Overall Study|Adverse Event|0|||
150172446|NCT04668339|541767952|FG000|Overall Study|Other than specified|3|||
150172447|NCT04668339|541767953|FG001|Overall Study|Other than specified|0|||
150172448|NCT04668339|541767954|FG002|Overall Study|Other than specified|1|||
150172449|NCT04668339|541767955|FG003|Overall Study|Other than specified|0|||
150172450|NCT04668339|541767952|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
150172451|NCT04668339|541767953|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
150172452|NCT04668339|541767954|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
150172453|NCT04668339|541767955|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
150172454|NCT04668339|541767952|FG000|Overall Study|Vaccine not Administered|0|||
150172455|NCT04668339|541767953|FG001|Overall Study|Vaccine not Administered|0|||
150172456|NCT04668339|541767954|FG002|Overall Study|Vaccine not Administered|1|||
150172457|NCT04668339|541767955|FG003|Overall Study|Vaccine not Administered|0|||
150172458|NCT04668339|541767952|FG000|Overall Study|Protocol Violation|18|||
150172459|NCT04668339|541767953|FG001|Overall Study|Protocol Violation|23|||
150172460|NCT04668339|541767954|FG002|Overall Study|Protocol Violation|12|||
150172461|NCT04668339|541767955|FG003|Overall Study|Protocol Violation|20|||
150172462|NCT04668339|541767952|FG000|Overall Study|Withdrawal by Subject|45|||
150172463|NCT04668339|541767953|FG001|Overall Study|Withdrawal by Subject|46|||
150172464|NCT04668339|541767954|FG002|Overall Study|Withdrawal by Subject|46|||
150172465|NCT04668339|541767955|FG003|Overall Study|Withdrawal by Subject|27|||
150172466|NCT04668339|541767952|FG000|Overall Study|Study Terminated by Sponsor|59|||
150172467|NCT04668339|541767953|FG001|Overall Study|Study Terminated by Sponsor|59|||
150172468|NCT04668339|541767954|FG002|Overall Study|Study Terminated by Sponsor|71|||
150172469|NCT04668339|541767955|FG003|Overall Study|Study Terminated by Sponsor|1|||
150285602|NCT00513409|542182549|FG000|Overall Study|Withdrawal by Subject|0|||
150285603|NCT00513409|542182550|FG001|Overall Study|Withdrawal by Subject|2|||
150285604|NCT00513409|542182549|FG000|Overall Study|Lost to Follow-up|0|||
150285605|NCT00513409|542182550|FG001|Overall Study|Lost to Follow-up|1|||
150285606|NCT00513409|542182549|FG000|Overall Study|Physician Decision|1|||
150285607|NCT00513409|542182550|FG001|Overall Study|Physician Decision|0|||
150285608|NCT00513409|542182549|FG000|Overall Study|Visit 3 not done|1|||
150285609|NCT00513409|542182550|FG001|Overall Study|Visit 3 not done|2|||
150285610|NCT01049035|542182551|FG000|Overall Study|Serious adverse event|0|||
150285611|NCT01049035|542182552|FG001|Overall Study|Serious adverse event|1|||
150285612|NCT01049035|542182553|FG002|Overall Study|Serious adverse event|1|||
150285613|NCT01049035|542182554|FG003|Overall Study|Serious adverse event|2|||
150285614|NCT01049035|542182555|FG004|Overall Study|Serious adverse event|0|||
150285615|NCT01049035|542182556|FG005|Overall Study|Serious adverse event|0|||
150285616|NCT01049035|542182557|FG006|Overall Study|Serious adverse event|0|||
150285617|NCT01049035|542182551|FG000|Overall Study|Other adverse event (AE)|0|||
150285618|NCT01049035|542182552|FG001|Overall Study|Other adverse event (AE)|0|||
150285619|NCT01049035|542182553|FG002|Overall Study|Other adverse event (AE)|0|||
150285620|NCT01049035|542182554|FG003|Overall Study|Other adverse event (AE)|1|||
150285621|NCT01049035|542182555|FG004|Overall Study|Other adverse event (AE)|0|||
150285622|NCT01049035|542182556|FG005|Overall Study|Other adverse event (AE)|0|||
150285623|NCT01049035|542182557|FG006|Overall Study|Other adverse event (AE)|0|||
150285624|NCT01049035|542182551|FG000|Overall Study|Non-compliance with the protocol|12|||
150285625|NCT01049035|542182552|FG001|Overall Study|Non-compliance with the protocol|6|||
150285626|NCT01049035|542182553|FG002|Overall Study|Non-compliance with the protocol|14|||
150285627|NCT01049035|542182554|FG003|Overall Study|Non-compliance with the protocol|5|||
150285628|NCT01049035|542182555|FG004|Overall Study|Non-compliance with the protocol|3|||
150285629|NCT01049035|542182556|FG005|Overall Study|Non-compliance with the protocol|4|||
150285630|NCT01049035|542182557|FG006|Overall Study|Non-compliance with the protocol|10|||
150285631|NCT01049035|542182551|FG000|Overall Study|Lost to Follow-up|5|||
150285632|NCT01049035|542182552|FG001|Overall Study|Lost to Follow-up|4|||
150285633|NCT01049035|542182553|FG002|Overall Study|Lost to Follow-up|4|||
150285634|NCT01049035|542182554|FG003|Overall Study|Lost to Follow-up|1|||
150285635|NCT01049035|542182555|FG004|Overall Study|Lost to Follow-up|0|||
150285636|NCT01049035|542182556|FG005|Overall Study|Lost to Follow-up|3|||
150285637|NCT01049035|542182557|FG006|Overall Study|Lost to Follow-up|3|||
150285638|NCT01049035|542182551|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
150285639|NCT01049035|542182552|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
150285640|NCT01049035|542182553|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
150285641|NCT01049035|542182554|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
150285642|NCT01049035|542182555|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
150285643|NCT01049035|542182556|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
150285644|NCT01049035|542182557|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
150285645|NCT02239939|542182558|FG000|Overall Study|Adverse Event|1|||
150285646|NCT02239939|542182559|FG001|Overall Study|Adverse Event|0|||
150285647|NCT02239939|542182558|FG000|Overall Study|Withdrawal by Subject|1|||
150285648|NCT02239939|542182559|FG001|Overall Study|Withdrawal by Subject|1|||
150285649|NCT02239939|542182558|FG000|Overall Study|Lost to Follow-up|0|||
149841410|NCT02105272|540550180|FG001|Overall Study|Protocol Violation|0|||
149841411|NCT02105272|540550179|FG000|Overall Study|Withdrawal by Subject|2|||
149841412|NCT02105272|540550180|FG001|Overall Study|Withdrawal by Subject|0|||
149841413|NCT02964039|540550185|FG000|Overall Study|Medical reason unrelated to study participation|1|||
150285650|NCT02239939|542182559|FG001|Overall Study|Lost to Follow-up|1|||
149841414|NCT02964039|540550186|FG001|Overall Study|Medical reason unrelated to study participation|0|||
149953050|NCT01471574|540960190|FG003|Treatment Period|Lost to Follow-up|0|||
149953051|NCT01471574|540960187|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
149953052|NCT01471574|540960188|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
149953053|NCT01471574|540960189|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
149953054|NCT01471574|540960190|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
149953055|NCT01471574|540960187|FG000|Treatment Period|Other|1|||
150285651|NCT00812214|542182563|FG000|Overall Study|Lost to Follow-up|3|||
150285652|NCT00812214|542182564|FG001|Overall Study|Lost to Follow-up|1|||
149841415|NCT02964039|540550187|FG002|Overall Study|Medical reason unrelated to study participation|3|||
149841416|NCT02964039|540550185|FG000|Overall Study|Research shutdown due to pandemic|2|||
150285653|NCT01514682|542182565|FG000|Overall Study|Withdrawal by Subject|2|||
150285654|NCT01514682|542182566|FG001|Overall Study|Withdrawal by Subject|3|||
150285655|NCT01514682|542182565|FG000|Overall Study|Physician Decision|4|||
150285656|NCT01514682|542182566|FG001|Overall Study|Physician Decision|3|||
150285657|NCT00132132|542182567|FG000|Overall Study|Lost to Follow-up|7|||
150285658|NCT00132132|542182568|FG001|Overall Study|Lost to Follow-up|2|||
150285659|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
150285660|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
149841417|NCT02964039|540550186|FG001|Overall Study|Research shutdown due to pandemic|0|||
149953056|NCT01471574|540960188|FG001|Treatment Period|Other|0|||
149841418|NCT02964039|540550187|FG002|Overall Study|Research shutdown due to pandemic|1|||
149841419|NCT02964039|540550185|FG000|Overall Study|Withdrawal by Subject|0|||
149841420|NCT02964039|540550186|FG001|Overall Study|Withdrawal by Subject|1|||
149841421|NCT02964039|540550187|FG002|Overall Study|Withdrawal by Subject|0|||
149841422|NCT02964039|540550185|FG000|Overall Study|Lost to Follow-up|1|||
149841423|NCT02964039|540550186|FG001|Overall Study|Lost to Follow-up|0|||
149841424|NCT02964039|540550187|FG002|Overall Study|Lost to Follow-up|1|||
149841425|NCT05479058|540550188|FG000|Overall Study|Withdrawal by Subject|1|||
149841426|NCT05479058|540550189|FG001|Overall Study|Withdrawal by Subject|1|||
149841427|NCT05479058|540550188|FG000|Overall Study|Study terminated by sponsor|10|||
149841428|NCT05479058|540550189|FG001|Overall Study|Study terminated by sponsor|10|||
149841429|NCT05630885|540550190|FG000|Study Completion|Took prohibited medications|2|||
149841430|NCT05630885|540550191|FG001|Study Completion|Took prohibited medications|0|||
149841431|NCT05630885|540550190|FG000|Study Completion|Non-compliance with study drug|1|||
149841432|NCT05630885|540550191|FG001|Study Completion|Non-compliance with study drug|0|||
149841433|NCT05630885|540550190|FG000|Study Completion|Adverse Event|1|||
149841434|NCT05630885|540550191|FG001|Study Completion|Adverse Event|0|||
149841435|NCT05630885|540550190|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
149841436|NCT05630885|540550191|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
149841437|NCT05630885|540550190|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
149841438|NCT05630885|540550191|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
149841439|NCT01878292|540550192|FG000|Randomized|Protocol Violation|1|||
149841440|NCT01878292|540550193|FG001|Randomized|Protocol Violation|0|||
149841441|NCT01878292|540550194|FG002|Randomized|Protocol Violation|0|||
149841442|NCT01878292|540550192|FG000|Randomized|Lost to Follow-up|1|||
149841443|NCT01878292|540550193|FG001|Randomized|Lost to Follow-up|0|||
149841444|NCT01878292|540550194|FG002|Randomized|Lost to Follow-up|0|||
149841445|NCT01878292|540550192|FG000|Randomized|Adverse Event|1|||
149841446|NCT01878292|540550193|FG001|Randomized|Adverse Event|0|||
149841447|NCT01878292|540550194|FG002|Randomized|Adverse Event|0|||
149841448|NCT01878292|540550192|FG000|Double-blind Treatment Period|Other Reasons|2|||
149841449|NCT01878292|540550193|FG001|Double-blind Treatment Period|Other Reasons|0|||
149841450|NCT01878292|540550194|FG002|Double-blind Treatment Period|Other Reasons|0|||
149841451|NCT01878292|540550192|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
149841452|NCT01878292|540550193|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
149841453|NCT01878292|540550194|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
149841454|NCT01878292|540550192|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
149841455|NCT01878292|540550193|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
149841456|NCT01878292|540550194|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
149841457|NCT01878292|540550192|FG000|Double-blind Treatment Period|Protocol Violation|3|||
149841458|NCT01878292|540550193|FG001|Double-blind Treatment Period|Protocol Violation|4|||
149841459|NCT01878292|540550194|FG002|Double-blind Treatment Period|Protocol Violation|2|||
149841460|NCT01878292|540550192|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
149841461|NCT01878292|540550193|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
149841462|NCT01878292|540550194|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
149841463|NCT01878292|540550192|FG000|Double-blind Treatment Period|Adverse Event|4|||
149841464|NCT01878292|540550193|FG001|Double-blind Treatment Period|Adverse Event|9|||
149841465|NCT01878292|540550194|FG002|Double-blind Treatment Period|Adverse Event|8|||
149841466|NCT01878292|540550192|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
149841467|NCT01878292|540550193|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
149841468|NCT01878292|540550194|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
149841469|NCT00950989|540550195|FG000|Overall Study|Death|0|||
149841470|NCT00950989|540550196|FG001|Overall Study|Death|0|||
149841471|NCT00950989|540550197|FG002|Overall Study|Death|1|||
149841472|NCT00950989|540550198|FG003|Overall Study|Death|0|||
149953057|NCT01471574|540960189|FG002|Treatment Period|Other|0|||
149953058|NCT01471574|540960190|FG003|Treatment Period|Other|0|||
149953059|NCT01471574|540960187|FG000|Follow-up Period|Withdrawal by Subject|3|||
149953060|NCT01471574|540960188|FG001|Follow-up Period|Withdrawal by Subject|0|||
149953061|NCT01471574|540960189|FG002|Follow-up Period|Withdrawal by Subject|3|||
149953062|NCT01471574|540960190|FG003|Follow-up Period|Withdrawal by Subject|1|||
149953063|NCT01471574|540960187|FG000|Follow-up Period|Lost to Follow-up|4|||
149953064|NCT01471574|540960188|FG001|Follow-up Period|Lost to Follow-up|1|||
150172470|NCT00178399|541767956|FG000|Overall Study|Physician Decision|4|||
149841473|NCT00950989|540550195|FG000|Overall Study|Administrative Decision|0|||
149841474|NCT00950989|540550196|FG001|Overall Study|Administrative Decision|1|||
149841475|NCT00950989|540550197|FG002|Overall Study|Administrative Decision|0|||
149841476|NCT00950989|540550198|FG003|Overall Study|Administrative Decision|0|||
149953065|NCT01471574|540960189|FG002|Follow-up Period|Lost to Follow-up|3|||
149953066|NCT01471574|540960190|FG003|Follow-up Period|Lost to Follow-up|2|||
149953067|NCT01471574|540960187|FG000|Follow-up Period|Death|0|||
149841477|NCT00950989|540550195|FG000|Overall Study|Disease Progression|0|||
149841478|NCT00950989|540550196|FG001|Overall Study|Disease Progression|0|||
149841479|NCT00950989|540550197|FG002|Overall Study|Disease Progression|1|||
149841480|NCT00950989|540550198|FG003|Overall Study|Disease Progression|0|||
149841481|NCT00950989|540550195|FG000|Overall Study|Withdrawal by Subject|2|||
149841482|NCT00950989|540550196|FG001|Overall Study|Withdrawal by Subject|1|||
149841483|NCT00950989|540550197|FG002|Overall Study|Withdrawal by Subject|0|||
149841484|NCT00950989|540550198|FG003|Overall Study|Withdrawal by Subject|0|||
149841485|NCT00950989|540550195|FG000|Overall Study|Adverse Event|2|||
149841486|NCT00950989|540550196|FG001|Overall Study|Adverse Event|1|||
149841487|NCT00950989|540550197|FG002|Overall Study|Adverse Event|1|||
149841488|NCT00950989|540550198|FG003|Overall Study|Adverse Event|0|||
149841489|NCT01686477|540550199|FG000|Feeding Intervention|Death|1|||
149841490|NCT01686477|540550200|FG001|Feeding Intervention|Death|0|||
149841491|NCT01686477|540550201|FG002|Feeding Intervention|Death|1|||
149841492|NCT01686477|540550199|FG000|Feeding Intervention|Withdrawal by Subject|0|||
149841493|NCT01686477|540550200|FG001|Feeding Intervention|Withdrawal by Subject|6|||
149841494|NCT01686477|540550201|FG002|Feeding Intervention|Withdrawal by Subject|0|||
149841495|NCT01686477|540550199|FG000|Feeding Intervention|Physician Decision|1|||
149841496|NCT01686477|540550200|FG001|Feeding Intervention|Physician Decision|2|||
149841497|NCT01686477|540550201|FG002|Feeding Intervention|Physician Decision|0|||
149841498|NCT01686477|540550199|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
149841499|NCT01686477|540550200|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
149841500|NCT01686477|540550201|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
149841501|NCT01686477|540550199|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
149841502|NCT01686477|540550200|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
149841503|NCT01686477|540550201|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
149841504|NCT01686477|540550199|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
149841505|NCT01686477|540550200|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
149841506|NCT01686477|540550201|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
149841507|NCT01686477|540550199|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
149841508|NCT01686477|540550200|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
149841509|NCT01686477|540550201|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
149841510|NCT01686477|540550199|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
149841511|NCT01686477|540550200|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
149841512|NCT01686477|540550201|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
149841513|NCT01686477|540550199|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
149841514|NCT01686477|540550200|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
149841515|NCT01686477|540550201|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
149841516|NCT01686477|540550199|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
149841517|NCT01686477|540550200|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
149841518|NCT01686477|540550201|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
149841519|NCT00813592|540550203|FG000|Overall Study|Disease assessment was not completed per|2|||
149841520|NCT03873272|540550206|FG000|Overall Study|Withdrawal by Subject|2|||
149841521|NCT03873272|540550207|FG001|Overall Study|Withdrawal by Subject|0|||
149841522|NCT03873272|540550208|FG002|Overall Study|Withdrawal by Subject|1|||
149841523|NCT03873272|540550206|FG000|Overall Study|Death|0|||
149841524|NCT03873272|540550207|FG001|Overall Study|Death|2|||
149841525|NCT03873272|540550208|FG002|Overall Study|Death|1|||
149841526|NCT04493684|540550209|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
149841527|NCT04493684|540550210|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841528|NCT04493684|540550211|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
149841529|NCT04493684|540550212|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841530|NCT04493684|540550213|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841531|NCT04493684|540550214|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
149841532|NCT04493684|540550215|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149953068|NCT01471574|540960188|FG001|Follow-up Period|Death|0|||
149953069|NCT01471574|540960189|FG002|Follow-up Period|Death|1|||
149953070|NCT01471574|540960190|FG003|Follow-up Period|Death|0|||
149953071|NCT01471574|540960187|FG000|Follow-up Period|Follow-up no longer required|0|||
149953072|NCT01471574|540960188|FG001|Follow-up Period|Follow-up no longer required|1|||
149953073|NCT01471574|540960189|FG002|Follow-up Period|Follow-up no longer required|0|||
149953074|NCT01471574|540960190|FG003|Follow-up Period|Follow-up no longer required|0|||
149953075|NCT01177410|540960191|FG000|Overall Study|Adverse Event|0|||
150172471|NCT00178399|541767956|FG000|Overall Study|Withdrawal by Subject|8|||
149841533|NCT04493684|540550216|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841534|NCT04493684|540550217|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841535|NCT04493684|540550218|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841536|NCT04493684|540550219|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149953076|NCT01177410|540960192|FG001|Overall Study|Adverse Event|2|||
149953077|NCT01177410|540960193|FG002|Overall Study|Adverse Event|2|||
149953078|NCT01177410|540960191|FG000|Overall Study|Withdrawal by Subject|1|||
149953079|NCT01177410|540960192|FG001|Overall Study|Withdrawal by Subject|4|||
149841537|NCT04493684|540550220|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841538|NCT04493684|540550221|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841539|NCT04493684|540550222|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841540|NCT04493684|540550223|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841541|NCT04493684|540550224|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841542|NCT04493684|540550225|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
149841543|NCT04493684|540550209|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
149841544|NCT04493684|540550210|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841545|NCT04493684|540550211|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841546|NCT04493684|540550212|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841547|NCT04493684|540550213|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841548|NCT04493684|540550214|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841549|NCT04493684|540550215|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149953080|NCT01177410|540960193|FG002|Overall Study|Withdrawal by Subject|3|||
149953081|NCT01177410|540960191|FG000|Overall Study|Lost to Follow-up|0|||
149953082|NCT01177410|540960192|FG001|Overall Study|Lost to Follow-up|1|||
149953083|NCT01177410|540960193|FG002|Overall Study|Lost to Follow-up|0|||
149953084|NCT05427916|540960194|FG000|Overall Study|Adverse Event|3|||
149953085|NCT05427916|540960195|FG001|Overall Study|Adverse Event|0|||
149953086|NCT05427916|540960194|FG000|Overall Study|Lack of Efficacy|6|||
149953087|NCT05427916|540960195|FG001|Overall Study|Lack of Efficacy|0|||
149953088|NCT05427916|540960194|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
149953089|NCT05427916|540960195|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
149953090|NCT00800540|540960196|FG000|Period One: 6 Weeks|Noncompliance|1|||
149953091|NCT00800540|540960197|FG001|Period One: 6 Weeks|Noncompliance|0|||
149953092|NCT00800540|540960196|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
149953093|NCT00800540|540960197|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
149953094|NCT00800540|540960196|FG000|Period 2: 6 Weeks|Adverse Event|0|||
149953095|NCT00800540|540960197|FG001|Period 2: 6 Weeks|Adverse Event|1|||
149953096|NCT03927157|540960199|FG000|Overall Study|Adverse Event|1|||
149953097|NCT03927157|540960200|FG001|Overall Study|Adverse Event|3|||
149953098|NCT03927157|540960199|FG000|Overall Study|Protocol Violation|1|||
149953099|NCT03927157|540960200|FG001|Overall Study|Protocol Violation|2|||
149953100|NCT03927157|540960199|FG000|Overall Study|Withdrawal by Subject|8|||
149953101|NCT03927157|540960200|FG001|Overall Study|Withdrawal by Subject|21|||
149953102|NCT03927157|540960199|FG000|Overall Study|Due to COVID-19 pandemic|5|||
149953103|NCT03927157|540960200|FG001|Overall Study|Due to COVID-19 pandemic|2|||
149953104|NCT03927157|540960199|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
149953105|NCT03927157|540960200|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
149953106|NCT03927157|540960199|FG000|Overall Study|Other than above|0|||
149953107|NCT03927157|540960200|FG001|Overall Study|Other than above|1|||
149953108|NCT00726557|540960201|FG000|Overall Study|Screening failure|4|||
149953109|NCT00726557|540960201|FG000|Overall Study|No end of treatment documentation|37|||
149953110|NCT00726557|540960201|FG000|Overall Study|No follow-up documentation available|55|||
149953111|NCT00726557|540960201|FG000|Overall Study|Treatment less than 3 months|17|||
149953112|NCT00726557|540960201|FG000|Overall Study|Inclusion criteria not met|15|||
149953113|NCT05950906|540960203|FG000|Overall Study|Adverse Event|0|||
149953114|NCT05950906|540960204|FG001|Overall Study|Adverse Event|0|||
149953115|NCT05950906|540960205|FG002|Overall Study|Adverse Event|0|||
149953116|NCT05950906|540960206|FG003|Overall Study|Adverse Event|0|||
149953117|NCT05950906|540960207|FG004|Overall Study|Adverse Event|0|||
149953118|NCT05950906|540960208|FG005|Overall Study|Adverse Event|0|||
149953119|NCT05950906|540960209|FG006|Overall Study|Adverse Event|0|||
149953120|NCT05950906|540960210|FG007|Overall Study|Adverse Event|0|||
149953121|NCT05950906|540960211|FG008|Overall Study|Adverse Event|0|||
149953122|NCT05950906|540960212|FG009|Overall Study|Adverse Event|0|||
149953123|NCT05950906|540960213|FG010|Overall Study|Adverse Event|0|||
149953124|NCT05950906|540960214|FG011|Overall Study|Adverse Event|0|||
150285661|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
150285662|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
150285663|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
150285664|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
150285665|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
150285666|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
150285667|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
149841550|NCT04493684|540550216|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149953125|NCT05950906|540960215|FG012|Overall Study|Adverse Event|1|||
149953126|NCT05950906|540960216|FG013|Overall Study|Adverse Event|0|||
149953127|NCT05950906|540960203|FG000|Overall Study|Physician Decision|0|||
149953128|NCT05950906|540960204|FG001|Overall Study|Physician Decision|0|||
149953129|NCT05950906|540960205|FG002|Overall Study|Physician Decision|0|||
149953130|NCT05950906|540960206|FG003|Overall Study|Physician Decision|0|||
149953131|NCT05950906|540960207|FG004|Overall Study|Physician Decision|0|||
150285668|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
150285669|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
150285670|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
150285671|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
150285672|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
150285673|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
150285674|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
150285675|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
150285676|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
150285677|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
150285678|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
150285679|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
150285680|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
150285681|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
150285682|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
150285683|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
150285684|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
150285685|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
150285686|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
150285687|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
150285688|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
150285689|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
150285690|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
150285691|NCT03605680|542182570|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
150285692|NCT03605680|542182571|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
150285693|NCT03605680|542182572|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
150285694|NCT03605680|542182573|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
150285695|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
150285696|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
150285697|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
150285698|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
150285699|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
150285700|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
150285701|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
150285702|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
150285703|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
150285704|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
150285705|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149841551|NCT04493684|540550217|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841552|NCT04493684|540550218|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841553|NCT04493684|540550219|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841554|NCT04493684|540550220|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841555|NCT04493684|540550221|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841556|NCT04493684|540550222|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841557|NCT04493684|540550223|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841558|NCT04493684|540550224|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
149841559|NCT04493684|540550225|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
150285706|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
150285707|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
150285708|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
150285709|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
150285710|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
150285711|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
150285712|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
150285713|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
150285714|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
150285715|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
150285716|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
150285717|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
150285718|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
149953132|NCT05950906|540960208|FG005|Overall Study|Physician Decision|0|||
149953133|NCT05950906|540960209|FG006|Overall Study|Physician Decision|0|||
150285719|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
150285720|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
150285721|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
150285722|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
150285723|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
150285724|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
150285725|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
150285726|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
150285727|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
150285728|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
150285729|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
150285730|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
150285731|NCT03605680|542182570|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
150285732|NCT03605680|542182571|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
150285733|NCT03605680|542182572|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
150285734|NCT03605680|542182573|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
150285735|NCT03189446|542182574|FG000|Overall Study|Adverse Event|2|||
149841560|NCT04493684|540550209|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841561|NCT04493684|540550210|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841562|NCT04493684|540550211|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841563|NCT04493684|540550212|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841564|NCT04493684|540550213|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841565|NCT04493684|540550214|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841566|NCT04493684|540550215|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
149841567|NCT04493684|540550216|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841568|NCT04493684|540550217|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841569|NCT04493684|540550218|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841570|NCT04493684|540550219|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841571|NCT04493684|540550220|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841572|NCT04493684|540550221|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841573|NCT04493684|540550222|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841574|NCT04493684|540550223|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841575|NCT04493684|540550224|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841576|NCT04493684|540550225|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
149841577|NCT04493684|540550209|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
149841578|NCT04493684|540550210|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841579|NCT04493684|540550211|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841580|NCT04493684|540550212|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149953134|NCT05950906|540960210|FG007|Overall Study|Physician Decision|0|||
149953135|NCT05950906|540960211|FG008|Overall Study|Physician Decision|0|||
149953136|NCT05950906|540960212|FG009|Overall Study|Physician Decision|0|||
149953137|NCT05950906|540960213|FG010|Overall Study|Physician Decision|0|||
149953138|NCT05950906|540960214|FG011|Overall Study|Physician Decision|0|||
149953139|NCT05950906|540960215|FG012|Overall Study|Physician Decision|1|||
149953140|NCT05950906|540960216|FG013|Overall Study|Physician Decision|0|||
149953141|NCT02541903|540960217|FG000|Overall Study|Death|1|||
149953142|NCT00021255|540960218|FG000|Overall Study|Death|1|||
149953143|NCT00021255|540960219|FG001|Overall Study|Death|0|||
149953144|NCT00021255|540960220|FG002|Overall Study|Death|2|||
149953145|NCT00021255|540960218|FG000|Overall Study|Breast cancer relapse|5|||
149953146|NCT00021255|540960219|FG001|Overall Study|Breast cancer relapse|18|||
149953147|NCT00021255|540960220|FG002|Overall Study|Breast cancer relapse|11|||
149953148|NCT00021255|540960218|FG000|Overall Study|Second primary malignancy|0|||
149953149|NCT00021255|540960219|FG001|Overall Study|Second primary malignancy|4|||
149953150|NCT00021255|540960220|FG002|Overall Study|Second primary malignancy|1|||
149953151|NCT00021255|540960218|FG000|Overall Study|Withdrawal by Subject|41|||
149953152|NCT00021255|540960219|FG001|Overall Study|Withdrawal by Subject|64|||
149953153|NCT00021255|540960220|FG002|Overall Study|Withdrawal by Subject|26|||
149953154|NCT00021255|540960218|FG000|Overall Study|Lost to Follow-up|0|||
149953155|NCT00021255|540960219|FG001|Overall Study|Lost to Follow-up|2|||
149953156|NCT00021255|540960220|FG002|Overall Study|Lost to Follow-up|3|||
150172472|NCT00178399|541767956|FG000|Overall Study|Lost to Follow-up|1|||
149841581|NCT04493684|540550213|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149953157|NCT00021255|540960218|FG000|Overall Study|Cardiac toxicity|0|||
149953158|NCT00021255|540960219|FG001|Overall Study|Cardiac toxicity|61|||
149953159|NCT00021255|540960220|FG002|Overall Study|Cardiac toxicity|32|||
149953160|NCT00021255|540960218|FG000|Overall Study|Herceptin toxicity|0|||
149953161|NCT00021255|540960219|FG001|Overall Study|Herceptin toxicity|22|||
149953162|NCT00021255|540960220|FG002|Overall Study|Herceptin toxicity|6|||
150285736|NCT03189446|542182574|FG000|Overall Study|Withdrawal by Subject|2|||
150285737|NCT03189446|542182574|FG000|Overall Study|Physician Decision|1|||
150285738|NCT00647556|542182575|FG000|Overall Study|Adverse Event|0|||
150285739|NCT00647556|542182576|FG001|Overall Study|Adverse Event|1|||
150285740|NCT00647556|542182575|FG000|Overall Study|Lost to Follow-up|1|||
150285741|NCT00647556|542182576|FG001|Overall Study|Lost to Follow-up|0|||
150285742|NCT00647556|542182575|FG000|Overall Study|Protocol Violation|0|||
150285743|NCT00647556|542182576|FG001|Overall Study|Protocol Violation|1|||
150285744|NCT00647556|542182575|FG000|Overall Study|Withdrawal by Subject|1|||
150285745|NCT00647556|542182576|FG001|Overall Study|Withdrawal by Subject|0|||
150285746|NCT00647556|542182575|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
150285747|NCT00647556|542182576|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
150285748|NCT05594173|542182577|FG000|Overall Study|Adverse Event|1|||
149953163|NCT00021255|540960218|FG000|Overall Study|Adverse Event|46|||
149953164|NCT00021255|540960219|FG001|Overall Study|Adverse Event|30|||
149953165|NCT00021255|540960220|FG002|Overall Study|Adverse Event|18|||
149953166|NCT00021255|540960218|FG000|Overall Study|Protocol Violation|0|||
149953167|NCT00021255|540960219|FG001|Overall Study|Protocol Violation|2|||
149953168|NCT00021255|540960220|FG002|Overall Study|Protocol Violation|0|||
149953169|NCT00021255|540960218|FG000|Overall Study|Other than specified above|0|||
149953170|NCT00021255|540960219|FG001|Overall Study|Other than specified above|38|||
149953171|NCT00021255|540960220|FG002|Overall Study|Other than specified above|19|||
149953172|NCT00021255|540960218|FG000|Overall Study|Missing|0|||
149953173|NCT00021255|540960219|FG001|Overall Study|Missing|27|||
149953174|NCT00021255|540960220|FG002|Overall Study|Missing|13|||
149953175|NCT00021255|540960218|FG000|Overall Study|Randomized but not treated|28|||
149953176|NCT00021255|540960219|FG001|Overall Study|Randomized but not treated|2|||
149953177|NCT00021255|540960220|FG002|Overall Study|Randomized but not treated|18|||
149953178|NCT02232698|540960221|FG000|Overall Study|Pregnancy|1|||
149953179|NCT02232698|540960222|FG001|Overall Study|Pregnancy|1|||
149953180|NCT02232698|540960221|FG000|Overall Study|Met exclusion criteria|1|||
149953181|NCT02232698|540960222|FG001|Overall Study|Met exclusion criteria|1|||
150285749|NCT05594173|542182577|FG000|Overall Study|COVID-19 Pandemic|2|||
150285750|NCT01496885|542182579|FG000|Overall Study|Lost to Follow-up|13|||
150285751|NCT01496885|542182579|FG000|Overall Study|Withdrawal by Subject|7|||
150285752|NCT01496885|542182579|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
150285753|NCT01496885|542182579|FG000|Overall Study|Death|1|||
150285754|NCT02915523|542182582|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
150285755|NCT02915523|542182583|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
150285756|NCT02915523|542182584|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
150285757|NCT02915523|542182585|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
150285758|NCT02915523|542182582|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
150285759|NCT02915523|542182583|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
150285760|NCT02915523|542182584|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
150285761|NCT02915523|542182585|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
150285762|NCT02915523|542182582|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
150285763|NCT02915523|542182583|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
150285764|NCT02915523|542182584|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
150285765|NCT02915523|542182585|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
150285766|NCT02915523|542182582|FG000|Expansion Phase (Phase 2)|Death|0|||
150285767|NCT02915523|542182583|FG001|Expansion Phase (Phase 2)|Death|0|||
150285768|NCT02915523|542182584|FG002|Expansion Phase (Phase 2)|Death|26|||
150285769|NCT02915523|542182585|FG003|Expansion Phase (Phase 2)|Death|53|||
150285770|NCT02915523|542182582|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
150285771|NCT02915523|542182583|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
150285772|NCT02915523|542182584|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
150285773|NCT02915523|542182585|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
150285774|NCT02915523|542182582|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
150285775|NCT02915523|542182583|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
150285776|NCT02915523|542182584|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
150285777|NCT02915523|542182585|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
150285778|NCT02915523|542182582|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
150285779|NCT02915523|542182583|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
150285780|NCT02915523|542182584|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
150285781|NCT02915523|542182585|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
150285782|NCT00915681|542182586|FG000|Overall Study|Screening failures|46|||
150285783|NCT03221751|542182589|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
150285784|NCT03221751|542182590|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
150285785|NCT00535132|542182596|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
149953182|NCT02232698|540960221|FG000|Overall Study|Had device-associated symptoms|7|||
149953183|NCT02232698|540960222|FG001|Overall Study|Had device-associated symptoms|0|||
149953184|NCT02232698|540960221|FG000|Overall Study|Non-compliance with study device|1|||
149953185|NCT02232698|540960222|FG001|Overall Study|Non-compliance with study device|4|||
149953186|NCT02232698|540960221|FG000|Overall Study|Allocated to control group|0|||
150285786|NCT00535132|542182597|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
150285787|NCT00535132|542182596|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
149841582|NCT04493684|540550214|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841583|NCT04493684|540550215|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841584|NCT04493684|540550216|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841585|NCT04493684|540550217|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841586|NCT04493684|540550218|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841587|NCT04493684|540550219|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841588|NCT04493684|540550220|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841589|NCT04493684|540550221|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841590|NCT04493684|540550222|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841591|NCT04493684|540550223|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841592|NCT04493684|540550224|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841593|NCT04493684|540550225|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
149841594|NCT04493684|540550209|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841595|NCT04493684|540550210|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841596|NCT04493684|540550211|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841597|NCT04493684|540550212|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841598|NCT04493684|540550213|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841599|NCT04493684|540550214|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
149841600|NCT04493684|540550215|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841601|NCT04493684|540550216|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841602|NCT04493684|540550217|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841603|NCT04493684|540550218|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841604|NCT04493684|540550219|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841605|NCT04493684|540550220|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841606|NCT04493684|540550221|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841607|NCT04493684|540550222|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841608|NCT04493684|540550223|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841609|NCT04493684|540550224|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841610|NCT04493684|540550225|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
149841611|NCT04493684|540550209|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841612|NCT04493684|540550210|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841613|NCT04493684|540550211|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841614|NCT04493684|540550212|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841615|NCT04493684|540550213|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841616|NCT04493684|540550214|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841617|NCT04493684|540550215|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841618|NCT04493684|540550216|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841619|NCT04493684|540550217|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841620|NCT04493684|540550218|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841621|NCT04493684|540550219|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841622|NCT04493684|540550220|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
149841623|NCT04493684|540550221|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841624|NCT04493684|540550222|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841625|NCT04493684|540550223|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841626|NCT04493684|540550224|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841627|NCT04493684|540550225|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
149841628|NCT04493684|540550209|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841629|NCT04493684|540550210|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841630|NCT04493684|540550211|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841631|NCT04493684|540550212|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841632|NCT04493684|540550213|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
150035466|NCT05138653|541269041|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035467|NCT05138653|541269042|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035468|NCT05138653|541269043|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035469|NCT05138653|541269044|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035470|NCT05138653|541269045|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035471|NCT05138653|541269046|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
149841633|NCT04493684|540550214|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841634|NCT04493684|540550215|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
150035472|NCT05138653|541269047|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
149841635|NCT04493684|540550216|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841636|NCT04493684|540550217|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841637|NCT04493684|540550218|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841638|NCT04493684|540550219|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841639|NCT04493684|540550220|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841640|NCT04493684|540550221|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841641|NCT04493684|540550222|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841642|NCT04493684|540550223|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
150035473|NCT05138653|541269048|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035474|NCT05138653|541269049|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
150035475|NCT05138653|541269034|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035476|NCT05138653|541269035|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035477|NCT05138653|541269036|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035478|NCT05138653|541269037|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035479|NCT05138653|541269038|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035480|NCT05138653|541269039|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035481|NCT05138653|541269040|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
150035482|NCT05138653|541269041|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035483|NCT05138653|541269042|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035484|NCT05138653|541269043|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035485|NCT05138653|541269044|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035486|NCT05138653|541269045|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035487|NCT05138653|541269046|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035488|NCT05138653|541269047|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035489|NCT05138653|541269048|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035490|NCT05138653|541269049|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
150035491|NCT05138653|541269034|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035492|NCT05138653|541269035|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035493|NCT05138653|541269036|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035494|NCT05138653|541269037|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035495|NCT05138653|541269038|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035496|NCT05138653|541269039|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035497|NCT05138653|541269040|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035498|NCT05138653|541269041|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035499|NCT05138653|541269042|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035500|NCT05138653|541269043|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035501|NCT05138653|541269044|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
150035502|NCT05138653|541269045|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035503|NCT05138653|541269046|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
150035504|NCT05138653|541269047|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035505|NCT05138653|541269048|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
150035506|NCT05138653|541269049|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
150035507|NCT05138653|541269034|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035508|NCT05138653|541269035|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035509|NCT05138653|541269036|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035510|NCT05138653|541269037|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035511|NCT05138653|541269038|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035512|NCT05138653|541269039|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035513|NCT05138653|541269040|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150285788|NCT00535132|542182597|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
150285789|NCT02590588|542182598|FG000|Overall Study|Adverse Event|1|||
150285790|NCT02559687|542182606|FG000|Overall Study|Death|112|||
150285791|NCT02559687|542182606|FG000|Overall Study|Sponsor Decision|5|||
150285792|NCT02559687|542182606|FG000|Overall Study|Withdrawal by Subject|4|||
150285793|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
149841643|NCT04493684|540550224|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
149841644|NCT04493684|540550225|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
149841645|NCT04493684|540550209|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841646|NCT04493684|540550210|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841647|NCT04493684|540550211|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
150035514|NCT05138653|541269041|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035515|NCT05138653|541269042|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035516|NCT05138653|541269043|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035517|NCT05138653|541269044|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150285794|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
150285795|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
150035518|NCT05138653|541269045|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035519|NCT05138653|541269046|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035520|NCT05138653|541269047|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035521|NCT05138653|541269048|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
150035522|NCT05138653|541269049|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
150035523|NCT05138653|541269034|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035524|NCT05138653|541269035|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035525|NCT05138653|541269036|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035526|NCT05138653|541269037|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035527|NCT05138653|541269038|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035528|NCT05138653|541269039|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
149841648|NCT04493684|540550212|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841649|NCT04493684|540550213|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841650|NCT04493684|540550214|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841651|NCT04493684|540550215|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841652|NCT04493684|540550216|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841653|NCT04493684|540550217|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841654|NCT04493684|540550218|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841655|NCT04493684|540550219|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
150035529|NCT05138653|541269040|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035530|NCT05138653|541269041|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035531|NCT05138653|541269042|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035532|NCT05138653|541269043|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035533|NCT05138653|541269044|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035534|NCT05138653|541269045|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035535|NCT05138653|541269046|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035536|NCT05138653|541269047|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
150035537|NCT05138653|541269048|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035538|NCT05138653|541269049|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
150035539|NCT02331134|541269050|FG000|Overall Study|Withdrawal by Subject|1|||
150035540|NCT05967260|541269051|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
150035541|NCT05967260|541269052|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
150035542|NCT00079417|541271314|FG000|Overall Study|Physician Decision|2|||
150035543|NCT00079417|541271314|FG000|Overall Study|Ineligible|7|||
150035544|NCT01615939|541271315|FG000|Overall Study|Lost to Follow-up|5|||
150035545|NCT01615939|541271316|FG001|Overall Study|Lost to Follow-up|0|||
150035546|NCT01586364|541271320|FG000|Overall Study|Withdrawal by Subject|40|||
150035547|NCT01586364|541271320|FG000|Overall Study|Adverse Event|37|||
150035548|NCT01586364|541271320|FG000|Overall Study|Lost to Follow-up|17|||
150035549|NCT01586364|541271320|FG000|Overall Study|Protocol Violation|16|||
150035550|NCT01586364|541271320|FG000|Overall Study|Lack of Efficacy|1|||
150035551|NCT01586364|541271320|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
150035552|NCT01586364|541271320|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
150035553|NCT01586364|541271320|FG000|Overall Study|Other-Site closure due to PI illness|1|||
150035554|NCT01586364|541271320|FG000|Overall Study|Other-PI discretion, site closing|2|||
150035555|NCT01586364|541271320|FG000|Overall Study|Other-Not specified|1|||
150035556|NCT00091949|541271321|FG000|Overall Study|Withdrawal by Subject|117|||
150035557|NCT00091949|541271322|FG001|Overall Study|Withdrawal by Subject|110|||
150035558|NCT00091949|541271321|FG000|Overall Study|Lost to Follow-up|58|||
150035559|NCT00091949|541271322|FG001|Overall Study|Lost to Follow-up|41|||
150035560|NCT01520506|541271323|FG000|Overall Study|Missed Visit|4|||
150035561|NCT01520506|541271323|FG000|Overall Study|Lost to Follow-up|1|||
150035562|NCT01520506|541271323|FG000|Overall Study|Withdrawal by Subject|1|||
150035563|NCT00425269|541271324|FG000|Overall Study|Pregnancy|5|||
150035564|NCT00425269|541271325|FG001|Overall Study|Pregnancy|7|||
150035565|NCT00425269|541271324|FG000|Overall Study|Lost to Follow-up|9|||
150035566|NCT00425269|541271325|FG001|Overall Study|Lost to Follow-up|9|||
150035567|NCT00425269|541271324|FG000|Overall Study|moved or medical reason|5|||
150285796|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
150035568|NCT00425269|541271325|FG001|Overall Study|moved or medical reason|4|||
150035569|NCT01084655|541271326|FG000|Overall Study|Radiographic disease progression|3|||
150285797|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
150035570|NCT01084655|541271327|FG001|Overall Study|Radiographic disease progression|2|||
150035571|NCT01084655|541271328|FG002|Overall Study|Radiographic disease progression|8|||
150035572|NCT01084655|541271326|FG000|Overall Study|Withdrawal by Subject|1|||
150035573|NCT01084655|541271327|FG001|Overall Study|Withdrawal by Subject|0|||
150035574|NCT01084655|541271328|FG002|Overall Study|Withdrawal by Subject|4|||
150285798|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
150285799|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
150285800|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
150285801|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
150285802|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
150285803|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
150285804|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
150285805|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
150285806|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
150285807|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
150285808|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
150285809|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
150285810|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
150285811|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
150285812|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
150285813|NCT02706873|542182609|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
150285814|NCT02706873|542182610|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
150285815|NCT02706873|542182611|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
150285816|NCT02706873|542182612|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
150285817|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
150285818|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
150285819|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
150285820|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
150285821|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
150285822|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
150285823|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
150285824|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
150285825|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
150285826|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
150285827|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
150285828|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
150285829|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
150285830|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
150285831|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
150285832|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
150285833|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
150285834|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
150285835|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
150285836|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
150285837|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
150285838|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
150285839|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
150285840|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
150285841|NCT02706873|542182609|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
150285842|NCT02706873|542182610|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
150285843|NCT02706873|542182611|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
150285844|NCT02706873|542182612|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
150285845|NCT05098041|542182613|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
150285846|NCT00618410|542182619|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
150285847|NCT00618410|542182620|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
150285848|NCT01297270|542182623|FG000|Overall Study|Adverse Event|19|||
150285849|NCT01297270|542182624|FG001|Overall Study|Adverse Event|32|||
150285850|NCT01297270|542182625|FG002|Overall Study|Adverse Event|5|||
150285851|NCT01297270|542182623|FG000|Overall Study|Lack of Efficacy|15|||
150285852|NCT01297270|542182624|FG001|Overall Study|Lack of Efficacy|17|||
150285853|NCT01297270|542182625|FG002|Overall Study|Lack of Efficacy|15|||
150285854|NCT01297270|542182623|FG000|Overall Study|Lost to Follow-up|1|||
150285855|NCT01297270|542182624|FG001|Overall Study|Lost to Follow-up|2|||
150285856|NCT01297270|542182625|FG002|Overall Study|Lost to Follow-up|1|||
150285857|NCT01297270|542182623|FG000|Overall Study|Protocol Violation|0|||
150285858|NCT01297270|542182624|FG001|Overall Study|Protocol Violation|2|||
149841656|NCT04493684|540550220|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
150285859|NCT01297270|542182625|FG002|Overall Study|Protocol Violation|0|||
150285860|NCT01297270|542182623|FG000|Overall Study|Withdrawal by Subject|7|||
150285861|NCT01297270|542182624|FG001|Overall Study|Withdrawal by Subject|15|||
149841657|NCT04493684|540550221|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841658|NCT04493684|540550222|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
150285862|NCT01297270|542182625|FG002|Overall Study|Withdrawal by Subject|7|||
150285863|NCT01297270|542182623|FG000|Overall Study|Other reason not defined above|3|||
149841659|NCT04493684|540550223|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
150285864|NCT01297270|542182624|FG001|Overall Study|Other reason not defined above|3|||
150285865|NCT01297270|542182625|FG002|Overall Study|Other reason not defined above|1|||
150285866|NCT01297270|542182623|FG000|Overall Study|Not treated|0|||
150035575|NCT01084655|541271326|FG000|Overall Study|Adverse Event|2|||
150035576|NCT01084655|541271327|FG001|Overall Study|Adverse Event|1|||
150035577|NCT01084655|541271328|FG002|Overall Study|Adverse Event|2|||
150035578|NCT01084655|541271326|FG000|Overall Study|Other|0|||
150035579|NCT01084655|541271327|FG001|Overall Study|Other|3|||
150035580|NCT01084655|541271328|FG002|Overall Study|Other|2|||
150035581|NCT01084655|541271326|FG000|Overall Study|Symptomatic deterioration|0|||
150035582|NCT01084655|541271327|FG001|Overall Study|Symptomatic deterioration|0|||
150035583|NCT01084655|541271328|FG002|Overall Study|Symptomatic deterioration|2|||
150035584|NCT01084655|541271326|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
150035585|NCT01084655|541271327|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
150035586|NCT01084655|541271328|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
150035587|NCT05366738|541271329|FG000|Overall Study|Adverse Event|0|||
150035588|NCT05366738|541271330|FG001|Overall Study|Adverse Event|1|||
150035589|NCT05366738|541271331|FG002|Overall Study|Adverse Event|0|||
150035590|NCT00906204|541271332|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
150035591|NCT00906204|541271333|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
150035592|NCT00906204|541271332|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
150035593|NCT00906204|541271333|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
150035594|NCT00906204|541271332|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
150035595|NCT00906204|541271333|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
150035596|NCT00906204|541271332|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
150035597|NCT00906204|541271333|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
150035598|NCT00906204|541271332|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
150035599|NCT00906204|541271333|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
150035600|NCT02151058|541271337|FG000|Overall Study|Withdrawal by Subject|1|||
150035601|NCT02151058|541271338|FG001|Overall Study|Withdrawal by Subject|1|||
150035602|NCT02151058|541271339|FG002|Overall Study|Withdrawal by Subject|3|||
150035603|NCT02151058|541271337|FG000|Overall Study|Lost to Follow-up|1|||
150035604|NCT02151058|541271338|FG001|Overall Study|Lost to Follow-up|0|||
150035605|NCT02151058|541271339|FG002|Overall Study|Lost to Follow-up|2|||
150035606|NCT00124943|541271340|FG000|Phase II|Adverse Event|0|||
150035607|NCT00124943|541271341|FG001|Phase II|Adverse Event|2|||
150035608|NCT00124943|541271342|FG002|Phase II|Adverse Event|0|||
150035609|NCT00124943|541271343|FG003|Phase II|Adverse Event|1|||
150035610|NCT00124943|541271340|FG000|Phase II|Protocol Violation|0|||
150035611|NCT00124943|541271341|FG001|Phase II|Protocol Violation|0|||
150035612|NCT00124943|541271342|FG002|Phase II|Protocol Violation|0|||
150035613|NCT00124943|541271343|FG003|Phase II|Protocol Violation|1|||
150035614|NCT00124943|541271340|FG000|Phase II|Lost to Follow-up|0|||
150035615|NCT00124943|541271341|FG001|Phase II|Lost to Follow-up|0|||
150035616|NCT00124943|541271342|FG002|Phase II|Lost to Follow-up|0|||
150035617|NCT00124943|541271343|FG003|Phase II|Lost to Follow-up|1|||
150035618|NCT00124943|541271340|FG000|Phase II|Withdrawal by Subject|0|||
150035619|NCT00124943|541271341|FG001|Phase II|Withdrawal by Subject|0|||
150035620|NCT00124943|541271342|FG002|Phase II|Withdrawal by Subject|0|||
150035621|NCT00124943|541271343|FG003|Phase II|Withdrawal by Subject|2|||
150035622|NCT03337477|541271344|FG000|Overall Study|not categorized into the listed ones|11|||
150035623|NCT03337477|541271345|FG001|Overall Study|not categorized into the listed ones|9|||
150035624|NCT03337477|541271344|FG000|Overall Study|Withdrawal by Subject|0|||
150035625|NCT03337477|541271345|FG001|Overall Study|Withdrawal by Subject|1|||
150035626|NCT03337477|541271344|FG000|Overall Study|Death|0|||
150035627|NCT03337477|541271345|FG001|Overall Study|Death|1|||
150035628|NCT03337477|541271344|FG000|Overall Study|Lost to Follow-up|0|||
150035629|NCT03337477|541271345|FG001|Overall Study|Lost to Follow-up|2|||
150035630|NCT03304626|541271346|FG000|Overall Study|Adverse Event|1|||
150035631|NCT03304626|541271347|FG001|Overall Study|Adverse Event|0|||
150035632|NCT03304626|541271346|FG000|Overall Study|Lack of Efficacy|1|||
150035633|NCT03304626|541271347|FG001|Overall Study|Lack of Efficacy|1|||
150035634|NCT00744497|541271348|FG000|Overall Study|Withdrawal by Subject|21|||
150035635|NCT00744497|541271349|FG001|Overall Study|Withdrawal by Subject|18|||
150035636|NCT00744497|541271348|FG000|Overall Study|Death|11|||
150035637|NCT00744497|541271349|FG001|Overall Study|Death|9|||
150035638|NCT00744497|541271348|FG000|Overall Study|Lost to Follow-up|4|||
150035639|NCT00744497|541271349|FG001|Overall Study|Lost to Follow-up|2|||
150035640|NCT00744497|541271348|FG000|Overall Study|Poor compliance/noncompliance|9|||
150035641|NCT00744497|541271349|FG001|Overall Study|Poor compliance/noncompliance|5|||
150035642|NCT00744497|541271348|FG000|Overall Study|No longer meets study criteria|7|||
150035643|NCT00744497|541271349|FG001|Overall Study|No longer meets study criteria|3|||
150035644|NCT00744497|541271348|FG000|Overall Study|Administrative Reason By Sponsor|25|||
150035645|NCT00744497|541271349|FG001|Overall Study|Administrative Reason By Sponsor|8|||
150035646|NCT00744497|541271348|FG000|Overall Study|Disease progression|312|||
150035647|NCT00744497|541271349|FG001|Overall Study|Disease progression|219|||
150035648|NCT00744497|541271348|FG000|Overall Study|Study drug toxicity|68|||
150035649|NCT00744497|541271349|FG001|Overall Study|Study drug toxicity|141|||
150035650|NCT00744497|541271348|FG000|Overall Study|Adverse event unrelated to study drug|78|||
149841660|NCT04493684|540550224|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
149841661|NCT04493684|540550225|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
149841662|NCT05152576|540550230|FG000|Overall Study|Lost to Follow-up|3|||
149841663|NCT05152576|540550231|FG001|Overall Study|Lost to Follow-up|0|||
149841664|NCT05152576|540550232|FG002|Overall Study|Lost to Follow-up|0|||
149841665|NCT05152576|540550233|FG003|Overall Study|Lost to Follow-up|1|||
149841666|NCT05152576|540550230|FG000|Overall Study|Withdrawal by Subject|0|||
149841667|NCT05152576|540550231|FG001|Overall Study|Withdrawal by Subject|1|||
149841668|NCT05152576|540550232|FG002|Overall Study|Withdrawal by Subject|0|||
149841669|NCT05152576|540550233|FG003|Overall Study|Withdrawal by Subject|1|||
149841670|NCT05152576|540550230|FG000|Overall Study|Other|2|||
149841671|NCT05152576|540550231|FG001|Overall Study|Other|0|||
149841672|NCT05152576|540550232|FG002|Overall Study|Other|0|||
149841673|NCT05152576|540550233|FG003|Overall Study|Other|0|||
149841674|NCT00859430|540550234|FG000|First Intervention|Withdrawal by Subject|0|||
149841675|NCT00859430|540550235|FG001|First Intervention|Withdrawal by Subject|1|||
149841676|NCT03049748|540551610|FG000|Overall Study|Lost to Follow-up|1|||
149841677|NCT03049748|540551611|FG001|Overall Study|Lost to Follow-up|0|||
150285867|NCT01297270|542182624|FG001|Overall Study|Not treated|1|||
150285868|NCT01297270|542182625|FG002|Overall Study|Not treated|0|||
150285869|NCT01965262|542182629|FG000|Second Intervention (7 Days)|Discontinued|0|||
150285870|NCT01965262|542182630|FG001|Second Intervention (7 Days)|Discontinued|1|||
150285871|NCT01965262|542182629|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
149841678|NCT03049748|540551610|FG000|Overall Study|Death|3|||
149841679|NCT03049748|540551611|FG001|Overall Study|Death|0|||
149841680|NCT03049748|540551610|FG000|Overall Study|Withdrawal by Subject|0|||
149841681|NCT03049748|540551611|FG001|Overall Study|Withdrawal by Subject|3|||
149841682|NCT03049748|540551610|FG000|Overall Study|Protocol Violation|0|||
149841683|NCT03049748|540551611|FG001|Overall Study|Protocol Violation|2|||
149841684|NCT03049748|540551610|FG000|Overall Study|Moved out of state (relocation)|0|||
149841685|NCT03049748|540551611|FG001|Overall Study|Moved out of state (relocation)|1|||
149841686|NCT05014828|540551620|FG000|Overall Study|Study Completed by Sponsor|16|||
149841687|NCT05014828|540551621|FG001|Overall Study|Study Completed by Sponsor|16|||
149841688|NCT05014828|540551622|FG002|Overall Study|Study Completed by Sponsor|3|||
149841689|NCT05014828|540551623|FG003|Overall Study|Study Completed by Sponsor|3|||
149841690|NCT05014828|540551620|FG000|Overall Study|Death|11|||
149841691|NCT05014828|540551621|FG001|Overall Study|Death|6|||
149841692|NCT05014828|540551622|FG002|Overall Study|Death|0|||
149841693|NCT05014828|540551623|FG003|Overall Study|Death|0|||
149841694|NCT05014828|540551620|FG000|Overall Study|Lost to Follow-up|0|||
149841695|NCT05014828|540551621|FG001|Overall Study|Lost to Follow-up|0|||
149841696|NCT05014828|540551622|FG002|Overall Study|Lost to Follow-up|2|||
149841697|NCT05014828|540551623|FG003|Overall Study|Lost to Follow-up|0|||
149841698|NCT05014828|540551620|FG000|Overall Study|Miscellaneous.|0|||
149841699|NCT05014828|540551621|FG001|Overall Study|Miscellaneous.|1|||
149841700|NCT05014828|540551622|FG002|Overall Study|Miscellaneous.|0|||
149841701|NCT05014828|540551623|FG003|Overall Study|Miscellaneous.|0|||
149841702|NCT02682238|540551624|FG000|Overall Study|Lost to Follow-up|0|||
149841703|NCT02682238|540551625|FG001|Overall Study|Lost to Follow-up|2|||
149841704|NCT02682238|540551624|FG000|Overall Study|Withdrawal by Subject|1|||
149841705|NCT02682238|540551625|FG001|Overall Study|Withdrawal by Subject|0|||
149841706|NCT02682238|540551624|FG000|Overall Study|Adverse Event|1|||
149841707|NCT02682238|540551625|FG001|Overall Study|Adverse Event|0|||
149841708|NCT02682238|540551624|FG000|Overall Study|Non-compliance with Study Drug|1|||
149841709|NCT02682238|540551625|FG001|Overall Study|Non-compliance with Study Drug|0|||
149841710|NCT02682238|540551624|FG000|Overall Study|Non-compliance with Protocol|0|||
149841711|NCT02682238|540551625|FG001|Overall Study|Non-compliance with Protocol|2|||
149841712|NCT01370317|540551626|FG000|Overall Study|Participant withdrew consent|1|||
149841713|NCT01370317|540551627|FG001|Overall Study|Participant withdrew consent|0|||
149841714|NCT01370317|540551626|FG000|Overall Study|Protocol deviation|0|||
149841715|NCT01370317|540551627|FG001|Overall Study|Protocol deviation|1|||
149841716|NCT00075478|540551628|FG000|Overall Study|not eligible|1|||
150285872|NCT01965262|542182630|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
149841717|NCT00075478|540551629|FG001|Overall Study|not eligible|0|||
149841718|NCT00075478|540551628|FG000|Overall Study|Physician Decision|0|||
149841719|NCT00075478|540551629|FG001|Overall Study|Physician Decision|1|||
149841720|NCT02075463|540551632|FG000|Overall Study|Adverse Event|3|||
149841721|NCT02075463|540551632|FG000|Overall Study|Par. reached stopping criteria|4|||
149841722|NCT02075463|540551632|FG000|Overall Study|Withdrawal by Subject|1|||
149841723|NCT00673660|540551633|FG000|Overall Study|Lost to Follow-up|107|||
149841724|NCT01527006|540551634|FG000|Core Study|Adverse Event|0|||
150285873|NCT01965262|542182629|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
149841725|NCT01527006|540551635|FG001|Core Study|Adverse Event|2|||
149841726|NCT01527006|540551634|FG000|Core Study|Lost to Follow-up|0|||
149841727|NCT01527006|540551635|FG001|Core Study|Lost to Follow-up|1|||
149841728|NCT01527006|540551634|FG000|Core Study|Subject Choice|1|||
149841729|NCT01527006|540551635|FG001|Core Study|Subject Choice|0|||
149841730|NCT01527006|540551634|FG000|Core Study|Inadequate Therapeutic Effect|1|||
149841731|NCT01527006|540551635|FG001|Core Study|Inadequate Therapeutic Effect|0|||
149841732|NCT01527006|540551634|FG000|Core Study|Withdrawal by Subject|0|||
149841733|NCT01527006|540551635|FG001|Core Study|Withdrawal by Subject|1|||
149841734|NCT01527006|540551634|FG000|Core Study|Other|0|||
149841735|NCT01527006|540551635|FG001|Core Study|Other|2|||
149841736|NCT01527006|540551634|FG000|Extension Phase|Adverse Event|4|||
149841737|NCT01527006|540551635|FG001|Extension Phase|Adverse Event|2|||
149841738|NCT01527006|540551634|FG000|Extension Phase|Lost to Follow-up|0|||
149841739|NCT01527006|540551635|FG001|Extension Phase|Lost to Follow-up|1|||
149841740|NCT01527006|540551634|FG000|Extension Phase|Subject Choice|1|||
149841741|NCT01527006|540551635|FG001|Extension Phase|Subject Choice|1|||
149841742|NCT01527006|540551634|FG000|Extension Phase|Inadequate therapeutic effect|1|||
149841743|NCT01527006|540551635|FG001|Extension Phase|Inadequate therapeutic effect|1|||
149841744|NCT01527006|540551634|FG000|Extension Phase|Other|0|||
149841745|NCT01527006|540551635|FG001|Extension Phase|Other|3|||
149841746|NCT00824291|540551636|FG000|Overall Study|Adverse Event|15|||
149841747|NCT00824291|540551637|FG001|Overall Study|Adverse Event|6|||
149841748|NCT00824291|540551636|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
149841749|NCT00824291|540551637|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
149841750|NCT00824291|540551636|FG000|Overall Study|Lost to Follow-up|11|||
149841751|NCT00824291|540551637|FG001|Overall Study|Lost to Follow-up|9|||
149841752|NCT00824291|540551636|FG000|Overall Study|Non-compliance|1|||
149841753|NCT00824291|540551637|FG001|Overall Study|Non-compliance|1|||
149841754|NCT00824291|540551636|FG000|Overall Study|Protocol Violation|4|||
149841755|NCT00824291|540551637|FG001|Overall Study|Protocol Violation|1|||
149841756|NCT00824291|540551636|FG000|Overall Study|Withdrawal by Subject|14|||
149841757|NCT00824291|540551637|FG001|Overall Study|Withdrawal by Subject|8|||
149841758|NCT00824291|540551636|FG000|Overall Study|Lack of Efficacy|7|||
149841759|NCT00824291|540551637|FG001|Overall Study|Lack of Efficacy|8|||
149841760|NCT00824291|540551636|FG000|Overall Study|Participant on prohibited medication|1|||
149841761|NCT00824291|540551637|FG001|Overall Study|Participant on prohibited medication|0|||
149841762|NCT00933686|540551638|FG000|Overall Study|Protocol Violation|0|||
149841763|NCT00933686|540551639|FG001|Overall Study|Protocol Violation|1|||
149841764|NCT00933686|540551638|FG000|Overall Study|Lost to Follow-up|2|||
149841765|NCT00933686|540551639|FG001|Overall Study|Lost to Follow-up|2|||
149841766|NCT00933686|540551638|FG000|Overall Study|Withdrawal by Subject|6|||
149841767|NCT00933686|540551639|FG001|Overall Study|Withdrawal by Subject|5|||
149841768|NCT00933686|540551638|FG000|Overall Study|Adverse Event|1|||
149841769|NCT00933686|540551639|FG001|Overall Study|Adverse Event|1|||
149841770|NCT00933686|540551638|FG000|Overall Study|Physician Decision|1|||
149841771|NCT00933686|540551639|FG001|Overall Study|Physician Decision|0|||
149841772|NCT00933686|540551638|FG000|Overall Study|Failure to show up at endpoint visits|0|||
149841773|NCT00933686|540551639|FG001|Overall Study|Failure to show up at endpoint visits|2|||
149841774|NCT00123734|540551641|FG000|Overall Study|Death|3|||
149953187|NCT02232698|540960222|FG001|Overall Study|Allocated to control group|3|||
149953188|NCT02232698|540960221|FG000|Overall Study|Withdrawal by Subject|0|||
149953189|NCT02232698|540960222|FG001|Overall Study|Withdrawal by Subject|11|||
149953190|NCT05324371|540960224|FG000|Overall Study|Withdrawal by Subject|1|||
149953191|NCT05324371|540960224|FG000|Overall Study|Death|1|||
149953192|NCT01131585|540960225|FG000|Overall Study|Adverse Event|0|||
149953193|NCT01131585|540960226|FG001|Overall Study|Adverse Event|2|||
149953194|NCT01131585|540960225|FG000|Overall Study|Abnormal laboratory value|1|||
149953195|NCT01131585|540960226|FG001|Overall Study|Abnormal laboratory value|0|||
149953196|NCT01131585|540960225|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149953197|NCT01131585|540960226|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149953198|NCT01131585|540960225|FG000|Overall Study|Protocol Violation|2|||
149953199|NCT01131585|540960226|FG001|Overall Study|Protocol Violation|1|||
149953200|NCT01131585|540960225|FG000|Overall Study|Withdrawal by Subject|3|||
149953201|NCT01131585|540960226|FG001|Overall Study|Withdrawal by Subject|3|||
149953202|NCT01131585|540960225|FG000|Overall Study|Lost to Follow-up|0|||
149953203|NCT01131585|540960226|FG001|Overall Study|Lost to Follow-up|1|||
149953204|NCT01131585|540960225|FG000|Overall Study|Administrative problems|1|||
149841775|NCT00123734|540551641|FG000|Overall Study|Lost to Follow-up|3|||
149841776|NCT00123734|540551641|FG000|Overall Study|Dropout|1|||
149841777|NCT00123734|540551641|FG000|Overall Study|Withdrawal by Subject|1|||
149841778|NCT00113386|540551642|FG000|Overall Study|Withdrawal by Subject|1|||
149841779|NCT00113386|540551643|FG001|Overall Study|Withdrawal by Subject|0|||
149841780|NCT00113386|540551642|FG000|Overall Study|Physician Decision|0|||
149841781|NCT00113386|540551643|FG001|Overall Study|Physician Decision|1|||
149841782|NCT00113386|540551642|FG000|Overall Study|Toxicity|3|||
149953205|NCT01131585|540960226|FG001|Overall Study|Administrative problems|1|||
149953206|NCT01131585|540960225|FG000|Overall Study|Study termination|78|||
149953207|NCT01131585|540960226|FG001|Overall Study|Study termination|32|||
149953208|NCT01786109|540960227|FG000|Overall Study|fail manometry barostat tube placement|1|||
149841783|NCT00113386|540551643|FG001|Overall Study|Toxicity|0|||
149841784|NCT00113386|540551642|FG000|Overall Study|Ineligible|1|||
149841785|NCT00113386|540551643|FG001|Overall Study|Ineligible|2|||
149841786|NCT00113386|540551642|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
149841787|NCT00113386|540551643|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
149841788|NCT01648582|540551644|FG000|Overall Study|Adverse Event|6|||
149841789|NCT01648582|540551645|FG001|Overall Study|Adverse Event|11|||
149841790|NCT01648582|540551646|FG002|Overall Study|Adverse Event|2|||
149841791|NCT01648582|540551644|FG000|Overall Study|Lost to Follow-up|9|||
149841792|NCT01648582|540551645|FG001|Overall Study|Lost to Follow-up|6|||
149841793|NCT01648582|540551646|FG002|Overall Study|Lost to Follow-up|8|||
149841794|NCT01648582|540551644|FG000|Overall Study|Protocol Violation|1|||
149841795|NCT01648582|540551645|FG001|Overall Study|Protocol Violation|2|||
149841796|NCT01648582|540551646|FG002|Overall Study|Protocol Violation|1|||
149841797|NCT01648582|540551644|FG000|Overall Study|Withdrawal by Subject|15|||
149841798|NCT01648582|540551645|FG001|Overall Study|Withdrawal by Subject|17|||
149841799|NCT01648582|540551646|FG002|Overall Study|Withdrawal by Subject|17|||
149841800|NCT01648582|540551644|FG000|Overall Study|Physician Decision|0|||
149841801|NCT01648582|540551645|FG001|Overall Study|Physician Decision|1|||
149841802|NCT01648582|540551646|FG002|Overall Study|Physician Decision|3|||
149841803|NCT01648582|540551644|FG000|Overall Study|Death|1|||
149841804|NCT01648582|540551645|FG001|Overall Study|Death|0|||
149841805|NCT01648582|540551646|FG002|Overall Study|Death|0|||
149841806|NCT01648582|540551644|FG000|Overall Study|Sponsor Decision|0|||
149841807|NCT01648582|540551645|FG001|Overall Study|Sponsor Decision|1|||
149841808|NCT01648582|540551646|FG002|Overall Study|Sponsor Decision|1|||
149841809|NCT02159183|540551647|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
149841810|NCT02159183|540551648|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
149841811|NCT02159183|540551647|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
149841812|NCT02159183|540551648|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
149841813|NCT02159183|540551647|FG000|Analysis After the 36 Months Follow-up|Death|0|||
149841814|NCT02159183|540551648|FG001|Analysis After the 36 Months Follow-up|Death|1|||
149841815|NCT02159183|540551647|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
149841816|NCT02159183|540551648|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
149841817|NCT02159183|540551647|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
149841818|NCT02159183|540551648|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
149841819|NCT01444378|540551649|FG000|Overall Study|Lost to Follow-up|1|||
149841820|NCT01444378|540551649|FG000|Overall Study|Withdrawal by Subject|1|||
149841821|NCT01444378|540551649|FG000|Overall Study|Death|3|||
149841822|NCT01444378|540551649|FG000|Overall Study|Administrative Closure Of The Study|2|||
149841823|NCT01444378|540551649|FG000|Overall Study|Missed Visits|10|||
149841824|NCT00556322|540551652|FG000|Overall Study|Insufficient therapeutic response|158|||
149841825|NCT00556322|540551653|FG001|Overall Study|Insufficient therapeutic response|168|||
149841826|NCT00556322|540551652|FG000|Overall Study|Adverse Event|7|||
149841827|NCT00556322|540551653|FG001|Overall Study|Adverse Event|4|||
149841828|NCT00556322|540551652|FG000|Overall Study|Other|4|||
149841829|NCT00556322|540551653|FG001|Overall Study|Other|1|||
149841830|NCT00556322|540551652|FG000|Overall Study|Lost to Follow-up|5|||
149841831|NCT00556322|540551653|FG001|Overall Study|Lost to Follow-up|3|||
149841832|NCT00556322|540551652|FG000|Overall Study|Withdrawal by Subject|19|||
149841833|NCT00556322|540551653|FG001|Overall Study|Withdrawal by Subject|7|||
149841834|NCT00556322|540551652|FG000|Overall Study|Protocol Violation|5|||
149841835|NCT00556322|540551653|FG001|Overall Study|Protocol Violation|1|||
149841836|NCT00556322|540551652|FG000|Overall Study|Ongoing at data cutoff|3|||
149841837|NCT00556322|540551653|FG001|Overall Study|Ongoing at data cutoff|5|||
149841838|NCT00556322|540551652|FG000|Overall Study|Death|20|||
149841839|NCT00556322|540551653|FG001|Overall Study|Death|14|||
149841840|NCT00796328|540551654|FG000|Overall Study|experienced hypotension requiring tx|6|||
149841841|NCT03249454|540551655|FG000|Overall Study|Withdrawal by Subject|0|||
149841842|NCT03249454|540551656|FG001|Overall Study|Withdrawal by Subject|0|||
149841843|NCT03249454|540551657|FG002|Overall Study|Withdrawal by Subject|0|||
149841844|NCT03249454|540551658|FG003|Overall Study|Withdrawal by Subject|0|||
150285874|NCT01965262|542182630|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
150285875|NCT01029366|542182631|FG000|Overall Study|Withdrawal by Subject|1|||
150285876|NCT01029366|542182632|FG001|Overall Study|Withdrawal by Subject|0|||
150285877|NCT01029366|542182631|FG000|Overall Study|Death|1|||
149841845|NCT03249454|540551659|FG004|Overall Study|Withdrawal by Subject|0|||
149841846|NCT03249454|540551660|FG005|Overall Study|Withdrawal by Subject|0|||
149841847|NCT03249454|540551661|FG006|Overall Study|Withdrawal by Subject|0|||
149841848|NCT03249454|540551662|FG007|Overall Study|Withdrawal by Subject|0|||
149841849|NCT03249454|540551663|FG008|Overall Study|Withdrawal by Subject|0|||
150285878|NCT01029366|542182632|FG001|Overall Study|Death|1|||
149841850|NCT03249454|540551664|FG009|Overall Study|Withdrawal by Subject|1|||
149841851|NCT03249454|540551665|FG010|Overall Study|Withdrawal by Subject|1|||
149841852|NCT03669861|540551668|FG000|Overall Study|Disease Flare|5|||
149841853|NCT03669861|540551668|FG000|Overall Study|Lack of Efficacy|2|||
149841854|NCT02760927|540551669|FG000|Overall Study|Tube Slippage from Device|1|||
149841855|NCT03256695|540551670|FG000|Overall Study|Adverse Event|8|||
149841856|NCT03256695|540551670|FG000|Overall Study|Death|2|||
149841857|NCT03256695|540551670|FG000|Overall Study|Withdrawal by Subject|14|||
149841858|NCT03256695|540551670|FG000|Overall Study|Non-compliance with study drug|1|||
149841859|NCT03256695|540551670|FG000|Overall Study|Lost to Follow-up|3|||
149841860|NCT03256695|540551670|FG000|Overall Study|Lack of Efficacy|3|||
149841861|NCT03256695|540551670|FG000|Overall Study|Protocol Violation|5|||
149841862|NCT03256695|540551670|FG000|Overall Study|Other than specified|3|||
149841863|NCT01103713|540551671|FG000|Overall Study|Lost to Follow-up|2|||
149841864|NCT01103713|540551671|FG000|Overall Study|Withdrawal by Subject|8|||
149841865|NCT01103713|540551671|FG000|Overall Study|Study terminated by sponsor|2|||
149841866|NCT01103713|540551671|FG000|Overall Study|Other|1|||
149841867|NCT01929863|540551676|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
149841868|NCT01929863|540551677|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
149841869|NCT01929863|540551676|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
149841870|NCT01929863|540551677|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
149841871|NCT01929863|540551676|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
149841872|NCT01929863|540551677|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
149841873|NCT00251979|540551678|FG000|Overall Study|Protocol Violation|3|||
149841874|NCT00251979|540551679|FG001|Overall Study|Protocol Violation|5|||
149841875|NCT00251979|540551678|FG000|Overall Study|Adverse Event|11|||
149841876|NCT00251979|540551679|FG001|Overall Study|Adverse Event|17|||
149841877|NCT00251979|540551678|FG000|Overall Study|Withdrawal by Subject|13|||
149841878|NCT00251979|540551679|FG001|Overall Study|Withdrawal by Subject|7|||
149841879|NCT00251979|540551678|FG000|Overall Study|Lost to Follow-up|8|||
149841880|NCT00251979|540551679|FG001|Overall Study|Lost to Follow-up|6|||
149841881|NCT00251979|540551678|FG000|Overall Study|Death|3|||
149841882|NCT00251979|540551679|FG001|Overall Study|Death|5|||
149841883|NCT00323882|540551685|FG000|Overall Study|Adverse Event|2|||
149841884|NCT00323882|540551686|FG001|Overall Study|Adverse Event|1|||
149841885|NCT00323882|540551687|FG002|Overall Study|Adverse Event|1|||
149841886|NCT00323882|540551688|FG003|Overall Study|Adverse Event|1|||
149841887|NCT00323882|540551689|FG004|Overall Study|Adverse Event|3|||
149841888|NCT00323882|540551685|FG000|Overall Study|Disease Progression|6|||
149841889|NCT00323882|540551686|FG001|Overall Study|Disease Progression|4|||
149841890|NCT00323882|540551687|FG002|Overall Study|Disease Progression|10|||
149841891|NCT00323882|540551688|FG003|Overall Study|Disease Progression|5|||
149841892|NCT00323882|540551689|FG004|Overall Study|Disease Progression|22|||
149841893|NCT00323882|540551685|FG000|Overall Study|Death|0|||
149841894|NCT00323882|540551686|FG001|Overall Study|Death|1|||
149841895|NCT00323882|540551687|FG002|Overall Study|Death|1|||
149841896|NCT00323882|540551688|FG003|Overall Study|Death|0|||
149841897|NCT00323882|540551689|FG004|Overall Study|Death|5|||
149841898|NCT00323882|540551685|FG000|Overall Study|Lost to Follow-up|0|||
149841899|NCT00323882|540551686|FG001|Overall Study|Lost to Follow-up|0|||
149841900|NCT00323882|540551687|FG002|Overall Study|Lost to Follow-up|1|||
149841901|NCT00323882|540551688|FG003|Overall Study|Lost to Follow-up|0|||
149841902|NCT00323882|540551689|FG004|Overall Study|Lost to Follow-up|1|||
149841903|NCT00323882|540551685|FG000|Overall Study|Other|0|||
149841904|NCT00323882|540551686|FG001|Overall Study|Other|0|||
149841905|NCT00323882|540551687|FG002|Overall Study|Other|0|||
149841906|NCT00323882|540551688|FG003|Overall Study|Other|1|||
149841907|NCT00323882|540551689|FG004|Overall Study|Other|1|||
149841908|NCT00835536|540551690|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
149841909|NCT00835536|540551691|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
149841910|NCT00429416|540551694|FG000|Overall Study|Death|1|||
149841911|NCT00730691|540551696|FG000|Overall Study|Adverse Event|4|||
149841912|NCT00730691|540551697|FG001|Overall Study|Adverse Event|8|||
149841913|NCT00730691|540551698|FG002|Overall Study|Adverse Event|11|||
149841914|NCT00730691|540551699|FG003|Overall Study|Adverse Event|11|||
149841915|NCT00730691|540551700|FG004|Overall Study|Adverse Event|23|||
149841916|NCT00730691|540551696|FG000|Overall Study|Lack of Efficacy|4|||
149841917|NCT00730691|540551697|FG001|Overall Study|Lack of Efficacy|4|||
149841918|NCT00730691|540551698|FG002|Overall Study|Lack of Efficacy|2|||
149953209|NCT01786109|540960228|FG001|Overall Study|fail manometry barostat tube placement|0|||
149841919|NCT00730691|540551699|FG003|Overall Study|Lack of Efficacy|1|||
149841920|NCT00730691|540551700|FG004|Overall Study|Lack of Efficacy|1|||
149841921|NCT00730691|540551696|FG000|Overall Study|Non-compliance with Study Drug|6|||
149841922|NCT00730691|540551697|FG001|Overall Study|Non-compliance with Study Drug|1|||
149841923|NCT00730691|540551698|FG002|Overall Study|Non-compliance with Study Drug|6|||
150285879|NCT01029366|542182631|FG000|Overall Study|disease progression|2|||
149841924|NCT00730691|540551699|FG003|Overall Study|Non-compliance with Study Drug|3|||
149841925|NCT00730691|540551700|FG004|Overall Study|Non-compliance with Study Drug|3|||
149841926|NCT00730691|540551696|FG000|Overall Study|Protocol Deviations|3|||
149841927|NCT00730691|540551697|FG001|Overall Study|Protocol Deviations|5|||
149841928|NCT00730691|540551698|FG002|Overall Study|Protocol Deviations|3|||
149841929|NCT00730691|540551699|FG003|Overall Study|Protocol Deviations|7|||
149841930|NCT00730691|540551700|FG004|Overall Study|Protocol Deviations|5|||
149841931|NCT00730691|540551696|FG000|Overall Study|Withdrawal of Consent|7|||
149841932|NCT00730691|540551697|FG001|Overall Study|Withdrawal of Consent|9|||
149841933|NCT00730691|540551698|FG002|Overall Study|Withdrawal of Consent|3|||
149841934|NCT00730691|540551699|FG003|Overall Study|Withdrawal of Consent|6|||
149841935|NCT00730691|540551700|FG004|Overall Study|Withdrawal of Consent|3|||
150035651|NCT00744497|541271349|FG001|Overall Study|Adverse event unrelated to study drug|122|||
150035652|NCT00744497|541271348|FG000|Overall Study|Patient requested to stop study drug|65|||
150035653|NCT00744497|541271349|FG001|Overall Study|Patient requested to stop study drug|80|||
150035654|NCT00744497|541271348|FG000|Overall Study|Maximum clinical benefit|141|||
150035655|NCT00744497|541271349|FG001|Overall Study|Maximum clinical benefit|142|||
150035656|NCT00744497|541271348|FG000|Overall Study|Not defined|19|||
150035657|NCT00744497|541271349|FG001|Overall Study|Not defined|13|||
150035658|NCT03182374|541271354|FG000|Overall Study|Lost to Follow-up|3|||
150035659|NCT03182374|541271355|FG001|Overall Study|Lost to Follow-up|2|||
150035660|NCT03182374|541271354|FG000|Overall Study|Lack of Efficacy|8|||
150035661|NCT03182374|541271355|FG001|Overall Study|Lack of Efficacy|14|||
150035662|NCT03182374|541271354|FG000|Overall Study|Withdrawal by Subject|1|||
150035663|NCT03182374|541271355|FG001|Overall Study|Withdrawal by Subject|1|||
150035664|NCT03182374|541271354|FG000|Overall Study|exit for non-compliance|1|||
150172473|NCT04860258|541767957|FG000|Overall Study|Withdrawal by Subject|0|||
150172474|NCT04860258|541767958|FG001|Overall Study|Withdrawal by Subject|0|||
149841936|NCT00730691|540551696|FG000|Overall Study|Lost to Follow-up|11|||
149841937|NCT00730691|540551697|FG001|Overall Study|Lost to Follow-up|8|||
149841938|NCT00730691|540551698|FG002|Overall Study|Lost to Follow-up|13|||
149841939|NCT00730691|540551699|FG003|Overall Study|Lost to Follow-up|15|||
149841940|NCT00730691|540551700|FG004|Overall Study|Lost to Follow-up|13|||
149841941|NCT00730691|540551696|FG000|Overall Study|Other|1|||
149841942|NCT00730691|540551697|FG001|Overall Study|Other|1|||
149841943|NCT00730691|540551698|FG002|Overall Study|Other|1|||
149841944|NCT00730691|540551699|FG003|Overall Study|Other|2|||
149841945|NCT00730691|540551700|FG004|Overall Study|Other|2|||
149841946|NCT02178787|540551701|FG000|Overall Study|Lost to Follow-up|1|||
149841947|NCT02178787|540551702|FG001|Overall Study|Lost to Follow-up|0|||
149841948|NCT02178787|540551701|FG000|Overall Study|Withdrawal by Subject|0|||
149841949|NCT02178787|540551702|FG001|Overall Study|Withdrawal by Subject|2|||
149841950|NCT02178787|540551701|FG000|Overall Study|No TCD window|3|||
149841951|NCT02178787|540551702|FG001|Overall Study|No TCD window|7|||
149841952|NCT02178787|540551701|FG000|Overall Study|Physician Decision|1|||
149841953|NCT02178787|540551702|FG001|Overall Study|Physician Decision|0|||
149841954|NCT02554890|540551703|FG000|Double-blind|Adverse Event|45|||
149841955|NCT02554890|540551704|FG001|Double-blind|Adverse Event|51|||
149841956|NCT02554890|540551703|FG000|Double-blind|Death|6|||
149841957|NCT02554890|540551704|FG001|Double-blind|Death|4|||
149841958|NCT02554890|540551703|FG000|Double-blind|Protocol Violation|1|||
149841959|NCT02554890|540551704|FG001|Double-blind|Protocol Violation|1|||
149841960|NCT02554890|540551703|FG000|Double-blind|Physician Decision|4|||
149841961|NCT02554890|540551704|FG001|Double-blind|Physician Decision|3|||
149841962|NCT02554890|540551703|FG000|Double-blind|Subject/Guardian decision|21|||
149841963|NCT02554890|540551704|FG001|Double-blind|Subject/Guardian decision|16|||
149841964|NCT02554890|540551703|FG000|Double-blind|Lost to Follow-up|7|||
149841965|NCT02554890|540551704|FG001|Double-blind|Lost to Follow-up|5|||
149841966|NCT02554890|540551703|FG000|Double-blind|Technical problems|1|||
149841967|NCT02554890|540551704|FG001|Double-blind|Technical problems|0|||
149841968|NCT02554890|540551703|FG000|Double-blind|Withdrawal by Subject|5|||
149841969|NCT02554890|540551704|FG001|Double-blind|Withdrawal by Subject|6|||
149841970|NCT02554890|540551703|FG000|Double-blind|Noncompliance with study treatment|6|||
149841971|NCT02554890|540551704|FG001|Double-blind|Noncompliance with study treatment|5|||
149841972|NCT02554890|540551703|FG000|Open-label|Adverse Event|0|||
149841973|NCT02554890|540551704|FG001|Open-label|Adverse Event|30|||
149841974|NCT02554890|540551703|FG000|Open-label|Death|0|||
149841975|NCT02554890|540551704|FG001|Open-label|Death|1|||
149841976|NCT02554890|540551703|FG000|Open-label|Physician Decision|0|||
149841977|NCT02554890|540551704|FG001|Open-label|Physician Decision|1|||
149841978|NCT02554890|540551703|FG000|Open-label|Subject/Guardian decision|0|||
149841979|NCT02554890|540551704|FG001|Open-label|Subject/Guardian decision|11|||
149841980|NCT02554890|540551703|FG000|Open-label|Lost to Follow-up|0|||
149841981|NCT02554890|540551704|FG001|Open-label|Lost to Follow-up|7|||
149841982|NCT02554890|540551703|FG000|Open-label|Technical problems|0|||
149841983|NCT02554890|540551704|FG001|Open-label|Technical problems|1|||
149841984|NCT02554890|540551703|FG000|Open-label|Withdrawal by Subject|0|||
149841985|NCT02554890|540551704|FG001|Open-label|Withdrawal by Subject|1|||
150035665|NCT03182374|541271355|FG001|Overall Study|exit for non-compliance|1|||
150035666|NCT03182374|541271354|FG000|Overall Study|one subject was randomized but not treated|1|||
150035667|NCT03182374|541271355|FG001|Overall Study|one subject was randomized but not treated|0|||
150035668|NCT03182374|541271354|FG000|Overall Study|Other reasons|0|||
150035669|NCT03182374|541271355|FG001|Overall Study|Other reasons|3|||
149841986|NCT03649477|540551710|FG000|Overall Study|Adverse Event|2|||
149841987|NCT03649477|540551711|FG001|Overall Study|Adverse Event|0|||
149841988|NCT03649477|540551712|FG002|Overall Study|Adverse Event|0|||
149841989|NCT04544410|540551713|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149841990|NCT04544410|540551714|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149841991|NCT04544410|540551713|FG000|Double-blind Treatment Period|Adverse Event|1|||
149841992|NCT04544410|540551714|FG001|Double-blind Treatment Period|Adverse Event|0|||
149841993|NCT04544410|540551713|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
149841994|NCT04544410|540551714|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149841995|NCT04544410|540551713|FG000|Double-blind Treatment Period|Protocol Violation|1|||
149841996|NCT04544410|540551714|FG001|Double-blind Treatment Period|Protocol Violation|0|||
149841997|NCT04544410|540551713|FG000|Open-Label Treatment Period|Study Terminated|15|||
149841998|NCT04544410|540551714|FG001|Open-Label Treatment Period|Study Terminated|19|||
149841999|NCT04544410|540551713|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
149842000|NCT04544410|540551714|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
149842001|NCT04544410|540551713|FG000|Open-Label Treatment Period|Adverse Event|0|||
149842002|NCT04544410|540551714|FG001|Open-Label Treatment Period|Adverse Event|1|||
149842003|NCT04544410|540551713|FG000|Open-Label Treatment Period|Physician Decision|1|||
149842004|NCT04544410|540551714|FG001|Open-Label Treatment Period|Physician Decision|0|||
149842005|NCT04544410|540551713|FG000|Open-Label Treatment Period|Other|0|||
149842006|NCT04544410|540551714|FG001|Open-Label Treatment Period|Other|1|||
149842007|NCT02430480|540551715|FG000|Overall Study|Death|1|||
149842008|NCT02430480|540551715|FG000|Overall Study|Anesthesia concerns|1|||
149842009|NCT02430480|540551715|FG000|Overall Study|Progressed on treatment|1|||
149842010|NCT01030133|540551716|FG000|Overall Study|failed to experience pain at level 7/10|2|||
149842011|NCT01030133|540551717|FG001|Overall Study|failed to experience pain at level 7/10|2|||
149842012|NCT01963728|540551718|FG000|Overall Study|Study terminated early|0|||
149842013|NCT01963728|540551719|FG001|Overall Study|Study terminated early|1|||
149842014|NCT05776901|540552895|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
149842015|NCT00682461|540552896|FG000|Overall Study|Adverse Event|5|||
149842016|NCT00682461|540552897|FG001|Overall Study|Adverse Event|7|||
149842017|NCT00682461|540552896|FG000|Overall Study|Lost to Follow-up|8|||
149842018|NCT00682461|540552897|FG001|Overall Study|Lost to Follow-up|5|||
149842019|NCT00682461|540552896|FG000|Overall Study|Withdrawal by Subject|12|||
149842020|NCT00682461|540552897|FG001|Overall Study|Withdrawal by Subject|19|||
149842021|NCT02328040|540552915|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
149842022|NCT02328040|540552916|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
149842023|NCT01471353|540552919|FG000|Overall Study|remain on study|3|||
149842024|NCT00836472|540552920|FG000|Washout|Adverse Event|1|||
149842025|NCT00836472|540552921|FG001|Washout|Adverse Event|2|||
149842026|NCT00836472|540552920|FG000|Washout|Withdrawal by Subject|1|||
149842027|NCT00836472|540552921|FG001|Washout|Withdrawal by Subject|1|||
149842028|NCT03246503|540552924|FG000|Overall Study|Lost to Follow-up|23|||
149842029|NCT03246503|540552924|FG000|Overall Study|Withdrawal by Subject|20|||
150285880|NCT01029366|542182632|FG001|Overall Study|disease progression|0|||
150285881|NCT01029366|542182631|FG000|Overall Study|manufacturing failure|0|||
150285882|NCT01029366|542182632|FG001|Overall Study|manufacturing failure|1|||
150285883|NCT00906087|542182638|FG000|Initial Washout|Withdrawal by Subject|1|||
150285884|NCT00906087|542182638|FG000|Initial Washout|Physician Decision|1|||
149842030|NCT03246503|540552924|FG000|Overall Study|Physician Decision|5|||
149842031|NCT03246503|540552924|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
149842032|NCT00466167|540552930|FG000|Overall Study|Adverse Event|8|||
149842033|NCT00466167|540552931|FG001|Overall Study|Adverse Event|8|||
149842034|NCT00466167|540552932|FG002|Overall Study|Adverse Event|7|||
149842035|NCT00466167|540552930|FG000|Overall Study|Lack of Efficacy|2|||
149842036|NCT00466167|540552931|FG001|Overall Study|Lack of Efficacy|0|||
149842037|NCT00466167|540552932|FG002|Overall Study|Lack of Efficacy|3|||
149842038|NCT00466167|540552930|FG000|Overall Study|Protocol Violation|1|||
149842039|NCT00466167|540552931|FG001|Overall Study|Protocol Violation|1|||
149842040|NCT00466167|540552932|FG002|Overall Study|Protocol Violation|2|||
149842041|NCT00466167|540552930|FG000|Overall Study|Lost to Follow-up|3|||
149842042|NCT00466167|540552931|FG001|Overall Study|Lost to Follow-up|2|||
149842043|NCT00466167|540552932|FG002|Overall Study|Lost to Follow-up|2|||
149842044|NCT00466167|540552930|FG000|Overall Study|Withdrawal by Subject|4|||
149842045|NCT00466167|540552931|FG001|Overall Study|Withdrawal by Subject|1|||
149842046|NCT00466167|540552932|FG002|Overall Study|Withdrawal by Subject|6|||
149842047|NCT00466167|540552930|FG000|Overall Study|patient did not meet inclusion criteria|1|||
149842048|NCT00466167|540552931|FG001|Overall Study|patient did not meet inclusion criteria|0|||
149842049|NCT00466167|540552932|FG002|Overall Study|patient did not meet inclusion criteria|1|||
149842050|NCT00466167|540552930|FG000|Overall Study|Not treated|1|||
149842051|NCT00466167|540552931|FG001|Overall Study|Not treated|0|||
149842052|NCT00466167|540552932|FG002|Overall Study|Not treated|0|||
149842053|NCT03199963|540552933|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
149842054|NCT03199963|540552934|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
149842055|NCT03199963|540552933|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
149842056|NCT03199963|540552934|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
149842057|NCT03199963|540552933|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
149842058|NCT03199963|540552934|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
149842059|NCT03199963|540552933|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
149842060|NCT03199963|540552934|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
149842061|NCT03199963|540552933|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
149842062|NCT03199963|540552934|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
149842063|NCT03199963|540552933|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
150285885|NCT00440947|542182639|FG000|36-Week Induction Phase|Adverse Event|16|||
150285886|NCT00440947|542182640|FG001|36-Week Induction Phase|Adverse Event|0|||
150285887|NCT00440947|542182641|FG002|36-Week Induction Phase|Adverse Event|0|||
149842064|NCT03199963|540552934|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
149842065|NCT02645409|540552937|FG000|Overall Study|Withdrawal by Subject|3|||
149842066|NCT02645409|540552938|FG001|Overall Study|Withdrawal by Subject|0|||
149842067|NCT02645409|540552937|FG000|Overall Study|Physician Decision|1|||
149842068|NCT02645409|540552938|FG001|Overall Study|Physician Decision|0|||
149842069|NCT02089685|540552941|FG000|Overall Study|Adverse Event|1|||
149842070|NCT02089685|540552942|FG001|Overall Study|Adverse Event|0|||
150285888|NCT00440947|542182642|FG003|36-Week Induction Phase|Adverse Event|0|||
150285889|NCT00440947|542182643|FG004|36-Week Induction Phase|Adverse Event|0|||
150285890|NCT00440947|542182639|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
150285891|NCT00440947|542182640|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
150285892|NCT00440947|542182641|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
150285893|NCT00440947|542182642|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
150285894|NCT00440947|542182643|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
150285895|NCT00440947|542182639|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
150285896|NCT00440947|542182640|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
150285897|NCT00440947|542182641|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
150285898|NCT00440947|542182642|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
150285899|NCT00440947|542182643|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
150285900|NCT00440947|542182639|FG000|36-Week Induction Phase|Non-compliance|10|||
150285901|NCT00440947|542182640|FG001|36-Week Induction Phase|Non-compliance|0|||
150285902|NCT00440947|542182641|FG002|36-Week Induction Phase|Non-compliance|0|||
150285903|NCT00440947|542182642|FG003|36-Week Induction Phase|Non-compliance|0|||
150285904|NCT00440947|542182643|FG004|36-Week Induction Phase|Non-compliance|0|||
150285905|NCT00440947|542182639|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
150285906|NCT00440947|542182640|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
150285907|NCT00440947|542182641|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
150285908|NCT00440947|542182642|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
150285909|NCT00440947|542182643|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
150285910|NCT00440947|542182639|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
150285911|NCT00440947|542182640|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
150285912|NCT00440947|542182641|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
150285913|NCT00440947|542182642|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
150285914|NCT00440947|542182643|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
150285915|NCT00440947|542182639|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
150285916|NCT00440947|542182640|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
150285917|NCT00440947|542182641|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
150285918|NCT00440947|542182642|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
150285919|NCT00440947|542182643|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
150285920|NCT00440947|542182639|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
150285921|NCT00440947|542182640|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
150285922|NCT00440947|542182641|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
150285923|NCT00440947|542182642|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
150285924|NCT00440947|542182643|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
150285925|NCT00440947|542182639|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
150285926|NCT00440947|542182640|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
150285927|NCT00440947|542182641|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
150285928|NCT00440947|542182642|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
150285929|NCT00440947|542182643|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
150285930|NCT00440947|542182639|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
150285931|NCT00440947|542182640|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
150285932|NCT00440947|542182641|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
150285933|NCT00440947|542182642|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
150285934|NCT00440947|542182643|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
150285935|NCT00440947|542182639|FG000|36-Week Induction Phase|Incarceration|3|||
150285936|NCT00440947|542182640|FG001|36-Week Induction Phase|Incarceration|0|||
150285937|NCT00440947|542182641|FG002|36-Week Induction Phase|Incarceration|0|||
150285938|NCT00440947|542182642|FG003|36-Week Induction Phase|Incarceration|0|||
149842071|NCT02089685|540552943|FG002|Overall Study|Adverse Event|0|||
149842072|NCT02089685|540552944|FG003|Overall Study|Adverse Event|0|||
149842073|NCT02089685|540552945|FG004|Overall Study|Adverse Event|1|||
150285939|NCT00440947|542182643|FG004|36-Week Induction Phase|Incarceration|0|||
150285940|NCT00440947|542182639|FG000|36-Week Induction Phase|Pregnancy|1|||
150285941|NCT00440947|542182640|FG001|36-Week Induction Phase|Pregnancy|0|||
150285942|NCT00440947|542182641|FG002|36-Week Induction Phase|Pregnancy|0|||
150285943|NCT00440947|542182642|FG003|36-Week Induction Phase|Pregnancy|0|||
149842074|NCT02089685|540552946|FG005|Overall Study|Adverse Event|0|||
149842075|NCT02089685|540552941|FG000|Overall Study|Clinical Progression|4|||
149842076|NCT02089685|540552942|FG001|Overall Study|Clinical Progression|0|||
149842077|NCT02089685|540552943|FG002|Overall Study|Clinical Progression|0|||
149842078|NCT02089685|540552944|FG003|Overall Study|Clinical Progression|5|||
149842079|NCT02089685|540552945|FG004|Overall Study|Clinical Progression|1|||
149842080|NCT02089685|540552946|FG005|Overall Study|Clinical Progression|2|||
149842081|NCT02089685|540552941|FG000|Overall Study|Excluded Medication|1|||
149842082|NCT02089685|540552942|FG001|Overall Study|Excluded Medication|0|||
149842083|NCT02089685|540552943|FG002|Overall Study|Excluded Medication|0|||
149842084|NCT02089685|540552944|FG003|Overall Study|Excluded Medication|11|||
149842085|NCT02089685|540552945|FG004|Overall Study|Excluded Medication|2|||
149842086|NCT02089685|540552946|FG005|Overall Study|Excluded Medication|1|||
149842087|NCT02089685|540552941|FG000|Overall Study|Progressive disease|13|||
149842088|NCT02089685|540552942|FG001|Overall Study|Progressive disease|10|||
149842089|NCT02089685|540552943|FG002|Overall Study|Progressive disease|3|||
149842090|NCT02089685|540552944|FG003|Overall Study|Progressive disease|51|||
149842091|NCT02089685|540552945|FG004|Overall Study|Progressive disease|17|||
149842092|NCT02089685|540552946|FG005|Overall Study|Progressive disease|12|||
149842093|NCT02089685|540552941|FG000|Overall Study|Follow up ended by sponsor|2|||
149842094|NCT02089685|540552942|FG001|Overall Study|Follow up ended by sponsor|2|||
149842095|NCT02089685|540552943|FG002|Overall Study|Follow up ended by sponsor|0|||
149842096|NCT02089685|540552944|FG003|Overall Study|Follow up ended by sponsor|70|||
149842097|NCT02089685|540552945|FG004|Overall Study|Follow up ended by sponsor|26|||
149842098|NCT02089685|540552946|FG005|Overall Study|Follow up ended by sponsor|26|||
149953210|NCT01786109|540960229|FG002|Overall Study|fail manometry barostat tube placement|0|||
149953211|NCT01786109|540960227|FG000|Overall Study|unrelated illness|0|||
149953212|NCT01786109|540960228|FG001|Overall Study|unrelated illness|0|||
149953213|NCT01786109|540960229|FG002|Overall Study|unrelated illness|1|||
149953214|NCT01786109|540960227|FG000|Overall Study|adverse effects colon preparation|0|||
150285944|NCT00440947|542182643|FG004|36-Week Induction Phase|Pregnancy|0|||
149953215|NCT01786109|540960228|FG001|Overall Study|adverse effects colon preparation|0|||
149953216|NCT01786109|540960229|FG002|Overall Study|adverse effects colon preparation|1|||
149953217|NCT01068912|540960234|FG000|Overall Study|Adverse Event|2|||
149953218|NCT01068912|540960235|FG001|Overall Study|Adverse Event|3|||
149953219|NCT01068912|540960236|FG002|Overall Study|Adverse Event|2|||
149953220|NCT01068912|540960234|FG000|Overall Study|Withdrawal by Subject|5|||
149953221|NCT01068912|540960235|FG001|Overall Study|Withdrawal by Subject|6|||
149953222|NCT01068912|540960236|FG002|Overall Study|Withdrawal by Subject|6|||
149953223|NCT01068912|540960234|FG000|Overall Study|Lost to Follow-up|3|||
149953224|NCT01068912|540960235|FG001|Overall Study|Lost to Follow-up|7|||
149953225|NCT01068912|540960236|FG002|Overall Study|Lost to Follow-up|3|||
149953226|NCT01068912|540960234|FG000|Overall Study|Protocol Violation|0|||
149953227|NCT01068912|540960235|FG001|Overall Study|Protocol Violation|2|||
149953228|NCT01068912|540960236|FG002|Overall Study|Protocol Violation|0|||
149953229|NCT01068912|540960234|FG000|Overall Study|aggravation influenza|1|||
149953230|NCT01068912|540960235|FG001|Overall Study|aggravation influenza|1|||
149953231|NCT01068912|540960236|FG002|Overall Study|aggravation influenza|1|||
149953232|NCT01068912|540960234|FG000|Overall Study|other underlying illness|0|||
149953233|NCT01068912|540960235|FG001|Overall Study|other underlying illness|3|||
149953234|NCT01068912|540960236|FG002|Overall Study|other underlying illness|3|||
149953235|NCT02762604|540960237|FG000|Overall Study|Lost to Follow-up|2|||
149953236|NCT02762604|540960238|FG001|Overall Study|Lost to Follow-up|7|||
149953237|NCT02762604|540960237|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
149953238|NCT02762604|540960238|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
149953239|NCT03442569|540960246|FG000|Overall Study|Subject was ineligible after enrollment|1|||
149953240|NCT03010501|540960250|FG000|Study Week 1|Withdrawal by Subject|2|||
150285945|NCT00440947|542182639|FG000|48-Week Randomization Phase|Adverse Event|0|||
150285946|NCT00440947|542182640|FG001|48-Week Randomization Phase|Adverse Event|2|||
149842099|NCT02089685|540552941|FG000|Overall Study|Withdrawal by Subject|0|||
149842100|NCT02089685|540552942|FG001|Overall Study|Withdrawal by Subject|2|||
149842101|NCT02089685|540552943|FG002|Overall Study|Withdrawal by Subject|0|||
149842102|NCT02089685|540552944|FG003|Overall Study|Withdrawal by Subject|8|||
149842103|NCT02089685|540552945|FG004|Overall Study|Withdrawal by Subject|1|||
149842104|NCT02089685|540552946|FG005|Overall Study|Withdrawal by Subject|1|||
149842105|NCT02089685|540552941|FG000|Overall Study|Status not recorded|1|||
149842106|NCT02089685|540552942|FG001|Overall Study|Status not recorded|0|||
149842107|NCT02089685|540552943|FG002|Overall Study|Status not recorded|0|||
149842108|NCT02089685|540552944|FG003|Overall Study|Status not recorded|0|||
149842109|NCT02089685|540552945|FG004|Overall Study|Status not recorded|1|||
149842110|NCT02089685|540552946|FG005|Overall Study|Status not recorded|0|||
149953241|NCT03010501|540960251|FG001|Study Week 1|Withdrawal by Subject|1|||
149953242|NCT03010501|540960252|FG002|Study Week 1|Withdrawal by Subject|0|||
149953243|NCT03010501|540960253|FG003|Study Week 1|Withdrawal by Subject|2|||
150285947|NCT00440947|542182641|FG002|48-Week Randomization Phase|Adverse Event|5|||
150285948|NCT00440947|542182642|FG003|48-Week Randomization Phase|Adverse Event|0|||
149842111|NCT02089685|540552941|FG000|Overall Study|Death|0|||
149842112|NCT02089685|540552942|FG001|Overall Study|Death|0|||
149842113|NCT02089685|540552943|FG002|Overall Study|Death|0|||
149842114|NCT02089685|540552944|FG003|Overall Study|Death|7|||
149842115|NCT02089685|540552945|FG004|Overall Study|Death|2|||
149842116|NCT02089685|540552946|FG005|Overall Study|Death|5|||
149842117|NCT02089685|540552941|FG000|Overall Study|Lost to Follow-up|0|||
149842118|NCT02089685|540552942|FG001|Overall Study|Lost to Follow-up|0|||
149842119|NCT02089685|540552943|FG002|Overall Study|Lost to Follow-up|0|||
149842120|NCT02089685|540552944|FG003|Overall Study|Lost to Follow-up|1|||
149842121|NCT02089685|540552945|FG004|Overall Study|Lost to Follow-up|0|||
149842122|NCT02089685|540552946|FG005|Overall Study|Lost to Follow-up|0|||
149842123|NCT02089685|540552941|FG000|Overall Study|Physician Decision|0|||
149842124|NCT02089685|540552942|FG001|Overall Study|Physician Decision|0|||
149842125|NCT02089685|540552943|FG002|Overall Study|Physician Decision|0|||
149842126|NCT02089685|540552944|FG003|Overall Study|Physician Decision|0|||
149842127|NCT02089685|540552945|FG004|Overall Study|Physician Decision|0|||
149842128|NCT02089685|540552946|FG005|Overall Study|Physician Decision|4|||
149842129|NCT02089685|540552941|FG000|Overall Study|Screen failure|1|||
149842130|NCT02089685|540552942|FG001|Overall Study|Screen failure|0|||
150285949|NCT00440947|542182643|FG004|48-Week Randomization Phase|Adverse Event|0|||
149842131|NCT02089685|540552943|FG002|Overall Study|Screen failure|0|||
149842132|NCT02089685|540552944|FG003|Overall Study|Screen failure|0|||
149842133|NCT02089685|540552945|FG004|Overall Study|Screen failure|0|||
149842134|NCT02089685|540552946|FG005|Overall Study|Screen failure|0|||
149842135|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Adverse Event|11|||
149842136|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Adverse Event|23|||
149842137|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Adverse Event|29|||
149842138|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Adverse Event|2|||
149842139|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Adverse Event|8|||
149842140|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
149842141|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
149842142|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
149842143|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
149842144|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
149842145|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
149842146|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
149842147|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
149842148|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
149842149|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
149842150|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
149842151|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
149842152|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
149842153|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
149842154|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
149842155|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
149842156|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
149842157|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
149842158|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
149842159|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
149842160|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
149842161|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
149842162|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
149842163|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
149842164|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
149842165|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
149842166|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
149842167|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
149842168|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
149842169|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
149842170|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Move|0|||
149842171|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Move|1|||
149953244|NCT03010501|540960254|FG004|Study Week 1|Withdrawal by Subject|0|||
149953245|NCT03010501|540960255|FG005|Study Week 1|Withdrawal by Subject|0|||
149953246|NCT03010501|540960250|FG000|Study Week 3|Withdrawal by Subject|0|||
149953247|NCT03010501|540960251|FG001|Study Week 3|Withdrawal by Subject|0|||
150285950|NCT00440947|542182639|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
149842172|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Move|0|||
149842173|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Move|0|||
149842174|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Move|0|||
149842175|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
149842176|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
149842177|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
150285951|NCT00440947|542182640|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
150285952|NCT00440947|542182641|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
150285953|NCT00440947|542182642|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
150285954|NCT00440947|542182643|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
150285955|NCT00440947|542182639|FG000|48-Week Randomization Phase|Non-compliance|0|||
150285956|NCT00440947|542182640|FG001|48-Week Randomization Phase|Non-compliance|3|||
150285957|NCT00440947|542182641|FG002|48-Week Randomization Phase|Non-compliance|4|||
150285958|NCT00440947|542182642|FG003|48-Week Randomization Phase|Non-compliance|0|||
150285959|NCT00440947|542182643|FG004|48-Week Randomization Phase|Non-compliance|0|||
150285960|NCT00440947|542182639|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
150285961|NCT00440947|542182640|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
150285962|NCT00440947|542182641|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
150285963|NCT00440947|542182642|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
150285964|NCT00440947|542182643|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
150285965|NCT00440947|542182639|FG000|48-Week Randomization Phase|Protocol Violation|0|||
150285966|NCT00440947|542182640|FG001|48-Week Randomization Phase|Protocol Violation|0|||
150285967|NCT00440947|542182641|FG002|48-Week Randomization Phase|Protocol Violation|1|||
150285968|NCT00440947|542182642|FG003|48-Week Randomization Phase|Protocol Violation|0|||
150285969|NCT00440947|542182643|FG004|48-Week Randomization Phase|Protocol Violation|0|||
150285970|NCT00440947|542182639|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
150285971|NCT00440947|542182640|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
150285972|NCT00440947|542182641|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
150285973|NCT00440947|542182642|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
150285974|NCT00440947|542182643|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
150285975|NCT00440947|542182639|FG000|48-Week Randomization Phase|Pregnancy|0|||
150285976|NCT00440947|542182640|FG001|48-Week Randomization Phase|Pregnancy|0|||
150285977|NCT00440947|542182641|FG002|48-Week Randomization Phase|Pregnancy|1|||
150285978|NCT00440947|542182642|FG003|48-Week Randomization Phase|Pregnancy|0|||
150285979|NCT00440947|542182643|FG004|48-Week Randomization Phase|Pregnancy|0|||
150285980|NCT00440947|542182639|FG000|48-Week Randomization Phase|Incarceration|0|||
150285981|NCT00440947|542182640|FG001|48-Week Randomization Phase|Incarceration|3|||
150285982|NCT00440947|542182641|FG002|48-Week Randomization Phase|Incarceration|0|||
150285983|NCT00440947|542182642|FG003|48-Week Randomization Phase|Incarceration|0|||
150285984|NCT00440947|542182643|FG004|48-Week Randomization Phase|Incarceration|0|||
149953248|NCT03010501|540960252|FG002|Study Week 3|Withdrawal by Subject|0|||
149953249|NCT03010501|540960253|FG003|Study Week 3|Withdrawal by Subject|1|||
149953250|NCT03010501|540960254|FG004|Study Week 3|Withdrawal by Subject|0|||
149953251|NCT03010501|540960255|FG005|Study Week 3|Withdrawal by Subject|0|||
149953252|NCT00308685|540960266|FG000|Overall Study|Lost to Follow-up|1|||
149953253|NCT00308685|540960267|FG001|Overall Study|Lost to Follow-up|0|||
149953254|NCT00308685|540960266|FG000|Overall Study|Need to administer prohibited medication|1|||
149953255|NCT00308685|540960267|FG001|Overall Study|Need to administer prohibited medication|2|||
149953256|NCT00308685|540960266|FG000|Overall Study|Other than specified|1|||
149953257|NCT00308685|540960267|FG001|Overall Study|Other than specified|3|||
149953258|NCT04937387|540960268|FG000|Overall Study|Adverse Event|1|||
149953259|NCT04937387|540960269|FG001|Overall Study|Adverse Event|0|||
149953260|NCT04937387|540960270|FG002|Overall Study|Adverse Event|2|||
149953261|NCT04937387|540960271|FG003|Overall Study|Adverse Event|0|||
149953262|NCT04937387|540960268|FG000|Overall Study|Lack of Efficacy|1|||
149953263|NCT04937387|540960269|FG001|Overall Study|Lack of Efficacy|0|||
149953264|NCT04937387|540960270|FG002|Overall Study|Lack of Efficacy|0|||
149953265|NCT04937387|540960271|FG003|Overall Study|Lack of Efficacy|1|||
149953266|NCT04937387|540960268|FG000|Overall Study|Withdrawal by Subject|1|||
149953267|NCT04937387|540960269|FG001|Overall Study|Withdrawal by Subject|0|||
149953268|NCT04937387|540960270|FG002|Overall Study|Withdrawal by Subject|1|||
149953269|NCT04937387|540960271|FG003|Overall Study|Withdrawal by Subject|1|||
149953270|NCT04937387|540960268|FG000|Overall Study|Randomized in error|0|||
149953271|NCT04937387|540960269|FG001|Overall Study|Randomized in error|0|||
150285985|NCT00440947|542182639|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
150285986|NCT00440947|542182640|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
149953272|NCT04937387|540960270|FG002|Overall Study|Randomized in error|0|||
149953273|NCT04937387|540960271|FG003|Overall Study|Randomized in error|1|||
149953274|NCT03853798|540960276|FG000|Overall Study|Death|0|||
149953275|NCT03853798|540960277|FG001|Overall Study|Death|0|||
149953276|NCT03853798|540960278|FG002|Overall Study|Death|0|||
149953277|NCT03853798|540960279|FG003|Overall Study|Death|0|||
149953278|NCT03853798|540960280|FG004|Overall Study|Death|0|||
149953279|NCT03853798|540960281|FG005|Overall Study|Death|1|||
149953280|NCT03853798|540960282|FG006|Overall Study|Death|0|||
149953281|NCT03853798|540960283|FG007|Overall Study|Death|0|||
149953282|NCT03853798|540960284|FG008|Overall Study|Death|0|||
149953283|NCT03853798|540960276|FG000|Overall Study|Adverse Event|0|||
150285987|NCT00440947|542182641|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
149953284|NCT03853798|540960277|FG001|Overall Study|Adverse Event|0|||
150285988|NCT00440947|542182642|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
150285989|NCT00440947|542182643|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
150285990|NCT00440947|542182639|FG000|48-Week Randomization Phase|Physician Decision|0|||
150285991|NCT00440947|542182640|FG001|48-Week Randomization Phase|Physician Decision|2|||
150285992|NCT00440947|542182641|FG002|48-Week Randomization Phase|Physician Decision|0|||
150285993|NCT00440947|542182642|FG003|48-Week Randomization Phase|Physician Decision|0|||
150285994|NCT00440947|542182643|FG004|48-Week Randomization Phase|Physician Decision|0|||
150285995|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
150285996|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
150285997|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
150285998|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
150285999|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
150286000|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
150286001|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
150286002|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
150286003|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
150286004|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
150286005|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
150286006|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
150286007|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
150286008|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
150286009|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
150286010|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
150286011|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
150286012|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
150286013|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
150286014|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
150286015|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
150286016|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
150286017|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
150286018|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
150286019|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
150286020|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
150286021|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
150286022|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
150286023|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
150286024|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
150286025|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
150286026|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
150286027|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
150286028|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
150286029|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
150286030|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
150286031|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
150286032|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
150286033|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
149842178|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
149842179|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
149842180|NCT00318461|540552949|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
149842181|NCT00318461|540552950|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
149842182|NCT00318461|540552951|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
149842183|NCT00318461|540552952|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
149842184|NCT00318461|540552953|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
149842185|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Work commitment|0|||
149842186|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Work commitment|0|||
149842187|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Work commitment|0|||
149842188|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Work commitment|0|||
149842189|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Work commitment|1|||
149953285|NCT03853798|540960278|FG002|Overall Study|Adverse Event|2|||
149953286|NCT03853798|540960279|FG003|Overall Study|Adverse Event|0|||
149953287|NCT03853798|540960280|FG004|Overall Study|Adverse Event|0|||
149953288|NCT03853798|540960281|FG005|Overall Study|Adverse Event|0|||
149953289|NCT03853798|540960282|FG006|Overall Study|Adverse Event|0|||
150286034|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
149953290|NCT03853798|540960283|FG007|Overall Study|Adverse Event|0|||
149842190|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Investigator decision|0|||
149953291|NCT03853798|540960284|FG008|Overall Study|Adverse Event|0|||
150286035|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
150286036|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
150286037|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
150286038|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
150286039|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
150286040|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
150286041|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
150286042|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
150286043|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
150286044|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
150286045|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
150286046|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
150286047|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
150286048|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
150286049|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
150286050|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Other|0|||
150286051|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Other|0|||
150286052|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Other|0|||
150286053|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Other|1|||
150286054|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Other|0|||
150286055|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
150286056|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
150286057|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
150286058|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
150286059|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
149842191|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Investigator decision|0|||
149842192|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Investigator decision|0|||
149842193|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Investigator decision|0|||
149842194|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Investigator decision|1|||
149842195|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Lack of time|1|||
149842196|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Lack of time|0|||
149842197|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Lack of time|0|||
149842198|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Lack of time|0|||
149842199|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Lack of time|0|||
149842200|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
149842201|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
149842202|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
149842203|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
149842204|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
149953292|NCT03853798|540960276|FG000|Overall Study|Withdrawal by Subject|0|||
149953293|NCT03853798|540960277|FG001|Overall Study|Withdrawal by Subject|1|||
149953294|NCT03853798|540960278|FG002|Overall Study|Withdrawal by Subject|4|||
149953295|NCT03853798|540960279|FG003|Overall Study|Withdrawal by Subject|0|||
149953296|NCT03853798|540960280|FG004|Overall Study|Withdrawal by Subject|0|||
149953297|NCT03853798|540960281|FG005|Overall Study|Withdrawal by Subject|5|||
149953298|NCT03853798|540960282|FG006|Overall Study|Withdrawal by Subject|0|||
149953299|NCT03853798|540960283|FG007|Overall Study|Withdrawal by Subject|0|||
149953300|NCT03853798|540960284|FG008|Overall Study|Withdrawal by Subject|4|||
149953301|NCT03853798|540960276|FG000|Overall Study|Physician Decision|1|||
149953302|NCT03853798|540960277|FG001|Overall Study|Physician Decision|0|||
149953303|NCT03853798|540960278|FG002|Overall Study|Physician Decision|0|||
149953304|NCT03853798|540960279|FG003|Overall Study|Physician Decision|0|||
149953305|NCT03853798|540960280|FG004|Overall Study|Physician Decision|0|||
149953306|NCT03853798|540960281|FG005|Overall Study|Physician Decision|0|||
149953307|NCT03853798|540960282|FG006|Overall Study|Physician Decision|0|||
149953308|NCT03853798|540960283|FG007|Overall Study|Physician Decision|0|||
149953309|NCT03853798|540960284|FG008|Overall Study|Physician Decision|1|||
149953310|NCT03853798|540960276|FG000|Overall Study|Lack of Efficacy|0|||
149953311|NCT03853798|540960277|FG001|Overall Study|Lack of Efficacy|0|||
149953312|NCT03853798|540960278|FG002|Overall Study|Lack of Efficacy|2|||
149953313|NCT03853798|540960279|FG003|Overall Study|Lack of Efficacy|0|||
149953314|NCT03853798|540960280|FG004|Overall Study|Lack of Efficacy|0|||
150172475|NCT04860258|541767959|FG002|Overall Study|Withdrawal by Subject|4|||
150286060|NCT00440947|542182639|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
149953315|NCT03853798|540960281|FG005|Overall Study|Lack of Efficacy|0|||
149953316|NCT03853798|540960282|FG006|Overall Study|Lack of Efficacy|0|||
149953317|NCT03853798|540960283|FG007|Overall Study|Lack of Efficacy|0|||
149953318|NCT03853798|540960284|FG008|Overall Study|Lack of Efficacy|1|||
149953319|NCT03853798|540960276|FG000|Overall Study|Approved Drug Available for Indication|0|||
149842205|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
149953320|NCT03853798|540960277|FG001|Overall Study|Approved Drug Available for Indication|0|||
149953321|NCT03853798|540960278|FG002|Overall Study|Approved Drug Available for Indication|1|||
149842206|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
149842207|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
149842208|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
149842209|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
149842210|NCT00318461|540552949|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
149842211|NCT00318461|540552950|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
149842212|NCT00318461|540552951|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
149842213|NCT00318461|540552952|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
149842214|NCT00318461|540552953|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
149842215|NCT00318461|540552949|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
149842216|NCT00318461|540552950|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
149842217|NCT00318461|540552951|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
149842218|NCT00318461|540552952|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
149842219|NCT00318461|540552953|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
149842220|NCT00318461|540552949|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
149842221|NCT00318461|540552950|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
149842222|NCT00318461|540552951|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
149842223|NCT00318461|540552952|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
149842224|NCT00318461|540552953|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
149842225|NCT00318461|540552949|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
149842226|NCT00318461|540552950|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
149842227|NCT00318461|540552951|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
149842228|NCT00318461|540552952|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
149842229|NCT00318461|540552953|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
149953322|NCT03853798|540960279|FG003|Overall Study|Approved Drug Available for Indication|0|||
149953323|NCT03853798|540960280|FG004|Overall Study|Approved Drug Available for Indication|0|||
149953324|NCT03853798|540960281|FG005|Overall Study|Approved Drug Available for Indication|1|||
149953325|NCT03853798|540960282|FG006|Overall Study|Approved Drug Available for Indication|0|||
149953326|NCT03853798|540960283|FG007|Overall Study|Approved Drug Available for Indication|0|||
149953327|NCT03853798|540960284|FG008|Overall Study|Approved Drug Available for Indication|0|||
149953328|NCT03853798|540960276|FG000|Overall Study|Other un-specified|0|||
149953329|NCT03853798|540960277|FG001|Overall Study|Other un-specified|0|||
149953330|NCT03853798|540960278|FG002|Overall Study|Other un-specified|2|||
149953331|NCT03853798|540960279|FG003|Overall Study|Other un-specified|0|||
149953332|NCT03853798|540960280|FG004|Overall Study|Other un-specified|0|||
149842230|NCT00318461|540552949|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
149842231|NCT00318461|540552950|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
149842232|NCT00318461|540552951|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
149842233|NCT00318461|540552952|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
149842234|NCT00318461|540552953|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
149842235|NCT00318461|540552949|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
149842236|NCT00318461|540552950|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
149842237|NCT00318461|540552951|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
149842238|NCT00318461|540552952|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
149842239|NCT00318461|540552953|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
149842240|NCT00505622|540552961|FG000|Overall Study|Adverse Event|5|||
149842241|NCT00505622|540552962|FG001|Overall Study|Adverse Event|6|||
149842242|NCT00505622|540552963|FG002|Overall Study|Adverse Event|4|||
149842243|NCT00505622|540552961|FG000|Overall Study|Protocol Violation|1|||
149842244|NCT00505622|540552962|FG001|Overall Study|Protocol Violation|1|||
149842245|NCT00505622|540552963|FG002|Overall Study|Protocol Violation|0|||
149842246|NCT00505622|540552961|FG000|Overall Study|Withdrawal by Subject|0|||
149842247|NCT00505622|540552962|FG001|Overall Study|Withdrawal by Subject|3|||
149842248|NCT00505622|540552963|FG002|Overall Study|Withdrawal by Subject|2|||
149842249|NCT00505622|540552961|FG000|Overall Study|Study termination by sponsor|115|||
149842250|NCT00505622|540552962|FG001|Overall Study|Study termination by sponsor|98|||
149842251|NCT00505622|540552963|FG002|Overall Study|Study termination by sponsor|90|||
149842252|NCT03084471|540552964|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
149842253|NCT03084471|540552964|FG000|Overall Study|Condition under investigation worsened|84|||
149842254|NCT03084471|540552964|FG000|Overall Study|Lack of therapeutic response|2|||
149842255|NCT03084471|540552964|FG000|Overall Study|Protocol Violation|1|||
149842256|NCT03084471|540552964|FG000|Overall Study|Adverse Event|73|||
149953333|NCT03853798|540960281|FG005|Overall Study|Other un-specified|1|||
149842257|NCT03084471|540552964|FG000|Overall Study|Withdrawal by Subject|12|||
149842258|NCT03084471|540552964|FG000|Overall Study|Disease relapse|181|||
149842259|NCT03084471|540552964|FG000|Overall Study|Subjective disease progression|359|||
149842260|NCT03084471|540552964|FG000|Overall Study|Other (as recorded)|33|||
149842261|NCT03084471|540552964|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
149953334|NCT03853798|540960282|FG006|Overall Study|Other un-specified|0|||
149953335|NCT03853798|540960283|FG007|Overall Study|Other un-specified|0|||
150286061|NCT00440947|542182640|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
150286062|NCT00440947|542182641|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
150286063|NCT00440947|542182642|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
150286064|NCT00440947|542182643|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
150286065|NCT01827670|542182644|FG000|Overall Study|Withdrawal of Consent|3|||
150286066|NCT01827670|542182645|FG001|Overall Study|Withdrawal of Consent|2|||
150286067|NCT01827670|542182644|FG000|Overall Study|Lost to Follow-up|0|||
149842262|NCT01848938|540552973|FG000|Overall Study|Lost to Follow-up|1|||
149842263|NCT01848938|540552974|FG001|Overall Study|Lost to Follow-up|1|||
149842264|NCT01757392|540552975|FG000|Overall Study|Withdrawal by Subject|1|||
149842265|NCT01757392|540552975|FG000|Overall Study|Screen Fail|3|||
149842266|NCT00207090|540552980|FG000|Overall Study|Study drug toxicity|3|||
149842267|NCT00207090|540552980|FG000|Overall Study|Chest wall mass larger|1|||
149842268|NCT00207090|540552980|FG000|Overall Study|Disease progression/relapse|2|||
149842269|NCT00207090|540552980|FG000|Overall Study|Physician Decision|1|||
149842270|NCT00841698|540552983|FG000|First Intervention|Withdrawal by Subject|1|||
149842271|NCT00841698|540552984|FG001|First Intervention|Withdrawal by Subject|0|||
149842272|NCT00835692|540552985|FG000|First Intervention|Withdrawal by Subject|1|||
149842273|NCT00835692|540552986|FG001|First Intervention|Withdrawal by Subject|0|||
149842274|NCT04078022|540552991|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
149842275|NCT04078022|540552992|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
149842276|NCT00191815|540552993|FG000|Overall Study|Adverse Event|2|||
149842277|NCT00191815|540552993|FG000|Overall Study|Disease progression or relapse|24|||
149842278|NCT00191815|540552993|FG000|Overall Study|Death|2|||
149842279|NCT00191815|540552993|FG000|Overall Study|Protocol Violation|3|||
149842280|NCT00191815|540552993|FG000|Overall Study|Physician Decision|2|||
149842281|NCT00191815|540552993|FG000|Overall Study|Withdrawal by Subject|7|||
149842282|NCT03644550|540552994|FG000|Overall Study|Withdrawal by Subject|3|||
149842283|NCT03644550|540552994|FG000|Overall Study|Progressive disease|15|||
149842284|NCT01348789|540552997|FG000|Overall Study|Protocol Violation|2|||
149842285|NCT01348789|540552997|FG000|Overall Study|Withdrawal by Subject|2|||
149842286|NCT00830024|540553002|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
149842287|NCT00830024|540553003|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
149842288|NCT01983969|540553004|FG000|Overall Study|Disease Progression|0|||
149842289|NCT01983969|540553005|FG001|Overall Study|Disease Progression|1|||
149842290|NCT01983969|540553006|FG002|Overall Study|Disease Progression|0|||
149842291|NCT02619682|540553007|FG000|Overall Study|Withdrawal by Subject|3|||
149842292|NCT02619682|540553007|FG000|Overall Study|Lack of Efficacy|8|||
149842293|NCT02619682|540553007|FG000|Overall Study|new secondary cancer|1|||
149842294|NCT02619682|540553007|FG000|Overall Study|post surgery complications|2|||
149842295|NCT00268203|540553008|FG000|Overall Study|Lost to Follow-up|92|||
149842296|NCT00268203|540553008|FG000|Overall Study|Withdrawal by Subject|9|||
149842297|NCT00268203|540553008|FG000|Overall Study|Received Other NHL Therapy|7|||
149842298|NCT00268203|540553008|FG000|Overall Study|Progressive Disease|359|||
149842299|NCT00268203|540553008|FG000|Overall Study|Death|84|||
149842300|NCT00268203|540553008|FG000|Overall Study|Reason Not Specified|34|||
149842301|NCT00268203|540553008|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
149842302|NCT03600376|540553009|FG000|Overall Study|Adverse Event|1|||
149842303|NCT03600376|540553010|FG001|Overall Study|Adverse Event|1|||
149842304|NCT03600376|540553009|FG000|Overall Study|Transferred to other facility|1|||
149842305|NCT03600376|540553010|FG001|Overall Study|Transferred to other facility|0|||
149842306|NCT03600376|540553009|FG000|Overall Study|Investigator Decision|0|||
149842307|NCT03600376|540553010|FG001|Overall Study|Investigator Decision|4|||
149842308|NCT03600376|540553009|FG000|Overall Study|Determined to be ineligible for study|0|||
149842309|NCT03600376|540553010|FG001|Overall Study|Determined to be ineligible for study|1|||
149842310|NCT03804983|540553011|FG000|Overall Study|Adverse Event|0|||
149842311|NCT03804983|540553012|FG001|Overall Study|Adverse Event|1|||
149842312|NCT03804983|540553011|FG000|Overall Study|Family Obligation|1|||
149842313|NCT03804983|540553012|FG001|Overall Study|Family Obligation|0|||
149842314|NCT02152163|540553013|FG000|Overall Study|Physician Decision|12|||
149842315|NCT02152163|540553014|FG001|Overall Study|Physician Decision|13|||
149842316|NCT02358538|540553018|FG000|Through Week 26|Adverse Event|0|||
149842317|NCT02358538|540553019|FG001|Through Week 26|Adverse Event|1|||
150286068|NCT01827670|542182645|FG001|Overall Study|Lost to Follow-up|1|||
150286069|NCT02813694|542182653|FG000|Overall Study|Physician Decision|0|||
149842318|NCT02358538|540553020|FG002|Through Week 26|Adverse Event|1|||
150286070|NCT02813694|542182654|FG001|Overall Study|Physician Decision|1|||
149842319|NCT02358538|540553021|FG003|Through Week 26|Adverse Event|2|||
149842320|NCT02358538|540553018|FG000|Through Week 26|Lack of Efficacy|1|||
149842321|NCT02358538|540553019|FG001|Through Week 26|Lack of Efficacy|1|||
149842322|NCT02358538|540553020|FG002|Through Week 26|Lack of Efficacy|3|||
149842323|NCT02358538|540553021|FG003|Through Week 26|Lack of Efficacy|3|||
149842324|NCT02358538|540553018|FG000|Through Week 26|Withdrawal by Subject|1|||
149842325|NCT02358538|540553019|FG001|Through Week 26|Withdrawal by Subject|0|||
149842326|NCT02358538|540553020|FG002|Through Week 26|Withdrawal by Subject|0|||
149842327|NCT02358538|540553021|FG003|Through Week 26|Withdrawal by Subject|0|||
149842328|NCT02358538|540553018|FG000|Through Week 26|Non-Compliance|0|||
149842329|NCT02358538|540553019|FG001|Through Week 26|Non-Compliance|0|||
149842330|NCT02358538|540553020|FG002|Through Week 26|Non-Compliance|1|||
149842331|NCT02358538|540553021|FG003|Through Week 26|Non-Compliance|0|||
149842332|NCT02358538|540553018|FG000|Through Week 26|Family did not see benefit from IP|1|||
149842333|NCT02358538|540553019|FG001|Through Week 26|Family did not see benefit from IP|0|||
149842334|NCT02358538|540553020|FG002|Through Week 26|Family did not see benefit from IP|0|||
149842335|NCT02358538|540553021|FG003|Through Week 26|Family did not see benefit from IP|0|||
149842336|NCT02358538|540553018|FG000|52 Week Extension Period|Lack of Efficacy|0|||
149842337|NCT02358538|540553019|FG001|52 Week Extension Period|Lack of Efficacy|0|||
149842338|NCT02358538|540553020|FG002|52 Week Extension Period|Lack of Efficacy|2|||
149842339|NCT02358538|540553021|FG003|52 Week Extension Period|Lack of Efficacy|4|||
149842340|NCT06999265|540553022|FG000|Overall Study|Lost to Follow-up|1|||
149842341|NCT06999265|540553023|FG001|Overall Study|Lost to Follow-up|1|||
149842342|NCT01154231|540553024|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
149842343|NCT01154231|540553024|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
149842344|NCT00835705|540554671|FG000|First Intervention|Difficulty with vein|1|||
149842345|NCT00835705|540554672|FG001|First Intervention|Difficulty with vein|0|||
149842346|NCT00835705|540554671|FG000|Second Intervention|Difficulty with vein|1|||
149842347|NCT00835705|540554672|FG001|Second Intervention|Difficulty with vein|0|||
149842348|NCT01750294|540554673|FG000|Overall Study|Withdrawal by Subject|1|||
149842349|NCT01750294|540554673|FG000|Overall Study|Safety Endpoint|1|||
149842350|NCT00665925|540554674|FG000|Overall Study|Lack of Efficacy|10|||
149842351|NCT00665925|540554675|FG001|Overall Study|Lack of Efficacy|8|||
149842352|NCT00665925|540554676|FG002|Overall Study|Lack of Efficacy|9|||
149842353|NCT00665925|540554677|FG003|Overall Study|Lack of Efficacy|8|||
149842354|NCT00665925|540554674|FG000|Overall Study|Lost to Follow-up|1|||
149842355|NCT00665925|540554675|FG001|Overall Study|Lost to Follow-up|2|||
149842356|NCT00665925|540554676|FG002|Overall Study|Lost to Follow-up|2|||
149842357|NCT00665925|540554677|FG003|Overall Study|Lost to Follow-up|2|||
149842358|NCT00665925|540554674|FG000|Overall Study|Withdrawal by Subject|2|||
149842359|NCT00665925|540554675|FG001|Overall Study|Withdrawal by Subject|2|||
149842360|NCT00665925|540554676|FG002|Overall Study|Withdrawal by Subject|3|||
149842361|NCT00665925|540554677|FG003|Overall Study|Withdrawal by Subject|2|||
149842362|NCT00665925|540554674|FG000|Overall Study|Physician Decision|0|||
149842363|NCT00665925|540554675|FG001|Overall Study|Physician Decision|0|||
149842364|NCT00665925|540554676|FG002|Overall Study|Physician Decision|1|||
149842365|NCT00665925|540554677|FG003|Overall Study|Physician Decision|2|||
149842366|NCT00665925|540554674|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
149842367|NCT00665925|540554675|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
149842368|NCT00665925|540554676|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
149842369|NCT00665925|540554677|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
149842370|NCT00665925|540554674|FG000|Overall Study|Adverse Event|1|||
149842371|NCT00665925|540554675|FG001|Overall Study|Adverse Event|5|||
149842372|NCT00665925|540554676|FG002|Overall Study|Adverse Event|10|||
149842373|NCT00665925|540554677|FG003|Overall Study|Adverse Event|5|||
149842374|NCT00665925|540554674|FG000|Overall Study|Enrolled by mistake|0|||
149842375|NCT00665925|540554675|FG001|Overall Study|Enrolled by mistake|0|||
149842376|NCT00665925|540554676|FG002|Overall Study|Enrolled by mistake|0|||
149842377|NCT00665925|540554677|FG003|Overall Study|Enrolled by mistake|1|||
149842378|NCT00665925|540554674|FG000|Overall Study|Due to exclusion criteria|1|||
149842379|NCT00665925|540554675|FG001|Overall Study|Due to exclusion criteria|0|||
149842380|NCT00665925|540554676|FG002|Overall Study|Due to exclusion criteria|0|||
149842381|NCT00665925|540554677|FG003|Overall Study|Due to exclusion criteria|0|||
149842382|NCT04035187|540554678|FG000|Overall Study|Withdrawal by Subject|2|||
149953336|NCT03853798|540960284|FG008|Overall Study|Other un-specified|0|||
149953337|NCT02743494|540960285|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
149953338|NCT02743494|540960286|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
149953339|NCT02743494|540960285|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
149953340|NCT02743494|540960286|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
149953341|NCT02743494|540960285|FG000|Treatment Period|Disease recurrence|152|||
149842383|NCT04035187|540554679|FG001|Overall Study|Withdrawal by Subject|1|||
149953342|NCT02743494|540960286|FG001|Treatment Period|Disease recurrence|115|||
149953343|NCT02743494|540960285|FG000|Treatment Period|Study drug toxicity|56|||
149953344|NCT02743494|540960286|FG001|Treatment Period|Study drug toxicity|8|||
149842384|NCT04035187|540554680|FG002|Overall Study|Withdrawal by Subject|0|||
149842385|NCT04035187|540554681|FG003|Overall Study|Withdrawal by Subject|0|||
149842386|NCT04035187|540554678|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
149842387|NCT04035187|540554679|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
149842388|NCT04035187|540554680|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
149842389|NCT04035187|540554681|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
149842390|NCT05090839|540554686|FG000|Overall Study|Lost to Follow-up|2|||
149842391|NCT05090839|540554687|FG001|Overall Study|Lost to Follow-up|3|||
149953345|NCT02743494|540960285|FG000|Treatment Period|Death|1|||
149842392|NCT05090839|540554688|FG002|Overall Study|Lost to Follow-up|1|||
149842393|NCT05090839|540554689|FG003|Overall Study|Lost to Follow-up|1|||
149842394|NCT00373256|540554690|FG000|Overall Study|Adverse Event (AE)|1|||
149842395|NCT00373256|540554691|FG001|Overall Study|Adverse Event (AE)|5|||
149842396|NCT00373256|540554690|FG000|Overall Study|Lost to Follow-up|2|||
149842397|NCT00373256|540554691|FG001|Overall Study|Lost to Follow-up|1|||
149842398|NCT00373256|540554690|FG000|Overall Study|Death|9|||
149842399|NCT00373256|540554691|FG001|Overall Study|Death|8|||
149842400|NCT00373256|540554690|FG000|Overall Study|Objective Progression or Relapse|111|||
149842401|NCT00373256|540554691|FG001|Overall Study|Objective Progression or Relapse|104|||
150286071|NCT02813694|542182653|FG000|Overall Study|Withdrawal by Subject|10|||
150286072|NCT02813694|542182654|FG001|Overall Study|Withdrawal by Subject|9|||
150286073|NCT02813694|542182653|FG000|Overall Study|Lost to Follow-up|1|||
150286074|NCT02813694|542182654|FG001|Overall Study|Lost to Follow-up|1|||
150286075|NCT02813694|542182653|FG000|Overall Study|Death|3|||
150286076|NCT02813694|542182654|FG001|Overall Study|Death|3|||
150286077|NCT02813694|542182653|FG000|Overall Study|Randomized- did not receive study drug|2|||
150286078|NCT02813694|542182654|FG001|Overall Study|Randomized- did not receive study drug|0|||
150286079|NCT02813694|542182653|FG000|Overall Study|Patient hospitalized|1|||
150286080|NCT02813694|542182654|FG001|Overall Study|Patient hospitalized|0|||
150286081|NCT01152021|542182662|FG000|Overall Study|Adverse Event|4|||
150286082|NCT01152021|542182663|FG001|Overall Study|Adverse Event|4|||
150286083|NCT01152021|542182662|FG000|Overall Study|Study drug had expired|1|||
150286084|NCT01152021|542182663|FG001|Overall Study|Study drug had expired|0|||
150286085|NCT01152021|542182662|FG000|Overall Study|Physician Decision|1|||
150286086|NCT01152021|542182663|FG001|Overall Study|Physician Decision|1|||
150286087|NCT01152021|542182662|FG000|Overall Study|No access to study drug in Pharmacy|0|||
150286088|NCT01152021|542182663|FG001|Overall Study|No access to study drug in Pharmacy|1|||
149842402|NCT00373256|540554690|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
149842403|NCT00373256|540554691|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
149842404|NCT00373256|540554690|FG000|Overall Study|Other|73|||
149953346|NCT02743494|540960286|FG001|Treatment Period|Death|1|||
149953347|NCT02743494|540960285|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
149953348|NCT02743494|540960286|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
149953349|NCT02743494|540960285|FG000|Treatment Period|Participant request to discontinue treatment|31|||
149953350|NCT02743494|540960286|FG001|Treatment Period|Participant request to discontinue treatment|5|||
149953351|NCT02743494|540960285|FG000|Treatment Period|Participant withdrew consent|11|||
149953352|NCT02743494|540960286|FG001|Treatment Period|Participant withdrew consent|4|||
149953353|NCT02743494|540960285|FG000|Treatment Period|Lost to Follow-up|0|||
149953354|NCT02743494|540960286|FG001|Treatment Period|Lost to Follow-up|1|||
149953355|NCT02743494|540960285|FG000|Treatment Period|Poor/Non-compliance|2|||
149953356|NCT02743494|540960286|FG001|Treatment Period|Poor/Non-compliance|0|||
149953357|NCT02743494|540960285|FG000|Treatment Period|Other reasons|4|||
149953358|NCT02743494|540960286|FG001|Treatment Period|Other reasons|1|||
149953359|NCT05399485|540961401|FG000|DBT Phase|Other|6|||
149953360|NCT05399485|540961402|FG001|DBT Phase|Other|5|||
149953361|NCT05399485|540961401|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
149953362|NCT05399485|540961402|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
149953363|NCT05399485|540961401|FG000|DBT Phase|Withdrawal by Subject|3|||
149953364|NCT05399485|540961402|FG001|DBT Phase|Withdrawal by Subject|2|||
149953365|NCT05399485|540961401|FG000|DBT Phase|Protocol Violation|2|||
149953366|NCT05399485|540961402|FG001|DBT Phase|Protocol Violation|1|||
149953367|NCT05399485|540961401|FG000|DBT Phase|Physician Decision|0|||
149953368|NCT05399485|540961402|FG001|DBT Phase|Physician Decision|1|||
149953369|NCT05399485|540961401|FG000|DBT Phase|Adverse Event|2|||
149953370|NCT05399485|540961402|FG001|DBT Phase|Adverse Event|1|||
149953371|NCT05399485|540961401|FG000|OLE Phase|Protocol deviation|1|||
149953372|NCT05399485|540961402|FG001|OLE Phase|Protocol deviation|0|||
149953373|NCT05399485|540961401|FG000|OLE Phase|Other|5|||
149953374|NCT05399485|540961402|FG001|OLE Phase|Other|5|||
149953375|NCT05399485|540961401|FG000|OLE Phase|Withdrawal by Subject|12|||
149953376|NCT05399485|540961402|FG001|OLE Phase|Withdrawal by Subject|7|||
149953377|NCT05399485|540961401|FG000|OLE Phase|Pregnancy|0|||
149953378|NCT05399485|540961402|FG001|OLE Phase|Pregnancy|2|||
149953379|NCT05399485|540961401|FG000|OLE Phase|Physician Decision|3|||
149953380|NCT05399485|540961402|FG001|OLE Phase|Physician Decision|0|||
150286089|NCT02595723|542182664|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
149953381|NCT05399485|540961401|FG000|OLE Phase|Adverse Event|2|||
149953382|NCT05399485|540961402|FG001|OLE Phase|Adverse Event|2|||
150286090|NCT02595723|542182665|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
150286091|NCT02595723|542182666|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
149953383|NCT01363076|540961405|FG000|Overall Study|Withdrawal by Subject|0|||
149953384|NCT01363076|540961406|FG001|Overall Study|Withdrawal by Subject|1|||
149953385|NCT02642679|540961407|FG000|Overall Study|Withdrawal by Subject|1|||
149953386|NCT02642679|540961407|FG000|Overall Study|Physician Decision|1|||
149842405|NCT00373256|540554691|FG001|Overall Study|Other|107|||
149842406|NCT00373256|540554690|FG000|Overall Study|Protocol Violation|0|||
149953387|NCT02642679|540961407|FG000|Overall Study|Physician Decision|1|||
149842407|NCT00373256|540554691|FG001|Overall Study|Protocol Violation|2|||
149842408|NCT00373256|540554690|FG000|Overall Study|Study Terminated by Sponsor|41|||
149842409|NCT00373256|540554691|FG001|Overall Study|Study Terminated by Sponsor|13|||
149842410|NCT01987765|540554692|FG000|Overall Study|Protocol Violation|65|||
149842411|NCT01987765|540554692|FG000|Overall Study|Lost to Follow-up|37|||
149842412|NCT01528696|540554693|FG000|Overall Study|See detailed description|18|||
149842413|NCT01528696|540554694|FG001|Overall Study|See detailed description|19|||
149842414|NCT01056484|540554695|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
149842415|NCT01056484|540554696|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
149842416|NCT01056484|540554695|FG000|Randomized Controlled Trial|Physician Decision|1|||
149842417|NCT01056484|540554696|FG001|Randomized Controlled Trial|Physician Decision|0|||
149842418|NCT01056484|540554695|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
149842419|NCT01056484|540554696|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
149842420|NCT00446966|540554700|FG000|Overall Study|Lost to Follow-up|10|||
149842421|NCT00446966|540554701|FG001|Overall Study|Lost to Follow-up|7|||
149842422|NCT00835575|540554702|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
149842423|NCT00835575|540554703|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
149842424|NCT01440803|540554704|FG000|Overall Study|Met study stopping rule|2|||
149842425|NCT01440803|540554705|FG001|Overall Study|Met study stopping rule|1|||
149842426|NCT01440803|540554704|FG000|Overall Study|Lost to Follow-up|0|||
149842427|NCT01440803|540554705|FG001|Overall Study|Lost to Follow-up|2|||
149842428|NCT01440803|540554704|FG000|Overall Study|Withdrawal by Subject|0|||
149842429|NCT01440803|540554705|FG001|Overall Study|Withdrawal by Subject|1|||
149842430|NCT01547286|540554714|FG000|Overall Study|Did not meet all eligibility criteria|1|||
149842431|NCT01547286|540554714|FG000|Overall Study|Physician Decision|1|||
149842432|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
149842433|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
149842434|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
149842435|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
149842436|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842437|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842438|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842439|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842440|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842441|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842442|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842443|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842444|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842445|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
149842446|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
149842447|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
149842448|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
149842449|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
149842450|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842451|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842452|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842453|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842454|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842455|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842456|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842457|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842458|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842459|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149842460|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
149842461|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842462|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
149842463|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149953388|NCT01653262|540961408|FG000|Overall Study|Lack of Efficacy|1|||
149953389|NCT01653262|540961408|FG000|Overall Study|SAE, non-fatal|1|||
149953390|NCT01653262|540961408|FG000|Overall Study|AE, non-serious non-fatal|1|||
149953391|NCT01022580|540961410|FG000|Overall Study|Death|18|||
149953392|NCT01022580|540961411|FG001|Overall Study|Death|22|||
149953393|NCT03439839|540961412|FG000|Overall Study|Death|3|||
149953394|NCT03439839|540961413|FG001|Overall Study|Death|0|||
149953395|NCT01500096|540961416|FG000|Overall Study|Lost to Follow-up|1|||
149953396|NCT01500096|540961417|FG001|Overall Study|Lost to Follow-up|0|||
149953397|NCT01500096|540961418|FG002|Overall Study|Lost to Follow-up|0|||
149842464|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149953398|NCT01500096|540961419|FG003|Overall Study|Lost to Follow-up|2|||
149953399|NCT00723944|540961420|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
149953400|NCT00723944|540961421|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
149953401|NCT00723944|540961420|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
149842465|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842466|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842467|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842468|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842469|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842470|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842471|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842472|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842473|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149842474|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
149842475|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
149842476|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
149842477|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842478|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842479|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842480|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842481|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150286092|NCT02595723|542182664|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
150286093|NCT02595723|542182665|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
150286094|NCT02595723|542182666|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
150286095|NCT04288154|542182667|FG000|Overall Study|Withdrawal by Subject|9|||
149842482|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842483|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149953402|NCT00723944|540961421|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
149953403|NCT00723944|540961420|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
149953404|NCT00723944|540961421|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
149953405|NCT04575324|540961424|FG000|Overall Study|Lost to Follow-up|29|||
149953406|NCT04575324|540961425|FG001|Overall Study|Lost to Follow-up|25|||
149953407|NCT04575324|540961424|FG000|Overall Study|Death|1|||
149953408|NCT04575324|540961425|FG001|Overall Study|Death|2|||
149953409|NCT04575324|540961424|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
149953410|NCT04575324|540961425|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
149953411|NCT02582632|540961426|FG000|Overall Study|Other|1|||
149953412|NCT01771913|540961429|FG000|Overall Study|Withdrawal by Subject|1|||
149953413|NCT01771913|540961430|FG001|Overall Study|Withdrawal by Subject|0|||
149953414|NCT00992836|540961431|FG000|Overall Study|Lost to Follow-up|1|||
149953415|NCT00992836|540961431|FG000|Overall Study|Withdrawal by Subject|2|||
149953416|NCT00992836|540961431|FG000|Overall Study|Protocol Violation|2|||
149953417|NCT01617967|540961432|FG000|Overall Study|Protocol Violation|0|||
149953418|NCT01617967|540961433|FG001|Overall Study|Protocol Violation|0|||
149953419|NCT01617967|540961434|FG002|Overall Study|Protocol Violation|0|||
149953420|NCT01617967|540961435|FG003|Overall Study|Protocol Violation|1|||
149953421|NCT01617967|540961436|FG004|Overall Study|Protocol Violation|0|||
149953422|NCT01617967|540961437|FG005|Overall Study|Protocol Violation|0|||
149953423|NCT01617967|540961432|FG000|Overall Study|Withdrawal by Subject|0|||
149953424|NCT01617967|540961433|FG001|Overall Study|Withdrawal by Subject|0|||
149953425|NCT01617967|540961434|FG002|Overall Study|Withdrawal by Subject|0|||
149953426|NCT01617967|540961435|FG003|Overall Study|Withdrawal by Subject|0|||
149953427|NCT01617967|540961436|FG004|Overall Study|Withdrawal by Subject|0|||
149953428|NCT01617967|540961437|FG005|Overall Study|Withdrawal by Subject|1|||
149953429|NCT01617967|540961432|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
149953430|NCT01617967|540961433|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
149953431|NCT01617967|540961434|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
149953432|NCT01617967|540961435|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
149953433|NCT01617967|540961436|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
149953434|NCT01617967|540961437|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
149953435|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
149953436|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
149953437|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
149953438|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
149953439|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
149953440|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
149953441|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
149953442|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
149953443|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
149953444|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
149953445|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
149953446|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
149953447|NCT00447278|540961442|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
149953448|NCT00447278|540961443|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
149953449|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
149842484|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842485|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842486|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842487|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149842488|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
149842489|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842490|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
149842491|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842492|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842493|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842494|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842495|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842496|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842497|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842498|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842499|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842500|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842501|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
149842502|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149842503|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842504|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149842505|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842506|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842507|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842508|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842509|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842510|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842511|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842512|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842513|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842514|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842515|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149842516|NCT01695239|540554717|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
149842517|NCT01695239|540554718|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842518|NCT01695239|540554719|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842519|NCT01695239|540554720|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842520|NCT01695239|540554721|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842521|NCT01695239|540554722|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842522|NCT01695239|540554723|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842523|NCT01695239|540554724|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842524|NCT01695239|540554725|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842525|NCT01695239|540554726|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842526|NCT01695239|540554727|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842527|NCT01695239|540554728|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842528|NCT01695239|540554729|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842529|NCT01695239|540554730|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149842530|NCT01695239|540554717|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842531|NCT01695239|540554718|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149953450|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
149953451|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
149953452|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
149953453|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
149953454|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
149953455|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
149953456|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
149953457|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
149953458|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
149953459|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
149953460|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
149953461|NCT00447278|540961442|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
149953462|NCT00447278|540961443|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
149953463|NCT03677401|540961444|FG000|Overall Study|Adverse Event|4|||
149953464|NCT03677401|540961445|FG001|Overall Study|Adverse Event|14|||
149953465|NCT03677401|540961444|FG000|Overall Study|Lack of Efficacy|3|||
149953466|NCT03677401|540961445|FG001|Overall Study|Lack of Efficacy|1|||
149953467|NCT03677401|540961444|FG000|Overall Study|Withdrawal by Subject|2|||
149842532|NCT01695239|540554719|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842533|NCT01695239|540554720|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842534|NCT01695239|540554721|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842535|NCT01695239|540554722|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842536|NCT01695239|540554723|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842537|NCT01695239|540554724|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
149842538|NCT01695239|540554725|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842539|NCT01695239|540554726|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842540|NCT01695239|540554727|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842541|NCT01695239|540554728|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842542|NCT01695239|540554729|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
149842543|NCT01695239|540554730|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
150286096|NCT04288154|542182668|FG001|Overall Study|Withdrawal by Subject|9|||
150286097|NCT00996944|542182670|FG000|Double-blind Treatment Period|Adverse Event|2|||
150286098|NCT00996944|542182671|FG001|Double-blind Treatment Period|Adverse Event|1|||
149842544|NCT01695239|540554717|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842545|NCT01695239|540554718|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842546|NCT01695239|540554719|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842547|NCT01695239|540554720|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842548|NCT01695239|540554721|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842549|NCT01695239|540554722|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149953468|NCT03677401|540961445|FG001|Overall Study|Withdrawal by Subject|2|||
149953469|NCT03677401|540961444|FG000|Overall Study|Sponsor decision|0|||
149953470|NCT03677401|540961445|FG001|Overall Study|Sponsor decision|1|||
149953471|NCT03677401|540961444|FG000|Overall Study|Reason Unspecified|1|||
149953472|NCT03677401|540961445|FG001|Overall Study|Reason Unspecified|0|||
149953473|NCT06262607|540961448|FG000|Overall Study|Physician Decision|0|||
149953474|NCT06262607|540961449|FG001|Overall Study|Physician Decision|1|||
149953475|NCT06262607|540961448|FG000|Overall Study|Withdrawal by Subject|2|||
149953476|NCT06262607|540961449|FG001|Overall Study|Withdrawal by Subject|0|||
149953477|NCT02969018|540961454|FG000|Overall Study|Adverse Event|2|||
149953478|NCT02969018|540961455|FG001|Overall Study|Adverse Event|4|||
149953479|NCT02969018|540961456|FG002|Overall Study|Adverse Event|1|||
149953480|NCT02969018|540961457|FG003|Overall Study|Adverse Event|2|||
149953481|NCT02969018|540961458|FG004|Overall Study|Adverse Event|0|||
149953482|NCT02969018|540961459|FG005|Overall Study|Adverse Event|1|||
149953483|NCT02969018|540961460|FG006|Overall Study|Adverse Event|2|||
149953484|NCT02969018|540961461|FG007|Overall Study|Adverse Event|0|||
149953485|NCT02969018|540961454|FG000|Overall Study|Lack of Efficacy|0|||
149953486|NCT02969018|540961455|FG001|Overall Study|Lack of Efficacy|1|||
149953487|NCT02969018|540961456|FG002|Overall Study|Lack of Efficacy|0|||
149953488|NCT02969018|540961457|FG003|Overall Study|Lack of Efficacy|0|||
149953489|NCT02969018|540961458|FG004|Overall Study|Lack of Efficacy|1|||
149953490|NCT02969018|540961459|FG005|Overall Study|Lack of Efficacy|1|||
149953491|NCT02969018|540961460|FG006|Overall Study|Lack of Efficacy|1|||
149953492|NCT02969018|540961461|FG007|Overall Study|Lack of Efficacy|1|||
149953493|NCT02969018|540961454|FG000|Overall Study|Lost to Follow-up|1|||
149953494|NCT02969018|540961455|FG001|Overall Study|Lost to Follow-up|2|||
149953495|NCT02969018|540961456|FG002|Overall Study|Lost to Follow-up|2|||
149953496|NCT02969018|540961457|FG003|Overall Study|Lost to Follow-up|0|||
149953497|NCT02969018|540961458|FG004|Overall Study|Lost to Follow-up|1|||
149953498|NCT02969018|540961459|FG005|Overall Study|Lost to Follow-up|1|||
149953499|NCT02969018|540961460|FG006|Overall Study|Lost to Follow-up|0|||
149953500|NCT02969018|540961461|FG007|Overall Study|Lost to Follow-up|1|||
149953501|NCT02969018|540961454|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953502|NCT02969018|540961455|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953503|NCT02969018|540961456|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953504|NCT02969018|540961457|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953505|NCT02969018|540961458|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953506|NCT02969018|540961459|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953507|NCT02969018|540961460|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
149953508|NCT02969018|540961461|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
149953509|NCT02969018|540961454|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149953510|NCT02969018|540961455|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149953511|NCT02969018|540961456|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149953512|NCT02969018|540961457|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149953513|NCT02969018|540961458|FG004|Overall Study|Non-Compliance With Study Drug|0|||
149953514|NCT02969018|540961459|FG005|Overall Study|Non-Compliance With Study Drug|0|||
149953515|NCT02969018|540961460|FG006|Overall Study|Non-Compliance With Study Drug|0|||
149953516|NCT02969018|540961461|FG007|Overall Study|Non-Compliance With Study Drug|0|||
149953517|NCT02969018|540961454|FG000|Overall Study|Other|0|||
150286099|NCT00996944|542182670|FG000|Double-blind Treatment Period|Protocol Violation|1|||
150286100|NCT00996944|542182671|FG001|Double-blind Treatment Period|Protocol Violation|0|||
150172476|NCT04860258|541767960|FG003|Overall Study|Withdrawal by Subject|1|||
150172477|NCT04860258|541767961|FG004|Overall Study|Withdrawal by Subject|4|||
150172478|NCT04860258|541767962|FG005|Overall Study|Withdrawal by Subject|1|||
150172479|NCT04860258|541767963|FG006|Overall Study|Withdrawal by Subject|0|||
150172480|NCT00708032|541767970|FG000|Overall Study|Adverse Event|0|||
149842550|NCT01695239|540554723|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842551|NCT01695239|540554724|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
149842552|NCT01695239|540554725|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842553|NCT01695239|540554726|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842554|NCT01695239|540554727|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842555|NCT01695239|540554728|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842556|NCT01695239|540554729|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842557|NCT01695239|540554730|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
149842558|NCT01695239|540554717|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842559|NCT01695239|540554718|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842560|NCT01695239|540554719|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842561|NCT01695239|540554720|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842562|NCT01695239|540554721|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842563|NCT01695239|540554722|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842564|NCT01695239|540554723|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842565|NCT01695239|540554724|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
149842566|NCT01695239|540554725|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842567|NCT01695239|540554726|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842568|NCT01695239|540554727|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842569|NCT01695239|540554728|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842570|NCT01695239|540554729|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842571|NCT01695239|540554730|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
149842572|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842573|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842574|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842575|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842576|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842577|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842578|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842579|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842580|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
149842581|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
149842582|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842583|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842584|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842585|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
149842586|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
149842587|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
149842588|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
149842589|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
149842590|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
149842591|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
149842592|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
149842593|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
149842594|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
149842595|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
149842596|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
149842597|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
149842598|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
149842599|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
150172481|NCT00708032|541767971|FG001|Overall Study|Adverse Event|2|||
149842600|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842601|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842602|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842603|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842604|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842605|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
150172482|NCT00708032|541767970|FG000|Overall Study|Lost to Follow-up|1|||
150172483|NCT00708032|541767971|FG001|Overall Study|Lost to Follow-up|2|||
150172484|NCT00708032|541767970|FG000|Overall Study|Pregnancy|0|||
150172485|NCT00708032|541767971|FG001|Overall Study|Pregnancy|1|||
149842606|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842607|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842608|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
149842609|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
149842610|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842611|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842612|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842613|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
149842614|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
150172486|NCT00708032|541767970|FG000|Overall Study|Poor vision|0|||
150172487|NCT00708032|541767971|FG001|Overall Study|Poor vision|6|||
150172488|NCT00708032|541767970|FG000|Overall Study|Visit out of range at month 12|4|||
150172489|NCT00708032|541767971|FG001|Overall Study|Visit out of range at month 12|1|||
149842615|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
150172490|NCT00708032|541767970|FG000|Overall Study|Did not meet protocol criteria|1|||
149842616|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
149842617|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
149842618|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
149842619|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
149842620|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
149842621|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
149842622|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
149953518|NCT02969018|540961455|FG001|Overall Study|Other|0|||
149953519|NCT02969018|540961456|FG002|Overall Study|Other|0|||
149953520|NCT02969018|540961457|FG003|Overall Study|Other|1|||
149953521|NCT02969018|540961458|FG004|Overall Study|Other|0|||
149953522|NCT02969018|540961459|FG005|Overall Study|Other|0|||
149953523|NCT02969018|540961460|FG006|Overall Study|Other|0|||
149953524|NCT02969018|540961461|FG007|Overall Study|Other|2|||
149953525|NCT02969018|540961454|FG000|Overall Study|Pregnancy|0|||
149953526|NCT02969018|540961455|FG001|Overall Study|Pregnancy|0|||
149953527|NCT02969018|540961456|FG002|Overall Study|Pregnancy|0|||
149953528|NCT02969018|540961457|FG003|Overall Study|Pregnancy|0|||
149953529|NCT02969018|540961458|FG004|Overall Study|Pregnancy|0|||
149953530|NCT02969018|540961459|FG005|Overall Study|Pregnancy|1|||
149953531|NCT02969018|540961460|FG006|Overall Study|Pregnancy|0|||
149953532|NCT02969018|540961461|FG007|Overall Study|Pregnancy|0|||
149953533|NCT02969018|540961454|FG000|Overall Study|Protocol Violation|0|||
149953534|NCT02969018|540961455|FG001|Overall Study|Protocol Violation|0|||
149953535|NCT02969018|540961456|FG002|Overall Study|Protocol Violation|1|||
149953536|NCT02969018|540961457|FG003|Overall Study|Protocol Violation|1|||
149953537|NCT02969018|540961458|FG004|Overall Study|Protocol Violation|0|||
149953538|NCT02969018|540961459|FG005|Overall Study|Protocol Violation|0|||
149953539|NCT02969018|540961460|FG006|Overall Study|Protocol Violation|0|||
149953540|NCT02969018|540961461|FG007|Overall Study|Protocol Violation|0|||
149953541|NCT02969018|540961454|FG000|Overall Study|Withdrawal by Subject|0|||
149953542|NCT02969018|540961455|FG001|Overall Study|Withdrawal by Subject|1|||
149953543|NCT02969018|540961456|FG002|Overall Study|Withdrawal by Subject|2|||
149953544|NCT02969018|540961457|FG003|Overall Study|Withdrawal by Subject|1|||
149953545|NCT02969018|540961458|FG004|Overall Study|Withdrawal by Subject|0|||
149953546|NCT02969018|540961459|FG005|Overall Study|Withdrawal by Subject|4|||
149953547|NCT02969018|540961460|FG006|Overall Study|Withdrawal by Subject|4|||
149953548|NCT02969018|540961461|FG007|Overall Study|Withdrawal by Subject|3|||
149953549|NCT03142750|540961468|FG000|Overall Study|Lost to Follow-up|4|||
149953550|NCT03142750|540961469|FG001|Overall Study|Lost to Follow-up|1|||
149953551|NCT02942407|540961471|FG000|Overall Study|Lost to Follow-up|3|||
149953552|NCT02942407|540961472|FG001|Overall Study|Lost to Follow-up|2|||
149953553|NCT02942407|540961471|FG000|Overall Study|Withdrawal by Subject|7|||
149953554|NCT02942407|540961472|FG001|Overall Study|Withdrawal by Subject|9|||
149953555|NCT02942407|540961471|FG000|Overall Study|Death|16|||
149953556|NCT02942407|540961472|FG001|Overall Study|Death|13|||
149953557|NCT00933166|540961473|FG000|Overall Study|Lost to Follow-up|4|||
149953558|NCT00933166|540961473|FG000|Overall Study|Lack of Efficacy|9|||
149953559|NCT00933166|540961473|FG000|Overall Study|Unavailable|4|||
149953560|NCT00933166|540961473|FG000|Overall Study|Withdrawal by Subject|1|||
149953561|NCT04618471|540961474|FG000|Overall Study|Screen Failure|62|||
149953562|NCT04618471|540961474|FG000|Overall Study|Withdrawal by Subject|6|||
150172491|NCT00708032|541767971|FG001|Overall Study|Did not meet protocol criteria|2|||
150172492|NCT00708032|541767970|FG000|Overall Study|Protocol Violation|4|||
149953563|NCT04618471|540961474|FG000|Overall Study|Physician Decision|2|||
149953564|NCT04618471|540961474|FG000|Overall Study|Lost to Follow-up|1|||
149953565|NCT04618471|540961474|FG000|Overall Study|Various other reasons|2|||
149953566|NCT04618471|540961474|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
149953567|NCT00374868|540961475|FG000|Overall Study|Adverse Event|12|||
149953568|NCT00374868|540961475|FG000|Overall Study|Progressive Disease|7|||
150172493|NCT00708032|541767971|FG001|Overall Study|Protocol Violation|1|||
149842623|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
149842624|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
149842625|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
149842626|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
149842627|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
149842628|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842629|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842630|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842631|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842632|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842633|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842634|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842635|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842636|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
149842637|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
149842638|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842639|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842640|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842641|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
149842642|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842643|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842644|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842645|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842646|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842647|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842648|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842649|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842650|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
149842651|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
149842652|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842653|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842654|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842655|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
149842656|NCT01695239|540554717|FG000|Extension Long-Term Extension Periods|Death|0|||
149842657|NCT01695239|540554718|FG001|Extension Long-Term Extension Periods|Death|0|||
149842658|NCT01695239|540554719|FG002|Extension Long-Term Extension Periods|Death|0|||
149842659|NCT01695239|540554720|FG003|Extension Long-Term Extension Periods|Death|0|||
149842660|NCT01695239|540554721|FG004|Extension Long-Term Extension Periods|Death|0|||
149842661|NCT01695239|540554722|FG005|Extension Long-Term Extension Periods|Death|0|||
149842662|NCT01695239|540554723|FG006|Extension Long-Term Extension Periods|Death|0|||
149842663|NCT01695239|540554724|FG007|Extension Long-Term Extension Periods|Death|0|||
149842664|NCT01695239|540554725|FG008|Extension Long-Term Extension Periods|Death|1|||
149842665|NCT01695239|540554726|FG009|Extension Long-Term Extension Periods|Death|0|||
149842666|NCT01695239|540554727|FG010|Extension Long-Term Extension Periods|Death|0|||
149842667|NCT01695239|540554728|FG011|Extension Long-Term Extension Periods|Death|0|||
149842668|NCT01695239|540554729|FG012|Extension Long-Term Extension Periods|Death|0|||
149842669|NCT01695239|540554730|FG013|Extension Long-Term Extension Periods|Death|0|||
149842670|NCT01695239|540554717|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842671|NCT01695239|540554718|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842672|NCT01695239|540554719|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842673|NCT01695239|540554720|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842674|NCT01695239|540554721|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842675|NCT01695239|540554722|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842676|NCT01695239|540554723|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842677|NCT01695239|540554724|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149953569|NCT00374868|540961475|FG000|Overall Study|Physician Decision|13|||
149953570|NCT00374868|540961475|FG000|Overall Study|Lost to Follow-up|1|||
149953571|NCT00374868|540961475|FG000|Overall Study|Death|2|||
149953572|NCT00374868|540961475|FG000|Overall Study|Other - Not Specified|1|||
149953573|NCT03325439|540961476|FG000|Overall Study|Ineligibility|3|||
149953574|NCT00774748|540961477|FG000|Overall Study|Lost to Follow-up|3|||
149953575|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
149953576|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
149953577|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
149953578|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
149953579|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
149953580|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
149953581|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
149842678|NCT01695239|540554725|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842679|NCT01695239|540554726|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842680|NCT01695239|540554727|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149842681|NCT01695239|540554728|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
149842682|NCT01695239|540554729|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
149842683|NCT01695239|540554730|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
149842684|NCT01695239|540554717|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842685|NCT01695239|540554718|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842686|NCT01695239|540554719|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842687|NCT01695239|540554720|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842688|NCT01695239|540554721|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842689|NCT01695239|540554722|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842690|NCT01695239|540554723|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149953582|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
149953583|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
149953584|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
149953585|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
149953586|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
149953587|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
149953588|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
149953589|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
149953590|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
149953591|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
149953592|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
149953593|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
149953594|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
149953595|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
149953596|NCT02337946|540961480|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
149953597|NCT02337946|540961481|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
149953598|NCT02337946|540961482|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
149953599|NCT02337946|540961480|FG000|In-between Period|Without Informed Consent|1|||
149953600|NCT02337946|540961481|FG001|In-between Period|Without Informed Consent|0|||
149953601|NCT02337946|540961482|FG002|In-between Period|Without Informed Consent|0|||
150286101|NCT00996944|542182670|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
150286102|NCT00996944|542182671|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
150286103|NCT00996944|542182670|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
150286104|NCT00996944|542182671|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
150286105|NCT00996944|542182670|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
150286106|NCT00996944|542182671|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
150286107|NCT01902290|542182672|FG000|Overall Study|Withdrawal by Subject|19|||
150286108|NCT01902290|542182673|FG001|Overall Study|Withdrawal by Subject|27|||
150286109|NCT01902290|542182672|FG000|Overall Study|Lost to Follow-up|2|||
150286110|NCT01902290|542182673|FG001|Overall Study|Lost to Follow-up|2|||
150286111|NCT01902290|542182672|FG000|Overall Study|Death|1|||
150286112|NCT01902290|542182673|FG001|Overall Study|Death|0|||
150286113|NCT01902290|542182672|FG000|Overall Study|Sponsor Decision|26|||
150286114|NCT01902290|542182673|FG001|Overall Study|Sponsor Decision|24|||
150286115|NCT00769184|542182674|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
150286116|NCT00769184|542182675|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
150286117|NCT00769184|542182674|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
150286118|NCT00769184|542182675|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
150286119|NCT00769184|542182674|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
150286120|NCT00769184|542182675|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
150286121|NCT00385255|542182677|FG000|Overall Study|Serious Adverse Event|1|||
150286122|NCT00385255|542182678|FG001|Overall Study|Serious Adverse Event|2|||
150286123|NCT00385255|542182677|FG000|Overall Study|Protocol Violation|0|||
150286124|NCT00385255|542182678|FG001|Overall Study|Protocol Violation|4|||
150286125|NCT00385255|542182677|FG000|Overall Study|Withdrawal by Subject|0|||
150286126|NCT00385255|542182678|FG001|Overall Study|Withdrawal by Subject|8|||
150286127|NCT00385255|542182677|FG000|Overall Study|Migrated/moved from study area|0|||
150286128|NCT00385255|542182678|FG001|Overall Study|Migrated/moved from study area|1|||
150286129|NCT00385255|542182677|FG000|Overall Study|Lost to Follow-up|20|||
150286130|NCT00385255|542182678|FG001|Overall Study|Lost to Follow-up|58|||
150286131|NCT02250274|542182679|FG000|Overall Study|Insufficient blood draw amount|7|||
150286132|NCT02250274|542182680|FG001|Overall Study|Insufficient blood draw amount|6|||
150286133|NCT00446511|542182681|FG000|Overall Study|Adverse Event|7|||
150286134|NCT00446511|542182682|FG001|Overall Study|Adverse Event|2|||
150286135|NCT00446511|542182683|FG002|Overall Study|Adverse Event|3|||
150286136|NCT00446511|542182684|FG003|Overall Study|Adverse Event|1|||
149842691|NCT01695239|540554724|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
150035670|NCT00408317|541271357|FG000|First Intervention Period|Adverse Event|0|||
150035671|NCT00408317|541271358|FG001|First Intervention Period|Adverse Event|1|||
150035672|NCT00408317|541271357|FG000|Second Intervention Period|Adverse Event|2|||
150035673|NCT00408317|541271358|FG001|Second Intervention Period|Adverse Event|0|||
150035674|NCT00408317|541271357|FG000|Second Intervention Period|Protocol Violation|0|||
150035675|NCT00408317|541271358|FG001|Second Intervention Period|Protocol Violation|1|||
150035676|NCT00408317|541271357|FG000|Second Intervention Period|Withdrawal of consent|0|||
150035677|NCT00408317|541271358|FG001|Second Intervention Period|Withdrawal of consent|1|||
150035678|NCT01462370|541271359|FG000|Overall Study|Lack of Qualifying Event|1|||
150035679|NCT01462370|541271360|FG001|Overall Study|Lack of Qualifying Event|1|||
150035680|NCT01462370|541271359|FG000|Overall Study|Physician Decision|0|||
150035681|NCT01462370|541271360|FG001|Overall Study|Physician Decision|1|||
150035682|NCT01462370|541271359|FG000|Overall Study|Withdrawal by Subject|0|||
150035683|NCT01462370|541271360|FG001|Overall Study|Withdrawal by Subject|3|||
150035684|NCT03198715|541271363|FG000|Overall Study|Death|0|||
150035685|NCT03198715|541271364|FG001|Overall Study|Death|0|||
150035686|NCT03198715|541271365|FG002|Overall Study|Death|1|||
150035687|NCT03198715|541271366|FG003|Overall Study|Death|0|||
149953602|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
150035688|NCT03198715|541271367|FG004|Overall Study|Death|2|||
150035689|NCT03198715|541271363|FG000|Overall Study|Other|0|||
150035690|NCT03198715|541271364|FG001|Overall Study|Other|1|||
150035691|NCT03198715|541271365|FG002|Overall Study|Other|1|||
150035692|NCT03198715|541271366|FG003|Overall Study|Other|0|||
150035693|NCT03198715|541271367|FG004|Overall Study|Other|0|||
150035694|NCT00853307|541271370|FG000|Overall Study|Adverse Event|1|||
150035695|NCT00853307|541271371|FG001|Overall Study|Adverse Event|2|||
150286137|NCT00446511|542182681|FG000|Overall Study|Protocol Violation|0|||
150286138|NCT00446511|542182682|FG001|Overall Study|Protocol Violation|0|||
150286139|NCT00446511|542182683|FG002|Overall Study|Protocol Violation|0|||
150286140|NCT00446511|542182684|FG003|Overall Study|Protocol Violation|1|||
149953603|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
149953604|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
149953605|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
149953606|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
149953607|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
149953608|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
149953609|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
149953610|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
149953611|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
149953612|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
149953613|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
149953614|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
149953615|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
149953616|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
149953617|NCT02337946|540961480|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
149953618|NCT02337946|540961481|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
149953619|NCT02337946|540961482|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
149953620|NCT00927082|540961483|FG000|Overall Study|Lost to Follow-up|9|||
149953621|NCT00927082|540961484|FG001|Overall Study|Lost to Follow-up|8|||
149953622|NCT00927082|540961485|FG002|Overall Study|Lost to Follow-up|12|||
149953623|NCT00927082|540961486|FG003|Overall Study|Lost to Follow-up|16|||
149953624|NCT00927082|540961483|FG000|Overall Study|Withdrawal by Subject|3|||
149953625|NCT00927082|540961484|FG001|Overall Study|Withdrawal by Subject|2|||
149953626|NCT00927082|540961485|FG002|Overall Study|Withdrawal by Subject|7|||
149953627|NCT00927082|540961486|FG003|Overall Study|Withdrawal by Subject|2|||
149953628|NCT00927082|540961483|FG000|Overall Study|Death|0|||
149953629|NCT00927082|540961484|FG001|Overall Study|Death|0|||
149953630|NCT00927082|540961485|FG002|Overall Study|Death|1|||
149953631|NCT00927082|540961486|FG003|Overall Study|Death|0|||
149953632|NCT00927082|540961483|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
149953633|NCT00927082|540961484|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
150286141|NCT00446511|542182681|FG000|Overall Study|Withdrawal by Subject|0|||
149953634|NCT00927082|540961485|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
149953635|NCT00927082|540961486|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
149953636|NCT06061952|540961491|FG000|Overall Study|Withdrawal by Subject|1|||
149953637|NCT06061952|540961492|FG001|Overall Study|Withdrawal by Subject|2|||
149953638|NCT06061952|540961491|FG000|Overall Study|Lost to Follow-up|2|||
150035696|NCT00853307|541271370|FG000|Overall Study|Withdrawal by Subject|1|||
149953639|NCT06061952|540961492|FG001|Overall Study|Lost to Follow-up|2|||
150172494|NCT00708032|541767970|FG000|Overall Study|Withdrawal by Subject|0|||
150286142|NCT00446511|542182682|FG001|Overall Study|Withdrawal by Subject|0|||
150286143|NCT00446511|542182683|FG002|Overall Study|Withdrawal by Subject|0|||
150035697|NCT00853307|541271371|FG001|Overall Study|Withdrawal by Subject|2|||
150035698|NCT00853307|541271370|FG000|Overall Study|Reason Not Specified|0|||
149842692|NCT01695239|540554725|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842693|NCT01695239|540554726|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842694|NCT01695239|540554727|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842695|NCT01695239|540554728|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149842696|NCT01695239|540554729|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
149842697|NCT01695239|540554730|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
149842698|NCT01695239|540554717|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842699|NCT01695239|540554718|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842700|NCT01695239|540554719|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842701|NCT01695239|540554720|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842702|NCT01695239|540554721|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842703|NCT01695239|540554722|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842704|NCT01695239|540554723|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842705|NCT01695239|540554724|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842706|NCT01695239|540554725|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842707|NCT01695239|540554726|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842708|NCT01695239|540554727|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842709|NCT01695239|540554728|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842710|NCT01695239|540554729|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
149842711|NCT01695239|540554730|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
149842712|NCT01695239|540554717|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842713|NCT01695239|540554718|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842714|NCT01695239|540554719|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842715|NCT01695239|540554720|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842716|NCT01695239|540554721|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842717|NCT01695239|540554722|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842718|NCT01695239|540554723|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842719|NCT01695239|540554724|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842720|NCT01695239|540554725|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842721|NCT01695239|540554726|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842722|NCT01695239|540554727|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842723|NCT01695239|540554728|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842724|NCT01695239|540554729|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149842725|NCT01695239|540554730|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
149842726|NCT03502811|540554733|FG000|Overall Study|Death|157|||
149842727|NCT03502811|540554733|FG000|Overall Study|Withdrawal by Subject|105|||
149842728|NCT03502811|540554733|FG000|Overall Study|Lost to Follow-up|26|||
149842729|NCT03502811|540554733|FG000|Overall Study|No Visits (Missed)|31|||
149842730|NCT03913377|540554734|FG000|Period 1|Test Article no longer available|0|||
149842731|NCT03913377|540554735|FG001|Period 1|Test Article no longer available|1|||
149842732|NCT03913377|540554736|FG002|Period 1|Test Article no longer available|0|||
149842733|NCT03913377|540554734|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
149842734|NCT03913377|540554735|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
149842735|NCT03913377|540554736|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
149842736|NCT02241551|540554737|FG000|Overall Study|Adverse Event|1|||
149842737|NCT02241551|540554738|FG001|Overall Study|Adverse Event|0|||
149842738|NCT01205035|540554739|FG000|Overall Study|Withdrawal by Subject|1|||
149842739|NCT01205035|540554740|FG001|Overall Study|Withdrawal by Subject|0|||
149842740|NCT01205035|540554739|FG000|Overall Study|Physician Decision|1|||
149842741|NCT01205035|540554740|FG001|Overall Study|Physician Decision|0|||
149842742|NCT02751424|540554748|FG000|Part 2|Adverse Event|0|||
149842743|NCT02751424|540554749|FG001|Part 2|Adverse Event|0|||
149842744|NCT02751424|540554750|FG002|Part 2|Adverse Event|0|||
149842745|NCT02751424|540554751|FG003|Part 2|Adverse Event|0|||
150286144|NCT00446511|542182684|FG003|Overall Study|Withdrawal by Subject|3|||
150286145|NCT00446511|542182681|FG000|Overall Study|Administrative Problems|3|||
150286146|NCT00446511|542182682|FG001|Overall Study|Administrative Problems|0|||
150286147|NCT00446511|542182683|FG002|Overall Study|Administrative Problems|4|||
150286148|NCT00446511|542182684|FG003|Overall Study|Administrative Problems|1|||
150286149|NCT01136655|542182685|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
150286150|NCT01136655|542182685|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
150286151|NCT01136655|542182685|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
150286152|NCT01136655|542182685|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
150286153|NCT02873936|542182688|FG000|Overall Study|Withdrew Consent|4|||
150286154|NCT02873936|542182689|FG001|Overall Study|Withdrew Consent|11|||
150286155|NCT02873936|542182690|FG002|Overall Study|Withdrew Consent|20|||
150286156|NCT02873936|542182688|FG000|Overall Study|Investigator's Discretion|3|||
150286157|NCT02873936|542182689|FG001|Overall Study|Investigator's Discretion|5|||
150286158|NCT02873936|542182690|FG002|Overall Study|Investigator's Discretion|4|||
150286159|NCT02873936|542182688|FG000|Overall Study|Adverse Event|3|||
150286160|NCT02873936|542182689|FG001|Overall Study|Adverse Event|5|||
150286161|NCT02873936|542182690|FG002|Overall Study|Adverse Event|3|||
149953640|NCT00544882|540961498|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
149953641|NCT00544882|540961499|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
149953642|NCT00544882|540961500|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
149953643|NCT00544882|540961498|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
149953644|NCT00544882|540961499|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
149953645|NCT00544882|540961500|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
149953646|NCT00544882|540961498|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
149953647|NCT00544882|540961499|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
149953648|NCT00544882|540961500|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
149953649|NCT00544882|540961498|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
149953650|NCT00544882|540961499|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
149953651|NCT00544882|540961500|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
149953652|NCT00544882|540961498|FG000|Cycle 3: Follow-up|Noncompliance|0|||
149953653|NCT00544882|540961499|FG001|Cycle 3: Follow-up|Noncompliance|1|||
149953654|NCT00544882|540961500|FG002|Cycle 3: Follow-up|Noncompliance|0|||
149953655|NCT00544882|540961498|FG000|Cycle 3: Follow-up|Pregnancy|0|||
149953656|NCT00544882|540961499|FG001|Cycle 3: Follow-up|Pregnancy|1|||
149953657|NCT00544882|540961500|FG002|Cycle 3: Follow-up|Pregnancy|0|||
149953658|NCT03770455|540961501|FG000|Overall Study|Screen failures|3|||
149953659|NCT02583269|540961502|FG000|Overall Study|Patient hospitalized prior to start|1|||
149953660|NCT02583269|540961503|FG001|Overall Study|Patient hospitalized prior to start|0|||
149953661|NCT02583269|540961504|FG002|Overall Study|Patient hospitalized prior to start|0|||
149953662|NCT02583269|540961505|FG003|Overall Study|Patient hospitalized prior to start|0|||
149953663|NCT02583269|540961506|FG004|Overall Study|Patient hospitalized prior to start|0|||
149953664|NCT01039675|540961507|FG000|Overall Study|Adverse Event|0|||
149953665|NCT01039675|540961508|FG001|Overall Study|Adverse Event|2|||
149953666|NCT01039675|540961507|FG000|Overall Study|Lack of Efficacy|0|||
149953667|NCT01039675|540961508|FG001|Overall Study|Lack of Efficacy|2|||
149953668|NCT01039675|540961507|FG000|Overall Study|Withdrawal by Subject|0|||
149953669|NCT01039675|540961508|FG001|Overall Study|Withdrawal by Subject|1|||
149953670|NCT01039675|540961507|FG000|Overall Study|Lost to Follow-up|0|||
149953671|NCT01039675|540961508|FG001|Overall Study|Lost to Follow-up|1|||
149953672|NCT01039675|540961507|FG000|Overall Study|Physician Decision|0|||
149953673|NCT01039675|540961508|FG001|Overall Study|Physician Decision|1|||
149953674|NCT02068794|540963076|FG000|Overall Study|Withdrawal by Subject|0|||
149953675|NCT02068794|540963077|FG001|Overall Study|Withdrawal by Subject|1|||
149953676|NCT02068794|540963078|FG002|Overall Study|Withdrawal by Subject|2|||
149953677|NCT02068794|540963076|FG000|Overall Study|Early Progression|1|||
149953678|NCT02068794|540963077|FG001|Overall Study|Early Progression|0|||
149953679|NCT02068794|540963078|FG002|Overall Study|Early Progression|1|||
149953680|NCT02068794|540963076|FG000|Overall Study|Ineligible|0|||
150286162|NCT02873936|542182688|FG000|Overall Study|Protocol Violation|0|||
150286163|NCT02873936|542182689|FG001|Overall Study|Protocol Violation|1|||
150286164|NCT02873936|542182690|FG002|Overall Study|Protocol Violation|3|||
150286165|NCT02873936|542182688|FG000|Overall Study|Lost to Follow-up|1|||
150286166|NCT02873936|542182689|FG001|Overall Study|Lost to Follow-up|1|||
150286167|NCT02873936|542182690|FG002|Overall Study|Lost to Follow-up|1|||
149953681|NCT02068794|540963077|FG001|Overall Study|Ineligible|0|||
149953682|NCT02068794|540963078|FG002|Overall Study|Ineligible|1|||
149953683|NCT00784927|540963086|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
149953684|NCT00784927|540963086|FG000|Overall Study|Protocol Violation|1|||
149953685|NCT00784927|540963086|FG000|Overall Study|Ineligible|1|||
149953686|NCT01137812|540963093|FG000|Overall Study|Adverse Event|21|||
149953687|NCT01137812|540963094|FG001|Overall Study|Adverse Event|14|||
149953688|NCT01137812|540963093|FG000|Overall Study|Lost to Follow-up|6|||
149953689|NCT01137812|540963094|FG001|Overall Study|Lost to Follow-up|8|||
149953690|NCT01137812|540963093|FG000|Overall Study|Physician Decision|25|||
149953691|NCT01137812|540963094|FG001|Overall Study|Physician Decision|17|||
149842746|NCT02751424|540554752|FG004|Part 2|Adverse Event|0|||
149842747|NCT02751424|540554753|FG005|Part 2|Adverse Event|0|||
149842748|NCT02751424|540554754|FG006|Part 2|Adverse Event|0|||
149842749|NCT02751424|540554755|FG007|Part 2|Adverse Event|5|||
149842750|NCT02751424|540554756|FG008|Part 2|Adverse Event|0|||
149842751|NCT01896934|540554757|FG000|Overall Study|Adverse Event|1|||
149842752|NCT01896934|540554757|FG000|Overall Study|Withdrawal by Subject|1|||
149842753|NCT02197416|540554758|FG000|Overall Study|Other reasons|0|||
149842754|NCT02197416|540554759|FG001|Overall Study|Other reasons|2|||
149842755|NCT02197416|540554760|FG002|Overall Study|Other reasons|5|||
149842756|NCT02197416|540554758|FG000|Overall Study|Withdrawal by Subject|0|||
149842757|NCT02197416|540554759|FG001|Overall Study|Withdrawal by Subject|2|||
149842758|NCT02197416|540554760|FG002|Overall Study|Withdrawal by Subject|1|||
149842759|NCT02197416|540554758|FG000|Overall Study|Protocol Violation|1|||
149842760|NCT02197416|540554759|FG001|Overall Study|Protocol Violation|0|||
149953692|NCT01137812|540963093|FG000|Overall Study|Protocol Violation|5|||
149953693|NCT01137812|540963094|FG001|Overall Study|Protocol Violation|4|||
149953694|NCT01137812|540963093|FG000|Overall Study|Withdrawal by Subject|5|||
149953695|NCT01137812|540963094|FG001|Overall Study|Withdrawal by Subject|13|||
149953696|NCT01137812|540963093|FG000|Overall Study|Death|2|||
149953697|NCT01137812|540963094|FG001|Overall Study|Death|0|||
149953698|NCT01137812|540963093|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
149953699|NCT01137812|540963094|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
149953700|NCT01137812|540963093|FG000|Overall Study|Other|19|||
149953701|NCT01137812|540963094|FG001|Overall Study|Other|27|||
149953702|NCT00845182|540963095|FG000|Overall Study|Lost to Follow-up|3|||
149953703|NCT00845182|540963096|FG001|Overall Study|Lost to Follow-up|3|||
149953704|NCT00845182|540963097|FG002|Overall Study|Lost to Follow-up|4|||
149953705|NCT00845182|540963095|FG000|Overall Study|Adverse Event|0|||
149953706|NCT00845182|540963096|FG001|Overall Study|Adverse Event|1|||
149953707|NCT00845182|540963097|FG002|Overall Study|Adverse Event|1|||
149953708|NCT00845182|540963095|FG000|Overall Study|Physician Decision|0|||
149953709|NCT00845182|540963096|FG001|Overall Study|Physician Decision|0|||
149953710|NCT00845182|540963097|FG002|Overall Study|Physician Decision|1|||
149953711|NCT04621760|540963098|FG000|Overall Study|Lost to Follow-up|2|||
149953712|NCT04621760|540963099|FG001|Overall Study|Lost to Follow-up|4|||
149953713|NCT04621760|540963098|FG000|Overall Study|Withdrawal by Subject|1|||
149953714|NCT04621760|540963099|FG001|Overall Study|Withdrawal by Subject|0|||
149953715|NCT00471354|540963105|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
149953716|NCT00471354|540963105|FG000|Overall Study|Adverse Event|13|||
149953717|NCT00471354|540963105|FG000|Overall Study|Protocol Violation|12|||
149953718|NCT00471354|540963105|FG000|Overall Study|Withdrawal by Subject|1|||
149953719|NCT00471354|540963105|FG000|Overall Study|Physician Decision|4|||
149953720|NCT00471354|540963105|FG000|Overall Study|Sponsor Decision|1|||
149953721|NCT00471354|540963105|FG000|Overall Study|Lost to Follow-up|3|||
149953722|NCT00471354|540963105|FG000|Overall Study|Lack of Efficacy|5|||
149953723|NCT00471354|540963105|FG000|Overall Study|Patient/Caregiver Decision|12|||
149953724|NCT02639559|540963107|FG000|Overall Study|Mobilization failure|0|||
149953725|NCT02639559|540963108|FG001|Overall Study|Mobilization failure|3|||
149953726|NCT02639559|540963107|FG000|Overall Study|Issues with vascular acess|1|||
149953727|NCT02639559|540963108|FG001|Overall Study|Issues with vascular acess|0|||
149953728|NCT04999020|540963109|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
149953729|NCT04999020|540963110|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
149953730|NCT04999020|540963111|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
149953731|NCT04999020|540963112|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
149953732|NCT04999020|540963109|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
149953733|NCT04999020|540963110|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
149953734|NCT04999020|540963111|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
149953735|NCT04999020|540963112|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
149953736|NCT04999020|540963109|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
149953737|NCT04999020|540963110|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
149953738|NCT04999020|540963111|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
149842761|NCT02197416|540554760|FG002|Overall Study|Protocol Violation|1|||
149842762|NCT02197416|540554758|FG000|Overall Study|Adverse Event|0|||
149953739|NCT04999020|540963112|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
149953740|NCT04999020|540963109|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149953741|NCT04999020|540963110|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149953742|NCT04999020|540963111|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
149953743|NCT04999020|540963112|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
149953744|NCT04999020|540963109|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
149953745|NCT04999020|540963110|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
150286168|NCT02873936|542182688|FG000|Overall Study|Non-compliance With Study Drug|1|||
149842763|NCT02197416|540554759|FG001|Overall Study|Adverse Event|0|||
149842764|NCT02197416|540554760|FG002|Overall Study|Adverse Event|1|||
149842765|NCT01492439|540554761|FG000|Overall Study|Withdrew from RTE|4|||
149842766|NCT01492439|540554762|FG001|Overall Study|Withdrew from RTE|9|||
150286169|NCT02873936|542182689|FG001|Overall Study|Non-compliance With Study Drug|0|||
150286170|NCT02873936|542182690|FG002|Overall Study|Non-compliance With Study Drug|1|||
150286171|NCT02873936|542182688|FG000|Overall Study|Randomized but not Dosed|1|||
150286172|NCT02873936|542182689|FG001|Overall Study|Randomized but not Dosed|0|||
149842767|NCT00716625|540554763|FG000|Overall Study|Safety was not Assessable|1|||
149842768|NCT01204294|540554764|FG000|Overall Study|Adverse Event|2|||
149842769|NCT01204294|540554765|FG001|Overall Study|Adverse Event|6|||
149842770|NCT01204294|540554766|FG002|Overall Study|Adverse Event|0|||
149842771|NCT01204294|540554767|FG003|Overall Study|Adverse Event|7|||
149953746|NCT04999020|540963111|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
149953747|NCT04999020|540963112|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
149953748|NCT04999020|540963109|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
149953749|NCT04999020|540963110|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
149953750|NCT04999020|540963111|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
149953751|NCT04999020|540963112|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
149953752|NCT04999020|540963109|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149953753|NCT04999020|540963110|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149953754|NCT04999020|540963111|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
149953755|NCT04999020|540963112|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149953756|NCT04999020|540963109|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
149953757|NCT04999020|540963110|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
149953758|NCT04999020|540963111|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
149953759|NCT04999020|540963112|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
149953760|NCT00827242|540963115|FG000|Overall Study|Withdrawal by Subject|2|||
149953761|NCT00827242|540963116|FG001|Overall Study|Withdrawal by Subject|4|||
149953762|NCT00827242|540963115|FG000|Overall Study|Protocol Violation|1|||
149953763|NCT00827242|540963116|FG001|Overall Study|Protocol Violation|3|||
149953764|NCT00827242|540963115|FG000|Overall Study|Lost to Follow-up|0|||
149953765|NCT00827242|540963116|FG001|Overall Study|Lost to Follow-up|3|||
149953766|NCT00827242|540963115|FG000|Overall Study|Adverse Event Excluding Death|2|||
149953767|NCT00827242|540963116|FG001|Overall Study|Adverse Event Excluding Death|1|||
149953768|NCT00827242|540963115|FG000|Overall Study|Entry Criteria Not Met|4|||
149953769|NCT00827242|540963116|FG001|Overall Study|Entry Criteria Not Met|1|||
149953770|NCT00827242|540963115|FG000|Overall Study|Physician Decision|2|||
149953771|NCT00827242|540963116|FG001|Overall Study|Physician Decision|0|||
149953772|NCT00827242|540963115|FG000|Overall Study|Death|1|||
149953773|NCT00827242|540963116|FG001|Overall Study|Death|0|||
149953774|NCT00827242|540963115|FG000|Overall Study|Lack of Efficacy|1|||
149953775|NCT00827242|540963116|FG001|Overall Study|Lack of Efficacy|0|||
149953776|NCT00471107|540963117|FG000|Overall Study|Technical problems/data loss|3|||
149953777|NCT00471107|540963118|FG001|Overall Study|Technical problems/data loss|1|||
149953778|NCT00471107|540963119|FG002|Overall Study|Technical problems/data loss|3|||
149953779|NCT03925220|540963120|FG000|Overall Study|Withdrawal by Subject|4|||
149953780|NCT03925220|540963121|FG001|Overall Study|Withdrawal by Subject|4|||
149953781|NCT03925220|540963122|FG002|Overall Study|Withdrawal by Subject|4|||
149953782|NCT03925220|540963123|FG003|Overall Study|Withdrawal by Subject|4|||
149953783|NCT03925220|540963120|FG000|Overall Study|Lost to Follow-up|40|||
149953784|NCT03925220|540963121|FG001|Overall Study|Lost to Follow-up|46|||
149953785|NCT03925220|540963122|FG002|Overall Study|Lost to Follow-up|37|||
149953786|NCT03925220|540963123|FG003|Overall Study|Lost to Follow-up|38|||
149953787|NCT04425018|540963124|FG000|Overall Study|Withdrawal by Subject|1|||
149953788|NCT04425018|540963125|FG001|Overall Study|Withdrawal by Subject|2|||
149953789|NCT01944774|540963126|FG000|Overall Study|Withdrawal by Subject|2|||
149953790|NCT01944774|540963127|FG001|Overall Study|Withdrawal by Subject|3|||
149953791|NCT01944774|540963128|FG002|Overall Study|Withdrawal by Subject|3|||
149953792|NCT01944774|540963126|FG000|Overall Study|Adverse Event|3|||
149953793|NCT01944774|540963127|FG001|Overall Study|Adverse Event|2|||
149953794|NCT01944774|540963128|FG002|Overall Study|Adverse Event|3|||
149953795|NCT01944774|540963126|FG000|Overall Study|Lack of Efficacy|1|||
149953796|NCT01944774|540963127|FG001|Overall Study|Lack of Efficacy|2|||
149953797|NCT01944774|540963128|FG002|Overall Study|Lack of Efficacy|2|||
149953798|NCT01944774|540963126|FG000|Overall Study|Lost to Follow-up|0|||
149953799|NCT01944774|540963127|FG001|Overall Study|Lost to Follow-up|1|||
149953800|NCT01944774|540963128|FG002|Overall Study|Lost to Follow-up|0|||
149953801|NCT05774977|540963131|FG000|Overall Study|Withdrawal by Subject|2|||
149953802|NCT03188185|540963132|FG000|Stage 1|Adverse Event|4|||
149953803|NCT03188185|540963133|FG001|Stage 1|Adverse Event|12|||
149953804|NCT03188185|540963134|FG002|Stage 1|Adverse Event|0|||
150286173|NCT02873936|542182690|FG002|Overall Study|Randomized but not Dosed|0|||
150286174|NCT01015768|542182691|FG000|Overall Study|Some subject data unuseable|4|||
150286175|NCT01015768|542182692|FG001|Overall Study|Some subject data unuseable|4|||
149842772|NCT01204294|540554768|FG004|Overall Study|Adverse Event|1|||
149842773|NCT01204294|540554769|FG005|Overall Study|Adverse Event|4|||
149842774|NCT01204294|540554770|FG006|Overall Study|Adverse Event|0|||
149842775|NCT01204294|540554764|FG000|Overall Study|Protocol Violation|1|||
149953805|NCT03188185|540963135|FG003|Stage 1|Adverse Event|0|||
149842776|NCT01204294|540554765|FG001|Overall Study|Protocol Violation|0|||
149842777|NCT01204294|540554766|FG002|Overall Study|Protocol Violation|2|||
149842778|NCT01204294|540554767|FG003|Overall Study|Protocol Violation|1|||
149953806|NCT03188185|540963132|FG000|Stage 1|Lack of Efficacy|0|||
149953807|NCT03188185|540963133|FG001|Stage 1|Lack of Efficacy|2|||
149953808|NCT03188185|540963134|FG002|Stage 1|Lack of Efficacy|0|||
149953809|NCT03188185|540963135|FG003|Stage 1|Lack of Efficacy|0|||
149953810|NCT03188185|540963132|FG000|Stage 1|Lost to Follow-up|6|||
149953811|NCT03188185|540963133|FG001|Stage 1|Lost to Follow-up|1|||
149953812|NCT03188185|540963134|FG002|Stage 1|Lost to Follow-up|0|||
149953813|NCT03188185|540963135|FG003|Stage 1|Lost to Follow-up|0|||
149842779|NCT01204294|540554768|FG004|Overall Study|Protocol Violation|0|||
149842780|NCT01204294|540554769|FG005|Overall Study|Protocol Violation|0|||
149842781|NCT01204294|540554770|FG006|Overall Study|Protocol Violation|0|||
149842782|NCT01204294|540554764|FG000|Overall Study|Withdrawal by Subject|0|||
149842783|NCT01204294|540554765|FG001|Overall Study|Withdrawal by Subject|2|||
149842784|NCT01204294|540554766|FG002|Overall Study|Withdrawal by Subject|2|||
149842785|NCT01204294|540554767|FG003|Overall Study|Withdrawal by Subject|1|||
149842786|NCT01204294|540554768|FG004|Overall Study|Withdrawal by Subject|1|||
149842787|NCT01204294|540554769|FG005|Overall Study|Withdrawal by Subject|1|||
149842788|NCT01204294|540554770|FG006|Overall Study|Withdrawal by Subject|2|||
149842789|NCT01204294|540554764|FG000|Overall Study|Lack of Efficacy|0|||
149842790|NCT01204294|540554765|FG001|Overall Study|Lack of Efficacy|0|||
149842791|NCT01204294|540554766|FG002|Overall Study|Lack of Efficacy|0|||
149842792|NCT01204294|540554767|FG003|Overall Study|Lack of Efficacy|2|||
149842793|NCT01204294|540554768|FG004|Overall Study|Lack of Efficacy|0|||
149842794|NCT01204294|540554769|FG005|Overall Study|Lack of Efficacy|0|||
149842795|NCT01204294|540554770|FG006|Overall Study|Lack of Efficacy|0|||
149842796|NCT01204294|540554764|FG000|Overall Study|Other (house moving)|0|||
149842797|NCT01204294|540554765|FG001|Overall Study|Other (house moving)|0|||
149842798|NCT01204294|540554766|FG002|Overall Study|Other (house moving)|1|||
149842799|NCT01204294|540554767|FG003|Overall Study|Other (house moving)|0|||
149842800|NCT01204294|540554768|FG004|Overall Study|Other (house moving)|0|||
149842801|NCT01204294|540554769|FG005|Overall Study|Other (house moving)|0|||
149842802|NCT01204294|540554770|FG006|Overall Study|Other (house moving)|0|||
149842803|NCT04590027|540554771|FG000|Overall Study|Lost to Follow-up|17|||
149842804|NCT04590027|540554772|FG001|Overall Study|Lost to Follow-up|14|||
149842805|NCT04590027|540554771|FG000|Overall Study|Protocol Violation|0|||
149842806|NCT04590027|540554772|FG001|Overall Study|Protocol Violation|3|||
149842807|NCT01383486|540554773|FG000|Overall Study|Lost to Follow-up|10|||
149842808|NCT01383486|540554773|FG000|Overall Study|Incomplete information for analysis|2|||
149842809|NCT01383486|540554773|FG000|Overall Study|Did not take any product|6|||
149842810|NCT00245063|540554774|FG000|Overall Study|Adverse Event|6|||
149842811|NCT00245063|540554775|FG001|Overall Study|Adverse Event|5|||
149842812|NCT00245063|540554774|FG000|Overall Study|Death|1|||
149842813|NCT00245063|540554775|FG001|Overall Study|Death|0|||
149842814|NCT01839279|540554777|FG000|Overall Study|Adverse Event|4|||
149842815|NCT01839279|540554778|FG001|Overall Study|Adverse Event|1|||
149842816|NCT01839279|540554779|FG002|Overall Study|Adverse Event|1|||
149842817|NCT01839279|540554777|FG000|Overall Study|Withdrawal by Subject|4|||
149842818|NCT01839279|540554778|FG001|Overall Study|Withdrawal by Subject|1|||
149842819|NCT01839279|540554779|FG002|Overall Study|Withdrawal by Subject|1|||
149842820|NCT01839279|540554777|FG000|Overall Study|Classified as 'Other'|5|||
149842821|NCT01839279|540554778|FG001|Overall Study|Classified as 'Other'|0|||
149842822|NCT01839279|540554779|FG002|Overall Study|Classified as 'Other'|0|||
149842823|NCT00840216|540554783|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
149842824|NCT00840216|540554784|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
149842825|NCT03276754|540554785|FG000|Overall Study|Withdrawal of informed consent|4|||
149842826|NCT03276754|540554785|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
149842827|NCT03276754|540554785|FG000|Overall Study|Lost to Follow-up|27|||
149842828|NCT03276754|540554785|FG000|Overall Study|No data reported at Month 24|31|||
149842829|NCT03276754|540554785|FG000|Overall Study|Death|39|||
149842830|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Adverse Event|8|||
149842831|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Adverse Event|15|||
149842832|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Adverse Event|25|||
149842833|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
149842834|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
149842835|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
149842836|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
149842837|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
149842838|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
149842839|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
149842840|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
149842841|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
149953814|NCT03188185|540963132|FG000|Stage 1|Withdrawal by Subject|9|||
149953815|NCT03188185|540963133|FG001|Stage 1|Withdrawal by Subject|0|||
150035699|NCT00853307|541271371|FG001|Overall Study|Reason Not Specified|1|||
150286176|NCT00542269|542182694|FG000|Overall Study|Adverse Event|10|||
149842842|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
149842843|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
149842844|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
149842845|NCT01058668|540554786|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
149842846|NCT01058668|540554787|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
149842847|NCT01058668|540554788|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
149842848|NCT00316277|540554789|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
149842849|NCT00316277|540554790|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
149842850|NCT00316277|540554789|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
149842851|NCT00316277|540554790|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
149842852|NCT00316277|540554789|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
149842853|NCT00316277|540554790|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
149842854|NCT00316277|540554789|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
149842855|NCT00316277|540554790|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
149842856|NCT00316277|540554789|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
149842857|NCT00316277|540554790|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
149842858|NCT00927069|540554795|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
149842859|NCT00927069|540554796|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
149842860|NCT00927069|540554797|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
149842861|NCT00927069|540554798|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
149842862|NCT00927069|540554795|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
149842863|NCT00927069|540554796|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
149842864|NCT00927069|540554797|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
149842865|NCT00927069|540554798|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
149842866|NCT00927069|540554795|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
149842867|NCT00927069|540554796|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
149842868|NCT00927069|540554797|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
149842869|NCT00927069|540554798|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
149842870|NCT00927069|540554795|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
149842871|NCT00927069|540554796|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
149842872|NCT00927069|540554797|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
149842873|NCT00927069|540554798|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
149842874|NCT00927069|540554795|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
149842875|NCT00927069|540554796|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
149842876|NCT00927069|540554797|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
149842877|NCT00927069|540554798|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
149842878|NCT02911792|540554799|FG000|Overall Study|Lost to Follow-up|3|||
149842879|NCT02911792|540554800|FG001|Overall Study|Lost to Follow-up|3|||
149842880|NCT02911792|540554801|FG002|Overall Study|Lost to Follow-up|3|||
149842881|NCT02911792|540554802|FG003|Overall Study|Lost to Follow-up|3|||
149842882|NCT00848536|540554803|FG000|Overall Study|Adverse Event|2|||
149842883|NCT00848536|540554804|FG001|Overall Study|Adverse Event|2|||
149842884|NCT00848536|540554803|FG000|Overall Study|Withdrawal by Subject|0|||
149842885|NCT00848536|540554804|FG001|Overall Study|Withdrawal by Subject|1|||
149842886|NCT00848536|540554803|FG000|Overall Study|Protocol Violation|0|||
149842887|NCT00848536|540554804|FG001|Overall Study|Protocol Violation|1|||
149842888|NCT00848536|540554803|FG000|Overall Study|Noncompliance|1|||
149842889|NCT00848536|540554804|FG001|Overall Study|Noncompliance|0|||
149842890|NCT00848536|540554803|FG000|Overall Study|Inadequate Control of IOP|1|||
149842891|NCT00848536|540554804|FG001|Overall Study|Inadequate Control of IOP|1|||
149842892|NCT00848536|540554803|FG000|Overall Study|Patient Moved|0|||
149842893|NCT00848536|540554804|FG001|Overall Study|Patient Moved|2|||
149842894|NCT00107991|540554807|FG000|Eligibility Assessment|Disease not severe enough|7|||
149842895|NCT00107991|540554807|FG000|Eligibility Assessment|Unwilling to participate|7|||
149842896|NCT00107991|540554807|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
149842897|NCT00107991|540554807|FG000|Eligibility Assessment|Abnormal labs|2|||
149842898|NCT00107991|540554807|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
149842899|NCT00107991|540554807|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
150286177|NCT00542269|542182695|FG001|Overall Study|Adverse Event|4|||
150286178|NCT00542269|542182696|FG002|Overall Study|Adverse Event|5|||
149842900|NCT00107991|540554807|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
149842901|NCT00107991|540554807|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
150286179|NCT00542269|542182694|FG000|Overall Study|Protocol Violation|1|||
150286180|NCT00542269|542182695|FG001|Overall Study|Protocol Violation|1|||
149842902|NCT00107991|540554807|FG000|12 Week Treatment Period|Adverse Event|1|||
150286181|NCT00542269|542182696|FG002|Overall Study|Protocol Violation|0|||
149842903|NCT00107991|540554807|FG000|12 Week Treatment Period|Protocol Violation|1|||
149842904|NCT00107991|540554807|FG000|12 Week Treatment Period|Incarcerated|1|||
150286182|NCT00542269|542182694|FG000|Overall Study|Withdrawal by Subject|1|||
149842905|NCT00107991|540554807|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
149842906|NCT01535222|540554808|FG000|Overall Study|Inclusion/exclusion|0|||
149842907|NCT01535222|540554809|FG001|Overall Study|Inclusion/exclusion|0|||
149842908|NCT01535222|540554810|FG002|Overall Study|Inclusion/exclusion|1|||
150286183|NCT00542269|542182695|FG001|Overall Study|Withdrawal by Subject|0|||
150286184|NCT00542269|542182696|FG002|Overall Study|Withdrawal by Subject|0|||
150286185|NCT00542269|542182694|FG000|Overall Study|Administrative problems|1|||
150286186|NCT00542269|542182695|FG001|Overall Study|Administrative problems|1|||
150286187|NCT00542269|542182696|FG002|Overall Study|Administrative problems|1|||
150286188|NCT00708123|542182697|FG000|Period 1|Protocol Violation|0|||
150286189|NCT00708123|542182698|FG001|Period 1|Protocol Violation|1|||
150286190|NCT00708123|542182699|FG002|Period 1|Protocol Violation|0|||
150286191|NCT00708123|542182700|FG003|Period 1|Protocol Violation|1|||
150286192|NCT00708123|542182701|FG004|Period 1|Protocol Violation|0|||
150286193|NCT00708123|542182697|FG000|Period 1|Adverse Event|0|||
150286194|NCT00708123|542182698|FG001|Period 1|Adverse Event|0|||
150286195|NCT00708123|542182699|FG002|Period 1|Adverse Event|1|||
150286196|NCT00708123|542182700|FG003|Period 1|Adverse Event|0|||
149842909|NCT01535222|540554811|FG003|Overall Study|Inclusion/exclusion|0|||
149842910|NCT01535222|540554812|FG004|Overall Study|Inclusion/exclusion|0|||
150286197|NCT00708123|542182701|FG004|Period 1|Adverse Event|0|||
150286198|NCT00708123|542182697|FG000|Period 2|Protocol Violation|0|||
150286199|NCT00708123|542182698|FG001|Period 2|Protocol Violation|0|||
150286200|NCT00708123|542182699|FG002|Period 2|Protocol Violation|0|||
150286201|NCT00708123|542182700|FG003|Period 2|Protocol Violation|1|||
150286202|NCT00708123|542182701|FG004|Period 2|Protocol Violation|0|||
150286203|NCT00708123|542182697|FG000|Period 2|Other Reason|1|||
150286204|NCT00708123|542182698|FG001|Period 2|Other Reason|0|||
149842911|NCT01535222|540554813|FG005|Overall Study|Inclusion/exclusion|0|||
149842912|NCT03930732|540554814|FG000|Overall Study|Adverse Event|9|||
149842913|NCT03930732|540554815|FG001|Overall Study|Adverse Event|7|||
149842914|NCT03930732|540554814|FG000|Overall Study|Poor compliance to protocol|0|||
149842915|NCT03930732|540554815|FG001|Overall Study|Poor compliance to protocol|1|||
149842916|NCT03930732|540554814|FG000|Overall Study|Withdrawal by Subject|23|||
149842917|NCT03930732|540554815|FG001|Overall Study|Withdrawal by Subject|11|||
149842918|NCT03930732|540554814|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
149842919|NCT03930732|540554815|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
149842920|NCT03930732|540554814|FG000|Overall Study|Other reason not related to COVID-19|5|||
149842921|NCT03930732|540554815|FG001|Overall Study|Other reason not related to COVID-19|8|||
149842922|NCT03808376|540554822|FG000|Overall Study|Withdrawal by Subject|10|||
149842923|NCT01097577|540554823|FG000|Overall Study|Adverse Event|0|||
149842924|NCT01097577|540554824|FG001|Overall Study|Adverse Event|1|||
149842925|NCT03114891|540554827|FG000|First Treatment Round|Lost to Follow-up|0|||
149842926|NCT03114891|540554828|FG001|First Treatment Round|Lost to Follow-up|1|||
149842927|NCT03114891|540554829|FG002|First Treatment Round|Lost to Follow-up|1|||
149842928|NCT03114891|540554830|FG003|First Treatment Round|Lost to Follow-up|0|||
149842929|NCT03114891|540554827|FG000|First Treatment Round|Withdrawal by Subject|0|||
149842930|NCT03114891|540554828|FG001|First Treatment Round|Withdrawal by Subject|2|||
149842931|NCT03114891|540554829|FG002|First Treatment Round|Withdrawal by Subject|0|||
149842932|NCT03114891|540554830|FG003|First Treatment Round|Withdrawal by Subject|1|||
149842933|NCT03114891|540554827|FG000|3 Week Break|Lost to Follow-up|1|||
149842934|NCT03114891|540554828|FG001|3 Week Break|Lost to Follow-up|0|||
149842935|NCT03114891|540554829|FG002|3 Week Break|Lost to Follow-up|0|||
149842936|NCT03114891|540554830|FG003|3 Week Break|Lost to Follow-up|1|||
149842937|NCT03114891|540554827|FG000|3 Week Break|Withdrawal by Subject|0|||
149842938|NCT03114891|540554828|FG001|3 Week Break|Withdrawal by Subject|1|||
149842939|NCT03114891|540554829|FG002|3 Week Break|Withdrawal by Subject|0|||
149842940|NCT03114891|540554830|FG003|3 Week Break|Withdrawal by Subject|0|||
149842941|NCT03114891|540554827|FG000|Second Treatment Round|Lost to Follow-up|1|||
149842942|NCT03114891|540554828|FG001|Second Treatment Round|Lost to Follow-up|0|||
149842943|NCT03114891|540554829|FG002|Second Treatment Round|Lost to Follow-up|0|||
149842944|NCT03114891|540554830|FG003|Second Treatment Round|Lost to Follow-up|0|||
149842945|NCT03114891|540554827|FG000|Second Treatment Round|Physician Decision|1|||
149842946|NCT03114891|540554828|FG001|Second Treatment Round|Physician Decision|0|||
149842947|NCT03114891|540554829|FG002|Second Treatment Round|Physician Decision|0|||
149842948|NCT03114891|540554830|FG003|Second Treatment Round|Physician Decision|0|||
149842949|NCT01952691|540556742|FG000|Overall Study|Lost to Follow-up|2|||
149842950|NCT00199901|540556743|FG000|Overall Study|Protocol Violation|2|||
150286205|NCT00708123|542182699|FG002|Period 2|Other Reason|0|||
150286206|NCT00708123|542182700|FG003|Period 2|Other Reason|0|||
149842951|NCT00199901|540556744|FG001|Overall Study|Protocol Violation|0|||
149842952|NCT00199901|540556743|FG000|Overall Study|Withdrawal by Subject|1|||
150286207|NCT00708123|542182701|FG004|Period 2|Other Reason|0|||
150286208|NCT00708123|542182697|FG000|Period 3|Lost to Follow-up|0|||
150286209|NCT00708123|542182698|FG001|Period 3|Lost to Follow-up|0|||
150286210|NCT00708123|542182699|FG002|Period 3|Lost to Follow-up|1|||
149842953|NCT00199901|540556744|FG001|Overall Study|Withdrawal by Subject|0|||
149842954|NCT00199901|540556743|FG000|Overall Study|Progressive Disease|24|||
149842955|NCT00199901|540556744|FG001|Overall Study|Progressive Disease|24|||
149842956|NCT01958294|540556754|FG000|Overall Study|Clinical Circumstances|2|||
149842957|NCT02566850|540556755|FG000|Overall Study|Protocol Violation|1|||
150286211|NCT00708123|542182700|FG003|Period 3|Lost to Follow-up|1|||
149842958|NCT01116739|540556756|FG000|Overall Study|Child had 2 years of HS|110|||
149842959|NCT01116739|540556757|FG001|Overall Study|Child had 2 years of HS|128|||
149842960|NCT01116739|540556756|FG000|Overall Study|Withdrawal by Subject|6|||
149842961|NCT01116739|540556757|FG001|Overall Study|Withdrawal by Subject|0|||
149842962|NCT01116739|540556756|FG000|Overall Study|child too young|2|||
149842963|NCT01116739|540556757|FG001|Overall Study|child too young|6|||
149842964|NCT01116739|540556756|FG000|Overall Study|child not enrolled in head start|10|||
149842965|NCT01116739|540556757|FG001|Overall Study|child not enrolled in head start|2|||
149842966|NCT01116739|540556756|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
149842967|NCT01116739|540556757|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
149842968|NCT05511935|540556758|FG000|Overall Study|Lost to Follow-up|9|||
149842969|NCT05511935|540556759|FG001|Overall Study|Lost to Follow-up|27|||
149842970|NCT01624233|540556760|FG000|Period 2 - Induction|Adverse Event|1|||
149842971|NCT01624233|540556760|FG000|Period 3 - Maintenance|Adverse Event|2|||
149842972|NCT01624233|540556760|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
149842973|NCT01624233|540556760|FG000|Period 3 - Maintenance|Physician Decision|2|||
149842974|NCT01624233|540556760|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
149842975|NCT01624233|540556760|FG000|Period 4 - Drug Free Period|Relapsed|61|||
149842976|NCT01624233|540556760|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
149842977|NCT01624233|540556760|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
149842978|NCT01624233|540556760|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
149842979|NCT01624233|540556760|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
149842980|NCT01624233|540556760|FG000|Period 6: Follow-up|Adverse Event|3|||
149842981|NCT01624233|540556760|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
149842982|NCT01624233|540556760|FG000|Period 6: Follow-up|Physician Decision|1|||
149842983|NCT01624233|540556760|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
149842984|NCT05710718|540556761|FG000|Overall Study|Withdrawal by Subject|5|||
149842985|NCT05710718|540556762|FG001|Overall Study|Withdrawal by Subject|1|||
149842986|NCT05710718|540556761|FG000|Overall Study|Lost to Follow-up|0|||
149842987|NCT05710718|540556762|FG001|Overall Study|Lost to Follow-up|1|||
149842988|NCT05710718|540556761|FG000|Overall Study|Death|0|||
149842989|NCT05710718|540556762|FG001|Overall Study|Death|1|||
149842990|NCT04372238|540556763|FG000|Overall Study|Duplicate|3|||
149842991|NCT04372238|540556764|FG001|Overall Study|Duplicate|3|||
149842992|NCT04372238|540556763|FG000|Overall Study|Did not consent for data linkage|6|||
149842993|NCT04372238|540556764|FG001|Overall Study|Did not consent for data linkage|10|||
149842994|NCT04241458|540556765|FG000|Overall Study|Withdrawal by Subject|0|||
149842995|NCT04241458|540556766|FG001|Overall Study|Withdrawal by Subject|0|||
149842996|NCT04241458|540556767|FG002|Overall Study|Withdrawal by Subject|0|||
149842997|NCT04241458|540556768|FG003|Overall Study|Withdrawal by Subject|0|||
149842998|NCT04241458|540556769|FG004|Overall Study|Withdrawal by Subject|1|||
149842999|NCT00334815|540556770|FG000|Overall Study|Adverse Event|3|||
149843000|NCT00334815|540556771|FG001|Overall Study|Adverse Event|2|||
149843001|NCT00334815|540556770|FG000|Overall Study|Death|0|||
149953816|NCT03188185|540963134|FG002|Stage 1|Withdrawal by Subject|0|||
149953817|NCT03188185|540963135|FG003|Stage 1|Withdrawal by Subject|0|||
149953818|NCT03188185|540963132|FG000|Stage 1|Identified as a professional patient|0|||
149953819|NCT03188185|540963133|FG001|Stage 1|Identified as a professional patient|1|||
149953820|NCT03188185|540963134|FG002|Stage 1|Identified as a professional patient|0|||
149953821|NCT03188185|540963135|FG003|Stage 1|Identified as a professional patient|0|||
149953822|NCT03188185|540963132|FG000|Stage 2|Adverse Event|0|||
150286212|NCT00708123|542182701|FG004|Period 3|Lost to Follow-up|0|||
150286213|NCT00708123|542182697|FG000|Period 4|Protocol Violation|0|||
150286214|NCT00708123|542182698|FG001|Period 4|Protocol Violation|1|||
149953823|NCT03188185|540963133|FG001|Stage 2|Adverse Event|0|||
150286215|NCT00708123|542182699|FG002|Period 4|Protocol Violation|0|||
150286216|NCT00708123|542182700|FG003|Period 4|Protocol Violation|0|||
150286217|NCT00708123|542182701|FG004|Period 4|Protocol Violation|0|||
150286218|NCT02970292|542182702|FG000|Overall Study|Physician Decision|1|||
150286219|NCT02970292|542182703|FG001|Overall Study|Physician Decision|1|||
150286220|NCT02970292|542182702|FG000|Overall Study|Withdrawal by Subject|11|||
150286221|NCT02970292|542182703|FG001|Overall Study|Withdrawal by Subject|5|||
150286222|NCT02970292|542182702|FG000|Overall Study|Noncompliance with study drug|2|||
150286223|NCT02970292|542182703|FG001|Overall Study|Noncompliance with study drug|2|||
149843002|NCT00334815|540556771|FG001|Overall Study|Death|2|||
149843003|NCT00334815|540556770|FG000|Overall Study|Progression|1|||
149843004|NCT00334815|540556771|FG001|Overall Study|Progression|0|||
149843005|NCT00334815|540556770|FG000|Overall Study|ineligible|1|||
149843006|NCT00334815|540556771|FG001|Overall Study|ineligible|1|||
149953824|NCT03188185|540963134|FG002|Stage 2|Adverse Event|2|||
150286224|NCT02970292|542182702|FG000|Overall Study|Adverse Event|5|||
150286225|NCT02970292|542182703|FG001|Overall Study|Adverse Event|0|||
149843007|NCT00334815|540556770|FG000|Overall Study|patient refused treatment|0|||
149843008|NCT00334815|540556771|FG001|Overall Study|patient refused treatment|1|||
149843009|NCT00334815|540556770|FG000|Overall Study|Physician Decision|2|||
149843010|NCT00334815|540556771|FG001|Overall Study|Physician Decision|4|||
149953825|NCT03188185|540963135|FG003|Stage 2|Adverse Event|4|||
150286226|NCT02970292|542182702|FG000|Overall Study|Lack of Efficacy|1|||
150286227|NCT02970292|542182703|FG001|Overall Study|Lack of Efficacy|0|||
150286228|NCT02970292|542182702|FG000|Overall Study|Lost to Follow-up|1|||
150286229|NCT02970292|542182703|FG001|Overall Study|Lost to Follow-up|0|||
150286230|NCT02970292|542182702|FG000|Overall Study|Protocol Violation|2|||
150286231|NCT02970292|542182703|FG001|Overall Study|Protocol Violation|0|||
150286232|NCT02970292|542182702|FG000|Overall Study|Other|1|||
150286233|NCT02970292|542182703|FG001|Overall Study|Other|0|||
150286234|NCT00845650|542182704|FG000|Overall Study|Withdrawal by Subject|0|||
150286235|NCT00845650|542182705|FG001|Overall Study|Withdrawal by Subject|0|||
150286236|NCT00845650|542182706|FG002|Overall Study|Withdrawal by Subject|0|||
150286237|NCT00845650|542182707|FG003|Overall Study|Withdrawal by Subject|0|||
150286238|NCT00845650|542182708|FG004|Overall Study|Withdrawal by Subject|2|||
150286239|NCT00845650|542182709|FG005|Overall Study|Withdrawal by Subject|0|||
150286240|NCT00845650|542182704|FG000|Overall Study|Lost to Follow-up|0|||
150286241|NCT00845650|542182705|FG001|Overall Study|Lost to Follow-up|0|||
150286242|NCT00845650|542182706|FG002|Overall Study|Lost to Follow-up|3|||
150286243|NCT00845650|542182707|FG003|Overall Study|Lost to Follow-up|1|||
150286244|NCT00845650|542182708|FG004|Overall Study|Lost to Follow-up|0|||
150286245|NCT00845650|542182709|FG005|Overall Study|Lost to Follow-up|1|||
150286246|NCT00845650|542182704|FG000|Overall Study|Sponsor hold on dosing|0|||
150286247|NCT00845650|542182705|FG001|Overall Study|Sponsor hold on dosing|0|||
150286248|NCT00845650|542182706|FG002|Overall Study|Sponsor hold on dosing|0|||
150286249|NCT00845650|542182707|FG003|Overall Study|Sponsor hold on dosing|0|||
150286250|NCT00845650|542182708|FG004|Overall Study|Sponsor hold on dosing|1|||
150286251|NCT00845650|542182709|FG005|Overall Study|Sponsor hold on dosing|1|||
150286252|NCT00845650|542182704|FG000|Overall Study|Unable to access IV line|1|||
150286253|NCT00845650|542182705|FG001|Overall Study|Unable to access IV line|0|||
150286254|NCT00845650|542182706|FG002|Overall Study|Unable to access IV line|0|||
150286255|NCT00845650|542182707|FG003|Overall Study|Unable to access IV line|0|||
150286256|NCT00845650|542182708|FG004|Overall Study|Unable to access IV line|0|||
150286257|NCT00845650|542182709|FG005|Overall Study|Unable to access IV line|0|||
150286258|NCT00814892|542182710|FG000|Overall Study|Disease Progression|1|||
150286259|NCT00814892|542182710|FG000|Overall Study|Study Termination|1|||
150286260|NCT01187953|542182711|FG000|Overall Study|Death|11|||
150286261|NCT01187953|542182712|FG001|Overall Study|Death|13|||
150286262|NCT01187953|542182711|FG000|Overall Study|Adverse Event|1|||
150286263|NCT01187953|542182712|FG001|Overall Study|Adverse Event|2|||
150286264|NCT01187953|542182711|FG000|Overall Study|Lost to Follow-up|0|||
150286265|NCT01187953|542182712|FG001|Overall Study|Lost to Follow-up|3|||
150286266|NCT01187953|542182711|FG000|Overall Study|Withdrawal by Subject|3|||
150286267|NCT01187953|542182712|FG001|Overall Study|Withdrawal by Subject|3|||
150286268|NCT01553136|542182714|FG000|Overall Study|Adverse Event|3|||
150286269|NCT01553136|542182715|FG001|Overall Study|Adverse Event|2|||
150286270|NCT01553136|542182714|FG000|Overall Study|Withdrawal by Subject|2|||
150286271|NCT01553136|542182715|FG001|Overall Study|Withdrawal by Subject|3|||
150286272|NCT01553136|542182714|FG000|Overall Study|Lost to Follow-up|4|||
150286273|NCT01553136|542182715|FG001|Overall Study|Lost to Follow-up|10|||
150286274|NCT01553136|542182714|FG000|Overall Study|Physician Decision|2|||
150286275|NCT01553136|542182715|FG001|Overall Study|Physician Decision|3|||
150286276|NCT01553136|542182714|FG000|Overall Study|Scheduling Difficulties|5|||
150286277|NCT01553136|542182715|FG001|Overall Study|Scheduling Difficulties|4|||
150286278|NCT01014689|542182718|FG000|Overall Study|Lack of Efficacy|0|||
150286279|NCT01014689|542182719|FG001|Overall Study|Lack of Efficacy|1|||
149843011|NCT06144424|540556772|FG000|Overall Study|Withdrawal by Subject|2|||
149843012|NCT06144424|540556773|FG001|Overall Study|Withdrawal by Subject|0|||
149843013|NCT06144424|540556772|FG000|Overall Study|Incarceration|1|||
150286280|NCT01014689|542182718|FG000|Overall Study|Adverse Event|3|||
150286281|NCT01014689|542182719|FG001|Overall Study|Adverse Event|0|||
150286282|NCT01014689|542182718|FG000|Overall Study|Withdrawal by Subject|5|||
150286283|NCT01014689|542182719|FG001|Overall Study|Withdrawal by Subject|4|||
150286284|NCT01014689|542182718|FG000|Overall Study|Protocol Violation|1|||
150286285|NCT01014689|542182719|FG001|Overall Study|Protocol Violation|1|||
150286286|NCT01014689|542182718|FG000|Overall Study|Lost to Follow-up|3|||
150286287|NCT01014689|542182719|FG001|Overall Study|Lost to Follow-up|7|||
149843014|NCT06144424|540556773|FG001|Overall Study|Incarceration|0|||
149843015|NCT03121586|540556774|FG000|Overall Study|Study terminated by sponsor|0|||
149843016|NCT03121586|540556775|FG001|Overall Study|Study terminated by sponsor|0|||
149843017|NCT03121586|540556776|FG002|Overall Study|Study terminated by sponsor|99|||
149843018|NCT03121586|540556774|FG000|Overall Study|Withdrawal by Subject|37|||
149843019|NCT03121586|540556775|FG001|Overall Study|Withdrawal by Subject|14|||
149953826|NCT03188185|540963132|FG000|Stage 2|Lack of Efficacy|0|||
149953827|NCT03188185|540963133|FG001|Stage 2|Lack of Efficacy|0|||
150286288|NCT01014689|542182718|FG000|Overall Study|Pregnancy|1|||
150286289|NCT01014689|542182719|FG001|Overall Study|Pregnancy|0|||
150286290|NCT03040999|542183674|FG000|Overall Study|Lost to Follow-up|2|||
150286291|NCT03040999|542183675|FG001|Overall Study|Lost to Follow-up|2|||
150286292|NCT03040999|542183674|FG000|Overall Study|Withdrawal by Subject|12|||
150286293|NCT03040999|542183675|FG001|Overall Study|Withdrawal by Subject|13|||
149843020|NCT03121586|540556776|FG002|Overall Study|Withdrawal by Subject|9|||
149843021|NCT03121586|540556774|FG000|Overall Study|Not further specified|6|||
149843022|NCT03121586|540556775|FG001|Overall Study|Not further specified|11|||
149843023|NCT03121586|540556776|FG002|Overall Study|Not further specified|10|||
149843024|NCT03121586|540556774|FG000|Overall Study|Adverse Event|16|||
150286294|NCT03040999|542183674|FG000|Overall Study|Death|155|||
149843025|NCT03121586|540556775|FG001|Overall Study|Adverse Event|5|||
149843026|NCT03121586|540556776|FG002|Overall Study|Adverse Event|6|||
149843027|NCT03121586|540556774|FG000|Overall Study|Protocol Violation|0|||
149843028|NCT03121586|540556775|FG001|Overall Study|Protocol Violation|5|||
149843029|NCT03121586|540556776|FG002|Overall Study|Protocol Violation|0|||
149843030|NCT03121586|540556774|FG000|Overall Study|Lack of Efficacy|3|||
149843031|NCT03121586|540556775|FG001|Overall Study|Lack of Efficacy|3|||
149843032|NCT03121586|540556776|FG002|Overall Study|Lack of Efficacy|1|||
149953828|NCT03188185|540963134|FG002|Stage 2|Lack of Efficacy|3|||
149953829|NCT03188185|540963135|FG003|Stage 2|Lack of Efficacy|0|||
149953830|NCT03188185|540963132|FG000|Stage 2|Lost to Follow-up|0|||
149953831|NCT03188185|540963133|FG001|Stage 2|Lost to Follow-up|0|||
149953832|NCT03188185|540963134|FG002|Stage 2|Lost to Follow-up|1|||
149953833|NCT03188185|540963135|FG003|Stage 2|Lost to Follow-up|0|||
149953834|NCT03188185|540963132|FG000|Stage 2|Physician Decision|0|||
149953835|NCT03188185|540963133|FG001|Stage 2|Physician Decision|0|||
149953836|NCT03188185|540963134|FG002|Stage 2|Physician Decision|0|||
149953837|NCT03188185|540963135|FG003|Stage 2|Physician Decision|1|||
149953838|NCT03188185|540963132|FG000|Stage 2|Withdrawal by Subject|0|||
149953839|NCT03188185|540963133|FG001|Stage 2|Withdrawal by Subject|0|||
149953840|NCT03188185|540963134|FG002|Stage 2|Withdrawal by Subject|3|||
149953841|NCT03188185|540963135|FG003|Stage 2|Withdrawal by Subject|1|||
149953842|NCT00896233|540963136|FG000|Overall Study|Claustrophobia during MRI|1|||
149953843|NCT02965456|540963137|FG000|Overall Study|Lost to Follow-up|40|||
149953844|NCT02965456|540963138|FG001|Overall Study|Lost to Follow-up|18|||
149953845|NCT02965456|540963137|FG000|Overall Study|Subject Request|22|||
149953846|NCT02965456|540963138|FG001|Overall Study|Subject Request|13|||
149953847|NCT02965456|540963137|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
149953848|NCT02965456|540963138|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
149953849|NCT02965456|540963137|FG000|Overall Study|Adverse Event|3|||
149953850|NCT02965456|540963138|FG001|Overall Study|Adverse Event|0|||
149953851|NCT02965456|540963137|FG000|Overall Study|Noncompliance with Study Drug|1|||
149953852|NCT02965456|540963138|FG001|Overall Study|Noncompliance with Study Drug|1|||
149953853|NCT02965456|540963137|FG000|Overall Study|Worsening Condition|0|||
149953854|NCT02965456|540963138|FG001|Overall Study|Worsening Condition|2|||
149953855|NCT02965456|540963137|FG000|Overall Study|Lack of Efficacy|1|||
149953856|NCT02965456|540963138|FG001|Overall Study|Lack of Efficacy|0|||
149953857|NCT02965456|540963137|FG000|Overall Study|Physician Decision|0|||
149953858|NCT02965456|540963138|FG001|Overall Study|Physician Decision|1|||
149953859|NCT02965456|540963137|FG000|Overall Study|Pregnancy|1|||
149953860|NCT02965456|540963138|FG001|Overall Study|Pregnancy|0|||
149953861|NCT02965456|540963137|FG000|Overall Study|Protocol Violation|0|||
149953862|NCT02965456|540963138|FG001|Overall Study|Protocol Violation|1|||
149953863|NCT02965456|540963137|FG000|Overall Study|Participant ran out of study drug|0|||
149953864|NCT02965456|540963138|FG001|Overall Study|Participant ran out of study drug|1|||
149953865|NCT04465955|540963139|FG000|Overall Study|Withdrew consent|6|||
149953866|NCT04465955|540963140|FG001|Overall Study|Withdrew consent|10|||
149953867|NCT04465955|540963141|FG002|Overall Study|Withdrew consent|7|||
149953868|NCT04465955|540963139|FG000|Overall Study|Adverse Event|6|||
149953869|NCT04465955|540963140|FG001|Overall Study|Adverse Event|5|||
149953870|NCT04465955|540963141|FG002|Overall Study|Adverse Event|1|||
149953871|NCT04465955|540963139|FG000|Overall Study|Lost to Follow-up|2|||
149953872|NCT04465955|540963140|FG001|Overall Study|Lost to Follow-up|0|||
149953873|NCT04465955|540963141|FG002|Overall Study|Lost to Follow-up|3|||
149953874|NCT04465955|540963139|FG000|Overall Study|Other|1|||
149953875|NCT04465955|540963140|FG001|Overall Study|Other|1|||
149953876|NCT04465955|540963141|FG002|Overall Study|Other|3|||
149953877|NCT05101317|540963142|FG000|Week1-13|Adverse Event|0|||
149953878|NCT05101317|540963143|FG001|Week1-13|Adverse Event|1|||
149953879|NCT05101317|540963144|FG002|Week1-13|Adverse Event|0|||
149953880|NCT05101317|540963145|FG003|Week1-13|Adverse Event|0|||
149953881|NCT05101317|540963142|FG000|Week1-13|Withdrawal by Subject|0|||
149953882|NCT05101317|540963143|FG001|Week1-13|Withdrawal by Subject|2|||
149953883|NCT05101317|540963144|FG002|Week1-13|Withdrawal by Subject|0|||
149953884|NCT05101317|540963145|FG003|Week1-13|Withdrawal by Subject|0|||
149953885|NCT05101317|540963142|FG000|Week1-13|Early Withdrawl|0|||
149953886|NCT05101317|540963143|FG001|Week1-13|Early Withdrawl|0|||
149953887|NCT05101317|540963144|FG002|Week1-13|Early Withdrawl|0|||
149953888|NCT05101317|540963145|FG003|Week1-13|Early Withdrawl|1|||
149953889|NCT05101317|540963142|FG000|Week 13-25|Lost to Follow-up|0|||
149953890|NCT05101317|540963143|FG001|Week 13-25|Lost to Follow-up|0|||
149843033|NCT03121586|540556774|FG000|Overall Study|Physician Decision|2|||
149843034|NCT03121586|540556775|FG001|Overall Study|Physician Decision|2|||
149953891|NCT05101317|540963144|FG002|Week 13-25|Lost to Follow-up|1|||
149953892|NCT05101317|540963145|FG003|Week 13-25|Lost to Follow-up|0|||
150286295|NCT03040999|542183675|FG001|Overall Study|Death|171|||
149843035|NCT03121586|540556776|FG002|Overall Study|Physician Decision|0|||
149843036|NCT03121586|540556774|FG000|Overall Study|Noncompliance with study drug|5|||
149843037|NCT03121586|540556775|FG001|Overall Study|Noncompliance with study drug|3|||
149843038|NCT03121586|540556776|FG002|Overall Study|Noncompliance with study drug|5|||
149843039|NCT03121586|540556774|FG000|Overall Study|Lost to Follow-up|4|||
149843040|NCT03121586|540556775|FG001|Overall Study|Lost to Follow-up|2|||
149953893|NCT05101317|540963142|FG000|Week 13-25|Withdrawal by Subject|1|||
149953894|NCT05101317|540963143|FG001|Week 13-25|Withdrawal by Subject|1|||
149953895|NCT05101317|540963144|FG002|Week 13-25|Withdrawal by Subject|0|||
149953896|NCT05101317|540963145|FG003|Week 13-25|Withdrawal by Subject|0|||
149953897|NCT05101317|540963142|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
149953898|NCT05101317|540963143|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
149953899|NCT05101317|540963144|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
149953900|NCT05101317|540963145|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
149953901|NCT01327703|540963148|FG000|Second Treatment Period|Adverse Event|1|||
149953902|NCT01327703|540963149|FG001|Second Treatment Period|Adverse Event|1|||
149953903|NCT01327703|540963148|FG000|Second Treatment Period|Protocol Violation|0|||
149953904|NCT01327703|540963149|FG001|Second Treatment Period|Protocol Violation|1|||
149953905|NCT00812097|540963150|FG000|Overall Study|Death|3|||
149953906|NCT00812097|540963151|FG001|Overall Study|Death|10|||
149953907|NCT00812097|540963152|FG002|Overall Study|Death|3|||
149953908|NCT00812097|540963153|FG003|Overall Study|Death|3|||
149953909|NCT00812097|540963150|FG000|Overall Study|Withdrawal by Subject|14|||
149953910|NCT00812097|540963151|FG001|Overall Study|Withdrawal by Subject|12|||
149953911|NCT00812097|540963152|FG002|Overall Study|Withdrawal by Subject|8|||
149953912|NCT00812097|540963153|FG003|Overall Study|Withdrawal by Subject|2|||
150172495|NCT00708032|541767971|FG001|Overall Study|Withdrawal by Subject|1|||
149843041|NCT03121586|540556776|FG002|Overall Study|Lost to Follow-up|0|||
149843042|NCT03121586|540556774|FG000|Overall Study|Death|2|||
149843043|NCT03121586|540556775|FG001|Overall Study|Death|0|||
149843044|NCT03121586|540556776|FG002|Overall Study|Death|0|||
150172496|NCT00004124|541767977|FG000|Overall Study|Received no protocol therapy|12|||
150172497|NCT00004124|541767978|FG001|Overall Study|Received no protocol therapy|20|||
150172498|NCT01613716|541767986|FG000|Overall Study|screen failures|3|||
150172499|NCT01613716|541767986|FG000|Overall Study|Lost to Follow-up|4|||
150172500|NCT03557008|541767987|FG000|Overall Study|Withdrawal by Subject|2|||
150172501|NCT03557008|541767988|FG001|Overall Study|Withdrawal by Subject|2|||
150172502|NCT03557008|541767987|FG000|Overall Study|Early termination from study|3|||
150172503|NCT03557008|541767988|FG001|Overall Study|Early termination from study|1|||
150172504|NCT03959241|541767991|FG000|Overall Study|Withdrawal by Subject|7|||
150172505|NCT03959241|541767992|FG001|Overall Study|Withdrawal by Subject|8|||
150172506|NCT03959241|541767991|FG000|Overall Study|Lost to Follow-up|1|||
150172507|NCT03959241|541767992|FG001|Overall Study|Lost to Follow-up|0|||
150172508|NCT03959241|541767991|FG000|Overall Study|Move to Hospice Care|1|||
150172509|NCT03959241|541767992|FG001|Overall Study|Move to Hospice Care|0|||
150172510|NCT03959241|541767991|FG000|Overall Study|Screen Failure|1|||
150172511|NCT03959241|541767992|FG001|Overall Study|Screen Failure|0|||
150172512|NCT03959241|541767991|FG000|Overall Study|Disease Relapse|0|||
150172513|NCT03959241|541767992|FG001|Overall Study|Disease Relapse|1|||
150172514|NCT03959241|541767991|FG000|Overall Study|Off Study|1|||
150172515|NCT03959241|541767992|FG001|Overall Study|Off Study|0|||
150172516|NCT03192046|541767995|FG000|Overall Study|Withdrawal by Subject|1|||
150172517|NCT03192046|541767996|FG001|Overall Study|Withdrawal by Subject|1|||
150172518|NCT01194154|541767999|FG000|Overall Study|Adverse Event|12|||
150172519|NCT01194154|541768000|FG001|Overall Study|Adverse Event|7|||
150172520|NCT01194154|541767999|FG000|Overall Study|Lost to Follow-up|2|||
150172521|NCT01194154|541768000|FG001|Overall Study|Lost to Follow-up|3|||
150172522|NCT01194154|541767999|FG000|Overall Study|Protocol Violation|0|||
150172523|NCT01194154|541768000|FG001|Overall Study|Protocol Violation|1|||
150172524|NCT01194154|541767999|FG000|Overall Study|Withdrawal by Subject|5|||
150172525|NCT01194154|541768000|FG001|Overall Study|Withdrawal by Subject|6|||
150172526|NCT01194154|541767999|FG000|Overall Study|Blood pressure increase|5|||
150172527|NCT01194154|541768000|FG001|Overall Study|Blood pressure increase|3|||
150172528|NCT01194154|541767999|FG000|Overall Study|Hemoglobin decrease|0|||
150172529|NCT01194154|541768000|FG001|Overall Study|Hemoglobin decrease|1|||
150172530|NCT01194154|541767999|FG000|Overall Study|Hemoglobin increase|12|||
150172531|NCT01194154|541768000|FG001|Overall Study|Hemoglobin increase|3|||
150172532|NCT01194154|541767999|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
150172533|NCT01194154|541768000|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
150172534|NCT01194154|541767999|FG000|Overall Study|Treatment with prohibited medication|4|||
150172535|NCT01194154|541768000|FG001|Overall Study|Treatment with prohibited medication|5|||
150172536|NCT01194154|541767999|FG000|Overall Study|Other|4|||
150172537|NCT01194154|541768000|FG001|Overall Study|Other|0|||
150172538|NCT01194154|541767999|FG000|Overall Study|Did not receive study medication|2|||
150172539|NCT01194154|541768000|FG001|Overall Study|Did not receive study medication|4|||
150172540|NCT01505881|541768001|FG000|Overall Study|Adverse Event|0|||
150286296|NCT03040999|542183674|FG000|Overall Study|Physician Decision|0|||
150286297|NCT03040999|542183675|FG001|Overall Study|Physician Decision|3|||
150286298|NCT03451773|542183676|FG000|Overall Study|Death on study|1|||
150286299|NCT03451773|542183677|FG001|Overall Study|Death on study|5|||
150286300|NCT03451773|542183676|FG000|Overall Study|Death during follow-up period|0|||
150286301|NCT03451773|542183677|FG001|Overall Study|Death during follow-up period|1|||
150286302|NCT03468855|542183678|FG000|Overall Study|Adverse Event|2|||
150286303|NCT03468855|542183678|FG000|Overall Study|Lost to Follow-up|5|||
150286304|NCT03468855|542183678|FG000|Overall Study|Withdrawal by Subject|3|||
150286305|NCT03468855|542183678|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
150286306|NCT03657043|542183679|FG000|Overall Study|Withdrawal by Subject|1|||
150286307|NCT03657043|542183680|FG001|Overall Study|Withdrawal by Subject|1|||
150286308|NCT03657043|542183681|FG002|Overall Study|Withdrawal by Subject|0|||
150286309|NCT03657043|542183682|FG003|Overall Study|Withdrawal by Subject|0|||
150286310|NCT03657043|542183683|FG004|Overall Study|Withdrawal by Subject|4|||
150286311|NCT03657043|542183679|FG000|Overall Study|Study closure by Sponsor|0|||
150286312|NCT03657043|542183680|FG001|Overall Study|Study closure by Sponsor|2|||
150286313|NCT03657043|542183681|FG002|Overall Study|Study closure by Sponsor|0|||
150286314|NCT03657043|542183682|FG003|Overall Study|Study closure by Sponsor|0|||
150286315|NCT03657043|542183683|FG004|Overall Study|Study closure by Sponsor|17|||
150286316|NCT03657043|542183679|FG000|Overall Study|Lost to Follow-up|0|||
150286317|NCT03657043|542183680|FG001|Overall Study|Lost to Follow-up|0|||
150286318|NCT03657043|542183681|FG002|Overall Study|Lost to Follow-up|0|||
150286319|NCT03657043|542183682|FG003|Overall Study|Lost to Follow-up|0|||
150286320|NCT03657043|542183683|FG004|Overall Study|Lost to Follow-up|4|||
150286321|NCT03657043|542183679|FG000|Overall Study|Death|6|||
150286322|NCT03657043|542183680|FG001|Overall Study|Death|5|||
150286323|NCT03657043|542183681|FG002|Overall Study|Death|0|||
150286324|NCT03657043|542183682|FG003|Overall Study|Death|0|||
150286325|NCT03657043|542183683|FG004|Overall Study|Death|53|||
150286326|NCT03657043|542183679|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
150286327|NCT03657043|542183680|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
150286328|NCT03657043|542183681|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
150286329|NCT03657043|542183682|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
150286330|NCT03657043|542183683|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
150286331|NCT03657043|542183679|FG000|Overall Study|Adverse Event|0|||
150286332|NCT03657043|542183680|FG001|Overall Study|Adverse Event|0|||
150172541|NCT01505881|541768002|FG001|Overall Study|Adverse Event|1|||
150172542|NCT01505881|541768001|FG000|Overall Study|Lost to Follow-up|2|||
150172543|NCT01505881|541768002|FG001|Overall Study|Lost to Follow-up|0|||
150172544|NCT01505881|541768001|FG000|Overall Study|Withdrawal by Subject|2|||
150286333|NCT03657043|542183681|FG002|Overall Study|Adverse Event|0|||
150286334|NCT03657043|542183682|FG003|Overall Study|Adverse Event|0|||
150286335|NCT03657043|542183683|FG004|Overall Study|Adverse Event|2|||
150286336|NCT03657043|542183679|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
150286337|NCT03657043|542183680|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
150286338|NCT03657043|542183681|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
150286339|NCT03657043|542183682|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
150286340|NCT03657043|542183683|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
150286341|NCT03657043|542183679|FG000|Overall Study|Withdrawal - declined follow-up|0|||
150286342|NCT03657043|542183680|FG001|Overall Study|Withdrawal - declined follow-up|0|||
150286343|NCT03657043|542183681|FG002|Overall Study|Withdrawal - declined follow-up|0|||
150286344|NCT03657043|542183682|FG003|Overall Study|Withdrawal - declined follow-up|0|||
150286345|NCT03657043|542183683|FG004|Overall Study|Withdrawal - declined follow-up|1|||
150286346|NCT02627495|542183686|FG000|Overall Study|Withdrawal by Subject|4|||
150286347|NCT01979523|542183687|FG000|Overall Study|Withdrawal by Subject|1|||
150286348|NCT01979523|542183688|FG001|Overall Study|Withdrawal by Subject|0|||
150286349|NCT01339559|542183696|FG000|Overall Study|Adverse Event|92|||
149843045|NCT06381102|540556777|FG000|Washout 5 Days|Withdrawal by Subject|0|||
149843046|NCT06381102|540556778|FG001|Washout 5 Days|Withdrawal by Subject|2|||
149843047|NCT02832063|540556780|FG000|Overall Study|Adverse Event|2|||
149843048|NCT02832063|540556781|FG001|Overall Study|Adverse Event|1|||
149843049|NCT02832063|540556780|FG000|Overall Study|Physician Decision|5|||
149843050|NCT02832063|540556781|FG001|Overall Study|Physician Decision|7|||
149843051|NCT02832063|540556780|FG000|Overall Study|Lost to Follow-up|15|||
149843052|NCT02832063|540556781|FG001|Overall Study|Lost to Follow-up|8|||
149843053|NCT02832063|540556780|FG000|Overall Study|Withdrawal by Subject|10|||
149843054|NCT02832063|540556781|FG001|Overall Study|Withdrawal by Subject|21|||
149843055|NCT02832063|540556780|FG000|Overall Study|Other|2|||
149843056|NCT02832063|540556781|FG001|Overall Study|Other|1|||
149843057|NCT03733730|540556782|FG000|Overall Study|Lost to Follow-up|1|||
149843058|NCT03733730|540556783|FG001|Overall Study|Lost to Follow-up|32|||
149843059|NCT03733730|540556782|FG000|Overall Study|Other|1|||
149843060|NCT03733730|540556783|FG001|Overall Study|Other|0|||
149843061|NCT03733730|540556782|FG000|Overall Study|Adverse Event|0|||
149843062|NCT03733730|540556783|FG001|Overall Study|Adverse Event|4|||
150172545|NCT01505881|541768002|FG001|Overall Study|Withdrawal by Subject|0|||
150286350|NCT01339559|542183696|FG000|Overall Study|Death|5|||
150286351|NCT01339559|542183696|FG000|Overall Study|Lack of Efficacy|164|||
150286352|NCT01339559|542183696|FG000|Overall Study|Lost to Follow-up|22|||
150286353|NCT01339559|542183696|FG000|Overall Study|Subject choice|89|||
150286354|NCT01339559|542183696|FG000|Overall Study|Protocol Violation|15|||
150286355|NCT01339559|542183696|FG000|Overall Study|Study closure at site|1|||
150286356|NCT01339559|542183696|FG000|Overall Study|Incarcerated|2|||
150286357|NCT01339559|542183696|FG000|Overall Study|Epilepsy surgery|1|||
150286358|NCT01339559|542183696|FG000|Overall Study|Pregnancy planned|2|||
150286359|NCT01339559|542183696|FG000|Overall Study|Left the country|1|||
150286360|NCT01339559|542183696|FG000|Overall Study|Investigator decision|2|||
150286361|NCT01339559|542183696|FG000|Overall Study|Patient didn't wish to continue|1|||
150286362|NCT01339559|542183696|FG000|Overall Study|PI decision|1|||
150286363|NCT00971945|542183697|FG000|Overall Study|Progressive Disease|3|||
150286364|NCT00971945|542183697|FG000|Overall Study|Change in treatment policy|1|||
150286365|NCT00971945|542183697|FG000|Overall Study|Other reasons|2|||
150286366|NCT03354663|542183698|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
150286367|NCT03354663|542183698|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
150286368|NCT03354663|542183698|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
150286369|NCT03354663|542183698|FG000|Completed 30-day Visit|Missed Visit|1|||
150286370|NCT01137773|542183699|FG000|Overall Study|Death|3|||
150286371|NCT01137773|542183700|FG001|Overall Study|Death|3|||
150286372|NCT01137773|542183699|FG000|Overall Study|Lost to Follow-up|6|||
150286373|NCT01137773|542183700|FG001|Overall Study|Lost to Follow-up|0|||
150286374|NCT03548051|542183704|FG000|Overall Study|Death|1|||
150286375|NCT03548051|542183705|FG001|Overall Study|Death|1|||
150286376|NCT03548051|542183704|FG000|Overall Study|Withdrawal by Subject|1|||
150286377|NCT03548051|542183705|FG001|Overall Study|Withdrawal by Subject|0|||
149843063|NCT03733730|540556782|FG000|Overall Study|Death|0|||
149843064|NCT03733730|540556783|FG001|Overall Study|Death|5|||
149843065|NCT03733730|540556782|FG000|Overall Study|Withdrawal by Subject|0|||
149843066|NCT03733730|540556783|FG001|Overall Study|Withdrawal by Subject|8|||
150286378|NCT03325673|542183707|FG000|Overall Study|Adverse Event|4|||
150286379|NCT03325673|542183708|FG001|Overall Study|Adverse Event|0|||
150286380|NCT01485627|542183712|FG000|Overall Study|Patient withdrew|6|||
150286381|NCT01485627|542183713|FG001|Overall Study|Patient withdrew|5|||
150286382|NCT01485627|542183712|FG000|Overall Study|Patient died|3|||
150286383|NCT01485627|542183713|FG001|Overall Study|Patient died|1|||
150286384|NCT01485627|542183712|FG000|Overall Study|Patient lost to followup|0|||
150286385|NCT01485627|542183713|FG001|Overall Study|Patient lost to followup|1|||
150286386|NCT01485627|542183712|FG000|Overall Study|Caregiver withdrew|3|||
150286387|NCT01485627|542183713|FG001|Overall Study|Caregiver withdrew|3|||
150286388|NCT01485627|542183712|FG000|Overall Study|Caregiver lost to follow up|11|||
150286389|NCT01485627|542183713|FG001|Overall Study|Caregiver lost to follow up|12|||
150286390|NCT01485627|542183712|FG000|Overall Study|Caregiver died|1|||
150286391|NCT01485627|542183713|FG001|Overall Study|Caregiver died|0|||
150286392|NCT01485627|542183712|FG000|Overall Study|caregiver was not bereaved|42|||
150286393|NCT01485627|542183713|FG001|Overall Study|caregiver was not bereaved|35|||
150286394|NCT01784861|542183714|FG000|Overall Study|Adverse Event|0|||
150286395|NCT01784861|542183715|FG001|Overall Study|Adverse Event|0|||
150286396|NCT01784861|542183716|FG002|Overall Study|Adverse Event|1|||
150286397|NCT01784861|542183717|FG003|Overall Study|Adverse Event|2|||
150286398|NCT01784861|542183718|FG004|Overall Study|Adverse Event|1|||
150172546|NCT00842257|541768003|FG000|Overall Study|Adverse Event|1|||
149843067|NCT00772603|540556784|FG000|Overall Study|Withdrawal by Subject|11|||
149843068|NCT00772603|540556785|FG001|Overall Study|Withdrawal by Subject|10|||
149843069|NCT00772603|540556786|FG002|Overall Study|Withdrawal by Subject|6|||
149843070|NCT00772603|540556784|FG000|Overall Study|Adverse Event|37|||
149843071|NCT00772603|540556785|FG001|Overall Study|Adverse Event|18|||
149843072|NCT00772603|540556786|FG002|Overall Study|Adverse Event|10|||
149843073|NCT00772603|540556784|FG000|Overall Study|Subject Non-compliance|1|||
149843074|NCT00772603|540556785|FG001|Overall Study|Subject Non-compliance|6|||
149843075|NCT00772603|540556786|FG002|Overall Study|Subject Non-compliance|4|||
149843076|NCT00772603|540556784|FG000|Overall Study|Protocol Violation|0|||
149843077|NCT00772603|540556785|FG001|Overall Study|Protocol Violation|1|||
150286399|NCT01784861|542183719|FG005|Overall Study|Adverse Event|0|||
150286400|NCT01784861|542183714|FG000|Overall Study|Withdrawal by Subject|0|||
150286401|NCT01784861|542183715|FG001|Overall Study|Withdrawal by Subject|0|||
150286402|NCT01784861|542183716|FG002|Overall Study|Withdrawal by Subject|0|||
150286403|NCT01784861|542183717|FG003|Overall Study|Withdrawal by Subject|1|||
150286404|NCT01784861|542183718|FG004|Overall Study|Withdrawal by Subject|0|||
150286405|NCT01784861|542183719|FG005|Overall Study|Withdrawal by Subject|0|||
150286406|NCT01784861|542183714|FG000|Overall Study|Physician Decision|0|||
149843078|NCT00772603|540556786|FG002|Overall Study|Protocol Violation|1|||
149843079|NCT00772603|540556784|FG000|Overall Study|Lost to Follow-up|1|||
149843080|NCT00772603|540556785|FG001|Overall Study|Lost to Follow-up|5|||
149843081|NCT00772603|540556786|FG002|Overall Study|Lost to Follow-up|2|||
149843082|NCT00772603|540556784|FG000|Overall Study|Physician Decision|0|||
150286407|NCT01784861|542183715|FG001|Overall Study|Physician Decision|0|||
149843083|NCT00772603|540556785|FG001|Overall Study|Physician Decision|0|||
149843084|NCT00772603|540556786|FG002|Overall Study|Physician Decision|1|||
149843085|NCT00772603|540556784|FG000|Overall Study|Other|2|||
149843086|NCT00772603|540556785|FG001|Overall Study|Other|0|||
149843087|NCT00772603|540556786|FG002|Overall Study|Other|2|||
149843088|NCT01564394|540556789|FG000|Overall Study|Withdrawal by Subject|6|||
149843089|NCT01564394|540556790|FG001|Overall Study|Withdrawal by Subject|10|||
149843090|NCT00443651|540556795|FG000|Overall Study|Death|1|||
149843091|NCT00443651|540556796|FG001|Overall Study|Death|5|||
149843092|NCT00443651|540556795|FG000|Overall Study|Adverse Event|5|||
149843093|NCT00443651|540556796|FG001|Overall Study|Adverse Event|6|||
149843094|NCT00443651|540556795|FG000|Overall Study|Lost to Follow-up|18|||
149843095|NCT00443651|540556796|FG001|Overall Study|Lost to Follow-up|12|||
149843096|NCT00443651|540556795|FG000|Overall Study|Patient's/Guardian's Decision|58|||
149843097|NCT00443651|540556796|FG001|Overall Study|Patient's/Guardian's Decision|30|||
149843098|NCT00443651|540556795|FG000|Overall Study|Physician Decision|13|||
149843099|NCT00443651|540556796|FG001|Overall Study|Physician Decision|4|||
149843100|NCT00443651|540556795|FG000|Overall Study|Pregnancy|0|||
149843101|NCT00443651|540556796|FG001|Overall Study|Pregnancy|1|||
149843102|NCT03606174|540556797|FG000|Overall Study|Death|37|||
149843103|NCT03606174|540556798|FG001|Overall Study|Death|15|||
149843104|NCT03606174|540556799|FG002|Overall Study|Death|15|||
149843105|NCT03606174|540556800|FG003|Overall Study|Death|7|||
149843106|NCT03606174|540556801|FG004|Overall Study|Death|35|||
149843107|NCT03606174|540556802|FG005|Overall Study|Death|12|||
149843108|NCT03606174|540556803|FG006|Overall Study|Death|35|||
149843109|NCT03606174|540556804|FG007|Overall Study|Death|8|||
149843110|NCT03606174|540556805|FG008|Overall Study|Death|5|||
149843111|NCT03606174|540556806|FG009|Overall Study|Death|3|||
149843112|NCT03606174|540556807|FG010|Overall Study|Death|0|||
149843113|NCT03606174|540556797|FG000|Overall Study|Lost to Follow-up|0|||
149843114|NCT03606174|540556798|FG001|Overall Study|Lost to Follow-up|0|||
149843115|NCT03606174|540556799|FG002|Overall Study|Lost to Follow-up|0|||
149843116|NCT03606174|540556800|FG003|Overall Study|Lost to Follow-up|0|||
149843117|NCT03606174|540556801|FG004|Overall Study|Lost to Follow-up|1|||
149843118|NCT03606174|540556802|FG005|Overall Study|Lost to Follow-up|1|||
149843119|NCT03606174|540556803|FG006|Overall Study|Lost to Follow-up|0|||
149843120|NCT03606174|540556804|FG007|Overall Study|Lost to Follow-up|0|||
149843121|NCT03606174|540556805|FG008|Overall Study|Lost to Follow-up|0|||
149843122|NCT03606174|540556806|FG009|Overall Study|Lost to Follow-up|0|||
149843123|NCT03606174|540556807|FG010|Overall Study|Lost to Follow-up|0|||
149843124|NCT03606174|540556797|FG000|Overall Study|Withdrawal by Subject|6|||
149843125|NCT03606174|540556798|FG001|Overall Study|Withdrawal by Subject|0|||
149843126|NCT03606174|540556799|FG002|Overall Study|Withdrawal by Subject|0|||
149843127|NCT03606174|540556800|FG003|Overall Study|Withdrawal by Subject|1|||
149843128|NCT03606174|540556801|FG004|Overall Study|Withdrawal by Subject|2|||
149843129|NCT03606174|540556802|FG005|Overall Study|Withdrawal by Subject|1|||
149843130|NCT03606174|540556803|FG006|Overall Study|Withdrawal by Subject|4|||
149843131|NCT03606174|540556804|FG007|Overall Study|Withdrawal by Subject|0|||
149843132|NCT03606174|540556805|FG008|Overall Study|Withdrawal by Subject|0|||
149843133|NCT03606174|540556806|FG009|Overall Study|Withdrawal by Subject|0|||
149843134|NCT03606174|540556807|FG010|Overall Study|Withdrawal by Subject|1|||
149843135|NCT03606174|540556797|FG000|Overall Study|Study Terminated by Sponsor|5|||
149843136|NCT03606174|540556798|FG001|Overall Study|Study Terminated by Sponsor|7|||
149843137|NCT03606174|540556799|FG002|Overall Study|Study Terminated by Sponsor|3|||
149843138|NCT03606174|540556800|FG003|Overall Study|Study Terminated by Sponsor|0|||
149843139|NCT03606174|540556801|FG004|Overall Study|Study Terminated by Sponsor|11|||
149843140|NCT03606174|540556802|FG005|Overall Study|Study Terminated by Sponsor|6|||
149843141|NCT03606174|540556803|FG006|Overall Study|Study Terminated by Sponsor|12|||
149843142|NCT03606174|540556804|FG007|Overall Study|Study Terminated by Sponsor|1|||
149953913|NCT00812097|540963150|FG000|Overall Study|Lost to Follow-up|90|||
149953914|NCT00812097|540963151|FG001|Overall Study|Lost to Follow-up|14|||
149953915|NCT00812097|540963152|FG002|Overall Study|Lost to Follow-up|17|||
150172547|NCT01147341|541768004|FG000|Double Blind Period|Lack of Efficacy|1|||
150172548|NCT01147341|541768005|FG001|Double Blind Period|Lack of Efficacy|1|||
149843143|NCT03606174|540556805|FG008|Overall Study|Study Terminated by Sponsor|3|||
149953916|NCT00812097|540963153|FG003|Overall Study|Lost to Follow-up|5|||
149953917|NCT00812097|540963150|FG000|Overall Study|Explantation of study device(s)|27|||
149843144|NCT03606174|540556806|FG009|Overall Study|Study Terminated by Sponsor|1|||
149843145|NCT03606174|540556807|FG010|Overall Study|Study Terminated by Sponsor|2|||
149843146|NCT03606174|540556797|FG000|Overall Study|Miscellaneous|1|||
149843147|NCT03606174|540556798|FG001|Overall Study|Miscellaneous|1|||
149843148|NCT03606174|540556799|FG002|Overall Study|Miscellaneous|0|||
149843149|NCT03606174|540556800|FG003|Overall Study|Miscellaneous|1|||
149843150|NCT03606174|540556801|FG004|Overall Study|Miscellaneous|4|||
149843151|NCT03606174|540556802|FG005|Overall Study|Miscellaneous|7|||
149843152|NCT03606174|540556803|FG006|Overall Study|Miscellaneous|5|||
149843153|NCT03606174|540556804|FG007|Overall Study|Miscellaneous|0|||
149843154|NCT03606174|540556805|FG008|Overall Study|Miscellaneous|0|||
149843155|NCT03606174|540556806|FG009|Overall Study|Miscellaneous|0|||
149843156|NCT03606174|540556807|FG010|Overall Study|Miscellaneous|1|||
149843157|NCT00859521|540556808|FG000|Washout|Withdrawal by Subject|0|||
149843158|NCT00859521|540556809|FG001|Washout|Withdrawal by Subject|1|||
149843159|NCT01609257|540556810|FG000|Overall Study|Lost to Follow-up|2|||
149843160|NCT01609257|540556811|FG001|Overall Study|Lost to Follow-up|1|||
149843161|NCT01609257|540556810|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
149843162|NCT01609257|540556811|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
149843163|NCT01609257|540556810|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
149843164|NCT01609257|540556811|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
149843165|NCT02125461|540556812|FG000|Overall Study|Withdrawal by Subject|30|||
149843166|NCT02125461|540556813|FG001|Overall Study|Withdrawal by Subject|16|||
149843167|NCT02125461|540556812|FG000|Overall Study|Lost to Follow-up|8|||
149843168|NCT02125461|540556813|FG001|Overall Study|Lost to Follow-up|3|||
149843169|NCT02125461|540556812|FG000|Overall Study|Death|260|||
149843170|NCT02125461|540556813|FG001|Overall Study|Death|149|||
149843171|NCT02125461|540556812|FG000|Overall Study|Missing Termination Reason|0|||
149843172|NCT02125461|540556813|FG001|Overall Study|Missing Termination Reason|1|||
149843173|NCT02888756|540556814|FG000|Analytical Treatment Interruption|Physician Decision|10|||
149843174|NCT02888756|540556815|FG001|Analytical Treatment Interruption|Physician Decision|6|||
149843175|NCT02888756|540556816|FG002|Analytical Treatment Interruption|Physician Decision|5|||
149843176|NCT03415308|540556821|FG000|Overall Study|Lost to Follow-up|0|||
149843177|NCT03415308|540556822|FG001|Overall Study|Lost to Follow-up|0|||
149843178|NCT03415308|540556823|FG002|Overall Study|Lost to Follow-up|1|||
149843179|NCT03415308|540556821|FG000|Overall Study|Scheduling Conflicts|0|||
149843180|NCT03415308|540556822|FG001|Overall Study|Scheduling Conflicts|0|||
149843181|NCT03415308|540556823|FG002|Overall Study|Scheduling Conflicts|7|||
149843182|NCT05239195|540556825|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
149843183|NCT05239195|540556826|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
149843184|NCT03552484|540556829|FG000|Overall Study|Death|6|||
149843185|NCT03552484|540556830|FG001|Overall Study|Death|4|||
149843186|NCT03552484|540556829|FG000|Overall Study|Lost to Follow-up|0|||
149843187|NCT03552484|540556830|FG001|Overall Study|Lost to Follow-up|16|||
149843188|NCT03499353|540556831|FG000|Treatment|Adverse Event|3|||
149843189|NCT03499353|540556831|FG000|Treatment|Progressive Disease|10|||
149843190|NCT03499353|540556831|FG000|Treatment|Other|1|||
149843191|NCT03499353|540556831|FG000|Treatment|Withdrawal by Subject|2|||
149843192|NCT03499353|540556831|FG000|Long-Term Follow-up|Death|2|||
149843193|NCT03499353|540556831|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
149843194|NCT03499353|540556831|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
149843195|NCT00081653|540556832|FG000|Overall Study|Adverse Event|23|||
149843196|NCT00081653|540556833|FG001|Overall Study|Adverse Event|17|||
149843197|NCT00081653|540556832|FG000|Overall Study|Lost to Follow-up|2|||
149843198|NCT00081653|540556833|FG001|Overall Study|Lost to Follow-up|4|||
149843199|NCT00081653|540556832|FG000|Overall Study|Refused Treatment|18|||
149843200|NCT00081653|540556833|FG001|Overall Study|Refused Treatment|14|||
149843201|NCT00081653|540556832|FG000|Overall Study|Low bone mineral density|1|||
149843202|NCT00081653|540556833|FG001|Overall Study|Low bone mineral density|0|||
149843203|NCT00081653|540556832|FG000|Overall Study|Bone loss|2|||
149843204|NCT00081653|540556833|FG001|Overall Study|Bone loss|0|||
149843205|NCT00081653|540556832|FG000|Overall Study|Participant leaving country|1|||
149843206|NCT00081653|540556833|FG001|Overall Study|Participant leaving country|0|||
149843207|NCT00081653|540556832|FG000|Overall Study|Loss of bone mass|0|||
149843208|NCT00081653|540556833|FG001|Overall Study|Loss of bone mass|2|||
149843209|NCT01015287|540556836|FG000|Overall Study|Death|21|||
149843210|NCT01015287|540556837|FG001|Overall Study|Death|16|||
149843211|NCT01015287|540556836|FG000|Overall Study|Adverse Event|1|||
149843212|NCT01015287|540556837|FG001|Overall Study|Adverse Event|0|||
149843213|NCT01015287|540556836|FG000|Overall Study|Sponsor Decision|3|||
149843214|NCT01015287|540556837|FG001|Overall Study|Sponsor Decision|7|||
149843215|NCT01015287|540556836|FG000|Overall Study|Physician Decision|19|||
149843216|NCT01015287|540556837|FG001|Overall Study|Physician Decision|21|||
149843217|NCT01015287|540556836|FG000|Overall Study|Withdrawal by Subject|14|||
149953918|NCT00812097|540963151|FG001|Overall Study|Explantation of study device(s)|29|||
149953919|NCT00812097|540963152|FG002|Overall Study|Explantation of study device(s)|14|||
149953920|NCT00812097|540963153|FG003|Overall Study|Explantation of study device(s)|20|||
149843218|NCT01015287|540556837|FG001|Overall Study|Withdrawal by Subject|19|||
149843219|NCT01015287|540556836|FG000|Overall Study|Entry Criteria not Met|11|||
149843220|NCT01015287|540556837|FG001|Overall Study|Entry Criteria not Met|14|||
149843221|NCT01015287|540556836|FG000|Overall Study|Lost to Follow-up|2|||
149843222|NCT01015287|540556837|FG001|Overall Study|Lost to Follow-up|1|||
149843223|NCT01015287|540556836|FG000|Overall Study|Protocol Violation|1|||
149843224|NCT01015287|540556837|FG001|Overall Study|Protocol Violation|1|||
149843225|NCT01592240|540556838|FG000|Overall Study|Adverse Event|1|||
149843226|NCT01592240|540556839|FG001|Overall Study|Adverse Event|0|||
149843227|NCT01592240|540556840|FG002|Overall Study|Adverse Event|0|||
149843228|NCT01592240|540556841|FG003|Overall Study|Adverse Event|1|||
149843229|NCT01592240|540556842|FG004|Overall Study|Adverse Event|1|||
149953921|NCT00812097|540963150|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
150035700|NCT00473564|541271372|FG000|Overall Study|robot surgery aborted in OR|23|||
150035701|NCT00914316|541271375|FG000|Phase 1|Physician Decision|4|||
150035702|NCT00914316|541271376|FG001|Phase 1|Physician Decision|0|||
150035703|NCT00914316|541271377|FG002|Phase 1|Physician Decision|1|||
149843230|NCT01592240|540556843|FG005|Overall Study|Adverse Event|0|||
149843231|NCT01592240|540556844|FG006|Overall Study|Adverse Event|0|||
149843232|NCT01592240|540556838|FG000|Overall Study|Death|0|||
149843233|NCT01592240|540556839|FG001|Overall Study|Death|1|||
149843234|NCT01592240|540556840|FG002|Overall Study|Death|0|||
149843235|NCT01592240|540556841|FG003|Overall Study|Death|0|||
149843236|NCT01592240|540556842|FG004|Overall Study|Death|0|||
149843237|NCT01592240|540556843|FG005|Overall Study|Death|0|||
149843238|NCT01592240|540556844|FG006|Overall Study|Death|0|||
149843239|NCT01592240|540556838|FG000|Overall Study|Lost to Follow-up|1|||
149843240|NCT01592240|540556839|FG001|Overall Study|Lost to Follow-up|3|||
149843241|NCT01592240|540556840|FG002|Overall Study|Lost to Follow-up|1|||
149843242|NCT01592240|540556841|FG003|Overall Study|Lost to Follow-up|0|||
150035704|NCT00914316|541271378|FG003|Phase 1|Physician Decision|2|||
150035705|NCT00914316|541271375|FG000|Phase 1|Withdrawal by Subject|0|||
150035706|NCT00914316|541271376|FG001|Phase 1|Withdrawal by Subject|2|||
150035707|NCT00914316|541271377|FG002|Phase 1|Withdrawal by Subject|4|||
150035708|NCT00914316|541271378|FG003|Phase 1|Withdrawal by Subject|0|||
150035709|NCT00914316|541271375|FG000|Phase 1|Adverse Event|1|||
150035710|NCT00914316|541271376|FG001|Phase 1|Adverse Event|0|||
150035711|NCT00914316|541271377|FG002|Phase 1|Adverse Event|0|||
150035712|NCT00914316|541271378|FG003|Phase 1|Adverse Event|0|||
150035713|NCT00914316|541271375|FG000|Phase 2|Withdrawal by Subject|1|||
150035714|NCT00914316|541271376|FG001|Phase 2|Withdrawal by Subject|0|||
150035715|NCT00914316|541271377|FG002|Phase 2|Withdrawal by Subject|1|||
149843243|NCT01592240|540556842|FG004|Overall Study|Lost to Follow-up|3|||
149843244|NCT01592240|540556843|FG005|Overall Study|Lost to Follow-up|2|||
149843245|NCT01592240|540556844|FG006|Overall Study|Lost to Follow-up|0|||
149843246|NCT01592240|540556838|FG000|Overall Study|Protocol Violation|0|||
149843247|NCT01592240|540556839|FG001|Overall Study|Protocol Violation|0|||
149843248|NCT01592240|540556840|FG002|Overall Study|Protocol Violation|0|||
149843249|NCT01592240|540556841|FG003|Overall Study|Protocol Violation|0|||
149843250|NCT01592240|540556842|FG004|Overall Study|Protocol Violation|0|||
149843251|NCT01592240|540556843|FG005|Overall Study|Protocol Violation|1|||
150035716|NCT00914316|541271378|FG003|Phase 2|Withdrawal by Subject|0|||
150035717|NCT03131219|541271379|FG000|Initial Evaluation Period|Adverse Event|2|||
150035718|NCT03131219|541271380|FG001|Initial Evaluation Period|Adverse Event|0|||
150035719|NCT03131219|541271379|FG000|Initial Evaluation Period|Protocol Violation|1|||
150035720|NCT03131219|541271380|FG001|Initial Evaluation Period|Protocol Violation|0|||
150035721|NCT03131219|541271379|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
150035722|NCT03131219|541271380|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
150035723|NCT03131219|541271379|FG000|Initial Evaluation Period|Physician Decision|1|||
150286408|NCT01784861|542183716|FG002|Overall Study|Physician Decision|0|||
150286409|NCT01784861|542183717|FG003|Overall Study|Physician Decision|2|||
150286410|NCT01784861|542183718|FG004|Overall Study|Physician Decision|0|||
150286411|NCT01784861|542183719|FG005|Overall Study|Physician Decision|1|||
150286412|NCT00401752|542183720|FG000|Overall Study|Adverse Event|2|||
150286413|NCT00401752|542183721|FG001|Overall Study|Adverse Event|5|||
150286414|NCT00401752|542183720|FG000|Overall Study|Withdrawal by Subject|2|||
150286415|NCT00401752|542183721|FG001|Overall Study|Withdrawal by Subject|6|||
150286416|NCT00401752|542183720|FG000|Overall Study|Lost to Follow-up|1|||
150286417|NCT00401752|542183721|FG001|Overall Study|Lost to Follow-up|4|||
150286418|NCT00401752|542183720|FG000|Overall Study|Development of any exclusion criteria|4|||
150286419|NCT00401752|542183721|FG001|Overall Study|Development of any exclusion criteria|2|||
150286420|NCT00401752|542183720|FG000|Overall Study|Physician Decision|1|||
150286421|NCT00401752|542183721|FG001|Overall Study|Physician Decision|1|||
150286422|NCT01046877|542183727|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
150035724|NCT03131219|541271380|FG001|Initial Evaluation Period|Physician Decision|0|||
150035725|NCT03131219|541271379|FG000|Extension Period|Physician Decision|1|||
150172549|NCT01147341|541768004|FG000|Double Blind Period|Withdrawal by Subject|0|||
150286423|NCT01046877|542183727|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
150286424|NCT03681119|542183728|FG000|Overall Study|No specific reason|4|||
150286425|NCT03681119|542183729|FG001|Overall Study|No specific reason|0|||
150286426|NCT03681119|542183728|FG000|Overall Study|Sickness|2|||
149843252|NCT01592240|540556844|FG006|Overall Study|Protocol Violation|0|||
149843253|NCT01592240|540556838|FG000|Overall Study|Withdrawal by Subject|0|||
149843254|NCT01592240|540556839|FG001|Overall Study|Withdrawal by Subject|4|||
149843255|NCT01592240|540556840|FG002|Overall Study|Withdrawal by Subject|4|||
149843256|NCT01592240|540556841|FG003|Overall Study|Withdrawal by Subject|1|||
149843257|NCT01592240|540556842|FG004|Overall Study|Withdrawal by Subject|3|||
149843258|NCT01592240|540556843|FG005|Overall Study|Withdrawal by Subject|0|||
150172550|NCT01147341|541768005|FG001|Double Blind Period|Withdrawal by Subject|1|||
149843259|NCT01592240|540556844|FG006|Overall Study|Withdrawal by Subject|2|||
149843260|NCT01592240|540556838|FG000|Overall Study|Other|0|||
150035726|NCT03131219|541271380|FG001|Extension Period|Physician Decision|0|||
149843261|NCT01592240|540556839|FG001|Overall Study|Other|3|||
149843262|NCT01592240|540556840|FG002|Overall Study|Other|1|||
149843263|NCT01592240|540556841|FG003|Overall Study|Other|1|||
149843264|NCT01592240|540556842|FG004|Overall Study|Other|0|||
149843265|NCT01592240|540556843|FG005|Overall Study|Other|0|||
149843266|NCT01592240|540556844|FG006|Overall Study|Other|1|||
149843267|NCT01592240|540556838|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
149843268|NCT01592240|540556839|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
149843269|NCT01592240|540556840|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
149843270|NCT01592240|540556841|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
150035727|NCT02399163|541271383|FG000|Overall Study|Adverse Event|2|||
150035728|NCT02399163|541271383|FG000|Overall Study|Protocol Deviation|2|||
149843271|NCT01592240|540556842|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
149843272|NCT01592240|540556843|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
149843273|NCT01592240|540556844|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
149843274|NCT01117623|540556845|FG000|Overall Study|Adverse Event|0|||
149843275|NCT01117623|540556846|FG001|Overall Study|Adverse Event|2|||
150035729|NCT02399163|541271383|FG000|Overall Study|Withdrawal by Participant|5|||
150035730|NCT01391546|541271389|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
150035731|NCT01391546|541271390|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
150035732|NCT04225897|541271396|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035733|NCT04225897|541271397|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
150035734|NCT04225897|541271398|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035735|NCT04225897|541271399|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035736|NCT04225897|541271400|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035737|NCT04225897|541271401|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035738|NCT04225897|541271402|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035739|NCT04225897|541271403|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035740|NCT04225897|541271404|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035741|NCT04225897|541271405|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035742|NCT04225897|541271406|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035743|NCT04225897|541271407|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
150035744|NCT04225897|541271396|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035745|NCT04225897|541271397|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035746|NCT04225897|541271398|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
150035747|NCT04225897|541271399|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035748|NCT04225897|541271400|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035749|NCT04225897|541271401|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035750|NCT04225897|541271402|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035751|NCT04225897|541271403|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035752|NCT04225897|541271404|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035753|NCT04225897|541271405|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035754|NCT04225897|541271406|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035755|NCT04225897|541271407|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
150035756|NCT04225897|541271396|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035757|NCT04225897|541271397|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035758|NCT04225897|541271398|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
150035759|NCT04225897|541271399|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035760|NCT04225897|541271400|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150286427|NCT03681119|542183729|FG001|Overall Study|Sickness|0|||
150286428|NCT01087905|542183732|FG000|Overall Study|Lost to Follow-up|24|||
150286429|NCT01087905|542183733|FG001|Overall Study|Lost to Follow-up|28|||
150286430|NCT01087905|542183734|FG002|Overall Study|Lost to Follow-up|18|||
150286431|NCT01087905|542183735|FG003|Overall Study|Lost to Follow-up|31|||
150286432|NCT01087905|542183736|FG004|Overall Study|Lost to Follow-up|27|||
150286433|NCT01087905|542183737|FG005|Overall Study|Lost to Follow-up|25|||
150286434|NCT01087905|542183738|FG006|Overall Study|Lost to Follow-up|20|||
150286435|NCT01087905|542183739|FG007|Overall Study|Lost to Follow-up|24|||
150286436|NCT01087905|542183732|FG000|Overall Study|Withdrawal by Subject|5|||
149843276|NCT01117623|540556847|FG002|Overall Study|Adverse Event|4|||
150035761|NCT04225897|541271401|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035762|NCT04225897|541271402|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
149843277|NCT01117623|540556848|FG003|Overall Study|Adverse Event|0|||
150035763|NCT04225897|541271403|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035764|NCT04225897|541271404|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150286437|NCT01087905|542183733|FG001|Overall Study|Withdrawal by Subject|4|||
150286438|NCT01087905|542183734|FG002|Overall Study|Withdrawal by Subject|4|||
150286439|NCT01087905|542183735|FG003|Overall Study|Withdrawal by Subject|5|||
149843278|NCT01117623|540556849|FG004|Overall Study|Adverse Event|2|||
149843279|NCT01117623|540556850|FG005|Overall Study|Adverse Event|0|||
149843280|NCT01117623|540556851|FG006|Overall Study|Adverse Event|0|||
149843281|NCT01117623|540556852|FG007|Overall Study|Adverse Event|2|||
150035765|NCT04225897|541271405|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035766|NCT04225897|541271406|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035767|NCT04225897|541271407|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
150035768|NCT04225897|541271396|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035769|NCT04225897|541271397|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035770|NCT04225897|541271398|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035771|NCT04225897|541271399|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035772|NCT04225897|541271400|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035773|NCT04225897|541271401|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035774|NCT04225897|541271402|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035775|NCT04225897|541271403|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
150035776|NCT04225897|541271404|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035777|NCT04225897|541271405|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035778|NCT04225897|541271406|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
150035779|NCT04225897|541271407|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
149843282|NCT01117623|540556845|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
149843283|NCT01117623|540556846|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
149843284|NCT01117623|540556847|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
149843285|NCT01117623|540556848|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
149843286|NCT01117623|540556849|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
149843287|NCT01117623|540556850|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
149843288|NCT01117623|540556851|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
149843289|NCT01117623|540556852|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
149843290|NCT01117623|540556845|FG000|Overall Study|Withdrawal by Subject|0|||
149843291|NCT01117623|540556846|FG001|Overall Study|Withdrawal by Subject|0|||
149843292|NCT01117623|540556847|FG002|Overall Study|Withdrawal by Subject|2|||
149843293|NCT01117623|540556848|FG003|Overall Study|Withdrawal by Subject|0|||
149843294|NCT01117623|540556849|FG004|Overall Study|Withdrawal by Subject|0|||
149843295|NCT01117623|540556850|FG005|Overall Study|Withdrawal by Subject|1|||
149843296|NCT01117623|540556851|FG006|Overall Study|Withdrawal by Subject|1|||
149843297|NCT01117623|540556852|FG007|Overall Study|Withdrawal by Subject|1|||
149843298|NCT01117623|540556845|FG000|Overall Study|Non-compliance with study medication|0|||
149843299|NCT01117623|540556846|FG001|Overall Study|Non-compliance with study medication|0|||
149843300|NCT01117623|540556847|FG002|Overall Study|Non-compliance with study medication|0|||
149843301|NCT01117623|540556848|FG003|Overall Study|Non-compliance with study medication|0|||
149843302|NCT01117623|540556849|FG004|Overall Study|Non-compliance with study medication|0|||
149843303|NCT01117623|540556850|FG005|Overall Study|Non-compliance with study medication|0|||
149843304|NCT01117623|540556851|FG006|Overall Study|Non-compliance with study medication|0|||
149843305|NCT01117623|540556852|FG007|Overall Study|Non-compliance with study medication|1|||
149843306|NCT01117623|540556845|FG000|Overall Study|Invest. text: completed all planned txs|0|||
149843307|NCT01117623|540556846|FG001|Overall Study|Invest. text: completed all planned txs|0|||
149843308|NCT01117623|540556847|FG002|Overall Study|Invest. text: completed all planned txs|0|||
149843309|NCT01117623|540556848|FG003|Overall Study|Invest. text: completed all planned txs|0|||
149843310|NCT01117623|540556849|FG004|Overall Study|Invest. text: completed all planned txs|0|||
149843311|NCT01117623|540556850|FG005|Overall Study|Invest. text: completed all planned txs|1|||
149843312|NCT01117623|540556851|FG006|Overall Study|Invest. text: completed all planned txs|0|||
149843313|NCT01117623|540556852|FG007|Overall Study|Invest. text: completed all planned txs|0|||
149843314|NCT00469898|540556860|FG000|Overall Study|Adverse Event|7|||
149843315|NCT00469898|540556860|FG000|Overall Study|Withdrawal by Subject|4|||
149843316|NCT00469898|540556860|FG000|Overall Study|Death|4|||
149843317|NCT00469898|540556860|FG000|Overall Study|Disease progression|9|||
149843318|NCT00469898|540556860|FG000|Overall Study|Decreased performance status|1|||
149843319|NCT02663349|540556863|FG000|Overall Study|Withdrawal by Subject|6|||
149843320|NCT01572662|540556864|FG000|Overall Study|Withdrawal by Subject|1|||
149843321|NCT01572662|540556865|FG001|Overall Study|Withdrawal by Subject|0|||
149843322|NCT01572662|540556864|FG000|Overall Study|Physician Decision|0|||
149843323|NCT01572662|540556865|FG001|Overall Study|Physician Decision|1|||
149843324|NCT04547192|540556868|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
149843325|NCT04547192|540556869|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
150172551|NCT01147341|541768004|FG000|Open Label Period|Lack of Efficacy|3|||
150172552|NCT01147341|541768005|FG001|Open Label Period|Lack of Efficacy|0|||
150172553|NCT01147341|541768004|FG000|Open Label Period|Subject moved|1|||
149843326|NCT04547192|540556870|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
149843327|NCT04547192|540556871|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
149843328|NCT04547192|540556868|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
149843329|NCT04547192|540556869|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
150172554|NCT01147341|541768005|FG001|Open Label Period|Subject moved|0|||
150172555|NCT01901276|541768006|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
150172556|NCT01901276|541768007|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
150286440|NCT01087905|542183736|FG004|Overall Study|Withdrawal by Subject|4|||
150286441|NCT01087905|542183737|FG005|Overall Study|Withdrawal by Subject|3|||
150286442|NCT01087905|542183738|FG006|Overall Study|Withdrawal by Subject|3|||
150286443|NCT01087905|542183739|FG007|Overall Study|Withdrawal by Subject|5|||
150286444|NCT00517829|542183746|FG000|Overall Study|Adverse Event|22|||
150286445|NCT00517829|542183747|FG001|Overall Study|Adverse Event|34|||
150286446|NCT00517829|542183746|FG000|Overall Study|Disease Progression|39|||
150286447|NCT00517829|542183747|FG001|Overall Study|Disease Progression|32|||
150286448|NCT00517829|542183746|FG000|Overall Study|Patient Request|6|||
150286449|NCT00517829|542183747|FG001|Overall Study|Patient Request|5|||
150286450|NCT00517829|542183746|FG000|Overall Study|Investigator Request|5|||
150286451|NCT00517829|542183747|FG001|Overall Study|Investigator Request|3|||
150286452|NCT00517829|542183746|FG000|Overall Study|Other|3|||
150286453|NCT00517829|542183747|FG001|Overall Study|Other|1|||
150286454|NCT01618214|542183754|FG000|Overall Study|Adverse Event|3|||
150286455|NCT01618214|542183755|FG001|Overall Study|Adverse Event|1|||
150286456|NCT01618214|542183754|FG000|Overall Study|Lack of Efficacy|1|||
150286457|NCT01618214|542183755|FG001|Overall Study|Lack of Efficacy|1|||
150286458|NCT01618214|542183754|FG000|Overall Study|Protocol Violation|1|||
150286459|NCT01618214|542183755|FG001|Overall Study|Protocol Violation|4|||
150286460|NCT01618214|542183754|FG000|Overall Study|Withdrawal Criteria|1|||
150286461|NCT01618214|542183755|FG001|Overall Study|Withdrawal Criteria|2|||
150286462|NCT01618214|542183754|FG000|Overall Study|Unclassified|4|||
150286463|NCT01618214|542183755|FG001|Overall Study|Unclassified|5|||
150286464|NCT00835237|542183756|FG000|Overall Study|Lost to Follow-up|4|||
150286465|NCT00835237|542183757|FG001|Overall Study|Lost to Follow-up|0|||
149843330|NCT04547192|540556870|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
149843331|NCT04547192|540556871|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
149843332|NCT04547192|540556868|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
149843333|NCT04547192|540556869|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
149843334|NCT04547192|540556870|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
149843335|NCT04547192|540556871|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
149843336|NCT04547192|540556868|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
149843337|NCT04547192|540556869|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
149843338|NCT04547192|540556870|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
149843339|NCT04547192|540556871|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
149843340|NCT04547192|540556868|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
149953922|NCT00812097|540963151|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
149953923|NCT00812097|540963152|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
149953924|NCT00812097|540963153|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
149953925|NCT02513563|540963154|FG000|Overall Study|Death|4|||
149953926|NCT02513563|540963154|FG000|Overall Study|Withdrawal by Subject|4|||
149953927|NCT02513563|540963154|FG000|Overall Study|Physician Decision|1|||
149953928|NCT00317369|540963158|FG000|Overall Study|Adverse Event|2|||
149953929|NCT00317369|540963159|FG001|Overall Study|Adverse Event|1|||
149953930|NCT00317369|540963160|FG002|Overall Study|Adverse Event|0|||
149953931|NCT00317369|540963158|FG000|Overall Study|Lack of Efficacy|0|||
149953932|NCT00317369|540963159|FG001|Overall Study|Lack of Efficacy|1|||
149953933|NCT00317369|540963160|FG002|Overall Study|Lack of Efficacy|1|||
149953934|NCT00317369|540963158|FG000|Overall Study|Withdrawal by Subject|0|||
149953935|NCT00317369|540963159|FG001|Overall Study|Withdrawal by Subject|0|||
149953936|NCT00317369|540963160|FG002|Overall Study|Withdrawal by Subject|1|||
150035780|NCT00074711|541271408|FG000|Overall Study|Withdrawal by Subject|1|||
150286466|NCT00835237|542183756|FG000|Overall Study|Withdrawal by Subject|2|||
150286467|NCT00835237|542183757|FG001|Overall Study|Withdrawal by Subject|0|||
150286468|NCT01265550|542183760|FG000|Pre Randomization|Withdrawal by Subject|0|||
150286469|NCT01265550|542183761|FG001|Pre Randomization|Withdrawal by Subject|0|||
149843341|NCT04547192|540556869|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
149843342|NCT04547192|540556870|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
149843343|NCT04547192|540556871|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
149843344|NCT00935012|540556874|FG000|Overall Study|Death|19|||
149843345|NCT00935012|540556874|FG000|Overall Study|Withdrawal by Subject|3|||
149953937|NCT03674411|540963164|FG000|Overall Study|Non-treatment|4|||
149953938|NCT06038643|540963168|FG000|Overall Study|Withdrawal by Subject|9|||
149953939|NCT06038643|540963169|FG001|Overall Study|Withdrawal by Subject|4|||
149953940|NCT06038643|540963168|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
149953941|NCT06038643|540963169|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
149953942|NCT02227199|540963170|FG000|Overall Study|Physician Decision|0|||
150035781|NCT00074711|541271409|FG001|Overall Study|Withdrawal by Subject|1|||
150286470|NCT01265550|542183762|FG002|Pre Randomization|Withdrawal by Subject|0|||
150286471|NCT01265550|542183763|FG003|Pre Randomization|Withdrawal by Subject|70|||
150286472|NCT01265550|542183760|FG000|Pre Randomization|Technical Exclusions|0|||
150286473|NCT01265550|542183761|FG001|Pre Randomization|Technical Exclusions|0|||
150286474|NCT01265550|542183762|FG002|Pre Randomization|Technical Exclusions|0|||
150286475|NCT01265550|542183763|FG003|Pre Randomization|Technical Exclusions|54|||
150286476|NCT01265550|542183760|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
150286477|NCT01265550|542183761|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
150286478|NCT01265550|542183762|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
150286479|NCT01265550|542183763|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
150286480|NCT01265550|542183760|FG000|Pre Randomization|Non-GERD organic disorders|0|||
150286481|NCT01265550|542183761|FG001|Pre Randomization|Non-GERD organic disorders|0|||
150286482|NCT01265550|542183762|FG002|Pre Randomization|Non-GERD organic disorders|0|||
150286483|NCT01265550|542183763|FG003|Pre Randomization|Non-GERD organic disorders|23|||
150286484|NCT01265550|542183760|FG000|Pre Randomization|Functional heartburn|0|||
150286485|NCT01265550|542183761|FG001|Pre Randomization|Functional heartburn|0|||
150286486|NCT01265550|542183762|FG002|Pre Randomization|Functional heartburn|0|||
150286487|NCT01265550|542183763|FG003|Pre Randomization|Functional heartburn|99|||
150286488|NCT01627860|542183765|FG000|Overall Study|Adverse Event|9|||
150286489|NCT01627860|542183766|FG001|Overall Study|Adverse Event|4|||
150286490|NCT01627860|542183765|FG000|Overall Study|Withdrawal by Subject|2|||
150286491|NCT01627860|542183766|FG001|Overall Study|Withdrawal by Subject|1|||
150286492|NCT01627860|542183765|FG000|Overall Study|Seizure frequency doubled|0|||
150286493|NCT01627860|542183766|FG001|Overall Study|Seizure frequency doubled|1|||
150286494|NCT01627860|542183765|FG000|Overall Study|Protocol Violation|1|||
150286495|NCT01627860|542183766|FG001|Overall Study|Protocol Violation|0|||
150286496|NCT01119248|542183769|FG000|Overall Study|Physician Decision|5|||
150286497|NCT01883635|542183770|FG000|Overall Study|Withdrawal by Subject|4|||
150286498|NCT01883635|542183771|FG001|Overall Study|Withdrawal by Subject|0|||
150286499|NCT00761514|542183772|FG000|Overall Study|Adverse Event|1|||
150286500|NCT00761514|542183772|FG000|Overall Study|Withdrawal by Subject|2|||
150286501|NCT00761514|542183772|FG000|Overall Study|Lost to Follow-up|1|||
150286502|NCT00761514|542183772|FG000|Overall Study|Health insurance didn't cover study drug|1|||
150286503|NCT00761514|542183772|FG000|Overall Study|Problem complying with study visit|1|||
150286504|NCT00761514|542183772|FG000|Overall Study|Unable to pay for medications|1|||
150286505|NCT01100437|542183773|FG000|Titration/Stabilization|Adverse Event|0|||
150286506|NCT01100437|542183774|FG001|Titration/Stabilization|Adverse Event|0|||
150286507|NCT01100437|542183775|FG002|Titration/Stabilization|Adverse Event|4|||
150286508|NCT01100437|542183773|FG000|Titration/Stabilization|Non-compliance|0|||
150286509|NCT01100437|542183774|FG001|Titration/Stabilization|Non-compliance|0|||
150286510|NCT01100437|542183775|FG002|Titration/Stabilization|Non-compliance|1|||
150286511|NCT01100437|542183773|FG000|Titration/Stabilization|Sponsor canceled study|0|||
150286512|NCT01100437|542183774|FG001|Titration/Stabilization|Sponsor canceled study|0|||
150286513|NCT01100437|542183775|FG002|Titration/Stabilization|Sponsor canceled study|1|||
150286514|NCT01100437|542183773|FG000|Maintenance|Withdrawal by Subject|0|||
150286515|NCT01100437|542183774|FG001|Maintenance|Withdrawal by Subject|0|||
150286516|NCT01100437|542183775|FG002|Maintenance|Withdrawal by Subject|1|||
150286517|NCT01100437|542183773|FG000|Maintenance|Sponsor termination of study|0|||
150286518|NCT01100437|542183774|FG001|Maintenance|Sponsor termination of study|0|||
150286519|NCT01100437|542183775|FG002|Maintenance|Sponsor termination of study|1|||
150286520|NCT00894556|542183776|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
150286521|NCT00894556|542183777|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
150286522|NCT00894556|542183778|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
150286523|NCT00894556|542183779|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
150286524|NCT00894556|542183776|FG000|Treatment Phase|Lost to Follow-up|2|||
150286525|NCT00894556|542183777|FG001|Treatment Phase|Lost to Follow-up|3|||
150286526|NCT00894556|542183778|FG002|Treatment Phase|Lost to Follow-up|1|||
150286527|NCT00894556|542183779|FG003|Treatment Phase|Lost to Follow-up|0|||
150286528|NCT00894556|542183776|FG000|Treatment Phase|Lack of Qualifying Event|2|||
150286529|NCT00894556|542183777|FG001|Treatment Phase|Lack of Qualifying Event|1|||
150286530|NCT00894556|542183778|FG002|Treatment Phase|Lack of Qualifying Event|0|||
150286531|NCT00894556|542183779|FG003|Treatment Phase|Lack of Qualifying Event|0|||
150286532|NCT00805480|542183786|FG000|Overall Study|Withdrawal by Subject|13|||
150286533|NCT00805480|542183787|FG001|Overall Study|Withdrawal by Subject|5|||
150286534|NCT00805480|542183788|FG002|Overall Study|Withdrawal by Subject|11|||
150286535|NCT00805480|542183789|FG003|Overall Study|Withdrawal by Subject|5|||
150286536|NCT00805480|542183786|FG000|Overall Study|Lost to Follow-up|1|||
150286537|NCT00805480|542183787|FG001|Overall Study|Lost to Follow-up|2|||
149843346|NCT00935012|540556874|FG000|Overall Study|Other|5|||
149843347|NCT00935012|540556874|FG000|Overall Study|Adverse Event|2|||
149843348|NCT01442155|540556875|FG000|Overall Study|Complete remission|35|||
149843349|NCT01442155|540556875|FG000|Overall Study|Recurrence|26|||
149843350|NCT01442155|540556875|FG000|Overall Study|Adverse Event|2|||
149843351|NCT01442155|540556875|FG000|Overall Study|Lost to Follow-up|2|||
149843352|NCT01590563|540556882|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
149843353|NCT06539676|540556889|FG000|Overall Study|Early study termination|1|||
149843354|NCT06539676|540556890|FG001|Overall Study|Early study termination|0|||
149843355|NCT06539676|540556891|FG002|Overall Study|Early study termination|6|||
149843356|NCT00909038|540556894|FG000|Overall Study|Protocol Violation|187|||
149843357|NCT00909038|540556894|FG000|Overall Study|Non-evaluable Subjects|230|||
149843358|NCT03480763|540556897|FG000|Overall Study|Withdrawal by Subject|18|||
149843359|NCT03480763|540556898|FG001|Overall Study|Withdrawal by Subject|10|||
150286538|NCT00805480|542183788|FG002|Overall Study|Lost to Follow-up|0|||
150286539|NCT00805480|542183789|FG003|Overall Study|Lost to Follow-up|0|||
150286540|NCT00805480|542183786|FG000|Overall Study|Adverse Event|0|||
150286541|NCT00805480|542183787|FG001|Overall Study|Adverse Event|0|||
150286542|NCT00805480|542183788|FG002|Overall Study|Adverse Event|1|||
150286543|NCT00805480|542183789|FG003|Overall Study|Adverse Event|0|||
150286544|NCT02068547|542185409|FG000|Overall Study|Lost to Follow-up|3|||
150286545|NCT02068547|542185410|FG001|Overall Study|Lost to Follow-up|3|||
150286546|NCT02068547|542185409|FG000|Overall Study|Physician Decision|1|||
150286547|NCT02068547|542185410|FG001|Overall Study|Physician Decision|0|||
150286548|NCT02404103|542185416|FG000|Overall Study|Adverse Event|1|||
150286549|NCT02404103|542185417|FG001|Overall Study|Adverse Event|0|||
150286550|NCT02404103|542185416|FG000|Overall Study|Lost to Follow-up|3|||
150286551|NCT02404103|542185417|FG001|Overall Study|Lost to Follow-up|3|||
150286552|NCT01995071|542185418|FG000|Overall Study|Adverse Event|0|||
150286553|NCT01995071|542185419|FG001|Overall Study|Adverse Event|0|||
150286554|NCT01995071|542185420|FG002|Overall Study|Adverse Event|0|||
150286555|NCT01995071|542185421|FG003|Overall Study|Adverse Event|0|||
150286556|NCT01995071|542185422|FG004|Overall Study|Adverse Event|0|||
150286557|NCT01995071|542185423|FG005|Overall Study|Adverse Event|0|||
150286558|NCT01995071|542185424|FG006|Overall Study|Adverse Event|1|||
150286559|NCT01995071|542185425|FG007|Overall Study|Adverse Event|0|||
150286560|NCT01995071|542185426|FG008|Overall Study|Adverse Event|0|||
150286561|NCT01995071|542185427|FG009|Overall Study|Adverse Event|0|||
150286562|NCT01995071|542185428|FG010|Overall Study|Adverse Event|0|||
150286563|NCT01995071|542185429|FG011|Overall Study|Adverse Event|0|||
150286564|NCT01995071|542185418|FG000|Overall Study|Moved|0|||
149843360|NCT03480763|540556897|FG000|Overall Study|Lost to Follow-up|4|||
149843361|NCT03480763|540556898|FG001|Overall Study|Lost to Follow-up|7|||
149843362|NCT03480763|540556897|FG000|Overall Study|non-study pneumococcal vaccine|1|||
149843363|NCT03480763|540556898|FG001|Overall Study|non-study pneumococcal vaccine|0|||
149843364|NCT03480763|540556897|FG000|Overall Study|oncological treatment|0|||
149843365|NCT03480763|540556898|FG001|Overall Study|oncological treatment|2|||
149953943|NCT02227199|540963171|FG001|Overall Study|Physician Decision|0|||
150286565|NCT01995071|542185419|FG001|Overall Study|Moved|0|||
150286566|NCT01995071|542185420|FG002|Overall Study|Moved|1|||
149843366|NCT03480763|540556897|FG000|Overall Study|pain with vaccination|1|||
149953944|NCT02227199|540963172|FG002|Overall Study|Physician Decision|1|||
149953945|NCT02227199|540963170|FG000|Overall Study|Adverse Event|0|||
149953946|NCT02227199|540963171|FG001|Overall Study|Adverse Event|0|||
149953947|NCT02227199|540963172|FG002|Overall Study|Adverse Event|3|||
149953948|NCT03998462|540963174|FG000|Overall Study|Withdrawal by Subject|10|||
149953949|NCT03998462|540963175|FG001|Overall Study|Withdrawal by Subject|4|||
149953950|NCT03998462|540963174|FG000|Overall Study|Lost to Follow-up|1|||
149953951|NCT03998462|540963175|FG001|Overall Study|Lost to Follow-up|0|||
149953952|NCT03998462|540963174|FG000|Overall Study|Technical Difficulties|1|||
149953953|NCT03998462|540963175|FG001|Overall Study|Technical Difficulties|2|||
149953954|NCT05710224|540963176|FG000|Overall Study|Death|1|||
149953955|NCT05710224|540963177|FG001|Overall Study|Death|0|||
149953956|NCT05710224|540963176|FG000|Overall Study|Lost to Follow-up|16|||
149953957|NCT05710224|540963177|FG001|Overall Study|Lost to Follow-up|7|||
149953958|NCT05710224|540963176|FG000|Overall Study|Withdrawal by Subject|4|||
149953959|NCT05710224|540963177|FG001|Overall Study|Withdrawal by Subject|6|||
149953960|NCT05710224|540963176|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149953961|NCT05710224|540963177|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
149953962|NCT05710224|540963176|FG000|Overall Study|Participants Left The City|0|||
149953963|NCT05710224|540963177|FG001|Overall Study|Participants Left The City|2|||
149953964|NCT03369223|540963178|FG000|Overall Study|Lost to Follow-up|0|||
149953965|NCT03369223|540963179|FG001|Overall Study|Lost to Follow-up|0|||
149953966|NCT03369223|540963180|FG002|Overall Study|Lost to Follow-up|0|||
149953967|NCT03369223|540963181|FG003|Overall Study|Lost to Follow-up|0|||
149953968|NCT03369223|540963182|FG004|Overall Study|Lost to Follow-up|0|||
149953969|NCT03369223|540963183|FG005|Overall Study|Lost to Follow-up|0|||
150286567|NCT01995071|542185421|FG003|Overall Study|Moved|0|||
150286568|NCT01995071|542185422|FG004|Overall Study|Moved|1|||
149843367|NCT03480763|540556898|FG001|Overall Study|pain with vaccination|0|||
149953970|NCT03369223|540963184|FG006|Overall Study|Lost to Follow-up|0|||
149953971|NCT03369223|540963185|FG007|Overall Study|Lost to Follow-up|0|||
149953972|NCT03369223|540963186|FG008|Overall Study|Lost to Follow-up|0|||
149953973|NCT03369223|540963187|FG009|Overall Study|Lost to Follow-up|0|||
149953974|NCT03369223|540963188|FG010|Overall Study|Lost to Follow-up|0|||
149953975|NCT03369223|540963189|FG011|Overall Study|Lost to Follow-up|0|||
149953976|NCT03369223|540963190|FG012|Overall Study|Lost to Follow-up|0|||
150286569|NCT01995071|542185423|FG005|Overall Study|Moved|0|||
150286570|NCT01995071|542185424|FG006|Overall Study|Moved|0|||
150286571|NCT01995071|542185425|FG007|Overall Study|Moved|0|||
150286572|NCT01995071|542185426|FG008|Overall Study|Moved|0|||
150286573|NCT01995071|542185427|FG009|Overall Study|Moved|0|||
150286574|NCT01995071|542185428|FG010|Overall Study|Moved|1|||
150286575|NCT01995071|542185429|FG011|Overall Study|Moved|0|||
149843368|NCT01895335|540556899|FG000|Overall Study|Adverse Event|106|||
149843369|NCT01895335|540556899|FG000|Overall Study|Lack of Efficacy|53|||
149843370|NCT01895335|540556899|FG000|Overall Study|Poor Compliance to Protocol|11|||
149843371|NCT01895335|540556899|FG000|Overall Study|Included But Not treated|1|||
149843372|NCT01895335|540556899|FG000|Overall Study|Other than Specified Above|44|||
149843373|NCT01838681|540556904|FG000|Period A|Adverse Event|39|||
149843374|NCT01838681|540556905|FG001|Period A|Adverse Event|0|||
149843375|NCT01838681|540556906|FG002|Period A|Adverse Event|0|||
149843376|NCT01838681|540556907|FG003|Period A|Adverse Event|0|||
149843377|NCT01838681|540556904|FG000|Period A|Lack of Efficacy|21|||
149843378|NCT01838681|540556905|FG001|Period A|Lack of Efficacy|0|||
149843379|NCT01838681|540556906|FG002|Period A|Lack of Efficacy|0|||
149843380|NCT01838681|540556907|FG003|Period A|Lack of Efficacy|0|||
149843381|NCT01838681|540556904|FG000|Period A|Early response|148|||
149843382|NCT01838681|540556905|FG001|Period A|Early response|0|||
149843383|NCT01838681|540556906|FG002|Period A|Early response|0|||
149843384|NCT01838681|540556907|FG003|Period A|Early response|0|||
149843385|NCT01838681|540556904|FG000|Period A|Withdrawal by Subject|70|||
149843386|NCT01838681|540556905|FG001|Period A|Withdrawal by Subject|0|||
149843387|NCT01838681|540556906|FG002|Period A|Withdrawal by Subject|0|||
149843388|NCT01838681|540556907|FG003|Period A|Withdrawal by Subject|0|||
149843389|NCT01838681|540556904|FG000|Period A|Protocol Violation|16|||
149843390|NCT01838681|540556905|FG001|Period A|Protocol Violation|0|||
149843391|NCT01838681|540556906|FG002|Period A|Protocol Violation|0|||
149843392|NCT01838681|540556907|FG003|Period A|Protocol Violation|0|||
149843393|NCT01838681|540556904|FG000|Period A|Non-compliance with IMP|6|||
149843394|NCT01838681|540556905|FG001|Period A|Non-compliance with IMP|0|||
149843395|NCT01838681|540556906|FG002|Period A|Non-compliance with IMP|0|||
149843396|NCT01838681|540556907|FG003|Period A|Non-compliance with IMP|0|||
149843397|NCT01838681|540556904|FG000|Period A|Lost to Follow-up|4|||
149843398|NCT01838681|540556905|FG001|Period A|Lost to Follow-up|0|||
149843399|NCT01838681|540556906|FG002|Period A|Lost to Follow-up|0|||
149843400|NCT01838681|540556907|FG003|Period A|Lost to Follow-up|0|||
149843401|NCT01838681|540556904|FG000|Period A|Withdrawal before treatment|4|||
149843402|NCT01838681|540556905|FG001|Period A|Withdrawal before treatment|0|||
149843403|NCT01838681|540556906|FG002|Period A|Withdrawal before treatment|0|||
149843404|NCT01838681|540556907|FG003|Period A|Withdrawal before treatment|0|||
149843405|NCT01838681|540556904|FG000|Period A|Administrative or other reasons|17|||
149843406|NCT01838681|540556905|FG001|Period A|Administrative or other reasons|0|||
149843407|NCT01838681|540556906|FG002|Period A|Administrative or other reasons|0|||
149843408|NCT01838681|540556907|FG003|Period A|Administrative or other reasons|0|||
149953977|NCT03369223|540963191|FG013|Overall Study|Lost to Follow-up|0|||
149953978|NCT03369223|540963192|FG014|Overall Study|Lost to Follow-up|0|||
149953979|NCT03369223|540963193|FG015|Overall Study|Lost to Follow-up|0|||
149953980|NCT03369223|540963194|FG016|Overall Study|Lost to Follow-up|0|||
149953981|NCT03369223|540963195|FG017|Overall Study|Lost to Follow-up|0|||
149953982|NCT03369223|540963196|FG018|Overall Study|Lost to Follow-up|2|||
149953983|NCT03369223|540963197|FG019|Overall Study|Lost to Follow-up|1|||
149953984|NCT03369223|540963178|FG000|Overall Study|Participant no longer meets study criteria|0|||
149953985|NCT03369223|540963179|FG001|Overall Study|Participant no longer meets study criteria|0|||
149953986|NCT03369223|540963180|FG002|Overall Study|Participant no longer meets study criteria|0|||
149953987|NCT03369223|540963181|FG003|Overall Study|Participant no longer meets study criteria|0|||
149953988|NCT03369223|540963182|FG004|Overall Study|Participant no longer meets study criteria|0|||
149953989|NCT03369223|540963183|FG005|Overall Study|Participant no longer meets study criteria|0|||
149953990|NCT03369223|540963184|FG006|Overall Study|Participant no longer meets study criteria|0|||
149953991|NCT03369223|540963185|FG007|Overall Study|Participant no longer meets study criteria|0|||
149953992|NCT03369223|540963186|FG008|Overall Study|Participant no longer meets study criteria|0|||
149953993|NCT03369223|540963187|FG009|Overall Study|Participant no longer meets study criteria|0|||
149953994|NCT03369223|540963188|FG010|Overall Study|Participant no longer meets study criteria|0|||
149953995|NCT03369223|540963189|FG011|Overall Study|Participant no longer meets study criteria|0|||
149953996|NCT03369223|540963190|FG012|Overall Study|Participant no longer meets study criteria|0|||
149953997|NCT03369223|540963191|FG013|Overall Study|Participant no longer meets study criteria|0|||
149953998|NCT03369223|540963192|FG014|Overall Study|Participant no longer meets study criteria|2|||
149843409|NCT01838681|540556904|FG000|Period B/A+|Adverse Event|0|||
149843410|NCT01838681|540556905|FG001|Period B/A+|Adverse Event|13|||
149843411|NCT01838681|540556906|FG002|Period B/A+|Adverse Event|27|||
149843412|NCT01838681|540556907|FG003|Period B/A+|Adverse Event|16|||
149843413|NCT01838681|540556904|FG000|Period B/A+|Lack of Efficacy|0|||
149953999|NCT03369223|540963193|FG015|Overall Study|Participant no longer meets study criteria|0|||
150035782|NCT00074711|541271408|FG000|Overall Study|Lost to Follow-up|10|||
149843414|NCT01838681|540556905|FG001|Period B/A+|Lack of Efficacy|9|||
149843415|NCT01838681|540556906|FG002|Period B/A+|Lack of Efficacy|11|||
149843416|NCT01838681|540556907|FG003|Period B/A+|Lack of Efficacy|6|||
149843417|NCT01838681|540556904|FG000|Period B/A+|Withdrawal by Subject|0|||
149843418|NCT01838681|540556905|FG001|Period B/A+|Withdrawal by Subject|28|||
149843419|NCT01838681|540556906|FG002|Period B/A+|Withdrawal by Subject|35|||
149843420|NCT01838681|540556907|FG003|Period B/A+|Withdrawal by Subject|47|||
149843421|NCT01838681|540556904|FG000|Period B/A+|Protocol Violation|0|||
150286576|NCT01995071|542185418|FG000|Overall Study|Lost to Follow-up|1|||
150286577|NCT01995071|542185419|FG001|Overall Study|Lost to Follow-up|0|||
149954000|NCT03369223|540963194|FG016|Overall Study|Participant no longer meets study criteria|2|||
149954001|NCT03369223|540963195|FG017|Overall Study|Participant no longer meets study criteria|0|||
149954002|NCT03369223|540963196|FG018|Overall Study|Participant no longer meets study criteria|0|||
149954003|NCT03369223|540963197|FG019|Overall Study|Participant no longer meets study criteria|0|||
149954004|NCT03369223|540963178|FG000|Overall Study|Other reasons|0|||
149954005|NCT03369223|540963179|FG001|Overall Study|Other reasons|0|||
149954006|NCT03369223|540963180|FG002|Overall Study|Other reasons|0|||
149954007|NCT03369223|540963181|FG003|Overall Study|Other reasons|0|||
149954008|NCT03369223|540963182|FG004|Overall Study|Other reasons|0|||
149954009|NCT03369223|540963183|FG005|Overall Study|Other reasons|0|||
149954010|NCT03369223|540963184|FG006|Overall Study|Other reasons|0|||
149954011|NCT03369223|540963185|FG007|Overall Study|Other reasons|0|||
149954012|NCT03369223|540963186|FG008|Overall Study|Other reasons|0|||
149954013|NCT03369223|540963187|FG009|Overall Study|Other reasons|0|||
149954014|NCT03369223|540963188|FG010|Overall Study|Other reasons|0|||
149954015|NCT03369223|540963189|FG011|Overall Study|Other reasons|0|||
149954016|NCT03369223|540963190|FG012|Overall Study|Other reasons|0|||
149954017|NCT03369223|540963191|FG013|Overall Study|Other reasons|1|||
149954018|NCT03369223|540963192|FG014|Overall Study|Other reasons|2|||
149954019|NCT03369223|540963193|FG015|Overall Study|Other reasons|0|||
149954020|NCT03369223|540963194|FG016|Overall Study|Other reasons|1|||
149954021|NCT03369223|540963195|FG017|Overall Study|Other reasons|0|||
149954022|NCT03369223|540963196|FG018|Overall Study|Other reasons|0|||
149954023|NCT03369223|540963197|FG019|Overall Study|Other reasons|2|||
149954024|NCT03369223|540963178|FG000|Overall Study|Death|0|||
149954025|NCT03369223|540963179|FG001|Overall Study|Death|0|||
149954026|NCT03369223|540963180|FG002|Overall Study|Death|0|||
149954027|NCT03369223|540963181|FG003|Overall Study|Death|0|||
149954028|NCT03369223|540963182|FG004|Overall Study|Death|0|||
149954029|NCT03369223|540963183|FG005|Overall Study|Death|0|||
149954030|NCT03369223|540963184|FG006|Overall Study|Death|0|||
149954031|NCT03369223|540963185|FG007|Overall Study|Death|0|||
149954032|NCT03369223|540963186|FG008|Overall Study|Death|0|||
149954033|NCT03369223|540963187|FG009|Overall Study|Death|0|||
149954034|NCT03369223|540963188|FG010|Overall Study|Death|0|||
149954035|NCT03369223|540963189|FG011|Overall Study|Death|0|||
149954036|NCT03369223|540963190|FG012|Overall Study|Death|0|||
149954037|NCT03369223|540963191|FG013|Overall Study|Death|1|||
149954038|NCT03369223|540963192|FG014|Overall Study|Death|0|||
149954039|NCT03369223|540963193|FG015|Overall Study|Death|0|||
149954040|NCT03369223|540963194|FG016|Overall Study|Death|0|||
149954041|NCT03369223|540963195|FG017|Overall Study|Death|0|||
149954042|NCT03369223|540963196|FG018|Overall Study|Death|1|||
149954043|NCT03369223|540963197|FG019|Overall Study|Death|0|||
149954044|NCT03369223|540963178|FG000|Overall Study|Adverse event unrelated to study drug|0|||
149954045|NCT03369223|540963179|FG001|Overall Study|Adverse event unrelated to study drug|0|||
149954046|NCT03369223|540963180|FG002|Overall Study|Adverse event unrelated to study drug|0|||
149954047|NCT03369223|540963181|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149954048|NCT03369223|540963182|FG004|Overall Study|Adverse event unrelated to study drug|0|||
149954049|NCT03369223|540963183|FG005|Overall Study|Adverse event unrelated to study drug|0|||
149954050|NCT03369223|540963184|FG006|Overall Study|Adverse event unrelated to study drug|1|||
149954051|NCT03369223|540963185|FG007|Overall Study|Adverse event unrelated to study drug|0|||
149954052|NCT03369223|540963186|FG008|Overall Study|Adverse event unrelated to study drug|0|||
149954053|NCT03369223|540963187|FG009|Overall Study|Adverse event unrelated to study drug|1|||
149954054|NCT03369223|540963188|FG010|Overall Study|Adverse event unrelated to study drug|0|||
149954055|NCT03369223|540963189|FG011|Overall Study|Adverse event unrelated to study drug|0|||
149954056|NCT03369223|540963190|FG012|Overall Study|Adverse event unrelated to study drug|0|||
149954057|NCT03369223|540963191|FG013|Overall Study|Adverse event unrelated to study drug|4|||
149954058|NCT03369223|540963192|FG014|Overall Study|Adverse event unrelated to study drug|2|||
149954059|NCT03369223|540963193|FG015|Overall Study|Adverse event unrelated to study drug|0|||
149954060|NCT03369223|540963194|FG016|Overall Study|Adverse event unrelated to study drug|2|||
149954061|NCT03369223|540963195|FG017|Overall Study|Adverse event unrelated to study drug|1|||
149954062|NCT03369223|540963196|FG018|Overall Study|Adverse event unrelated to study drug|3|||
149954063|NCT03369223|540963197|FG019|Overall Study|Adverse event unrelated to study drug|2|||
149954064|NCT03369223|540963178|FG000|Overall Study|Disease progression|6|||
149954065|NCT03369223|540963179|FG001|Overall Study|Disease progression|8|||
149954066|NCT03369223|540963180|FG002|Overall Study|Disease progression|5|||
149954067|NCT03369223|540963181|FG003|Overall Study|Disease progression|1|||
149954068|NCT03369223|540963182|FG004|Overall Study|Disease progression|9|||
149954069|NCT03369223|540963183|FG005|Overall Study|Disease progression|9|||
149954070|NCT03369223|540963184|FG006|Overall Study|Disease progression|4|||
149954071|NCT03369223|540963185|FG007|Overall Study|Disease progression|6|||
149954072|NCT03369223|540963186|FG008|Overall Study|Disease progression|10|||
149954073|NCT03369223|540963187|FG009|Overall Study|Disease progression|7|||
149954074|NCT03369223|540963188|FG010|Overall Study|Disease progression|4|||
149954075|NCT03369223|540963189|FG011|Overall Study|Disease progression|1|||
149954076|NCT03369223|540963190|FG012|Overall Study|Disease progression|1|||
149954077|NCT03369223|540963191|FG013|Overall Study|Disease progression|25|||
149954078|NCT03369223|540963192|FG014|Overall Study|Disease progression|22|||
149954079|NCT03369223|540963193|FG015|Overall Study|Disease progression|2|||
149954080|NCT03369223|540963194|FG016|Overall Study|Disease progression|10|||
149954081|NCT03369223|540963195|FG017|Overall Study|Disease progression|1|||
149954082|NCT03369223|540963196|FG018|Overall Study|Disease progression|18|||
149954083|NCT03369223|540963197|FG019|Overall Study|Disease progression|28|||
149954084|NCT03369223|540963178|FG000|Overall Study|Study drug toxicity|0|||
149954085|NCT03369223|540963179|FG001|Overall Study|Study drug toxicity|1|||
149954086|NCT03369223|540963180|FG002|Overall Study|Study drug toxicity|4|||
149954087|NCT03369223|540963181|FG003|Overall Study|Study drug toxicity|0|||
149954088|NCT03369223|540963182|FG004|Overall Study|Study drug toxicity|1|||
149954089|NCT03369223|540963183|FG005|Overall Study|Study drug toxicity|2|||
149954090|NCT03369223|540963184|FG006|Overall Study|Study drug toxicity|4|||
149954091|NCT03369223|540963185|FG007|Overall Study|Study drug toxicity|2|||
149954092|NCT03369223|540963186|FG008|Overall Study|Study drug toxicity|2|||
149954093|NCT03369223|540963187|FG009|Overall Study|Study drug toxicity|0|||
149954094|NCT03369223|540963188|FG010|Overall Study|Study drug toxicity|6|||
149954095|NCT03369223|540963189|FG011|Overall Study|Study drug toxicity|1|||
149954096|NCT03369223|540963190|FG012|Overall Study|Study drug toxicity|2|||
149954097|NCT03369223|540963191|FG013|Overall Study|Study drug toxicity|19|||
149954098|NCT03369223|540963192|FG014|Overall Study|Study drug toxicity|19|||
149954099|NCT03369223|540963193|FG015|Overall Study|Study drug toxicity|0|||
149954100|NCT03369223|540963194|FG016|Overall Study|Study drug toxicity|18|||
149954101|NCT03369223|540963195|FG017|Overall Study|Study drug toxicity|3|||
149954102|NCT03369223|540963196|FG018|Overall Study|Study drug toxicity|11|||
149954103|NCT03369223|540963197|FG019|Overall Study|Study drug toxicity|7|||
149954104|NCT03369223|540963178|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149954105|NCT03369223|540963179|FG001|Overall Study|Participant request to discontinue study treatment|1|||
149954106|NCT03369223|540963180|FG002|Overall Study|Participant request to discontinue study treatment|0|||
150286578|NCT01995071|542185420|FG002|Overall Study|Lost to Follow-up|0|||
150286579|NCT01995071|542185421|FG003|Overall Study|Lost to Follow-up|0|||
150286580|NCT01995071|542185422|FG004|Overall Study|Lost to Follow-up|0|||
150286581|NCT01995071|542185423|FG005|Overall Study|Lost to Follow-up|0|||
150286582|NCT01995071|542185424|FG006|Overall Study|Lost to Follow-up|0|||
150286583|NCT01995071|542185425|FG007|Overall Study|Lost to Follow-up|1|||
150286584|NCT01995071|542185426|FG008|Overall Study|Lost to Follow-up|1|||
150286585|NCT01995071|542185427|FG009|Overall Study|Lost to Follow-up|0|||
150286586|NCT01995071|542185428|FG010|Overall Study|Lost to Follow-up|0|||
150286587|NCT01995071|542185429|FG011|Overall Study|Lost to Follow-up|0|||
149954107|NCT03369223|540963181|FG003|Overall Study|Participant request to discontinue study treatment|0|||
149954108|NCT03369223|540963182|FG004|Overall Study|Participant request to discontinue study treatment|1|||
149954109|NCT03369223|540963183|FG005|Overall Study|Participant request to discontinue study treatment|1|||
149954110|NCT03369223|540963184|FG006|Overall Study|Participant request to discontinue study treatment|1|||
149954111|NCT03369223|540963185|FG007|Overall Study|Participant request to discontinue study treatment|0|||
149954112|NCT03369223|540963186|FG008|Overall Study|Participant request to discontinue study treatment|0|||
149954113|NCT03369223|540963187|FG009|Overall Study|Participant request to discontinue study treatment|0|||
149954114|NCT03369223|540963188|FG010|Overall Study|Participant request to discontinue study treatment|0|||
149954115|NCT03369223|540963189|FG011|Overall Study|Participant request to discontinue study treatment|0|||
149954116|NCT03369223|540963190|FG012|Overall Study|Participant request to discontinue study treatment|0|||
149954117|NCT03369223|540963191|FG013|Overall Study|Participant request to discontinue study treatment|1|||
149954118|NCT03369223|540963192|FG014|Overall Study|Participant request to discontinue study treatment|1|||
149954119|NCT03369223|540963193|FG015|Overall Study|Participant request to discontinue study treatment|0|||
149954120|NCT03369223|540963194|FG016|Overall Study|Participant request to discontinue study treatment|0|||
149954121|NCT03369223|540963195|FG017|Overall Study|Participant request to discontinue study treatment|0|||
149954122|NCT03369223|540963196|FG018|Overall Study|Participant request to discontinue study treatment|1|||
149954123|NCT03369223|540963197|FG019|Overall Study|Participant request to discontinue study treatment|0|||
149954124|NCT03369223|540963178|FG000|Overall Study|Participant withdrew consent|0|||
149954125|NCT03369223|540963179|FG001|Overall Study|Participant withdrew consent|1|||
149954126|NCT03369223|540963180|FG002|Overall Study|Participant withdrew consent|1|||
149954127|NCT03369223|540963181|FG003|Overall Study|Participant withdrew consent|0|||
149954128|NCT03369223|540963182|FG004|Overall Study|Participant withdrew consent|0|||
149954129|NCT03369223|540963183|FG005|Overall Study|Participant withdrew consent|0|||
149954130|NCT03369223|540963184|FG006|Overall Study|Participant withdrew consent|1|||
149954131|NCT03369223|540963185|FG007|Overall Study|Participant withdrew consent|1|||
149954132|NCT03369223|540963186|FG008|Overall Study|Participant withdrew consent|1|||
149954133|NCT03369223|540963187|FG009|Overall Study|Participant withdrew consent|0|||
150286588|NCT01995071|542185418|FG000|Overall Study|Incarcerated|0|||
150286589|NCT01995071|542185419|FG001|Overall Study|Incarcerated|0|||
150286590|NCT01995071|542185420|FG002|Overall Study|Incarcerated|0|||
150286591|NCT01995071|542185421|FG003|Overall Study|Incarcerated|0|||
150286592|NCT01995071|542185422|FG004|Overall Study|Incarcerated|0|||
150286593|NCT01995071|542185423|FG005|Overall Study|Incarcerated|0|||
150286594|NCT01995071|542185424|FG006|Overall Study|Incarcerated|0|||
150286595|NCT01995071|542185425|FG007|Overall Study|Incarcerated|1|||
150286596|NCT01995071|542185426|FG008|Overall Study|Incarcerated|0|||
150286597|NCT01995071|542185427|FG009|Overall Study|Incarcerated|0|||
150286598|NCT01995071|542185428|FG010|Overall Study|Incarcerated|0|||
150286599|NCT01995071|542185429|FG011|Overall Study|Incarcerated|0|||
150286600|NCT02543528|542185430|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
150286601|NCT02543528|542185431|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
150286602|NCT02543528|542185432|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
150286603|NCT02543528|542185433|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
150286604|NCT02543528|542185434|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
150286605|NCT02543528|542185430|FG000|Adaptation Period|Lens Handling Difficultes|0|||
150286606|NCT02543528|542185431|FG001|Adaptation Period|Lens Handling Difficultes|0|||
150286607|NCT02543528|542185432|FG002|Adaptation Period|Lens Handling Difficultes|0|||
150286608|NCT02543528|542185433|FG003|Adaptation Period|Lens Handling Difficultes|0|||
150286609|NCT02543528|542185434|FG004|Adaptation Period|Lens Handling Difficultes|8|||
150286610|NCT02543528|542185430|FG000|Adaptation Period|Lost to Follow-up|0|||
150286611|NCT02543528|542185431|FG001|Adaptation Period|Lost to Follow-up|0|||
150286612|NCT02543528|542185432|FG002|Adaptation Period|Lost to Follow-up|0|||
150286613|NCT02543528|542185433|FG003|Adaptation Period|Lost to Follow-up|0|||
150286614|NCT02543528|542185434|FG004|Adaptation Period|Lost to Follow-up|14|||
150286615|NCT02543528|542185430|FG000|Adaptation Period|Adverse Event|0|||
150286616|NCT02543528|542185431|FG001|Adaptation Period|Adverse Event|0|||
150286617|NCT02543528|542185432|FG002|Adaptation Period|Adverse Event|0|||
150286618|NCT02543528|542185433|FG003|Adaptation Period|Adverse Event|0|||
150286619|NCT02543528|542185434|FG004|Adaptation Period|Adverse Event|2|||
150286620|NCT02543528|542185430|FG000|Extended Wear Period|Adverse Event|17|||
150286621|NCT02543528|542185431|FG001|Extended Wear Period|Adverse Event|11|||
150286622|NCT02543528|542185432|FG002|Extended Wear Period|Adverse Event|16|||
150286623|NCT02543528|542185433|FG003|Extended Wear Period|Adverse Event|3|||
150286624|NCT02543528|542185434|FG004|Extended Wear Period|Adverse Event|0|||
150286625|NCT02543528|542185430|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
149843422|NCT01838681|540556905|FG001|Period B/A+|Protocol Violation|1|||
149843423|NCT01838681|540556906|FG002|Period B/A+|Protocol Violation|4|||
150035783|NCT00074711|541271409|FG001|Overall Study|Lost to Follow-up|8|||
150035784|NCT00074711|541271408|FG000|Overall Study|Participant stopped study drug|4|||
150035785|NCT00074711|541271409|FG001|Overall Study|Participant stopped study drug|6|||
150286626|NCT02543528|542185431|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
150286627|NCT02543528|542185432|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
150286628|NCT02543528|542185433|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
150286629|NCT02543528|542185434|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
149843424|NCT01838681|540556907|FG003|Period B/A+|Protocol Violation|6|||
150286630|NCT02543528|542185430|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
150286631|NCT02543528|542185431|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
150286632|NCT02543528|542185432|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
150286633|NCT02543528|542185433|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
150286634|NCT02543528|542185434|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
150286635|NCT02543528|542185430|FG000|Extended Wear Period|Lost to Follow-up|0|||
149843425|NCT01838681|540556904|FG000|Period B/A+|Non-compliance with IMP|0|||
149843426|NCT01838681|540556905|FG001|Period B/A+|Non-compliance with IMP|2|||
149843427|NCT01838681|540556906|FG002|Period B/A+|Non-compliance with IMP|3|||
149843428|NCT01838681|540556907|FG003|Period B/A+|Non-compliance with IMP|3|||
149843429|NCT01838681|540556904|FG000|Period B/A+|Lost to Follow-up|0|||
149843430|NCT01838681|540556905|FG001|Period B/A+|Lost to Follow-up|2|||
149843431|NCT01838681|540556906|FG002|Period B/A+|Lost to Follow-up|5|||
149843432|NCT01838681|540556907|FG003|Period B/A+|Lost to Follow-up|11|||
149843433|NCT01838681|540556904|FG000|Period B/A+|Withdrawal before treatment|0|||
149843434|NCT01838681|540556905|FG001|Period B/A+|Withdrawal before treatment|1|||
149843435|NCT01838681|540556906|FG002|Period B/A+|Withdrawal before treatment|0|||
149843436|NCT01838681|540556907|FG003|Period B/A+|Withdrawal before treatment|0|||
149843437|NCT01838681|540556904|FG000|Period B/A+|Administrative or other reasons|0|||
149843438|NCT01838681|540556905|FG001|Period B/A+|Administrative or other reasons|6|||
149843439|NCT01838681|540556906|FG002|Period B/A+|Administrative or other reasons|10|||
149843440|NCT01838681|540556907|FG003|Period B/A+|Administrative or other reasons|28|||
149843441|NCT00796562|540556908|FG000|Overall Study|Death|49|||
149843442|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
149843443|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
149843444|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
149843445|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
150035786|NCT03466658|541271410|FG000|Overall Study|Withdrawal by Subject|3|||
150286636|NCT02543528|542185431|FG001|Extended Wear Period|Lost to Follow-up|1|||
150286637|NCT02543528|542185432|FG002|Extended Wear Period|Lost to Follow-up|2|||
150286638|NCT02543528|542185433|FG003|Extended Wear Period|Lost to Follow-up|1|||
150286639|NCT02543528|542185434|FG004|Extended Wear Period|Lost to Follow-up|0|||
150286640|NCT02543528|542185430|FG000|Extended Wear Period|Withdrawal by Subject|10|||
150286641|NCT02543528|542185431|FG001|Extended Wear Period|Withdrawal by Subject|9|||
150286642|NCT02543528|542185432|FG002|Extended Wear Period|Withdrawal by Subject|4|||
150286643|NCT02543528|542185433|FG003|Extended Wear Period|Withdrawal by Subject|5|||
150286644|NCT02543528|542185434|FG004|Extended Wear Period|Withdrawal by Subject|0|||
150286645|NCT01982292|542185435|FG000|Overall Study|Adverse Event|2|||
150286646|NCT01982292|542185436|FG001|Overall Study|Adverse Event|0|||
150286647|NCT01982292|542185435|FG000|Overall Study|Death|1|||
150286648|NCT01982292|542185436|FG001|Overall Study|Death|0|||
150286649|NCT01982292|542185435|FG000|Overall Study|Lost to Follow-up|2|||
150286650|NCT01982292|542185436|FG001|Overall Study|Lost to Follow-up|0|||
150286651|NCT01982292|542185435|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
150286652|NCT01982292|542185436|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
150286653|NCT01982292|542185435|FG000|Overall Study|Protocol Deviation|1|||
150286654|NCT01982292|542185436|FG001|Overall Study|Protocol Deviation|0|||
150286655|NCT01982292|542185435|FG000|Overall Study|Patient/Guardian Decision|3|||
150286656|NCT01982292|542185436|FG001|Overall Study|Patient/Guardian Decision|1|||
150286657|NCT01982292|542185435|FG000|Overall Study|Technical Problems|2|||
150286658|NCT01982292|542185436|FG001|Overall Study|Technical Problems|0|||
150286659|NCT00879229|542185437|FG000|Overall Study|Study terminated by Sponsor|13|||
150286660|NCT00879229|542185438|FG001|Overall Study|Study terminated by Sponsor|12|||
150286661|NCT00879229|542185437|FG000|Overall Study|Death|4|||
150286662|NCT00879229|542185438|FG001|Overall Study|Death|2|||
150286663|NCT00879229|542185437|FG000|Overall Study|Adverse Event|2|||
150286664|NCT00879229|542185438|FG001|Overall Study|Adverse Event|0|||
150286665|NCT00879229|542185437|FG000|Overall Study|Withdrawal by Subject|1|||
150286666|NCT00879229|542185438|FG001|Overall Study|Withdrawal by Subject|0|||
150286667|NCT00879229|542185437|FG000|Overall Study|Clinical status did not improve|1|||
150286668|NCT00879229|542185438|FG001|Overall Study|Clinical status did not improve|0|||
150286669|NCT00879229|542185437|FG000|Overall Study|Other|1|||
150286670|NCT00879229|542185438|FG001|Overall Study|Other|0|||
150286671|NCT00817531|542185439|FG000|Overall Study|Adverse Event|1|||
150286672|NCT00817531|542185439|FG000|Overall Study|Lack of Efficacy|1|||
150286673|NCT02669017|542185441|FG000|Overall Study|Death|1|||
150286674|NCT02669017|542185442|FG001|Overall Study|Death|2|||
150286675|NCT02669017|542185443|FG002|Overall Study|Death|2|||
150286676|NCT02669017|542185444|FG003|Overall Study|Death|3|||
150286677|NCT02669017|542185445|FG004|Overall Study|Death|8|||
150286678|NCT02669017|542185446|FG005|Overall Study|Death|18|||
150286679|NCT02669017|542185447|FG006|Overall Study|Death|10|||
150286680|NCT02669017|542185448|FG007|Overall Study|Death|47|||
150286681|NCT02669017|542185449|FG008|Overall Study|Death|20|||
150286682|NCT02669017|542185441|FG000|Overall Study|Withdrawal by Subject|0|||
150286683|NCT02669017|542185442|FG001|Overall Study|Withdrawal by Subject|0|||
150286684|NCT02669017|542185443|FG002|Overall Study|Withdrawal by Subject|0|||
150286685|NCT02669017|542185444|FG003|Overall Study|Withdrawal by Subject|1|||
150286686|NCT02669017|542185445|FG004|Overall Study|Withdrawal by Subject|2|||
150286687|NCT02669017|542185446|FG005|Overall Study|Withdrawal by Subject|0|||
150286688|NCT02669017|542185447|FG006|Overall Study|Withdrawal by Subject|0|||
150286689|NCT02669017|542185448|FG007|Overall Study|Withdrawal by Subject|2|||
150286690|NCT02669017|542185449|FG008|Overall Study|Withdrawal by Subject|2|||
150286691|NCT02669017|542185441|FG000|Overall Study|Lost to Follow-up|0|||
150286692|NCT02669017|542185442|FG001|Overall Study|Lost to Follow-up|0|||
150286693|NCT02669017|542185443|FG002|Overall Study|Lost to Follow-up|0|||
150286694|NCT02669017|542185444|FG003|Overall Study|Lost to Follow-up|0|||
150286695|NCT02669017|542185445|FG004|Overall Study|Lost to Follow-up|0|||
150286696|NCT02669017|542185446|FG005|Overall Study|Lost to Follow-up|0|||
150286697|NCT02669017|542185447|FG006|Overall Study|Lost to Follow-up|0|||
150286698|NCT02669017|542185448|FG007|Overall Study|Lost to Follow-up|0|||
150286699|NCT02669017|542185449|FG008|Overall Study|Lost to Follow-up|1|||
150286700|NCT02669017|542185441|FG000|Overall Study|Miscellaneous|0|||
150286701|NCT02669017|542185442|FG001|Overall Study|Miscellaneous|0|||
150286702|NCT02669017|542185443|FG002|Overall Study|Miscellaneous|0|||
150286703|NCT02669017|542185444|FG003|Overall Study|Miscellaneous|0|||
150286704|NCT02669017|542185445|FG004|Overall Study|Miscellaneous|2|||
150286705|NCT02669017|542185446|FG005|Overall Study|Miscellaneous|1|||
150286706|NCT02669017|542185447|FG006|Overall Study|Miscellaneous|1|||
150286707|NCT02669017|542185448|FG007|Overall Study|Miscellaneous|13|||
150286708|NCT02669017|542185449|FG008|Overall Study|Miscellaneous|2|||
150286709|NCT00763815|542185451|FG000|Overall Study|Adverse Event|14|||
150286710|NCT00763815|542185452|FG001|Overall Study|Adverse Event|29|||
150286711|NCT00763815|542185451|FG000|Overall Study|Lack of Efficacy|10|||
150286712|NCT00763815|542185452|FG001|Overall Study|Lack of Efficacy|11|||
149843446|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
150286713|NCT00763815|542185451|FG000|Overall Study|Poor Compliance to Protocol|6|||
149843447|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
149843448|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
149843449|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
149843450|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
149843451|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
149843452|NCT00424047|540556909|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
149843453|NCT00424047|540556910|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
149843454|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Adverse Event|22|||
149843455|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Adverse Event|12|||
149843456|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Progression of disease|92|||
149843457|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Progression of disease|128|||
149843458|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
149843459|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
149843460|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
149843461|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
149843462|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Death|11|||
149843463|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Death|11|||
149843464|NCT00424047|540556909|FG000|On Study at Time of Unblinding|Other|5|||
149843465|NCT00424047|540556910|FG001|On Study at Time of Unblinding|Other|4|||
149843466|NCT00424047|540556909|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
149843467|NCT00424047|540556910|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
149843468|NCT00424047|540556909|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
149843469|NCT00424047|540556910|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
149843470|NCT00424047|540556909|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
149843471|NCT00424047|540556910|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
149843472|NCT00424047|540556909|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
149843473|NCT00424047|540556910|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
149843474|NCT00424047|540556909|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
149843475|NCT00424047|540556910|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
149843476|NCT03100344|540556912|FG000|Overall Study|Adverse Event|0|||
149843477|NCT03100344|540556913|FG001|Overall Study|Adverse Event|3|||
149843478|NCT03100344|540556914|FG002|Overall Study|Adverse Event|2|||
149843479|NCT03100344|540556915|FG003|Overall Study|Adverse Event|3|||
149843480|NCT03100344|540556912|FG000|Overall Study|Lack of Efficacy|2|||
149843481|NCT03100344|540556913|FG001|Overall Study|Lack of Efficacy|0|||
149843482|NCT03100344|540556914|FG002|Overall Study|Lack of Efficacy|0|||
149843483|NCT03100344|540556915|FG003|Overall Study|Lack of Efficacy|0|||
149843484|NCT03100344|540556912|FG000|Overall Study|Protocol Violation|1|||
149843485|NCT03100344|540556913|FG001|Overall Study|Protocol Violation|0|||
149843486|NCT03100344|540556914|FG002|Overall Study|Protocol Violation|0|||
149954134|NCT03369223|540963188|FG010|Overall Study|Participant withdrew consent|0|||
149954135|NCT03369223|540963189|FG011|Overall Study|Participant withdrew consent|1|||
149954136|NCT03369223|540963190|FG012|Overall Study|Participant withdrew consent|0|||
149954137|NCT03369223|540963191|FG013|Overall Study|Participant withdrew consent|0|||
149954138|NCT03369223|540963192|FG014|Overall Study|Participant withdrew consent|3|||
149954139|NCT03369223|540963193|FG015|Overall Study|Participant withdrew consent|0|||
149954140|NCT03369223|540963194|FG016|Overall Study|Participant withdrew consent|1|||
149954141|NCT03369223|540963195|FG017|Overall Study|Participant withdrew consent|0|||
149954142|NCT03369223|540963196|FG018|Overall Study|Participant withdrew consent|4|||
149954143|NCT03369223|540963197|FG019|Overall Study|Participant withdrew consent|2|||
149954144|NCT03369223|540963178|FG000|Overall Study|Randomized but not treated|0|||
149954145|NCT03369223|540963179|FG001|Overall Study|Randomized but not treated|0|||
149954146|NCT03369223|540963180|FG002|Overall Study|Randomized but not treated|0|||
149954147|NCT03369223|540963181|FG003|Overall Study|Randomized but not treated|0|||
149954148|NCT03369223|540963182|FG004|Overall Study|Randomized but not treated|0|||
149954149|NCT03369223|540963183|FG005|Overall Study|Randomized but not treated|0|||
149954150|NCT03369223|540963184|FG006|Overall Study|Randomized but not treated|0|||
149954151|NCT03369223|540963185|FG007|Overall Study|Randomized but not treated|0|||
149954152|NCT03369223|540963186|FG008|Overall Study|Randomized but not treated|0|||
149954153|NCT03369223|540963187|FG009|Overall Study|Randomized but not treated|0|||
149954154|NCT03369223|540963188|FG010|Overall Study|Randomized but not treated|0|||
149954155|NCT03369223|540963189|FG011|Overall Study|Randomized but not treated|0|||
149954156|NCT03369223|540963190|FG012|Overall Study|Randomized but not treated|0|||
149843487|NCT03100344|540556915|FG003|Overall Study|Protocol Violation|0|||
149843488|NCT03100344|540556912|FG000|Overall Study|Withdrawal by Subject|10|||
149843489|NCT03100344|540556913|FG001|Overall Study|Withdrawal by Subject|7|||
149843490|NCT03100344|540556914|FG002|Overall Study|Withdrawal by Subject|4|||
149954157|NCT03369223|540963191|FG013|Overall Study|Randomized but not treated|1|||
150035787|NCT01921205|541271411|FG000|Overall Study|Adverse Event|12|||
149843491|NCT03100344|540556915|FG003|Overall Study|Withdrawal by Subject|8|||
149843492|NCT03100344|540556912|FG000|Overall Study|Lost to Follow-up|1|||
149843493|NCT03100344|540556913|FG001|Overall Study|Lost to Follow-up|1|||
149843494|NCT03100344|540556914|FG002|Overall Study|Lost to Follow-up|1|||
149843495|NCT03100344|540556915|FG003|Overall Study|Lost to Follow-up|1|||
149843496|NCT01010503|540556916|FG000|Overall Study|Adverse Event|1|||
149843497|NCT01010503|540556916|FG000|Overall Study|Death|1|||
149843498|NCT03599193|540558649|FG000|Overall Study|Adverse Event|0|||
149843499|NCT03599193|540558650|FG001|Overall Study|Adverse Event|2|||
149843500|NCT03599193|540558649|FG000|Overall Study|Withdrawal by Subject|1|||
149843501|NCT03599193|540558650|FG001|Overall Study|Withdrawal by Subject|0|||
149843502|NCT03599193|540558649|FG000|Overall Study|Protocol Violation|1|||
149843503|NCT03599193|540558650|FG001|Overall Study|Protocol Violation|0|||
149843504|NCT03599193|540558649|FG000|Overall Study|Lost to Follow-up|0|||
149954158|NCT03369223|540963192|FG014|Overall Study|Randomized but not treated|1|||
149954159|NCT03369223|540963193|FG015|Overall Study|Randomized but not treated|0|||
149954160|NCT03369223|540963194|FG016|Overall Study|Randomized but not treated|0|||
149954161|NCT03369223|540963195|FG017|Overall Study|Randomized but not treated|0|||
149954162|NCT03369223|540963196|FG018|Overall Study|Randomized but not treated|0|||
150286714|NCT00763815|542185452|FG001|Overall Study|Poor Compliance to Protocol|6|||
150286715|NCT00763815|542185451|FG000|Overall Study|Lost to Follow-up|2|||
150286716|NCT00763815|542185452|FG001|Overall Study|Lost to Follow-up|4|||
150286717|NCT00763815|542185451|FG000|Overall Study|Early Termination|1|||
150286718|NCT00763815|542185452|FG001|Overall Study|Early Termination|0|||
150286719|NCT00763815|542185451|FG000|Overall Study|Familial and Personal Reasons|9|||
150286720|NCT00763815|542185452|FG001|Overall Study|Familial and Personal Reasons|16|||
150286721|NCT00763815|542185451|FG000|Overall Study|Physician Decision|1|||
150286722|NCT00763815|542185452|FG001|Overall Study|Physician Decision|0|||
149954163|NCT03369223|540963197|FG019|Overall Study|Randomized but not treated|0|||
149954164|NCT03573882|540963198|FG000|Overall Study|Study Terminated by Sponsor|22|||
149954165|NCT03573882|540963199|FG001|Overall Study|Study Terminated by Sponsor|17|||
149954166|NCT03573882|540963200|FG002|Overall Study|Study Terminated by Sponsor|18|||
149954167|NCT03573882|540963198|FG000|Overall Study|Withdrawal by Subject|6|||
149954168|NCT03573882|540963199|FG001|Overall Study|Withdrawal by Subject|11|||
149954169|NCT03573882|540963200|FG002|Overall Study|Withdrawal by Subject|7|||
149954170|NCT03573882|540963198|FG000|Overall Study|Adverse Event|7|||
149954171|NCT03573882|540963199|FG001|Overall Study|Adverse Event|5|||
149954172|NCT03573882|540963200|FG002|Overall Study|Adverse Event|6|||
149954173|NCT03573882|540963198|FG000|Overall Study|Lost to Follow-up|2|||
149954174|NCT03573882|540963199|FG001|Overall Study|Lost to Follow-up|5|||
149954175|NCT03573882|540963200|FG002|Overall Study|Lost to Follow-up|3|||
149954176|NCT03573882|540963198|FG000|Overall Study|Physician Decision|4|||
149954177|NCT03573882|540963199|FG001|Overall Study|Physician Decision|3|||
149954178|NCT03573882|540963200|FG002|Overall Study|Physician Decision|2|||
149954179|NCT03573882|540963198|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
149954180|NCT03573882|540963199|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
149954181|NCT03573882|540963200|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
149954182|NCT03573882|540963198|FG000|Overall Study|Pregnancy|1|||
149954183|NCT03573882|540963199|FG001|Overall Study|Pregnancy|2|||
149954184|NCT03573882|540963200|FG002|Overall Study|Pregnancy|0|||
149954185|NCT03573882|540963198|FG000|Overall Study|Other|4|||
149954186|NCT03573882|540963199|FG001|Overall Study|Other|2|||
149954187|NCT03573882|540963200|FG002|Overall Study|Other|2|||
149954188|NCT01685437|540963205|FG000|Overall Study|Withdrawal by Subject|22|||
149954189|NCT01685437|540963205|FG000|Overall Study|Lost to Follow-up|3|||
149954190|NCT01685437|540963205|FG000|Overall Study|Adverse Event|1|||
149954191|NCT01685437|540963205|FG000|Overall Study|Protocol Violation|4|||
150286723|NCT00763815|542185451|FG000|Overall Study|Withdrawal by Subject|7|||
150286724|NCT00763815|542185452|FG001|Overall Study|Withdrawal by Subject|12|||
150286725|NCT00763815|542185451|FG000|Overall Study|Protocol Violation|2|||
150286726|NCT00763815|542185452|FG001|Overall Study|Protocol Violation|5|||
150286727|NCT00763815|542185451|FG000|Overall Study|Sponsor's Decision|0|||
150286728|NCT00763815|542185452|FG001|Overall Study|Sponsor's Decision|1|||
149843505|NCT03599193|540558650|FG001|Overall Study|Lost to Follow-up|1|||
149843506|NCT00798603|540558651|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
150286729|NCT03245450|542185457|FG000|Overall Study|Radiological disease progression|3|||
149843507|NCT00798603|540558651|FG000|Overall Study|Withdrawal by Subject|10|||
149843508|NCT00798603|540558651|FG000|Overall Study|Adverse Event|22|||
150286730|NCT03245450|542185458|FG001|Overall Study|Radiological disease progression|3|||
149843509|NCT00798603|540558651|FG000|Overall Study|Physician Decision|1|||
149954192|NCT01685437|540963205|FG000|Overall Study|Unable to make visits due to work|1|||
149954193|NCT01121575|540963210|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
149954194|NCT01121575|540963211|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
149954195|NCT01121575|540963212|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
149954196|NCT01121575|540963213|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
149954197|NCT01121575|540963214|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
149954198|NCT01121575|540963215|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
150286731|NCT03245450|542185459|FG002|Overall Study|Radiological disease progression|2|||
150286732|NCT03245450|542185460|FG003|Overall Study|Radiological disease progression|2|||
150286733|NCT03245450|542185461|FG004|Overall Study|Radiological disease progression|7|||
150286734|NCT03245450|542185462|FG005|Overall Study|Radiological disease progression|6|||
150286735|NCT03245450|542185463|FG006|Overall Study|Radiological disease progression|6|||
150286736|NCT03245450|542185457|FG000|Overall Study|Clinical disease progression|0|||
150286737|NCT03245450|542185458|FG001|Overall Study|Clinical disease progression|0|||
150172557|NCT01596504|541768008|FG000|Overall Study|Participant's Private Reason|0|||
150172558|NCT01596504|541768009|FG001|Overall Study|Participant's Private Reason|1|||
150172559|NCT01596504|541768010|FG002|Overall Study|Participant's Private Reason|0|||
150172560|NCT01596504|541768008|FG000|Overall Study|Adverse Event|1|||
150172561|NCT01596504|541768009|FG001|Overall Study|Adverse Event|2|||
150286738|NCT03245450|542185459|FG002|Overall Study|Clinical disease progression|1|||
150286739|NCT03245450|542185460|FG003|Overall Study|Clinical disease progression|0|||
150286740|NCT03245450|542185461|FG004|Overall Study|Clinical disease progression|0|||
150286741|NCT03245450|542185462|FG005|Overall Study|Clinical disease progression|2|||
150286742|NCT03245450|542185463|FG006|Overall Study|Clinical disease progression|0|||
150286743|NCT03245450|542185457|FG000|Overall Study|Other|0|||
150286744|NCT03245450|542185458|FG001|Overall Study|Other|0|||
150286745|NCT03245450|542185459|FG002|Overall Study|Other|0|||
150286746|NCT03245450|542185460|FG003|Overall Study|Other|1|||
150286747|NCT03245450|542185461|FG004|Overall Study|Other|1|||
150286748|NCT03245450|542185462|FG005|Overall Study|Other|1|||
150286749|NCT03245450|542185463|FG006|Overall Study|Other|1|||
150286750|NCT03245450|542185457|FG000|Overall Study|Withdrawal by Subject|0|||
150286751|NCT03245450|542185458|FG001|Overall Study|Withdrawal by Subject|1|||
150286752|NCT03245450|542185459|FG002|Overall Study|Withdrawal by Subject|0|||
150286753|NCT03245450|542185460|FG003|Overall Study|Withdrawal by Subject|0|||
150286754|NCT03245450|542185461|FG004|Overall Study|Withdrawal by Subject|0|||
150286755|NCT03245450|542185462|FG005|Overall Study|Withdrawal by Subject|0|||
150286756|NCT03245450|542185463|FG006|Overall Study|Withdrawal by Subject|0|||
150286757|NCT03245450|542185457|FG000|Overall Study|Adverse Event|0|||
150172562|NCT01596504|541768010|FG002|Overall Study|Adverse Event|1|||
150172563|NCT01596504|541768008|FG000|Overall Study|Withdrawal by Subject|1|||
150172564|NCT01596504|541768009|FG001|Overall Study|Withdrawal by Subject|0|||
150286758|NCT03245450|542185458|FG001|Overall Study|Adverse Event|0|||
150286759|NCT03245450|542185459|FG002|Overall Study|Adverse Event|0|||
150286760|NCT03245450|542185460|FG003|Overall Study|Adverse Event|0|||
150286761|NCT03245450|542185461|FG004|Overall Study|Adverse Event|1|||
150286762|NCT03245450|542185462|FG005|Overall Study|Adverse Event|0|||
150286763|NCT03245450|542185463|FG006|Overall Study|Adverse Event|2|||
150286764|NCT02429414|542185464|FG000|Overall Study|Physician Decision|0|||
149843510|NCT00798603|540558651|FG000|Overall Study|Lack of insurance coverage|1|||
149843511|NCT02727192|540558659|FG000|Overall Study|Lost to Follow-up|1|||
149843512|NCT02727192|540558660|FG001|Overall Study|Lost to Follow-up|0|||
149843513|NCT02727192|540558661|FG002|Overall Study|Lost to Follow-up|0|||
149843514|NCT00928057|540558662|FG000|Overall Study|Adverse Event|1|||
149843515|NCT00928057|540558663|FG001|Overall Study|Adverse Event|2|||
149843516|NCT00928057|540558662|FG000|Overall Study|Withdrawal by Subject|1|||
149843517|NCT00928057|540558663|FG001|Overall Study|Withdrawal by Subject|0|||
149843518|NCT00928057|540558662|FG000|Overall Study|Lost to Follow-up|0|||
149843519|NCT00928057|540558663|FG001|Overall Study|Lost to Follow-up|1|||
149843520|NCT00928057|540558662|FG000|Overall Study|Protocol Violation|0|||
149843521|NCT00928057|540558663|FG001|Overall Study|Protocol Violation|1|||
149843522|NCT03206749|540558664|FG000|Overall Study|Withdrawal of consent|5|||
149843523|NCT03206749|540558665|FG001|Overall Study|Withdrawal of consent|3|||
149843524|NCT03206749|540558666|FG002|Overall Study|Withdrawal of consent|6|||
149843525|NCT03206749|540558664|FG000|Overall Study|Lost to Follow-up|0|||
149843526|NCT03206749|540558665|FG001|Overall Study|Lost to Follow-up|0|||
149843527|NCT03206749|540558666|FG002|Overall Study|Lost to Follow-up|1|||
149843528|NCT02451696|540558667|FG000|Overall Study|Surgery postponed|1|||
149843529|NCT02451696|540558668|FG001|Overall Study|Surgery postponed|0|||
149843530|NCT01557751|540558669|FG000|Overall Study|Physician Decision|3|||
149843531|NCT02752074|540558670|FG000|Overall Study|Lost to Follow-up|1|||
149843532|NCT02752074|540558671|FG001|Overall Study|Lost to Follow-up|4|||
149843533|NCT02752074|540558670|FG000|Overall Study|Death|146|||
149843534|NCT02752074|540558671|FG001|Overall Study|Death|129|||
149843535|NCT02752074|540558670|FG000|Overall Study|Withdrawal by Subject|9|||
149843536|NCT02752074|540558671|FG001|Overall Study|Withdrawal by Subject|10|||
149843537|NCT03674892|540558673|FG000|Overall Study|Lack of Efficacy|5|||
149843538|NCT03674892|540558673|FG000|Overall Study|Lost to Follow-up|3|||
149843539|NCT03674892|540558673|FG000|Overall Study|Migraine|2|||
150286765|NCT02429414|542185465|FG001|Overall Study|Physician Decision|1|||
149843540|NCT03674892|540558673|FG000|Overall Study|Excessive Tearing|1|||
149843541|NCT03674892|540558673|FG000|Overall Study|Increased Eye Pain|1|||
149843542|NCT03674892|540558673|FG000|Overall Study|Increased Facial Pain|1|||
149843543|NCT03674892|540558673|FG000|Overall Study|Sinus Irritation|1|||
150286766|NCT00267748|542185466|FG000|Non-randomized Period|Progressive disease|10|||
150286767|NCT00267748|542185467|FG001|Non-randomized Period|Progressive disease|0|||
150286768|NCT00267748|542185468|FG002|Non-randomized Period|Progressive disease|0|||
150286769|NCT00267748|542185466|FG000|Non-randomized Period|Adverse Event|8|||
150286770|NCT00267748|542185467|FG001|Non-randomized Period|Adverse Event|0|||
150286771|NCT00267748|542185468|FG002|Non-randomized Period|Adverse Event|0|||
149954199|NCT01121575|540963210|FG000|Overall Study|Unspecified Reasons|8|||
149954200|NCT01121575|540963211|FG001|Overall Study|Unspecified Reasons|6|||
149954201|NCT01121575|540963212|FG002|Overall Study|Unspecified Reasons|7|||
149954202|NCT01121575|540963213|FG003|Overall Study|Unspecified Reasons|5|||
149954203|NCT01121575|540963214|FG004|Overall Study|Unspecified Reasons|13|||
149954204|NCT01121575|540963215|FG005|Overall Study|Unspecified Reasons|10|||
149954205|NCT01121575|540963210|FG000|Overall Study|Death|6|||
149954206|NCT01121575|540963211|FG001|Overall Study|Death|0|||
149954207|NCT01121575|540963212|FG002|Overall Study|Death|0|||
149954208|NCT01121575|540963213|FG003|Overall Study|Death|1|||
149954209|NCT01121575|540963214|FG004|Overall Study|Death|7|||
149954210|NCT01121575|540963215|FG005|Overall Study|Death|1|||
149954211|NCT02369458|540963219|FG000|Overall Study|Determined to be not eligible|1|||
149954212|NCT02369458|540963220|FG001|Overall Study|Determined to be not eligible|0|||
149954213|NCT04439175|540964592|FG000|Overall Study|Never started treatment|4|||
149954214|NCT04439175|540964592|FG000|Overall Study|Ineligible|5|||
149954215|NCT04439175|540964592|FG000|Overall Study|Adverse Event|6|||
149954216|NCT04439175|540964592|FG000|Overall Study|Death|4|||
149954217|NCT04439175|540964592|FG000|Overall Study|Disease progression|44|||
149954218|NCT04439175|540964592|FG000|Overall Study|Withdrawal by Subject|4|||
149954219|NCT04439175|540964592|FG000|Overall Study|Alternative Therapy|1|||
149954220|NCT04439175|540964592|FG000|Overall Study|Other|2|||
149954221|NCT01631188|540964593|FG000|Overall Study|Physician Decision|75|||
149954222|NCT03600350|540964594|FG000|Overall Study|Death|1|||
149954223|NCT03600350|540964594|FG000|Overall Study|On Follow Up|18|||
149954224|NCT00835978|540964595|FG000|Overall Study|Death|33|||
149954225|NCT00835978|540964596|FG001|Overall Study|Death|40|||
149954226|NCT00835978|540964597|FG002|Overall Study|Death|49|||
149954227|NCT00835978|540964598|FG003|Overall Study|Death|4|||
149954228|NCT00835978|540964595|FG000|Overall Study|Lost to Follow-up|3|||
149954229|NCT00835978|540964596|FG001|Overall Study|Lost to Follow-up|4|||
149954230|NCT00835978|540964597|FG002|Overall Study|Lost to Follow-up|2|||
149954231|NCT00835978|540964598|FG003|Overall Study|Lost to Follow-up|1|||
149954232|NCT00835978|540964595|FG000|Overall Study|Other|5|||
149954233|NCT00835978|540964596|FG001|Overall Study|Other|1|||
149954234|NCT00835978|540964597|FG002|Overall Study|Other|8|||
149954235|NCT00835978|540964598|FG003|Overall Study|Other|0|||
149954236|NCT00835978|540964595|FG000|Overall Study|Objective progression or relapse|2|||
149954237|NCT00835978|540964596|FG001|Overall Study|Objective progression or relapse|0|||
149954238|NCT00835978|540964597|FG002|Overall Study|Objective progression or relapse|1|||
149954239|NCT00835978|540964598|FG003|Overall Study|Objective progression or relapse|0|||
149954240|NCT00835978|540964595|FG000|Overall Study|Adverse Event|1|||
149954241|NCT00835978|540964596|FG001|Overall Study|Adverse Event|0|||
149954242|NCT00835978|540964597|FG002|Overall Study|Adverse Event|1|||
149954243|NCT00835978|540964598|FG003|Overall Study|Adverse Event|0|||
149954244|NCT00835978|540964595|FG000|Overall Study|Withdrawal by Subject|0|||
149954245|NCT00835978|540964596|FG001|Overall Study|Withdrawal by Subject|3|||
149954246|NCT00835978|540964597|FG002|Overall Study|Withdrawal by Subject|0|||
149954247|NCT00835978|540964598|FG003|Overall Study|Withdrawal by Subject|5|||
149954248|NCT00835978|540964595|FG000|Overall Study|Study terminated by sponsor|12|||
149954249|NCT00835978|540964596|FG001|Overall Study|Study terminated by sponsor|8|||
149954250|NCT00835978|540964597|FG002|Overall Study|Study terminated by sponsor|30|||
150172565|NCT01596504|541768010|FG002|Overall Study|Withdrawal by Subject|0|||
150172566|NCT02314117|541768011|FG000|Overall Study|Lost to Follow-up|9|||
150172567|NCT02314117|541768012|FG001|Overall Study|Lost to Follow-up|14|||
149954251|NCT00835978|540964598|FG003|Overall Study|Study terminated by sponsor|0|||
149954252|NCT01105130|540964599|FG000|Overall Study|Withdrawal by Subject|4|||
149954253|NCT01105130|540964600|FG001|Overall Study|Withdrawal by Subject|6|||
149954254|NCT01105130|540964601|FG002|Overall Study|Withdrawal by Subject|2|||
149954255|NCT01105130|540964599|FG000|Overall Study|Never Started|2|||
149954256|NCT01105130|540964600|FG001|Overall Study|Never Started|2|||
149954257|NCT01105130|540964601|FG002|Overall Study|Never Started|4|||
149954258|NCT01105130|540964599|FG000|Overall Study|Toxicity|1|||
150286772|NCT00267748|542185466|FG000|Non-randomized Period|Death|1|||
149954259|NCT01105130|540964600|FG001|Overall Study|Toxicity|3|||
149954260|NCT01105130|540964601|FG002|Overall Study|Toxicity|2|||
149954261|NCT01105130|540964599|FG000|Overall Study|Multiple Reasons|3|||
149954262|NCT01105130|540964600|FG001|Overall Study|Multiple Reasons|0|||
149954263|NCT01105130|540964601|FG002|Overall Study|Multiple Reasons|2|||
150286773|NCT00267748|542185467|FG001|Non-randomized Period|Death|0|||
149954264|NCT01002105|540964602|FG000|Overall Study|Lost to Follow-up|10|||
149954265|NCT01002105|540964603|FG001|Overall Study|Lost to Follow-up|16|||
149954266|NCT01002105|540964602|FG000|Overall Study|non compliance|5|||
149954267|NCT01002105|540964603|FG001|Overall Study|non compliance|3|||
149843544|NCT03674892|540558673|FG000|Overall Study|Sinus Infection|1|||
149843545|NCT05099380|540558674|FG000|Overall Study|Subject enrolled in error|1|||
149843546|NCT05099380|540558675|FG001|Overall Study|Subject enrolled in error|0|||
149843547|NCT05099380|540558674|FG000|Overall Study|Study Procedure|1|||
149843548|NCT05099380|540558675|FG001|Overall Study|Study Procedure|0|||
149843549|NCT05099380|540558674|FG000|Overall Study|Protocol Violation|1|||
149843550|NCT05099380|540558675|FG001|Overall Study|Protocol Violation|0|||
149843551|NCT05099380|540558674|FG000|Overall Study|Adverse Event|1|||
149843552|NCT05099380|540558675|FG001|Overall Study|Adverse Event|1|||
149843553|NCT05099380|540558674|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
149843554|NCT05099380|540558675|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
149843555|NCT01959672|540558681|FG000|Overall Study|Death|1|||
149843556|NCT02392195|540558682|FG000|Overall Study|Lost to Follow-up|4|||
149843557|NCT02392195|540558682|FG000|Overall Study|Withdrawal by Subject|4|||
149843558|NCT00545792|540558685|FG000|Overall Study|Withdrawal by Subject|1|||
149843559|NCT02842853|540558687|FG000|Overall Study|Non-compliance with the protocol|3|||
149843560|NCT02842853|540558688|FG001|Overall Study|Non-compliance with the protocol|7|||
149843561|NCT02842853|540558689|FG002|Overall Study|Non-compliance with the protocol|2|||
149843562|NCT02842853|540558690|FG003|Overall Study|Non-compliance with the protocol|5|||
149843563|NCT02842853|540558687|FG000|Overall Study|Subject met exclusion criteria|0|||
149843564|NCT02842853|540558688|FG001|Overall Study|Subject met exclusion criteria|1|||
149843565|NCT02842853|540558689|FG002|Overall Study|Subject met exclusion criteria|0|||
149843566|NCT02842853|540558690|FG003|Overall Study|Subject met exclusion criteria|0|||
149843567|NCT02842853|540558687|FG000|Overall Study|Withdrawal by Subject|11|||
149843568|NCT02842853|540558688|FG001|Overall Study|Withdrawal by Subject|13|||
149843569|NCT02842853|540558689|FG002|Overall Study|Withdrawal by Subject|9|||
149843570|NCT02842853|540558690|FG003|Overall Study|Withdrawal by Subject|8|||
149843571|NCT02842853|540558687|FG000|Overall Study|Lost to Follow-up|9|||
149843572|NCT02842853|540558688|FG001|Overall Study|Lost to Follow-up|13|||
149843573|NCT02842853|540558689|FG002|Overall Study|Lost to Follow-up|10|||
149843574|NCT02842853|540558690|FG003|Overall Study|Lost to Follow-up|11|||
149843575|NCT04089553|540558691|FG000|Overall Study|Death|1|||
149843576|NCT04089553|540558692|FG001|Overall Study|Death|1|||
149843577|NCT04089553|540558691|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
149843578|NCT04089553|540558692|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
149843579|NCT04089553|540558691|FG000|Overall Study|Withdrawal by Subject|3|||
149843580|NCT04089553|540558692|FG001|Overall Study|Withdrawal by Subject|3|||
149843581|NCT04089553|540558691|FG000|Overall Study|Physician Decision|1|||
149843582|NCT04089553|540558692|FG001|Overall Study|Physician Decision|0|||
149954268|NCT01002105|540964602|FG000|Overall Study|condition worsened|4|||
149954269|NCT01002105|540964603|FG001|Overall Study|condition worsened|2|||
149954270|NCT01363440|540964605|FG000|Overall Study|Adverse Event|5|||
149954271|NCT01363440|540964606|FG001|Overall Study|Adverse Event|4|||
149954272|NCT01363440|540964607|FG002|Overall Study|Adverse Event|4|||
149954273|NCT01363440|540964605|FG000|Overall Study|Death|3|||
149954274|NCT01363440|540964606|FG001|Overall Study|Death|7|||
149954275|NCT01363440|540964607|FG002|Overall Study|Death|5|||
149954276|NCT01363440|540964605|FG000|Overall Study|Withdrawal by Subject|9|||
149954277|NCT01363440|540964606|FG001|Overall Study|Withdrawal by Subject|11|||
149954278|NCT01363440|540964607|FG002|Overall Study|Withdrawal by Subject|11|||
149954279|NCT01363440|540964605|FG000|Overall Study|Lost to Follow-up|2|||
149954280|NCT01363440|540964606|FG001|Overall Study|Lost to Follow-up|4|||
149954281|NCT01363440|540964607|FG002|Overall Study|Lost to Follow-up|5|||
149954282|NCT01363440|540964605|FG000|Overall Study|Other|4|||
149954283|NCT01363440|540964606|FG001|Overall Study|Other|5|||
149954284|NCT01363440|540964607|FG002|Overall Study|Other|2|||
149954285|NCT03695094|540964608|FG000|Overall Study|Adverse Event|1|||
149954286|NCT03695094|540964609|FG001|Overall Study|Adverse Event|1|||
149954287|NCT03695094|540964608|FG000|Overall Study|Withdrawal by Subject|1|||
149954288|NCT03695094|540964609|FG001|Overall Study|Withdrawal by Subject|0|||
149954289|NCT01166945|540964610|FG000|Randomized|diagnosed with Group A strep|4|||
149843583|NCT04089553|540558691|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
149954290|NCT01166945|540964611|FG001|Randomized|diagnosed with Group A strep|4|||
149954291|NCT01166945|540964610|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
149954292|NCT01166945|540964611|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
149954293|NCT01166945|540964610|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
149954294|NCT01166945|540964611|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
149954295|NCT01166945|540964610|FG000|Day 30|Lost to Follow-up|4|||
149954296|NCT01166945|540964611|FG001|Day 30|Lost to Follow-up|3|||
149954297|NCT00552058|540964615|FG000|Overall Study|Adverse Event|8|||
149843584|NCT04089553|540558692|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
149843585|NCT04089553|540558691|FG000|Overall Study|Other|1|||
149843586|NCT04089553|540558692|FG001|Overall Study|Other|0|||
149843587|NCT04089553|540558691|FG000|Overall Study|Adverse Event|1|||
149843588|NCT04089553|540558692|FG001|Overall Study|Adverse Event|1|||
149843589|NCT01175135|540558700|FG000|Overall Study|Adverse Event|2|||
149843590|NCT01175135|540558701|FG001|Overall Study|Adverse Event|5|||
149843591|NCT01175135|540558702|FG002|Overall Study|Adverse Event|3|||
150286774|NCT00267748|542185468|FG002|Non-randomized Period|Death|0|||
150286775|NCT00267748|542185466|FG000|Non-randomized Period|Participant not willing to participate|1|||
150286776|NCT00267748|542185467|FG001|Non-randomized Period|Participant not willing to participate|0|||
150286777|NCT00267748|542185468|FG002|Non-randomized Period|Participant not willing to participate|0|||
150286778|NCT00267748|542185466|FG000|Non-randomized Period|Other|3|||
150286779|NCT00267748|542185467|FG001|Non-randomized Period|Other|0|||
150286780|NCT00267748|542185468|FG002|Non-randomized Period|Other|0|||
150286781|NCT00267748|542185466|FG000|Randomized Period|Death|0|||
150286782|NCT00267748|542185467|FG001|Randomized Period|Death|2|||
150286783|NCT00267748|542185468|FG002|Randomized Period|Death|3|||
150286784|NCT00267748|542185466|FG000|Randomized Period|Adverse Event|0|||
150286785|NCT00267748|542185467|FG001|Randomized Period|Adverse Event|23|||
150286786|NCT00267748|542185468|FG002|Randomized Period|Adverse Event|25|||
150286787|NCT00267748|542185466|FG000|Randomized Period|Global deterioration of health status|0|||
150286788|NCT00267748|542185467|FG001|Randomized Period|Global deterioration of health status|6|||
150286789|NCT00267748|542185468|FG002|Randomized Period|Global deterioration of health status|7|||
150286790|NCT00267748|542185466|FG000|Randomized Period|Lost to Follow-up|0|||
150286791|NCT00267748|542185467|FG001|Randomized Period|Lost to Follow-up|1|||
150286792|NCT00267748|542185468|FG002|Randomized Period|Lost to Follow-up|0|||
150286793|NCT00267748|542185466|FG000|Randomized Period|Objective progression or relapse|0|||
150286794|NCT00267748|542185467|FG001|Randomized Period|Objective progression or relapse|77|||
150286795|NCT00267748|542185468|FG002|Randomized Period|Objective progression or relapse|86|||
150286796|NCT00267748|542185466|FG000|Randomized Period|Withdrawal by Subject|0|||
150286797|NCT00267748|542185467|FG001|Randomized Period|Withdrawal by Subject|9|||
150286798|NCT00267748|542185468|FG002|Randomized Period|Withdrawal by Subject|2|||
150286799|NCT00267748|542185466|FG000|Randomized Period|Other|0|||
150286800|NCT00267748|542185467|FG001|Randomized Period|Other|9|||
150286801|NCT00267748|542185468|FG002|Randomized Period|Other|6|||
150286802|NCT00267748|542185466|FG000|Randomized Period|randomized but not treated|0|||
150286803|NCT00267748|542185467|FG001|Randomized Period|randomized but not treated|0|||
150286804|NCT00267748|542185468|FG002|Randomized Period|randomized but not treated|3|||
150286805|NCT00464334|542185473|FG000|Overall Study|Adverse Event|0|||
150286806|NCT00464334|542185474|FG001|Overall Study|Adverse Event|0|||
150286807|NCT00464334|542185475|FG002|Overall Study|Adverse Event|0|||
150286808|NCT00464334|542185476|FG003|Overall Study|Adverse Event|1|||
150286809|NCT00464334|542185477|FG004|Overall Study|Adverse Event|1|||
150286810|NCT00464334|542185478|FG005|Overall Study|Adverse Event|1|||
150286811|NCT00464334|542185479|FG006|Overall Study|Adverse Event|0|||
150286812|NCT00464334|542185480|FG007|Overall Study|Adverse Event|0|||
150286813|NCT00464334|542185481|FG008|Overall Study|Adverse Event|2|||
150286814|NCT00464334|542185482|FG009|Overall Study|Adverse Event|1|||
150286815|NCT00464334|542185483|FG010|Overall Study|Adverse Event|2|||
150286816|NCT00464334|542185473|FG000|Overall Study|Lack of Efficacy|0|||
150286817|NCT00464334|542185474|FG001|Overall Study|Lack of Efficacy|1|||
150286818|NCT00464334|542185475|FG002|Overall Study|Lack of Efficacy|0|||
150286819|NCT00464334|542185476|FG003|Overall Study|Lack of Efficacy|0|||
150286820|NCT00464334|542185477|FG004|Overall Study|Lack of Efficacy|0|||
150286821|NCT00464334|542185478|FG005|Overall Study|Lack of Efficacy|0|||
150286822|NCT00464334|542185479|FG006|Overall Study|Lack of Efficacy|0|||
150286823|NCT00464334|542185480|FG007|Overall Study|Lack of Efficacy|0|||
150286824|NCT00464334|542185481|FG008|Overall Study|Lack of Efficacy|0|||
150286825|NCT00464334|542185482|FG009|Overall Study|Lack of Efficacy|0|||
150286826|NCT00464334|542185483|FG010|Overall Study|Lack of Efficacy|0|||
150286827|NCT00464334|542185473|FG000|Overall Study|Lost to Follow-up|0|||
150286828|NCT00464334|542185474|FG001|Overall Study|Lost to Follow-up|0|||
150286829|NCT00464334|542185475|FG002|Overall Study|Lost to Follow-up|1|||
150286830|NCT00464334|542185476|FG003|Overall Study|Lost to Follow-up|0|||
150286831|NCT00464334|542185477|FG004|Overall Study|Lost to Follow-up|1|||
150286832|NCT00464334|542185478|FG005|Overall Study|Lost to Follow-up|0|||
150286833|NCT00464334|542185479|FG006|Overall Study|Lost to Follow-up|1|||
150286834|NCT00464334|542185480|FG007|Overall Study|Lost to Follow-up|0|||
150286835|NCT00464334|542185481|FG008|Overall Study|Lost to Follow-up|0|||
150286836|NCT00464334|542185482|FG009|Overall Study|Lost to Follow-up|0|||
150286837|NCT00464334|542185483|FG010|Overall Study|Lost to Follow-up|2|||
150286838|NCT00464334|542185473|FG000|Overall Study|Progressive Disease|0|||
150286839|NCT00464334|542185474|FG001|Overall Study|Progressive Disease|0|||
150286840|NCT00464334|542185475|FG002|Overall Study|Progressive Disease|0|||
150286841|NCT00464334|542185476|FG003|Overall Study|Progressive Disease|0|||
150286842|NCT00464334|542185477|FG004|Overall Study|Progressive Disease|0|||
150286843|NCT00464334|542185478|FG005|Overall Study|Progressive Disease|1|||
150286844|NCT00464334|542185479|FG006|Overall Study|Progressive Disease|0|||
150286845|NCT00464334|542185480|FG007|Overall Study|Progressive Disease|0|||
150286846|NCT00464334|542185481|FG008|Overall Study|Progressive Disease|1|||
150286847|NCT00464334|542185482|FG009|Overall Study|Progressive Disease|0|||
150286848|NCT00464334|542185483|FG010|Overall Study|Progressive Disease|0|||
150286849|NCT00464334|542185473|FG000|Overall Study|Study Terminated by Sponsor|0|||
150286850|NCT00464334|542185474|FG001|Overall Study|Study Terminated by Sponsor|0|||
150286851|NCT00464334|542185475|FG002|Overall Study|Study Terminated by Sponsor|0|||
150286852|NCT00464334|542185476|FG003|Overall Study|Study Terminated by Sponsor|1|||
150286853|NCT00464334|542185477|FG004|Overall Study|Study Terminated by Sponsor|0|||
150286854|NCT00464334|542185478|FG005|Overall Study|Study Terminated by Sponsor|0|||
150286855|NCT00464334|542185479|FG006|Overall Study|Study Terminated by Sponsor|0|||
150286856|NCT00464334|542185480|FG007|Overall Study|Study Terminated by Sponsor|0|||
150286857|NCT00464334|542185481|FG008|Overall Study|Study Terminated by Sponsor|0|||
150286858|NCT00464334|542185482|FG009|Overall Study|Study Terminated by Sponsor|0|||
150286859|NCT00464334|542185483|FG010|Overall Study|Study Terminated by Sponsor|0|||
150286860|NCT00464334|542185473|FG000|Overall Study|Withdrawal by Subject|1|||
150286861|NCT00464334|542185474|FG001|Overall Study|Withdrawal by Subject|7|||
150286862|NCT00464334|542185475|FG002|Overall Study|Withdrawal by Subject|4|||
150286863|NCT00464334|542185476|FG003|Overall Study|Withdrawal by Subject|2|||
150286864|NCT00464334|542185477|FG004|Overall Study|Withdrawal by Subject|2|||
150286865|NCT00464334|542185478|FG005|Overall Study|Withdrawal by Subject|2|||
150286866|NCT00464334|542185479|FG006|Overall Study|Withdrawal by Subject|2|||
150286867|NCT00464334|542185480|FG007|Overall Study|Withdrawal by Subject|1|||
150286868|NCT00464334|542185481|FG008|Overall Study|Withdrawal by Subject|3|||
150286869|NCT00464334|542185482|FG009|Overall Study|Withdrawal by Subject|0|||
150286870|NCT00464334|542185483|FG010|Overall Study|Withdrawal by Subject|0|||
149954298|NCT00552058|540964616|FG001|Overall Study|Adverse Event|7|||
150286871|NCT03948178|542185484|FG000|Overall Study|Protocol Violation|1|||
150286872|NCT03948178|542185484|FG000|Overall Study|Lost to Follow-up|2|||
150286873|NCT03948178|542185484|FG000|Overall Study|Withdrawal by Subject|2|||
150286874|NCT03948178|542185484|FG000|Overall Study|Reason not known|2|||
150286875|NCT03948178|542185484|FG000|Overall Study|Personal reason|14|||
150286876|NCT03948178|542185484|FG000|Overall Study|Disease progression|30|||
150286877|NCT03948178|542185484|FG000|Overall Study|Adverse Event|12|||
150286878|NCT03948178|542185484|FG000|Overall Study|Sponsor terminated study|164|||
150286879|NCT02898259|542185485|FG000|Overall Study|Adverse Event|0|||
150286880|NCT02898259|542185486|FG001|Overall Study|Adverse Event|0|||
150286881|NCT02898259|542185487|FG002|Overall Study|Adverse Event|1|||
150286882|NCT02898259|542185488|FG003|Overall Study|Adverse Event|0|||
150286883|NCT02898259|542185489|FG004|Overall Study|Adverse Event|0|||
150286884|NCT02898259|542185485|FG000|Overall Study|Lack of Efficacy|1|||
150286885|NCT02898259|542185486|FG001|Overall Study|Lack of Efficacy|1|||
150286886|NCT02898259|542185487|FG002|Overall Study|Lack of Efficacy|3|||
150286887|NCT02898259|542185488|FG003|Overall Study|Lack of Efficacy|0|||
150286888|NCT02898259|542185489|FG004|Overall Study|Lack of Efficacy|0|||
150286889|NCT02898259|542185485|FG000|Overall Study|Lost to Follow-up|0|||
150286890|NCT02898259|542185486|FG001|Overall Study|Lost to Follow-up|0|||
150286891|NCT02898259|542185487|FG002|Overall Study|Lost to Follow-up|1|||
150286892|NCT02898259|542185488|FG003|Overall Study|Lost to Follow-up|0|||
150286893|NCT02898259|542185489|FG004|Overall Study|Lost to Follow-up|0|||
149954299|NCT00552058|540964615|FG000|Overall Study|Lack of Efficacy|1|||
150286894|NCT02898259|542185485|FG000|Overall Study|Transformation before study began|0|||
150286895|NCT02898259|542185486|FG001|Overall Study|Transformation before study began|0|||
150286896|NCT02898259|542185487|FG002|Overall Study|Transformation before study began|0|||
150286897|NCT02898259|542185488|FG003|Overall Study|Transformation before study began|1|||
150286898|NCT02898259|542185489|FG004|Overall Study|Transformation before study began|0|||
150286899|NCT03016325|542185496|FG000|Treatment Period|Participant withdrew consent|0|||
150286900|NCT03016325|542185497|FG001|Treatment Period|Participant withdrew consent|1|||
150286901|NCT03016325|542185498|FG002|Treatment Period|Participant withdrew consent|0|||
150286902|NCT03016325|542185499|FG003|Treatment Period|Participant withdrew consent|0|||
150286903|NCT03016325|542185500|FG004|Treatment Period|Participant withdrew consent|0|||
150286904|NCT03016325|542185501|FG005|Treatment Period|Participant withdrew consent|0|||
150286905|NCT03016325|542185502|FG006|Treatment Period|Participant withdrew consent|0|||
150286906|NCT03016325|542185503|FG007|Treatment Period|Participant withdrew consent|0|||
150286907|NCT03016325|542185496|FG000|Treatment Period|Death|0|||
150286908|NCT03016325|542185497|FG001|Treatment Period|Death|0|||
150286909|NCT03016325|542185498|FG002|Treatment Period|Death|0|||
150286910|NCT03016325|542185499|FG003|Treatment Period|Death|0|||
149954300|NCT00552058|540964616|FG001|Overall Study|Lack of Efficacy|5|||
149954301|NCT00552058|540964615|FG000|Overall Study|Lost to Follow-up|1|||
149954302|NCT00552058|540964616|FG001|Overall Study|Lost to Follow-up|0|||
150286911|NCT03016325|542185500|FG004|Treatment Period|Death|2|||
150286912|NCT03016325|542185501|FG005|Treatment Period|Death|0|||
150286913|NCT03016325|542185502|FG006|Treatment Period|Death|0|||
150286914|NCT03016325|542185503|FG007|Treatment Period|Death|0|||
150286915|NCT03016325|542185496|FG000|Treatment Period|Participant refuses assessments|0|||
150286916|NCT03016325|542185497|FG001|Treatment Period|Participant refuses assessments|0|||
150286917|NCT03016325|542185498|FG002|Treatment Period|Participant refuses assessments|1|||
150286918|NCT03016325|542185499|FG003|Treatment Period|Participant refuses assessments|0|||
150286919|NCT03016325|542185500|FG004|Treatment Period|Participant refuses assessments|0|||
150286920|NCT03016325|542185501|FG005|Treatment Period|Participant refuses assessments|0|||
150286921|NCT03016325|542185502|FG006|Treatment Period|Participant refuses assessments|0|||
150286922|NCT03016325|542185503|FG007|Treatment Period|Participant refuses assessments|0|||
150286923|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Death|2|||
149843592|NCT01175135|540558703|FG003|Overall Study|Adverse Event|4|||
149843593|NCT01175135|540558700|FG000|Overall Study|Death|1|||
149843594|NCT01175135|540558701|FG001|Overall Study|Death|0|||
149843595|NCT01175135|540558702|FG002|Overall Study|Death|0|||
149843596|NCT01175135|540558703|FG003|Overall Study|Death|0|||
149843597|NCT01175135|540558700|FG000|Overall Study|Lack of Efficacy|4|||
149843598|NCT01175135|540558701|FG001|Overall Study|Lack of Efficacy|5|||
149843599|NCT01175135|540558702|FG002|Overall Study|Lack of Efficacy|0|||
149843600|NCT01175135|540558703|FG003|Overall Study|Lack of Efficacy|5|||
149843601|NCT01175135|540558700|FG000|Overall Study|Lost to Follow-up|1|||
149843602|NCT01175135|540558701|FG001|Overall Study|Lost to Follow-up|2|||
149843603|NCT01175135|540558702|FG002|Overall Study|Lost to Follow-up|0|||
149843604|NCT01175135|540558703|FG003|Overall Study|Lost to Follow-up|0|||
149843605|NCT01175135|540558700|FG000|Overall Study|Protocol Violation|1|||
149843606|NCT01175135|540558701|FG001|Overall Study|Protocol Violation|1|||
149843607|NCT01175135|540558702|FG002|Overall Study|Protocol Violation|0|||
149843608|NCT01175135|540558703|FG003|Overall Study|Protocol Violation|0|||
149843609|NCT01175135|540558700|FG000|Overall Study|Withdrawal by Subject|4|||
149843610|NCT01175135|540558701|FG001|Overall Study|Withdrawal by Subject|8|||
149843611|NCT01175135|540558702|FG002|Overall Study|Withdrawal by Subject|5|||
150286924|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Death|0|||
150286925|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Death|5|||
150286926|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Death|6|||
150286927|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Death|3|||
150286928|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Death|0|||
150286929|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Death|0|||
150286930|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Death|0|||
150286931|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
150286932|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
150286933|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
150286934|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
150286935|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
150286936|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
150286937|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
150286938|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
150286939|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
150286940|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
150286941|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
150286942|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
150286943|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
150286944|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
150286945|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
150286946|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
150286947|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
150286948|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
150286949|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
150286950|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
150286951|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
150286952|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
150286953|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
150286954|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
150286955|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286956|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286957|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286958|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286959|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
150286960|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286961|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
150286962|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
150286963|NCT03016325|542185496|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286964|NCT03016325|542185497|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286965|NCT03016325|542185498|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
150286966|NCT03016325|542185499|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286967|NCT03016325|542185500|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286968|NCT03016325|542185501|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286969|NCT03016325|542185502|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286970|NCT03016325|542185503|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
150286971|NCT03016325|542185496|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149843612|NCT01175135|540558703|FG003|Overall Study|Withdrawal by Subject|5|||
149843613|NCT01175135|540558700|FG000|Overall Study|Other|3|||
149843614|NCT01175135|540558701|FG001|Overall Study|Other|1|||
149843615|NCT01175135|540558702|FG002|Overall Study|Other|3|||
149843616|NCT01175135|540558703|FG003|Overall Study|Other|0|||
149843617|NCT01175135|540558700|FG000|Overall Study|Randomized But Not Treated|0|||
149843618|NCT01175135|540558701|FG001|Overall Study|Randomized But Not Treated|0|||
149843619|NCT01175135|540558702|FG002|Overall Study|Randomized But Not Treated|1|||
149843620|NCT01175135|540558703|FG003|Overall Study|Randomized But Not Treated|0|||
149843621|NCT03364192|540558704|FG000|Overall Study|Ineligible|10|||
149843622|NCT03364192|540558704|FG000|Overall Study|Withdrawal by Subject|5|||
149843623|NCT03364192|540558704|FG000|Overall Study|Lost to Follow-up|1|||
149843624|NCT04692155|540558705|FG000|Overall Study|Death|1|||
149843625|NCT02699463|540558706|FG000|Overall Study|Lost to Follow-up|11|||
149843626|NCT02699463|540558707|FG001|Overall Study|Lost to Follow-up|8|||
149843627|NCT02699463|540558706|FG000|Overall Study|Withdrawal by Subject|4|||
149843628|NCT02699463|540558707|FG001|Overall Study|Withdrawal by Subject|1|||
149843629|NCT02488239|540558710|FG000|Overall Study|Death|3|||
149843630|NCT02488239|540558710|FG000|Overall Study|Withdrawal by Subject|3|||
149843631|NCT02488239|540558710|FG000|Overall Study|Physician Decision|2|||
149843632|NCT02488239|540558710|FG000|Overall Study|Consent ineligible|1|||
149843633|NCT02488239|540558710|FG000|Overall Study|Did not undergo implant procedure|1|||
149843634|NCT01370733|540558713|FG000|Overall Study|Withdrawal by Subject|8|||
149843635|NCT01370733|540558714|FG001|Overall Study|Withdrawal by Subject|8|||
149843636|NCT01370733|540558713|FG000|Overall Study|Lost to Follow-up|3|||
149843637|NCT01370733|540558714|FG001|Overall Study|Lost to Follow-up|0|||
149843638|NCT01370733|540558713|FG000|Overall Study|Adverse Event|2|||
149843639|NCT01370733|540558714|FG001|Overall Study|Adverse Event|4|||
149843640|NCT01370733|540558713|FG000|Overall Study|Lack of Efficacy|3|||
149843641|NCT01370733|540558714|FG001|Overall Study|Lack of Efficacy|5|||
149843642|NCT01370733|540558713|FG000|Overall Study|Physician Decision|0|||
149843643|NCT01370733|540558714|FG001|Overall Study|Physician Decision|2|||
149843644|NCT01370733|540558713|FG000|Overall Study|Protocol Violation|1|||
149843645|NCT01370733|540558714|FG001|Overall Study|Protocol Violation|3|||
149843646|NCT02294981|540558715|FG000|Overall Study|Lost to Follow-up|1|||
149843647|NCT00909753|540558717|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
149843648|NCT00909753|540558718|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
149843649|NCT00909753|540558717|FG000|Period: Second Intervention|Protocol Violation|1|||
149843650|NCT00909753|540558718|FG001|Period: Second Intervention|Protocol Violation|0|||
149843651|NCT04345653|540558719|FG000|Overall Study|Withdrawal by Subject|2|||
149843652|NCT03214588|540558720|FG000|Overall Study|Adverse Event|1|||
149843653|NCT03214588|540558721|FG001|Overall Study|Adverse Event|0|||
149843654|NCT03214588|540558722|FG002|Overall Study|Adverse Event|2|||
149843655|NCT03214588|540558720|FG000|Overall Study|Reason Not Specified|0|||
149843656|NCT03214588|540558721|FG001|Overall Study|Reason Not Specified|1|||
149843657|NCT03214588|540558722|FG002|Overall Study|Reason Not Specified|0|||
149843658|NCT01647828|540558727|FG000|Overall Study|Death|3|||
149843659|NCT01647828|540558728|FG001|Overall Study|Death|4|||
149843660|NCT01647828|540558729|FG002|Overall Study|Death|4|||
149843661|NCT01647828|540558730|FG003|Overall Study|Death|5|||
149843662|NCT01647828|540558731|FG004|Overall Study|Death|6|||
149843663|NCT01647828|540558732|FG005|Overall Study|Death|3|||
149843664|NCT01647828|540558733|FG006|Overall Study|Death|10|||
149843665|NCT01647828|540558734|FG007|Overall Study|Death|60|||
149843666|NCT01647828|540558735|FG008|Overall Study|Death|71|||
149843667|NCT01647828|540558727|FG000|Overall Study|Withdrawal by Subject|2|||
149843668|NCT01647828|540558728|FG001|Overall Study|Withdrawal by Subject|0|||
149843669|NCT01647828|540558729|FG002|Overall Study|Withdrawal by Subject|0|||
149843670|NCT01647828|540558730|FG003|Overall Study|Withdrawal by Subject|1|||
149843671|NCT01647828|540558731|FG004|Overall Study|Withdrawal by Subject|0|||
149843672|NCT01647828|540558732|FG005|Overall Study|Withdrawal by Subject|0|||
149843673|NCT01647828|540558733|FG006|Overall Study|Withdrawal by Subject|1|||
149843674|NCT01647828|540558734|FG007|Overall Study|Withdrawal by Subject|0|||
149843675|NCT01647828|540558735|FG008|Overall Study|Withdrawal by Subject|2|||
149843676|NCT01647828|540558727|FG000|Overall Study|Study terminated by Sponsor|0|||
149843677|NCT01647828|540558728|FG001|Overall Study|Study terminated by Sponsor|0|||
149843678|NCT01647828|540558729|FG002|Overall Study|Study terminated by Sponsor|0|||
149843679|NCT01647828|540558730|FG003|Overall Study|Study terminated by Sponsor|0|||
149843680|NCT01647828|540558731|FG004|Overall Study|Study terminated by Sponsor|0|||
149843681|NCT01647828|540558732|FG005|Overall Study|Study terminated by Sponsor|0|||
149843682|NCT01647828|540558733|FG006|Overall Study|Study terminated by Sponsor|1|||
149843683|NCT01647828|540558734|FG007|Overall Study|Study terminated by Sponsor|26|||
149843684|NCT01647828|540558735|FG008|Overall Study|Study terminated by Sponsor|16|||
149843685|NCT01647828|540558727|FG000|Overall Study|Lost to Follow-up|0|||
149843686|NCT01647828|540558728|FG001|Overall Study|Lost to Follow-up|0|||
149954303|NCT00552058|540964615|FG000|Overall Study|Withdrawal by Subject|4|||
149843687|NCT01647828|540558729|FG002|Overall Study|Lost to Follow-up|0|||
149843688|NCT01647828|540558730|FG003|Overall Study|Lost to Follow-up|0|||
149843689|NCT01647828|540558731|FG004|Overall Study|Lost to Follow-up|0|||
149843690|NCT01647828|540558732|FG005|Overall Study|Lost to Follow-up|0|||
149843691|NCT01647828|540558733|FG006|Overall Study|Lost to Follow-up|0|||
149843692|NCT01647828|540558734|FG007|Overall Study|Lost to Follow-up|2|||
149843693|NCT01647828|540558735|FG008|Overall Study|Lost to Follow-up|0|||
150286972|NCT03016325|542185497|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
150286973|NCT03016325|542185498|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286974|NCT03016325|542185499|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286975|NCT03016325|542185500|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286976|NCT03016325|542185501|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286977|NCT03016325|542185502|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286978|NCT03016325|542185503|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
150286979|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Death|3|||
150286980|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Death|3|||
150286981|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Death|11|||
150286982|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Death|12|||
150286983|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Death|9|||
150286984|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Death|0|||
150286985|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Death|0|||
150286986|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Death|1|||
150286987|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
150286988|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286989|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149843694|NCT00418938|540558736|FG000|Overall Study|Reimbursement|1|||
149843695|NCT00418938|540558737|FG001|Overall Study|Reimbursement|0|||
149843696|NCT00418938|540558736|FG000|Overall Study|Administrative decision|3|||
149843697|NCT00418938|540558737|FG001|Overall Study|Administrative decision|3|||
149843698|NCT00418938|540558736|FG000|Overall Study|Withdrawal by Subject|16|||
149843699|NCT00418938|540558737|FG001|Overall Study|Withdrawal by Subject|15|||
149843700|NCT00418938|540558736|FG000|Overall Study|Lost to Follow-up|1|||
149843701|NCT00418938|540558737|FG001|Overall Study|Lost to Follow-up|3|||
149843702|NCT00418938|540558736|FG000|Overall Study|Adverse Event|1|||
149843703|NCT00418938|540558737|FG001|Overall Study|Adverse Event|1|||
149843704|NCT00418938|540558736|FG000|Overall Study|On-going|1|||
149843705|NCT00418938|540558737|FG001|Overall Study|On-going|1|||
149843706|NCT00418938|540558736|FG000|Overall Study|Ineligibility Determined|1|||
149843707|NCT00418938|540558737|FG001|Overall Study|Ineligibility Determined|0|||
149843708|NCT00115063|540558740|FG000|Overall Study|Lost to Follow-up|98|||
149843709|NCT00115063|540558741|FG001|Overall Study|Lost to Follow-up|104|||
149843710|NCT00115063|540558740|FG000|Overall Study|Death|1|||
149843711|NCT00115063|540558741|FG001|Overall Study|Death|0|||
149843712|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
149843713|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
149843714|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
149843715|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
149843716|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
149843717|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
149843718|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Death|9|||
149843719|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Death|7|||
149843720|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Death|14|||
149843721|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Death|7|||
149843722|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Death|0|||
149954304|NCT00552058|540964616|FG001|Overall Study|Withdrawal by Subject|4|||
149954305|NCT00552058|540964615|FG000|Overall Study|Other: Protocol Violation|0|||
149954306|NCT00552058|540964616|FG001|Overall Study|Other: Protocol Violation|1|||
149954307|NCT00552058|540964615|FG000|Overall Study|Other: Non Compliance|1|||
149954308|NCT00552058|540964616|FG001|Overall Study|Other: Non Compliance|2|||
149954309|NCT00552058|540964615|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
149954310|NCT00552058|540964616|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
149954311|NCT00552058|540964615|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
150286990|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286991|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286992|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286993|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286994|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
150286995|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
149843723|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Death|0|||
149843724|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
149843725|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
149843726|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
149843727|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
149843728|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
149843729|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
149843730|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Other Event|49|||
149843731|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Other Event|52|||
149843732|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Other Event|41|||
149843733|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Other Event|58|||
149843734|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Other Event|0|||
149843735|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Other Event|0|||
149843736|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
149843737|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
149843738|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
149843739|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
149843740|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
149843741|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
149843742|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
150035788|NCT01921205|541271412|FG001|Overall Study|Adverse Event|7|||
150035789|NCT01921205|541271411|FG000|Overall Study|Lack of Efficacy|1|||
150035790|NCT01921205|541271412|FG001|Overall Study|Lack of Efficacy|0|||
150035791|NCT01921205|541271411|FG000|Overall Study|Protocol Violation|1|||
150035792|NCT01921205|541271412|FG001|Overall Study|Protocol Violation|3|||
150035793|NCT01921205|541271411|FG000|Overall Study|Lost to Follow-up|1|||
150035794|NCT01921205|541271412|FG001|Overall Study|Lost to Follow-up|1|||
150035795|NCT01921205|541271411|FG000|Overall Study|Withdrawal by Subject|6|||
150035796|NCT01921205|541271412|FG001|Overall Study|Withdrawal by Subject|5|||
150035797|NCT01921205|541271411|FG000|Overall Study|Use Of Prohibited Medication|0|||
150035798|NCT01921205|541271412|FG001|Overall Study|Use Of Prohibited Medication|1|||
150035799|NCT01921205|541271411|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
150035800|NCT01921205|541271412|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
149843743|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
149843744|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
149843745|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
149843746|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
149843747|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
149843748|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
149843749|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
149843750|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
149843751|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
149843752|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
149843753|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
149843754|NCT00205777|540558742|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
149843755|NCT00205777|540558743|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
149843756|NCT00205777|540558744|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
149843757|NCT00205777|540558745|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
149843758|NCT00205777|540558746|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
149843759|NCT00205777|540558747|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
149843760|NCT00205777|540558742|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
149843761|NCT00205777|540558743|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
149843762|NCT00205777|540558744|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
149843763|NCT00205777|540558745|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
149843764|NCT00205777|540558746|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
149843765|NCT00205777|540558747|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
149843766|NCT00205777|540558742|FG000|Completed Core Study, Entered SE I|Other Event|52|||
149843767|NCT00205777|540558743|FG001|Completed Core Study, Entered SE I|Other Event|46|||
149954312|NCT00552058|540964616|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
149954313|NCT00552058|540964615|FG000|Overall Study|Other: Positive Stool Result|0|||
149954314|NCT00552058|540964616|FG001|Overall Study|Other: Positive Stool Result|1|||
149954315|NCT00552058|540964615|FG000|Overall Study|Other: Randomized in error|0|||
149954316|NCT00552058|540964616|FG001|Overall Study|Other: Randomized in error|1|||
149954317|NCT00552058|540964615|FG000|Overall Study|Other: Sponsors Decision|0|||
149954318|NCT00552058|540964616|FG001|Overall Study|Other: Sponsors Decision|1|||
149954319|NCT00552058|540964615|FG000|Overall Study|Other: Early Roll Over|1|||
150035801|NCT01921205|541271411|FG000|Overall Study|Non Compliance Of The Parent|0|||
150035802|NCT01921205|541271412|FG001|Overall Study|Non Compliance Of The Parent|1|||
150035803|NCT01921205|541271411|FG000|Overall Study|Non Compliance Of Child|0|||
150035804|NCT01921205|541271412|FG001|Overall Study|Non Compliance Of Child|1|||
149843768|NCT00205777|540558744|FG002|Completed Core Study, Entered SE I|Other Event|47|||
149843769|NCT00205777|540558745|FG003|Completed Core Study, Entered SE I|Other Event|50|||
149954320|NCT00552058|540964616|FG001|Overall Study|Other: Early Roll Over|0|||
149954321|NCT03520569|540964617|FG000|Overall Study|Withdrawal by Subject|1|||
150286996|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
150286997|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
149843770|NCT00205777|540558746|FG004|Completed Core Study, Entered SE I|Other Event|0|||
149843771|NCT00205777|540558747|FG005|Completed Core Study, Entered SE I|Other Event|0|||
149843772|NCT00205777|540558742|FG000|Study Extension I|Adverse Event|57|||
149843773|NCT00205777|540558743|FG001|Study Extension I|Adverse Event|0|||
149843774|NCT00205777|540558744|FG002|Study Extension I|Adverse Event|0|||
149843775|NCT00205777|540558745|FG003|Study Extension I|Adverse Event|61|||
149843776|NCT00205777|540558746|FG004|Study Extension I|Adverse Event|58|||
149843777|NCT00205777|540558747|FG005|Study Extension I|Adverse Event|0|||
149843778|NCT00205777|540558742|FG000|Study Extension I|Death|5|||
149843779|NCT00205777|540558743|FG001|Study Extension I|Death|0|||
149954322|NCT02965716|540964620|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149954323|NCT02965716|540964621|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
149954324|NCT02965716|540964620|FG000|Overall Study|Progression/Relapse|8|||
149954325|NCT02965716|540964621|FG001|Overall Study|Progression/Relapse|16|||
149954326|NCT02965716|540964620|FG000|Overall Study|Death|1|||
149954327|NCT02965716|540964621|FG001|Overall Study|Death|0|||
149954328|NCT02965716|540964620|FG000|Overall Study|Not Protocol Specified|1|||
149954329|NCT02965716|540964621|FG001|Overall Study|Not Protocol Specified|3|||
149954330|NCT05558410|540964622|FG000|Overall Study|Adverse Event|1|||
149954331|NCT05558410|540964623|FG001|Overall Study|Adverse Event|2|||
149954332|NCT05558410|540964624|FG002|Overall Study|Adverse Event|0|||
149954333|NCT05558410|540964622|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
149954334|NCT05558410|540964623|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
149954335|NCT05558410|540964624|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
149954336|NCT05558410|540964622|FG000|Overall Study|Lost to Follow-up|10|||
149954337|NCT05558410|540964623|FG001|Overall Study|Lost to Follow-up|17|||
149954338|NCT05558410|540964624|FG002|Overall Study|Lost to Follow-up|19|||
149954339|NCT05558410|540964622|FG000|Overall Study|Death|1|||
149954340|NCT05558410|540964623|FG001|Overall Study|Death|0|||
149954341|NCT05558410|540964624|FG002|Overall Study|Death|0|||
149954342|NCT05558410|540964622|FG000|Overall Study|Other non-compliance|0|||
149954343|NCT05558410|540964623|FG001|Overall Study|Other non-compliance|1|||
149954344|NCT05558410|540964624|FG002|Overall Study|Other non-compliance|2|||
149954345|NCT05558410|540964622|FG000|Overall Study|Sponsor Decision|1|||
149954346|NCT05558410|540964623|FG001|Overall Study|Sponsor Decision|0|||
149954347|NCT05558410|540964624|FG002|Overall Study|Sponsor Decision|0|||
149954348|NCT05558410|540964622|FG000|Overall Study|Other|1|||
149954349|NCT05558410|540964623|FG001|Overall Study|Other|0|||
149954350|NCT05558410|540964624|FG002|Overall Study|Other|1|||
149954351|NCT02265744|540964627|FG000|Overall Study|Poor/Non-compliance|1|||
149954352|NCT02265744|540964628|FG001|Overall Study|Poor/Non-compliance|1|||
149954353|NCT02265744|540964629|FG002|Overall Study|Poor/Non-compliance|0|||
149954354|NCT02265744|540964630|FG003|Overall Study|Poor/Non-compliance|0|||
149954355|NCT02265744|540964631|FG004|Overall Study|Poor/Non-compliance|2|||
149954356|NCT02265744|540964627|FG000|Overall Study|Lost to Follow-up|0|||
149954357|NCT02265744|540964628|FG001|Overall Study|Lost to Follow-up|0|||
149954358|NCT02265744|540964629|FG002|Overall Study|Lost to Follow-up|0|||
149954359|NCT02265744|540964630|FG003|Overall Study|Lost to Follow-up|1|||
149954360|NCT02265744|540964631|FG004|Overall Study|Lost to Follow-up|0|||
149954361|NCT02265744|540964627|FG000|Overall Study|Death|0|||
149954362|NCT02265744|540964628|FG001|Overall Study|Death|0|||
149954363|NCT02265744|540964629|FG002|Overall Study|Death|0|||
149954364|NCT02265744|540964630|FG003|Overall Study|Death|2|||
149954365|NCT02265744|540964631|FG004|Overall Study|Death|0|||
149954366|NCT02265744|540964627|FG000|Overall Study|Withdrawal by Subject|2|||
149954367|NCT02265744|540964628|FG001|Overall Study|Withdrawal by Subject|0|||
150286998|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
150286999|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
150287000|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
149954368|NCT02265744|540964629|FG002|Overall Study|Withdrawal by Subject|0|||
149954369|NCT02265744|540964630|FG003|Overall Study|Withdrawal by Subject|2|||
149954370|NCT02265744|540964631|FG004|Overall Study|Withdrawal by Subject|0|||
149954371|NCT02265744|540964627|FG000|Overall Study|Participant request to discontinue|2|||
150287001|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
149843780|NCT00205777|540558744|FG002|Study Extension I|Death|0|||
149843781|NCT00205777|540558745|FG003|Study Extension I|Death|1|||
149843782|NCT00205777|540558746|FG004|Study Extension I|Death|2|||
149954372|NCT02265744|540964628|FG001|Overall Study|Participant request to discontinue|2|||
149954373|NCT02265744|540964629|FG002|Overall Study|Participant request to discontinue|2|||
149954374|NCT02265744|540964630|FG003|Overall Study|Participant request to discontinue|0|||
149954375|NCT02265744|540964631|FG004|Overall Study|Participant request to discontinue|0|||
149954376|NCT02265744|540964627|FG000|Overall Study|Adverse Event|8|||
149954377|NCT02265744|540964628|FG001|Overall Study|Adverse Event|4|||
150287002|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
149954378|NCT02265744|540964629|FG002|Overall Study|Adverse Event|9|||
149954379|NCT02265744|540964630|FG003|Overall Study|Adverse Event|8|||
149843783|NCT00205777|540558747|FG005|Study Extension I|Death|0|||
149843784|NCT00205777|540558742|FG000|Study Extension I|Withdrawal by Subject|99|||
149843785|NCT00205777|540558743|FG001|Study Extension I|Withdrawal by Subject|0|||
149843786|NCT00205777|540558744|FG002|Study Extension I|Withdrawal by Subject|0|||
149843787|NCT00205777|540558745|FG003|Study Extension I|Withdrawal by Subject|106|||
149843788|NCT00205777|540558746|FG004|Study Extension I|Withdrawal by Subject|89|||
149843789|NCT00205777|540558747|FG005|Study Extension I|Withdrawal by Subject|0|||
149843790|NCT00205777|540558742|FG000|Study Extension I|Protocol Violation|4|||
149843791|NCT00205777|540558743|FG001|Study Extension I|Protocol Violation|0|||
149843792|NCT00205777|540558744|FG002|Study Extension I|Protocol Violation|0|||
149843793|NCT00205777|540558745|FG003|Study Extension I|Protocol Violation|8|||
149843794|NCT00205777|540558746|FG004|Study Extension I|Protocol Violation|8|||
149843795|NCT00205777|540558747|FG005|Study Extension I|Protocol Violation|0|||
149843796|NCT00205777|540558742|FG000|Study Extension I|Lack of Efficacy|0|||
149843797|NCT00205777|540558743|FG001|Study Extension I|Lack of Efficacy|0|||
149843798|NCT00205777|540558744|FG002|Study Extension I|Lack of Efficacy|0|||
149843799|NCT00205777|540558745|FG003|Study Extension I|Lack of Efficacy|1|||
149843800|NCT00205777|540558746|FG004|Study Extension I|Lack of Efficacy|2|||
149843801|NCT00205777|540558747|FG005|Study Extension I|Lack of Efficacy|0|||
149954380|NCT02265744|540964631|FG004|Overall Study|Adverse Event|2|||
149954381|NCT02265744|540964627|FG000|Overall Study|Lack of Efficacy|2|||
149954382|NCT02265744|540964628|FG001|Overall Study|Lack of Efficacy|4|||
149954383|NCT02265744|540964629|FG002|Overall Study|Lack of Efficacy|3|||
149954384|NCT02265744|540964630|FG003|Overall Study|Lack of Efficacy|4|||
149954385|NCT02265744|540964631|FG004|Overall Study|Lack of Efficacy|5|||
149954386|NCT02265744|540964627|FG000|Overall Study|Reason not provided by Investigator|1|||
149954387|NCT02265744|540964628|FG001|Overall Study|Reason not provided by Investigator|0|||
149954388|NCT02265744|540964629|FG002|Overall Study|Reason not provided by Investigator|0|||
149954389|NCT02265744|540964630|FG003|Overall Study|Reason not provided by Investigator|2|||
149954390|NCT02265744|540964631|FG004|Overall Study|Reason not provided by Investigator|0|||
149954391|NCT02265744|540964627|FG000|Overall Study|Administrative reason by sponsor|3|||
149954392|NCT02265744|540964628|FG001|Overall Study|Administrative reason by sponsor|2|||
149954393|NCT02265744|540964629|FG002|Overall Study|Administrative reason by sponsor|2|||
149954394|NCT02265744|540964630|FG003|Overall Study|Administrative reason by sponsor|3|||
149954395|NCT02265744|540964631|FG004|Overall Study|Administrative reason by sponsor|3|||
149954396|NCT02265744|540964627|FG000|Overall Study|Subject no longer meets study criteria|0|||
149954397|NCT02265744|540964628|FG001|Overall Study|Subject no longer meets study criteria|0|||
149954398|NCT02265744|540964629|FG002|Overall Study|Subject no longer meets study criteria|0|||
149954399|NCT02265744|540964630|FG003|Overall Study|Subject no longer meets study criteria|0|||
149954400|NCT02265744|540964631|FG004|Overall Study|Subject no longer meets study criteria|1|||
149954401|NCT02265744|540964627|FG000|Overall Study|Pregnancy|1|||
149954402|NCT02265744|540964628|FG001|Overall Study|Pregnancy|2|||
149954403|NCT02265744|540964629|FG002|Overall Study|Pregnancy|1|||
149954404|NCT02265744|540964630|FG003|Overall Study|Pregnancy|1|||
149954405|NCT02265744|540964631|FG004|Overall Study|Pregnancy|0|||
149954406|NCT00923702|540964632|FG000|Overall Study|Ongoing enrollment|0|||
149954407|NCT00923702|540964633|FG001|Overall Study|Ongoing enrollment|0|||
149954408|NCT00923702|540964634|FG002|Overall Study|Ongoing enrollment|0|||
149954409|NCT00923702|540964635|FG003|Overall Study|Ongoing enrollment|0|||
149954410|NCT00923702|540964636|FG004|Overall Study|Ongoing enrollment|354|||
149954411|NCT05161936|540964637|FG000|Overall Study|Study terminated by Sponsor|1|||
149954412|NCT05161936|540964638|FG001|Overall Study|Study terminated by Sponsor|0|||
149954413|NCT05161936|540964639|FG002|Overall Study|Study terminated by Sponsor|0|||
149954414|NCT05161936|540964637|FG000|Overall Study|Withdrawal by Subject|0|||
149954415|NCT05161936|540964638|FG001|Overall Study|Withdrawal by Subject|0|||
149954416|NCT05161936|540964639|FG002|Overall Study|Withdrawal by Subject|1|||
149954417|NCT01158404|540964642|FG000|Overall Study|Withdrawal by Subject|0|||
149954418|NCT01158404|540964643|FG001|Overall Study|Withdrawal by Subject|1|||
149954419|NCT01158404|540964644|FG002|Overall Study|Withdrawal by Subject|0|||
149954420|NCT01158404|540964645|FG003|Overall Study|Withdrawal by Subject|0|||
149954421|NCT01158404|540964646|FG004|Overall Study|Withdrawal by Subject|3|||
149954422|NCT01158404|540964647|FG005|Overall Study|Withdrawal by Subject|1|||
149843802|NCT00205777|540558742|FG000|Study Extension I|Failed to return|15|||
149843803|NCT00205777|540558743|FG001|Study Extension I|Failed to return|0|||
149843804|NCT00205777|540558744|FG002|Study Extension I|Failed to return|0|||
149843805|NCT00205777|540558745|FG003|Study Extension I|Failed to return|17|||
149954423|NCT01158404|540964648|FG006|Overall Study|Withdrawal by Subject|0|||
149954424|NCT01158404|540964649|FG007|Overall Study|Withdrawal by Subject|1|||
149954425|NCT01158404|540964642|FG000|Overall Study|Physician Decision|0|||
149954426|NCT01158404|540964643|FG001|Overall Study|Physician Decision|0|||
149954427|NCT01158404|540964644|FG002|Overall Study|Physician Decision|0|||
149954428|NCT01158404|540964645|FG003|Overall Study|Physician Decision|0|||
149954429|NCT01158404|540964646|FG004|Overall Study|Physician Decision|0|||
149954430|NCT01158404|540964647|FG005|Overall Study|Physician Decision|0|||
149954431|NCT01158404|540964648|FG006|Overall Study|Physician Decision|0|||
149954432|NCT01158404|540964649|FG007|Overall Study|Physician Decision|1|||
149954433|NCT01158404|540964642|FG000|Overall Study|Progressive Disease|0|||
149954434|NCT01158404|540964643|FG001|Overall Study|Progressive Disease|0|||
149954435|NCT01158404|540964644|FG002|Overall Study|Progressive Disease|0|||
149954436|NCT01158404|540964645|FG003|Overall Study|Progressive Disease|0|||
149954437|NCT01158404|540964646|FG004|Overall Study|Progressive Disease|0|||
149954438|NCT01158404|540964647|FG005|Overall Study|Progressive Disease|0|||
149954439|NCT01158404|540964648|FG006|Overall Study|Progressive Disease|1|||
149954440|NCT01158404|540964649|FG007|Overall Study|Progressive Disease|0|||
149954441|NCT02441114|540964653|FG000|Washout2|Withdrawal by Subject|4|||
149954442|NCT04790201|540964655|FG000|Overall Study|Lost to Follow-up|0|||
149954443|NCT04790201|540964656|FG001|Overall Study|Lost to Follow-up|0|||
149954444|NCT04790201|540964657|FG002|Overall Study|Lost to Follow-up|2|||
149954445|NCT04790201|540964655|FG000|Overall Study|Death|0|||
149954446|NCT04790201|540964656|FG001|Overall Study|Death|1|||
149954447|NCT04790201|540964657|FG002|Overall Study|Death|0|||
149954448|NCT04790201|540964655|FG000|Overall Study|Protocol Violation|1|||
149954449|NCT04790201|540964656|FG001|Overall Study|Protocol Violation|0|||
149954450|NCT04790201|540964657|FG002|Overall Study|Protocol Violation|1|||
149954451|NCT02609633|540964658|FG000|Overall Study|Consent Withdrawn|0|||
149954452|NCT02609633|540964659|FG001|Overall Study|Consent Withdrawn|1|||
149954453|NCT02609633|540964658|FG000|Overall Study|Protocol Deviation|1|||
149954454|NCT02609633|540964659|FG001|Overall Study|Protocol Deviation|0|||
149954455|NCT02609633|540964658|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
149954456|NCT02609633|540964659|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
149954457|NCT02609633|540964658|FG000|Overall Study|Reason not Specified|2|||
149954458|NCT02609633|540964659|FG001|Overall Study|Reason not Specified|1|||
149954459|NCT00997126|540964665|FG000|Overall Study|Physician Decision|7|||
149954460|NCT00997126|540964666|FG001|Overall Study|Physician Decision|11|||
149954461|NCT02691663|540964667|FG000|Overall Study|Screen failure after baseline|2|||
149954462|NCT02691663|540964668|FG001|Overall Study|Screen failure after baseline|2|||
149954463|NCT02691663|540964667|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
149954464|NCT02691663|540964668|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
149954465|NCT02691663|540964667|FG000|Overall Study|Withdrawn after Follow up 2|1|||
149954466|NCT02691663|540964668|FG001|Overall Study|Withdrawn after Follow up 2|1|||
149954467|NCT02691663|540964667|FG000|Overall Study|Lost to Follow-up|3|||
149954468|NCT02691663|540964668|FG001|Overall Study|Lost to Follow-up|2|||
149954469|NCT01769443|540964671|FG000|Overall Study|Study closure|1|||
149954470|NCT01769443|540964672|FG001|Overall Study|Study closure|0|||
149954471|NCT04828486|540964675|FG000|Overall Study|Adverse Event|2|||
149954472|NCT04828486|540964675|FG000|Overall Study|Death|1|||
149954473|NCT04828486|540964675|FG000|Overall Study|Disease Progression|8|||
149954474|NCT04828486|540964675|FG000|Overall Study|Other Complicating Disease|1|||
149954475|NCT04828486|540964675|FG000|Overall Study|Withdrawal by Subject|1|||
149954476|NCT00866320|540964677|FG000|Overall Study|Withdrawal by Subject|4|||
149954477|NCT00866320|540964677|FG000|Overall Study|Death|2|||
149954478|NCT03412890|540964682|FG000|Overall Study|Adverse Event|5|||
149954479|NCT03412890|540964683|FG001|Overall Study|Adverse Event|5|||
149954480|NCT03412890|540964684|FG002|Overall Study|Adverse Event|9|||
149954481|NCT03412890|540964682|FG000|Overall Study|Protocol deviation|2|||
149954482|NCT03412890|540964683|FG001|Overall Study|Protocol deviation|1|||
149954483|NCT03412890|540964684|FG002|Overall Study|Protocol deviation|2|||
149954484|NCT03412890|540964682|FG000|Overall Study|Lost to Follow-up|7|||
149954485|NCT03412890|540964683|FG001|Overall Study|Lost to Follow-up|10|||
149954486|NCT03412890|540964684|FG002|Overall Study|Lost to Follow-up|10|||
149954487|NCT03412890|540964682|FG000|Overall Study|Withdrawal by Subject|9|||
149954488|NCT03412890|540964683|FG001|Overall Study|Withdrawal by Subject|12|||
149954489|NCT03412890|540964684|FG002|Overall Study|Withdrawal by Subject|11|||
149954490|NCT03412890|540964682|FG000|Overall Study|Lack of Efficacy|2|||
149954491|NCT03412890|540964683|FG001|Overall Study|Lack of Efficacy|7|||
149954492|NCT03412890|540964684|FG002|Overall Study|Lack of Efficacy|5|||
149954493|NCT03412890|540964682|FG000|Overall Study|Other|5|||
149954494|NCT03412890|540964683|FG001|Overall Study|Other|6|||
149954495|NCT03412890|540964684|FG002|Overall Study|Other|5|||
150287003|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
150287004|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149954496|NCT03412890|540964682|FG000|Overall Study|Participants who did not receive any study drug|0|||
149954497|NCT03412890|540964683|FG001|Overall Study|Participants who did not receive any study drug|1|||
150287005|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149954498|NCT03412890|540964684|FG002|Overall Study|Participants who did not receive any study drug|0|||
149954499|NCT02063724|540964685|FG000|Overall Study|Disease progression|1|||
149954500|NCT02315625|540964686|FG000|First Intervention|Disease Progression|1|||
150287006|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149954501|NCT02315625|540964687|FG001|First Intervention|Disease Progression|0|||
149954502|NCT02315625|540964686|FG000|Second Intervention|Physician Decision|2|||
149954503|NCT02315625|540964687|FG001|Second Intervention|Physician Decision|1|||
149954504|NCT02315625|540964686|FG000|Second Intervention|Study closure|1|||
149954505|NCT02315625|540964687|FG001|Second Intervention|Study closure|0|||
149954506|NCT02315625|540964686|FG000|Second Intervention|Disease Progression|1|||
149843806|NCT00205777|540558746|FG004|Study Extension I|Failed to return|13|||
149843807|NCT00205777|540558747|FG005|Study Extension I|Failed to return|0|||
149843808|NCT00205777|540558742|FG000|Study Extension I|Other Event|34|||
149843809|NCT00205777|540558743|FG001|Study Extension I|Other Event|0|||
149843810|NCT00205777|540558744|FG002|Study Extension I|Other Event|0|||
149843811|NCT00205777|540558745|FG003|Study Extension I|Other Event|34|||
149843812|NCT00205777|540558746|FG004|Study Extension I|Other Event|29|||
149843813|NCT00205777|540558747|FG005|Study Extension I|Other Event|0|||
149843814|NCT00205777|540558742|FG000|Study Extension I|Withdrawn as per protocol|0|||
149843815|NCT00205777|540558743|FG001|Study Extension I|Withdrawn as per protocol|0|||
149954507|NCT02315625|540964687|FG001|Second Intervention|Disease Progression|0|||
149954508|NCT00387127|540964688|FG000|Overall Study|Lost to Follow-up|0|||
149954509|NCT00387127|540964689|FG001|Overall Study|Lost to Follow-up|4|||
149954510|NCT00387127|540964688|FG000|Overall Study|Death|16|||
149954511|NCT00387127|540964689|FG001|Overall Study|Death|16|||
149954512|NCT00387127|540964688|FG000|Overall Study|Physician Decision|0|||
149954513|NCT00387127|540964689|FG001|Overall Study|Physician Decision|1|||
149954514|NCT00387127|540964688|FG000|Overall Study|Withdrawal by Subject|3|||
149954515|NCT00387127|540964689|FG001|Overall Study|Withdrawal by Subject|2|||
149954516|NCT00387127|540964688|FG000|Overall Study|Required by Protocol Amendment #4|12|||
149954517|NCT00387127|540964689|FG001|Overall Study|Required by Protocol Amendment #4|10|||
149954518|NCT00387127|540964688|FG000|Overall Study|Serious Adverse Event|1|||
149954519|NCT00387127|540964689|FG001|Overall Study|Serious Adverse Event|1|||
149954520|NCT00387127|540964688|FG000|Overall Study|Sponsor Unblinded|1|||
149954521|NCT00387127|540964689|FG001|Overall Study|Sponsor Unblinded|0|||
149954522|NCT02965833|540964691|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
149954523|NCT02965833|540964692|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
149954524|NCT02965833|540964691|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
149954525|NCT02965833|540964692|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
149954526|NCT02965833|540964691|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
149954527|NCT02965833|540964692|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
149954528|NCT02965833|540964691|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
149954529|NCT02965833|540964692|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
149954530|NCT02965833|540964691|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
149954531|NCT02965833|540964692|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
149954532|NCT03370302|540964693|FG000|Dose Escalation Phase|Other|0|||
149954533|NCT03370302|540964694|FG001|Dose Escalation Phase|Other|1|||
149954534|NCT03370302|540964695|FG002|Dose Escalation Phase|Other|1|||
149954535|NCT03370302|540964696|FG003|Dose Escalation Phase|Other|0|||
149954536|NCT03370302|540964697|FG004|Dose Escalation Phase|Other|0|||
149954537|NCT03370302|540964698|FG005|Dose Escalation Phase|Other|0|||
149954538|NCT03370302|540964693|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149954539|NCT03370302|540964694|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
149954540|NCT03370302|540964695|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
149954541|NCT03370302|540964696|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149954542|NCT03370302|540964697|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
149954543|NCT03370302|540964698|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
149954544|NCT03370302|540964693|FG000|Dose Escalation Phase|Adverse Event|1|||
149954545|NCT03370302|540964694|FG001|Dose Escalation Phase|Adverse Event|0|||
149954546|NCT03370302|540964695|FG002|Dose Escalation Phase|Adverse Event|2|||
150035805|NCT00360230|541271413|FG000|Overall Study|Withdrawal by Subject|1|||
150172568|NCT02314117|541768011|FG000|Overall Study|Withdrawal by Subject|3|||
150172569|NCT02314117|541768012|FG001|Overall Study|Withdrawal by Subject|2|||
150172570|NCT04439799|541768013|FG000|Overall Study|Lost to Follow-up|6|||
150172571|NCT04439799|541768014|FG001|Overall Study|Lost to Follow-up|6|||
150172572|NCT04439799|541768013|FG000|Overall Study|Withdrawal by Subject|2|||
150172573|NCT04439799|541768014|FG001|Overall Study|Withdrawal by Subject|6|||
150172574|NCT04439799|541768013|FG000|Overall Study|Adverse Event|2|||
150172575|NCT04439799|541768014|FG001|Overall Study|Adverse Event|5|||
150172576|NCT00949975|541768022|FG000|Overall Study|Voluntary discontinuation|6|||
150172577|NCT00949975|541768023|FG001|Overall Study|Voluntary discontinuation|5|||
150172578|NCT00949975|541768024|FG002|Overall Study|Voluntary discontinuation|3|||
150172579|NCT00949975|541768025|FG003|Overall Study|Voluntary discontinuation|6|||
150172580|NCT00949975|541768022|FG000|Overall Study|Adverse Event|11|||
150172581|NCT00949975|541768023|FG001|Overall Study|Adverse Event|11|||
150172582|NCT00949975|541768024|FG002|Overall Study|Adverse Event|10|||
150172583|NCT00949975|541768025|FG003|Overall Study|Adverse Event|10|||
150172584|NCT00949975|541768022|FG000|Overall Study|Safety reason|0|||
150172585|NCT00949975|541768023|FG001|Overall Study|Safety reason|1|||
150172586|NCT00949975|541768024|FG002|Overall Study|Safety reason|0|||
150172587|NCT00949975|541768025|FG003|Overall Study|Safety reason|0|||
150172588|NCT00949975|541768022|FG000|Overall Study|Study-specific criteria|0|||
150172589|NCT00949975|541768023|FG001|Overall Study|Study-specific criteria|1|||
150172590|NCT00949975|541768024|FG002|Overall Study|Study-specific criteria|1|||
150172591|NCT00949975|541768025|FG003|Overall Study|Study-specific criteria|0|||
150172592|NCT00949975|541768022|FG000|Overall Study|Incorrect enrolment|5|||
150287007|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
150287008|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
150287009|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
150287010|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
150287011|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287012|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287013|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287014|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287015|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
150287016|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287017|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287018|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
150287019|NCT03016325|542185496|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287020|NCT03016325|542185497|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287021|NCT03016325|542185498|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287022|NCT03016325|542185499|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
150287023|NCT03016325|542185500|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287024|NCT03016325|542185501|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287025|NCT03016325|542185502|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287026|NCT03016325|542185503|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
150287027|NCT03016325|542185496|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287028|NCT03016325|542185497|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
150287029|NCT03016325|542185498|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287030|NCT03016325|542185499|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287031|NCT03016325|542185500|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287032|NCT03016325|542185501|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287033|NCT03016325|542185502|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287034|NCT03016325|542185503|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
150287035|NCT03016325|542185496|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
150287036|NCT03016325|542185497|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
150287037|NCT03016325|542185498|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
150035806|NCT00360230|541271414|FG001|Overall Study|Withdrawal by Subject|1|||
150035807|NCT00360230|541271415|FG002|Overall Study|Withdrawal by Subject|0|||
150035808|NCT00360230|541271416|FG003|Overall Study|Withdrawal by Subject|1|||
150035809|NCT00360230|541271417|FG004|Overall Study|Withdrawal by Subject|1|||
150035810|NCT00360230|541271418|FG005|Overall Study|Withdrawal by Subject|1|||
150035811|NCT00360230|541271419|FG006|Overall Study|Withdrawal by Subject|0|||
150035812|NCT00360230|541271413|FG000|Overall Study|Migrated|4|||
150035813|NCT00360230|541271414|FG001|Overall Study|Migrated|1|||
150035814|NCT00360230|541271415|FG002|Overall Study|Migrated|3|||
150035815|NCT00360230|541271416|FG003|Overall Study|Migrated|1|||
150035816|NCT00360230|541271417|FG004|Overall Study|Migrated|4|||
150035817|NCT00360230|541271418|FG005|Overall Study|Migrated|1|||
150035818|NCT00360230|541271419|FG006|Overall Study|Migrated|1|||
150035819|NCT00360230|541271413|FG000|Overall Study|Other|1|||
150035820|NCT00360230|541271414|FG001|Overall Study|Other|0|||
150035821|NCT00360230|541271415|FG002|Overall Study|Other|0|||
150035822|NCT00360230|541271416|FG003|Overall Study|Other|0|||
150035823|NCT00360230|541271417|FG004|Overall Study|Other|0|||
150035824|NCT00360230|541271418|FG005|Overall Study|Other|0|||
150035825|NCT00360230|541271419|FG006|Overall Study|Other|0|||
150035826|NCT00360230|541271413|FG000|Overall Study|Protocol Violation|0|||
150035827|NCT00360230|541271414|FG001|Overall Study|Protocol Violation|0|||
150035828|NCT00360230|541271415|FG002|Overall Study|Protocol Violation|0|||
150035829|NCT00360230|541271416|FG003|Overall Study|Protocol Violation|0|||
150035830|NCT00360230|541271417|FG004|Overall Study|Protocol Violation|0|||
150035831|NCT00360230|541271418|FG005|Overall Study|Protocol Violation|1|||
150035832|NCT00360230|541271419|FG006|Overall Study|Protocol Violation|0|||
150287038|NCT03016325|542185499|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
150287039|NCT03016325|542185500|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
150287040|NCT03016325|542185501|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
150287041|NCT03016325|542185502|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
150287042|NCT03016325|542185503|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
150287043|NCT01347554|542185505|FG000|Overall Study|Lack of Efficacy|7|||
150287044|NCT01347554|542185506|FG001|Overall Study|Lack of Efficacy|11|||
150287045|NCT00004259|542185507|FG000|Overall Study|Protocol Violation|1|||
150287046|NCT00004259|542185508|FG001|Overall Study|Protocol Violation|2|||
150035833|NCT00360230|541271413|FG000|Overall Study|Death|0|||
150035834|NCT00360230|541271414|FG001|Overall Study|Death|1|||
150035835|NCT00360230|541271415|FG002|Overall Study|Death|0|||
150035836|NCT00360230|541271416|FG003|Overall Study|Death|0|||
150035837|NCT00360230|541271417|FG004|Overall Study|Death|0|||
150035838|NCT00360230|541271418|FG005|Overall Study|Death|1|||
149843816|NCT00205777|540558744|FG002|Study Extension I|Withdrawn as per protocol|1070|||
149843817|NCT00205777|540558745|FG003|Study Extension I|Withdrawn as per protocol|0|||
149843818|NCT00205777|540558746|FG004|Study Extension I|Withdrawn as per protocol|0|||
149843819|NCT00205777|540558747|FG005|Study Extension I|Withdrawn as per protocol|0|||
149843820|NCT00205777|540558742|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
149843821|NCT00205777|540558743|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
149843822|NCT00205777|540558744|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
149843823|NCT00205777|540558745|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
149843824|NCT00205777|540558746|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
149843825|NCT00205777|540558747|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
149954547|NCT03370302|540964696|FG003|Dose Escalation Phase|Adverse Event|0|||
150287047|NCT00004259|542185509|FG002|Overall Study|Protocol Violation|0|||
150287048|NCT00004259|542185510|FG003|Overall Study|Protocol Violation|0|||
150287049|NCT00004259|542185507|FG000|Overall Study|Withdrawal by Subject|0|||
149954548|NCT03370302|540964697|FG004|Dose Escalation Phase|Adverse Event|0|||
149954549|NCT03370302|540964698|FG005|Dose Escalation Phase|Adverse Event|0|||
149954550|NCT03370302|540964693|FG000|Dose Escalation Phase|Progressive Disease|2|||
149954551|NCT03370302|540964694|FG001|Dose Escalation Phase|Progressive Disease|4|||
149954552|NCT03370302|540964695|FG002|Dose Escalation Phase|Progressive Disease|2|||
149954553|NCT03370302|540964696|FG003|Dose Escalation Phase|Progressive Disease|0|||
149954554|NCT03370302|540964697|FG004|Dose Escalation Phase|Progressive Disease|3|||
149954555|NCT03370302|540964698|FG005|Dose Escalation Phase|Progressive Disease|1|||
149954556|NCT03370302|540964693|FG000|Dose Expansion Phase|Progressive Disease|0|||
149954557|NCT03370302|540964694|FG001|Dose Expansion Phase|Progressive Disease|0|||
149954558|NCT03370302|540964695|FG002|Dose Expansion Phase|Progressive Disease|0|||
149954559|NCT03370302|540964696|FG003|Dose Expansion Phase|Progressive Disease|6|||
149954560|NCT03370302|540964697|FG004|Dose Expansion Phase|Progressive Disease|0|||
149954561|NCT03370302|540964698|FG005|Dose Expansion Phase|Progressive Disease|0|||
149954562|NCT00250718|540964702|FG000|Overall Study|Death|1|||
149954563|NCT00250718|540964702|FG000|Overall Study|Adverse Event|1|||
149954564|NCT00250718|540964702|FG000|Overall Study|Withdrawal by Subject|1|||
149954565|NCT03407482|540964703|FG000|Overall Study|Adverse Event|12|||
149954566|NCT03407482|540964703|FG000|Overall Study|Disease Relapse|1|||
149954567|NCT03407482|540964703|FG000|Overall Study|Lost to Follow-up|1|||
149954568|NCT03407482|540964703|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149954569|NCT03407482|540964703|FG000|Overall Study|Pregnancy|2|||
149954570|NCT03407482|540964703|FG000|Overall Study|Protocol Violation|1|||
149954571|NCT03407482|540964703|FG000|Overall Study|Study Terminated By Sponsor|106|||
149954572|NCT03407482|540964703|FG000|Overall Study|Withdrawal by Subject|6|||
149954573|NCT03407482|540964703|FG000|Overall Study|Data Entry Error|1|||
149954574|NCT05942040|540964704|FG000|Overall Study|No longer employed at study site.|0|||
149954575|NCT05942040|540964705|FG001|Overall Study|No longer employed at study site.|0|||
149954576|NCT05942040|540964706|FG002|Overall Study|No longer employed at study site.|3|||
149954577|NCT04337021|540964707|FG000|Overall Study|Lost to Follow-up|54|||
149954578|NCT04337021|540964708|FG001|Overall Study|Lost to Follow-up|66|||
149954579|NCT03860584|540964719|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
149954580|NCT03860584|540964720|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
149954581|NCT03860584|540964719|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149954582|NCT03860584|540964720|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
149954583|NCT03860584|540964719|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
149954584|NCT03860584|540964720|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
149954585|NCT03860584|540964719|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
149954586|NCT03860584|540964720|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
149954587|NCT03554473|540966218|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
149954588|NCT03554473|540966219|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
149954589|NCT03554473|540966220|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
149954590|NCT03554473|540966218|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
149954591|NCT03554473|540966219|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
149954592|NCT03554473|540966220|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
149954593|NCT03554473|540966218|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
149954594|NCT03554473|540966219|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
149954595|NCT03554473|540966220|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
149954596|NCT05206604|540966221|FG000|Overall Study|Non-compliance with study drug|0|||
149954597|NCT05206604|540966222|FG001|Overall Study|Non-compliance with study drug|0|||
149954598|NCT05206604|540966223|FG002|Overall Study|Non-compliance with study drug|0|||
149954599|NCT05206604|540966224|FG003|Overall Study|Non-compliance with study drug|0|||
150035839|NCT00360230|541271419|FG006|Overall Study|Death|1|||
149954600|NCT05206604|540966225|FG004|Overall Study|Non-compliance with study drug|0|||
149954601|NCT05206604|540966226|FG005|Overall Study|Non-compliance with study drug|1|||
149954602|NCT05206604|540966227|FG006|Overall Study|Non-compliance with study drug|0|||
149954603|NCT05206604|540966228|FG007|Overall Study|Non-compliance with study drug|0|||
149954604|NCT03735498|540966229|FG000|Overall Study|Withdrawal by Subject|3|||
149954605|NCT03735498|540966229|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
149954606|NCT00160615|540966230|FG000|Overall Study|Adverse Event|5|||
149954607|NCT00160615|540966231|FG001|Overall Study|Adverse Event|12|||
149954608|NCT00160615|540966230|FG000|Overall Study|Withdrawal by Subject|0|||
149954609|NCT00160615|540966231|FG001|Overall Study|Withdrawal by Subject|2|||
149954610|NCT00160615|540966230|FG000|Overall Study|Lack of Efficacy|11|||
149954611|NCT00160615|540966231|FG001|Overall Study|Lack of Efficacy|23|||
149954612|NCT00160615|540966230|FG000|Overall Study|Patient decision|1|||
149954613|NCT00160615|540966231|FG001|Overall Study|Patient decision|2|||
149954614|NCT00160615|540966230|FG000|Overall Study|Investigator decision|1|||
149954615|NCT00160615|540966231|FG001|Overall Study|Investigator decision|1|||
149954616|NCT00160615|540966230|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
149954617|NCT00160615|540966231|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
149954618|NCT00160615|540966230|FG000|Overall Study|Switch to surgical treatment|0|||
149954619|NCT00160615|540966231|FG001|Overall Study|Switch to surgical treatment|2|||
149954620|NCT00160615|540966230|FG000|Overall Study|Non-compliance was suspected|0|||
149954621|NCT00160615|540966231|FG001|Overall Study|Non-compliance was suspected|1|||
149954622|NCT00160615|540966230|FG000|Overall Study|Poor compliance|0|||
149954623|NCT00160615|540966231|FG001|Overall Study|Poor compliance|1|||
149954624|NCT03787212|540966233|FG000|Period 1|Study Termination|2|||
149954625|NCT03787212|540966234|FG001|Period 1|Study Termination|2|||
149954626|NCT02014103|540966235|FG000|Overall Study|Protocol Violation|7|||
149954627|NCT02014103|540966236|FG001|Overall Study|Protocol Violation|7|||
149954628|NCT02014103|540966235|FG000|Overall Study|Adverse Event|1|||
149954629|NCT02014103|540966236|FG001|Overall Study|Adverse Event|0|||
149954630|NCT02014103|540966235|FG000|Overall Study|Lost venous access|1|||
149954631|NCT02014103|540966236|FG001|Overall Study|Lost venous access|0|||
149954632|NCT02014103|540966235|FG000|Overall Study|Withdrawal by Subject|0|||
149954633|NCT02014103|540966236|FG001|Overall Study|Withdrawal by Subject|2|||
149954634|NCT05638737|540966237|FG000|Overall Study|Withdrawal by Subject|4|||
149954635|NCT05638737|540966238|FG001|Overall Study|Withdrawal by Subject|7|||
149954636|NCT00504231|540966239|FG000|Overall Study|Discrepant chart documentation re route|0|||
149954637|NCT00504231|540966240|FG001|Overall Study|Discrepant chart documentation re route|0|||
149954638|NCT00504231|540966241|FG002|Overall Study|Discrepant chart documentation re route|1|||
149954639|NCT00504231|540966242|FG003|Overall Study|Discrepant chart documentation re route|0|||
149954640|NCT00327171|540966244|FG000|Overall Study|Did not receive study medication|3|||
149954641|NCT00327171|540966245|FG001|Overall Study|Did not receive study medication|0|||
149954642|NCT00327171|540966244|FG000|Overall Study|Adverse Event|23|||
149954643|NCT00327171|540966245|FG001|Overall Study|Adverse Event|23|||
149954644|NCT00327171|540966244|FG000|Overall Study|Disease progression/lack of efficacy|68|||
149954645|NCT00327171|540966245|FG001|Overall Study|Disease progression/lack of efficacy|69|||
149954646|NCT00327171|540966244|FG000|Overall Study|Investigator/participant request|1|||
149954647|NCT00327171|540966245|FG001|Overall Study|Investigator/participant request|8|||
149954648|NCT00327171|540966244|FG000|Overall Study|Clinical progression|12|||
149954649|NCT00327171|540966245|FG001|Overall Study|Clinical progression|8|||
149954650|NCT00327171|540966244|FG000|Overall Study|Undisclosed history of ischemia|0|||
149954651|NCT00327171|540966245|FG001|Overall Study|Undisclosed history of ischemia|1|||
149954652|NCT00327171|540966244|FG000|Overall Study|Other|1|||
149954653|NCT00327171|540966245|FG001|Overall Study|Other|0|||
149954654|NCT00266812|540966246|FG000|Overall Study|Disease Progression|9|||
149954655|NCT00266812|540966247|FG001|Overall Study|Disease Progression|3|||
149954656|NCT00266812|540966246|FG000|Overall Study|Death|5|||
149954657|NCT00266812|540966247|FG001|Overall Study|Death|4|||
149954658|NCT00266812|540966246|FG000|Overall Study|Adverse Event|3|||
149954659|NCT00266812|540966247|FG001|Overall Study|Adverse Event|1|||
149954660|NCT00266812|540966246|FG000|Overall Study|Protocol Violation|0|||
149954661|NCT00266812|540966247|FG001|Overall Study|Protocol Violation|1|||
149954662|NCT00266812|540966246|FG000|Overall Study|Withdrawal by Subject|0|||
149954663|NCT00266812|540966247|FG001|Overall Study|Withdrawal by Subject|2|||
149954664|NCT00266812|540966246|FG000|Overall Study|Discontinued before starting study drug|4|||
149954665|NCT00266812|540966247|FG001|Overall Study|Discontinued before starting study drug|0|||
149954666|NCT00530075|540966248|FG000|Overall Study|Adverse Event|1|||
149954667|NCT00530075|540966248|FG000|Overall Study|Death|1|||
149954668|NCT00530075|540966248|FG000|Overall Study|Lack of Efficacy|3|||
149954669|NCT00530075|540966248|FG000|Overall Study|Protocol Violation|1|||
149954670|NCT00530075|540966248|FG000|Overall Study|Withdrawal by Subject|1|||
150172593|NCT00949975|541768023|FG001|Overall Study|Incorrect enrolment|10|||
149954671|NCT03422718|540966249|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
149954672|NCT03422718|540966250|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
149954673|NCT03422718|540966251|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
149843826|NCT00205777|540558742|FG000|Study Extension II|Adverse Event|0|||
149843827|NCT00205777|540558743|FG001|Study Extension II|Adverse Event|0|||
149843828|NCT00205777|540558744|FG002|Study Extension II|Adverse Event|0|||
149843829|NCT00205777|540558745|FG003|Study Extension II|Adverse Event|14|||
149843830|NCT00205777|540558746|FG004|Study Extension II|Adverse Event|0|||
149843831|NCT00205777|540558747|FG005|Study Extension II|Adverse Event|30|||
149843832|NCT00205777|540558742|FG000|Study Extension II|Death|0|||
149843833|NCT00205777|540558743|FG001|Study Extension II|Death|0|||
149843834|NCT00205777|540558744|FG002|Study Extension II|Death|0|||
149843835|NCT00205777|540558745|FG003|Study Extension II|Death|2|||
149843836|NCT00205777|540558746|FG004|Study Extension II|Death|0|||
149843837|NCT00205777|540558747|FG005|Study Extension II|Death|5|||
149843838|NCT00205777|540558742|FG000|Study Extension II|Withdrawal by Subject|0|||
149843839|NCT00205777|540558743|FG001|Study Extension II|Withdrawal by Subject|0|||
149843840|NCT00205777|540558744|FG002|Study Extension II|Withdrawal by Subject|0|||
149843841|NCT00205777|540558745|FG003|Study Extension II|Withdrawal by Subject|35|||
149843842|NCT00205777|540558746|FG004|Study Extension II|Withdrawal by Subject|0|||
149843843|NCT00205777|540558747|FG005|Study Extension II|Withdrawal by Subject|59|||
149843844|NCT00205777|540558742|FG000|Study Extension II|Protocol Violation|0|||
149843845|NCT00205777|540558743|FG001|Study Extension II|Protocol Violation|0|||
149843846|NCT00205777|540558744|FG002|Study Extension II|Protocol Violation|0|||
149843847|NCT00205777|540558745|FG003|Study Extension II|Protocol Violation|1|||
149843848|NCT00205777|540558746|FG004|Study Extension II|Protocol Violation|0|||
149843849|NCT00205777|540558747|FG005|Study Extension II|Protocol Violation|10|||
149843850|NCT00205777|540558742|FG000|Study Extension II|Lack of Efficacy|0|||
149843851|NCT00205777|540558743|FG001|Study Extension II|Lack of Efficacy|0|||
149843852|NCT00205777|540558744|FG002|Study Extension II|Lack of Efficacy|0|||
149843853|NCT00205777|540558745|FG003|Study Extension II|Lack of Efficacy|0|||
149843854|NCT00205777|540558746|FG004|Study Extension II|Lack of Efficacy|0|||
149843855|NCT00205777|540558747|FG005|Study Extension II|Lack of Efficacy|1|||
149843856|NCT00205777|540558742|FG000|Study Extension II|Failed to return|0|||
149843857|NCT00205777|540558743|FG001|Study Extension II|Failed to return|0|||
149843858|NCT00205777|540558744|FG002|Study Extension II|Failed to return|0|||
149843859|NCT00205777|540558745|FG003|Study Extension II|Failed to return|14|||
149843860|NCT00205777|540558746|FG004|Study Extension II|Failed to return|0|||
149843861|NCT00205777|540558747|FG005|Study Extension II|Failed to return|26|||
149843862|NCT00205777|540558742|FG000|Study Extension II|Other Event|0|||
149843863|NCT00205777|540558743|FG001|Study Extension II|Other Event|0|||
149843864|NCT00205777|540558744|FG002|Study Extension II|Other Event|0|||
149843865|NCT00205777|540558745|FG003|Study Extension II|Other Event|12|||
149843866|NCT00205777|540558746|FG004|Study Extension II|Other Event|0|||
149843867|NCT00205777|540558747|FG005|Study Extension II|Other Event|20|||
149843868|NCT00205777|540558742|FG000|Study Extension II|Enrolled but not treated|0|||
149843869|NCT00205777|540558743|FG001|Study Extension II|Enrolled but not treated|0|||
149843870|NCT00205777|540558744|FG002|Study Extension II|Enrolled but not treated|0|||
149843871|NCT00205777|540558745|FG003|Study Extension II|Enrolled but not treated|71|||
149843872|NCT00205777|540558746|FG004|Study Extension II|Enrolled but not treated|0|||
149843873|NCT00205777|540558747|FG005|Study Extension II|Enrolled but not treated|131|||
149843874|NCT00700739|540558748|FG000|Overall Study|Lost to Follow-up|4|||
149843875|NCT00700739|540558749|FG001|Overall Study|Lost to Follow-up|4|||
149843876|NCT00185458|540558753|FG000|Contraception Phase|Adverse Event|37|||
149843877|NCT00185458|540558753|FG000|Contraception Phase|Lost to Follow-up|10|||
149843878|NCT00185458|540558753|FG000|Contraception Phase|Protocol Violation|2|||
149843879|NCT00185458|540558753|FG000|Contraception Phase|Physician Decision|2|||
149843880|NCT00185458|540558753|FG000|Contraception Phase|Withdrawal by Subject|7|||
149843881|NCT00185458|540558753|FG000|HRT Phase|Adverse Event|18|||
149843882|NCT00185458|540558753|FG000|HRT Phase|Lost to Follow-up|4|||
149843883|NCT00185458|540558753|FG000|HRT Phase|Protocol Violation|2|||
149843884|NCT00185458|540558753|FG000|HRT Phase|Withdrawal by Subject|3|||
149954674|NCT03422718|540966252|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
149954675|NCT03422718|540966253|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
149954676|NCT03422718|540966254|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
149954677|NCT03422718|540966255|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
149954678|NCT03422718|540966256|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
149954679|NCT03422718|540966249|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
149954680|NCT03422718|540966250|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
149954681|NCT03422718|540966251|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
149843885|NCT03503318|540558754|FG000|Overall Study|Death|1|||
149843886|NCT03503318|540558755|FG001|Overall Study|Death|0|||
149843887|NCT03503318|540558756|FG002|Overall Study|Death|4|||
149843888|NCT03503318|540558754|FG000|Overall Study|Adverse Event|3|||
150287050|NCT00004259|542185508|FG001|Overall Study|Withdrawal by Subject|2|||
149843889|NCT03503318|540558755|FG001|Overall Study|Adverse Event|4|||
149843890|NCT03503318|540558756|FG002|Overall Study|Adverse Event|2|||
149954682|NCT03422718|540966252|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
149954683|NCT03422718|540966253|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
149843891|NCT03503318|540558754|FG000|Overall Study|Withdrawal by Subject|12|||
149843892|NCT03503318|540558755|FG001|Overall Study|Withdrawal by Subject|17|||
149843893|NCT03503318|540558756|FG002|Overall Study|Withdrawal by Subject|16|||
149843894|NCT03503318|540558754|FG000|Overall Study|Protocol Violation|5|||
149843895|NCT03503318|540558755|FG001|Overall Study|Protocol Violation|0|||
149843896|NCT03503318|540558756|FG002|Overall Study|Protocol Violation|3|||
149843897|NCT03503318|540558754|FG000|Overall Study|Lost to Follow-up|17|||
149843898|NCT03503318|540558755|FG001|Overall Study|Lost to Follow-up|15|||
149843899|NCT03503318|540558756|FG002|Overall Study|Lost to Follow-up|12|||
149843900|NCT03503318|540558754|FG000|Overall Study|Other than specified|1|||
149843901|NCT03503318|540558755|FG001|Overall Study|Other than specified|3|||
149843902|NCT03503318|540558756|FG002|Overall Study|Other than specified|3|||
149843903|NCT01794845|540558758|FG000|Overall Study|Withdrawal by Subject|1|||
149843904|NCT02139826|540558759|FG000|Overall Study|Adverse Event|1|||
149843905|NCT00436163|540558762|FG000|Overall Study|Lost to Follow-up|2|||
149843906|NCT00436163|540558762|FG000|Overall Study|Adverse Event|1|||
149843907|NCT03719040|540558763|FG000|Overall Study|Withdrawal by Subject|177|||
149843908|NCT03719040|540558763|FG000|Overall Study|Lost to Follow-up|26|||
149843909|NCT06647173|540558767|FG000|Overall Study|Lost to Follow-up|24|||
149843910|NCT02923349|540558768|FG000|Overall Study|Other|1|||
149843911|NCT02923349|540558769|FG001|Overall Study|Other|2|||
149843912|NCT02923349|540558770|FG002|Overall Study|Other|4|||
149843913|NCT02923349|540558771|FG003|Overall Study|Other|1|||
149843914|NCT02923349|540558772|FG004|Overall Study|Other|3|||
149843915|NCT02923349|540558773|FG005|Overall Study|Other|0|||
149843916|NCT02923349|540558774|FG006|Overall Study|Other|1|||
149843917|NCT02923349|540558768|FG000|Overall Study|Withdrawal by Subject|2|||
149843918|NCT02923349|540558769|FG001|Overall Study|Withdrawal by Subject|2|||
149843919|NCT02923349|540558770|FG002|Overall Study|Withdrawal by Subject|8|||
149843920|NCT02923349|540558771|FG003|Overall Study|Withdrawal by Subject|10|||
149843921|NCT02923349|540558772|FG004|Overall Study|Withdrawal by Subject|12|||
149843922|NCT02923349|540558773|FG005|Overall Study|Withdrawal by Subject|3|||
150287051|NCT00004259|542185509|FG002|Overall Study|Withdrawal by Subject|0|||
149843923|NCT02923349|540558774|FG006|Overall Study|Withdrawal by Subject|0|||
149843924|NCT02923349|540558768|FG000|Overall Study|Physician Decision|0|||
149843925|NCT02923349|540558769|FG001|Overall Study|Physician Decision|0|||
149843926|NCT02923349|540558770|FG002|Overall Study|Physician Decision|0|||
149843927|NCT02923349|540558771|FG003|Overall Study|Physician Decision|1|||
149843928|NCT02923349|540558772|FG004|Overall Study|Physician Decision|1|||
149843929|NCT02923349|540558773|FG005|Overall Study|Physician Decision|0|||
149843930|NCT02923349|540558774|FG006|Overall Study|Physician Decision|2|||
149954684|NCT03422718|540966254|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
149954685|NCT03422718|540966255|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
149954686|NCT03422718|540966256|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
149954687|NCT03422718|540966249|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
149954688|NCT03422718|540966250|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
149954689|NCT03422718|540966251|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
149954690|NCT03422718|540966252|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
150287052|NCT00004259|542185510|FG003|Overall Study|Withdrawal by Subject|0|||
150287053|NCT00790907|542185511|FG000|Overall Study|Adverse Event|9|||
150287054|NCT00790907|542185512|FG001|Overall Study|Adverse Event|7|||
149954691|NCT03422718|540966253|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
150287055|NCT00790907|542185513|FG002|Overall Study|Adverse Event|6|||
149954692|NCT03422718|540966254|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
149954693|NCT03422718|540966255|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
149954694|NCT03422718|540966256|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
149954695|NCT03422718|540966249|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
149954696|NCT03422718|540966250|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
149954697|NCT03422718|540966251|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
150035840|NCT00456846|541271420|FG000|Overall Study|Adverse Event|2|||
150035841|NCT00456846|541271421|FG001|Overall Study|Adverse Event|15|||
150287056|NCT00790907|542185511|FG000|Overall Study|Physician Decision|304|||
150287057|NCT00790907|542185512|FG001|Overall Study|Physician Decision|271|||
150287058|NCT00790907|542185513|FG002|Overall Study|Physician Decision|255|||
150287059|NCT00790907|542185511|FG000|Overall Study|Withdrawal by Subject|1|||
149843931|NCT02923349|540558768|FG000|Overall Study|Lost to Follow-up|0|||
149843932|NCT02923349|540558769|FG001|Overall Study|Lost to Follow-up|0|||
149843933|NCT02923349|540558770|FG002|Overall Study|Lost to Follow-up|3|||
149843934|NCT02923349|540558771|FG003|Overall Study|Lost to Follow-up|0|||
149843935|NCT02923349|540558772|FG004|Overall Study|Lost to Follow-up|1|||
149843936|NCT02923349|540558773|FG005|Overall Study|Lost to Follow-up|1|||
149843937|NCT02923349|540558774|FG006|Overall Study|Lost to Follow-up|0|||
149843938|NCT02923349|540558768|FG000|Overall Study|Death|1|||
149843939|NCT02923349|540558769|FG001|Overall Study|Death|0|||
149843940|NCT02923349|540558770|FG002|Overall Study|Death|2|||
149843941|NCT02923349|540558771|FG003|Overall Study|Death|4|||
149843942|NCT02923349|540558772|FG004|Overall Study|Death|2|||
149843943|NCT02923349|540558773|FG005|Overall Study|Death|3|||
149843944|NCT02923349|540558774|FG006|Overall Study|Death|0|||
149843945|NCT01120028|540558777|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
149843946|NCT01120028|540558778|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
149843947|NCT01120028|540558779|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
149843948|NCT01120028|540558780|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
149843949|NCT01120028|540558777|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
149843950|NCT01120028|540558778|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
149843951|NCT01120028|540558779|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
149843952|NCT01120028|540558780|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
149843953|NCT03250117|540558781|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
149843954|NCT03250117|540558782|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
149843955|NCT03250117|540558783|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
149843956|NCT03250117|540558784|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
149843957|NCT04063878|540558785|FG000|Overall Study|Withdrawal by Subject|2|||
149843958|NCT04063878|540558785|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
149843959|NCT02751827|540558786|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
149843960|NCT02751827|540558787|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
149843961|NCT02751827|540558788|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
149843962|NCT01248728|540558789|FG000|Overall Study|Adverse Event|1|||
149843963|NCT01248728|540558790|FG001|Overall Study|Adverse Event|1|||
149843964|NCT01248728|540558789|FG000|Overall Study|Withdrawal by Subject|2|||
149843965|NCT01248728|540558790|FG001|Overall Study|Withdrawal by Subject|1|||
149843966|NCT01248728|540558789|FG000|Overall Study|Lack of Efficacy|1|||
149843967|NCT01248728|540558790|FG001|Overall Study|Lack of Efficacy|0|||
149843968|NCT01841554|540558791|FG000|Overall Study|Death|7|||
149843969|NCT01841554|540558791|FG000|Overall Study|No Implantation|1|||
149843970|NCT01841554|540558791|FG000|Overall Study|Discontinued Follow Up|5|||
149843971|NCT01841554|540558791|FG000|Overall Study|Study exit due to secondary intervention|6|||
149843972|NCT04633564|540558795|FG000|Period 1|Adverse Event|28|||
149843973|NCT04633564|540558796|FG001|Period 1|Adverse Event|19|||
149843974|NCT04633564|540558795|FG000|Period 1|Death|8|||
149843975|NCT04633564|540558796|FG001|Period 1|Death|7|||
149843976|NCT04633564|540558795|FG000|Period 1|Lost to Follow-up|3|||
149843977|NCT04633564|540558796|FG001|Period 1|Lost to Follow-up|5|||
149843978|NCT04633564|540558795|FG000|Period 1|Physician Decision|4|||
149843979|NCT04633564|540558796|FG001|Period 1|Physician Decision|12|||
149843980|NCT04633564|540558795|FG000|Period 1|Protocol Violation|0|||
149843981|NCT04633564|540558796|FG001|Period 1|Protocol Violation|1|||
149843982|NCT04633564|540558795|FG000|Period 1|Withdrawal by Subject|10|||
149843983|NCT04633564|540558796|FG001|Period 1|Withdrawal by Subject|8|||
149843984|NCT04633564|540558795|FG000|Period 1|Progressive disease|47|||
149843985|NCT04633564|540558796|FG001|Period 1|Progressive disease|51|||
149843986|NCT04633564|540558795|FG000|Period 1|Terminated by Sponsor|8|||
149843987|NCT04633564|540558796|FG001|Period 1|Terminated by Sponsor|6|||
149843988|NCT04633564|540558795|FG000|Period 2|Adverse Event|3|||
149843989|NCT04633564|540558796|FG001|Period 2|Adverse Event|4|||
149843990|NCT04633564|540558795|FG000|Period 2|Death|0|||
149843991|NCT04633564|540558796|FG001|Period 2|Death|2|||
149843992|NCT04633564|540558795|FG000|Period 2|Lost to Follow-up|0|||
149843993|NCT04633564|540558796|FG001|Period 2|Lost to Follow-up|1|||
149843994|NCT04633564|540558795|FG000|Period 2|Physician Decision|2|||
149843995|NCT04633564|540558796|FG001|Period 2|Physician Decision|4|||
149843996|NCT04633564|540558795|FG000|Period 2|Withdrawal by Subject|5|||
150035842|NCT00456846|541271420|FG000|Overall Study|Physician Decision|11|||
150035843|NCT00456846|541271421|FG001|Overall Study|Physician Decision|6|||
150035844|NCT00456846|541271420|FG000|Overall Study|Protocol Deviation|2|||
150035845|NCT00456846|541271421|FG001|Overall Study|Protocol Deviation|0|||
150035846|NCT00456846|541271420|FG000|Overall Study|Participant Discretion|1|||
150035847|NCT00456846|541271421|FG001|Overall Study|Participant Discretion|5|||
150035848|NCT00456846|541271420|FG000|Overall Study|Other|0|||
150035849|NCT00456846|541271421|FG001|Overall Study|Other|2|||
150035850|NCT03219723|541271425|FG000|Overall Study|Case Report Forms Uncollected|6|||
150035851|NCT03219723|541271425|FG000|Overall Study|Protocol Deviation|4|||
150035852|NCT00459316|541271426|FG000|Steps 1 & 2|Other eligibility failure|1|||
149843997|NCT04633564|540558796|FG001|Period 2|Withdrawal by Subject|1|||
149843998|NCT04633564|540558795|FG000|Period 2|Progressive Disease|74|||
149843999|NCT04633564|540558796|FG001|Period 2|Progressive Disease|82|||
149844000|NCT04633564|540558795|FG000|Period 2|Terminated by Sponsor|9|||
149844001|NCT04633564|540558796|FG001|Period 2|Terminated by Sponsor|3|||
150035853|NCT00459316|541271427|FG001|Steps 1 & 2|Other eligibility failure|1|||
149844002|NCT00725322|540558797|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
149844003|NCT00725322|540558798|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
150287060|NCT00790907|542185512|FG001|Overall Study|Withdrawal by Subject|7|||
150287061|NCT00790907|542185513|FG002|Overall Study|Withdrawal by Subject|5|||
150287062|NCT00790907|542185511|FG000|Overall Study|Bleeding Event|11|||
149844004|NCT00725322|540558797|FG000|Washout (28 Days)|Protocol Violation|0|||
149844005|NCT00725322|540558798|FG001|Washout (28 Days)|Protocol Violation|1|||
149844006|NCT00640341|540560206|FG000|Overall Study|Adverse Event|0|||
149844007|NCT00640341|540560207|FG001|Overall Study|Adverse Event|0|||
149844008|NCT00640341|540560208|FG002|Overall Study|Adverse Event|1|||
149844009|NCT00640341|540560206|FG000|Overall Study|Positive Slit Lamp Findings|0|||
149844010|NCT00640341|540560207|FG001|Overall Study|Positive Slit Lamp Findings|0|||
149844011|NCT00640341|540560208|FG002|Overall Study|Positive Slit Lamp Findings|1|||
149844012|NCT00640341|540560206|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
149844013|NCT00640341|540560207|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
149844014|NCT00640341|540560208|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
149844015|NCT00640341|540560206|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
149844016|NCT00640341|540560207|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
149844017|NCT00640341|540560208|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
149844018|NCT00640341|540560206|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
149844019|NCT00640341|540560207|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
149844020|NCT00640341|540560208|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
149844021|NCT00640341|540560206|FG000|Overall Study|Lost to Follow-up|2|||
149844022|NCT00640341|540560207|FG001|Overall Study|Lost to Follow-up|0|||
149844023|NCT00640341|540560208|FG002|Overall Study|Lost to Follow-up|0|||
149844024|NCT00640341|540560206|FG000|Overall Study|Withdrawal by Subject|4|||
149844025|NCT00640341|540560207|FG001|Overall Study|Withdrawal by Subject|0|||
149844026|NCT00640341|540560208|FG002|Overall Study|Withdrawal by Subject|1|||
149844027|NCT00640341|540560206|FG000|Overall Study|Unacceptable Lens Movement|1|||
149844028|NCT00640341|540560207|FG001|Overall Study|Unacceptable Lens Movement|0|||
149954698|NCT03422718|540966252|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
149954699|NCT03422718|540966253|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
149954700|NCT03422718|540966254|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
149954701|NCT03422718|540966255|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
149954702|NCT03422718|540966256|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
149954703|NCT03422718|540966249|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
149954704|NCT03422718|540966250|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
149954705|NCT03422718|540966251|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
149954706|NCT03422718|540966252|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
149954707|NCT03422718|540966253|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
149954708|NCT03422718|540966254|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
149954709|NCT03422718|540966255|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
149954710|NCT03422718|540966256|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
149954711|NCT03422718|540966249|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
149954712|NCT03422718|540966250|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
149954713|NCT03422718|540966251|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
149954714|NCT03422718|540966252|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
149954715|NCT03422718|540966253|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
149954716|NCT03422718|540966254|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
149954717|NCT03422718|540966255|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
149954718|NCT03422718|540966256|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
149954719|NCT03309605|540966257|FG000|Overall Study|Adverse Event|0|||
149954720|NCT03309605|540966258|FG001|Overall Study|Adverse Event|0|||
149954721|NCT03309605|540966259|FG002|Overall Study|Adverse Event|0|||
149954722|NCT03309605|540966260|FG003|Overall Study|Adverse Event|1|||
149954723|NCT03309605|540966261|FG004|Overall Study|Adverse Event|0|||
149954724|NCT03309605|540966262|FG005|Overall Study|Adverse Event|0|||
149954725|NCT03309605|540966263|FG006|Overall Study|Adverse Event|2|||
149954726|NCT03309605|540966264|FG007|Overall Study|Adverse Event|1|||
149954727|NCT03309605|540966257|FG000|Overall Study|Withdrawal by Subject|0|||
149954728|NCT03309605|540966258|FG001|Overall Study|Withdrawal by Subject|0|||
149954729|NCT03309605|540966259|FG002|Overall Study|Withdrawal by Subject|0|||
149954730|NCT03309605|540966260|FG003|Overall Study|Withdrawal by Subject|0|||
149954731|NCT03309605|540966261|FG004|Overall Study|Withdrawal by Subject|1|||
149954732|NCT03309605|540966262|FG005|Overall Study|Withdrawal by Subject|0|||
149954733|NCT03309605|540966263|FG006|Overall Study|Withdrawal by Subject|1|||
149954734|NCT03309605|540966264|FG007|Overall Study|Withdrawal by Subject|1|||
150287063|NCT00790907|542185512|FG001|Overall Study|Bleeding Event|16|||
149844029|NCT00640341|540560208|FG002|Overall Study|Unacceptable Lens Movement|0|||
149844030|NCT00640341|540560206|FG000|Overall Study|Poor fit/Uncomfortable|4|||
149954735|NCT01129284|540966265|FG000|Overall Study|Adverse Event|2|||
149954736|NCT01129284|540966266|FG001|Overall Study|Adverse Event|0|||
149954737|NCT01129284|540966267|FG002|Overall Study|Adverse Event|1|||
150287064|NCT00790907|542185513|FG002|Overall Study|Bleeding Event|21|||
150287065|NCT00790907|542185511|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
149844031|NCT00640341|540560207|FG001|Overall Study|Poor fit/Uncomfortable|0|||
149844032|NCT00640341|540560208|FG002|Overall Study|Poor fit/Uncomfortable|0|||
149844033|NCT00640341|540560206|FG000|Overall Study|Ineligable at Baseline|5|||
149844034|NCT00640341|540560207|FG001|Overall Study|Ineligable at Baseline|3|||
149844035|NCT00640341|540560208|FG002|Overall Study|Ineligable at Baseline|2|||
149844036|NCT00640341|540560206|FG000|Overall Study|Adverse event and positive slit lamp|1|||
149844037|NCT00640341|540560207|FG001|Overall Study|Adverse event and positive slit lamp|0|||
149844038|NCT00640341|540560208|FG002|Overall Study|Adverse event and positive slit lamp|0|||
149844039|NCT03578809|540560209|FG000|Overall Study|Death|0|||
149844040|NCT03578809|540560210|FG001|Overall Study|Death|2|||
149844041|NCT03578809|540560211|FG002|Overall Study|Death|0|||
149844042|NCT03578809|540560212|FG003|Overall Study|Death|1|||
149844043|NCT03578809|540560209|FG000|Overall Study|Lost to Follow-up|0|||
149844044|NCT03578809|540560210|FG001|Overall Study|Lost to Follow-up|1|||
149844045|NCT03578809|540560211|FG002|Overall Study|Lost to Follow-up|0|||
149844046|NCT03578809|540560212|FG003|Overall Study|Lost to Follow-up|0|||
149844047|NCT03578809|540560209|FG000|Overall Study|Withdrawal by Subject|3|||
149844048|NCT03578809|540560210|FG001|Overall Study|Withdrawal by Subject|5|||
149844049|NCT03578809|540560211|FG002|Overall Study|Withdrawal by Subject|2|||
149844050|NCT03578809|540560212|FG003|Overall Study|Withdrawal by Subject|0|||
149844051|NCT03578809|540560209|FG000|Overall Study|Other|3|||
149844052|NCT03578809|540560210|FG001|Overall Study|Other|6|||
149844053|NCT03578809|540560211|FG002|Overall Study|Other|2|||
149844054|NCT03578809|540560212|FG003|Overall Study|Other|8|||
149844055|NCT00830258|540560213|FG000|First Intervention|Adverse Event|1|||
149844056|NCT00830258|540560214|FG001|First Intervention|Adverse Event|0|||
149844057|NCT00830258|540560213|FG000|Washout: 7 Days|Protocol Violation|1|||
149844058|NCT00830258|540560214|FG001|Washout: 7 Days|Protocol Violation|0|||
149844059|NCT00488774|540560217|FG000|Overall Study|Withdrawal of consent|2|||
149844060|NCT00488774|540560218|FG001|Overall Study|Withdrawal of consent|2|||
149844061|NCT00488774|540560219|FG002|Overall Study|Withdrawal of consent|2|||
149844062|NCT00488774|540560220|FG003|Overall Study|Withdrawal of consent|0|||
149844063|NCT00488774|540560217|FG000|Overall Study|Other|6|||
149844064|NCT00488774|540560218|FG001|Overall Study|Other|3|||
149844065|NCT00488774|540560219|FG002|Overall Study|Other|2|||
149844066|NCT00488774|540560220|FG003|Overall Study|Other|2|||
150172594|NCT00949975|541768024|FG002|Overall Study|Incorrect enrolment|4|||
149844067|NCT00488774|540560217|FG000|Overall Study|Lost to Follow-up|0|||
149844068|NCT00488774|540560218|FG001|Overall Study|Lost to Follow-up|0|||
149844069|NCT00488774|540560219|FG002|Overall Study|Lost to Follow-up|1|||
149844070|NCT00488774|540560220|FG003|Overall Study|Lost to Follow-up|1|||
149844071|NCT05523895|540560221|FG000|Overall Study|Adverse Event|2|||
149844072|NCT05523895|540560222|FG001|Overall Study|Adverse Event|1|||
149844073|NCT05523895|540560223|FG002|Overall Study|Adverse Event|1|||
149844074|NCT05523895|540560221|FG000|Overall Study|Lost to Follow-up|0|||
149844075|NCT05523895|540560222|FG001|Overall Study|Lost to Follow-up|1|||
149844076|NCT05523895|540560223|FG002|Overall Study|Lost to Follow-up|2|||
149844077|NCT05523895|540560221|FG000|Overall Study|Noncompliance with study drug|1|||
149844078|NCT05523895|540560222|FG001|Overall Study|Noncompliance with study drug|1|||
149844079|NCT05523895|540560223|FG002|Overall Study|Noncompliance with study drug|1|||
149844080|NCT05523895|540560221|FG000|Overall Study|Protocol Violation|0|||
149844081|NCT05523895|540560222|FG001|Overall Study|Protocol Violation|2|||
149844082|NCT05523895|540560223|FG002|Overall Study|Protocol Violation|0|||
149844083|NCT05523895|540560221|FG000|Overall Study|Withdrawal by Subject|1|||
149844084|NCT05523895|540560222|FG001|Overall Study|Withdrawal by Subject|3|||
149844085|NCT05523895|540560223|FG002|Overall Study|Withdrawal by Subject|1|||
149844086|NCT05523895|540560221|FG000|Overall Study|Not further specified|0|||
149844087|NCT05523895|540560222|FG001|Overall Study|Not further specified|3|||
149844088|NCT05523895|540560223|FG002|Overall Study|Not further specified|1|||
149844089|NCT05041361|540560224|FG000|Overall Study|Lost to Follow-up|1|||
149844090|NCT05041361|540560225|FG001|Overall Study|Lost to Follow-up|3|||
149844091|NCT01642277|540560226|FG000|Overall Study|Adverse Event|10|||
149844092|NCT01642277|540560227|FG001|Overall Study|Adverse Event|0|||
149844093|NCT01642277|540560226|FG000|Overall Study|Physician Decision|2|||
149844094|NCT01642277|540560227|FG001|Overall Study|Physician Decision|0|||
149844095|NCT01642277|540560226|FG000|Overall Study|Protocol Violation|1|||
149844096|NCT01642277|540560227|FG001|Overall Study|Protocol Violation|0|||
149844097|NCT01642277|540560226|FG000|Overall Study|Withdrawal by Subject|11|||
149844098|NCT01642277|540560227|FG001|Overall Study|Withdrawal by Subject|0|||
149844099|NCT03679598|540560228|FG000|Overall Study|Adverse Event|2|||
149844100|NCT03679598|540560229|FG001|Overall Study|Adverse Event|0|||
149844101|NCT03605342|540560230|FG000|Overall Study|Withdrawal by Subject|9|||
149844102|NCT03605342|540560231|FG001|Overall Study|Withdrawal by Subject|7|||
149844103|NCT03605342|540560230|FG000|Overall Study|Lost to Follow-up|1|||
149844104|NCT03605342|540560231|FG001|Overall Study|Lost to Follow-up|1|||
149844105|NCT01403194|540560234|FG000|Overall Study|Screen Failure|2|||
149844106|NCT01403194|540560234|FG000|Overall Study|Lost to Follow-up|8|||
149954738|NCT00422461|540966268|FG000|Overall Study|Adverse Event|1|||
149954739|NCT00422461|540966269|FG001|Overall Study|Adverse Event|2|||
149844107|NCT03428750|540560237|FG000|Overall Study|Withdrawal by Subject|11|||
149844108|NCT03428750|540560238|FG001|Overall Study|Withdrawal by Subject|10|||
149844109|NCT03428750|540560237|FG000|Overall Study|Lost to Follow-up|3|||
149844110|NCT03428750|540560238|FG001|Overall Study|Lost to Follow-up|9|||
149844111|NCT03428750|540560237|FG000|Overall Study|Adverse Event|9|||
149844112|NCT03428750|540560238|FG001|Overall Study|Adverse Event|1|||
149844113|NCT03428750|540560237|FG000|Overall Study|Protocol Violation|1|||
149844114|NCT03428750|540560238|FG001|Overall Study|Protocol Violation|0|||
149844115|NCT03428750|540560237|FG000|Overall Study|Administrative|0|||
149844116|NCT03428750|540560238|FG001|Overall Study|Administrative|1|||
149844117|NCT01919112|540560239|FG000|Secondary Analysis-day 30|Death|1|||
149844118|NCT01919112|540560240|FG001|Secondary Analysis-day 30|Death|1|||
149844119|NCT01919112|540560241|FG002|Secondary Analysis-day 30|Death|1|||
149844120|NCT01919112|540560239|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
149844121|NCT01919112|540560240|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
149844122|NCT01919112|540560241|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
149844123|NCT02554877|540560244|FG000|Overall Study|Adverse Event|2|||
149844124|NCT02554877|540560245|FG001|Overall Study|Adverse Event|0|||
149844125|NCT02554877|540560246|FG002|Overall Study|Adverse Event|0|||
149844126|NCT02554877|540560247|FG003|Overall Study|Adverse Event|1|||
149844127|NCT02554877|540560244|FG000|Overall Study|Lost to Follow-up|1|||
149844128|NCT02554877|540560245|FG001|Overall Study|Lost to Follow-up|1|||
149844129|NCT02554877|540560246|FG002|Overall Study|Lost to Follow-up|1|||
149844130|NCT02554877|540560247|FG003|Overall Study|Lost to Follow-up|2|||
149844131|NCT02554877|540560244|FG000|Overall Study|Did not meet entrance criteria|0|||
149844132|NCT02554877|540560245|FG001|Overall Study|Did not meet entrance criteria|0|||
149844133|NCT02554877|540560246|FG002|Overall Study|Did not meet entrance criteria|1|||
149844134|NCT02554877|540560247|FG003|Overall Study|Did not meet entrance criteria|0|||
149844135|NCT02554877|540560244|FG000|Overall Study|No longer met eligibility criteria|1|||
149844136|NCT02554877|540560245|FG001|Overall Study|No longer met eligibility criteria|0|||
149844137|NCT02554877|540560246|FG002|Overall Study|No longer met eligibility criteria|1|||
149844138|NCT02554877|540560247|FG003|Overall Study|No longer met eligibility criteria|1|||
149844139|NCT02554877|540560244|FG000|Overall Study|Protocol Violation|3|||
149844140|NCT02554877|540560245|FG001|Overall Study|Protocol Violation|1|||
149844141|NCT02554877|540560246|FG002|Overall Study|Protocol Violation|1|||
149844142|NCT02554877|540560247|FG003|Overall Study|Protocol Violation|0|||
149844143|NCT02554877|540560244|FG000|Overall Study|Other|1|||
149844144|NCT02554877|540560245|FG001|Overall Study|Other|3|||
149844145|NCT02554877|540560246|FG002|Overall Study|Other|0|||
149844146|NCT02554877|540560247|FG003|Overall Study|Other|3|||
149844147|NCT02554877|540560244|FG000|Overall Study|Insufficient clinical response|4|||
149844148|NCT02554877|540560245|FG001|Overall Study|Insufficient clinical response|0|||
149844149|NCT02554877|540560246|FG002|Overall Study|Insufficient clinical response|0|||
149844150|NCT02554877|540560247|FG003|Overall Study|Insufficient clinical response|0|||
149844151|NCT02554877|540560244|FG000|Overall Study|No longer willing to participate|0|||
149844152|NCT02554877|540560245|FG001|Overall Study|No longer willing to participate|2|||
149844153|NCT02554877|540560246|FG002|Overall Study|No longer willing to participate|2|||
149844154|NCT02554877|540560247|FG003|Overall Study|No longer willing to participate|0|||
149844155|NCT04474405|540560248|FG000|Overall Study|Withdrawal by Subject|0|||
149844156|NCT04474405|540560249|FG001|Overall Study|Withdrawal by Subject|0|||
149844157|NCT04474405|540560250|FG002|Overall Study|Withdrawal by Subject|1|||
149844158|NCT04474405|540560251|FG003|Overall Study|Withdrawal by Subject|0|||
149844159|NCT04474405|540560252|FG004|Overall Study|Withdrawal by Subject|1|||
149844160|NCT04474405|540560253|FG005|Overall Study|Withdrawal by Subject|0|||
149844161|NCT04474405|540560248|FG000|Overall Study|Other|0|||
149844162|NCT04474405|540560249|FG001|Overall Study|Other|0|||
149844163|NCT04474405|540560250|FG002|Overall Study|Other|0|||
149844164|NCT04474405|540560251|FG003|Overall Study|Other|0|||
149844165|NCT04474405|540560252|FG004|Overall Study|Other|3|||
149844166|NCT04474405|540560253|FG005|Overall Study|Other|0|||
149844167|NCT00274651|540560254|FG000|Overall Study|Adverse Event|6|||
149844168|NCT00274651|540560255|FG001|Overall Study|Adverse Event|3|||
149844169|NCT00274651|540560254|FG000|Overall Study|Lack of Efficacy|13|||
149844170|NCT00274651|540560255|FG001|Overall Study|Lack of Efficacy|6|||
149844171|NCT00274651|540560254|FG000|Overall Study|Death|1|||
149844172|NCT00274651|540560255|FG001|Overall Study|Death|3|||
149844173|NCT00274651|540560254|FG000|Overall Study|Withdrawal by Subject|0|||
149844174|NCT00274651|540560255|FG001|Overall Study|Withdrawal by Subject|1|||
149844175|NCT00274651|540560254|FG000|Overall Study|Physician Decision|8|||
149844176|NCT00274651|540560255|FG001|Overall Study|Physician Decision|7|||
149844177|NCT00918645|540560256|FG000|Overall Study|Withdrawal by Subject|1|||
149844178|NCT05133180|540560257|FG000|Overall Study|Withdrawal of consent|1|||
149844179|NCT05133180|540560258|FG001|Overall Study|Withdrawal of consent|1|||
149844180|NCT05133180|540560257|FG000|Overall Study|Lost to Follow-up|1|||
149844181|NCT05133180|540560258|FG001|Overall Study|Lost to Follow-up|1|||
149844182|NCT05133180|540560257|FG000|Overall Study|Documented disease progression|0|||
149844183|NCT05133180|540560258|FG001|Overall Study|Documented disease progression|1|||
149844184|NCT03446768|540560259|FG000|Overall Study|Withdrawal by Subject|0|||
149844185|NCT03446768|540560260|FG001|Overall Study|Withdrawal by Subject|1|||
149844186|NCT01604941|540560261|FG000|Overall Study|Adverse Event|1|||
149844187|NCT01604941|540560262|FG001|Overall Study|Adverse Event|2|||
149844188|NCT01604941|540560263|FG002|Overall Study|Adverse Event|0|||
149844189|NCT01604941|540560264|FG003|Overall Study|Adverse Event|0|||
149844190|NCT01604941|540560265|FG004|Overall Study|Adverse Event|1|||
149844191|NCT01604941|540560266|FG005|Overall Study|Adverse Event|5|||
149844192|NCT01604941|540560261|FG000|Overall Study|Non-compliance|1|||
149844193|NCT01604941|540560262|FG001|Overall Study|Non-compliance|0|||
149844194|NCT01604941|540560263|FG002|Overall Study|Non-compliance|0|||
149844195|NCT01604941|540560264|FG003|Overall Study|Non-compliance|0|||
149844196|NCT01604941|540560265|FG004|Overall Study|Non-compliance|0|||
149844197|NCT01604941|540560266|FG005|Overall Study|Non-compliance|0|||
149844198|NCT01604941|540560261|FG000|Overall Study|Participant Decision|0|||
149844199|NCT01604941|540560262|FG001|Overall Study|Participant Decision|0|||
149844200|NCT01604941|540560263|FG002|Overall Study|Participant Decision|0|||
149844201|NCT01604941|540560264|FG003|Overall Study|Participant Decision|0|||
149844202|NCT01604941|540560265|FG004|Overall Study|Participant Decision|0|||
149844203|NCT01604941|540560266|FG005|Overall Study|Participant Decision|2|||
149844204|NCT01604941|540560261|FG000|Overall Study|Early Study Termination|9|||
149844205|NCT01604941|540560262|FG001|Overall Study|Early Study Termination|2|||
149844206|NCT01604941|540560263|FG002|Overall Study|Early Study Termination|3|||
149844207|NCT01604941|540560264|FG003|Overall Study|Early Study Termination|3|||
149844208|NCT01604941|540560265|FG004|Overall Study|Early Study Termination|0|||
149844209|NCT01604941|540560266|FG005|Overall Study|Early Study Termination|0|||
149844210|NCT03366792|540560267|FG000|Overall Study|Withdrawal by Subject|7|||
149844211|NCT03366792|540560267|FG000|Overall Study|Lost to Follow-up|2|||
149844212|NCT03366792|540560267|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
150287066|NCT00790907|542185512|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
149844213|NCT03366792|540560267|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
149844214|NCT03325881|540560271|FG000|Overall Study|Protocol Violation|0|||
149844215|NCT03325881|540560272|FG001|Overall Study|Protocol Violation|1|||
149844216|NCT03325881|540560271|FG000|Overall Study|Withdrawal by Subject|0|||
149844217|NCT03325881|540560272|FG001|Overall Study|Withdrawal by Subject|2|||
149844218|NCT03325881|540560271|FG000|Overall Study|Lack of Efficacy|2|||
149844219|NCT03325881|540560272|FG001|Overall Study|Lack of Efficacy|0|||
149954740|NCT00422461|540966270|FG002|Overall Study|Adverse Event|1|||
149954741|NCT00422461|540966271|FG003|Overall Study|Adverse Event|1|||
149954742|NCT00422461|540966268|FG000|Overall Study|Other|0|||
149954743|NCT00422461|540966269|FG001|Overall Study|Other|0|||
149954744|NCT00422461|540966270|FG002|Overall Study|Other|0|||
149954745|NCT00422461|540966271|FG003|Overall Study|Other|2|||
149954746|NCT00422461|540966268|FG000|Overall Study|Participants no longer willing to participate in study|1|||
149954747|NCT00422461|540966269|FG001|Overall Study|Participants no longer willing to participate in study|0|||
149954748|NCT00422461|540966270|FG002|Overall Study|Participants no longer willing to participate in study|0|||
149954749|NCT00422461|540966271|FG003|Overall Study|Participants no longer willing to participate in study|0|||
149954750|NCT00422461|540966268|FG000|Overall Study|Randomized but not treated|1|||
149954751|NCT00422461|540966269|FG001|Overall Study|Randomized but not treated|1|||
149954752|NCT00422461|540966270|FG002|Overall Study|Randomized but not treated|0|||
149954753|NCT00422461|540966271|FG003|Overall Study|Randomized but not treated|0|||
150287067|NCT00790907|542185513|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
150287068|NCT00790907|542185511|FG000|Overall Study|Qualifying Condition Not Present|29|||
149844220|NCT03325881|540560271|FG000|Overall Study|Not treated|1|||
149844221|NCT03325881|540560272|FG001|Overall Study|Not treated|0|||
149844222|NCT03676634|540560273|FG000|Overall Study|Red blood cell loss|1|||
149844223|NCT03676634|540560273|FG000|Overall Study|Out-of-limit pulse|2|||
149844224|NCT02213263|540560277|FG000|Overall Study|Insufficient clinical response|4|||
149844225|NCT02213263|540560278|FG001|Overall Study|Insufficient clinical response|3|||
149844226|NCT02213263|540560277|FG000|Overall Study|Lost to Follow-up|0|||
149844227|NCT02213263|540560278|FG001|Overall Study|Lost to Follow-up|1|||
149844228|NCT02213263|540560277|FG000|Overall Study|No longer willing to participate|3|||
149954754|NCT01028053|540966273|FG000|Overall Study|Screen Failure|113|||
150287069|NCT00790907|542185512|FG001|Overall Study|Qualifying Condition Not Present|14|||
150287070|NCT00790907|542185513|FG002|Overall Study|Qualifying Condition Not Present|16|||
150287071|NCT00790907|542185511|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
150287072|NCT00790907|542185512|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
149844229|NCT02213263|540560278|FG001|Overall Study|No longer willing to participate|4|||
149844230|NCT02213263|540560277|FG000|Overall Study|Progressive disease|20|||
149844231|NCT02213263|540560278|FG001|Overall Study|Progressive disease|14|||
149844232|NCT02213263|540560277|FG000|Overall Study|Protocol Violation|0|||
149844233|NCT02213263|540560278|FG001|Overall Study|Protocol Violation|1|||
149844234|NCT02213263|540560277|FG000|Overall Study|Adverse Event|1|||
149844235|NCT02213263|540560278|FG001|Overall Study|Adverse Event|3|||
149844236|NCT01188681|540560279|FG000|Overall Study|bladder cancer|0|||
149844237|NCT01188681|540560280|FG001|Overall Study|bladder cancer|0|||
149844238|NCT01188681|540560281|FG002|Overall Study|bladder cancer|1|||
150035854|NCT00459316|541271428|FG002|Steps 1 & 2|Other eligibility failure|0|||
150035855|NCT00459316|541271426|FG000|Steps 1 & 2|Death|1|||
150035856|NCT00459316|541271427|FG001|Steps 1 & 2|Death|1|||
150035857|NCT00459316|541271428|FG002|Steps 1 & 2|Death|0|||
150035858|NCT00459316|541271426|FG000|Steps 1 & 2|Not able to get to clinic|7|||
150035859|NCT00459316|541271427|FG001|Steps 1 & 2|Not able to get to clinic|4|||
150035860|NCT00459316|541271428|FG002|Steps 1 & 2|Not able to get to clinic|0|||
150035861|NCT00459316|541271426|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
150035862|NCT00459316|541271427|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
150035863|NCT00459316|541271428|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
150035864|NCT00459316|541271426|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
150035865|NCT00459316|541271427|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
150035866|NCT00459316|541271428|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
150035867|NCT00459316|541271426|FG000|Steps 1 & 2|Lost to Follow-up|5|||
150035868|NCT00459316|541271427|FG001|Steps 1 & 2|Lost to Follow-up|0|||
150035869|NCT00459316|541271428|FG002|Steps 1 & 2|Lost to Follow-up|2|||
150035870|NCT00459316|541271426|FG000|Step 3|Withdrawal by Subject|3|||
150035871|NCT00459316|541271427|FG001|Step 3|Withdrawal by Subject|0|||
150035872|NCT00459316|541271428|FG002|Step 3|Withdrawal by Subject|1|||
150035873|NCT00910650|541271429|FG000|Overall Study|Death|2|||
150035874|NCT04543279|541271432|FG000|Overall Study|Withdrawal by Subject|1|||
150035875|NCT04543279|541271433|FG001|Overall Study|Withdrawal by Subject|0|||
150035876|NCT04543279|541271432|FG000|Overall Study|Adverse Event|1|||
150035877|NCT04543279|541271433|FG001|Overall Study|Adverse Event|0|||
150035878|NCT04543279|541271432|FG000|Overall Study|Physician Decision|1|||
150035879|NCT04543279|541271433|FG001|Overall Study|Physician Decision|0|||
150035880|NCT00929695|541271434|FG000|Overall Study|Death|2|||
150035881|NCT00929695|541271435|FG001|Overall Study|Death|1|||
150035882|NCT00929695|541271434|FG000|Overall Study|Withdrawal by Subject|0|||
150035883|NCT00929695|541271435|FG001|Overall Study|Withdrawal by Subject|2|||
150035884|NCT00929695|541271434|FG000|Overall Study|discharge home|4|||
150035885|NCT00929695|541271435|FG001|Overall Study|discharge home|3|||
150035886|NCT00929695|541271434|FG000|Overall Study|incorrect stratification|2|||
150035887|NCT00929695|541271435|FG001|Overall Study|incorrect stratification|0|||
150035888|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
150035889|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
150035890|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
150035891|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
150035892|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
150035893|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
150035894|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
150035895|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
150035896|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
150035897|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
150035898|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
150035899|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
150035900|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
150035901|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
150035902|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
150035903|NCT01436149|541271436|FG000|Antidepressant Lead-in Phase|Other|119|||
150035904|NCT01436149|541271437|FG001|Antidepressant Lead-in Phase|Other|0|||
150035905|NCT01436149|541271438|FG002|Antidepressant Lead-in Phase|Other|0|||
150035906|NCT01436149|541271436|FG000|Randomized Phase|Adverse Event|9|||
150035907|NCT01436149|541271437|FG001|Randomized Phase|Adverse Event|10|||
150035908|NCT01436149|541271438|FG002|Randomized Phase|Adverse Event|11|||
150035909|NCT01436149|541271436|FG000|Randomized Phase|Protocol Violation|4|||
150035910|NCT01436149|541271437|FG001|Randomized Phase|Protocol Violation|5|||
150035911|NCT01436149|541271438|FG002|Randomized Phase|Protocol Violation|0|||
150035912|NCT01436149|541271436|FG000|Randomized Phase|Withdrawal by Subject|16|||
150035913|NCT01436149|541271437|FG001|Randomized Phase|Withdrawal by Subject|10|||
150035914|NCT01436149|541271438|FG002|Randomized Phase|Withdrawal by Subject|10|||
150035915|NCT01436149|541271436|FG000|Randomized Phase|Lost to Follow-up|34|||
150035916|NCT01436149|541271437|FG001|Randomized Phase|Lost to Follow-up|5|||
150035917|NCT01436149|541271438|FG002|Randomized Phase|Lost to Follow-up|6|||
150035918|NCT01436149|541271436|FG000|Randomized Phase|Lack of Efficacy|0|||
150035919|NCT01436149|541271437|FG001|Randomized Phase|Lack of Efficacy|0|||
150035920|NCT01436149|541271438|FG002|Randomized Phase|Lack of Efficacy|1|||
149844239|NCT01188681|540560282|FG003|Overall Study|bladder cancer|0|||
150035921|NCT01436149|541271436|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
150035922|NCT01436149|541271437|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
150035923|NCT01436149|541271438|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
150035924|NCT01436149|541271436|FG000|Randomized Phase|Other|12|||
150035925|NCT01436149|541271437|FG001|Randomized Phase|Other|5|||
150035926|NCT01436149|541271438|FG002|Randomized Phase|Other|11|||
150035927|NCT00528112|541271441|FG000|Treatment up to 3 Years|Adverse Event|313|||
150035928|NCT00528112|541271442|FG001|Treatment up to 3 Years|Adverse Event|278|||
149844240|NCT01188681|540560279|FG000|Overall Study|Withdrawal by Subject|0|||
150035929|NCT00528112|541271441|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
150035930|NCT00528112|541271442|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
150035931|NCT00528112|541271441|FG000|Treatment up to 3 Years|Protocol Violation|16|||
150035932|NCT00528112|541271442|FG001|Treatment up to 3 Years|Protocol Violation|16|||
150035933|NCT00528112|541271441|FG000|Treatment up to 3 Years|Death|0|||
150035934|NCT00528112|541271442|FG001|Treatment up to 3 Years|Death|1|||
150035935|NCT00528112|541271441|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
150035936|NCT00528112|541271442|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
150035937|NCT00528112|541271441|FG000|Treatment up to 3 Years|Pregnancy|9|||
150035938|NCT00528112|541271442|FG001|Treatment up to 3 Years|Pregnancy|10|||
150035939|NCT00528112|541271441|FG000|Treatment up to 3 Years|Other reasons|186|||
150035940|NCT00528112|541271442|FG001|Treatment up to 3 Years|Other reasons|186|||
150035941|NCT00528112|541271441|FG000|Extension Phase|Withdrawal by Subject|0|||
149844241|NCT01188681|540560280|FG001|Overall Study|Withdrawal by Subject|0|||
149844242|NCT01188681|540560281|FG002|Overall Study|Withdrawal by Subject|0|||
149844243|NCT01188681|540560282|FG003|Overall Study|Withdrawal by Subject|1|||
149844244|NCT01316055|540560287|FG000|Overall Study|Lost to Follow-up|1|||
149844245|NCT01316055|540560288|FG001|Overall Study|Lost to Follow-up|0|||
149844246|NCT01316055|540560289|FG002|Overall Study|Lost to Follow-up|0|||
149844247|NCT00003470|540560290|FG000|Overall Study|Not evaluable|6|||
149844248|NCT02679729|540560292|FG000|Overall Study|Lost to Follow-up|0|||
149844249|NCT02679729|540560293|FG001|Overall Study|Lost to Follow-up|1|||
149844250|NCT02679729|540560294|FG002|Overall Study|Lost to Follow-up|0|||
149844251|NCT02679729|540560295|FG003|Overall Study|Lost to Follow-up|0|||
149844252|NCT02679729|540560296|FG004|Overall Study|Lost to Follow-up|1|||
149844253|NCT02679729|540560297|FG005|Overall Study|Lost to Follow-up|0|||
149844254|NCT02679729|540560298|FG006|Overall Study|Lost to Follow-up|0|||
149844255|NCT02679729|540560299|FG007|Overall Study|Lost to Follow-up|0|||
149844256|NCT02679729|540560300|FG008|Overall Study|Lost to Follow-up|0|||
149844257|NCT02679729|540560292|FG000|Overall Study|Participant decision|0|||
149844258|NCT02679729|540560293|FG001|Overall Study|Participant decision|1|||
149844259|NCT02679729|540560294|FG002|Overall Study|Participant decision|0|||
149844260|NCT02679729|540560295|FG003|Overall Study|Participant decision|0|||
149844261|NCT02679729|540560296|FG004|Overall Study|Participant decision|0|||
149844262|NCT02679729|540560297|FG005|Overall Study|Participant decision|0|||
149844263|NCT02679729|540560298|FG006|Overall Study|Participant decision|1|||
149844264|NCT02679729|540560299|FG007|Overall Study|Participant decision|0|||
149844265|NCT02679729|540560300|FG008|Overall Study|Participant decision|0|||
149844266|NCT00748566|540560303|FG000|Overall Study|Adverse Event|49|||
149844267|NCT00748566|540560303|FG000|Overall Study|Death|1|||
149844268|NCT00748566|540560303|FG000|Overall Study|Lack of Efficacy|12|||
149844269|NCT00748566|540560303|FG000|Overall Study|Lost to Follow-up|1|||
149844270|NCT00748566|540560303|FG000|Overall Study|Protocol Violation|13|||
149844271|NCT00748566|540560303|FG000|Overall Study|Withdrawal by Subject|22|||
149844272|NCT00748566|540560303|FG000|Overall Study|Study terminated by sponsor|5|||
149844273|NCT00748566|540560303|FG000|Overall Study|Other|9|||
149844274|NCT01442376|540560310|FG000|Overall Study|Adverse Event|0|||
149844275|NCT01442376|540560311|FG001|Overall Study|Adverse Event|3|||
149844276|NCT01442376|540560312|FG002|Overall Study|Adverse Event|2|||
149844277|NCT01442376|540560310|FG000|Overall Study|Death|0|||
149844278|NCT01442376|540560311|FG001|Overall Study|Death|1|||
149844279|NCT01442376|540560312|FG002|Overall Study|Death|1|||
149844280|NCT01442376|540560310|FG000|Overall Study|Withdrawal of consent|0|||
149844281|NCT01442376|540560311|FG001|Overall Study|Withdrawal of consent|0|||
149844282|NCT01442376|540560312|FG002|Overall Study|Withdrawal of consent|1|||
149844283|NCT01442376|540560310|FG000|Overall Study|Patients not treated|2|||
149844284|NCT01442376|540560311|FG001|Overall Study|Patients not treated|3|||
150035942|NCT00528112|541271442|FG001|Extension Phase|Withdrawal by Subject|3|||
150035943|NCT00528112|541271441|FG000|Extension Phase|Other reasons|0|||
150035944|NCT00528112|541271442|FG001|Extension Phase|Other reasons|100|||
150172595|NCT00949975|541768025|FG003|Overall Study|Incorrect enrolment|7|||
150172596|NCT00949975|541768022|FG000|Overall Study|Severe non-compliance|3|||
150172597|NCT00949975|541768023|FG001|Overall Study|Severe non-compliance|1|||
150172598|NCT00949975|541768024|FG002|Overall Study|Severe non-compliance|0|||
149844285|NCT01442376|540560312|FG002|Overall Study|Patients not treated|1|||
149844286|NCT01442376|540560310|FG000|Overall Study|Not eligible for subsequent cycles|1|||
149844287|NCT01442376|540560311|FG001|Overall Study|Not eligible for subsequent cycles|2|||
149844288|NCT01442376|540560312|FG002|Overall Study|Not eligible for subsequent cycles|0|||
150035945|NCT00528112|541271441|FG000|Extension Phase|Pregnancy|0|||
149844289|NCT04404725|540560313|FG000|First Intervention|Withdrawal by Subject|0|||
149844290|NCT04404725|540560314|FG001|First Intervention|Withdrawal by Subject|2|||
149844291|NCT04404725|540560313|FG000|Second Intervention|Adverse Event|1|||
149844292|NCT04404725|540560314|FG001|Second Intervention|Adverse Event|1|||
149844293|NCT04404725|540560313|FG000|Second Intervention|Withdrawal by Subject|0|||
149844294|NCT04404725|540560314|FG001|Second Intervention|Withdrawal by Subject|1|||
149844295|NCT01075516|540560315|FG000|Overall Study|Death|5|||
149844296|NCT01075516|540560316|FG001|Overall Study|Death|9|||
149844297|NCT01075516|540560315|FG000|Overall Study|Lost to Follow-up|10|||
149844298|NCT01075516|540560316|FG001|Overall Study|Lost to Follow-up|2|||
149844299|NCT01075516|540560315|FG000|Overall Study|Withdrawal by Subject|3|||
149844300|NCT01075516|540560316|FG001|Overall Study|Withdrawal by Subject|5|||
149844301|NCT02911025|540560317|FG000|Overall Study|Lost to Follow-up|3|||
149844302|NCT01473953|540560322|FG000|Overall Study|Other|1|||
149844303|NCT01473953|540560323|FG001|Overall Study|Other|0|||
149844304|NCT01473953|540560324|FG002|Overall Study|Other|0|||
149844305|NCT01473953|540560325|FG003|Overall Study|Other|0|||
149844306|NCT01473953|540560326|FG004|Overall Study|Other|0|||
149844307|NCT00312897|540560327|FG000|Overall Study|Adverse Event|1|||
150287073|NCT00790907|542185513|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
150287074|NCT00790907|542185511|FG000|Overall Study|Did Not Receive Study Drug|10|||
150287075|NCT00790907|542185512|FG001|Overall Study|Did Not Receive Study Drug|0|||
150287076|NCT00790907|542185513|FG002|Overall Study|Did Not Receive Study Drug|0|||
150287077|NCT01888640|542185514|FG000|Overall Study|Lost to Follow-up|1|||
150287078|NCT01888640|542185515|FG001|Overall Study|Lost to Follow-up|2|||
150287079|NCT01888640|542185516|FG002|Overall Study|Lost to Follow-up|0|||
150287080|NCT01888640|542185514|FG000|Overall Study|Withdrawal by Subject|15|||
150287081|NCT01888640|542185515|FG001|Overall Study|Withdrawal by Subject|11|||
150287082|NCT01888640|542185516|FG002|Overall Study|Withdrawal by Subject|4|||
150287083|NCT01888640|542185514|FG000|Overall Study|Minimum dose not met|10|||
150287084|NCT01888640|542185515|FG001|Overall Study|Minimum dose not met|16|||
150287085|NCT01888640|542185516|FG002|Overall Study|Minimum dose not met|0|||
150287086|NCT01888640|542185514|FG000|Overall Study|Given wrong unit (placebo)|1|||
150287087|NCT01888640|542185515|FG001|Overall Study|Given wrong unit (placebo)|0|||
150287088|NCT01888640|542185516|FG002|Overall Study|Given wrong unit (placebo)|0|||
150287089|NCT01888640|542185514|FG000|Overall Study|Excluded for prior TENS|0|||
150287090|NCT01888640|542185515|FG001|Overall Study|Excluded for prior TENS|1|||
150287091|NCT01888640|542185516|FG002|Overall Study|Excluded for prior TENS|0|||
150287092|NCT01888640|542185514|FG000|Overall Study|Researcher Termination of Participant|0|||
150287093|NCT01888640|542185515|FG001|Overall Study|Researcher Termination of Participant|1|||
150287094|NCT01888640|542185516|FG002|Overall Study|Researcher Termination of Participant|1|||
150172599|NCT00949975|541768025|FG003|Overall Study|Severe non-compliance|2|||
150172600|NCT00949975|541768022|FG000|Overall Study|Lost to Follow-up|1|||
150287095|NCT00109707|542185521|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
150287096|NCT00109707|542185522|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
150287097|NCT00109707|542185523|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
150287098|NCT00109707|542185521|FG000|Overall Study|Abnormal laboratory values|1|||
150287099|NCT00109707|542185522|FG001|Overall Study|Abnormal laboratory values|0|||
150287100|NCT00109707|542185523|FG002|Overall Study|Abnormal laboratory values|0|||
150287101|NCT00109707|542185521|FG000|Overall Study|Administrative problems|2|||
150287102|NCT00109707|542185522|FG001|Overall Study|Administrative problems|0|||
150287103|NCT00109707|542185523|FG002|Overall Study|Administrative problems|1|||
150287104|NCT00109707|542185521|FG000|Overall Study|Adverse Event|10|||
150287105|NCT00109707|542185522|FG001|Overall Study|Adverse Event|2|||
150287106|NCT00109707|542185523|FG002|Overall Study|Adverse Event|3|||
150287107|NCT00109707|542185521|FG000|Overall Study|Death|4|||
150287108|NCT00109707|542185522|FG001|Overall Study|Death|0|||
150287109|NCT00109707|542185523|FG002|Overall Study|Death|0|||
149844308|NCT00312897|540560328|FG001|Overall Study|Adverse Event|0|||
149844309|NCT00312897|540560327|FG000|Overall Study|Lost to Follow-up|2|||
149844310|NCT00312897|540560328|FG001|Overall Study|Lost to Follow-up|0|||
149844311|NCT00312897|540560327|FG000|Overall Study|Physician Decision|1|||
149844312|NCT00312897|540560328|FG001|Overall Study|Physician Decision|0|||
149844313|NCT00312897|540560327|FG000|Overall Study|Withdrawal by Subject|1|||
149844314|NCT00312897|540560328|FG001|Overall Study|Withdrawal by Subject|3|||
149844315|NCT00312897|540560327|FG000|Overall Study|Pregnancy|1|||
149844316|NCT00312897|540560328|FG001|Overall Study|Pregnancy|0|||
149844317|NCT00312897|540560327|FG000|Overall Study|discontinued prior to getting treatment|0|||
149844318|NCT00312897|540560328|FG001|Overall Study|discontinued prior to getting treatment|3|||
149844319|NCT02011945|540560329|FG000|Overall Study|Participant requested to Discontinue|0|||
149844320|NCT02011945|540560330|FG001|Overall Study|Participant requested to Discontinue|1|||
149844321|NCT02011945|540560331|FG002|Overall Study|Participant requested to Discontinue|1|||
149844322|NCT02011945|540560329|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
149844323|NCT02011945|540560330|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
149844324|NCT02011945|540560331|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
149844325|NCT02011945|540560329|FG000|Overall Study|Study Drug Toxicity|0|||
149844326|NCT02011945|540560330|FG001|Overall Study|Study Drug Toxicity|0|||
149844327|NCT02011945|540560331|FG002|Overall Study|Study Drug Toxicity|1|||
149844328|NCT02011945|540560329|FG000|Overall Study|Treatment Failure|0|||
149844329|NCT02011945|540560330|FG001|Overall Study|Treatment Failure|7|||
149844330|NCT02011945|540560331|FG002|Overall Study|Treatment Failure|6|||
149844331|NCT02011945|540560329|FG000|Overall Study|No Longer Meets Study Criteria|1|||
149844332|NCT02011945|540560330|FG001|Overall Study|No Longer Meets Study Criteria|0|||
150287110|NCT00109707|542185521|FG000|Overall Study|Disease progression|12|||
150287111|NCT00109707|542185522|FG001|Overall Study|Disease progression|4|||
150287112|NCT00109707|542185523|FG002|Overall Study|Disease progression|3|||
150287113|NCT00109707|542185521|FG000|Overall Study|Lost to Follow-up|3|||
150287114|NCT00109707|542185522|FG001|Overall Study|Lost to Follow-up|0|||
150287115|NCT00109707|542185523|FG002|Overall Study|Lost to Follow-up|0|||
150287116|NCT00109707|542185521|FG000|Overall Study|Protocol Violation|1|||
150287117|NCT00109707|542185522|FG001|Overall Study|Protocol Violation|0|||
150287118|NCT00109707|542185523|FG002|Overall Study|Protocol Violation|0|||
150287119|NCT00109707|542185521|FG000|Overall Study|Patient withdrew consent|6|||
150287120|NCT00109707|542185522|FG001|Overall Study|Patient withdrew consent|1|||
150287121|NCT00109707|542185523|FG002|Overall Study|Patient withdrew consent|0|||
150287122|NCT02199080|542185525|FG000|Overall Study|Protocol Violation|12|||
150287123|NCT02443883|542185526|FG000|Overall Study|Adverse Event|0|||
150287124|NCT02443883|542185527|FG001|Overall Study|Adverse Event|1|||
150287125|NCT02443883|542185528|FG002|Overall Study|Adverse Event|0|||
150287126|NCT02443883|542185529|FG003|Overall Study|Adverse Event|0|||
150287127|NCT02443883|542185526|FG000|Overall Study|Lost to Follow-up|3|||
150287128|NCT02443883|542185527|FG001|Overall Study|Lost to Follow-up|2|||
150287129|NCT02443883|542185528|FG002|Overall Study|Lost to Follow-up|1|||
150287130|NCT02443883|542185529|FG003|Overall Study|Lost to Follow-up|0|||
150287131|NCT02443883|542185526|FG000|Overall Study|Physician Decision|1|||
150287132|NCT02443883|542185527|FG001|Overall Study|Physician Decision|1|||
150287133|NCT02443883|542185528|FG002|Overall Study|Physician Decision|0|||
150287134|NCT02443883|542185529|FG003|Overall Study|Physician Decision|3|||
150287135|NCT02443883|542185526|FG000|Overall Study|Withdrawal by Subject|1|||
150287136|NCT02443883|542185527|FG001|Overall Study|Withdrawal by Subject|0|||
150287137|NCT02443883|542185528|FG002|Overall Study|Withdrawal by Subject|0|||
150287138|NCT02443883|542185529|FG003|Overall Study|Withdrawal by Subject|2|||
150287139|NCT02443883|542185526|FG000|Overall Study|Randomized, but never treated|1|||
149954755|NCT01028053|540966273|FG000|Overall Study|Patient Request|11|||
149954756|NCT01028053|540966273|FG000|Overall Study|Protocol Violation|1|||
149954757|NCT01028053|540966273|FG000|Overall Study|Physician Decision|2|||
149954758|NCT01028053|540966273|FG000|Overall Study|Technical Problem|1|||
149954759|NCT01028053|540966273|FG000|Overall Study|Terminated by Sponsor|1|||
149954760|NCT01028053|540966273|FG000|Overall Study|Various reasons|4|||
149954761|NCT00574951|540966275|FG000|Overall Study|Ineligible - improper prior treatment|1|||
149954762|NCT01060111|540966276|FG000|Overall Study|Adverse Event|9|||
149954763|NCT01060111|540966277|FG001|Overall Study|Adverse Event|5|||
149954764|NCT01060111|540966278|FG002|Overall Study|Adverse Event|18|||
149954765|NCT01060111|540966276|FG000|Overall Study|Lack of Efficacy|2|||
149954766|NCT01060111|540966277|FG001|Overall Study|Lack of Efficacy|1|||
149954767|NCT01060111|540966278|FG002|Overall Study|Lack of Efficacy|0|||
149954768|NCT01060111|540966276|FG000|Overall Study|Inappropriate participant|5|||
149954769|NCT01060111|540966277|FG001|Overall Study|Inappropriate participant|4|||
149954770|NCT01060111|540966278|FG002|Overall Study|Inappropriate participant|5|||
149954771|NCT01060111|540966276|FG000|Overall Study|Participants' evasion for hospital visit|0|||
149954772|NCT01060111|540966277|FG001|Overall Study|Participants' evasion for hospital visit|3|||
149954773|NCT01060111|540966278|FG002|Overall Study|Participants' evasion for hospital visit|2|||
149954774|NCT01060111|540966276|FG000|Overall Study|Participants' non-cooperation|8|||
149954775|NCT01060111|540966277|FG001|Overall Study|Participants' non-cooperation|6|||
149954776|NCT01060111|540966278|FG002|Overall Study|Participants' non-cooperation|6|||
149954777|NCT01060111|540966276|FG000|Overall Study|Adverse event and insufficient effect|0|||
149954778|NCT01060111|540966277|FG001|Overall Study|Adverse event and insufficient effect|1|||
149954779|NCT01060111|540966278|FG002|Overall Study|Adverse event and insufficient effect|0|||
149954780|NCT01060111|540966276|FG000|Overall Study|Participants' non-cooperation|1|||
149954781|NCT01060111|540966277|FG001|Overall Study|Participants' non-cooperation|0|||
149954782|NCT01060111|540966278|FG002|Overall Study|Participants' non-cooperation|0|||
149954783|NCT01060111|540966276|FG000|Overall Study|Other|2|||
149954784|NCT01060111|540966277|FG001|Overall Study|Other|3|||
150035946|NCT00528112|541271442|FG001|Extension Phase|Pregnancy|3|||
150035947|NCT00528112|541271441|FG000|Extension Phase|Lost to Follow-up|0|||
150035948|NCT00528112|541271442|FG001|Extension Phase|Lost to Follow-up|12|||
150035949|NCT00528112|541271441|FG000|Extension Phase|Death|0|||
150035950|NCT00528112|541271442|FG001|Extension Phase|Death|1|||
150287140|NCT02443883|542185527|FG001|Overall Study|Randomized, but never treated|0|||
150287141|NCT02443883|542185528|FG002|Overall Study|Randomized, but never treated|0|||
149954785|NCT01060111|540966278|FG002|Overall Study|Other|4|||
150172601|NCT00949975|541768023|FG001|Overall Study|Lost to Follow-up|0|||
150287142|NCT02443883|542185529|FG003|Overall Study|Randomized, but never treated|0|||
150287143|NCT03436862|542185530|FG000|Overall Study|Adverse Event|4|||
150287144|NCT03436862|542185530|FG000|Overall Study|Progressive Disease|2|||
150287145|NCT02937818|542185531|FG000|Overall Study|Participants decision|2|||
150287146|NCT02937818|542185532|FG001|Overall Study|Participants decision|1|||
149954786|NCT01336972|540966281|FG000|Overall Study|Adverse Event|1|||
149954787|NCT01336972|540966282|FG001|Overall Study|Adverse Event|1|||
150035951|NCT00528112|541271441|FG000|Extension Phase|Adverse Event|0|||
150287147|NCT02937818|542185533|FG002|Overall Study|Participants decision|1|||
150287148|NCT02937818|542185534|FG003|Overall Study|Participants decision|1|||
150287149|NCT02937818|542185531|FG000|Overall Study|Adverse Event|2|||
150287150|NCT02937818|542185532|FG001|Overall Study|Adverse Event|4|||
150287151|NCT02937818|542185533|FG002|Overall Study|Adverse Event|1|||
150287152|NCT02937818|542185534|FG003|Overall Study|Adverse Event|1|||
150287153|NCT02937818|542185531|FG000|Overall Study|Disease progression|17|||
150287154|NCT02937818|542185532|FG001|Overall Study|Disease progression|15|||
150287155|NCT02937818|542185533|FG002|Overall Study|Disease progression|7|||
150287156|NCT02937818|542185534|FG003|Overall Study|Disease progression|19|||
150287157|NCT02937818|542185531|FG000|Overall Study|Condition under investigation worsened|0|||
150287158|NCT02937818|542185532|FG001|Overall Study|Condition under investigation worsened|0|||
150287159|NCT02937818|542185533|FG002|Overall Study|Condition under investigation worsened|1|||
150287160|NCT02937818|542185534|FG003|Overall Study|Condition under investigation worsened|0|||
150287161|NCT00606086|542185535|FG000|Overall Study|Adverse Event|1|||
150287162|NCT00606086|542185536|FG001|Overall Study|Adverse Event|1|||
150287163|NCT00606086|542185535|FG000|Overall Study|Lost to Follow-up|4|||
150287164|NCT00606086|542185536|FG001|Overall Study|Lost to Follow-up|8|||
150287165|NCT00606086|542185535|FG000|Overall Study|Protocol Violation|1|||
150287166|NCT00606086|542185536|FG001|Overall Study|Protocol Violation|0|||
150287167|NCT00606086|542185535|FG000|Overall Study|Withdrawal by Subject|5|||
150287168|NCT00606086|542185536|FG001|Overall Study|Withdrawal by Subject|3|||
150287169|NCT00606086|542185535|FG000|Overall Study|Non-compliance|0|||
150287170|NCT00606086|542185536|FG001|Overall Study|Non-compliance|1|||
150287171|NCT00606086|542185535|FG000|Overall Study|Randomized, not treated|1|||
150287172|NCT00606086|542185536|FG001|Overall Study|Randomized, not treated|2|||
150287173|NCT01929408|542185540|FG000|Overall Study|received HCT as initial treatment|8|||
150287174|NCT00391222|542185543|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
150287175|NCT00391222|542185544|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
150287176|NCT00391222|542185545|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
150287177|NCT00391222|542185546|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
150287178|NCT00391222|542185543|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
150287179|NCT00391222|542185544|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
150287180|NCT00391222|542185545|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
150287181|NCT00391222|542185546|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
150287182|NCT00391222|542185543|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
150287183|NCT00391222|542185544|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
150287184|NCT00391222|542185545|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
150287185|NCT00391222|542185546|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
150287186|NCT00391222|542185543|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
150287187|NCT00391222|542185544|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
150287188|NCT00391222|542185545|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
150287189|NCT00391222|542185546|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
150287190|NCT00391222|542185543|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
150287191|NCT00391222|542185544|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
150287192|NCT00391222|542185545|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
150287193|NCT00391222|542185546|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
150287194|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
150287195|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
150287196|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
150287197|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
150287198|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
150287199|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
150287200|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
150287201|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
150287202|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
150287203|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
150287204|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
150287205|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
150287206|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
150287207|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
150287208|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
150287209|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
150287210|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
150287211|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
150287212|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
150287213|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
150287214|NCT00391222|542185543|FG000|Period III (Double-Blind Treatment)|Other|6|||
150287215|NCT00391222|542185544|FG001|Period III (Double-Blind Treatment)|Other|1|||
150287216|NCT00391222|542185545|FG002|Period III (Double-Blind Treatment)|Other|6|||
150287217|NCT00391222|542185546|FG003|Period III (Double-Blind Treatment)|Other|0|||
150287218|NCT00889265|542185547|FG000|Overall Study|Adverse Event|1|||
150287219|NCT00889265|542185547|FG000|Overall Study|Lost to Follow-up|5|||
150287220|NCT00889265|542185547|FG000|Overall Study|Protocol Violation|1|||
149954788|NCT01336972|540966283|FG002|Overall Study|Adverse Event|0|||
149954789|NCT05278065|540966284|FG000|Overall Study|Withdrawal by Subject|1|||
149954790|NCT05278065|540966285|FG001|Overall Study|Withdrawal by Subject|0|||
149954791|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
149954792|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
149954793|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
149954794|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
149954795|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
149954796|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
149954797|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
149954798|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
149954799|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
149954800|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
149954801|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
149954802|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
149954803|NCT03446573|540966286|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
149954804|NCT03446573|540966287|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
149954805|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
149954806|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
149954807|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
149954808|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
149954809|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
149954810|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
149954811|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
149954812|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
149954813|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
149954814|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
149954815|NCT03446573|540966286|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
149954816|NCT03446573|540966287|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
149954817|NCT02029443|540966288|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
149954818|NCT02029443|540966289|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
149954819|NCT02029443|540966290|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
149954820|NCT02029443|540966291|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
149954821|NCT02029443|540966292|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
149954822|NCT02029443|540966288|FG000|Overall Study|Death|13|||
149954823|NCT02029443|540966289|FG001|Overall Study|Death|2|||
149954824|NCT02029443|540966290|FG002|Overall Study|Death|2|||
149954825|NCT02029443|540966291|FG003|Overall Study|Death|11|||
149954826|NCT02029443|540966292|FG004|Overall Study|Death|2|||
149954827|NCT02029443|540966288|FG000|Overall Study|Lost to Follow-up|1|||
149954828|NCT02029443|540966289|FG001|Overall Study|Lost to Follow-up|0|||
149954829|NCT02029443|540966290|FG002|Overall Study|Lost to Follow-up|1|||
149954830|NCT02029443|540966291|FG003|Overall Study|Lost to Follow-up|1|||
149954831|NCT02029443|540966292|FG004|Overall Study|Lost to Follow-up|0|||
149954832|NCT02029443|540966288|FG000|Overall Study|Started other anti-cancer therapy|17|||
149954833|NCT02029443|540966289|FG001|Overall Study|Started other anti-cancer therapy|4|||
149954834|NCT02029443|540966290|FG002|Overall Study|Started other anti-cancer therapy|7|||
149954835|NCT02029443|540966291|FG003|Overall Study|Started other anti-cancer therapy|9|||
150287221|NCT02069899|542185548|FG000|Overall Study|Adverse Event|6|||
150287222|NCT02069899|542185549|FG001|Overall Study|Adverse Event|0|||
150287223|NCT02069899|542185550|FG002|Overall Study|Adverse Event|1|||
150287224|NCT02069899|542185548|FG000|Overall Study|Withdrawal by Participant|2|||
150287225|NCT02069899|542185549|FG001|Overall Study|Withdrawal by Participant|0|||
150287226|NCT02069899|542185550|FG002|Overall Study|Withdrawal by Participant|0|||
150287227|NCT02069899|542185548|FG000|Overall Study|Lost to Follow-up|1|||
150287228|NCT02069899|542185549|FG001|Overall Study|Lost to Follow-up|0|||
150287229|NCT02069899|542185550|FG002|Overall Study|Lost to Follow-up|1|||
150287230|NCT02069899|542185548|FG000|Overall Study|Other|4|||
150287231|NCT02069899|542185549|FG001|Overall Study|Other|0|||
150287232|NCT02069899|542185550|FG002|Overall Study|Other|0|||
150287233|NCT02069899|542185548|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
150287234|NCT02069899|542185549|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
150287235|NCT02069899|542185550|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
150287236|NCT02069899|542185548|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
150287237|NCT02069899|542185549|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
150287238|NCT02069899|542185550|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
150287239|NCT00531752|542185551|FG000|First Double-blind Intervention Period|Adverse Event|2|||
150287240|NCT00531752|542185552|FG001|First Double-blind Intervention Period|Adverse Event|0|||
150287241|NCT00531752|542185553|FG002|First Double-blind Intervention Period|Adverse Event|1|||
150287242|NCT00531752|542185554|FG003|First Double-blind Intervention Period|Adverse Event|1|||
149954836|NCT02029443|540966292|FG004|Overall Study|Started other anti-cancer therapy|3|||
149954837|NCT02029443|540966288|FG000|Overall Study|Withdrawal by Subject|3|||
149954838|NCT02029443|540966289|FG001|Overall Study|Withdrawal by Subject|1|||
149954839|NCT02029443|540966290|FG002|Overall Study|Withdrawal by Subject|1|||
149954840|NCT02029443|540966291|FG003|Overall Study|Withdrawal by Subject|1|||
149954841|NCT02029443|540966292|FG004|Overall Study|Withdrawal by Subject|0|||
149954842|NCT02029443|540966288|FG000|Overall Study|Other|6|||
149954843|NCT02029443|540966289|FG001|Overall Study|Other|6|||
149954844|NCT02029443|540966290|FG002|Overall Study|Other|4|||
149954845|NCT02029443|540966291|FG003|Overall Study|Other|2|||
149954846|NCT02029443|540966292|FG004|Overall Study|Other|0|||
149954847|NCT02070991|540966299|FG000|Overall Study|Death|2|||
149954848|NCT02070991|540966300|FG001|Overall Study|Death|0|||
149954849|NCT02070991|540966299|FG000|Overall Study|Withdrawal by Subject|1|||
149954850|NCT02070991|540966300|FG001|Overall Study|Withdrawal by Subject|0|||
149954851|NCT02448043|540966301|FG000|Overall Study|Withdrawal by Subject|2|||
149954852|NCT02448043|540966302|FG001|Overall Study|Withdrawal by Subject|2|||
149954853|NCT02448043|540966301|FG000|Overall Study|Protocol Violation|1|||
149954854|NCT02448043|540966302|FG001|Overall Study|Protocol Violation|2|||
149954855|NCT05762679|540966303|FG000|Overall Study|Withdrawal by Subject|1|||
149954856|NCT05762679|540966303|FG000|Overall Study|No analyzable imaging data|1|||
149954857|NCT02068599|540966308|FG000|Overall Study|Adverse Event|4|||
149954858|NCT02068599|540966309|FG001|Overall Study|Adverse Event|1|||
149954859|NCT02068599|540966310|FG002|Overall Study|Adverse Event|1|||
149954860|NCT02068599|540966308|FG000|Overall Study|Withdrawal by Subject|2|||
149954861|NCT02068599|540966309|FG001|Overall Study|Withdrawal by Subject|7|||
149954862|NCT02068599|540966310|FG002|Overall Study|Withdrawal by Subject|5|||
149954863|NCT02068599|540966308|FG000|Overall Study|Protocol Violation|4|||
149954864|NCT02068599|540966309|FG001|Overall Study|Protocol Violation|2|||
149954865|NCT02068599|540966310|FG002|Overall Study|Protocol Violation|3|||
149954866|NCT02068599|540966308|FG000|Overall Study|Lost to Follow-up|1|||
149954867|NCT02068599|540966309|FG001|Overall Study|Lost to Follow-up|0|||
149954868|NCT02068599|540966310|FG002|Overall Study|Lost to Follow-up|0|||
149954869|NCT02068599|540966308|FG000|Overall Study|Lack of Efficacy|0|||
149954870|NCT02068599|540966309|FG001|Overall Study|Lack of Efficacy|0|||
149954871|NCT02068599|540966310|FG002|Overall Study|Lack of Efficacy|3|||
149954872|NCT02068599|540966308|FG000|Overall Study|Noncompliance|0|||
149954873|NCT02068599|540966309|FG001|Overall Study|Noncompliance|0|||
149954874|NCT02068599|540966310|FG002|Overall Study|Noncompliance|1|||
149954875|NCT02958527|540966313|FG000|Overall Study|Not collected CRFs|12|||
149954876|NCT06042855|540966314|FG000|Overall Study|No Receipt of Study Drug|48|||
149954877|NCT06042855|540966315|FG001|Overall Study|No Receipt of Study Drug|57|||
150287243|NCT00531752|542185551|FG000|First Double-blind Intervention Period|Other|1|||
150287244|NCT00531752|542185552|FG001|First Double-blind Intervention Period|Other|4|||
149844333|NCT02011945|540560331|FG002|Overall Study|No Longer Meets Study Criteria|0|||
149844334|NCT02011945|540560329|FG000|Overall Study|Proceeded to stem cell transplant|0|||
149844335|NCT02011945|540560330|FG001|Overall Study|Proceeded to stem cell transplant|0|||
149844336|NCT02011945|540560331|FG002|Overall Study|Proceeded to stem cell transplant|1|||
149844337|NCT02011945|540560329|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
149844338|NCT02011945|540560330|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
149844339|NCT02011945|540560331|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
149844340|NCT00902538|540560332|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
149844341|NCT00902538|540560333|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
149844342|NCT00902538|540560334|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
149844343|NCT00902538|540560335|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
149844344|NCT00902538|540560336|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
149844345|NCT00902538|540560337|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
149844346|NCT00902538|540560332|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
149844347|NCT00902538|540560333|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
149844348|NCT00902538|540560334|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
149844349|NCT00902538|540560335|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
149844350|NCT00902538|540560336|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
149954878|NCT06042855|540966314|FG000|Overall Study|Administratively Withdrawn|59|||
149954879|NCT06042855|540966315|FG001|Overall Study|Administratively Withdrawn|59|||
149954880|NCT02691572|540966317|FG000|Overall Study|Withdrawal by Subject|1|||
149954881|NCT02691572|540966318|FG001|Overall Study|Withdrawal by Subject|0|||
149954882|NCT02691572|540966317|FG000|Overall Study|Protocol Violation|0|||
149954883|NCT02691572|540966318|FG001|Overall Study|Protocol Violation|1|||
150035952|NCT00528112|541271442|FG001|Extension Phase|Adverse Event|36|||
150035953|NCT00528112|541271441|FG000|Extension Phase|Protocol Violation|0|||
150035954|NCT00528112|541271442|FG001|Extension Phase|Protocol Violation|2|||
150035955|NCT02559622|541271444|FG000|Overall Study|Progressive disease|0|||
150035956|NCT02559622|541271445|FG001|Overall Study|Progressive disease|1|||
150035957|NCT02559622|541271446|FG002|Overall Study|Progressive disease|0|||
150035958|NCT02559622|541271447|FG003|Overall Study|Progressive disease|0|||
150035959|NCT02559622|541271444|FG000|Overall Study|Adverse Event|0|||
150035960|NCT02559622|541271445|FG001|Overall Study|Adverse Event|2|||
150035961|NCT02559622|541271446|FG002|Overall Study|Adverse Event|2|||
150035962|NCT02559622|541271447|FG003|Overall Study|Adverse Event|2|||
150035963|NCT02559622|541271444|FG000|Overall Study|Patient/guardian decision|1|||
150035964|NCT02559622|541271445|FG001|Overall Study|Patient/guardian decision|2|||
150035965|NCT02559622|541271446|FG002|Overall Study|Patient/guardian decision|0|||
150035966|NCT02559622|541271447|FG003|Overall Study|Patient/guardian decision|1|||
150035967|NCT02246530|541271454|FG000|Overall Study|Lost to Follow-up|4|||
150035968|NCT02246530|541271455|FG001|Overall Study|Lost to Follow-up|0|||
150035969|NCT01506596|541271456|FG000|Overall Study|ineligible pathology|1|||
150035970|NCT01488890|541271459|FG000|Overall Study|Serious adverse event|2|||
150035971|NCT01488890|541271460|FG001|Overall Study|Serious adverse event|0|||
150035972|NCT01488890|541271461|FG002|Overall Study|Serious adverse event|0|||
150035973|NCT01488890|541271462|FG003|Overall Study|Serious adverse event|0|||
150035974|NCT01488890|541271459|FG000|Overall Study|Protocol Violation|3|||
150035975|NCT01488890|541271460|FG001|Overall Study|Protocol Violation|0|||
150035976|NCT01488890|541271461|FG002|Overall Study|Protocol Violation|4|||
150035977|NCT01488890|541271462|FG003|Overall Study|Protocol Violation|0|||
150035978|NCT01488890|541271459|FG000|Overall Study|Lost to Follow-up|13|||
150035979|NCT01488890|541271460|FG001|Overall Study|Lost to Follow-up|10|||
150035980|NCT01488890|541271461|FG002|Overall Study|Lost to Follow-up|20|||
150035981|NCT01488890|541271462|FG003|Overall Study|Lost to Follow-up|3|||
150035982|NCT01488890|541271459|FG000|Overall Study|Withdrawal by Subject|14|||
150035983|NCT01488890|541271460|FG001|Overall Study|Withdrawal by Subject|10|||
150035984|NCT01488890|541271461|FG002|Overall Study|Withdrawal by Subject|11|||
150035985|NCT01488890|541271462|FG003|Overall Study|Withdrawal by Subject|2|||
150035986|NCT04408989|541271465|FG000|Overall Study|Lost to Follow-up|0|||
150035987|NCT04408989|541271466|FG001|Overall Study|Lost to Follow-up|0|||
150035988|NCT04408989|541271467|FG002|Overall Study|Lost to Follow-up|1|||
150035989|NCT04408989|541271465|FG000|Overall Study|Withdrawal by Subject|0|||
150035990|NCT04408989|541271466|FG001|Overall Study|Withdrawal by Subject|0|||
150035991|NCT04408989|541271467|FG002|Overall Study|Withdrawal by Subject|2|||
150035992|NCT02694185|541271468|FG000|Overall Study|Withdrawal by Subject|45|||
150035993|NCT02694185|541271469|FG001|Overall Study|Withdrawal by Subject|0|||
150035994|NCT05082857|541271470|FG000|Overall Study|participants relocated and could not continue|2|||
150035995|NCT05082857|541271471|FG001|Overall Study|participants relocated and could not continue|1|||
150035996|NCT05082857|541271470|FG000|Overall Study|Lost to Follow-up|1|||
150035997|NCT05082857|541271471|FG001|Overall Study|Lost to Follow-up|3|||
150287245|NCT00531752|542185553|FG002|First Double-blind Intervention Period|Other|4|||
150287246|NCT00531752|542185554|FG003|First Double-blind Intervention Period|Other|0|||
150287247|NCT00531752|542185551|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
150287248|NCT00531752|542185552|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
150287249|NCT00531752|542185553|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
150287250|NCT00531752|542185554|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
150287251|NCT00531752|542185551|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
150287252|NCT00531752|542185552|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
150287253|NCT00531752|542185553|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
150287254|NCT00531752|542185554|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
150287255|NCT00531752|542185551|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
150287256|NCT00531752|542185552|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
150287257|NCT00531752|542185553|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
150287258|NCT00531752|542185554|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
150287259|NCT00531752|542185551|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
150287260|NCT00531752|542185552|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
150287261|NCT00531752|542185553|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
150287262|NCT00531752|542185554|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
150287263|NCT00531752|542185551|FG000|Second Double-blind Intervention Period|Other|1|||
150287264|NCT00531752|542185552|FG001|Second Double-blind Intervention Period|Other|1|||
150287265|NCT00531752|542185553|FG002|Second Double-blind Intervention Period|Other|0|||
150035998|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
150035999|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
150036000|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
150036001|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
150036002|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
150172602|NCT00949975|541768024|FG002|Overall Study|Lost to Follow-up|1|||
150287266|NCT00531752|542185554|FG003|Second Double-blind Intervention Period|Other|0|||
150036003|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
150036004|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
150036005|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
150036006|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
150036007|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
150036008|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
150036009|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
150036010|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
150036011|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
150036012|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
150036013|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
150036014|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
150036015|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
150287267|NCT00531752|542185551|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
150287268|NCT00531752|542185552|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
150287269|NCT00531752|542185553|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
150287270|NCT00531752|542185554|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
150287271|NCT00531752|542185551|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
150287272|NCT00531752|542185552|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
150287273|NCT00531752|542185553|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
150287274|NCT00531752|542185554|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
150287275|NCT00490451|542185555|FG000|Overall Study|Adverse Event|3|||
150036016|NCT03605667|541271481|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
150036017|NCT03605667|541271482|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
150036018|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
150036019|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
150036020|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Other|6|||
150036021|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Other|8|||
150036022|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
150036023|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
150036024|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
150036025|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
150036026|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
150036027|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
150036028|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
150036029|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
150036030|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
150036031|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
150036032|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
150036033|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
150036034|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Death|0|||
150036035|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Death|2|||
150036036|NCT03605667|541271481|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
150036037|NCT03605667|541271482|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
150036038|NCT05632211|541271483|FG000|Overall Study|Withdrawal by Subject|2|||
150036039|NCT05632211|541271484|FG001|Overall Study|Withdrawal by Subject|0|||
150036040|NCT05632211|541271485|FG002|Overall Study|Withdrawal by Subject|2|||
150036041|NCT05632211|541271483|FG000|Overall Study|Other reasons|1|||
150036042|NCT05632211|541271484|FG001|Overall Study|Other reasons|1|||
150036043|NCT05632211|541271485|FG002|Overall Study|Other reasons|1|||
150036044|NCT04366349|541271486|FG000|Overall Study|Withdrawal by Subject|1|||
150036045|NCT04366349|541271487|FG001|Overall Study|Withdrawal by Subject|0|||
150036046|NCT04366349|541271488|FG002|Overall Study|Withdrawal by Subject|0|||
150036047|NCT04366349|541271489|FG003|Overall Study|Withdrawal by Subject|0|||
150036048|NCT04366349|541271490|FG004|Overall Study|Withdrawal by Subject|0|||
150036049|NCT04366349|541271491|FG005|Overall Study|Withdrawal by Subject|0|||
150036050|NCT03253393|541271492|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
150036051|NCT03253393|541271493|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
150036052|NCT03253393|541271494|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
150036053|NCT01350999|541271496|FG000|Overall Study|Adverse Event|4|||
150287276|NCT00490451|542185556|FG001|Overall Study|Adverse Event|3|||
150287277|NCT00490451|542185555|FG000|Overall Study|Death|3|||
150287278|NCT00490451|542185556|FG001|Overall Study|Death|1|||
150287279|NCT00490451|542185555|FG000|Overall Study|Withdrawal by Subject|2|||
150036054|NCT01350999|541271497|FG001|Overall Study|Adverse Event|9|||
150036055|NCT01350999|541271498|FG002|Overall Study|Adverse Event|10|||
150036056|NCT01350999|541271496|FG000|Overall Study|Voluntary withdrawal|3|||
150036057|NCT01350999|541271497|FG001|Overall Study|Voluntary withdrawal|4|||
150036058|NCT01350999|541271498|FG002|Overall Study|Voluntary withdrawal|6|||
150287280|NCT00490451|542185556|FG001|Overall Study|Withdrawal by Subject|0|||
150036059|NCT01350999|541271496|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
150036060|NCT01350999|541271497|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
150036061|NCT01350999|541271498|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
150036062|NCT02121535|541272889|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
150036063|NCT02121535|541272890|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
150036064|NCT02121535|541272889|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
150036065|NCT02121535|541272890|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
150036066|NCT00092417|541272891|FG000|Overall Study|Lost to Follow-up|2|||
150036067|NCT00092417|541272892|FG001|Overall Study|Lost to Follow-up|0|||
150036068|NCT00092417|541272891|FG000|Overall Study|Withdrawal by Subject|2|||
150036069|NCT00092417|541272892|FG001|Overall Study|Withdrawal by Subject|1|||
150036070|NCT00092417|541272891|FG000|Overall Study|Other|1|||
150036071|NCT00092417|541272892|FG001|Overall Study|Other|0|||
150036072|NCT01256788|541272893|FG000|Overall Study|Lost to Follow-up|5|||
150036073|NCT01256788|541272894|FG001|Overall Study|Lost to Follow-up|8|||
150036074|NCT01256788|541272895|FG002|Overall Study|Lost to Follow-up|3|||
150036075|NCT00696072|541272896|FG000|Overall Study|continuing active treatment|10|||
150036076|NCT00696072|541272897|FG001|Overall Study|continuing active treatment|13|||
150036077|NCT00696072|541272896|FG000|Overall Study|Adverse Event|10|||
150036078|NCT00696072|541272897|FG001|Overall Study|Adverse Event|6|||
150036079|NCT00696072|541272896|FG000|Overall Study|Patient Request|3|||
150036080|NCT00696072|541272897|FG001|Overall Study|Patient Request|7|||
150036081|NCT00696072|541272896|FG000|Overall Study|Investigator Request|1|||
150036082|NCT00696072|541272897|FG001|Overall Study|Investigator Request|4|||
150036083|NCT00696072|541272896|FG000|Overall Study|Sponsor Request|0|||
150036084|NCT00696072|541272897|FG001|Overall Study|Sponsor Request|1|||
150036085|NCT00696072|541272896|FG000|Overall Study|Disease Progression|32|||
150036086|NCT00696072|541272897|FG001|Overall Study|Disease Progression|30|||
150036087|NCT00696072|541272896|FG000|Overall Study|Non-specified|1|||
150036088|NCT00696072|541272897|FG001|Overall Study|Non-specified|2|||
150036089|NCT01597596|541272898|FG000|Overall Study|Study terminated by sponsor|1|||
150036090|NCT01597596|541272899|FG001|Overall Study|Study terminated by sponsor|0|||
150036091|NCT01597596|541272898|FG000|Overall Study|Physician Decision|0|||
150036092|NCT01597596|541272899|FG001|Overall Study|Physician Decision|1|||
150036093|NCT00992108|541272906|FG000|Overall Study|Lost to Follow-up|0|||
150036094|NCT00992108|541272907|FG001|Overall Study|Lost to Follow-up|1|||
150036095|NCT00535496|541272910|FG000|Overall Study|Lost to Follow-up|0|||
150036096|NCT00535496|541272911|FG001|Overall Study|Lost to Follow-up|1|||
150036097|NCT00535496|541272912|FG002|Overall Study|Lost to Follow-up|0|||
150036098|NCT00535496|541272913|FG003|Overall Study|Lost to Follow-up|0|||
150036099|NCT00535496|541272910|FG000|Overall Study|Not treated with sugammadex|0|||
150036100|NCT00535496|541272911|FG001|Overall Study|Not treated with sugammadex|1|||
150036101|NCT00535496|541272912|FG002|Overall Study|Not treated with sugammadex|0|||
150036102|NCT00535496|541272913|FG003|Overall Study|Not treated with sugammadex|0|||
150036103|NCT01083771|541272915|FG000|Overall Study|non-compliant|2|||
150036104|NCT01083771|541272915|FG000|Overall Study|Withdrawal by Subject|3|||
150036105|NCT03181932|541272918|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
150036106|NCT03181932|541272919|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
150036107|NCT03181932|541272918|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
150036108|NCT03181932|541272919|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
150036109|NCT03181932|541272918|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
150036110|NCT03181932|541272919|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
150287281|NCT00490451|542185555|FG000|Overall Study|Investigator Decision|1|||
150287282|NCT00490451|542185556|FG001|Overall Study|Investigator Decision|0|||
150287283|NCT00490451|542185555|FG000|Overall Study|Protocol Violation|1|||
150287284|NCT00490451|542185556|FG001|Overall Study|Protocol Violation|0|||
150287285|NCT00490451|542185555|FG000|Overall Study|Progressive Disease|53|||
150287286|NCT00490451|542185556|FG001|Overall Study|Progressive Disease|34|||
150287287|NCT01181011|542185557|FG000|Overall Study|Adverse Event|2|||
150287288|NCT01181011|542185557|FG000|Overall Study|Lost to Follow-up|1|||
150287289|NCT00254501|542185560|FG000|Overall Study|Lost to Follow-up|1|||
150287290|NCT00254501|542185561|FG001|Overall Study|Lost to Follow-up|1|||
150036111|NCT03181932|541272918|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
150036112|NCT03181932|541272919|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
150036113|NCT03181932|541272918|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
150036114|NCT03181932|541272919|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
150036115|NCT03181932|541272918|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
150036116|NCT03181932|541272919|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
150036117|NCT03181932|541272918|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
150036118|NCT03181932|541272919|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
150036119|NCT03181932|541272918|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
150036120|NCT03181932|541272919|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
150036121|NCT03181932|541272918|FG000|Period 2 (Open-label Period)|Reason missing|2|||
150287291|NCT00550680|542185562|FG000|Overall Study|Administrative Reasons|1|||
150287292|NCT00550680|542185562|FG000|Overall Study|Adverse Event|5|||
150036122|NCT03181932|541272919|FG001|Period 2 (Open-label Period)|Reason missing|0|||
150036123|NCT02461758|541272922|FG000|Overall Study|Lost to Follow-up|0|||
150036124|NCT02461758|541272923|FG001|Overall Study|Lost to Follow-up|1|||
150036125|NCT02461758|541272924|FG002|Overall Study|Lost to Follow-up|1|||
150036126|NCT02461758|541272925|FG003|Overall Study|Lost to Follow-up|0|||
150036127|NCT04030143|541272926|FG000|Overall Study|Adverse Event|5|||
150036128|NCT04030143|541272927|FG001|Overall Study|Adverse Event|10|||
150036129|NCT04030143|541272926|FG000|Overall Study|Lost to Follow-up|3|||
150036130|NCT04030143|541272927|FG001|Overall Study|Lost to Follow-up|7|||
150036131|NCT04030143|541272926|FG000|Overall Study|Protocol Deviation|2|||
150036132|NCT04030143|541272927|FG001|Overall Study|Protocol Deviation|2|||
150036133|NCT04030143|541272926|FG000|Overall Study|Withdrawal by Subject|16|||
150036134|NCT04030143|541272927|FG001|Overall Study|Withdrawal by Subject|18|||
150036135|NCT04030143|541272926|FG000|Overall Study|Physician Decision|1|||
150036136|NCT04030143|541272927|FG001|Overall Study|Physician Decision|1|||
150036137|NCT04030143|541272926|FG000|Overall Study|Due to Covid-19|2|||
150036138|NCT04030143|541272927|FG001|Overall Study|Due to Covid-19|3|||
150036139|NCT04030143|541272926|FG000|Overall Study|Not Due to Covid-19|1|||
150036140|NCT04030143|541272927|FG001|Overall Study|Not Due to Covid-19|1|||
150036141|NCT03216226|541272928|FG000|Overall Study|Adverse Event|3|||
150036142|NCT03216226|541272929|FG001|Overall Study|Adverse Event|0|||
150036143|NCT03216226|541272928|FG000|Overall Study|Protocol Violation|1|||
150036144|NCT03216226|541272929|FG001|Overall Study|Protocol Violation|3|||
150036145|NCT03216226|541272928|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
150036146|NCT03216226|541272929|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
150036147|NCT03216226|541272928|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
150036148|NCT03216226|541272929|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
150036149|NCT03216226|541272928|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
150036150|NCT03216226|541272929|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
150036151|NCT05966142|541272930|FG000|Overall Study|Death|3|||
150036152|NCT05966142|541272931|FG001|Overall Study|Death|3|||
150036153|NCT05966142|541272930|FG000|Overall Study|Lost to Follow-up|55|||
150036154|NCT05966142|541272931|FG001|Overall Study|Lost to Follow-up|52|||
150036155|NCT05966142|541272930|FG000|Overall Study|Physician Decision|1|||
150036156|NCT05966142|541272931|FG001|Overall Study|Physician Decision|0|||
150036157|NCT05966142|541272930|FG000|Overall Study|Withdrawal by Subject|9|||
150036158|NCT05966142|541272931|FG001|Overall Study|Withdrawal by Subject|8|||
150036159|NCT05966142|541272930|FG000|Overall Study|Duplicate Enrollment|1|||
150036160|NCT05966142|541272931|FG001|Overall Study|Duplicate Enrollment|0|||
150036161|NCT05966142|541272930|FG000|Overall Study|Study Logistical Reason|1|||
150036162|NCT05966142|541272931|FG001|Overall Study|Study Logistical Reason|0|||
150036163|NCT05966142|541272930|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
150036164|NCT05966142|541272931|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
150036165|NCT04849364|541272932|FG000|Overall Study|Eligibility criteria not meet|0|||
150036166|NCT04849364|541272933|FG001|Overall Study|Eligibility criteria not meet|1|||
150036167|NCT04849364|541272934|FG002|Overall Study|Eligibility criteria not meet|0|||
150036168|NCT02738801|541272938|FG000|Overall Study|Adverse Event|1|||
150036169|NCT02738801|541272939|FG001|Overall Study|Adverse Event|1|||
150036170|NCT02738801|541272938|FG000|Overall Study|Withdrawal by Subject|0|||
150172603|NCT00949975|541768025|FG003|Overall Study|Lost to Follow-up|3|||
150172604|NCT00949975|541768022|FG000|Overall Study|Other|1|||
150172605|NCT00949975|541768023|FG001|Overall Study|Other|0|||
150172606|NCT00949975|541768024|FG002|Overall Study|Other|0|||
150172607|NCT00949975|541768025|FG003|Overall Study|Other|0|||
150172608|NCT04347954|541768026|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
150172609|NCT04347954|541768027|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
150172610|NCT04347954|541768028|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
150172611|NCT04347954|541768026|FG000|Overall Study|Lost to Follow-up|0|||
150172612|NCT04347954|541768027|FG001|Overall Study|Lost to Follow-up|1|||
150172613|NCT04347954|541768028|FG002|Overall Study|Lost to Follow-up|0|||
150172614|NCT00909363|541768029|FG000|Overall Study|Withdrawal by Subject|1|||
150172615|NCT00909363|541768030|FG001|Overall Study|Withdrawal by Subject|0|||
150172616|NCT00909363|541768031|FG002|Overall Study|Withdrawal by Subject|0|||
150172617|NCT00909363|541768029|FG000|Overall Study|Lack of Efficacy|1|||
150172618|NCT00909363|541768030|FG001|Overall Study|Lack of Efficacy|0|||
150172619|NCT00909363|541768031|FG002|Overall Study|Lack of Efficacy|0|||
150172620|NCT02954848|541768039|FG000|Overall Study|Randomized but Not Treated|0|||
150172621|NCT02954848|541768040|FG001|Overall Study|Randomized but Not Treated|1|||
150287293|NCT00550680|542185562|FG000|Overall Study|Death|3|||
150287294|NCT00550680|542185562|FG000|Overall Study|Early Improvement|1|||
150287295|NCT00550680|542185562|FG000|Overall Study|Lost to Follow-up|3|||
150172622|NCT02954848|541768039|FG000|Overall Study|Adverse Event|2|||
150172623|NCT02954848|541768040|FG001|Overall Study|Adverse Event|3|||
150172624|NCT02954848|541768039|FG000|Overall Study|Withdrawal by Participant|0|||
150172625|NCT02954848|541768040|FG001|Overall Study|Withdrawal by Participant|1|||
149954884|NCT01947933|540966319|FG000|Overall Study|Withdrawal by Subject|0|||
149954885|NCT01947933|540966320|FG001|Overall Study|Withdrawal by Subject|0|||
149954886|NCT01947933|540966321|FG002|Overall Study|Withdrawal by Subject|1|||
149954887|NCT01947933|540966322|FG003|Overall Study|Withdrawal by Subject|0|||
149954888|NCT01947933|540966323|FG004|Overall Study|Withdrawal by Subject|0|||
149954889|NCT01947933|540966324|FG005|Overall Study|Withdrawal by Subject|0|||
149954890|NCT01947933|540966325|FG006|Overall Study|Withdrawal by Subject|0|||
149954891|NCT01947933|540966326|FG007|Overall Study|Withdrawal by Subject|0|||
149954892|NCT01947933|540966327|FG008|Overall Study|Withdrawal by Subject|0|||
149954893|NCT01947933|540966319|FG000|Overall Study|Lost to Follow-up|0|||
149954894|NCT01947933|540966320|FG001|Overall Study|Lost to Follow-up|0|||
149954895|NCT01947933|540966321|FG002|Overall Study|Lost to Follow-up|0|||
149954896|NCT01947933|540966322|FG003|Overall Study|Lost to Follow-up|0|||
149954897|NCT01947933|540966323|FG004|Overall Study|Lost to Follow-up|0|||
149954898|NCT01947933|540966324|FG005|Overall Study|Lost to Follow-up|0|||
149954899|NCT01947933|540966325|FG006|Overall Study|Lost to Follow-up|0|||
149954900|NCT01947933|540966326|FG007|Overall Study|Lost to Follow-up|0|||
149954901|NCT01947933|540966327|FG008|Overall Study|Lost to Follow-up|1|||
149954902|NCT01428128|540966331|FG000|Overall Study|Withdrawal by Subject|4|||
149954903|NCT01428128|540966331|FG000|Overall Study|Screen failure by p53|10|||
149954904|NCT01428128|540966331|FG000|Overall Study|Received Neulasta in one cycle|2|||
149954905|NCT01428128|540966331|FG000|Overall Study|Adverse Event|1|||
149954906|NCT05259033|540966335|FG000|Overall Study|Withdrawal by Subject|10|||
149954907|NCT05259033|540966336|FG001|Overall Study|Withdrawal by Subject|5|||
149954908|NCT05259033|540966335|FG000|Overall Study|Lost to Follow-up|1|||
149954909|NCT05259033|540966336|FG001|Overall Study|Lost to Follow-up|0|||
149954910|NCT05259033|540966335|FG000|Overall Study|Death|2|||
149954911|NCT05259033|540966336|FG001|Overall Study|Death|0|||
149954912|NCT01068249|540966337|FG000|Overall Study|Death|1|||
149954913|NCT01068249|540966337|FG000|Overall Study|Withdrawal by Subject|3|||
149954914|NCT04210375|540966343|FG000|Overall Study|Death|0|||
149954915|NCT04210375|540966344|FG001|Overall Study|Death|1|||
149954916|NCT04210375|540966345|FG002|Overall Study|Death|0|||
149954917|NCT04210375|540966346|FG003|Overall Study|Death|0|||
149954918|NCT00424008|540966347|FG000|Overall Study|Adverse Event|8|||
149954919|NCT00424008|540966348|FG001|Overall Study|Adverse Event|6|||
149954920|NCT00424008|540966347|FG000|Overall Study|Lack of Efficacy|40|||
149954921|NCT00424008|540966348|FG001|Overall Study|Lack of Efficacy|34|||
149954922|NCT00424008|540966347|FG000|Overall Study|Lost to Follow-up|1|||
149954923|NCT00424008|540966348|FG001|Overall Study|Lost to Follow-up|2|||
149954924|NCT00424008|540966347|FG000|Overall Study|Withdrawal by Subject|5|||
149954925|NCT00424008|540966348|FG001|Overall Study|Withdrawal by Subject|8|||
149954926|NCT00424008|540966347|FG000|Overall Study|Noncompliance with protocol|13|||
149954927|NCT00424008|540966348|FG001|Overall Study|Noncompliance with protocol|7|||
150172626|NCT02950558|541768042|FG000|Overall Study|Lost to Follow-up|2|||
150287296|NCT00550680|542185562|FG000|Overall Study|Lack of Efficacy|1|||
150287297|NCT00550680|542185562|FG000|Overall Study|Other|10|||
150287298|NCT00550680|542185562|FG000|Overall Study|Protocol Violation|7|||
150287299|NCT00550680|542185562|FG000|Overall Study|Refused Treatment|19|||
150287300|NCT00550680|542185562|FG000|Overall Study|Screen Failure|6|||
150287301|NCT01967550|542185563|FG000|Overall Study|Withdrawal by Subject|1|||
150287302|NCT01967550|542185564|FG001|Overall Study|Withdrawal by Subject|0|||
150287303|NCT01967550|542185563|FG000|Overall Study|Adverse Event|2|||
150287304|NCT01967550|542185564|FG001|Overall Study|Adverse Event|0|||
150287305|NCT01967550|542185563|FG000|Overall Study|Protocol Violation|2|||
149844351|NCT00902538|540560337|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
149844352|NCT00902538|540560332|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
149844353|NCT00902538|540560333|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
149844354|NCT00902538|540560334|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
149844355|NCT00902538|540560335|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
149844356|NCT00902538|540560336|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
149844357|NCT00902538|540560337|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
149844358|NCT00902538|540560332|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
149844359|NCT00902538|540560333|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
149844360|NCT00902538|540560334|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
149844361|NCT00902538|540560335|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
149844362|NCT00902538|540560336|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
149844363|NCT00902538|540560337|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
149844364|NCT00902538|540560332|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
149844365|NCT00902538|540560333|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
150172627|NCT02950558|541768043|FG001|Overall Study|Lost to Follow-up|0|||
149844366|NCT00902538|540560334|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
149954928|NCT00424008|540966347|FG000|Overall Study|Did not meet protocol eligibility|16|||
150287306|NCT01967550|542185564|FG001|Overall Study|Protocol Violation|1|||
149954929|NCT00424008|540966348|FG001|Overall Study|Did not meet protocol eligibility|21|||
149954930|NCT00424008|540966347|FG000|Overall Study|Administrative|266|||
149954931|NCT00424008|540966348|FG001|Overall Study|Administrative|257|||
149954932|NCT02593864|540966349|FG000|Overall Study|Withdrawal by Subject|3|||
149954933|NCT02593864|540966349|FG000|Overall Study|Lost to Follow-up|3|||
149954934|NCT01405911|540966350|FG000|Overall Study|Pre-treatment lab AE|0|||
149954935|NCT01405911|540966351|FG001|Overall Study|Pre-treatment lab AE|1|||
149954936|NCT01405911|540966352|FG002|Overall Study|Pre-treatment lab AE|0|||
149954937|NCT01405911|540966350|FG000|Overall Study|Lost to Follow-up|0|||
149954938|NCT01405911|540966351|FG001|Overall Study|Lost to Follow-up|1|||
149954939|NCT01405911|540966352|FG002|Overall Study|Lost to Follow-up|0|||
149954940|NCT01405911|540966350|FG000|Overall Study|Protocol Violation|1|||
149954941|NCT01405911|540966351|FG001|Overall Study|Protocol Violation|0|||
149954942|NCT01405911|540966352|FG002|Overall Study|Protocol Violation|0|||
149954943|NCT01405911|540966350|FG000|Overall Study|Withdrawal by Subject|3|||
149954944|NCT01405911|540966351|FG001|Overall Study|Withdrawal by Subject|1|||
149954945|NCT01405911|540966352|FG002|Overall Study|Withdrawal by Subject|1|||
149954946|NCT06375655|540966353|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
149954947|NCT06375655|540966354|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
149954948|NCT02530242|540966357|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
149954949|NCT02530242|540966358|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
149954950|NCT01397747|540966363|FG000|Overall Study|Multitarget DNA test excluded|689|||
149954951|NCT01397747|540966363|FG000|Overall Study|Colonoscopy excluded|304|||
149954952|NCT01397747|540966363|FG000|Overall Study|FIT excluded|34|||
149954953|NCT03828383|540966364|FG000|Overall Study|Lost to Follow-up|3|||
149954954|NCT03828383|540966365|FG001|Overall Study|Lost to Follow-up|2|||
149954955|NCT03828383|540966364|FG000|Overall Study|Withdrawal by Subject|4|||
149954956|NCT03828383|540966365|FG001|Overall Study|Withdrawal by Subject|5|||
149954957|NCT00504309|540966367|FG000|Overall Study|Death|0|||
149954958|NCT00504309|540966368|FG001|Overall Study|Death|0|||
149954959|NCT00504309|540966369|FG002|Overall Study|Death|0|||
149954960|NCT00504309|540966370|FG003|Overall Study|Death|0|||
149954961|NCT00504309|540966371|FG004|Overall Study|Death|1|||
149954962|NCT00504309|540966372|FG005|Overall Study|Death|0|||
149954963|NCT00504309|540966367|FG000|Overall Study|Withdrawal by Subject|0|||
149954964|NCT00504309|540966368|FG001|Overall Study|Withdrawal by Subject|0|||
149954965|NCT00504309|540966369|FG002|Overall Study|Withdrawal by Subject|1|||
149954966|NCT00504309|540966370|FG003|Overall Study|Withdrawal by Subject|0|||
149954967|NCT00504309|540966371|FG004|Overall Study|Withdrawal by Subject|0|||
149954968|NCT00504309|540966372|FG005|Overall Study|Withdrawal by Subject|0|||
149954969|NCT03345095|540966373|FG000|Overall Study|Lack of Efficacy|184|||
149954970|NCT03345095|540966374|FG001|Overall Study|Lack of Efficacy|156|||
149954971|NCT03345095|540966373|FG000|Overall Study|Adverse Event|36|||
149954972|NCT03345095|540966374|FG001|Overall Study|Adverse Event|118|||
149954973|NCT03345095|540966373|FG000|Overall Study|Withdrawal by Subject|22|||
149954974|NCT03345095|540966374|FG001|Overall Study|Withdrawal by Subject|59|||
149954975|NCT03345095|540966373|FG000|Overall Study|Physician Decision|3|||
149954976|NCT03345095|540966374|FG001|Overall Study|Physician Decision|18|||
149954977|NCT03345095|540966373|FG000|Overall Study|Death|2|||
149954978|NCT03345095|540966374|FG001|Overall Study|Death|4|||
149954979|NCT03345095|540966373|FG000|Overall Study|Other reasons|2|||
149954980|NCT03345095|540966374|FG001|Overall Study|Other reasons|11|||
149954981|NCT03345095|540966373|FG000|Overall Study|Protocol Violation|0|||
149954982|NCT03345095|540966374|FG001|Overall Study|Protocol Violation|1|||
149954983|NCT02665455|540966375|FG000|Overall Study|Withdrawal by Subject|6|||
149954984|NCT02665455|540966375|FG000|Overall Study|Lost to Follow-up|1|||
149954985|NCT02665455|540966375|FG000|Overall Study|Adverse Event|1|||
149954986|NCT02665455|540966375|FG000|Overall Study|Protocol Violation|1|||
149954987|NCT01671059|540966379|FG000|Overall Study|Adverse Event|4|||
149954988|NCT01671059|540966379|FG000|Overall Study|Lack of Efficacy|1|||
149954989|NCT03166631|540967925|FG000|Overall Study|Progressive disease|2|||
149954990|NCT03166631|540967926|FG001|Overall Study|Progressive disease|1|||
149954991|NCT03166631|540967927|FG002|Overall Study|Progressive disease|3|||
149954992|NCT03166631|540967928|FG003|Overall Study|Progressive disease|4|||
149954993|NCT03166631|540967929|FG004|Overall Study|Progressive disease|2|||
149954994|NCT03166631|540967930|FG005|Overall Study|Progressive disease|2|||
149954995|NCT03166631|540967931|FG006|Overall Study|Progressive disease|5|||
149954996|NCT03166631|540967932|FG007|Overall Study|Progressive disease|6|||
149954997|NCT03166631|540967933|FG008|Overall Study|Progressive disease|11|||
149954998|NCT03166631|540967934|FG009|Overall Study|Progressive disease|5|||
149954999|NCT03166631|540967935|FG010|Overall Study|Progressive disease|7|||
149955000|NCT03166631|540967925|FG000|Overall Study|Physician Decision|0|||
149955001|NCT03166631|540967926|FG001|Overall Study|Physician Decision|0|||
149955002|NCT03166631|540967927|FG002|Overall Study|Physician Decision|0|||
149955003|NCT03166631|540967928|FG003|Overall Study|Physician Decision|0|||
149955004|NCT03166631|540967929|FG004|Overall Study|Physician Decision|0|||
149955005|NCT03166631|540967930|FG005|Overall Study|Physician Decision|0|||
149955006|NCT03166631|540967931|FG006|Overall Study|Physician Decision|1|||
149955007|NCT03166631|540967932|FG007|Overall Study|Physician Decision|0|||
150172628|NCT02808338|541768045|FG000|Screening|Screen Failure|10|||
150172629|NCT02808338|541768045|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
150172630|NCT02808338|541768045|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
150172631|NCT02194933|541768046|FG000|Overall Study|Lost to Follow-up|1|||
150172632|NCT02194933|541768047|FG001|Overall Study|Lost to Follow-up|2|||
150172633|NCT02194933|541768046|FG000|Overall Study|Participant met withdrawal criteria|1|||
150172634|NCT02194933|541768047|FG001|Overall Study|Participant met withdrawal criteria|3|||
150172635|NCT02194933|541768046|FG000|Overall Study|Withdrawal by Subject|0|||
150172636|NCT02194933|541768047|FG001|Overall Study|Withdrawal by Subject|2|||
150172637|NCT02194933|541768046|FG000|Overall Study|Lack of Efficacy|1|||
150172638|NCT02194933|541768047|FG001|Overall Study|Lack of Efficacy|2|||
150172639|NCT02000817|541768050|FG000|Overall Study|Withdrawal by Subject|2|||
150172640|NCT02000817|541768051|FG001|Overall Study|Withdrawal by Subject|0|||
150172641|NCT02000817|541768052|FG002|Overall Study|Withdrawal by Subject|0|||
150172642|NCT02000817|541768053|FG003|Overall Study|Withdrawal by Subject|0|||
150172643|NCT02000817|541768050|FG000|Overall Study|Adverse Event|0|||
150172644|NCT02000817|541768051|FG001|Overall Study|Adverse Event|1|||
150036171|NCT02738801|541272939|FG001|Overall Study|Withdrawal by Subject|1|||
150036172|NCT01643668|541272940|FG000|Overall Study|Death|1|||
150036173|NCT03253796|541272949|FG000|Period 1: Run-In|Adverse Event|4|||
150036174|NCT03253796|541272950|FG001|Period 1: Run-In|Adverse Event|0|||
150036175|NCT03253796|541272951|FG002|Period 1: Run-In|Adverse Event|0|||
150036176|NCT03253796|541272952|FG003|Period 1: Run-In|Adverse Event|0|||
150036177|NCT03253796|541272953|FG004|Period 1: Run-In|Adverse Event|0|||
150036178|NCT03253796|541272949|FG000|Period 1: Run-In|Lack of Efficacy|1|||
150036179|NCT03253796|541272950|FG001|Period 1: Run-In|Lack of Efficacy|0|||
150036180|NCT03253796|541272951|FG002|Period 1: Run-In|Lack of Efficacy|0|||
150036181|NCT03253796|541272952|FG003|Period 1: Run-In|Lack of Efficacy|0|||
150036182|NCT03253796|541272953|FG004|Period 1: Run-In|Lack of Efficacy|0|||
150036183|NCT03253796|541272949|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
150036184|NCT03253796|541272950|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
150036185|NCT03253796|541272951|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
150036186|NCT03253796|541272952|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
150036187|NCT03253796|541272953|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
150036188|NCT03253796|541272949|FG000|Period 1: Run-In|Protocol Violation|5|||
150036189|NCT03253796|541272950|FG001|Period 1: Run-In|Protocol Violation|0|||
150036190|NCT03253796|541272951|FG002|Period 1: Run-In|Protocol Violation|0|||
150036191|NCT03253796|541272952|FG003|Period 1: Run-In|Protocol Violation|0|||
150036192|NCT03253796|541272953|FG004|Period 1: Run-In|Protocol Violation|0|||
150036193|NCT03253796|541272949|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
150036194|NCT03253796|541272950|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
150036195|NCT03253796|541272951|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
150036196|NCT03253796|541272952|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
150036197|NCT03253796|541272953|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
150036198|NCT03253796|541272949|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
150036199|NCT03253796|541272950|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
150036200|NCT03253796|541272951|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
150036201|NCT03253796|541272952|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
150036202|NCT03253796|541272953|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
150036203|NCT03253796|541272949|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
150036204|NCT03253796|541272950|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
150036205|NCT03253796|541272951|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
150036206|NCT03253796|541272952|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
150036207|NCT03253796|541272953|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
150036208|NCT03253796|541272949|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
150036209|NCT03253796|541272950|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
150036210|NCT03253796|541272951|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
150036211|NCT03253796|541272952|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
150036212|NCT03253796|541272953|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
150036213|NCT03253796|541272949|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
150036214|NCT03253796|541272950|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
150036215|NCT03253796|541272951|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
150036216|NCT03253796|541272952|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
150036217|NCT03253796|541272953|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
150036218|NCT03253796|541272949|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
150036219|NCT03253796|541272950|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
150172645|NCT02000817|541768052|FG002|Overall Study|Adverse Event|0|||
150172646|NCT02000817|541768053|FG003|Overall Study|Adverse Event|0|||
149844367|NCT00902538|540560335|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
149844368|NCT00902538|540560336|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
150287307|NCT01967550|542185563|FG000|Overall Study|Non Compliance|0|||
150287308|NCT01967550|542185564|FG001|Overall Study|Non Compliance|1|||
150287309|NCT00250835|542185569|FG000|Overall Study|Withdrawal by Subject|1|||
150287310|NCT01836783|542185573|FG000|Overall Study|Withdrawal by Subject|0|||
150287311|NCT01836783|542185574|FG001|Overall Study|Withdrawal by Subject|2|||
150287312|NCT01035905|542185576|FG000|Overall Study|Lack of Efficacy|1|||
150287313|NCT01035905|542185577|FG001|Overall Study|Lack of Efficacy|1|||
150287314|NCT01273883|542185578|FG000|First Intervention|Adverse Event|2|||
150287315|NCT01273883|542185579|FG001|First Intervention|Adverse Event|1|||
150287316|NCT01273883|542185578|FG000|Second Intervention|Lost to Follow-up|1|||
150287317|NCT01273883|542185579|FG001|Second Intervention|Lost to Follow-up|1|||
150287318|NCT01273883|542185578|FG000|Second Intervention|Lack of Efficacy|1|||
150287319|NCT01273883|542185579|FG001|Second Intervention|Lack of Efficacy|0|||
150287320|NCT04489888|542185580|FG000|Overall Study|Death|75|||
150287321|NCT04489888|542185580|FG000|Overall Study|Sponsor Decision|26|||
150287322|NCT00333359|542185586|FG000|Overall Study|Adverse Event|29|||
150287323|NCT00333359|542185587|FG001|Overall Study|Adverse Event|35|||
150287324|NCT00333359|542185586|FG000|Overall Study|Withdrawal by Subject|19|||
150287325|NCT00333359|542185587|FG001|Overall Study|Withdrawal by Subject|37|||
150287326|NCT00333359|542185586|FG000|Overall Study|Physician Decision|2|||
150287327|NCT00333359|542185587|FG001|Overall Study|Physician Decision|2|||
150287328|NCT00333359|542185586|FG000|Overall Study|Protocol Non-compliance|2|||
150287329|NCT00333359|542185587|FG001|Overall Study|Protocol Non-compliance|8|||
150287330|NCT00333359|542185586|FG000|Overall Study|Lost to Follow-up|15|||
150287331|NCT00333359|542185587|FG001|Overall Study|Lost to Follow-up|25|||
150287332|NCT00333359|542185586|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
150287333|NCT00333359|542185587|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
150287334|NCT00333359|542185586|FG000|Overall Study|Treatment Failure|3|||
150287335|NCT00333359|542185587|FG001|Overall Study|Treatment Failure|8|||
150287336|NCT00333359|542185586|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
150287337|NCT00333359|542185587|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
150287338|NCT02867995|542185589|FG000|Overall Study|Withdrawal by Subject|0|||
150287339|NCT02867995|542185590|FG001|Overall Study|Withdrawal by Subject|1|||
149844369|NCT00902538|540560337|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
150287340|NCT02867995|542185589|FG000|Overall Study|Lost to Follow-up|0|||
150287341|NCT02867995|542185590|FG001|Overall Study|Lost to Follow-up|2|||
150287342|NCT01534533|542185591|FG000|Overall Study|Lost to Follow-up|3|||
150287343|NCT01534533|542185592|FG001|Overall Study|Lost to Follow-up|0|||
150287344|NCT01534533|542185593|FG002|Overall Study|Lost to Follow-up|4|||
150287345|NCT01534533|542185594|FG003|Overall Study|Lost to Follow-up|3|||
149844370|NCT00902538|540560332|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
149844371|NCT00902538|540560333|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
149844372|NCT00902538|540560334|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
150287346|NCT01534533|542185591|FG000|Overall Study|Withdrawal by Subject|5|||
150287347|NCT01534533|542185592|FG001|Overall Study|Withdrawal by Subject|3|||
150287348|NCT01534533|542185593|FG002|Overall Study|Withdrawal by Subject|4|||
149844373|NCT00902538|540560335|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
149844374|NCT00902538|540560336|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
149844375|NCT00902538|540560337|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
149844376|NCT00902538|540560332|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
149844377|NCT00902538|540560333|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
149844378|NCT00902538|540560334|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
149844379|NCT00902538|540560335|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
149844380|NCT00902538|540560336|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
149844381|NCT00902538|540560337|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
149844382|NCT00902538|540560332|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
149844383|NCT00902538|540560333|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
149844384|NCT00902538|540560334|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
149844385|NCT00902538|540560335|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
149844386|NCT00902538|540560336|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
149844387|NCT00902538|540560337|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
149844388|NCT00902538|540560332|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
149844389|NCT00902538|540560333|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
149844390|NCT00902538|540560334|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
149844391|NCT00902538|540560335|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
149844392|NCT00902538|540560336|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
150287349|NCT01534533|542185594|FG003|Overall Study|Withdrawal by Subject|1|||
150287350|NCT04099251|542187318|FG000|Pre-Treatment|Other reasons|1|||
150287351|NCT04099251|542187319|FG001|Pre-Treatment|Other reasons|0|||
150287352|NCT04099251|542187318|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
150287353|NCT04099251|542187319|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
150287354|NCT04099251|542187318|FG000|Blinded Treatment Phase|Other reasons|16|||
150287355|NCT04099251|542187319|FG001|Blinded Treatment Phase|Other reasons|7|||
150287356|NCT04099251|542187318|FG000|Blinded Treatment Phase|Disease recurrence|26|||
150287357|NCT04099251|542187319|FG001|Blinded Treatment Phase|Disease recurrence|41|||
150287358|NCT04099251|542187318|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
150287359|NCT04099251|542187319|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
150287360|NCT04099251|542187318|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
150287361|NCT04099251|542187319|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
150287362|NCT04099251|542187318|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
150287363|NCT04099251|542187319|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
150287364|NCT04099251|542187318|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
150287365|NCT04099251|542187319|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
150287366|NCT04099251|542187318|FG000|Blinded Treatment Phase|Death|6|||
150287367|NCT04099251|542187319|FG001|Blinded Treatment Phase|Death|2|||
150287368|NCT04099251|542187318|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
150287369|NCT04099251|542187319|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
150287370|NCT04099251|542187318|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
150287371|NCT04099251|542187319|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
150287372|NCT04099251|542187318|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
150287373|NCT04099251|542187319|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
150287374|NCT04099251|542187318|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
150287375|NCT04099251|542187319|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
150287376|NCT04099251|542187318|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
150287377|NCT04099251|542187319|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
150287378|NCT04099251|542187318|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
150287379|NCT04099251|542187319|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
150287380|NCT04099251|542187318|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
150287381|NCT04099251|542187319|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
150287382|NCT04099251|542187318|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
150287383|NCT04099251|542187319|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
150287384|NCT04099251|542187318|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
150287385|NCT04099251|542187319|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
150287386|NCT05032157|542187320|FG000|Overall Study|Adverse Event|12|||
150287387|NCT05032157|542187321|FG001|Overall Study|Adverse Event|7|||
150287388|NCT05032157|542187320|FG000|Overall Study|Pregnancy|0|||
150287389|NCT05032157|542187321|FG001|Overall Study|Pregnancy|2|||
150287390|NCT05032157|542187320|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
150287391|NCT05032157|542187321|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
150287392|NCT05032157|542187320|FG000|Overall Study|Protocol Deviation|8|||
150287393|NCT05032157|542187321|FG001|Overall Study|Protocol Deviation|4|||
150287394|NCT05032157|542187320|FG000|Overall Study|Lost to Follow-up|1|||
150287395|NCT05032157|542187321|FG001|Overall Study|Lost to Follow-up|3|||
150036220|NCT03253796|541272951|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
150036221|NCT03253796|541272952|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
150036222|NCT03253796|541272953|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
150036223|NCT03253796|541272949|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
150036224|NCT03253796|541272950|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
150036225|NCT03253796|541272951|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
150036226|NCT03253796|541272952|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
150036227|NCT03253796|541272953|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
150036228|NCT00894803|541272954|FG000|Overall Study|Death|20|||
150036229|NCT00894803|541272955|FG001|Overall Study|Death|4|||
150036230|NCT00894803|541272954|FG000|Overall Study|Lost to Follow-up|0|||
150287396|NCT05032157|542187320|FG000|Overall Study|Physician Decision|7|||
150287397|NCT05032157|542187321|FG001|Overall Study|Physician Decision|2|||
150287398|NCT05032157|542187320|FG000|Overall Study|Patient Decision|38|||
150287399|NCT05032157|542187321|FG001|Overall Study|Patient Decision|19|||
150287400|NCT03368170|542187322|FG000|Overall Study|Adverse Event|2|||
150287401|NCT03368170|542187323|FG001|Overall Study|Adverse Event|1|||
150287402|NCT00880893|542187324|FG000|Overall Study|Protocol Violation|13|||
150287403|NCT00880893|542187325|FG001|Overall Study|Protocol Violation|1|||
150287404|NCT00880893|542187324|FG000|Overall Study|Withdrawal by Subject|15|||
150287405|NCT00880893|542187325|FG001|Overall Study|Withdrawal by Subject|11|||
150287406|NCT00880893|542187324|FG000|Overall Study|Lost to Follow-up|76|||
150036231|NCT00894803|541272955|FG001|Overall Study|Lost to Follow-up|1|||
150036232|NCT00449696|541272956|FG000|Overall Study|Other Treatment Required|6|||
150172647|NCT02000817|541768050|FG000|Overall Study|Lost to Follow-up|0|||
150172648|NCT02000817|541768051|FG001|Overall Study|Lost to Follow-up|0|||
150172649|NCT02000817|541768052|FG002|Overall Study|Lost to Follow-up|1|||
150287407|NCT00880893|542187325|FG001|Overall Study|Lost to Follow-up|33|||
150287408|NCT00880893|542187324|FG000|Overall Study|Serious adverse event|3|||
150287409|NCT00880893|542187325|FG001|Overall Study|Serious adverse event|0|||
150172650|NCT02000817|541768053|FG003|Overall Study|Lost to Follow-up|0|||
150172651|NCT03383146|541768055|FG000|Overall Study|Screen Failure|1|||
150172652|NCT03383146|541768056|FG001|Overall Study|Screen Failure|0|||
150172653|NCT03383146|541768055|FG000|Overall Study|Adverse Event|6|||
150172654|NCT03383146|541768056|FG001|Overall Study|Adverse Event|18|||
150172655|NCT03383146|541768055|FG000|Overall Study|Lack of Efficacy|0|||
150172656|NCT03383146|541768056|FG001|Overall Study|Lack of Efficacy|3|||
150172657|NCT03383146|541768055|FG000|Overall Study|Withdrawal by Subject|20|||
150172658|NCT03383146|541768056|FG001|Overall Study|Withdrawal by Subject|36|||
150172659|NCT03383146|541768055|FG000|Overall Study|Lost to Follow-up|5|||
150172660|NCT03383146|541768056|FG001|Overall Study|Lost to Follow-up|15|||
150172661|NCT03383146|541768055|FG000|Overall Study|Death|0|||
150172662|NCT03383146|541768056|FG001|Overall Study|Death|2|||
150172663|NCT03383146|541768055|FG000|Overall Study|Physician Decision|0|||
150172664|NCT03383146|541768056|FG001|Overall Study|Physician Decision|1|||
150172665|NCT03383146|541768055|FG000|Overall Study|Protocol Deviation|1|||
150172666|NCT03383146|541768056|FG001|Overall Study|Protocol Deviation|8|||
150172667|NCT03383146|541768055|FG000|Overall Study|Study Terminated by the Sponsor|48|||
150172668|NCT03383146|541768056|FG001|Overall Study|Study Terminated by the Sponsor|95|||
150172669|NCT03383146|541768055|FG000|Overall Study|Reason not Specified|4|||
150172670|NCT03383146|541768056|FG001|Overall Study|Reason not Specified|6|||
150172671|NCT05382104|541768057|FG000|Period 2 (2 Days)|Adverse Event|0|||
150172672|NCT05382104|541768058|FG001|Period 2 (2 Days)|Adverse Event|1|||
150172673|NCT05382104|541768059|FG002|Period 2 (2 Days)|Adverse Event|0|||
150172674|NCT05382104|541768060|FG003|Period 2 (2 Days)|Adverse Event|0|||
150172675|NCT05382104|541768061|FG004|Period 2 (2 Days)|Adverse Event|0|||
150172676|NCT05382104|541768062|FG005|Period 2 (2 Days)|Adverse Event|0|||
150172677|NCT01317420|541768067|FG000|Overall Study|Progressive disease according to RECIST|2|||
150172678|NCT01317420|541768068|FG001|Overall Study|Progressive disease according to RECIST|3|||
149955008|NCT03166631|540967933|FG008|Overall Study|Physician Decision|1|||
149955009|NCT03166631|540967934|FG009|Overall Study|Physician Decision|0|||
149955010|NCT03166631|540967935|FG010|Overall Study|Physician Decision|1|||
149955011|NCT03166631|540967925|FG000|Overall Study|Death|0|||
149955012|NCT03166631|540967926|FG001|Overall Study|Death|0|||
149955013|NCT03166631|540967927|FG002|Overall Study|Death|0|||
149955014|NCT03166631|540967928|FG003|Overall Study|Death|0|||
149955015|NCT03166631|540967929|FG004|Overall Study|Death|1|||
149955016|NCT03166631|540967930|FG005|Overall Study|Death|0|||
149955017|NCT03166631|540967931|FG006|Overall Study|Death|1|||
149955018|NCT03166631|540967932|FG007|Overall Study|Death|0|||
149955019|NCT03166631|540967933|FG008|Overall Study|Death|0|||
149955020|NCT03166631|540967934|FG009|Overall Study|Death|0|||
149955021|NCT03166631|540967935|FG010|Overall Study|Death|0|||
149955022|NCT03166631|540967925|FG000|Overall Study|Adverse Event|1|||
149955023|NCT03166631|540967926|FG001|Overall Study|Adverse Event|0|||
150036233|NCT00449696|541272957|FG001|Overall Study|Other Treatment Required|1|||
150036234|NCT00449696|541272956|FG000|Overall Study|Withdrawal by Subject|5|||
150036235|NCT00449696|541272957|FG001|Overall Study|Withdrawal by Subject|5|||
150036236|NCT00449696|541272956|FG000|Overall Study|Lost to Follow-up|2|||
150036237|NCT00449696|541272957|FG001|Overall Study|Lost to Follow-up|3|||
150036238|NCT00449696|541272956|FG000|Overall Study|Others|7|||
150036239|NCT00449696|541272957|FG001|Overall Study|Others|0|||
150036240|NCT01033019|541272958|FG000|Overall Study|Withdrawal by Subject|1|||
150036241|NCT01033019|541272959|FG001|Overall Study|Withdrawal by Subject|0|||
150036242|NCT01409707|541272964|FG000|Overall Study|Withdrawal by Subject|5|||
150036243|NCT01409707|541272965|FG001|Overall Study|Withdrawal by Subject|17|||
150036244|NCT01409707|541272966|FG002|Overall Study|Withdrawal by Subject|16|||
150036245|NCT01903460|541272968|FG000|Overall Study|Adverse Event|0|||
150036246|NCT01903460|541272969|FG001|Overall Study|Adverse Event|0|||
150036247|NCT01903460|541272970|FG002|Overall Study|Adverse Event|0|||
150036248|NCT01903460|541272971|FG003|Overall Study|Adverse Event|1|||
150036249|NCT03104868|541272972|FG000|6 Week Follow up|Lost to Follow-up|5|||
150036250|NCT03104868|541272973|FG001|6 Week Follow up|Lost to Follow-up|8|||
150172679|NCT01317420|541768069|FG002|Overall Study|Progressive disease according to RECIST|3|||
150172680|NCT01317420|541768070|FG003|Overall Study|Progressive disease according to RECIST|3|||
150036251|NCT03104868|541272972|FG000|6 Week Follow up|Death|1|||
150036252|NCT03104868|541272973|FG001|6 Week Follow up|Death|1|||
150172681|NCT01317420|541768071|FG004|Overall Study|Progressive disease according to RECIST|3|||
150172682|NCT01317420|541768072|FG005|Overall Study|Progressive disease according to RECIST|3|||
150172683|NCT01317420|541768073|FG006|Overall Study|Progressive disease according to RECIST|3|||
150172684|NCT01317420|541768074|FG007|Overall Study|Progressive disease according to RECIST|3|||
150172685|NCT01317420|541768075|FG008|Overall Study|Progressive disease according to RECIST|3|||
150172686|NCT01317420|541768076|FG009|Overall Study|Progressive disease according to RECIST|2|||
149955024|NCT03166631|540967927|FG002|Overall Study|Adverse Event|0|||
149955025|NCT03166631|540967928|FG003|Overall Study|Adverse Event|0|||
150036253|NCT03104868|541272972|FG000|6 Week Follow up|Withdrawal by Subject|7|||
150036254|NCT03104868|541272973|FG001|6 Week Follow up|Withdrawal by Subject|6|||
150036255|NCT03104868|541272972|FG000|6 Week Follow up|Completed Later Timepoint|24|||
149844393|NCT00902538|540560337|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
149844394|NCT00902538|540560332|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
149844395|NCT00902538|540560333|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
149844396|NCT00902538|540560334|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
149844397|NCT00902538|540560335|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
149844398|NCT00902538|540560336|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
149844399|NCT00902538|540560337|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
149844400|NCT00902538|540560332|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
149844401|NCT00902538|540560333|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
149844402|NCT00902538|540560334|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
149844403|NCT00902538|540560335|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
149844404|NCT00902538|540560336|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
149844405|NCT00902538|540560337|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
149844406|NCT00902538|540560332|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
149844407|NCT00902538|540560333|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
149844408|NCT00902538|540560334|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
149844409|NCT00902538|540560335|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
149844410|NCT00902538|540560336|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
149844411|NCT00902538|540560337|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
149844412|NCT00902538|540560332|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149844413|NCT00902538|540560333|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
149844414|NCT00902538|540560334|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149844415|NCT00902538|540560335|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149844416|NCT00902538|540560336|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149844417|NCT00902538|540560337|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149844418|NCT00902538|540560332|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
149955026|NCT03166631|540967929|FG004|Overall Study|Adverse Event|0|||
149955027|NCT03166631|540967930|FG005|Overall Study|Adverse Event|1|||
149955028|NCT03166631|540967931|FG006|Overall Study|Adverse Event|1|||
149955029|NCT03166631|540967932|FG007|Overall Study|Adverse Event|0|||
149955030|NCT03166631|540967933|FG008|Overall Study|Adverse Event|1|||
149955031|NCT03166631|540967934|FG009|Overall Study|Adverse Event|2|||
149955032|NCT03166631|540967935|FG010|Overall Study|Adverse Event|1|||
149955033|NCT03166631|540967925|FG000|Overall Study|Withdrawal by Subject|0|||
149955034|NCT03166631|540967926|FG001|Overall Study|Withdrawal by Subject|0|||
149955035|NCT03166631|540967927|FG002|Overall Study|Withdrawal by Subject|0|||
149955036|NCT03166631|540967928|FG003|Overall Study|Withdrawal by Subject|0|||
149955037|NCT03166631|540967929|FG004|Overall Study|Withdrawal by Subject|0|||
149955038|NCT03166631|540967930|FG005|Overall Study|Withdrawal by Subject|0|||
149955039|NCT03166631|540967931|FG006|Overall Study|Withdrawal by Subject|0|||
149955040|NCT03166631|540967932|FG007|Overall Study|Withdrawal by Subject|0|||
149955041|NCT03166631|540967933|FG008|Overall Study|Withdrawal by Subject|1|||
149955042|NCT03166631|540967934|FG009|Overall Study|Withdrawal by Subject|1|||
149955043|NCT03166631|540967935|FG010|Overall Study|Withdrawal by Subject|0|||
149955044|NCT02400736|540967938|FG000|Overall Study|Lost to Follow-up|6|||
149955045|NCT02400736|540967939|FG001|Overall Study|Lost to Follow-up|6|||
149955046|NCT02400736|540967938|FG000|Overall Study|Withdrawal by Subject|2|||
149955047|NCT02400736|540967939|FG001|Overall Study|Withdrawal by Subject|1|||
149955048|NCT02400736|540967938|FG000|Overall Study|Moved from the area|3|||
149955049|NCT02400736|540967939|FG001|Overall Study|Moved from the area|1|||
149955050|NCT02927145|540967940|FG000|Initial Recruitment|Withdrawal by Subject|0|||
149955051|NCT02927145|540967941|FG001|Initial Recruitment|Withdrawal by Subject|1|||
149955052|NCT02927145|540967942|FG002|Initial Recruitment|Withdrawal by Subject|1|||
149955053|NCT02927145|540967943|FG003|Initial Recruitment|Withdrawal by Subject|4|||
149955054|NCT02927145|540967944|FG004|Initial Recruitment|Withdrawal by Subject|1|||
149955055|NCT02927145|540967945|FG005|Initial Recruitment|Withdrawal by Subject|1|||
149955056|NCT02927145|540967946|FG006|Initial Recruitment|Withdrawal by Subject|0|||
149844419|NCT00902538|540560333|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
149844420|NCT00902538|540560334|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
149844421|NCT00902538|540560335|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
149844422|NCT00902538|540560336|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
149844423|NCT00902538|540560337|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
149955057|NCT02927145|540967947|FG007|Initial Recruitment|Withdrawal by Subject|0|||
149955058|NCT02927145|540967948|FG008|Initial Recruitment|Withdrawal by Subject|2|||
149955059|NCT02927145|540967940|FG000|Initial Recruitment|Adverse Event|0|||
149955060|NCT02927145|540967941|FG001|Initial Recruitment|Adverse Event|0|||
149955061|NCT02927145|540967942|FG002|Initial Recruitment|Adverse Event|0|||
149844424|NCT00902538|540560332|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
149844425|NCT00902538|540560333|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
149844426|NCT00902538|540560334|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
149844427|NCT00902538|540560335|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
149844428|NCT00902538|540560336|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
149844429|NCT00902538|540560337|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
149844430|NCT00902538|540560332|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
149844431|NCT00902538|540560333|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
149844432|NCT00902538|540560334|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
149844433|NCT00902538|540560335|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
149844434|NCT00902538|540560336|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
149844435|NCT00902538|540560337|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
149844436|NCT00902538|540560332|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
149844437|NCT00902538|540560333|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
149844438|NCT00902538|540560334|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
149844439|NCT00902538|540560335|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
149844440|NCT00902538|540560336|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
149844441|NCT00902538|540560337|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
149844442|NCT01279486|540560342|FG000|Overall Study|Lost to Follow-up|1|||
149844443|NCT04198363|540560343|FG000|Overall Study|Adverse Event|1|||
149844444|NCT04198363|540560344|FG001|Overall Study|Adverse Event|1|||
149844445|NCT04198363|540560343|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
149955062|NCT02927145|540967943|FG003|Initial Recruitment|Adverse Event|0|||
149955063|NCT02927145|540967944|FG004|Initial Recruitment|Adverse Event|2|||
149955064|NCT02927145|540967945|FG005|Initial Recruitment|Adverse Event|0|||
149955065|NCT02927145|540967946|FG006|Initial Recruitment|Adverse Event|0|||
149955066|NCT02927145|540967947|FG007|Initial Recruitment|Adverse Event|0|||
149955067|NCT02927145|540967948|FG008|Initial Recruitment|Adverse Event|0|||
149955068|NCT02927145|540967940|FG000|Invitation for Additional Challenge|Pregnancy|0|||
149955069|NCT02927145|540967941|FG001|Invitation for Additional Challenge|Pregnancy|0|||
149955070|NCT02927145|540967942|FG002|Invitation for Additional Challenge|Pregnancy|0|||
149955071|NCT02927145|540967943|FG003|Invitation for Additional Challenge|Pregnancy|0|||
149955072|NCT02927145|540967944|FG004|Invitation for Additional Challenge|Pregnancy|0|||
149955073|NCT02927145|540967945|FG005|Invitation for Additional Challenge|Pregnancy|0|||
149955074|NCT02927145|540967946|FG006|Invitation for Additional Challenge|Pregnancy|1|||
149955075|NCT02927145|540967947|FG007|Invitation for Additional Challenge|Pregnancy|0|||
149955076|NCT02927145|540967948|FG008|Invitation for Additional Challenge|Pregnancy|0|||
149955077|NCT02323334|540967949|FG000|Period 3|Lost to Follow-up|0|||
149955078|NCT02323334|540967950|FG001|Period 3|Lost to Follow-up|0|||
149955079|NCT02323334|540967951|FG002|Period 3|Lost to Follow-up|1|||
149955080|NCT02323334|540967952|FG003|Period 3|Lost to Follow-up|0|||
149955081|NCT02323334|540967953|FG004|Period 3|Lost to Follow-up|0|||
149955082|NCT02323334|540967954|FG005|Period 3|Lost to Follow-up|0|||
149955083|NCT02323334|540967955|FG006|Period 3|Lost to Follow-up|0|||
149955084|NCT02323334|540967956|FG007|Period 3|Lost to Follow-up|0|||
149955085|NCT02323334|540967957|FG008|Period 3|Lost to Follow-up|0|||
149955086|NCT02323334|540967958|FG009|Period 3|Lost to Follow-up|0|||
149955087|NCT02323334|540967959|FG010|Period 3|Lost to Follow-up|0|||
149955088|NCT02323334|540967960|FG011|Period 3|Lost to Follow-up|0|||
149955089|NCT02323334|540967961|FG012|Period 3|Lost to Follow-up|0|||
149955090|NCT02323334|540967962|FG013|Period 3|Lost to Follow-up|0|||
150287410|NCT02164981|542187326|FG000|Started|Withdrawal by Subject|2|||
149955091|NCT02323334|540967963|FG014|Period 3|Lost to Follow-up|0|||
149955092|NCT02323334|540967964|FG015|Period 3|Lost to Follow-up|0|||
149955093|NCT02323334|540967965|FG016|Period 3|Lost to Follow-up|0|||
149955094|NCT02323334|540967949|FG000|Period 3|Withdrawal by Subject|1|||
149955095|NCT02323334|540967950|FG001|Period 3|Withdrawal by Subject|0|||
149955096|NCT02323334|540967951|FG002|Period 3|Withdrawal by Subject|0|||
149955097|NCT02323334|540967952|FG003|Period 3|Withdrawal by Subject|0|||
150287411|NCT02164981|542187327|FG001|Started|Withdrawal by Subject|1|||
150287412|NCT02164981|542187328|FG002|Started|Withdrawal by Subject|0|||
150287413|NCT02164981|542187326|FG000|Started|Protocol Violation|2|||
150287414|NCT02164981|542187327|FG001|Started|Protocol Violation|0|||
150287415|NCT02164981|542187328|FG002|Started|Protocol Violation|0|||
149955098|NCT02323334|540967953|FG004|Period 3|Withdrawal by Subject|0|||
149955099|NCT02323334|540967954|FG005|Period 3|Withdrawal by Subject|0|||
149955100|NCT02323334|540967955|FG006|Period 3|Withdrawal by Subject|0|||
149955101|NCT02323334|540967956|FG007|Period 3|Withdrawal by Subject|0|||
149955102|NCT02323334|540967957|FG008|Period 3|Withdrawal by Subject|0|||
149955103|NCT02323334|540967958|FG009|Period 3|Withdrawal by Subject|0|||
149955104|NCT02323334|540967959|FG010|Period 3|Withdrawal by Subject|0|||
149955105|NCT02323334|540967960|FG011|Period 3|Withdrawal by Subject|0|||
149955106|NCT02323334|540967961|FG012|Period 3|Withdrawal by Subject|0|||
149955107|NCT02323334|540967962|FG013|Period 3|Withdrawal by Subject|0|||
149955108|NCT02323334|540967963|FG014|Period 3|Withdrawal by Subject|0|||
149844446|NCT04198363|540560344|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
149844447|NCT04198363|540560343|FG000|Overall Study|Reason not Specified|1|||
149844448|NCT04198363|540560344|FG001|Overall Study|Reason not Specified|0|||
149844449|NCT03067987|540560346|FG000|Overall Study|Lost to Follow-up|7|||
149844450|NCT03067987|540560347|FG001|Overall Study|Lost to Follow-up|10|||
149844451|NCT03067987|540560346|FG000|Overall Study|Protocol Violation|1|||
149844452|NCT03067987|540560347|FG001|Overall Study|Protocol Violation|2|||
149844453|NCT03067987|540560346|FG000|Overall Study|Withdrawal by Subject|2|||
149844454|NCT03067987|540560347|FG001|Overall Study|Withdrawal by Subject|1|||
149844455|NCT04827394|540560351|FG000|Overall Study|Physician Decision|0|||
149844456|NCT04827394|540560352|FG001|Overall Study|Physician Decision|2|||
149844457|NCT01404988|540560353|FG000|Overall Study|Death|2|||
149844458|NCT01404988|540560354|FG001|Overall Study|Death|0|||
149844459|NCT01404988|540560355|FG002|Overall Study|Death|2|||
149844460|NCT01404988|540560353|FG000|Overall Study|Adverse Event|1|||
149844461|NCT01404988|540560354|FG001|Overall Study|Adverse Event|0|||
149844462|NCT01404988|540560355|FG002|Overall Study|Adverse Event|0|||
149844463|NCT01404988|540560353|FG000|Overall Study|Withdrawal by Subject|2|||
149844464|NCT01404988|540560354|FG001|Overall Study|Withdrawal by Subject|2|||
149844465|NCT01404988|540560355|FG002|Overall Study|Withdrawal by Subject|0|||
149844466|NCT01404988|540560353|FG000|Overall Study|Lost to Follow-up|1|||
149844467|NCT01404988|540560354|FG001|Overall Study|Lost to Follow-up|2|||
149844468|NCT01404988|540560355|FG002|Overall Study|Lost to Follow-up|1|||
149844469|NCT00477594|540560356|FG000|Year 1 and Year 2|Adverse Event|4|||
149844470|NCT00477594|540560357|FG001|Year 1 and Year 2|Adverse Event|2|||
149844471|NCT00477594|540560356|FG000|Year 1 and Year 2|Physician Decision|2|||
149844472|NCT00477594|540560357|FG001|Year 1 and Year 2|Physician Decision|1|||
149844473|NCT00477594|540560356|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
149844474|NCT00477594|540560357|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
149844475|NCT00477594|540560356|FG000|Year 1 and Year 2|Other|1|||
150036256|NCT03104868|541272973|FG001|6 Week Follow up|Completed Later Timepoint|22|||
150172687|NCT01317420|541768077|FG010|Overall Study|Progressive disease according to RECIST|3|||
150287416|NCT02164981|542187326|FG000|Started|Adverse Event|1|||
150287417|NCT02164981|542187327|FG001|Started|Adverse Event|2|||
150287418|NCT02164981|542187328|FG002|Started|Adverse Event|0|||
150287419|NCT02164981|542187326|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
149844476|NCT00477594|540560357|FG001|Year 1 and Year 2|Other|0|||
149844477|NCT00477594|540560356|FG000|Year 3|Adverse Event|1|||
149844478|NCT00477594|540560357|FG001|Year 3|Adverse Event|0|||
149844479|NCT00477594|540560356|FG000|Year 3|Withdrawal by Subject|1|||
149844480|NCT00477594|540560357|FG001|Year 3|Withdrawal by Subject|0|||
149844481|NCT00477594|540560356|FG000|Follow-up Period|Withdrawal by Subject|2|||
149844482|NCT00477594|540560357|FG001|Follow-up Period|Withdrawal by Subject|1|||
149844483|NCT00477594|540560356|FG000|Follow-up Period|Other|1|||
149844484|NCT00477594|540560357|FG001|Follow-up Period|Other|0|||
149844485|NCT02488109|540562086|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
149844486|NCT02488109|540562087|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
149844487|NCT02488109|540562086|FG000|12-month Follow-Up|Lost to Follow-up|4|||
149844488|NCT02488109|540562087|FG001|12-month Follow-Up|Lost to Follow-up|7|||
149844489|NCT02302716|540562088|FG000|Overall Study|Adverse Event|1|||
149844490|NCT02302716|540562089|FG001|Overall Study|Adverse Event|1|||
149844491|NCT02302716|540562088|FG000|Overall Study|Death|0|||
149844492|NCT02302716|540562089|FG001|Overall Study|Death|1|||
149844493|NCT02302716|540562088|FG000|Overall Study|Lack of Efficacy|0|||
149844494|NCT02302716|540562089|FG001|Overall Study|Lack of Efficacy|1|||
149844495|NCT02302716|540562088|FG000|Overall Study|Lost to Follow-up|2|||
149844496|NCT02302716|540562089|FG001|Overall Study|Lost to Follow-up|4|||
149844497|NCT02302716|540562088|FG000|Overall Study|Physician Decision|3|||
149844498|NCT02302716|540562089|FG001|Overall Study|Physician Decision|4|||
149844499|NCT02302716|540562088|FG000|Overall Study|Withdrawal by Subject|13|||
149844500|NCT02302716|540562089|FG001|Overall Study|Withdrawal by Subject|7|||
149844501|NCT02302716|540562088|FG000|Overall Study|Protocol Violation|0|||
149844502|NCT02302716|540562089|FG001|Overall Study|Protocol Violation|1|||
149844503|NCT00557245|540562093|FG000|Overall Study|Lost to Follow-up|7|||
149844504|NCT00557245|540562094|FG001|Overall Study|Lost to Follow-up|8|||
149844505|NCT00557245|540562095|FG002|Overall Study|Lost to Follow-up|10|||
149844506|NCT00557245|540562093|FG000|Overall Study|Ineligible|5|||
149844507|NCT00557245|540562094|FG001|Overall Study|Ineligible|4|||
149844508|NCT00557245|540562095|FG002|Overall Study|Ineligible|2|||
149844509|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Subject request|8|||
149844510|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Subject request|11|||
149844511|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
149844512|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
149844513|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
149844514|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
149844515|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
149844516|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
149844517|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
150287420|NCT02164981|542187327|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
150287421|NCT02164981|542187328|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
150287422|NCT02164981|542187326|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
150287423|NCT02164981|542187327|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
150287424|NCT02164981|542187328|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
150287425|NCT02164981|542187326|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
150287426|NCT02164981|542187327|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
150287427|NCT02164981|542187328|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
150287428|NCT01783678|542187329|FG000|Overall Study|Randomized but Not Treated|0|||
150287429|NCT01783678|542187330|FG001|Overall Study|Randomized but Not Treated|0|||
150287430|NCT01783678|542187331|FG002|Overall Study|Randomized but Not Treated|0|||
150287431|NCT01783678|542187332|FG003|Overall Study|Randomized but Not Treated|1|||
150287432|NCT01783678|542187333|FG004|Overall Study|Randomized but Not Treated|0|||
150287433|NCT01783678|542187334|FG005|Overall Study|Randomized but Not Treated|0|||
150287434|NCT01783678|542187329|FG000|Overall Study|Lack of Efficacy|1|||
150287435|NCT01783678|542187330|FG001|Overall Study|Lack of Efficacy|13|||
150287436|NCT01783678|542187331|FG002|Overall Study|Lack of Efficacy|1|||
150287437|NCT01783678|542187332|FG003|Overall Study|Lack of Efficacy|3|||
149955109|NCT02323334|540967964|FG015|Period 3|Withdrawal by Subject|0|||
149955110|NCT02323334|540967965|FG016|Period 3|Withdrawal by Subject|0|||
149955111|NCT01795937|540967971|FG000|Overall Study|Withdrawal by Subject|1|||
149955112|NCT01795937|540967972|FG001|Overall Study|Withdrawal by Subject|0|||
150287438|NCT01783678|542187333|FG004|Overall Study|Lack of Efficacy|6|||
150287439|NCT01783678|542187334|FG005|Overall Study|Lack of Efficacy|5|||
150287440|NCT01783678|542187329|FG000|Overall Study|Lost to Follow-up|0|||
150287441|NCT01783678|542187330|FG001|Overall Study|Lost to Follow-up|4|||
150287442|NCT01783678|542187331|FG002|Overall Study|Lost to Follow-up|0|||
150287443|NCT01783678|542187332|FG003|Overall Study|Lost to Follow-up|2|||
150287444|NCT01783678|542187333|FG004|Overall Study|Lost to Follow-up|1|||
150287445|NCT01783678|542187334|FG005|Overall Study|Lost to Follow-up|0|||
149955113|NCT01795937|540967973|FG002|Overall Study|Withdrawal by Subject|0|||
149955114|NCT01795937|540967971|FG000|Overall Study|Physician Decision|0|||
149955115|NCT01795937|540967972|FG001|Overall Study|Physician Decision|1|||
149955116|NCT01795937|540967973|FG002|Overall Study|Physician Decision|0|||
149955117|NCT01875237|540967974|FG000|Overall Study|GVDH before DLI|1|||
149955118|NCT01875237|540967975|FG001|Overall Study|GVDH before DLI|0|||
149955119|NCT01875237|540967974|FG000|Overall Study|DLI cells could not be produced|1|||
149955120|NCT01875237|540967975|FG001|Overall Study|DLI cells could not be produced|0|||
149955121|NCT00875667|540967976|FG000|Overall Study|Adverse Event|29|||
149955122|NCT00875667|540967977|FG001|Overall Study|Adverse Event|10|||
149955123|NCT00875667|540967976|FG000|Overall Study|Withdrawal by Subject|17|||
149955124|NCT00875667|540967977|FG001|Overall Study|Withdrawal by Subject|5|||
149955125|NCT00875667|540967976|FG000|Overall Study|Death|7|||
149955126|NCT00875667|540967977|FG001|Overall Study|Death|2|||
149955127|NCT00875667|540967976|FG000|Overall Study|Protocol Violation|2|||
149955128|NCT00875667|540967977|FG001|Overall Study|Protocol Violation|0|||
149955129|NCT00875667|540967976|FG000|Overall Study|Disease Progression|100|||
149955130|NCT00875667|540967977|FG001|Overall Study|Disease Progression|49|||
149955131|NCT00875667|540967976|FG000|Overall Study|Miscellaneous|12|||
149955132|NCT00875667|540967977|FG001|Overall Study|Miscellaneous|6|||
149955133|NCT00875667|540967976|FG000|Overall Study|Randomized but no Study Drug Given|3|||
149955134|NCT00875667|540967977|FG001|Overall Study|Randomized but no Study Drug Given|1|||
149955135|NCT02384460|540967980|FG000|Overall Study|Protocol Violation|0|||
149955136|NCT02384460|540967981|FG001|Overall Study|Protocol Violation|1|||
149955137|NCT02384460|540967980|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
149955138|NCT02384460|540967981|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
150287446|NCT01783678|542187329|FG000|Overall Study|Withdrew Consent|1|||
150287447|NCT01783678|542187330|FG001|Overall Study|Withdrew Consent|1|||
150287448|NCT01783678|542187331|FG002|Overall Study|Withdrew Consent|0|||
150287449|NCT01783678|542187332|FG003|Overall Study|Withdrew Consent|2|||
150287450|NCT01783678|542187333|FG004|Overall Study|Withdrew Consent|0|||
150287451|NCT01783678|542187334|FG005|Overall Study|Withdrew Consent|0|||
150287452|NCT01408147|542187335|FG000|Overall Study|Withdrawal by Subject|0|||
150287453|NCT01408147|542187336|FG001|Overall Study|Withdrawal by Subject|1|||
149955139|NCT02384460|540967980|FG000|Overall Study|Adverse Event|5|||
149955140|NCT02384460|540967981|FG001|Overall Study|Adverse Event|2|||
149955141|NCT02384460|540967980|FG000|Overall Study|Withdrawal by Subject|0|||
149955142|NCT02384460|540967981|FG001|Overall Study|Withdrawal by Subject|3|||
150287454|NCT01761266|542187337|FG000|Overall Study|Death|415|||
150287455|NCT01761266|542187338|FG001|Overall Study|Death|402|||
150287456|NCT01761266|542187337|FG000|Overall Study|Lost to Follow-up|8|||
150287457|NCT01761266|542187338|FG001|Overall Study|Lost to Follow-up|12|||
150287458|NCT01761266|542187337|FG000|Overall Study|Withdrawal by Subject|14|||
150287459|NCT01761266|542187338|FG001|Overall Study|Withdrawal by Subject|10|||
150287460|NCT01761266|542187337|FG000|Overall Study|Sponsor Decision|41|||
149955143|NCT02384460|540967980|FG000|Overall Study|Elective medical treatment|1|||
149955144|NCT02384460|540967981|FG001|Overall Study|Elective medical treatment|0|||
149955145|NCT02384460|540967980|FG000|Overall Study|Non-compliance|1|||
149844518|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
149844519|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
149844520|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
149844521|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Death|1|||
149844522|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Death|0|||
149844523|NCT00521586|540562096|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
149844524|NCT00521586|540562097|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
149844525|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
149844526|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
149844527|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
149844528|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
149844529|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
149844530|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
149844531|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
149844532|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
149955146|NCT02384460|540967981|FG001|Overall Study|Non-compliance|0|||
149955147|NCT00625378|540967982|FG000|Overall Study|Adverse Event|22|||
149955148|NCT00625378|540967983|FG001|Overall Study|Adverse Event|0|||
149955149|NCT00625378|540967982|FG000|Overall Study|Withdrawal by Subject|16|||
149955150|NCT00625378|540967983|FG001|Overall Study|Withdrawal by Subject|0|||
149955151|NCT00625378|540967982|FG000|Overall Study|Death|38|||
149955152|NCT00625378|540967983|FG001|Overall Study|Death|0|||
149955153|NCT00625378|540967982|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
149955154|NCT00625378|540967983|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
149955155|NCT00625378|540967982|FG000|Overall Study|Lost to Follow-up|17|||
149955156|NCT00625378|540967983|FG001|Overall Study|Lost to Follow-up|0|||
149955157|NCT00625378|540967982|FG000|Overall Study|Non-compliant with study medication|3|||
149955158|NCT00625378|540967983|FG001|Overall Study|Non-compliant with study medication|0|||
149955159|NCT00625378|540967982|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
149955160|NCT00625378|540967983|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
149955161|NCT00625378|540967982|FG000|Overall Study|Medical decision|1|||
149955162|NCT00625378|540967983|FG001|Overall Study|Medical decision|0|||
149955163|NCT00625378|540967982|FG000|Overall Study|Multiple toxicities|1|||
149955164|NCT00625378|540967983|FG001|Overall Study|Multiple toxicities|0|||
149955165|NCT00625378|540967982|FG000|Overall Study|New cancer|1|||
149955166|NCT00625378|540967983|FG001|Overall Study|New cancer|0|||
149955167|NCT00625378|540967982|FG000|Overall Study|PTA program|2|||
149955168|NCT00625378|540967983|FG001|Overall Study|PTA program|0|||
149955169|NCT00625378|540967982|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
149955170|NCT00625378|540967983|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
149955171|NCT00625378|540967982|FG000|Overall Study|Sponsor decision|1|||
149955172|NCT00625378|540967983|FG001|Overall Study|Sponsor decision|0|||
149955173|NCT00625378|540967982|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
149955174|NCT00625378|540967983|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
149955175|NCT00625378|540967982|FG000|Overall Study|Switch to commercial drug|6|||
149955176|NCT00625378|540967983|FG001|Overall Study|Switch to commercial drug|1|||
149955177|NCT00625378|540967982|FG000|Overall Study|Missing|2|||
149955178|NCT00625378|540967983|FG001|Overall Study|Missing|0|||
149955179|NCT00625378|540967982|FG000|Overall Study|End of treatment not available|2|||
149955180|NCT00625378|540967983|FG001|Overall Study|End of treatment not available|0|||
149955181|NCT00625378|540967982|FG000|Overall Study|Never treated|2|||
149955182|NCT00625378|540967983|FG001|Overall Study|Never treated|0|||
149955183|NCT04270760|540967984|FG000|Overall Study|Withdrawal by Subject|0|||
149955184|NCT04270760|540967985|FG001|Overall Study|Withdrawal by Subject|1|||
149955185|NCT04270760|540967986|FG002|Overall Study|Withdrawal by Subject|3|||
149955186|NCT04270760|540967987|FG003|Overall Study|Withdrawal by Subject|0|||
149955187|NCT04270760|540967988|FG004|Overall Study|Withdrawal by Subject|0|||
149955188|NCT04270760|540967984|FG000|Overall Study|Lost to Follow-up|1|||
149955189|NCT04270760|540967985|FG001|Overall Study|Lost to Follow-up|2|||
149955190|NCT04270760|540967986|FG002|Overall Study|Lost to Follow-up|1|||
149955191|NCT04270760|540967987|FG003|Overall Study|Lost to Follow-up|0|||
149955192|NCT04270760|540967988|FG004|Overall Study|Lost to Follow-up|0|||
149955193|NCT04270760|540967984|FG000|Overall Study|Death|0|||
149955194|NCT04270760|540967985|FG001|Overall Study|Death|0|||
149955195|NCT04270760|540967986|FG002|Overall Study|Death|0|||
149955196|NCT04270760|540967987|FG003|Overall Study|Death|0|||
149955197|NCT04270760|540967988|FG004|Overall Study|Death|1|||
149955198|NCT03670628|540967996|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
149955199|NCT03670628|540967997|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
149844533|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
149844534|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
149955200|NCT03670628|540967996|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
150287461|NCT01761266|542187338|FG001|Overall Study|Sponsor Decision|52|||
150287462|NCT00112905|542187339|FG000|Overall Study|Adverse Event|4|||
150287463|NCT00112905|542187339|FG000|Overall Study|Death|1|||
150287464|NCT00112905|542187339|FG000|Overall Study|Ineligibility|5|||
150287465|NCT00112905|542187339|FG000|Overall Study|Alternative treatment|1|||
150287466|NCT00112905|542187339|FG000|Overall Study|performance status was deteiorating|1|||
150287467|NCT01042600|542187340|FG000|Overall Study|Ineligible|1|||
150287468|NCT01042600|542187341|FG001|Overall Study|Ineligible|0|||
150287469|NCT04541004|542187342|FG000|Overall Study|Adverse Event|2|||
150287470|NCT00621504|542187343|FG000|Overall Study|Adverse Event|1|||
150287471|NCT00621504|542187344|FG001|Overall Study|Adverse Event|3|||
150287472|NCT00621504|542187343|FG000|Overall Study|At the request of sponsor/investigator|1|||
150287473|NCT00621504|542187344|FG001|Overall Study|At the request of sponsor/investigator|0|||
150287474|NCT00621504|542187343|FG000|Overall Study|Withdrew consent|9|||
150287475|NCT00621504|542187344|FG001|Overall Study|Withdrew consent|6|||
150287476|NCT00621504|542187343|FG000|Overall Study|Lost to Follow-up|8|||
150287477|NCT00621504|542187344|FG001|Overall Study|Lost to Follow-up|10|||
150287478|NCT00621504|542187343|FG000|Overall Study|Other|1|||
150287479|NCT00621504|542187344|FG001|Overall Study|Other|0|||
150287480|NCT00621504|542187343|FG000|Overall Study|Death|6|||
150287481|NCT00621504|542187344|FG001|Overall Study|Death|6|||
150287482|NCT03257267|542187347|FG000|Overall Study|Adverse Event|17|||
150287483|NCT03257267|542187348|FG001|Overall Study|Adverse Event|7|||
150287484|NCT03257267|542187347|FG000|Overall Study|Death|96|||
150287485|NCT03257267|542187348|FG001|Overall Study|Death|98|||
150287486|NCT03257267|542187347|FG000|Overall Study|Lost to Follow-up|2|||
150287487|NCT03257267|542187348|FG001|Overall Study|Lost to Follow-up|2|||
150287488|NCT03257267|542187347|FG000|Overall Study|Non-compliance with Study Drug|0|||
150287489|NCT03257267|542187348|FG001|Overall Study|Non-compliance with Study Drug|2|||
150287490|NCT03257267|542187347|FG000|Overall Study|Participant Decision|35|||
150287491|NCT03257267|542187348|FG001|Overall Study|Participant Decision|43|||
150287492|NCT03257267|542187347|FG000|Overall Study|Sponsor Decision|1|||
150287493|NCT03257267|542187348|FG001|Overall Study|Sponsor Decision|0|||
150287494|NCT03257267|542187347|FG000|Overall Study|Physician Decision|1|||
150287495|NCT03257267|542187348|FG001|Overall Study|Physician Decision|3|||
150287496|NCT03257267|542187347|FG000|Overall Study|Disease Progression|109|||
150287497|NCT03257267|542187348|FG001|Overall Study|Disease Progression|121|||
150287498|NCT03257267|542187347|FG000|Overall Study|Withdrawal by Subject|8|||
150287499|NCT03257267|542187348|FG001|Overall Study|Withdrawal by Subject|26|||
150287500|NCT03257267|542187347|FG000|Overall Study|Other|0|||
150287501|NCT03257267|542187348|FG001|Overall Study|Other|2|||
150287502|NCT03445000|542187349|FG000|Overall Study|Disease progression|8|||
150287503|NCT03445000|542187349|FG000|Overall Study|Adverse Event|3|||
150287504|NCT03445000|542187349|FG000|Overall Study|Death|2|||
150287505|NCT03445000|542187349|FG000|Overall Study|Physician Decision|1|||
150287506|NCT03311711|542187350|FG000|Overall Study|Death|1|||
150287507|NCT03311711|542187351|FG001|Overall Study|Death|0|||
150287508|NCT03311711|542187352|FG002|Overall Study|Death|0|||
150287509|NCT03311711|542187353|FG003|Overall Study|Death|0|||
150287510|NCT03311711|542187354|FG004|Overall Study|Death|0|||
150287511|NCT03311711|542187355|FG005|Overall Study|Death|0|||
150287512|NCT03311711|542187356|FG006|Overall Study|Death|1|||
150287513|NCT03311711|542187357|FG007|Overall Study|Death|0|||
150287514|NCT03311711|542187358|FG008|Overall Study|Death|1|||
150287515|NCT03311711|542187359|FG009|Overall Study|Death|0|||
150287516|NCT03311711|542187350|FG000|Overall Study|Death of dyad partner|0|||
150287517|NCT03311711|542187351|FG001|Overall Study|Death of dyad partner|1|||
150287518|NCT03311711|542187352|FG002|Overall Study|Death of dyad partner|0|||
150287519|NCT03311711|542187353|FG003|Overall Study|Death of dyad partner|0|||
150287520|NCT03311711|542187354|FG004|Overall Study|Death of dyad partner|0|||
150287521|NCT03311711|542187355|FG005|Overall Study|Death of dyad partner|0|||
150287522|NCT03311711|542187356|FG006|Overall Study|Death of dyad partner|0|||
150287523|NCT03311711|542187357|FG007|Overall Study|Death of dyad partner|1|||
150287524|NCT03311711|542187358|FG008|Overall Study|Death of dyad partner|0|||
150287525|NCT03311711|542187359|FG009|Overall Study|Death of dyad partner|1|||
150287526|NCT03311711|542187350|FG000|Overall Study|Lost to Follow-up|2|||
150287527|NCT03311711|542187351|FG001|Overall Study|Lost to Follow-up|2|||
150287528|NCT03311711|542187352|FG002|Overall Study|Lost to Follow-up|0|||
150287529|NCT03311711|542187353|FG003|Overall Study|Lost to Follow-up|0|||
150287530|NCT03311711|542187354|FG004|Overall Study|Lost to Follow-up|0|||
150172688|NCT01317420|541768078|FG011|Overall Study|Progressive disease according to RECIST|11|||
150287531|NCT03311711|542187355|FG005|Overall Study|Lost to Follow-up|0|||
150287532|NCT03311711|542187356|FG006|Overall Study|Lost to Follow-up|1|||
150287533|NCT03311711|542187357|FG007|Overall Study|Lost to Follow-up|1|||
150287534|NCT03311711|542187358|FG008|Overall Study|Lost to Follow-up|0|||
150287535|NCT03311711|542187359|FG009|Overall Study|Lost to Follow-up|0|||
150287536|NCT03311711|542187350|FG000|Overall Study|Withdrawal by Subject|1|||
150287537|NCT03311711|542187351|FG001|Overall Study|Withdrawal by Subject|1|||
150287538|NCT03311711|542187352|FG002|Overall Study|Withdrawal by Subject|0|||
150287539|NCT03311711|542187353|FG003|Overall Study|Withdrawal by Subject|0|||
150287540|NCT03311711|542187354|FG004|Overall Study|Withdrawal by Subject|0|||
150287541|NCT03311711|542187355|FG005|Overall Study|Withdrawal by Subject|0|||
150287542|NCT03311711|542187356|FG006|Overall Study|Withdrawal by Subject|3|||
150287543|NCT03311711|542187357|FG007|Overall Study|Withdrawal by Subject|3|||
150287544|NCT03311711|542187358|FG008|Overall Study|Withdrawal by Subject|0|||
150287545|NCT03311711|542187359|FG009|Overall Study|Withdrawal by Subject|0|||
150287546|NCT02229552|542187360|FG000|Baseline|Withdrawal by Subject|6|||
150287547|NCT02229552|542187360|FG000|1-year Follow up|Withdrawal by Subject|7|||
150287548|NCT02229552|542187360|FG000|1-year Follow up|Lost to Follow-up|18|||
150287549|NCT02229552|542187360|FG000|2-Year Follow up|Withdrawal by Subject|9|||
150287550|NCT02229552|542187360|FG000|2-Year Follow up|Lost to Follow-up|17|||
150287551|NCT02684981|542187361|FG000|Overall Study|Permanently discontinued the treatment|157|||
150287552|NCT02684981|542187362|FG001|Overall Study|Permanently discontinued the treatment|161|||
150287553|NCT02684981|542187363|FG002|Overall Study|Permanently discontinued the treatment|110|||
150287554|NCT02684981|542187361|FG000|Overall Study|Other|83|||
150036257|NCT03104868|541272972|FG000|6 Month Follow up|Lost to Follow-up|2|||
150036258|NCT03104868|541272973|FG001|6 Month Follow up|Lost to Follow-up|2|||
150036259|NCT03104868|541272972|FG000|6 Month Follow up|Death|0|||
150036260|NCT03104868|541272973|FG001|6 Month Follow up|Death|1|||
150036261|NCT03104868|541272972|FG000|6 Month Follow up|Completed Later Timepoint|22|||
150036262|NCT03104868|541272973|FG001|6 Month Follow up|Completed Later Timepoint|32|||
150036263|NCT03104868|541272972|FG000|12 Month Follow up|Lost to Follow-up|1|||
150036264|NCT03104868|541272973|FG001|12 Month Follow up|Lost to Follow-up|2|||
150036265|NCT03104868|541272972|FG000|12 Month Follow up|Death|0|||
150036266|NCT03104868|541272973|FG001|12 Month Follow up|Death|1|||
150036267|NCT03104868|541272972|FG000|12 Month Follow up|Withdrawal by Subject|0|||
150036268|NCT03104868|541272973|FG001|12 Month Follow up|Withdrawal by Subject|3|||
150036269|NCT03104868|541272972|FG000|12 Month Follow up|Completed Later Timepoint|32|||
150036270|NCT03104868|541272973|FG001|12 Month Follow up|Completed Later Timepoint|29|||
150036271|NCT03104868|541272972|FG000|18 Month Follow up|Lost to Follow-up|7|||
150036272|NCT03104868|541272973|FG001|18 Month Follow up|Lost to Follow-up|11|||
150036273|NCT03104868|541272972|FG000|18 Month Follow up|Death|2|||
150036274|NCT03104868|541272973|FG001|18 Month Follow up|Death|1|||
150036275|NCT03104868|541272972|FG000|18 Month Follow up|Withdrawal by Subject|1|||
150036276|NCT03104868|541272973|FG001|18 Month Follow up|Withdrawal by Subject|2|||
150287555|NCT02684981|542187362|FG001|Overall Study|Other|49|||
150287556|NCT02684981|542187363|FG002|Overall Study|Other|17|||
150287557|NCT00820898|542187366|FG000|Overall Study|Inelgible - wrong primary site|1|||
150287558|NCT02921971|542187369|FG000|Overall Study|Adverse Event|1|||
150287559|NCT02921971|542187370|FG001|Overall Study|Adverse Event|2|||
150287560|NCT02921971|542187369|FG000|Overall Study|Lack of Efficacy|3|||
150287561|NCT02921971|542187370|FG001|Overall Study|Lack of Efficacy|1|||
150287562|NCT02921971|542187369|FG000|Overall Study|Other than specified above|2|||
150287563|NCT02921971|542187370|FG001|Overall Study|Other than specified above|1|||
150287564|NCT00452699|542187371|FG000|Overall Study|Adverse Event|10|||
150287565|NCT00452699|542187372|FG001|Overall Study|Adverse Event|3|||
150287566|NCT00452699|542187371|FG000|Overall Study|Lack of Efficacy|6|||
150287567|NCT00452699|542187372|FG001|Overall Study|Lack of Efficacy|4|||
150287568|NCT00452699|542187371|FG000|Overall Study|Lost to Follow-up|6|||
150287569|NCT00452699|542187372|FG001|Overall Study|Lost to Follow-up|9|||
150287570|NCT00452699|542187371|FG000|Overall Study|Protocol Violation|21|||
150287571|NCT00452699|542187372|FG001|Overall Study|Protocol Violation|25|||
150287572|NCT00452699|542187371|FG000|Overall Study|Withdrawal by Subject|26|||
150287573|NCT00452699|542187372|FG001|Overall Study|Withdrawal by Subject|25|||
150287574|NCT00452699|542187371|FG000|Overall Study|Other|12|||
150287575|NCT00452699|542187372|FG001|Overall Study|Other|7|||
150287576|NCT03509350|542187378|FG000|Overall Study|Withdrawal by Subject|0|||
150287577|NCT03509350|542187379|FG001|Overall Study|Withdrawal by Subject|2|||
150287578|NCT01425203|542187380|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
150287579|NCT01425203|542187381|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
150036277|NCT03104868|541272972|FG000|18 Month Follow up|Graft Loss|1|||
150036278|NCT03104868|541272973|FG001|18 Month Follow up|Graft Loss|1|||
150036279|NCT03104868|541272972|FG000|18 Month Follow up|Completed Later Timepoint|19|||
150036280|NCT03104868|541272973|FG001|18 Month Follow up|Completed Later Timepoint|20|||
150036281|NCT03104868|541272972|FG000|24 Month Follow up|Lost to Follow-up|15|||
150036282|NCT03104868|541272973|FG001|24 Month Follow up|Lost to Follow-up|16|||
150287580|NCT01425203|542187382|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
150287581|NCT01425203|542187380|FG000|Treatment Phase|Failure at futility timepoint|8|||
150287582|NCT01425203|542187381|FG001|Treatment Phase|Failure at futility timepoint|27|||
150287583|NCT01425203|542187382|FG002|Treatment Phase|Failure at futility timepoint|0|||
150287584|NCT01425203|542187380|FG000|Treatment Phase|Other virologic failure criteria|5|||
150287585|NCT01425203|542187381|FG001|Treatment Phase|Other virologic failure criteria|3|||
150287586|NCT01425203|542187382|FG002|Treatment Phase|Other virologic failure criteria|0|||
149844535|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
149844536|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
149844537|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
149844538|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
149844539|NCT00521586|540562096|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
149844540|NCT00521586|540562097|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
149844541|NCT00521586|540562096|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
149844542|NCT00521586|540562097|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
149844543|NCT00521586|540562096|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
149844544|NCT00521586|540562097|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
149844545|NCT00521586|540562096|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
149844546|NCT00521586|540562097|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
149844547|NCT00585286|540562110|FG000|Overall Study|Lost to Follow-up|1|||
149844548|NCT00608322|540562113|FG000|Overall Study|Death|2|||
149844549|NCT00608322|540562114|FG001|Overall Study|Death|1|||
149844550|NCT03497130|540562115|FG000|Overall Study|Lost to Follow-up|1|||
149844551|NCT03497130|540562116|FG001|Overall Study|Lost to Follow-up|1|||
149844552|NCT04002648|540562117|FG000|Overall Study|Lost to Follow-up|2|||
149844553|NCT04002648|540562118|FG001|Overall Study|Lost to Follow-up|0|||
149844554|NCT00216736|540562122|FG000|Overall Study|Lost to Follow-up|1|||
149844555|NCT00216736|540562123|FG001|Overall Study|Lost to Follow-up|1|||
149844556|NCT03158727|540562124|FG000|Overall Study|Withdrawal by Subject|2|||
149844557|NCT03158727|540562125|FG001|Overall Study|Withdrawal by Subject|6|||
149844558|NCT03158727|540562124|FG000|Overall Study|Death|11|||
149844559|NCT03158727|540562125|FG001|Overall Study|Death|12|||
149844560|NCT03158727|540562124|FG000|Overall Study|Lost to Follow-up|1|||
149844561|NCT03158727|540562125|FG001|Overall Study|Lost to Follow-up|0|||
149844562|NCT03158727|540562124|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
149844563|NCT03158727|540562125|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
149844564|NCT03158727|540562124|FG000|Overall Study|Visit 11 not done by mistake|0|||
149844565|NCT03158727|540562125|FG001|Overall Study|Visit 11 not done by mistake|1|||
149844566|NCT03158727|540562124|FG000|Overall Study|Enrolled, not treated|1|||
149844567|NCT03158727|540562125|FG001|Overall Study|Enrolled, not treated|0|||
149844568|NCT00918684|540562127|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
149844569|NCT00918684|540562127|FG000|Treatment Phase|Lack of Efficacy|6|||
149844570|NCT00918684|540562127|FG000|Treatment Phase|Lost to Follow-up|2|||
149844571|NCT00918684|540562127|FG000|Treatment Phase|Physician Decision|8|||
149844572|NCT00918684|540562127|FG000|Treatment Phase|Protocol Violation|1|||
149844573|NCT00918684|540562127|FG000|Treatment Phase|Withdrawal by Subject|8|||
150036283|NCT03104868|541272972|FG000|24 Month Follow up|Death|3|||
150036284|NCT03104868|541272973|FG001|24 Month Follow up|Death|2|||
150036285|NCT03104868|541272972|FG000|24 Month Follow up|Withdrawal by Subject|1|||
150036286|NCT03104868|541272973|FG001|24 Month Follow up|Withdrawal by Subject|0|||
150036287|NCT03104868|541272972|FG000|24 Month Follow up|Graft Loss|2|||
150036288|NCT03104868|541272973|FG001|24 Month Follow up|Graft Loss|0|||
150036289|NCT00521079|541272976|FG000|Overall Study|Adverse Event|7|||
150172689|NCT01317420|541768079|FG012|Overall Study|Progressive disease according to RECIST|16|||
150172690|NCT01317420|541768067|FG000|Overall Study|Other adverse event|1|||
150172691|NCT01317420|541768068|FG001|Overall Study|Other adverse event|0|||
150172692|NCT01317420|541768069|FG002|Overall Study|Other adverse event|0|||
150172693|NCT01317420|541768070|FG003|Overall Study|Other adverse event|0|||
150172694|NCT01317420|541768071|FG004|Overall Study|Other adverse event|0|||
150172695|NCT01317420|541768072|FG005|Overall Study|Other adverse event|0|||
150172696|NCT01317420|541768073|FG006|Overall Study|Other adverse event|0|||
150172697|NCT01317420|541768074|FG007|Overall Study|Other adverse event|0|||
150172698|NCT01317420|541768075|FG008|Overall Study|Other adverse event|0|||
149844574|NCT01051349|540562128|FG000|Overall Study|Adverse Event|88|||
149844575|NCT01051349|540562128|FG000|Overall Study|Consent Withdrawn|54|||
150172699|NCT01317420|541768076|FG009|Overall Study|Other adverse event|0|||
150172700|NCT01317420|541768077|FG010|Overall Study|Other adverse event|0|||
149844576|NCT01051349|540562128|FG000|Overall Study|Investigator Decision|6|||
149844577|NCT01051349|540562128|FG000|Overall Study|Lost to Follow-up|6|||
149844578|NCT01051349|540562128|FG000|Overall Study|Subject non-compliance|7|||
150172701|NCT01317420|541768078|FG011|Overall Study|Other adverse event|0|||
149844579|NCT01051349|540562128|FG000|Overall Study|Reason not Specified|12|||
149844580|NCT00402103|540562129|FG000|Overall Study|Adverse Event|60|||
149844581|NCT00402103|540562130|FG001|Overall Study|Adverse Event|7|||
149844582|NCT00402103|540562129|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149844583|NCT00402103|540562130|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149844584|NCT00402103|540562129|FG000|Overall Study|Condition no longer requires study drug|2|||
150172702|NCT01317420|541768079|FG012|Overall Study|Other adverse event|2|||
150172703|NCT01317420|541768067|FG000|Overall Study|Non-compliant with protocol|0|||
150172704|NCT01317420|541768068|FG001|Overall Study|Non-compliant with protocol|0|||
150172705|NCT01317420|541768069|FG002|Overall Study|Non-compliant with protocol|0|||
150172706|NCT01317420|541768070|FG003|Overall Study|Non-compliant with protocol|0|||
149844585|NCT00402103|540562130|FG001|Overall Study|Condition no longer requires study drug|0|||
149844586|NCT00402103|540562129|FG000|Overall Study|Protocol Deviation|8|||
149844587|NCT00402103|540562130|FG001|Overall Study|Protocol Deviation|0|||
149844588|NCT00402103|540562129|FG000|Overall Study|Patient withdrew consent|12|||
149844589|NCT00402103|540562130|FG001|Overall Study|Patient withdrew consent|1|||
149844590|NCT00402103|540562129|FG000|Overall Study|Lost to Follow-up|6|||
149844591|NCT00402103|540562130|FG001|Overall Study|Lost to Follow-up|3|||
149844592|NCT00402103|540562129|FG000|Overall Study|Administrative problems|2|||
149844593|NCT00402103|540562130|FG001|Overall Study|Administrative problems|0|||
149844594|NCT00418145|540562131|FG000|Overall Study|study terminated|6|||
149844595|NCT00624286|540562132|FG000|Overall Study|Protocol Deviation|7|||
149844596|NCT00624286|540562133|FG001|Overall Study|Protocol Deviation|9|||
149844597|NCT00624286|540562132|FG000|Overall Study|Adverse Event|6|||
149844598|NCT00624286|540562133|FG001|Overall Study|Adverse Event|3|||
149844599|NCT00624286|540562132|FG000|Overall Study|Withdrawal by Subject|5|||
149844600|NCT00624286|540562133|FG001|Overall Study|Withdrawal by Subject|4|||
149844601|NCT00624286|540562132|FG000|Overall Study|Lost to Follow-up|3|||
149844602|NCT00624286|540562133|FG001|Overall Study|Lost to Follow-up|2|||
149844603|NCT00624286|540562132|FG000|Overall Study|Administrative problems|3|||
149844604|NCT00624286|540562133|FG001|Overall Study|Administrative problems|0|||
149844605|NCT00624286|540562132|FG000|Overall Study|Lack of Efficacy|1|||
149844606|NCT00624286|540562133|FG001|Overall Study|Lack of Efficacy|6|||
149844607|NCT00624286|540562132|FG000|Overall Study|Not stated|0|||
149955201|NCT03670628|540967997|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
149955202|NCT04149353|540968004|FG000|Overall Study|Study terminated|1|||
149844608|NCT00624286|540562133|FG001|Overall Study|Not stated|1|||
149844609|NCT00624286|540562132|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149844610|NCT00624286|540562133|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149844611|NCT00624286|540562132|FG000|Overall Study|Death|0|||
149844612|NCT00624286|540562133|FG001|Overall Study|Death|1|||
149955203|NCT00887588|540968005|FG000|Core Period|Death|1|||
149955204|NCT00887588|540968006|FG001|Core Period|Death|1|||
149955205|NCT00887588|540968005|FG000|Core Period|Lost to Follow-up|3|||
149955206|NCT00887588|540968006|FG001|Core Period|Lost to Follow-up|1|||
149955207|NCT00887588|540968005|FG000|Core Period|Withdrawal by Subject|6|||
149955208|NCT00887588|540968006|FG001|Core Period|Withdrawal by Subject|8|||
149955209|NCT00887588|540968005|FG000|Core Period|Adverse Event|9|||
149955210|NCT00887588|540968006|FG001|Core Period|Adverse Event|11|||
149955211|NCT00887588|540968005|FG000|Extension Period|Adverse Event|4|||
149955212|NCT00887588|540968006|FG001|Extension Period|Adverse Event|4|||
149955213|NCT00887588|540968005|FG000|Extension Period|Death|0|||
149955214|NCT00887588|540968006|FG001|Extension Period|Death|1|||
149955215|NCT00887588|540968005|FG000|Extension Period|Protocol deviation|1|||
149955216|NCT00887588|540968006|FG001|Extension Period|Protocol deviation|0|||
149955217|NCT00887588|540968005|FG000|Extension Period|Lost to Follow-up|1|||
149955218|NCT00887588|540968006|FG001|Extension Period|Lost to Follow-up|0|||
149955219|NCT00366535|540968007|FG000|First Phase: 12 Weeks|Adverse Event|1|||
149955220|NCT00366535|540968008|FG001|First Phase: 12 Weeks|Adverse Event|3|||
149955221|NCT00366535|540968007|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
149955222|NCT00366535|540968008|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
149955223|NCT00366535|540968007|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
149955224|NCT00366535|540968008|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
149955225|NCT00366535|540968007|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
149955226|NCT00366535|540968008|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
149955227|NCT00699751|540968013|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
149955228|NCT00699751|540968014|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
149955229|NCT00699751|540968013|FG000|Period 1: Without/Before Drug Switch|Death|28|||
149955230|NCT00699751|540968014|FG001|Period 1: Without/Before Drug Switch|Death|29|||
149955231|NCT00699751|540968013|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
149955232|NCT00699751|540968014|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
150036290|NCT00521079|541272977|FG001|Overall Study|Adverse Event|1|||
150036291|NCT00521079|541272976|FG000|Overall Study|Lost to Follow-up|2|||
149844613|NCT00863330|540562134|FG000|Overall Study|study terminated early due to administra|6|||
149844614|NCT02252016|540562135|FG000|Overall Study|Lost to Follow-up|2|||
149844615|NCT02252016|540562136|FG001|Overall Study|Lost to Follow-up|1|||
149844616|NCT02252016|540562135|FG000|Overall Study|Physician Decision|1|||
149844617|NCT02252016|540562136|FG001|Overall Study|Physician Decision|0|||
149844618|NCT02252016|540562135|FG000|Overall Study|Withdrawal by Subject|0|||
149955233|NCT00699751|540968013|FG000|Period 1: Without/Before Drug Switch|Other|30|||
149955234|NCT00699751|540968014|FG001|Period 1: Without/Before Drug Switch|Other|20|||
149955235|NCT00699751|540968013|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
149955236|NCT00699751|540968014|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
149955237|NCT00699751|540968013|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
149844619|NCT02252016|540562136|FG001|Overall Study|Withdrawal by Subject|2|||
149844620|NCT00674128|540562137|FG000|Overall Study|Withdrawal by Subject|25|||
149844621|NCT00674128|540562138|FG001|Overall Study|Withdrawal by Subject|23|||
149844622|NCT04631562|540562139|FG000|Overall Study|Withdrawal by Subject|0|||
149844623|NCT04631562|540562140|FG001|Overall Study|Withdrawal by Subject|0|||
149955238|NCT00699751|540968014|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
149955239|NCT00699751|540968013|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
149955240|NCT00699751|540968014|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
149955241|NCT00699751|540968013|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
149955242|NCT00699751|540968014|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
149955243|NCT06100250|540968017|FG000|Overall Study|Lost to Follow-up|5|||
149955244|NCT05537571|540968018|FG000|Overall Study|Withdrawal by Subject|1|||
149955245|NCT05537571|540968019|FG001|Overall Study|Withdrawal by Subject|1|||
149955246|NCT05537571|540968020|FG002|Overall Study|Withdrawal by Subject|0|||
149955247|NCT05537571|540968021|FG003|Overall Study|Withdrawal by Subject|0|||
149955248|NCT05537571|540968022|FG004|Overall Study|Withdrawal by Subject|0|||
149955249|NCT05537571|540968018|FG000|Overall Study|Adverse Event|2|||
149955250|NCT05537571|540968019|FG001|Overall Study|Adverse Event|0|||
149955251|NCT05537571|540968020|FG002|Overall Study|Adverse Event|0|||
149955252|NCT05537571|540968021|FG003|Overall Study|Adverse Event|0|||
149955253|NCT05537571|540968022|FG004|Overall Study|Adverse Event|0|||
149955254|NCT05537571|540968018|FG000|Overall Study|Hepatitis A screening result|2|||
149955255|NCT05537571|540968019|FG001|Overall Study|Hepatitis A screening result|0|||
149955256|NCT05537571|540968020|FG002|Overall Study|Hepatitis A screening result|0|||
149955257|NCT05537571|540968021|FG003|Overall Study|Hepatitis A screening result|0|||
149955258|NCT05537571|540968022|FG004|Overall Study|Hepatitis A screening result|0|||
149955259|NCT05537571|540968018|FG000|Overall Study|Lost to Follow-up|0|||
149955260|NCT05537571|540968019|FG001|Overall Study|Lost to Follow-up|0|||
149955261|NCT05537571|540968020|FG002|Overall Study|Lost to Follow-up|1|||
149955262|NCT05537571|540968021|FG003|Overall Study|Lost to Follow-up|0|||
149955263|NCT05537571|540968022|FG004|Overall Study|Lost to Follow-up|1|||
149955264|NCT04439123|540968026|FG000|Overall Study|Adverse Event|11|||
149955265|NCT04439123|540968026|FG000|Overall Study|Death|1|||
149844624|NCT04631562|540562141|FG002|Overall Study|Withdrawal by Subject|0|||
149844625|NCT04631562|540562142|FG003|Overall Study|Withdrawal by Subject|0|||
149844626|NCT04631562|540562143|FG004|Overall Study|Withdrawal by Subject|0|||
149844627|NCT04631562|540562144|FG005|Overall Study|Withdrawal by Subject|0|||
149844628|NCT04631562|540562145|FG006|Overall Study|Withdrawal by Subject|0|||
149844629|NCT04631562|540562146|FG007|Overall Study|Withdrawal by Subject|1|||
149844630|NCT04631562|540562147|FG008|Overall Study|Withdrawal by Subject|0|||
149844631|NCT04631562|540562139|FG000|Overall Study|Other|0|||
149844632|NCT04631562|540562140|FG001|Overall Study|Other|0|||
149844633|NCT04631562|540562141|FG002|Overall Study|Other|0|||
149844634|NCT04631562|540562142|FG003|Overall Study|Other|0|||
149844635|NCT04631562|540562143|FG004|Overall Study|Other|0|||
149844636|NCT04631562|540562144|FG005|Overall Study|Other|0|||
149844637|NCT04631562|540562145|FG006|Overall Study|Other|0|||
149844638|NCT04631562|540562146|FG007|Overall Study|Other|0|||
149844639|NCT04631562|540562147|FG008|Overall Study|Other|1|||
149844640|NCT04631562|540562139|FG000|Overall Study|Lost to Follow-up|0|||
149844641|NCT04631562|540562140|FG001|Overall Study|Lost to Follow-up|0|||
149844642|NCT04631562|540562141|FG002|Overall Study|Lost to Follow-up|0|||
149844643|NCT04631562|540562142|FG003|Overall Study|Lost to Follow-up|1|||
149844644|NCT04631562|540562143|FG004|Overall Study|Lost to Follow-up|0|||
149844645|NCT04631562|540562144|FG005|Overall Study|Lost to Follow-up|0|||
149844646|NCT04631562|540562145|FG006|Overall Study|Lost to Follow-up|0|||
149844647|NCT04631562|540562146|FG007|Overall Study|Lost to Follow-up|0|||
149844648|NCT04631562|540562147|FG008|Overall Study|Lost to Follow-up|0|||
149844649|NCT04631562|540562139|FG000|Overall Study|Adverse Event|0|||
149844650|NCT04631562|540562140|FG001|Overall Study|Adverse Event|0|||
149844651|NCT04631562|540562141|FG002|Overall Study|Adverse Event|0|||
149844652|NCT04631562|540562142|FG003|Overall Study|Adverse Event|0|||
149844653|NCT04631562|540562143|FG004|Overall Study|Adverse Event|0|||
149844654|NCT04631562|540562144|FG005|Overall Study|Adverse Event|0|||
149844655|NCT04631562|540562145|FG006|Overall Study|Adverse Event|1|||
149844656|NCT04631562|540562146|FG007|Overall Study|Adverse Event|0|||
149844657|NCT04631562|540562147|FG008|Overall Study|Adverse Event|0|||
149844658|NCT01825798|540562149|FG000|Overall Study|Adverse Event|1|||
149844659|NCT01825798|540562150|FG001|Overall Study|Adverse Event|5|||
149844660|NCT01825798|540562149|FG000|Overall Study|Lost to Follow-up|1|||
149844661|NCT01825798|540562150|FG001|Overall Study|Lost to Follow-up|0|||
149844662|NCT00834873|540562156|FG000|First Intervention|Adverse Event|0|||
149844663|NCT00834873|540562157|FG001|First Intervention|Adverse Event|1|||
149844664|NCT02055547|540562159|FG000|Overall Study|Protocol Violation|0|||
149844665|NCT02055547|540562160|FG001|Overall Study|Protocol Violation|0|||
149844666|NCT02055547|540562161|FG002|Overall Study|Protocol Violation|1|||
149844667|NCT02055547|540562162|FG003|Overall Study|Protocol Violation|0|||
149844668|NCT02055547|540562163|FG004|Overall Study|Protocol Violation|0|||
149844669|NCT02055547|540562164|FG005|Overall Study|Protocol Violation|0|||
149844670|NCT02055547|540562165|FG006|Overall Study|Protocol Violation|1|||
149844671|NCT02055547|540562166|FG007|Overall Study|Protocol Violation|0|||
149844672|NCT02055547|540562167|FG008|Overall Study|Protocol Violation|0|||
149844673|NCT02055547|540562168|FG009|Overall Study|Protocol Violation|0|||
149844674|NCT02055547|540562169|FG010|Overall Study|Protocol Violation|0|||
149844675|NCT02055547|540562170|FG011|Overall Study|Protocol Violation|0|||
149844676|NCT02055547|540562171|FG012|Overall Study|Protocol Violation|0|||
149844677|NCT02055547|540562172|FG013|Overall Study|Protocol Violation|0|||
149844678|NCT02055547|540562173|FG014|Overall Study|Protocol Violation|0|||
149844679|NCT02055547|540562174|FG015|Overall Study|Protocol Violation|0|||
149844680|NCT02055547|540562175|FG016|Overall Study|Protocol Violation|0|||
149844681|NCT02055547|540562176|FG017|Overall Study|Protocol Violation|0|||
149844682|NCT02055547|540562177|FG018|Overall Study|Protocol Violation|0|||
149844683|NCT02055547|540562159|FG000|Overall Study|Physician Decision|0|||
149844684|NCT02055547|540562160|FG001|Overall Study|Physician Decision|1|||
149844685|NCT02055547|540562161|FG002|Overall Study|Physician Decision|1|||
149844686|NCT02055547|540562162|FG003|Overall Study|Physician Decision|0|||
149844687|NCT02055547|540562163|FG004|Overall Study|Physician Decision|1|||
149844688|NCT02055547|540562164|FG005|Overall Study|Physician Decision|0|||
149844689|NCT02055547|540562165|FG006|Overall Study|Physician Decision|0|||
149844690|NCT02055547|540562166|FG007|Overall Study|Physician Decision|0|||
149844691|NCT02055547|540562167|FG008|Overall Study|Physician Decision|0|||
149844692|NCT02055547|540562168|FG009|Overall Study|Physician Decision|1|||
149844693|NCT02055547|540562169|FG010|Overall Study|Physician Decision|1|||
149844694|NCT02055547|540562170|FG011|Overall Study|Physician Decision|0|||
149844695|NCT02055547|540562171|FG012|Overall Study|Physician Decision|0|||
149844696|NCT02055547|540562172|FG013|Overall Study|Physician Decision|0|||
149844697|NCT02055547|540562173|FG014|Overall Study|Physician Decision|0|||
149844698|NCT02055547|540562174|FG015|Overall Study|Physician Decision|0|||
149844699|NCT02055547|540562175|FG016|Overall Study|Physician Decision|0|||
149844700|NCT02055547|540562176|FG017|Overall Study|Physician Decision|0|||
149844701|NCT02055547|540562177|FG018|Overall Study|Physician Decision|0|||
149844702|NCT02055547|540562159|FG000|Overall Study|Adverse Event|0|||
149844703|NCT02055547|540562160|FG001|Overall Study|Adverse Event|0|||
149844704|NCT02055547|540562161|FG002|Overall Study|Adverse Event|0|||
149844705|NCT02055547|540562162|FG003|Overall Study|Adverse Event|0|||
149844706|NCT02055547|540562163|FG004|Overall Study|Adverse Event|0|||
149844707|NCT02055547|540562164|FG005|Overall Study|Adverse Event|0|||
149844708|NCT02055547|540562165|FG006|Overall Study|Adverse Event|1|||
149844709|NCT02055547|540562166|FG007|Overall Study|Adverse Event|0|||
149844710|NCT02055547|540562167|FG008|Overall Study|Adverse Event|1|||
149844711|NCT02055547|540562168|FG009|Overall Study|Adverse Event|0|||
149844712|NCT02055547|540562169|FG010|Overall Study|Adverse Event|0|||
149844713|NCT02055547|540562170|FG011|Overall Study|Adverse Event|0|||
149844714|NCT02055547|540562171|FG012|Overall Study|Adverse Event|0|||
149844715|NCT02055547|540562172|FG013|Overall Study|Adverse Event|0|||
149844716|NCT02055547|540562173|FG014|Overall Study|Adverse Event|0|||
149844717|NCT02055547|540562174|FG015|Overall Study|Adverse Event|0|||
149844718|NCT02055547|540562175|FG016|Overall Study|Adverse Event|0|||
149844719|NCT02055547|540562176|FG017|Overall Study|Adverse Event|0|||
149844720|NCT02055547|540562177|FG018|Overall Study|Adverse Event|0|||
149844721|NCT02055547|540562159|FG000|Overall Study|Withdrawal by Subject|0|||
149844722|NCT02055547|540562160|FG001|Overall Study|Withdrawal by Subject|0|||
149844723|NCT02055547|540562161|FG002|Overall Study|Withdrawal by Subject|0|||
149844724|NCT02055547|540562162|FG003|Overall Study|Withdrawal by Subject|0|||
149844725|NCT02055547|540562163|FG004|Overall Study|Withdrawal by Subject|0|||
149844726|NCT02055547|540562164|FG005|Overall Study|Withdrawal by Subject|1|||
149844727|NCT02055547|540562165|FG006|Overall Study|Withdrawal by Subject|0|||
149844728|NCT02055547|540562166|FG007|Overall Study|Withdrawal by Subject|0|||
149844729|NCT02055547|540562167|FG008|Overall Study|Withdrawal by Subject|1|||
149844730|NCT02055547|540562168|FG009|Overall Study|Withdrawal by Subject|0|||
149844731|NCT02055547|540562169|FG010|Overall Study|Withdrawal by Subject|0|||
149844732|NCT02055547|540562170|FG011|Overall Study|Withdrawal by Subject|0|||
149844733|NCT02055547|540562171|FG012|Overall Study|Withdrawal by Subject|0|||
149844734|NCT02055547|540562172|FG013|Overall Study|Withdrawal by Subject|1|||
149844735|NCT02055547|540562173|FG014|Overall Study|Withdrawal by Subject|0|||
149844736|NCT02055547|540562174|FG015|Overall Study|Withdrawal by Subject|1|||
149844737|NCT02055547|540562175|FG016|Overall Study|Withdrawal by Subject|0|||
149844738|NCT02055547|540562176|FG017|Overall Study|Withdrawal by Subject|0|||
149844739|NCT02055547|540562177|FG018|Overall Study|Withdrawal by Subject|0|||
149844740|NCT02055547|540562159|FG000|Overall Study|Lost to Follow-up|0|||
149844741|NCT02055547|540562160|FG001|Overall Study|Lost to Follow-up|0|||
149844742|NCT02055547|540562161|FG002|Overall Study|Lost to Follow-up|1|||
149844743|NCT02055547|540562162|FG003|Overall Study|Lost to Follow-up|0|||
149844744|NCT02055547|540562163|FG004|Overall Study|Lost to Follow-up|0|||
149844745|NCT02055547|540562164|FG005|Overall Study|Lost to Follow-up|0|||
149844746|NCT02055547|540562165|FG006|Overall Study|Lost to Follow-up|0|||
149844747|NCT02055547|540562166|FG007|Overall Study|Lost to Follow-up|0|||
149844748|NCT02055547|540562167|FG008|Overall Study|Lost to Follow-up|0|||
149844749|NCT02055547|540562168|FG009|Overall Study|Lost to Follow-up|0|||
149844750|NCT02055547|540562169|FG010|Overall Study|Lost to Follow-up|0|||
149844751|NCT02055547|540562170|FG011|Overall Study|Lost to Follow-up|0|||
149844752|NCT02055547|540562171|FG012|Overall Study|Lost to Follow-up|0|||
149844753|NCT02055547|540562172|FG013|Overall Study|Lost to Follow-up|0|||
149844754|NCT02055547|540562173|FG014|Overall Study|Lost to Follow-up|0|||
149844755|NCT02055547|540562174|FG015|Overall Study|Lost to Follow-up|0|||
149844756|NCT02055547|540562175|FG016|Overall Study|Lost to Follow-up|0|||
149844757|NCT02055547|540562176|FG017|Overall Study|Lost to Follow-up|0|||
149844758|NCT02055547|540562177|FG018|Overall Study|Lost to Follow-up|0|||
149844759|NCT01456221|540562178|FG000|Overall Study|Withdrawal by Subject|56|||
149844760|NCT01456221|540562179|FG001|Overall Study|Withdrawal by Subject|49|||
149844761|NCT01456221|540562178|FG000|Overall Study|Lost to Follow-up|1|||
149955266|NCT04439123|540968026|FG000|Overall Study|Disease progression|19|||
149955267|NCT04439123|540968026|FG000|Overall Study|Withdrawal by Subject|2|||
149955268|NCT04439123|540968026|FG000|Overall Study|Still on treatment|2|||
149955269|NCT04124965|540968027|FG000|Overall Study|Adverse event, non-fatal|3|||
149955270|NCT04124965|540968028|FG001|Overall Study|Adverse event, non-fatal|1|||
149955271|NCT04124965|540968027|FG000|Overall Study|Withdrawal by Subject|1|||
149955272|NCT04124965|540968028|FG001|Overall Study|Withdrawal by Subject|1|||
149955273|NCT04124965|540968027|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
149955274|NCT04124965|540968028|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
149955275|NCT04124965|540968027|FG000|Overall Study|Pregnancy|1|||
149955276|NCT04124965|540968028|FG001|Overall Study|Pregnancy|0|||
149955277|NCT04124965|540968027|FG000|Overall Study|Sponsor and participant decision|0|||
149955278|NCT04124965|540968028|FG001|Overall Study|Sponsor and participant decision|1|||
149955279|NCT04124965|540968027|FG000|Overall Study|Personal surgery|0|||
149955280|NCT04124965|540968028|FG001|Overall Study|Personal surgery|1|||
149955281|NCT04124965|540968027|FG000|Overall Study|Physician Decision|0|||
149955282|NCT04124965|540968028|FG001|Overall Study|Physician Decision|1|||
149955283|NCT02184156|540968029|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
149955284|NCT02184156|540968030|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
149955285|NCT02184156|540968029|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
149955286|NCT02184156|540968030|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
149955287|NCT00002874|540968036|FG000|Overall Study|Withdrawal by Subject|1|||
149955288|NCT00002874|540968037|FG001|Overall Study|Withdrawal by Subject|1|||
149955289|NCT00002874|540968036|FG000|Overall Study|Protocol Violation|44|||
149955290|NCT00002874|540968037|FG001|Overall Study|Protocol Violation|34|||
149955291|NCT02114684|540968043|FG000|Overall Study|Death|6|||
149955292|NCT02114684|540968044|FG001|Overall Study|Death|4|||
149955293|NCT02114684|540968043|FG000|Overall Study|Lost to Follow-up|1|||
149955294|NCT02114684|540968044|FG001|Overall Study|Lost to Follow-up|2|||
149955295|NCT02114684|540968043|FG000|Overall Study|Withdrawal by Subject|1|||
149955296|NCT02114684|540968044|FG001|Overall Study|Withdrawal by Subject|2|||
149955297|NCT02114684|540968043|FG000|Overall Study|Relocation|3|||
149955298|NCT02114684|540968044|FG001|Overall Study|Relocation|1|||
149955299|NCT02114684|540968043|FG000|Overall Study|Rifampicin resistant on culture|0|||
149955300|NCT02114684|540968044|FG001|Overall Study|Rifampicin resistant on culture|1|||
149955301|NCT02114684|540968043|FG000|Overall Study|Patient Incarcerated|1|||
149955302|NCT02114684|540968044|FG001|Overall Study|Patient Incarcerated|0|||
149955303|NCT00283959|540968045|FG000|Extension Period|Low Compliance|1|||
149955304|NCT01214720|540968046|FG000|Overall Study|Alive and still on treatment|34|||
149955305|NCT01214720|540968047|FG001|Overall Study|Alive and still on treatment|18|||
149955306|NCT01214720|540968046|FG000|Overall Study|Alive and in follow-up|45|||
149955307|NCT01214720|540968047|FG001|Overall Study|Alive and in follow-up|48|||
149955308|NCT01214720|540968046|FG000|Overall Study|Lost to Follow-up|6|||
149955309|NCT01214720|540968047|FG001|Overall Study|Lost to Follow-up|2|||
149955310|NCT05591755|540968048|FG000|Overall Study|Screen Failure|1|||
149955311|NCT05591755|540968049|FG001|Overall Study|Screen Failure|0|||
149955312|NCT05591755|540968050|FG002|Overall Study|Screen Failure|0|||
149955313|NCT05591755|540968051|FG003|Overall Study|Screen Failure|0|||
149955314|NCT05591755|540968048|FG000|Overall Study|Protocol Violation|0|||
149955315|NCT05591755|540968049|FG001|Overall Study|Protocol Violation|0|||
149955316|NCT05591755|540968050|FG002|Overall Study|Protocol Violation|2|||
149955317|NCT05591755|540968051|FG003|Overall Study|Protocol Violation|0|||
149955318|NCT05591755|540968048|FG000|Overall Study|Withdrawal by Subject|0|||
149955319|NCT05591755|540968049|FG001|Overall Study|Withdrawal by Subject|1|||
149955320|NCT05591755|540968050|FG002|Overall Study|Withdrawal by Subject|0|||
149955321|NCT05591755|540968051|FG003|Overall Study|Withdrawal by Subject|0|||
149844762|NCT01456221|540562179|FG001|Overall Study|Lost to Follow-up|4|||
149955322|NCT05865886|540968053|FG000|Overall Study|Serious adverse event|0|||
149955323|NCT05865886|540968054|FG001|Overall Study|Serious adverse event|1|||
149955324|NCT02564978|540968061|FG000|Overall Study|Adverse Event|8|||
149955325|NCT02564978|540968061|FG000|Overall Study|Death|1|||
149955326|NCT02564978|540968061|FG000|Overall Study|Lost to Follow-up|1|||
149955327|NCT02564978|540968061|FG000|Overall Study|Withdrawal by Subject|15|||
149955328|NCT02564978|540968061|FG000|Overall Study|Early Study Closure|2|||
149955329|NCT02564978|540968061|FG000|Overall Study|Other Reason|5|||
149844763|NCT01456221|540562178|FG000|Overall Study|Received medication|3|||
149955330|NCT04971837|540970173|FG000|Overall Study|Long Term Illness|1|||
149955331|NCT04971837|540970173|FG000|Overall Study|BMI too low|9|||
149844764|NCT01456221|540562179|FG001|Overall Study|Received medication|2|||
149844765|NCT01456221|540562178|FG000|Overall Study|Incomplete data|4|||
149844766|NCT01456221|540562179|FG001|Overall Study|Incomplete data|2|||
149844767|NCT04025021|540562180|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
149844768|NCT04025021|540562181|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
149844769|NCT03498560|540562182|FG000|Overall Study|Found Ineligible|2|||
149844770|NCT03498560|540562182|FG000|Overall Study|Withdrawal by Subject|14|||
149844771|NCT03498560|540562182|FG000|Overall Study|Lost to Follow-up|4|||
149844772|NCT03498560|540562182|FG000|Overall Study|Death|1|||
149844773|NCT00867360|540562183|FG000|Overall Study|Withdrawal by Subject|1|||
149844774|NCT00867360|540562184|FG001|Overall Study|Withdrawal by Subject|0|||
149844775|NCT00867360|540562183|FG000|Overall Study|Physician Decision|0|||
149844776|NCT00867360|540562184|FG001|Overall Study|Physician Decision|1|||
149844777|NCT01004510|540562189|FG000|Overall Study|Adverse Event|1|||
149844778|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
149844779|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
149844780|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
149844781|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
149844782|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
149844783|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844784|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844785|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844786|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844787|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844788|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844789|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
149955332|NCT04971837|540970173|FG000|Overall Study|geographic location|1|||
149955333|NCT04971837|540970173|FG000|Overall Study|Discontinued scheduling conflict|1|||
149955334|NCT00567580|540970178|FG000|Overall Study|Protocol Violation|28|||
149955335|NCT00567580|540970179|FG001|Overall Study|Protocol Violation|24|||
149955336|NCT00567580|540970180|FG002|Overall Study|Protocol Violation|24|||
149955337|NCT03022630|540970181|FG000|Overall Study|Death|9|||
149955338|NCT03022630|540970182|FG001|Overall Study|Death|7|||
149955339|NCT03022630|540970181|FG000|Overall Study|Withdrawal by Subject|0|||
149955340|NCT03022630|540970182|FG001|Overall Study|Withdrawal by Subject|5|||
149955341|NCT00884949|540970183|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
149955342|NCT00884949|540970183|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
149955343|NCT00382070|540970184|FG000|Overall Study|No follow up data mapped to Other|17|||
149955344|NCT00382070|540970185|FG001|Overall Study|No follow up data mapped to Other|19|||
149955345|NCT00382070|540970184|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
149955346|NCT00382070|540970185|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
149955347|NCT00382070|540970184|FG000|Overall Study|No clinical assessment|9|||
149955348|NCT00382070|540970185|FG001|Overall Study|No clinical assessment|11|||
149955349|NCT01629563|540970189|FG000|Overall Study|Adverse Event|16|||
149955350|NCT01629563|540970190|FG001|Overall Study|Adverse Event|16|||
149955351|NCT01629563|540970189|FG000|Overall Study|Death|2|||
149955352|NCT01629563|540970190|FG001|Overall Study|Death|0|||
149955353|NCT01629563|540970189|FG000|Overall Study|Lack of Efficacy|2|||
149955354|NCT01629563|540970190|FG001|Overall Study|Lack of Efficacy|3|||
149955355|NCT01629563|540970189|FG000|Overall Study|Lost to Follow-up|1|||
149955356|NCT01629563|540970190|FG001|Overall Study|Lost to Follow-up|0|||
150036292|NCT00521079|541272977|FG001|Overall Study|Lost to Follow-up|1|||
149844790|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844791|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844792|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
149955357|NCT01629563|540970189|FG000|Overall Study|Pregnancy|1|||
149955358|NCT01629563|540970190|FG001|Overall Study|Pregnancy|2|||
149955359|NCT01629563|540970189|FG000|Overall Study|Protocol Violation|0|||
149955360|NCT01629563|540970190|FG001|Overall Study|Protocol Violation|1|||
149955361|NCT01629563|540970189|FG000|Overall Study|Withdrawal by Subject|27|||
149955362|NCT01629563|540970190|FG001|Overall Study|Withdrawal by Subject|20|||
149955363|NCT01629563|540970189|FG000|Overall Study|surgery|0|||
149955364|NCT01629563|540970190|FG001|Overall Study|surgery|3|||
150036293|NCT00521079|541272976|FG000|Overall Study|Withdrawal by Subject|5|||
149844793|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844794|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844795|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844796|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844797|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
149955365|NCT01629563|540970189|FG000|Overall Study|Lack of return of menses|12|||
149955366|NCT01629563|540970190|FG001|Overall Study|Lack of return of menses|7|||
149955367|NCT01629563|540970189|FG000|Overall Study|Protocol Violation|0|||
149955368|NCT01629563|540970190|FG001|Overall Study|Protocol Violation|1|||
149955369|NCT00456612|540970192|FG000|Overall Study|Withdrawal by Subject|3|||
150036294|NCT00521079|541272977|FG001|Overall Study|Withdrawal by Subject|3|||
149844798|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844799|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844800|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844801|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844802|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844803|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
149844804|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844805|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
149844806|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844807|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844808|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844809|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844810|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844811|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844812|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844813|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844814|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844815|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844816|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844817|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844818|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844819|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844820|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844821|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844822|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844823|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844824|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844825|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844826|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844827|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844828|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844829|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
149844830|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844831|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
149844832|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844833|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844834|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844835|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844836|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844837|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844838|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844839|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844840|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844841|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844842|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844843|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844844|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844845|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844846|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149955370|NCT03073109|540970198|FG000|Overall Study|Adverse Event|0|||
149955371|NCT03073109|540970199|FG001|Overall Study|Adverse Event|1|||
149955372|NCT03073109|540970198|FG000|Overall Study|Other|2|||
150287587|NCT01425203|542187380|FG000|Treatment Phase|Unidentified reasons|11|||
150287588|NCT01425203|542187381|FG001|Treatment Phase|Unidentified reasons|5|||
149844847|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844848|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149955373|NCT03073109|540970199|FG001|Overall Study|Other|0|||
150287589|NCT01425203|542187382|FG002|Treatment Phase|Unidentified reasons|0|||
150287590|NCT01425203|542187380|FG000|Treatment Phase|Did not receive treatment|0|||
150287591|NCT01425203|542187381|FG001|Treatment Phase|Did not receive treatment|1|||
150287592|NCT01425203|542187382|FG002|Treatment Phase|Did not receive treatment|0|||
149844849|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844850|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844851|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844852|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844853|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844854|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149844855|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
149955374|NCT03073109|540970198|FG000|Overall Study|Lost to Follow-up|8|||
150287593|NCT01425203|542187380|FG000|Crossover Phase|Failure at futility timepoint|0|||
150287594|NCT01425203|542187381|FG001|Crossover Phase|Failure at futility timepoint|0|||
150172707|NCT01317420|541768071|FG004|Overall Study|Non-compliant with protocol|0|||
150172708|NCT01317420|541768072|FG005|Overall Study|Non-compliant with protocol|0|||
150172709|NCT01317420|541768073|FG006|Overall Study|Non-compliant with protocol|0|||
150172710|NCT01317420|541768074|FG007|Overall Study|Non-compliant with protocol|0|||
150172711|NCT01317420|541768075|FG008|Overall Study|Non-compliant with protocol|0|||
150287595|NCT01425203|542187382|FG002|Crossover Phase|Failure at futility timepoint|3|||
150287596|NCT01425203|542187380|FG000|Crossover Phase|Other virologic failure criteria|0|||
150287597|NCT01425203|542187381|FG001|Crossover Phase|Other virologic failure criteria|0|||
149844856|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
149844857|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149955375|NCT03073109|540970199|FG001|Overall Study|Lost to Follow-up|1|||
149955376|NCT01297244|540970200|FG000|Overall Study|Progressive disease|22|||
149955377|NCT01297244|540970201|FG001|Overall Study|Progressive disease|3|||
149955378|NCT01297244|540970200|FG000|Overall Study|Adverse Event|9|||
149955379|NCT01297244|540970201|FG001|Overall Study|Adverse Event|1|||
149955380|NCT01297244|540970200|FG000|Overall Study|Death|1|||
149955381|NCT01297244|540970201|FG001|Overall Study|Death|1|||
149955382|NCT01297244|540970200|FG000|Overall Study|Clinical progression|1|||
149955383|NCT01297244|540970201|FG001|Overall Study|Clinical progression|1|||
149955384|NCT01297244|540970200|FG000|Overall Study|Withdrawal by Subject|2|||
149955385|NCT01297244|540970201|FG001|Overall Study|Withdrawal by Subject|0|||
149955386|NCT03558672|540970202|FG000|Overall Study|Study Early Termination|10|||
149955387|NCT00983957|540970205|FG000|Overall Study|Adverse Event|1|||
149955388|NCT00983957|540970205|FG000|Overall Study|Personal Reasons|1|||
149955389|NCT03055195|540970206|FG000|Overall Study|Lack of Efficacy|1|||
149955390|NCT03055195|540970207|FG001|Overall Study|Lack of Efficacy|0|||
149955391|NCT03055195|540970206|FG000|Overall Study|Withdrawal by Subject|6|||
149955392|NCT03055195|540970207|FG001|Overall Study|Withdrawal by Subject|7|||
149955393|NCT03055195|540970206|FG000|Overall Study|Study Terminated by Sponsor|2|||
149955394|NCT03055195|540970207|FG001|Overall Study|Study Terminated by Sponsor|6|||
149955395|NCT03055195|540970206|FG000|Overall Study|Protocol Violation|2|||
149955396|NCT03055195|540970207|FG001|Overall Study|Protocol Violation|1|||
149955397|NCT03055195|540970206|FG000|Overall Study|Physician Decision|1|||
149955398|NCT03055195|540970207|FG001|Overall Study|Physician Decision|0|||
149955399|NCT00986232|540970208|FG000|Overall Study|Adverse Event|1|||
149955400|NCT00986232|540970209|FG001|Overall Study|Adverse Event|2|||
149955401|NCT00986232|540970210|FG002|Overall Study|Adverse Event|3|||
149955402|NCT00986232|540970211|FG003|Overall Study|Adverse Event|0|||
149955403|NCT00986232|540970208|FG000|Overall Study|Lost to Follow-up|19|||
149955404|NCT00986232|540970209|FG001|Overall Study|Lost to Follow-up|12|||
149955405|NCT00986232|540970210|FG002|Overall Study|Lost to Follow-up|12|||
149955406|NCT00986232|540970211|FG003|Overall Study|Lost to Follow-up|7|||
149955407|NCT00986232|540970208|FG000|Overall Study|Protocol Violation|2|||
149955408|NCT00986232|540970209|FG001|Overall Study|Protocol Violation|3|||
149955409|NCT00986232|540970210|FG002|Overall Study|Protocol Violation|0|||
149955410|NCT00986232|540970211|FG003|Overall Study|Protocol Violation|1|||
149955411|NCT00986232|540970208|FG000|Overall Study|Withdrawal by Subject|13|||
149955412|NCT00986232|540970209|FG001|Overall Study|Withdrawal by Subject|16|||
149955413|NCT00986232|540970210|FG002|Overall Study|Withdrawal by Subject|12|||
149955414|NCT00986232|540970211|FG003|Overall Study|Withdrawal by Subject|3|||
149955415|NCT00986232|540970208|FG000|Overall Study|Missed one or more bleeds|13|||
149955416|NCT00986232|540970209|FG001|Overall Study|Missed one or more bleeds|10|||
149955417|NCT00986232|540970210|FG002|Overall Study|Missed one or more bleeds|6|||
149955418|NCT00986232|540970211|FG003|Overall Study|Missed one or more bleeds|7|||
149955419|NCT00986232|540970208|FG000|Overall Study|Incomplete safety follow-up|3|||
149955420|NCT00986232|540970209|FG001|Overall Study|Incomplete safety follow-up|7|||
149955421|NCT00986232|540970210|FG002|Overall Study|Incomplete safety follow-up|2|||
149955422|NCT00986232|540970211|FG003|Overall Study|Incomplete safety follow-up|2|||
149955423|NCT00790933|540970212|FG000|Overall Study|Adverse Event|94|||
149955424|NCT00790933|540970213|FG001|Overall Study|Adverse Event|119|||
149955425|NCT00790933|540970214|FG002|Overall Study|Adverse Event|65|||
149955426|NCT00790933|540970215|FG003|Overall Study|Adverse Event|5|||
149955427|NCT00790933|540970216|FG004|Overall Study|Adverse Event|69|||
149955428|NCT00790933|540970212|FG000|Overall Study|Protocol Violation(s)|8|||
149955429|NCT00790933|540970213|FG001|Overall Study|Protocol Violation(s)|18|||
149955430|NCT00790933|540970214|FG002|Overall Study|Protocol Violation(s)|7|||
149955431|NCT00790933|540970215|FG003|Overall Study|Protocol Violation(s)|0|||
149955432|NCT00790933|540970216|FG004|Overall Study|Protocol Violation(s)|12|||
149955433|NCT00790933|540970212|FG000|Overall Study|Lack of Efficacy|192|||
149955434|NCT00790933|540970213|FG001|Overall Study|Lack of Efficacy|176|||
149955435|NCT00790933|540970214|FG002|Overall Study|Lack of Efficacy|130|||
149955436|NCT00790933|540970215|FG003|Overall Study|Lack of Efficacy|1|||
149955437|NCT00790933|540970216|FG004|Overall Study|Lack of Efficacy|121|||
149955438|NCT00790933|540970212|FG000|Overall Study|Study Terminated by Sponsor|0|||
149955439|NCT00790933|540970213|FG001|Overall Study|Study Terminated by Sponsor|0|||
149844858|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
149844859|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
149844860|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
149844861|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844862|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844863|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844864|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844865|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844866|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844867|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844868|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844869|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844870|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844871|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844872|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844873|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844874|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844875|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844876|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844877|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844878|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844879|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844880|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844881|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
149844882|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
149844883|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
149844884|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
149844885|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
149844886|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
149844887|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844888|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844889|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844890|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844891|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844892|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844893|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844894|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844895|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844896|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844897|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844898|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844899|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844900|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844901|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844902|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844903|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844904|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149955440|NCT00790933|540970214|FG002|Overall Study|Study Terminated by Sponsor|1|||
149955441|NCT00790933|540970215|FG003|Overall Study|Study Terminated by Sponsor|0|||
150287598|NCT01425203|542187382|FG002|Crossover Phase|Other virologic failure criteria|3|||
150287599|NCT04951037|542187387|FG000|Overall Study|Lost to Follow-up|16|||
150287600|NCT04951037|542187387|FG000|Overall Study|Withdrawal by Subject|5|||
150287601|NCT04951037|542187387|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
149955442|NCT00790933|540970216|FG004|Overall Study|Study Terminated by Sponsor|0|||
149955443|NCT00790933|540970212|FG000|Overall Study|Withdrawal by Subject|123|||
149955444|NCT00790933|540970213|FG001|Overall Study|Withdrawal by Subject|120|||
149955445|NCT00790933|540970214|FG002|Overall Study|Withdrawal by Subject|52|||
149955446|NCT00790933|540970215|FG003|Overall Study|Withdrawal by Subject|6|||
149955447|NCT00790933|540970216|FG004|Overall Study|Withdrawal by Subject|50|||
149955448|NCT00790933|540970212|FG000|Overall Study|Lost to Follow-up|13|||
149955449|NCT00790933|540970213|FG001|Overall Study|Lost to Follow-up|31|||
149844905|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149955450|NCT00790933|540970214|FG002|Overall Study|Lost to Follow-up|10|||
149844906|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844907|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
149844908|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|moved|0|||
149955451|NCT00790933|540970215|FG003|Overall Study|Lost to Follow-up|1|||
149955452|NCT00790933|540970216|FG004|Overall Study|Lost to Follow-up|15|||
149955453|NCT00790933|540970212|FG000|Overall Study|Reason Not Specified|8|||
149844909|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|moved|1|||
149844910|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|moved|1|||
149844911|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|moved|0|||
149844912|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|moved|0|||
150036295|NCT04986904|541272978|FG000|Overall Study|Lost to Follow-up|11|||
150036296|NCT04986904|541272978|FG000|Overall Study|Withdrawal by Subject|1|||
150036297|NCT02018562|541272983|FG000|Overall Study|Withdrawal by Subject|2|||
150036298|NCT02018562|541272984|FG001|Overall Study|Withdrawal by Subject|0|||
150036299|NCT02018562|541272983|FG000|Overall Study|Discharged prior to study completion|1|||
150036300|NCT02018562|541272984|FG001|Overall Study|Discharged prior to study completion|0|||
150036301|NCT01253291|541272994|FG000|Overall Study|Withdrawal by Subject|1|||
150036302|NCT01253291|541272995|FG001|Overall Study|Withdrawal by Subject|1|||
150036303|NCT01253291|541272996|FG002|Overall Study|Withdrawal by Subject|0|||
150036304|NCT01253291|541272997|FG003|Overall Study|Withdrawal by Subject|0|||
150036305|NCT01253291|541272998|FG004|Overall Study|Withdrawal by Subject|0|||
150036306|NCT01253291|541272994|FG000|Overall Study|Adverse Event|0|||
150036307|NCT01253291|541272995|FG001|Overall Study|Adverse Event|1|||
150036308|NCT01253291|541272996|FG002|Overall Study|Adverse Event|0|||
150036309|NCT01253291|541272997|FG003|Overall Study|Adverse Event|0|||
150036310|NCT01253291|541272998|FG004|Overall Study|Adverse Event|0|||
150036311|NCT01253291|541272994|FG000|Overall Study|Lack of Efficacy|1|||
150036312|NCT01253291|541272995|FG001|Overall Study|Lack of Efficacy|0|||
150036313|NCT01253291|541272996|FG002|Overall Study|Lack of Efficacy|0|||
150036314|NCT01253291|541272997|FG003|Overall Study|Lack of Efficacy|0|||
150036315|NCT01253291|541272998|FG004|Overall Study|Lack of Efficacy|0|||
150036316|NCT01253291|541272994|FG000|Overall Study|Physician Decision|2|||
150036317|NCT01253291|541272995|FG001|Overall Study|Physician Decision|0|||
150036318|NCT01253291|541272996|FG002|Overall Study|Physician Decision|0|||
150036319|NCT01253291|541272997|FG003|Overall Study|Physician Decision|0|||
149844913|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|moved|0|||
149844914|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|moved|0|||
149844915|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|moved|0|||
149844916|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|moved|0|||
149844917|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|moved|0|||
149844918|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|moved|0|||
149844919|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|moved|0|||
149844920|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|moved|0|||
149844921|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|moved|0|||
149844922|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|moved|0|||
150036320|NCT01253291|541272998|FG004|Overall Study|Physician Decision|2|||
150036321|NCT01838395|541273002|FG000|Overall Study|Withdrawal by Subject|0|||
150036322|NCT01838395|541273003|FG001|Overall Study|Withdrawal by Subject|0|||
150036323|NCT01838395|541273004|FG002|Overall Study|Withdrawal by Subject|0|||
150036324|NCT01838395|541273005|FG003|Overall Study|Withdrawal by Subject|0|||
150036325|NCT01838395|541273006|FG004|Overall Study|Withdrawal by Subject|1|||
150036326|NCT01838395|541273007|FG005|Overall Study|Withdrawal by Subject|0|||
150036327|NCT01838395|541273002|FG000|Overall Study|Death|0|||
150036328|NCT01838395|541273003|FG001|Overall Study|Death|0|||
149844923|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|moved|0|||
149844924|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|moved|0|||
149844925|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|moved|0|||
149844926|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|moved|0|||
149844927|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|moved|0|||
149844928|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|moved|0|||
149844929|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|moved|0|||
149844930|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|moved|0|||
149844931|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|moved|0|||
149844932|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|moved|0|||
149844933|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|moved|0|||
149844934|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844935|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844936|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844937|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
150036329|NCT01838395|541273004|FG002|Overall Study|Death|1|||
150036330|NCT01838395|541273005|FG003|Overall Study|Death|0|||
150036331|NCT01838395|541273006|FG004|Overall Study|Death|0|||
150036332|NCT01838395|541273007|FG005|Overall Study|Death|0|||
150036333|NCT01838395|541273002|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
150172712|NCT01317420|541768076|FG009|Overall Study|Non-compliant with protocol|0|||
150172713|NCT01317420|541768077|FG010|Overall Study|Non-compliant with protocol|0|||
149844938|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844939|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
150036334|NCT01838395|541273003|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
150036335|NCT01838395|541273004|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
149844940|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844941|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844942|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844943|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844944|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844945|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844946|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844947|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844948|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844949|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844950|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844951|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844952|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844953|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844954|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844955|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844956|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844957|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844958|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844959|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
149844960|NCT00112437|540562192|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844961|NCT00112437|540562193|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844962|NCT00112437|540562194|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844963|NCT00112437|540562195|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844964|NCT00112437|540562196|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
149844965|NCT00112437|540562197|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
150287602|NCT05630937|542187388|FG000|Overall Study|Study terminated by sponsor|1|||
149844966|NCT00112437|540562198|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844967|NCT00112437|540562199|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844968|NCT00112437|540562200|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844969|NCT00112437|540562201|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844970|NCT00112437|540562202|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844971|NCT00112437|540562203|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844972|NCT00112437|540562204|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844973|NCT00112437|540562205|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844974|NCT00112437|540562206|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844975|NCT00112437|540562207|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844976|NCT00112437|540562208|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844977|NCT00112437|540562209|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844978|NCT00112437|540562210|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844979|NCT00112437|540562211|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844980|NCT00112437|540562212|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844981|NCT00112437|540562213|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844982|NCT00112437|540562214|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844983|NCT00112437|540562215|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149955454|NCT00790933|540970213|FG001|Overall Study|Reason Not Specified|16|||
149955455|NCT00790933|540970214|FG002|Overall Study|Reason Not Specified|4|||
149955456|NCT00790933|540970215|FG003|Overall Study|Reason Not Specified|1|||
149955457|NCT00790933|540970216|FG004|Overall Study|Reason Not Specified|9|||
149955458|NCT00894647|540970219|FG000|Overall Study|Adverse Event|5|||
149955459|NCT00894647|540970220|FG001|Overall Study|Adverse Event|4|||
149955460|NCT00894647|540970219|FG000|Overall Study|Withdrawal by Subject|4|||
149955461|NCT00894647|540970220|FG001|Overall Study|Withdrawal by Subject|4|||
149955462|NCT00894647|540970219|FG000|Overall Study|Lost to Follow-up|0|||
149955463|NCT00894647|540970220|FG001|Overall Study|Lost to Follow-up|2|||
149955464|NCT00894647|540970219|FG000|Overall Study|Non-compliance with study procedures|0|||
149955465|NCT00894647|540970220|FG001|Overall Study|Non-compliance with study procedures|2|||
149955466|NCT00894647|540970219|FG000|Overall Study|Other, not due to AE|1|||
149955467|NCT00894647|540970220|FG001|Overall Study|Other, not due to AE|2|||
149955468|NCT01967277|540970222|FG000|Overall Study|Lost to Follow-up|1|||
150287603|NCT05630937|542187389|FG001|Overall Study|Study terminated by sponsor|1|||
150287604|NCT05630937|542187390|FG002|Overall Study|Study terminated by sponsor|8|||
150287605|NCT05630937|542187391|FG003|Overall Study|Study terminated by sponsor|0|||
150287606|NCT05630937|542187388|FG000|Overall Study|Lost to Follow-up|0|||
149844984|NCT00112437|540562216|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844985|NCT00112437|540562217|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
149844986|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
149844987|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
149844988|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
149844989|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
149844990|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
149844991|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
149844992|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
149844993|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
149844994|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
149844995|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
149844996|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
149844997|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
149844998|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
149844999|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
149845000|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
149845001|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
149845002|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
149845003|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
149845004|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
149845005|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
149845006|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
149845007|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
149845008|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
149845009|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
149845010|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
149845011|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
149845012|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845013|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845014|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845015|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845016|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845017|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
149845018|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
149845019|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845020|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845021|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
149845022|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845023|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845024|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845025|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845026|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845027|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845028|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845029|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845030|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845031|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845032|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845033|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845034|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845035|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845036|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845037|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
149845038|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845039|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845040|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845041|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845042|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845043|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845044|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845045|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845046|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
149845047|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845048|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845049|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845050|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845051|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845052|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845053|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845054|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149955469|NCT01967277|540970223|FG001|Overall Study|Lost to Follow-up|2|||
150172714|NCT01317420|541768078|FG011|Overall Study|Non-compliant with protocol|0|||
150172715|NCT01317420|541768079|FG012|Overall Study|Non-compliant with protocol|1|||
150287607|NCT05630937|542187389|FG001|Overall Study|Lost to Follow-up|0|||
150287608|NCT05630937|542187390|FG002|Overall Study|Lost to Follow-up|1|||
150287609|NCT05630937|542187391|FG003|Overall Study|Lost to Follow-up|0|||
150287610|NCT05630937|542187388|FG000|Overall Study|Enrolled but not treated|0|||
150287611|NCT05630937|542187389|FG001|Overall Study|Enrolled but not treated|0|||
150287612|NCT05630937|542187390|FG002|Overall Study|Enrolled but not treated|0|||
150287613|NCT05630937|542187391|FG003|Overall Study|Enrolled but not treated|1|||
150287614|NCT01098071|542187392|FG000|Overall Study|Surgery (adenoidectomy)|2|||
150287615|NCT01098071|542187392|FG000|Overall Study|Lost to Follow-up|13|||
150287616|NCT01604265|542187396|FG000|Overall Study|Adverse Event|1|||
150287617|NCT01604265|542187397|FG001|Overall Study|Adverse Event|0|||
150287618|NCT01604265|542187396|FG000|Overall Study|Withdrawal by Subject|1|||
150287619|NCT01604265|542187397|FG001|Overall Study|Withdrawal by Subject|0|||
150287620|NCT01903837|542187399|FG000|Part A|Withdrawal by Subject|4|||
150287621|NCT01903837|542187400|FG001|Part A|Withdrawal by Subject|9|||
150287622|NCT01903837|542187401|FG002|Part A|Withdrawal by Subject|8|||
150287623|NCT01903837|542187402|FG003|Part A|Withdrawal by Subject|5|||
150287624|NCT01903837|542187399|FG000|Part A|Adverse Event|3|||
150287625|NCT01903837|542187400|FG001|Part A|Adverse Event|6|||
150287626|NCT01903837|542187401|FG002|Part A|Adverse Event|9|||
150287627|NCT01903837|542187402|FG003|Part A|Adverse Event|6|||
150287628|NCT01903837|542187399|FG000|Part A|Lost to Follow-up|9|||
150287629|NCT01903837|542187400|FG001|Part A|Lost to Follow-up|7|||
150287630|NCT01903837|542187401|FG002|Part A|Lost to Follow-up|7|||
150287631|NCT01903837|542187402|FG003|Part A|Lost to Follow-up|2|||
150287632|NCT01903837|542187399|FG000|Part A|Non-compliance with study drug|1|||
150287633|NCT01903837|542187400|FG001|Part A|Non-compliance with study drug|4|||
150287634|NCT01903837|542187401|FG002|Part A|Non-compliance with study drug|4|||
150287635|NCT01903837|542187402|FG003|Part A|Non-compliance with study drug|0|||
150287636|NCT01903837|542187399|FG000|Part A|Physician Decision|1|||
150287637|NCT01903837|542187400|FG001|Part A|Physician Decision|1|||
150287638|NCT01903837|542187401|FG002|Part A|Physician Decision|0|||
150287639|NCT01903837|542187402|FG003|Part A|Physician Decision|0|||
150287640|NCT01903837|542187399|FG000|Part A|Protocol Violation|1|||
150287641|NCT01903837|542187400|FG001|Part A|Protocol Violation|1|||
150287642|NCT01903837|542187401|FG002|Part A|Protocol Violation|0|||
150287643|NCT01903837|542187402|FG003|Part A|Protocol Violation|0|||
150287644|NCT01903837|542187399|FG000|Part B|Lost to Follow-up|0|||
150287645|NCT01903837|542187400|FG001|Part B|Lost to Follow-up|3|||
150287646|NCT01903837|542187401|FG002|Part B|Lost to Follow-up|3|||
150287647|NCT01903837|542187402|FG003|Part B|Lost to Follow-up|4|||
150287648|NCT01903837|542187399|FG000|Part B|Withdrawal by Subject|1|||
150287649|NCT01903837|542187400|FG001|Part B|Withdrawal by Subject|2|||
150287650|NCT01903837|542187401|FG002|Part B|Withdrawal by Subject|0|||
150287651|NCT01903837|542187402|FG003|Part B|Withdrawal by Subject|3|||
150287652|NCT01903837|542187399|FG000|Part B|Adverse Event|3|||
150287653|NCT01903837|542187400|FG001|Part B|Adverse Event|0|||
150287654|NCT01903837|542187401|FG002|Part B|Adverse Event|2|||
150287655|NCT01903837|542187402|FG003|Part B|Adverse Event|0|||
150287656|NCT01903837|542187399|FG000|Part B|Non-compliance with study drug|2|||
150287657|NCT01903837|542187400|FG001|Part B|Non-compliance with study drug|0|||
150287658|NCT01903837|542187401|FG002|Part B|Non-compliance with study drug|0|||
150287659|NCT01903837|542187402|FG003|Part B|Non-compliance with study drug|1|||
149955470|NCT01967277|540970222|FG000|Overall Study|Unrelated illness|0|||
149955471|NCT01967277|540970223|FG001|Overall Study|Unrelated illness|1|||
149955472|NCT01913470|540970226|FG000|Overall Study|Lost to Follow-up|0|||
149955473|NCT01913470|540970227|FG001|Overall Study|Lost to Follow-up|1|||
149955474|NCT01913470|540970226|FG000|Overall Study|Physician Decision|0|||
149955475|NCT01913470|540970227|FG001|Overall Study|Physician Decision|1|||
149955476|NCT01913470|540970226|FG000|Overall Study|Withdrawal by Subject|0|||
149955477|NCT01913470|540970227|FG001|Overall Study|Withdrawal by Subject|1|||
149955478|NCT02573467|540970236|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
149955479|NCT02573467|540970237|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
149955480|NCT02573467|540970238|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
150172716|NCT01317420|541768067|FG000|Overall Study|Refused to cont. taking trial medication|0|||
150287660|NCT01903837|542187399|FG000|Part B|Incarceration|2|||
150287661|NCT01903837|542187400|FG001|Part B|Incarceration|0|||
150287662|NCT01903837|542187401|FG002|Part B|Incarceration|0|||
150287663|NCT01903837|542187402|FG003|Part B|Incarceration|1|||
150287664|NCT01903837|542187399|FG000|Part B|Physician Decision|1|||
150287665|NCT01903837|542187400|FG001|Part B|Physician Decision|0|||
150287666|NCT01903837|542187401|FG002|Part B|Physician Decision|0|||
150287667|NCT01903837|542187402|FG003|Part B|Physician Decision|2|||
150287668|NCT01903837|542187399|FG000|Part B|Lack of Efficacy|0|||
149955481|NCT02573467|540970239|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
150287669|NCT01903837|542187400|FG001|Part B|Lack of Efficacy|1|||
150287670|NCT01903837|542187401|FG002|Part B|Lack of Efficacy|0|||
150287671|NCT01903837|542187402|FG003|Part B|Lack of Efficacy|0|||
150287672|NCT02599961|542187405|FG000|Overall Study|Withdrawal by Subject|1|||
150287673|NCT02599961|542187405|FG000|Overall Study|Subject Non-Compliance|2|||
149845055|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845056|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845057|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845058|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845059|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845060|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149955482|NCT02573467|540970236|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
149955483|NCT02573467|540970237|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
149955484|NCT02573467|540970238|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
149955485|NCT02573467|540970239|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
149955486|NCT02573467|540970236|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
149955487|NCT02573467|540970237|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
149955488|NCT02573467|540970238|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
149955489|NCT02573467|540970239|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
149955490|NCT02573467|540970236|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
149955491|NCT02573467|540970237|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
149955492|NCT02573467|540970238|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
149955493|NCT02573467|540970239|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
149955494|NCT02573467|540970236|FG000|Post-treatment Follow up Epoch|Death|1|||
149955495|NCT02573467|540970237|FG001|Post-treatment Follow up Epoch|Death|1|||
149955496|NCT02573467|540970238|FG002|Post-treatment Follow up Epoch|Death|0|||
149955497|NCT02573467|540970239|FG003|Post-treatment Follow up Epoch|Death|1|||
149955498|NCT02573467|540970236|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
149955499|NCT02573467|540970237|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
149955500|NCT02573467|540970238|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
149955501|NCT02573467|540970239|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
149955502|NCT02573467|540970236|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
149955503|NCT02573467|540970237|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
149955504|NCT02573467|540970238|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
149955505|NCT02573467|540970239|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
149955506|NCT01829165|540970240|FG000|Overall Study|Did not complete intervention|2|||
149955507|NCT01829165|540970241|FG001|Overall Study|Did not complete intervention|0|||
149955508|NCT00710970|540970247|FG000|Overall Study|Never took drug|3|||
149955509|NCT01028560|540970248|FG000|Overall Study|Lack of Efficacy|3|||
149955510|NCT01028560|540970249|FG001|Overall Study|Lack of Efficacy|6|||
149955511|NCT01028560|540970248|FG000|Overall Study|Withdrawal by Subject|7|||
149955512|NCT01028560|540970249|FG001|Overall Study|Withdrawal by Subject|12|||
149955513|NCT02153827|540970250|FG000|Overall Study|Lost to Follow-up|3|||
149955514|NCT02153827|540970251|FG001|Overall Study|Lost to Follow-up|9|||
149955515|NCT01960842|540970256|FG000|Overall Study|Adverse Event|1|||
149955516|NCT01960842|540970256|FG000|Overall Study|Withdrawal by Subject|2|||
149955517|NCT00397930|540970257|FG000|Overall Study|Personal reasons|14|||
149955518|NCT00397930|540970258|FG001|Overall Study|Personal reasons|8|||
149955519|NCT00397930|540970257|FG000|Overall Study|Other medical|9|||
149955520|NCT00397930|540970258|FG001|Overall Study|Other medical|4|||
149955521|NCT00397930|540970257|FG000|Overall Study|Unknown reasons|9|||
149955522|NCT00397930|540970258|FG001|Overall Study|Unknown reasons|14|||
149955523|NCT00397930|540970257|FG000|Overall Study|Noncompliant|3|||
149955524|NCT00397930|540970258|FG001|Overall Study|Noncompliant|2|||
149955525|NCT00397930|540970257|FG000|Overall Study|Too time-consuming|2|||
149955526|NCT00397930|540970258|FG001|Overall Study|Too time-consuming|9|||
149955527|NCT00397930|540970257|FG000|Overall Study|Started own yoga program|1|||
149955528|NCT00397930|540970258|FG001|Overall Study|Started own yoga program|1|||
149955529|NCT00397930|540970257|FG000|Overall Study|Did not want to be in control group|0|||
149955530|NCT00397930|540970258|FG001|Overall Study|Did not want to be in control group|1|||
149955531|NCT00397930|540970257|FG000|Overall Study|Withdrawal by Subject|0|||
149955532|NCT00397930|540970258|FG001|Overall Study|Withdrawal by Subject|8|||
149955533|NCT00397930|540970257|FG000|Overall Study|Missing data|0|||
149955534|NCT00397930|540970258|FG001|Overall Study|Missing data|4|||
149955535|NCT02391584|540970259|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
149955536|NCT02391584|540970260|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
149955537|NCT02391584|540970259|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
149955538|NCT02391584|540970260|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
149955539|NCT02391584|540970259|FG000|3 Month|Lost to Follow-up|1|||
149955540|NCT02391584|540970260|FG001|3 Month|Lost to Follow-up|0|||
149845061|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149955541|NCT02391584|540970259|FG000|6 Month|Withdrawal by Subject|1|||
149955542|NCT02391584|540970260|FG001|6 Month|Withdrawal by Subject|0|||
149955543|NCT02391584|540970259|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
150036336|NCT01838395|541273005|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
149845062|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845063|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
149845064|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845065|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845066|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845067|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845068|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845069|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845070|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
149955544|NCT02391584|540970260|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
149955545|NCT02056288|540970281|FG000|In-Hospital Data|Surgery cancelled|1|||
149955546|NCT02056288|540970282|FG001|In-Hospital Data|Surgery cancelled|0|||
149955547|NCT02056288|540970281|FG000|In-Hospital Data|Protocol Violation|3|||
149955548|NCT02056288|540970282|FG001|In-Hospital Data|Protocol Violation|0|||
149955549|NCT02056288|540970281|FG000|In-Hospital Data|Physician Decision|1|||
149955550|NCT02056288|540970282|FG001|In-Hospital Data|Physician Decision|0|||
149955551|NCT02056288|540970281|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
149955552|NCT02056288|540970282|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
149955553|NCT02400580|540970285|FG000|Overall Study|Withdrawal by Subject|1|||
149955554|NCT02400580|540970286|FG001|Overall Study|Withdrawal by Subject|1|||
149955555|NCT02400580|540970285|FG000|Overall Study|Adverse Event|1|||
149955556|NCT02400580|540970286|FG001|Overall Study|Adverse Event|0|||
149955557|NCT00965094|540970287|FG000|Overall Study|Adverse Event|5|||
149955558|NCT00965094|540970288|FG001|Overall Study|Adverse Event|0|||
149955559|NCT00965094|540970287|FG000|Overall Study|Lost to Follow-up|0|||
149955560|NCT00965094|540970288|FG001|Overall Study|Lost to Follow-up|1|||
149955561|NCT01441414|540970289|FG000|Overall Study|Participant died|9|||
149955562|NCT01441414|540970289|FG000|Overall Study|Other reasons|3|||
149955563|NCT01441414|540970289|FG000|Overall Study|Study terminated by sponsor|2|||
149955564|NCT01441414|540970289|FG000|Overall Study|Subject refused further follow-up|1|||
149955565|NCT01773889|540970290|FG000|Overall Study|lack of funding|2|||
149955566|NCT04233580|540970291|FG000|Overall Study|Adverse Event|3|||
149955567|NCT04233580|540970292|FG001|Overall Study|Adverse Event|3|||
149955568|NCT04233580|540970291|FG000|Overall Study|Withdrawal by Subject|2|||
149955569|NCT04233580|540970292|FG001|Overall Study|Withdrawal by Subject|1|||
149955570|NCT03123588|540970293|FG000|Overall Study|Study Terminated by Sponsor|2|||
149955571|NCT03123588|540970294|FG001|Overall Study|Study Terminated by Sponsor|5|||
149955572|NCT03123588|540970293|FG000|Overall Study|Withdrawal by Subject|1|||
149955573|NCT03123588|540970294|FG001|Overall Study|Withdrawal by Subject|0|||
149955574|NCT03123588|540970293|FG000|Overall Study|Adverse Event|1|||
149955575|NCT03123588|540970294|FG001|Overall Study|Adverse Event|0|||
149955576|NCT03123588|540970293|FG000|Overall Study|Physician Decision|2|||
149955577|NCT03123588|540970294|FG001|Overall Study|Physician Decision|1|||
149955578|NCT01623752|540970296|FG000|Phase 1 (78 Weeks)|No Data|249|||
149955579|NCT01623752|540970297|FG001|Phase 1 (78 Weeks)|No Data|66|||
149955580|NCT01623752|540970298|FG002|Phase 1 (78 Weeks)|No Data|2|||
149955581|NCT01623752|540970296|FG000|Phase 1 (78 Weeks)|Other|33|||
149955582|NCT01623752|540970297|FG001|Phase 1 (78 Weeks)|Other|20|||
149955583|NCT01623752|540970298|FG002|Phase 1 (78 Weeks)|Other|0|||
149955584|NCT01623752|540970296|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
149955585|NCT01623752|540970297|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
149955586|NCT01623752|540970298|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
149955587|NCT01623752|540970296|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
149955588|NCT01623752|540970297|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
149955589|NCT01623752|540970298|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
149955590|NCT01623752|540970296|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
149955591|NCT01623752|540970297|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
149955592|NCT01623752|540970298|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
149955593|NCT01623752|540970296|FG000|Phase 2 (78 Weeks)|Other|5|||
149955594|NCT01623752|540970297|FG001|Phase 2 (78 Weeks)|Other|1|||
149955595|NCT01623752|540970298|FG002|Phase 2 (78 Weeks)|Other|0|||
149955596|NCT01623752|540970296|FG000|Phase 2 (78 Weeks)|No Data|43|||
149955597|NCT01623752|540970297|FG001|Phase 2 (78 Weeks)|No Data|11|||
149955598|NCT01623752|540970298|FG002|Phase 2 (78 Weeks)|No Data|0|||
149955599|NCT01623752|540970296|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
149955600|NCT01623752|540970297|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
149845071|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845072|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
149845073|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845074|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
149955601|NCT01623752|540970298|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
149955602|NCT01814332|540970299|FG000|Overall Study|Adverse Event|8|||
149955603|NCT01814332|540970300|FG001|Overall Study|Adverse Event|3|||
149955604|NCT01814332|540970299|FG000|Overall Study|Withdrawal by Subject|3|||
149955605|NCT01814332|540970300|FG001|Overall Study|Withdrawal by Subject|8|||
149955606|NCT01814332|540970299|FG000|Overall Study|Protocol Violation|0|||
149955607|NCT01814332|540970300|FG001|Overall Study|Protocol Violation|4|||
149955608|NCT01814332|540970299|FG000|Overall Study|Lost to Follow-up|5|||
149955609|NCT01814332|540970300|FG001|Overall Study|Lost to Follow-up|1|||
149955610|NCT02697422|540970302|FG000|Overall Study|Declined exit survey|9|||
149845075|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845076|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845077|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845078|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845079|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845080|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845081|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845082|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845083|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845084|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845085|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845086|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845087|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845088|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845089|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
149845090|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845091|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845092|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845093|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845094|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845095|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
149845096|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
149845097|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
149845098|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
149845099|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
149845100|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845101|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845102|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845103|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845104|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845105|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845106|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845107|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845108|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845109|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845110|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845111|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845112|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845113|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845114|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845115|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
149845116|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845117|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845118|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845119|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845120|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845121|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845122|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845123|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845124|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845125|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
149845126|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845127|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845128|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845129|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845130|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
150036337|NCT01838395|541273006|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
150287674|NCT02599961|542187405|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
150287675|NCT02599961|542187405|FG000|Overall Study|Other, Not Specified|3|||
150287676|NCT02432235|542187406|FG000|Overall Study|Death|1|||
149845131|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845132|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845133|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
150036338|NCT01838395|541273007|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
150287677|NCT02432235|542187407|FG001|Overall Study|Death|1|||
150287678|NCT02432235|542187408|FG002|Overall Study|Death|2|||
150287679|NCT02432235|542187409|FG003|Overall Study|Death|2|||
150287680|NCT02432235|542187410|FG004|Overall Study|Death|1|||
149845134|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845135|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845136|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845137|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845138|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845139|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845140|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845141|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
149845142|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845143|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845144|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845145|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845146|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845147|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845148|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845149|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845150|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845151|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
149845152|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845153|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845154|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845155|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845156|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845157|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845158|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845159|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845160|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845161|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845162|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845163|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845164|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845165|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845166|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845167|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
149845168|NCT00112437|540562192|FG000|Year 2 (12-Month Extension)|Moved|0|||
149845169|NCT00112437|540562193|FG001|Year 2 (12-Month Extension)|Moved|0|||
149845170|NCT00112437|540562194|FG002|Year 2 (12-Month Extension)|Moved|0|||
149845171|NCT00112437|540562195|FG003|Year 2 (12-Month Extension)|Moved|0|||
149845172|NCT00112437|540562196|FG004|Year 2 (12-Month Extension)|Moved|0|||
149845173|NCT00112437|540562197|FG005|Year 2 (12-Month Extension)|Moved|0|||
149845174|NCT00112437|540562198|FG006|Year 2 (12-Month Extension)|Moved|0|||
149845175|NCT00112437|540562199|FG007|Year 2 (12-Month Extension)|Moved|0|||
149845176|NCT00112437|540562200|FG008|Year 2 (12-Month Extension)|Moved|0|||
149845177|NCT00112437|540562201|FG009|Year 2 (12-Month Extension)|Moved|1|||
149845178|NCT00112437|540562202|FG010|Year 2 (12-Month Extension)|Moved|0|||
149845179|NCT00112437|540562203|FG011|Year 2 (12-Month Extension)|Moved|0|||
149845180|NCT00112437|540562204|FG012|Year 2 (12-Month Extension)|Moved|0|||
149845181|NCT00112437|540562205|FG013|Year 2 (12-Month Extension)|Moved|0|||
149845182|NCT00112437|540562206|FG014|Year 2 (12-Month Extension)|Moved|0|||
149845183|NCT00112437|540562207|FG015|Year 2 (12-Month Extension)|Moved|0|||
149845184|NCT00112437|540562208|FG016|Year 2 (12-Month Extension)|Moved|0|||
149845185|NCT00112437|540562209|FG017|Year 2 (12-Month Extension)|Moved|0|||
149845186|NCT00112437|540562210|FG018|Year 2 (12-Month Extension)|Moved|0|||
149845187|NCT00112437|540562211|FG019|Year 2 (12-Month Extension)|Moved|0|||
149845188|NCT00112437|540562212|FG020|Year 2 (12-Month Extension)|Moved|0|||
149845189|NCT00112437|540562213|FG021|Year 2 (12-Month Extension)|Moved|0|||
149845190|NCT00112437|540562214|FG022|Year 2 (12-Month Extension)|Moved|0|||
149845191|NCT00112437|540562215|FG023|Year 2 (12-Month Extension)|Moved|0|||
149845192|NCT00112437|540562216|FG024|Year 2 (12-Month Extension)|Moved|0|||
149845193|NCT00112437|540562217|FG025|Year 2 (12-Month Extension)|Moved|0|||
149845194|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
149845195|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
149845196|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
149845197|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
149845198|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
149845199|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
149845200|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
149845201|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
149845202|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
149845203|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
149845204|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
150287681|NCT02432235|542187411|FG005|Overall Study|Death|3|||
149845205|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
149845206|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
149845207|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
149845208|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
149845209|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
150287682|NCT02432235|542187412|FG006|Overall Study|Death|11|||
150287683|NCT02432235|542187413|FG007|Overall Study|Death|15|||
149845210|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
149845211|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
149845212|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
149845213|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
149845214|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
149845215|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
149845216|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
149845217|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
149845218|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
149845219|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
149845220|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845221|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845222|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845223|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845224|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845225|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845226|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
150287684|NCT02432235|542187414|FG008|Overall Study|Death|15|||
149845227|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845228|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845229|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845230|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845231|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
149845232|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845233|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
149845234|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845235|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
149845236|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845237|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845238|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
149845239|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845240|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845241|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845242|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845243|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845244|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845245|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
149845246|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845247|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845248|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845249|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845250|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845251|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845252|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845253|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149955611|NCT02697422|540970303|FG001|Overall Study|Declined exit survey|2|||
149955612|NCT02697422|540970302|FG000|Overall Study|Lost to Follow-up|13|||
149955613|NCT02697422|540970303|FG001|Overall Study|Lost to Follow-up|8|||
149955614|NCT02697422|540970302|FG000|Overall Study|Death|2|||
149955615|NCT02697422|540970303|FG001|Overall Study|Death|1|||
150287685|NCT02432235|542187415|FG009|Overall Study|Death|3|||
149845254|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845255|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149955616|NCT02697422|540970302|FG000|Overall Study|Withdrawal by Subject|0|||
149955617|NCT02697422|540970303|FG001|Overall Study|Withdrawal by Subject|1|||
150036339|NCT05720897|541273012|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
150172717|NCT01317420|541768068|FG001|Overall Study|Refused to cont. taking trial medication|0|||
150287686|NCT02432235|542187416|FG010|Overall Study|Death|1|||
150287687|NCT02432235|542187417|FG011|Overall Study|Death|0|||
150287688|NCT02432235|542187406|FG000|Overall Study|Withdrawal by Subject|0|||
149845256|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845257|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149955618|NCT02697422|540970302|FG000|Overall Study|Physician Decision|1|||
149955619|NCT02697422|540970303|FG001|Overall Study|Physician Decision|1|||
150287689|NCT02432235|542187407|FG001|Overall Study|Withdrawal by Subject|1|||
150287690|NCT02432235|542187408|FG002|Overall Study|Withdrawal by Subject|0|||
149845258|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845259|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845260|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845261|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
149845262|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845263|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845264|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845265|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845266|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845267|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845268|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845269|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845270|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845271|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
149845272|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845273|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845274|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845275|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845276|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845277|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845278|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845279|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845280|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845281|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845282|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845283|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845284|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845285|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845286|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845287|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
149845288|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845289|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845290|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845291|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845292|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
149955620|NCT02697422|540970302|FG000|Overall Study|Exit survey data lost|1|||
149955621|NCT02697422|540970303|FG001|Overall Study|Exit survey data lost|0|||
149955622|NCT01871727|540970306|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
149955623|NCT01871727|540970307|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
149955624|NCT01871727|540970308|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
149955625|NCT01871727|540970309|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
149955626|NCT01871727|540970310|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
149955627|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
149955628|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
149955629|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
149955630|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
149955631|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
149955632|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
149955633|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
149955634|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
149955635|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
149955636|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
149955637|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
149955638|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
149955639|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
149955640|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
149955641|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
150287691|NCT02432235|542187409|FG003|Overall Study|Withdrawal by Subject|0|||
150287692|NCT02432235|542187410|FG004|Overall Study|Withdrawal by Subject|0|||
149955642|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
149955643|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
149955644|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
150287693|NCT02432235|542187411|FG005|Overall Study|Withdrawal by Subject|2|||
150287694|NCT02432235|542187412|FG006|Overall Study|Withdrawal by Subject|5|||
149845293|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845294|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845295|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
149955645|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
149955646|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
150036340|NCT05720897|541273013|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
150036341|NCT00400179|541273014|FG000|Overall Study|Adverse Event|2|||
150036342|NCT00400179|541273015|FG001|Overall Study|Adverse Event|2|||
150036343|NCT00400179|541273014|FG000|Overall Study|Death|1|||
150036344|NCT00400179|541273015|FG001|Overall Study|Death|2|||
150036345|NCT00400179|541273014|FG000|Overall Study|Withdrew Consent|1|||
150036346|NCT00400179|541273015|FG001|Overall Study|Withdrew Consent|5|||
150036347|NCT00400179|541273014|FG000|Overall Study|Disease progression|1|||
150036348|NCT00400179|541273015|FG001|Overall Study|Disease progression|1|||
150036349|NCT00400179|541273014|FG000|Overall Study|Intercurrent illness|0|||
150036350|NCT00400179|541273015|FG001|Overall Study|Intercurrent illness|1|||
150036351|NCT00400179|541273014|FG000|Overall Study|Investigator judgment|0|||
150036352|NCT00400179|541273015|FG001|Overall Study|Investigator judgment|1|||
150036353|NCT00400179|541273014|FG000|Overall Study|Randomization error/patient ineligible|1|||
150036354|NCT00400179|541273015|FG001|Overall Study|Randomization error/patient ineligible|6|||
150036355|NCT04780061|541273016|FG000|Overall Study|Withdrawal by Subject|5|||
150036356|NCT04780061|541273017|FG001|Overall Study|Withdrawal by Subject|8|||
150036357|NCT04780061|541273016|FG000|Overall Study|Adverse Event|2|||
150036358|NCT04780061|541273017|FG001|Overall Study|Adverse Event|2|||
150036359|NCT04780061|541273016|FG000|Overall Study|Lost to Follow-up|1|||
150036360|NCT04780061|541273017|FG001|Overall Study|Lost to Follow-up|5|||
150036361|NCT04050553|541273018|FG000|Period 1|Physician Decision|2|||
150036362|NCT04050553|541273019|FG001|Period 1|Physician Decision|2|||
150036363|NCT04050553|541273018|FG000|Period 1|Adverse Event|1|||
150036364|NCT04050553|541273019|FG001|Period 1|Adverse Event|1|||
150036365|NCT04050553|541273018|FG000|Period 1|Withdrawal by Subject|0|||
150036366|NCT04050553|541273019|FG001|Period 1|Withdrawal by Subject|1|||
150036367|NCT04050553|541273018|FG000|Wash-out|Adverse Event|0|||
150036368|NCT04050553|541273019|FG001|Wash-out|Adverse Event|1|||
150036369|NCT04050553|541273018|FG000|Wash-out|Withdrawal by Subject|0|||
150036370|NCT04050553|541273019|FG001|Wash-out|Withdrawal by Subject|1|||
149845296|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
150036371|NCT05430854|541273021|FG000|Overall Study|Trial terminated by Sponsor|39|||
150036372|NCT05430854|541273022|FG001|Overall Study|Trial terminated by Sponsor|50|||
150036373|NCT05430854|541273023|FG002|Overall Study|Trial terminated by Sponsor|46|||
150036374|NCT05430854|541273021|FG000|Overall Study|Withdrawal by Subject|0|||
150036375|NCT05430854|541273022|FG001|Overall Study|Withdrawal by Subject|3|||
150036376|NCT05430854|541273023|FG002|Overall Study|Withdrawal by Subject|0|||
150036377|NCT00734149|541273024|FG000|Overall Study|Withdrawal by Subject|1|||
150036378|NCT04314284|541273025|FG000|Overall Study|Withdrawal by Subject|4|||
150036379|NCT04314284|541273026|FG001|Overall Study|Withdrawal by Subject|7|||
150036380|NCT04314284|541273025|FG000|Overall Study|Consented but did not complete survey|0|||
150036381|NCT04314284|541273026|FG001|Overall Study|Consented but did not complete survey|6|||
150036382|NCT01652235|541273032|FG000|Overall Study|Death|9|||
150036383|NCT01652235|541273032|FG000|Overall Study|Lost to Follow-up|5|||
150036384|NCT01652235|541273032|FG000|Overall Study|Withdrawal by Subject|2|||
150036385|NCT02023086|541273035|FG000|Overall Study|Withdrawal by Subject|2|||
150036386|NCT02023086|541273036|FG001|Overall Study|Withdrawal by Subject|0|||
150036387|NCT03589859|541273039|FG000|Overall Study|Withdrawal by Subject|0|||
150036388|NCT03589859|541273040|FG001|Overall Study|Withdrawal by Subject|6|||
150036389|NCT05565742|541273042|FG000|Overall Study|Withdrawal by Subject|0|||
150036390|NCT05565742|541273043|FG001|Overall Study|Withdrawal by Subject|0|||
150036391|NCT05565742|541273044|FG002|Overall Study|Withdrawal by Subject|2|||
150036392|NCT05565742|541273045|FG003|Overall Study|Withdrawal by Subject|2|||
150036393|NCT05565742|541273046|FG004|Overall Study|Withdrawal by Subject|2|||
150036394|NCT05565742|541273042|FG000|Overall Study|Death|1|||
150036395|NCT05565742|541273043|FG001|Overall Study|Death|0|||
150036396|NCT05565742|541273044|FG002|Overall Study|Death|0|||
150036397|NCT05565742|541273045|FG003|Overall Study|Death|0|||
150036398|NCT05565742|541273046|FG004|Overall Study|Death|0|||
150036399|NCT05565742|541273042|FG000|Overall Study|Participant Travelled Abroad|0|||
150036400|NCT05565742|541273043|FG001|Overall Study|Participant Travelled Abroad|0|||
150036401|NCT05565742|541273044|FG002|Overall Study|Participant Travelled Abroad|0|||
150036402|NCT05565742|541273045|FG003|Overall Study|Participant Travelled Abroad|0|||
150036403|NCT05565742|541273046|FG004|Overall Study|Participant Travelled Abroad|1|||
150036404|NCT04163341|541273047|FG000|Overall Study|Withdrawal by Subject|2|||
150036405|NCT04163341|541273048|FG001|Overall Study|Withdrawal by Subject|0|||
150036406|NCT04163341|541273047|FG000|Overall Study|Lost to Follow-up|3|||
150036407|NCT04163341|541273048|FG001|Overall Study|Lost to Follow-up|4|||
150036408|NCT05417438|541273049|FG000|Overall Study|Withdrawal by Subject|3|||
150036409|NCT04272242|541273050|FG000|Overall Study|Withdrawal by Subject|3|||
150036410|NCT04272242|541273050|FG000|Overall Study|Lost to Follow-up|1|||
150036411|NCT04272242|541273050|FG000|Overall Study|Adverse Event|1|||
150036412|NCT02681523|541273053|FG000|Overall Study|Adverse Event|1|||
150036413|NCT02681523|541273053|FG000|Overall Study|Patient Non-compliance|1|||
150036414|NCT05291520|541274384|FG000|Overall Study|Lost to Follow-up|0|||
150287695|NCT02432235|542187413|FG007|Overall Study|Withdrawal by Subject|3|||
150287696|NCT02432235|542187414|FG008|Overall Study|Withdrawal by Subject|1|||
150287697|NCT02432235|542187415|FG009|Overall Study|Withdrawal by Subject|0|||
150287698|NCT02432235|542187416|FG010|Overall Study|Withdrawal by Subject|0|||
150287699|NCT02432235|542187417|FG011|Overall Study|Withdrawal by Subject|0|||
149845297|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
149845298|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845299|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845300|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845301|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845302|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845303|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845304|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845305|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845306|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845307|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845308|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845309|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
149845310|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845311|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845312|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
149845313|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845314|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845315|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845316|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845317|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845318|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845319|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845320|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845321|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845322|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845323|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
149845324|NCT00112437|540562192|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149955647|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
149955648|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
149955649|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
149955650|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
149955651|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
149955652|NCT01871727|540970306|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
149955653|NCT01871727|540970307|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
149955654|NCT01871727|540970308|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
149955655|NCT01871727|540970309|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
149955656|NCT01871727|540970310|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
149955657|NCT01263028|540970311|FG000|Overall Study|Withdrawal by Subject|1|||
149955658|NCT01263028|540970311|FG000|Overall Study|Adverse Event|1|||
149955659|NCT01263028|540970311|FG000|Overall Study|Study terminated due to low enrollment.|4|||
149955660|NCT03019588|540970312|FG000|Overall Study|Death|44|||
149955661|NCT03019588|540970313|FG001|Overall Study|Death|46|||
149955662|NCT03019588|540970312|FG000|Overall Study|Study terminated by Sponsor|3|||
149955663|NCT03019588|540970313|FG001|Overall Study|Study terminated by Sponsor|1|||
149955664|NCT00294398|540970314|FG000|Overall Study|Lost to Follow-up|21|||
149955665|NCT00294398|540970315|FG001|Overall Study|Lost to Follow-up|26|||
149955666|NCT00985790|540970316|FG000|Overall Study|Withdrawal by Subject|1|||
149955667|NCT00985790|540970317|FG001|Overall Study|Withdrawal by Subject|1|||
149955668|NCT00985790|540970316|FG000|Overall Study|Lost to Follow-up|6|||
149955669|NCT00985790|540970317|FG001|Overall Study|Lost to Follow-up|7|||
149955670|NCT02939781|540970321|FG000|Overall Study|Protocol Violation|8|||
149955671|NCT02939781|540970321|FG000|Overall Study|Withdrawal by Subject|1|||
149955672|NCT03753542|540970322|FG000|Overall Study|Lost to Follow-up|9|||
149955673|NCT03753542|540970323|FG001|Overall Study|Lost to Follow-up|14|||
149955674|NCT03158311|540970328|FG000|Overall Study|Subject/Guardian Decision|10|||
149955675|NCT03158311|540970329|FG001|Overall Study|Subject/Guardian Decision|6|||
149955676|NCT03158311|540970330|FG002|Overall Study|Subject/Guardian Decision|11|||
149955677|NCT03158311|540970328|FG000|Overall Study|Adverse Event|5|||
149955678|NCT03158311|540970329|FG001|Overall Study|Adverse Event|3|||
149955679|NCT03158311|540970330|FG002|Overall Study|Adverse Event|3|||
149955680|NCT03158311|540970328|FG000|Overall Study|Techinical Problems|3|||
150287700|NCT02432235|542187406|FG000|Overall Study|Lost to Follow-up|0|||
149955681|NCT03158311|540970329|FG001|Overall Study|Techinical Problems|1|||
149955682|NCT03158311|540970330|FG002|Overall Study|Techinical Problems|5|||
149955683|NCT03158311|540970328|FG000|Overall Study|Physician Decision|2|||
149955684|NCT03158311|540970329|FG001|Overall Study|Physician Decision|3|||
149955685|NCT03158311|540970330|FG002|Overall Study|Physician Decision|7|||
149845325|NCT00112437|540562193|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845326|NCT00112437|540562194|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845327|NCT00112437|540562195|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845328|NCT00112437|540562196|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845329|NCT00112437|540562197|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845330|NCT00112437|540562198|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845331|NCT00112437|540562199|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845332|NCT00112437|540562200|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845333|NCT00112437|540562201|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845334|NCT00112437|540562202|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
149845335|NCT00112437|540562203|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
149845336|NCT00112437|540562204|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845337|NCT00112437|540562205|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845338|NCT00112437|540562206|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845339|NCT00112437|540562207|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845340|NCT00112437|540562208|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845341|NCT00112437|540562209|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845342|NCT00112437|540562210|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845343|NCT00112437|540562211|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845344|NCT00112437|540562212|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845345|NCT00112437|540562213|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845346|NCT00112437|540562214|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845347|NCT00112437|540562215|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845348|NCT00112437|540562216|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845349|NCT00112437|540562217|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
149845350|NCT00112437|540562192|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845351|NCT00112437|540562193|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845352|NCT00112437|540562194|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845353|NCT00112437|540562195|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845354|NCT00112437|540562196|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845355|NCT00112437|540562197|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845356|NCT00112437|540562198|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845357|NCT00112437|540562199|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845358|NCT00112437|540562200|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845359|NCT00112437|540562201|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845360|NCT00112437|540562202|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845361|NCT00112437|540562203|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845362|NCT00112437|540562204|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845363|NCT00112437|540562205|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845364|NCT00112437|540562206|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845365|NCT00112437|540562207|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845366|NCT00112437|540562208|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845367|NCT00112437|540562209|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845368|NCT00112437|540562210|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845369|NCT00112437|540562211|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
150287701|NCT02432235|542187407|FG001|Overall Study|Lost to Follow-up|0|||
150287702|NCT02432235|542187408|FG002|Overall Study|Lost to Follow-up|0|||
150287703|NCT02432235|542187409|FG003|Overall Study|Lost to Follow-up|0|||
150287704|NCT02432235|542187410|FG004|Overall Study|Lost to Follow-up|0|||
150287705|NCT02432235|542187411|FG005|Overall Study|Lost to Follow-up|1|||
150287706|NCT02432235|542187412|FG006|Overall Study|Lost to Follow-up|0|||
150287707|NCT02432235|542187413|FG007|Overall Study|Lost to Follow-up|0|||
150287708|NCT02432235|542187414|FG008|Overall Study|Lost to Follow-up|1|||
149845370|NCT00112437|540562212|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
149955686|NCT03158311|540970328|FG000|Overall Study|Lost to Follow-up|1|||
149955687|NCT03158311|540970329|FG001|Overall Study|Lost to Follow-up|1|||
149955688|NCT03158311|540970330|FG002|Overall Study|Lost to Follow-up|1|||
149955689|NCT03158311|540970328|FG000|Overall Study|Sponsor decision|1|||
149955690|NCT03158311|540970329|FG001|Overall Study|Sponsor decision|0|||
149955691|NCT03158311|540970330|FG002|Overall Study|Sponsor decision|0|||
149955692|NCT03158311|540970328|FG000|Overall Study|Pregnancy|0|||
149955693|NCT03158311|540970329|FG001|Overall Study|Pregnancy|2|||
149955694|NCT03158311|540970330|FG002|Overall Study|Pregnancy|0|||
149955695|NCT03158311|540970328|FG000|Overall Study|Randomized in error|0|||
149955696|NCT03158311|540970329|FG001|Overall Study|Randomized in error|0|||
149955697|NCT03158311|540970330|FG002|Overall Study|Randomized in error|1|||
149955698|NCT03011372|540970331|FG000|Overall Study|Death|16|||
149955699|NCT03011372|540970331|FG000|Overall Study|Lost to Follow-up|2|||
149955700|NCT03011372|540970331|FG000|Overall Study|Sponsor Decision|17|||
149955701|NCT03011372|540970331|FG000|Overall Study|Withdrawal by Subject|7|||
149845371|NCT00112437|540562213|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
149845372|NCT00112437|540562214|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845373|NCT00112437|540562215|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845374|NCT00112437|540562216|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845375|NCT00112437|540562217|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
149845376|NCT00112437|540562192|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845377|NCT00112437|540562193|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845378|NCT00112437|540562194|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845379|NCT00112437|540562195|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845380|NCT00112437|540562196|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845381|NCT00112437|540562197|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845382|NCT00112437|540562198|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845383|NCT00112437|540562199|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845384|NCT00112437|540562200|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845385|NCT00112437|540562201|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845386|NCT00112437|540562202|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845387|NCT00112437|540562203|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845388|NCT00112437|540562204|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845389|NCT00112437|540562205|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845390|NCT00112437|540562206|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845391|NCT00112437|540562207|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845392|NCT00112437|540562208|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845393|NCT00112437|540562209|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845394|NCT00112437|540562210|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845395|NCT00112437|540562211|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845396|NCT00112437|540562212|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
149845397|NCT00112437|540562213|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845398|NCT00112437|540562214|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845399|NCT00112437|540562215|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845400|NCT00112437|540562216|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845401|NCT00112437|540562217|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
149845402|NCT00112437|540562192|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845403|NCT00112437|540562193|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845404|NCT00112437|540562194|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845405|NCT00112437|540562195|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845406|NCT00112437|540562196|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845407|NCT00112437|540562197|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845408|NCT00112437|540562198|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845409|NCT00112437|540562199|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845410|NCT00112437|540562200|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845411|NCT00112437|540562201|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845412|NCT00112437|540562202|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845413|NCT00112437|540562203|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845414|NCT00112437|540562204|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845415|NCT00112437|540562205|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845416|NCT00112437|540562206|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845417|NCT00112437|540562207|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845418|NCT00112437|540562208|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845419|NCT00112437|540562209|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845420|NCT00112437|540562210|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845421|NCT00112437|540562211|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845422|NCT00112437|540562212|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845423|NCT00112437|540562213|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
149845424|NCT00112437|540562214|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845425|NCT00112437|540562215|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845426|NCT00112437|540562216|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149845427|NCT00112437|540562217|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
149955702|NCT03011372|540970331|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
149955703|NCT03011372|540970331|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
149955704|NCT03011372|540970331|FG000|Overall Study|Sponsor's Decision|2|||
149955705|NCT04289298|540972114|FG000|Overall Study|Lost to Follow-up|5|||
149955706|NCT04289298|540972115|FG001|Overall Study|Lost to Follow-up|0|||
149955707|NCT04289298|540972114|FG000|Overall Study|Withdrawal by Subject|2|||
149955708|NCT04289298|540972115|FG001|Overall Study|Withdrawal by Subject|0|||
149955709|NCT01734928|540972116|FG000|Randomization|Physician Decision|0|||
149955710|NCT01734928|540972117|FG001|Randomization|Physician Decision|1|||
149955711|NCT01734928|540972116|FG000|Randomization|clinical progression|0|||
150287709|NCT02432235|542187415|FG009|Overall Study|Lost to Follow-up|0|||
150287710|NCT02432235|542187416|FG010|Overall Study|Lost to Follow-up|0|||
150287711|NCT02432235|542187417|FG011|Overall Study|Lost to Follow-up|0|||
150287712|NCT02432235|542187406|FG000|Overall Study|Miscellaneous|0|||
150287713|NCT02432235|542187407|FG001|Overall Study|Miscellaneous|0|||
150287714|NCT02432235|542187408|FG002|Overall Study|Miscellaneous|0|||
150287715|NCT02432235|542187409|FG003|Overall Study|Miscellaneous|0|||
150287716|NCT02432235|542187410|FG004|Overall Study|Miscellaneous|1|||
150287717|NCT02432235|542187411|FG005|Overall Study|Miscellaneous|6|||
150287718|NCT02432235|542187412|FG006|Overall Study|Miscellaneous|2|||
150287719|NCT02432235|542187413|FG007|Overall Study|Miscellaneous|2|||
150287720|NCT02432235|542187414|FG008|Overall Study|Miscellaneous|4|||
150287721|NCT02432235|542187415|FG009|Overall Study|Miscellaneous|0|||
150287722|NCT02432235|542187416|FG010|Overall Study|Miscellaneous|0|||
150287723|NCT02432235|542187417|FG011|Overall Study|Miscellaneous|1|||
150287724|NCT01895322|542187418|FG000|Overall Study|Adverse Event|1|||
150287725|NCT01895322|542187418|FG000|Overall Study|Withdrawal by Subject|2|||
150287726|NCT01895322|542187418|FG000|Overall Study|Protocol Violation|10|||
150287727|NCT00143312|542187426|FG000|Overall Study|Death|11|||
150287728|NCT00143312|542187426|FG000|Overall Study|Adverse Event|2|||
150287729|NCT00143312|542187426|FG000|Overall Study|Lost to Follow-up|1|||
150287730|NCT00143312|542187426|FG000|Overall Study|Other|1|||
150287731|NCT00143312|542187426|FG000|Overall Study|Withdrawal by Subject|1|||
150287732|NCT01834274|542187427|FG000|Overall Study|Study Termination|41|||
150287733|NCT01834274|542187428|FG001|Overall Study|Study Termination|38|||
150287734|NCT01834274|542187427|FG000|Overall Study|Withdrawal by Subject|1|||
150287735|NCT01834274|542187428|FG001|Overall Study|Withdrawal by Subject|1|||
150287736|NCT01834274|542187427|FG000|Overall Study|Lost to Follow-up|3|||
150287737|NCT01834274|542187428|FG001|Overall Study|Lost to Follow-up|1|||
150287738|NCT01834274|542187427|FG000|Overall Study|Other|2|||
150287739|NCT01834274|542187428|FG001|Overall Study|Other|1|||
150287740|NCT03603496|542187429|FG000|Overall Study|Death|19|||
150287741|NCT03603496|542187430|FG001|Overall Study|Death|24|||
150287742|NCT03603496|542187429|FG000|Overall Study|Lost to Follow-up|141|||
150287743|NCT03603496|542187430|FG001|Overall Study|Lost to Follow-up|141|||
150287744|NCT03603496|542187429|FG000|Overall Study|Withdrawal by Subject|26|||
150287745|NCT03603496|542187430|FG001|Overall Study|Withdrawal by Subject|20|||
150287746|NCT03594227|542187431|FG000|Overall Study|Adverse Event|2|||
150287747|NCT03594227|542187432|FG001|Overall Study|Adverse Event|1|||
150287748|NCT03594227|542187433|FG002|Overall Study|Adverse Event|0|||
150287749|NCT03594227|542187434|FG003|Overall Study|Adverse Event|2|||
150287750|NCT03594227|542187431|FG000|Overall Study|Lost to Follow-up|1|||
150287751|NCT03594227|542187432|FG001|Overall Study|Lost to Follow-up|1|||
150287752|NCT03594227|542187433|FG002|Overall Study|Lost to Follow-up|1|||
150287753|NCT03594227|542187434|FG003|Overall Study|Lost to Follow-up|0|||
150287754|NCT03594227|542187431|FG000|Overall Study|Withdrawal by Subject|1|||
150287755|NCT03594227|542187432|FG001|Overall Study|Withdrawal by Subject|1|||
149955712|NCT01734928|540972117|FG001|Randomization|clinical progression|1|||
149955713|NCT01734928|540972116|FG000|Randomization|progressive disease|0|||
149955714|NCT01734928|540972117|FG001|Randomization|progressive disease|2|||
149955715|NCT01734928|540972116|FG000|Randomization|Withdrew informed consent|0|||
149955716|NCT01734928|540972117|FG001|Randomization|Withdrew informed consent|4|||
150287756|NCT03594227|542187433|FG002|Overall Study|Withdrawal by Subject|1|||
150287757|NCT03594227|542187434|FG003|Overall Study|Withdrawal by Subject|1|||
150287758|NCT03594227|542187431|FG000|Overall Study|Pregnancy|0|||
150287759|NCT03594227|542187432|FG001|Overall Study|Pregnancy|1|||
150287760|NCT03594227|542187433|FG002|Overall Study|Pregnancy|0|||
150287761|NCT03594227|542187434|FG003|Overall Study|Pregnancy|0|||
150287762|NCT03594227|542187431|FG000|Overall Study|Sponsor Decision|0|||
150287763|NCT03594227|542187432|FG001|Overall Study|Sponsor Decision|0|||
149955717|NCT01734928|540972116|FG000|Randomization|Death|1|||
149955718|NCT01734928|540972117|FG001|Randomization|Death|0|||
149955719|NCT01734928|540972116|FG000|Randomization|Randomization error|1|||
150287764|NCT03594227|542187433|FG002|Overall Study|Sponsor Decision|0|||
150287765|NCT03594227|542187434|FG003|Overall Study|Sponsor Decision|1|||
150287766|NCT03594227|542187431|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
149955720|NCT01734928|540972117|FG001|Randomization|Randomization error|0|||
149955721|NCT01734928|540972116|FG000|Randomization|Lost to Follow-up|1|||
149955722|NCT01734928|540972117|FG001|Randomization|Lost to Follow-up|0|||
150287767|NCT03594227|542187432|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
150287768|NCT03594227|542187433|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
150287769|NCT03594227|542187434|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
150287770|NCT00774345|542187435|FG000|Pre-treatment|Other reasons|2|||
150287771|NCT00774345|542187436|FG001|Pre-treatment|Other reasons|0|||
149955723|NCT01734928|540972116|FG000|Treatment Period|Lost to Follow-up|0|||
149955724|NCT01734928|540972117|FG001|Treatment Period|Lost to Follow-up|2|||
149955725|NCT01734928|540972116|FG000|Treatment Period|Progressive Disease|167|||
150287772|NCT00774345|542187435|FG000|Treatment|Adverse Event|61|||
150287773|NCT00774345|542187436|FG001|Treatment|Adverse Event|15|||
150287774|NCT00774345|542187435|FG000|Treatment|Progressive Disease without histologic transformation|51|||
149845428|NCT00112437|540562192|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845429|NCT00112437|540562193|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845430|NCT00112437|540562194|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845431|NCT00112437|540562195|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845432|NCT00112437|540562196|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845433|NCT00112437|540562197|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845434|NCT00112437|540562198|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845435|NCT00112437|540562199|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845436|NCT00112437|540562200|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845437|NCT00112437|540562201|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845438|NCT00112437|540562202|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845439|NCT00112437|540562203|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845440|NCT00112437|540562204|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845441|NCT00112437|540562205|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845442|NCT00112437|540562206|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845443|NCT00112437|540562207|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845444|NCT00112437|540562208|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845445|NCT00112437|540562209|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845446|NCT00112437|540562210|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845447|NCT00112437|540562211|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845448|NCT00112437|540562212|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845449|NCT00112437|540562213|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
149845450|NCT00112437|540562214|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845451|NCT00112437|540562215|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845452|NCT00112437|540562216|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
150287775|NCT00774345|542187436|FG001|Treatment|Progressive Disease without histologic transformation|111|||
149845453|NCT00112437|540562217|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
149845454|NCT00112437|540562192|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845455|NCT00112437|540562193|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845456|NCT00112437|540562194|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845457|NCT00112437|540562195|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845458|NCT00112437|540562196|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845459|NCT00112437|540562197|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845460|NCT00112437|540562198|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845461|NCT00112437|540562199|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845462|NCT00112437|540562200|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845463|NCT00112437|540562201|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149955726|NCT01734928|540972117|FG001|Treatment Period|Progressive Disease|165|||
149955727|NCT01734928|540972116|FG000|Treatment Period|Adverse Event|39|||
149955728|NCT01734928|540972117|FG001|Treatment Period|Adverse Event|52|||
149955729|NCT01734928|540972116|FG000|Treatment Period|Withdrawal of Consent|25|||
149955730|NCT01734928|540972117|FG001|Treatment Period|Withdrawal of Consent|22|||
149955731|NCT01734928|540972116|FG000|Treatment Period|Death|20|||
149955732|NCT01734928|540972117|FG001|Treatment Period|Death|9|||
149955733|NCT01734928|540972116|FG000|Treatment Period|Other Reasons|27|||
149955734|NCT01734928|540972117|FG001|Treatment Period|Other Reasons|19|||
149955735|NCT01734928|540972116|FG000|Treatment Period|Pregnancy|0|||
149955736|NCT01734928|540972117|FG001|Treatment Period|Pregnancy|1|||
149955737|NCT00620035|540972118|FG000|Overall Study|Adverse Event|106|||
149955738|NCT00620035|540972118|FG000|Overall Study|Withdrawal of Informed Consent|1|||
149955739|NCT00620035|540972118|FG000|Overall Study|Other Reason|38|||
149955740|NCT01778985|540972119|FG000|Overall Study|Lost to Follow-up|1|||
149955741|NCT01778985|540972120|FG001|Overall Study|Lost to Follow-up|0|||
149955742|NCT01778985|540972119|FG000|Overall Study|Physician Decision|2|||
149955743|NCT01778985|540972120|FG001|Overall Study|Physician Decision|2|||
149955744|NCT01778985|540972119|FG000|Overall Study|Protocol Violation|4|||
149955745|NCT01778985|540972120|FG001|Overall Study|Protocol Violation|1|||
149955746|NCT00088881|540972123|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
149955747|NCT00088881|540972123|FG000|Step 1 - R-CHOP|Adverse Event|1|||
149955748|NCT00088881|540972123|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
149955749|NCT00088881|540972123|FG000|Step 1 - R-CHOP|Physician Decision|1|||
149955750|NCT00088881|540972123|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
149955751|NCT00088881|540972123|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
149955752|NCT00088881|540972123|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
149955753|NCT02370394|540972131|FG000|Overall Study|Lost to Follow-up|2|||
149955754|NCT02370394|540972132|FG001|Overall Study|Lost to Follow-up|1|||
149955755|NCT02370394|540972131|FG000|Overall Study|Withdrawal by Subject|0|||
149955756|NCT02370394|540972132|FG001|Overall Study|Withdrawal by Subject|1|||
149955757|NCT02316613|540972135|FG000|Overall Study|Death|63|||
149955758|NCT02316613|540972135|FG000|Overall Study|Lost to Follow-up|9|||
149955759|NCT02316613|540972135|FG000|Overall Study|Lymphoma transformation|2|||
149955760|NCT02316613|540972135|FG000|Overall Study|Participant moved/changed medical team|11|||
150287776|NCT00774345|542187435|FG000|Treatment|Progressive Disease with histologic transformation|4|||
150287777|NCT00774345|542187436|FG001|Treatment|Progressive Disease with histologic transformation|2|||
150287778|NCT00774345|542187435|FG000|Treatment|Withdrawal by Subject|5|||
150287779|NCT00774345|542187436|FG001|Treatment|Withdrawal by Subject|2|||
150287780|NCT00774345|542187435|FG000|Treatment|Lost to Follow-up|1|||
150287781|NCT00774345|542187436|FG001|Treatment|Lost to Follow-up|1|||
150287782|NCT00774345|542187435|FG000|Treatment|Death|4|||
150287783|NCT00774345|542187436|FG001|Treatment|Death|0|||
150287784|NCT00774345|542187435|FG000|Treatment|Other Reasons|32|||
150287785|NCT00774345|542187436|FG001|Treatment|Other Reasons|26|||
150287786|NCT02054897|542187448|FG000|Overall Study|Withdrawal by Subject|2|||
150287787|NCT02054897|542187449|FG001|Overall Study|Withdrawal by Subject|0|||
150287788|NCT02054897|542187450|FG002|Overall Study|Withdrawal by Subject|2|||
150287789|NCT02054897|542187448|FG000|Overall Study|Missing follow-up information|3|||
150287790|NCT02054897|542187449|FG001|Overall Study|Missing follow-up information|5|||
150287791|NCT02054897|542187450|FG002|Overall Study|Missing follow-up information|3|||
150287792|NCT02054897|542187448|FG000|Overall Study|Lost to Follow-up|4|||
149845464|NCT00112437|540562202|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845465|NCT00112437|540562203|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845466|NCT00112437|540562204|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845467|NCT00112437|540562205|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845468|NCT00112437|540562206|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845469|NCT00112437|540562207|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845470|NCT00112437|540562208|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845471|NCT00112437|540562209|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845472|NCT00112437|540562210|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845473|NCT00112437|540562211|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845474|NCT00112437|540562212|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
149845475|NCT00112437|540562213|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
149845476|NCT00112437|540562214|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845477|NCT00112437|540562215|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845478|NCT00112437|540562216|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845479|NCT00112437|540562217|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
149845480|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845481|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845482|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
150287793|NCT02054897|542187449|FG001|Overall Study|Lost to Follow-up|2|||
150287794|NCT02054897|542187450|FG002|Overall Study|Lost to Follow-up|7|||
150287795|NCT02054897|542187448|FG000|Overall Study|Randomized but not exposed|1|||
150287796|NCT02054897|542187449|FG001|Overall Study|Randomized but not exposed|0|||
149845483|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845484|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845485|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845486|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845487|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149955761|NCT02316613|540972135|FG000|Overall Study|No data and duplicate cases|5|||
149955762|NCT02316613|540972135|FG000|Overall Study|Did not met selection criteria|14|||
149955763|NCT01108796|540972136|FG000|Overall Study|Adverse Event|0|||
149955764|NCT01108796|540972137|FG001|Overall Study|Adverse Event|1|||
149955765|NCT01108796|540972136|FG000|Overall Study|Lost to Follow-up|7|||
149955766|NCT01108796|540972137|FG001|Overall Study|Lost to Follow-up|6|||
149955767|NCT00758043|540972138|FG000|Overall Study|Adverse Event|1|||
149955768|NCT00758043|540972139|FG001|Overall Study|Adverse Event|20|||
149955769|NCT00758043|540972140|FG002|Overall Study|Adverse Event|12|||
149955770|NCT00758043|540972141|FG003|Overall Study|Adverse Event|62|||
149955771|NCT00758043|540972138|FG000|Overall Study|Lack of Efficacy|0|||
149955772|NCT00758043|540972139|FG001|Overall Study|Lack of Efficacy|6|||
149955773|NCT00758043|540972140|FG002|Overall Study|Lack of Efficacy|18|||
149955774|NCT00758043|540972141|FG003|Overall Study|Lack of Efficacy|12|||
149955775|NCT00758043|540972138|FG000|Overall Study|Refused Further Treatment|0|||
149955776|NCT00758043|540972139|FG001|Overall Study|Refused Further Treatment|11|||
149955777|NCT00758043|540972140|FG002|Overall Study|Refused Further Treatment|5|||
150287797|NCT02054897|542187450|FG002|Overall Study|Randomized but not exposed|0|||
150287798|NCT00960843|542187451|FG000|Overall Study|Lost to Follow-up|2|||
150287799|NCT00960843|542187452|FG001|Overall Study|Lost to Follow-up|0|||
150287800|NCT00960843|542187451|FG000|Overall Study|Protocol Violation|0|||
149845488|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149955778|NCT00758043|540972141|FG003|Overall Study|Refused Further Treatment|8|||
149955779|NCT00758043|540972138|FG000|Overall Study|Lost to Follow-up|0|||
149955780|NCT00758043|540972139|FG001|Overall Study|Lost to Follow-up|2|||
150287801|NCT00960843|542187452|FG001|Overall Study|Protocol Violation|4|||
150287802|NCT00960843|542187451|FG000|Overall Study|Repeated needle dislodgment|0|||
150287803|NCT00960843|542187452|FG001|Overall Study|Repeated needle dislodgment|1|||
150287804|NCT00652366|542187453|FG000|Overall Study|Adverse Event|8|||
150287805|NCT00652366|542187454|FG001|Overall Study|Adverse Event|4|||
150287806|NCT00652366|542187455|FG002|Overall Study|Adverse Event|7|||
150287807|NCT00652366|542187456|FG003|Overall Study|Adverse Event|17|||
150287808|NCT00652366|542187457|FG004|Overall Study|Adverse Event|13|||
150287809|NCT00652366|542187453|FG000|Overall Study|Death|5|||
150287810|NCT00652366|542187454|FG001|Overall Study|Death|4|||
150287811|NCT00652366|542187455|FG002|Overall Study|Death|1|||
149845489|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845490|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845491|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845492|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845493|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845494|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845495|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845496|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845497|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845498|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845499|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845500|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845501|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845502|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
149845503|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
149845504|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149845505|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
149845506|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Death|0|||
149845507|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Death|0|||
149845508|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Death|0|||
149845509|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Death|0|||
149845510|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Death|0|||
149845511|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Death|0|||
149845512|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Death|0|||
149845513|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Death|0|||
149845514|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Death|0|||
149845515|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Death|0|||
149845516|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Death|0|||
149845517|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Death|0|||
149845518|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Death|0|||
149845519|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Death|0|||
149845520|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Death|0|||
149845521|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Death|0|||
149845522|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Death|0|||
149845523|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Death|0|||
149845524|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Death|0|||
149845525|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Death|0|||
149845526|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Death|0|||
149845527|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Death|0|||
149845528|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Death|0|||
149845529|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Death|2|||
149845530|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Death|0|||
149845531|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Death|0|||
149845532|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845533|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845534|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845535|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845536|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845537|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
150287812|NCT00652366|542187456|FG003|Overall Study|Death|8|||
150287813|NCT00652366|542187457|FG004|Overall Study|Death|5|||
150287814|NCT00652366|542187453|FG000|Overall Study|Lack of Efficacy|84|||
150287815|NCT00652366|542187454|FG001|Overall Study|Lack of Efficacy|58|||
150287816|NCT00652366|542187455|FG002|Overall Study|Lack of Efficacy|53|||
150287817|NCT00652366|542187456|FG003|Overall Study|Lack of Efficacy|133|||
150287818|NCT00652366|542187457|FG004|Overall Study|Lack of Efficacy|13|||
150036415|NCT05291520|541274385|FG001|Overall Study|Lost to Follow-up|0|||
150036416|NCT05291520|541274386|FG002|Overall Study|Lost to Follow-up|1|||
150036417|NCT01347112|541274387|FG000|Overall Study|Withdrawal by Subject|1|||
150036418|NCT01347112|541274388|FG001|Overall Study|Withdrawal by Subject|7|||
150036419|NCT01347112|541274387|FG000|Overall Study|Lost to Follow-up|3|||
150036420|NCT01347112|541274388|FG001|Overall Study|Lost to Follow-up|5|||
150036421|NCT04639245|541274389|FG000|Overall Study|Death|1|||
150036422|NCT02419001|541274390|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
150036423|NCT02419001|541274391|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
150036424|NCT03591406|541274392|FG000|Overall Study|Adverse Event|5|||
150036425|NCT03591406|541274393|FG001|Overall Study|Adverse Event|3|||
150036426|NCT03591406|541274392|FG000|Overall Study|Protocol Violation|2|||
150036427|NCT03591406|541274393|FG001|Overall Study|Protocol Violation|1|||
150036428|NCT03591406|541274392|FG000|Overall Study|Withdrawal by Subject|0|||
150036429|NCT03591406|541274393|FG001|Overall Study|Withdrawal by Subject|5|||
150036430|NCT02703597|541274419|FG000|Assignment to Baseline|Lost to Follow-up|17|||
150036431|NCT02703597|541274420|FG001|Assignment to Baseline|Lost to Follow-up|16|||
150036432|NCT02703597|541274419|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
150036433|NCT02703597|541274420|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
150036434|NCT02703597|541274419|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
150287819|NCT00652366|542187453|FG000|Overall Study|Violation of Selection Criteria|0|||
150287820|NCT00652366|542187454|FG001|Overall Study|Violation of Selection Criteria|0|||
150287821|NCT00652366|542187455|FG002|Overall Study|Violation of Selection Criteria|1|||
150036435|NCT02703597|541274420|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
150036436|NCT02703597|541274419|FG000|First Post-test to First Follow-up|Site drop out|0|||
150036437|NCT02703597|541274420|FG001|First Post-test to First Follow-up|Site drop out|58|||
150036438|NCT02703597|541274419|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
150036439|NCT02703597|541274420|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
150036440|NCT02703597|541274419|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
150036441|NCT02703597|541274420|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
150036442|NCT02703597|541274419|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
150036443|NCT02703597|541274420|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
150036444|NCT01614886|541274421|FG000|Overall Study|Adverse Event|15|||
150036445|NCT01614886|541274422|FG001|Overall Study|Adverse Event|20|||
150036446|NCT01614886|541274421|FG000|Overall Study|Withdrawal by Subject|4|||
150036447|NCT01614886|541274422|FG001|Overall Study|Withdrawal by Subject|4|||
150036448|NCT01614886|541274421|FG000|Overall Study|Death|1|||
150036449|NCT01614886|541274422|FG001|Overall Study|Death|0|||
150036450|NCT01614886|541274421|FG000|Overall Study|Protocol deviation|0|||
150036451|NCT01614886|541274422|FG001|Overall Study|Protocol deviation|2|||
150036452|NCT02224560|541274426|FG000|Overall Study|Protocol Deviation|1|||
150036453|NCT02224560|541274427|FG001|Overall Study|Protocol Deviation|0|||
150036454|NCT02224560|541274428|FG002|Overall Study|Protocol Deviation|0|||
150036455|NCT02224560|541274426|FG000|Overall Study|Withdrawal by Subject|2|||
150036456|NCT02224560|541274427|FG001|Overall Study|Withdrawal by Subject|0|||
150036457|NCT02224560|541274428|FG002|Overall Study|Withdrawal by Subject|1|||
150036458|NCT02224560|541274426|FG000|Overall Study|Met Withdrawal Criteria|1|||
150036459|NCT02224560|541274427|FG001|Overall Study|Met Withdrawal Criteria|0|||
150036460|NCT02224560|541274428|FG002|Overall Study|Met Withdrawal Criteria|0|||
150036461|NCT02224560|541274426|FG000|Overall Study|Adverse Event|4|||
150036462|NCT02224560|541274427|FG001|Overall Study|Adverse Event|1|||
150287822|NCT00652366|542187456|FG003|Overall Study|Violation of Selection Criteria|0|||
150287823|NCT00652366|542187457|FG004|Overall Study|Violation of Selection Criteria|0|||
150287824|NCT00652366|542187453|FG000|Overall Study|Protocol Violation|1|||
150287825|NCT00652366|542187454|FG001|Overall Study|Protocol Violation|0|||
150287826|NCT00652366|542187455|FG002|Overall Study|Protocol Violation|0|||
150287827|NCT00652366|542187456|FG003|Overall Study|Protocol Violation|0|||
150287828|NCT00652366|542187457|FG004|Overall Study|Protocol Violation|0|||
150287829|NCT00652366|542187453|FG000|Overall Study|Refused treatment|3|||
150287830|NCT00652366|542187454|FG001|Overall Study|Refused treatment|7|||
150287831|NCT00652366|542187455|FG002|Overall Study|Refused treatment|6|||
150036463|NCT02224560|541274428|FG002|Overall Study|Adverse Event|1|||
150036464|NCT02224560|541274426|FG000|Overall Study|Withdrawn by Investigator|1|||
150036465|NCT02224560|541274427|FG001|Overall Study|Withdrawn by Investigator|1|||
150036466|NCT02224560|541274428|FG002|Overall Study|Withdrawn by Investigator|0|||
150036467|NCT01523366|541274429|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150036468|NCT01523366|541274430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150036469|NCT01523366|541274429|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
150036470|NCT01523366|541274430|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
150036471|NCT01352715|541274431|FG000|Overall Study|Death|3|||
150036472|NCT01352715|541274432|FG001|Overall Study|Death|3|||
150036473|NCT01352715|541274431|FG000|Overall Study|Lost to Follow-up|5|||
150036474|NCT01352715|541274432|FG001|Overall Study|Lost to Follow-up|7|||
150036475|NCT01352715|541274431|FG000|Overall Study|Withdrawal by Subject|4|||
150036476|NCT01352715|541274432|FG001|Overall Study|Withdrawal by Subject|8|||
150036477|NCT01352715|541274431|FG000|Overall Study|site closure|16|||
150036478|NCT01352715|541274432|FG001|Overall Study|site closure|15|||
150036479|NCT01352715|541274431|FG000|Overall Study|no final visit in closeout period|15|||
150036480|NCT01352715|541274432|FG001|Overall Study|no final visit in closeout period|12|||
150036481|NCT01352715|541274431|FG000|Overall Study|major ineligibility|2|||
150036482|NCT01352715|541274432|FG001|Overall Study|major ineligibility|1|||
150036483|NCT01690143|541274441|FG000|Overall Study|Withdrawal by Subject|1|||
150036484|NCT01710345|541274443|FG000|Overall Study|Adverse Event|0|||
150036485|NCT01710345|541274444|FG001|Overall Study|Adverse Event|2|||
150036486|NCT01710345|541274445|FG002|Overall Study|Adverse Event|0|||
150036487|NCT01710345|541274443|FG000|Overall Study|Lack of Efficacy|2|||
150036488|NCT01710345|541274444|FG001|Overall Study|Lack of Efficacy|3|||
150036489|NCT01710345|541274445|FG002|Overall Study|Lack of Efficacy|1|||
150036490|NCT01710345|541274443|FG000|Overall Study|Drug Dosing Error|1|||
150036491|NCT01710345|541274444|FG001|Overall Study|Drug Dosing Error|0|||
150036492|NCT01710345|541274445|FG002|Overall Study|Drug Dosing Error|0|||
150036493|NCT01052493|541274447|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
150036494|NCT01052493|541274448|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
150036495|NCT01052493|541274449|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
150036496|NCT03944577|541274453|FG000|Overall Study|Adverse Event|3|||
150036497|NCT00551642|541274454|FG000|Treatment Period|Protocol Deviation|6|||
150036498|NCT00551642|541274455|FG001|Treatment Period|Protocol Deviation|11|||
150036499|NCT00551642|541274454|FG000|Treatment Period|Delivery device failure|1|||
150036500|NCT00551642|541274455|FG001|Treatment Period|Delivery device failure|3|||
150036501|NCT00551642|541274454|FG000|Treatment Period|Physician Decision|0|||
150036502|NCT00551642|541274455|FG001|Treatment Period|Physician Decision|1|||
150036503|NCT00551642|541274454|FG000|Treatment Period|Death|33|||
150036504|NCT00551642|541274455|FG001|Treatment Period|Death|31|||
150036505|NCT00551642|541274454|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
150036506|NCT00551642|541274455|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
150036507|NCT00551642|541274454|FG000|Treatment Period|Adverse Event|15|||
150036508|NCT00551642|541274455|FG001|Treatment Period|Adverse Event|12|||
150036509|NCT00551642|541274454|FG000|Treatment Period|Withdrawal by Subject|2|||
150036510|NCT00551642|541274455|FG001|Treatment Period|Withdrawal by Subject|1|||
150036511|NCT00391586|541274456|FG000|Overall Study|Progressive disease|13|||
150036512|NCT00391586|541274456|FG000|Overall Study|Adverse Event|5|||
150036513|NCT00391586|541274456|FG000|Overall Study|Physician Decision|2|||
150036514|NCT00391586|541274456|FG000|Overall Study|Death|4|||
150036515|NCT00198822|541274457|FG000|Overall Study|Lost to Follow-up|14|||
150036516|NCT00198822|541274458|FG001|Overall Study|Lost to Follow-up|20|||
150036517|NCT00198822|541274459|FG002|Overall Study|Lost to Follow-up|21|||
150036518|NCT03011099|541274460|FG000|Overall Study|Withdrawal by Subject|0|||
150036519|NCT03011099|541274461|FG001|Overall Study|Withdrawal by Subject|2|||
150036520|NCT00283296|541274467|FG000|Overall Study|in-home trial not completed|5|||
150036521|NCT01353898|541274468|FG000|Overall Study|Study site terminated|0|||
150036522|NCT01353898|541274469|FG001|Overall Study|Study site terminated|0|||
150036523|NCT01353898|541274470|FG002|Overall Study|Study site terminated|0|||
150036524|NCT01353898|541274471|FG003|Overall Study|Study site terminated|0|||
150036525|NCT01353898|541274472|FG004|Overall Study|Study site terminated|0|||
150036526|NCT01353898|541274473|FG005|Overall Study|Study site terminated|1|||
150036527|NCT02668653|541274474|FG000|Overall Study|Refractory disease|41|||
150036528|NCT02668653|541274475|FG001|Overall Study|Refractory disease|70|||
150287832|NCT00652366|542187456|FG003|Overall Study|Refused treatment|17|||
150287833|NCT00652366|542187457|FG004|Overall Study|Refused treatment|5|||
150287834|NCT00652366|542187453|FG000|Overall Study|Other|5|||
150287835|NCT00652366|542187454|FG001|Overall Study|Other|2|||
150287836|NCT00652366|542187455|FG002|Overall Study|Other|3|||
150287837|NCT00652366|542187456|FG003|Overall Study|Other|4|||
150287838|NCT00652366|542187457|FG004|Overall Study|Other|0|||
150036529|NCT02668653|541274474|FG000|Overall Study|Relapse|44|||
150036530|NCT02668653|541274475|FG001|Overall Study|Relapse|65|||
150036531|NCT02668653|541274474|FG000|Overall Study|Adverse Event|58|||
150036532|NCT02668653|541274475|FG001|Overall Study|Adverse Event|23|||
150036533|NCT02668653|541274474|FG000|Overall Study|Subject decision to stop study drug|25|||
150036534|NCT02668653|541274475|FG001|Overall Study|Subject decision to stop study drug|23|||
150036535|NCT02668653|541274474|FG000|Overall Study|Other reasons not specified|16|||
150036536|NCT02668653|541274475|FG001|Overall Study|Other reasons not specified|11|||
150036537|NCT02668653|541274474|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
150036538|NCT02668653|541274475|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
150036539|NCT02668653|541274474|FG000|Overall Study|Investigator decision|10|||
150036540|NCT02668653|541274475|FG001|Overall Study|Investigator decision|7|||
150287839|NCT01967537|542187460|FG000|Overall Study|Withdrawal by Subject|52|||
149845538|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845539|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845540|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845541|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845542|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845543|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845544|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845545|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845546|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845547|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845548|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845549|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845550|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845551|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845552|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845553|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845554|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845555|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845556|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
149845557|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
149845558|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Other|0|||
149845559|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Other|0|||
149845560|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Other|0|||
149845561|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Other|0|||
149845562|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Other|0|||
149845563|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Other|0|||
149845564|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Other|0|||
149845565|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Other|0|||
149845566|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Other|0|||
149845567|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Other|0|||
149845568|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Other|0|||
149845569|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Other|0|||
149845570|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Other|0|||
149845571|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Other|0|||
149845572|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Other|0|||
149845573|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Other|0|||
149845574|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Other|0|||
149845575|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Other|0|||
149845576|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Other|0|||
149845577|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Other|0|||
149845578|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Other|0|||
149845579|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Other|0|||
149845580|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Other|0|||
149845581|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Other|0|||
149845582|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Other|1|||
149845583|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Other|0|||
149845584|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845585|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845586|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845587|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845588|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845589|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845590|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845591|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845592|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845593|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845594|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845595|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845596|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845597|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845598|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149955781|NCT00758043|540972140|FG002|Overall Study|Lost to Follow-up|2|||
149955782|NCT00758043|540972141|FG003|Overall Study|Lost to Follow-up|5|||
149955783|NCT00758043|540972138|FG000|Overall Study|Withdrawal by Subject|0|||
149955784|NCT00758043|540972139|FG001|Overall Study|Withdrawal by Subject|1|||
149845599|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845600|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845601|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845602|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149955785|NCT00758043|540972140|FG002|Overall Study|Withdrawal by Subject|1|||
149955786|NCT00758043|540972141|FG003|Overall Study|Withdrawal by Subject|4|||
149845603|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845604|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845605|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845606|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149955787|NCT00758043|540972138|FG000|Overall Study|Required Prohibited Medication|0|||
149955788|NCT00758043|540972139|FG001|Overall Study|Required Prohibited Medication|0|||
149955789|NCT00758043|540972140|FG002|Overall Study|Required Prohibited Medication|1|||
149955790|NCT00758043|540972141|FG003|Overall Study|Required Prohibited Medication|3|||
149955791|NCT00758043|540972138|FG000|Overall Study|Non-Compliant With study Drug|0|||
149955792|NCT00758043|540972139|FG001|Overall Study|Non-Compliant With study Drug|0|||
149955793|NCT00758043|540972140|FG002|Overall Study|Non-Compliant With study Drug|0|||
149955794|NCT00758043|540972141|FG003|Overall Study|Non-Compliant With study Drug|1|||
149955795|NCT00758043|540972138|FG000|Overall Study|Other Reasons|0|||
149955796|NCT00758043|540972139|FG001|Overall Study|Other Reasons|1|||
149955797|NCT00758043|540972140|FG002|Overall Study|Other Reasons|0|||
149955798|NCT00758043|540972141|FG003|Overall Study|Other Reasons|5|||
149955799|NCT02545127|540972142|FG000|Overall Study|Lost to Follow-up|1|||
149955800|NCT02545127|540972143|FG001|Overall Study|Lost to Follow-up|0|||
149955801|NCT05788328|540972144|FG000|Treatment Period 4 (5 Days)|Other|1|||
149955802|NCT05788328|540972144|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
149955803|NCT03197935|540972150|FG000|Overall Study|Death due to any cause|26|||
149955804|NCT03197935|540972151|FG001|Overall Study|Death due to any cause|15|||
149955805|NCT03197935|540972150|FG000|Overall Study|Lost to Follow-up|3|||
149955806|NCT03197935|540972151|FG001|Overall Study|Lost to Follow-up|5|||
149955807|NCT03197935|540972150|FG000|Overall Study|Physician Decision|2|||
150036541|NCT02668653|541274474|FG000|Overall Study|Failure to meet continuation criteria|5|||
150036542|NCT02668653|541274475|FG001|Overall Study|Failure to meet continuation criteria|12|||
149845607|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
149845608|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845609|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
149845610|NCT00112437|540562192|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845611|NCT00112437|540562193|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845612|NCT00112437|540562194|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845613|NCT00112437|540562195|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845614|NCT00112437|540562196|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845615|NCT00112437|540562197|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845616|NCT00112437|540562198|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845617|NCT00112437|540562199|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845618|NCT00112437|540562200|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845619|NCT00112437|540562201|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845620|NCT00112437|540562202|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845621|NCT00112437|540562203|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845622|NCT00112437|540562204|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845623|NCT00112437|540562205|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845624|NCT00112437|540562206|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845625|NCT00112437|540562207|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845626|NCT00112437|540562208|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845627|NCT00112437|540562209|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845628|NCT00112437|540562210|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845629|NCT00112437|540562211|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845630|NCT00112437|540562212|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845631|NCT00112437|540562213|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845632|NCT00112437|540562214|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
149845633|NCT00112437|540562215|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
149845634|NCT00112437|540562216|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
149845635|NCT00112437|540562217|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
149845636|NCT01824576|540562219|FG000|Overall Study|Device deficiency|2|||
149845637|NCT03218787|540562223|FG000|Overall Study|Lost to Follow-up|12|||
149845638|NCT03218787|540562223|FG000|Overall Study|Withdrawal by Subject|72|||
149845639|NCT03218787|540562223|FG000|Overall Study|Physician Decision|11|||
149845640|NCT03218787|540562223|FG000|Overall Study|Death|111|||
149845641|NCT00147498|540562224|FG000|Overall Study|Adverse Event|1|||
149955808|NCT03197935|540972151|FG001|Overall Study|Physician Decision|1|||
149955809|NCT03197935|540972150|FG000|Overall Study|Withdrawal by Subject|16|||
149955810|NCT03197935|540972151|FG001|Overall Study|Withdrawal by Subject|8|||
150036543|NCT02668653|541274474|FG000|Overall Study|Lost to Follow-up|1|||
149845642|NCT00147498|540562225|FG001|Overall Study|Adverse Event|6|||
149845643|NCT00147498|540562226|FG002|Overall Study|Adverse Event|7|||
149845644|NCT00147498|540562227|FG003|Overall Study|Adverse Event|3|||
149845645|NCT00147498|540562224|FG000|Overall Study|Lack of Efficacy|1|||
150036544|NCT02668653|541274475|FG001|Overall Study|Lost to Follow-up|0|||
149845646|NCT00147498|540562225|FG001|Overall Study|Lack of Efficacy|1|||
149845647|NCT00147498|540562226|FG002|Overall Study|Lack of Efficacy|1|||
149955811|NCT00145327|540972152|FG000|Overall Study|Withdrawal by Subject|77|||
149955812|NCT00145327|540972153|FG001|Overall Study|Withdrawal by Subject|72|||
149955813|NCT00145327|540972154|FG002|Overall Study|Withdrawal by Subject|164|||
149955814|NCT00145327|540972152|FG000|Overall Study|Death|26|||
149955815|NCT00145327|540972153|FG001|Overall Study|Death|18|||
149955816|NCT00145327|540972154|FG002|Overall Study|Death|30|||
149955817|NCT00145327|540972152|FG000|Overall Study|Adverse Event|14|||
149955818|NCT00145327|540972153|FG001|Overall Study|Adverse Event|11|||
149955819|NCT00145327|540972154|FG002|Overall Study|Adverse Event|22|||
149955820|NCT00145327|540972152|FG000|Overall Study|Lost to Follow-up|9|||
149955821|NCT00145327|540972153|FG001|Overall Study|Lost to Follow-up|14|||
149955822|NCT00145327|540972154|FG002|Overall Study|Lost to Follow-up|14|||
149955823|NCT00145327|540972152|FG000|Overall Study|Administrative problems|12|||
149955824|NCT00145327|540972153|FG001|Overall Study|Administrative problems|9|||
149955825|NCT00145327|540972154|FG002|Overall Study|Administrative problems|13|||
149955826|NCT00145327|540972152|FG000|Overall Study|Protocol Violation|2|||
149955827|NCT00145327|540972153|FG001|Overall Study|Protocol Violation|0|||
149955828|NCT00145327|540972154|FG002|Overall Study|Protocol Violation|2|||
149955829|NCT00145327|540972152|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149955830|NCT00145327|540972153|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149955831|NCT00145327|540972154|FG002|Overall Study|Abnormal laboratory value(s)|2|||
149955832|NCT00145327|540972152|FG000|Overall Study|Missing - not stated|1|||
149955833|NCT00145327|540972153|FG001|Overall Study|Missing - not stated|0|||
149955834|NCT00145327|540972154|FG002|Overall Study|Missing - not stated|1|||
149955835|NCT00960856|540972156|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149955836|NCT00960856|540972157|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
149955837|NCT00960856|540972158|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
149955838|NCT00960856|540972159|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
150287840|NCT01967537|542187460|FG000|Overall Study|Refuse treatment|2|||
150287841|NCT01967537|542187460|FG000|Overall Study|Lost to Follow-up|6|||
150287842|NCT04703075|542187461|FG000|Overall Study|Adverse Event|11|||
150287843|NCT04703075|542187462|FG001|Overall Study|Adverse Event|7|||
150287844|NCT04703075|542187461|FG000|Overall Study|Lost to Follow-up|6|||
150287845|NCT04703075|542187462|FG001|Overall Study|Lost to Follow-up|12|||
149845648|NCT00147498|540562227|FG003|Overall Study|Lack of Efficacy|8|||
149845649|NCT00147498|540562224|FG000|Overall Study|Laboratory abnormality|0|||
149845650|NCT00147498|540562225|FG001|Overall Study|Laboratory abnormality|0|||
149845651|NCT00147498|540562226|FG002|Overall Study|Laboratory abnormality|2|||
149845652|NCT00147498|540562227|FG003|Overall Study|Laboratory abnormality|0|||
149845653|NCT00147498|540562224|FG000|Overall Study|Participant defaulted|0|||
149845654|NCT00147498|540562225|FG001|Overall Study|Participant defaulted|1|||
149845655|NCT00147498|540562226|FG002|Overall Study|Participant defaulted|4|||
149845656|NCT00147498|540562227|FG003|Overall Study|Participant defaulted|3|||
149845657|NCT00147498|540562224|FG000|Overall Study|Other|1|||
149845658|NCT00147498|540562225|FG001|Overall Study|Other|1|||
149845659|NCT00147498|540562226|FG002|Overall Study|Other|3|||
149845660|NCT00147498|540562227|FG003|Overall Study|Other|3|||
149845661|NCT01229150|540562228|FG000|Overall Study|Toxicity|2|||
149845662|NCT01229150|540562229|FG001|Overall Study|Toxicity|2|||
149845663|NCT01229150|540562230|FG002|Overall Study|Toxicity|0|||
149845664|NCT01229150|540562231|FG003|Overall Study|Toxicity|0|||
149845665|NCT03531827|540562232|FG000|Overall Study|Adverse Event|2|||
149845666|NCT03531827|540562233|FG001|Overall Study|Adverse Event|0|||
149845667|NCT03531827|540562232|FG000|Overall Study|Progressive disease|1|||
149845668|NCT03531827|540562233|FG001|Overall Study|Progressive disease|0|||
149845669|NCT01494532|540562234|FG000|Overall Study|Adverse Event|4|||
149845670|NCT01494532|540562235|FG001|Overall Study|Adverse Event|1|||
149845671|NCT01494532|540562236|FG002|Overall Study|Adverse Event|8|||
149845672|NCT01494532|540562237|FG003|Overall Study|Adverse Event|6|||
149845673|NCT01494532|540562238|FG004|Overall Study|Adverse Event|5|||
149845674|NCT01494532|540562239|FG005|Overall Study|Adverse Event|0|||
149845675|NCT01494532|540562234|FG000|Overall Study|Lack of Efficacy|0|||
149845676|NCT01494532|540562235|FG001|Overall Study|Lack of Efficacy|0|||
149845677|NCT01494532|540562236|FG002|Overall Study|Lack of Efficacy|0|||
149845678|NCT01494532|540562237|FG003|Overall Study|Lack of Efficacy|0|||
149845679|NCT01494532|540562238|FG004|Overall Study|Lack of Efficacy|2|||
149955839|NCT00960856|540972156|FG000|Washout Period of 7 Days|Adverse Event|0|||
149955840|NCT00960856|540972157|FG001|Washout Period of 7 Days|Adverse Event|0|||
150287846|NCT04703075|542187461|FG000|Overall Study|Physician Decision|3|||
149845680|NCT01494532|540562239|FG005|Overall Study|Lack of Efficacy|0|||
149845681|NCT01494532|540562234|FG000|Overall Study|Protocol deviation|2|||
149845682|NCT01494532|540562235|FG001|Overall Study|Protocol deviation|1|||
149845683|NCT01494532|540562236|FG002|Overall Study|Protocol deviation|3|||
149845684|NCT01494532|540562237|FG003|Overall Study|Protocol deviation|2|||
149845685|NCT01494532|540562238|FG004|Overall Study|Protocol deviation|3|||
149845686|NCT01494532|540562239|FG005|Overall Study|Protocol deviation|0|||
149845687|NCT01494532|540562234|FG000|Overall Study|Protocol-defined stopping criteria|0|||
150036545|NCT02668653|541274474|FG000|Overall Study|Pregnancy|0|||
150036546|NCT02668653|541274475|FG001|Overall Study|Pregnancy|1|||
150036547|NCT02668653|541274474|FG000|Overall Study|Death|0|||
150036548|NCT02668653|541274475|FG001|Overall Study|Death|1|||
150036549|NCT03558737|541274476|FG000|Overall Study|Death|1|||
150036550|NCT03558737|541274477|FG001|Overall Study|Death|1|||
150036551|NCT01294553|541274478|FG000|Overall Study|Duplicated Participants|1|||
150036552|NCT01294553|541274478|FG000|Overall Study|Protocol Violation|268|||
150036553|NCT01217229|541274479|FG000|Overall Study|Adverse Event|1|||
150036554|NCT01217229|541274479|FG000|Overall Study|Disease progression, deterioration|2|||
150036555|NCT01217229|541274479|FG000|Overall Study|Disease progression, Cheson criteria|14|||
150036556|NCT01217229|541274479|FG000|Overall Study|Protocol Violation|1|||
150036557|NCT01217229|541274479|FG000|Overall Study|Disease progression not confirmed|2|||
150036558|NCT00453206|541274481|FG000|Overall Study|Death|1|||
150036559|NCT00577889|541274483|FG000|Overall Study|Withdrawal by Subject|1|||
150036560|NCT00577889|541274484|FG001|Overall Study|Withdrawal by Subject|0|||
150036561|NCT00577889|541274485|FG002|Overall Study|Withdrawal by Subject|0|||
150036562|NCT03041181|541274486|FG000|Overall Study|Disease Progression|1|||
150036563|NCT03041181|541274487|FG001|Overall Study|Disease Progression|2|||
150036564|NCT00005780|541274490|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
150036565|NCT04973449|541274491|FG000|Overall Study|Withdrawal by Subject|3|||
150036566|NCT04973449|541274492|FG001|Overall Study|Withdrawal by Subject|3|||
150036567|NCT04973449|541274493|FG002|Overall Study|Withdrawal by Subject|2|||
150036568|NCT04973449|541274494|FG003|Overall Study|Withdrawal by Subject|5|||
150036569|NCT04973449|541274495|FG004|Overall Study|Withdrawal by Subject|5|||
150036570|NCT04973449|541274496|FG005|Overall Study|Withdrawal by Subject|4|||
150036571|NCT04973449|541274497|FG006|Overall Study|Withdrawal by Subject|7|||
150036572|NCT04973449|541274498|FG007|Overall Study|Withdrawal by Subject|5|||
150036573|NCT04973449|541274491|FG000|Overall Study|Lost to Follow-up|15|||
150036574|NCT04973449|541274492|FG001|Overall Study|Lost to Follow-up|16|||
150036575|NCT04973449|541274493|FG002|Overall Study|Lost to Follow-up|16|||
150036576|NCT04973449|541274494|FG003|Overall Study|Lost to Follow-up|13|||
150036577|NCT04973449|541274495|FG004|Overall Study|Lost to Follow-up|5|||
150036578|NCT04973449|541274496|FG005|Overall Study|Lost to Follow-up|6|||
150036579|NCT04973449|541274497|FG006|Overall Study|Lost to Follow-up|10|||
150036580|NCT04973449|541274498|FG007|Overall Study|Lost to Follow-up|6|||
150036581|NCT04973449|541274491|FG000|Overall Study|Death|1|||
150036582|NCT04973449|541274492|FG001|Overall Study|Death|0|||
150036583|NCT04973449|541274493|FG002|Overall Study|Death|0|||
150036584|NCT04973449|541274494|FG003|Overall Study|Death|0|||
150036585|NCT04973449|541274495|FG004|Overall Study|Death|0|||
150036586|NCT04973449|541274496|FG005|Overall Study|Death|1|||
150036587|NCT04973449|541274497|FG006|Overall Study|Death|0|||
150036588|NCT04973449|541274498|FG007|Overall Study|Death|0|||
150036589|NCT04973449|541274491|FG000|Overall Study|Other|1|||
150036590|NCT04973449|541274492|FG001|Overall Study|Other|1|||
150036591|NCT04973449|541274493|FG002|Overall Study|Other|2|||
150036592|NCT04973449|541274494|FG003|Overall Study|Other|1|||
150036593|NCT04973449|541274495|FG004|Overall Study|Other|4|||
150036594|NCT04973449|541274496|FG005|Overall Study|Other|0|||
150036595|NCT04973449|541274497|FG006|Overall Study|Other|2|||
150036596|NCT04973449|541274498|FG007|Overall Study|Other|2|||
150036597|NCT01467960|541274499|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
150036598|NCT01467960|541274500|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
150036599|NCT01467960|541274501|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
150036600|NCT01467960|541274502|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
150036601|NCT01467960|541274503|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
150036602|NCT01467960|541274504|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
150036603|NCT00888173|541274505|FG000|Overall Study|Wrong Primary|1|||
150036604|NCT00888173|541274505|FG000|Overall Study|Ineligible: required test not done|1|||
150036605|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
150036606|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
150036607|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
150036608|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
150036609|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Adverse Event|2|||
150036610|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Adverse Event|5|||
150036611|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Adverse Event|1|||
150036612|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Adverse Event|2|||
150036613|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Death|13|||
150036614|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Death|17|||
150036615|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Death|1|||
150036616|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Death|0|||
150036617|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
150036618|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
150036619|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
150036620|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
150036621|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Disease Progression|2|||
149845688|NCT01494532|540562235|FG001|Overall Study|Protocol-defined stopping criteria|0|||
149845689|NCT01494532|540562236|FG002|Overall Study|Protocol-defined stopping criteria|1|||
149845690|NCT01494532|540562237|FG003|Overall Study|Protocol-defined stopping criteria|0|||
149845691|NCT01494532|540562238|FG004|Overall Study|Protocol-defined stopping criteria|0|||
149845692|NCT01494532|540562239|FG005|Overall Study|Protocol-defined stopping criteria|0|||
149845693|NCT01494532|540562234|FG000|Overall Study|Lost to Follow-up|1|||
149845694|NCT01494532|540562235|FG001|Overall Study|Lost to Follow-up|0|||
149845695|NCT01494532|540562236|FG002|Overall Study|Lost to Follow-up|0|||
149845696|NCT01494532|540562237|FG003|Overall Study|Lost to Follow-up|2|||
149955841|NCT00960856|540972158|FG002|Washout Period of 7 Days|Adverse Event|1|||
149955842|NCT00960856|540972159|FG003|Washout Period of 7 Days|Adverse Event|0|||
149955843|NCT04027946|540972160|FG000|Overall Study|Screen failures|3|||
149955844|NCT03315689|540972165|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
149955845|NCT03315689|540972166|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
149955846|NCT03315689|540972165|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
149955847|NCT03315689|540972166|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
149955848|NCT03315689|540972165|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
149955849|NCT03315689|540972166|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
149955850|NCT00864513|540972167|FG000|Overall Study|Withdrawal by Subject|3|||
149955851|NCT05938010|540972168|FG000|Overall Study|Lost to Follow-up|2|||
149955852|NCT00985192|540972170|FG000|Overall Study|Withdrawal by Subject|1|||
149955853|NCT00985192|540972170|FG000|Overall Study|Disease Progression|1|||
149955854|NCT00985192|540972170|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
149955855|NCT01348698|540972173|FG000|Overall Study|Does not meet lesion size criteria|1|||
149955856|NCT01348698|540972173|FG000|Overall Study|Death|3|||
149955857|NCT01348698|540972173|FG000|Overall Study|PI decision to close study|68|||
149955858|NCT02595749|540972174|FG000|Overall Study|Withdrawal by Subject|12|||
149955859|NCT02595749|540972175|FG001|Overall Study|Withdrawal by Subject|7|||
149955860|NCT00669331|540972176|FG000|Randomisation to First Dose|Adverse Event|1|||
149955861|NCT00669331|540972177|FG001|Randomisation to First Dose|Adverse Event|0|||
149955862|NCT00669331|540972176|FG000|Randomisation to First Dose|Protocol Violation|1|||
149955863|NCT00669331|540972177|FG001|Randomisation to First Dose|Protocol Violation|0|||
149955864|NCT00669331|540972176|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
149955865|NCT00669331|540972177|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
149955866|NCT00669331|540972176|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
149955867|NCT00669331|540972177|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
149955868|NCT00669331|540972176|FG000|Randomisation to First Dose|Death|1|||
149955869|NCT00669331|540972177|FG001|Randomisation to First Dose|Death|0|||
149955870|NCT00669331|540972176|FG000|Randomisation to First Dose|Sponsor decision|0|||
149955871|NCT00669331|540972177|FG001|Randomisation to First Dose|Sponsor decision|1|||
149955872|NCT00669331|540972176|FG000|Randomisation to First Dose|Randomised in error|3|||
149955873|NCT00669331|540972177|FG001|Randomisation to First Dose|Randomised in error|10|||
149955874|NCT00669331|540972176|FG000|Blinded Treatment Period|Adverse Event|16|||
149955875|NCT00669331|540972177|FG001|Blinded Treatment Period|Adverse Event|10|||
149955876|NCT00669331|540972176|FG000|Blinded Treatment Period|Protocol Violation|1|||
149955877|NCT00669331|540972177|FG001|Blinded Treatment Period|Protocol Violation|1|||
149955878|NCT00669331|540972176|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
149955879|NCT00669331|540972177|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
149955880|NCT00669331|540972176|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
149955881|NCT00669331|540972177|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
149955882|NCT00669331|540972176|FG000|Blinded Treatment Period|Death|0|||
149955883|NCT00669331|540972177|FG001|Blinded Treatment Period|Death|2|||
149955884|NCT00669331|540972176|FG000|Blinded Treatment Period|Physician Decision|3|||
149955885|NCT00669331|540972177|FG001|Blinded Treatment Period|Physician Decision|3|||
149955886|NCT00669331|540972176|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
149955887|NCT00669331|540972177|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
149955888|NCT01454063|540972178|FG000|Randomized|Adverse Event|1|||
149955889|NCT01454063|540972179|FG001|Randomized|Adverse Event|1|||
149955890|NCT01454063|540972178|FG000|Randomized|Protocol Violation|0|||
149955891|NCT01454063|540972179|FG001|Randomized|Protocol Violation|1|||
149955892|NCT01562444|540972184|FG000|Overall Study|Did not meet entry criteria|2|||
149955893|NCT01562444|540972185|FG001|Overall Study|Did not meet entry criteria|0|||
149955894|NCT01562444|540972186|FG002|Overall Study|Did not meet entry criteria|3|||
149955895|NCT01562444|540972184|FG000|Overall Study|Did not comply with blood draw schedule|1|||
149955896|NCT01562444|540972185|FG001|Overall Study|Did not comply with blood draw schedule|0|||
149955897|NCT01562444|540972186|FG002|Overall Study|Did not comply with blood draw schedule|1|||
149955898|NCT01562444|540972184|FG000|Overall Study|Unavailable serological results|0|||
150036622|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Disease Progression|0|||
149845697|NCT01494532|540562238|FG004|Overall Study|Lost to Follow-up|0|||
149845698|NCT01494532|540562239|FG005|Overall Study|Lost to Follow-up|0|||
149845699|NCT01494532|540562234|FG000|Overall Study|Physician Decision|0|||
149845700|NCT01494532|540562235|FG001|Overall Study|Physician Decision|1|||
149845701|NCT01494532|540562236|FG002|Overall Study|Physician Decision|1|||
149845702|NCT01494532|540562237|FG003|Overall Study|Physician Decision|2|||
149845703|NCT01494532|540562238|FG004|Overall Study|Physician Decision|0|||
149845704|NCT01494532|540562239|FG005|Overall Study|Physician Decision|0|||
149845705|NCT01494532|540562234|FG000|Overall Study|Withdrawal by Subject|3|||
149845706|NCT01494532|540562235|FG001|Overall Study|Withdrawal by Subject|1|||
149845707|NCT01494532|540562236|FG002|Overall Study|Withdrawal by Subject|4|||
149845708|NCT01494532|540562237|FG003|Overall Study|Withdrawal by Subject|3|||
149845709|NCT01494532|540562238|FG004|Overall Study|Withdrawal by Subject|2|||
149845710|NCT01494532|540562239|FG005|Overall Study|Withdrawal by Subject|0|||
149845711|NCT00849797|540562240|FG000|First Intervention|bad veins|1|||
149845712|NCT00849797|540562241|FG001|First Intervention|bad veins|0|||
149845713|NCT00849797|540562240|FG000|First Intervention|Adverse Event|0|||
149845714|NCT00849797|540562241|FG001|First Intervention|Adverse Event|1|||
149845715|NCT00849797|540562240|FG000|Washout: One Week|Withdrawal by Subject|0|||
149845716|NCT00849797|540562241|FG001|Washout: One Week|Withdrawal by Subject|2|||
149845717|NCT00679081|540562242|FG000|Overall Study|Lost to Follow-up|1|||
149845718|NCT03500094|540562243|FG000|Overall Study|Withdrawal by Subject|1|||
149845719|NCT03500094|540562243|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
149845720|NCT03500094|540562243|FG000|Overall Study|Lost to Follow-up|1|||
149845721|NCT00829764|540562244|FG000|First Intervention|Adverse Event|1|||
149845722|NCT00829764|540562245|FG001|First Intervention|Adverse Event|0|||
149845723|NCT00829764|540562244|FG000|First Intervention|Withdrawal by Subject|1|||
149845724|NCT00829764|540562245|FG001|First Intervention|Withdrawal by Subject|1|||
149845725|NCT04594252|540562246|FG000|Overall Study|Adverse Event|0|||
149845726|NCT04594252|540562247|FG001|Overall Study|Adverse Event|2|||
149845727|NCT03506633|540564565|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
149845728|NCT03506633|540564566|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
149845729|NCT00258856|540564570|FG000|Overall Study|Lost to Follow-up|1|||
149845730|NCT00258856|540564571|FG001|Overall Study|Lost to Follow-up|0|||
149845731|NCT00258856|540564572|FG002|Overall Study|Lost to Follow-up|2|||
149845732|NCT00258856|540564573|FG003|Overall Study|Lost to Follow-up|0|||
149845733|NCT00258856|540564570|FG000|Overall Study|Non-compliance|2|||
149845734|NCT00258856|540564571|FG001|Overall Study|Non-compliance|0|||
149845735|NCT00258856|540564572|FG002|Overall Study|Non-compliance|0|||
149845736|NCT00258856|540564573|FG003|Overall Study|Non-compliance|1|||
149845737|NCT03247686|540564574|FG000|Overall Study|Withdrawal by Subject|1|||
149845738|NCT03247686|540564575|FG001|Overall Study|Withdrawal by Subject|2|||
149845739|NCT01109849|540564578|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
149845740|NCT01109849|540564579|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
149845741|NCT01109849|540564580|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
149845742|NCT01109849|540564581|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
149845743|NCT01109849|540564582|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
149845744|NCT01109849|540564578|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
149845745|NCT01109849|540564579|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
149845746|NCT01109849|540564580|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
149845747|NCT01109849|540564581|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
149845748|NCT01109849|540564582|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
149845749|NCT01109849|540564578|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
149845750|NCT01109849|540564579|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
149845751|NCT01109849|540564580|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
149845752|NCT01109849|540564581|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
149845753|NCT01109849|540564582|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
149845754|NCT01109849|540564578|FG000|Initial Randomization: ADHD Treatment|move away|2|||
149845755|NCT01109849|540564579|FG001|Initial Randomization: ADHD Treatment|move away|7|||
149845756|NCT01109849|540564580|FG002|Initial Randomization: ADHD Treatment|move away|0|||
149845757|NCT01109849|540564581|FG003|Initial Randomization: ADHD Treatment|move away|0|||
149845758|NCT01109849|540564582|FG004|Initial Randomization: ADHD Treatment|move away|0|||
149845759|NCT01109849|540564578|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
149845760|NCT01109849|540564579|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
149845761|NCT01109849|540564580|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
149845762|NCT01109849|540564581|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
149845763|NCT01109849|540564582|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
149845764|NCT01109849|540564578|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
149845765|NCT01109849|540564579|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
149845766|NCT01109849|540564580|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
149845767|NCT01109849|540564581|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
149845768|NCT01109849|540564582|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
149845769|NCT01541215|540564590|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
149845770|NCT01541215|540564591|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
149845771|NCT01541215|540564590|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
149845772|NCT01541215|540564591|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
149845773|NCT01541215|540564590|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
149845774|NCT01541215|540564591|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
149845775|NCT01541215|540564590|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
149845776|NCT01541215|540564591|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
149845777|NCT01541215|540564590|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
149845778|NCT01541215|540564591|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
149845779|NCT01541215|540564590|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
149845780|NCT01541215|540564591|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
149845781|NCT02316223|540564602|FG000|Overall Study|Lack of Efficacy|0|||
149845782|NCT02316223|540564603|FG001|Overall Study|Lack of Efficacy|1|||
149845783|NCT02316223|540564604|FG002|Overall Study|Lack of Efficacy|1|||
149845784|NCT02316223|540564602|FG000|Overall Study|Lost to Follow-up|27|||
149845785|NCT02316223|540564603|FG001|Overall Study|Lost to Follow-up|34|||
149845786|NCT02316223|540564604|FG002|Overall Study|Lost to Follow-up|36|||
149845787|NCT02316223|540564602|FG000|Overall Study|COPD Diagnosis|3|||
149845788|NCT02316223|540564603|FG001|Overall Study|COPD Diagnosis|2|||
149845789|NCT02316223|540564604|FG002|Overall Study|COPD Diagnosis|3|||
149845790|NCT02316223|540564602|FG000|Overall Study|Reside outside study area|1|||
149845791|NCT02316223|540564603|FG001|Overall Study|Reside outside study area|1|||
149845792|NCT02316223|540564604|FG002|Overall Study|Reside outside study area|1|||
149845793|NCT02316223|540564602|FG000|Overall Study|No asthma|2|||
149845794|NCT02316223|540564603|FG001|Overall Study|No asthma|0|||
149845795|NCT02316223|540564604|FG002|Overall Study|No asthma|0|||
149845796|NCT02316223|540564602|FG000|Overall Study|Discontinued by PI|11|||
149845797|NCT02316223|540564603|FG001|Overall Study|Discontinued by PI|19|||
149845798|NCT02316223|540564604|FG002|Overall Study|Discontinued by PI|3|||
149845799|NCT00529763|540564606|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
149845800|NCT00529763|540564607|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
149845801|NCT00529763|540564608|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
149845802|NCT00529763|540564606|FG000|Overall Study|Death|1|||
149845803|NCT00529763|540564607|FG001|Overall Study|Death|1|||
149845804|NCT00529763|540564608|FG002|Overall Study|Death|1|||
149845805|NCT00529763|540564606|FG000|Overall Study|Disease Progression|10|||
149845806|NCT00529763|540564607|FG001|Overall Study|Disease Progression|16|||
149845807|NCT00529763|540564608|FG002|Overall Study|Disease Progression|11|||
149845808|NCT00529763|540564606|FG000|Overall Study|Lost to Follow-up|1|||
149845809|NCT00529763|540564607|FG001|Overall Study|Lost to Follow-up|2|||
149845810|NCT00529763|540564608|FG002|Overall Study|Lost to Follow-up|3|||
149845811|NCT00529763|540564606|FG000|Overall Study|Stem Cell Transplant|0|||
149845812|NCT00529763|540564607|FG001|Overall Study|Stem Cell Transplant|3|||
149845813|NCT00529763|540564608|FG002|Overall Study|Stem Cell Transplant|1|||
149845814|NCT00529763|540564606|FG000|Overall Study|Study Drug Toxicity|3|||
149845815|NCT00529763|540564607|FG001|Overall Study|Study Drug Toxicity|6|||
149845816|NCT00529763|540564608|FG002|Overall Study|Study Drug Toxicity|4|||
149845817|NCT00529763|540564606|FG000|Overall Study|Participant Withdrew Consent|2|||
149845818|NCT00529763|540564607|FG001|Overall Study|Participant Withdrew Consent|3|||
149845819|NCT00529763|540564608|FG002|Overall Study|Participant Withdrew Consent|4|||
149845820|NCT00529763|540564606|FG000|Overall Study|Other reasons|2|||
149845821|NCT00529763|540564607|FG001|Overall Study|Other reasons|0|||
149845822|NCT00529763|540564608|FG002|Overall Study|Other reasons|2|||
149845823|NCT00529763|540564606|FG000|Overall Study|Participant request to discontinue treatment|1|||
149845824|NCT00529763|540564607|FG001|Overall Study|Participant request to discontinue treatment|1|||
149845825|NCT00529763|540564608|FG002|Overall Study|Participant request to discontinue treatment|3|||
149845826|NCT03669250|540564609|FG000|Overall Study|Adverse Event|0|||
149845827|NCT03669250|540564610|FG001|Overall Study|Adverse Event|0|||
149845828|NCT03669250|540564611|FG002|Overall Study|Adverse Event|0|||
149845829|NCT03669250|540564612|FG003|Overall Study|Adverse Event|0|||
149955899|NCT01562444|540972185|FG001|Overall Study|Unavailable serological results|2|||
149955900|NCT01562444|540972186|FG002|Overall Study|Unavailable serological results|2|||
149955901|NCT01562444|540972184|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
149955902|NCT01562444|540972185|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
149955903|NCT01562444|540972186|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
149845830|NCT03669250|540564613|FG004|Overall Study|Adverse Event|1|||
149845831|NCT03669250|540564614|FG005|Overall Study|Adverse Event|0|||
149845832|NCT03669250|540564609|FG000|Overall Study|Withdrawal by Subject|0|||
149845833|NCT03669250|540564610|FG001|Overall Study|Withdrawal by Subject|1|||
149845834|NCT03669250|540564611|FG002|Overall Study|Withdrawal by Subject|0|||
149845835|NCT03669250|540564612|FG003|Overall Study|Withdrawal by Subject|1|||
149845836|NCT03669250|540564613|FG004|Overall Study|Withdrawal by Subject|0|||
149845837|NCT03669250|540564614|FG005|Overall Study|Withdrawal by Subject|0|||
149845838|NCT00828321|540564615|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
149845839|NCT00828321|540564616|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
149845840|NCT00828321|540564615|FG000|Second Intervention|Protocol Violation|0|||
149845841|NCT00828321|540564616|FG001|Second Intervention|Protocol Violation|1|||
149845842|NCT02997176|540564617|FG000|Overall Study|Adverse Event|0|||
149845843|NCT02997176|540564618|FG001|Overall Study|Adverse Event|0|||
149845844|NCT02997176|540564619|FG002|Overall Study|Adverse Event|0|||
149845845|NCT02997176|540564620|FG003|Overall Study|Adverse Event|8|||
149845846|NCT02997176|540564617|FG000|Overall Study|Progressive Disease|1|||
149845847|NCT02997176|540564618|FG001|Overall Study|Progressive Disease|0|||
149845848|NCT02997176|540564619|FG002|Overall Study|Progressive Disease|1|||
149845849|NCT02997176|540564620|FG003|Overall Study|Progressive Disease|1|||
149845850|NCT02997176|540564617|FG000|Overall Study|Death|0|||
149845851|NCT02997176|540564618|FG001|Overall Study|Death|0|||
149845852|NCT02997176|540564619|FG002|Overall Study|Death|1|||
149845853|NCT02997176|540564620|FG003|Overall Study|Death|1|||
149845854|NCT02997176|540564617|FG000|Overall Study|Withdrawal by Subject|0|||
149845855|NCT02997176|540564618|FG001|Overall Study|Withdrawal by Subject|2|||
150287847|NCT04703075|542187462|FG001|Overall Study|Physician Decision|0|||
150287848|NCT04703075|542187461|FG000|Overall Study|Moved|0|||
150287849|NCT04703075|542187462|FG001|Overall Study|Moved|2|||
150287850|NCT04703075|542187461|FG000|Overall Study|Index INH Resistant|0|||
150287851|NCT04703075|542187462|FG001|Overall Study|Index INH Resistant|1|||
150287852|NCT04703075|542187461|FG000|Overall Study|Lack of Efficacy|6|||
150287853|NCT04703075|542187462|FG001|Overall Study|Lack of Efficacy|18|||
150287854|NCT04942925|542187466|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
150287855|NCT04942925|542187467|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
150287856|NCT04942925|542187466|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
150287857|NCT04942925|542187467|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
150287858|NCT02124564|542187470|FG000|Treatment Period|Adverse Event|2|||
150287859|NCT02124564|542187470|FG000|Treatment Period|Lack of Efficacy|3|||
150287860|NCT02124564|542187470|FG000|Treatment Period|Withdrawal by Subject|2|||
150287861|NCT02043548|542187473|FG000|Overall Study|Lack of Efficacy|1|||
150287862|NCT02043548|542187474|FG001|Overall Study|Lack of Efficacy|0|||
150287863|NCT02043548|542187473|FG000|Overall Study|Adverse Event|0|||
150287864|NCT02043548|542187474|FG001|Overall Study|Adverse Event|1|||
150287865|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
150287866|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
150287867|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
150287868|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
150287869|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
150287870|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
150287871|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150287872|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150287873|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150287874|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
150287875|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
150287876|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
150287877|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
150287878|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
150287879|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
150287880|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
150287881|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
150287882|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
150287883|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150287884|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
150287885|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
150287886|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
150287887|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
149845856|NCT02997176|540564619|FG002|Overall Study|Withdrawal by Subject|0|||
149845857|NCT02997176|540564620|FG003|Overall Study|Withdrawal by Subject|1|||
149845858|NCT01630616|540564625|FG000|Overall Study|Adverse Event|0|||
149845859|NCT01630616|540564626|FG001|Overall Study|Adverse Event|0|||
149955904|NCT01562444|540972184|FG000|Overall Study|Protocol forbidden medication|1|||
150287888|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
150287889|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
150287890|NCT03829657|542187478|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
150287891|NCT03829657|542187479|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
150287892|NCT03829657|542187480|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
149955905|NCT01562444|540972185|FG001|Overall Study|Protocol forbidden medication|0|||
149845860|NCT01630616|540564627|FG002|Overall Study|Adverse Event|0|||
149845861|NCT01630616|540564628|FG003|Overall Study|Adverse Event|1|||
149845862|NCT01630616|540564629|FG004|Overall Study|Adverse Event|0|||
149845863|NCT01630616|540564630|FG005|Overall Study|Adverse Event|0|||
149845864|NCT01630616|540564625|FG000|Overall Study|Withdrawal by Subject|0|||
149845865|NCT01630616|540564626|FG001|Overall Study|Withdrawal by Subject|0|||
149845866|NCT01630616|540564627|FG002|Overall Study|Withdrawal by Subject|0|||
149845867|NCT01630616|540564628|FG003|Overall Study|Withdrawal by Subject|2|||
149845868|NCT01630616|540564629|FG004|Overall Study|Withdrawal by Subject|0|||
149845869|NCT01630616|540564630|FG005|Overall Study|Withdrawal by Subject|0|||
149845870|NCT00691704|540564631|FG000|Induction Therapy|Disease Progression|1|||
149845871|NCT00691704|540564631|FG000|Induction Therapy|Active Hepatitis|1|||
149845872|NCT00691704|540564631|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
149845873|NCT00691704|540564631|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
149845874|NCT00691704|540564631|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
149845875|NCT04406194|540564633|FG000|Period 1|Withdrawal by Subject|0|||
149845876|NCT04406194|540564634|FG001|Period 1|Withdrawal by Subject|1|||
149845877|NCT04102345|540564635|FG000|Overall Study|Withdrawal by Subject|1|||
149845878|NCT04102345|540564636|FG001|Overall Study|Withdrawal by Subject|0|||
149845879|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
149845880|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
149845881|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
149845882|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
149845883|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
149845884|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
149845885|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
149845886|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
149845887|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
149845888|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
149845889|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
149845890|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
149845891|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
149845892|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
149845893|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
149845894|NCT00385736|540564637|FG000|Efficacy Analysis Set - Induction|Other|0|||
149845895|NCT00385736|540564638|FG001|Efficacy Analysis Set - Induction|Other|0|||
149845896|NCT00385736|540564639|FG002|Efficacy Analysis Set - Induction|Other|1|||
149845897|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
149845898|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
149845899|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
149845900|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
149845901|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
149845902|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
149845903|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
149845904|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
149845905|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
149845906|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
149845907|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
149845908|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
149845909|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
149845910|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
149845911|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
149845912|NCT00385736|540564637|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
149845913|NCT00385736|540564638|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
149845914|NCT00385736|540564639|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
149845915|NCT00385736|540564637|FG000|Safety Analysis Set|Adverse Event|23|||
149845916|NCT00385736|540564638|FG001|Safety Analysis Set|Adverse Event|15|||
149845917|NCT00385736|540564639|FG002|Safety Analysis Set|Adverse Event|23|||
149845918|NCT00385736|540564637|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
149845919|NCT00385736|540564638|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
149955906|NCT01562444|540972186|FG002|Overall Study|Protocol forbidden medication|0|||
149955907|NCT03387046|540972194|FG000|Overall Study|Adverse Event|1|||
149955908|NCT03387046|540972195|FG001|Overall Study|Adverse Event|1|||
149955909|NCT00509600|540972196|FG000|Overall Study|Adverse Event|1|||
149955910|NCT02568423|540972199|FG000|Overall Study|Lost to Follow-up|0|||
149955911|NCT02568423|540972200|FG001|Overall Study|Lost to Follow-up|2|||
149955912|NCT02568423|540972201|FG002|Overall Study|Lost to Follow-up|0|||
149955913|NCT02568423|540972202|FG003|Overall Study|Lost to Follow-up|0|||
149955914|NCT02568423|540972203|FG004|Overall Study|Lost to Follow-up|0|||
149845920|NCT00385736|540564639|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
149845921|NCT00385736|540564637|FG000|Safety Analysis Set|Lost to Follow-up|0|||
149845922|NCT00385736|540564638|FG001|Safety Analysis Set|Lost to Follow-up|2|||
149845923|NCT00385736|540564639|FG002|Safety Analysis Set|Lost to Follow-up|2|||
149955915|NCT02568423|540972204|FG005|Overall Study|Lost to Follow-up|0|||
149955916|NCT02568423|540972205|FG006|Overall Study|Lost to Follow-up|0|||
149845924|NCT00385736|540564637|FG000|Safety Analysis Set|Lack of Efficacy|38|||
149845925|NCT00385736|540564638|FG001|Safety Analysis Set|Lack of Efficacy|16|||
149845926|NCT00385736|540564639|FG002|Safety Analysis Set|Lack of Efficacy|31|||
149845927|NCT00385736|540564637|FG000|Safety Analysis Set|Protocol Violation|2|||
149845928|NCT00385736|540564638|FG001|Safety Analysis Set|Protocol Violation|1|||
149845929|NCT00385736|540564639|FG002|Safety Analysis Set|Protocol Violation|6|||
149845930|NCT00385736|540564637|FG000|Safety Analysis Set|Other|1|||
149845931|NCT00385736|540564638|FG001|Safety Analysis Set|Other|4|||
149845932|NCT00385736|540564639|FG002|Safety Analysis Set|Other|4|||
149845933|NCT01380782|540564640|FG000|Overall Study|Adverse Event|0|||
149845934|NCT01380782|540564641|FG001|Overall Study|Adverse Event|1|||
149845935|NCT01380782|540564642|FG002|Overall Study|Adverse Event|0|||
149845936|NCT01380782|540564643|FG003|Overall Study|Adverse Event|0|||
149845937|NCT01380782|540564640|FG000|Overall Study|Death|1|||
149845938|NCT01380782|540564641|FG001|Overall Study|Death|0|||
149845939|NCT01380782|540564642|FG002|Overall Study|Death|0|||
149845940|NCT01380782|540564643|FG003|Overall Study|Death|0|||
149845941|NCT01380782|540564640|FG000|Overall Study|Lack of Efficacy|10|||
149845942|NCT01380782|540564641|FG001|Overall Study|Lack of Efficacy|9|||
149845943|NCT01380782|540564642|FG002|Overall Study|Lack of Efficacy|10|||
149845944|NCT01380782|540564643|FG003|Overall Study|Lack of Efficacy|3|||
149845945|NCT01380782|540564640|FG000|Overall Study|Physician Decision|1|||
149845946|NCT01380782|540564641|FG001|Overall Study|Physician Decision|0|||
149845947|NCT01380782|540564642|FG002|Overall Study|Physician Decision|0|||
149845948|NCT01380782|540564643|FG003|Overall Study|Physician Decision|0|||
149845949|NCT01380782|540564640|FG000|Overall Study|Withdrawal by Subject|0|||
149845950|NCT01380782|540564641|FG001|Overall Study|Withdrawal by Subject|0|||
149845951|NCT01380782|540564642|FG002|Overall Study|Withdrawal by Subject|1|||
149845952|NCT01380782|540564643|FG003|Overall Study|Withdrawal by Subject|1|||
149845953|NCT01701063|540564644|FG000|Overall Study|Lost to Follow-up|0|||
149845954|NCT01701063|540564645|FG001|Overall Study|Lost to Follow-up|1|||
149845955|NCT01701063|540564646|FG002|Overall Study|Lost to Follow-up|0|||
149845956|NCT01701063|540564644|FG000|Overall Study|Withdrawal by Subject|0|||
149845957|NCT01701063|540564645|FG001|Overall Study|Withdrawal by Subject|0|||
149845958|NCT01701063|540564646|FG002|Overall Study|Withdrawal by Subject|1|||
149845959|NCT01701063|540564644|FG000|Overall Study|Other|0|||
149845960|NCT01701063|540564645|FG001|Overall Study|Other|0|||
149845961|NCT01701063|540564646|FG002|Overall Study|Other|1|||
149845962|NCT02043132|540564647|FG000|Overall Study|Lost to Follow-up|1|||
149845963|NCT02043132|540564648|FG001|Overall Study|Lost to Follow-up|1|||
149845964|NCT02043132|540564647|FG000|Overall Study|screen failures|4|||
149845965|NCT02043132|540564648|FG001|Overall Study|screen failures|8|||
149845966|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
149845967|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
149845968|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
149845969|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
149845970|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
149845971|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
149845972|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
149845973|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
149845974|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
149845975|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
149845976|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
149845977|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
149845978|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
149845979|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
149845980|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
149845981|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
149845982|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
149845983|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
149845984|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
149845985|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
149845986|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
149845987|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
149845988|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
149845989|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
149955917|NCT02568423|540972206|FG007|Overall Study|Lost to Follow-up|0|||
149845990|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
149845991|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
149845992|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
149845993|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
149845994|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
149845995|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
149845996|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
149845997|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
149845998|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
149845999|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
149846000|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
149846001|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
149846002|NCT04194801|540564649|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
149846003|NCT04194801|540564650|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
149846004|NCT04194801|540564651|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
149846005|NCT04194801|540564649|FG000|Part Ib/II End of Study|Death|2|||
149846006|NCT04194801|540564650|FG001|Part Ib/II End of Study|Death|3|||
149846007|NCT04194801|540564651|FG002|Part Ib/II End of Study|Death|3|||
149846008|NCT04194801|540564649|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
149846009|NCT04194801|540564650|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
149846010|NCT04194801|540564651|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
149846011|NCT04194801|540564649|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
149846012|NCT04194801|540564650|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
149846013|NCT04194801|540564651|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
149846014|NCT04194801|540564649|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
149846015|NCT04194801|540564650|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
149846016|NCT04194801|540564651|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
149846017|NCT04194801|540564649|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
149846018|NCT04194801|540564650|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
149846019|NCT04194801|540564651|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
149846020|NCT00506831|540564652|FG000|Overall Study|Death|1|||
149846021|NCT00506831|540564652|FG000|Overall Study|Withdrawal by Subject|1|||
149846022|NCT01410227|540564656|FG000|Overall Study|Adverse Event|1|||
149846023|NCT01410227|540564657|FG001|Overall Study|Adverse Event|0|||
149846024|NCT01410227|540564658|FG002|Overall Study|Adverse Event|0|||
149846025|NCT01410227|540564659|FG003|Overall Study|Adverse Event|0|||
149846026|NCT01410227|540564656|FG000|Overall Study|Withdrawal by Subject|3|||
149846027|NCT01410227|540564657|FG001|Overall Study|Withdrawal by Subject|0|||
149846028|NCT01410227|540564658|FG002|Overall Study|Withdrawal by Subject|1|||
149846029|NCT01410227|540564659|FG003|Overall Study|Withdrawal by Subject|0|||
149846030|NCT01410227|540564656|FG000|Overall Study|Pregnancy|0|||
149846031|NCT01410227|540564657|FG001|Overall Study|Pregnancy|0|||
149846032|NCT01410227|540564658|FG002|Overall Study|Pregnancy|0|||
149846033|NCT01410227|540564659|FG003|Overall Study|Pregnancy|1|||
149846034|NCT01410227|540564656|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
149846035|NCT01410227|540564657|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
149846036|NCT01410227|540564658|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
149846037|NCT01410227|540564659|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
149846038|NCT01808651|540564660|FG000|Study Period 1|Lost to Follow-up|1|||
149846039|NCT01808651|540564661|FG001|Study Period 1|Lost to Follow-up|3|||
149846040|NCT01808651|540564662|FG002|Study Period 1|Lost to Follow-up|0|||
149846041|NCT01808651|540564660|FG000|Study Period 1|Protocol Violation|1|||
149846042|NCT01808651|540564661|FG001|Study Period 1|Protocol Violation|0|||
149846043|NCT01808651|540564662|FG002|Study Period 1|Protocol Violation|1|||
149846044|NCT01808651|540564660|FG000|Study Period 1|Physician Decision|3|||
149846045|NCT01808651|540564661|FG001|Study Period 1|Physician Decision|2|||
149846046|NCT01808651|540564662|FG002|Study Period 1|Physician Decision|0|||
149846047|NCT01808651|540564660|FG000|Study Period 1|Lack of Efficacy|2|||
149846048|NCT01808651|540564661|FG001|Study Period 1|Lack of Efficacy|1|||
149846049|NCT01808651|540564662|FG002|Study Period 1|Lack of Efficacy|0|||
150172718|NCT01317420|541768069|FG002|Overall Study|Refused to cont. taking trial medication|0|||
150172719|NCT01317420|541768070|FG003|Overall Study|Refused to cont. taking trial medication|0|||
149846050|NCT01808651|540564660|FG000|Study Period 1|Adverse Event|10|||
149846051|NCT01808651|540564661|FG001|Study Period 1|Adverse Event|4|||
149846052|NCT01808651|540564662|FG002|Study Period 1|Adverse Event|1|||
149846053|NCT01808651|540564660|FG000|Study Period 1|Participant Decision|9|||
149846054|NCT01808651|540564661|FG001|Study Period 1|Participant Decision|7|||
149846055|NCT01808651|540564662|FG002|Study Period 1|Participant Decision|3|||
149846056|NCT00829712|540564668|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
149846057|NCT00829712|540564669|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
149846058|NCT00606281|540564670|FG000|Overall Study|Adverse Event|11|||
149846059|NCT00606281|540564671|FG001|Overall Study|Adverse Event|12|||
149846060|NCT00606281|540564670|FG000|Overall Study|Death|1|||
149846061|NCT00606281|540564671|FG001|Overall Study|Death|0|||
149846062|NCT00606281|540564670|FG000|Overall Study|Lack of Efficacy|28|||
150172720|NCT01317420|541768071|FG004|Overall Study|Refused to cont. taking trial medication|0|||
149846063|NCT00606281|540564671|FG001|Overall Study|Lack of Efficacy|35|||
149846064|NCT00606281|540564670|FG000|Overall Study|Physician Decision|0|||
149846065|NCT00606281|540564671|FG001|Overall Study|Physician Decision|1|||
149846066|NCT00606281|540564670|FG000|Overall Study|Protocol Violation|3|||
149846067|NCT00606281|540564671|FG001|Overall Study|Protocol Violation|3|||
149846068|NCT00606281|540564670|FG000|Overall Study|Withdrawal by Subject|11|||
149846069|NCT00606281|540564671|FG001|Overall Study|Withdrawal by Subject|13|||
149846070|NCT00606281|540564670|FG000|Overall Study|Progression to depressive phase|1|||
149846071|NCT00606281|540564671|FG001|Overall Study|Progression to depressive phase|1|||
149846072|NCT00606281|540564670|FG000|Overall Study|Change of residence or other commitments|1|||
149846073|NCT00606281|540564671|FG001|Overall Study|Change of residence or other commitments|1|||
149846074|NCT03131895|540564673|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
149846075|NCT03131895|540564674|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
149846076|NCT03131895|540564675|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
149846077|NCT03131895|540564676|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
149846078|NCT03131895|540564673|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
149846079|NCT03131895|540564674|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
149846080|NCT03131895|540564675|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
149846081|NCT03131895|540564676|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
149846082|NCT03131895|540564673|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149846083|NCT03131895|540564674|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
149846084|NCT03131895|540564675|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149846085|NCT03131895|540564676|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
149846086|NCT03131895|540564673|FG000|Washout Period (at Least 5 Days)|Other|0|||
149846087|NCT03131895|540564674|FG001|Washout Period (at Least 5 Days)|Other|0|||
149846088|NCT03131895|540564675|FG002|Washout Period (at Least 5 Days)|Other|2|||
149846089|NCT03131895|540564676|FG003|Washout Period (at Least 5 Days)|Other|0|||
149846090|NCT03131895|540564673|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
149846091|NCT03131895|540564674|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
149846092|NCT03131895|540564675|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
149846093|NCT03131895|540564676|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
149846094|NCT03131895|540564673|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
149846095|NCT03131895|540564674|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
149846096|NCT03131895|540564675|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
149846097|NCT03131895|540564676|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
149846098|NCT05752721|540564679|FG000|Overall Study|Lost to Follow-up|22|||
149846099|NCT05752721|540564680|FG001|Overall Study|Lost to Follow-up|20|||
149846100|NCT05752721|540564679|FG000|Overall Study|Withdrawal by Subject|15|||
149846101|NCT05752721|540564680|FG001|Overall Study|Withdrawal by Subject|12|||
149846102|NCT02280863|540564681|FG000|Integrated Platform|Met stopping criteria|0|||
149846103|NCT02280863|540564682|FG001|Integrated Platform|Met stopping criteria|1|||
149846104|NCT02622386|540564691|FG000|First Assignment|Withdrawal by Subject|3|||
149846105|NCT02622386|540564692|FG001|First Assignment|Withdrawal by Subject|2|||
149846106|NCT02622386|540564691|FG000|Washout|Withdrawal by Subject|4|||
149846107|NCT02622386|540564692|FG001|Washout|Withdrawal by Subject|4|||
149846108|NCT02622386|540564691|FG000|Second Assignment|Withdrawal by Subject|0|||
149846109|NCT02622386|540564692|FG001|Second Assignment|Withdrawal by Subject|2|||
149846110|NCT02890992|540564693|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846111|NCT02890992|540564694|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
149846112|NCT02890992|540564695|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846113|NCT02890992|540564696|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846114|NCT02890992|540564697|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846115|NCT02890992|540564698|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846116|NCT02890992|540564699|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846117|NCT02890992|540564700|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
149846118|NCT02890992|540564693|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846119|NCT02890992|540564694|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846120|NCT02890992|540564695|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846121|NCT02890992|540564696|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846122|NCT02890992|540564697|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846123|NCT02890992|540564698|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
149846124|NCT02890992|540564699|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
149846125|NCT02890992|540564700|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
149846126|NCT02890992|540564693|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
149846127|NCT02890992|540564694|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
149846128|NCT02890992|540564695|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
149846129|NCT02890992|540564696|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
149955918|NCT02568423|540972199|FG000|Overall Study|Physician Decision|0|||
149955919|NCT02568423|540972200|FG001|Overall Study|Physician Decision|0|||
149955920|NCT02568423|540972201|FG002|Overall Study|Physician Decision|0|||
149955921|NCT02568423|540972202|FG003|Overall Study|Physician Decision|0|||
149846130|NCT02890992|540564697|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
149955922|NCT02568423|540972203|FG004|Overall Study|Physician Decision|0|||
149846131|NCT02890992|540564698|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
149846132|NCT02890992|540564699|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
149846133|NCT02890992|540564700|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
149846134|NCT03236311|540564701|FG000|Overall Study|Study terminated by sponsor|0|||
149846135|NCT03236311|540564702|FG001|Overall Study|Study terminated by sponsor|2|||
149846136|NCT03236311|540564701|FG000|Overall Study|Adverse Event|0|||
149846137|NCT03236311|540564702|FG001|Overall Study|Adverse Event|1|||
149846138|NCT00669162|540564703|FG000|Overall Study|Withdrawal by Subject|1|||
149846139|NCT00807495|540564704|FG000|Overall Study|Adverse Event|6|||
149846140|NCT00807495|540564705|FG001|Overall Study|Adverse Event|3|||
149846141|NCT00807495|540564706|FG002|Overall Study|Adverse Event|1|||
149846142|NCT00807495|540564707|FG003|Overall Study|Adverse Event|1|||
149846143|NCT00807495|540564708|FG004|Overall Study|Adverse Event|2|||
149846144|NCT00807495|540564704|FG000|Overall Study|Withdrawal by Patient|2|||
149846145|NCT00807495|540564705|FG001|Overall Study|Withdrawal by Patient|0|||
149846146|NCT00807495|540564706|FG002|Overall Study|Withdrawal by Patient|1|||
149846147|NCT00807495|540564707|FG003|Overall Study|Withdrawal by Patient|0|||
149846148|NCT00807495|540564708|FG004|Overall Study|Withdrawal by Patient|0|||
149846149|NCT00807495|540564704|FG000|Overall Study|Reason Not Specified|0|||
149846150|NCT00807495|540564705|FG001|Overall Study|Reason Not Specified|3|||
149846151|NCT00807495|540564706|FG002|Overall Study|Reason Not Specified|2|||
149846152|NCT00807495|540564707|FG003|Overall Study|Reason Not Specified|0|||
149846153|NCT00807495|540564708|FG004|Overall Study|Reason Not Specified|3|||
149846154|NCT00484679|540564709|FG000|Overall Study|Withdrawal by Subject|3|||
149846155|NCT00841542|540564710|FG000|Period 1|Adverse Event|1|||
149846156|NCT00841542|540564711|FG001|Period 1|Adverse Event|0|||
149846157|NCT00463684|540564716|FG000|Overall Study|Withdrawal by Subject|1|||
149846158|NCT00463684|540564716|FG000|Overall Study|Lost to Follow-up|3|||
149846159|NCT02462837|540564718|FG000|Overall Study|pt developed hives|1|||
149846160|NCT02462837|540564719|FG001|Overall Study|pt developed hives|0|||
149846161|NCT02462837|540564718|FG000|Overall Study|Withdrawal by Subject|1|||
149846162|NCT02462837|540564719|FG001|Overall Study|Withdrawal by Subject|0|||
149846163|NCT01075282|540564720|FG000|Overall Study|Withdrawal by Subject|11|||
149846164|NCT01075282|540564721|FG001|Overall Study|Withdrawal by Subject|7|||
149846165|NCT01075282|540564722|FG002|Overall Study|Withdrawal by Subject|11|||
149846166|NCT01075282|540564720|FG000|Overall Study|Adverse Event|9|||
149846167|NCT01075282|540564721|FG001|Overall Study|Adverse Event|8|||
149846168|NCT01075282|540564722|FG002|Overall Study|Adverse Event|5|||
149846169|NCT01075282|540564720|FG000|Overall Study|Entry Criteria Not Met|3|||
149846170|NCT01075282|540564721|FG001|Overall Study|Entry Criteria Not Met|2|||
149846171|NCT01075282|540564722|FG002|Overall Study|Entry Criteria Not Met|0|||
149846172|NCT01075282|540564720|FG000|Overall Study|Lost to Follow-up|3|||
149846173|NCT01075282|540564721|FG001|Overall Study|Lost to Follow-up|3|||
149846174|NCT01075282|540564722|FG002|Overall Study|Lost to Follow-up|3|||
149846175|NCT01075282|540564720|FG000|Overall Study|Physician Decision|3|||
149846176|NCT01075282|540564721|FG001|Overall Study|Physician Decision|3|||
149846177|NCT01075282|540564722|FG002|Overall Study|Physician Decision|3|||
149846178|NCT01075282|540564720|FG000|Overall Study|Lack of Efficacy|1|||
149846179|NCT01075282|540564721|FG001|Overall Study|Lack of Efficacy|1|||
149846180|NCT01075282|540564722|FG002|Overall Study|Lack of Efficacy|0|||
149846181|NCT01075282|540564720|FG000|Overall Study|Treatment Non-compliance|1|||
149846182|NCT01075282|540564721|FG001|Overall Study|Treatment Non-compliance|2|||
149846183|NCT01075282|540564722|FG002|Overall Study|Treatment Non-compliance|2|||
149846184|NCT01075282|540564720|FG000|Overall Study|Protocol Violation|0|||
149846185|NCT01075282|540564721|FG001|Overall Study|Protocol Violation|2|||
149846186|NCT01075282|540564722|FG002|Overall Study|Protocol Violation|1|||
149846187|NCT01075282|540564720|FG000|Overall Study|Death|0|||
149846188|NCT01075282|540564721|FG001|Overall Study|Death|1|||
149846189|NCT01075282|540564722|FG002|Overall Study|Death|2|||
149846190|NCT01252953|540564726|FG000|Overall Study|Withdrawal by Subject|16|||
149846191|NCT01252953|540564727|FG001|Overall Study|Withdrawal by Subject|17|||
149846192|NCT01252953|540564726|FG000|Overall Study|Lost to Follow-up|22|||
149846193|NCT01252953|540564727|FG001|Overall Study|Lost to Follow-up|21|||
149846194|NCT00906399|540564745|FG000|Year 1|Randomized But Not Treated|0|||
149846195|NCT00906399|540564746|FG001|Year 1|Randomized But Not Treated|1|||
149846196|NCT00906399|540564747|FG002|Year 1|Randomized But Not Treated|3|||
149846197|NCT00906399|540564748|FG003|Year 1|Randomized But Not Treated|0|||
149846198|NCT00906399|540564749|FG004|Year 1|Randomized But Not Treated|0|||
149846199|NCT00906399|540564750|FG005|Year 1|Randomized But Not Treated|0|||
149846200|NCT00906399|540564751|FG006|Year 1|Randomized But Not Treated|0|||
149846201|NCT00906399|540564745|FG000|Year 1|Adverse Event|4|||
149846202|NCT00906399|540564746|FG001|Year 1|Adverse Event|22|||
149846203|NCT00906399|540564747|FG002|Year 1|Adverse Event|24|||
149846204|NCT00906399|540564748|FG003|Year 1|Adverse Event|0|||
149846205|NCT00906399|540564749|FG004|Year 1|Adverse Event|0|||
149846206|NCT00906399|540564750|FG005|Year 1|Adverse Event|0|||
149846207|NCT00906399|540564751|FG006|Year 1|Adverse Event|0|||
149846208|NCT00906399|540564745|FG000|Year 1|Lost to Follow-up|4|||
149846209|NCT00906399|540564746|FG001|Year 1|Lost to Follow-up|4|||
149846210|NCT00906399|540564747|FG002|Year 1|Lost to Follow-up|2|||
149846211|NCT00906399|540564748|FG003|Year 1|Lost to Follow-up|0|||
149846212|NCT00906399|540564749|FG004|Year 1|Lost to Follow-up|0|||
149846213|NCT00906399|540564750|FG005|Year 1|Lost to Follow-up|0|||
149846214|NCT00906399|540564751|FG006|Year 1|Lost to Follow-up|0|||
149846215|NCT00906399|540564745|FG000|Year 1|Withdrawal by Subject|30|||
149846216|NCT00906399|540564746|FG001|Year 1|Withdrawal by Subject|32|||
149846217|NCT00906399|540564747|FG002|Year 1|Withdrawal by Subject|36|||
149846218|NCT00906399|540564748|FG003|Year 1|Withdrawal by Subject|0|||
149846219|NCT00906399|540564749|FG004|Year 1|Withdrawal by Subject|0|||
149846220|NCT00906399|540564750|FG005|Year 1|Withdrawal by Subject|0|||
149846221|NCT00906399|540564751|FG006|Year 1|Withdrawal by Subject|0|||
149846222|NCT00906399|540564745|FG000|Year 1|Physician Decision|0|||
149846223|NCT00906399|540564746|FG001|Year 1|Physician Decision|1|||
149846224|NCT00906399|540564747|FG002|Year 1|Physician Decision|3|||
149846225|NCT00906399|540564748|FG003|Year 1|Physician Decision|0|||
149846226|NCT00906399|540564749|FG004|Year 1|Physician Decision|0|||
149846227|NCT00906399|540564750|FG005|Year 1|Physician Decision|0|||
149846228|NCT00906399|540564751|FG006|Year 1|Physician Decision|0|||
149846229|NCT00906399|540564745|FG000|Year 1|Death|2|||
149846230|NCT00906399|540564746|FG001|Year 1|Death|1|||
149846231|NCT00906399|540564747|FG002|Year 1|Death|1|||
149846232|NCT00906399|540564748|FG003|Year 1|Death|0|||
149846233|NCT00906399|540564749|FG004|Year 1|Death|0|||
149846234|NCT00906399|540564750|FG005|Year 1|Death|0|||
149846235|NCT00906399|540564751|FG006|Year 1|Death|0|||
149846236|NCT00906399|540564745|FG000|Year 1|Other|4|||
149846237|NCT00906399|540564746|FG001|Year 1|Other|2|||
149846238|NCT00906399|540564747|FG002|Year 1|Other|7|||
149846239|NCT00906399|540564748|FG003|Year 1|Other|0|||
149846240|NCT00906399|540564749|FG004|Year 1|Other|0|||
149846241|NCT00906399|540564750|FG005|Year 1|Other|0|||
149846242|NCT00906399|540564751|FG006|Year 1|Other|0|||
149846243|NCT00906399|540564745|FG000|Year 2|Adverse Event|0|||
149846244|NCT00906399|540564746|FG001|Year 2|Adverse Event|0|||
149846245|NCT00906399|540564747|FG002|Year 2|Adverse Event|0|||
149846246|NCT00906399|540564748|FG003|Year 2|Adverse Event|9|||
149846247|NCT00906399|540564749|FG004|Year 2|Adverse Event|8|||
149846248|NCT00906399|540564750|FG005|Year 2|Adverse Event|11|||
149846249|NCT00906399|540564751|FG006|Year 2|Adverse Event|6|||
149846250|NCT00906399|540564745|FG000|Year 2|Lost to Follow-up|0|||
149846251|NCT00906399|540564746|FG001|Year 2|Lost to Follow-up|0|||
149846252|NCT00906399|540564747|FG002|Year 2|Lost to Follow-up|0|||
149846253|NCT00906399|540564748|FG003|Year 2|Lost to Follow-up|1|||
149846254|NCT00906399|540564749|FG004|Year 2|Lost to Follow-up|4|||
149846255|NCT00906399|540564750|FG005|Year 2|Lost to Follow-up|2|||
149846256|NCT00906399|540564751|FG006|Year 2|Lost to Follow-up|4|||
149846257|NCT00906399|540564745|FG000|Year 2|Withdrawal by Subject|0|||
149846258|NCT00906399|540564746|FG001|Year 2|Withdrawal by Subject|0|||
149846259|NCT00906399|540564747|FG002|Year 2|Withdrawal by Subject|0|||
150036623|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Disease Progression|0|||
150036624|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Disease Progression|0|||
150036625|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
150036626|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
149846260|NCT00906399|540564748|FG003|Year 2|Withdrawal by Subject|17|||
149846261|NCT00906399|540564749|FG004|Year 2|Withdrawal by Subject|18|||
149846262|NCT00906399|540564750|FG005|Year 2|Withdrawal by Subject|27|||
149846263|NCT00906399|540564751|FG006|Year 2|Withdrawal by Subject|13|||
149846264|NCT00906399|540564745|FG000|Year 2|Physician Decision|0|||
149846265|NCT00906399|540564746|FG001|Year 2|Physician Decision|0|||
149846266|NCT00906399|540564747|FG002|Year 2|Physician Decision|0|||
149846267|NCT00906399|540564748|FG003|Year 2|Physician Decision|0|||
149846268|NCT00906399|540564749|FG004|Year 2|Physician Decision|2|||
149846269|NCT00906399|540564750|FG005|Year 2|Physician Decision|6|||
149846270|NCT00906399|540564751|FG006|Year 2|Physician Decision|3|||
149846271|NCT00906399|540564745|FG000|Year 2|Death|0|||
150036627|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
149846272|NCT00906399|540564746|FG001|Year 2|Death|0|||
149846273|NCT00906399|540564747|FG002|Year 2|Death|0|||
149846274|NCT00906399|540564748|FG003|Year 2|Death|1|||
149846275|NCT00906399|540564749|FG004|Year 2|Death|0|||
149846276|NCT00906399|540564750|FG005|Year 2|Death|0|||
149846277|NCT00906399|540564751|FG006|Year 2|Death|3|||
149846278|NCT00906399|540564745|FG000|Year 2|Other|0|||
149846279|NCT00906399|540564746|FG001|Year 2|Other|0|||
149846280|NCT00906399|540564747|FG002|Year 2|Other|0|||
149846281|NCT00906399|540564748|FG003|Year 2|Other|2|||
149846282|NCT00906399|540564749|FG004|Year 2|Other|3|||
149846283|NCT00906399|540564750|FG005|Year 2|Other|1|||
149846284|NCT00906399|540564751|FG006|Year 2|Other|0|||
149846285|NCT03488108|540564755|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
149846286|NCT03488108|540564756|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149846287|NCT03488108|540564755|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
149846288|NCT03488108|540564756|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
149846289|NCT02615249|540564765|FG000|Overall Study|Withdrawal by Subject|1|||
149846290|NCT05098743|540564766|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
149846291|NCT05098743|540564767|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
149846292|NCT05098743|540564766|FG000|Overall Study|Lost to Follow-up|1|||
149846293|NCT05098743|540564767|FG001|Overall Study|Lost to Follow-up|2|||
149846294|NCT02896296|540564773|FG000|Overall Study|Adverse Event|1|||
149846295|NCT02896296|540564773|FG000|Overall Study|Lost to Follow-up|19|||
149846296|NCT02896296|540564773|FG000|Overall Study|Pregnancy|1|||
149846297|NCT02896296|540564773|FG000|Overall Study|Physician Decision|2|||
149846298|NCT02896296|540564773|FG000|Overall Study|Withdrawal by Subject|10|||
149846299|NCT02896296|540564773|FG000|Overall Study|Site closing|7|||
149846300|NCT02896296|540564773|FG000|Overall Study|Incarceration|1|||
149846301|NCT02896296|540564773|FG000|Overall Study|Relocation|1|||
149846302|NCT02597049|540564774|FG000|Overall Study|Lost to Follow-up|0|||
149846303|NCT02597049|540564775|FG001|Overall Study|Lost to Follow-up|3|||
149846304|NCT02597049|540564776|FG002|Overall Study|Lost to Follow-up|2|||
149846305|NCT02597049|540564774|FG000|Overall Study|Withdrawal by Subject|2|||
149846306|NCT02597049|540564775|FG001|Overall Study|Withdrawal by Subject|2|||
149846307|NCT02597049|540564776|FG002|Overall Study|Withdrawal by Subject|1|||
149846308|NCT02597049|540564774|FG000|Overall Study|Adverse Event|2|||
149846309|NCT02597049|540564775|FG001|Overall Study|Adverse Event|0|||
149846310|NCT02597049|540564776|FG002|Overall Study|Adverse Event|0|||
149846311|NCT02597049|540564774|FG000|Overall Study|Death|2|||
149846312|NCT02597049|540564775|FG001|Overall Study|Death|0|||
149846313|NCT02597049|540564776|FG002|Overall Study|Death|0|||
149846314|NCT02597049|540564774|FG000|Overall Study|Noncompliant with Study Visits|1|||
149846315|NCT02597049|540564775|FG001|Overall Study|Noncompliant with Study Visits|0|||
149846316|NCT02597049|540564776|FG002|Overall Study|Noncompliant with Study Visits|0|||
149846317|NCT00227370|540564781|FG000|Overall Study|Withdrawal by Subject|1|||
149846318|NCT00227370|540564782|FG001|Overall Study|Withdrawal by Subject|2|||
149846319|NCT00227370|540564781|FG000|Overall Study|Death|3|||
149846320|NCT00227370|540564782|FG001|Overall Study|Death|4|||
149846321|NCT00227370|540564781|FG000|Overall Study|Adverse Event|6|||
149846322|NCT00227370|540564782|FG001|Overall Study|Adverse Event|11|||
149846323|NCT00227370|540564781|FG000|Overall Study|Physician Decision|9|||
149846324|NCT00227370|540564782|FG001|Overall Study|Physician Decision|6|||
149846325|NCT00227370|540564781|FG000|Overall Study|Other reasons|2|||
149846326|NCT00227370|540564782|FG001|Overall Study|Other reasons|1|||
149846327|NCT00754052|540566564|FG000|Overall Study|Study terminated by Sponsor|5|||
149846328|NCT00754052|540566565|FG001|Overall Study|Study terminated by Sponsor|3|||
149846329|NCT02658019|540566569|FG000|Overall Study|Adverse Event|1|||
149846330|NCT02485158|540566573|FG000|Overall Study|Withdrawal by Subject|3|||
149846331|NCT02485158|540566573|FG000|Overall Study|expected drug side effect|1|||
149846332|NCT01098851|540566574|FG000|Overall Study|Equipment failure|1|||
149846333|NCT01098851|540566575|FG001|Overall Study|Equipment failure|0|||
149846334|NCT03087786|540566576|FG000|Overall Study|Withdrawal by Subject|2|||
149846335|NCT03087786|540566577|FG001|Overall Study|Withdrawal by Subject|0|||
149846336|NCT03234907|540566580|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
149846337|NCT03234907|540566581|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
149846338|NCT03234907|540566582|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
149846339|NCT03234907|540566583|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
149846340|NCT03234907|540566584|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
149846341|NCT03234907|540566585|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
149846342|NCT03234907|540566580|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
149846343|NCT03234907|540566581|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
149846344|NCT03234907|540566582|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
149846345|NCT03234907|540566583|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
149846346|NCT03234907|540566584|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
149846347|NCT03234907|540566585|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
149846348|NCT03234907|540566580|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
149846349|NCT03234907|540566581|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
150287893|NCT03829657|542187481|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
150287894|NCT03829657|542187482|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
149846350|NCT03234907|540566582|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
149846351|NCT03234907|540566583|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
150287895|NCT03829657|542187478|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
149846352|NCT03234907|540566584|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
149846353|NCT03234907|540566585|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
149846354|NCT03234907|540566580|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
149846355|NCT03234907|540566581|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
149846356|NCT03234907|540566582|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
149955923|NCT02568423|540972204|FG005|Overall Study|Physician Decision|1|||
149846357|NCT03234907|540566583|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
149846358|NCT03234907|540566584|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
149846359|NCT03234907|540566585|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
149846360|NCT03234907|540566580|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
149846361|NCT03234907|540566581|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
149846362|NCT03234907|540566582|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
149846363|NCT03234907|540566583|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
149846364|NCT03234907|540566584|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
149846365|NCT03234907|540566585|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
149846366|NCT03234907|540566580|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
149846367|NCT03234907|540566581|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
149846368|NCT03234907|540566582|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
149846369|NCT03234907|540566583|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
149846370|NCT03234907|540566584|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
149846371|NCT03234907|540566585|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
149846372|NCT03234907|540566580|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
149846373|NCT03234907|540566581|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
149846374|NCT03234907|540566582|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
149846375|NCT03234907|540566583|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
149846376|NCT03234907|540566584|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
149846377|NCT03234907|540566585|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
149846378|NCT02986139|540566586|FG000|Overall Study|Sponsor Decision|1|||
149846379|NCT02986139|540566587|FG001|Overall Study|Sponsor Decision|2|||
149846380|NCT02986139|540566586|FG000|Overall Study|Withdrawal by Subject|0|||
149846381|NCT02986139|540566587|FG001|Overall Study|Withdrawal by Subject|1|||
149846382|NCT02986139|540566586|FG000|Overall Study|Lost to Follow-up|0|||
149846383|NCT02986139|540566587|FG001|Overall Study|Lost to Follow-up|1|||
149846384|NCT00414726|540566588|FG000|Overall Study|Withdrawal by Subject|0|||
149846385|NCT00414726|540566589|FG001|Overall Study|Withdrawal by Subject|1|||
149846386|NCT02107196|540566590|FG000|12-week Treatment Period|Adverse Event|6|||
149846387|NCT02107196|540566591|FG001|12-week Treatment Period|Adverse Event|3|||
149846388|NCT02107196|540566590|FG000|12-week Treatment Period|Lack of Efficacy|2|||
149846389|NCT02107196|540566591|FG001|12-week Treatment Period|Lack of Efficacy|1|||
149846390|NCT02107196|540566590|FG000|12-week Treatment Period|Lost to Follow-up|3|||
149846391|NCT02107196|540566591|FG001|12-week Treatment Period|Lost to Follow-up|6|||
149846392|NCT02107196|540566590|FG000|12-week Treatment Period|Physician Decision|0|||
149846393|NCT02107196|540566591|FG001|12-week Treatment Period|Physician Decision|1|||
149846394|NCT02107196|540566590|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
149846395|NCT02107196|540566591|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
149846396|NCT02107196|540566590|FG000|12-week Treatment Period|Protocol Violation|7|||
149846397|NCT02107196|540566591|FG001|12-week Treatment Period|Protocol Violation|8|||
149846398|NCT02107196|540566590|FG000|12-week Treatment Period|Reason Missing|11|||
149955924|NCT02568423|540972205|FG006|Overall Study|Physician Decision|0|||
149955925|NCT02568423|540972206|FG007|Overall Study|Physician Decision|0|||
149955926|NCT03794544|540972209|FG000|Overall Study|Withdrawal by Subject|1|||
149955927|NCT03794544|540972210|FG001|Overall Study|Withdrawal by Subject|1|||
149955928|NCT03794544|540972211|FG002|Overall Study|Withdrawal by Subject|0|||
149955929|NCT03794544|540972212|FG003|Overall Study|Withdrawal by Subject|0|||
149955930|NCT03794544|540972209|FG000|Overall Study|Death|0|||
149955931|NCT03794544|540972210|FG001|Overall Study|Death|0|||
149955932|NCT03794544|540972211|FG002|Overall Study|Death|0|||
149955933|NCT03794544|540972212|FG003|Overall Study|Death|1|||
149955934|NCT03794544|540972209|FG000|Overall Study|Lost to Follow-up|0|||
149955935|NCT03794544|540972210|FG001|Overall Study|Lost to Follow-up|1|||
149955936|NCT03794544|540972211|FG002|Overall Study|Lost to Follow-up|1|||
149955937|NCT03794544|540972212|FG003|Overall Study|Lost to Follow-up|0|||
149955938|NCT03794544|540972209|FG000|Overall Study|Other|0|||
149955939|NCT03794544|540972210|FG001|Overall Study|Other|1|||
149955940|NCT03794544|540972211|FG002|Overall Study|Other|0|||
149955941|NCT03794544|540972212|FG003|Overall Study|Other|0|||
149955942|NCT01027416|540972213|FG000|Overall Study|Withdrawal by Subject|0|||
149955943|NCT01027416|540972214|FG001|Overall Study|Withdrawal by Subject|1|||
149955944|NCT01027416|540972213|FG000|Overall Study|Physician Decision|1|||
150036628|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
149955945|NCT01027416|540972214|FG001|Overall Study|Physician Decision|4|||
149955946|NCT00421733|540972215|FG000|Overall Study|Adverse Event|4|||
149955947|NCT00421733|540972216|FG001|Overall Study|Adverse Event|9|||
149955948|NCT00421733|540972217|FG002|Overall Study|Adverse Event|2|||
149955949|NCT00421733|540972215|FG000|Overall Study|Lost to Follow-up|1|||
149955950|NCT00421733|540972216|FG001|Overall Study|Lost to Follow-up|2|||
149955951|NCT00421733|540972217|FG002|Overall Study|Lost to Follow-up|4|||
149955952|NCT00421733|540972215|FG000|Overall Study|Withdrawal by Subject|1|||
149955953|NCT00421733|540972216|FG001|Overall Study|Withdrawal by Subject|2|||
149955954|NCT00421733|540972217|FG002|Overall Study|Withdrawal by Subject|7|||
149955955|NCT00421733|540972215|FG000|Overall Study|Death|0|||
149955956|NCT00421733|540972216|FG001|Overall Study|Death|3|||
149955957|NCT00421733|540972217|FG002|Overall Study|Death|0|||
149955958|NCT00421733|540972215|FG000|Overall Study|Required dialysis|1|||
149955959|NCT00421733|540972216|FG001|Overall Study|Required dialysis|0|||
149955960|NCT00421733|540972217|FG002|Overall Study|Required dialysis|0|||
149955961|NCT00421733|540972215|FG000|Overall Study|Administrative|2|||
149955962|NCT00421733|540972216|FG001|Overall Study|Administrative|0|||
149955963|NCT00421733|540972217|FG002|Overall Study|Administrative|0|||
149955964|NCT00421733|540972215|FG000|Overall Study|Did not satisfy entry criteria|1|||
149955965|NCT00421733|540972216|FG001|Overall Study|Did not satisfy entry criteria|3|||
149955966|NCT00421733|540972217|FG002|Overall Study|Did not satisfy entry criteria|2|||
149955967|NCT00421733|540972215|FG000|Overall Study|Sponsor request|1|||
149955968|NCT00421733|540972216|FG001|Overall Study|Sponsor request|0|||
149955969|NCT00421733|540972217|FG002|Overall Study|Sponsor request|3|||
149955970|NCT00421733|540972215|FG000|Overall Study|Protocol deviation|4|||
149955971|NCT00421733|540972216|FG001|Overall Study|Protocol deviation|7|||
149955972|NCT00421733|540972217|FG002|Overall Study|Protocol deviation|2|||
149955973|NCT00120250|540972218|FG000|Overall Study|Lost to Follow-up|1|||
149955974|NCT00120250|540972219|FG001|Overall Study|Lost to Follow-up|1|||
149846399|NCT02107196|540566591|FG001|12-week Treatment Period|Reason Missing|8|||
149846400|NCT02107196|540566590|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
149955975|NCT00120250|540972218|FG000|Overall Study|Protocol Violation|0|||
149955976|NCT00120250|540972219|FG001|Overall Study|Protocol Violation|1|||
150287896|NCT03829657|542187479|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
150287897|NCT03829657|542187480|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
150287898|NCT03829657|542187481|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
150287899|NCT03829657|542187482|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
150287900|NCT03829657|542187478|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
150287901|NCT03829657|542187479|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
149846401|NCT02107196|540566591|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
149846402|NCT02107196|540566590|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
149846403|NCT02107196|540566591|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149846404|NCT02107196|540566590|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
149846405|NCT02107196|540566591|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
149846406|NCT02107196|540566590|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
149846407|NCT02107196|540566591|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
149846408|NCT01993186|540566592|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
149846409|NCT01993186|540566593|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
149846410|NCT01993186|540566592|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
149846411|NCT01993186|540566593|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
149846412|NCT01993186|540566592|FG000|Open-Label Extension Period|Other, Not Specified|0|||
149846413|NCT01993186|540566593|FG001|Open-Label Extension Period|Other, Not Specified|1|||
149846414|NCT01993186|540566592|FG000|Open-Label Extension Period|Adverse Event|1|||
149846415|NCT01993186|540566593|FG001|Open-Label Extension Period|Adverse Event|0|||
149846416|NCT01993186|540566592|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
150287902|NCT03829657|542187480|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
150287903|NCT03829657|542187481|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
150287904|NCT03829657|542187482|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
150287905|NCT03829657|542187478|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
149846417|NCT01993186|540566593|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
149955977|NCT00720083|540972220|FG000|Overall Study|Ineligible|1|||
149955978|NCT00720083|540972221|FG001|Overall Study|Ineligible|2|||
149955979|NCT00245570|540972225|FG000|Washout Between Periods III and IV|Adverse Event|0|||
149955980|NCT00245570|540972226|FG001|Washout Between Periods III and IV|Adverse Event|1|||
149955981|NCT00245570|540972227|FG002|Washout Between Periods III and IV|Adverse Event|0|||
149955982|NCT00245570|540972228|FG003|Washout Between Periods III and IV|Adverse Event|0|||
149955983|NCT00245570|540972229|FG004|Washout Between Periods III and IV|Adverse Event|0|||
149955984|NCT00245570|540972230|FG005|Washout Between Periods III and IV|Adverse Event|0|||
149955985|NCT00103506|540972233|FG000|Overall Study|Study closed by sponsor|34|||
149955986|NCT00103506|540972234|FG001|Overall Study|Study closed by sponsor|37|||
149955987|NCT00103506|540972233|FG000|Overall Study|Death|257|||
149955988|NCT00103506|540972234|FG001|Overall Study|Death|253|||
149955989|NCT00103506|540972233|FG000|Overall Study|Lost to Follow-up|13|||
149955990|NCT00103506|540972234|FG001|Overall Study|Lost to Follow-up|13|||
149955991|NCT00103506|540972233|FG000|Overall Study|Withdrawal by Subject|18|||
149955992|NCT00103506|540972234|FG001|Overall Study|Withdrawal by Subject|21|||
149955993|NCT00585585|540972235|FG000|Overall Study|Adverse Event|1|||
149846418|NCT01993186|540566592|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
149846419|NCT01993186|540566593|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
149846420|NCT01993186|540566592|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
149846421|NCT01993186|540566593|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
149846422|NCT04158687|540566594|FG000|Overall Study|Adverse Event|2|||
149846423|NCT04158687|540566595|FG001|Overall Study|Adverse Event|3|||
149846424|NCT04158687|540566596|FG002|Overall Study|Adverse Event|0|||
149846425|NCT04158687|540566597|FG003|Overall Study|Adverse Event|3|||
149846426|NCT04158687|540566594|FG000|Overall Study|Lost to Follow-up|5|||
149846427|NCT04158687|540566595|FG001|Overall Study|Lost to Follow-up|12|||
149846428|NCT04158687|540566596|FG002|Overall Study|Lost to Follow-up|4|||
149846429|NCT04158687|540566597|FG003|Overall Study|Lost to Follow-up|5|||
149955994|NCT05987540|540972241|FG000|Overall Study|Withdrawal by Subject|2|||
149955995|NCT05987540|540972241|FG000|Overall Study|Death|1|||
149955996|NCT05987540|540972241|FG000|Overall Study|Study Termination|1|||
149955997|NCT05987540|540972241|FG000|Overall Study|Adverse Event|2|||
149955998|NCT02959892|540972242|FG000|Overall Study|PET tracer synthesis failure|1|||
149955999|NCT02959892|540972243|FG001|Overall Study|PET tracer synthesis failure|0|||
149956000|NCT02959892|540972242|FG000|Overall Study|Study termination|0|||
150287906|NCT03829657|542187479|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
150287907|NCT03829657|542187480|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
150287908|NCT03829657|542187481|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
150287909|NCT03829657|542187482|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
150287910|NCT03829657|542187478|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
150287911|NCT03829657|542187479|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
150287912|NCT03829657|542187480|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
150287913|NCT03829657|542187481|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
150287914|NCT03829657|542187482|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
150287915|NCT04418076|542187483|FG000|Overall Study|Death|1|||
150287916|NCT04418076|542187484|FG001|Overall Study|Death|0|||
150287917|NCT04418076|542187485|FG002|Overall Study|Death|0|||
150287918|NCT04418076|542187486|FG003|Overall Study|Death|0|||
150287919|NCT04418076|542187483|FG000|Overall Study|Lost to Follow-up|2|||
150287920|NCT04418076|542187484|FG001|Overall Study|Lost to Follow-up|5|||
150287921|NCT04418076|542187485|FG002|Overall Study|Lost to Follow-up|1|||
150287922|NCT04418076|542187486|FG003|Overall Study|Lost to Follow-up|2|||
150287923|NCT04418076|542187483|FG000|Overall Study|Withdrawal by Subject|1|||
150287924|NCT04418076|542187484|FG001|Overall Study|Withdrawal by Subject|0|||
150287925|NCT04418076|542187485|FG002|Overall Study|Withdrawal by Subject|1|||
150287926|NCT04418076|542187486|FG003|Overall Study|Withdrawal by Subject|1|||
150287927|NCT04418076|542187483|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
150287928|NCT04418076|542187484|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
150287929|NCT04418076|542187485|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
150287930|NCT04418076|542187486|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
150287931|NCT01452152|542187489|FG000|Overall Study|Study termination by sponsor|5|||
150287932|NCT01452152|542187490|FG001|Overall Study|Study termination by sponsor|0|||
150287933|NCT01452152|542187491|FG002|Overall Study|Study termination by sponsor|4|||
150287934|NCT03315871|542187493|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
150287935|NCT03315871|542187494|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
150287936|NCT03315871|542187495|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
150287937|NCT03315871|542187493|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
150287938|NCT03315871|542187494|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
150287939|NCT03315871|542187495|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
150287940|NCT03315871|542187493|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
150287941|NCT03315871|542187494|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
150287942|NCT03315871|542187495|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
150287943|NCT03315871|542187493|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
150287944|NCT03315871|542187494|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
150287945|NCT03315871|542187495|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
150287946|NCT03315871|542187493|FG000|PROSTVAC + CV301|Progressive disease|0|||
150287947|NCT03315871|542187494|FG001|PROSTVAC + CV301|Progressive disease|0|||
150287948|NCT03315871|542187495|FG002|PROSTVAC + CV301|Progressive disease|1|||
150287949|NCT03315871|542187493|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
150287950|NCT03315871|542187494|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
150287951|NCT03315871|542187495|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
150287952|NCT03047980|542189151|FG000|Overall Study|Adverse Event|1|||
150287953|NCT01736579|542189152|FG000|Overall Study|Termination of Study by Sponsor|2|||
150287954|NCT01736579|542189153|FG001|Overall Study|Termination of Study by Sponsor|2|||
150287955|NCT05048719|542189158|FG000|Overall Study|Withdrawal by Subject|2|||
149846430|NCT04158687|540566594|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
149956001|NCT02959892|540972243|FG001|Overall Study|Study termination|1|||
149846431|NCT04158687|540566595|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
149846432|NCT04158687|540566596|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
149846433|NCT04158687|540566597|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
149846434|NCT04158687|540566594|FG000|Overall Study|Non-Compliance with Study Medication|2|||
149846435|NCT04158687|540566595|FG001|Overall Study|Non-Compliance with Study Medication|2|||
149846436|NCT04158687|540566596|FG002|Overall Study|Non-Compliance with Study Medication|3|||
149846437|NCT04158687|540566597|FG003|Overall Study|Non-Compliance with Study Medication|0|||
149846438|NCT04158687|540566594|FG000|Overall Study|Investigator Decision|0|||
149846439|NCT04158687|540566595|FG001|Overall Study|Investigator Decision|0|||
149846440|NCT04158687|540566596|FG002|Overall Study|Investigator Decision|2|||
149846441|NCT04158687|540566597|FG003|Overall Study|Investigator Decision|0|||
149846442|NCT04158687|540566594|FG000|Overall Study|Protocol Violation|0|||
149846443|NCT04158687|540566595|FG001|Overall Study|Protocol Violation|2|||
150287956|NCT05048719|542189159|FG001|Overall Study|Withdrawal by Subject|1|||
149846444|NCT04158687|540566596|FG002|Overall Study|Protocol Violation|1|||
149846445|NCT04158687|540566597|FG003|Overall Study|Protocol Violation|0|||
149846446|NCT04158687|540566594|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
149846447|NCT04158687|540566595|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
149846448|NCT04158687|540566596|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
149846449|NCT04158687|540566597|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
149846450|NCT04158687|540566594|FG000|Overall Study|Reason not Specified|3|||
149846451|NCT04158687|540566595|FG001|Overall Study|Reason not Specified|2|||
149846452|NCT04158687|540566596|FG002|Overall Study|Reason not Specified|4|||
149846453|NCT04158687|540566597|FG003|Overall Study|Reason not Specified|4|||
149846454|NCT04523480|540566598|FG000|Overall Study|Lost to Follow-up|30|||
149846455|NCT04523480|540566599|FG001|Overall Study|Lost to Follow-up|35|||
149846456|NCT04523480|540566600|FG002|Overall Study|Lost to Follow-up|0|||
149846457|NCT00640393|540566601|FG000|Part 1|Lost to Follow-up|2|||
149846458|NCT00640393|540566602|FG001|Part 1|Lost to Follow-up|0|||
149846459|NCT00640393|540566603|FG002|Part 1|Lost to Follow-up|0|||
149846460|NCT00640393|540566601|FG000|Part 1|Withdrawal by Subject|3|||
149846461|NCT00640393|540566602|FG001|Part 1|Withdrawal by Subject|0|||
149846462|NCT00640393|540566603|FG002|Part 1|Withdrawal by Subject|0|||
149846463|NCT00640393|540566601|FG000|Randomization|Withdrawn per protocol|17|||
149846464|NCT00640393|540566602|FG001|Randomization|Withdrawn per protocol|0|||
149846465|NCT00640393|540566603|FG002|Randomization|Withdrawn per protocol|0|||
149846466|NCT00640393|540566601|FG000|Randomization|Never randomized by site|2|||
149846467|NCT00640393|540566602|FG001|Randomization|Never randomized by site|0|||
149846468|NCT00640393|540566603|FG002|Randomization|Never randomized by site|0|||
149846469|NCT00640393|540566601|FG000|Part 2|Lost to Follow-up|0|||
149846470|NCT00640393|540566602|FG001|Part 2|Lost to Follow-up|2|||
149846471|NCT00640393|540566603|FG002|Part 2|Lost to Follow-up|2|||
149846472|NCT00640393|540566601|FG000|Part 2|Withdrawal by Subject|0|||
149846473|NCT00640393|540566602|FG001|Part 2|Withdrawal by Subject|6|||
149846474|NCT00640393|540566603|FG002|Part 2|Withdrawal by Subject|1|||
149846475|NCT00640393|540566601|FG000|Part 2|Non-adherence|0|||
149846476|NCT00640393|540566602|FG001|Part 2|Non-adherence|1|||
149846477|NCT00640393|540566603|FG002|Part 2|Non-adherence|0|||
149846478|NCT00640393|540566601|FG000|Part 2|Adverse Event|0|||
149846479|NCT00640393|540566602|FG001|Part 2|Adverse Event|1|||
149846480|NCT00640393|540566603|FG002|Part 2|Adverse Event|0|||
149846481|NCT05497557|540566607|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
149846482|NCT05497557|540566608|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
149846483|NCT05497557|540566609|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
149846484|NCT03540160|540566611|FG000|Overall Study|Protocol Violation|1|||
150287957|NCT05048719|542189160|FG002|Overall Study|Withdrawal by Subject|3|||
149846485|NCT03540160|540566611|FG000|Overall Study|Physician Decision|8|||
149846486|NCT03540160|540566611|FG000|Overall Study|Lack of Efficacy|60|||
149846487|NCT03540160|540566611|FG000|Overall Study|Pregnancy|1|||
149846488|NCT03540160|540566611|FG000|Overall Study|Adverse Event|20|||
149846489|NCT03540160|540566611|FG000|Overall Study|Withdrawal by Subject|68|||
149846490|NCT03540160|540566611|FG000|Overall Study|COVID-19|2|||
149846491|NCT03540160|540566611|FG000|Overall Study|Study Closure|10|||
149846492|NCT03540160|540566611|FG000|Overall Study|Lost to Follow-up|18|||
149846493|NCT03540160|540566611|FG000|Overall Study|Sponsor decision|191|||
149846494|NCT00198133|540566612|FG000|Overall Study|Disease progression|2|||
149846495|NCT00198133|540566613|FG001|Overall Study|Disease progression|5|||
149846496|NCT00198133|540566612|FG000|Overall Study|Adverse Event|1|||
149846497|NCT00198133|540566613|FG001|Overall Study|Adverse Event|3|||
149846498|NCT00198133|540566612|FG000|Overall Study|Withdrawal by Subject|1|||
149846499|NCT00198133|540566613|FG001|Overall Study|Withdrawal by Subject|0|||
149846500|NCT00198133|540566612|FG000|Overall Study|Physician Decision|1|||
149846501|NCT00198133|540566613|FG001|Overall Study|Physician Decision|0|||
149846502|NCT00835666|540566616|FG000|Washout|Protocol Violation|1|||
150287958|NCT05048719|542189161|FG003|Overall Study|Withdrawal by Subject|1|||
149846503|NCT00835666|540566617|FG001|Washout|Protocol Violation|0|||
149846504|NCT00835666|540566616|FG000|Washout|Withdrawal by Subject|1|||
150287959|NCT05048719|542189162|FG004|Overall Study|Withdrawal by Subject|0|||
149846505|NCT00835666|540566617|FG001|Washout|Withdrawal by Subject|0|||
149846506|NCT00635648|540566618|FG000|Overall Study|Adverse Event|12|||
149846507|NCT00635648|540566618|FG000|Overall Study|Withdrawal by Subject|9|||
149846508|NCT00635648|540566618|FG000|Overall Study|Physician Decision|4|||
149846509|NCT00635648|540566618|FG000|Overall Study|Rapid progression of baseline disease|4|||
149846510|NCT00635648|540566618|FG000|Overall Study|Use of other antifungal agent needed|1|||
149846511|NCT00635648|540566618|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
149846512|NCT00635648|540566618|FG000|Overall Study|Noncompliance with protocol|1|||
149846513|NCT00635648|540566618|FG000|Overall Study|Other reason|2|||
149846514|NCT03827395|540566622|FG000|Overall Study|Lost to Follow-up|1|||
150287960|NCT05048719|542189163|FG005|Overall Study|Withdrawal by Subject|2|||
150287961|NCT05048719|542189164|FG006|Overall Study|Withdrawal by Subject|1|||
149846515|NCT03827395|540566623|FG001|Overall Study|Lost to Follow-up|0|||
149846516|NCT03827395|540566622|FG000|Overall Study|Protocol Violation|1|||
149846517|NCT03827395|540566623|FG001|Overall Study|Protocol Violation|0|||
149846518|NCT03827395|540566622|FG000|Overall Study|Became ineligible after enrollment|1|||
149846519|NCT03827395|540566623|FG001|Overall Study|Became ineligible after enrollment|2|||
149846520|NCT01923740|540566624|FG000|Overall Study|Lost to Follow-up|4|||
149846521|NCT01923740|540566625|FG001|Overall Study|Lost to Follow-up|9|||
149846522|NCT01923740|540566624|FG000|Overall Study|Withdrawal by Subject|2|||
149846523|NCT01923740|540566625|FG001|Overall Study|Withdrawal by Subject|0|||
149846524|NCT01537887|540566626|FG000|Period 1|Physician Decision|0|||
149846525|NCT01537887|540566627|FG001|Period 1|Physician Decision|0|||
149846526|NCT01537887|540566628|FG002|Period 1|Physician Decision|0|||
149846527|NCT01537887|540566629|FG003|Period 1|Physician Decision|0|||
149846528|NCT01537887|540566630|FG004|Period 1|Physician Decision|1|||
149846529|NCT01537887|540566631|FG005|Period 1|Physician Decision|1|||
149846530|NCT01537887|540566626|FG000|Period 1|Did not receive treatment|0|||
149846531|NCT01537887|540566627|FG001|Period 1|Did not receive treatment|0|||
149846532|NCT01537887|540566628|FG002|Period 1|Did not receive treatment|1|||
149846533|NCT01537887|540566629|FG003|Period 1|Did not receive treatment|0|||
149846534|NCT01537887|540566630|FG004|Period 1|Did not receive treatment|0|||
149846535|NCT01537887|540566631|FG005|Period 1|Did not receive treatment|0|||
149846536|NCT01537887|540566626|FG000|Period 2|Withdrawal by Subject|0|||
149846537|NCT01537887|540566627|FG001|Period 2|Withdrawal by Subject|1|||
149846538|NCT01537887|540566628|FG002|Period 2|Withdrawal by Subject|0|||
149846539|NCT01537887|540566629|FG003|Period 2|Withdrawal by Subject|0|||
149846540|NCT01537887|540566630|FG004|Period 2|Withdrawal by Subject|0|||
149846541|NCT01537887|540566631|FG005|Period 2|Withdrawal by Subject|0|||
149846542|NCT01537887|540566626|FG000|Period 3|Adverse Event|0|||
149846543|NCT01537887|540566627|FG001|Period 3|Adverse Event|0|||
149846544|NCT01537887|540566628|FG002|Period 3|Adverse Event|1|||
149846545|NCT01537887|540566629|FG003|Period 3|Adverse Event|0|||
149846546|NCT01537887|540566630|FG004|Period 3|Adverse Event|0|||
149846547|NCT01537887|540566631|FG005|Period 3|Adverse Event|0|||
149846548|NCT01537887|540566626|FG000|Period 3|Withdrawal by Subject|0|||
149846549|NCT01537887|540566627|FG001|Period 3|Withdrawal by Subject|1|||
149846550|NCT01537887|540566628|FG002|Period 3|Withdrawal by Subject|0|||
149846551|NCT01537887|540566629|FG003|Period 3|Withdrawal by Subject|0|||
149846552|NCT01537887|540566630|FG004|Period 3|Withdrawal by Subject|0|||
149846553|NCT01537887|540566631|FG005|Period 3|Withdrawal by Subject|0|||
149846554|NCT04723693|540566632|FG000|Overall Study|Withdrawal by Subject|2|||
149846555|NCT00294047|540566633|FG000|Month 48|Adverse Event|28|||
149846556|NCT00294047|540566634|FG001|Month 48|Adverse Event|13|||
149846557|NCT00294047|540566633|FG000|Month 48|Protocol Violation|4|||
149846558|NCT00294047|540566634|FG001|Month 48|Protocol Violation|4|||
150036629|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
150287962|NCT05048719|542189165|FG007|Overall Study|Withdrawal by Subject|1|||
150287963|NCT05048719|542189166|FG008|Overall Study|Withdrawal by Subject|0|||
150287964|NCT05048719|542189158|FG000|Overall Study|Death|1|||
149846559|NCT00294047|540566633|FG000|Month 48|Withdrawal by Subject|111|||
149846560|NCT00294047|540566634|FG001|Month 48|Withdrawal by Subject|115|||
149846561|NCT00294047|540566633|FG000|Month 48|Lost to Follow-up|272|||
149846562|NCT00294047|540566634|FG001|Month 48|Lost to Follow-up|287|||
149846563|NCT00294047|540566633|FG000|Month 48|Other|10|||
149846564|NCT00294047|540566634|FG001|Month 48|Other|14|||
149846565|NCT00294047|540566633|FG000|Month 84|Adverse Event|4|||
149846566|NCT00294047|540566634|FG001|Month 84|Adverse Event|2|||
149846567|NCT00294047|540566633|FG000|Month 84|Protocol Violation|1|||
149846568|NCT00294047|540566634|FG001|Month 84|Protocol Violation|1|||
149846569|NCT00294047|540566633|FG000|Month 84|Withdrawal by Subject|33|||
149846570|NCT00294047|540566634|FG001|Month 84|Withdrawal by Subject|31|||
149846571|NCT00294047|540566633|FG000|Month 84|Lost to Follow-up|187|||
149846572|NCT00294047|540566634|FG001|Month 84|Lost to Follow-up|190|||
149846573|NCT00294047|540566633|FG000|Month 84|Absent Cervix|2|||
149846574|NCT00294047|540566634|FG001|Month 84|Absent Cervix|0|||
150287965|NCT05048719|542189159|FG001|Overall Study|Death|0|||
149846575|NCT00294047|540566633|FG000|Month 84|Work related reasons|4|||
149846576|NCT00294047|540566634|FG001|Month 84|Work related reasons|2|||
149846577|NCT00294047|540566633|FG000|Month 84|Center closed, subject did not transfer|1|||
149846578|NCT00294047|540566634|FG001|Month 84|Center closed, subject did not transfer|0|||
149846579|NCT00294047|540566633|FG000|Month 84|Family problems|2|||
149846580|NCT00294047|540566634|FG001|Month 84|Family problems|2|||
149846581|NCT00294047|540566633|FG000|Month 84|Lack of time|3|||
149846582|NCT00294047|540566634|FG001|Month 84|Lack of time|1|||
149846583|NCT00294047|540566633|FG000|Month 84|Personal reason|2|||
149846584|NCT00294047|540566634|FG001|Month 84|Personal reason|4|||
149846585|NCT00294047|540566633|FG000|Month 84|Subject does not want male physician|1|||
149846586|NCT00294047|540566634|FG001|Month 84|Subject does not want male physician|0|||
149846587|NCT00294047|540566633|FG000|Month 84|Transport reimbursement delayed|0|||
149846588|NCT00294047|540566634|FG001|Month 84|Transport reimbursement delayed|1|||
149846589|NCT00294047|540566633|FG000|Month 84|Unable to reach study site|1|||
149846590|NCT00294047|540566634|FG001|Month 84|Unable to reach study site|0|||
149846591|NCT00294047|540566633|FG000|Month 84|Under investigation locally|1|||
149846592|NCT00294047|540566634|FG001|Month 84|Under investigation locally|0|||
149846593|NCT00294047|540566633|FG000|Month 84|Visit missed|0|||
149846594|NCT00294047|540566634|FG001|Month 84|Visit missed|1|||
149846595|NCT00294047|540566633|FG000|Month 84|No consent for Month 84 Follow-up|731|||
149846596|NCT00294047|540566634|FG001|Month 84|No consent for Month 84 Follow-up|754|||
149846597|NCT02157974|540566635|FG000|Overall Study|Withdrawal by Subject|0|||
149846598|NCT02157974|540566636|FG001|Overall Study|Withdrawal by Subject|1|||
149846599|NCT02157974|540566637|FG002|Overall Study|Withdrawal by Subject|0|||
149846600|NCT02157974|540566638|FG003|Overall Study|Withdrawal by Subject|0|||
149846601|NCT02157974|540566639|FG004|Overall Study|Withdrawal by Subject|0|||
149846602|NCT02157974|540566635|FG000|Overall Study|Screen Failure|0|||
149846603|NCT02157974|540566636|FG001|Overall Study|Screen Failure|1|||
149846604|NCT02157974|540566637|FG002|Overall Study|Screen Failure|0|||
149846605|NCT02157974|540566638|FG003|Overall Study|Screen Failure|0|||
149846606|NCT02157974|540566639|FG004|Overall Study|Screen Failure|0|||
149846607|NCT02157974|540566635|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
149846608|NCT02157974|540566636|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
149846609|NCT02157974|540566637|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
149846610|NCT02157974|540566638|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
149846611|NCT02157974|540566639|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
149846612|NCT01484912|540566642|FG000|Overall Study|Withdrawal by Subject|1|||
149846613|NCT01484912|540566643|FG001|Overall Study|Withdrawal by Subject|0|||
149846614|NCT01484912|540566642|FG000|Overall Study|Physician Decision|0|||
149846615|NCT01484912|540566643|FG001|Overall Study|Physician Decision|1|||
149846616|NCT00540423|540566644|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149846617|NCT00540423|540566645|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149846618|NCT00540423|540566646|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149846619|NCT00540423|540566644|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
149846620|NCT00540423|540566645|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
149846621|NCT00540423|540566646|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
149846622|NCT00731939|540566650|FG000|Overall Study|Adverse Event|6|||
149846623|NCT00731939|540566650|FG000|Overall Study|Lost to Follow-up|15|||
149846624|NCT00731939|540566650|FG000|Overall Study|Not implanted with study device|9|||
149846625|NCT00731939|540566650|FG000|Overall Study|Withdrawal by Subject|2|||
149846626|NCT00731939|540566650|FG000|Overall Study|Did not meet enrollment criteria|2|||
149846627|NCT00263588|540566651|FG000|Overall Study|Death|54|||
149846628|NCT00263588|540566652|FG001|Overall Study|Death|90|||
149846629|NCT00263588|540566651|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
149846630|NCT00263588|540566652|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
149846631|NCT00263588|540566651|FG000|Overall Study|Lost to Follow-up|7|||
149846632|NCT00263588|540566652|FG001|Overall Study|Lost to Follow-up|10|||
149846633|NCT00263588|540566651|FG000|Overall Study|Withdrawal by Subject|3|||
149846634|NCT00263588|540566652|FG001|Overall Study|Withdrawal by Subject|4|||
149956002|NCT02061592|540972244|FG000|Period 1|Withdrawal by Subject|1|||
149956003|NCT02061592|540972245|FG001|Period 1|Withdrawal by Subject|0|||
149956004|NCT02061592|540972244|FG000|Period 1|Protocol Violation|1|||
149956005|NCT02061592|540972245|FG001|Period 1|Protocol Violation|0|||
149956006|NCT02061592|540972244|FG000|Period 2|Lost to Follow-up|0|||
149846635|NCT00263588|540566651|FG000|Overall Study|Protocol Violation|0|||
149956007|NCT02061592|540972245|FG001|Period 2|Lost to Follow-up|1|||
149956008|NCT03338023|540972246|FG000|Overall Study|Withdrawal by Subject|3|||
149956009|NCT03338023|540972247|FG001|Overall Study|Withdrawal by Subject|4|||
150036630|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
150036631|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
149846636|NCT00263588|540566652|FG001|Overall Study|Protocol Violation|1|||
149846637|NCT00263588|540566651|FG000|Overall Study|Investigator decision|7|||
149846638|NCT00263588|540566652|FG001|Overall Study|Investigator decision|15|||
149846639|NCT00263588|540566651|FG000|Overall Study|Sponsor terminated study|0|||
149956010|NCT03338023|540972246|FG000|Overall Study|Protocol Violation|3|||
149956011|NCT03338023|540972247|FG001|Overall Study|Protocol Violation|3|||
150036632|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
149846640|NCT00263588|540566652|FG001|Overall Study|Sponsor terminated study|1|||
149846641|NCT02412852|540566653|FG000|Overall Study|Withdrawal by Subject|0|||
149846642|NCT02412852|540566654|FG001|Overall Study|Withdrawal by Subject|1|||
149846643|NCT02412852|540566655|FG002|Overall Study|Withdrawal by Subject|0|||
149846644|NCT02412852|540566656|FG003|Overall Study|Withdrawal by Subject|0|||
149846645|NCT02412852|540566653|FG000|Overall Study|Physician Decision|0|||
149846646|NCT02412852|540566654|FG001|Overall Study|Physician Decision|0|||
149846647|NCT02412852|540566655|FG002|Overall Study|Physician Decision|0|||
149846648|NCT02412852|540566656|FG003|Overall Study|Physician Decision|1|||
149846649|NCT00985439|540566657|FG000|Overall Study|Adverse Event|0|||
149846650|NCT00985439|540566658|FG001|Overall Study|Adverse Event|0|||
149846651|NCT00985439|540566659|FG002|Overall Study|Adverse Event|1|||
149846652|NCT00985439|540566660|FG003|Overall Study|Adverse Event|0|||
149846653|NCT01174186|540566661|FG000|Overall Study|Lost to Follow-up|0|||
149846654|NCT01174186|540566662|FG001|Overall Study|Lost to Follow-up|1|||
149846655|NCT01174186|540566661|FG000|Overall Study|Withdrawal by Subject|0|||
149846656|NCT01174186|540566662|FG001|Overall Study|Withdrawal by Subject|2|||
149846657|NCT05274763|540566663|FG000|Overall Study|Lost to Follow-up|1|||
149846658|NCT01906372|540566666|FG000|Overall Study|Withdrawal by Subject|2|||
149846659|NCT03629054|540566667|FG000|Period 2 (4 Days)|Not treated|0|||
149956012|NCT03338023|540972246|FG000|Overall Study|Lost to Follow-up|2|||
149956013|NCT03338023|540972247|FG001|Overall Study|Lost to Follow-up|1|||
149956014|NCT03338023|540972246|FG000|Overall Study|Physician Decision|1|||
149956015|NCT03338023|540972247|FG001|Overall Study|Physician Decision|2|||
149956016|NCT04996264|540972248|FG000|Overall Study|Lost to Follow-up|0|||
149956017|NCT04996264|540972249|FG001|Overall Study|Lost to Follow-up|1|||
149956018|NCT04996264|540972248|FG000|Overall Study|Withdrawal by Subject|4|||
149956019|NCT04996264|540972249|FG001|Overall Study|Withdrawal by Subject|3|||
149956020|NCT04996264|540972248|FG000|Overall Study|1 left AMA|0|||
149956021|NCT04996264|540972249|FG001|Overall Study|1 left AMA|1|||
149956022|NCT04996264|540972248|FG000|Overall Study|Subject changed hospitals|0|||
149956023|NCT04996264|540972249|FG001|Overall Study|Subject changed hospitals|1|||
149956024|NCT04996264|540972248|FG000|Overall Study|unable to complete due to work|0|||
149956025|NCT04996264|540972249|FG001|Overall Study|unable to complete due to work|1|||
149956026|NCT04433975|540972250|FG000|1-month Follow Up|Withdrawal by Subject|1|||
149956027|NCT04433975|540972251|FG001|1-month Follow Up|Withdrawal by Subject|1|||
149956028|NCT04433975|540972250|FG000|1-month Follow Up|Lost to Follow-up|21|||
149956029|NCT04433975|540972251|FG001|1-month Follow Up|Lost to Follow-up|25|||
149956030|NCT04433975|540972250|FG000|3-month Follow Up|Lost to Follow-up|20|||
149956031|NCT04433975|540972251|FG001|3-month Follow Up|Lost to Follow-up|24|||
149956032|NCT04433975|540972250|FG000|3-month Follow Up|Death|1|||
149956033|NCT04433975|540972251|FG001|3-month Follow Up|Death|0|||
149956034|NCT04433975|540972250|FG000|3-month Follow Up|Withdrawal by Subject|2|||
149956035|NCT04433975|540972251|FG001|3-month Follow Up|Withdrawal by Subject|0|||
149956036|NCT04433975|540972250|FG000|6-month Follow Up|Lost to Follow-up|23|||
149956037|NCT04433975|540972251|FG001|6-month Follow Up|Lost to Follow-up|28|||
149956038|NCT04433975|540972250|FG000|6-month Follow Up|Withdrawal by Subject|1|||
149956039|NCT04433975|540972251|FG001|6-month Follow Up|Withdrawal by Subject|1|||
149956040|NCT04433975|540972250|FG000|9-month Follow Up|Lost to Follow-up|27|||
149956041|NCT04433975|540972251|FG001|9-month Follow Up|Lost to Follow-up|36|||
149956042|NCT04433975|540972250|FG000|9-month Follow Up|Death|0|||
149956043|NCT04433975|540972251|FG001|9-month Follow Up|Death|1|||
149956044|NCT04433975|540972250|FG000|12-month Follow Up|Lost to Follow-up|27|||
149956045|NCT04433975|540972251|FG001|12-month Follow Up|Lost to Follow-up|31|||
149956046|NCT04392635|540972254|FG000|Overall Study|Lost to Follow-up|0|||
149956047|NCT04392635|540972255|FG001|Overall Study|Lost to Follow-up|1|||
149956048|NCT04180696|540972258|FG000|Overall Study|Death|5|||
149956049|NCT04180696|540972259|FG001|Overall Study|Death|6|||
149956050|NCT04180696|540972258|FG000|Overall Study|Lost to Follow-up|1|||
149956051|NCT04180696|540972259|FG001|Overall Study|Lost to Follow-up|0|||
149956052|NCT04180696|540972258|FG000|Overall Study|Withdrawal by Subject|0|||
149956053|NCT04180696|540972259|FG001|Overall Study|Withdrawal by Subject|1|||
149846660|NCT03629054|540566668|FG001|Period 2 (4 Days)|Not treated|1|||
149956054|NCT01740427|540972260|FG000|Overall Study|Objective Progression or Relapse|286|||
149956055|NCT01740427|540972261|FG001|Overall Study|Objective Progression or Relapse|172|||
149956056|NCT01740427|540972260|FG000|Overall Study|Adverse Event|32|||
149956057|NCT01740427|540972261|FG001|Overall Study|Adverse Event|9|||
149956058|NCT01740427|540972260|FG000|Overall Study|Global Deterioration of Health Status|28|||
149956059|NCT01740427|540972261|FG001|Overall Study|Global Deterioration of Health Status|12|||
149846661|NCT00924638|540566669|FG000|Overall Study|Death|3|||
149846662|NCT00924638|540566670|FG001|Overall Study|Death|2|||
149846663|NCT00924638|540566669|FG000|Overall Study|Lost to Follow-up|1|||
149956060|NCT01740427|540972260|FG000|Overall Study|Participant Refused Continued Treatment|27|||
149956061|NCT01740427|540972261|FG001|Overall Study|Participant Refused Continued Treatment|15|||
149956062|NCT01740427|540972260|FG000|Overall Study|Unspecified reasons|52|||
149956063|NCT01740427|540972261|FG001|Overall Study|Unspecified reasons|8|||
149956064|NCT01740427|540972260|FG000|Overall Study|Death|10|||
149956065|NCT01740427|540972261|FG001|Overall Study|Death|3|||
149846664|NCT00924638|540566670|FG001|Overall Study|Lost to Follow-up|1|||
149846665|NCT00924638|540566669|FG000|Overall Study|Withdrawal by Subject|5|||
149846666|NCT00924638|540566670|FG001|Overall Study|Withdrawal by Subject|7|||
149846667|NCT00924638|540566669|FG000|Overall Study|Physician Decision|3|||
149846668|NCT00924638|540566670|FG001|Overall Study|Physician Decision|3|||
149846669|NCT00367133|540566671|FG000|2 Years|Death|20|||
149846670|NCT00367133|540566672|FG001|2 Years|Death|12|||
149846671|NCT00367133|540566673|FG002|2 Years|Death|12|||
149846672|NCT00367133|540566671|FG000|2 Years|Dropped|34|||
149846673|NCT00367133|540566672|FG001|2 Years|Dropped|19|||
149846674|NCT00367133|540566673|FG002|2 Years|Dropped|33|||
149846675|NCT00367133|540566671|FG000|2 Years|Missed visit|4|||
149846676|NCT00367133|540566672|FG001|2 Years|Missed visit|5|||
149846677|NCT00367133|540566673|FG002|2 Years|Missed visit|4|||
149846678|NCT00847535|540566679|FG000|Overall Study|Withdrawal by Subject|2|||
149846679|NCT00847535|540566680|FG001|Overall Study|Withdrawal by Subject|1|||
149846680|NCT00847535|540566681|FG002|Overall Study|Withdrawal by Subject|1|||
149846681|NCT00847535|540566679|FG000|Overall Study|Lost to Follow-up|0|||
149846682|NCT00847535|540566680|FG001|Overall Study|Lost to Follow-up|1|||
149846683|NCT00847535|540566681|FG002|Overall Study|Lost to Follow-up|0|||
149846684|NCT02336074|540566682|FG000|Overall Study|Adverse Event|0|||
149846685|NCT02336074|540566683|FG001|Overall Study|Adverse Event|2|||
149846686|NCT00958724|540566684|FG000|Overall Study|Disease Progression|6|||
149846687|NCT02121184|540566686|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
149846688|NCT02121184|540566687|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
149846689|NCT02121184|540566686|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
149846690|NCT02121184|540566687|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
149846691|NCT02121184|540566686|FG000|Overall Study|Emergency cesarean section required|0|||
149846692|NCT02121184|540566687|FG001|Overall Study|Emergency cesarean section required|2|||
149846693|NCT02121184|540566686|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
149846694|NCT02121184|540566687|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
149846695|NCT00840203|540566688|FG000|First Intervention|Protocol Violation|1|||
149846696|NCT00840203|540566689|FG001|First Intervention|Protocol Violation|1|||
149846697|NCT00840203|540566688|FG000|Washout|Protocol Violation|1|||
149846698|NCT00840203|540566689|FG001|Washout|Protocol Violation|0|||
149846699|NCT00989950|540566696|FG000|Randomized Phase|Protocol Violation|1|||
149846700|NCT00989950|540566697|FG001|Randomized Phase|Protocol Violation|0|||
149846701|NCT00989950|540566698|FG002|Randomized Phase|Protocol Violation|0|||
149846702|NCT00989950|540566699|FG003|Randomized Phase|Protocol Violation|0|||
149846703|NCT00989950|540566696|FG000|Randomized Phase|Adverse Event|0|||
149846704|NCT00989950|540566697|FG001|Randomized Phase|Adverse Event|1|||
149846705|NCT00989950|540566698|FG002|Randomized Phase|Adverse Event|0|||
149846706|NCT00989950|540566699|FG003|Randomized Phase|Adverse Event|0|||
149846707|NCT00101439|540566700|FG000|Period 2|Withdrawal by Subject|0|||
149846708|NCT00101439|540566701|FG001|Period 2|Withdrawal by Subject|2|||
149846709|NCT02845336|540566705|FG000|Overall Study|Lost to Follow-up|3|||
149846710|NCT02845336|540566706|FG001|Overall Study|Lost to Follow-up|1|||
149846711|NCT02845336|540566705|FG000|Overall Study|Inability to get medication|2|||
149846712|NCT02845336|540566706|FG001|Overall Study|Inability to get medication|0|||
149846713|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Refused|1|||
149846714|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Refused|3|||
150036633|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
150036634|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
150036635|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
150036636|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
150036637|NCT03955146|541274507|FG000|DB Period (48 Weeks)|Participant Decision|9|||
150036638|NCT03955146|541274508|FG001|DB Period (48 Weeks)|Participant Decision|12|||
150036639|NCT03955146|541274509|FG002|DB Period (48 Weeks)|Participant Decision|1|||
150036640|NCT03955146|541274510|FG003|DB Period (48 Weeks)|Participant Decision|1|||
150036641|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
150036642|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
150036643|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
150036644|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
150036645|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
149846715|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Medical|0|||
149846716|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Medical|1|||
149846717|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
150036646|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
150287966|NCT05048719|542189160|FG002|Overall Study|Death|0|||
149846718|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
149846719|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
149846720|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
149846721|NCT02054715|540566708|FG000|Baseline/Follow-up 1|No Reason|0|||
150036647|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
149846722|NCT02054715|540566709|FG001|Baseline/Follow-up 1|No Reason|1|||
150036648|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
149846723|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
149846724|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
149846725|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Ineligible|3|||
149846726|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Ineligible|0|||
149846727|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Hospitalization|1|||
149846728|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Hospitalization|0|||
149846729|NCT02054715|540566708|FG000|Baseline/Follow-up 1|Changed Mind|1|||
149846730|NCT02054715|540566709|FG001|Baseline/Follow-up 1|Changed Mind|0|||
149846731|NCT02054715|540566708|FG000|Follow-up 2|Lost to Followup|3|||
149846732|NCT02054715|540566709|FG001|Follow-up 2|Lost to Followup|1|||
149846733|NCT02054715|540566708|FG000|Follow-up 2|Refused|3|||
149846734|NCT02054715|540566709|FG001|Follow-up 2|Refused|2|||
149846735|NCT02054715|540566708|FG000|Follow-up 2|Followup Not Completed|3|||
149846736|NCT02054715|540566709|FG001|Follow-up 2|Followup Not Completed|4|||
149846737|NCT02054715|540566708|FG000|Follow-up 2|Ineligible|4|||
149846738|NCT02054715|540566709|FG001|Follow-up 2|Ineligible|5|||
149846739|NCT02054715|540566708|FG000|Follow-up 2|Death|3|||
149846740|NCT02054715|540566709|FG001|Follow-up 2|Death|3|||
149846741|NCT02054715|540566708|FG000|Follow-up 2|Hospitalization|0|||
149846742|NCT02054715|540566709|FG001|Follow-up 2|Hospitalization|2|||
149846743|NCT02054715|540566708|FG000|Follow-up 2|Changed MD/Facility|0|||
149846744|NCT02054715|540566709|FG001|Follow-up 2|Changed MD/Facility|1|||
149846745|NCT02054715|540566708|FG000|Follow-up 2|Changed Mind|0|||
149846746|NCT02054715|540566709|FG001|Follow-up 2|Changed Mind|1|||
149846747|NCT02054715|540566708|FG000|Follow-up 2|No Reason|2|||
149846748|NCT02054715|540566709|FG001|Follow-up 2|No Reason|0|||
149846749|NCT02054715|540566708|FG000|Follow-up 2|Treatment Change or Delay|1|||
149846750|NCT02054715|540566709|FG001|Follow-up 2|Treatment Change or Delay|0|||
149846751|NCT00858780|540566710|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
149846752|NCT00858780|540566711|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
149846753|NCT00858780|540566712|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
149846754|NCT00858780|540566713|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
149846755|NCT00858780|540566714|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
149846756|NCT00858780|540566710|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
149846757|NCT00858780|540566711|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
149846758|NCT00858780|540566712|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
149846759|NCT00858780|540566713|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
149846760|NCT00858780|540566714|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
149846761|NCT00858780|540566710|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
149846762|NCT00858780|540566711|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
149846763|NCT00858780|540566712|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
149846764|NCT00858780|540566713|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
149846765|NCT00858780|540566714|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
149846766|NCT00858780|540566710|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
149846767|NCT00858780|540566711|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
149846768|NCT00858780|540566712|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
149846769|NCT00858780|540566713|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
149846770|NCT00858780|540566714|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
149846771|NCT00858780|540566710|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
149846772|NCT00858780|540566711|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
149846773|NCT00858780|540566712|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
149846774|NCT00858780|540566713|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
149846775|NCT00858780|540566714|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
149846776|NCT00858780|540566710|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
149846777|NCT00858780|540566711|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
149846778|NCT00858780|540566712|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
149846779|NCT00858780|540566713|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
149846780|NCT00858780|540566714|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
149846781|NCT03969641|540568282|FG000|Overall Study|Lost to Follow-up|5|||
149846782|NCT03969641|540568283|FG001|Overall Study|Lost to Follow-up|3|||
149846783|NCT03969641|540568282|FG000|Overall Study|Withdrawal by Subject|1|||
149846784|NCT03969641|540568283|FG001|Overall Study|Withdrawal by Subject|2|||
150036649|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
149846785|NCT03969641|540568282|FG000|Overall Study|Found to be ineligible|1|||
149846786|NCT03969641|540568283|FG001|Overall Study|Found to be ineligible|1|||
149846787|NCT03969641|540568282|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
149846788|NCT03969641|540568283|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
149846789|NCT03969641|540568282|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
149846790|NCT03969641|540568283|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
149846791|NCT03969641|540568282|FG000|Overall Study|Elective termination|0|||
149846792|NCT03969641|540568283|FG001|Overall Study|Elective termination|1|||
149846793|NCT05604014|540568290|FG000|Overall Study|Lost to Follow-up|13|||
149846794|NCT01867658|540568291|FG000|Overall Study|Withdrawal by Subject|6|||
149846795|NCT01867658|540568291|FG000|Overall Study|Death|2|||
149846796|NCT01867658|540568291|FG000|Overall Study|Subject could not be contacted|1|||
149846797|NCT02426918|540568292|FG000|Overall Study|Adverse Event|2|||
149846798|NCT02426918|540568293|FG001|Overall Study|Adverse Event|2|||
149846799|NCT02426918|540568294|FG002|Overall Study|Adverse Event|0|||
149846800|NCT02426918|540568292|FG000|Overall Study|Physician Decision|1|||
149846801|NCT02426918|540568293|FG001|Overall Study|Physician Decision|1|||
149846802|NCT02426918|540568294|FG002|Overall Study|Physician Decision|1|||
149846803|NCT02426918|540568292|FG000|Overall Study|Withdrawal by Subject|5|||
149846804|NCT02426918|540568293|FG001|Overall Study|Withdrawal by Subject|5|||
149846805|NCT02426918|540568294|FG002|Overall Study|Withdrawal by Subject|4|||
149846806|NCT02426918|540568292|FG000|Overall Study|Other|9|||
149846807|NCT02426918|540568293|FG001|Overall Study|Other|11|||
149846808|NCT02426918|540568294|FG002|Overall Study|Other|9|||
149846809|NCT01496118|540568295|FG000|Overall Study|Disease progression|3|||
149846810|NCT01496118|540568296|FG001|Overall Study|Disease progression|2|||
149846811|NCT01496118|540568297|FG002|Overall Study|Disease progression|3|||
149846812|NCT01496118|540568298|FG003|Overall Study|Disease progression|1|||
149846813|NCT01496118|540568299|FG004|Overall Study|Disease progression|2|||
149846814|NCT01496118|540568300|FG005|Overall Study|Disease progression|2|||
149846815|NCT01496118|540568301|FG006|Overall Study|Disease progression|14|||
149846816|NCT01496118|540568302|FG007|Overall Study|Disease progression|10|||
149846817|NCT01496118|540568295|FG000|Overall Study|Physician Decision|0|||
149846818|NCT01496118|540568296|FG001|Overall Study|Physician Decision|0|||
149846819|NCT01496118|540568297|FG002|Overall Study|Physician Decision|0|||
149846820|NCT01496118|540568298|FG003|Overall Study|Physician Decision|0|||
149846821|NCT01496118|540568299|FG004|Overall Study|Physician Decision|1|||
149846822|NCT01496118|540568300|FG005|Overall Study|Physician Decision|0|||
149846823|NCT01496118|540568301|FG006|Overall Study|Physician Decision|3|||
149846824|NCT01496118|540568302|FG007|Overall Study|Physician Decision|6|||
149846825|NCT01496118|540568295|FG000|Overall Study|Adverse Event|1|||
149846826|NCT01496118|540568296|FG001|Overall Study|Adverse Event|1|||
149846827|NCT01496118|540568297|FG002|Overall Study|Adverse Event|0|||
149846828|NCT01496118|540568298|FG003|Overall Study|Adverse Event|0|||
149846829|NCT01496118|540568299|FG004|Overall Study|Adverse Event|0|||
149846830|NCT01496118|540568300|FG005|Overall Study|Adverse Event|0|||
149846831|NCT01496118|540568301|FG006|Overall Study|Adverse Event|6|||
149846832|NCT01496118|540568302|FG007|Overall Study|Adverse Event|10|||
149846833|NCT01496118|540568295|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846834|NCT01496118|540568296|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846835|NCT01496118|540568297|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846836|NCT01496118|540568298|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846837|NCT01496118|540568299|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846838|NCT01496118|540568300|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846839|NCT01496118|540568301|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
149846840|NCT01496118|540568302|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
149846841|NCT01496118|540568295|FG000|Overall Study|Death|0|||
149846842|NCT01496118|540568296|FG001|Overall Study|Death|0|||
149846843|NCT01496118|540568297|FG002|Overall Study|Death|0|||
149846844|NCT01496118|540568298|FG003|Overall Study|Death|0|||
150172721|NCT01317420|541768072|FG005|Overall Study|Refused to cont. taking trial medication|0|||
150287967|NCT05048719|542189161|FG003|Overall Study|Death|0|||
150287968|NCT05048719|542189162|FG004|Overall Study|Death|0|||
150287969|NCT05048719|542189163|FG005|Overall Study|Death|0|||
149846845|NCT01496118|540568299|FG004|Overall Study|Death|0|||
149846846|NCT01496118|540568300|FG005|Overall Study|Death|0|||
149846847|NCT01496118|540568301|FG006|Overall Study|Death|1|||
149846848|NCT01496118|540568302|FG007|Overall Study|Death|1|||
149846849|NCT01496118|540568295|FG000|Overall Study|Withdrawal by Subject|0|||
149846850|NCT01496118|540568296|FG001|Overall Study|Withdrawal by Subject|0|||
149846851|NCT01496118|540568297|FG002|Overall Study|Withdrawal by Subject|0|||
149846852|NCT01496118|540568298|FG003|Overall Study|Withdrawal by Subject|2|||
149846853|NCT01496118|540568299|FG004|Overall Study|Withdrawal by Subject|0|||
149846854|NCT01496118|540568300|FG005|Overall Study|Withdrawal by Subject|1|||
149846855|NCT01496118|540568301|FG006|Overall Study|Withdrawal by Subject|6|||
149846856|NCT01496118|540568302|FG007|Overall Study|Withdrawal by Subject|3|||
149846857|NCT01190865|540568307|FG000|Overall Study|Withdrawal by Subject|1|||
149846858|NCT01190865|540568307|FG000|Overall Study|Non-compliance|2|||
149846859|NCT00574847|540568308|FG000|Overall Study|Adverse Event|2|||
150287970|NCT05048719|542189164|FG006|Overall Study|Death|0|||
149846860|NCT00574847|540568309|FG001|Overall Study|Adverse Event|0|||
149846861|NCT00574847|540568308|FG000|Overall Study|Death|1|||
149846862|NCT00574847|540568309|FG001|Overall Study|Death|0|||
149846863|NCT00574847|540568308|FG000|Overall Study|Withdrawal by Subject|2|||
149846864|NCT00574847|540568309|FG001|Overall Study|Withdrawal by Subject|2|||
150287971|NCT05048719|542189165|FG007|Overall Study|Death|0|||
149846865|NCT00574847|540568308|FG000|Overall Study|Physician Decision|1|||
149846866|NCT00574847|540568309|FG001|Overall Study|Physician Decision|0|||
149846867|NCT00574847|540568308|FG000|Overall Study|Did not receive medication (declined)|2|||
149846868|NCT00574847|540568309|FG001|Overall Study|Did not receive medication (declined)|5|||
149846869|NCT02471807|540568314|FG000|Overall Study|Death|14|||
149846870|NCT02471807|540568314|FG000|Overall Study|Withdrawal by Subject|2|||
149846871|NCT02471807|540568314|FG000|Overall Study|Explant|5|||
149846872|NCT02471807|540568314|FG000|Overall Study|Lost to Follow-up|1|||
149846873|NCT04060251|540568326|FG000|Overall Study|Study terminated due to low enrollment.|7|||
149846874|NCT04060251|540568327|FG001|Overall Study|Study terminated due to low enrollment.|5|||
149846875|NCT04060251|540568328|FG002|Overall Study|Study terminated due to low enrollment.|7|||
149846876|NCT04060251|540568326|FG000|Overall Study|Adverse Event|1|||
149846877|NCT04060251|540568327|FG001|Overall Study|Adverse Event|1|||
149846878|NCT04060251|540568328|FG002|Overall Study|Adverse Event|0|||
149846879|NCT00487435|540568329|FG000|Overall Study|Adverse Event|146|||
149846880|NCT00487435|540568329|FG000|Overall Study|Death|2|||
149846881|NCT00487435|540568329|FG000|Overall Study|Lack of Efficacy|33|||
149846882|NCT00487435|540568329|FG000|Overall Study|Lost to Follow-up|54|||
149846883|NCT00487435|540568329|FG000|Overall Study|Pregnancy|2|||
149846884|NCT00487435|540568329|FG000|Overall Study|Withdrawal by Subject|132|||
149846885|NCT00487435|540568329|FG000|Overall Study|Resolution Of Pain|1|||
149846886|NCT00487435|540568329|FG000|Overall Study|Study Medication Non-Compliant|32|||
149846887|NCT00487435|540568329|FG000|Overall Study|Other|83|||
149846888|NCT01155531|540568336|FG000|Overall Study|Adverse Event|0|||
149846889|NCT01155531|540568337|FG001|Overall Study|Adverse Event|0|||
149846890|NCT01155531|540568338|FG002|Overall Study|Adverse Event|1|||
149846891|NCT01155531|540568339|FG003|Overall Study|Adverse Event|0|||
149846892|NCT01155531|540568336|FG000|Overall Study|Lost to Follow-up|0|||
149846893|NCT01155531|540568337|FG001|Overall Study|Lost to Follow-up|0|||
149846894|NCT01155531|540568338|FG002|Overall Study|Lost to Follow-up|0|||
149846895|NCT01155531|540568339|FG003|Overall Study|Lost to Follow-up|1|||
149846896|NCT01155531|540568336|FG000|Overall Study|Withdrawal by Subject|1|||
149846897|NCT01155531|540568337|FG001|Overall Study|Withdrawal by Subject|0|||
149846898|NCT01155531|540568338|FG002|Overall Study|Withdrawal by Subject|1|||
149846899|NCT01155531|540568339|FG003|Overall Study|Withdrawal by Subject|0|||
149846900|NCT01087502|540568340|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
149846901|NCT01087502|540568341|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
149846902|NCT01087502|540568340|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
149846903|NCT01087502|540568341|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
149846904|NCT01087502|540568340|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
149846905|NCT01087502|540568341|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
149846906|NCT01087502|540568340|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
149846907|NCT01087502|540568341|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
149846908|NCT01087502|540568340|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
149846909|NCT01087502|540568341|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
149846910|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
149846911|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
149846912|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
149846913|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
149846914|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
149846915|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
149846916|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
149846917|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
149846918|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
149956066|NCT01740427|540972260|FG000|Overall Study|Protocol Violation|5|||
149956067|NCT01740427|540972261|FG001|Overall Study|Protocol Violation|3|||
149956068|NCT01740427|540972260|FG000|Overall Study|Lost to Follow-up|3|||
149956069|NCT01740427|540972261|FG001|Overall Study|Lost to Follow-up|0|||
149956070|NCT01740427|540972260|FG000|Overall Study|Site Terminated by Sponsor|1|||
149956071|NCT01740427|540972261|FG001|Overall Study|Site Terminated by Sponsor|0|||
149846919|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
149846920|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
149846921|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
149846922|NCT01087502|540568340|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
149846923|NCT01087502|540568341|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
149846924|NCT01653704|540568342|FG000|Overall Study|Technical failure during recording|1|||
149956072|NCT05752487|540972262|FG000|Overall Study|Enrolled, not treated|9|||
149956073|NCT05752487|540972262|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
149956074|NCT05752487|540972262|FG000|Overall Study|Withdrawal by Subject|2|||
149956075|NCT01860989|540972265|FG000|Overall Study|Unsatisfactory therapeutic|5|||
149956076|NCT04739709|540972269|FG000|Overall Study|Physician Decision|1|||
149846925|NCT01653704|540568343|FG001|Overall Study|Technical failure during recording|1|||
149846926|NCT01653704|540568342|FG000|Overall Study|Performance not reflective of training|1|||
149846927|NCT01653704|540568343|FG001|Overall Study|Performance not reflective of training|0|||
149846928|NCT02705716|540568344|FG000|Overall Study|Adverse Event|0|||
149846929|NCT02705716|540568345|FG001|Overall Study|Adverse Event|1|||
149846930|NCT02705716|540568344|FG000|Overall Study|Protocol Violation|3|||
149846931|NCT02705716|540568345|FG001|Overall Study|Protocol Violation|0|||
149846932|NCT02705716|540568344|FG000|Overall Study|Withdrawal of Consent|1|||
149846933|NCT02705716|540568345|FG001|Overall Study|Withdrawal of Consent|1|||
149846934|NCT01151618|540568346|FG000|Overall Study|Adverse Event|2|||
149846935|NCT01151618|540568346|FG000|Overall Study|Withdrawal by Subject|7|||
149846936|NCT00562718|540568347|FG000|Overall Study|Death|1|||
149846937|NCT00562718|540568347|FG000|Overall Study|Withdrawal by Subject|3|||
149846938|NCT00562718|540568347|FG000|Overall Study|Adverse Event|4|||
149846939|NCT00562718|540568347|FG000|Overall Study|Lack of Efficacy|2|||
149846940|NCT00562718|540568347|FG000|Overall Study|not stated|1|||
149846941|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
149846942|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
149846943|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
149846944|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
149846945|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
149846946|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
149846947|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
149846948|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
149846949|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
149846950|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
149846951|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
149846952|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
149846953|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
149846954|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
149846955|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
149846956|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
149846957|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
149846958|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
149846959|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
149846960|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
149846961|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
149846962|NCT02227238|540568348|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
149846963|NCT02227238|540568349|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
149846964|NCT02227238|540568350|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
149846965|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
149846966|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
149846967|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
149846968|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
149846969|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
149846970|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
149846971|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
149846972|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
149846973|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
149846974|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
149846975|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
149846976|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
149846977|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
149846978|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
150287972|NCT05048719|542189166|FG008|Overall Study|Death|0|||
150287973|NCT05048719|542189158|FG000|Overall Study|Adverse Event|0|||
150287974|NCT05048719|542189159|FG001|Overall Study|Adverse Event|1|||
150287975|NCT05048719|542189160|FG002|Overall Study|Adverse Event|2|||
150287976|NCT05048719|542189161|FG003|Overall Study|Adverse Event|0|||
150287977|NCT05048719|542189162|FG004|Overall Study|Adverse Event|1|||
150287978|NCT05048719|542189163|FG005|Overall Study|Adverse Event|0|||
150287979|NCT05048719|542189164|FG006|Overall Study|Adverse Event|0|||
149846979|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
149846980|NCT02227238|540568348|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
149846981|NCT02227238|540568349|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
149846982|NCT02227238|540568350|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
150287980|NCT05048719|542189165|FG007|Overall Study|Adverse Event|0|||
150287981|NCT05048719|542189166|FG008|Overall Study|Adverse Event|0|||
150287982|NCT05048719|542189158|FG000|Overall Study|Lost to Follow-up|0|||
150287983|NCT05048719|542189159|FG001|Overall Study|Lost to Follow-up|0|||
149846983|NCT00985751|540568352|FG000|Overall Study|Adverse Event|0|||
149846984|NCT00985751|540568353|FG001|Overall Study|Adverse Event|0|||
149846985|NCT00985751|540568354|FG002|Overall Study|Adverse Event|0|||
149846986|NCT00985751|540568355|FG003|Overall Study|Adverse Event|0|||
149846987|NCT00985751|540568356|FG004|Overall Study|Adverse Event|1|||
149846988|NCT00868998|540568357|FG000|Overall Study|Screen Failure|1|||
149846989|NCT00868998|540568357|FG000|Overall Study|Withdrawal by Subject|1|||
149846990|NCT00868998|540568357|FG000|Overall Study|Progression of disease|2|||
149846991|NCT00868998|540568357|FG000|Overall Study|Death|1|||
149846992|NCT01986647|540568359|FG000|Overall Study|Lost to Follow-up|4|||
149846993|NCT01986647|540568360|FG001|Overall Study|Lost to Follow-up|1|||
149846994|NCT01986647|540568361|FG002|Overall Study|Lost to Follow-up|4|||
149846995|NCT01986647|540568362|FG003|Overall Study|Lost to Follow-up|4|||
149846996|NCT01986647|540568359|FG000|Overall Study|Withdrawal by Subject|1|||
149846997|NCT01986647|540568360|FG001|Overall Study|Withdrawal by Subject|3|||
149846998|NCT01986647|540568361|FG002|Overall Study|Withdrawal by Subject|2|||
149846999|NCT01986647|540568362|FG003|Overall Study|Withdrawal by Subject|3|||
149847000|NCT01986647|540568359|FG000|Overall Study|Health|5|||
149847001|NCT01986647|540568360|FG001|Overall Study|Health|3|||
149847002|NCT01986647|540568361|FG002|Overall Study|Health|6|||
149847003|NCT01986647|540568362|FG003|Overall Study|Health|4|||
149847004|NCT01483820|540568363|FG000|Overall Study|Lack of Efficacy|6|||
149847005|NCT01483820|540568363|FG000|Overall Study|Adverse Event|1|||
149847006|NCT01483820|540568363|FG000|Overall Study|Death|1|||
149847007|NCT01507662|540568364|FG000|Overall Study|Death|26|||
149847008|NCT01507662|540568365|FG001|Overall Study|Death|18|||
149847009|NCT01507662|540568364|FG000|Overall Study|Withdrawal by Subject|290|||
149847010|NCT01507662|540568365|FG001|Overall Study|Withdrawal by Subject|287|||
149847011|NCT01507662|540568364|FG000|Overall Study|Lost to Follow-up|498|||
149847012|NCT01507662|540568365|FG001|Overall Study|Lost to Follow-up|523|||
149847013|NCT01507662|540568364|FG000|Overall Study|Proxy interview done|2|||
149847014|NCT01507662|540568365|FG001|Overall Study|Proxy interview done|3|||
149847015|NCT03541252|540568372|FG000|Overall Study|Withdrawal by Subject|1|||
149847016|NCT01960296|540568379|FG000|Overall Study|Postponed surgery|1|||
149847017|NCT01960296|540568380|FG001|Overall Study|Postponed surgery|0|||
149847018|NCT01960296|540568379|FG000|Overall Study|Received different procedure|1|||
149847019|NCT01960296|540568380|FG001|Overall Study|Received different procedure|3|||
149847020|NCT02003391|540568381|FG000|Overall Study|Withdrawal by Subject|2|||
149847021|NCT02003391|540568382|FG001|Overall Study|Withdrawal by Subject|1|||
150172722|NCT01317420|541768073|FG006|Overall Study|Refused to cont. taking trial medication|0|||
150287984|NCT05048719|542189160|FG002|Overall Study|Lost to Follow-up|1|||
150287985|NCT05048719|542189161|FG003|Overall Study|Lost to Follow-up|3|||
149847022|NCT02003391|540568381|FG000|Overall Study|Protocol Violation|0|||
149847023|NCT02003391|540568382|FG001|Overall Study|Protocol Violation|1|||
149847024|NCT02003391|540568381|FG000|Overall Study|Adverse Event|1|||
149847025|NCT02003391|540568382|FG001|Overall Study|Adverse Event|0|||
149847026|NCT02272803|540568383|FG000|Overall Study|Disease progression|16|||
149847027|NCT02272803|540568384|FG001|Overall Study|Disease progression|8|||
149847028|NCT02272803|540568383|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
149847029|NCT02272803|540568384|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
149847030|NCT02272803|540568383|FG000|Overall Study|Study drug toxicity|4|||
149847031|NCT02272803|540568384|FG001|Overall Study|Study drug toxicity|9|||
149847032|NCT02272803|540568383|FG000|Overall Study|Participant request to discontinue study treatment|3|||
149847033|NCT02272803|540568384|FG001|Overall Study|Participant request to discontinue study treatment|7|||
149847034|NCT02272803|540568383|FG000|Overall Study|Maximum clinical benefit|4|||
149847035|NCT02272803|540568384|FG001|Overall Study|Maximum clinical benefit|2|||
149847036|NCT02272803|540568383|FG000|Overall Study|Poor/non-compliance|2|||
149847037|NCT02272803|540568384|FG001|Overall Study|Poor/non-compliance|2|||
149847038|NCT02272803|540568383|FG000|Overall Study|Withdrawal by Subject|2|||
149847039|NCT02272803|540568384|FG001|Overall Study|Withdrawal by Subject|1|||
149847040|NCT02272803|540568383|FG000|Overall Study|Death|0|||
149847041|NCT02272803|540568384|FG001|Overall Study|Death|1|||
149847042|NCT02272803|540568383|FG000|Overall Study|Other reasons|1|||
149847043|NCT02272803|540568384|FG001|Overall Study|Other reasons|3|||
149847044|NCT02272803|540568383|FG000|Overall Study|Administrative reason by sponsor|5|||
149956077|NCT04739709|540972270|FG001|Overall Study|Physician Decision|0|||
149956078|NCT01033071|540972274|FG000|Overall Study|Adverse Event|28|||
149956079|NCT01033071|540972275|FG001|Overall Study|Adverse Event|51|||
149956080|NCT01033071|540972276|FG002|Overall Study|Adverse Event|26|||
149956081|NCT01033071|540972274|FG000|Overall Study|Protocol Violation|0|||
149956082|NCT01033071|540972275|FG001|Overall Study|Protocol Violation|2|||
149956083|NCT01033071|540972276|FG002|Overall Study|Protocol Violation|1|||
149956084|NCT01033071|540972274|FG000|Overall Study|Lost to Follow-up|4|||
149956085|NCT01033071|540972275|FG001|Overall Study|Lost to Follow-up|5|||
149956086|NCT01033071|540972276|FG002|Overall Study|Lost to Follow-up|5|||
149956087|NCT01033071|540972274|FG000|Overall Study|Withdrawal by Subject|17|||
149956088|NCT01033071|540972275|FG001|Overall Study|Withdrawal by Subject|14|||
149956089|NCT01033071|540972276|FG002|Overall Study|Withdrawal by Subject|11|||
149847045|NCT02272803|540568384|FG001|Overall Study|Administrative reason by sponsor|4|||
149847046|NCT02611323|540568385|FG000|Overall Study|Death|3|||
149847047|NCT02611323|540568386|FG001|Overall Study|Death|1|||
149847048|NCT02611323|540568387|FG002|Overall Study|Death|0|||
149847049|NCT02611323|540568388|FG003|Overall Study|Death|0|||
149847050|NCT02611323|540568389|FG004|Overall Study|Death|1|||
149847051|NCT02611323|540568390|FG005|Overall Study|Death|1|||
149847052|NCT02611323|540568391|FG006|Overall Study|Death|8|||
149847053|NCT02611323|540568392|FG007|Overall Study|Death|0|||
149847054|NCT02611323|540568393|FG008|Overall Study|Death|4|||
149847055|NCT02611323|540568394|FG009|Overall Study|Death|6|||
149847056|NCT02611323|540568395|FG010|Overall Study|Death|26|||
149847057|NCT02611323|540568385|FG000|Overall Study|Lost to Follow-up|1|||
149847058|NCT02611323|540568386|FG001|Overall Study|Lost to Follow-up|0|||
149847059|NCT02611323|540568387|FG002|Overall Study|Lost to Follow-up|0|||
149847060|NCT02611323|540568388|FG003|Overall Study|Lost to Follow-up|0|||
149847061|NCT02611323|540568389|FG004|Overall Study|Lost to Follow-up|0|||
149847062|NCT02611323|540568390|FG005|Overall Study|Lost to Follow-up|0|||
149847063|NCT02611323|540568391|FG006|Overall Study|Lost to Follow-up|3|||
149847064|NCT02611323|540568392|FG007|Overall Study|Lost to Follow-up|0|||
149847065|NCT02611323|540568393|FG008|Overall Study|Lost to Follow-up|0|||
149847066|NCT02611323|540568394|FG009|Overall Study|Lost to Follow-up|0|||
149847067|NCT02611323|540568395|FG010|Overall Study|Lost to Follow-up|2|||
149847068|NCT02611323|540568385|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847069|NCT02611323|540568386|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847070|NCT02611323|540568387|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847071|NCT02611323|540568388|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847072|NCT02611323|540568389|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847073|NCT02611323|540568390|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847074|NCT02611323|540568391|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847075|NCT02611323|540568392|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847076|NCT02611323|540568393|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847077|NCT02611323|540568394|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
149847078|NCT02611323|540568395|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
149847079|NCT02611323|540568385|FG000|Overall Study|Progressive Disease|0|||
149847080|NCT02611323|540568386|FG001|Overall Study|Progressive Disease|0|||
149847081|NCT02611323|540568387|FG002|Overall Study|Progressive Disease|0|||
149847082|NCT02611323|540568388|FG003|Overall Study|Progressive Disease|0|||
149847083|NCT02611323|540568389|FG004|Overall Study|Progressive Disease|0|||
149847084|NCT02611323|540568390|FG005|Overall Study|Progressive Disease|0|||
149847085|NCT02611323|540568391|FG006|Overall Study|Progressive Disease|0|||
149956090|NCT01033071|540972274|FG000|Overall Study|Lack of Efficacy|0|||
149956091|NCT01033071|540972275|FG001|Overall Study|Lack of Efficacy|1|||
149956092|NCT01033071|540972276|FG002|Overall Study|Lack of Efficacy|1|||
149956093|NCT01033071|540972274|FG000|Overall Study|Other|6|||
149956094|NCT01033071|540972275|FG001|Overall Study|Other|4|||
149956095|NCT01033071|540972276|FG002|Overall Study|Other|3|||
149956096|NCT03684057|540973926|FG000|Overall Study|Withdrawal by Subject|4|||
149956097|NCT03684057|540973927|FG001|Overall Study|Withdrawal by Subject|5|||
149956098|NCT02082483|540973931|FG000|Overall Study|Lost to Follow-up|1|||
150287986|NCT05048719|542189162|FG004|Overall Study|Lost to Follow-up|1|||
150287987|NCT05048719|542189163|FG005|Overall Study|Lost to Follow-up|1|||
150287988|NCT05048719|542189164|FG006|Overall Study|Lost to Follow-up|1|||
150287989|NCT05048719|542189165|FG007|Overall Study|Lost to Follow-up|1|||
150287990|NCT05048719|542189166|FG008|Overall Study|Lost to Follow-up|0|||
150287991|NCT05048719|542189158|FG000|Overall Study|Physician Decision|0|||
150287992|NCT05048719|542189159|FG001|Overall Study|Physician Decision|0|||
150287993|NCT05048719|542189160|FG002|Overall Study|Physician Decision|0|||
149847086|NCT02611323|540568392|FG007|Overall Study|Progressive Disease|0|||
149847087|NCT02611323|540568393|FG008|Overall Study|Progressive Disease|0|||
149847088|NCT02611323|540568394|FG009|Overall Study|Progressive Disease|0|||
149847089|NCT02611323|540568395|FG010|Overall Study|Progressive Disease|1|||
149847090|NCT02611323|540568385|FG000|Overall Study|Withdrawal by Subject|1|||
149847091|NCT02611323|540568386|FG001|Overall Study|Withdrawal by Subject|0|||
149847092|NCT02611323|540568387|FG002|Overall Study|Withdrawal by Subject|0|||
149847093|NCT02611323|540568388|FG003|Overall Study|Withdrawal by Subject|0|||
149847094|NCT02611323|540568389|FG004|Overall Study|Withdrawal by Subject|0|||
149847095|NCT02611323|540568390|FG005|Overall Study|Withdrawal by Subject|0|||
149847096|NCT02611323|540568391|FG006|Overall Study|Withdrawal by Subject|0|||
149847097|NCT02611323|540568392|FG007|Overall Study|Withdrawal by Subject|1|||
149847098|NCT02611323|540568393|FG008|Overall Study|Withdrawal by Subject|0|||
149847099|NCT02611323|540568394|FG009|Overall Study|Withdrawal by Subject|1|||
149847100|NCT02611323|540568395|FG010|Overall Study|Withdrawal by Subject|0|||
149847101|NCT00858403|540568396|FG000|Overall Study|Withdrawal by Subject|1|||
149847102|NCT00858403|540568396|FG000|Overall Study|Death|3|||
149847103|NCT00858403|540568396|FG000|Overall Study|Disease Progression|1|||
149956099|NCT02082483|540973932|FG001|Overall Study|Lost to Follow-up|1|||
150287994|NCT05048719|542189161|FG003|Overall Study|Physician Decision|0|||
149847104|NCT02264977|540568397|FG000|Overall Study|Death|3|||
149847105|NCT02264977|540568397|FG000|Overall Study|Physician Decision|1|||
149847106|NCT02264977|540568397|FG000|Overall Study|Refuse to return|1|||
149847107|NCT00243347|540568398|FG000|Overall Study|Lack of Efficacy|4|||
149847108|NCT00243347|540568398|FG000|Overall Study|Adverse Event|2|||
149847109|NCT00243347|540568398|FG000|Overall Study|Death|1|||
149847110|NCT00243347|540568398|FG000|Overall Study|Withdrawal by Subject|5|||
149847111|NCT00243347|540568398|FG000|Overall Study|Condition worsened|7|||
149847112|NCT03573544|540568399|FG000|Overall Study|Adverse Event|0|||
149847113|NCT03573544|540568400|FG001|Overall Study|Adverse Event|0|||
149847114|NCT03573544|540568401|FG002|Overall Study|Adverse Event|0|||
149847115|NCT03573544|540568402|FG003|Overall Study|Adverse Event|3|||
149847116|NCT03573544|540568403|FG004|Overall Study|Adverse Event|1|||
149847117|NCT03573544|540568404|FG005|Overall Study|Adverse Event|0|||
149847118|NCT03573544|540568405|FG006|Overall Study|Adverse Event|2|||
149847119|NCT03573544|540568406|FG007|Overall Study|Adverse Event|0|||
149847120|NCT03573544|540568399|FG000|Overall Study|Physician Decision|0|||
149847121|NCT03573544|540568400|FG001|Overall Study|Physician Decision|0|||
149847122|NCT03573544|540568401|FG002|Overall Study|Physician Decision|0|||
149847123|NCT03573544|540568402|FG003|Overall Study|Physician Decision|0|||
149847124|NCT03573544|540568403|FG004|Overall Study|Physician Decision|0|||
149847125|NCT03573544|540568404|FG005|Overall Study|Physician Decision|0|||
149847126|NCT03573544|540568405|FG006|Overall Study|Physician Decision|1|||
149847127|NCT03573544|540568406|FG007|Overall Study|Physician Decision|0|||
149847128|NCT03573544|540568399|FG000|Overall Study|Withdrawal by Subject|2|||
149847129|NCT03573544|540568400|FG001|Overall Study|Withdrawal by Subject|0|||
149847130|NCT03573544|540568401|FG002|Overall Study|Withdrawal by Subject|0|||
149847131|NCT03573544|540568402|FG003|Overall Study|Withdrawal by Subject|1|||
149847132|NCT03573544|540568403|FG004|Overall Study|Withdrawal by Subject|1|||
149847133|NCT03573544|540568404|FG005|Overall Study|Withdrawal by Subject|1|||
149847134|NCT03573544|540568405|FG006|Overall Study|Withdrawal by Subject|0|||
149847135|NCT03573544|540568406|FG007|Overall Study|Withdrawal by Subject|1|||
149847136|NCT03573544|540568399|FG000|Overall Study|Disease progression|3|||
149847137|NCT03573544|540568400|FG001|Overall Study|Disease progression|3|||
150287995|NCT05048719|542189162|FG004|Overall Study|Physician Decision|0|||
149847138|NCT03573544|540568401|FG002|Overall Study|Disease progression|6|||
149847139|NCT03573544|540568402|FG003|Overall Study|Disease progression|4|||
149956100|NCT02082483|540973931|FG000|Overall Study|Withdrawal by Subject|2|||
149956101|NCT02082483|540973932|FG001|Overall Study|Withdrawal by Subject|1|||
149956102|NCT02082483|540973931|FG000|Overall Study|Physician Decision|1|||
149956103|NCT02082483|540973932|FG001|Overall Study|Physician Decision|1|||
149956104|NCT02082483|540973931|FG000|Overall Study|Death|2|||
149956105|NCT02082483|540973932|FG001|Overall Study|Death|3|||
149956106|NCT02181621|540973933|FG000|Overall Study|Adverse Event|1|||
150287996|NCT05048719|542189163|FG005|Overall Study|Physician Decision|0|||
150287997|NCT05048719|542189164|FG006|Overall Study|Physician Decision|0|||
150287998|NCT05048719|542189165|FG007|Overall Study|Physician Decision|1|||
150287999|NCT05048719|542189166|FG008|Overall Study|Physician Decision|1|||
150288000|NCT05048719|542189158|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
149847140|NCT03573544|540568403|FG004|Overall Study|Disease progression|5|||
149847141|NCT03573544|540568404|FG005|Overall Study|Disease progression|7|||
149847142|NCT03573544|540568405|FG006|Overall Study|Disease progression|6|||
149847143|NCT03573544|540568406|FG007|Overall Study|Disease progression|7|||
149847144|NCT01899053|540568407|FG000|Overall Study|Progressive Disease|4|||
149847145|NCT01899053|540568408|FG001|Overall Study|Progressive Disease|0|||
149847146|NCT01899053|540568409|FG002|Overall Study|Progressive Disease|3|||
149847147|NCT01899053|540568410|FG003|Overall Study|Progressive Disease|0|||
149847148|NCT01899053|540568411|FG004|Overall Study|Progressive Disease|3|||
149847149|NCT01899053|540568412|FG005|Overall Study|Progressive Disease|1|||
149847150|NCT01899053|540568413|FG006|Overall Study|Progressive Disease|1|||
149847151|NCT01899053|540568414|FG007|Overall Study|Progressive Disease|1|||
149847152|NCT01899053|540568415|FG008|Overall Study|Progressive Disease|4|||
149847153|NCT01899053|540568416|FG009|Overall Study|Progressive Disease|3|||
149847154|NCT01899053|540568417|FG010|Overall Study|Progressive Disease|12|||
149847155|NCT01899053|540568418|FG011|Overall Study|Progressive Disease|5|||
149847156|NCT01899053|540568419|FG012|Overall Study|Progressive Disease|8|||
149847157|NCT01899053|540568420|FG013|Overall Study|Progressive Disease|17|||
149847158|NCT01899053|540568407|FG000|Overall Study|Adverse Event|1|||
149847159|NCT01899053|540568408|FG001|Overall Study|Adverse Event|1|||
149847160|NCT01899053|540568409|FG002|Overall Study|Adverse Event|1|||
149847161|NCT01899053|540568410|FG003|Overall Study|Adverse Event|3|||
149847162|NCT01899053|540568411|FG004|Overall Study|Adverse Event|1|||
149847163|NCT01899053|540568412|FG005|Overall Study|Adverse Event|1|||
149847164|NCT01899053|540568413|FG006|Overall Study|Adverse Event|1|||
150288001|NCT05048719|542189159|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149847165|NCT01899053|540568414|FG007|Overall Study|Adverse Event|0|||
149847166|NCT01899053|540568415|FG008|Overall Study|Adverse Event|2|||
149847167|NCT01899053|540568416|FG009|Overall Study|Adverse Event|0|||
149847168|NCT01899053|540568417|FG010|Overall Study|Adverse Event|3|||
149847169|NCT01899053|540568418|FG011|Overall Study|Adverse Event|1|||
149847170|NCT01899053|540568419|FG012|Overall Study|Adverse Event|2|||
149847171|NCT01899053|540568420|FG013|Overall Study|Adverse Event|2|||
149847172|NCT01899053|540568407|FG000|Overall Study|Reason Not Specified|0|||
149847173|NCT01899053|540568408|FG001|Overall Study|Reason Not Specified|0|||
149847174|NCT01899053|540568409|FG002|Overall Study|Reason Not Specified|0|||
149847175|NCT01899053|540568410|FG003|Overall Study|Reason Not Specified|0|||
149847176|NCT01899053|540568411|FG004|Overall Study|Reason Not Specified|0|||
149847177|NCT01899053|540568412|FG005|Overall Study|Reason Not Specified|0|||
149847178|NCT01899053|540568413|FG006|Overall Study|Reason Not Specified|1|||
149847179|NCT01899053|540568414|FG007|Overall Study|Reason Not Specified|0|||
149847180|NCT01899053|540568415|FG008|Overall Study|Reason Not Specified|0|||
149847181|NCT01899053|540568416|FG009|Overall Study|Reason Not Specified|0|||
149847182|NCT01899053|540568417|FG010|Overall Study|Reason Not Specified|0|||
149847183|NCT01899053|540568418|FG011|Overall Study|Reason Not Specified|0|||
149847184|NCT01899053|540568419|FG012|Overall Study|Reason Not Specified|1|||
149847185|NCT01899053|540568420|FG013|Overall Study|Reason Not Specified|0|||
149847186|NCT01899053|540568407|FG000|Overall Study|Withdrawal by Subject|1|||
149847187|NCT01899053|540568408|FG001|Overall Study|Withdrawal by Subject|1|||
150036650|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
149847188|NCT01899053|540568409|FG002|Overall Study|Withdrawal by Subject|2|||
149847189|NCT01899053|540568410|FG003|Overall Study|Withdrawal by Subject|0|||
149847190|NCT01899053|540568411|FG004|Overall Study|Withdrawal by Subject|2|||
149847191|NCT01899053|540568412|FG005|Overall Study|Withdrawal by Subject|0|||
150036651|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
150036652|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
150036653|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
150036654|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
150036655|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
150036656|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
150036657|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
150036658|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
150288002|NCT05048719|542189160|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149847192|NCT01899053|540568413|FG006|Overall Study|Withdrawal by Subject|0|||
149847193|NCT01899053|540568414|FG007|Overall Study|Withdrawal by Subject|1|||
149847194|NCT01899053|540568415|FG008|Overall Study|Withdrawal by Subject|0|||
149847195|NCT01899053|540568416|FG009|Overall Study|Withdrawal by Subject|0|||
149847196|NCT01899053|540568417|FG010|Overall Study|Withdrawal by Subject|0|||
149847197|NCT01899053|540568418|FG011|Overall Study|Withdrawal by Subject|0|||
149847198|NCT01899053|540568419|FG012|Overall Study|Withdrawal by Subject|1|||
149847199|NCT01899053|540568420|FG013|Overall Study|Withdrawal by Subject|1|||
149847200|NCT01899053|540568407|FG000|Overall Study|Protocol Violation|0|||
149847201|NCT01899053|540568408|FG001|Overall Study|Protocol Violation|0|||
149847202|NCT01899053|540568409|FG002|Overall Study|Protocol Violation|1|||
149847203|NCT01899053|540568410|FG003|Overall Study|Protocol Violation|0|||
149847204|NCT01899053|540568411|FG004|Overall Study|Protocol Violation|0|||
149847205|NCT01899053|540568412|FG005|Overall Study|Protocol Violation|0|||
149847206|NCT01899053|540568413|FG006|Overall Study|Protocol Violation|0|||
149847207|NCT01899053|540568414|FG007|Overall Study|Protocol Violation|0|||
149847208|NCT01899053|540568415|FG008|Overall Study|Protocol Violation|0|||
149847209|NCT01899053|540568416|FG009|Overall Study|Protocol Violation|0|||
149847210|NCT01899053|540568417|FG010|Overall Study|Protocol Violation|0|||
149847211|NCT01899053|540568418|FG011|Overall Study|Protocol Violation|0|||
149847212|NCT01899053|540568419|FG012|Overall Study|Protocol Violation|0|||
149847213|NCT01899053|540568420|FG013|Overall Study|Protocol Violation|0|||
149847214|NCT01899053|540568407|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
149847215|NCT01899053|540568408|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
149847216|NCT01899053|540568409|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847217|NCT01899053|540568410|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847218|NCT01899053|540568411|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847219|NCT01899053|540568412|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847220|NCT01899053|540568413|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847221|NCT01899053|540568414|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
150036659|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
150288003|NCT05048719|542189161|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
150288004|NCT05048719|542189162|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
150288005|NCT05048719|542189163|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
150288006|NCT05048719|542189164|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
150288007|NCT05048719|542189165|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
150288008|NCT05048719|542189166|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149847222|NCT01899053|540568415|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847223|NCT01899053|540568416|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847224|NCT01899053|540568417|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
149847225|NCT01899053|540568418|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847226|NCT01899053|540568419|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847227|NCT01899053|540568420|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
149847228|NCT01899053|540568407|FG000|Overall Study|Symptomatic Deterioration|0|||
149847229|NCT01899053|540568408|FG001|Overall Study|Symptomatic Deterioration|0|||
149847230|NCT01899053|540568409|FG002|Overall Study|Symptomatic Deterioration|0|||
149847231|NCT01899053|540568410|FG003|Overall Study|Symptomatic Deterioration|0|||
149847232|NCT01899053|540568411|FG004|Overall Study|Symptomatic Deterioration|0|||
149847233|NCT01899053|540568412|FG005|Overall Study|Symptomatic Deterioration|1|||
149847234|NCT01899053|540568413|FG006|Overall Study|Symptomatic Deterioration|0|||
149847235|NCT01899053|540568414|FG007|Overall Study|Symptomatic Deterioration|1|||
149847236|NCT01899053|540568415|FG008|Overall Study|Symptomatic Deterioration|0|||
149847237|NCT01899053|540568416|FG009|Overall Study|Symptomatic Deterioration|0|||
149847238|NCT01899053|540568417|FG010|Overall Study|Symptomatic Deterioration|0|||
149847239|NCT01899053|540568418|FG011|Overall Study|Symptomatic Deterioration|1|||
149847240|NCT01899053|540568419|FG012|Overall Study|Symptomatic Deterioration|2|||
149847241|NCT01899053|540568420|FG013|Overall Study|Symptomatic Deterioration|0|||
149847242|NCT03105297|540568423|FG000|Baseline Phase (Day 1)|Other|21|||
149847243|NCT03105297|540568423|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
149847244|NCT03105297|540568423|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
149847245|NCT03846193|540568425|FG000|Overall Study|Physician Decision|0|||
149847246|NCT03846193|540568426|FG001|Overall Study|Physician Decision|0|||
149847247|NCT03846193|540568427|FG002|Overall Study|Physician Decision|1|||
149847248|NCT03846193|540568428|FG003|Overall Study|Physician Decision|0|||
149847249|NCT03846193|540568429|FG004|Overall Study|Physician Decision|0|||
149847250|NCT03846193|540568425|FG000|Overall Study|Lost to Follow-up|0|||
149847251|NCT03846193|540568426|FG001|Overall Study|Lost to Follow-up|0|||
149847252|NCT03846193|540568427|FG002|Overall Study|Lost to Follow-up|0|||
149847253|NCT03846193|540568428|FG003|Overall Study|Lost to Follow-up|0|||
149847254|NCT03846193|540568429|FG004|Overall Study|Lost to Follow-up|1|||
149847255|NCT03846193|540568425|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
149847256|NCT03846193|540568426|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
149847257|NCT03846193|540568427|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
149847258|NCT03846193|540568428|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
149847259|NCT03846193|540568429|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
149847260|NCT03961204|540568431|FG000|Overall Study|Withdrawal by Subject|2|||
149847261|NCT03961204|540568431|FG000|Overall Study|Lost to Follow-up|3|||
149847262|NCT03961204|540568431|FG000|Overall Study|Other|1|||
149847263|NCT03961204|540568431|FG000|Overall Study|Missing|1|||
149847264|NCT02452463|540568434|FG000|Overall Study|Death|1|||
149847265|NCT02452463|540568435|FG001|Overall Study|Death|0|||
149847266|NCT02452463|540568436|FG002|Overall Study|Death|0|||
149847267|NCT02452463|540568434|FG000|Overall Study|Study Suspended|1|||
149847268|NCT02452463|540568435|FG001|Overall Study|Study Suspended|0|||
149847269|NCT02452463|540568436|FG002|Overall Study|Study Suspended|0|||
149847270|NCT02452463|540568434|FG000|Overall Study|Recommended by DSMB|0|||
149847271|NCT02452463|540568435|FG001|Overall Study|Recommended by DSMB|1|||
149847272|NCT02452463|540568436|FG002|Overall Study|Recommended by DSMB|0|||
149847273|NCT02452463|540568434|FG000|Overall Study|Withdrawal by Subject|0|||
149847274|NCT02452463|540568435|FG001|Overall Study|Withdrawal by Subject|1|||
149847275|NCT02452463|540568436|FG002|Overall Study|Withdrawal by Subject|0|||
149847276|NCT03867760|540568437|FG000|Overall Study|Lost to Follow-up|2|||
149847277|NCT03867760|540568438|FG001|Overall Study|Lost to Follow-up|3|||
149847278|NCT03867760|540568437|FG000|Overall Study|Withdrawal by Subject|1|||
149847279|NCT03867760|540568438|FG001|Overall Study|Withdrawal by Subject|2|||
149847280|NCT03867760|540568437|FG000|Overall Study|subject could not meet study logistics|3|||
149847281|NCT03867760|540568438|FG001|Overall Study|subject could not meet study logistics|3|||
149847282|NCT01073631|540568439|FG000|Overall Study|Death|82|||
149847283|NCT01073631|540568439|FG000|Overall Study|Adverse Event|24|||
149847284|NCT01073631|540568439|FG000|Overall Study|Other|63|||
149847285|NCT01018862|540568446|FG000|Overall Study|Adverse Event|2|||
149847286|NCT01018862|540568447|FG001|Overall Study|Adverse Event|0|||
149847287|NCT01018862|540568448|FG002|Overall Study|Adverse Event|6|||
149847288|NCT01018862|540568446|FG000|Overall Study|Lack of Efficacy|1|||
149847289|NCT01018862|540568447|FG001|Overall Study|Lack of Efficacy|0|||
149847290|NCT01018862|540568448|FG002|Overall Study|Lack of Efficacy|2|||
149847291|NCT01018862|540568446|FG000|Overall Study|Lost to Follow-up|3|||
149847292|NCT01018862|540568447|FG001|Overall Study|Lost to Follow-up|1|||
149847293|NCT01018862|540568448|FG002|Overall Study|Lost to Follow-up|0|||
149847294|NCT01018862|540568446|FG000|Overall Study|Protocol Violation|1|||
149847295|NCT01018862|540568447|FG001|Overall Study|Protocol Violation|3|||
149847296|NCT01018862|540568448|FG002|Overall Study|Protocol Violation|3|||
149847297|NCT01018862|540568446|FG000|Overall Study|Withdrawal by Subject|1|||
149847298|NCT01018862|540568447|FG001|Overall Study|Withdrawal by Subject|2|||
150172723|NCT01317420|541768074|FG007|Overall Study|Refused to cont. taking trial medication|0|||
150172724|NCT01317420|541768075|FG008|Overall Study|Refused to cont. taking trial medication|0|||
149847299|NCT01018862|540568448|FG002|Overall Study|Withdrawal by Subject|1|||
149847300|NCT01018862|540568446|FG000|Overall Study|administrative problems|5|||
149847301|NCT01018862|540568447|FG001|Overall Study|administrative problems|4|||
149847302|NCT01018862|540568448|FG002|Overall Study|administrative problems|4|||
149847303|NCT01968031|540568452|FG000|Overall Study|Adverse Event|13|||
149847304|NCT01968031|540568453|FG001|Overall Study|Adverse Event|10|||
149847305|NCT01968031|540568454|FG002|Overall Study|Adverse Event|22|||
149847306|NCT01968031|540568452|FG000|Overall Study|Withdrawal by Subject|3|||
149847307|NCT01968031|540568453|FG001|Overall Study|Withdrawal by Subject|7|||
149847308|NCT01968031|540568454|FG002|Overall Study|Withdrawal by Subject|3|||
149847309|NCT01968031|540568452|FG000|Overall Study|Did not meet entry criteria|1|||
149847310|NCT01968031|540568453|FG001|Overall Study|Did not meet entry criteria|1|||
149847311|NCT01968031|540568454|FG002|Overall Study|Did not meet entry criteria|1|||
149847312|NCT01968031|540568452|FG000|Overall Study|Noncompliance|0|||
149847313|NCT01968031|540568453|FG001|Overall Study|Noncompliance|0|||
149847314|NCT01968031|540568454|FG002|Overall Study|Noncompliance|2|||
149847315|NCT01968031|540568452|FG000|Overall Study|Failed inclusion criteria|0|||
149847316|NCT01968031|540568453|FG001|Overall Study|Failed inclusion criteria|2|||
149847317|NCT01968031|540568454|FG002|Overall Study|Failed inclusion criteria|0|||
149847318|NCT01968031|540568452|FG000|Overall Study|Death|0|||
149847319|NCT01968031|540568453|FG001|Overall Study|Death|0|||
149847320|NCT01968031|540568454|FG002|Overall Study|Death|1|||
149847321|NCT01968031|540568452|FG000|Overall Study|Prohibited concomitant medication|1|||
149847322|NCT01968031|540568453|FG001|Overall Study|Prohibited concomitant medication|0|||
149847323|NCT01968031|540568454|FG002|Overall Study|Prohibited concomitant medication|0|||
149847324|NCT01891357|540568455|FG000|Overall Study|Protocol Violation|3|||
149847325|NCT00840879|540568456|FG000|Second Intervention|Withdrawal by Subject|1|||
149847326|NCT00840879|540568457|FG001|Second Intervention|Withdrawal by Subject|0|||
149847327|NCT02313558|540569858|FG000|Overall Study|Withdrawal by Subject|2|||
149847328|NCT02313558|540569859|FG001|Overall Study|Withdrawal by Subject|0|||
149847329|NCT02313558|540569858|FG000|Overall Study|Lost to Follow-up|4|||
149847330|NCT02313558|540569859|FG001|Overall Study|Lost to Follow-up|4|||
149847331|NCT01911429|540569860|FG000|Overall Study|Adverse Event|5|||
149847332|NCT01911429|540569861|FG001|Overall Study|Adverse Event|3|||
149847333|NCT01911429|540569862|FG002|Overall Study|Adverse Event|9|||
149847334|NCT01911429|540569860|FG000|Overall Study|Lack of Efficacy|1|||
149847335|NCT01911429|540569861|FG001|Overall Study|Lack of Efficacy|2|||
149847336|NCT01911429|540569862|FG002|Overall Study|Lack of Efficacy|4|||
149847337|NCT01911429|540569860|FG000|Overall Study|Lost to Follow-up|0|||
149847338|NCT01911429|540569861|FG001|Overall Study|Lost to Follow-up|0|||
149847339|NCT01911429|540569862|FG002|Overall Study|Lost to Follow-up|1|||
149847340|NCT01911429|540569860|FG000|Overall Study|Protocol Violation|0|||
149847341|NCT01911429|540569861|FG001|Overall Study|Protocol Violation|0|||
149847342|NCT01911429|540569862|FG002|Overall Study|Protocol Violation|1|||
149847343|NCT01911429|540569860|FG000|Overall Study|Withdrawal by Subject|5|||
149847344|NCT01911429|540569861|FG001|Overall Study|Withdrawal by Subject|5|||
149847345|NCT01911429|540569862|FG002|Overall Study|Withdrawal by Subject|4|||
149847346|NCT01911429|540569860|FG000|Overall Study|Accidental randomization|0|||
149847347|NCT01911429|540569861|FG001|Overall Study|Accidental randomization|0|||
149847348|NCT01911429|540569862|FG002|Overall Study|Accidental randomization|1|||
149847349|NCT01911429|540569860|FG000|Overall Study|subject left study|1|||
149847350|NCT01911429|540569861|FG001|Overall Study|subject left study|0|||
149847351|NCT01911429|540569862|FG002|Overall Study|subject left study|0|||
149847352|NCT03707587|540569863|FG000|Overall Study|Death|0|||
149847353|NCT03707587|540569864|FG001|Overall Study|Death|1|||
149847354|NCT01370083|540569865|FG000|Overall Study|Lost to Follow-up|2|||
149847355|NCT01370083|540569866|FG001|Overall Study|Lost to Follow-up|0|||
149847356|NCT01370083|540569865|FG000|Overall Study|Adverse Event|0|||
149847357|NCT01370083|540569866|FG001|Overall Study|Adverse Event|1|||
149956107|NCT02181621|540973934|FG001|Overall Study|Adverse Event|0|||
149956108|NCT02181621|540973933|FG000|Overall Study|Previously Enrolled|0|||
149956109|NCT02181621|540973934|FG001|Overall Study|Previously Enrolled|1|||
149956110|NCT02181621|540973933|FG000|Overall Study|Enrollment Hold|1|||
149956111|NCT02181621|540973934|FG001|Overall Study|Enrollment Hold|1|||
149956112|NCT00762788|540973935|FG000|Overall Study|Lost to Follow-up|26|||
149847358|NCT02450539|540569867|FG000|Overall Study|Withdrawal by Subject|12|||
149847359|NCT02450539|540569868|FG001|Overall Study|Withdrawal by Subject|6|||
149847360|NCT02450539|540569867|FG000|Overall Study|Lost to Follow-up|4|||
149956113|NCT00762788|540973936|FG001|Overall Study|Lost to Follow-up|37|||
149956114|NCT00762788|540973937|FG002|Overall Study|Lost to Follow-up|21|||
149847361|NCT02450539|540569868|FG001|Overall Study|Lost to Follow-up|1|||
149847362|NCT00834444|540569869|FG000|First Intervention|Adverse Event|1|||
149847363|NCT00834444|540569870|FG001|First Intervention|Adverse Event|0|||
149847364|NCT00834444|540569869|FG000|First Intervention|Intolerance to Venopuncture|0|||
149847365|NCT00834444|540569870|FG001|First Intervention|Intolerance to Venopuncture|1|||
149847366|NCT00834444|540569869|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
149847367|NCT00834444|540569870|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
149847368|NCT00834444|540569869|FG000|Second Intervention|Adverse Event|1|||
149847369|NCT00834444|540569870|FG001|Second Intervention|Adverse Event|0|||
149847370|NCT02704091|540569876|FG000|Overall Study|Adverse Event|4|||
149847371|NCT02704091|540569877|FG001|Overall Study|Adverse Event|3|||
149847372|NCT02704091|540569876|FG000|Overall Study|Protocol Violation|5|||
149847373|NCT02704091|540569877|FG001|Overall Study|Protocol Violation|3|||
149847374|NCT02704091|540569876|FG000|Overall Study|Consent withdrawn|4|||
149847375|NCT02704091|540569877|FG001|Overall Study|Consent withdrawn|4|||
149847376|NCT02704091|540569876|FG000|Overall Study|Lost to Follow-up|13|||
149847377|NCT02704091|540569877|FG001|Overall Study|Lost to Follow-up|5|||
149847378|NCT02704091|540569876|FG000|Overall Study|Other|2|||
149847379|NCT02704091|540569877|FG001|Overall Study|Other|8|||
149847380|NCT00472212|540569878|FG000|Overall Study|Lost to Follow-up|6|||
149847381|NCT00472212|540569879|FG001|Overall Study|Lost to Follow-up|4|||
149847382|NCT00425308|540569880|FG000|Overall Study|Adverse Event|2|||
149847383|NCT00425308|540569881|FG001|Overall Study|Adverse Event|1|||
149847384|NCT00425308|540569880|FG000|Overall Study|Withdrawal by Subject|1|||
149847385|NCT00425308|540569881|FG001|Overall Study|Withdrawal by Subject|0|||
149847386|NCT00425308|540569880|FG000|Overall Study|Death|1|||
149847387|NCT00425308|540569881|FG001|Overall Study|Death|0|||
149847388|NCT01266902|540569888|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
149847389|NCT01266902|540569889|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
149847390|NCT01266902|540569890|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
149847391|NCT01266902|540569888|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
149847392|NCT01266902|540569889|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
149847393|NCT01266902|540569890|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
149847394|NCT01266902|540569888|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
149847395|NCT01266902|540569889|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
149847396|NCT01266902|540569890|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
149847397|NCT01266902|540569888|FG000|Period 1 (Main Study)|Adverse Event|3|||
149847398|NCT01266902|540569889|FG001|Period 1 (Main Study)|Adverse Event|11|||
149847399|NCT01266902|540569890|FG002|Period 1 (Main Study)|Adverse Event|0|||
149847400|NCT01266902|540569888|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
150288009|NCT05048719|542189158|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288010|NCT05048719|542189159|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
150288011|NCT05048719|542189160|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288012|NCT05048719|542189161|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288013|NCT05048719|542189162|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288014|NCT05048719|542189163|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288015|NCT05048719|542189164|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288016|NCT05048719|542189165|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
150288017|NCT05048719|542189166|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149847401|NCT01266902|540569889|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
149847402|NCT01266902|540569890|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
149847403|NCT01266902|540569888|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
149847404|NCT01266902|540569889|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
149847405|NCT01266902|540569890|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
149847406|NCT01266902|540569888|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
149847407|NCT01266902|540569889|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
149847408|NCT01266902|540569890|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
149847409|NCT01266902|540569888|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
149847410|NCT01266902|540569889|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
149847411|NCT01266902|540569890|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
149847412|NCT01266902|540569888|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
149847413|NCT01266902|540569889|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
149847414|NCT01266902|540569890|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
149847415|NCT01266902|540569888|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
149847416|NCT01266902|540569889|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
149847417|NCT01266902|540569890|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
149847418|NCT05562011|540569900|FG000|Overall Study|Withdrawal by Subject|3|||
149847419|NCT05562011|540569900|FG000|Overall Study|Lost to Follow-up|1|||
149847420|NCT05562011|540569900|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
149847421|NCT05562011|540569900|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
149847422|NCT05562011|540569900|FG000|Overall Study|Device malfunction|13|||
149847423|NCT01945580|540569901|FG000|Overall Study|Withdrawal by Subject|13|||
149847424|NCT01945580|540569902|FG001|Overall Study|Withdrawal by Subject|35|||
149847425|NCT01945580|540569901|FG000|Overall Study|Physician Decision|3|||
149847426|NCT01945580|540569902|FG001|Overall Study|Physician Decision|2|||
149847427|NCT01945580|540569901|FG000|Overall Study|Lost to Follow-up|26|||
149847428|NCT01945580|540569902|FG001|Overall Study|Lost to Follow-up|39|||
149847429|NCT01945580|540569901|FG000|Overall Study|Death|7|||
149847430|NCT01945580|540569902|FG001|Overall Study|Death|2|||
149847431|NCT01945580|540569901|FG000|Overall Study|Patient moved out of state|0|||
149847432|NCT01945580|540569902|FG001|Overall Study|Patient moved out of state|1|||
149847433|NCT01945580|540569901|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
149847434|NCT01945580|540569902|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
149847435|NCT01945580|540569901|FG000|Overall Study|Family illness - unable to return|0|||
149847436|NCT01945580|540569902|FG001|Overall Study|Family illness - unable to return|1|||
149847437|NCT01945580|540569901|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
149847438|NCT01945580|540569902|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
149847439|NCT01945580|540569901|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
149847440|NCT01945580|540569902|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
149847441|NCT01945580|540569901|FG000|Overall Study|Noncompliance with 36 month visit|1|||
149847442|NCT01945580|540569902|FG001|Overall Study|Noncompliance with 36 month visit|0|||
149847443|NCT01945580|540569901|FG000|Overall Study|The patient moved.|1|||
149847444|NCT01945580|540569902|FG001|Overall Study|The patient moved.|0|||
149847445|NCT01945580|540569901|FG000|Overall Study|No data available|0|||
149847446|NCT01945580|540569902|FG001|Overall Study|No data available|2|||
149847447|NCT02933060|540569903|FG000|Overall Study|Withdrawal by Subject|0|||
149847448|NCT02933060|540569904|FG001|Overall Study|Withdrawal by Subject|1|||
149847449|NCT04411680|540569907|FG000|Treatment Period|Adverse Event|3|||
149847450|NCT04411680|540569908|FG001|Treatment Period|Adverse Event|0|||
149847451|NCT04411680|540569907|FG000|Treatment Period|Discharged from hospital|18|||
149847452|NCT04411680|540569908|FG001|Treatment Period|Discharged from hospital|7|||
149847453|NCT04411680|540569907|FG000|Treatment Period|Missed 1 or more doses|8|||
149847454|NCT04411680|540569908|FG001|Treatment Period|Missed 1 or more doses|0|||
149847455|NCT04411680|540569907|FG000|Treatment Period|Transferred to another hospital|0|||
149847456|NCT04411680|540569908|FG001|Treatment Period|Transferred to another hospital|1|||
149847457|NCT04411680|540569907|FG000|Follow up Period|Withdrawal by Subject|2|||
149847458|NCT04411680|540569908|FG001|Follow up Period|Withdrawal by Subject|0|||
149956115|NCT00762788|540973938|FG003|Overall Study|Lost to Follow-up|26|||
149956116|NCT00762788|540973939|FG004|Overall Study|Lost to Follow-up|13|||
149956117|NCT00762788|540973940|FG005|Overall Study|Lost to Follow-up|21|||
149956118|NCT01524705|540973941|FG000|Overall Study|Adverse Event|2|||
149956119|NCT01524705|540973942|FG001|Overall Study|Adverse Event|0|||
149956120|NCT01524705|540973941|FG000|Overall Study|Death|1|||
149956121|NCT01524705|540973942|FG001|Overall Study|Death|0|||
149956122|NCT01524705|540973941|FG000|Overall Study|Lost to Follow-up|0|||
149956123|NCT01524705|540973942|FG001|Overall Study|Lost to Follow-up|1|||
149956124|NCT01524705|540973941|FG000|Overall Study|Withdrawal by Subject|0|||
149956125|NCT01524705|540973942|FG001|Overall Study|Withdrawal by Subject|1|||
149956126|NCT01524705|540973941|FG000|Overall Study|Pancreatic Cancer|0|||
149956127|NCT01524705|540973942|FG001|Overall Study|Pancreatic Cancer|1|||
149956128|NCT01433978|540973947|FG000|Core Study|Adverse Event, Non-Fatal|0|||
149956129|NCT01433978|540973948|FG001|Core Study|Adverse Event, Non-Fatal|1|||
149956130|NCT01433978|540973949|FG002|Core Study|Adverse Event, Non-Fatal|0|||
149956131|NCT01433978|540973947|FG000|Core Study|Lack of Efficacy|5|||
149956132|NCT01433978|540973948|FG001|Core Study|Lack of Efficacy|1|||
149956133|NCT01433978|540973949|FG002|Core Study|Lack of Efficacy|0|||
149956134|NCT01433978|540973947|FG000|Core Study|Study Terminated by Sponsor|6|||
149956135|NCT01433978|540973948|FG001|Core Study|Study Terminated by Sponsor|9|||
149956136|NCT01433978|540973949|FG002|Core Study|Study Terminated by Sponsor|0|||
149956137|NCT01433978|540973947|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
149956138|NCT01433978|540973948|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
149956139|NCT01433978|540973949|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
149956140|NCT01433978|540973947|FG000|Extension Phase|Lack of Efficacy|0|||
149956141|NCT01433978|540973948|FG001|Extension Phase|Lack of Efficacy|0|||
149956142|NCT01433978|540973949|FG002|Extension Phase|Lack of Efficacy|1|||
149956143|NCT01433978|540973947|FG000|Extension Phase|Study Terminated by Sponsor|0|||
149956144|NCT01433978|540973948|FG001|Extension Phase|Study Terminated by Sponsor|0|||
150172725|NCT01317420|541768076|FG009|Overall Study|Refused to cont. taking trial medication|0|||
150172726|NCT01317420|541768077|FG010|Overall Study|Refused to cont. taking trial medication|0|||
150288018|NCT05048719|542189158|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288019|NCT05048719|542189159|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
149847459|NCT04411680|540569907|FG000|Follow up Period|Lost to Follow-up|5|||
149847460|NCT04411680|540569908|FG001|Follow up Period|Lost to Follow-up|6|||
149847461|NCT04411680|540569907|FG000|Follow up Period|Death|11|||
149956145|NCT01433978|540973949|FG002|Extension Phase|Study Terminated by Sponsor|4|||
149956146|NCT03954938|540973950|FG000|Overall Study|Withdrawal by Subject|2|||
149956147|NCT03954938|540973950|FG000|Overall Study|Adverse Event|1|||
149956148|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
150172727|NCT01317420|541768078|FG011|Overall Study|Refused to cont. taking trial medication|0|||
149847462|NCT04411680|540569908|FG001|Follow up Period|Death|8|||
149847463|NCT05034874|540569909|FG000|Overall Study|Withdrawal by Subject|6|||
149847464|NCT05034874|540569910|FG001|Overall Study|Withdrawal by Subject|6|||
149847465|NCT05034874|540569909|FG000|Overall Study|Lost to Follow-up|18|||
149956149|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
149956150|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
149956151|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
149956152|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
149847466|NCT05034874|540569910|FG001|Overall Study|Lost to Follow-up|8|||
149847467|NCT05034874|540569909|FG000|Overall Study|Physician Decision|0|||
149847468|NCT05034874|540569910|FG001|Overall Study|Physician Decision|1|||
149847469|NCT05034874|540569909|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
149847470|NCT05034874|540569910|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
149847471|NCT03101358|540569911|FG000|Overall Study|Non-compliance with study schedule|1|||
149847472|NCT03101358|540569912|FG001|Overall Study|Non-compliance with study schedule|0|||
149847473|NCT03101358|540569913|FG002|Overall Study|Non-compliance with study schedule|0|||
149847474|NCT03101358|540569914|FG003|Overall Study|Non-compliance with study schedule|1|||
149847475|NCT03101358|540569911|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
149847476|NCT03101358|540569912|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
149847477|NCT03101358|540569913|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
149847478|NCT03101358|540569914|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
149847479|NCT03101358|540569911|FG000|Overall Study|Physician Decision|1|||
149847480|NCT03101358|540569912|FG001|Overall Study|Physician Decision|0|||
149847481|NCT03101358|540569913|FG002|Overall Study|Physician Decision|0|||
149847482|NCT03101358|540569914|FG003|Overall Study|Physician Decision|3|||
149847483|NCT03101358|540569911|FG000|Overall Study|Adverse Event|0|||
149847484|NCT03101358|540569912|FG001|Overall Study|Adverse Event|0|||
149847485|NCT03101358|540569913|FG002|Overall Study|Adverse Event|1|||
149847486|NCT03101358|540569914|FG003|Overall Study|Adverse Event|0|||
149847487|NCT03101358|540569911|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
149847488|NCT03101358|540569912|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
149847489|NCT03101358|540569913|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
149847490|NCT03101358|540569914|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
149847491|NCT03101358|540569911|FG000|Overall Study|Lost to Follow-up|1|||
149847492|NCT03101358|540569912|FG001|Overall Study|Lost to Follow-up|0|||
149847493|NCT03101358|540569913|FG002|Overall Study|Lost to Follow-up|0|||
149847494|NCT03101358|540569914|FG003|Overall Study|Lost to Follow-up|1|||
149847495|NCT02640235|540569915|FG000|Overall Study|Withdrawal by Subject|7|||
149847496|NCT02640235|540569916|FG001|Overall Study|Withdrawal by Subject|6|||
149847497|NCT02640235|540569915|FG000|Overall Study|Lost to Follow-up|4|||
149847498|NCT02640235|540569916|FG001|Overall Study|Lost to Follow-up|3|||
149847499|NCT02640235|540569915|FG000|Overall Study|Death|2|||
149847500|NCT02640235|540569916|FG001|Overall Study|Death|3|||
149847501|NCT02640235|540569915|FG000|Overall Study|Other|1|||
149847502|NCT02640235|540569916|FG001|Overall Study|Other|2|||
149847503|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
149847504|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
149847505|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
149847506|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
149847507|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
149956153|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
149956154|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
149956155|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
149956156|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
149956157|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
149956158|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
149956159|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
149956160|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
149847508|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
149847509|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
149847510|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
149847511|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
149956161|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
149956162|NCT00976391|540973951|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
149956163|NCT00976391|540973952|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
149956164|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
149956165|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
150172728|NCT01317420|541768079|FG012|Overall Study|Refused to cont. taking trial medication|1|||
150172729|NCT01317420|541768067|FG000|Overall Study|Reason other than those specified|0|||
150172730|NCT01317420|541768068|FG001|Overall Study|Reason other than those specified|0|||
150036660|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
150036661|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
150036662|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
150036663|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
150036664|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
150036665|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
150036666|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
150036667|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
150036668|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
150036669|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
150036670|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
150036671|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
150036672|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
150036673|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
150036674|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
150036675|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
150036676|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
150036677|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
150036678|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
150036679|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
150036680|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
150036681|NCT03955146|541274507|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
150036682|NCT03955146|541274508|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
150036683|NCT03955146|541274509|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
150036684|NCT03955146|541274510|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
150036685|NCT02628873|541274513|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
150036686|NCT02628873|541274514|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
150036687|NCT02628873|541274513|FG000|Second Test (1 Hour)|Physician Decision|1|||
150036688|NCT02628873|541274514|FG001|Second Test (1 Hour)|Physician Decision|0|||
150036689|NCT03597347|541274516|FG000|Overall Study|Withdrawal by Subject|1|||
150036690|NCT03597347|541274517|FG001|Overall Study|Withdrawal by Subject|1|||
150036691|NCT03597347|541274518|FG002|Overall Study|Withdrawal by Subject|0|||
150036692|NCT03597347|541274516|FG000|Overall Study|Withdrawal due to Covid-19|3|||
150036693|NCT03597347|541274517|FG001|Overall Study|Withdrawal due to Covid-19|0|||
150036694|NCT03597347|541274518|FG002|Overall Study|Withdrawal due to Covid-19|0|||
150036695|NCT03597347|541274516|FG000|Overall Study|Sponsor decision to terminate study|3|||
150036696|NCT03597347|541274517|FG001|Overall Study|Sponsor decision to terminate study|2|||
150036697|NCT03597347|541274518|FG002|Overall Study|Sponsor decision to terminate study|4|||
150036698|NCT00107653|541274519|FG000|Overall Study|Adverse Event|24|||
149956166|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
149956167|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
149956168|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
149956169|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
149956170|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
149956171|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
149956172|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
149956173|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
149956174|NCT00976391|540973951|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
149956175|NCT00976391|540973952|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
149956176|NCT00617903|540973953|FG000|Overall Study|Withdrawal by Subject|2|||
149956177|NCT00617903|540973954|FG001|Overall Study|Withdrawal by Subject|3|||
149956178|NCT00617903|540973953|FG000|Overall Study|Lost to Follow-up|1|||
149956179|NCT00617903|540973954|FG001|Overall Study|Lost to Follow-up|1|||
149956180|NCT00617903|540973953|FG000|Overall Study|Lack of Efficacy|0|||
149956181|NCT00617903|540973954|FG001|Overall Study|Lack of Efficacy|1|||
149956182|NCT00617903|540973953|FG000|Overall Study|Adverse Event|0|||
149956183|NCT00617903|540973954|FG001|Overall Study|Adverse Event|1|||
149956184|NCT00617903|540973953|FG000|Overall Study|noncompliance|0|||
149956185|NCT00617903|540973954|FG001|Overall Study|noncompliance|1|||
150036699|NCT00107653|541274520|FG001|Overall Study|Adverse Event|43|||
150288020|NCT05048719|542189160|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288021|NCT05048719|542189161|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149956186|NCT02565186|540973955|FG000|Overall Study|Adverse Event|113|||
149956187|NCT02565186|540973956|FG001|Overall Study|Adverse Event|148|||
149956188|NCT02565186|540973955|FG000|Overall Study|Lost to Follow-up|102|||
149956189|NCT02565186|540973956|FG001|Overall Study|Lost to Follow-up|93|||
149956190|NCT02565186|540973955|FG000|Overall Study|Non-Compliance|57|||
149956191|NCT02565186|540973956|FG001|Overall Study|Non-Compliance|55|||
149956192|NCT02565186|540973955|FG000|Overall Study|Withdrawal by Subject|229|||
149956193|NCT02565186|540973956|FG001|Overall Study|Withdrawal by Subject|214|||
149956194|NCT02565186|540973955|FG000|Overall Study|Physician Decision|18|||
149956195|NCT02565186|540973956|FG001|Overall Study|Physician Decision|16|||
149956196|NCT02565186|540973955|FG000|Overall Study|Sponsor Request|5|||
149956197|NCT02565186|540973956|FG001|Overall Study|Sponsor Request|9|||
149956198|NCT02565186|540973955|FG000|Overall Study|Missing|1|||
149956199|NCT02565186|540973956|FG001|Overall Study|Missing|0|||
149956200|NCT02565186|540973955|FG000|Overall Study|Did Not Receive Study Drug|55|||
149956201|NCT02565186|540973956|FG001|Overall Study|Did Not Receive Study Drug|86|||
149956202|NCT01371565|540973957|FG000|Overall Study|Withdrawal by Subject|1|||
149956203|NCT01371565|540973957|FG000|Overall Study|Death|1|||
149956204|NCT01371565|540973957|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
149956205|NCT02217982|540973958|FG000|Overall Study|Trial discontinued|1|||
149956206|NCT02217982|540973959|FG001|Overall Study|Trial discontinued|0|||
149956207|NCT02217982|540973958|FG000|Overall Study|Adverse Event|0|||
149956208|NCT02217982|540973959|FG001|Overall Study|Adverse Event|1|||
149956209|NCT04676646|540973960|FG000|Open-label Run-in Phase|Adverse Event|3|||
149956210|NCT04676646|540973961|FG001|Open-label Run-in Phase|Adverse Event|0|||
149956211|NCT04676646|540973962|FG002|Open-label Run-in Phase|Adverse Event|0|||
149956212|NCT04676646|540973960|FG000|Open-label Run-in Phase|Death|3|||
149956213|NCT04676646|540973961|FG001|Open-label Run-in Phase|Death|0|||
149956214|NCT04676646|540973962|FG002|Open-label Run-in Phase|Death|0|||
149956215|NCT04676646|540973960|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
149956216|NCT04676646|540973961|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
149847512|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
149847513|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
149847514|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
149847515|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
149847516|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
149847517|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
149847518|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
149847519|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
149847520|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
149847521|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
149847522|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
149847523|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
149847524|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
149847525|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
149847526|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
149847527|NCT00073307|540569927|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
149847528|NCT00073307|540569928|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
149847529|NCT00073307|540569929|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
149847530|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
149847531|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
149847532|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
149847533|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
149847534|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
149847535|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
149847536|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
149847537|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
149847538|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
149847539|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
149847540|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
149847541|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
149847542|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
149847543|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
149847544|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
149847545|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
149847546|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
149847547|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
149847548|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
149847549|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
149847550|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
149847551|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
149847552|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
149956217|NCT04676646|540973962|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
149956218|NCT04676646|540973960|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
149847553|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
149847554|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
149847555|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
149847556|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
149847557|NCT00073307|540569927|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
149847558|NCT00073307|540569928|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
149847559|NCT00073307|540569929|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
149847560|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
149847561|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
149847562|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
149847563|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
149847564|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
149847565|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
149847566|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
149847567|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
149847568|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
149847569|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
149847570|NCT01438060|540569930|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
149847571|NCT01438060|540569931|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
149847572|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
149847573|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
149847574|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
149847575|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
149847576|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
149847577|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
149847578|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
149847579|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
149847580|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
149956219|NCT04676646|540973961|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
149956220|NCT04676646|540973962|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
149956221|NCT04676646|540973960|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
149956222|NCT04676646|540973961|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
149956223|NCT04676646|540973962|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
149956224|NCT04676646|540973960|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
149956225|NCT04676646|540973961|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
149956226|NCT04676646|540973962|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
149956227|NCT04676646|540973960|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
149956228|NCT04676646|540973961|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
149956229|NCT04676646|540973962|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
149956230|NCT04676646|540973960|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
149956231|NCT04676646|540973961|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
149956232|NCT04676646|540973962|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
149956233|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
149956234|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
149956235|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
149956236|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Death|0|||
149956237|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Death|1|||
149956238|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Death|2|||
149956239|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
149956240|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
149956241|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
149956242|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
149956243|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
149956244|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
149956245|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
149956246|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
150172731|NCT01317420|541768069|FG002|Overall Study|Reason other than those specified|0|||
150172732|NCT01317420|541768070|FG003|Overall Study|Reason other than those specified|0|||
150172733|NCT01317420|541768071|FG004|Overall Study|Reason other than those specified|0|||
149847581|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
149847582|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
149847583|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
149847584|NCT01438060|540569930|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
149847585|NCT01438060|540569931|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
149847586|NCT01438060|540569930|FG000|On Study Beyond Week 140|Adverse Event|0|||
149847587|NCT01438060|540569931|FG001|On Study Beyond Week 140|Adverse Event|2|||
149847588|NCT01438060|540569930|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
149847589|NCT01438060|540569931|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
149847590|NCT01438060|540569930|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
149847591|NCT01438060|540569931|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
149847592|NCT01438060|540569930|FG000|On Study Beyond Week 140|Death|0|||
149847593|NCT01438060|540569931|FG001|On Study Beyond Week 140|Death|1|||
149847594|NCT01438060|540569930|FG000|On Study Beyond Week 140|Other Reason|0|||
149847595|NCT01438060|540569931|FG001|On Study Beyond Week 140|Other Reason|3|||
149847596|NCT03499873|540569932|FG000|Overall Study|Withdrawal by Subject|4|||
149847597|NCT03499873|540569933|FG001|Overall Study|Withdrawal by Subject|6|||
149847598|NCT03499873|540569934|FG002|Overall Study|Withdrawal by Subject|1|||
149847599|NCT03499873|540569932|FG000|Overall Study|Subjects condition worsened|0|||
149847600|NCT03499873|540569933|FG001|Overall Study|Subjects condition worsened|3|||
149847601|NCT03499873|540569934|FG002|Overall Study|Subjects condition worsened|11|||
149847602|NCT03499873|540569932|FG000|Overall Study|Adverse Event|8|||
149847603|NCT03499873|540569933|FG001|Overall Study|Adverse Event|3|||
149847604|NCT03499873|540569934|FG002|Overall Study|Adverse Event|6|||
149847605|NCT03499873|540569932|FG000|Overall Study|Physician Decision|1|||
149847606|NCT03499873|540569933|FG001|Overall Study|Physician Decision|0|||
149847607|NCT03499873|540569934|FG002|Overall Study|Physician Decision|0|||
149847608|NCT03499873|540569932|FG000|Overall Study|Administrative reasons|0|||
149847609|NCT03499873|540569933|FG001|Overall Study|Administrative reasons|1|||
149847610|NCT03499873|540569934|FG002|Overall Study|Administrative reasons|0|||
149847611|NCT03499873|540569932|FG000|Overall Study|Concomitant therapy|5|||
149847612|NCT03499873|540569933|FG001|Overall Study|Concomitant therapy|4|||
149847613|NCT03499873|540569934|FG002|Overall Study|Concomitant therapy|7|||
149847614|NCT03499873|540569932|FG000|Overall Study|Miscellaneous|1|||
149847615|NCT03499873|540569933|FG001|Overall Study|Miscellaneous|2|||
149847616|NCT03499873|540569934|FG002|Overall Study|Miscellaneous|2|||
149847617|NCT03499873|540569932|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
149847618|NCT03499873|540569933|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
149847619|NCT03499873|540569934|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
149847620|NCT04608448|540569935|FG000|Overall Study|Withdrawal by Subject|1|||
149847621|NCT04608448|540569935|FG000|Overall Study|Adverse Event|1|||
149847622|NCT01964950|540569936|FG000|Overall Study|Protocol Violation|25|||
149847623|NCT01149057|540569937|FG000|Overall Study|Lack of Efficacy|16|||
149847624|NCT01149057|540569937|FG000|Overall Study|Adverse Event|13|||
149847625|NCT01149057|540569937|FG000|Overall Study|Withdrawal by Subject|9|||
149847626|NCT01149057|540569937|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
149847627|NCT01149057|540569937|FG000|Overall Study|B Cell Depletion|4|||
149847628|NCT01149057|540569937|FG000|Overall Study|Participant Non-Compliance|2|||
149847629|NCT01149057|540569937|FG000|Overall Study|Lost to Follow-up|1|||
149847630|NCT01149057|540569937|FG000|Overall Study|High Parathyroid Hormone Value|1|||
150288022|NCT05048719|542189162|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288023|NCT05048719|542189163|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288024|NCT05048719|542189164|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288025|NCT05048719|542189165|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288026|NCT05048719|542189166|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
150288027|NCT05048719|542189158|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149847631|NCT01149057|540569937|FG000|Overall Study|Other|6|||
149847632|NCT03602339|540569938|FG000|Overall Study|Withdrawal by Subject|9|||
149847633|NCT03602339|540569938|FG000|Overall Study|Physician Decision|2|||
149847634|NCT03602339|540569938|FG000|Overall Study|Other reason|4|||
149847635|NCT01297504|540569939|FG000|Overall Study|Invalid Consent|1|||
149847636|NCT01297504|540569939|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
149847637|NCT01297504|540569939|FG000|Overall Study|No Study Visits|4|||
149847638|NCT01297504|540569939|FG000|Overall Study|Death|3|||
149847639|NCT01297504|540569939|FG000|Overall Study|Lost to Follow-up|43|||
149847640|NCT01297504|540569939|FG000|Overall Study|Withdrawal by Subject|9|||
149847641|NCT01297504|540569939|FG000|Overall Study|Site Closure|3|||
149847642|NCT01297504|540569939|FG000|Overall Study|Protocol Violation|3|||
149847643|NCT01024855|540569942|FG000|Overall Study|Inclusion/exclusion criteria|1|||
149847644|NCT03306277|540569950|FG000|Overall Study|Death|1|||
149847645|NCT03306277|540569950|FG000|Overall Study|Adverse Event|1|||
149847646|NCT03306277|540569950|FG000|Overall Study|Withdrawal by Subject|1|||
149847647|NCT00829452|540569954|FG000|First Intervention|Withdrawal by Subject|0|||
149847648|NCT00829452|540569955|FG001|First Intervention|Withdrawal by Subject|1|||
149847649|NCT00829452|540569954|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
149847650|NCT00829452|540569955|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
149847651|NCT00829452|540569954|FG000|Second Intervention|Physician Decision|0|||
149847652|NCT00829452|540569955|FG001|Second Intervention|Physician Decision|1|||
150288028|NCT05048719|542189159|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288029|NCT05048719|542189160|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288030|NCT05048719|542189161|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
150288031|NCT05048719|542189162|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288032|NCT05048719|542189163|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288033|NCT05048719|542189164|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288034|NCT05048719|542189165|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288035|NCT05048719|542189166|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
150288036|NCT05048719|542189158|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288037|NCT05048719|542189159|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288038|NCT05048719|542189160|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288039|NCT05048719|542189161|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288040|NCT05048719|542189162|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288041|NCT05048719|542189163|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
150288042|NCT05048719|542189164|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149847653|NCT00881751|540569966|FG000|Overall Study|Physician Decision|0|||
149847654|NCT00881751|540569967|FG001|Overall Study|Physician Decision|1|||
149847655|NCT00881751|540569966|FG000|Overall Study|Adverse Event|0|||
149847656|NCT00881751|540569967|FG001|Overall Study|Adverse Event|2|||
149847657|NCT00881751|540569966|FG000|Overall Study|Withdrawal by Subject|0|||
149847658|NCT00881751|540569967|FG001|Overall Study|Withdrawal by Subject|2|||
149847659|NCT02436200|540569968|FG000|Overall Study|Significant outlier|1|||
149847660|NCT01559363|540569971|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
149847661|NCT01559363|540569972|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
149847662|NCT01559363|540569973|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
149847663|NCT01559363|540569974|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
149847664|NCT01559363|540569975|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
149847665|NCT01559363|540569976|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
149847666|NCT01559363|540569971|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
149847667|NCT01559363|540569972|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
149847668|NCT01559363|540569973|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
149847669|NCT01559363|540569974|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
149847670|NCT01559363|540569975|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
149847671|NCT01559363|540569976|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
149847672|NCT01559363|540569971|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
149847673|NCT01559363|540569972|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
150288043|NCT05048719|542189165|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288044|NCT05048719|542189166|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
150288045|NCT00706134|542189169|FG000|Overall Study|Adverse Event|8|||
150288046|NCT00706134|542189170|FG001|Overall Study|Adverse Event|7|||
149847674|NCT01559363|540569973|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
149847675|NCT01559363|540569974|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
149847676|NCT01559363|540569975|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
149847677|NCT01559363|540569976|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
149847678|NCT01559363|540569971|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
149847679|NCT01559363|540569972|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
149847680|NCT01559363|540569973|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
150288047|NCT00706134|542189171|FG002|Overall Study|Adverse Event|2|||
149847681|NCT01559363|540569974|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
149847682|NCT01559363|540569975|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
149847683|NCT01559363|540569976|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
149847684|NCT01559363|540569971|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
149847685|NCT01559363|540569972|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
149847686|NCT01559363|540569973|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
149847687|NCT01559363|540569974|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
149847688|NCT01559363|540569975|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
149847689|NCT01559363|540569976|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
149847690|NCT01559363|540569971|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
149847691|NCT01559363|540569972|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
150288048|NCT00706134|542189172|FG003|Overall Study|Adverse Event|3|||
149847692|NCT01559363|540569973|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
149847693|NCT01559363|540569974|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
149847694|NCT01559363|540569975|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
149847695|NCT01559363|540569976|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
149847696|NCT01559363|540569971|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
149847697|NCT01559363|540569972|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
149847698|NCT01559363|540569973|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
149847699|NCT01559363|540569974|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
149847700|NCT01559363|540569975|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
149847701|NCT01559363|540569976|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
149847702|NCT00957021|540569977|FG000|Overall Study|Death|5|||
149847703|NCT00957021|540569977|FG000|Overall Study|Lost to Follow-up|8|||
149847704|NCT00957021|540569977|FG000|Overall Study|Withdrawal by Subject|34|||
149847705|NCT00957021|540569977|FG000|Overall Study|No 2 yr ROM data|35|||
149847706|NCT00957021|540569977|FG000|Overall Study|Revised study component by 2 yr visit|8|||
149847707|NCT00957021|540569977|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
149847708|NCT00957021|540569977|FG000|Overall Study|Surgery Cancelled|9|||
149847709|NCT00957021|540569977|FG000|Overall Study|Termination due to language issue|2|||
149847710|NCT03966911|540569981|FG000|Overall Study|Adverse Event|1|||
149847711|NCT03966911|540569982|FG001|Overall Study|Adverse Event|1|||
149847712|NCT03966911|540569981|FG000|Overall Study|Withdrawal by Subject|8|||
149847713|NCT03966911|540569982|FG001|Overall Study|Withdrawal by Subject|2|||
149847714|NCT03966911|540569981|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
149847715|NCT03966911|540569982|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
149956247|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
149956248|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
149956249|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
149956250|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
149956251|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
149956252|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
149956253|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
149956254|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
149956255|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
149956256|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
149956257|NCT04676646|540973960|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
149956258|NCT04676646|540973961|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
149956259|NCT04676646|540973962|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
149956260|NCT05156125|540973963|FG000|Overall Study|Lack of Efficacy|1|||
149956261|NCT05156125|540973964|FG001|Overall Study|Lack of Efficacy|1|||
149956262|NCT05156125|540973965|FG002|Overall Study|Lack of Efficacy|1|||
149956263|NCT05156125|540973963|FG000|Overall Study|Physician Decision|0|||
149956264|NCT05156125|540973964|FG001|Overall Study|Physician Decision|0|||
149956265|NCT05156125|540973965|FG002|Overall Study|Physician Decision|1|||
149956266|NCT05156125|540973963|FG000|Overall Study|Non-compliance|0|||
149956267|NCT05156125|540973964|FG001|Overall Study|Non-compliance|1|||
149956268|NCT05156125|540973965|FG002|Overall Study|Non-compliance|1|||
149956269|NCT05156125|540973963|FG000|Overall Study|Withdrawal by Subject|0|||
149956270|NCT05156125|540973964|FG001|Overall Study|Withdrawal by Subject|0|||
149956271|NCT05156125|540973965|FG002|Overall Study|Withdrawal by Subject|1|||
149956272|NCT05156125|540973963|FG000|Overall Study|Adverse Event|2|||
149956273|NCT05156125|540973964|FG001|Overall Study|Adverse Event|1|||
149956274|NCT05156125|540973965|FG002|Overall Study|Adverse Event|0|||
149956275|NCT01755637|540973969|FG000|Period 1|Adverse Event|0|||
149956276|NCT01755637|540973970|FG001|Period 1|Adverse Event|1|||
149956277|NCT04389671|540973972|FG000|Overall Study|Death|7|||
149956278|NCT01421134|540973973|FG000|Overall Study|Adverse Event|3|||
149956279|NCT01421134|540973974|FG001|Overall Study|Adverse Event|5|||
149956280|NCT01421134|540973973|FG000|Overall Study|Lack of Efficacy|2|||
149956281|NCT01421134|540973974|FG001|Overall Study|Lack of Efficacy|4|||
149956282|NCT01421134|540973973|FG000|Overall Study|Protocol Violation|0|||
149956283|NCT01421134|540973974|FG001|Overall Study|Protocol Violation|3|||
149956284|NCT01421134|540973973|FG000|Overall Study|Withdrawal by Subject|1|||
149956285|NCT01421134|540973974|FG001|Overall Study|Withdrawal by Subject|1|||
149847716|NCT01395017|540569983|FG000|Overall Study|Lost to Follow-up|1|||
149847717|NCT01395017|540569984|FG001|Overall Study|Lost to Follow-up|0|||
149956286|NCT01421134|540973973|FG000|Overall Study|Administrative|0|||
149956287|NCT01421134|540973974|FG001|Overall Study|Administrative|1|||
149956288|NCT01421134|540973973|FG000|Overall Study|Lost to Follow-up|1|||
149847718|NCT01395017|540569983|FG000|Overall Study|Adverse Event|26|||
149956289|NCT01421134|540973974|FG001|Overall Study|Lost to Follow-up|1|||
150288049|NCT00706134|542189169|FG000|Overall Study|Lost to Follow-up|0|||
149847719|NCT01395017|540569984|FG001|Overall Study|Adverse Event|12|||
149847720|NCT01395017|540569983|FG000|Overall Study|Physician Decision|11|||
149847721|NCT01395017|540569984|FG001|Overall Study|Physician Decision|15|||
149847722|NCT01395017|540569983|FG000|Overall Study|Withdrawal by Subject|14|||
149847723|NCT01395017|540569984|FG001|Overall Study|Withdrawal by Subject|8|||
149847724|NCT01395017|540569983|FG000|Overall Study|Protocol deviation|1|||
149847725|NCT01395017|540569984|FG001|Overall Study|Protocol deviation|2|||
149847726|NCT01395017|540569983|FG000|Overall Study|Death|4|||
149847727|NCT01395017|540569984|FG001|Overall Study|Death|3|||
149847728|NCT01395017|540569983|FG000|Overall Study|Disease progression|42|||
149847729|NCT01395017|540569984|FG001|Overall Study|Disease progression|58|||
150036700|NCT00107653|541274519|FG000|Overall Study|Insufficient Therapeutic Response|25|||
150036701|NCT00107653|541274520|FG001|Overall Study|Insufficient Therapeutic Response|11|||
150036702|NCT00107653|541274519|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
150036703|NCT00107653|541274520|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
150036704|NCT00107653|541274519|FG000|Overall Study|Protocol Violation|1|||
150036705|NCT00107653|541274520|FG001|Overall Study|Protocol Violation|0|||
150036706|NCT00107653|541274519|FG000|Overall Study|Withdrawal by Subject|12|||
150036707|NCT00107653|541274520|FG001|Overall Study|Withdrawal by Subject|13|||
150036708|NCT00107653|541274519|FG000|Overall Study|Lost to Follow-up|13|||
150036709|NCT00107653|541274520|FG001|Overall Study|Lost to Follow-up|5|||
150036710|NCT00107653|541274519|FG000|Overall Study|Administrative Reasons|3|||
150036711|NCT00107653|541274520|FG001|Overall Study|Administrative Reasons|3|||
150036712|NCT00541658|541274522|FG000|Overall Study|Adverse Event|28|||
150036713|NCT00541658|541274523|FG001|Overall Study|Adverse Event|37|||
150036714|NCT00541658|541274524|FG002|Overall Study|Adverse Event|25|||
150036715|NCT00541658|541274522|FG000|Overall Study|Physician Decision|0|||
150036716|NCT00541658|541274523|FG001|Overall Study|Physician Decision|0|||
150036717|NCT00541658|541274524|FG002|Overall Study|Physician Decision|4|||
150036718|NCT00541658|541274522|FG000|Overall Study|Lost to Follow-up|3|||
150036719|NCT00541658|541274523|FG001|Overall Study|Lost to Follow-up|3|||
150036720|NCT00541658|541274524|FG002|Overall Study|Lost to Follow-up|6|||
150036721|NCT00541658|541274522|FG000|Overall Study|Protocol Violation|0|||
150036722|NCT00541658|541274523|FG001|Overall Study|Protocol Violation|1|||
150036723|NCT00541658|541274524|FG002|Overall Study|Protocol Violation|1|||
150036724|NCT00541658|541274522|FG000|Overall Study|Withdrawal by Subject|28|||
150036725|NCT00541658|541274523|FG001|Overall Study|Withdrawal by Subject|32|||
150036726|NCT00541658|541274524|FG002|Overall Study|Withdrawal by Subject|32|||
150036727|NCT00541658|541274522|FG000|Overall Study|Took No Study Drug|1|||
150036728|NCT00541658|541274523|FG001|Overall Study|Took No Study Drug|0|||
150036729|NCT00541658|541274524|FG002|Overall Study|Took No Study Drug|0|||
150036730|NCT01074970|541274525|FG000|Overall Study|Never Treated|0|||
150036731|NCT01074970|541274526|FG001|Overall Study|Never Treated|0|||
150036732|NCT01074970|541274527|FG002|Overall Study|Never Treated|8|||
150036733|NCT01074970|541274528|FG003|Overall Study|Never Treated|1|||
150036734|NCT01074970|541274525|FG000|Overall Study|Adverse Event|1|||
150036735|NCT01074970|541274526|FG001|Overall Study|Adverse Event|0|||
150036736|NCT01074970|541274527|FG002|Overall Study|Adverse Event|4|||
150036737|NCT01074970|541274528|FG003|Overall Study|Adverse Event|3|||
150036738|NCT01074970|541274525|FG000|Overall Study|Disease progression during treatment|3|||
150036739|NCT01074970|541274526|FG001|Overall Study|Disease progression during treatment|1|||
150036740|NCT01074970|541274527|FG002|Overall Study|Disease progression during treatment|2|||
150036741|NCT01074970|541274528|FG003|Overall Study|Disease progression during treatment|9|||
150036742|NCT01074970|541274525|FG000|Overall Study|Lost to Follow-up|0|||
150036743|NCT01074970|541274526|FG001|Overall Study|Lost to Follow-up|0|||
149847730|NCT01395017|540569983|FG000|Overall Study|Sponsor discontinued study|1|||
149847731|NCT01395017|540569984|FG001|Overall Study|Sponsor discontinued study|4|||
150036744|NCT01074970|541274527|FG002|Overall Study|Lost to Follow-up|1|||
150036745|NCT01074970|541274528|FG003|Overall Study|Lost to Follow-up|0|||
150036746|NCT01074970|541274525|FG000|Overall Study|Withdrawal by Subject|0|||
149847732|NCT01663896|540569985|FG000|Overall Study|Various reasons|43|||
149847733|NCT00999687|540569987|FG000|First Intervention|Withdrawal by Subject|1|||
149847734|NCT00999687|540569987|FG000|Second Intervention|Withdrawal by Subject|2|||
149847735|NCT00999687|540569987|FG000|Second Intervention|Lack of Efficacy|1|||
149847736|NCT00842309|540569990|FG000|Overall Study|Withdrawal by Subject|3|||
150036747|NCT01074970|541274526|FG001|Overall Study|Withdrawal by Subject|0|||
150036748|NCT01074970|541274527|FG002|Overall Study|Withdrawal by Subject|6|||
150036749|NCT01074970|541274528|FG003|Overall Study|Withdrawal by Subject|4|||
149956290|NCT00685698|540973975|FG000|Overall Study|Withdrawal by Subject|1|||
149956291|NCT00685698|540973975|FG000|Overall Study|Protocol Violation|6|||
149956292|NCT00685698|540973975|FG000|Overall Study|Adverse Event|3|||
149956293|NCT00685698|540973975|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
149956294|NCT00685698|540973975|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
149956295|NCT00685698|540973975|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
149956296|NCT02030418|540973979|FG000|Overall Study|Death|78|||
149956297|NCT02030418|540973979|FG000|Overall Study|Missed 12-Month Visit|9|||
149956298|NCT02030418|540973979|FG000|Overall Study|Withdrawn|57|||
149956299|NCT00724893|540973980|FG000|Overall Study|Adverse Event|76|||
149956300|NCT00724893|540973981|FG001|Overall Study|Adverse Event|142|||
149956301|NCT00724893|540973980|FG000|Overall Study|Withdrawal by Subject|0|||
149956302|NCT00724893|540973981|FG001|Overall Study|Withdrawal by Subject|1|||
149956303|NCT00724893|540973980|FG000|Overall Study|Lack of virologic response|94|||
149956304|NCT00724893|540973981|FG001|Overall Study|Lack of virologic response|202|||
149956305|NCT00724893|540973980|FG000|Overall Study|Reason not specified|193|||
149956306|NCT00724893|540973981|FG001|Overall Study|Reason not specified|7|||
149956307|NCT00724893|540973980|FG000|Overall Study|Patient choice|0|||
149956308|NCT00724893|540973981|FG001|Overall Study|Patient choice|26|||
149956309|NCT00724893|540973980|FG000|Overall Study|Geographic reasons|0|||
149956310|NCT00724893|540973981|FG001|Overall Study|Geographic reasons|11|||
149956311|NCT00724893|540973980|FG000|Overall Study|Incarceration|0|||
149956312|NCT00724893|540973981|FG001|Overall Study|Incarceration|9|||
149956313|NCT00724893|540973980|FG000|Overall Study|Substance abuse|0|||
149956314|NCT00724893|540973981|FG001|Overall Study|Substance abuse|3|||
149956315|NCT00724893|540973980|FG000|Overall Study|Financial reasons|0|||
149956316|NCT00724893|540973981|FG001|Overall Study|Financial reasons|2|||
149956317|NCT00724893|540973980|FG000|Overall Study|Assigned shorter treatment|0|||
149956318|NCT00724893|540973981|FG001|Overall Study|Assigned shorter treatment|2|||
149956319|NCT00724893|540973980|FG000|Overall Study|Lost to Follow-up|0|||
149956320|NCT00724893|540973981|FG001|Overall Study|Lost to Follow-up|52|||
149956321|NCT00724893|540973980|FG000|Overall Study|Unknown, missing data|1|||
149956322|NCT00724893|540973981|FG001|Overall Study|Unknown, missing data|1|||
149956323|NCT01290731|540973984|FG000|Overall Study|Withdrawal by Subject|1|||
149956324|NCT01279200|540973985|FG000|Overall Study|Withdrawal by Subject|1|||
149956325|NCT01279200|540973986|FG001|Overall Study|Withdrawal by Subject|3|||
149956326|NCT01279200|540973985|FG000|Overall Study|Patient withdrawal due to high cost|0|||
149956327|NCT01279200|540973986|FG001|Overall Study|Patient withdrawal due to high cost|1|||
149956328|NCT01279200|540973985|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
149956329|NCT01279200|540973986|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
149956330|NCT01279200|540973985|FG000|Overall Study|ultrasound screening failure|0|||
149956331|NCT01279200|540973986|FG001|Overall Study|ultrasound screening failure|1|||
149956332|NCT01279200|540973985|FG000|Overall Study|Lost to Follow-up|0|||
149956333|NCT01279200|540973986|FG001|Overall Study|Lost to Follow-up|1|||
149956334|NCT01279200|540973985|FG000|Overall Study|Adverse Event|1|||
149956335|NCT01279200|540973986|FG001|Overall Study|Adverse Event|0|||
149956336|NCT01399099|540973987|FG000|Overall Study|Lost to Follow-up|14|||
149956337|NCT01399099|540973987|FG000|Overall Study|Physician Decision|1|||
149956338|NCT01399099|540973987|FG000|Overall Study|Protocol Violation|1|||
149956339|NCT01399099|540973987|FG000|Overall Study|Skin Irritation|13|||
150288050|NCT00706134|542189170|FG001|Overall Study|Lost to Follow-up|1|||
150288051|NCT00706134|542189171|FG002|Overall Study|Lost to Follow-up|0|||
150288052|NCT00706134|542189172|FG003|Overall Study|Lost to Follow-up|0|||
150288053|NCT00706134|542189169|FG000|Overall Study|Protocol Violation|0|||
150288054|NCT00706134|542189170|FG001|Overall Study|Protocol Violation|6|||
150288055|NCT00706134|542189171|FG002|Overall Study|Protocol Violation|0|||
150288056|NCT00706134|542189172|FG003|Overall Study|Protocol Violation|3|||
150288057|NCT00706134|542189169|FG000|Overall Study|Withdrawal by Subject|1|||
150288058|NCT00706134|542189170|FG001|Overall Study|Withdrawal by Subject|2|||
150288059|NCT00706134|542189171|FG002|Overall Study|Withdrawal by Subject|1|||
150288060|NCT00706134|542189172|FG003|Overall Study|Withdrawal by Subject|0|||
150288061|NCT00706134|542189169|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
150288062|NCT00706134|542189170|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
150288063|NCT00706134|542189171|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
150288064|NCT00706134|542189172|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
150288065|NCT00706134|542189169|FG000|Overall Study|Did not meet study criteria|2|||
150288066|NCT00706134|542189170|FG001|Overall Study|Did not meet study criteria|0|||
150288067|NCT00706134|542189171|FG002|Overall Study|Did not meet study criteria|0|||
149956340|NCT01399099|540973987|FG000|Overall Study|Infection|1|||
149956341|NCT01399099|540973987|FG000|Overall Study|Miscellaneous|4|||
149956342|NCT01179516|540973989|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
149956343|NCT01179516|540973990|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
149956344|NCT01179516|540973991|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
149956345|NCT01179516|540973989|FG000|Overall Study|Lack of Efficacy|4|||
149956346|NCT01179516|540973990|FG001|Overall Study|Lack of Efficacy|2|||
150288068|NCT00706134|542189172|FG003|Overall Study|Did not meet study criteria|0|||
149956347|NCT01179516|540973991|FG002|Overall Study|Lack of Efficacy|0|||
149847737|NCT00842309|540569991|FG001|Overall Study|Withdrawal by Subject|1|||
149847738|NCT03727139|540569992|FG000|Overall Study|Protocol Violation|60|||
149956348|NCT01179516|540973989|FG000|Overall Study|Noncompliance with Study Drug|2|||
149956349|NCT01179516|540973990|FG001|Overall Study|Noncompliance with Study Drug|0|||
149956350|NCT01179516|540973991|FG002|Overall Study|Noncompliance with Study Drug|1|||
149956351|NCT01179516|540973989|FG000|Overall Study|Protocol Deviations|4|||
149956352|NCT01179516|540973990|FG001|Overall Study|Protocol Deviations|3|||
149956353|NCT01179516|540973991|FG002|Overall Study|Protocol Deviations|3|||
149956354|NCT01179516|540973989|FG000|Overall Study|Withdrawal of Consent|2|||
149956355|NCT01179516|540973990|FG001|Overall Study|Withdrawal of Consent|6|||
149956356|NCT01179516|540973991|FG002|Overall Study|Withdrawal of Consent|10|||
149956357|NCT01179516|540973989|FG000|Overall Study|Lost to Follow-up|7|||
149956358|NCT01179516|540973990|FG001|Overall Study|Lost to Follow-up|7|||
149956359|NCT01179516|540973991|FG002|Overall Study|Lost to Follow-up|3|||
149956360|NCT01179516|540973989|FG000|Overall Study|Other|2|||
149956361|NCT01179516|540973990|FG001|Overall Study|Other|0|||
149956362|NCT01179516|540973991|FG002|Overall Study|Other|2|||
149956363|NCT01149538|540973992|FG000|Overall Study|Lost to Follow-up|0|||
149956364|NCT01149538|540973993|FG001|Overall Study|Lost to Follow-up|1|||
149956365|NCT01149538|540973992|FG000|Overall Study|Withdrawal by Subject|5|||
149956366|NCT01149538|540973993|FG001|Overall Study|Withdrawal by Subject|3|||
149956367|NCT00888849|540973994|FG000|Overall Study|Death|4|||
149956368|NCT00888849|540973995|FG001|Overall Study|Death|7|||
149956369|NCT00888849|540973994|FG000|Overall Study|Lost to Follow-up|1|||
149956370|NCT00888849|540973995|FG001|Overall Study|Lost to Follow-up|2|||
149956371|NCT05064800|540973996|FG000|Period 3|Withdrawal by Subject|0|||
149956372|NCT05064800|540973997|FG001|Period 3|Withdrawal by Subject|0|||
149956373|NCT05064800|540973998|FG002|Period 3|Withdrawal by Subject|0|||
149956374|NCT05064800|540973999|FG003|Period 3|Withdrawal by Subject|0|||
149956375|NCT05064800|540974000|FG004|Period 3|Withdrawal by Subject|1|||
149847739|NCT00566722|540569993|FG000|Overall Study|Adverse Event|0|||
149847740|NCT00566722|540569994|FG001|Overall Study|Adverse Event|1|||
149847741|NCT00566722|540569995|FG002|Overall Study|Adverse Event|0|||
149847742|NCT00566722|540569993|FG000|Overall Study|Withdrawal by Subject|0|||
149847743|NCT00566722|540569994|FG001|Overall Study|Withdrawal by Subject|0|||
149847744|NCT00566722|540569995|FG002|Overall Study|Withdrawal by Subject|1|||
149847745|NCT00566722|540569993|FG000|Overall Study|Lost to Follow-up|1|||
149847746|NCT00566722|540569994|FG001|Overall Study|Lost to Follow-up|1|||
149847747|NCT00566722|540569995|FG002|Overall Study|Lost to Follow-up|1|||
149847748|NCT00566722|540569993|FG000|Overall Study|Lack of Efficacy|1|||
149847749|NCT00566722|540569994|FG001|Overall Study|Lack of Efficacy|2|||
149847750|NCT00566722|540569995|FG002|Overall Study|Lack of Efficacy|4|||
149847751|NCT00566722|540569993|FG000|Overall Study|Did not meet exclusion criteria|0|||
149847752|NCT00566722|540569994|FG001|Overall Study|Did not meet exclusion criteria|0|||
149847753|NCT00566722|540569995|FG002|Overall Study|Did not meet exclusion criteria|2|||
149847754|NCT00566722|540569993|FG000|Overall Study|Serious adverse event|0|||
149847755|NCT00566722|540569994|FG001|Overall Study|Serious adverse event|1|||
149847756|NCT00566722|540569995|FG002|Overall Study|Serious adverse event|0|||
149847757|NCT00566722|540569993|FG000|Overall Study|Noncompliant with drug administration|0|||
149847758|NCT00566722|540569994|FG001|Overall Study|Noncompliant with drug administration|0|||
149847759|NCT00566722|540569995|FG002|Overall Study|Noncompliant with drug administration|1|||
149847760|NCT02218216|540569998|FG000|Overall Study|Study terminated before completed|6|||
149847761|NCT02218216|540569999|FG001|Overall Study|Study terminated before completed|0|||
149847762|NCT02218216|540570000|FG002|Overall Study|Study terminated before completed|0|||
149847763|NCT01401062|540570005|FG000|Overall Study|Death|9|||
149847764|NCT01401062|540570006|FG001|Overall Study|Death|7|||
149847765|NCT01401062|540570005|FG000|Overall Study|Physician Decision|1|||
149847766|NCT01401062|540570006|FG001|Overall Study|Physician Decision|0|||
149847767|NCT01401062|540570005|FG000|Overall Study|Withdrawal by Subject|1|||
149847768|NCT01401062|540570006|FG001|Overall Study|Withdrawal by Subject|1|||
149847769|NCT01131260|540570009|FG000|Overall Study|Randomization error|5|||
149847770|NCT01131260|540570010|FG001|Overall Study|Randomization error|1|||
149847771|NCT01131260|540570009|FG000|Overall Study|Declined to continue participation|8|||
149847772|NCT01131260|540570010|FG001|Overall Study|Declined to continue participation|13|||
149847773|NCT01131260|540570009|FG000|Overall Study|Physician Decision|22|||
149847774|NCT01131260|540570010|FG001|Overall Study|Physician Decision|24|||
149847775|NCT01131260|540570009|FG000|Overall Study|Technical problems|7|||
149956376|NCT05064800|540974001|FG005|Period 3|Withdrawal by Subject|0|||
149956377|NCT00629239|540974002|FG000|Overall Study|Adverse Event|7|||
149847776|NCT01131260|540570010|FG001|Overall Study|Technical problems|6|||
149847777|NCT01131260|540570009|FG000|Overall Study|Staff error|2|||
149847778|NCT01131260|540570010|FG001|Overall Study|Staff error|1|||
149847779|NCT01131260|540570009|FG000|Overall Study|Ineligible|0|||
149847780|NCT01131260|540570010|FG001|Overall Study|Ineligible|2|||
149847781|NCT03684928|540570014|FG000|First Intervention|Lost to Follow-up|0|||
149847782|NCT03684928|540570015|FG001|First Intervention|Lost to Follow-up|1|||
149847783|NCT03684928|540570014|FG000|First Intervention|Withdrawal by Subject|0|||
149956378|NCT00629239|540974003|FG001|Overall Study|Adverse Event|4|||
149956379|NCT00629239|540974002|FG000|Overall Study|Physician Decision|1|||
149956380|NCT00629239|540974003|FG001|Overall Study|Physician Decision|0|||
149956381|NCT01851369|540974004|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956382|NCT01851369|540974005|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956383|NCT01851369|540974006|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956384|NCT01851369|540974007|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956385|NCT01851369|540974008|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956386|NCT01851369|540974009|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
149956387|NCT01851369|540974010|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956388|NCT01851369|540974011|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956389|NCT01851369|540974012|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956390|NCT01851369|540974013|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956391|NCT01851369|540974014|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956392|NCT01851369|540974015|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956393|NCT01851369|540974016|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149956394|NCT00395512|540974019|FG000|Overall Study|Adverse Event|3|||
149956395|NCT00395512|540974020|FG001|Overall Study|Adverse Event|8|||
149956396|NCT00395512|540974021|FG002|Overall Study|Adverse Event|6|||
149956397|NCT00395512|540974022|FG003|Overall Study|Adverse Event|6|||
149956398|NCT00395512|540974019|FG000|Overall Study|Protocol Violation|2|||
149956399|NCT00395512|540974020|FG001|Overall Study|Protocol Violation|3|||
149956400|NCT00395512|540974021|FG002|Overall Study|Protocol Violation|6|||
149956401|NCT00395512|540974022|FG003|Overall Study|Protocol Violation|7|||
149956402|NCT00395512|540974019|FG000|Overall Study|Lost to Follow-up|2|||
149956403|NCT00395512|540974020|FG001|Overall Study|Lost to Follow-up|6|||
149956404|NCT00395512|540974021|FG002|Overall Study|Lost to Follow-up|5|||
149956405|NCT00395512|540974022|FG003|Overall Study|Lost to Follow-up|5|||
149956406|NCT00395512|540974019|FG000|Overall Study|Withdrawal by Subject|6|||
149956407|NCT00395512|540974020|FG001|Overall Study|Withdrawal by Subject|5|||
149956408|NCT00395512|540974021|FG002|Overall Study|Withdrawal by Subject|5|||
149956409|NCT00395512|540974022|FG003|Overall Study|Withdrawal by Subject|12|||
149956410|NCT00395512|540974019|FG000|Overall Study|Physician Decision|6|||
149956411|NCT00395512|540974020|FG001|Overall Study|Physician Decision|4|||
149956412|NCT00395512|540974021|FG002|Overall Study|Physician Decision|2|||
149956413|NCT00395512|540974022|FG003|Overall Study|Physician Decision|2|||
149956414|NCT00395512|540974019|FG000|Overall Study|Other|1|||
149956415|NCT00395512|540974020|FG001|Overall Study|Other|1|||
149956416|NCT00395512|540974021|FG002|Overall Study|Other|0|||
149956417|NCT00395512|540974022|FG003|Overall Study|Other|0|||
149956418|NCT00395512|540974019|FG000|Overall Study|Hyperglycemic Rescue|18|||
149956419|NCT00395512|540974020|FG001|Overall Study|Hyperglycemic Rescue|10|||
149956420|NCT00395512|540974021|FG002|Overall Study|Hyperglycemic Rescue|4|||
149956421|NCT00395512|540974022|FG003|Overall Study|Hyperglycemic Rescue|6|||
149956422|NCT03983109|540974023|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
149956423|NCT03983109|540974024|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
149956424|NCT01980888|540974025|FG000|Overall Study|Study Terminated by Sponsor|116|||
149956425|NCT01980888|540974026|FG001|Overall Study|Study Terminated by Sponsor|122|||
149956426|NCT01980888|540974025|FG000|Overall Study|Withdrew Consent|17|||
149956427|NCT01980888|540974026|FG001|Overall Study|Withdrew Consent|6|||
149956428|NCT01980888|540974025|FG000|Overall Study|Investigator's Discretion|8|||
149956429|NCT01980888|540974026|FG001|Overall Study|Investigator's Discretion|3|||
149956430|NCT01980888|540974025|FG000|Overall Study|Non-Compliance with Study Drug|3|||
149956431|NCT01980888|540974026|FG001|Overall Study|Non-Compliance with Study Drug|2|||
149956432|NCT04625972|540974027|FG000|Overall Study|Death|3|||
149956433|NCT04625972|540974028|FG001|Overall Study|Death|2|||
149956434|NCT04625972|540974027|FG000|Overall Study|Lost to Follow-up|82|||
149956435|NCT04625972|540974028|FG001|Overall Study|Lost to Follow-up|38|||
149956436|NCT04625972|540974027|FG000|Overall Study|Physician Decision|2|||
149956437|NCT04625972|540974028|FG001|Overall Study|Physician Decision|0|||
149956438|NCT04625972|540974027|FG000|Overall Study|Protocol Violation|0|||
149956439|NCT04625972|540974028|FG001|Overall Study|Protocol Violation|1|||
149956440|NCT04625972|540974027|FG000|Overall Study|Withdrawal by Subject|37|||
149956441|NCT04625972|540974028|FG001|Overall Study|Withdrawal by Subject|24|||
149956442|NCT04625972|540974027|FG000|Overall Study|Not specified elsewhere|8|||
149956443|NCT04625972|540974028|FG001|Overall Study|Not specified elsewhere|6|||
149956444|NCT00433290|540974029|FG000|Overall Study|Adverse Event|24|||
149956445|NCT00433290|540974030|FG001|Overall Study|Adverse Event|7|||
149956446|NCT00433290|540974029|FG000|Overall Study|Lack of Efficacy|1|||
149956447|NCT00433290|540974030|FG001|Overall Study|Lack of Efficacy|5|||
149956448|NCT00433290|540974029|FG000|Overall Study|Withdrawal by Subject|4|||
149956449|NCT00433290|540974030|FG001|Overall Study|Withdrawal by Subject|2|||
149956450|NCT00433290|540974029|FG000|Overall Study|Protocol Violation|3|||
149956451|NCT00433290|540974030|FG001|Overall Study|Protocol Violation|2|||
149956452|NCT00433290|540974029|FG000|Overall Study|Physician Decision|2|||
149956453|NCT00433290|540974030|FG001|Overall Study|Physician Decision|0|||
149956454|NCT00433290|540974029|FG000|Overall Study|Entry Criteria Not Met|0|||
149956455|NCT00433290|540974030|FG001|Overall Study|Entry Criteria Not Met|1|||
149956456|NCT00433290|540974029|FG000|Overall Study|Lost to Follow-up|1|||
149956457|NCT00433290|540974030|FG001|Overall Study|Lost to Follow-up|0|||
149956458|NCT01483651|540974031|FG000|Overall Study|Withdrawal by Subject|0|||
149956459|NCT01483651|540974032|FG001|Overall Study|Withdrawal by Subject|1|||
149956460|NCT01483651|540974033|FG002|Overall Study|Withdrawal by Subject|1|||
149956461|NCT01483651|540974034|FG003|Overall Study|Withdrawal by Subject|0|||
149956462|NCT01483651|540974035|FG004|Overall Study|Withdrawal by Subject|0|||
149956463|NCT01483651|540974036|FG005|Overall Study|Withdrawal by Subject|1|||
149956464|NCT01018953|540974037|FG000|Overall Study|Adverse Event|2|||
149956465|NCT01018953|540974037|FG000|Overall Study|Withdrawal by Subject|1|||
149956466|NCT01018953|540974037|FG000|Overall Study|Study termination by sponsor|5|||
149956467|NCT00724503|540974038|FG000|Overall Study|Lost to Follow-up|4|||
149956468|NCT00724503|540974039|FG001|Overall Study|Lost to Follow-up|8|||
149956469|NCT00724503|540974038|FG000|Overall Study|Withdrawal by Subject|11|||
149956470|NCT00724503|540974039|FG001|Overall Study|Withdrawal by Subject|23|||
149956471|NCT00724503|540974038|FG000|Overall Study|Death|190|||
149956472|NCT00724503|540974039|FG001|Overall Study|Death|182|||
149956473|NCT00724503|540974038|FG000|Overall Study|Adverse Event|1|||
149956474|NCT00724503|540974039|FG001|Overall Study|Adverse Event|0|||
149956475|NCT00724503|540974038|FG000|Overall Study|Not otherwise specified|4|||
149956476|NCT00724503|540974039|FG001|Overall Study|Not otherwise specified|7|||
149956477|NCT01186419|540974042|FG000|Overall Study|Withdrawal by Subject|5|||
149956478|NCT01186419|540974043|FG001|Overall Study|Withdrawal by Subject|3|||
149956479|NCT01186419|540974042|FG000|Overall Study|Adverse Event|1|||
149956480|NCT01186419|540974043|FG001|Overall Study|Adverse Event|2|||
149956481|NCT01186419|540974042|FG000|Overall Study|Physician Decision|0|||
149956482|NCT01186419|540974043|FG001|Overall Study|Physician Decision|3|||
149956483|NCT01186419|540974042|FG000|Overall Study|Other|1|||
149956484|NCT01186419|540974043|FG001|Overall Study|Other|1|||
149956485|NCT01928771|540974045|FG000|Overall Study|Adverse Event|6|||
149956486|NCT01928771|540974046|FG001|Overall Study|Adverse Event|5|||
149956487|NCT01928771|540974047|FG002|Overall Study|Adverse Event|1|||
149956488|NCT01928771|540974045|FG000|Overall Study|Death|2|||
149956489|NCT01928771|540974046|FG001|Overall Study|Death|2|||
149956490|NCT01928771|540974047|FG002|Overall Study|Death|2|||
150288069|NCT00691483|542189176|FG000|Overall Study|Adverse Event|14|||
150288070|NCT00691483|542189177|FG001|Overall Study|Adverse Event|6|||
150288071|NCT00691483|542189176|FG000|Overall Study|Lost to Follow-up|17|||
150288072|NCT00691483|542189177|FG001|Overall Study|Lost to Follow-up|10|||
150288073|NCT00691483|542189176|FG000|Overall Study|Withdrawal by Subject|24|||
150288074|NCT00691483|542189177|FG001|Overall Study|Withdrawal by Subject|7|||
150288075|NCT00691483|542189176|FG000|Overall Study|Other known cause|6|||
150288076|NCT00691483|542189177|FG001|Overall Study|Other known cause|1|||
150288077|NCT00691483|542189176|FG000|Overall Study|Randomized by not treated|7|||
150288078|NCT00691483|542189177|FG001|Overall Study|Randomized by not treated|1|||
150288079|NCT00746252|542189178|FG000|Overall Study|weight gain >7.5 %|1|||
150288080|NCT00746252|542189179|FG001|Overall Study|weight gain >7.5 %|2|||
150288081|NCT01391000|542189180|FG000|Overall Study|Lost to Follow-up|2|||
150288082|NCT01391000|542189181|FG001|Overall Study|Lost to Follow-up|0|||
150288083|NCT00082888|542189182|FG000|Overall Study|Ineligible|1|||
150288084|NCT00082888|542189183|FG001|Overall Study|Ineligible|0|||
150288085|NCT00082888|542189184|FG002|Overall Study|Ineligible|0|||
150288086|NCT03860961|542189185|FG000|Overall Study|Withdrawal by Subject|6|||
150288087|NCT03860961|542189186|FG001|Overall Study|Withdrawal by Subject|11|||
150288088|NCT03860961|542189185|FG000|Overall Study|Death|10|||
150288089|NCT03860961|542189186|FG001|Overall Study|Death|6|||
150288090|NCT03860961|542189185|FG000|Overall Study|Incomplete two-year data|4|||
150288091|NCT03860961|542189186|FG001|Overall Study|Incomplete two-year data|0|||
150288092|NCT02105454|542189189|FG000|Overall Study|Withdrawal by Subject|1|||
150288093|NCT00272038|542189190|FG000|Overall Study|withdrew before they received 2 cycles|7|||
150288094|NCT00493870|542189191|FG000|Overall Study|Lost to Follow-up|12|||
150288095|NCT00493870|542189192|FG001|Overall Study|Lost to Follow-up|15|||
150288096|NCT00883337|542189193|FG000|Core Treatment Period|Adverse Event|9|||
150288097|NCT00883337|542189194|FG001|Core Treatment Period|Adverse Event|12|||
150288098|NCT00883337|542189195|FG002|Core Treatment Period|Adverse Event|22|||
150288099|NCT00883337|542189193|FG000|Core Treatment Period|Lack of Efficacy|7|||
150288100|NCT00883337|542189194|FG001|Core Treatment Period|Lack of Efficacy|4|||
150288101|NCT00883337|542189195|FG002|Core Treatment Period|Lack of Efficacy|2|||
150288102|NCT00883337|542189193|FG000|Core Treatment Period|Lost to Follow-up|1|||
150288103|NCT00883337|542189194|FG001|Core Treatment Period|Lost to Follow-up|1|||
150288104|NCT00883337|542189195|FG002|Core Treatment Period|Lost to Follow-up|0|||
150288105|NCT00883337|542189193|FG000|Core Treatment Period|Withdrawal by Subject|2|||
150288106|NCT00883337|542189194|FG001|Core Treatment Period|Withdrawal by Subject|2|||
150288107|NCT00883337|542189195|FG002|Core Treatment Period|Withdrawal by Subject|6|||
150288108|NCT00883337|542189193|FG000|Core Treatment Period|Wish to be pregnant|1|||
150288109|NCT00883337|542189194|FG001|Core Treatment Period|Wish to be pregnant|2|||
149956491|NCT01928771|540974045|FG000|Overall Study|Lost to Follow-up|5|||
149956492|NCT01928771|540974046|FG001|Overall Study|Lost to Follow-up|6|||
149956493|NCT01928771|540974047|FG002|Overall Study|Lost to Follow-up|3|||
149956494|NCT01928771|540974045|FG000|Overall Study|Withdrawal by Subject|20|||
149956495|NCT01928771|540974046|FG001|Overall Study|Withdrawal by Subject|15|||
149956496|NCT01928771|540974047|FG002|Overall Study|Withdrawal by Subject|17|||
149956497|NCT01928771|540974045|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
149956498|NCT01928771|540974046|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
149956499|NCT01928771|540974047|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
149956500|NCT01928771|540974045|FG000|Overall Study|Other Reasons|9|||
149956501|NCT01928771|540974046|FG001|Overall Study|Other Reasons|9|||
149956502|NCT01928771|540974047|FG002|Overall Study|Other Reasons|14|||
149956503|NCT01928771|540974045|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
149956504|NCT01928771|540974046|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149956505|NCT01928771|540974047|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
150288110|NCT00883337|542189195|FG002|Core Treatment Period|Wish to be pregnant|1|||
150288111|NCT00883337|542189193|FG000|Core Treatment Period|Poor compliance to protocol|0|||
150288112|NCT00883337|542189194|FG001|Core Treatment Period|Poor compliance to protocol|0|||
150288113|NCT00883337|542189195|FG002|Core Treatment Period|Poor compliance to protocol|1|||
150288114|NCT00883337|542189193|FG000|Core Treatment Period|Other than above|0|||
149956506|NCT01937117|540974048|FG000|Overall Study|Disease Progression|7|||
149956507|NCT01937117|540974048|FG000|Overall Study|Physician Decision|4|||
149956508|NCT01937117|540974048|FG000|Overall Study|Adverse Event|2|||
149956509|NCT01407367|540974049|FG000|Overall Study|Death|24|||
149956510|NCT01407367|540974050|FG001|Overall Study|Death|32|||
149956511|NCT01407367|540974049|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
150288115|NCT00883337|542189194|FG001|Core Treatment Period|Other than above|1|||
150288116|NCT00883337|542189195|FG002|Core Treatment Period|Other than above|1|||
150288117|NCT00883337|542189193|FG000|Extension Treatment Period|Adverse Event|8|||
150288118|NCT00883337|542189194|FG001|Extension Treatment Period|Adverse Event|5|||
150288119|NCT00883337|542189195|FG002|Extension Treatment Period|Adverse Event|5|||
149956512|NCT01407367|540974050|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
149956513|NCT01407367|540974049|FG000|Overall Study|Withdrawal by Subject|4|||
149956514|NCT01407367|540974050|FG001|Overall Study|Withdrawal by Subject|15|||
150172734|NCT01317420|541768072|FG005|Overall Study|Reason other than those specified|0|||
150288120|NCT00883337|542189193|FG000|Extension Treatment Period|Lack of Efficacy|8|||
150288121|NCT00883337|542189194|FG001|Extension Treatment Period|Lack of Efficacy|8|||
150288122|NCT00883337|542189195|FG002|Extension Treatment Period|Lack of Efficacy|8|||
149956515|NCT01407367|540974049|FG000|Overall Study|Lost to Follow-up|0|||
149956516|NCT01407367|540974050|FG001|Overall Study|Lost to Follow-up|2|||
149956517|NCT01245062|540974052|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
149956518|NCT01245062|540974053|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
149956519|NCT01245062|540974054|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
149956520|NCT01245062|540974052|FG000|Randomization and Crossover Phase|Physician Decision|2|||
149956521|NCT01245062|540974053|FG001|Randomization and Crossover Phase|Physician Decision|4|||
149956522|NCT01245062|540974054|FG002|Randomization and Crossover Phase|Physician Decision|0|||
149956523|NCT01245062|540974052|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
149956524|NCT01245062|540974053|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
149956525|NCT01245062|540974054|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
149956526|NCT01245062|540974052|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
149956527|NCT01245062|540974053|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
149956528|NCT01245062|540974054|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
149956529|NCT01245062|540974052|FG000|Cross-over Phase|Lost to Follow-up|0|||
149956530|NCT01245062|540974053|FG001|Cross-over Phase|Lost to Follow-up|0|||
149956531|NCT01245062|540974054|FG002|Cross-over Phase|Lost to Follow-up|1|||
149956532|NCT01245062|540974052|FG000|Cross-over Phase|Physician Decision|0|||
149956533|NCT01245062|540974053|FG001|Cross-over Phase|Physician Decision|0|||
149956534|NCT01245062|540974054|FG002|Cross-over Phase|Physician Decision|1|||
149956535|NCT01245062|540974052|FG000|Cross-over Phase|Withdrew Consent|0|||
149956536|NCT01245062|540974053|FG001|Cross-over Phase|Withdrew Consent|0|||
149956537|NCT01245062|540974054|FG002|Cross-over Phase|Withdrew Consent|4|||
149956538|NCT01245062|540974052|FG000|Cross-over Phase|Study closed/ terminated|0|||
149956539|NCT01245062|540974053|FG001|Cross-over Phase|Study closed/ terminated|0|||
149956540|NCT01245062|540974054|FG002|Cross-over Phase|Study closed/ terminated|11|||
149956541|NCT06025695|540974055|FG000|Overall Study|Adverse Event|5|||
149956542|NCT06025695|540974056|FG001|Overall Study|Adverse Event|6|||
149956543|NCT06025695|540974055|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
149956544|NCT06025695|540974056|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
149956545|NCT06025695|540974055|FG000|Overall Study|Other|23|||
149956546|NCT06025695|540974056|FG001|Overall Study|Other|19|||
149956547|NCT06025695|540974055|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
149956548|NCT06025695|540974056|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
149956549|NCT01452347|540974057|FG000|Overall Study|Adverse Event|2|||
149956550|NCT01452347|540974058|FG001|Overall Study|Adverse Event|1|||
149956551|NCT01452347|540974057|FG000|Overall Study|Non compliance protocol|2|||
149956552|NCT01452347|540974058|FG001|Overall Study|Non compliance protocol|0|||
149956553|NCT01452347|540974057|FG000|Overall Study|Lost to Follow-up|2|||
149956554|NCT01452347|540974058|FG001|Overall Study|Lost to Follow-up|0|||
149956555|NCT01452347|540974057|FG000|Overall Study|Withdrawal by Subject|3|||
149956556|NCT01452347|540974058|FG001|Overall Study|Withdrawal by Subject|3|||
149956557|NCT01452347|540974057|FG000|Overall Study|Not treated|6|||
149956558|NCT01452347|540974058|FG001|Overall Study|Not treated|3|||
149956559|NCT01452347|540974057|FG000|Overall Study|Other reason not defined above|2|||
149956560|NCT01452347|540974058|FG001|Overall Study|Other reason not defined above|0|||
149956561|NCT05762744|540974059|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
149956562|NCT05762744|540974060|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
149956563|NCT05762744|540974059|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
149956564|NCT05762744|540974060|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
149956565|NCT01560416|540974064|FG000|Randomized Phase|Crossover Participants|7|||
149956566|NCT01560416|540974065|FG001|Randomized Phase|Crossover Participants|0|||
149956567|NCT00853047|540974069|FG000|Core Phase|Participant Request|0|||
149956568|NCT00853047|540974070|FG001|Core Phase|Participant Request|0|||
149956569|NCT00853047|540974071|FG002|Core Phase|Participant Request|0|||
149956570|NCT00853047|540974072|FG003|Core Phase|Participant Request|1|||
150172735|NCT01317420|541768073|FG006|Overall Study|Reason other than those specified|0|||
150172736|NCT01317420|541768074|FG007|Overall Study|Reason other than those specified|0|||
150172737|NCT01317420|541768075|FG008|Overall Study|Reason other than those specified|0|||
150172738|NCT01317420|541768076|FG009|Overall Study|Reason other than those specified|1|||
149956571|NCT00853047|540974073|FG004|Core Phase|Participant Request|0|||
150172739|NCT01317420|541768077|FG010|Overall Study|Reason other than those specified|0|||
149956572|NCT00853047|540974074|FG005|Core Phase|Participant Request|0|||
149956573|NCT00853047|540974069|FG000|Open-Label Extension Phase|Participant Request|0|||
149956574|NCT00853047|540974070|FG001|Open-Label Extension Phase|Participant Request|0|||
149956575|NCT00853047|540974071|FG002|Open-Label Extension Phase|Participant Request|0|||
149956576|NCT00853047|540974072|FG003|Open-Label Extension Phase|Participant Request|0|||
149956577|NCT00853047|540974073|FG004|Open-Label Extension Phase|Participant Request|0|||
149956578|NCT00853047|540974074|FG005|Open-Label Extension Phase|Participant Request|7|||
149956579|NCT00853047|540974069|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
149956580|NCT00853047|540974070|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
149956581|NCT00853047|540974071|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
149956582|NCT00853047|540974072|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
149956583|NCT00853047|540974073|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
149956584|NCT00853047|540974074|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
149956585|NCT00853047|540974069|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
149956586|NCT00853047|540974070|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
149956587|NCT00853047|540974071|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
149956588|NCT00853047|540974072|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
149956589|NCT00853047|540974073|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
149956590|NCT00853047|540974074|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
149956591|NCT00853047|540974069|FG000|Open-Label Extension Phase|Investigator Decision|0|||
149956592|NCT00853047|540974070|FG001|Open-Label Extension Phase|Investigator Decision|0|||
149956593|NCT00853047|540974071|FG002|Open-Label Extension Phase|Investigator Decision|0|||
149956594|NCT00853047|540974072|FG003|Open-Label Extension Phase|Investigator Decision|0|||
149956595|NCT00853047|540974073|FG004|Open-Label Extension Phase|Investigator Decision|0|||
149956596|NCT00853047|540974074|FG005|Open-Label Extension Phase|Investigator Decision|1|||
149956597|NCT00853047|540974069|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
149956598|NCT00853047|540974070|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
149956599|NCT00853047|540974071|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
149956600|NCT00853047|540974072|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
149956601|NCT00853047|540974073|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
149956602|NCT00853047|540974074|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
149956603|NCT01695772|540974078|FG000|Overall Study|Withdrawal by Subject|18|||
149956604|NCT01695772|540974078|FG000|Overall Study|Progressive Disease|8|||
149956605|NCT01695772|540974078|FG000|Overall Study|Investigator Decision|5|||
149956606|NCT01695772|540974078|FG000|Overall Study|Lost to Follow-up|4|||
149956607|NCT01695772|540974078|FG000|Overall Study|Protocol Violation|2|||
149956608|NCT01695772|540974078|FG000|Overall Study|Unspecified Reason|1|||
149956609|NCT00004859|540974079|FG000|Overall Study|Lack of Efficacy|43|||
149956610|NCT00004859|540974080|FG001|Overall Study|Lack of Efficacy|113|||
149956611|NCT00004859|540974079|FG000|Overall Study|Adverse Event|31|||
149956612|NCT00004859|540974080|FG001|Overall Study|Adverse Event|93|||
149956613|NCT00004859|540974079|FG000|Overall Study|Death|5|||
149956614|NCT00004859|540974080|FG001|Overall Study|Death|5|||
149956615|NCT00004859|540974079|FG000|Overall Study|Withdrawal by Subject|7|||
149956616|NCT00004859|540974080|FG001|Overall Study|Withdrawal by Subject|33|||
149956617|NCT00004859|540974079|FG000|Overall Study|Protocol Violation|2|||
149956618|NCT00004859|540974080|FG001|Overall Study|Protocol Violation|2|||
149956619|NCT00004859|540974079|FG000|Overall Study|other disease|0|||
149956620|NCT00004859|540974080|FG001|Overall Study|other disease|3|||
149956621|NCT00004859|540974079|FG000|Overall Study|error|3|||
149956622|NCT00004859|540974080|FG001|Overall Study|error|1|||
149956623|NCT00004859|540974079|FG000|Overall Study|missing data|14|||
149956624|NCT00004859|540974080|FG001|Overall Study|missing data|11|||
149956625|NCT00004859|540974079|FG000|Overall Study|Other|13|||
149956626|NCT00004859|540974080|FG001|Overall Study|Other|21|||
149956627|NCT04073407|540974081|FG000|Part 1|Withdrawal by Subject|1|||
149956628|NCT04073407|540974082|FG001|Part 1|Withdrawal by Subject|0|||
149956629|NCT04073407|540974081|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
149956630|NCT04073407|540974082|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
149956631|NCT04073407|540974081|FG000|Part 2|Withdrawal by Subject|0|||
149956632|NCT04073407|540974082|FG001|Part 2|Withdrawal by Subject|1|||
149956633|NCT01717859|540975346|FG000|Overall Study|Adverse Event|5|||
149956634|NCT01717859|540975346|FG000|Overall Study|Moved out of state|1|||
149956635|NCT01717859|540975346|FG000|Overall Study|Patient concerned about mental health|1|||
149956636|NCT01717859|540975346|FG000|Overall Study|Lost to Follow-up|1|||
149956637|NCT01717859|540975346|FG000|Overall Study|Withdrawal by Subject|2|||
149956638|NCT00899847|540975347|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
149956639|NCT00183391|540975350|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
149956640|NCT00183391|540975351|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
150172740|NCT01317420|541768078|FG011|Overall Study|Reason other than those specified|0|||
150172741|NCT01317420|541768079|FG012|Overall Study|Reason other than those specified|0|||
150172742|NCT05686421|541768080|FG000|Overall Study|Screen failure|22|||
149956641|NCT00183391|540975350|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
149956642|NCT00183391|540975351|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
149956643|NCT02336503|540975352|FG000|Overall Study|Lost to Follow-up|0|||
149956644|NCT02336503|540975353|FG001|Overall Study|Lost to Follow-up|3|||
149956645|NCT02336503|540975354|FG002|Overall Study|Lost to Follow-up|0|||
149956646|NCT02336503|540975355|FG003|Overall Study|Lost to Follow-up|2|||
149956647|NCT02336503|540975352|FG000|Overall Study|Withdrawal by Subject|2|||
149956648|NCT02336503|540975353|FG001|Overall Study|Withdrawal by Subject|0|||
149956649|NCT02336503|540975354|FG002|Overall Study|Withdrawal by Subject|0|||
150288123|NCT00883337|542189193|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
149956650|NCT02336503|540975355|FG003|Overall Study|Withdrawal by Subject|4|||
149956651|NCT02336503|540975352|FG000|Overall Study|Adverse Event|0|||
149956652|NCT02336503|540975353|FG001|Overall Study|Adverse Event|0|||
149956653|NCT02336503|540975354|FG002|Overall Study|Adverse Event|1|||
149956654|NCT02336503|540975355|FG003|Overall Study|Adverse Event|0|||
149956655|NCT01478087|540975358|FG000|Overall Study|due to sponsor closing study|1|||
149956656|NCT04584554|540975363|FG000|Overall Study|Withdrawal by Subject|2|||
149956657|NCT04584554|540975364|FG001|Overall Study|Withdrawal by Subject|2|||
149956658|NCT02583477|540975368|FG000|Overall Study|Adverse Event|0|||
149956659|NCT02583477|540975369|FG001|Overall Study|Adverse Event|2|||
149956660|NCT02583477|540975368|FG000|Overall Study|Death|1|||
149956661|NCT02583477|540975369|FG001|Overall Study|Death|16|||
149956662|NCT02583477|540975368|FG000|Overall Study|Study terminated|2|||
149956663|NCT02583477|540975369|FG001|Overall Study|Study terminated|2|||
149956664|NCT05507450|540975370|FG000|Overall Study|Death|0|||
149956665|NCT05507450|540975371|FG001|Overall Study|Death|0|||
149956666|NCT05507450|540975372|FG002|Overall Study|Death|1|||
149956667|NCT05507450|540975373|FG003|Overall Study|Death|0|||
149956668|NCT05507450|540975370|FG000|Overall Study|Lost to Follow-up|22|||
149956669|NCT05507450|540975371|FG001|Overall Study|Lost to Follow-up|20|||
149956670|NCT05507450|540975372|FG002|Overall Study|Lost to Follow-up|20|||
149956671|NCT05507450|540975373|FG003|Overall Study|Lost to Follow-up|7|||
149956672|NCT05507450|540975370|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149956673|NCT05507450|540975371|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
149956674|NCT05507450|540975372|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149956675|NCT05507450|540975373|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149956676|NCT05507450|540975370|FG000|Overall Study|Withdrawal by Subject|4|||
149956677|NCT05507450|540975371|FG001|Overall Study|Withdrawal by Subject|11|||
149956678|NCT05507450|540975372|FG002|Overall Study|Withdrawal by Subject|7|||
149956679|NCT05507450|540975373|FG003|Overall Study|Withdrawal by Subject|3|||
149956680|NCT05507450|540975370|FG000|Overall Study|Participant left the country|0|||
149956681|NCT05507450|540975371|FG001|Overall Study|Participant left the country|0|||
149956682|NCT05507450|540975372|FG002|Overall Study|Participant left the country|1|||
149956683|NCT05507450|540975373|FG003|Overall Study|Participant left the country|0|||
149956684|NCT05436288|540975375|FG000|Overall Study|Lost to Follow-up|1|||
149956685|NCT05436288|540975375|FG000|Overall Study|Adverse Event|1|||
149956686|NCT03767894|540975383|FG000|Overall Study|Withdrawal by Subject|1|||
149956687|NCT03501277|540975384|FG000|Intervention Period 1 (4 Days)|Other|0|||
149956688|NCT03501277|540975385|FG001|Intervention Period 1 (4 Days)|Other|0|||
149956689|NCT03501277|540975386|FG002|Intervention Period 1 (4 Days)|Other|1|||
149956690|NCT03501277|540975387|FG003|Intervention Period 1 (4 Days)|Other|0|||
149956691|NCT03501277|540975384|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
149956692|NCT03501277|540975385|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
149956693|NCT03501277|540975386|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
149956694|NCT03501277|540975387|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
149956695|NCT03501277|540975384|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
149956696|NCT03501277|540975385|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
149956697|NCT03501277|540975386|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
149956698|NCT03501277|540975387|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
149956699|NCT03501277|540975384|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
149956700|NCT03501277|540975385|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
149956701|NCT03501277|540975386|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
149956702|NCT03501277|540975387|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
149956703|NCT01436500|540975390|FG000|Overall Study|Death|1|||
149956704|NCT01436500|540975391|FG001|Overall Study|Death|0|||
149956705|NCT01436500|540975392|FG002|Overall Study|Death|0|||
149956706|NCT01436500|540975393|FG003|Overall Study|Death|0|||
149956707|NCT01436500|540975394|FG004|Overall Study|Death|0|||
149956708|NCT01436500|540975390|FG000|Overall Study|Adverse Event|0|||
149956709|NCT01436500|540975391|FG001|Overall Study|Adverse Event|2|||
149956710|NCT01436500|540975392|FG002|Overall Study|Adverse Event|2|||
149956711|NCT01436500|540975393|FG003|Overall Study|Adverse Event|0|||
149956712|NCT01436500|540975394|FG004|Overall Study|Adverse Event|1|||
149956713|NCT01436500|540975390|FG000|Overall Study|Withdrawal by Subject|0|||
149956714|NCT01436500|540975391|FG001|Overall Study|Withdrawal by Subject|0|||
149956715|NCT01436500|540975392|FG002|Overall Study|Withdrawal by Subject|2|||
149956716|NCT01436500|540975393|FG003|Overall Study|Withdrawal by Subject|0|||
149956717|NCT01436500|540975394|FG004|Overall Study|Withdrawal by Subject|2|||
149956718|NCT01436500|540975390|FG000|Overall Study|Physician Decision|0|||
149956719|NCT01436500|540975391|FG001|Overall Study|Physician Decision|0|||
149956720|NCT01436500|540975392|FG002|Overall Study|Physician Decision|1|||
149956721|NCT01436500|540975393|FG003|Overall Study|Physician Decision|0|||
149956722|NCT01436500|540975394|FG004|Overall Study|Physician Decision|0|||
149956723|NCT01436500|540975390|FG000|Overall Study|liver transplant|1|||
149956724|NCT01436500|540975391|FG001|Overall Study|liver transplant|0|||
149956725|NCT01436500|540975392|FG002|Overall Study|liver transplant|0|||
149956726|NCT01436500|540975393|FG003|Overall Study|liver transplant|0|||
149956727|NCT01436500|540975394|FG004|Overall Study|liver transplant|0|||
149956728|NCT01436500|540975390|FG000|Overall Study|initiation of dialysis|0|||
149956729|NCT01436500|540975391|FG001|Overall Study|initiation of dialysis|0|||
149956730|NCT01436500|540975392|FG002|Overall Study|initiation of dialysis|0|||
149956731|NCT01436500|540975393|FG003|Overall Study|initiation of dialysis|0|||
149956732|NCT01436500|540975394|FG004|Overall Study|initiation of dialysis|1|||
149956733|NCT01436500|540975390|FG000|Overall Study|discontinued study drug|1|||
149956734|NCT01436500|540975391|FG001|Overall Study|discontinued study drug|0|||
149956735|NCT01436500|540975392|FG002|Overall Study|discontinued study drug|0|||
149956736|NCT01436500|540975393|FG003|Overall Study|discontinued study drug|0|||
149956737|NCT01436500|540975394|FG004|Overall Study|discontinued study drug|0|||
149956738|NCT01436500|540975390|FG000|Overall Study|Other|0|||
149956739|NCT01436500|540975391|FG001|Overall Study|Other|1|||
149956740|NCT01436500|540975392|FG002|Overall Study|Other|0|||
149956741|NCT01436500|540975393|FG003|Overall Study|Other|1|||
149956742|NCT01436500|540975394|FG004|Overall Study|Other|0|||
149956743|NCT01873833|540975396|FG000|Overall Study|Withdrawal by Subject|1|||
149956744|NCT04560309|540975399|FG000|Overall Study|Meet drop out criteria|1|||
149956745|NCT04560309|540975400|FG001|Overall Study|Meet drop out criteria|1|||
149956746|NCT04146909|540975401|FG000|Overall Study|Withdrawal by Subject|3|||
149956747|NCT04146909|540975401|FG000|Overall Study|Did not qualify after consented|1|||
149956748|NCT01860404|540975402|FG000|Overall Study|Lost to Follow-up|3|||
149956749|NCT01860404|540975403|FG001|Overall Study|Lost to Follow-up|4|||
149956750|NCT01860404|540975404|FG002|Overall Study|Lost to Follow-up|1|||
149956751|NCT01860404|540975405|FG003|Overall Study|Lost to Follow-up|6|||
149956752|NCT01860404|540975406|FG004|Overall Study|Lost to Follow-up|4|||
149956753|NCT01860404|540975402|FG000|Overall Study|Withdrawal by Subject|0|||
149956754|NCT01860404|540975403|FG001|Overall Study|Withdrawal by Subject|0|||
149956755|NCT01860404|540975404|FG002|Overall Study|Withdrawal by Subject|4|||
149956756|NCT01860404|540975405|FG003|Overall Study|Withdrawal by Subject|0|||
149956757|NCT01860404|540975406|FG004|Overall Study|Withdrawal by Subject|0|||
149956758|NCT00676689|540975409|FG000|Overall Study|Screen Failure|2|||
149956759|NCT00676689|540975409|FG000|Overall Study|Death|2|||
149956760|NCT00676689|540975409|FG000|Overall Study|Lost to Follow-up|4|||
149956761|NCT00676689|540975409|FG000|Overall Study|Physician Decision|1|||
149956762|NCT00676689|540975409|FG000|Overall Study|Withdrawal by Subject|3|||
149956763|NCT00676689|540975409|FG000|Overall Study|Continuing FU|49|||
149956764|NCT00356421|540975411|FG000|Overall Study|Lack of Efficacy|3|||
149956765|NCT00356421|540975412|FG001|Overall Study|Lack of Efficacy|0|||
149956766|NCT00356421|540975411|FG000|Overall Study|Withdrawal by Subject|9|||
149956767|NCT00356421|540975412|FG001|Overall Study|Withdrawal by Subject|2|||
149956768|NCT00356421|540975411|FG000|Overall Study|Related to study drug|15|||
149956769|NCT00356421|540975412|FG001|Overall Study|Related to study drug|12|||
149956770|NCT00356421|540975411|FG000|Overall Study|Not related to study drug|5|||
149956771|NCT00356421|540975412|FG001|Overall Study|Not related to study drug|3|||
149956772|NCT00567112|540975413|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
149956773|NCT00567112|540975414|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
149956774|NCT00567112|540975415|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
149956775|NCT00567112|540975413|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
149956776|NCT00567112|540975414|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
149956777|NCT00567112|540975415|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
149956778|NCT00567112|540975413|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
149956779|NCT00567112|540975414|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
149956780|NCT00567112|540975415|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
149956781|NCT04689009|540975416|FG000|Overall Study|Adverse Event|1|||
149956782|NCT04689009|540975417|FG001|Overall Study|Adverse Event|0|||
149956783|NCT04689009|540975416|FG000|Overall Study|Lost to Follow-up|1|||
149956784|NCT04689009|540975417|FG001|Overall Study|Lost to Follow-up|2|||
149956785|NCT04689009|540975416|FG000|Overall Study|Withdrawal by Subject|4|||
149956786|NCT04689009|540975417|FG001|Overall Study|Withdrawal by Subject|3|||
149956787|NCT04689009|540975416|FG000|Overall Study|Protocol Violation|1|||
149956788|NCT04689009|540975417|FG001|Overall Study|Protocol Violation|0|||
149956789|NCT05089357|540975418|FG000|Overall Study|Withdrawal by Subject|23|||
150288124|NCT00883337|542189194|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
149956790|NCT05089357|540975418|FG000|Overall Study|Lost to Follow-up|6|||
149956791|NCT05089357|540975418|FG000|Overall Study|Medical reason|1|||
149956792|NCT05089357|540975418|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
149956793|NCT05089357|540975418|FG000|Overall Study|Pregnancy|2|||
149956794|NCT04796207|540975421|FG000|Overall Study|Lost to Follow-up|7|||
149956795|NCT04796207|540975422|FG001|Overall Study|Lost to Follow-up|2|||
149956796|NCT03003468|540975423|FG000|Overall Study|Withdrawal by Subject|0|||
149956797|NCT03003468|540975424|FG001|Overall Study|Withdrawal by Subject|0|||
149956798|NCT03003468|540975425|FG002|Overall Study|Withdrawal by Subject|1|||
149956799|NCT03003468|540975423|FG000|Overall Study|No measurable lesions|0|||
150036750|NCT00626106|541274529|FG000|Overall Study|Withdrawal by Subject|2|||
150036751|NCT00626106|541274530|FG001|Overall Study|Withdrawal by Subject|1|||
150036752|NCT00626106|541274529|FG000|Overall Study|Lost to Follow-up|1|||
150036753|NCT00626106|541274530|FG001|Overall Study|Lost to Follow-up|4|||
150036754|NCT00626106|541274529|FG000|Overall Study|Death|64|||
150036755|NCT00626106|541274530|FG001|Overall Study|Death|19|||
150036756|NCT03472885|541274531|FG000|24-Week Treatment Period|Adverse Event|1|||
150036757|NCT02201953|541274534|FG000|Overall Study|Randomized but Never Treated|1|||
150036758|NCT02201953|541274535|FG001|Overall Study|Randomized but Never Treated|5|||
150036759|NCT02201953|541274534|FG000|Overall Study|Lack of Efficacy|9|||
150036760|NCT02201953|541274535|FG001|Overall Study|Lack of Efficacy|30|||
150036761|NCT02201953|541274534|FG000|Overall Study|Lost to Follow-up|8|||
150036762|NCT02201953|541274535|FG001|Overall Study|Lost to Follow-up|8|||
150036763|NCT02201953|541274534|FG000|Overall Study|Withdrew Consent|2|||
150036764|NCT02201953|541274535|FG001|Overall Study|Withdrew Consent|5|||
150036765|NCT02201953|541274534|FG000|Overall Study|Adverse Event|0|||
150036766|NCT02201953|541274535|FG001|Overall Study|Adverse Event|5|||
150036767|NCT02201953|541274534|FG000|Overall Study|Death|0|||
150036768|NCT02201953|541274535|FG001|Overall Study|Death|3|||
150036769|NCT00321620|541276977|FG000|Overall Study|Death|269|||
150036770|NCT00321620|541276978|FG001|Overall Study|Death|294|||
150036771|NCT00321620|541276977|FG000|Overall Study|Withdrawal by Subject|164|||
150036772|NCT00321620|541276978|FG001|Overall Study|Withdrawal by Subject|147|||
150036773|NCT00321620|541276977|FG000|Overall Study|Disease progression|113|||
150036774|NCT00321620|541276978|FG001|Overall Study|Disease progression|117|||
150036775|NCT00321620|541276977|FG000|Overall Study|Adverse Event|43|||
150036776|NCT00321620|541276978|FG001|Overall Study|Adverse Event|56|||
150036777|NCT00321620|541276977|FG000|Overall Study|Lost to Follow-up|13|||
150036778|NCT00321620|541276978|FG001|Overall Study|Lost to Follow-up|9|||
150036779|NCT00321620|541276977|FG000|Overall Study|Physician Decision|4|||
150036780|NCT00321620|541276978|FG001|Overall Study|Physician Decision|1|||
150036781|NCT00321620|541276977|FG000|Overall Study|Noncompliance|14|||
150036782|NCT00321620|541276978|FG001|Overall Study|Noncompliance|7|||
150036783|NCT00321620|541276977|FG000|Overall Study|Protocol deviation|4|||
150036784|NCT00321620|541276978|FG001|Overall Study|Protocol deviation|3|||
150036785|NCT00321620|541276977|FG000|Overall Study|Ineligibility determined|2|||
150036786|NCT00321620|541276978|FG001|Overall Study|Ineligibility determined|3|||
150036787|NCT00321620|541276977|FG000|Overall Study|Participant request|75|||
150036788|NCT00321620|541276978|FG001|Overall Study|Participant request|52|||
150036789|NCT00321620|541276977|FG000|Overall Study|Other|42|||
150036790|NCT00321620|541276978|FG001|Overall Study|Other|33|||
150036791|NCT01747876|541276983|FG000|Overall Study|Adverse Event|1|||
150036792|NCT01747876|541276984|FG001|Overall Study|Adverse Event|0|||
150036793|NCT01747876|541276985|FG002|Overall Study|Adverse Event|2|||
150036794|NCT01747876|541276983|FG000|Overall Study|Withdrawal by Subject|0|||
150036795|NCT01747876|541276984|FG001|Overall Study|Withdrawal by Subject|1|||
150036796|NCT01747876|541276985|FG002|Overall Study|Withdrawal by Subject|1|||
150036797|NCT01747876|541276983|FG000|Overall Study|Disease progression|4|||
150036798|NCT01747876|541276984|FG001|Overall Study|Disease progression|13|||
150036799|NCT01747876|541276985|FG002|Overall Study|Disease progression|8|||
150036800|NCT01747876|541276983|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
150036801|NCT01747876|541276984|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
150036802|NCT01747876|541276985|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
150036803|NCT00129402|541276987|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
150036804|NCT00129402|541276988|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
150036805|NCT00129402|541276989|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
150036806|NCT00129402|541276990|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
150036807|NCT00129402|541276991|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
150036808|NCT00129402|541276992|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
150288125|NCT00883337|542189195|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
150288126|NCT00883337|542189193|FG000|Extension Treatment Period|Lost to Follow-up|1|||
150288127|NCT00883337|542189194|FG001|Extension Treatment Period|Lost to Follow-up|0|||
150288128|NCT00883337|542189195|FG002|Extension Treatment Period|Lost to Follow-up|0|||
150288129|NCT00883337|542189193|FG000|Extension Treatment Period|Other than above|10|||
150288130|NCT00883337|542189194|FG001|Extension Treatment Period|Other than above|9|||
150036809|NCT00129402|541276993|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
150036810|NCT00129402|541276987|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036811|NCT00129402|541276988|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036812|NCT00129402|541276989|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036813|NCT00129402|541276990|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036814|NCT00129402|541276991|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036815|NCT00129402|541276992|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
150036816|NCT00129402|541276993|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
150036817|NCT00129402|541276987|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
150036818|NCT00129402|541276988|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
149847784|NCT03684928|540570015|FG001|First Intervention|Withdrawal by Subject|2|||
149847785|NCT03684928|540570014|FG000|Second Intervention|Soft Tissue Injury|1|||
149847786|NCT03684928|540570015|FG001|Second Intervention|Soft Tissue Injury|0|||
149847787|NCT00874276|540570016|FG000|Overall Study|Withdrawal by Subject|1|||
149847788|NCT00874276|540570017|FG001|Overall Study|Withdrawal by Subject|1|||
149847789|NCT03733145|540570018|FG000|Overall Study|screenfail|3|||
149847790|NCT03733145|540570019|FG001|Overall Study|screenfail|3|||
149847791|NCT03733145|540570020|FG002|Overall Study|screenfail|2|||
149847792|NCT01691430|540571779|FG000|Overall Study|Death|17|||
149847793|NCT01691430|540571780|FG001|Overall Study|Death|16|||
149847794|NCT01691430|540571779|FG000|Overall Study|Withdrawal by Subject|5|||
149847795|NCT01691430|540571780|FG001|Overall Study|Withdrawal by Subject|1|||
149847796|NCT01691430|540571779|FG000|Overall Study|Lost to Follow-up|0|||
149847797|NCT01691430|540571780|FG001|Overall Study|Lost to Follow-up|3|||
149847798|NCT00660387|540571781|FG000|Overall Study|Adverse Event|1|||
149847799|NCT00660387|540571782|FG001|Overall Study|Adverse Event|2|||
149847800|NCT00660387|540571781|FG000|Overall Study|Lack of Efficacy|0|||
149847801|NCT00660387|540571782|FG001|Overall Study|Lack of Efficacy|1|||
149847802|NCT00660387|540571781|FG000|Overall Study|Protocol Violation|1|||
149847803|NCT00660387|540571782|FG001|Overall Study|Protocol Violation|0|||
149847804|NCT01622660|540571783|FG000|Overall Study|Adverse Event|1|||
149847805|NCT02259348|540571784|FG000|Overall Study|Donors|6|||
149847806|NCT02259348|540571784|FG000|Overall Study|Death|4|||
149847807|NCT04211766|540571785|FG000|Overall Study|Withdrawal by Subject|5|||
149847808|NCT04211766|540571786|FG001|Overall Study|Withdrawal by Subject|1|||
149847809|NCT02583048|540571787|FG000|Overall Study|Withdrawal by Subject|0|||
149847810|NCT02583048|540571788|FG001|Overall Study|Withdrawal by Subject|1|||
149847811|NCT02583048|540571789|FG002|Overall Study|Withdrawal by Subject|0|||
149847812|NCT02583048|540571787|FG000|Overall Study|Failed to meet eligibility criterion|0|||
149847813|NCT02583048|540571788|FG001|Overall Study|Failed to meet eligibility criterion|0|||
149847814|NCT02583048|540571789|FG002|Overall Study|Failed to meet eligibility criterion|1|||
149847815|NCT00516295|540571793|FG000|Overall Study|Lack of Efficacy|2|||
149847816|NCT00516295|540571794|FG001|Overall Study|Lack of Efficacy|0|||
149847817|NCT00516295|540571795|FG002|Overall Study|Lack of Efficacy|0|||
149847818|NCT00516295|540571793|FG000|Overall Study|Ineligible|1|||
149847819|NCT00516295|540571794|FG001|Overall Study|Ineligible|0|||
149847820|NCT00516295|540571795|FG002|Overall Study|Ineligible|0|||
149847821|NCT02034513|540571796|FG000|Overall Study|Adverse Event|11|||
149847822|NCT02034513|540571797|FG001|Overall Study|Adverse Event|10|||
149847823|NCT02034513|540571796|FG000|Overall Study|Lack of Efficacy|0|||
149847824|NCT02034513|540571797|FG001|Overall Study|Lack of Efficacy|1|||
149847825|NCT02034513|540571796|FG000|Overall Study|Lost to Follow-up|6|||
149847826|NCT02034513|540571797|FG001|Overall Study|Lost to Follow-up|7|||
149847827|NCT02034513|540571796|FG000|Overall Study|Pregnancy|0|||
149847828|NCT02034513|540571797|FG001|Overall Study|Pregnancy|3|||
149847829|NCT02034513|540571796|FG000|Overall Study|Protocol Violation|7|||
149847830|NCT02034513|540571797|FG001|Overall Study|Protocol Violation|10|||
149847831|NCT02034513|540571796|FG000|Overall Study|Withdrawal by Subject|25|||
149847832|NCT02034513|540571797|FG001|Overall Study|Withdrawal by Subject|25|||
149847833|NCT02034513|540571796|FG000|Overall Study|Unclassified|0|||
149847834|NCT02034513|540571797|FG001|Overall Study|Unclassified|1|||
149847835|NCT00960154|540571798|FG000|Overall Study|Study termination|25|||
149847836|NCT00960154|540571799|FG001|Overall Study|Study termination|25|||
149847837|NCT00757705|540571800|FG000|Overall Study|Adverse Event|19|||
149847838|NCT00757705|540571800|FG000|Overall Study|Lost to Follow-up|16|||
149847839|NCT00757705|540571800|FG000|Overall Study|Withdrawal by Subject|25|||
149847840|NCT00757705|540571800|FG000|Overall Study|Insufficient Response|26|||
149847841|NCT00757705|540571800|FG000|Overall Study|Ineligible to continue|8|||
149847842|NCT00757705|540571800|FG000|Overall Study|Non-compliant|9|||
149847843|NCT00757705|540571800|FG000|Overall Study|Other|18|||
149847844|NCT00660660|540571801|FG000|Overall Study|Adverse Event|1|||
149847845|NCT00660660|540571802|FG001|Overall Study|Adverse Event|0|||
149847846|NCT00660660|540571801|FG000|Overall Study|Lost to Follow-up|0|||
149847847|NCT00660660|540571802|FG001|Overall Study|Lost to Follow-up|6|||
149847848|NCT00660660|540571801|FG000|Overall Study|Lack of Efficacy|0|||
149847849|NCT00660660|540571802|FG001|Overall Study|Lack of Efficacy|2|||
149847850|NCT00660660|540571801|FG000|Overall Study|Withdrawal by Subject|3|||
149847851|NCT00660660|540571802|FG001|Overall Study|Withdrawal by Subject|0|||
149847852|NCT00660660|540571801|FG000|Overall Study|Incorrect enrollment and other|0|||
149847853|NCT00660660|540571802|FG001|Overall Study|Incorrect enrollment and other|1|||
149847854|NCT00660660|540571801|FG000|Overall Study|New medication after randomization|1|||
149847855|NCT00660660|540571802|FG001|Overall Study|New medication after randomization|0|||
149847856|NCT02218541|540571806|FG000|Overall Study|Lost to Follow-up|2|||
149847857|NCT02218541|540571807|FG001|Overall Study|Lost to Follow-up|1|||
149847858|NCT02218541|540571806|FG000|Overall Study|Implant Failure|4|||
149847859|NCT02218541|540571807|FG001|Overall Study|Implant Failure|1|||
149847860|NCT04661202|540571808|FG000|Overall Study|Withdrawal by Subject|1|||
149847861|NCT04661202|540571809|FG001|Overall Study|Withdrawal by Subject|1|||
149847862|NCT04661202|540571808|FG000|Overall Study|Lack of Efficacy|2|||
150172743|NCT05686421|541768081|FG001|Overall Study|Screen failure|0|||
149847863|NCT04661202|540571809|FG001|Overall Study|Lack of Efficacy|0|||
149847864|NCT00856349|540571810|FG000|Overall Study|Death|418|||
149847865|NCT00856349|540571810|FG000|Overall Study|Withdrawal by Subject|116|||
149847866|NCT00856349|540571810|FG000|Overall Study|Lost to Follow-up|91|||
149847867|NCT00856349|540571810|FG000|Overall Study|Protocol Violation|38|||
149847868|NCT00856349|540571810|FG000|Overall Study|Physician Decision|13|||
149847869|NCT00856349|540571810|FG000|Overall Study|Subject relocation|104|||
149847870|NCT00856349|540571810|FG000|Overall Study|Device explant|33|||
149847871|NCT00856349|540571810|FG000|Overall Study|Site closure|78|||
149847872|NCT00856349|540571810|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
149847873|NCT02578641|540571811|FG000|Overall Study|Adverse Event|5|||
149847874|NCT02578641|540571812|FG001|Overall Study|Adverse Event|15|||
149847875|NCT02578641|540571811|FG000|Overall Study|Death|16|||
149847876|NCT02578641|540571812|FG001|Overall Study|Death|8|||
149847877|NCT02578641|540571811|FG000|Overall Study|Lost to Follow-up|0|||
149847878|NCT02578641|540571812|FG001|Overall Study|Lost to Follow-up|1|||
149847879|NCT02578641|540571811|FG000|Overall Study|Withdrawal by Subject|14|||
149847880|NCT02578641|540571812|FG001|Overall Study|Withdrawal by Subject|7|||
149847881|NCT02578641|540571811|FG000|Overall Study|Progressive Disease|69|||
149847882|NCT02578641|540571812|FG001|Overall Study|Progressive Disease|21|||
149847883|NCT02578641|540571811|FG000|Overall Study|No Study Drug|2|||
149847884|NCT02578641|540571812|FG001|Overall Study|No Study Drug|0|||
149847885|NCT02578641|540571811|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
149847886|NCT02578641|540571812|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
149847887|NCT02578641|540571811|FG000|Overall Study|Non-compliance with Study Schedule|1|||
149847888|NCT02578641|540571812|FG001|Overall Study|Non-compliance with Study Schedule|0|||
149847889|NCT02578641|540571811|FG000|Overall Study|Other|1|||
149847890|NCT02578641|540571812|FG001|Overall Study|Other|10|||
149847891|NCT02578641|540571811|FG000|Overall Study|Not treated|1|||
149847892|NCT02578641|540571812|FG001|Overall Study|Not treated|4|||
149847893|NCT02998541|540571819|FG000|Overall Study|Adverse Event|4|||
149847894|NCT02998541|540571820|FG001|Overall Study|Adverse Event|5|||
149847895|NCT02998541|540571821|FG002|Overall Study|Adverse Event|1|||
149847896|NCT02998541|540571819|FG000|Overall Study|Protocol Violation|1|||
149847897|NCT02998541|540571820|FG001|Overall Study|Protocol Violation|0|||
149847898|NCT02998541|540571821|FG002|Overall Study|Protocol Violation|0|||
149847899|NCT02998541|540571819|FG000|Overall Study|Withdrawal by Subject|3|||
149847900|NCT02998541|540571820|FG001|Overall Study|Withdrawal by Subject|1|||
149847901|NCT02998541|540571821|FG002|Overall Study|Withdrawal by Subject|0|||
149847902|NCT02998541|540571819|FG000|Overall Study|Lost to Follow-up|0|||
149847903|NCT02998541|540571820|FG001|Overall Study|Lost to Follow-up|3|||
149847904|NCT02998541|540571821|FG002|Overall Study|Lost to Follow-up|1|||
149847905|NCT02998541|540571819|FG000|Overall Study|Physician Decision|0|||
149847906|NCT02998541|540571820|FG001|Overall Study|Physician Decision|0|||
149847907|NCT02998541|540571821|FG002|Overall Study|Physician Decision|3|||
149847908|NCT02998541|540571819|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149847909|NCT02998541|540571820|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149847910|NCT02998541|540571821|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
149847911|NCT01513239|540571829|FG000|Period 1: Main Phase|Adverse Event|1|||
149847912|NCT01513239|540571830|FG001|Period 1: Main Phase|Adverse Event|1|||
149847913|NCT01513239|540571831|FG002|Period 1: Main Phase|Adverse Event|2|||
149847914|NCT01513239|540571832|FG003|Period 1: Main Phase|Adverse Event|0|||
149847915|NCT01513239|540571833|FG004|Period 1: Main Phase|Adverse Event|0|||
149847916|NCT01513239|540571834|FG005|Period 1: Main Phase|Adverse Event|0|||
149847917|NCT01513239|540571829|FG000|Period 1: Main Phase|Death|29|||
149847918|NCT01513239|540571830|FG001|Period 1: Main Phase|Death|22|||
149847919|NCT01513239|540571831|FG002|Period 1: Main Phase|Death|32|||
149847920|NCT01513239|540571832|FG003|Period 1: Main Phase|Death|0|||
149847921|NCT01513239|540571833|FG004|Period 1: Main Phase|Death|0|||
149847922|NCT01513239|540571834|FG005|Period 1: Main Phase|Death|0|||
149847923|NCT01513239|540571829|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
149847924|NCT01513239|540571830|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
149847925|NCT01513239|540571831|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
149847926|NCT01513239|540571832|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
149847927|NCT01513239|540571833|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
149847928|NCT01513239|540571834|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
149847929|NCT01513239|540571829|FG000|Period 1: Main Phase|Physician Decision|4|||
149847930|NCT01513239|540571830|FG001|Period 1: Main Phase|Physician Decision|4|||
149956800|NCT03003468|540975424|FG001|Overall Study|No measurable lesions|0|||
149956801|NCT03003468|540975425|FG002|Overall Study|No measurable lesions|1|||
149956802|NCT00421993|540975428|FG000|Overall Study|Withdrawal by Subject|22|||
149956803|NCT00421993|540975429|FG001|Overall Study|Withdrawal by Subject|23|||
149956804|NCT00421993|540975430|FG002|Overall Study|Withdrawal by Subject|23|||
149956805|NCT00421993|540975431|FG003|Overall Study|Withdrawal by Subject|24|||
149956806|NCT00421993|540975428|FG000|Overall Study|Lost to Follow-up|18|||
149956807|NCT00421993|540975429|FG001|Overall Study|Lost to Follow-up|19|||
149956808|NCT00421993|540975430|FG002|Overall Study|Lost to Follow-up|22|||
149956809|NCT00421993|540975431|FG003|Overall Study|Lost to Follow-up|20|||
149956810|NCT00421993|540975428|FG000|Overall Study|Adverse Event|11|||
149956811|NCT00421993|540975429|FG001|Overall Study|Adverse Event|1|||
149956812|NCT00421993|540975430|FG002|Overall Study|Adverse Event|6|||
149956813|NCT00421993|540975431|FG003|Overall Study|Adverse Event|4|||
149956814|NCT00421993|540975428|FG000|Overall Study|Protocol Violation|2|||
149956815|NCT00421993|540975429|FG001|Overall Study|Protocol Violation|2|||
149956816|NCT00421993|540975430|FG002|Overall Study|Protocol Violation|0|||
149956817|NCT00421993|540975431|FG003|Overall Study|Protocol Violation|1|||
149956818|NCT00421993|540975428|FG000|Overall Study|Lack of Efficacy|0|||
149956819|NCT00421993|540975429|FG001|Overall Study|Lack of Efficacy|3|||
149956820|NCT00421993|540975430|FG002|Overall Study|Lack of Efficacy|0|||
149956821|NCT00421993|540975431|FG003|Overall Study|Lack of Efficacy|5|||
149956822|NCT00421993|540975428|FG000|Overall Study|Pregnancy|0|||
149956823|NCT00421993|540975429|FG001|Overall Study|Pregnancy|1|||
149956824|NCT00421993|540975430|FG002|Overall Study|Pregnancy|1|||
149956825|NCT00421993|540975431|FG003|Overall Study|Pregnancy|2|||
149956826|NCT00421993|540975428|FG000|Overall Study|Subject transportation issues|0|||
149956827|NCT00421993|540975429|FG001|Overall Study|Subject transportation issues|0|||
149956828|NCT00421993|540975430|FG002|Overall Study|Subject transportation issues|0|||
149956829|NCT00421993|540975431|FG003|Overall Study|Subject transportation issues|1|||
149956830|NCT00165698|540975433|FG000|Overall Study|Adverse Event|2|||
149956831|NCT00165698|540975434|FG001|Overall Study|Adverse Event|10|||
149956832|NCT00165698|540975433|FG000|Overall Study|Lost to Follow-up|2|||
149956833|NCT00165698|540975434|FG001|Overall Study|Lost to Follow-up|2|||
149956834|NCT00165698|540975433|FG000|Overall Study|Withdrawal by Subject|2|||
149956835|NCT00165698|540975434|FG001|Overall Study|Withdrawal by Subject|1|||
149956836|NCT00165698|540975433|FG000|Overall Study|Protocol Violation|1|||
149956837|NCT00165698|540975434|FG001|Overall Study|Protocol Violation|0|||
149956838|NCT00165698|540975433|FG000|Overall Study|Not Taken/Lost the medicine|1|||
149956839|NCT00165698|540975434|FG001|Overall Study|Not Taken/Lost the medicine|2|||
149956840|NCT02547935|540975441|FG000|Overall Study|Other|0|||
149956841|NCT02547935|540975442|FG001|Overall Study|Other|1|||
149956842|NCT02547935|540975443|FG002|Overall Study|Other|0|||
149956843|NCT02547935|540975441|FG000|Overall Study|Withdrawal by Subject|2|||
149956844|NCT02547935|540975442|FG001|Overall Study|Withdrawal by Subject|3|||
149956845|NCT02547935|540975443|FG002|Overall Study|Withdrawal by Subject|4|||
149956846|NCT02547935|540975441|FG000|Overall Study|Screen Failure|2|||
149956847|NCT02547935|540975442|FG001|Overall Study|Screen Failure|0|||
149956848|NCT02547935|540975443|FG002|Overall Study|Screen Failure|0|||
149956849|NCT02547935|540975441|FG000|Overall Study|Physician Decision|0|||
149956850|NCT02547935|540975442|FG001|Overall Study|Physician Decision|1|||
149956851|NCT02547935|540975443|FG002|Overall Study|Physician Decision|0|||
149956852|NCT02547935|540975441|FG000|Overall Study|Lost to Follow-up|0|||
149956853|NCT02547935|540975442|FG001|Overall Study|Lost to Follow-up|2|||
149956854|NCT02547935|540975443|FG002|Overall Study|Lost to Follow-up|1|||
149956855|NCT02547935|540975441|FG000|Overall Study|Death|1|||
149956856|NCT02547935|540975442|FG001|Overall Study|Death|1|||
149956857|NCT02547935|540975443|FG002|Overall Study|Death|0|||
149956858|NCT00086307|540975448|FG000|Overall Study|Lack of Efficacy|1|||
149956859|NCT00086307|540975449|FG001|Overall Study|Lack of Efficacy|1|||
149956860|NCT00086307|540975450|FG002|Overall Study|Lack of Efficacy|2|||
150172744|NCT05686421|541768082|FG002|Overall Study|Screen failure|0|||
150172745|NCT05686421|541768083|FG003|Overall Study|Screen failure|0|||
150172746|NCT00857649|541768084|FG000|Overall Study|Adverse Event|15|||
149956861|NCT00086307|540975448|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
149956862|NCT00086307|540975449|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
149956863|NCT00086307|540975450|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
149956864|NCT00086307|540975448|FG000|Overall Study|Nausea and headaches|0|||
149956865|NCT00086307|540975449|FG001|Overall Study|Nausea and headaches|0|||
149956866|NCT00086307|540975450|FG002|Overall Study|Nausea and headaches|1|||
149956867|NCT00086307|540975448|FG000|Overall Study|Constipation and sleepiness|0|||
150172747|NCT00857649|541768085|FG001|Overall Study|Adverse Event|10|||
149956868|NCT00086307|540975449|FG001|Overall Study|Constipation and sleepiness|0|||
149956869|NCT00086307|540975450|FG002|Overall Study|Constipation and sleepiness|1|||
149956870|NCT00086307|540975448|FG000|Overall Study|Suicidal ideation|0|||
149956871|NCT00086307|540975449|FG001|Overall Study|Suicidal ideation|0|||
149956872|NCT00086307|540975450|FG002|Overall Study|Suicidal ideation|1|||
149956873|NCT00086307|540975448|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
150172748|NCT00857649|541768084|FG000|Overall Study|Non-compliance|1|||
150288131|NCT00883337|542189195|FG002|Extension Treatment Period|Other than above|5|||
150288132|NCT00527605|542189196|FG000|Overall Study|Adverse Event|3|||
150288133|NCT00527605|542189197|FG001|Overall Study|Adverse Event|0|||
150288134|NCT00527605|542189196|FG000|Overall Study|Withdrawal by Subject|3|||
150288135|NCT00527605|542189197|FG001|Overall Study|Withdrawal by Subject|7|||
150288136|NCT00527605|542189196|FG000|Overall Study|Lost to Follow-up|6|||
150288137|NCT00527605|542189197|FG001|Overall Study|Lost to Follow-up|2|||
150288138|NCT00527605|542189196|FG000|Overall Study|Protocol Violation|1|||
150288139|NCT00527605|542189197|FG001|Overall Study|Protocol Violation|2|||
150288140|NCT00763139|542189201|FG000|Overall Study|Adverse Event|4|||
150288141|NCT00763139|542189202|FG001|Overall Study|Adverse Event|2|||
149956874|NCT00086307|540975449|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
149956875|NCT00086307|540975450|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
149956876|NCT00086307|540975448|FG000|Overall Study|Withdrawal by Subject|0|||
149956877|NCT00086307|540975449|FG001|Overall Study|Withdrawal by Subject|0|||
149956878|NCT00086307|540975450|FG002|Overall Study|Withdrawal by Subject|2|||
149956879|NCT01727154|540975454|FG000|Overall Study|Death|17|||
149956880|NCT01727154|540975454|FG000|Overall Study|Withdrawal by Subject|14|||
149956881|NCT01727154|540975454|FG000|Overall Study|Subject Withdrew Consent|18|||
149956882|NCT01727154|540975454|FG000|Overall Study|Study Terminated|6|||
149956883|NCT01727154|540975454|FG000|Overall Study|No Discontinuation Documentation|4|||
149956884|NCT00003474|540975455|FG000|Overall Study|Not Evaluable|14|||
149956885|NCT03020888|540975456|FG000|Overall Study|Physician Decision|4|||
149956886|NCT03020888|540975456|FG000|Overall Study|Withdrawal by Subject|6|||
149956887|NCT03020888|540975456|FG000|Overall Study|Insurance coverage|2|||
149956888|NCT03020888|540975456|FG000|Overall Study|Lost to Follow-up|1|||
149956889|NCT01184118|540975458|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
149956890|NCT01184118|540975458|FG000|Overall Study|No physiologic confirmation of asthma|8|||
149956891|NCT01184118|540975458|FG000|Overall Study|FEV1 <60% predicted|2|||
149956892|NCT01184118|540975458|FG000|Overall Study|Exclusionary medical condition|2|||
149956893|NCT01184118|540975458|FG000|Overall Study|Withdrawal by Subject|5|||
149956894|NCT01198548|540975466|FG000|Overall Study|Disease Progression|9|||
149956895|NCT01198548|540975466|FG000|Overall Study|Administrative Decision|1|||
149956896|NCT02186171|540975471|FG000|Overall Study|Withdrawal by Subject|1|||
149956897|NCT02186171|540975472|FG001|Overall Study|Withdrawal by Subject|9|||
149956898|NCT02186171|540975471|FG000|Overall Study|Lost to Follow-up|2|||
149956899|NCT02186171|540975472|FG001|Overall Study|Lost to Follow-up|2|||
149956900|NCT02186171|540975471|FG000|Overall Study|Death|1|||
149956901|NCT02186171|540975472|FG001|Overall Study|Death|2|||
149956902|NCT02186171|540975471|FG000|Overall Study|Protocol-specified Criteria|0|||
149956903|NCT02186171|540975472|FG001|Overall Study|Protocol-specified Criteria|2|||
149956904|NCT02015104|540975474|FG000|Overall Study|Withdrew consent after first dose drug|1|||
149956905|NCT02015104|540975475|FG001|Overall Study|Withdrew consent after first dose drug|0|||
149956906|NCT02015104|540975474|FG000|Overall Study|Withdrew consent prior to treatment|0|||
149956907|NCT02015104|540975475|FG001|Overall Study|Withdrew consent prior to treatment|1|||
149956908|NCT01301092|540975476|FG000|Overall Study|Lost to Follow-up|0|||
149956909|NCT01301092|540975477|FG001|Overall Study|Lost to Follow-up|0|||
149956910|NCT01301092|540975478|FG002|Overall Study|Lost to Follow-up|1|||
149956911|NCT03334175|540975479|FG000|Overall Study|Lost to Follow-up|0|||
149956912|NCT03334175|540975480|FG001|Overall Study|Lost to Follow-up|1|||
149956913|NCT01350973|540975481|FG000|Overall Study|Adverse Event|4|||
149956914|NCT01350973|540975482|FG001|Overall Study|Adverse Event|7|||
149956915|NCT01350973|540975483|FG002|Overall Study|Adverse Event|7|||
149956916|NCT01350973|540975481|FG000|Overall Study|Voluntary Withdrawal|2|||
149956917|NCT01350973|540975482|FG001|Overall Study|Voluntary Withdrawal|1|||
149956918|NCT01350973|540975483|FG002|Overall Study|Voluntary Withdrawal|1|||
149956919|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149956920|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
149956921|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149956922|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
149956923|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
149956924|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149956925|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
149956926|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
149956927|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
149956928|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
149956929|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
149956930|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
149956931|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
149956932|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
149956933|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
149956934|NCT03738215|540975484|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
150288142|NCT00763139|542189201|FG000|Overall Study|Withdrawal by Subject|0|||
150288143|NCT00763139|542189202|FG001|Overall Study|Withdrawal by Subject|1|||
150288144|NCT00763139|542189201|FG000|Overall Study|med change not allowed by protocol|1|||
150288145|NCT00763139|542189202|FG001|Overall Study|med change not allowed by protocol|0|||
150288146|NCT04312009|542189203|FG000|Overall Study|Withdrawal by Subject|2|||
150288147|NCT04312009|542189204|FG001|Overall Study|Withdrawal by Subject|1|||
150288148|NCT02111564|542189205|FG000|Overall Study|Death|109|||
150288149|NCT02111564|542189206|FG001|Overall Study|Death|120|||
150288150|NCT02111564|542189205|FG000|Overall Study|Lost to Follow-up|2|||
149956935|NCT03738215|540975485|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
149956936|NCT03738215|540975486|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
149956937|NCT03738215|540975484|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
149956938|NCT03738215|540975485|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
149956939|NCT03738215|540975486|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
149956940|NCT03738215|540975484|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
149956941|NCT03738215|540975485|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
149956942|NCT03738215|540975486|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
149956943|NCT03738215|540975484|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
149956944|NCT03738215|540975485|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
149956945|NCT03738215|540975486|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
149956946|NCT03738215|540975484|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
149956947|NCT03738215|540975485|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
149956948|NCT03738215|540975486|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
149956949|NCT02638493|540975487|FG000|Overall Study|Inability to provide semen samples|2|||
149956950|NCT02638493|540975488|FG001|Overall Study|Inability to provide semen samples|0|||
149956951|NCT02638493|540975489|FG002|Overall Study|Inability to provide semen samples|0|||
149956952|NCT02724644|540977355|FG000|Overall Study|Adverse Event|7|||
149956953|NCT02724644|540977356|FG001|Overall Study|Adverse Event|1|||
149956954|NCT02724644|540977355|FG000|Overall Study|Lost to Follow-up|6|||
149956955|NCT02724644|540977356|FG001|Overall Study|Lost to Follow-up|2|||
149956956|NCT02724644|540977355|FG000|Overall Study|Withdrawal by Subject|7|||
149956957|NCT02724644|540977356|FG001|Overall Study|Withdrawal by Subject|1|||
149956958|NCT02724644|540977355|FG000|Overall Study|Administrative|1|||
149956959|NCT02724644|540977356|FG001|Overall Study|Administrative|0|||
149956960|NCT04193176|540977357|FG000|Overall Study|Withdrawal by Subject|6|||
149956961|NCT04193176|540977358|FG001|Overall Study|Withdrawal by Subject|10|||
149956962|NCT00944645|540977359|FG000|Period 2|Adverse Event|1|||
149956963|NCT00944645|540977360|FG001|Period 2|Adverse Event|0|||
149956964|NCT00944645|540977359|FG000|Period 2|Lost to Follow-up|0|||
149956965|NCT00944645|540977360|FG001|Period 2|Lost to Follow-up|3|||
149956966|NCT00944645|540977359|FG000|Period 2|Withdrawal by Subject|7|||
149956967|NCT00944645|540977360|FG001|Period 2|Withdrawal by Subject|6|||
149956968|NCT03928704|540977364|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
149956969|NCT03928704|540977365|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
149956970|NCT03928704|540977366|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
149956971|NCT03928704|540977367|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
149956972|NCT03928704|540977368|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
149956973|NCT03928704|540977369|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
149956974|NCT03928704|540977364|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
149956975|NCT03928704|540977365|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
149956976|NCT03928704|540977366|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
149956977|NCT03928704|540977367|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
149956978|NCT03928704|540977368|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
149956979|NCT03928704|540977369|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
149956980|NCT03928704|540977364|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
149956981|NCT03928704|540977365|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
149956982|NCT03928704|540977366|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
149956983|NCT03928704|540977367|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
149956984|NCT03928704|540977368|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
149956985|NCT03928704|540977369|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
149956986|NCT03928704|540977364|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
149956987|NCT03928704|540977365|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
149956988|NCT03928704|540977366|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
149956989|NCT03928704|540977367|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
149956990|NCT03928704|540977368|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
149956991|NCT03928704|540977369|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
149956992|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
150172749|NCT00857649|541768085|FG001|Overall Study|Non-compliance|1|||
150288151|NCT02111564|542189206|FG001|Overall Study|Lost to Follow-up|3|||
150288152|NCT02111564|542189205|FG000|Overall Study|Withdrawal by Subject|20|||
149956993|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
149956994|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
149956995|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
149956996|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
149956997|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
149956998|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
149956999|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
149957000|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
149957001|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
149957002|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
149957003|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
149957004|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
149957005|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
149957006|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
149957007|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
149957008|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
149957009|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
149957010|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
149957011|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
149957012|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
149957013|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
149957014|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
149957015|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
149957016|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
149957017|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
149957018|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
149957019|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
149957020|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
149957021|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
149957022|NCT03928704|540977364|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
149957023|NCT03928704|540977365|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
149957024|NCT03928704|540977366|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
149957025|NCT03928704|540977367|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
149957026|NCT03928704|540977368|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
149957027|NCT03928704|540977369|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
149957028|NCT01245751|540977370|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
149957029|NCT01245751|540977371|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
149957030|NCT01245751|540977372|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
149957031|NCT01245751|540977373|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
149957032|NCT01245751|540977370|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
149957033|NCT01245751|540977371|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
149957034|NCT01245751|540977372|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
149957035|NCT01245751|540977373|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
149957036|NCT01245751|540977370|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
149957037|NCT01245751|540977371|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
149957038|NCT01245751|540977372|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
149957039|NCT01245751|540977373|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
149957040|NCT01783015|540977374|FG000|Blinded Treatment|Adverse Event|0|||
149957041|NCT01783015|540977375|FG001|Blinded Treatment|Adverse Event|1|||
149957042|NCT01783015|540977376|FG002|Blinded Treatment|Adverse Event|0|||
149957043|NCT01783015|540977374|FG000|Blinded Treatment|Protocol Violation|0|||
149957044|NCT01783015|540977375|FG001|Blinded Treatment|Protocol Violation|1|||
149957045|NCT01783015|540977376|FG002|Blinded Treatment|Protocol Violation|0|||
149957046|NCT01783015|540977374|FG000|Blinded Treatment|Withdrawal by Subject|0|||
149957047|NCT01783015|540977375|FG001|Blinded Treatment|Withdrawal by Subject|1|||
149957048|NCT01783015|540977376|FG002|Blinded Treatment|Withdrawal by Subject|0|||
149957049|NCT01783015|540977374|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
149957050|NCT01783015|540977375|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
149957051|NCT01783015|540977376|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
149957052|NCT01783015|540977374|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
149957053|NCT01783015|540977375|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
149957054|NCT01783015|540977376|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
149957055|NCT01428713|540977380|FG000|Overall Study|Non-compliance|2|||
149957056|NCT01428713|540977381|FG001|Overall Study|Non-compliance|2|||
149957057|NCT01428713|540977380|FG000|Overall Study|Withdrawal by Subject|1|||
150036819|NCT00129402|541276989|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
150036820|NCT00129402|541276990|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
150036821|NCT00129402|541276991|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
150036822|NCT00129402|541276992|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
150036823|NCT00129402|541276993|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
149847931|NCT01513239|540571831|FG002|Period 1: Main Phase|Physician Decision|4|||
149847932|NCT01513239|540571832|FG003|Period 1: Main Phase|Physician Decision|0|||
149847933|NCT01513239|540571833|FG004|Period 1: Main Phase|Physician Decision|0|||
149847934|NCT01513239|540571834|FG005|Period 1: Main Phase|Physician Decision|0|||
149847935|NCT01513239|540571829|FG000|Period 1: Main Phase|Protocol Violation|2|||
149847936|NCT01513239|540571830|FG001|Period 1: Main Phase|Protocol Violation|2|||
149847937|NCT01513239|540571831|FG002|Period 1: Main Phase|Protocol Violation|2|||
149847938|NCT01513239|540571832|FG003|Period 1: Main Phase|Protocol Violation|0|||
149847939|NCT01513239|540571833|FG004|Period 1: Main Phase|Protocol Violation|0|||
149847940|NCT01513239|540571834|FG005|Period 1: Main Phase|Protocol Violation|0|||
149847941|NCT01513239|540571829|FG000|Period 1: Main Phase|Technical Problems|1|||
149847942|NCT01513239|540571830|FG001|Period 1: Main Phase|Technical Problems|2|||
149847943|NCT01513239|540571831|FG002|Period 1: Main Phase|Technical Problems|0|||
149847944|NCT01513239|540571832|FG003|Period 1: Main Phase|Technical Problems|0|||
149847945|NCT01513239|540571833|FG004|Period 1: Main Phase|Technical Problems|0|||
149847946|NCT01513239|540571834|FG005|Period 1: Main Phase|Technical Problems|0|||
149847947|NCT01513239|540571829|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
149847948|NCT01513239|540571830|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
149847949|NCT01513239|540571831|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
149847950|NCT01513239|540571832|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
149847951|NCT01513239|540571833|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
149847952|NCT01513239|540571834|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
149847953|NCT01513239|540571829|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
149847954|NCT01513239|540571830|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
149847955|NCT01513239|540571831|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
149847956|NCT01513239|540571832|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
149847957|NCT01513239|540571833|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
149847958|NCT01513239|540571834|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
149847959|NCT01513239|540571829|FG000|Period 2: 9 Month Extension Phase|Death|0|||
149847960|NCT01513239|540571830|FG001|Period 2: 9 Month Extension Phase|Death|0|||
149847961|NCT01513239|540571831|FG002|Period 2: 9 Month Extension Phase|Death|0|||
149847962|NCT01513239|540571832|FG003|Period 2: 9 Month Extension Phase|Death|2|||
149847963|NCT01513239|540571833|FG004|Period 2: 9 Month Extension Phase|Death|5|||
149847964|NCT01513239|540571834|FG005|Period 2: 9 Month Extension Phase|Death|2|||
149847965|NCT01513239|540571829|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
149847966|NCT01513239|540571830|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
149847967|NCT01513239|540571831|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
149847968|NCT01513239|540571832|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
149847969|NCT01513239|540571833|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
149847970|NCT01513239|540571834|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
149847971|NCT01513239|540571829|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
149847972|NCT01513239|540571830|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
149847973|NCT01513239|540571831|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
149847974|NCT01513239|540571832|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
149847975|NCT01513239|540571833|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
149847976|NCT01513239|540571834|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
149847977|NCT01513239|540571829|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
149957058|NCT01428713|540977381|FG001|Overall Study|Withdrawal by Subject|1|||
149957059|NCT01428713|540977380|FG000|Overall Study|Adverse Event|0|||
149957060|NCT01428713|540977381|FG001|Overall Study|Adverse Event|2|||
149957061|NCT00289978|540977382|FG000|Overall Study|Withdrawal by Subject|31|||
149957062|NCT00289978|540977383|FG001|Overall Study|Withdrawal by Subject|17|||
149957063|NCT00289978|540977384|FG002|Overall Study|Withdrawal by Subject|28|||
149957064|NCT00289978|540977382|FG000|Overall Study|Adverse Event|22|||
150036824|NCT00129402|541276987|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
150036825|NCT00129402|541276988|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
150036826|NCT00129402|541276989|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
150036827|NCT00129402|541276990|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
149847978|NCT01513239|540571830|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
150172750|NCT00857649|541768084|FG000|Overall Study|Protocol Violation|2|||
149847979|NCT01513239|540571831|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
149847980|NCT01513239|540571832|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
149847981|NCT01513239|540571833|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
149957065|NCT00289978|540977383|FG001|Overall Study|Adverse Event|13|||
149847982|NCT01513239|540571834|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
149847983|NCT00396162|540571835|FG000|Overall Study|Withdrawal by Subject|2|||
149847984|NCT00396162|540571836|FG001|Overall Study|Withdrawal by Subject|3|||
149847985|NCT02694536|540571840|FG000|Overall Study|Progressive Disease|40|||
149847986|NCT02694536|540571840|FG000|Overall Study|Lost to Follow-up|1|||
149847987|NCT02694536|540571840|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
149847988|NCT02694536|540571840|FG000|Overall Study|Withdrawal by Subject|8|||
149847989|NCT02694536|540571840|FG000|Overall Study|Death|8|||
149847990|NCT02694536|540571840|FG000|Overall Study|Other|22|||
149847991|NCT01741545|540571841|FG000|Treatment Period|Lack of Efficacy|0|||
149847992|NCT01741545|540571842|FG001|Treatment Period|Lack of Efficacy|1|||
149847993|NCT01741545|540571841|FG000|Treatment Period|Adverse event, non-fatal|1|||
149847994|NCT01741545|540571842|FG001|Treatment Period|Adverse event, non-fatal|3|||
149847995|NCT01741545|540571841|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
149847996|NCT01741545|540571842|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
149847997|NCT01741545|540571841|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
149847998|NCT01741545|540571842|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
149847999|NCT01456962|540571843|FG000|Overall Study|Lost to Follow-up|2|||
149848000|NCT01456962|540571844|FG001|Overall Study|Lost to Follow-up|1|||
149848001|NCT01944722|540571849|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
149848002|NCT01944722|540571849|FG000|Overall Study|Specimen Shipping Issues|34|||
149848003|NCT01944722|540571849|FG000|Overall Study|Improper Storage/Transport|5|||
149848004|NCT01944722|540571849|FG000|Overall Study|Insufficient Volume for Test|1|||
149848005|NCT01944722|540571849|FG000|Overall Study|Missing Specimens|3|||
149848006|NCT01944722|540571849|FG000|Overall Study|Specimens Mislabeled|2|||
149848007|NCT01944722|540571849|FG000|Overall Study|Withdrawal by Subject|8|||
149848008|NCT01944722|540571849|FG000|Overall Study|NILM Subjects <30 years old|8106|||
149848009|NCT01944722|540571849|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
149848010|NCT01944722|540571849|FG000|Overall Study|>ASCUS Cytology|1122|||
149848011|NCT03358147|540571855|FG000|Overall Study|Withdrawal by Subject|13|||
149848012|NCT03358147|540571856|FG001|Overall Study|Withdrawal by Subject|19|||
149848013|NCT03358147|540571857|FG002|Overall Study|Withdrawal by Subject|16|||
149848014|NCT03358147|540571858|FG003|Overall Study|Withdrawal by Subject|10|||
149848015|NCT03358147|540571859|FG004|Overall Study|Withdrawal by Subject|5|||
149848016|NCT03358147|540571855|FG000|Overall Study|Adverse Event|3|||
149848017|NCT03358147|540571856|FG001|Overall Study|Adverse Event|9|||
149848018|NCT03358147|540571857|FG002|Overall Study|Adverse Event|7|||
149848019|NCT03358147|540571858|FG003|Overall Study|Adverse Event|5|||
150288153|NCT02111564|542189206|FG001|Overall Study|Withdrawal by Subject|20|||
149848020|NCT03358147|540571859|FG004|Overall Study|Adverse Event|2|||
149848021|NCT03358147|540571855|FG000|Overall Study|Lost to Follow-up|4|||
149848022|NCT03358147|540571856|FG001|Overall Study|Lost to Follow-up|3|||
149848023|NCT03358147|540571857|FG002|Overall Study|Lost to Follow-up|7|||
149848024|NCT03358147|540571858|FG003|Overall Study|Lost to Follow-up|6|||
149848025|NCT03358147|540571859|FG004|Overall Study|Lost to Follow-up|4|||
149848026|NCT03358147|540571855|FG000|Overall Study|Major Protocol Deviation|11|||
149848027|NCT03358147|540571856|FG001|Overall Study|Major Protocol Deviation|3|||
149848028|NCT03358147|540571857|FG002|Overall Study|Major Protocol Deviation|2|||
149848029|NCT03358147|540571858|FG003|Overall Study|Major Protocol Deviation|3|||
149848030|NCT03358147|540571859|FG004|Overall Study|Major Protocol Deviation|1|||
149848031|NCT03358147|540571855|FG000|Overall Study|Protocol specified criteria|2|||
149848032|NCT03358147|540571856|FG001|Overall Study|Protocol specified criteria|3|||
149848033|NCT03358147|540571857|FG002|Overall Study|Protocol specified criteria|0|||
149848034|NCT03358147|540571858|FG003|Overall Study|Protocol specified criteria|3|||
149848035|NCT03358147|540571859|FG004|Overall Study|Protocol specified criteria|1|||
149848036|NCT03358147|540571855|FG000|Overall Study|Physician Decision|1|||
149848037|NCT03358147|540571856|FG001|Overall Study|Physician Decision|0|||
149848038|NCT03358147|540571857|FG002|Overall Study|Physician Decision|1|||
149848039|NCT03358147|540571858|FG003|Overall Study|Physician Decision|6|||
149848040|NCT03358147|540571859|FG004|Overall Study|Physician Decision|1|||
149848041|NCT03358147|540571855|FG000|Overall Study|Administrative reasons|0|||
149848042|NCT03358147|540571856|FG001|Overall Study|Administrative reasons|1|||
149848043|NCT03358147|540571857|FG002|Overall Study|Administrative reasons|0|||
149848044|NCT03358147|540571858|FG003|Overall Study|Administrative reasons|3|||
149848045|NCT03358147|540571859|FG004|Overall Study|Administrative reasons|0|||
150288154|NCT03468309|542189207|FG000|Overall Study|Lost to Follow-up|4|||
150288155|NCT03468309|542189207|FG000|Overall Study|Withdrawal by Subject|2|||
149848046|NCT03358147|540571855|FG000|Overall Study|Lack of Efficacy|0|||
149848047|NCT03358147|540571856|FG001|Overall Study|Lack of Efficacy|1|||
149848048|NCT03358147|540571857|FG002|Overall Study|Lack of Efficacy|1|||
149848049|NCT03358147|540571858|FG003|Overall Study|Lack of Efficacy|0|||
149848050|NCT03358147|540571859|FG004|Overall Study|Lack of Efficacy|0|||
149848051|NCT01634139|540571860|FG000|Overall Study|Non compliant with protocol|1|||
149848052|NCT01634139|540571861|FG001|Overall Study|Non compliant with protocol|0|||
149848053|NCT01634139|540571862|FG002|Overall Study|Non compliant with protocol|0|||
149848054|NCT01634139|540571860|FG000|Overall Study|Consent withdrawn not due to AE|4|||
149848055|NCT01634139|540571861|FG001|Overall Study|Consent withdrawn not due to AE|3|||
149848056|NCT01634139|540571862|FG002|Overall Study|Consent withdrawn not due to AE|2|||
149848057|NCT01634139|540571860|FG000|Overall Study|Other|4|||
149848058|NCT01634139|540571861|FG001|Overall Study|Other|0|||
149848059|NCT01634139|540571862|FG002|Overall Study|Other|3|||
149848060|NCT01634139|540571860|FG000|Overall Study|Lost to Follow-up|0|||
149848061|NCT01634139|540571861|FG001|Overall Study|Lost to Follow-up|2|||
149848062|NCT01634139|540571862|FG002|Overall Study|Lost to Follow-up|0|||
149848063|NCT01634139|540571860|FG000|Overall Study|Not treated|1|||
149848064|NCT01634139|540571861|FG001|Overall Study|Not treated|1|||
149848065|NCT01634139|540571862|FG002|Overall Study|Not treated|0|||
149848066|NCT01168856|540571864|FG000|Overall Study|Lost to Follow-up|4|||
149848067|NCT01168856|540571865|FG001|Overall Study|Lost to Follow-up|34|||
149848068|NCT01168856|540571864|FG000|Overall Study|Withdrawal by Subject|6|||
149848069|NCT01168856|540571865|FG001|Overall Study|Withdrawal by Subject|8|||
149848070|NCT01168856|540571864|FG000|Overall Study|Physician Decision|2|||
149848071|NCT01168856|540571865|FG001|Overall Study|Physician Decision|1|||
149848072|NCT01168856|540571864|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
150288156|NCT04986202|542189210|FG000|Overall Study|Death|10|||
149848073|NCT01168856|540571865|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
149848074|NCT01168856|540571864|FG000|Overall Study|Participant received anti-HCV treatment|1|||
149848075|NCT01168856|540571865|FG001|Overall Study|Participant received anti-HCV treatment|0|||
149848076|NCT01168856|540571864|FG000|Overall Study|Death|0|||
149848077|NCT01168856|540571865|FG001|Overall Study|Death|2|||
149848078|NCT01168856|540571864|FG000|Overall Study|Other|1|||
149848079|NCT01168856|540571865|FG001|Overall Study|Other|291|||
149848080|NCT01168856|540571864|FG000|Overall Study|Protocol Violation|4|||
149848081|NCT01168856|540571865|FG001|Overall Study|Protocol Violation|6|||
149848082|NCT00387153|540571868|FG000|Overall Study|Adverse Event|1|||
149848083|NCT00387153|540571868|FG000|Overall Study|Disease Progression|3|||
149848084|NCT00387153|540571868|FG000|Overall Study|Lack of Response|4|||
149848085|NCT04567329|540571869|FG000|Overall Study|Withdrawal by Subject|5|||
149848086|NCT04567329|540571870|FG001|Overall Study|Withdrawal by Subject|6|||
149848087|NCT04567329|540571869|FG000|Overall Study|Protocol Violation|2|||
149848088|NCT04567329|540571870|FG001|Overall Study|Protocol Violation|3|||
149848089|NCT04567329|540571869|FG000|Overall Study|Discontinued|2|||
149848090|NCT04567329|540571870|FG001|Overall Study|Discontinued|2|||
149848091|NCT04567329|540571869|FG000|Overall Study|Lost to Follow-up|0|||
149848092|NCT04567329|540571870|FG001|Overall Study|Lost to Follow-up|1|||
149848093|NCT04567329|540571869|FG000|Overall Study|Lack of Efficacy|0|||
149848094|NCT04567329|540571870|FG001|Overall Study|Lack of Efficacy|1|||
149848095|NCT00841659|540571871|FG000|Washout: 2 Weeks|Protocol Violation|1|||
149848096|NCT00841659|540571872|FG001|Washout: 2 Weeks|Protocol Violation|0|||
149848097|NCT02420353|540571875|FG000|Overall Study|Withdrawal by Subject|0|||
149848098|NCT02420353|540571876|FG001|Overall Study|Withdrawal by Subject|1|||
149848099|NCT00654186|540571877|FG000|Overall Study|Withdrawal by Subject|5|||
149848100|NCT01968551|540571880|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
149848101|NCT01968551|540571881|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
149848102|NCT01968551|540571882|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
149848103|NCT01968551|540571880|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
149848104|NCT01968551|540571881|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
149848105|NCT01968551|540571882|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
149848106|NCT01968551|540571880|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
149848107|NCT01968551|540571881|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
149848108|NCT01968551|540571882|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
149848109|NCT01968551|540571880|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
149848110|NCT01968551|540571881|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
149848111|NCT01968551|540571882|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
149848112|NCT01968551|540571880|FG000|Extension Phase|Adverse Event|0|||
149848113|NCT01968551|540571881|FG001|Extension Phase|Adverse Event|0|||
149848114|NCT01968551|540571882|FG002|Extension Phase|Adverse Event|2|||
149848115|NCT01968551|540571880|FG000|Extension Phase|Death|0|||
149848116|NCT01968551|540571881|FG001|Extension Phase|Death|1|||
149848117|NCT01968551|540571882|FG002|Extension Phase|Death|0|||
149848118|NCT01968551|540571880|FG000|Extension Phase|Withdrew Consent|0|||
149848119|NCT01968551|540571881|FG001|Extension Phase|Withdrew Consent|0|||
149848120|NCT01968551|540571882|FG002|Extension Phase|Withdrew Consent|1|||
149848121|NCT01968551|540571880|FG000|Extension Phase|Lost to Follow-up|1|||
149848122|NCT01968551|540571881|FG001|Extension Phase|Lost to Follow-up|0|||
149848123|NCT01968551|540571882|FG002|Extension Phase|Lost to Follow-up|1|||
149848124|NCT00819169|540571883|FG000|Overall Study|Withdrawal by Subject|2|||
149848125|NCT00819169|540571884|FG001|Overall Study|Withdrawal by Subject|0|||
149848126|NCT00819169|540571885|FG002|Overall Study|Withdrawal by Subject|0|||
149848127|NCT00819169|540571886|FG003|Overall Study|Withdrawal by Subject|1|||
149848128|NCT00819169|540571887|FG004|Overall Study|Withdrawal by Subject|1|||
149848129|NCT00819169|540571888|FG005|Overall Study|Withdrawal by Subject|1|||
150288157|NCT04986202|542189211|FG001|Overall Study|Death|3|||
149848130|NCT00819169|540571889|FG006|Overall Study|Withdrawal by Subject|5|||
149848131|NCT00819169|540571890|FG007|Overall Study|Withdrawal by Subject|1|||
150036828|NCT00129402|541276991|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
150036829|NCT00129402|541276992|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
150036830|NCT00129402|541276993|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
150036831|NCT00129402|541276987|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036832|NCT00129402|541276988|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036833|NCT00129402|541276989|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
150036834|NCT00129402|541276990|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036835|NCT00129402|541276991|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036836|NCT00129402|541276992|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036837|NCT00129402|541276993|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
150036838|NCT00129402|541276987|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
150036839|NCT00129402|541276988|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
150036840|NCT00129402|541276989|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
150036841|NCT00129402|541276990|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
150036842|NCT00129402|541276991|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
150036843|NCT00129402|541276992|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
150036844|NCT00129402|541276993|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
150036845|NCT00129402|541276987|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036846|NCT00129402|541276988|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036847|NCT00129402|541276989|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
150036848|NCT00129402|541276990|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036849|NCT00129402|541276991|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036850|NCT00129402|541276992|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036851|NCT00129402|541276993|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
150036852|NCT00129402|541276987|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
150036853|NCT00129402|541276988|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
150036854|NCT00129402|541276989|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
150036855|NCT00129402|541276990|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
150036856|NCT00129402|541276991|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
150036857|NCT00129402|541276992|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
150036858|NCT00129402|541276993|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
150036859|NCT00129402|541276987|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
150036860|NCT00129402|541276988|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
150036861|NCT00129402|541276989|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
150036862|NCT00129402|541276990|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
150036863|NCT00129402|541276991|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
150036864|NCT00129402|541276992|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
150036865|NCT00129402|541276993|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
150036866|NCT00129402|541276987|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
149848132|NCT00819169|540571891|FG008|Overall Study|Withdrawal by Subject|4|||
149848133|NCT00819169|540571883|FG000|Overall Study|Lost to Follow-up|0|||
149848134|NCT00819169|540571884|FG001|Overall Study|Lost to Follow-up|2|||
149848135|NCT00819169|540571885|FG002|Overall Study|Lost to Follow-up|0|||
149848136|NCT00819169|540571886|FG003|Overall Study|Lost to Follow-up|1|||
149957066|NCT00289978|540977384|FG002|Overall Study|Adverse Event|18|||
149957067|NCT00289978|540977382|FG000|Overall Study|Lack of Efficacy|13|||
149957068|NCT00289978|540977383|FG001|Overall Study|Lack of Efficacy|6|||
150036867|NCT00129402|541276988|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
150036868|NCT00129402|541276989|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
150036869|NCT00129402|541276990|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
150036870|NCT00129402|541276991|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
149848137|NCT00819169|540571887|FG004|Overall Study|Lost to Follow-up|0|||
149848138|NCT00819169|540571888|FG005|Overall Study|Lost to Follow-up|6|||
149957069|NCT00289978|540977384|FG002|Overall Study|Lack of Efficacy|25|||
149957070|NCT00289978|540977382|FG000|Overall Study|Abnormal laboratory value(s)|20|||
149957071|NCT00289978|540977383|FG001|Overall Study|Abnormal laboratory value(s)|9|||
149957072|NCT00289978|540977384|FG002|Overall Study|Abnormal laboratory value(s)|1|||
149957073|NCT00289978|540977382|FG000|Overall Study|Lost to Follow-up|3|||
149957074|NCT00289978|540977383|FG001|Overall Study|Lost to Follow-up|5|||
149957075|NCT00289978|540977384|FG002|Overall Study|Lost to Follow-up|7|||
149848139|NCT00819169|540571889|FG006|Overall Study|Lost to Follow-up|2|||
149848140|NCT00819169|540571890|FG007|Overall Study|Lost to Follow-up|2|||
149957076|NCT00289978|540977382|FG000|Overall Study|Protocol Violation|5|||
149957077|NCT00289978|540977383|FG001|Overall Study|Protocol Violation|5|||
149957078|NCT00289978|540977384|FG002|Overall Study|Protocol Violation|4|||
149848141|NCT00819169|540571891|FG008|Overall Study|Lost to Follow-up|1|||
149957079|NCT00289978|540977382|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149848142|NCT00819169|540571883|FG000|Overall Study|Death|1|||
149848143|NCT00819169|540571884|FG001|Overall Study|Death|1|||
149848144|NCT00819169|540571885|FG002|Overall Study|Death|3|||
149848145|NCT00819169|540571886|FG003|Overall Study|Death|8|||
149848146|NCT00819169|540571887|FG004|Overall Study|Death|5|||
149848147|NCT00819169|540571888|FG005|Overall Study|Death|7|||
149848148|NCT00819169|540571889|FG006|Overall Study|Death|9|||
149848149|NCT00819169|540571890|FG007|Overall Study|Death|4|||
149848150|NCT00819169|540571891|FG008|Overall Study|Death|7|||
149848151|NCT00819169|540571883|FG000|Overall Study|Ineligibility determined|0|||
149848152|NCT00819169|540571884|FG001|Overall Study|Ineligibility determined|0|||
149848153|NCT00819169|540571885|FG002|Overall Study|Ineligibility determined|0|||
149848154|NCT00819169|540571886|FG003|Overall Study|Ineligibility determined|2|||
149848155|NCT00819169|540571887|FG004|Overall Study|Ineligibility determined|0|||
149848156|NCT00819169|540571888|FG005|Overall Study|Ineligibility determined|0|||
149848157|NCT00819169|540571889|FG006|Overall Study|Ineligibility determined|0|||
149848158|NCT00819169|540571890|FG007|Overall Study|Ineligibility determined|0|||
149848159|NCT00819169|540571891|FG008|Overall Study|Ineligibility determined|1|||
149848160|NCT00819169|540571883|FG000|Overall Study|Adverse Event|0|||
149848161|NCT00819169|540571884|FG001|Overall Study|Adverse Event|0|||
149848162|NCT00819169|540571885|FG002|Overall Study|Adverse Event|0|||
149848163|NCT00819169|540571886|FG003|Overall Study|Adverse Event|0|||
149848164|NCT00819169|540571887|FG004|Overall Study|Adverse Event|1|||
149848165|NCT00819169|540571888|FG005|Overall Study|Adverse Event|0|||
149848166|NCT00819169|540571889|FG006|Overall Study|Adverse Event|0|||
149848167|NCT00819169|540571890|FG007|Overall Study|Adverse Event|0|||
149848168|NCT00819169|540571891|FG008|Overall Study|Adverse Event|0|||
149848169|NCT00819169|540571883|FG000|Overall Study|Administrative Decision|0|||
149848170|NCT00819169|540571884|FG001|Overall Study|Administrative Decision|0|||
149848171|NCT00819169|540571885|FG002|Overall Study|Administrative Decision|0|||
149848172|NCT00819169|540571886|FG003|Overall Study|Administrative Decision|0|||
149848173|NCT00819169|540571887|FG004|Overall Study|Administrative Decision|1|||
149848174|NCT00819169|540571888|FG005|Overall Study|Administrative Decision|2|||
149848175|NCT00819169|540571889|FG006|Overall Study|Administrative Decision|0|||
149848176|NCT00819169|540571890|FG007|Overall Study|Administrative Decision|2|||
149848177|NCT00819169|540571891|FG008|Overall Study|Administrative Decision|0|||
149848178|NCT02096705|540571892|FG000|Treatment|Adverse Event|6|||
149848179|NCT02096705|540571893|FG001|Treatment|Adverse Event|3|||
149848180|NCT02096705|540571892|FG000|Treatment|Subject request to discontinue treatment|1|||
149848181|NCT02096705|540571893|FG001|Treatment|Subject request to discontinue treatment|1|||
149848182|NCT02096705|540571892|FG000|Treatment|Withdrawal by Subject|1|||
149848183|NCT02096705|540571893|FG001|Treatment|Withdrawal by Subject|0|||
149848184|NCT02096705|540571892|FG000|Treatment|Other|1|||
149848185|NCT02096705|540571893|FG001|Treatment|Other|1|||
149848186|NCT02096705|540571892|FG000|Follow-up|Withdrawal by Subject|1|||
149848187|NCT02096705|540571893|FG001|Follow-up|Withdrawal by Subject|0|||
149848188|NCT02096705|540571892|FG000|Follow-up|Adverse Event|2|||
149848189|NCT02096705|540571893|FG001|Follow-up|Adverse Event|2|||
149848190|NCT02096705|540571892|FG000|Follow-up|Subjects not reporting status|1|||
149848191|NCT02096705|540571893|FG001|Follow-up|Subjects not reporting status|2|||
150288158|NCT04986202|542189212|FG002|Overall Study|Death|10|||
150288159|NCT04986202|542189210|FG000|Overall Study|Physician Decision|3|||
149848192|NCT01046084|540571903|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
149848193|NCT01046084|540571904|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
149848194|NCT00474188|540571905|FG000|Overall Study|Withdrawal by Subject|1|||
149848195|NCT00474188|540571905|FG000|Overall Study|Study discontinued by sponsor|5|||
149848196|NCT03614728|540571906|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
149848197|NCT03614728|540571907|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
149848198|NCT03614728|540571908|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
149848199|NCT03614728|540571909|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
149848200|NCT03614728|540571906|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
149848201|NCT03614728|540571907|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
149848202|NCT03614728|540571908|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
150288160|NCT04986202|542189211|FG001|Overall Study|Physician Decision|1|||
149848203|NCT03614728|540571909|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
149848204|NCT05412121|540571910|FG000|Overall Study|Withdrawal by Subject|4|||
149848205|NCT05412121|540571910|FG000|Overall Study|Physician Decision|1|||
149848206|NCT05412121|540571910|FG000|Overall Study|Lost to Follow-up|5|||
149848207|NCT04476277|540571913|FG000|Overall Study|Withdrawal by Subject|0|||
150288161|NCT04986202|542189212|FG002|Overall Study|Physician Decision|2|||
149848208|NCT04476277|540571914|FG001|Overall Study|Withdrawal by Subject|0|||
149848209|NCT04476277|540571915|FG002|Overall Study|Withdrawal by Subject|1|||
149848210|NCT04476277|540571916|FG003|Overall Study|Withdrawal by Subject|0|||
149848211|NCT01962298|540571917|FG000|Overall Study|Protocol Violation|1|||
150288162|NCT04986202|542189210|FG000|Overall Study|Withdrawal by Subject|4|||
149848212|NCT01962298|540571918|FG001|Overall Study|Protocol Violation|0|||
149848213|NCT01962298|540571919|FG002|Overall Study|Protocol Violation|1|||
149848214|NCT01962298|540571920|FG003|Overall Study|Protocol Violation|1|||
149957080|NCT00289978|540977383|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149957081|NCT00289978|540977384|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149957082|NCT00289978|540977382|FG000|Overall Study|Death|1|||
149957083|NCT00289978|540977383|FG001|Overall Study|Death|0|||
149957084|NCT00289978|540977384|FG002|Overall Study|Death|2|||
149957085|NCT00903344|540977385|FG000|Overall Study|Pregnancy|2|||
149957086|NCT00903344|540977386|FG001|Overall Study|Pregnancy|3|||
149957087|NCT00903344|540977385|FG000|Overall Study|Lost to Follow-up|3|||
149957088|NCT00903344|540977386|FG001|Overall Study|Lost to Follow-up|0|||
149957089|NCT03055221|540977387|FG000|Overall Study|Adverse Event|2|||
149957090|NCT03055221|540977387|FG000|Overall Study|Withdrawal by Subject|4|||
149957091|NCT03055221|540977387|FG000|Overall Study|Death|6|||
149957092|NCT03055221|540977387|FG000|Overall Study|Physician Decision|1|||
149957093|NCT03055221|540977387|FG000|Overall Study|Study terminated by Sponsor|3|||
149957094|NCT03055221|540977387|FG000|Overall Study|Lost to Follow-up|4|||
149957095|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
149957096|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
149957097|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
149957098|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
149957099|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
149957100|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
149957101|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
149957102|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
149957103|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
149957104|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
149957105|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
149957106|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
149957107|NCT01243424|540977388|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
149957108|NCT01243424|540977389|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
149957109|NCT01243424|540977388|FG000|Discontinuation From Treatment|Not treated|5|||
149957110|NCT01243424|540977389|FG001|Discontinuation From Treatment|Not treated|4|||
149957111|NCT01243424|540977388|FG000|Discontinuation From Treatment|Adverse Event|457|||
149957112|NCT01243424|540977389|FG001|Discontinuation From Treatment|Adverse Event|523|||
149957113|NCT01243424|540977388|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
149957114|NCT01243424|540977389|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
149957115|NCT01243424|540977388|FG000|Discontinuation From Treatment|Protocol Violation|46|||
149957116|NCT01243424|540977389|FG001|Discontinuation From Treatment|Protocol Violation|47|||
149957117|NCT01243424|540977388|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
149957118|NCT01243424|540977389|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
149957119|NCT01243424|540977388|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
149957120|NCT01243424|540977389|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
149957121|NCT01243424|540977388|FG000|Discontinuation From Treatment|Other than listed above|230|||
149957122|NCT01243424|540977389|FG001|Discontinuation From Treatment|Other than listed above|211|||
149957123|NCT01160744|540977394|FG000|Overall Study|Withdrawal by Subject|11|||
149957124|NCT01160744|540977395|FG001|Overall Study|Withdrawal by Subject|5|||
149957125|NCT01160744|540977396|FG002|Overall Study|Withdrawal by Subject|6|||
149957126|NCT01160744|540977397|FG003|Overall Study|Withdrawal by Subject|4|||
149957127|NCT01160744|540977394|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
149957128|NCT01160744|540977395|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
149957129|NCT01160744|540977396|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
149957130|NCT01160744|540977397|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
149957131|NCT00500110|540977400|FG000|Overall Study|Withdrawal by Subject|3|||
149957132|NCT03791060|540977406|FG000|Overall Study|Withdrawal by Subject|1|||
149957133|NCT02421510|540977407|FG000|Overall Study|Other|4|||
149957134|NCT02421510|540977408|FG001|Overall Study|Other|2|||
150288163|NCT04986202|542189211|FG001|Overall Study|Withdrawal by Subject|2|||
150288164|NCT04986202|542189212|FG002|Overall Study|Withdrawal by Subject|4|||
150288165|NCT03548558|542189215|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
150288166|NCT03548558|542189216|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
150288167|NCT03548558|542189217|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
150288168|NCT03548558|542189218|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
150288169|NCT03548558|542189219|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
150288170|NCT03548558|542189220|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
150288171|NCT03548558|542189221|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
149957135|NCT02421510|540977409|FG002|Overall Study|Other|3|||
149957136|NCT02421510|540977407|FG000|Overall Study|Protocol Violation|1|||
149957137|NCT02421510|540977408|FG001|Overall Study|Protocol Violation|2|||
149957138|NCT02421510|540977409|FG002|Overall Study|Protocol Violation|0|||
149957139|NCT02421510|540977407|FG000|Overall Study|Death|1|||
150288172|NCT03548558|542189215|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
149848215|NCT01962298|540571921|FG004|Overall Study|Protocol Violation|0|||
149848216|NCT01962298|540571917|FG000|Overall Study|Data quality insufficient|2|||
149848217|NCT01962298|540571918|FG001|Overall Study|Data quality insufficient|0|||
149848218|NCT01962298|540571919|FG002|Overall Study|Data quality insufficient|3|||
149848219|NCT01962298|540571920|FG003|Overall Study|Data quality insufficient|1|||
149848220|NCT01962298|540571921|FG004|Overall Study|Data quality insufficient|4|||
149848221|NCT01962298|540571917|FG000|Overall Study|Insufficient data|0|||
149848222|NCT01962298|540571918|FG001|Overall Study|Insufficient data|2|||
149848223|NCT01962298|540571919|FG002|Overall Study|Insufficient data|1|||
149848224|NCT01962298|540571920|FG003|Overall Study|Insufficient data|0|||
149848225|NCT01962298|540571921|FG004|Overall Study|Insufficient data|1|||
149848226|NCT01962298|540571917|FG000|Overall Study|Incorrect data recorded|0|||
149848227|NCT01962298|540571918|FG001|Overall Study|Incorrect data recorded|1|||
149848228|NCT01962298|540571919|FG002|Overall Study|Incorrect data recorded|0|||
149848229|NCT01962298|540571920|FG003|Overall Study|Incorrect data recorded|0|||
149848230|NCT01962298|540571921|FG004|Overall Study|Incorrect data recorded|0|||
149848231|NCT01962298|540571917|FG000|Overall Study|Physician Decision|0|||
149848232|NCT01962298|540571918|FG001|Overall Study|Physician Decision|1|||
149848233|NCT01962298|540571919|FG002|Overall Study|Physician Decision|0|||
149848234|NCT01962298|540571920|FG003|Overall Study|Physician Decision|0|||
149848235|NCT01962298|540571921|FG004|Overall Study|Physician Decision|1|||
149848236|NCT01576705|540571922|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
149848237|NCT01576705|540571923|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
149848238|NCT01576705|540571924|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
149848239|NCT01576705|540571925|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
149848240|NCT01576705|540571922|FG000|Overall Study|invalid ICF|0|||
149957140|NCT02421510|540977408|FG001|Overall Study|Death|0|||
149957141|NCT02421510|540977409|FG002|Overall Study|Death|0|||
149957142|NCT02421510|540977407|FG000|Overall Study|Noncompliance with study drug|1|||
149957143|NCT02421510|540977408|FG001|Overall Study|Noncompliance with study drug|0|||
149957144|NCT02421510|540977409|FG002|Overall Study|Noncompliance with study drug|0|||
149848241|NCT01576705|540571923|FG001|Overall Study|invalid ICF|1|||
149848242|NCT01576705|540571924|FG002|Overall Study|invalid ICF|0|||
149848243|NCT01576705|540571925|FG003|Overall Study|invalid ICF|0|||
149848244|NCT01390948|540571926|FG000|Overall Study|End of Study|1|||
149848245|NCT01390948|540571927|FG001|Overall Study|End of Study|0|||
149848246|NCT01390948|540571928|FG002|Overall Study|End of Study|0|||
149848247|NCT01390948|540571926|FG000|Overall Study|Withdrew consent|2|||
149848248|NCT01390948|540571927|FG001|Overall Study|Withdrew consent|2|||
149848249|NCT01390948|540571928|FG002|Overall Study|Withdrew consent|0|||
149848250|NCT01390948|540571926|FG000|Overall Study|Progressive Disease|2|||
149848251|NCT01390948|540571927|FG001|Overall Study|Progressive Disease|5|||
149848252|NCT01390948|540571928|FG002|Overall Study|Progressive Disease|0|||
149848253|NCT01390948|540571926|FG000|Overall Study|Death during follow-up|10|||
149848254|NCT01390948|540571927|FG001|Overall Study|Death during follow-up|11|||
149848255|NCT01390948|540571928|FG002|Overall Study|Death during follow-up|1|||
149848256|NCT05740098|540571931|FG000|Overall Study|Lost to Follow-up|26|||
149848257|NCT05740098|540571932|FG001|Overall Study|Lost to Follow-up|17|||
149848258|NCT05740098|540571933|FG002|Overall Study|Lost to Follow-up|21|||
149848259|NCT02588339|540571937|FG000|Overall Study|Withdrawal by Subject|1|||
149848260|NCT02588339|540571937|FG000|Overall Study|GVHD Progression prior to treatment|2|||
149848261|NCT04573309|540573235|FG000|Overall Study|Protocol Violation|1|||
149848262|NCT04573309|540573236|FG001|Overall Study|Protocol Violation|0|||
149848263|NCT01894230|540573238|FG000|Overall Study|Lost to Follow-up|2|||
149848264|NCT01894230|540573239|FG001|Overall Study|Lost to Follow-up|2|||
149848265|NCT01894230|540573238|FG000|Overall Study|Withdrawal by Subject|4|||
149848266|NCT01894230|540573239|FG001|Overall Study|Withdrawal by Subject|4|||
149848267|NCT01894230|540573238|FG000|Overall Study|Non-adherent|0|||
149848268|NCT01894230|540573239|FG001|Overall Study|Non-adherent|1|||
149848269|NCT01894230|540573238|FG000|Overall Study|Death|1|||
149848270|NCT01894230|540573239|FG001|Overall Study|Death|0|||
149848271|NCT02219009|540573242|FG000|Overall Study|Withdrawal by Subject|5|||
149848272|NCT02219009|540573243|FG001|Overall Study|Withdrawal by Subject|1|||
149848273|NCT02219009|540573242|FG000|Overall Study|Adverse Event|2|||
149848274|NCT02219009|540573243|FG001|Overall Study|Adverse Event|4|||
149848275|NCT02219009|540573242|FG000|Overall Study|Lost to Follow-up|2|||
149848276|NCT02219009|540573243|FG001|Overall Study|Lost to Follow-up|2|||
149957145|NCT02421510|540977407|FG000|Overall Study|Physician Decision|1|||
149957146|NCT02421510|540977408|FG001|Overall Study|Physician Decision|1|||
149957147|NCT02421510|540977409|FG002|Overall Study|Physician Decision|3|||
150036871|NCT00129402|541276992|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
149957148|NCT02421510|540977407|FG000|Overall Study|Adverse Event|9|||
149848277|NCT02219009|540573242|FG000|Overall Study|Protocol deviation|1|||
149848278|NCT02219009|540573243|FG001|Overall Study|Protocol deviation|0|||
149848279|NCT02219009|540573242|FG000|Overall Study|Physician Decision|0|||
149848280|NCT02219009|540573243|FG001|Overall Study|Physician Decision|1|||
149848281|NCT03086135|540573244|FG000|Overall Study|Adverse Event|1|||
149848282|NCT03086135|540573244|FG000|Overall Study|Lost to Follow-up|2|||
149848283|NCT01023061|540573245|FG000|Overall Study|Withdrawal prior to treatment|2|||
149848284|NCT02966340|540573246|FG000|Overall Study|Adverse Event|0|||
149848285|NCT02966340|540573247|FG001|Overall Study|Adverse Event|1|||
149848286|NCT02966340|540573246|FG000|Overall Study|Lost to Follow-up|0|||
149848287|NCT02966340|540573247|FG001|Overall Study|Lost to Follow-up|1|||
149848288|NCT02966340|540573246|FG000|Overall Study|Withdrawal by Subject|1|||
149848289|NCT02966340|540573247|FG001|Overall Study|Withdrawal by Subject|0|||
149848290|NCT02966340|540573246|FG000|Overall Study|data acquisition error|1|||
149848291|NCT02966340|540573247|FG001|Overall Study|data acquisition error|0|||
149848292|NCT02966340|540573246|FG000|Overall Study|startle non-responder|1|||
149848293|NCT02966340|540573247|FG001|Overall Study|startle non-responder|1|||
149848294|NCT00202839|540573248|FG000|Overall Study|Adverse Event|1|||
149848295|NCT00202839|540573249|FG001|Overall Study|Adverse Event|5|||
149848296|NCT00202839|540573248|FG000|Overall Study|Physician Decision|12|||
149848297|NCT00202839|540573249|FG001|Overall Study|Physician Decision|0|||
149848298|NCT00202839|540573248|FG000|Overall Study|Withdrawal by Subject|6|||
149848299|NCT00202839|540573249|FG001|Overall Study|Withdrawal by Subject|2|||
149848300|NCT00202839|540573248|FG000|Overall Study|Protocol Violation|2|||
149848301|NCT00202839|540573249|FG001|Overall Study|Protocol Violation|1|||
149848302|NCT00202839|540573248|FG000|Overall Study|Lost to Follow-up|3|||
149848303|NCT00202839|540573249|FG001|Overall Study|Lost to Follow-up|2|||
149848304|NCT00642993|540573250|FG000|Overall Study|Adverse Event|85|||
149848305|NCT00642993|540573251|FG001|Overall Study|Adverse Event|4|||
149848306|NCT00642993|540573250|FG000|Overall Study|Lost to Follow-up|8|||
149848307|NCT00642993|540573251|FG001|Overall Study|Lost to Follow-up|4|||
149848308|NCT00642993|540573250|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
149848309|NCT00642993|540573251|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
149848310|NCT00642993|540573250|FG000|Overall Study|Protocol Violation|1|||
149848311|NCT00642993|540573251|FG001|Overall Study|Protocol Violation|4|||
149848312|NCT00642993|540573250|FG000|Overall Study|Did not meet protocol eligibility|0|||
149848313|NCT00642993|540573251|FG001|Overall Study|Did not meet protocol eligibility|1|||
149848314|NCT00642993|540573250|FG000|Overall Study|Administrative|1|||
149848315|NCT00642993|540573251|FG001|Overall Study|Administrative|0|||
149848316|NCT03119662|540573252|FG000|Overall Study|Withdrawal by Subject|0|||
149848317|NCT03119662|540573253|FG001|Overall Study|Withdrawal by Subject|1|||
149848318|NCT02817828|540573254|FG000|Overall Study|Lost to Follow-up|41|||
149848319|NCT02817828|540573254|FG000|Overall Study|Adverse event not related to bleeding|104|||
149848320|NCT02817828|540573254|FG000|Overall Study|Adverse event related to bleeding|53|||
149848321|NCT02817828|540573254|FG000|Overall Study|Protocol Violation|11|||
149848322|NCT02817828|540573254|FG000|Overall Study|Pregnancy|7|||
149848323|NCT02817828|540573254|FG000|Overall Study|Pregnancy wish|15|||
149848324|NCT02817828|540573254|FG000|Overall Study|Withdrawal by Subject|78|||
149848325|NCT02817828|540573254|FG000|Overall Study|Other|26|||
149848326|NCT02308241|540573258|FG000|Overall Study|Withdrawal by Subject|3|||
149848327|NCT00659815|540573259|FG000|Overall Study|Study related symptoms and complaints|2|||
149848328|NCT00659815|540573260|FG001|Overall Study|Study related symptoms and complaints|1|||
149848329|NCT00659815|540573259|FG000|Overall Study|Inability to maintain wearing schedule|1|||
149848330|NCT00659815|540573260|FG001|Overall Study|Inability to maintain wearing schedule|2|||
149848331|NCT00659815|540573259|FG000|Overall Study|Withdrawal by Subject|1|||
149848332|NCT00659815|540573260|FG001|Overall Study|Withdrawal by Subject|1|||
149848333|NCT02651987|540573261|FG000|Overall Study|Adverse Event|2|||
149848334|NCT02651987|540573262|FG001|Overall Study|Adverse Event|2|||
149848335|NCT02651987|540573261|FG000|Overall Study|Consent Withdrawn|2|||
149848336|NCT02651987|540573262|FG001|Overall Study|Consent Withdrawn|0|||
149848337|NCT02651987|540573261|FG000|Overall Study|Local PD|0|||
149848338|NCT02651987|540573262|FG001|Overall Study|Local PD|2|||
149848339|NCT02651987|540573261|FG000|Overall Study|Investigator Decision|1|||
149848340|NCT02651987|540573262|FG001|Overall Study|Investigator Decision|1|||
149848341|NCT04408924|540573263|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
150288173|NCT03548558|542189216|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
150288174|NCT03548558|542189217|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
150288175|NCT03548558|542189218|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
150288176|NCT03548558|542189219|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
149848342|NCT04408924|540573263|FG000|Overall Study|Lost to Follow-up|3|||
149848343|NCT04408924|540573263|FG000|Overall Study|Withdrawal by Subject|5|||
149848344|NCT04408924|540573263|FG000|Overall Study|Sponsor Decision|2|||
149848345|NCT00486434|540573264|FG000|Overall Study|Withdrawal by Subject|34|||
149848346|NCT00486434|540573265|FG001|Overall Study|Withdrawal by Subject|39|||
149848347|NCT00486434|540573264|FG000|Overall Study|Adverse Event|118|||
149848348|NCT00486434|540573265|FG001|Overall Study|Adverse Event|44|||
149848349|NCT00486434|540573264|FG000|Overall Study|Protocol Violation|22|||
149848350|NCT00486434|540573265|FG001|Overall Study|Protocol Violation|21|||
149848351|NCT00486434|540573264|FG000|Overall Study|Lack of Efficacy|12|||
149848352|NCT00486434|540573265|FG001|Overall Study|Lack of Efficacy|19|||
149848353|NCT00486434|540573264|FG000|Overall Study|Lost to Follow-up|2|||
149848354|NCT00486434|540573265|FG001|Overall Study|Lost to Follow-up|3|||
149848355|NCT00486434|540573264|FG000|Overall Study|Death|1|||
149848356|NCT00486434|540573265|FG001|Overall Study|Death|2|||
149848357|NCT00486434|540573264|FG000|Overall Study|Personal reasons|5|||
149848358|NCT00486434|540573265|FG001|Overall Study|Personal reasons|6|||
149848359|NCT02725515|540573266|FG000|Overall Study|Refused infusion (no study treatment)|1|||
149848360|NCT02725515|540573267|FG001|Overall Study|Refused infusion (no study treatment)|0|||
149848361|NCT02725515|540573266|FG000|Overall Study|Loss of Improvement per Protocol|14|||
149848362|NCT02725515|540573267|FG001|Overall Study|Loss of Improvement per Protocol|25|||
149848363|NCT02725515|540573266|FG000|Overall Study|Withdrawal by Subject|2|||
149848364|NCT02725515|540573267|FG001|Overall Study|Withdrawal by Subject|1|||
149848365|NCT02725515|540573266|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149848366|NCT02725515|540573267|FG001|Overall Study|Non-Compliance With Study Drug|3|||
149848367|NCT02725515|540573266|FG000|Overall Study|Lost to Follow-up|1|||
149848368|NCT02725515|540573267|FG001|Overall Study|Lost to Follow-up|1|||
149848369|NCT02725515|540573266|FG000|Overall Study|Adverse Event|7|||
149848370|NCT02725515|540573267|FG001|Overall Study|Adverse Event|2|||
149848371|NCT02725515|540573266|FG000|Overall Study|No Documented Disease Improvement|0|||
149848372|NCT02725515|540573267|FG001|Overall Study|No Documented Disease Improvement|1|||
149848373|NCT02725515|540573266|FG000|Overall Study|Completed Study Under Original Protocol|0|||
149848374|NCT02725515|540573267|FG001|Overall Study|Completed Study Under Original Protocol|1|||
149848375|NCT02725515|540573266|FG000|Overall Study|Lack of Response|0|||
149848376|NCT02725515|540573267|FG001|Overall Study|Lack of Response|1|||
149848377|NCT02906917|540573274|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
149848378|NCT02906917|540573275|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
149848379|NCT02906917|540573274|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
149848380|NCT02906917|540573275|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
149848381|NCT02906917|540573274|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
149848382|NCT02906917|540573275|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
149848383|NCT02906917|540573274|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
149848384|NCT02906917|540573275|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
149848385|NCT02906917|540573274|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
149848386|NCT02906917|540573275|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
149848387|NCT02906917|540573274|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
149848388|NCT02906917|540573275|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
149848389|NCT02906917|540573274|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
149848390|NCT02906917|540573275|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
149848391|NCT02906917|540573274|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
149848392|NCT02906917|540573275|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
149848393|NCT00687739|540573276|FG000|Overall Study|Lost to Follow-up|2|||
149848394|NCT00687739|540573277|FG001|Overall Study|Lost to Follow-up|2|||
149848395|NCT00687739|540573278|FG002|Overall Study|Lost to Follow-up|1|||
149848396|NCT00687739|540573279|FG003|Overall Study|Lost to Follow-up|2|||
149848397|NCT00687739|540573276|FG000|Overall Study|Adverse Event|0|||
149848398|NCT00687739|540573277|FG001|Overall Study|Adverse Event|1|||
149848399|NCT00687739|540573278|FG002|Overall Study|Adverse Event|1|||
149848400|NCT00687739|540573279|FG003|Overall Study|Adverse Event|0|||
149848401|NCT03599362|540573284|FG000|Overall Study|Screen Failure|3|||
149848402|NCT02072096|540573287|FG000|Overall Study|Lack of Efficacy|18|||
149848403|NCT02072096|540573288|FG001|Overall Study|Lack of Efficacy|29|||
149848404|NCT02072096|540573287|FG000|Overall Study|Protocol Violation|7|||
149848405|NCT02072096|540573288|FG001|Overall Study|Protocol Violation|7|||
149848406|NCT02072096|540573287|FG000|Overall Study|Withdrawal by Subject|5|||
149848407|NCT02072096|540573288|FG001|Overall Study|Withdrawal by Subject|7|||
149848408|NCT02072096|540573287|FG000|Overall Study|Adverse Event|5|||
149848409|NCT02072096|540573288|FG001|Overall Study|Adverse Event|2|||
149848410|NCT02072096|540573287|FG000|Overall Study|No Reason Provided|4|||
149848411|NCT02072096|540573288|FG001|Overall Study|No Reason Provided|2|||
149848412|NCT02072096|540573287|FG000|Overall Study|Death|2|||
149848413|NCT02072096|540573288|FG001|Overall Study|Death|0|||
149848414|NCT02072096|540573287|FG000|Overall Study|Physician Decision|0|||
149848415|NCT02072096|540573288|FG001|Overall Study|Physician Decision|1|||
149848416|NCT02072096|540573287|FG000|Overall Study|Study Terminated by Sponsor|43|||
149848417|NCT02072096|540573288|FG001|Overall Study|Study Terminated by Sponsor|30|||
149848418|NCT02072096|540573287|FG000|Overall Study|Lost to Follow-up|1|||
149848419|NCT02072096|540573288|FG001|Overall Study|Lost to Follow-up|0|||
149848420|NCT04442503|540573296|FG000|Overall Study|Adverse Event|1|||
149848421|NCT04442503|540573297|FG001|Overall Study|Adverse Event|1|||
149848422|NCT04442503|540573296|FG000|Overall Study|Lost to Follow-up|8|||
149848423|NCT04442503|540573297|FG001|Overall Study|Lost to Follow-up|6|||
149848424|NCT04442503|540573296|FG000|Overall Study|Physician Decision|0|||
149848425|NCT04442503|540573297|FG001|Overall Study|Physician Decision|2|||
149848426|NCT04442503|540573296|FG000|Overall Study|Withdrawal by Subject|3|||
149848427|NCT04442503|540573297|FG001|Overall Study|Withdrawal by Subject|4|||
149848428|NCT04442503|540573296|FG000|Overall Study|Reason not Specified|0|||
149848429|NCT04442503|540573297|FG001|Overall Study|Reason not Specified|1|||
149848430|NCT04442503|540573296|FG000|Overall Study|Randomized but not Treated|3|||
150172751|NCT00857649|541768085|FG001|Overall Study|Protocol Violation|2|||
149848431|NCT04442503|540573297|FG001|Overall Study|Randomized but not Treated|1|||
149848432|NCT00474058|540573300|FG000|Overall Study|Adverse Event|11|||
149848433|NCT00474058|540573301|FG001|Overall Study|Adverse Event|6|||
149848434|NCT00474058|540573300|FG000|Overall Study|Lack of Efficacy|0|||
149848435|NCT00474058|540573301|FG001|Overall Study|Lack of Efficacy|4|||
149848436|NCT00474058|540573300|FG000|Overall Study|Withdrawal by Subject|11|||
149848437|NCT00474058|540573301|FG001|Overall Study|Withdrawal by Subject|7|||
149848438|NCT00474058|540573300|FG000|Overall Study|Other|2|||
149848439|NCT00474058|540573301|FG001|Overall Study|Other|0|||
149848440|NCT00503867|540573310|FG000|Overall Study|Lost to Follow-up|1|||
149848441|NCT00503867|540573310|FG000|Overall Study|Adverse Event|1|||
149848442|NCT05616728|540573311|FG000|Overall Study|Lost to Follow-up|0|||
149848443|NCT05616728|540573312|FG001|Overall Study|Lost to Follow-up|0|||
149848444|NCT05616728|540573313|FG002|Overall Study|Lost to Follow-up|1|||
149848445|NCT05616728|540573311|FG000|Overall Study|Withdrawal by Subject|1|||
149848446|NCT05616728|540573312|FG001|Overall Study|Withdrawal by Subject|1|||
149848447|NCT05616728|540573313|FG002|Overall Study|Withdrawal by Subject|0|||
149848448|NCT05616728|540573311|FG000|Overall Study|Physician Decision|1|||
149848449|NCT05616728|540573312|FG001|Overall Study|Physician Decision|1|||
149848450|NCT05616728|540573313|FG002|Overall Study|Physician Decision|1|||
150036872|NCT00129402|541276993|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
150036873|NCT00129402|541276987|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036874|NCT00129402|541276988|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036875|NCT00129402|541276989|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036876|NCT00129402|541276990|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036877|NCT00129402|541276991|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036878|NCT00129402|541276992|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
150036879|NCT00129402|541276993|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
150288177|NCT03548558|542189220|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
150288178|NCT03548558|542189221|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
150288179|NCT03548558|542189215|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
150288180|NCT03548558|542189216|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
150288181|NCT03548558|542189217|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
150288182|NCT03548558|542189218|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
150288183|NCT03548558|542189219|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
150288184|NCT03548558|542189220|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
150288185|NCT03548558|542189221|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
150036880|NCT00129402|541276987|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036881|NCT00129402|541276988|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036882|NCT00129402|541276989|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036883|NCT00129402|541276990|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036884|NCT00129402|541276991|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036885|NCT00129402|541276992|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
150036886|NCT00129402|541276993|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
150036887|NCT00129402|541276987|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150036888|NCT00129402|541276988|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150036889|NCT00129402|541276989|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150036890|NCT00129402|541276990|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150036891|NCT00129402|541276991|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150288186|NCT03548558|542189215|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
150288187|NCT03548558|542189216|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
150288188|NCT03548558|542189217|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
150288189|NCT03548558|542189218|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
150288190|NCT03548558|542189219|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
150288191|NCT03548558|542189220|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
150288192|NCT03548558|542189221|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
149848451|NCT05616728|540573311|FG000|Overall Study|Other|0|||
149848452|NCT05616728|540573312|FG001|Overall Study|Other|2|||
149848453|NCT05616728|540573313|FG002|Overall Study|Other|0|||
149848454|NCT00577655|540573314|FG000|Overall Study|Patient Request|0|||
149848455|NCT00577655|540573315|FG001|Overall Study|Patient Request|2|||
149848456|NCT00577655|540573314|FG000|Overall Study|Protocol Violation|0|||
149848457|NCT00577655|540573315|FG001|Overall Study|Protocol Violation|1|||
149848458|NCT00577655|540573314|FG000|Overall Study|Lost to Follow-up|1|||
149848459|NCT00577655|540573315|FG001|Overall Study|Lost to Follow-up|1|||
149848460|NCT00672984|540573319|FG000|First Intervention|Adverse Event|5|||
149848461|NCT00672984|540573320|FG001|First Intervention|Adverse Event|0|||
149848462|NCT00672984|540573321|FG002|First Intervention|Adverse Event|0|||
149848463|NCT00672984|540573319|FG000|First Intervention|Withdrawal by Subject|1|||
149848464|NCT00672984|540573320|FG001|First Intervention|Withdrawal by Subject|2|||
150036892|NCT00129402|541276992|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
150036893|NCT00129402|541276993|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
150036894|NCT03041038|541276994|FG000|Overall Study|Withdrawal by Subject|4|||
150036895|NCT03041038|541276995|FG001|Overall Study|Withdrawal by Subject|0|||
150036896|NCT03041038|541276994|FG000|Overall Study|Lost to Follow-up|1|||
150036897|NCT03041038|541276995|FG001|Overall Study|Lost to Follow-up|1|||
150036898|NCT03041038|541276994|FG000|Overall Study|Protocol Violation|1|||
150036899|NCT03041038|541276995|FG001|Overall Study|Protocol Violation|1|||
150036900|NCT02131259|541276998|FG000|Overall Study|Progressive disease|751|||
150036901|NCT02131259|541276998|FG000|Overall Study|Adverse Event|341|||
150036902|NCT02131259|541276998|FG000|Overall Study|Lost to Follow-up|7|||
150036903|NCT02131259|541276998|FG000|Overall Study|Relocation|32|||
150036904|NCT02131259|541276998|FG000|Overall Study|Other|63|||
150036905|NCT02131259|541276998|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
150288193|NCT03548558|542189215|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
150288194|NCT03548558|542189216|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
150288195|NCT03548558|542189217|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
150288196|NCT03548558|542189218|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
150288197|NCT03548558|542189219|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
150288198|NCT03548558|542189220|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
150288199|NCT03548558|542189221|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
150288200|NCT03548558|542189215|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
150288201|NCT03548558|542189216|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
150288202|NCT03548558|542189217|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
150288203|NCT03548558|542189218|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
150288204|NCT03548558|542189219|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
150288205|NCT03548558|542189220|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
150288206|NCT03548558|542189221|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
150288207|NCT01289015|542189222|FG000|Overall Study|Protocol Violation|12|||
150288208|NCT01289015|542189223|FG001|Overall Study|Protocol Violation|9|||
150288209|NCT01289015|542189222|FG000|Overall Study|Adverse Event|3|||
150288210|NCT01289015|542189223|FG001|Overall Study|Adverse Event|0|||
150288211|NCT01289015|542189222|FG000|Overall Study|Lost to Follow-up|33|||
150288212|NCT01289015|542189223|FG001|Overall Study|Lost to Follow-up|17|||
150288213|NCT01289015|542189222|FG000|Overall Study|Withdrawal by Subject|17|||
150288214|NCT01289015|542189223|FG001|Overall Study|Withdrawal by Subject|8|||
149957149|NCT02421510|540977408|FG001|Overall Study|Adverse Event|10|||
149957150|NCT02421510|540977409|FG002|Overall Study|Adverse Event|18|||
149957151|NCT02421510|540977407|FG000|Overall Study|Pregnancy|1|||
149957152|NCT02421510|540977408|FG001|Overall Study|Pregnancy|1|||
149957153|NCT02421510|540977409|FG002|Overall Study|Pregnancy|0|||
149957154|NCT02421510|540977407|FG000|Overall Study|Withdrawal by Subject|14|||
149957155|NCT02421510|540977408|FG001|Overall Study|Withdrawal by Subject|18|||
149957156|NCT02421510|540977409|FG002|Overall Study|Withdrawal by Subject|12|||
149957157|NCT02421510|540977407|FG000|Overall Study|Lost to Follow-up|1|||
149957158|NCT02421510|540977408|FG001|Overall Study|Lost to Follow-up|1|||
149957159|NCT02421510|540977409|FG002|Overall Study|Lost to Follow-up|0|||
149957160|NCT02852434|540977410|FG000|Overall Study|Withdrawal by Subject|0|||
149957161|NCT02852434|540977411|FG001|Overall Study|Withdrawal by Subject|1|||
149957162|NCT02852434|540977410|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
149957163|NCT02852434|540977411|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
149957164|NCT01058005|540977416|FG000|Overall Study|Adverse Event|0|||
149957165|NCT01058005|540977417|FG001|Overall Study|Adverse Event|2|||
149957166|NCT01058005|540977418|FG002|Overall Study|Adverse Event|1|||
149957167|NCT01058005|540977416|FG000|Overall Study|Physician Decision|2|||
149957168|NCT01058005|540977417|FG001|Overall Study|Physician Decision|2|||
150036906|NCT02131259|541276998|FG000|Overall Study|Progressive disease/relocation|1|||
150288215|NCT01289015|542189222|FG000|Overall Study|Disease progression|1|||
150288216|NCT01289015|542189223|FG001|Overall Study|Disease progression|0|||
150288217|NCT01289015|542189222|FG000|Overall Study|Negative baseline culture and others|33|||
150288218|NCT01289015|542189223|FG001|Overall Study|Negative baseline culture and others|20|||
150288219|NCT01709149|542189224|FG000|Open-label Lead-in Phase|Adverse Event|109|||
150288220|NCT01709149|542189225|FG001|Open-label Lead-in Phase|Adverse Event|0|||
150288221|NCT01709149|542189226|FG002|Open-label Lead-in Phase|Adverse Event|0|||
150288222|NCT01709149|542189224|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
149957169|NCT01058005|540977418|FG002|Overall Study|Physician Decision|0|||
150036907|NCT02131259|541276998|FG000|Overall Study|Progressive disease/other|2|||
150036908|NCT02131259|541276998|FG000|Overall Study|AE/lost to follow-up|1|||
149957170|NCT01058005|540977416|FG000|Overall Study|Withdrawal by Subject|4|||
149957171|NCT01058005|540977417|FG001|Overall Study|Withdrawal by Subject|5|||
149957172|NCT01058005|540977418|FG002|Overall Study|Withdrawal by Subject|11|||
150036909|NCT02131259|541276998|FG000|Overall Study|AE/other|1|||
150036910|NCT02131259|541276998|FG000|Overall Study|Progressive disease/AE/other|1|||
150288223|NCT01709149|542189225|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
150288224|NCT01709149|542189226|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
150288225|NCT01709149|542189224|FG000|Open-label Lead-in Phase|Death|1|||
150288226|NCT01709149|542189225|FG001|Open-label Lead-in Phase|Death|0|||
150288227|NCT01709149|542189226|FG002|Open-label Lead-in Phase|Death|0|||
150288228|NCT01709149|542189224|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
150288229|NCT01709149|542189225|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
150288230|NCT01709149|542189226|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
150288231|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
150288232|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
150288233|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
150288234|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
150288235|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
150288236|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
150288237|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150288238|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
150288239|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
150288240|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
150288241|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
150288242|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
150288243|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
150288244|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
150288245|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
150288246|NCT01709149|542189224|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150288247|NCT01709149|542189225|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
150288248|NCT01709149|542189226|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150288249|NCT00290433|542189229|FG000|Overall Study|Disease Progression|13|||
150288250|NCT00290433|542189229|FG000|Overall Study|Adverse Event|14|||
150288251|NCT00290433|542189229|FG000|Overall Study|Withdrawal by Subject|1|||
150288252|NCT00290433|542189229|FG000|Overall Study|Non-Compliance|1|||
150288253|NCT00290433|542189229|FG000|Overall Study|Congestive Heart Failure|1|||
150288254|NCT00290433|542189229|FG000|Overall Study|Transplant in CR|5|||
150288255|NCT00290433|542189229|FG000|Overall Study|Unrelated Infection/Death|1|||
150288256|NCT00797732|542189237|FG000|Overall Study|Withdrawal by Subject|3|||
150288257|NCT00797732|542189238|FG001|Overall Study|Withdrawal by Subject|3|||
150288258|NCT00797732|542189239|FG002|Overall Study|Withdrawal by Subject|0|||
149848465|NCT00672984|540573321|FG002|First Intervention|Withdrawal by Subject|2|||
149848466|NCT00672984|540573319|FG000|First Intervention|Sponsor decision|3|||
149848467|NCT00672984|540573320|FG001|First Intervention|Sponsor decision|0|||
149848468|NCT00672984|540573321|FG002|First Intervention|Sponsor decision|0|||
149848469|NCT00672984|540573319|FG000|Second Intervention|Non-compliance with facility policies|0|||
149848470|NCT00672984|540573320|FG001|Second Intervention|Non-compliance with facility policies|2|||
150036911|NCT02131259|541276998|FG000|Overall Study|Missing|3|||
150288259|NCT00797732|542189237|FG000|Overall Study|Lost to Follow-up|1|||
150288260|NCT00797732|542189238|FG001|Overall Study|Lost to Follow-up|0|||
150288261|NCT00797732|542189239|FG002|Overall Study|Lost to Follow-up|0|||
150288262|NCT00797732|542189237|FG000|Overall Study|Death|1|||
150288263|NCT00797732|542189238|FG001|Overall Study|Death|0|||
150288264|NCT00797732|542189239|FG002|Overall Study|Death|0|||
149848471|NCT00672984|540573321|FG002|Second Intervention|Non-compliance with facility policies|0|||
149848472|NCT00672984|540573319|FG000|Second Intervention|Withdrawal by Subject|0|||
149848473|NCT00672984|540573320|FG001|Second Intervention|Withdrawal by Subject|3|||
149848474|NCT00672984|540573321|FG002|Second Intervention|Withdrawal by Subject|0|||
149848475|NCT00672984|540573319|FG000|Second Intervention|Protocol Violation|0|||
149848476|NCT00672984|540573320|FG001|Second Intervention|Protocol Violation|1|||
149848477|NCT00672984|540573321|FG002|Second Intervention|Protocol Violation|1|||
149848478|NCT00672984|540573319|FG000|Third Intervention|Adverse Event|1|||
149848479|NCT00672984|540573320|FG001|Third Intervention|Adverse Event|0|||
149848480|NCT00672984|540573321|FG002|Third Intervention|Adverse Event|1|||
149848481|NCT00009945|540573322|FG000|Overall Study|no follow up data|7|||
149848482|NCT00009945|540573323|FG001|Overall Study|no follow up data|5|||
149848483|NCT00406393|540573324|FG000|Overall Study|Did not undergo transplantation|2|||
149848484|NCT00406393|540573325|FG001|Overall Study|Did not undergo transplantation|1|||
150036912|NCT02796170|541276999|FG000|Overall Study|Lost to Follow-up|3|||
150036913|NCT02796170|541277000|FG001|Overall Study|Lost to Follow-up|0|||
150288265|NCT00797732|542189237|FG000|Overall Study|Not meet inclusion criteria|0|||
150288266|NCT00797732|542189238|FG001|Overall Study|Not meet inclusion criteria|0|||
150288267|NCT00797732|542189239|FG002|Overall Study|Not meet inclusion criteria|7|||
150288268|NCT00797732|542189237|FG000|Overall Study|Excluded due to time constraints|0|||
149848485|NCT01632306|540573326|FG000|Overall Study|Protocol Violation|1|||
149848486|NCT01632306|540573327|FG001|Overall Study|Protocol Violation|0|||
149848487|NCT01632306|540573328|FG002|Overall Study|Protocol Violation|0|||
150036914|NCT01527370|541277001|FG000|Overall Study|Withdrawal by Subject|4|||
150036915|NCT01527370|541277001|FG000|Overall Study|Physician Decision|1|||
150036916|NCT01527370|541277001|FG000|Overall Study|Death|1|||
150036917|NCT01472289|541277003|FG000|Overall Study|Death|2|||
150036918|NCT04004988|541277004|FG000|Period 1|Physician Decision|2|||
150036919|NCT04004988|541277005|FG001|Period 1|Physician Decision|0|||
150036920|NCT04004988|541277004|FG000|Period 1|Withdrawal by Subject|0|||
150036921|NCT04004988|541277005|FG001|Period 1|Withdrawal by Subject|1|||
150036922|NCT04004988|541277004|FG000|Period 1|Adverse Event|1|||
150036923|NCT04004988|541277005|FG001|Period 1|Adverse Event|2|||
150036924|NCT03873116|541277006|FG000|Part 1|Study drug discontinuation due to rash|0|||
150036925|NCT03873116|541277007|FG001|Part 1|Study drug discontinuation due to rash|0|||
150036926|NCT03873116|541277008|FG002|Part 1|Study drug discontinuation due to rash|0|||
150288269|NCT00797732|542189238|FG001|Overall Study|Excluded due to time constraints|0|||
150288270|NCT00797732|542189239|FG002|Overall Study|Excluded due to time constraints|24|||
150288271|NCT00797732|542189237|FG000|Overall Study|Refused to Participate|0|||
150288272|NCT00797732|542189238|FG001|Overall Study|Refused to Participate|0|||
150288273|NCT00797732|542189239|FG002|Overall Study|Refused to Participate|123|||
150288274|NCT01857869|542189242|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
150288275|NCT01857869|542189243|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
150288276|NCT01857869|542189244|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
150288277|NCT01857869|542189245|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
150288278|NCT01857869|542189246|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
150288279|NCT01857869|542189247|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
150288280|NCT01857869|542189248|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
150288281|NCT01857869|542189249|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
150288282|NCT01857869|542189250|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
150288283|NCT01857869|542189251|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
150288284|NCT01857869|542189242|FG000|Primary/Challenge Phase|Pregnancy|1|||
150288285|NCT01857869|542189243|FG001|Primary/Challenge Phase|Pregnancy|0|||
150288286|NCT01857869|542189244|FG002|Primary/Challenge Phase|Pregnancy|0|||
150288287|NCT01857869|542189245|FG003|Primary/Challenge Phase|Pregnancy|0|||
150288288|NCT01857869|542189246|FG004|Primary/Challenge Phase|Pregnancy|0|||
150288289|NCT01857869|542189247|FG005|Primary/Challenge Phase|Pregnancy|0|||
150288290|NCT01857869|542189248|FG006|Primary/Challenge Phase|Pregnancy|0|||
150288291|NCT01857869|542189249|FG007|Primary/Challenge Phase|Pregnancy|0|||
150288292|NCT01857869|542189250|FG008|Primary/Challenge Phase|Pregnancy|0|||
150288293|NCT01857869|542189251|FG009|Primary/Challenge Phase|Pregnancy|0|||
150288294|NCT01857869|542189242|FG000|Primary/Challenge Phase|Protocol Violation|1|||
150036927|NCT03873116|541277009|FG003|Part 1|Study drug discontinuation due to rash|0|||
150036928|NCT03873116|541277010|FG004|Part 1|Study drug discontinuation due to rash|0|||
150172752|NCT00857649|541768084|FG000|Overall Study|Withdrawal of Consent|10|||
150288295|NCT01857869|542189243|FG001|Primary/Challenge Phase|Protocol Violation|0|||
150288296|NCT01857869|542189244|FG002|Primary/Challenge Phase|Protocol Violation|0|||
150288297|NCT01857869|542189245|FG003|Primary/Challenge Phase|Protocol Violation|0|||
150288298|NCT01857869|542189246|FG004|Primary/Challenge Phase|Protocol Violation|0|||
150172753|NCT00857649|541768085|FG001|Overall Study|Withdrawal of Consent|7|||
150288299|NCT01857869|542189247|FG005|Primary/Challenge Phase|Protocol Violation|0|||
150288300|NCT01857869|542189248|FG006|Primary/Challenge Phase|Protocol Violation|0|||
150288301|NCT01857869|542189249|FG007|Primary/Challenge Phase|Protocol Violation|0|||
150288302|NCT01857869|542189250|FG008|Primary/Challenge Phase|Protocol Violation|0|||
150288303|NCT01857869|542189251|FG009|Primary/Challenge Phase|Protocol Violation|0|||
150288304|NCT01857869|542189242|FG000|Primary/Challenge Phase|Other|1|||
150288305|NCT01857869|542189243|FG001|Primary/Challenge Phase|Other|1|||
150288306|NCT01857869|542189244|FG002|Primary/Challenge Phase|Other|0|||
150288307|NCT01857869|542189245|FG003|Primary/Challenge Phase|Other|0|||
150288308|NCT01857869|542189246|FG004|Primary/Challenge Phase|Other|0|||
150288309|NCT01857869|542189247|FG005|Primary/Challenge Phase|Other|0|||
150288310|NCT01857869|542189248|FG006|Primary/Challenge Phase|Other|0|||
150288311|NCT01857869|542189249|FG007|Primary/Challenge Phase|Other|0|||
150288312|NCT01857869|542189250|FG008|Primary/Challenge Phase|Other|0|||
150288313|NCT01857869|542189251|FG009|Primary/Challenge Phase|Other|0|||
150288314|NCT01857869|542189242|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288315|NCT01857869|542189243|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288316|NCT01857869|542189244|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288317|NCT01857869|542189245|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
150288318|NCT01857869|542189246|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288319|NCT01857869|542189247|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288320|NCT01857869|542189248|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288321|NCT01857869|542189249|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288322|NCT01857869|542189250|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288323|NCT01857869|542189251|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
150288324|NCT01857869|542189242|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288325|NCT01857869|542189243|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288326|NCT01857869|542189244|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288327|NCT01857869|542189245|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
150288328|NCT01857869|542189246|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288329|NCT01857869|542189247|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288330|NCT01857869|542189248|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288331|NCT01857869|542189249|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288332|NCT01857869|542189250|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288333|NCT01857869|542189251|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
150288334|NCT01277549|542189255|FG000|Overall Study|Failed to meet eligibility criteria|13|||
150288335|NCT01277549|542189256|FG001|Overall Study|Failed to meet eligibility criteria|9|||
150288336|NCT01277549|542189255|FG000|Overall Study|Withdrawal by Subject|1|||
150288337|NCT01277549|542189256|FG001|Overall Study|Withdrawal by Subject|3|||
150288338|NCT01277549|542189255|FG000|Overall Study|Protocol Violation|10|||
150288339|NCT01277549|542189256|FG001|Overall Study|Protocol Violation|1|||
150288340|NCT01277549|542189255|FG000|Overall Study|Physician Decision|2|||
150288341|NCT01277549|542189256|FG001|Overall Study|Physician Decision|1|||
150288342|NCT02228590|542189257|FG000|Overall Study|Withdrawal by Subject|1|||
150288343|NCT02109484|542189258|FG000|Overall Study|Lost to Follow-up|0|||
150288344|NCT02109484|542189259|FG001|Overall Study|Lost to Follow-up|0|||
150288345|NCT02109484|542189260|FG002|Overall Study|Lost to Follow-up|0|||
150288346|NCT02109484|542189261|FG003|Overall Study|Lost to Follow-up|1|||
150288347|NCT02109484|542189262|FG004|Overall Study|Lost to Follow-up|1|||
149957173|NCT01058005|540977416|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
149957174|NCT01058005|540977417|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
149957175|NCT01058005|540977418|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
149957176|NCT01058005|540977416|FG000|Overall Study|Reason Missing|5|||
149957177|NCT01058005|540977417|FG001|Overall Study|Reason Missing|3|||
149957178|NCT01058005|540977418|FG002|Overall Study|Reason Missing|1|||
149957179|NCT01698008|540977419|FG000|Overall Study|Withdrawal by Subject|1|||
149957180|NCT01698008|540977420|FG001|Overall Study|Withdrawal by Subject|2|||
149957181|NCT02287025|540977421|FG000|Overall Study|Not treated|2|||
149957182|NCT02287025|540977422|FG001|Overall Study|Not treated|0|||
149957183|NCT02287025|540977421|FG000|Overall Study|Progression of disease|3|||
149957184|NCT02287025|540977422|FG001|Overall Study|Progression of disease|2|||
149957185|NCT02287025|540977421|FG000|Overall Study|Adverse Event|2|||
150172754|NCT00857649|541768084|FG000|Overall Study|Nursing Home Placement|2|||
150288348|NCT02109484|542189263|FG005|Overall Study|Lost to Follow-up|0|||
150288349|NCT02109484|542189264|FG006|Overall Study|Lost to Follow-up|1|||
150288350|NCT02109484|542189265|FG007|Overall Study|Lost to Follow-up|0|||
149957186|NCT02287025|540977422|FG001|Overall Study|Adverse Event|4|||
150288351|NCT02109484|542189258|FG000|Overall Study|Withdrawal by Subject|0|||
150288352|NCT02109484|542189259|FG001|Overall Study|Withdrawal by Subject|0|||
150288353|NCT02109484|542189260|FG002|Overall Study|Withdrawal by Subject|0|||
150288354|NCT02109484|542189261|FG003|Overall Study|Withdrawal by Subject|0|||
150288355|NCT02109484|542189262|FG004|Overall Study|Withdrawal by Subject|1|||
150288356|NCT02109484|542189263|FG005|Overall Study|Withdrawal by Subject|1|||
150288357|NCT02109484|542189264|FG006|Overall Study|Withdrawal by Subject|1|||
150288358|NCT02109484|542189265|FG007|Overall Study|Withdrawal by Subject|0|||
150288359|NCT02109484|542189258|FG000|Overall Study|Physician Decision|0|||
150288360|NCT02109484|542189259|FG001|Overall Study|Physician Decision|0|||
150288361|NCT02109484|542189260|FG002|Overall Study|Physician Decision|0|||
149848488|NCT00380588|540573331|FG000|Overall Study|Unequivocal Disease Progression|25|||
149848489|NCT00380588|540573332|FG001|Overall Study|Unequivocal Disease Progression|34|||
150288362|NCT02109484|542189261|FG003|Overall Study|Physician Decision|0|||
149957187|NCT02287025|540977421|FG000|Overall Study|Withdrawal by Subject|2|||
149957188|NCT02287025|540977422|FG001|Overall Study|Withdrawal by Subject|2|||
149957189|NCT02287025|540977421|FG000|Overall Study|Screening failed|1|||
149957190|NCT02287025|540977422|FG001|Overall Study|Screening failed|1|||
149957191|NCT04053452|540977423|FG000|Overall Study|Withdrawal by Subject|1|||
149957192|NCT04053452|540977424|FG001|Overall Study|Withdrawal by Subject|0|||
149957193|NCT04053452|540977423|FG000|Overall Study|Time restraint due to inpatient needs|1|||
149957194|NCT04053452|540977424|FG001|Overall Study|Time restraint due to inpatient needs|2|||
149957195|NCT00122187|540977425|FG000|Overall Study|Withdrew because of resource limitations|2|||
149957196|NCT00122187|540977426|FG001|Overall Study|Withdrew because of resource limitations|2|||
149957197|NCT03528577|540977432|FG000|Sequence 1|Failed Spirometry|1|||
149957198|NCT03528577|540977432|FG000|Sequence 1|Restricted medication|1|||
149957199|NCT03528577|540977432|FG000|Sequence 2|Adverse Event|1|||
149957200|NCT03528577|540977432|FG000|Sequence 2|Withdrawal by Subject|1|||
149957201|NCT03528577|540977432|FG000|Sequence 2|Failed Spirometry|1|||
149957202|NCT03528577|540977432|FG000|Sequence 3|Failed Spirometry|1|||
149957203|NCT03528577|540977432|FG000|Sequence 4|Failed Spirometry|2|||
149957204|NCT03528577|540977432|FG000|Sequence 4|Adverse Event|1|||
149957205|NCT04882215|540977433|FG000|Overall Study|Withdrawal by Subject|5|||
149957206|NCT04882215|540977434|FG001|Overall Study|Withdrawal by Subject|0|||
149957207|NCT04098302|540977437|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
149957208|NCT04098302|540977438|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
149957209|NCT04098302|540977439|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
149957210|NCT04098302|540977440|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
149957211|NCT04098302|540977437|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
149957212|NCT04098302|540977438|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
149957213|NCT04098302|540977439|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
149957214|NCT04098302|540977440|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
149957215|NCT04098302|540977437|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
149957216|NCT04098302|540977438|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
150288363|NCT02109484|542189262|FG004|Overall Study|Physician Decision|2|||
150288364|NCT02109484|542189263|FG005|Overall Study|Physician Decision|0|||
150288365|NCT02109484|542189264|FG006|Overall Study|Physician Decision|0|||
150288366|NCT02109484|542189265|FG007|Overall Study|Physician Decision|0|||
150288367|NCT02109484|542189258|FG000|Overall Study|Death|0|||
149848490|NCT00380588|540573331|FG000|Overall Study|Next Cycle Not Started|4|||
149848491|NCT00380588|540573332|FG001|Overall Study|Next Cycle Not Started|0|||
149848492|NCT00380588|540573331|FG000|Overall Study|Adverse Event|7|||
149848493|NCT00380588|540573332|FG001|Overall Study|Adverse Event|3|||
149848494|NCT00380588|540573331|FG000|Overall Study|Withdrawal by Subject|1|||
149848495|NCT00380588|540573332|FG001|Overall Study|Withdrawal by Subject|3|||
149848496|NCT00380588|540573331|FG000|Overall Study|Physician Decision|2|||
149848497|NCT00380588|540573332|FG001|Overall Study|Physician Decision|0|||
149848498|NCT02905435|540573333|FG000|Overall Study|Death|2|||
149848499|NCT02905435|540573333|FG000|Overall Study|Physician Decision|1|||
149848500|NCT02905435|540573333|FG000|Overall Study|Lost to Follow-up|4|||
149848501|NCT02377349|540573334|FG000|Overall Study|Serious Adverse Event|1|||
149848502|NCT02377349|540573335|FG001|Overall Study|Serious Adverse Event|0|||
149848503|NCT02377349|540573334|FG000|Overall Study|Protocol Violation|3|||
149848504|NCT02377349|540573335|FG001|Overall Study|Protocol Violation|2|||
149848505|NCT02377349|540573334|FG000|Overall Study|Withdrawal by Subject|5|||
149848506|NCT02377349|540573335|FG001|Overall Study|Withdrawal by Subject|3|||
149848507|NCT02377349|540573334|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
149848508|NCT02377349|540573335|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
149848509|NCT02377349|540573334|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
149848510|NCT02377349|540573335|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
149848511|NCT02377349|540573334|FG000|Overall Study|Other|0|||
149848512|NCT02377349|540573335|FG001|Overall Study|Other|1|||
149848513|NCT03366428|540573340|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
149848514|NCT03366428|540573340|FG000|Overall Study|Adverse Event|12|||
149848515|NCT03366428|540573340|FG000|Overall Study|Clinical progression|2|||
150288368|NCT02109484|542189259|FG001|Overall Study|Death|0|||
150288369|NCT02109484|542189260|FG002|Overall Study|Death|0|||
150288370|NCT02109484|542189261|FG003|Overall Study|Death|0|||
150288371|NCT02109484|542189262|FG004|Overall Study|Death|0|||
150288372|NCT02109484|542189263|FG005|Overall Study|Death|0|||
150288373|NCT02109484|542189264|FG006|Overall Study|Death|0|||
150288374|NCT02109484|542189265|FG007|Overall Study|Death|2|||
150288375|NCT02109484|542189258|FG000|Overall Study|Moved away from study area|0|||
150288376|NCT02109484|542189259|FG001|Overall Study|Moved away from study area|0|||
150288377|NCT02109484|542189260|FG002|Overall Study|Moved away from study area|0|||
150288378|NCT02109484|542189261|FG003|Overall Study|Moved away from study area|0|||
150288379|NCT02109484|542189262|FG004|Overall Study|Moved away from study area|0|||
150288380|NCT02109484|542189263|FG005|Overall Study|Moved away from study area|0|||
150288381|NCT02109484|542189264|FG006|Overall Study|Moved away from study area|1|||
150288382|NCT02109484|542189265|FG007|Overall Study|Moved away from study area|1|||
150288383|NCT02111993|542189266|FG000|Overall Study|Physician Decision|5|||
150288384|NCT02111993|542189267|FG001|Overall Study|Physician Decision|4|||
150288385|NCT01097863|542189268|FG000|Overall Study|Discomfort|1|||
150288386|NCT01097863|542189269|FG001|Overall Study|Discomfort|0|||
150288387|NCT01097863|542189270|FG002|Overall Study|Discomfort|1|||
150288388|NCT01097863|542189268|FG000|Overall Study|Did not return for final visit|0|||
150288389|NCT01097863|542189269|FG001|Overall Study|Did not return for final visit|0|||
150288390|NCT01097863|542189270|FG002|Overall Study|Did not return for final visit|1|||
150288391|NCT00796315|542189271|FG000|Overall Study|Protocol Violation|0|||
150288392|NCT00796315|542189272|FG001|Overall Study|Protocol Violation|1|||
150288393|NCT00796315|542189273|FG002|Overall Study|Protocol Violation|0|||
150288394|NCT01400451|542189274|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
150288395|NCT01400451|542189275|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
150288396|NCT01400451|542189276|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
150288397|NCT01400451|542189274|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
150288398|NCT01400451|542189275|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
150288399|NCT01400451|542189276|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
150288400|NCT01400451|542189274|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
150288401|NCT01400451|542189275|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
150288402|NCT01400451|542189276|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
150288403|NCT01400451|542189274|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
150288404|NCT01400451|542189275|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
150288405|NCT01400451|542189276|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
150288406|NCT01400451|542189274|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
150288407|NCT01400451|542189275|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
150288408|NCT01400451|542189276|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
150288409|NCT00689871|542189279|FG000|Overall Study|Lost to Follow-up|123|||
149957217|NCT04098302|540977439|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
149957218|NCT04098302|540977440|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
149957219|NCT04098302|540977437|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
149957220|NCT04098302|540977438|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
149957221|NCT04098302|540977439|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
149957222|NCT04098302|540977440|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
149957223|NCT04098302|540977437|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
149957224|NCT04098302|540977438|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
149957225|NCT04098302|540977439|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
149957226|NCT04098302|540977440|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
149957227|NCT04098302|540977437|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
149957228|NCT04098302|540977438|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
149957229|NCT04098302|540977439|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
149957230|NCT04098302|540977440|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
149957231|NCT04098302|540977437|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
149957232|NCT04098302|540977438|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
149957233|NCT04098302|540977439|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
149957234|NCT04098302|540977440|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
149957235|NCT04098302|540977437|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
149957236|NCT04098302|540977438|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
149957237|NCT04098302|540977439|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
149957238|NCT04098302|540977440|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
149957239|NCT05061706|540977443|FG000|Overall Study|Adverse Event|29|||
150288410|NCT00689871|542189280|FG001|Overall Study|Lost to Follow-up|13|||
150288411|NCT00689871|542189281|FG002|Overall Study|Lost to Follow-up|37|||
150288412|NCT00689871|542189282|FG003|Overall Study|Lost to Follow-up|1|||
150288413|NCT00689871|542189279|FG000|Overall Study|Explanted of All Study Devices|36|||
150288414|NCT00689871|542189280|FG001|Overall Study|Explanted of All Study Devices|25|||
150288415|NCT00689871|542189281|FG002|Overall Study|Explanted of All Study Devices|29|||
150288416|NCT00689871|542189282|FG003|Overall Study|Explanted of All Study Devices|3|||
150288417|NCT00689871|542189279|FG000|Overall Study|Withdrawal by Subject|13|||
150288418|NCT00689871|542189280|FG001|Overall Study|Withdrawal by Subject|3|||
150288419|NCT00689871|542189281|FG002|Overall Study|Withdrawal by Subject|4|||
149848516|NCT03366428|540573340|FG000|Overall Study|Withdrawal by Subject|4|||
149848517|NCT02166606|540573341|FG000|Overall Study|Adverse Event|3|||
150036929|NCT03873116|541277011|FG005|Part 1|Study drug discontinuation due to rash|1|||
150036930|NCT03873116|541277006|FG000|Part 2|Withdrawal by Subject|0|||
150036931|NCT03873116|541277007|FG001|Part 2|Withdrawal by Subject|0|||
150036932|NCT03873116|541277008|FG002|Part 2|Withdrawal by Subject|1|||
150036933|NCT03873116|541277009|FG003|Part 2|Withdrawal by Subject|0|||
150036934|NCT03873116|541277010|FG004|Part 2|Withdrawal by Subject|0|||
150036935|NCT03873116|541277011|FG005|Part 2|Withdrawal by Subject|0|||
150036936|NCT03873116|541277006|FG000|Part 2|Lab abnormality or AE|0|||
150036937|NCT03873116|541277007|FG001|Part 2|Lab abnormality or AE|0|||
150036938|NCT03873116|541277008|FG002|Part 2|Lab abnormality or AE|0|||
150036939|NCT03873116|541277009|FG003|Part 2|Lab abnormality or AE|0|||
150036940|NCT03873116|541277010|FG004|Part 2|Lab abnormality or AE|1|||
150036941|NCT03873116|541277011|FG005|Part 2|Lab abnormality or AE|0|||
150036942|NCT03873116|541277006|FG000|Part 3|Withdrawal by Subject|0|||
150036943|NCT03873116|541277007|FG001|Part 3|Withdrawal by Subject|0|||
150036944|NCT03873116|541277008|FG002|Part 3|Withdrawal by Subject|0|||
150036945|NCT03873116|541277009|FG003|Part 3|Withdrawal by Subject|0|||
150036946|NCT03873116|541277010|FG004|Part 3|Withdrawal by Subject|1|||
150036947|NCT03873116|541277011|FG005|Part 3|Withdrawal by Subject|0|||
150036948|NCT02531802|541277014|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
150036949|NCT02531802|541277015|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
150036950|NCT02531802|541277016|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
150036951|NCT02531802|541277017|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
150036952|NCT02531802|541277018|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
150036953|NCT02531802|541277019|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
150036954|NCT02531802|541277020|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
150036955|NCT02531802|541277021|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
150036956|NCT02531802|541277022|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
150036957|NCT02531802|541277023|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
150036958|NCT02531802|541277024|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
150036959|NCT02531802|541277025|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
150036960|NCT02531802|541277026|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
150036961|NCT02531802|541277027|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
150036962|NCT02531802|541277028|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
150036963|NCT02531802|541277029|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
150036964|NCT02531802|541277030|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
150036965|NCT02531802|541277031|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
150036966|NCT02531802|541277032|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
150036967|NCT02531802|541277033|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
150036968|NCT02531802|541277034|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
150036969|NCT02531802|541277014|FG000|Received Vaccination 2|Physician Decision|0|||
150036970|NCT02531802|541277015|FG001|Received Vaccination 2|Physician Decision|0|||
150036971|NCT02531802|541277016|FG002|Received Vaccination 2|Physician Decision|0|||
150036972|NCT02531802|541277017|FG003|Received Vaccination 2|Physician Decision|0|||
150036973|NCT02531802|541277018|FG004|Received Vaccination 2|Physician Decision|0|||
150036974|NCT02531802|541277019|FG005|Received Vaccination 2|Physician Decision|1|||
150036975|NCT02531802|541277020|FG006|Received Vaccination 2|Physician Decision|0|||
150036976|NCT02531802|541277021|FG007|Received Vaccination 2|Physician Decision|0|||
150036977|NCT02531802|541277022|FG008|Received Vaccination 2|Physician Decision|0|||
150036978|NCT02531802|541277023|FG009|Received Vaccination 2|Physician Decision|2|||
150036979|NCT02531802|541277024|FG010|Received Vaccination 2|Physician Decision|0|||
149848518|NCT02166606|540573341|FG000|Overall Study|Death|31|||
150036980|NCT02531802|541277025|FG011|Received Vaccination 2|Physician Decision|0|||
150036981|NCT02531802|541277026|FG012|Received Vaccination 2|Physician Decision|0|||
150036982|NCT02531802|541277027|FG013|Received Vaccination 2|Physician Decision|1|||
150036983|NCT02531802|541277028|FG014|Received Vaccination 2|Physician Decision|0|||
150036984|NCT02531802|541277029|FG015|Received Vaccination 2|Physician Decision|0|||
150036985|NCT02531802|541277030|FG016|Received Vaccination 2|Physician Decision|0|||
150036986|NCT02531802|541277031|FG017|Received Vaccination 2|Physician Decision|1|||
150036987|NCT02531802|541277032|FG018|Received Vaccination 2|Physician Decision|0|||
150036988|NCT02531802|541277033|FG019|Received Vaccination 2|Physician Decision|0|||
150036989|NCT02531802|541277034|FG020|Received Vaccination 2|Physician Decision|0|||
150036990|NCT02531802|541277014|FG000|Received Vaccination 2|Adverse Event|0|||
150288420|NCT00689871|542189282|FG003|Overall Study|Withdrawal by Subject|1|||
150288421|NCT00689871|542189279|FG000|Overall Study|Death|1|||
149848519|NCT02166606|540573341|FG000|Overall Study|Protocol Violation|7|||
149848520|NCT02166606|540573341|FG000|Overall Study|Lost to Follow-up|30|||
150288422|NCT00689871|542189280|FG001|Overall Study|Death|10|||
150288423|NCT00689871|542189281|FG002|Overall Study|Death|2|||
150288424|NCT00689871|542189282|FG003|Overall Study|Death|2|||
150288425|NCT00689871|542189279|FG000|Overall Study|Physician Decision|2|||
150288426|NCT00689871|542189280|FG001|Overall Study|Physician Decision|1|||
150288427|NCT00689871|542189281|FG002|Overall Study|Physician Decision|1|||
150288428|NCT00689871|542189282|FG003|Overall Study|Physician Decision|0|||
150288429|NCT03028870|542189287|FG000|Overall Study|Adverse Event|7|||
150288430|NCT03028870|542189288|FG001|Overall Study|Adverse Event|4|||
150288431|NCT03028870|542189289|FG002|Overall Study|Adverse Event|3|||
150288432|NCT03028870|542189290|FG003|Overall Study|Adverse Event|3|||
150288433|NCT03028870|542189287|FG000|Overall Study|Withdrawal by Subject|1|||
150288434|NCT03028870|542189288|FG001|Overall Study|Withdrawal by Subject|1|||
150288435|NCT03028870|542189289|FG002|Overall Study|Withdrawal by Subject|1|||
150288436|NCT03028870|542189290|FG003|Overall Study|Withdrawal by Subject|2|||
150288437|NCT03028870|542189287|FG000|Overall Study|Lost to Follow-up|1|||
150288438|NCT03028870|542189288|FG001|Overall Study|Lost to Follow-up|0|||
149848521|NCT02166606|540573341|FG000|Overall Study|Withdrawal by Subject|1|||
149848522|NCT02166606|540573341|FG000|Overall Study|Physician Decision|1|||
149848523|NCT02166606|540573341|FG000|Overall Study|Device upgrade|1|||
149848524|NCT02166606|540573341|FG000|Overall Study|Enrolled after End of Enrollment|4|||
149848525|NCT01958476|540573344|FG000|Overall Study|Parent requested exclusion from analysis|1|||
149848526|NCT01958476|540573345|FG001|Overall Study|Parent requested exclusion from analysis|0|||
149848527|NCT02670551|540573346|FG000|Overall Study|Adverse Event|4|||
149848528|NCT02670551|540573347|FG001|Overall Study|Adverse Event|7|||
149848529|NCT02670551|540573348|FG002|Overall Study|Adverse Event|9|||
149848530|NCT02670551|540573346|FG000|Overall Study|Lack of Efficacy|2|||
149848531|NCT02670551|540573347|FG001|Overall Study|Lack of Efficacy|0|||
149848532|NCT02670551|540573348|FG002|Overall Study|Lack of Efficacy|3|||
149848533|NCT02670551|540573346|FG000|Overall Study|Withdrawal of Consent|6|||
149848534|NCT02670551|540573347|FG001|Overall Study|Withdrawal of Consent|3|||
149848535|NCT02670551|540573348|FG002|Overall Study|Withdrawal of Consent|8|||
149848536|NCT02670551|540573346|FG000|Overall Study|Lost to Follow-up|5|||
149848537|NCT02670551|540573347|FG001|Overall Study|Lost to Follow-up|7|||
149848538|NCT02670551|540573348|FG002|Overall Study|Lost to Follow-up|6|||
149848539|NCT02670551|540573346|FG000|Overall Study|Protocol Violation|1|||
149848540|NCT02670551|540573347|FG001|Overall Study|Protocol Violation|0|||
149848541|NCT02670551|540573348|FG002|Overall Study|Protocol Violation|0|||
149848542|NCT02670551|540573346|FG000|Overall Study|Noncompliance with study drug|3|||
149848543|NCT02670551|540573347|FG001|Overall Study|Noncompliance with study drug|3|||
149848544|NCT02670551|540573348|FG002|Overall Study|Noncompliance with study drug|2|||
149848545|NCT02670551|540573346|FG000|Overall Study|Other Miscellaneous Reasons|2|||
149848546|NCT02670551|540573347|FG001|Overall Study|Other Miscellaneous Reasons|3|||
149848547|NCT02670551|540573348|FG002|Overall Study|Other Miscellaneous Reasons|3|||
149848548|NCT02670551|540573346|FG000|Overall Study|Did Not Receive Treatment|5|||
149848549|NCT02670551|540573347|FG001|Overall Study|Did Not Receive Treatment|3|||
149848550|NCT02670551|540573348|FG002|Overall Study|Did Not Receive Treatment|0|||
149848551|NCT01971645|540573349|FG000|Overall Study|Adverse Event|1|||
149848552|NCT01971645|540573350|FG001|Overall Study|Adverse Event|0|||
149848553|NCT01971645|540573351|FG002|Overall Study|Adverse Event|0|||
149848554|NCT01971645|540573349|FG000|Overall Study|Lost to Follow-up|1|||
149848555|NCT01971645|540573350|FG001|Overall Study|Lost to Follow-up|0|||
149848556|NCT01971645|540573351|FG002|Overall Study|Lost to Follow-up|1|||
149848557|NCT01971645|540573349|FG000|Overall Study|Protocol Violation|0|||
149848558|NCT01971645|540573350|FG001|Overall Study|Protocol Violation|0|||
149848559|NCT01971645|540573351|FG002|Overall Study|Protocol Violation|1|||
149848560|NCT00714051|540573352|FG000|Overall Study|Withdrawal by Subject|1|||
149848561|NCT00714051|540573353|FG001|Overall Study|Withdrawal by Subject|0|||
149848562|NCT00714051|540573352|FG000|Overall Study|Death|0|||
149848563|NCT00714051|540573353|FG001|Overall Study|Death|1|||
149848564|NCT00570128|540573354|FG000|Overall Study|Adverse Event|1|||
149848565|NCT00570128|540573355|FG001|Overall Study|Adverse Event|0|||
149848566|NCT00570128|540573354|FG000|Overall Study|Lost to Follow-up|1|||
149848567|NCT00570128|540573355|FG001|Overall Study|Lost to Follow-up|0|||
150036991|NCT02531802|541277015|FG001|Received Vaccination 2|Adverse Event|0|||
150288439|NCT03028870|542189289|FG002|Overall Study|Lost to Follow-up|0|||
150288440|NCT03028870|542189290|FG003|Overall Study|Lost to Follow-up|0|||
150288441|NCT03028870|542189287|FG000|Overall Study|Lack of Efficacy|3|||
150288442|NCT03028870|542189288|FG001|Overall Study|Lack of Efficacy|0|||
149848568|NCT00570128|540573354|FG000|Overall Study|Withdrawal by Subject|2|||
149848569|NCT00570128|540573355|FG001|Overall Study|Withdrawal by Subject|0|||
149848570|NCT03868631|540573356|FG000|Baseline to Week 6|Adverse Event|0|||
149848571|NCT03868631|540573357|FG001|Baseline to Week 6|Adverse Event|3|||
149848572|NCT03868631|540573356|FG000|Baseline to Week 6|Protocol Violation|1|||
150288443|NCT03028870|542189289|FG002|Overall Study|Lack of Efficacy|0|||
150288444|NCT03028870|542189290|FG003|Overall Study|Lack of Efficacy|0|||
150288445|NCT03028870|542189287|FG000|Overall Study|Administrative|5|||
149848573|NCT03868631|540573357|FG001|Baseline to Week 6|Protocol Violation|1|||
150288446|NCT03028870|542189288|FG001|Overall Study|Administrative|5|||
150288447|NCT03028870|542189289|FG002|Overall Study|Administrative|12|||
150288448|NCT03028870|542189290|FG003|Overall Study|Administrative|4|||
150288449|NCT00317109|542189291|FG000|Overall Study|Withdrawal by Subject|2|||
150288450|NCT00317109|542189292|FG001|Overall Study|Withdrawal by Subject|0|||
150288451|NCT00317109|542189291|FG000|Overall Study|Migated/moved from study area|1|||
150288452|NCT00317109|542189292|FG001|Overall Study|Migated/moved from study area|0|||
150288453|NCT01079182|542189294|FG000|Overall Study|Lost to Follow-up|1634|||
150288454|NCT01079182|542189294|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
150288455|NCT01079182|542189294|FG000|Overall Study|Lack of Efficacy|514|||
150288456|NCT01079182|542189294|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
150288457|NCT01079182|542189294|FG000|Overall Study|Reasons not Evaluated|271|||
150288458|NCT01508702|542189295|FG000|Overall Study|Adverse Event|7|||
150288459|NCT01508702|542189296|FG001|Overall Study|Adverse Event|3|||
150288460|NCT01508702|542189295|FG000|Overall Study|Gout flare|2|||
150288461|NCT01508702|542189296|FG001|Overall Study|Gout flare|0|||
150288462|NCT01508702|542189295|FG000|Overall Study|Protocol Violation|2|||
150288463|NCT01508702|542189296|FG001|Overall Study|Protocol Violation|1|||
150288464|NCT01508702|542189295|FG000|Overall Study|Lost to Follow-up|1|||
150288465|NCT01508702|542189296|FG001|Overall Study|Lost to Follow-up|2|||
149848574|NCT03868631|540573356|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
150036992|NCT02531802|541277016|FG002|Received Vaccination 2|Adverse Event|0|||
150036993|NCT02531802|541277017|FG003|Received Vaccination 2|Adverse Event|0|||
150036994|NCT02531802|541277018|FG004|Received Vaccination 2|Adverse Event|0|||
150036995|NCT02531802|541277019|FG005|Received Vaccination 2|Adverse Event|2|||
150036996|NCT02531802|541277020|FG006|Received Vaccination 2|Adverse Event|0|||
150036997|NCT02531802|541277021|FG007|Received Vaccination 2|Adverse Event|0|||
150036998|NCT02531802|541277022|FG008|Received Vaccination 2|Adverse Event|0|||
150036999|NCT02531802|541277023|FG009|Received Vaccination 2|Adverse Event|0|||
150037000|NCT02531802|541277024|FG010|Received Vaccination 2|Adverse Event|0|||
150037001|NCT02531802|541277025|FG011|Received Vaccination 2|Adverse Event|0|||
150037002|NCT02531802|541277026|FG012|Received Vaccination 2|Adverse Event|0|||
150037003|NCT02531802|541277027|FG013|Received Vaccination 2|Adverse Event|0|||
150037004|NCT02531802|541277028|FG014|Received Vaccination 2|Adverse Event|0|||
150037005|NCT02531802|541277029|FG015|Received Vaccination 2|Adverse Event|0|||
150037006|NCT02531802|541277030|FG016|Received Vaccination 2|Adverse Event|0|||
150037007|NCT02531802|541277031|FG017|Received Vaccination 2|Adverse Event|2|||
150037008|NCT02531802|541277032|FG018|Received Vaccination 2|Adverse Event|1|||
150037009|NCT02531802|541277033|FG019|Received Vaccination 2|Adverse Event|0|||
150037010|NCT02531802|541277034|FG020|Received Vaccination 2|Adverse Event|1|||
150037011|NCT02531802|541277014|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
150037012|NCT02531802|541277015|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
150037013|NCT02531802|541277016|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
150037014|NCT02531802|541277017|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
150037015|NCT02531802|541277018|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
150037016|NCT02531802|541277019|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
150037017|NCT02531802|541277020|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
150037018|NCT02531802|541277021|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
150037019|NCT02531802|541277022|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
150037020|NCT02531802|541277023|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
150037021|NCT02531802|541277024|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
150037022|NCT02531802|541277025|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
150037023|NCT02531802|541277026|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
150037024|NCT02531802|541277027|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
150037025|NCT02531802|541277028|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
150037026|NCT02531802|541277029|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
150037027|NCT02531802|541277030|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
150037028|NCT02531802|541277031|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
150037029|NCT02531802|541277032|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
150288466|NCT01508702|542189295|FG000|Overall Study|Withdrawal by Subject|11|||
150288467|NCT01508702|542189296|FG001|Overall Study|Withdrawal by Subject|7|||
150288468|NCT02425826|542189297|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
149848575|NCT03868631|540573357|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
149848576|NCT03868631|540573356|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
150037030|NCT02531802|541277033|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
150037031|NCT02531802|541277034|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
150037032|NCT03131570|541277037|FG000|Overall Study|Adverse Event|1|||
150037033|NCT03131570|541277038|FG001|Overall Study|Adverse Event|0|||
150037034|NCT04596267|541277039|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
150037035|NCT04596267|541277040|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
150037036|NCT04596267|541277039|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
150288469|NCT02425826|542189298|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
149848577|NCT03868631|540573357|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
150288470|NCT02425826|542189299|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
150288471|NCT02425826|542189297|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
150288472|NCT02425826|542189298|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
150288473|NCT02425826|542189299|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
150288474|NCT02425826|542189297|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
150288475|NCT02425826|542189298|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
150288476|NCT02425826|542189299|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
150288477|NCT02425826|542189297|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
149848578|NCT03868631|540573356|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
149848579|NCT03868631|540573357|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
149848580|NCT03868631|540573356|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
149848581|NCT03868631|540573357|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
149848582|NCT02286466|540573358|FG000|Overall Study|Death|1|||
149848583|NCT02286466|540573359|FG001|Overall Study|Death|3|||
149848584|NCT02286466|540573358|FG000|Overall Study|Withdrawal by Subject|5|||
149848585|NCT02286466|540573359|FG001|Overall Study|Withdrawal by Subject|2|||
150288478|NCT02425826|542189298|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
150288479|NCT02425826|542189299|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
150288480|NCT02425826|542189297|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
150288481|NCT02425826|542189298|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
150288482|NCT02425826|542189299|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
150288483|NCT02425826|542189297|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
150288484|NCT02425826|542189298|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
150288485|NCT02425826|542189299|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
150288486|NCT02425826|542189297|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
150288487|NCT02425826|542189298|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
150288488|NCT02425826|542189299|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
150288489|NCT02425826|542189297|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
150288490|NCT02425826|542189298|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
150288491|NCT02425826|542189299|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
150288492|NCT02425826|542189297|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
150288493|NCT02425826|542189298|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
149848586|NCT02286466|540573358|FG000|Overall Study|Lost to Follow-up|1|||
149848587|NCT02286466|540573359|FG001|Overall Study|Lost to Follow-up|4|||
149848588|NCT02286466|540573358|FG000|Overall Study|Declined Clinician Assessment|0|||
149848589|NCT02286466|540573359|FG001|Overall Study|Declined Clinician Assessment|1|||
149848590|NCT00835081|540573360|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149848591|NCT00835081|540573361|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149848592|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
149848593|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
149848594|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
149848595|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
149848596|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
149848597|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
149848598|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
149848599|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
149848600|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
149848601|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
149848602|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
149848603|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
149848604|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
149848605|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
149957240|NCT05061706|540977444|FG001|Overall Study|Adverse Event|1|||
149957241|NCT05061706|540977443|FG000|Overall Study|Lack of Efficacy|0|||
149957242|NCT05061706|540977444|FG001|Overall Study|Lack of Efficacy|1|||
150288494|NCT02425826|542189299|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
150288495|NCT02425826|542189297|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
149957243|NCT05061706|540977443|FG000|Overall Study|Lost to Follow-up|2|||
149957244|NCT05061706|540977444|FG001|Overall Study|Lost to Follow-up|2|||
149957245|NCT05061706|540977443|FG000|Overall Study|Protocol Violation|3|||
149957246|NCT05061706|540977444|FG001|Overall Study|Protocol Violation|1|||
149957247|NCT05061706|540977443|FG000|Overall Study|Withdrawal by Subject|3|||
149957248|NCT05061706|540977444|FG001|Overall Study|Withdrawal by Subject|9|||
149957249|NCT02181738|540977453|FG000|Overall Study|Participant Withdrew Consent|2|||
149957250|NCT02181738|540977454|FG001|Overall Study|Participant Withdrew Consent|1|||
149957251|NCT02181738|540977455|FG002|Overall Study|Participant Withdrew Consent|1|||
149848606|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
149848607|NCT01139762|540573362|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
149957252|NCT02181738|540977456|FG003|Overall Study|Participant Withdrew Consent|1|||
149848608|NCT01139762|540573363|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
149848609|NCT01139762|540573364|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
149848610|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
150288496|NCT02425826|542189298|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
150288497|NCT02425826|542189299|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
150288498|NCT00879697|542189302|FG000|Overall Study|Physician Decision|2|||
150288499|NCT00879697|542189303|FG001|Overall Study|Physician Decision|2|||
150288500|NCT02500121|542189304|FG000|Overall Study|Lost to Follow-up|0|||
150288501|NCT02500121|542189305|FG001|Overall Study|Lost to Follow-up|1|||
150288502|NCT02500121|542189304|FG000|Overall Study|Withdrawal by Subject|1|||
150288503|NCT02500121|542189305|FG001|Overall Study|Withdrawal by Subject|1|||
150288504|NCT02500121|542189304|FG000|Overall Study|Death|26|||
150288505|NCT02500121|542189305|FG001|Overall Study|Death|24|||
149848611|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
150288506|NCT01430455|542189310|FG000|Overall Study|Withdrawal by Subject|1|||
150288507|NCT01430455|542189310|FG000|Overall Study|Switched to follow-up phase|1|||
149848612|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
149848613|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Death|0|||
149848614|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Death|1|||
149848615|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Death|1|||
149848616|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
149848617|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
149848618|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
150288508|NCT01425008|542189312|FG000|Dose Escalation Phase|Progressive Disease|2|||
150288509|NCT01425008|542189313|FG001|Dose Escalation Phase|Progressive Disease|3|||
150288510|NCT01425008|542189314|FG002|Dose Escalation Phase|Progressive Disease|2|||
150288511|NCT01425008|542189315|FG003|Dose Escalation Phase|Progressive Disease|3|||
150288512|NCT01425008|542189316|FG004|Dose Escalation Phase|Progressive Disease|5|||
150288513|NCT01425008|542189317|FG005|Dose Escalation Phase|Progressive Disease|4|||
149848619|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
149848620|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
149957253|NCT02181738|540977453|FG000|Overall Study|Lost to Follow-up|1|||
149957254|NCT02181738|540977454|FG001|Overall Study|Lost to Follow-up|2|||
149957255|NCT02181738|540977455|FG002|Overall Study|Lost to Follow-up|1|||
149957256|NCT02181738|540977456|FG003|Overall Study|Lost to Follow-up|1|||
149957257|NCT02181738|540977453|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
149957258|NCT02181738|540977454|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
149957259|NCT02181738|540977455|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
149957260|NCT02181738|540977456|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
149957261|NCT02181738|540977453|FG000|Overall Study|Poor/Non-Compliance|1|||
149957262|NCT02181738|540977454|FG001|Overall Study|Poor/Non-Compliance|0|||
149957263|NCT02181738|540977455|FG002|Overall Study|Poor/Non-Compliance|2|||
150288514|NCT01425008|542189318|FG006|Dose Escalation Phase|Progressive Disease|0|||
150288515|NCT01425008|542189319|FG007|Dose Escalation Phase|Progressive Disease|2|||
150288516|NCT01425008|542189320|FG008|Dose Escalation Phase|Progressive Disease|6|||
149848621|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
149848622|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
149957264|NCT02181738|540977456|FG003|Overall Study|Poor/Non-Compliance|1|||
149957265|NCT02181738|540977453|FG000|Overall Study|Disease Progression|28|||
149957266|NCT02181738|540977454|FG001|Overall Study|Disease Progression|35|||
149957267|NCT02181738|540977455|FG002|Overall Study|Disease Progression|40|||
149957268|NCT02181738|540977456|FG003|Overall Study|Disease Progression|0|||
150288517|NCT01425008|542189321|FG009|Dose Escalation Phase|Progressive Disease|2|||
150288518|NCT01425008|542189322|FG010|Dose Escalation Phase|Progressive Disease|0|||
150288519|NCT01425008|542189323|FG011|Dose Escalation Phase|Progressive Disease|0|||
150288520|NCT01425008|542189324|FG012|Dose Escalation Phase|Progressive Disease|0|||
149848623|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
149848624|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
149848625|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
149848626|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
149848627|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
149848628|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
149848629|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
149848630|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
149848631|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
149848632|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
149848633|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
149848634|NCT01139762|540573362|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
149848635|NCT01139762|540573363|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
149957269|NCT02181738|540977453|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
149957270|NCT02181738|540977454|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
149957271|NCT02181738|540977455|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
149957272|NCT02181738|540977456|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
149957273|NCT02181738|540977453|FG000|Overall Study|Study Drug Toxicity|6|||
149957274|NCT02181738|540977454|FG001|Overall Study|Study Drug Toxicity|11|||
149957275|NCT02181738|540977455|FG002|Overall Study|Study Drug Toxicity|8|||
149957276|NCT02181738|540977456|FG003|Overall Study|Study Drug Toxicity|1|||
150288521|NCT01425008|542189325|FG013|Dose Escalation Phase|Progressive Disease|0|||
150288522|NCT01425008|542189326|FG014|Dose Escalation Phase|Progressive Disease|0|||
150288523|NCT01425008|542189327|FG015|Dose Escalation Phase|Progressive Disease|0|||
150288524|NCT01425008|542189328|FG016|Dose Escalation Phase|Progressive Disease|0|||
150288525|NCT01425008|542189329|FG017|Dose Escalation Phase|Progressive Disease|0|||
150288526|NCT01425008|542189330|FG018|Dose Escalation Phase|Progressive Disease|0|||
150288527|NCT01425008|542189312|FG000|Dose Escalation Phase|Adverse Event|2|||
150288528|NCT01425008|542189313|FG001|Dose Escalation Phase|Adverse Event|0|||
150288529|NCT01425008|542189314|FG002|Dose Escalation Phase|Adverse Event|0|||
150288530|NCT01425008|542189315|FG003|Dose Escalation Phase|Adverse Event|0|||
150288531|NCT01425008|542189316|FG004|Dose Escalation Phase|Adverse Event|0|||
150288532|NCT01425008|542189317|FG005|Dose Escalation Phase|Adverse Event|2|||
150288533|NCT01425008|542189318|FG006|Dose Escalation Phase|Adverse Event|0|||
149957277|NCT02181738|540977453|FG000|Overall Study|Other Reasons|14|||
149957278|NCT02181738|540977454|FG001|Overall Study|Other Reasons|16|||
149957279|NCT02181738|540977455|FG002|Overall Study|Other Reasons|28|||
149957280|NCT02181738|540977456|FG003|Overall Study|Other Reasons|0|||
149957281|NCT02181738|540977453|FG000|Overall Study|Maximum Clinical Benefit|3|||
149957282|NCT02181738|540977454|FG001|Overall Study|Maximum Clinical Benefit|0|||
149957283|NCT02181738|540977455|FG002|Overall Study|Maximum Clinical Benefit|1|||
149957284|NCT02181738|540977456|FG003|Overall Study|Maximum Clinical Benefit|0|||
149957285|NCT02181738|540977453|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
149957286|NCT02181738|540977454|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
149957287|NCT02181738|540977455|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
149957288|NCT02181738|540977456|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149957289|NCT01668537|540977457|FG000|Overall Study|Request to Discontinue Prematurely|1|||
149957290|NCT01668537|540977458|FG001|Overall Study|Request to Discontinue Prematurely|1|||
149957291|NCT01668537|540977457|FG000|Overall Study|Subject unwilling/unable to comply|5|||
149957292|NCT01668537|540977458|FG001|Overall Study|Subject unwilling/unable to comply|0|||
149957293|NCT01668537|540977457|FG000|Overall Study|Reason Precludes Participation|1|||
149957294|NCT01668537|540977458|FG001|Overall Study|Reason Precludes Participation|0|||
149957295|NCT01668537|540977457|FG000|Overall Study|Lost to Follow-up|13|||
149957296|NCT01668537|540977458|FG001|Overall Study|Lost to Follow-up|6|||
149957297|NCT01668537|540977457|FG000|Overall Study|Other|2|||
149957298|NCT01668537|540977458|FG001|Overall Study|Other|3|||
149957299|NCT00191152|540977461|FG000|Initial Treatment|Adverse Event|43|||
149957300|NCT00191152|540977462|FG001|Initial Treatment|Adverse Event|67|||
150288534|NCT01425008|542189319|FG007|Dose Escalation Phase|Adverse Event|0|||
150288535|NCT01425008|542189320|FG008|Dose Escalation Phase|Adverse Event|2|||
150288536|NCT01425008|542189321|FG009|Dose Escalation Phase|Adverse Event|0|||
150288537|NCT01425008|542189322|FG010|Dose Escalation Phase|Adverse Event|0|||
149957301|NCT00191152|540977461|FG000|Initial Treatment|Physician Decision|40|||
150288538|NCT01425008|542189323|FG011|Dose Escalation Phase|Adverse Event|0|||
150288539|NCT01425008|542189324|FG012|Dose Escalation Phase|Adverse Event|0|||
150288540|NCT01425008|542189325|FG013|Dose Escalation Phase|Adverse Event|0|||
150288541|NCT01425008|542189326|FG014|Dose Escalation Phase|Adverse Event|0|||
150288542|NCT01425008|542189327|FG015|Dose Escalation Phase|Adverse Event|0|||
150288543|NCT01425008|542189328|FG016|Dose Escalation Phase|Adverse Event|0|||
150288544|NCT01425008|542189329|FG017|Dose Escalation Phase|Adverse Event|0|||
150288545|NCT01425008|542189330|FG018|Dose Escalation Phase|Adverse Event|0|||
150288546|NCT01425008|542189312|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288547|NCT01425008|542189313|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288548|NCT01425008|542189314|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288549|NCT01425008|542189315|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288550|NCT01425008|542189316|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
150288551|NCT01425008|542189317|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288552|NCT01425008|542189318|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
150288553|NCT01425008|542189319|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
150288554|NCT01425008|542189320|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
150288555|NCT01425008|542189321|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288556|NCT01425008|542189322|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288557|NCT01425008|542189323|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288558|NCT01425008|542189324|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150037037|NCT04596267|541277040|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
150037038|NCT00071058|541277041|FG000|Overall Study|brain tumor-removed from study|1|||
150037039|NCT02000440|541277042|FG000|Overall Study|Adverse Event|3|||
150037040|NCT02000440|541277042|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
150037041|NCT00871975|541277043|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
150037042|NCT00871975|541277043|FG000|Overall Study|Catheters could not be inserted|1|||
150037043|NCT00871975|541277043|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
150037044|NCT00871975|541277043|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
150037045|NCT01210313|541277046|FG000|Overall Study|Withdrawal by Subject|3|||
150037046|NCT01210313|541277046|FG000|Overall Study|Adverse Event|2|||
150037047|NCT01210313|541277046|FG000|Overall Study|Distant recurrence|4|||
150037048|NCT01210313|541277046|FG000|Overall Study|Non-compliance|7|||
150037049|NCT00870740|541277049|FG000|Overall Study|Adverse Event|2|||
150037050|NCT00870740|541277050|FG001|Overall Study|Adverse Event|1|||
150037051|NCT00870740|541277051|FG002|Overall Study|Adverse Event|3|||
150037052|NCT00870740|541277052|FG003|Overall Study|Adverse Event|2|||
150037053|NCT00870740|541277053|FG004|Overall Study|Adverse Event|1|||
150037054|NCT00870740|541277054|FG005|Overall Study|Adverse Event|6|||
150037055|NCT00870740|541277049|FG000|Overall Study|Consent Withdrawn|6|||
150037056|NCT00870740|541277050|FG001|Overall Study|Consent Withdrawn|3|||
150037057|NCT00870740|541277051|FG002|Overall Study|Consent Withdrawn|4|||
150037058|NCT00870740|541277052|FG003|Overall Study|Consent Withdrawn|6|||
150037059|NCT00870740|541277053|FG004|Overall Study|Consent Withdrawn|6|||
150037060|NCT00870740|541277054|FG005|Overall Study|Consent Withdrawn|5|||
150037061|NCT00870740|541277049|FG000|Overall Study|Investigator Decision|2|||
150037062|NCT00870740|541277050|FG001|Overall Study|Investigator Decision|0|||
150037063|NCT00870740|541277051|FG002|Overall Study|Investigator Decision|1|||
150037064|NCT00870740|541277052|FG003|Overall Study|Investigator Decision|0|||
150037065|NCT00870740|541277053|FG004|Overall Study|Investigator Decision|0|||
150037066|NCT00870740|541277054|FG005|Overall Study|Investigator Decision|0|||
150037067|NCT00870740|541277049|FG000|Overall Study|Subject Non-compliance|0|||
150037068|NCT00870740|541277050|FG001|Overall Study|Subject Non-compliance|0|||
150037069|NCT00870740|541277051|FG002|Overall Study|Subject Non-compliance|0|||
150037070|NCT00870740|541277052|FG003|Overall Study|Subject Non-compliance|0|||
150037071|NCT00870740|541277053|FG004|Overall Study|Subject Non-compliance|0|||
150037072|NCT00870740|541277054|FG005|Overall Study|Subject Non-compliance|1|||
150037073|NCT00870740|541277049|FG000|Overall Study|Death|0|||
150037074|NCT00870740|541277050|FG001|Overall Study|Death|0|||
150037075|NCT00870740|541277051|FG002|Overall Study|Death|0|||
150037076|NCT00870740|541277052|FG003|Overall Study|Death|0|||
150037077|NCT00870740|541277053|FG004|Overall Study|Death|1|||
150037078|NCT00870740|541277054|FG005|Overall Study|Death|0|||
150037079|NCT00870740|541277049|FG000|Overall Study|Other|2|||
150037080|NCT00870740|541277050|FG001|Overall Study|Other|5|||
150288559|NCT01425008|542189325|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288560|NCT01425008|542189326|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150037081|NCT00870740|541277051|FG002|Overall Study|Other|2|||
150037082|NCT00870740|541277052|FG003|Overall Study|Other|4|||
150037083|NCT00870740|541277053|FG004|Overall Study|Other|3|||
150037084|NCT00870740|541277054|FG005|Overall Study|Other|5|||
150037085|NCT03592186|541277061|FG000|Overall Study|Withdrawal by Subject|1|||
150037086|NCT03592186|541277062|FG001|Overall Study|Withdrawal by Subject|0|||
150288561|NCT01425008|542189327|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288562|NCT01425008|542189328|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288563|NCT01425008|542189329|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150288564|NCT01425008|542189330|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
150037087|NCT03592186|541277061|FG000|Overall Study|Lost to Follow-up|16|||
150288565|NCT01425008|542189312|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
150037088|NCT03592186|541277062|FG001|Overall Study|Lost to Follow-up|11|||
150037089|NCT00307801|541277063|FG000|Overall Study|Adverse Event|12|||
150037090|NCT00307801|541277064|FG001|Overall Study|Adverse Event|4|||
150037091|NCT00307801|541277063|FG000|Overall Study|Withdrawal by Subject|9|||
150037092|NCT00307801|541277064|FG001|Overall Study|Withdrawal by Subject|4|||
150288566|NCT01425008|542189313|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
150288567|NCT01425008|542189314|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
150288568|NCT01425008|542189315|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
150288569|NCT01425008|542189316|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
150288570|NCT01425008|542189317|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
150288571|NCT01425008|542189318|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
150288572|NCT01425008|542189319|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
150288573|NCT01425008|542189320|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
150288574|NCT01425008|542189321|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
150288575|NCT01425008|542189322|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
150288576|NCT01425008|542189323|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
149848636|NCT01139762|540573364|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
149848637|NCT01675596|540573365|FG000|Overall Study|Death|6|||
149848638|NCT01675596|540573365|FG000|Overall Study|Exit with other reason|1|||
149848639|NCT01675596|540573365|FG000|Overall Study|Missed Visit|1|||
149848640|NCT04236596|540573366|FG000|Overall Study|Withdrawal by Subject|1|||
149848641|NCT04236596|540573366|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
149848642|NCT04236596|540573366|FG000|Overall Study|Participants did not receive implant at all|4|||
149848643|NCT01120899|540574415|FG000|Overall Study|Withdrawal by Subject|3|||
149848644|NCT02664415|540574416|FG000|Overall Study|Adverse Event|1|||
149848645|NCT02664415|540574417|FG001|Overall Study|Adverse Event|0|||
149848646|NCT01151280|540574418|FG000|Overall Study|Adverse Event|1|||
149848647|NCT01151280|540574418|FG000|Overall Study|Lack of Efficacy|3|||
149848648|NCT00183196|540574419|FG000|Overall Study|Withdrawal by Subject|18|||
149848649|NCT00183196|540574420|FG001|Overall Study|Withdrawal by Subject|11|||
149848650|NCT00183196|540574421|FG002|Overall Study|Withdrawal by Subject|13|||
149848651|NCT00183196|540574419|FG000|Overall Study|Adverse Event|1|||
149848652|NCT00183196|540574420|FG001|Overall Study|Adverse Event|2|||
149848653|NCT00183196|540574421|FG002|Overall Study|Adverse Event|2|||
149848654|NCT00183196|540574419|FG000|Overall Study|Legal event|1|||
149848655|NCT00183196|540574420|FG001|Overall Study|Legal event|1|||
149848656|NCT00183196|540574421|FG002|Overall Study|Legal event|1|||
149848657|NCT00183196|540574419|FG000|Overall Study|Required more intensive care|0|||
149848658|NCT00183196|540574420|FG001|Overall Study|Required more intensive care|1|||
149848659|NCT00183196|540574421|FG002|Overall Study|Required more intensive care|2|||
149848660|NCT03387462|540574422|FG000|Overall Study|Lost to Follow-up|1|||
149848661|NCT01460628|540574423|FG000|Overall Study|Adverse Event|3|||
149848662|NCT01460628|540574423|FG000|Overall Study|Withdrawal by Subject|2|||
149848663|NCT01664039|540574427|FG000|Overall Study|Adverse Event|3|||
149848664|NCT01664039|540574428|FG001|Overall Study|Adverse Event|4|||
149848665|NCT01664039|540574427|FG000|Overall Study|Lost to Follow-up|1|||
149848666|NCT01664039|540574428|FG001|Overall Study|Lost to Follow-up|1|||
149848667|NCT01664039|540574427|FG000|Overall Study|Withdrawal by Subject|1|||
149848668|NCT01664039|540574428|FG001|Overall Study|Withdrawal by Subject|3|||
149848669|NCT01664039|540574427|FG000|Overall Study|Noncompliance|1|||
149848670|NCT01664039|540574428|FG001|Overall Study|Noncompliance|1|||
149848671|NCT01853176|540574429|FG000|Overall Study|Study terminated|4|||
149848672|NCT01853176|540574430|FG001|Overall Study|Study terminated|0|||
149848673|NCT00874822|540574431|FG000|Overall Study|excluded by criteria|8|||
149848674|NCT02854800|540574432|FG000|Overall Study|Protocol Violation|16|||
149848675|NCT02854800|540574433|FG001|Overall Study|Protocol Violation|11|||
149848676|NCT02854800|540574434|FG002|Overall Study|Protocol Violation|3|||
149848677|NCT02854800|540574432|FG000|Overall Study|Withdrawal by Subject|4|||
149848678|NCT02854800|540574433|FG001|Overall Study|Withdrawal by Subject|2|||
149848679|NCT02854800|540574434|FG002|Overall Study|Withdrawal by Subject|3|||
149848680|NCT00875524|540574437|FG000|Overall Study|Serious adverse event|0|||
149848681|NCT00875524|540574438|FG001|Overall Study|Serious adverse event|1|||
149848682|NCT00875524|540574437|FG000|Overall Study|Protocol Violation|4|||
149848683|NCT00875524|540574438|FG001|Overall Study|Protocol Violation|0|||
149848684|NCT00875524|540574437|FG000|Overall Study|Lost to Follow-up|1|||
149848685|NCT00875524|540574438|FG001|Overall Study|Lost to Follow-up|0|||
149848686|NCT00875524|540574437|FG000|Overall Study|Withdrawal by Subject|3|||
149848687|NCT00875524|540574438|FG001|Overall Study|Withdrawal by Subject|5|||
149848688|NCT01370863|540574439|FG000|Overall Study|Adverse Event|1|||
149848689|NCT01370863|540574440|FG001|Overall Study|Adverse Event|1|||
149848690|NCT01370863|540574439|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
149848691|NCT01370863|540574440|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
149848692|NCT01370863|540574439|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149848693|NCT01370863|540574440|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149848694|NCT03504085|540574445|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
149848695|NCT03504085|540574446|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
149848696|NCT03504085|540574445|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
149848697|NCT03504085|540574446|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
149848698|NCT01926119|540574460|FG000|Overall Study|Withdrawal by Subject|1|||
149848699|NCT02654145|540574461|FG000|Overall Study|Lack of Efficacy|1|||
149957302|NCT00191152|540977462|FG001|Initial Treatment|Physician Decision|31|||
149957303|NCT00191152|540977461|FG000|Initial Treatment|Withdrawal by Subject|40|||
149957304|NCT00191152|540977462|FG001|Initial Treatment|Withdrawal by Subject|28|||
149957305|NCT00191152|540977461|FG000|Initial Treatment|Lost to Follow-up|0|||
149957306|NCT00191152|540977462|FG001|Initial Treatment|Lost to Follow-up|6|||
149848700|NCT02654145|540574461|FG000|Overall Study|Protocol Violation|1|||
149848701|NCT02654145|540574461|FG000|Overall Study|Withdrawal by Subject|5|||
149848702|NCT00354835|540574462|FG000|Overall Study|Death|1|||
149848703|NCT00354835|540574463|FG001|Overall Study|Death|1|||
149848704|NCT00354835|540574462|FG000|Overall Study|Physician Decision|8|||
149848705|NCT00354835|540574463|FG001|Overall Study|Physician Decision|13|||
149848706|NCT00354835|540574462|FG000|Overall Study|Withdrawal by Subject|2|||
149848707|NCT00354835|540574463|FG001|Overall Study|Withdrawal by Subject|1|||
149848708|NCT00354835|540574462|FG000|Overall Study|Ineligible|17|||
149848709|NCT00354835|540574463|FG001|Overall Study|Ineligible|16|||
149848710|NCT00354835|540574462|FG000|Overall Study|Disease progression or relapse|15|||
149848711|NCT00354835|540574463|FG001|Overall Study|Disease progression or relapse|22|||
149848712|NCT00354835|540574462|FG000|Overall Study|Adverse Event|6|||
149848713|NCT00354835|540574463|FG001|Overall Study|Adverse Event|0|||
149848714|NCT00354835|540574462|FG000|Overall Study|Refusal of further therapy|3|||
149848715|NCT00354835|540574463|FG001|Overall Study|Refusal of further therapy|8|||
149848716|NCT00645853|540574464|FG000|Overall Study|Adverse Event|18|||
149848717|NCT00645853|540574465|FG001|Overall Study|Adverse Event|7|||
149848718|NCT00645853|540574464|FG000|Overall Study|AZ study closure in Hungary|60|||
149848719|NCT00645853|540574465|FG001|Overall Study|AZ study closure in Hungary|40|||
149848720|NCT00645853|540574464|FG000|Overall Study|Withdrawal by Subject|5|||
149848721|NCT00645853|540574465|FG001|Overall Study|Withdrawal by Subject|2|||
149848722|NCT00645853|540574464|FG000|Overall Study|Protocol Violation|0|||
149848723|NCT00645853|540574465|FG001|Overall Study|Protocol Violation|2|||
149848724|NCT00645853|540574464|FG000|Overall Study|Discontinuation criteria|2|||
149848725|NCT00645853|540574465|FG001|Overall Study|Discontinuation criteria|2|||
149848726|NCT00645853|540574464|FG000|Overall Study|recall of ICF, planned operation, death|7|||
149848727|NCT00645853|540574465|FG001|Overall Study|recall of ICF, planned operation, death|4|||
149848728|NCT02637141|540574468|FG000|Overall Study|Adverse Event|1|||
149848729|NCT02637141|540574469|FG001|Overall Study|Adverse Event|1|||
149848730|NCT02637141|540574470|FG002|Overall Study|Adverse Event|0|||
149848731|NCT02637141|540574468|FG000|Overall Study|Withdrawal by Subject|1|||
149848732|NCT02637141|540574469|FG001|Overall Study|Withdrawal by Subject|1|||
149848733|NCT02637141|540574470|FG002|Overall Study|Withdrawal by Subject|1|||
149848734|NCT03885934|540574471|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
149848735|NCT03885934|540574472|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
149848736|NCT03885934|540574473|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
149848737|NCT03885934|540574474|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
149848738|NCT03885934|540574475|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
149848739|NCT03885934|540574476|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
149848740|NCT03255980|540574477|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
149848741|NCT03255980|540574478|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
149848742|NCT03255980|540574479|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
149848743|NCT03255980|540574480|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
149848744|NCT03255980|540574477|FG000|Overall Study|Adverse Event|1|||
149848745|NCT03255980|540574478|FG001|Overall Study|Adverse Event|1|||
149848746|NCT03255980|540574479|FG002|Overall Study|Adverse Event|0|||
149848747|NCT03255980|540574480|FG003|Overall Study|Adverse Event|1|||
149848748|NCT03255980|540574477|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
149848749|NCT03255980|540574478|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
149848750|NCT03255980|540574479|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
149848751|NCT03255980|540574480|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
149848752|NCT03255980|540574477|FG000|Overall Study|Lost to Follow-up|1|||
149848753|NCT03255980|540574478|FG001|Overall Study|Lost to Follow-up|1|||
149848754|NCT03255980|540574479|FG002|Overall Study|Lost to Follow-up|0|||
149848755|NCT03255980|540574480|FG003|Overall Study|Lost to Follow-up|3|||
149848756|NCT03255980|540574477|FG000|Overall Study|Withdrawal by Subject|0|||
150288577|NCT01425008|542189324|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
150288578|NCT01425008|542189325|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
150288579|NCT01425008|542189326|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
150288580|NCT01425008|542189327|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
150288581|NCT01425008|542189328|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
150288582|NCT01425008|542189329|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
150288583|NCT01425008|542189330|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
150288584|NCT01425008|542189312|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288585|NCT01425008|542189313|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288586|NCT01425008|542189314|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
150288587|NCT01425008|542189315|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288588|NCT01425008|542189316|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288589|NCT01425008|542189317|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288590|NCT01425008|542189318|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288591|NCT01425008|542189319|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288592|NCT01425008|542189320|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
150288593|NCT01425008|542189321|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
150288594|NCT01425008|542189322|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288595|NCT01425008|542189323|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288596|NCT01425008|542189324|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288597|NCT01425008|542189325|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288598|NCT01425008|542189326|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288599|NCT01425008|542189327|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288600|NCT01425008|542189328|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288601|NCT01425008|542189329|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288602|NCT01425008|542189330|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
150288603|NCT01425008|542189312|FG000|Dose Escalation Phase|Other|0|||
150288604|NCT01425008|542189313|FG001|Dose Escalation Phase|Other|0|||
150288605|NCT01425008|542189314|FG002|Dose Escalation Phase|Other|0|||
150288606|NCT01425008|542189315|FG003|Dose Escalation Phase|Other|0|||
150288607|NCT01425008|542189316|FG004|Dose Escalation Phase|Other|0|||
150288608|NCT01425008|542189317|FG005|Dose Escalation Phase|Other|0|||
150288609|NCT01425008|542189318|FG006|Dose Escalation Phase|Other|0|||
150288610|NCT01425008|542189319|FG007|Dose Escalation Phase|Other|0|||
150288611|NCT01425008|542189320|FG008|Dose Escalation Phase|Other|1|||
150288612|NCT01425008|542189321|FG009|Dose Escalation Phase|Other|0|||
150288613|NCT01425008|542189322|FG010|Dose Escalation Phase|Other|0|||
150288614|NCT01425008|542189323|FG011|Dose Escalation Phase|Other|0|||
150288615|NCT01425008|542189324|FG012|Dose Escalation Phase|Other|0|||
150288616|NCT01425008|542189325|FG013|Dose Escalation Phase|Other|0|||
150288617|NCT01425008|542189326|FG014|Dose Escalation Phase|Other|0|||
150288618|NCT01425008|542189327|FG015|Dose Escalation Phase|Other|0|||
150288619|NCT01425008|542189328|FG016|Dose Escalation Phase|Other|0|||
150288620|NCT01425008|542189329|FG017|Dose Escalation Phase|Other|0|||
150288621|NCT01425008|542189330|FG018|Dose Escalation Phase|Other|0|||
150288622|NCT01425008|542189312|FG000|Dose Expansion Phase|Progressive Disease|0|||
150288623|NCT01425008|542189313|FG001|Dose Expansion Phase|Progressive Disease|0|||
149848757|NCT03255980|540574478|FG001|Overall Study|Withdrawal by Subject|1|||
150288624|NCT01425008|542189314|FG002|Dose Expansion Phase|Progressive Disease|0|||
150288625|NCT01425008|542189315|FG003|Dose Expansion Phase|Progressive Disease|0|||
150288626|NCT01425008|542189316|FG004|Dose Expansion Phase|Progressive Disease|0|||
150288627|NCT01425008|542189317|FG005|Dose Expansion Phase|Progressive Disease|0|||
150288628|NCT01425008|542189318|FG006|Dose Expansion Phase|Progressive Disease|0|||
150288629|NCT01425008|542189319|FG007|Dose Expansion Phase|Progressive Disease|0|||
150288630|NCT01425008|542189320|FG008|Dose Expansion Phase|Progressive Disease|0|||
150288631|NCT01425008|542189321|FG009|Dose Expansion Phase|Progressive Disease|0|||
150288632|NCT01425008|542189322|FG010|Dose Expansion Phase|Progressive Disease|10|||
150288633|NCT01425008|542189323|FG011|Dose Expansion Phase|Progressive Disease|4|||
150288634|NCT01425008|542189324|FG012|Dose Expansion Phase|Progressive Disease|12|||
150288635|NCT01425008|542189325|FG013|Dose Expansion Phase|Progressive Disease|1|||
150288636|NCT01425008|542189326|FG014|Dose Expansion Phase|Progressive Disease|5|||
149848758|NCT03255980|540574479|FG002|Overall Study|Withdrawal by Subject|0|||
149848759|NCT03255980|540574480|FG003|Overall Study|Withdrawal by Subject|3|||
149848760|NCT01597791|540574481|FG000|Overall Study|Physician Decision|2|||
149848761|NCT01597791|540574482|FG001|Overall Study|Physician Decision|1|||
149848762|NCT01597791|540574481|FG000|Overall Study|Cesarean Section|6|||
150288637|NCT01425008|542189327|FG015|Dose Expansion Phase|Progressive Disease|8|||
150288638|NCT01425008|542189328|FG016|Dose Expansion Phase|Progressive Disease|9|||
150288639|NCT01425008|542189329|FG017|Dose Expansion Phase|Progressive Disease|2|||
150288640|NCT01425008|542189330|FG018|Dose Expansion Phase|Progressive Disease|10|||
150288641|NCT01425008|542189312|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
150288642|NCT01425008|542189313|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
150288643|NCT01425008|542189314|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
150288644|NCT01425008|542189315|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
150288645|NCT01425008|542189316|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
150288646|NCT01425008|542189317|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
150288647|NCT01425008|542189318|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
150288648|NCT01425008|542189319|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
150288649|NCT01425008|542189320|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
150288650|NCT01425008|542189321|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
150288651|NCT01425008|542189322|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
150288652|NCT01425008|542189323|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
150288653|NCT01425008|542189324|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
150288654|NCT01425008|542189325|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
150288655|NCT01425008|542189326|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
150288656|NCT01425008|542189327|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
150288657|NCT01425008|542189328|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
150288658|NCT01425008|542189329|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
150288659|NCT01425008|542189330|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
150288660|NCT01425008|542189312|FG000|Dose Expansion Phase|Other|0|||
150288661|NCT01425008|542189313|FG001|Dose Expansion Phase|Other|0|||
150288662|NCT01425008|542189314|FG002|Dose Expansion Phase|Other|0|||
150288663|NCT01425008|542189315|FG003|Dose Expansion Phase|Other|0|||
150288664|NCT01425008|542189316|FG004|Dose Expansion Phase|Other|0|||
150288665|NCT01425008|542189317|FG005|Dose Expansion Phase|Other|0|||
149848763|NCT01597791|540574482|FG001|Overall Study|Cesarean Section|7|||
149848764|NCT01597791|540574481|FG000|Overall Study|Subject withdrawal|0|||
149848765|NCT01597791|540574482|FG001|Overall Study|Subject withdrawal|1|||
149848766|NCT01597791|540574481|FG000|Overall Study|Protocol Violation|0|||
149848767|NCT01597791|540574482|FG001|Overall Study|Protocol Violation|1|||
149848768|NCT01728116|540574485|FG000|Overall Study|Sponsor Terminated Study|106|||
149848769|NCT01728116|540574486|FG001|Overall Study|Sponsor Terminated Study|35|||
149848770|NCT01728116|540574485|FG000|Overall Study|Withdrawal by Subject|16|||
149848771|NCT01728116|540574486|FG001|Overall Study|Withdrawal by Subject|9|||
149848772|NCT01728116|540574485|FG000|Overall Study|Adverse Event|13|||
149848773|NCT01728116|540574486|FG001|Overall Study|Adverse Event|0|||
149848774|NCT01728116|540574485|FG000|Overall Study|Procedure/device failure|7|||
149848775|NCT01728116|540574486|FG001|Overall Study|Procedure/device failure|0|||
149848776|NCT01728116|540574485|FG000|Overall Study|Lost to Follow-up|9|||
149848777|NCT01728116|540574486|FG001|Overall Study|Lost to Follow-up|2|||
149848778|NCT01728116|540574485|FG000|Overall Study|Physician Decision|2|||
149848779|NCT01728116|540574486|FG001|Overall Study|Physician Decision|0|||
149848780|NCT01728116|540574485|FG000|Overall Study|Subject Non-Compliance|2|||
149848781|NCT01728116|540574486|FG001|Overall Study|Subject Non-Compliance|0|||
149848782|NCT01728116|540574485|FG000|Overall Study|Inter-current finding at procedure|1|||
149848783|NCT01728116|540574486|FG001|Overall Study|Inter-current finding at procedure|0|||
149848784|NCT01728116|540574485|FG000|Overall Study|Incorrectly enrolled in Study|0|||
149848785|NCT01728116|540574486|FG001|Overall Study|Incorrectly enrolled in Study|1|||
149848786|NCT01728116|540574485|FG000|Overall Study|various not noted previously|5|||
149848787|NCT01728116|540574486|FG001|Overall Study|various not noted previously|0|||
149848788|NCT03277248|540574487|FG000|Overall Study|Adverse Event|3|||
149848789|NCT03277248|540574488|FG001|Overall Study|Adverse Event|1|||
149848790|NCT03277248|540574487|FG000|Overall Study|Subject Withdrawal of Consent|6|||
149848791|NCT03277248|540574488|FG001|Overall Study|Subject Withdrawal of Consent|23|||
149848792|NCT03277248|540574487|FG000|Overall Study|Investigator/Sponsor Decision|2|||
149848793|NCT03277248|540574488|FG001|Overall Study|Investigator/Sponsor Decision|2|||
149848794|NCT03277248|540574487|FG000|Overall Study|Pregnancy|4|||
149848795|NCT03277248|540574488|FG001|Overall Study|Pregnancy|1|||
149957307|NCT00191152|540977461|FG000|Initial Treatment|Other|18|||
149957308|NCT00191152|540977462|FG001|Initial Treatment|Other|21|||
149957309|NCT00191152|540977461|FG000|Crossover Treatment|Adverse Event|8|||
149957310|NCT00191152|540977462|FG001|Crossover Treatment|Adverse Event|8|||
149957311|NCT00191152|540977461|FG000|Crossover Treatment|Physician Decision|7|||
149957312|NCT00191152|540977462|FG001|Crossover Treatment|Physician Decision|7|||
149957313|NCT00191152|540977461|FG000|Crossover Treatment|Withdrawal by Subject|6|||
150172755|NCT00857649|541768085|FG001|Overall Study|Nursing Home Placement|9|||
150288666|NCT01425008|542189318|FG006|Dose Expansion Phase|Other|0|||
150288667|NCT01425008|542189319|FG007|Dose Expansion Phase|Other|0|||
149848796|NCT03277248|540574487|FG000|Overall Study|Lost to Follow-up|0|||
149848797|NCT03277248|540574488|FG001|Overall Study|Lost to Follow-up|2|||
149848798|NCT03277248|540574487|FG000|Overall Study|Lack of Efficacy|0|||
149848799|NCT03277248|540574488|FG001|Overall Study|Lack of Efficacy|2|||
149848800|NCT03277248|540574487|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
149848801|NCT03277248|540574488|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
149957314|NCT00191152|540977462|FG001|Crossover Treatment|Withdrawal by Subject|9|||
149957315|NCT00191152|540977461|FG000|Crossover Treatment|Lost to Follow-up|2|||
150288668|NCT01425008|542189320|FG008|Dose Expansion Phase|Other|0|||
150288669|NCT01425008|542189321|FG009|Dose Expansion Phase|Other|0|||
149848802|NCT01451541|540574495|FG000|Overall Study|Adverse Event|4|||
149848803|NCT01451541|540574496|FG001|Overall Study|Adverse Event|3|||
149848804|NCT01451541|540574497|FG002|Overall Study|Adverse Event|6|||
149848805|NCT01451541|540574495|FG000|Overall Study|Lack of Efficacy|2|||
149848806|NCT01451541|540574496|FG001|Overall Study|Lack of Efficacy|0|||
149848807|NCT01451541|540574497|FG002|Overall Study|Lack of Efficacy|0|||
149848808|NCT01451541|540574495|FG000|Overall Study|Lost to Follow-up|4|||
149848809|NCT01451541|540574496|FG001|Overall Study|Lost to Follow-up|4|||
149848810|NCT01451541|540574497|FG002|Overall Study|Lost to Follow-up|7|||
149848811|NCT01451541|540574495|FG000|Overall Study|Withdrawal by Subject|15|||
149848812|NCT01451541|540574496|FG001|Overall Study|Withdrawal by Subject|8|||
149848813|NCT01451541|540574497|FG002|Overall Study|Withdrawal by Subject|6|||
149848814|NCT01451541|540574495|FG000|Overall Study|randomization error, noncompliance|11|||
149848815|NCT01451541|540574496|FG001|Overall Study|randomization error, noncompliance|10|||
149848816|NCT01451541|540574497|FG002|Overall Study|randomization error, noncompliance|8|||
149848817|NCT04164758|540574498|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
149848818|NCT04164758|540574499|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
149848819|NCT04164758|540574500|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
149848820|NCT04164758|540574498|FG000|Overall Study|Adverse Event|0|||
149848821|NCT04164758|540574499|FG001|Overall Study|Adverse Event|1|||
149848822|NCT04164758|540574500|FG002|Overall Study|Adverse Event|0|||
149848823|NCT02119936|540574503|FG000|Overall Study|Lost to Follow-up|10|||
149848824|NCT05315713|540574504|FG000|Overall Study|Death|5|||
149848825|NCT05315713|540574504|FG000|Overall Study|Progressive disease|1|||
149848826|NCT05315713|540574504|FG000|Overall Study|Withdrawal by Subject|1|||
149848827|NCT05315713|540574504|FG000|Overall Study|Study terminated by sponsor|1|||
149848828|NCT00757172|540574506|FG000|Overall Study|Withdrawal by Subject|4|||
149848829|NCT00757172|540574506|FG000|Overall Study|Physician Decision|3|||
149848830|NCT00757172|540574506|FG000|Overall Study|Progression|4|||
149848831|NCT03555695|540574509|FG000|Overall Study|Withdrawal by Subject|1|||
149848832|NCT03555695|540574509|FG000|Overall Study|Lost to Follow-up|1|||
149848833|NCT03555695|540574509|FG000|Overall Study|appendicitis (unrelated)|1|||
149848834|NCT03555695|540574509|FG000|Overall Study|pre-existing sciatica|1|||
149848835|NCT01971554|540574510|FG000|Overall Study|Lost to Follow-up|1|||
149848836|NCT01971554|540574511|FG001|Overall Study|Lost to Follow-up|0|||
149848837|NCT01971554|540574512|FG002|Overall Study|Lost to Follow-up|0|||
149848838|NCT01971554|540574513|FG003|Overall Study|Lost to Follow-up|0|||
149848839|NCT01426854|540574514|FG000|Overall Study|Adverse Event|1|||
149848840|NCT01426854|540574515|FG001|Overall Study|Adverse Event|5|||
149848841|NCT01426854|540574514|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
149848842|NCT01426854|540574515|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
149848843|NCT01426854|540574514|FG000|Overall Study|Lost to Follow-up|3|||
149848844|NCT01426854|540574515|FG001|Overall Study|Lost to Follow-up|0|||
149957316|NCT00191152|540977462|FG001|Crossover Treatment|Lost to Follow-up|1|||
149957317|NCT00191152|540977461|FG000|Crossover Treatment|Other|4|||
149957318|NCT00191152|540977462|FG001|Crossover Treatment|Other|3|||
149957319|NCT00114777|540977463|FG000|Randomization to Month 36|Death|10|||
149957320|NCT00114777|540977464|FG001|Randomization to Month 36|Death|4|||
149957321|NCT00114777|540977465|FG002|Randomization to Month 36|Death|3|||
149957322|NCT00114777|540977463|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
149957323|NCT00114777|540977464|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
149957324|NCT00114777|540977465|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
149957325|NCT00114777|540977463|FG000|Randomization to Month 36|Lack of Efficacy|19|||
149957326|NCT00114777|540977464|FG001|Randomization to Month 36|Lack of Efficacy|15|||
149957327|NCT00114777|540977465|FG002|Randomization to Month 36|Lack of Efficacy|17|||
149957328|NCT00114777|540977463|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
149957329|NCT00114777|540977464|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
149957330|NCT00114777|540977465|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
149957331|NCT00114777|540977463|FG000|Randomization to Month 36|Adverse Event|34|||
149957332|NCT00114777|540977464|FG001|Randomization to Month 36|Adverse Event|35|||
149848845|NCT01426854|540574514|FG000|Overall Study|Noncompliance|0|||
149848846|NCT01426854|540574515|FG001|Overall Study|Noncompliance|1|||
149957333|NCT00114777|540977465|FG002|Randomization to Month 36|Adverse Event|44|||
149957334|NCT00114777|540977463|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
149957335|NCT00114777|540977464|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
149957336|NCT00114777|540977465|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
149848847|NCT01426854|540574514|FG000|Overall Study|Treatment Failure|0|||
149848848|NCT01426854|540574515|FG001|Overall Study|Treatment Failure|16|||
149848849|NCT01426854|540574514|FG000|Overall Study|Protocol Deviation|0|||
149848850|NCT01426854|540574515|FG001|Overall Study|Protocol Deviation|1|||
149848851|NCT01426854|540574514|FG000|Overall Study|Other|3|||
149848852|NCT01426854|540574515|FG001|Overall Study|Other|2|||
149848853|NCT01942135|540574519|FG000|Overall Study|Adverse Event|21|||
149957337|NCT00114777|540977463|FG000|Randomization to Month 36|Other|9|||
149957338|NCT00114777|540977464|FG001|Randomization to Month 36|Other|3|||
149848854|NCT01942135|540574520|FG001|Overall Study|Adverse Event|7|||
149848855|NCT01942135|540574519|FG000|Overall Study|Global Deterioration of Health Status|9|||
149848856|NCT01942135|540574520|FG001|Overall Study|Global Deterioration of Health Status|6|||
149848857|NCT01942135|540574519|FG000|Overall Study|Randomized Not Treated|2|||
149848858|NCT01942135|540574520|FG001|Overall Study|Randomized Not Treated|2|||
149848859|NCT01942135|540574519|FG000|Overall Study|Death|2|||
149848860|NCT01942135|540574520|FG001|Overall Study|Death|1|||
149848861|NCT01942135|540574519|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
149848862|NCT01942135|540574520|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
149848863|NCT01942135|540574519|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
149848864|NCT01942135|540574520|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
149848865|NCT01942135|540574519|FG000|Overall Study|Withdrawal by Subject|4|||
149848866|NCT01942135|540574520|FG001|Overall Study|Withdrawal by Subject|3|||
149848867|NCT01942135|540574519|FG000|Overall Study|Protocol Violation|1|||
149848868|NCT01942135|540574520|FG001|Overall Study|Protocol Violation|0|||
149848869|NCT01942135|540574519|FG000|Overall Study|Other|19|||
149848870|NCT01942135|540574520|FG001|Overall Study|Other|4|||
149848871|NCT01499043|540574521|FG000|Overall Study|Progressive disease (radiographic)|2|||
149848872|NCT01499043|540574521|FG000|Overall Study|Progressive disease (clinical)|1|||
149848873|NCT01499043|540574521|FG000|Overall Study|Withdrawal by Subject|2|||
149848874|NCT01499043|540574521|FG000|Overall Study|Adverse Event|1|||
149848875|NCT04203823|540574522|FG000|Overall Study|Withdrawal by Subject|2|||
149848876|NCT04203823|540574523|FG001|Overall Study|Withdrawal by Subject|2|||
149848877|NCT04203823|540574522|FG000|Overall Study|Adverse Event|1|||
149848878|NCT04203823|540574523|FG001|Overall Study|Adverse Event|1|||
149848879|NCT04203823|540574522|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149848880|NCT04203823|540574523|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
149848881|NCT01566435|540574524|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
149848882|NCT03193021|540574525|FG000|Overall Study|Lost to Follow-up|1|||
149848883|NCT03193021|540574526|FG001|Overall Study|Lost to Follow-up|1|||
149848884|NCT02535923|540574527|FG000|Overall Study|Lost to Follow-up|5|||
149848885|NCT02535923|540574528|FG001|Overall Study|Lost to Follow-up|5|||
149848886|NCT02535923|540574527|FG000|Overall Study|Withdrawal by Subject|4|||
149848887|NCT02535923|540574528|FG001|Overall Study|Withdrawal by Subject|3|||
149848888|NCT00685334|540574532|FG000|Overall Study|Withdrawal by Subject|5|||
149848889|NCT00685334|540574533|FG001|Overall Study|Withdrawal by Subject|6|||
149848890|NCT00685334|540574532|FG000|Overall Study|Lost to Follow-up|4|||
149848891|NCT00685334|540574533|FG001|Overall Study|Lost to Follow-up|0|||
149848892|NCT00685334|540574532|FG000|Overall Study|Chose to enter hospital|1|||
149957339|NCT00114777|540977465|FG002|Randomization to Month 36|Other|12|||
149957340|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Death|8|||
149957341|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Death|13|||
149957342|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Death|7|||
149957343|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
149957344|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
149957345|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
149957346|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
149957347|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
149957348|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
149957349|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
149957350|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
149957351|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
149957352|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
149957353|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
149957354|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
149957355|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
149957356|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
149957357|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
149957358|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
149957359|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
149957360|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
149957361|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
149957362|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
149957363|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
149957364|NCT00114777|540977463|FG000|Long-Term Extension to Month 84|Other|2|||
149957365|NCT00114777|540977464|FG001|Long-Term Extension to Month 84|Other|0|||
149957366|NCT00114777|540977465|FG002|Long-Term Extension to Month 84|Other|2|||
149957367|NCT01181128|540977469|FG000|Overall Study|Withdrawal by Subject|2|||
149957368|NCT01181128|540977470|FG001|Overall Study|Withdrawal by Subject|2|||
150288670|NCT01425008|542189322|FG010|Dose Expansion Phase|Other|0|||
150288671|NCT01425008|542189323|FG011|Dose Expansion Phase|Other|0|||
149848893|NCT00685334|540574533|FG001|Overall Study|Chose to enter hospital|1|||
149848894|NCT02957331|540574534|FG000|Overall Study|Protocol Violation|1|||
150288672|NCT01425008|542189324|FG012|Dose Expansion Phase|Other|1|||
150288673|NCT01425008|542189325|FG013|Dose Expansion Phase|Other|0|||
149848895|NCT02957331|540574535|FG001|Overall Study|Protocol Violation|0|||
149848896|NCT01520987|540575950|FG000|Overall Study|Withdrawal by Subject|1|||
149848897|NCT01520987|540575951|FG001|Overall Study|Withdrawal by Subject|0|||
149848898|NCT01520987|540575952|FG002|Overall Study|Withdrawal by Subject|0|||
149848899|NCT01520987|540575953|FG003|Overall Study|Withdrawal by Subject|0|||
149848900|NCT01520987|540575954|FG004|Overall Study|Withdrawal by Subject|0|||
149848901|NCT01520987|540575955|FG005|Overall Study|Withdrawal by Subject|1|||
149848902|NCT01520987|540575956|FG006|Overall Study|Withdrawal by Subject|0|||
149848903|NCT01520987|540575957|FG007|Overall Study|Withdrawal by Subject|0|||
149848904|NCT02005562|540575958|FG000|Overall Study|Death|2|||
149848905|NCT02005562|540575959|FG001|Overall Study|Death|2|||
150288674|NCT01425008|542189326|FG014|Dose Expansion Phase|Other|0|||
150288675|NCT01425008|542189327|FG015|Dose Expansion Phase|Other|0|||
150288676|NCT01425008|542189328|FG016|Dose Expansion Phase|Other|2|||
150288677|NCT01425008|542189329|FG017|Dose Expansion Phase|Other|0|||
150288678|NCT01425008|542189330|FG018|Dose Expansion Phase|Other|4|||
150288679|NCT01425008|542189312|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288680|NCT01425008|542189313|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288681|NCT01425008|542189314|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288682|NCT01425008|542189315|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288683|NCT01425008|542189316|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288684|NCT01425008|542189317|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288685|NCT01425008|542189318|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288686|NCT01425008|542189319|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288687|NCT01425008|542189320|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288688|NCT01425008|542189321|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288689|NCT01425008|542189322|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
149848906|NCT02005562|540575958|FG000|Overall Study|Graft loss|7|||
149848907|NCT02005562|540575959|FG001|Overall Study|Graft loss|6|||
149848908|NCT02005562|540575958|FG000|Overall Study|Withdrawal by Subject|2|||
149848909|NCT02005562|540575959|FG001|Overall Study|Withdrawal by Subject|2|||
149848910|NCT02005562|540575958|FG000|Overall Study|No transplant|1|||
150288690|NCT01425008|542189323|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
150288691|NCT01425008|542189324|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288692|NCT01425008|542189325|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288693|NCT01425008|542189326|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288694|NCT01425008|542189327|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
150288695|NCT01425008|542189328|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
150288696|NCT01425008|542189329|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
150288697|NCT01425008|542189330|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
150288698|NCT01425008|542189312|FG000|Dose Expansion Phase|Adverse Event|0|||
150288699|NCT01425008|542189313|FG001|Dose Expansion Phase|Adverse Event|0|||
150288700|NCT01425008|542189314|FG002|Dose Expansion Phase|Adverse Event|0|||
150288701|NCT01425008|542189315|FG003|Dose Expansion Phase|Adverse Event|0|||
150288702|NCT01425008|542189316|FG004|Dose Expansion Phase|Adverse Event|0|||
150288703|NCT01425008|542189317|FG005|Dose Expansion Phase|Adverse Event|0|||
150288704|NCT01425008|542189318|FG006|Dose Expansion Phase|Adverse Event|0|||
150288705|NCT01425008|542189319|FG007|Dose Expansion Phase|Adverse Event|0|||
150288706|NCT01425008|542189320|FG008|Dose Expansion Phase|Adverse Event|0|||
150288707|NCT01425008|542189321|FG009|Dose Expansion Phase|Adverse Event|0|||
150288708|NCT01425008|542189322|FG010|Dose Expansion Phase|Adverse Event|2|||
150288709|NCT01425008|542189323|FG011|Dose Expansion Phase|Adverse Event|3|||
150288710|NCT01425008|542189324|FG012|Dose Expansion Phase|Adverse Event|3|||
150288711|NCT01425008|542189325|FG013|Dose Expansion Phase|Adverse Event|0|||
150288712|NCT01425008|542189326|FG014|Dose Expansion Phase|Adverse Event|1|||
150288713|NCT01425008|542189327|FG015|Dose Expansion Phase|Adverse Event|1|||
149848911|NCT02005562|540575959|FG001|Overall Study|No transplant|4|||
149848912|NCT02005562|540575958|FG000|Overall Study|Physician Decision|0|||
150288714|NCT01425008|542189328|FG016|Dose Expansion Phase|Adverse Event|5|||
149848913|NCT02005562|540575959|FG001|Overall Study|Physician Decision|1|||
149848914|NCT02300987|540575960|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
149848915|NCT02300987|540575961|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
149957369|NCT01181128|540977471|FG002|Overall Study|Withdrawal by Subject|0|||
149957370|NCT01181128|540977469|FG000|Overall Study|Death|1|||
149957371|NCT01181128|540977470|FG001|Overall Study|Death|0|||
149957372|NCT01181128|540977471|FG002|Overall Study|Death|0|||
149957373|NCT01181128|540977469|FG000|Overall Study|Physician Decision|2|||
149957374|NCT01181128|540977470|FG001|Overall Study|Physician Decision|0|||
149957375|NCT01181128|540977471|FG002|Overall Study|Physician Decision|0|||
149957376|NCT01181128|540977469|FG000|Overall Study|Adverse Event|0|||
149957377|NCT01181128|540977470|FG001|Overall Study|Adverse Event|2|||
149957378|NCT01181128|540977471|FG002|Overall Study|Adverse Event|0|||
150288715|NCT01425008|542189329|FG017|Dose Expansion Phase|Adverse Event|0|||
150288716|NCT01425008|542189330|FG018|Dose Expansion Phase|Adverse Event|3|||
150288717|NCT01425008|542189312|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
150288718|NCT01425008|542189313|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
150288719|NCT01425008|542189314|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
150288720|NCT01425008|542189315|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
150288721|NCT01425008|542189316|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
150288722|NCT01425008|542189317|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
150288723|NCT01425008|542189318|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
150288724|NCT01425008|542189319|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
150288725|NCT01425008|542189320|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
150288726|NCT01425008|542189321|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
150288727|NCT01425008|542189322|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
150288728|NCT01425008|542189323|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
150288729|NCT01425008|542189324|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
150288730|NCT01425008|542189325|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
150288731|NCT01425008|542189326|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
149848916|NCT02300987|540575960|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
149848917|NCT02300987|540575961|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
149848918|NCT02300987|540575960|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
150288732|NCT01425008|542189327|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
150288733|NCT01425008|542189328|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
150288734|NCT01425008|542189329|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
150288735|NCT01425008|542189330|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
150288736|NCT01425008|542189312|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288737|NCT01425008|542189313|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288738|NCT01425008|542189314|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288739|NCT01425008|542189315|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288740|NCT01425008|542189316|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288741|NCT01425008|542189317|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288742|NCT01425008|542189318|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288743|NCT01425008|542189319|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288744|NCT01425008|542189320|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288745|NCT01425008|542189321|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288746|NCT01425008|542189322|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288747|NCT01425008|542189323|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288748|NCT01425008|542189324|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288749|NCT01425008|542189325|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288750|NCT01425008|542189326|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288751|NCT01425008|542189327|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288752|NCT01425008|542189328|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
150288753|NCT01425008|542189329|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149848919|NCT02300987|540575961|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
149848920|NCT02300987|540575960|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
149848921|NCT02300987|540575961|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
149848922|NCT02300987|540575960|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
149848923|NCT02300987|540575961|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
149848924|NCT04590781|540575963|FG000|Overall Study|Death|0|||
149848925|NCT04590781|540575964|FG001|Overall Study|Death|2|||
149848926|NCT04590781|540575963|FG000|Overall Study|Withdrawal by Subject|2|||
149848927|NCT04590781|540575964|FG001|Overall Study|Withdrawal by Subject|0|||
149848928|NCT00820599|540575967|FG000|Overall Study|Death|129|||
149848929|NCT00820599|540575967|FG000|Overall Study|Withdrawal by Subject|2|||
149848930|NCT03686215|540575968|FG000|Overall Study|Adverse Event|0|||
149848931|NCT03686215|540575969|FG001|Overall Study|Adverse Event|0|||
149848932|NCT03686215|540575970|FG002|Overall Study|Adverse Event|7|||
149848933|NCT03686215|540575968|FG000|Overall Study|Physician Decision|0|||
149848934|NCT03686215|540575969|FG001|Overall Study|Physician Decision|0|||
149848935|NCT03686215|540575970|FG002|Overall Study|Physician Decision|1|||
149848936|NCT03686215|540575968|FG000|Overall Study|Protocol Violation|0|||
149848937|NCT03686215|540575969|FG001|Overall Study|Protocol Violation|0|||
149848938|NCT03686215|540575970|FG002|Overall Study|Protocol Violation|4|||
149848939|NCT03686215|540575968|FG000|Overall Study|Device issue|1|||
149848940|NCT03686215|540575969|FG001|Overall Study|Device issue|0|||
149848941|NCT03686215|540575970|FG002|Overall Study|Device issue|2|||
149848942|NCT00522041|540575971|FG000|Overall Study|Adverse Event|9|||
149848943|NCT00522041|540575972|FG001|Overall Study|Adverse Event|3|||
149957379|NCT01181128|540977469|FG000|Overall Study|Other|1|||
149957380|NCT01181128|540977470|FG001|Overall Study|Other|1|||
149957381|NCT01181128|540977471|FG002|Overall Study|Other|1|||
149957382|NCT04477486|540977474|FG000|Overall Study|Death|2|||
150288754|NCT01425008|542189330|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
150288755|NCT00264238|542189331|FG000|Overall Study|Protocol Violation|1|||
150288756|NCT00562588|542189332|FG000|Overall Study|Adverse Event|40|||
150288757|NCT00562588|542189333|FG001|Overall Study|Adverse Event|58|||
150288758|NCT00562588|542189332|FG000|Overall Study|Protocol Violation|30|||
150288759|NCT00562588|542189333|FG001|Overall Study|Protocol Violation|26|||
150288760|NCT00562588|542189332|FG000|Overall Study|Lost to Follow-up|12|||
150288761|NCT00562588|542189333|FG001|Overall Study|Lost to Follow-up|4|||
150288762|NCT00562588|542189332|FG000|Overall Study|Withdrawal by Subject|10|||
150288763|NCT00562588|542189333|FG001|Overall Study|Withdrawal by Subject|9|||
150288764|NCT00562588|542189332|FG000|Overall Study|Other|0|||
150288765|NCT00562588|542189333|FG001|Overall Study|Other|2|||
150288766|NCT00328627|542192509|FG000|Overall Study|Hyperglycemic Rescue|41|||
150288767|NCT00328627|542192510|FG001|Overall Study|Hyperglycemic Rescue|18|||
150288768|NCT00328627|542192511|FG002|Overall Study|Hyperglycemic Rescue|16|||
150288769|NCT00328627|542192512|FG003|Overall Study|Hyperglycemic Rescue|13|||
150288770|NCT00328627|542192513|FG004|Overall Study|Hyperglycemic Rescue|6|||
150288771|NCT00328627|542192514|FG005|Overall Study|Hyperglycemic Rescue|5|||
150288772|NCT00328627|542192515|FG006|Overall Study|Hyperglycemic Rescue|19|||
150288773|NCT00328627|542192516|FG007|Overall Study|Hyperglycemic Rescue|6|||
150288774|NCT00328627|542192517|FG008|Overall Study|Hyperglycemic Rescue|6|||
150288775|NCT00328627|542192518|FG009|Overall Study|Hyperglycemic Rescue|11|||
150288776|NCT00328627|542192519|FG010|Overall Study|Hyperglycemic Rescue|3|||
150288777|NCT00328627|542192520|FG011|Overall Study|Hyperglycemic Rescue|2|||
150288778|NCT00328627|542192509|FG000|Overall Study|Adverse Event|3|||
150288779|NCT00328627|542192510|FG001|Overall Study|Adverse Event|1|||
150288780|NCT00328627|542192511|FG002|Overall Study|Adverse Event|2|||
150288781|NCT00328627|542192512|FG003|Overall Study|Adverse Event|3|||
150288782|NCT00328627|542192513|FG004|Overall Study|Adverse Event|1|||
150288783|NCT00328627|542192514|FG005|Overall Study|Adverse Event|2|||
150288784|NCT00328627|542192515|FG006|Overall Study|Adverse Event|1|||
150288785|NCT00328627|542192516|FG007|Overall Study|Adverse Event|2|||
150288786|NCT00328627|542192517|FG008|Overall Study|Adverse Event|0|||
150288787|NCT00328627|542192518|FG009|Overall Study|Adverse Event|7|||
150288788|NCT00328627|542192519|FG010|Overall Study|Adverse Event|5|||
150288789|NCT00328627|542192520|FG011|Overall Study|Adverse Event|4|||
150288790|NCT00328627|542192509|FG000|Overall Study|Protocol Violation|2|||
150288791|NCT00328627|542192510|FG001|Overall Study|Protocol Violation|2|||
150288792|NCT00328627|542192511|FG002|Overall Study|Protocol Violation|2|||
150288793|NCT00328627|542192512|FG003|Overall Study|Protocol Violation|8|||
150288794|NCT00328627|542192513|FG004|Overall Study|Protocol Violation|5|||
150288795|NCT00328627|542192514|FG005|Overall Study|Protocol Violation|5|||
150288796|NCT00328627|542192515|FG006|Overall Study|Protocol Violation|6|||
150288797|NCT00328627|542192516|FG007|Overall Study|Protocol Violation|2|||
150288798|NCT00328627|542192517|FG008|Overall Study|Protocol Violation|1|||
150288799|NCT00328627|542192518|FG009|Overall Study|Protocol Violation|4|||
149848944|NCT00522041|540575971|FG000|Overall Study|Protocol Violation|2|||
149848945|NCT00522041|540575972|FG001|Overall Study|Protocol Violation|0|||
149848946|NCT00522041|540575971|FG000|Overall Study|Lost to Follow-up|1|||
149848947|NCT00522041|540575972|FG001|Overall Study|Lost to Follow-up|4|||
149848948|NCT00522041|540575971|FG000|Overall Study|Voluntary withdrawal|5|||
149848949|NCT00522041|540575972|FG001|Overall Study|Voluntary withdrawal|4|||
149848950|NCT00522041|540575971|FG000|Overall Study|Did not receive treatment|0|||
149848951|NCT00522041|540575972|FG001|Overall Study|Did not receive treatment|1|||
149848952|NCT00874549|540575973|FG000|Overall Study|Adverse Event|0|||
149848953|NCT00874549|540575974|FG001|Overall Study|Adverse Event|0|||
149848954|NCT00874549|540575975|FG002|Overall Study|Adverse Event|1|||
149848955|NCT00874549|540575976|FG003|Overall Study|Adverse Event|0|||
149848956|NCT00874549|540575973|FG000|Overall Study|Protocol Violation|1|||
149848957|NCT00874549|540575974|FG001|Overall Study|Protocol Violation|0|||
149848958|NCT00874549|540575975|FG002|Overall Study|Protocol Violation|2|||
149848959|NCT00874549|540575976|FG003|Overall Study|Protocol Violation|1|||
149848960|NCT00874549|540575973|FG000|Overall Study|Lost to Follow-up|0|||
149848961|NCT00874549|540575974|FG001|Overall Study|Lost to Follow-up|0|||
149848962|NCT00874549|540575975|FG002|Overall Study|Lost to Follow-up|1|||
149848963|NCT00874549|540575976|FG003|Overall Study|Lost to Follow-up|0|||
149848964|NCT00874549|540575973|FG000|Overall Study|Withdrawal by Subject|0|||
149848965|NCT00874549|540575974|FG001|Overall Study|Withdrawal by Subject|1|||
149848966|NCT00874549|540575975|FG002|Overall Study|Withdrawal by Subject|0|||
149848967|NCT00874549|540575976|FG003|Overall Study|Withdrawal by Subject|1|||
149848968|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
149848969|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
149848970|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
150288800|NCT00328627|542192519|FG010|Overall Study|Protocol Violation|6|||
150288801|NCT00328627|542192520|FG011|Overall Study|Protocol Violation|2|||
150288802|NCT00328627|542192509|FG000|Overall Study|Lost to Follow-up|4|||
150288803|NCT00328627|542192510|FG001|Overall Study|Lost to Follow-up|2|||
150288804|NCT00328627|542192511|FG002|Overall Study|Lost to Follow-up|2|||
150288805|NCT00328627|542192512|FG003|Overall Study|Lost to Follow-up|4|||
150288806|NCT00328627|542192513|FG004|Overall Study|Lost to Follow-up|0|||
150288807|NCT00328627|542192514|FG005|Overall Study|Lost to Follow-up|2|||
150288808|NCT00328627|542192515|FG006|Overall Study|Lost to Follow-up|3|||
150288809|NCT00328627|542192516|FG007|Overall Study|Lost to Follow-up|0|||
150288810|NCT00328627|542192517|FG008|Overall Study|Lost to Follow-up|3|||
150288811|NCT00328627|542192518|FG009|Overall Study|Lost to Follow-up|2|||
150288812|NCT00328627|542192519|FG010|Overall Study|Lost to Follow-up|0|||
150288813|NCT00328627|542192520|FG011|Overall Study|Lost to Follow-up|1|||
150288814|NCT00328627|542192509|FG000|Overall Study|Withdrawal by Subject|5|||
150288815|NCT00328627|542192510|FG001|Overall Study|Withdrawal by Subject|4|||
150288816|NCT00328627|542192511|FG002|Overall Study|Withdrawal by Subject|5|||
150288817|NCT00328627|542192512|FG003|Overall Study|Withdrawal by Subject|6|||
150288818|NCT00328627|542192513|FG004|Overall Study|Withdrawal by Subject|2|||
150288819|NCT00328627|542192514|FG005|Overall Study|Withdrawal by Subject|5|||
150288820|NCT00328627|542192515|FG006|Overall Study|Withdrawal by Subject|4|||
150288821|NCT00328627|542192516|FG007|Overall Study|Withdrawal by Subject|4|||
150288822|NCT00328627|542192517|FG008|Overall Study|Withdrawal by Subject|4|||
150288823|NCT00328627|542192518|FG009|Overall Study|Withdrawal by Subject|5|||
150288824|NCT00328627|542192519|FG010|Overall Study|Withdrawal by Subject|2|||
150288825|NCT00328627|542192520|FG011|Overall Study|Withdrawal by Subject|7|||
150288826|NCT00328627|542192509|FG000|Overall Study|Pregnancy|0|||
150288827|NCT00328627|542192510|FG001|Overall Study|Pregnancy|1|||
150288828|NCT00328627|542192511|FG002|Overall Study|Pregnancy|0|||
150288829|NCT00328627|542192512|FG003|Overall Study|Pregnancy|0|||
150288830|NCT00328627|542192513|FG004|Overall Study|Pregnancy|0|||
150288831|NCT00328627|542192514|FG005|Overall Study|Pregnancy|0|||
150288832|NCT00328627|542192515|FG006|Overall Study|Pregnancy|0|||
150288833|NCT00328627|542192516|FG007|Overall Study|Pregnancy|0|||
150288834|NCT00328627|542192517|FG008|Overall Study|Pregnancy|0|||
150288835|NCT00328627|542192518|FG009|Overall Study|Pregnancy|0|||
150288836|NCT00328627|542192519|FG010|Overall Study|Pregnancy|0|||
149957383|NCT04477486|540977474|FG000|Overall Study|Ongoing at Time of Analysis|11|||
149957384|NCT01543503|540977475|FG000|Overall Study|Lost to Follow-up|32|||
149957385|NCT01543503|540977476|FG001|Overall Study|Lost to Follow-up|36|||
149957386|NCT01543503|540977475|FG000|Overall Study|Adverse Event|9|||
149957387|NCT01543503|540977476|FG001|Overall Study|Adverse Event|13|||
149957388|NCT01543503|540977475|FG000|Overall Study|Lack of Efficacy|4|||
149957389|NCT01543503|540977476|FG001|Overall Study|Lack of Efficacy|16|||
149957390|NCT01543503|540977475|FG000|Overall Study|Participant withdrew informed consent|8|||
149957391|NCT01543503|540977476|FG001|Overall Study|Participant withdrew informed consent|10|||
149957392|NCT01543503|540977475|FG000|Overall Study|Change of jobs|0|||
149957393|NCT01543503|540977476|FG001|Overall Study|Change of jobs|1|||
149957394|NCT01543503|540977475|FG000|Overall Study|Intolerance to the biologic treatment|0|||
149957395|NCT01543503|540977476|FG001|Overall Study|Intolerance to the biologic treatment|1|||
149957396|NCT01543503|540977475|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
149957397|NCT01543503|540977476|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
149957398|NCT01543503|540977475|FG000|Overall Study|Participant did not complete last visit|0|||
149957399|NCT01543503|540977476|FG001|Overall Study|Participant did not complete last visit|2|||
150172756|NCT00857649|541768084|FG000|Overall Study|Other Reasons|1|||
150288837|NCT00328627|542192520|FG011|Overall Study|Pregnancy|0|||
150288838|NCT00328627|542192509|FG000|Overall Study|Physician Decision|4|||
150288839|NCT00328627|542192510|FG001|Overall Study|Physician Decision|3|||
150288840|NCT00328627|542192511|FG002|Overall Study|Physician Decision|1|||
150288841|NCT00328627|542192512|FG003|Overall Study|Physician Decision|2|||
150288842|NCT00328627|542192513|FG004|Overall Study|Physician Decision|1|||
150288843|NCT00328627|542192514|FG005|Overall Study|Physician Decision|1|||
150288844|NCT00328627|542192515|FG006|Overall Study|Physician Decision|1|||
149848971|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
149848972|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
149848973|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
149848974|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
149848975|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
149848976|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
149848977|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
149848978|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
149848979|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
149848980|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
149848981|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
149848982|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
149848983|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
149848984|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
149957400|NCT01543503|540977475|FG000|Overall Study|Refused to continue treatment|7|||
150288845|NCT00328627|542192516|FG007|Overall Study|Physician Decision|0|||
150288846|NCT00328627|542192517|FG008|Overall Study|Physician Decision|3|||
150288847|NCT00328627|542192518|FG009|Overall Study|Physician Decision|2|||
150288848|NCT00328627|542192519|FG010|Overall Study|Physician Decision|1|||
150288849|NCT00328627|542192520|FG011|Overall Study|Physician Decision|0|||
150288850|NCT00328627|542192509|FG000|Overall Study|Other|0|||
150288851|NCT00328627|542192510|FG001|Overall Study|Other|0|||
150288852|NCT00328627|542192511|FG002|Overall Study|Other|0|||
150288853|NCT00328627|542192512|FG003|Overall Study|Other|1|||
150288854|NCT00328627|542192513|FG004|Overall Study|Other|0|||
150288855|NCT00328627|542192514|FG005|Overall Study|Other|0|||
150288856|NCT00328627|542192515|FG006|Overall Study|Other|1|||
150288857|NCT00328627|542192516|FG007|Overall Study|Other|0|||
150288858|NCT00328627|542192517|FG008|Overall Study|Other|0|||
150288859|NCT00328627|542192518|FG009|Overall Study|Other|1|||
150288860|NCT00328627|542192519|FG010|Overall Study|Other|1|||
150288861|NCT00328627|542192520|FG011|Overall Study|Other|0|||
150288862|NCT02049944|542192521|FG000|Overall Study|Protocol Violation|2|||
150288863|NCT01662440|542192522|FG000|Overall Study|Adverse Event|1|||
150288864|NCT01662440|542192523|FG001|Overall Study|Adverse Event|0|||
150288865|NCT01662440|542192524|FG002|Overall Study|Adverse Event|0|||
150288866|NCT01662440|542192525|FG003|Overall Study|Adverse Event|1|||
149848985|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
149848986|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
149848987|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
149848988|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
149848989|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
149848990|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
149848991|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
150037093|NCT00307801|541277063|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
150037094|NCT00307801|541277064|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
150037095|NCT00307801|541277063|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
150037096|NCT00307801|541277064|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
150037097|NCT00307801|541277063|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
150037098|NCT00307801|541277064|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
150037099|NCT00307801|541277063|FG000|Overall Study|Wrong Randomization|1|||
150037100|NCT00307801|541277064|FG001|Overall Study|Wrong Randomization|0|||
150037101|NCT00307801|541277063|FG000|Overall Study|Lack of Efficacy|0|||
150037102|NCT00307801|541277064|FG001|Overall Study|Lack of Efficacy|2|||
150037103|NCT00307801|541277063|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
150037104|NCT00307801|541277064|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
150037105|NCT00307801|541277063|FG000|Overall Study|Frustration with e-diary|1|||
150037106|NCT00307801|541277064|FG001|Overall Study|Frustration with e-diary|0|||
150037107|NCT00307801|541277063|FG000|Overall Study|Protocol Violation|3|||
150037108|NCT00307801|541277064|FG001|Overall Study|Protocol Violation|2|||
150037109|NCT00307801|541277063|FG000|Overall Study|No reason specified|2|||
150037110|NCT00307801|541277064|FG001|Overall Study|No reason specified|0|||
150037111|NCT00307801|541277063|FG000|Overall Study|Pregnancy|0|||
150037112|NCT00307801|541277064|FG001|Overall Study|Pregnancy|1|||
149848992|NCT01710358|540575977|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
149848993|NCT01710358|540575978|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
149957401|NCT01543503|540977476|FG001|Overall Study|Refused to continue treatment|0|||
149957402|NCT01543503|540977475|FG000|Overall Study|Incorrect medication received|1|||
149957403|NCT01543503|540977476|FG001|Overall Study|Incorrect medication received|0|||
149957404|NCT01543503|540977475|FG000|Overall Study|Participant moved to another city|2|||
149957405|NCT01543503|540977476|FG001|Overall Study|Participant moved to another city|0|||
149957406|NCT01543503|540977475|FG000|Overall Study|Participant will not return for visits|0|||
149957407|NCT01543503|540977476|FG001|Overall Study|Participant will not return for visits|2|||
149957408|NCT01543503|540977475|FG000|Overall Study|Participant transferred to another city|1|||
149957409|NCT01543503|540977476|FG001|Overall Study|Participant transferred to another city|0|||
149957410|NCT01543503|540977475|FG000|Overall Study|Participant moved to Scotland|1|||
149957411|NCT01543503|540977476|FG001|Overall Study|Participant moved to Scotland|0|||
149957412|NCT01543503|540977475|FG000|Overall Study|Participant decision to stop treatment|1|||
149957413|NCT01543503|540977476|FG001|Overall Study|Participant decision to stop treatment|0|||
149957414|NCT01543503|540977475|FG000|Overall Study|Investigator did not wish to participate|1|||
149957415|NCT01543503|540977476|FG001|Overall Study|Investigator did not wish to participate|1|||
149957416|NCT01543503|540977475|FG000|Overall Study|Participant recruited after closing date|0|||
149957417|NCT01543503|540977476|FG001|Overall Study|Participant recruited after closing date|1|||
149957418|NCT01543503|540977475|FG000|Overall Study|Site stopped participation|5|||
149957419|NCT01543503|540977476|FG001|Overall Study|Site stopped participation|1|||
149957420|NCT01543503|540977475|FG000|Overall Study|Participant did not attend a visit|1|||
149957421|NCT01543503|540977476|FG001|Overall Study|Participant did not attend a visit|0|||
150037113|NCT01498068|541277065|FG000|Overall Study|Withdrawal by Subject|1|||
150037114|NCT01498068|541277066|FG001|Overall Study|Withdrawal by Subject|1|||
150288867|NCT01662440|542192522|FG000|Overall Study|Death|0|||
150288868|NCT01662440|542192523|FG001|Overall Study|Death|1|||
150288869|NCT01662440|542192524|FG002|Overall Study|Death|0|||
150288870|NCT01662440|542192525|FG003|Overall Study|Death|0|||
150288871|NCT01662440|542192522|FG000|Overall Study|Lost to Follow-up|2|||
150288872|NCT01662440|542192523|FG001|Overall Study|Lost to Follow-up|2|||
150288873|NCT01662440|542192524|FG002|Overall Study|Lost to Follow-up|4|||
150288874|NCT01662440|542192525|FG003|Overall Study|Lost to Follow-up|1|||
149848994|NCT01710358|540575979|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
149848995|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
149848996|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
149848997|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
149848998|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
149848999|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
149849000|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
149849001|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
149849002|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
149849003|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
149849004|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
149849005|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
149849006|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
149957422|NCT01543503|540977475|FG000|Overall Study|Moved to other rheumatologic site|0|||
149957423|NCT01543503|540977476|FG001|Overall Study|Moved to other rheumatologic site|1|||
149957424|NCT01543503|540977475|FG000|Overall Study|Participant consented to another study|0|||
149957425|NCT01543503|540977476|FG001|Overall Study|Participant consented to another study|2|||
149957426|NCT01543503|540977475|FG000|Overall Study|Participant went to United States|1|||
149957427|NCT01543503|540977476|FG001|Overall Study|Participant went to United States|0|||
149957428|NCT01543503|540977475|FG000|Overall Study|Screen failure|1|||
149957429|NCT01543503|540977476|FG001|Overall Study|Screen failure|0|||
149957430|NCT02460380|540977477|FG000|Overall Study|Withdrawal by Subject|10|||
149957431|NCT02460380|540977478|FG001|Overall Study|Withdrawal by Subject|5|||
149957432|NCT04576949|540977480|FG000|Overall Study|Adverse Event|1|||
149957433|NCT04576949|540977481|FG001|Overall Study|Adverse Event|3|||
149957434|NCT04576949|540977482|FG002|Overall Study|Adverse Event|2|||
149957435|NCT04576949|540977480|FG000|Overall Study|Withdrawal by Subject|41|||
149957436|NCT04576949|540977481|FG001|Overall Study|Withdrawal by Subject|26|||
149957437|NCT04576949|540977482|FG002|Overall Study|Withdrawal by Subject|18|||
149957438|NCT04576949|540977480|FG000|Overall Study|Physician Decision|3|||
149957439|NCT04576949|540977481|FG001|Overall Study|Physician Decision|0|||
149957440|NCT04576949|540977482|FG002|Overall Study|Physician Decision|0|||
149957441|NCT04576949|540977480|FG000|Overall Study|Death|0|||
149957442|NCT04576949|540977481|FG001|Overall Study|Death|1|||
149957443|NCT04576949|540977482|FG002|Overall Study|Death|0|||
149957444|NCT04576949|540977480|FG000|Overall Study|Lost to Follow-up|29|||
149957445|NCT04576949|540977481|FG001|Overall Study|Lost to Follow-up|37|||
149957446|NCT04576949|540977482|FG002|Overall Study|Lost to Follow-up|24|||
149957447|NCT04576949|540977480|FG000|Overall Study|Other, Not Specified|2|||
149957448|NCT04576949|540977481|FG001|Overall Study|Other, Not Specified|3|||
149957449|NCT04576949|540977482|FG002|Overall Study|Other, Not Specified|1|||
149957450|NCT04576949|540977480|FG000|Overall Study|Other|1|||
149957451|NCT04576949|540977481|FG001|Overall Study|Other|0|||
149957452|NCT04576949|540977482|FG002|Overall Study|Other|0|||
149957453|NCT00052715|540977483|FG000|Overall Study|wrong histology|1|||
149957454|NCT01936974|540977484|FG000|Overall Study|Physician Decision|2|||
149957455|NCT01936974|540977485|FG001|Overall Study|Physician Decision|5|||
149957456|NCT02280499|540977490|FG000|Overall Study|Death|14|||
149957457|NCT02280499|540977490|FG000|Overall Study|Lost to Follow-up|42|||
149957458|NCT02280499|540977490|FG000|Overall Study|Adverse Event|5|||
149957459|NCT03511066|540977503|FG000|Overall Study|Withdrawal by Subject|1|||
149957460|NCT03511066|540977504|FG001|Overall Study|Withdrawal by Subject|2|||
149957461|NCT03511066|540977505|FG002|Overall Study|Withdrawal by Subject|3|||
149957462|NCT03511066|540977503|FG000|Overall Study|Lost to Follow-up|2|||
149957463|NCT03511066|540977504|FG001|Overall Study|Lost to Follow-up|3|||
149957464|NCT03511066|540977505|FG002|Overall Study|Lost to Follow-up|0|||
149957465|NCT05085405|540977509|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
149957466|NCT05085405|540977510|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
149957467|NCT05085405|540977511|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
149957468|NCT05085405|540977512|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
149957469|NCT05085405|540977513|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
149957470|NCT05085405|540977514|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
149957471|NCT05085405|540977509|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
149957472|NCT05085405|540977510|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
149957473|NCT05085405|540977511|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
149957474|NCT05085405|540977512|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
149957475|NCT05085405|540977513|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
149957476|NCT05085405|540977514|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
149957477|NCT04193527|540977517|FG000|Overall Study|Other|1|||
149957478|NCT04193527|540977518|FG001|Overall Study|Other|1|||
149957479|NCT04193527|540977519|FG002|Overall Study|Other|0|||
149957480|NCT03808909|540977520|FG000|Overall Study|Lost to Follow-up|3|||
150037115|NCT03058146|541277068|FG000|Overall Study|Withdrawal by Subject|4|||
150037116|NCT03058146|541277069|FG001|Overall Study|Withdrawal by Subject|1|||
150037117|NCT03058146|541277068|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
150037118|NCT03058146|541277069|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
150037119|NCT00632229|541277070|FG000|Overall Study|Adverse Event|6|||
149849007|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
149849008|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
149849009|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
149849010|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
149849011|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
149849012|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
149849013|NCT01710358|540575977|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
149849014|NCT01710358|540575978|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
149849015|NCT01710358|540575979|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
149849016|NCT01710358|540575977|FG000|Rescue Period|Adverse Event|0|||
149849017|NCT01710358|540575978|FG001|Rescue Period|Adverse Event|15|||
149849018|NCT01710358|540575979|FG002|Rescue Period|Adverse Event|0|||
149849019|NCT01710358|540575977|FG000|Rescue Period|Death|0|||
149849020|NCT01710358|540575978|FG001|Rescue Period|Death|1|||
149849021|NCT01710358|540575979|FG002|Rescue Period|Death|0|||
149849022|NCT01710358|540575977|FG000|Rescue Period|Lack of Efficacy|0|||
149849023|NCT01710358|540575978|FG001|Rescue Period|Lack of Efficacy|7|||
149849024|NCT01710358|540575979|FG002|Rescue Period|Lack of Efficacy|0|||
149849025|NCT01710358|540575977|FG000|Rescue Period|Withdrawal by Subject|0|||
149849026|NCT01710358|540575978|FG001|Rescue Period|Withdrawal by Subject|8|||
149849027|NCT01710358|540575979|FG002|Rescue Period|Withdrawal by Subject|0|||
149849028|NCT00084864|540575980|FG000|Overall Study|Adverse Event|1|||
149849029|NCT00084864|540575981|FG001|Overall Study|Adverse Event|0|||
149849030|NCT00084864|540575982|FG002|Overall Study|Adverse Event|0|||
150037120|NCT00632229|541277071|FG001|Overall Study|Adverse Event|0|||
150037121|NCT00632229|541277070|FG000|Overall Study|Lost to Follow-up|0|||
150037122|NCT00632229|541277071|FG001|Overall Study|Lost to Follow-up|3|||
150037123|NCT00632229|541277070|FG000|Overall Study|Lack of Efficacy|0|||
150037124|NCT00632229|541277071|FG001|Overall Study|Lack of Efficacy|2|||
150037125|NCT00632229|541277070|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
150037126|NCT00632229|541277071|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
150037127|NCT03224819|541277073|FG000|Overall Study|Withdrawal by Subject|0|||
150037128|NCT03224819|541277074|FG001|Overall Study|Withdrawal by Subject|0|||
150037129|NCT03224819|541277075|FG002|Overall Study|Withdrawal by Subject|0|||
150037130|NCT03224819|541277076|FG003|Overall Study|Withdrawal by Subject|0|||
150037131|NCT03224819|541277077|FG004|Overall Study|Withdrawal by Subject|0|||
150037132|NCT03224819|541277078|FG005|Overall Study|Withdrawal by Subject|0|||
150037133|NCT03224819|541277079|FG006|Overall Study|Withdrawal by Subject|0|||
150037134|NCT03224819|541277080|FG007|Overall Study|Withdrawal by Subject|0|||
150037135|NCT03224819|541277081|FG008|Overall Study|Withdrawal by Subject|0|||
150037136|NCT03224819|541277082|FG009|Overall Study|Withdrawal by Subject|0|||
150037137|NCT03224819|541277083|FG010|Overall Study|Withdrawal by Subject|0|||
149849031|NCT00084864|540575983|FG003|Overall Study|Adverse Event|0|||
149849032|NCT01721772|540575989|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
149849033|NCT01721772|540575990|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
149849034|NCT01721772|540575989|FG000|Pre-Treatment|Poor/non-compliance|0|||
149849035|NCT01721772|540575990|FG001|Pre-Treatment|Poor/non-compliance|1|||
149849036|NCT01721772|540575989|FG000|Pre-Treatment|Participant withdrew consent|0|||
149849037|NCT01721772|540575990|FG001|Pre-Treatment|Participant withdrew consent|1|||
149849038|NCT01721772|540575989|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
149849039|NCT01721772|540575990|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
149849040|NCT01721772|540575989|FG000|Treatment|Disease progression|119|||
149849041|NCT01721772|540575990|FG001|Treatment|Disease progression|168|||
150037138|NCT03224819|541277084|FG011|Overall Study|Withdrawal by Subject|0|||
150172757|NCT00857649|541768085|FG001|Overall Study|Other Reasons|3|||
150037139|NCT03224819|541277085|FG012|Overall Study|Withdrawal by Subject|1|||
150037140|NCT03224819|541277086|FG013|Overall Study|Withdrawal by Subject|0|||
150037141|NCT03224819|541277073|FG000|Overall Study|Sponsor Decision|0|||
150037142|NCT03224819|541277074|FG001|Overall Study|Sponsor Decision|0|||
149849042|NCT01721772|540575989|FG000|Treatment|Study drug toxicity|19|||
149849043|NCT01721772|540575990|FG001|Treatment|Study drug toxicity|10|||
149849044|NCT01721772|540575989|FG000|Treatment|Adverse event unrelated to study drug|7|||
149849045|NCT01721772|540575990|FG001|Treatment|Adverse event unrelated to study drug|7|||
149849046|NCT01721772|540575989|FG000|Treatment|Maximum clinical benefit|16|||
149849047|NCT01721772|540575990|FG001|Treatment|Maximum clinical benefit|4|||
149849048|NCT01721772|540575989|FG000|Treatment|Other|19|||
149849049|NCT01721772|540575990|FG001|Treatment|Other|2|||
150037143|NCT03224819|541277075|FG002|Overall Study|Sponsor Decision|0|||
150037144|NCT03224819|541277076|FG003|Overall Study|Sponsor Decision|1|||
150037145|NCT03224819|541277077|FG004|Overall Study|Sponsor Decision|1|||
149957481|NCT03808909|540977521|FG001|Overall Study|Lost to Follow-up|0|||
149957482|NCT01827943|540977522|FG000|Overall Study|Protocol Violation|8|||
149957483|NCT01827943|540977522|FG000|Overall Study|Never treated because of an rapid progression|1|||
149957484|NCT00501085|540977523|FG000|Overall Study|Lost to Follow-up|195|||
149957485|NCT00501085|540977523|FG000|Overall Study|Withdrawal by Subject|34|||
149957486|NCT00501085|540977523|FG000|Overall Study|Subject Decision|1|||
149957487|NCT00501085|540977523|FG000|Overall Study|Revision Surgery|7|||
149957488|NCT00501085|540977523|FG000|Overall Study|Explantation Surgery|26|||
149957489|NCT00501085|540977523|FG000|Overall Study|Adverse Event|4|||
150037146|NCT03224819|541277078|FG005|Overall Study|Sponsor Decision|2|||
150037147|NCT03224819|541277079|FG006|Overall Study|Sponsor Decision|1|||
150037148|NCT03224819|541277080|FG007|Overall Study|Sponsor Decision|1|||
150037149|NCT03224819|541277081|FG008|Overall Study|Sponsor Decision|1|||
150037150|NCT03224819|541277082|FG009|Overall Study|Sponsor Decision|2|||
150037151|NCT03224819|541277083|FG010|Overall Study|Sponsor Decision|1|||
150037152|NCT03224819|541277084|FG011|Overall Study|Sponsor Decision|1|||
150037153|NCT03224819|541277085|FG012|Overall Study|Sponsor Decision|1|||
150037154|NCT03224819|541277086|FG013|Overall Study|Sponsor Decision|0|||
150037155|NCT03224819|541277073|FG000|Overall Study|Lost to Follow-up|0|||
150037156|NCT03224819|541277074|FG001|Overall Study|Lost to Follow-up|0|||
150037157|NCT03224819|541277075|FG002|Overall Study|Lost to Follow-up|0|||
150037158|NCT03224819|541277076|FG003|Overall Study|Lost to Follow-up|0|||
150037159|NCT03224819|541277077|FG004|Overall Study|Lost to Follow-up|0|||
150037160|NCT03224819|541277078|FG005|Overall Study|Lost to Follow-up|0|||
150037161|NCT03224819|541277079|FG006|Overall Study|Lost to Follow-up|0|||
150037162|NCT03224819|541277080|FG007|Overall Study|Lost to Follow-up|0|||
150037163|NCT03224819|541277081|FG008|Overall Study|Lost to Follow-up|1|||
150037164|NCT03224819|541277082|FG009|Overall Study|Lost to Follow-up|0|||
150037165|NCT03224819|541277083|FG010|Overall Study|Lost to Follow-up|0|||
150037166|NCT03224819|541277084|FG011|Overall Study|Lost to Follow-up|0|||
150037167|NCT03224819|541277085|FG012|Overall Study|Lost to Follow-up|0|||
150037168|NCT03224819|541277086|FG013|Overall Study|Lost to Follow-up|0|||
150037169|NCT03224819|541277073|FG000|Overall Study|Death|0|||
150037170|NCT03224819|541277074|FG001|Overall Study|Death|1|||
150037171|NCT03224819|541277075|FG002|Overall Study|Death|0|||
150037172|NCT03224819|541277076|FG003|Overall Study|Death|0|||
150037173|NCT03224819|541277077|FG004|Overall Study|Death|0|||
150037174|NCT03224819|541277078|FG005|Overall Study|Death|0|||
150037175|NCT03224819|541277079|FG006|Overall Study|Death|0|||
150037176|NCT03224819|541277080|FG007|Overall Study|Death|1|||
150037177|NCT03224819|541277081|FG008|Overall Study|Death|0|||
150037178|NCT03224819|541277082|FG009|Overall Study|Death|0|||
150037179|NCT03224819|541277083|FG010|Overall Study|Death|0|||
150037180|NCT03224819|541277084|FG011|Overall Study|Death|1|||
150037181|NCT03224819|541277085|FG012|Overall Study|Death|0|||
150037182|NCT03224819|541277086|FG013|Overall Study|Death|0|||
150037183|NCT00737672|541277093|FG000|Overall Study|Graft Abandonment|48|||
150037184|NCT00737672|541277094|FG001|Overall Study|Graft Abandonment|56|||
150037185|NCT00737672|541277093|FG000|Overall Study|Death|23|||
150037186|NCT00737672|541277094|FG001|Overall Study|Death|22|||
150037187|NCT00737672|541277093|FG000|Overall Study|Withdrawal by Subject|1|||
150037188|NCT00737672|541277094|FG001|Overall Study|Withdrawal by Subject|2|||
150037189|NCT00737672|541277093|FG000|Overall Study|Lost to Follow-up|1|||
150037190|NCT00737672|541277094|FG001|Overall Study|Lost to Follow-up|0|||
150037191|NCT00737672|541277093|FG000|Overall Study|Miscellaneous|7|||
150037192|NCT00737672|541277094|FG001|Overall Study|Miscellaneous|1|||
150037193|NCT00737672|541277093|FG000|Overall Study|Physician Decision|0|||
150037194|NCT00737672|541277094|FG001|Overall Study|Physician Decision|2|||
150037195|NCT00829426|541277099|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
150037196|NCT00829426|541277100|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
150037197|NCT02002598|541277103|FG000|Dose Level 1|Withdrawal by Subject|1|||
150037198|NCT02002598|541277104|FG001|Dose Level 1|Withdrawal by Subject|0|||
150037199|NCT02002598|541277105|FG002|Dose Level 1|Withdrawal by Subject|0|||
150037200|NCT02002598|541277106|FG003|Dose Level 1|Withdrawal by Subject|0|||
150037201|NCT02002598|541277107|FG004|Dose Level 1|Withdrawal by Subject|0|||
150037202|NCT04672239|541277108|FG000|Week 2 Survey|Failed survey check items|1|||
149957490|NCT00501085|540977523|FG000|Overall Study|Non-Compliance|24|||
149957491|NCT00501085|540977523|FG000|Overall Study|Study closed by sponsor|109|||
150037203|NCT04672239|541277109|FG001|Week 2 Survey|Failed survey check items|2|||
150037204|NCT04672239|541277110|FG002|Week 2 Survey|Failed survey check items|3|||
150037205|NCT04672239|541277108|FG000|Week 2 Survey|Partially completed survey|7|||
150037206|NCT04672239|541277109|FG001|Week 2 Survey|Partially completed survey|1|||
150037207|NCT04672239|541277110|FG002|Week 2 Survey|Partially completed survey|4|||
149957492|NCT00501085|540977523|FG000|Overall Study|Other loss to follow-up|32|||
149957493|NCT01487161|540977524|FG000|Overall Study|Adverse Event|1|||
150037208|NCT04672239|541277108|FG000|Week 2 Survey|Withdrawal by Subject|0|||
150037209|NCT04672239|541277109|FG001|Week 2 Survey|Withdrawal by Subject|1|||
150037210|NCT04672239|541277110|FG002|Week 2 Survey|Withdrawal by Subject|0|||
150037211|NCT04672239|541277108|FG000|Week 2 Survey|Lost to Follow-up|3|||
149957494|NCT01487161|540977525|FG001|Overall Study|Adverse Event|0|||
149849050|NCT01721772|540575989|FG000|Treatment|Participant withdrew consent|2|||
149849051|NCT01721772|540575990|FG001|Treatment|Participant withdrew consent|5|||
149849052|NCT01721772|540575989|FG000|Treatment|Participant request to discontinue study treatment|21|||
149849053|NCT01721772|540575990|FG001|Treatment|Participant request to discontinue study treatment|8|||
150037212|NCT04672239|541277109|FG001|Week 2 Survey|Lost to Follow-up|2|||
150037213|NCT04672239|541277110|FG002|Week 2 Survey|Lost to Follow-up|5|||
150037214|NCT04672239|541277108|FG000|Week 6 Survey|Failed survey check items|2|||
150037215|NCT04672239|541277109|FG001|Week 6 Survey|Failed survey check items|2|||
150037216|NCT04672239|541277110|FG002|Week 6 Survey|Failed survey check items|2|||
150037217|NCT04672239|541277108|FG000|Week 6 Survey|Partially completed survey|3|||
150037218|NCT04672239|541277109|FG001|Week 6 Survey|Partially completed survey|3|||
150037219|NCT04672239|541277110|FG002|Week 6 Survey|Partially completed survey|2|||
150037220|NCT04672239|541277108|FG000|Week 6 Survey|Withdrawal by Subject|1|||
150037221|NCT04672239|541277109|FG001|Week 6 Survey|Withdrawal by Subject|1|||
150037222|NCT04672239|541277110|FG002|Week 6 Survey|Withdrawal by Subject|1|||
150037223|NCT04672239|541277108|FG000|Week 6 Survey|Withdrawn by PI|0|||
150037224|NCT04672239|541277109|FG001|Week 6 Survey|Withdrawn by PI|1|||
150037225|NCT04672239|541277110|FG002|Week 6 Survey|Withdrawn by PI|0|||
150037226|NCT04672239|541277108|FG000|Week 6 Survey|Lost to Follow-up|12|||
150037227|NCT04672239|541277109|FG001|Week 6 Survey|Lost to Follow-up|2|||
150037228|NCT04672239|541277110|FG002|Week 6 Survey|Lost to Follow-up|5|||
150037229|NCT04672239|541277108|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
150037230|NCT04672239|541277109|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
150037231|NCT04672239|541277110|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
150037232|NCT04672239|541277108|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
150037233|NCT04672239|541277109|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
150037234|NCT04672239|541277110|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
150037235|NCT04672239|541277108|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
150037236|NCT04672239|541277109|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
150037237|NCT04672239|541277110|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
150037238|NCT04672239|541277108|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
150037239|NCT04672239|541277109|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
150037240|NCT04672239|541277110|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
150037241|NCT04672239|541277108|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
150037242|NCT04672239|541277109|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
150037243|NCT04672239|541277110|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
150037244|NCT04672239|541277108|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
150037245|NCT04672239|541277109|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
150037246|NCT04672239|541277110|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
150037247|NCT04672239|541277108|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
150037248|NCT04672239|541277109|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
150037249|NCT04672239|541277110|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
150037250|NCT04606134|541277113|FG000|Overall Study|Adverse Event|0|||
150037251|NCT04606134|541277114|FG001|Overall Study|Adverse Event|1|||
150037252|NCT01099267|541277115|FG000|MDS-003 Study|Adverse Event|37|||
150037253|NCT01099267|541277115|FG000|MDS-003 Study|Lack of Efficacy|52|||
150037254|NCT01099267|541277115|FG000|MDS-003 Study|Withdrawal by Subject|8|||
150037255|NCT01099267|541277115|FG000|MDS-003 Study|Lost to Follow-up|1|||
150037256|NCT01099267|541277115|FG000|MDS-003 Study|Death|11|||
150037257|NCT01099267|541277115|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
150037258|NCT01099267|541277115|FG000|MDS-003 Study|Disease Progression|7|||
150037259|NCT01099267|541277115|FG000|MDS-003 Study|Investigator Decision|2|||
150037260|NCT01099267|541277115|FG000|MDS-003 Study|Non-Compliance|2|||
150037261|NCT01099267|541277115|FG000|MDS-003 Study|Loss of Response|1|||
150037262|NCT01099267|541277115|FG000|MDS-003 Study|Secondary Malign Disease|1|||
150037263|NCT04123470|541277118|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
150037264|NCT04123470|541277119|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
150037265|NCT04123470|541277118|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
150037266|NCT04123470|541277119|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
150037267|NCT04123470|541277118|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
150037268|NCT04123470|541277119|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
150037269|NCT04123470|541277118|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
149849054|NCT01721772|540575989|FG000|Treatment|Death|1|||
149849055|NCT01721772|540575990|FG001|Treatment|Death|0|||
149849056|NCT01721772|540575989|FG000|Treatment|Not reported|1|||
149849057|NCT01721772|540575990|FG001|Treatment|Not reported|0|||
149849058|NCT01721772|540575989|FG000|Treatment|Poor/non-compliance|1|||
149849059|NCT01721772|540575990|FG001|Treatment|Poor/non-compliance|0|||
149849060|NCT01721772|540575989|FG000|Treatment|Lost to Follow-up|0|||
149849061|NCT01721772|540575990|FG001|Treatment|Lost to Follow-up|1|||
149849062|NCT04542694|540575992|FG000|Overall Study|The need for prohibited therapy|2|||
150172758|NCT00367055|541768087|FG000|Overall Study|Adverse Event|6|||
149849063|NCT04542694|540575993|FG001|Overall Study|The need for prohibited therapy|0|||
149849064|NCT04542694|540575992|FG000|Overall Study|Adverse Event|1|||
150037270|NCT04123470|541277119|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
150037271|NCT05972993|541277125|FG000|Overall Study|Lost to Follow-up|2|||
150037272|NCT05972993|541277126|FG001|Overall Study|Lost to Follow-up|0|||
150037273|NCT05972993|541277127|FG002|Overall Study|Lost to Follow-up|1|||
150037274|NCT05972993|541277128|FG003|Overall Study|Lost to Follow-up|0|||
150037275|NCT05972993|541277129|FG004|Overall Study|Lost to Follow-up|0|||
150037276|NCT05972993|541277130|FG005|Overall Study|Lost to Follow-up|0|||
150037277|NCT05972993|541277131|FG006|Overall Study|Lost to Follow-up|0|||
150037278|NCT05972993|541277132|FG007|Overall Study|Lost to Follow-up|2|||
150037279|NCT05972993|541277133|FG008|Overall Study|Lost to Follow-up|0|||
150037280|NCT03866577|541277136|FG000|Overall Study|Protocol Violation|0|||
150037281|NCT03866577|541277137|FG001|Overall Study|Protocol Violation|0|||
150037282|NCT03866577|541277138|FG002|Overall Study|Protocol Violation|0|||
150037283|NCT03866577|541277139|FG003|Overall Study|Protocol Violation|0|||
149849065|NCT04542694|540575993|FG001|Overall Study|Adverse Event|0|||
150037284|NCT03866577|541277140|FG004|Overall Study|Protocol Violation|0|||
149849066|NCT04542694|540575992|FG000|Overall Study|Protocol Violation|1|||
150037285|NCT03866577|541277141|FG005|Overall Study|Protocol Violation|0|||
150037286|NCT03866577|541277142|FG006|Overall Study|Protocol Violation|0|||
150037287|NCT03866577|541277143|FG007|Overall Study|Protocol Violation|0|||
150037288|NCT03866577|541277144|FG008|Overall Study|Protocol Violation|0|||
150037289|NCT03866577|541277145|FG009|Overall Study|Protocol Violation|0|||
150037290|NCT03866577|541277146|FG010|Overall Study|Protocol Violation|0|||
150037291|NCT03866577|541277147|FG011|Overall Study|Protocol Violation|1|||
150037292|NCT03866577|541277148|FG012|Overall Study|Protocol Violation|0|||
150037293|NCT03866577|541277136|FG000|Overall Study|Withdrawal by Subject|0|||
150037294|NCT03866577|541277137|FG001|Overall Study|Withdrawal by Subject|0|||
150037295|NCT03866577|541277138|FG002|Overall Study|Withdrawal by Subject|0|||
150037296|NCT03866577|541277139|FG003|Overall Study|Withdrawal by Subject|0|||
150037297|NCT03866577|541277140|FG004|Overall Study|Withdrawal by Subject|0|||
150037298|NCT03866577|541277141|FG005|Overall Study|Withdrawal by Subject|0|||
150037299|NCT03866577|541277142|FG006|Overall Study|Withdrawal by Subject|0|||
150037300|NCT03866577|541277143|FG007|Overall Study|Withdrawal by Subject|0|||
150037301|NCT03866577|541277144|FG008|Overall Study|Withdrawal by Subject|1|||
150037302|NCT03866577|541277145|FG009|Overall Study|Withdrawal by Subject|1|||
150037303|NCT03866577|541277146|FG010|Overall Study|Withdrawal by Subject|0|||
150037304|NCT03866577|541277147|FG011|Overall Study|Withdrawal by Subject|0|||
150037305|NCT03866577|541277148|FG012|Overall Study|Withdrawal by Subject|0|||
150037306|NCT03866577|541277136|FG000|Overall Study|Not qualified for IVIg infusion|0|||
150037307|NCT03866577|541277137|FG001|Overall Study|Not qualified for IVIg infusion|0|||
150037308|NCT03866577|541277138|FG002|Overall Study|Not qualified for IVIg infusion|0|||
150037309|NCT03866577|541277139|FG003|Overall Study|Not qualified for IVIg infusion|0|||
150037310|NCT03866577|541277140|FG004|Overall Study|Not qualified for IVIg infusion|0|||
150037311|NCT03866577|541277141|FG005|Overall Study|Not qualified for IVIg infusion|0|||
150037312|NCT03866577|541277142|FG006|Overall Study|Not qualified for IVIg infusion|0|||
150037313|NCT03866577|541277143|FG007|Overall Study|Not qualified for IVIg infusion|0|||
150037314|NCT03866577|541277144|FG008|Overall Study|Not qualified for IVIg infusion|0|||
150037315|NCT03866577|541277145|FG009|Overall Study|Not qualified for IVIg infusion|1|||
150037316|NCT03866577|541277146|FG010|Overall Study|Not qualified for IVIg infusion|0|||
150037317|NCT03866577|541277147|FG011|Overall Study|Not qualified for IVIg infusion|0|||
150037318|NCT03866577|541277148|FG012|Overall Study|Not qualified for IVIg infusion|0|||
150037319|NCT05530252|541277149|FG000|Overall Study|Lost to Follow-up|1|||
150037320|NCT05530252|541277150|FG001|Overall Study|Lost to Follow-up|1|||
150037321|NCT05530252|541277151|FG002|Overall Study|Lost to Follow-up|1|||
150037322|NCT04825678|541277152|FG000|Overall Study|Decision by Sponsor|2|||
150037323|NCT04825678|541277153|FG001|Overall Study|Decision by Sponsor|3|||
149849067|NCT04542694|540575993|FG001|Overall Study|Protocol Violation|0|||
150037324|NCT04825678|541277152|FG000|Overall Study|Withdrawal of Consent From Study|7|||
150037325|NCT04825678|541277153|FG001|Overall Study|Withdrawal of Consent From Study|9|||
150037326|NCT04825678|541277152|FG000|Overall Study|Lost to Follow-up|3|||
150037327|NCT04825678|541277153|FG001|Overall Study|Lost to Follow-up|4|||
150037328|NCT04825678|541277152|FG000|Overall Study|Never Received Investigational Product|1|||
150037329|NCT04825678|541277153|FG001|Overall Study|Never Received Investigational Product|1|||
150037330|NCT00651742|541277158|FG000|Overall Study|Objective Disease Progression|22|||
150037331|NCT00651742|541277158|FG000|Overall Study|Toxicity|3|||
150037332|NCT00651742|541277158|FG000|Overall Study|Investigator Judgment|1|||
150037333|NCT00651742|541277158|FG000|Overall Study|Withdrawal of Consent|1|||
150037334|NCT00651742|541277158|FG000|Overall Study|Enrolled but not treated|1|||
150037335|NCT01535040|541277160|FG000|Overall Study|Physician Decision|0|||
150037336|NCT01535040|541277161|FG001|Overall Study|Physician Decision|1|||
150172759|NCT00367055|541768088|FG001|Overall Study|Adverse Event|3|||
150037337|NCT01535040|541277160|FG000|Overall Study|Withdrawal by Subject|13|||
150037338|NCT01535040|541277161|FG001|Overall Study|Withdrawal by Subject|10|||
150037339|NCT01535040|541277160|FG000|Overall Study|Never Started|9|||
150037340|NCT01535040|541277161|FG001|Overall Study|Never Started|4|||
149849068|NCT00969124|540575994|FG000|Overall Study|Protocol Violation|2|||
150037341|NCT01535040|541277160|FG000|Overall Study|Toxicity|7|||
150037342|NCT01535040|541277161|FG001|Overall Study|Toxicity|5|||
150037343|NCT01535040|541277160|FG000|Overall Study|Multiple Reasons|1|||
150037344|NCT01535040|541277161|FG001|Overall Study|Multiple Reasons|1|||
150037345|NCT00911170|541277162|FG000|Treatment Period|Randomized in error|1|||
150037346|NCT00911170|541277163|FG001|Treatment Period|Randomized in error|1|||
150037347|NCT00911170|541277162|FG000|Treatment Period|Ineligibility determined|1|||
150037348|NCT00911170|541277163|FG001|Treatment Period|Ineligibility determined|3|||
150037349|NCT00911170|541277162|FG000|Treatment Period|Protocol deviation|1|||
150037350|NCT00911170|541277163|FG001|Treatment Period|Protocol deviation|2|||
150037351|NCT00911170|541277162|FG000|Treatment Period|Adverse Event|9|||
150037352|NCT00911170|541277163|FG001|Treatment Period|Adverse Event|10|||
150037353|NCT00911170|541277162|FG000|Treatment Period|Withdrawal by Subject|4|||
150037354|NCT00911170|541277163|FG001|Treatment Period|Withdrawal by Subject|4|||
150037355|NCT00911170|541277162|FG000|Treatment Period|Disease progression|0|||
150037356|NCT00911170|541277163|FG001|Treatment Period|Disease progression|2|||
150037357|NCT00911170|541277162|FG000|Treatment Period|Physician Decision|5|||
150037358|NCT00911170|541277163|FG001|Treatment Period|Physician Decision|5|||
150037359|NCT00911170|541277162|FG000|Treatment Period|Lost to Follow-up|0|||
150037360|NCT00911170|541277163|FG001|Treatment Period|Lost to Follow-up|1|||
150037361|NCT00911170|541277162|FG000|Treatment Period|Death|6|||
150037362|NCT00911170|541277163|FG001|Treatment Period|Death|9|||
150037363|NCT00911170|541277162|FG000|Long Term Follow-Up|Continuing in study|274|||
149849069|NCT00969124|540575994|FG000|Overall Study|Inadequate bowel preparation|15|||
149849070|NCT00969124|540575994|FG000|Overall Study|Inability to reach cecum|9|||
149849071|NCT00969124|540575994|FG000|Overall Study|Previously unrecognized disease|3|||
149849072|NCT00969124|540575994|FG000|Overall Study|Technical error|1|||
149849073|NCT05387408|540575995|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
149849074|NCT02786953|540576006|FG000|Overall Study|Withdrawal by Subject|3|||
149849075|NCT02786953|540576007|FG001|Overall Study|Withdrawal by Subject|0|||
149849076|NCT02786953|540576006|FG000|Overall Study|Physician Decision|0|||
150037364|NCT00911170|541277163|FG001|Long Term Follow-Up|Continuing in study|269|||
150037365|NCT00911170|541277162|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
150037366|NCT00911170|541277163|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
150037367|NCT00911170|541277162|FG000|Long Term Follow-Up|Physician Decision|5|||
150037368|NCT00911170|541277163|FG001|Long Term Follow-Up|Physician Decision|4|||
150037369|NCT00911170|541277162|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
150037370|NCT00911170|541277163|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
150037371|NCT00911170|541277162|FG000|Long Term Follow-Up|Death|116|||
150037372|NCT00911170|541277163|FG001|Long Term Follow-Up|Death|121|||
150037373|NCT01824836|541277164|FG000|Overall Study|Adverse Event|48|||
150037374|NCT01824836|541277164|FG000|Overall Study|Withdrawal by Subject|63|||
150037375|NCT01824836|541277164|FG000|Overall Study|Other complicating disease|116|||
150037376|NCT01824836|541277164|FG000|Overall Study|Disease progression|5|||
150037377|NCT01824836|541277164|FG000|Overall Study|Alternative therapy|2|||
150037378|NCT01824836|541277164|FG000|Overall Study|Depression|1|||
150037379|NCT01824836|541277164|FG000|Overall Study|Non-compliance|3|||
150037380|NCT01824836|541277164|FG000|Overall Study|Patient regained ovarian function|3|||
150037381|NCT01824836|541277164|FG000|Overall Study|Lost to Follow-up|8|||
150037382|NCT01824836|541277164|FG000|Overall Study|Physician Decision|2|||
150037383|NCT01824836|541277164|FG000|Overall Study|Research office was closed|3|||
150037384|NCT01824836|541277164|FG000|Overall Study|Relocation|3|||
150037385|NCT01824836|541277164|FG000|Overall Study|Insurance-related issue|1|||
150037386|NCT01824836|541277164|FG000|Overall Study|Transportation issue|1|||
150037387|NCT01824836|541277164|FG000|Overall Study|Patient transferred care|1|||
150037388|NCT01824836|541277164|FG000|Overall Study|Unknown reasons|4|||
150037389|NCT01824836|541277164|FG000|Overall Study|Never started treatment|16|||
150037390|NCT02638220|541277165|FG000|Overall Study|Lost to Follow-up|6|||
150037391|NCT02638220|541277165|FG000|Overall Study|Withdrawal by Subject|3|||
150037392|NCT02638220|541277165|FG000|Overall Study|Physician Decision|1|||
150037393|NCT02638220|541277165|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
150037394|NCT04323124|541277171|FG000|Overall Study|Adverse Event|0|||
149849077|NCT02786953|540576007|FG001|Overall Study|Physician Decision|1|||
149849078|NCT05278858|540576008|FG000|Overall Study|Withdrawal by Subject|1|||
150037395|NCT04323124|541277172|FG001|Overall Study|Adverse Event|0|||
150037396|NCT04323124|541277173|FG002|Overall Study|Adverse Event|0|||
150037397|NCT04323124|541277174|FG003|Overall Study|Adverse Event|0|||
150037398|NCT04323124|541277175|FG004|Overall Study|Adverse Event|0|||
150037399|NCT04323124|541277176|FG005|Overall Study|Adverse Event|1|||
150037400|NCT04323124|541277177|FG006|Overall Study|Adverse Event|0|||
150172760|NCT00367055|541768087|FG000|Overall Study|Patient's Willing|3|||
150037401|NCT04323124|541277178|FG007|Overall Study|Adverse Event|1|||
150037402|NCT04323124|541277179|FG008|Overall Study|Adverse Event|1|||
150037403|NCT04323124|541277180|FG009|Overall Study|Adverse Event|0|||
150172761|NCT00367055|541768088|FG001|Overall Study|Patient's Willing|2|||
149849079|NCT00840658|540576009|FG000|Overall Study|Death|2|||
149849080|NCT00840658|540576010|FG001|Overall Study|Death|2|||
150037404|NCT04323124|541277181|FG010|Overall Study|Adverse Event|0|||
150172762|NCT00367055|541768087|FG000|Overall Study|Lack of Efficacy|1|||
150037405|NCT04323124|541277182|FG011|Overall Study|Adverse Event|0|||
150037406|NCT04323124|541277183|FG012|Overall Study|Adverse Event|0|||
150037407|NCT04323124|541277184|FG013|Overall Study|Adverse Event|0|||
150037408|NCT04323124|541277185|FG014|Overall Study|Adverse Event|0|||
150037409|NCT04323124|541277171|FG000|Overall Study|Other|0|||
150037410|NCT04323124|541277172|FG001|Overall Study|Other|0|||
150037411|NCT04323124|541277173|FG002|Overall Study|Other|0|||
150037412|NCT04323124|541277174|FG003|Overall Study|Other|0|||
150037413|NCT04323124|541277175|FG004|Overall Study|Other|1|||
150037414|NCT04323124|541277176|FG005|Overall Study|Other|0|||
150037415|NCT04323124|541277177|FG006|Overall Study|Other|0|||
150037416|NCT04323124|541277178|FG007|Overall Study|Other|0|||
150037417|NCT04323124|541277179|FG008|Overall Study|Other|1|||
150037418|NCT04323124|541277180|FG009|Overall Study|Other|0|||
150037419|NCT04323124|541277181|FG010|Overall Study|Other|0|||
150037420|NCT04323124|541277182|FG011|Overall Study|Other|0|||
150037421|NCT04323124|541277183|FG012|Overall Study|Other|0|||
150037422|NCT04323124|541277184|FG013|Overall Study|Other|0|||
149957495|NCT01487161|540977526|FG002|Overall Study|Adverse Event|0|||
149957496|NCT01487161|540977527|FG003|Overall Study|Adverse Event|0|||
149957497|NCT01487161|540977524|FG000|Overall Study|Withdrawal by Subject|1|||
149957498|NCT01487161|540977525|FG001|Overall Study|Withdrawal by Subject|1|||
149957499|NCT01487161|540977526|FG002|Overall Study|Withdrawal by Subject|1|||
149957500|NCT01487161|540977527|FG003|Overall Study|Withdrawal by Subject|2|||
149957501|NCT01487161|540977524|FG000|Overall Study|missing data|0|||
149957502|NCT01487161|540977525|FG001|Overall Study|missing data|1|||
149957503|NCT01487161|540977526|FG002|Overall Study|missing data|0|||
149957504|NCT01487161|540977527|FG003|Overall Study|missing data|0|||
149957505|NCT00663351|540977528|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
149957506|NCT00663351|540977529|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
149957507|NCT00663351|540977528|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
149957508|NCT00663351|540977529|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
149957509|NCT00663351|540977528|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
149957510|NCT00663351|540977529|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
149957511|NCT00663351|540977528|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
149957512|NCT00663351|540977529|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
149957513|NCT00663351|540977528|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
149957514|NCT00663351|540977529|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
149957515|NCT00663351|540977528|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
149957516|NCT00663351|540977529|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
149957517|NCT03113136|540977530|FG000|Overall Study|Lost to Follow-up|22|||
149957518|NCT03113136|540977531|FG001|Overall Study|Lost to Follow-up|47|||
149957519|NCT03113136|540977532|FG002|Overall Study|Lost to Follow-up|54|||
149957520|NCT03113136|540977530|FG000|Overall Study|Withdrawal by Subject|4|||
149957521|NCT03113136|540977531|FG001|Overall Study|Withdrawal by Subject|13|||
149957522|NCT03113136|540977532|FG002|Overall Study|Withdrawal by Subject|14|||
149957523|NCT03113136|540977530|FG000|Overall Study|Ineligible|0|||
149957524|NCT03113136|540977531|FG001|Overall Study|Ineligible|2|||
149957525|NCT03113136|540977532|FG002|Overall Study|Ineligible|1|||
149957526|NCT03113136|540977530|FG000|Overall Study|Study Team Decision|1|||
149957527|NCT03113136|540977531|FG001|Overall Study|Study Team Decision|4|||
149957528|NCT03113136|540977532|FG002|Overall Study|Study Team Decision|0|||
149957529|NCT02362412|540977533|FG000|Treatment Period III|Lost to Follow-up|0|||
149957530|NCT02362412|540977534|FG001|Treatment Period III|Lost to Follow-up|1|||
149957531|NCT00977561|540977535|FG000|Overall Study|Death|3|||
149957532|NCT00977561|540977536|FG001|Overall Study|Death|2|||
149957533|NCT00977561|540977535|FG000|Overall Study|Study terminated|0|||
149957534|NCT00977561|540977536|FG001|Overall Study|Study terminated|2|||
149957535|NCT00977561|540977535|FG000|Overall Study|Other|2|||
149957536|NCT00977561|540977536|FG001|Overall Study|Other|0|||
149957537|NCT02021318|540977539|FG000|Overall Study|Adverse Event|2|||
149957538|NCT02021318|540977540|FG001|Overall Study|Adverse Event|1|||
149957539|NCT02021318|540977539|FG000|Overall Study|Death|33|||
149957540|NCT02021318|540977540|FG001|Overall Study|Death|34|||
149957541|NCT02021318|540977539|FG000|Overall Study|Lost to Follow-up|3|||
149957542|NCT02021318|540977540|FG001|Overall Study|Lost to Follow-up|3|||
150037423|NCT04323124|541277185|FG014|Overall Study|Other|0|||
150037424|NCT04323124|541277171|FG000|Overall Study|Coming from a red zone (COVID)|0|||
150037425|NCT04323124|541277172|FG001|Overall Study|Coming from a red zone (COVID)|0|||
149957543|NCT02021318|540977539|FG000|Overall Study|Progressive Disease|0|||
149957544|NCT02021318|540977540|FG001|Overall Study|Progressive Disease|1|||
149957545|NCT02021318|540977539|FG000|Overall Study|Withdrawal by Subject|30|||
149957546|NCT02021318|540977540|FG001|Overall Study|Withdrawal by Subject|18|||
149957547|NCT02021318|540977539|FG000|Overall Study|Physician Decision|3|||
149957548|NCT02021318|540977540|FG001|Overall Study|Physician Decision|3|||
150037426|NCT04323124|541277173|FG002|Overall Study|Coming from a red zone (COVID)|0|||
150037427|NCT04323124|541277174|FG003|Overall Study|Coming from a red zone (COVID)|0|||
150037428|NCT04323124|541277175|FG004|Overall Study|Coming from a red zone (COVID)|1|||
150037429|NCT04323124|541277176|FG005|Overall Study|Coming from a red zone (COVID)|1|||
150037430|NCT04323124|541277177|FG006|Overall Study|Coming from a red zone (COVID)|0|||
150037431|NCT04323124|541277178|FG007|Overall Study|Coming from a red zone (COVID)|0|||
150037432|NCT04323124|541277179|FG008|Overall Study|Coming from a red zone (COVID)|0|||
150037433|NCT04323124|541277180|FG009|Overall Study|Coming from a red zone (COVID)|0|||
150037434|NCT04323124|541277181|FG010|Overall Study|Coming from a red zone (COVID)|0|||
150037435|NCT04323124|541277182|FG011|Overall Study|Coming from a red zone (COVID)|0|||
150037436|NCT04323124|541277183|FG012|Overall Study|Coming from a red zone (COVID)|0|||
150037437|NCT04323124|541277184|FG013|Overall Study|Coming from a red zone (COVID)|0|||
150037438|NCT04323124|541277185|FG014|Overall Study|Coming from a red zone (COVID)|0|||
150037439|NCT04323124|541277171|FG000|Overall Study|No longer meets eligibility criteria|0|||
150037440|NCT04323124|541277172|FG001|Overall Study|No longer meets eligibility criteria|0|||
150037441|NCT04323124|541277173|FG002|Overall Study|No longer meets eligibility criteria|0|||
150037442|NCT04323124|541277174|FG003|Overall Study|No longer meets eligibility criteria|0|||
150037443|NCT04323124|541277175|FG004|Overall Study|No longer meets eligibility criteria|0|||
150037444|NCT04323124|541277176|FG005|Overall Study|No longer meets eligibility criteria|0|||
150037445|NCT04323124|541277177|FG006|Overall Study|No longer meets eligibility criteria|0|||
150037446|NCT04323124|541277178|FG007|Overall Study|No longer meets eligibility criteria|1|||
150037447|NCT04323124|541277179|FG008|Overall Study|No longer meets eligibility criteria|0|||
150037448|NCT04323124|541277180|FG009|Overall Study|No longer meets eligibility criteria|0|||
150037449|NCT04323124|541277181|FG010|Overall Study|No longer meets eligibility criteria|0|||
150037450|NCT04323124|541277182|FG011|Overall Study|No longer meets eligibility criteria|0|||
150037451|NCT04323124|541277183|FG012|Overall Study|No longer meets eligibility criteria|0|||
150037452|NCT04323124|541277184|FG013|Overall Study|No longer meets eligibility criteria|1|||
150037453|NCT04323124|541277185|FG014|Overall Study|No longer meets eligibility criteria|1|||
150037454|NCT04323124|541277171|FG000|Overall Study|Study terminated by sponsor|0|||
150037455|NCT04323124|541277172|FG001|Overall Study|Study terminated by sponsor|0|||
150037456|NCT04323124|541277173|FG002|Overall Study|Study terminated by sponsor|0|||
150037457|NCT04323124|541277174|FG003|Overall Study|Study terminated by sponsor|0|||
150037458|NCT04323124|541277175|FG004|Overall Study|Study terminated by sponsor|0|||
150037459|NCT04323124|541277176|FG005|Overall Study|Study terminated by sponsor|0|||
150037460|NCT04323124|541277177|FG006|Overall Study|Study terminated by sponsor|0|||
150037461|NCT04323124|541277178|FG007|Overall Study|Study terminated by sponsor|0|||
150037462|NCT04323124|541277179|FG008|Overall Study|Study terminated by sponsor|0|||
150037463|NCT04323124|541277180|FG009|Overall Study|Study terminated by sponsor|0|||
150037464|NCT04323124|541277181|FG010|Overall Study|Study terminated by sponsor|0|||
150037465|NCT04323124|541277182|FG011|Overall Study|Study terminated by sponsor|2|||
150037466|NCT04323124|541277183|FG012|Overall Study|Study terminated by sponsor|1|||
150037467|NCT04323124|541277184|FG013|Overall Study|Study terminated by sponsor|0|||
150037468|NCT04323124|541277185|FG014|Overall Study|Study terminated by sponsor|0|||
150037469|NCT01710501|541278777|FG000|Overall Study|Lost to Follow-up|2|||
150037470|NCT01710501|541278778|FG001|Overall Study|Lost to Follow-up|0|||
150037471|NCT01710501|541278779|FG002|Overall Study|Lost to Follow-up|0|||
150037472|NCT02536976|541278780|FG000|Overall Study|Physician Decision|0|||
150037473|NCT02536976|541278781|FG001|Overall Study|Physician Decision|1|||
150037474|NCT02144610|541278782|FG000|Overall Study|Physician Decision|1|||
150037475|NCT02144610|541278783|FG001|Overall Study|Physician Decision|0|||
150037476|NCT02144610|541278782|FG000|Overall Study|Withdrawal by Subject|1|||
150037477|NCT02144610|541278783|FG001|Overall Study|Withdrawal by Subject|5|||
150037478|NCT02144610|541278782|FG000|Overall Study|Death|2|||
150037479|NCT02144610|541278783|FG001|Overall Study|Death|2|||
150037480|NCT02144610|541278782|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
150037481|NCT02144610|541278783|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
150037482|NCT02144610|541278782|FG000|Overall Study|Other|0|||
150037483|NCT02144610|541278783|FG001|Overall Study|Other|1|||
150037484|NCT01354899|541278785|FG000|Overall Study|discharge from the hospital|2|||
150037485|NCT01354899|541278785|FG000|Overall Study|Protocol Violation|1|||
150037486|NCT00463567|541278786|FG000|Overall Study|Adverse Event|29|||
150037487|NCT00463567|541278787|FG001|Overall Study|Adverse Event|26|||
150037488|NCT00463567|541278788|FG002|Overall Study|Adverse Event|17|||
150037489|NCT00463567|541278789|FG003|Overall Study|Adverse Event|46|||
150037490|NCT00463567|541278790|FG004|Overall Study|Adverse Event|10|||
150037491|NCT00463567|541278791|FG005|Overall Study|Adverse Event|10|||
150037492|NCT00463567|541278792|FG006|Overall Study|Adverse Event|4|||
150037493|NCT00463567|541278786|FG000|Overall Study|Withdrawal by Subject|29|||
150172763|NCT00367055|541768088|FG001|Overall Study|Lack of Efficacy|2|||
150172764|NCT00367055|541768087|FG000|Overall Study|Lost to Follow-up|1|||
150172765|NCT00367055|541768088|FG001|Overall Study|Lost to Follow-up|1|||
150037494|NCT00463567|541278787|FG001|Overall Study|Withdrawal by Subject|22|||
150037495|NCT00463567|541278788|FG002|Overall Study|Withdrawal by Subject|20|||
150037496|NCT00463567|541278789|FG003|Overall Study|Withdrawal by Subject|37|||
150037497|NCT00463567|541278790|FG004|Overall Study|Withdrawal by Subject|6|||
150037498|NCT00463567|541278791|FG005|Overall Study|Withdrawal by Subject|5|||
150037499|NCT00463567|541278792|FG006|Overall Study|Withdrawal by Subject|1|||
150037500|NCT00463567|541278786|FG000|Overall Study|Protocol Deviation|13|||
150037501|NCT00463567|541278787|FG001|Overall Study|Protocol Deviation|9|||
150037502|NCT00463567|541278788|FG002|Overall Study|Protocol Deviation|14|||
150037503|NCT00463567|541278789|FG003|Overall Study|Protocol Deviation|11|||
150037504|NCT00463567|541278790|FG004|Overall Study|Protocol Deviation|1|||
150037505|NCT00463567|541278791|FG005|Overall Study|Protocol Deviation|1|||
150037506|NCT00463567|541278792|FG006|Overall Study|Protocol Deviation|2|||
150037507|NCT00463567|541278786|FG000|Overall Study|Lost to Follow-up|12|||
150037508|NCT00463567|541278787|FG001|Overall Study|Lost to Follow-up|6|||
150037509|NCT00463567|541278788|FG002|Overall Study|Lost to Follow-up|13|||
150037510|NCT00463567|541278789|FG003|Overall Study|Lost to Follow-up|8|||
150037511|NCT00463567|541278790|FG004|Overall Study|Lost to Follow-up|1|||
150037512|NCT00463567|541278791|FG005|Overall Study|Lost to Follow-up|1|||
150037513|NCT00463567|541278792|FG006|Overall Study|Lost to Follow-up|1|||
150037514|NCT00463567|541278786|FG000|Overall Study|Administrative problems|5|||
150037515|NCT00463567|541278787|FG001|Overall Study|Administrative problems|3|||
150037516|NCT00463567|541278788|FG002|Overall Study|Administrative problems|6|||
150037517|NCT00463567|541278789|FG003|Overall Study|Administrative problems|9|||
150037518|NCT00463567|541278790|FG004|Overall Study|Administrative problems|3|||
150037519|NCT00463567|541278791|FG005|Overall Study|Administrative problems|2|||
150037520|NCT00463567|541278792|FG006|Overall Study|Administrative problems|2|||
150037521|NCT00463567|541278786|FG000|Overall Study|Lack of Efficacy|4|||
150037522|NCT00463567|541278787|FG001|Overall Study|Lack of Efficacy|9|||
150037523|NCT00463567|541278788|FG002|Overall Study|Lack of Efficacy|9|||
150037524|NCT00463567|541278789|FG003|Overall Study|Lack of Efficacy|17|||
150037525|NCT00463567|541278790|FG004|Overall Study|Lack of Efficacy|1|||
150037526|NCT00463567|541278791|FG005|Overall Study|Lack of Efficacy|0|||
150037527|NCT00463567|541278792|FG006|Overall Study|Lack of Efficacy|1|||
150037528|NCT00463567|541278786|FG000|Overall Study|Abnormal lab value(s)|1|||
150037529|NCT00463567|541278787|FG001|Overall Study|Abnormal lab value(s)|1|||
150037530|NCT00463567|541278788|FG002|Overall Study|Abnormal lab value(s)|2|||
150037531|NCT00463567|541278789|FG003|Overall Study|Abnormal lab value(s)|1|||
150037532|NCT00463567|541278790|FG004|Overall Study|Abnormal lab value(s)|1|||
150037533|NCT00463567|541278791|FG005|Overall Study|Abnormal lab value(s)|0|||
150037534|NCT00463567|541278792|FG006|Overall Study|Abnormal lab value(s)|0|||
150037535|NCT00463567|541278786|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150037536|NCT00463567|541278787|FG001|Overall Study|Abnormal test procedure result(s)|1|||
150037537|NCT00463567|541278788|FG002|Overall Study|Abnormal test procedure result(s)|6|||
150037538|NCT00463567|541278789|FG003|Overall Study|Abnormal test procedure result(s)|2|||
150037539|NCT00463567|541278790|FG004|Overall Study|Abnormal test procedure result(s)|0|||
150037540|NCT00463567|541278791|FG005|Overall Study|Abnormal test procedure result(s)|2|||
150037541|NCT00463567|541278792|FG006|Overall Study|Abnormal test procedure result(s)|0|||
150037542|NCT00463567|541278786|FG000|Overall Study|Death|1|||
150037543|NCT00463567|541278787|FG001|Overall Study|Death|0|||
150037544|NCT00463567|541278788|FG002|Overall Study|Death|2|||
150037545|NCT00463567|541278789|FG003|Overall Study|Death|0|||
150037546|NCT00463567|541278790|FG004|Overall Study|Death|0|||
150037547|NCT00463567|541278791|FG005|Overall Study|Death|0|||
149849081|NCT00840658|540576011|FG002|Overall Study|Death|3|||
149849082|NCT00840658|540576012|FG003|Overall Study|Death|3|||
149849083|NCT00840658|540576009|FG000|Overall Study|Lost to Follow-up|3|||
149849084|NCT00840658|540576010|FG001|Overall Study|Lost to Follow-up|1|||
149849085|NCT00840658|540576011|FG002|Overall Study|Lost to Follow-up|2|||
149849086|NCT00840658|540576012|FG003|Overall Study|Lost to Follow-up|1|||
149849087|NCT04697173|540576013|FG000|Overall Study|Withdrawal by Subject|34|||
149849088|NCT04697173|540576014|FG001|Overall Study|Withdrawal by Subject|38|||
149849089|NCT05004649|540576019|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
149849090|NCT05004649|540576019|FG000|Overall Study|Lost to Follow-up|1|||
149849091|NCT05004649|540576019|FG000|Overall Study|Withdrawal by Subject|2|||
149849092|NCT05004649|540576019|FG000|Overall Study|COVID-19|1|||
149849093|NCT00301964|540576020|FG000|Overall Study|Second primary|2|||
149849094|NCT00301964|540576020|FG000|Overall Study|Wrong primary|1|||
149849095|NCT00301964|540576020|FG000|Overall Study|Inadequate pathology|1|||
149849096|NCT02385708|540576021|FG000|Overall Study|Withdrawal by Subject|0|||
149849097|NCT02385708|540576022|FG001|Overall Study|Withdrawal by Subject|2|||
149849098|NCT02385708|540576021|FG000|Overall Study|Withdrawn - surgery canceled|2|||
149957549|NCT02021318|540977539|FG000|Overall Study|Miscellaneous|2|||
149957550|NCT02021318|540977540|FG001|Overall Study|Miscellaneous|3|||
149957551|NCT00689052|540977541|FG000|Overall Study|Adverse Event|4|||
149957552|NCT00689052|540977542|FG001|Overall Study|Adverse Event|6|||
149957553|NCT00689052|540977541|FG000|Overall Study|Protocol Violation|1|||
149957554|NCT00689052|540977542|FG001|Overall Study|Protocol Violation|0|||
149957555|NCT00689052|540977541|FG000|Overall Study|Lost to Follow-up|2|||
149957556|NCT00689052|540977542|FG001|Overall Study|Lost to Follow-up|0|||
149957557|NCT00689052|540977541|FG000|Overall Study|Withdrawal by Subject|2|||
149957558|NCT00689052|540977542|FG001|Overall Study|Withdrawal by Subject|0|||
149957559|NCT00689052|540977541|FG000|Overall Study|Early termination of the trial|22|||
149957560|NCT00689052|540977542|FG001|Overall Study|Early termination of the trial|24|||
150037548|NCT00463567|541278792|FG006|Overall Study|Death|0|||
150037549|NCT00641667|541278795|FG000|Overall Study|Withdrawal by Subject|1|||
150037550|NCT00641667|541278795|FG000|Overall Study|Adverse Event|1|||
150037551|NCT00641667|541278795|FG000|Overall Study|Physician Decision|1|||
150037552|NCT00641667|541278795|FG000|Overall Study|Worsening of underlying disease|3|||
150037553|NCT01421719|541278796|FG000|Overall Study|Withdrawal by Subject|4|||
150037554|NCT01124006|541278797|FG000|Overall Study|Withdrawal by Subject|2|||
150037555|NCT01124006|541278798|FG001|Overall Study|Withdrawal by Subject|2|||
150037556|NCT01124006|541278799|FG002|Overall Study|Withdrawal by Subject|0|||
150037557|NCT01124006|541278797|FG000|Overall Study|Lost to Follow-up|1|||
150037558|NCT01124006|541278798|FG001|Overall Study|Lost to Follow-up|0|||
150037559|NCT01124006|541278799|FG002|Overall Study|Lost to Follow-up|1|||
150037560|NCT01124006|541278797|FG000|Overall Study|Other|0|||
150037561|NCT01124006|541278798|FG001|Overall Study|Other|0|||
150037562|NCT01124006|541278799|FG002|Overall Study|Other|1|||
150037563|NCT01712399|541278803|FG000|Overall Study|Lost to Follow-up|1|||
150037564|NCT01712399|541278803|FG000|Overall Study|Withdrawal by Subject|39|||
150037565|NCT01712399|541278803|FG000|Overall Study|Death|1|||
150037566|NCT01712399|541278803|FG000|Overall Study|Adverse Event|11|||
150037567|NCT01712399|541278803|FG000|Overall Study|Study closure|345|||
150037568|NCT01357850|541278804|FG000|Overall Study|Lost to Follow-up|1|||
150037569|NCT01357850|541278805|FG001|Overall Study|Lost to Follow-up|0|||
150037570|NCT01357850|541278806|FG002|Overall Study|Lost to Follow-up|0|||
150037571|NCT01357850|541278807|FG003|Overall Study|Lost to Follow-up|0|||
150037572|NCT04610281|541278808|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
150037573|NCT04610281|541278809|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
150037574|NCT02435992|541278820|FG000|Overall Study|non compliance with protocol|2|||
150037575|NCT02435992|541278821|FG001|Overall Study|non compliance with protocol|0|||
150037576|NCT02435992|541278822|FG002|Overall Study|non compliance with protocol|1|||
150037577|NCT02435992|541278823|FG003|Overall Study|non compliance with protocol|0|||
150037578|NCT02435992|541278824|FG004|Overall Study|non compliance with protocol|0|||
150037579|NCT02435992|541278820|FG000|Overall Study|Adverse Event|11|||
150037580|NCT02435992|541278821|FG001|Overall Study|Adverse Event|6|||
150037581|NCT02435992|541278822|FG002|Overall Study|Adverse Event|12|||
150037582|NCT02435992|541278823|FG003|Overall Study|Adverse Event|0|||
150037583|NCT02435992|541278824|FG004|Overall Study|Adverse Event|0|||
150037584|NCT02435992|541278820|FG000|Overall Study|Lack of Efficacy|4|||
150037585|NCT02435992|541278821|FG001|Overall Study|Lack of Efficacy|10|||
150037586|NCT02435992|541278822|FG002|Overall Study|Lack of Efficacy|9|||
150037587|NCT02435992|541278823|FG003|Overall Study|Lack of Efficacy|0|||
150037588|NCT02435992|541278824|FG004|Overall Study|Lack of Efficacy|0|||
150037589|NCT02435992|541278820|FG000|Overall Study|Withdrawal by Subject|10|||
150037590|NCT02435992|541278821|FG001|Overall Study|Withdrawal by Subject|8|||
150037591|NCT02435992|541278822|FG002|Overall Study|Withdrawal by Subject|20|||
150037592|NCT02435992|541278823|FG003|Overall Study|Withdrawal by Subject|0|||
150037593|NCT02435992|541278824|FG004|Overall Study|Withdrawal by Subject|0|||
150037594|NCT02435992|541278820|FG000|Overall Study|Other Reason|1|||
150037595|NCT02435992|541278821|FG001|Overall Study|Other Reason|0|||
150037596|NCT02435992|541278822|FG002|Overall Study|Other Reason|0|||
150037597|NCT02435992|541278823|FG003|Overall Study|Other Reason|0|||
150037598|NCT02435992|541278824|FG004|Overall Study|Other Reason|0|||
150037599|NCT02435992|541278820|FG000|Overall Study|Physician Decision|0|||
150037600|NCT02435992|541278821|FG001|Overall Study|Physician Decision|0|||
150037601|NCT02435992|541278822|FG002|Overall Study|Physician Decision|1|||
150037602|NCT02435992|541278823|FG003|Overall Study|Physician Decision|0|||
150037603|NCT02435992|541278824|FG004|Overall Study|Physician Decision|0|||
150037604|NCT00907335|541278825|FG000|Overall Study|Withdrawal by Subject|2|||
150037605|NCT00907335|541278826|FG001|Overall Study|Withdrawal by Subject|0|||
150037606|NCT00907335|541278825|FG000|Overall Study|Adverse Event|4|||
150037607|NCT00907335|541278826|FG001|Overall Study|Adverse Event|1|||
150037608|NCT00907335|541278825|FG000|Overall Study|Lost to Follow-up|2|||
150037609|NCT00907335|541278826|FG001|Overall Study|Lost to Follow-up|0|||
150037610|NCT03879772|541278827|FG000|Overall Study|Adverse Event|2|||
150037611|NCT03879772|541278828|FG001|Overall Study|Adverse Event|2|||
150037612|NCT03879772|541278829|FG002|Overall Study|Adverse Event|3|||
150037613|NCT03879772|541278830|FG003|Overall Study|Adverse Event|4|||
150037614|NCT03879772|541278831|FG004|Overall Study|Adverse Event|3|||
150037615|NCT03879772|541278827|FG000|Overall Study|Treatment Failure|1|||
150037616|NCT03879772|541278828|FG001|Overall Study|Treatment Failure|0|||
150037617|NCT03879772|541278829|FG002|Overall Study|Treatment Failure|0|||
150037618|NCT03879772|541278830|FG003|Overall Study|Treatment Failure|2|||
150037619|NCT03879772|541278831|FG004|Overall Study|Treatment Failure|1|||
150037620|NCT03879772|541278827|FG000|Overall Study|Lost to Follow-up|0|||
150037621|NCT03879772|541278828|FG001|Overall Study|Lost to Follow-up|0|||
150037622|NCT03879772|541278829|FG002|Overall Study|Lost to Follow-up|0|||
150037623|NCT03879772|541278830|FG003|Overall Study|Lost to Follow-up|0|||
150037624|NCT03879772|541278831|FG004|Overall Study|Lost to Follow-up|1|||
150037625|NCT03879772|541278827|FG000|Overall Study|Withdrawal by Subject|0|||
149849099|NCT02385708|540576022|FG001|Overall Study|Withdrawn - surgery canceled|5|||
149849100|NCT02385708|540576021|FG000|Overall Study|Investigator decision|5|||
149849101|NCT02385708|540576022|FG001|Overall Study|Investigator decision|7|||
149849102|NCT02385708|540576021|FG000|Overall Study|Protocol Violation|1|||
149849103|NCT02385708|540576022|FG001|Overall Study|Protocol Violation|1|||
149849104|NCT01143337|540576024|FG000|Overall Study|Adverse Event|3|||
149849105|NCT01143337|540576025|FG001|Overall Study|Adverse Event|9|||
149849106|NCT01143337|540576026|FG002|Overall Study|Adverse Event|5|||
149849107|NCT01143337|540576024|FG000|Overall Study|Lack of Efficacy|6|||
149849108|NCT01143337|540576025|FG001|Overall Study|Lack of Efficacy|2|||
149849109|NCT01143337|540576026|FG002|Overall Study|Lack of Efficacy|1|||
149849110|NCT01143337|540576024|FG000|Overall Study|Protocol Violation|1|||
149849111|NCT01143337|540576025|FG001|Overall Study|Protocol Violation|0|||
149849112|NCT01143337|540576026|FG002|Overall Study|Protocol Violation|0|||
149849113|NCT01143337|540576024|FG000|Overall Study|Withdrawal by Subject|0|||
149849114|NCT01143337|540576025|FG001|Overall Study|Withdrawal by Subject|0|||
149849115|NCT01143337|540576026|FG002|Overall Study|Withdrawal by Subject|1|||
149849116|NCT01143337|540576024|FG000|Overall Study|Other reason|0|||
149849117|NCT01143337|540576025|FG001|Overall Study|Other reason|0|||
149849118|NCT01143337|540576026|FG002|Overall Study|Other reason|5|||
149849119|NCT02761915|540576027|FG000|Overall Study|Death|3|||
149849120|NCT02761915|540576028|FG001|Overall Study|Death|1|||
149849121|NCT02761915|540576029|FG002|Overall Study|Death|1|||
149957561|NCT02405962|540977543|FG000|Overall Study|Lost to Follow-up|1|||
149957562|NCT02405962|540977544|FG001|Overall Study|Lost to Follow-up|4|||
149957563|NCT02405962|540977543|FG000|Overall Study|A participant has moved to another place|0|||
149957564|NCT02405962|540977544|FG001|Overall Study|A participant has moved to another place|1|||
149957565|NCT03601052|540977545|FG000|Overall Study|Lost to Follow-up|2|||
149957566|NCT00837330|540977546|FG000|Overall Study|Lost to Follow-up|1|||
149957567|NCT00837330|540977547|FG001|Overall Study|Lost to Follow-up|3|||
149957568|NCT03882801|540979947|FG000|Period 1|Adverse Event|0|||
149957569|NCT03882801|540979948|FG001|Period 1|Adverse Event|1|||
149957570|NCT03882801|540979947|FG000|Period 1|Non-compliance with study drug|1|||
149957571|NCT03882801|540979948|FG001|Period 1|Non-compliance with study drug|1|||
149957572|NCT03882801|540979947|FG000|Period 1|Never treated with study drug|1|||
149957573|NCT03882801|540979948|FG001|Period 1|Never treated with study drug|0|||
149957574|NCT03882801|540979947|FG000|Washout Period|Physician Decision|0|||
149957575|NCT03882801|540979948|FG001|Washout Period|Physician Decision|1|||
149957576|NCT03882801|540979947|FG000|Period 2|Non-compliance with study drug|0|||
149957577|NCT03882801|540979948|FG001|Period 2|Non-compliance with study drug|1|||
149957578|NCT01567085|540979949|FG000|Overall Study|Death|6|||
149957579|NCT01567085|540979949|FG000|Overall Study|Adverse Event|6|||
149957580|NCT01567085|540979949|FG000|Overall Study|Lost to Follow-up|3|||
149957581|NCT01567085|540979949|FG000|Overall Study|Graft loss|2|||
149957582|NCT01567085|540979949|FG000|Overall Study|Renal transplantectomy|1|||
149957583|NCT01567085|540979949|FG000|Overall Study|Returned to chronic dialysis|1|||
149957584|NCT01567085|540979949|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
149957585|NCT03537729|540979953|FG000|Overall Study|Death|2|||
149957586|NCT03537729|540979954|FG001|Overall Study|Death|2|||
149957587|NCT03537729|540979955|FG002|Overall Study|Death|7|||
149957588|NCT03537729|540979953|FG000|Overall Study|Withdrawal by Subject|3|||
149957589|NCT03537729|540979954|FG001|Overall Study|Withdrawal by Subject|3|||
149957590|NCT03537729|540979955|FG002|Overall Study|Withdrawal by Subject|0|||
149957591|NCT03537729|540979953|FG000|Overall Study|Subject Moved|8|||
149957592|NCT03537729|540979954|FG001|Overall Study|Subject Moved|5|||
149957593|NCT03537729|540979955|FG002|Overall Study|Subject Moved|4|||
149957594|NCT03537729|540979953|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
149957595|NCT03537729|540979954|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
149957596|NCT03537729|540979955|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
149957597|NCT03537729|540979953|FG000|Overall Study|COVID-19 Site Restrictions|11|||
149957598|NCT03537729|540979954|FG001|Overall Study|COVID-19 Site Restrictions|15|||
149957599|NCT03537729|540979955|FG002|Overall Study|COVID-19 Site Restrictions|18|||
149957600|NCT03537729|540979953|FG000|Overall Study|Decline in Health|5|||
149957601|NCT03537729|540979954|FG001|Overall Study|Decline in Health|9|||
149957602|NCT03537729|540979955|FG002|Overall Study|Decline in Health|4|||
149957603|NCT03537729|540979953|FG000|Overall Study|Determined Ineligible|0|||
149957604|NCT03537729|540979954|FG001|Overall Study|Determined Ineligible|0|||
149957605|NCT03537729|540979955|FG002|Overall Study|Determined Ineligible|1|||
149957606|NCT00504556|540979963|FG000|Overall Study|Adverse Event|11|||
149957607|NCT00504556|540979964|FG001|Overall Study|Adverse Event|11|||
149957608|NCT00504556|540979965|FG002|Overall Study|Adverse Event|14|||
149957609|NCT00504556|540979966|FG003|Overall Study|Adverse Event|13|||
149957610|NCT00504556|540979967|FG004|Overall Study|Adverse Event|5|||
149957611|NCT00504556|540979963|FG000|Overall Study|Death|3|||
149957612|NCT00504556|540979964|FG001|Overall Study|Death|3|||
149957613|NCT00504556|540979965|FG002|Overall Study|Death|1|||
149957614|NCT00504556|540979966|FG003|Overall Study|Death|0|||
149849122|NCT02761915|540576030|FG003|Overall Study|Death|1|||
150037626|NCT03879772|541278828|FG001|Overall Study|Withdrawal by Subject|1|||
150037627|NCT03879772|541278829|FG002|Overall Study|Withdrawal by Subject|3|||
150037628|NCT03879772|541278830|FG003|Overall Study|Withdrawal by Subject|1|||
150037629|NCT03879772|541278831|FG004|Overall Study|Withdrawal by Subject|1|||
150037630|NCT03879772|541278827|FG000|Overall Study|Protocol Violation|0|||
150037631|NCT03879772|541278828|FG001|Overall Study|Protocol Violation|0|||
150037632|NCT03879772|541278829|FG002|Overall Study|Protocol Violation|3|||
150037633|NCT03879772|541278830|FG003|Overall Study|Protocol Violation|1|||
150037634|NCT03879772|541278831|FG004|Overall Study|Protocol Violation|2|||
150037635|NCT03879772|541278827|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
150037636|NCT03879772|541278828|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
150037637|NCT03879772|541278829|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
150037638|NCT03879772|541278830|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
150037639|NCT03879772|541278831|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
150037640|NCT00912808|541278832|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
150037641|NCT00912808|541278833|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
150037642|NCT00912808|541278832|FG000|Washout|Withdrawal by Subject|0|||
150037643|NCT00912808|541278833|FG001|Washout|Withdrawal by Subject|1|||
150037644|NCT00912808|541278832|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
150037645|NCT00912808|541278833|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
150037646|NCT00912808|541278832|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
150037647|NCT00912808|541278833|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
150037648|NCT03345784|541278836|FG000|Overall Study|Withdrawal by Subject|2|||
150037649|NCT03345784|541278837|FG001|Overall Study|Withdrawal by Subject|1|||
150037650|NCT00482053|541278842|FG000|Inter-treatment Period|Disease progression|1|||
150037651|NCT00728689|541278845|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
150037652|NCT00728689|541278846|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
150037653|NCT00389610|541278855|FG000|Overall Study|Disease Progression|0|||
150037654|NCT00389610|541278856|FG001|Overall Study|Disease Progression|19|||
150037655|NCT00389610|541278855|FG000|Overall Study|Death|0|||
150037656|NCT00389610|541278856|FG001|Overall Study|Death|1|||
150037657|NCT00389610|541278855|FG000|Overall Study|Physician Decision|0|||
150037658|NCT00389610|541278856|FG001|Overall Study|Physician Decision|1|||
150037659|NCT00389610|541278855|FG000|Overall Study|Withdrawal by Subject|0|||
150037660|NCT00389610|541278856|FG001|Overall Study|Withdrawal by Subject|1|||
150037661|NCT00538902|541278857|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
150037662|NCT00538902|541278858|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
150037663|NCT00538902|541278859|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
150037664|NCT00538902|541278857|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
149849123|NCT02761915|540576031|FG004|Overall Study|Death|0|||
150037665|NCT00538902|541278858|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
150037666|NCT00538902|541278859|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
150037667|NCT00538902|541278857|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
149849124|NCT02761915|540576032|FG005|Overall Study|Death|1|||
150037668|NCT00538902|541278858|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
150037669|NCT00538902|541278859|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
150037670|NCT00538902|541278857|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
150037671|NCT00538902|541278858|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
150172766|NCT00367055|541768087|FG000|Overall Study|Protocol Violation|0|||
149957615|NCT00504556|540979967|FG004|Overall Study|Death|2|||
149957616|NCT00504556|540979963|FG000|Overall Study|Protocol Violation|1|||
149957617|NCT00504556|540979964|FG001|Overall Study|Protocol Violation|3|||
149957618|NCT00504556|540979965|FG002|Overall Study|Protocol Violation|2|||
149957619|NCT00504556|540979966|FG003|Overall Study|Protocol Violation|1|||
149957620|NCT00504556|540979967|FG004|Overall Study|Protocol Violation|2|||
149957621|NCT00504556|540979963|FG000|Overall Study|Lost to Follow-up|0|||
149957622|NCT00504556|540979964|FG001|Overall Study|Lost to Follow-up|0|||
149957623|NCT00504556|540979965|FG002|Overall Study|Lost to Follow-up|1|||
149957624|NCT00504556|540979966|FG003|Overall Study|Lost to Follow-up|1|||
149957625|NCT00504556|540979967|FG004|Overall Study|Lost to Follow-up|1|||
149957626|NCT00504556|540979963|FG000|Overall Study|Withdrawal by Subject|16|||
149957627|NCT00504556|540979964|FG001|Overall Study|Withdrawal by Subject|16|||
149957628|NCT00504556|540979965|FG002|Overall Study|Withdrawal by Subject|7|||
149957629|NCT00504556|540979966|FG003|Overall Study|Withdrawal by Subject|8|||
149957630|NCT00504556|540979967|FG004|Overall Study|Withdrawal by Subject|12|||
149957631|NCT00504556|540979963|FG000|Overall Study|administrative reasons|0|||
149957632|NCT00504556|540979964|FG001|Overall Study|administrative reasons|2|||
149957633|NCT00504556|540979965|FG002|Overall Study|administrative reasons|2|||
149957634|NCT00504556|540979966|FG003|Overall Study|administrative reasons|1|||
149957635|NCT00504556|540979967|FG004|Overall Study|administrative reasons|2|||
149957636|NCT00504556|540979963|FG000|Overall Study|did not meet entry criteria|2|||
149957637|NCT00504556|540979964|FG001|Overall Study|did not meet entry criteria|0|||
149957638|NCT00504556|540979965|FG002|Overall Study|did not meet entry criteria|1|||
149957639|NCT00504556|540979966|FG003|Overall Study|did not meet entry criteria|1|||
149957640|NCT00504556|540979967|FG004|Overall Study|did not meet entry criteria|0|||
149957641|NCT00504556|540979963|FG000|Overall Study|data monitor committee decision|0|||
149957642|NCT00504556|540979964|FG001|Overall Study|data monitor committee decision|0|||
149957643|NCT00504556|540979965|FG002|Overall Study|data monitor committee decision|0|||
149957644|NCT00504556|540979966|FG003|Overall Study|data monitor committee decision|100|||
149957645|NCT00504556|540979967|FG004|Overall Study|data monitor committee decision|0|||
149957646|NCT00504556|540979963|FG000|Overall Study|Other|2|||
149957647|NCT00504556|540979964|FG001|Overall Study|Other|2|||
149957648|NCT00504556|540979965|FG002|Overall Study|Other|2|||
149957649|NCT00504556|540979966|FG003|Overall Study|Other|3|||
149957650|NCT00504556|540979967|FG004|Overall Study|Other|0|||
149957651|NCT00504556|540979963|FG000|Overall Study|not in safety analysis set|0|||
149957652|NCT00504556|540979964|FG001|Overall Study|not in safety analysis set|1|||
149957653|NCT00504556|540979965|FG002|Overall Study|not in safety analysis set|1|||
149957654|NCT00504556|540979966|FG003|Overall Study|not in safety analysis set|0|||
149957655|NCT00504556|540979967|FG004|Overall Study|not in safety analysis set|1|||
149957656|NCT00676052|540979968|FG000|Overall Study|Adverse Event|0|||
149957657|NCT00676052|540979969|FG001|Overall Study|Adverse Event|1|||
149957658|NCT00676052|540979970|FG002|Overall Study|Adverse Event|1|||
149957659|NCT00676052|540979971|FG003|Overall Study|Adverse Event|2|||
149957660|NCT00676052|540979972|FG004|Overall Study|Adverse Event|2|||
149957661|NCT00676052|540979973|FG005|Overall Study|Adverse Event|2|||
149957662|NCT00676052|540979968|FG000|Overall Study|Lack of Efficacy|2|||
149957663|NCT00676052|540979969|FG001|Overall Study|Lack of Efficacy|2|||
149957664|NCT00676052|540979970|FG002|Overall Study|Lack of Efficacy|1|||
149957665|NCT00676052|540979971|FG003|Overall Study|Lack of Efficacy|1|||
149957666|NCT00676052|540979972|FG004|Overall Study|Lack of Efficacy|2|||
149957667|NCT00676052|540979973|FG005|Overall Study|Lack of Efficacy|1|||
149957668|NCT00676052|540979968|FG000|Overall Study|Protocol Violation|5|||
149957669|NCT00676052|540979969|FG001|Overall Study|Protocol Violation|3|||
149957670|NCT00676052|540979970|FG002|Overall Study|Protocol Violation|2|||
149957671|NCT00676052|540979971|FG003|Overall Study|Protocol Violation|2|||
149957672|NCT00676052|540979972|FG004|Overall Study|Protocol Violation|1|||
149957673|NCT00676052|540979973|FG005|Overall Study|Protocol Violation|2|||
149957674|NCT00676052|540979968|FG000|Overall Study|Lost to Follow-up|0|||
149957675|NCT00676052|540979969|FG001|Overall Study|Lost to Follow-up|0|||
149957676|NCT00676052|540979970|FG002|Overall Study|Lost to Follow-up|0|||
149957677|NCT00676052|540979971|FG003|Overall Study|Lost to Follow-up|0|||
149957678|NCT00676052|540979972|FG004|Overall Study|Lost to Follow-up|1|||
149957679|NCT00676052|540979973|FG005|Overall Study|Lost to Follow-up|0|||
149957680|NCT00676052|540979968|FG000|Overall Study|Physician Decision|1|||
149957681|NCT00676052|540979969|FG001|Overall Study|Physician Decision|1|||
149957682|NCT00676052|540979970|FG002|Overall Study|Physician Decision|1|||
149957683|NCT00676052|540979971|FG003|Overall Study|Physician Decision|0|||
149957684|NCT00676052|540979972|FG004|Overall Study|Physician Decision|0|||
149957685|NCT00676052|540979973|FG005|Overall Study|Physician Decision|1|||
149957686|NCT00676052|540979968|FG000|Overall Study|Withdrawal by Subject|1|||
149957687|NCT00676052|540979969|FG001|Overall Study|Withdrawal by Subject|0|||
149957688|NCT00676052|540979970|FG002|Overall Study|Withdrawal by Subject|1|||
149957689|NCT00676052|540979971|FG003|Overall Study|Withdrawal by Subject|0|||
149957690|NCT00676052|540979972|FG004|Overall Study|Withdrawal by Subject|0|||
149957691|NCT00676052|540979973|FG005|Overall Study|Withdrawal by Subject|0|||
149957692|NCT02930941|540979974|FG000|Overall Study|Lost to Follow-up|1|||
150037672|NCT00538902|541278859|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
150037673|NCT00538902|541278857|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
150037674|NCT00538902|541278858|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
150037675|NCT00538902|541278859|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
150037676|NCT00538902|541278857|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
150037677|NCT00538902|541278858|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
150037678|NCT00538902|541278859|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
150037679|NCT00538902|541278857|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
150037680|NCT00538902|541278858|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
150037681|NCT00538902|541278859|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
150037682|NCT00538902|541278857|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
150037683|NCT00538902|541278858|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
150037684|NCT00538902|541278859|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
150037685|NCT00887809|541278860|FG000|Overall Study|Patient Not Treated|3|||
150037686|NCT00887809|541278861|FG001|Overall Study|Patient Not Treated|0|||
150037687|NCT00887809|541278860|FG000|Overall Study|Death|1|||
150037688|NCT00887809|541278861|FG001|Overall Study|Death|0|||
150037689|NCT04109547|541278866|FG000|Overall Study|Withdrawal by Subject|3|||
150037690|NCT04109547|541278867|FG001|Overall Study|Withdrawal by Subject|2|||
150037691|NCT04109547|541278868|FG002|Overall Study|Withdrawal by Subject|6|||
150037692|NCT04109547|541278869|FG003|Overall Study|Withdrawal by Subject|6|||
150037693|NCT04109547|541278866|FG000|Overall Study|Lost to Follow-up|0|||
150037694|NCT04109547|541278867|FG001|Overall Study|Lost to Follow-up|0|||
150037695|NCT04109547|541278868|FG002|Overall Study|Lost to Follow-up|0|||
150037696|NCT04109547|541278869|FG003|Overall Study|Lost to Follow-up|1|||
150037697|NCT04109547|541278866|FG000|Overall Study|Physician Decision|1|||
150037698|NCT04109547|541278867|FG001|Overall Study|Physician Decision|2|||
150037699|NCT04109547|541278868|FG002|Overall Study|Physician Decision|0|||
150037700|NCT04109547|541278869|FG003|Overall Study|Physician Decision|0|||
150037701|NCT01550003|541278870|FG000|Overall Study|Adverse Event|0|||
150037702|NCT01550003|541278871|FG001|Overall Study|Adverse Event|9|||
149849125|NCT02761915|540576027|FG000|Overall Study|Withdrawal by Subject|1|||
149849126|NCT02761915|540576028|FG001|Overall Study|Withdrawal by Subject|0|||
149849127|NCT02761915|540576029|FG002|Overall Study|Withdrawal by Subject|0|||
149849128|NCT02761915|540576030|FG003|Overall Study|Withdrawal by Subject|0|||
149849129|NCT02761915|540576031|FG004|Overall Study|Withdrawal by Subject|1|||
149849130|NCT02761915|540576032|FG005|Overall Study|Withdrawal by Subject|2|||
149849131|NCT02761915|540576027|FG000|Overall Study|Disease Progression|0|||
149849132|NCT02761915|540576028|FG001|Overall Study|Disease Progression|0|||
149849133|NCT02761915|540576029|FG002|Overall Study|Disease Progression|0|||
149849134|NCT02761915|540576030|FG003|Overall Study|Disease Progression|2|||
149849135|NCT02761915|540576031|FG004|Overall Study|Disease Progression|2|||
149849136|NCT02761915|540576032|FG005|Overall Study|Disease Progression|2|||
149849137|NCT04133311|540576033|FG000|Period 1 Double Masked Treatment Period|Death|1|||
149849138|NCT04133311|540576034|FG001|Period 1 Double Masked Treatment Period|Death|0|||
149849139|NCT04133311|540576035|FG002|Period 1 Double Masked Treatment Period|Death|0|||
149849140|NCT04133311|540576036|FG003|Period 1 Double Masked Treatment Period|Death|0|||
149849141|NCT04133311|540576033|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
149849142|NCT04133311|540576034|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
149849143|NCT04133311|540576035|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
149849144|NCT04133311|540576036|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
149849145|NCT04133311|540576033|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
149849146|NCT04133311|540576034|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
149849147|NCT04133311|540576035|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
149849148|NCT04133311|540576036|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
149849149|NCT04133311|540576033|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
149849150|NCT04133311|540576034|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
149849151|NCT04133311|540576035|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
149849152|NCT04133311|540576036|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
149849153|NCT04133311|540576033|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
149849154|NCT04133311|540576034|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
149849155|NCT04133311|540576035|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
149849156|NCT04133311|540576036|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
149849157|NCT04133311|540576033|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
149849158|NCT04133311|540576034|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
149849159|NCT04133311|540576035|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
150037703|NCT01550003|541278872|FG002|Overall Study|Adverse Event|15|||
150037704|NCT01550003|541278870|FG000|Overall Study|Lack of Efficacy|4|||
150037705|NCT01550003|541278871|FG001|Overall Study|Lack of Efficacy|11|||
150037706|NCT01550003|541278872|FG002|Overall Study|Lack of Efficacy|15|||
150037707|NCT01550003|541278870|FG000|Overall Study|Protocol Violation|0|||
150037708|NCT01550003|541278871|FG001|Overall Study|Protocol Violation|3|||
150037709|NCT01550003|541278872|FG002|Overall Study|Protocol Violation|2|||
150037710|NCT01550003|541278870|FG000|Overall Study|Lost to Follow-up|1|||
150037711|NCT01550003|541278871|FG001|Overall Study|Lost to Follow-up|4|||
150037712|NCT01550003|541278872|FG002|Overall Study|Lost to Follow-up|8|||
150037713|NCT01550003|541278870|FG000|Overall Study|Consent withdrawn|2|||
150037714|NCT01550003|541278871|FG001|Overall Study|Consent withdrawn|11|||
150037715|NCT01550003|541278872|FG002|Overall Study|Consent withdrawn|23|||
150037716|NCT01550003|541278870|FG000|Overall Study|Missing|1|||
150037717|NCT01550003|541278871|FG001|Overall Study|Missing|0|||
150037718|NCT01550003|541278872|FG002|Overall Study|Missing|2|||
150037719|NCT01550003|541278870|FG000|Overall Study|Study closure as announced by sponsor|7|||
150037720|NCT01550003|541278871|FG001|Overall Study|Study closure as announced by sponsor|6|||
150037721|NCT01550003|541278872|FG002|Overall Study|Study closure as announced by sponsor|24|||
150037722|NCT01550003|541278870|FG000|Overall Study|Protocol Noncompliance|1|||
150037723|NCT01550003|541278871|FG001|Overall Study|Protocol Noncompliance|0|||
150037724|NCT01550003|541278872|FG002|Overall Study|Protocol Noncompliance|0|||
150037725|NCT01550003|541278870|FG000|Overall Study|Study closure|0|||
150037726|NCT01550003|541278871|FG001|Overall Study|Study closure|1|||
150037727|NCT01550003|541278872|FG002|Overall Study|Study closure|1|||
150037728|NCT01550003|541278870|FG000|Overall Study|Patient reached adulthood|0|||
150037729|NCT01550003|541278871|FG001|Overall Study|Patient reached adulthood|1|||
150037730|NCT01550003|541278872|FG002|Overall Study|Patient reached adulthood|0|||
150037731|NCT01550003|541278870|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
150037732|NCT01550003|541278871|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
150037733|NCT01550003|541278872|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
150037734|NCT01550003|541278870|FG000|Overall Study|Sponsor's order|0|||
150037735|NCT01550003|541278871|FG001|Overall Study|Sponsor's order|3|||
150037736|NCT01550003|541278872|FG002|Overall Study|Sponsor's order|3|||
150037737|NCT01550003|541278870|FG000|Overall Study|Sponsor's decision|1|||
150037738|NCT01550003|541278871|FG001|Overall Study|Sponsor's decision|5|||
150037739|NCT01550003|541278872|FG002|Overall Study|Sponsor's decision|4|||
150037740|NCT01550003|541278870|FG000|Overall Study|Subject mother passed away|0|||
150037741|NCT01550003|541278871|FG001|Overall Study|Subject mother passed away|1|||
150037742|NCT01550003|541278872|FG002|Overall Study|Subject mother passed away|0|||
150037743|NCT01550003|541278870|FG000|Overall Study|Discontinuation|0|||
150037744|NCT01550003|541278871|FG001|Overall Study|Discontinuation|1|||
150037745|NCT01550003|541278872|FG002|Overall Study|Discontinuation|0|||
150037746|NCT01550003|541278870|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
150037747|NCT01550003|541278871|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
150037748|NCT01550003|541278872|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
150037749|NCT01550003|541278870|FG000|Overall Study|Site closure|0|||
150037750|NCT01550003|541278871|FG001|Overall Study|Site closure|2|||
150037751|NCT01550003|541278872|FG002|Overall Study|Site closure|0|||
150037752|NCT01550003|541278870|FG000|Overall Study|Pregnancy|0|||
150037753|NCT01550003|541278871|FG001|Overall Study|Pregnancy|1|||
150037754|NCT01550003|541278872|FG002|Overall Study|Pregnancy|0|||
150037755|NCT01550003|541278870|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
150037756|NCT01550003|541278871|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
149849160|NCT04133311|540576036|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
149849161|NCT04133311|540576033|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
149849162|NCT04133311|540576034|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
149849163|NCT04133311|540576035|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
149849164|NCT04133311|540576036|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
149849165|NCT04133311|540576033|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
149849166|NCT04133311|540576034|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
149849167|NCT04133311|540576035|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
149849168|NCT04133311|540576036|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
150037757|NCT01550003|541278872|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
150037758|NCT01550003|541278870|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
150037759|NCT01550003|541278871|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
150037760|NCT01550003|541278872|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
150037761|NCT01550003|541278870|FG000|Overall Study|Switching to adult rheumatologist|0|||
150037762|NCT01550003|541278871|FG001|Overall Study|Switching to adult rheumatologist|0|||
150037763|NCT01550003|541278872|FG002|Overall Study|Switching to adult rheumatologist|1|||
150037764|NCT01550003|541278870|FG000|Overall Study|Patient transition to adult care|0|||
150037765|NCT01550003|541278871|FG001|Overall Study|Patient transition to adult care|0|||
150037766|NCT01550003|541278872|FG002|Overall Study|Patient transition to adult care|1|||
150037767|NCT01550003|541278870|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
150037768|NCT01550003|541278871|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
149849169|NCT00728754|540576039|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
150037769|NCT01550003|541278872|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
150172767|NCT00367055|541768088|FG001|Overall Study|Protocol Violation|1|||
149849170|NCT00728754|540576040|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
149849171|NCT00728754|540576039|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
149849172|NCT00728754|540576040|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
150037770|NCT01550003|541278870|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
150037771|NCT01550003|541278871|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
150037772|NCT01550003|541278872|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
150037773|NCT01550003|541278870|FG000|Overall Study|Per Sponsor request|1|||
150037774|NCT01550003|541278871|FG001|Overall Study|Per Sponsor request|0|||
150037775|NCT01550003|541278872|FG002|Overall Study|Per Sponsor request|1|||
150037776|NCT01550003|541278870|FG000|Overall Study|Patient not compliance|0|||
150037777|NCT01550003|541278871|FG001|Overall Study|Patient not compliance|0|||
150037778|NCT01550003|541278872|FG002|Overall Study|Patient not compliance|1|||
150037779|NCT01550003|541278870|FG000|Overall Study|Non-compliance|0|||
150037780|NCT01550003|541278871|FG001|Overall Study|Non-compliance|0|||
150037781|NCT01550003|541278872|FG002|Overall Study|Non-compliance|1|||
150037782|NCT01550003|541278870|FG000|Overall Study|Study closed|0|||
150037783|NCT01550003|541278871|FG001|Overall Study|Study closed|1|||
150037784|NCT01550003|541278872|FG002|Overall Study|Study closed|0|||
150037785|NCT01550003|541278870|FG000|Overall Study|Transitioned to adult rheumatology|0|||
150037786|NCT01550003|541278871|FG001|Overall Study|Transitioned to adult rheumatology|0|||
150037787|NCT01550003|541278872|FG002|Overall Study|Transitioned to adult rheumatology|1|||
150037788|NCT05567783|541278873|FG000|Overall Study|Death|2|||
150037789|NCT05567783|541278874|FG001|Overall Study|Death|3|||
150037790|NCT05567783|541278875|FG002|Overall Study|Death|0|||
150037791|NCT05567783|541278873|FG000|Overall Study|Lost to Follow-up|25|||
150172768|NCT00367055|541768087|FG000|Overall Study|Stopping Criterion Met|0|||
150172769|NCT00367055|541768088|FG001|Overall Study|Stopping Criterion Met|1|||
149849173|NCT00728754|540576039|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
149849174|NCT00728754|540576040|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
149849175|NCT01859598|540576041|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
149849176|NCT00573313|540576046|FG000|Overall Study|Protocol Violation|5|||
149849177|NCT00573313|540576047|FG001|Overall Study|Protocol Violation|0|||
149849178|NCT00573313|540576048|FG002|Overall Study|Protocol Violation|6|||
149849179|NCT00573313|540576049|FG003|Overall Study|Protocol Violation|0|||
149849180|NCT00354159|540576053|FG000|Randomized Study Period|Withdrawal by Subject|5|||
149849181|NCT00354159|540576054|FG001|Randomized Study Period|Withdrawal by Subject|3|||
149849182|NCT00354159|540576053|FG000|Randomized Study Period|Physician Decision|6|||
149849183|NCT00354159|540576054|FG001|Randomized Study Period|Physician Decision|10|||
149849184|NCT00354159|540576053|FG000|Randomized Study Period|Lost to Follow-up|4|||
149849185|NCT00354159|540576054|FG001|Randomized Study Period|Lost to Follow-up|0|||
149849186|NCT00354159|540576053|FG000|Randomized Study Period|Death|7|||
149849187|NCT00354159|540576054|FG001|Randomized Study Period|Death|9|||
149849188|NCT00354159|540576053|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
149849189|NCT00354159|540576054|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
149849190|NCT00354159|540576053|FG000|Long-term Follow-up|Physician Decision|127|||
149849191|NCT00354159|540576054|FG001|Long-term Follow-up|Physician Decision|122|||
149849192|NCT00354159|540576053|FG000|Long-term Follow-up|Lost to Follow-up|1|||
149849193|NCT00354159|540576054|FG001|Long-term Follow-up|Lost to Follow-up|0|||
149849194|NCT00354159|540576053|FG000|Long-term Follow-up|Death|14|||
149849195|NCT00354159|540576054|FG001|Long-term Follow-up|Death|11|||
149849196|NCT00354159|540576053|FG000|Long-term Follow-up|Study Closed|29|||
149849197|NCT00354159|540576054|FG001|Long-term Follow-up|Study Closed|34|||
149849198|NCT02229084|540576055|FG000|Overall Study|Adverse Event|1|||
149849199|NCT02229084|540576056|FG001|Overall Study|Adverse Event|0|||
149849200|NCT02229084|540576057|FG002|Overall Study|Adverse Event|0|||
149849201|NCT02229084|540576058|FG003|Overall Study|Adverse Event|0|||
149849202|NCT02229084|540576059|FG004|Overall Study|Adverse Event|0|||
149849203|NCT02229084|540576060|FG005|Overall Study|Adverse Event|0|||
149849204|NCT02229084|540576061|FG006|Overall Study|Adverse Event|0|||
149849205|NCT02229084|540576055|FG000|Overall Study|Lost to Follow-up|0|||
149849206|NCT02229084|540576056|FG001|Overall Study|Lost to Follow-up|0|||
149849207|NCT02229084|540576057|FG002|Overall Study|Lost to Follow-up|1|||
149849208|NCT02229084|540576058|FG003|Overall Study|Lost to Follow-up|1|||
149849209|NCT02229084|540576059|FG004|Overall Study|Lost to Follow-up|0|||
149849210|NCT02229084|540576060|FG005|Overall Study|Lost to Follow-up|0|||
149849211|NCT02229084|540576061|FG006|Overall Study|Lost to Follow-up|1|||
149849212|NCT02229084|540576055|FG000|Overall Study|Physician Decision|0|||
149849213|NCT02229084|540576056|FG001|Overall Study|Physician Decision|0|||
149849214|NCT02229084|540576057|FG002|Overall Study|Physician Decision|0|||
149849215|NCT02229084|540576058|FG003|Overall Study|Physician Decision|1|||
149849216|NCT02229084|540576059|FG004|Overall Study|Physician Decision|3|||
149849217|NCT02229084|540576060|FG005|Overall Study|Physician Decision|0|||
149849218|NCT02229084|540576061|FG006|Overall Study|Physician Decision|1|||
149849219|NCT02229084|540576055|FG000|Overall Study|Withdrawal by Subject|0|||
150037792|NCT05567783|541278874|FG001|Overall Study|Lost to Follow-up|19|||
150037793|NCT05567783|541278875|FG002|Overall Study|Lost to Follow-up|17|||
150037794|NCT05567783|541278873|FG000|Overall Study|Physician Decision|10|||
149849220|NCT02229084|540576056|FG001|Overall Study|Withdrawal by Subject|0|||
149849221|NCT02229084|540576057|FG002|Overall Study|Withdrawal by Subject|1|||
149849222|NCT02229084|540576058|FG003|Overall Study|Withdrawal by Subject|0|||
149849223|NCT02229084|540576059|FG004|Overall Study|Withdrawal by Subject|1|||
149849224|NCT02229084|540576060|FG005|Overall Study|Withdrawal by Subject|1|||
149849225|NCT02229084|540576061|FG006|Overall Study|Withdrawal by Subject|1|||
149849226|NCT02229084|540576055|FG000|Overall Study|Death|0|||
149849227|NCT02229084|540576056|FG001|Overall Study|Death|0|||
149849228|NCT02229084|540576057|FG002|Overall Study|Death|0|||
149849229|NCT02229084|540576058|FG003|Overall Study|Death|0|||
149849230|NCT02229084|540576059|FG004|Overall Study|Death|0|||
149957693|NCT02930941|540979975|FG001|Overall Study|Lost to Follow-up|2|||
149957694|NCT00585169|540979980|FG000|Overall Study|Withdrawal by Subject|1|||
149957695|NCT01964560|540979996|FG000|Overall Study|Adverse Event|23|||
149957696|NCT01964560|540979996|FG000|Overall Study|Lack of Efficacy|46|||
149957697|NCT01964560|540979996|FG000|Overall Study|Protocol deviation|2|||
149957698|NCT01964560|540979996|FG000|Overall Study|Lost to Follow-up|4|||
149957699|NCT01964560|540979996|FG000|Overall Study|Withdrawal by Subject|64|||
149957700|NCT01964560|540979996|FG000|Overall Study|Surgery-hemispherotomy|1|||
149957701|NCT01964560|540979996|FG000|Overall Study|Surgery|1|||
149957702|NCT01964560|540979996|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
149957703|NCT01964560|540979996|FG000|Overall Study|Patient and Investigator choice|1|||
149957704|NCT01964560|540979996|FG000|Overall Study|Patient was prescribed CBD|1|||
149957705|NCT01964560|540979996|FG000|Overall Study|Participant moved to another country|1|||
149957706|NCT00710554|540980002|FG000|Overall Study|Adverse Event|24|||
149957707|NCT00710554|540980003|FG001|Overall Study|Adverse Event|7|||
149957708|NCT00710554|540980002|FG000|Overall Study|Withdrawal by Subject|7|||
149957709|NCT00710554|540980003|FG001|Overall Study|Withdrawal by Subject|3|||
149957710|NCT00710554|540980002|FG000|Overall Study|Lost to Follow-up|7|||
149957711|NCT00710554|540980003|FG001|Overall Study|Lost to Follow-up|1|||
149957712|NCT00710554|540980002|FG000|Overall Study|Lack of Efficacy|11|||
149957713|NCT00710554|540980003|FG001|Overall Study|Lack of Efficacy|12|||
149957714|NCT00710554|540980002|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
149957715|NCT00710554|540980003|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
149957716|NCT01093885|540980004|FG000|Overall Study|Adverse Event|4|||
149957717|NCT01093885|540980004|FG000|Overall Study|Lost to Follow-up|1|||
149957718|NCT01301001|540980005|FG000|First Intervention|Lost to Follow-up|4|||
149957719|NCT01301001|540980006|FG001|First Intervention|Lost to Follow-up|4|||
149957720|NCT01301001|540980005|FG000|First Intervention|Withdrawal by Subject|1|||
149957721|NCT01301001|540980006|FG001|First Intervention|Withdrawal by Subject|4|||
149957722|NCT01301001|540980005|FG000|First Intervention|Adverse Event|5|||
149957723|NCT01301001|540980006|FG001|First Intervention|Adverse Event|0|||
149957724|NCT01301001|540980005|FG000|First Intervention|Protocol Violation|0|||
149957725|NCT01301001|540980006|FG001|First Intervention|Protocol Violation|1|||
149957726|NCT01301001|540980005|FG000|Second Intervention|Adverse Event|2|||
149957727|NCT01301001|540980006|FG001|Second Intervention|Adverse Event|0|||
149957728|NCT01301001|540980005|FG000|Second Intervention|Withdrawal by Subject|2|||
149957729|NCT01301001|540980006|FG001|Second Intervention|Withdrawal by Subject|0|||
149957730|NCT01560988|540980007|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
149957731|NCT01560988|540980008|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
149957732|NCT01560988|540980007|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
149957733|NCT01560988|540980008|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
149957734|NCT01560988|540980007|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
149957735|NCT01560988|540980008|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
149957736|NCT02301429|540980015|FG000|Overall Study|not acceptable vascular anatomy|3|||
149957737|NCT01502072|540980016|FG000|Overall Study|Withdrawal by Subject|1|||
149957738|NCT01502072|540980017|FG001|Overall Study|Withdrawal by Subject|0|||
149957739|NCT01502072|540980018|FG002|Overall Study|Withdrawal by Subject|0|||
149957740|NCT01502072|540980016|FG000|Overall Study|Death|0|||
149957741|NCT01502072|540980017|FG001|Overall Study|Death|1|||
149957742|NCT01502072|540980018|FG002|Overall Study|Death|0|||
149957743|NCT04535362|540980033|FG000|Overall Study|Lost to Follow-up|3|||
149957744|NCT04535362|540980034|FG001|Overall Study|Lost to Follow-up|1|||
149957745|NCT02018887|540980037|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
149957746|NCT02018887|540980038|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957747|NCT02018887|540980039|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957748|NCT02018887|540980040|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957749|NCT02018887|540980041|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957750|NCT02018887|540980042|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149849231|NCT02229084|540576060|FG005|Overall Study|Death|0|||
149957751|NCT02018887|540980043|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149849232|NCT02229084|540576061|FG006|Overall Study|Death|1|||
149849233|NCT01868243|540576064|FG000|Overall Study|Death|0|||
149957752|NCT02018887|540980044|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
150037795|NCT05567783|541278874|FG001|Overall Study|Physician Decision|7|||
150037796|NCT05567783|541278875|FG002|Overall Study|Physician Decision|9|||
150037797|NCT05567783|541278873|FG000|Overall Study|Study Terminated by Sponsor|924|||
150037798|NCT05567783|541278874|FG001|Overall Study|Study Terminated by Sponsor|937|||
150037799|NCT05567783|541278875|FG002|Overall Study|Study Terminated by Sponsor|941|||
150037800|NCT05567783|541278873|FG000|Overall Study|Withdrawal by Subject|23|||
150037801|NCT05567783|541278874|FG001|Overall Study|Withdrawal by Subject|27|||
150037802|NCT05567783|541278875|FG002|Overall Study|Withdrawal by Subject|24|||
150037803|NCT05567783|541278873|FG000|Overall Study|Incarcerated|1|||
150037804|NCT05567783|541278874|FG001|Overall Study|Incarcerated|0|||
150037805|NCT05567783|541278875|FG002|Overall Study|Incarcerated|0|||
150037806|NCT05567783|541278873|FG000|Overall Study|Participant randomized in error|4|||
150037807|NCT05567783|541278874|FG001|Overall Study|Participant randomized in error|2|||
150037808|NCT05567783|541278875|FG002|Overall Study|Participant randomized in error|2|||
150037809|NCT03675126|541278878|FG000|Overall Study|Study Terminated by Sponsor|9|||
150037810|NCT03675126|541278878|FG000|Overall Study|Death|2|||
150037811|NCT03675126|541278878|FG000|Overall Study|Withdrawal by Subject|4|||
150037812|NCT00001959|541278879|FG000|Overall Study|newly diagnosed colon cancer|1|||
150037813|NCT00001959|541278879|FG000|Overall Study|disabling sedation|1|||
150037814|NCT00001959|541278879|FG000|Overall Study|non-compliance|1|||
150037815|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
150037816|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
150037817|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
150037818|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
150037819|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
150037820|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
150037821|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
150037822|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
150037823|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
150037824|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
150037825|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
150037826|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
150037827|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
150037828|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
150037829|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
150037830|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
150037831|NCT03773978|541278882|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
150037832|NCT03773978|541278883|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
150037833|NCT03773978|541278882|FG000|DBW Period|Adverse Event|2|||
150037834|NCT03773978|541278883|FG001|DBW Period|Adverse Event|2|||
150037835|NCT03773978|541278882|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
150037836|NCT03773978|541278883|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
150037837|NCT03773978|541278882|FG000|DBW Period|Withdrawal by Subject|2|||
150037838|NCT03773978|541278883|FG001|DBW Period|Withdrawal by Subject|1|||
150037839|NCT03773978|541278882|FG000|DBW Period|Due to epidemic or pandemic|5|||
150037840|NCT03773978|541278883|FG001|DBW Period|Due to epidemic or pandemic|6|||
150037841|NCT03773978|541278882|FG000|DBW Period|Study team decision|1|||
150037842|NCT03773978|541278883|FG001|DBW Period|Study team decision|0|||
150037843|NCT03113487|541278884|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
150037844|NCT03777982|541278885|FG000|Overall Study|Physician Decision|0|||
150037845|NCT03777982|541278886|FG001|Overall Study|Physician Decision|1|||
150037846|NCT03995368|541278889|FG000|Overall Study|Lost to Follow-up|1|||
150037847|NCT03995368|541278890|FG001|Overall Study|Lost to Follow-up|4|||
150037848|NCT03995368|541278891|FG002|Overall Study|Lost to Follow-up|1|||
150037849|NCT03995368|541278889|FG000|Overall Study|Did not meet inclusion criteria|1|||
150037850|NCT03995368|541278890|FG001|Overall Study|Did not meet inclusion criteria|6|||
150037851|NCT03995368|541278891|FG002|Overall Study|Did not meet inclusion criteria|3|||
150037852|NCT03995368|541278889|FG000|Overall Study|Withdrawal by Subject|0|||
150037853|NCT03995368|541278890|FG001|Overall Study|Withdrawal by Subject|1|||
150037854|NCT03995368|541278891|FG002|Overall Study|Withdrawal by Subject|1|||
150172770|NCT00367055|541768087|FG000|Overall Study|Participant Living too Far from Hospital|0|||
150172771|NCT00367055|541768088|FG001|Overall Study|Participant Living too Far from Hospital|1|||
150172772|NCT01123083|541768091|FG000|Overall Study|Investigator recommendation|1|||
150037855|NCT03755934|541278894|FG000|Overall Study|Adverse Event|4|||
150037856|NCT03755934|541278895|FG001|Overall Study|Adverse Event|1|||
150037857|NCT03755934|541278896|FG002|Overall Study|Adverse Event|1|||
150037858|NCT03755934|541278897|FG003|Overall Study|Adverse Event|3|||
150037859|NCT03755934|541278894|FG000|Overall Study|Physician Decision|2|||
150037860|NCT03755934|541278895|FG001|Overall Study|Physician Decision|0|||
150037861|NCT03755934|541278896|FG002|Overall Study|Physician Decision|0|||
150037862|NCT03755934|541278897|FG003|Overall Study|Physician Decision|1|||
150037863|NCT03755934|541278894|FG000|Overall Study|Withdrawal by Subject|5|||
149849234|NCT01868243|540576065|FG001|Overall Study|Death|1|||
150037864|NCT03755934|541278895|FG001|Overall Study|Withdrawal by Subject|0|||
150037865|NCT03755934|541278896|FG002|Overall Study|Withdrawal by Subject|0|||
150037866|NCT03755934|541278897|FG003|Overall Study|Withdrawal by Subject|1|||
150037867|NCT03755934|541278894|FG000|Overall Study|Other|3|||
150037868|NCT03755934|541278895|FG001|Overall Study|Other|1|||
150037869|NCT03755934|541278896|FG002|Overall Study|Other|3|||
150037870|NCT03755934|541278897|FG003|Overall Study|Other|1|||
150037871|NCT00361296|541278900|FG000|Overall Study|Physician Decision|1|||
150037872|NCT00361296|541278900|FG000|Overall Study|Lack of Efficacy|2|||
150037873|NCT02072668|541278904|FG000|Second Intervention|Lost to Follow-up|1|||
150037874|NCT02072668|541278905|FG001|Second Intervention|Lost to Follow-up|0|||
150037875|NCT05523089|541278906|FG000|Overall Study|Withdrawal by Subject|1|||
150037876|NCT05523089|541278907|FG001|Overall Study|Withdrawal by Subject|0|||
150037877|NCT05523089|541278908|FG002|Overall Study|Withdrawal by Subject|0|||
150037878|NCT05523089|541278906|FG000|Overall Study|Lost to Follow-up|1|||
150037879|NCT05523089|541278907|FG001|Overall Study|Lost to Follow-up|0|||
150037880|NCT05523089|541278908|FG002|Overall Study|Lost to Follow-up|0|||
150037881|NCT02514083|541278909|FG000|Overall Study|Adverse Event|1|||
150037882|NCT01899040|541278910|FG000|Overall Study|Randomized in error|0|||
150037883|NCT01899040|541278911|FG001|Overall Study|Randomized in error|1|||
150037884|NCT01899040|541278912|FG002|Overall Study|Randomized in error|1|||
150037885|NCT01899040|541278910|FG000|Overall Study|Adverse Event|3|||
150037886|NCT01899040|541278911|FG001|Overall Study|Adverse Event|1|||
150037887|NCT01899040|541278912|FG002|Overall Study|Adverse Event|2|||
150037888|NCT01899040|541278910|FG000|Overall Study|Unspecified reasons|4|||
150037889|NCT01899040|541278911|FG001|Overall Study|Unspecified reasons|4|||
150037890|NCT01899040|541278912|FG002|Overall Study|Unspecified reasons|0|||
150037891|NCT01899040|541278910|FG000|Overall Study|Compliance issues|1|||
150037892|NCT01899040|541278911|FG001|Overall Study|Compliance issues|2|||
150037893|NCT01899040|541278912|FG002|Overall Study|Compliance issues|0|||
150037894|NCT02083354|541280831|FG000|Overall Study|Withdrawal by Subject|9|||
150037895|NCT02083354|541280831|FG000|Overall Study|Lost to Follow-up|1|||
150037896|NCT02083354|541280831|FG000|Overall Study|Adverse Event|3|||
150037897|NCT02083354|541280831|FG000|Overall Study|Disease progression|46|||
150037898|NCT02083354|541280831|FG000|Overall Study|Study closed/terminated|5|||
150037899|NCT01148979|541280832|FG000|Overall Study|Lost to Follow-up|0|||
150037900|NCT01148979|541280833|FG001|Overall Study|Lost to Follow-up|1|||
150037901|NCT00777153|541280834|FG000|Overall Study|Lost to Follow-up|1|||
150037902|NCT00777153|541280835|FG001|Overall Study|Lost to Follow-up|1|||
150037903|NCT00777153|541280836|FG002|Overall Study|Lost to Follow-up|0|||
150037904|NCT00777153|541280834|FG000|Overall Study|Death|85|||
150037905|NCT00777153|541280835|FG001|Overall Study|Death|73|||
150037906|NCT00777153|541280836|FG002|Overall Study|Death|33|||
150037907|NCT00777153|541280834|FG000|Overall Study|Withdrawal by Subject|3|||
150037908|NCT00777153|541280835|FG001|Overall Study|Withdrawal by Subject|4|||
150037909|NCT00777153|541280836|FG002|Overall Study|Withdrawal by Subject|3|||
150037910|NCT00777153|541280834|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
150037911|NCT00777153|541280835|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
149957753|NCT02018887|540980045|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957754|NCT02018887|540980046|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957755|NCT02018887|540980047|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
149957756|NCT02018887|540980037|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957757|NCT02018887|540980038|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957758|NCT02018887|540980039|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957759|NCT02018887|540980040|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957760|NCT02018887|540980041|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
149957761|NCT02018887|540980042|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957762|NCT02018887|540980043|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
149957763|NCT02018887|540980044|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
149957764|NCT02018887|540980045|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957765|NCT02018887|540980046|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
149957766|NCT02018887|540980047|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
150037912|NCT00777153|541280836|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
150037913|NCT00554216|541280837|FG000|Overall Study|Lost to Follow-up|92|||
150037914|NCT00554216|541280838|FG001|Overall Study|Lost to Follow-up|31|||
150037915|NCT00554216|541280839|FG002|Overall Study|Lost to Follow-up|63|||
150037916|NCT00554216|541280837|FG000|Overall Study|Adverse Event|16|||
149957767|NCT02018887|540980037|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
149957768|NCT02018887|540980038|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
149957769|NCT02018887|540980039|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
150037917|NCT00554216|541280838|FG001|Overall Study|Adverse Event|16|||
150037918|NCT00554216|541280839|FG002|Overall Study|Adverse Event|36|||
150037919|NCT00554216|541280837|FG000|Overall Study|Withdrawal by Subject|92|||
150037920|NCT00554216|541280838|FG001|Overall Study|Withdrawal by Subject|31|||
150037921|NCT00554216|541280839|FG002|Overall Study|Withdrawal by Subject|43|||
150037922|NCT00554216|541280837|FG000|Overall Study|Non compliance|10|||
150037923|NCT00554216|541280838|FG001|Overall Study|Non compliance|4|||
150037924|NCT00554216|541280839|FG002|Overall Study|Non compliance|5|||
150037925|NCT00554216|541280837|FG000|Overall Study|Pregnancy|2|||
150037926|NCT00554216|541280838|FG001|Overall Study|Pregnancy|1|||
150037927|NCT00554216|541280839|FG002|Overall Study|Pregnancy|14|||
150037928|NCT00554216|541280837|FG000|Overall Study|Restricted med|3|||
150037929|NCT00554216|541280838|FG001|Overall Study|Restricted med|1|||
150037930|NCT00554216|541280839|FG002|Overall Study|Restricted med|1|||
150037931|NCT00554216|541280837|FG000|Overall Study|Other|12|||
150037932|NCT00554216|541280838|FG001|Overall Study|Other|7|||
150037933|NCT00554216|541280839|FG002|Overall Study|Other|10|||
150037934|NCT00554216|541280837|FG000|Overall Study|Lack of Efficacy|15|||
150037935|NCT00554216|541280838|FG001|Overall Study|Lack of Efficacy|3|||
150037936|NCT00554216|541280839|FG002|Overall Study|Lack of Efficacy|0|||
150037937|NCT01389596|541280848|FG000|Overall Study|Protocol Violation|3|||
150037938|NCT01389596|541280849|FG001|Overall Study|Protocol Violation|4|||
150037939|NCT01389596|541280850|FG002|Overall Study|Protocol Violation|3|||
150037940|NCT01389596|541280848|FG000|Overall Study|Withdrawal by Subject|1|||
150037941|NCT01389596|541280849|FG001|Overall Study|Withdrawal by Subject|2|||
150037942|NCT01389596|541280850|FG002|Overall Study|Withdrawal by Subject|2|||
150037943|NCT01389596|541280848|FG000|Overall Study|Insufficient Clinical Response|3|||
150037944|NCT01389596|541280849|FG001|Overall Study|Insufficient Clinical Response|4|||
150037945|NCT01389596|541280850|FG002|Overall Study|Insufficient Clinical Response|5|||
150037946|NCT01389596|541280848|FG000|Overall Study|Adverse Event|1|||
150037947|NCT01389596|541280849|FG001|Overall Study|Adverse Event|4|||
150037948|NCT01389596|541280850|FG002|Overall Study|Adverse Event|0|||
150037949|NCT01389596|541280848|FG000|Overall Study|Death|0|||
150037950|NCT01389596|541280849|FG001|Overall Study|Death|1|||
150037951|NCT01389596|541280850|FG002|Overall Study|Death|0|||
150037952|NCT01389596|541280848|FG000|Overall Study|Other Unspecified|2|||
150037953|NCT01389596|541280849|FG001|Overall Study|Other Unspecified|1|||
150037954|NCT01389596|541280850|FG002|Overall Study|Other Unspecified|0|||
150037955|NCT01671319|541280851|FG000|Overall Study|Withdrawal by Subject|1|||
150037956|NCT03038100|541280862|FG000|Overall Study|Death|289|||
150037957|NCT03038100|541280863|FG001|Overall Study|Death|272|||
150037958|NCT03038100|541280862|FG000|Overall Study|Lost to Follow-up|9|||
150037959|NCT03038100|541280863|FG001|Overall Study|Lost to Follow-up|10|||
150037960|NCT03038100|541280862|FG000|Overall Study|Protocol Deviation|1|||
150037961|NCT03038100|541280863|FG001|Overall Study|Protocol Deviation|4|||
150037962|NCT03038100|541280862|FG000|Overall Study|Withdrawal by Subject|45|||
150037963|NCT03038100|541280863|FG001|Overall Study|Withdrawal by Subject|51|||
150037964|NCT03038100|541280862|FG000|Overall Study|Study Terminated By Sponsor|305|||
150037965|NCT03038100|541280863|FG001|Overall Study|Study Terminated By Sponsor|311|||
150037966|NCT03038100|541280862|FG000|Overall Study|Physician Decision|1|||
150037967|NCT03038100|541280863|FG001|Overall Study|Physician Decision|3|||
150037968|NCT01198795|541280864|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
150037969|NCT01198795|541280864|FG000|Overall Study|Withdrawal by Subject|17|||
150037970|NCT01198795|541280864|FG000|Overall Study|Lost to Follow-up|15|||
150037971|NCT01198795|541280864|FG000|Overall Study|Adverse Event|9|||
150037972|NCT01198795|541280864|FG000|Overall Study|Lack of Efficacy|5|||
150037973|NCT01198795|541280864|FG000|Overall Study|Protocol Violation|2|||
150037974|NCT01198795|541280864|FG000|Overall Study|Other Reason|4|||
150037975|NCT03250273|541280897|FG000|Overall Study|Disease Progression|2|||
150037976|NCT03250273|541280898|FG001|Overall Study|Disease Progression|11|||
150037977|NCT03250273|541280897|FG000|Overall Study|Death|0|||
150037978|NCT03250273|541280898|FG001|Overall Study|Death|1|||
150037979|NCT04154904|541280899|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
150037980|NCT04154904|541280900|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
150037981|NCT04154904|541280901|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
150037982|NCT02392624|541280902|FG000|Overall Study|Withdrawal by Subject|15|||
150037983|NCT02392624|541280903|FG001|Overall Study|Withdrawal by Subject|12|||
150037984|NCT02392624|541280904|FG002|Overall Study|Withdrawal by Subject|9|||
150037985|NCT02392624|541280902|FG000|Overall Study|Adverse Event|4|||
150037986|NCT02392624|541280903|FG001|Overall Study|Adverse Event|1|||
150037987|NCT02392624|541280904|FG002|Overall Study|Adverse Event|2|||
150037988|NCT02392624|541280902|FG000|Overall Study|Pregnancy|1|||
150037989|NCT02392624|541280903|FG001|Overall Study|Pregnancy|0|||
150037990|NCT02392624|541280904|FG002|Overall Study|Pregnancy|0|||
150037991|NCT02392624|541280902|FG000|Overall Study|Protocol Violation|0|||
150037992|NCT02392624|541280903|FG001|Overall Study|Protocol Violation|0|||
150037993|NCT02392624|541280904|FG002|Overall Study|Protocol Violation|1|||
149849235|NCT00467597|540576066|FG000|Overall Study|Withdrawal by Subject|2|||
150037994|NCT02392624|541280902|FG000|Overall Study|Sponsor/Investigator Decision|2|||
150037995|NCT02392624|541280903|FG001|Overall Study|Sponsor/Investigator Decision|1|||
150037996|NCT02392624|541280904|FG002|Overall Study|Sponsor/Investigator Decision|0|||
150037997|NCT02392624|541280902|FG000|Overall Study|Other|49|||
150037998|NCT02392624|541280903|FG001|Overall Study|Other|1|||
150037999|NCT02392624|541280904|FG002|Overall Study|Other|1|||
150038000|NCT00936715|541280905|FG000|Overall Study|Investigators Discretion|1|||
150038001|NCT00936715|541280905|FG000|Overall Study|Protocol Violation|1|||
150038002|NCT00936715|541280905|FG000|Overall Study|Safety or Tolerability Reasons|4|||
150038003|NCT03819114|541280906|FG000|Overall Study|Protocol Violation|0|||
150038004|NCT03819114|541280907|FG001|Overall Study|Protocol Violation|1|||
150038005|NCT03819114|541280908|FG002|Overall Study|Protocol Violation|1|||
150038006|NCT03819114|541280909|FG003|Overall Study|Protocol Violation|0|||
150038007|NCT03819114|541280906|FG000|Overall Study|Lost to Follow-up|0|||
150038008|NCT03819114|541280907|FG001|Overall Study|Lost to Follow-up|0|||
150038009|NCT03819114|541280908|FG002|Overall Study|Lost to Follow-up|1|||
150038010|NCT03819114|541280909|FG003|Overall Study|Lost to Follow-up|0|||
150038011|NCT03841604|541280910|FG000|Overall Study|Withdrawal by Subject|3|||
150038012|NCT03841604|541280911|FG001|Overall Study|Withdrawal by Subject|1|||
150038013|NCT03841604|541280910|FG000|Overall Study|Adverse Event|4|||
150038014|NCT03841604|541280911|FG001|Overall Study|Adverse Event|2|||
150038015|NCT03841604|541280910|FG000|Overall Study|Physician Decision|1|||
150038016|NCT03841604|541280911|FG001|Overall Study|Physician Decision|0|||
150038017|NCT02492763|541280912|FG000|Overall Study|Withdrawal by Subject|0|||
150038018|NCT02492763|541280913|FG001|Overall Study|Withdrawal by Subject|2|||
150038019|NCT02492763|541280914|FG002|Overall Study|Withdrawal by Subject|1|||
150038020|NCT02492763|541280915|FG003|Overall Study|Withdrawal by Subject|0|||
150038021|NCT02492763|541280912|FG000|Overall Study|Adverse Event|3|||
150038022|NCT02492763|541280913|FG001|Overall Study|Adverse Event|1|||
150038023|NCT02492763|541280914|FG002|Overall Study|Adverse Event|1|||
150038024|NCT02492763|541280915|FG003|Overall Study|Adverse Event|2|||
150038025|NCT02492763|541280912|FG000|Overall Study|Death|0|||
150038026|NCT02492763|541280913|FG001|Overall Study|Death|0|||
150038027|NCT02492763|541280914|FG002|Overall Study|Death|1|||
150038028|NCT02492763|541280915|FG003|Overall Study|Death|0|||
150038029|NCT02492763|541280912|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
150038030|NCT02492763|541280913|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
150038031|NCT02492763|541280914|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
150038032|NCT02492763|541280915|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
150038033|NCT02492763|541280912|FG000|Overall Study|Lost to Follow-up|0|||
150038034|NCT02492763|541280913|FG001|Overall Study|Lost to Follow-up|0|||
150038035|NCT02492763|541280914|FG002|Overall Study|Lost to Follow-up|1|||
150038036|NCT02492763|541280915|FG003|Overall Study|Lost to Follow-up|0|||
150038037|NCT02492763|541280912|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150038038|NCT02492763|541280913|FG001|Overall Study|Non-Compliance With Study Drug|1|||
150038039|NCT02492763|541280914|FG002|Overall Study|Non-Compliance With Study Drug|0|||
150038040|NCT02492763|541280915|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150038041|NCT02492763|541280912|FG000|Overall Study|Screen Failure|0|||
150038042|NCT02492763|541280913|FG001|Overall Study|Screen Failure|0|||
150038043|NCT02492763|541280914|FG002|Overall Study|Screen Failure|0|||
150038044|NCT02492763|541280915|FG003|Overall Study|Screen Failure|1|||
150038045|NCT02492763|541280912|FG000|Overall Study|Study Terminated by Sponsor|13|||
150038046|NCT02492763|541280913|FG001|Overall Study|Study Terminated by Sponsor|10|||
150038047|NCT02492763|541280914|FG002|Overall Study|Study Terminated by Sponsor|6|||
150038048|NCT02492763|541280915|FG003|Overall Study|Study Terminated by Sponsor|10|||
150038049|NCT03877510|541280916|FG000|Overall Study|Death|6|||
150038050|NCT03877510|541280916|FG000|Overall Study|Lost to Follow-up|2|||
150038051|NCT03877510|541280916|FG000|Overall Study|Non-compliance with study drug|2|||
150038052|NCT03877510|541280916|FG000|Overall Study|Lack of Efficacy|14|||
150038053|NCT03877510|541280916|FG000|Overall Study|Adverse Event|20|||
150038054|NCT03877510|541280916|FG000|Overall Study|Withdrawal by Subject|22|||
150038055|NCT03877510|541280916|FG000|Overall Study|Miscellaneous|1|||
150038056|NCT01337960|541280917|FG000|Overall Study|Lost to Follow-up|1|||
150038057|NCT01337960|541280918|FG001|Overall Study|Lost to Follow-up|0|||
150038058|NCT01337960|541280919|FG002|Overall Study|Lost to Follow-up|0|||
150038059|NCT01337960|541280917|FG000|Overall Study|Withdrawal by Subject|1|||
150038060|NCT01337960|541280918|FG001|Overall Study|Withdrawal by Subject|0|||
150038061|NCT01337960|541280919|FG002|Overall Study|Withdrawal by Subject|0|||
150038062|NCT01772316|541280920|FG000|Overall Study|Serious adverse event|1|||
150038063|NCT01772316|541280920|FG000|Overall Study|Inform consent withdrawn|1|||
150038064|NCT01772316|541280920|FG000|Overall Study|Withdrawn by sponsor decision|5|||
150038065|NCT02085161|541280922|FG000|Overall Study|Not Treated|1|||
150038066|NCT02085161|541280923|FG001|Overall Study|Not Treated|0|||
150038067|NCT02085161|541280924|FG002|Overall Study|Not Treated|0|||
150038068|NCT02085161|541280925|FG003|Overall Study|Not Treated|0|||
150038069|NCT02085161|541280922|FG000|Overall Study|Adverse Event|8|||
150038070|NCT02085161|541280923|FG001|Overall Study|Adverse Event|5|||
150038071|NCT02085161|541280924|FG002|Overall Study|Adverse Event|4|||
150038072|NCT02085161|541280925|FG003|Overall Study|Adverse Event|5|||
150038073|NCT02085161|541280922|FG000|Overall Study|Protocol Violation|0|||
150038074|NCT02085161|541280923|FG001|Overall Study|Protocol Violation|1|||
150038075|NCT02085161|541280924|FG002|Overall Study|Protocol Violation|0|||
150038076|NCT02085161|541280925|FG003|Overall Study|Protocol Violation|1|||
150038077|NCT02085161|541280922|FG000|Overall Study|Withdrawal by Subject|2|||
150038078|NCT02085161|541280923|FG001|Overall Study|Withdrawal by Subject|4|||
150038079|NCT02085161|541280924|FG002|Overall Study|Withdrawal by Subject|0|||
150038080|NCT02085161|541280925|FG003|Overall Study|Withdrawal by Subject|3|||
150038081|NCT02085161|541280922|FG000|Overall Study|Other Reason|1|||
149957770|NCT02018887|540980040|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
149957771|NCT02018887|540980041|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
149957772|NCT02018887|540980042|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
149957773|NCT02018887|540980043|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
149957774|NCT02018887|540980044|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
149957775|NCT02018887|540980045|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
149957776|NCT02018887|540980046|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
149957777|NCT02018887|540980047|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
149957778|NCT02018887|540980037|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
149957779|NCT02018887|540980038|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
149957780|NCT02018887|540980039|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
149957781|NCT02018887|540980040|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
149957782|NCT02018887|540980041|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
149957783|NCT02018887|540980042|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
149957784|NCT02018887|540980043|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
149957785|NCT02018887|540980044|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
149957786|NCT02018887|540980045|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
149957787|NCT02018887|540980046|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
149957788|NCT02018887|540980047|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
149957789|NCT01145222|540980048|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
149957790|NCT01145222|540980049|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
149957791|NCT01145222|540980050|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
149957792|NCT01145222|540980051|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
149957793|NCT01145222|540980048|FG000|Overall Study|Poor bowel preparation|0|||
149957794|NCT01145222|540980049|FG001|Overall Study|Poor bowel preparation|0|||
149957795|NCT01145222|540980050|FG002|Overall Study|Poor bowel preparation|0|||
149957796|NCT01145222|540980051|FG003|Overall Study|Poor bowel preparation|1|||
149957797|NCT00927186|540980052|FG000|12 Months Primary Study|Adverse Event|5|||
149957798|NCT00927186|540980053|FG001|12 Months Primary Study|Adverse Event|2|||
149957799|NCT00927186|540980052|FG000|12 Months Primary Study|Lost to Follow-up|1|||
149957800|NCT00927186|540980053|FG001|12 Months Primary Study|Lost to Follow-up|0|||
149957801|NCT00927186|540980052|FG000|12 Months Primary Study|Protocol Violation|0|||
149957802|NCT00927186|540980053|FG001|12 Months Primary Study|Protocol Violation|1|||
149957803|NCT00927186|540980052|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
149957804|NCT00927186|540980053|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
149957805|NCT00604383|540980054|FG000|Overall Study|Withdrawal by Subject|33|||
149957806|NCT00604383|540980055|FG001|Overall Study|Withdrawal by Subject|31|||
149957807|NCT00604383|540980054|FG000|Overall Study|Lost to Follow-up|24|||
149957808|NCT00604383|540980055|FG001|Overall Study|Lost to Follow-up|19|||
149957809|NCT00604383|540980054|FG000|Overall Study|Death|14|||
149957810|NCT00604383|540980055|FG001|Overall Study|Death|22|||
149957811|NCT00604383|540980054|FG000|Overall Study|Adverse Event|16|||
149957812|NCT00604383|540980055|FG001|Overall Study|Adverse Event|9|||
149957813|NCT00604383|540980054|FG000|Overall Study|Physician Decision|0|||
149957814|NCT00604383|540980055|FG001|Overall Study|Physician Decision|3|||
149957815|NCT01011283|540980059|FG000|Overall Study|Adverse Event|4|||
149957816|NCT01011283|540980060|FG001|Overall Study|Adverse Event|2|||
149957817|NCT01011283|540980059|FG000|Overall Study|Progressive Disease|0|||
149957818|NCT01011283|540980060|FG001|Overall Study|Progressive Disease|2|||
149957819|NCT01011283|540980059|FG000|Overall Study|Terminated by Sponsor|5|||
149957820|NCT01011283|540980060|FG001|Overall Study|Terminated by Sponsor|5|||
149957821|NCT01011283|540980059|FG000|Overall Study|Other|2|||
149957822|NCT01011283|540980060|FG001|Overall Study|Other|2|||
149957823|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
149957824|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
149957825|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
149957826|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
149957827|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
149957828|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
149957829|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
149957830|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
149957831|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
149957832|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
149957833|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
149957834|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
149957835|NCT00290758|540980065|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
149957836|NCT00290758|540980066|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
149957837|NCT00290758|540980065|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
149957838|NCT00290758|540980066|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
149957839|NCT02187055|540980074|FG000|Overall Study|Lack of Efficacy|10|||
149957840|NCT02187055|540980075|FG001|Overall Study|Lack of Efficacy|3|||
150038082|NCT02085161|541280923|FG001|Overall Study|Other Reason|0|||
150038083|NCT02085161|541280924|FG002|Overall Study|Other Reason|1|||
150038084|NCT02085161|541280925|FG003|Overall Study|Other Reason|1|||
150038085|NCT01936870|541280929|FG000|Overall Study|No Visit After Treatment|176|||
150038086|NCT01936870|541280929|FG000|Overall Study|Protocol Violation|12|||
150038087|NCT01936870|541280929|FG000|Overall Study|No Drug Administration|1|||
150038088|NCT00628108|541280938|FG000|Overall Study|Adverse Event|0|||
150038089|NCT00628108|541280939|FG001|Overall Study|Adverse Event|3|||
149957841|NCT02187055|540980076|FG002|Overall Study|Lack of Efficacy|7|||
149957842|NCT02187055|540980074|FG000|Overall Study|Lost to Follow-up|2|||
150038090|NCT00628108|541280938|FG000|Overall Study|Withdrawal by Subject|1|||
150038091|NCT00628108|541280939|FG001|Overall Study|Withdrawal by Subject|0|||
150038092|NCT03848832|541280940|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
150038093|NCT03848832|541280941|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
150038094|NCT03848832|541280942|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
150038095|NCT03848832|541280940|FG000|Overall Study|Withdrawal by Subject|0|||
150038096|NCT03848832|541280941|FG001|Overall Study|Withdrawal by Subject|0|||
150038097|NCT03848832|541280942|FG002|Overall Study|Withdrawal by Subject|1|||
150038098|NCT03848832|541280940|FG000|Overall Study|Withdrawal (Covid-19)|0|||
150038099|NCT03848832|541280941|FG001|Overall Study|Withdrawal (Covid-19)|2|||
150038100|NCT03848832|541280942|FG002|Overall Study|Withdrawal (Covid-19)|0|||
150038101|NCT03848832|541280940|FG000|Overall Study|Physician Decision|2|||
150038102|NCT03848832|541280941|FG001|Overall Study|Physician Decision|1|||
150038103|NCT03848832|541280942|FG002|Overall Study|Physician Decision|3|||
150038104|NCT03848832|541280940|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
150038105|NCT03848832|541280941|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
150038106|NCT03848832|541280942|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
150038107|NCT03848832|541280940|FG000|Overall Study|Adverse Event|1|||
150038108|NCT03848832|541280941|FG001|Overall Study|Adverse Event|0|||
150038109|NCT03848832|541280942|FG002|Overall Study|Adverse Event|0|||
150038110|NCT00719472|541280944|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
150038111|NCT00719472|541280944|FG000|Enrolled in Study|Subject decision to withdraw|8|||
149957843|NCT02187055|540980075|FG001|Overall Study|Lost to Follow-up|7|||
149957844|NCT02187055|540980076|FG002|Overall Study|Lost to Follow-up|3|||
149957845|NCT02187055|540980074|FG000|Overall Study|No longer meets eligibility criteria|0|||
149957846|NCT02187055|540980075|FG001|Overall Study|No longer meets eligibility criteria|2|||
149957847|NCT02187055|540980076|FG002|Overall Study|No longer meets eligibility criteria|0|||
149957848|NCT02187055|540980074|FG000|Overall Study|No longer willing to participate|6|||
149957849|NCT02187055|540980075|FG001|Overall Study|No longer willing to participate|8|||
149957850|NCT02187055|540980076|FG002|Overall Study|No longer willing to participate|10|||
149957851|NCT02187055|540980074|FG000|Overall Study|Other|5|||
149957852|NCT02187055|540980075|FG001|Overall Study|Other|6|||
149957853|NCT02187055|540980076|FG002|Overall Study|Other|3|||
149957854|NCT02187055|540980074|FG000|Overall Study|Protocol Violation|9|||
149957855|NCT02187055|540980075|FG001|Overall Study|Protocol Violation|9|||
149957856|NCT02187055|540980076|FG002|Overall Study|Protocol Violation|4|||
149957857|NCT02187055|540980074|FG000|Overall Study|Pregnancy|3|||
149957858|NCT02187055|540980075|FG001|Overall Study|Pregnancy|1|||
149957859|NCT02187055|540980076|FG002|Overall Study|Pregnancy|0|||
149957860|NCT02187055|540980074|FG000|Overall Study|Withdrawal by Subject|11|||
149957861|NCT02187055|540980075|FG001|Overall Study|Withdrawal by Subject|11|||
149957862|NCT02187055|540980076|FG002|Overall Study|Withdrawal by Subject|11|||
149957863|NCT02187055|540980074|FG000|Overall Study|Adverse Event|21|||
149957864|NCT02187055|540980075|FG001|Overall Study|Adverse Event|26|||
149957865|NCT02187055|540980076|FG002|Overall Study|Adverse Event|36|||
149957866|NCT02187055|540980074|FG000|Overall Study|Death|2|||
149957867|NCT02187055|540980075|FG001|Overall Study|Death|0|||
149957868|NCT02187055|540980076|FG002|Overall Study|Death|0|||
150038112|NCT00719472|541280944|FG000|Enrolled in Study|Various Reasons|17|||
150038113|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
150038114|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Death|5|||
150038115|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
150038116|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
150038117|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
150038118|NCT00719472|541280944|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
150038119|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
150038120|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Death|6|||
149957869|NCT03336866|540980077|FG000|Overall Study|Lost to Follow-up|2|||
149957870|NCT03336866|540980078|FG001|Overall Study|Lost to Follow-up|0|||
149957871|NCT03336866|540980079|FG002|Overall Study|Lost to Follow-up|3|||
149957872|NCT03336866|540980077|FG000|Overall Study|Withdrawal by Subject|1|||
149957873|NCT03336866|540980078|FG001|Overall Study|Withdrawal by Subject|1|||
149957874|NCT03336866|540980079|FG002|Overall Study|Withdrawal by Subject|0|||
150038121|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Disease progression|3|||
150038122|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
150038123|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
150038124|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
150038125|NCT00719472|541280944|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
150038126|NCT00711191|541280947|FG000|Overall Study|Adverse Event|1|||
150038127|NCT00711191|541280948|FG001|Overall Study|Adverse Event|1|||
150038128|NCT00711191|541280949|FG002|Overall Study|Adverse Event|2|||
150038129|NCT00711191|541280947|FG000|Overall Study|Objective progression or relapse|2|||
150038130|NCT00711191|541280948|FG001|Overall Study|Objective progression or relapse|3|||
150038131|NCT00711191|541280949|FG002|Overall Study|Objective progression or relapse|7|||
150038132|NCT00711191|541280947|FG000|Overall Study|Withdrawal by Subject|0|||
150038133|NCT00711191|541280948|FG001|Overall Study|Withdrawal by Subject|1|||
150038134|NCT00711191|541280949|FG002|Overall Study|Withdrawal by Subject|3|||
150038135|NCT02633306|541280950|FG000|Overall Study|Withdrawal by Subject|3|||
150038136|NCT01744977|541280951|FG000|Overall Study|Withdrawal by Subject|1|||
150038137|NCT01744977|541280952|FG001|Overall Study|Withdrawal by Subject|2|||
150038138|NCT01744977|541280951|FG000|Overall Study|Death|2|||
150038139|NCT01744977|541280952|FG001|Overall Study|Death|3|||
150038140|NCT01744977|541280951|FG000|Overall Study|Lost to Follow-up|2|||
150038141|NCT01744977|541280952|FG001|Overall Study|Lost to Follow-up|0|||
150038142|NCT01744977|541280951|FG000|Overall Study|No longer meets inclusion|6|||
150038143|NCT01744977|541280952|FG001|Overall Study|No longer meets inclusion|0|||
150038144|NCT01213472|541280953|FG000|Overall Study|Recurrence/Progressive disease|25|||
150038145|NCT01213472|541280953|FG000|Overall Study|Withdrawal by Subject|1|||
150038146|NCT01213472|541280953|FG000|Overall Study|Physician Decision|1|||
150038147|NCT03774576|541280954|FG000|Period 2|Adverse Event|1|||
150038148|NCT00930046|541280957|FG000|Overall Study|Wound catheter malfunctioned|1|||
150038149|NCT00930046|541280958|FG001|Overall Study|Wound catheter malfunctioned|2|||
150038150|NCT01598532|541280959|FG000|Overall Study|Lost to Follow-up|3|||
150038151|NCT01598532|541280959|FG000|Overall Study|Did not meet inclusion criteria|8|||
150038152|NCT01967940|541280961|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
150038153|NCT01967940|541280962|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
150038154|NCT01967940|541280963|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
150038155|NCT01967940|541280964|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
150038156|NCT01967940|541280961|FG000|Part 2|Adverse Event|0|||
150038157|NCT01967940|541280962|FG001|Part 2|Adverse Event|0|||
150038158|NCT01967940|541280963|FG002|Part 2|Adverse Event|0|||
150038159|NCT01967940|541280964|FG003|Part 2|Adverse Event|1|||
150038160|NCT01967940|541280961|FG000|Part 2|Unknown Reason|0|||
150038161|NCT01967940|541280962|FG001|Part 2|Unknown Reason|0|||
150038162|NCT01967940|541280963|FG002|Part 2|Unknown Reason|0|||
150038163|NCT01967940|541280964|FG003|Part 2|Unknown Reason|1|||
149849236|NCT00467597|540576067|FG001|Overall Study|Withdrawal by Subject|0|||
149849237|NCT00379353|540576070|FG000|Overall Study|Hospitalization|3|||
150038164|NCT04189952|541280965|FG000|Follow-up Period|Death|1|||
150038165|NCT04189952|541280965|FG000|Follow-up Period|Withdrawal by Subject|1|||
150038166|NCT04298697|541280968|FG000|Overall Study|Lost to Follow-up|5|||
150038167|NCT04298697|541280969|FG001|Overall Study|Lost to Follow-up|5|||
149849238|NCT00379353|540576071|FG001|Overall Study|Hospitalization|3|||
149849239|NCT00379353|540576070|FG000|Overall Study|Withdrawal by Subject|5|||
149849240|NCT00379353|540576071|FG001|Overall Study|Withdrawal by Subject|2|||
149849241|NCT00379353|540576070|FG000|Overall Study|Death|1|||
149849242|NCT00379353|540576071|FG001|Overall Study|Death|0|||
149849243|NCT00379353|540576070|FG000|Overall Study|Cardiac Tamponade|1|||
149849244|NCT00379353|540576071|FG001|Overall Study|Cardiac Tamponade|0|||
149849245|NCT00379353|540576070|FG000|Overall Study|Non-compliance|1|||
149849246|NCT00379353|540576071|FG001|Overall Study|Non-compliance|0|||
149849247|NCT00379353|540576070|FG000|Overall Study|Conflicting drug treatment|0|||
149849248|NCT00379353|540576071|FG001|Overall Study|Conflicting drug treatment|1|||
150038168|NCT04298697|541280970|FG002|Overall Study|Lost to Follow-up|1|||
149849249|NCT01050764|540576072|FG000|Overall Study|Death, before HSCT|1|||
149849250|NCT01050764|540576072|FG000|Overall Study|Donor mobilization failure, death|1|||
149849251|NCT01050764|540576072|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
150038169|NCT04298697|541280971|FG003|Overall Study|Lost to Follow-up|0|||
150038170|NCT04298697|541280968|FG000|Overall Study|Withdrawal by Subject|0|||
150038171|NCT04298697|541280969|FG001|Overall Study|Withdrawal by Subject|3|||
150038172|NCT04298697|541280970|FG002|Overall Study|Withdrawal by Subject|2|||
150038173|NCT04298697|541280971|FG003|Overall Study|Withdrawal by Subject|3|||
150038174|NCT00904982|541280972|FG000|Overall Study|Withdrawal by Subject|2|||
150038175|NCT00904982|541280973|FG001|Overall Study|Withdrawal by Subject|0|||
150038176|NCT00904982|541280974|FG002|Overall Study|Withdrawal by Subject|0|||
150038177|NCT00904982|541280975|FG003|Overall Study|Withdrawal by Subject|0|||
150038178|NCT01352793|541280989|FG000|Overall Study|Lost to Follow-up|289|||
150038179|NCT01352793|541280990|FG001|Overall Study|Lost to Follow-up|125|||
150038180|NCT01352793|541280989|FG000|Overall Study|Withdrawal by Subject|120|||
150038181|NCT01352793|541280990|FG001|Overall Study|Withdrawal by Subject|55|||
150038182|NCT01352793|541280989|FG000|Overall Study|Protocol Violation|44|||
150038183|NCT01352793|541280990|FG001|Overall Study|Protocol Violation|23|||
150038184|NCT01352793|541280989|FG000|Overall Study|Adverse Event|44|||
150038185|NCT01352793|541280990|FG001|Overall Study|Adverse Event|10|||
150038186|NCT01352793|541280989|FG000|Overall Study|Physician Decision|1|||
150038187|NCT01352793|541280990|FG001|Overall Study|Physician Decision|0|||
150038188|NCT01352793|541280989|FG000|Overall Study|Pregnancy|26|||
150038189|NCT01352793|541280990|FG001|Overall Study|Pregnancy|8|||
150038190|NCT01352793|541280989|FG000|Overall Study|Other|25|||
150038191|NCT01352793|541280990|FG001|Overall Study|Other|7|||
150038192|NCT01352793|541280989|FG000|Overall Study|Medication error|2|||
150038193|NCT01352793|541280990|FG001|Overall Study|Medication error|2|||
150038194|NCT01352793|541280989|FG000|Overall Study|Death|1|||
150038195|NCT01352793|541280990|FG001|Overall Study|Death|0|||
150038196|NCT01352793|541280989|FG000|Overall Study|Randomized but not vaccinated|8|||
150038197|NCT01352793|541280990|FG001|Overall Study|Randomized but not vaccinated|0|||
150038198|NCT01352793|541280989|FG000|Overall Study|No longer meets eligibility criteria|25|||
150038199|NCT01352793|541280990|FG001|Overall Study|No longer meets eligibility criteria|15|||
150038200|NCT01929317|541280993|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
150038201|NCT01929317|541280994|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
150038202|NCT01929317|541280993|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
150038203|NCT01929317|541280994|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
150038204|NCT01929317|541280993|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
150038205|NCT01929317|541280994|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
150038206|NCT01929317|541280993|FG000|Long-term Phase|Adverse Event|5|||
149849252|NCT01929681|540576085|FG000|Overall Study|Withdrawal by Subject|1|||
149849253|NCT01929681|540576086|FG001|Overall Study|Withdrawal by Subject|0|||
149849254|NCT01929681|540576085|FG000|Overall Study|Physician Decision|1|||
149849255|NCT01929681|540576086|FG001|Overall Study|Physician Decision|1|||
149849256|NCT01717040|540576087|FG000|Overall Study|Lost to Follow-up|2|||
149849257|NCT01717040|540576088|FG001|Overall Study|Lost to Follow-up|3|||
149849258|NCT01717040|540576087|FG000|Overall Study|Lack of Efficacy|1|||
149849259|NCT01717040|540576088|FG001|Overall Study|Lack of Efficacy|1|||
149849260|NCT01717040|540576087|FG000|Overall Study|Adverse Event|1|||
149849261|NCT01717040|540576088|FG001|Overall Study|Adverse Event|0|||
149849262|NCT01717040|540576087|FG000|Overall Study|Required Medication Change|0|||
149849263|NCT01717040|540576088|FG001|Overall Study|Required Medication Change|1|||
149849264|NCT01717040|540576087|FG000|Overall Study|New Substance Use Disorder|1|||
149849265|NCT01717040|540576088|FG001|Overall Study|New Substance Use Disorder|0|||
149849266|NCT04194151|540576089|FG000|Overall Study|Physician Decision|1|||
149849267|NCT04194151|540576090|FG001|Overall Study|Physician Decision|1|||
149849268|NCT04194151|540576091|FG002|Overall Study|Physician Decision|1|||
149849269|NCT04194151|540576092|FG003|Overall Study|Physician Decision|1|||
149849270|NCT04194151|540576093|FG004|Overall Study|Physician Decision|0|||
149849271|NCT04194151|540576094|FG005|Overall Study|Physician Decision|1|||
149849272|NCT04194151|540576089|FG000|Overall Study|Monitorization problem|0|||
149849273|NCT04194151|540576090|FG001|Overall Study|Monitorization problem|1|||
149849274|NCT04194151|540576091|FG002|Overall Study|Monitorization problem|0|||
149849275|NCT04194151|540576092|FG003|Overall Study|Monitorization problem|0|||
149849276|NCT04194151|540576093|FG004|Overall Study|Monitorization problem|0|||
150038207|NCT01929317|541280994|FG001|Long-term Phase|Adverse Event|1|||
150038208|NCT01929317|541280993|FG000|Long-term Phase|Physician Decision|3|||
150038209|NCT01929317|541280994|FG001|Long-term Phase|Physician Decision|0|||
150038210|NCT01929317|541280993|FG000|Long-term Phase|Withdrawal by Subject|4|||
150038211|NCT01929317|541280994|FG001|Long-term Phase|Withdrawal by Subject|0|||
150038212|NCT01929317|541280993|FG000|Long-term Phase|Protocol Violation|1|||
150038213|NCT01929317|541280994|FG001|Long-term Phase|Protocol Violation|0|||
150038214|NCT01929317|541280993|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
150038215|NCT01929317|541280994|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
149849277|NCT04194151|540576094|FG005|Overall Study|Monitorization problem|0|||
149849278|NCT03196284|540576095|FG000|Main Part|Withdrawal by Subject|0|||
150038216|NCT01929317|541280993|FG000|Long-term Phase|Study Closed/Terminated|5|||
150038217|NCT01929317|541280994|FG001|Long-term Phase|Study Closed/Terminated|3|||
149849279|NCT03196284|540576096|FG001|Main Part|Withdrawal by Subject|1|||
149849280|NCT03196284|540576097|FG002|Main Part|Withdrawal by Subject|0|||
149849281|NCT03196284|540576095|FG000|Extension Part|Lack of Efficacy|0|||
149849282|NCT03196284|540576096|FG001|Extension Part|Lack of Efficacy|0|||
149957875|NCT03336866|540980077|FG000|Overall Study|Noncompliance with clinic house rules|0|||
149957876|NCT03336866|540980078|FG001|Overall Study|Noncompliance with clinic house rules|0|||
149957877|NCT03336866|540980079|FG002|Overall Study|Noncompliance with clinic house rules|1|||
149957878|NCT01666314|540980080|FG000|Overall Study|Adverse Event|3|||
149957879|NCT01666314|540980081|FG001|Overall Study|Adverse Event|13|||
149957880|NCT01666314|540980082|FG002|Overall Study|Adverse Event|7|||
149957881|NCT01666314|540980083|FG003|Overall Study|Adverse Event|7|||
150038218|NCT04322526|541280995|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
150038219|NCT04322526|541280996|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
150038220|NCT04322526|541280995|FG000|Washout (1 Week)|Lost to Follow-up|1|||
150038221|NCT04322526|541280996|FG001|Washout (1 Week)|Lost to Follow-up|2|||
150038222|NCT01716234|541281000|FG000|Overall Study|Protocol Violation|0|||
150038223|NCT01716234|541281001|FG001|Overall Study|Protocol Violation|0|||
150038224|NCT01716234|541281002|FG002|Overall Study|Protocol Violation|0|||
150038225|NCT01716234|541281003|FG003|Overall Study|Protocol Violation|1|||
150038226|NCT01716234|541281004|FG004|Overall Study|Protocol Violation|1|||
150038227|NCT01716234|541281005|FG005|Overall Study|Protocol Violation|1|||
150038228|NCT01716234|541281006|FG006|Overall Study|Protocol Violation|0|||
150038229|NCT01716234|541281000|FG000|Overall Study|Lack of Efficacy|0|||
150038230|NCT01716234|541281001|FG001|Overall Study|Lack of Efficacy|0|||
150038231|NCT01716234|541281002|FG002|Overall Study|Lack of Efficacy|0|||
150038232|NCT01716234|541281003|FG003|Overall Study|Lack of Efficacy|1|||
150038233|NCT01716234|541281004|FG004|Overall Study|Lack of Efficacy|0|||
150038234|NCT01716234|541281005|FG005|Overall Study|Lack of Efficacy|0|||
150038235|NCT01716234|541281006|FG006|Overall Study|Lack of Efficacy|0|||
150038236|NCT01716234|541281000|FG000|Overall Study|Did not meet protocol eligibility|0|||
150038237|NCT01716234|541281001|FG001|Overall Study|Did not meet protocol eligibility|0|||
150038238|NCT01716234|541281002|FG002|Overall Study|Did not meet protocol eligibility|1|||
150038239|NCT01716234|541281003|FG003|Overall Study|Did not meet protocol eligibility|0|||
150038240|NCT01716234|541281004|FG004|Overall Study|Did not meet protocol eligibility|0|||
150038241|NCT01716234|541281005|FG005|Overall Study|Did not meet protocol eligibility|4|||
150038242|NCT01716234|541281006|FG006|Overall Study|Did not meet protocol eligibility|0|||
150038243|NCT01716234|541281000|FG000|Overall Study|Adverse Event|7|||
150038244|NCT01716234|541281001|FG001|Overall Study|Adverse Event|10|||
150038245|NCT01716234|541281002|FG002|Overall Study|Adverse Event|2|||
150038246|NCT01716234|541281003|FG003|Overall Study|Adverse Event|8|||
150038247|NCT01716234|541281004|FG004|Overall Study|Adverse Event|3|||
150038248|NCT01716234|541281005|FG005|Overall Study|Adverse Event|6|||
150038249|NCT01716234|541281006|FG006|Overall Study|Adverse Event|0|||
150038250|NCT01716234|541281000|FG000|Overall Study|Withdrawal by Subject|3|||
150038251|NCT01716234|541281001|FG001|Overall Study|Withdrawal by Subject|0|||
150038252|NCT01716234|541281002|FG002|Overall Study|Withdrawal by Subject|2|||
150038253|NCT01716234|541281003|FG003|Overall Study|Withdrawal by Subject|2|||
150038254|NCT01716234|541281004|FG004|Overall Study|Withdrawal by Subject|1|||
150038255|NCT01716234|541281005|FG005|Overall Study|Withdrawal by Subject|3|||
150038256|NCT01716234|541281006|FG006|Overall Study|Withdrawal by Subject|0|||
150038257|NCT02667119|541281007|FG000|Overall Study|Lost to Follow-up|3|||
150038258|NCT02667119|541281008|FG001|Overall Study|Lost to Follow-up|0|||
150038259|NCT01523756|541281009|FG000|Baseline Period|Adverse Event|0|||
150038260|NCT01523756|541281010|FG001|Baseline Period|Adverse Event|1|||
150038261|NCT01523756|541281009|FG000|Test Period 1|Adverse Event|1|||
150038262|NCT01523756|541281010|FG001|Test Period 1|Adverse Event|0|||
150038263|NCT01523756|541281009|FG000|Test Period 2|Withdrawal by Subject|0|||
150038264|NCT01523756|541281010|FG001|Test Period 2|Withdrawal by Subject|1|||
150038265|NCT00993967|541281011|FG000|Overall Study|Adverse Event|8|||
150038266|NCT00993967|541281011|FG000|Overall Study|Death|1|||
150038267|NCT00993967|541281011|FG000|Overall Study|Lost to Follow-up|14|||
150038268|NCT00993967|541281011|FG000|Overall Study|Withdrawal by Subject|36|||
150038269|NCT00993967|541281011|FG000|Overall Study|Protocol Violation|2|||
150038270|NCT03783078|541281014|FG000|Overall Study|Death|31|||
149957882|NCT01666314|540980080|FG000|Overall Study|Progressive Disease|11|||
150038271|NCT03783078|541281014|FG000|Overall Study|Sponsor Decision|23|||
150038272|NCT03783078|541281014|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150038273|NCT00474812|541281016|FG000|Overall Study|Withdrawal by Subject|5|||
150038274|NCT00474812|541281016|FG000|Overall Study|No Initiation of treatment|2|||
150038275|NCT02059278|541281019|FG000|Overall Study|Adverse Event|1|||
150172773|NCT01123083|541768092|FG001|Overall Study|Investigator recommendation|1|||
149957883|NCT01666314|540980081|FG001|Overall Study|Progressive Disease|9|||
149957884|NCT01666314|540980082|FG002|Overall Study|Progressive Disease|19|||
149957885|NCT01666314|540980083|FG003|Overall Study|Progressive Disease|20|||
150038276|NCT02059278|541281020|FG001|Overall Study|Adverse Event|1|||
150038277|NCT02059278|541281019|FG000|Overall Study|Lost to Follow-up|1|||
150038278|NCT02059278|541281020|FG001|Overall Study|Lost to Follow-up|0|||
150038279|NCT02059278|541281019|FG000|Overall Study|Withdrawal by Subject|0|||
150038280|NCT02059278|541281020|FG001|Overall Study|Withdrawal by Subject|3|||
150038281|NCT02059278|541281019|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
150038282|NCT02059278|541281020|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
150038283|NCT05408429|541281025|FG000|Overall Study|Lost to Follow-up|1|||
150038284|NCT05408429|541281026|FG001|Overall Study|Lost to Follow-up|1|||
149957886|NCT01666314|540980080|FG000|Overall Study|Symptomatic Deterioration|1|||
150038285|NCT05408429|541281027|FG002|Overall Study|Lost to Follow-up|0|||
150038286|NCT05408429|541281025|FG000|Overall Study|Withdrawal by Subject|5|||
150038287|NCT05408429|541281026|FG001|Overall Study|Withdrawal by Subject|0|||
150038288|NCT05408429|541281027|FG002|Overall Study|Withdrawal by Subject|1|||
150038289|NCT03435211|541281028|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
150038290|NCT02195518|541281029|FG000|Overall Study|Adverse Event|1|||
150038291|NCT02195518|541281029|FG000|Overall Study|Protocol Violation|4|||
150038292|NCT02195518|541281029|FG000|Overall Study|Pregnancy|2|||
150038293|NCT02195518|541281029|FG000|Overall Study|Withdrawal by Subject|1|||
150038294|NCT02195518|541281029|FG000|Overall Study|Lost to Follow-up|1|||
150038295|NCT03818256|541281030|FG000|Overall Study|Withdrawal by Subject|2|||
150038296|NCT03818256|541281031|FG001|Overall Study|Withdrawal by Subject|2|||
150038297|NCT03818256|541281030|FG000|Overall Study|Adverse Event|3|||
150038298|NCT03818256|541281031|FG001|Overall Study|Adverse Event|1|||
150038299|NCT03818256|541281030|FG000|Overall Study|Lost to Follow-up|0|||
150038300|NCT03818256|541281031|FG001|Overall Study|Lost to Follow-up|5|||
150038301|NCT03818256|541281030|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
150038302|NCT03818256|541281031|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
150038303|NCT03818256|541281030|FG000|Overall Study|Not reporting for scheduled visits|1|||
150038304|NCT03818256|541281031|FG001|Overall Study|Not reporting for scheduled visits|0|||
150038305|NCT03818256|541281030|FG000|Overall Study|Non-compliant with investigational product|1|||
150038306|NCT03818256|541281031|FG001|Overall Study|Non-compliant with investigational product|0|||
150038307|NCT03043794|541281034|FG000|Overall Study|Lost to Follow-up|1|||
150038308|NCT03205423|541281037|FG000|Overall Study|Personal|1|||
150038309|NCT03205423|541281038|FG001|Overall Study|Personal|1|||
150038310|NCT03205423|541281037|FG000|Overall Study|Physician Decision|0|||
150038311|NCT03205423|541281038|FG001|Overall Study|Physician Decision|2|||
150038312|NCT02749422|541281039|FG000|Overall Study|Lost to Follow-up|0|||
150038313|NCT02749422|541281040|FG001|Overall Study|Lost to Follow-up|2|||
150038314|NCT02749422|541281039|FG000|Overall Study|Ineligible|0|||
150038315|NCT02749422|541281040|FG001|Overall Study|Ineligible|1|||
150038316|NCT02594124|541281041|FG000|Overall Study|Adverse Event|0|||
149957887|NCT01666314|540980081|FG001|Overall Study|Symptomatic Deterioration|0|||
149957888|NCT01666314|540980082|FG002|Overall Study|Symptomatic Deterioration|2|||
149957889|NCT01666314|540980083|FG003|Overall Study|Symptomatic Deterioration|0|||
149957890|NCT01666314|540980080|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
149957891|NCT01666314|540980081|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
149957892|NCT01666314|540980082|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
149957893|NCT01666314|540980083|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
149957894|NCT01666314|540980080|FG000|Overall Study|Withdrawal by Subject|1|||
149957895|NCT01666314|540980081|FG001|Overall Study|Withdrawal by Subject|1|||
149957896|NCT01666314|540980082|FG002|Overall Study|Withdrawal by Subject|2|||
149957897|NCT01666314|540980083|FG003|Overall Study|Withdrawal by Subject|3|||
149957898|NCT01666314|540980080|FG000|Overall Study|Reason not Specified|10|||
149957899|NCT01666314|540980081|FG001|Overall Study|Reason not Specified|7|||
149957900|NCT01666314|540980082|FG002|Overall Study|Reason not Specified|5|||
149957901|NCT01666314|540980083|FG003|Overall Study|Reason not Specified|5|||
149957902|NCT03462563|540980088|FG000|Overall Study|Death|1|||
149957903|NCT03462563|540980089|FG001|Overall Study|Death|1|||
149957904|NCT03462563|540980088|FG000|Overall Study|Termination of study|2|||
149957905|NCT03462563|540980089|FG001|Overall Study|Termination of study|1|||
149957906|NCT03462563|540980088|FG000|Overall Study|Adverse Event|1|||
149957907|NCT03462563|540980089|FG001|Overall Study|Adverse Event|3|||
149957908|NCT03462563|540980088|FG000|Overall Study|Unspecified reason|10|||
149957909|NCT03462563|540980089|FG001|Overall Study|Unspecified reason|12|||
149957910|NCT03462563|540980088|FG000|Overall Study|Physician Decision|1|||
149957911|NCT03462563|540980089|FG001|Overall Study|Physician Decision|0|||
149957912|NCT05737745|540980090|FG000|Overall Study|Withdrawal by Subject|0|||
150172774|NCT01123083|541768091|FG000|Overall Study|Administrative reasons|0|||
149957913|NCT05737745|540980091|FG001|Overall Study|Withdrawal by Subject|6|||
149957914|NCT05737745|540980092|FG002|Overall Study|Withdrawal by Subject|1|||
149957915|NCT02569242|540980093|FG000|Overall Study|Death|1|||
149957916|NCT02569242|540980094|FG001|Overall Study|Death|0|||
149957917|NCT02569242|540980093|FG000|Overall Study|Withdrawal by Subject|0|||
149957918|NCT02569242|540980094|FG001|Overall Study|Withdrawal by Subject|1|||
149957919|NCT01125748|540980095|FG000|Overall Study|Adverse Event|0|||
150038317|NCT02594124|541281042|FG001|Overall Study|Adverse Event|5|||
150038318|NCT02594124|541281043|FG002|Overall Study|Adverse Event|8|||
150038319|NCT02594124|541281044|FG003|Overall Study|Adverse Event|1|||
150038320|NCT02594124|541281045|FG004|Overall Study|Adverse Event|0|||
150038321|NCT02594124|541281046|FG005|Overall Study|Adverse Event|0|||
150038322|NCT02594124|541281047|FG006|Overall Study|Adverse Event|2|||
150038323|NCT02594124|541281048|FG007|Overall Study|Adverse Event|2|||
150038324|NCT02594124|541281049|FG008|Overall Study|Adverse Event|0|||
150038325|NCT02594124|541281041|FG000|Overall Study|Withdrawal by Subject|2|||
150038326|NCT02594124|541281042|FG001|Overall Study|Withdrawal by Subject|3|||
150038327|NCT02594124|541281043|FG002|Overall Study|Withdrawal by Subject|5|||
150038328|NCT02594124|541281044|FG003|Overall Study|Withdrawal by Subject|1|||
150038329|NCT02594124|541281045|FG004|Overall Study|Withdrawal by Subject|8|||
150038330|NCT02594124|541281046|FG005|Overall Study|Withdrawal by Subject|4|||
150038331|NCT02594124|541281047|FG006|Overall Study|Withdrawal by Subject|13|||
150038332|NCT02594124|541281048|FG007|Overall Study|Withdrawal by Subject|19|||
150038333|NCT02594124|541281049|FG008|Overall Study|Withdrawal by Subject|0|||
150038334|NCT02594124|541281041|FG000|Overall Study|Physician Decision|0|||
150038335|NCT02594124|541281042|FG001|Overall Study|Physician Decision|2|||
150038336|NCT02594124|541281043|FG002|Overall Study|Physician Decision|0|||
150038337|NCT02594124|541281044|FG003|Overall Study|Physician Decision|0|||
150038338|NCT02594124|541281045|FG004|Overall Study|Physician Decision|0|||
150038339|NCT02594124|541281046|FG005|Overall Study|Physician Decision|0|||
150038340|NCT02594124|541281047|FG006|Overall Study|Physician Decision|0|||
150038341|NCT02594124|541281048|FG007|Overall Study|Physician Decision|1|||
150038342|NCT02594124|541281049|FG008|Overall Study|Physician Decision|0|||
150038343|NCT02594124|541281041|FG000|Overall Study|Commercial drug|0|||
150038344|NCT02594124|541281042|FG001|Overall Study|Commercial drug|1|||
150038345|NCT02594124|541281043|FG002|Overall Study|Commercial drug|6|||
150038346|NCT02594124|541281044|FG003|Overall Study|Commercial drug|3|||
150038347|NCT02594124|541281045|FG004|Overall Study|Commercial drug|0|||
150038348|NCT02594124|541281046|FG005|Overall Study|Commercial drug|0|||
150038349|NCT02594124|541281047|FG006|Overall Study|Commercial drug|7|||
150038350|NCT02594124|541281048|FG007|Overall Study|Commercial drug|11|||
150038351|NCT02594124|541281049|FG008|Overall Study|Commercial drug|2|||
150038352|NCT02594124|541281041|FG000|Overall Study|Reason Not Specified|1|||
150038353|NCT02594124|541281042|FG001|Overall Study|Reason Not Specified|3|||
150038354|NCT02594124|541281043|FG002|Overall Study|Reason Not Specified|4|||
150038355|NCT02594124|541281044|FG003|Overall Study|Reason Not Specified|0|||
150038356|NCT02594124|541281045|FG004|Overall Study|Reason Not Specified|0|||
150038357|NCT02594124|541281046|FG005|Overall Study|Reason Not Specified|1|||
150038358|NCT02594124|541281047|FG006|Overall Study|Reason Not Specified|1|||
150038359|NCT02594124|541281048|FG007|Overall Study|Reason Not Specified|6|||
150038360|NCT02594124|541281049|FG008|Overall Study|Reason Not Specified|1|||
150038361|NCT04586205|541281057|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
150038362|NCT04586205|541281058|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
150038363|NCT03312634|541283278|FG000|Overall Study|Adverse Event|11|||
150038364|NCT03312634|541283279|FG001|Overall Study|Adverse Event|0|||
150038365|NCT03312634|541283278|FG000|Overall Study|Sponsor request|2|||
150038366|NCT03312634|541283279|FG001|Overall Study|Sponsor request|0|||
150038367|NCT03312634|541283278|FG000|Overall Study|Withdrawal by Subject|31|||
150038368|NCT03312634|541283279|FG001|Overall Study|Withdrawal by Subject|9|||
150038369|NCT03312634|541283278|FG000|Overall Study|Enrolled in an interventional study|0|||
150038370|NCT03312634|541283279|FG001|Overall Study|Enrolled in an interventional study|52|||
150038371|NCT03312634|541283278|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
150038372|NCT03312634|541283279|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
150038373|NCT03312634|541283278|FG000|Overall Study|Death|0|||
150038374|NCT03312634|541283279|FG001|Overall Study|Death|1|||
150038375|NCT03312634|541283278|FG000|Overall Study|Non-compliance|0|||
150038376|NCT03312634|541283279|FG001|Overall Study|Non-compliance|2|||
150038377|NCT03312634|541283278|FG000|Overall Study|Lost to Follow-up|0|||
150038378|NCT03312634|541283279|FG001|Overall Study|Lost to Follow-up|1|||
150038379|NCT03312634|541283278|FG000|Overall Study|Enrolled into non-interventional study|0|||
150038380|NCT03312634|541283279|FG001|Overall Study|Enrolled into non-interventional study|5|||
150038381|NCT03312634|541283278|FG000|Overall Study|Worsening clinical condition|0|||
150038382|NCT03312634|541283279|FG001|Overall Study|Worsening clinical condition|1|||
150038383|NCT03312634|541283278|FG000|Overall Study|Participant did not want to travel|0|||
150172775|NCT01123083|541768092|FG001|Overall Study|Administrative reasons|4|||
150172776|NCT01123083|541768091|FG000|Overall Study|Lost to Follow-up|2|||
150172777|NCT01123083|541768092|FG001|Overall Study|Lost to Follow-up|6|||
150038384|NCT03312634|541283279|FG001|Overall Study|Participant did not want to travel|1|||
150038385|NCT03312634|541283278|FG000|Overall Study|Physician Decision|1|||
150038386|NCT03312634|541283279|FG001|Overall Study|Physician Decision|0|||
150038387|NCT03312634|541283278|FG000|Overall Study|Other|13|||
150038388|NCT03312634|541283279|FG001|Overall Study|Other|0|||
150038389|NCT02079246|541283300|FG000|OLEX|Withdrawal before treatment|1|||
150038390|NCT02079246|541283301|FG001|OLEX|Withdrawal before treatment|0|||
150038391|NCT02079246|541283300|FG000|OLEX|Death|11|||
150038392|NCT02079246|541283301|FG001|OLEX|Death|0|||
150038393|NCT02079246|541283300|FG000|OLEX|Adverse Event|66|||
150038394|NCT02079246|541283301|FG001|OLEX|Adverse Event|0|||
150038395|NCT02079246|541283300|FG000|OLEX|Withdrawal by Subject|60|||
150038396|NCT02079246|541283301|FG001|OLEX|Withdrawal by Subject|0|||
150038397|NCT02079246|541283300|FG000|OLEX|Lost to Follow-up|6|||
150038398|NCT02079246|541283301|FG001|OLEX|Lost to Follow-up|0|||
150038399|NCT02079246|541283300|FG000|OLEX|Protocol Violation|6|||
149957920|NCT01125748|540980096|FG001|Overall Study|Adverse Event|2|||
149957921|NCT01125748|540980095|FG000|Overall Study|Lost to Follow-up|0|||
149957922|NCT01125748|540980096|FG001|Overall Study|Lost to Follow-up|1|||
149957923|NCT01125748|540980095|FG000|Overall Study|Physician Decision|8|||
149957924|NCT01125748|540980096|FG001|Overall Study|Physician Decision|7|||
149957925|NCT01125748|540980095|FG000|Overall Study|Patient Decision to Withdraw|2|||
149957926|NCT01125748|540980096|FG001|Overall Study|Patient Decision to Withdraw|4|||
149957927|NCT01751685|540980097|FG000|6-mo Followup|Missed study visit|1|||
149957928|NCT01751685|540980098|FG001|6-mo Followup|Missed study visit|0|||
149957929|NCT01751685|540980097|FG000|6-mo Followup|Withdrawal by Subject|2|||
149957930|NCT01751685|540980098|FG001|6-mo Followup|Withdrawal by Subject|2|||
149957931|NCT01751685|540980097|FG000|6-mo Followup|Lost to Follow-up|0|||
149957932|NCT01751685|540980098|FG001|6-mo Followup|Lost to Follow-up|1|||
149957933|NCT01751685|540980097|FG000|12-mo Followup|Lost to Follow-up|5|||
149957934|NCT01751685|540980098|FG001|12-mo Followup|Lost to Follow-up|0|||
149957935|NCT01028391|540980099|FG000|Overall Study|Adverse Event|4|||
149957936|NCT01028391|540980100|FG001|Overall Study|Adverse Event|0|||
149957937|NCT01028391|540980099|FG000|Overall Study|Lack of Efficacy|0|||
149957938|NCT01028391|540980100|FG001|Overall Study|Lack of Efficacy|2|||
149957939|NCT01028391|540980099|FG000|Overall Study|Lost to Follow-up|3|||
149957940|NCT01028391|540980100|FG001|Overall Study|Lost to Follow-up|4|||
149957941|NCT01028391|540980099|FG000|Overall Study|Physician Decision|0|||
149957942|NCT01028391|540980100|FG001|Overall Study|Physician Decision|1|||
149957943|NCT01028391|540980099|FG000|Overall Study|Withdrawal by Subject|6|||
149957944|NCT01028391|540980100|FG001|Overall Study|Withdrawal by Subject|3|||
149957945|NCT01028391|540980099|FG000|Overall Study|Needed excluded medication|1|||
149957946|NCT01028391|540980100|FG001|Overall Study|Needed excluded medication|1|||
149957947|NCT01107457|540980101|FG000|Part A|Adverse Event|1|||
149957948|NCT01107457|540980102|FG001|Part A|Adverse Event|2|||
149957949|NCT01107457|540980103|FG002|Part A|Adverse Event|1|||
149957950|NCT01107457|540980104|FG003|Part A|Adverse Event|0|||
149957951|NCT01107457|540980105|FG004|Part A|Adverse Event|0|||
149957952|NCT01107457|540980106|FG005|Part A|Adverse Event|0|||
149957953|NCT01107457|540980101|FG000|Part A|Withdrawal by Subject|3|||
149957954|NCT01107457|540980102|FG001|Part A|Withdrawal by Subject|3|||
149957955|NCT01107457|540980103|FG002|Part A|Withdrawal by Subject|0|||
149957956|NCT01107457|540980104|FG003|Part A|Withdrawal by Subject|3|||
149957957|NCT01107457|540980105|FG004|Part A|Withdrawal by Subject|1|||
149957958|NCT01107457|540980106|FG005|Part A|Withdrawal by Subject|0|||
149957959|NCT01107457|540980101|FG000|Part A|Lost to Follow-up|0|||
149957960|NCT01107457|540980102|FG001|Part A|Lost to Follow-up|1|||
149957961|NCT01107457|540980103|FG002|Part A|Lost to Follow-up|0|||
149957962|NCT01107457|540980104|FG003|Part A|Lost to Follow-up|0|||
149957963|NCT01107457|540980105|FG004|Part A|Lost to Follow-up|0|||
149957964|NCT01107457|540980106|FG005|Part A|Lost to Follow-up|0|||
149957965|NCT01107457|540980101|FG000|Part A|Lack of Efficacy|1|||
149957966|NCT01107457|540980102|FG001|Part A|Lack of Efficacy|0|||
149957967|NCT01107457|540980103|FG002|Part A|Lack of Efficacy|0|||
149957968|NCT01107457|540980104|FG003|Part A|Lack of Efficacy|0|||
149957969|NCT01107457|540980105|FG004|Part A|Lack of Efficacy|0|||
149957970|NCT01107457|540980106|FG005|Part A|Lack of Efficacy|0|||
149957971|NCT01107457|540980101|FG000|Part A|Protocol Violation|0|||
149957972|NCT01107457|540980102|FG001|Part A|Protocol Violation|1|||
149957973|NCT01107457|540980103|FG002|Part A|Protocol Violation|0|||
149957974|NCT01107457|540980104|FG003|Part A|Protocol Violation|0|||
149957975|NCT01107457|540980105|FG004|Part A|Protocol Violation|0|||
149957976|NCT01107457|540980106|FG005|Part A|Protocol Violation|0|||
149957977|NCT01107457|540980101|FG000|Part B and C|Adverse Event|0|||
149957978|NCT01107457|540980102|FG001|Part B and C|Adverse Event|0|||
149957979|NCT01107457|540980103|FG002|Part B and C|Adverse Event|0|||
149957980|NCT01107457|540980104|FG003|Part B and C|Adverse Event|0|||
149957981|NCT01107457|540980105|FG004|Part B and C|Adverse Event|0|||
149957982|NCT01107457|540980106|FG005|Part B and C|Adverse Event|12|||
149957983|NCT01107457|540980101|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
149957984|NCT01107457|540980102|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
149957985|NCT01107457|540980103|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
150172778|NCT01123083|541768091|FG000|Overall Study|Adverse Event|1|||
149957986|NCT01107457|540980104|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
149957987|NCT01107457|540980105|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
149957988|NCT01107457|540980106|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
149957989|NCT01107457|540980101|FG000|Part B and C|Physician Decision|0|||
149957990|NCT01107457|540980102|FG001|Part B and C|Physician Decision|0|||
149957991|NCT01107457|540980103|FG002|Part B and C|Physician Decision|0|||
149957992|NCT01107457|540980104|FG003|Part B and C|Physician Decision|0|||
149957993|NCT01107457|540980105|FG004|Part B and C|Physician Decision|0|||
149957994|NCT01107457|540980106|FG005|Part B and C|Physician Decision|3|||
149957995|NCT01107457|540980101|FG000|Part B and C|Lack of Efficacy|0|||
149957996|NCT01107457|540980102|FG001|Part B and C|Lack of Efficacy|0|||
149957997|NCT01107457|540980103|FG002|Part B and C|Lack of Efficacy|0|||
149957998|NCT01107457|540980104|FG003|Part B and C|Lack of Efficacy|0|||
149957999|NCT01107457|540980105|FG004|Part B and C|Lack of Efficacy|0|||
149958000|NCT01107457|540980106|FG005|Part B and C|Lack of Efficacy|7|||
149958001|NCT01107457|540980101|FG000|Part B and C|Lost to Follow-up|0|||
149958002|NCT01107457|540980102|FG001|Part B and C|Lost to Follow-up|0|||
149958003|NCT01107457|540980103|FG002|Part B and C|Lost to Follow-up|0|||
149958004|NCT01107457|540980104|FG003|Part B and C|Lost to Follow-up|0|||
149958005|NCT01107457|540980105|FG004|Part B and C|Lost to Follow-up|0|||
149958006|NCT01107457|540980106|FG005|Part B and C|Lost to Follow-up|10|||
149958007|NCT01107457|540980101|FG000|Part B and C|Protocol Violation|0|||
149958008|NCT01107457|540980102|FG001|Part B and C|Protocol Violation|0|||
149958009|NCT01107457|540980103|FG002|Part B and C|Protocol Violation|0|||
149958010|NCT01107457|540980104|FG003|Part B and C|Protocol Violation|0|||
149958011|NCT01107457|540980105|FG004|Part B and C|Protocol Violation|0|||
149958012|NCT01107457|540980106|FG005|Part B and C|Protocol Violation|1|||
149958013|NCT01107457|540980101|FG000|Part B and C|Sponsor Decision|0|||
149958014|NCT01107457|540980102|FG001|Part B and C|Sponsor Decision|0|||
149958015|NCT01107457|540980103|FG002|Part B and C|Sponsor Decision|0|||
149958016|NCT01107457|540980104|FG003|Part B and C|Sponsor Decision|0|||
149958017|NCT01107457|540980105|FG004|Part B and C|Sponsor Decision|0|||
149958018|NCT01107457|540980106|FG005|Part B and C|Sponsor Decision|66|||
149958019|NCT01107457|540980101|FG000|Part B and C|Withdrawal by Subject|0|||
149958020|NCT01107457|540980102|FG001|Part B and C|Withdrawal by Subject|0|||
149958021|NCT01107457|540980103|FG002|Part B and C|Withdrawal by Subject|0|||
149958022|NCT01107457|540980104|FG003|Part B and C|Withdrawal by Subject|0|||
149958023|NCT01107457|540980105|FG004|Part B and C|Withdrawal by Subject|0|||
149958024|NCT01107457|540980106|FG005|Part B and C|Withdrawal by Subject|16|||
149958025|NCT01107457|540980101|FG000|Part B and C|Clinical Relapse|0|||
149958026|NCT01107457|540980102|FG001|Part B and C|Clinical Relapse|0|||
149958027|NCT01107457|540980103|FG002|Part B and C|Clinical Relapse|0|||
149958028|NCT01107457|540980104|FG003|Part B and C|Clinical Relapse|0|||
149958029|NCT01107457|540980105|FG004|Part B and C|Clinical Relapse|0|||
149958030|NCT01107457|540980106|FG005|Part B and C|Clinical Relapse|4|||
149958031|NCT00694161|540980107|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
149958032|NCT00694161|540980107|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
149958033|NCT00694161|540980107|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
149958034|NCT00694122|540980108|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
149958035|NCT00694122|540980109|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
149958036|NCT00694122|540980108|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
149958037|NCT00694122|540980109|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
149958038|NCT00694122|540980108|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
149958039|NCT00694122|540980109|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
149958040|NCT00105508|540980110|FG000|Overall Study|Prephase Dropout|1|||
149958041|NCT00105508|540980111|FG001|Overall Study|Prephase Dropout|0|||
149958042|NCT00105508|540980110|FG000|Overall Study|Adverse Event|16|||
149958043|NCT00105508|540980111|FG001|Overall Study|Adverse Event|19|||
149958044|NCT00105508|540980110|FG000|Overall Study|Insufficient Efficacy|1|||
149958045|NCT00105508|540980111|FG001|Overall Study|Insufficient Efficacy|0|||
149958046|NCT00105508|540980110|FG000|Overall Study|Withdrawal by Subject|10|||
149958047|NCT00105508|540980111|FG001|Overall Study|Withdrawal by Subject|6|||
149958048|NCT00105508|540980110|FG000|Overall Study|Lost to Follow-up|3|||
149958049|NCT00105508|540980111|FG001|Overall Study|Lost to Follow-up|0|||
149958050|NCT00105508|540980110|FG000|Overall Study|Protocol Violation|1|||
149958051|NCT00105508|540980111|FG001|Overall Study|Protocol Violation|2|||
149958052|NCT00105508|540980110|FG000|Overall Study|Other|8|||
149958053|NCT00105508|540980111|FG001|Overall Study|Other|9|||
149958054|NCT00683384|540980112|FG000|Overall Study|Death|1|||
149958055|NCT00683384|540980112|FG000|Overall Study|Adverse Event|1|||
149958056|NCT00120874|540980113|FG000|Overall Study|Death|0|||
149958057|NCT00120874|540980114|FG001|Overall Study|Death|1|||
149958058|NCT01348490|540980121|FG000|Overall Study|Death|1|||
149958059|NCT01348490|540980121|FG000|Overall Study|Adverse Event|3|||
149958060|NCT01348490|540980121|FG000|Overall Study|Consent withdrawn|7|||
149958061|NCT01348490|540980121|FG000|Overall Study|Disease progression|3|||
149958062|NCT01348490|540980121|FG000|Overall Study|Lost to Follow-up|1|||
149958063|NCT01348490|540980121|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
149958064|NCT01348490|540980121|FG000|Overall Study|Other Unspecified|8|||
149958065|NCT00300495|540980122|FG000|Overall Study|Protocol Violation|4|||
149958066|NCT00300495|540980123|FG001|Overall Study|Protocol Violation|1|||
149958067|NCT03834883|540980130|FG000|Second Treatment|Withdrawal by Subject|1|||
149958068|NCT03834883|540980131|FG001|Second Treatment|Withdrawal by Subject|0|||
149958069|NCT03834883|540980132|FG002|Second Treatment|Withdrawal by Subject|0|||
149958070|NCT03834883|540980133|FG003|Second Treatment|Withdrawal by Subject|0|||
149958071|NCT03834883|540980130|FG000|Second Treatment|COVID-19 pandemic|1|||
149958072|NCT03834883|540980131|FG001|Second Treatment|COVID-19 pandemic|0|||
149958073|NCT03834883|540980132|FG002|Second Treatment|COVID-19 pandemic|1|||
149958074|NCT03834883|540980133|FG003|Second Treatment|COVID-19 pandemic|1|||
149958075|NCT01030900|540980134|FG000|Overall Study|Not treated due to congestive heart failure|1|||
149958076|NCT01030900|540980134|FG000|Overall Study|Not treated due to rapid disease|1|||
149849283|NCT03196284|540576097|FG002|Extension Part|Lack of Efficacy|1|||
149849284|NCT03196284|540576095|FG000|Extension Part|Withdrawal by Subject|0|||
149849285|NCT03196284|540576096|FG001|Extension Part|Withdrawal by Subject|0|||
149849286|NCT03196284|540576097|FG002|Extension Part|Withdrawal by Subject|1|||
149849287|NCT03196284|540576095|FG000|Extension Part|Physician Decision|0|||
149849288|NCT03196284|540576096|FG001|Extension Part|Physician Decision|0|||
149849289|NCT03196284|540576097|FG002|Extension Part|Physician Decision|1|||
149849290|NCT00087529|540576099|FG000|Overall Study|Death|1|||
149849291|NCT00087529|540576100|FG001|Overall Study|Death|0|||
149849292|NCT00087529|540576099|FG000|Overall Study|Adverse Event|0|||
149958077|NCT01179399|540980135|FG000|Overall Study|Adverse Event|1|||
149958078|NCT01179399|540980135|FG000|Overall Study|Lack of Efficacy|30|||
149958079|NCT01179399|540980135|FG000|Overall Study|Withdrawal by Subject|1|||
149958080|NCT00441896|540980136|FG000|Overall Study|Withdrawal by Subject|0|||
149958081|NCT00441896|540980137|FG001|Overall Study|Withdrawal by Subject|0|||
149958082|NCT00441896|540980138|FG002|Overall Study|Withdrawal by Subject|0|||
149958083|NCT00441896|540980139|FG003|Overall Study|Withdrawal by Subject|1|||
149958084|NCT00441896|540980140|FG004|Overall Study|Withdrawal by Subject|0|||
149958085|NCT00441896|540980141|FG005|Overall Study|Withdrawal by Subject|0|||
149958086|NCT00441896|540980142|FG006|Overall Study|Withdrawal by Subject|0|||
149958087|NCT00441896|540980143|FG007|Overall Study|Withdrawal by Subject|0|||
149958088|NCT00441896|540980144|FG008|Overall Study|Withdrawal by Subject|0|||
149958089|NCT00441896|540980145|FG009|Overall Study|Withdrawal by Subject|0|||
149958090|NCT00441896|540980136|FG000|Overall Study|Other|0|||
149958091|NCT00441896|540980137|FG001|Overall Study|Other|0|||
149958092|NCT00441896|540980138|FG002|Overall Study|Other|0|||
149958093|NCT00441896|540980139|FG003|Overall Study|Other|0|||
149958094|NCT00441896|540980140|FG004|Overall Study|Other|1|||
149958095|NCT00441896|540980141|FG005|Overall Study|Other|0|||
149958096|NCT00441896|540980142|FG006|Overall Study|Other|0|||
149958097|NCT00441896|540980143|FG007|Overall Study|Other|0|||
149958098|NCT00441896|540980144|FG008|Overall Study|Other|0|||
149958099|NCT00441896|540980145|FG009|Overall Study|Other|0|||
149958100|NCT03572218|540980146|FG000|Overall Study|Lost to Follow-up|3|||
149958101|NCT03572218|540980147|FG001|Overall Study|Lost to Follow-up|2|||
149958102|NCT03572218|540980146|FG000|Overall Study|No longer available for study visits|2|||
149958103|NCT03572218|540980147|FG001|Overall Study|No longer available for study visits|1|||
149958104|NCT03572218|540980146|FG000|Overall Study|No longer interested|1|||
149958105|NCT03572218|540980147|FG001|Overall Study|No longer interested|2|||
149958106|NCT01793129|540981781|FG000|Overall Study|Lost to Follow-up|3|||
149958107|NCT01793129|540981782|FG001|Overall Study|Lost to Follow-up|7|||
149958108|NCT01793129|540981781|FG000|Overall Study|Withdrawal by Subject|0|||
149958109|NCT01793129|540981782|FG001|Overall Study|Withdrawal by Subject|2|||
149958110|NCT00284934|540981789|FG000|Overall Study|Adverse Event|1|||
149958111|NCT00284934|540981790|FG001|Overall Study|Adverse Event|2|||
149958112|NCT00284934|540981789|FG000|Overall Study|Other reasons|3|||
149958113|NCT00284934|540981790|FG001|Overall Study|Other reasons|1|||
149958114|NCT00454142|540981791|FG000|Overall Study|Withdrawal by Subject|1|||
149958115|NCT01748552|540981796|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
149958116|NCT01748552|540981797|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
149958117|NCT01748552|540981798|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
149958118|NCT01748552|540981799|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
149958119|NCT01748552|540981800|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
149958120|NCT01748552|540981801|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
149958121|NCT01748552|540981802|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
149958122|NCT01748552|540981803|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
149958123|NCT01748552|540981804|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
149958124|NCT01748552|540981805|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
149958125|NCT01748552|540981806|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
149958126|NCT01748552|540981807|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
149958127|NCT01748552|540981796|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958128|NCT01748552|540981797|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958129|NCT01748552|540981798|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958130|NCT01748552|540981799|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958131|NCT01748552|540981800|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958132|NCT01748552|540981801|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958133|NCT01748552|540981802|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
149958134|NCT01748552|540981803|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
149849293|NCT00087529|540576100|FG001|Overall Study|Adverse Event|8|||
149849294|NCT00087529|540576099|FG000|Overall Study|Pregnancy|0|||
149958135|NCT01748552|540981804|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
149958136|NCT01748552|540981805|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958137|NCT01748552|540981806|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149849295|NCT00087529|540576100|FG001|Overall Study|Pregnancy|1|||
150038400|NCT02079246|541283301|FG001|OLEX|Protocol Violation|0|||
150038401|NCT02079246|541283300|FG000|OLEX|Lack of Efficacy|3|||
150038402|NCT02079246|541283301|FG001|OLEX|Lack of Efficacy|0|||
150038403|NCT02079246|541283300|FG000|OLEX|Results of the lead-in studies|58|||
150038404|NCT02079246|541283301|FG001|OLEX|Results of the lead-in studies|0|||
150038405|NCT02079246|541283300|FG000|OLEX|Other: Disallowed medication|8|||
150038406|NCT02079246|541283301|FG001|OLEX|Other: Disallowed medication|0|||
150038407|NCT02079246|541283300|FG000|OLEX|Other: Insufficient compliance|2|||
150038408|NCT02079246|541283301|FG001|OLEX|Other: Insufficient compliance|0|||
150038409|NCT02079246|541283300|FG000|OLEX|Other: Caregiver unavailable|3|||
150038410|NCT02079246|541283301|FG001|OLEX|Other: Caregiver unavailable|0|||
150038411|NCT02079246|541283300|FG000|OLEX|Other: Coordinator decision|1|||
150038412|NCT02079246|541283301|FG001|OLEX|Other: Coordinator decision|0|||
150038413|NCT02079246|541283300|FG000|OLEX|Other: Worsening of condition|1|||
150038414|NCT02079246|541283301|FG001|OLEX|Other: Worsening of condition|0|||
150038415|NCT02079246|541283300|FG000|OLEX|Other: Moved to nursing home|1|||
149849296|NCT00087529|540576099|FG000|Overall Study|Lost to Follow-up|2|||
149849297|NCT00087529|540576100|FG001|Overall Study|Lost to Follow-up|3|||
149849298|NCT00087529|540576099|FG000|Overall Study|Participant Decision|14|||
149849299|NCT00087529|540576100|FG001|Overall Study|Participant Decision|37|||
149849300|NCT00087529|540576099|FG000|Overall Study|Physician Decision|4|||
149849301|NCT00087529|540576100|FG001|Overall Study|Physician Decision|8|||
149849302|NCT00087529|540576099|FG000|Overall Study|Initiation of Excluded Therapy|0|||
149849303|NCT00087529|540576100|FG001|Overall Study|Initiation of Excluded Therapy|1|||
149849304|NCT00087529|540576099|FG000|Overall Study|Participant Noncompliance|0|||
149849305|NCT00087529|540576100|FG001|Overall Study|Participant Noncompliance|1|||
149849306|NCT00087529|540576099|FG000|Overall Study|Disease Progression|5|||
149849307|NCT00087529|540576100|FG001|Overall Study|Disease Progression|4|||
149849308|NCT00087529|540576099|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
149849309|NCT00087529|540576100|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
149849310|NCT01253564|540576105|FG000|Overall Study|Disease Progression|22|||
149849311|NCT01253564|540576105|FG000|Overall Study|Withdrawal by Subject|1|||
149849312|NCT01253564|540576105|FG000|Overall Study|Serious Adverse Event|1|||
149849313|NCT03694197|540576108|FG000|Overall Study|Adverse Event|9|||
149849314|NCT03694197|540576108|FG000|Overall Study|Protocol became inconvenient to participate|1|||
149849315|NCT03694197|540576108|FG000|Overall Study|Physician Decision|4|||
149849316|NCT03694197|540576108|FG000|Overall Study|Study terminated by sponsor|1350|||
149849317|NCT03694197|540576108|FG000|Overall Study|Participant moved|5|||
149849318|NCT03694197|540576108|FG000|Overall Study|Participant withdrew consent|10|||
149849319|NCT03694197|540576108|FG000|Overall Study|Related to IMP administration|1|||
149849320|NCT03694197|540576108|FG000|Overall Study|Not disclosed|5|||
149849321|NCT04729101|540577933|FG000|Overall Study|Adverse Event|1|||
149849322|NCT04729101|540577934|FG001|Overall Study|Adverse Event|0|||
149849323|NCT04729101|540577933|FG000|Overall Study|Physician Decision|1|||
149849324|NCT04729101|540577934|FG001|Overall Study|Physician Decision|0|||
149849325|NCT04729101|540577933|FG000|Overall Study|Withdrawal by Subject|1|||
149849326|NCT04729101|540577934|FG001|Overall Study|Withdrawal by Subject|0|||
149849327|NCT02940522|540577935|FG000|Overall Study|Lost to Follow-up|1|||
149849328|NCT02940522|540577936|FG001|Overall Study|Lost to Follow-up|2|||
149849329|NCT02940522|540577935|FG000|Overall Study|Withdrawal by Subject|1|||
149849330|NCT02940522|540577936|FG001|Overall Study|Withdrawal by Subject|0|||
149849331|NCT00274625|540577937|FG000|Overall Study|Lost to Follow-up|46|||
149849332|NCT00274625|540577938|FG001|Overall Study|Lost to Follow-up|54|||
149849333|NCT00274625|540577937|FG000|Overall Study|Excluded from analysis|14|||
149849334|NCT00274625|540577938|FG001|Overall Study|Excluded from analysis|8|||
149849335|NCT00762411|540577939|FG000|Initial Treatment|Death|7|||
149849336|NCT00762411|540577940|FG001|Initial Treatment|Death|6|||
149849337|NCT00762411|540577939|FG000|Initial Treatment|Adverse Event|132|||
149849338|NCT00762411|540577940|FG001|Initial Treatment|Adverse Event|40|||
149849339|NCT00762411|540577939|FG000|Initial Treatment|Protocol Violation|4|||
149849340|NCT00762411|540577940|FG001|Initial Treatment|Protocol Violation|1|||
149849341|NCT00762411|540577939|FG000|Initial Treatment|Withdrawal by Subject|65|||
149849342|NCT00762411|540577940|FG001|Initial Treatment|Withdrawal by Subject|52|||
149849343|NCT00762411|540577939|FG000|Initial Treatment|Physician Decision|1|||
149849344|NCT00762411|540577940|FG001|Initial Treatment|Physician Decision|0|||
149849345|NCT00762411|540577939|FG000|Initial Treatment|Sponsor Decision|293|||
149849346|NCT00762411|540577940|FG001|Initial Treatment|Sponsor Decision|401|||
149849347|NCT00762411|540577939|FG000|Initial Treatment|Lost to Follow-up|5|||
149849348|NCT00762411|540577940|FG001|Initial Treatment|Lost to Follow-up|0|||
149849349|NCT00762411|540577939|FG000|Initial Treatment|Caregiver Decision|21|||
149849350|NCT00762411|540577940|FG001|Initial Treatment|Caregiver Decision|16|||
149849351|NCT00762411|540577939|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
149849352|NCT00762411|540577940|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
149849353|NCT00762411|540577939|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
149849354|NCT00762411|540577940|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
149849355|NCT00762411|540577939|FG000|Delayed Start|Adverse Event|0|||
149849356|NCT00762411|540577940|FG001|Delayed Start|Adverse Event|4|||
149849357|NCT00762411|540577939|FG000|Delayed Start|Protocol Violation|0|||
149849358|NCT00762411|540577940|FG001|Delayed Start|Protocol Violation|1|||
149849359|NCT00762411|540577939|FG000|Delayed Start|Sponsor Decision|16|||
149958138|NCT01748552|540981807|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
149958139|NCT02741193|540981808|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
149849360|NCT00762411|540577940|FG001|Delayed Start|Sponsor Decision|20|||
149958140|NCT02741193|540981808|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
149958141|NCT02502383|540981809|FG000|Overall Study|Lost to Follow-up|130|||
149849361|NCT00762411|540577939|FG000|Delayed Start|Caregiver Decision|1|||
149849362|NCT00762411|540577940|FG001|Delayed Start|Caregiver Decision|1|||
149958142|NCT02502383|540981810|FG001|Overall Study|Lost to Follow-up|131|||
149849363|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
149849364|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
149849365|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
149849366|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
149849367|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
149849368|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
149849369|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
149849370|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
149849371|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
149849372|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
149849373|NCT00762411|540577939|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
149849374|NCT00762411|540577940|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
149849375|NCT01662024|540577958|FG000|Overall Study|Pregnancy|2|||
149849376|NCT01662024|540577958|FG000|Overall Study|Withdrawal by Subject|3|||
149849377|NCT04768296|540577959|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
149849378|NCT04768296|540577960|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
149849379|NCT00452348|540577965|FG000|Overall Study|Adverse Event|6|||
149849380|NCT00452348|540577966|FG001|Overall Study|Adverse Event|9|||
149849381|NCT00452348|540577965|FG000|Overall Study|Lack of Efficacy|10|||
149849382|NCT00452348|540577966|FG001|Overall Study|Lack of Efficacy|9|||
149849383|NCT00452348|540577965|FG000|Overall Study|Lost to Follow-up|14|||
149849384|NCT00452348|540577966|FG001|Overall Study|Lost to Follow-up|8|||
149849385|NCT00452348|540577965|FG000|Overall Study|Protocol Violation|22|||
149849386|NCT00452348|540577966|FG001|Overall Study|Protocol Violation|28|||
149849387|NCT00452348|540577965|FG000|Overall Study|Withdrawal by Subject|18|||
149849388|NCT00452348|540577966|FG001|Overall Study|Withdrawal by Subject|21|||
149849389|NCT00452348|540577965|FG000|Overall Study|Other|9|||
149849390|NCT00452348|540577966|FG001|Overall Study|Other|9|||
149849391|NCT01490190|540577967|FG000|Overall Study|Withdrawal by Subject|9|||
149849392|NCT01490190|540577967|FG000|Overall Study|Adverse Event|17|||
149849393|NCT01490190|540577967|FG000|Overall Study|Protocol Violation|5|||
149849394|NCT01490190|540577967|FG000|Overall Study|Lost to Follow-up|13|||
149849395|NCT01490190|540577967|FG000|Overall Study|Relocation|1|||
149849396|NCT01490190|540577967|FG000|Overall Study|Inconvenience|1|||
149849397|NCT01490190|540577967|FG000|Overall Study|Ring expulsion|2|||
149849398|NCT02435433|540577973|FG000|Overall Study|Withdrawal by Subject|2|||
149849399|NCT02435433|540577974|FG001|Overall Study|Withdrawal by Subject|3|||
149849400|NCT02435433|540577975|FG002|Overall Study|Withdrawal by Subject|1|||
149849401|NCT02435433|540577976|FG003|Overall Study|Withdrawal by Subject|0|||
149849402|NCT02435433|540577977|FG004|Overall Study|Withdrawal by Subject|0|||
149849403|NCT02435433|540577973|FG000|Overall Study|Lost to Follow-up|2|||
149849404|NCT02435433|540577974|FG001|Overall Study|Lost to Follow-up|2|||
149849405|NCT02435433|540577975|FG002|Overall Study|Lost to Follow-up|4|||
149958143|NCT02502383|540981809|FG000|Overall Study|Withdrawal by Subject|31|||
149958144|NCT02502383|540981810|FG001|Overall Study|Withdrawal by Subject|24|||
149958145|NCT00527748|540981812|FG000|Overall Study|Other|3|||
149958146|NCT01975285|540981822|FG000|Overall Study|Failed Block and follow up|2|||
149958147|NCT01975285|540981823|FG001|Overall Study|Failed Block and follow up|2|||
149958148|NCT03774810|540981824|FG000|Phase 1|Lack of Efficacy|21|||
149958149|NCT03774810|540981825|FG001|Phase 1|Lack of Efficacy|0|||
149958150|NCT03774810|540981826|FG002|Phase 1|Lack of Efficacy|0|||
149958151|NCT03774810|540981827|FG003|Phase 1|Lack of Efficacy|0|||
149958152|NCT03774810|540981828|FG004|Phase 1|Lack of Efficacy|0|||
149958153|NCT03774810|540981824|FG000|Phase 1|Withdrawal by Subject|9|||
149958154|NCT03774810|540981825|FG001|Phase 1|Withdrawal by Subject|0|||
149958155|NCT03774810|540981826|FG002|Phase 1|Withdrawal by Subject|0|||
149958156|NCT03774810|540981827|FG003|Phase 1|Withdrawal by Subject|0|||
149958157|NCT03774810|540981828|FG004|Phase 1|Withdrawal by Subject|0|||
149958158|NCT03774810|540981824|FG000|Phase 1|Lost to Follow-up|2|||
149958159|NCT03774810|540981825|FG001|Phase 1|Lost to Follow-up|0|||
149958160|NCT03774810|540981826|FG002|Phase 1|Lost to Follow-up|0|||
149958161|NCT03774810|540981827|FG003|Phase 1|Lost to Follow-up|0|||
149958162|NCT03774810|540981828|FG004|Phase 1|Lost to Follow-up|0|||
149958163|NCT03774810|540981824|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
149958164|NCT03774810|540981825|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
149958165|NCT03774810|540981826|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
149958166|NCT03774810|540981827|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
149958167|NCT03774810|540981828|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
149958168|NCT03774810|540981824|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
150038416|NCT02079246|541283301|FG001|OLEX|Other: Moved to nursing home|0|||
149849406|NCT02435433|540577976|FG003|Overall Study|Lost to Follow-up|1|||
149849407|NCT02435433|540577977|FG004|Overall Study|Lost to Follow-up|0|||
149849408|NCT01119625|540577979|FG000|Overall Study|Lost to Follow-up|1|||
149849409|NCT01119625|540577980|FG001|Overall Study|Lost to Follow-up|2|||
149849410|NCT01119625|540577979|FG000|Overall Study|Withdrawal by Subject|2|||
149849411|NCT01119625|540577980|FG001|Overall Study|Withdrawal by Subject|1|||
149958169|NCT03774810|540981825|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
150038417|NCT02079246|541283300|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
149849412|NCT01119625|540577979|FG000|Overall Study|Other|0|||
149958170|NCT03774810|540981826|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
149958171|NCT03774810|540981827|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
149958172|NCT03774810|540981828|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
150038418|NCT02079246|541283301|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
150038419|NCT02079246|541283300|FG000|OLEX-MEM|Adverse Event|0|||
150038420|NCT02079246|541283301|FG001|OLEX-MEM|Adverse Event|6|||
150038421|NCT02079246|541283300|FG000|OLEX-MEM|Withdrawal by Subject|0|||
150038422|NCT02079246|541283301|FG001|OLEX-MEM|Withdrawal by Subject|7|||
150038423|NCT02079246|541283300|FG000|OLEX-MEM|Protocol Violation|0|||
150038424|NCT02079246|541283301|FG001|OLEX-MEM|Protocol Violation|2|||
150038425|NCT02079246|541283300|FG000|OLEX-MEM|Lost to Follow-up|0|||
150038426|NCT02079246|541283301|FG001|OLEX-MEM|Lost to Follow-up|1|||
150038427|NCT02079246|541283300|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
150038428|NCT02079246|541283301|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
150038429|NCT04040933|541283302|FG000|Overall Study|Protocol Violation|1|||
150038430|NCT04040933|541283302|FG000|Overall Study|Withdrawal by Subject|2|||
150038431|NCT02066181|541283303|FG000|Overall Study|Withdrawal by Subject|1|||
150038432|NCT02066181|541283304|FG001|Overall Study|Withdrawal by Subject|1|||
150038433|NCT00775190|541283306|FG000|Overall Study|Lost to Follow-up|2|||
150038434|NCT00775190|541283307|FG001|Overall Study|Lost to Follow-up|3|||
150038435|NCT00775190|541283306|FG000|Overall Study|Withdrawal by Subject|1|||
150038436|NCT00775190|541283307|FG001|Overall Study|Withdrawal by Subject|2|||
150038437|NCT00775190|541283306|FG000|Overall Study|Protocol Violation|1|||
150038438|NCT00775190|541283307|FG001|Overall Study|Protocol Violation|0|||
150038439|NCT02141295|541283308|FG000|Overall Study|Adverse Event|1|||
150038440|NCT02141295|541283309|FG001|Overall Study|Adverse Event|18|||
150038441|NCT02141295|541283310|FG002|Overall Study|Adverse Event|11|||
150038442|NCT02141295|541283308|FG000|Overall Study|Physician Decision|2|||
150038443|NCT02141295|541283309|FG001|Overall Study|Physician Decision|19|||
150038444|NCT02141295|541283310|FG002|Overall Study|Physician Decision|14|||
150038445|NCT02141295|541283308|FG000|Overall Study|Study terminated by sponsor|0|||
150038446|NCT02141295|541283309|FG001|Overall Study|Study terminated by sponsor|6|||
150038447|NCT02141295|541283310|FG002|Overall Study|Study terminated by sponsor|6|||
150038448|NCT02141295|541283308|FG000|Overall Study|Non-compliance|0|||
150038449|NCT02141295|541283309|FG001|Overall Study|Non-compliance|1|||
150038450|NCT02141295|541283310|FG002|Overall Study|Non-compliance|0|||
150038451|NCT02141295|541283308|FG000|Overall Study|Progressive disease|3|||
150038452|NCT02141295|541283309|FG001|Overall Study|Progressive disease|32|||
150038453|NCT02141295|541283310|FG002|Overall Study|Progressive disease|50|||
150038454|NCT02141295|541283308|FG000|Overall Study|Reason not specified|0|||
150038455|NCT02141295|541283309|FG001|Overall Study|Reason not specified|9|||
150038456|NCT02141295|541283310|FG002|Overall Study|Reason not specified|10|||
150038457|NCT02141295|541283308|FG000|Overall Study|Withdrawal by Subject|0|||
150038458|NCT02141295|541283309|FG001|Overall Study|Withdrawal by Subject|9|||
150038459|NCT02141295|541283310|FG002|Overall Study|Withdrawal by Subject|4|||
150038460|NCT01709084|541283311|FG000|Overall Study|Lost to Follow-up|4|||
150038461|NCT01709084|541283312|FG001|Overall Study|Lost to Follow-up|7|||
150038462|NCT01709084|541283311|FG000|Overall Study|Withdrawal by Subject|2|||
150038463|NCT01709084|541283312|FG001|Overall Study|Withdrawal by Subject|2|||
150038464|NCT01709084|541283311|FG000|Overall Study|Adverse Event|5|||
150038465|NCT01709084|541283312|FG001|Overall Study|Adverse Event|0|||
150038466|NCT01709084|541283311|FG000|Overall Study|Other|5|||
150038467|NCT01709084|541283312|FG001|Overall Study|Other|3|||
150038468|NCT01709084|541283311|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
150038469|NCT01709084|541283312|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
150038470|NCT01709084|541283311|FG000|Overall Study|Not Treated|0|||
150038471|NCT01709084|541283312|FG001|Overall Study|Not Treated|2|||
150038472|NCT00214201|541283313|FG000|Overall Study|Withdrawal by Subject|2|||
150038473|NCT00214201|541283314|FG001|Overall Study|Withdrawal by Subject|0|||
150038474|NCT00214201|541283313|FG000|Overall Study|Death|0|||
150038475|NCT00214201|541283314|FG001|Overall Study|Death|2|||
150038476|NCT01432730|541283315|FG000|Period 1|Adverse Event|2|||
150038477|NCT01432730|541283316|FG001|Period 1|Adverse Event|0|||
150038478|NCT01432730|541283315|FG000|Period 2|Adverse Event|0|||
150038479|NCT01432730|541283316|FG001|Period 2|Adverse Event|4|||
150038480|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
150038481|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
150038482|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
150038483|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
150038484|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
150038485|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
150038486|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
150038487|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
150038488|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
150038489|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
150038490|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
150038491|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
150038492|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
150038493|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
149849413|NCT01119625|540577980|FG001|Overall Study|Other|1|||
149849414|NCT02754492|540577985|FG000|Overall Study|Protocol Violation|2|||
149849415|NCT02754492|540577986|FG001|Overall Study|Protocol Violation|2|||
149849416|NCT02754492|540577987|FG002|Overall Study|Protocol Violation|0|||
149849417|NCT02754492|540577988|FG003|Overall Study|Protocol Violation|1|||
149849418|NCT02754492|540577985|FG000|Overall Study|Withdrawal by Subject|2|||
149849419|NCT02754492|540577986|FG001|Overall Study|Withdrawal by Subject|0|||
149849420|NCT02754492|540577987|FG002|Overall Study|Withdrawal by Subject|0|||
149849421|NCT02754492|540577988|FG003|Overall Study|Withdrawal by Subject|0|||
149849422|NCT02754492|540577985|FG000|Overall Study|Equipment malfuntion|0|||
149849423|NCT02754492|540577986|FG001|Overall Study|Equipment malfuntion|0|||
149849424|NCT02754492|540577987|FG002|Overall Study|Equipment malfuntion|2|||
149849425|NCT02754492|540577988|FG003|Overall Study|Equipment malfuntion|5|||
149849426|NCT02754492|540577985|FG000|Overall Study|Adverse Event|0|||
149849427|NCT02754492|540577986|FG001|Overall Study|Adverse Event|0|||
149849428|NCT02754492|540577987|FG002|Overall Study|Adverse Event|0|||
149849429|NCT02754492|540577988|FG003|Overall Study|Adverse Event|13|||
149849430|NCT02754492|540577985|FG000|Overall Study|Venous access issues not resulting in AE|0|||
149849431|NCT02754492|540577986|FG001|Overall Study|Venous access issues not resulting in AE|0|||
149849432|NCT02754492|540577987|FG002|Overall Study|Venous access issues not resulting in AE|0|||
149849433|NCT02754492|540577988|FG003|Overall Study|Venous access issues not resulting in AE|4|||
149849434|NCT00397254|540577991|FG000|Overall Study|Lost to Follow-up|2|||
149849435|NCT00397254|540577992|FG001|Overall Study|Lost to Follow-up|2|||
149849436|NCT00210639|540577993|FG000|Overall Study|Lost to Follow-up|37|||
149849437|NCT00210639|540577994|FG001|Overall Study|Lost to Follow-up|29|||
149849438|NCT00210639|540577993|FG000|Overall Study|Withdrawal by Subject|8|||
149849439|NCT00210639|540577994|FG001|Overall Study|Withdrawal by Subject|1|||
149849440|NCT00210639|540577993|FG000|Overall Study|Other|18|||
149849441|NCT00210639|540577994|FG001|Overall Study|Other|12|||
149849442|NCT02627963|540578000|FG000|Overall Study|Randomized but not treated|2|||
149849443|NCT02627963|540578001|FG001|Overall Study|Randomized but not treated|6|||
149849444|NCT03073798|540578002|FG000|Overall Study|Adverse Event|1|||
149849445|NCT03073798|540578002|FG000|Overall Study|Withdrawal by Subject|1|||
149849446|NCT01186458|540578003|FG000|Overall Study|Adverse Event|1|||
149849447|NCT02372006|540578006|FG000|Overall Study|Progressive disease|8|||
149849448|NCT02372006|540578007|FG001|Overall Study|Progressive disease|7|||
149849449|NCT02372006|540578008|FG002|Overall Study|Progressive disease|34|||
149849450|NCT02372006|540578006|FG000|Overall Study|Dose limiting toxicity|0|||
149849451|NCT02372006|540578007|FG001|Overall Study|Dose limiting toxicity|1|||
149849452|NCT02372006|540578008|FG002|Overall Study|Dose limiting toxicity|0|||
149849453|NCT02372006|540578006|FG000|Overall Study|Adverse Event|0|||
149849454|NCT02372006|540578007|FG001|Overall Study|Adverse Event|0|||
149849455|NCT02372006|540578008|FG002|Overall Study|Adverse Event|3|||
149849456|NCT02372006|540578006|FG000|Overall Study|Withdrawal by Subject|0|||
149849457|NCT02372006|540578007|FG001|Overall Study|Withdrawal by Subject|1|||
149849458|NCT02372006|540578008|FG002|Overall Study|Withdrawal by Subject|1|||
149849459|NCT02372006|540578006|FG000|Overall Study|Other reason for not completing|0|||
149849460|NCT02372006|540578007|FG001|Overall Study|Other reason for not completing|0|||
149849461|NCT02372006|540578008|FG002|Overall Study|Other reason for not completing|1|||
149849462|NCT00295490|540578009|FG000|Overall Study|Protocol Violation|0|||
149849463|NCT00295490|540578010|FG001|Overall Study|Protocol Violation|0|||
149849464|NCT00295490|540578011|FG002|Overall Study|Protocol Violation|3|||
149849465|NCT00295490|540578012|FG003|Overall Study|Protocol Violation|3|||
149849466|NCT00295490|540578009|FG000|Overall Study|Withdrawal by Subject|0|||
149849467|NCT00295490|540578010|FG001|Overall Study|Withdrawal by Subject|2|||
149849468|NCT00295490|540578011|FG002|Overall Study|Withdrawal by Subject|0|||
149849469|NCT00295490|540578012|FG003|Overall Study|Withdrawal by Subject|1|||
149849470|NCT00295490|540578009|FG000|Overall Study|Lost to Follow-up|0|||
149849471|NCT00295490|540578010|FG001|Overall Study|Lost to Follow-up|0|||
149849472|NCT00295490|540578011|FG002|Overall Study|Lost to Follow-up|1|||
149849473|NCT00295490|540578012|FG003|Overall Study|Lost to Follow-up|0|||
149849474|NCT00295490|540578009|FG000|Overall Study|Adverse Event|1|||
149849475|NCT00295490|540578010|FG001|Overall Study|Adverse Event|0|||
149849476|NCT00295490|540578011|FG002|Overall Study|Adverse Event|0|||
149849477|NCT00295490|540578012|FG003|Overall Study|Adverse Event|0|||
149849478|NCT00295490|540578009|FG000|Overall Study|Other|0|||
149849479|NCT00295490|540578010|FG001|Overall Study|Other|2|||
149849480|NCT00295490|540578011|FG002|Overall Study|Other|0|||
150288875|NCT01662440|542192522|FG000|Overall Study|Subject moved to another country.|0|||
149849481|NCT00295490|540578012|FG003|Overall Study|Other|1|||
149849482|NCT04473326|540578013|FG000|Overall Study|Death|0|||
149849483|NCT04473326|540578014|FG001|Overall Study|Death|1|||
149849484|NCT04473326|540578013|FG000|Overall Study|Withdrawal by Subject|1|||
149849485|NCT04473326|540578014|FG001|Overall Study|Withdrawal by Subject|2|||
149849486|NCT02611362|540578015|FG000|Overall Study|Withdrawal by Subject|7|||
149849487|NCT02611362|540578016|FG001|Overall Study|Withdrawal by Subject|2|||
149849488|NCT02611362|540578015|FG000|Overall Study|Lost to Follow-up|2|||
149849489|NCT02611362|540578016|FG001|Overall Study|Lost to Follow-up|4|||
149849490|NCT01532908|540578028|FG000|Overall Study|Not Transplanted|1|||
149849491|NCT01532908|540578029|FG001|Overall Study|Not Transplanted|0|||
149849492|NCT01559116|540578030|FG000|Overall Study|Adverse Event|10|||
149849493|NCT01559116|540578030|FG000|Overall Study|Lack of Efficacy|1|||
149849494|NCT01559116|540578030|FG000|Overall Study|Lost to Follow-up|1|||
149849495|NCT01559116|540578030|FG000|Overall Study|Protocol Violation|1|||
149849496|NCT01559116|540578030|FG000|Overall Study|Withdrawal by Subject|4|||
149849497|NCT01559116|540578030|FG000|Overall Study|other than stated above|9|||
149849498|NCT04610580|540578031|FG000|Two-way Crossover Period|Adverse Event|1|||
149849499|NCT04610580|540578032|FG001|Two-way Crossover Period|Adverse Event|0|||
149849500|NCT04610580|540578033|FG002|Two-way Crossover Period|Adverse Event|0|||
149849501|NCT04610580|540578034|FG003|Two-way Crossover Period|Adverse Event|0|||
149849502|NCT04610580|540578035|FG004|Two-way Crossover Period|Adverse Event|0|||
149849503|NCT04610580|540578036|FG005|Two-way Crossover Period|Adverse Event|0|||
149849504|NCT04610580|540578031|FG000|Two-way Crossover Period|Physician Decision|1|||
149849505|NCT04610580|540578032|FG001|Two-way Crossover Period|Physician Decision|0|||
149849506|NCT04610580|540578033|FG002|Two-way Crossover Period|Physician Decision|0|||
149849507|NCT04610580|540578034|FG003|Two-way Crossover Period|Physician Decision|0|||
149849508|NCT04610580|540578035|FG004|Two-way Crossover Period|Physician Decision|0|||
149849509|NCT04610580|540578036|FG005|Two-way Crossover Period|Physician Decision|0|||
149849510|NCT04610580|540578031|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
149849511|NCT04610580|540578032|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
149849512|NCT04610580|540578033|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
149849513|NCT04610580|540578034|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
149849514|NCT04610580|540578035|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
149849515|NCT04610580|540578036|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
149849516|NCT04610580|540578031|FG000|Two-way Crossover Period|Other than specified|0|||
149849517|NCT04610580|540578032|FG001|Two-way Crossover Period|Other than specified|1|||
149849518|NCT04610580|540578033|FG002|Two-way Crossover Period|Other than specified|0|||
149849519|NCT04610580|540578034|FG003|Two-way Crossover Period|Other than specified|0|||
149849520|NCT04610580|540578035|FG004|Two-way Crossover Period|Other than specified|0|||
149849521|NCT04610580|540578036|FG005|Two-way Crossover Period|Other than specified|0|||
149849522|NCT04610580|540578031|FG000|Washout Before Extension Period|Other than specified|0|||
149849523|NCT04610580|540578032|FG001|Washout Before Extension Period|Other than specified|1|||
149849524|NCT04610580|540578033|FG002|Washout Before Extension Period|Other than specified|0|||
149849525|NCT04610580|540578034|FG003|Washout Before Extension Period|Other than specified|0|||
149849526|NCT04610580|540578035|FG004|Washout Before Extension Period|Other than specified|0|||
149849527|NCT04610580|540578036|FG005|Washout Before Extension Period|Other than specified|0|||
149849528|NCT04610580|540578031|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
149849529|NCT04610580|540578032|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
149849530|NCT04610580|540578033|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
149849531|NCT04610580|540578034|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
149849532|NCT04610580|540578035|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
149849533|NCT04610580|540578036|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
149849534|NCT04610580|540578031|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
149849535|NCT04610580|540578032|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
149849536|NCT04610580|540578033|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
149849537|NCT04610580|540578034|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
149849538|NCT04610580|540578035|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
149849539|NCT04610580|540578036|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
149958173|NCT03774810|540981824|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
149958174|NCT03774810|540981825|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
149958175|NCT03774810|540981826|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
149958176|NCT03774810|540981827|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
149958177|NCT03774810|540981828|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
149958178|NCT03774810|540981824|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
149849540|NCT01993940|540578037|FG000|Overall Study|Adverse Event|16|||
149849541|NCT01993940|540578038|FG001|Overall Study|Adverse Event|11|||
149849542|NCT01993940|540578037|FG000|Overall Study|Withdrawal by Subject|15|||
149958179|NCT03774810|540981825|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
149958180|NCT03774810|540981826|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
149958181|NCT03774810|540981827|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
149958182|NCT03774810|540981828|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
149958183|NCT03774810|540981824|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
149958184|NCT03774810|540981825|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
150038494|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
149849543|NCT01993940|540578038|FG001|Overall Study|Withdrawal by Subject|19|||
149849544|NCT01993940|540578037|FG000|Overall Study|Lost to Follow-up|2|||
149849545|NCT01993940|540578038|FG001|Overall Study|Lost to Follow-up|5|||
149958185|NCT03774810|540981826|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
149849546|NCT01993940|540578037|FG000|Overall Study|Protocol Violation|5|||
149849547|NCT01993940|540578038|FG001|Overall Study|Protocol Violation|8|||
149849548|NCT01993940|540578037|FG000|Overall Study|Death|1|||
149849549|NCT01993940|540578038|FG001|Overall Study|Death|0|||
149849550|NCT01993940|540578037|FG000|Overall Study|Other - Miscellaneous|1|||
149849551|NCT01993940|540578038|FG001|Overall Study|Other - Miscellaneous|1|||
149849552|NCT03922750|540578039|FG000|Overall Study|Unclassified|0|||
149849553|NCT03922750|540578040|FG001|Overall Study|Unclassified|0|||
149849554|NCT03922750|540578041|FG002|Overall Study|Unclassified|1|||
149849555|NCT03922750|540578039|FG000|Overall Study|Adverse Event|0|||
149849556|NCT03922750|540578040|FG001|Overall Study|Adverse Event|1|||
149849557|NCT03922750|540578041|FG002|Overall Study|Adverse Event|0|||
149849558|NCT01670097|540578046|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
149849559|NCT01670097|540578047|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
149849560|NCT01670097|540578046|FG000|Overall Study|Study burden|1|||
149849561|NCT01670097|540578047|FG001|Overall Study|Study burden|0|||
149849562|NCT01670097|540578046|FG000|Overall Study|COPD exacerbation|0|||
149849563|NCT01670097|540578047|FG001|Overall Study|COPD exacerbation|1|||
149849564|NCT01670097|540578046|FG000|Overall Study|Neutropenia|0|||
149849565|NCT01670097|540578047|FG001|Overall Study|Neutropenia|1|||
149849566|NCT01670097|540578046|FG000|Overall Study|Clinical deterioration|0|||
149849567|NCT01670097|540578047|FG001|Overall Study|Clinical deterioration|1|||
149849568|NCT01670097|540578046|FG000|Overall Study|Disease progression|0|||
149849569|NCT01670097|540578047|FG001|Overall Study|Disease progression|1|||
149849570|NCT01824498|540578048|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
149849571|NCT01824498|540578049|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
149849572|NCT01824498|540578050|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
149849573|NCT01824498|540578051|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
149849574|NCT01824498|540578052|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
149849575|NCT01824498|540578053|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
149849576|NCT01567527|540578054|FG000|Conversion Phase.|Protocol deviation|3|||
149849577|NCT01567527|540578055|FG001|Conversion Phase.|Protocol deviation|0|||
149849578|NCT01567527|540578056|FG002|Conversion Phase.|Protocol deviation|0|||
149849579|NCT01567527|540578057|FG003|Conversion Phase.|Protocol deviation|0|||
149849580|NCT01567527|540578058|FG004|Conversion Phase.|Protocol deviation|0|||
149849581|NCT01567527|540578054|FG000|Conversion Phase.|Met withdrawal criteria|10|||
149849582|NCT01567527|540578055|FG001|Conversion Phase.|Met withdrawal criteria|0|||
149849583|NCT01567527|540578056|FG002|Conversion Phase.|Met withdrawal criteria|0|||
149849584|NCT01567527|540578057|FG003|Conversion Phase.|Met withdrawal criteria|0|||
149849585|NCT01567527|540578058|FG004|Conversion Phase.|Met withdrawal criteria|0|||
149849586|NCT01567527|540578054|FG000|Conversion Phase.|Withdrawal by Subject|32|||
149849587|NCT01567527|540578055|FG001|Conversion Phase.|Withdrawal by Subject|0|||
149849588|NCT01567527|540578056|FG002|Conversion Phase.|Withdrawal by Subject|0|||
149849589|NCT01567527|540578057|FG003|Conversion Phase.|Withdrawal by Subject|0|||
149849590|NCT01567527|540578058|FG004|Conversion Phase.|Withdrawal by Subject|0|||
149849591|NCT01567527|540578054|FG000|Conversion Phase.|Lost to Follow-up|16|||
149849592|NCT01567527|540578055|FG001|Conversion Phase.|Lost to Follow-up|0|||
149849593|NCT01567527|540578056|FG002|Conversion Phase.|Lost to Follow-up|0|||
149849594|NCT01567527|540578057|FG003|Conversion Phase.|Lost to Follow-up|0|||
149849595|NCT01567527|540578058|FG004|Conversion Phase.|Lost to Follow-up|0|||
149849596|NCT01567527|540578054|FG000|Conversion Phase.|Lack of Efficacy|2|||
149849597|NCT01567527|540578055|FG001|Conversion Phase.|Lack of Efficacy|0|||
149849598|NCT01567527|540578056|FG002|Conversion Phase.|Lack of Efficacy|0|||
149849599|NCT01567527|540578057|FG003|Conversion Phase.|Lack of Efficacy|0|||
149849600|NCT01567527|540578058|FG004|Conversion Phase.|Lack of Efficacy|0|||
149849601|NCT01567527|540578054|FG000|Conversion Phase.|Adverse Event|33|||
149849602|NCT01567527|540578055|FG001|Conversion Phase.|Adverse Event|0|||
149849603|NCT01567527|540578056|FG002|Conversion Phase.|Adverse Event|0|||
149849604|NCT01567527|540578057|FG003|Conversion Phase.|Adverse Event|0|||
149849605|NCT01567527|540578058|FG004|Conversion Phase.|Adverse Event|0|||
149849606|NCT01567527|540578054|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
149849607|NCT01567527|540578055|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
149849608|NCT01567527|540578056|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
149958186|NCT03774810|540981827|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
149958187|NCT03774810|540981828|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
149958188|NCT03774810|540981824|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
149958189|NCT03774810|540981825|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
149849609|NCT01567527|540578057|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
149849610|NCT01567527|540578058|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
149958190|NCT03774810|540981826|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
149958191|NCT03774810|540981827|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
149849611|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
149849612|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
149849613|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
149849614|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
149849615|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
149849616|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
149849617|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
149849618|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
149849619|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
149849620|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
149849621|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
149849622|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
149958192|NCT03774810|540981828|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
149958193|NCT03994120|540981829|FG000|Overall Study|Lost to Follow-up|3|||
149958194|NCT03994120|540981830|FG001|Overall Study|Lost to Follow-up|1|||
149958195|NCT01111292|540981831|FG000|Treatment|Physician Decision|1|||
149958196|NCT01111292|540981832|FG001|Treatment|Physician Decision|1|||
149958197|NCT04914000|540981833|FG000|Overall Study|Lost to Follow-up|8|||
149958198|NCT04914000|540981833|FG000|Overall Study|Withdrawal by Subject|1|||
149958199|NCT02619812|540981834|FG000|Overall Study|Withdrawal by Subject|0|||
149849623|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
149849624|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
149849625|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
149849626|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
149849627|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
149849628|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
149849629|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
149849630|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
149849631|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
149849632|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
149849633|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
149849634|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
149849635|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
149849636|NCT01567527|540578054|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
149849637|NCT01567527|540578055|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
149849638|NCT01567527|540578056|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
149849639|NCT01567527|540578057|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
149849640|NCT01567527|540578058|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
149849641|NCT01567527|540578054|FG000|IM Depot Stabilization.|Protocol deviation|0|||
149849642|NCT01567527|540578055|FG001|IM Depot Stabilization.|Protocol deviation|0|||
150038495|NCT01235741|541283317|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
150038496|NCT01235741|541283318|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
149849643|NCT01567527|540578056|FG002|IM Depot Stabilization.|Protocol deviation|5|||
149849644|NCT01567527|540578057|FG003|IM Depot Stabilization.|Protocol deviation|0|||
149849645|NCT01567527|540578058|FG004|IM Depot Stabilization.|Protocol deviation|0|||
149958200|NCT02619812|540981835|FG001|Overall Study|Withdrawal by Subject|0|||
149958201|NCT02619812|540981836|FG002|Overall Study|Withdrawal by Subject|1|||
149958202|NCT02619812|540981837|FG003|Overall Study|Withdrawal by Subject|2|||
149958203|NCT01096186|540981838|FG000|Overall Study|Adverse Event|16|||
149958204|NCT01096186|540981838|FG000|Overall Study|Death|4|||
149958205|NCT01096186|540981838|FG000|Overall Study|Lack of Efficacy|4|||
149958206|NCT01096186|540981838|FG000|Overall Study|Lost to Follow-up|2|||
149958207|NCT01096186|540981838|FG000|Overall Study|Withdrawal by Subject|22|||
149958208|NCT01096186|540981838|FG000|Overall Study|Physician Decision|1|||
149958209|NCT01096186|540981838|FG000|Overall Study|Noncompliance with study drug|1|||
149958210|NCT00799864|540981848|FG000|Overall Study|Participant reached a virologic endpoint|9|||
149958211|NCT00799864|540981849|FG001|Overall Study|Participant reached a virologic endpoint|2|||
149958212|NCT00799864|540981850|FG002|Overall Study|Participant reached a virologic endpoint|2|||
149958213|NCT00799864|540981851|FG003|Overall Study|Participant reached a virologic endpoint|0|||
149958214|NCT00799864|540981852|FG004|Overall Study|Participant reached a virologic endpoint|0|||
149958215|NCT00799864|540981848|FG000|Overall Study|Other|2|||
150038497|NCT01235741|541283319|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
150038498|NCT01235741|541283317|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
149849646|NCT01567527|540578054|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
149958216|NCT00799864|540981849|FG001|Overall Study|Other|1|||
149849647|NCT01567527|540578055|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
149958217|NCT00799864|540981850|FG002|Overall Study|Other|0|||
150038499|NCT01235741|541283318|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
149849648|NCT01567527|540578056|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
149849649|NCT01567527|540578057|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
149849650|NCT01567527|540578058|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
149849651|NCT01567527|540578054|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
149849652|NCT01567527|540578055|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
149849653|NCT01567527|540578056|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
149849654|NCT01567527|540578057|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
149849655|NCT01567527|540578058|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
149849656|NCT01567527|540578054|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
149849657|NCT01567527|540578055|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
149849658|NCT01567527|540578056|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
149849659|NCT01567527|540578057|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
149849660|NCT01567527|540578058|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
149849661|NCT01567527|540578054|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
149849662|NCT01567527|540578055|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
149849663|NCT01567527|540578056|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
149849664|NCT01567527|540578057|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
149849665|NCT01567527|540578058|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
149849666|NCT01567527|540578054|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
149849667|NCT01567527|540578055|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
149849668|NCT01567527|540578056|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
149849669|NCT01567527|540578057|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
149849670|NCT01567527|540578058|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
149849671|NCT01567527|540578054|FG000|IM Depot Stabilization.|Adverse Event|0|||
149849672|NCT01567527|540578055|FG001|IM Depot Stabilization.|Adverse Event|0|||
149849673|NCT01567527|540578056|FG002|IM Depot Stabilization.|Adverse Event|37|||
149849674|NCT01567527|540578057|FG003|IM Depot Stabilization.|Adverse Event|0|||
149849675|NCT01567527|540578058|FG004|IM Depot Stabilization.|Adverse Event|0|||
149849676|NCT01567527|540578054|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
149849677|NCT01567527|540578055|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
149849678|NCT01567527|540578056|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
149849679|NCT01567527|540578057|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
149849680|NCT01567527|540578058|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
149849681|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
149849682|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
149849683|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
149849684|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
149849685|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
149849686|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
149849687|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
149849688|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
149849689|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
149849690|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
149849691|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
149849692|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
149849693|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
149849694|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
149849695|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
149849696|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
149849697|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
149849698|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
149849699|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
149958218|NCT00799864|540981851|FG003|Overall Study|Other|0|||
149958219|NCT00799864|540981852|FG004|Overall Study|Other|0|||
149958220|NCT04865978|540981853|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
149849700|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
149849701|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149849702|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149849703|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149849704|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
149849705|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
149958221|NCT04865978|540981854|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
149958222|NCT05587998|540981855|FG000|Overall Study|Withdrawal by Subject|1|||
150038500|NCT01235741|541283319|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
150038501|NCT01235741|541283317|FG000|Randomized to Treatment|Adverse Event|0|||
150038502|NCT01235741|541283318|FG001|Randomized to Treatment|Adverse Event|1|||
150038503|NCT01235741|541283319|FG002|Randomized to Treatment|Adverse Event|1|||
150038504|NCT01235741|541283317|FG000|Randomized to Treatment|Sponsor terminated study|0|||
150038505|NCT01235741|541283318|FG001|Randomized to Treatment|Sponsor terminated study|35|||
150038506|NCT01235741|541283319|FG002|Randomized to Treatment|Sponsor terminated study|34|||
150038507|NCT01235741|541283317|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
150038508|NCT01235741|541283318|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
150038509|NCT01235741|541283319|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
150038510|NCT01235741|541283317|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
149958223|NCT05587998|540981856|FG001|Overall Study|Withdrawal by Subject|1|||
149958224|NCT05587998|540981855|FG000|Overall Study|Not treated|3|||
149958225|NCT05587998|540981856|FG001|Overall Study|Not treated|1|||
149958226|NCT05587998|540981855|FG000|Overall Study|Non-compliance with study procedures|0|||
149958227|NCT05587998|540981856|FG001|Overall Study|Non-compliance with study procedures|1|||
149958228|NCT04263532|540981857|FG000|Overall Study|Withdrawal by Subject|2|||
149958229|NCT04263532|540981858|FG001|Overall Study|Withdrawal by Subject|0|||
149958230|NCT03225989|540981862|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
149958231|NCT03225989|540981863|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
149958232|NCT03225989|540981864|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
149958233|NCT03225989|540981862|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
149958234|NCT03225989|540981863|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
149958235|NCT03225989|540981864|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
149958236|NCT03225989|540981862|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
149958237|NCT03225989|540981863|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
149958238|NCT03225989|540981864|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
149958239|NCT03225989|540981862|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
149958240|NCT03225989|540981863|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
149958241|NCT03225989|540981864|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
149958242|NCT03225989|540981862|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
149958243|NCT03225989|540981863|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
149958244|NCT03225989|540981864|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
149958245|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
149958246|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
149958247|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
149958248|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
149958249|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
149958250|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
149958251|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
149958252|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
149958253|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
149958254|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
149958255|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
149958256|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
149958257|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
149958258|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
149958259|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
149958260|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
149958261|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
149958262|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
149958263|NCT03225989|540981862|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
149958264|NCT03225989|540981863|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
149958265|NCT03225989|540981864|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
149958266|NCT00601107|540981865|FG000|Overall Study|Adverse Event|0|||
149958267|NCT00601107|540981866|FG001|Overall Study|Adverse Event|1|||
149958268|NCT00601107|540981867|FG002|Overall Study|Adverse Event|3|||
149958269|NCT00601107|540981868|FG003|Overall Study|Adverse Event|0|||
149958270|NCT00601107|540981865|FG000|Overall Study|Withdrawal by Subject|5|||
149958271|NCT00601107|540981866|FG001|Overall Study|Withdrawal by Subject|4|||
149958272|NCT00601107|540981867|FG002|Overall Study|Withdrawal by Subject|7|||
149958273|NCT00601107|540981868|FG003|Overall Study|Withdrawal by Subject|4|||
149958274|NCT00601107|540981865|FG000|Overall Study|Lost to Follow-up|3|||
149958275|NCT00601107|540981866|FG001|Overall Study|Lost to Follow-up|3|||
149958276|NCT00601107|540981867|FG002|Overall Study|Lost to Follow-up|0|||
149958277|NCT00601107|540981868|FG003|Overall Study|Lost to Follow-up|3|||
149958278|NCT00601107|540981865|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
149958279|NCT00601107|540981866|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
149958280|NCT00601107|540981867|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
149849706|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
149849707|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
149849708|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
149849709|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
149849710|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
149849711|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
149849712|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
149849713|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
149849714|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
149849715|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
149849716|NCT01567527|540578054|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149849717|NCT01567527|540578055|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149849718|NCT01567527|540578056|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149849719|NCT01567527|540578057|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
149849720|NCT01567527|540578058|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
149849721|NCT02311894|540578060|FG000|Overall Study|Discontinued in error|1|||
149849722|NCT02311894|540578060|FG000|Overall Study|Lost to Follow-up|1|||
149849723|NCT02311894|540578060|FG000|Overall Study|Adverse Event|1|||
149849724|NCT02311894|540578060|FG000|Overall Study|Withdrawal by Subject|1|||
149849725|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
149849726|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
149849727|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
149849728|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
149849729|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|Death|3|||
149849730|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|Death|1|||
149849731|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
149849732|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
149849733|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
149849734|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
149849735|NCT00537095|540578062|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
149849736|NCT00537095|540578063|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
149849737|NCT00537095|540578062|FG000|Open-label Period (590 Days)|Adverse Event|2|||
149849738|NCT00537095|540578063|FG001|Open-label Period (590 Days)|Adverse Event|11|||
149849739|NCT00537095|540578062|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
149849740|NCT00537095|540578063|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
149849741|NCT00537095|540578062|FG000|Open-label Period (590 Days)|Death|2|||
149849742|NCT00537095|540578063|FG001|Open-label Period (590 Days)|Death|2|||
149849743|NCT00537095|540578062|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
149958281|NCT00601107|540981868|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
149958282|NCT00601107|540981865|FG000|Overall Study|Worsening of Psoriasis|4|||
149958283|NCT00601107|540981866|FG001|Overall Study|Worsening of Psoriasis|1|||
149958284|NCT00601107|540981867|FG002|Overall Study|Worsening of Psoriasis|1|||
149958285|NCT00601107|540981868|FG003|Overall Study|Worsening of Psoriasis|4|||
149958286|NCT00601107|540981865|FG000|Overall Study|Undefined|1|||
149958287|NCT00601107|540981866|FG001|Overall Study|Undefined|0|||
149958288|NCT00601107|540981867|FG002|Overall Study|Undefined|1|||
149958289|NCT00601107|540981868|FG003|Overall Study|Undefined|0|||
149958290|NCT03892915|540981869|FG000|Overall Study|Lost to Follow-up|6|||
149958291|NCT03892915|540981870|FG001|Overall Study|Lost to Follow-up|12|||
149958292|NCT03892915|540981869|FG000|Overall Study|Death|0|||
149958293|NCT03892915|540981870|FG001|Overall Study|Death|2|||
149958294|NCT03892915|540981869|FG000|Overall Study|Withdrawal by Subject|1|||
149958295|NCT03892915|540981870|FG001|Overall Study|Withdrawal by Subject|1|||
149958296|NCT03892915|540981869|FG000|Overall Study|unsuccessful delivery|13|||
149958297|NCT03892915|540981870|FG001|Overall Study|unsuccessful delivery|18|||
149958298|NCT03364686|540981871|FG000|Overall Study|Physician Decision|2|||
149958299|NCT03566550|540981874|FG000|Overall Study|Withdrawal by Subject|0|||
149958300|NCT03566550|540981875|FG001|Overall Study|Withdrawal by Subject|1|||
149958301|NCT01210443|540981877|FG000|Overall Study|Study terminated by sponsor|2|||
149958302|NCT02807181|540981878|FG000|Overall Study|Death|28|||
149958303|NCT02807181|540981879|FG001|Overall Study|Death|24|||
149958304|NCT02807181|540981878|FG000|Overall Study|Withdrawal by Subject|1|||
149958305|NCT02807181|540981879|FG001|Overall Study|Withdrawal by Subject|1|||
149958306|NCT02807181|540981878|FG000|Overall Study|Lost to Follow-up|0|||
149958307|NCT02807181|540981879|FG001|Overall Study|Lost to Follow-up|2|||
149958308|NCT02807181|540981878|FG000|Overall Study|Subject decision|1|||
149958309|NCT02807181|540981879|FG001|Overall Study|Subject decision|0|||
149958310|NCT02807181|540981878|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
149958311|NCT02807181|540981879|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
149849744|NCT00537095|540578063|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
149849745|NCT00537095|540578062|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
149849746|NCT00537095|540578063|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
149849747|NCT00533507|540578064|FG000|Overall Study|Withdrawal by Subject|1|||
149849748|NCT02943096|540578067|FG000|Overall Study|Lack of Efficacy|0|||
149849749|NCT02943096|540578068|FG001|Overall Study|Lack of Efficacy|1|||
149849750|NCT05065619|540578069|FG000|Up to Day 42|Lost to Follow-up|1|||
149849751|NCT05065619|540578070|FG001|Up to Day 42|Lost to Follow-up|0|||
149849752|NCT05065619|540578069|FG000|Up to Day 42|Withdrawal by Subject|1|||
149849753|NCT05065619|540578070|FG001|Up to Day 42|Withdrawal by Subject|0|||
149849754|NCT05065619|540578069|FG000|After Day 43|Lost to Follow-up|1|||
149849755|NCT05065619|540578070|FG001|After Day 43|Lost to Follow-up|0|||
149849756|NCT05065619|540578069|FG000|After Day 43|Physician Decision|3|||
149849757|NCT05065619|540578070|FG001|After Day 43|Physician Decision|0|||
149849758|NCT05065619|540578069|FG000|After Day 43|Withdrawal by Subject|1|||
149849759|NCT05065619|540578070|FG001|After Day 43|Withdrawal by Subject|2|||
149849760|NCT05065619|540578069|FG000|After Day 43|Public vaccination|6|||
149849761|NCT05065619|540578070|FG001|After Day 43|Public vaccination|8|||
149849762|NCT05065619|540578069|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
149849763|NCT05065619|540578070|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
149849764|NCT05065619|540578069|FG000|After Day 43|Study Terminated by Sponsor|88|||
149849765|NCT05065619|540578070|FG001|After Day 43|Study Terminated by Sponsor|16|||
149849766|NCT00939523|540578071|FG000|Overall Study|Lack of Efficacy|1|||
149849767|NCT00939523|540578071|FG000|Overall Study|Physician Decision|2|||
149849768|NCT01528735|540578077|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
149849769|NCT01528735|540578078|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
149849770|NCT01528735|540578077|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
149849771|NCT01528735|540578078|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
149849772|NCT00556673|540578079|FG000|Overall Study|Protocol deviation|3|||
149849773|NCT00556673|540578080|FG001|Overall Study|Protocol deviation|2|||
149849774|NCT00494013|540578081|FG000|Overall Study|Adverse Event|0|||
149849775|NCT00494013|540578082|FG001|Overall Study|Adverse Event|1|||
149849776|NCT00494013|540578081|FG000|Overall Study|Entry Criteria Not Met|1|||
149958312|NCT02807181|540981878|FG000|Overall Study|In Study|3|||
149958313|NCT02807181|540981879|FG001|Overall Study|In Study|3|||
149958314|NCT02807181|540981878|FG000|Overall Study|Post Progression|3|||
149958315|NCT02807181|540981879|FG001|Overall Study|Post Progression|2|||
149958316|NCT00063999|540981880|FG000|Overall Study|Withdrawal by Subject|1|||
149958317|NCT00063999|540981881|FG001|Overall Study|Withdrawal by Subject|0|||
149958318|NCT00063999|540981880|FG000|Overall Study|Ineligible|44|||
149958319|NCT00063999|540981881|FG001|Overall Study|Ineligible|24|||
149958320|NCT02497755|540981883|FG000|Overall Study|Protocol Violation|1|||
150038511|NCT01235741|541283318|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
150038512|NCT01235741|541283319|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
150038513|NCT01235741|541283317|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
150038514|NCT01235741|541283318|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
150038515|NCT01235741|541283319|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
150038516|NCT01803607|541283324|FG000|Overall Study|Adverse Event|5|||
150038517|NCT01803607|541283325|FG001|Overall Study|Adverse Event|3|||
150038518|NCT01803607|541283324|FG000|Overall Study|Lack of Efficacy|0|||
150038519|NCT01803607|541283325|FG001|Overall Study|Lack of Efficacy|1|||
150038520|NCT01803607|541283324|FG000|Overall Study|Protocol Violation|3|||
150038521|NCT01803607|541283325|FG001|Overall Study|Protocol Violation|2|||
150038522|NCT01803607|541283324|FG000|Overall Study|Study terminated by sponsor|54|||
150038523|NCT01803607|541283325|FG001|Overall Study|Study terminated by sponsor|56|||
150038524|NCT01803607|541283324|FG000|Overall Study|Withdrawal by Subject|6|||
150038525|NCT01803607|541283325|FG001|Overall Study|Withdrawal by Subject|5|||
150038526|NCT00706238|541283329|FG000|Overall Study|Disease progression|4|||
150038527|NCT00706238|541283329|FG000|Overall Study|Other|1|||
149958321|NCT02497755|540981884|FG001|Overall Study|Protocol Violation|0|||
150038528|NCT00753506|541283330|FG000|Overall Study|Withdrawal by Subject|4|||
149958322|NCT01774370|540981885|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
150038529|NCT00753506|541283331|FG001|Overall Study|Withdrawal by Subject|1|||
149849777|NCT00494013|540578082|FG001|Overall Study|Entry Criteria Not Met|4|||
149849778|NCT00494013|540578081|FG000|Overall Study|Lost to Follow-up|5|||
149849779|NCT00494013|540578082|FG001|Overall Study|Lost to Follow-up|6|||
149849780|NCT00494013|540578081|FG000|Overall Study|Physician Decision|3|||
149849781|NCT00494013|540578082|FG001|Overall Study|Physician Decision|5|||
149849782|NCT00494013|540578081|FG000|Overall Study|Protocol Violation|8|||
149849783|NCT00494013|540578082|FG001|Overall Study|Protocol Violation|5|||
150038530|NCT00753506|541283330|FG000|Overall Study|Lost to Follow-up|2|||
150038531|NCT00753506|541283331|FG001|Overall Study|Lost to Follow-up|0|||
150038532|NCT00753506|541283330|FG000|Overall Study|Other reason|1|||
150038533|NCT00753506|541283331|FG001|Overall Study|Other reason|1|||
149849784|NCT00494013|540578081|FG000|Overall Study|Withdrawal by Subject|13|||
149849785|NCT00494013|540578082|FG001|Overall Study|Withdrawal by Subject|14|||
150038534|NCT03763877|541283335|FG000|Overall Study|Withdrawal by Subject|3|||
150038535|NCT03763877|541283336|FG001|Overall Study|Withdrawal by Subject|1|||
150038536|NCT03763877|541283337|FG002|Overall Study|Withdrawal by Subject|3|||
150038537|NCT03763877|541283338|FG003|Overall Study|Withdrawal by Subject|4|||
150038538|NCT03763877|541283335|FG000|Overall Study|Adverse Event|1|||
150038539|NCT03763877|541283336|FG001|Overall Study|Adverse Event|1|||
150038540|NCT03763877|541283337|FG002|Overall Study|Adverse Event|3|||
150038541|NCT03763877|541283338|FG003|Overall Study|Adverse Event|1|||
150038542|NCT03763877|541283335|FG000|Overall Study|Protocol Violation|1|||
150038543|NCT03763877|541283336|FG001|Overall Study|Protocol Violation|1|||
150038544|NCT03763877|541283337|FG002|Overall Study|Protocol Violation|0|||
150038545|NCT03763877|541283338|FG003|Overall Study|Protocol Violation|0|||
150038546|NCT03763877|541283335|FG000|Overall Study|Lost to Follow-up|0|||
150038547|NCT03763877|541283336|FG001|Overall Study|Lost to Follow-up|1|||
150038548|NCT03763877|541283337|FG002|Overall Study|Lost to Follow-up|1|||
150038549|NCT03763877|541283338|FG003|Overall Study|Lost to Follow-up|0|||
150038550|NCT01774721|541283341|FG000|Overall Study|Death|133|||
150038551|NCT01774721|541283342|FG001|Overall Study|Death|152|||
149849786|NCT00494013|540578081|FG000|Overall Study|Sponsor Decision|0|||
149849787|NCT00494013|540578082|FG001|Overall Study|Sponsor Decision|1|||
149849788|NCT00421304|540578083|FG000|Overall Study|Lost to Follow-up|5|||
149849789|NCT00421304|540578084|FG001|Overall Study|Lost to Follow-up|2|||
149849790|NCT00421304|540578085|FG002|Overall Study|Lost to Follow-up|5|||
149849791|NCT00421304|540578083|FG000|Overall Study|Withdrawal by Subject|2|||
149849792|NCT00421304|540578084|FG001|Overall Study|Withdrawal by Subject|2|||
150038552|NCT01774721|541283341|FG000|Overall Study|Withdrawal by Subject|20|||
150038553|NCT01774721|541283342|FG001|Overall Study|Withdrawal by Subject|14|||
150038554|NCT01774721|541283341|FG000|Overall Study|Lost to Follow-up|6|||
150038555|NCT01774721|541283342|FG001|Overall Study|Lost to Follow-up|7|||
150038556|NCT01774721|541283341|FG000|Overall Study|Did not meet eligibility criteria|0|||
150038557|NCT01774721|541283342|FG001|Overall Study|Did not meet eligibility criteria|3|||
150038558|NCT01774721|541283341|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
150038559|NCT01774721|541283342|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
150038560|NCT01774721|541283341|FG000|Overall Study|Study terminated by sponsor|5|||
150038561|NCT01774721|541283342|FG001|Overall Study|Study terminated by sponsor|0|||
150038562|NCT01774721|541283341|FG000|Overall Study|Disease progression|5|||
150038563|NCT01774721|541283342|FG001|Overall Study|Disease progression|0|||
150038564|NCT01600716|541283344|FG000|Overall Study|Other Reasons|3|||
150038565|NCT01600716|541283345|FG001|Overall Study|Other Reasons|1|||
150038566|NCT01600716|541283344|FG000|Overall Study|Personal Reasons|0|||
150038567|NCT01600716|541283345|FG001|Overall Study|Personal Reasons|2|||
150038568|NCT01600716|541283344|FG000|Overall Study|Lost to Follow-up|0|||
150038569|NCT01600716|541283345|FG001|Overall Study|Lost to Follow-up|2|||
150038570|NCT01600716|541283344|FG000|Overall Study|Pregnancy|1|||
150038571|NCT01600716|541283345|FG001|Overall Study|Pregnancy|0|||
150038572|NCT01600716|541283344|FG000|Overall Study|Lack of Efficacy|2|||
150038573|NCT01600716|541283345|FG001|Overall Study|Lack of Efficacy|1|||
150038574|NCT01600716|541283344|FG000|Overall Study|Adverse Event|1|||
150038575|NCT01600716|541283345|FG001|Overall Study|Adverse Event|1|||
150038576|NCT00248040|541283346|FG000|Overall Study|transplantectomy|2|||
150038577|NCT00248040|541283347|FG001|Overall Study|transplantectomy|1|||
150038578|NCT00248040|541283348|FG002|Overall Study|transplantectomy|3|||
150038579|NCT00248040|541283346|FG000|Overall Study|transplant cancelled post treat start|1|||
150038580|NCT00248040|541283347|FG001|Overall Study|transplant cancelled post treat start|0|||
150038581|NCT00248040|541283348|FG002|Overall Study|transplant cancelled post treat start|0|||
150038582|NCT00248040|541283346|FG000|Overall Study|Death|0|||
150038583|NCT00248040|541283347|FG001|Overall Study|Death|0|||
150038584|NCT00248040|541283348|FG002|Overall Study|Death|1|||
150038585|NCT01760733|541283349|FG000|Waiting List|Death|18|||
150038586|NCT01760733|541283349|FG000|Waiting List|Removed from waiting list|41|||
150038587|NCT01760733|541283349|FG000|Waiting List|Not received a transplant yet|13|||
150038588|NCT01760733|541283349|FG000|Transplanted|Not reached 10 years post transplant|184|||
150038589|NCT01760733|541283349|FG000|Transplanted|Death|26|||
150038590|NCT01760733|541283349|FG000|Transplanted|Graft loss|7|||
149849793|NCT00421304|540578085|FG002|Overall Study|Withdrawal by Subject|2|||
150038591|NCT02282605|541283350|FG000|Overall Study|negative SA result on Day -1|3|||
150038592|NCT02282605|541283351|FG001|Overall Study|negative SA result on Day -1|0|||
149849794|NCT00421304|540578083|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
149849795|NCT00421304|540578084|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
149849796|NCT00421304|540578085|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
150038593|NCT02282605|541283352|FG002|Overall Study|negative SA result on Day -1|0|||
150038594|NCT03926611|541283353|FG000|Overall Study|Adverse Event|0|||
150038595|NCT03926611|541283354|FG001|Overall Study|Adverse Event|0|||
150038596|NCT03926611|541283355|FG002|Overall Study|Adverse Event|0|||
150038597|NCT03926611|541283356|FG003|Overall Study|Adverse Event|3|||
150038598|NCT03926611|541283357|FG004|Overall Study|Adverse Event|1|||
150038599|NCT03926611|541283358|FG005|Overall Study|Adverse Event|3|||
149849797|NCT00421304|540578083|FG000|Overall Study|Did not attend Day 360 visit|0|||
149849798|NCT00421304|540578084|FG001|Overall Study|Did not attend Day 360 visit|0|||
149849799|NCT00421304|540578085|FG002|Overall Study|Did not attend Day 360 visit|1|||
149849800|NCT04750239|540578086|FG000|Overall Study|Withdrawal by Subject|2|||
149849801|NCT04750239|540578086|FG000|Overall Study|Trial terminated by sponsor|1|||
149849802|NCT01912807|540578087|FG000|Overall Study|Did not meet elegibility criteria|6|||
149849803|NCT01912807|540578088|FG001|Overall Study|Did not meet elegibility criteria|4|||
149849804|NCT01912807|540578087|FG000|Overall Study|Lost to Follow-up|36|||
149849805|NCT01912807|540578088|FG001|Overall Study|Lost to Follow-up|37|||
149849806|NCT00903877|540578089|FG000|Overall Study|Did not meet study criteria|33|||
149849807|NCT00903877|540578089|FG000|Overall Study|Withdrawal by Subject|3|||
149849808|NCT00903877|540578089|FG000|Overall Study|Adverse Event|2|||
149849809|NCT00903877|540578089|FG000|Overall Study|Lost to Follow-up|1|||
149849810|NCT00903877|540578089|FG000|Overall Study|Participation put on hold|4|||
149849811|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Adverse Event|8|||
149849812|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Adverse Event|5|||
149849813|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Adverse Event|9|||
149849814|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Adverse Event|0|||
149849815|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Adverse Event|0|||
149849816|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Adverse Event|0|||
149849817|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
149849818|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
149849819|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
149849820|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
149849821|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
149849822|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
149849823|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
149849824|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
149849825|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
149849826|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
149849827|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
149849828|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
149849829|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Physician Decision|4|||
149849830|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Physician Decision|0|||
149849831|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Physician Decision|2|||
149849832|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Physician Decision|0|||
149849833|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Physician Decision|0|||
150038600|NCT03926611|541283359|FG006|Overall Study|Adverse Event|0|||
150038601|NCT03926611|541283353|FG000|Overall Study|Lack of Efficacy|1|||
150038602|NCT03926611|541283354|FG001|Overall Study|Lack of Efficacy|2|||
150038603|NCT03926611|541283355|FG002|Overall Study|Lack of Efficacy|0|||
150038604|NCT03926611|541283356|FG003|Overall Study|Lack of Efficacy|0|||
150038605|NCT03926611|541283357|FG004|Overall Study|Lack of Efficacy|1|||
150038606|NCT03926611|541283358|FG005|Overall Study|Lack of Efficacy|0|||
150038607|NCT03926611|541283359|FG006|Overall Study|Lack of Efficacy|1|||
150038608|NCT03926611|541283353|FG000|Overall Study|Physician Decision|0|||
150038609|NCT03926611|541283354|FG001|Overall Study|Physician Decision|0|||
150038610|NCT03926611|541283355|FG002|Overall Study|Physician Decision|0|||
150038611|NCT03926611|541283356|FG003|Overall Study|Physician Decision|0|||
150038612|NCT03926611|541283357|FG004|Overall Study|Physician Decision|0|||
150038613|NCT03926611|541283358|FG005|Overall Study|Physician Decision|1|||
150038614|NCT03926611|541283359|FG006|Overall Study|Physician Decision|0|||
150038615|NCT03926611|541283353|FG000|Overall Study|Protocol Violation|1|||
150038616|NCT03926611|541283354|FG001|Overall Study|Protocol Violation|0|||
150038617|NCT03926611|541283355|FG002|Overall Study|Protocol Violation|0|||
150038618|NCT03926611|541283356|FG003|Overall Study|Protocol Violation|1|||
150038619|NCT03926611|541283357|FG004|Overall Study|Protocol Violation|1|||
150038620|NCT03926611|541283358|FG005|Overall Study|Protocol Violation|1|||
150038621|NCT03926611|541283359|FG006|Overall Study|Protocol Violation|1|||
150038622|NCT03926611|541283353|FG000|Overall Study|Technical problems|0|||
150038623|NCT03926611|541283354|FG001|Overall Study|Technical problems|0|||
150038624|NCT03926611|541283355|FG002|Overall Study|Technical problems|0|||
150038625|NCT03926611|541283356|FG003|Overall Study|Technical problems|0|||
149849834|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Physician Decision|0|||
149849835|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Pregnancy|1|||
149849836|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Pregnancy|2|||
149849837|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Pregnancy|0|||
149849838|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Pregnancy|0|||
150038626|NCT03926611|541283357|FG004|Overall Study|Technical problems|0|||
150038627|NCT03926611|541283358|FG005|Overall Study|Technical problems|1|||
150038628|NCT03926611|541283359|FG006|Overall Study|Technical problems|0|||
150038629|NCT03926611|541283353|FG000|Overall Study|Withdrawal by Subject|1|||
150038630|NCT03926611|541283354|FG001|Overall Study|Withdrawal by Subject|1|||
150038631|NCT03926611|541283355|FG002|Overall Study|Withdrawal by Subject|1|||
150038632|NCT03926611|541283356|FG003|Overall Study|Withdrawal by Subject|0|||
150172779|NCT01123083|541768092|FG001|Overall Study|Adverse Event|0|||
149849839|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Pregnancy|0|||
149849840|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Pregnancy|0|||
149849841|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
149849842|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
149849843|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
149849844|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
149849845|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
149849846|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
149849847|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
149849848|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
149849849|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
149849850|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
149849851|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
149849852|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
149849853|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
149849854|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
149849855|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
149849856|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
149849857|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
149849858|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
149849859|NCT02614196|540578090|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
149849860|NCT02614196|540578091|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
149849861|NCT02614196|540578092|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
149849862|NCT02614196|540578093|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
149849863|NCT02614196|540578094|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
149849864|NCT02614196|540578095|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
149849865|NCT02614196|540578090|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
149849866|NCT02614196|540578091|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
149849867|NCT02614196|540578092|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
149849868|NCT02614196|540578093|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
149849869|NCT02614196|540578094|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
149849870|NCT02614196|540578095|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
149849871|NCT02614196|540578090|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
149849872|NCT02614196|540578091|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
149849873|NCT02614196|540578092|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
149849874|NCT02614196|540578093|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
149849875|NCT02614196|540578094|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
149849876|NCT02614196|540578095|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
149849877|NCT02614196|540578090|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
149849878|NCT02614196|540578091|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
149849879|NCT02614196|540578092|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
149849880|NCT02614196|540578093|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
149849881|NCT02614196|540578094|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
149849882|NCT02614196|540578095|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
149849883|NCT02614196|540578090|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
149849884|NCT02614196|540578091|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
150038633|NCT03926611|541283357|FG004|Overall Study|Withdrawal by Subject|0|||
150038634|NCT03926611|541283358|FG005|Overall Study|Withdrawal by Subject|1|||
150038635|NCT03926611|541283359|FG006|Overall Study|Withdrawal by Subject|3|||
150038636|NCT03926611|541283353|FG000|Overall Study|Covid-19 pandemic|0|||
150038637|NCT03926611|541283354|FG001|Overall Study|Covid-19 pandemic|0|||
150038638|NCT03926611|541283355|FG002|Overall Study|Covid-19 pandemic|1|||
150038639|NCT03926611|541283356|FG003|Overall Study|Covid-19 pandemic|0|||
150038640|NCT03926611|541283357|FG004|Overall Study|Covid-19 pandemic|1|||
150038641|NCT03926611|541283358|FG005|Overall Study|Covid-19 pandemic|2|||
149849885|NCT02614196|540578092|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
149849886|NCT02614196|540578093|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
149849887|NCT02614196|540578094|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
149849888|NCT02614196|540578095|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
149849889|NCT00919711|540578096|FG000|Overall Study|Withdrawal by Subject|15|||
149849890|NCT00919711|540578097|FG001|Overall Study|Withdrawal by Subject|7|||
149849891|NCT00919711|540578096|FG000|Overall Study|Adverse Event|13|||
149849892|NCT00919711|540578097|FG001|Overall Study|Adverse Event|3|||
150038642|NCT03926611|541283359|FG006|Overall Study|Covid-19 pandemic|0|||
149849893|NCT00919711|540578096|FG000|Overall Study|Other|1|||
149849894|NCT00919711|540578097|FG001|Overall Study|Other|2|||
149849895|NCT00919711|540578096|FG000|Overall Study|Administrative Decision|0|||
149849896|NCT00919711|540578097|FG001|Overall Study|Administrative Decision|1|||
149849897|NCT00919711|540578096|FG000|Overall Study|Lost to Follow-up|2|||
149849898|NCT00919711|540578097|FG001|Overall Study|Lost to Follow-up|0|||
149849899|NCT00919711|540578096|FG000|Overall Study|Death|1|||
150038643|NCT00836693|541283362|FG000|Overall Study|Adverse Event|4|||
149849900|NCT00919711|540578097|FG001|Overall Study|Death|0|||
149849901|NCT00919711|540578096|FG000|Overall Study|Noncompliance|1|||
149849902|NCT00919711|540578097|FG001|Overall Study|Noncompliance|0|||
149849903|NCT01562613|540578098|FG000|Overall Study|Lost to Follow-up|2|||
149849904|NCT01562613|540578098|FG000|Overall Study|Withdrawal by Subject|2|||
149849905|NCT04388787|540578099|FG000|Blinded Period|Patient could not follow instructions|1|||
149849906|NCT04388787|540578099|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
149849907|NCT00663234|540578100|FG000|Overall Study|Not willing to adhere to requirements|1|||
149849908|NCT02710214|540580045|FG000|Overall Study|Lost to Follow-up|1|||
149849909|NCT02710214|540580046|FG001|Overall Study|Lost to Follow-up|0|||
149849910|NCT02710214|540580045|FG000|Overall Study|Lack of Efficacy|0|||
149849911|NCT02710214|540580046|FG001|Overall Study|Lack of Efficacy|1|||
150038644|NCT00836693|541283363|FG001|Overall Study|Adverse Event|1|||
150038645|NCT00836693|541283362|FG000|Overall Study|Sponsor Decision|0|||
150038646|NCT00836693|541283363|FG001|Overall Study|Sponsor Decision|1|||
150038647|NCT00836693|541283362|FG000|Overall Study|Physician Decision|2|||
150038648|NCT00836693|541283363|FG001|Overall Study|Physician Decision|0|||
150038649|NCT00836693|541283362|FG000|Overall Study|Withdrawal by Subject|9|||
150038650|NCT00836693|541283363|FG001|Overall Study|Withdrawal by Subject|4|||
150038651|NCT00836693|541283362|FG000|Overall Study|Protocol Violation|1|||
150038652|NCT00836693|541283363|FG001|Overall Study|Protocol Violation|0|||
150038653|NCT00836693|541283362|FG000|Overall Study|Lost to Follow-up|1|||
150038654|NCT00836693|541283363|FG001|Overall Study|Lost to Follow-up|0|||
150038655|NCT03938259|541283364|FG000|Overall Study|unable to establish baseline for ventilation|1|||
150038656|NCT03938259|541283365|FG001|Overall Study|unable to establish baseline for ventilation|1|||
150038657|NCT02612779|541283366|FG000|Overall Study|Administrative reason by sponsor|4|||
150038658|NCT02612779|541283367|FG001|Overall Study|Administrative reason by sponsor|1|||
150038659|NCT02612779|541283366|FG000|Overall Study|No longer meet study criteria|0|||
150038660|NCT02612779|541283367|FG001|Overall Study|No longer meet study criteria|1|||
150038661|NCT02612779|541283366|FG000|Overall Study|Disease progression|29|||
150038662|NCT02612779|541283367|FG001|Overall Study|Disease progression|2|||
150038663|NCT02612779|541283366|FG000|Overall Study|Study drug toxicity|10|||
150038664|NCT02612779|541283367|FG001|Overall Study|Study drug toxicity|1|||
150038665|NCT02612779|541283366|FG000|Overall Study|Death|1|||
150038666|NCT02612779|541283367|FG001|Overall Study|Death|0|||
150038667|NCT02612779|541283366|FG000|Overall Study|Adverse event unrelated to study drug|5|||
150038668|NCT02612779|541283367|FG001|Overall Study|Adverse event unrelated to study drug|0|||
150038669|NCT02612779|541283366|FG000|Overall Study|Participant withdrew consent|4|||
150038670|NCT02612779|541283367|FG001|Overall Study|Participant withdrew consent|0|||
150038671|NCT02612779|541283366|FG000|Overall Study|Lost to Follow-up|1|||
150038672|NCT02612779|541283367|FG001|Overall Study|Lost to Follow-up|0|||
150038673|NCT02612779|541283366|FG000|Overall Study|Maximum clinical benefit|10|||
150038674|NCT02612779|541283367|FG001|Overall Study|Maximum clinical benefit|1|||
150038675|NCT02612779|541283366|FG000|Overall Study|Other reasons|4|||
150038676|NCT02612779|541283367|FG001|Overall Study|Other reasons|0|||
150038677|NCT03910244|541283370|FG000|Overall Study|Adverse Event|14|||
150038678|NCT03910244|541283371|FG001|Overall Study|Adverse Event|0|||
150038679|NCT03910244|541283370|FG000|Overall Study|Death|1|||
150038680|NCT03910244|541283371|FG001|Overall Study|Death|0|||
150038681|NCT03910244|541283370|FG000|Overall Study|Lost to Follow-up|0|||
150038682|NCT03910244|541283371|FG001|Overall Study|Lost to Follow-up|2|||
150038683|NCT03910244|541283370|FG000|Overall Study|Joint withdrawal decision|1|||
150038684|NCT03910244|541283371|FG001|Overall Study|Joint withdrawal decision|0|||
150038685|NCT03910244|541283370|FG000|Overall Study|Study Terminated by Sponsor|7|||
150038686|NCT03910244|541283371|FG001|Overall Study|Study Terminated by Sponsor|4|||
149849912|NCT02710214|540580045|FG000|Overall Study|Death|0|||
149849913|NCT02710214|540580046|FG001|Overall Study|Death|1|||
149849914|NCT02832167|540580047|FG000|Treatment Period 1|Disease progression|90|||
150038687|NCT03910244|541283370|FG000|Overall Study|Physician Decision|1|||
149849915|NCT02832167|540580047|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
150038688|NCT03910244|541283371|FG001|Overall Study|Physician Decision|0|||
150038689|NCT03910244|541283370|FG000|Overall Study|Protocol Violation|1|||
150038690|NCT03910244|541283371|FG001|Overall Study|Protocol Violation|0|||
150038691|NCT03910244|541283370|FG000|Overall Study|Withdrawal by Subject|7|||
150172780|NCT01123083|541768091|FG000|Overall Study|Withdrew for another reason not covered|0|||
150172781|NCT01123083|541768092|FG001|Overall Study|Withdrew for another reason not covered|1|||
150038692|NCT03910244|541283371|FG001|Overall Study|Withdrawal by Subject|2|||
150038693|NCT01746901|541283374|FG000|Naloxone Challenge Phase|Adverse Event|2|||
150038694|NCT01746901|541283375|FG001|Naloxone Challenge Phase|Adverse Event|0|||
150038695|NCT01746901|541283376|FG002|Naloxone Challenge Phase|Adverse Event|0|||
150038696|NCT01746901|541283377|FG003|Naloxone Challenge Phase|Adverse Event|0|||
150038697|NCT01746901|541283378|FG004|Naloxone Challenge Phase|Adverse Event|0|||
150038698|NCT01746901|541283379|FG005|Naloxone Challenge Phase|Adverse Event|0|||
149849916|NCT02832167|540580047|FG000|Treatment Period 1|Death|2|||
149849917|NCT02832167|540580047|FG000|Treatment Period 1|Study Drug Toxicity|6|||
149849918|NCT02832167|540580047|FG000|Treatment Period 1|Participant request to discontinue|9|||
150038699|NCT01746901|541283380|FG006|Naloxone Challenge Phase|Adverse Event|0|||
150038700|NCT01746901|541283381|FG007|Naloxone Challenge Phase|Adverse Event|0|||
150038701|NCT01746901|541283382|FG008|Naloxone Challenge Phase|Adverse Event|0|||
150038702|NCT01746901|541283374|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
150038703|NCT01746901|541283375|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038704|NCT01746901|541283376|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038705|NCT01746901|541283377|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038706|NCT01746901|541283378|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038707|NCT01746901|541283379|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038708|NCT01746901|541283380|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038709|NCT01746901|541283381|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038710|NCT01746901|541283382|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
150038711|NCT01746901|541283374|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038712|NCT01746901|541283375|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
150038713|NCT01746901|541283376|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038714|NCT01746901|541283377|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038715|NCT01746901|541283378|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038716|NCT01746901|541283379|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038717|NCT01746901|541283380|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038718|NCT01746901|541283381|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038719|NCT01746901|541283382|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
150038720|NCT01746901|541283374|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038721|NCT01746901|541283375|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
150038722|NCT01746901|541283376|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
150038723|NCT01746901|541283377|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038724|NCT01746901|541283378|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038725|NCT01746901|541283379|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038726|NCT01746901|541283380|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038727|NCT01746901|541283381|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038728|NCT01746901|541283382|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
150038729|NCT01746901|541283374|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038730|NCT01746901|541283375|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
150038731|NCT01746901|541283376|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
150038732|NCT01746901|541283377|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038733|NCT01746901|541283378|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038734|NCT01746901|541283379|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038735|NCT01746901|541283380|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038736|NCT01746901|541283381|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038737|NCT01746901|541283382|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
150038738|NCT01746901|541283374|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038739|NCT01746901|541283375|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
150038740|NCT01746901|541283376|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
150038741|NCT01746901|541283377|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038742|NCT01746901|541283378|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038743|NCT01746901|541283379|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038744|NCT01746901|541283380|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038745|NCT01746901|541283381|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038746|NCT01746901|541283382|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
150038747|NCT01746901|541283374|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
150038748|NCT01746901|541283375|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
150038749|NCT01746901|541283376|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
150038750|NCT01746901|541283377|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
150038751|NCT01746901|541283378|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
150038752|NCT01746901|541283379|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
150038753|NCT01746901|541283380|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
150038754|NCT01746901|541283381|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
150038755|NCT01746901|541283382|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
150038756|NCT01746901|541283374|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
149849919|NCT02832167|540580047|FG000|Treatment Period 1|No longer meet study criteria|1|||
149849920|NCT02832167|540580047|FG000|Treatment Period 1|Participant withdrew consent|3|||
149849921|NCT02832167|540580047|FG000|Treatment Period 1|Other reasons|6|||
150038757|NCT01746901|541283375|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
150038758|NCT01746901|541283376|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
150172782|NCT01123083|541768091|FG000|Overall Study|Participant/legal representative request|7|||
149849922|NCT02832167|540580047|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
149849923|NCT02832167|540580047|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
149849924|NCT02832167|540580047|FG000|Transition From Period 1 to Period 2|Death|2|||
149849925|NCT02832167|540580047|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
149849926|NCT02832167|540580047|FG000|Treatment Period 2|Disease progression|69|||
149849927|NCT02832167|540580047|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
149849928|NCT02832167|540580047|FG000|Treatment Period 2|Maximum clinical benefit|1|||
149849929|NCT02832167|540580047|FG000|Treatment Period 2|Study Drug Toxicity|5|||
149849930|NCT02832167|540580047|FG000|Treatment Period 2|Participant request to discontinue|2|||
149849931|NCT02832167|540580047|FG000|Treatment Period 2|Participant withdrew consent|3|||
149849932|NCT02832167|540580047|FG000|Treatment Period 2|Other reasons|3|||
149849933|NCT01754376|540580048|FG000|Overall Study|Adverse Event|1|||
149958323|NCT01774370|540981885|FG000|Overall Study|Administered prior to the contract date|4|||
149958324|NCT01774370|540981885|FG000|Overall Study|Subjects of contraindications|34|||
149958325|NCT01774370|540981885|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
149958326|NCT01774370|540981885|FG000|Overall Study|Follow-up failure|34|||
149958327|NCT00514917|540981886|FG000|Overall Study|Death|4|||
149958328|NCT00514917|540981887|FG001|Overall Study|Death|10|||
149958329|NCT00514917|540981886|FG000|Overall Study|Protocol Violation|1|||
149958330|NCT00514917|540981887|FG001|Overall Study|Protocol Violation|0|||
149958331|NCT00514917|540981886|FG000|Overall Study|Lost to Follow-up|4|||
149958332|NCT00514917|540981887|FG001|Overall Study|Lost to Follow-up|3|||
149958333|NCT00514917|540981886|FG000|Overall Study|Withdrawal by Subject|18|||
149958334|NCT00514917|540981887|FG001|Overall Study|Withdrawal by Subject|16|||
149958335|NCT00514917|540981886|FG000|Overall Study|Discontinued due to study closure|88|||
149958336|NCT00514917|540981887|FG001|Overall Study|Discontinued due to study closure|81|||
149958337|NCT00514917|540981886|FG000|Overall Study|Undefined|11|||
149958338|NCT00514917|540981887|FG001|Overall Study|Undefined|5|||
149958339|NCT04243837|540981888|FG000|Overall Study|Adverse Event|2|||
149958340|NCT04243837|540981889|FG001|Overall Study|Adverse Event|1|||
149958341|NCT04243837|540981888|FG000|Overall Study|Withdrawal by Subject|4|||
149958342|NCT04243837|540981889|FG001|Overall Study|Withdrawal by Subject|2|||
149958343|NCT04243837|540981888|FG000|Overall Study|Covid-19 lock down|1|||
149958344|NCT04243837|540981889|FG001|Overall Study|Covid-19 lock down|0|||
149958345|NCT04243837|540981888|FG000|Overall Study|Study Terminated by Sponsor|11|||
149958346|NCT04243837|540981889|FG001|Overall Study|Study Terminated by Sponsor|12|||
149958347|NCT02829957|540981892|FG000|Overall Study|Lost to Follow-up|2|||
149958348|NCT02829957|540981893|FG001|Overall Study|Lost to Follow-up|1|||
149958349|NCT00309244|540981897|FG000|Overall Study|Adverse Event|29|||
149958350|NCT00309244|540981898|FG001|Overall Study|Adverse Event|12|||
149958351|NCT00309244|540981897|FG000|Overall Study|Lost to Follow-up|6|||
149958352|NCT00309244|540981898|FG001|Overall Study|Lost to Follow-up|22|||
149958353|NCT00309244|540981897|FG000|Overall Study|Physician Decision|5|||
149958354|NCT00309244|540981898|FG001|Overall Study|Physician Decision|8|||
149958355|NCT00309244|540981897|FG000|Overall Study|Protocol Violation|6|||
149958356|NCT00309244|540981898|FG001|Overall Study|Protocol Violation|3|||
149958357|NCT00309244|540981897|FG000|Overall Study|Withdrawal by Subject|50|||
149958358|NCT00309244|540981898|FG001|Overall Study|Withdrawal by Subject|32|||
149958359|NCT00309244|540981897|FG000|Overall Study|Various|7|||
149958360|NCT00309244|540981898|FG001|Overall Study|Various|7|||
149958361|NCT00309244|540981897|FG000|Overall Study|Randomized but not dosed|11|||
149958362|NCT00309244|540981898|FG001|Overall Study|Randomized but not dosed|12|||
149958363|NCT00309244|540981897|FG000|Overall Study|Death|4|||
149958364|NCT00309244|540981898|FG001|Overall Study|Death|1|||
149958365|NCT00545948|540981900|FG000|Overall Study|Not Treated|1|||
149958366|NCT00545948|540981901|FG001|Overall Study|Not Treated|1|||
149958367|NCT00545948|540981902|FG002|Overall Study|Not Treated|7|||
149958368|NCT03467945|540981903|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149958369|NCT03467945|540981904|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149958370|NCT03467945|540981905|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149958371|NCT03467945|540981906|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149958372|NCT03467945|540981903|FG000|Treatment Period 3|Withdrawal by Subject|1|||
149958373|NCT03467945|540981904|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149958374|NCT03467945|540981905|FG002|Treatment Period 3|Withdrawal by Subject|2|||
149958375|NCT03467945|540981906|FG003|Treatment Period 3|Withdrawal by Subject|1|||
149849934|NCT01754376|540580048|FG000|Overall Study|Lack of Efficacy|2|||
149958376|NCT00541775|540981917|FG000|Overall Study|Adverse Event|3|||
149958377|NCT00541775|540981918|FG001|Overall Study|Adverse Event|2|||
149958378|NCT00541775|540981919|FG002|Overall Study|Adverse Event|1|||
149958379|NCT00541775|540981917|FG000|Overall Study|Lack of Efficacy|0|||
149958380|NCT00541775|540981918|FG001|Overall Study|Lack of Efficacy|0|||
149958381|NCT00541775|540981919|FG002|Overall Study|Lack of Efficacy|3|||
149958382|NCT00541775|540981917|FG000|Overall Study|Lost to Follow-up|0|||
149958383|NCT00541775|540981918|FG001|Overall Study|Lost to Follow-up|0|||
149958384|NCT00541775|540981919|FG002|Overall Study|Lost to Follow-up|2|||
149958385|NCT00541775|540981917|FG000|Overall Study|Protocol Violation|1|||
149849935|NCT04556734|540580049|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
149849936|NCT04556734|540580050|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149958386|NCT00541775|540981918|FG001|Overall Study|Protocol Violation|0|||
149958387|NCT00541775|540981919|FG002|Overall Study|Protocol Violation|0|||
150172783|NCT01123083|541768092|FG001|Overall Study|Participant/legal representative request|3|||
149849937|NCT04556734|540580051|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
149849938|NCT04556734|540580052|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149849939|NCT04556734|540580053|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149849940|NCT04556734|540580054|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149849941|NCT04556734|540580055|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149849942|NCT04556734|540580056|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149849943|NCT04556734|540580049|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
149849944|NCT04556734|540580050|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849945|NCT04556734|540580051|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849946|NCT04556734|540580052|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849947|NCT04556734|540580053|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849948|NCT04556734|540580054|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849949|NCT04556734|540580055|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849950|NCT04556734|540580056|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149849951|NCT04556734|540580049|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149849952|NCT04556734|540580050|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849953|NCT04556734|540580051|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149849954|NCT04556734|540580052|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849955|NCT04556734|540580053|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849956|NCT04556734|540580054|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849957|NCT04556734|540580055|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849958|NCT04556734|540580056|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149849959|NCT04556734|540580049|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
149849960|NCT04556734|540580050|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849961|NCT04556734|540580051|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849962|NCT04556734|540580052|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849963|NCT04556734|540580053|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849964|NCT04556734|540580054|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849965|NCT04556734|540580055|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149958388|NCT00541775|540981917|FG000|Overall Study|Withdrawal by Subject and Other|5|||
149958389|NCT00541775|540981918|FG001|Overall Study|Withdrawal by Subject and Other|0|||
149958390|NCT00541775|540981919|FG002|Overall Study|Withdrawal by Subject and Other|2|||
149958391|NCT00032487|540981920|FG000|Overall Study|Withdrawal by Subject|67|||
149958392|NCT00032487|540981921|FG001|Overall Study|Withdrawal by Subject|43|||
149958393|NCT00032487|540981920|FG000|Overall Study|Adverse Event|3|||
149958394|NCT00032487|540981921|FG001|Overall Study|Adverse Event|7|||
149958395|NCT00032487|540981920|FG000|Overall Study|Lost to Follow-up|57|||
149958396|NCT00032487|540981921|FG001|Overall Study|Lost to Follow-up|58|||
149958397|NCT00032487|540981920|FG000|Overall Study|Had other reason|12|||
149958398|NCT00032487|540981921|FG001|Overall Study|Had other reason|12|||
149958399|NCT04913675|540981923|FG000|Main Study (Up to Week 36)|Death|0|||
149958400|NCT04913675|540981924|FG001|Main Study (Up to Week 36)|Death|2|||
149958401|NCT04913675|540981925|FG002|Main Study (Up to Week 36)|Death|2|||
149958402|NCT04913675|540981926|FG003|Main Study (Up to Week 36)|Death|0|||
149958403|NCT04913675|540981923|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
149958404|NCT04913675|540981924|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
149958405|NCT04913675|540981925|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
149958406|NCT04913675|540981926|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
149958407|NCT04913675|540981923|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
149958408|NCT04913675|540981924|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
149958409|NCT04913675|540981925|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
149958410|NCT04913675|540981926|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
149958411|NCT04913675|540981923|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
149958412|NCT04913675|540981924|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
149958413|NCT04913675|540981925|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
149958414|NCT04913675|540981926|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
149849966|NCT04556734|540580056|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149849967|NCT04556734|540580049|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149849968|NCT04556734|540580050|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149958415|NCT04913675|540981923|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
149958416|NCT04913675|540981924|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
150172784|NCT00961636|541768093|FG000|Overall Study|Adverse Event|35|||
149958417|NCT04913675|540981925|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
149958418|NCT04913675|540981926|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
149958419|NCT02975700|540981927|FG000|Overall Study|Adverse Event|1|||
149958420|NCT02975700|540981927|FG000|Overall Study|Progressive disease|3|||
149958421|NCT02975700|540981927|FG000|Overall Study|Failed screening criteria|2|||
149849969|NCT04556734|540580051|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
149849970|NCT04556734|540580052|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149849971|NCT04556734|540580053|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149849972|NCT04556734|540580054|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149849973|NCT04556734|540580055|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
149849974|NCT04556734|540580056|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
150038759|NCT01746901|541283377|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
149849975|NCT04556734|540580049|FG000|OLE Period (28 Weeks)|Not reported|0|||
149849976|NCT04556734|540580050|FG001|OLE Period (28 Weeks)|Not reported|0|||
149849977|NCT04556734|540580051|FG002|OLE Period (28 Weeks)|Not reported|0|||
149849978|NCT04556734|540580052|FG003|OLE Period (28 Weeks)|Not reported|0|||
149849979|NCT04556734|540580053|FG004|OLE Period (28 Weeks)|Not reported|0|||
149849980|NCT04556734|540580054|FG005|OLE Period (28 Weeks)|Not reported|1|||
149849981|NCT04556734|540580055|FG006|OLE Period (28 Weeks)|Not reported|0|||
149849982|NCT04556734|540580056|FG007|OLE Period (28 Weeks)|Not reported|0|||
149849983|NCT04556734|540580049|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849984|NCT04556734|540580050|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849985|NCT04556734|540580051|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849986|NCT04556734|540580052|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849987|NCT04556734|540580053|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849988|NCT04556734|540580054|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849989|NCT04556734|540580055|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
149849990|NCT04556734|540580056|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
149849991|NCT04556734|540580049|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
149849992|NCT04556734|540580050|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
149849993|NCT04556734|540580051|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
149849994|NCT04556734|540580052|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
149849995|NCT04556734|540580053|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
149849996|NCT04556734|540580054|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
149849997|NCT04556734|540580055|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
149849998|NCT04556734|540580056|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
149849999|NCT04556734|540580049|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149850000|NCT04556734|540580050|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149850001|NCT04556734|540580051|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149850002|NCT04556734|540580052|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
149850003|NCT04556734|540580053|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
149850004|NCT04556734|540580054|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
149850005|NCT04556734|540580055|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
149850006|NCT04556734|540580056|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
149850007|NCT04264819|540580057|FG000|Overall Study|Physician Decision|19|||
149850008|NCT04264819|540580057|FG000|Overall Study|Adverse Event|12|||
149850009|NCT04264819|540580057|FG000|Overall Study|Withdrawal by Subject|11|||
149850010|NCT04264819|540580057|FG000|Overall Study|Lost to Follow-up|2|||
150038760|NCT01746901|541283378|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
149850011|NCT04264819|540580057|FG000|Overall Study|Death|2|||
149958422|NCT01541254|540981928|FG000|Overall Study|Withdrawal by Subject|1|||
149958423|NCT01541254|540981928|FG000|Overall Study|excluded - metal allergy|1|||
149958424|NCT01541254|540981928|FG000|Overall Study|enrolled after study closed|1|||
149958425|NCT01541254|540981928|FG000|Overall Study|GI bleed prior to procedure|1|||
149958426|NCT01541254|540981928|FG000|Overall Study|stent not required|1|||
149958427|NCT01541254|540981928|FG000|Overall Study|alternate stent used|1|||
149958428|NCT01227395|540981930|FG000|Overall Study|Protocol Violation|0|||
149958429|NCT01227395|540981931|FG001|Overall Study|Protocol Violation|1|||
149958430|NCT03259308|540981936|FG000|Overall Study|Adverse Event|5|||
149958431|NCT03259308|540981937|FG001|Overall Study|Adverse Event|4|||
149958432|NCT03259308|540981938|FG002|Overall Study|Adverse Event|1|||
149958433|NCT03259308|540981936|FG000|Overall Study|Withdrawal by Subject|2|||
149958434|NCT03259308|540981937|FG001|Overall Study|Withdrawal by Subject|1|||
149958435|NCT03259308|540981938|FG002|Overall Study|Withdrawal by Subject|3|||
149958436|NCT03259308|540981936|FG000|Overall Study|Lost to Follow-up|0|||
149958437|NCT03259308|540981937|FG001|Overall Study|Lost to Follow-up|0|||
149958438|NCT03259308|540981938|FG002|Overall Study|Lost to Follow-up|1|||
149958439|NCT03259308|540981936|FG000|Overall Study|Pregnancy|0|||
149958440|NCT03259308|540981937|FG001|Overall Study|Pregnancy|0|||
150038761|NCT01746901|541283379|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
150038762|NCT01746901|541283380|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
149958441|NCT03259308|540981938|FG002|Overall Study|Pregnancy|1|||
149958442|NCT03259308|540981936|FG000|Overall Study|Protocol Deviation|0|||
150172785|NCT00961636|541768094|FG001|Overall Study|Adverse Event|54|||
149850012|NCT01680016|540580058|FG000|Overall Study|Adverse Event|0|||
149850013|NCT01680016|540580059|FG001|Overall Study|Adverse Event|0|||
149850014|NCT01680016|540580060|FG002|Overall Study|Adverse Event|1|||
149850015|NCT01680016|540580061|FG003|Overall Study|Adverse Event|4|||
149850016|NCT01680016|540580058|FG000|Overall Study|The Subject went out of The Trial|1|||
149850017|NCT01680016|540580059|FG001|Overall Study|The Subject went out of The Trial|0|||
149958443|NCT03259308|540981937|FG001|Overall Study|Protocol Deviation|3|||
149958444|NCT03259308|540981938|FG002|Overall Study|Protocol Deviation|0|||
149958445|NCT03259308|540981936|FG000|Overall Study|Lack of Efficacy|0|||
149850018|NCT01680016|540580060|FG002|Overall Study|The Subject went out of The Trial|3|||
149850019|NCT01680016|540580061|FG003|Overall Study|The Subject went out of The Trial|0|||
149850020|NCT01680016|540580058|FG000|Overall Study|Protocol Violation|0|||
149850021|NCT01680016|540580059|FG001|Overall Study|Protocol Violation|1|||
149850022|NCT01680016|540580060|FG002|Overall Study|Protocol Violation|0|||
149850023|NCT01680016|540580061|FG003|Overall Study|Protocol Violation|0|||
150038763|NCT01746901|541283381|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
150038764|NCT01746901|541283382|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
150038765|NCT01746901|541283374|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038766|NCT01746901|541283375|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038767|NCT01746901|541283376|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038768|NCT01746901|541283377|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
150172786|NCT00961636|541768095|FG002|Overall Study|Adverse Event|13|||
149850024|NCT01680016|540580058|FG000|Overall Study|Withdrawal by Subject|5|||
149850025|NCT01680016|540580059|FG001|Overall Study|Withdrawal by Subject|7|||
149850026|NCT01680016|540580060|FG002|Overall Study|Withdrawal by Subject|1|||
149850027|NCT01680016|540580061|FG003|Overall Study|Withdrawal by Subject|1|||
149850028|NCT02846883|540580066|FG000|Overall Study|Death|0|||
149850029|NCT02846883|540580067|FG001|Overall Study|Death|1|||
149850030|NCT02846883|540580068|FG002|Overall Study|Death|1|||
149850031|NCT02846883|540580066|FG000|Overall Study|Lost to Follow-up|0|||
149850032|NCT02846883|540580067|FG001|Overall Study|Lost to Follow-up|0|||
149850033|NCT02846883|540580068|FG002|Overall Study|Lost to Follow-up|1|||
149850034|NCT02846883|540580066|FG000|Overall Study|Withdrawal by Subject|1|||
149850035|NCT02846883|540580067|FG001|Overall Study|Withdrawal by Subject|0|||
149850036|NCT02846883|540580068|FG002|Overall Study|Withdrawal by Subject|0|||
149958446|NCT03259308|540981937|FG001|Overall Study|Lack of Efficacy|0|||
149958447|NCT03259308|540981938|FG002|Overall Study|Lack of Efficacy|1|||
149958448|NCT03632720|540981943|FG000|Overall Study|Adverse Event|2|||
149958449|NCT03632720|540981944|FG001|Overall Study|Adverse Event|0|||
149958450|NCT03632720|540981945|FG002|Overall Study|Adverse Event|0|||
149958451|NCT03632720|540981943|FG000|Overall Study|Lost to Follow-up|0|||
149958452|NCT03632720|540981944|FG001|Overall Study|Lost to Follow-up|1|||
149958453|NCT03632720|540981945|FG002|Overall Study|Lost to Follow-up|0|||
149958454|NCT03632720|540981943|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
149958455|NCT03632720|540981944|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
149958456|NCT03632720|540981945|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
149958457|NCT03632720|540981943|FG000|Overall Study|Screen failure|0|||
149958458|NCT03632720|540981944|FG001|Overall Study|Screen failure|1|||
149958459|NCT03632720|540981945|FG002|Overall Study|Screen failure|0|||
149958460|NCT01117350|540981946|FG000|Comparative Period|Not Treated|5|||
149958461|NCT01117350|540981947|FG001|Comparative Period|Not Treated|8|||
149958462|NCT01117350|540981946|FG000|Comparative Period|Adverse Event|6|||
149958463|NCT01117350|540981947|FG001|Comparative Period|Adverse Event|33|||
149958464|NCT01117350|540981946|FG000|Comparative Period|Lost to Follow-up|11|||
149958465|NCT01117350|540981947|FG001|Comparative Period|Lost to Follow-up|7|||
149958466|NCT01117350|540981946|FG000|Comparative Period|Withdrawal by Subject|9|||
149958467|NCT01117350|540981947|FG001|Comparative Period|Withdrawal by Subject|13|||
149958468|NCT01117350|540981946|FG000|Comparative Period|Protocol Violation|8|||
149958469|NCT01117350|540981947|FG001|Comparative Period|Protocol Violation|12|||
149958470|NCT01117350|540981946|FG000|Comparative Period|Lack of Efficacy|1|||
149958471|NCT01117350|540981947|FG001|Comparative Period|Lack of Efficacy|0|||
149958472|NCT01117350|540981946|FG000|Comparative Period|Physician Decision|0|||
149958473|NCT01117350|540981947|FG001|Comparative Period|Physician Decision|1|||
149958474|NCT01117350|540981946|FG000|Comparative Period|Move to another city/country|2|||
149958475|NCT01117350|540981947|FG001|Comparative Period|Move to another city/country|1|||
149958476|NCT01117350|540981946|FG000|Extension Period|Not included in extension, not treated|0|||
149958477|NCT01117350|540981947|FG001|Extension Period|Not included in extension, not treated|50|||
149958478|NCT01117350|540981946|FG000|Extension Period|Adverse Event|0|||
149958479|NCT01117350|540981947|FG001|Extension Period|Adverse Event|2|||
149958480|NCT01117350|540981946|FG000|Extension Period|Protocol Violation|0|||
149958481|NCT01117350|540981947|FG001|Extension Period|Protocol Violation|2|||
149958482|NCT01117350|540981946|FG000|Extension Period|Lost to Follow-up|0|||
150172787|NCT00961636|541768093|FG000|Overall Study|Flushing Symptoms|29|||
149850037|NCT02846883|540580066|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
149850038|NCT02846883|540580067|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
149850039|NCT02846883|540580068|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
149958483|NCT01117350|540981947|FG001|Extension Period|Lost to Follow-up|2|||
149958484|NCT01117350|540981946|FG000|Extension Period|Withdrawal by Subject|0|||
149958485|NCT01117350|540981947|FG001|Extension Period|Withdrawal by Subject|3|||
149958486|NCT01117350|540981946|FG000|Extension Period|Lack of Efficacy|0|||
149958487|NCT01117350|540981947|FG001|Extension Period|Lack of Efficacy|2|||
149958488|NCT01117350|540981946|FG000|Extension Period|Inclusion criteria not respected|0|||
149958489|NCT01117350|540981947|FG001|Extension Period|Inclusion criteria not respected|1|||
149958490|NCT01117350|540981946|FG000|Extension Period|Prohibited medication|0|||
149958491|NCT01117350|540981947|FG001|Extension Period|Prohibited medication|1|||
149958492|NCT01049828|540981950|FG000|Overall Study|Claustrophibia and Frustration|2|||
149958493|NCT00290238|540981951|FG000|Overall Study|Study terminated|27|||
149958494|NCT00290238|540981952|FG001|Overall Study|Study terminated|27|||
149958495|NCT00290238|540981951|FG000|Overall Study|Lost to Follow-up|0|||
149958496|NCT00290238|540981952|FG001|Overall Study|Lost to Follow-up|1|||
149958497|NCT00290238|540981951|FG000|Overall Study|Withdrawal by Subject|15|||
149958498|NCT00290238|540981952|FG001|Overall Study|Withdrawal by Subject|13|||
149958499|NCT03312114|540983992|FG000|Overall Study|All the five enrolled dropped out of the|5|||
149958500|NCT03607695|540983995|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
149958501|NCT03607695|540983995|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
149958502|NCT01346709|540983996|FG000|Overall Study|Protocol Violation|35|||
149958503|NCT01346709|540983996|FG000|Overall Study|Lost to Follow-up|31|||
149958504|NCT01346709|540983996|FG000|Overall Study|Missing data in candidate risk factor|285|||
149958505|NCT04821245|540984003|FG000|Overall Study|Withdrawal by Subject|3|||
149958506|NCT04821245|540984003|FG000|Overall Study|Physician Decision|1|||
149958507|NCT04821245|540984003|FG000|Overall Study|Protocol Violation|5|||
149958508|NCT00605657|540984004|FG000|Overall Study|Adverse Event|1|||
149958509|NCT00605657|540984004|FG000|Overall Study|Protocol Violation|1|||
149958510|NCT02773537|540984007|FG000|Overall Study|Lost to Follow-up|0|||
149958511|NCT02773537|540984008|FG001|Overall Study|Lost to Follow-up|1|||
149958512|NCT02773537|540984009|FG002|Overall Study|Lost to Follow-up|4|||
149958513|NCT01840163|540984010|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
149958514|NCT01840163|540984011|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
149958515|NCT01840163|540984010|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
149958516|NCT01840163|540984011|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
149958517|NCT01840163|540984010|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
149958518|NCT01840163|540984011|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
149958519|NCT00662038|540984012|FG000|Overall Study|Reason not specified|3|||
149958520|NCT00662038|540984012|FG000|Overall Study|Withdrawn consent|22|||
149958521|NCT00662038|540984012|FG000|Overall Study|Withdrawal by Subject|83|||
149958522|NCT00662038|540984012|FG000|Overall Study|Sponsor decision|1|||
149958523|NCT00662038|540984012|FG000|Overall Study|Physician Decision|19|||
149958524|NCT00662038|540984012|FG000|Overall Study|Lung transplantation|44|||
149958525|NCT00662038|540984012|FG000|Overall Study|Lost to Follow-up|1|||
149958526|NCT00662038|540984012|FG000|Overall Study|Death|95|||
149958527|NCT00662038|540984012|FG000|Overall Study|Adverse Event|358|||
149958528|NCT00662038|540984012|FG000|Overall Study|Continued treatment|5|||
149958529|NCT00397046|540984013|FG000|Overall Study|Disease Progression|3|||
149958530|NCT00397046|540984014|FG001|Overall Study|Disease Progression|3|||
149958531|NCT00397046|540984015|FG002|Overall Study|Disease Progression|10|||
149958532|NCT00397046|540984016|FG003|Overall Study|Disease Progression|5|||
149958533|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
149958534|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
149958535|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
149958536|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
149958537|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
149958538|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
149958539|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
149958540|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
149958541|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
149958542|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
149958543|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
149958544|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
149958545|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Other|6|||
149958546|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Other|3|||
149958547|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Other|0|||
149958548|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
149958549|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149958550|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149958551|NCT03636269|540984018|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
149958552|NCT03636269|540984019|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
149958553|NCT03636269|540984020|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
149958554|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Adverse Event|0|||
149958555|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Adverse Event|0|||
149958556|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Adverse Event|21|||
149958557|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
149958558|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
149958559|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
149958560|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
149850040|NCT02846883|540580066|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
149850041|NCT02846883|540580067|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
149850042|NCT02846883|540580068|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
149850043|NCT00927251|540580069|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
149850044|NCT00442351|540580073|FG000|Overall Study|Administrative|6|||
149958561|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
149958562|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
149958563|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
150172788|NCT00961636|541768094|FG001|Overall Study|Flushing Symptoms|46|||
149850045|NCT00442351|540580074|FG001|Overall Study|Administrative|5|||
149850046|NCT00442351|540580073|FG000|Overall Study|Did not meet protocol eligibility|1|||
149850047|NCT00442351|540580074|FG001|Overall Study|Did not meet protocol eligibility|0|||
149850048|NCT00442351|540580073|FG000|Overall Study|Other|0|||
149850049|NCT00442351|540580074|FG001|Overall Study|Other|1|||
149850050|NCT00108628|540580080|FG000|Overall Study|Withdrawal by Subject|17|||
149850051|NCT00108628|540580081|FG001|Overall Study|Withdrawal by Subject|9|||
149850052|NCT00108628|540580080|FG000|Overall Study|Lack of Efficacy|2|||
149850053|NCT00108628|540580081|FG001|Overall Study|Lack of Efficacy|1|||
149850054|NCT00108628|540580080|FG000|Overall Study|Death|1|||
149850055|NCT00108628|540580081|FG001|Overall Study|Death|0|||
149850056|NCT01453153|540580082|FG000|Overall Study|Physician Decision|0|||
149850057|NCT01453153|540580083|FG001|Overall Study|Physician Decision|0|||
149850058|NCT01453153|540580084|FG002|Overall Study|Physician Decision|1|||
149850059|NCT01453153|540580082|FG000|Overall Study|Progressive Disease|3|||
149850060|NCT01453153|540580083|FG001|Overall Study|Progressive Disease|2|||
149850061|NCT01453153|540580084|FG002|Overall Study|Progressive Disease|16|||
149850062|NCT01453153|540580082|FG000|Overall Study|Withdrawal by Subject|0|||
149850063|NCT01453153|540580083|FG001|Overall Study|Withdrawal by Subject|1|||
149850064|NCT01453153|540580084|FG002|Overall Study|Withdrawal by Subject|2|||
149850065|NCT01453153|540580082|FG000|Overall Study|Adverse Event|1|||
149850066|NCT01453153|540580083|FG001|Overall Study|Adverse Event|1|||
149850067|NCT01453153|540580084|FG002|Overall Study|Adverse Event|1|||
149850068|NCT01813435|540580085|FG000|Overall Study|did not finish experimental regimen|1902|||
149850069|NCT01813435|540580086|FG001|Overall Study|did not finish experimental regimen|770|||
149850070|NCT01813435|540580085|FG000|Overall Study|Lost to Follow-up|268|||
149850071|NCT01813435|540580086|FG001|Overall Study|Lost to Follow-up|237|||
149850072|NCT02415387|540580087|FG000|Overall Study|Withdrawal by Subject|6|||
149850073|NCT02415387|540580088|FG001|Overall Study|Withdrawal by Subject|1|||
149850074|NCT02415387|540580087|FG000|Overall Study|blood draw problem|0|||
149850075|NCT02415387|540580088|FG001|Overall Study|blood draw problem|1|||
149850076|NCT02415387|540580087|FG000|Overall Study|Protocol Violation|1|||
149850077|NCT02415387|540580088|FG001|Overall Study|Protocol Violation|0|||
149850078|NCT03035890|540580089|FG000|Overall Study|Death|1|||
149850079|NCT03243396|540580090|FG000|Overall Study|Lost to Follow-up|2|||
149850080|NCT03243396|540580091|FG001|Overall Study|Lost to Follow-up|3|||
149850081|NCT03243396|540580092|FG002|Overall Study|Lost to Follow-up|15|||
149850082|NCT03243396|540580093|FG003|Overall Study|Lost to Follow-up|8|||
149850083|NCT03243396|540580094|FG004|Overall Study|Lost to Follow-up|1|||
149850084|NCT03243396|540580095|FG005|Overall Study|Lost to Follow-up|4|||
149850085|NCT03243396|540580096|FG006|Overall Study|Lost to Follow-up|9|||
149850086|NCT01243151|540580099|FG000|Overall Study|Adverse Event|0|||
149850087|NCT01243151|540580100|FG001|Overall Study|Adverse Event|1|||
149850088|NCT01243151|540580101|FG002|Overall Study|Adverse Event|0|||
149850089|NCT01243151|540580102|FG003|Overall Study|Adverse Event|0|||
149850090|NCT01243151|540580103|FG004|Overall Study|Adverse Event|0|||
149850091|NCT01243151|540580099|FG000|Overall Study|Protocol Violation|0|||
149850092|NCT01243151|540580100|FG001|Overall Study|Protocol Violation|0|||
149850093|NCT01243151|540580101|FG002|Overall Study|Protocol Violation|1|||
149850094|NCT01243151|540580102|FG003|Overall Study|Protocol Violation|0|||
149850095|NCT01243151|540580103|FG004|Overall Study|Protocol Violation|0|||
149850096|NCT01243151|540580099|FG000|Overall Study|Other|0|||
149850097|NCT01243151|540580100|FG001|Overall Study|Other|0|||
149850098|NCT01243151|540580101|FG002|Overall Study|Other|0|||
149850099|NCT01243151|540580102|FG003|Overall Study|Other|1|||
149850100|NCT01243151|540580103|FG004|Overall Study|Other|0|||
149850101|NCT01243151|540580099|FG000|Overall Study|Randomized but not treated|0|||
149850102|NCT01243151|540580100|FG001|Overall Study|Randomized but not treated|0|||
149850103|NCT01243151|540580101|FG002|Overall Study|Randomized but not treated|0|||
149850104|NCT01243151|540580102|FG003|Overall Study|Randomized but not treated|1|||
149850105|NCT01243151|540580103|FG004|Overall Study|Randomized but not treated|0|||
149850106|NCT00544167|540580104|FG000|Overall Study|Adverse Event|21|||
149850107|NCT00544167|540580104|FG000|Overall Study|Physician Decision|8|||
149850108|NCT03343639|540580109|FG000|Overall Study|Withdrawal by Subject|10|||
149850109|NCT03343639|540580110|FG001|Overall Study|Withdrawal by Subject|6|||
149850110|NCT03343639|540580109|FG000|Overall Study|Lost to Follow-up|4|||
149850111|NCT03343639|540580110|FG001|Overall Study|Lost to Follow-up|5|||
149850112|NCT03343639|540580109|FG000|Overall Study|Protocol Violation|0|||
149850113|NCT03343639|540580110|FG001|Overall Study|Protocol Violation|1|||
149958564|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
149958565|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
149958566|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Administrative|0|||
149958567|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Administrative|0|||
149958568|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Administrative|36|||
149958569|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Other|0|||
149958570|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Other|0|||
149958571|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Other|9|||
149958572|NCT03636269|540984018|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
149958573|NCT03636269|540984019|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
149958574|NCT03636269|540984020|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
149958575|NCT03021005|540984023|FG000|Overall Study|Lost to Follow-up|39|||
149958576|NCT03021005|540984024|FG001|Overall Study|Lost to Follow-up|26|||
149958577|NCT03156621|540984025|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
149958578|NCT03156621|540984026|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
149958579|NCT03156621|540984025|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
149958580|NCT03156621|540984026|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
149958581|NCT02264821|540984029|FG000|Overall Study|Protocol Violation|1|||
149958582|NCT02264821|540984030|FG001|Overall Study|Protocol Violation|3|||
149958583|NCT02264821|540984031|FG002|Overall Study|Protocol Violation|6|||
149958584|NCT03835117|540984032|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
149958585|NCT03835117|540984033|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
149958586|NCT06083493|540984034|FG000|Overall Study|Technical issues with the interventional device|2|||
149958587|NCT06083493|540984035|FG001|Overall Study|Technical issues with the interventional device|2|||
149958588|NCT06083493|540984034|FG000|Overall Study|Performed incorrect visual task|1|||
149958589|NCT06083493|540984035|FG001|Overall Study|Performed incorrect visual task|0|||
149958590|NCT06083493|540984034|FG000|Overall Study|Insufficient baseline performance|0|||
149958591|NCT06083493|540984035|FG001|Overall Study|Insufficient baseline performance|1|||
149958592|NCT03093870|540984036|FG000|Overall Study|Withdrawal by Subject|2|||
149958593|NCT03093870|540984037|FG001|Overall Study|Withdrawal by Subject|6|||
149958594|NCT03093870|540984038|FG002|Overall Study|Withdrawal by Subject|5|||
149958595|NCT03093870|540984036|FG000|Overall Study|Death|1|||
149958596|NCT03093870|540984037|FG001|Overall Study|Death|35|||
149958597|NCT03093870|540984038|FG002|Overall Study|Death|35|||
149958598|NCT03093870|540984036|FG000|Overall Study|Radiographic disease progression|10|||
149958599|NCT03093870|540984037|FG001|Overall Study|Radiographic disease progression|0|||
149958600|NCT03093870|540984038|FG002|Overall Study|Radiographic disease progression|0|||
149958601|NCT03093870|540984036|FG000|Overall Study|Clinical disease progression|1|||
149958602|NCT03093870|540984037|FG001|Overall Study|Clinical disease progression|0|||
149958603|NCT03093870|540984038|FG002|Overall Study|Clinical disease progression|0|||
149958604|NCT03093870|540984036|FG000|Overall Study|Physician Decision|2|||
149958605|NCT03093870|540984037|FG001|Overall Study|Physician Decision|0|||
149958606|NCT03093870|540984038|FG002|Overall Study|Physician Decision|0|||
149958607|NCT03093870|540984036|FG000|Overall Study|Adverse Event|7|||
149958608|NCT03093870|540984037|FG001|Overall Study|Adverse Event|0|||
149958609|NCT03093870|540984038|FG002|Overall Study|Adverse Event|0|||
149958610|NCT03093870|540984036|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
149958611|NCT03093870|540984037|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
149958612|NCT03093870|540984038|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
149958613|NCT03093870|540984036|FG000|Overall Study|Lost to Follow-up|0|||
149958614|NCT03093870|540984037|FG001|Overall Study|Lost to Follow-up|0|||
149958615|NCT03093870|540984038|FG002|Overall Study|Lost to Follow-up|1|||
149958616|NCT02318277|540984039|FG000|Overall Study|Physician Decision|0|||
149958617|NCT02318277|540984040|FG001|Overall Study|Physician Decision|0|||
149958618|NCT02318277|540984041|FG002|Overall Study|Physician Decision|0|||
149958619|NCT02318277|540984042|FG003|Overall Study|Physician Decision|0|||
149958620|NCT02318277|540984043|FG004|Overall Study|Physician Decision|0|||
149958621|NCT02318277|540984044|FG005|Overall Study|Physician Decision|0|||
149958622|NCT02318277|540984045|FG006|Overall Study|Physician Decision|0|||
149958623|NCT02318277|540984046|FG007|Overall Study|Physician Decision|1|||
149958624|NCT02318277|540984039|FG000|Overall Study|Other|0|||
149958625|NCT02318277|540984040|FG001|Overall Study|Other|0|||
149958626|NCT02318277|540984041|FG002|Overall Study|Other|0|||
149958627|NCT02318277|540984042|FG003|Overall Study|Other|0|||
149958628|NCT02318277|540984043|FG004|Overall Study|Other|0|||
149958629|NCT02318277|540984044|FG005|Overall Study|Other|0|||
149958630|NCT02318277|540984045|FG006|Overall Study|Other|1|||
149958631|NCT02318277|540984046|FG007|Overall Study|Other|0|||
149958632|NCT02318277|540984039|FG000|Overall Study|Withdrawal by Subject|0|||
149958633|NCT02318277|540984040|FG001|Overall Study|Withdrawal by Subject|0|||
149958634|NCT02318277|540984041|FG002|Overall Study|Withdrawal by Subject|1|||
149958635|NCT02318277|540984042|FG003|Overall Study|Withdrawal by Subject|0|||
149958636|NCT02318277|540984043|FG004|Overall Study|Withdrawal by Subject|1|||
149958637|NCT02318277|540984044|FG005|Overall Study|Withdrawal by Subject|1|||
149958638|NCT02318277|540984045|FG006|Overall Study|Withdrawal by Subject|6|||
150038769|NCT01746901|541283378|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038770|NCT01746901|541283379|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
150038771|NCT01746901|541283380|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
150038772|NCT01746901|541283381|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038773|NCT01746901|541283382|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
150038774|NCT01746901|541283374|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038775|NCT01746901|541283375|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038776|NCT01746901|541283376|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038777|NCT01746901|541283377|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
150038778|NCT01746901|541283378|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038779|NCT01746901|541283379|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038780|NCT01746901|541283380|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038781|NCT01746901|541283381|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038782|NCT01746901|541283382|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
150038783|NCT01746901|541283374|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038784|NCT01746901|541283375|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038785|NCT01746901|541283376|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038786|NCT01746901|541283377|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038787|NCT01746901|541283378|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038788|NCT01746901|541283379|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
150038789|NCT01746901|541283380|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038790|NCT01746901|541283381|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
150038791|NCT01746901|541283382|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
150038792|NCT01746901|541283374|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038793|NCT01746901|541283375|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038794|NCT01746901|541283376|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038795|NCT01746901|541283377|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038796|NCT01746901|541283378|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038797|NCT01746901|541283379|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038798|NCT01746901|541283380|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
150038799|NCT01746901|541283381|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
150038800|NCT01746901|541283382|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
150038801|NCT03594110|541283386|FG000|Interventional Part|Participant concerned about study treatment|23|||
150038802|NCT03594110|541283387|FG001|Interventional Part|Participant concerned about study treatment|28|||
150038803|NCT03594110|541283386|FG000|Interventional Part|Doctor advice|38|||
150038804|NCT03594110|541283387|FG001|Interventional Part|Doctor advice|40|||
150038805|NCT03594110|541283386|FG000|Interventional Part|Participants' wish|89|||
150038806|NCT03594110|541283387|FG001|Interventional Part|Participants' wish|68|||
150038807|NCT03594110|541283386|FG000|Interventional Part|Adverse event-non-fatal events|119|||
150038808|NCT03594110|541283387|FG001|Interventional Part|Adverse event-non-fatal events|116|||
150038809|NCT03594110|541283386|FG000|Interventional Part|Study drug stopped, reason missing|336|||
150038810|NCT03594110|541283387|FG001|Interventional Part|Study drug stopped, reason missing|294|||
150038811|NCT03594110|541283386|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
150038812|NCT03594110|541283387|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
150038813|NCT03594110|541283386|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
150038814|NCT03594110|541283387|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
150038815|NCT03594110|541283386|FG000|Interventional Part|Contraindicated drug started|32|||
150038816|NCT03594110|541283387|FG001|Interventional Part|Contraindicated drug started|18|||
150038817|NCT03594110|541283386|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
150038818|NCT03594110|541283387|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
150038819|NCT03594110|541283386|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
150038820|NCT03594110|541283387|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
150038821|NCT03594110|541283386|FG000|Non-interventional Part|Withdrawal by Subject|3|||
150038822|NCT03594110|541283387|FG001|Non-interventional Part|Withdrawal by Subject|4|||
150038823|NCT03594110|541283386|FG000|Non-interventional Part|Lost to Follow-up|45|||
150038824|NCT03594110|541283387|FG001|Non-interventional Part|Lost to Follow-up|41|||
150038825|NCT00763035|541283388|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
150038826|NCT00763035|541283389|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
150038827|NCT00763035|541283388|FG000|First Intervention|Adverse Event|0|||
150038828|NCT00763035|541283389|FG001|First Intervention|Adverse Event|1|||
150038829|NCT00763035|541283388|FG000|Second Intervention|Adverse Event|1|||
150038830|NCT00763035|541283389|FG001|Second Intervention|Adverse Event|0|||
150038831|NCT00763035|541283388|FG000|Second Intervention|Physician Decision|2|||
150038832|NCT00763035|541283389|FG001|Second Intervention|Physician Decision|0|||
150038833|NCT00702221|541283390|FG000|Overall Study|Adverse Event|4|||
150038834|NCT00702221|541283391|FG001|Overall Study|Adverse Event|3|||
150038835|NCT04798196|541283396|FG000|Overall Study|Lost to Follow-up|3|||
150038836|NCT04798196|541283397|FG001|Overall Study|Lost to Follow-up|1|||
150038837|NCT04798196|541283398|FG002|Overall Study|Lost to Follow-up|3|||
150038838|NCT01249261|541283399|FG000|Overall Study|Withdrawal by Subject|1|||
150038839|NCT01249261|541283400|FG001|Overall Study|Withdrawal by Subject|0|||
150038840|NCT01055197|541283402|FG000|Overall Study|Protocol Violation|7|||
150038841|NCT01055197|541283403|FG001|Overall Study|Protocol Violation|2|||
150038842|NCT01055197|541283402|FG000|Overall Study|Withdrawal by Subject|2|||
150038843|NCT01055197|541283403|FG001|Overall Study|Withdrawal by Subject|0|||
150038844|NCT01658436|541283413|FG000|Overall Study|Adverse Event|6|||
150038845|NCT01658436|541283414|FG001|Overall Study|Adverse Event|5|||
150038846|NCT01658436|541283413|FG000|Overall Study|Physician Decision|1|||
150038847|NCT01658436|541283414|FG001|Overall Study|Physician Decision|0|||
150038848|NCT01658436|541283413|FG000|Overall Study|Progressive disease|12|||
150038849|NCT01658436|541283414|FG001|Overall Study|Progressive disease|4|||
150038850|NCT01658436|541283413|FG000|Overall Study|Study terminated by sponsor|0|||
150038851|NCT01658436|541283414|FG001|Overall Study|Study terminated by sponsor|1|||
150038852|NCT01658436|541283413|FG000|Overall Study|Subject/guardian decision|0|||
150038853|NCT01658436|541283414|FG001|Overall Study|Subject/guardian decision|1|||
150038854|NCT01658436|541283413|FG000|Overall Study|Death|1|||
150038855|NCT01658436|541283414|FG001|Overall Study|Death|0|||
150038856|NCT00686712|541283415|FG000|Overall Study|Protocol Violation|8|||
150038857|NCT00686712|541283416|FG001|Overall Study|Protocol Violation|8|||
150038858|NCT00686712|541283417|FG002|Overall Study|Protocol Violation|10|||
150038859|NCT00686712|541283415|FG000|Overall Study|Lost to Follow-up|1|||
150038860|NCT00686712|541283416|FG001|Overall Study|Lost to Follow-up|2|||
150038861|NCT00686712|541283417|FG002|Overall Study|Lost to Follow-up|3|||
150038862|NCT00686712|541283415|FG000|Overall Study|Adverse Event|1|||
150038863|NCT00686712|541283416|FG001|Overall Study|Adverse Event|1|||
150038864|NCT00686712|541283417|FG002|Overall Study|Adverse Event|0|||
150038865|NCT01318915|541283420|FG000|Overall Study|Lost to Follow-up|1|||
150038866|NCT00926237|541283421|FG000|Overall Study|Withdrawal by Subject|2|||
150038867|NCT00926237|541283422|FG001|Overall Study|Withdrawal by Subject|1|||
150038868|NCT04119414|541283423|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
150038869|NCT01342211|541283424|FG000|Overall Study|Lost to Follow-up|0|||
150038870|NCT01342211|541283425|FG001|Overall Study|Lost to Follow-up|0|||
150038871|NCT01342211|541283426|FG002|Overall Study|Lost to Follow-up|0|||
150038872|NCT01342211|541283427|FG003|Overall Study|Lost to Follow-up|1|||
150038873|NCT01342211|541283428|FG004|Overall Study|Lost to Follow-up|0|||
150038874|NCT01342211|541283424|FG000|Overall Study|Adverse Event|0|||
150038875|NCT01342211|541283425|FG001|Overall Study|Adverse Event|0|||
150038876|NCT01342211|541283426|FG002|Overall Study|Adverse Event|0|||
150038877|NCT01342211|541283427|FG003|Overall Study|Adverse Event|0|||
150038878|NCT01342211|541283428|FG004|Overall Study|Adverse Event|1|||
150038879|NCT01342211|541283424|FG000|Overall Study|Withdrawal by Subject|0|||
150038880|NCT01342211|541283425|FG001|Overall Study|Withdrawal by Subject|0|||
150038881|NCT01342211|541283426|FG002|Overall Study|Withdrawal by Subject|0|||
150038882|NCT01342211|541283427|FG003|Overall Study|Withdrawal by Subject|1|||
150038883|NCT01342211|541283428|FG004|Overall Study|Withdrawal by Subject|0|||
150038884|NCT01342211|541283424|FG000|Overall Study|Randomized, but not Treated|0|||
150038885|NCT01342211|541283425|FG001|Overall Study|Randomized, but not Treated|2|||
150038886|NCT01342211|541283426|FG002|Overall Study|Randomized, but not Treated|0|||
150038887|NCT01342211|541283427|FG003|Overall Study|Randomized, but not Treated|0|||
150038888|NCT01342211|541283428|FG004|Overall Study|Randomized, but not Treated|1|||
150038889|NCT01588522|541283431|FG000|Overall Study|Withdrawal by Subject|1|||
150038890|NCT01588522|541283432|FG001|Overall Study|Withdrawal by Subject|5|||
150038891|NCT01588522|541283433|FG002|Overall Study|Withdrawal by Subject|3|||
150038892|NCT01588522|541283434|FG003|Overall Study|Withdrawal by Subject|1|||
150038893|NCT01588522|541283435|FG004|Overall Study|Withdrawal by Subject|2|||
150038894|NCT01588522|541283436|FG005|Overall Study|Withdrawal by Subject|0|||
150038895|NCT01588522|541283431|FG000|Overall Study|Lack of Efficacy|0|||
150038896|NCT01588522|541283432|FG001|Overall Study|Lack of Efficacy|0|||
150038897|NCT01588522|541283433|FG002|Overall Study|Lack of Efficacy|0|||
150038898|NCT01588522|541283434|FG003|Overall Study|Lack of Efficacy|0|||
150038899|NCT01588522|541283435|FG004|Overall Study|Lack of Efficacy|1|||
150038900|NCT01588522|541283436|FG005|Overall Study|Lack of Efficacy|0|||
150038901|NCT01588522|541283431|FG000|Overall Study|Adverse Event|0|||
150038902|NCT01588522|541283432|FG001|Overall Study|Adverse Event|0|||
150038903|NCT01588522|541283433|FG002|Overall Study|Adverse Event|0|||
150038904|NCT01588522|541283434|FG003|Overall Study|Adverse Event|1|||
150038905|NCT01588522|541283435|FG004|Overall Study|Adverse Event|0|||
150038906|NCT01588522|541283436|FG005|Overall Study|Adverse Event|0|||
150038907|NCT01588522|541283431|FG000|Overall Study|Grade 2 alopecia|1|||
150038908|NCT01588522|541283432|FG001|Overall Study|Grade 2 alopecia|0|||
150038909|NCT01588522|541283433|FG002|Overall Study|Grade 2 alopecia|0|||
150038910|NCT01588522|541283434|FG003|Overall Study|Grade 2 alopecia|0|||
150038911|NCT01588522|541283435|FG004|Overall Study|Grade 2 alopecia|0|||
150038912|NCT01588522|541283436|FG005|Overall Study|Grade 2 alopecia|0|||
150038913|NCT01588522|541283431|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
150172789|NCT00961636|541768095|FG002|Overall Study|Flushing Symptoms|3|||
150038914|NCT01588522|541283432|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
150038915|NCT01588522|541283433|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
150038916|NCT01588522|541283434|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
150038917|NCT01588522|541283435|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
149850114|NCT00735696|540580115|FG000|Overall Study|Withdrawal by Subject|1|||
149850115|NCT00735696|540580115|FG000|Overall Study|Enrolled but never Treated|1|||
149850116|NCT02460835|540580116|FG000|Overall Study|Disease progression prior to treatment|3|||
149850117|NCT02460835|540580116|FG000|Overall Study|Unable to complete planning scans|2|||
149850118|NCT02460835|540580116|FG000|Overall Study|Decrease in performance status|1|||
149850119|NCT02460835|540580116|FG000|Overall Study|Withdrawal by Subject|3|||
150038918|NCT01588522|541283436|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
150038919|NCT01588522|541283431|FG000|Overall Study|Taken off taxane-based regimen|0|||
149850120|NCT02460835|540580116|FG000|Overall Study|Underwent fractionated RT|10|||
149850121|NCT02460835|540580116|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
149850122|NCT02655224|540580117|FG000|Overall Study|Adverse Event|1|||
149850123|NCT02655224|540580118|FG001|Overall Study|Adverse Event|1|||
149850124|NCT00063258|540580130|FG000|Overall Study|Physician Decision|2|||
149850125|NCT00063258|540580131|FG001|Overall Study|Physician Decision|0|||
149850126|NCT00063258|540580130|FG000|Overall Study|Lack of Efficacy|2|||
150038920|NCT01588522|541283432|FG001|Overall Study|Taken off taxane-based regimen|0|||
150038921|NCT01588522|541283433|FG002|Overall Study|Taken off taxane-based regimen|0|||
150038922|NCT01588522|541283434|FG003|Overall Study|Taken off taxane-based regimen|1|||
150038923|NCT01588522|541283435|FG004|Overall Study|Taken off taxane-based regimen|0|||
150038924|NCT01588522|541283436|FG005|Overall Study|Taken off taxane-based regimen|0|||
150038925|NCT01588522|541283431|FG000|Overall Study|Did not initiate chemotherapy|0|||
150038926|NCT01588522|541283432|FG001|Overall Study|Did not initiate chemotherapy|0|||
150038927|NCT01588522|541283433|FG002|Overall Study|Did not initiate chemotherapy|0|||
150038928|NCT01588522|541283434|FG003|Overall Study|Did not initiate chemotherapy|0|||
150038929|NCT01588522|541283435|FG004|Overall Study|Did not initiate chemotherapy|1|||
150038930|NCT01588522|541283436|FG005|Overall Study|Did not initiate chemotherapy|0|||
150038931|NCT02855125|541283439|FG000|Overall Study|Withdrawal by Subject|2|||
150038932|NCT02855125|541283440|FG001|Overall Study|Withdrawal by Subject|2|||
150038933|NCT02855125|541283439|FG000|Overall Study|Clinical Disease Progression|5|||
150038934|NCT02855125|541283440|FG001|Overall Study|Clinical Disease Progression|4|||
150038935|NCT02855125|541283439|FG000|Overall Study|Radiologic Disease Progression|36|||
150038936|NCT02855125|541283440|FG001|Overall Study|Radiologic Disease Progression|39|||
149850127|NCT00063258|540580131|FG001|Overall Study|Lack of Efficacy|0|||
149850128|NCT04281472|540580135|FG000|Stage A|Lack of Efficacy|8|||
149850129|NCT04281472|540580136|FG001|Stage A|Lack of Efficacy|0|||
149850130|NCT04281472|540580137|FG002|Stage A|Lack of Efficacy|0|||
149850131|NCT04281472|540580135|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
149850132|NCT04281472|540580136|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
149850133|NCT04281472|540580137|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
150038937|NCT02855125|541283439|FG000|Overall Study|Adverse Event|11|||
150038938|NCT02855125|541283440|FG001|Overall Study|Adverse Event|7|||
150038939|NCT02855125|541283439|FG000|Overall Study|Physician Decision|1|||
150038940|NCT02855125|541283440|FG001|Overall Study|Physician Decision|0|||
150038941|NCT02855125|541283439|FG000|Overall Study|On Treatment|9|||
150038942|NCT02855125|541283440|FG001|Overall Study|On Treatment|11|||
150038943|NCT02855125|541283439|FG000|Overall Study|Randomized but not treated|0|||
150038944|NCT02855125|541283440|FG001|Overall Study|Randomized but not treated|1|||
150038945|NCT04467905|541283441|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
150038946|NCT04467905|541283442|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
150038947|NCT04467905|541283443|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
150038948|NCT04467905|541283441|FG000|Overall Study|Conversion to SR|0|||
150038949|NCT04467905|541283442|FG001|Overall Study|Conversion to SR|0|||
150038950|NCT04467905|541283443|FG002|Overall Study|Conversion to SR|3|||
149850134|NCT04281472|540580135|FG000|Stage A|Adverse Event|20|||
150038951|NCT04467905|541283441|FG000|Overall Study|Technical issue with Holter ECG|0|||
150038952|NCT04467905|541283442|FG001|Overall Study|Technical issue with Holter ECG|0|||
150038953|NCT04467905|541283443|FG002|Overall Study|Technical issue with Holter ECG|3|||
150038954|NCT04467905|541283441|FG000|Overall Study|Hemodynamic instability|0|||
150038955|NCT04467905|541283442|FG001|Overall Study|Hemodynamic instability|0|||
150038956|NCT04467905|541283443|FG002|Overall Study|Hemodynamic instability|1|||
150172790|NCT00961636|541768093|FG000|Overall Study|Lost to Follow-up|2|||
149850135|NCT04281472|540580136|FG001|Stage A|Adverse Event|0|||
149850136|NCT04281472|540580137|FG002|Stage A|Adverse Event|0|||
149850137|NCT04281472|540580135|FG000|Stage A|Death|1|||
150038957|NCT04467905|541283441|FG000|Overall Study|Site misinterpretation of protocol|0|||
150038958|NCT04467905|541283442|FG001|Overall Study|Site misinterpretation of protocol|0|||
150038959|NCT04467905|541283443|FG002|Overall Study|Site misinterpretation of protocol|1|||
150038960|NCT05462756|541285030|FG000|Treatment Period|Adverse Event|3|||
150038961|NCT05462756|541285031|FG001|Treatment Period|Adverse Event|0|||
150172791|NCT00961636|541768094|FG001|Overall Study|Lost to Follow-up|3|||
149850138|NCT04281472|540580136|FG001|Stage A|Death|0|||
149850139|NCT04281472|540580137|FG002|Stage A|Death|0|||
149850140|NCT04281472|540580135|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
149850141|NCT04281472|540580136|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
149850142|NCT04281472|540580137|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
149850143|NCT04281472|540580135|FG000|Stage A|Lost to Follow-up|2|||
149850144|NCT04281472|540580136|FG001|Stage A|Lost to Follow-up|0|||
149850145|NCT04281472|540580137|FG002|Stage A|Lost to Follow-up|0|||
149850146|NCT04281472|540580135|FG000|Stage A|Non-compliance with study drug|1|||
149850147|NCT04281472|540580136|FG001|Stage A|Non-compliance with study drug|0|||
149850148|NCT04281472|540580137|FG002|Stage A|Non-compliance with study drug|0|||
149850149|NCT04281472|540580135|FG000|Stage A|Physician Decision|1|||
149850150|NCT04281472|540580136|FG001|Stage A|Physician Decision|0|||
149850151|NCT04281472|540580137|FG002|Stage A|Physician Decision|0|||
149850152|NCT04281472|540580135|FG000|Stage A|Prohibited medications|2|||
149850153|NCT04281472|540580136|FG001|Stage A|Prohibited medications|0|||
149850154|NCT04281472|540580137|FG002|Stage A|Prohibited medications|0|||
149850155|NCT04281472|540580135|FG000|Stage A|Withdrawal by Subject|11|||
149850156|NCT04281472|540580136|FG001|Stage A|Withdrawal by Subject|0|||
149850157|NCT04281472|540580137|FG002|Stage A|Withdrawal by Subject|0|||
149850158|NCT04281472|540580135|FG000|Stage A|Other|5|||
149850159|NCT04281472|540580136|FG001|Stage A|Other|0|||
149850160|NCT04281472|540580137|FG002|Stage A|Other|0|||
149850161|NCT04281472|540580135|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
149850162|NCT04281472|540580136|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
149850163|NCT04281472|540580137|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
149850164|NCT04281472|540580135|FG000|Stage B|Adverse Event|0|||
149850165|NCT04281472|540580136|FG001|Stage B|Adverse Event|3|||
149850166|NCT04281472|540580137|FG002|Stage B|Adverse Event|0|||
149850167|NCT04281472|540580135|FG000|Stage B|Death|0|||
149850168|NCT04281472|540580136|FG001|Stage B|Death|0|||
149850169|NCT04281472|540580137|FG002|Stage B|Death|1|||
149850170|NCT04281472|540580135|FG000|Stage B|Lack of Efficacy|0|||
149850171|NCT04281472|540580136|FG001|Stage B|Lack of Efficacy|0|||
149850172|NCT04281472|540580137|FG002|Stage B|Lack of Efficacy|1|||
149850173|NCT04281472|540580135|FG000|Stage B|Lost to Follow-up|0|||
149850174|NCT04281472|540580136|FG001|Stage B|Lost to Follow-up|0|||
149850175|NCT04281472|540580137|FG002|Stage B|Lost to Follow-up|2|||
149850176|NCT04281472|540580135|FG000|Stage B|Prohibited medications|0|||
149850177|NCT04281472|540580136|FG001|Stage B|Prohibited medications|2|||
149850178|NCT04281472|540580137|FG002|Stage B|Prohibited medications|1|||
149850179|NCT04281472|540580135|FG000|Stage B|Protocol Violation|0|||
149850180|NCT04281472|540580136|FG001|Stage B|Protocol Violation|1|||
149850181|NCT04281472|540580137|FG002|Stage B|Protocol Violation|1|||
149850182|NCT04281472|540580135|FG000|Stage B|Sponsor decision|0|||
149850183|NCT04281472|540580136|FG001|Stage B|Sponsor decision|0|||
149850184|NCT04281472|540580137|FG002|Stage B|Sponsor decision|1|||
149850185|NCT04281472|540580135|FG000|Stage B|Withdrawal by Subject|0|||
149850186|NCT04281472|540580136|FG001|Stage B|Withdrawal by Subject|3|||
149850187|NCT04281472|540580137|FG002|Stage B|Withdrawal by Subject|3|||
149850188|NCT04281472|540580135|FG000|Stage B|Other|0|||
149850189|NCT04281472|540580136|FG001|Stage B|Other|3|||
149850190|NCT04281472|540580137|FG002|Stage B|Other|0|||
149850191|NCT01055834|540580141|FG000|Treatment Period I|Adverse Event|1|||
149850192|NCT01055834|540580142|FG001|Treatment Period I|Adverse Event|0|||
149850193|NCT01717313|540580143|FG000|Phase A (Weeks 0 to 24)|Death|0|||
149850194|NCT01717313|540580144|FG001|Phase A (Weeks 0 to 24)|Death|1|||
149850195|NCT01717313|540580143|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
149850196|NCT01717313|540580144|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
149850197|NCT01717313|540580143|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
149850198|NCT01717313|540580144|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
149850199|NCT01717313|540580143|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
149850200|NCT01717313|540580144|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
149850201|NCT01717313|540580143|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
149850202|NCT01717313|540580144|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
149850203|NCT01717313|540580143|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
149850204|NCT01717313|540580144|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
149850205|NCT01717313|540580143|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
149850206|NCT01717313|540580144|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
149850207|NCT01717313|540580143|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
149850208|NCT01717313|540580144|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
149850209|NCT01717313|540580143|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
149850210|NCT01717313|540580144|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
149850211|NCT01745094|540580148|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
149850212|NCT01745094|540580149|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
149850213|NCT01745094|540580150|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
149850214|NCT01745094|540580151|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
149850215|NCT01745094|540580148|FG000|Overall Study|Adverse Event|0|||
150038962|NCT05462756|541285030|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
150038963|NCT05462756|541285031|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
150038964|NCT05462756|541285030|FG000|Treatment Period|Death|0|||
150038965|NCT05462756|541285031|FG001|Treatment Period|Death|1|||
150038966|NCT05462756|541285030|FG000|Treatment Period|Lost to Follow-up|2|||
150038967|NCT05462756|541285031|FG001|Treatment Period|Lost to Follow-up|1|||
150038968|NCT05462756|541285030|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
150038969|NCT05462756|541285031|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
150038970|NCT05462756|541285030|FG000|Treatment Period|Physician Decision|2|||
150038971|NCT05462756|541285031|FG001|Treatment Period|Physician Decision|0|||
150038972|NCT05462756|541285030|FG000|Treatment Period|Protocol Violation|0|||
150038973|NCT05462756|541285031|FG001|Treatment Period|Protocol Violation|1|||
150038974|NCT05462756|541285030|FG000|Treatment Period|Withdrawal by Subject|5|||
150038975|NCT05462756|541285031|FG001|Treatment Period|Withdrawal by Subject|12|||
150038976|NCT05462756|541285030|FG000|Follow-Up Period|Adverse Event|1|||
150038977|NCT05462756|541285031|FG001|Follow-Up Period|Adverse Event|0|||
149850216|NCT01745094|540580149|FG001|Overall Study|Adverse Event|0|||
149850217|NCT01745094|540580150|FG002|Overall Study|Adverse Event|3|||
149850218|NCT01745094|540580151|FG003|Overall Study|Adverse Event|0|||
149850219|NCT01745094|540580148|FG000|Overall Study|Withdrawal by Subject|2|||
149850220|NCT01745094|540580149|FG001|Overall Study|Withdrawal by Subject|0|||
149850221|NCT01745094|540580150|FG002|Overall Study|Withdrawal by Subject|1|||
149850222|NCT01745094|540580151|FG003|Overall Study|Withdrawal by Subject|2|||
149850223|NCT01745094|540580148|FG000|Overall Study|Protocol Violation|1|||
149850224|NCT01745094|540580149|FG001|Overall Study|Protocol Violation|0|||
149850225|NCT01745094|540580150|FG002|Overall Study|Protocol Violation|3|||
149850226|NCT01745094|540580151|FG003|Overall Study|Protocol Violation|1|||
149850227|NCT01745094|540580148|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
149850228|NCT01745094|540580149|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
149850229|NCT01745094|540580150|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
149850230|NCT01745094|540580151|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
149850231|NCT01745094|540580148|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
149850232|NCT01745094|540580149|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
149850233|NCT01745094|540580150|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
149850234|NCT01745094|540580151|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
149850235|NCT01745094|540580148|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
149850236|NCT01745094|540580149|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
149850237|NCT01745094|540580150|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
149850238|NCT01745094|540580151|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
149850239|NCT01097694|540580152|FG000|Overall Study|Adverse Event|5|||
149850240|NCT01097694|540580153|FG001|Overall Study|Adverse Event|0|||
149850241|NCT01097694|540580152|FG000|Overall Study|Lost to Follow-up|0|||
149850242|NCT01097694|540580153|FG001|Overall Study|Lost to Follow-up|3|||
149850243|NCT01097694|540580152|FG000|Overall Study|Withdrawal by Subject|3|||
149850244|NCT01097694|540580153|FG001|Overall Study|Withdrawal by Subject|1|||
149850245|NCT02179190|540580154|FG000|Enrollment|Exit Prior to Device Attempt|11|||
149850246|NCT02179190|540580154|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
149850247|NCT02179190|540580154|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
150038978|NCT05462756|541285030|FG000|Follow-Up Period|Death|1|||
150038979|NCT05462756|541285031|FG001|Follow-Up Period|Death|0|||
150038980|NCT05462756|541285030|FG000|Follow-Up Period|Lost to Follow-up|3|||
150038981|NCT05462756|541285031|FG001|Follow-Up Period|Lost to Follow-up|1|||
150038982|NCT05462756|541285030|FG000|Follow-Up Period|Withdrawal by Subject|0|||
149850248|NCT02179190|540580154|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
149850249|NCT02179190|540580154|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
149850250|NCT02179190|540580154|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
149850251|NCT00881569|540580157|FG000|Overall Study|Disease progression|1|||
149850252|NCT00881569|540580158|FG001|Overall Study|Disease progression|1|||
149850253|NCT03480022|540580159|FG000|Overall Study|Pregnancy|2|||
149850254|NCT03480022|540580160|FG001|Overall Study|Pregnancy|0|||
149850255|NCT03480022|540580159|FG000|Overall Study|Adverse Event|6|||
149850256|NCT03480022|540580160|FG001|Overall Study|Adverse Event|0|||
149850257|NCT03480022|540580159|FG000|Overall Study|Lack of Efficacy|0|||
149850258|NCT03480022|540580160|FG001|Overall Study|Lack of Efficacy|2|||
149850259|NCT03480022|540580159|FG000|Overall Study|Physician Decision|0|||
149850260|NCT03480022|540580160|FG001|Overall Study|Physician Decision|1|||
149850261|NCT03480022|540580159|FG000|Overall Study|Withdrawal by Subject|2|||
149850262|NCT03480022|540580160|FG001|Overall Study|Withdrawal by Subject|0|||
149850263|NCT03480022|540580159|FG000|Overall Study|Medication concerns|1|||
149850264|NCT03480022|540580160|FG001|Overall Study|Medication concerns|0|||
149850265|NCT03480022|540580159|FG000|Overall Study|Family member COVID exposure|0|||
150038983|NCT05462756|541285031|FG001|Follow-Up Period|Withdrawal by Subject|4|||
150038984|NCT01942837|541285045|FG000|Overall Study|Death|1|||
150038985|NCT01942837|541285045|FG000|Overall Study|Symptomatic or radiographic progression|49|||
150038986|NCT01942837|541285045|FG000|Overall Study|Adverse Event|6|||
150038987|NCT01942837|541285045|FG000|Overall Study|Physician Decision|3|||
149850266|NCT03480022|540580160|FG001|Overall Study|Family member COVID exposure|1|||
149850267|NCT00668395|540580165|FG000|Overall Study|Withdrawal by Subject|4|||
149850268|NCT00668395|540580166|FG001|Overall Study|Withdrawal by Subject|4|||
149850269|NCT00668395|540580167|FG002|Overall Study|Withdrawal by Subject|1|||
149850270|NCT00668395|540580165|FG000|Overall Study|Adverse Event|1|||
149850271|NCT00668395|540580166|FG001|Overall Study|Adverse Event|1|||
149850272|NCT00668395|540580167|FG002|Overall Study|Adverse Event|0|||
149850273|NCT00668395|540580165|FG000|Overall Study|Physician Decision|1|||
149850274|NCT00668395|540580166|FG001|Overall Study|Physician Decision|1|||
149850275|NCT00668395|540580167|FG002|Overall Study|Physician Decision|0|||
149850276|NCT03259165|540580168|FG000|Overall Study|COVID 19 pandemic|1|||
149850277|NCT03259165|540580169|FG001|Overall Study|COVID 19 pandemic|1|||
149850278|NCT01949532|540580170|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
149850279|NCT01949532|540580171|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
149850280|NCT05665387|540580172|FG000|Overall Study|Withdrawal by Subject|1|||
149850281|NCT05665387|540580173|FG001|Overall Study|Withdrawal by Subject|0|||
149850282|NCT05665387|540580174|FG002|Overall Study|Withdrawal by Subject|1|||
149850283|NCT01277510|540580175|FG000|Double-blind Phase|Non-compliance|0|||
149850284|NCT01277510|540580176|FG001|Double-blind Phase|Non-compliance|1|||
149850285|NCT01277510|540580175|FG000|Double-blind Phase|Adverse Event|1|||
149850286|NCT01277510|540580176|FG001|Double-blind Phase|Adverse Event|0|||
149850287|NCT01277510|540580175|FG000|Double-blind Phase|Withdrawal by Subject|2|||
149850288|NCT01277510|540580176|FG001|Double-blind Phase|Withdrawal by Subject|0|||
149850289|NCT01277510|540580175|FG000|Double-blind Phase|Administrative decision|7|||
149850290|NCT01277510|540580176|FG001|Double-blind Phase|Administrative decision|9|||
149850291|NCT01277510|540580175|FG000|Double-blind Phase|Death|0|||
149850292|NCT01277510|540580176|FG001|Double-blind Phase|Death|1|||
149850293|NCT01277510|540580175|FG000|Double-blind Phase|Protocol-specified criteria|2|||
149850294|NCT01277510|540580176|FG001|Double-blind Phase|Protocol-specified criteria|6|||
149850295|NCT01277510|540580175|FG000|Double-blind Phase|Other|1|||
149850296|NCT01277510|540580176|FG001|Double-blind Phase|Other|1|||
149850297|NCT01277510|540580175|FG000|Open-label Phase|Administrative decision|4|||
149850298|NCT01277510|540580176|FG001|Open-label Phase|Administrative decision|3|||
149850299|NCT01277510|540580175|FG000|Open-label Phase|Protocol-specified criteria|1|||
149850300|NCT01277510|540580176|FG001|Open-label Phase|Protocol-specified criteria|0|||
149850301|NCT01277510|540580175|FG000|Open-label Phase|Never received investigational product|2|||
149850302|NCT01277510|540580176|FG001|Open-label Phase|Never received investigational product|0|||
149850303|NCT00021541|540580177|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
149850304|NCT00021541|540580178|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
149850305|NCT00021541|540580177|FG000|Period 1-First Treatment|Adverse Event|2|||
149850306|NCT00021541|540580178|FG001|Period 1-First Treatment|Adverse Event|1|||
149850307|NCT00021541|540580177|FG000|Period 1-First Treatment|non-adherence|3|||
149850308|NCT00021541|540580178|FG001|Period 1-First Treatment|non-adherence|0|||
149850309|NCT00021541|540580177|FG000|Period 1-First Treatment|Death|1|||
149850310|NCT00021541|540580178|FG001|Period 1-First Treatment|Death|0|||
149850311|NCT00021541|540580177|FG000|Period 1-First Treatment|Pts that did not progress|2|||
149850312|NCT00021541|540580178|FG001|Period 1-First Treatment|Pts that did not progress|2|||
149850313|NCT00021541|540580177|FG000|Period 1-First Treatment|Ineligible|0|||
149850314|NCT00021541|540580178|FG001|Period 1-First Treatment|Ineligible|2|||
149850315|NCT00021541|540580177|FG000|Period 2-crossover|refused phase B|2|||
149850316|NCT00021541|540580178|FG001|Period 2-crossover|refused phase B|2|||
149850317|NCT00021541|540580177|FG000|Period 2-crossover|Withdrawal by Subject|3|||
149850318|NCT00021541|540580178|FG001|Period 2-crossover|Withdrawal by Subject|4|||
149850319|NCT00021541|540580177|FG000|Period 2-crossover|Adverse Event|2|||
149850320|NCT00021541|540580178|FG001|Period 2-crossover|Adverse Event|2|||
149850321|NCT00021541|540580177|FG000|Period 2-crossover|non-adherence|1|||
149850322|NCT00021541|540580178|FG001|Period 2-crossover|non-adherence|0|||
150038988|NCT01942837|541285045|FG000|Overall Study|Withdrawal by Subject|2|||
150038989|NCT01942837|541285045|FG000|Overall Study|Intercurrent Illness|1|||
150038990|NCT01942837|541285045|FG000|Overall Study|On treatment|3|||
150038991|NCT01942837|541285045|FG000|Overall Study|Never initiate the treatment|2|||
149850323|NCT00021541|540580177|FG000|Period 2-crossover|Pts that did not progress|2|||
149850324|NCT00021541|540580178|FG001|Period 2-crossover|Pts that did not progress|3|||
149850325|NCT01874535|540580179|FG000|Overall Study|Lost to Follow-up|10|||
149850326|NCT01874535|540580180|FG001|Overall Study|Lost to Follow-up|9|||
149850327|NCT01874535|540580179|FG000|Overall Study|incomplete symptom resolution|45|||
149850328|NCT01874535|540580180|FG001|Overall Study|incomplete symptom resolution|35|||
149850329|NCT01215721|540580184|FG000|Overall Study|Adverse Event|2|||
149850330|NCT03828539|540580185|FG000|Overall Study|Adverse Event|3|||
149850331|NCT03828539|540580186|FG001|Overall Study|Adverse Event|12|||
149850332|NCT03828539|540580185|FG000|Overall Study|Patient's/guardian's decision|3|||
149850333|NCT03828539|540580186|FG001|Overall Study|Patient's/guardian's decision|5|||
149850334|NCT03828539|540580185|FG000|Overall Study|Lost to Follow-up|4|||
150038992|NCT01298648|541285046|FG000|Overall Study|Withdrawal by Subject|2|||
149850335|NCT03828539|540580186|FG001|Overall Study|Lost to Follow-up|2|||
150038993|NCT01298648|541285046|FG000|Overall Study|Lost to Follow-up|21|||
149850336|NCT03828539|540580185|FG000|Overall Study|Protocol Violation|3|||
149850337|NCT03828539|540580186|FG001|Overall Study|Protocol Violation|2|||
149850338|NCT03828539|540580185|FG000|Overall Study|Withdrawal of informed consent|2|||
149850339|NCT03828539|540580186|FG001|Overall Study|Withdrawal of informed consent|1|||
149850340|NCT03828539|540580185|FG000|Overall Study|New therapy for study indication|1|||
149850341|NCT03828539|540580186|FG001|Overall Study|New therapy for study indication|0|||
149850342|NCT05263505|540580187|FG000|Overall Study|Adverse Event|0|||
149850343|NCT05263505|540580188|FG001|Overall Study|Adverse Event|1|||
149850344|NCT02616380|540580189|FG000|Overall Study|Lost to Follow-up|1|||
149850345|NCT02616380|540580189|FG000|Overall Study|Other|2|||
149850346|NCT00826241|540580190|FG000|Overall Study|Withdrawal from Follow-up|1|||
149850347|NCT00826241|540580190|FG000|Overall Study|Withdrew consent|2|||
149850348|NCT00826241|540580190|FG000|Overall Study|Death|4|||
149850349|NCT00826241|540580190|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
149850350|NCT00826241|540580190|FG000|Overall Study|Non-compliance|1|||
149850351|NCT00826241|540580190|FG000|Overall Study|Progression of disease|1|||
149850352|NCT00826241|540580190|FG000|Overall Study|Patient refused follow-up|3|||
149850353|NCT00826241|540580190|FG000|Overall Study|Lost to Follow-up|9|||
149850354|NCT00826241|540580190|FG000|Overall Study|Could not obtain records|1|||
149850355|NCT00826241|540580190|FG000|Overall Study|Screen failure|2|||
149850356|NCT00826241|540580190|FG000|Overall Study|Pt unable to proceed to registration|1|||
149850357|NCT00826241|540580190|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
149850358|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
149850359|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
149850360|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
149850361|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
149850362|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
149850363|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
149850364|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
149850365|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
149850366|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
149850367|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
149850368|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
149850369|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
149850370|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
149850371|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
149850372|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
149850373|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
149850374|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
149850375|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
149850376|NCT00950300|540580191|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
149850377|NCT00950300|540580192|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
149850378|NCT00950300|540580191|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
149850379|NCT00950300|540580192|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
149850380|NCT00950300|540580191|FG000|TFFU Period|Death|4|||
149850381|NCT00950300|540580192|FG001|TFFU Period|Death|1|||
149850382|NCT00950300|540580191|FG000|TFFU Period|Refused Treatment|10|||
149850383|NCT00950300|540580192|FG001|TFFU Period|Refused Treatment|11|||
149850384|NCT00950300|540580191|FG000|TFFU Period|Failure to Return|16|||
149850385|NCT00950300|540580192|FG001|TFFU Period|Failure to Return|16|||
149850386|NCT00950300|540580191|FG000|TFFU Period|Recurrence of Disease|63|||
149850387|NCT00950300|540580192|FG001|TFFU Period|Recurrence of Disease|72|||
149850388|NCT00950300|540580191|FG000|TFFU Period|Other|4|||
149850389|NCT00950300|540580192|FG001|TFFU Period|Other|3|||
149850390|NCT00950300|540580191|FG000|SFU Period|Death|44|||
149850391|NCT00950300|540580192|FG001|SFU Period|Death|42|||
149850392|NCT00950300|540580191|FG000|SFU Period|Lost to Follow-up|30|||
149850393|NCT00950300|540580192|FG001|SFU Period|Lost to Follow-up|28|||
149850394|NCT00950300|540580191|FG000|SFU Period|Withdrawal by Subject|4|||
149850395|NCT00950300|540580192|FG001|SFU Period|Withdrawal by Subject|8|||
149850396|NCT01596127|540580194|FG000|Overall Study|Patient Ineligible|1|||
149850397|NCT00438633|540580195|FG000|Overall Study|Withdrawal by Subject|1|||
149850398|NCT00438633|540580196|FG001|Overall Study|Withdrawal by Subject|0|||
149850399|NCT00438633|540580195|FG000|Overall Study|Lost to Follow-up|15|||
149850400|NCT00438633|540580196|FG001|Overall Study|Lost to Follow-up|17|||
149850401|NCT01539239|540580197|FG000|Overall Study|Death|5|||
149850402|NCT01539239|540580198|FG001|Overall Study|Death|5|||
149850403|NCT01539239|540580197|FG000|Overall Study|Lost to Follow-up|7|||
149850404|NCT01539239|540580198|FG001|Overall Study|Lost to Follow-up|12|||
149850405|NCT00633022|540580199|FG000|Overall Study|Adverse Event|1|||
149850406|NCT00633022|540580200|FG001|Overall Study|Adverse Event|0|||
149850407|NCT00633022|540580201|FG002|Overall Study|Adverse Event|5|||
149850408|NCT00633022|540580199|FG000|Overall Study|Physician Decision|0|||
149850409|NCT00633022|540580200|FG001|Overall Study|Physician Decision|1|||
149850410|NCT00633022|540580201|FG002|Overall Study|Physician Decision|0|||
149850411|NCT01751087|540580204|FG000|Overall Study|Withdrawal by Subject|1|||
149850412|NCT01751087|540580205|FG001|Overall Study|Withdrawal by Subject|0|||
149850413|NCT01751087|540580206|FG002|Overall Study|Withdrawal by Subject|0|||
149850414|NCT01751087|540580204|FG000|Overall Study|Physician Decision|0|||
149850415|NCT01751087|540580205|FG001|Overall Study|Physician Decision|0|||
149850416|NCT01751087|540580206|FG002|Overall Study|Physician Decision|1|||
149850417|NCT01074008|540581600|FG000|Overall Study|Adverse Event|0|||
149850418|NCT01074008|540581601|FG001|Overall Study|Adverse Event|1|||
149850419|NCT01074008|540581602|FG002|Overall Study|Adverse Event|0|||
149850420|NCT01074008|540581603|FG003|Overall Study|Adverse Event|0|||
149850421|NCT01074008|540581604|FG004|Overall Study|Adverse Event|0|||
149850422|NCT01074008|540581605|FG005|Overall Study|Adverse Event|0|||
149850423|NCT01074008|540581606|FG006|Overall Study|Adverse Event|0|||
149850424|NCT01074008|540581607|FG007|Overall Study|Adverse Event|0|||
149850425|NCT01074008|540581608|FG008|Overall Study|Adverse Event|0|||
149850426|NCT01074008|540581600|FG000|Overall Study|Withdrawal by Subject|1|||
149850427|NCT01074008|540581601|FG001|Overall Study|Withdrawal by Subject|1|||
149850428|NCT01074008|540581602|FG002|Overall Study|Withdrawal by Subject|1|||
149850429|NCT01074008|540581603|FG003|Overall Study|Withdrawal by Subject|0|||
149850430|NCT01074008|540581604|FG004|Overall Study|Withdrawal by Subject|1|||
149850431|NCT01074008|540581605|FG005|Overall Study|Withdrawal by Subject|0|||
149850432|NCT01074008|540581606|FG006|Overall Study|Withdrawal by Subject|0|||
149850433|NCT01074008|540581607|FG007|Overall Study|Withdrawal by Subject|0|||
149850434|NCT01074008|540581608|FG008|Overall Study|Withdrawal by Subject|0|||
149850435|NCT01074008|540581600|FG000|Overall Study|Lost to Follow-up|0|||
149850436|NCT01074008|540581601|FG001|Overall Study|Lost to Follow-up|1|||
149850437|NCT01074008|540581602|FG002|Overall Study|Lost to Follow-up|1|||
149850438|NCT01074008|540581603|FG003|Overall Study|Lost to Follow-up|1|||
149850439|NCT01074008|540581604|FG004|Overall Study|Lost to Follow-up|1|||
149850440|NCT01074008|540581605|FG005|Overall Study|Lost to Follow-up|0|||
149850441|NCT01074008|540581606|FG006|Overall Study|Lost to Follow-up|1|||
149850442|NCT01074008|540581607|FG007|Overall Study|Lost to Follow-up|0|||
149850443|NCT01074008|540581608|FG008|Overall Study|Lost to Follow-up|4|||
149850444|NCT01350934|540581614|FG000|Base Study|Adverse Event|6|||
149850445|NCT01350934|540581615|FG001|Base Study|Adverse Event|0|||
149850446|NCT01350934|540581614|FG000|Base Study|Lost to Follow-up|1|||
149850447|NCT01350934|540581615|FG001|Base Study|Lost to Follow-up|0|||
149850448|NCT01350934|540581614|FG000|Base Study|Protocol Violation|1|||
149850449|NCT01350934|540581615|FG001|Base Study|Protocol Violation|1|||
149850450|NCT01350934|540581614|FG000|Base Study|Withdrawal by Subject|1|||
149850451|NCT01350934|540581615|FG001|Base Study|Withdrawal by Subject|2|||
149850452|NCT01350934|540581614|FG000|Base Study|Non-Compliance With Study Drug|2|||
149850453|NCT01350934|540581615|FG001|Base Study|Non-Compliance With Study Drug|0|||
149850454|NCT01350934|540581614|FG000|Extension Study|Adverse Event|2|||
149850455|NCT01350934|540581615|FG001|Extension Study|Adverse Event|1|||
149850456|NCT01350934|540581614|FG000|Extension Study|Lost to Follow-up|2|||
149958639|NCT02318277|540984046|FG007|Overall Study|Withdrawal by Subject|14|||
149958640|NCT02318277|540984039|FG000|Overall Study|Participant trial terminated by sponsor|0|||
149958641|NCT02318277|540984040|FG001|Overall Study|Participant trial terminated by sponsor|0|||
149958642|NCT02318277|540984041|FG002|Overall Study|Participant trial terminated by sponsor|1|||
149958643|NCT02318277|540984042|FG003|Overall Study|Participant trial terminated by sponsor|0|||
149958644|NCT02318277|540984043|FG004|Overall Study|Participant trial terminated by sponsor|1|||
149958645|NCT02318277|540984044|FG005|Overall Study|Participant trial terminated by sponsor|2|||
149958646|NCT02318277|540984045|FG006|Overall Study|Participant trial terminated by sponsor|5|||
149958647|NCT02318277|540984046|FG007|Overall Study|Participant trial terminated by sponsor|16|||
149958648|NCT02318277|540984039|FG000|Overall Study|Lost to Follow-up|1|||
149958649|NCT02318277|540984040|FG001|Overall Study|Lost to Follow-up|0|||
149958650|NCT02318277|540984041|FG002|Overall Study|Lost to Follow-up|1|||
149958651|NCT02318277|540984042|FG003|Overall Study|Lost to Follow-up|0|||
149958652|NCT02318277|540984043|FG004|Overall Study|Lost to Follow-up|0|||
149958653|NCT02318277|540984044|FG005|Overall Study|Lost to Follow-up|0|||
149958654|NCT02318277|540984045|FG006|Overall Study|Lost to Follow-up|3|||
149850457|NCT01350934|540581615|FG001|Extension Study|Lost to Follow-up|0|||
149850458|NCT01350934|540581614|FG000|Extension Study|Protocol Violation|1|||
149850459|NCT01350934|540581615|FG001|Extension Study|Protocol Violation|1|||
149850460|NCT01350934|540581614|FG000|Extension Study|Lack of Efficacy|0|||
149850461|NCT01350934|540581615|FG001|Extension Study|Lack of Efficacy|1|||
149850462|NCT01350934|540581614|FG000|Extension Study|Withdrawal by Subject|0|||
149850463|NCT01350934|540581615|FG001|Extension Study|Withdrawal by Subject|1|||
149850464|NCT03547635|540581616|FG000|Overall Study|Adverse Event|5|||
149850465|NCT03547635|540581617|FG001|Overall Study|Adverse Event|2|||
149850466|NCT03547635|540581618|FG002|Overall Study|Adverse Event|3|||
149850467|NCT03547635|540581616|FG000|Overall Study|Lost to Follow-up|1|||
149850468|NCT03547635|540581617|FG001|Overall Study|Lost to Follow-up|3|||
149850469|NCT03547635|540581618|FG002|Overall Study|Lost to Follow-up|4|||
149958655|NCT02318277|540984046|FG007|Overall Study|Lost to Follow-up|4|||
149958656|NCT02318277|540984039|FG000|Overall Study|Death|5|||
149850470|NCT03547635|540581616|FG000|Overall Study|Withdrawal by Subject|1|||
149850471|NCT03547635|540581617|FG001|Overall Study|Withdrawal by Subject|0|||
149850472|NCT03547635|540581618|FG002|Overall Study|Withdrawal by Subject|0|||
149850473|NCT03547635|540581616|FG000|Overall Study|Withdrawal By PI|0|||
149850474|NCT03547635|540581617|FG001|Overall Study|Withdrawal By PI|1|||
149850475|NCT03547635|540581618|FG002|Overall Study|Withdrawal By PI|0|||
149850476|NCT03547635|540581616|FG000|Overall Study|Withdrawal by Sponsor|0|||
149850477|NCT03547635|540581617|FG001|Overall Study|Withdrawal by Sponsor|0|||
149850478|NCT03547635|540581618|FG002|Overall Study|Withdrawal by Sponsor|1|||
149850479|NCT03547635|540581616|FG000|Overall Study|Errant Randomization before Treatment|0|||
149850480|NCT03547635|540581617|FG001|Overall Study|Errant Randomization before Treatment|1|||
149850481|NCT03547635|540581618|FG002|Overall Study|Errant Randomization before Treatment|0|||
149850482|NCT03547635|540581616|FG000|Overall Study|Withdrawal by Subject|1|||
149850483|NCT03547635|540581617|FG001|Overall Study|Withdrawal by Subject|0|||
149850484|NCT03547635|540581618|FG002|Overall Study|Withdrawal by Subject|0|||
149850485|NCT01011335|540581619|FG000|Overall Study|Lost to Follow-up|0|||
149850486|NCT01011335|540581620|FG001|Overall Study|Lost to Follow-up|0|||
149850487|NCT01011335|540581621|FG002|Overall Study|Lost to Follow-up|1|||
149850488|NCT01011335|540581622|FG003|Overall Study|Lost to Follow-up|1|||
149850489|NCT01011335|540581623|FG004|Overall Study|Lost to Follow-up|1|||
149850490|NCT01011335|540581624|FG005|Overall Study|Lost to Follow-up|1|||
149850491|NCT01011335|540581625|FG006|Overall Study|Lost to Follow-up|2|||
149850492|NCT01011335|540581626|FG007|Overall Study|Lost to Follow-up|2|||
149850493|NCT01011335|540581627|FG008|Overall Study|Lost to Follow-up|1|||
149850494|NCT01011335|540581628|FG009|Overall Study|Lost to Follow-up|0|||
149850495|NCT01011335|540581629|FG010|Overall Study|Lost to Follow-up|0|||
149850496|NCT01011335|540581630|FG011|Overall Study|Lost to Follow-up|1|||
149850497|NCT01011335|540581631|FG012|Overall Study|Lost to Follow-up|2|||
149850498|NCT01011335|540581619|FG000|Overall Study|Protocol Violation|0|||
149850499|NCT01011335|540581620|FG001|Overall Study|Protocol Violation|1|||
149850500|NCT01011335|540581621|FG002|Overall Study|Protocol Violation|0|||
149850501|NCT01011335|540581622|FG003|Overall Study|Protocol Violation|0|||
149850502|NCT01011335|540581623|FG004|Overall Study|Protocol Violation|0|||
149850503|NCT01011335|540581624|FG005|Overall Study|Protocol Violation|0|||
149850504|NCT01011335|540581625|FG006|Overall Study|Protocol Violation|0|||
149850505|NCT01011335|540581626|FG007|Overall Study|Protocol Violation|0|||
149850506|NCT01011335|540581627|FG008|Overall Study|Protocol Violation|0|||
149850507|NCT01011335|540581628|FG009|Overall Study|Protocol Violation|0|||
149850508|NCT01011335|540581629|FG010|Overall Study|Protocol Violation|0|||
149850509|NCT01011335|540581630|FG011|Overall Study|Protocol Violation|0|||
149850510|NCT01011335|540581631|FG012|Overall Study|Protocol Violation|0|||
149850511|NCT01011335|540581619|FG000|Overall Study|Moved/deployed or no booster|1|||
149850512|NCT01011335|540581620|FG001|Overall Study|Moved/deployed or no booster|0|||
149850513|NCT01011335|540581621|FG002|Overall Study|Moved/deployed or no booster|0|||
149850514|NCT01011335|540581622|FG003|Overall Study|Moved/deployed or no booster|1|||
149850515|NCT01011335|540581623|FG004|Overall Study|Moved/deployed or no booster|0|||
149850516|NCT01011335|540581624|FG005|Overall Study|Moved/deployed or no booster|0|||
149850517|NCT01011335|540581625|FG006|Overall Study|Moved/deployed or no booster|1|||
149850518|NCT01011335|540581626|FG007|Overall Study|Moved/deployed or no booster|0|||
149850519|NCT01011335|540581627|FG008|Overall Study|Moved/deployed or no booster|1|||
149850520|NCT01011335|540581628|FG009|Overall Study|Moved/deployed or no booster|0|||
149850521|NCT01011335|540581629|FG010|Overall Study|Moved/deployed or no booster|2|||
149850522|NCT01011335|540581630|FG011|Overall Study|Moved/deployed or no booster|0|||
149850523|NCT01011335|540581631|FG012|Overall Study|Moved/deployed or no booster|0|||
149850524|NCT01011335|540581619|FG000|Overall Study|Adverse Event|0|||
149850525|NCT01011335|540581620|FG001|Overall Study|Adverse Event|0|||
149850526|NCT01011335|540581621|FG002|Overall Study|Adverse Event|0|||
149850527|NCT01011335|540581622|FG003|Overall Study|Adverse Event|0|||
149850528|NCT01011335|540581623|FG004|Overall Study|Adverse Event|0|||
149850529|NCT01011335|540581624|FG005|Overall Study|Adverse Event|0|||
149850530|NCT01011335|540581625|FG006|Overall Study|Adverse Event|0|||
149850531|NCT01011335|540581626|FG007|Overall Study|Adverse Event|0|||
149850532|NCT01011335|540581627|FG008|Overall Study|Adverse Event|0|||
149850533|NCT01011335|540581628|FG009|Overall Study|Adverse Event|0|||
149850534|NCT01011335|540581629|FG010|Overall Study|Adverse Event|4|||
149850535|NCT01011335|540581630|FG011|Overall Study|Adverse Event|0|||
149850536|NCT01011335|540581631|FG012|Overall Study|Adverse Event|1|||
149850537|NCT01765751|540581641|FG000|Overall Study|Lost to Follow-up|0|||
149958657|NCT02318277|540984040|FG001|Overall Study|Death|3|||
149850538|NCT01765751|540581642|FG001|Overall Study|Lost to Follow-up|2|||
149850539|NCT01765751|540581643|FG002|Overall Study|Lost to Follow-up|1|||
149850540|NCT03167606|540581647|FG000|Overall Study|Lost to Follow-up|73|||
149850541|NCT03167606|540581648|FG001|Overall Study|Lost to Follow-up|64|||
149850542|NCT03167606|540581647|FG000|Overall Study|Withdrawal by Subject|6|||
149850543|NCT03167606|540581648|FG001|Overall Study|Withdrawal by Subject|5|||
149850544|NCT03167606|540581647|FG000|Overall Study|Withdrawal by Investigator|0|||
149958658|NCT02318277|540984041|FG002|Overall Study|Death|1|||
149850545|NCT03167606|540581648|FG001|Overall Study|Withdrawal by Investigator|2|||
149850546|NCT00059332|540581649|FG000|Overall Study|Withdrawal by Subject|2|||
149850547|NCT00059332|540581650|FG001|Overall Study|Withdrawal by Subject|1|||
149850548|NCT00059332|540581649|FG000|Overall Study|Lost to Follow-up|1|||
149850549|NCT00059332|540581650|FG001|Overall Study|Lost to Follow-up|1|||
149850550|NCT02483416|540581651|FG000|Overall Study|Other reason|0|||
149850551|NCT02483416|540581652|FG001|Overall Study|Other reason|1|||
149850552|NCT02483416|540581651|FG000|Overall Study|Treatment stop|3|||
149850553|NCT02483416|540581652|FG001|Overall Study|Treatment stop|0|||
149850554|NCT02587143|540581654|FG000|Overall Study|Adverse Event|1|||
149850555|NCT02587143|540581655|FG001|Overall Study|Adverse Event|0|||
149850556|NCT03314857|540581656|FG000|Overall Study|Death|4|||
149850557|NCT03314857|540581656|FG000|Overall Study|Physician Decision|1|||
149850558|NCT00152451|540581661|FG000|Overall Study|Adverse Event|4|||
149850559|NCT00323258|540581662|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
149850560|NCT00323258|540581663|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
149850561|NCT00323258|540581662|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
149850562|NCT00323258|540581663|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
149850563|NCT00323258|540581662|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
149850564|NCT00323258|540581663|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
149850565|NCT00323258|540581662|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
149850566|NCT00323258|540581663|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
149958659|NCT02318277|540984042|FG003|Overall Study|Death|4|||
149958660|NCT02318277|540984043|FG004|Overall Study|Death|6|||
149958661|NCT02318277|540984044|FG005|Overall Study|Death|5|||
149958662|NCT02318277|540984045|FG006|Overall Study|Death|34|||
149958663|NCT02318277|540984046|FG007|Overall Study|Death|58|||
149958664|NCT02318277|540984039|FG000|Overall Study|Transitioned to Hospice|0|||
149958665|NCT02318277|540984040|FG001|Overall Study|Transitioned to Hospice|0|||
149958666|NCT02318277|540984041|FG002|Overall Study|Transitioned to Hospice|0|||
149958667|NCT02318277|540984042|FG003|Overall Study|Transitioned to Hospice|0|||
149958668|NCT02318277|540984043|FG004|Overall Study|Transitioned to Hospice|0|||
149958669|NCT02318277|540984044|FG005|Overall Study|Transitioned to Hospice|1|||
149958670|NCT02318277|540984045|FG006|Overall Study|Transitioned to Hospice|0|||
149958671|NCT02318277|540984046|FG007|Overall Study|Transitioned to Hospice|0|||
149958672|NCT01520714|540984047|FG000|Overall Study|Protocol Violation|0|||
149958673|NCT01520714|540984048|FG001|Overall Study|Protocol Violation|3|||
149958674|NCT01520714|540984047|FG000|Overall Study|Adverse Event|0|||
149958675|NCT01520714|540984048|FG001|Overall Study|Adverse Event|2|||
149958676|NCT01520714|540984047|FG000|Overall Study|Lack of Efficacy|0|||
149958677|NCT01520714|540984048|FG001|Overall Study|Lack of Efficacy|1|||
149958678|NCT01078545|540984056|FG000|Overall Study|Lost to Follow-up|13|||
149958679|NCT01078545|540984056|FG000|Overall Study|Physician Decision|6|||
149958680|NCT01078545|540984056|FG000|Overall Study|Withdrawal by Subject|3|||
149958681|NCT01078545|540984056|FG000|Overall Study|Death|3|||
149958682|NCT01078545|540984056|FG000|Overall Study|Participant moved to another physician|1|||
149958683|NCT01489358|540984062|FG000|Overall Study|Lost to Follow-up|0|||
149958684|NCT01489358|540984063|FG001|Overall Study|Lost to Follow-up|0|||
149958685|NCT01489358|540984064|FG002|Overall Study|Lost to Follow-up|2|||
149958686|NCT03722030|540984065|FG000|Overall Study|Withdrawal by Subject|1|||
149958687|NCT03722030|540984066|FG001|Overall Study|Withdrawal by Subject|0|||
149958688|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Adverse Event|14|||
149958689|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Adverse Event|27|||
149958690|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Adverse Event|60|||
149958691|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Adverse Event|0|||
149958692|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Adverse Event|0|||
149958693|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Pregnancy|0|||
149958694|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Pregnancy|7|||
149958695|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Pregnancy|9|||
149958696|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Pregnancy|0|||
149958697|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Pregnancy|0|||
149958698|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
149958699|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
149958700|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
149958701|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
149958702|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
149958703|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
149958704|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
149958705|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
149850567|NCT00323258|540581662|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
149958706|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
149850568|NCT00323258|540581663|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
149850569|NCT00323258|540581662|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
149850570|NCT00323258|540581663|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
149850571|NCT00323258|540581662|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
149850572|NCT00323258|540581663|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
149850573|NCT00743145|540581666|FG000|Overall Study|Withdrawal by Subject|1|||
149850574|NCT00743145|540581666|FG000|Overall Study|Adverse Event|2|||
149850575|NCT00743145|540581666|FG000|Overall Study|Pregnancy|1|||
149850576|NCT00697827|540581667|FG000|Overall Study|enrolled but not treated|2|||
149850577|NCT00697827|540581668|FG001|Overall Study|enrolled but not treated|1|||
149850578|NCT02004691|540581673|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
149850579|NCT02004691|540581674|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
149850580|NCT02004691|540581673|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
149850581|NCT02004691|540581674|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
149850582|NCT02004691|540581673|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
149850583|NCT02004691|540581674|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
149850584|NCT02004691|540581673|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
149850585|NCT02004691|540581674|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
149850586|NCT02004691|540581673|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
149850587|NCT02004691|540581674|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
149850588|NCT02004691|540581673|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
149850589|NCT02004691|540581674|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
149850590|NCT00884390|540581675|FG000|Overall Study|Adverse Event|0|||
149850591|NCT00884390|540581676|FG001|Overall Study|Adverse Event|1|||
149850592|NCT00884390|540581675|FG000|Overall Study|Lost to Follow-up|0|||
149850593|NCT00884390|540581676|FG001|Overall Study|Lost to Follow-up|1|||
149850594|NCT00884390|540581675|FG000|Overall Study|Physician Decision|2|||
149850595|NCT00884390|540581676|FG001|Overall Study|Physician Decision|1|||
149850596|NCT00884390|540581675|FG000|Overall Study|Protocol Violation|4|||
149850597|NCT00884390|540581676|FG001|Overall Study|Protocol Violation|1|||
149850598|NCT00884390|540581675|FG000|Overall Study|Withdrawal by Subject|4|||
149850599|NCT00884390|540581676|FG001|Overall Study|Withdrawal by Subject|1|||
149850600|NCT00884390|540581675|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
149850601|NCT00884390|540581676|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
149850602|NCT00884390|540581675|FG000|Overall Study|Other|11|||
149850603|NCT00884390|540581676|FG001|Overall Study|Other|1|||
149850604|NCT01691612|540581679|FG000|Overall Study|deemed ineligible after 1st visit|6|||
149850605|NCT01691612|540581679|FG000|Overall Study|Adverse Event|1|||
149850606|NCT02623218|540581681|FG000|Overall Study|Lost to Follow-up|0|||
149850607|NCT02623218|540581682|FG001|Overall Study|Lost to Follow-up|1|||
149850608|NCT02623218|540581683|FG002|Overall Study|Lost to Follow-up|0|||
149850609|NCT02623218|540581684|FG003|Overall Study|Lost to Follow-up|0|||
149850610|NCT02623218|540581685|FG004|Overall Study|Lost to Follow-up|0|||
149850611|NCT01726803|540581686|FG000|Overall Study|Lost to Follow-up|6|||
149958707|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
149958708|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Death|1|||
149958709|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Death|2|||
149958710|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Death|2|||
149958711|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Death|0|||
149958712|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Death|0|||
149958713|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
149958714|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
149958715|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
149958716|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
149958717|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
149958718|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
149958719|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
149958720|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
149958721|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
149958722|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
149958723|NCT00098293|540984067|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
149958724|NCT00098293|540984068|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
149958725|NCT00098293|540984069|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
149958726|NCT00098293|540984070|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
149958727|NCT00098293|540984071|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
149958728|NCT00098293|540984067|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
149958729|NCT00098293|540984068|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
149850612|NCT01726803|540581687|FG001|Overall Study|Lost to Follow-up|1|||
149850613|NCT01726803|540581686|FG000|Overall Study|Withdrawal by Subject|1|||
149850614|NCT01726803|540581687|FG001|Overall Study|Withdrawal by Subject|0|||
149850615|NCT01211262|540581690|FG000|Overall Study|Progressive Disease|18|||
149850616|NCT01211262|540581691|FG001|Overall Study|Progressive Disease|9|||
149850617|NCT01211262|540581690|FG000|Overall Study|Adverse Event|4|||
149850618|NCT01211262|540581691|FG001|Overall Study|Adverse Event|0|||
149850619|NCT01211262|540581690|FG000|Overall Study|Withdrawal of Consent|1|||
149850620|NCT01211262|540581691|FG001|Overall Study|Withdrawal of Consent|0|||
149850621|NCT01211262|540581690|FG000|Overall Study|Other|0|||
149850622|NCT01211262|540581691|FG001|Overall Study|Other|1|||
149850623|NCT04049097|540581694|FG000|Overall Study|Adverse Event|18|||
149850624|NCT04049097|540581694|FG000|Overall Study|Death|2|||
149850625|NCT04049097|540581694|FG000|Overall Study|Lost to Follow-up|1|||
149850626|NCT04049097|540581694|FG000|Overall Study|Physician Decision|2|||
149850627|NCT04049097|540581694|FG000|Overall Study|Withdrawal by Subject|9|||
149850628|NCT04049097|540581694|FG000|Overall Study|Protocol Violation|2|||
149850629|NCT04049097|540581694|FG000|Overall Study|Other|1|||
149850630|NCT04049097|540581694|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
149850631|NCT02005276|540581695|FG000|Overall Study|No longer interested|5|||
149850632|NCT02005276|540581696|FG001|Overall Study|No longer interested|2|||
149850633|NCT02005276|540581697|FG002|Overall Study|No longer interested|3|||
149850634|NCT02005276|540581698|FG003|Overall Study|No longer interested|3|||
149850635|NCT01970592|540581699|FG000|Overall Study|Withdrawal by Subject|4|||
149850636|NCT01970592|540581699|FG000|Overall Study|Physician Decision|1|||
149850637|NCT01970592|540581699|FG000|Overall Study|Adverse Event|1|||
149850638|NCT01320722|540581702|FG000|Overall Study|Did not Receive Intervention|3|||
149850639|NCT01320722|540581703|FG001|Overall Study|Did not Receive Intervention|2|||
149850640|NCT01320722|540581704|FG002|Overall Study|Did not Receive Intervention|1|||
149850641|NCT01320722|540581705|FG003|Overall Study|Did not Receive Intervention|1|||
149850642|NCT01320722|540581706|FG004|Overall Study|Did not Receive Intervention|2|||
149850643|NCT01320722|540581702|FG000|Overall Study|Lost to Follow-up|0|||
149850644|NCT01320722|540581703|FG001|Overall Study|Lost to Follow-up|1|||
149850645|NCT01320722|540581704|FG002|Overall Study|Lost to Follow-up|0|||
149850646|NCT01320722|540581705|FG003|Overall Study|Lost to Follow-up|1|||
149850647|NCT01320722|540581706|FG004|Overall Study|Lost to Follow-up|3|||
149850648|NCT01320722|540581702|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
149850649|NCT01320722|540581703|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
149850650|NCT01320722|540581704|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
149850651|NCT01320722|540581705|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
149850652|NCT01320722|540581706|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
149850653|NCT01320722|540581702|FG000|Overall Study|Participant Developed a Rash|0|||
149850654|NCT01320722|540581703|FG001|Overall Study|Participant Developed a Rash|0|||
149850655|NCT01320722|540581704|FG002|Overall Study|Participant Developed a Rash|2|||
149958730|NCT00098293|540984069|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
149958731|NCT00098293|540984070|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
149958732|NCT00098293|540984071|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
149958733|NCT00098293|540984067|FG000|Open-label (OL) Phase|Adverse Event|0|||
149958734|NCT00098293|540984068|FG001|Open-label (OL) Phase|Adverse Event|3|||
149958735|NCT00098293|540984069|FG002|Open-label (OL) Phase|Adverse Event|7|||
149958736|NCT00098293|540984070|FG003|Open-label (OL) Phase|Adverse Event|6|||
149958737|NCT00098293|540984071|FG004|Open-label (OL) Phase|Adverse Event|0|||
149958738|NCT00098293|540984067|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
149958739|NCT00098293|540984068|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
149958740|NCT00098293|540984069|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
149958741|NCT00098293|540984070|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
149958742|NCT00098293|540984071|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
149958743|NCT00098293|540984067|FG000|Open-label (OL) Phase|Pregnancy|0|||
149958744|NCT00098293|540984068|FG001|Open-label (OL) Phase|Pregnancy|1|||
149958745|NCT00098293|540984069|FG002|Open-label (OL) Phase|Pregnancy|0|||
149958746|NCT00098293|540984070|FG003|Open-label (OL) Phase|Pregnancy|3|||
149958747|NCT00098293|540984071|FG004|Open-label (OL) Phase|Pregnancy|0|||
149958748|NCT00098293|540984067|FG000|Open-label (OL) Phase|Protocol Violation|0|||
149958749|NCT00098293|540984068|FG001|Open-label (OL) Phase|Protocol Violation|6|||
149958750|NCT00098293|540984069|FG002|Open-label (OL) Phase|Protocol Violation|13|||
149958751|NCT00098293|540984070|FG003|Open-label (OL) Phase|Protocol Violation|16|||
149958752|NCT00098293|540984071|FG004|Open-label (OL) Phase|Protocol Violation|0|||
149958753|NCT00098293|540984067|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
149958754|NCT00098293|540984068|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
149958755|NCT00098293|540984069|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
149958756|NCT00098293|540984070|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
150172792|NCT00961636|541768095|FG002|Overall Study|Lost to Follow-up|1|||
149850656|NCT01320722|540581705|FG003|Overall Study|Participant Developed a Rash|1|||
149958757|NCT00098293|540984071|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
149850657|NCT01320722|540581706|FG004|Overall Study|Participant Developed a Rash|1|||
149850658|NCT01320722|540581702|FG000|Overall Study|Non-compliant with Medication|0|||
149850659|NCT01320722|540581703|FG001|Overall Study|Non-compliant with Medication|0|||
149850660|NCT01320722|540581704|FG002|Overall Study|Non-compliant with Medication|1|||
149850661|NCT01320722|540581705|FG003|Overall Study|Non-compliant with Medication|0|||
149850662|NCT01320722|540581706|FG004|Overall Study|Non-compliant with Medication|0|||
149850663|NCT01320722|540581702|FG000|Overall Study|Adverse Event|0|||
149850664|NCT01320722|540581703|FG001|Overall Study|Adverse Event|0|||
149850665|NCT01320722|540581704|FG002|Overall Study|Adverse Event|3|||
149850666|NCT01320722|540581705|FG003|Overall Study|Adverse Event|6|||
149850667|NCT01320722|540581706|FG004|Overall Study|Adverse Event|0|||
149850668|NCT01320722|540581702|FG000|Overall Study|Not Compliant with Study Procedures|0|||
149850669|NCT01320722|540581703|FG001|Overall Study|Not Compliant with Study Procedures|0|||
149850670|NCT01320722|540581704|FG002|Overall Study|Not Compliant with Study Procedures|0|||
149850671|NCT01320722|540581705|FG003|Overall Study|Not Compliant with Study Procedures|4|||
149850672|NCT01320722|540581706|FG004|Overall Study|Not Compliant with Study Procedures|0|||
149850673|NCT01320722|540581702|FG000|Overall Study|Pregnancy|0|||
149850674|NCT01320722|540581703|FG001|Overall Study|Pregnancy|0|||
149850675|NCT01320722|540581704|FG002|Overall Study|Pregnancy|0|||
149850676|NCT01320722|540581705|FG003|Overall Study|Pregnancy|1|||
149850677|NCT01320722|540581706|FG004|Overall Study|Pregnancy|0|||
149850678|NCT01320722|540581702|FG000|Overall Study|Started an Exclusionary Medication|0|||
149850679|NCT01320722|540581703|FG001|Overall Study|Started an Exclusionary Medication|0|||
149850680|NCT01320722|540581704|FG002|Overall Study|Started an Exclusionary Medication|0|||
149850681|NCT01320722|540581705|FG003|Overall Study|Started an Exclusionary Medication|0|||
149850682|NCT01320722|540581706|FG004|Overall Study|Started an Exclusionary Medication|1|||
149850683|NCT01320722|540581702|FG000|Overall Study|Withdrew due to Health Condition|0|||
149850684|NCT01320722|540581703|FG001|Overall Study|Withdrew due to Health Condition|0|||
149850685|NCT01320722|540581704|FG002|Overall Study|Withdrew due to Health Condition|0|||
149850686|NCT01320722|540581705|FG003|Overall Study|Withdrew due to Health Condition|0|||
149850687|NCT01320722|540581706|FG004|Overall Study|Withdrew due to Health Condition|1|||
149850688|NCT03980522|540581707|FG000|Treatment Period|Adverse Event|1|||
149850689|NCT03980522|540581708|FG001|Treatment Period|Adverse Event|0|||
149850690|NCT03980522|540581709|FG002|Treatment Period|Adverse Event|0|||
149850691|NCT03980522|540581710|FG003|Treatment Period|Adverse Event|0|||
149850692|NCT03980522|540581711|FG004|Treatment Period|Adverse Event|0|||
149850693|NCT01091363|540581712|FG000|Overall Study|Withdrawal by Subject|11|||
149850694|NCT01091363|540581713|FG001|Overall Study|Withdrawal by Subject|15|||
149850695|NCT01091363|540581712|FG000|Overall Study|Lost to Follow-up|2|||
149850696|NCT01091363|540581713|FG001|Overall Study|Lost to Follow-up|2|||
149850697|NCT00045162|540581715|FG000|Overall Study|Ineligible|12|||
149850698|NCT00045162|540581716|FG001|Overall Study|Ineligible|8|||
149850699|NCT00045162|540581715|FG000|Overall Study|Not treated|7|||
149850700|NCT00045162|540581716|FG001|Overall Study|Not treated|2|||
149850701|NCT00045162|540581715|FG000|Overall Study|Adverse Event|55|||
149850702|NCT00045162|540581716|FG001|Overall Study|Adverse Event|50|||
149850703|NCT00045162|540581715|FG000|Overall Study|Lack of Efficacy|32|||
149850704|NCT00045162|540581716|FG001|Overall Study|Lack of Efficacy|29|||
149850705|NCT00045162|540581715|FG000|Overall Study|Death|10|||
149850706|NCT00045162|540581716|FG001|Overall Study|Death|10|||
149850707|NCT00045162|540581715|FG000|Overall Study|Withdrawal by Subject|5|||
149850708|NCT00045162|540581716|FG001|Overall Study|Withdrawal by Subject|3|||
149850709|NCT00045162|540581715|FG000|Overall Study|Other|21|||
149850710|NCT00045162|540581716|FG001|Overall Study|Other|16|||
149850711|NCT01044433|540581719|FG000|Overall Study|Lost to Follow-up|3|||
149850712|NCT01044433|540581719|FG000|Overall Study|Withdrawal by Subject|3|||
149850713|NCT01341405|540581721|FG000|Overall Study|Adverse Event|0|||
149850714|NCT01341405|540581722|FG001|Overall Study|Adverse Event|1|||
149850715|NCT01341405|540581723|FG002|Overall Study|Adverse Event|1|||
149850716|NCT01341405|540581721|FG000|Overall Study|Withdrawal by Subject|3|||
149958758|NCT00098293|540984067|FG000|Open-label (OL) Phase|Death|0|||
149958759|NCT00098293|540984068|FG001|Open-label (OL) Phase|Death|2|||
149958760|NCT00098293|540984069|FG002|Open-label (OL) Phase|Death|3|||
149958761|NCT00098293|540984070|FG003|Open-label (OL) Phase|Death|0|||
149958762|NCT00098293|540984071|FG004|Open-label (OL) Phase|Death|0|||
149958763|NCT00098293|540984067|FG000|Supplemental Phase (SP)|Death|0|||
149958764|NCT00098293|540984068|FG001|Supplemental Phase (SP)|Death|0|||
149958765|NCT00098293|540984069|FG002|Supplemental Phase (SP)|Death|0|||
149958766|NCT00098293|540984070|FG003|Supplemental Phase (SP)|Death|0|||
149958767|NCT00098293|540984071|FG004|Supplemental Phase (SP)|Death|1|||
149958768|NCT00098293|540984067|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
149958769|NCT00098293|540984068|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
149958770|NCT00098293|540984069|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
149958771|NCT00098293|540984070|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
149958772|NCT00098293|540984071|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
149850717|NCT01341405|540581722|FG001|Overall Study|Withdrawal by Subject|2|||
149850718|NCT01341405|540581723|FG002|Overall Study|Withdrawal by Subject|1|||
149850719|NCT03407729|540581724|FG000|Overall Study|Lost to Follow-up|2|||
149850720|NCT03407729|540581725|FG001|Overall Study|Lost to Follow-up|0|||
149850721|NCT03407729|540581724|FG000|Overall Study|Unable to schedule|0|||
149850722|NCT03407729|540581725|FG001|Overall Study|Unable to schedule|3|||
149850723|NCT01849458|540581726|FG000|Overall Study|Lost to Follow-up|4|||
149850724|NCT00024258|540581731|FG000|Overall Study|Withdrawal by Subject|1|||
149850725|NCT00024258|540581731|FG000|Overall Study|Disease Progression|8|||
149850726|NCT03950674|540581732|FG000|Overall Study|Death|16|||
149850727|NCT03950674|540581733|FG001|Overall Study|Death|15|||
149850728|NCT03950674|540581732|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
149850729|NCT03950674|540581733|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
149850730|NCT01898598|540581734|FG000|Overall Study|Adverse Event|1|||
149850731|NCT01898598|540581735|FG001|Overall Study|Adverse Event|0|||
149850732|NCT01898598|540581734|FG000|Overall Study|Withdrawal by Subject|3|||
149850733|NCT01898598|540581735|FG001|Overall Study|Withdrawal by Subject|0|||
149850734|NCT01898598|540581734|FG000|Overall Study|Lost to Follow-up|0|||
149850735|NCT01898598|540581735|FG001|Overall Study|Lost to Follow-up|1|||
149850736|NCT01898598|540581734|FG000|Overall Study|Other|0|||
149850737|NCT01898598|540581735|FG001|Overall Study|Other|1|||
149850738|NCT03833427|540581736|FG000|Overall Study|Death|4|||
149850739|NCT03833427|540581737|FG001|Overall Study|Death|2|||
149850740|NCT03833427|540581738|FG002|Overall Study|Death|9|||
149850741|NCT03833427|540581739|FG003|Overall Study|Death|11|||
149850742|NCT03833427|540581740|FG004|Overall Study|Death|0|||
149850743|NCT03833427|540581741|FG005|Overall Study|Death|0|||
149850744|NCT03833427|540581742|FG006|Overall Study|Death|0|||
149850745|NCT03833427|540581736|FG000|Overall Study|Withdrawal by Subject|0|||
149850746|NCT03833427|540581737|FG001|Overall Study|Withdrawal by Subject|1|||
149850747|NCT03833427|540581738|FG002|Overall Study|Withdrawal by Subject|1|||
149850748|NCT03833427|540581739|FG003|Overall Study|Withdrawal by Subject|0|||
149850749|NCT03833427|540581740|FG004|Overall Study|Withdrawal by Subject|0|||
149850750|NCT03833427|540581741|FG005|Overall Study|Withdrawal by Subject|0|||
149850751|NCT03833427|540581742|FG006|Overall Study|Withdrawal by Subject|0|||
149850752|NCT03833427|540581736|FG000|Overall Study|Sponsor Decision|0|||
149850753|NCT03833427|540581737|FG001|Overall Study|Sponsor Decision|0|||
149850754|NCT03833427|540581738|FG002|Overall Study|Sponsor Decision|1|||
149850755|NCT03833427|540581739|FG003|Overall Study|Sponsor Decision|3|||
149850756|NCT03833427|540581740|FG004|Overall Study|Sponsor Decision|0|||
149850757|NCT03833427|540581741|FG005|Overall Study|Sponsor Decision|0|||
149850758|NCT03833427|540581742|FG006|Overall Study|Sponsor Decision|0|||
149850759|NCT03428945|540581750|FG000|Overall Study|Lost to Follow-up|5|||
149850760|NCT03428945|540581751|FG001|Overall Study|Lost to Follow-up|3|||
149850761|NCT03428945|540581750|FG000|Overall Study|Withdrawal by Subject|10|||
149850762|NCT03428945|540581751|FG001|Overall Study|Withdrawal by Subject|10|||
149850763|NCT00982228|540581752|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
149850764|NCT00982228|540581753|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
149850765|NCT00982228|540581752|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
149850766|NCT00982228|540581753|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
149850767|NCT00982228|540581752|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
149850768|NCT00982228|540581753|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
149850769|NCT00982228|540581752|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
149850770|NCT00982228|540581753|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
149850771|NCT00982228|540581752|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
149850772|NCT00982228|540581753|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
149850773|NCT00982228|540581752|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
149850774|NCT00982228|540581753|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
149850775|NCT00982228|540581752|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
149850776|NCT00982228|540581753|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
149850777|NCT00982228|540581752|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
149850778|NCT00982228|540581753|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
149850779|NCT00982228|540581752|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
149850780|NCT00982228|540581753|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
149850781|NCT00982228|540581752|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
149850782|NCT00982228|540581753|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
149850783|NCT00360490|540581757|FG000|Overall Study|Adverse Event|4|||
149850784|NCT00360490|540581758|FG001|Overall Study|Adverse Event|2|||
149850785|NCT00360490|540581757|FG000|Overall Study|Lost to Follow-up|2|||
149850786|NCT00360490|540581758|FG001|Overall Study|Lost to Follow-up|1|||
149850787|NCT00360490|540581757|FG000|Overall Study|Physician Decision|2|||
149850788|NCT00360490|540581758|FG001|Overall Study|Physician Decision|1|||
149958773|NCT00098293|540984067|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
149958774|NCT00098293|540984068|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
149958775|NCT00098293|540984069|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
149850789|NCT00360490|540581757|FG000|Overall Study|Protocol Violation|0|||
149850790|NCT00360490|540581758|FG001|Overall Study|Protocol Violation|4|||
149850791|NCT00360490|540581757|FG000|Overall Study|Withdrawal by Subject|1|||
149850792|NCT00360490|540581758|FG001|Overall Study|Withdrawal by Subject|3|||
149850793|NCT05135273|540583145|FG000|Overall Study|Recruited into the army|0|||
149850794|NCT05135273|540583146|FG001|Overall Study|Recruited into the army|0|||
149850795|NCT05135273|540583147|FG002|Overall Study|Recruited into the army|0|||
149850796|NCT05135273|540583148|FG003|Overall Study|Recruited into the army|0|||
149850797|NCT05135273|540583149|FG004|Overall Study|Recruited into the army|1|||
149850798|NCT05135273|540583150|FG005|Overall Study|Recruited into the army|0|||
149850799|NCT05135273|540583151|FG006|Overall Study|Recruited into the army|0|||
149850800|NCT05135273|540583152|FG007|Overall Study|Recruited into the army|0|||
149850801|NCT05135273|540583145|FG000|Overall Study|Moved away from study site|0|||
149850802|NCT05135273|540583146|FG001|Overall Study|Moved away from study site|0|||
149850803|NCT05135273|540583147|FG002|Overall Study|Moved away from study site|0|||
149850804|NCT05135273|540583148|FG003|Overall Study|Moved away from study site|0|||
149850805|NCT05135273|540583149|FG004|Overall Study|Moved away from study site|0|||
149850806|NCT05135273|540583150|FG005|Overall Study|Moved away from study site|1|||
149850807|NCT05135273|540583151|FG006|Overall Study|Moved away from study site|1|||
149850808|NCT05135273|540583152|FG007|Overall Study|Moved away from study site|0|||
149850809|NCT05135273|540583145|FG000|Overall Study|Travel|0|||
149850810|NCT05135273|540583146|FG001|Overall Study|Travel|0|||
149850811|NCT05135273|540583147|FG002|Overall Study|Travel|0|||
149850812|NCT05135273|540583148|FG003|Overall Study|Travel|0|||
149850813|NCT05135273|540583149|FG004|Overall Study|Travel|0|||
149850814|NCT05135273|540583150|FG005|Overall Study|Travel|0|||
149850815|NCT05135273|540583151|FG006|Overall Study|Travel|0|||
149850816|NCT05135273|540583152|FG007|Overall Study|Travel|1|||
149850817|NCT01958060|540583158|FG000|Overall Study|Not treated|2|||
149850818|NCT01958060|540583159|FG001|Overall Study|Not treated|0|||
149850819|NCT01958060|540583160|FG002|Overall Study|Not treated|0|||
149850820|NCT01958060|540583161|FG003|Overall Study|Not treated|0|||
149850821|NCT01958060|540583162|FG004|Overall Study|Not treated|1|||
149850822|NCT01958060|540583163|FG005|Overall Study|Not treated|0|||
149850823|NCT01705717|540583164|FG000|Overall Study|Adverse Event|2|||
149850824|NCT01705717|540583165|FG001|Overall Study|Adverse Event|2|||
149850825|NCT01705717|540583164|FG000|Overall Study|Lack of Efficacy|0|||
149850826|NCT01705717|540583165|FG001|Overall Study|Lack of Efficacy|1|||
149850827|NCT01705717|540583164|FG000|Overall Study|Other|0|||
149850828|NCT01705717|540583165|FG001|Overall Study|Other|2|||
149850829|NCT01188226|540583166|FG000|Overall Study|Withdrawal by Subject|4|||
149850830|NCT04980456|540583167|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
149850831|NCT04980456|540583168|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
149850832|NCT04980456|540583167|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
149850833|NCT04980456|540583168|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
149850834|NCT04980456|540583167|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
149850835|NCT04980456|540583168|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
150038994|NCT03077412|541285049|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
150038995|NCT03077412|541285050|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
150038996|NCT03077412|541285051|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
150038997|NCT03077412|541285049|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
150038998|NCT03077412|541285050|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
150038999|NCT03077412|541285051|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
150039000|NCT03077412|541285049|FG000|Overall Study|Adverse Event|1|||
150039001|NCT03077412|541285050|FG001|Overall Study|Adverse Event|2|||
150039002|NCT03077412|541285051|FG002|Overall Study|Adverse Event|2|||
150039003|NCT03077412|541285049|FG000|Overall Study|Investigator's Discretion|0|||
149850836|NCT04980456|540583167|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
149850837|NCT04980456|540583168|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
150039004|NCT03077412|541285050|FG001|Overall Study|Investigator's Discretion|1|||
150039005|NCT03077412|541285051|FG002|Overall Study|Investigator's Discretion|1|||
150039006|NCT03077412|541285049|FG000|Overall Study|Withdrew Consent|0|||
150039007|NCT03077412|541285050|FG001|Overall Study|Withdrew Consent|2|||
150039008|NCT03077412|541285051|FG002|Overall Study|Withdrew Consent|0|||
150039009|NCT02266888|541285053|FG000|Overall Study|Death|2|||
150288876|NCT01662440|542192523|FG001|Overall Study|Subject moved to another country.|1|||
149850838|NCT02293460|540583169|FG000|Overall Study|Protocol Violation|1|||
149850839|NCT02293460|540583169|FG000|Overall Study|Lack of Efficacy|2|||
149850840|NCT02293460|540583169|FG000|Overall Study|Adverse Event|2|||
149850841|NCT02293460|540583169|FG000|Overall Study|Withdrawal by Subject|1|||
149850842|NCT00500318|540583174|FG000|Overall Study|Adverse Event|3|||
149850843|NCT00500318|540583175|FG001|Overall Study|Adverse Event|8|||
149850844|NCT00500318|540583174|FG000|Overall Study|Protocol Violation|1|||
149850845|NCT00500318|540583175|FG001|Overall Study|Protocol Violation|3|||
149850846|NCT00500318|540583174|FG000|Overall Study|Withdrawal by Subject|1|||
149850847|NCT00500318|540583175|FG001|Overall Study|Withdrawal by Subject|2|||
149850848|NCT00500318|540583174|FG000|Overall Study|Lack of Efficacy|0|||
149850849|NCT00500318|540583175|FG001|Overall Study|Lack of Efficacy|3|||
149850850|NCT00500318|540583174|FG000|Overall Study|Other Reason|0|||
149850851|NCT00500318|540583175|FG001|Overall Study|Other Reason|1|||
149850852|NCT00224484|540583192|FG000|Overall Study|Serious Adverse Event|1|||
149850853|NCT00224484|540583193|FG001|Overall Study|Serious Adverse Event|1|||
149850854|NCT00224484|540583194|FG002|Overall Study|Serious Adverse Event|0|||
149850855|NCT00224484|540583192|FG000|Overall Study|Non-Serious Adverse Event|5|||
149850856|NCT00224484|540583193|FG001|Overall Study|Non-Serious Adverse Event|7|||
149850857|NCT00224484|540583194|FG002|Overall Study|Non-Serious Adverse Event|3|||
149850858|NCT00224484|540583192|FG000|Overall Study|Protocol Violation|2|||
149850859|NCT00224484|540583193|FG001|Overall Study|Protocol Violation|2|||
149850860|NCT00224484|540583194|FG002|Overall Study|Protocol Violation|0|||
149850861|NCT00224484|540583192|FG000|Overall Study|Withdrawal by Subject|49|||
149850862|NCT00224484|540583193|FG001|Overall Study|Withdrawal by Subject|18|||
149850863|NCT00224484|540583194|FG002|Overall Study|Withdrawal by Subject|16|||
149850864|NCT00224484|540583192|FG000|Overall Study|Migrated/moved from study area|18|||
149850865|NCT00224484|540583193|FG001|Overall Study|Migrated/moved from study area|5|||
149850866|NCT00224484|540583194|FG002|Overall Study|Migrated/moved from study area|5|||
149850867|NCT00224484|540583192|FG000|Overall Study|Lost to Follow-up|66|||
149850868|NCT00224484|540583193|FG001|Overall Study|Lost to Follow-up|28|||
149850869|NCT00224484|540583194|FG002|Overall Study|Lost to Follow-up|36|||
150039010|NCT02266888|541285054|FG001|Overall Study|Death|2|||
150039011|NCT02266888|541285055|FG002|Overall Study|Death|4|||
150039012|NCT02266888|541285056|FG003|Overall Study|Death|2|||
150039013|NCT02266888|541285053|FG000|Overall Study|Physician Decision|0|||
150039014|NCT02266888|541285054|FG001|Overall Study|Physician Decision|1|||
150039015|NCT02266888|541285055|FG002|Overall Study|Physician Decision|2|||
150039016|NCT02266888|541285056|FG003|Overall Study|Physician Decision|2|||
150039017|NCT02266888|541285053|FG000|Overall Study|Study Terminated|5|||
150039018|NCT02266888|541285054|FG001|Overall Study|Study Terminated|1|||
150039019|NCT02266888|541285055|FG002|Overall Study|Study Terminated|0|||
150039020|NCT02266888|541285056|FG003|Overall Study|Study Terminated|0|||
150039021|NCT02266888|541285053|FG000|Overall Study|No Longer Eligible|0|||
150039022|NCT02266888|541285054|FG001|Overall Study|No Longer Eligible|0|||
150039023|NCT02266888|541285055|FG002|Overall Study|No Longer Eligible|0|||
150039024|NCT02266888|541285056|FG003|Overall Study|No Longer Eligible|2|||
150039025|NCT02266888|541285053|FG000|Overall Study|Randomization Closed|0|||
150039026|NCT02266888|541285054|FG001|Overall Study|Randomization Closed|0|||
150039027|NCT02266888|541285055|FG002|Overall Study|Randomization Closed|4|||
150039028|NCT02266888|541285056|FG003|Overall Study|Randomization Closed|0|||
150039029|NCT02266888|541285053|FG000|Overall Study|Personnel unavailable at transplant|0|||
150039030|NCT02266888|541285054|FG001|Overall Study|Personnel unavailable at transplant|0|||
150039031|NCT02266888|541285055|FG002|Overall Study|Personnel unavailable at transplant|0|||
150039032|NCT02266888|541285056|FG003|Overall Study|Personnel unavailable at transplant|1|||
150039033|NCT02266888|541285053|FG000|Overall Study|Transfer of care|0|||
150039034|NCT02266888|541285054|FG001|Overall Study|Transfer of care|0|||
150039035|NCT02266888|541285055|FG002|Overall Study|Transfer of care|1|||
150039036|NCT02266888|541285056|FG003|Overall Study|Transfer of care|0|||
150039037|NCT02351856|541285057|FG000|Overall Study|Adverse Event|2|||
150039038|NCT02351856|541285057|FG000|Overall Study|Physician Decision|5|||
150039039|NCT02351856|541285057|FG000|Overall Study|Study terminated by sponsor|1|||
150039040|NCT01458392|541285060|FG000|Overall Study|Death|2|||
150039041|NCT01458392|541285061|FG001|Overall Study|Death|11|||
150039042|NCT01458392|541285062|FG002|Overall Study|Death|22|||
150039043|NCT01458392|541285060|FG000|Overall Study|At the discretion of the sponsor|0|||
150039044|NCT01458392|541285061|FG001|Overall Study|At the discretion of the sponsor|2|||
150039045|NCT01458392|541285062|FG002|Overall Study|At the discretion of the sponsor|7|||
150039046|NCT01458392|541285060|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
150039047|NCT01458392|541285061|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
150039048|NCT01458392|541285062|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
150039049|NCT01281124|541285065|FG000|Overall Study|Death|1|||
150039050|NCT00918255|541285066|FG000|Overall Study|Adverse Event|1|||
150039051|NCT00918255|541285067|FG001|Overall Study|Adverse Event|0|||
150039052|NCT00918255|541285068|FG002|Overall Study|Adverse Event|0|||
150039053|NCT00918255|541285066|FG000|Overall Study|Withdrawal by Subject|1|||
150039054|NCT00918255|541285067|FG001|Overall Study|Withdrawal by Subject|0|||
150039055|NCT00918255|541285068|FG002|Overall Study|Withdrawal by Subject|2|||
150039056|NCT00918255|541285066|FG000|Overall Study|Lack of Efficacy|1|||
150039057|NCT00918255|541285067|FG001|Overall Study|Lack of Efficacy|0|||
150039058|NCT00918255|541285068|FG002|Overall Study|Lack of Efficacy|0|||
150039059|NCT00918255|541285066|FG000|Overall Study|Lost to Follow-up|1|||
150039060|NCT00918255|541285067|FG001|Overall Study|Lost to Follow-up|0|||
150039061|NCT00918255|541285068|FG002|Overall Study|Lost to Follow-up|2|||
150039062|NCT00918255|541285066|FG000|Overall Study|Exceeded allowed number of interventions|0|||
150039063|NCT00918255|541285067|FG001|Overall Study|Exceeded allowed number of interventions|0|||
150039064|NCT00918255|541285068|FG002|Overall Study|Exceeded allowed number of interventions|1|||
150039065|NCT00918255|541285066|FG000|Overall Study|Non-compliance|1|||
150039066|NCT00918255|541285067|FG001|Overall Study|Non-compliance|0|||
150039067|NCT00918255|541285068|FG002|Overall Study|Non-compliance|0|||
150039068|NCT00918255|541285066|FG000|Overall Study|Investigator discretion|1|||
150039069|NCT00918255|541285067|FG001|Overall Study|Investigator discretion|0|||
150039070|NCT00918255|541285068|FG002|Overall Study|Investigator discretion|0|||
150039071|NCT02038933|541285069|FG000|Overall Study|Disease progression|104|||
150039072|NCT02038933|541285069|FG000|Overall Study|Study drug toxicity|6|||
149850870|NCT00224484|540583192|FG000|Overall Study|Reason not specified|5|||
149850871|NCT00224484|540583193|FG001|Overall Study|Reason not specified|4|||
149850872|NCT00224484|540583194|FG002|Overall Study|Reason not specified|2|||
149850873|NCT02805309|540583195|FG000|Overall Study|Lost to Follow-up|2|||
149850874|NCT02805309|540583196|FG001|Overall Study|Lost to Follow-up|2|||
149850875|NCT02805309|540583197|FG002|Overall Study|Lost to Follow-up|2|||
149850876|NCT02805309|540583195|FG000|Overall Study|Post-Randomization Exclusion|0|||
149850877|NCT02805309|540583196|FG001|Overall Study|Post-Randomization Exclusion|2|||
149850878|NCT02805309|540583197|FG002|Overall Study|Post-Randomization Exclusion|1|||
149850879|NCT01636934|540583200|FG000|Overall Study|Withdrawal by Subject|3|||
149850880|NCT01636934|540583201|FG001|Overall Study|Withdrawal by Subject|2|||
149850881|NCT01636934|540583200|FG000|Overall Study|Chemo cancel|1|||
149850882|NCT01636934|540583201|FG001|Overall Study|Chemo cancel|0|||
149850883|NCT01636934|540583200|FG000|Overall Study|Too ill to continue|1|||
149850884|NCT01636934|540583201|FG001|Overall Study|Too ill to continue|0|||
149850885|NCT01636934|540583200|FG000|Overall Study|Never started study medication|1|||
149850886|NCT01636934|540583201|FG001|Overall Study|Never started study medication|1|||
149850887|NCT03687242|540583206|FG000|Overall Study|Adverse Event|1|||
149850888|NCT02274558|540583211|FG000|Overall Study|Adverse Event|2|||
149850889|NCT02274558|540583212|FG001|Overall Study|Adverse Event|4|||
149850890|NCT02274558|540583213|FG002|Overall Study|Adverse Event|2|||
149850891|NCT02274558|540583211|FG000|Overall Study|Non-compliance|2|||
149850892|NCT02274558|540583212|FG001|Overall Study|Non-compliance|1|||
149850893|NCT02274558|540583213|FG002|Overall Study|Non-compliance|0|||
149850894|NCT02274558|540583211|FG000|Overall Study|Withdrawal by Subject|1|||
149850895|NCT02274558|540583212|FG001|Overall Study|Withdrawal by Subject|5|||
149850896|NCT02274558|540583213|FG002|Overall Study|Withdrawal by Subject|4|||
149850897|NCT02274558|540583211|FG000|Overall Study|Death|0|||
149850898|NCT02274558|540583212|FG001|Overall Study|Death|0|||
149850899|NCT02274558|540583213|FG002|Overall Study|Death|1|||
149850900|NCT02274558|540583211|FG000|Overall Study|Lost to Follow-up|2|||
149850901|NCT02274558|540583212|FG001|Overall Study|Lost to Follow-up|1|||
149850902|NCT02274558|540583213|FG002|Overall Study|Lost to Follow-up|1|||
149850903|NCT02274558|540583211|FG000|Overall Study|Physician Decision|0|||
149850904|NCT02274558|540583212|FG001|Overall Study|Physician Decision|2|||
149850905|NCT02274558|540583213|FG002|Overall Study|Physician Decision|1|||
149850906|NCT01257581|540583214|FG000|Overall Study|Early Termination|3|||
149850907|NCT01257581|540583215|FG001|Overall Study|Early Termination|1|||
149850908|NCT01257581|540583216|FG002|Overall Study|Early Termination|2|||
149850909|NCT01257581|540583214|FG000|Overall Study|Death|2|||
149850910|NCT01257581|540583215|FG001|Overall Study|Death|2|||
149850911|NCT01257581|540583216|FG002|Overall Study|Death|4|||
149850912|NCT01157234|540583217|FG000|Overall Study|Withdrawal by Subject|1|||
149850913|NCT01157234|540583218|FG001|Overall Study|Withdrawal by Subject|0|||
149850914|NCT00517192|540583227|FG000|Overall Study|Adverse Event|1|||
149850915|NCT00517192|540583228|FG001|Overall Study|Adverse Event|1|||
149850916|NCT00517192|540583227|FG000|Overall Study|Lost to Follow-up|1|||
149850917|NCT00517192|540583228|FG001|Overall Study|Lost to Follow-up|1|||
149850918|NCT00517192|540583227|FG000|Overall Study|Withdrawal by Subject|1|||
149850919|NCT00517192|540583228|FG001|Overall Study|Withdrawal by Subject|0|||
149850920|NCT00517192|540583227|FG000|Overall Study|Early termination of the trial|16|||
149850921|NCT00517192|540583228|FG001|Overall Study|Early termination of the trial|18|||
149850922|NCT02733627|540583233|FG000|Overall Study|Adverse Event|0|||
149850923|NCT02733627|540583234|FG001|Overall Study|Adverse Event|1|||
149850924|NCT02733627|540583235|FG002|Overall Study|Adverse Event|1|||
149850925|NCT02733627|540583236|FG003|Overall Study|Adverse Event|0|||
149850926|NCT02733627|540583233|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
149850927|NCT02733627|540583234|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
149850928|NCT02733627|540583235|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
149850929|NCT02733627|540583236|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
149850930|NCT02246764|540583237|FG000|Overall Study|Adverse Event|15|||
149850931|NCT02246764|540583238|FG001|Overall Study|Adverse Event|29|||
149850932|NCT02246764|540583239|FG002|Overall Study|Adverse Event|1|||
149850933|NCT02246764|540583237|FG000|Overall Study|Withdrawal by Subject|0|||
149850934|NCT02246764|540583238|FG001|Overall Study|Withdrawal by Subject|0|||
149850935|NCT02246764|540583239|FG002|Overall Study|Withdrawal by Subject|1|||
149850936|NCT02246764|540583237|FG000|Overall Study|Disallowed Concomitant Medication|1|||
149850937|NCT02246764|540583238|FG001|Overall Study|Disallowed Concomitant Medication|0|||
149958776|NCT00098293|540984070|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
149958777|NCT00098293|540984071|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
149958778|NCT00098293|540984067|FG000|Supplemental Phase (SP)|Other|0|||
149958779|NCT00098293|540984068|FG001|Supplemental Phase (SP)|Other|0|||
149958780|NCT00098293|540984069|FG002|Supplemental Phase (SP)|Other|0|||
149958781|NCT00098293|540984070|FG003|Supplemental Phase (SP)|Other|0|||
149850938|NCT02246764|540583239|FG002|Overall Study|Disallowed Concomitant Medication|0|||
149850939|NCT02246764|540583237|FG000|Overall Study|Physician Decision|0|||
149850940|NCT02246764|540583238|FG001|Overall Study|Physician Decision|2|||
149850941|NCT02246764|540583239|FG002|Overall Study|Physician Decision|1|||
149850942|NCT02246764|540583237|FG000|Overall Study|Protocol Violation|2|||
149850943|NCT02246764|540583238|FG001|Overall Study|Protocol Violation|1|||
149850944|NCT02246764|540583239|FG002|Overall Study|Protocol Violation|1|||
149850945|NCT01408888|540583240|FG000|First Intervention|Adverse Event|0|||
149850946|NCT01408888|540583241|FG001|First Intervention|Adverse Event|1|||
149850947|NCT01408888|540583240|FG000|First Intervention|Withdrawal by Subject|0|||
149850948|NCT01408888|540583241|FG001|First Intervention|Withdrawal by Subject|2|||
149850949|NCT01408888|540583240|FG000|Second Intervention|Withdrawal by Subject|1|||
149850950|NCT01408888|540583241|FG001|Second Intervention|Withdrawal by Subject|0|||
149850951|NCT01408888|540583240|FG000|Second Intervention|Adverse Event|1|||
149850952|NCT01408888|540583241|FG001|Second Intervention|Adverse Event|0|||
149850953|NCT00487695|540583242|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
149850954|NCT00487695|540583243|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
149850955|NCT00487695|540583242|FG000|First Procedure|active wheezing (did not have procedure)|1|||
149850956|NCT00487695|540583243|FG001|First Procedure|active wheezing (did not have procedure)|0|||
149850957|NCT00487695|540583242|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
149850958|NCT00487695|540583243|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
149850959|NCT00487695|540583242|FG000|Second Procedure|active wheezing|0|||
149850960|NCT00487695|540583243|FG001|Second Procedure|active wheezing|1|||
149850961|NCT00487695|540583242|FG000|Second Procedure|Withdrawal by Subject|1|||
149850962|NCT00487695|540583243|FG001|Second Procedure|Withdrawal by Subject|2|||
149850963|NCT02104817|540583244|FG000|Overall Study|Death|363|||
149850964|NCT02104817|540583245|FG001|Overall Study|Death|330|||
149850965|NCT02104817|540583244|FG000|Overall Study|Lost to Follow-up|3|||
149850966|NCT02104817|540583245|FG001|Overall Study|Lost to Follow-up|2|||
149850967|NCT02104817|540583244|FG000|Overall Study|Protocol Violation|0|||
149850968|NCT02104817|540583245|FG001|Overall Study|Protocol Violation|1|||
149850969|NCT02104817|540583244|FG000|Overall Study|Study terminated by sponsor|5854|||
149850970|NCT02104817|540583245|FG001|Overall Study|Study terminated by sponsor|5901|||
149850971|NCT02104817|540583244|FG000|Overall Study|Withdrawal by Subject|111|||
149850972|NCT02104817|540583245|FG001|Overall Study|Withdrawal by Subject|78|||
149850973|NCT02104817|540583244|FG000|Overall Study|Other reasons|128|||
149850974|NCT02104817|540583245|FG001|Overall Study|Other reasons|135|||
149850975|NCT04633642|540583248|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
149958782|NCT00098293|540984071|FG004|Supplemental Phase (SP)|Other|22|||
149958783|NCT03518203|540984073|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
149958784|NCT03518203|540984073|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
149850976|NCT04633642|540583249|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
149850977|NCT00611884|540583250|FG000|Overall Study|Adverse Event|1|||
149850978|NCT00611884|540583251|FG001|Overall Study|Adverse Event|0|||
149850979|NCT00611884|540583252|FG002|Overall Study|Adverse Event|0|||
149850980|NCT00611884|540583253|FG003|Overall Study|Adverse Event|1|||
149850981|NCT00611884|540583250|FG000|Overall Study|Non-Compliance|1|||
149850982|NCT00611884|540583251|FG001|Overall Study|Non-Compliance|4|||
149958785|NCT00754559|540984075|FG000|Overall Study|Adverse Event|15|||
149958786|NCT00754559|540984075|FG000|Overall Study|Protocol Violation|11|||
149850983|NCT00611884|540583252|FG002|Overall Study|Non-Compliance|2|||
149850984|NCT00611884|540583253|FG003|Overall Study|Non-Compliance|2|||
149850985|NCT00611884|540583250|FG000|Overall Study|Lack of Efficacy|0|||
149850986|NCT00611884|540583251|FG001|Overall Study|Lack of Efficacy|1|||
149850987|NCT00611884|540583252|FG002|Overall Study|Lack of Efficacy|0|||
149850988|NCT00611884|540583253|FG003|Overall Study|Lack of Efficacy|0|||
149850989|NCT00611884|540583250|FG000|Overall Study|Unclassified|7|||
149850990|NCT00611884|540583251|FG001|Overall Study|Unclassified|4|||
149850991|NCT00611884|540583252|FG002|Overall Study|Unclassified|2|||
149850992|NCT00611884|540583253|FG003|Overall Study|Unclassified|3|||
149850993|NCT00981799|540583254|FG000|Overall Study|Adverse Event|1|||
149850994|NCT00981799|540583255|FG001|Overall Study|Adverse Event|1|||
149850995|NCT00981799|540583256|FG002|Overall Study|Adverse Event|0|||
149850996|NCT00981799|540583257|FG003|Overall Study|Adverse Event|0|||
149958787|NCT00754559|540984075|FG000|Overall Study|Lack of Efficacy|10|||
149958788|NCT00754559|540984075|FG000|Overall Study|Lost to Follow-up|2|||
149958789|NCT00754559|540984075|FG000|Overall Study|Administrative reason|1|||
149958790|NCT00754559|540984075|FG000|Overall Study|Other|5|||
149958791|NCT00754559|540984075|FG000|Overall Study|Withdrawal by Subject|3|||
149958792|NCT00345592|540984076|FG000|Overall Study|Death|14|||
149958793|NCT00345592|540984077|FG001|Overall Study|Death|16|||
149958794|NCT00345592|540984076|FG000|Overall Study|Withdrawal by Subject|11|||
149958795|NCT00345592|540984077|FG001|Overall Study|Withdrawal by Subject|8|||
149958796|NCT01663987|540984078|FG000|Overall Study|Adverse Event|7|||
149958797|NCT01663987|540984079|FG001|Overall Study|Adverse Event|2|||
149958798|NCT01663987|540984078|FG000|Overall Study|Lost to Follow-up|1|||
149958799|NCT01663987|540984079|FG001|Overall Study|Lost to Follow-up|1|||
149958800|NCT01663987|540984078|FG000|Overall Study|Withdrawal by Subject|2|||
149850997|NCT02167594|540583258|FG000|Overall Study|Withdrawal by Subject|2|||
149850998|NCT02167594|540583259|FG001|Overall Study|Withdrawal by Subject|0|||
149850999|NCT02167594|540583260|FG002|Overall Study|Withdrawal by Subject|0|||
149851000|NCT02167594|540583258|FG000|Overall Study|Death|0|||
149851001|NCT02167594|540583259|FG001|Overall Study|Death|1|||
149851002|NCT02167594|540583260|FG002|Overall Study|Death|0|||
149851003|NCT03433703|540583261|FG000|Overall Study|Study terminated by Sponsor|2|||
149851004|NCT01698554|540583272|FG000|Overall Study|Adverse Event|2|||
149851005|NCT01698554|540583273|FG001|Overall Study|Adverse Event|5|||
149851006|NCT01698554|540583274|FG002|Overall Study|Adverse Event|0|||
149851007|NCT01698554|540583275|FG003|Overall Study|Adverse Event|1|||
149851008|NCT01698554|540583272|FG000|Overall Study|Lost to Follow-up|1|||
149851009|NCT01698554|540583273|FG001|Overall Study|Lost to Follow-up|0|||
149851010|NCT01698554|540583274|FG002|Overall Study|Lost to Follow-up|0|||
149851011|NCT01698554|540583275|FG003|Overall Study|Lost to Follow-up|0|||
149851012|NCT01698554|540583272|FG000|Overall Study|Personal Reasons|0|||
149851013|NCT01698554|540583273|FG001|Overall Study|Personal Reasons|5|||
149851014|NCT01698554|540583274|FG002|Overall Study|Personal Reasons|1|||
149851015|NCT01698554|540583275|FG003|Overall Study|Personal Reasons|1|||
149851016|NCT01698554|540583272|FG000|Overall Study|Protocol Violation|2|||
149851017|NCT01698554|540583273|FG001|Overall Study|Protocol Violation|0|||
149851018|NCT01698554|540583274|FG002|Overall Study|Protocol Violation|1|||
149851019|NCT01698554|540583275|FG003|Overall Study|Protocol Violation|0|||
149851020|NCT01698554|540583272|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149851021|NCT01698554|540583273|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149851022|NCT01698554|540583274|FG002|Overall Study|Other Miscellaneous Reasons|0|||
149851023|NCT01698554|540583275|FG003|Overall Study|Other Miscellaneous Reasons|0|||
149851024|NCT01943435|540583278|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
149851025|NCT01943435|540583279|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
149851026|NCT01943435|540583280|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
149851027|NCT01943435|540583278|FG000|Intervention Period|Withdrawal by Subject|3|||
149851028|NCT01943435|540583279|FG001|Intervention Period|Withdrawal by Subject|3|||
149958801|NCT01663987|540984079|FG001|Overall Study|Withdrawal by Subject|3|||
149958802|NCT01663987|540984078|FG000|Overall Study|Other reason not defined above|3|||
149958803|NCT01663987|540984079|FG001|Overall Study|Other reason not defined above|0|||
149958804|NCT04000724|540984083|FG000|Overall Study|Withdrawal by Subject|5|||
149958805|NCT04000724|540984084|FG001|Overall Study|Withdrawal by Subject|3|||
149958806|NCT04000724|540984085|FG002|Overall Study|Withdrawal by Subject|4|||
149958807|NCT04000724|540984083|FG000|Overall Study|Lost to Follow-up|11|||
149958808|NCT04000724|540984084|FG001|Overall Study|Lost to Follow-up|7|||
149958809|NCT04000724|540984085|FG002|Overall Study|Lost to Follow-up|13|||
149958810|NCT00455455|540984086|FG000|Washout|Withdrawal by Subject|0|||
149958811|NCT00455455|540984087|FG001|Washout|Withdrawal by Subject|1|||
149958812|NCT00455455|540984086|FG000|Washout|Withdrawal by Subject|1|||
149958813|NCT00455455|540984087|FG001|Washout|Withdrawal by Subject|0|||
149958814|NCT01370538|540984088|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
149958815|NCT01370538|540984089|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
149958816|NCT01370538|540984088|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149958817|NCT01370538|540984089|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149958818|NCT01370538|540984088|FG000|Overall Study|Adverse Event|1|||
149958819|NCT01370538|540984089|FG001|Overall Study|Adverse Event|0|||
149958820|NCT01370538|540984088|FG000|Overall Study|Protocol Violation|8|||
149958821|NCT01370538|540984089|FG001|Overall Study|Protocol Violation|5|||
149958822|NCT01370538|540984088|FG000|Overall Study|Development of study specific withdrawal|1|||
149958823|NCT01370538|540984089|FG001|Overall Study|Development of study specific withdrawal|1|||
149958824|NCT01370538|540984088|FG000|Overall Study|Lost to follow up|6|||
149958825|NCT01370538|540984089|FG001|Overall Study|Lost to follow up|10|||
149958826|NCT01084135|540984090|FG000|20 Week|Physician Decision|0|||
149958827|NCT01084135|540984091|FG001|20 Week|Physician Decision|1|||
149958828|NCT03335566|540984092|FG000|Overall Study|Adverse Event|0|||
149958829|NCT03335566|540984093|FG001|Overall Study|Adverse Event|1|||
149958830|NCT03335566|540984092|FG000|Overall Study|Lost to Follow-up|1|||
149958831|NCT03335566|540984093|FG001|Overall Study|Lost to Follow-up|0|||
149958832|NCT03335566|540984092|FG000|Overall Study|Technical Problems|1|||
149958833|NCT03335566|540984093|FG001|Overall Study|Technical Problems|0|||
149958834|NCT03335566|540984092|FG000|Overall Study|Protocol Violation|1|||
149958835|NCT03335566|540984093|FG001|Overall Study|Protocol Violation|0|||
149958836|NCT03335566|540984092|FG000|Overall Study|Other than specified above|1|||
149958837|NCT03335566|540984093|FG001|Overall Study|Other than specified above|2|||
149958838|NCT02366130|540984094|FG000|Overall Study|Withdrawal by Subject|3|||
149958839|NCT02366130|540984094|FG000|Overall Study|Ineligible|6|||
149958840|NCT01065766|540984095|FG000|Overall Study|Assessed before the contracted date|1|||
149958841|NCT01065766|540984095|FG000|Overall Study|Contraindication to administration|6|||
149958842|NCT01065766|540984095|FG000|Overall Study|Violated dosage/administration|25|||
149958843|NCT02945046|540984096|FG000|Overall Study|Adverse Event|1|||
149958844|NCT02945046|540984097|FG001|Overall Study|Adverse Event|0|||
149958845|NCT02945046|540984098|FG002|Overall Study|Adverse Event|2|||
149958846|NCT02945046|540984096|FG000|Overall Study|Withdrawal by Subject|3|||
149958847|NCT02945046|540984097|FG001|Overall Study|Withdrawal by Subject|3|||
150039073|NCT02038933|541285069|FG000|Overall Study|Adverse event unrelated to study drug|6|||
150039074|NCT02038933|541285069|FG000|Overall Study|Participant request to discontinue treatment|2|||
150039075|NCT02038933|541285069|FG000|Overall Study|Lost to Follow-up|1|||
150039076|NCT02038933|541285069|FG000|Overall Study|Other reasons|2|||
150039077|NCT04226742|541285070|FG000|Overall Study|Lost to Follow-up|16|||
150039078|NCT04226742|541285071|FG001|Overall Study|Lost to Follow-up|13|||
150039079|NCT04226742|541285070|FG000|Overall Study|Withdrawal by Subject|5|||
150039080|NCT04226742|541285071|FG001|Overall Study|Withdrawal by Subject|3|||
150039081|NCT01193244|541285074|FG000|Overall Study|Withdrawal by Subject|79|||
150039082|NCT01193244|541285075|FG001|Overall Study|Withdrawal by Subject|97|||
150039083|NCT01193244|541285074|FG000|Overall Study|Other|303|||
150039084|NCT01193244|541285075|FG001|Overall Study|Other|278|||
149851029|NCT01943435|540583280|FG002|Intervention Period|Withdrawal by Subject|4|||
149851030|NCT01943435|540583278|FG000|2 Month Follow up|Lost to Follow-up|2|||
149851031|NCT01943435|540583279|FG001|2 Month Follow up|Lost to Follow-up|3|||
149851032|NCT01943435|540583280|FG002|2 Month Follow up|Lost to Follow-up|0|||
149851033|NCT01943435|540583278|FG000|6 Month Follow up|Lost to Follow-up|12|||
149851034|NCT01943435|540583279|FG001|6 Month Follow up|Lost to Follow-up|7|||
149851035|NCT01943435|540583280|FG002|6 Month Follow up|Lost to Follow-up|15|||
149851036|NCT01617096|540583287|FG000|Overall Study|Withdrawal by Subject|96|||
149851037|NCT01617096|540583288|FG001|Overall Study|Withdrawal by Subject|81|||
149851038|NCT01617096|540583287|FG000|Overall Study|Lost to Follow-up|37|||
149851039|NCT01617096|540583288|FG001|Overall Study|Lost to Follow-up|32|||
149851040|NCT01617096|540583287|FG000|Overall Study|Physician Decision|10|||
149851041|NCT01617096|540583288|FG001|Overall Study|Physician Decision|18|||
149851042|NCT01617096|540583287|FG000|Overall Study|Death|4|||
149851043|NCT01617096|540583288|FG001|Overall Study|Death|3|||
149851044|NCT01617096|540583287|FG000|Overall Study|Other|1|||
149851045|NCT01617096|540583288|FG001|Overall Study|Other|3|||
149851046|NCT02046122|540583293|FG000|Overall Study|Physician Decision|8|||
149851047|NCT02046122|540583293|FG000|Overall Study|Withdrawal by Subject|1|||
149851048|NCT04535986|540583296|FG000|Overall Study|Death|4|||
149851049|NCT04535986|540583297|FG001|Overall Study|Death|5|||
149851050|NCT04535986|540583296|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
149851051|NCT04535986|540583297|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
149851052|NCT04535986|540583296|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
149958848|NCT02945046|540984098|FG002|Overall Study|Withdrawal by Subject|3|||
149958849|NCT02945046|540984096|FG000|Overall Study|Protocol Violation|2|||
149958850|NCT02945046|540984097|FG001|Overall Study|Protocol Violation|3|||
149958851|NCT02945046|540984098|FG002|Overall Study|Protocol Violation|2|||
149958852|NCT02945046|540984096|FG000|Overall Study|Lost to Follow-up|1|||
149958853|NCT02945046|540984097|FG001|Overall Study|Lost to Follow-up|1|||
149958854|NCT02945046|540984098|FG002|Overall Study|Lost to Follow-up|0|||
149958855|NCT02945046|540984096|FG000|Overall Study|Lack of Efficacy|1|||
149958856|NCT02945046|540984097|FG001|Overall Study|Lack of Efficacy|2|||
149958857|NCT02945046|540984098|FG002|Overall Study|Lack of Efficacy|1|||
149958858|NCT02945046|540984096|FG000|Overall Study|Other than specified|5|||
149958859|NCT02945046|540984097|FG001|Overall Study|Other than specified|4|||
149958860|NCT02945046|540984098|FG002|Overall Study|Other than specified|7|||
149958861|NCT02675452|540984103|FG000|Overall Study|Sponsor decision|0|||
149958862|NCT02675452|540984104|FG001|Overall Study|Sponsor decision|0|||
149958863|NCT02675452|540984105|FG002|Overall Study|Sponsor decision|0|||
149958864|NCT02675452|540984106|FG003|Overall Study|Sponsor decision|0|||
149958865|NCT02675452|540984107|FG004|Overall Study|Sponsor decision|0|||
149958866|NCT02675452|540984108|FG005|Overall Study|Sponsor decision|0|||
149958867|NCT02675452|540984109|FG006|Overall Study|Sponsor decision|0|||
149958868|NCT02675452|540984110|FG007|Overall Study|Sponsor decision|0|||
149958869|NCT02675452|540984111|FG008|Overall Study|Sponsor decision|0|||
149958870|NCT02675452|540984112|FG009|Overall Study|Sponsor decision|1|||
149958871|NCT02675452|540984113|FG010|Overall Study|Sponsor decision|0|||
150039085|NCT01193244|541285074|FG000|Overall Study|Lost to Follow-up|6|||
149851053|NCT04535986|540583297|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
149851054|NCT04535986|540583296|FG000|Overall Study|Adverse Event|10|||
149851055|NCT04535986|540583297|FG001|Overall Study|Adverse Event|1|||
149958872|NCT02675452|540984114|FG011|Overall Study|Sponsor decision|0|||
149958873|NCT02675452|540984115|FG012|Overall Study|Sponsor decision|0|||
149958874|NCT02675452|540984116|FG013|Overall Study|Sponsor decision|2|||
149958875|NCT02675452|540984117|FG014|Overall Study|Sponsor decision|1|||
150039086|NCT01193244|541285075|FG001|Overall Study|Lost to Follow-up|15|||
150039087|NCT01417377|541285076|FG000|Overall Study|Lost to Follow-up|12|||
150039088|NCT01417377|541285076|FG000|Overall Study|Enrolled, but not treated|1|||
150039089|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
149851056|NCT04535986|540583296|FG000|Overall Study|Lack of Efficacy|3|||
149958876|NCT02675452|540984118|FG015|Overall Study|Sponsor decision|0|||
149958877|NCT02675452|540984119|FG016|Overall Study|Sponsor decision|1|||
149958878|NCT02675452|540984120|FG017|Overall Study|Sponsor decision|0|||
149851057|NCT04535986|540583297|FG001|Overall Study|Lack of Efficacy|2|||
149958879|NCT02675452|540984121|FG018|Overall Study|Sponsor decision|0|||
150039090|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
149958880|NCT02675452|540984122|FG019|Overall Study|Sponsor decision|0|||
149958881|NCT02675452|540984123|FG020|Overall Study|Sponsor decision|0|||
149958882|NCT02675452|540984124|FG021|Overall Study|Sponsor decision|0|||
149958883|NCT02675452|540984125|FG022|Overall Study|Sponsor decision|0|||
149958884|NCT02675452|540984126|FG023|Overall Study|Sponsor decision|0|||
149958885|NCT02675452|540984127|FG024|Overall Study|Sponsor decision|0|||
149958886|NCT02675452|540984128|FG025|Overall Study|Sponsor decision|0|||
149958887|NCT02675452|540984129|FG026|Overall Study|Sponsor decision|2|||
149958888|NCT02675452|540984130|FG027|Overall Study|Sponsor decision|0|||
149958889|NCT02675452|540984131|FG028|Overall Study|Sponsor decision|0|||
149958890|NCT02675452|540984103|FG000|Overall Study|Withdrawal by Subject|0|||
149958891|NCT02675452|540984104|FG001|Overall Study|Withdrawal by Subject|0|||
149958892|NCT02675452|540984105|FG002|Overall Study|Withdrawal by Subject|0|||
149958893|NCT02675452|540984106|FG003|Overall Study|Withdrawal by Subject|0|||
149958894|NCT02675452|540984107|FG004|Overall Study|Withdrawal by Subject|0|||
149958895|NCT02675452|540984108|FG005|Overall Study|Withdrawal by Subject|0|||
149958896|NCT02675452|540984109|FG006|Overall Study|Withdrawal by Subject|0|||
149958897|NCT02675452|540984110|FG007|Overall Study|Withdrawal by Subject|0|||
149958898|NCT02675452|540984111|FG008|Overall Study|Withdrawal by Subject|0|||
149958899|NCT02675452|540984112|FG009|Overall Study|Withdrawal by Subject|1|||
149958900|NCT02675452|540984113|FG010|Overall Study|Withdrawal by Subject|0|||
149958901|NCT02675452|540984114|FG011|Overall Study|Withdrawal by Subject|1|||
149958902|NCT02675452|540984115|FG012|Overall Study|Withdrawal by Subject|0|||
149958903|NCT02675452|540984116|FG013|Overall Study|Withdrawal by Subject|1|||
149958904|NCT02675452|540984117|FG014|Overall Study|Withdrawal by Subject|1|||
149958905|NCT02675452|540984118|FG015|Overall Study|Withdrawal by Subject|0|||
149958906|NCT02675452|540984119|FG016|Overall Study|Withdrawal by Subject|2|||
149958907|NCT02675452|540984120|FG017|Overall Study|Withdrawal by Subject|0|||
149958908|NCT02675452|540984121|FG018|Overall Study|Withdrawal by Subject|0|||
149958909|NCT02675452|540984122|FG019|Overall Study|Withdrawal by Subject|0|||
149958910|NCT02675452|540984123|FG020|Overall Study|Withdrawal by Subject|0|||
149958911|NCT02675452|540984124|FG021|Overall Study|Withdrawal by Subject|0|||
149958912|NCT02675452|540984125|FG022|Overall Study|Withdrawal by Subject|3|||
149958913|NCT02675452|540984126|FG023|Overall Study|Withdrawal by Subject|0|||
149958914|NCT02675452|540984127|FG024|Overall Study|Withdrawal by Subject|1|||
149958915|NCT02675452|540984128|FG025|Overall Study|Withdrawal by Subject|0|||
149958916|NCT02675452|540984129|FG026|Overall Study|Withdrawal by Subject|1|||
149958917|NCT02675452|540984130|FG027|Overall Study|Withdrawal by Subject|3|||
149958918|NCT02675452|540984131|FG028|Overall Study|Withdrawal by Subject|4|||
149958919|NCT02675452|540984103|FG000|Overall Study|Death|0|||
149958920|NCT02675452|540984104|FG001|Overall Study|Death|0|||
149958921|NCT02675452|540984105|FG002|Overall Study|Death|1|||
149958922|NCT02675452|540984106|FG003|Overall Study|Death|0|||
149958923|NCT02675452|540984107|FG004|Overall Study|Death|0|||
149958924|NCT02675452|540984108|FG005|Overall Study|Death|1|||
149958925|NCT02675452|540984109|FG006|Overall Study|Death|0|||
149958926|NCT02675452|540984110|FG007|Overall Study|Death|0|||
149958927|NCT02675452|540984111|FG008|Overall Study|Death|1|||
149958928|NCT02675452|540984112|FG009|Overall Study|Death|0|||
149958929|NCT02675452|540984113|FG010|Overall Study|Death|0|||
149958930|NCT02675452|540984114|FG011|Overall Study|Death|0|||
149958931|NCT02675452|540984115|FG012|Overall Study|Death|1|||
149958932|NCT02675452|540984116|FG013|Overall Study|Death|0|||
149958933|NCT02675452|540984117|FG014|Overall Study|Death|0|||
149958934|NCT02675452|540984118|FG015|Overall Study|Death|2|||
149958935|NCT02675452|540984119|FG016|Overall Study|Death|0|||
149958936|NCT02675452|540984120|FG017|Overall Study|Death|0|||
149958937|NCT02675452|540984121|FG018|Overall Study|Death|4|||
149958938|NCT02675452|540984122|FG019|Overall Study|Death|3|||
149958939|NCT02675452|540984123|FG020|Overall Study|Death|3|||
149958940|NCT02675452|540984124|FG021|Overall Study|Death|3|||
149958941|NCT02675452|540984125|FG022|Overall Study|Death|7|||
149958942|NCT02675452|540984126|FG023|Overall Study|Death|5|||
149958943|NCT02675452|540984127|FG024|Overall Study|Death|3|||
149958944|NCT02675452|540984128|FG025|Overall Study|Death|4|||
149958945|NCT02675452|540984129|FG026|Overall Study|Death|7|||
149958946|NCT02675452|540984130|FG027|Overall Study|Death|6|||
149958947|NCT02675452|540984131|FG028|Overall Study|Death|9|||
149958948|NCT02675452|540984103|FG000|Overall Study|Lost to Follow-up|0|||
149958949|NCT02675452|540984104|FG001|Overall Study|Lost to Follow-up|1|||
149958950|NCT02675452|540984105|FG002|Overall Study|Lost to Follow-up|0|||
149958951|NCT02675452|540984106|FG003|Overall Study|Lost to Follow-up|0|||
150039091|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
150039092|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
149958952|NCT02675452|540984107|FG004|Overall Study|Lost to Follow-up|0|||
149958953|NCT02675452|540984108|FG005|Overall Study|Lost to Follow-up|0|||
149958954|NCT02675452|540984109|FG006|Overall Study|Lost to Follow-up|0|||
149958955|NCT02675452|540984110|FG007|Overall Study|Lost to Follow-up|0|||
149958956|NCT02675452|540984111|FG008|Overall Study|Lost to Follow-up|0|||
149958957|NCT02675452|540984112|FG009|Overall Study|Lost to Follow-up|0|||
149958958|NCT02675452|540984113|FG010|Overall Study|Lost to Follow-up|0|||
149851058|NCT04535986|540583296|FG000|Overall Study|Investigator discretion|3|||
149851059|NCT04535986|540583297|FG001|Overall Study|Investigator discretion|0|||
149851060|NCT04535986|540583296|FG000|Overall Study|Withdrawal by Subject|32|||
149851061|NCT04535986|540583297|FG001|Overall Study|Withdrawal by Subject|14|||
149851062|NCT04535986|540583296|FG000|Overall Study|Lost to Follow-up|5|||
149851063|NCT04535986|540583297|FG001|Overall Study|Lost to Follow-up|3|||
149851064|NCT04535986|540583296|FG000|Overall Study|Other|7|||
149851065|NCT04535986|540583297|FG001|Overall Study|Other|3|||
149851066|NCT01196390|540583298|FG000|Overall Study|Protocol Violation|4|||
149851067|NCT01196390|540583299|FG001|Overall Study|Protocol Violation|5|||
149851068|NCT00252564|540583300|FG000|Overall Study|Adverse Event|17|||
149851069|NCT00252564|540583301|FG001|Overall Study|Adverse Event|13|||
149851070|NCT00252564|540583300|FG000|Overall Study|Unrelated Complication|2|||
149851071|NCT00252564|540583301|FG001|Overall Study|Unrelated Complication|1|||
149851072|NCT00252564|540583300|FG000|Overall Study|Disease Progression|14|||
149851073|NCT00252564|540583301|FG001|Overall Study|Disease Progression|20|||
149851074|NCT00252564|540583300|FG000|Overall Study|Death|0|||
149851075|NCT00252564|540583301|FG001|Overall Study|Death|3|||
149851076|NCT00252564|540583300|FG000|Overall Study|Physician Decision|1|||
149851077|NCT00252564|540583301|FG001|Overall Study|Physician Decision|0|||
149851078|NCT00252564|540583300|FG000|Overall Study|Lost to Follow-up|1|||
149851079|NCT00252564|540583301|FG001|Overall Study|Lost to Follow-up|0|||
150039093|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
150039094|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
150039095|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
150039096|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
150039097|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
150039098|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
150039099|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
150039100|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
150039101|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
150039102|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
149851080|NCT00252564|540583300|FG000|Overall Study|Patient Request|4|||
149851081|NCT00252564|540583301|FG001|Overall Study|Patient Request|5|||
149851082|NCT00252564|540583300|FG000|Overall Study|Withdrawal by Subject|0|||
149851083|NCT00252564|540583301|FG001|Overall Study|Withdrawal by Subject|2|||
149851084|NCT03141151|540583310|FG000|Overall Study|Lost to Follow-up|3|||
149851085|NCT03141151|540583311|FG001|Overall Study|Lost to Follow-up|2|||
150039103|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
149851086|NCT03141151|540583310|FG000|Overall Study|Withdrawal by Subject|3|||
149851087|NCT03141151|540583311|FG001|Overall Study|Withdrawal by Subject|2|||
149851088|NCT04561115|540583312|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
149851089|NCT04561115|540583313|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
149851090|NCT04561115|540583312|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
149851091|NCT04561115|540583313|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
149851092|NCT04561115|540583312|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
149851093|NCT04561115|540583313|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
149851094|NCT03732833|540583314|FG000|Overall Study|Adverse Event|0|||
149851095|NCT03732833|540583315|FG001|Overall Study|Adverse Event|3|||
149851096|NCT03732833|540583316|FG002|Overall Study|Adverse Event|1|||
149851097|NCT03732833|540583314|FG000|Overall Study|Withdrawal by Subject|11|||
149851098|NCT03732833|540583315|FG001|Overall Study|Withdrawal by Subject|13|||
149851099|NCT03732833|540583316|FG002|Overall Study|Withdrawal by Subject|8|||
149851100|NCT03732833|540583314|FG000|Overall Study|Lost to Follow-up|3|||
149851101|NCT03732833|540583315|FG001|Overall Study|Lost to Follow-up|5|||
149851102|NCT03732833|540583316|FG002|Overall Study|Lost to Follow-up|4|||
149851103|NCT03732833|540583314|FG000|Overall Study|Pregnancy|0|||
149851104|NCT03732833|540583315|FG001|Overall Study|Pregnancy|2|||
149851105|NCT03732833|540583316|FG002|Overall Study|Pregnancy|0|||
149851106|NCT03732833|540583314|FG000|Overall Study|Physician Decision|2|||
149851107|NCT03732833|540583315|FG001|Overall Study|Physician Decision|3|||
149851108|NCT03732833|540583316|FG002|Overall Study|Physician Decision|1|||
149851109|NCT03732833|540583314|FG000|Overall Study|Covid-19 related and other reasons|2|||
149851110|NCT03732833|540583315|FG001|Overall Study|Covid-19 related and other reasons|7|||
149851111|NCT03732833|540583316|FG002|Overall Study|Covid-19 related and other reasons|3|||
149851112|NCT01863433|540583321|FG000|Overall Study|Protocol Violation|1|||
149851113|NCT00697619|540583323|FG000|Overall Study|Lack of Efficacy|2|||
149851114|NCT00697619|540583324|FG001|Overall Study|Lack of Efficacy|2|||
149851115|NCT00697619|540583323|FG000|Overall Study|Adverse Event|4|||
149851116|NCT00697619|540583324|FG001|Overall Study|Adverse Event|6|||
150039104|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
150039105|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
150039106|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
149851117|NCT00288704|540585125|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
149851118|NCT00288704|540585126|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
149851119|NCT00288704|540585127|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
149851120|NCT00288704|540585125|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
149851121|NCT00288704|540585126|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
149851122|NCT00288704|540585127|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
149851123|NCT00288704|540585125|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
149851124|NCT00288704|540585126|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
149851125|NCT00288704|540585127|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
149851126|NCT00288704|540585125|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
149851127|NCT00288704|540585126|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
149851128|NCT00288704|540585127|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
149851129|NCT00288704|540585125|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
149851130|NCT00288704|540585126|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
149851131|NCT00288704|540585127|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
149851132|NCT00288704|540585125|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
149851133|NCT00288704|540585126|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
149851134|NCT00288704|540585127|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
149851135|NCT00288704|540585125|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
149851136|NCT00288704|540585126|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
149851137|NCT00288704|540585127|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
149851138|NCT01579006|540585128|FG000|Overall Study|Lack of Efficacy|10|||
149851139|NCT01579006|540585128|FG000|Overall Study|Adverse Event|13|||
149851140|NCT01579006|540585128|FG000|Overall Study|Withdrawal by Subject|5|||
149851141|NCT01579006|540585128|FG000|Overall Study|Non-compliance|3|||
149851142|NCT01579006|540585128|FG000|Overall Study|Due to participant's health fund|1|||
149851143|NCT01579006|540585128|FG000|Overall Study|Scheduled surgery|1|||
149851144|NCT00799708|540585129|FG000|Overall Study|non-compliance|1|||
149851145|NCT00799708|540585130|FG001|Overall Study|non-compliance|0|||
149851146|NCT00799708|540585131|FG002|Overall Study|non-compliance|0|||
149851147|NCT00880334|540585132|FG000|Randomized Phase|Physician Decision|1|||
149851148|NCT00880334|540585133|FG001|Randomized Phase|Physician Decision|0|||
149851149|NCT00880334|540585132|FG000|Randomized Phase|Withdrawal by Subject|2|||
149851150|NCT00880334|540585133|FG001|Randomized Phase|Withdrawal by Subject|1|||
149851151|NCT00880334|540585132|FG000|Randomized Phase|Inadequate Labs|1|||
149851152|NCT00880334|540585133|FG001|Randomized Phase|Inadequate Labs|1|||
149851153|NCT00880334|540585132|FG000|Randomized Phase|Brain Metastasis|0|||
149851154|NCT00880334|540585133|FG001|Randomized Phase|Brain Metastasis|1|||
149851155|NCT00880334|540585132|FG000|Randomized Phase|Crossover Participants|0|||
149851156|NCT00880334|540585133|FG001|Randomized Phase|Crossover Participants|37|||
149851157|NCT02473393|540585134|FG000|Overall Study|Adverse Event|0|||
149851158|NCT02473393|540585135|FG001|Overall Study|Adverse Event|0|||
149851159|NCT02473393|540585136|FG002|Overall Study|Adverse Event|1|||
149851160|NCT02473393|540585137|FG003|Overall Study|Adverse Event|0|||
149851161|NCT02473393|540585134|FG000|Overall Study|Withdrawal by Subject|0|||
149851162|NCT02473393|540585135|FG001|Overall Study|Withdrawal by Subject|0|||
149851163|NCT02473393|540585136|FG002|Overall Study|Withdrawal by Subject|1|||
149851164|NCT02473393|540585137|FG003|Overall Study|Withdrawal by Subject|1|||
149851165|NCT05393271|540585141|FG000|Overall Study|Physician Decision|0|||
149851166|NCT05393271|540585142|FG001|Overall Study|Physician Decision|0|||
149851167|NCT05393271|540585143|FG002|Overall Study|Physician Decision|0|||
149851168|NCT05393271|540585144|FG003|Overall Study|Physician Decision|0|||
149851169|NCT05393271|540585145|FG004|Overall Study|Physician Decision|0|||
149851170|NCT05393271|540585146|FG005|Overall Study|Physician Decision|0|||
149851171|NCT05393271|540585147|FG006|Overall Study|Physician Decision|1|||
149851172|NCT05393271|540585148|FG007|Overall Study|Physician Decision|0|||
149851173|NCT05393271|540585149|FG008|Overall Study|Physician Decision|0|||
149851174|NCT05393271|540585150|FG009|Overall Study|Physician Decision|0|||
149851175|NCT05393271|540585151|FG010|Overall Study|Physician Decision|0|||
149851176|NCT02048813|540585152|FG000|Overall Study|Still on treatment|279|||
149851177|NCT02048813|540585153|FG001|Overall Study|Still on treatment|0|||
149851178|NCT02048813|540585152|FG000|Overall Study|Adverse Event|40|||
149851179|NCT02048813|540585153|FG001|Overall Study|Adverse Event|38|||
149851180|NCT02048813|540585152|FG000|Overall Study|Disease progression|13|||
149851181|NCT02048813|540585153|FG001|Overall Study|Disease progression|3|||
149851182|NCT02048813|540585152|FG000|Overall Study|Withdrawal by Subject|7|||
149851183|NCT02048813|540585153|FG001|Overall Study|Withdrawal by Subject|8|||
149851184|NCT02048813|540585152|FG000|Overall Study|Death|2|||
149851185|NCT02048813|540585153|FG001|Overall Study|Death|1|||
149851186|NCT02048813|540585152|FG000|Overall Study|Complication|2|||
149851187|NCT02048813|540585153|FG001|Overall Study|Complication|2|||
149851188|NCT02048813|540585152|FG000|Overall Study|Non-protocol therapy|0|||
149851189|NCT02048813|540585153|FG001|Overall Study|Non-protocol therapy|1|||
149851190|NCT02048813|540585152|FG000|Overall Study|Second primary cancer|2|||
149851191|NCT02048813|540585153|FG001|Overall Study|Second primary cancer|0|||
149851192|NCT02048813|540585152|FG000|Overall Study|Insurance|2|||
149851193|NCT02048813|540585153|FG001|Overall Study|Insurance|0|||
149851194|NCT02048813|540585152|FG000|Overall Study|Wound infection/healing|2|||
149851195|NCT02048813|540585153|FG001|Overall Study|Wound infection/healing|0|||
149851196|NCT02048813|540585152|FG000|Overall Study|Missed appointment|3|||
149851197|NCT02048813|540585153|FG001|Overall Study|Missed appointment|0|||
149851198|NCT02048813|540585152|FG000|Overall Study|Never started treatment|2|||
149851199|NCT02048813|540585153|FG001|Overall Study|Never started treatment|17|||
149851200|NCT01708954|540585154|FG000|Step 1|Disease progression|26|||
149851201|NCT01708954|540585155|FG001|Step 1|Disease progression|17|||
149851202|NCT01708954|540585156|FG002|Step 1|Disease progression|14|||
149851203|NCT01708954|540585154|FG000|Step 1|Adverse Event|3|||
149851204|NCT01708954|540585155|FG001|Step 1|Adverse Event|11|||
149851205|NCT01708954|540585156|FG002|Step 1|Adverse Event|13|||
149851206|NCT01708954|540585154|FG000|Step 1|Death|3|||
149851207|NCT01708954|540585155|FG001|Step 1|Death|2|||
149851208|NCT01708954|540585156|FG002|Step 1|Death|3|||
149851209|NCT01708954|540585154|FG000|Step 1|Withdrawal by Subject|2|||
149851210|NCT01708954|540585155|FG001|Step 1|Withdrawal by Subject|5|||
149851211|NCT01708954|540585156|FG002|Step 1|Withdrawal by Subject|3|||
149851212|NCT01708954|540585154|FG000|Step 1|Other complicating disease|0|||
149851213|NCT01708954|540585155|FG001|Step 1|Other complicating disease|2|||
149851214|NCT01708954|540585156|FG002|Step 1|Other complicating disease|0|||
149851215|NCT01708954|540585154|FG000|Step 1|Crossed over to Step 2|2|||
149851216|NCT01708954|540585155|FG001|Step 1|Crossed over to Step 2|0|||
149851217|NCT01708954|540585156|FG002|Step 1|Crossed over to Step 2|0|||
149851218|NCT01708954|540585154|FG000|Step 1|Symptomatic deterioration|1|||
149851219|NCT01708954|540585155|FG001|Step 1|Symptomatic deterioration|0|||
149851220|NCT01708954|540585156|FG002|Step 1|Symptomatic deterioration|1|||
149851221|NCT01708954|540585154|FG000|Step 1|Off-treatment reason not submitted|1|||
149851222|NCT01708954|540585155|FG001|Step 1|Off-treatment reason not submitted|1|||
149851223|NCT01708954|540585156|FG002|Step 1|Off-treatment reason not submitted|1|||
149851224|NCT01708954|540585154|FG000|Step 1|Ineligible or never received treatment|4|||
149851225|NCT01708954|540585155|FG001|Step 1|Ineligible or never received treatment|2|||
149851226|NCT01708954|540585156|FG002|Step 1|Ineligible or never received treatment|8|||
149851227|NCT01708954|540585154|FG000|Step 2|Disease progression|9|||
149851228|NCT01708954|540585155|FG001|Step 2|Disease progression|4|||
149851229|NCT01708954|540585156|FG002|Step 2|Disease progression|0|||
149851230|NCT01708954|540585154|FG000|Step 2|Adverse Event|3|||
149851231|NCT01708954|540585155|FG001|Step 2|Adverse Event|2|||
149851232|NCT01708954|540585156|FG002|Step 2|Adverse Event|0|||
149851233|NCT01708954|540585154|FG000|Step 2|Withdrawal by Subject|1|||
149851234|NCT01708954|540585155|FG001|Step 2|Withdrawal by Subject|1|||
149851235|NCT01708954|540585156|FG002|Step 2|Withdrawal by Subject|0|||
149851236|NCT05996198|540585157|FG000|Overall Study|Withdrawal by Subject|1|||
149851237|NCT05996198|540585158|FG001|Overall Study|Withdrawal by Subject|0|||
149851238|NCT01192776|540585159|FG000|Overall Study|Death|8|||
149851239|NCT01192776|540585160|FG001|Overall Study|Death|15|||
149851240|NCT01192776|540585161|FG002|Overall Study|Death|18|||
149851241|NCT01192776|540585162|FG003|Overall Study|Death|15|||
149851242|NCT01192776|540585159|FG000|Overall Study|Lost to Follow-up|3|||
149851243|NCT01192776|540585160|FG001|Overall Study|Lost to Follow-up|6|||
149851244|NCT01192776|540585161|FG002|Overall Study|Lost to Follow-up|3|||
149851245|NCT01192776|540585162|FG003|Overall Study|Lost to Follow-up|5|||
149851246|NCT00413049|540585170|FG000|Overall Study|Adverse Event|10|||
149851247|NCT00413049|540585171|FG001|Overall Study|Adverse Event|8|||
149851248|NCT00413049|540585170|FG000|Overall Study|Withdrawal by Subject|7|||
149851249|NCT00413049|540585171|FG001|Overall Study|Withdrawal by Subject|5|||
149851250|NCT00413049|540585170|FG000|Overall Study|Lost to Follow-up|2|||
149851251|NCT00413049|540585171|FG001|Overall Study|Lost to Follow-up|3|||
149851252|NCT00413049|540585170|FG000|Overall Study|Protocol Violation|3|||
149851253|NCT00413049|540585171|FG001|Overall Study|Protocol Violation|1|||
149851254|NCT00413049|540585170|FG000|Overall Study|Subject no longer requires study drug|0|||
149851255|NCT00413049|540585171|FG001|Overall Study|Subject no longer requires study drug|1|||
149851256|NCT00413049|540585170|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149851257|NCT00413049|540585171|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149851258|NCT00413049|540585170|FG000|Overall Study|Lack of Efficacy|1|||
149851259|NCT00413049|540585171|FG001|Overall Study|Lack of Efficacy|0|||
149851260|NCT00695110|540585176|FG000|Treatment Period 1|Adverse Event|1|||
149851261|NCT00695110|540585176|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149851262|NCT00695110|540585176|FG000|Treatment Period 3|Withdrawal by Subject|1|||
149851263|NCT00695110|540585176|FG000|Treatment Period 4|Adverse Event|1|||
149851264|NCT02575339|540585182|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
149851265|NCT02575339|540585183|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
149851266|NCT02575339|540585184|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
149851267|NCT02575339|540585182|FG000|Study Treatment|Disease Progression|5|||
149851268|NCT02575339|540585183|FG001|Study Treatment|Disease Progression|2|||
149851269|NCT02575339|540585184|FG002|Study Treatment|Disease Progression|0|||
149851270|NCT02575339|540585182|FG000|Study Treatment|Adverse Event|1|||
149851271|NCT02575339|540585183|FG001|Study Treatment|Adverse Event|2|||
149851272|NCT02575339|540585184|FG002|Study Treatment|Adverse Event|0|||
149851273|NCT02575339|540585182|FG000|Follow up|Death|6|||
149851274|NCT02575339|540585183|FG001|Follow up|Death|2|||
149851275|NCT02575339|540585184|FG002|Follow up|Death|0|||
149851276|NCT02575339|540585182|FG000|Follow up|Study Terminated|0|||
149851277|NCT02575339|540585183|FG001|Follow up|Study Terminated|2|||
149851278|NCT02575339|540585184|FG002|Follow up|Study Terminated|0|||
149851279|NCT02575339|540585182|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
149851280|NCT02575339|540585183|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
149851281|NCT02575339|540585184|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
149851282|NCT04675775|540585185|FG000|Overall Study|Withdrawal by Subject|7|||
149851283|NCT02340780|540585187|FG000|Overall Study|Ineligible|1|||
149851284|NCT01957150|540585188|FG000|Overall Study|Adverse Event|23|||
149851285|NCT01957150|540585189|FG001|Overall Study|Adverse Event|20|||
149851286|NCT01957150|540585188|FG000|Overall Study|Withdrawal by Subject|13|||
149851287|NCT01957150|540585189|FG001|Overall Study|Withdrawal by Subject|17|||
149851288|NCT01957150|540585188|FG000|Overall Study|Physician Decision|3|||
149851289|NCT01957150|540585189|FG001|Overall Study|Physician Decision|6|||
149958959|NCT02675452|540984114|FG011|Overall Study|Lost to Follow-up|0|||
149958960|NCT02675452|540984115|FG012|Overall Study|Lost to Follow-up|1|||
149958961|NCT02675452|540984116|FG013|Overall Study|Lost to Follow-up|0|||
149958962|NCT02675452|540984117|FG014|Overall Study|Lost to Follow-up|0|||
149958963|NCT02675452|540984118|FG015|Overall Study|Lost to Follow-up|0|||
149958964|NCT02675452|540984119|FG016|Overall Study|Lost to Follow-up|0|||
149958965|NCT02675452|540984120|FG017|Overall Study|Lost to Follow-up|0|||
149958966|NCT02675452|540984121|FG018|Overall Study|Lost to Follow-up|0|||
149958967|NCT02675452|540984122|FG019|Overall Study|Lost to Follow-up|0|||
149958968|NCT02675452|540984123|FG020|Overall Study|Lost to Follow-up|0|||
149958969|NCT02675452|540984124|FG021|Overall Study|Lost to Follow-up|0|||
149958970|NCT02675452|540984125|FG022|Overall Study|Lost to Follow-up|0|||
149958971|NCT02675452|540984126|FG023|Overall Study|Lost to Follow-up|0|||
149958972|NCT02675452|540984127|FG024|Overall Study|Lost to Follow-up|0|||
149958973|NCT02675452|540984128|FG025|Overall Study|Lost to Follow-up|0|||
149958974|NCT02675452|540984129|FG026|Overall Study|Lost to Follow-up|1|||
149958975|NCT02675452|540984130|FG027|Overall Study|Lost to Follow-up|0|||
149958976|NCT02675452|540984131|FG028|Overall Study|Lost to Follow-up|0|||
149958977|NCT02675452|540984103|FG000|Overall Study|Other|0|||
149958978|NCT02675452|540984104|FG001|Overall Study|Other|0|||
149958979|NCT02675452|540984105|FG002|Overall Study|Other|0|||
149958980|NCT02675452|540984106|FG003|Overall Study|Other|0|||
149958981|NCT02675452|540984107|FG004|Overall Study|Other|0|||
149958982|NCT02675452|540984108|FG005|Overall Study|Other|0|||
149958983|NCT02675452|540984109|FG006|Overall Study|Other|0|||
149958984|NCT02675452|540984110|FG007|Overall Study|Other|0|||
149958985|NCT02675452|540984111|FG008|Overall Study|Other|0|||
149958986|NCT02675452|540984112|FG009|Overall Study|Other|0|||
149958987|NCT02675452|540984113|FG010|Overall Study|Other|0|||
149958988|NCT02675452|540984114|FG011|Overall Study|Other|0|||
149958989|NCT02675452|540984115|FG012|Overall Study|Other|0|||
149958990|NCT02675452|540984116|FG013|Overall Study|Other|0|||
149958991|NCT02675452|540984117|FG014|Overall Study|Other|0|||
149958992|NCT02675452|540984118|FG015|Overall Study|Other|0|||
149958993|NCT02675452|540984119|FG016|Overall Study|Other|0|||
149958994|NCT02675452|540984120|FG017|Overall Study|Other|0|||
149958995|NCT02675452|540984121|FG018|Overall Study|Other|0|||
149958996|NCT02675452|540984122|FG019|Overall Study|Other|0|||
149958997|NCT02675452|540984123|FG020|Overall Study|Other|0|||
149958998|NCT02675452|540984124|FG021|Overall Study|Other|0|||
149958999|NCT02675452|540984125|FG022|Overall Study|Other|0|||
149959000|NCT02675452|540984126|FG023|Overall Study|Other|0|||
149959001|NCT02675452|540984127|FG024|Overall Study|Other|0|||
149959002|NCT02675452|540984128|FG025|Overall Study|Other|0|||
149959003|NCT02675452|540984129|FG026|Overall Study|Other|1|||
149959004|NCT02675452|540984130|FG027|Overall Study|Other|0|||
149959005|NCT02675452|540984131|FG028|Overall Study|Other|0|||
149959006|NCT04595370|540984134|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
149959007|NCT04595370|540984135|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
149959008|NCT04595370|540984136|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
149959009|NCT04595370|540984137|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
149851290|NCT01957150|540585188|FG000|Overall Study|Lost to Follow-up|4|||
149851291|NCT01957150|540585189|FG001|Overall Study|Lost to Follow-up|4|||
149959010|NCT04595370|540984138|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
149959011|NCT04595370|540984139|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
149959012|NCT04595370|540984134|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
149959013|NCT04595370|540984135|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
149959014|NCT04595370|540984136|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
149959015|NCT04595370|540984137|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
149851292|NCT01957150|540585188|FG000|Overall Study|Protocol Violation|1|||
149851293|NCT01957150|540585189|FG001|Overall Study|Protocol Violation|0|||
149851294|NCT01957150|540585188|FG000|Overall Study|Lack of Efficacy|11|||
149851295|NCT01957150|540585189|FG001|Overall Study|Lack of Efficacy|11|||
149851296|NCT02985398|540585190|FG000|Overall Study|Adverse Event|1|||
149851297|NCT02985398|540585190|FG000|Overall Study|Lost to Follow-up|4|||
149851298|NCT02985398|540585190|FG000|Overall Study|Withdrawal by Subject|8|||
149851299|NCT02985398|540585190|FG000|Overall Study|Study Burden|9|||
149851300|NCT00283842|540585193|FG000|Overall Study|Adverse Event|8|||
149851301|NCT00283842|540585194|FG001|Overall Study|Adverse Event|7|||
149851302|NCT00283842|540585195|FG002|Overall Study|Adverse Event|21|||
149851303|NCT00283842|540585196|FG003|Overall Study|Adverse Event|21|||
149851304|NCT00283842|540585197|FG004|Overall Study|Adverse Event|5|||
149851305|NCT00283842|540585193|FG000|Overall Study|Protocol Violation|1|||
149851306|NCT00283842|540585194|FG001|Overall Study|Protocol Violation|5|||
149851307|NCT00283842|540585195|FG002|Overall Study|Protocol Violation|4|||
149851308|NCT00283842|540585196|FG003|Overall Study|Protocol Violation|0|||
149851309|NCT00283842|540585197|FG004|Overall Study|Protocol Violation|0|||
149851310|NCT00283842|540585193|FG000|Overall Study|Protocol deviation|0|||
149851311|NCT00283842|540585194|FG001|Overall Study|Protocol deviation|0|||
149851312|NCT00283842|540585195|FG002|Overall Study|Protocol deviation|0|||
149851313|NCT00283842|540585196|FG003|Overall Study|Protocol deviation|0|||
149851314|NCT00283842|540585197|FG004|Overall Study|Protocol deviation|2|||
149851315|NCT00283842|540585193|FG000|Overall Study|Withdrawal by Subject|2|||
149851316|NCT00283842|540585194|FG001|Overall Study|Withdrawal by Subject|1|||
149851317|NCT00283842|540585195|FG002|Overall Study|Withdrawal by Subject|1|||
149851318|NCT00283842|540585196|FG003|Overall Study|Withdrawal by Subject|5|||
149851319|NCT00283842|540585197|FG004|Overall Study|Withdrawal by Subject|4|||
149851320|NCT00283842|540585193|FG000|Overall Study|Lack of Efficacy|1|||
149851321|NCT00283842|540585194|FG001|Overall Study|Lack of Efficacy|3|||
149851322|NCT00283842|540585195|FG002|Overall Study|Lack of Efficacy|1|||
149851323|NCT00283842|540585196|FG003|Overall Study|Lack of Efficacy|0|||
149851324|NCT00283842|540585197|FG004|Overall Study|Lack of Efficacy|3|||
149851325|NCT00283842|540585193|FG000|Overall Study|Lost to Follow-up|0|||
149851326|NCT00283842|540585194|FG001|Overall Study|Lost to Follow-up|2|||
149851327|NCT00283842|540585195|FG002|Overall Study|Lost to Follow-up|4|||
149851328|NCT00283842|540585196|FG003|Overall Study|Lost to Follow-up|1|||
149851329|NCT00283842|540585197|FG004|Overall Study|Lost to Follow-up|1|||
149851330|NCT00550147|540585198|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
149851331|NCT00550147|540585198|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
149851332|NCT00550147|540585198|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
149851333|NCT00550147|540585198|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
149851334|NCT00550147|540585198|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
149851335|NCT04320745|540585199|FG000|Overall Study|Adverse Event|26|||
150039107|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
150039108|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
150039109|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
150039110|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
150039111|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
150039112|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
150039113|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
150039114|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
150039115|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
150039116|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
150039117|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039118|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039119|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039120|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039121|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039122|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039123|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
150039124|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039125|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
149851336|NCT04320745|540585199|FG000|Overall Study|Withdrawal by Subject|4|||
149851337|NCT04320745|540585199|FG000|Overall Study|Lost to Follow-up|12|||
149851338|NCT04320745|540585199|FG000|Overall Study|Protocol Deviation|2|||
149851339|NCT04320745|540585199|FG000|Overall Study|Non-compliance With Study Drug|2|||
149851340|NCT04320745|540585199|FG000|Overall Study|Reason Not Specified|1|||
149851341|NCT00046839|540585200|FG000|Overall Study|Ineligible / No protocol treatment|0|||
149851342|NCT00046839|540585201|FG001|Overall Study|Ineligible / No protocol treatment|2|||
149851343|NCT00046839|540585200|FG000|Overall Study|Withdrawal of consent|1|||
150039126|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039127|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
149851344|NCT00046839|540585201|FG001|Overall Study|Withdrawal of consent|0|||
149851345|NCT02472639|540585202|FG000|Overall Study|Physician Decision|4|||
149851346|NCT02472639|540585203|FG001|Overall Study|Physician Decision|3|||
149851347|NCT00751023|540585204|FG000|Overall Study|Lost to Follow-up|11|||
149851348|NCT00751023|540585205|FG001|Overall Study|Lost to Follow-up|7|||
149851349|NCT04768114|540585206|FG000|Overall Study|Lost to Follow-up|5|||
149851350|NCT04768114|540585207|FG001|Overall Study|Lost to Follow-up|10|||
149851351|NCT04768114|540585206|FG000|Overall Study|Withdrawal by Subject|0|||
149851352|NCT04768114|540585207|FG001|Overall Study|Withdrawal by Subject|1|||
149851353|NCT01685008|540585208|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
149851354|NCT01685008|540585209|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
149851355|NCT01685008|540585210|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
149851356|NCT01685008|540585211|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
149851357|NCT01685008|540585208|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
149851358|NCT01685008|540585209|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
149851359|NCT01685008|540585210|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
149851360|NCT01685008|540585211|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
149851361|NCT01685008|540585208|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
149851362|NCT01685008|540585209|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
149851363|NCT01685008|540585210|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
149851364|NCT01685008|540585211|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
149851365|NCT01685008|540585208|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
149851366|NCT01685008|540585209|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
149851367|NCT01685008|540585210|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
149851368|NCT01685008|540585211|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
149851369|NCT01685008|540585208|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
149851370|NCT01685008|540585209|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
149851371|NCT01685008|540585210|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
149851372|NCT01685008|540585211|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
149851373|NCT00715676|540585220|FG000|Overall Study|Adverse Event|3|||
149851374|NCT00715676|540585221|FG001|Overall Study|Adverse Event|5|||
149851375|NCT00715676|540585222|FG002|Overall Study|Adverse Event|21|||
149851376|NCT00715676|540585220|FG000|Overall Study|Withdrawal by Subject|1|||
149851377|NCT00715676|540585221|FG001|Overall Study|Withdrawal by Subject|3|||
149851378|NCT00715676|540585222|FG002|Overall Study|Withdrawal by Subject|8|||
149851379|NCT00715676|540585220|FG000|Overall Study|Lost to Follow-up|1|||
149851380|NCT00715676|540585221|FG001|Overall Study|Lost to Follow-up|2|||
149851381|NCT00715676|540585222|FG002|Overall Study|Lost to Follow-up|1|||
149851382|NCT00715676|540585220|FG000|Overall Study|Terminated by Sponsor|1|||
149851383|NCT00715676|540585221|FG001|Overall Study|Terminated by Sponsor|0|||
149851384|NCT00715676|540585222|FG002|Overall Study|Terminated by Sponsor|0|||
149851385|NCT00715676|540585220|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
149851386|NCT00715676|540585221|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
149851387|NCT00715676|540585222|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
149851388|NCT00715676|540585220|FG000|Overall Study|Use of Exclusionary Medication|0|||
149851389|NCT00715676|540585221|FG001|Overall Study|Use of Exclusionary Medication|0|||
149851390|NCT00715676|540585222|FG002|Overall Study|Use of Exclusionary Medication|1|||
149851391|NCT00715676|540585220|FG000|Overall Study|Elevated Blood Glucose|0|||
149851392|NCT00715676|540585221|FG001|Overall Study|Elevated Blood Glucose|1|||
149851393|NCT00715676|540585222|FG002|Overall Study|Elevated Blood Glucose|0|||
149851394|NCT01963260|540585223|FG000|Overall Study|Withdrawal by Subject|2|||
149851395|NCT01963260|540585224|FG001|Overall Study|Withdrawal by Subject|0|||
149959016|NCT04595370|540984138|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
149959017|NCT04595370|540984139|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
149959018|NCT04595370|540984134|FG000|Overall Study|Adverse Event|0|||
149959019|NCT04595370|540984135|FG001|Overall Study|Adverse Event|4|||
149959020|NCT04595370|540984136|FG002|Overall Study|Adverse Event|3|||
149851396|NCT01963260|540585225|FG002|Overall Study|Withdrawal by Subject|0|||
149851397|NCT01963260|540585226|FG003|Overall Study|Withdrawal by Subject|1|||
149851398|NCT01963260|540585227|FG004|Overall Study|Withdrawal by Subject|2|||
149851399|NCT01963260|540585228|FG005|Overall Study|Withdrawal by Subject|0|||
149851400|NCT01963260|540585229|FG006|Overall Study|Withdrawal by Subject|0|||
149851401|NCT01963260|540585230|FG007|Overall Study|Withdrawal by Subject|0|||
149959021|NCT04595370|540984137|FG003|Overall Study|Adverse Event|1|||
149959022|NCT04595370|540984138|FG004|Overall Study|Adverse Event|1|||
149959023|NCT04595370|540984139|FG005|Overall Study|Adverse Event|1|||
149959024|NCT04595370|540984134|FG000|Overall Study|Withdrawal of Consent|1|||
149959025|NCT04595370|540984135|FG001|Overall Study|Withdrawal of Consent|1|||
149851402|NCT01963260|540585231|FG008|Overall Study|Withdrawal by Subject|0|||
149851403|NCT01963260|540585232|FG009|Overall Study|Withdrawal by Subject|0|||
149851404|NCT04994431|540585233|FG000|Overall Study|Adverse Event|1|||
149851405|NCT04994431|540585234|FG001|Overall Study|Adverse Event|0|||
149851406|NCT04892147|540585235|FG000|Overall Study|Withdrawal by Subject|2|||
149851407|NCT04892147|540585236|FG001|Overall Study|Withdrawal by Subject|0|||
149851408|NCT01547728|540585237|FG000|Overall Study|Change in procedure and equipment|1|||
149959026|NCT04595370|540984136|FG002|Overall Study|Withdrawal of Consent|1|||
149851409|NCT01547728|540585237|FG000|Overall Study|Drug not ready for subject|1|||
149851410|NCT01547728|540585237|FG000|Overall Study|Screen failure|39|||
150039128|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039129|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
149851411|NCT00057941|540585238|FG000|Overall Study|Death|1|||
149851412|NCT00057941|540585239|FG001|Overall Study|Death|2|||
149851413|NCT00057941|540585238|FG000|Overall Study|Adverse Event|7|||
150039130|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
150039131|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Transplant|0|||
150039132|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Transplant|1|||
150039133|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Transplant|0|||
150039134|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Transplant|0|||
150039135|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Transplant|0|||
150039136|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Transplant|1|||
150039137|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Transplant|0|||
150039138|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Transplant|0|||
150039139|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Transplant|0|||
150039140|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Transplant|0|||
150039141|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Transplant|0|||
149851414|NCT00057941|540585239|FG001|Overall Study|Adverse Event|9|||
149851415|NCT00057941|540585238|FG000|Overall Study|Lack of Efficacy|54|||
149851416|NCT00057941|540585239|FG001|Overall Study|Lack of Efficacy|53|||
149851417|NCT00057941|540585238|FG000|Overall Study|Withdrawal by Subject|6|||
149851418|NCT00057941|540585239|FG001|Overall Study|Withdrawal by Subject|1|||
149851419|NCT00057941|540585238|FG000|Overall Study|still on treatment|3|||
149851420|NCT00057941|540585239|FG001|Overall Study|still on treatment|1|||
149851421|NCT00057941|540585238|FG000|Overall Study|insurance, symptomatic deterioration|1|||
149851422|NCT00057941|540585239|FG001|Overall Study|insurance, symptomatic deterioration|3|||
149851423|NCT00057941|540585238|FG000|Overall Study|Ineligible|2|||
149851424|NCT00057941|540585239|FG001|Overall Study|Ineligible|5|||
149851425|NCT02760433|540585240|FG000|Overall Study|Lost to Follow-up|1|||
149851426|NCT02760433|540585241|FG001|Overall Study|Lost to Follow-up|0|||
149851427|NCT02760433|540585242|FG002|Overall Study|Lost to Follow-up|1|||
149851428|NCT02760433|540585243|FG003|Overall Study|Lost to Follow-up|0|||
150039142|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Transplant|0|||
150039143|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Transplant|0|||
150039144|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Transplant|0|||
150039145|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
150039146|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
150039147|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
150039148|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
150039149|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
150039150|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
150039151|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
149851429|NCT02760433|540585244|FG004|Overall Study|Lost to Follow-up|0|||
149851430|NCT02760433|540585240|FG000|Overall Study|Withdrawal by Subject|23|||
149851431|NCT02760433|540585241|FG001|Overall Study|Withdrawal by Subject|9|||
149851432|NCT02760433|540585242|FG002|Overall Study|Withdrawal by Subject|0|||
149851433|NCT02760433|540585243|FG003|Overall Study|Withdrawal by Subject|2|||
149851434|NCT02760433|540585244|FG004|Overall Study|Withdrawal by Subject|9|||
149851435|NCT02760433|540585240|FG000|Overall Study|Lack of Response At Week 14|0|||
149851436|NCT02760433|540585241|FG001|Overall Study|Lack of Response At Week 14|0|||
149851437|NCT02760433|540585242|FG002|Overall Study|Lack of Response At Week 14|0|||
149851438|NCT02760433|540585243|FG003|Overall Study|Lack of Response At Week 14|0|||
149851439|NCT02760433|540585244|FG004|Overall Study|Lack of Response At Week 14|1|||
149851440|NCT02760433|540585240|FG000|Overall Study|Subject refused to continue the study|1|||
149851441|NCT02760433|540585241|FG001|Overall Study|Subject refused to continue the study|0|||
149851442|NCT02760433|540585242|FG002|Overall Study|Subject refused to continue the study|0|||
149851443|NCT02760433|540585243|FG003|Overall Study|Subject refused to continue the study|0|||
149851444|NCT02760433|540585244|FG004|Overall Study|Subject refused to continue the study|0|||
149851445|NCT02760433|540585240|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
150039152|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
150039153|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
150039154|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
150039155|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
150039156|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
150039157|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
150039158|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
150039159|NCT02113982|541285077|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
149851446|NCT02760433|540585241|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
149851447|NCT02760433|540585242|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
149851448|NCT02760433|540585243|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
149851449|NCT02760433|540585244|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
149851450|NCT02760433|540585240|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
149851451|NCT02760433|540585241|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
149851452|NCT02760433|540585242|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
149851453|NCT02760433|540585243|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
149851454|NCT02760433|540585244|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
149851455|NCT00766493|540585245|FG000|30 Days Post-Procedure|Discontinued|7|||
149851456|NCT00766493|540585245|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
149851457|NCT00766493|540585245|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
149851458|NCT03439085|540585247|FG000|Overall Study|Death|2|||
149851459|NCT03439085|540585247|FG000|Overall Study|Screen Failure|20|||
149851460|NCT00830167|540585250|FG000|Overall Study|Lack of Efficacy|26|||
149851461|NCT00830167|540585251|FG001|Overall Study|Lack of Efficacy|10|||
149851462|NCT00830167|540585250|FG000|Overall Study|Adverse Event|8|||
149851463|NCT00830167|540585251|FG001|Overall Study|Adverse Event|24|||
149851464|NCT00830167|540585250|FG000|Overall Study|Not meeting entrance criteria|2|||
149851465|NCT00830167|540585251|FG001|Overall Study|Not meeting entrance criteria|5|||
149851466|NCT00830167|540585250|FG000|Overall Study|Withdrawal by Subject|2|||
149851467|NCT00830167|540585251|FG001|Overall Study|Withdrawal by Subject|0|||
149851468|NCT00830167|540585250|FG000|Overall Study|Lost to Follow-up|0|||
149851469|NCT00830167|540585251|FG001|Overall Study|Lost to Follow-up|1|||
149851470|NCT00830167|540585250|FG000|Overall Study|Protocol Violation|0|||
149851471|NCT00830167|540585251|FG001|Overall Study|Protocol Violation|1|||
149851472|NCT00830167|540585250|FG000|Overall Study|Other|2|||
149851473|NCT00830167|540585251|FG001|Overall Study|Other|2|||
149851474|NCT02224053|540585252|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
149851475|NCT02224053|540585252|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
149851476|NCT02224053|540585252|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
149851477|NCT02224053|540585252|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
149851478|NCT02224053|540585252|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
149851479|NCT03448692|540585253|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
149851480|NCT03448692|540585254|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
149851481|NCT03448692|540585253|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
149851482|NCT03448692|540585254|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
149851483|NCT03448692|540585253|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
149851484|NCT03448692|540585254|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
149851485|NCT03448692|540585253|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
149851486|NCT03448692|540585254|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
149851487|NCT03448692|540585253|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
149851488|NCT03448692|540585254|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
149851489|NCT02289820|540585255|FG000|Overall Study|Withdrawal by Subject|2|||
149851490|NCT02289820|540585256|FG001|Overall Study|Withdrawal by Subject|1|||
149851491|NCT02289820|540585257|FG002|Overall Study|Withdrawal by Subject|2|||
149851492|NCT02289820|540585258|FG003|Overall Study|Withdrawal by Subject|1|||
149851493|NCT02289820|540585259|FG004|Overall Study|Withdrawal by Subject|0|||
149851494|NCT02289820|540585260|FG005|Overall Study|Withdrawal by Subject|0|||
149851495|NCT02289820|540585261|FG006|Overall Study|Withdrawal by Subject|1|||
149851496|NCT02289820|540585255|FG000|Overall Study|Death|0|||
149851497|NCT02289820|540585256|FG001|Overall Study|Death|0|||
149851498|NCT02289820|540585257|FG002|Overall Study|Death|1|||
149851499|NCT02289820|540585258|FG003|Overall Study|Death|0|||
149851500|NCT02289820|540585259|FG004|Overall Study|Death|0|||
149851501|NCT02289820|540585260|FG005|Overall Study|Death|0|||
149851502|NCT02289820|540585261|FG006|Overall Study|Death|0|||
149851503|NCT02289820|540585255|FG000|Overall Study|Lost to Follow-up|0|||
149851504|NCT02289820|540585256|FG001|Overall Study|Lost to Follow-up|0|||
149851505|NCT02289820|540585257|FG002|Overall Study|Lost to Follow-up|3|||
149851506|NCT02289820|540585258|FG003|Overall Study|Lost to Follow-up|1|||
149851507|NCT02289820|540585259|FG004|Overall Study|Lost to Follow-up|0|||
149851508|NCT02289820|540585260|FG005|Overall Study|Lost to Follow-up|1|||
149851509|NCT02289820|540585261|FG006|Overall Study|Lost to Follow-up|1|||
149851510|NCT02289820|540585255|FG000|Overall Study|withdrawal of consent|0|||
149851511|NCT02289820|540585256|FG001|Overall Study|withdrawal of consent|1|||
149851512|NCT02289820|540585257|FG002|Overall Study|withdrawal of consent|0|||
149851513|NCT02289820|540585258|FG003|Overall Study|withdrawal of consent|0|||
149959027|NCT04595370|540984137|FG003|Overall Study|Withdrawal of Consent|0|||
149959028|NCT04595370|540984138|FG004|Overall Study|Withdrawal of Consent|0|||
149851514|NCT02289820|540585259|FG004|Overall Study|withdrawal of consent|0|||
149959029|NCT04595370|540984139|FG005|Overall Study|Withdrawal of Consent|0|||
149851515|NCT02289820|540585260|FG005|Overall Study|withdrawal of consent|0|||
149851516|NCT02289820|540585261|FG006|Overall Study|withdrawal of consent|0|||
149851517|NCT02786927|540585268|FG000|Overall Study|Adverse Event|1|||
149851518|NCT02786927|540585268|FG000|Overall Study|Protocol Violation|4|||
149851519|NCT01801917|540585269|FG000|Period 1 - Randomized|Adverse Event|1|||
149851520|NCT01801917|540585270|FG001|Period 1 - Randomized|Adverse Event|0|||
149851521|NCT01801917|540585271|FG002|Period 1 - Randomized|Adverse Event|1|||
149851522|NCT01801917|540585272|FG003|Period 1 - Randomized|Adverse Event|0|||
149851523|NCT01924364|540585273|FG000|Overall Study|Physician Decision|3|||
149851524|NCT00265785|540585274|FG000|Overall Study|Adverse Event|4|||
149851525|NCT00265785|540585274|FG000|Overall Study|Withdrawal by Subject|3|||
149851526|NCT00265785|540585274|FG000|Overall Study|Progression/Relapse|15|||
149851527|NCT00265785|540585274|FG000|Overall Study|Not protocol specified|2|||
149851528|NCT00265785|540585274|FG000|Overall Study|Ineligible|1|||
149851529|NCT00265785|540585274|FG000|Overall Study|Did not receive protocol treatment|2|||
149851530|NCT03919695|540585275|FG000|3-month Follow-up|Death|1|||
149851531|NCT03919695|540585276|FG001|3-month Follow-up|Death|1|||
149851532|NCT03919695|540585275|FG000|3-month Follow-up|unable to contact|0|||
149851533|NCT03919695|540585276|FG001|3-month Follow-up|unable to contact|3|||
149851534|NCT03919695|540585275|FG000|3-month Follow-up|in prison|0|||
149851535|NCT03919695|540585276|FG001|3-month Follow-up|in prison|1|||
149851536|NCT03919695|540585275|FG000|6-month Follow-up|Death|0|||
149851537|NCT03919695|540585276|FG001|6-month Follow-up|Death|1|||
149851538|NCT03919695|540585275|FG000|6-month Follow-up|Lost to Follow-up|1|||
149851539|NCT03919695|540585276|FG001|6-month Follow-up|Lost to Follow-up|2|||
149959030|NCT04595370|540984134|FG000|Overall Study|Death|0|||
149959031|NCT04595370|540984135|FG001|Overall Study|Death|1|||
149959032|NCT04595370|540984136|FG002|Overall Study|Death|0|||
149959033|NCT04595370|540984137|FG003|Overall Study|Death|0|||
149959034|NCT04595370|540984138|FG004|Overall Study|Death|1|||
149959035|NCT04595370|540984139|FG005|Overall Study|Death|0|||
149959036|NCT04595370|540984134|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149959037|NCT04595370|540984135|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149959038|NCT04595370|540984136|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
149959039|NCT04595370|540984137|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149851540|NCT03919695|540585275|FG000|6-month Follow-up|in prison|0|||
149851541|NCT03919695|540585276|FG001|6-month Follow-up|in prison|2|||
149851542|NCT03919695|540585275|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
149851543|NCT03919695|540585276|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
149851544|NCT03919695|540585275|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
149851545|NCT03919695|540585276|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
149851546|NCT01688882|540585277|FG000|Overall Study|Adverse Event|1|||
149851547|NCT01688882|540585278|FG001|Overall Study|Adverse Event|0|||
149851548|NCT01688882|540585277|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149851549|NCT01688882|540585278|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149851550|NCT01688882|540585277|FG000|Overall Study|Administrative problems|1|||
149851551|NCT01688882|540585278|FG001|Overall Study|Administrative problems|0|||
149851552|NCT02416934|540585280|FG000|Overall Study|given steroids|1|||
149851553|NCT02416934|540585281|FG001|Overall Study|given steroids|2|||
149959040|NCT04595370|540984138|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149959041|NCT04595370|540984139|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149959042|NCT04595370|540984134|FG000|Overall Study|Withdrawal by Subject|0|||
149959043|NCT04595370|540984135|FG001|Overall Study|Withdrawal by Subject|0|||
149851554|NCT02416934|540585280|FG000|Overall Study|Lost to Follow-up|0|||
149851555|NCT02416934|540585281|FG001|Overall Study|Lost to Follow-up|2|||
149851556|NCT02416934|540585280|FG000|Overall Study|Withdrawal by Subject|1|||
149851557|NCT02416934|540585281|FG001|Overall Study|Withdrawal by Subject|0|||
149851558|NCT02416934|540585280|FG000|Overall Study|recruited during continuing renewal proc|0|||
149959044|NCT04595370|540984136|FG002|Overall Study|Withdrawal by Subject|1|||
149959045|NCT04595370|540984137|FG003|Overall Study|Withdrawal by Subject|0|||
149959046|NCT04595370|540984138|FG004|Overall Study|Withdrawal by Subject|2|||
149959047|NCT04595370|540984139|FG005|Overall Study|Withdrawal by Subject|0|||
150039160|NCT02113982|541285078|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
150039161|NCT02113982|541285079|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
150039162|NCT02113982|541285080|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
149851559|NCT02416934|540585281|FG001|Overall Study|recruited during continuing renewal proc|1|||
150039163|NCT02113982|541285081|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
150039164|NCT02113982|541285082|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
149851560|NCT02416934|540585280|FG000|Overall Study|Protocol Violation|0|||
149851561|NCT02416934|540585281|FG001|Overall Study|Protocol Violation|1|||
149851562|NCT02416934|540585280|FG000|Overall Study|surgery started late|0|||
149851563|NCT02416934|540585281|FG001|Overall Study|surgery started late|1|||
149851564|NCT02416934|540585280|FG000|Overall Study|re-operation|1|||
149851565|NCT02416934|540585281|FG001|Overall Study|re-operation|0|||
149851566|NCT01337596|540585295|FG000|Overall Study|Withdrawal by Subject|0|||
149851567|NCT01337596|540585296|FG001|Overall Study|Withdrawal by Subject|0|||
149959048|NCT04595370|540984134|FG000|Overall Study|Lost to Follow-up|0|||
149959049|NCT04595370|540984135|FG001|Overall Study|Lost to Follow-up|0|||
149959050|NCT04595370|540984136|FG002|Overall Study|Lost to Follow-up|0|||
149851568|NCT01337596|540585297|FG002|Overall Study|Withdrawal by Subject|0|||
149851569|NCT01337596|540585298|FG003|Overall Study|Withdrawal by Subject|0|||
149851570|NCT01337596|540585299|FG004|Overall Study|Withdrawal by Subject|2|||
149851571|NCT01337596|540585300|FG005|Overall Study|Withdrawal by Subject|0|||
149851572|NCT01337596|540585301|FG006|Overall Study|Withdrawal by Subject|0|||
149851573|NCT01337596|540585302|FG007|Overall Study|Withdrawal by Subject|0|||
149851574|NCT01337596|540585303|FG008|Overall Study|Withdrawal by Subject|0|||
149851575|NCT03201003|540585307|FG000|Overall Study|Adverse Event|14|||
149851576|NCT03201003|540585308|FG001|Overall Study|Adverse Event|1|||
149851577|NCT03201003|540585307|FG000|Overall Study|Other reasons|5|||
149851578|NCT03201003|540585308|FG001|Overall Study|Other reasons|1|||
149851579|NCT03201003|540585307|FG000|Overall Study|Withdrawal by Subject|4|||
149851580|NCT03201003|540585308|FG001|Overall Study|Withdrawal by Subject|1|||
149851581|NCT03201003|540585307|FG000|Overall Study|Lost to Follow-up|2|||
149851582|NCT03201003|540585308|FG001|Overall Study|Lost to Follow-up|0|||
149851583|NCT03201003|540585307|FG000|Overall Study|Protocol Violation|1|||
149851584|NCT03201003|540585308|FG001|Overall Study|Protocol Violation|0|||
149851585|NCT00834613|540585309|FG000|First Intervention|Protocol Violation|1|||
149851586|NCT00834613|540585310|FG001|First Intervention|Protocol Violation|0|||
149851587|NCT01709903|540585314|FG000|Overall Study|administrative problems|2|||
149851588|NCT01709903|540585315|FG001|Overall Study|administrative problems|6|||
149851589|NCT01709903|540585314|FG000|Overall Study|Abnormal test procedure results|1|||
149851590|NCT01709903|540585315|FG001|Overall Study|Abnormal test procedure results|0|||
149851591|NCT01709903|540585314|FG000|Overall Study|In ability to use device|1|||
149851592|NCT01709903|540585315|FG001|Overall Study|In ability to use device|1|||
149851593|NCT01709903|540585314|FG000|Overall Study|no longer needed study drug|0|||
149851594|NCT01709903|540585315|FG001|Overall Study|no longer needed study drug|1|||
149851595|NCT01709903|540585314|FG000|Overall Study|Lost to Follow-up|0|||
149851596|NCT01709903|540585315|FG001|Overall Study|Lost to Follow-up|2|||
149851597|NCT01709903|540585314|FG000|Overall Study|Death|2|||
149851598|NCT01709903|540585315|FG001|Overall Study|Death|0|||
149851599|NCT01709903|540585314|FG000|Overall Study|Protocol Violation|3|||
149851600|NCT01709903|540585315|FG001|Overall Study|Protocol Violation|2|||
149851601|NCT01709903|540585314|FG000|Overall Study|Lack of Efficacy|3|||
149851602|NCT01709903|540585315|FG001|Overall Study|Lack of Efficacy|3|||
149851603|NCT01709903|540585314|FG000|Overall Study|Withdrawal by Subject|6|||
149851604|NCT01709903|540585315|FG001|Overall Study|Withdrawal by Subject|6|||
149851605|NCT01709903|540585314|FG000|Overall Study|Adverse Event|11|||
149851606|NCT01709903|540585315|FG001|Overall Study|Adverse Event|18|||
149851607|NCT04662710|540586575|FG000|Overall Study|Death|14|||
149851608|NCT04662710|540586576|FG001|Overall Study|Death|331|||
149851609|NCT04662710|540586577|FG002|Overall Study|Death|367|||
149851610|NCT04662710|540586575|FG000|Overall Study|Ongoing|1|||
149851611|NCT04662710|540586576|FG001|Overall Study|Ongoing|109|||
149851612|NCT04662710|540586577|FG002|Overall Study|Ongoing|56|||
149851613|NCT04662710|540586575|FG000|Overall Study|Withdrawal by Subject|0|||
149851614|NCT04662710|540586576|FG001|Overall Study|Withdrawal by Subject|3|||
149851615|NCT04662710|540586577|FG002|Overall Study|Withdrawal by Subject|14|||
149851616|NCT05480800|540586582|FG000|Overall Study|Withdrawal by Subject|0|||
149851617|NCT05480800|540586583|FG001|Overall Study|Withdrawal by Subject|0|||
149851618|NCT05480800|540586584|FG002|Overall Study|Withdrawal by Subject|2|||
149851619|NCT05480800|540586585|FG003|Overall Study|Withdrawal by Subject|1|||
149851620|NCT05480800|540586586|FG004|Overall Study|Withdrawal by Subject|0|||
149851621|NCT05480800|540586587|FG005|Overall Study|Withdrawal by Subject|0|||
149851622|NCT05480800|540586588|FG006|Overall Study|Withdrawal by Subject|1|||
149851623|NCT05480800|540586589|FG007|Overall Study|Withdrawal by Subject|0|||
149851624|NCT05480800|540586582|FG000|Overall Study|Other|0|||
149851625|NCT05480800|540586583|FG001|Overall Study|Other|0|||
149851626|NCT05480800|540586584|FG002|Overall Study|Other|0|||
149959051|NCT04595370|540984137|FG003|Overall Study|Lost to Follow-up|0|||
149959052|NCT04595370|540984138|FG004|Overall Study|Lost to Follow-up|1|||
149959053|NCT04595370|540984139|FG005|Overall Study|Lost to Follow-up|0|||
149959054|NCT04595370|540984134|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
149959055|NCT04595370|540984135|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
149851627|NCT05480800|540586585|FG003|Overall Study|Other|0|||
149851628|NCT05480800|540586586|FG004|Overall Study|Other|0|||
149851629|NCT05480800|540586587|FG005|Overall Study|Other|0|||
149851630|NCT05480800|540586588|FG006|Overall Study|Other|1|||
149851631|NCT05480800|540586589|FG007|Overall Study|Other|0|||
149851632|NCT00377156|540586592|FG000|Overall Study|Death|23|||
149851633|NCT00377156|540586593|FG001|Overall Study|Death|19|||
149851634|NCT00377156|540586592|FG000|Overall Study|Withdrawal by Subject|16|||
149959056|NCT04595370|540984136|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
149851635|NCT00377156|540586593|FG001|Overall Study|Withdrawal by Subject|24|||
149851636|NCT00377156|540586592|FG000|Overall Study|Had follow-up <90 d|3|||
149851637|NCT00377156|540586593|FG001|Overall Study|Had follow-up <90 d|6|||
149851638|NCT00377156|540586592|FG000|Overall Study|Cancellation|1|||
149851639|NCT00377156|540586593|FG001|Overall Study|Cancellation|0|||
149851640|NCT00377156|540586592|FG000|Overall Study|Refused testing|0|||
149851641|NCT00377156|540586593|FG001|Overall Study|Refused testing|1|||
149851642|NCT00377156|540586592|FG000|Overall Study|Ineligible|0|||
149851643|NCT00377156|540586593|FG001|Overall Study|Ineligible|1|||
149851644|NCT00377156|540586592|FG000|Overall Study|Disability or language problem|0|||
149851645|NCT00377156|540586593|FG001|Overall Study|Disability or language problem|1|||
149851646|NCT00377156|540586592|FG000|Overall Study|Other|5|||
149851647|NCT00377156|540586593|FG001|Overall Study|Other|2|||
149851648|NCT01802216|540586596|FG000|4 Month Visit|Participant did not show to visit|3|||
149851649|NCT01802216|540586597|FG001|4 Month Visit|Participant did not show to visit|4|||
149851650|NCT01802216|540586596|FG000|8 Month Visit|Participant did not show to visit|3|||
149851651|NCT01802216|540586597|FG001|8 Month Visit|Participant did not show to visit|5|||
149851652|NCT01802216|540586596|FG000|12 Month Visit|Participant did not show to visit|3|||
149851653|NCT01802216|540586597|FG001|12 Month Visit|Participant did not show to visit|4|||
149851654|NCT05061992|540586598|FG000|Overall Study|Excess bowel movements|1|||
149851655|NCT05061992|540586599|FG001|Overall Study|Excess bowel movements|0|||
149851656|NCT05061992|540586598|FG000|Overall Study|Complications of Medical Care|1|||
149851657|NCT05061992|540586599|FG001|Overall Study|Complications of Medical Care|0|||
149851658|NCT05061992|540586598|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
149851659|NCT05061992|540586599|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
149851660|NCT05061992|540586598|FG000|Overall Study|Withdrawal by Subject|0|||
149851661|NCT05061992|540586599|FG001|Overall Study|Withdrawal by Subject|1|||
149851662|NCT05693805|540586605|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
149851663|NCT05693805|540586606|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
149851664|NCT05212948|540586608|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
149851665|NCT05212948|540586609|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
149851666|NCT05212948|540586608|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
149851667|NCT05212948|540586609|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
149851668|NCT05212948|540586608|FG000|Initial Vaccination Period|Pregnancy|20|||
149851669|NCT05212948|540586609|FG001|Initial Vaccination Period|Pregnancy|14|||
149851670|NCT05212948|540586608|FG000|Initial Vaccination Period|Physician Decision|686|||
149851671|NCT05212948|540586609|FG001|Initial Vaccination Period|Physician Decision|401|||
149851672|NCT05212948|540586608|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
149851673|NCT05212948|540586609|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
149851674|NCT05212948|540586608|FG000|Initial Vaccination Period|Death|23|||
149851675|NCT05212948|540586609|FG001|Initial Vaccination Period|Death|18|||
149851676|NCT05212948|540586608|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
149851677|NCT05212948|540586609|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
149851678|NCT05212948|540586608|FG000|Initial Vaccination Period|Adverse Event|36|||
149851679|NCT05212948|540586609|FG001|Initial Vaccination Period|Adverse Event|23|||
149959057|NCT04595370|540984137|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
149959058|NCT04595370|540984138|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
149959059|NCT04595370|540984139|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
149959060|NCT05660538|540984140|FG000|Overall Study|Adverse Event|0|||
150039165|NCT02113982|541285083|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
150039166|NCT02113982|541285084|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
150039167|NCT02113982|541285085|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
150039168|NCT02113982|541285086|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
150039169|NCT02113982|541285087|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
149959061|NCT05660538|540984141|FG001|Overall Study|Adverse Event|0|||
149959062|NCT05660538|540984142|FG002|Overall Study|Adverse Event|1|||
149959063|NCT05660538|540984143|FG003|Overall Study|Adverse Event|0|||
149959064|NCT05660538|540984140|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
149959065|NCT05660538|540984141|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
149959066|NCT05660538|540984142|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
149959067|NCT05660538|540984143|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
149959068|NCT05660538|540984140|FG000|Overall Study|Lost to Follow-up|0|||
149959069|NCT05660538|540984141|FG001|Overall Study|Lost to Follow-up|0|||
149959070|NCT05660538|540984142|FG002|Overall Study|Lost to Follow-up|1|||
149959071|NCT05660538|540984143|FG003|Overall Study|Lost to Follow-up|1|||
149959072|NCT05660538|540984140|FG000|Overall Study|Death|0|||
149959073|NCT05660538|540984141|FG001|Overall Study|Death|0|||
149959074|NCT05660538|540984142|FG002|Overall Study|Death|1|||
149959075|NCT05660538|540984143|FG003|Overall Study|Death|0|||
149959076|NCT05660538|540984140|FG000|Overall Study|Physician Decision|0|||
149959077|NCT05660538|540984141|FG001|Overall Study|Physician Decision|0|||
150039170|NCT02113982|541285088|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
149959078|NCT05660538|540984142|FG002|Overall Study|Physician Decision|0|||
149851680|NCT05212948|540586608|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
149851681|NCT05212948|540586609|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
149851682|NCT05212948|540586608|FG000|Crossover Vaccination Period|Pregnancy|6|||
149851683|NCT05212948|540586609|FG001|Crossover Vaccination Period|Pregnancy|1|||
149851684|NCT05212948|540586608|FG000|Crossover Vaccination Period|Physician Decision|49|||
149851685|NCT05212948|540586609|FG001|Crossover Vaccination Period|Physician Decision|24|||
149851686|NCT05212948|540586608|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
149851687|NCT05212948|540586609|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
149851688|NCT05212948|540586608|FG000|Crossover Vaccination Period|Death|10|||
149851689|NCT05212948|540586609|FG001|Crossover Vaccination Period|Death|5|||
149851690|NCT05212948|540586608|FG000|Crossover Vaccination Period|Adverse Event|9|||
149851691|NCT05212948|540586609|FG001|Crossover Vaccination Period|Adverse Event|4|||
149851692|NCT05347693|540586610|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
149851693|NCT05347693|540586611|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
149851694|NCT05347693|540586612|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
149851695|NCT05347693|540586610|FG000|Inpatient Period|Withdrawal of consent|10|||
149851696|NCT05347693|540586611|FG001|Inpatient Period|Withdrawal of consent|0|||
149851697|NCT05347693|540586612|FG002|Inpatient Period|Withdrawal of consent|0|||
149851698|NCT05347693|540586610|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
149851699|NCT05347693|540586611|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
149851700|NCT05347693|540586612|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
149851701|NCT05347693|540586610|FG000|Inpatient Period|Screening Failure|8|||
149851702|NCT05347693|540586611|FG001|Inpatient Period|Screening Failure|0|||
149851703|NCT05347693|540586612|FG002|Inpatient Period|Screening Failure|0|||
149851704|NCT05347693|540586610|FG000|Inpatient Period|Death|2|||
149851705|NCT05347693|540586611|FG001|Inpatient Period|Death|0|||
149851706|NCT05347693|540586612|FG002|Inpatient Period|Death|0|||
149851707|NCT05347693|540586610|FG000|Inpatient Period|Physician Decision|5|||
149851708|NCT05347693|540586611|FG001|Inpatient Period|Physician Decision|0|||
149851709|NCT05347693|540586612|FG002|Inpatient Period|Physician Decision|0|||
149851710|NCT05347693|540586610|FG000|Inpatient Period|Adverse Event|3|||
149851711|NCT05347693|540586611|FG001|Inpatient Period|Adverse Event|0|||
149851712|NCT05347693|540586612|FG002|Inpatient Period|Adverse Event|0|||
149851713|NCT05347693|540586610|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
149851714|NCT05347693|540586611|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
149851715|NCT05347693|540586612|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
149851716|NCT05347693|540586610|FG000|Outpatient Period|Adverse Event|0|||
149851717|NCT05347693|540586611|FG001|Outpatient Period|Adverse Event|9|||
149851718|NCT05347693|540586612|FG002|Outpatient Period|Adverse Event|0|||
149851719|NCT05347693|540586610|FG000|Outpatient Period|Death|0|||
149851720|NCT05347693|540586611|FG001|Outpatient Period|Death|6|||
149851721|NCT05347693|540586612|FG002|Outpatient Period|Death|2|||
149851722|NCT05347693|540586610|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
149851723|NCT05347693|540586611|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
149851724|NCT05347693|540586612|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
149851725|NCT05347693|540586610|FG000|Outpatient Period|Lost to Follow-up|0|||
149851726|NCT05347693|540586611|FG001|Outpatient Period|Lost to Follow-up|0|||
149851727|NCT05347693|540586612|FG002|Outpatient Period|Lost to Follow-up|1|||
149851728|NCT05347693|540586610|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
149851729|NCT05347693|540586611|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
149851730|NCT05347693|540586612|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
149851731|NCT05347693|540586610|FG000|Outpatient Period|Scheduled hemodialysis|0|||
149851732|NCT05347693|540586611|FG001|Outpatient Period|Scheduled hemodialysis|1|||
149851733|NCT05347693|540586612|FG002|Outpatient Period|Scheduled hemodialysis|0|||
149851734|NCT05347693|540586610|FG000|Outpatient Period|Severe HK|0|||
149851735|NCT05347693|540586611|FG001|Outpatient Period|Severe HK|0|||
149851736|NCT05347693|540586612|FG002|Outpatient Period|Severe HK|1|||
149851737|NCT05347693|540586610|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
149851738|NCT05347693|540586611|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
149851739|NCT05347693|540586612|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
149851740|NCT05347693|540586610|FG000|Outpatient Period|Start of dialysis|0|||
149851741|NCT05347693|540586611|FG001|Outpatient Period|Start of dialysis|0|||
149851742|NCT05347693|540586612|FG002|Outpatient Period|Start of dialysis|1|||
149959079|NCT05660538|540984143|FG003|Overall Study|Physician Decision|1|||
149959080|NCT05660538|540984140|FG000|Overall Study|Sponsor Decision|1|||
149959081|NCT05660538|540984141|FG001|Overall Study|Sponsor Decision|0|||
149959082|NCT05660538|540984142|FG002|Overall Study|Sponsor Decision|0|||
149959083|NCT05660538|540984143|FG003|Overall Study|Sponsor Decision|0|||
149959084|NCT05660538|540984140|FG000|Overall Study|Other|1|||
149959085|NCT05660538|540984141|FG001|Overall Study|Other|0|||
149959086|NCT05660538|540984142|FG002|Overall Study|Other|0|||
149959087|NCT05660538|540984143|FG003|Overall Study|Other|1|||
149851743|NCT05347693|540586610|FG000|Outpatient Period|The participant entered hemodialysis|0|||
149959088|NCT05660538|540984140|FG000|Overall Study|Randomized but did not receive study drug|1|||
149851744|NCT05347693|540586611|FG001|Outpatient Period|The participant entered hemodialysis|0|||
149851745|NCT05347693|540586612|FG002|Outpatient Period|The participant entered hemodialysis|1|||
149851746|NCT05347693|540586610|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
149851747|NCT05347693|540586611|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
149851748|NCT05347693|540586612|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
149851749|NCT05347693|540586610|FG000|Outpatient Period|Withdrawal by Subject|0|||
149851750|NCT05347693|540586611|FG001|Outpatient Period|Withdrawal by Subject|8|||
149851751|NCT05347693|540586612|FG002|Outpatient Period|Withdrawal by Subject|5|||
149851752|NCT03223909|540586613|FG000|Overall Study|Protocol Violation|48|||
149851753|NCT03223909|540586614|FG001|Overall Study|Protocol Violation|45|||
149851754|NCT03223909|540586615|FG002|Overall Study|Protocol Violation|16|||
149851755|NCT01856192|540586618|FG000|Overall Study|Adverse Event|12|||
149851756|NCT01856192|540586619|FG001|Overall Study|Adverse Event|4|||
149851757|NCT01856192|540586618|FG000|Overall Study|Alternative therapy|0|||
149851758|NCT01856192|540586619|FG001|Overall Study|Alternative therapy|3|||
149851759|NCT01856192|540586618|FG000|Overall Study|Death|3|||
149851760|NCT01856192|540586619|FG001|Overall Study|Death|5|||
149851761|NCT01856192|540586618|FG000|Overall Study|Lack of Efficacy|0|||
149851762|NCT01856192|540586619|FG001|Overall Study|Lack of Efficacy|5|||
149851763|NCT01856192|540586618|FG000|Overall Study|Withdrawal by Subject|1|||
149851764|NCT01856192|540586619|FG001|Overall Study|Withdrawal by Subject|1|||
149851765|NCT01856192|540586618|FG000|Overall Study|Other diseases|1|||
149851766|NCT01856192|540586619|FG001|Overall Study|Other diseases|0|||
149851767|NCT01856192|540586618|FG000|Overall Study|Never started treatment|7|||
149851768|NCT01856192|540586619|FG001|Overall Study|Never started treatment|5|||
149851769|NCT01856192|540586618|FG000|Overall Study|Path ineligible|20|||
149851770|NCT01856192|540586619|FG001|Overall Study|Path ineligible|34|||
149851771|NCT01856192|540586618|FG000|Overall Study|Non-path ineligible|2|||
149851772|NCT01856192|540586619|FG001|Overall Study|Non-path ineligible|2|||
149851773|NCT01856192|540586618|FG000|Overall Study|Physician Decision|1|||
149851774|NCT01856192|540586619|FG001|Overall Study|Physician Decision|1|||
149851775|NCT01856192|540586618|FG000|Overall Study|Suspicion of progressive disease|1|||
149851776|NCT01856192|540586619|FG001|Overall Study|Suspicion of progressive disease|0|||
149851777|NCT01856192|540586618|FG000|Overall Study|Non-compliance|1|||
149851778|NCT01856192|540586619|FG001|Overall Study|Non-compliance|0|||
149851779|NCT00098475|540586620|FG000|Step 1|Progressive disease|33|||
149851780|NCT00098475|540586621|FG001|Step 1|Progressive disease|35|||
149851781|NCT00098475|540586622|FG002|Step 1|Progressive disease|2|||
149851782|NCT00098475|540586623|FG003|Step 1|Progressive disease|1|||
149851783|NCT00098475|540586620|FG000|Step 1|Adverse Event|56|||
149851784|NCT00098475|540586621|FG001|Step 1|Adverse Event|37|||
149851785|NCT00098475|540586622|FG002|Step 1|Adverse Event|0|||
149851786|NCT00098475|540586623|FG003|Step 1|Adverse Event|1|||
149851787|NCT00098475|540586620|FG000|Step 1|Death|8|||
149851788|NCT00098475|540586621|FG001|Step 1|Death|5|||
149851789|NCT00098475|540586622|FG002|Step 1|Death|0|||
149959089|NCT05660538|540984141|FG001|Overall Study|Randomized but did not receive study drug|0|||
149959090|NCT05660538|540984142|FG002|Overall Study|Randomized but did not receive study drug|0|||
149959091|NCT05660538|540984143|FG003|Overall Study|Randomized but did not receive study drug|1|||
149959092|NCT05660538|540984140|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
149959093|NCT05660538|540984141|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
149959094|NCT05660538|540984142|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
149959095|NCT05660538|540984143|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
149959096|NCT04518410|540984144|FG000|Overall Study|Lost to Follow-up|1|||
149959097|NCT04518410|540984145|FG001|Overall Study|Lost to Follow-up|1|||
149959098|NCT04518410|540984146|FG002|Overall Study|Lost to Follow-up|8|||
149959099|NCT04518410|540984147|FG003|Overall Study|Lost to Follow-up|5|||
149959100|NCT04518410|540984148|FG004|Overall Study|Lost to Follow-up|92|||
149959101|NCT04518410|540984149|FG005|Overall Study|Lost to Follow-up|25|||
149959102|NCT04518410|540984150|FG006|Overall Study|Lost to Follow-up|25|||
149959103|NCT04518410|540984151|FG007|Overall Study|Lost to Follow-up|3|||
149959104|NCT04518410|540984152|FG008|Overall Study|Lost to Follow-up|2|||
149959105|NCT04518410|540984153|FG009|Overall Study|Lost to Follow-up|13|||
150172793|NCT00961636|541768093|FG000|Overall Study|Physician Decision|3|||
150172794|NCT00961636|541768094|FG001|Overall Study|Physician Decision|1|||
149851790|NCT00098475|540586623|FG003|Step 1|Death|1|||
149851791|NCT00098475|540586620|FG000|Step 1|Withdrawal by Subject|14|||
149851792|NCT00098475|540586621|FG001|Step 1|Withdrawal by Subject|11|||
149851793|NCT00098475|540586622|FG002|Step 1|Withdrawal by Subject|0|||
149851794|NCT00098475|540586623|FG003|Step 1|Withdrawal by Subject|0|||
149851795|NCT00098475|540586620|FG000|Step 1|Physician Decision|5|||
149851796|NCT00098475|540586621|FG001|Step 1|Physician Decision|2|||
149959106|NCT04518410|540984154|FG010|Overall Study|Lost to Follow-up|9|||
149959107|NCT04518410|540984155|FG011|Overall Study|Lost to Follow-up|13|||
149959108|NCT04518410|540984156|FG012|Overall Study|Lost to Follow-up|9|||
149851797|NCT00098475|540586622|FG002|Step 1|Physician Decision|0|||
149851798|NCT00098475|540586623|FG003|Step 1|Physician Decision|0|||
149851799|NCT00098475|540586620|FG000|Step 1|Alternative therapy|31|||
149851800|NCT00098475|540586621|FG001|Step 1|Alternative therapy|43|||
149851801|NCT00098475|540586622|FG002|Step 1|Alternative therapy|1|||
149851802|NCT00098475|540586623|FG003|Step 1|Alternative therapy|0|||
149851803|NCT00098475|540586620|FG000|Step 1|Other disease|2|||
149851804|NCT00098475|540586621|FG001|Step 1|Other disease|1|||
149851805|NCT00098475|540586622|FG002|Step 1|Other disease|1|||
149851806|NCT00098475|540586623|FG003|Step 1|Other disease|0|||
149851807|NCT00098475|540586620|FG000|Step 1|Never started treatment|0|||
149851808|NCT00098475|540586621|FG001|Step 1|Never started treatment|2|||
149851809|NCT00098475|540586622|FG002|Step 1|Never started treatment|0|||
149851810|NCT00098475|540586623|FG003|Step 1|Never started treatment|0|||
149851811|NCT00098475|540586620|FG000|Step 1|Still on treatment as of this analysis|14|||
149851812|NCT00098475|540586621|FG001|Step 1|Still on treatment as of this analysis|27|||
149851813|NCT00098475|540586622|FG002|Step 1|Still on treatment as of this analysis|0|||
149851814|NCT00098475|540586623|FG003|Step 1|Still on treatment as of this analysis|0|||
149851815|NCT00098475|540586620|FG000|Step 1|Knee surgery|1|||
149851816|NCT00098475|540586621|FG001|Step 1|Knee surgery|0|||
149851817|NCT00098475|540586622|FG002|Step 1|Knee surgery|0|||
149851818|NCT00098475|540586623|FG003|Step 1|Knee surgery|0|||
149851819|NCT00098475|540586620|FG000|Step 1|Complications|1|||
149851820|NCT00098475|540586621|FG001|Step 1|Complications|0|||
149851821|NCT00098475|540586622|FG002|Step 1|Complications|0|||
149851822|NCT00098475|540586623|FG003|Step 1|Complications|0|||
149851823|NCT00098475|540586620|FG000|Step 1|Cannot comply due to other tx|0|||
149851824|NCT00098475|540586621|FG001|Step 1|Cannot comply due to other tx|1|||
149851825|NCT00098475|540586622|FG002|Step 1|Cannot comply due to other tx|0|||
149851826|NCT00098475|540586623|FG003|Step 1|Cannot comply due to other tx|0|||
149851827|NCT00098475|540586620|FG000|Step 1|Both patient and physician's decision|2|||
149851828|NCT00098475|540586621|FG001|Step 1|Both patient and physician's decision|1|||
149851829|NCT00098475|540586622|FG002|Step 1|Both patient and physician's decision|0|||
149851830|NCT00098475|540586623|FG003|Step 1|Both patient and physician's decision|0|||
149851831|NCT00098475|540586620|FG000|Step 1|Incorrect disease assessment|2|||
149851832|NCT00098475|540586621|FG001|Step 1|Incorrect disease assessment|0|||
149851833|NCT00098475|540586622|FG002|Step 1|Incorrect disease assessment|0|||
149851834|NCT00098475|540586623|FG003|Step 1|Incorrect disease assessment|0|||
149851835|NCT00098475|540586620|FG000|Step 1|Off treatment for > specified timeframe|1|||
149851836|NCT00098475|540586621|FG001|Step 1|Off treatment for > specified timeframe|1|||
149851837|NCT00098475|540586622|FG002|Step 1|Off treatment for > specified timeframe|0|||
149851838|NCT00098475|540586623|FG003|Step 1|Off treatment for > specified timeframe|0|||
149851839|NCT00098475|540586620|FG000|Step 1|Declining performance status|0|||
149851840|NCT00098475|540586621|FG001|Step 1|Declining performance status|1|||
149851841|NCT00098475|540586622|FG002|Step 1|Declining performance status|0|||
149851842|NCT00098475|540586623|FG003|Step 1|Declining performance status|0|||
149851843|NCT00098475|540586620|FG000|Step 1|Insurance issue|0|||
149851844|NCT00098475|540586621|FG001|Step 1|Insurance issue|1|||
149851845|NCT00098475|540586622|FG002|Step 1|Insurance issue|0|||
149851846|NCT00098475|540586623|FG003|Step 1|Insurance issue|0|||
149851847|NCT00098475|540586620|FG000|Step 1|Rising paraprotein|0|||
149851848|NCT00098475|540586621|FG001|Step 1|Rising paraprotein|1|||
149851849|NCT00098475|540586622|FG002|Step 1|Rising paraprotein|0|||
149851850|NCT00098475|540586623|FG003|Step 1|Rising paraprotein|0|||
149851851|NCT00098475|540586620|FG000|Step 1|Referred to other physicians|0|||
149851852|NCT00098475|540586621|FG001|Step 1|Referred to other physicians|1|||
149851853|NCT00098475|540586622|FG002|Step 1|Referred to other physicians|0|||
149851854|NCT00098475|540586623|FG003|Step 1|Referred to other physicians|0|||
149851855|NCT00098475|540586620|FG000|Step 1|Criteria to continue treatment not met|0|||
149851856|NCT00098475|540586621|FG001|Step 1|Criteria to continue treatment not met|1|||
149851857|NCT00098475|540586622|FG002|Step 1|Criteria to continue treatment not met|0|||
149851858|NCT00098475|540586623|FG003|Step 1|Criteria to continue treatment not met|0|||
149851859|NCT00098475|540586620|FG000|Step 1|Misinterpretation of lab data|0|||
149851860|NCT00098475|540586621|FG001|Step 1|Misinterpretation of lab data|1|||
149851861|NCT00098475|540586622|FG002|Step 1|Misinterpretation of lab data|0|||
149851862|NCT00098475|540586623|FG003|Step 1|Misinterpretation of lab data|0|||
149851863|NCT00098475|540586620|FG000|Step 1|Patient fell with fracture|1|||
149851864|NCT00098475|540586621|FG001|Step 1|Patient fell with fracture|0|||
149851865|NCT00098475|540586622|FG002|Step 1|Patient fell with fracture|0|||
149851866|NCT00098475|540586623|FG003|Step 1|Patient fell with fracture|0|||
149851867|NCT00098475|540586620|FG000|Step 1|Not documented|0|||
149851868|NCT00098475|540586621|FG001|Step 1|Not documented|1|||
149851869|NCT00098475|540586622|FG002|Step 1|Not documented|0|||
149851870|NCT00098475|540586623|FG003|Step 1|Not documented|0|||
149851871|NCT00098475|540586620|FG000|Step 2|Disease progression|1|||
149851872|NCT00098475|540586621|FG001|Step 2|Disease progression|4|||
149851873|NCT00098475|540586622|FG002|Step 2|Disease progression|0|||
149851874|NCT00098475|540586623|FG003|Step 2|Disease progression|0|||
149851875|NCT00098475|540586620|FG000|Step 2|Adverse Event|2|||
150039171|NCT02113982|541285089|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
150039172|NCT02113982|541285090|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
150039173|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
150039174|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
150039175|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
150039176|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
150039177|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
150039178|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
150039179|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
150039180|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
150039181|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
150039182|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
150039183|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
150039184|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
150039185|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
150039186|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
150039187|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
150039188|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
150039189|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
150039190|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
150039191|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
150039192|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
150039193|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
150039194|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
150039195|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
150039196|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
150039197|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
150039198|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
150039199|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
150039200|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
150039201|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039202|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039203|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039204|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039205|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039206|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039207|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039208|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
150039209|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039210|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
150039211|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
150039212|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039213|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039214|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
150039215|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039216|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039217|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039218|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039219|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039220|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039221|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039222|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
150039223|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039224|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
150039225|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039226|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039227|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039228|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
150039229|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039230|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039231|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039232|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039233|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039234|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039235|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039236|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
150039237|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039238|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039239|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039240|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039241|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
149851876|NCT00098475|540586621|FG001|Step 2|Adverse Event|0|||
149851877|NCT00098475|540586622|FG002|Step 2|Adverse Event|0|||
149851878|NCT00098475|540586623|FG003|Step 2|Adverse Event|0|||
149851879|NCT00098475|540586620|FG000|Step 2|Withdrawal by Subject|0|||
149851880|NCT00098475|540586621|FG001|Step 2|Withdrawal by Subject|2|||
149851881|NCT00098475|540586622|FG002|Step 2|Withdrawal by Subject|0|||
149851882|NCT00098475|540586623|FG003|Step 2|Withdrawal by Subject|0|||
149851883|NCT00098475|540586620|FG000|Step 2|Physician Decision|0|||
149851884|NCT00098475|540586621|FG001|Step 2|Physician Decision|1|||
149851885|NCT00098475|540586622|FG002|Step 2|Physician Decision|0|||
149851886|NCT00098475|540586623|FG003|Step 2|Physician Decision|0|||
149851887|NCT00098475|540586620|FG000|Step 2|Alternative therapy|1|||
149851888|NCT00098475|540586621|FG001|Step 2|Alternative therapy|2|||
149851889|NCT00098475|540586622|FG002|Step 2|Alternative therapy|0|||
149851890|NCT00098475|540586623|FG003|Step 2|Alternative therapy|0|||
149851891|NCT00098475|540586620|FG000|Step 2|Never started treatment|1|||
149851892|NCT00098475|540586621|FG001|Step 2|Never started treatment|1|||
149851893|NCT00098475|540586622|FG002|Step 2|Never started treatment|0|||
149851894|NCT00098475|540586623|FG003|Step 2|Never started treatment|0|||
149851895|NCT03422068|540586624|FG000|Overall Study|Adverse Event|0|||
149851896|NCT03422068|540586625|FG001|Overall Study|Adverse Event|1|||
149851897|NCT03422068|540586624|FG000|Overall Study|Inconvenience to frequent study visits|0|||
149851898|NCT03422068|540586625|FG001|Overall Study|Inconvenience to frequent study visits|1|||
149851899|NCT01583530|540586626|FG000|Overall Study|Adverse Event|0|||
149851900|NCT01583530|540586627|FG001|Overall Study|Adverse Event|0|||
149851901|NCT01583530|540586628|FG002|Overall Study|Adverse Event|0|||
149851902|NCT01583530|540586629|FG003|Overall Study|Adverse Event|0|||
149851903|NCT01583530|540586630|FG004|Overall Study|Adverse Event|0|||
149851904|NCT01583530|540586631|FG005|Overall Study|Adverse Event|1|||
149851905|NCT01583530|540586626|FG000|Overall Study|Withdrawal by Subject|0|||
149851906|NCT01583530|540586627|FG001|Overall Study|Withdrawal by Subject|3|||
149851907|NCT01583530|540586628|FG002|Overall Study|Withdrawal by Subject|0|||
149851908|NCT01583530|540586629|FG003|Overall Study|Withdrawal by Subject|1|||
149851909|NCT01583530|540586630|FG004|Overall Study|Withdrawal by Subject|1|||
149851910|NCT01583530|540586631|FG005|Overall Study|Withdrawal by Subject|2|||
149851911|NCT01583530|540586626|FG000|Overall Study|Lost to Follow-up|0|||
149851912|NCT01583530|540586627|FG001|Overall Study|Lost to Follow-up|0|||
149851913|NCT01583530|540586628|FG002|Overall Study|Lost to Follow-up|0|||
149851914|NCT01583530|540586629|FG003|Overall Study|Lost to Follow-up|0|||
149851915|NCT01583530|540586630|FG004|Overall Study|Lost to Follow-up|3|||
149851916|NCT01583530|540586631|FG005|Overall Study|Lost to Follow-up|0|||
149851917|NCT01583530|540586626|FG000|Overall Study|Lack of compliance|0|||
149851918|NCT01583530|540586627|FG001|Overall Study|Lack of compliance|0|||
149851919|NCT01583530|540586628|FG002|Overall Study|Lack of compliance|0|||
149851920|NCT01583530|540586629|FG003|Overall Study|Lack of compliance|0|||
149851921|NCT01583530|540586630|FG004|Overall Study|Lack of compliance|1|||
149851922|NCT01583530|540586631|FG005|Overall Study|Lack of compliance|0|||
149851923|NCT02416180|540586632|FG000|Overall Study|Withdrawal by Subject|1|||
149851924|NCT00640926|540586633|FG000|Overall Study|Adverse Event|2|||
149851925|NCT00640926|540586634|FG001|Overall Study|Adverse Event|3|||
149851926|NCT00640926|540586635|FG002|Overall Study|Adverse Event|2|||
149851927|NCT00640926|540586633|FG000|Overall Study|Lack of Efficacy|0|||
149959109|NCT04518410|540984157|FG013|Overall Study|Lost to Follow-up|13|||
149959110|NCT04518410|540984158|FG014|Overall Study|Lost to Follow-up|8|||
149959111|NCT04518410|540984159|FG015|Overall Study|Lost to Follow-up|10|||
149959112|NCT04518410|540984160|FG016|Overall Study|Lost to Follow-up|6|||
149959113|NCT04518410|540984161|FG017|Overall Study|Lost to Follow-up|13|||
149959114|NCT04518410|540984162|FG018|Overall Study|Lost to Follow-up|21|||
149959115|NCT04518410|540984163|FG019|Overall Study|Lost to Follow-up|6|||
150039242|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
150039243|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Transplant|0|||
150172795|NCT00961636|541768095|FG002|Overall Study|Physician Decision|1|||
149851928|NCT00640926|540586634|FG001|Overall Study|Lack of Efficacy|2|||
149851929|NCT00640926|540586635|FG002|Overall Study|Lack of Efficacy|1|||
149851930|NCT00640926|540586633|FG000|Overall Study|Protocol Violation|2|||
149851931|NCT00640926|540586634|FG001|Overall Study|Protocol Violation|0|||
149851932|NCT00640926|540586635|FG002|Overall Study|Protocol Violation|2|||
149851933|NCT00640926|540586633|FG000|Overall Study|Lost to Follow-up|3|||
149851934|NCT00640926|540586634|FG001|Overall Study|Lost to Follow-up|1|||
149851935|NCT00640926|540586635|FG002|Overall Study|Lost to Follow-up|2|||
149851936|NCT00640926|540586633|FG000|Overall Study|Withdrawal by Subject|1|||
149851937|NCT00640926|540586634|FG001|Overall Study|Withdrawal by Subject|0|||
149851938|NCT00640926|540586635|FG002|Overall Study|Withdrawal by Subject|1|||
149851939|NCT01841073|540586638|FG000|Overall Study|Adverse Event|1|||
149851940|NCT01841073|540586639|FG001|Overall Study|Adverse Event|1|||
149851941|NCT01841073|540586638|FG000|Overall Study|Physician Decision|1|||
149851942|NCT01841073|540586639|FG001|Overall Study|Physician Decision|0|||
149851943|NCT01841073|540586638|FG000|Overall Study|Lost to Follow-up|0|||
149959116|NCT04518410|540984164|FG020|Overall Study|Lost to Follow-up|7|||
149959117|NCT04518410|540984165|FG021|Overall Study|Lost to Follow-up|21|||
149851944|NCT01841073|540586639|FG001|Overall Study|Lost to Follow-up|2|||
149851945|NCT02858037|540586640|FG000|Overall Study|Death|1|||
149851946|NCT02858037|540586640|FG000|Overall Study|Withdrawal by Subject|18|||
149851947|NCT02858037|540586640|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
149851948|NCT02858037|540586640|FG000|Overall Study|Lost to Follow-up|3|||
149851949|NCT02858037|540586640|FG000|Overall Study|Other|4|||
149851950|NCT02050321|540586645|FG000|Overall Study|Withdrawal by Subject|1|||
149851951|NCT02050321|540586645|FG000|Overall Study|Adverse Event|1|||
149851952|NCT00160524|540586647|FG000|Overall Study|Adverse Event|119|||
149851953|NCT00160524|540586647|FG000|Overall Study|Adverse Event and Other|94|||
149851954|NCT00160524|540586647|FG000|Overall Study|Protocol Violation|16|||
149851955|NCT00160524|540586647|FG000|Overall Study|Protocol Violation and Other|2|||
149851956|NCT00160524|540586647|FG000|Overall Study|Withdrawal by Subject|141|||
149851957|NCT00160524|540586647|FG000|Overall Study|Withdrawal by Subject and Other|17|||
149851958|NCT00160524|540586647|FG000|Overall Study|Physician Decision|27|||
149851959|NCT00160524|540586647|FG000|Overall Study|Physician Decision and Other|6|||
149851960|NCT00160524|540586647|FG000|Overall Study|Lost to Follow-up|13|||
149851961|NCT00160524|540586647|FG000|Overall Study|Lost to Follow-up and Other|1|||
149851962|NCT00160524|540586647|FG000|Overall Study|Lack of Efficacy|21|||
149851963|NCT00160524|540586647|FG000|Overall Study|Lack of Efficacy and Other|1|||
149851964|NCT00160524|540586647|FG000|Overall Study|Other|20|||
149851965|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
149851966|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
149851967|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
149851968|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
149851969|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
149851970|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
149851971|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
149851972|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
149851973|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
149851974|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
149851975|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
149851976|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
149851977|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
149851978|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
149851979|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
149851980|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
149851981|NCT01067521|540586649|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
149851982|NCT01067521|540586650|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
149851983|NCT01067521|540586649|FG000|Open-Label Period|Death|3|||
149851984|NCT01067521|540586650|FG001|Open-Label Period|Death|1|||
149851985|NCT01067521|540586649|FG000|Open-Label Period|Adverse Event|30|||
149851986|NCT01067521|540586650|FG001|Open-Label Period|Adverse Event|28|||
149851987|NCT01067521|540586649|FG000|Open-Label Period|Withdrawal by Subject|160|||
149851988|NCT01067521|540586650|FG001|Open-Label Period|Withdrawal by Subject|88|||
149851989|NCT01067521|540586649|FG000|Open-Label Period|Physician Decision|13|||
149851990|NCT01067521|540586650|FG001|Open-Label Period|Physician Decision|11|||
149851991|NCT01067521|540586649|FG000|Open-Label Period|Non-compliance with study drug|5|||
149851992|NCT01067521|540586650|FG001|Open-Label Period|Non-compliance with study drug|0|||
149851993|NCT01067521|540586649|FG000|Open-Label Period|Protocol Violation|3|||
149851994|NCT01067521|540586650|FG001|Open-Label Period|Protocol Violation|0|||
149959118|NCT04518410|540984166|FG022|Overall Study|Lost to Follow-up|1|||
149851995|NCT01067521|540586649|FG000|Open-Label Period|Pregnancy|14|||
149851996|NCT01067521|540586650|FG001|Open-Label Period|Pregnancy|8|||
149959119|NCT04518410|540984167|FG023|Overall Study|Lost to Follow-up|7|||
149959120|NCT04518410|540984168|FG024|Overall Study|Lost to Follow-up|6|||
149959121|NCT04518410|540984144|FG000|Overall Study|Withdrawal by Subject|1|||
149959122|NCT04518410|540984145|FG001|Overall Study|Withdrawal by Subject|2|||
149959123|NCT04518410|540984146|FG002|Overall Study|Withdrawal by Subject|2|||
149851997|NCT01067521|540586649|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
149851998|NCT01067521|540586650|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
149851999|NCT01067521|540586649|FG000|Open-Label Period|Lost to Follow-up|21|||
149959124|NCT04518410|540984147|FG003|Overall Study|Withdrawal by Subject|3|||
149959125|NCT04518410|540984148|FG004|Overall Study|Withdrawal by Subject|20|||
149959126|NCT04518410|540984149|FG005|Overall Study|Withdrawal by Subject|20|||
149959127|NCT04518410|540984150|FG006|Overall Study|Withdrawal by Subject|25|||
149959128|NCT04518410|540984151|FG007|Overall Study|Withdrawal by Subject|6|||
149852000|NCT01067521|540586650|FG001|Open-Label Period|Lost to Follow-up|20|||
149852001|NCT02151149|540586654|FG000|Treatment Period|Death|2|||
149959129|NCT04518410|540984152|FG008|Overall Study|Withdrawal by Subject|1|||
149959130|NCT04518410|540984153|FG009|Overall Study|Withdrawal by Subject|12|||
149959131|NCT04518410|540984154|FG010|Overall Study|Withdrawal by Subject|5|||
149959132|NCT04518410|540984155|FG011|Overall Study|Withdrawal by Subject|7|||
149852002|NCT02151149|540586655|FG001|Treatment Period|Death|3|||
149852003|NCT02151149|540586654|FG000|Treatment Period|Adverse Event|17|||
149852004|NCT02151149|540586655|FG001|Treatment Period|Adverse Event|14|||
149852005|NCT02151149|540586654|FG000|Treatment Period|Progressive Disease|25|||
149852006|NCT02151149|540586655|FG001|Treatment Period|Progressive Disease|24|||
149852007|NCT02151149|540586654|FG000|Treatment Period|Symptomatic Deterioration|2|||
149852008|NCT02151149|540586655|FG001|Treatment Period|Symptomatic Deterioration|10|||
149852009|NCT02151149|540586654|FG000|Treatment Period|Withdrawal by Subject|13|||
149852010|NCT02151149|540586655|FG001|Treatment Period|Withdrawal by Subject|11|||
149852011|NCT02151149|540586654|FG000|Treatment Period|Miscellaneous|8|||
149852012|NCT02151149|540586655|FG001|Treatment Period|Miscellaneous|7|||
149852013|NCT02151149|540586654|FG000|Treatment Period|Participants randomized but not treated|3|||
149852014|NCT02151149|540586655|FG001|Treatment Period|Participants randomized but not treated|2|||
149852015|NCT02151149|540586654|FG000|Follow-Up Period|Lost to Follow-up|2|||
149852016|NCT02151149|540586655|FG001|Follow-Up Period|Lost to Follow-up|3|||
149852017|NCT02151149|540586654|FG000|Follow-Up Period|Death|37|||
149852018|NCT02151149|540586655|FG001|Follow-Up Period|Death|34|||
149852019|NCT03419962|540586656|FG000|Overall Study|Change to other medication|1|||
149852020|NCT03419962|540586656|FG000|Overall Study|Refusal of continuing with trial drug|1|||
149959133|NCT04518410|540984156|FG012|Overall Study|Withdrawal by Subject|2|||
149959134|NCT04518410|540984157|FG013|Overall Study|Withdrawal by Subject|13|||
149959135|NCT04518410|540984158|FG014|Overall Study|Withdrawal by Subject|4|||
149959136|NCT04518410|540984159|FG015|Overall Study|Withdrawal by Subject|9|||
149959137|NCT04518410|540984160|FG016|Overall Study|Withdrawal by Subject|0|||
149959138|NCT04518410|540984161|FG017|Overall Study|Withdrawal by Subject|15|||
149959139|NCT04518410|540984162|FG018|Overall Study|Withdrawal by Subject|12|||
149959140|NCT04518410|540984163|FG019|Overall Study|Withdrawal by Subject|9|||
149959141|NCT04518410|540984164|FG020|Overall Study|Withdrawal by Subject|14|||
149959142|NCT04518410|540984165|FG021|Overall Study|Withdrawal by Subject|3|||
149959143|NCT04518410|540984166|FG022|Overall Study|Withdrawal by Subject|2|||
149959144|NCT04518410|540984167|FG023|Overall Study|Withdrawal by Subject|9|||
149959145|NCT04518410|540984168|FG024|Overall Study|Withdrawal by Subject|8|||
149959146|NCT04518410|540984144|FG000|Overall Study|Other|1|||
149959147|NCT04518410|540984145|FG001|Overall Study|Other|0|||
149959148|NCT04518410|540984146|FG002|Overall Study|Other|0|||
149959149|NCT04518410|540984147|FG003|Overall Study|Other|1|||
149959150|NCT04518410|540984148|FG004|Overall Study|Other|6|||
149959151|NCT04518410|540984149|FG005|Overall Study|Other|6|||
149959152|NCT04518410|540984150|FG006|Overall Study|Other|5|||
149959153|NCT04518410|540984151|FG007|Overall Study|Other|2|||
149959154|NCT04518410|540984152|FG008|Overall Study|Other|0|||
149959155|NCT04518410|540984153|FG009|Overall Study|Other|1|||
149959156|NCT04518410|540984154|FG010|Overall Study|Other|0|||
149959157|NCT04518410|540984155|FG011|Overall Study|Other|2|||
149959158|NCT04518410|540984156|FG012|Overall Study|Other|0|||
149959159|NCT04518410|540984157|FG013|Overall Study|Other|0|||
149959160|NCT04518410|540984158|FG014|Overall Study|Other|0|||
149959161|NCT04518410|540984159|FG015|Overall Study|Other|3|||
149959162|NCT04518410|540984160|FG016|Overall Study|Other|1|||
149959163|NCT04518410|540984161|FG017|Overall Study|Other|1|||
149959164|NCT04518410|540984162|FG018|Overall Study|Other|1|||
149959165|NCT04518410|540984163|FG019|Overall Study|Other|0|||
149959166|NCT04518410|540984164|FG020|Overall Study|Other|1|||
149959167|NCT04518410|540984165|FG021|Overall Study|Other|0|||
149959168|NCT04518410|540984166|FG022|Overall Study|Other|1|||
149959169|NCT04518410|540984167|FG023|Overall Study|Other|2|||
149959170|NCT04518410|540984168|FG024|Overall Study|Other|2|||
149959171|NCT04518410|540984144|FG000|Overall Study|Protocol Violation|0|||
149959172|NCT04518410|540984145|FG001|Overall Study|Protocol Violation|0|||
149959173|NCT04518410|540984146|FG002|Overall Study|Protocol Violation|0|||
149959174|NCT04518410|540984147|FG003|Overall Study|Protocol Violation|2|||
149959175|NCT04518410|540984148|FG004|Overall Study|Protocol Violation|17|||
149959176|NCT04518410|540984149|FG005|Overall Study|Protocol Violation|1|||
149959177|NCT04518410|540984150|FG006|Overall Study|Protocol Violation|2|||
149959178|NCT04518410|540984151|FG007|Overall Study|Protocol Violation|1|||
149959179|NCT04518410|540984152|FG008|Overall Study|Protocol Violation|0|||
149959180|NCT04518410|540984153|FG009|Overall Study|Protocol Violation|0|||
149959181|NCT04518410|540984154|FG010|Overall Study|Protocol Violation|0|||
149959182|NCT04518410|540984155|FG011|Overall Study|Protocol Violation|0|||
149959183|NCT04518410|540984156|FG012|Overall Study|Protocol Violation|0|||
150172796|NCT00961636|541768093|FG000|Overall Study|Protocol Violation|9|||
149959184|NCT04518410|540984157|FG013|Overall Study|Protocol Violation|0|||
149959185|NCT04518410|540984158|FG014|Overall Study|Protocol Violation|0|||
149959186|NCT04518410|540984159|FG015|Overall Study|Protocol Violation|0|||
149959187|NCT04518410|540984160|FG016|Overall Study|Protocol Violation|1|||
149959188|NCT04518410|540984161|FG017|Overall Study|Protocol Violation|1|||
149959189|NCT04518410|540984162|FG018|Overall Study|Protocol Violation|0|||
149959190|NCT04518410|540984163|FG019|Overall Study|Protocol Violation|0|||
149959191|NCT04518410|540984164|FG020|Overall Study|Protocol Violation|1|||
149959192|NCT04518410|540984165|FG021|Overall Study|Protocol Violation|2|||
149959193|NCT04518410|540984166|FG022|Overall Study|Protocol Violation|0|||
149852021|NCT03419962|540586656|FG000|Overall Study|Lost to Follow-up|3|||
149852022|NCT03419962|540586656|FG000|Overall Study|Difficulty in inhaling the doses|1|||
149852023|NCT03419962|540586656|FG000|Overall Study|Missing completion data|31|||
149852024|NCT04142658|540586659|FG000|Overall Study|Death|2|||
149852025|NCT04142658|540586660|FG001|Overall Study|Death|1|||
149852026|NCT04142658|540586659|FG000|Overall Study|Lost to Follow-up|4|||
150039244|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Transplant|0|||
150039245|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Transplant|0|||
150039246|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Transplant|0|||
150039247|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Transplant|0|||
150039248|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Transplant|0|||
150039249|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Transplant|0|||
149852027|NCT04142658|540586660|FG001|Overall Study|Lost to Follow-up|13|||
149852028|NCT04142658|540586659|FG000|Overall Study|Withdrawal by Subject|9|||
149852029|NCT04142658|540586660|FG001|Overall Study|Withdrawal by Subject|16|||
149852030|NCT01781234|540586661|FG000|Overall Study|Adverse Event|2|||
149852031|NCT01781234|540586662|FG001|Overall Study|Adverse Event|0|||
149852032|NCT01781234|540586661|FG000|Overall Study|Protocol Violation|3|||
149852033|NCT01781234|540586662|FG001|Overall Study|Protocol Violation|0|||
149852034|NCT01781234|540586661|FG000|Overall Study|Withdrawal by Subject|4|||
149852035|NCT01781234|540586662|FG001|Overall Study|Withdrawal by Subject|3|||
149852036|NCT03294317|540586664|FG000|Overall Study|Physician Decision|1|||
149852037|NCT03294317|540586664|FG000|Overall Study|Withdrawal by Subject|6|||
149852038|NCT03294317|540586664|FG000|Overall Study|Lost to Follow-up|1|||
149852039|NCT03294317|540586664|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
149852040|NCT03294317|540586664|FG000|Overall Study|Failed HB lead implant|8|||
149852041|NCT03294317|540586664|FG000|Overall Study|Received CRT instead|1|||
149852042|NCT03294317|540586664|FG000|Overall Study|Exited after lead revision|2|||
149852043|NCT02911935|540586665|FG000|Overall Study|Lost to Follow-up|5|||
149852044|NCT02911935|540586666|FG001|Overall Study|Lost to Follow-up|7|||
149852045|NCT00603512|540586667|FG000|Overall Study|Adverse Event|0|||
149852046|NCT00603512|540586668|FG001|Overall Study|Adverse Event|2|||
149852047|NCT00603512|540586669|FG002|Overall Study|Adverse Event|4|||
149852048|NCT00603512|540586670|FG003|Overall Study|Adverse Event|4|||
149852049|NCT00603512|540586671|FG004|Overall Study|Adverse Event|2|||
149852050|NCT00603512|540586667|FG000|Overall Study|Lack of Efficacy|0|||
149852051|NCT00603512|540586668|FG001|Overall Study|Lack of Efficacy|1|||
149852052|NCT00603512|540586669|FG002|Overall Study|Lack of Efficacy|0|||
149852053|NCT00603512|540586670|FG003|Overall Study|Lack of Efficacy|0|||
149852054|NCT00603512|540586671|FG004|Overall Study|Lack of Efficacy|1|||
149852055|NCT00603512|540586667|FG000|Overall Study|Other|2|||
149852056|NCT00603512|540586668|FG001|Overall Study|Other|1|||
149852057|NCT00603512|540586669|FG002|Overall Study|Other|0|||
149852058|NCT00603512|540586670|FG003|Overall Study|Other|1|||
150039250|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Transplant|0|||
150039251|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Transplant|0|||
149852059|NCT00603512|540586671|FG004|Overall Study|Other|1|||
149852060|NCT00603512|540586667|FG000|Overall Study|Withdrawal by Subject|0|||
149852061|NCT00603512|540586668|FG001|Overall Study|Withdrawal by Subject|0|||
149852062|NCT00603512|540586669|FG002|Overall Study|Withdrawal by Subject|0|||
149852063|NCT00603512|540586670|FG003|Overall Study|Withdrawal by Subject|0|||
149852064|NCT00603512|540586671|FG004|Overall Study|Withdrawal by Subject|1|||
149852065|NCT00603512|540586667|FG000|Overall Study|Randomized but not treated|0|||
149852066|NCT00603512|540586668|FG001|Overall Study|Randomized but not treated|1|||
149852067|NCT00603512|540586669|FG002|Overall Study|Randomized but not treated|1|||
149852068|NCT00603512|540586670|FG003|Overall Study|Randomized but not treated|2|||
149852069|NCT00603512|540586671|FG004|Overall Study|Randomized but not treated|0|||
149852070|NCT04979858|540586672|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
149852071|NCT04979858|540586673|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
149852072|NCT04253236|540586674|FG000|Overall Study|Adverse Event|1|||
149852073|NCT04253236|540586675|FG001|Overall Study|Adverse Event|0|||
149852074|NCT04253236|540586674|FG000|Overall Study|Safety Concerns|1|||
149852075|NCT04253236|540586675|FG001|Overall Study|Safety Concerns|0|||
149852076|NCT04253236|540586674|FG000|Overall Study|Study Terminated by Sponsor|1|||
149852077|NCT04253236|540586675|FG001|Overall Study|Study Terminated by Sponsor|0|||
149852078|NCT03493919|540586676|FG000|Overall Study|Other|2|||
149852079|NCT03493919|540586677|FG001|Overall Study|Other|0|||
149852080|NCT03493919|540586678|FG002|Overall Study|Other|1|||
149852081|NCT03493919|540586679|FG003|Overall Study|Other|0|||
149852082|NCT03493919|540586676|FG000|Overall Study|Withdrawal by Subject|9|||
149852083|NCT03493919|540586677|FG001|Overall Study|Withdrawal by Subject|3|||
149852084|NCT03493919|540586678|FG002|Overall Study|Withdrawal by Subject|1|||
150039252|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Transplant|4|||
149852085|NCT03493919|540586679|FG003|Overall Study|Withdrawal by Subject|1|||
149852086|NCT03493919|540586676|FG000|Overall Study|Lost to Follow-up|5|||
149852087|NCT03493919|540586677|FG001|Overall Study|Lost to Follow-up|0|||
149852088|NCT03493919|540586678|FG002|Overall Study|Lost to Follow-up|0|||
150039253|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Transplant|2|||
149852089|NCT03493919|540586679|FG003|Overall Study|Lost to Follow-up|3|||
149852090|NCT03493919|540586676|FG000|Overall Study|Adverse Event|0|||
149852091|NCT03493919|540586677|FG001|Overall Study|Adverse Event|1|||
149852092|NCT03493919|540586678|FG002|Overall Study|Adverse Event|0|||
149852093|NCT03493919|540586679|FG003|Overall Study|Adverse Event|0|||
149852094|NCT04640194|540586680|FG000|Overall Study|Adverse Event|3|||
149852095|NCT04640194|540586681|FG001|Overall Study|Adverse Event|7|||
149852096|NCT04640194|540586682|FG002|Overall Study|Adverse Event|0|||
149852097|NCT04640194|540586683|FG003|Overall Study|Adverse Event|5|||
149852098|NCT04640194|540586684|FG004|Overall Study|Adverse Event|0|||
149852099|NCT04640194|540586685|FG005|Overall Study|Adverse Event|4|||
149852100|NCT04640194|540586686|FG006|Overall Study|Adverse Event|0|||
149852101|NCT04640194|540586680|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
149852102|NCT04640194|540586681|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
149852103|NCT04640194|540586682|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
149852104|NCT04640194|540586683|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
149852105|NCT04640194|540586684|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
149852106|NCT04640194|540586685|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
149852107|NCT04640194|540586686|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
149852108|NCT04640194|540586680|FG000|Overall Study|fibrinogen level too low|0|||
149852109|NCT04640194|540586681|FG001|Overall Study|fibrinogen level too low|0|||
149852110|NCT04640194|540586682|FG002|Overall Study|fibrinogen level too low|0|||
149852111|NCT04640194|540586683|FG003|Overall Study|fibrinogen level too low|1|||
149852112|NCT04640194|540586684|FG004|Overall Study|fibrinogen level too low|0|||
149852113|NCT04640194|540586685|FG005|Overall Study|fibrinogen level too low|0|||
149852114|NCT04640194|540586686|FG006|Overall Study|fibrinogen level too low|0|||
149852115|NCT04640194|540586680|FG000|Overall Study|mild bleeding|0|||
149852116|NCT04640194|540586681|FG001|Overall Study|mild bleeding|0|||
149852117|NCT04640194|540586682|FG002|Overall Study|mild bleeding|0|||
149852118|NCT04640194|540586683|FG003|Overall Study|mild bleeding|1|||
149852119|NCT04640194|540586684|FG004|Overall Study|mild bleeding|0|||
149852120|NCT04640194|540586685|FG005|Overall Study|mild bleeding|0|||
149852121|NCT04640194|540586686|FG006|Overall Study|mild bleeding|0|||
149852122|NCT04640194|540586680|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852123|NCT04640194|540586681|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
149852124|NCT04640194|540586682|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852125|NCT04640194|540586683|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852126|NCT04640194|540586684|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852127|NCT04640194|540586685|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852128|NCT04640194|540586686|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
149852129|NCT02061280|540586687|FG000|Overall Study|Protocol Violation|12|||
149852130|NCT02061280|540586688|FG001|Overall Study|Protocol Violation|8|||
149852131|NCT02061280|540586687|FG000|Overall Study|moved out of state|0|||
149852132|NCT02061280|540586688|FG001|Overall Study|moved out of state|1|||
149852133|NCT02061280|540586687|FG000|Overall Study|Withdrawal by Subject|1|||
149852134|NCT02061280|540586688|FG001|Overall Study|Withdrawal by Subject|2|||
149852135|NCT02061280|540586687|FG000|Overall Study|Lost to Follow-up|5|||
149852136|NCT02061280|540586688|FG001|Overall Study|Lost to Follow-up|1|||
149852137|NCT02722616|540587526|FG000|Overall Study|Sponsor closed study after one month|2|||
149852138|NCT02722616|540587527|FG001|Overall Study|Sponsor closed study after one month|0|||
149852139|NCT02722616|540587528|FG002|Overall Study|Sponsor closed study after one month|0|||
149852140|NCT02031237|540587529|FG000|Overall Study|Death|1|||
149852141|NCT02031237|540587530|FG001|Overall Study|Death|5|||
149852142|NCT02031237|540587531|FG002|Overall Study|Death|0|||
149852143|NCT02031237|540587529|FG000|Overall Study|Physician Decision|0|||
149852144|NCT02031237|540587530|FG001|Overall Study|Physician Decision|1|||
149852145|NCT02031237|540587531|FG002|Overall Study|Physician Decision|0|||
149852146|NCT02031237|540587529|FG000|Overall Study|Withdrawal by Subject|2|||
149852147|NCT02031237|540587530|FG001|Overall Study|Withdrawal by Subject|2|||
149852148|NCT02031237|540587531|FG002|Overall Study|Withdrawal by Subject|0|||
149852149|NCT02031237|540587529|FG000|Overall Study|Protocol Violation|2|||
149852150|NCT02031237|540587530|FG001|Overall Study|Protocol Violation|6|||
149852151|NCT02031237|540587531|FG002|Overall Study|Protocol Violation|0|||
149852152|NCT02031237|540587529|FG000|Overall Study|Alternate Treatment Given|0|||
149852153|NCT02031237|540587530|FG001|Overall Study|Alternate Treatment Given|0|||
149852154|NCT02031237|540587531|FG002|Overall Study|Alternate Treatment Given|3|||
149852155|NCT00676650|540587536|FG000|Overall Study|Death|45|||
149852156|NCT00676650|540587537|FG001|Overall Study|Death|14|||
149852157|NCT00676650|540587536|FG000|Overall Study|Adverse Event|159|||
149852158|NCT00676650|540587537|FG001|Overall Study|Adverse Event|21|||
149852159|NCT00676650|540587536|FG000|Overall Study|Global deterioration of health status|66|||
149852160|NCT00676650|540587537|FG001|Overall Study|Global deterioration of health status|31|||
149852161|NCT00676650|540587536|FG000|Overall Study|Lost to Follow-up|0|||
149852162|NCT00676650|540587537|FG001|Overall Study|Lost to Follow-up|1|||
149852163|NCT00676650|540587536|FG000|Overall Study|Objective progression or relapse|189|||
149852164|NCT00676650|540587537|FG001|Overall Study|Objective progression or relapse|140|||
149852165|NCT00676650|540587536|FG000|Overall Study|Other|14|||
149852166|NCT00676650|540587537|FG001|Overall Study|Other|10|||
149852167|NCT00676650|540587536|FG000|Overall Study|Protocol Violation|3|||
149852168|NCT00676650|540587537|FG001|Overall Study|Protocol Violation|1|||
149852169|NCT00676650|540587536|FG000|Overall Study|Study terminated by sponsor|57|||
149852170|NCT00676650|540587537|FG001|Overall Study|Study terminated by sponsor|43|||
149852171|NCT00676650|540587536|FG000|Overall Study|Withdrawal by Subject|48|||
149852172|NCT00676650|540587537|FG001|Overall Study|Withdrawal by Subject|24|||
149852173|NCT00676650|540587536|FG000|Overall Study|Randomized but not treated|3|||
149852174|NCT00676650|540587537|FG001|Overall Study|Randomized but not treated|4|||
149852175|NCT02297841|540587541|FG000|Overall Study|Withdrawal by Subject|1|||
149852176|NCT02297841|540587541|FG000|Overall Study|Protocol Violation|7|||
149852177|NCT02152982|540587545|FG000|Overall Study|Withdrawal by Subject|17|||
149852178|NCT02152982|540587546|FG001|Overall Study|Withdrawal by Subject|16|||
149852179|NCT02152982|540587545|FG000|Overall Study|Did not start treatment|11|||
149852180|NCT02152982|540587546|FG001|Overall Study|Did not start treatment|5|||
149852181|NCT02152982|540587545|FG000|Overall Study|Disease progression|41|||
149852182|NCT02152982|540587546|FG001|Overall Study|Disease progression|52|||
149852183|NCT02152982|540587545|FG000|Overall Study|Adverse Event|7|||
149852184|NCT02152982|540587546|FG001|Overall Study|Adverse Event|12|||
149852185|NCT02152982|540587545|FG000|Overall Study|Complicating disease|1|||
149852186|NCT02152982|540587546|FG001|Overall Study|Complicating disease|1|||
149852187|NCT02152982|540587545|FG000|Overall Study|Death|0|||
149852188|NCT02152982|540587546|FG001|Overall Study|Death|3|||
149852189|NCT02152982|540587545|FG000|Overall Study|Physician Decision|3|||
149852190|NCT02152982|540587546|FG001|Overall Study|Physician Decision|0|||
149852191|NCT03230487|540587552|FG000|Overall Study|Adverse Event|0|||
149852192|NCT03230487|540587553|FG001|Overall Study|Adverse Event|0|||
149852193|NCT03230487|540587554|FG002|Overall Study|Adverse Event|0|||
149852194|NCT03230487|540587555|FG003|Overall Study|Adverse Event|1|||
149852195|NCT03230487|540587556|FG004|Overall Study|Adverse Event|0|||
149852196|NCT03230487|540587557|FG005|Overall Study|Adverse Event|0|||
149852197|NCT01755975|540587558|FG000|Overall Study|Adverse Event|0|||
149852198|NCT01755975|540587559|FG001|Overall Study|Adverse Event|0|||
149852199|NCT01755975|540587560|FG002|Overall Study|Adverse Event|1|||
149852200|NCT01755975|540587561|FG003|Overall Study|Adverse Event|0|||
149852201|NCT01755975|540587562|FG004|Overall Study|Adverse Event|2|||
149852202|NCT05148299|540587563|FG000|Treatment Period|Adverse Event|1|||
149852203|NCT05148299|540587563|FG000|Treatment Period|Physician Decision|1|||
149852204|NCT05148299|540587563|FG000|Treatment Period|Death|1|||
149852205|NCT05148299|540587563|FG000|Follow-up Period|Death|3|||
149852206|NCT02161549|540587564|FG000|Overall Study|Physician Decision|6|||
149852207|NCT02161549|540587565|FG001|Overall Study|Physician Decision|2|||
149852208|NCT00702507|540587569|FG000|Initial Treatment Phase|Adverse Event|2|||
149852209|NCT00702507|540587569|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
149852210|NCT00702507|540587569|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
149852211|NCT00702507|540587569|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
149852212|NCT00702507|540587569|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
149852213|NCT00702507|540587569|FG000|Follow-up Phase|Protocol Violation|2|||
149852214|NCT00702507|540587569|FG000|Follow-up Phase|Lost to Follow-up|23|||
149852215|NCT00702507|540587569|FG000|Follow-up Phase|Late Enrollment|1|||
149852216|NCT01499160|540587573|FG000|Overall Study|Adverse Event|1|||
149852217|NCT01499160|540587573|FG000|Overall Study|Withdrawal by Subject|1|||
149852218|NCT01438476|540587577|FG000|Overall Study|Protocol Violation|1|||
149852219|NCT01438476|540587578|FG001|Overall Study|Protocol Violation|0|||
149852220|NCT01438476|540587577|FG000|Overall Study|Withdrawal by Subject|1|||
149852221|NCT01438476|540587578|FG001|Overall Study|Withdrawal by Subject|0|||
149852222|NCT01438476|540587577|FG000|Overall Study|No Surgery- Disease|8|||
149852223|NCT01438476|540587578|FG001|Overall Study|No Surgery- Disease|10|||
149852224|NCT01438476|540587577|FG000|Overall Study|Communication barrier|0|||
149852225|NCT01438476|540587578|FG001|Overall Study|Communication barrier|1|||
149852226|NCT03566238|540587580|FG000|Overall Study|Adverse Event|0|||
149852227|NCT03566238|540587581|FG001|Overall Study|Adverse Event|0|||
149852228|NCT03566238|540587582|FG002|Overall Study|Adverse Event|1|||
149852229|NCT03566238|540587580|FG000|Overall Study|Lack of Efficacy|5|||
149852230|NCT03566238|540587581|FG001|Overall Study|Lack of Efficacy|4|||
149852231|NCT03566238|540587582|FG002|Overall Study|Lack of Efficacy|2|||
149852232|NCT03566238|540587580|FG000|Overall Study|Other|0|||
149852233|NCT03566238|540587581|FG001|Overall Study|Other|1|||
149852234|NCT03566238|540587582|FG002|Overall Study|Other|0|||
149852235|NCT00860262|540587586|FG000|Overall Study|Adverse Event|9|||
149852236|NCT00860262|540587587|FG001|Overall Study|Adverse Event|6|||
149852237|NCT00860262|540587588|FG002|Overall Study|Adverse Event|7|||
149852238|NCT00860262|540587586|FG000|Overall Study|Protocol Violation|0|||
149852239|NCT00860262|540587587|FG001|Overall Study|Protocol Violation|1|||
150172797|NCT00961636|541768094|FG001|Overall Study|Protocol Violation|5|||
149852240|NCT00860262|540587588|FG002|Overall Study|Protocol Violation|0|||
149852241|NCT00860262|540587586|FG000|Overall Study|Lost to Follow-up|2|||
149852242|NCT00860262|540587587|FG001|Overall Study|Lost to Follow-up|0|||
149852243|NCT00860262|540587588|FG002|Overall Study|Lost to Follow-up|1|||
149852244|NCT00860262|540587586|FG000|Overall Study|Withdrawal by Subject|4|||
149852245|NCT00860262|540587587|FG001|Overall Study|Withdrawal by Subject|8|||
149852246|NCT00860262|540587588|FG002|Overall Study|Withdrawal by Subject|6|||
149852247|NCT00860262|540587586|FG000|Overall Study|Lack of Efficacy|0|||
149852248|NCT00860262|540587587|FG001|Overall Study|Lack of Efficacy|4|||
149959194|NCT04518410|540984167|FG023|Overall Study|Protocol Violation|3|||
149959195|NCT04518410|540984168|FG024|Overall Study|Protocol Violation|0|||
149959196|NCT04518410|540984144|FG000|Overall Study|Death|0|||
149959197|NCT04518410|540984145|FG001|Overall Study|Death|0|||
149959198|NCT04518410|540984146|FG002|Overall Study|Death|0|||
149959199|NCT04518410|540984147|FG003|Overall Study|Death|0|||
149959200|NCT04518410|540984148|FG004|Overall Study|Death|12|||
149959201|NCT04518410|540984149|FG005|Overall Study|Death|2|||
149959202|NCT04518410|540984150|FG006|Overall Study|Death|11|||
149852249|NCT00860262|540587588|FG002|Overall Study|Lack of Efficacy|3|||
149852250|NCT00860262|540587586|FG000|Overall Study|Other|5|||
149852251|NCT00860262|540587587|FG001|Overall Study|Other|3|||
149852252|NCT00860262|540587588|FG002|Overall Study|Other|1|||
149852253|NCT00124618|540587589|FG000|Overall Study|Ineligible|1|||
149852254|NCT05467540|540587590|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
149852255|NCT05467540|540587590|FG000|3-Month Follow-up|Lost to Follow-up|4|||
149852256|NCT05467540|540587590|FG000|3-Month Follow-up|Death|5|||
149852257|NCT05467540|540587590|FG000|12-Month Follow-up|Lost to Follow-up|6|||
149852258|NCT05467540|540587590|FG000|12-Month Follow-up|Death|8|||
149852259|NCT05467540|540587590|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
149852260|NCT03382041|540587610|FG000|Overall Study|Consent Form Lost|2|||
149852261|NCT03382041|540587611|FG001|Overall Study|Consent Form Lost|1|||
149852262|NCT03382041|540587610|FG000|Overall Study|Withdrawal by Subject|1|||
149852263|NCT03382041|540587611|FG001|Overall Study|Withdrawal by Subject|4|||
149852264|NCT03382041|540587610|FG000|Overall Study|Lost to Follow-up|1|||
149852265|NCT03382041|540587611|FG001|Overall Study|Lost to Follow-up|4|||
149852266|NCT00688844|540587612|FG000|Overall Study|Lost to Follow-up|10|||
149852267|NCT04490057|540587614|FG000|Stage 1|Death|1|||
149852268|NCT04490057|540587615|FG001|Stage 1|Death|2|||
149852269|NCT04490057|540587616|FG002|Stage 1|Death|0|||
149852270|NCT04490057|540587617|FG003|Stage 1|Death|0|||
149852271|NCT04490057|540587618|FG004|Stage 1|Death|0|||
149852272|NCT04490057|540587619|FG005|Stage 1|Death|0|||
149852273|NCT04490057|540587620|FG006|Stage 1|Death|0|||
149852274|NCT04490057|540587621|FG007|Stage 1|Death|0|||
149959203|NCT04518410|540984151|FG007|Overall Study|Death|0|||
149852275|NCT04490057|540587614|FG000|Stage 1|Withdrawal by Subject|2|||
149852276|NCT04490057|540587615|FG001|Stage 1|Withdrawal by Subject|0|||
149852277|NCT04490057|540587616|FG002|Stage 1|Withdrawal by Subject|0|||
149959204|NCT04518410|540984152|FG008|Overall Study|Death|1|||
149959205|NCT04518410|540984153|FG009|Overall Study|Death|0|||
149959206|NCT04518410|540984154|FG010|Overall Study|Death|0|||
149852278|NCT04490057|540587617|FG003|Stage 1|Withdrawal by Subject|0|||
149852279|NCT04490057|540587618|FG004|Stage 1|Withdrawal by Subject|0|||
149852280|NCT04490057|540587619|FG005|Stage 1|Withdrawal by Subject|0|||
149852281|NCT04490057|540587620|FG006|Stage 1|Withdrawal by Subject|0|||
149852282|NCT04490057|540587621|FG007|Stage 1|Withdrawal by Subject|0|||
149852283|NCT04490057|540587614|FG000|Stage 2|Death|0|||
149852284|NCT04490057|540587615|FG001|Stage 2|Death|0|||
149852285|NCT04490057|540587616|FG002|Stage 2|Death|0|||
149852286|NCT04490057|540587617|FG003|Stage 2|Death|0|||
149852287|NCT04490057|540587618|FG004|Stage 2|Death|1|||
149852288|NCT04490057|540587619|FG005|Stage 2|Death|0|||
149852289|NCT04490057|540587620|FG006|Stage 2|Death|0|||
149852290|NCT04490057|540587621|FG007|Stage 2|Death|0|||
149852291|NCT04490057|540587614|FG000|Stage 2|Lost to Follow-up|0|||
149852292|NCT04490057|540587615|FG001|Stage 2|Lost to Follow-up|0|||
149852293|NCT04490057|540587616|FG002|Stage 2|Lost to Follow-up|0|||
149852294|NCT04490057|540587617|FG003|Stage 2|Lost to Follow-up|11|||
149852295|NCT04490057|540587618|FG004|Stage 2|Lost to Follow-up|17|||
149852296|NCT04490057|540587619|FG005|Stage 2|Lost to Follow-up|4|||
149852297|NCT04490057|540587620|FG006|Stage 2|Lost to Follow-up|21|||
149852298|NCT04490057|540587621|FG007|Stage 2|Lost to Follow-up|14|||
149852299|NCT04584983|540587624|FG000|Overall Study|Parental request for withdraw|2|||
149852300|NCT04584983|540587625|FG001|Overall Study|Parental request for withdraw|0|||
149852301|NCT05377489|540587626|FG000|Overall Study|Withdrawal by Subject|122|||
149852302|NCT05377489|540587626|FG000|Overall Study|Lost to Follow-up|21|||
149852303|NCT05377489|540587626|FG000|Overall Study|Lack of Efficacy|10|||
149852304|NCT05377489|540587626|FG000|Overall Study|Adverse Event|5|||
149852305|NCT05377489|540587626|FG000|Overall Study|Death|4|||
149852306|NCT05377489|540587626|FG000|Overall Study|Physician Decision|3|||
149852307|NCT05377489|540587626|FG000|Overall Study|Protocol Violation|1|||
149852308|NCT05377489|540587626|FG000|Overall Study|Other|9|||
149852309|NCT00724958|540587627|FG000|Overall Study|Adverse Event|28|||
149852310|NCT00724958|540587627|FG000|Overall Study|Loss of Response|40|||
149852311|NCT00724958|540587627|FG000|Overall Study|No Response|18|||
149852312|NCT00724958|540587627|FG000|Overall Study|Remission|7|||
149852313|NCT00724958|540587627|FG000|Overall Study|Other Reason|76|||
149852314|NCT00724958|540587627|FG000|Overall Study|No documentation for end of therapy|13|||
149852315|NCT02459418|540589317|FG000|Overall Study|Exclusion Criteria|4|||
149852316|NCT02459418|540589318|FG001|Overall Study|Exclusion Criteria|0|||
149852317|NCT02459418|540589317|FG000|Overall Study|Protocol Violation|0|||
149852318|NCT02459418|540589318|FG001|Overall Study|Protocol Violation|2|||
149852319|NCT02459418|540589317|FG000|Overall Study|Physician Decision|0|||
149852320|NCT02459418|540589318|FG001|Overall Study|Physician Decision|2|||
149852321|NCT02459418|540589317|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
149852322|NCT02459418|540589318|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
149852323|NCT02459418|540589317|FG000|Overall Study|Adverse Event|0|||
149852324|NCT02459418|540589318|FG001|Overall Study|Adverse Event|1|||
149852325|NCT02459418|540589317|FG000|Overall Study|Withdrawal by Subject|1|||
149852326|NCT02459418|540589318|FG001|Overall Study|Withdrawal by Subject|1|||
149852327|NCT02459418|540589317|FG000|Overall Study|Elevated Creatine Kinase|1|||
149852328|NCT02459418|540589318|FG001|Overall Study|Elevated Creatine Kinase|0|||
149852329|NCT02459418|540589317|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
149852330|NCT02459418|540589318|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
149852331|NCT00653159|540589319|FG000|Overall Study|Adverse Event|4|||
150288877|NCT01662440|542192524|FG002|Overall Study|Subject moved to another country.|0|||
149852332|NCT00653159|540589320|FG001|Overall Study|Adverse Event|1|||
149852333|NCT00653159|540589319|FG000|Overall Study|Lost to Follow-up|1|||
149852334|NCT00653159|540589320|FG001|Overall Study|Lost to Follow-up|2|||
149852335|NCT01872715|540589321|FG000|Overall Study|Adverse Event|1|||
149852336|NCT01872715|540589321|FG000|Overall Study|Protocol Violation|1|||
149852337|NCT01872715|540589321|FG000|Overall Study|Withdrawal by Subject|2|||
149959207|NCT04518410|540984155|FG011|Overall Study|Death|0|||
149959208|NCT04518410|540984156|FG012|Overall Study|Death|0|||
149959209|NCT04518410|540984157|FG013|Overall Study|Death|1|||
149959210|NCT04518410|540984158|FG014|Overall Study|Death|1|||
149959211|NCT04518410|540984159|FG015|Overall Study|Death|0|||
149959212|NCT04518410|540984160|FG016|Overall Study|Death|0|||
149852338|NCT00329160|540589322|FG000|Overall Study|Adverse Event|27|||
149852339|NCT00329160|540589322|FG000|Overall Study|Withdrawal by Subject|13|||
149852340|NCT00329160|540589322|FG000|Overall Study|Protocol Violation|2|||
149852341|NCT00329160|540589322|FG000|Overall Study|Did not Receive Study Drug|1|||
149959213|NCT04518410|540984161|FG017|Overall Study|Death|1|||
149959214|NCT04518410|540984162|FG018|Overall Study|Death|4|||
149852342|NCT00329160|540589322|FG000|Overall Study|Incomplete IVUS|45|||
149852343|NCT02419573|540589323|FG000|Overall Study|Lost to Follow-up|3|||
149852344|NCT02419573|540589324|FG001|Overall Study|Lost to Follow-up|0|||
149852345|NCT02419573|540589323|FG000|Overall Study|Withdrawal by Subject|1|||
149852346|NCT02419573|540589324|FG001|Overall Study|Withdrawal by Subject|0|||
149852347|NCT04167618|540589328|FG000|Overall Study|Trial terminated by sponsor|1|||
149852348|NCT04167618|540589329|FG001|Overall Study|Trial terminated by sponsor|1|||
149959215|NCT04518410|540984163|FG019|Overall Study|Death|4|||
149959216|NCT04518410|540984164|FG020|Overall Study|Death|1|||
149852349|NCT03653026|540589334|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
149852350|NCT03653026|540589335|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
149852351|NCT03653026|540589336|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
149852352|NCT03653026|540589337|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
149852353|NCT03653026|540589334|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
149852354|NCT03653026|540589335|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
149852355|NCT03653026|540589336|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149852356|NCT03653026|540589337|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149852357|NCT03653026|540589334|FG000|Part 1: Placebo-controlled Period|Other|0|||
149852358|NCT03653026|540589335|FG001|Part 1: Placebo-controlled Period|Other|3|||
149852359|NCT03653026|540589336|FG002|Part 1: Placebo-controlled Period|Other|0|||
149852360|NCT03653026|540589337|FG003|Part 1: Placebo-controlled Period|Other|0|||
149852361|NCT03653026|540589334|FG000|Part 2: Open-label Extension|Adverse Event|0|||
149852362|NCT03653026|540589335|FG001|Part 2: Open-label Extension|Adverse Event|0|||
149852363|NCT03653026|540589336|FG002|Part 2: Open-label Extension|Adverse Event|1|||
149852364|NCT03653026|540589337|FG003|Part 2: Open-label Extension|Adverse Event|1|||
149852365|NCT03653026|540589334|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
149852366|NCT03653026|540589335|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
149852367|NCT03653026|540589336|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
149852368|NCT03653026|540589337|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
149852369|NCT03653026|540589334|FG000|Part 2: Open-label Extension|Other|0|||
149852370|NCT03653026|540589335|FG001|Part 2: Open-label Extension|Other|0|||
149852371|NCT03653026|540589336|FG002|Part 2: Open-label Extension|Other|1|||
149852372|NCT03653026|540589337|FG003|Part 2: Open-label Extension|Other|2|||
149852373|NCT01933919|540589340|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
149852374|NCT01933919|540589341|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
149852375|NCT01933919|540589340|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
149852376|NCT01933919|540589341|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
149852377|NCT01933919|540589340|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
149852378|NCT01933919|540589341|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
149852379|NCT01933919|540589340|FG000|Open-label Long-term Phase|Adverse Event|2|||
149852380|NCT01933919|540589341|FG001|Open-label Long-term Phase|Adverse Event|0|||
149852381|NCT01933919|540589340|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
149852382|NCT01933919|540589341|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
149852383|NCT01933919|540589340|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
149852384|NCT01933919|540589341|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
149852385|NCT01933919|540589340|FG000|Open-label Long-term Phase|Other|1|||
149852386|NCT01933919|540589341|FG001|Open-label Long-term Phase|Other|2|||
149852387|NCT00852917|540589342|FG000|Overall Study|Adverse Event|13|||
149852388|NCT00852917|540589343|FG001|Overall Study|Adverse Event|20|||
149852389|NCT00852917|540589344|FG002|Overall Study|Adverse Event|35|||
149852390|NCT00852917|540589345|FG003|Overall Study|Adverse Event|17|||
149852391|NCT00852917|540589342|FG000|Overall Study|Lack of Efficacy|21|||
149852392|NCT00852917|540589343|FG001|Overall Study|Lack of Efficacy|11|||
149852393|NCT00852917|540589344|FG002|Overall Study|Lack of Efficacy|11|||
149852394|NCT00852917|540589345|FG003|Overall Study|Lack of Efficacy|47|||
149852395|NCT00852917|540589342|FG000|Overall Study|Withdrawal by Subject|4|||
149852396|NCT00852917|540589343|FG001|Overall Study|Withdrawal by Subject|8|||
149852397|NCT00852917|540589344|FG002|Overall Study|Withdrawal by Subject|10|||
149852398|NCT00852917|540589345|FG003|Overall Study|Withdrawal by Subject|9|||
149852399|NCT00852917|540589342|FG000|Overall Study|Physician Decision|6|||
149852400|NCT00852917|540589343|FG001|Overall Study|Physician Decision|7|||
149852401|NCT00852917|540589344|FG002|Overall Study|Physician Decision|2|||
149852402|NCT00852917|540589345|FG003|Overall Study|Physician Decision|19|||
149852403|NCT00852917|540589342|FG000|Overall Study|Death|0|||
149852404|NCT00852917|540589343|FG001|Overall Study|Death|0|||
149852405|NCT00852917|540589344|FG002|Overall Study|Death|0|||
149852406|NCT00852917|540589345|FG003|Overall Study|Death|1|||
149852407|NCT01358877|540589346|FG000|Overall Study|Withdrawal by Subject|475|||
149852408|NCT01358877|540589347|FG001|Overall Study|Withdrawal by Subject|466|||
149852409|NCT01358877|540589346|FG000|Overall Study|Recurrence of disease|181|||
149852410|NCT01358877|540589347|FG001|Overall Study|Recurrence of disease|269|||
149852411|NCT01358877|540589346|FG000|Overall Study|Lost to Follow-up|181|||
149852412|NCT01358877|540589347|FG001|Overall Study|Lost to Follow-up|176|||
150039254|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Transplant|0|||
149852413|NCT01358877|540589346|FG000|Overall Study|Death|41|||
149852414|NCT01358877|540589347|FG001|Overall Study|Death|46|||
149852415|NCT01358877|540589346|FG000|Overall Study|Adverse Event|39|||
149852416|NCT01358877|540589347|FG001|Overall Study|Adverse Event|42|||
149852417|NCT01358877|540589346|FG000|Overall Study|Physician Decision|43|||
149852418|NCT01358877|540589347|FG001|Overall Study|Physician Decision|32|||
149852419|NCT01358877|540589346|FG000|Overall Study|Contralateral breast cancer|42|||
149852420|NCT01358877|540589347|FG001|Overall Study|Contralateral breast cancer|28|||
149852421|NCT01358877|540589346|FG000|Overall Study|Reason not specified|37|||
149852422|NCT01358877|540589347|FG001|Overall Study|Reason not specified|29|||
149852423|NCT05552261|540589353|FG000|Overall Study|Withdrawal by Subject|1|||
149852424|NCT05552261|540589353|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
149852425|NCT02003222|540589354|FG000|Induction|Never started treatment|0|||
149852426|NCT02003222|540589355|FG001|Induction|Never started treatment|0|||
149852427|NCT02003222|540589356|FG002|Induction|Never started treatment|0|||
149852428|NCT02003222|540589357|FG003|Induction|Never started treatment|0|||
149852429|NCT02003222|540589358|FG004|Induction|Never started treatment|8|||
150172798|NCT00961636|541768095|FG002|Overall Study|Protocol Violation|1|||
149852430|NCT02003222|540589354|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
149852431|NCT02003222|540589355|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
149852432|NCT02003222|540589356|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
149852433|NCT02003222|540589357|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
149852434|NCT02003222|540589358|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
149852435|NCT02003222|540589354|FG000|Induction|Adverse Event|0|||
149852436|NCT02003222|540589355|FG001|Induction|Adverse Event|0|||
149852437|NCT02003222|540589356|FG002|Induction|Adverse Event|0|||
149852438|NCT02003222|540589357|FG003|Induction|Adverse Event|0|||
149852439|NCT02003222|540589358|FG004|Induction|Adverse Event|13|||
149852440|NCT02003222|540589354|FG000|Induction|Alternative therapy|0|||
149852441|NCT02003222|540589355|FG001|Induction|Alternative therapy|0|||
149852442|NCT02003222|540589356|FG002|Induction|Alternative therapy|0|||
149852443|NCT02003222|540589357|FG003|Induction|Alternative therapy|0|||
149852444|NCT02003222|540589358|FG004|Induction|Alternative therapy|12|||
149852445|NCT02003222|540589354|FG000|Induction|Disease progression|0|||
149852446|NCT02003222|540589355|FG001|Induction|Disease progression|0|||
149852447|NCT02003222|540589356|FG002|Induction|Disease progression|0|||
149852448|NCT02003222|540589357|FG003|Induction|Disease progression|0|||
149852449|NCT02003222|540589358|FG004|Induction|Disease progression|22|||
149852450|NCT02003222|540589354|FG000|Induction|Death|0|||
149852451|NCT02003222|540589355|FG001|Induction|Death|0|||
149852452|NCT02003222|540589356|FG002|Induction|Death|0|||
149852453|NCT02003222|540589357|FG003|Induction|Death|0|||
149852454|NCT02003222|540589358|FG004|Induction|Death|3|||
149852455|NCT02003222|540589354|FG000|Induction|Withdrawal by Subject|0|||
149852456|NCT02003222|540589355|FG001|Induction|Withdrawal by Subject|0|||
149852457|NCT02003222|540589356|FG002|Induction|Withdrawal by Subject|0|||
149852458|NCT02003222|540589357|FG003|Induction|Withdrawal by Subject|0|||
149852459|NCT02003222|540589358|FG004|Induction|Withdrawal by Subject|8|||
149852460|NCT02003222|540589354|FG000|Induction|Other reasons|0|||
149852461|NCT02003222|540589355|FG001|Induction|Other reasons|0|||
149852462|NCT02003222|540589356|FG002|Induction|Other reasons|0|||
149852463|NCT02003222|540589357|FG003|Induction|Other reasons|0|||
149852464|NCT02003222|540589358|FG004|Induction|Other reasons|22|||
149852465|NCT02003222|540589354|FG000|Intensification|Never started treatment|0|||
149852466|NCT02003222|540589355|FG001|Intensification|Never started treatment|0|||
149959217|NCT04518410|540984165|FG021|Overall Study|Death|0|||
149959218|NCT04518410|540984166|FG022|Overall Study|Death|0|||
149852467|NCT02003222|540589356|FG002|Intensification|Never started treatment|0|||
149852468|NCT02003222|540589357|FG003|Intensification|Never started treatment|0|||
149852469|NCT02003222|540589358|FG004|Intensification|Never started treatment|2|||
149852470|NCT02003222|540589354|FG000|Intensification|Adverse Event|0|||
149852471|NCT02003222|540589355|FG001|Intensification|Adverse Event|0|||
149959219|NCT04518410|540984167|FG023|Overall Study|Death|0|||
149959220|NCT04518410|540984168|FG024|Overall Study|Death|0|||
149959221|NCT04518410|540984144|FG000|Overall Study|Requirement to start alternative therapy|0|||
149959222|NCT04518410|540984145|FG001|Overall Study|Requirement to start alternative therapy|0|||
149959223|NCT04518410|540984146|FG002|Overall Study|Requirement to start alternative therapy|1|||
149959224|NCT04518410|540984147|FG003|Overall Study|Requirement to start alternative therapy|0|||
149959225|NCT04518410|540984148|FG004|Overall Study|Requirement to start alternative therapy|0|||
149959226|NCT04518410|540984149|FG005|Overall Study|Requirement to start alternative therapy|0|||
149959227|NCT04518410|540984150|FG006|Overall Study|Requirement to start alternative therapy|0|||
149959228|NCT04518410|540984151|FG007|Overall Study|Requirement to start alternative therapy|0|||
149959229|NCT04518410|540984152|FG008|Overall Study|Requirement to start alternative therapy|0|||
149959230|NCT04518410|540984153|FG009|Overall Study|Requirement to start alternative therapy|0|||
149959231|NCT04518410|540984154|FG010|Overall Study|Requirement to start alternative therapy|0|||
149959232|NCT04518410|540984155|FG011|Overall Study|Requirement to start alternative therapy|0|||
149959233|NCT04518410|540984156|FG012|Overall Study|Requirement to start alternative therapy|0|||
149959234|NCT04518410|540984157|FG013|Overall Study|Requirement to start alternative therapy|0|||
149959235|NCT04518410|540984158|FG014|Overall Study|Requirement to start alternative therapy|0|||
149959236|NCT04518410|540984159|FG015|Overall Study|Requirement to start alternative therapy|0|||
149959237|NCT04518410|540984160|FG016|Overall Study|Requirement to start alternative therapy|0|||
149959238|NCT04518410|540984161|FG017|Overall Study|Requirement to start alternative therapy|0|||
149959239|NCT04518410|540984162|FG018|Overall Study|Requirement to start alternative therapy|0|||
149959240|NCT04518410|540984163|FG019|Overall Study|Requirement to start alternative therapy|0|||
149959241|NCT04518410|540984164|FG020|Overall Study|Requirement to start alternative therapy|0|||
149959242|NCT04518410|540984165|FG021|Overall Study|Requirement to start alternative therapy|0|||
150288878|NCT01662440|542192525|FG003|Overall Study|Subject moved to another country.|0|||
149852472|NCT02003222|540589356|FG002|Intensification|Adverse Event|0|||
149852473|NCT02003222|540589357|FG003|Intensification|Adverse Event|0|||
149852474|NCT02003222|540589358|FG004|Intensification|Adverse Event|6|||
149852475|NCT02003222|540589354|FG000|Intensification|Alternative therapy|0|||
149852476|NCT02003222|540589355|FG001|Intensification|Alternative therapy|0|||
149852477|NCT02003222|540589356|FG002|Intensification|Alternative therapy|0|||
149852478|NCT02003222|540589357|FG003|Intensification|Alternative therapy|0|||
149852479|NCT02003222|540589358|FG004|Intensification|Alternative therapy|8|||
149852480|NCT02003222|540589354|FG000|Intensification|Disease progression|0|||
149852481|NCT02003222|540589355|FG001|Intensification|Disease progression|0|||
149852482|NCT02003222|540589356|FG002|Intensification|Disease progression|0|||
149852483|NCT02003222|540589357|FG003|Intensification|Disease progression|0|||
149852484|NCT02003222|540589358|FG004|Intensification|Disease progression|18|||
149852485|NCT02003222|540589354|FG000|Intensification|Withdrawal by Subject|0|||
149852486|NCT02003222|540589355|FG001|Intensification|Withdrawal by Subject|0|||
149852487|NCT02003222|540589356|FG002|Intensification|Withdrawal by Subject|0|||
149852488|NCT02003222|540589357|FG003|Intensification|Withdrawal by Subject|0|||
149852489|NCT02003222|540589358|FG004|Intensification|Withdrawal by Subject|5|||
149852490|NCT02003222|540589354|FG000|Intensification|Other reasons|0|||
149852491|NCT02003222|540589355|FG001|Intensification|Other reasons|0|||
149852492|NCT02003222|540589356|FG002|Intensification|Other reasons|0|||
149852493|NCT02003222|540589357|FG003|Intensification|Other reasons|0|||
149852494|NCT02003222|540589358|FG004|Intensification|Other reasons|8|||
149852495|NCT04941768|540589363|FG000|Overall Study|Lost to Follow-up|10|||
149852496|NCT04941768|540589363|FG000|Overall Study|Death|24|||
149852497|NCT04941768|540589363|FG000|Overall Study|Progressive Disease|4|||
149852498|NCT04941768|540589363|FG000|Overall Study|Withdrawal by Subject|4|||
149852499|NCT04941768|540589363|FG000|Overall Study|Other|3|||
149852500|NCT04941768|540589363|FG000|Overall Study|Treatment ongoing|21|||
149852501|NCT04941768|540589363|FG000|Overall Study|Off treatment and in follow-up|21|||
149852502|NCT03302078|540589365|FG000|Washout Period|Adverse Event|0|||
149852503|NCT03302078|540589366|FG001|Washout Period|Adverse Event|1|||
149852504|NCT01886872|540589367|FG000|Overall Study|Ineligible|7|||
149959243|NCT04518410|540984166|FG022|Overall Study|Requirement to start alternative therapy|0|||
149959244|NCT04518410|540984167|FG023|Overall Study|Requirement to start alternative therapy|0|||
149959245|NCT04518410|540984168|FG024|Overall Study|Requirement to start alternative therapy|0|||
149959246|NCT04518410|540984144|FG000|Overall Study|Randomized but not treated|0|||
149959247|NCT04518410|540984145|FG001|Overall Study|Randomized but not treated|0|||
149959248|NCT04518410|540984146|FG002|Overall Study|Randomized but not treated|0|||
149959249|NCT04518410|540984147|FG003|Overall Study|Randomized but not treated|2|||
149959250|NCT04518410|540984148|FG004|Overall Study|Randomized but not treated|6|||
149959251|NCT04518410|540984149|FG005|Overall Study|Randomized but not treated|4|||
149959252|NCT04518410|540984150|FG006|Overall Study|Randomized but not treated|3|||
149852505|NCT01886872|540589368|FG001|Overall Study|Ineligible|4|||
149852506|NCT01886872|540589369|FG002|Overall Study|Ineligible|12|||
149852507|NCT00979212|540589373|FG000|Overall Study|Protocol Violation|1|||
149852508|NCT00979212|540589374|FG001|Overall Study|Protocol Violation|8|||
149852509|NCT00979212|540589373|FG000|Overall Study|No protocol therapy received|1|||
149852510|NCT00979212|540589374|FG001|Overall Study|No protocol therapy received|0|||
149852511|NCT00177164|540589382|FG000|Overall Study|Protocol Violation|0|||
149852512|NCT00177164|540589383|FG001|Overall Study|Protocol Violation|7|||
149852513|NCT00177164|540589382|FG000|Overall Study|Lost to Follow-up|4|||
149852514|NCT00177164|540589383|FG001|Overall Study|Lost to Follow-up|5|||
149852515|NCT00177164|540589382|FG000|Overall Study|increase in alcohol and drug use|1|||
149852516|NCT00177164|540589383|FG001|Overall Study|increase in alcohol and drug use|2|||
149852517|NCT00177164|540589382|FG000|Overall Study|Adverse Event|1|||
149852518|NCT00177164|540589383|FG001|Overall Study|Adverse Event|0|||
149852519|NCT00177164|540589382|FG000|Overall Study|discharge from hospital|1|||
149852520|NCT00177164|540589383|FG001|Overall Study|discharge from hospital|0|||
149852521|NCT00177164|540589382|FG000|Overall Study|Lack of Efficacy|2|||
149852522|NCT00177164|540589383|FG001|Overall Study|Lack of Efficacy|1|||
149852523|NCT00177164|540589382|FG000|Overall Study|Pregnancy|0|||
149852524|NCT00177164|540589383|FG001|Overall Study|Pregnancy|1|||
149852525|NCT00965757|540589386|FG000|Double-blind Phase|Progression of concomitant disease|1|||
149852526|NCT00965757|540589387|FG001|Double-blind Phase|Progression of concomitant disease|2|||
149852527|NCT00965757|540589388|FG002|Double-blind Phase|Progression of concomitant disease|0|||
149852528|NCT00965757|540589389|FG003|Double-blind Phase|Progression of concomitant disease|0|||
149852529|NCT00965757|540589386|FG000|Double-blind Phase|Adverse drug reaction|2|||
149852530|NCT00965757|540589387|FG001|Double-blind Phase|Adverse drug reaction|1|||
149852531|NCT00965757|540589388|FG002|Double-blind Phase|Adverse drug reaction|0|||
149852532|NCT00965757|540589389|FG003|Double-blind Phase|Adverse drug reaction|0|||
149852533|NCT00965757|540589386|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
149852534|NCT00965757|540589387|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
149852535|NCT00965757|540589388|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
149852536|NCT00965757|540589389|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
149852537|NCT00965757|540589386|FG000|Double-blind Phase|Lack of Efficacy|7|||
149852538|NCT00965757|540589387|FG001|Double-blind Phase|Lack of Efficacy|11|||
149852539|NCT00965757|540589388|FG002|Double-blind Phase|Lack of Efficacy|0|||
149852540|NCT00965757|540589389|FG003|Double-blind Phase|Lack of Efficacy|0|||
149852541|NCT00965757|540589386|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
149852542|NCT00965757|540589387|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
149852543|NCT00965757|540589388|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
149852544|NCT00965757|540589389|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
149959253|NCT04518410|540984151|FG007|Overall Study|Randomized but not treated|3|||
149959254|NCT04518410|540984152|FG008|Overall Study|Randomized but not treated|0|||
149959255|NCT04518410|540984153|FG009|Overall Study|Randomized but not treated|4|||
149959256|NCT04518410|540984154|FG010|Overall Study|Randomized but not treated|0|||
149959257|NCT04518410|540984155|FG011|Overall Study|Randomized but not treated|0|||
149959258|NCT04518410|540984156|FG012|Overall Study|Randomized but not treated|1|||
149959259|NCT04518410|540984157|FG013|Overall Study|Randomized but not treated|3|||
149959260|NCT04518410|540984158|FG014|Overall Study|Randomized but not treated|3|||
149852545|NCT00965757|540589386|FG000|Double-blind Phase|Lost to Follow-up|0|||
149852546|NCT00965757|540589387|FG001|Double-blind Phase|Lost to Follow-up|1|||
149852547|NCT00965757|540589388|FG002|Double-blind Phase|Lost to Follow-up|0|||
149852548|NCT00965757|540589389|FG003|Double-blind Phase|Lost to Follow-up|0|||
149959261|NCT04518410|540984159|FG015|Overall Study|Randomized but not treated|3|||
149959262|NCT04518410|540984160|FG016|Overall Study|Randomized but not treated|4|||
149959263|NCT04518410|540984161|FG017|Overall Study|Randomized but not treated|5|||
150172799|NCT00961636|541768093|FG000|Overall Study|Withdrawal by Subject|29|||
149852549|NCT00965757|540589386|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
149852550|NCT00965757|540589387|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
149852551|NCT00965757|540589388|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
149852552|NCT00965757|540589389|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
149852553|NCT00965757|540589386|FG000|Double-blind Phase|Other|1|||
149852554|NCT00965757|540589387|FG001|Double-blind Phase|Other|0|||
149852555|NCT00965757|540589388|FG002|Double-blind Phase|Other|0|||
149852556|NCT00965757|540589389|FG003|Double-blind Phase|Other|0|||
149852557|NCT00965757|540589386|FG000|Extension Phase|Progression of concomitant disease|0|||
149852558|NCT00965757|540589387|FG001|Extension Phase|Progression of concomitant disease|0|||
149852559|NCT00965757|540589388|FG002|Extension Phase|Progression of concomitant disease|4|||
149852560|NCT00965757|540589389|FG003|Extension Phase|Progression of concomitant disease|2|||
149852561|NCT00965757|540589386|FG000|Extension Phase|Adverse drug reaction|0|||
149852562|NCT00965757|540589387|FG001|Extension Phase|Adverse drug reaction|0|||
149852563|NCT00965757|540589388|FG002|Extension Phase|Adverse drug reaction|6|||
149852564|NCT00965757|540589389|FG003|Extension Phase|Adverse drug reaction|3|||
149852565|NCT00965757|540589386|FG000|Extension Phase|Abnormal Laboratory Value|0|||
149852566|NCT00965757|540589387|FG001|Extension Phase|Abnormal Laboratory Value|0|||
149852567|NCT00965757|540589388|FG002|Extension Phase|Abnormal Laboratory Value|6|||
149852568|NCT00965757|540589389|FG003|Extension Phase|Abnormal Laboratory Value|1|||
149852569|NCT00965757|540589386|FG000|Extension Phase|Lack of Efficacy|0|||
149852570|NCT00965757|540589387|FG001|Extension Phase|Lack of Efficacy|0|||
149852571|NCT00965757|540589388|FG002|Extension Phase|Lack of Efficacy|8|||
149852572|NCT00965757|540589389|FG003|Extension Phase|Lack of Efficacy|12|||
149852573|NCT00965757|540589386|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
149852574|NCT00965757|540589387|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
149852575|NCT00965757|540589388|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
149852576|NCT00965757|540589389|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
149852577|NCT00965757|540589386|FG000|Extension Phase|Lost to Follow-up|0|||
149852578|NCT00965757|540589387|FG001|Extension Phase|Lost to Follow-up|0|||
149852579|NCT00965757|540589388|FG002|Extension Phase|Lost to Follow-up|0|||
149852580|NCT00965757|540589389|FG003|Extension Phase|Lost to Follow-up|1|||
149852581|NCT00965757|540589386|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
149852582|NCT00965757|540589387|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
149852583|NCT00965757|540589388|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
149852584|NCT00965757|540589389|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
149852585|NCT00965757|540589386|FG000|Extension Phase|Protocol Violation|0|||
150288879|NCT01662440|542192522|FG000|Overall Study|Protocol Violation|1|||
149852586|NCT00965757|540589387|FG001|Extension Phase|Protocol Violation|0|||
149852587|NCT00965757|540589388|FG002|Extension Phase|Protocol Violation|0|||
149852588|NCT00965757|540589389|FG003|Extension Phase|Protocol Violation|1|||
149852589|NCT00965757|540589386|FG000|Extension Phase|Other|0|||
149852590|NCT00965757|540589387|FG001|Extension Phase|Other|0|||
149852591|NCT00965757|540589388|FG002|Extension Phase|Other|2|||
149852592|NCT00965757|540589389|FG003|Extension Phase|Other|1|||
149852593|NCT03807440|540589390|FG000|Overall Study|No documentation of index date 2|320|||
149852594|NCT03807440|540589390|FG000|Overall Study|No informed consent for index date 2|117|||
149852595|NCT02451358|540589391|FG000|Overall Study|Withdrawal by Subject|1|||
149852596|NCT02451358|540589392|FG001|Overall Study|Withdrawal by Subject|1|||
149852597|NCT02451358|540589393|FG002|Overall Study|Withdrawal by Subject|0|||
149852598|NCT02451358|540589394|FG003|Overall Study|Withdrawal by Subject|0|||
149852599|NCT02451358|540589391|FG000|Overall Study|Protocol Violation|0|||
149852600|NCT02451358|540589392|FG001|Overall Study|Protocol Violation|1|||
149852601|NCT02451358|540589393|FG002|Overall Study|Protocol Violation|1|||
149852602|NCT02451358|540589394|FG003|Overall Study|Protocol Violation|0|||
149852603|NCT06128525|540589395|FG000|Overall Study|Patient withdrew consent|1|||
149852604|NCT01398787|540589398|FG000|Overall Study|Adverse Event|1|||
149852605|NCT03414034|540589399|FG000|Overall Study|Adverse Event|6|||
149852606|NCT03414034|540589400|FG001|Overall Study|Adverse Event|1|||
149852607|NCT03414034|540589401|FG002|Overall Study|Adverse Event|1|||
149852608|NCT03414034|540589399|FG000|Overall Study|Death|0|||
149852609|NCT03414034|540589400|FG001|Overall Study|Death|0|||
149852610|NCT03414034|540589401|FG002|Overall Study|Death|1|||
149852611|NCT03414034|540589399|FG000|Overall Study|Non-compliance With Study Drug|0|||
149852612|NCT03414034|540589400|FG001|Overall Study|Non-compliance With Study Drug|0|||
149852613|NCT03414034|540589401|FG002|Overall Study|Non-compliance With Study Drug|1|||
149852614|NCT03414034|540589399|FG000|Overall Study|Physician Decision|1|||
149852615|NCT03414034|540589400|FG001|Overall Study|Physician Decision|3|||
149852616|NCT03414034|540589401|FG002|Overall Study|Physician Decision|2|||
149852617|NCT03414034|540589399|FG000|Overall Study|Withdrawal of Informed Consent|2|||
149852618|NCT03414034|540589400|FG001|Overall Study|Withdrawal of Informed Consent|1|||
149852619|NCT03414034|540589401|FG002|Overall Study|Withdrawal of Informed Consent|4|||
149852620|NCT03414034|540589399|FG000|Overall Study|Progressive Disease|15|||
149852621|NCT03414034|540589400|FG001|Overall Study|Progressive Disease|15|||
149852622|NCT03414034|540589401|FG002|Overall Study|Progressive Disease|17|||
149852623|NCT03414034|540589399|FG000|Overall Study|Miscellaneous|0|||
149852624|NCT03414034|540589400|FG001|Overall Study|Miscellaneous|0|||
149852625|NCT03414034|540589401|FG002|Overall Study|Miscellaneous|2|||
149852626|NCT02351167|540589402|FG000|Overall Study|Withdrawal by Subject|19|||
149852627|NCT02351167|540589403|FG001|Overall Study|Withdrawal by Subject|18|||
149852628|NCT02351167|540589404|FG002|Overall Study|Withdrawal by Subject|21|||
149852629|NCT04010227|540589405|FG000|Overall Study|Death|1|||
149852630|NCT04010227|540589406|FG001|Overall Study|Death|2|||
149852631|NCT04010227|540589405|FG000|Overall Study|Medical Reasons|4|||
149852632|NCT04010227|540589406|FG001|Overall Study|Medical Reasons|3|||
149852633|NCT04010227|540589405|FG000|Overall Study|Withdrawal by Subject|2|||
149852634|NCT04010227|540589406|FG001|Overall Study|Withdrawal by Subject|0|||
149852635|NCT04010227|540589405|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
149852636|NCT04010227|540589406|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
149852637|NCT02308696|540589407|FG000|Overall Study|Lost to Follow-up|28|||
149852638|NCT02308696|540589408|FG001|Overall Study|Lost to Follow-up|21|||
149852639|NCT02308696|540589407|FG000|Overall Study|Death|8|||
149852640|NCT02308696|540589408|FG001|Overall Study|Death|4|||
149852641|NCT02308696|540589407|FG000|Overall Study|Moved to a Higher Level of Care|17|||
149852642|NCT02308696|540589408|FG001|Overall Study|Moved to a Higher Level of Care|6|||
149852643|NCT02522780|540589409|FG000|Overall Study|Consent withdrawn by subject|5|||
149852644|NCT02522780|540589410|FG001|Overall Study|Consent withdrawn by subject|7|||
149852645|NCT02522780|540589409|FG000|Overall Study|Protocol deviation|1|||
149852646|NCT02522780|540589410|FG001|Overall Study|Protocol deviation|3|||
149852647|NCT02522780|540589409|FG000|Overall Study|Subject refused endoscopic procedure|0|||
149852648|NCT02522780|540589410|FG001|Overall Study|Subject refused endoscopic procedure|1|||
149852649|NCT02522780|540589409|FG000|Overall Study|Adverse event, non-fatal|11|||
149852650|NCT02522780|540589410|FG001|Overall Study|Adverse event, non-fatal|16|||
149852651|NCT02260635|540589411|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
149852652|NCT02260635|540589412|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
149852653|NCT02260635|540589411|FG000|Open-Label Extension|Study Termination|25|||
149852654|NCT02260635|540589412|FG001|Open-Label Extension|Study Termination|25|||
149852655|NCT02260635|540589411|FG000|Open-Label Extension|Withdrawal by Subject|1|||
149852656|NCT02260635|540589412|FG001|Open-Label Extension|Withdrawal by Subject|0|||
149852657|NCT02466386|540589418|FG000|Overall Study|Adverse Event|5|||
149852658|NCT02466386|540589418|FG000|Overall Study|Protocol Violation|2|||
149852659|NCT02466386|540589418|FG000|Overall Study|Withdrawal by Subject|14|||
149852660|NCT02466386|540589418|FG000|Overall Study|Lost to Follow-up|5|||
149852661|NCT02466386|540589418|FG000|Overall Study|Lack of Efficacy|8|||
149852662|NCT02466386|540589418|FG000|Overall Study|Other|10|||
149852663|NCT05317195|540589419|FG000|Randomization|Withdrawal by Subject|1|||
149852664|NCT05317195|540589419|FG000|Randomization|Discontinued|6|||
149852665|NCT05317195|540589419|FG000|Admission|Withdrawal by Subject|2|||
149852666|NCT02169336|540589424|FG000|Overall Study|Lack of Efficacy|1|||
149852667|NCT02169336|540589425|FG001|Overall Study|Lack of Efficacy|1|||
149852668|NCT02169336|540589426|FG002|Overall Study|Lack of Efficacy|0|||
149852669|NCT02169336|540589424|FG000|Overall Study|Adverse Event|2|||
150039255|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Transplant|0|||
150039256|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Transplant|0|||
150039257|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
150039258|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
149852670|NCT02169336|540589425|FG001|Overall Study|Adverse Event|3|||
149852671|NCT02169336|540589426|FG002|Overall Study|Adverse Event|1|||
149852672|NCT02169336|540589424|FG000|Overall Study|Withdrawal by Subject|1|||
149852673|NCT02169336|540589425|FG001|Overall Study|Withdrawal by Subject|0|||
149852674|NCT02169336|540589426|FG002|Overall Study|Withdrawal by Subject|0|||
149852675|NCT02169336|540589424|FG000|Overall Study|Physician Decision|0|||
149852676|NCT02169336|540589425|FG001|Overall Study|Physician Decision|0|||
149852677|NCT02169336|540589426|FG002|Overall Study|Physician Decision|1|||
149852678|NCT02169336|540589424|FG000|Overall Study|Subject declined to continue dosing|0|||
149852679|NCT02169336|540589425|FG001|Overall Study|Subject declined to continue dosing|0|||
149852680|NCT02169336|540589426|FG002|Overall Study|Subject declined to continue dosing|1|||
149852681|NCT00420095|540589427|FG000|Overall Study|Adverse Event|1|||
150039259|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
150039260|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
150039261|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
149852682|NCT00420095|540589428|FG001|Overall Study|Adverse Event|0|||
150039262|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
149852683|NCT00420095|540589427|FG000|Overall Study|Protocol Violation|1|||
149852684|NCT00420095|540589428|FG001|Overall Study|Protocol Violation|1|||
149852685|NCT00420095|540589427|FG000|Overall Study|Lost to Follow-up|1|||
149852686|NCT00420095|540589428|FG001|Overall Study|Lost to Follow-up|0|||
149852687|NCT00393705|540589429|FG000|Overall Study|Adverse Event|0|||
149852688|NCT00393705|540589430|FG001|Overall Study|Adverse Event|2|||
149852689|NCT00393705|540589429|FG000|Overall Study|Death|0|||
149852690|NCT00393705|540589430|FG001|Overall Study|Death|1|||
150039263|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
149852691|NCT00393705|540589429|FG000|Overall Study|Lost to Follow-up|2|||
149852692|NCT00393705|540589430|FG001|Overall Study|Lost to Follow-up|2|||
149852693|NCT00393705|540589429|FG000|Overall Study|Entry Criteria Not Met|10|||
149852694|NCT00393705|540589430|FG001|Overall Study|Entry Criteria Not Met|10|||
149852695|NCT00393705|540589429|FG000|Overall Study|Protocol Violation|4|||
149852696|NCT00393705|540589430|FG001|Overall Study|Protocol Violation|3|||
149852697|NCT00393705|540589429|FG000|Overall Study|Withdrawal by Subject|5|||
149852698|NCT00393705|540589430|FG001|Overall Study|Withdrawal by Subject|3|||
149852699|NCT00393705|540589429|FG000|Overall Study|Physician Decision|2|||
149852700|NCT00393705|540589430|FG001|Overall Study|Physician Decision|2|||
149852701|NCT03370510|540589434|FG000|Overall Study|COVID-19|2|||
149959264|NCT04518410|540984162|FG018|Overall Study|Randomized but not treated|4|||
149959265|NCT04518410|540984163|FG019|Overall Study|Randomized but not treated|0|||
149959266|NCT04518410|540984164|FG020|Overall Study|Randomized but not treated|0|||
150039264|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
150039265|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
150039266|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
150039267|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
150039268|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
150039269|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
150039270|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
150039271|NCT02113982|541285077|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
150039272|NCT02113982|541285078|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
150039273|NCT02113982|541285079|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
150039274|NCT02113982|541285080|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
150039275|NCT02113982|541285081|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
150039276|NCT02113982|541285082|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
150039277|NCT02113982|541285083|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
150039278|NCT02113982|541285084|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
150039279|NCT02113982|541285085|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
150039280|NCT02113982|541285086|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
150039281|NCT02113982|541285087|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
150039282|NCT02113982|541285088|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
150039283|NCT02113982|541285089|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
150039284|NCT02113982|541285090|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
150039285|NCT02113982|541285077|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039286|NCT02113982|541285078|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039287|NCT02113982|541285079|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039288|NCT02113982|541285080|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039289|NCT02113982|541285081|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039290|NCT02113982|541285082|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039291|NCT02113982|541285083|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039292|NCT02113982|541285084|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039293|NCT02113982|541285085|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039294|NCT02113982|541285086|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039295|NCT02113982|541285087|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039296|NCT02113982|541285088|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
150039297|NCT02113982|541285089|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039298|NCT02113982|541285090|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
150039299|NCT02113982|541285077|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039300|NCT02113982|541285078|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039301|NCT02113982|541285079|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039302|NCT02113982|541285080|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039303|NCT02113982|541285081|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
150172800|NCT00961636|541768094|FG001|Overall Study|Withdrawal by Subject|22|||
149852702|NCT03370510|540589435|FG001|Overall Study|COVID-19|0|||
149852703|NCT01374451|540589436|FG000|Overall Study|Administrative problems|1|||
149959267|NCT04518410|540984165|FG021|Overall Study|Randomized but not treated|5|||
149959268|NCT04518410|540984166|FG022|Overall Study|Randomized but not treated|0|||
149959269|NCT04518410|540984167|FG023|Overall Study|Randomized but not treated|3|||
149959270|NCT04518410|540984168|FG024|Overall Study|Randomized but not treated|1|||
149959271|NCT04518410|540984144|FG000|Overall Study|Screen Fail but Randomized|0|||
149959272|NCT04518410|540984145|FG001|Overall Study|Screen Fail but Randomized|0|||
149959273|NCT04518410|540984146|FG002|Overall Study|Screen Fail but Randomized|0|||
150039304|NCT02113982|541285082|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039305|NCT02113982|541285083|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039306|NCT02113982|541285084|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039307|NCT02113982|541285085|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039308|NCT02113982|541285086|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039309|NCT02113982|541285087|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039310|NCT02113982|541285088|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
149852704|NCT01374451|540589437|FG001|Overall Study|Administrative problems|0|||
149852705|NCT00089973|540589440|FG000|Overall Study|Adverse Event|3|||
149959274|NCT04518410|540984147|FG003|Overall Study|Screen Fail but Randomized|0|||
149852706|NCT00089973|540589440|FG000|Overall Study|Withdrawal by Subject|1|||
149852707|NCT00089973|540589440|FG000|Overall Study|Disease progression|45|||
149852708|NCT00089973|540589440|FG000|Overall Study|Death|1|||
149852709|NCT01223027|540589441|FG000|Overall Study|Adverse Event|20|||
149852710|NCT01223027|540589442|FG001|Overall Study|Adverse Event|10|||
149852711|NCT01223027|540589441|FG000|Overall Study|Death|42|||
149852712|NCT01223027|540589442|FG001|Overall Study|Death|42|||
149852713|NCT01223027|540589441|FG000|Overall Study|Lost to Follow-up|2|||
149852714|NCT01223027|540589442|FG001|Overall Study|Lost to Follow-up|1|||
149852715|NCT01223027|540589441|FG000|Overall Study|Physician Decision|4|||
149852716|NCT01223027|540589442|FG001|Overall Study|Physician Decision|8|||
149852717|NCT01223027|540589441|FG000|Overall Study|Progressive Disease|167|||
149852718|NCT01223027|540589442|FG001|Overall Study|Progressive Disease|183|||
149852719|NCT01223027|540589441|FG000|Overall Study|Protocol Violation|2|||
149852720|NCT01223027|540589442|FG001|Overall Study|Protocol Violation|1|||
149852721|NCT01223027|540589441|FG000|Overall Study|Subject/guardian decicion|18|||
149852722|NCT01223027|540589442|FG001|Overall Study|Subject/guardian decicion|16|||
149852723|NCT01223027|540589441|FG000|Overall Study|New therapy for study indication|17|||
149852724|NCT01223027|540589442|FG001|Overall Study|New therapy for study indication|8|||
149852725|NCT01223027|540589441|FG000|Overall Study|Study terminated by sponsor|2|||
149852726|NCT01223027|540589442|FG001|Overall Study|Study terminated by sponsor|8|||
149852727|NCT01475487|540589443|FG000|Overall Study|had to leave early for personal reasons|2|||
149852728|NCT01475487|540589444|FG001|Overall Study|had to leave early for personal reasons|1|||
149852729|NCT00857818|540589445|FG000|Overall Study|Lack of Efficacy|1|||
149852730|NCT00857818|540589446|FG001|Overall Study|Lack of Efficacy|0|||
149852731|NCT00857818|540589445|FG000|Overall Study|Adverse Event|3|||
149852732|NCT00857818|540589446|FG001|Overall Study|Adverse Event|0|||
149852733|NCT00857818|540589445|FG000|Overall Study|Withdrawal by Subject|0|||
149852734|NCT00857818|540589446|FG001|Overall Study|Withdrawal by Subject|4|||
149852735|NCT00857818|540589445|FG000|Overall Study|Sponsor terminated study|6|||
149852736|NCT00857818|540589446|FG001|Overall Study|Sponsor terminated study|4|||
149852737|NCT00857818|540589445|FG000|Overall Study|Investigator decision|1|||
149852738|NCT00857818|540589446|FG001|Overall Study|Investigator decision|0|||
149852739|NCT01977456|540589450|FG000|Overall Study|Death|5|||
149852740|NCT00965731|540589453|FG000|Overall Study|Death|0|||
149852741|NCT00965731|540589454|FG001|Overall Study|Death|4|||
149852742|NCT00965731|540589453|FG000|Overall Study|Withdrawal by Subject|0|||
149852743|NCT00965731|540589454|FG001|Overall Study|Withdrawal by Subject|1|||
149852744|NCT00965731|540589453|FG000|Overall Study|Other|7|||
149852745|NCT00965731|540589454|FG001|Overall Study|Other|15|||
149852746|NCT00683592|540591469|FG000|Overall Study|Adverse Event|12|||
149852747|NCT00683592|540591470|FG001|Overall Study|Adverse Event|4|||
149852748|NCT00683592|540591469|FG000|Overall Study|Withdrawal by Subject|11|||
149852749|NCT00683592|540591470|FG001|Overall Study|Withdrawal by Subject|11|||
149852750|NCT00683592|540591469|FG000|Overall Study|Lost to Follow-up|17|||
149852751|NCT00683592|540591470|FG001|Overall Study|Lost to Follow-up|17|||
149852752|NCT00683592|540591469|FG000|Overall Study|Lack of Efficacy|3|||
149959275|NCT04518410|540984148|FG004|Overall Study|Screen Fail but Randomized|2|||
149959276|NCT04518410|540984149|FG005|Overall Study|Screen Fail but Randomized|0|||
149959277|NCT04518410|540984150|FG006|Overall Study|Screen Fail but Randomized|0|||
149959278|NCT04518410|540984151|FG007|Overall Study|Screen Fail but Randomized|0|||
149959279|NCT04518410|540984152|FG008|Overall Study|Screen Fail but Randomized|0|||
149959280|NCT04518410|540984153|FG009|Overall Study|Screen Fail but Randomized|0|||
149959281|NCT04518410|540984154|FG010|Overall Study|Screen Fail but Randomized|0|||
149959282|NCT04518410|540984155|FG011|Overall Study|Screen Fail but Randomized|0|||
149959283|NCT04518410|540984156|FG012|Overall Study|Screen Fail but Randomized|0|||
149959284|NCT04518410|540984157|FG013|Overall Study|Screen Fail but Randomized|0|||
149959285|NCT04518410|540984158|FG014|Overall Study|Screen Fail but Randomized|0|||
149959286|NCT04518410|540984159|FG015|Overall Study|Screen Fail but Randomized|0|||
149959287|NCT04518410|540984160|FG016|Overall Study|Screen Fail but Randomized|0|||
149959288|NCT04518410|540984161|FG017|Overall Study|Screen Fail but Randomized|0|||
149959289|NCT04518410|540984162|FG018|Overall Study|Screen Fail but Randomized|0|||
150172801|NCT00961636|541768095|FG002|Overall Study|Withdrawal by Subject|13|||
149852753|NCT00683592|540591470|FG001|Overall Study|Lack of Efficacy|7|||
150172802|NCT02486588|541768100|FG000|Overall Study|Randomized in error- ineligible|738|||
149852754|NCT00683592|540591469|FG000|Overall Study|Physician Decision|0|||
149852755|NCT00683592|540591470|FG001|Overall Study|Physician Decision|1|||
149852756|NCT00683592|540591469|FG000|Overall Study|Non-compliance|3|||
149852757|NCT00683592|540591470|FG001|Overall Study|Non-compliance|5|||
149852758|NCT00683592|540591469|FG000|Overall Study|Other|1|||
149959290|NCT04518410|540984163|FG019|Overall Study|Screen Fail but Randomized|0|||
149852759|NCT00683592|540591470|FG001|Overall Study|Other|1|||
149852760|NCT02697617|540591478|FG000|Overall Study|Withdrawal by Subject|0|||
149852761|NCT02697617|540591479|FG001|Overall Study|Withdrawal by Subject|2|||
149852762|NCT02697617|540591478|FG000|Overall Study|Pregnancy|1|||
149852763|NCT02697617|540591479|FG001|Overall Study|Pregnancy|0|||
149959291|NCT04518410|540984164|FG020|Overall Study|Screen Fail but Randomized|0|||
149959292|NCT04518410|540984165|FG021|Overall Study|Screen Fail but Randomized|0|||
149852764|NCT03303417|540591480|FG000|Overall Study|Withdrawal by Subject|1|||
149852765|NCT03303417|540591481|FG001|Overall Study|Withdrawal by Subject|1|||
149852766|NCT00381849|540591484|FG000|Wash Out|Withdrawal by Subject|0|||
149852767|NCT00381849|540591485|FG001|Wash Out|Withdrawal by Subject|1|||
149852768|NCT01765270|540591489|FG000|Overall Study|Physician Decision|1|||
149852769|NCT01765270|540591490|FG001|Overall Study|Physician Decision|0|||
149852770|NCT01765270|540591489|FG000|Overall Study|Withdrawal by Subject|0|||
149852771|NCT01765270|540591490|FG001|Overall Study|Withdrawal by Subject|1|||
149852772|NCT00493792|540591491|FG000|Overall Study|Death|55|||
149852773|NCT00493792|540591492|FG001|Overall Study|Death|50|||
149852774|NCT00493792|540591491|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
149852775|NCT00493792|540591492|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
149852776|NCT02426541|540591493|FG000|Overall Study|Protocol Violation|1|||
149852777|NCT02426541|540591494|FG001|Overall Study|Protocol Violation|0|||
149852778|NCT02943993|540591497|FG000|Overall Study|Withdrawal by Subject|52|||
149852779|NCT02943993|540591497|FG000|Overall Study|Transfer to another institution|6|||
149852780|NCT02943993|540591497|FG000|Overall Study|Lost to Follow-up|135|||
149852781|NCT02943993|540591497|FG000|Overall Study|Death|98|||
149852782|NCT02943993|540591497|FG000|Overall Study|Other reason for premature termination|32|||
149852783|NCT02943993|540591497|FG000|Overall Study|Missing reason for termination|7|||
149852784|NCT00876265|540591501|FG000|Overall Study|Miscellaneous reasons|4|||
149852785|NCT00876265|540591501|FG000|Overall Study|Lost to Follow-up|6|||
149852786|NCT00876265|540591501|FG000|Overall Study|Withdrawal by Subject|2|||
149852787|NCT00996437|540591506|FG000|Overall Study|Death|1|||
149852788|NCT00996437|540591507|FG001|Overall Study|Death|0|||
149852789|NCT00996437|540591506|FG000|Overall Study|Dropped|2|||
149852790|NCT00996437|540591507|FG001|Overall Study|Dropped|2|||
149852791|NCT00996437|540591506|FG000|Overall Study|Missed|2|||
149852792|NCT00996437|540591507|FG001|Overall Study|Missed|5|||
149852793|NCT02510261|540591508|FG000|Overall Study|Adverse Event|5|||
149852794|NCT02510261|540591509|FG001|Overall Study|Adverse Event|8|||
149852795|NCT02510261|540591510|FG002|Overall Study|Adverse Event|0|||
149852796|NCT02510261|540591508|FG000|Overall Study|Physician Decision|1|||
149852797|NCT02510261|540591509|FG001|Overall Study|Physician Decision|5|||
149852798|NCT02510261|540591510|FG002|Overall Study|Physician Decision|0|||
149852799|NCT02510261|540591508|FG000|Overall Study|Death|19|||
149852800|NCT02510261|540591509|FG001|Overall Study|Death|19|||
149852801|NCT02510261|540591510|FG002|Overall Study|Death|0|||
149852802|NCT02510261|540591508|FG000|Overall Study|Withdrawal by Subject|3|||
149852803|NCT02510261|540591509|FG001|Overall Study|Withdrawal by Subject|10|||
149852804|NCT02510261|540591510|FG002|Overall Study|Withdrawal by Subject|3|||
149852805|NCT04886063|540591513|FG000|Overall Study|Adverse Event|50|||
149852806|NCT04886063|540591513|FG000|Overall Study|Lack of Efficacy|31|||
149852807|NCT04886063|540591513|FG000|Overall Study|Withdrawal by Subject|45|||
149852808|NCT04886063|540591513|FG000|Overall Study|Physician Decision|3|||
149852809|NCT04886063|540591513|FG000|Overall Study|Protocol Violation|3|||
149852810|NCT04886063|540591513|FG000|Overall Study|Site closure|4|||
149852811|NCT04886063|540591513|FG000|Overall Study|Nursing home replacement|3|||
149852812|NCT04886063|540591513|FG000|Overall Study|Lost to Follow-up|5|||
149852813|NCT04886063|540591513|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
149852814|NCT04886063|540591513|FG000|Overall Study|>1 reason|20|||
149852815|NCT01344018|540591518|FG000|Overall Study|Death|22|||
149852816|NCT01344018|540591519|FG001|Overall Study|Death|25|||
149852817|NCT01344018|540591518|FG000|Overall Study|Lost to Follow-up|4|||
149852818|NCT01344018|540591519|FG001|Overall Study|Lost to Follow-up|7|||
149852819|NCT05070754|540591520|FG000|Overall Study|Withdrawal by Subject|0|||
149852820|NCT05070754|540591521|FG001|Overall Study|Withdrawal by Subject|0|||
149852821|NCT05070754|540591522|FG002|Overall Study|Withdrawal by Subject|0|||
149852822|NCT05070754|540591523|FG003|Overall Study|Withdrawal by Subject|1|||
149852823|NCT05070754|540591520|FG000|Overall Study|Protocol Violation|0|||
149852824|NCT05070754|540591521|FG001|Overall Study|Protocol Violation|0|||
149852825|NCT05070754|540591522|FG002|Overall Study|Protocol Violation|0|||
149852826|NCT05070754|540591523|FG003|Overall Study|Protocol Violation|1|||
149852827|NCT00726895|540591525|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149959293|NCT04518410|540984166|FG022|Overall Study|Screen Fail but Randomized|0|||
149959294|NCT04518410|540984167|FG023|Overall Study|Screen Fail but Randomized|0|||
149959295|NCT04518410|540984168|FG024|Overall Study|Screen Fail but Randomized|0|||
149959296|NCT04518410|540984144|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959297|NCT04518410|540984145|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959298|NCT04518410|540984146|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
150039311|NCT02113982|541285089|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
150039312|NCT02113982|541285090|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
149852828|NCT00726895|540591526|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
150039313|NCT02113982|541285077|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
149852829|NCT04194008|540591531|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
149852830|NCT04194008|540591531|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
150039314|NCT02113982|541285078|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039315|NCT02113982|541285079|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039316|NCT02113982|541285080|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039317|NCT02113982|541285081|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039318|NCT02113982|541285082|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039319|NCT02113982|541285083|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039320|NCT02113982|541285084|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039321|NCT02113982|541285085|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039322|NCT02113982|541285086|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039323|NCT02113982|541285087|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039324|NCT02113982|541285088|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
150039325|NCT02113982|541285089|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039326|NCT02113982|541285090|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
150039327|NCT02113982|541285077|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
150039328|NCT02113982|541285078|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
150039329|NCT02113982|541285079|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
150039330|NCT02113982|541285080|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
150039331|NCT02113982|541285081|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
150039332|NCT02113982|541285082|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
150039333|NCT02113982|541285083|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
150039334|NCT02113982|541285084|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
150039335|NCT02113982|541285085|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
150039336|NCT02113982|541285086|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
150039337|NCT02113982|541285087|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
150039338|NCT02113982|541285088|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
150039339|NCT02113982|541285089|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
150039340|NCT02113982|541285090|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
150039341|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039342|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039343|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039344|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039345|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039346|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039347|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039348|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039349|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039350|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039351|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039352|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039353|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
150039354|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
150039355|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039356|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039357|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039358|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039359|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039360|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039361|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039362|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039363|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039364|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039365|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039366|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
150039367|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
150039368|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
150039369|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039370|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039371|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039372|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039373|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039374|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039375|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039376|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039377|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039378|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039379|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039380|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
150039381|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
150039382|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
149852831|NCT04194008|540591531|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
149852832|NCT04194008|540591531|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
149852833|NCT04194008|540591531|FG000|Treatment Phase With Nerivio|Missing data|4|||
149852834|NCT04194008|540591531|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
149852835|NCT01785615|540591532|FG000|Dietary Phase|Lost to Follow-up|0|||
149852836|NCT01785615|540591533|FG001|Dietary Phase|Lost to Follow-up|0|||
149959299|NCT04518410|540984147|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959300|NCT04518410|540984148|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
149959301|NCT04518410|540984149|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
149959302|NCT04518410|540984150|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
149959303|NCT04518410|540984151|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
149959304|NCT04518410|540984152|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
149975717|NCT00443703|541049398|FG000|Overall Study|Withdrawal by Subject|9|||
149975718|NCT00443703|541049399|FG001|Overall Study|Withdrawal by Subject|6|||
149975719|NCT00443703|541049398|FG000|Overall Study|Progressive Disease|1|||
150172803|NCT02486588|541768101|FG001|Overall Study|Randomized in error- ineligible|750|||
149852837|NCT01785615|540591534|FG002|Dietary Phase|Lost to Follow-up|0|||
149852838|NCT01785615|540591535|FG003|Dietary Phase|Lost to Follow-up|24|||
149852839|NCT01881737|540591536|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
149852840|NCT01881737|540591536|FG000|Overall Study|Withdrawal by Subject|1|||
149852841|NCT01881737|540591536|FG000|Overall Study|Worsening of baseline behavior|1|||
149852842|NCT02608476|540591537|FG000|Overall Study|Withdrawal by Subject|30|||
149852843|NCT02608476|540591538|FG001|Overall Study|Withdrawal by Subject|37|||
149852844|NCT02608476|540591537|FG000|Overall Study|Lost to Follow-up|24|||
149852845|NCT02608476|540591538|FG001|Overall Study|Lost to Follow-up|24|||
149852846|NCT02608476|540591537|FG000|Overall Study|Adverse Event|2|||
149852847|NCT02608476|540591538|FG001|Overall Study|Adverse Event|8|||
149852848|NCT02608476|540591537|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
149852849|NCT02608476|540591538|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
150172804|NCT02486588|541768102|FG002|Overall Study|Randomized in error- ineligible|755|||
149852850|NCT02608476|540591537|FG000|Overall Study|Noncompliance with treatment|1|||
149852851|NCT02608476|540591538|FG001|Overall Study|Noncompliance with treatment|5|||
149852852|NCT02608476|540591537|FG000|Overall Study|Lack of Efficacy|3|||
149852853|NCT02608476|540591538|FG001|Overall Study|Lack of Efficacy|1|||
149852854|NCT02608476|540591537|FG000|Overall Study|Other|0|||
149852855|NCT02608476|540591538|FG001|Overall Study|Other|1|||
149975720|NCT00443703|541049399|FG001|Overall Study|Progressive Disease|0|||
149975721|NCT01047007|541049400|FG000|Overall Study|Adverse Event|0|||
149975722|NCT01047007|541049401|FG001|Overall Study|Adverse Event|2|||
149975723|NCT01047007|541049402|FG002|Overall Study|Adverse Event|1|||
149975724|NCT01047007|541049403|FG003|Overall Study|Adverse Event|0|||
149975725|NCT01047007|541049400|FG000|Overall Study|Progressive Disease|2|||
149975726|NCT01047007|541049401|FG001|Overall Study|Progressive Disease|4|||
149975727|NCT01047007|541049402|FG002|Overall Study|Progressive Disease|1|||
149975728|NCT01047007|541049403|FG003|Overall Study|Progressive Disease|0|||
149975729|NCT01669902|541049408|FG000|Overall Study|Adverse Event|11|||
149975730|NCT01669902|541049408|FG000|Overall Study|Lack of Efficacy|10|||
149975731|NCT01669902|541049408|FG000|Overall Study|Other|8|||
149975732|NCT00305877|541049409|FG000|Overall Study|Lack of Efficacy|6|||
149975733|NCT00305877|541049410|FG001|Overall Study|Lack of Efficacy|9|||
149975734|NCT00305877|541049409|FG000|Overall Study|Adverse Event|9|||
149975735|NCT00305877|541049410|FG001|Overall Study|Adverse Event|14|||
149975736|NCT00305877|541049409|FG000|Overall Study|Death|0|||
149975737|NCT00305877|541049410|FG001|Overall Study|Death|1|||
149975738|NCT00305877|541049409|FG000|Overall Study|Withdrawal by Subject|4|||
149975739|NCT00305877|541049410|FG001|Overall Study|Withdrawal by Subject|2|||
149975740|NCT00305877|541049409|FG000|Overall Study|Physician Decision|1|||
149975741|NCT00305877|541049410|FG001|Overall Study|Physician Decision|1|||
149975742|NCT00305877|541049409|FG000|Overall Study|Never start treatment|2|||
149975743|NCT00305877|541049410|FG001|Overall Study|Never start treatment|5|||
149975744|NCT00305877|541049409|FG000|Overall Study|Ineligible|2|||
149975745|NCT00305877|541049410|FG001|Overall Study|Ineligible|1|||
149975746|NCT00305877|541049409|FG000|Overall Study|Transportation issue with daily RT|0|||
149975747|NCT00305877|541049410|FG001|Overall Study|Transportation issue with daily RT|1|||
149975748|NCT00517699|541049411|FG000|Overall Study|Withdrawal by Subject|1|||
149975749|NCT00517699|541049411|FG000|Overall Study|Lack of Efficacy|1|||
149975750|NCT00517699|541049411|FG000|Overall Study|Administrative error|1|||
149975751|NCT00517699|541049411|FG000|Overall Study|Study terminated by Sponsor|2|||
149975752|NCT02332187|541049412|FG000|Overall Study|Withdrawal by Subject|2|||
149975753|NCT02332187|541049413|FG001|Overall Study|Withdrawal by Subject|2|||
149975754|NCT02332187|541049412|FG000|Overall Study|Adverse Event|0|||
149975755|NCT02332187|541049413|FG001|Overall Study|Adverse Event|1|||
149852856|NCT02608476|540591537|FG000|Overall Study|Physician Decision|1|||
149852857|NCT02608476|540591538|FG001|Overall Study|Physician Decision|0|||
149852858|NCT02608476|540591537|FG000|Overall Study|Pregnancy|0|||
149852859|NCT02608476|540591538|FG001|Overall Study|Pregnancy|1|||
149852860|NCT02608476|540591537|FG000|Overall Study|Progressive disease|1|||
149852861|NCT02608476|540591538|FG001|Overall Study|Progressive disease|0|||
149852862|NCT04106817|540591539|FG000|Overall Study|Lost to Follow-up|1|||
149852863|NCT04106817|540591540|FG001|Overall Study|Lost to Follow-up|0|||
149852864|NCT04106817|540591541|FG002|Overall Study|Lost to Follow-up|0|||
149852865|NCT03310619|540591542|FG000|Pre-Treatment Period|Death|1|||
149852866|NCT03310619|540591543|FG001|Pre-Treatment Period|Death|0|||
149852867|NCT03310619|540591544|FG002|Pre-Treatment Period|Death|0|||
149852868|NCT03310619|540591545|FG003|Pre-Treatment Period|Death|0|||
149852869|NCT03310619|540591546|FG004|Pre-Treatment Period|Death|1|||
149852870|NCT03310619|540591547|FG005|Pre-Treatment Period|Death|0|||
149852871|NCT03310619|540591548|FG006|Pre-Treatment Period|Death|0|||
149852872|NCT03310619|540591549|FG007|Pre-Treatment Period|Death|0|||
149852873|NCT03310619|540591542|FG000|Pre-Treatment Period|Other reasons|2|||
149852874|NCT03310619|540591543|FG001|Pre-Treatment Period|Other reasons|1|||
149852875|NCT03310619|540591544|FG002|Pre-Treatment Period|Other reasons|2|||
149852876|NCT03310619|540591545|FG003|Pre-Treatment Period|Other reasons|0|||
149852877|NCT03310619|540591546|FG004|Pre-Treatment Period|Other reasons|0|||
149852878|NCT03310619|540591547|FG005|Pre-Treatment Period|Other reasons|0|||
149852879|NCT03310619|540591548|FG006|Pre-Treatment Period|Other reasons|2|||
149852880|NCT03310619|540591549|FG007|Pre-Treatment Period|Other reasons|0|||
149852881|NCT03310619|540591542|FG000|Treatment Period|Death|1|||
149852882|NCT03310619|540591543|FG001|Treatment Period|Death|2|||
149852883|NCT03310619|540591544|FG002|Treatment Period|Death|0|||
149852884|NCT03310619|540591545|FG003|Treatment Period|Death|0|||
149852885|NCT03310619|540591546|FG004|Treatment Period|Death|1|||
149852886|NCT03310619|540591547|FG005|Treatment Period|Death|0|||
149852887|NCT03310619|540591548|FG006|Treatment Period|Death|2|||
149852888|NCT03310619|540591549|FG007|Treatment Period|Death|0|||
149852889|NCT03310619|540591542|FG000|Treatment Period|Adverse Event|0|||
149852890|NCT03310619|540591543|FG001|Treatment Period|Adverse Event|1|||
149852891|NCT03310619|540591544|FG002|Treatment Period|Adverse Event|4|||
149852892|NCT03310619|540591545|FG003|Treatment Period|Adverse Event|1|||
149852893|NCT03310619|540591546|FG004|Treatment Period|Adverse Event|0|||
149852894|NCT03310619|540591547|FG005|Treatment Period|Adverse Event|0|||
149852895|NCT03310619|540591548|FG006|Treatment Period|Adverse Event|0|||
149852896|NCT03310619|540591549|FG007|Treatment Period|Adverse Event|0|||
149852897|NCT03310619|540591542|FG000|Treatment Period|Withdrawal by participant|0|||
149852898|NCT03310619|540591543|FG001|Treatment Period|Withdrawal by participant|0|||
149852899|NCT03310619|540591544|FG002|Treatment Period|Withdrawal by participant|1|||
149852900|NCT03310619|540591545|FG003|Treatment Period|Withdrawal by participant|0|||
149852901|NCT03310619|540591546|FG004|Treatment Period|Withdrawal by participant|0|||
149852902|NCT03310619|540591547|FG005|Treatment Period|Withdrawal by participant|0|||
149852903|NCT03310619|540591548|FG006|Treatment Period|Withdrawal by participant|0|||
149852904|NCT03310619|540591549|FG007|Treatment Period|Withdrawal by participant|0|||
149852905|NCT03310619|540591542|FG000|Treatment Period|Lost to Follow-up|0|||
149852906|NCT03310619|540591543|FG001|Treatment Period|Lost to Follow-up|0|||
149852907|NCT03310619|540591544|FG002|Treatment Period|Lost to Follow-up|0|||
149852908|NCT03310619|540591545|FG003|Treatment Period|Lost to Follow-up|0|||
149852909|NCT03310619|540591546|FG004|Treatment Period|Lost to Follow-up|0|||
149852910|NCT03310619|540591547|FG005|Treatment Period|Lost to Follow-up|0|||
149852911|NCT03310619|540591548|FG006|Treatment Period|Lost to Follow-up|0|||
149852912|NCT03310619|540591549|FG007|Treatment Period|Lost to Follow-up|1|||
149852913|NCT03310619|540591542|FG000|Treatment Period|Study terminated by sponsor|0|||
149852914|NCT03310619|540591543|FG001|Treatment Period|Study terminated by sponsor|0|||
149852915|NCT03310619|540591544|FG002|Treatment Period|Study terminated by sponsor|0|||
149852916|NCT03310619|540591545|FG003|Treatment Period|Study terminated by sponsor|0|||
149852917|NCT03310619|540591546|FG004|Treatment Period|Study terminated by sponsor|0|||
149852918|NCT03310619|540591547|FG005|Treatment Period|Study terminated by sponsor|0|||
149852919|NCT03310619|540591548|FG006|Treatment Period|Study terminated by sponsor|0|||
149852920|NCT03310619|540591549|FG007|Treatment Period|Study terminated by sponsor|1|||
149852921|NCT03310619|540591542|FG000|Treatment Period|Physician Decision|0|||
149852922|NCT03310619|540591543|FG001|Treatment Period|Physician Decision|0|||
149852923|NCT03310619|540591544|FG002|Treatment Period|Physician Decision|0|||
149852924|NCT03310619|540591545|FG003|Treatment Period|Physician Decision|0|||
149852925|NCT03310619|540591546|FG004|Treatment Period|Physician Decision|3|||
149852926|NCT03310619|540591547|FG005|Treatment Period|Physician Decision|0|||
149852927|NCT03310619|540591548|FG006|Treatment Period|Physician Decision|0|||
149959305|NCT04518410|540984153|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
150288880|NCT01662440|542192523|FG001|Overall Study|Protocol Violation|0|||
149852928|NCT03310619|540591549|FG007|Treatment Period|Physician Decision|0|||
149852929|NCT03310619|540591542|FG000|Treatment Period|Other reasons|1|||
149852930|NCT03310619|540591543|FG001|Treatment Period|Other reasons|0|||
149852931|NCT03310619|540591544|FG002|Treatment Period|Other reasons|2|||
149852932|NCT03310619|540591545|FG003|Treatment Period|Other reasons|0|||
149852933|NCT03310619|540591546|FG004|Treatment Period|Other reasons|0|||
149852934|NCT03310619|540591547|FG005|Treatment Period|Other reasons|0|||
149852935|NCT03310619|540591548|FG006|Treatment Period|Other reasons|0|||
149852936|NCT03310619|540591549|FG007|Treatment Period|Other reasons|0|||
149852937|NCT00926367|540591552|FG000|Overall Study|Withdrawal by Subject|0|||
149852938|NCT00926367|540591553|FG001|Overall Study|Withdrawal by Subject|1|||
149852939|NCT00926367|540591552|FG000|Overall Study|Lost to Follow-up|1|||
149852940|NCT00926367|540591553|FG001|Overall Study|Lost to Follow-up|0|||
149852941|NCT00926367|540591552|FG000|Overall Study|Skin Irritation|1|||
149852942|NCT00926367|540591553|FG001|Overall Study|Skin Irritation|2|||
149852943|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
149852944|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
149852945|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
149852946|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
149852947|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
149852948|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
149852949|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
149852950|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
149852951|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
149852952|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Other|1|||
149852953|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Other|4|||
149852954|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Other|5|||
149852955|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
149852956|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
149852957|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
149852958|NCT02725411|540591554|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
149852959|NCT02725411|540591555|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
149852960|NCT02725411|540591556|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
149852961|NCT02725411|540591554|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
149852962|NCT02725411|540591555|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
149852963|NCT02725411|540591556|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
149852964|NCT02725411|540591554|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
149852965|NCT02725411|540591555|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
149852966|NCT02725411|540591556|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
149852967|NCT02725411|540591554|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
149852968|NCT02725411|540591555|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
149852969|NCT02725411|540591556|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
149852970|NCT02725411|540591554|FG000|Follow-up Period (24 Weeks)|Other|1|||
149852971|NCT02725411|540591555|FG001|Follow-up Period (24 Weeks)|Other|4|||
149852972|NCT02725411|540591556|FG002|Follow-up Period (24 Weeks)|Other|2|||
149852973|NCT02725411|540591554|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
149852974|NCT02725411|540591555|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
149852975|NCT02725411|540591556|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
149852976|NCT03847974|540591557|FG000|Overall Study|relocated out of region|3|||
149852977|NCT03847974|540591557|FG000|Overall Study|Withdrawal by Subject|2|||
149852978|NCT03847974|540591557|FG000|Overall Study|Adverse Event|1|||
149852979|NCT04307849|540591558|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
149852980|NCT04307849|540591559|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
149852981|NCT04307849|540591560|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
149852982|NCT04307849|540591561|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
149852983|NCT04307849|540591562|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
149852984|NCT04307849|540591563|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
149852985|NCT04307849|540591558|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
149852986|NCT04307849|540591559|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
149852987|NCT04307849|540591560|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
149852988|NCT04307849|540591561|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
149852989|NCT04307849|540591562|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
149852990|NCT04307849|540591563|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
149852991|NCT04307849|540591558|FG000|Overall Study|Family member did not want them to continue|0|||
149852992|NCT04307849|540591559|FG001|Overall Study|Family member did not want them to continue|0|||
149852993|NCT04307849|540591560|FG002|Overall Study|Family member did not want them to continue|1|||
150039383|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
149852994|NCT04307849|540591561|FG003|Overall Study|Family member did not want them to continue|0|||
149852995|NCT04307849|540591562|FG004|Overall Study|Family member did not want them to continue|0|||
149852996|NCT04307849|540591563|FG005|Overall Study|Family member did not want them to continue|0|||
149852997|NCT04307849|540591558|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
149852998|NCT04307849|540591559|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
150039384|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039385|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039386|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039387|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039388|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039389|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039390|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039391|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039392|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039393|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039394|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
150039395|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
150039396|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
150039397|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039398|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039399|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039400|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039401|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039402|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039403|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039404|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039405|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039406|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039407|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039408|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039409|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
150039410|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
150039411|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039412|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039413|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039414|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039415|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039416|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039417|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039418|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039419|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039420|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039421|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039422|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039423|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
150039424|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
150039425|NCT02113982|541285077|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039426|NCT02113982|541285078|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039427|NCT02113982|541285079|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039428|NCT02113982|541285080|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039429|NCT02113982|541285081|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039430|NCT02113982|541285082|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039431|NCT02113982|541285083|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039432|NCT02113982|541285084|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039433|NCT02113982|541285085|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039434|NCT02113982|541285086|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039435|NCT02113982|541285087|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039436|NCT02113982|541285088|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039437|NCT02113982|541285089|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
150039438|NCT02113982|541285090|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
150039439|NCT03040336|541285099|FG000|Overall Study|Death|1|||
150039440|NCT03040336|541285100|FG001|Overall Study|Death|0|||
150039441|NCT03040336|541285099|FG000|Overall Study|Withdrawal by Subject|2|||
150039442|NCT03040336|541285100|FG001|Overall Study|Withdrawal by Subject|3|||
150039443|NCT00068692|541285103|FG000|Step 1: Registration|Disese progression/relapse|5|||
150039444|NCT00068692|541285104|FG001|Step 1: Registration|Disese progression/relapse|0|||
150039445|NCT00068692|541285105|FG002|Step 1: Registration|Disese progression/relapse|0|||
150039446|NCT00068692|541285106|FG003|Step 1: Registration|Disese progression/relapse|0|||
150039447|NCT00068692|541285107|FG004|Step 1: Registration|Disese progression/relapse|0|||
150039448|NCT00068692|541285108|FG005|Step 1: Registration|Disese progression/relapse|0|||
150039449|NCT00068692|541285109|FG006|Step 1: Registration|Disese progression/relapse|0|||
150039450|NCT00068692|541285110|FG007|Step 1: Registration|Disese progression/relapse|0|||
149852999|NCT04307849|540591560|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
149853000|NCT04307849|540591561|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
149853001|NCT04307849|540591562|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
150039451|NCT00068692|541285103|FG000|Step 1: Registration|Adverse Event|7|||
150039452|NCT00068692|541285104|FG001|Step 1: Registration|Adverse Event|0|||
149853002|NCT04307849|540591563|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
150039453|NCT00068692|541285105|FG002|Step 1: Registration|Adverse Event|0|||
149853003|NCT01294449|540591564|FG000|Overall Study|Death|11|||
149853004|NCT01294449|540591565|FG001|Overall Study|Death|12|||
149853005|NCT01294449|540591564|FG000|Overall Study|Withdrawal by Subject|1|||
149853006|NCT01294449|540591565|FG001|Overall Study|Withdrawal by Subject|3|||
149853007|NCT03259789|540591568|FG000|Overall Study|Adverse Event|3|||
149853008|NCT03259789|540591569|FG001|Overall Study|Adverse Event|2|||
149959306|NCT04518410|540984154|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
149959307|NCT04518410|540984155|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959308|NCT04518410|540984156|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959309|NCT04518410|540984157|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
149959310|NCT04518410|540984158|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
149959311|NCT04518410|540984159|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
149959312|NCT04518410|540984160|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
149959313|NCT04518410|540984161|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
149959314|NCT04518410|540984162|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
149959315|NCT04518410|540984163|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
149959316|NCT04518410|540984164|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
149959317|NCT04518410|540984165|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
149959318|NCT04518410|540984166|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
149959319|NCT04518410|540984167|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
149959320|NCT04518410|540984168|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
149959321|NCT04518410|540984144|FG000|Overall Study|Dual Enrolled Subject|0|||
149959322|NCT04518410|540984145|FG001|Overall Study|Dual Enrolled Subject|0|||
149959323|NCT04518410|540984146|FG002|Overall Study|Dual Enrolled Subject|0|||
149959324|NCT04518410|540984147|FG003|Overall Study|Dual Enrolled Subject|0|||
149959325|NCT04518410|540984148|FG004|Overall Study|Dual Enrolled Subject|0|||
149959326|NCT04518410|540984149|FG005|Overall Study|Dual Enrolled Subject|0|||
149959327|NCT04518410|540984150|FG006|Overall Study|Dual Enrolled Subject|0|||
149959328|NCT04518410|540984151|FG007|Overall Study|Dual Enrolled Subject|0|||
149959329|NCT04518410|540984152|FG008|Overall Study|Dual Enrolled Subject|0|||
149959330|NCT04518410|540984153|FG009|Overall Study|Dual Enrolled Subject|0|||
149959331|NCT04518410|540984154|FG010|Overall Study|Dual Enrolled Subject|0|||
149959332|NCT04518410|540984155|FG011|Overall Study|Dual Enrolled Subject|0|||
149959333|NCT04518410|540984156|FG012|Overall Study|Dual Enrolled Subject|0|||
149959334|NCT04518410|540984157|FG013|Overall Study|Dual Enrolled Subject|0|||
149959335|NCT04518410|540984158|FG014|Overall Study|Dual Enrolled Subject|0|||
149959336|NCT04518410|540984159|FG015|Overall Study|Dual Enrolled Subject|0|||
149959337|NCT04518410|540984160|FG016|Overall Study|Dual Enrolled Subject|0|||
149959338|NCT04518410|540984161|FG017|Overall Study|Dual Enrolled Subject|1|||
149959339|NCT04518410|540984162|FG018|Overall Study|Dual Enrolled Subject|0|||
149959340|NCT04518410|540984163|FG019|Overall Study|Dual Enrolled Subject|0|||
149959341|NCT04518410|540984164|FG020|Overall Study|Dual Enrolled Subject|0|||
149959342|NCT04518410|540984165|FG021|Overall Study|Dual Enrolled Subject|0|||
149959343|NCT04518410|540984166|FG022|Overall Study|Dual Enrolled Subject|0|||
149959344|NCT04518410|540984167|FG023|Overall Study|Dual Enrolled Subject|0|||
149959345|NCT04518410|540984168|FG024|Overall Study|Dual Enrolled Subject|0|||
149959346|NCT02218268|540984169|FG000|24 Hour Washout|Physician Decision|11|||
149959347|NCT02218268|540984170|FG001|24 Hour Washout|Physician Decision|9|||
149959348|NCT03651336|540984171|FG000|Overall Study|Withdrawal by Subject|4|||
149959349|NCT01341990|540984172|FG000|Overall Study|Adverse Event|0|||
149959350|NCT01341990|540984173|FG001|Overall Study|Adverse Event|1|||
149959351|NCT01341990|540984172|FG000|Overall Study|Torn Study Lens|1|||
149959352|NCT01341990|540984173|FG001|Overall Study|Torn Study Lens|0|||
149959353|NCT01341990|540984172|FG000|Overall Study|Withdrawal by Subject|2|||
150039454|NCT00068692|541285106|FG003|Step 1: Registration|Adverse Event|0|||
150039455|NCT00068692|541285107|FG004|Step 1: Registration|Adverse Event|0|||
149853009|NCT03259789|540591570|FG002|Overall Study|Adverse Event|1|||
149853010|NCT03259789|540591568|FG000|Overall Study|Withdrawal by Subject|9|||
150288881|NCT01662440|542192524|FG002|Overall Study|Protocol Violation|0|||
149853011|NCT03259789|540591569|FG001|Overall Study|Withdrawal by Subject|5|||
149853012|NCT03259789|540591570|FG002|Overall Study|Withdrawal by Subject|1|||
149853013|NCT03259789|540591568|FG000|Overall Study|Lost to Follow-up|5|||
149853014|NCT03259789|540591569|FG001|Overall Study|Lost to Follow-up|9|||
149853015|NCT03259789|540591570|FG002|Overall Study|Lost to Follow-up|4|||
149853016|NCT03259789|540591568|FG000|Overall Study|Physician Decision|0|||
149853017|NCT03259789|540591569|FG001|Overall Study|Physician Decision|1|||
149853018|NCT03259789|540591570|FG002|Overall Study|Physician Decision|0|||
149853019|NCT02063217|540591571|FG000|Overall Study|Withdrawal by Subject|1|||
149853020|NCT02063217|540591572|FG001|Overall Study|Withdrawal by Subject|0|||
149853021|NCT02063217|540591573|FG002|Overall Study|Withdrawal by Subject|0|||
149853022|NCT00889252|540591574|FG000|Overall Study|Adverse Event|2|||
149853023|NCT00889252|540591575|FG001|Overall Study|Adverse Event|4|||
149853024|NCT00889252|540591574|FG000|Overall Study|Withdrawal by Subject|3|||
149853025|NCT00889252|540591575|FG001|Overall Study|Withdrawal by Subject|0|||
149853026|NCT00889252|540591574|FG000|Overall Study|Protocol Violation|2|||
149853027|NCT00889252|540591575|FG001|Overall Study|Protocol Violation|0|||
149853028|NCT02387762|540591582|FG000|Overall Study|Withdrawal by Subject|1|||
149853029|NCT02387762|540591583|FG001|Overall Study|Withdrawal by Subject|0|||
149853030|NCT04203667|540591584|FG000|Overall Study|Withdrawal by Subject|1|||
149853031|NCT04203667|540591584|FG000|Overall Study|Lost to Follow-up|1|||
149853032|NCT04203667|540591584|FG000|Overall Study|Death|1|||
149853033|NCT04203667|540591584|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
149853034|NCT00593827|540591585|FG000|Overall Study|On Active Treatment/Pending|0|||
149853035|NCT00593827|540591586|FG001|Overall Study|On Active Treatment/Pending|2|||
149853036|NCT01833169|540591587|FG000|Overall Study|Disease Progression|99|||
149959354|NCT01341990|540984173|FG001|Overall Study|Withdrawal by Subject|0|||
149959355|NCT02487199|540984181|FG000|Overall Study|Withdrew Consent|0|||
149959356|NCT02487199|540984182|FG001|Overall Study|Withdrew Consent|1|||
149959357|NCT01213251|540985826|FG000|Overall Study|Death|2|||
149959358|NCT01213251|540985827|FG001|Overall Study|Death|1|||
149959359|NCT01213251|540985828|FG002|Overall Study|Death|2|||
149959360|NCT01213251|540985826|FG000|Overall Study|Exit|3|||
149959361|NCT01213251|540985827|FG001|Overall Study|Exit|2|||
149959362|NCT01213251|540985828|FG002|Overall Study|Exit|8|||
149959363|NCT01213251|540985826|FG000|Overall Study|Protocol Violation|1|||
149959364|NCT01213251|540985827|FG001|Overall Study|Protocol Violation|1|||
149959365|NCT01213251|540985828|FG002|Overall Study|Protocol Violation|0|||
149959366|NCT01213251|540985826|FG000|Overall Study|Missed 18-Month Follow-up|0|||
149959367|NCT01213251|540985827|FG001|Overall Study|Missed 18-Month Follow-up|0|||
149959368|NCT01213251|540985828|FG002|Overall Study|Missed 18-Month Follow-up|1|||
149959369|NCT00520572|540985832|FG000|Overall Study|Adverse Event|9|||
149959370|NCT00520572|540985833|FG001|Overall Study|Adverse Event|3|||
149959371|NCT00520572|540985834|FG002|Overall Study|Adverse Event|6|||
149959372|NCT00520572|540985835|FG003|Overall Study|Adverse Event|9|||
149959373|NCT00520572|540985836|FG004|Overall Study|Adverse Event|7|||
149959374|NCT00520572|540985837|FG005|Overall Study|Adverse Event|2|||
149959375|NCT00520572|540985832|FG000|Overall Study|Withdrawal by Subject|0|||
149959376|NCT00520572|540985833|FG001|Overall Study|Withdrawal by Subject|9|||
149959377|NCT00520572|540985834|FG002|Overall Study|Withdrawal by Subject|5|||
149959378|NCT00520572|540985835|FG003|Overall Study|Withdrawal by Subject|2|||
149959379|NCT00520572|540985836|FG004|Overall Study|Withdrawal by Subject|2|||
149959380|NCT00520572|540985837|FG005|Overall Study|Withdrawal by Subject|0|||
149959381|NCT00520572|540985832|FG000|Overall Study|Protocol Violation|0|||
149959382|NCT00520572|540985833|FG001|Overall Study|Protocol Violation|0|||
149959383|NCT00520572|540985834|FG002|Overall Study|Protocol Violation|1|||
149959384|NCT00520572|540985835|FG003|Overall Study|Protocol Violation|0|||
149959385|NCT00520572|540985836|FG004|Overall Study|Protocol Violation|0|||
149959386|NCT00520572|540985837|FG005|Overall Study|Protocol Violation|0|||
149959387|NCT00520572|540985832|FG000|Overall Study|Lack of Efficacy|1|||
149959388|NCT00520572|540985833|FG001|Overall Study|Lack of Efficacy|1|||
149959389|NCT00520572|540985834|FG002|Overall Study|Lack of Efficacy|1|||
149959390|NCT00520572|540985835|FG003|Overall Study|Lack of Efficacy|2|||
149959391|NCT00520572|540985836|FG004|Overall Study|Lack of Efficacy|1|||
149959392|NCT00520572|540985837|FG005|Overall Study|Lack of Efficacy|0|||
149959393|NCT00520572|540985832|FG000|Overall Study|Lost to Follow-up|0|||
149959394|NCT00520572|540985833|FG001|Overall Study|Lost to Follow-up|0|||
149959395|NCT00520572|540985834|FG002|Overall Study|Lost to Follow-up|0|||
149959396|NCT00520572|540985835|FG003|Overall Study|Lost to Follow-up|0|||
149959397|NCT00520572|540985836|FG004|Overall Study|Lost to Follow-up|1|||
149959398|NCT00520572|540985837|FG005|Overall Study|Lost to Follow-up|0|||
149959399|NCT00520572|540985832|FG000|Overall Study|Incorrect enrollment|1|||
149959400|NCT00520572|540985833|FG001|Overall Study|Incorrect enrollment|0|||
149959401|NCT00520572|540985834|FG002|Overall Study|Incorrect enrollment|1|||
149959402|NCT00520572|540985835|FG003|Overall Study|Incorrect enrollment|0|||
149959403|NCT00520572|540985836|FG004|Overall Study|Incorrect enrollment|1|||
149959404|NCT00520572|540985837|FG005|Overall Study|Incorrect enrollment|0|||
149959405|NCT00520572|540985832|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
150039456|NCT00068692|541285108|FG005|Step 1: Registration|Adverse Event|0|||
149853037|NCT01833169|540591587|FG000|Overall Study|Adverse Event|33|||
149853038|NCT01833169|540591587|FG000|Overall Study|Withdrawal by Subject|9|||
149853039|NCT01833169|540591587|FG000|Overall Study|Death|3|||
149853040|NCT01833169|540591587|FG000|Overall Study|Physician Decision|2|||
149853041|NCT01183884|540591591|FG000|Overall Study|Progressive Disease|26|||
149853042|NCT01183884|540591591|FG000|Overall Study|Adverse Event|3|||
149853043|NCT01183884|540591591|FG000|Overall Study|Withdrawal by Subject|1|||
149853044|NCT01183884|540591591|FG000|Overall Study|Other Complicating Disease|3|||
149853045|NCT01183884|540591591|FG000|Overall Study|Not Treated|1|||
149959406|NCT00520572|540985833|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
149959407|NCT00520572|540985834|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
149959408|NCT00520572|540985835|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
149959409|NCT00520572|540985836|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
149959410|NCT00520572|540985837|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
149959411|NCT00520572|540985832|FG000|Overall Study|Long break in taking Medication|0|||
149959412|NCT00520572|540985833|FG001|Overall Study|Long break in taking Medication|0|||
149959413|NCT00520572|540985834|FG002|Overall Study|Long break in taking Medication|0|||
149959414|NCT00520572|540985835|FG003|Overall Study|Long break in taking Medication|1|||
149959415|NCT00520572|540985836|FG004|Overall Study|Long break in taking Medication|0|||
150039457|NCT00068692|541285109|FG006|Step 1: Registration|Adverse Event|0|||
149853046|NCT01183884|540591591|FG000|Overall Study|Other|4|||
149853047|NCT01160640|540591592|FG000|Overall Study|Physician Decision|3|||
149853048|NCT01160640|540591593|FG001|Overall Study|Physician Decision|3|||
149853049|NCT01160640|540591592|FG000|Overall Study|Incarceration|1|||
149853050|NCT01160640|540591593|FG001|Overall Study|Incarceration|0|||
149853051|NCT01160640|540591592|FG000|Overall Study|Withdrawal by Subject|0|||
149853052|NCT01160640|540591593|FG001|Overall Study|Withdrawal by Subject|3|||
149853053|NCT04718129|540591594|FG000|Overall Study|Lost to Follow-up|6|||
149853054|NCT04718129|540591595|FG001|Overall Study|Lost to Follow-up|7|||
149853055|NCT02212457|540591596|FG000|Overall Study|Adverse Event|1|||
149853056|NCT02212457|540591597|FG001|Overall Study|Adverse Event|2|||
149853057|NCT02212457|540591598|FG002|Overall Study|Adverse Event|2|||
149853058|NCT02212457|540591599|FG003|Overall Study|Adverse Event|2|||
149853059|NCT02212457|540591600|FG004|Overall Study|Adverse Event|0|||
149853060|NCT02212457|540591601|FG005|Overall Study|Adverse Event|1|||
149853061|NCT02212457|540591596|FG000|Overall Study|Withdrawal by Subject|8|||
149853062|NCT02212457|540591597|FG001|Overall Study|Withdrawal by Subject|10|||
149853063|NCT02212457|540591598|FG002|Overall Study|Withdrawal by Subject|8|||
149853064|NCT02212457|540591599|FG003|Overall Study|Withdrawal by Subject|6|||
149853065|NCT02212457|540591600|FG004|Overall Study|Withdrawal by Subject|5|||
149853066|NCT02212457|540591601|FG005|Overall Study|Withdrawal by Subject|4|||
149853067|NCT02212457|540591596|FG000|Overall Study|Lost to Follow-up|6|||
149853068|NCT02212457|540591597|FG001|Overall Study|Lost to Follow-up|7|||
149853069|NCT02212457|540591598|FG002|Overall Study|Lost to Follow-up|4|||
149853070|NCT02212457|540591599|FG003|Overall Study|Lost to Follow-up|1|||
149853071|NCT02212457|540591600|FG004|Overall Study|Lost to Follow-up|8|||
149853072|NCT02212457|540591601|FG005|Overall Study|Lost to Follow-up|4|||
149853073|NCT02212457|540591596|FG000|Overall Study|Protocol Violation|2|||
149853074|NCT02212457|540591597|FG001|Overall Study|Protocol Violation|1|||
149853075|NCT02212457|540591598|FG002|Overall Study|Protocol Violation|0|||
149853076|NCT02212457|540591599|FG003|Overall Study|Protocol Violation|1|||
149853077|NCT02212457|540591600|FG004|Overall Study|Protocol Violation|2|||
149853078|NCT02212457|540591601|FG005|Overall Study|Protocol Violation|3|||
149853079|NCT02212457|540591596|FG000|Overall Study|Other|2|||
149853080|NCT02212457|540591597|FG001|Overall Study|Other|1|||
149853081|NCT02212457|540591598|FG002|Overall Study|Other|2|||
149853082|NCT02212457|540591599|FG003|Overall Study|Other|1|||
149853083|NCT02212457|540591600|FG004|Overall Study|Other|0|||
149853084|NCT02212457|540591601|FG005|Overall Study|Other|1|||
149853085|NCT01598896|540591602|FG000|Overall Study|Withdrawal by Subject|0|||
149853086|NCT01598896|540591603|FG001|Overall Study|Withdrawal by Subject|1|||
149853087|NCT01598896|540591602|FG000|Overall Study|Lack of Efficacy|0|||
149853088|NCT01598896|540591603|FG001|Overall Study|Lack of Efficacy|1|||
149853089|NCT00642811|540591605|FG000|Overall Study|Adverse Event|2|||
149853090|NCT00642811|540591606|FG001|Overall Study|Adverse Event|3|||
150039458|NCT00068692|541285110|FG007|Step 1: Registration|Adverse Event|0|||
150039459|NCT00068692|541285103|FG000|Step 1: Registration|Death|1|||
149853091|NCT00642811|540591607|FG002|Overall Study|Adverse Event|0|||
149853092|NCT00642811|540591608|FG003|Overall Study|Adverse Event|0|||
149853093|NCT00642811|540591609|FG004|Overall Study|Adverse Event|0|||
149853094|NCT00642811|540591610|FG005|Overall Study|Adverse Event|1|||
149853095|NCT00642811|540591605|FG000|Overall Study|Developement of discontinuation criteria|0|||
149853096|NCT00642811|540591606|FG001|Overall Study|Developement of discontinuation criteria|0|||
149853097|NCT00642811|540591607|FG002|Overall Study|Developement of discontinuation criteria|0|||
149853098|NCT00642811|540591608|FG003|Overall Study|Developement of discontinuation criteria|0|||
149853099|NCT00642811|540591609|FG004|Overall Study|Developement of discontinuation criteria|1|||
149853100|NCT00642811|540591610|FG005|Overall Study|Developement of discontinuation criteria|0|||
149853101|NCT00642811|540591605|FG000|Overall Study|Severe Non-compliance to protocol|1|||
149853102|NCT00642811|540591606|FG001|Overall Study|Severe Non-compliance to protocol|0|||
149853103|NCT00642811|540591607|FG002|Overall Study|Severe Non-compliance to protocol|0|||
149853104|NCT00642811|540591608|FG003|Overall Study|Severe Non-compliance to protocol|0|||
149853105|NCT00642811|540591609|FG004|Overall Study|Severe Non-compliance to protocol|0|||
149853106|NCT00642811|540591610|FG005|Overall Study|Severe Non-compliance to protocol|0|||
149853107|NCT00642811|540591605|FG000|Overall Study|Other|0|||
149853108|NCT00642811|540591606|FG001|Overall Study|Other|1|||
149853109|NCT00642811|540591607|FG002|Overall Study|Other|0|||
149853110|NCT00642811|540591608|FG003|Overall Study|Other|1|||
149853111|NCT00642811|540591609|FG004|Overall Study|Other|0|||
149853112|NCT00642811|540591610|FG005|Overall Study|Other|0|||
149853113|NCT01120691|540591611|FG000|Overall Study|Adverse Event|59|||
149853114|NCT01120691|540591612|FG001|Overall Study|Adverse Event|67|||
149853115|NCT01120691|540591613|FG002|Overall Study|Adverse Event|47|||
149853116|NCT01120691|540591611|FG000|Overall Study|Subject withdrew consent|33|||
149853117|NCT01120691|540591612|FG001|Overall Study|Subject withdrew consent|50|||
149853118|NCT01120691|540591613|FG002|Overall Study|Subject withdrew consent|44|||
149853119|NCT01120691|540591611|FG000|Overall Study|Death|21|||
149853120|NCT01120691|540591612|FG001|Overall Study|Death|22|||
149853121|NCT01120691|540591613|FG002|Overall Study|Death|24|||
149853122|NCT01120691|540591611|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
149853123|NCT01120691|540591612|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
149853124|NCT01120691|540591613|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
149853125|NCT01120691|540591611|FG000|Overall Study|Administrative problems|15|||
149853126|NCT01120691|540591612|FG001|Overall Study|Administrative problems|8|||
149853127|NCT01120691|540591613|FG002|Overall Study|Administrative problems|9|||
149853128|NCT01120691|540591611|FG000|Overall Study|Protocol deviation|13|||
149853129|NCT01120691|540591612|FG001|Overall Study|Protocol deviation|12|||
149853130|NCT01120691|540591613|FG002|Overall Study|Protocol deviation|12|||
149853131|NCT01120691|540591611|FG000|Overall Study|Lost to Follow-up|5|||
149853132|NCT01120691|540591612|FG001|Overall Study|Lost to Follow-up|6|||
149853133|NCT01120691|540591613|FG002|Overall Study|Lost to Follow-up|4|||
149853134|NCT01120691|540591611|FG000|Overall Study|Abnormal test procedure result(s)|3|||
149853135|NCT01120691|540591612|FG001|Overall Study|Abnormal test procedure result(s)|2|||
149853136|NCT01120691|540591613|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149853137|NCT01120691|540591611|FG000|Overall Study|Patient's inability to use the device|3|||
149853138|NCT01120691|540591612|FG001|Overall Study|Patient's inability to use the device|1|||
149853139|NCT01120691|540591613|FG002|Overall Study|Patient's inability to use the device|0|||
149853140|NCT01120691|540591611|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149853141|NCT01120691|540591612|FG001|Overall Study|Abnormal laboratory value(s)|3|||
149853142|NCT01120691|540591613|FG002|Overall Study|Abnormal laboratory value(s)|4|||
149853143|NCT04553406|540591616|FG000|Overall Study|Study Discontinuation|0|||
149853144|NCT04553406|540591617|FG001|Overall Study|Study Discontinuation|1|||
149853145|NCT00772148|540591618|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
149853146|NCT00772148|540591619|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
149853147|NCT00772148|540591618|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
149853148|NCT00772148|540591619|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
149853149|NCT00772148|540591618|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
149853150|NCT00772148|540591619|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
149853151|NCT00772148|540591618|FG000|Maintenance Phase (Week 52)|Death|2|||
149853152|NCT00772148|540591619|FG001|Maintenance Phase (Week 52)|Death|2|||
149853153|NCT00772148|540591618|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
149853154|NCT00772148|540591619|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
149853155|NCT00772148|540591618|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
149853156|NCT00772148|540591619|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
149853157|NCT00772148|540591618|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
149853158|NCT00772148|540591619|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
149853159|NCT03573336|540591622|FG000|Overall Study|Study terminated|2|||
149853160|NCT03573336|540591623|FG001|Overall Study|Study terminated|4|||
150039460|NCT00068692|541285104|FG001|Step 1: Registration|Death|0|||
150039461|NCT00068692|541285105|FG002|Step 1: Registration|Death|0|||
150039462|NCT00068692|541285106|FG003|Step 1: Registration|Death|0|||
150039463|NCT00068692|541285107|FG004|Step 1: Registration|Death|0|||
149853161|NCT03573336|540591624|FG002|Overall Study|Study terminated|2|||
149853162|NCT01525628|540591625|FG000|Overall Study|Adverse Event|1|||
149853163|NCT01525628|540591626|FG001|Overall Study|Adverse Event|1|||
149853164|NCT01525628|540591627|FG002|Overall Study|Adverse Event|2|||
149853165|NCT01525628|540591628|FG003|Overall Study|Adverse Event|0|||
149853166|NCT01525628|540591629|FG004|Overall Study|Adverse Event|1|||
149853167|NCT01525628|540591625|FG000|Overall Study|Lack of Efficacy|0|||
149853168|NCT01525628|540591626|FG001|Overall Study|Lack of Efficacy|2|||
149853169|NCT01525628|540591627|FG002|Overall Study|Lack of Efficacy|2|||
149853170|NCT01525628|540591628|FG003|Overall Study|Lack of Efficacy|1|||
149853171|NCT01525628|540591629|FG004|Overall Study|Lack of Efficacy|2|||
149853172|NCT01525628|540591625|FG000|Overall Study|Protocol Violation|0|||
149853173|NCT01525628|540591626|FG001|Overall Study|Protocol Violation|0|||
149853174|NCT01525628|540591627|FG002|Overall Study|Protocol Violation|1|||
149853175|NCT01525628|540591628|FG003|Overall Study|Protocol Violation|0|||
149853176|NCT01525628|540591629|FG004|Overall Study|Protocol Violation|0|||
149853177|NCT01525628|540591625|FG000|Overall Study|Lost to Follow-up|1|||
149853178|NCT01525628|540591626|FG001|Overall Study|Lost to Follow-up|1|||
149853179|NCT01525628|540591627|FG002|Overall Study|Lost to Follow-up|0|||
149853180|NCT01525628|540591628|FG003|Overall Study|Lost to Follow-up|0|||
149853181|NCT01525628|540591629|FG004|Overall Study|Lost to Follow-up|0|||
149853182|NCT01525628|540591625|FG000|Overall Study|Withdrawal by Subject|0|||
149853183|NCT01525628|540591626|FG001|Overall Study|Withdrawal by Subject|1|||
149853184|NCT01525628|540591627|FG002|Overall Study|Withdrawal by Subject|0|||
149959416|NCT00520572|540985837|FG005|Overall Study|Long break in taking Medication|0|||
149959417|NCT00520572|540985832|FG000|Overall Study|Did not receive Treatment|1|||
149959418|NCT00520572|540985833|FG001|Overall Study|Did not receive Treatment|0|||
149959419|NCT00520572|540985834|FG002|Overall Study|Did not receive Treatment|1|||
149959420|NCT00520572|540985835|FG003|Overall Study|Did not receive Treatment|0|||
149959421|NCT00520572|540985836|FG004|Overall Study|Did not receive Treatment|0|||
149959422|NCT00520572|540985837|FG005|Overall Study|Did not receive Treatment|0|||
149959423|NCT03548415|540985838|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
149959424|NCT03548415|540985839|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
149959425|NCT03548415|540985840|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
149959426|NCT03548415|540985841|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
149959427|NCT03548415|540985842|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
149959428|NCT04605588|540985845|FG000|Overall Study|Withdrawal by Subject|1|||
149959429|NCT04605588|540985846|FG001|Overall Study|Withdrawal by Subject|0|||
149959430|NCT01803737|540985849|FG000|Overall Study|Lack of Time|1|||
149959431|NCT01803737|540985850|FG001|Overall Study|Lack of Time|0|||
149959432|NCT01803737|540985849|FG000|Overall Study|Medical Reason|0|||
149959433|NCT01803737|540985850|FG001|Overall Study|Medical Reason|1|||
149959434|NCT01803737|540985849|FG000|Overall Study|Lost to Follow-up|0|||
149959435|NCT01803737|540985850|FG001|Overall Study|Lost to Follow-up|2|||
149959436|NCT01529112|540985851|FG000|Overall Study|Adverse Event|2|||
149959437|NCT01529112|540985852|FG001|Overall Study|Adverse Event|0|||
149959438|NCT01529112|540985851|FG000|Overall Study|Death|59|||
149959439|NCT01529112|540985852|FG001|Overall Study|Death|38|||
149959440|NCT01529112|540985851|FG000|Overall Study|Protocol Violation|1|||
149959441|NCT01529112|540985852|FG001|Overall Study|Protocol Violation|0|||
149959442|NCT01529112|540985851|FG000|Overall Study|Withdrawal by Subject|7|||
149959443|NCT01529112|540985852|FG001|Overall Study|Withdrawal by Subject|3|||
149959444|NCT01530256|540985853|FG000|Overall Study|Death|2|||
149959445|NCT04621786|540985854|FG000|Overall Study|Lost to Follow-up|9|||
149959446|NCT04621786|540985854|FG000|Overall Study|Protocol Violation|3|||
149959447|NCT02123511|540985858|FG000|Overall Study|Cancelled treatment|1|||
149959448|NCT02123511|540985859|FG001|Overall Study|Cancelled treatment|0|||
149959449|NCT02123511|540985858|FG000|Overall Study|Incomplete data|1|||
149959450|NCT02123511|540985859|FG001|Overall Study|Incomplete data|3|||
149959451|NCT02123511|540985858|FG000|Overall Study|Ineligible|0|||
149959452|NCT02123511|540985859|FG001|Overall Study|Ineligible|1|||
149959453|NCT00458705|540985860|FG000|Overall Study|Adverse Event|4|||
149959454|NCT00458705|540985860|FG000|Overall Study|Not Treated|1|||
149959455|NCT00378560|540985863|FG000|Overall Study|Adverse Event|1|||
149959456|NCT00378560|540985864|FG001|Overall Study|Adverse Event|0|||
149959457|NCT00378560|540985863|FG000|Overall Study|Lost to Follow-up|24|||
149959458|NCT00378560|540985864|FG001|Overall Study|Lost to Follow-up|29|||
149959459|NCT00378560|540985863|FG000|Overall Study|Protocol Violation|2|||
149959460|NCT00378560|540985864|FG001|Overall Study|Protocol Violation|0|||
149959461|NCT00378560|540985863|FG000|Overall Study|Withdrawal by Subject|17|||
149959462|NCT00378560|540985864|FG001|Overall Study|Withdrawal by Subject|21|||
149959463|NCT00378560|540985863|FG000|Overall Study|Moved|4|||
149959464|NCT00378560|540985864|FG001|Overall Study|Moved|3|||
149959465|NCT00378560|540985863|FG000|Overall Study|Pregnancy|7|||
149959466|NCT00378560|540985864|FG001|Overall Study|Pregnancy|5|||
149959467|NCT00378560|540985863|FG000|Overall Study|Laboratory test values abnormal|1|||
149959468|NCT00378560|540985864|FG001|Overall Study|Laboratory test values abnormal|0|||
149959469|NCT00337194|540985865|FG000|Overall Study|Adverse Event|5|||
149959470|NCT00337194|540985866|FG001|Overall Study|Adverse Event|1|||
149959471|NCT00337194|540985865|FG000|Overall Study|Death|2|||
149853185|NCT01525628|540591628|FG003|Overall Study|Withdrawal by Subject|0|||
149853186|NCT01525628|540591629|FG004|Overall Study|Withdrawal by Subject|0|||
149853187|NCT01525628|540591625|FG000|Overall Study|Other reason not defined above|0|||
149959472|NCT00337194|540985866|FG001|Overall Study|Death|0|||
149959473|NCT00337194|540985865|FG000|Overall Study|Withdrawal by Subject|1|||
149959474|NCT00337194|540985866|FG001|Overall Study|Withdrawal by Subject|0|||
149959475|NCT00337194|540985865|FG000|Overall Study|Disease progression|1|||
149959476|NCT00337194|540985866|FG001|Overall Study|Disease progression|2|||
149959477|NCT00337194|540985865|FG000|Overall Study|Subsequent non-protocol therapy|3|||
150039464|NCT00068692|541285108|FG005|Step 1: Registration|Death|0|||
149853188|NCT01525628|540591626|FG001|Overall Study|Other reason not defined above|0|||
149853189|NCT01525628|540591627|FG002|Overall Study|Other reason not defined above|0|||
149853190|NCT01525628|540591628|FG003|Overall Study|Other reason not defined above|3|||
149853191|NCT01525628|540591629|FG004|Overall Study|Other reason not defined above|0|||
149853192|NCT02614898|540591630|FG000|Overall Study|Participated until study termination|10|||
149853193|NCT02614898|540591631|FG001|Overall Study|Participated until study termination|26|||
149853194|NCT02614898|540591630|FG000|Overall Study|Lost to Follow-up|0|||
149853195|NCT02614898|540591631|FG001|Overall Study|Lost to Follow-up|2|||
149853196|NCT02614898|540591630|FG000|Overall Study|Physician Decision|1|||
149853197|NCT02614898|540591631|FG001|Overall Study|Physician Decision|8|||
149853198|NCT02614898|540591630|FG000|Overall Study|Study Terminated by Sponsor|3|||
149853199|NCT02614898|540591631|FG001|Overall Study|Study Terminated by Sponsor|0|||
149853200|NCT02614898|540591630|FG000|Overall Study|Withdrawal by Subject|0|||
149853201|NCT02614898|540591631|FG001|Overall Study|Withdrawal by Subject|2|||
149853202|NCT02614898|540591630|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149853203|NCT02614898|540591631|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149853204|NCT02614898|540591630|FG000|Overall Study|Other-Additional Information Unavailable|0|||
149853205|NCT02614898|540591631|FG001|Overall Study|Other-Additional Information Unavailable|11|||
149853206|NCT02614898|540591630|FG000|Overall Study|Missing|0|||
149853207|NCT02614898|540591631|FG001|Overall Study|Missing|1|||
149853208|NCT00239005|540591632|FG000|Overall Study|Adverse Event|6|||
149853209|NCT00239005|540591633|FG001|Overall Study|Adverse Event|6|||
149853210|NCT00239005|540591632|FG000|Overall Study|Withdrawal by Subject|3|||
149853211|NCT00239005|540591633|FG001|Overall Study|Withdrawal by Subject|4|||
149853212|NCT00239005|540591632|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
149853213|NCT00239005|540591633|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
149853214|NCT00239005|540591632|FG000|Overall Study|Protocol Violation|1|||
149853215|NCT00239005|540591633|FG001|Overall Study|Protocol Violation|0|||
149853216|NCT00239005|540591632|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
149853217|NCT00239005|540591633|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
149853218|NCT00239005|540591632|FG000|Overall Study|Lost to Follow-up|0|||
149853219|NCT00239005|540591633|FG001|Overall Study|Lost to Follow-up|1|||
149853220|NCT03108820|540591634|FG000|Overall Study|Lost to Follow-up|30|||
149853221|NCT03108820|540591635|FG001|Overall Study|Lost to Follow-up|28|||
149853222|NCT03108820|540591634|FG000|Overall Study|Withdrawal by Subject|32|||
149853223|NCT03108820|540591635|FG001|Overall Study|Withdrawal by Subject|24|||
149853224|NCT03108820|540591634|FG000|Overall Study|Death|6|||
149853225|NCT03108820|540591635|FG001|Overall Study|Death|11|||
149853226|NCT00787605|540591636|FG000|Overall Study|Administrative Problems|3|||
149853227|NCT00787605|540591637|FG001|Overall Study|Administrative Problems|0|||
149853228|NCT00787605|540591636|FG000|Overall Study|Adverse Event|14|||
149853229|NCT00787605|540591637|FG001|Overall Study|Adverse Event|25|||
149853230|NCT00787605|540591636|FG000|Overall Study|Lost to Follow-up|3|||
149853231|NCT00787605|540591637|FG001|Overall Study|Lost to Follow-up|6|||
149853232|NCT00787605|540591636|FG000|Overall Study|Protocol Violation|7|||
149853233|NCT00787605|540591637|FG001|Overall Study|Protocol Violation|3|||
149853234|NCT00787605|540591636|FG000|Overall Study|Withdrawal by Subject|6|||
149853235|NCT00787605|540591637|FG001|Overall Study|Withdrawal by Subject|13|||
149853236|NCT00787605|540591636|FG000|Overall Study|Lack of Efficacy|13|||
149853237|NCT00787605|540591637|FG001|Overall Study|Lack of Efficacy|9|||
149853238|NCT04428645|540591644|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
149853239|NCT01214239|540591647|FG000|Overall Study|Adverse Event|3|||
149853240|NCT01214239|540591648|FG001|Overall Study|Adverse Event|4|||
149853241|NCT01214239|540591647|FG000|Overall Study|Protocol Violation|2|||
149853242|NCT01214239|540591648|FG001|Overall Study|Protocol Violation|1|||
149853243|NCT01214239|540591647|FG000|Overall Study|Lost to Follow-up|1|||
149853244|NCT01214239|540591648|FG001|Overall Study|Lost to Follow-up|1|||
149853245|NCT01214239|540591647|FG000|Overall Study|Withdrawal by Subject|4|||
149853246|NCT01214239|540591648|FG001|Overall Study|Withdrawal by Subject|9|||
149853247|NCT01214239|540591647|FG000|Overall Study|Lack of Efficacy|1|||
149853248|NCT01214239|540591648|FG001|Overall Study|Lack of Efficacy|2|||
149853249|NCT01214239|540591647|FG000|Overall Study|patient's private reason|1|||
149959478|NCT00337194|540985866|FG001|Overall Study|Subsequent non-protocol therapy|1|||
149853250|NCT01214239|540591648|FG001|Overall Study|patient's private reason|1|||
149853251|NCT01321697|540591649|FG000|Overall Study|Study Terminated|7|||
149853252|NCT01049581|540591652|FG000|Overall Study|Lost to Follow-up|2|||
149853253|NCT01049581|540591653|FG001|Overall Study|Lost to Follow-up|1|||
149853254|NCT02625974|540591654|FG000|Part 1|Lost to Follow-up|9|||
149853255|NCT02625974|540591655|FG001|Part 1|Lost to Follow-up|3|||
149853256|NCT02625974|540591654|FG000|Part 2|Lost to Follow-up|4|||
149853257|NCT02625974|540591655|FG001|Part 2|Lost to Follow-up|6|||
149853258|NCT02625974|540591654|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
149853259|NCT02625974|540591655|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
149853260|NCT01142661|540591656|FG000|Overall Study|Adverse Event|2|||
149853261|NCT01142661|540591656|FG000|Overall Study|Withdrawal by Subject|1|||
150039465|NCT00068692|541285109|FG006|Step 1: Registration|Death|0|||
150039466|NCT00068692|541285110|FG007|Step 1: Registration|Death|0|||
150039467|NCT00068692|541285103|FG000|Step 1: Registration|Withdrawal by Subject|11|||
149853262|NCT01142661|540591656|FG000|Overall Study|Physician Decision|1|||
149853263|NCT04773600|540591659|FG000|Overall Study|Withdrawal by Subject|15|||
149853264|NCT04773600|540591660|FG001|Overall Study|Withdrawal by Subject|9|||
149853265|NCT04773600|540591659|FG000|Overall Study|Lost to Follow-up|10|||
149853266|NCT04773600|540591660|FG001|Overall Study|Lost to Follow-up|6|||
149853267|NCT04773600|540591659|FG000|Overall Study|Adverse Event|8|||
149853268|NCT04773600|540591660|FG001|Overall Study|Adverse Event|2|||
149853269|NCT04773600|540591659|FG000|Overall Study|Lack of Efficacy|2|||
149853270|NCT04773600|540591660|FG001|Overall Study|Lack of Efficacy|3|||
149853271|NCT04773600|540591659|FG000|Overall Study|Noncompliance|2|||
149853272|NCT04773600|540591660|FG001|Overall Study|Noncompliance|0|||
149853273|NCT04773600|540591659|FG000|Overall Study|Protocol Violation|2|||
149853274|NCT04773600|540591660|FG001|Overall Study|Protocol Violation|0|||
149853275|NCT04773600|540591659|FG000|Overall Study|Physician Decision|0|||
149853276|NCT04773600|540591660|FG001|Overall Study|Physician Decision|1|||
149853277|NCT04773600|540591659|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
149853278|NCT04773600|540591660|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
149853279|NCT04773600|540591659|FG000|Overall Study|Emergency Travel Out of Country|1|||
149853280|NCT04773600|540591660|FG001|Overall Study|Emergency Travel Out of Country|0|||
149853281|NCT02129062|540593600|FG000|Overall Study|Death|1|||
149853282|NCT02129062|540593600|FG000|Overall Study|Disease Progression|2|||
149853283|NCT01841060|540593604|FG000|Overall Study|Protocol Violation|10|||
149853284|NCT01848210|540593606|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
149853285|NCT01848210|540593607|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
149959479|NCT03188705|540985867|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
149959480|NCT03188705|540985867|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
149959481|NCT01658735|540985876|FG000|Overall Study|Lack of Efficacy|1|||
149959482|NCT01658735|540985877|FG001|Overall Study|Lack of Efficacy|0|||
149959483|NCT01658735|540985878|FG002|Overall Study|Lack of Efficacy|1|||
150039468|NCT00068692|541285104|FG001|Step 1: Registration|Withdrawal by Subject|0|||
150039469|NCT00068692|541285105|FG002|Step 1: Registration|Withdrawal by Subject|0|||
150039470|NCT00068692|541285106|FG003|Step 1: Registration|Withdrawal by Subject|0|||
150039471|NCT00068692|541285107|FG004|Step 1: Registration|Withdrawal by Subject|0|||
150039472|NCT00068692|541285108|FG005|Step 1: Registration|Withdrawal by Subject|0|||
150039473|NCT00068692|541285109|FG006|Step 1: Registration|Withdrawal by Subject|0|||
150039474|NCT00068692|541285110|FG007|Step 1: Registration|Withdrawal by Subject|0|||
150039475|NCT00068692|541285103|FG000|Step 1: Registration|Alternative therapy|2|||
150039476|NCT00068692|541285104|FG001|Step 1: Registration|Alternative therapy|0|||
150039477|NCT00068692|541285105|FG002|Step 1: Registration|Alternative therapy|0|||
150039478|NCT00068692|541285106|FG003|Step 1: Registration|Alternative therapy|0|||
150039479|NCT00068692|541285107|FG004|Step 1: Registration|Alternative therapy|0|||
150039480|NCT00068692|541285108|FG005|Step 1: Registration|Alternative therapy|0|||
150039481|NCT00068692|541285109|FG006|Step 1: Registration|Alternative therapy|0|||
150039482|NCT00068692|541285110|FG007|Step 1: Registration|Alternative therapy|0|||
150039483|NCT00068692|541285103|FG000|Step 1: Registration|Complicating disease|2|||
150039484|NCT00068692|541285104|FG001|Step 1: Registration|Complicating disease|0|||
150039485|NCT00068692|541285105|FG002|Step 1: Registration|Complicating disease|0|||
150039486|NCT00068692|541285106|FG003|Step 1: Registration|Complicating disease|0|||
150039487|NCT00068692|541285107|FG004|Step 1: Registration|Complicating disease|0|||
150039488|NCT00068692|541285108|FG005|Step 1: Registration|Complicating disease|0|||
150039489|NCT00068692|541285109|FG006|Step 1: Registration|Complicating disease|0|||
150039490|NCT00068692|541285110|FG007|Step 1: Registration|Complicating disease|0|||
150039491|NCT00068692|541285103|FG000|Step 1: Registration|Protocol Violation|1|||
150039492|NCT00068692|541285104|FG001|Step 1: Registration|Protocol Violation|0|||
149959484|NCT01658735|540985876|FG000|Overall Study|Lost to Follow-up|1|||
149959485|NCT01658735|540985877|FG001|Overall Study|Lost to Follow-up|1|||
149959486|NCT01658735|540985878|FG002|Overall Study|Lost to Follow-up|0|||
149959487|NCT01658735|540985876|FG000|Overall Study|Protocol Violation|0|||
150039493|NCT00068692|541285105|FG002|Step 1: Registration|Protocol Violation|0|||
149853286|NCT01848210|540593606|FG000|Overall Study|Lost to Follow-up|24|||
149853287|NCT01848210|540593607|FG001|Overall Study|Lost to Follow-up|12|||
149853288|NCT01848210|540593606|FG000|Overall Study|Protocol Violation|3|||
149959488|NCT01658735|540985877|FG001|Overall Study|Protocol Violation|1|||
149959489|NCT01658735|540985878|FG002|Overall Study|Protocol Violation|0|||
149959490|NCT01658735|540985876|FG000|Overall Study|Withdrawal by Subject|3|||
149959491|NCT01658735|540985877|FG001|Overall Study|Withdrawal by Subject|5|||
149959492|NCT01658735|540985878|FG002|Overall Study|Withdrawal by Subject|3|||
149853289|NCT01848210|540593607|FG001|Overall Study|Protocol Violation|5|||
149853290|NCT01848210|540593606|FG000|Overall Study|Use of Forbidden Drugs|9|||
149853291|NCT01848210|540593607|FG001|Overall Study|Use of Forbidden Drugs|10|||
149959493|NCT03757715|540985881|FG000|Overall Study|Lost to Follow-up|4|||
149959494|NCT03757715|540985882|FG001|Overall Study|Lost to Follow-up|9|||
150288882|NCT01662440|542192525|FG003|Overall Study|Protocol Violation|0|||
149853292|NCT01848210|540593606|FG000|Overall Study|Impedition Condition|5|||
149853293|NCT01848210|540593607|FG001|Overall Study|Impedition Condition|9|||
149853294|NCT01848210|540593606|FG000|Overall Study|Adverse Event|7|||
149853295|NCT01848210|540593607|FG001|Overall Study|Adverse Event|9|||
149853296|NCT01848210|540593606|FG000|Overall Study|Discontinuation Criterion|5|||
149853297|NCT01848210|540593607|FG001|Overall Study|Discontinuation Criterion|7|||
149853298|NCT01848210|540593606|FG000|Overall Study|Hypesensitivity|1|||
149853299|NCT01848210|540593607|FG001|Overall Study|Hypesensitivity|0|||
149853300|NCT01848210|540593606|FG000|Overall Study|Hepatic Function Alteration|4|||
149853301|NCT01848210|540593607|FG001|Overall Study|Hepatic Function Alteration|0|||
149853302|NCT01848210|540593606|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
149853303|NCT01848210|540593607|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
149853304|NCT01848210|540593606|FG000|Overall Study|Administrative|1|||
149853305|NCT01848210|540593607|FG001|Overall Study|Administrative|0|||
149853306|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
149853307|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
149853308|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
149853309|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
149853310|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
149853311|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
149853312|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
149853313|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
149853314|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
149853315|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
149853316|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
149853317|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
149853318|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
149853319|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
149853320|NCT04592419|540593608|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
149853321|NCT04592419|540593609|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
149853322|NCT04592419|540593608|FG000|Open-Label Extension Period|Adverse Event|1|||
149853323|NCT04592419|540593609|FG001|Open-Label Extension Period|Adverse Event|2|||
149853324|NCT04592419|540593608|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
149853325|NCT04592419|540593609|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
149853326|NCT04592419|540593608|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
149853327|NCT04592419|540593609|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
149853328|NCT04592419|540593608|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
149853329|NCT04592419|540593609|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
149853330|NCT04592419|540593608|FG000|Open-Label Extension Period|Sponsor Request|73|||
149853331|NCT04592419|540593609|FG001|Open-Label Extension Period|Sponsor Request|84|||
149853332|NCT00685035|540593616|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
149853333|NCT00685035|540593617|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
149853334|NCT00784979|540593618|FG000|Overall Study|incomplete data|6|||
149853335|NCT00894933|540593622|FG000|Overall Study|Lost to Follow-up|2|||
149853336|NCT00894933|540593622|FG000|Overall Study|Cancelled Procedure|1|||
149853337|NCT00894933|540593622|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
149853338|NCT04241133|540593626|FG000|Overall Study|COVID19 Precautions|14|||
149853339|NCT04241133|540593627|FG001|Overall Study|COVID19 Precautions|34|||
149853340|NCT00631007|540593629|FG000|Overall Study|Adverse Event|0|||
149853341|NCT00631007|540593630|FG001|Overall Study|Adverse Event|2|||
149853342|NCT00631007|540593631|FG002|Overall Study|Adverse Event|0|||
149853343|NCT00631007|540593632|FG003|Overall Study|Adverse Event|2|||
149853344|NCT00631007|540593633|FG004|Overall Study|Adverse Event|3|||
149853345|NCT00631007|540593634|FG005|Overall Study|Adverse Event|2|||
149853346|NCT00631007|540593629|FG000|Overall Study|Lost to Follow-up|2|||
149959495|NCT03757715|540985881|FG000|Overall Study|Withdrawal by Subject|1|||
149959496|NCT03757715|540985882|FG001|Overall Study|Withdrawal by Subject|1|||
149959497|NCT03302936|540985883|FG000|Overall Study|Protocol Violation|3|||
149959498|NCT03302936|540985884|FG001|Overall Study|Protocol Violation|4|||
149959499|NCT01122680|540985885|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
149959500|NCT01122680|540985886|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
149853347|NCT00631007|540593630|FG001|Overall Study|Lost to Follow-up|1|||
149853348|NCT00631007|540593631|FG002|Overall Study|Lost to Follow-up|2|||
149853349|NCT00631007|540593632|FG003|Overall Study|Lost to Follow-up|4|||
149853350|NCT00631007|540593633|FG004|Overall Study|Lost to Follow-up|5|||
149853351|NCT00631007|540593634|FG005|Overall Study|Lost to Follow-up|3|||
149853352|NCT00631007|540593629|FG000|Overall Study|Physician Decision|1|||
149853353|NCT00631007|540593630|FG001|Overall Study|Physician Decision|0|||
149853354|NCT00631007|540593631|FG002|Overall Study|Physician Decision|1|||
149853355|NCT00631007|540593632|FG003|Overall Study|Physician Decision|0|||
149853356|NCT00631007|540593633|FG004|Overall Study|Physician Decision|0|||
149959501|NCT01122680|540985887|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
149853357|NCT00631007|540593634|FG005|Overall Study|Physician Decision|2|||
149853358|NCT00631007|540593629|FG000|Overall Study|Persistent Hyperglycemia|2|||
149853359|NCT00631007|540593630|FG001|Overall Study|Persistent Hyperglycemia|2|||
149853360|NCT00631007|540593631|FG002|Overall Study|Persistent Hyperglycemia|5|||
149853361|NCT00631007|540593632|FG003|Overall Study|Persistent Hyperglycemia|1|||
149853362|NCT00631007|540593633|FG004|Overall Study|Persistent Hyperglycemia|2|||
149853363|NCT00631007|540593634|FG005|Overall Study|Persistent Hyperglycemia|5|||
149853364|NCT00631007|540593629|FG000|Overall Study|Withdrawal by Subject|4|||
149959502|NCT01122680|540985888|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
149959503|NCT01122680|540985885|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
149959504|NCT01122680|540985886|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
149959505|NCT01122680|540985887|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
149959506|NCT01122680|540985888|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
149959507|NCT01122680|540985885|FG000|Period 1 (4 Weeks)|Other|1|||
149959508|NCT01122680|540985886|FG001|Period 1 (4 Weeks)|Other|1|||
149959509|NCT01122680|540985887|FG002|Period 1 (4 Weeks)|Other|0|||
149959510|NCT01122680|540985888|FG003|Period 1 (4 Weeks)|Other|0|||
149959511|NCT01122680|540985885|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
149959512|NCT01122680|540985886|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
149959513|NCT01122680|540985887|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
149959514|NCT01122680|540985888|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
149959515|NCT01122680|540985885|FG000|Period 2 (4 Weeks)|Other|1|||
149959516|NCT01122680|540985886|FG001|Period 2 (4 Weeks)|Other|0|||
149959517|NCT01122680|540985887|FG002|Period 2 (4 Weeks)|Other|0|||
149959518|NCT01122680|540985888|FG003|Period 2 (4 Weeks)|Other|0|||
149959519|NCT01122680|540985885|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
149959520|NCT01122680|540985886|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
149959521|NCT01122680|540985887|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
149959522|NCT01122680|540985888|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
149959523|NCT01122680|540985885|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149959524|NCT01122680|540985886|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
149959525|NCT01122680|540985887|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149959526|NCT01122680|540985888|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
149959527|NCT04985682|540985889|FG000|Overall Study|Withdrawal by Subject|1|||
149959528|NCT03016403|540985896|FG000|Baseline|Death|5|||
149959529|NCT03016403|540985897|FG001|Baseline|Death|8|||
149959530|NCT03016403|540985898|FG002|Baseline|Death|1|||
149959531|NCT03016403|540985899|FG003|Baseline|Death|0|||
149959532|NCT03016403|540985896|FG000|Baseline|Withdrawal by Subject|2|||
149959533|NCT03016403|540985897|FG001|Baseline|Withdrawal by Subject|8|||
149959534|NCT03016403|540985898|FG002|Baseline|Withdrawal by Subject|4|||
149959535|NCT03016403|540985899|FG003|Baseline|Withdrawal by Subject|10|||
149959536|NCT03016403|540985896|FG000|Baseline|Lost to Follow-up|9|||
149959537|NCT03016403|540985897|FG001|Baseline|Lost to Follow-up|11|||
149959538|NCT03016403|540985898|FG002|Baseline|Lost to Follow-up|6|||
149959539|NCT03016403|540985899|FG003|Baseline|Lost to Follow-up|24|||
149959540|NCT03016403|540985896|FG000|6-week Follow-up|Death|1|||
149959541|NCT03016403|540985897|FG001|6-week Follow-up|Death|4|||
149959542|NCT03016403|540985898|FG002|6-week Follow-up|Death|0|||
149959543|NCT03016403|540985899|FG003|6-week Follow-up|Death|0|||
150288883|NCT01662440|542192522|FG000|Overall Study|Withdrawal by Subject|5|||
150288884|NCT01662440|542192523|FG001|Overall Study|Withdrawal by Subject|2|||
150288885|NCT01662440|542192524|FG002|Overall Study|Withdrawal by Subject|2|||
150288886|NCT01662440|542192525|FG003|Overall Study|Withdrawal by Subject|2|||
149853365|NCT00631007|540593630|FG001|Overall Study|Withdrawal by Subject|5|||
149959544|NCT03016403|540985896|FG000|6-week Follow-up|Lost to Follow-up|2|||
149959545|NCT03016403|540985897|FG001|6-week Follow-up|Lost to Follow-up|7|||
149959546|NCT03016403|540985898|FG002|6-week Follow-up|Lost to Follow-up|4|||
149959547|NCT03016403|540985899|FG003|6-week Follow-up|Lost to Follow-up|8|||
149959548|NCT03016403|540985896|FG000|6-week Follow-up|Withdrawal by Subject|0|||
149959549|NCT03016403|540985897|FG001|6-week Follow-up|Withdrawal by Subject|2|||
149959550|NCT03016403|540985898|FG002|6-week Follow-up|Withdrawal by Subject|0|||
149959551|NCT03016403|540985899|FG003|6-week Follow-up|Withdrawal by Subject|1|||
149959552|NCT03016403|540985896|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
149959553|NCT03016403|540985897|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
149959554|NCT03016403|540985898|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
149959555|NCT03016403|540985899|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
149853366|NCT00631007|540593631|FG002|Overall Study|Withdrawal by Subject|2|||
149959556|NCT03016403|540985896|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
149959557|NCT03016403|540985897|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
149959558|NCT03016403|540985898|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
149959559|NCT03016403|540985899|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
149959560|NCT03016403|540985896|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
149959561|NCT03016403|540985897|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
149959562|NCT03016403|540985898|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
149959563|NCT03016403|540985899|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
149959564|NCT05463705|540985900|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
149853367|NCT00631007|540593632|FG003|Overall Study|Withdrawal by Subject|2|||
149853368|NCT00631007|540593633|FG004|Overall Study|Withdrawal by Subject|1|||
149853369|NCT00631007|540593634|FG005|Overall Study|Withdrawal by Subject|3|||
149853370|NCT00631007|540593629|FG000|Overall Study|Other|2|||
149853371|NCT00631007|540593630|FG001|Overall Study|Other|1|||
149853372|NCT00631007|540593631|FG002|Overall Study|Other|0|||
149853373|NCT00631007|540593632|FG003|Overall Study|Other|0|||
149853374|NCT00631007|540593633|FG004|Overall Study|Other|1|||
149853375|NCT00631007|540593634|FG005|Overall Study|Other|0|||
149853376|NCT00683787|540593635|FG000|Overall Study|Progression|3|||
149853377|NCT00683787|540593636|FG001|Overall Study|Progression|3|||
149853378|NCT00683787|540593637|FG002|Overall Study|Progression|0|||
149853379|NCT00683787|540593635|FG000|Overall Study|Adverse Event|0|||
149853380|NCT00683787|540593636|FG001|Overall Study|Adverse Event|0|||
149853381|NCT00683787|540593637|FG002|Overall Study|Adverse Event|2|||
149853382|NCT02674633|540593638|FG000|Overall Study|Lost to Follow-up|3|||
149853383|NCT02674633|540593639|FG001|Overall Study|Lost to Follow-up|2|||
149853384|NCT02674633|540593638|FG000|Overall Study|Physician Decision|1|||
149853385|NCT02674633|540593639|FG001|Overall Study|Physician Decision|0|||
149853386|NCT02674633|540593638|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149853387|NCT02674633|540593639|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
149853388|NCT00460109|540593640|FG000|Overall Study|Death|1|||
149853389|NCT01235715|540593641|FG000|Overall Study|Physician Decision|0|||
149853390|NCT01235715|540593642|FG001|Overall Study|Physician Decision|2|||
149853391|NCT02994394|540593643|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
149853392|NCT02994394|540593644|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
149853393|NCT02994394|540593645|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
149853394|NCT02994394|540593646|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
149853395|NCT02994394|540593647|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
149853396|NCT02994394|540593648|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
149853397|NCT02994394|540593643|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
149853398|NCT02994394|540593644|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
149853399|NCT02994394|540593645|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
149853400|NCT02994394|540593646|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
149853401|NCT02994394|540593647|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
149853402|NCT02994394|540593648|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
149853403|NCT03619876|540593649|FG000|Overall Study|Withdrawal by Subject|1|||
149853404|NCT03619876|540593650|FG001|Overall Study|Withdrawal by Subject|2|||
149853405|NCT03619876|540593649|FG000|Overall Study|Withdrawal due to incidental finding|0|||
149853406|NCT03619876|540593650|FG001|Overall Study|Withdrawal due to incidental finding|2|||
149853407|NCT02344745|540593651|FG000|Overall Study|Data collection sheets were lost|2|||
149853408|NCT02344745|540593652|FG001|Overall Study|Data collection sheets were lost|0|||
149853409|NCT02788513|540593653|FG000|Overall Study|Withdrawal by Subject|3|||
149853410|NCT02788513|540593654|FG001|Overall Study|Withdrawal by Subject|0|||
149853411|NCT02788513|540593655|FG002|Overall Study|Withdrawal by Subject|2|||
149853412|NCT02788513|540593656|FG003|Overall Study|Withdrawal by Subject|3|||
149853413|NCT02788513|540593657|FG004|Overall Study|Withdrawal by Subject|1|||
149853414|NCT02788513|540593653|FG000|Overall Study|Lost to Follow-up|1|||
149853415|NCT02788513|540593654|FG001|Overall Study|Lost to Follow-up|0|||
149853416|NCT02788513|540593655|FG002|Overall Study|Lost to Follow-up|0|||
149853417|NCT02788513|540593656|FG003|Overall Study|Lost to Follow-up|0|||
149853418|NCT02788513|540593657|FG004|Overall Study|Lost to Follow-up|1|||
149853419|NCT02788513|540593653|FG000|Overall Study|Adverse Event|5|||
149853420|NCT02788513|540593654|FG001|Overall Study|Adverse Event|8|||
149853421|NCT02788513|540593655|FG002|Overall Study|Adverse Event|4|||
149853422|NCT02788513|540593656|FG003|Overall Study|Adverse Event|2|||
149853423|NCT02788513|540593657|FG004|Overall Study|Adverse Event|2|||
149853424|NCT02788513|540593653|FG000|Overall Study|Protocol Violation|0|||
149853425|NCT02788513|540593654|FG001|Overall Study|Protocol Violation|0|||
149853426|NCT02788513|540593655|FG002|Overall Study|Protocol Violation|1|||
149853427|NCT02788513|540593656|FG003|Overall Study|Protocol Violation|1|||
149853428|NCT02788513|540593657|FG004|Overall Study|Protocol Violation|0|||
149853429|NCT02788513|540593653|FG000|Overall Study|Subject decided to stop taking treatment|0|||
149853430|NCT02788513|540593654|FG001|Overall Study|Subject decided to stop taking treatment|0|||
149853431|NCT02788513|540593655|FG002|Overall Study|Subject decided to stop taking treatment|1|||
149853432|NCT02788513|540593656|FG003|Overall Study|Subject decided to stop taking treatment|0|||
149853433|NCT02788513|540593657|FG004|Overall Study|Subject decided to stop taking treatment|0|||
149853434|NCT02788513|540593653|FG000|Overall Study|Decision by the study team|0|||
149853435|NCT02788513|540593654|FG001|Overall Study|Decision by the study team|0|||
149853436|NCT02788513|540593655|FG002|Overall Study|Decision by the study team|0|||
149853437|NCT02788513|540593656|FG003|Overall Study|Decision by the study team|0|||
149853438|NCT02788513|540593657|FG004|Overall Study|Decision by the study team|1|||
149853439|NCT04982445|540593658|FG000|Overall Study|Protocol Violation|1|||
149853440|NCT04982445|540593658|FG000|Overall Study|Withdrawal by Subject|4|||
149853441|NCT04982445|540593658|FG000|Overall Study|Lost to Follow-up|1|||
149853442|NCT04968925|540593661|FG000|Phase I- Period 1|COVID-19 related|0|||
149853443|NCT04968925|540593662|FG001|Phase I- Period 1|COVID-19 related|1|||
149853444|NCT04968925|540593663|FG002|Phase I- Period 1|COVID-19 related|0|||
150288887|NCT02600507|542192526|FG000|Overall Study|Adverse Event|3|||
149853445|NCT04968925|540593664|FG003|Phase I- Period 1|COVID-19 related|0|||
149853446|NCT04968925|540593661|FG000|Phase I- Period 1|Subject enrolled in error|1|||
149853447|NCT04968925|540593662|FG001|Phase I- Period 1|Subject enrolled in error|1|||
149853448|NCT04968925|540593663|FG002|Phase I- Period 1|Subject enrolled in error|0|||
149853449|NCT04968925|540593664|FG003|Phase I- Period 1|Subject enrolled in error|0|||
149853450|NCT04968925|540593661|FG000|Phase II- Period 1|COVID-19 Related|0|||
149853451|NCT04968925|540593662|FG001|Phase II- Period 1|COVID-19 Related|0|||
149853452|NCT04968925|540593663|FG002|Phase II- Period 1|COVID-19 Related|6|||
149853453|NCT04968925|540593664|FG003|Phase II- Period 1|COVID-19 Related|6|||
149853454|NCT04968925|540593661|FG000|Phase II- Period 1|Subject enrolled in error|0|||
149853455|NCT04968925|540593662|FG001|Phase II- Period 1|Subject enrolled in error|0|||
149853456|NCT04968925|540593663|FG002|Phase II- Period 1|Subject enrolled in error|1|||
149853457|NCT04968925|540593664|FG003|Phase II- Period 1|Subject enrolled in error|0|||
149853458|NCT04968925|540593661|FG000|Phase II -Period 2|COVID-19 related|0|||
149853459|NCT04968925|540593662|FG001|Phase II -Period 2|COVID-19 related|0|||
149853460|NCT04968925|540593663|FG002|Phase II -Period 2|COVID-19 related|4|||
149853461|NCT04968925|540593664|FG003|Phase II -Period 2|COVID-19 related|3|||
149853462|NCT04968925|540593661|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
149853463|NCT04968925|540593662|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
149853464|NCT04968925|540593663|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
149853465|NCT04968925|540593664|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
149853466|NCT00396630|540593666|FG000|Overall Study|Lost to Follow-up|1|||
149853467|NCT00396630|540593667|FG001|Overall Study|Lost to Follow-up|1|||
149853468|NCT00396630|540593666|FG000|Overall Study|Withdrawal by Subject|1|||
149853469|NCT00396630|540593667|FG001|Overall Study|Withdrawal by Subject|1|||
149853470|NCT00396630|540593666|FG000|Overall Study|Not vaccinated at Visit 3|3|||
149853471|NCT00396630|540593667|FG001|Overall Study|Not vaccinated at Visit 3|3|||
149853472|NCT02327325|540593668|FG000|Overall Study|Withdrawal by Subject|1|||
149853473|NCT02327325|540593669|FG001|Overall Study|Withdrawal by Subject|4|||
149853474|NCT02327325|540593670|FG002|Overall Study|Withdrawal by Subject|4|||
149853475|NCT02327325|540593668|FG000|Overall Study|Excluded by Study Team|0|||
149853476|NCT02327325|540593669|FG001|Overall Study|Excluded by Study Team|0|||
149853477|NCT02327325|540593670|FG002|Overall Study|Excluded by Study Team|1|||
149853478|NCT02457819|540593674|FG000|Overall Study|reason not given|8|||
149853479|NCT02457819|540593674|FG000|Overall Study|Withdrawal by Subject|24|||
149853480|NCT02457819|540593674|FG000|Overall Study|Protocol Violation|1|||
149853481|NCT02457819|540593674|FG000|Overall Study|non compliance with study drug|4|||
149853482|NCT02457819|540593674|FG000|Overall Study|Lost to Follow-up|10|||
149853483|NCT02457819|540593674|FG000|Overall Study|Lack of Efficacy|19|||
149853484|NCT02457819|540593674|FG000|Overall Study|Adverse Event|33|||
149853485|NCT03330236|540593675|FG000|Overall Study|Death|2|||
149853486|NCT03330236|540593676|FG001|Overall Study|Death|1|||
149853487|NCT03330236|540593675|FG000|Overall Study|Withdrawal by Subject|2|||
149853488|NCT03330236|540593676|FG001|Overall Study|Withdrawal by Subject|4|||
149853489|NCT03330236|540593675|FG000|Overall Study|Lost to Follow-up|0|||
149853490|NCT03330236|540593676|FG001|Overall Study|Lost to Follow-up|2|||
149853491|NCT03330236|540593675|FG000|Overall Study|Physician Decision|2|||
149853492|NCT03330236|540593676|FG001|Overall Study|Physician Decision|0|||
149853493|NCT03330236|540593675|FG000|Overall Study|Protocol Violation|4|||
149853494|NCT03330236|540593676|FG001|Overall Study|Protocol Violation|3|||
149853495|NCT03330236|540593675|FG000|Overall Study|SedLine malfunction/blinding|19|||
149853496|NCT03330236|540593676|FG001|Overall Study|SedLine malfunction/blinding|14|||
149853497|NCT03330236|540593675|FG000|Overall Study|Volatile anesthetics used|11|||
149853498|NCT03330236|540593676|FG001|Overall Study|Volatile anesthetics used|8|||
149853499|NCT03330236|540593675|FG000|Overall Study|Surgery aborted/converted to open|60|||
149853500|NCT03330236|540593676|FG001|Overall Study|Surgery aborted/converted to open|52|||
149853501|NCT00763555|540593677|FG000|Overall Study|Adverse Event|2|||
149853502|NCT00763555|540593678|FG001|Overall Study|Adverse Event|1|||
149959565|NCT05463705|540985901|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
149959566|NCT05463705|540985902|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
149959567|NCT05463705|540985903|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
149959568|NCT05463705|540985904|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
149959569|NCT05463705|540985905|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
149959570|NCT00576407|540985906|FG000|Overall Study|Death|7|||
149959571|NCT00576407|540985906|FG000|Overall Study|Physician Decision|1|||
149853503|NCT00763555|540593677|FG000|Overall Study|Withdrawal by Subject|2|||
149853504|NCT00763555|540593678|FG001|Overall Study|Withdrawal by Subject|6|||
149853505|NCT00763555|540593677|FG000|Overall Study|Lost to Follow-up|0|||
149853506|NCT00763555|540593678|FG001|Overall Study|Lost to Follow-up|3|||
149959572|NCT00225758|540985907|FG000|Overall Study|Adverse Event|4|||
149959573|NCT00079781|540985908|FG000|Pre-implant Period|Withdrawal by Subject|2|||
149959574|NCT00079781|540985909|FG001|Pre-implant Period|Withdrawal by Subject|0|||
149959575|NCT00079781|540985910|FG002|Pre-implant Period|Withdrawal by Subject|0|||
149853507|NCT01332968|540593683|FG000|Induction Period|Adverse Event|23|||
149853508|NCT01332968|540593684|FG001|Induction Period|Adverse Event|26|||
149853509|NCT01332968|540593685|FG002|Induction Period|Adverse Event|0|||
149853510|NCT01332968|540593686|FG003|Induction Period|Adverse Event|0|||
149853511|NCT01332968|540593687|FG004|Induction Period|Adverse Event|0|||
149853512|NCT01332968|540593688|FG005|Induction Period|Adverse Event|0|||
149853513|NCT01332968|540593689|FG006|Induction Period|Adverse Event|0|||
149853514|NCT01332968|540593690|FG007|Induction Period|Adverse Event|0|||
149853515|NCT01332968|540593683|FG000|Induction Period|Death|1|||
149853516|NCT01332968|540593684|FG001|Induction Period|Death|4|||
149853517|NCT01332968|540593685|FG002|Induction Period|Death|0|||
149853518|NCT01332968|540593686|FG003|Induction Period|Death|0|||
149853519|NCT01332968|540593687|FG004|Induction Period|Death|0|||
149853520|NCT01332968|540593688|FG005|Induction Period|Death|0|||
149853521|NCT01332968|540593689|FG006|Induction Period|Death|0|||
149853522|NCT01332968|540593690|FG007|Induction Period|Death|0|||
149853523|NCT01332968|540593683|FG000|Induction Period|Non-compliance|1|||
149853524|NCT01332968|540593684|FG001|Induction Period|Non-compliance|0|||
149853525|NCT01332968|540593685|FG002|Induction Period|Non-compliance|0|||
149853526|NCT01332968|540593686|FG003|Induction Period|Non-compliance|0|||
149853527|NCT01332968|540593687|FG004|Induction Period|Non-compliance|0|||
149853528|NCT01332968|540593688|FG005|Induction Period|Non-compliance|0|||
149853529|NCT01332968|540593689|FG006|Induction Period|Non-compliance|0|||
149853530|NCT01332968|540593690|FG007|Induction Period|Non-compliance|0|||
149853531|NCT01332968|540593683|FG000|Induction Period|Other|2|||
149853532|NCT01332968|540593684|FG001|Induction Period|Other|2|||
149853533|NCT01332968|540593685|FG002|Induction Period|Other|0|||
149853534|NCT01332968|540593686|FG003|Induction Period|Other|0|||
149853535|NCT01332968|540593687|FG004|Induction Period|Other|0|||
149853536|NCT01332968|540593688|FG005|Induction Period|Other|0|||
149853537|NCT01332968|540593689|FG006|Induction Period|Other|0|||
149853538|NCT01332968|540593690|FG007|Induction Period|Other|0|||
149853539|NCT01332968|540593683|FG000|Induction Period|Physician Decision|6|||
149853540|NCT01332968|540593684|FG001|Induction Period|Physician Decision|1|||
149853541|NCT01332968|540593685|FG002|Induction Period|Physician Decision|0|||
149853542|NCT01332968|540593686|FG003|Induction Period|Physician Decision|0|||
149853543|NCT01332968|540593687|FG004|Induction Period|Physician Decision|0|||
149853544|NCT01332968|540593688|FG005|Induction Period|Physician Decision|0|||
149853545|NCT01332968|540593689|FG006|Induction Period|Physician Decision|0|||
149853546|NCT01332968|540593690|FG007|Induction Period|Physician Decision|0|||
149853547|NCT01332968|540593683|FG000|Induction Period|Progressive Disease|15|||
149853548|NCT01332968|540593684|FG001|Induction Period|Progressive Disease|7|||
149853549|NCT01332968|540593685|FG002|Induction Period|Progressive Disease|0|||
149853550|NCT01332968|540593686|FG003|Induction Period|Progressive Disease|0|||
149853551|NCT01332968|540593687|FG004|Induction Period|Progressive Disease|0|||
149853552|NCT01332968|540593688|FG005|Induction Period|Progressive Disease|0|||
149853553|NCT01332968|540593689|FG006|Induction Period|Progressive Disease|0|||
149853554|NCT01332968|540593690|FG007|Induction Period|Progressive Disease|0|||
149959576|NCT00079781|540985908|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
149959577|NCT00079781|540985909|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
149959578|NCT00079781|540985910|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
149959579|NCT00079781|540985908|FG000|Follow-up Period|Withdrawal by Subject|3|||
149959580|NCT00079781|540985909|FG001|Follow-up Period|Withdrawal by Subject|0|||
149959581|NCT00079781|540985910|FG002|Follow-up Period|Withdrawal by Subject|1|||
149959582|NCT00079781|540985908|FG000|Follow-up Period|Lost to Follow-up|1|||
149959583|NCT00079781|540985909|FG001|Follow-up Period|Lost to Follow-up|0|||
149959584|NCT00079781|540985910|FG002|Follow-up Period|Lost to Follow-up|0|||
149853555|NCT01332968|540593683|FG000|Induction Period|Protocol Violation|3|||
149853556|NCT01332968|540593684|FG001|Induction Period|Protocol Violation|4|||
149853557|NCT01332968|540593685|FG002|Induction Period|Protocol Violation|0|||
149959585|NCT00079781|540985908|FG000|Follow-up Period|Death|0|||
149959586|NCT00079781|540985909|FG001|Follow-up Period|Death|0|||
149959587|NCT00079781|540985910|FG002|Follow-up Period|Death|1|||
149959588|NCT00621322|540985911|FG000|Overall Study|Lost to Follow-up|0|||
149853558|NCT01332968|540593686|FG003|Induction Period|Protocol Violation|0|||
149959589|NCT00621322|540985912|FG001|Overall Study|Lost to Follow-up|0|||
149853559|NCT01332968|540593687|FG004|Induction Period|Protocol Violation|0|||
149853560|NCT01332968|540593688|FG005|Induction Period|Protocol Violation|0|||
149853561|NCT01332968|540593689|FG006|Induction Period|Protocol Violation|0|||
149853562|NCT01332968|540593690|FG007|Induction Period|Protocol Violation|0|||
149853563|NCT01332968|540593683|FG000|Induction Period|Withdrawal by Subject|3|||
149853564|NCT01332968|540593684|FG001|Induction Period|Withdrawal by Subject|5|||
149853565|NCT01332968|540593685|FG002|Induction Period|Withdrawal by Subject|0|||
149959590|NCT00621322|540985913|FG002|Overall Study|Lost to Follow-up|0|||
149959591|NCT00621322|540985914|FG003|Overall Study|Lost to Follow-up|0|||
149959592|NCT00621322|540985915|FG004|Overall Study|Lost to Follow-up|1|||
149959593|NCT00621322|540985916|FG005|Overall Study|Lost to Follow-up|0|||
149853566|NCT01332968|540593686|FG003|Induction Period|Withdrawal by Subject|0|||
149853567|NCT01332968|540593687|FG004|Induction Period|Withdrawal by Subject|0|||
149853568|NCT01332968|540593688|FG005|Induction Period|Withdrawal by Subject|0|||
149853569|NCT01332968|540593689|FG006|Induction Period|Withdrawal by Subject|0|||
149853570|NCT01332968|540593690|FG007|Induction Period|Withdrawal by Subject|0|||
149853571|NCT01332968|540593683|FG000|Induction Period|Randomised but not treated|4|||
149853572|NCT01332968|540593684|FG001|Induction Period|Randomised but not treated|7|||
149853573|NCT01332968|540593685|FG002|Induction Period|Randomised but not treated|0|||
149853574|NCT01332968|540593686|FG003|Induction Period|Randomised but not treated|0|||
149853575|NCT01332968|540593687|FG004|Induction Period|Randomised but not treated|0|||
149853576|NCT01332968|540593688|FG005|Induction Period|Randomised but not treated|0|||
149853577|NCT01332968|540593689|FG006|Induction Period|Randomised but not treated|0|||
149853578|NCT01332968|540593690|FG007|Induction Period|Randomised but not treated|0|||
149853579|NCT01332968|540593683|FG000|Maintenance/Observation Period|Adverse Event|0|||
149853580|NCT01332968|540593684|FG001|Maintenance/Observation Period|Adverse Event|0|||
149853581|NCT01332968|540593685|FG002|Maintenance/Observation Period|Adverse Event|53|||
149853582|NCT01332968|540593686|FG003|Maintenance/Observation Period|Adverse Event|66|||
149853583|NCT01332968|540593687|FG004|Maintenance/Observation Period|Adverse Event|0|||
149853584|NCT01332968|540593688|FG005|Maintenance/Observation Period|Adverse Event|0|||
149853585|NCT01332968|540593689|FG006|Maintenance/Observation Period|Adverse Event|0|||
149853586|NCT01332968|540593690|FG007|Maintenance/Observation Period|Adverse Event|0|||
149853587|NCT01332968|540593683|FG000|Maintenance/Observation Period|Death|0|||
149853588|NCT01332968|540593684|FG001|Maintenance/Observation Period|Death|0|||
149853589|NCT01332968|540593685|FG002|Maintenance/Observation Period|Death|5|||
149853590|NCT01332968|540593686|FG003|Maintenance/Observation Period|Death|6|||
149853591|NCT01332968|540593687|FG004|Maintenance/Observation Period|Death|0|||
149853592|NCT01332968|540593688|FG005|Maintenance/Observation Period|Death|0|||
149853593|NCT01332968|540593689|FG006|Maintenance/Observation Period|Death|0|||
149853594|NCT01332968|540593690|FG007|Maintenance/Observation Period|Death|0|||
149853595|NCT01332968|540593683|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
149853596|NCT01332968|540593684|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
149853597|NCT01332968|540593685|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
149853598|NCT01332968|540593686|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
149853599|NCT01332968|540593687|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
149853600|NCT01332968|540593688|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
149853601|NCT01332968|540593689|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
149853602|NCT01332968|540593690|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
149853603|NCT01332968|540593683|FG000|Maintenance/Observation Period|Non-compliance|0|||
149853604|NCT01332968|540593684|FG001|Maintenance/Observation Period|Non-compliance|0|||
149853605|NCT01332968|540593685|FG002|Maintenance/Observation Period|Non-compliance|4|||
149853606|NCT01332968|540593686|FG003|Maintenance/Observation Period|Non-compliance|3|||
149853607|NCT01332968|540593687|FG004|Maintenance/Observation Period|Non-compliance|0|||
149853608|NCT01332968|540593688|FG005|Maintenance/Observation Period|Non-compliance|0|||
149853609|NCT01332968|540593689|FG006|Maintenance/Observation Period|Non-compliance|0|||
149853610|NCT01332968|540593690|FG007|Maintenance/Observation Period|Non-compliance|0|||
149853611|NCT01332968|540593683|FG000|Maintenance/Observation Period|Other|0|||
149853612|NCT01332968|540593684|FG001|Maintenance/Observation Period|Other|0|||
149853613|NCT01332968|540593685|FG002|Maintenance/Observation Period|Other|4|||
149853614|NCT01332968|540593686|FG003|Maintenance/Observation Period|Other|7|||
149853615|NCT01332968|540593687|FG004|Maintenance/Observation Period|Other|0|||
149853616|NCT01332968|540593688|FG005|Maintenance/Observation Period|Other|0|||
149853617|NCT01332968|540593689|FG006|Maintenance/Observation Period|Other|0|||
149853618|NCT01332968|540593690|FG007|Maintenance/Observation Period|Other|0|||
149853619|NCT01332968|540593683|FG000|Maintenance/Observation Period|Physician Decision|0|||
149853620|NCT01332968|540593684|FG001|Maintenance/Observation Period|Physician Decision|0|||
149853621|NCT01332968|540593685|FG002|Maintenance/Observation Period|Physician Decision|14|||
149853622|NCT01332968|540593686|FG003|Maintenance/Observation Period|Physician Decision|19|||
149853623|NCT01332968|540593687|FG004|Maintenance/Observation Period|Physician Decision|0|||
150039494|NCT00068692|541285106|FG003|Step 1: Registration|Protocol Violation|0|||
150039495|NCT00068692|541285107|FG004|Step 1: Registration|Protocol Violation|0|||
150039496|NCT00068692|541285108|FG005|Step 1: Registration|Protocol Violation|0|||
150039497|NCT00068692|541285109|FG006|Step 1: Registration|Protocol Violation|0|||
150039498|NCT00068692|541285110|FG007|Step 1: Registration|Protocol Violation|0|||
150039499|NCT00068692|541285103|FG000|Step 1: Registration|Not eligible|6|||
150039500|NCT00068692|541285104|FG001|Step 1: Registration|Not eligible|0|||
150039501|NCT00068692|541285105|FG002|Step 1: Registration|Not eligible|0|||
150039502|NCT00068692|541285106|FG003|Step 1: Registration|Not eligible|0|||
150039503|NCT00068692|541285107|FG004|Step 1: Registration|Not eligible|0|||
150039504|NCT00068692|541285108|FG005|Step 1: Registration|Not eligible|0|||
149853624|NCT01332968|540593688|FG005|Maintenance/Observation Period|Physician Decision|1|||
149853625|NCT01332968|540593689|FG006|Maintenance/Observation Period|Physician Decision|0|||
149853626|NCT01332968|540593690|FG007|Maintenance/Observation Period|Physician Decision|0|||
150039505|NCT00068692|541285109|FG006|Step 1: Registration|Not eligible|0|||
149853627|NCT01332968|540593683|FG000|Maintenance/Observation Period|Progressive Disease|0|||
149853628|NCT01332968|540593684|FG001|Maintenance/Observation Period|Progressive Disease|0|||
149853629|NCT01332968|540593685|FG002|Maintenance/Observation Period|Progressive Disease|72|||
149853630|NCT01332968|540593686|FG003|Maintenance/Observation Period|Progressive Disease|40|||
149853631|NCT01332968|540593687|FG004|Maintenance/Observation Period|Progressive Disease|0|||
149853632|NCT01332968|540593688|FG005|Maintenance/Observation Period|Progressive Disease|0|||
149853633|NCT01332968|540593689|FG006|Maintenance/Observation Period|Progressive Disease|0|||
149853634|NCT01332968|540593690|FG007|Maintenance/Observation Period|Progressive Disease|0|||
149853635|NCT01332968|540593683|FG000|Maintenance/Observation Period|Protocol Violation|0|||
149853636|NCT01332968|540593684|FG001|Maintenance/Observation Period|Protocol Violation|0|||
149853637|NCT01332968|540593685|FG002|Maintenance/Observation Period|Protocol Violation|1|||
149853638|NCT01332968|540593686|FG003|Maintenance/Observation Period|Protocol Violation|1|||
149853639|NCT01332968|540593687|FG004|Maintenance/Observation Period|Protocol Violation|0|||
149853640|NCT01332968|540593688|FG005|Maintenance/Observation Period|Protocol Violation|0|||
149853641|NCT01332968|540593689|FG006|Maintenance/Observation Period|Protocol Violation|0|||
149853642|NCT01332968|540593690|FG007|Maintenance/Observation Period|Protocol Violation|0|||
149853643|NCT01332968|540593683|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853644|NCT01332968|540593684|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853645|NCT01332968|540593685|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
149853646|NCT01332968|540593686|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
149853647|NCT01332968|540593687|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853648|NCT01332968|540593688|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853649|NCT01332968|540593689|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853650|NCT01332968|540593690|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
149853651|NCT01332968|540593683|FG000|Follow-Up Period|Adverse Event|0|||
149853652|NCT01332968|540593684|FG001|Follow-Up Period|Adverse Event|0|||
149853653|NCT01332968|540593685|FG002|Follow-Up Period|Adverse Event|0|||
149853654|NCT01332968|540593686|FG003|Follow-Up Period|Adverse Event|0|||
149853655|NCT01332968|540593687|FG004|Follow-Up Period|Adverse Event|0|||
149853656|NCT01332968|540593688|FG005|Follow-Up Period|Adverse Event|0|||
149853657|NCT01332968|540593689|FG006|Follow-Up Period|Adverse Event|0|||
149853658|NCT01332968|540593690|FG007|Follow-Up Period|Adverse Event|4|||
149853659|NCT01332968|540593683|FG000|Follow-Up Period|Death|0|||
149853660|NCT01332968|540593684|FG001|Follow-Up Period|Death|0|||
149853661|NCT01332968|540593685|FG002|Follow-Up Period|Death|0|||
149853662|NCT01332968|540593686|FG003|Follow-Up Period|Death|0|||
149853663|NCT01332968|540593687|FG004|Follow-Up Period|Death|0|||
149853664|NCT01332968|540593688|FG005|Follow-Up Period|Death|0|||
149853665|NCT01332968|540593689|FG006|Follow-Up Period|Death|27|||
149853666|NCT01332968|540593690|FG007|Follow-Up Period|Death|30|||
149853667|NCT01332968|540593683|FG000|Follow-Up Period|Lost to Follow-up|0|||
149853668|NCT01332968|540593684|FG001|Follow-Up Period|Lost to Follow-up|0|||
149853669|NCT01332968|540593685|FG002|Follow-Up Period|Lost to Follow-up|0|||
149853670|NCT01332968|540593686|FG003|Follow-Up Period|Lost to Follow-up|0|||
149853671|NCT01332968|540593687|FG004|Follow-Up Period|Lost to Follow-up|0|||
149853672|NCT01332968|540593688|FG005|Follow-Up Period|Lost to Follow-up|0|||
149853673|NCT01332968|540593689|FG006|Follow-Up Period|Lost to Follow-up|11|||
149853674|NCT01332968|540593690|FG007|Follow-Up Period|Lost to Follow-up|15|||
149853675|NCT01332968|540593683|FG000|Follow-Up Period|Non-compliance|0|||
149853676|NCT01332968|540593684|FG001|Follow-Up Period|Non-compliance|0|||
149853677|NCT01332968|540593685|FG002|Follow-Up Period|Non-compliance|0|||
149853678|NCT01332968|540593686|FG003|Follow-Up Period|Non-compliance|0|||
149853679|NCT01332968|540593687|FG004|Follow-Up Period|Non-compliance|0|||
149853680|NCT01332968|540593688|FG005|Follow-Up Period|Non-compliance|0|||
149853681|NCT01332968|540593689|FG006|Follow-Up Period|Non-compliance|4|||
150172805|NCT02486588|541768103|FG003|Overall Study|Randomized in error- ineligible|738|||
150172806|NCT02486588|541768104|FG004|Overall Study|Randomized in error- ineligible|746|||
149853682|NCT01332968|540593690|FG007|Follow-Up Period|Non-compliance|9|||
149853683|NCT01332968|540593683|FG000|Follow-Up Period|Other|0|||
149853684|NCT01332968|540593684|FG001|Follow-Up Period|Other|0|||
149853685|NCT01332968|540593685|FG002|Follow-Up Period|Other|0|||
149853686|NCT01332968|540593686|FG003|Follow-Up Period|Other|0|||
149853687|NCT01332968|540593687|FG004|Follow-Up Period|Other|0|||
149853688|NCT01332968|540593688|FG005|Follow-Up Period|Other|0|||
149853689|NCT01332968|540593689|FG006|Follow-Up Period|Other|18|||
149853690|NCT01332968|540593690|FG007|Follow-Up Period|Other|21|||
149853691|NCT01332968|540593683|FG000|Follow-Up Period|Physician Decision|0|||
149853692|NCT01332968|540593684|FG001|Follow-Up Period|Physician Decision|0|||
149853693|NCT01332968|540593685|FG002|Follow-Up Period|Physician Decision|0|||
149853694|NCT01332968|540593686|FG003|Follow-Up Period|Physician Decision|0|||
149853695|NCT01332968|540593687|FG004|Follow-Up Period|Physician Decision|0|||
149853696|NCT01332968|540593688|FG005|Follow-Up Period|Physician Decision|0|||
149853697|NCT01332968|540593689|FG006|Follow-Up Period|Physician Decision|12|||
149853698|NCT01332968|540593690|FG007|Follow-Up Period|Physician Decision|15|||
149853699|NCT01332968|540593683|FG000|Follow-Up Period|Progressive Disease|0|||
149853700|NCT01332968|540593684|FG001|Follow-Up Period|Progressive Disease|0|||
149853701|NCT01332968|540593685|FG002|Follow-Up Period|Progressive Disease|0|||
149853702|NCT01332968|540593686|FG003|Follow-Up Period|Progressive Disease|0|||
149853703|NCT01332968|540593687|FG004|Follow-Up Period|Progressive Disease|0|||
149853704|NCT01332968|540593688|FG005|Follow-Up Period|Progressive Disease|0|||
149853705|NCT01332968|540593689|FG006|Follow-Up Period|Progressive Disease|126|||
149853706|NCT01332968|540593690|FG007|Follow-Up Period|Progressive Disease|106|||
149853707|NCT01332968|540593683|FG000|Follow-Up Period|Protocol Violation|0|||
149853708|NCT01332968|540593684|FG001|Follow-Up Period|Protocol Violation|0|||
149853709|NCT01332968|540593685|FG002|Follow-Up Period|Protocol Violation|0|||
149853710|NCT01332968|540593686|FG003|Follow-Up Period|Protocol Violation|0|||
149853711|NCT01332968|540593687|FG004|Follow-Up Period|Protocol Violation|0|||
149853712|NCT01332968|540593688|FG005|Follow-Up Period|Protocol Violation|0|||
149853713|NCT01332968|540593689|FG006|Follow-Up Period|Protocol Violation|1|||
149853714|NCT01332968|540593690|FG007|Follow-Up Period|Protocol Violation|0|||
149853715|NCT01332968|540593683|FG000|Follow-Up Period|Withdrawal by Subject|0|||
149853716|NCT01332968|540593684|FG001|Follow-Up Period|Withdrawal by Subject|0|||
149853717|NCT01332968|540593685|FG002|Follow-Up Period|Withdrawal by Subject|0|||
149853718|NCT01332968|540593686|FG003|Follow-Up Period|Withdrawal by Subject|0|||
149853719|NCT01332968|540593687|FG004|Follow-Up Period|Withdrawal by Subject|0|||
149853720|NCT01332968|540593688|FG005|Follow-Up Period|Withdrawal by Subject|0|||
149853721|NCT01332968|540593689|FG006|Follow-Up Period|Withdrawal by Subject|29|||
149853722|NCT01332968|540593690|FG007|Follow-Up Period|Withdrawal by Subject|32|||
149853723|NCT01332968|540593683|FG000|Follow-Up Period|No reason provided|0|||
149853724|NCT01332968|540593684|FG001|Follow-Up Period|No reason provided|0|||
149853725|NCT01332968|540593685|FG002|Follow-Up Period|No reason provided|0|||
149853726|NCT01332968|540593686|FG003|Follow-Up Period|No reason provided|0|||
149853727|NCT01332968|540593687|FG004|Follow-Up Period|No reason provided|0|||
149853728|NCT01332968|540593688|FG005|Follow-Up Period|No reason provided|0|||
149853729|NCT01332968|540593689|FG006|Follow-Up Period|No reason provided|2|||
149853730|NCT01332968|540593690|FG007|Follow-Up Period|No reason provided|3|||
149853731|NCT00194792|540593691|FG000|Overall Study|Withdrawal by Subject|1|||
149853732|NCT02448563|540593692|FG000|Overall Study|Lost to Follow-up|16|||
149853733|NCT02448563|540593693|FG001|Overall Study|Lost to Follow-up|10|||
149853734|NCT02448563|540593692|FG000|Overall Study|Withdrawal by Subject|0|||
149853735|NCT02448563|540593693|FG001|Overall Study|Withdrawal by Subject|1|||
149853736|NCT00113919|540593694|FG000|Overall Study|Physician Decision|8|||
149853737|NCT00113919|540593694|FG000|Overall Study|Death|6|||
149853738|NCT02340962|540593699|FG000|Overall Study|Lost to Follow-up|1|||
149853739|NCT02340962|540593700|FG001|Overall Study|Lost to Follow-up|0|||
149853740|NCT01292837|540593706|FG000|Overall Study|Adverse Event|1|||
149853741|NCT01292837|540593706|FG000|Overall Study|Further treatment determined|1|||
149853742|NCT02174276|540593709|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
149853743|NCT02174276|540593710|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
149853744|NCT02174276|540593711|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
149853745|NCT02174276|540593712|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
149853746|NCT02174276|540593709|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
149853747|NCT02174276|540593710|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
149853748|NCT02174276|540593711|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
149853749|NCT02174276|540593712|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
149853750|NCT02174276|540593709|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
149853751|NCT02174276|540593710|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
149853752|NCT02174276|540593711|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
149853753|NCT02174276|540593712|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
149853754|NCT02174276|540593709|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
149853755|NCT02174276|540593710|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
149853756|NCT02174276|540593711|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
149853757|NCT02174276|540593712|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
149853758|NCT02174276|540593709|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
149853759|NCT02174276|540593710|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
149853760|NCT02174276|540593711|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
149853761|NCT02174276|540593712|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
149853762|NCT02174276|540593709|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
149853763|NCT02174276|540593710|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
149853764|NCT02174276|540593711|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
149853765|NCT02174276|540593712|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
149853766|NCT01206439|540593713|FG000|Overall Study|subject did not meet inclusion criteria|1|||
150172807|NCT02486588|541768105|FG005|Overall Study|Randomized in error- ineligible|746|||
149853767|NCT02661022|540593715|FG000|Overall Study|Withdrawal by Subject|3|||
149853768|NCT02661022|540593716|FG001|Overall Study|Withdrawal by Subject|0|||
149853769|NCT02661022|540593715|FG000|Overall Study|Adverse Event|1|||
149853770|NCT02661022|540593716|FG001|Overall Study|Adverse Event|1|||
149853771|NCT02661022|540593715|FG000|Overall Study|Physician Decision|1|||
149853772|NCT02661022|540593716|FG001|Overall Study|Physician Decision|0|||
149853773|NCT02661022|540593715|FG000|Overall Study|Progressive Disease|2|||
149853774|NCT02661022|540593716|FG001|Overall Study|Progressive Disease|1|||
149853775|NCT05889039|540593717|FG000|Overall Study|error in completing survey|0|||
149853776|NCT05889039|540593718|FG001|Overall Study|error in completing survey|2|||
149853777|NCT05889039|540593719|FG002|Overall Study|error in completing survey|0|||
149853778|NCT05889039|540593720|FG003|Overall Study|error in completing survey|0|||
149853779|NCT05889039|540593717|FG000|Overall Study|Lost to Follow-up|4|||
149853780|NCT05889039|540593718|FG001|Overall Study|Lost to Follow-up|0|||
149853781|NCT05889039|540593719|FG002|Overall Study|Lost to Follow-up|0|||
149853782|NCT05889039|540593720|FG003|Overall Study|Lost to Follow-up|0|||
149853783|NCT01055886|540593721|FG000|Overall Study|Withdrawal by Subject|4|||
149853784|NCT01055886|540593722|FG001|Overall Study|Withdrawal by Subject|9|||
149853785|NCT01055886|540593721|FG000|Overall Study|Lost to Follow-up|1|||
149853786|NCT01055886|540593722|FG001|Overall Study|Lost to Follow-up|1|||
149853787|NCT01055886|540593721|FG000|Overall Study|Withdrawal by PI|0|||
149853788|NCT01055886|540593722|FG001|Overall Study|Withdrawal by PI|1|||
149853789|NCT00609154|540593723|FG000|Overall Study|Protocol Violation|1|||
149853790|NCT00609154|540593724|FG001|Overall Study|Protocol Violation|2|||
149853791|NCT00609154|540593723|FG000|Overall Study|Unable to establish IV access|0|||
149853792|NCT00609154|540593724|FG001|Overall Study|Unable to establish IV access|4|||
149853793|NCT00609154|540593723|FG000|Overall Study|Adverse Event|0|||
149853794|NCT00609154|540593724|FG001|Overall Study|Adverse Event|2|||
149853795|NCT04531527|540593725|FG000|Overall Study|Found to be Ineligible|3|||
149853796|NCT00434837|540593732|FG000|Overall Study|Lost to Follow-up|20|||
149853797|NCT00434837|540593733|FG001|Overall Study|Lost to Follow-up|23|||
149853798|NCT00434837|540593734|FG002|Overall Study|Lost to Follow-up|30|||
149853799|NCT01077258|540593735|FG000|Overall Study|Lost to Follow-up|1390|||
149853800|NCT01077258|540593735|FG000|Overall Study|Adverse drug reaction|218|||
149853801|NCT01077258|540593735|FG000|Overall Study|Lack of Efficacy|663|||
149853802|NCT01077258|540593735|FG000|Overall Study|Clinical remission|37|||
149853803|NCT01077258|540593735|FG000|Overall Study|Other reasons|260|||
149853804|NCT01517867|540593752|FG000|Overall Study|never started treatment|29|||
149853805|NCT01517867|540593753|FG001|Overall Study|never started treatment|32|||
149853806|NCT01517867|540593752|FG000|Overall Study|Withdrawal by Subject|34|||
149853807|NCT01517867|540593753|FG001|Overall Study|Withdrawal by Subject|30|||
149853808|NCT01517867|540593752|FG000|Overall Study|Still in treatment at study end|0|||
149853809|NCT01517867|540593753|FG001|Overall Study|Still in treatment at study end|3|||
149853810|NCT01266603|540593754|FG000|Overall Study|Adverse Event|1|||
149853811|NCT01266603|540593754|FG000|Overall Study|Lack of Efficacy|14|||
149853812|NCT01266603|540593754|FG000|Overall Study|Withdrawal by Subject|1|||
149853813|NCT01266603|540593754|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
149853814|NCT01685216|540593755|FG000|Overall Study|Did not receive study drug|1|||
149853815|NCT00756717|540593758|FG000|Overall Study|Withdrawal by Subject|2|||
149853816|NCT02654015|540593759|FG000|Overall Study|Death|12|||
149853817|NCT02654015|540593759|FG000|Overall Study|Lost to Follow-up|3|||
149853818|NCT02418754|540593760|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
149853819|NCT02418754|540593761|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
149853820|NCT02418754|540593762|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
149853821|NCT02418754|540593763|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
149853822|NCT02418754|540593764|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
149853823|NCT02418754|540593760|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
149853824|NCT02418754|540593761|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
149853825|NCT02418754|540593762|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
149853826|NCT02418754|540593763|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
149853827|NCT02418754|540593764|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
149853828|NCT02418754|540593760|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
149853829|NCT02418754|540593761|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
149853830|NCT02418754|540593762|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
149959594|NCT00621322|540985911|FG000|Overall Study|Physician Decision|0|||
149959595|NCT00621322|540985912|FG001|Overall Study|Physician Decision|0|||
149959596|NCT00621322|540985913|FG002|Overall Study|Physician Decision|1|||
149959597|NCT00621322|540985914|FG003|Overall Study|Physician Decision|1|||
149853831|NCT02418754|540593763|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
149853832|NCT02418754|540593764|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
149853833|NCT02418754|540593760|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
149853834|NCT02418754|540593761|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
149853835|NCT02418754|540593762|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
149853836|NCT02418754|540593763|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
149853837|NCT02418754|540593764|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
149853838|NCT02418754|540593760|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
149959598|NCT00621322|540985915|FG004|Overall Study|Physician Decision|0|||
149959599|NCT00621322|540985916|FG005|Overall Study|Physician Decision|0|||
149853839|NCT02418754|540593761|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
149853840|NCT02418754|540593762|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
149853841|NCT02418754|540593763|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
149853842|NCT02418754|540593764|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
149959600|NCT00621322|540985911|FG000|Overall Study|Withdrawal by Subject|0|||
149853843|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
149853844|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
149853845|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
150039506|NCT00068692|541285110|FG007|Step 1: Registration|Not eligible|0|||
150039507|NCT00068692|541285103|FG000|Step 1: Registration|Other|2|||
149853846|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
149853847|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
149853848|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
149853849|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
149853850|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
149853851|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
149853852|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
149853853|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
149853854|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
149853855|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
149853856|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
149853857|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
149853858|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
149853859|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
149853860|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
149853861|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
149853862|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
149853863|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
149853864|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
149853865|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
149853866|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
150039508|NCT00068692|541285104|FG001|Step 1: Registration|Other|0|||
150039509|NCT00068692|541285105|FG002|Step 1: Registration|Other|0|||
149853867|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
149853868|NCT02418754|540593760|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
149853869|NCT02418754|540593761|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
149853870|NCT02418754|540593762|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
149853871|NCT02418754|540593763|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
149853872|NCT02418754|540593764|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
149853873|NCT01896505|540593765|FG000|Overall Study|Adverse Event|1|||
149853874|NCT01896505|540593766|FG001|Overall Study|Adverse Event|0|||
149853875|NCT01896505|540593767|FG002|Overall Study|Adverse Event|2|||
149853876|NCT01896505|540593768|FG003|Overall Study|Adverse Event|1|||
149853877|NCT01896505|540593769|FG004|Overall Study|Adverse Event|1|||
150039510|NCT00068692|541285106|FG003|Step 1: Registration|Other|0|||
150039511|NCT00068692|541285107|FG004|Step 1: Registration|Other|0|||
149853878|NCT01896505|540593770|FG005|Overall Study|Adverse Event|0|||
149853879|NCT01896505|540593765|FG000|Overall Study|Physician Decision|1|||
149853880|NCT01896505|540593766|FG001|Overall Study|Physician Decision|3|||
149853881|NCT01896505|540593767|FG002|Overall Study|Physician Decision|2|||
149853882|NCT01896505|540593768|FG003|Overall Study|Physician Decision|0|||
149853883|NCT01896505|540593769|FG004|Overall Study|Physician Decision|0|||
149853884|NCT01896505|540593770|FG005|Overall Study|Physician Decision|1|||
149853885|NCT01896505|540593765|FG000|Overall Study|Withdrawal by Subject|1|||
149853886|NCT01896505|540593766|FG001|Overall Study|Withdrawal by Subject|0|||
149853887|NCT01896505|540593767|FG002|Overall Study|Withdrawal by Subject|3|||
149853888|NCT01896505|540593768|FG003|Overall Study|Withdrawal by Subject|1|||
149853889|NCT01896505|540593769|FG004|Overall Study|Withdrawal by Subject|0|||
149853890|NCT01896505|540593770|FG005|Overall Study|Withdrawal by Subject|0|||
149853891|NCT01896505|540593765|FG000|Overall Study|Disease Progression|7|||
149853892|NCT01896505|540593766|FG001|Overall Study|Disease Progression|5|||
149853893|NCT01896505|540593767|FG002|Overall Study|Disease Progression|8|||
150039512|NCT00068692|541285108|FG005|Step 1: Registration|Other|0|||
150039513|NCT00068692|541285109|FG006|Step 1: Registration|Other|0|||
150039514|NCT00068692|541285110|FG007|Step 1: Registration|Other|0|||
150039515|NCT00068692|541285103|FG000|Step 1: Registration|Not start protocol therapy|3|||
150288888|NCT02600507|542192527|FG001|Overall Study|Adverse Event|15|||
150288889|NCT02600507|542192528|FG002|Overall Study|Adverse Event|5|||
149853894|NCT01896505|540593768|FG003|Overall Study|Disease Progression|4|||
149853895|NCT01896505|540593769|FG004|Overall Study|Disease Progression|4|||
149853896|NCT01896505|540593770|FG005|Overall Study|Disease Progression|4|||
149853897|NCT01896505|540593765|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
149853898|NCT01896505|540593766|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
150039516|NCT00068692|541285104|FG001|Step 1: Registration|Not start protocol therapy|0|||
150039517|NCT00068692|541285105|FG002|Step 1: Registration|Not start protocol therapy|0|||
150288890|NCT02600507|542192526|FG000|Overall Study|Lack of Efficacy|3|||
149853899|NCT01896505|540593767|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
149853900|NCT01896505|540593768|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
149853901|NCT01896505|540593769|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
149853902|NCT01896505|540593770|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
149853903|NCT01896505|540593765|FG000|Overall Study|Intercurrent illness|0|||
149853904|NCT01896505|540593766|FG001|Overall Study|Intercurrent illness|1|||
149853905|NCT01896505|540593767|FG002|Overall Study|Intercurrent illness|0|||
149853906|NCT01896505|540593768|FG003|Overall Study|Intercurrent illness|0|||
149853907|NCT01896505|540593769|FG004|Overall Study|Intercurrent illness|0|||
149853908|NCT01896505|540593770|FG005|Overall Study|Intercurrent illness|0|||
149853909|NCT01896505|540593765|FG000|Overall Study|Death|0|||
149853910|NCT01896505|540593766|FG001|Overall Study|Death|0|||
149853911|NCT01896505|540593767|FG002|Overall Study|Death|1|||
149853912|NCT01896505|540593768|FG003|Overall Study|Death|1|||
150039518|NCT00068692|541285106|FG003|Step 1: Registration|Not start protocol therapy|0|||
150039519|NCT00068692|541285107|FG004|Step 1: Registration|Not start protocol therapy|0|||
150039520|NCT00068692|541285108|FG005|Step 1: Registration|Not start protocol therapy|0|||
150039521|NCT00068692|541285109|FG006|Step 1: Registration|Not start protocol therapy|0|||
150039522|NCT00068692|541285110|FG007|Step 1: Registration|Not start protocol therapy|0|||
150039523|NCT00068692|541285103|FG000|Step 1: Registration|Registered but not randomized|0|||
150039524|NCT00068692|541285104|FG001|Step 1: Registration|Registered but not randomized|1|||
150039525|NCT00068692|541285105|FG002|Step 1: Registration|Registered but not randomized|0|||
150039526|NCT00068692|541285106|FG003|Step 1: Registration|Registered but not randomized|0|||
150039527|NCT00068692|541285107|FG004|Step 1: Registration|Registered but not randomized|0|||
150039528|NCT00068692|541285108|FG005|Step 1: Registration|Registered but not randomized|0|||
150039529|NCT00068692|541285109|FG006|Step 1: Registration|Registered but not randomized|0|||
150039530|NCT00068692|541285110|FG007|Step 1: Registration|Registered but not randomized|0|||
150039531|NCT00068692|541285103|FG000|Step 2: Randomization|Disesae progression/replase|0|||
150039532|NCT00068692|541285104|FG001|Step 2: Randomization|Disesae progression/replase|0|||
150039533|NCT00068692|541285105|FG002|Step 2: Randomization|Disesae progression/replase|1|||
150039534|NCT00068692|541285106|FG003|Step 2: Randomization|Disesae progression/replase|1|||
150039535|NCT00068692|541285107|FG004|Step 2: Randomization|Disesae progression/replase|0|||
150039536|NCT00068692|541285108|FG005|Step 2: Randomization|Disesae progression/replase|0|||
150039537|NCT00068692|541285109|FG006|Step 2: Randomization|Disesae progression/replase|0|||
150039538|NCT00068692|541285110|FG007|Step 2: Randomization|Disesae progression/replase|0|||
150039539|NCT00068692|541285103|FG000|Step 2: Randomization|Adverse Event|0|||
150039540|NCT00068692|541285104|FG001|Step 2: Randomization|Adverse Event|0|||
150039541|NCT00068692|541285105|FG002|Step 2: Randomization|Adverse Event|4|||
150288891|NCT02600507|542192527|FG001|Overall Study|Lack of Efficacy|8|||
150039542|NCT00068692|541285106|FG003|Step 2: Randomization|Adverse Event|2|||
150288892|NCT02600507|542192528|FG002|Overall Study|Lack of Efficacy|5|||
150288893|NCT02600507|542192526|FG000|Overall Study|Lost to Follow-up|3|||
150288894|NCT02600507|542192527|FG001|Overall Study|Lost to Follow-up|5|||
150288895|NCT02600507|542192528|FG002|Overall Study|Lost to Follow-up|2|||
150288896|NCT02600507|542192526|FG000|Overall Study|Protocol Violation|12|||
150288897|NCT02600507|542192527|FG001|Overall Study|Protocol Violation|4|||
150288898|NCT02600507|542192528|FG002|Overall Study|Protocol Violation|4|||
150288899|NCT02600507|542192526|FG000|Overall Study|Physician Decision|1|||
150288900|NCT02600507|542192527|FG001|Overall Study|Physician Decision|0|||
150288901|NCT02600507|542192528|FG002|Overall Study|Physician Decision|1|||
150288902|NCT02600507|542192526|FG000|Overall Study|Withdrawal by Subject|7|||
149853913|NCT01896505|540593769|FG004|Overall Study|Death|0|||
149853914|NCT01896505|540593770|FG005|Overall Study|Death|1|||
150039543|NCT00068692|541285107|FG004|Step 2: Randomization|Adverse Event|2|||
150039544|NCT00068692|541285108|FG005|Step 2: Randomization|Adverse Event|3|||
150039545|NCT00068692|541285109|FG006|Step 2: Randomization|Adverse Event|4|||
150039546|NCT00068692|541285110|FG007|Step 2: Randomization|Adverse Event|4|||
150039547|NCT00068692|541285103|FG000|Step 2: Randomization|Death|0|||
150039548|NCT00068692|541285104|FG001|Step 2: Randomization|Death|0|||
150039549|NCT00068692|541285105|FG002|Step 2: Randomization|Death|0|||
150039550|NCT00068692|541285106|FG003|Step 2: Randomization|Death|0|||
150039551|NCT00068692|541285107|FG004|Step 2: Randomization|Death|1|||
150039552|NCT00068692|541285108|FG005|Step 2: Randomization|Death|0|||
150039553|NCT00068692|541285109|FG006|Step 2: Randomization|Death|0|||
149853915|NCT04291508|540593771|FG000|Overall Study|Withdrawal by Subject|1|||
149853916|NCT04291508|540593772|FG001|Overall Study|Withdrawal by Subject|0|||
150039554|NCT00068692|541285110|FG007|Step 2: Randomization|Death|1|||
150039555|NCT00068692|541285103|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
150039556|NCT00068692|541285104|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
150288903|NCT02600507|542192527|FG001|Overall Study|Withdrawal by Subject|11|||
150288904|NCT02600507|542192528|FG002|Overall Study|Withdrawal by Subject|7|||
150288905|NCT02600507|542192526|FG000|Overall Study|Other|0|||
150288906|NCT02600507|542192527|FG001|Overall Study|Other|1|||
150288907|NCT02600507|542192528|FG002|Overall Study|Other|1|||
149853917|NCT04291508|540593773|FG002|Overall Study|Withdrawal by Subject|1|||
149853918|NCT04291508|540593774|FG003|Overall Study|Withdrawal by Subject|0|||
149853919|NCT04291508|540593771|FG000|Overall Study|lost to follow up|4|||
149853920|NCT04291508|540593772|FG001|Overall Study|lost to follow up|0|||
149853921|NCT04291508|540593773|FG002|Overall Study|lost to follow up|1|||
149853922|NCT04291508|540593774|FG003|Overall Study|lost to follow up|0|||
149853923|NCT01992094|540593776|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
149853924|NCT01992094|540593777|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
149853925|NCT01992094|540593778|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
149853926|NCT01992094|540593776|FG000|Overall Study|Adverse Event|1|||
149853927|NCT01992094|540593777|FG001|Overall Study|Adverse Event|0|||
149853928|NCT01992094|540593778|FG002|Overall Study|Adverse Event|0|||
149853929|NCT01992094|540593776|FG000|Overall Study|Death|5|||
149853930|NCT01992094|540593777|FG001|Overall Study|Death|5|||
149853931|NCT01992094|540593778|FG002|Overall Study|Death|2|||
149853932|NCT01992094|540593776|FG000|Overall Study|Lost to Follow-up|26|||
149853933|NCT01992094|540593777|FG001|Overall Study|Lost to Follow-up|9|||
149853934|NCT01992094|540593778|FG002|Overall Study|Lost to Follow-up|13|||
149853935|NCT01992094|540593776|FG000|Overall Study|OTHER|4|||
149853936|NCT01992094|540593777|FG001|Overall Study|OTHER|0|||
149853937|NCT01992094|540593778|FG002|Overall Study|OTHER|0|||
149853938|NCT01992094|540593776|FG000|Overall Study|Protocol Violation|1|||
149853939|NCT01992094|540593777|FG001|Overall Study|Protocol Violation|0|||
149853940|NCT01992094|540593778|FG002|Overall Study|Protocol Violation|1|||
149853941|NCT01992094|540593776|FG000|Overall Study|Withdrawal by Subject|7|||
149853942|NCT01992094|540593777|FG001|Overall Study|Withdrawal by Subject|3|||
149853943|NCT01992094|540593778|FG002|Overall Study|Withdrawal by Subject|4|||
149853944|NCT03168906|540593779|FG000|Overall Study|Lack of Efficacy|6|||
149853945|NCT03168906|540593780|FG001|Overall Study|Lack of Efficacy|6|||
149853946|NCT00559637|540595142|FG000|Overall Study|Adverse Event|22|||
149853947|NCT00559637|540595142|FG000|Overall Study|Withdrawal by Subject|4|||
149853948|NCT00559637|540595142|FG000|Overall Study|Protocol Violation|6|||
149853949|NCT00559637|540595142|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
149853950|NCT00559637|540595142|FG000|Overall Study|Failure to return|6|||
149853951|NCT00559637|540595142|FG000|Overall Study|Insufficient response|3|||
149853952|NCT00559637|540595142|FG000|Overall Study|Started requiring dialysis after month 7|2|||
149853953|NCT00559637|540595142|FG000|Overall Study|Suspected lung cancer|1|||
149853954|NCT00559637|540595142|FG000|Overall Study|Participation in another study|1|||
149853955|NCT00559637|540595142|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
149853956|NCT00559637|540595142|FG000|Overall Study|Change of center|1|||
149853957|NCT00559637|540595142|FG000|Overall Study|Change of home|1|||
149853958|NCT00559637|540595142|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
149853959|NCT04129944|540595145|FG000|Overall Study|Death|0|||
149853960|NCT04129944|540595146|FG001|Overall Study|Death|0|||
149853961|NCT04129944|540595147|FG002|Overall Study|Death|0|||
149853962|NCT04129944|540595148|FG003|Overall Study|Death|1|||
149853963|NCT04129944|540595145|FG000|Overall Study|Lost to Follow-up|1|||
150039557|NCT00068692|541285105|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
150039558|NCT00068692|541285106|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
150039559|NCT00068692|541285107|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
150039560|NCT00068692|541285108|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
150039561|NCT00068692|541285109|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
150039562|NCT00068692|541285110|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
150039563|NCT00068692|541285103|FG000|Step 2: Randomization|alternative therapy|0|||
150039564|NCT00068692|541285104|FG001|Step 2: Randomization|alternative therapy|0|||
150039565|NCT00068692|541285105|FG002|Step 2: Randomization|alternative therapy|0|||
150039566|NCT00068692|541285106|FG003|Step 2: Randomization|alternative therapy|1|||
150039567|NCT00068692|541285107|FG004|Step 2: Randomization|alternative therapy|1|||
150039568|NCT00068692|541285108|FG005|Step 2: Randomization|alternative therapy|0|||
150039569|NCT00068692|541285109|FG006|Step 2: Randomization|alternative therapy|0|||
150039570|NCT00068692|541285110|FG007|Step 2: Randomization|alternative therapy|0|||
150039571|NCT00068692|541285103|FG000|Step 2: Randomization|Physician Decision|0|||
150039572|NCT00068692|541285104|FG001|Step 2: Randomization|Physician Decision|0|||
150039573|NCT00068692|541285105|FG002|Step 2: Randomization|Physician Decision|0|||
150172808|NCT02754479|541768106|FG000|Overall Study|Lost to Follow-up|1|||
149853964|NCT04129944|540595146|FG001|Overall Study|Lost to Follow-up|0|||
149853965|NCT04129944|540595147|FG002|Overall Study|Lost to Follow-up|0|||
149853966|NCT04129944|540595148|FG003|Overall Study|Lost to Follow-up|0|||
149853967|NCT04129944|540595145|FG000|Overall Study|Withdrawal by Subject|1|||
149853968|NCT04129944|540595146|FG001|Overall Study|Withdrawal by Subject|0|||
149853969|NCT04129944|540595147|FG002|Overall Study|Withdrawal by Subject|1|||
149853970|NCT04129944|540595148|FG003|Overall Study|Withdrawal by Subject|2|||
149853971|NCT04501094|540595149|FG000|Overall Study|Death (unrelated to research)|1|||
149853972|NCT04501094|540595150|FG001|Overall Study|Death (unrelated to research)|0|||
149853973|NCT00835796|540595154|FG000|First Intervention|Withdrawal by Subject|0|||
149853974|NCT00835796|540595155|FG001|First Intervention|Withdrawal by Subject|1|||
149853975|NCT00651183|540595156|FG000|Overall Study|Lack of Efficacy|1|||
149853976|NCT00651183|540595157|FG001|Overall Study|Lack of Efficacy|0|||
149853977|NCT00651183|540595156|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
149853978|NCT00651183|540595157|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
149853979|NCT00651183|540595156|FG000|Overall Study|Tolerability insufficient|5|||
149853980|NCT00651183|540595157|FG001|Overall Study|Tolerability insufficient|2|||
149853981|NCT00651183|540595156|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
149853982|NCT00651183|540595157|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
149853983|NCT00651183|540595156|FG000|Overall Study|Withdrawal by Subject|6|||
149853984|NCT00651183|540595157|FG001|Overall Study|Withdrawal by Subject|3|||
149853985|NCT00651183|540595156|FG000|Overall Study|Lost to Follow-up|3|||
149853986|NCT00651183|540595157|FG001|Overall Study|Lost to Follow-up|1|||
149853987|NCT00651183|540595156|FG000|Overall Study|Other reasons|4|||
149853988|NCT00651183|540595157|FG001|Overall Study|Other reasons|2|||
149853989|NCT00651183|540595156|FG000|Overall Study|missing|1|||
149853990|NCT00651183|540595157|FG001|Overall Study|missing|0|||
149853991|NCT02014441|540595160|FG000|Overall Study|Withdrawal by Subject|12|||
149853992|NCT02576717|540595161|FG000|Overall Study|Other Reasons|16|||
149853993|NCT02576717|540595162|FG001|Overall Study|Other Reasons|18|||
149853994|NCT02576717|540595163|FG002|Overall Study|Other Reasons|15|||
149853995|NCT02576717|540595161|FG000|Overall Study|Covid-19 Pandemic|0|||
149853996|NCT02576717|540595162|FG001|Overall Study|Covid-19 Pandemic|1|||
150039574|NCT00068692|541285106|FG003|Step 2: Randomization|Physician Decision|1|||
149853997|NCT02576717|540595163|FG002|Overall Study|Covid-19 Pandemic|1|||
149853998|NCT02576717|540595161|FG000|Overall Study|Sponsor Decision|0|||
149853999|NCT02576717|540595162|FG001|Overall Study|Sponsor Decision|0|||
149854000|NCT02576717|540595163|FG002|Overall Study|Sponsor Decision|1|||
149854001|NCT02576717|540595161|FG000|Overall Study|Physician Decision|3|||
149854002|NCT02576717|540595162|FG001|Overall Study|Physician Decision|8|||
149854003|NCT02576717|540595163|FG002|Overall Study|Physician Decision|9|||
149854004|NCT02576717|540595161|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
149854005|NCT02576717|540595162|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
149854006|NCT02576717|540595163|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
149854007|NCT02576717|540595161|FG000|Overall Study|Death|3|||
149854008|NCT02576717|540595162|FG001|Overall Study|Death|5|||
149854009|NCT02576717|540595163|FG002|Overall Study|Death|3|||
149854010|NCT02576717|540595161|FG000|Overall Study|Lost to Follow-up|9|||
149854011|NCT02576717|540595162|FG001|Overall Study|Lost to Follow-up|10|||
149854012|NCT02576717|540595163|FG002|Overall Study|Lost to Follow-up|19|||
149854013|NCT02576717|540595161|FG000|Overall Study|Protocol Violation|4|||
149854014|NCT02576717|540595162|FG001|Overall Study|Protocol Violation|0|||
149854015|NCT02576717|540595163|FG002|Overall Study|Protocol Violation|5|||
149854016|NCT02576717|540595161|FG000|Overall Study|Lack of Efficacy|24|||
149854017|NCT02576717|540595162|FG001|Overall Study|Lack of Efficacy|28|||
149854018|NCT02576717|540595163|FG002|Overall Study|Lack of Efficacy|20|||
149854019|NCT02576717|540595161|FG000|Overall Study|Adverse Event|26|||
149854020|NCT02576717|540595162|FG001|Overall Study|Adverse Event|32|||
149854021|NCT02576717|540595163|FG002|Overall Study|Adverse Event|26|||
149854022|NCT00399893|540595164|FG000|Overall Study|Withdrawal by Subject|1|||
149854023|NCT00399893|540595165|FG001|Overall Study|Withdrawal by Subject|0|||
149854024|NCT01363011|540595166|FG000|Main Study|Adverse Event|2|||
149854025|NCT01363011|540595167|FG001|Main Study|Adverse Event|3|||
149854026|NCT01363011|540595166|FG000|Main Study|Investigator's Discretion|1|||
149854027|NCT01363011|540595167|FG001|Main Study|Investigator's Discretion|1|||
149854028|NCT01363011|540595166|FG000|Main Study|Withdrew Consent|1|||
149854029|NCT01363011|540595167|FG001|Main Study|Withdrew Consent|4|||
149854030|NCT01363011|540595166|FG000|Main Study|Protocol Violation|0|||
149854031|NCT01363011|540595167|FG001|Main Study|Protocol Violation|1|||
149854032|NCT01363011|540595166|FG000|Extension Phase|Adverse Event|1|||
149854033|NCT01363011|540595167|FG001|Extension Phase|Adverse Event|1|||
149854034|NCT01363011|540595166|FG000|Extension Phase|Lack of Efficacy|0|||
150039575|NCT00068692|541285107|FG004|Step 2: Randomization|Physician Decision|1|||
150039576|NCT00068692|541285108|FG005|Step 2: Randomization|Physician Decision|0|||
150039577|NCT00068692|541285109|FG006|Step 2: Randomization|Physician Decision|0|||
150039578|NCT00068692|541285110|FG007|Step 2: Randomization|Physician Decision|0|||
149854035|NCT01363011|540595167|FG001|Extension Phase|Lack of Efficacy|1|||
149854036|NCT01363011|540595166|FG000|Extension Phase|Investigator's Discretion|2|||
149854037|NCT01363011|540595167|FG001|Extension Phase|Investigator's Discretion|2|||
149854038|NCT01363011|540595166|FG000|Extension Phase|Withdrew Consent|0|||
149854039|NCT01363011|540595167|FG001|Extension Phase|Withdrew Consent|1|||
149854040|NCT01363011|540595166|FG000|Extension Phase|Lost to Follow-up|0|||
149854041|NCT01363011|540595167|FG001|Extension Phase|Lost to Follow-up|2|||
149854042|NCT01363011|540595166|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
149854043|NCT01363011|540595167|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
149854044|NCT01901848|540595172|FG000|Randomized and Treated|Lost to Follow-up|3|||
149854045|NCT01901848|540595173|FG001|Randomized and Treated|Lost to Follow-up|6|||
149854046|NCT01901848|540595172|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
149854047|NCT01901848|540595173|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
149854048|NCT01729026|540595174|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
150039579|NCT00068692|541285103|FG000|Step 2: Randomization|Other|0|||
150039580|NCT00068692|541285104|FG001|Step 2: Randomization|Other|0|||
150039581|NCT00068692|541285105|FG002|Step 2: Randomization|Other|0|||
150039582|NCT00068692|541285106|FG003|Step 2: Randomization|Other|1|||
150039583|NCT00068692|541285107|FG004|Step 2: Randomization|Other|0|||
150039584|NCT00068692|541285108|FG005|Step 2: Randomization|Other|1|||
150039585|NCT00068692|541285109|FG006|Step 2: Randomization|Other|0|||
149854049|NCT01729026|540595175|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
149854050|NCT01729026|540595174|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
149854051|NCT01729026|540595175|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
149854052|NCT00407745|540595177|FG000|Overall Study|Lack of Efficacy|1|||
149854053|NCT00407745|540595178|FG001|Overall Study|Lack of Efficacy|2|||
149854054|NCT00407745|540595177|FG000|Overall Study|Withdrawal by Subject|3|||
149854055|NCT00407745|540595178|FG001|Overall Study|Withdrawal by Subject|3|||
149854056|NCT00407745|540595177|FG000|Overall Study|Protocol Violation|5|||
149854057|NCT00407745|540595178|FG001|Overall Study|Protocol Violation|3|||
149854058|NCT00407745|540595177|FG000|Overall Study|Adverse Event|8|||
149854059|NCT00407745|540595178|FG001|Overall Study|Adverse Event|8|||
149854060|NCT00407745|540595177|FG000|Overall Study|Other|2|||
149854061|NCT00407745|540595178|FG001|Overall Study|Other|0|||
149854062|NCT00407745|540595177|FG000|Overall Study|Randomized, unknown if treated|0|||
149854063|NCT00407745|540595178|FG001|Overall Study|Randomized, unknown if treated|1|||
149854064|NCT00108082|540595179|FG000|Overall Study|Adverse Event|14|||
149854065|NCT00108082|540595180|FG001|Overall Study|Adverse Event|12|||
149854066|NCT00108082|540595181|FG002|Overall Study|Adverse Event|17|||
149854067|NCT00108082|540595179|FG000|Overall Study|Lost to Follow-up|6|||
149854068|NCT00108082|540595180|FG001|Overall Study|Lost to Follow-up|3|||
149854069|NCT00108082|540595181|FG002|Overall Study|Lost to Follow-up|7|||
149854070|NCT00108082|540595179|FG000|Overall Study|Consent Withdrawn|3|||
149854071|NCT00108082|540595180|FG001|Overall Study|Consent Withdrawn|3|||
149854072|NCT00108082|540595181|FG002|Overall Study|Consent Withdrawn|5|||
149854073|NCT00108082|540595179|FG000|Overall Study|Protocol Violation|1|||
149854074|NCT00108082|540595180|FG001|Overall Study|Protocol Violation|2|||
149854075|NCT00108082|540595181|FG002|Overall Study|Protocol Violation|0|||
149854076|NCT00108082|540595179|FG000|Overall Study|Lack of Efficacy|3|||
149854077|NCT00108082|540595180|FG001|Overall Study|Lack of Efficacy|1|||
149854078|NCT00108082|540595181|FG002|Overall Study|Lack of Efficacy|2|||
149854079|NCT00108082|540595179|FG000|Overall Study|Amendment 4: > Month 12|5|||
150039586|NCT00068692|541285110|FG007|Step 2: Randomization|Other|0|||
150039587|NCT00068692|541285103|FG000|Step 2: Randomization|never start protocol therapy|0|||
150039588|NCT00068692|541285104|FG001|Step 2: Randomization|never start protocol therapy|0|||
150039589|NCT00068692|541285105|FG002|Step 2: Randomization|never start protocol therapy|1|||
150039590|NCT00068692|541285106|FG003|Step 2: Randomization|never start protocol therapy|0|||
150039591|NCT00068692|541285107|FG004|Step 2: Randomization|never start protocol therapy|1|||
150039592|NCT00068692|541285108|FG005|Step 2: Randomization|never start protocol therapy|0|||
150039593|NCT00068692|541285109|FG006|Step 2: Randomization|never start protocol therapy|0|||
150039594|NCT00068692|541285110|FG007|Step 2: Randomization|never start protocol therapy|0|||
150039595|NCT03557034|541285115|FG000|Overall Study|Withdrawal by Subject|1|||
150039596|NCT03557034|541285116|FG001|Overall Study|Withdrawal by Subject|0|||
150039597|NCT01759446|541285119|FG000|Overall Study|Protocol Violation|1|||
150039598|NCT01759446|541285120|FG001|Overall Study|Protocol Violation|0|||
150039599|NCT01759446|541285121|FG002|Overall Study|Protocol Violation|1|||
150039600|NCT01759446|541285122|FG003|Overall Study|Protocol Violation|0|||
150039601|NCT01759446|541285123|FG004|Overall Study|Protocol Violation|0|||
150039602|NCT01759446|541285119|FG000|Overall Study|Withdrawal by Subject|0|||
150039603|NCT01759446|541285120|FG001|Overall Study|Withdrawal by Subject|1|||
150039604|NCT01759446|541285121|FG002|Overall Study|Withdrawal by Subject|0|||
150039605|NCT01759446|541285122|FG003|Overall Study|Withdrawal by Subject|1|||
150039606|NCT01759446|541285123|FG004|Overall Study|Withdrawal by Subject|0|||
150039607|NCT00815659|541285124|FG000|Overall Study|Adverse Event|9|||
150039608|NCT00815659|541285124|FG000|Overall Study|Withdrawal by Subject|9|||
150172809|NCT02106442|541768107|FG000|Overall Study|Case Report Forms Uncollected|7|||
149854080|NCT00108082|540595180|FG001|Overall Study|Amendment 4: > Month 12|7|||
149854081|NCT00108082|540595181|FG002|Overall Study|Amendment 4: > Month 12|5|||
149854082|NCT00108082|540595179|FG000|Overall Study|Woman of Child-bearing Potential|2|||
149854083|NCT00108082|540595180|FG001|Overall Study|Woman of Child-bearing Potential|0|||
149854084|NCT00108082|540595181|FG002|Overall Study|Woman of Child-bearing Potential|2|||
149854085|NCT00108082|540595179|FG000|Overall Study|Incorrectly Randomized|0|||
149854086|NCT00108082|540595180|FG001|Overall Study|Incorrectly Randomized|0|||
149854087|NCT00108082|540595181|FG002|Overall Study|Incorrectly Randomized|2|||
149854088|NCT00108082|540595179|FG000|Overall Study|Non-compliance|1|||
150039609|NCT00815659|541285124|FG000|Overall Study|Lost to Follow-up|4|||
150039610|NCT00815659|541285124|FG000|Overall Study|Protocol Violation|1|||
150039611|NCT03847896|541285125|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
150039612|NCT03847896|541285126|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
150172810|NCT02106442|541768107|FG000|Overall Study|Protocol Deviation|30|||
150172811|NCT03284957|541769774|FG000|Overall Study|Adverse Event|0|||
149854089|NCT00108082|540595180|FG001|Overall Study|Non-compliance|0|||
149854090|NCT00108082|540595181|FG002|Overall Study|Non-compliance|2|||
149854091|NCT00108082|540595179|FG000|Overall Study|Stopped Study Medication|0|||
149854092|NCT00108082|540595180|FG001|Overall Study|Stopped Study Medication|0|||
149854093|NCT00108082|540595181|FG002|Overall Study|Stopped Study Medication|1|||
149854094|NCT00108082|540595179|FG000|Overall Study|Site Closed Study|0|||
149854095|NCT00108082|540595180|FG001|Overall Study|Site Closed Study|2|||
149854096|NCT00108082|540595181|FG002|Overall Study|Site Closed Study|0|||
149854097|NCT00108082|540595179|FG000|Overall Study|Protocol Amendment|0|||
149854098|NCT00108082|540595180|FG001|Overall Study|Protocol Amendment|1|||
149854099|NCT00108082|540595181|FG002|Overall Study|Protocol Amendment|0|||
149854100|NCT00108082|540595179|FG000|Overall Study|Study Medication Not Tapered|0|||
149854101|NCT00108082|540595180|FG001|Overall Study|Study Medication Not Tapered|1|||
149854102|NCT00108082|540595181|FG002|Overall Study|Study Medication Not Tapered|0|||
149854103|NCT00108082|540595179|FG000|Overall Study|Subject Left Site Location|1|||
149854104|NCT00108082|540595180|FG001|Overall Study|Subject Left Site Location|0|||
149854105|NCT00108082|540595181|FG002|Overall Study|Subject Left Site Location|0|||
149854106|NCT00108082|540595179|FG000|Overall Study|Investigator Not at Site|1|||
149854107|NCT00108082|540595180|FG001|Overall Study|Investigator Not at Site|0|||
149854108|NCT00108082|540595181|FG002|Overall Study|Investigator Not at Site|0|||
150172812|NCT03284957|541769775|FG001|Overall Study|Adverse Event|0|||
150172813|NCT03284957|541769776|FG002|Overall Study|Adverse Event|0|||
150172814|NCT03284957|541769777|FG003|Overall Study|Adverse Event|0|||
150172815|NCT03284957|541769778|FG004|Overall Study|Adverse Event|0|||
150172816|NCT03284957|541769779|FG005|Overall Study|Adverse Event|1|||
150172817|NCT03284957|541769780|FG006|Overall Study|Adverse Event|1|||
150172818|NCT03284957|541769781|FG007|Overall Study|Adverse Event|1|||
150172819|NCT03284957|541769782|FG008|Overall Study|Adverse Event|0|||
150172820|NCT03284957|541769783|FG009|Overall Study|Adverse Event|4|||
150172821|NCT03284957|541769784|FG010|Overall Study|Adverse Event|1|||
150172822|NCT03284957|541769785|FG011|Overall Study|Adverse Event|1|||
150172823|NCT03284957|541769786|FG012|Overall Study|Adverse Event|0|||
150172824|NCT03284957|541769787|FG013|Overall Study|Adverse Event|0|||
150172825|NCT03284957|541769788|FG014|Overall Study|Adverse Event|0|||
150172826|NCT03284957|541769789|FG015|Overall Study|Adverse Event|0|||
150172827|NCT03284957|541769774|FG000|Overall Study|Progressive Disease|3|||
150172828|NCT03284957|541769775|FG001|Overall Study|Progressive Disease|3|||
150172829|NCT03284957|541769776|FG002|Overall Study|Progressive Disease|4|||
149854109|NCT00108082|540595179|FG000|Overall Study|Blood Pressure Not Controlled|1|||
150172830|NCT03284957|541769777|FG003|Overall Study|Progressive Disease|3|||
150288908|NCT00605085|542192533|FG000|Overall Study|Withdrawal by Subject|8|||
150288909|NCT00605085|542192534|FG001|Overall Study|Withdrawal by Subject|5|||
150288910|NCT00605085|542192533|FG000|Overall Study|Adverse Event|9|||
150288911|NCT00605085|542192534|FG001|Overall Study|Adverse Event|5|||
150288912|NCT00605085|542192533|FG000|Overall Study|Pregnancy|2|||
150288913|NCT00605085|542192534|FG001|Overall Study|Pregnancy|0|||
150288914|NCT00605085|542192533|FG000|Overall Study|Protocol Violation|3|||
150288915|NCT00605085|542192534|FG001|Overall Study|Protocol Violation|2|||
150288916|NCT00605085|542192533|FG000|Overall Study|Lost to Follow-up|10|||
150288917|NCT00605085|542192534|FG001|Overall Study|Lost to Follow-up|5|||
150288918|NCT00605085|542192533|FG000|Overall Study|administrative reasons|18|||
150288919|NCT00605085|542192534|FG001|Overall Study|administrative reasons|8|||
150288920|NCT04872101|542192537|FG000|Overall Study|Withdrawal by Subject|10|||
150288921|NCT04872101|542192538|FG001|Overall Study|Withdrawal by Subject|16|||
150288922|NCT04872101|542192537|FG000|Overall Study|Lack of Efficacy|6|||
150288923|NCT04872101|542192538|FG001|Overall Study|Lack of Efficacy|14|||
150288924|NCT04872101|542192537|FG000|Overall Study|Adverse Event|1|||
150288925|NCT04872101|542192538|FG001|Overall Study|Adverse Event|6|||
150288926|NCT04872101|542192537|FG000|Overall Study|Lost to Follow-up|2|||
150288927|NCT04872101|542192538|FG001|Overall Study|Lost to Follow-up|1|||
150288928|NCT04872101|542192537|FG000|Overall Study|Pregnancy|2|||
150288929|NCT04872101|542192538|FG001|Overall Study|Pregnancy|0|||
150288930|NCT04872101|542192537|FG000|Overall Study|Prohibited Medication|1|||
149854110|NCT00108082|540595180|FG001|Overall Study|Blood Pressure Not Controlled|0|||
149854111|NCT00108082|540595181|FG002|Overall Study|Blood Pressure Not Controlled|0|||
150288931|NCT04872101|542192538|FG001|Overall Study|Prohibited Medication|0|||
150288932|NCT04872101|542192537|FG000|Overall Study|Not dosed|1|||
150288933|NCT04872101|542192538|FG001|Overall Study|Not dosed|0|||
150288934|NCT00264004|542192539|FG000|Overall Study|Adverse Event|2|||
149854112|NCT02940730|540595185|FG000|Intervention 2|Physician Decision|7|||
149854113|NCT02940730|540595186|FG001|Intervention 2|Physician Decision|0|||
149854114|NCT03449199|540595187|FG000|Overall Study|Lost to Follow-up|1|||
149854115|NCT03449199|540595188|FG001|Overall Study|Lost to Follow-up|1|||
150172831|NCT03284957|541769778|FG004|Overall Study|Progressive Disease|3|||
150172832|NCT03284957|541769779|FG005|Overall Study|Progressive Disease|5|||
150172833|NCT03284957|541769780|FG006|Overall Study|Progressive Disease|45|||
150288935|NCT00264004|542192540|FG001|Overall Study|Adverse Event|3|||
149854116|NCT03449199|540595189|FG002|Overall Study|Lost to Follow-up|0|||
149854117|NCT03449199|540595187|FG000|Overall Study|Protocol Deviation|0|||
149854118|NCT03449199|540595188|FG001|Overall Study|Protocol Deviation|0|||
149854119|NCT03449199|540595189|FG002|Overall Study|Protocol Deviation|1|||
149854120|NCT03449199|540595187|FG000|Overall Study|Withdrawal by Subject|0|||
149854121|NCT03449199|540595188|FG001|Overall Study|Withdrawal by Subject|0|||
149854122|NCT03449199|540595189|FG002|Overall Study|Withdrawal by Subject|1|||
149854123|NCT00906373|540595191|FG000|Overall Study|Withdrawal by Subject|0|||
149854124|NCT00906373|540595192|FG001|Overall Study|Withdrawal by Subject|5|||
149854125|NCT00906373|540595191|FG000|Overall Study|Other|0|||
149854126|NCT00906373|540595192|FG001|Overall Study|Other|1|||
149854127|NCT00906373|540595191|FG000|Overall Study|Still on treatment at cutoff date|0|||
149854128|NCT00906373|540595192|FG001|Overall Study|Still on treatment at cutoff date|2|||
149854129|NCT01597479|540595193|FG000|Overall Study|Protocol Violation|1|||
149854130|NCT01597479|540595194|FG001|Overall Study|Protocol Violation|0|||
149854131|NCT01597479|540595193|FG000|Overall Study|Lost to Follow-up|1|||
149854132|NCT01597479|540595194|FG001|Overall Study|Lost to Follow-up|0|||
149854133|NCT00348816|540595195|FG000|Overall Study|Noncompliance with radiation treatment|1|||
149959601|NCT00621322|540985912|FG001|Overall Study|Withdrawal by Subject|0|||
149959602|NCT00621322|540985913|FG002|Overall Study|Withdrawal by Subject|0|||
149959603|NCT00621322|540985914|FG003|Overall Study|Withdrawal by Subject|1|||
149959604|NCT00621322|540985915|FG004|Overall Study|Withdrawal by Subject|0|||
149959605|NCT00621322|540985916|FG005|Overall Study|Withdrawal by Subject|2|||
149959606|NCT00621322|540985911|FG000|Overall Study|Migrated/moved from study area|1|||
149959607|NCT00621322|540985912|FG001|Overall Study|Migrated/moved from study area|0|||
149959608|NCT00621322|540985913|FG002|Overall Study|Migrated/moved from study area|1|||
149959609|NCT00621322|540985914|FG003|Overall Study|Migrated/moved from study area|1|||
149959610|NCT00621322|540985915|FG004|Overall Study|Migrated/moved from study area|0|||
149959611|NCT00621322|540985916|FG005|Overall Study|Migrated/moved from study area|2|||
149959612|NCT04641975|540985917|FG000|Overall Study|Protocol Violation|1|||
149959613|NCT04641975|540985918|FG001|Overall Study|Protocol Violation|2|||
149959614|NCT04641975|540985919|FG002|Overall Study|Protocol Violation|0|||
149959615|NCT04641975|540985920|FG003|Overall Study|Protocol Violation|0|||
149959616|NCT04641975|540985917|FG000|Overall Study|Adverse Event|0|||
149959617|NCT04641975|540985918|FG001|Overall Study|Adverse Event|0|||
149959618|NCT04641975|540985919|FG002|Overall Study|Adverse Event|1|||
149959619|NCT04641975|540985920|FG003|Overall Study|Adverse Event|1|||
149959620|NCT04641975|540985917|FG000|Overall Study|Withdrawal by Subject|1|||
149959621|NCT04641975|540985918|FG001|Overall Study|Withdrawal by Subject|0|||
149959622|NCT04641975|540985919|FG002|Overall Study|Withdrawal by Subject|0|||
149959623|NCT04641975|540985920|FG003|Overall Study|Withdrawal by Subject|0|||
149959624|NCT01259024|540985923|FG000|Overall Study|Physician Decision|1|||
149959625|NCT01657500|540985924|FG000|Overall Study|set impropperly matched|3|||
149959626|NCT01657500|540985925|FG001|Overall Study|set impropperly matched|3|||
149959627|NCT01657500|540985924|FG000|Overall Study|Lost to Follow-up|2|||
149959628|NCT01657500|540985925|FG001|Overall Study|Lost to Follow-up|2|||
149959629|NCT00756444|540985926|FG000|Overall Study|Adverse Event|1|||
149959630|NCT00756444|540985927|FG001|Overall Study|Adverse Event|1|||
149959631|NCT00756444|540985926|FG000|Overall Study|Withdrawal by Subject|6|||
149959632|NCT00756444|540985927|FG001|Overall Study|Withdrawal by Subject|8|||
149854134|NCT00848042|540595196|FG000|Overall Study|Death|1|||
149854135|NCT00848042|540595197|FG001|Overall Study|Death|2|||
149854136|NCT00848042|540595198|FG002|Overall Study|Death|0|||
149854137|NCT00848042|540595196|FG000|Overall Study|Other Therapy|3|||
149854138|NCT00848042|540595197|FG001|Overall Study|Other Therapy|0|||
149854139|NCT00848042|540595198|FG002|Overall Study|Other Therapy|0|||
149854140|NCT02916693|540595200|FG000|Overall Study|Lost to Follow-up|7|||
149854141|NCT01190930|540595201|FG000|Induction|Adverse Event|17|||
149854142|NCT01190930|540595202|FG001|Induction|Adverse Event|0|||
149854143|NCT01190930|540595203|FG002|Induction|Adverse Event|0|||
149854144|NCT01190930|540595204|FG003|Induction|Adverse Event|0|||
149854145|NCT01190930|540595205|FG004|Induction|Adverse Event|0|||
149854146|NCT01190930|540595206|FG005|Induction|Adverse Event|0|||
149854147|NCT01190930|540595207|FG006|Induction|Adverse Event|0|||
149854148|NCT01190930|540595208|FG007|Induction|Adverse Event|0|||
149854149|NCT01190930|540595209|FG008|Induction|Adverse Event|0|||
149854150|NCT01190930|540595210|FG009|Induction|Adverse Event|0|||
149854151|NCT01190930|540595201|FG000|Induction|Death|34|||
149854152|NCT01190930|540595202|FG001|Induction|Death|0|||
149959633|NCT00756444|540985926|FG000|Overall Study|Lost to Follow-up|0|||
149959634|NCT00756444|540985927|FG001|Overall Study|Lost to Follow-up|1|||
149959635|NCT00756444|540985926|FG000|Overall Study|Death|5|||
149959636|NCT00756444|540985927|FG001|Overall Study|Death|4|||
149854153|NCT01190930|540595203|FG002|Induction|Death|0|||
149854154|NCT01190930|540595204|FG003|Induction|Death|0|||
149854155|NCT01190930|540595205|FG004|Induction|Death|0|||
149959637|NCT00756444|540985926|FG000|Overall Study|Disease Progression|2|||
149959638|NCT00756444|540985927|FG001|Overall Study|Disease Progression|7|||
149959639|NCT00756444|540985926|FG000|Overall Study|Ineligibility Determined|1|||
149959640|NCT00756444|540985927|FG001|Overall Study|Ineligibility Determined|0|||
149854156|NCT01190930|540595206|FG005|Induction|Death|0|||
149854157|NCT01190930|540595207|FG006|Induction|Death|0|||
149854158|NCT01190930|540595208|FG007|Induction|Death|0|||
149854159|NCT01190930|540595209|FG008|Induction|Death|0|||
149854160|NCT01190930|540595210|FG009|Induction|Death|0|||
149854161|NCT01190930|540595201|FG000|Induction|Lost to Follow-up|1|||
149854162|NCT01190930|540595202|FG001|Induction|Lost to Follow-up|0|||
149854163|NCT01190930|540595203|FG002|Induction|Lost to Follow-up|0|||
149854164|NCT01190930|540595204|FG003|Induction|Lost to Follow-up|0|||
149854165|NCT01190930|540595205|FG004|Induction|Lost to Follow-up|0|||
149854166|NCT01190930|540595206|FG005|Induction|Lost to Follow-up|0|||
149854167|NCT01190930|540595207|FG006|Induction|Lost to Follow-up|0|||
149854168|NCT01190930|540595208|FG007|Induction|Lost to Follow-up|0|||
149854169|NCT01190930|540595209|FG008|Induction|Lost to Follow-up|0|||
149854170|NCT01190930|540595210|FG009|Induction|Lost to Follow-up|0|||
149854171|NCT01190930|540595201|FG000|Induction|Physician Decision|125|||
149854172|NCT01190930|540595202|FG001|Induction|Physician Decision|3|||
149854173|NCT01190930|540595203|FG002|Induction|Physician Decision|0|||
149854174|NCT01190930|540595204|FG003|Induction|Physician Decision|0|||
149854175|NCT01190930|540595205|FG004|Induction|Physician Decision|0|||
149854176|NCT01190930|540595206|FG005|Induction|Physician Decision|0|||
149854177|NCT01190930|540595207|FG006|Induction|Physician Decision|0|||
149854178|NCT01190930|540595208|FG007|Induction|Physician Decision|0|||
149854179|NCT01190930|540595209|FG008|Induction|Physician Decision|0|||
149854180|NCT01190930|540595210|FG009|Induction|Physician Decision|0|||
149854181|NCT01190930|540595201|FG000|Induction|Withdrawal by Subject|9|||
149854182|NCT01190930|540595202|FG001|Induction|Withdrawal by Subject|0|||
149854183|NCT01190930|540595203|FG002|Induction|Withdrawal by Subject|0|||
149854184|NCT01190930|540595204|FG003|Induction|Withdrawal by Subject|0|||
149854185|NCT01190930|540595205|FG004|Induction|Withdrawal by Subject|0|||
149854186|NCT01190930|540595206|FG005|Induction|Withdrawal by Subject|0|||
149959641|NCT00564070|540985928|FG000|Overall Study|Lost to Follow-up|9|||
149959642|NCT00564070|540985929|FG001|Overall Study|Lost to Follow-up|7|||
149959643|NCT00564070|540985928|FG000|Overall Study|Worsening depression, referred to care|3|||
149959644|NCT00564070|540985929|FG001|Overall Study|Worsening depression, referred to care|0|||
149959645|NCT00552279|540985930|FG000|Overall Study|Adverse Event|0|||
149959646|NCT00552279|540985931|FG001|Overall Study|Adverse Event|1|||
149959647|NCT00552279|540985930|FG000|Overall Study|Withdrawal by Subject|12|||
149959648|NCT00552279|540985931|FG001|Overall Study|Withdrawal by Subject|1|||
149959649|NCT00552279|540985930|FG000|Overall Study|Lost to Follow-up|1|||
149959650|NCT00552279|540985931|FG001|Overall Study|Lost to Follow-up|0|||
149959651|NCT00552279|540985930|FG000|Overall Study|Other|1|||
149959652|NCT00552279|540985931|FG001|Overall Study|Other|1|||
149959653|NCT03142334|540985933|FG000|Overall Study|Death|18|||
149959654|NCT03142334|540985934|FG001|Overall Study|Death|33|||
149959655|NCT03142334|540985933|FG000|Overall Study|Withdrawal by Subject|15|||
149959656|NCT03142334|540985934|FG001|Overall Study|Withdrawal by Subject|11|||
149959657|NCT03142334|540985933|FG000|Overall Study|Ongoing on trial follow up|463|||
149959658|NCT03142334|540985934|FG001|Overall Study|Ongoing on trial follow up|454|||
149959659|NCT02346370|540985935|FG000|Overall Study|Not treated|1|||
149959660|NCT02346370|540985936|FG001|Overall Study|Not treated|0|||
149959661|NCT02346370|540985937|FG002|Overall Study|Not treated|0|||
149959662|NCT02346370|540985935|FG000|Overall Study|Withdrawal of consent|1|||
149959663|NCT02346370|540985936|FG001|Overall Study|Withdrawal of consent|0|||
149959664|NCT02346370|540985937|FG002|Overall Study|Withdrawal of consent|0|||
149959665|NCT02346370|540985935|FG000|Overall Study|Death|1|||
149959666|NCT02346370|540985936|FG001|Overall Study|Death|3|||
149959667|NCT02346370|540985937|FG002|Overall Study|Death|1|||
149959668|NCT02346370|540985935|FG000|Overall Study|Sponsor discontinued study|5|||
149854187|NCT01190930|540595207|FG006|Induction|Withdrawal by Subject|0|||
149854188|NCT01190930|540595208|FG007|Induction|Withdrawal by Subject|0|||
149854189|NCT01190930|540595209|FG008|Induction|Withdrawal by Subject|0|||
149854190|NCT01190930|540595210|FG009|Induction|Withdrawal by Subject|0|||
149854191|NCT01190930|540595201|FG000|Induction|Refusal|235|||
149854192|NCT01190930|540595202|FG001|Induction|Refusal|0|||
149854193|NCT01190930|540595203|FG002|Induction|Refusal|0|||
149959669|NCT02346370|540985936|FG001|Overall Study|Sponsor discontinued study|0|||
149959670|NCT02346370|540985937|FG002|Overall Study|Sponsor discontinued study|2|||
149854194|NCT01190930|540595204|FG003|Induction|Refusal|0|||
149854195|NCT01190930|540595205|FG004|Induction|Refusal|0|||
149959671|NCT02346370|540985935|FG000|Overall Study|Radiologic progression|0|||
149959672|NCT02346370|540985936|FG001|Overall Study|Radiologic progression|0|||
149959673|NCT02346370|540985937|FG002|Overall Study|Radiologic progression|1|||
149959674|NCT02346370|540985935|FG000|Overall Study|Physician Decision|0|||
149959675|NCT02346370|540985936|FG001|Overall Study|Physician Decision|1|||
149854196|NCT01190930|540595206|FG005|Induction|Refusal|0|||
149854197|NCT01190930|540595207|FG006|Induction|Refusal|0|||
149854198|NCT01190930|540595208|FG007|Induction|Refusal|0|||
149854199|NCT01190930|540595209|FG008|Induction|Refusal|0|||
149854200|NCT01190930|540595210|FG009|Induction|Refusal|0|||
149854201|NCT01190930|540595201|FG000|Induction|Inevaluable|23|||
149854202|NCT01190930|540595202|FG001|Induction|Inevaluable|1|||
149854203|NCT01190930|540595203|FG002|Induction|Inevaluable|0|||
149854204|NCT01190930|540595204|FG003|Induction|Inevaluable|0|||
149854205|NCT01190930|540595205|FG004|Induction|Inevaluable|0|||
149854206|NCT01190930|540595206|FG005|Induction|Inevaluable|0|||
149854207|NCT01190930|540595207|FG006|Induction|Inevaluable|0|||
149854208|NCT01190930|540595208|FG007|Induction|Inevaluable|0|||
149854209|NCT01190930|540595209|FG008|Induction|Inevaluable|0|||
149854210|NCT01190930|540595210|FG009|Induction|Inevaluable|0|||
149854211|NCT01190930|540595201|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
149854212|NCT01190930|540595202|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854213|NCT01190930|540595203|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149959676|NCT02346370|540985937|FG002|Overall Study|Physician Decision|0|||
149959677|NCT01217047|540985938|FG000|Overall Study|Lost to Follow-up|0|||
149959678|NCT01217047|540985939|FG001|Overall Study|Lost to Follow-up|1|||
149854214|NCT01190930|540595204|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854215|NCT01190930|540595205|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854216|NCT01190930|540595206|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854217|NCT01190930|540595207|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854218|NCT01190930|540595208|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854219|NCT01190930|540595209|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854220|NCT01190930|540595210|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
149854221|NCT01190930|540595201|FG000|Induction|High Risk Downs|80|||
149854222|NCT01190930|540595202|FG001|Induction|High Risk Downs|0|||
149854223|NCT01190930|540595203|FG002|Induction|High Risk Downs|0|||
149854224|NCT01190930|540595204|FG003|Induction|High Risk Downs|0|||
149854225|NCT01190930|540595205|FG004|Induction|High Risk Downs|0|||
149854226|NCT01190930|540595206|FG005|Induction|High Risk Downs|0|||
149854227|NCT01190930|540595207|FG006|Induction|High Risk Downs|0|||
149854228|NCT01190930|540595208|FG007|Induction|High Risk Downs|0|||
149854229|NCT01190930|540595209|FG008|Induction|High Risk Downs|0|||
149854230|NCT01190930|540595210|FG009|Induction|High Risk Downs|0|||
149854231|NCT01190930|540595201|FG000|Induction|Enrollment onto another COG Protocol|1|||
149854232|NCT01190930|540595202|FG001|Induction|Enrollment onto another COG Protocol|0|||
149854233|NCT01190930|540595203|FG002|Induction|Enrollment onto another COG Protocol|0|||
149854234|NCT01190930|540595204|FG003|Induction|Enrollment onto another COG Protocol|0|||
149854235|NCT01190930|540595205|FG004|Induction|Enrollment onto another COG Protocol|0|||
149854236|NCT01190930|540595206|FG005|Induction|Enrollment onto another COG Protocol|0|||
149854237|NCT01190930|540595207|FG006|Induction|Enrollment onto another COG Protocol|0|||
149854238|NCT01190930|540595208|FG007|Induction|Enrollment onto another COG Protocol|0|||
149854239|NCT01190930|540595209|FG008|Induction|Enrollment onto another COG Protocol|0|||
149854240|NCT01190930|540595210|FG009|Induction|Enrollment onto another COG Protocol|0|||
149854241|NCT01190930|540595201|FG000|Induction|Average Risk|1847|||
149854242|NCT01190930|540595202|FG001|Induction|Average Risk|0|||
149854243|NCT01190930|540595203|FG002|Induction|Average Risk|0|||
149854244|NCT01190930|540595204|FG003|Induction|Average Risk|0|||
149854245|NCT01190930|540595205|FG004|Induction|Average Risk|0|||
149854246|NCT01190930|540595206|FG005|Induction|Average Risk|0|||
149854247|NCT01190930|540595207|FG006|Induction|Average Risk|0|||
149854248|NCT01190930|540595208|FG007|Induction|Average Risk|0|||
149854249|NCT01190930|540595209|FG008|Induction|Average Risk|0|||
149854250|NCT01190930|540595210|FG009|Induction|Average Risk|0|||
149854251|NCT01190930|540595201|FG000|Induction|High Risk|1227|||
149854252|NCT01190930|540595202|FG001|Induction|High Risk|0|||
149854253|NCT01190930|540595203|FG002|Induction|High Risk|0|||
149854254|NCT01190930|540595204|FG003|Induction|High Risk|0|||
149854255|NCT01190930|540595205|FG004|Induction|High Risk|0|||
149854256|NCT01190930|540595206|FG005|Induction|High Risk|0|||
149854257|NCT01190930|540595207|FG006|Induction|High Risk|0|||
149854258|NCT01190930|540595208|FG007|Induction|High Risk|0|||
149854259|NCT01190930|540595209|FG008|Induction|High Risk|0|||
149854260|NCT01190930|540595210|FG009|Induction|High Risk|0|||
149854261|NCT01190930|540595201|FG000|Induction|Low Risk|443|||
149854262|NCT01190930|540595202|FG001|Induction|Low Risk|0|||
149854263|NCT01190930|540595203|FG002|Induction|Low Risk|0|||
149854264|NCT01190930|540595204|FG003|Induction|Low Risk|0|||
149854265|NCT01190930|540595205|FG004|Induction|Low Risk|0|||
149854266|NCT01190930|540595206|FG005|Induction|Low Risk|0|||
149854267|NCT01190930|540595207|FG006|Induction|Low Risk|0|||
149959679|NCT01217047|540985940|FG002|Overall Study|Lost to Follow-up|0|||
149854268|NCT01190930|540595208|FG007|Induction|Low Risk|0|||
149854269|NCT01190930|540595209|FG008|Induction|Low Risk|0|||
149854270|NCT01190930|540595210|FG009|Induction|Low Risk|0|||
149854271|NCT01190930|540595201|FG000|Induction|Very High Risk|1012|||
149854272|NCT01190930|540595202|FG001|Induction|Very High Risk|0|||
149854273|NCT01190930|540595203|FG002|Induction|Very High Risk|0|||
149959680|NCT04034056|540985941|FG000|Overall Study|Withdrawal by Subject|2|||
149854274|NCT01190930|540595204|FG003|Induction|Very High Risk|0|||
149854275|NCT01190930|540595205|FG004|Induction|Very High Risk|0|||
149854276|NCT01190930|540595206|FG005|Induction|Very High Risk|0|||
149854277|NCT01190930|540595207|FG006|Induction|Very High Risk|0|||
149854278|NCT01190930|540595208|FG007|Induction|Very High Risk|0|||
149854279|NCT01190930|540595209|FG008|Induction|Very High Risk|0|||
149854280|NCT01190930|540595210|FG009|Induction|Very High Risk|0|||
149854281|NCT01190930|540595201|FG000|Induction|Philadelphia chromosome-positive|99|||
149854282|NCT01190930|540595202|FG001|Induction|Philadelphia chromosome-positive|0|||
149854283|NCT01190930|540595203|FG002|Induction|Philadelphia chromosome-positive|0|||
149854284|NCT01190930|540595204|FG003|Induction|Philadelphia chromosome-positive|0|||
149959681|NCT04034056|540985941|FG000|Overall Study|Reason Not Specified|13|||
150288936|NCT00264004|542192541|FG002|Overall Study|Adverse Event|6|||
150288937|NCT00264004|542192542|FG003|Overall Study|Adverse Event|4|||
150288938|NCT00264004|542192539|FG000|Overall Study|Withdrawal by Subject|0|||
149854285|NCT01190930|540595205|FG004|Induction|Philadelphia chromosome-positive|0|||
149959682|NCT04034056|540985941|FG000|Overall Study|Adverse Event|56|||
149959683|NCT01530997|540985942|FG000|Overall Study|Physician Decision|1|||
149959684|NCT01530997|540985942|FG000|Overall Study|Withdrawal by Subject|1|||
149959685|NCT01362270|540985945|FG000|Overall Study|Withdrawal by Subject|1|||
149959686|NCT01362270|540985946|FG001|Overall Study|Withdrawal by Subject|0|||
149959687|NCT01362270|540985945|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
149959688|NCT01362270|540985946|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
149959689|NCT01362270|540985945|FG000|Overall Study|Met excl. criteria before 1st session|1|||
149959690|NCT01362270|540985946|FG001|Overall Study|Met excl. criteria before 1st session|1|||
149959691|NCT02453191|540985949|FG000|Overall Study|Withdrawal by Subject|1|||
149959692|NCT01691482|540985950|FG000|Treatment Period 2|Adverse Event|0|||
149959693|NCT01691482|540985951|FG001|Treatment Period 2|Adverse Event|1|||
149959694|NCT01691482|540985950|FG000|Treatment Period 2|Protocol Violation|1|||
149959695|NCT01691482|540985951|FG001|Treatment Period 2|Protocol Violation|1|||
149959696|NCT01986751|540985957|FG000|Overall Study|improperly consented|10|||
149959697|NCT01986751|540985958|FG001|Overall Study|improperly consented|2|||
149959698|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
149959699|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
149959700|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
149959701|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
149959702|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
149959703|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
149959704|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
149959705|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
149959706|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
149959707|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
149959708|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
149959709|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
149959710|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
149959711|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
149959712|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
149959713|NCT00407030|540985961|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
149959714|NCT00407030|540985962|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
149959715|NCT00407030|540985963|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
149959716|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
149959717|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
149959718|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
149959719|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
149959720|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
149959721|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
149959722|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
149959723|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
149959724|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
149959725|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
149959726|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
149959727|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
149959728|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
149959729|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
149959730|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
149959731|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
149959732|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
149959733|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
149959734|NCT00407030|540985961|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
149959735|NCT00407030|540985962|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
150288939|NCT00264004|542192540|FG001|Overall Study|Withdrawal by Subject|1|||
149854286|NCT01190930|540595206|FG005|Induction|Philadelphia chromosome-positive|0|||
149854287|NCT01190930|540595207|FG006|Induction|Philadelphia chromosome-positive|0|||
149854288|NCT01190930|540595208|FG007|Induction|Philadelphia chromosome-positive|0|||
149854289|NCT01190930|540595209|FG008|Induction|Philadelphia chromosome-positive|0|||
149854290|NCT01190930|540595210|FG009|Induction|Philadelphia chromosome-positive|0|||
149854291|NCT01190930|540595201|FG000|Induction|Incomplete Induction data|63|||
149854292|NCT01190930|540595202|FG001|Induction|Incomplete Induction data|0|||
149854293|NCT01190930|540595203|FG002|Induction|Incomplete Induction data|0|||
149854294|NCT01190930|540595204|FG003|Induction|Incomplete Induction data|0|||
149854295|NCT01190930|540595205|FG004|Induction|Incomplete Induction data|0|||
149854296|NCT01190930|540595206|FG005|Induction|Incomplete Induction data|0|||
149854297|NCT01190930|540595207|FG006|Induction|Incomplete Induction data|0|||
149854298|NCT01190930|540595208|FG007|Induction|Incomplete Induction data|0|||
149854299|NCT01190930|540595209|FG008|Induction|Incomplete Induction data|0|||
149854300|NCT01190930|540595210|FG009|Induction|Incomplete Induction data|0|||
149854301|NCT01190930|540595201|FG000|Induction|Progressive disease|0|||
149854302|NCT01190930|540595202|FG001|Induction|Progressive disease|1|||
149854303|NCT01190930|540595203|FG002|Induction|Progressive disease|0|||
149854304|NCT01190930|540595204|FG003|Induction|Progressive disease|0|||
149854305|NCT01190930|540595205|FG004|Induction|Progressive disease|0|||
149854306|NCT01190930|540595206|FG005|Induction|Progressive disease|0|||
149854307|NCT01190930|540595207|FG006|Induction|Progressive disease|0|||
149854308|NCT01190930|540595208|FG007|Induction|Progressive disease|0|||
149854309|NCT01190930|540595209|FG008|Induction|Progressive disease|0|||
149854310|NCT01190930|540595210|FG009|Induction|Progressive disease|0|||
149854311|NCT01190930|540595201|FG000|Induction|No treatment|3|||
149854312|NCT01190930|540595202|FG001|Induction|No treatment|0|||
149854313|NCT01190930|540595203|FG002|Induction|No treatment|0|||
149854314|NCT01190930|540595204|FG003|Induction|No treatment|0|||
149854315|NCT01190930|540595205|FG004|Induction|No treatment|0|||
149854316|NCT01190930|540595206|FG005|Induction|No treatment|0|||
149854317|NCT01190930|540595207|FG006|Induction|No treatment|0|||
149854318|NCT01190930|540595208|FG007|Induction|No treatment|0|||
149854319|NCT01190930|540595209|FG008|Induction|No treatment|0|||
149854320|NCT01190930|540595210|FG009|Induction|No treatment|0|||
149854321|NCT01190930|540595201|FG000|Induction|Ineligible|69|||
149854322|NCT01190930|540595202|FG001|Induction|Ineligible|4|||
149854323|NCT01190930|540595203|FG002|Induction|Ineligible|0|||
149854324|NCT01190930|540595204|FG003|Induction|Ineligible|0|||
149854325|NCT01190930|540595205|FG004|Induction|Ineligible|0|||
149854326|NCT01190930|540595206|FG005|Induction|Ineligible|0|||
149854327|NCT01190930|540595207|FG006|Induction|Ineligible|0|||
149854328|NCT01190930|540595208|FG007|Induction|Ineligible|0|||
149854329|NCT01190930|540595209|FG008|Induction|Ineligible|0|||
149854330|NCT01190930|540595210|FG009|Induction|Ineligible|0|||
149854331|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
149959736|NCT00407030|540985963|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
149959737|NCT01968785|540985964|FG000|Overall Study|Withdrawal by Subject|1|||
149959738|NCT01968785|540985965|FG001|Overall Study|Withdrawal by Subject|0|||
149959739|NCT04223687|540985971|FG000|Overall Study|Missing primary outcome|1|||
149854332|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
149854333|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
149854334|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
149854335|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
149854336|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
149854337|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
149854338|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
149854339|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
149854340|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
149854341|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Death|0|||
149854342|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Death|0|||
149854343|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Death|8|||
149854344|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Death|4|||
149959740|NCT04223687|540985972|FG001|Overall Study|Missing primary outcome|0|||
149959741|NCT01608308|540985973|FG000|Overall Study|pretreatment medical and billing reasons|0|||
149959742|NCT01608308|540985974|FG001|Overall Study|pretreatment medical and billing reasons|2|||
149959743|NCT03520387|540985975|FG000|Pre-Randomization|Withdrawal by Subject|1|||
149959744|NCT03520387|540985976|FG001|Pre-Randomization|Withdrawal by Subject|0|||
149854345|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Death|0|||
149854346|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Death|0|||
149854347|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Death|0|||
149959745|NCT03520387|540985977|FG002|Pre-Randomization|Withdrawal by Subject|0|||
149854348|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Death|0|||
149854349|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Death|0|||
149854350|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Death|0|||
149854351|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
149854352|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
150172834|NCT03284957|541769781|FG007|Overall Study|Progressive Disease|8|||
150172835|NCT03284957|541769782|FG008|Overall Study|Progressive Disease|5|||
150172836|NCT03284957|541769783|FG009|Overall Study|Progressive Disease|18|||
150172837|NCT03284957|541769784|FG010|Overall Study|Progressive Disease|7|||
150172838|NCT03284957|541769785|FG011|Overall Study|Progressive Disease|2|||
150172839|NCT03284957|541769786|FG012|Overall Study|Progressive Disease|3|||
150172840|NCT03284957|541769787|FG013|Overall Study|Progressive Disease|1|||
150172841|NCT03284957|541769788|FG014|Overall Study|Progressive Disease|1|||
150172842|NCT03284957|541769789|FG015|Overall Study|Progressive Disease|2|||
150172843|NCT03284957|541769774|FG000|Overall Study|Withdrawal by Subject|0|||
150172844|NCT03284957|541769775|FG001|Overall Study|Withdrawal by Subject|0|||
150172845|NCT03284957|541769776|FG002|Overall Study|Withdrawal by Subject|0|||
150172846|NCT03284957|541769777|FG003|Overall Study|Withdrawal by Subject|0|||
150172847|NCT03284957|541769778|FG004|Overall Study|Withdrawal by Subject|0|||
150172848|NCT03284957|541769779|FG005|Overall Study|Withdrawal by Subject|0|||
150172849|NCT03284957|541769780|FG006|Overall Study|Withdrawal by Subject|0|||
150172850|NCT03284957|541769781|FG007|Overall Study|Withdrawal by Subject|0|||
150172851|NCT03284957|541769782|FG008|Overall Study|Withdrawal by Subject|0|||
150172852|NCT03284957|541769783|FG009|Overall Study|Withdrawal by Subject|2|||
150172853|NCT03284957|541769784|FG010|Overall Study|Withdrawal by Subject|0|||
150172854|NCT03284957|541769785|FG011|Overall Study|Withdrawal by Subject|0|||
150172855|NCT03284957|541769786|FG012|Overall Study|Withdrawal by Subject|0|||
150172856|NCT03284957|541769787|FG013|Overall Study|Withdrawal by Subject|0|||
150172857|NCT03284957|541769788|FG014|Overall Study|Withdrawal by Subject|0|||
150172858|NCT03284957|541769789|FG015|Overall Study|Withdrawal by Subject|0|||
150172859|NCT03284957|541769774|FG000|Overall Study|Other|0|||
150172860|NCT03284957|541769775|FG001|Overall Study|Other|0|||
150172861|NCT03284957|541769776|FG002|Overall Study|Other|0|||
150172862|NCT03284957|541769777|FG003|Overall Study|Other|0|||
150172863|NCT03284957|541769778|FG004|Overall Study|Other|0|||
150172864|NCT03284957|541769779|FG005|Overall Study|Other|0|||
150172865|NCT03284957|541769780|FG006|Overall Study|Other|3|||
150172866|NCT03284957|541769781|FG007|Overall Study|Other|0|||
150172867|NCT03284957|541769782|FG008|Overall Study|Other|1|||
150172868|NCT03284957|541769783|FG009|Overall Study|Other|6|||
150172869|NCT03284957|541769784|FG010|Overall Study|Other|0|||
150172870|NCT03284957|541769785|FG011|Overall Study|Other|0|||
150172871|NCT03284957|541769786|FG012|Overall Study|Other|0|||
150172872|NCT03284957|541769787|FG013|Overall Study|Other|0|||
150172873|NCT03284957|541769788|FG014|Overall Study|Other|2|||
150172874|NCT03284957|541769789|FG015|Overall Study|Other|0|||
150172875|NCT03544515|541769792|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
150172876|NCT03544515|541769793|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
150172877|NCT03544515|541769792|FG000|Overall Study|Lost to Follow-up|2|||
150172878|NCT03544515|541769793|FG001|Overall Study|Lost to Follow-up|0|||
150172879|NCT02496702|541769794|FG000|Overall Study|Lost to Follow-up|8|||
150172880|NCT02496702|541769795|FG001|Overall Study|Lost to Follow-up|6|||
150172881|NCT02496702|541769794|FG000|Overall Study|Only partially tested|0|||
150172882|NCT02496702|541769795|FG001|Overall Study|Only partially tested|2|||
150172883|NCT01400776|541769796|FG000|Overall Study|Adverse Event|7|||
150172884|NCT01400776|541769797|FG001|Overall Study|Adverse Event|2|||
150172885|NCT01400776|541769798|FG002|Overall Study|Adverse Event|9|||
150172886|NCT01400776|541769799|FG003|Overall Study|Adverse Event|2|||
150172887|NCT01400776|541769796|FG000|Overall Study|Lost to Follow-up|1|||
150172888|NCT01400776|541769797|FG001|Overall Study|Lost to Follow-up|0|||
150172889|NCT01400776|541769798|FG002|Overall Study|Lost to Follow-up|4|||
150172890|NCT01400776|541769799|FG003|Overall Study|Lost to Follow-up|1|||
150172891|NCT01400776|541769796|FG000|Overall Study|Withdrew Consent|4|||
150172892|NCT01400776|541769797|FG001|Overall Study|Withdrew Consent|2|||
150172893|NCT01400776|541769798|FG002|Overall Study|Withdrew Consent|6|||
150172894|NCT01400776|541769799|FG003|Overall Study|Withdrew Consent|1|||
150172895|NCT01400776|541769796|FG000|Overall Study|Protocol Deviation|6|||
150172896|NCT01400776|541769797|FG001|Overall Study|Protocol Deviation|1|||
150172897|NCT01400776|541769798|FG002|Overall Study|Protocol Deviation|5|||
150172898|NCT01400776|541769799|FG003|Overall Study|Protocol Deviation|2|||
150172899|NCT01400776|541769796|FG000|Overall Study|Reason not Specified|3|||
150172900|NCT01400776|541769797|FG001|Overall Study|Reason not Specified|0|||
150172901|NCT01400776|541769798|FG002|Overall Study|Reason not Specified|4|||
150172902|NCT01400776|541769799|FG003|Overall Study|Reason not Specified|3|||
150172903|NCT00941655|541769807|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
150172904|NCT00941655|541769808|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
150172905|NCT00941655|541769807|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
150172906|NCT00941655|541769808|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
150172907|NCT00941655|541769807|FG000|Overall Study|progressed while on chemo|0|||
150172908|NCT00941655|541769808|FG001|Overall Study|progressed while on chemo|2|||
150172909|NCT00941655|541769807|FG000|Overall Study|refused further treatment|0|||
150172910|NCT00941655|541769808|FG001|Overall Study|refused further treatment|1|||
150172911|NCT00941655|541769807|FG000|Overall Study|withdrew consent|0|||
150172912|NCT00941655|541769808|FG001|Overall Study|withdrew consent|1|||
150172913|NCT00941655|541769807|FG000|Overall Study|non-compliant|0|||
150172914|NCT00941655|541769808|FG001|Overall Study|non-compliant|1|||
150172915|NCT00446550|541769809|FG000|Overall Study|Adverse Event|1|||
150172916|NCT00446550|541769810|FG001|Overall Study|Adverse Event|0|||
150172917|NCT01759264|541769811|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
150172918|NCT01759264|541769811|FG000|Overall Study|Adverse Event|1|||
150172919|NCT01759264|541769811|FG000|Overall Study|Other|2|||
150172920|NCT01759264|541769811|FG000|Overall Study|Lost to Follow-up|2|||
150172921|NCT01759264|541769811|FG000|Overall Study|Withdrawal by Subject|3|||
150172922|NCT01759264|541769811|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
150172923|NCT02698891|541769812|FG000|Overall Study|Withdrawal by Subject|2|||
150172924|NCT02698891|541769812|FG000|Overall Study|deemed ineligible|1|||
150172925|NCT02698891|541769812|FG000|Overall Study|Adverse Event|9|||
150172926|NCT00711958|541769813|FG000|Overall Study|Withdrawal by Subject|6|||
150172927|NCT00711958|541769814|FG001|Overall Study|Withdrawal by Subject|8|||
150172928|NCT00711958|541769813|FG000|Overall Study|Lack of Efficacy|3|||
150172929|NCT00711958|541769814|FG001|Overall Study|Lack of Efficacy|1|||
150172930|NCT00711958|541769813|FG000|Overall Study|Clinical deterioration|1|||
150172931|NCT00711958|541769814|FG001|Overall Study|Clinical deterioration|0|||
150172932|NCT00711958|541769813|FG000|Overall Study|Adverse Event|9|||
150172933|NCT00711958|541769814|FG001|Overall Study|Adverse Event|7|||
150172934|NCT00711958|541769813|FG000|Overall Study|Protocol Violation|1|||
150172935|NCT00711958|541769814|FG001|Overall Study|Protocol Violation|0|||
150172936|NCT00711958|541769813|FG000|Overall Study|Lost to Follow-up|2|||
150172937|NCT00711958|541769814|FG001|Overall Study|Lost to Follow-up|2|||
150172938|NCT00711958|541769813|FG000|Overall Study|Death|10|||
149854353|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
149854354|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
149854355|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
149854356|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
149854357|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
149854358|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
149854359|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
149854360|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
149854361|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854362|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
149854363|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
150039613|NCT03847896|541285127|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
150039614|NCT03847896|541285128|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
150039615|NCT03847896|541285129|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
150039616|NCT03847896|541285125|FG000|Overall Study|Withdrawal by Subject|2|||
150039617|NCT03847896|541285126|FG001|Overall Study|Withdrawal by Subject|10|||
150039618|NCT03847896|541285127|FG002|Overall Study|Withdrawal by Subject|5|||
150172939|NCT00711958|541769814|FG001|Overall Study|Death|5|||
150172940|NCT00711958|541769813|FG000|Overall Study|Progression of disease|1|||
150172941|NCT00711958|541769814|FG001|Overall Study|Progression of disease|0|||
150172942|NCT02383472|541769815|FG000|Overall Study|Withdrawal by Subject|1|||
149854364|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
149854365|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854366|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854367|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854368|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854369|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854370|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
149854371|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Refusal|0|||
149854372|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Refusal|2|||
150172943|NCT02383472|541769816|FG001|Overall Study|Withdrawal by Subject|1|||
150172944|NCT02013830|541769817|FG000|Overall Study|Adverse Event|3|||
150172945|NCT02013830|541769817|FG000|Overall Study|Death|1|||
149854373|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Refusal|694|||
149854374|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Refusal|4|||
149854375|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Refusal|0|||
149854376|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Refusal|3|||
149854377|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Refusal|0|||
149854378|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Refusal|0|||
150172946|NCT02013830|541769817|FG000|Overall Study|Insufficient therapeutic response|25|||
150172947|NCT02013830|541769817|FG000|Overall Study|Refused treatment|1|||
150172948|NCT01111526|541769818|FG000|Overall Study|GVHD Disease Progression|0|||
150172949|NCT01111526|541769819|FG001|Overall Study|GVHD Disease Progression|1|||
150172950|NCT01111526|541769820|FG002|Overall Study|GVHD Disease Progression|2|||
150172951|NCT04424641|541769821|FG000|Overall Study|Death|1|||
150172952|NCT04424641|541769822|FG001|Overall Study|Death|2|||
150172953|NCT04424641|541769823|FG002|Overall Study|Death|3|||
150172954|NCT04424641|541769824|FG003|Overall Study|Death|0|||
150172955|NCT04424641|541769825|FG004|Overall Study|Death|3|||
150172956|NCT04424641|541769826|FG005|Overall Study|Death|0|||
149854379|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Refusal|0|||
149854380|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Refusal|0|||
149854381|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
149854382|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
149854383|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
149854384|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
149854385|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
149854386|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
149854387|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
149854388|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
149854389|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
149854390|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
149854391|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854392|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
149959746|NCT03520387|540985978|FG003|Pre-Randomization|Withdrawal by Subject|0|||
149959747|NCT03520387|540985979|FG004|Pre-Randomization|Withdrawal by Subject|0|||
149959748|NCT03520387|540985975|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
149959749|NCT03520387|540985976|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
149959750|NCT03520387|540985977|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
149959751|NCT03520387|540985978|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
149959752|NCT03520387|540985979|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
149959753|NCT01945242|540985980|FG000|Overall Study|Physician Decision|3|||
149959754|NCT01945242|540985981|FG001|Overall Study|Physician Decision|3|||
149959755|NCT03163264|540985982|FG000|Overall Study|Withdrawal by Subject|13|||
149959756|NCT03163264|540985983|FG001|Overall Study|Withdrawal by Subject|3|||
149959757|NCT03163264|540985984|FG002|Overall Study|Withdrawal by Subject|4|||
149959758|NCT03163264|540985985|FG003|Overall Study|Withdrawal by Subject|2|||
149959759|NCT03163264|540985982|FG000|Overall Study|Lost to Follow-up|17|||
149959760|NCT03163264|540985983|FG001|Overall Study|Lost to Follow-up|20|||
149959761|NCT03163264|540985984|FG002|Overall Study|Lost to Follow-up|0|||
149959762|NCT03163264|540985985|FG003|Overall Study|Lost to Follow-up|0|||
149959763|NCT03163264|540985982|FG000|Overall Study|Death|0|||
149959764|NCT03163264|540985983|FG001|Overall Study|Death|2|||
149959765|NCT03163264|540985984|FG002|Overall Study|Death|0|||
149959766|NCT03163264|540985985|FG003|Overall Study|Death|0|||
149959767|NCT00286455|540985986|FG000|Overall Study|Hyperglycemia rescue|19|||
149959768|NCT00286455|540985987|FG001|Overall Study|Hyperglycemia rescue|13|||
149959769|NCT00286455|540985988|FG002|Overall Study|Hyperglycemia rescue|10|||
149959770|NCT00286455|540985986|FG000|Overall Study|Adverse Event|1|||
149959771|NCT00286455|540985987|FG001|Overall Study|Adverse Event|3|||
149959772|NCT00286455|540985988|FG002|Overall Study|Adverse Event|2|||
149959773|NCT00286455|540985986|FG000|Overall Study|Lost to Follow-up|0|||
149959774|NCT00286455|540985987|FG001|Overall Study|Lost to Follow-up|3|||
149959775|NCT00286455|540985988|FG002|Overall Study|Lost to Follow-up|3|||
149959776|NCT00286455|540985986|FG000|Overall Study|Physician Decision|3|||
149959777|NCT00286455|540985987|FG001|Overall Study|Physician Decision|0|||
149959778|NCT00286455|540985988|FG002|Overall Study|Physician Decision|2|||
149959779|NCT00286455|540985986|FG000|Overall Study|Protocol Violation|1|||
149959780|NCT00286455|540985987|FG001|Overall Study|Protocol Violation|1|||
149959781|NCT00286455|540985988|FG002|Overall Study|Protocol Violation|0|||
149959782|NCT00286455|540985986|FG000|Overall Study|Participant Non-compliance|1|||
149959783|NCT00286455|540985987|FG001|Overall Study|Participant Non-compliance|0|||
149959784|NCT00286455|540985988|FG002|Overall Study|Participant Non-compliance|0|||
149959785|NCT00286455|540985986|FG000|Overall Study|Withdrawal by Subject|0|||
149959786|NCT00286455|540985987|FG001|Overall Study|Withdrawal by Subject|8|||
149959787|NCT00286455|540985988|FG002|Overall Study|Withdrawal by Subject|7|||
149959788|NCT02730169|540987962|FG000|Overall Study|Protocol Violation|1|||
149959789|NCT02730169|540987963|FG001|Overall Study|Protocol Violation|0|||
149959790|NCT02730169|540987964|FG002|Overall Study|Protocol Violation|0|||
149959791|NCT02730169|540987965|FG003|Overall Study|Protocol Violation|1|||
149959792|NCT02730169|540987962|FG000|Overall Study|Adverse Event|2|||
149959793|NCT02730169|540987963|FG001|Overall Study|Adverse Event|3|||
149959794|NCT02730169|540987964|FG002|Overall Study|Adverse Event|3|||
149959795|NCT02730169|540987965|FG003|Overall Study|Adverse Event|0|||
149959796|NCT02730169|540987962|FG000|Overall Study|Adverse Event of Special Interest|0|||
149959797|NCT02730169|540987963|FG001|Overall Study|Adverse Event of Special Interest|1|||
149959798|NCT02730169|540987964|FG002|Overall Study|Adverse Event of Special Interest|2|||
149959799|NCT02730169|540987965|FG003|Overall Study|Adverse Event of Special Interest|0|||
149959800|NCT02730169|540987962|FG000|Overall Study|Withdrawal by Subject|6|||
150172957|NCT04424641|541769827|FG006|Overall Study|Death|1|||
150172958|NCT04424641|541769828|FG007|Overall Study|Death|2|||
149959801|NCT02730169|540987963|FG001|Overall Study|Withdrawal by Subject|11|||
149854393|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854394|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854395|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854396|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854397|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854398|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854399|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854400|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
149854401|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
149854402|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
149854403|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
149854404|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
149854405|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
149854406|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
149854407|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
149854408|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
149854409|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
149854410|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
149854411|NCT01190930|540595201|FG000|Post Induction Pre-Maintenance|Relapse|0|||
149854412|NCT01190930|540595202|FG001|Post Induction Pre-Maintenance|Relapse|0|||
150039619|NCT03847896|541285128|FG003|Overall Study|Withdrawal by Subject|9|||
149854413|NCT01190930|540595203|FG002|Post Induction Pre-Maintenance|Relapse|1|||
149854414|NCT01190930|540595204|FG003|Post Induction Pre-Maintenance|Relapse|0|||
149854415|NCT01190930|540595205|FG004|Post Induction Pre-Maintenance|Relapse|0|||
149854416|NCT01190930|540595206|FG005|Post Induction Pre-Maintenance|Relapse|0|||
149854417|NCT01190930|540595207|FG006|Post Induction Pre-Maintenance|Relapse|0|||
149854418|NCT01190930|540595208|FG007|Post Induction Pre-Maintenance|Relapse|0|||
149854419|NCT01190930|540595209|FG008|Post Induction Pre-Maintenance|Relapse|0|||
149854420|NCT01190930|540595210|FG009|Post Induction Pre-Maintenance|Relapse|0|||
149854421|NCT01190930|540595201|FG000|Maintenance|Adverse Event|0|||
149854422|NCT01190930|540595202|FG001|Maintenance|Adverse Event|0|||
149854423|NCT01190930|540595203|FG002|Maintenance|Adverse Event|0|||
149854424|NCT01190930|540595204|FG003|Maintenance|Adverse Event|0|||
149854425|NCT01190930|540595205|FG004|Maintenance|Adverse Event|0|||
149854426|NCT01190930|540595206|FG005|Maintenance|Adverse Event|1|||
149854427|NCT01190930|540595207|FG006|Maintenance|Adverse Event|1|||
149854428|NCT01190930|540595208|FG007|Maintenance|Adverse Event|3|||
149854429|NCT01190930|540595209|FG008|Maintenance|Adverse Event|3|||
149854430|NCT01190930|540595210|FG009|Maintenance|Adverse Event|0|||
149854431|NCT01190930|540595201|FG000|Maintenance|Death|0|||
149854432|NCT01190930|540595202|FG001|Maintenance|Death|0|||
149854433|NCT01190930|540595203|FG002|Maintenance|Death|0|||
149854434|NCT01190930|540595204|FG003|Maintenance|Death|1|||
149854435|NCT01190930|540595205|FG004|Maintenance|Death|0|||
149854436|NCT01190930|540595206|FG005|Maintenance|Death|0|||
149854437|NCT01190930|540595207|FG006|Maintenance|Death|2|||
149959802|NCT02730169|540987964|FG002|Overall Study|Withdrawal by Subject|6|||
149959803|NCT02730169|540987965|FG003|Overall Study|Withdrawal by Subject|8|||
149959804|NCT02730169|540987962|FG000|Overall Study|Lost to Follow-up|5|||
149959805|NCT02730169|540987963|FG001|Overall Study|Lost to Follow-up|6|||
149959806|NCT02730169|540987964|FG002|Overall Study|Lost to Follow-up|5|||
149959807|NCT02730169|540987965|FG003|Overall Study|Lost to Follow-up|6|||
149959808|NCT02730169|540987962|FG000|Overall Study|Other|0|||
149959809|NCT02730169|540987963|FG001|Overall Study|Other|0|||
149959810|NCT02730169|540987964|FG002|Overall Study|Other|1|||
149959811|NCT02730169|540987965|FG003|Overall Study|Other|1|||
149959812|NCT03004183|540987966|FG000|Overall Study|Adverse Event|7|||
149959813|NCT03004183|540987966|FG000|Overall Study|Lost to Follow-up|1|||
150039620|NCT03847896|541285129|FG004|Overall Study|Withdrawal by Subject|8|||
150039621|NCT03847896|541285125|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149854438|NCT01190930|540595208|FG007|Maintenance|Death|2|||
149854439|NCT01190930|540595209|FG008|Maintenance|Death|2|||
149854440|NCT01190930|540595210|FG009|Maintenance|Death|2|||
149854441|NCT01190930|540595201|FG000|Maintenance|Lost to Follow-up|0|||
149854442|NCT01190930|540595202|FG001|Maintenance|Lost to Follow-up|0|||
149854443|NCT01190930|540595203|FG002|Maintenance|Lost to Follow-up|0|||
149854444|NCT01190930|540595204|FG003|Maintenance|Lost to Follow-up|0|||
149854445|NCT01190930|540595205|FG004|Maintenance|Lost to Follow-up|0|||
149959814|NCT03004183|540987966|FG000|Overall Study|Physician Decision|40|||
149854446|NCT01190930|540595206|FG005|Maintenance|Lost to Follow-up|0|||
149854447|NCT01190930|540595207|FG006|Maintenance|Lost to Follow-up|1|||
149854448|NCT01190930|540595208|FG007|Maintenance|Lost to Follow-up|1|||
149959815|NCT03004183|540987966|FG000|Overall Study|Withdrawal by Subject|1|||
149959816|NCT03004183|540987966|FG000|Overall Study|COVID-19|1|||
149959817|NCT03681093|540987967|FG000|Overall Study|Subject decision|0|||
150039622|NCT03847896|541285126|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149854449|NCT01190930|540595209|FG008|Maintenance|Lost to Follow-up|1|||
149854450|NCT01190930|540595210|FG009|Maintenance|Lost to Follow-up|0|||
149854451|NCT01190930|540595201|FG000|Maintenance|Physician Decision|0|||
149854452|NCT01190930|540595202|FG001|Maintenance|Physician Decision|1|||
149854453|NCT01190930|540595203|FG002|Maintenance|Physician Decision|0|||
149854454|NCT01190930|540595204|FG003|Maintenance|Physician Decision|5|||
149854455|NCT01190930|540595205|FG004|Maintenance|Physician Decision|9|||
149854456|NCT01190930|540595206|FG005|Maintenance|Physician Decision|4|||
149854457|NCT01190930|540595207|FG006|Maintenance|Physician Decision|8|||
149854458|NCT01190930|540595208|FG007|Maintenance|Physician Decision|8|||
149854459|NCT01190930|540595209|FG008|Maintenance|Physician Decision|10|||
149854460|NCT01190930|540595210|FG009|Maintenance|Physician Decision|17|||
149854461|NCT01190930|540595201|FG000|Maintenance|Withdrawal by Subject|0|||
149854462|NCT01190930|540595202|FG001|Maintenance|Withdrawal by Subject|0|||
149854463|NCT01190930|540595203|FG002|Maintenance|Withdrawal by Subject|0|||
149854464|NCT01190930|540595204|FG003|Maintenance|Withdrawal by Subject|0|||
149854465|NCT01190930|540595205|FG004|Maintenance|Withdrawal by Subject|0|||
149854466|NCT01190930|540595206|FG005|Maintenance|Withdrawal by Subject|0|||
149854467|NCT01190930|540595207|FG006|Maintenance|Withdrawal by Subject|2|||
149854468|NCT01190930|540595208|FG007|Maintenance|Withdrawal by Subject|1|||
149854469|NCT01190930|540595209|FG008|Maintenance|Withdrawal by Subject|4|||
149854470|NCT01190930|540595210|FG009|Maintenance|Withdrawal by Subject|1|||
149854471|NCT01190930|540595201|FG000|Maintenance|Refusal|0|||
149854472|NCT01190930|540595202|FG001|Maintenance|Refusal|1|||
149854473|NCT01190930|540595203|FG002|Maintenance|Refusal|0|||
149854474|NCT01190930|540595204|FG003|Maintenance|Refusal|2|||
149854475|NCT01190930|540595205|FG004|Maintenance|Refusal|0|||
149854476|NCT01190930|540595206|FG005|Maintenance|Refusal|4|||
149854477|NCT01190930|540595207|FG006|Maintenance|Refusal|5|||
149854478|NCT01190930|540595208|FG007|Maintenance|Refusal|17|||
149854479|NCT01190930|540595209|FG008|Maintenance|Refusal|13|||
149854480|NCT01190930|540595210|FG009|Maintenance|Refusal|6|||
149854481|NCT01190930|540595201|FG000|Maintenance|second malignant neoplasm|0|||
149854482|NCT01190930|540595202|FG001|Maintenance|second malignant neoplasm|0|||
149854483|NCT01190930|540595203|FG002|Maintenance|second malignant neoplasm|0|||
149854484|NCT01190930|540595204|FG003|Maintenance|second malignant neoplasm|1|||
149854485|NCT01190930|540595205|FG004|Maintenance|second malignant neoplasm|0|||
149854486|NCT01190930|540595206|FG005|Maintenance|second malignant neoplasm|1|||
149854487|NCT01190930|540595207|FG006|Maintenance|second malignant neoplasm|0|||
149854488|NCT01190930|540595208|FG007|Maintenance|second malignant neoplasm|0|||
149854489|NCT01190930|540595209|FG008|Maintenance|second malignant neoplasm|1|||
149854490|NCT01190930|540595210|FG009|Maintenance|second malignant neoplasm|0|||
149854491|NCT01190930|540595201|FG000|Maintenance|Inevaluable|0|||
149854492|NCT01190930|540595202|FG001|Maintenance|Inevaluable|0|||
149854493|NCT01190930|540595203|FG002|Maintenance|Inevaluable|0|||
149854494|NCT01190930|540595204|FG003|Maintenance|Inevaluable|0|||
149854495|NCT01190930|540595205|FG004|Maintenance|Inevaluable|0|||
149854496|NCT01190930|540595206|FG005|Maintenance|Inevaluable|1|||
149854497|NCT01190930|540595207|FG006|Maintenance|Inevaluable|1|||
149854498|NCT01190930|540595208|FG007|Maintenance|Inevaluable|1|||
149959818|NCT03681093|540987968|FG001|Overall Study|Subject decision|2|||
149959819|NCT03681093|540987969|FG002|Overall Study|Subject decision|1|||
149959820|NCT02698787|540987970|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
149959821|NCT02698787|540987971|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
149959822|NCT01882829|540987973|FG000|Overall Study|Adverse Event|4|||
149959823|NCT01882829|540987973|FG000|Overall Study|Protocol Violation|1|||
149959824|NCT01882829|540987973|FG000|Overall Study|Withdrawal by Subject|1|||
149959825|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
149959826|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
149959827|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
149959828|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
149959829|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
149959830|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
149959831|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
149959832|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
149959833|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
149959834|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
149959835|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
149959836|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
149959837|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
150172959|NCT04424641|541769821|FG000|Overall Study|Sponsor decision|0|||
149854499|NCT01190930|540595209|FG008|Maintenance|Inevaluable|0|||
149854500|NCT01190930|540595210|FG009|Maintenance|Inevaluable|0|||
149854501|NCT01190930|540595201|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
149854502|NCT01190930|540595202|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
149854503|NCT01190930|540595203|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
149854504|NCT01190930|540595204|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
149854505|NCT01190930|540595205|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
149854506|NCT01190930|540595206|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
149854507|NCT01190930|540595207|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
149854508|NCT01190930|540595208|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
149854509|NCT01190930|540595209|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
149854510|NCT01190930|540595210|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
149854511|NCT01190930|540595201|FG000|Maintenance|Relapse|0|||
149854512|NCT01190930|540595202|FG001|Maintenance|Relapse|0|||
149854513|NCT01190930|540595203|FG002|Maintenance|Relapse|0|||
150288940|NCT00264004|542192541|FG002|Overall Study|Withdrawal by Subject|2|||
150288941|NCT00264004|542192542|FG003|Overall Study|Withdrawal by Subject|2|||
150288942|NCT00264004|542192539|FG000|Overall Study|Other|2|||
149854514|NCT01190930|540595204|FG003|Maintenance|Relapse|2|||
149854515|NCT01190930|540595205|FG004|Maintenance|Relapse|0|||
149854516|NCT01190930|540595206|FG005|Maintenance|Relapse|1|||
149854517|NCT01190930|540595207|FG006|Maintenance|Relapse|6|||
149854518|NCT01190930|540595208|FG007|Maintenance|Relapse|13|||
149854519|NCT01190930|540595209|FG008|Maintenance|Relapse|11|||
149959838|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
149959839|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
149854520|NCT01190930|540595210|FG009|Maintenance|Relapse|11|||
149959840|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959841|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959842|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959843|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959844|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959845|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
149959846|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
149959847|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
149959848|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
149959849|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
149959850|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
149959851|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
149959852|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
149959853|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959854|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
149959855|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959856|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959857|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959858|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959859|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
149959860|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
149959861|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
149959862|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
149959863|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
149959864|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
149959865|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
149959866|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
149959867|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
149959868|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
149959869|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
149959870|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
149959871|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
149959872|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
149959873|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
149959874|NCT01557244|540987974|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
149959875|NCT01557244|540987975|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
149959876|NCT01557244|540987976|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
149959877|NCT01557244|540987977|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
150288943|NCT00264004|542192540|FG001|Overall Study|Other|2|||
150288944|NCT00264004|542192541|FG002|Overall Study|Other|0|||
150288945|NCT00264004|542192542|FG003|Overall Study|Other|3|||
149854521|NCT01190930|540595201|FG000|Maintenance|Still on therapy|0|||
149854522|NCT01190930|540595202|FG001|Maintenance|Still on therapy|8|||
149854523|NCT01190930|540595203|FG002|Maintenance|Still on therapy|0|||
149854524|NCT01190930|540595204|FG003|Maintenance|Still on therapy|29|||
149854525|NCT01190930|540595205|FG004|Maintenance|Still on therapy|0|||
149854526|NCT01190930|540595206|FG005|Maintenance|Still on therapy|0|||
149854527|NCT01190930|540595207|FG006|Maintenance|Still on therapy|0|||
149854528|NCT01190930|540595208|FG007|Maintenance|Still on therapy|0|||
149854529|NCT01190930|540595209|FG008|Maintenance|Still on therapy|0|||
149854530|NCT01190930|540595210|FG009|Maintenance|Still on therapy|0|||
149854531|NCT01628549|540595213|FG000|Overall Study|Adverse Event|1|||
149854532|NCT01628549|540595214|FG001|Overall Study|Adverse Event|1|||
149854533|NCT01628549|540595215|FG002|Overall Study|Adverse Event|0|||
149854534|NCT01628549|540595216|FG003|Overall Study|Adverse Event|4|||
149854535|NCT01628549|540595213|FG000|Overall Study|Lost to Follow-up|3|||
149854536|NCT01628549|540595214|FG001|Overall Study|Lost to Follow-up|4|||
149854537|NCT01628549|540595215|FG002|Overall Study|Lost to Follow-up|3|||
149854538|NCT01628549|540595216|FG003|Overall Study|Lost to Follow-up|3|||
149854539|NCT01628549|540595213|FG000|Overall Study|Withdrawal by Subject|3|||
149854540|NCT01628549|540595214|FG001|Overall Study|Withdrawal by Subject|4|||
149854541|NCT01628549|540595215|FG002|Overall Study|Withdrawal by Subject|4|||
149854542|NCT01628549|540595216|FG003|Overall Study|Withdrawal by Subject|1|||
149854543|NCT01628549|540595213|FG000|Overall Study|Protocol Violation|2|||
149854544|NCT01628549|540595214|FG001|Overall Study|Protocol Violation|1|||
149854545|NCT01628549|540595215|FG002|Overall Study|Protocol Violation|1|||
149854546|NCT01628549|540595216|FG003|Overall Study|Protocol Violation|0|||
149854547|NCT01628549|540595213|FG000|Overall Study|withdrawn for noncompliance|0|||
149854548|NCT01628549|540595214|FG001|Overall Study|withdrawn for noncompliance|2|||
149854549|NCT01628549|540595215|FG002|Overall Study|withdrawn for noncompliance|1|||
149854550|NCT01628549|540595216|FG003|Overall Study|withdrawn for noncompliance|0|||
149854551|NCT01628549|540595213|FG000|Overall Study|abnormal laboratory test results|0|||
149854552|NCT01628549|540595214|FG001|Overall Study|abnormal laboratory test results|0|||
149854553|NCT01628549|540595215|FG002|Overall Study|abnormal laboratory test results|1|||
149854554|NCT01628549|540595216|FG003|Overall Study|abnormal laboratory test results|0|||
149854555|NCT01628549|540595213|FG000|Overall Study|positive pregnancy test|0|||
149854556|NCT01628549|540595214|FG001|Overall Study|positive pregnancy test|0|||
149854557|NCT01628549|540595215|FG002|Overall Study|positive pregnancy test|0|||
149854558|NCT01628549|540595216|FG003|Overall Study|positive pregnancy test|1|||
149854559|NCT04205162|540595219|FG000|Overall Study|Lost to Follow-up|1|||
149854560|NCT04205162|540595220|FG001|Overall Study|Lost to Follow-up|0|||
149854561|NCT04205162|540595219|FG000|Overall Study|Withdrawal by Subject|2|||
150172960|NCT04424641|541769822|FG001|Overall Study|Sponsor decision|2|||
149854562|NCT04205162|540595220|FG001|Overall Study|Withdrawal by Subject|0|||
149854563|NCT04205162|540595219|FG000|Overall Study|University closure due to COVID-19|1|||
149854564|NCT04205162|540595220|FG001|Overall Study|University closure due to COVID-19|0|||
149854565|NCT01999894|540595221|FG000|Overall Study|Adverse Event|9|||
149854566|NCT01999894|540595221|FG000|Overall Study|Lack of Efficacy|5|||
149854567|NCT01999894|540595221|FG000|Overall Study|Protocol Violation|1|||
149854568|NCT01999894|540595221|FG000|Overall Study|Withdrawal by Subject|7|||
149854569|NCT01999894|540595221|FG000|Overall Study|Lost to Follow-up|10|||
149854570|NCT01999894|540595221|FG000|Overall Study|Other Reason|3|||
149854571|NCT01999894|540595221|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
149854572|NCT02914457|540595224|FG000|Overall Study|Withdrawal by Subject|1|||
149854573|NCT02914457|540595224|FG000|Overall Study|Physician Decision|1|||
149854574|NCT02914457|540595224|FG000|Overall Study|No veins available for lead placement|1|||
149854575|NCT02914457|540595224|FG000|Overall Study|Electrical instability of patient|1|||
149854576|NCT02914457|540595224|FG000|Overall Study|ECG acquisition error due to sweating|1|||
149854577|NCT02914457|540595224|FG000|Overall Study|Protocol Violation|1|||
149854578|NCT01450800|540595229|FG000|Overall Study|Protocol Violation|1|||
149854579|NCT01450800|540595230|FG001|Overall Study|Protocol Violation|3|||
149854580|NCT02058160|540595233|FG000|Overall Study|Randomized but not treated|2|||
149854581|NCT02058160|540595234|FG001|Overall Study|Randomized but not treated|4|||
149854582|NCT02058160|540595233|FG000|Overall Study|Poor compliance to protocol|4|||
149854583|NCT02058160|540595234|FG001|Overall Study|Poor compliance to protocol|1|||
149854584|NCT02058160|540595233|FG000|Overall Study|Adverse Event|12|||
149854585|NCT02058160|540595234|FG001|Overall Study|Adverse Event|3|||
149854586|NCT02058160|540595233|FG000|Overall Study|Lost to Follow-up|1|||
149854587|NCT02058160|540595234|FG001|Overall Study|Lost to Follow-up|0|||
149854588|NCT02058160|540595233|FG000|Overall Study|Other than specified above|12|||
149854589|NCT02058160|540595234|FG001|Overall Study|Other than specified above|6|||
149854590|NCT00152516|540595236|FG000|Overall Study|Adverse Event|18|||
149854591|NCT00152516|540595236|FG000|Overall Study|Lack and Loss of Efficacy|30|||
149854592|NCT00152516|540595236|FG000|Overall Study|Lost to Follow-up|5|||
149854593|NCT00152516|540595236|FG000|Overall Study|Withdrawal by Subject|8|||
149854594|NCT00152516|540595236|FG000|Overall Study|Protocol Violation|3|||
149854595|NCT00152516|540595236|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
149854596|NCT00152516|540595236|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
149854597|NCT00152516|540595236|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
149854598|NCT00152516|540595236|FG000|Overall Study|Other: Non-Compliance|2|||
149854599|NCT00152516|540595236|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
149854600|NCT00152516|540595236|FG000|Overall Study|Other: Moved Out Of State|1|||
149854601|NCT00152516|540595236|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
149854602|NCT00152516|540595236|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
149854603|NCT01086969|540595243|FG000|Overall Study|Withdrawal by Subject|1|||
149854604|NCT01086969|540595244|FG001|Overall Study|Withdrawal by Subject|2|||
149854605|NCT01086969|540595245|FG002|Overall Study|Withdrawal by Subject|0|||
149854606|NCT02762994|540595250|FG000|Overall Study|Withdrawal by Subject|0|||
149854607|NCT02762994|540595251|FG001|Overall Study|Withdrawal by Subject|1|||
149854608|NCT02762994|540595252|FG002|Overall Study|Withdrawal by Subject|2|||
149854609|NCT02762994|540595253|FG003|Overall Study|Withdrawal by Subject|0|||
149854610|NCT02762994|540595250|FG000|Overall Study|Protocol Violation|1|||
149854611|NCT02762994|540595251|FG001|Overall Study|Protocol Violation|0|||
149854612|NCT02762994|540595252|FG002|Overall Study|Protocol Violation|0|||
149854613|NCT02762994|540595253|FG003|Overall Study|Protocol Violation|2|||
149854614|NCT01488448|540595262|FG000|Overall Study|Withdrawal by Subject|3|||
149854615|NCT01488448|540595263|FG001|Overall Study|Withdrawal by Subject|1|||
149854616|NCT01488448|540595262|FG000|Overall Study|Adverse Event|9|||
149854617|NCT01488448|540595263|FG001|Overall Study|Adverse Event|4|||
149854618|NCT01488448|540595262|FG000|Overall Study|Physician Decision|4|||
149854619|NCT01488448|540595263|FG001|Overall Study|Physician Decision|9|||
149854620|NCT01488448|540595262|FG000|Overall Study|Protocol Violation|4|||
149854621|NCT01488448|540595263|FG001|Overall Study|Protocol Violation|3|||
149854622|NCT00654641|540595264|FG000|Overall Study|Lost to Follow-up|2|||
149854623|NCT00654641|540595265|FG001|Overall Study|Lost to Follow-up|3|||
149854624|NCT00810602|540595266|FG000|Overall Study|Withdrawal by Subject|8|||
149854625|NCT00810602|540595267|FG001|Overall Study|Withdrawal by Subject|3|||
149854626|NCT03840382|540595268|FG000|Overall Study|Lost to Follow-up|11|||
149854627|NCT00434590|540595269|FG000|Overall Study|Administrative problems|5|||
149854628|NCT00434590|540595270|FG001|Overall Study|Administrative problems|5|||
149854629|NCT03429049|540596974|FG000|Overall Study|Adverse Event|2|||
149854630|NCT03429049|540596975|FG001|Overall Study|Adverse Event|3|||
149854631|NCT03429049|540596974|FG000|Overall Study|Death|0|||
149854632|NCT03429049|540596975|FG001|Overall Study|Death|1|||
149854633|NCT03429049|540596974|FG000|Overall Study|Lack of Efficacy|4|||
149854634|NCT03429049|540596975|FG001|Overall Study|Lack of Efficacy|2|||
149854635|NCT03429049|540596974|FG000|Overall Study|Lost to Follow-up|9|||
149854636|NCT03429049|540596975|FG001|Overall Study|Lost to Follow-up|8|||
149854637|NCT03429049|540596974|FG000|Overall Study|Physician Decision|1|||
149854638|NCT03429049|540596975|FG001|Overall Study|Physician Decision|0|||
149854639|NCT03429049|540596974|FG000|Overall Study|Protocol Violation|3|||
149854640|NCT03429049|540596975|FG001|Overall Study|Protocol Violation|0|||
149854641|NCT03429049|540596974|FG000|Overall Study|Sponsor Decision|2|||
149854642|NCT03429049|540596975|FG001|Overall Study|Sponsor Decision|0|||
149854643|NCT03429049|540596974|FG000|Overall Study|Withdrawal by Subject|4|||
149854644|NCT03429049|540596975|FG001|Overall Study|Withdrawal by Subject|20|||
149854645|NCT03429049|540596974|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
149854646|NCT03429049|540596975|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
149854647|NCT04703855|540596976|FG000|Overall Study|Heart Transplant|1|||
149854648|NCT01560819|540596978|FG000|Overall Study|Physician Decision|1|||
149854649|NCT01560819|540596979|FG001|Overall Study|Physician Decision|0|||
149854650|NCT04412057|540596980|FG000|Overall Study|Death|3|||
149854651|NCT04412057|540596981|FG001|Overall Study|Death|7|||
149854652|NCT04412057|540596980|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
149959878|NCT01557244|540987978|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
149959879|NCT01557244|540987979|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
149959880|NCT01557244|540987980|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
149959881|NCT01557244|540987974|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
149959882|NCT01557244|540987975|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
149959883|NCT01557244|540987976|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
149959884|NCT01557244|540987977|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
149959885|NCT01557244|540987978|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
149854653|NCT04412057|540596981|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
149854654|NCT00114231|540596982|FG000|Overall Study|No consent|2|||
149854655|NCT00114231|540596983|FG001|Overall Study|No consent|0|||
149854656|NCT00114231|540596982|FG000|Overall Study|QARC requirement not met|1|||
149854657|NCT00114231|540596983|FG001|Overall Study|QARC requirement not met|0|||
149854658|NCT00114231|540596982|FG000|Overall Study|Suspected metastatic disease|1|||
150039623|NCT03847896|541285127|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149854659|NCT00114231|540596983|FG001|Overall Study|Suspected metastatic disease|0|||
149854660|NCT00114231|540596982|FG000|Overall Study|No adenocarcinoma|1|||
149854661|NCT00114231|540596983|FG001|Overall Study|No adenocarcinoma|0|||
149854662|NCT00114231|540596982|FG000|Overall Study|Low creatinine clearance|0|||
149854663|NCT00114231|540596983|FG001|Overall Study|Low creatinine clearance|1|||
149854664|NCT00114231|540596982|FG000|Overall Study|Tumor size > 4cm|1|||
149854665|NCT00114231|540596983|FG001|Overall Study|Tumor size > 4cm|0|||
149854666|NCT00114231|540596982|FG000|Overall Study|Tumor fixed on digital exam|0|||
149854667|NCT00114231|540596983|FG001|Overall Study|Tumor fixed on digital exam|1|||
149854668|NCT00114231|540596982|FG000|Overall Study|No Absolute Neutrophil Count|2|||
149854669|NCT00114231|540596983|FG001|Overall Study|No Absolute Neutrophil Count|0|||
149854670|NCT00114231|540596982|FG000|Overall Study|Biopsy done after registration|1|||
149854671|NCT00114231|540596983|FG001|Overall Study|Biopsy done after registration|0|||
149854672|NCT01961882|540596988|FG000|Overall Study|Adverse Event|3|||
149854673|NCT01961882|540596989|FG001|Overall Study|Adverse Event|2|||
149854674|NCT01961882|540596988|FG000|Overall Study|Physician Decision|1|||
149854675|NCT01961882|540596989|FG001|Overall Study|Physician Decision|0|||
149854676|NCT01961882|540596988|FG000|Overall Study|Withdrawal by Subject|4|||
149854677|NCT01961882|540596989|FG001|Overall Study|Withdrawal by Subject|1|||
149854678|NCT01961882|540596988|FG000|Overall Study|Relapse of AML|39|||
149854679|NCT01961882|540596989|FG001|Overall Study|Relapse of AML|37|||
149854680|NCT01961882|540596988|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
149854681|NCT01961882|540596989|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
149854682|NCT01961882|540596988|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
149854683|NCT01961882|540596989|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
149854684|NCT03710590|540596996|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
149854685|NCT03710590|540596997|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
149854686|NCT02488824|540596998|FG000|Overall Study|Adverse Event|1|||
149854687|NCT02488824|540596999|FG001|Overall Study|Adverse Event|1|||
149854688|NCT02668822|540597004|FG000|Overall Study|Protocol Violation|2|||
149854689|NCT02668822|540597005|FG001|Overall Study|Protocol Violation|0|||
149854690|NCT02668822|540597004|FG000|Overall Study|Study Terminated by Sponsor|7|||
149854691|NCT02668822|540597005|FG001|Overall Study|Study Terminated by Sponsor|9|||
149854692|NCT01522950|540597006|FG000|Overall Study|Withdrawal by Subject|3|||
149854693|NCT01522950|540597007|FG001|Overall Study|Withdrawal by Subject|2|||
149854694|NCT01522950|540597008|FG002|Overall Study|Withdrawal by Subject|1|||
149854695|NCT01522950|540597006|FG000|Overall Study|Adverse Event|3|||
149854696|NCT01522950|540597007|FG001|Overall Study|Adverse Event|1|||
149854697|NCT01522950|540597008|FG002|Overall Study|Adverse Event|1|||
149854698|NCT01522950|540597006|FG000|Overall Study|Protocol Violation|0|||
149854699|NCT01522950|540597007|FG001|Overall Study|Protocol Violation|0|||
149854700|NCT01522950|540597008|FG002|Overall Study|Protocol Violation|2|||
149854701|NCT01522950|540597006|FG000|Overall Study|Death|0|||
149854702|NCT01522950|540597007|FG001|Overall Study|Death|1|||
149854703|NCT01522950|540597008|FG002|Overall Study|Death|1|||
149854704|NCT01522950|540597006|FG000|Overall Study|Study Medication Sensitivity|0|||
149854705|NCT01522950|540597007|FG001|Overall Study|Study Medication Sensitivity|1|||
149854706|NCT01522950|540597008|FG002|Overall Study|Study Medication Sensitivity|0|||
149854707|NCT03036839|540597011|FG000|Overall Study|Adverse Event|0|||
149854708|NCT03036839|540597012|FG001|Overall Study|Adverse Event|0|||
149854709|NCT03036839|540597013|FG002|Overall Study|Adverse Event|1|||
149854710|NCT03036839|540597011|FG000|Overall Study|Death|3|||
149854711|NCT03036839|540597012|FG001|Overall Study|Death|0|||
149854712|NCT03036839|540597013|FG002|Overall Study|Death|3|||
149854713|NCT03036839|540597011|FG000|Overall Study|Withdrew Consent|0|||
149854714|NCT03036839|540597012|FG001|Overall Study|Withdrew Consent|0|||
149854715|NCT03036839|540597013|FG002|Overall Study|Withdrew Consent|1|||
149854716|NCT00412737|540597015|FG000|Overall Study|Death|1|||
149854717|NCT00412737|540597016|FG001|Overall Study|Death|0|||
149854718|NCT00412737|540597015|FG000|Overall Study|Adverse Event|3|||
149854719|NCT00412737|540597016|FG001|Overall Study|Adverse Event|2|||
149959886|NCT01557244|540987979|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
149959887|NCT01557244|540987980|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
149959888|NCT01557244|540987974|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
149959889|NCT01557244|540987975|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
149959890|NCT01557244|540987976|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
149959891|NCT01557244|540987977|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
149959892|NCT01557244|540987978|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
149959893|NCT01557244|540987979|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
149959894|NCT01557244|540987980|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
149854720|NCT00412737|540597015|FG000|Overall Study|Refused Treatment|6|||
149959895|NCT01557244|540987974|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149854721|NCT00412737|540597016|FG001|Overall Study|Refused Treatment|2|||
149854722|NCT00412737|540597015|FG000|Overall Study|Failure to Return|6|||
149854723|NCT00412737|540597016|FG001|Overall Study|Failure to Return|2|||
149854724|NCT01064531|540597018|FG000|Overall Study|Lost to Follow-up|0|||
149854725|NCT01064531|540597019|FG001|Overall Study|Lost to Follow-up|2|||
149854726|NCT01064531|540597018|FG000|Overall Study|Physician Decision|0|||
149854727|NCT01064531|540597019|FG001|Overall Study|Physician Decision|1|||
149854728|NCT01064531|540597018|FG000|Overall Study|Withdrawal by Subject|2|||
149854729|NCT01064531|540597019|FG001|Overall Study|Withdrawal by Subject|2|||
149854730|NCT01064531|540597018|FG000|Overall Study|Revision due to femoral stem loosening|1|||
149854731|NCT01064531|540597019|FG001|Overall Study|Revision due to femoral stem loosening|0|||
149854732|NCT01064531|540597018|FG000|Overall Study|Revision due to dislocation|0|||
149854733|NCT01064531|540597019|FG001|Overall Study|Revision due to dislocation|1|||
149854734|NCT01064531|540597018|FG000|Overall Study|Death|0|||
149854735|NCT01064531|540597019|FG001|Overall Study|Death|1|||
149854736|NCT00298740|540597020|FG000|Overall Study|Lack of Efficacy|6|||
149854737|NCT00298740|540597020|FG000|Overall Study|Withdrawal by Subject|3|||
149854738|NCT01091103|540597025|FG000|Overall Study|Adverse Event|1|||
149854739|NCT01091103|540597025|FG000|Overall Study|Progressive Disease|3|||
149854740|NCT01270620|540597026|FG000|Overall Study|Withdrawal by Subject|1|||
149854741|NCT01270620|540597027|FG001|Overall Study|Withdrawal by Subject|3|||
149854742|NCT00684567|540597028|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
149854743|NCT00684567|540597028|FG000|Monotherapy Period|Adverse Event|2|||
149854744|NCT00684567|540597028|FG000|Monotherapy Period|Death|1|||
149854745|NCT00684567|540597028|FG000|Monotherapy Period|Progression of primary disease|11|||
149854746|NCT03136406|540597029|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
149854747|NCT01201759|540597030|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
149854748|NCT01201759|540597031|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
149854749|NCT01201759|540597030|FG000|Visit 3 - Washout|Adverse Event|0|||
149854750|NCT01201759|540597031|FG001|Visit 3 - Washout|Adverse Event|3|||
149854751|NCT01201759|540597030|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
149854752|NCT01201759|540597031|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
149854753|NCT01201759|540597030|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
149854754|NCT01201759|540597031|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
149854755|NCT01045707|540597032|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
149854756|NCT01045707|540597033|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
149854757|NCT01045707|540597032|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
149854758|NCT01045707|540597033|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
149854759|NCT01045707|540597032|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
149854760|NCT01045707|540597033|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
149854761|NCT01045707|540597032|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
149854762|NCT01045707|540597033|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
149854763|NCT01045707|540597032|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
149854764|NCT01045707|540597033|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
149854765|NCT01045707|540597032|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
149854766|NCT01045707|540597033|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
149854767|NCT01045707|540597032|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
149854768|NCT01045707|540597033|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
149854769|NCT01045707|540597032|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
149854770|NCT01045707|540597033|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
149854771|NCT01045707|540597032|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
149854772|NCT01045707|540597033|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
149854773|NCT02744755|540597034|FG000|Study Period 1|Protocol Violation|2|||
149854774|NCT02744755|540597035|FG001|Study Period 1|Protocol Violation|1|||
149854775|NCT02744755|540597034|FG000|Study Period 1|not defined|0|||
150039624|NCT03847896|541285128|FG003|Overall Study|Withdrawal by parent/guardian|0|||
150039625|NCT03847896|541285129|FG004|Overall Study|Withdrawal by parent/guardian|0|||
150039626|NCT03847896|541285125|FG000|Overall Study|Adverse Event|2|||
150039627|NCT03847896|541285126|FG001|Overall Study|Adverse Event|1|||
150039628|NCT03847896|541285127|FG002|Overall Study|Adverse Event|3|||
150039629|NCT03847896|541285128|FG003|Overall Study|Adverse Event|2|||
150039630|NCT03847896|541285129|FG004|Overall Study|Adverse Event|4|||
150039631|NCT03847896|541285125|FG000|Overall Study|A severe exacerbation event|0|||
150039632|NCT03847896|541285126|FG001|Overall Study|A severe exacerbation event|0|||
150039633|NCT03847896|541285127|FG002|Overall Study|A severe exacerbation event|0|||
150039634|NCT03847896|541285128|FG003|Overall Study|A severe exacerbation event|0|||
150039635|NCT03847896|541285129|FG004|Overall Study|A severe exacerbation event|3|||
150039636|NCT03847896|541285125|FG000|Overall Study|Protocol Violation|0|||
150039637|NCT03847896|541285126|FG001|Overall Study|Protocol Violation|2|||
149854776|NCT02744755|540597035|FG001|Study Period 1|not defined|1|||
149854777|NCT02744755|540597034|FG000|Study Period 1|Pregnancy|1|||
149854778|NCT02744755|540597035|FG001|Study Period 1|Pregnancy|0|||
149854779|NCT02744755|540597034|FG000|Study Period 1|Adverse Event|1|||
149854780|NCT02744755|540597035|FG001|Study Period 1|Adverse Event|1|||
150039638|NCT03847896|541285127|FG002|Overall Study|Protocol Violation|1|||
149854781|NCT02744755|540597034|FG000|Study Period 1|Lost to Follow-up|1|||
149854782|NCT02744755|540597035|FG001|Study Period 1|Lost to Follow-up|1|||
150039639|NCT03847896|541285128|FG003|Overall Study|Protocol Violation|0|||
150039640|NCT03847896|541285129|FG004|Overall Study|Protocol Violation|2|||
150039641|NCT03847896|541285125|FG000|Overall Study|Lost to Follow-up|0|||
150039642|NCT03847896|541285126|FG001|Overall Study|Lost to Follow-up|0|||
150039643|NCT03847896|541285127|FG002|Overall Study|Lost to Follow-up|0|||
150039644|NCT03847896|541285128|FG003|Overall Study|Lost to Follow-up|1|||
150039645|NCT03847896|541285129|FG004|Overall Study|Lost to Follow-up|0|||
150039646|NCT03847896|541285125|FG000|Overall Study|Condition under investigation worsened|0|||
150039647|NCT03847896|541285126|FG001|Overall Study|Condition under investigation worsened|0|||
150039648|NCT03847896|541285127|FG002|Overall Study|Condition under investigation worsened|0|||
150039649|NCT03847896|541285128|FG003|Overall Study|Condition under investigation worsened|1|||
150039650|NCT03847896|541285129|FG004|Overall Study|Condition under investigation worsened|1|||
150039651|NCT03847896|541285125|FG000|Overall Study|Lack of Efficacy|0|||
149854783|NCT02744755|540597034|FG000|Study Period 1|Lack of Efficacy|1|||
149854784|NCT02744755|540597035|FG001|Study Period 1|Lack of Efficacy|0|||
149854785|NCT02744755|540597034|FG000|Study Period 1|Withdrawal by Subject|8|||
149854786|NCT02744755|540597035|FG001|Study Period 1|Withdrawal by Subject|4|||
149854787|NCT02744755|540597034|FG000|Study Period 2|Adverse Event|5|||
149854788|NCT02744755|540597035|FG001|Study Period 2|Adverse Event|0|||
149854789|NCT02744755|540597034|FG000|Study Period 2|Protocol Violation|1|||
149854790|NCT02744755|540597035|FG001|Study Period 2|Protocol Violation|0|||
149854791|NCT02744755|540597034|FG000|Study Period 2|not defined|3|||
149854792|NCT02744755|540597035|FG001|Study Period 2|not defined|2|||
149854793|NCT02744755|540597034|FG000|Study Period 2|Lost to Follow-up|0|||
149854794|NCT02744755|540597035|FG001|Study Period 2|Lost to Follow-up|2|||
149854795|NCT02744755|540597034|FG000|Study Period 2|Withdrawal by Subject|2|||
149854796|NCT02744755|540597035|FG001|Study Period 2|Withdrawal by Subject|2|||
149854797|NCT02744755|540597034|FG000|Study Period 2|Lack of Efficacy|3|||
149854798|NCT02744755|540597035|FG001|Study Period 2|Lack of Efficacy|2|||
149854799|NCT04317599|540597036|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
149854800|NCT04317599|540597036|FG000|Overall Study|treatment outside standard of care|4|||
149854801|NCT00809965|540597037|FG000|Overall Study|Death|194|||
149854802|NCT00809965|540597038|FG001|Overall Study|Death|147|||
149854803|NCT00809965|540597039|FG002|Overall Study|Death|196|||
149854804|NCT00809965|540597037|FG000|Overall Study|Lost to Follow-up|17|||
149854805|NCT00809965|540597038|FG001|Overall Study|Lost to Follow-up|10|||
149854806|NCT00809965|540597039|FG002|Overall Study|Lost to Follow-up|18|||
149854807|NCT00809965|540597037|FG000|Overall Study|Withdrawal by Subject|405|||
149854808|NCT00809965|540597038|FG001|Overall Study|Withdrawal by Subject|448|||
149854809|NCT00809965|540597039|FG002|Overall Study|Withdrawal by Subject|441|||
149854810|NCT00809965|540597037|FG000|Overall Study|Other Reason|167|||
149854811|NCT00809965|540597038|FG001|Overall Study|Other Reason|170|||
149854812|NCT00809965|540597039|FG002|Overall Study|Other Reason|189|||
149854813|NCT02780167|540597040|FG000|Overall Study|Adverse Event|9|||
149854814|NCT02780167|540597041|FG001|Overall Study|Adverse Event|8|||
149854815|NCT02780167|540597042|FG002|Overall Study|Adverse Event|8|||
149854816|NCT02780167|540597043|FG003|Overall Study|Adverse Event|12|||
149854817|NCT02780167|540597044|FG004|Overall Study|Adverse Event|8|||
149854818|NCT02780167|540597040|FG000|Overall Study|Lack of Efficacy|6|||
149854819|NCT02780167|540597041|FG001|Overall Study|Lack of Efficacy|5|||
149854820|NCT02780167|540597042|FG002|Overall Study|Lack of Efficacy|6|||
149854821|NCT02780167|540597043|FG003|Overall Study|Lack of Efficacy|1|||
149854822|NCT02780167|540597044|FG004|Overall Study|Lack of Efficacy|0|||
149854823|NCT02780167|540597040|FG000|Overall Study|Lost to Follow-up|2|||
149854824|NCT02780167|540597041|FG001|Overall Study|Lost to Follow-up|0|||
149854825|NCT02780167|540597042|FG002|Overall Study|Lost to Follow-up|1|||
149854826|NCT02780167|540597043|FG003|Overall Study|Lost to Follow-up|0|||
149854827|NCT02780167|540597044|FG004|Overall Study|Lost to Follow-up|0|||
149854828|NCT02780167|540597040|FG000|Overall Study|Does not meet entrance criteria|0|||
149854829|NCT02780167|540597041|FG001|Overall Study|Does not meet entrance criteria|0|||
149854830|NCT02780167|540597042|FG002|Overall Study|Does not meet entrance criteria|1|||
149854831|NCT02780167|540597043|FG003|Overall Study|Does not meet entrance criteria|0|||
149854832|NCT02780167|540597044|FG004|Overall Study|Does not meet entrance criteria|0|||
149854833|NCT02780167|540597040|FG000|Overall Study|No longer meets eligibility criteria|0|||
149854834|NCT02780167|540597041|FG001|Overall Study|No longer meets eligibility criteria|0|||
149854835|NCT02780167|540597042|FG002|Overall Study|No longer meets eligibility criteria|0|||
149854836|NCT02780167|540597043|FG003|Overall Study|No longer meets eligibility criteria|1|||
149854837|NCT02780167|540597044|FG004|Overall Study|No longer meets eligibility criteria|1|||
149854838|NCT02780167|540597040|FG000|Overall Study|Protocol Violation|5|||
149854839|NCT02780167|540597041|FG001|Overall Study|Protocol Violation|5|||
149854840|NCT02780167|540597042|FG002|Overall Study|Protocol Violation|1|||
149854841|NCT02780167|540597043|FG003|Overall Study|Protocol Violation|1|||
149854842|NCT02780167|540597044|FG004|Overall Study|Protocol Violation|2|||
150039652|NCT03847896|541285126|FG001|Overall Study|Lack of Efficacy|0|||
150039653|NCT03847896|541285127|FG002|Overall Study|Lack of Efficacy|0|||
150172961|NCT04424641|541769823|FG002|Overall Study|Sponsor decision|3|||
150288946|NCT00264004|542192539|FG000|Overall Study|Development study specific disc. crit.|1|||
150172962|NCT04424641|541769824|FG003|Overall Study|Sponsor decision|7|||
150172963|NCT04424641|541769825|FG004|Overall Study|Sponsor decision|2|||
150172964|NCT04424641|541769826|FG005|Overall Study|Sponsor decision|2|||
150172965|NCT04424641|541769827|FG006|Overall Study|Sponsor decision|3|||
150172966|NCT04424641|541769828|FG007|Overall Study|Sponsor decision|4|||
150172967|NCT04424641|541769821|FG000|Overall Study|Withdrawal by Subject|0|||
149854843|NCT02780167|540597040|FG000|Overall Study|Withdrawal by Subject|6|||
149854844|NCT02780167|540597041|FG001|Overall Study|Withdrawal by Subject|4|||
149854845|NCT02780167|540597042|FG002|Overall Study|Withdrawal by Subject|4|||
149854846|NCT02780167|540597043|FG003|Overall Study|Withdrawal by Subject|3|||
149854847|NCT02780167|540597044|FG004|Overall Study|Withdrawal by Subject|4|||
149854848|NCT02780167|540597040|FG000|Overall Study|Other|0|||
149854849|NCT02780167|540597041|FG001|Overall Study|Other|0|||
149854850|NCT02780167|540597042|FG002|Overall Study|Other|3|||
149854851|NCT02780167|540597043|FG003|Overall Study|Other|1|||
149854852|NCT02780167|540597044|FG004|Overall Study|Other|2|||
149854853|NCT02315066|540597045|FG000|Overall Study|Lost to Follow-up|0|||
149854854|NCT02315066|540597046|FG001|Overall Study|Lost to Follow-up|1|||
149854855|NCT02315066|540597047|FG002|Overall Study|Lost to Follow-up|1|||
149854856|NCT02315066|540597048|FG003|Overall Study|Lost to Follow-up|0|||
149854857|NCT02315066|540597049|FG004|Overall Study|Lost to Follow-up|1|||
149854858|NCT02315066|540597050|FG005|Overall Study|Lost to Follow-up|0|||
149854859|NCT02315066|540597051|FG006|Overall Study|Lost to Follow-up|2|||
149854860|NCT02315066|540597052|FG007|Overall Study|Lost to Follow-up|1|||
149854861|NCT02315066|540597053|FG008|Overall Study|Lost to Follow-up|0|||
149854862|NCT02315066|540597054|FG009|Overall Study|Lost to Follow-up|0|||
149854863|NCT02315066|540597055|FG010|Overall Study|Lost to Follow-up|1|||
149854864|NCT02315066|540597056|FG011|Overall Study|Lost to Follow-up|2|||
149854865|NCT02315066|540597057|FG012|Overall Study|Lost to Follow-up|0|||
149854866|NCT02315066|540597058|FG013|Overall Study|Lost to Follow-up|4|||
149854867|NCT02315066|540597045|FG000|Overall Study|Death|2|||
149854868|NCT02315066|540597046|FG001|Overall Study|Death|7|||
149854869|NCT02315066|540597047|FG002|Overall Study|Death|6|||
149854870|NCT02315066|540597048|FG003|Overall Study|Death|11|||
149854871|NCT02315066|540597049|FG004|Overall Study|Death|10|||
149854872|NCT02315066|540597050|FG005|Overall Study|Death|3|||
149854873|NCT02315066|540597051|FG006|Overall Study|Death|9|||
149854874|NCT02315066|540597052|FG007|Overall Study|Death|9|||
149854875|NCT02315066|540597053|FG008|Overall Study|Death|10|||
149854876|NCT02315066|540597054|FG009|Overall Study|Death|8|||
149854877|NCT02315066|540597055|FG010|Overall Study|Death|10|||
149854878|NCT02315066|540597056|FG011|Overall Study|Death|7|||
149854879|NCT02315066|540597057|FG012|Overall Study|Death|8|||
149854880|NCT02315066|540597058|FG013|Overall Study|Death|21|||
149854881|NCT02315066|540597045|FG000|Overall Study|Other|0|||
149854882|NCT02315066|540597046|FG001|Overall Study|Other|0|||
149854883|NCT02315066|540597047|FG002|Overall Study|Other|0|||
149854884|NCT02315066|540597048|FG003|Overall Study|Other|0|||
149854885|NCT02315066|540597049|FG004|Overall Study|Other|0|||
149854886|NCT02315066|540597050|FG005|Overall Study|Other|0|||
149854887|NCT02315066|540597051|FG006|Overall Study|Other|0|||
149854888|NCT02315066|540597052|FG007|Overall Study|Other|1|||
149854889|NCT02315066|540597053|FG008|Overall Study|Other|1|||
149854890|NCT02315066|540597054|FG009|Overall Study|Other|2|||
149854891|NCT02315066|540597055|FG010|Overall Study|Other|0|||
150172968|NCT04424641|541769822|FG001|Overall Study|Withdrawal by Subject|0|||
150172969|NCT04424641|541769823|FG002|Overall Study|Withdrawal by Subject|0|||
150172970|NCT04424641|541769824|FG003|Overall Study|Withdrawal by Subject|0|||
150172971|NCT04424641|541769825|FG004|Overall Study|Withdrawal by Subject|1|||
150172972|NCT04424641|541769826|FG005|Overall Study|Withdrawal by Subject|0|||
150172973|NCT04424641|541769827|FG006|Overall Study|Withdrawal by Subject|0|||
150172974|NCT04424641|541769828|FG007|Overall Study|Withdrawal by Subject|0|||
150172975|NCT04424641|541769821|FG000|Overall Study|Other|0|||
150172976|NCT04424641|541769822|FG001|Overall Study|Other|0|||
150172977|NCT04424641|541769823|FG002|Overall Study|Other|1|||
150172978|NCT04424641|541769824|FG003|Overall Study|Other|0|||
150039654|NCT03847896|541285128|FG003|Overall Study|Lack of Efficacy|2|||
150039655|NCT03847896|541285129|FG004|Overall Study|Lack of Efficacy|2|||
150039656|NCT03847896|541285125|FG000|Overall Study|Other reasons|3|||
150039657|NCT03847896|541285126|FG001|Overall Study|Other reasons|3|||
150172979|NCT04424641|541769825|FG004|Overall Study|Other|0|||
149854892|NCT02315066|540597056|FG011|Overall Study|Other|0|||
149854893|NCT02315066|540597057|FG012|Overall Study|Other|0|||
149854894|NCT02315066|540597058|FG013|Overall Study|Other|0|||
149854895|NCT02315066|540597045|FG000|Overall Study|Subject refused further follow-up|0|||
149854896|NCT02315066|540597046|FG001|Overall Study|Subject refused further follow-up|2|||
150172980|NCT04424641|541769826|FG005|Overall Study|Other|0|||
149854897|NCT02315066|540597047|FG002|Overall Study|Subject refused further follow-up|2|||
149854898|NCT02315066|540597048|FG003|Overall Study|Subject refused further follow-up|0|||
149854899|NCT02315066|540597049|FG004|Overall Study|Subject refused further follow-up|0|||
149854900|NCT02315066|540597050|FG005|Overall Study|Subject refused further follow-up|0|||
149854901|NCT02315066|540597051|FG006|Overall Study|Subject refused further follow-up|2|||
149854902|NCT02315066|540597052|FG007|Overall Study|Subject refused further follow-up|3|||
149854903|NCT02315066|540597053|FG008|Overall Study|Subject refused further follow-up|0|||
149854904|NCT02315066|540597054|FG009|Overall Study|Subject refused further follow-up|1|||
149854905|NCT02315066|540597055|FG010|Overall Study|Subject refused further follow-up|1|||
149959896|NCT01557244|540987975|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149959897|NCT01557244|540987976|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149854906|NCT02315066|540597056|FG011|Overall Study|Subject refused further follow-up|2|||
149959898|NCT01557244|540987977|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
149959899|NCT01557244|540987978|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149959900|NCT01557244|540987979|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149959901|NCT01557244|540987980|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149959902|NCT01557244|540987974|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
149959903|NCT01557244|540987975|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
149959904|NCT01557244|540987976|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
149959905|NCT01557244|540987977|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
149959906|NCT01557244|540987978|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
149959907|NCT01557244|540987979|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
149959908|NCT01557244|540987980|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
149959909|NCT01313676|540987981|FG000|Overall Study|Adverse Event|395|||
149959910|NCT01313676|540987982|FG001|Overall Study|Adverse Event|365|||
149959911|NCT01313676|540987983|FG002|Overall Study|Adverse Event|372|||
149959912|NCT01313676|540987984|FG003|Overall Study|Adverse Event|333|||
149959913|NCT01313676|540987981|FG000|Overall Study|Lack of Efficacy|98|||
149959914|NCT01313676|540987982|FG001|Overall Study|Lack of Efficacy|90|||
149959915|NCT01313676|540987983|FG002|Overall Study|Lack of Efficacy|65|||
149959916|NCT01313676|540987984|FG003|Overall Study|Lack of Efficacy|46|||
149959917|NCT01313676|540987981|FG000|Overall Study|Protocol Violation|37|||
149959918|NCT01313676|540987982|FG001|Overall Study|Protocol Violation|44|||
149959919|NCT01313676|540987983|FG002|Overall Study|Protocol Violation|46|||
149959920|NCT01313676|540987984|FG003|Overall Study|Protocol Violation|44|||
149959921|NCT01313676|540987981|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
149959922|NCT01313676|540987982|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
149959923|NCT01313676|540987983|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
149959924|NCT01313676|540987984|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
149959925|NCT01313676|540987981|FG000|Overall Study|Study Closed/terminated|7|||
149959926|NCT01313676|540987982|FG001|Overall Study|Study Closed/terminated|6|||
149959927|NCT01313676|540987983|FG002|Overall Study|Study Closed/terminated|9|||
149959928|NCT01313676|540987984|FG003|Overall Study|Study Closed/terminated|9|||
149959929|NCT01313676|540987981|FG000|Overall Study|Lost to Follow-up|0|||
149959930|NCT01313676|540987982|FG001|Overall Study|Lost to Follow-up|0|||
149959931|NCT01313676|540987983|FG002|Overall Study|Lost to Follow-up|1|||
149959932|NCT01313676|540987984|FG003|Overall Study|Lost to Follow-up|0|||
149959933|NCT01313676|540987981|FG000|Overall Study|Physician Decision|53|||
149959934|NCT01313676|540987982|FG001|Overall Study|Physician Decision|64|||
149959935|NCT01313676|540987983|FG002|Overall Study|Physician Decision|62|||
149959936|NCT01313676|540987984|FG003|Overall Study|Physician Decision|48|||
149959937|NCT01313676|540987981|FG000|Overall Study|Decision by Participant or Proxy|643|||
149959938|NCT01313676|540987982|FG001|Overall Study|Decision by Participant or Proxy|527|||
149959939|NCT01313676|540987983|FG002|Overall Study|Decision by Participant or Proxy|515|||
149959940|NCT01313676|540987984|FG003|Overall Study|Decision by Participant or Proxy|492|||
149959941|NCT01313676|540987981|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
149959942|NCT01313676|540987982|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
149959943|NCT01313676|540987983|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
149959944|NCT01313676|540987984|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
149959945|NCT01313676|540987981|FG000|Overall Study|Investigator Site Closed|12|||
149959946|NCT01313676|540987982|FG001|Overall Study|Investigator Site Closed|11|||
149959947|NCT01313676|540987983|FG002|Overall Study|Investigator Site Closed|15|||
149959948|NCT01313676|540987984|FG003|Overall Study|Investigator Site Closed|10|||
149959949|NCT01313676|540987981|FG000|Overall Study|Missing|1|||
149959950|NCT01313676|540987982|FG001|Overall Study|Missing|1|||
149959951|NCT01313676|540987983|FG002|Overall Study|Missing|1|||
149959952|NCT01313676|540987984|FG003|Overall Study|Missing|0|||
149959953|NCT02469961|540987991|FG000|Overall Study|Physician Decision|4|||
149959954|NCT02469961|540987992|FG001|Overall Study|Physician Decision|1|||
149959955|NCT00326495|540987995|FG000|Overall Study|Switched to alternative treatment|1|||
149854907|NCT02315066|540597057|FG012|Overall Study|Subject refused further follow-up|2|||
149854908|NCT02315066|540597058|FG013|Overall Study|Subject refused further follow-up|4|||
149854909|NCT02315066|540597045|FG000|Overall Study|Study ongoing at date of cut-off|0|||
149959956|NCT00326495|540987995|FG000|Overall Study|Disease progression before treatment|1|||
149959957|NCT00326495|540987995|FG000|Overall Study|Refused further treatment|2|||
149959958|NCT00326495|540987995|FG000|Overall Study|Subject off study before assessment|1|||
150039658|NCT03847896|541285127|FG002|Overall Study|Other reasons|1|||
149854910|NCT02315066|540597046|FG001|Overall Study|Study ongoing at date of cut-off|0|||
149854911|NCT02315066|540597047|FG002|Overall Study|Study ongoing at date of cut-off|0|||
149854912|NCT02315066|540597048|FG003|Overall Study|Study ongoing at date of cut-off|0|||
149854913|NCT02315066|540597049|FG004|Overall Study|Study ongoing at date of cut-off|0|||
149854914|NCT02315066|540597050|FG005|Overall Study|Study ongoing at date of cut-off|0|||
149854915|NCT02315066|540597051|FG006|Overall Study|Study ongoing at date of cut-off|0|||
149854916|NCT02315066|540597052|FG007|Overall Study|Study ongoing at date of cut-off|0|||
149854917|NCT02315066|540597053|FG008|Overall Study|Study ongoing at date of cut-off|0|||
149854918|NCT02315066|540597054|FG009|Overall Study|Study ongoing at date of cut-off|0|||
149854919|NCT02315066|540597055|FG010|Overall Study|Study ongoing at date of cut-off|0|||
149854920|NCT02315066|540597056|FG011|Overall Study|Study ongoing at date of cut-off|0|||
149854921|NCT02315066|540597057|FG012|Overall Study|Study ongoing at date of cut-off|0|||
149854922|NCT02315066|540597058|FG013|Overall Study|Study ongoing at date of cut-off|1|||
149854923|NCT00035555|540597059|FG000|Overall Study|Adverse Event|5|||
149854924|NCT00035555|540597060|FG001|Overall Study|Adverse Event|8|||
149854925|NCT00035555|540597061|FG002|Overall Study|Adverse Event|9|||
149854926|NCT00035555|540597059|FG000|Overall Study|Allograft loss|1|||
149854927|NCT00035555|540597060|FG001|Overall Study|Allograft loss|1|||
149854928|NCT00035555|540597061|FG002|Overall Study|Allograft loss|2|||
149959959|NCT02933151|540987996|FG000|Overall Study|Lost to Follow-up|19|||
149959960|NCT02933151|540987997|FG001|Overall Study|Lost to Follow-up|18|||
149959961|NCT02933151|540987996|FG000|Overall Study|Death|1732|||
149959962|NCT02933151|540987997|FG001|Overall Study|Death|1827|||
149959963|NCT02933151|540987996|FG000|Overall Study|Transplant|210|||
149959964|NCT02933151|540987997|FG001|Overall Study|Transplant|278|||
149959965|NCT02933151|540987996|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
149959966|NCT02933151|540987997|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
149959967|NCT02933151|540987996|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
149959968|NCT02933151|540987997|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
149959969|NCT02933151|540987996|FG000|Overall Study|Recovered Kidney Function|47|||
149959970|NCT02933151|540987997|FG001|Overall Study|Recovered Kidney Function|29|||
149959971|NCT00394472|540987998|FG000|Overall Study|Protocol Violation|1|||
149959972|NCT00394472|540987999|FG001|Overall Study|Protocol Violation|3|||
149959973|NCT00394472|540987998|FG000|Overall Study|incorrect enrolment|4|||
149959974|NCT00394472|540987999|FG001|Overall Study|incorrect enrolment|2|||
149959975|NCT00394472|540987998|FG000|Overall Study|Adverse Event|4|||
149959976|NCT00394472|540987999|FG001|Overall Study|Adverse Event|2|||
149959977|NCT00394472|540987998|FG000|Overall Study|Withdrawal by Subject|0|||
149959978|NCT00394472|540987999|FG001|Overall Study|Withdrawal by Subject|2|||
149959979|NCT00394472|540987998|FG000|Overall Study|Physician Decision|0|||
149959980|NCT00394472|540987999|FG001|Overall Study|Physician Decision|1|||
149959981|NCT00394472|540987998|FG000|Overall Study|Lost to Follow-up|0|||
149959982|NCT00394472|540987999|FG001|Overall Study|Lost to Follow-up|1|||
149959983|NCT02802865|540988002|FG000|Overall Study|Pregnancy|1|||
149959984|NCT02802865|540988003|FG001|Overall Study|Pregnancy|1|||
149959985|NCT02802865|540988002|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
149959986|NCT02802865|540988003|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
149959987|NCT01230814|540988005|FG000|Overall Study|Lost to Follow-up|11|||
149959988|NCT01230814|540988006|FG001|Overall Study|Lost to Follow-up|3|||
149959989|NCT01230814|540988005|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
149959990|NCT01230814|540988006|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
149959991|NCT02004275|540988010|FG000|Phase 1|Ineligible|0|||
149959992|NCT02004275|540988011|FG001|Phase 1|Ineligible|0|||
149959993|NCT02004275|540988012|FG002|Phase 1|Ineligible|0|||
149959994|NCT02004275|540988013|FG003|Phase 1|Ineligible|1|||
149959995|NCT02004275|540988014|FG004|Phase 1|Ineligible|1|||
149959996|NCT02004275|540988015|FG005|Phase 1|Ineligible|0|||
149959997|NCT02004275|540988010|FG000|Phase 1|Protocol Violation|0|||
149959998|NCT02004275|540988011|FG001|Phase 1|Protocol Violation|0|||
149959999|NCT02004275|540988012|FG002|Phase 1|Protocol Violation|0|||
149960000|NCT02004275|540988013|FG003|Phase 1|Protocol Violation|1|||
149960001|NCT02004275|540988014|FG004|Phase 1|Protocol Violation|0|||
149960002|NCT02004275|540988015|FG005|Phase 1|Protocol Violation|5|||
149960003|NCT02004275|540988010|FG000|Phase 2 Part 1|Ineligible|6|||
149960004|NCT02004275|540988011|FG001|Phase 2 Part 1|Ineligible|9|||
149960005|NCT02004275|540988012|FG002|Phase 2 Part 1|Ineligible|0|||
149960006|NCT02004275|540988013|FG003|Phase 2 Part 1|Ineligible|0|||
149960007|NCT02004275|540988014|FG004|Phase 2 Part 1|Ineligible|0|||
149960008|NCT02004275|540988015|FG005|Phase 2 Part 1|Ineligible|0|||
149960009|NCT02004275|540988010|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
149960010|NCT02004275|540988011|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
149960011|NCT02004275|540988012|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
149960012|NCT02004275|540988013|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
149960013|NCT02004275|540988014|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
149960014|NCT02004275|540988015|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
149960015|NCT00292370|540988016|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
149960016|NCT00292370|540988017|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
149854929|NCT00035555|540597059|FG000|Overall Study|Death|0|||
149854930|NCT00035555|540597060|FG001|Overall Study|Death|0|||
149854931|NCT00035555|540597061|FG002|Overall Study|Death|2|||
149854932|NCT00035555|540597059|FG000|Overall Study|Lost to Follow-up|0|||
149854933|NCT00035555|540597060|FG001|Overall Study|Lost to Follow-up|0|||
149854934|NCT00035555|540597061|FG002|Overall Study|Lost to Follow-up|1|||
149854935|NCT00035555|540597059|FG000|Overall Study|Noncompliance|0|||
149854936|NCT00035555|540597060|FG001|Overall Study|Noncompliance|1|||
149854937|NCT00035555|540597061|FG002|Overall Study|Noncompliance|1|||
149854938|NCT00035555|540597059|FG000|Overall Study|Prohibited medication|1|||
149854939|NCT00035555|540597060|FG001|Overall Study|Prohibited medication|1|||
149854940|NCT00035555|540597061|FG002|Overall Study|Prohibited medication|0|||
149854941|NCT00035555|540597059|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
149854942|NCT00035555|540597060|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
149854943|NCT00035555|540597061|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
149854944|NCT00035555|540597059|FG000|Overall Study|Withdrawal by Subject|2|||
149854945|NCT00035555|540597060|FG001|Overall Study|Withdrawal by Subject|0|||
149854946|NCT00035555|540597061|FG002|Overall Study|Withdrawal by Subject|2|||
149854947|NCT00035555|540597059|FG000|Overall Study|Investigator deemed not a good candidate|0|||
150039659|NCT03847896|541285128|FG003|Overall Study|Other reasons|2|||
150039660|NCT03847896|541285129|FG004|Overall Study|Other reasons|1|||
150039661|NCT02395471|541285130|FG000|Overall Study|Lost to Follow-up|2|||
150039662|NCT02395471|541285131|FG001|Overall Study|Lost to Follow-up|0|||
149854948|NCT00035555|540597060|FG001|Overall Study|Investigator deemed not a good candidate|0|||
149960017|NCT00292370|540988018|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
149960018|NCT00292370|540988016|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
149960019|NCT00292370|540988017|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
149960020|NCT00292370|540988018|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
149960021|NCT00292370|540988016|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
149960022|NCT00292370|540988017|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
149960023|NCT00292370|540988018|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
149960024|NCT00292370|540988016|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
149960025|NCT00292370|540988017|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
149960026|NCT00292370|540988018|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
149960027|NCT00292370|540988016|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
149960028|NCT00292370|540988017|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
149960029|NCT00292370|540988018|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
149960030|NCT00292370|540988016|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
149960031|NCT00292370|540988017|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
149960032|NCT00292370|540988018|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
149960033|NCT02533674|540988019|FG000|Dose Level I|Progressive disease|1|||
149960034|NCT02533674|540988020|FG001|Dose Level I|Progressive disease|0|||
149960035|NCT02533674|540988021|FG002|Dose Level I|Progressive disease|0|||
149960036|NCT02533674|540988022|FG003|Dose Level I|Progressive disease|0|||
149960037|NCT02533674|540988023|FG004|Dose Level I|Progressive disease|0|||
149960038|NCT02533674|540988024|FG005|Dose Level I|Progressive disease|0|||
149960039|NCT02533674|540988025|FG006|Dose Level I|Progressive disease|0|||
149960040|NCT02533674|540988026|FG007|Dose Level I|Progressive disease|0|||
149960041|NCT02533674|540988019|FG000|Dose Level I|Withdrawal by Subject|1|||
149960042|NCT02533674|540988020|FG001|Dose Level I|Withdrawal by Subject|0|||
149960043|NCT02533674|540988021|FG002|Dose Level I|Withdrawal by Subject|0|||
149960044|NCT02533674|540988022|FG003|Dose Level I|Withdrawal by Subject|0|||
149960045|NCT02533674|540988023|FG004|Dose Level I|Withdrawal by Subject|0|||
149960046|NCT02533674|540988024|FG005|Dose Level I|Withdrawal by Subject|0|||
149960047|NCT02533674|540988025|FG006|Dose Level I|Withdrawal by Subject|0|||
149960048|NCT02533674|540988026|FG007|Dose Level I|Withdrawal by Subject|0|||
149960049|NCT02533674|540988019|FG000|Dose Level I|Physician Decision|1|||
149960050|NCT02533674|540988020|FG001|Dose Level I|Physician Decision|0|||
149960051|NCT02533674|540988021|FG002|Dose Level I|Physician Decision|0|||
149960052|NCT02533674|540988022|FG003|Dose Level I|Physician Decision|0|||
149960053|NCT02533674|540988023|FG004|Dose Level I|Physician Decision|0|||
149960054|NCT02533674|540988024|FG005|Dose Level I|Physician Decision|0|||
150039663|NCT02395471|541285130|FG000|Overall Study|Withdrawal by Subject|2|||
149854949|NCT00035555|540597061|FG002|Overall Study|Investigator deemed not a good candidate|1|||
149854950|NCT00035555|540597059|FG000|Overall Study|Received cyclosporin in error|0|||
149854951|NCT00035555|540597060|FG001|Overall Study|Received cyclosporin in error|0|||
149854952|NCT00035555|540597061|FG002|Overall Study|Received cyclosporin in error|1|||
149960055|NCT02533674|540988025|FG006|Dose Level I|Physician Decision|0|||
149960056|NCT02533674|540988026|FG007|Dose Level I|Physician Decision|0|||
149854953|NCT00337428|540597062|FG000|Overall Study|Withdrawal by Subject|1|||
149960057|NCT02533674|540988019|FG000|Dose Level I|Death|1|||
149960058|NCT02533674|540988020|FG001|Dose Level I|Death|0|||
150039664|NCT02395471|541285131|FG001|Overall Study|Withdrawal by Subject|1|||
150039665|NCT02395471|541285130|FG000|Overall Study|Physician Decision|1|||
149854954|NCT00337428|540597063|FG001|Overall Study|Withdrawal by Subject|2|||
149854955|NCT00337428|540597062|FG000|Overall Study|Lack of Time|1|||
149854956|NCT00337428|540597063|FG001|Overall Study|Lack of Time|1|||
149854957|NCT00337428|540597062|FG000|Overall Study|Unwilling to Continue|1|||
149854958|NCT00337428|540597063|FG001|Overall Study|Unwilling to Continue|0|||
149854959|NCT00337428|540597062|FG000|Overall Study|Anorexia|1|||
149854960|NCT00337428|540597063|FG001|Overall Study|Anorexia|0|||
149854961|NCT02618382|540597064|FG000|Overall Study|Physician Decision|1|||
149854962|NCT02618382|540597064|FG000|Overall Study|Withdrawal by Subject|1|||
149854963|NCT02618382|540597064|FG000|Overall Study|Protocol Violation|1|||
149854964|NCT00372996|540597066|FG000|Overall Study|Death|11|||
149854965|NCT00372996|540597067|FG001|Overall Study|Death|4|||
149854966|NCT00372996|540597068|FG002|Overall Study|Death|8|||
149854967|NCT00372996|540597069|FG003|Overall Study|Death|7|||
149854968|NCT00372996|540597066|FG000|Overall Study|Lost to Follow-up|0|||
149854969|NCT00372996|540597067|FG001|Overall Study|Lost to Follow-up|2|||
149854970|NCT00372996|540597068|FG002|Overall Study|Lost to Follow-up|0|||
149854971|NCT00372996|540597069|FG003|Overall Study|Lost to Follow-up|1|||
149854972|NCT00372996|540597066|FG000|Overall Study|Withdrawal by Subject|12|||
149854973|NCT00372996|540597067|FG001|Overall Study|Withdrawal by Subject|6|||
149854974|NCT00372996|540597068|FG002|Overall Study|Withdrawal by Subject|9|||
149960059|NCT02533674|540988021|FG002|Dose Level I|Death|0|||
149960060|NCT02533674|540988022|FG003|Dose Level I|Death|0|||
149960061|NCT02533674|540988023|FG004|Dose Level I|Death|0|||
149960062|NCT02533674|540988024|FG005|Dose Level I|Death|0|||
149960063|NCT02533674|540988025|FG006|Dose Level I|Death|0|||
149960064|NCT02533674|540988026|FG007|Dose Level I|Death|0|||
149960065|NCT02533674|540988019|FG000|Dose Level I|Never Treated|1|||
149960066|NCT02533674|540988020|FG001|Dose Level I|Never Treated|0|||
149960067|NCT02533674|540988021|FG002|Dose Level I|Never Treated|0|||
149960068|NCT02533674|540988022|FG003|Dose Level I|Never Treated|0|||
149960069|NCT02533674|540988023|FG004|Dose Level I|Never Treated|0|||
149960070|NCT02533674|540988024|FG005|Dose Level I|Never Treated|0|||
149960071|NCT02533674|540988025|FG006|Dose Level I|Never Treated|0|||
149960072|NCT02533674|540988026|FG007|Dose Level I|Never Treated|0|||
149960073|NCT02533674|540988019|FG000|Dose Level II|Progressive disease|0|||
149960074|NCT02533674|540988020|FG001|Dose Level II|Progressive disease|3|||
149960075|NCT02533674|540988021|FG002|Dose Level II|Progressive disease|0|||
149960076|NCT02533674|540988022|FG003|Dose Level II|Progressive disease|0|||
149960077|NCT02533674|540988023|FG004|Dose Level II|Progressive disease|0|||
149960078|NCT02533674|540988024|FG005|Dose Level II|Progressive disease|0|||
149960079|NCT02533674|540988025|FG006|Dose Level II|Progressive disease|0|||
149960080|NCT02533674|540988026|FG007|Dose Level II|Progressive disease|0|||
149960081|NCT02533674|540988019|FG000|Dose Level II|Withdrawal by Subject|0|||
149960082|NCT02533674|540988020|FG001|Dose Level II|Withdrawal by Subject|1|||
149960083|NCT02533674|540988021|FG002|Dose Level II|Withdrawal by Subject|0|||
149960084|NCT02533674|540988022|FG003|Dose Level II|Withdrawal by Subject|0|||
149960085|NCT02533674|540988023|FG004|Dose Level II|Withdrawal by Subject|0|||
149960086|NCT02533674|540988024|FG005|Dose Level II|Withdrawal by Subject|0|||
149960087|NCT02533674|540988025|FG006|Dose Level II|Withdrawal by Subject|0|||
149960088|NCT02533674|540988026|FG007|Dose Level II|Withdrawal by Subject|0|||
149960089|NCT02533674|540988019|FG000|Dose Level II|Treatment-related AE|0|||
149960090|NCT02533674|540988020|FG001|Dose Level II|Treatment-related AE|1|||
149854975|NCT00372996|540597069|FG003|Overall Study|Withdrawal by Subject|5|||
149854976|NCT00372996|540597066|FG000|Overall Study|Study Terminated by Sponsor|4|||
149854977|NCT00372996|540597067|FG001|Overall Study|Study Terminated by Sponsor|0|||
149854978|NCT00372996|540597068|FG002|Overall Study|Study Terminated by Sponsor|4|||
149854979|NCT00372996|540597069|FG003|Overall Study|Study Terminated by Sponsor|0|||
149854980|NCT00372996|540597066|FG000|Overall Study|Other|10|||
149854981|NCT00372996|540597067|FG001|Overall Study|Other|2|||
149854982|NCT00372996|540597068|FG002|Overall Study|Other|7|||
149854983|NCT00372996|540597069|FG003|Overall Study|Other|7|||
149854984|NCT00721955|540597070|FG000|Overall Study|Adverse Event|0|||
149854985|NCT00721955|540597071|FG001|Overall Study|Adverse Event|0|||
149960091|NCT02533674|540988021|FG002|Dose Level II|Treatment-related AE|0|||
149960092|NCT02533674|540988022|FG003|Dose Level II|Treatment-related AE|0|||
149960093|NCT02533674|540988023|FG004|Dose Level II|Treatment-related AE|0|||
149960094|NCT02533674|540988024|FG005|Dose Level II|Treatment-related AE|0|||
149960095|NCT02533674|540988025|FG006|Dose Level II|Treatment-related AE|0|||
149854986|NCT00721955|540597072|FG002|Overall Study|Adverse Event|2|||
149960096|NCT02533674|540988026|FG007|Dose Level II|Treatment-related AE|0|||
149960097|NCT02533674|540988019|FG000|Dose Level II|Physician Decision|0|||
149854987|NCT00515216|540597074|FG000|Overall Study|Withdrawal by Subject|1|||
149854988|NCT03496298|540597077|FG000|Overall Study|Adverse Event|49|||
149960098|NCT02533674|540988020|FG001|Dose Level II|Physician Decision|1|||
149960099|NCT02533674|540988021|FG002|Dose Level II|Physician Decision|0|||
149854989|NCT03496298|540597078|FG001|Overall Study|Adverse Event|68|||
149960100|NCT02533674|540988022|FG003|Dose Level II|Physician Decision|0|||
149960101|NCT02533674|540988023|FG004|Dose Level II|Physician Decision|0|||
149960102|NCT02533674|540988024|FG005|Dose Level II|Physician Decision|0|||
150172981|NCT04424641|541769827|FG006|Overall Study|Other|0|||
150172982|NCT04424641|541769828|FG007|Overall Study|Other|0|||
150172983|NCT01171625|541769833|FG000|Overall Study|On-Protocol|67|||
150172984|NCT01171625|541769833|FG000|Overall Study|Death|38|||
149854990|NCT03496298|540597079|FG002|Overall Study|Adverse Event|79|||
149854991|NCT03496298|540597077|FG000|Overall Study|Study terminated by Sponsor|1050|||
149854992|NCT03496298|540597078|FG001|Overall Study|Study terminated by Sponsor|1063|||
149854993|NCT03496298|540597079|FG002|Overall Study|Study terminated by Sponsor|1071|||
149854994|NCT03496298|540597077|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
149854995|NCT03496298|540597078|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
150172985|NCT01171625|541769833|FG000|Overall Study|Withdrawal by Subject|31|||
150172986|NCT01171625|541769833|FG000|Overall Study|Explanted|10|||
150172987|NCT01171625|541769833|FG000|Overall Study|Lost to Follow-up|5|||
150172988|NCT01171625|541769833|FG000|Overall Study|Patient received valve-in-valve|3|||
150172989|NCT01171625|541769833|FG000|Overall Study|Other|1|||
150172990|NCT01171625|541769833|FG000|Overall Study|Consented but did not receive device|25|||
150172991|NCT03262935|541769834|FG000|Overall Study|Withdrawal by Subject|6|||
150172992|NCT03262935|541769835|FG001|Overall Study|Withdrawal by Subject|7|||
150172993|NCT03262935|541769834|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
150172994|NCT03262935|541769835|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
150172995|NCT03262935|541769834|FG000|Overall Study|Death|181|||
150172996|NCT03262935|541769835|FG001|Overall Study|Death|94|||
150172997|NCT03262935|541769834|FG000|Overall Study|Lost to Follow-up|9|||
150172998|NCT03262935|541769835|FG001|Overall Study|Lost to Follow-up|4|||
150172999|NCT03262935|541769834|FG000|Overall Study|Other reason|5|||
150173000|NCT03262935|541769835|FG001|Overall Study|Other reason|0|||
150173001|NCT00186186|541769836|FG000|Overall Study|Lack of Efficacy|3|||
150173002|NCT00186186|541769836|FG000|Overall Study|Withdrawal by Subject|3|||
150173003|NCT00186186|541769836|FG000|Overall Study|Not reported as to reason|2|||
150173004|NCT00762606|541769839|FG000|Overall Study|Lost to Follow-up|18|||
150173005|NCT00762606|541769840|FG001|Overall Study|Lost to Follow-up|13|||
150173006|NCT05641311|541769841|FG000|Dosing Period 1|Adverse Event|1|||
150173007|NCT05641311|541769842|FG001|Dosing Period 1|Adverse Event|0|||
150173008|NCT00922207|541769849|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
150173009|NCT00922207|541769850|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
150173010|NCT00922207|541769851|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
150173011|NCT00922207|541769849|FG000|Overall Study|Insufficient Therapeutic Response|0|||
150173012|NCT00922207|541769850|FG001|Overall Study|Insufficient Therapeutic Response|0|||
150173013|NCT00922207|541769851|FG002|Overall Study|Insufficient Therapeutic Response|1|||
150288947|NCT00264004|542192540|FG001|Overall Study|Development study specific disc. crit.|0|||
150288948|NCT00264004|542192541|FG002|Overall Study|Development study specific disc. crit.|1|||
150288949|NCT00264004|542192542|FG003|Overall Study|Development study specific disc. crit.|0|||
150288950|NCT00264004|542192539|FG000|Overall Study|Cond. under inv. worsened|9|||
150288951|NCT00264004|542192540|FG001|Overall Study|Cond. under inv. worsened|5|||
149854996|NCT03496298|540597079|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
149854997|NCT03496298|540597077|FG000|Overall Study|Withdrawal by Subject|176|||
149854998|NCT03496298|540597078|FG001|Overall Study|Withdrawal by Subject|154|||
149854999|NCT03496298|540597079|FG002|Overall Study|Withdrawal by Subject|151|||
149855000|NCT03496298|540597077|FG000|Overall Study|Other|29|||
149855001|NCT03496298|540597078|FG001|Overall Study|Other|20|||
149855002|NCT03496298|540597079|FG002|Overall Study|Other|23|||
149855003|NCT03496298|540597077|FG000|Overall Study|Randomized and not treated|1|||
149855004|NCT03496298|540597078|FG001|Overall Study|Randomized and not treated|1|||
149855005|NCT03496298|540597079|FG002|Overall Study|Randomized and not treated|1|||
149855006|NCT00676494|540597080|FG000|Overall Study|Missed Visit|8|||
149960103|NCT02533674|540988025|FG006|Dose Level II|Physician Decision|0|||
149960104|NCT02533674|540988026|FG007|Dose Level II|Physician Decision|0|||
149960105|NCT02533674|540988019|FG000|Dose Level II|Non-treatment-related AE|0|||
149960106|NCT02533674|540988020|FG001|Dose Level II|Non-treatment-related AE|1|||
149960107|NCT02533674|540988021|FG002|Dose Level II|Non-treatment-related AE|0|||
149960108|NCT02533674|540988022|FG003|Dose Level II|Non-treatment-related AE|0|||
149960109|NCT02533674|540988023|FG004|Dose Level II|Non-treatment-related AE|0|||
149960110|NCT02533674|540988024|FG005|Dose Level II|Non-treatment-related AE|0|||
149960111|NCT02533674|540988025|FG006|Dose Level II|Non-treatment-related AE|0|||
149960112|NCT02533674|540988026|FG007|Dose Level II|Non-treatment-related AE|0|||
149960113|NCT02533674|540988019|FG000|Dose Level III|Progressive disease|0|||
149960114|NCT02533674|540988020|FG001|Dose Level III|Progressive disease|0|||
149960115|NCT02533674|540988021|FG002|Dose Level III|Progressive disease|2|||
149960116|NCT02533674|540988022|FG003|Dose Level III|Progressive disease|0|||
149960117|NCT02533674|540988023|FG004|Dose Level III|Progressive disease|0|||
149960118|NCT02533674|540988024|FG005|Dose Level III|Progressive disease|0|||
149960119|NCT02533674|540988025|FG006|Dose Level III|Progressive disease|0|||
149960120|NCT02533674|540988026|FG007|Dose Level III|Progressive disease|0|||
149960121|NCT02533674|540988019|FG000|Dose Level III|Withdrawal by Subject|0|||
149960122|NCT02533674|540988020|FG001|Dose Level III|Withdrawal by Subject|0|||
149960123|NCT02533674|540988021|FG002|Dose Level III|Withdrawal by Subject|1|||
149855007|NCT00676494|540597080|FG000|Overall Study|Withdrawal by Subject|6|||
149855008|NCT01203917|540597081|FG000|Overall Study|Death|29|||
149855009|NCT01203917|540597081|FG000|Overall Study|Lost to Follow-up|2|||
149855010|NCT01203917|540597081|FG000|Overall Study|Withdrawal by Subject|3|||
149855011|NCT01203917|540597081|FG000|Overall Study|Due to objective disease progression|1|||
149855012|NCT01203917|540597081|FG000|Overall Study|Due to EGFR M+I patient|1|||
149855013|NCT01115933|540597086|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
149855014|NCT00090753|540597087|FG000|First Treatment Period|Adverse Event|20|||
149855015|NCT00090753|540597088|FG001|First Treatment Period|Adverse Event|8|||
149855016|NCT00090753|540597087|FG000|First Treatment Period|Death|88|||
149855017|NCT00090753|540597088|FG001|First Treatment Period|Death|62|||
149855018|NCT00090753|540597087|FG000|First Treatment Period|Lack of Efficacy|2|||
149855019|NCT00090753|540597088|FG001|First Treatment Period|Lack of Efficacy|1|||
149855020|NCT00090753|540597087|FG000|First Treatment Period|Refused Treatment|32|||
149855021|NCT00090753|540597088|FG001|First Treatment Period|Refused Treatment|25|||
149855022|NCT00090753|540597087|FG000|First Treatment Period|Lost to Follow-up|4|||
149855023|NCT00090753|540597088|FG001|First Treatment Period|Lost to Follow-up|4|||
149855024|NCT00090753|540597087|FG000|First Treatment Period|Renal Transplant|70|||
149855025|NCT00090753|540597088|FG001|First Treatment Period|Renal Transplant|50|||
149855026|NCT00090753|540597087|FG000|First Treatment Period|Mircera Commercialization|1|||
149855027|NCT00090753|540597088|FG001|First Treatment Period|Mircera Commercialization|0|||
149855028|NCT00090753|540597087|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
149855029|NCT00090753|540597088|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
149855030|NCT00090753|540597087|FG000|Extended Treatment Period|Adverse Event|11|||
149855031|NCT00090753|540597088|FG001|Extended Treatment Period|Adverse Event|0|||
149855032|NCT00090753|540597087|FG000|Extended Treatment Period|Death|58|||
149855033|NCT00090753|540597088|FG001|Extended Treatment Period|Death|30|||
149855034|NCT00090753|540597087|FG000|Extended Treatment Period|Lack of Efficacy|1|||
149855035|NCT00090753|540597088|FG001|Extended Treatment Period|Lack of Efficacy|0|||
149855036|NCT00090753|540597087|FG000|Extended Treatment Period|Refused Treatment|18|||
149855037|NCT00090753|540597088|FG001|Extended Treatment Period|Refused Treatment|12|||
149855038|NCT00090753|540597087|FG000|Extended Treatment Period|Lost to Follow-up|3|||
149855039|NCT00090753|540597088|FG001|Extended Treatment Period|Lost to Follow-up|1|||
149855040|NCT00090753|540597087|FG000|Extended Treatment Period|Renal Transplant|15|||
149855041|NCT00090753|540597088|FG001|Extended Treatment Period|Renal Transplant|12|||
149855042|NCT00090753|540597087|FG000|Extended Treatment Period|Mircera Commercialization|188|||
149855043|NCT00090753|540597088|FG001|Extended Treatment Period|Mircera Commercialization|93|||
149855044|NCT00090753|540597087|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
149855045|NCT00090753|540597088|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
149855046|NCT01466036|540597091|FG000|Overall Study|Death|1|||
149855047|NCT01466036|540597092|FG001|Overall Study|Death|1|||
149855048|NCT01466036|540597091|FG000|Overall Study|Physician Decision|0|||
149855049|NCT01466036|540597092|FG001|Overall Study|Physician Decision|4|||
149855050|NCT01466036|540597091|FG000|Overall Study|Adverse Event|2|||
149855051|NCT01466036|540597092|FG001|Overall Study|Adverse Event|6|||
149855052|NCT01466036|540597091|FG000|Overall Study|Withdrawal by Subject|2|||
149855053|NCT01466036|540597092|FG001|Overall Study|Withdrawal by Subject|8|||
149855054|NCT01466036|540597091|FG000|Overall Study|progression/relapse|14|||
149855055|NCT01466036|540597092|FG001|Overall Study|progression/relapse|21|||
149855056|NCT01466036|540597091|FG000|Overall Study|prolonged treatment delay|1|||
149855057|NCT01466036|540597092|FG001|Overall Study|prolonged treatment delay|1|||
149855058|NCT00819767|540597097|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149855059|NCT00819767|540597098|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149855060|NCT00250705|540597101|FG000|Overall Study|Lack of Efficacy|2|||
149855061|NCT05103657|540597102|FG000|Overall Study|Other reasons than listed|9|||
149855062|NCT05103657|540597103|FG001|Overall Study|Other reasons than listed|8|||
149855063|NCT05103657|540597102|FG000|Overall Study|Protocol deviation|2|||
149855064|NCT05103657|540597103|FG001|Overall Study|Protocol deviation|2|||
149855065|NCT05103657|540597102|FG000|Overall Study|No reason available|5|||
149855066|NCT05103657|540597103|FG001|Overall Study|No reason available|4|||
149855067|NCT05103657|540597102|FG000|Overall Study|Burden of study procedures|3|||
149855068|NCT05103657|540597103|FG001|Overall Study|Burden of study procedures|1|||
149855069|NCT05103657|540597102|FG000|Overall Study|Perceived lack of efficacy|1|||
149855070|NCT05103657|540597103|FG001|Overall Study|Perceived lack of efficacy|1|||
150039666|NCT02395471|541285131|FG001|Overall Study|Physician Decision|0|||
150039667|NCT02395471|541285130|FG000|Overall Study|Protocol Violation|0|||
149855071|NCT05103657|540597102|FG000|Overall Study|Adverse Event|6|||
149855072|NCT05103657|540597103|FG001|Overall Study|Adverse Event|14|||
149855073|NCT05103657|540597102|FG000|Overall Study|Not Treated|1|||
149855074|NCT05103657|540597103|FG001|Overall Study|Not Treated|1|||
149855075|NCT00398073|540597105|FG000|Overall Study|Withdrawal by Subject|1|||
149855076|NCT00398073|540597106|FG001|Overall Study|Withdrawal by Subject|0|||
149855077|NCT01263561|540597107|FG000|Overall Study|Death|1|||
149855078|NCT01263561|540597108|FG001|Overall Study|Death|2|||
149855079|NCT00879684|540597109|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
149855080|NCT00879684|540597110|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
149855081|NCT00879684|540597111|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
149855082|NCT00879684|540597112|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
149855083|NCT00879684|540597113|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
149855084|NCT00879684|540597114|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
149855085|NCT00879684|540597115|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
149855086|NCT00879684|540597109|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
149855087|NCT00879684|540597110|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
149855088|NCT00879684|540597111|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
149855089|NCT00879684|540597112|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
149855090|NCT00879684|540597113|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
149855091|NCT00879684|540597114|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
149855092|NCT00879684|540597115|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
149855093|NCT00879684|540597109|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
149855094|NCT00879684|540597110|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
149855095|NCT00879684|540597111|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
149855096|NCT00879684|540597112|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
149855097|NCT00879684|540597113|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
149855098|NCT00879684|540597114|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
149855099|NCT00879684|540597115|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
149855100|NCT00879684|540597109|FG000|Stage 1: Dose Escalation|Death|0|||
149855101|NCT00879684|540597110|FG001|Stage 1: Dose Escalation|Death|0|||
149855102|NCT00879684|540597111|FG002|Stage 1: Dose Escalation|Death|1|||
149855103|NCT00879684|540597112|FG003|Stage 1: Dose Escalation|Death|0|||
149855104|NCT00879684|540597113|FG004|Stage 1: Dose Escalation|Death|0|||
149855105|NCT00879684|540597114|FG005|Stage 1: Dose Escalation|Death|0|||
149855106|NCT00879684|540597115|FG006|Stage 1: Dose Escalation|Death|0|||
149855107|NCT00879684|540597109|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855108|NCT00879684|540597110|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855109|NCT00879684|540597111|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855110|NCT00879684|540597112|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855111|NCT00879684|540597113|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855112|NCT00879684|540597114|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
149855113|NCT00879684|540597115|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
149855114|NCT00879684|540597109|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855115|NCT00879684|540597110|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855116|NCT00879684|540597111|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855117|NCT00879684|540597112|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855118|NCT00879684|540597113|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855119|NCT00879684|540597114|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
149855120|NCT00879684|540597115|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
149855121|NCT00879684|540597109|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
149855122|NCT00879684|540597110|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
149855123|NCT00879684|540597111|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
149855124|NCT00879684|540597112|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
149855125|NCT00879684|540597113|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
149855126|NCT00879684|540597114|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
150173014|NCT00922207|541769849|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
150173015|NCT00922207|541769850|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
149855127|NCT00879684|540597115|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
149855128|NCT00708682|540597116|FG000|Infant Series|Adverse Event|1|||
149855129|NCT00708682|540597116|FG000|Infant Series|Lost to Follow-up|4|||
149855130|NCT00708682|540597116|FG000|Infant Series|Protocol Violation|1|||
149855131|NCT00708682|540597116|FG000|Infant Series|Parent/legal guardian request|6|||
149855132|NCT00708682|540597116|FG000|Infant Series|Failed to return|2|||
149855133|NCT00708682|540597116|FG000|Infant Series|Other|19|||
149855134|NCT00708682|540597116|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
149855135|NCT00708682|540597116|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
149855136|NCT00708682|540597116|FG000|Toddler Dose|Lost to Follow-up|3|||
149855137|NCT00708682|540597116|FG000|Toddler Dose|Failed to Return|4|||
149855138|NCT03185741|540597121|FG000|Baseline|Withdrawal by Subject|1|||
149855139|NCT03185741|540597122|FG001|Baseline|Withdrawal by Subject|3|||
149855140|NCT03185741|540597123|FG002|Baseline|Withdrawal by Subject|2|||
149855141|NCT03185741|540597121|FG000|Baseline|Lost to Follow-up|1|||
149855142|NCT03185741|540597122|FG001|Baseline|Lost to Follow-up|2|||
149855143|NCT03185741|540597123|FG002|Baseline|Lost to Follow-up|3|||
149855144|NCT03185741|540597121|FG000|3Month|Death|1|||
150039668|NCT02395471|541285131|FG001|Overall Study|Protocol Violation|1|||
150288952|NCT00264004|542192541|FG002|Overall Study|Cond. under inv. worsened|3|||
149855145|NCT03185741|540597122|FG001|3Month|Death|1|||
149855146|NCT03185741|540597123|FG002|3Month|Death|2|||
149855147|NCT03185741|540597121|FG000|3Month|Withdrawal by Subject|1|||
149855148|NCT03185741|540597122|FG001|3Month|Withdrawal by Subject|5|||
149855149|NCT03185741|540597123|FG002|3Month|Withdrawal by Subject|1|||
149855150|NCT03185741|540597121|FG000|3Month|Lost to Follow-up|7|||
149855151|NCT03185741|540597122|FG001|3Month|Lost to Follow-up|9|||
149855152|NCT03185741|540597123|FG002|3Month|Lost to Follow-up|8|||
149855153|NCT03185741|540597121|FG000|3Month|Unavailable for 3Month|11|||
149855154|NCT03185741|540597122|FG001|3Month|Unavailable for 3Month|10|||
149855155|NCT03185741|540597123|FG002|3Month|Unavailable for 3Month|11|||
149855156|NCT03185741|540597121|FG000|3Month|Protocol Violation|0|||
149855157|NCT03185741|540597122|FG001|3Month|Protocol Violation|0|||
149855158|NCT03185741|540597123|FG002|3Month|Protocol Violation|3|||
149855159|NCT03185741|540597121|FG000|6Month|Death|1|||
149855160|NCT03185741|540597122|FG001|6Month|Death|1|||
149855161|NCT03185741|540597123|FG002|6Month|Death|2|||
149855162|NCT03185741|540597121|FG000|6Month|Withdrawal by Subject|2|||
149855163|NCT03185741|540597122|FG001|6Month|Withdrawal by Subject|3|||
149855164|NCT03185741|540597123|FG002|6Month|Withdrawal by Subject|1|||
149855165|NCT03185741|540597121|FG000|6Month|Lost to Follow-up|16|||
149855166|NCT03185741|540597122|FG001|6Month|Lost to Follow-up|15|||
149855167|NCT03185741|540597123|FG002|6Month|Lost to Follow-up|16|||
149855168|NCT01923311|540598701|FG000|Overall Study|Pregnancy|1|||
149855169|NCT01923311|540598702|FG001|Overall Study|Pregnancy|0|||
149855170|NCT01923311|540598701|FG000|Overall Study|Investigator's Discretion|1|||
149855171|NCT01923311|540598702|FG001|Overall Study|Investigator's Discretion|0|||
149855172|NCT01923311|540598701|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149855173|NCT01923311|540598702|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149855174|NCT01923311|540598701|FG000|Overall Study|Withdrew Consent|1|||
149855175|NCT01923311|540598702|FG001|Overall Study|Withdrew Consent|0|||
149855176|NCT01923311|540598701|FG000|Overall Study|Study Terminated by Sponsor|12|||
149855177|NCT01923311|540598702|FG001|Overall Study|Study Terminated by Sponsor|0|||
149855178|NCT02839798|540598704|FG000|Overall Study|Withdrawal by Subject|2|||
149855179|NCT05258630|540598705|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
149855180|NCT05258630|540598706|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
149855181|NCT05258630|540598705|FG000|Overall Study|Lost to Follow-up|0|||
149855182|NCT05258630|540598706|FG001|Overall Study|Lost to Follow-up|2|||
149855183|NCT03431337|540598707|FG000|Overall Study|Lost to Follow-up|21|||
149855184|NCT03431337|540598708|FG001|Overall Study|Lost to Follow-up|19|||
149855185|NCT03431337|540598707|FG000|Overall Study|Withdrawal by Subject|8|||
149855186|NCT03431337|540598708|FG001|Overall Study|Withdrawal by Subject|3|||
149855187|NCT00401245|540598709|FG000|Double Blind Titration Phase|Adverse Event|3|||
149855188|NCT00401245|540598710|FG001|Double Blind Titration Phase|Adverse Event|2|||
149855189|NCT00401245|540598711|FG002|Double Blind Titration Phase|Adverse Event|5|||
149855190|NCT00401245|540598712|FG003|Double Blind Titration Phase|Adverse Event|12|||
149855191|NCT00401245|540598713|FG004|Double Blind Titration Phase|Adverse Event|0|||
149855192|NCT00401245|540598714|FG005|Double Blind Titration Phase|Adverse Event|0|||
149960124|NCT02533674|540988022|FG003|Dose Level III|Withdrawal by Subject|0|||
149960125|NCT02533674|540988023|FG004|Dose Level III|Withdrawal by Subject|0|||
149960126|NCT02533674|540988024|FG005|Dose Level III|Withdrawal by Subject|0|||
149960127|NCT02533674|540988025|FG006|Dose Level III|Withdrawal by Subject|0|||
149960128|NCT02533674|540988026|FG007|Dose Level III|Withdrawal by Subject|0|||
149960129|NCT02533674|540988019|FG000|Dose Level III|Treatment-related AE|0|||
149960130|NCT02533674|540988020|FG001|Dose Level III|Treatment-related AE|0|||
149960131|NCT02533674|540988021|FG002|Dose Level III|Treatment-related AE|1|||
149960132|NCT02533674|540988022|FG003|Dose Level III|Treatment-related AE|0|||
149960133|NCT02533674|540988023|FG004|Dose Level III|Treatment-related AE|0|||
149960134|NCT02533674|540988024|FG005|Dose Level III|Treatment-related AE|0|||
149960135|NCT02533674|540988025|FG006|Dose Level III|Treatment-related AE|0|||
149960136|NCT02533674|540988026|FG007|Dose Level III|Treatment-related AE|0|||
149960137|NCT02533674|540988019|FG000|Dose Level IV|Progressive disease|0|||
149960138|NCT02533674|540988020|FG001|Dose Level IV|Progressive disease|0|||
149960139|NCT02533674|540988021|FG002|Dose Level IV|Progressive disease|0|||
149960140|NCT02533674|540988022|FG003|Dose Level IV|Progressive disease|3|||
149960141|NCT02533674|540988023|FG004|Dose Level IV|Progressive disease|0|||
149960142|NCT02533674|540988024|FG005|Dose Level IV|Progressive disease|0|||
149960143|NCT02533674|540988025|FG006|Dose Level IV|Progressive disease|0|||
149960144|NCT02533674|540988026|FG007|Dose Level IV|Progressive disease|0|||
149855193|NCT00401245|540598715|FG006|Double Blind Titration Phase|Adverse Event|0|||
149855194|NCT00401245|540598716|FG007|Double Blind Titration Phase|Adverse Event|0|||
149855195|NCT00401245|540598709|FG000|Double Blind Titration Phase|Other|0|||
149855196|NCT00401245|540598710|FG001|Double Blind Titration Phase|Other|0|||
149855197|NCT00401245|540598711|FG002|Double Blind Titration Phase|Other|1|||
149855198|NCT00401245|540598712|FG003|Double Blind Titration Phase|Other|0|||
149855199|NCT00401245|540598713|FG004|Double Blind Titration Phase|Other|0|||
149855200|NCT00401245|540598714|FG005|Double Blind Titration Phase|Other|0|||
149855201|NCT00401245|540598715|FG006|Double Blind Titration Phase|Other|0|||
149855202|NCT00401245|540598716|FG007|Double Blind Titration Phase|Other|0|||
149855203|NCT00401245|540598709|FG000|Double Blind Titration Phase|Protocol Violation|0|||
149960145|NCT02533674|540988019|FG000|Dose Level IV|Withdrawal by Subject|0|||
149855204|NCT00401245|540598710|FG001|Double Blind Titration Phase|Protocol Violation|0|||
149855205|NCT00401245|540598711|FG002|Double Blind Titration Phase|Protocol Violation|0|||
149855206|NCT00401245|540598712|FG003|Double Blind Titration Phase|Protocol Violation|1|||
149855207|NCT00401245|540598713|FG004|Double Blind Titration Phase|Protocol Violation|0|||
149855208|NCT00401245|540598714|FG005|Double Blind Titration Phase|Protocol Violation|0|||
149855209|NCT00401245|540598715|FG006|Double Blind Titration Phase|Protocol Violation|0|||
149855210|NCT00401245|540598716|FG007|Double Blind Titration Phase|Protocol Violation|0|||
149855211|NCT00401245|540598709|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
149855212|NCT00401245|540598710|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
149855213|NCT00401245|540598711|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
149855214|NCT00401245|540598712|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
149855215|NCT00401245|540598713|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
149855216|NCT00401245|540598714|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
149855217|NCT00401245|540598715|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
149855218|NCT00401245|540598716|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
149855219|NCT00401245|540598709|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855220|NCT00401245|540598710|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
149855221|NCT00401245|540598711|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855222|NCT00401245|540598712|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
149855223|NCT00401245|540598713|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855224|NCT00401245|540598714|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855225|NCT00401245|540598715|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855226|NCT00401245|540598716|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
149855227|NCT00401245|540598709|FG000|Open Label Phase|Adverse Event|5|||
149855228|NCT00401245|540598710|FG001|Open Label Phase|Adverse Event|14|||
149855229|NCT00401245|540598711|FG002|Open Label Phase|Adverse Event|6|||
149855230|NCT00401245|540598712|FG003|Open Label Phase|Adverse Event|7|||
149855231|NCT00401245|540598713|FG004|Open Label Phase|Adverse Event|0|||
149855232|NCT00401245|540598714|FG005|Open Label Phase|Adverse Event|0|||
149855233|NCT00401245|540598715|FG006|Open Label Phase|Adverse Event|0|||
149855234|NCT00401245|540598716|FG007|Open Label Phase|Adverse Event|0|||
149855235|NCT00401245|540598709|FG000|Open Label Phase|Lost to Follow-up|5|||
149855236|NCT00401245|540598710|FG001|Open Label Phase|Lost to Follow-up|7|||
149855237|NCT00401245|540598711|FG002|Open Label Phase|Lost to Follow-up|5|||
149855238|NCT00401245|540598712|FG003|Open Label Phase|Lost to Follow-up|4|||
149960146|NCT02533674|540988020|FG001|Dose Level IV|Withdrawal by Subject|0|||
149960147|NCT02533674|540988021|FG002|Dose Level IV|Withdrawal by Subject|0|||
149960148|NCT02533674|540988022|FG003|Dose Level IV|Withdrawal by Subject|1|||
149960149|NCT02533674|540988023|FG004|Dose Level IV|Withdrawal by Subject|0|||
149960150|NCT02533674|540988024|FG005|Dose Level IV|Withdrawal by Subject|0|||
149960151|NCT02533674|540988025|FG006|Dose Level IV|Withdrawal by Subject|0|||
149960152|NCT02533674|540988026|FG007|Dose Level IV|Withdrawal by Subject|0|||
149960153|NCT02533674|540988019|FG000|Dose Level IV|Physician Decision|0|||
149960154|NCT02533674|540988020|FG001|Dose Level IV|Physician Decision|0|||
149960155|NCT02533674|540988021|FG002|Dose Level IV|Physician Decision|0|||
149960156|NCT02533674|540988022|FG003|Dose Level IV|Physician Decision|1|||
149960157|NCT02533674|540988023|FG004|Dose Level IV|Physician Decision|0|||
149960158|NCT02533674|540988024|FG005|Dose Level IV|Physician Decision|0|||
149960159|NCT02533674|540988025|FG006|Dose Level IV|Physician Decision|0|||
149855239|NCT00401245|540598713|FG004|Open Label Phase|Lost to Follow-up|0|||
149855240|NCT00401245|540598714|FG005|Open Label Phase|Lost to Follow-up|0|||
149855241|NCT00401245|540598715|FG006|Open Label Phase|Lost to Follow-up|0|||
149855242|NCT00401245|540598716|FG007|Open Label Phase|Lost to Follow-up|0|||
149855243|NCT00401245|540598709|FG000|Open Label Phase|Other|4|||
149855244|NCT00401245|540598710|FG001|Open Label Phase|Other|8|||
149855245|NCT00401245|540598711|FG002|Open Label Phase|Other|7|||
149855246|NCT00401245|540598712|FG003|Open Label Phase|Other|8|||
149855247|NCT00401245|540598713|FG004|Open Label Phase|Other|0|||
149855248|NCT00401245|540598714|FG005|Open Label Phase|Other|0|||
149855249|NCT00401245|540598715|FG006|Open Label Phase|Other|0|||
149855250|NCT00401245|540598716|FG007|Open Label Phase|Other|0|||
149855251|NCT00401245|540598709|FG000|Open Label Phase|Protocol Violation|0|||
149960160|NCT02533674|540988026|FG007|Dose Level IV|Physician Decision|0|||
149960161|NCT02533674|540988019|FG000|Dose Level V|Progressive disease|0|||
149960162|NCT02533674|540988020|FG001|Dose Level V|Progressive disease|0|||
149855252|NCT00401245|540598710|FG001|Open Label Phase|Protocol Violation|1|||
149855253|NCT00401245|540598711|FG002|Open Label Phase|Protocol Violation|0|||
149960163|NCT02533674|540988021|FG002|Dose Level V|Progressive disease|0|||
149855254|NCT00401245|540598712|FG003|Open Label Phase|Protocol Violation|1|||
149855255|NCT00401245|540598713|FG004|Open Label Phase|Protocol Violation|0|||
149960164|NCT02533674|540988022|FG003|Dose Level V|Progressive disease|0|||
149960165|NCT02533674|540988023|FG004|Dose Level V|Progressive disease|3|||
149960166|NCT02533674|540988024|FG005|Dose Level V|Progressive disease|0|||
149960167|NCT02533674|540988025|FG006|Dose Level V|Progressive disease|0|||
149855256|NCT00401245|540598714|FG005|Open Label Phase|Protocol Violation|0|||
149855257|NCT00401245|540598715|FG006|Open Label Phase|Protocol Violation|0|||
149855258|NCT00401245|540598716|FG007|Open Label Phase|Protocol Violation|0|||
149855259|NCT00401245|540598709|FG000|Open Label Phase|Withdrawal by Subject|3|||
149855260|NCT00401245|540598710|FG001|Open Label Phase|Withdrawal by Subject|3|||
149855261|NCT00401245|540598711|FG002|Open Label Phase|Withdrawal by Subject|2|||
149855262|NCT00401245|540598712|FG003|Open Label Phase|Withdrawal by Subject|1|||
149855263|NCT00401245|540598713|FG004|Open Label Phase|Withdrawal by Subject|0|||
149855264|NCT00401245|540598714|FG005|Open Label Phase|Withdrawal by Subject|0|||
149855265|NCT00401245|540598715|FG006|Open Label Phase|Withdrawal by Subject|0|||
149855266|NCT00401245|540598716|FG007|Open Label Phase|Withdrawal by Subject|0|||
149855267|NCT00401245|540598709|FG000|Open Label Phase|Lack of Efficacy|4|||
149855268|NCT00401245|540598710|FG001|Open Label Phase|Lack of Efficacy|2|||
149855269|NCT00401245|540598711|FG002|Open Label Phase|Lack of Efficacy|3|||
149855270|NCT00401245|540598712|FG003|Open Label Phase|Lack of Efficacy|0|||
149855271|NCT00401245|540598713|FG004|Open Label Phase|Lack of Efficacy|0|||
149855272|NCT00401245|540598714|FG005|Open Label Phase|Lack of Efficacy|0|||
149855273|NCT00401245|540598715|FG006|Open Label Phase|Lack of Efficacy|0|||
149855274|NCT00401245|540598716|FG007|Open Label Phase|Lack of Efficacy|0|||
149855275|NCT00401245|540598709|FG000|Double Blind Tapering Phase|Adverse Event|0|||
149855276|NCT00401245|540598710|FG001|Double Blind Tapering Phase|Adverse Event|0|||
149855277|NCT00401245|540598711|FG002|Double Blind Tapering Phase|Adverse Event|0|||
149855278|NCT00401245|540598712|FG003|Double Blind Tapering Phase|Adverse Event|0|||
149855279|NCT00401245|540598713|FG004|Double Blind Tapering Phase|Adverse Event|1|||
149855280|NCT00401245|540598714|FG005|Double Blind Tapering Phase|Adverse Event|1|||
149855281|NCT00401245|540598715|FG006|Double Blind Tapering Phase|Adverse Event|2|||
149855282|NCT00401245|540598716|FG007|Double Blind Tapering Phase|Adverse Event|4|||
149855283|NCT00401245|540598709|FG000|Double Blind Tapering Phase|Investigator request|0|||
149855284|NCT00401245|540598710|FG001|Double Blind Tapering Phase|Investigator request|0|||
149855285|NCT00401245|540598711|FG002|Double Blind Tapering Phase|Investigator request|0|||
149855286|NCT00401245|540598712|FG003|Double Blind Tapering Phase|Investigator request|0|||
149855287|NCT00401245|540598713|FG004|Double Blind Tapering Phase|Investigator request|0|||
149855288|NCT00401245|540598714|FG005|Double Blind Tapering Phase|Investigator request|0|||
149855289|NCT00401245|540598715|FG006|Double Blind Tapering Phase|Investigator request|0|||
149855290|NCT00401245|540598716|FG007|Double Blind Tapering Phase|Investigator request|1|||
149855291|NCT00401245|540598709|FG000|Double Blind Tapering Phase|Other|0|||
149855292|NCT00401245|540598710|FG001|Double Blind Tapering Phase|Other|0|||
149855293|NCT00401245|540598711|FG002|Double Blind Tapering Phase|Other|0|||
149855294|NCT00401245|540598712|FG003|Double Blind Tapering Phase|Other|0|||
149855295|NCT00401245|540598713|FG004|Double Blind Tapering Phase|Other|1|||
149855296|NCT00401245|540598714|FG005|Double Blind Tapering Phase|Other|0|||
149855297|NCT00401245|540598715|FG006|Double Blind Tapering Phase|Other|2|||
149855298|NCT00401245|540598716|FG007|Double Blind Tapering Phase|Other|2|||
149855299|NCT00401245|540598709|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
149855300|NCT00401245|540598710|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
149855301|NCT00401245|540598711|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
149855302|NCT00401245|540598712|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
149855303|NCT00401245|540598713|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
149855304|NCT00401245|540598714|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
149855305|NCT00401245|540598715|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
149855306|NCT00401245|540598716|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
149855307|NCT00401245|540598709|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
149855308|NCT00401245|540598710|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
149855309|NCT00401245|540598711|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
149855310|NCT00401245|540598712|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
150039669|NCT02395471|541285130|FG000|Overall Study|Failure to swollow sponge twice|1|||
150039670|NCT02395471|541285131|FG001|Overall Study|Failure to swollow sponge twice|0|||
150039671|NCT02395471|541285130|FG000|Overall Study|Patient did not return for procedure|0|||
150039672|NCT02395471|541285131|FG001|Overall Study|Patient did not return for procedure|1|||
150039673|NCT02395471|541285130|FG000|Overall Study|Subject not eligible|1|||
149855311|NCT00401245|540598713|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
150039674|NCT02395471|541285131|FG001|Overall Study|Subject not eligible|0|||
149855312|NCT00401245|540598714|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
149855313|NCT00401245|540598715|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
149855314|NCT00401245|540598716|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
149855315|NCT04364737|540598720|FG000|Overall Study|Withdrawal by Subject|4|||
149855316|NCT04364737|540598721|FG001|Overall Study|Withdrawal by Subject|9|||
149855317|NCT04364737|540598720|FG000|Overall Study|Lost to Follow-up|1|||
149855318|NCT04364737|540598721|FG001|Overall Study|Lost to Follow-up|1|||
149855319|NCT01220609|540598722|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
149855320|NCT01220609|540598722|FG000|Overall Study|Ineligible- Wrong cell type|1|||
149855321|NCT01220609|540598722|FG000|Overall Study|Ineligible-Never treated|1|||
149855322|NCT01519947|540598733|FG000|Overall Study|Death|0|||
149855323|NCT01519947|540598734|FG001|Overall Study|Death|0|||
149855324|NCT01519947|540598735|FG002|Overall Study|Death|0|||
149960168|NCT02533674|540988026|FG007|Dose Level V|Progressive disease|0|||
149960169|NCT02533674|540988019|FG000|Dose Level V|Withdrawal by Subject|0|||
150173016|NCT00922207|541769851|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
150173017|NCT00922207|541769849|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
150173018|NCT00922207|541769850|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
150173019|NCT00922207|541769851|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
150173020|NCT00922207|541769849|FG000|Overall Study|Withdrew Consent|2|||
150173021|NCT00922207|541769850|FG001|Overall Study|Withdrew Consent|5|||
150173022|NCT00922207|541769851|FG002|Overall Study|Withdrew Consent|2|||
150173023|NCT00922207|541769849|FG000|Overall Study|Abnormality of Laboratory Test|0|||
150173024|NCT00922207|541769850|FG001|Overall Study|Abnormality of Laboratory Test|1|||
150173025|NCT00922207|541769851|FG002|Overall Study|Abnormality of Laboratory Test|1|||
149960170|NCT02533674|540988020|FG001|Dose Level V|Withdrawal by Subject|0|||
149960171|NCT02533674|540988021|FG002|Dose Level V|Withdrawal by Subject|0|||
149960172|NCT02533674|540988022|FG003|Dose Level V|Withdrawal by Subject|0|||
149960173|NCT02533674|540988023|FG004|Dose Level V|Withdrawal by Subject|1|||
149960174|NCT02533674|540988024|FG005|Dose Level V|Withdrawal by Subject|0|||
149960175|NCT02533674|540988025|FG006|Dose Level V|Withdrawal by Subject|0|||
149960176|NCT02533674|540988026|FG007|Dose Level V|Withdrawal by Subject|0|||
149960177|NCT02533674|540988019|FG000|Dose Level V|Physician Decision|0|||
149960178|NCT02533674|540988020|FG001|Dose Level V|Physician Decision|0|||
150173026|NCT01802632|541769852|FG000|Overall Study|Death|28|||
150173027|NCT01802632|541769853|FG001|Overall Study|Death|1|||
149960179|NCT02533674|540988021|FG002|Dose Level V|Physician Decision|0|||
150039675|NCT00118417|541285132|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
150039676|NCT00118417|541285133|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
150173028|NCT01802632|541769854|FG002|Overall Study|Death|38|||
150039677|NCT00118417|541285132|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
150039678|NCT00118417|541285133|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
150039679|NCT00118417|541285132|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
150173029|NCT01802632|541769855|FG003|Overall Study|Death|0|||
150173030|NCT01802632|541769856|FG004|Overall Study|Death|2|||
150173031|NCT01802632|541769857|FG005|Overall Study|Death|0|||
150173032|NCT01802632|541769852|FG000|Overall Study|Withdrawal by Subject|4|||
150173033|NCT01802632|541769853|FG001|Overall Study|Withdrawal by Subject|2|||
150173034|NCT01802632|541769854|FG002|Overall Study|Withdrawal by Subject|7|||
150173035|NCT01802632|541769855|FG003|Overall Study|Withdrawal by Subject|3|||
150173036|NCT01802632|541769856|FG004|Overall Study|Withdrawal by Subject|0|||
150173037|NCT01802632|541769857|FG005|Overall Study|Withdrawal by Subject|1|||
149960180|NCT02533674|540988022|FG003|Dose Level V|Physician Decision|0|||
150039680|NCT00118417|541285133|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
150039681|NCT00118417|541285132|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
150039682|NCT00118417|541285133|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
150039683|NCT00118417|541285132|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
150039684|NCT00118417|541285133|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
150039685|NCT02978781|541285134|FG000|Part A|Adverse Event|1|||
150039686|NCT02978781|541285135|FG001|Part A|Adverse Event|1|||
150039687|NCT02978781|541285136|FG002|Part A|Adverse Event|0|||
150039688|NCT02978781|541285137|FG003|Part A|Adverse Event|0|||
150039689|NCT02978781|541285138|FG004|Part A|Adverse Event|0|||
150039690|NCT02978781|541285134|FG000|Part A|Withdrawal by Subject|0|||
150039691|NCT02978781|541285135|FG001|Part A|Withdrawal by Subject|1|||
150039692|NCT02978781|541285136|FG002|Part A|Withdrawal by Subject|0|||
150039693|NCT02978781|541285137|FG003|Part A|Withdrawal by Subject|0|||
150039694|NCT02978781|541285138|FG004|Part A|Withdrawal by Subject|0|||
150039695|NCT02978781|541285134|FG000|Part B|Withdrawal by Subject|0|||
150173038|NCT01802632|541769852|FG000|Overall Study|Objective Disease Progression|1|||
150173039|NCT01802632|541769853|FG001|Overall Study|Objective Disease Progression|12|||
150288953|NCT00264004|542192542|FG003|Overall Study|Cond. under inv. worsened|4|||
150288954|NCT00264004|542192539|FG000|Overall Study|Not treated|3|||
150288955|NCT00264004|542192540|FG001|Overall Study|Not treated|0|||
149960181|NCT02533674|540988023|FG004|Dose Level V|Physician Decision|1|||
149960182|NCT02533674|540988024|FG005|Dose Level V|Physician Decision|0|||
149960183|NCT02533674|540988025|FG006|Dose Level V|Physician Decision|0|||
149960184|NCT02533674|540988026|FG007|Dose Level V|Physician Decision|0|||
149960185|NCT02533674|540988019|FG000|Dose Level VI|Progressive disease|0|||
150039696|NCT02978781|541285135|FG001|Part B|Withdrawal by Subject|0|||
150039697|NCT02978781|541285136|FG002|Part B|Withdrawal by Subject|0|||
150039698|NCT02978781|541285137|FG003|Part B|Withdrawal by Subject|1|||
150039699|NCT02978781|541285138|FG004|Part B|Withdrawal by Subject|0|||
150173040|NCT01802632|541769854|FG002|Overall Study|Objective Disease Progression|104|||
150173041|NCT01802632|541769855|FG003|Overall Study|Objective Disease Progression|6|||
150173042|NCT01802632|541769856|FG004|Overall Study|Objective Disease Progression|4|||
150173043|NCT01802632|541769857|FG005|Overall Study|Objective Disease Progression|4|||
150288956|NCT00264004|542192541|FG002|Overall Study|Not treated|2|||
150039700|NCT02978781|541285134|FG000|Part C|Adverse Event|0|||
150039701|NCT02978781|541285135|FG001|Part C|Adverse Event|0|||
150039702|NCT02978781|541285136|FG002|Part C|Adverse Event|0|||
149960186|NCT02533674|540988020|FG001|Dose Level VI|Progressive disease|0|||
149960187|NCT02533674|540988021|FG002|Dose Level VI|Progressive disease|0|||
149960188|NCT02533674|540988022|FG003|Dose Level VI|Progressive disease|0|||
149960189|NCT02533674|540988023|FG004|Dose Level VI|Progressive disease|0|||
149960190|NCT02533674|540988024|FG005|Dose Level VI|Progressive disease|7|||
149960191|NCT02533674|540988025|FG006|Dose Level VI|Progressive disease|0|||
149960192|NCT02533674|540988026|FG007|Dose Level VI|Progressive disease|0|||
149960193|NCT02533674|540988019|FG000|Dose Level VI|Withdrawal by Subject|0|||
149960194|NCT02533674|540988020|FG001|Dose Level VI|Withdrawal by Subject|0|||
149960195|NCT02533674|540988021|FG002|Dose Level VI|Withdrawal by Subject|0|||
149960196|NCT02533674|540988022|FG003|Dose Level VI|Withdrawal by Subject|0|||
149960197|NCT02533674|540988023|FG004|Dose Level VI|Withdrawal by Subject|0|||
149960198|NCT02533674|540988024|FG005|Dose Level VI|Withdrawal by Subject|1|||
149960199|NCT02533674|540988025|FG006|Dose Level VI|Withdrawal by Subject|0|||
149960200|NCT02533674|540988026|FG007|Dose Level VI|Withdrawal by Subject|0|||
149960201|NCT02533674|540988019|FG000|Dose Level VI|Treatment-related AE|0|||
149960202|NCT02533674|540988020|FG001|Dose Level VI|Treatment-related AE|0|||
149960203|NCT02533674|540988021|FG002|Dose Level VI|Treatment-related AE|0|||
149960204|NCT02533674|540988022|FG003|Dose Level VI|Treatment-related AE|0|||
149960205|NCT02533674|540988023|FG004|Dose Level VI|Treatment-related AE|0|||
149960206|NCT02533674|540988024|FG005|Dose Level VI|Treatment-related AE|1|||
149960207|NCT02533674|540988025|FG006|Dose Level VI|Treatment-related AE|0|||
149960208|NCT02533674|540988026|FG007|Dose Level VI|Treatment-related AE|0|||
150039703|NCT02978781|541285137|FG003|Part C|Adverse Event|0|||
150039704|NCT02978781|541285138|FG004|Part C|Adverse Event|2|||
150039705|NCT02978781|541285134|FG000|Part C|Withdrawal by Subject|0|||
150039706|NCT02978781|541285135|FG001|Part C|Withdrawal by Subject|0|||
150039707|NCT02978781|541285136|FG002|Part C|Withdrawal by Subject|0|||
150039708|NCT02978781|541285137|FG003|Part C|Withdrawal by Subject|0|||
150039709|NCT02978781|541285138|FG004|Part C|Withdrawal by Subject|1|||
150288957|NCT00264004|542192542|FG003|Overall Study|Not treated|2|||
150288958|NCT03691974|542192543|FG000|Overall Study|Physician Decision|1|||
150288959|NCT03691974|542192544|FG001|Overall Study|Physician Decision|0|||
149855325|NCT01519947|540598736|FG003|Overall Study|Death|1|||
149855326|NCT01519947|540598733|FG000|Overall Study|Protocol Violation|0|||
149855327|NCT01519947|540598734|FG001|Overall Study|Protocol Violation|0|||
149855328|NCT01519947|540598735|FG002|Overall Study|Protocol Violation|2|||
149855329|NCT01519947|540598736|FG003|Overall Study|Protocol Violation|1|||
149855330|NCT01519947|540598733|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
149855331|NCT01519947|540598734|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
149855332|NCT01519947|540598735|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
149855333|NCT01519947|540598736|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
149855334|NCT01519947|540598733|FG000|Overall Study|Development of Anemia|0|||
149855335|NCT01519947|540598734|FG001|Overall Study|Development of Anemia|1|||
149855336|NCT01519947|540598735|FG002|Overall Study|Development of Anemia|0|||
149855337|NCT01519947|540598736|FG003|Overall Study|Development of Anemia|1|||
149855338|NCT01519947|540598733|FG000|Overall Study|Blood Transfusion|0|||
149855339|NCT01519947|540598734|FG001|Overall Study|Blood Transfusion|1|||
149855340|NCT01519947|540598735|FG002|Overall Study|Blood Transfusion|1|||
149855341|NCT01519947|540598736|FG003|Overall Study|Blood Transfusion|0|||
149855342|NCT01519947|540598733|FG000|Overall Study|Withdrawal by Subject|0|||
149855343|NCT01519947|540598734|FG001|Overall Study|Withdrawal by Subject|1|||
149855344|NCT01519947|540598735|FG002|Overall Study|Withdrawal by Subject|0|||
149855345|NCT01519947|540598736|FG003|Overall Study|Withdrawal by Subject|1|||
149855346|NCT01519947|540598733|FG000|Overall Study|Lost to Follow-up|0|||
149855347|NCT01519947|540598734|FG001|Overall Study|Lost to Follow-up|0|||
149855348|NCT01519947|540598735|FG002|Overall Study|Lost to Follow-up|3|||
149855349|NCT01519947|540598736|FG003|Overall Study|Lost to Follow-up|2|||
149855350|NCT01519947|540598733|FG000|Overall Study|Poor Response|1|||
149855351|NCT01519947|540598734|FG001|Overall Study|Poor Response|0|||
149855352|NCT01519947|540598735|FG002|Overall Study|Poor Response|0|||
149855353|NCT01519947|540598736|FG003|Overall Study|Poor Response|1|||
149855354|NCT01519947|540598733|FG000|Overall Study|Adverse Event|1|||
149855355|NCT01519947|540598734|FG001|Overall Study|Adverse Event|0|||
149855356|NCT01519947|540598735|FG002|Overall Study|Adverse Event|1|||
149855357|NCT01519947|540598736|FG003|Overall Study|Adverse Event|1|||
149855358|NCT01186016|540598738|FG000|Overall Study|Withdrawal by Subject|46|||
149855359|NCT01186016|540598739|FG001|Overall Study|Withdrawal by Subject|29|||
149855360|NCT03843125|540598741|FG000|Overall Study|Adverse Event|17|||
149855361|NCT03843125|540598742|FG001|Overall Study|Adverse Event|13|||
149855362|NCT03843125|540598743|FG002|Overall Study|Adverse Event|5|||
149855363|NCT03843125|540598744|FG003|Overall Study|Adverse Event|9|||
149855364|NCT03843125|540598741|FG000|Overall Study|Death|0|||
149855365|NCT03843125|540598742|FG001|Overall Study|Death|6|||
149960209|NCT02533674|540988019|FG000|Dose Level VII|Progressive disease|0|||
149960210|NCT02533674|540988020|FG001|Dose Level VII|Progressive disease|0|||
149960211|NCT02533674|540988021|FG002|Dose Level VII|Progressive disease|0|||
149960212|NCT02533674|540988022|FG003|Dose Level VII|Progressive disease|0|||
150288960|NCT03691974|542192543|FG000|Overall Study|Adverse Event|1|||
149855366|NCT03843125|540598743|FG002|Overall Study|Death|2|||
149855367|NCT03843125|540598744|FG003|Overall Study|Death|0|||
149855368|NCT03843125|540598741|FG000|Overall Study|Lack of Efficacy|14|||
149855369|NCT03843125|540598742|FG001|Overall Study|Lack of Efficacy|11|||
149855370|NCT03843125|540598743|FG002|Overall Study|Lack of Efficacy|9|||
149855371|NCT03843125|540598744|FG003|Overall Study|Lack of Efficacy|4|||
149855372|NCT03843125|540598741|FG000|Overall Study|Lost to Follow-up|3|||
149855373|NCT03843125|540598742|FG001|Overall Study|Lost to Follow-up|4|||
149855374|NCT03843125|540598743|FG002|Overall Study|Lost to Follow-up|0|||
149855375|NCT03843125|540598744|FG003|Overall Study|Lost to Follow-up|2|||
149855376|NCT03843125|540598741|FG000|Overall Study|Other|12|||
149855377|NCT03843125|540598742|FG001|Overall Study|Other|14|||
149855378|NCT03843125|540598743|FG002|Overall Study|Other|3|||
149855379|NCT03843125|540598744|FG003|Overall Study|Other|4|||
149855380|NCT03843125|540598741|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
149855381|NCT03843125|540598742|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
149855382|NCT03843125|540598743|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
149855383|NCT03843125|540598744|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
149855384|NCT03843125|540598741|FG000|Overall Study|Study Terminated by Sponsor|318|||
149855385|NCT03843125|540598742|FG001|Overall Study|Study Terminated by Sponsor|318|||
149855386|NCT03843125|540598743|FG002|Overall Study|Study Terminated by Sponsor|163|||
149855387|NCT03843125|540598744|FG003|Overall Study|Study Terminated by Sponsor|163|||
149855388|NCT03843125|540598741|FG000|Overall Study|Withdrawal by Subject|23|||
149855389|NCT03843125|540598742|FG001|Overall Study|Withdrawal by Subject|12|||
149855390|NCT03843125|540598743|FG002|Overall Study|Withdrawal by Subject|6|||
149855391|NCT03843125|540598744|FG003|Overall Study|Withdrawal by Subject|9|||
149855392|NCT03843125|540598741|FG000|Overall Study|Missing data|0|||
149855393|NCT03843125|540598742|FG001|Overall Study|Missing data|1|||
149855394|NCT03843125|540598743|FG002|Overall Study|Missing data|1|||
149855395|NCT03843125|540598744|FG003|Overall Study|Missing data|0|||
149855396|NCT01386125|540598745|FG000|Overall Study|Lost to Follow-up|3|||
149855397|NCT01386125|540598746|FG001|Overall Study|Lost to Follow-up|9|||
149855398|NCT01386125|540598745|FG000|Overall Study|Physician Decision|0|||
149855399|NCT01386125|540598746|FG001|Overall Study|Physician Decision|1|||
149855400|NCT01386125|540598745|FG000|Overall Study|Protocol Violation|5|||
149855401|NCT01386125|540598746|FG001|Overall Study|Protocol Violation|7|||
149855402|NCT01386125|540598745|FG000|Overall Study|Disease Progress|1|||
149855403|NCT01386125|540598746|FG001|Overall Study|Disease Progress|2|||
149855404|NCT01386125|540598745|FG000|Overall Study|Withdrawal by Subject|13|||
149855405|NCT01386125|540598746|FG001|Overall Study|Withdrawal by Subject|12|||
149855406|NCT01386125|540598745|FG000|Overall Study|Adverse Event|2|||
149855407|NCT01386125|540598746|FG001|Overall Study|Adverse Event|5|||
149855408|NCT01386125|540598745|FG000|Overall Study|Lack of Efficacy|0|||
149855409|NCT01386125|540598746|FG001|Overall Study|Lack of Efficacy|1|||
149855410|NCT01386125|540598745|FG000|Overall Study|Participant Leaving Country|1|||
149855411|NCT01386125|540598746|FG001|Overall Study|Participant Leaving Country|0|||
149855412|NCT03173560|540598747|FG000|Overall Study|Death|70|||
149855413|NCT03173560|540598748|FG001|Overall Study|Death|60|||
149855414|NCT03173560|540598747|FG000|Overall Study|Lost to Follow-up|1|||
149855415|NCT03173560|540598748|FG001|Overall Study|Lost to Follow-up|4|||
149855416|NCT03173560|540598747|FG000|Overall Study|Withdrawal by Subject|10|||
149855417|NCT03173560|540598748|FG001|Overall Study|Withdrawal by Subject|5|||
150039710|NCT02978781|541285134|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
150039711|NCT02978781|541285135|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
150039712|NCT02978781|541285136|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
150039713|NCT02978781|541285137|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
150039714|NCT02978781|541285138|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
150039715|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
150039716|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
150288961|NCT03691974|542192544|FG001|Overall Study|Adverse Event|0|||
149855418|NCT03173560|540598747|FG000|Overall Study|Other|0|||
149855419|NCT03173560|540598748|FG001|Overall Study|Other|1|||
149855420|NCT04254809|540598751|FG000|Overall Study|Lost to Follow-up|5|||
149855421|NCT04254809|540598752|FG001|Overall Study|Lost to Follow-up|10|||
149855422|NCT01928615|540598753|FG000|Overall Study|Study Terminated by Sponsor|2|||
149855423|NCT02972515|540598754|FG000|Overall Study|Lost to Follow-up|78|||
149855424|NCT03023137|540598759|FG000|Overall Study|Multiple pregnancy|2|||
150039717|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Adverse Event|31|||
150039718|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Adverse Event|21|||
150288962|NCT03691974|542192543|FG000|Overall Study|Withdrawal by Subject|11|||
149855425|NCT03023137|540598760|FG001|Overall Study|Multiple pregnancy|4|||
149855426|NCT03023137|540598759|FG000|Overall Study|Lost to Follow-up|1|||
149855427|NCT03023137|540598760|FG001|Overall Study|Lost to Follow-up|1|||
149855428|NCT03023137|540598759|FG000|Overall Study|Protocol Violation|0|||
149855429|NCT03023137|540598760|FG001|Overall Study|Protocol Violation|4|||
149855430|NCT03023137|540598759|FG000|Overall Study|Lost the baby in a car accident|1|||
149855431|NCT03023137|540598760|FG001|Overall Study|Lost the baby in a car accident|0|||
149855432|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
150039719|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
150039720|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
150039721|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
150039722|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
150039723|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
150039724|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
150039725|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
150039726|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
150039727|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Administrative problems|3|||
150039728|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Administrative problems|3|||
150039729|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Death|5|||
150039730|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Death|8|||
150039731|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Disease progression|139|||
150039732|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Disease progression|119|||
150039733|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
150039734|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
150039735|NCT00785785|541285139|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
150039736|NCT00785785|541285140|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
150039737|NCT00785785|541285139|FG000|Optional Extension Phase|Adverse Event|4|||
150039738|NCT00785785|541285140|FG001|Optional Extension Phase|Adverse Event|5|||
149855433|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
149855434|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
149855435|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
149855436|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
149855437|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
149855438|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
149855439|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
149855440|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
149855441|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
149855442|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
149855443|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
149855444|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
149855445|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
149855446|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
149855447|NCT02250651|540598761|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
149855448|NCT02250651|540598762|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
149855449|NCT02250651|540598763|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
149855450|NCT02250651|540598761|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
149855451|NCT02250651|540598762|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
149855452|NCT02250651|540598763|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
149855453|NCT02250651|540598761|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
149855454|NCT02250651|540598762|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
149855455|NCT02250651|540598763|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
149855456|NCT02250651|540598761|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
149855457|NCT02250651|540598762|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
149855458|NCT02250651|540598763|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
149855459|NCT02250651|540598761|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
149855460|NCT02250651|540598762|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
149855461|NCT02250651|540598763|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
149855462|NCT02250651|540598761|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
149855463|NCT02250651|540598762|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
149855464|NCT02250651|540598763|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
149855465|NCT02250651|540598761|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
149855466|NCT02250651|540598762|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
149855467|NCT02250651|540598763|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
149855468|NCT02250651|540598761|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
149855469|NCT02250651|540598762|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
149855470|NCT02250651|540598763|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
149855471|NCT02250651|540598761|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
149855472|NCT02250651|540598762|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
149855473|NCT02250651|540598763|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
149855474|NCT02250651|540598761|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
149855475|NCT02250651|540598762|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
150039739|NCT00785785|541285139|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
150039740|NCT00785785|541285140|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
150039741|NCT00785785|541285139|FG000|Optional Extension Phase|Lost to Follow-up|1|||
149855476|NCT02250651|540598763|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
149855477|NCT00732160|540598767|FG000|Overall Study|Adverse Event|1|||
149855478|NCT00732160|540598768|FG001|Overall Study|Adverse Event|0|||
149855479|NCT00732160|540598769|FG002|Overall Study|Adverse Event|1|||
150288963|NCT03691974|542192544|FG001|Overall Study|Withdrawal by Subject|9|||
150288964|NCT03691974|542192543|FG000|Overall Study|Protocol Violation|1|||
150288965|NCT03691974|542192544|FG001|Overall Study|Protocol Violation|0|||
150288966|NCT03691974|542192543|FG000|Overall Study|Lost to Follow-up|8|||
150288967|NCT03691974|542192544|FG001|Overall Study|Lost to Follow-up|7|||
150288968|NCT04623242|542192546|FG000|Overall Study|Withdrawal by Subject|7|||
150288969|NCT04623242|542192547|FG001|Overall Study|Withdrawal by Subject|12|||
150288970|NCT04623242|542192548|FG002|Overall Study|Withdrawal by Subject|5|||
150288971|NCT04623242|542192549|FG003|Overall Study|Withdrawal by Subject|7|||
150288972|NCT04623242|542192550|FG004|Overall Study|Withdrawal by Subject|0|||
150288973|NCT04623242|542192546|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
150288974|NCT04623242|542192547|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
150288975|NCT04623242|542192548|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
150288976|NCT04623242|542192549|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
150288977|NCT04623242|542192550|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
150288978|NCT04623242|542192546|FG000|Overall Study|Subject unblinded to mutation status|0|||
150288979|NCT04623242|542192547|FG001|Overall Study|Subject unblinded to mutation status|0|||
150288980|NCT04623242|542192548|FG002|Overall Study|Subject unblinded to mutation status|0|||
150288981|NCT04623242|542192549|FG003|Overall Study|Subject unblinded to mutation status|13|||
150288982|NCT04623242|542192550|FG004|Overall Study|Subject unblinded to mutation status|0|||
150288983|NCT00326898|542192553|FG000|Overall Study|Disease progression|52|||
150288984|NCT00326898|542192554|FG001|Overall Study|Disease progression|54|||
150288985|NCT00326898|542192555|FG002|Overall Study|Disease progression|102|||
150288986|NCT00326898|542192553|FG000|Overall Study|Adverse Event|124|||
150288987|NCT00326898|542192554|FG001|Overall Study|Adverse Event|128|||
150288988|NCT00326898|542192555|FG002|Overall Study|Adverse Event|33|||
150288989|NCT00326898|542192553|FG000|Overall Study|Death|2|||
150288990|NCT00326898|542192554|FG001|Overall Study|Death|0|||
150288991|NCT00326898|542192555|FG002|Overall Study|Death|0|||
150288992|NCT00326898|542192553|FG000|Overall Study|Withdrawal by Subject|134|||
150288993|NCT00326898|542192554|FG001|Overall Study|Withdrawal by Subject|128|||
150288994|NCT00326898|542192555|FG002|Overall Study|Withdrawal by Subject|32|||
150288995|NCT00326898|542192553|FG000|Overall Study|Alternative therapy|1|||
150288996|NCT00326898|542192554|FG001|Overall Study|Alternative therapy|0|||
150288997|NCT00326898|542192555|FG002|Overall Study|Alternative therapy|0|||
150288998|NCT00326898|542192553|FG000|Overall Study|Other complicating disease|5|||
150288999|NCT00326898|542192554|FG001|Overall Study|Other complicating disease|5|||
150289000|NCT00326898|542192555|FG002|Overall Study|Other complicating disease|4|||
150289001|NCT00326898|542192553|FG000|Overall Study|Other/Missing/Unknown|33|||
150289002|NCT00326898|542192554|FG001|Overall Study|Other/Missing/Unknown|28|||
150289003|NCT00326898|542192555|FG002|Overall Study|Other/Missing/Unknown|32|||
150289004|NCT03847987|542192556|FG000|Overall Study|Lost to Follow-up|1|||
150289005|NCT03847987|542192557|FG001|Overall Study|Lost to Follow-up|0|||
150289006|NCT03847987|542192556|FG000|Overall Study|Adverse Event|2|||
150289007|NCT03847987|542192557|FG001|Overall Study|Adverse Event|0|||
150289008|NCT02721355|542192558|FG000|Overall Study|Lost to Follow-up|6|||
150289009|NCT02721355|542192559|FG001|Overall Study|Lost to Follow-up|1|||
150289010|NCT01652287|542192563|FG000|Overall Study|Withdrawal by Subject|2|||
150289011|NCT01652287|542192564|FG001|Overall Study|Withdrawal by Subject|0|||
150289012|NCT01592760|542192567|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
150289013|NCT01592760|542192568|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
150289014|NCT01592760|542192569|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
150289015|NCT02605642|542192570|FG000|Overall Study|Other|11|||
150289016|NCT02605642|542192571|FG001|Overall Study|Other|1|||
150289017|NCT02605642|542192570|FG000|Overall Study|Participant non-compliance|2|||
150289018|NCT02605642|542192571|FG001|Overall Study|Participant non-compliance|4|||
150289019|NCT02605642|542192570|FG000|Overall Study|Physician Decision|10|||
150289020|NCT02605642|542192571|FG001|Overall Study|Physician Decision|0|||
150289021|NCT02605642|542192570|FG000|Overall Study|Lost to Follow-up|12|||
150289022|NCT02605642|542192571|FG001|Overall Study|Lost to Follow-up|1|||
150289023|NCT02605642|542192570|FG000|Overall Study|Adverse Event|14|||
150289024|NCT02605642|542192571|FG001|Overall Study|Adverse Event|2|||
150289025|NCT02605642|542192570|FG000|Overall Study|Withdrawal by Subject|23|||
150289026|NCT02605642|542192571|FG001|Overall Study|Withdrawal by Subject|2|||
150289027|NCT02605642|542192570|FG000|Overall Study|Lack of response|24|||
149855480|NCT00732160|540598770|FG003|Overall Study|Adverse Event|1|||
149855481|NCT00732160|540598767|FG000|Overall Study|scheduling|4|||
150289028|NCT02605642|542192571|FG001|Overall Study|Lack of response|11|||
150289029|NCT00925015|542192578|FG000|Overall Study|Adverse Event|1|||
150289030|NCT00925015|542192579|FG001|Overall Study|Adverse Event|2|||
150289031|NCT00925015|542192580|FG002|Overall Study|Adverse Event|1|||
150289032|NCT00925015|542192578|FG000|Overall Study|Physician Decision|0|||
150289033|NCT00925015|542192579|FG001|Overall Study|Physician Decision|1|||
149960213|NCT02533674|540988023|FG004|Dose Level VII|Progressive disease|0|||
149960214|NCT02533674|540988024|FG005|Dose Level VII|Progressive disease|0|||
149960215|NCT02533674|540988025|FG006|Dose Level VII|Progressive disease|10|||
149960216|NCT02533674|540988026|FG007|Dose Level VII|Progressive disease|0|||
149960217|NCT02533674|540988019|FG000|Dose Level VII|Withdrawal by Subject|0|||
149960218|NCT02533674|540988020|FG001|Dose Level VII|Withdrawal by Subject|0|||
149960219|NCT02533674|540988021|FG002|Dose Level VII|Withdrawal by Subject|0|||
149960220|NCT02533674|540988022|FG003|Dose Level VII|Withdrawal by Subject|0|||
149960221|NCT02533674|540988023|FG004|Dose Level VII|Withdrawal by Subject|0|||
149960222|NCT02533674|540988024|FG005|Dose Level VII|Withdrawal by Subject|0|||
149960223|NCT02533674|540988025|FG006|Dose Level VII|Withdrawal by Subject|3|||
149960224|NCT02533674|540988026|FG007|Dose Level VII|Withdrawal by Subject|0|||
149960225|NCT02533674|540988019|FG000|Dose Level VII|Treatment-related AE|0|||
149960226|NCT02533674|540988020|FG001|Dose Level VII|Treatment-related AE|0|||
149960227|NCT02533674|540988021|FG002|Dose Level VII|Treatment-related AE|0|||
149960228|NCT02533674|540988022|FG003|Dose Level VII|Treatment-related AE|0|||
150173044|NCT01802632|541769852|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
150173045|NCT01802632|541769853|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
150173046|NCT01802632|541769854|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
150173047|NCT01802632|541769855|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
150173048|NCT01802632|541769856|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
150173049|NCT01802632|541769857|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
150173050|NCT01802632|541769852|FG000|Overall Study|Other (not specified)|0|||
150173051|NCT01802632|541769853|FG001|Overall Study|Other (not specified)|0|||
150173052|NCT01802632|541769854|FG002|Overall Study|Other (not specified)|7|||
150173053|NCT01802632|541769855|FG003|Overall Study|Other (not specified)|1|||
150173054|NCT01802632|541769856|FG004|Overall Study|Other (not specified)|0|||
150173055|NCT01802632|541769857|FG005|Overall Study|Other (not specified)|1|||
150173056|NCT03299816|541769858|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
150173057|NCT03299816|541769859|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
150173058|NCT03299816|541769858|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
150173059|NCT03299816|541769859|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
150173060|NCT03299816|541769858|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
150173061|NCT03299816|541769859|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
150173062|NCT00367991|541769863|FG000|Overall Study|Withdrawal by Subject|1|||
150173063|NCT00367991|541769864|FG001|Overall Study|Withdrawal by Subject|1|||
150173064|NCT00367991|541769863|FG000|Overall Study|Adverse Event|1|||
150173065|NCT00367991|541769864|FG001|Overall Study|Adverse Event|1|||
150173066|NCT03515304|541769865|FG000|Overall Study|Lost to Follow-up|0|||
150173067|NCT03515304|541769866|FG001|Overall Study|Lost to Follow-up|3|||
150173068|NCT03586544|541769870|FG000|First Intervention|Adverse Event|0|||
150173069|NCT03586544|541769871|FG001|First Intervention|Adverse Event|1|||
150173070|NCT03586544|541769870|FG000|Second Intervention|Withdrawal by Subject|0|||
150173071|NCT03586544|541769871|FG001|Second Intervention|Withdrawal by Subject|1|||
150173072|NCT00539292|541769875|FG000|Overall Study|Physician Decision|1|||
150173073|NCT00539292|541769876|FG001|Overall Study|Physician Decision|0|||
150173074|NCT02020616|541769880|FG000|Overall Study|Adverse Event|0|||
150173075|NCT02020616|541769881|FG001|Overall Study|Adverse Event|0|||
150173076|NCT02020616|541769882|FG002|Overall Study|Adverse Event|0|||
150173077|NCT02020616|541769883|FG003|Overall Study|Adverse Event|0|||
150173078|NCT02020616|541769884|FG004|Overall Study|Adverse Event|0|||
150173079|NCT02020616|541769885|FG005|Overall Study|Adverse Event|1|||
150173080|NCT02020616|541769886|FG006|Overall Study|Adverse Event|1|||
150173081|NCT02020616|541769880|FG000|Overall Study|Physician Decision|0|||
150173082|NCT02020616|541769881|FG001|Overall Study|Physician Decision|0|||
150173083|NCT02020616|541769882|FG002|Overall Study|Physician Decision|0|||
150173084|NCT02020616|541769883|FG003|Overall Study|Physician Decision|0|||
150173085|NCT02020616|541769884|FG004|Overall Study|Physician Decision|0|||
150173086|NCT02020616|541769885|FG005|Overall Study|Physician Decision|1|||
150173087|NCT02020616|541769886|FG006|Overall Study|Physician Decision|2|||
150173088|NCT02020616|541769880|FG000|Overall Study|Withdrawal by Subject|0|||
150173089|NCT02020616|541769881|FG001|Overall Study|Withdrawal by Subject|0|||
150173090|NCT02020616|541769882|FG002|Overall Study|Withdrawal by Subject|1|||
150173091|NCT02020616|541769883|FG003|Overall Study|Withdrawal by Subject|0|||
150173092|NCT02020616|541769884|FG004|Overall Study|Withdrawal by Subject|0|||
150173093|NCT02020616|541769885|FG005|Overall Study|Withdrawal by Subject|1|||
150173094|NCT02020616|541769886|FG006|Overall Study|Withdrawal by Subject|1|||
150173095|NCT02020616|541769880|FG000|Overall Study|Lost to Follow-up|0|||
150173096|NCT02020616|541769881|FG001|Overall Study|Lost to Follow-up|1|||
150173097|NCT02020616|541769882|FG002|Overall Study|Lost to Follow-up|0|||
150173098|NCT02020616|541769883|FG003|Overall Study|Lost to Follow-up|1|||
150289034|NCT00925015|542192580|FG002|Overall Study|Physician Decision|0|||
149960229|NCT02533674|540988023|FG004|Dose Level VII|Treatment-related AE|0|||
149960230|NCT02533674|540988024|FG005|Dose Level VII|Treatment-related AE|0|||
149960231|NCT02533674|540988025|FG006|Dose Level VII|Treatment-related AE|1|||
149960232|NCT02533674|540988026|FG007|Dose Level VII|Treatment-related AE|0|||
149960233|NCT02533674|540988019|FG000|Dose Level VII|Death|0|||
149960234|NCT02533674|540988020|FG001|Dose Level VII|Death|0|||
149960235|NCT02533674|540988021|FG002|Dose Level VII|Death|0|||
149960236|NCT02533674|540988022|FG003|Dose Level VII|Death|0|||
149960237|NCT02533674|540988023|FG004|Dose Level VII|Death|0|||
149960238|NCT02533674|540988024|FG005|Dose Level VII|Death|0|||
149960239|NCT02533674|540988025|FG006|Dose Level VII|Death|2|||
150173099|NCT02020616|541769884|FG004|Overall Study|Lost to Follow-up|1|||
149960240|NCT02533674|540988026|FG007|Dose Level VII|Death|0|||
149960241|NCT02533674|540988019|FG000|Dose Level VIII|Progressive disease|0|||
149960242|NCT02533674|540988020|FG001|Dose Level VIII|Progressive disease|0|||
149960243|NCT02533674|540988021|FG002|Dose Level VIII|Progressive disease|0|||
149960244|NCT02533674|540988022|FG003|Dose Level VIII|Progressive disease|0|||
149960245|NCT02533674|540988023|FG004|Dose Level VIII|Progressive disease|0|||
149960246|NCT02533674|540988024|FG005|Dose Level VIII|Progressive disease|0|||
149960247|NCT02533674|540988025|FG006|Dose Level VIII|Progressive disease|0|||
149960248|NCT02533674|540988026|FG007|Dose Level VIII|Progressive disease|3|||
149960249|NCT02533674|540988019|FG000|Dose Level VIII|Withdrawal by Subject|0|||
149960250|NCT02533674|540988020|FG001|Dose Level VIII|Withdrawal by Subject|0|||
149960251|NCT02533674|540988021|FG002|Dose Level VIII|Withdrawal by Subject|0|||
149960252|NCT02533674|540988022|FG003|Dose Level VIII|Withdrawal by Subject|0|||
149960253|NCT02533674|540988023|FG004|Dose Level VIII|Withdrawal by Subject|0|||
149960254|NCT02533674|540988024|FG005|Dose Level VIII|Withdrawal by Subject|0|||
150173100|NCT02020616|541769885|FG005|Overall Study|Lost to Follow-up|1|||
150173101|NCT02020616|541769886|FG006|Overall Study|Lost to Follow-up|0|||
150173102|NCT02020616|541769880|FG000|Overall Study|Early Termination Criteria Met|0|||
150173103|NCT02020616|541769881|FG001|Overall Study|Early Termination Criteria Met|0|||
150173104|NCT02020616|541769882|FG002|Overall Study|Early Termination Criteria Met|1|||
150173105|NCT02020616|541769883|FG003|Overall Study|Early Termination Criteria Met|0|||
150173106|NCT02020616|541769884|FG004|Overall Study|Early Termination Criteria Met|0|||
150173107|NCT02020616|541769885|FG005|Overall Study|Early Termination Criteria Met|1|||
150173108|NCT02020616|541769886|FG006|Overall Study|Early Termination Criteria Met|0|||
150173109|NCT02020616|541769880|FG000|Overall Study|Randomized in Error|0|||
150173110|NCT02020616|541769881|FG001|Overall Study|Randomized in Error|0|||
150173111|NCT02020616|541769882|FG002|Overall Study|Randomized in Error|0|||
150173112|NCT02020616|541769883|FG003|Overall Study|Randomized in Error|1|||
150173113|NCT02020616|541769884|FG004|Overall Study|Randomized in Error|0|||
150173114|NCT02020616|541769885|FG005|Overall Study|Randomized in Error|0|||
150173115|NCT02020616|541769886|FG006|Overall Study|Randomized in Error|0|||
150173116|NCT02020616|541769880|FG000|Overall Study|Lack of Efficacy|0|||
150173117|NCT02020616|541769881|FG001|Overall Study|Lack of Efficacy|0|||
150173118|NCT02020616|541769882|FG002|Overall Study|Lack of Efficacy|0|||
150173119|NCT02020616|541769883|FG003|Overall Study|Lack of Efficacy|0|||
150173120|NCT02020616|541769884|FG004|Overall Study|Lack of Efficacy|1|||
150173121|NCT02020616|541769885|FG005|Overall Study|Lack of Efficacy|0|||
150173122|NCT02020616|541769886|FG006|Overall Study|Lack of Efficacy|0|||
150173123|NCT00324038|541769891|FG000|Overall Study|Adverse Event|38|||
150173124|NCT00324038|541769892|FG001|Overall Study|Adverse Event|23|||
150173125|NCT00324038|541769891|FG000|Overall Study|Lack of Efficacy|5|||
150173126|NCT00324038|541769892|FG001|Overall Study|Lack of Efficacy|13|||
150173127|NCT00324038|541769891|FG000|Overall Study|Lost to Follow-up|0|||
150173128|NCT00324038|541769892|FG001|Overall Study|Lost to Follow-up|2|||
150173129|NCT00324038|541769891|FG000|Overall Study|Other|6|||
150173130|NCT00324038|541769892|FG001|Overall Study|Other|13|||
150173131|NCT03070483|541769893|FG000|Overall Study|Lost to Follow-up|2|||
150173132|NCT02031471|541769894|FG000|24 Week Treatment Period|Adverse Event|6|||
150173133|NCT02031471|541769894|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
150173134|NCT02031471|541769894|FG000|24 Week Treatment Period|Protocol Violation|1|||
150173135|NCT02031471|541769894|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
150173136|NCT02031471|541769894|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
150173137|NCT02031471|541769894|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
150173138|NCT02031471|541769894|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
150173139|NCT00361283|541769898|FG000|Overall Study|Lost to Follow-up|27|||
150173140|NCT01837641|541769899|FG000|Overall Study|Sponsor decision|1|||
150173141|NCT01837641|541769900|FG001|Overall Study|Sponsor decision|0|||
150173142|NCT01837641|541769901|FG002|Overall Study|Sponsor decision|0|||
150173143|NCT01837641|541769902|FG003|Overall Study|Sponsor decision|0|||
150173144|NCT01837641|541769903|FG004|Overall Study|Sponsor decision|0|||
150173145|NCT01837641|541769904|FG005|Overall Study|Sponsor decision|1|||
149960255|NCT02533674|540988025|FG006|Dose Level VIII|Withdrawal by Subject|0|||
149960256|NCT02533674|540988026|FG007|Dose Level VIII|Withdrawal by Subject|1|||
149960257|NCT02533674|540988019|FG000|Dose Level VIII|Treatment-related AE|0|||
150039742|NCT00785785|541285140|FG001|Optional Extension Phase|Lost to Follow-up|0|||
150173146|NCT01837641|541769905|FG006|Overall Study|Sponsor decision|0|||
149960258|NCT02533674|540988020|FG001|Dose Level VIII|Treatment-related AE|0|||
150173147|NCT01837641|541769906|FG007|Overall Study|Sponsor decision|0|||
150289035|NCT00925015|542192578|FG000|Overall Study|Progressive Disease|7|||
150289036|NCT00925015|542192579|FG001|Overall Study|Progressive Disease|3|||
150289037|NCT00925015|542192580|FG002|Overall Study|Progressive Disease|4|||
150289038|NCT00925015|542192578|FG000|Overall Study|Withdrawal by Subject|0|||
150289039|NCT00925015|542192579|FG001|Overall Study|Withdrawal by Subject|0|||
150289040|NCT00925015|542192580|FG002|Overall Study|Withdrawal by Subject|1|||
150289041|NCT00179309|542192581|FG000|Treatment|Toxicity|2|||
150289042|NCT00179309|542192582|FG001|Treatment|Toxicity|3|||
150289043|NCT00179309|542192581|FG000|Treatment|Withdrawal by Subject|1|||
150289044|NCT00179309|542192582|FG001|Treatment|Withdrawal by Subject|2|||
150289045|NCT00179309|542192581|FG000|Treatment|Allergy|1|||
150289046|NCT00179309|542192582|FG001|Treatment|Allergy|0|||
150289047|NCT00488982|542192583|FG000|Course 1|Physician Decision|0|||
150289048|NCT00488982|542192584|FG001|Course 1|Physician Decision|2|||
150289049|NCT00488982|542192585|FG002|Course 1|Physician Decision|4|||
150289050|NCT00488982|542192583|FG000|Course 1|Withdrawal by Subject|0|||
150289051|NCT00488982|542192584|FG001|Course 1|Withdrawal by Subject|8|||
149960259|NCT02533674|540988021|FG002|Dose Level VIII|Treatment-related AE|0|||
149960260|NCT02533674|540988022|FG003|Dose Level VIII|Treatment-related AE|0|||
149960261|NCT02533674|540988023|FG004|Dose Level VIII|Treatment-related AE|0|||
149960262|NCT02533674|540988024|FG005|Dose Level VIII|Treatment-related AE|0|||
149960263|NCT02533674|540988025|FG006|Dose Level VIII|Treatment-related AE|0|||
149960264|NCT02533674|540988026|FG007|Dose Level VIII|Treatment-related AE|1|||
149960265|NCT02533674|540988019|FG000|Dose Level VIII|Never treated|0|||
149960266|NCT02533674|540988020|FG001|Dose Level VIII|Never treated|0|||
150039743|NCT00785785|541285139|FG000|Optional Extension Phase|Administrative problems|2|||
150039744|NCT00785785|541285140|FG001|Optional Extension Phase|Administrative problems|0|||
150039745|NCT00785785|541285139|FG000|Optional Extension Phase|Death|1|||
150039746|NCT00785785|541285140|FG001|Optional Extension Phase|Death|5|||
150039747|NCT00785785|541285139|FG000|Optional Extension Phase|Disease progression|22|||
150039748|NCT00785785|541285140|FG001|Optional Extension Phase|Disease progression|70|||
150039749|NCT00785785|541285139|FG000|Optional Extension Phase|Protocol deviation|0|||
150039750|NCT00785785|541285140|FG001|Optional Extension Phase|Protocol deviation|2|||
150039751|NCT00785785|541285139|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
150039752|NCT00785785|541285140|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
150039753|NCT02453321|541285141|FG000|Overall Study|Weakness|1|||
150039754|NCT02453321|541285142|FG001|Overall Study|Weakness|1|||
150039755|NCT02453321|541285143|FG002|Overall Study|Weakness|2|||
150289052|NCT00488982|542192585|FG002|Course 1|Withdrawal by Subject|2|||
150289053|NCT00488982|542192583|FG000|Course 1|nonprotocol therapy|0|||
150289054|NCT00488982|542192584|FG001|Course 1|nonprotocol therapy|2|||
150289055|NCT00488982|542192585|FG002|Course 1|nonprotocol therapy|2|||
150289056|NCT00488982|542192583|FG000|Course 1|Adverse Event|0|||
150289057|NCT00488982|542192584|FG001|Course 1|Adverse Event|0|||
150289058|NCT00488982|542192585|FG002|Course 1|Adverse Event|6|||
150289059|NCT05882318|542192597|FG000|Overall Study|Withdrawal by Subject|1|||
150289060|NCT05882318|542192598|FG001|Overall Study|Withdrawal by Subject|0|||
150289061|NCT05882318|542192597|FG000|Overall Study|Protocol Violation|0|||
150289062|NCT05882318|542192598|FG001|Overall Study|Protocol Violation|1|||
150289063|NCT05980299|542192605|FG000|Overall Study|Death|28|||
150289064|NCT05980299|542192606|FG001|Overall Study|Death|0|||
150289065|NCT05980299|542192605|FG000|Overall Study|Discharged from Nursing Home|9|||
149855482|NCT00732160|540598768|FG001|Overall Study|scheduling|4|||
149855483|NCT00732160|540598769|FG002|Overall Study|scheduling|2|||
149855484|NCT00732160|540598770|FG003|Overall Study|scheduling|1|||
149855485|NCT02795676|540598771|FG000|Overall Study|Adverse Event|2|||
149855486|NCT02795676|540598772|FG001|Overall Study|Adverse Event|0|||
149855487|NCT02795676|540598771|FG000|Overall Study|Withdrawal by Subject|3|||
149855488|NCT02795676|540598772|FG001|Overall Study|Withdrawal by Subject|1|||
149855489|NCT01264835|540598773|FG000|Overall Study|Lost to Follow-up|1|||
149855490|NCT02427399|540598778|FG000|Overall Study|Protocol Violation|14|||
149855491|NCT02427399|540598779|FG001|Overall Study|Protocol Violation|16|||
149855492|NCT02427399|540598780|FG002|Overall Study|Protocol Violation|12|||
149855493|NCT02427399|540598781|FG003|Overall Study|Protocol Violation|18|||
149855494|NCT02427399|540598782|FG004|Overall Study|Protocol Violation|15|||
149855495|NCT04660032|540598783|FG000|Overall Study|Protocol Violation|1|||
150289066|NCT05980299|542192606|FG001|Overall Study|Discharged from Nursing Home|0|||
150289067|NCT05980299|542192605|FG000|Overall Study|Lost to Follow-up|0|||
149855496|NCT04660032|540598784|FG001|Overall Study|Protocol Violation|1|||
149855497|NCT01609582|540598785|FG000|Overall Study|Adverse Event|20|||
149855498|NCT01609582|540598786|FG001|Overall Study|Adverse Event|18|||
149960267|NCT02533674|540988021|FG002|Dose Level VIII|Never treated|0|||
149960268|NCT02533674|540988022|FG003|Dose Level VIII|Never treated|0|||
149960269|NCT02533674|540988023|FG004|Dose Level VIII|Never treated|0|||
149960270|NCT02533674|540988024|FG005|Dose Level VIII|Never treated|0|||
149960271|NCT02533674|540988025|FG006|Dose Level VIII|Never treated|0|||
149960272|NCT02533674|540988026|FG007|Dose Level VIII|Never treated|1|||
149960273|NCT02365064|540988027|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
149960274|NCT02365064|540988028|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
150289068|NCT05980299|542192606|FG001|Overall Study|Lost to Follow-up|10|||
150289069|NCT02264990|542192607|FG000|Overall Study|Death|255|||
150289070|NCT02264990|542192608|FG001|Overall Study|Death|250|||
150289071|NCT02264990|542192607|FG000|Overall Study|Withdrawal by Subject|4|||
150289072|NCT02264990|542192608|FG001|Overall Study|Withdrawal by Subject|5|||
150289073|NCT02264990|542192607|FG000|Overall Study|Lost to Follow-up|1|||
150289074|NCT02264990|542192608|FG001|Overall Study|Lost to Follow-up|3|||
150289075|NCT02264990|542192607|FG000|Overall Study|Other|0|||
150289076|NCT02264990|542192608|FG001|Overall Study|Other|1|||
150289077|NCT03031301|542192609|FG000|Overall Study|Protocol Violation|4|||
150289078|NCT03031301|542192610|FG001|Overall Study|Protocol Violation|8|||
150289079|NCT03031301|542192609|FG000|Overall Study|Withdrawal by Subject|7|||
150289080|NCT03031301|542192610|FG001|Overall Study|Withdrawal by Subject|4|||
150289081|NCT03031301|542192609|FG000|Overall Study|Lost to Follow-up|4|||
150289082|NCT03031301|542192610|FG001|Overall Study|Lost to Follow-up|12|||
150289083|NCT03031301|542192609|FG000|Overall Study|Noncompliance|1|||
150289084|NCT03031301|542192610|FG001|Overall Study|Noncompliance|3|||
150289085|NCT03031301|542192609|FG000|Overall Study|Technical issue|1|||
150289086|NCT03031301|542192610|FG001|Overall Study|Technical issue|1|||
150289087|NCT03031301|542192609|FG000|Overall Study|Adverse Event|1|||
150289088|NCT03031301|542192610|FG001|Overall Study|Adverse Event|0|||
150289089|NCT00705939|542192618|FG000|Overall Study|Protocol Violation|0|||
150289090|NCT00705939|542192619|FG001|Overall Study|Protocol Violation|0|||
150289091|NCT00705939|542192620|FG002|Overall Study|Protocol Violation|1|||
150289092|NCT00705939|542192618|FG000|Overall Study|Withdrawal by Subject|0|||
150289093|NCT00705939|542192619|FG001|Overall Study|Withdrawal by Subject|1|||
150289094|NCT00705939|542192620|FG002|Overall Study|Withdrawal by Subject|3|||
150289095|NCT00705939|542192618|FG000|Overall Study|Physician Decision|0|||
150289096|NCT00705939|542192619|FG001|Overall Study|Physician Decision|1|||
150289097|NCT00705939|542192620|FG002|Overall Study|Physician Decision|0|||
150289098|NCT05048342|542192621|FG000|Overall Study|Adverse Event|1|||
150289099|NCT05048342|542192621|FG000|Overall Study|Subject decision|2|||
150289100|NCT00493038|542192622|FG000|Treatment|Adverse Event|8|||
150289101|NCT00493038|542192623|FG001|Treatment|Adverse Event|4|||
150289102|NCT00493038|542192622|FG000|Treatment|Lost to Follow-up|5|||
150289103|NCT00493038|542192623|FG001|Treatment|Lost to Follow-up|3|||
150289104|NCT00493038|542192622|FG000|Treatment|Withdrawal by Subject|11|||
150289105|NCT00493038|542192623|FG001|Treatment|Withdrawal by Subject|12|||
150289106|NCT00493038|542192622|FG000|Treatment|Other|0|||
150289107|NCT00493038|542192623|FG001|Treatment|Other|1|||
150289108|NCT00493038|542192622|FG000|Follow-up|Lost to Follow-up|1|||
150289109|NCT00493038|542192623|FG001|Follow-up|Lost to Follow-up|0|||
150289110|NCT01441063|542192624|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
150289111|NCT01441063|542192624|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
150289112|NCT04607733|542192631|FG000|Overall Study|Lost to Follow-up|1|||
150289113|NCT04607733|542192632|FG001|Overall Study|Lost to Follow-up|0|||
150289114|NCT04607733|542192633|FG002|Overall Study|Lost to Follow-up|0|||
150289115|NCT04607733|542192634|FG003|Overall Study|Lost to Follow-up|1|||
150289116|NCT04607733|542192635|FG004|Overall Study|Lost to Follow-up|1|||
150289117|NCT04607733|542192636|FG005|Overall Study|Lost to Follow-up|0|||
150289118|NCT04607733|542192631|FG000|Overall Study|Withdrawal by Subject|0|||
150289119|NCT04607733|542192632|FG001|Overall Study|Withdrawal by Subject|0|||
150289120|NCT04607733|542192633|FG002|Overall Study|Withdrawal by Subject|0|||
150039756|NCT02453321|541285141|FG000|Overall Study|Deep Venous Thrombosis|0|||
150039757|NCT02453321|541285142|FG001|Overall Study|Deep Venous Thrombosis|1|||
150039758|NCT02453321|541285143|FG002|Overall Study|Deep Venous Thrombosis|0|||
150039759|NCT01244893|541285144|FG000|Baseline|Protocol Violation|0|||
150039760|NCT01244893|541285145|FG001|Baseline|Protocol Violation|1|||
150039761|NCT01244893|541285144|FG000|1-Week Follow Up|Lost to Follow-up|1|||
150039762|NCT01244893|541285145|FG001|1-Week Follow Up|Lost to Follow-up|0|||
150039763|NCT00357552|541285146|FG000|Screening|Did not meet eligibility criteria|84|||
150039764|NCT00357552|541285146|FG000|Weeks 0 to 24|Death|1|||
150039765|NCT00357552|541285146|FG000|Weeks 24 to 104|Death|3|||
150039766|NCT00357552|541285146|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
150039767|NCT00521404|541285149|FG000|Overall Study|Adverse Event|13|||
150289121|NCT04607733|542192634|FG003|Overall Study|Withdrawal by Subject|0|||
150289122|NCT04607733|542192635|FG004|Overall Study|Withdrawal by Subject|1|||
150289123|NCT04607733|542192636|FG005|Overall Study|Withdrawal by Subject|0|||
150289124|NCT01665807|542192637|FG000|Overall Study|Withdrawal by Subject|2|||
150289125|NCT01665807|542192638|FG001|Overall Study|Withdrawal by Subject|0|||
150289126|NCT01665807|542192639|FG002|Overall Study|Withdrawal by Subject|1|||
150289127|NCT02728830|542192644|FG000|Overall Study|Exclusionary Surgery|9|||
150289128|NCT02728830|542192644|FG000|Overall Study|Exclusionary Pathology|6|||
150289129|NCT02728830|542192644|FG000|Overall Study|Physician Decision|3|||
150289130|NCT02728830|542192644|FG000|Overall Study|Withdrawal by Subject|2|||
150289131|NCT02728830|542192644|FG000|Overall Study|Lost to Follow-up|1|||
150039768|NCT00521404|541285149|FG000|Overall Study|Disease Progression|33|||
150039769|NCT00521404|541285149|FG000|Overall Study|Investigator decision|5|||
150289132|NCT02728830|542192644|FG000|Overall Study|Exclusionary Lab Values|1|||
150289133|NCT02728830|542192644|FG000|Overall Study|Contraindicated Illness|1|||
150289134|NCT02728830|542192644|FG000|Overall Study|Language Barrier|1|||
150289135|NCT03504397|542192645|FG000|Overall Study|Progressive Disease|151|||
150289136|NCT03504397|542192646|FG001|Overall Study|Progressive Disease|199|||
150289137|NCT03504397|542192645|FG000|Overall Study|Withdrawal by Subject|29|||
150289138|NCT03504397|542192646|FG001|Overall Study|Withdrawal by Subject|17|||
150289139|NCT03504397|542192645|FG000|Overall Study|Lost to Follow-up|1|||
150289140|NCT03504397|542192646|FG001|Overall Study|Lost to Follow-up|0|||
150289141|NCT03504397|542192645|FG000|Overall Study|Death|14|||
150289142|NCT03504397|542192646|FG001|Overall Study|Death|16|||
150289143|NCT03504397|542192645|FG000|Overall Study|Adverse Event|40|||
150289144|NCT03504397|542192646|FG001|Overall Study|Adverse Event|14|||
150289145|NCT03504397|542192645|FG000|Overall Study|miscellaneous|17|||
150289146|NCT03504397|542192646|FG001|Overall Study|miscellaneous|15|||
150289147|NCT03504397|542192645|FG000|Overall Study|Protocol deviation|1|||
150289148|NCT03504397|542192646|FG001|Overall Study|Protocol deviation|0|||
150289149|NCT03504397|542192645|FG000|Overall Study|Participants who did not take the study drug|4|||
150289150|NCT03504397|542192646|FG001|Overall Study|Participants who did not take the study drug|4|||
150289151|NCT03215771|542192651|FG000|Overall Study|Withdrawal by Subject|2|||
150289152|NCT03215771|542192651|FG000|Overall Study|Physician Decision|1|||
150289153|NCT00574275|542192656|FG000|Overall Study|Randomized but not treated|2|||
150289154|NCT00574275|542192657|FG001|Overall Study|Randomized but not treated|3|||
150289155|NCT00574275|542192656|FG000|Overall Study|Adverse Event|32|||
150289156|NCT00574275|542192657|FG001|Overall Study|Adverse Event|76|||
150289157|NCT00574275|542192656|FG000|Overall Study|Disease progression|160|||
150289158|NCT00574275|542192657|FG001|Overall Study|Disease progression|146|||
150289159|NCT00574275|542192656|FG000|Overall Study|Lost to Follow-up|2|||
150289160|NCT00574275|542192657|FG001|Overall Study|Lost to Follow-up|1|||
150289161|NCT00574275|542192656|FG000|Overall Study|Study stopped based on DMC decision|62|||
150289162|NCT00574275|542192657|FG001|Overall Study|Study stopped based on DMC decision|23|||
150289163|NCT00574275|542192656|FG000|Overall Study|Withdrawal by Subject|15|||
150289164|NCT00574275|542192657|FG001|Overall Study|Withdrawal by Subject|17|||
150289165|NCT00574275|542192656|FG000|Overall Study|Error calculating tumor measurement|1|||
150289166|NCT00574275|542192657|FG001|Overall Study|Error calculating tumor measurement|0|||
150289167|NCT00574275|542192656|FG000|Overall Study|Physician Decision|1|||
150289168|NCT00574275|542192657|FG001|Overall Study|Physician Decision|1|||
150289169|NCT00574275|542192656|FG000|Overall Study|Protocol Violation|0|||
150289170|NCT00574275|542192657|FG001|Overall Study|Protocol Violation|1|||
150289171|NCT00574275|542192656|FG000|Overall Study|Patient and Investigator decision|0|||
150289172|NCT00574275|542192657|FG001|Overall Study|Patient and Investigator decision|1|||
150289173|NCT00574275|542192656|FG000|Overall Study|Insurance change|0|||
150289174|NCT00574275|542192657|FG001|Overall Study|Insurance change|1|||
150289175|NCT00574275|542192656|FG000|Overall Study|Operation for curative intent|0|||
150289176|NCT00574275|542192657|FG001|Overall Study|Operation for curative intent|1|||
150289177|NCT02788747|542192660|FG000|Overall Study|Adverse Event|1|||
150289178|NCT02788747|542192661|FG001|Overall Study|Adverse Event|0|||
150289179|NCT02788747|542192662|FG002|Overall Study|Adverse Event|0|||
150289180|NCT01026831|542192663|FG000|Overall Study|Adverse Event|4|||
150289181|NCT01026831|542192664|FG001|Overall Study|Adverse Event|3|||
150289182|NCT01026831|542192663|FG000|Overall Study|Lost to Follow-up|2|||
150289183|NCT01026831|542192664|FG001|Overall Study|Lost to Follow-up|0|||
150289184|NCT01026831|542192663|FG000|Overall Study|Physician Decision|1|||
150289185|NCT01026831|542192664|FG001|Overall Study|Physician Decision|1|||
150289186|NCT01026831|542192663|FG000|Overall Study|Protocol Violation|0|||
150289187|NCT01026831|542192664|FG001|Overall Study|Protocol Violation|2|||
150289188|NCT01026831|542192663|FG000|Overall Study|Withdrawal by Subject|7|||
150289189|NCT01026831|542192664|FG001|Overall Study|Withdrawal by Subject|5|||
149960275|NCT02365064|540988027|FG000|Overall Study|Withdrawal by Subject|6|||
149960276|NCT02365064|540988028|FG001|Overall Study|Withdrawal by Subject|9|||
149960277|NCT02365064|540988027|FG000|Overall Study|Treatment intolerance|2|||
149960278|NCT02365064|540988028|FG001|Overall Study|Treatment intolerance|4|||
150289190|NCT04417894|542192665|FG000|Overall Study|Lost to Follow-up|3|||
150289191|NCT04417894|542192666|FG001|Overall Study|Lost to Follow-up|0|||
150289192|NCT04417894|542192665|FG000|Overall Study|Withdrawal by Subject|7|||
150289193|NCT04417894|542192666|FG001|Overall Study|Withdrawal by Subject|6|||
150289194|NCT04417894|542192665|FG000|Overall Study|Lack of Efficacy|3|||
150289195|NCT04417894|542192666|FG001|Overall Study|Lack of Efficacy|1|||
150289196|NCT03461757|542192667|FG000|Overall Study|Adverse Event|1|||
150289197|NCT03461757|542192668|FG001|Overall Study|Adverse Event|0|||
150289198|NCT03461757|542192667|FG000|Overall Study|Lost to Follow-up|13|||
150289199|NCT03461757|542192668|FG001|Overall Study|Lost to Follow-up|7|||
150289200|NCT03461757|542192667|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
150289201|NCT03461757|542192668|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
150289202|NCT03461757|542192667|FG000|Overall Study|Non-compliance with study treatment|0|||
150289203|NCT03461757|542192668|FG001|Overall Study|Non-compliance with study treatment|1|||
150289204|NCT03461757|542192667|FG000|Overall Study|Pregnancy|2|||
150289205|NCT03461757|542192668|FG001|Overall Study|Pregnancy|0|||
150289206|NCT03461757|542192667|FG000|Overall Study|Protocol Violation|1|||
150289207|NCT03461757|542192668|FG001|Overall Study|Protocol Violation|1|||
150289208|NCT03461757|542192667|FG000|Overall Study|Withdrawal by Subject|7|||
150289209|NCT03461757|542192668|FG001|Overall Study|Withdrawal by Subject|7|||
150289210|NCT03461757|542192667|FG000|Overall Study|Other Reasons|1|||
150289211|NCT03461757|542192668|FG001|Overall Study|Other Reasons|4|||
150289212|NCT03861559|542192674|FG000|Overall Study|Adverse Event|0|||
150289213|NCT03861559|542192675|FG001|Overall Study|Adverse Event|2|||
150289214|NCT03861559|542192674|FG000|Overall Study|Treatment failure|0|||
150289215|NCT03861559|542192675|FG001|Overall Study|Treatment failure|2|||
150289216|NCT03861559|542192674|FG000|Overall Study|Noncompliance|1|||
150289217|NCT03861559|542192675|FG001|Overall Study|Noncompliance|1|||
150289218|NCT03861559|542192674|FG000|Overall Study|Did not meet eligibility requirements|1|||
150289219|NCT03861559|542192675|FG001|Overall Study|Did not meet eligibility requirements|0|||
150289220|NCT01344876|542192681|FG000|Overall Study|Adverse Event|0|||
150289221|NCT01344876|542192682|FG001|Overall Study|Adverse Event|0|||
150289222|NCT01344876|542192683|FG002|Overall Study|Adverse Event|0|||
150289223|NCT01344876|542192684|FG003|Overall Study|Adverse Event|0|||
150289224|NCT01344876|542192685|FG004|Overall Study|Adverse Event|1|||
150289225|NCT01344876|542192681|FG000|Overall Study|Withdrawal by Subject|0|||
150289226|NCT01344876|542192682|FG001|Overall Study|Withdrawal by Subject|0|||
150289227|NCT01344876|542192683|FG002|Overall Study|Withdrawal by Subject|1|||
150289228|NCT01344876|542192684|FG003|Overall Study|Withdrawal by Subject|0|||
150289229|NCT01344876|542192685|FG004|Overall Study|Withdrawal by Subject|0|||
150289230|NCT01344876|542192681|FG000|Overall Study|Definite progression of primary disease|1|||
150289231|NCT01344876|542192682|FG001|Overall Study|Definite progression of primary disease|0|||
150289232|NCT01344876|542192683|FG002|Overall Study|Definite progression of primary disease|0|||
150289233|NCT01344876|542192684|FG003|Overall Study|Definite progression of primary disease|3|||
150289234|NCT01344876|542192685|FG004|Overall Study|Definite progression of primary disease|0|||
150289235|NCT05107765|542192686|FG000|Overall Study|Lost to Follow-up|4|||
150289236|NCT05107765|542192687|FG001|Overall Study|Lost to Follow-up|1|||
150289237|NCT05107765|542192686|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
150289238|NCT05107765|542192687|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
150289239|NCT05107765|542192686|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
150289240|NCT05107765|542192687|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
150289241|NCT01765673|542194435|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
150289242|NCT02475681|542194436|FG000|Overall Study|Death|16|||
150289243|NCT02475681|542194437|FG001|Overall Study|Death|6|||
150289244|NCT02475681|542194438|FG002|Overall Study|Death|9|||
150289245|NCT02475681|542194436|FG000|Overall Study|Physician Decision|0|||
150289246|NCT02475681|542194437|FG001|Overall Study|Physician Decision|3|||
150289247|NCT02475681|542194438|FG002|Overall Study|Physician Decision|1|||
150289248|NCT02475681|542194436|FG000|Overall Study|Withdrawal by Subject|12|||
150289249|NCT02475681|542194437|FG001|Overall Study|Withdrawal by Subject|6|||
150289250|NCT02475681|542194438|FG002|Overall Study|Withdrawal by Subject|9|||
150289251|NCT02475681|542194436|FG000|Overall Study|Lost to Follow-up|2|||
150289252|NCT02475681|542194437|FG001|Overall Study|Lost to Follow-up|1|||
150289253|NCT02475681|542194438|FG002|Overall Study|Lost to Follow-up|3|||
150289254|NCT02475681|542194436|FG000|Overall Study|Ongoing in Study|0|||
150289255|NCT02475681|542194437|FG001|Overall Study|Ongoing in Study|163|||
150289256|NCT02475681|542194438|FG002|Overall Study|Ongoing in Study|157|||
150289257|NCT02475681|542194436|FG000|Overall Study|Reasons other than above listed|2|||
150289258|NCT02475681|542194437|FG001|Overall Study|Reasons other than above listed|0|||
150289259|NCT02475681|542194438|FG002|Overall Study|Reasons other than above listed|0|||
150289260|NCT00356278|542194447|FG000|Overall Study|Withdrawal by Subject|25|||
150289261|NCT00356278|542194448|FG001|Overall Study|Withdrawal by Subject|15|||
149960279|NCT00493285|540988035|FG000|Overall Study|Lost to Follow-up|0|||
149960280|NCT00493285|540988036|FG001|Overall Study|Lost to Follow-up|0|||
150289262|NCT00356278|542194449|FG002|Overall Study|Withdrawal by Subject|19|||
150289263|NCT01363986|542194454|FG000|Overall Study|Disease progression|1|||
150289264|NCT01637142|542194455|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
150289265|NCT00687362|542194461|FG000|Overall Study|Protocol Violation|2|||
150289266|NCT00687362|542194461|FG000|Overall Study|Withdrawal by Subject|1|||
150289267|NCT02354703|542194462|FG000|Overall Study|Withdrawal by Subject|1|||
150289268|NCT02354703|542194463|FG001|Overall Study|Withdrawal by Subject|1|||
150289269|NCT02354703|542194464|FG002|Overall Study|Withdrawal by Subject|1|||
150289270|NCT02354703|542194465|FG003|Overall Study|Withdrawal by Subject|1|||
150289271|NCT02354703|542194462|FG000|Overall Study|Lost to Follow-up|2|||
150289272|NCT02354703|542194463|FG001|Overall Study|Lost to Follow-up|7|||
150289273|NCT02354703|542194464|FG002|Overall Study|Lost to Follow-up|9|||
150289274|NCT02354703|542194465|FG003|Overall Study|Lost to Follow-up|2|||
149960281|NCT00493285|540988037|FG002|Overall Study|Lost to Follow-up|0|||
150289275|NCT02354703|542194462|FG000|Overall Study|Adverse Event|0|||
150289276|NCT02354703|542194463|FG001|Overall Study|Adverse Event|0|||
150289277|NCT02354703|542194464|FG002|Overall Study|Adverse Event|1|||
150289278|NCT02354703|542194465|FG003|Overall Study|Adverse Event|0|||
150289279|NCT01268293|542194470|FG000|Overall Study|Disease progression|7|||
150289280|NCT01268293|542194470|FG000|Overall Study|Adverse Event|1|||
150289281|NCT01268293|542194470|FG000|Overall Study|Subject choice|1|||
150289282|NCT02597855|542194471|FG000|Overall Study|Lost to Follow-up|2|||
150289283|NCT02597855|542194472|FG001|Overall Study|Lost to Follow-up|1|||
150289284|NCT04681170|542194475|FG000|Stratified Enrolment & run-in|Death|1|||
150289285|NCT04681170|542194476|FG001|Stratified Enrolment & run-in|Death|0|||
150289286|NCT04681170|542194475|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
150289287|NCT04681170|542194476|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
150289288|NCT04681170|542194475|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
150289289|NCT04681170|542194476|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
150289290|NCT04681170|542194475|FG000|Open Label Efficacy Phase|Adverse Event|0|||
150289291|NCT04681170|542194476|FG001|Open Label Efficacy Phase|Adverse Event|2|||
150289292|NCT04681170|542194475|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
150289293|NCT04681170|542194476|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
150289294|NCT04681170|542194475|FG000|Open Label Safety Phase|AEs and none compliance|0|||
150289295|NCT04681170|542194476|FG001|Open Label Safety Phase|AEs and none compliance|1|||
150289296|NCT01407926|542194481|FG000|Overall Study|Lost to Follow-up|55|||
150289297|NCT02814565|542194482|FG000|Overall Study|Lack of Efficacy|0|||
150289298|NCT02814565|542194483|FG001|Overall Study|Lack of Efficacy|1|||
150289299|NCT02814565|542194482|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
150289300|NCT02814565|542194483|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
149960282|NCT00493285|540988038|FG003|Overall Study|Lost to Follow-up|0|||
149960283|NCT00493285|540988039|FG004|Overall Study|Lost to Follow-up|1|||
149960284|NCT00493285|540988040|FG005|Overall Study|Lost to Follow-up|0|||
150289301|NCT02468648|542194484|FG000|Overall Study|Death|1|||
149960285|NCT01174459|540988045|FG000|Overall Study|case report form (CRF) not collected|5|||
149960286|NCT01429623|540988052|FG000|Overall Study|Death|1|||
150289302|NCT02118792|542194485|FG000|Overall Study|Withdrawal by Subject|6|||
150289303|NCT02118792|542194486|FG001|Overall Study|Withdrawal by Subject|3|||
150289304|NCT02118792|542194485|FG000|Overall Study|Lost to Follow-up|4|||
149960287|NCT01429623|540988053|FG001|Overall Study|Death|0|||
149960288|NCT01429623|540988052|FG000|Overall Study|Adverse Event|7|||
149855499|NCT01609582|540598785|FG000|Overall Study|Lost to Follow-up|10|||
149855500|NCT01609582|540598786|FG001|Overall Study|Lost to Follow-up|10|||
149855501|NCT01609582|540598785|FG000|Overall Study|Withdrawal by Subject|21|||
149855502|NCT01609582|540598786|FG001|Overall Study|Withdrawal by Subject|15|||
149855503|NCT01609582|540598785|FG000|Overall Study|Study Terminated by Sponsor|1543|||
149855504|NCT01609582|540598786|FG001|Overall Study|Study Terminated by Sponsor|1548|||
149855505|NCT01609582|540598785|FG000|Overall Study|Other|9|||
149960289|NCT01429623|540988053|FG001|Overall Study|Adverse Event|14|||
149960290|NCT01429623|540988052|FG000|Overall Study|Withdrawal by Subject|19|||
150289305|NCT02118792|542194486|FG001|Overall Study|Lost to Follow-up|4|||
150289306|NCT02118792|542194485|FG000|Overall Study|Adverse Event|5|||
150289307|NCT02118792|542194486|FG001|Overall Study|Adverse Event|4|||
150289308|NCT02118792|542194485|FG000|Overall Study|Withdrawal by parent/guardian|14|||
150289309|NCT02118792|542194486|FG001|Overall Study|Withdrawal by parent/guardian|20|||
150289310|NCT02118792|542194485|FG000|Overall Study|Other|1|||
150289311|NCT02118792|542194486|FG001|Overall Study|Other|6|||
150289312|NCT02118792|542194485|FG000|Overall Study|Randomised but not treated|1|||
150289313|NCT02118792|542194486|FG001|Overall Study|Randomised but not treated|0|||
150289314|NCT05131204|542194487|FG000|Overall Study|Sponsor request|2|||
150289315|NCT05131204|542194488|FG001|Overall Study|Sponsor request|1|||
150289316|NCT01777152|542194490|FG000|Overall Study|Withdrawal by Subject|22|||
150289317|NCT01777152|542194491|FG001|Overall Study|Withdrawal by Subject|16|||
150289318|NCT01777152|542194490|FG000|Overall Study|Lost to Follow-up|3|||
150289319|NCT01777152|542194491|FG001|Overall Study|Lost to Follow-up|5|||
150289320|NCT01777152|542194490|FG000|Overall Study|Death|68|||
150289321|NCT01777152|542194491|FG001|Overall Study|Death|89|||
150289322|NCT01777152|542194490|FG000|Overall Study|Not eligible, no study drug received|1|||
150289323|NCT01777152|542194491|FG001|Overall Study|Not eligible, no study drug received|0|||
149960291|NCT01429623|540988053|FG001|Overall Study|Withdrawal by Subject|13|||
149960292|NCT01429623|540988052|FG000|Overall Study|Physician Decision|2|||
149960293|NCT01429623|540988053|FG001|Overall Study|Physician Decision|3|||
149960294|NCT01429623|540988052|FG000|Overall Study|Protocol Violation|3|||
149960295|NCT01429623|540988053|FG001|Overall Study|Protocol Violation|2|||
149960296|NCT01429623|540988052|FG000|Overall Study|Assorted|1|||
149960297|NCT01429623|540988053|FG001|Overall Study|Assorted|2|||
149960298|NCT01429623|540988052|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
149960299|NCT01429623|540988053|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
149960300|NCT01429623|540988052|FG000|Overall Study|No post baseline data|4|||
149960301|NCT01429623|540988053|FG001|Overall Study|No post baseline data|4|||
149960302|NCT00981175|540988054|FG000|Primary Dose Vaccination|Adverse Event|1|||
149960303|NCT00981175|540988055|FG001|Primary Dose Vaccination|Adverse Event|0|||
149960304|NCT00981175|540988054|FG000|Primary Dose Vaccination|Protocol Violation|0|||
149960305|NCT00981175|540988055|FG001|Primary Dose Vaccination|Protocol Violation|1|||
149960306|NCT00981175|540988054|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
149960307|NCT00981175|540988055|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
149960308|NCT00981175|540988054|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
149960309|NCT00981175|540988055|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
149960310|NCT01750281|540988056|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
149960311|NCT01750281|540988057|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
149960312|NCT01750281|540988058|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
149960313|NCT01750281|540988056|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
149960314|NCT01750281|540988057|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
149960315|NCT01750281|540988058|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
149960316|NCT01750281|540988056|FG000|Overall Study|Did not receive treatment|0|||
149960317|NCT01750281|540988057|FG001|Overall Study|Did not receive treatment|1|||
150289324|NCT01777152|542194490|FG000|Overall Study|Change of diagnosis|1|||
150289325|NCT01777152|542194491|FG001|Overall Study|Change of diagnosis|0|||
150289326|NCT02363686|542194494|FG000|Overall Study|Withdrawal by Subject|22|||
150289327|NCT02363686|542194494|FG000|Overall Study|incomplete FEES examinations|13|||
150289328|NCT02469090|542194495|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
150289329|NCT02469090|542194496|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
150289330|NCT02469090|542194497|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
150289331|NCT02469090|542194495|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
150289332|NCT02469090|542194496|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
150289333|NCT02469090|542194497|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
150289334|NCT02469090|542194495|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
150289335|NCT02469090|542194496|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
150289336|NCT02469090|542194497|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
150289337|NCT02469090|542194495|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
150289338|NCT02469090|542194496|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
149855506|NCT01609582|540598786|FG001|Overall Study|Other|10|||
149960318|NCT01750281|540988058|FG002|Overall Study|Did not receive treatment|0|||
149960319|NCT04189588|540988059|FG000|Overall Study|Death|0|||
149960320|NCT04189588|540988060|FG001|Overall Study|Death|1|||
149960321|NCT04189588|540988059|FG000|Overall Study|Lost to Follow-up|0|||
150289339|NCT02469090|542194497|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
150289340|NCT02469090|542194495|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
150289341|NCT02469090|542194496|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
150289342|NCT02469090|542194497|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
150289343|NCT02469090|542194495|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
150289344|NCT02469090|542194496|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
150289345|NCT02469090|542194497|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
150289346|NCT02469090|542194495|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
150289347|NCT02469090|542194496|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
150289348|NCT02469090|542194497|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
150289349|NCT02469090|542194495|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
150289350|NCT02469090|542194496|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
150289351|NCT02469090|542194497|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
150289352|NCT03446885|542194500|FG000|Overall Study|Lost to Follow-up|1|||
150289353|NCT03446885|542194501|FG001|Overall Study|Lost to Follow-up|0|||
150289354|NCT03446885|542194500|FG000|Overall Study|Did not complete entire visit|1|||
150289355|NCT03446885|542194501|FG001|Overall Study|Did not complete entire visit|0|||
150289356|NCT03823391|542194504|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
150289357|NCT03823391|542194505|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
150289358|NCT03823391|542194504|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
150289359|NCT03823391|542194505|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
150289360|NCT05030311|542194512|FG000|Overall Study|Technical problems|0|||
150289361|NCT05030311|542194513|FG001|Overall Study|Technical problems|1|||
150289362|NCT05030311|542194512|FG000|Overall Study|Withdrawal by Subject|31|||
150289363|NCT05030311|542194513|FG001|Overall Study|Withdrawal by Subject|17|||
150289364|NCT05030311|542194512|FG000|Overall Study|Adverse Event|13|||
150289365|NCT05030311|542194513|FG001|Overall Study|Adverse Event|5|||
150289366|NCT05030311|542194512|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
150289367|NCT05030311|542194513|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
150289368|NCT05030311|542194512|FG000|Overall Study|Physician Decision|5|||
150289369|NCT05030311|542194513|FG001|Overall Study|Physician Decision|2|||
150289370|NCT05030311|542194512|FG000|Overall Study|Lost to Follow-up|5|||
150289371|NCT05030311|542194513|FG001|Overall Study|Lost to Follow-up|1|||
150289372|NCT05030311|542194512|FG000|Overall Study|Protocol Violation|4|||
150289373|NCT05030311|542194513|FG001|Overall Study|Protocol Violation|4|||
150289374|NCT03042468|542194514|FG000|Overall Study|Death|0|||
150289375|NCT03042468|542194515|FG001|Overall Study|Death|1|||
150289376|NCT03042468|542194516|FG002|Overall Study|Death|1|||
150289377|NCT03042468|542194517|FG003|Overall Study|Death|0|||
150289378|NCT03042468|542194518|FG004|Overall Study|Death|0|||
150289379|NCT03042468|542194519|FG005|Overall Study|Death|0|||
150289380|NCT03042468|542194514|FG000|Overall Study|Withdrawal by Subject|0|||
150289381|NCT03042468|542194515|FG001|Overall Study|Withdrawal by Subject|0|||
150289382|NCT03042468|542194516|FG002|Overall Study|Withdrawal by Subject|0|||
150289383|NCT03042468|542194517|FG003|Overall Study|Withdrawal by Subject|0|||
150289384|NCT03042468|542194518|FG004|Overall Study|Withdrawal by Subject|0|||
150289385|NCT03042468|542194519|FG005|Overall Study|Withdrawal by Subject|1|||
150289386|NCT03042468|542194514|FG000|Overall Study|Lost to Follow-up|0|||
150289387|NCT03042468|542194515|FG001|Overall Study|Lost to Follow-up|0|||
150289388|NCT03042468|542194516|FG002|Overall Study|Lost to Follow-up|0|||
150289389|NCT03042468|542194517|FG003|Overall Study|Lost to Follow-up|0|||
150289390|NCT03042468|542194518|FG004|Overall Study|Lost to Follow-up|1|||
150289391|NCT03042468|542194519|FG005|Overall Study|Lost to Follow-up|1|||
150289392|NCT03557359|542194520|FG000|Dose 1: 240 mg|Adverse Event|1|||
150289393|NCT03557359|542194521|FG001|Dose 1: 240 mg|Adverse Event|0|||
150289394|NCT01662895|542194525|FG000|Overall Study|Lost to Follow-up|0|||
150289395|NCT01662895|542194526|FG001|Overall Study|Lost to Follow-up|1|||
150289396|NCT03345472|542194527|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
150289397|NCT03345472|542194527|FG000|Implant to 3 Months|Physician Decision|1|||
150289398|NCT03345472|542194527|FG000|Implant to 3 Months|Adverse Event|1|||
150289399|NCT03345472|542194527|FG000|3 Months to 12 Months|Physician Decision|3|||
150289400|NCT03345472|542194527|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
150289401|NCT03345472|542194527|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
150289402|NCT03345472|542194527|FG000|3 Months to 12 Months|Adverse Event|1|||
150289403|NCT03345472|542194527|FG000|3 Months to 12 Months|Death|1|||
150289404|NCT01926782|542194528|FG000|Overall Study|Participant moved|2|||
150289405|NCT01926782|542194529|FG001|Overall Study|Participant moved|0|||
150289406|NCT01926782|542194530|FG002|Overall Study|Participant moved|1|||
150289407|NCT01926782|542194531|FG003|Overall Study|Participant moved|1|||
150289408|NCT01926782|542194532|FG004|Overall Study|Participant moved|0|||
150289409|NCT01926782|542194533|FG005|Overall Study|Participant moved|3|||
150289410|NCT01926782|542194528|FG000|Overall Study|Physician Decision|0|||
150289411|NCT01926782|542194529|FG001|Overall Study|Physician Decision|2|||
150289412|NCT01926782|542194530|FG002|Overall Study|Physician Decision|1|||
150289413|NCT01926782|542194531|FG003|Overall Study|Physician Decision|1|||
150289414|NCT01926782|542194532|FG004|Overall Study|Physician Decision|0|||
150289415|NCT01926782|542194533|FG005|Overall Study|Physician Decision|0|||
150289416|NCT01926782|542194528|FG000|Overall Study|Other than specified|2|||
149855507|NCT01609582|540598785|FG000|Overall Study|Randomized, but not treated|0|||
149855508|NCT01609582|540598786|FG001|Overall Study|Randomized, but not treated|3|||
149855509|NCT00761176|540598789|FG000|Overall Study|Death|1|||
149855510|NCT00761176|540598790|FG001|Overall Study|Death|0|||
149855511|NCT00761176|540598789|FG000|Overall Study|Withdrawal by Subject|1|||
149855512|NCT00761176|540598790|FG001|Overall Study|Withdrawal by Subject|1|||
149855513|NCT02020967|540598791|FG000|Overall Study|Withdrawal by Subject|51|||
149855514|NCT03507686|540598792|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
149855515|NCT03507686|540598793|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
149855516|NCT03507686|540598792|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
149855517|NCT03507686|540598793|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
149855518|NCT03507686|540598792|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
149855519|NCT03507686|540598793|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
149960322|NCT04189588|540988060|FG001|Overall Study|Lost to Follow-up|1|||
149960323|NCT01379937|540988065|FG000|Overall Study|Protocol Violation|0|||
149960324|NCT01379937|540988066|FG001|Overall Study|Protocol Violation|0|||
149960325|NCT01379937|540988067|FG002|Overall Study|Protocol Violation|0|||
149960326|NCT01379937|540988068|FG003|Overall Study|Protocol Violation|1|||
149960327|NCT01379937|540988065|FG000|Overall Study|Consent withdrawal|0|||
150173148|NCT01837641|541769899|FG000|Overall Study|Adverse Event|0|||
150173149|NCT01837641|541769900|FG001|Overall Study|Adverse Event|0|||
150173150|NCT01837641|541769901|FG002|Overall Study|Adverse Event|0|||
150173151|NCT01837641|541769902|FG003|Overall Study|Adverse Event|0|||
150173152|NCT01837641|541769903|FG004|Overall Study|Adverse Event|0|||
150173153|NCT01837641|541769904|FG005|Overall Study|Adverse Event|1|||
150173154|NCT01837641|541769905|FG006|Overall Study|Adverse Event|0|||
150173155|NCT01837641|541769906|FG007|Overall Study|Adverse Event|0|||
150173156|NCT01837641|541769899|FG000|Overall Study|Withdrawal by Subject|0|||
150173157|NCT01837641|541769900|FG001|Overall Study|Withdrawal by Subject|0|||
150173158|NCT01837641|541769901|FG002|Overall Study|Withdrawal by Subject|0|||
150173159|NCT01837641|541769902|FG003|Overall Study|Withdrawal by Subject|0|||
150173160|NCT01837641|541769903|FG004|Overall Study|Withdrawal by Subject|1|||
150173161|NCT01837641|541769904|FG005|Overall Study|Withdrawal by Subject|0|||
150173162|NCT01837641|541769905|FG006|Overall Study|Withdrawal by Subject|1|||
150173163|NCT01837641|541769906|FG007|Overall Study|Withdrawal by Subject|0|||
150173164|NCT01579916|541769907|FG000|Overall Study|Lost to Follow-up|6|||
150173165|NCT01579916|541769908|FG001|Overall Study|Lost to Follow-up|1|||
150173166|NCT01579916|541769907|FG000|Overall Study|Withdrawal by Subject|1|||
150173167|NCT01579916|541769908|FG001|Overall Study|Withdrawal by Subject|1|||
150173168|NCT01579916|541769907|FG000|Overall Study|Death|1|||
150173169|NCT01579916|541769908|FG001|Overall Study|Death|0|||
150173170|NCT03264456|541769909|FG000|Overall Study|Withdrawal by Subject|3|||
150173171|NCT03264456|541769909|FG000|Overall Study|Lost to Follow-up|1|||
150173172|NCT00688519|541769912|FG000|Overall Study|Adverse Event|2|||
150173173|NCT00688519|541769913|FG001|Overall Study|Adverse Event|3|||
150173174|NCT00688519|541769912|FG000|Overall Study|Lost to Follow-up|3|||
150173175|NCT00688519|541769913|FG001|Overall Study|Lost to Follow-up|3|||
150173176|NCT00688519|541769912|FG000|Overall Study|Lack of Efficacy|3|||
150173177|NCT00688519|541769913|FG001|Overall Study|Lack of Efficacy|1|||
150173178|NCT00688519|541769912|FG000|Overall Study|Withdrawal by Subject|7|||
150173179|NCT00688519|541769913|FG001|Overall Study|Withdrawal by Subject|6|||
150173180|NCT00688519|541769912|FG000|Overall Study|Prohibited medication|1|||
150173181|NCT00688519|541769913|FG001|Overall Study|Prohibited medication|0|||
150173182|NCT00688519|541769912|FG000|Overall Study|Non-compliance|0|||
150173183|NCT00688519|541769913|FG001|Overall Study|Non-compliance|1|||
150173184|NCT00688519|541769912|FG000|Overall Study|Subject moved out of state|1|||
150173185|NCT00688519|541769913|FG001|Overall Study|Subject moved out of state|0|||
150173186|NCT00688519|541769912|FG000|Overall Study|Investigator decision|1|||
150173187|NCT00688519|541769913|FG001|Overall Study|Investigator decision|0|||
150173188|NCT00688519|541769912|FG000|Overall Study|Subject moved out of area|1|||
150173189|NCT00688519|541769913|FG001|Overall Study|Subject moved out of area|0|||
150173190|NCT00688519|541769912|FG000|Overall Study|Pregnancy|0|||
150173191|NCT00688519|541769913|FG001|Overall Study|Pregnancy|1|||
150173192|NCT02551055|541769916|FG000|Overall Study|Death|2|||
150173193|NCT02551055|541769917|FG001|Overall Study|Death|4|||
150173194|NCT02551055|541769918|FG002|Overall Study|Death|2|||
150173195|NCT02551055|541769919|FG003|Overall Study|Death|2|||
150173196|NCT02551055|541769920|FG004|Overall Study|Death|2|||
150173197|NCT02551055|541769921|FG005|Overall Study|Death|1|||
150173198|NCT02551055|541769922|FG006|Overall Study|Death|2|||
150173199|NCT02551055|541769923|FG007|Overall Study|Death|0|||
149960328|NCT01379937|540988066|FG001|Overall Study|Consent withdrawal|1|||
149960329|NCT01379937|540988067|FG002|Overall Study|Consent withdrawal|0|||
149960330|NCT01379937|540988068|FG003|Overall Study|Consent withdrawal|0|||
150173200|NCT02551055|541769916|FG000|Overall Study|Study Terminated by Sponsor|1|||
150289417|NCT01926782|542194529|FG001|Overall Study|Other than specified|3|||
149855520|NCT03507686|540598792|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
149855521|NCT03507686|540598793|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
149855522|NCT03507686|540598792|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
149855523|NCT03507686|540598793|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
149855524|NCT03507686|540598792|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
149855525|NCT03507686|540598793|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
149855526|NCT00585312|540598794|FG000|Overall Study|Adverse Event|3|||
149855527|NCT00585312|540598795|FG001|Overall Study|Adverse Event|0|||
149855528|NCT00585312|540598794|FG000|Overall Study|Lack of Efficacy|6|||
149855529|NCT00585312|540598795|FG001|Overall Study|Lack of Efficacy|11|||
149855530|NCT00585312|540598794|FG000|Overall Study|Lost to Follow-up|1|||
149855531|NCT00585312|540598795|FG001|Overall Study|Lost to Follow-up|1|||
149855532|NCT00585312|540598794|FG000|Overall Study|Reason not specified|2|||
149855533|NCT00585312|540598795|FG001|Overall Study|Reason not specified|0|||
150173201|NCT02551055|541769917|FG001|Overall Study|Study Terminated by Sponsor|1|||
150173202|NCT02551055|541769918|FG002|Overall Study|Study Terminated by Sponsor|0|||
150173203|NCT02551055|541769919|FG003|Overall Study|Study Terminated by Sponsor|2|||
150173204|NCT02551055|541769920|FG004|Overall Study|Study Terminated by Sponsor|2|||
150173205|NCT02551055|541769921|FG005|Overall Study|Study Terminated by Sponsor|0|||
150173206|NCT02551055|541769922|FG006|Overall Study|Study Terminated by Sponsor|0|||
150173207|NCT02551055|541769923|FG007|Overall Study|Study Terminated by Sponsor|0|||
150173208|NCT02551055|541769916|FG000|Overall Study|Withdrawal by Subject|1|||
150173209|NCT02551055|541769917|FG001|Overall Study|Withdrawal by Subject|1|||
150173210|NCT02551055|541769918|FG002|Overall Study|Withdrawal by Subject|0|||
150173211|NCT02551055|541769919|FG003|Overall Study|Withdrawal by Subject|1|||
150173212|NCT02551055|541769920|FG004|Overall Study|Withdrawal by Subject|2|||
150173213|NCT02551055|541769921|FG005|Overall Study|Withdrawal by Subject|0|||
150173214|NCT02551055|541769922|FG006|Overall Study|Withdrawal by Subject|0|||
150173215|NCT02551055|541769923|FG007|Overall Study|Withdrawal by Subject|0|||
150173216|NCT02551055|541769916|FG000|Overall Study|Reason not specified|0|||
150173217|NCT02551055|541769917|FG001|Overall Study|Reason not specified|0|||
150173218|NCT02551055|541769918|FG002|Overall Study|Reason not specified|0|||
150173219|NCT02551055|541769919|FG003|Overall Study|Reason not specified|0|||
150173220|NCT02551055|541769920|FG004|Overall Study|Reason not specified|1|||
150173221|NCT02551055|541769921|FG005|Overall Study|Reason not specified|0|||
150173222|NCT02551055|541769922|FG006|Overall Study|Reason not specified|1|||
150173223|NCT02551055|541769923|FG007|Overall Study|Reason not specified|0|||
150173224|NCT00430300|541769924|FG000|Overall Study|Adverse Event|0|||
150173225|NCT00430300|541769925|FG001|Overall Study|Adverse Event|2|||
150173226|NCT00430300|541769926|FG002|Overall Study|Adverse Event|1|||
150173227|NCT00430300|541769927|FG003|Overall Study|Adverse Event|1|||
150173228|NCT00430300|541769924|FG000|Overall Study|Withdrawal by Subject|1|||
150173229|NCT00430300|541769925|FG001|Overall Study|Withdrawal by Subject|0|||
150173230|NCT00430300|541769926|FG002|Overall Study|Withdrawal by Subject|5|||
150173231|NCT00430300|541769927|FG003|Overall Study|Withdrawal by Subject|0|||
150173232|NCT00430300|541769924|FG000|Overall Study|Laboratory abnormality|1|||
150173233|NCT00430300|541769925|FG001|Overall Study|Laboratory abnormality|0|||
150173234|NCT00430300|541769926|FG002|Overall Study|Laboratory abnormality|0|||
150173235|NCT00430300|541769927|FG003|Overall Study|Laboratory abnormality|0|||
150173236|NCT00430300|541769924|FG000|Overall Study|Other|0|||
150173237|NCT00430300|541769925|FG001|Overall Study|Other|0|||
150173238|NCT00430300|541769926|FG002|Overall Study|Other|0|||
150173239|NCT00430300|541769927|FG003|Overall Study|Other|1|||
150173240|NCT01063517|541769930|FG000|Overall Study|Consent withdrawal|1|||
150173241|NCT01063517|541769931|FG001|Overall Study|Consent withdrawal|0|||
150173242|NCT01063517|541769930|FG000|Overall Study|Study reached data cut-off|19|||
150173243|NCT01063517|541769931|FG001|Overall Study|Study reached data cut-off|7|||
150173244|NCT01063517|541769930|FG000|Overall Study|Lost to Follow-up|4|||
150173245|NCT01063517|541769931|FG001|Overall Study|Lost to Follow-up|3|||
150173246|NCT01063517|541769930|FG000|Overall Study|Withdrawal by Subject|1|||
150173247|NCT01063517|541769931|FG001|Overall Study|Withdrawal by Subject|2|||
150173248|NCT01063517|541769930|FG000|Overall Study|Death|33|||
150173249|NCT01063517|541769931|FG001|Overall Study|Death|48|||
150173250|NCT02041104|541769932|FG000|Overall Study|Lost to Follow-up|1|||
150173251|NCT02041104|541769933|FG001|Overall Study|Lost to Follow-up|4|||
150173252|NCT02041104|541769932|FG000|Overall Study|discomfort during OGTT|0|||
150173253|NCT02041104|541769933|FG001|Overall Study|discomfort during OGTT|3|||
150173254|NCT04001829|541771226|FG000|Overall Study|Never start protocol therapy|5|||
150173255|NCT04001829|541771227|FG001|Overall Study|Never start protocol therapy|5|||
150173256|NCT04001829|541771226|FG000|Overall Study|Adverse Event|11|||
150173257|NCT04001829|541771227|FG001|Overall Study|Adverse Event|7|||
150173258|NCT04001829|541771226|FG000|Overall Study|Alternative therapy|1|||
149960331|NCT01379937|540988065|FG000|Overall Study|Lost to Follow-up|1|||
149855534|NCT00585312|540598794|FG000|Overall Study|Withdrawal by Subject|5|||
150039770|NCT00521404|541285149|FG000|Overall Study|Withdrawal of consent|3|||
150039771|NCT00521404|541285149|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
150039772|NCT00521404|541285149|FG000|Overall Study|Other|7|||
150039773|NCT00882557|541285154|FG000|Overall Study|Withdrawal by Subject|1|||
150039774|NCT00882557|541285155|FG001|Overall Study|Withdrawal by Subject|0|||
150289418|NCT01926782|542194530|FG002|Overall Study|Other than specified|5|||
150289419|NCT01926782|542194531|FG003|Overall Study|Other than specified|12|||
150289420|NCT01926782|542194532|FG004|Overall Study|Other than specified|4|||
150289421|NCT01926782|542194533|FG005|Overall Study|Other than specified|11|||
150289422|NCT01926782|542194528|FG000|Overall Study|Adverse Event|13|||
150289423|NCT01926782|542194529|FG001|Overall Study|Adverse Event|4|||
150289424|NCT01926782|542194530|FG002|Overall Study|Adverse Event|17|||
150289425|NCT01926782|542194531|FG003|Overall Study|Adverse Event|4|||
150289426|NCT01926782|542194532|FG004|Overall Study|Adverse Event|3|||
150289427|NCT01926782|542194533|FG005|Overall Study|Adverse Event|14|||
150289428|NCT01926782|542194528|FG000|Overall Study|Poor compliance to protocol|5|||
150289429|NCT01926782|542194529|FG001|Overall Study|Poor compliance to protocol|3|||
150289430|NCT01926782|542194530|FG002|Overall Study|Poor compliance to protocol|8|||
150289431|NCT01926782|542194531|FG003|Overall Study|Poor compliance to protocol|0|||
150289432|NCT01926782|542194532|FG004|Overall Study|Poor compliance to protocol|1|||
150289433|NCT01926782|542194533|FG005|Overall Study|Poor compliance to protocol|6|||
150289434|NCT01926782|542194528|FG000|Overall Study|Randomized and not treated|0|||
150289435|NCT01926782|542194529|FG001|Overall Study|Randomized and not treated|0|||
150289436|NCT01926782|542194530|FG002|Overall Study|Randomized and not treated|0|||
150289437|NCT01926782|542194531|FG003|Overall Study|Randomized and not treated|1|||
150289438|NCT01926782|542194532|FG004|Overall Study|Randomized and not treated|0|||
150289439|NCT01926782|542194533|FG005|Overall Study|Randomized and not treated|0|||
150289440|NCT01926782|542194528|FG000|Overall Study|Withdrawal by Subject|6|||
150289441|NCT01926782|542194529|FG001|Overall Study|Withdrawal by Subject|1|||
150039775|NCT00882557|541285154|FG000|Overall Study|Trouble with Vein Access|1|||
150039776|NCT00882557|541285155|FG001|Overall Study|Trouble with Vein Access|0|||
150039777|NCT00882557|541285154|FG000|Overall Study|Randomized Not Treated|0|||
150289442|NCT01926782|542194530|FG002|Overall Study|Withdrawal by Subject|8|||
150289443|NCT01926782|542194531|FG003|Overall Study|Withdrawal by Subject|1|||
150289444|NCT01926782|542194532|FG004|Overall Study|Withdrawal by Subject|0|||
150289445|NCT01926782|542194533|FG005|Overall Study|Withdrawal by Subject|5|||
150289446|NCT01926782|542194528|FG000|Overall Study|Related to study drug administration|0|||
150289447|NCT01926782|542194529|FG001|Overall Study|Related to study drug administration|0|||
150289448|NCT01926782|542194530|FG002|Overall Study|Related to study drug administration|0|||
150289449|NCT01926782|542194531|FG003|Overall Study|Related to study drug administration|0|||
150289450|NCT01926782|542194532|FG004|Overall Study|Related to study drug administration|0|||
149855535|NCT00585312|540598795|FG001|Overall Study|Withdrawal by Subject|1|||
149855536|NCT00585312|540598794|FG000|Overall Study|Study terminated by the sponsor|34|||
149855537|NCT00585312|540598795|FG001|Overall Study|Study terminated by the sponsor|31|||
149855538|NCT00129116|540598796|FG000|Primary Phase|Lost to Follow-up|1|||
149855539|NCT00129116|540598797|FG001|Primary Phase|Lost to Follow-up|1|||
149855540|NCT00129116|540598798|FG002|Primary Phase|Lost to Follow-up|0|||
149855541|NCT00129116|540598799|FG003|Primary Phase|Lost to Follow-up|1|||
149855542|NCT00129116|540598800|FG004|Primary Phase|Lost to Follow-up|1|||
149855543|NCT00129116|540598796|FG000|Primary Phase|Protocol Violation|0|||
149855544|NCT00129116|540598797|FG001|Primary Phase|Protocol Violation|1|||
149855545|NCT00129116|540598798|FG002|Primary Phase|Protocol Violation|0|||
149855546|NCT00129116|540598799|FG003|Primary Phase|Protocol Violation|0|||
149855547|NCT00129116|540598800|FG004|Primary Phase|Protocol Violation|0|||
149855548|NCT00129116|540598796|FG000|Primary Phase|Adverse Event|1|||
149855549|NCT00129116|540598797|FG001|Primary Phase|Adverse Event|1|||
149855550|NCT00129116|540598798|FG002|Primary Phase|Adverse Event|0|||
149855551|NCT00129116|540598799|FG003|Primary Phase|Adverse Event|0|||
149855552|NCT00129116|540598800|FG004|Primary Phase|Adverse Event|0|||
149855553|NCT00129116|540598796|FG000|Primary Phase|Withdrawal by Subject|0|||
149855554|NCT00129116|540598797|FG001|Primary Phase|Withdrawal by Subject|1|||
149855555|NCT00129116|540598798|FG002|Primary Phase|Withdrawal by Subject|0|||
149855556|NCT00129116|540598799|FG003|Primary Phase|Withdrawal by Subject|0|||
149855557|NCT00129116|540598800|FG004|Primary Phase|Withdrawal by Subject|0|||
149855558|NCT00129116|540598796|FG000|Primary Phase|Other|0|||
149855559|NCT00129116|540598797|FG001|Primary Phase|Other|0|||
149855560|NCT00129116|540598798|FG002|Primary Phase|Other|1|||
149855561|NCT00129116|540598799|FG003|Primary Phase|Other|0|||
149855562|NCT00129116|540598800|FG004|Primary Phase|Other|0|||
149855563|NCT00129116|540598796|FG000|Booster Phase|Lost to Follow-up|2|||
149855564|NCT00129116|540598797|FG001|Booster Phase|Lost to Follow-up|0|||
149855565|NCT00129116|540598798|FG002|Booster Phase|Lost to Follow-up|0|||
149855566|NCT00129116|540598799|FG003|Booster Phase|Lost to Follow-up|0|||
149855567|NCT00129116|540598800|FG004|Booster Phase|Lost to Follow-up|1|||
149855568|NCT02539368|540598803|FG000|Overall Study|Death|4|||
149855569|NCT02539368|540598804|FG001|Overall Study|Death|2|||
149855570|NCT02539368|540598805|FG002|Overall Study|Death|1|||
150289451|NCT01926782|542194533|FG005|Overall Study|Related to study drug administration|2|||
150289452|NCT02275338|542194534|FG000|Overall Study|Adverse Event|15|||
150289453|NCT02275338|542194534|FG000|Overall Study|Lack of Efficacy|3|||
150289454|NCT02275338|542194534|FG000|Overall Study|Withdrawal by Subject|4|||
150289455|NCT02275338|542194534|FG000|Overall Study|Disease progression (death)|1|||
150289456|NCT02275338|542194534|FG000|Overall Study|Ineligible to start Phase 2|4|||
150289457|NCT02275338|542194534|FG000|Overall Study|Reason not specified|5|||
150289458|NCT02275338|542194534|FG000|Overall Study|Does not meet entry criteria|1|||
150289459|NCT00070941|542194561|FG000|Overall Study|Adverse Event|10|||
150289460|NCT00070941|542194562|FG001|Overall Study|Adverse Event|8|||
150289461|NCT00070941|542194563|FG002|Overall Study|Adverse Event|4|||
149960332|NCT01379937|540988066|FG001|Overall Study|Lost to Follow-up|2|||
149960333|NCT01379937|540988067|FG002|Overall Study|Lost to Follow-up|2|||
149960334|NCT01379937|540988068|FG003|Overall Study|Lost to Follow-up|0|||
150289462|NCT00075504|542194568|FG000|Overall Study|Withdrawal by Subject|9|||
150289463|NCT00075504|542194569|FG001|Overall Study|Withdrawal by Subject|7|||
150289464|NCT00623428|542194570|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
150289465|NCT00623428|542194571|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
150289466|NCT00623428|542194570|FG000|Treatment Period|Death|0|||
150289467|NCT00623428|542194571|FG001|Treatment Period|Death|1|||
150289468|NCT00623428|542194570|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
150289469|NCT00623428|542194571|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
150289470|NCT00623428|542194570|FG000|Treatment Period|Insufficient therapeutic response|0|||
150289471|NCT00623428|542194571|FG001|Treatment Period|Insufficient therapeutic response|2|||
150289472|NCT00623428|542194570|FG000|Treatment Period|Other|0|||
150289473|NCT00623428|542194571|FG001|Treatment Period|Other|1|||
150289474|NCT00623428|542194570|FG000|Treatment Period|Withdrawal by Subject|0|||
150289475|NCT00623428|542194571|FG001|Treatment Period|Withdrawal by Subject|1|||
150289476|NCT00623428|542194570|FG000|Follow-up Period|Relapse post-treatment|11|||
150289477|NCT00623428|542194571|FG001|Follow-up Period|Relapse post-treatment|3|||
150289478|NCT00623428|542194570|FG000|Follow-up Period|Failure to return|10|||
150289479|NCT00623428|542194571|FG001|Follow-up Period|Failure to return|2|||
150289480|NCT00623428|542194570|FG000|Follow-up Period|Patient withdrew consent|5|||
150289481|NCT00623428|542194571|FG001|Follow-up Period|Patient withdrew consent|4|||
150289482|NCT00623428|542194570|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
150289483|NCT00623428|542194571|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
150289484|NCT00623428|542194570|FG000|Follow-up Period|Did not cooperate|0|||
150289485|NCT00623428|542194571|FG001|Follow-up Period|Did not cooperate|3|||
150289486|NCT00623428|542194570|FG000|Follow-up Period|Reason not specified|1|||
150289487|NCT00623428|542194571|FG001|Follow-up Period|Reason not specified|1|||
150289488|NCT00623428|542194570|FG000|Follow-up Period|Death|0|||
150289489|NCT00623428|542194571|FG001|Follow-up Period|Death|1|||
150289490|NCT01142726|542194572|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
150289491|NCT01142726|542194573|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
150289492|NCT01142726|542194574|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
150289493|NCT01142726|542194572|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
150289494|NCT01142726|542194573|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
150289495|NCT01142726|542194574|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
150289496|NCT01142726|542194572|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
150289497|NCT01142726|542194573|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
150289498|NCT01142726|542194574|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
150289499|NCT01142726|542194572|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
150289500|NCT01142726|542194573|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
150289501|NCT01142726|542194574|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
150289502|NCT01142726|542194572|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
150289503|NCT01142726|542194573|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
150289504|NCT01142726|542194574|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
150289505|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
150289506|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
150289507|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
150289508|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
150289509|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
150289510|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
150289511|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
150289512|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
150289513|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
150289514|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
150289515|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
150289516|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
149960335|NCT01655069|540988072|FG000|Overall Study|Physician Decision|0|||
150289517|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
150289518|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
150289519|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
150289520|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
150289521|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
150289522|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
150289523|NCT01142726|542194572|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
150289524|NCT01142726|542194573|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
150289525|NCT01142726|542194574|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
150289526|NCT01142726|542194572|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
150289527|NCT01142726|542194573|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
150289528|NCT01142726|542194574|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
150289529|NCT01142726|542194572|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
150289530|NCT01142726|542194573|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
150289531|NCT01142726|542194574|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
150289532|NCT01142726|542194572|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
150289533|NCT01142726|542194573|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
150289534|NCT01142726|542194574|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
150289535|NCT01142726|542194572|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
150289536|NCT01142726|542194573|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
150289537|NCT01142726|542194574|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
150289538|NCT00419380|542194575|FG000|Overall Study|Lack of Efficacy|1|||
150289539|NCT00419380|542194576|FG001|Overall Study|Lack of Efficacy|7|||
150289540|NCT00419380|542194575|FG000|Overall Study|Physician Decision|0|||
150289541|NCT00419380|542194576|FG001|Overall Study|Physician Decision|1|||
150289542|NCT00419380|542194575|FG000|Overall Study|Lost to Follow-up|0|||
150289543|NCT00419380|542194576|FG001|Overall Study|Lost to Follow-up|1|||
150289544|NCT00419380|542194575|FG000|Overall Study|Withdrawal by Subject|0|||
150289545|NCT00419380|542194576|FG001|Overall Study|Withdrawal by Subject|1|||
150289546|NCT03099707|542194577|FG000|Overall Study|Withdrawal by Subject|0|||
150289547|NCT03099707|542194578|FG001|Overall Study|Withdrawal by Subject|3|||
150289548|NCT03099707|542194577|FG000|Overall Study|Lost to Follow-up|0|||
150289549|NCT03099707|542194578|FG001|Overall Study|Lost to Follow-up|1|||
150289550|NCT03167073|542194579|FG000|Overall Study|Stillbirth|1|||
150289551|NCT03167073|542194580|FG001|Overall Study|Stillbirth|0|||
150289552|NCT03127384|542194583|FG000|Overall Study|Lost to Follow-up|4|||
150289553|NCT03127384|542194583|FG000|Overall Study|Subject request|2|||
150289554|NCT02703311|542194584|FG000|Overall Study|Death|5|||
150289555|NCT02703311|542194584|FG000|Overall Study|Withdrawal by Subject|3|||
150289556|NCT00343889|542194592|FG000|Overall Study|Lost to Follow-up|2|||
150289557|NCT00343889|542194593|FG001|Overall Study|Lost to Follow-up|0|||
150289558|NCT00343889|542194592|FG000|Overall Study|Withdrawal by Subject|0|||
150289559|NCT00343889|542194593|FG001|Overall Study|Withdrawal by Subject|1|||
150289560|NCT00343889|542194592|FG000|Overall Study|Protocol Violation|1|||
150289561|NCT00343889|542194593|FG001|Overall Study|Protocol Violation|0|||
150289562|NCT01294579|542194598|FG000|Overall Study|Disease progression|12|||
150289563|NCT01294579|542194598|FG000|Overall Study|Adverse Event|11|||
150289564|NCT01294579|542194598|FG000|Overall Study|Study closed/terminated|3|||
150289565|NCT01294579|542194598|FG000|Overall Study|Lost to Follow-up|1|||
150289566|NCT01294579|542194598|FG000|Overall Study|Physician Decision|3|||
150289567|NCT01294579|542194598|FG000|Overall Study|Withdrawal by Subject|5|||
150289568|NCT00137111|542194599|FG000|Total Therapy|Death|35|||
150289569|NCT00137111|542194600|FG001|Total Therapy|Death|0|||
150289570|NCT00137111|542194601|FG002|Total Therapy|Death|0|||
150289571|NCT00137111|542194602|FG003|Total Therapy|Death|0|||
150289572|NCT00137111|542194599|FG000|Total Therapy|Non Compliance|5|||
150039778|NCT00882557|541285155|FG001|Overall Study|Randomized Not Treated|1|||
150039779|NCT01528969|541285157|FG000|Overall Study|absent from the school at baseline|2|||
150039780|NCT01528969|541285158|FG001|Overall Study|absent from the school at baseline|0|||
150039781|NCT01383356|541285161|FG000|Period 1|Adverse Event|5|||
150039782|NCT01383356|541285162|FG001|Period 1|Adverse Event|3|||
150039783|NCT01383356|541285161|FG000|Period 1|Non-compliance|3|||
150039784|NCT01383356|541285162|FG001|Period 1|Non-compliance|0|||
150289573|NCT00137111|542194600|FG001|Total Therapy|Non Compliance|0|||
150289574|NCT00137111|542194601|FG002|Total Therapy|Non Compliance|0|||
149855571|NCT02539368|540598806|FG003|Overall Study|Death|0|||
149855572|NCT02539368|540598807|FG004|Overall Study|Death|0|||
150039785|NCT01383356|541285161|FG000|Period 1|Out of Range Mid-study-Test|0|||
150039786|NCT01383356|541285162|FG001|Period 1|Out of Range Mid-study-Test|1|||
150173259|NCT04001829|541771227|FG001|Overall Study|Alternative therapy|2|||
150289575|NCT00137111|542194602|FG003|Total Therapy|Non Compliance|0|||
150289576|NCT00562354|542194603|FG000|Overall Study|Physician Decision|0|||
150289577|NCT00562354|542194604|FG001|Overall Study|Physician Decision|1|||
150289578|NCT00562354|542194603|FG000|Overall Study|Lost to Follow-up|0|||
149855573|NCT02539368|540598803|FG000|Overall Study|Withdrawal by Subject|44|||
150289579|NCT00562354|542194604|FG001|Overall Study|Lost to Follow-up|1|||
149855574|NCT02539368|540598804|FG001|Overall Study|Withdrawal by Subject|35|||
149855575|NCT02539368|540598805|FG002|Overall Study|Withdrawal by Subject|9|||
149855576|NCT02539368|540598806|FG003|Overall Study|Withdrawal by Subject|1|||
149855577|NCT02539368|540598807|FG004|Overall Study|Withdrawal by Subject|3|||
149855578|NCT02539368|540598803|FG000|Overall Study|Physician Decision|49|||
149855579|NCT02539368|540598804|FG001|Overall Study|Physician Decision|15|||
149855580|NCT02539368|540598805|FG002|Overall Study|Physician Decision|7|||
149855581|NCT02539368|540598806|FG003|Overall Study|Physician Decision|0|||
149855582|NCT02539368|540598807|FG004|Overall Study|Physician Decision|2|||
149855583|NCT02539368|540598803|FG000|Overall Study|Lost to Follow-up|96|||
149855584|NCT02539368|540598804|FG001|Overall Study|Lost to Follow-up|21|||
149855585|NCT02539368|540598805|FG002|Overall Study|Lost to Follow-up|16|||
149855586|NCT02539368|540598806|FG003|Overall Study|Lost to Follow-up|4|||
149855587|NCT02539368|540598807|FG004|Overall Study|Lost to Follow-up|3|||
149855588|NCT02539368|540598803|FG000|Overall Study|Adverse Event|44|||
149855589|NCT02539368|540598804|FG001|Overall Study|Adverse Event|5|||
149855590|NCT02539368|540598805|FG002|Overall Study|Adverse Event|9|||
149855591|NCT02539368|540598806|FG003|Overall Study|Adverse Event|0|||
149855592|NCT02539368|540598807|FG004|Overall Study|Adverse Event|3|||
149855593|NCT02539368|540598803|FG000|Overall Study|Participant Non-compliant|13|||
149855594|NCT02539368|540598804|FG001|Overall Study|Participant Non-compliant|2|||
149855595|NCT02539368|540598805|FG002|Overall Study|Participant Non-compliant|1|||
149855596|NCT02539368|540598806|FG003|Overall Study|Participant Non-compliant|1|||
149855597|NCT02539368|540598807|FG004|Overall Study|Participant Non-compliant|0|||
149855598|NCT02539368|540598803|FG000|Overall Study|Other|145|||
149960336|NCT01655069|540988073|FG001|Overall Study|Physician Decision|0|||
149960337|NCT01655069|540988074|FG002|Overall Study|Physician Decision|0|||
149960338|NCT01655069|540988075|FG003|Overall Study|Physician Decision|1|||
149960339|NCT01655069|540988072|FG000|Overall Study|Adverse Event|6|||
149960340|NCT01655069|540988073|FG001|Overall Study|Adverse Event|7|||
150289580|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
150289581|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
150289582|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
150289583|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
150289584|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
150289585|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
150289586|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
150289587|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
150289588|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
150289589|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
150289590|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
150289591|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
150289592|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
150289593|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
150289594|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
150289595|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
150289596|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
150289597|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
150289598|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
150289599|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
150289600|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
150289601|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
150289602|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
150289603|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
150289604|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
150289605|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
150289606|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
149855599|NCT02539368|540598804|FG001|Overall Study|Other|18|||
149855600|NCT02539368|540598805|FG002|Overall Study|Other|24|||
149855601|NCT02539368|540598806|FG003|Overall Study|Other|1|||
149960341|NCT01655069|540988074|FG002|Overall Study|Adverse Event|2|||
149960342|NCT01655069|540988075|FG003|Overall Study|Adverse Event|3|||
149960343|NCT01655069|540988072|FG000|Overall Study|Lack of Efficacy|0|||
150039787|NCT01383356|541285161|FG000|Period 1|Personal|0|||
149855602|NCT02539368|540598807|FG004|Overall Study|Other|3|||
149855603|NCT02539368|540598803|FG000|Overall Study|Missing|10|||
149855604|NCT02539368|540598804|FG001|Overall Study|Missing|3|||
149855605|NCT02539368|540598805|FG002|Overall Study|Missing|0|||
149960344|NCT01655069|540988073|FG001|Overall Study|Lack of Efficacy|1|||
150039788|NCT01383356|541285162|FG001|Period 1|Personal|2|||
149855606|NCT02539368|540598806|FG003|Overall Study|Missing|0|||
149855607|NCT02539368|540598807|FG004|Overall Study|Missing|0|||
149960345|NCT01655069|540988074|FG002|Overall Study|Lack of Efficacy|0|||
150039789|NCT03584789|541285163|FG000|Overall Study|refused EHR permission|19|||
150039790|NCT03584789|541285164|FG001|Overall Study|refused EHR permission|28|||
150039791|NCT03584789|541285165|FG002|Overall Study|refused EHR permission|23|||
150039792|NCT03584789|541285163|FG000|Overall Study|patients tied to a provider who retired|0|||
150039793|NCT03584789|541285164|FG001|Overall Study|patients tied to a provider who retired|0|||
149855608|NCT01148225|540598808|FG000|Overall Study|Other|185|||
149855609|NCT03689894|540598810|FG000|Overall Study|Adverse Event|1|||
149855610|NCT00569777|540598811|FG000|Overall Study|Withdrawal by Subject|4|||
149855611|NCT00569777|540598812|FG001|Overall Study|Withdrawal by Subject|0|||
149855612|NCT00569777|540598811|FG000|Overall Study|Adverse Event|3|||
149855613|NCT00569777|540598812|FG001|Overall Study|Adverse Event|0|||
150039794|NCT03584789|541285165|FG002|Overall Study|patients tied to a provider who retired|3|||
149855614|NCT00569777|540598811|FG000|Overall Study|Lost to Follow-up|1|||
149855615|NCT00569777|540598812|FG001|Overall Study|Lost to Follow-up|0|||
149855616|NCT00569777|540598811|FG000|Overall Study|scheduled eye surgery|0|||
149855617|NCT00569777|540598812|FG001|Overall Study|scheduled eye surgery|1|||
149855618|NCT00569777|540598811|FG000|Overall Study|did not meet exclusion criteria|1|||
149855619|NCT00569777|540598812|FG001|Overall Study|did not meet exclusion criteria|2|||
149855620|NCT00569777|540598811|FG000|Overall Study|pregnant|1|||
149855621|NCT00569777|540598812|FG001|Overall Study|pregnant|0|||
149855622|NCT02030535|540598817|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
149855623|NCT01169038|540598818|FG000|Overall Study|Death|1|||
149960346|NCT01655069|540988075|FG003|Overall Study|Lack of Efficacy|0|||
149960347|NCT01655069|540988072|FG000|Overall Study|No Treatment Needed|0|||
149960348|NCT01655069|540988073|FG001|Overall Study|No Treatment Needed|1|||
149960349|NCT01655069|540988074|FG002|Overall Study|No Treatment Needed|0|||
149960350|NCT01655069|540988075|FG003|Overall Study|No Treatment Needed|0|||
149960351|NCT01655069|540988072|FG000|Overall Study|Withdrawal by Subject|2|||
149960352|NCT01655069|540988073|FG001|Overall Study|Withdrawal by Subject|3|||
149960353|NCT01655069|540988074|FG002|Overall Study|Withdrawal by Subject|0|||
149960354|NCT01655069|540988075|FG003|Overall Study|Withdrawal by Subject|0|||
149960355|NCT06399471|540988076|FG000|Overall Study|Withdrawal by Subject|1|||
150039795|NCT02035267|541285167|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
150039796|NCT02035267|541285168|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
150039797|NCT02035267|541285169|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
150039798|NCT02035267|541285170|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
150039799|NCT02035267|541285167|FG000|Overall Study|Adverse Event|0|||
150039800|NCT02035267|541285168|FG001|Overall Study|Adverse Event|0|||
150039801|NCT02035267|541285169|FG002|Overall Study|Adverse Event|1|||
150039802|NCT02035267|541285170|FG003|Overall Study|Adverse Event|0|||
150039803|NCT02035267|541285167|FG000|Overall Study|Lost to Follow-up|0|||
150039804|NCT02035267|541285168|FG001|Overall Study|Lost to Follow-up|0|||
150039805|NCT02035267|541285169|FG002|Overall Study|Lost to Follow-up|0|||
150039806|NCT02035267|541285170|FG003|Overall Study|Lost to Follow-up|1|||
150039807|NCT02035267|541285167|FG000|Overall Study|Other unspecified|0|||
150039808|NCT02035267|541285168|FG001|Overall Study|Other unspecified|1|||
150039809|NCT02035267|541285169|FG002|Overall Study|Other unspecified|0|||
150039810|NCT02035267|541285170|FG003|Overall Study|Other unspecified|0|||
150039811|NCT04646044|541285171|FG000|Overall Study|Lost to Follow-up|0|||
150039812|NCT04646044|541285172|FG001|Overall Study|Lost to Follow-up|0|||
150173260|NCT04001829|541771226|FG000|Overall Study|Disease progression/relapse|2|||
150173261|NCT04001829|541771227|FG001|Overall Study|Disease progression/relapse|1|||
150173262|NCT04001829|541771226|FG000|Overall Study|Other complicating disease|1|||
150173263|NCT04001829|541771227|FG001|Overall Study|Other complicating disease|0|||
150173264|NCT04001829|541771226|FG000|Overall Study|Withdrawal by Subject|1|||
150173265|NCT04001829|541771227|FG001|Overall Study|Withdrawal by Subject|4|||
150173266|NCT04001829|541771226|FG000|Overall Study|Ineligible|2|||
150173267|NCT04001829|541771227|FG001|Overall Study|Ineligible|2|||
150173268|NCT04001829|541771226|FG000|Overall Study|Reason missing due to delinquent data|1|||
150173269|NCT04001829|541771227|FG001|Overall Study|Reason missing due to delinquent data|0|||
150173270|NCT05011396|541771228|FG000|Overall Study|Lost to Follow-up|3|||
150173271|NCT05011396|541771229|FG001|Overall Study|Lost to Follow-up|1|||
150173272|NCT05011396|541771228|FG000|Overall Study|Withdrawal by Subject|0|||
150173273|NCT05011396|541771229|FG001|Overall Study|Withdrawal by Subject|1|||
150173274|NCT05011396|541771228|FG000|Overall Study|Positive Drug Screen|0|||
150173275|NCT05011396|541771229|FG001|Overall Study|Positive Drug Screen|1|||
150173276|NCT03253848|541771230|FG000|Overall Study|Adverse Event|7|||
150173277|NCT03253848|541771230|FG000|Overall Study|Death|5|||
150173278|NCT03253848|541771230|FG000|Overall Study|initiation of other treatments|3|||
149855624|NCT01169038|540598818|FG000|Overall Study|Adverse Event|5|||
149855625|NCT01169038|540598818|FG000|Overall Study|Required antibiotic administration|1|||
149855626|NCT03257254|540598819|FG000|Overall Study|Withdrawal by Subject|7|||
149855627|NCT03257254|540598819|FG000|Overall Study|Lost to Follow-up|9|||
149960356|NCT05529173|540988077|FG000|Overall Study|Physician Decision|3|||
150173279|NCT03253848|541771230|FG000|Overall Study|Other complicating disease|1|||
149960357|NCT05529173|540988078|FG001|Overall Study|Physician Decision|6|||
149960358|NCT05529173|540988077|FG000|Overall Study|Sample shipment delay more than one day|4|||
150039813|NCT04646044|541285173|FG002|Overall Study|Lost to Follow-up|1|||
150039814|NCT04646044|541285174|FG003|Overall Study|Lost to Follow-up|0|||
150039815|NCT04646044|541285171|FG000|Overall Study|Withdrawal by Subject|0|||
150039816|NCT04646044|541285172|FG001|Overall Study|Withdrawal by Subject|1|||
150039817|NCT04646044|541285173|FG002|Overall Study|Withdrawal by Subject|0|||
150039818|NCT04646044|541285174|FG003|Overall Study|Withdrawal by Subject|0|||
150289607|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
150289608|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
150289609|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
150289610|NCT00784654|542194605|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
150289611|NCT00784654|542194606|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
150289612|NCT00784654|542194607|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
150289613|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
150289614|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
150289615|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
150289616|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
150289617|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
150289618|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
150289619|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
150289620|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
150289621|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
150289622|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
150289623|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
150289624|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
150289625|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Adverse Event|0|||
150289626|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Adverse Event|1|||
150289627|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Adverse Event|1|||
150289628|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
150289629|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
150289630|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
150289631|NCT00784654|542194605|FG000|Randomized Withdrawal Period|Family reasons|0|||
150289632|NCT00784654|542194606|FG001|Randomized Withdrawal Period|Family reasons|0|||
150289633|NCT00784654|542194607|FG002|Randomized Withdrawal Period|Family reasons|1|||
150289634|NCT00262873|542194608|FG000|Overall Study|Adverse Event|3|||
150289635|NCT00262873|542194608|FG000|Overall Study|Withdrawal by Subject|5|||
150289636|NCT03440814|542194609|FG000|Overall Study|Adverse Event|2|||
150289637|NCT03440814|542194610|FG001|Overall Study|Adverse Event|1|||
150289638|NCT03440814|542194609|FG000|Overall Study|Lost to Follow-up|2|||
150289639|NCT03440814|542194610|FG001|Overall Study|Lost to Follow-up|0|||
150289640|NCT03440814|542194609|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
150289641|NCT03440814|542194610|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
150289642|NCT01437397|542194611|FG000|Overall Study|Lost to Follow-up|9|||
150289643|NCT01437397|542194612|FG001|Overall Study|Lost to Follow-up|4|||
150289644|NCT01437397|542194613|FG002|Overall Study|Lost to Follow-up|2|||
150289645|NCT01437397|542194614|FG003|Overall Study|Lost to Follow-up|4|||
150289646|NCT01437397|542194615|FG004|Overall Study|Lost to Follow-up|5|||
150289647|NCT01437397|542194611|FG000|Overall Study|Withdrawal by Subject|11|||
150289648|NCT01437397|542194612|FG001|Overall Study|Withdrawal by Subject|12|||
150289649|NCT01437397|542194613|FG002|Overall Study|Withdrawal by Subject|24|||
150289650|NCT01437397|542194614|FG003|Overall Study|Withdrawal by Subject|11|||
150289651|NCT01437397|542194615|FG004|Overall Study|Withdrawal by Subject|22|||
150289652|NCT01437397|542194611|FG000|Overall Study|Protocol Violation|10|||
150289653|NCT01437397|542194612|FG001|Overall Study|Protocol Violation|12|||
150289654|NCT01437397|542194613|FG002|Overall Study|Protocol Violation|13|||
150039819|NCT03038880|541285181|FG000|Overall Study|Death|1|||
150039820|NCT03038880|541285182|FG001|Overall Study|Death|2|||
150289655|NCT01437397|542194614|FG003|Overall Study|Protocol Violation|21|||
150289656|NCT01437397|542194615|FG004|Overall Study|Protocol Violation|19|||
150289657|NCT01437397|542194611|FG000|Overall Study|Lack of Efficacy|5|||
150289658|NCT01437397|542194612|FG001|Overall Study|Lack of Efficacy|4|||
150289659|NCT01437397|542194613|FG002|Overall Study|Lack of Efficacy|8|||
150289660|NCT01437397|542194614|FG003|Overall Study|Lack of Efficacy|10|||
150289661|NCT01437397|542194615|FG004|Overall Study|Lack of Efficacy|20|||
150289662|NCT01437397|542194611|FG000|Overall Study|Adverse Event|21|||
150289663|NCT01437397|542194612|FG001|Overall Study|Adverse Event|22|||
150289664|NCT01437397|542194613|FG002|Overall Study|Adverse Event|16|||
150289665|NCT01437397|542194614|FG003|Overall Study|Adverse Event|14|||
150289666|NCT01437397|542194615|FG004|Overall Study|Adverse Event|21|||
150289667|NCT01437397|542194611|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
150039821|NCT03038880|541285183|FG002|Overall Study|Death|0|||
150039822|NCT03038880|541285181|FG000|Overall Study|Physician Decision|2|||
150289668|NCT01437397|542194612|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
149855628|NCT03257254|540598819|FG000|Overall Study|Study discontinued by sponsor|5|||
149855629|NCT02329431|540598820|FG000|Overall Study|Lost to Follow-up|20|||
149855630|NCT02329431|540598821|FG001|Overall Study|Lost to Follow-up|13|||
149855631|NCT01557582|540598822|FG000|Overall Study|Protocol Violation|4|||
149855632|NCT01557582|540598822|FG000|Overall Study|Operator error|2|||
149855633|NCT02843659|540598823|FG000|Overall Study|Subject Withdrew Consent|0|||
149855634|NCT02843659|540598824|FG001|Overall Study|Subject Withdrew Consent|0|||
149855635|NCT02843659|540598825|FG002|Overall Study|Subject Withdrew Consent|1|||
149855636|NCT02843659|540598823|FG000|Overall Study|Administrative Reason by Sponsor|4|||
149855637|NCT02843659|540598824|FG001|Overall Study|Administrative Reason by Sponsor|5|||
149855638|NCT02843659|540598825|FG002|Overall Study|Administrative Reason by Sponsor|4|||
149855639|NCT02843659|540598823|FG000|Overall Study|Adverse Event|0|||
149855640|NCT02843659|540598824|FG001|Overall Study|Adverse Event|1|||
149855641|NCT02843659|540598825|FG002|Overall Study|Adverse Event|0|||
149855642|NCT03203642|540598826|FG000|Overall Study|Adverse Event|3|||
149855643|NCT03203642|540598827|FG001|Overall Study|Adverse Event|1|||
149855644|NCT03203642|540598826|FG000|Overall Study|Withdrawal by Subject|6|||
149855645|NCT03203642|540598827|FG001|Overall Study|Withdrawal by Subject|6|||
149855646|NCT03203642|540598826|FG000|Overall Study|Lost to Follow-up|2|||
149855647|NCT03203642|540598827|FG001|Overall Study|Lost to Follow-up|1|||
149855648|NCT03203642|540598826|FG000|Overall Study|Termination of the study by sponsor|1|||
149855649|NCT03203642|540598827|FG001|Overall Study|Termination of the study by sponsor|1|||
149855650|NCT03203642|540598826|FG000|Overall Study|Participant moved|0|||
149855651|NCT03203642|540598827|FG001|Overall Study|Participant moved|1|||
149855652|NCT03203642|540598826|FG000|Overall Study|Investigator's decision|3|||
149855653|NCT03203642|540598827|FG001|Overall Study|Investigator's decision|0|||
149855654|NCT03203642|540598826|FG000|Overall Study|Other than above specified|0|||
149855655|NCT03203642|540598827|FG001|Overall Study|Other than above specified|1|||
149855656|NCT02413294|540598828|FG000|Overall Study|Withdrawal by Subject|1|||
149855657|NCT04149535|540598832|FG000|Overall Study|Death|11|||
149855658|NCT04149535|540598833|FG001|Overall Study|Death|7|||
149855659|NCT04149535|540598832|FG000|Overall Study|Physician Decision|10|||
149855660|NCT04149535|540598833|FG001|Overall Study|Physician Decision|4|||
149855661|NCT04149535|540598832|FG000|Overall Study|Withdrawal by Subject|6|||
149855662|NCT04149535|540598833|FG001|Overall Study|Withdrawal by Subject|7|||
149855663|NCT04149535|540598832|FG000|Overall Study|Not described|2|||
149855664|NCT04149535|540598833|FG001|Overall Study|Not described|0|||
149855665|NCT00991510|540600825|FG000|Period I (Days 1-14)|Adverse Event|1|||
149855666|NCT00991510|540600826|FG001|Period I (Days 1-14)|Adverse Event|0|||
149855667|NCT00991510|540600825|FG000|Period III (Days 29-112)|Adverse Event|1|||
149855668|NCT00991510|540600826|FG001|Period III (Days 29-112)|Adverse Event|1|||
149855669|NCT02356211|540600827|FG000|Overall Study|Withdrawal by Subject|2|||
149855670|NCT02356211|540600828|FG001|Overall Study|Withdrawal by Subject|2|||
149855671|NCT02356211|540600827|FG000|Overall Study|ineligible|1|||
149855672|NCT02356211|540600828|FG001|Overall Study|ineligible|8|||
149855673|NCT00988208|540600830|FG000|Overall Study|Adverse Event|71|||
149855674|NCT00988208|540600831|FG001|Overall Study|Adverse Event|122|||
149855675|NCT00988208|540600830|FG000|Overall Study|Disease Progression|103|||
149855676|NCT00988208|540600831|FG001|Overall Study|Disease Progression|89|||
149855677|NCT00988208|540600830|FG000|Overall Study|Withdrawal by Subject|50|||
149855678|NCT00988208|540600831|FG001|Overall Study|Withdrawal by Subject|57|||
149855679|NCT00988208|540600830|FG000|Overall Study|Death|9|||
149855680|NCT00988208|540600831|FG001|Overall Study|Death|15|||
149855681|NCT00988208|540600830|FG000|Overall Study|Lost to Follow-up|2|||
149855682|NCT00988208|540600831|FG001|Overall Study|Lost to Follow-up|3|||
149855683|NCT00988208|540600830|FG000|Overall Study|Protocol Violation|9|||
149855684|NCT00988208|540600831|FG001|Overall Study|Protocol Violation|2|||
149855685|NCT00988208|540600830|FG000|Overall Study|Sponsor Decision|102|||
149855686|NCT00988208|540600831|FG001|Overall Study|Sponsor Decision|78|||
149855687|NCT00988208|540600830|FG000|Overall Study|Clinical Progression|17|||
149855688|NCT00988208|540600831|FG001|Overall Study|Clinical Progression|16|||
149855689|NCT00988208|540600830|FG000|Overall Study|Biochemical Progression|21|||
149855690|NCT00988208|540600831|FG001|Overall Study|Biochemical Progression|7|||
149960359|NCT05529173|540988078|FG001|Overall Study|Sample shipment delay more than one day|0|||
149960360|NCT00609973|540988079|FG000|Overall Study|Adverse Event|2|||
149855691|NCT00988208|540600830|FG000|Overall Study|Clinical Deterioration|7|||
149855692|NCT00988208|540600831|FG001|Overall Study|Clinical Deterioration|14|||
149855693|NCT00988208|540600830|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
149855694|NCT00988208|540600831|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
149855695|NCT00988208|540600830|FG000|Overall Study|Other|8|||
149855696|NCT00988208|540600831|FG001|Overall Study|Other|3|||
149855697|NCT01796964|540600834|FG000|Overall Study|Adverse Event|1|||
149855698|NCT01796964|540600835|FG001|Overall Study|Adverse Event|1|||
149855699|NCT01796964|540600834|FG000|Overall Study|Death|1|||
149855700|NCT01796964|540600835|FG001|Overall Study|Death|0|||
149855701|NCT01796964|540600834|FG000|Overall Study|Protocol Violation|0|||
149855702|NCT01796964|540600835|FG001|Overall Study|Protocol Violation|1|||
149855703|NCT01796964|540600834|FG000|Overall Study|Withdrawal by Subject|1|||
149855704|NCT01796964|540600835|FG001|Overall Study|Withdrawal by Subject|1|||
149855705|NCT03180801|540600836|FG000|Overall Study|Physician Decision|3|||
149855706|NCT03180801|540600837|FG001|Overall Study|Physician Decision|3|||
149855707|NCT03180801|540600838|FG002|Overall Study|Physician Decision|1|||
149855708|NCT03180801|540600836|FG000|Overall Study|Non-compliance|1|||
149855709|NCT03180801|540600837|FG001|Overall Study|Non-compliance|4|||
149855710|NCT03180801|540600838|FG002|Overall Study|Non-compliance|0|||
149855711|NCT03180801|540600836|FG000|Overall Study|Inoculation Target Reached|1|||
149855712|NCT03180801|540600837|FG001|Overall Study|Inoculation Target Reached|1|||
149855713|NCT03180801|540600838|FG002|Overall Study|Inoculation Target Reached|3|||
149855714|NCT03180801|540600836|FG000|Overall Study|Adverse Event|1|||
149855715|NCT03180801|540600837|FG001|Overall Study|Adverse Event|0|||
149855716|NCT03180801|540600838|FG002|Overall Study|Adverse Event|2|||
149855717|NCT03180801|540600836|FG000|Overall Study|Withdrawal by Subject|2|||
149855718|NCT03180801|540600837|FG001|Overall Study|Withdrawal by Subject|2|||
149855719|NCT03180801|540600838|FG002|Overall Study|Withdrawal by Subject|1|||
149855720|NCT03180801|540600836|FG000|Overall Study|Lost to Follow-up|0|||
149855721|NCT03180801|540600837|FG001|Overall Study|Lost to Follow-up|2|||
149855722|NCT03180801|540600838|FG002|Overall Study|Lost to Follow-up|3|||
149855723|NCT00868296|540600840|FG000|Overall Study|Adverse Event|0|||
149855724|NCT00868296|540600841|FG001|Overall Study|Adverse Event|2|||
149855725|NCT00868296|540600840|FG000|Overall Study|Withdrawal by Subject|0|||
149855726|NCT00868296|540600841|FG001|Overall Study|Withdrawal by Subject|1|||
149855727|NCT00112294|540600842|FG000|Overall Study|Still on study|5|||
149855728|NCT00112294|540600843|FG001|Overall Study|Still on study|0|||
149855729|NCT01142908|540600846|FG000|Overall Study|Lost to Follow-up|19|||
149855730|NCT01142908|540600847|FG001|Overall Study|Lost to Follow-up|13|||
149855731|NCT01142908|540600846|FG000|Overall Study|Death|1|||
149855732|NCT01142908|540600847|FG001|Overall Study|Death|4|||
149855733|NCT01142908|540600846|FG000|Overall Study|Excluded - did not meet criteria|9|||
149855734|NCT01142908|540600847|FG001|Overall Study|Excluded - did not meet criteria|5|||
149855735|NCT01142908|540600846|FG000|Overall Study|Withdrawal by Subject|3|||
149855736|NCT01142908|540600847|FG001|Overall Study|Withdrawal by Subject|0|||
149855737|NCT02418455|540600849|FG000|48-Week Treatment Period|Other- Not Specified|1|||
149855738|NCT02418455|540600849|FG000|Continuation Period|Sponsor Decision|7|||
149855739|NCT03235479|540600850|FG000|Overall Study|Lost to Follow-up|8|||
149855740|NCT03235479|540600851|FG001|Overall Study|Lost to Follow-up|11|||
149855741|NCT03235479|540600850|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
149855742|NCT03235479|540600851|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
149855743|NCT03235479|540600850|FG000|Overall Study|Pregnancy|1|||
149855744|NCT03235479|540600851|FG001|Overall Study|Pregnancy|0|||
149855745|NCT03235479|540600850|FG000|Overall Study|Protocol Deviation|1|||
149855746|NCT03235479|540600851|FG001|Overall Study|Protocol Deviation|3|||
149855747|NCT03235479|540600850|FG000|Overall Study|Technical Problems|3|||
149960361|NCT00609973|540988080|FG001|Overall Study|Adverse Event|1|||
149960362|NCT00609973|540988079|FG000|Overall Study|Protocol Violation|4|||
149960363|NCT00609973|540988080|FG001|Overall Study|Protocol Violation|3|||
149960364|NCT00609973|540988079|FG000|Overall Study|Lost to Follow-up|2|||
149960365|NCT00609973|540988080|FG001|Overall Study|Lost to Follow-up|1|||
149960366|NCT00609973|540988079|FG000|Overall Study|Withdrawal by Subject|0|||
149960367|NCT00609973|540988080|FG001|Overall Study|Withdrawal by Subject|1|||
149960368|NCT01309100|540988081|FG000|Overall Study|Protocol Violation|1|||
149960369|NCT01309100|540988081|FG000|Overall Study|Positive Slit lamp finding|1|||
149960370|NCT00736476|540988086|FG000|Overall Study|Adverse Event|1|||
149960371|NCT00736476|540988087|FG001|Overall Study|Adverse Event|0|||
149960372|NCT01796470|540988088|FG000|Overall Study|Adverse Event|4|||
149960373|NCT01796470|540988089|FG001|Overall Study|Adverse Event|2|||
149960374|NCT01796470|540988090|FG002|Overall Study|Adverse Event|2|||
149960375|NCT01796470|540988091|FG003|Overall Study|Adverse Event|1|||
150289669|NCT01437397|542194613|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
150289670|NCT01437397|542194614|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
150289671|NCT01437397|542194615|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
150289672|NCT00903175|542194616|FG000|Period 1 - First Line|Adverse Event|36|||
150289673|NCT00903175|542194617|FG001|Period 1 - First Line|Adverse Event|50|||
150289674|NCT00903175|542194616|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
149855748|NCT03235479|540600851|FG001|Overall Study|Technical Problems|2|||
149855749|NCT03235479|540600850|FG000|Overall Study|Withdrawal by Subject|2|||
149855750|NCT03235479|540600851|FG001|Overall Study|Withdrawal by Subject|2|||
149855751|NCT03235479|540600850|FG000|Overall Study|Other Reasons|3|||
149855752|NCT03235479|540600851|FG001|Overall Study|Other Reasons|5|||
149855753|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
149855754|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
149855755|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
149855756|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
149960376|NCT01796470|540988092|FG004|Overall Study|Adverse Event|3|||
149960377|NCT01796470|540988088|FG000|Overall Study|Death|2|||
149960378|NCT01796470|540988089|FG001|Overall Study|Death|0|||
150289675|NCT00903175|542194617|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
150289676|NCT00903175|542194616|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
150289677|NCT00903175|542194617|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
150289678|NCT00903175|542194616|FG000|Period 1 - First Line|Protocol Violation|3|||
150289679|NCT00903175|542194617|FG001|Period 1 - First Line|Protocol Violation|3|||
150289680|NCT00903175|542194616|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
150289681|NCT00903175|542194617|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
150289682|NCT00903175|542194616|FG000|Period 1 - First Line|Administrative problems|12|||
150289683|NCT00903175|542194617|FG001|Period 1 - First Line|Administrative problems|13|||
150289684|NCT00903175|542194616|FG000|Period 1 - First Line|Death|17|||
150289685|NCT00903175|542194617|FG001|Period 1 - First Line|Death|10|||
150289686|NCT00903175|542194616|FG000|Period 2 - Second Line|Missing|1|||
150289687|NCT00903175|542194617|FG001|Period 2 - Second Line|Missing|0|||
150289688|NCT00903175|542194616|FG000|Period 2 - Second Line|Adverse Event|16|||
150289689|NCT00903175|542194617|FG001|Period 2 - Second Line|Adverse Event|20|||
150289690|NCT00903175|542194616|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
150289691|NCT00903175|542194617|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
150289692|NCT00903175|542194616|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
150289693|NCT00903175|542194617|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
149855757|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
149855758|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
149855759|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149855760|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149855761|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
149855762|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
149855763|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
149855764|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149855765|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
149855766|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
149855767|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
149855768|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
149855769|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Death|2|||
149855770|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Death|1|||
149855771|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Death|0|||
149855772|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Death|0|||
149855773|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
149855774|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
149855775|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
149855776|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
149855777|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
149855778|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
149855779|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
149855780|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
149855781|NCT03110380|540600854|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
149855782|NCT03110380|540600855|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
149855783|NCT03110380|540600856|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
149855784|NCT03110380|540600857|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
149855785|NCT03110380|540600854|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
149855786|NCT03110380|540600855|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
149855787|NCT03110380|540600856|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
149855788|NCT03110380|540600857|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
149855789|NCT03110380|540600854|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
149855790|NCT03110380|540600855|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
149855791|NCT03110380|540600856|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
149855792|NCT03110380|540600857|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
149855793|NCT03110380|540600854|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
149855794|NCT03110380|540600855|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
149855795|NCT03110380|540600856|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
149855796|NCT03110380|540600857|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
149855797|NCT00529217|540600860|FG000|Overall Study|Lack of Efficacy|2|||
149855798|NCT00529217|540600860|FG000|Overall Study|Unable to adhere to study schedule|2|||
149855799|NCT01546519|540600861|FG000|Overall Study|Adverse Event|0|||
149855800|NCT01546519|540600862|FG001|Overall Study|Adverse Event|0|||
149855801|NCT01546519|540600863|FG002|Overall Study|Adverse Event|1|||
149855802|NCT01546519|540600864|FG003|Overall Study|Adverse Event|1|||
149855803|NCT01546519|540600861|FG000|Overall Study|Death|0|||
149855804|NCT01546519|540600862|FG001|Overall Study|Death|1|||
150289694|NCT00903175|542194616|FG000|Period 2 - Second Line|Administrative problems|19|||
150289695|NCT00903175|542194617|FG001|Period 2 - Second Line|Administrative problems|9|||
150289696|NCT00903175|542194616|FG000|Period 2 - Second Line|Death|5|||
150289697|NCT00903175|542194617|FG001|Period 2 - Second Line|Death|2|||
149855805|NCT01546519|540600863|FG002|Overall Study|Death|3|||
149855806|NCT01546519|540600864|FG003|Overall Study|Death|1|||
149855807|NCT01546519|540600861|FG000|Overall Study|related to disease progression|2|||
149855808|NCT01546519|540600862|FG001|Overall Study|related to disease progression|2|||
149855809|NCT01546519|540600863|FG002|Overall Study|related to disease progression|2|||
149855810|NCT01546519|540600864|FG003|Overall Study|related to disease progression|1|||
149855811|NCT01546519|540600861|FG000|Overall Study|Physician Decision|6|||
149855812|NCT01546519|540600862|FG001|Overall Study|Physician Decision|5|||
149855813|NCT01546519|540600863|FG002|Overall Study|Physician Decision|2|||
149855814|NCT01546519|540600864|FG003|Overall Study|Physician Decision|3|||
149855815|NCT01546519|540600861|FG000|Overall Study|Withdrawal by Subject|1|||
149855816|NCT01546519|540600862|FG001|Overall Study|Withdrawal by Subject|0|||
149855817|NCT01546519|540600863|FG002|Overall Study|Withdrawal by Subject|0|||
149855818|NCT01546519|540600864|FG003|Overall Study|Withdrawal by Subject|0|||
149855819|NCT00779402|540600865|FG000|Treatment Phase 1|Disease Progression|1|||
149855820|NCT00779402|540600866|FG001|Treatment Phase 1|Disease Progression|0|||
149855821|NCT00779402|540600865|FG000|Treatment Phase 1|Adverse Event|2|||
149855822|NCT00779402|540600866|FG001|Treatment Phase 1|Adverse Event|0|||
149855823|NCT00779402|540600865|FG000|Treatment Phase 1|Protocol Violation|1|||
149855824|NCT00779402|540600866|FG001|Treatment Phase 1|Protocol Violation|0|||
149855825|NCT00779402|540600865|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
149855826|NCT00779402|540600866|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
149855827|NCT00779402|540600865|FG000|Treatment Phase 1|Lost to Follow-up|0|||
149855828|NCT00779402|540600866|FG001|Treatment Phase 1|Lost to Follow-up|1|||
149855829|NCT00779402|540600865|FG000|Treatment Phase 1|Death|0|||
149855830|NCT00779402|540600866|FG001|Treatment Phase 1|Death|1|||
149855831|NCT00779402|540600865|FG000|Treatment Phase 1|Intercurrent Illness|1|||
149855832|NCT00779402|540600866|FG001|Treatment Phase 1|Intercurrent Illness|1|||
149855833|NCT00779402|540600865|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
149855834|NCT00779402|540600866|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
149855835|NCT00779402|540600865|FG000|Treatment Phase 1|Other|4|||
149855836|NCT00779402|540600866|FG001|Treatment Phase 1|Other|2|||
149855837|NCT00779402|540600865|FG000|Treatment Phase 1|Closure of Study|3|||
149855838|NCT00779402|540600866|FG001|Treatment Phase 1|Closure of Study|2|||
150289698|NCT03074474|542194620|FG000|Overall Study|Lost to Follow-up|10|||
150289699|NCT03074474|542194620|FG000|Overall Study|Withdrawal by Subject|10|||
149855839|NCT00779402|540600865|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
149855840|NCT00779402|540600866|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
149855841|NCT00779402|540600865|FG000|Surveillance Phase|Protocol Violation|0|||
149855842|NCT00779402|540600866|FG001|Surveillance Phase|Protocol Violation|1|||
149855843|NCT00779402|540600865|FG000|Surveillance Phase|Patient refused to continue|22|||
149855844|NCT00779402|540600866|FG001|Surveillance Phase|Patient refused to continue|14|||
149855845|NCT00779402|540600865|FG000|Surveillance Phase|Lost to Follow-up|2|||
149855846|NCT00779402|540600866|FG001|Surveillance Phase|Lost to Follow-up|1|||
150173280|NCT03253848|541771230|FG000|Overall Study|Withdrawal by Subject|1|||
150289700|NCT03074474|542194620|FG000|Overall Study|Death|4|||
150289701|NCT03074474|542194620|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
150289702|NCT01358864|542194626|FG000|Overall Study|Adverse Event|0|||
150289703|NCT01358864|542194627|FG001|Overall Study|Adverse Event|6|||
150289704|NCT01358864|542194628|FG002|Overall Study|Adverse Event|9|||
150289705|NCT01358864|542194629|FG003|Overall Study|Adverse Event|0|||
150289706|NCT01358864|542194630|FG004|Overall Study|Adverse Event|4|||
150289707|NCT01358864|542194631|FG005|Overall Study|Adverse Event|8|||
150289708|NCT01358864|542194632|FG006|Overall Study|Adverse Event|12|||
150289709|NCT01358864|542194633|FG007|Overall Study|Adverse Event|7|||
150289710|NCT01358864|542194626|FG000|Overall Study|Lack of Efficacy|26|||
150289711|NCT01358864|542194627|FG001|Overall Study|Lack of Efficacy|3|||
150289712|NCT01358864|542194628|FG002|Overall Study|Lack of Efficacy|4|||
150289713|NCT01358864|542194629|FG003|Overall Study|Lack of Efficacy|19|||
150289714|NCT01358864|542194630|FG004|Overall Study|Lack of Efficacy|7|||
150289715|NCT01358864|542194631|FG005|Overall Study|Lack of Efficacy|4|||
150289716|NCT01358864|542194632|FG006|Overall Study|Lack of Efficacy|49|||
150289717|NCT01358864|542194633|FG007|Overall Study|Lack of Efficacy|44|||
150289718|NCT01358864|542194626|FG000|Overall Study|Lost to Follow-up|0|||
150289719|NCT01358864|542194627|FG001|Overall Study|Lost to Follow-up|0|||
150289720|NCT01358864|542194628|FG002|Overall Study|Lost to Follow-up|1|||
150289721|NCT01358864|542194629|FG003|Overall Study|Lost to Follow-up|0|||
149855847|NCT00779402|540600865|FG000|Surveillance Phase|Death|0|||
149855848|NCT00779402|540600866|FG001|Surveillance Phase|Death|1|||
149855849|NCT00779402|540600865|FG000|Surveillance Phase|Intercurrent Illness|2|||
149855850|NCT00779402|540600866|FG001|Surveillance Phase|Intercurrent Illness|0|||
149855851|NCT00779402|540600865|FG000|Surveillance Phase|Other|5|||
149855852|NCT00779402|540600866|FG001|Surveillance Phase|Other|5|||
149855853|NCT00779402|540600865|FG000|Surveillance Phase|Withdrawal by Subject|4|||
150289722|NCT01358864|542194630|FG004|Overall Study|Lost to Follow-up|0|||
150289723|NCT01358864|542194631|FG005|Overall Study|Lost to Follow-up|0|||
150289724|NCT01358864|542194632|FG006|Overall Study|Lost to Follow-up|0|||
150289725|NCT01358864|542194633|FG007|Overall Study|Lost to Follow-up|1|||
149855854|NCT00779402|540600866|FG001|Surveillance Phase|Withdrawal by Subject|1|||
149855855|NCT00779402|540600865|FG000|Surveillance Phase|Closure of study|5|||
149855856|NCT00779402|540600866|FG001|Surveillance Phase|Closure of study|6|||
149855857|NCT00779402|540600865|FG000|Surveillance Phase|Completed Protocol Visits|3|||
149855858|NCT00779402|540600866|FG001|Surveillance Phase|Completed Protocol Visits|2|||
149855859|NCT00779402|540600865|FG000|Long-term Follow-up|Patient refused to continue|2|||
149855860|NCT00779402|540600866|FG001|Long-term Follow-up|Patient refused to continue|0|||
149855861|NCT00779402|540600865|FG000|Long-term Follow-up|Other|5|||
149855862|NCT00779402|540600866|FG001|Long-term Follow-up|Other|0|||
149855863|NCT00779402|540600865|FG000|Long-term Follow-up|Closure of Study|8|||
149855864|NCT00779402|540600866|FG001|Long-term Follow-up|Closure of Study|4|||
149855865|NCT00779402|540600865|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
149855866|NCT00779402|540600866|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
149855867|NCT00693225|540600871|FG000|Overall Study|Lost to Follow-up|1|||
149855868|NCT00693225|540600872|FG001|Overall Study|Lost to Follow-up|2|||
149855869|NCT00693225|540600871|FG000|Overall Study|Adverse Event|1|||
149855870|NCT00693225|540600872|FG001|Overall Study|Adverse Event|3|||
149855871|NCT01315028|540600873|FG000|Overall Study|Lost to Follow-up|1|||
149855872|NCT01315028|540600874|FG001|Overall Study|Lost to Follow-up|0|||
149855873|NCT01315028|540600873|FG000|Overall Study|Death|0|||
150289726|NCT01358864|542194626|FG000|Overall Study|Withdrawal by Subject|3|||
150289727|NCT01358864|542194627|FG001|Overall Study|Withdrawal by Subject|4|||
150289728|NCT01358864|542194628|FG002|Overall Study|Withdrawal by Subject|2|||
150289729|NCT01358864|542194629|FG003|Overall Study|Withdrawal by Subject|0|||
150289730|NCT01358864|542194630|FG004|Overall Study|Withdrawal by Subject|0|||
150289731|NCT01358864|542194631|FG005|Overall Study|Withdrawal by Subject|1|||
150289732|NCT01358864|542194632|FG006|Overall Study|Withdrawal by Subject|1|||
150289733|NCT01358864|542194633|FG007|Overall Study|Withdrawal by Subject|3|||
150289734|NCT01358864|542194626|FG000|Overall Study|Other reason not defined above|2|||
150289735|NCT01358864|542194627|FG001|Overall Study|Other reason not defined above|0|||
150289736|NCT01358864|542194628|FG002|Overall Study|Other reason not defined above|0|||
150289737|NCT01358864|542194629|FG003|Overall Study|Other reason not defined above|0|||
150289738|NCT01358864|542194630|FG004|Overall Study|Other reason not defined above|0|||
150289739|NCT01358864|542194631|FG005|Overall Study|Other reason not defined above|0|||
150289740|NCT01358864|542194632|FG006|Overall Study|Other reason not defined above|2|||
150289741|NCT01358864|542194633|FG007|Overall Study|Other reason not defined above|0|||
150289742|NCT01358864|542194626|FG000|Overall Study|Not treated|0|||
150289743|NCT01358864|542194627|FG001|Overall Study|Not treated|0|||
150289744|NCT01358864|542194628|FG002|Overall Study|Not treated|0|||
150289745|NCT01358864|542194629|FG003|Overall Study|Not treated|0|||
150289746|NCT01358864|542194630|FG004|Overall Study|Not treated|0|||
150289747|NCT01358864|542194631|FG005|Overall Study|Not treated|0|||
150289748|NCT01358864|542194632|FG006|Overall Study|Not treated|1|||
150289749|NCT01358864|542194633|FG007|Overall Study|Not treated|0|||
150289750|NCT04209855|542194634|FG000|Overall Study|Death|161|||
150289751|NCT04209855|542194635|FG001|Overall Study|Death|177|||
150289752|NCT04209855|542194634|FG000|Overall Study|PI Discretion|1|||
150289753|NCT04209855|542194635|FG001|Overall Study|PI Discretion|1|||
150289754|NCT04209855|542194634|FG000|Overall Study|Lost to Follow-up|5|||
150289755|NCT04209855|542194635|FG001|Overall Study|Lost to Follow-up|2|||
150289756|NCT04209855|542194634|FG000|Overall Study|Withdrew consent|10|||
150289757|NCT04209855|542194635|FG001|Overall Study|Withdrew consent|24|||
150289758|NCT04209855|542194634|FG000|Overall Study|Sponsor decision|44|||
150289759|NCT04209855|542194635|FG001|Overall Study|Sponsor decision|18|||
150289760|NCT04209855|542194634|FG000|Overall Study|Other than specified|6|||
150289761|NCT04209855|542194635|FG001|Overall Study|Other than specified|4|||
150289762|NCT01284114|542195887|FG000|Overall Study|viral infection|1|||
150289763|NCT01284114|542195887|FG000|Overall Study|From the results of ALLTITUDE study|1|||
150289764|NCT01284114|542195887|FG000|Overall Study|Symptomatic hypotension|1|||
150289765|NCT01284114|542195887|FG000|Overall Study|dizziness|1|||
150289766|NCT03409744|542195888|FG000|Overall Study|Death|2|||
150289767|NCT03409744|542195888|FG000|Overall Study|Physician Decision|5|||
150289768|NCT03409744|542195888|FG000|Overall Study|Pregnancy|1|||
150289769|NCT03409744|542195888|FG000|Overall Study|Lost to Follow-up|1|||
150289770|NCT03409744|542195888|FG000|Overall Study|Protocol Violation|1|||
150289771|NCT01745146|542195891|FG000|Overall Study|Withdrawal by Subject|1|||
150289772|NCT01745146|542195892|FG001|Overall Study|Withdrawal by Subject|3|||
150289773|NCT01745146|542195891|FG000|Overall Study|Lost to Follow-up|2|||
150289774|NCT01745146|542195892|FG001|Overall Study|Lost to Follow-up|0|||
150289775|NCT04161131|542195893|FG000|Overall Study|Ineligible|2|||
150289776|NCT04161131|542195893|FG000|Overall Study|Lost to Follow-up|4|||
149855874|NCT01315028|540600874|FG001|Overall Study|Death|1|||
149855875|NCT02274948|540600875|FG000|Overall Study|Lost to Follow-up|28|||
149855876|NCT02274948|540600876|FG001|Overall Study|Lost to Follow-up|25|||
149855877|NCT02274948|540600875|FG000|Overall Study|Withdrawal by Subject|64|||
150289777|NCT00699348|542195897|FG000|Overall Study|Death|6|||
150289778|NCT00699348|542195897|FG000|Overall Study|Adverse Event|15|||
150289779|NCT00699348|542195897|FG000|Overall Study|Withdrawal by Subject|11|||
150289780|NCT00699348|542195897|FG000|Overall Study|Protocol Violation|10|||
150289781|NCT00699348|542195897|FG000|Overall Study|Lack of Efficacy|8|||
150289782|NCT00699348|542195897|FG000|Overall Study|Failure to return|1|||
150289783|NCT00699348|542195897|FG000|Overall Study|Blood transfusion|24|||
150289784|NCT00699348|542195897|FG000|Overall Study|Renal transplantation|10|||
150289785|NCT00699348|542195897|FG000|Overall Study|Other|5|||
150289786|NCT03704194|542195903|FG000|Overall Study|Withdrawal by Subject|0|||
150289787|NCT03704194|542195904|FG001|Overall Study|Withdrawal by Subject|1|||
150289788|NCT01368835|542195909|FG000|Overall Study|Inclusion criteria/photography quality|22|||
150289789|NCT01368835|542195909|FG000|Overall Study|Lost to Follow-up|11|||
150289790|NCT02754726|542195910|FG000|Overall Study|Progressive Disease by RECIST|13|||
150289791|NCT02754726|542195910|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
150289792|NCT02754726|542195910|FG000|Overall Study|Clinical Disease Progression|5|||
150289793|NCT02754726|542195910|FG000|Overall Study|Adverse Event|3|||
150289794|NCT02754726|542195910|FG000|Overall Study|Withdrawal by Subject|1|||
150289795|NCT02754726|542195910|FG000|Overall Study|Tolerability|1|||
150289796|NCT01885000|542195911|FG000|Overall Study|Adverse Event|1|||
150289797|NCT01885000|542195912|FG001|Overall Study|Adverse Event|0|||
150289798|NCT01885000|542195911|FG000|Overall Study|Withdrawal by Subject|1|||
150289799|NCT01885000|542195912|FG001|Overall Study|Withdrawal by Subject|1|||
150289800|NCT01885000|542195911|FG000|Overall Study|Protocol Violation|0|||
150289801|NCT01885000|542195912|FG001|Overall Study|Protocol Violation|1|||
150289802|NCT02792842|542195915|FG000|Overall Study|Adverse Event|4|||
150289803|NCT02792842|542195916|FG001|Overall Study|Adverse Event|2|||
150289804|NCT02792842|542195917|FG002|Overall Study|Adverse Event|3|||
149855878|NCT02274948|540600876|FG001|Overall Study|Withdrawal by Subject|58|||
149855879|NCT02274948|540600875|FG000|Overall Study|Stopped on family Practitioner advice|2|||
149855880|NCT02274948|540600876|FG001|Overall Study|Stopped on family Practitioner advice|5|||
149855881|NCT02274948|540600875|FG000|Overall Study|Left the area|4|||
149855882|NCT02274948|540600876|FG001|Overall Study|Left the area|3|||
149855883|NCT01098539|540600881|FG000|Overall Study|Adverse Event|26|||
149855884|NCT01098539|540600882|FG001|Overall Study|Adverse Event|26|||
149855885|NCT01098539|540600881|FG000|Overall Study|Protocol Violation|1|||
149855886|NCT01098539|540600882|FG001|Overall Study|Protocol Violation|4|||
149855887|NCT01098539|540600881|FG000|Overall Study|Noncompliance|3|||
149855888|NCT01098539|540600882|FG001|Overall Study|Noncompliance|5|||
149855889|NCT01098539|540600881|FG000|Overall Study|Lost to Follow-up|4|||
149855890|NCT01098539|540600882|FG001|Overall Study|Lost to Follow-up|4|||
149855891|NCT01098539|540600881|FG000|Overall Study|Withdrawal by Subject|12|||
149855892|NCT01098539|540600882|FG001|Overall Study|Withdrawal by Subject|26|||
149855893|NCT01098539|540600881|FG000|Overall Study|Physician Decision|5|||
149855894|NCT01098539|540600882|FG001|Overall Study|Physician Decision|3|||
149855895|NCT02359864|540600883|FG000|Overall Study|Withdrawal by Subject|1|||
149855896|NCT02359864|540600884|FG001|Overall Study|Withdrawal by Subject|0|||
149855897|NCT00725764|540600885|FG000|Overall Study|Withdrawal by Subject|2|||
149855898|NCT00725764|540600885|FG000|Overall Study|Physician Decision|1|||
149855899|NCT00725764|540600885|FG000|Overall Study|Progressive Disease|7|||
149855900|NCT00725764|540600885|FG000|Overall Study|Lost to Follow-up|1|||
149855901|NCT00725764|540600885|FG000|Overall Study|Death|1|||
149855902|NCT00725764|540600885|FG000|Overall Study|Participant non compliant with protocol|1|||
149855903|NCT00725764|540600885|FG000|Overall Study|Decline in performance status|1|||
149855904|NCT04480307|540600886|FG000|Overall Study|Withdrawal by Subject|0|||
149855905|NCT04480307|540600887|FG001|Overall Study|Withdrawal by Subject|1|||
149855906|NCT04480307|540600888|FG002|Overall Study|Withdrawal by Subject|0|||
149855907|NCT04480307|540600889|FG003|Overall Study|Withdrawal by Subject|0|||
149855908|NCT04480307|540600886|FG000|Overall Study|Adverse Event|0|||
149855909|NCT04480307|540600887|FG001|Overall Study|Adverse Event|0|||
149855910|NCT04480307|540600888|FG002|Overall Study|Adverse Event|0|||
149855911|NCT04480307|540600889|FG003|Overall Study|Adverse Event|1|||
150039823|NCT03038880|541285182|FG001|Overall Study|Physician Decision|1|||
149855912|NCT00605176|540600892|FG000|Overall Study|Adverse Event|2|||
149855913|NCT00605176|540600893|FG001|Overall Study|Adverse Event|1|||
149855914|NCT00605176|540600894|FG002|Overall Study|Adverse Event|3|||
149855915|NCT00605176|540600892|FG000|Overall Study|Withdrawal by Subject|4|||
149855916|NCT00605176|540600893|FG001|Overall Study|Withdrawal by Subject|2|||
150039824|NCT03038880|541285183|FG002|Overall Study|Physician Decision|0|||
150289805|NCT02792842|542195915|FG000|Overall Study|Withdrawal by Subject|0|||
150289806|NCT02792842|542195916|FG001|Overall Study|Withdrawal by Subject|1|||
150289807|NCT02792842|542195917|FG002|Overall Study|Withdrawal by Subject|2|||
150289808|NCT02792842|542195915|FG000|Overall Study|Lost to Follow-up|0|||
150289809|NCT02792842|542195916|FG001|Overall Study|Lost to Follow-up|0|||
150289810|NCT02792842|542195917|FG002|Overall Study|Lost to Follow-up|1|||
149855917|NCT00605176|540600894|FG002|Overall Study|Withdrawal by Subject|4|||
149855918|NCT00605176|540600892|FG000|Overall Study|Lost to Follow-up|2|||
149855919|NCT00605176|540600893|FG001|Overall Study|Lost to Follow-up|2|||
150039825|NCT02803580|541285184|FG000|Overall Study|Death|13|||
150289811|NCT02792842|542195915|FG000|Overall Study|Schedule delay|0|||
150289812|NCT02792842|542195916|FG001|Overall Study|Schedule delay|1|||
149855920|NCT00605176|540600894|FG002|Overall Study|Lost to Follow-up|1|||
149855921|NCT00605176|540600892|FG000|Overall Study|Non-complicance with study procedures|1|||
149855922|NCT00605176|540600893|FG001|Overall Study|Non-complicance with study procedures|0|||
149855923|NCT00605176|540600894|FG002|Overall Study|Non-complicance with study procedures|0|||
149855924|NCT00605176|540600892|FG000|Overall Study|Use of concomitant therapy|1|||
149855925|NCT00605176|540600893|FG001|Overall Study|Use of concomitant therapy|0|||
149855926|NCT00605176|540600894|FG002|Overall Study|Use of concomitant therapy|1|||
149855927|NCT00605176|540600892|FG000|Overall Study|Other (not due to AE)|1|||
149855928|NCT00605176|540600893|FG001|Overall Study|Other (not due to AE)|1|||
149855929|NCT00605176|540600894|FG002|Overall Study|Other (not due to AE)|0|||
149855930|NCT01808248|540600895|FG000|Overall Study|Lack of Efficacy|3|||
149855931|NCT01808248|540600895|FG000|Overall Study|Withdrawal by Subject|1|||
149855932|NCT01808248|540600895|FG000|Overall Study|Lost to Follow-up|1|||
149855933|NCT00685750|540600898|FG000|Overall Study|Tumor sampling failure|0|||
149855934|NCT00685750|540600899|FG001|Overall Study|Tumor sampling failure|0|||
149855935|NCT00685750|540600900|FG002|Overall Study|Tumor sampling failure|1|||
149855936|NCT00685750|540600901|FG003|Overall Study|Tumor sampling failure|0|||
149855937|NCT00685750|540600902|FG004|Overall Study|Tumor sampling failure|0|||
149855938|NCT00685750|540600903|FG005|Overall Study|Tumor sampling failure|0|||
149855939|NCT00685750|540600904|FG006|Overall Study|Tumor sampling failure|0|||
149855940|NCT00685750|540600898|FG000|Overall Study|Patient didn't receive the treatment|0|||
149855941|NCT00685750|540600899|FG001|Overall Study|Patient didn't receive the treatment|0|||
149855942|NCT00685750|540600900|FG002|Overall Study|Patient didn't receive the treatment|0|||
149855943|NCT00685750|540600901|FG003|Overall Study|Patient didn't receive the treatment|0|||
149855944|NCT00685750|540600902|FG004|Overall Study|Patient didn't receive the treatment|0|||
149855945|NCT00685750|540600903|FG005|Overall Study|Patient didn't receive the treatment|0|||
149855946|NCT00685750|540600904|FG006|Overall Study|Patient didn't receive the treatment|1|||
149855947|NCT00685750|540600898|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149855948|NCT00685750|540600899|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149855949|NCT00685750|540600900|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
149855950|NCT00685750|540600901|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
149855951|NCT00685750|540600902|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
149855952|NCT00685750|540600903|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
149855953|NCT00685750|540600904|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
149855954|NCT04974580|540600905|FG000|Overall Study|Lost to Follow-up|33|||
149855955|NCT04974580|540600906|FG001|Overall Study|Lost to Follow-up|39|||
149855956|NCT04974580|540600907|FG002|Overall Study|Lost to Follow-up|30|||
149855957|NCT04974580|540600908|FG003|Overall Study|Lost to Follow-up|29|||
149855958|NCT00587431|540600909|FG000|Overall Study|Adverse Event|1|||
149855959|NCT00587431|540600910|FG001|Overall Study|Adverse Event|0|||
149855960|NCT00587431|540600909|FG000|Overall Study|Withdrawal by Subject|0|||
149855961|NCT00587431|540600910|FG001|Overall Study|Withdrawal by Subject|1|||
149855962|NCT05467982|540600911|FG000|Overall Study|Death|0|||
149855963|NCT05467982|540600912|FG001|Overall Study|Death|1|||
149855964|NCT05467982|540600911|FG000|Overall Study|Lost to Follow-up|3|||
149855965|NCT05467982|540600912|FG001|Overall Study|Lost to Follow-up|1|||
149855966|NCT00220727|540600937|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
149855967|NCT00220727|540600938|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
149855968|NCT02508116|540600941|FG000|Overall Study|Lost to Follow-up|2|||
149855969|NCT02508116|540600942|FG001|Overall Study|Lost to Follow-up|3|||
149960379|NCT01796470|540988090|FG002|Overall Study|Death|0|||
149960380|NCT01796470|540988091|FG003|Overall Study|Death|0|||
149960381|NCT01796470|540988092|FG004|Overall Study|Death|1|||
149960382|NCT01796470|540988088|FG000|Overall Study|Initiated New Therapy|9|||
149960383|NCT01796470|540988089|FG001|Overall Study|Initiated New Therapy|0|||
149960384|NCT01796470|540988090|FG002|Overall Study|Initiated New Therapy|0|||
149960385|NCT01796470|540988091|FG003|Overall Study|Initiated New Therapy|0|||
149960386|NCT01796470|540988092|FG004|Overall Study|Initiated New Therapy|2|||
149960387|NCT01796470|540988088|FG000|Overall Study|Lost to Follow-up|0|||
149960388|NCT01796470|540988089|FG001|Overall Study|Lost to Follow-up|1|||
149960389|NCT01796470|540988090|FG002|Overall Study|Lost to Follow-up|0|||
149960390|NCT01796470|540988091|FG003|Overall Study|Lost to Follow-up|0|||
149855970|NCT02508116|540600941|FG000|Overall Study|Withdrawal by Subject|3|||
149855971|NCT02508116|540600942|FG001|Overall Study|Withdrawal by Subject|2|||
149855972|NCT02508116|540600941|FG000|Overall Study|Protocol Violation|1|||
149960391|NCT01796470|540988092|FG004|Overall Study|Lost to Follow-up|0|||
149960392|NCT01796470|540988088|FG000|Overall Study|Physician Decision|5|||
149960393|NCT01796470|540988089|FG001|Overall Study|Physician Decision|4|||
149855973|NCT02508116|540600942|FG001|Overall Study|Protocol Violation|2|||
149855974|NCT02508116|540600941|FG000|Overall Study|Physician Decision|2|||
149855975|NCT02508116|540600942|FG001|Overall Study|Physician Decision|0|||
149855976|NCT00109850|540600943|FG000|Overall Study|Adverse Event|1|||
149855977|NCT00109850|540600943|FG000|Overall Study|Death|2|||
149855978|NCT00109850|540600943|FG000|Overall Study|Ineligible|1|||
149960394|NCT01796470|540988090|FG002|Overall Study|Physician Decision|1|||
149960395|NCT01796470|540988091|FG003|Overall Study|Physician Decision|0|||
149855979|NCT04234464|540600944|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
149855980|NCT04234464|540600945|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
149855981|NCT00476593|540600946|FG000|Overall Study|Lost to Follow-up|10|||
149855982|NCT00476593|540600947|FG001|Overall Study|Lost to Follow-up|2|||
149855983|NCT00476593|540600948|FG002|Overall Study|Lost to Follow-up|8|||
149855984|NCT00476593|540600949|FG003|Overall Study|Lost to Follow-up|22|||
149855985|NCT00983528|540600950|FG000|Overall Study|Death|4|||
150289813|NCT02792842|542195917|FG002|Overall Study|Schedule delay|1|||
150289814|NCT03806127|542195922|FG000|Overall Study|Withdrawal by Subject|4|||
150289815|NCT03806127|542195923|FG001|Overall Study|Withdrawal by Subject|5|||
150289816|NCT03806127|542195922|FG000|Overall Study|Protocol Violation|3|||
150289817|NCT03806127|542195923|FG001|Overall Study|Protocol Violation|1|||
150289818|NCT03806127|542195922|FG000|Overall Study|Adverse Event|3|||
150289819|NCT03806127|542195923|FG001|Overall Study|Adverse Event|0|||
150289820|NCT03806127|542195922|FG000|Overall Study|Unable to Complete Procedures|0|||
150289821|NCT03806127|542195923|FG001|Overall Study|Unable to Complete Procedures|1|||
150289822|NCT03806127|542195922|FG000|Overall Study|Pregnancy|0|||
150289823|NCT03806127|542195923|FG001|Overall Study|Pregnancy|1|||
150289824|NCT03806127|542195922|FG000|Overall Study|Lost to Follow-up|5|||
150289825|NCT03806127|542195923|FG001|Overall Study|Lost to Follow-up|1|||
150289826|NCT03806127|542195922|FG000|Overall Study|Physician Decision|1|||
150289827|NCT03806127|542195923|FG001|Overall Study|Physician Decision|1|||
150289828|NCT03806127|542195922|FG000|Overall Study|Could Not Come Due to Covid|1|||
150289829|NCT03806127|542195923|FG001|Overall Study|Could Not Come Due to Covid|0|||
150289830|NCT03806127|542195922|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
150289831|NCT03806127|542195923|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
150289832|NCT03806127|542195922|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
150289833|NCT03806127|542195923|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
150289834|NCT03806127|542195922|FG000|Overall Study|Covid 19 Restrictions|2|||
150289835|NCT03806127|542195923|FG001|Overall Study|Covid 19 Restrictions|0|||
150289836|NCT03806127|542195922|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
150289837|NCT03806127|542195923|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
150289838|NCT03806127|542195922|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
150289839|NCT03806127|542195923|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
150289840|NCT03092726|542195928|FG000|Overall Study|Adverse Event|3|||
150289841|NCT03092726|542195929|FG001|Overall Study|Adverse Event|10|||
150289842|NCT03092726|542195928|FG000|Overall Study|Lack of Efficacy|0|||
150289843|NCT03092726|542195929|FG001|Overall Study|Lack of Efficacy|1|||
150289844|NCT03092726|542195928|FG000|Overall Study|Lost to Follow-up|1|||
149855986|NCT00983528|540600950|FG000|Overall Study|Lost to Follow-up|1|||
150039826|NCT02803580|541285184|FG000|Overall Study|Lost to Follow-up|19|||
150039827|NCT02803580|541285184|FG000|Overall Study|Withdrawal by Subject|3|||
150039828|NCT02803580|541285184|FG000|Overall Study|Inclusion in clinical trial|1|||
150039829|NCT02054104|541285185|FG000|Overall Study|Did not want to continue due to college classes|1|||
150039830|NCT02054104|541285186|FG001|Overall Study|Did not want to continue due to college classes|0|||
150039831|NCT02054104|541285185|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
150039832|NCT02054104|541285186|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
150039833|NCT02054104|541285185|FG000|Overall Study|No evidence of immunologic response|2|||
150039834|NCT02054104|541285186|FG001|Overall Study|No evidence of immunologic response|2|||
150039835|NCT02054104|541285185|FG000|Overall Study|Disease Progression On Study|4|||
150039836|NCT02054104|541285186|FG001|Overall Study|Disease Progression On Study|5|||
150039837|NCT02054104|541285185|FG000|Overall Study|Diagnosis of lymphoma|0|||
150039838|NCT02054104|541285186|FG001|Overall Study|Diagnosis of lymphoma|1|||
150039839|NCT02054104|541285185|FG000|Overall Study|Inconclusive response|0|||
150039840|NCT02054104|541285186|FG001|Overall Study|Inconclusive response|1|||
150039841|NCT00084136|541285189|FG000|PI Comparison|Death|10|||
150039842|NCT00084136|541285190|FG001|PI Comparison|Death|9|||
150039843|NCT00084136|541285191|FG002|PI Comparison|Death|0|||
150039844|NCT00084136|541285189|FG000|PI Comparison|Lost to Follow-up|11|||
150039845|NCT00084136|541285190|FG001|PI Comparison|Lost to Follow-up|8|||
150039846|NCT00084136|541285191|FG002|PI Comparison|Lost to Follow-up|0|||
150039847|NCT00084136|541285189|FG000|PI Comparison|Withdrawal by Subject|33|||
150039848|NCT00084136|541285190|FG001|PI Comparison|Withdrawal by Subject|30|||
150039849|NCT00084136|541285191|FG002|PI Comparison|Withdrawal by Subject|0|||
150039850|NCT00084136|541285189|FG000|PI Comparison|Clinic site closed|1|||
150039851|NCT00084136|541285190|FG001|PI Comparison|Clinic site closed|0|||
150289845|NCT03092726|542195929|FG001|Overall Study|Lost to Follow-up|0|||
150289846|NCT03092726|542195928|FG000|Overall Study|Withdrawal by Subject|5|||
150289847|NCT03092726|542195929|FG001|Overall Study|Withdrawal by Subject|3|||
150289848|NCT02217566|542195932|FG000|Overall Study|Lost to Follow-up|2|||
150289849|NCT02217566|542195932|FG000|Overall Study|Death|3|||
150289850|NCT02217566|542195932|FG000|Overall Study|Early study termination|6|||
150289851|NCT02436876|542195935|FG000|Overall Study|Lost to Follow-up|0|||
150289852|NCT02436876|542195936|FG001|Overall Study|Lost to Follow-up|1|||
150289853|NCT02436876|542195937|FG002|Overall Study|Lost to Follow-up|1|||
150289854|NCT02436876|542195938|FG003|Overall Study|Lost to Follow-up|1|||
150289855|NCT02436876|542195935|FG000|Overall Study|Withdrawal by Subject|1|||
150289856|NCT02436876|542195936|FG001|Overall Study|Withdrawal by Subject|0|||
150289857|NCT02436876|542195937|FG002|Overall Study|Withdrawal by Subject|0|||
150289858|NCT02436876|542195938|FG003|Overall Study|Withdrawal by Subject|1|||
150289859|NCT02436876|542195935|FG000|Overall Study|Physician Decision|0|||
150289860|NCT02436876|542195936|FG001|Overall Study|Physician Decision|2|||
150289861|NCT02436876|542195937|FG002|Overall Study|Physician Decision|1|||
150289862|NCT02436876|542195938|FG003|Overall Study|Physician Decision|0|||
150289863|NCT02436876|542195935|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
150289864|NCT02436876|542195936|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
150289865|NCT02436876|542195937|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
150289866|NCT02436876|542195938|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
150289867|NCT00999908|542195939|FG000|Treatment Period 1|Subject withdrew consent|2|||
150289868|NCT00999908|542195940|FG001|Treatment Period 1|Subject withdrew consent|0|||
150289869|NCT00999908|542195941|FG002|Treatment Period 1|Subject withdrew consent|0|||
150039852|NCT00084136|541285191|FG002|PI Comparison|Clinic site closed|0|||
150039853|NCT00084136|541285189|FG000|NRTI Comparison|Death|20|||
150039854|NCT00084136|541285190|FG001|NRTI Comparison|Death|0|||
150039855|NCT00084136|541285191|FG002|NRTI Comparison|Death|18|||
150039856|NCT00084136|541285189|FG000|NRTI Comparison|Lost to Follow-up|14|||
150039857|NCT00084136|541285190|FG001|NRTI Comparison|Lost to Follow-up|0|||
150039858|NCT00084136|541285191|FG002|NRTI Comparison|Lost to Follow-up|12|||
150039859|NCT00084136|541285189|FG000|NRTI Comparison|Withdrawal by Subject|54|||
150039860|NCT00084136|541285190|FG001|NRTI Comparison|Withdrawal by Subject|0|||
150039861|NCT00084136|541285191|FG002|NRTI Comparison|Withdrawal by Subject|38|||
150039862|NCT00084136|541285189|FG000|NRTI Comparison|Clinic site closed|12|||
150039863|NCT00084136|541285190|FG001|NRTI Comparison|Clinic site closed|0|||
150039864|NCT00084136|541285191|FG002|NRTI Comparison|Clinic site closed|14|||
150039865|NCT00084136|541285189|FG000|NRTI Comparison|Not reason above|1|||
150289870|NCT00999908|542195939|FG000|Treatment Period 2|Protocol Violation|1|||
150289871|NCT00999908|542195940|FG001|Treatment Period 2|Protocol Violation|0|||
150289872|NCT00999908|542195941|FG002|Treatment Period 2|Protocol Violation|0|||
150289873|NCT01692301|542195942|FG000|Overall Study|Adverse Event|15|||
150289874|NCT01692301|542195943|FG001|Overall Study|Adverse Event|12|||
150289875|NCT01692301|542195942|FG000|Overall Study|Death|1|||
150289876|NCT01692301|542195943|FG001|Overall Study|Death|2|||
150289877|NCT01692301|542195942|FG000|Overall Study|Lack of Efficacy|0|||
150289878|NCT01692301|542195943|FG001|Overall Study|Lack of Efficacy|5|||
150289879|NCT01692301|542195942|FG000|Overall Study|Non-compliance with study treatment|1|||
150289880|NCT01692301|542195943|FG001|Overall Study|Non-compliance with study treatment|2|||
150289881|NCT01692301|542195942|FG000|Overall Study|Protocol deviation|9|||
150039866|NCT00084136|541285190|FG001|NRTI Comparison|Not reason above|0|||
150289882|NCT01692301|542195943|FG001|Overall Study|Protocol deviation|2|||
150289883|NCT01692301|542195942|FG000|Overall Study|Patient/guardian decision|16|||
150289884|NCT01692301|542195943|FG001|Overall Study|Patient/guardian decision|15|||
150289885|NCT01692301|542195942|FG000|Overall Study|Technical problems|0|||
150289886|NCT01692301|542195943|FG001|Overall Study|Technical problems|1|||
150289887|NCT01692301|542195942|FG000|Overall Study|Physician Decision|2|||
150289888|NCT01692301|542195943|FG001|Overall Study|Physician Decision|2|||
150289889|NCT01692301|542195942|FG000|Overall Study|Lost to Follow-up|1|||
150289890|NCT01692301|542195943|FG001|Overall Study|Lost to Follow-up|1|||
150289891|NCT01290692|542195944|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
150289892|NCT01568593|542195945|FG000|Overall Study|Lack of Efficacy|4|||
150289893|NCT01568593|542195946|FG001|Overall Study|Lack of Efficacy|1|||
150289894|NCT01568593|542195945|FG000|Overall Study|Adverse Event|3|||
150289895|NCT01568593|542195946|FG001|Overall Study|Adverse Event|2|||
150039867|NCT00084136|541285191|FG002|NRTI Comparison|Not reason above|0|||
150289896|NCT02780648|542195948|FG000|Overall Study|Disease Progression|1|||
150289897|NCT02780648|542195949|FG001|Overall Study|Disease Progression|0|||
150289898|NCT00293579|542195956|FG000|Overall Study|Withdrawal by Subject|1|||
150289899|NCT01276236|542195957|FG000|Overall Study|Lack of Efficacy|2|||
150289900|NCT01276236|542195957|FG000|Overall Study|Withdrawal by Subject|4|||
150289901|NCT04472429|542195959|FG000|Randomized Period|Ongoing|90|||
150039868|NCT02230670|541285192|FG000|Overall Study|Adverse Event|1|||
150039869|NCT02230670|541285193|FG001|Overall Study|Adverse Event|2|||
150039870|NCT02230670|541285192|FG000|Overall Study|Withdrawal by Subject|2|||
150039871|NCT02230670|541285193|FG001|Overall Study|Withdrawal by Subject|2|||
150289902|NCT04472429|542195960|FG001|Randomized Period|Ongoing|40|||
150289903|NCT04472429|542195961|FG002|Randomized Period|Ongoing|0|||
150289904|NCT04472429|542195959|FG000|Randomized Period|Death|52|||
150289905|NCT04472429|542195960|FG001|Randomized Period|Death|37|||
150289906|NCT04472429|542195961|FG002|Randomized Period|Death|0|||
150289907|NCT04472429|542195959|FG000|Randomized Period|Lost to Follow-up|4|||
150039872|NCT02230670|541285192|FG000|Overall Study|Physician Decision|0|||
150039873|NCT02230670|541285193|FG001|Overall Study|Physician Decision|1|||
150289908|NCT04472429|542195960|FG001|Randomized Period|Lost to Follow-up|0|||
150289909|NCT04472429|542195961|FG002|Randomized Period|Lost to Follow-up|0|||
150289910|NCT04472429|542195959|FG000|Randomized Period|Physician Decision|1|||
150289911|NCT04472429|542195960|FG001|Randomized Period|Physician Decision|2|||
150289912|NCT04472429|542195961|FG002|Randomized Period|Physician Decision|0|||
150289913|NCT04472429|542195959|FG000|Randomized Period|Withdrawal by Subject|6|||
150289914|NCT04472429|542195960|FG001|Randomized Period|Withdrawal by Subject|5|||
150289915|NCT04472429|542195961|FG002|Randomized Period|Withdrawal by Subject|0|||
150289916|NCT04472429|542195959|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
150289917|NCT04472429|542195960|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
150289918|NCT04472429|542195961|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
150289919|NCT04472429|542195959|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
150289920|NCT04472429|542195960|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
150289921|NCT04472429|542195961|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
150289922|NCT04472429|542195959|FG000|Open-label Monotherapy Period|Ongoing|0|||
150289923|NCT04472429|542195960|FG001|Open-label Monotherapy Period|Ongoing|0|||
150289924|NCT04472429|542195961|FG002|Open-label Monotherapy Period|Ongoing|32|||
150289925|NCT04472429|542195959|FG000|Open-label Monotherapy Period|Death|0|||
150289926|NCT04472429|542195960|FG001|Open-label Monotherapy Period|Death|0|||
150289927|NCT04472429|542195961|FG002|Open-label Monotherapy Period|Death|35|||
150289928|NCT04472429|542195959|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
150289929|NCT04472429|542195960|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
150289930|NCT04472429|542195961|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
150289931|NCT01180660|542195962|FG000|Overall Study|Changed to open surgery|1|||
150289932|NCT01180660|542195963|FG001|Overall Study|Changed to open surgery|0|||
150289933|NCT05130463|542195964|FG000|Overall Study|Unspecified reasons|2|||
150289934|NCT05130463|542195964|FG000|Overall Study|off-label indication dose|435|||
150289935|NCT00844753|542195965|FG000|Overall Study|Lack of Efficacy|1|||
150289936|NCT00844753|542195966|FG001|Overall Study|Lack of Efficacy|0|||
150289937|NCT00844753|542195967|FG002|Overall Study|Lack of Efficacy|2|||
150289938|NCT00844753|542195968|FG003|Overall Study|Lack of Efficacy|2|||
150289939|NCT00844753|542195965|FG000|Overall Study|Adverse Event|3|||
150289940|NCT00844753|542195966|FG001|Overall Study|Adverse Event|2|||
150289941|NCT00844753|542195967|FG002|Overall Study|Adverse Event|5|||
150289942|NCT00844753|542195968|FG003|Overall Study|Adverse Event|5|||
150289943|NCT00844753|542195965|FG000|Overall Study|Lost to Follow-up|1|||
150289944|NCT00844753|542195966|FG001|Overall Study|Lost to Follow-up|1|||
150289945|NCT00844753|542195967|FG002|Overall Study|Lost to Follow-up|0|||
150289946|NCT00844753|542195968|FG003|Overall Study|Lost to Follow-up|1|||
150289947|NCT00844753|542195965|FG000|Overall Study|could not swallow medication|2|||
150289948|NCT00844753|542195966|FG001|Overall Study|could not swallow medication|0|||
150289949|NCT00844753|542195967|FG002|Overall Study|could not swallow medication|0|||
150289950|NCT00844753|542195968|FG003|Overall Study|could not swallow medication|0|||
150289951|NCT00844753|542195965|FG000|Overall Study|Withdrawal by Subject|1|||
150289952|NCT00844753|542195966|FG001|Overall Study|Withdrawal by Subject|0|||
150289953|NCT00844753|542195967|FG002|Overall Study|Withdrawal by Subject|0|||
150289954|NCT00844753|542195968|FG003|Overall Study|Withdrawal by Subject|3|||
150289955|NCT00088374|542195971|FG000|Overall Study|patient did not receive any 17AAG|1|||
150289956|NCT00088374|542195971|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
150289957|NCT00371865|542195974|FG000|Overall Study|Lack of Efficacy|0|||
150289958|NCT00371865|542195975|FG001|Overall Study|Lack of Efficacy|2|||
150039874|NCT02230670|541285192|FG000|Overall Study|Protocol Violation|0|||
150039875|NCT02230670|541285193|FG001|Overall Study|Protocol Violation|1|||
150039876|NCT02230670|541285192|FG000|Overall Study|Progression to Child-Pugh C|1|||
150289959|NCT00371865|542195974|FG000|Overall Study|Protocol Violation|3|||
150289960|NCT00371865|542195975|FG001|Overall Study|Protocol Violation|2|||
150289961|NCT00371865|542195974|FG000|Overall Study|Withdrawal by Subject|12|||
150289962|NCT00371865|542195975|FG001|Overall Study|Withdrawal by Subject|10|||
150289963|NCT05073458|542195979|FG000|24-week Double-blind Period|Adverse Event|1|||
150289964|NCT05073458|542195980|FG001|24-week Double-blind Period|Adverse Event|0|||
150289965|NCT05073458|542195979|FG000|24-week Double-blind Period|Physician Decision|1|||
150289966|NCT05073458|542195980|FG001|24-week Double-blind Period|Physician Decision|0|||
150289967|NCT05073458|542195979|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
150289968|NCT05073458|542195980|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
150289969|NCT05073458|542195979|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
150289970|NCT05073458|542195980|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
150289971|NCT05073458|542195979|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
150289972|NCT05073458|542195980|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
150289973|NCT05073458|542195979|FG000|24-week Open-label Period|Adverse Event|1|||
150289974|NCT05073458|542195980|FG001|24-week Open-label Period|Adverse Event|2|||
150039877|NCT02230670|541285193|FG001|Overall Study|Progression to Child-Pugh C|2|||
150039878|NCT01524796|541285194|FG000|Overall Study|Adverse Event|13|||
150289975|NCT01627899|542195992|FG000|Overall Study|Study terminated early by sponsor.|5|||
150289976|NCT00861744|542196002|FG000|Overall Study|Adverse Event|0|||
150289977|NCT00861744|542196003|FG001|Overall Study|Adverse Event|0|||
150289978|NCT00861744|542196004|FG002|Overall Study|Adverse Event|0|||
150289979|NCT00861744|542196005|FG003|Overall Study|Adverse Event|1|||
150289980|NCT00861744|542196002|FG000|Overall Study|Lost to Follow-up|7|||
150289981|NCT00861744|542196003|FG001|Overall Study|Lost to Follow-up|19|||
150289982|NCT00861744|542196004|FG002|Overall Study|Lost to Follow-up|17|||
150289983|NCT00861744|542196005|FG003|Overall Study|Lost to Follow-up|12|||
150289984|NCT00861744|542196002|FG000|Overall Study|Withdrawal by Subject|10|||
150289985|NCT00861744|542196003|FG001|Overall Study|Withdrawal by Subject|6|||
150289986|NCT00861744|542196004|FG002|Overall Study|Withdrawal by Subject|6|||
150289987|NCT00861744|542196005|FG003|Overall Study|Withdrawal by Subject|19|||
150289988|NCT00861744|542196002|FG000|Overall Study|Protocol Violation|0|||
150289989|NCT00861744|542196003|FG001|Overall Study|Protocol Violation|1|||
150289990|NCT00861744|542196004|FG002|Overall Study|Protocol Violation|0|||
150289991|NCT00861744|542196005|FG003|Overall Study|Protocol Violation|0|||
150289992|NCT00861744|542196002|FG000|Overall Study|Migration from study area|0|||
150289993|NCT00861744|542196003|FG001|Overall Study|Migration from study area|3|||
150289994|NCT00861744|542196004|FG002|Overall Study|Migration from study area|1|||
150289995|NCT00861744|542196005|FG003|Overall Study|Migration from study area|0|||
150289996|NCT00861744|542196002|FG000|Overall Study|Blood draws|0|||
150289997|NCT00861744|542196003|FG001|Overall Study|Blood draws|0|||
150289998|NCT00861744|542196004|FG002|Overall Study|Blood draws|0|||
150289999|NCT00861744|542196005|FG003|Overall Study|Blood draws|1|||
150290000|NCT04428424|542196006|FG000|Overall Study|Does not meet entrance criteria|132|||
150290001|NCT04428424|542196006|FG000|Overall Study|Lost to Follow-up|115|||
150290002|NCT03809611|542196007|FG000|Overall Study|Withdrawal by Subject|1|||
150290003|NCT03809611|542196008|FG001|Overall Study|Withdrawal by Subject|1|||
150290004|NCT02193074|542196009|FG000|Overall Study|Withdrawal by Subject|1|||
150290005|NCT02193074|542196010|FG001|Overall Study|Withdrawal by Subject|2|||
149855987|NCT00983528|540600950|FG000|Overall Study|Study Terminated|1|||
149855988|NCT03635983|540600951|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
149855989|NCT03635983|540600952|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
149855990|NCT03635983|540600951|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149855991|NCT03635983|540600952|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149855992|NCT03635983|540600951|FG000|Pre-Treatment Period|Other reasons|0|||
149855993|NCT03635983|540600952|FG001|Pre-Treatment Period|Other reasons|1|||
149855994|NCT03635983|540600951|FG000|Pre-Treatment Period|Disease Progression|0|||
150290006|NCT02193074|542196009|FG000|Overall Study|Adverse Event|16|||
150290007|NCT02193074|542196010|FG001|Overall Study|Adverse Event|13|||
150290008|NCT04179175|542197703|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
150290009|NCT04179175|542197704|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
150290010|NCT04179175|542197705|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
150290011|NCT04179175|542197706|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
150290012|NCT04179175|542197707|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
150290013|NCT04179175|542197708|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
150290014|NCT04179175|542197703|FG000|Overall Study|Adverse Event|5|||
150290015|NCT04179175|542197704|FG001|Overall Study|Adverse Event|3|||
150290016|NCT04179175|542197705|FG002|Overall Study|Adverse Event|3|||
150290017|NCT04179175|542197706|FG003|Overall Study|Adverse Event|4|||
150290018|NCT04179175|542197707|FG004|Overall Study|Adverse Event|6|||
150290019|NCT04179175|542197708|FG005|Overall Study|Adverse Event|6|||
150290020|NCT04179175|542197703|FG000|Overall Study|Lack of Efficacy|5|||
150290021|NCT04179175|542197704|FG001|Overall Study|Lack of Efficacy|1|||
150290022|NCT04179175|542197705|FG002|Overall Study|Lack of Efficacy|3|||
150290023|NCT04179175|542197706|FG003|Overall Study|Lack of Efficacy|2|||
150290024|NCT04179175|542197707|FG004|Overall Study|Lack of Efficacy|18|||
150290025|NCT04179175|542197708|FG005|Overall Study|Lack of Efficacy|7|||
150290026|NCT04179175|542197703|FG000|Overall Study|Lost to Follow-up|5|||
150290027|NCT04179175|542197704|FG001|Overall Study|Lost to Follow-up|3|||
150290028|NCT04179175|542197705|FG002|Overall Study|Lost to Follow-up|2|||
150290029|NCT04179175|542197706|FG003|Overall Study|Lost to Follow-up|2|||
150290030|NCT04179175|542197707|FG004|Overall Study|Lost to Follow-up|4|||
150290031|NCT04179175|542197708|FG005|Overall Study|Lost to Follow-up|5|||
150290032|NCT04179175|542197703|FG000|Overall Study|Physician Decision|2|||
149855995|NCT03635983|540600952|FG001|Pre-Treatment Period|Disease Progression|1|||
149855996|NCT03635983|540600951|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
149855997|NCT03635983|540600952|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
149855998|NCT03635983|540600951|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
149855999|NCT03635983|540600952|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
149856000|NCT03635983|540600951|FG000|Treatment Period|Withdrawal by Subject|3|||
149856001|NCT03635983|540600952|FG001|Treatment Period|Withdrawal by Subject|5|||
149856002|NCT03635983|540600951|FG000|Treatment Period|Death|3|||
149856003|NCT03635983|540600952|FG001|Treatment Period|Death|5|||
149960396|NCT01796470|540988092|FG004|Overall Study|Physician Decision|1|||
150290033|NCT04179175|542197704|FG001|Overall Study|Physician Decision|0|||
150290034|NCT04179175|542197705|FG002|Overall Study|Physician Decision|2|||
150290035|NCT04179175|542197706|FG003|Overall Study|Physician Decision|3|||
150290036|NCT04179175|542197707|FG004|Overall Study|Physician Decision|1|||
150290037|NCT04179175|542197708|FG005|Overall Study|Physician Decision|1|||
150290038|NCT04179175|542197703|FG000|Overall Study|Pregnancy|3|||
150290039|NCT04179175|542197704|FG001|Overall Study|Pregnancy|0|||
150290040|NCT04179175|542197705|FG002|Overall Study|Pregnancy|3|||
150290041|NCT04179175|542197706|FG003|Overall Study|Pregnancy|0|||
150290042|NCT04179175|542197707|FG004|Overall Study|Pregnancy|1|||
150290043|NCT04179175|542197708|FG005|Overall Study|Pregnancy|2|||
150290044|NCT04179175|542197703|FG000|Overall Study|Withdrawal by Subject|22|||
150290045|NCT04179175|542197704|FG001|Overall Study|Withdrawal by Subject|10|||
150290046|NCT04179175|542197705|FG002|Overall Study|Withdrawal by Subject|12|||
150290047|NCT04179175|542197706|FG003|Overall Study|Withdrawal by Subject|8|||
150290048|NCT04179175|542197707|FG004|Overall Study|Withdrawal by Subject|23|||
150290049|NCT04179175|542197708|FG005|Overall Study|Withdrawal by Subject|31|||
150290050|NCT04179175|542197703|FG000|Overall Study|Technical problems|0|||
150290051|NCT04179175|542197704|FG001|Overall Study|Technical problems|0|||
150290052|NCT04179175|542197705|FG002|Overall Study|Technical problems|1|||
150290053|NCT04179175|542197706|FG003|Overall Study|Technical problems|1|||
150290054|NCT04179175|542197707|FG004|Overall Study|Technical problems|0|||
150290055|NCT04179175|542197708|FG005|Overall Study|Technical problems|0|||
150290056|NCT01262365|542197709|FG000|Overall Study|Lack of Efficacy|35|||
150290057|NCT01262365|542197710|FG001|Overall Study|Lack of Efficacy|30|||
150290058|NCT01262365|542197711|FG002|Overall Study|Lack of Efficacy|47|||
150290059|NCT01262365|542197709|FG000|Overall Study|Protocol Violation|3|||
150290060|NCT01262365|542197710|FG001|Overall Study|Protocol Violation|1|||
150290061|NCT01262365|542197711|FG002|Overall Study|Protocol Violation|1|||
150290062|NCT01262365|542197709|FG000|Overall Study|Lost to Follow-up|3|||
150290063|NCT01262365|542197710|FG001|Overall Study|Lost to Follow-up|7|||
150290064|NCT01262365|542197711|FG002|Overall Study|Lost to Follow-up|6|||
150290065|NCT01262365|542197709|FG000|Overall Study|Withdrawal by Subject|17|||
150290066|NCT01262365|542197710|FG001|Overall Study|Withdrawal by Subject|22|||
150290067|NCT01262365|542197711|FG002|Overall Study|Withdrawal by Subject|22|||
150290068|NCT01262365|542197709|FG000|Overall Study|Death|1|||
150290069|NCT01262365|542197710|FG001|Overall Study|Death|2|||
150290070|NCT01262365|542197711|FG002|Overall Study|Death|1|||
150290071|NCT01262365|542197709|FG000|Overall Study|Adverse Event|26|||
150290072|NCT01262365|542197710|FG001|Overall Study|Adverse Event|16|||
150290073|NCT01262365|542197711|FG002|Overall Study|Adverse Event|11|||
150290074|NCT01262365|542197709|FG000|Overall Study|sponsor decision|1|||
150290075|NCT01262365|542197710|FG001|Overall Study|sponsor decision|1|||
150290076|NCT01262365|542197711|FG002|Overall Study|sponsor decision|0|||
150290077|NCT01262365|542197709|FG000|Overall Study|Randomization error|1|||
150290078|NCT01262365|542197710|FG001|Overall Study|Randomization error|0|||
150290079|NCT01262365|542197711|FG002|Overall Study|Randomization error|2|||
150290080|NCT01262365|542197709|FG000|Overall Study|Non-compliance|1|||
150290081|NCT01262365|542197710|FG001|Overall Study|Non-compliance|0|||
150290082|NCT01262365|542197711|FG002|Overall Study|Non-compliance|2|||
150290083|NCT01262365|542197709|FG000|Overall Study|Suspected pregnancy|1|||
150290084|NCT01262365|542197710|FG001|Overall Study|Suspected pregnancy|0|||
150290085|NCT01262365|542197711|FG002|Overall Study|Suspected pregnancy|0|||
150290086|NCT01262365|542197709|FG000|Overall Study|Patient pregnant|1|||
150290087|NCT01262365|542197710|FG001|Overall Study|Patient pregnant|0|||
150290088|NCT01262365|542197711|FG002|Overall Study|Patient pregnant|1|||
150290089|NCT01262365|542197709|FG000|Overall Study|Toxicity related to study drug|0|||
150290090|NCT01262365|542197710|FG001|Overall Study|Toxicity related to study drug|1|||
150290091|NCT01262365|542197711|FG002|Overall Study|Toxicity related to study drug|0|||
150290092|NCT01262365|542197709|FG000|Overall Study|Cannot tolerate the protocol|0|||
150290093|NCT01262365|542197710|FG001|Overall Study|Cannot tolerate the protocol|1|||
150290094|NCT01262365|542197711|FG002|Overall Study|Cannot tolerate the protocol|0|||
150290095|NCT01262365|542197709|FG000|Overall Study|Patient unavailable|0|||
150290096|NCT01262365|542197710|FG001|Overall Study|Patient unavailable|0|||
150290097|NCT01262365|542197711|FG002|Overall Study|Patient unavailable|1|||
150290098|NCT00494091|542197712|FG000|Overall Study|Death|5|||
150290099|NCT00494091|542197713|FG001|Overall Study|Death|54|||
150290100|NCT00494091|542197712|FG000|Overall Study|Lost to Follow-up|0|||
150290101|NCT00494091|542197713|FG001|Overall Study|Lost to Follow-up|4|||
150290102|NCT00494091|542197712|FG000|Overall Study|Other|1|||
150290103|NCT00494091|542197713|FG001|Overall Study|Other|11|||
150290104|NCT00494091|542197712|FG000|Overall Study|Withdrawal by Subject|0|||
150290105|NCT00494091|542197713|FG001|Overall Study|Withdrawal by Subject|7|||
150290106|NCT00130832|542197714|FG000|Overall Study|Adverse Event|1|||
150290107|NCT00130832|542197715|FG001|Overall Study|Adverse Event|1|||
150290108|NCT00130832|542197714|FG000|Overall Study|Lost to Follow-up|1|||
150290109|NCT00130832|542197715|FG001|Overall Study|Lost to Follow-up|2|||
150290110|NCT00130832|542197714|FG000|Overall Study|Protocol Violation|6|||
150290111|NCT00130832|542197715|FG001|Overall Study|Protocol Violation|8|||
150290112|NCT00130832|542197714|FG000|Overall Study|Withdrawal by Subject|6|||
150290113|NCT00130832|542197715|FG001|Overall Study|Withdrawal by Subject|1|||
150290114|NCT00130832|542197714|FG000|Overall Study|Moved|2|||
150290115|NCT00130832|542197715|FG001|Overall Study|Moved|2|||
150290116|NCT00130832|542197714|FG000|Overall Study|Other|0|||
150290117|NCT00130832|542197715|FG001|Overall Study|Other|3|||
150290118|NCT00559507|542197717|FG000|Overall Study|Not treated, patient ineligible|3|||
150290119|NCT04232696|542197718|FG000|Overall Study|Implant attempted but not completed|5|||
150290120|NCT04232696|542197719|FG001|Overall Study|Implant attempted but not completed|2|||
150290121|NCT04232696|542197718|FG000|Overall Study|Not satisfied with therapy outcome|0|||
150290122|NCT04232696|542197719|FG001|Overall Study|Not satisfied with therapy outcome|8|||
150290123|NCT04232696|542197718|FG000|Overall Study|Adverse Event|0|||
150290124|NCT04232696|542197719|FG001|Overall Study|Adverse Event|3|||
150290125|NCT04232696|542197718|FG000|Overall Study|Withdrawal by Subject|0|||
150290126|NCT04232696|542197719|FG001|Overall Study|Withdrawal by Subject|3|||
150290127|NCT04232696|542197718|FG000|Overall Study|Missed Visit|0|||
150290128|NCT04232696|542197719|FG001|Overall Study|Missed Visit|2|||
150290129|NCT04232696|542197718|FG000|Overall Study|Other reason|0|||
150290130|NCT04232696|542197719|FG001|Overall Study|Other reason|1|||
150290131|NCT01678144|542197720|FG000|Stage 1: MAR Classic|Adverse Event|1|||
150290132|NCT03118297|542197721|FG000|Overall Study|Lost to Follow-up|0|||
150290133|NCT03118297|542197722|FG001|Overall Study|Lost to Follow-up|2|||
150290134|NCT04227899|542197723|FG000|Overall Study|Withdrawal by Subject|6|||
150290135|NCT04227899|542197724|FG001|Overall Study|Withdrawal by Subject|3|||
150290136|NCT04227899|542197723|FG000|Overall Study|Death|12|||
150290137|NCT04227899|542197724|FG001|Overall Study|Death|6|||
150290138|NCT04227899|542197723|FG000|Overall Study|Lost to Follow-up|2|||
150290139|NCT04227899|542197724|FG001|Overall Study|Lost to Follow-up|1|||
150290140|NCT04735653|542197726|FG000|Overall Study|Lost to Follow-up|17|||
150290141|NCT04735653|542197727|FG001|Overall Study|Lost to Follow-up|7|||
150290142|NCT04735653|542197726|FG000|Overall Study|Withdrawal by Subject|8|||
150290143|NCT04735653|542197727|FG001|Overall Study|Withdrawal by Subject|2|||
150290144|NCT04735653|542197726|FG000|Overall Study|Death|0|||
150290145|NCT04735653|542197727|FG001|Overall Study|Death|2|||
150290146|NCT04735653|542197726|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
150290147|NCT04735653|542197727|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
150290148|NCT01294800|542197729|FG000|Overall Study|Adverse Event|7|||
150290149|NCT01294800|542197730|FG001|Overall Study|Adverse Event|6|||
150290150|NCT01294800|542197731|FG002|Overall Study|Adverse Event|12|||
150290151|NCT01294800|542197732|FG003|Overall Study|Adverse Event|5|||
150290152|NCT01294800|542197729|FG000|Overall Study|Subject Withdrew Consent|2|||
150290153|NCT01294800|542197730|FG001|Overall Study|Subject Withdrew Consent|2|||
150290154|NCT01294800|542197731|FG002|Overall Study|Subject Withdrew Consent|2|||
150290155|NCT01294800|542197732|FG003|Overall Study|Subject Withdrew Consent|11|||
150290156|NCT01294800|542197729|FG000|Overall Study|Lost to Follow-up|0|||
150290157|NCT01294800|542197730|FG001|Overall Study|Lost to Follow-up|0|||
150290158|NCT01294800|542197731|FG002|Overall Study|Lost to Follow-up|1|||
150290159|NCT01294800|542197732|FG003|Overall Study|Lost to Follow-up|0|||
150290160|NCT01294800|542197729|FG000|Overall Study|Non-compliance With Protocol|0|||
150290161|NCT01294800|542197730|FG001|Overall Study|Non-compliance With Protocol|1|||
150290162|NCT01294800|542197731|FG002|Overall Study|Non-compliance With Protocol|1|||
150290163|NCT01294800|542197732|FG003|Overall Study|Non-compliance With Protocol|0|||
149960397|NCT01796470|540988088|FG000|Overall Study|Progressive Disease|7|||
149960398|NCT01796470|540988089|FG001|Overall Study|Progressive Disease|7|||
149960399|NCT01796470|540988090|FG002|Overall Study|Progressive Disease|3|||
149960400|NCT01796470|540988091|FG003|Overall Study|Progressive Disease|2|||
149960401|NCT01796470|540988092|FG004|Overall Study|Progressive Disease|0|||
149960402|NCT01796470|540988088|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
149960403|NCT01796470|540988089|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
149960404|NCT01796470|540988090|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
149960405|NCT01796470|540988091|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
149960406|NCT01796470|540988092|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
149960407|NCT01796470|540988088|FG000|Overall Study|Withdrawal by Subject|7|||
150039879|NCT01524796|541285194|FG000|Overall Study|Lack of Efficacy|3|||
150039880|NCT01524796|541285194|FG000|Overall Study|Lost to Follow-up|1|||
150290164|NCT01294800|542197729|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
150290165|NCT01294800|542197730|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
150290166|NCT01294800|542197731|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
150290167|NCT01294800|542197732|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
150290168|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
149960408|NCT01796470|540988089|FG001|Overall Study|Withdrawal by Subject|0|||
150290169|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
150290170|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
150290171|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
150290172|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
150290173|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
150039881|NCT01524796|541285194|FG000|Overall Study|The price|1|||
150039882|NCT01524796|541285194|FG000|Overall Study|Withdrawal by Subject|4|||
150039883|NCT01524796|541285194|FG000|Overall Study|Move|1|||
150039884|NCT01524796|541285194|FG000|Overall Study|Deterioration of pains|1|||
150039885|NCT01524796|541285194|FG000|Overall Study|Gall stone surgery|1|||
150039886|NCT01524796|541285194|FG000|Overall Study|Nervous about confidentiality|1|||
150039887|NCT01524796|541285194|FG000|Overall Study|Switch to carbamazapine|1|||
150039888|NCT01524796|541285194|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
150039889|NCT02202759|541287243|FG000|Overall Study|Study Terminated by Sponsor|3|||
150039890|NCT02202759|541287244|FG001|Overall Study|Study Terminated by Sponsor|3|||
150039891|NCT02202759|541287245|FG002|Overall Study|Study Terminated by Sponsor|3|||
150039892|NCT02202759|541287243|FG000|Overall Study|Withdrawal by Subject|2|||
150039893|NCT02202759|541287244|FG001|Overall Study|Withdrawal by Subject|1|||
150039894|NCT02202759|541287245|FG002|Overall Study|Withdrawal by Subject|1|||
150039895|NCT02202759|541287243|FG000|Overall Study|Reason not Specified|4|||
150039896|NCT02202759|541287244|FG001|Overall Study|Reason not Specified|11|||
150039897|NCT02202759|541287245|FG002|Overall Study|Reason not Specified|10|||
150039898|NCT01646125|541287246|FG000|Overall Study|Untreated|2|||
150039899|NCT01646125|541287247|FG001|Overall Study|Untreated|5|||
150039900|NCT01646125|541287246|FG000|Overall Study|Adverse Event|2|||
150039901|NCT01646125|541287247|FG001|Overall Study|Adverse Event|1|||
150039902|NCT01646125|541287246|FG000|Overall Study|Death|1|||
150039903|NCT01646125|541287247|FG001|Overall Study|Death|1|||
150039904|NCT01646125|541287246|FG000|Overall Study|Physician Decision|1|||
150039905|NCT01646125|541287247|FG001|Overall Study|Physician Decision|3|||
150039906|NCT01646125|541287246|FG000|Overall Study|Progressive disease|22|||
150039907|NCT01646125|541287247|FG001|Overall Study|Progressive disease|16|||
150039908|NCT01646125|541287246|FG000|Overall Study|Study terminated by sponsor|2|||
150039909|NCT01646125|541287247|FG001|Overall Study|Study terminated by sponsor|1|||
150039910|NCT01646125|541287246|FG000|Overall Study|Subject/Guardian decision|1|||
150039911|NCT01646125|541287247|FG001|Overall Study|Subject/Guardian decision|1|||
150039912|NCT00904033|541287250|FG000|Overall Study|Withdrawal by Subject|1|||
150039913|NCT00904033|541287251|FG001|Overall Study|Withdrawal by Subject|1|||
150039914|NCT00904033|541287252|FG002|Overall Study|Withdrawal by Subject|0|||
150039915|NCT00904033|541287253|FG003|Overall Study|Withdrawal by Subject|0|||
150039916|NCT00904033|541287250|FG000|Overall Study|Physician Decision|0|||
150039917|NCT00904033|541287251|FG001|Overall Study|Physician Decision|0|||
150039918|NCT00904033|541287252|FG002|Overall Study|Physician Decision|1|||
150039919|NCT00904033|541287253|FG003|Overall Study|Physician Decision|0|||
150039920|NCT00904033|541287250|FG000|Overall Study|Unable to obtain final blood draw|0|||
150039921|NCT00904033|541287251|FG001|Overall Study|Unable to obtain final blood draw|0|||
150039922|NCT00904033|541287252|FG002|Overall Study|Unable to obtain final blood draw|0|||
150039923|NCT00904033|541287253|FG003|Overall Study|Unable to obtain final blood draw|2|||
150039924|NCT00865566|541287255|FG000|Overall Study|Death|1|||
150039925|NCT00865566|541287256|FG001|Overall Study|Death|11|||
150039926|NCT00865566|541287255|FG000|Overall Study|Lost to Follow-up|314|||
150039927|NCT00865566|541287256|FG001|Overall Study|Lost to Follow-up|315|||
150039928|NCT00865566|541287255|FG000|Overall Study|Withdrawal by Subject|45|||
150039929|NCT00865566|541287256|FG001|Overall Study|Withdrawal by Subject|65|||
150039930|NCT00865566|541287255|FG000|Overall Study|Physician Decision|0|||
150290174|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
150290175|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
150290176|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
150290177|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
150290178|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
150290179|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
150290180|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
150290181|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
150290182|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
150290183|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
150290184|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
150290185|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
150039931|NCT00865566|541287256|FG001|Overall Study|Physician Decision|1|||
150039932|NCT00865566|541287255|FG000|Overall Study|Participant relocated|78|||
150039933|NCT00865566|541287256|FG001|Overall Study|Participant relocated|107|||
150039934|NCT00865566|541287255|FG000|Overall Study|Participant unable to adhere|27|||
150039935|NCT00865566|541287256|FG001|Overall Study|Participant unable to adhere|42|||
150039936|NCT00865566|541287255|FG000|Overall Study|Other; N=245 due to early study closure|154|||
150039937|NCT00865566|541287256|FG001|Overall Study|Other; N=245 due to early study closure|139|||
150039938|NCT00865566|541287255|FG000|Overall Study|HIV infection|5|||
150039939|NCT00865566|541287256|FG001|Overall Study|HIV infection|7|||
150039940|NCT00602472|541287257|FG000|Overall Study|Adverse Event|5|||
150039941|NCT00602472|541287258|FG001|Overall Study|Adverse Event|23|||
150039942|NCT00602472|541287257|FG000|Overall Study|Protocol Violation|4|||
150039943|NCT00602472|541287258|FG001|Overall Study|Protocol Violation|19|||
150290186|NCT04418765|542197734|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
150290187|NCT04418765|542197735|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
150290188|NCT04418765|542197736|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
150290189|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
150290190|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
150039944|NCT00602472|541287257|FG000|Overall Study|Withdrawal by Subject|8|||
150290191|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
150290192|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
150290193|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
150290194|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
150290195|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
150290196|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
150290197|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
150290198|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
150290199|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
150290200|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
150290201|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
150290202|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
150290203|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
150290204|NCT04418765|542197734|FG000|Extension Period (48 Weeks)|Other than specified|0|||
150290205|NCT04418765|542197735|FG001|Extension Period (48 Weeks)|Other than specified|5|||
150290206|NCT04418765|542197736|FG002|Extension Period (48 Weeks)|Other than specified|2|||
150290207|NCT01100944|542197737|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
150290208|NCT01100944|542197738|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
150290209|NCT01100944|542197739|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
150290210|NCT01100944|542197737|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
150290211|NCT01100944|542197738|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
150290212|NCT01100944|542197739|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
150290213|NCT01100944|542197737|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
150290214|NCT01100944|542197738|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
150290215|NCT01100944|542197739|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
150290216|NCT01100944|542197737|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
150290217|NCT01100944|542197738|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
150290218|NCT01100944|542197739|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
150290219|NCT02296242|542197742|FG000|Overall Study|Death|1|||
150290220|NCT02296242|542197743|FG001|Overall Study|Death|1|||
150290221|NCT02296242|542197744|FG002|Overall Study|Death|1|||
150290222|NCT02296242|542197745|FG003|Overall Study|Death|1|||
150290223|NCT02296242|542197746|FG004|Overall Study|Death|1|||
150290224|NCT02296242|542197742|FG000|Overall Study|Withdrawal by Subject|0|||
150290225|NCT02296242|542197743|FG001|Overall Study|Withdrawal by Subject|0|||
150290226|NCT02296242|542197744|FG002|Overall Study|Withdrawal by Subject|1|||
150290227|NCT02296242|542197745|FG003|Overall Study|Withdrawal by Subject|1|||
150039945|NCT00602472|541287258|FG001|Overall Study|Withdrawal by Subject|14|||
150290228|NCT02296242|542197746|FG004|Overall Study|Withdrawal by Subject|3|||
150290229|NCT02296242|542197742|FG000|Overall Study|Disease Progression|1|||
149856004|NCT03635983|540600951|FG000|Treatment Period|Poor/Non-compliance|2|||
149856005|NCT03635983|540600952|FG001|Treatment Period|Poor/Non-compliance|1|||
149856006|NCT03635983|540600951|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
149856007|NCT03635983|540600952|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
149856008|NCT03635983|540600951|FG000|Treatment Period|Other reasons|7|||
149856009|NCT03635983|540600952|FG001|Treatment Period|Other reasons|4|||
149856010|NCT03635983|540600951|FG000|Treatment Period|Disease progression|230|||
149856011|NCT03635983|540600952|FG001|Treatment Period|Disease progression|201|||
149856012|NCT03635983|540600951|FG000|Treatment Period|Study drug toxicity|35|||
149856013|NCT03635983|540600952|FG001|Treatment Period|Study drug toxicity|36|||
149856014|NCT03635983|540600951|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
149856015|NCT03635983|540600952|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
149856016|NCT03635983|540600951|FG000|Treatment Period|Maximum clinical benefit|3|||
149856017|NCT03635983|540600952|FG001|Treatment Period|Maximum clinical benefit|5|||
149856018|NCT03635983|540600951|FG000|Treatment Period|Administrative reason by the sponsor|1|||
149856019|NCT03635983|540600952|FG001|Treatment Period|Administrative reason by the sponsor|2|||
149856020|NCT03635983|540600951|FG000|Treatment Period|Lost to Follow-up|0|||
149856021|NCT03635983|540600952|FG001|Treatment Period|Lost to Follow-up|1|||
149856022|NCT03430011|540600953|FG000|Pre-Treatment|Death|1|||
149856023|NCT03430011|540600954|FG001|Pre-Treatment|Death|0|||
149856024|NCT03430011|540600955|FG002|Pre-Treatment|Death|0|||
150039946|NCT00602472|541287257|FG000|Overall Study|Other incl. lack of efficacy|4|||
150290230|NCT02296242|542197743|FG001|Overall Study|Disease Progression|3|||
150290231|NCT02296242|542197744|FG002|Overall Study|Disease Progression|2|||
150039947|NCT00602472|541287258|FG001|Overall Study|Other incl. lack of efficacy|2|||
149856025|NCT03430011|540600956|FG003|Pre-Treatment|Death|0|||
149856026|NCT03430011|540600957|FG004|Pre-Treatment|Death|1|||
149856027|NCT03430011|540600958|FG005|Pre-Treatment|Death|0|||
149856028|NCT03430011|540600959|FG006|Pre-Treatment|Death|1|||
149856029|NCT03430011|540600960|FG007|Pre-Treatment|Death|0|||
149856030|NCT03430011|540600953|FG000|Pre-Treatment|Screen Fail|0|||
149856031|NCT03430011|540600954|FG001|Pre-Treatment|Screen Fail|0|||
149856032|NCT03430011|540600955|FG002|Pre-Treatment|Screen Fail|0|||
149856033|NCT03430011|540600956|FG003|Pre-Treatment|Screen Fail|0|||
149856034|NCT03430011|540600957|FG004|Pre-Treatment|Screen Fail|1|||
149856035|NCT03430011|540600958|FG005|Pre-Treatment|Screen Fail|0|||
149856036|NCT03430011|540600959|FG006|Pre-Treatment|Screen Fail|0|||
149856037|NCT03430011|540600960|FG007|Pre-Treatment|Screen Fail|0|||
149856038|NCT03430011|540600953|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
150290232|NCT02296242|542197745|FG003|Overall Study|Disease Progression|8|||
150290233|NCT02296242|542197746|FG004|Overall Study|Disease Progression|11|||
150290234|NCT02296242|542197742|FG000|Overall Study|Unacceptable Toxicity|0|||
150290235|NCT02296242|542197743|FG001|Overall Study|Unacceptable Toxicity|0|||
150290236|NCT02296242|542197744|FG002|Overall Study|Unacceptable Toxicity|0|||
150290237|NCT02296242|542197745|FG003|Overall Study|Unacceptable Toxicity|0|||
150290238|NCT02296242|542197746|FG004|Overall Study|Unacceptable Toxicity|1|||
150290239|NCT02296242|542197742|FG000|Overall Study|Patient Condition Changed|0|||
150290240|NCT02296242|542197743|FG001|Overall Study|Patient Condition Changed|0|||
150290241|NCT02296242|542197744|FG002|Overall Study|Patient Condition Changed|2|||
150290242|NCT02296242|542197745|FG003|Overall Study|Patient Condition Changed|0|||
150290243|NCT02296242|542197746|FG004|Overall Study|Patient Condition Changed|1|||
150290244|NCT02296242|542197742|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
150290245|NCT02296242|542197743|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
150290246|NCT02296242|542197744|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
150290247|NCT02296242|542197745|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
150290248|NCT02296242|542197746|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
149856039|NCT03430011|540600954|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
149856040|NCT03430011|540600955|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
149856041|NCT03430011|540600956|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
149960409|NCT01796470|540988090|FG002|Overall Study|Withdrawal by Subject|0|||
149856042|NCT03430011|540600957|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
149856043|NCT03430011|540600958|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
149960410|NCT01796470|540988091|FG003|Overall Study|Withdrawal by Subject|0|||
149960411|NCT01796470|540988092|FG004|Overall Study|Withdrawal by Subject|1|||
149960412|NCT01927861|540988093|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
149960413|NCT01927861|540988094|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
149960414|NCT01927861|540988093|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
149960415|NCT01927861|540988094|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
149960416|NCT01905267|540988095|FG000|Overall Study|Physician Decision|2|||
149960417|NCT01905267|540988096|FG001|Overall Study|Physician Decision|2|||
149960418|NCT02991859|540988097|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960419|NCT02991859|540988098|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
149960420|NCT02991859|540988099|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960421|NCT02991859|540988100|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
150039948|NCT00823615|541287263|FG000|Period 2|Lost to Follow-up|2|||
150039949|NCT00823615|541287264|FG001|Period 2|Lost to Follow-up|0|||
150039950|NCT00823615|541287263|FG000|Period 2|Time/Job Conflict|1|||
150039951|NCT00823615|541287264|FG001|Period 2|Time/Job Conflict|2|||
150039952|NCT02404025|541287265|FG000|Overall Study|Adverse Event|1|||
150039953|NCT02404025|541287265|FG000|Overall Study|Lack of Efficacy|3|||
150039954|NCT00956007|541287267|FG000|Overall Study|Protocol Violation|27|||
150039955|NCT00956007|541287268|FG001|Overall Study|Protocol Violation|23|||
150039956|NCT01750229|541287269|FG000|Randomized Crossover Phase|Adverse Event|1|||
150039957|NCT01750229|541287269|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
150039958|NCT01750229|541287269|FG000|Long-term Follow-up Phase|Adverse Event|2|||
150039959|NCT01750229|541287269|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
150039960|NCT00419952|541287273|FG000|Overall Study|Adverse Event|8|||
150290249|NCT02296242|542197742|FG000|Overall Study|Lost to Follow-up|1|||
149960422|NCT02991859|540988101|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
149960423|NCT02991859|540988102|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
150039961|NCT00419952|541287274|FG001|Overall Study|Adverse Event|10|||
150039962|NCT00419952|541287273|FG000|Overall Study|Withdrawal by Subject|44|||
150290250|NCT02296242|542197743|FG001|Overall Study|Lost to Follow-up|0|||
150290251|NCT02296242|542197744|FG002|Overall Study|Lost to Follow-up|0|||
150290252|NCT02296242|542197745|FG003|Overall Study|Lost to Follow-up|0|||
149856044|NCT03430011|540600959|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
149856045|NCT03430011|540600960|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
149856046|NCT03430011|540600953|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
150039963|NCT00419952|541287274|FG001|Overall Study|Withdrawal by Subject|43|||
150039964|NCT00419952|541287273|FG000|Overall Study|Lost to Follow-up|43|||
150290253|NCT02296242|542197746|FG004|Overall Study|Lost to Follow-up|0|||
150290254|NCT02296242|542197742|FG000|Overall Study|Need for Hydroxyurea|2|||
150290255|NCT02296242|542197743|FG001|Overall Study|Need for Hydroxyurea|0|||
150290256|NCT02296242|542197744|FG002|Overall Study|Need for Hydroxyurea|0|||
150290257|NCT02296242|542197745|FG003|Overall Study|Need for Hydroxyurea|0|||
150290258|NCT02296242|542197746|FG004|Overall Study|Need for Hydroxyurea|0|||
150290259|NCT02296242|542197742|FG000|Overall Study|Screened for Other Protocol|0|||
150290260|NCT02296242|542197743|FG001|Overall Study|Screened for Other Protocol|1|||
150290261|NCT02296242|542197744|FG002|Overall Study|Screened for Other Protocol|0|||
150290262|NCT02296242|542197745|FG003|Overall Study|Screened for Other Protocol|0|||
150290263|NCT02296242|542197746|FG004|Overall Study|Screened for Other Protocol|0|||
150290264|NCT02296242|542197742|FG000|Overall Study|Physician Decision|0|||
150290265|NCT02296242|542197743|FG001|Overall Study|Physician Decision|1|||
150290266|NCT02296242|542197744|FG002|Overall Study|Physician Decision|0|||
150290267|NCT02296242|542197745|FG003|Overall Study|Physician Decision|1|||
150290268|NCT02296242|542197746|FG004|Overall Study|Physician Decision|0|||
150290269|NCT02296242|542197742|FG000|Overall Study|Alternative Treatment|0|||
150290270|NCT02296242|542197743|FG001|Overall Study|Alternative Treatment|0|||
150290271|NCT02296242|542197744|FG002|Overall Study|Alternative Treatment|0|||
150290272|NCT02296242|542197745|FG003|Overall Study|Alternative Treatment|1|||
150290273|NCT02296242|542197746|FG004|Overall Study|Alternative Treatment|0|||
150290274|NCT02296242|542197742|FG000|Overall Study|Adverse Event|0|||
150290275|NCT02296242|542197743|FG001|Overall Study|Adverse Event|0|||
150290276|NCT02296242|542197744|FG002|Overall Study|Adverse Event|0|||
150290277|NCT02296242|542197745|FG003|Overall Study|Adverse Event|1|||
150290278|NCT02296242|542197746|FG004|Overall Study|Adverse Event|0|||
150290279|NCT02296242|542197742|FG000|Overall Study|Lack of Efficacy|0|||
150290280|NCT02296242|542197743|FG001|Overall Study|Lack of Efficacy|0|||
150290281|NCT02296242|542197744|FG002|Overall Study|Lack of Efficacy|0|||
150290282|NCT02296242|542197745|FG003|Overall Study|Lack of Efficacy|0|||
150290283|NCT02296242|542197746|FG004|Overall Study|Lack of Efficacy|3|||
150290284|NCT01639833|542197747|FG000|Overall Study|Death|4|||
150290285|NCT01639833|542197748|FG001|Overall Study|Death|2|||
150290286|NCT01639833|542197747|FG000|Overall Study|Withdrawal by Subject|2|||
150290287|NCT01639833|542197748|FG001|Overall Study|Withdrawal by Subject|2|||
150290288|NCT02064387|542197749|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290289|NCT02064387|542197750|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290290|NCT02064387|542197751|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290291|NCT02064387|542197752|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290292|NCT02064387|542197753|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149960424|NCT02991859|540988103|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960425|NCT02991859|540988104|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960426|NCT02991859|540988105|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960427|NCT02991859|540988106|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960428|NCT02991859|540988107|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
150290293|NCT02064387|542197754|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290294|NCT02064387|542197755|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290295|NCT02064387|542197756|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
150290296|NCT02064387|542197757|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290297|NCT02064387|542197758|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
149960429|NCT02991859|540988108|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960430|NCT02991859|540988109|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960431|NCT02991859|540988110|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960432|NCT02991859|540988111|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960433|NCT02991859|540988112|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960434|NCT02991859|540988113|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
149960435|NCT02991859|540988097|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960436|NCT02991859|540988098|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960437|NCT02991859|540988099|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960438|NCT02991859|540988100|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960439|NCT02991859|540988101|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
150039965|NCT00419952|541287274|FG001|Overall Study|Lost to Follow-up|34|||
150290298|NCT02064387|542197759|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290299|NCT02064387|542197760|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
150290300|NCT02064387|542197749|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290301|NCT02064387|542197750|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290302|NCT02064387|542197751|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290303|NCT02064387|542197752|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290304|NCT02064387|542197753|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290305|NCT02064387|542197754|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290306|NCT02064387|542197755|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290307|NCT02064387|542197756|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
150290308|NCT02064387|542197757|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290309|NCT02064387|542197758|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290310|NCT02064387|542197759|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290311|NCT02064387|542197760|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
150290312|NCT02064387|542197749|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290313|NCT02064387|542197750|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290314|NCT02064387|542197751|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290315|NCT02064387|542197752|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290316|NCT02064387|542197753|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290317|NCT02064387|542197754|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290318|NCT02064387|542197755|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290319|NCT02064387|542197756|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290320|NCT02064387|542197757|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
150290321|NCT02064387|542197758|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290322|NCT02064387|542197759|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290323|NCT02064387|542197760|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
150290324|NCT02064387|542197749|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
150290325|NCT02064387|542197750|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
150290326|NCT02064387|542197751|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
150290327|NCT02064387|542197752|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
150290328|NCT02064387|542197753|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
150290329|NCT02064387|542197754|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
150290330|NCT02064387|542197755|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
150290331|NCT02064387|542197756|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
150290332|NCT02064387|542197757|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
150290333|NCT02064387|542197758|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
150290334|NCT02064387|542197759|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
150290335|NCT02064387|542197760|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
150290336|NCT02064387|542197749|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290337|NCT02064387|542197750|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290338|NCT02064387|542197751|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290339|NCT02064387|542197752|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290340|NCT02064387|542197753|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290341|NCT02064387|542197754|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290342|NCT02064387|542197755|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290343|NCT02064387|542197756|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290344|NCT02064387|542197757|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290345|NCT02064387|542197758|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290346|NCT02064387|542197759|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
150290347|NCT02064387|542197760|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
150290348|NCT03728309|542197764|FG000|Overall Study|Randomized but not Treated|0|||
150290349|NCT03728309|542197765|FG001|Overall Study|Randomized but not Treated|1|||
150290350|NCT03728309|542197764|FG000|Overall Study|Adverse Event|0|||
150290351|NCT03728309|542197765|FG001|Overall Study|Adverse Event|1|||
150290352|NCT03728309|542197764|FG000|Overall Study|Withdrawal by Subject|2|||
150290353|NCT03728309|542197765|FG001|Overall Study|Withdrawal by Subject|8|||
150290354|NCT03728309|542197764|FG000|Overall Study|Lost to Follow-up|9|||
149856047|NCT03430011|540600954|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
150290355|NCT03728309|542197765|FG001|Overall Study|Lost to Follow-up|10|||
150290356|NCT03728309|542197764|FG000|Overall Study|Protocol Deviation|0|||
149856048|NCT03430011|540600955|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
149856049|NCT03430011|540600956|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
149856050|NCT03430011|540600957|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
149856051|NCT03430011|540600958|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
149856052|NCT03430011|540600959|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
149856053|NCT03430011|540600960|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
149856054|NCT03430011|540600953|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
149856055|NCT03430011|540600954|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
149856056|NCT03430011|540600955|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
149856057|NCT03430011|540600956|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
149856058|NCT03430011|540600957|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
149856059|NCT03430011|540600958|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
149856060|NCT03430011|540600959|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
149856061|NCT03430011|540600960|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
150039966|NCT00419952|541287273|FG000|Overall Study|Protocol Violation|32|||
149856062|NCT03430011|540600953|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
149856063|NCT03430011|540600954|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
149856064|NCT03430011|540600955|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
149856065|NCT03430011|540600956|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
149856066|NCT03430011|540600957|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
149856067|NCT03430011|540600958|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
149856068|NCT03430011|540600959|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
149856069|NCT03430011|540600960|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
149856070|NCT03430011|540600953|FG000|JCARH125 Treatment|Death|4|||
149856071|NCT03430011|540600954|FG001|JCARH125 Treatment|Death|19|||
149856072|NCT03430011|540600955|FG002|JCARH125 Treatment|Death|10|||
149856073|NCT03430011|540600956|FG003|JCARH125 Treatment|Death|8|||
149856074|NCT03430011|540600957|FG004|JCARH125 Treatment|Death|5|||
150290357|NCT03728309|542197765|FG001|Overall Study|Protocol Deviation|1|||
150290358|NCT03728309|542197764|FG000|Overall Study|Due to COVID|1|||
150290359|NCT03728309|542197765|FG001|Overall Study|Due to COVID|3|||
150290360|NCT00927095|542197768|FG000|Overall Study|Adverse Event|3|||
150290361|NCT00927095|542197769|FG001|Overall Study|Adverse Event|1|||
150290362|NCT00927095|542197770|FG002|Overall Study|Adverse Event|0|||
150290363|NCT00927095|542197768|FG000|Overall Study|Withdrawal by Subject|2|||
150290364|NCT00927095|542197769|FG001|Overall Study|Withdrawal by Subject|1|||
150290365|NCT00927095|542197770|FG002|Overall Study|Withdrawal by Subject|1|||
150290366|NCT00927095|542197768|FG000|Overall Study|Physician Decision|1|||
150290367|NCT00927095|542197769|FG001|Overall Study|Physician Decision|2|||
150290368|NCT00927095|542197770|FG002|Overall Study|Physician Decision|1|||
150290369|NCT00044512|542197777|FG000|Follow Up|Lost to Follow-up|2|||
150290370|NCT00866307|542197778|FG000|Induction|Adverse Event|5|||
150290371|NCT00866307|542197779|FG001|Induction|Adverse Event|0|||
150290372|NCT00866307|542197780|FG002|Induction|Adverse Event|0|||
150290373|NCT00866307|542197778|FG000|Induction|Death|2|||
150290374|NCT00866307|542197779|FG001|Induction|Death|0|||
150290375|NCT00866307|542197780|FG002|Induction|Death|0|||
150290376|NCT00866307|542197778|FG000|Induction|Physician Decision|5|||
150290377|NCT00866307|542197779|FG001|Induction|Physician Decision|0|||
150290378|NCT00866307|542197780|FG002|Induction|Physician Decision|0|||
150290379|NCT00866307|542197778|FG000|Induction|Progressive Disease|1|||
150290380|NCT00866307|542197779|FG001|Induction|Progressive Disease|0|||
150290381|NCT00866307|542197780|FG002|Induction|Progressive Disease|0|||
150290382|NCT00866307|542197778|FG000|Induction|Identification of Patients with Day 29 M|3|||
150290383|NCT00866307|542197779|FG001|Induction|Identification of Patients with Day 29 M|0|||
150290384|NCT00866307|542197780|FG002|Induction|Identification of Patients with Day 29 M|0|||
150290385|NCT00866307|542197778|FG000|Induction|Inadequate cytognetic samples th|1|||
150290386|NCT00866307|542197779|FG001|Induction|Inadequate cytognetic samples th|0|||
150290387|NCT00866307|542197780|FG002|Induction|Inadequate cytognetic samples th|0|||
150290388|NCT00866307|542197778|FG000|Induction|Improper post-induction consent|2|||
149856075|NCT03430011|540600958|FG005|JCARH125 Treatment|Death|3|||
149856076|NCT03430011|540600959|FG006|JCARH125 Treatment|Death|4|||
149856077|NCT03430011|540600960|FG007|JCARH125 Treatment|Death|2|||
149856078|NCT03430011|540600953|FG000|JCARH125 Treatment|Other reasons|1|||
149856079|NCT03430011|540600954|FG001|JCARH125 Treatment|Other reasons|0|||
150290389|NCT00866307|542197779|FG001|Induction|Improper post-induction consent|0|||
150290390|NCT00866307|542197780|FG002|Induction|Improper post-induction consent|0|||
150290391|NCT00866307|542197778|FG000|Induction|Study was closed at the time|1|||
150290392|NCT00866307|542197779|FG001|Induction|Study was closed at the time|0|||
150290393|NCT00866307|542197780|FG002|Induction|Study was closed at the time|0|||
150290394|NCT00866307|542197778|FG000|Consolidation/Maintenance|Adverse Event|0|||
150290395|NCT00866307|542197779|FG001|Consolidation/Maintenance|Adverse Event|0|||
150290396|NCT00866307|542197780|FG002|Consolidation/Maintenance|Adverse Event|8|||
150290397|NCT00866307|542197778|FG000|Consolidation/Maintenance|Death|0|||
150290398|NCT00866307|542197779|FG001|Consolidation/Maintenance|Death|0|||
150290399|NCT00866307|542197780|FG002|Consolidation/Maintenance|Death|1|||
150290400|NCT00866307|542197778|FG000|Consolidation/Maintenance|Physician Decision|0|||
150290401|NCT00866307|542197779|FG001|Consolidation/Maintenance|Physician Decision|3|||
150290402|NCT00866307|542197780|FG002|Consolidation/Maintenance|Physician Decision|2|||
150290403|NCT00866307|542197778|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
150290404|NCT00866307|542197779|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
150290405|NCT00866307|542197780|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
150290406|NCT00866307|542197778|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
150290407|NCT00866307|542197779|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
149856080|NCT03430011|540600955|FG002|JCARH125 Treatment|Other reasons|4|||
149856081|NCT03430011|540600956|FG003|JCARH125 Treatment|Other reasons|2|||
150290408|NCT00866307|542197780|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
150290409|NCT00866307|542197778|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
149856082|NCT03430011|540600957|FG004|JCARH125 Treatment|Other reasons|2|||
149856083|NCT03430011|540600958|FG005|JCARH125 Treatment|Other reasons|1|||
150290410|NCT00866307|542197779|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
150290411|NCT00866307|542197780|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
150290412|NCT00866307|542197778|FG000|Consolidation/Maintenance|Therapy error|0|||
150290413|NCT00866307|542197779|FG001|Consolidation/Maintenance|Therapy error|1|||
150290414|NCT00866307|542197780|FG002|Consolidation/Maintenance|Therapy error|0|||
150290415|NCT00866307|542197778|FG000|Consolidation/Maintenance|Non-compliance|0|||
150290416|NCT00866307|542197779|FG001|Consolidation/Maintenance|Non-compliance|0|||
150290417|NCT00866307|542197780|FG002|Consolidation/Maintenance|Non-compliance|1|||
150290418|NCT00866307|542197778|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
150290419|NCT00866307|542197779|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
150290420|NCT00866307|542197780|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
150290421|NCT02573155|542197781|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
150290422|NCT02573155|542197782|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
150290423|NCT02573155|542197781|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
150290424|NCT02573155|542197782|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
150290425|NCT02573155|542197781|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
150290426|NCT02573155|542197782|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
150290427|NCT02573155|542197781|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
150290428|NCT02573155|542197782|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
150290429|NCT02573155|542197781|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
150290430|NCT02573155|542197782|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
150290431|NCT02573155|542197781|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
150290432|NCT02573155|542197782|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
150290433|NCT02573155|542197781|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
150290434|NCT02573155|542197782|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
150290435|NCT02573155|542197781|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
150290436|NCT02573155|542197782|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
150290437|NCT02508194|542197785|FG000|Overall Study|Death|5|||
150290438|NCT02508194|542197786|FG001|Overall Study|Death|3|||
150290439|NCT02508194|542197785|FG000|Overall Study|Lost to Follow-up|25|||
150290440|NCT02508194|542197786|FG001|Overall Study|Lost to Follow-up|18|||
150290441|NCT02508194|542197785|FG000|Overall Study|Withdrawal by Subject|20|||
150290442|NCT02508194|542197786|FG001|Overall Study|Withdrawal by Subject|18|||
150290443|NCT02508194|542197785|FG000|Overall Study|Error in Randomization|1|||
150290444|NCT02508194|542197786|FG001|Overall Study|Error in Randomization|3|||
150290445|NCT02508194|542197785|FG000|Overall Study|Principal Investigator Decision|1|||
150290446|NCT02508194|542197786|FG001|Overall Study|Principal Investigator Decision|2|||
150290447|NCT00454805|542197788|FG000|Overall Study|Withdrawal by Subject|9|||
149960440|NCT02991859|540988102|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960441|NCT02991859|540988103|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960442|NCT02991859|540988104|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960443|NCT02991859|540988105|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960444|NCT02991859|540988106|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960445|NCT02991859|540988107|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960446|NCT02991859|540988108|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960447|NCT02991859|540988109|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
149960448|NCT02991859|540988110|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
149960449|NCT02991859|540988111|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960450|NCT02991859|540988112|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960451|NCT02991859|540988113|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
149960452|NCT02991859|540988097|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960453|NCT02991859|540988098|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960454|NCT02991859|540988099|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960455|NCT02991859|540988100|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960456|NCT02991859|540988101|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960457|NCT02991859|540988102|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
149960458|NCT02991859|540988103|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960459|NCT02991859|540988104|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960460|NCT02991859|540988105|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960461|NCT02991859|540988106|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960462|NCT02991859|540988107|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960463|NCT02991859|540988108|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960464|NCT02991859|540988109|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
150173281|NCT03253848|541771230|FG000|Overall Study|Declining health|1|||
150173282|NCT01393119|541771231|FG000|Overall Study|Adverse Event|1|||
150290448|NCT00454805|542197789|FG001|Overall Study|Withdrawal by Subject|2|||
150290449|NCT00454805|542197788|FG000|Overall Study|Death|0|||
149856084|NCT03430011|540600959|FG006|JCARH125 Treatment|Other reasons|3|||
149856085|NCT03430011|540600960|FG007|JCARH125 Treatment|Other reasons|2|||
149856086|NCT00330460|540600966|FG000|Overall Study|Physician Decision|1|||
149856087|NCT00330460|540600967|FG001|Overall Study|Physician Decision|0|||
149856088|NCT00330460|540600966|FG000|Overall Study|Adverse Event|10|||
149856089|NCT00330460|540600967|FG001|Overall Study|Adverse Event|8|||
149856090|NCT00330460|540600966|FG000|Overall Study|Withdrawal by Subject|18|||
149856091|NCT00330460|540600967|FG001|Overall Study|Withdrawal by Subject|17|||
149856092|NCT00330460|540600966|FG000|Overall Study|Death|1|||
149856093|NCT00330460|540600967|FG001|Overall Study|Death|1|||
149856094|NCT00330460|540600966|FG000|Overall Study|Ineligibility determined|1|||
149856095|NCT00330460|540600967|FG001|Overall Study|Ineligibility determined|3|||
149856096|NCT00330460|540600966|FG000|Overall Study|Lost to Follow-up|8|||
149856097|NCT00330460|540600967|FG001|Overall Study|Lost to Follow-up|3|||
149856098|NCT00330460|540600966|FG000|Overall Study|Noncompliance|2|||
149856099|NCT00330460|540600967|FG001|Overall Study|Noncompliance|1|||
149856100|NCT00330460|540600966|FG000|Overall Study|Other|1|||
149856101|NCT00330460|540600967|FG001|Overall Study|Other|0|||
149856102|NCT03712124|540600968|FG000|Overall Study|Protocol Violation|1|||
149856103|NCT03712124|540600969|FG001|Overall Study|Protocol Violation|0|||
149856104|NCT00388037|540600973|FG000|Overall Study|Protocol Violation|1|||
149856105|NCT00602537|540600974|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
149856106|NCT00602537|540600975|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
149856107|NCT00602537|540600974|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
149856108|NCT00602537|540600975|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
150290450|NCT00454805|542197789|FG001|Overall Study|Death|2|||
150290451|NCT00454805|542197788|FG000|Overall Study|Disease progression|16|||
150290452|NCT00454805|542197789|FG001|Overall Study|Disease progression|19|||
150290453|NCT00454805|542197788|FG000|Overall Study|In order to begin radiotherapy|1|||
150290454|NCT00454805|542197789|FG001|Overall Study|In order to begin radiotherapy|0|||
150290455|NCT00217087|542197790|FG000|Overall Study|decided to have esophagectomy|1|||
150290456|NCT00217087|542197791|FG001|Overall Study|decided to have esophagectomy|2|||
150290457|NCT00217087|542197790|FG000|Overall Study|completed less than 12 months return|10|||
150290458|NCT00217087|542197791|FG001|Overall Study|completed less than 12 months return|18|||
150290459|NCT05913232|542197794|FG000|Overall Study|Adverse Event|0|||
150290460|NCT05913232|542197795|FG001|Overall Study|Adverse Event|2|||
150290461|NCT05913232|542197796|FG002|Overall Study|Adverse Event|1|||
150290462|NCT05913232|542197797|FG003|Overall Study|Adverse Event|1|||
150290463|NCT01328951|542197798|FG000|Overall Study|Disease Progression|17|||
150290464|NCT01328951|542197799|FG001|Overall Study|Disease Progression|14|||
150290465|NCT01328951|542197798|FG000|Overall Study|Adverse Event|2|||
150290466|NCT01328951|542197799|FG001|Overall Study|Adverse Event|0|||
150290467|NCT01328951|542197798|FG000|Overall Study|Death|243|||
150290468|NCT01328951|542197799|FG001|Overall Study|Death|258|||
150290469|NCT01328951|542197798|FG000|Overall Study|Lost to Follow-up|6|||
150290470|NCT01328951|542197799|FG001|Overall Study|Lost to Follow-up|7|||
150290471|NCT01328951|542197798|FG000|Overall Study|Withdrawal by Subject|6|||
150290472|NCT01328951|542197799|FG001|Overall Study|Withdrawal by Subject|6|||
150290473|NCT01328951|542197798|FG000|Overall Study|Study Closed by the Sponsor|36|||
150290474|NCT01328951|542197799|FG001|Overall Study|Study Closed by the Sponsor|31|||
150290475|NCT01328951|542197798|FG000|Overall Study|Other|11|||
150290476|NCT01328951|542197799|FG001|Overall Study|Other|6|||
150290477|NCT05103332|542197800|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290478|NCT05103332|542197801|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
150290479|NCT05103332|542197802|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
150290480|NCT05103332|542197803|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290481|NCT05103332|542197804|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290482|NCT05103332|542197805|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
150290483|NCT05103332|542197806|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290484|NCT05103332|542197807|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290485|NCT05103332|542197808|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290486|NCT05103332|542197809|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290487|NCT05103332|542197810|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290488|NCT05103332|542197811|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149856109|NCT00602537|540600974|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
149856110|NCT00602537|540600975|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
149856111|NCT00602537|540600974|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
150290489|NCT05103332|542197812|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290490|NCT05103332|542197813|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290491|NCT05103332|542197814|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290492|NCT05103332|542197815|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290493|NCT05103332|542197816|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290494|NCT05103332|542197817|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290495|NCT05103332|542197800|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856112|NCT00602537|540600975|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
149856113|NCT00602537|540600974|FG000|Follow Up Study Comparison|Adverse Event|1|||
149856114|NCT00602537|540600975|FG001|Follow Up Study Comparison|Adverse Event|0|||
149856115|NCT00602537|540600974|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
149856116|NCT00602537|540600975|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
149856117|NCT00602537|540600974|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
149856118|NCT00602537|540600975|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
149856119|NCT02941523|540600976|FG000|Monotherapy|Withdrawal by Subject|0|||
149856120|NCT02941523|540600977|FG001|Monotherapy|Withdrawal by Subject|1|||
149856121|NCT02941523|540600976|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
149856122|NCT02941523|540600977|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
149856123|NCT02941523|540600976|FG000|Carboplatin Combination Therapy|Death|1|||
149856124|NCT02941523|540600977|FG001|Carboplatin Combination Therapy|Death|2|||
149856125|NCT02941523|540600976|FG000|Carboplatin Combination Therapy|Disease progression|2|||
149856126|NCT02941523|540600977|FG001|Carboplatin Combination Therapy|Disease progression|0|||
149856127|NCT02941523|540600976|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
149856128|NCT02941523|540600977|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
149856129|NCT04330157|540600978|FG000|Overall Study|Protocol Violation|4|||
149856130|NCT04330157|540600978|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
149856131|NCT04314843|540600980|FG000|Overall Study|Death|2|||
149856132|NCT04314843|540600981|FG001|Overall Study|Death|2|||
149856133|NCT04314843|540600980|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
149856134|NCT04314843|540600981|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
149856135|NCT01020526|540600982|FG000|Overall Study|Withdrawal by Subject|5|||
149856136|NCT01020526|540600982|FG000|Overall Study|Other reasons|3|||
149856137|NCT01020526|540600982|FG000|Overall Study|Insufficient clinical response|3|||
149856138|NCT01020526|540600982|FG000|Overall Study|Lost to Follow-up|1|||
149856139|NCT01020526|540600982|FG000|Overall Study|Adverse Event|2|||
149856140|NCT01899326|540600983|FG000|Overall Study|Withdrawal by Subject|1|||
149856141|NCT01899326|540600983|FG000|Overall Study|Adverse Event|2|||
149856142|NCT01899326|540600983|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
149856143|NCT03558139|540600984|FG000|Overall Study|Consent Withdrawn|1|||
149856144|NCT03558139|540600985|FG001|Overall Study|Consent Withdrawn|1|||
149856145|NCT03558139|540600986|FG002|Overall Study|Consent Withdrawn|4|||
149856146|NCT03558139|540600984|FG000|Overall Study|Death|5|||
149856147|NCT03558139|540600985|FG001|Overall Study|Death|3|||
149856148|NCT03558139|540600986|FG002|Overall Study|Death|8|||
149856149|NCT03558139|540600984|FG000|Overall Study|Lost to Follow-up|0|||
149856150|NCT03558139|540600985|FG001|Overall Study|Lost to Follow-up|0|||
149856151|NCT03558139|540600986|FG002|Overall Study|Lost to Follow-up|3|||
149856152|NCT03558139|540600984|FG000|Overall Study|Study Ended Per Protocol|0|||
149856153|NCT03558139|540600985|FG001|Overall Study|Study Ended Per Protocol|3|||
149856154|NCT03558139|540600986|FG002|Overall Study|Study Ended Per Protocol|6|||
149856155|NCT00373425|540600987|FG000|Overall Study|Relapse of NSCLC|116|||
149856156|NCT00373425|540600988|FG001|Overall Study|Relapse of NSCLC|104|||
149856157|NCT00373425|540600989|FG002|Overall Study|Relapse of NSCLC|19|||
149856158|NCT00373425|540600990|FG003|Overall Study|Relapse of NSCLC|2|||
149856159|NCT00373425|540600991|FG004|Overall Study|Relapse of NSCLC|26|||
149856160|NCT00373425|540600987|FG000|Overall Study|Adverse Event|191|||
149856161|NCT00373425|540600988|FG001|Overall Study|Adverse Event|22|||
149856162|NCT00373425|540600989|FG002|Overall Study|Adverse Event|59|||
149856163|NCT00373425|540600990|FG003|Overall Study|Adverse Event|0|||
149856164|NCT00373425|540600991|FG004|Overall Study|Adverse Event|34|||
149856165|NCT00373425|540600987|FG000|Overall Study|Patient request|35|||
149856166|NCT00373425|540600988|FG001|Overall Study|Patient request|18|||
149856167|NCT00373425|540600989|FG002|Overall Study|Patient request|43|||
149856168|NCT00373425|540600990|FG003|Overall Study|Patient request|6|||
149856169|NCT00373425|540600991|FG004|Overall Study|Patient request|7|||
149856170|NCT00373425|540600987|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
149856171|NCT00373425|540600988|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
149856172|NCT00373425|540600989|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
149856173|NCT00373425|540600990|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
149856174|NCT00373425|540600991|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
149856175|NCT00373425|540600987|FG000|Overall Study|Death|7|||
149856176|NCT00373425|540600988|FG001|Overall Study|Death|0|||
149856177|NCT00373425|540600989|FG002|Overall Study|Death|3|||
149856178|NCT00373425|540600990|FG003|Overall Study|Death|1|||
149856179|NCT00373425|540600991|FG004|Overall Study|Death|0|||
149856180|NCT02752802|540600992|FG000|Overall Study|Contrast Volume Not Collected|1|||
149856181|NCT02752802|540600993|FG001|Overall Study|Contrast Volume Not Collected|0|||
149960465|NCT02991859|540988110|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960466|NCT02991859|540988111|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960467|NCT02991859|540988112|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960468|NCT02991859|540988113|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
149960469|NCT02991859|540988097|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149856182|NCT02808819|540600994|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
149856183|NCT02808819|540600995|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
149856184|NCT02808819|540600994|FG000|Overall Study|Withdrawal by Subject|10|||
149856185|NCT02808819|540600995|FG001|Overall Study|Withdrawal by Subject|13|||
149856186|NCT02808819|540600994|FG000|Overall Study|Site terminated by sponsor|2|||
149856187|NCT02808819|540600995|FG001|Overall Study|Site terminated by sponsor|0|||
149856188|NCT02808819|540600994|FG000|Overall Study|Pregnancy|1|||
149856189|NCT02808819|540600995|FG001|Overall Study|Pregnancy|0|||
149856190|NCT02808819|540600994|FG000|Overall Study|Lost to Follow-up|1|||
149856191|NCT02808819|540600995|FG001|Overall Study|Lost to Follow-up|6|||
149856192|NCT02808819|540600994|FG000|Overall Study|Protocol Violation|0|||
149856193|NCT02808819|540600995|FG001|Overall Study|Protocol Violation|1|||
149856194|NCT02808819|540600994|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
149856195|NCT02808819|540600995|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
149856196|NCT02808819|540600994|FG000|Overall Study|Death|1|||
149856197|NCT02808819|540600995|FG001|Overall Study|Death|0|||
149856198|NCT02808819|540600994|FG000|Overall Study|Adverse Event|3|||
149856199|NCT02808819|540600995|FG001|Overall Study|Adverse Event|4|||
149856200|NCT00251316|540600996|FG000|Overall Study|Physician Decision|2|||
149856201|NCT00251316|540600997|FG001|Overall Study|Physician Decision|3|||
149856202|NCT00127166|540600998|FG000|Period I|Protocol Violation|0|||
149856203|NCT00127166|540600999|FG001|Period I|Protocol Violation|2|||
149856204|NCT00127166|540600998|FG000|Period I|Withdrawal by Subject|2|||
149856205|NCT00127166|540600999|FG001|Period I|Withdrawal by Subject|0|||
149856206|NCT00127166|540600998|FG000|Period I|Patient did not meet inclusion criteria|1|||
149856207|NCT00127166|540600999|FG001|Period I|Patient did not meet inclusion criteria|0|||
149856208|NCT00127166|540600998|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
150039967|NCT00419952|541287274|FG001|Overall Study|Protocol Violation|24|||
150039968|NCT00419952|541287273|FG000|Overall Study|Pregnancy|4|||
150039969|NCT00419952|541287274|FG001|Overall Study|Pregnancy|2|||
150039970|NCT00419952|541287273|FG000|Overall Study|Physician Decision|1|||
150039971|NCT00419952|541287274|FG001|Overall Study|Physician Decision|3|||
150039972|NCT00419952|541287273|FG000|Overall Study|Incorrectly enrolled|10|||
150039973|NCT00419952|541287274|FG001|Overall Study|Incorrectly enrolled|3|||
150039974|NCT00419952|541287273|FG000|Overall Study|Intake of prohibited medication|2|||
150039975|NCT00419952|541287274|FG001|Overall Study|Intake of prohibited medication|2|||
150039976|NCT00419952|541287273|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
150039977|NCT00419952|541287274|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
150290496|NCT05103332|542197801|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
150290497|NCT05103332|542197802|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856209|NCT00127166|540600999|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
149856210|NCT00127166|540600998|FG000|Period II|Withdrawal by Subject|2|||
149856211|NCT00127166|540600999|FG001|Period II|Withdrawal by Subject|0|||
149856212|NCT00127166|540600998|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
149856213|NCT00127166|540600999|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
149856214|NCT00105157|540601000|FG000|Double-Blind (DB)|Never Treated|1|||
149856215|NCT00105157|540601001|FG001|Double-Blind (DB)|Never Treated|0|||
149856216|NCT00105157|540601002|FG002|Double-Blind (DB)|Never Treated|0|||
149856217|NCT00105157|540601003|FG003|Double-Blind (DB)|Never Treated|0|||
149856218|NCT00105157|540601000|FG000|Double-Blind (DB)|Adverse Event|2|||
149856219|NCT00105157|540601001|FG001|Double-Blind (DB)|Adverse Event|0|||
149856220|NCT00105157|540601002|FG002|Double-Blind (DB)|Adverse Event|1|||
149856221|NCT00105157|540601003|FG003|Double-Blind (DB)|Adverse Event|1|||
149856222|NCT00105157|540601000|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
149856223|NCT00105157|540601001|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
149856224|NCT00105157|540601002|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
149856225|NCT00105157|540601003|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
149856226|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Adverse Event|3|||
149856227|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Adverse Event|1|||
149856228|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Adverse Event|0|||
149856229|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Adverse Event|0|||
149856230|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
149856231|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
149856232|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
149856233|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
149856234|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
149856235|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
149856236|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
149856237|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
149856238|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
150039978|NCT00419952|541287273|FG000|Overall Study|Diary or medication non-compliance|2|||
149856239|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
150039979|NCT00419952|541287274|FG001|Overall Study|Diary or medication non-compliance|4|||
150039980|NCT00419952|541287273|FG000|Overall Study|Abnormal ECG|1|||
150290498|NCT05103332|542197803|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
149856240|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
149856241|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
149856242|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
149856243|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
149856244|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
149856245|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
149856246|NCT00105157|540601000|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
149856247|NCT00105157|540601001|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
149856248|NCT00105157|540601002|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
149856249|NCT00105157|540601003|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
149856250|NCT00105157|540601000|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
149856251|NCT00105157|540601001|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
149856252|NCT00105157|540601002|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
149856253|NCT00105157|540601003|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
149856254|NCT00105157|540601000|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
149856255|NCT00105157|540601001|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
149856256|NCT00105157|540601002|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
149856257|NCT00105157|540601003|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
149856258|NCT00105157|540601000|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
149856259|NCT00105157|540601001|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
149856260|NCT00105157|540601002|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
149856261|NCT00105157|540601003|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
149856262|NCT00105157|540601000|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
149856263|NCT00105157|540601001|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
149856264|NCT00105157|540601002|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
149856265|NCT00105157|540601003|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
149856266|NCT00105157|540601000|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
149856267|NCT00105157|540601001|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
149856268|NCT00105157|540601002|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
149856269|NCT00105157|540601003|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
149856270|NCT01396421|540601006|FG000|Overall Study|Lost to Follow-up|0|||
149856271|NCT01396421|540601007|FG001|Overall Study|Lost to Follow-up|0|||
149856272|NCT01396421|540601008|FG002|Overall Study|Lost to Follow-up|0|||
149856273|NCT01396421|540601009|FG003|Overall Study|Lost to Follow-up|1|||
149856274|NCT01396421|540601006|FG000|Overall Study|Adverse Event|17|||
149856275|NCT01396421|540601007|FG001|Overall Study|Adverse Event|15|||
149856276|NCT01396421|540601008|FG002|Overall Study|Adverse Event|12|||
149856277|NCT01396421|540601009|FG003|Overall Study|Adverse Event|32|||
149856278|NCT01396421|540601006|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
149856279|NCT01396421|540601007|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
149856280|NCT01396421|540601008|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
149856281|NCT01396421|540601009|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
149856282|NCT01396421|540601006|FG000|Overall Study|Physician Decision|1|||
150039981|NCT00419952|541287274|FG001|Overall Study|Abnormal ECG|0|||
150039982|NCT03126591|541287275|FG000|Overall Study|Death|6|||
150039983|NCT03126591|541287276|FG001|Overall Study|Death|3|||
150039984|NCT03126591|541287277|FG002|Overall Study|Death|17|||
150039985|NCT03126591|541287275|FG000|Overall Study|Progressive Disease|0|||
150039986|NCT03126591|541287276|FG001|Overall Study|Progressive Disease|1|||
150039987|NCT03126591|541287277|FG002|Overall Study|Progressive Disease|2|||
150039988|NCT03126591|541287275|FG000|Overall Study|Terminated by Sponsor|0|||
150039989|NCT03126591|541287276|FG001|Overall Study|Terminated by Sponsor|1|||
150039990|NCT03126591|541287277|FG002|Overall Study|Terminated by Sponsor|4|||
150039991|NCT03126591|541287275|FG000|Overall Study|Withdrawal by Subject|1|||
150039992|NCT03126591|541287276|FG001|Overall Study|Withdrawal by Subject|1|||
150290499|NCT05103332|542197804|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290500|NCT05103332|542197805|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290501|NCT05103332|542197806|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290502|NCT05103332|542197807|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290503|NCT05103332|542197808|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290504|NCT05103332|542197809|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856283|NCT01396421|540601007|FG001|Overall Study|Physician Decision|1|||
149856284|NCT01396421|540601008|FG002|Overall Study|Physician Decision|0|||
150039993|NCT03126591|541287277|FG002|Overall Study|Withdrawal by Subject|4|||
150039994|NCT02085460|541287278|FG000|Overall Study|Adverse Event|2|||
150039995|NCT02085460|541287279|FG001|Overall Study|Adverse Event|2|||
150039996|NCT02085460|541287280|FG002|Overall Study|Adverse Event|1|||
150290505|NCT05103332|542197810|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290506|NCT05103332|542197811|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856285|NCT01396421|540601009|FG003|Overall Study|Physician Decision|3|||
149856286|NCT01396421|540601006|FG000|Overall Study|Withdrawal by Subject|31|||
149856287|NCT01396421|540601007|FG001|Overall Study|Withdrawal by Subject|24|||
149856288|NCT01396421|540601008|FG002|Overall Study|Withdrawal by Subject|13|||
149856289|NCT01396421|540601009|FG003|Overall Study|Withdrawal by Subject|21|||
149856290|NCT01396421|540601006|FG000|Overall Study|Protocol Deviation|2|||
149856291|NCT01396421|540601007|FG001|Overall Study|Protocol Deviation|1|||
149856292|NCT01396421|540601008|FG002|Overall Study|Protocol Deviation|1|||
149856293|NCT01396421|540601009|FG003|Overall Study|Protocol Deviation|0|||
149856294|NCT01396421|540601006|FG000|Overall Study|Lack of Efficacy|7|||
149856295|NCT01396421|540601007|FG001|Overall Study|Lack of Efficacy|17|||
149856296|NCT01396421|540601008|FG002|Overall Study|Lack of Efficacy|7|||
149856297|NCT01396421|540601009|FG003|Overall Study|Lack of Efficacy|18|||
149856298|NCT01378962|540601010|FG000|Overall Study|Death|14|||
149856299|NCT01378962|540601010|FG000|Overall Study|Lost to Follow-up|1|||
149856300|NCT01378962|540601010|FG000|Overall Study|Other|2|||
149856301|NCT01835548|540601017|FG000|Dose Optimization Period|Adverse Event|0|||
149856302|NCT01835548|540601018|FG001|Dose Optimization Period|Adverse Event|0|||
149856303|NCT01835548|540601019|FG002|Dose Optimization Period|Adverse Event|1|||
149856304|NCT01835548|540601017|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
149856305|NCT01835548|540601018|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
149856306|NCT01835548|540601019|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
149856307|NCT01835548|540601017|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149856308|NCT01835548|540601018|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149856309|NCT01835548|540601019|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149856310|NCT01835548|540601017|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149856311|NCT01835548|540601018|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149856312|NCT01835548|540601019|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149856313|NCT02490800|540601020|FG000|Overall Study|Adverse Event|0|||
149856314|NCT02490800|540601021|FG001|Overall Study|Adverse Event|0|||
149856315|NCT02490800|540601022|FG002|Overall Study|Adverse Event|0|||
149856316|NCT02490800|540601023|FG003|Overall Study|Adverse Event|2|||
149856317|NCT02490800|540601024|FG004|Overall Study|Adverse Event|3|||
149856318|NCT02490800|540601025|FG005|Overall Study|Adverse Event|2|||
149856319|NCT02490800|540601026|FG006|Overall Study|Adverse Event|0|||
149856320|NCT02490800|540601027|FG007|Overall Study|Adverse Event|0|||
149856321|NCT02490800|540601028|FG008|Overall Study|Adverse Event|0|||
149856322|NCT02490800|540601029|FG009|Overall Study|Adverse Event|0|||
149856323|NCT02490800|540601030|FG010|Overall Study|Adverse Event|0|||
149856324|NCT02490800|540601031|FG011|Overall Study|Adverse Event|2|||
149856325|NCT02490800|540601032|FG012|Overall Study|Adverse Event|2|||
149856326|NCT02490800|540601020|FG000|Overall Study|Withdrawal by Subject|0|||
149856327|NCT02490800|540601021|FG001|Overall Study|Withdrawal by Subject|0|||
149856328|NCT02490800|540601022|FG002|Overall Study|Withdrawal by Subject|0|||
149856329|NCT02490800|540601023|FG003|Overall Study|Withdrawal by Subject|1|||
149856330|NCT02490800|540601024|FG004|Overall Study|Withdrawal by Subject|0|||
149856331|NCT02490800|540601025|FG005|Overall Study|Withdrawal by Subject|0|||
149856332|NCT02490800|540601026|FG006|Overall Study|Withdrawal by Subject|0|||
149856333|NCT02490800|540601027|FG007|Overall Study|Withdrawal by Subject|0|||
149856334|NCT02490800|540601028|FG008|Overall Study|Withdrawal by Subject|1|||
149856335|NCT02490800|540601029|FG009|Overall Study|Withdrawal by Subject|0|||
149856336|NCT02490800|540601030|FG010|Overall Study|Withdrawal by Subject|0|||
149856337|NCT02490800|540601031|FG011|Overall Study|Withdrawal by Subject|0|||
150039997|NCT02085460|541287278|FG000|Overall Study|Physician Decision|1|||
150290507|NCT05103332|542197812|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290508|NCT05103332|542197813|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290509|NCT05103332|542197814|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290510|NCT05103332|542197815|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856338|NCT02490800|540601032|FG012|Overall Study|Withdrawal by Subject|0|||
149856339|NCT02490800|540601020|FG000|Overall Study|Progressive disease|3|||
149856340|NCT02490800|540601021|FG001|Overall Study|Progressive disease|3|||
149856341|NCT02490800|540601022|FG002|Overall Study|Progressive disease|3|||
149856342|NCT02490800|540601023|FG003|Overall Study|Progressive disease|4|||
149856343|NCT02490800|540601024|FG004|Overall Study|Progressive disease|4|||
149856344|NCT02490800|540601025|FG005|Overall Study|Progressive disease|1|||
149856345|NCT02490800|540601026|FG006|Overall Study|Progressive disease|4|||
149856346|NCT02490800|540601027|FG007|Overall Study|Progressive disease|3|||
149856347|NCT02490800|540601028|FG008|Overall Study|Progressive disease|6|||
149856348|NCT02490800|540601029|FG009|Overall Study|Progressive disease|2|||
150290511|NCT05103332|542197816|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
149856349|NCT02490800|540601030|FG010|Overall Study|Progressive disease|7|||
149856350|NCT02490800|540601031|FG011|Overall Study|Progressive disease|1|||
149856351|NCT02490800|540601032|FG012|Overall Study|Progressive disease|10|||
149856352|NCT02490800|540601020|FG000|Overall Study|Patient enrolled in post-trial access|0|||
149856353|NCT02490800|540601021|FG001|Overall Study|Patient enrolled in post-trial access|0|||
149856354|NCT02490800|540601022|FG002|Overall Study|Patient enrolled in post-trial access|0|||
149856355|NCT02490800|540601023|FG003|Overall Study|Patient enrolled in post-trial access|0|||
149856356|NCT02490800|540601024|FG004|Overall Study|Patient enrolled in post-trial access|0|||
149856357|NCT02490800|540601025|FG005|Overall Study|Patient enrolled in post-trial access|0|||
149856358|NCT02490800|540601026|FG006|Overall Study|Patient enrolled in post-trial access|0|||
149856359|NCT02490800|540601027|FG007|Overall Study|Patient enrolled in post-trial access|0|||
149856360|NCT02490800|540601028|FG008|Overall Study|Patient enrolled in post-trial access|0|||
149856361|NCT02490800|540601029|FG009|Overall Study|Patient enrolled in post-trial access|1|||
149856362|NCT02490800|540601030|FG010|Overall Study|Patient enrolled in post-trial access|1|||
149856363|NCT02490800|540601031|FG011|Overall Study|Patient enrolled in post-trial access|0|||
149856364|NCT02490800|540601032|FG012|Overall Study|Patient enrolled in post-trial access|6|||
149856365|NCT01634854|540601033|FG000|Overall Study|Cesarean delivery|2|||
149856366|NCT01634854|540601034|FG001|Overall Study|Cesarean delivery|7|||
149856367|NCT00987831|540601035|FG000|Overall Study|Never flared in 12 months|1|||
149856368|NCT00987831|540601036|FG001|Overall Study|Never flared in 12 months|0|||
149856369|NCT00987831|540601037|FG002|Overall Study|Never flared in 12 months|0|||
149856370|NCT00987831|540601035|FG000|Overall Study|Lost to Follow-up|0|||
149856371|NCT00987831|540601036|FG001|Overall Study|Lost to Follow-up|3|||
149856372|NCT00987831|540601037|FG002|Overall Study|Lost to Follow-up|0|||
149856373|NCT02219308|540601038|FG000|Overall Study|Withdrawal by Subject|1|||
149856374|NCT02219308|540601039|FG001|Overall Study|Withdrawal by Subject|2|||
149856375|NCT02175368|540601040|FG000|Overall Study|Lost to Follow-up|1|||
149856376|NCT02875028|540601041|FG000|Washout Period|Withdrawal by Subject|0|||
149856377|NCT02875028|540601042|FG001|Washout Period|Withdrawal by Subject|1|||
149856378|NCT05068284|540601043|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
149856379|NCT05068284|540601044|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
149856380|NCT05068284|540601045|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856381|NCT05068284|540601046|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856382|NCT05068284|540601047|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856383|NCT05068284|540601048|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856384|NCT05068284|540601049|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856385|NCT05068284|540601050|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
149856386|NCT05068284|540601043|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856387|NCT05068284|540601044|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856388|NCT05068284|540601045|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
149856389|NCT05068284|540601046|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856390|NCT05068284|540601047|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856391|NCT05068284|540601048|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856392|NCT05068284|540601049|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856393|NCT05068284|540601050|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
149856394|NCT05068284|540601043|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
149856395|NCT05068284|540601044|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
149856396|NCT05068284|540601045|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
149856397|NCT05068284|540601046|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
149856398|NCT05068284|540601047|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
149856399|NCT05068284|540601048|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
149856400|NCT05068284|540601049|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
149856401|NCT05068284|540601050|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
149856402|NCT05068284|540601043|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149856403|NCT05068284|540601044|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149856404|NCT05068284|540601045|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
149856405|NCT05068284|540601046|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149856406|NCT05068284|540601047|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
149856407|NCT05068284|540601048|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149856408|NCT05068284|540601049|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149856409|NCT05068284|540601050|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
149960470|NCT02991859|540988098|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960471|NCT02991859|540988099|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960472|NCT02991859|540988100|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960473|NCT02991859|540988101|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960474|NCT02991859|540988102|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960475|NCT02991859|540988103|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960476|NCT02991859|540988104|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960477|NCT02991859|540988105|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960478|NCT02991859|540988106|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
149856410|NCT05068284|540601043|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856411|NCT05068284|540601044|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149960479|NCT02991859|540988107|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960480|NCT02991859|540988108|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960481|NCT02991859|540988109|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149856412|NCT05068284|540601045|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856413|NCT05068284|540601046|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
149856414|NCT05068284|540601047|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856415|NCT05068284|540601048|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856416|NCT05068284|540601049|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856417|NCT05068284|540601050|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
149856418|NCT05068284|540601043|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856419|NCT05068284|540601044|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856420|NCT05068284|540601045|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
149856421|NCT05068284|540601046|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
149856422|NCT05068284|540601047|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856423|NCT05068284|540601048|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856424|NCT05068284|540601049|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856425|NCT05068284|540601050|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
149856426|NCT05068284|540601043|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856427|NCT05068284|540601044|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856428|NCT05068284|540601045|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
149856429|NCT05068284|540601046|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856430|NCT05068284|540601047|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856431|NCT05068284|540601048|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856432|NCT05068284|540601049|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856433|NCT05068284|540601050|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
149856434|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
149856435|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856436|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856437|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856438|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856439|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856440|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856441|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
149856442|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
149856443|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
149856444|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
149856445|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
149856446|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
149856447|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
149960482|NCT02991859|540988110|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960483|NCT02991859|540988111|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960484|NCT02991859|540988112|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
150290512|NCT05103332|542197817|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
150290513|NCT05103332|542197800|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
149960485|NCT02991859|540988113|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
149960486|NCT02991859|540988097|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960487|NCT02991859|540988098|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960488|NCT02991859|540988099|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960489|NCT02991859|540988100|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960490|NCT02991859|540988101|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960491|NCT02991859|540988102|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960492|NCT02991859|540988103|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960493|NCT02991859|540988104|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960494|NCT02991859|540988105|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
149960495|NCT02991859|540988106|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960496|NCT02991859|540988107|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960497|NCT02991859|540988108|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960498|NCT02991859|540988109|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960499|NCT02991859|540988110|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960500|NCT02991859|540988111|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960501|NCT02991859|540988112|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960502|NCT02991859|540988113|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
149960503|NCT01016015|540988117|FG000|Overall Study|Not Treated|3|||
149960504|NCT01016015|540988117|FG000|Overall Study|Withdrawal by Subject|1|||
150039998|NCT02085460|541287279|FG001|Overall Study|Physician Decision|1|||
150039999|NCT02085460|541287280|FG002|Overall Study|Physician Decision|2|||
149856448|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
149856449|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
149856450|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
149856451|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856452|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856453|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856454|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856455|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856456|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
149856457|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
149856458|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
149856459|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856460|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856461|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856462|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856463|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856464|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856465|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
149856466|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
149856467|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856468|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856469|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856470|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856471|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856472|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856473|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
149856474|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
149856475|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
149856476|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
149856477|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
149856478|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
149856479|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
149856480|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
149856481|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
149856482|NCT05068284|540601043|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856483|NCT05068284|540601044|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856484|NCT05068284|540601045|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856485|NCT05068284|540601046|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856486|NCT05068284|540601047|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856487|NCT05068284|540601048|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856488|NCT05068284|540601049|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
149856489|NCT05068284|540601050|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
149856490|NCT03180528|540603048|FG000|Overall Study|Adverse Event|1|||
149856491|NCT03180528|540603048|FG000|Overall Study|Withdrawal by Subject|1|||
149856492|NCT03180528|540603048|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
149856493|NCT02447887|540603049|FG000|Overall Study|Study was terminated|3|||
149856494|NCT00109837|540603050|FG000|Overall Study|Adverse Event|2|||
149856495|NCT00109837|540603050|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
149856496|NCT00109837|540603050|FG000|Overall Study|Death|1|||
149856497|NCT00109837|540603050|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
149856498|NCT00109837|540603050|FG000|Overall Study|Not treated|1|||
149856499|NCT00109837|540603050|FG000|Overall Study|Ineligible|1|||
149856500|NCT03941834|540603051|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
149856501|NCT03941834|540603052|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
150173283|NCT01393119|541771232|FG001|Overall Study|Adverse Event|1|||
150173284|NCT01393119|541771233|FG002|Overall Study|Adverse Event|0|||
149856502|NCT03941834|540603053|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
149856503|NCT03941834|540603051|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
150173285|NCT01393119|541771234|FG003|Overall Study|Adverse Event|1|||
149856504|NCT03941834|540603052|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
149856505|NCT03941834|540603053|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
149856506|NCT03941834|540603051|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
149856507|NCT03941834|540603052|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
149856508|NCT03941834|540603053|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
149856509|NCT03941834|540603051|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
149856510|NCT03941834|540603052|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
149856511|NCT03941834|540603053|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
149856512|NCT03941834|540603051|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
149856513|NCT03941834|540603052|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
149856514|NCT03941834|540603053|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
149856515|NCT03941834|540603051|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
149856516|NCT03941834|540603052|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
149856517|NCT03941834|540603053|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
149856518|NCT02688387|540603056|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856519|NCT02688387|540603057|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856520|NCT02688387|540603058|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
149856521|NCT02688387|540603059|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856522|NCT02688387|540603060|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856523|NCT02688387|540603061|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856524|NCT02688387|540603062|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856525|NCT02688387|540603063|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856526|NCT02688387|540603064|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856527|NCT02688387|540603065|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856528|NCT02688387|540603066|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856529|NCT02688387|540603067|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856530|NCT02688387|540603068|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856531|NCT02688387|540603069|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856532|NCT02688387|540603070|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856533|NCT02688387|540603071|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856534|NCT02688387|540603072|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856535|NCT02688387|540603073|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856536|NCT02688387|540603074|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856537|NCT02688387|540603075|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856538|NCT02688387|540603076|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856539|NCT02688387|540603077|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
149856540|NCT02688387|540603056|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856541|NCT02688387|540603057|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856542|NCT02688387|540603058|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856543|NCT02688387|540603059|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
149856544|NCT02688387|540603060|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856545|NCT02688387|540603061|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856546|NCT02688387|540603062|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856547|NCT02688387|540603063|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
150290514|NCT05103332|542197801|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
150290515|NCT05103332|542197802|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
149856548|NCT02688387|540603064|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149960505|NCT01016015|540988117|FG000|Overall Study|Adverse Event|15|||
149960506|NCT04648241|540988118|FG000|Overall Study|Lost to Follow-up|1|||
150290516|NCT05103332|542197803|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
150290517|NCT05103332|542197804|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
149960507|NCT04648241|540988119|FG001|Overall Study|Lost to Follow-up|0|||
149960508|NCT02057666|540988120|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
149960509|NCT02057666|540988121|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
149960510|NCT02057666|540988120|FG000|Double Blind Treatment Period|Poor tolerability|7|||
149960511|NCT02057666|540988121|FG001|Double Blind Treatment Period|Poor tolerability|2|||
149960512|NCT02057666|540988120|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
149960513|NCT02057666|540988121|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
149960514|NCT02057666|540988120|FG000|Double Blind Treatment Period|Physician Decision|1|||
149960515|NCT02057666|540988121|FG001|Double Blind Treatment Period|Physician Decision|0|||
149960516|NCT02057666|540988120|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
149960517|NCT02057666|540988121|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
149960518|NCT02057666|540988120|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
149856549|NCT02688387|540603065|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856550|NCT02688387|540603066|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856551|NCT02688387|540603067|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856552|NCT02688387|540603068|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856553|NCT02688387|540603069|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856554|NCT02688387|540603070|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856555|NCT02688387|540603071|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856556|NCT02688387|540603072|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856557|NCT02688387|540603073|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856558|NCT02688387|540603074|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856559|NCT02688387|540603075|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856560|NCT02688387|540603076|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856561|NCT02688387|540603077|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856562|NCT02688387|540603056|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856563|NCT02688387|540603057|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
149856564|NCT02688387|540603058|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856565|NCT02688387|540603059|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856566|NCT02688387|540603060|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856567|NCT02688387|540603061|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856568|NCT02688387|540603062|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856569|NCT02688387|540603063|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856570|NCT02688387|540603064|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856571|NCT02688387|540603065|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856572|NCT02688387|540603066|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856573|NCT02688387|540603067|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856574|NCT02688387|540603068|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856575|NCT02688387|540603069|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856576|NCT02688387|540603070|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856577|NCT02688387|540603071|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856578|NCT02688387|540603072|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856579|NCT02688387|540603073|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856580|NCT02688387|540603074|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856581|NCT02688387|540603075|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856582|NCT02688387|540603076|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856583|NCT02688387|540603077|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
149856584|NCT02688387|540603056|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856585|NCT02688387|540603057|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856586|NCT02688387|540603058|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
149856587|NCT02688387|540603059|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856588|NCT02688387|540603060|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
149856589|NCT02688387|540603061|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856590|NCT02688387|540603062|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856591|NCT02688387|540603063|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856592|NCT02688387|540603064|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856593|NCT02688387|540603065|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856594|NCT02688387|540603066|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856595|NCT02688387|540603067|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856596|NCT02688387|540603068|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856597|NCT02688387|540603069|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856598|NCT02688387|540603070|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856599|NCT02688387|540603071|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856600|NCT02688387|540603072|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856601|NCT02688387|540603073|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856602|NCT02688387|540603074|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856603|NCT02688387|540603075|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856604|NCT02688387|540603076|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856605|NCT02688387|540603077|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
149856606|NCT02688387|540603056|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
149856607|NCT02688387|540603057|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856608|NCT02688387|540603058|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
150290518|NCT05103332|542197805|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
150290519|NCT05103332|542197806|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290520|NCT05103332|542197807|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290521|NCT05103332|542197808|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149856609|NCT02688387|540603059|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856610|NCT02688387|540603060|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856611|NCT02688387|540603061|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856612|NCT02688387|540603062|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856613|NCT02688387|540603063|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856614|NCT02688387|540603064|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856615|NCT02688387|540603065|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856616|NCT02688387|540603066|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856617|NCT02688387|540603067|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856618|NCT02688387|540603068|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856619|NCT02688387|540603069|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856620|NCT02688387|540603070|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856621|NCT02688387|540603071|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856622|NCT02688387|540603072|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856623|NCT02688387|540603073|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856624|NCT02688387|540603074|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856625|NCT02688387|540603075|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856626|NCT02688387|540603076|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856627|NCT02688387|540603077|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
149856628|NCT02688387|540603056|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856629|NCT02688387|540603057|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856630|NCT02688387|540603058|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856631|NCT02688387|540603059|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856632|NCT02688387|540603060|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856633|NCT02688387|540603061|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856634|NCT02688387|540603062|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856635|NCT02688387|540603063|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856636|NCT02688387|540603064|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856637|NCT02688387|540603065|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856638|NCT02688387|540603066|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
149856639|NCT02688387|540603067|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856640|NCT02688387|540603068|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856641|NCT02688387|540603069|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856642|NCT02688387|540603070|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856643|NCT02688387|540603071|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856644|NCT02688387|540603072|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856645|NCT02688387|540603073|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856646|NCT02688387|540603074|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856647|NCT02688387|540603075|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856648|NCT02688387|540603076|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856649|NCT02688387|540603077|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
149856650|NCT02688387|540603056|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856651|NCT02688387|540603057|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856652|NCT02688387|540603058|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856653|NCT02688387|540603059|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856654|NCT02688387|540603060|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856655|NCT02688387|540603061|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856656|NCT02688387|540603062|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856657|NCT02688387|540603063|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856658|NCT02688387|540603064|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856659|NCT02688387|540603065|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856660|NCT02688387|540603066|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856661|NCT02688387|540603067|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856662|NCT02688387|540603068|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856663|NCT02688387|540603069|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856664|NCT02688387|540603070|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
149856665|NCT02688387|540603071|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856666|NCT02688387|540603072|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856667|NCT02688387|540603073|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856668|NCT02688387|540603074|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149960519|NCT02057666|540988121|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
149960520|NCT02057666|540988120|FG000|Double Blind Treatment Period|Sponsor's request|70|||
149960521|NCT02057666|540988121|FG001|Double Blind Treatment Period|Sponsor's request|34|||
149960522|NCT02057666|540988120|FG000|Open-Label Treatment Period|Poor tolerability|0|||
149960523|NCT02057666|540988121|FG001|Open-Label Treatment Period|Poor tolerability|1|||
149960524|NCT02057666|540988120|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
149960525|NCT02057666|540988121|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
150290522|NCT05103332|542197809|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290523|NCT05103332|542197810|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290524|NCT05103332|542197811|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290525|NCT05103332|542197812|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290526|NCT05103332|542197813|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290527|NCT05103332|542197814|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290528|NCT05103332|542197815|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290529|NCT05103332|542197816|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290530|NCT05103332|542197817|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290531|NCT05103332|542197800|FG000|DB Period (6 Months=168 Days)|Other|0|||
150290532|NCT05103332|542197801|FG001|DB Period (6 Months=168 Days)|Other|0|||
150290533|NCT05103332|542197802|FG002|DB Period (6 Months=168 Days)|Other|0|||
150290534|NCT05103332|542197803|FG003|DB Period (6 Months=168 Days)|Other|1|||
150290535|NCT05103332|542197804|FG004|DB Period (6 Months=168 Days)|Other|0|||
150290536|NCT05103332|542197805|FG005|DB Period (6 Months=168 Days)|Other|0|||
149856669|NCT02688387|540603075|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856670|NCT02688387|540603076|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856671|NCT02688387|540603077|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
149856672|NCT02688387|540603056|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856673|NCT02688387|540603057|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856674|NCT02688387|540603058|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856675|NCT02688387|540603059|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856676|NCT02688387|540603060|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856677|NCT02688387|540603061|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856678|NCT02688387|540603062|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149960526|NCT02057666|540988120|FG000|Open-Label Treatment Period|Sponsor's request|0|||
149960527|NCT02057666|540988121|FG001|Open-Label Treatment Period|Sponsor's request|4|||
149960528|NCT05661734|540988122|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
149960529|NCT05661734|540988122|FG000|Overall Study|Lost to Follow-up|13|||
149960530|NCT05661734|540988122|FG000|Overall Study|Enrolled but not dosed|2|||
149960531|NCT02489045|540988123|FG000|Overall Study|unable to collect usable data|53|||
149960532|NCT02489045|540988123|FG000|Follow-up|Lost to Follow-up|10|||
149960533|NCT00930176|540988128|FG000|Overall Study|Death|1|||
149960534|NCT01108055|540988129|FG000|Overall Study|Ineligible|11|||
149960535|NCT01108055|540988129|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
149960536|NCT03339453|540988130|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
149960537|NCT03339453|540988131|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
149960538|NCT00362609|540988132|FG000|Overall Study|Withdrawal by Subject|0|||
149960539|NCT00362609|540988133|FG001|Overall Study|Withdrawal by Subject|1|||
149960540|NCT00362609|540988132|FG000|Overall Study|Protocol Violation|0|||
149960541|NCT00362609|540988133|FG001|Overall Study|Protocol Violation|1|||
149960542|NCT01569763|540990006|FG000|Overall Study|Lack of Efficacy|2|||
149960543|NCT01569763|540990007|FG001|Overall Study|Lack of Efficacy|7|||
149960544|NCT01569763|540990006|FG000|Overall Study|Adverse Event|1|||
149960545|NCT01569763|540990007|FG001|Overall Study|Adverse Event|0|||
149960546|NCT01926509|540990008|FG000|Overall Study|vital sign met discontinuation criteria|1|||
149960547|NCT01926509|540990009|FG001|Overall Study|vital sign met discontinuation criteria|0|||
149960548|NCT01926509|540990010|FG002|Overall Study|vital sign met discontinuation criteria|0|||
149960549|NCT01926509|540990011|FG003|Overall Study|vital sign met discontinuation criteria|0|||
149960550|NCT02529488|540990012|FG000|Overall Study|Adverse Event|1|||
149960551|NCT02529488|540990012|FG000|Overall Study|Death|3|||
149960552|NCT02821000|540990017|FG000|Overall Study|Death|89|||
149960553|NCT02821000|540990017|FG000|Overall Study|Sponsor Decision|12|||
149960554|NCT02821000|540990017|FG000|Overall Study|Withdrawal by Subject|2|||
149960555|NCT01862029|540990018|FG000|Overall Study|Physician Decision|1|||
149960556|NCT03931785|540990020|FG000|Overall Study|Lost to Follow-up|4|||
149960557|NCT03931785|540990021|FG001|Overall Study|Lost to Follow-up|1|||
149960558|NCT03931785|540990022|FG002|Overall Study|Lost to Follow-up|4|||
149960559|NCT03931785|540990023|FG003|Overall Study|Lost to Follow-up|3|||
149960560|NCT03931785|540990020|FG000|Overall Study|Adverse Event|1|||
149960561|NCT03931785|540990021|FG001|Overall Study|Adverse Event|0|||
149960562|NCT03931785|540990022|FG002|Overall Study|Adverse Event|3|||
150290537|NCT05103332|542197806|FG006|DB Period (6 Months=168 Days)|Other|0|||
149960563|NCT03931785|540990023|FG003|Overall Study|Adverse Event|4|||
149960564|NCT03931785|540990020|FG000|Overall Study|Protocol Violation|0|||
149960565|NCT03931785|540990021|FG001|Overall Study|Protocol Violation|1|||
149960566|NCT03931785|540990022|FG002|Overall Study|Protocol Violation|0|||
149960567|NCT03931785|540990023|FG003|Overall Study|Protocol Violation|0|||
149960568|NCT03931785|540990020|FG000|Overall Study|Noncompliance With Study drug|0|||
149960569|NCT03931785|540990021|FG001|Overall Study|Noncompliance With Study drug|1|||
149856679|NCT02688387|540603063|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856680|NCT02688387|540603064|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856681|NCT02688387|540603065|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856682|NCT02688387|540603066|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856683|NCT02688387|540603067|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856684|NCT02688387|540603068|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856685|NCT02688387|540603069|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856686|NCT02688387|540603070|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856687|NCT02688387|540603071|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856688|NCT02688387|540603072|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856689|NCT02688387|540603073|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856690|NCT02688387|540603074|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856691|NCT02688387|540603075|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856692|NCT02688387|540603076|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
149856693|NCT02688387|540603077|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
149856694|NCT02688387|540603056|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856695|NCT02688387|540603057|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856696|NCT02688387|540603058|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856697|NCT02688387|540603059|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856698|NCT02688387|540603060|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856699|NCT02688387|540603061|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856700|NCT02688387|540603062|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856701|NCT02688387|540603063|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856702|NCT02688387|540603064|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856703|NCT02688387|540603065|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856704|NCT02688387|540603066|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856705|NCT02688387|540603067|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856706|NCT02688387|540603068|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856707|NCT02688387|540603069|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856708|NCT02688387|540603070|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856709|NCT02688387|540603071|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856710|NCT02688387|540603072|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856711|NCT02688387|540603073|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856712|NCT02688387|540603074|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
149856713|NCT02688387|540603075|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856714|NCT02688387|540603076|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
149856715|NCT02688387|540603077|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
149856716|NCT02688387|540603056|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856717|NCT02688387|540603057|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856718|NCT02688387|540603058|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856719|NCT02688387|540603059|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856720|NCT02688387|540603060|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856721|NCT02688387|540603061|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856722|NCT02688387|540603062|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856723|NCT02688387|540603063|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856724|NCT02688387|540603064|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856725|NCT02688387|540603065|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856726|NCT02688387|540603066|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856727|NCT02688387|540603067|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856728|NCT02688387|540603068|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856729|NCT02688387|540603069|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856730|NCT02688387|540603070|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856731|NCT02688387|540603071|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856732|NCT02688387|540603072|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856733|NCT02688387|540603073|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856734|NCT02688387|540603074|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856735|NCT02688387|540603075|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
149856736|NCT02688387|540603076|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856737|NCT02688387|540603077|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
149856738|NCT04100096|540603078|FG000|Overall Study|Adverse Event|19|||
149856739|NCT04100096|540603079|FG001|Overall Study|Adverse Event|7|||
149856740|NCT04100096|540603078|FG000|Overall Study|Lack of Efficacy|0|||
149856741|NCT04100096|540603079|FG001|Overall Study|Lack of Efficacy|1|||
149856742|NCT04100096|540603078|FG000|Overall Study|Lost to Follow-up|13|||
149856743|NCT04100096|540603079|FG001|Overall Study|Lost to Follow-up|11|||
149856744|NCT04100096|540603078|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149856745|NCT04100096|540603079|FG001|Overall Study|Non-Compliance With Study Drug|3|||
149856746|NCT04100096|540603078|FG000|Overall Study|Protocol Deviation|1|||
150173286|NCT01393119|541771231|FG000|Overall Study|Withdrawal by Subject|0|||
150173287|NCT01393119|541771232|FG001|Overall Study|Withdrawal by Subject|1|||
150173288|NCT01393119|541771233|FG002|Overall Study|Withdrawal by Subject|1|||
150173289|NCT01393119|541771234|FG003|Overall Study|Withdrawal by Subject|0|||
150173290|NCT01393119|541771231|FG000|Overall Study|Lack of Efficacy|1|||
150173291|NCT01393119|541771232|FG001|Overall Study|Lack of Efficacy|0|||
150173292|NCT01393119|541771233|FG002|Overall Study|Lack of Efficacy|2|||
150173293|NCT01393119|541771234|FG003|Overall Study|Lack of Efficacy|1|||
150173294|NCT01393119|541771231|FG000|Overall Study|Protocol Violation|0|||
150173295|NCT01393119|541771232|FG001|Overall Study|Protocol Violation|0|||
150173296|NCT01393119|541771233|FG002|Overall Study|Protocol Violation|1|||
150173297|NCT01393119|541771234|FG003|Overall Study|Protocol Violation|0|||
150173298|NCT01393119|541771231|FG000|Overall Study|Death|0|||
150173299|NCT01393119|541771232|FG001|Overall Study|Death|0|||
150173300|NCT01393119|541771233|FG002|Overall Study|Death|0|||
150173301|NCT01393119|541771234|FG003|Overall Study|Death|1|||
150173302|NCT01393119|541771231|FG000|Overall Study|Randomized but Not treated|1|||
150173303|NCT01393119|541771232|FG001|Overall Study|Randomized but Not treated|0|||
150173304|NCT01393119|541771233|FG002|Overall Study|Randomized but Not treated|1|||
150173305|NCT01393119|541771234|FG003|Overall Study|Randomized but Not treated|1|||
150173306|NCT01393119|541771231|FG000|Overall Study|Sponsor Termination of Study|11|||
150173307|NCT01393119|541771232|FG001|Overall Study|Sponsor Termination of Study|12|||
150173308|NCT01393119|541771233|FG002|Overall Study|Sponsor Termination of Study|9|||
150173309|NCT01393119|541771234|FG003|Overall Study|Sponsor Termination of Study|12|||
150173310|NCT01266265|541771235|FG000|Overall Study|Death|95|||
150173311|NCT01266265|541771236|FG001|Overall Study|Death|73|||
150173312|NCT01266265|541771235|FG000|Overall Study|Lost to Follow-up|23|||
150173313|NCT01266265|541771236|FG001|Overall Study|Lost to Follow-up|28|||
150173314|NCT01266265|541771235|FG000|Overall Study|Withdrawal by Subject|13|||
150173315|NCT01266265|541771236|FG001|Overall Study|Withdrawal by Subject|11|||
150173316|NCT01266265|541771235|FG000|Overall Study|Respiratory-related adverse event|2|||
150173317|NCT01266265|541771236|FG001|Overall Study|Respiratory-related adverse event|1|||
150173318|NCT01266265|541771235|FG000|Overall Study|Transferred care to another provider|22|||
150173319|NCT01266265|541771236|FG001|Overall Study|Transferred care to another provider|28|||
150173320|NCT01266265|541771235|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
150173321|NCT01266265|541771236|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
150173322|NCT01266265|541771235|FG000|Overall Study|Enrolled in another clinical study|15|||
150173323|NCT01266265|541771236|FG001|Overall Study|Enrolled in another clinical study|26|||
150173324|NCT01266265|541771235|FG000|Overall Study|Non-compliance|8|||
150173325|NCT01266265|541771236|FG001|Overall Study|Non-compliance|5|||
150173326|NCT01266265|541771235|FG000|Overall Study|Lung transplant|6|||
150173327|NCT01266265|541771236|FG001|Overall Study|Lung transplant|5|||
150173328|NCT01266265|541771235|FG000|Overall Study|Site closed early|4|||
150173329|NCT01266265|541771236|FG001|Overall Study|Site closed early|3|||
150173330|NCT01266265|541771235|FG000|Overall Study|Clinical worsening|1|||
150173331|NCT01266265|541771236|FG001|Overall Study|Clinical worsening|1|||
150173332|NCT01580293|541771237|FG000|Part A_Main Trial|Adverse Event|0|||
150173333|NCT01580293|541771238|FG001|Part A_Main Trial|Adverse Event|2|||
150173334|NCT01580293|541771239|FG002|Part A_Main Trial|Adverse Event|0|||
149856747|NCT04100096|540603079|FG001|Overall Study|Protocol Deviation|1|||
149856748|NCT04100096|540603078|FG000|Overall Study|Withdrawal by Participant|13|||
149856749|NCT04100096|540603079|FG001|Overall Study|Withdrawal by Participant|15|||
149856750|NCT01976728|540603082|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
150040000|NCT02085460|541287278|FG000|Overall Study|Withdrawal by Subject|11|||
150040001|NCT02085460|541287279|FG001|Overall Study|Withdrawal by Subject|5|||
150040002|NCT02085460|541287280|FG002|Overall Study|Withdrawal by Subject|7|||
150040003|NCT01285323|541287281|FG000|Overall Study|Adverse Event|9|||
150040004|NCT01285323|541287282|FG001|Overall Study|Adverse Event|8|||
150040005|NCT01285323|541287281|FG000|Overall Study|Lack of Efficacy|4|||
150040006|NCT01285323|541287282|FG001|Overall Study|Lack of Efficacy|2|||
150040007|NCT01285323|541287281|FG000|Overall Study|Withdrawal by Subject|15|||
150040008|NCT01285323|541287282|FG001|Overall Study|Withdrawal by Subject|11|||
150040009|NCT01285323|541287281|FG000|Overall Study|Protocol Violation|1|||
150040010|NCT01285323|541287282|FG001|Overall Study|Protocol Violation|2|||
150040011|NCT01285323|541287281|FG000|Overall Study|Non-compliance with study procedures|2|||
150040012|NCT01285323|541287282|FG001|Overall Study|Non-compliance with study procedures|3|||
150040013|NCT01285323|541287281|FG000|Overall Study|Lost to Follow-up|1|||
150040014|NCT01285323|541287282|FG001|Overall Study|Lost to Follow-up|1|||
150040015|NCT01285323|541287281|FG000|Overall Study|Other|1|||
150173335|NCT01580293|541771237|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
150173336|NCT01580293|541771238|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
150173337|NCT01580293|541771239|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
150173338|NCT01580293|541771237|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
150173339|NCT01580293|541771238|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
150173340|NCT01580293|541771239|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
150173341|NCT01580293|541771237|FG000|Part A_Extension|Adverse Event|0|||
150173342|NCT01580293|541771238|FG001|Part A_Extension|Adverse Event|2|||
150290538|NCT05103332|542197807|FG007|DB Period (6 Months=168 Days)|Other|0|||
150290539|NCT05103332|542197808|FG008|DB Period (6 Months=168 Days)|Other|0|||
149856751|NCT01976728|540603083|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
149856752|NCT01976728|540603084|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
149856753|NCT01976728|540603085|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
149856754|NCT01563237|540603086|FG000|Overall Study|Lost to Follow-up|6|||
149856755|NCT01563237|540603087|FG001|Overall Study|Lost to Follow-up|0|||
149856756|NCT01563237|540603086|FG000|Overall Study|Withdrawal by Subject|1|||
150173343|NCT01580293|541771239|FG002|Part A_Extension|Adverse Event|0|||
150173344|NCT01580293|541771237|FG000|Part A_Extension|Withdrawal by Subject|0|||
150173345|NCT01580293|541771238|FG001|Part A_Extension|Withdrawal by Subject|3|||
150173346|NCT01580293|541771239|FG002|Part A_Extension|Withdrawal by Subject|0|||
150173347|NCT01580293|541771237|FG000|Part A_Extension|Lost to Follow-up|0|||
150173348|NCT01580293|541771238|FG001|Part A_Extension|Lost to Follow-up|1|||
150173349|NCT01580293|541771239|FG002|Part A_Extension|Lost to Follow-up|0|||
150173350|NCT01580293|541771237|FG000|Part A_Extension|Other Reason|0|||
150173351|NCT01580293|541771238|FG001|Part A_Extension|Other Reason|1|||
150173352|NCT01580293|541771239|FG002|Part A_Extension|Other Reason|0|||
150173353|NCT01580293|541771237|FG000|Part A_Extension|Completed Japan only|0|||
150173354|NCT01580293|541771238|FG001|Part A_Extension|Completed Japan only|5|||
150173355|NCT01580293|541771239|FG002|Part A_Extension|Completed Japan only|0|||
150173356|NCT01580293|541771237|FG000|Part B|Withdrawal by Subject|0|||
150173357|NCT01580293|541771238|FG001|Part B|Withdrawal by Subject|0|||
150173358|NCT01580293|541771239|FG002|Part B|Withdrawal by Subject|1|||
150173359|NCT01580293|541771237|FG000|Part B|Other reason|0|||
150173360|NCT01580293|541771238|FG001|Part B|Other reason|0|||
150173361|NCT01580293|541771239|FG002|Part B|Other reason|1|||
150173362|NCT02983617|541771241|FG000|Overall Study|Adverse Event|0|||
150173363|NCT02983617|541771242|FG001|Overall Study|Adverse Event|7|||
150173364|NCT02983617|541771241|FG000|Overall Study|Death|0|||
150173365|NCT02983617|541771242|FG001|Overall Study|Death|1|||
150173366|NCT02983617|541771241|FG000|Overall Study|Investigator's Discretion|0|||
150173367|NCT02983617|541771242|FG001|Overall Study|Investigator's Discretion|1|||
150173368|NCT04218110|541771245|FG000|Overall Study|Withdrawal by Subject|0|||
150173369|NCT04218110|541771246|FG001|Overall Study|Withdrawal by Subject|0|||
150173370|NCT04218110|541771247|FG002|Overall Study|Withdrawal by Subject|0|||
150173371|NCT04218110|541771248|FG003|Overall Study|Withdrawal by Subject|1|||
150173372|NCT00516386|541771249|FG000|Overall Study|not interested in the study|4|||
150173373|NCT00516386|541771249|FG000|Overall Study|Lost to Follow-up|2|||
150173374|NCT00002842|541771250|FG000|Overall Study|ineligible for surgical resection|27|||
150173375|NCT02015546|541771251|FG000|Overall Study|Withdrawal by Subject|1|||
150173376|NCT02015546|541771252|FG001|Overall Study|Withdrawal by Subject|1|||
150173377|NCT02015546|541771253|FG002|Overall Study|Withdrawal by Subject|1|||
150173378|NCT02015546|541771251|FG000|Overall Study|Screem Failure|2|||
150173379|NCT02015546|541771252|FG001|Overall Study|Screem Failure|1|||
150173380|NCT02015546|541771253|FG002|Overall Study|Screem Failure|3|||
150173381|NCT05855655|541771254|FG000|Overall Study|Withdrawal by Subject|0|||
150173382|NCT05855655|541771255|FG001|Overall Study|Withdrawal by Subject|1|||
150173383|NCT05855655|541771254|FG000|Overall Study|Lost to Follow-up|4|||
150173384|NCT05855655|541771255|FG001|Overall Study|Lost to Follow-up|0|||
150173385|NCT02296424|541771257|FG000|Part 1|New therapy for study indication|0|||
150290540|NCT05103332|542197809|FG009|DB Period (6 Months=168 Days)|Other|0|||
150290541|NCT05103332|542197810|FG010|DB Period (6 Months=168 Days)|Other|0|||
150290542|NCT05103332|542197811|FG011|DB Period (6 Months=168 Days)|Other|0|||
150290543|NCT05103332|542197812|FG012|DB Period (6 Months=168 Days)|Other|0|||
150290544|NCT05103332|542197813|FG013|DB Period (6 Months=168 Days)|Other|0|||
150290545|NCT05103332|542197814|FG014|DB Period (6 Months=168 Days)|Other|0|||
150290546|NCT05103332|542197815|FG015|DB Period (6 Months=168 Days)|Other|0|||
149856757|NCT01563237|540603087|FG001|Overall Study|Withdrawal by Subject|0|||
149856758|NCT01563237|540603086|FG000|Overall Study|Adverse Event|1|||
149856759|NCT01563237|540603087|FG001|Overall Study|Adverse Event|0|||
150173386|NCT02296424|541771258|FG001|Part 1|New therapy for study indication|1|||
150173387|NCT02296424|541771259|FG002|Part 1|New therapy for study indication|0|||
150173388|NCT02296424|541771260|FG003|Part 1|New therapy for study indication|0|||
150173389|NCT02296424|541771257|FG000|Part 1|Protocol Violation|0|||
150173390|NCT02296424|541771258|FG001|Part 1|Protocol Violation|1|||
150173391|NCT02296424|541771259|FG002|Part 1|Protocol Violation|0|||
150173392|NCT02296424|541771260|FG003|Part 1|Protocol Violation|0|||
150290547|NCT05103332|542197816|FG016|DB Period (6 Months=168 Days)|Other|0|||
150290548|NCT05103332|542197817|FG017|DB Period (6 Months=168 Days)|Other|0|||
150290549|NCT05103332|542197800|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150173393|NCT02296424|541771257|FG000|Part 1|Withdrawal by Subject|0|||
150173394|NCT02296424|541771258|FG001|Part 1|Withdrawal by Subject|2|||
150290550|NCT05103332|542197801|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150173395|NCT02296424|541771259|FG002|Part 1|Withdrawal by Subject|0|||
150173396|NCT02296424|541771260|FG003|Part 1|Withdrawal by Subject|0|||
150173397|NCT02296424|541771257|FG000|Part 1|Study terminated by sponsor|0|||
149856760|NCT01563237|540603086|FG000|Overall Study|Medical Reasons|1|||
149856761|NCT01563237|540603087|FG001|Overall Study|Medical Reasons|0|||
149856762|NCT01563237|540603086|FG000|Overall Study|Death|1|||
149856763|NCT01563237|540603087|FG001|Overall Study|Death|0|||
149856764|NCT02000531|540603093|FG000|Overall Study|Lost to Follow-up|1|||
149856765|NCT02000531|540603094|FG001|Overall Study|Lost to Follow-up|0|||
149856766|NCT02000531|540603093|FG000|Overall Study|Discontinued due to data cut-off|3|||
149856767|NCT02000531|540603094|FG001|Overall Study|Discontinued due to data cut-off|8|||
149856768|NCT00317642|540603099|FG000|Overall Study|Not Received Either Study Drug|1|||
149856769|NCT00317642|540603100|FG001|Overall Study|Not Received Either Study Drug|3|||
149856770|NCT00317642|540603099|FG000|Overall Study|Physician Decision|15|||
149856771|NCT00317642|540603100|FG001|Overall Study|Physician Decision|7|||
149856772|NCT00317642|540603099|FG000|Overall Study|Participant declined treatment|14|||
149856773|NCT00317642|540603100|FG001|Overall Study|Participant declined treatment|3|||
149856774|NCT00317642|540603099|FG000|Overall Study|Adverse Event|17|||
149856775|NCT00317642|540603100|FG001|Overall Study|Adverse Event|5|||
149856776|NCT00317642|540603099|FG000|Overall Study|Treatment Failure|56|||
149856777|NCT00317642|540603100|FG001|Overall Study|Treatment Failure|102|||
149856778|NCT00317642|540603099|FG000|Overall Study|Disease Recurrence|1|||
149856779|NCT00317642|540603100|FG001|Overall Study|Disease Recurrence|2|||
149856780|NCT00317642|540603099|FG000|Overall Study|Death|14|||
149856781|NCT00317642|540603100|FG001|Overall Study|Death|7|||
149856782|NCT00317642|540603099|FG000|Overall Study|Not Continue to Consolidation|2|||
149856783|NCT00317642|540603100|FG001|Overall Study|Not Continue to Consolidation|0|||
150290551|NCT05103332|542197802|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290552|NCT05103332|542197803|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290553|NCT05103332|542197804|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290554|NCT05103332|542197805|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290555|NCT05103332|542197806|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290556|NCT05103332|542197807|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290557|NCT05103332|542197808|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149856784|NCT00317642|540603099|FG000|Overall Study|Withdrawal by Subject|0|||
149856785|NCT00317642|540603100|FG001|Overall Study|Withdrawal by Subject|1|||
149856786|NCT00317642|540603099|FG000|Overall Study|Referred For Transplantation|1|||
149856787|NCT00317642|540603100|FG001|Overall Study|Referred For Transplantation|0|||
149856788|NCT00317642|540603099|FG000|Overall Study|AML Not Centrally Confirmed|1|||
149856789|NCT00317642|540603100|FG001|Overall Study|AML Not Centrally Confirmed|5|||
149856790|NCT00418522|540603104|FG000|Overall Study|Adverse Event|7|||
149856791|NCT00418522|540603105|FG001|Overall Study|Adverse Event|1|||
149856792|NCT00418522|540603104|FG000|Overall Study|Lack of Efficacy|1|||
149856793|NCT00418522|540603105|FG001|Overall Study|Lack of Efficacy|3|||
149856794|NCT00418522|540603104|FG000|Overall Study|Lost to Follow-up|10|||
149856795|NCT00418522|540603105|FG001|Overall Study|Lost to Follow-up|4|||
149856796|NCT00418522|540603104|FG000|Overall Study|Withdrawal by Subject|31|||
149856797|NCT00418522|540603105|FG001|Overall Study|Withdrawal by Subject|7|||
149856798|NCT00418522|540603104|FG000|Overall Study|Other|27|||
149856799|NCT00418522|540603105|FG001|Overall Study|Other|23|||
149856800|NCT00418522|540603104|FG000|Overall Study|Randomized but did not receive treatment|7|||
149856801|NCT00418522|540603105|FG001|Overall Study|Randomized but did not receive treatment|4|||
149856802|NCT02695719|540603106|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
149856803|NCT02695719|540603107|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
149856804|NCT02695719|540603106|FG000|Overall Study|Significant Protocol Deviation|0|||
149856805|NCT02695719|540603107|FG001|Overall Study|Significant Protocol Deviation|1|||
149856806|NCT02695719|540603106|FG000|Overall Study|Voluntary Withdrawal|1|||
149856807|NCT02695719|540603107|FG001|Overall Study|Voluntary Withdrawal|0|||
149856808|NCT01652729|540603110|FG000|Overall Study|Withdrawal by Subject|14|||
149856809|NCT01652729|540603111|FG001|Overall Study|Withdrawal by Subject|7|||
149856810|NCT01652729|540603112|FG002|Overall Study|Withdrawal by Subject|7|||
149856811|NCT01652729|540603110|FG000|Overall Study|Adverse Event|4|||
150290558|NCT05103332|542197809|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149856812|NCT01652729|540603111|FG001|Overall Study|Adverse Event|0|||
149856813|NCT01652729|540603112|FG002|Overall Study|Adverse Event|3|||
149856814|NCT01652729|540603110|FG000|Overall Study|Physician Decision|1|||
149856815|NCT01652729|540603111|FG001|Overall Study|Physician Decision|0|||
149856816|NCT01652729|540603112|FG002|Overall Study|Physician Decision|1|||
150290559|NCT05103332|542197810|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
149856817|NCT01652729|540603110|FG000|Overall Study|Protocol Violation|1|||
149856818|NCT01652729|540603111|FG001|Overall Study|Protocol Violation|0|||
149856819|NCT01652729|540603112|FG002|Overall Study|Protocol Violation|0|||
149856820|NCT01652729|540603110|FG000|Overall Study|Lost to Follow-up|6|||
149960570|NCT03931785|540990022|FG002|Overall Study|Noncompliance With Study drug|0|||
149960571|NCT03931785|540990023|FG003|Overall Study|Noncompliance With Study drug|0|||
150290560|NCT05103332|542197811|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149856821|NCT01652729|540603111|FG001|Overall Study|Lost to Follow-up|6|||
149856822|NCT01652729|540603112|FG002|Overall Study|Lost to Follow-up|3|||
149856823|NCT01652729|540603110|FG000|Overall Study|Administrative|1|||
149856824|NCT01652729|540603111|FG001|Overall Study|Administrative|0|||
149856825|NCT01652729|540603112|FG002|Overall Study|Administrative|0|||
149856826|NCT00483548|540603113|FG000|Overall Study|Randomized; not treated with study drug|1|||
149856827|NCT00483548|540603114|FG001|Overall Study|Randomized; not treated with study drug|3|||
149856828|NCT00483548|540603113|FG000|Overall Study|Adverse Event|25|||
149856829|NCT00483548|540603114|FG001|Overall Study|Adverse Event|14|||
149856830|NCT00483548|540603113|FG000|Overall Study|Laboratory abnormality|1|||
149856831|NCT00483548|540603114|FG001|Overall Study|Laboratory abnormality|2|||
149856832|NCT00483548|540603113|FG000|Overall Study|Lack of Efficacy|4|||
149856833|NCT00483548|540603114|FG001|Overall Study|Lack of Efficacy|8|||
149856834|NCT00483548|540603113|FG000|Overall Study|Protocol Violation|11|||
149856835|NCT00483548|540603114|FG001|Overall Study|Protocol Violation|7|||
149856836|NCT00483548|540603113|FG000|Overall Study|Pregnancy|1|||
149856837|NCT00483548|540603114|FG001|Overall Study|Pregnancy|0|||
149856838|NCT00483548|540603113|FG000|Overall Study|Protocol required discontinuation|6|||
149856839|NCT00483548|540603114|FG001|Overall Study|Protocol required discontinuation|6|||
149856840|NCT00483548|540603113|FG000|Overall Study|Unable to comply with protocol schedule|1|||
149856841|NCT00483548|540603114|FG001|Overall Study|Unable to comply with protocol schedule|0|||
149856842|NCT00483548|540603113|FG000|Overall Study|Non-compliance with medication|2|||
149856843|NCT00483548|540603114|FG001|Overall Study|Non-compliance with medication|0|||
149856844|NCT00483548|540603113|FG000|Overall Study|Lost to Follow-up|3|||
149856845|NCT00483548|540603114|FG001|Overall Study|Lost to Follow-up|4|||
149856846|NCT00483548|540603113|FG000|Overall Study|Withdrawal by Subject|5|||
149856847|NCT00483548|540603114|FG001|Overall Study|Withdrawal by Subject|2|||
149856848|NCT01049412|540603117|FG000|Period I|Withdrawal by Subject|4|||
149856849|NCT01049412|540603118|FG001|Period I|Withdrawal by Subject|6|||
149856850|NCT01049412|540603117|FG000|Period I|Lost to Follow-up|2|||
149856851|NCT01049412|540603118|FG001|Period I|Lost to Follow-up|2|||
149856852|NCT01049412|540603117|FG000|Period I|Physician Decision|0|||
149856853|NCT01049412|540603118|FG001|Period I|Physician Decision|3|||
149856854|NCT01049412|540603117|FG000|Period I|Protocol Violation|1|||
149856855|NCT01049412|540603118|FG001|Period I|Protocol Violation|2|||
149856856|NCT01049412|540603117|FG000|Period I|Adverse Event|1|||
149856857|NCT01049412|540603118|FG001|Period I|Adverse Event|0|||
149856858|NCT01049412|540603117|FG000|Period II|Withdrawal by Subject|2|||
149856859|NCT01049412|540603118|FG001|Period II|Withdrawal by Subject|3|||
149856860|NCT01049412|540603117|FG000|Period II|Adverse Event|1|||
149856861|NCT01049412|540603118|FG001|Period II|Adverse Event|0|||
149856862|NCT01049412|540603117|FG000|Period II|Lost to Follow-up|1|||
149856863|NCT01049412|540603118|FG001|Period II|Lost to Follow-up|0|||
149856864|NCT05966090|540603123|FG000|Overall Study|Lost to Follow-up|6|||
149856865|NCT05966090|540603124|FG001|Overall Study|Lost to Follow-up|6|||
149856866|NCT05966090|540603123|FG000|Overall Study|Adverse Event|1|||
149856867|NCT05966090|540603124|FG001|Overall Study|Adverse Event|1|||
149856868|NCT05966090|540603123|FG000|Overall Study|Withdrawal by Subject|1|||
149856869|NCT05966090|540603124|FG001|Overall Study|Withdrawal by Subject|1|||
149856870|NCT05966090|540603123|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149856871|NCT05966090|540603124|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
149856872|NCT05966090|540603123|FG000|Overall Study|Other|1|||
149856873|NCT05966090|540603124|FG001|Overall Study|Other|1|||
149856874|NCT00804141|540603125|FG000|Overall Study|Adverse Event|157|||
149856875|NCT00804141|540603125|FG000|Overall Study|Death|4|||
149856876|NCT00804141|540603125|FG000|Overall Study|Failed to return|96|||
149856877|NCT00804141|540603125|FG000|Overall Study|Investigator request|8|||
149856878|NCT00804141|540603125|FG000|Overall Study|Protocol Violation|85|||
149856879|NCT00804141|540603125|FG000|Overall Study|Withdrawal by Subject|131|||
149856880|NCT00804141|540603125|FG000|Overall Study|Lack of Efficacy|46|||
149856881|NCT00804141|540603125|FG000|Overall Study|Other than specified|30|||
149856882|NCT00804141|540603125|FG000|Overall Study|Enrolled but not treated|6|||
149856883|NCT02001051|540603128|FG000|Overall Study|Deemed not eligible following enrollment|0|||
149856884|NCT02001051|540603129|FG001|Overall Study|Deemed not eligible following enrollment|1|||
149856885|NCT03750695|540603143|FG000|Overall Study|Lost to Follow-up|0|||
149856886|NCT03750695|540603144|FG001|Overall Study|Lost to Follow-up|1|||
149856887|NCT01256060|540603148|FG000|Overall Study|Lost to Follow-up|0|||
149856888|NCT01256060|540603149|FG001|Overall Study|Lost to Follow-up|1|||
149856889|NCT01256060|540603150|FG002|Overall Study|Lost to Follow-up|0|||
149856890|NCT01256060|540603151|FG003|Overall Study|Lost to Follow-up|0|||
149856891|NCT01557920|540603162|FG000|Overall Study|Withdrawal by Subject|2|||
149856892|NCT01557920|540603163|FG001|Overall Study|Withdrawal by Subject|3|||
149856893|NCT01557920|540603162|FG000|Overall Study|Lack of Efficacy|1|||
149856894|NCT01557920|540603163|FG001|Overall Study|Lack of Efficacy|0|||
149856895|NCT01857206|540603177|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
149856896|NCT01857206|540603178|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
149856897|NCT01857206|540603177|FG000|Overall Study|Lost to Follow-up|9|||
149856898|NCT01857206|540603178|FG001|Overall Study|Lost to Follow-up|6|||
149856899|NCT01857206|540603177|FG000|Overall Study|Unclassified|3|||
149856900|NCT01857206|540603178|FG001|Overall Study|Unclassified|3|||
149856901|NCT01857206|540603177|FG000|Overall Study|Withdrawal by Subject|1|||
150173398|NCT02296424|541771258|FG001|Part 1|Study terminated by sponsor|1|||
150173399|NCT02296424|541771259|FG002|Part 1|Study terminated by sponsor|0|||
150173400|NCT02296424|541771260|FG003|Part 1|Study terminated by sponsor|0|||
150173401|NCT02296424|541771257|FG000|Part 1|Adverse Event|2|||
150173402|NCT02296424|541771258|FG001|Part 1|Adverse Event|11|||
150173403|NCT02296424|541771259|FG002|Part 1|Adverse Event|0|||
150173404|NCT02296424|541771260|FG003|Part 1|Adverse Event|0|||
150173405|NCT02296424|541771257|FG000|Part 1|Lack of Efficacy|5|||
150173406|NCT02296424|541771258|FG001|Part 1|Lack of Efficacy|17|||
150173407|NCT02296424|541771259|FG002|Part 1|Lack of Efficacy|0|||
150173408|NCT02296424|541771260|FG003|Part 1|Lack of Efficacy|0|||
150173409|NCT02296424|541771257|FG000|Part 1|16 directly started part II|16|||
150173410|NCT02296424|541771258|FG001|Part 1|16 directly started part II|0|||
150173411|NCT02296424|541771259|FG002|Part 1|16 directly started part II|0|||
150173412|NCT02296424|541771260|FG003|Part 1|16 directly started part II|0|||
150173413|NCT02296424|541771257|FG000|Part 2|Lack of Efficacy|0|||
150173414|NCT02296424|541771258|FG001|Part 2|Lack of Efficacy|0|||
150173415|NCT02296424|541771259|FG002|Part 2|Lack of Efficacy|1|||
150173416|NCT02296424|541771260|FG003|Part 2|Lack of Efficacy|0|||
150173417|NCT02296424|541771257|FG000|Part 2|Adverse Event|0|||
150173418|NCT02296424|541771258|FG001|Part 2|Adverse Event|0|||
150173419|NCT02296424|541771259|FG002|Part 2|Adverse Event|1|||
150173420|NCT02296424|541771260|FG003|Part 2|Adverse Event|0|||
149856902|NCT01857206|540603178|FG001|Overall Study|Withdrawal by Subject|0|||
149856903|NCT00575380|540603185|FG000|Overall Study|Withdrawal by Subject|1|||
149856904|NCT00575380|540603186|FG001|Overall Study|Withdrawal by Subject|0|||
149856905|NCT00575380|540603185|FG000|Overall Study|Adverse Event|0|||
149856906|NCT00575380|540603186|FG001|Overall Study|Adverse Event|1|||
149856907|NCT00575380|540603185|FG000|Overall Study|Various|0|||
149856908|NCT00575380|540603186|FG001|Overall Study|Various|2|||
149856909|NCT04126343|540603188|FG000|Overall Study|Adverse Event|0|||
149856910|NCT04126343|540603189|FG001|Overall Study|Adverse Event|0|||
149856911|NCT04126343|540603190|FG002|Overall Study|Adverse Event|0|||
149856912|NCT04126343|540603191|FG003|Overall Study|Adverse Event|0|||
149856913|NCT04126343|540603192|FG004|Overall Study|Adverse Event|0|||
149856914|NCT04126343|540603193|FG005|Overall Study|Adverse Event|1|||
149856915|NCT04126343|540603188|FG000|Overall Study|Withdrawal by Subject|0|||
149856916|NCT04126343|540603189|FG001|Overall Study|Withdrawal by Subject|0|||
149856917|NCT04126343|540603190|FG002|Overall Study|Withdrawal by Subject|0|||
149856918|NCT04126343|540603191|FG003|Overall Study|Withdrawal by Subject|1|||
149856919|NCT04126343|540603192|FG004|Overall Study|Withdrawal by Subject|0|||
149856920|NCT04126343|540603193|FG005|Overall Study|Withdrawal by Subject|0|||
149856921|NCT04126343|540603188|FG000|Overall Study|Related to COVID-19 pandemic|3|||
149856922|NCT04126343|540603189|FG001|Overall Study|Related to COVID-19 pandemic|4|||
149856923|NCT04126343|540603190|FG002|Overall Study|Related to COVID-19 pandemic|3|||
149856924|NCT04126343|540603191|FG003|Overall Study|Related to COVID-19 pandemic|3|||
149856925|NCT04126343|540603192|FG004|Overall Study|Related to COVID-19 pandemic|3|||
149856926|NCT04126343|540603193|FG005|Overall Study|Related to COVID-19 pandemic|3|||
149856927|NCT00559364|540603194|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
149856928|NCT00559364|540603195|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
149856929|NCT01235442|540603196|FG000|Overall Study|Lost to Follow-up|12|||
149856930|NCT01235442|540603197|FG001|Overall Study|Lost to Follow-up|10|||
149856931|NCT01235442|540603196|FG000|Overall Study|Death|0|||
149856932|NCT01235442|540603197|FG001|Overall Study|Death|2|||
149856933|NCT01235442|540603196|FG000|Overall Study|Pregnancy|1|||
149856934|NCT01235442|540603197|FG001|Overall Study|Pregnancy|1|||
149856935|NCT01235442|540603196|FG000|Overall Study|Ineligibility determined|5|||
149856936|NCT01235442|540603197|FG001|Overall Study|Ineligibility determined|4|||
149856937|NCT01235442|540603196|FG000|Overall Study|Protocol Violation|3|||
149856938|NCT01235442|540603197|FG001|Overall Study|Protocol Violation|3|||
149856939|NCT01235442|540603196|FG000|Overall Study|Adverse Event|4|||
149856940|NCT01235442|540603197|FG001|Overall Study|Adverse Event|6|||
149856941|NCT01235442|540603196|FG000|Overall Study|Withdrawal by Subject|15|||
149856942|NCT01235442|540603197|FG001|Overall Study|Withdrawal by Subject|9|||
149856943|NCT01235442|540603196|FG000|Overall Study|Lack of Efficacy|1|||
149960572|NCT03931785|540990020|FG000|Overall Study|Other Not specified|0|||
150173421|NCT02296424|541771257|FG000|Part 2|Lost to Follow-up|0|||
149856944|NCT01235442|540603197|FG001|Overall Study|Lack of Efficacy|3|||
149856945|NCT01235442|540603196|FG000|Overall Study|Noncompliance|1|||
149856946|NCT01235442|540603197|FG001|Overall Study|Noncompliance|2|||
149856947|NCT01235442|540603196|FG000|Overall Study|Administrative decision|1|||
149856948|NCT01235442|540603197|FG001|Overall Study|Administrative decision|2|||
149856949|NCT01235442|540603196|FG000|Overall Study|Other unspecified|1|||
149856950|NCT01235442|540603197|FG001|Overall Study|Other unspecified|2|||
149856951|NCT01857973|540603202|FG000|Overall Study|Subject did not meet required BG range|3|||
150173422|NCT02296424|541771258|FG001|Part 2|Lost to Follow-up|0|||
149856952|NCT01857973|540603202|FG000|Overall Study|drop out after 3 failed attempts|1|||
150173423|NCT02296424|541771259|FG002|Part 2|Lost to Follow-up|1|||
150173424|NCT02296424|541771260|FG003|Part 2|Lost to Follow-up|0|||
150173425|NCT01337635|541771261|FG000|Overall Study|Lost to Follow-up|0|||
149856953|NCT01857973|540603202|FG000|Overall Study|Physician Decision|1|||
149856954|NCT01701973|540603205|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856955|NCT01701973|540603206|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
149856956|NCT01701973|540603207|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856957|NCT01701973|540603208|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856958|NCT01701973|540603209|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856959|NCT01701973|540603210|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856960|NCT01701973|540603211|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856961|NCT01701973|540603212|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
149856962|NCT02663882|540603213|FG000|Overall Study|Lost to Follow-up|4|||
149856963|NCT02663882|540603214|FG001|Overall Study|Lost to Follow-up|2|||
149856964|NCT04499482|540603219|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
149856965|NCT00869440|540603220|FG000|Overall Study|Withdrawal by Subject|1|||
149856966|NCT00869440|540603221|FG001|Overall Study|Withdrawal by Subject|0|||
149856967|NCT00869440|540603222|FG002|Overall Study|Withdrawal by Subject|0|||
149856968|NCT00869440|540603223|FG003|Overall Study|Withdrawal by Subject|0|||
149856969|NCT00869440|540603220|FG000|Overall Study|Physician Decision|1|||
149856970|NCT00869440|540603221|FG001|Overall Study|Physician Decision|1|||
149856971|NCT00869440|540603222|FG002|Overall Study|Physician Decision|0|||
149856972|NCT00869440|540603223|FG003|Overall Study|Physician Decision|0|||
149856973|NCT00551616|540603224|FG000|Overall Study|Lost to Follow-up|48|||
149856974|NCT00551616|540603225|FG001|Overall Study|Lost to Follow-up|40|||
149856975|NCT03546647|540603226|FG000|Overall Study|Adverse Event|1|||
149856976|NCT03546647|540603227|FG001|Overall Study|Adverse Event|0|||
149856977|NCT00124462|540603228|FG000|Overall Study|Lost to Follow-up|3|||
149856978|NCT00124462|540603229|FG001|Overall Study|Lost to Follow-up|3|||
149856979|NCT00124462|540603228|FG000|Overall Study|Physician Decision|3|||
150290561|NCT05103332|542197812|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290562|NCT05103332|542197813|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290563|NCT05103332|542197814|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290564|NCT05103332|542197815|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290565|NCT05103332|542197816|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290566|NCT05103332|542197817|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
150290567|NCT05103332|542197800|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290568|NCT05103332|542197801|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290569|NCT05103332|542197802|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290570|NCT05103332|542197803|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290571|NCT05103332|542197804|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290572|NCT05103332|542197805|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290573|NCT05103332|542197806|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290574|NCT05103332|542197807|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290575|NCT05103332|542197808|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
150290576|NCT05103332|542197809|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290577|NCT05103332|542197810|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290578|NCT05103332|542197811|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290579|NCT05103332|542197812|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290580|NCT05103332|542197813|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290581|NCT05103332|542197814|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290582|NCT05103332|542197815|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290583|NCT05103332|542197816|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290584|NCT05103332|542197817|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
150290585|NCT05103332|542197800|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290586|NCT05103332|542197801|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290587|NCT05103332|542197802|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290588|NCT05103332|542197803|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290589|NCT05103332|542197804|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290590|NCT05103332|542197805|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290591|NCT05103332|542197806|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290592|NCT05103332|542197807|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290593|NCT05103332|542197808|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290594|NCT05103332|542197809|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290595|NCT05103332|542197810|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290596|NCT05103332|542197811|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
150290597|NCT05103332|542197812|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290598|NCT05103332|542197813|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290599|NCT05103332|542197814|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290600|NCT05103332|542197815|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149856980|NCT00124462|540603229|FG001|Overall Study|Physician Decision|4|||
149856981|NCT00124462|540603228|FG000|Overall Study|Withdrawal by Subject|4|||
149856982|NCT00124462|540603229|FG001|Overall Study|Withdrawal by Subject|5|||
149856983|NCT00124462|540603228|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
149856984|NCT00124462|540603229|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
149856985|NCT03139240|540603230|FG000|Overall Study|Lost to Follow-up|0|||
149856986|NCT03139240|540603231|FG001|Overall Study|Lost to Follow-up|1|||
149856987|NCT03139240|540603232|FG002|Overall Study|Lost to Follow-up|1|||
149856988|NCT03139240|540603233|FG003|Overall Study|Lost to Follow-up|0|||
149856989|NCT03314662|540603234|FG000|Overall Study|Withdrawal by Subject|1|||
149856990|NCT03314662|540603235|FG001|Overall Study|Withdrawal by Subject|1|||
149856991|NCT03314662|540603236|FG002|Overall Study|Withdrawal by Subject|1|||
149856992|NCT03314662|540603234|FG000|Overall Study|Lost to Follow-up|5|||
149856993|NCT03314662|540603235|FG001|Overall Study|Lost to Follow-up|4|||
149856994|NCT03314662|540603236|FG002|Overall Study|Lost to Follow-up|4|||
149856995|NCT03314662|540603234|FG000|Overall Study|Death|2|||
149856996|NCT03314662|540603235|FG001|Overall Study|Death|0|||
149856997|NCT03314662|540603236|FG002|Overall Study|Death|0|||
149856998|NCT01867606|540603241|FG000|Overall Study|Withdrawal by Subject|10|||
149856999|NCT01867606|540603242|FG001|Overall Study|Withdrawal by Subject|14|||
149857000|NCT01867606|540603241|FG000|Overall Study|Protocol Violation|0|||
149857001|NCT01867606|540603242|FG001|Overall Study|Protocol Violation|1|||
149857002|NCT00292227|540603244|FG000|Patch Period|Adverse Event|1|||
149857003|NCT00292227|540603245|FG001|Patch Period|Adverse Event|0|||
149857004|NCT00292227|540603246|FG002|Patch Period|Adverse Event|2|||
149857005|NCT00292227|540603244|FG000|Patch Period|Withdrawal by Subject|0|||
149857006|NCT00292227|540603245|FG001|Patch Period|Withdrawal by Subject|0|||
149857007|NCT00292227|540603246|FG002|Patch Period|Withdrawal by Subject|1|||
149857008|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
149857009|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857010|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857011|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857012|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857013|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857014|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857015|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857016|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
149857017|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
149857018|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857019|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857020|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857021|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857022|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857023|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857024|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857025|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
149857026|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
149857027|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857028|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857029|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857030|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857031|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857032|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857033|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857034|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
149857035|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
149857036|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857037|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857038|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857039|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857040|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857041|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857042|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149857043|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
149960573|NCT03931785|540990021|FG001|Overall Study|Other Not specified|2|||
149960574|NCT03931785|540990022|FG002|Overall Study|Other Not specified|2|||
149857044|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
149960575|NCT03931785|540990023|FG003|Overall Study|Other Not specified|2|||
149857045|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149960576|NCT03931785|540990020|FG000|Overall Study|Withdrawal by Subject|0|||
149960577|NCT03931785|540990021|FG001|Overall Study|Withdrawal by Subject|2|||
149960578|NCT03931785|540990022|FG002|Overall Study|Withdrawal by Subject|4|||
149857046|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857047|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857048|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857049|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857050|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857051|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857052|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
149857053|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
149857054|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857055|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857056|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857057|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857058|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857059|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857060|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857061|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
149857062|NCT00739973|540603247|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
149857063|NCT00739973|540603248|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857064|NCT00739973|540603249|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857065|NCT00739973|540603250|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857066|NCT00739973|540603251|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857067|NCT00739973|540603252|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857068|NCT00739973|540603253|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857069|NCT00739973|540603254|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857070|NCT00739973|540603255|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
149857071|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
149857072|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
149857073|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
149857074|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
149857075|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
149857076|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
149857077|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
149857078|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
149857079|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
149857080|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857081|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857082|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857083|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857084|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
149857085|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857086|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857087|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
149857088|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
149857089|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
149857090|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
149857091|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857092|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857093|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857094|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857095|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857096|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857097|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
149857098|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
149857099|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
149857100|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
149857101|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
149857102|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
149857103|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
149857104|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
149857105|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
149857106|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
150290601|NCT05103332|542197816|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290602|NCT05103332|542197817|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
150290603|NCT05103332|542197800|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290604|NCT05103332|542197801|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290605|NCT05103332|542197802|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290606|NCT05103332|542197803|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290607|NCT05103332|542197804|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290608|NCT05103332|542197805|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290609|NCT05103332|542197806|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
150290610|NCT05103332|542197807|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
150290611|NCT05103332|542197808|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290612|NCT05103332|542197809|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
150290613|NCT05103332|542197810|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
150290614|NCT05103332|542197811|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
150290615|NCT05103332|542197812|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290616|NCT05103332|542197813|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290617|NCT05103332|542197814|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290618|NCT05103332|542197815|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290619|NCT05103332|542197816|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290620|NCT05103332|542197817|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
150290621|NCT05103332|542197800|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290622|NCT05103332|542197801|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290623|NCT05103332|542197802|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290624|NCT05103332|542197803|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290625|NCT05103332|542197804|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290626|NCT05103332|542197805|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149857107|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857108|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857109|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
149857110|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857111|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857112|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857113|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857114|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857115|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
149857116|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
149857117|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
149857118|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
149857119|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
149857120|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
149857121|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
149857122|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
149960579|NCT03931785|540990023|FG003|Overall Study|Withdrawal by Subject|1|||
149960580|NCT03931785|540990020|FG000|Overall Study|Pregnancy|0|||
149960581|NCT03931785|540990021|FG001|Overall Study|Pregnancy|0|||
149960582|NCT03931785|540990022|FG002|Overall Study|Pregnancy|0|||
149960583|NCT03931785|540990023|FG003|Overall Study|Pregnancy|1|||
149960584|NCT03211858|540990024|FG000|Overall Study|Adverse Event|8|||
149960585|NCT03211858|540990025|FG001|Overall Study|Adverse Event|6|||
149960586|NCT03211858|540990024|FG000|Overall Study|Lack of Efficacy|0|||
149960587|NCT03211858|540990025|FG001|Overall Study|Lack of Efficacy|4|||
149960588|NCT03211858|540990024|FG000|Overall Study|Poor compliance to protocol|6|||
149960589|NCT03211858|540990025|FG001|Overall Study|Poor compliance to protocol|2|||
149960590|NCT03211858|540990024|FG000|Overall Study|Non-serious Hypoglycemia|1|||
149960591|NCT03211858|540990025|FG001|Overall Study|Non-serious Hypoglycemia|0|||
149960592|NCT03211858|540990024|FG000|Overall Study|Other than specified above|22|||
149960593|NCT03211858|540990025|FG001|Overall Study|Other than specified above|21|||
149960594|NCT01013870|540990026|FG000|Overall Study|Lost to Follow-up|1|||
149960595|NCT01013870|540990027|FG001|Overall Study|Lost to Follow-up|3|||
149960596|NCT01386645|540990028|FG000|Overall Study|Physician Decision|0|||
149960597|NCT01386645|540990029|FG001|Overall Study|Physician Decision|0|||
149960598|NCT01386645|540990030|FG002|Overall Study|Physician Decision|1|||
149960599|NCT01386645|540990028|FG000|Overall Study|Withdrawal by Subject|0|||
150290627|NCT05103332|542197806|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290628|NCT05103332|542197807|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290629|NCT05103332|542197808|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149857123|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
149857124|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
149857125|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
149857126|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
149857127|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
149857128|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
149857129|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
149857130|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
149857131|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
149857132|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
149857133|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
149857134|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857135|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857136|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857137|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857138|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857139|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857140|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
149857141|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857142|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
149857143|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
149857144|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
149857145|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
149857146|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
149857147|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
149857148|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
149857149|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
149857150|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
149857151|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
149857152|NCT00739973|540603247|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857153|NCT00739973|540603248|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
149857154|NCT00739973|540603249|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857155|NCT00739973|540603250|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857156|NCT00739973|540603251|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857157|NCT00739973|540603252|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857158|NCT00739973|540603253|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
149857159|NCT00739973|540603254|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857160|NCT00739973|540603255|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
149857161|NCT01989676|540605258|FG000|Overall Study|Death|52|||
149857162|NCT01989676|540605259|FG001|Overall Study|Death|60|||
149857163|NCT01989676|540605258|FG000|Overall Study|Protocol Violation|2|||
149857164|NCT01989676|540605259|FG001|Overall Study|Protocol Violation|1|||
149857165|NCT01989676|540605258|FG000|Overall Study|Lost to Follow-up|8|||
149857166|NCT01989676|540605259|FG001|Overall Study|Lost to Follow-up|18|||
149857167|NCT01989676|540605258|FG000|Overall Study|No longer willing to participate in study|26|||
149857168|NCT01989676|540605259|FG001|Overall Study|No longer willing to participate in study|26|||
149857169|NCT01989676|540605258|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
149857170|NCT01989676|540605259|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
149857171|NCT01989676|540605258|FG000|Overall Study|Other|4|||
149857172|NCT01989676|540605259|FG001|Overall Study|Other|3|||
149857173|NCT02012452|540605260|FG000|Overall Study|Lost to Follow-up|2|||
149857174|NCT02012452|540605261|FG001|Overall Study|Lost to Follow-up|1|||
149857175|NCT02012452|540605260|FG000|Overall Study|Withdrawal by Subject|4|||
149857176|NCT02012452|540605261|FG001|Overall Study|Withdrawal by Subject|0|||
149857177|NCT02190279|540605262|FG000|Overall Study|Withdrawal consent|1|||
149857178|NCT02190279|540605263|FG001|Overall Study|Withdrawal consent|0|||
149857179|NCT02190279|540605264|FG002|Overall Study|Withdrawal consent|1|||
149857180|NCT02190279|540605262|FG000|Overall Study|Lost to Follow-up|2|||
149857181|NCT02190279|540605263|FG001|Overall Study|Lost to Follow-up|0|||
149857182|NCT02190279|540605264|FG002|Overall Study|Lost to Follow-up|0|||
149857183|NCT02190279|540605262|FG000|Overall Study|Refused further treatment|0|||
149857184|NCT02190279|540605263|FG001|Overall Study|Refused further treatment|0|||
149857185|NCT02190279|540605264|FG002|Overall Study|Refused further treatment|1|||
149857186|NCT02190279|540605262|FG000|Overall Study|Screening failure|0|||
150290630|NCT05103332|542197809|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
150290631|NCT05103332|542197810|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149857187|NCT02190279|540605263|FG001|Overall Study|Screening failure|0|||
149857188|NCT02190279|540605264|FG002|Overall Study|Screening failure|1|||
149857189|NCT02938442|540605265|FG000|Overall Study|Death|0|||
149857190|NCT02938442|540605266|FG001|Overall Study|Death|1|||
149857191|NCT02938442|540605265|FG000|Overall Study|Lost to Follow-up|0|||
149857192|NCT02938442|540605266|FG001|Overall Study|Lost to Follow-up|1|||
149857193|NCT02938442|540605265|FG000|Overall Study|Physician Decision|0|||
149857194|NCT02938442|540605266|FG001|Overall Study|Physician Decision|1|||
149857195|NCT02938442|540605265|FG000|Overall Study|Withdrawal by Subject|2|||
149857196|NCT02938442|540605266|FG001|Overall Study|Withdrawal by Subject|0|||
149857197|NCT04403399|540605267|FG000|Period 2|Physician Decision|0|||
149857198|NCT04403399|540605268|FG001|Period 2|Physician Decision|1|||
149857199|NCT00802178|540605269|FG000|Overall Study|Lack of Efficacy|36|||
149857200|NCT00802178|540605269|FG000|Overall Study|Insufficient tolerability (IT)|17|||
149857201|NCT00802178|540605269|FG000|Overall Study|Withdrawal by Subject|18|||
149857202|NCT00802178|540605269|FG000|Overall Study|Other|32|||
149857203|NCT00802178|540605269|FG000|Overall Study|Lack of efficacy and patient wish|1|||
149857204|NCT00802178|540605269|FG000|Overall Study|IT and patient wish|8|||
149857205|NCT00802178|540605269|FG000|Overall Study|Patients wish and other reason|1|||
149857206|NCT01606228|540605270|FG000|Overall Study|Lost to Follow-up|20|||
149857207|NCT01606228|540605270|FG000|Overall Study|Withdrawal by Subject|3|||
149857208|NCT01606228|540605270|FG000|Overall Study|Non-compliant|3|||
149857209|NCT01606228|540605270|FG000|Overall Study|Lack of Efficacy|2|||
149857210|NCT01606228|540605270|FG000|Overall Study|Adverse Event|1|||
149857211|NCT01115855|540605271|FG000|Overall Study|Adverse Event|16|||
149857212|NCT01115855|540605272|FG001|Overall Study|Adverse Event|18|||
149857213|NCT01115855|540605271|FG000|Overall Study|Death|6|||
149857214|NCT01115855|540605272|FG001|Overall Study|Death|5|||
149857215|NCT01115855|540605271|FG000|Overall Study|Lab Abnormality|1|||
149857216|NCT01115855|540605272|FG001|Overall Study|Lab Abnormality|1|||
149857217|NCT01115855|540605271|FG000|Overall Study|Protocol Violation|0|||
149857218|NCT01115855|540605272|FG001|Overall Study|Protocol Violation|1|||
149857219|NCT01115855|540605271|FG000|Overall Study|Withdrawal by Subject|5|||
149857220|NCT01115855|540605272|FG001|Overall Study|Withdrawal by Subject|5|||
149857221|NCT01115855|540605271|FG000|Overall Study|Other|8|||
149857222|NCT01115855|540605272|FG001|Overall Study|Other|6|||
149857223|NCT00480324|540605273|FG000|Overall Study|Adverse Event|1|||
149857224|NCT00480324|540605274|FG001|Overall Study|Adverse Event|1|||
149857225|NCT00480324|540605273|FG000|Overall Study|Protocol Violation|0|||
149857226|NCT00480324|540605274|FG001|Overall Study|Protocol Violation|1|||
149857227|NCT00480324|540605273|FG000|Overall Study|Withdrawal by Subject|14|||
149857228|NCT00480324|540605274|FG001|Overall Study|Withdrawal by Subject|5|||
149857229|NCT00480324|540605273|FG000|Overall Study|Lost to Follow-up|17|||
149857230|NCT00480324|540605274|FG001|Overall Study|Lost to Follow-up|8|||
149857231|NCT00480324|540605273|FG000|Overall Study|Subject's mother pregnant|0|||
149857232|NCT00480324|540605274|FG001|Overall Study|Subject's mother pregnant|1|||
149857233|NCT00966381|540605275|FG000|Overall Study|Withdrawal by Subject|2|||
149857234|NCT00966381|540605276|FG001|Overall Study|Withdrawal by Subject|2|||
149857235|NCT02211014|540605277|FG000|Overall Study|Adverse Event|0|||
149857236|NCT02211014|540605278|FG001|Overall Study|Adverse Event|2|||
149857237|NCT02211014|540605277|FG000|Overall Study|Physician Decision|1|||
149857238|NCT02211014|540605278|FG001|Overall Study|Physician Decision|2|||
149857239|NCT02211014|540605277|FG000|Overall Study|Started another cancer therapy|1|||
149857240|NCT02211014|540605278|FG001|Overall Study|Started another cancer therapy|0|||
149857241|NCT02211014|540605277|FG000|Overall Study|Withdrawal by Subject|0|||
149857242|NCT02211014|540605278|FG001|Overall Study|Withdrawal by Subject|1|||
149857243|NCT02211014|540605277|FG000|Overall Study|In agreement with patient, no benefit|0|||
149857244|NCT02211014|540605278|FG001|Overall Study|In agreement with patient, no benefit|1|||
149857245|NCT01124695|540605282|FG000|Overall Study|Disease progression|77|||
149857246|NCT01124695|540605282|FG000|Overall Study|Adverse Event|11|||
149857247|NCT01124695|540605282|FG000|Overall Study|Death|1|||
149857248|NCT01124695|540605282|FG000|Overall Study|Withdrawal by Subject|7|||
149857249|NCT01124695|540605282|FG000|Overall Study|Physician Decision|3|||
149857250|NCT01124695|540605282|FG000|Overall Study|Alternative therapy|9|||
149857251|NCT01124695|540605282|FG000|Overall Study|No documentation that patient went off treatment|4|||
149857252|NCT01124695|540605282|FG000|Overall Study|Ineligible|9|||
149857253|NCT01124695|540605282|FG000|Overall Study|Ineligible and never start treatment|2|||
149857254|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
149857255|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
149857256|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
150040016|NCT01285323|541287282|FG001|Overall Study|Other|3|||
149857257|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
149857258|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
149857259|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
149857260|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
149857261|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
149857262|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
149857263|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
149857264|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
149857265|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
149857266|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
149857267|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
149857268|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
149857269|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
149857270|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
149857271|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
149857272|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
149857273|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
149857274|NCT02960438|540605283|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
149857275|NCT02960438|540605284|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
149960600|NCT01386645|540990029|FG001|Overall Study|Withdrawal by Subject|1|||
149960601|NCT01386645|540990030|FG002|Overall Study|Withdrawal by Subject|1|||
149960602|NCT01423084|540990033|FG000|Overall Study|Adverse Event|0|||
149960603|NCT01423084|540990034|FG001|Overall Study|Adverse Event|1|||
149960604|NCT01423084|540990033|FG000|Overall Study|Withdrawal by Subject|2|||
149960605|NCT01423084|540990034|FG001|Overall Study|Withdrawal by Subject|3|||
149960606|NCT01133977|540990048|FG000|Overall Study|Adverse Event|0|||
149960607|NCT01133977|540990049|FG001|Overall Study|Adverse Event|0|||
149960608|NCT01133977|540990050|FG002|Overall Study|Adverse Event|1|||
149960609|NCT01133977|540990051|FG003|Overall Study|Adverse Event|0|||
149960610|NCT01133977|540990052|FG004|Overall Study|Adverse Event|0|||
149960611|NCT01133977|540990048|FG000|Overall Study|Death|1|||
149960612|NCT01133977|540990049|FG001|Overall Study|Death|1|||
149960613|NCT01133977|540990050|FG002|Overall Study|Death|1|||
149960614|NCT01133977|540990051|FG003|Overall Study|Death|7|||
149960615|NCT01133977|540990052|FG004|Overall Study|Death|3|||
149960616|NCT01133977|540990048|FG000|Overall Study|Started a New Line of Therapy|2|||
149960617|NCT01133977|540990049|FG001|Overall Study|Started a New Line of Therapy|6|||
149960618|NCT01133977|540990050|FG002|Overall Study|Started a New Line of Therapy|4|||
149960619|NCT01133977|540990051|FG003|Overall Study|Started a New Line of Therapy|25|||
149960620|NCT01133977|540990052|FG004|Overall Study|Started a New Line of Therapy|33|||
149960621|NCT01133977|540990048|FG000|Overall Study|Lost to Follow-up|0|||
149960622|NCT01133977|540990049|FG001|Overall Study|Lost to Follow-up|0|||
149960623|NCT01133977|540990050|FG002|Overall Study|Lost to Follow-up|0|||
149960624|NCT01133977|540990051|FG003|Overall Study|Lost to Follow-up|2|||
149960625|NCT01133977|540990052|FG004|Overall Study|Lost to Follow-up|1|||
149960626|NCT01133977|540990048|FG000|Overall Study|Withdrawal by Subject|0|||
149960627|NCT01133977|540990049|FG001|Overall Study|Withdrawal by Subject|0|||
149960628|NCT01133977|540990050|FG002|Overall Study|Withdrawal by Subject|0|||
149960629|NCT01133977|540990051|FG003|Overall Study|Withdrawal by Subject|5|||
149960630|NCT01133977|540990052|FG004|Overall Study|Withdrawal by Subject|1|||
149960631|NCT02462057|540990053|FG000|Overall Study|Left Vitality|32|||
149960632|NCT02462057|540990054|FG001|Overall Study|Left Vitality|27|||
149960633|NCT02462057|540990055|FG002|Overall Study|Left Vitality|23|||
149960634|NCT02462057|540990056|FG003|Overall Study|Left Vitality|35|||
149960635|NCT02462057|540990057|FG004|Overall Study|Left Vitality|33|||
149960636|NCT02462057|540990053|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
149960637|NCT02462057|540990054|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
149960638|NCT02462057|540990055|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
149960639|NCT02462057|540990056|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
149960640|NCT02462057|540990057|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
149960641|NCT01908699|540990063|FG000|Overall Study|Adverse Event|8|||
149960642|NCT01908699|540990064|FG001|Overall Study|Adverse Event|12|||
149960643|NCT01908699|540990063|FG000|Overall Study|Lack of Efficacy|2|||
149960644|NCT01908699|540990064|FG001|Overall Study|Lack of Efficacy|2|||
149960645|NCT01908699|540990063|FG000|Overall Study|Lost to Follow-up|2|||
149960646|NCT01908699|540990064|FG001|Overall Study|Lost to Follow-up|4|||
149960647|NCT01908699|540990063|FG000|Overall Study|Physician Decision|8|||
149960648|NCT01908699|540990064|FG001|Overall Study|Physician Decision|8|||
149960649|NCT01908699|540990063|FG000|Overall Study|Withdrawal by Subject|15|||
149960650|NCT01908699|540990064|FG001|Overall Study|Withdrawal by Subject|10|||
149960651|NCT01908699|540990063|FG000|Overall Study|Pregnancy|0|||
149960652|NCT01908699|540990064|FG001|Overall Study|Pregnancy|1|||
149960653|NCT01908699|540990063|FG000|Overall Study|Randomized in Error|1|||
149960654|NCT01908699|540990064|FG001|Overall Study|Randomized in Error|0|||
149960655|NCT01908699|540990063|FG000|Overall Study|Death|9|||
149960656|NCT01908699|540990064|FG001|Overall Study|Death|12|||
149960657|NCT01908699|540990063|FG000|Overall Study|Progressive Disease|30|||
149960658|NCT01908699|540990064|FG001|Overall Study|Progressive Disease|29|||
149960659|NCT02105012|540990065|FG000|Overall Study|Withdrawal by Subject|11|||
149960660|NCT02105012|540990065|FG000|Overall Study|Protocol Specified Criteria|9|||
149960661|NCT02105012|540990065|FG000|Overall Study|Lost to Follow-up|4|||
149960662|NCT02105012|540990065|FG000|Overall Study|Protocol Violation|4|||
149960663|NCT02105012|540990065|FG000|Overall Study|Physician Decision|3|||
149960664|NCT02105012|540990065|FG000|Overall Study|Adverse Event|1|||
149960665|NCT02105012|540990065|FG000|Overall Study|Lack of Efficacy|1|||
149960666|NCT00474968|540990070|FG000|Overall Study|Withdrawal by Subject|8|||
149960667|NCT00474968|540990071|FG001|Overall Study|Withdrawal by Subject|7|||
149960668|NCT00474968|540990070|FG000|Overall Study|Protocol Violation|9|||
149960669|NCT00474968|540990071|FG001|Overall Study|Protocol Violation|8|||
149960670|NCT00474968|540990070|FG000|Overall Study|Sample not collected|1|||
149960671|NCT00474968|540990071|FG001|Overall Study|Sample not collected|1|||
149960672|NCT00215553|540990072|FG000|Overall Study|Adverse Event|0|||
149960673|NCT00215553|540990073|FG001|Overall Study|Adverse Event|1|||
149960674|NCT00215553|540990074|FG002|Overall Study|Adverse Event|2|||
149960675|NCT00215553|540990075|FG003|Overall Study|Adverse Event|1|||
149960676|NCT00215553|540990076|FG004|Overall Study|Adverse Event|2|||
149960677|NCT00215553|540990077|FG005|Overall Study|Adverse Event|6|||
149960678|NCT00215553|540990078|FG006|Overall Study|Adverse Event|0|||
149960679|NCT05345405|540990079|FG000|Overall Study|Withdrawal by Subject|2|||
149960680|NCT05345405|540990080|FG001|Overall Study|Withdrawal by Subject|0|||
149960681|NCT05345405|540990081|FG002|Overall Study|Withdrawal by Subject|0|||
149960682|NCT05345405|540990079|FG000|Overall Study|Did not meet eligibility criteria|0|||
149960683|NCT05345405|540990080|FG001|Overall Study|Did not meet eligibility criteria|2|||
149960684|NCT05345405|540990081|FG002|Overall Study|Did not meet eligibility criteria|0|||
149960685|NCT05345405|540990079|FG000|Overall Study|Lost to Follow-up|0|||
149960686|NCT05345405|540990080|FG001|Overall Study|Lost to Follow-up|0|||
149960687|NCT05345405|540990081|FG002|Overall Study|Lost to Follow-up|1|||
149960688|NCT01896986|540990082|FG000|Overall Study|samples lost|14|||
149960689|NCT01896986|540990083|FG001|Overall Study|samples lost|23|||
149960690|NCT00281580|540990085|FG000|Overall Study|Adverse Event|2|||
149960691|NCT00281580|540990086|FG001|Overall Study|Adverse Event|0|||
149960692|NCT00281580|540990087|FG002|Overall Study|Adverse Event|2|||
149960693|NCT00281580|540990088|FG003|Overall Study|Adverse Event|4|||
149960694|NCT00281580|540990089|FG004|Overall Study|Adverse Event|1|||
149960695|NCT00281580|540990090|FG005|Overall Study|Adverse Event|0|||
149960696|NCT00281580|540990091|FG006|Overall Study|Adverse Event|1|||
149960697|NCT00281580|540990092|FG007|Overall Study|Adverse Event|0|||
149960698|NCT00281580|540990093|FG008|Overall Study|Adverse Event|1|||
149960699|NCT00281580|540990094|FG009|Overall Study|Adverse Event|6|||
149960700|NCT00281580|540990095|FG010|Overall Study|Adverse Event|0|||
149960701|NCT00281580|540990096|FG011|Overall Study|Adverse Event|5|||
149960702|NCT00281580|540990097|FG012|Overall Study|Adverse Event|8|||
149960703|NCT00281580|540990098|FG013|Overall Study|Adverse Event|2|||
149960704|NCT00281580|540990099|FG014|Overall Study|Adverse Event|3|||
149960705|NCT00281580|540990100|FG015|Overall Study|Adverse Event|3|||
149960706|NCT00281580|540990085|FG000|Overall Study|Protocol Violation|0|||
149960707|NCT00281580|540990086|FG001|Overall Study|Protocol Violation|0|||
149960708|NCT00281580|540990087|FG002|Overall Study|Protocol Violation|1|||
149960709|NCT00281580|540990088|FG003|Overall Study|Protocol Violation|1|||
149960710|NCT00281580|540990089|FG004|Overall Study|Protocol Violation|0|||
149960711|NCT00281580|540990090|FG005|Overall Study|Protocol Violation|0|||
149960712|NCT00281580|540990091|FG006|Overall Study|Protocol Violation|1|||
149960713|NCT00281580|540990092|FG007|Overall Study|Protocol Violation|0|||
149960714|NCT00281580|540990093|FG008|Overall Study|Protocol Violation|2|||
149960715|NCT00281580|540990094|FG009|Overall Study|Protocol Violation|0|||
149960716|NCT00281580|540990095|FG010|Overall Study|Protocol Violation|1|||
149960717|NCT00281580|540990096|FG011|Overall Study|Protocol Violation|2|||
149960718|NCT00281580|540990097|FG012|Overall Study|Protocol Violation|0|||
149960719|NCT00281580|540990098|FG013|Overall Study|Protocol Violation|1|||
149960720|NCT00281580|540990099|FG014|Overall Study|Protocol Violation|1|||
149960721|NCT00281580|540990100|FG015|Overall Study|Protocol Violation|3|||
149960722|NCT00281580|540990085|FG000|Overall Study|Withdrawal by Subject|3|||
150290632|NCT05103332|542197811|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149960723|NCT00281580|540990086|FG001|Overall Study|Withdrawal by Subject|0|||
150290633|NCT05103332|542197812|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
150290634|NCT05103332|542197813|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
149960724|NCT00281580|540990087|FG002|Overall Study|Withdrawal by Subject|1|||
149960725|NCT00281580|540990088|FG003|Overall Study|Withdrawal by Subject|1|||
149960726|NCT00281580|540990089|FG004|Overall Study|Withdrawal by Subject|1|||
149960727|NCT00281580|540990090|FG005|Overall Study|Withdrawal by Subject|2|||
149960728|NCT00281580|540990091|FG006|Overall Study|Withdrawal by Subject|2|||
149960729|NCT00281580|540990092|FG007|Overall Study|Withdrawal by Subject|0|||
149960730|NCT00281580|540990093|FG008|Overall Study|Withdrawal by Subject|1|||
149960731|NCT00281580|540990094|FG009|Overall Study|Withdrawal by Subject|4|||
149960732|NCT00281580|540990095|FG010|Overall Study|Withdrawal by Subject|1|||
149960733|NCT00281580|540990096|FG011|Overall Study|Withdrawal by Subject|1|||
149960734|NCT00281580|540990097|FG012|Overall Study|Withdrawal by Subject|2|||
150040017|NCT02158546|541287284|FG000|Overall Study|Physician Decision|0|||
149960735|NCT00281580|540990098|FG013|Overall Study|Withdrawal by Subject|2|||
150040018|NCT02158546|541287285|FG001|Overall Study|Physician Decision|1|||
150040019|NCT02158546|541287286|FG002|Overall Study|Physician Decision|0|||
150040020|NCT02158546|541287287|FG003|Overall Study|Physician Decision|0|||
150040021|NCT02158546|541287284|FG000|Overall Study|Non-compliance|0|||
150040022|NCT02158546|541287285|FG001|Overall Study|Non-compliance|1|||
150040023|NCT02158546|541287286|FG002|Overall Study|Non-compliance|0|||
150040024|NCT02158546|541287287|FG003|Overall Study|Non-compliance|1|||
150040025|NCT02158546|541287284|FG000|Overall Study|Failure to meet eligibility criteria|0|||
150040026|NCT02158546|541287285|FG001|Overall Study|Failure to meet eligibility criteria|1|||
150040027|NCT02158546|541287286|FG002|Overall Study|Failure to meet eligibility criteria|0|||
150040028|NCT02158546|541287287|FG003|Overall Study|Failure to meet eligibility criteria|0|||
150040029|NCT02158546|541287284|FG000|Overall Study|Lack of Efficacy|1|||
150040030|NCT02158546|541287285|FG001|Overall Study|Lack of Efficacy|1|||
150040031|NCT02158546|541287286|FG002|Overall Study|Lack of Efficacy|0|||
150040032|NCT02158546|541287287|FG003|Overall Study|Lack of Efficacy|0|||
150040033|NCT02158546|541287284|FG000|Overall Study|Adverse Event|2|||
150040034|NCT02158546|541287285|FG001|Overall Study|Adverse Event|2|||
150040035|NCT02158546|541287286|FG002|Overall Study|Adverse Event|0|||
150040036|NCT02158546|541287287|FG003|Overall Study|Adverse Event|0|||
150040037|NCT02158546|541287284|FG000|Overall Study|Withdrawal by Subject|6|||
150040038|NCT02158546|541287285|FG001|Overall Study|Withdrawal by Subject|2|||
150040039|NCT02158546|541287286|FG002|Overall Study|Withdrawal by Subject|1|||
150040040|NCT02158546|541287287|FG003|Overall Study|Withdrawal by Subject|0|||
150040041|NCT02158546|541287284|FG000|Overall Study|Lost to Follow-up|5|||
150040042|NCT02158546|541287285|FG001|Overall Study|Lost to Follow-up|4|||
150040043|NCT02158546|541287286|FG002|Overall Study|Lost to Follow-up|0|||
150040044|NCT02158546|541287287|FG003|Overall Study|Lost to Follow-up|1|||
150040045|NCT02158546|541287284|FG000|Overall Study|Site Excluded|5|||
150040046|NCT02158546|541287285|FG001|Overall Study|Site Excluded|5|||
150040047|NCT02158546|541287286|FG002|Overall Study|Site Excluded|3|||
150040048|NCT02158546|541287287|FG003|Overall Study|Site Excluded|4|||
150040049|NCT02351817|541287289|FG000|Period 1|Adverse Event|1|||
150040050|NCT02351817|541287290|FG001|Period 1|Adverse Event|2|||
150040051|NCT02351817|541287289|FG000|Period 1|Lack of Efficacy|0|||
150040052|NCT02351817|541287290|FG001|Period 1|Lack of Efficacy|1|||
150040053|NCT02351817|541287289|FG000|Period 2|Adverse Event|0|||
150040054|NCT02351817|541287290|FG001|Period 2|Adverse Event|2|||
150040055|NCT02351817|541287289|FG000|Period 2|Protocol Violation|1|||
150040056|NCT02351817|541287290|FG001|Period 2|Protocol Violation|0|||
150040057|NCT00803569|541287293|FG000|Overall Study|Progressive Disease|3|||
150040058|NCT00803569|541287293|FG000|Overall Study|Noncompliance|1|||
150040059|NCT02488915|541287294|FG000|Overall Study|Death|21|||
150040060|NCT02488915|541287294|FG000|Overall Study|Lost to Follow-up|4|||
150040061|NCT02488915|541287294|FG000|Overall Study|Withdrawal by Subject|1|||
150040062|NCT00885170|541287295|FG000|Overall Study|Adverse Event|12|||
150040063|NCT00885170|541287296|FG001|Overall Study|Adverse Event|4|||
150040064|NCT00885170|541287295|FG000|Overall Study|Excessive bone loss|6|||
150040065|NCT00885170|541287296|FG001|Overall Study|Excessive bone loss|3|||
150040066|NCT00885170|541287295|FG000|Overall Study|Lost to Follow-up|2|||
150040067|NCT00885170|541287296|FG001|Overall Study|Lost to Follow-up|1|||
150040068|NCT00885170|541287295|FG000|Overall Study|Physician Decision|2|||
150040069|NCT00885170|541287296|FG001|Overall Study|Physician Decision|1|||
150040070|NCT00885170|541287295|FG000|Overall Study|Protocol Violation|3|||
150040071|NCT00885170|541287296|FG001|Overall Study|Protocol Violation|1|||
150040072|NCT00885170|541287295|FG000|Overall Study|Withdrawal by Subject|13|||
150040073|NCT00885170|541287296|FG001|Overall Study|Withdrawal by Subject|13|||
150040074|NCT03771664|541287297|FG000|Overall Study|Adverse Event|1|||
150040075|NCT03771664|541287298|FG001|Overall Study|Adverse Event|0|||
150040076|NCT03771664|541287297|FG000|Overall Study|Lost to Follow-up|1|||
150040077|NCT03771664|541287298|FG001|Overall Study|Lost to Follow-up|0|||
150040078|NCT03771664|541287297|FG000|Overall Study|Withdrawal by Participant|1|||
150040079|NCT03771664|541287298|FG001|Overall Study|Withdrawal by Participant|4|||
150040080|NCT03771664|541287297|FG000|Overall Study|Randomized but not Treated|0|||
150040081|NCT03771664|541287298|FG001|Overall Study|Randomized but not Treated|1|||
150040082|NCT01208207|541287301|FG000|Part I|Adverse Event|19|||
150040083|NCT01208207|541287302|FG001|Part I|Adverse Event|2|||
150040084|NCT01208207|541287303|FG002|Part I|Adverse Event|6|||
150040085|NCT01208207|541287304|FG003|Part I|Adverse Event|0|||
150040086|NCT01208207|541287305|FG004|Part I|Adverse Event|0|||
150040087|NCT01208207|541287306|FG005|Part I|Adverse Event|0|||
150040088|NCT01208207|541287307|FG006|Part I|Adverse Event|0|||
150040089|NCT01208207|541287301|FG000|Part I|Lack of Efficacy|21|||
150040090|NCT01208207|541287302|FG001|Part I|Lack of Efficacy|3|||
150040091|NCT01208207|541287303|FG002|Part I|Lack of Efficacy|2|||
150040092|NCT01208207|541287304|FG003|Part I|Lack of Efficacy|0|||
150040093|NCT01208207|541287305|FG004|Part I|Lack of Efficacy|0|||
150040094|NCT01208207|541287306|FG005|Part I|Lack of Efficacy|0|||
150040095|NCT01208207|541287307|FG006|Part I|Lack of Efficacy|0|||
150040096|NCT01208207|541287301|FG000|Part I|Lost to Follow-up|6|||
150040097|NCT01208207|541287302|FG001|Part I|Lost to Follow-up|1|||
150040098|NCT01208207|541287303|FG002|Part I|Lost to Follow-up|0|||
149960736|NCT00281580|540990099|FG014|Overall Study|Withdrawal by Subject|1|||
149960737|NCT00281580|540990100|FG015|Overall Study|Withdrawal by Subject|5|||
149960738|NCT00281580|540990085|FG000|Overall Study|Lack of Efficacy|2|||
149960739|NCT00281580|540990086|FG001|Overall Study|Lack of Efficacy|1|||
149960740|NCT00281580|540990087|FG002|Overall Study|Lack of Efficacy|1|||
149960741|NCT00281580|540990088|FG003|Overall Study|Lack of Efficacy|6|||
149960742|NCT00281580|540990089|FG004|Overall Study|Lack of Efficacy|2|||
149960743|NCT00281580|540990090|FG005|Overall Study|Lack of Efficacy|0|||
149960744|NCT00281580|540990091|FG006|Overall Study|Lack of Efficacy|0|||
149960745|NCT00281580|540990092|FG007|Overall Study|Lack of Efficacy|0|||
149960746|NCT00281580|540990093|FG008|Overall Study|Lack of Efficacy|0|||
149960747|NCT00281580|540990094|FG009|Overall Study|Lack of Efficacy|0|||
149960748|NCT00281580|540990095|FG010|Overall Study|Lack of Efficacy|0|||
149960749|NCT00281580|540990096|FG011|Overall Study|Lack of Efficacy|1|||
149960750|NCT00281580|540990097|FG012|Overall Study|Lack of Efficacy|0|||
149960751|NCT00281580|540990098|FG013|Overall Study|Lack of Efficacy|2|||
149960752|NCT00281580|540990099|FG014|Overall Study|Lack of Efficacy|1|||
149960753|NCT00281580|540990100|FG015|Overall Study|Lack of Efficacy|0|||
149960754|NCT00281580|540990085|FG000|Overall Study|Lost to Follow-up|0|||
149960755|NCT00281580|540990086|FG001|Overall Study|Lost to Follow-up|0|||
149960756|NCT00281580|540990087|FG002|Overall Study|Lost to Follow-up|0|||
149960757|NCT00281580|540990088|FG003|Overall Study|Lost to Follow-up|3|||
149960758|NCT00281580|540990089|FG004|Overall Study|Lost to Follow-up|0|||
149960759|NCT00281580|540990090|FG005|Overall Study|Lost to Follow-up|1|||
149960760|NCT00281580|540990091|FG006|Overall Study|Lost to Follow-up|0|||
149960761|NCT00281580|540990092|FG007|Overall Study|Lost to Follow-up|1|||
149960762|NCT00281580|540990093|FG008|Overall Study|Lost to Follow-up|2|||
149960763|NCT00281580|540990094|FG009|Overall Study|Lost to Follow-up|1|||
149960764|NCT00281580|540990095|FG010|Overall Study|Lost to Follow-up|1|||
149960765|NCT00281580|540990096|FG011|Overall Study|Lost to Follow-up|0|||
149960766|NCT00281580|540990097|FG012|Overall Study|Lost to Follow-up|1|||
149960767|NCT00281580|540990098|FG013|Overall Study|Lost to Follow-up|0|||
149960768|NCT00281580|540990099|FG014|Overall Study|Lost to Follow-up|0|||
149960769|NCT00281580|540990100|FG015|Overall Study|Lost to Follow-up|0|||
149960770|NCT00281580|540990085|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
149960771|NCT00281580|540990086|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
149960772|NCT00281580|540990087|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
149960773|NCT00281580|540990088|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
149960774|NCT00281580|540990089|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
149960775|NCT00281580|540990090|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
149960776|NCT00281580|540990091|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
149960777|NCT00281580|540990092|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
149960778|NCT00281580|540990093|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
149960779|NCT00281580|540990094|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
149960780|NCT00281580|540990095|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
149960781|NCT00281580|540990096|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
149960782|NCT00281580|540990097|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
149960783|NCT00281580|540990098|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
149960784|NCT00281580|540990099|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
149960785|NCT00281580|540990100|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
149960786|NCT03071965|540990101|FG000|Overall Study|Adverse Event|0|||
149960787|NCT03071965|540990102|FG001|Overall Study|Adverse Event|0|||
149960788|NCT03071965|540990103|FG002|Overall Study|Adverse Event|1|||
149960789|NCT03071965|540990104|FG003|Overall Study|Adverse Event|0|||
149960790|NCT03071965|540990101|FG000|Overall Study|Death|0|||
149960791|NCT03071965|540990102|FG001|Overall Study|Death|0|||
149960792|NCT03071965|540990103|FG002|Overall Study|Death|1|||
149960793|NCT03071965|540990104|FG003|Overall Study|Death|1|||
149960794|NCT03071965|540990101|FG000|Overall Study|COVID-19|0|||
149960795|NCT03071965|540990102|FG001|Overall Study|COVID-19|1|||
149960796|NCT03071965|540990103|FG002|Overall Study|COVID-19|0|||
149960797|NCT03071965|540990104|FG003|Overall Study|COVID-19|1|||
149960798|NCT03071965|540990101|FG000|Overall Study|Other Health Reason|0|||
149960799|NCT03071965|540990102|FG001|Overall Study|Other Health Reason|0|||
149960800|NCT03071965|540990103|FG002|Overall Study|Other Health Reason|0|||
149960801|NCT03071965|540990104|FG003|Overall Study|Other Health Reason|1|||
149960802|NCT00986102|540990105|FG000|Overall Study|Lost to Follow-up|0|||
149960803|NCT00986102|540990106|FG001|Overall Study|Lost to Follow-up|1|||
149960804|NCT00986102|540990107|FG002|Overall Study|Lost to Follow-up|0|||
149960805|NCT00986102|540990108|FG003|Overall Study|Lost to Follow-up|1|||
149960806|NCT00986102|540990105|FG000|Overall Study|Withdrawal by Subject|1|||
149960807|NCT00986102|540990106|FG001|Overall Study|Withdrawal by Subject|1|||
149960808|NCT00986102|540990107|FG002|Overall Study|Withdrawal by Subject|0|||
149960809|NCT00986102|540990108|FG003|Overall Study|Withdrawal by Subject|0|||
149960810|NCT04135352|540990110|FG000|Overall Study|Not treated-randomization error|0|||
149960811|NCT04135352|540990111|FG001|Overall Study|Not treated-randomization error|0|||
149960812|NCT04135352|540990112|FG002|Overall Study|Not treated-randomization error|1|||
150290635|NCT05103332|542197814|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
150290636|NCT05103332|542197815|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
150290637|NCT05103332|542197816|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
150290638|NCT05103332|542197817|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
150290639|NCT05103332|542197800|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290640|NCT05103332|542197801|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149960813|NCT04135352|540990113|FG003|Overall Study|Not treated-randomization error|0|||
149960814|NCT04135352|540990114|FG004|Overall Study|Not treated-randomization error|0|||
149960815|NCT04135352|540990115|FG005|Overall Study|Not treated-randomization error|0|||
149960816|NCT04135352|540990116|FG006|Overall Study|Not treated-randomization error|0|||
150290641|NCT05103332|542197802|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149960817|NCT04135352|540990117|FG007|Overall Study|Not treated-randomization error|0|||
149960818|NCT04135352|540990110|FG000|Overall Study|Withdrawal by Subject|0|||
149960819|NCT04135352|540990111|FG001|Overall Study|Withdrawal by Subject|0|||
149960820|NCT04135352|540990112|FG002|Overall Study|Withdrawal by Subject|2|||
149960821|NCT04135352|540990113|FG003|Overall Study|Withdrawal by Subject|0|||
149960822|NCT04135352|540990114|FG004|Overall Study|Withdrawal by Subject|0|||
149960823|NCT04135352|540990115|FG005|Overall Study|Withdrawal by Subject|0|||
149960824|NCT04135352|540990116|FG006|Overall Study|Withdrawal by Subject|0|||
149960825|NCT04135352|540990117|FG007|Overall Study|Withdrawal by Subject|0|||
149960826|NCT04135352|540990110|FG000|Overall Study|Sponsor Decision|0|||
150290642|NCT05103332|542197803|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149960827|NCT04135352|540990111|FG001|Overall Study|Sponsor Decision|0|||
149960828|NCT04135352|540990112|FG002|Overall Study|Sponsor Decision|2|||
149960829|NCT04135352|540990113|FG003|Overall Study|Sponsor Decision|5|||
149960830|NCT04135352|540990114|FG004|Overall Study|Sponsor Decision|1|||
149960831|NCT04135352|540990115|FG005|Overall Study|Sponsor Decision|4|||
149960832|NCT04135352|540990116|FG006|Overall Study|Sponsor Decision|0|||
149960833|NCT04135352|540990117|FG007|Overall Study|Sponsor Decision|0|||
149960834|NCT04135352|540990110|FG000|Overall Study|Physician Decision|0|||
149960835|NCT04135352|540990111|FG001|Overall Study|Physician Decision|0|||
149960836|NCT04135352|540990112|FG002|Overall Study|Physician Decision|1|||
149960837|NCT04135352|540990113|FG003|Overall Study|Physician Decision|0|||
149960838|NCT04135352|540990114|FG004|Overall Study|Physician Decision|1|||
149960839|NCT04135352|540990115|FG005|Overall Study|Physician Decision|0|||
149960840|NCT04135352|540990116|FG006|Overall Study|Physician Decision|0|||
149960841|NCT04135352|540990117|FG007|Overall Study|Physician Decision|0|||
149960842|NCT04135352|540990110|FG000|Overall Study|Death|3|||
149960843|NCT04135352|540990111|FG001|Overall Study|Death|4|||
149960844|NCT04135352|540990112|FG002|Overall Study|Death|7|||
149960845|NCT04135352|540990113|FG003|Overall Study|Death|0|||
149960846|NCT04135352|540990114|FG004|Overall Study|Death|3|||
149960847|NCT04135352|540990115|FG005|Overall Study|Death|1|||
149960848|NCT04135352|540990116|FG006|Overall Study|Death|0|||
149960849|NCT04135352|540990117|FG007|Overall Study|Death|0|||
149960850|NCT01392495|540990120|FG000|Overall Study|Death|3|||
149960851|NCT01392495|540990120|FG000|Overall Study|Administrative problems|8|||
149960852|NCT01392495|540990120|FG000|Overall Study|Withdrawal by Subject|2|||
149960853|NCT01392495|540990120|FG000|Overall Study|Adverse Event|3|||
149960854|NCT00819832|540990123|FG000|Overall Study|Sponsor Termination of Study|3|||
149960855|NCT00819832|540990124|FG001|Overall Study|Sponsor Termination of Study|0|||
149960856|NCT00819832|540990125|FG002|Overall Study|Sponsor Termination of Study|0|||
149960857|NCT00819832|540990126|FG003|Overall Study|Sponsor Termination of Study|0|||
149960858|NCT00819832|540990127|FG004|Overall Study|Sponsor Termination of Study|0|||
149960859|NCT00819832|540990128|FG005|Overall Study|Sponsor Termination of Study|0|||
149960860|NCT01452789|540990129|FG000|Overall Study|Withdrawal by Subject|3|||
149960861|NCT01452789|540990130|FG001|Overall Study|Withdrawal by Subject|2|||
149960862|NCT00147537|540990131|FG000|Phase 1b|Death|0|||
149960863|NCT00147537|540990132|FG001|Phase 1b|Death|1|||
149960864|NCT00147537|540990133|FG002|Phase 1b|Death|2|||
149960865|NCT00147537|540990134|FG003|Phase 1b|Death|1|||
149960866|NCT00147537|540990135|FG004|Phase 1b|Death|2|||
149960867|NCT00147537|540990136|FG005|Phase 1b|Death|2|||
149960868|NCT00147537|540990137|FG006|Phase 1b|Death|1|||
149960869|NCT00147537|540990138|FG007|Phase 1b|Death|3|||
149960870|NCT00147537|540990139|FG008|Phase 1b|Death|9|||
149960871|NCT00147537|540990140|FG009|Phase 1b|Death|0|||
149960872|NCT00147537|540990141|FG010|Phase 1b|Death|0|||
149960873|NCT00147537|540990131|FG000|Phase 1b|Lost to Follow-up|2|||
149960874|NCT00147537|540990132|FG001|Phase 1b|Lost to Follow-up|1|||
149960875|NCT00147537|540990133|FG002|Phase 1b|Lost to Follow-up|0|||
149960876|NCT00147537|540990134|FG003|Phase 1b|Lost to Follow-up|0|||
149960877|NCT00147537|540990135|FG004|Phase 1b|Lost to Follow-up|0|||
149960878|NCT00147537|540990136|FG005|Phase 1b|Lost to Follow-up|0|||
149960879|NCT00147537|540990137|FG006|Phase 1b|Lost to Follow-up|2|||
149960880|NCT00147537|540990138|FG007|Phase 1b|Lost to Follow-up|0|||
149960881|NCT00147537|540990139|FG008|Phase 1b|Lost to Follow-up|1|||
149960882|NCT00147537|540990140|FG009|Phase 1b|Lost to Follow-up|0|||
149960883|NCT00147537|540990141|FG010|Phase 1b|Lost to Follow-up|0|||
149960884|NCT00147537|540990131|FG000|Phase 1b|Other|0|||
149960885|NCT00147537|540990132|FG001|Phase 1b|Other|0|||
149960886|NCT00147537|540990133|FG002|Phase 1b|Other|2|||
149960887|NCT00147537|540990134|FG003|Phase 1b|Other|1|||
149960888|NCT00147537|540990135|FG004|Phase 1b|Other|1|||
149960889|NCT00147537|540990136|FG005|Phase 1b|Other|1|||
149960890|NCT00147537|540990137|FG006|Phase 1b|Other|14|||
149960891|NCT00147537|540990138|FG007|Phase 1b|Other|4|||
149960892|NCT00147537|540990139|FG008|Phase 1b|Other|4|||
149960893|NCT00147537|540990140|FG009|Phase 1b|Other|0|||
149960894|NCT00147537|540990141|FG010|Phase 1b|Other|0|||
149960895|NCT00147537|540990131|FG000|Phase 1b|Withdrawal by Subject|0|||
149960896|NCT00147537|540990132|FG001|Phase 1b|Withdrawal by Subject|0|||
149960897|NCT00147537|540990133|FG002|Phase 1b|Withdrawal by Subject|0|||
149960898|NCT00147537|540990134|FG003|Phase 1b|Withdrawal by Subject|0|||
149960899|NCT00147537|540990135|FG004|Phase 1b|Withdrawal by Subject|0|||
149960900|NCT00147537|540990136|FG005|Phase 1b|Withdrawal by Subject|0|||
149960901|NCT00147537|540990137|FG006|Phase 1b|Withdrawal by Subject|0|||
149960902|NCT00147537|540990138|FG007|Phase 1b|Withdrawal by Subject|0|||
149960903|NCT00147537|540990139|FG008|Phase 1b|Withdrawal by Subject|2|||
149960904|NCT00147537|540990140|FG009|Phase 1b|Withdrawal by Subject|0|||
149960905|NCT00147537|540990141|FG010|Phase 1b|Withdrawal by Subject|0|||
149960906|NCT00147537|540990131|FG000|Phase 1b|Randomized but not treated|0|||
149960907|NCT00147537|540990132|FG001|Phase 1b|Randomized but not treated|0|||
149960908|NCT00147537|540990133|FG002|Phase 1b|Randomized but not treated|0|||
149960909|NCT00147537|540990134|FG003|Phase 1b|Randomized but not treated|0|||
149960910|NCT00147537|540990135|FG004|Phase 1b|Randomized but not treated|0|||
149960911|NCT00147537|540990136|FG005|Phase 1b|Randomized but not treated|0|||
149960912|NCT00147537|540990137|FG006|Phase 1b|Randomized but not treated|1|||
149960913|NCT00147537|540990138|FG007|Phase 1b|Randomized but not treated|0|||
149960914|NCT00147537|540990139|FG008|Phase 1b|Randomized but not treated|1|||
149960915|NCT00147537|540990140|FG009|Phase 1b|Randomized but not treated|0|||
149960916|NCT00147537|540990141|FG010|Phase 1b|Randomized but not treated|0|||
149960917|NCT00147537|540990131|FG000|Phase 2|Death|0|||
149960918|NCT00147537|540990132|FG001|Phase 2|Death|0|||
149960919|NCT00147537|540990133|FG002|Phase 2|Death|0|||
149960920|NCT00147537|540990134|FG003|Phase 2|Death|0|||
149960921|NCT00147537|540990135|FG004|Phase 2|Death|0|||
149960922|NCT00147537|540990136|FG005|Phase 2|Death|0|||
149960923|NCT00147537|540990137|FG006|Phase 2|Death|0|||
149960924|NCT00147537|540990138|FG007|Phase 2|Death|0|||
149960925|NCT00147537|540990139|FG008|Phase 2|Death|0|||
149960926|NCT00147537|540990140|FG009|Phase 2|Death|85|||
149960927|NCT00147537|540990141|FG010|Phase 2|Death|31|||
149960928|NCT00147537|540990131|FG000|Phase 2|Lost to Follow-up|0|||
149960929|NCT00147537|540990132|FG001|Phase 2|Lost to Follow-up|0|||
149960930|NCT00147537|540990133|FG002|Phase 2|Lost to Follow-up|0|||
149960931|NCT00147537|540990134|FG003|Phase 2|Lost to Follow-up|0|||
149960932|NCT00147537|540990135|FG004|Phase 2|Lost to Follow-up|0|||
149960933|NCT00147537|540990136|FG005|Phase 2|Lost to Follow-up|0|||
149960934|NCT00147537|540990137|FG006|Phase 2|Lost to Follow-up|0|||
149960935|NCT00147537|540990138|FG007|Phase 2|Lost to Follow-up|0|||
149960936|NCT00147537|540990139|FG008|Phase 2|Lost to Follow-up|0|||
149960937|NCT00147537|540990140|FG009|Phase 2|Lost to Follow-up|12|||
149960938|NCT00147537|540990141|FG010|Phase 2|Lost to Follow-up|4|||
149960939|NCT00147537|540990131|FG000|Phase 2|Other|0|||
149960940|NCT00147537|540990132|FG001|Phase 2|Other|0|||
149960941|NCT00147537|540990133|FG002|Phase 2|Other|0|||
149960942|NCT00147537|540990134|FG003|Phase 2|Other|0|||
149960943|NCT00147537|540990135|FG004|Phase 2|Other|0|||
149960944|NCT00147537|540990136|FG005|Phase 2|Other|0|||
149960945|NCT00147537|540990137|FG006|Phase 2|Other|0|||
149960946|NCT00147537|540990138|FG007|Phase 2|Other|0|||
149960947|NCT00147537|540990139|FG008|Phase 2|Other|0|||
149960948|NCT00147537|540990140|FG009|Phase 2|Other|47|||
149960949|NCT00147537|540990141|FG010|Phase 2|Other|12|||
150173426|NCT01337635|541771262|FG001|Overall Study|Lost to Follow-up|1|||
149960950|NCT00147537|540990131|FG000|Phase 2|Withdrawal by Subject|0|||
149960951|NCT00147537|540990132|FG001|Phase 2|Withdrawal by Subject|0|||
149960952|NCT00147537|540990133|FG002|Phase 2|Withdrawal by Subject|0|||
149960953|NCT00147537|540990134|FG003|Phase 2|Withdrawal by Subject|0|||
149960954|NCT00147537|540990135|FG004|Phase 2|Withdrawal by Subject|0|||
149960955|NCT00147537|540990136|FG005|Phase 2|Withdrawal by Subject|0|||
149960956|NCT00147537|540990137|FG006|Phase 2|Withdrawal by Subject|0|||
149960957|NCT00147537|540990138|FG007|Phase 2|Withdrawal by Subject|0|||
149960958|NCT00147537|540990139|FG008|Phase 2|Withdrawal by Subject|0|||
149960959|NCT00147537|540990140|FG009|Phase 2|Withdrawal by Subject|16|||
149960960|NCT00147537|540990141|FG010|Phase 2|Withdrawal by Subject|4|||
149960961|NCT00147537|540990131|FG000|Phase 2|Randomized but not treated|0|||
149960962|NCT00147537|540990132|FG001|Phase 2|Randomized but not treated|0|||
149960963|NCT00147537|540990133|FG002|Phase 2|Randomized but not treated|0|||
149960964|NCT00147537|540990134|FG003|Phase 2|Randomized but not treated|0|||
149960965|NCT00147537|540990135|FG004|Phase 2|Randomized but not treated|0|||
149960966|NCT00147537|540990136|FG005|Phase 2|Randomized but not treated|0|||
149960967|NCT00147537|540990137|FG006|Phase 2|Randomized but not treated|0|||
149960968|NCT00147537|540990138|FG007|Phase 2|Randomized but not treated|0|||
149960969|NCT00147537|540990139|FG008|Phase 2|Randomized but not treated|0|||
149960970|NCT00147537|540990140|FG009|Phase 2|Randomized but not treated|1|||
149960971|NCT00147537|540990141|FG010|Phase 2|Randomized but not treated|1|||
149960972|NCT01089543|540990142|FG000|Overall Study|Withdrawal by Subject|2|||
149960973|NCT01089543|540990143|FG001|Overall Study|Withdrawal by Subject|3|||
149960974|NCT01089543|540990144|FG002|Overall Study|Withdrawal by Subject|3|||
149960975|NCT01089543|540990145|FG003|Overall Study|Withdrawal by Subject|1|||
149960976|NCT01089543|540990142|FG000|Overall Study|Physician Decision|1|||
149960977|NCT01089543|540990143|FG001|Overall Study|Physician Decision|0|||
149960978|NCT01089543|540990144|FG002|Overall Study|Physician Decision|0|||
149960979|NCT01089543|540990145|FG003|Overall Study|Physician Decision|1|||
149960980|NCT01089543|540990142|FG000|Overall Study|Adverse Event|0|||
149960981|NCT01089543|540990143|FG001|Overall Study|Adverse Event|1|||
149960982|NCT01089543|540990144|FG002|Overall Study|Adverse Event|0|||
149960983|NCT01089543|540990145|FG003|Overall Study|Adverse Event|0|||
149960984|NCT00468546|540990147|FG000|Week 24 Analysis|Lack of Efficacy|83|||
149960985|NCT00468546|540990148|FG001|Week 24 Analysis|Lack of Efficacy|37|||
149960986|NCT00468546|540990147|FG000|Week 24 Analysis|Refused treatment|5|||
149960987|NCT00468546|540990148|FG001|Week 24 Analysis|Refused treatment|5|||
149960988|NCT00468546|540990147|FG000|Week 24 Analysis|Adverse Event|1|||
149960989|NCT00468546|540990148|FG001|Week 24 Analysis|Adverse Event|8|||
149960990|NCT00468546|540990147|FG000|Week 24 Analysis|Failure to return|3|||
149960991|NCT00468546|540990148|FG001|Week 24 Analysis|Failure to return|4|||
149960992|NCT00468546|540990147|FG000|Week 24 Analysis|Rescue therapy|2|||
149960993|NCT00468546|540990148|FG001|Week 24 Analysis|Rescue therapy|0|||
149960994|NCT00468546|540990147|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
149960995|NCT00468546|540990148|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
149960996|NCT00468546|540990147|FG000|Week 24 Analysis|Due to clinical hold|1|||
149960997|NCT00468546|540990148|FG001|Week 24 Analysis|Due to clinical hold|0|||
149960998|NCT00468546|540990147|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
149960999|NCT00468546|540990148|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
149961000|NCT00468546|540990147|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
149961001|NCT00468546|540990148|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
149961002|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
149961003|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
149961004|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Death|1|||
149961005|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Death|0|||
149961006|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
149961007|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
149961008|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
149961009|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
149961010|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
149961011|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
149961012|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
149961013|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
149961014|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
149961015|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
149961016|NCT00468546|540990147|FG000|Week 24 to Week 104 Analysis|Other|17|||
149961017|NCT00468546|540990148|FG001|Week 24 to Week 104 Analysis|Other|14|||
149961018|NCT00472641|540990150|FG000|Overall Study|Lack of Efficacy|3|||
149961019|NCT00472641|540990150|FG000|Overall Study|Adverse Event|3|||
149961020|NCT00472641|540990150|FG000|Overall Study|Lost to Follow-up|1|||
149961021|NCT02006654|540990151|FG000|Overall Study|Withdrawal before treatment|4|||
150290643|NCT05103332|542197804|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149961022|NCT02006654|540990152|FG001|Overall Study|Withdrawal before treatment|2|||
149961023|NCT02006654|540990151|FG000|Overall Study|Adverse Event|16|||
149961024|NCT02006654|540990152|FG001|Overall Study|Adverse Event|17|||
149961025|NCT02006654|540990151|FG000|Overall Study|Death|1|||
149961026|NCT02006654|540990152|FG001|Overall Study|Death|0|||
149961027|NCT02006654|540990151|FG000|Overall Study|Withdrawal by Subject|14|||
149961028|NCT02006654|540990152|FG001|Overall Study|Withdrawal by Subject|12|||
149961029|NCT02006654|540990151|FG000|Overall Study|Protocol Violation|5|||
149961030|NCT02006654|540990152|FG001|Overall Study|Protocol Violation|8|||
149961031|NCT02006654|540990151|FG000|Overall Study|Lost to Follow-up|1|||
149961032|NCT02006654|540990152|FG001|Overall Study|Lost to Follow-up|0|||
149961033|NCT02006654|540990151|FG000|Overall Study|patient's will|2|||
149961034|NCT02006654|540990152|FG001|Overall Study|patient's will|1|||
149961035|NCT02006654|540990151|FG000|Overall Study|insufficient compliance|1|||
149961036|NCT02006654|540990152|FG001|Overall Study|insufficient compliance|0|||
149961037|NCT02006654|540990151|FG000|Overall Study|worsening cognitive condition|0|||
149961038|NCT02006654|540990152|FG001|Overall Study|worsening cognitive condition|1|||
149961039|NCT02006654|540990151|FG000|Overall Study|faecal incontinence|0|||
149961040|NCT02006654|540990152|FG001|Overall Study|faecal incontinence|1|||
149961041|NCT02006654|540990151|FG000|Overall Study|mood disorder|0|||
149961042|NCT02006654|540990152|FG001|Overall Study|mood disorder|1|||
149961043|NCT02006654|540990151|FG000|Overall Study|disallowed medication|1|||
149961044|NCT02006654|540990152|FG001|Overall Study|disallowed medication|0|||
149961045|NCT02006654|540990151|FG000|Overall Study|moving out of state|0|||
149961046|NCT02006654|540990152|FG001|Overall Study|moving out of state|1|||
149961047|NCT03438656|540990155|FG000|Overall Study|Lost to Follow-up|2|||
149961048|NCT04128228|540990160|FG000|Overall Study|Withdrawal by Subject|3|||
149961049|NCT04128228|540990161|FG001|Overall Study|Withdrawal by Subject|3|||
149961050|NCT04128228|540990162|FG002|Overall Study|Withdrawal by Subject|0|||
149961051|NCT04128228|540990163|FG003|Overall Study|Withdrawal by Subject|0|||
149961052|NCT04128228|540990160|FG000|Overall Study|noncompliance|2|||
149961053|NCT04128228|540990161|FG001|Overall Study|noncompliance|2|||
149961054|NCT04128228|540990162|FG002|Overall Study|noncompliance|0|||
149961055|NCT04128228|540990163|FG003|Overall Study|noncompliance|0|||
149961056|NCT05652140|540990164|FG000|Overall Study|Lost to Follow-up|7|||
149961057|NCT05652140|540990165|FG001|Overall Study|Lost to Follow-up|16|||
149961058|NCT05652140|540990166|FG002|Overall Study|Lost to Follow-up|22|||
149961059|NCT05652140|540990167|FG003|Overall Study|Lost to Follow-up|31|||
149961060|NCT04401293|540990170|FG000|Overall Study|Withdrawal by Subject|1|||
149961061|NCT04401293|540990171|FG001|Overall Study|Withdrawal by Subject|3|||
149961062|NCT01026038|540990172|FG000|Overall Study|Lost to Follow-up|1|||
149961063|NCT01026038|540990173|FG001|Overall Study|Lost to Follow-up|1|||
149961064|NCT01026038|540990174|FG002|Overall Study|Lost to Follow-up|0|||
149961065|NCT03679884|540990175|FG000|Overall Study|Other|12|||
149961066|NCT03679884|540990176|FG001|Overall Study|Other|12|||
149961067|NCT03679884|540990177|FG002|Overall Study|Other|12|||
149961068|NCT03679884|540990178|FG003|Overall Study|Other|7|||
149961069|NCT03679884|540990179|FG004|Overall Study|Other|8|||
149961070|NCT03679884|540990175|FG000|Overall Study|Lack of Efficacy|15|||
149961071|NCT03679884|540990176|FG001|Overall Study|Lack of Efficacy|29|||
149961072|NCT03679884|540990177|FG002|Overall Study|Lack of Efficacy|13|||
149961073|NCT03679884|540990178|FG003|Overall Study|Lack of Efficacy|29|||
149961074|NCT03679884|540990179|FG004|Overall Study|Lack of Efficacy|10|||
149961075|NCT03679884|540990175|FG000|Overall Study|Death|1|||
149961076|NCT03679884|540990176|FG001|Overall Study|Death|0|||
149961077|NCT03679884|540990177|FG002|Overall Study|Death|0|||
149961078|NCT03679884|540990178|FG003|Overall Study|Death|0|||
149961079|NCT03679884|540990179|FG004|Overall Study|Death|0|||
149961080|NCT03679884|540990175|FG000|Overall Study|Adverse Event|2|||
149961081|NCT03679884|540990176|FG001|Overall Study|Adverse Event|10|||
149961082|NCT03679884|540990177|FG002|Overall Study|Adverse Event|9|||
149961083|NCT03679884|540990178|FG003|Overall Study|Adverse Event|6|||
149961084|NCT03679884|540990179|FG004|Overall Study|Adverse Event|6|||
149961085|NCT03679884|540990175|FG000|Overall Study|Withdrawal by Subject|12|||
149961086|NCT03679884|540990176|FG001|Overall Study|Withdrawal by Subject|23|||
149961087|NCT03679884|540990177|FG002|Overall Study|Withdrawal by Subject|8|||
149961088|NCT03679884|540990178|FG003|Overall Study|Withdrawal by Subject|8|||
149961089|NCT03679884|540990179|FG004|Overall Study|Withdrawal by Subject|9|||
149961090|NCT03679884|540990175|FG000|Overall Study|Lost to Follow-up|1|||
149961091|NCT03679884|540990176|FG001|Overall Study|Lost to Follow-up|4|||
149961092|NCT03679884|540990177|FG002|Overall Study|Lost to Follow-up|2|||
149961093|NCT03679884|540990178|FG003|Overall Study|Lost to Follow-up|0|||
149961094|NCT03679884|540990179|FG004|Overall Study|Lost to Follow-up|3|||
149961095|NCT02774278|540990180|FG000|Overall Study|Lack of Efficacy|199|||
149961096|NCT02774278|540990180|FG000|Overall Study|Death|29|||
149961097|NCT02774278|540990180|FG000|Overall Study|Adverse event/intercurrent illness|16|||
150290644|NCT05103332|542197805|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149961098|NCT02774278|540990180|FG000|Overall Study|Refused treatment/did not cooperate|9|||
149961099|NCT02774278|540990180|FG000|Overall Study|Administrative reasons|6|||
149961100|NCT02774278|540990180|FG000|Overall Study|Withdrawal by Subject|3|||
149961101|NCT02774278|540990180|FG000|Overall Study|Protocol Violation|2|||
149961102|NCT00236197|540990190|FG000|Overall Study|Withdrawal by Subject|3|||
149961103|NCT00236197|540990191|FG001|Overall Study|Withdrawal by Subject|2|||
149961104|NCT00236197|540990190|FG000|Overall Study|Lost to Follow-up|1|||
149961105|NCT00236197|540990191|FG001|Overall Study|Lost to Follow-up|5|||
149961106|NCT00236197|540990190|FG000|Overall Study|Protocol Violation|0|||
149961107|NCT00236197|540990191|FG001|Overall Study|Protocol Violation|3|||
149961108|NCT00236197|540990190|FG000|Overall Study|Medication non-compliance|1|||
149961109|NCT00236197|540990191|FG001|Overall Study|Medication non-compliance|2|||
149961110|NCT00236197|540990190|FG000|Overall Study|Other|0|||
149961111|NCT00236197|540990191|FG001|Overall Study|Other|2|||
149961112|NCT06868667|540990192|FG000|Overall Study|Death|0|||
149961113|NCT06868667|540990193|FG001|Overall Study|Death|4|||
149961114|NCT06868667|540990192|FG000|Overall Study|Lost to Follow-up|0|||
149961115|NCT06868667|540990193|FG001|Overall Study|Lost to Follow-up|1|||
149961116|NCT06868667|540990192|FG000|Overall Study|Withdrawal by Subject|1|||
149961117|NCT06868667|540990193|FG001|Overall Study|Withdrawal by Subject|0|||
149961118|NCT06868667|540990192|FG000|Overall Study|Ongoing|9|||
149961119|NCT06868667|540990193|FG001|Overall Study|Ongoing|9|||
149961120|NCT05330429|540990194|FG000|Overall Study|Study Terminated by Sponsor|4|||
149961121|NCT05330429|540990195|FG001|Overall Study|Study Terminated by Sponsor|33|||
149961122|NCT05330429|540990196|FG002|Overall Study|Study Terminated by Sponsor|12|||
149961123|NCT05330429|540990194|FG000|Overall Study|Death|5|||
149961124|NCT05330429|540990195|FG001|Overall Study|Death|2|||
149961125|NCT05330429|540990196|FG002|Overall Study|Death|4|||
149961126|NCT05330429|540990194|FG000|Overall Study|Withdrew Consent|0|||
149961127|NCT05330429|540990195|FG001|Overall Study|Withdrew Consent|5|||
149961128|NCT05330429|540990196|FG002|Overall Study|Withdrew Consent|4|||
149961129|NCT05330429|540990194|FG000|Overall Study|Investigator's Discretion|0|||
149961130|NCT05330429|540990195|FG001|Overall Study|Investigator's Discretion|1|||
149961131|NCT05330429|540990196|FG002|Overall Study|Investigator's Discretion|3|||
149961132|NCT05330429|540990194|FG000|Overall Study|Subject Decision|1|||
149961133|NCT05330429|540990195|FG001|Overall Study|Subject Decision|2|||
149961134|NCT05330429|540990196|FG002|Overall Study|Subject Decision|0|||
149961135|NCT05330429|540990194|FG000|Overall Study|Lost to Follow-up|0|||
149961136|NCT05330429|540990195|FG001|Overall Study|Lost to Follow-up|1|||
149961137|NCT05330429|540990196|FG002|Overall Study|Lost to Follow-up|0|||
149961138|NCT00655746|540990197|FG000|Overall Study|Withdrawal by Subject|1|||
149961139|NCT03178942|540990198|FG000|Overall Study|Withdrawal by Subject|2|||
149961140|NCT03178942|540990199|FG001|Overall Study|Withdrawal by Subject|0|||
149961141|NCT03178942|540990198|FG000|Overall Study|Lost to Follow-up|1|||
149961142|NCT03178942|540990199|FG001|Overall Study|Lost to Follow-up|2|||
149961143|NCT06097273|540990200|FG000|Overall Study|Death|2|||
149961144|NCT06097273|540990201|FG001|Overall Study|Death|1|||
149961145|NCT06097273|540990202|FG002|Overall Study|Death|2|||
149961146|NCT06097273|540990203|FG003|Overall Study|Death|2|||
149961147|NCT06097273|540990200|FG000|Overall Study|Lost to Follow-up|27|||
149961148|NCT06097273|540990201|FG001|Overall Study|Lost to Follow-up|18|||
149961149|NCT06097273|540990202|FG002|Overall Study|Lost to Follow-up|36|||
149961150|NCT06097273|540990203|FG003|Overall Study|Lost to Follow-up|31|||
149961151|NCT06097273|540990200|FG000|Overall Study|Physician Decision|0|||
149961152|NCT06097273|540990201|FG001|Overall Study|Physician Decision|1|||
149961153|NCT06097273|540990202|FG002|Overall Study|Physician Decision|0|||
149961154|NCT06097273|540990203|FG003|Overall Study|Physician Decision|3|||
149961155|NCT06097273|540990200|FG000|Overall Study|Protocol Violation|1|||
149961156|NCT06097273|540990201|FG001|Overall Study|Protocol Violation|1|||
149961157|NCT06097273|540990202|FG002|Overall Study|Protocol Violation|2|||
149961158|NCT06097273|540990203|FG003|Overall Study|Protocol Violation|1|||
149961159|NCT06097273|540990200|FG000|Overall Study|Withdrawal by Subject|14|||
149961160|NCT06097273|540990201|FG001|Overall Study|Withdrawal by Subject|11|||
149961161|NCT06097273|540990202|FG002|Overall Study|Withdrawal by Subject|14|||
149961162|NCT06097273|540990203|FG003|Overall Study|Withdrawal by Subject|15|||
149961163|NCT06097273|540990200|FG000|Overall Study|Other Than Specified|7|||
149961164|NCT06097273|540990201|FG001|Overall Study|Other Than Specified|3|||
149961165|NCT06097273|540990202|FG002|Overall Study|Other Than Specified|11|||
149961166|NCT06097273|540990203|FG003|Overall Study|Other Than Specified|6|||
149961167|NCT03635996|540992020|FG000|Overall Study|Study terminated by Sponsor|94|||
149961168|NCT03635996|540992020|FG000|Overall Study|Withdrawal by Subject|20|||
149961169|NCT03635996|540992020|FG000|Overall Study|Ablation|26|||
149961170|NCT03635996|540992020|FG000|Overall Study|Adverse Event|7|||
149961171|NCT03635996|540992020|FG000|Overall Study|Physician Decision|3|||
149961172|NCT03635996|540992020|FG000|Overall Study|Prohibited medication|5|||
149961173|NCT03635996|540992020|FG000|Overall Study|Did not meet eligibility criteria|5|||
149961174|NCT03635996|540992020|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
149961175|NCT03635996|540992020|FG000|Overall Study|Protocol Violation|1|||
149961176|NCT03635996|540992020|FG000|Overall Study|Lost to Follow-up|1|||
149961177|NCT04359680|540992021|FG000|Overall Study|Withdrawal by Subject|29|||
149961178|NCT04359680|540992022|FG001|Overall Study|Withdrawal by Subject|24|||
149961179|NCT04359680|540992021|FG000|Overall Study|Adverse Event|6|||
149961180|NCT04359680|540992022|FG001|Overall Study|Adverse Event|2|||
149961181|NCT04359680|540992021|FG000|Overall Study|Lost to Follow-up|56|||
149961182|NCT04359680|540992022|FG001|Overall Study|Lost to Follow-up|59|||
149961183|NCT04359680|540992021|FG000|Overall Study|Protocol Violation|3|||
149961184|NCT04359680|540992022|FG001|Overall Study|Protocol Violation|5|||
149961185|NCT04359680|540992021|FG000|Overall Study|Physician Decision|1|||
149961186|NCT04359680|540992022|FG001|Overall Study|Physician Decision|1|||
149961187|NCT04359680|540992021|FG000|Overall Study|Sponsor Decision|0|||
149961188|NCT04359680|540992022|FG001|Overall Study|Sponsor Decision|1|||
149961189|NCT01832038|540992023|FG000|Overall Study|Death|5|||
149961190|NCT01832038|540992023|FG000|Overall Study|Adverse Event|50|||
149961191|NCT01832038|540992023|FG000|Overall Study|Lack of Efficacy|81|||
150040099|NCT01208207|541287304|FG003|Part I|Lost to Follow-up|0|||
150040100|NCT01208207|541287305|FG004|Part I|Lost to Follow-up|0|||
150040101|NCT01208207|541287306|FG005|Part I|Lost to Follow-up|0|||
150040102|NCT01208207|541287307|FG006|Part I|Lost to Follow-up|0|||
150040103|NCT01208207|541287301|FG000|Part I|Non-Compliance With Study Drug|1|||
150040104|NCT01208207|541287302|FG001|Part I|Non-Compliance With Study Drug|0|||
149961192|NCT01832038|540992023|FG000|Overall Study|Protocol Violation|7|||
149961193|NCT01832038|540992023|FG000|Overall Study|Lost to Follow-up|10|||
150040105|NCT01208207|541287303|FG002|Part I|Non-Compliance With Study Drug|1|||
150040106|NCT01208207|541287304|FG003|Part I|Non-Compliance With Study Drug|0|||
150040107|NCT01208207|541287305|FG004|Part I|Non-Compliance With Study Drug|0|||
150040108|NCT01208207|541287306|FG005|Part I|Non-Compliance With Study Drug|0|||
150173427|NCT01113931|541771263|FG000|Overall Study|Adverse Event|2|||
149961194|NCT01832038|540992023|FG000|Overall Study|Withdrawal by Subject|49|||
149961195|NCT01832038|540992023|FG000|Overall Study|Visit non-compliance|2|||
149961196|NCT01832038|540992023|FG000|Overall Study|Subject refused to return visit|2|||
149961197|NCT01832038|540992023|FG000|Overall Study|Not convenient to come back to site|2|||
149961198|NCT01832038|540992023|FG000|Overall Study|Participant was asked to quit|5|||
149961199|NCT01832038|540992023|FG000|Overall Study|Back home|1|||
149961200|NCT01832038|540992023|FG000|Overall Study|Pregnancy|1|||
149961201|NCT01832038|540992023|FG000|Overall Study|Low compliance|3|||
149961202|NCT01832038|540992023|FG000|Overall Study|Prohibit procedure|2|||
149961203|NCT01832038|540992023|FG000|Overall Study|Not possible to visit the hospital|1|||
149961204|NCT01832038|540992023|FG000|Overall Study|Changes of implementation system|3|||
149961205|NCT01832038|540992023|FG000|Overall Study|Plan to pregnancy|7|||
149961206|NCT01832038|540992023|FG000|Overall Study|Bad mood and has suicidal thought|1|||
149961207|NCT01832038|540992023|FG000|Overall Study|Prohibited concomitant medication|1|||
149961208|NCT01832038|540992023|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
149961209|NCT01832038|540992023|FG000|Overall Study|Subject considered the efficacy was poor|1|||
149961210|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
149961211|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
149961212|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
149961213|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
149961214|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
149961215|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
149961216|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
149961217|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
149961218|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
149961219|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
149961220|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
149961221|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
149961222|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
149961223|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
149961224|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
149961225|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
149961226|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
149961227|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
149961228|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
149961229|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
149961230|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
149961231|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
149961232|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
149961233|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
149961234|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
149961235|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
149961236|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
150173428|NCT01113931|541771264|FG001|Overall Study|Adverse Event|2|||
150173429|NCT01113931|541771263|FG000|Overall Study|Physician Decision|0|||
150173430|NCT01113931|541771264|FG001|Overall Study|Physician Decision|2|||
150290645|NCT05103332|542197806|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290646|NCT05103332|542197807|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290647|NCT05103332|542197808|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290648|NCT05103332|542197809|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149961237|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
149961238|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
149961239|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
150040109|NCT01208207|541287307|FG006|Part I|Non-Compliance With Study Drug|0|||
150173431|NCT01113931|541771263|FG000|Overall Study|Lost to Follow-up|12|||
150040110|NCT01208207|541287301|FG000|Part I|Physician Decision|0|||
150040111|NCT01208207|541287302|FG001|Part I|Physician Decision|1|||
150290649|NCT05103332|542197810|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149961240|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
149961241|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
149961242|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
149961243|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
149961244|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
149961245|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
149961246|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
149961247|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
149961248|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
149961249|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
149961250|NCT02596893|540992024|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
149961251|NCT02596893|540992025|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
149961252|NCT02596893|540992026|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
149961253|NCT02596893|540992027|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
149961254|NCT03280615|540992028|FG000|Overall Study|Lost to Follow-up|1|||
149961255|NCT03280615|540992029|FG001|Overall Study|Lost to Follow-up|2|||
149961256|NCT03280615|540992028|FG000|Overall Study|Adverse Event|1|||
149961257|NCT03280615|540992029|FG001|Overall Study|Adverse Event|1|||
149961258|NCT03280615|540992028|FG000|Overall Study|Withdrawal by Subject|2|||
149961259|NCT03280615|540992029|FG001|Overall Study|Withdrawal by Subject|2|||
149961260|NCT00004228|540992032|FG000|Overall Study|Adverse Event|0|||
149961261|NCT00004228|540992033|FG001|Overall Study|Adverse Event|1|||
149961262|NCT00004228|540992034|FG002|Overall Study|Adverse Event|0|||
149961263|NCT00004228|540992035|FG003|Overall Study|Adverse Event|0|||
149857276|NCT02960438|540605285|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
149857277|NCT02960438|540605286|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
149857278|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
149857279|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
149857280|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
149857281|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
149857282|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
149857283|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
149857284|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
149857285|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
149857286|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
149857287|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
149961264|NCT00004228|540992036|FG004|Overall Study|Adverse Event|1|||
149961265|NCT00004228|540992037|FG005|Overall Study|Adverse Event|0|||
149961266|NCT00004228|540992038|FG006|Overall Study|Adverse Event|0|||
149961267|NCT00004228|540992032|FG000|Overall Study|Death|0|||
149961268|NCT00004228|540992033|FG001|Overall Study|Death|1|||
149961269|NCT00004228|540992034|FG002|Overall Study|Death|2|||
149961270|NCT00004228|540992035|FG003|Overall Study|Death|0|||
149961271|NCT00004228|540992036|FG004|Overall Study|Death|1|||
149961272|NCT00004228|540992037|FG005|Overall Study|Death|0|||
149857288|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
149857289|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
149857290|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
149961273|NCT00004228|540992038|FG006|Overall Study|Death|0|||
149961274|NCT00004228|540992032|FG000|Overall Study|Lack of Efficacy|1|||
149961275|NCT00004228|540992033|FG001|Overall Study|Lack of Efficacy|6|||
149961276|NCT00004228|540992034|FG002|Overall Study|Lack of Efficacy|5|||
149961277|NCT00004228|540992035|FG003|Overall Study|Lack of Efficacy|3|||
149961278|NCT00004228|540992036|FG004|Overall Study|Lack of Efficacy|9|||
149961279|NCT00004228|540992037|FG005|Overall Study|Lack of Efficacy|8|||
149961280|NCT00004228|540992038|FG006|Overall Study|Lack of Efficacy|4|||
149961281|NCT00004228|540992032|FG000|Overall Study|Lost to Follow-up|0|||
149961282|NCT00004228|540992033|FG001|Overall Study|Lost to Follow-up|0|||
149961283|NCT00004228|540992034|FG002|Overall Study|Lost to Follow-up|1|||
149961284|NCT00004228|540992035|FG003|Overall Study|Lost to Follow-up|0|||
149961285|NCT00004228|540992036|FG004|Overall Study|Lost to Follow-up|0|||
149961286|NCT00004228|540992037|FG005|Overall Study|Lost to Follow-up|0|||
149961287|NCT00004228|540992038|FG006|Overall Study|Lost to Follow-up|0|||
149961288|NCT00004228|540992032|FG000|Overall Study|Physician Decision|1|||
149961289|NCT00004228|540992033|FG001|Overall Study|Physician Decision|0|||
149961290|NCT00004228|540992034|FG002|Overall Study|Physician Decision|3|||
149961291|NCT00004228|540992035|FG003|Overall Study|Physician Decision|2|||
149961292|NCT00004228|540992036|FG004|Overall Study|Physician Decision|1|||
149961293|NCT00004228|540992037|FG005|Overall Study|Physician Decision|1|||
149961294|NCT00004228|540992038|FG006|Overall Study|Physician Decision|1|||
149961295|NCT00004228|540992032|FG000|Overall Study|Protocol Violation|0|||
149961296|NCT00004228|540992033|FG001|Overall Study|Protocol Violation|5|||
149961297|NCT00004228|540992034|FG002|Overall Study|Protocol Violation|2|||
149961298|NCT00004228|540992035|FG003|Overall Study|Protocol Violation|1|||
149857291|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
149857292|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
149857293|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
149857294|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
149857295|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
149857296|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
149857297|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
149857298|NCT02960438|540605283|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
149857299|NCT02960438|540605284|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
149857300|NCT02960438|540605285|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
149857301|NCT02960438|540605286|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
149857302|NCT03686150|540605287|FG000|Overall Study|Withdrawal by Subject|1|||
149857303|NCT03686150|540605288|FG001|Overall Study|Withdrawal by Subject|1|||
149857304|NCT03686150|540605289|FG002|Overall Study|Withdrawal by Subject|1|||
150040112|NCT01208207|541287303|FG002|Part I|Physician Decision|0|||
149857305|NCT03686150|540605290|FG003|Overall Study|Withdrawal by Subject|0|||
149857306|NCT03686150|540605291|FG004|Overall Study|Withdrawal by Subject|1|||
149857307|NCT03686150|540605292|FG005|Overall Study|Withdrawal by Subject|2|||
150040113|NCT01208207|541287304|FG003|Part I|Physician Decision|0|||
150040114|NCT01208207|541287305|FG004|Part I|Physician Decision|0|||
150040115|NCT01208207|541287306|FG005|Part I|Physician Decision|0|||
150290650|NCT05103332|542197811|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290651|NCT05103332|542197812|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290652|NCT05103332|542197813|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290653|NCT05103332|542197814|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290654|NCT05103332|542197815|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290655|NCT05103332|542197816|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
150290656|NCT05103332|542197817|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
150290657|NCT05103332|542197800|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290658|NCT05103332|542197801|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290659|NCT05103332|542197802|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857308|NCT03686150|540605287|FG000|Overall Study|Physician Decision|1|||
149857309|NCT03686150|540605288|FG001|Overall Study|Physician Decision|0|||
149857310|NCT03686150|540605289|FG002|Overall Study|Physician Decision|0|||
149857311|NCT03686150|540605290|FG003|Overall Study|Physician Decision|0|||
149857312|NCT03686150|540605291|FG004|Overall Study|Physician Decision|0|||
149857313|NCT03686150|540605292|FG005|Overall Study|Physician Decision|1|||
149857314|NCT03686150|540605287|FG000|Overall Study|Lost to Follow-up|0|||
149857315|NCT03686150|540605288|FG001|Overall Study|Lost to Follow-up|1|||
149857316|NCT03686150|540605289|FG002|Overall Study|Lost to Follow-up|0|||
149857317|NCT03686150|540605290|FG003|Overall Study|Lost to Follow-up|0|||
149857318|NCT03686150|540605291|FG004|Overall Study|Lost to Follow-up|0|||
149857319|NCT03686150|540605292|FG005|Overall Study|Lost to Follow-up|0|||
149857320|NCT02443324|540605295|FG000|Overall Study|Death|4|||
149857321|NCT02443324|540605296|FG001|Overall Study|Death|1|||
149857322|NCT02443324|540605297|FG002|Overall Study|Death|0|||
149857323|NCT02443324|540605298|FG003|Overall Study|Death|3|||
149857324|NCT02443324|540605299|FG004|Overall Study|Death|1|||
149857325|NCT02443324|540605300|FG005|Overall Study|Death|3|||
149857326|NCT02443324|540605301|FG006|Overall Study|Death|2|||
149857327|NCT02443324|540605295|FG000|Overall Study|Lost to Follow-up|0|||
149857328|NCT02443324|540605296|FG001|Overall Study|Lost to Follow-up|0|||
149857329|NCT02443324|540605297|FG002|Overall Study|Lost to Follow-up|0|||
149857330|NCT02443324|540605298|FG003|Overall Study|Lost to Follow-up|1|||
149857331|NCT02443324|540605299|FG004|Overall Study|Lost to Follow-up|0|||
149857332|NCT02443324|540605300|FG005|Overall Study|Lost to Follow-up|1|||
149857333|NCT02443324|540605301|FG006|Overall Study|Lost to Follow-up|0|||
149857334|NCT02443324|540605295|FG000|Overall Study|Physician Decision|0|||
149857335|NCT02443324|540605296|FG001|Overall Study|Physician Decision|3|||
149857336|NCT02443324|540605297|FG002|Overall Study|Physician Decision|5|||
149857337|NCT02443324|540605298|FG003|Overall Study|Physician Decision|1|||
149857338|NCT02443324|540605299|FG004|Overall Study|Physician Decision|1|||
149857339|NCT02443324|540605300|FG005|Overall Study|Physician Decision|0|||
149857340|NCT02443324|540605301|FG006|Overall Study|Physician Decision|2|||
149857341|NCT02443324|540605295|FG000|Overall Study|Progressive Disease|20|||
149857342|NCT02443324|540605296|FG001|Overall Study|Progressive Disease|20|||
150040116|NCT01208207|541287307|FG006|Part I|Physician Decision|0|||
149857343|NCT02443324|540605297|FG002|Overall Study|Progressive Disease|13|||
149857344|NCT02443324|540605298|FG003|Overall Study|Progressive Disease|10|||
149857345|NCT02443324|540605299|FG004|Overall Study|Progressive Disease|13|||
149857346|NCT02443324|540605300|FG005|Overall Study|Progressive Disease|17|||
149857347|NCT02443324|540605301|FG006|Overall Study|Progressive Disease|10|||
149857348|NCT02443324|540605295|FG000|Overall Study|Withdrawal by Subject|0|||
150040117|NCT01208207|541287301|FG000|Part I|Progressive Disease|1|||
150040118|NCT01208207|541287302|FG001|Part I|Progressive Disease|0|||
150173432|NCT01113931|541771264|FG001|Overall Study|Lost to Follow-up|9|||
149857349|NCT02443324|540605296|FG001|Overall Study|Withdrawal by Subject|0|||
149857350|NCT02443324|540605297|FG002|Overall Study|Withdrawal by Subject|3|||
149857351|NCT02443324|540605298|FG003|Overall Study|Withdrawal by Subject|1|||
149857352|NCT02443324|540605299|FG004|Overall Study|Withdrawal by Subject|1|||
149857353|NCT02443324|540605300|FG005|Overall Study|Withdrawal by Subject|0|||
149857354|NCT02443324|540605301|FG006|Overall Study|Withdrawal by Subject|1|||
149857355|NCT02443324|540605295|FG000|Overall Study|Adverse Event|0|||
149857356|NCT02443324|540605296|FG001|Overall Study|Adverse Event|1|||
149857357|NCT02443324|540605297|FG002|Overall Study|Adverse Event|3|||
149857358|NCT02443324|540605298|FG003|Overall Study|Adverse Event|0|||
149857359|NCT02443324|540605299|FG004|Overall Study|Adverse Event|4|||
149857360|NCT02443324|540605300|FG005|Overall Study|Adverse Event|3|||
149857361|NCT02443324|540605301|FG006|Overall Study|Adverse Event|3|||
149857362|NCT02443324|540605295|FG000|Overall Study|Enrolled but Never Treated|0|||
149857363|NCT02443324|540605296|FG001|Overall Study|Enrolled but Never Treated|0|||
149857364|NCT02443324|540605297|FG002|Overall Study|Enrolled but Never Treated|1|||
149857365|NCT02443324|540605298|FG003|Overall Study|Enrolled but Never Treated|0|||
149857366|NCT02443324|540605299|FG004|Overall Study|Enrolled but Never Treated|1|||
149857367|NCT02443324|540605300|FG005|Overall Study|Enrolled but Never Treated|0|||
149857368|NCT02443324|540605301|FG006|Overall Study|Enrolled but Never Treated|1|||
149857369|NCT01844531|540605304|FG000|Overall Study|Withdrawal by Subject|0|||
149857370|NCT01844531|540605305|FG001|Overall Study|Withdrawal by Subject|1|||
149857371|NCT01844531|540605306|FG002|Overall Study|Withdrawal by Subject|0|||
149857372|NCT01844531|540605307|FG003|Overall Study|Withdrawal by Subject|0|||
149857373|NCT01613378|540605313|FG000|Overall Study|Lack of Efficacy|13|||
149857374|NCT01613378|540605313|FG000|Overall Study|Adverse Event|11|||
149857375|NCT01613378|540605313|FG000|Overall Study|Withdrawal by Subject|8|||
149857376|NCT01613378|540605313|FG000|Overall Study|Death|2|||
149857377|NCT01613378|540605313|FG000|Overall Study|Lost to Follow-up|1|||
149857378|NCT01613378|540605313|FG000|Overall Study|Other Reason|4|||
149857379|NCT00794417|540605314|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
149857380|NCT00794417|540605315|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
149857381|NCT00794417|540605316|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
149857382|NCT00794417|540605317|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
149857383|NCT00794417|540605314|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
149857384|NCT00794417|540605315|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
149857385|NCT00794417|540605316|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
149857386|NCT00794417|540605317|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
149857387|NCT00794417|540605314|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
149857388|NCT00794417|540605315|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
149857389|NCT00794417|540605316|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
149857390|NCT00794417|540605317|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
149857391|NCT00794417|540605314|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
149857392|NCT00794417|540605315|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
149857393|NCT00794417|540605316|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
149857394|NCT00794417|540605317|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
149857395|NCT00794417|540605314|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
149857396|NCT00794417|540605315|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
149857397|NCT00794417|540605316|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
149857398|NCT00794417|540605317|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
149857399|NCT00794417|540605314|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
149857400|NCT00794417|540605315|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
149857401|NCT00794417|540605316|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
149857402|NCT00794417|540605317|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
149857403|NCT01345318|540605323|FG000|Overall Study|Adverse Event|16|||
149857404|NCT01345318|540605323|FG000|Overall Study|Lack of Efficacy|17|||
149857405|NCT01345318|540605323|FG000|Overall Study|Lost to Follow-up|2|||
149857406|NCT01345318|540605323|FG000|Overall Study|Protocol Violation|1|||
149857407|NCT01345318|540605323|FG000|Overall Study|Withdrawal by Subject|41|||
149857408|NCT01345318|540605323|FG000|Overall Study|Other|3|||
149857409|NCT00255151|540605324|FG000|Overall Study|Adverse Event|10|||
149857410|NCT00255151|540605325|FG001|Overall Study|Adverse Event|6|||
149857411|NCT00255151|540605326|FG002|Overall Study|Adverse Event|9|||
149961299|NCT00004228|540992036|FG004|Overall Study|Protocol Violation|1|||
149857412|NCT00255151|540605324|FG000|Overall Study|Lost to Follow-up|4|||
149857413|NCT00255151|540605325|FG001|Overall Study|Lost to Follow-up|3|||
149857414|NCT00255151|540605326|FG002|Overall Study|Lost to Follow-up|4|||
149857415|NCT00255151|540605324|FG000|Overall Study|Withdrawal by Subject|18|||
149857416|NCT00255151|540605325|FG001|Overall Study|Withdrawal by Subject|17|||
149857417|NCT00255151|540605326|FG002|Overall Study|Withdrawal by Subject|8|||
149857418|NCT00255151|540605324|FG000|Overall Study|Noncompliance|0|||
149961300|NCT00004228|540992037|FG005|Overall Study|Protocol Violation|2|||
150173433|NCT01113931|541771263|FG000|Overall Study|Various|2|||
150173434|NCT01113931|541771264|FG001|Overall Study|Various|4|||
149857419|NCT00255151|540605325|FG001|Overall Study|Noncompliance|1|||
149857420|NCT00255151|540605326|FG002|Overall Study|Noncompliance|2|||
149857421|NCT00255151|540605324|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
149857422|NCT00255151|540605325|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
149857423|NCT00255151|540605326|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
149857424|NCT00255151|540605324|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
149857425|NCT00255151|540605325|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
149857426|NCT00255151|540605326|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
149857427|NCT00255151|540605324|FG000|Overall Study|Possible Barrett's Esophagus|1|||
149857428|NCT00255151|540605325|FG001|Overall Study|Possible Barrett's Esophagus|3|||
149857429|NCT00255151|540605326|FG002|Overall Study|Possible Barrett's Esophagus|8|||
149857430|NCT00255151|540605324|FG000|Overall Study|Esophageal Stricture|0|||
149857431|NCT00255151|540605325|FG001|Overall Study|Esophageal Stricture|0|||
149857432|NCT00255151|540605326|FG002|Overall Study|Esophageal Stricture|1|||
149857433|NCT00255151|540605324|FG000|Overall Study|Therapeutic Failure|11|||
149857434|NCT00255151|540605325|FG001|Overall Study|Therapeutic Failure|2|||
149857435|NCT00255151|540605326|FG002|Overall Study|Therapeutic Failure|3|||
149857436|NCT00792623|540605328|FG000|Overall Study|Adverse Event|2|||
149857437|NCT00792623|540605328|FG000|Overall Study|Withdrawal by Subject|5|||
149857438|NCT00743509|540605329|FG000|Overall Study|Withdrawal by Subject|2|||
149857439|NCT01239472|540605330|FG000|Overall Study|Withdrawal by Subject|5|||
149857440|NCT01239472|540605331|FG001|Overall Study|Withdrawal by Subject|1|||
149857441|NCT01239472|540605330|FG000|Overall Study|Adverse Event|0|||
149857442|NCT01239472|540605331|FG001|Overall Study|Adverse Event|1|||
149857443|NCT01239472|540605330|FG000|Overall Study|Lack of Efficacy|0|||
149857444|NCT01239472|540605331|FG001|Overall Study|Lack of Efficacy|1|||
149857445|NCT00263887|540605333|FG000|Overall Study|Withdrawal by Subject|1|||
149857446|NCT00263887|540605334|FG001|Overall Study|Withdrawal by Subject|1|||
149857447|NCT00263887|540605333|FG000|Overall Study|Lung transplantation|1|||
149857448|NCT00263887|540605334|FG001|Overall Study|Lung transplantation|2|||
149857449|NCT00263887|540605333|FG000|Overall Study|Too ill to attend visit|1|||
149857450|NCT00263887|540605334|FG001|Overall Study|Too ill to attend visit|0|||
149857451|NCT00263887|540605333|FG000|Overall Study|Adverse Event|0|||
149857452|NCT00263887|540605334|FG001|Overall Study|Adverse Event|2|||
149857453|NCT00263887|540605333|FG000|Overall Study|Disease progression|0|||
149857454|NCT00263887|540605334|FG001|Overall Study|Disease progression|1|||
149857455|NCT00263887|540605333|FG000|Overall Study|Lack of Efficacy|0|||
149857456|NCT00263887|540605334|FG001|Overall Study|Lack of Efficacy|1|||
149857457|NCT01714739|540605335|FG000|Overall Study|Disease progression|3|||
149857458|NCT01714739|540605336|FG001|Overall Study|Disease progression|5|||
149857459|NCT01714739|540605337|FG002|Overall Study|Disease progression|5|||
149857460|NCT01714739|540605338|FG003|Overall Study|Disease progression|204|||
149857461|NCT01714739|540605339|FG004|Overall Study|Disease progression|1|||
149857462|NCT01714739|540605340|FG005|Overall Study|Disease progression|3|||
149857463|NCT01714739|540605341|FG006|Overall Study|Disease progression|5|||
149857464|NCT01714739|540605335|FG000|Overall Study|Study drug toxicity|1|||
149857465|NCT01714739|540605336|FG001|Overall Study|Study drug toxicity|1|||
149857466|NCT01714739|540605337|FG002|Overall Study|Study drug toxicity|1|||
149857467|NCT01714739|540605338|FG003|Overall Study|Study drug toxicity|15|||
149857468|NCT01714739|540605339|FG004|Overall Study|Study drug toxicity|0|||
149857469|NCT01714739|540605340|FG005|Overall Study|Study drug toxicity|0|||
149857470|NCT01714739|540605341|FG006|Overall Study|Study drug toxicity|5|||
149857471|NCT01714739|540605335|FG000|Overall Study|Death|0|||
149857472|NCT01714739|540605336|FG001|Overall Study|Death|0|||
149857473|NCT01714739|540605337|FG002|Overall Study|Death|0|||
149857474|NCT01714739|540605338|FG003|Overall Study|Death|1|||
149857475|NCT01714739|540605339|FG004|Overall Study|Death|0|||
149857476|NCT01714739|540605340|FG005|Overall Study|Death|0|||
149857477|NCT01714739|540605341|FG006|Overall Study|Death|0|||
149857478|NCT01714739|540605335|FG000|Overall Study|Adverse Event unrelated to drug|0|||
149857479|NCT01714739|540605336|FG001|Overall Study|Adverse Event unrelated to drug|0|||
149857480|NCT01714739|540605337|FG002|Overall Study|Adverse Event unrelated to drug|3|||
149857481|NCT01714739|540605338|FG003|Overall Study|Adverse Event unrelated to drug|21|||
149857482|NCT01714739|540605339|FG004|Overall Study|Adverse Event unrelated to drug|0|||
149857483|NCT01714739|540605340|FG005|Overall Study|Adverse Event unrelated to drug|0|||
149857484|NCT01714739|540605341|FG006|Overall Study|Adverse Event unrelated to drug|0|||
149857485|NCT01714739|540605335|FG000|Overall Study|Participant request to stop therapy|0|||
149857486|NCT01714739|540605336|FG001|Overall Study|Participant request to stop therapy|1|||
149857487|NCT01714739|540605337|FG002|Overall Study|Participant request to stop therapy|0|||
149857488|NCT01714739|540605338|FG003|Overall Study|Participant request to stop therapy|6|||
149857489|NCT01714739|540605339|FG004|Overall Study|Participant request to stop therapy|0|||
149857490|NCT01714739|540605340|FG005|Overall Study|Participant request to stop therapy|0|||
149857491|NCT01714739|540605341|FG006|Overall Study|Participant request to stop therapy|0|||
149857492|NCT01714739|540605335|FG000|Overall Study|Participant withdrew consent|0|||
149961301|NCT00004228|540992038|FG006|Overall Study|Protocol Violation|0|||
149961302|NCT00004228|540992032|FG000|Overall Study|Withdrawal by Subject|3|||
149857493|NCT01714739|540605336|FG001|Overall Study|Participant withdrew consent|1|||
149857494|NCT01714739|540605337|FG002|Overall Study|Participant withdrew consent|0|||
149857495|NCT01714739|540605338|FG003|Overall Study|Participant withdrew consent|8|||
149857496|NCT01714739|540605339|FG004|Overall Study|Participant withdrew consent|0|||
149857497|NCT01714739|540605340|FG005|Overall Study|Participant withdrew consent|0|||
149857498|NCT01714739|540605341|FG006|Overall Study|Participant withdrew consent|0|||
149857499|NCT01714739|540605335|FG000|Overall Study|Lost to Follow-up|0|||
149857500|NCT01714739|540605336|FG001|Overall Study|Lost to Follow-up|0|||
149857501|NCT01714739|540605337|FG002|Overall Study|Lost to Follow-up|0|||
149857502|NCT01714739|540605338|FG003|Overall Study|Lost to Follow-up|1|||
149857503|NCT01714739|540605339|FG004|Overall Study|Lost to Follow-up|0|||
149857504|NCT01714739|540605340|FG005|Overall Study|Lost to Follow-up|0|||
149857505|NCT01714739|540605341|FG006|Overall Study|Lost to Follow-up|0|||
149857506|NCT01714739|540605335|FG000|Overall Study|Maximum clinical benefit|0|||
149857507|NCT01714739|540605336|FG001|Overall Study|Maximum clinical benefit|1|||
149857508|NCT01714739|540605337|FG002|Overall Study|Maximum clinical benefit|1|||
149857509|NCT01714739|540605338|FG003|Overall Study|Maximum clinical benefit|3|||
149857510|NCT01714739|540605339|FG004|Overall Study|Maximum clinical benefit|0|||
149857511|NCT01714739|540605340|FG005|Overall Study|Maximum clinical benefit|0|||
149857512|NCT01714739|540605341|FG006|Overall Study|Maximum clinical benefit|0|||
149857513|NCT01714739|540605335|FG000|Overall Study|Poor/non-comliance|0|||
149857514|NCT01714739|540605336|FG001|Overall Study|Poor/non-comliance|1|||
149857515|NCT01714739|540605337|FG002|Overall Study|Poor/non-comliance|0|||
149857516|NCT01714739|540605338|FG003|Overall Study|Poor/non-comliance|1|||
149857517|NCT01714739|540605339|FG004|Overall Study|Poor/non-comliance|0|||
149857518|NCT01714739|540605340|FG005|Overall Study|Poor/non-comliance|0|||
149857519|NCT01714739|540605341|FG006|Overall Study|Poor/non-comliance|0|||
149857520|NCT01714739|540605335|FG000|Overall Study|No longer meets study criteria|0|||
149857521|NCT01714739|540605336|FG001|Overall Study|No longer meets study criteria|0|||
149857522|NCT01714739|540605337|FG002|Overall Study|No longer meets study criteria|0|||
149857523|NCT01714739|540605338|FG003|Overall Study|No longer meets study criteria|1|||
149857524|NCT01714739|540605339|FG004|Overall Study|No longer meets study criteria|0|||
149857525|NCT01714739|540605340|FG005|Overall Study|No longer meets study criteria|0|||
149857526|NCT01714739|540605341|FG006|Overall Study|No longer meets study criteria|0|||
149857527|NCT01714739|540605335|FG000|Overall Study|Other reason|0|||
149857528|NCT01714739|540605336|FG001|Overall Study|Other reason|0|||
149857529|NCT01714739|540605337|FG002|Overall Study|Other reason|0|||
149857530|NCT01714739|540605338|FG003|Overall Study|Other reason|3|||
149857531|NCT01714739|540605339|FG004|Overall Study|Other reason|1|||
149857532|NCT01714739|540605340|FG005|Overall Study|Other reason|0|||
149857533|NCT01714739|540605341|FG006|Overall Study|Other reason|0|||
149857534|NCT00707434|540605344|FG000|Overall Study|Adverse Event|1|||
149857535|NCT03585959|540605345|FG000|Overall Study|Physician Decision|1|||
149857536|NCT03585959|540605345|FG000|Overall Study|Unsuccessful Procedure|2|||
149857537|NCT02531594|540605346|FG000|Overall Study|Withdrawal by Subject|7|||
149857538|NCT02531594|540605347|FG001|Overall Study|Withdrawal by Subject|8|||
149857539|NCT00614822|540605348|FG000|Overall Study|Adverse Event|3|||
149857540|NCT00931463|540605349|FG000|Overall Study|Death|8|||
149857541|NCT00931463|540605350|FG001|Overall Study|Death|4|||
149857542|NCT00931463|540605349|FG000|Overall Study|Withdrawal by Subject|5|||
149857543|NCT00931463|540605350|FG001|Overall Study|Withdrawal by Subject|0|||
149857544|NCT00931463|540605349|FG000|Overall Study|Lost to Follow-up|4|||
149857545|NCT00931463|540605350|FG001|Overall Study|Lost to Follow-up|1|||
149857546|NCT01175473|540605351|FG000|Overall Study|Adverse Event|2|||
149857547|NCT01175473|540605352|FG001|Overall Study|Adverse Event|2|||
149857548|NCT00084799|540605355|FG000|Overall Study|Disease Progression|1|||
149857549|NCT00084799|540605356|FG001|Overall Study|Disease Progression|0|||
149857550|NCT02412722|540605359|FG000|Overall Study|Adverse Event|0|||
149857551|NCT02412722|540605360|FG001|Overall Study|Adverse Event|2|||
149857552|NCT02412722|540605361|FG002|Overall Study|Adverse Event|0|||
149857553|NCT02412722|540605362|FG003|Overall Study|Adverse Event|3|||
149857554|NCT02412722|540605363|FG004|Overall Study|Adverse Event|0|||
149857555|NCT02412722|540605364|FG005|Overall Study|Adverse Event|3|||
149857556|NCT02412722|540605359|FG000|Overall Study|Progressive Disease|6|||
149857557|NCT02412722|540605360|FG001|Overall Study|Progressive Disease|4|||
149857558|NCT02412722|540605361|FG002|Overall Study|Progressive Disease|4|||
149857559|NCT02412722|540605362|FG003|Overall Study|Progressive Disease|9|||
149857560|NCT02412722|540605363|FG004|Overall Study|Progressive Disease|3|||
149857561|NCT02412722|540605364|FG005|Overall Study|Progressive Disease|3|||
149857562|NCT02412722|540605359|FG000|Overall Study|Withdrawal by Subject|2|||
149857563|NCT02412722|540605360|FG001|Overall Study|Withdrawal by Subject|0|||
149857564|NCT02412722|540605361|FG002|Overall Study|Withdrawal by Subject|1|||
149857565|NCT02412722|540605362|FG003|Overall Study|Withdrawal by Subject|2|||
149857566|NCT02412722|540605363|FG004|Overall Study|Withdrawal by Subject|1|||
149857567|NCT02412722|540605364|FG005|Overall Study|Withdrawal by Subject|1|||
149857568|NCT02412722|540605359|FG000|Overall Study|Lost to Follow-up|0|||
149857569|NCT02412722|540605360|FG001|Overall Study|Lost to Follow-up|0|||
149857570|NCT02412722|540605361|FG002|Overall Study|Lost to Follow-up|0|||
149857571|NCT02412722|540605362|FG003|Overall Study|Lost to Follow-up|0|||
149857572|NCT02412722|540605363|FG004|Overall Study|Lost to Follow-up|1|||
149857573|NCT02412722|540605364|FG005|Overall Study|Lost to Follow-up|0|||
149857574|NCT02412722|540605359|FG000|Overall Study|Received drug in run-in and discontinued|0|||
149857575|NCT02412722|540605360|FG001|Overall Study|Received drug in run-in and discontinued|2|||
149857576|NCT02412722|540605361|FG002|Overall Study|Received drug in run-in and discontinued|0|||
149857577|NCT02412722|540605362|FG003|Overall Study|Received drug in run-in and discontinued|0|||
149857578|NCT02412722|540605363|FG004|Overall Study|Received drug in run-in and discontinued|0|||
149857579|NCT02412722|540605364|FG005|Overall Study|Received drug in run-in and discontinued|0|||
149857580|NCT02412722|540605359|FG000|Overall Study|Reason not Specified|3|||
149857581|NCT02412722|540605360|FG001|Overall Study|Reason not Specified|0|||
149857582|NCT02412722|540605361|FG002|Overall Study|Reason not Specified|2|||
149857583|NCT02412722|540605362|FG003|Overall Study|Reason not Specified|1|||
149857584|NCT02412722|540605363|FG004|Overall Study|Reason not Specified|2|||
149857585|NCT02412722|540605364|FG005|Overall Study|Reason not Specified|6|||
149857586|NCT04449341|540605365|FG000|Overall Study|Protocol Violation|1|||
149857587|NCT04449341|540605366|FG001|Overall Study|Protocol Violation|0|||
149857588|NCT02400476|540605370|FG000|Overall Study|Adverse Event|57|||
149857589|NCT02400476|540605371|FG001|Overall Study|Adverse Event|10|||
149857590|NCT02400476|540605372|FG002|Overall Study|Adverse Event|22|||
149857591|NCT02400476|540605373|FG003|Overall Study|Adverse Event|19|||
149857592|NCT02400476|540605374|FG004|Overall Study|Adverse Event|5|||
149857593|NCT02400476|540605375|FG005|Overall Study|Adverse Event|8|||
149857594|NCT02400476|540605370|FG000|Overall Study|Withdrawal by Subject|4|||
149857595|NCT02400476|540605371|FG001|Overall Study|Withdrawal by Subject|1|||
149857596|NCT02400476|540605372|FG002|Overall Study|Withdrawal by Subject|12|||
149857597|NCT02400476|540605373|FG003|Overall Study|Withdrawal by Subject|7|||
149857598|NCT02400476|540605374|FG004|Overall Study|Withdrawal by Subject|5|||
149857599|NCT02400476|540605375|FG005|Overall Study|Withdrawal by Subject|5|||
149857600|NCT02400476|540605370|FG000|Overall Study|Lost to Follow-up|0|||
149857601|NCT02400476|540605371|FG001|Overall Study|Lost to Follow-up|0|||
149857602|NCT02400476|540605372|FG002|Overall Study|Lost to Follow-up|0|||
149857603|NCT02400476|540605373|FG003|Overall Study|Lost to Follow-up|1|||
149857604|NCT02400476|540605374|FG004|Overall Study|Lost to Follow-up|3|||
149857605|NCT02400476|540605375|FG005|Overall Study|Lost to Follow-up|1|||
149961303|NCT00004228|540992033|FG001|Overall Study|Withdrawal by Subject|0|||
149961304|NCT00004228|540992034|FG002|Overall Study|Withdrawal by Subject|1|||
149961305|NCT00004228|540992035|FG003|Overall Study|Withdrawal by Subject|0|||
149961306|NCT00004228|540992036|FG004|Overall Study|Withdrawal by Subject|2|||
149961307|NCT00004228|540992037|FG005|Overall Study|Withdrawal by Subject|1|||
149961308|NCT00004228|540992038|FG006|Overall Study|Withdrawal by Subject|2|||
149961309|NCT00004228|540992032|FG000|Overall Study|Other|0|||
149961310|NCT00004228|540992033|FG001|Overall Study|Other|0|||
149961311|NCT00004228|540992034|FG002|Overall Study|Other|1|||
149961312|NCT00004228|540992035|FG003|Overall Study|Other|0|||
149961313|NCT00004228|540992036|FG004|Overall Study|Other|0|||
149961314|NCT00004228|540992037|FG005|Overall Study|Other|0|||
149961315|NCT00004228|540992038|FG006|Overall Study|Other|0|||
149961316|NCT00004228|540992032|FG000|Overall Study|ineligible|4|||
149961317|NCT00004228|540992033|FG001|Overall Study|ineligible|2|||
149961318|NCT00004228|540992034|FG002|Overall Study|ineligible|4|||
149961319|NCT00004228|540992035|FG003|Overall Study|ineligible|1|||
149961320|NCT00004228|540992036|FG004|Overall Study|ineligible|1|||
149961321|NCT00004228|540992037|FG005|Overall Study|ineligible|2|||
149961322|NCT00004228|540992038|FG006|Overall Study|ineligible|5|||
149961323|NCT00432991|540992041|FG000|Overall Study|Protocol Violation|7|||
149961324|NCT00432991|540992042|FG001|Overall Study|Protocol Violation|12|||
149961325|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
149961326|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
149961327|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
150173435|NCT01113931|541771263|FG000|Overall Study|Withdrawal by Subject|3|||
149857606|NCT02400476|540605370|FG000|Overall Study|Physician Decision|0|||
149857607|NCT02400476|540605371|FG001|Overall Study|Physician Decision|0|||
149857608|NCT02400476|540605372|FG002|Overall Study|Physician Decision|1|||
149857609|NCT02400476|540605373|FG003|Overall Study|Physician Decision|1|||
149857610|NCT02400476|540605374|FG004|Overall Study|Physician Decision|0|||
149857611|NCT02400476|540605375|FG005|Overall Study|Physician Decision|1|||
149961328|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
149961329|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
149961330|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
149961331|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
149961332|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
149961333|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
149857612|NCT02400476|540605370|FG000|Overall Study|Other, Disease Progression|0|||
149857613|NCT02400476|540605371|FG001|Overall Study|Other, Disease Progression|1|||
149857614|NCT02400476|540605372|FG002|Overall Study|Other, Disease Progression|2|||
149857615|NCT02400476|540605373|FG003|Overall Study|Other, Disease Progression|1|||
149857616|NCT02400476|540605374|FG004|Overall Study|Other, Disease Progression|2|||
149857617|NCT02400476|540605375|FG005|Overall Study|Other, Disease Progression|1|||
149857618|NCT02400476|540605370|FG000|Overall Study|Other, Decreased Quality of Life|0|||
149857619|NCT02400476|540605371|FG001|Overall Study|Other, Decreased Quality of Life|0|||
149857620|NCT02400476|540605372|FG002|Overall Study|Other, Decreased Quality of Life|2|||
149857621|NCT02400476|540605373|FG003|Overall Study|Other, Decreased Quality of Life|0|||
149857622|NCT02400476|540605374|FG004|Overall Study|Other, Decreased Quality of Life|0|||
149857623|NCT02400476|540605375|FG005|Overall Study|Other, Decreased Quality of Life|0|||
149857624|NCT02400476|540605370|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
149857625|NCT02400476|540605371|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
149857626|NCT02400476|540605372|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
149857627|NCT02400476|540605373|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
149857628|NCT02400476|540605374|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
149857629|NCT02400476|540605375|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
149857630|NCT02487082|540605376|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
149857631|NCT02487082|540605377|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
149857632|NCT02487082|540605376|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
149857633|NCT02487082|540605377|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
149857634|NCT03297294|540605378|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
149857635|NCT03297294|540605379|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
149857636|NCT03297294|540605380|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149857637|NCT03297294|540605381|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149857638|NCT03297294|540605382|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149857639|NCT03297294|540605378|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
149857640|NCT03297294|540605379|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
149857641|NCT03297294|540605380|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149857642|NCT03297294|540605381|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149857643|NCT03297294|540605382|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149857644|NCT03297294|540605378|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
149857645|NCT03297294|540605379|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
149857646|NCT03297294|540605380|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149857647|NCT03297294|540605381|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149857648|NCT03297294|540605382|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149857649|NCT03297294|540605378|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
149857650|NCT03297294|540605379|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
149857651|NCT03297294|540605380|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149857652|NCT03297294|540605381|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149857653|NCT03297294|540605382|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149961334|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
149961335|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
149961336|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
149961337|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
149961338|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
149961339|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
149961340|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
149961341|NCT01755156|540992043|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
149961342|NCT01755156|540992044|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
149961343|NCT01755156|540992043|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
149961344|NCT01755156|540992044|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
149961345|NCT01755156|540992043|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
149961346|NCT01755156|540992044|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
149961347|NCT03048019|540992045|FG000|Overall Study|Adverse Event|1|||
149961348|NCT03048019|540992046|FG001|Overall Study|Adverse Event|0|||
149961349|NCT00862277|540992047|FG000|Overall Study|Protocol Violation|1|||
149961350|NCT00862277|540992048|FG001|Overall Study|Protocol Violation|2|||
149961351|NCT00862277|540992049|FG002|Overall Study|Protocol Violation|5|||
149961352|NCT00382863|540992050|FG000|Overall Study|Death|9|||
149961353|NCT00382863|540992051|FG001|Overall Study|Death|9|||
149961354|NCT00382863|540992050|FG000|Overall Study|Lost to Follow-up|1|||
149961355|NCT00382863|540992051|FG001|Overall Study|Lost to Follow-up|2|||
149961356|NCT00382863|540992050|FG000|Overall Study|Withdrawal by Subject|5|||
149961357|NCT00382863|540992051|FG001|Overall Study|Withdrawal by Subject|25|||
149961358|NCT01292473|540992052|FG000|Overall Study|Adverse Event|1|||
149961359|NCT01292473|540992053|FG001|Overall Study|Adverse Event|0|||
149961360|NCT01292473|540992054|FG002|Overall Study|Adverse Event|1|||
149857654|NCT03297294|540605378|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
149857655|NCT03297294|540605379|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
149857656|NCT03297294|540605380|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
149857657|NCT03297294|540605381|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
149857658|NCT03297294|540605382|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
149857659|NCT02692482|540605389|FG000|Overall Study|Death|2|||
149857660|NCT02692482|540605390|FG001|Overall Study|Death|2|||
149857661|NCT02692482|540605389|FG000|Overall Study|Withdrawal by Subject|1|||
149857662|NCT02692482|540605390|FG001|Overall Study|Withdrawal by Subject|2|||
149857663|NCT00605917|540605393|FG000|Overall Study|Protocol Violation|79|||
149857664|NCT01610063|540605394|FG000|Overall Study|Lost to Follow-up|42|||
149857665|NCT01610063|540605395|FG001|Overall Study|Lost to Follow-up|20|||
149857666|NCT00925301|540605398|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
149857667|NCT00925301|540605399|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
149857668|NCT00925301|540605400|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
149857669|NCT00925301|540605401|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
149857670|NCT00925301|540605398|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
149857671|NCT00925301|540605399|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
149857672|NCT00925301|540605400|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
149857673|NCT00925301|540605401|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
149857674|NCT00925301|540605398|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
149857675|NCT00925301|540605399|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
149857676|NCT00925301|540605400|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
149857677|NCT00925301|540605401|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
149857678|NCT00925301|540605398|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
149857679|NCT00925301|540605399|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
149857680|NCT00925301|540605400|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
149857681|NCT00925301|540605401|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
149857682|NCT00925301|540605398|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
149857683|NCT00925301|540605399|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
149857684|NCT00925301|540605400|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
149857685|NCT00925301|540605401|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
149857686|NCT00925301|540605398|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
149857687|NCT00925301|540605399|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
149857688|NCT00925301|540605400|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
149857689|NCT00925301|540605401|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
149857690|NCT00925301|540605398|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
149857691|NCT00925301|540605399|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
149857692|NCT00925301|540605400|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
149857693|NCT00925301|540605401|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
149857694|NCT03043560|540605402|FG000|Overall Study|Discontinued Intervention|1|||
149857695|NCT03043560|540605403|FG001|Overall Study|Discontinued Intervention|2|||
149857696|NCT03043560|540605402|FG000|Overall Study|Lost to Follow-up|0|||
149857697|NCT03043560|540605403|FG001|Overall Study|Lost to Follow-up|1|||
149857698|NCT01117766|540605404|FG000|First Intervention|Adverse Event|0|||
149857699|NCT01117766|540605405|FG001|First Intervention|Adverse Event|1|||
149857700|NCT01117766|540605404|FG000|First Intervention|Protocol Violation|1|||
149857701|NCT01117766|540605405|FG001|First Intervention|Protocol Violation|0|||
149857702|NCT01117766|540605404|FG000|Washout Period|Protocol Violation|0|||
149857703|NCT01117766|540605405|FG001|Washout Period|Protocol Violation|2|||
149857704|NCT01117766|540605404|FG000|Second Intervention|Lost to Follow-up|1|||
149857705|NCT01117766|540605405|FG001|Second Intervention|Lost to Follow-up|0|||
149857706|NCT01117766|540605404|FG000|Second Intervention|Other|1|||
149857707|NCT01117766|540605405|FG001|Second Intervention|Other|2|||
149857708|NCT01117766|540605404|FG000|Second Intervention|Adverse Event|0|||
149857709|NCT01117766|540605405|FG001|Second Intervention|Adverse Event|2|||
149857710|NCT01117766|540605404|FG000|Second Intervention|Withdrawal by Subject|0|||
149857711|NCT01117766|540605405|FG001|Second Intervention|Withdrawal by Subject|1|||
149857712|NCT04405739|540605406|FG000|Overall Study|Adverse Event|0|||
149857713|NCT04405739|540605407|FG001|Overall Study|Adverse Event|1|||
149857714|NCT04405739|540605408|FG002|Overall Study|Adverse Event|0|||
150290660|NCT05103332|542197803|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857715|NCT04405739|540605409|FG003|Overall Study|Adverse Event|0|||
149857716|NCT04405739|540605406|FG000|Overall Study|Lost to Follow-up|0|||
150290661|NCT05103332|542197804|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857717|NCT04405739|540605407|FG001|Overall Study|Lost to Follow-up|2|||
149857718|NCT04405739|540605408|FG002|Overall Study|Lost to Follow-up|1|||
149857719|NCT04405739|540605409|FG003|Overall Study|Lost to Follow-up|3|||
149961361|NCT01292473|540992055|FG003|Overall Study|Adverse Event|1|||
149961362|NCT01292473|540992052|FG000|Overall Study|Lost to Follow-up|1|||
150290662|NCT05103332|542197805|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857720|NCT04405739|540605406|FG000|Overall Study|Withdrawal by Subject|0|||
149857721|NCT04405739|540605407|FG001|Overall Study|Withdrawal by Subject|2|||
149857722|NCT04405739|540605408|FG002|Overall Study|Withdrawal by Subject|1|||
149857723|NCT04405739|540605409|FG003|Overall Study|Withdrawal by Subject|1|||
149857724|NCT04405739|540605406|FG000|Overall Study|Death|0|||
149857725|NCT04405739|540605407|FG001|Overall Study|Death|0|||
149857726|NCT04405739|540605408|FG002|Overall Study|Death|1|||
149857727|NCT04405739|540605409|FG003|Overall Study|Death|0|||
149857728|NCT04405739|540605406|FG000|Overall Study|Transferred to rehab|0|||
149857729|NCT04405739|540605407|FG001|Overall Study|Transferred to rehab|0|||
149857730|NCT04405739|540605408|FG002|Overall Study|Transferred to rehab|0|||
149857731|NCT04405739|540605409|FG003|Overall Study|Transferred to rehab|1|||
149857732|NCT04405739|540605406|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
149857733|NCT04405739|540605407|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
149857734|NCT04405739|540605408|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
149857735|NCT04405739|540605409|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
149857736|NCT05766787|540605410|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
149857737|NCT05766787|540605411|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
149857738|NCT05766787|540605410|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
149857739|NCT05766787|540605411|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
149857740|NCT05766787|540605410|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
149857741|NCT05766787|540605411|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
149857742|NCT00438659|540605412|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
149857743|NCT00438659|540605413|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
149857744|NCT00438659|540605412|FG000|Overall Study|Cancel|5|||
149857745|NCT00438659|540605413|FG001|Overall Study|Cancel|2|||
149857746|NCT02056652|540605415|FG000|Overall Study|Withdrawal by Subject|1|||
149857747|NCT02056652|540605416|FG001|Overall Study|Withdrawal by Subject|0|||
149857748|NCT02056652|540605415|FG000|Overall Study|Lost to Follow-up|0|||
149857749|NCT02056652|540605416|FG001|Overall Study|Lost to Follow-up|3|||
149857750|NCT01588548|540605417|FG000|Overall Study|Withdrawal by Subject|0|||
149857751|NCT01588548|540605418|FG001|Overall Study|Withdrawal by Subject|1|||
149857752|NCT01588548|540605419|FG002|Overall Study|Withdrawal by Subject|1|||
149857753|NCT01588548|540605420|FG003|Overall Study|Withdrawal by Subject|1|||
149857754|NCT01588548|540605421|FG004|Overall Study|Withdrawal by Subject|2|||
149857755|NCT01588548|540605422|FG005|Overall Study|Withdrawal by Subject|3|||
149857756|NCT01588548|540605417|FG000|Overall Study|Adverse Event|0|||
149857757|NCT01588548|540605418|FG001|Overall Study|Adverse Event|0|||
149857758|NCT01588548|540605419|FG002|Overall Study|Adverse Event|1|||
149857759|NCT01588548|540605420|FG003|Overall Study|Adverse Event|2|||
149857760|NCT01588548|540605421|FG004|Overall Study|Adverse Event|1|||
149857761|NCT01588548|540605422|FG005|Overall Study|Adverse Event|0|||
149857762|NCT01588548|540605417|FG000|Overall Study|Condition Under Investigation Worsened|3|||
149857763|NCT01588548|540605418|FG001|Overall Study|Condition Under Investigation Worsened|6|||
149857764|NCT01588548|540605419|FG002|Overall Study|Condition Under Investigation Worsened|4|||
149857765|NCT01588548|540605420|FG003|Overall Study|Condition Under Investigation Worsened|4|||
149857766|NCT01588548|540605421|FG004|Overall Study|Condition Under Investigation Worsened|3|||
149857767|NCT01588548|540605422|FG005|Overall Study|Condition Under Investigation Worsened|3|||
149857768|NCT00537017|540605425|FG000|Treatment Phase|Adverse Event|19|||
149857769|NCT00537017|540605425|FG000|Treatment Phase|Withdrawal by Subject|13|||
149857770|NCT00537017|540605425|FG000|Treatment Phase|Protocol Violation|2|||
149857771|NCT00537017|540605425|FG000|Follow-up Phase|Withdrawal by Subject|9|||
149857772|NCT03365791|540605427|FG000|Overall Study|Adverse Event|5|||
149857773|NCT03365791|540605427|FG000|Overall Study|Death|1|||
149857774|NCT03365791|540605427|FG000|Overall Study|Lost to Follow-up|1|||
149857775|NCT03365791|540605427|FG000|Overall Study|Physician Decision|9|||
149857776|NCT03365791|540605427|FG000|Overall Study|Progressive disease|51|||
149857777|NCT03365791|540605427|FG000|Overall Study|Subject/guardian decision|5|||
149857778|NCT03253094|540605428|FG000|Overall Study|Adverse Event|2|||
149857779|NCT03253094|540605429|FG001|Overall Study|Adverse Event|0|||
149857780|NCT03253094|540605430|FG002|Overall Study|Adverse Event|0|||
149857781|NCT03253094|540605431|FG003|Overall Study|Adverse Event|0|||
149857782|NCT03253094|540605432|FG004|Overall Study|Adverse Event|0|||
149857783|NCT03253094|540605433|FG005|Overall Study|Adverse Event|0|||
149857784|NCT03253094|540605428|FG000|Overall Study|Lack of Efficacy|0|||
149857785|NCT03253094|540605429|FG001|Overall Study|Lack of Efficacy|0|||
149961363|NCT01292473|540992053|FG001|Overall Study|Lost to Follow-up|1|||
149961364|NCT01292473|540992054|FG002|Overall Study|Lost to Follow-up|2|||
149857786|NCT03253094|540605430|FG002|Overall Study|Lack of Efficacy|2|||
149857787|NCT03253094|540605431|FG003|Overall Study|Lack of Efficacy|1|||
149857788|NCT03253094|540605432|FG004|Overall Study|Lack of Efficacy|2|||
149857789|NCT03253094|540605433|FG005|Overall Study|Lack of Efficacy|1|||
149857790|NCT03253094|540605428|FG000|Overall Study|Lost to Follow-up|0|||
149857791|NCT03253094|540605429|FG001|Overall Study|Lost to Follow-up|0|||
149857792|NCT03253094|540605430|FG002|Overall Study|Lost to Follow-up|1|||
149961365|NCT01292473|540992055|FG003|Overall Study|Lost to Follow-up|2|||
150290663|NCT05103332|542197806|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857793|NCT03253094|540605431|FG003|Overall Study|Lost to Follow-up|1|||
149857794|NCT03253094|540605432|FG004|Overall Study|Lost to Follow-up|0|||
149857795|NCT03253094|540605433|FG005|Overall Study|Lost to Follow-up|1|||
149857796|NCT03253094|540605428|FG000|Overall Study|Physician Decision|1|||
149857797|NCT03253094|540605429|FG001|Overall Study|Physician Decision|0|||
149857798|NCT03253094|540605430|FG002|Overall Study|Physician Decision|0|||
149857799|NCT03253094|540605431|FG003|Overall Study|Physician Decision|1|||
149857800|NCT03253094|540605432|FG004|Overall Study|Physician Decision|0|||
149857801|NCT03253094|540605433|FG005|Overall Study|Physician Decision|2|||
149857802|NCT03253094|540605428|FG000|Overall Study|Withdrawal by Subject|1|||
149857803|NCT03253094|540605429|FG001|Overall Study|Withdrawal by Subject|2|||
149857804|NCT03253094|540605430|FG002|Overall Study|Withdrawal by Subject|1|||
149857805|NCT03253094|540605431|FG003|Overall Study|Withdrawal by Subject|0|||
149857806|NCT03253094|540605432|FG004|Overall Study|Withdrawal by Subject|3|||
149857807|NCT03253094|540605433|FG005|Overall Study|Withdrawal by Subject|0|||
149857808|NCT03253094|540605428|FG000|Overall Study|Other|0|||
149857809|NCT03253094|540605429|FG001|Overall Study|Other|1|||
149857810|NCT03253094|540605430|FG002|Overall Study|Other|2|||
149857811|NCT03253094|540605431|FG003|Overall Study|Other|1|||
149857812|NCT03253094|540605432|FG004|Overall Study|Other|0|||
149857813|NCT03253094|540605433|FG005|Overall Study|Other|0|||
149857814|NCT00576303|540605434|FG000|Dose Titration Period|Early withdrawal|17|||
149857815|NCT00576303|540605434|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
149857816|NCT00576303|540605434|FG000|Long Term Safety Period|Early withdrawal|16|||
149857817|NCT00824369|540605435|FG000|Overall Study|Nolonger willing to participate in study|1|||
149857818|NCT00824369|540605436|FG001|Overall Study|Nolonger willing to participate in study|0|||
149857819|NCT00824369|540605437|FG002|Overall Study|Nolonger willing to participate in study|1|||
149857820|NCT00824369|540605438|FG003|Overall Study|Nolonger willing to participate in study|2|||
149857821|NCT00824369|540605439|FG004|Overall Study|Nolonger willing to participate in study|0|||
149857822|NCT00824369|540605440|FG005|Overall Study|Nolonger willing to participate in study|1|||
149857823|NCT00824369|540605435|FG000|Overall Study|Lost to Follow-up|0|||
149857824|NCT00824369|540605436|FG001|Overall Study|Lost to Follow-up|0|||
149857825|NCT00824369|540605437|FG002|Overall Study|Lost to Follow-up|0|||
149857826|NCT00824369|540605438|FG003|Overall Study|Lost to Follow-up|0|||
149857827|NCT00824369|540605439|FG004|Overall Study|Lost to Follow-up|1|||
149857828|NCT00824369|540605440|FG005|Overall Study|Lost to Follow-up|0|||
149857829|NCT00442546|540605441|FG000|Overall Study|Adverse Event|11|||
149857830|NCT00442546|540605442|FG001|Overall Study|Adverse Event|17|||
149857831|NCT00442546|540605443|FG002|Overall Study|Adverse Event|13|||
149857832|NCT00442546|540605441|FG000|Overall Study|Lost to Follow-up|1|||
149857833|NCT00442546|540605442|FG001|Overall Study|Lost to Follow-up|2|||
149857834|NCT00442546|540605443|FG002|Overall Study|Lost to Follow-up|1|||
149857835|NCT00442546|540605441|FG000|Overall Study|Other|4|||
149857836|NCT00442546|540605442|FG001|Overall Study|Other|9|||
149857837|NCT00442546|540605443|FG002|Overall Study|Other|6|||
149857838|NCT00442546|540605441|FG000|Overall Study|Withdrawal by Subject|5|||
149857839|NCT00442546|540605442|FG001|Overall Study|Withdrawal by Subject|5|||
149857840|NCT00442546|540605443|FG002|Overall Study|Withdrawal by Subject|7|||
149857841|NCT00442546|540605441|FG000|Overall Study|Randomized But Not Treated|5|||
149857842|NCT00442546|540605442|FG001|Overall Study|Randomized But Not Treated|4|||
149857843|NCT00442546|540605443|FG002|Overall Study|Randomized But Not Treated|6|||
149857844|NCT00831233|540607596|FG000|Overall Study|Adverse Event|0|||
149857845|NCT00831233|540607597|FG001|Overall Study|Adverse Event|1|||
149857846|NCT00831233|540607596|FG000|Overall Study|Protocol Violation|1|||
149857847|NCT00831233|540607597|FG001|Overall Study|Protocol Violation|0|||
149857848|NCT00831233|540607596|FG000|Overall Study|Selection Criteria Not Met|2|||
149857849|NCT00831233|540607597|FG001|Overall Study|Selection Criteria Not Met|0|||
149857850|NCT00784134|540607598|FG000|Overall Study|Lost to Follow-up|3|||
150290664|NCT05103332|542197807|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290665|NCT05103332|542197808|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290666|NCT05103332|542197809|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290667|NCT05103332|542197810|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
150290668|NCT05103332|542197811|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149857851|NCT00784134|540607599|FG001|Overall Study|Lost to Follow-up|6|||
149857852|NCT03785145|540607600|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
149857853|NCT03785145|540607601|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
149857854|NCT03785145|540607600|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
149857855|NCT03785145|540607601|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
149857856|NCT03785145|540607600|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
149857857|NCT03785145|540607601|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
149857858|NCT03785145|540607600|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
149857859|NCT03785145|540607601|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
149857860|NCT03785145|540607600|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
150173436|NCT01113931|541771264|FG001|Overall Study|Withdrawal by Subject|0|||
150173437|NCT01290224|541771267|FG000|Overall Study|Adverse Event|1|||
149857861|NCT03785145|540607601|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
149857862|NCT03785145|540607600|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
149857863|NCT03785145|540607601|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
149857864|NCT03785145|540607600|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
149857865|NCT03785145|540607601|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
149857866|NCT03785145|540607600|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
149857867|NCT03785145|540607601|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
149857868|NCT03785145|540607600|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
149857869|NCT03785145|540607601|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
149857870|NCT03785145|540607600|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
149857871|NCT03785145|540607601|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
149857872|NCT03785145|540607600|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
149857873|NCT03785145|540607601|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
149857874|NCT00097786|540607602|FG000|Overall Study|lost to follow-up for all-cause death|296|||
149857875|NCT00097786|540607603|FG001|Overall Study|lost to follow-up for all-cause death|292|||
149857876|NCT00097786|540607604|FG002|Overall Study|lost to follow-up for all-cause death|313|||
149857877|NCT00097786|540607605|FG003|Overall Study|lost to follow-up for all-cause death|310|||
149857878|NCT01647711|540607606|FG000|Overall Study|Progressive disease|6|||
149857879|NCT01647711|540607607|FG001|Overall Study|Progressive disease|2|||
149857880|NCT01647711|540607608|FG002|Overall Study|Progressive disease|6|||
149857881|NCT01647711|540607609|FG003|Overall Study|Progressive disease|8|||
149857882|NCT01647711|540607610|FG004|Overall Study|Progressive disease|2|||
149857883|NCT01647711|540607606|FG000|Overall Study|Other adverse event|0|||
149857884|NCT01647711|540607607|FG001|Overall Study|Other adverse event|0|||
149857885|NCT01647711|540607608|FG002|Overall Study|Other adverse event|2|||
149857886|NCT01647711|540607609|FG003|Overall Study|Other adverse event|0|||
149857887|NCT01647711|540607610|FG004|Overall Study|Other adverse event|2|||
149857888|NCT01647711|540607606|FG000|Overall Study|Protocol Violation|0|||
149857889|NCT01647711|540607607|FG001|Overall Study|Protocol Violation|0|||
149857890|NCT01647711|540607608|FG002|Overall Study|Protocol Violation|0|||
149857891|NCT01647711|540607609|FG003|Overall Study|Protocol Violation|0|||
149857892|NCT01647711|540607610|FG004|Overall Study|Protocol Violation|1|||
149857893|NCT01647711|540607606|FG000|Overall Study|Refused to continue taking medication|0|||
149857894|NCT01647711|540607607|FG001|Overall Study|Refused to continue taking medication|0|||
149857895|NCT01647711|540607608|FG002|Overall Study|Refused to continue taking medication|0|||
149857896|NCT01647711|540607609|FG003|Overall Study|Refused to continue taking medication|2|||
149857897|NCT01647711|540607610|FG004|Overall Study|Refused to continue taking medication|1|||
149857898|NCT01647711|540607606|FG000|Overall Study|Other reason not defined|0|||
149857899|NCT01647711|540607607|FG001|Overall Study|Other reason not defined|1|||
149857900|NCT01647711|540607608|FG002|Overall Study|Other reason not defined|1|||
149857901|NCT01647711|540607609|FG003|Overall Study|Other reason not defined|1|||
149857902|NCT01647711|540607610|FG004|Overall Study|Other reason not defined|0|||
149857903|NCT01316419|540607611|FG000|Overall Study|Not treated|103|||
149857904|NCT01316419|540607611|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
149857905|NCT01316419|540607611|FG000|Overall Study|Lost to Follow-up|19|||
149857906|NCT04025684|540607622|FG000|Overall Study|Withdrawal by Subject|1|||
149857907|NCT04025684|540607623|FG001|Overall Study|Withdrawal by Subject|1|||
149857908|NCT04025684|540607624|FG002|Overall Study|Withdrawal by Subject|0|||
149857909|NCT04025684|540607625|FG003|Overall Study|Withdrawal by Subject|0|||
149857910|NCT04025684|540607622|FG000|Overall Study|Multiple reasons|1|||
149857911|NCT04025684|540607623|FG001|Overall Study|Multiple reasons|3|||
149857912|NCT04025684|540607624|FG002|Overall Study|Multiple reasons|0|||
149857913|NCT04025684|540607625|FG003|Overall Study|Multiple reasons|1|||
149857914|NCT02070757|540607628|FG000|Overall Study|Adverse Event|107|||
149857915|NCT02070757|540607629|FG001|Overall Study|Adverse Event|99|||
149857916|NCT02070757|540607628|FG000|Overall Study|Lost to Follow-up|7|||
149857917|NCT02070757|540607629|FG001|Overall Study|Lost to Follow-up|4|||
149857918|NCT02070757|540607628|FG000|Overall Study|Protocol Violation|0|||
149857919|NCT02070757|540607629|FG001|Overall Study|Protocol Violation|4|||
149857920|NCT02070757|540607628|FG000|Overall Study|Withdrawal by Subject|1|||
149857921|NCT02070757|540607629|FG001|Overall Study|Withdrawal by Subject|3|||
150173438|NCT01290224|541771267|FG000|Overall Study|Refused Further Treatment|4|||
150173439|NCT02969863|541771272|FG000|Overall Study|Physician Decision|1|||
150290669|NCT05103332|542197812|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
149857922|NCT02070757|540607628|FG000|Overall Study|Investigator Decision|0|||
149857923|NCT02070757|540607629|FG001|Overall Study|Investigator Decision|2|||
150173440|NCT02969863|541771273|FG001|Overall Study|Physician Decision|0|||
149857924|NCT02070757|540607628|FG000|Overall Study|Discharged from Study Hospital|2|||
149857925|NCT02070757|540607629|FG001|Overall Study|Discharged from Study Hospital|2|||
150173441|NCT02969863|541771274|FG002|Overall Study|Physician Decision|0|||
149857926|NCT01546922|540607630|FG000|First Period of 10 Weeks|Protocol Violation|3|||
149857927|NCT01546922|540607631|FG001|First Period of 10 Weeks|Protocol Violation|1|||
149857928|NCT01546922|540607630|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
149857929|NCT01546922|540607631|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
149857930|NCT01546922|540607630|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
149857931|NCT01546922|540607631|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
149857932|NCT01546922|540607630|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
149857933|NCT01546922|540607631|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
149857934|NCT01546922|540607630|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
149857935|NCT01546922|540607631|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
149857936|NCT01685073|540607632|FG000|Overall Study|Lost to Follow-up|6|||
149857937|NCT01685073|540607633|FG001|Overall Study|Lost to Follow-up|8|||
149857938|NCT01685073|540607632|FG000|Overall Study|Withdrawal by Subject|24|||
149857939|NCT01685073|540607633|FG001|Overall Study|Withdrawal by Subject|24|||
149857940|NCT00880087|540607636|FG000|Overall Study|Lost to Follow-up|0|||
149857941|NCT00880087|540607637|FG001|Overall Study|Lost to Follow-up|2|||
149857942|NCT01534078|540607638|FG000|Overall Study|Death|1|||
149857943|NCT01534078|540607638|FG000|Overall Study|Withdrawal by Subject|1|||
149857944|NCT01280617|540607639|FG000|Overall Study|Adverse Event|0|||
149857945|NCT01280617|540607640|FG001|Overall Study|Adverse Event|1|||
149857946|NCT00573170|540607641|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
149857947|NCT00573170|540607642|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
149857948|NCT00573170|540607643|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
149857949|NCT00573170|540607644|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
149857950|NCT00573170|540607645|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
149857951|NCT00573170|540607646|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
149857952|NCT00573170|540607641|FG000|First Washout Period|Adverse Event|1|||
149857953|NCT00573170|540607642|FG001|First Washout Period|Adverse Event|1|||
149857954|NCT00573170|540607643|FG002|First Washout Period|Adverse Event|0|||
149857955|NCT00573170|540607644|FG003|First Washout Period|Adverse Event|0|||
149857956|NCT00573170|540607645|FG004|First Washout Period|Adverse Event|0|||
149857957|NCT00573170|540607646|FG005|First Washout Period|Adverse Event|1|||
149857958|NCT00573170|540607641|FG000|First Washout Period|Lack of Efficacy|0|||
149857959|NCT00573170|540607642|FG001|First Washout Period|Lack of Efficacy|0|||
149857960|NCT00573170|540607643|FG002|First Washout Period|Lack of Efficacy|0|||
149857961|NCT00573170|540607644|FG003|First Washout Period|Lack of Efficacy|0|||
149857962|NCT00573170|540607645|FG004|First Washout Period|Lack of Efficacy|0|||
150173442|NCT02969863|541771275|FG003|Overall Study|Physician Decision|0|||
150173443|NCT02969863|541771276|FG004|Overall Study|Physician Decision|0|||
150173444|NCT02969863|541771277|FG005|Overall Study|Physician Decision|0|||
150173445|NCT02705586|541771278|FG000|Overall Study|Health Issues|2|||
150173446|NCT02705586|541771278|FG000|Overall Study|Transportation Difficulties|5|||
150173447|NCT02705586|541771278|FG000|Overall Study|Vacation/Planned Absence|1|||
150290670|NCT05103332|542197813|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
150290671|NCT05103332|542197814|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
150290672|NCT05103332|542197815|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
149857963|NCT00573170|540607646|FG005|First Washout Period|Lack of Efficacy|1|||
149857964|NCT00573170|540607641|FG000|First Washout Period|Lost to Follow-up|1|||
149857965|NCT00573170|540607642|FG001|First Washout Period|Lost to Follow-up|1|||
149857966|NCT00573170|540607643|FG002|First Washout Period|Lost to Follow-up|0|||
149857967|NCT00573170|540607644|FG003|First Washout Period|Lost to Follow-up|2|||
149857968|NCT00573170|540607645|FG004|First Washout Period|Lost to Follow-up|0|||
149857969|NCT00573170|540607646|FG005|First Washout Period|Lost to Follow-up|2|||
149857970|NCT00573170|540607641|FG000|First Washout Period|Withdrawal by Subject|2|||
149857971|NCT00573170|540607642|FG001|First Washout Period|Withdrawal by Subject|0|||
149857972|NCT00573170|540607643|FG002|First Washout Period|Withdrawal by Subject|0|||
149857973|NCT00573170|540607644|FG003|First Washout Period|Withdrawal by Subject|2|||
149857974|NCT00573170|540607645|FG004|First Washout Period|Withdrawal by Subject|3|||
149857975|NCT00573170|540607646|FG005|First Washout Period|Withdrawal by Subject|3|||
149857976|NCT00573170|540607641|FG000|First Washout Period|Other|4|||
149857977|NCT00573170|540607642|FG001|First Washout Period|Other|0|||
149857978|NCT00573170|540607643|FG002|First Washout Period|Other|1|||
149857979|NCT00573170|540607644|FG003|First Washout Period|Other|1|||
149857980|NCT00573170|540607645|FG004|First Washout Period|Other|0|||
149857981|NCT00573170|540607646|FG005|First Washout Period|Other|0|||
149857982|NCT00573170|540607641|FG000|Second Washout Period|Adverse Event|1|||
150173448|NCT02045836|541771282|FG000|Overall Study|Adverse Event|4|||
149857983|NCT00573170|540607642|FG001|Second Washout Period|Adverse Event|0|||
149857984|NCT00573170|540607643|FG002|Second Washout Period|Adverse Event|0|||
149857985|NCT00573170|540607644|FG003|Second Washout Period|Adverse Event|0|||
149961366|NCT01292473|540992052|FG000|Overall Study|Withdrawal by Subject|3|||
150173449|NCT02045836|541771283|FG001|Overall Study|Adverse Event|4|||
150173450|NCT02045836|541771282|FG000|Overall Study|Withdrawal by Subject|1|||
149857986|NCT00573170|540607645|FG004|Second Washout Period|Adverse Event|1|||
149857987|NCT00573170|540607646|FG005|Second Washout Period|Adverse Event|0|||
149857988|NCT00573170|540607641|FG000|Second Washout Period|Protocol Violation|2|||
149857989|NCT00573170|540607642|FG001|Second Washout Period|Protocol Violation|1|||
149857990|NCT00573170|540607643|FG002|Second Washout Period|Protocol Violation|1|||
149857991|NCT00573170|540607644|FG003|Second Washout Period|Protocol Violation|0|||
149857992|NCT00573170|540607645|FG004|Second Washout Period|Protocol Violation|0|||
149857993|NCT00573170|540607646|FG005|Second Washout Period|Protocol Violation|0|||
149857994|NCT00573170|540607641|FG000|Second Washout Period|Withdrawal by Subject|1|||
149857995|NCT00573170|540607642|FG001|Second Washout Period|Withdrawal by Subject|1|||
149857996|NCT00573170|540607643|FG002|Second Washout Period|Withdrawal by Subject|2|||
149857997|NCT00573170|540607644|FG003|Second Washout Period|Withdrawal by Subject|0|||
149857998|NCT00573170|540607645|FG004|Second Washout Period|Withdrawal by Subject|1|||
149857999|NCT00573170|540607646|FG005|Second Washout Period|Withdrawal by Subject|0|||
149858000|NCT00573170|540607641|FG000|Second Washout Period|Lost to Follow-up|0|||
149858001|NCT00573170|540607642|FG001|Second Washout Period|Lost to Follow-up|0|||
149858002|NCT00573170|540607643|FG002|Second Washout Period|Lost to Follow-up|0|||
149858003|NCT00573170|540607644|FG003|Second Washout Period|Lost to Follow-up|1|||
149858004|NCT00573170|540607645|FG004|Second Washout Period|Lost to Follow-up|0|||
149858005|NCT00573170|540607646|FG005|Second Washout Period|Lost to Follow-up|0|||
149858006|NCT00573170|540607641|FG000|Second Washout Period|Other|1|||
149858007|NCT00573170|540607642|FG001|Second Washout Period|Other|2|||
149858008|NCT00573170|540607643|FG002|Second Washout Period|Other|1|||
149858009|NCT00573170|540607644|FG003|Second Washout Period|Other|4|||
149858010|NCT00573170|540607645|FG004|Second Washout Period|Other|6|||
149858011|NCT00573170|540607646|FG005|Second Washout Period|Other|2|||
149858012|NCT00573170|540607641|FG000|Third Treatment Period|Withdrawal by Subject|1|||
149858013|NCT00573170|540607642|FG001|Third Treatment Period|Withdrawal by Subject|0|||
149858014|NCT00573170|540607643|FG002|Third Treatment Period|Withdrawal by Subject|0|||
149858015|NCT00573170|540607644|FG003|Third Treatment Period|Withdrawal by Subject|0|||
149858016|NCT00573170|540607645|FG004|Third Treatment Period|Withdrawal by Subject|0|||
149858017|NCT00573170|540607646|FG005|Third Treatment Period|Withdrawal by Subject|0|||
149858018|NCT00573170|540607641|FG000|Third Treatment Period|Lost to Follow-up|0|||
149858019|NCT00573170|540607642|FG001|Third Treatment Period|Lost to Follow-up|0|||
149858020|NCT00573170|540607643|FG002|Third Treatment Period|Lost to Follow-up|0|||
149858021|NCT00573170|540607644|FG003|Third Treatment Period|Lost to Follow-up|0|||
149858022|NCT00573170|540607645|FG004|Third Treatment Period|Lost to Follow-up|0|||
149858023|NCT00573170|540607646|FG005|Third Treatment Period|Lost to Follow-up|2|||
149858024|NCT00572039|540607647|FG000|Overall Study|Withdrawal by Subject|9|||
149858025|NCT00572039|540607648|FG001|Overall Study|Withdrawal by Subject|6|||
149858026|NCT00572039|540607647|FG000|Overall Study|Death|2|||
149858027|NCT00572039|540607648|FG001|Overall Study|Death|3|||
149858028|NCT00572039|540607647|FG000|Overall Study|Ill|5|||
149858029|NCT00572039|540607648|FG001|Overall Study|Ill|1|||
149858030|NCT02147587|540607650|FG000|Overall Study|Adverse Event|9|||
149858031|NCT02147587|540607651|FG001|Overall Study|Adverse Event|4|||
149858032|NCT02147587|540607650|FG000|Overall Study|Lack of Efficacy|2|||
149858033|NCT02147587|540607651|FG001|Overall Study|Lack of Efficacy|1|||
149858034|NCT01355302|540607652|FG000|Phase 1b|Death|4|||
149858035|NCT01355302|540607653|FG001|Phase 1b|Death|0|||
149858036|NCT01355302|540607654|FG002|Phase 1b|Death|0|||
149858037|NCT01355302|540607652|FG000|Phase 1b|Study terminated by sponsor|2|||
149858038|NCT01355302|540607653|FG001|Phase 1b|Study terminated by sponsor|0|||
149858039|NCT01355302|540607654|FG002|Phase 1b|Study terminated by sponsor|0|||
149858040|NCT03649412|540607655|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
149858041|NCT03649412|540607656|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
149858042|NCT03649412|540607655|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
150040119|NCT01208207|541287303|FG002|Part I|Progressive Disease|0|||
150290673|NCT05103332|542197816|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
150290674|NCT05103332|542197817|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
150290675|NCT05103332|542197800|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290676|NCT05103332|542197801|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290677|NCT05103332|542197802|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290678|NCT05103332|542197803|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149858043|NCT03649412|540607656|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
149858044|NCT03649412|540607655|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
149858045|NCT03649412|540607656|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149858046|NCT03649412|540607655|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
149858047|NCT03649412|540607656|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
149858048|NCT03649412|540607655|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
149858049|NCT03649412|540607656|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
149858050|NCT03649412|540607655|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
149858051|NCT03649412|540607656|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
149858052|NCT00530348|540607657|FG000|Overall Study|Adverse Event|5|||
149858053|NCT00530348|540607658|FG001|Overall Study|Adverse Event|1|||
149858054|NCT00530348|540607657|FG000|Overall Study|Death|0|||
149858055|NCT00530348|540607658|FG001|Overall Study|Death|1|||
149858056|NCT00530348|540607657|FG000|Overall Study|Lack of Efficacy|2|||
149858057|NCT00530348|540607658|FG001|Overall Study|Lack of Efficacy|0|||
149858058|NCT00530348|540607657|FG000|Overall Study|Lost to Follow-up|0|||
149858059|NCT00530348|540607658|FG001|Overall Study|Lost to Follow-up|2|||
149858060|NCT00530348|540607657|FG000|Overall Study|Physician Decision|1|||
149858061|NCT00530348|540607658|FG001|Overall Study|Physician Decision|2|||
149858062|NCT00530348|540607657|FG000|Overall Study|Pregnancy|1|||
149858063|NCT00530348|540607658|FG001|Overall Study|Pregnancy|0|||
149858064|NCT00530348|540607657|FG000|Overall Study|Withdrawal by Subject|12|||
149858065|NCT00530348|540607658|FG001|Overall Study|Withdrawal by Subject|12|||
149858066|NCT00530348|540607657|FG000|Overall Study|Randomised in error|1|||
149858067|NCT00530348|540607658|FG001|Overall Study|Randomised in error|0|||
149858068|NCT00530348|540607657|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
149858069|NCT00530348|540607658|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
149858070|NCT04364763|540607659|FG000|Overall Study|Death|1|||
149858071|NCT04364763|540607660|FG001|Overall Study|Death|2|||
149858072|NCT04364763|540607659|FG000|Overall Study|Lost to Follow-up|1|||
149858073|NCT04364763|540607660|FG001|Overall Study|Lost to Follow-up|0|||
149858074|NCT00985231|540607661|FG000|Overall Study|ineligible|1|||
149858075|NCT00985231|540607662|FG001|Overall Study|ineligible|0|||
149858076|NCT00985231|540607661|FG000|Overall Study|Protocol Violation|1|||
149858077|NCT00985231|540607662|FG001|Overall Study|Protocol Violation|0|||
149858078|NCT00985231|540607661|FG000|Overall Study|Withdrawal by Subject|1|||
149858079|NCT00985231|540607662|FG001|Overall Study|Withdrawal by Subject|0|||
149858080|NCT00985231|540607661|FG000|Overall Study|Lost to Follow-up|0|||
149858081|NCT00985231|540607662|FG001|Overall Study|Lost to Follow-up|1|||
149858082|NCT00985231|540607661|FG000|Overall Study|Study related symptoms & complaints|0|||
149858083|NCT00985231|540607662|FG001|Overall Study|Study related symptoms & complaints|2|||
149858084|NCT01083680|540607669|FG000|Overall Study|Lost to Follow-up|2758|||
149858085|NCT01083680|540607669|FG000|Overall Study|Withdrawal by Subject|1086|||
149858086|NCT00003531|540607670|FG000|Overall Study|Not evaluable|10|||
149858087|NCT00346164|540607671|FG000|Overall Study|Adverse Event|0|||
149858088|NCT00346164|540607672|FG001|Overall Study|Adverse Event|0|||
149858089|NCT00346164|540607673|FG002|Overall Study|Adverse Event|0|||
149858090|NCT00346164|540607674|FG003|Overall Study|Adverse Event|1|||
149858091|NCT00346164|540607671|FG000|Overall Study|Lack of Efficacy|0|||
149858092|NCT00346164|540607672|FG001|Overall Study|Lack of Efficacy|1|||
149858093|NCT00346164|540607673|FG002|Overall Study|Lack of Efficacy|7|||
149858094|NCT00346164|540607674|FG003|Overall Study|Lack of Efficacy|25|||
149858095|NCT00346164|540607671|FG000|Overall Study|Physician Decision|0|||
149858096|NCT00346164|540607672|FG001|Overall Study|Physician Decision|1|||
149858097|NCT00346164|540607673|FG002|Overall Study|Physician Decision|2|||
149858098|NCT00346164|540607674|FG003|Overall Study|Physician Decision|27|||
149858099|NCT00346164|540607671|FG000|Overall Study|Protocol Violation|6|||
149858100|NCT00346164|540607672|FG001|Overall Study|Protocol Violation|2|||
149858101|NCT00346164|540607673|FG002|Overall Study|Protocol Violation|10|||
149858102|NCT00346164|540607674|FG003|Overall Study|Protocol Violation|4|||
149858103|NCT00346164|540607671|FG000|Overall Study|Withdrawal by Subject|0|||
149858104|NCT00346164|540607672|FG001|Overall Study|Withdrawal by Subject|0|||
149858105|NCT00346164|540607673|FG002|Overall Study|Withdrawal by Subject|2|||
149858106|NCT00346164|540607674|FG003|Overall Study|Withdrawal by Subject|0|||
149858107|NCT00346164|540607671|FG000|Overall Study|Ineligible|11|||
149858108|NCT00346164|540607672|FG001|Overall Study|Ineligible|2|||
149858109|NCT00346164|540607673|FG002|Overall Study|Ineligible|2|||
149858110|NCT00346164|540607674|FG003|Overall Study|Ineligible|23|||
149858111|NCT00346164|540607671|FG000|Overall Study|Refusal of further protocol therapy|0|||
149858112|NCT00346164|540607672|FG001|Overall Study|Refusal of further protocol therapy|1|||
149858113|NCT00346164|540607673|FG002|Overall Study|Refusal of further protocol therapy|3|||
149858114|NCT00346164|540607674|FG003|Overall Study|Refusal of further protocol therapy|15|||
149858115|NCT00346164|540607671|FG000|Overall Study|Inability to start week 16 tx on time|0|||
149858116|NCT00346164|540607672|FG001|Overall Study|Inability to start week 16 tx on time|0|||
149858117|NCT00346164|540607673|FG002|Overall Study|Inability to start week 16 tx on time|0|||
149858118|NCT00346164|540607674|FG003|Overall Study|Inability to start week 16 tx on time|11|||
149858119|NCT02260258|540607675|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
149858120|NCT02260258|540607676|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
149858121|NCT01506908|540607679|FG000|Overall Study|Adverse Event|1|||
149858122|NCT01506908|540607680|FG001|Overall Study|Adverse Event|0|||
149858123|NCT03718117|540607687|FG000|Overall Study|Death|12|||
149858124|NCT03718117|540607688|FG001|Overall Study|Death|11|||
149858125|NCT03718117|540607689|FG002|Overall Study|Death|0|||
149858126|NCT03718117|540607687|FG000|Overall Study|Other|0|||
149858127|NCT03718117|540607688|FG001|Overall Study|Other|1|||
149858128|NCT03718117|540607689|FG002|Overall Study|Other|0|||
149858129|NCT03718117|540607687|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
149858130|NCT03718117|540607688|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
149858131|NCT03718117|540607689|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
149858132|NCT03718117|540607687|FG000|Overall Study|Participant not met eligibility criteria|0|||
149858133|NCT03718117|540607688|FG001|Overall Study|Participant not met eligibility criteria|0|||
149858134|NCT03718117|540607689|FG002|Overall Study|Participant not met eligibility criteria|2|||
149858135|NCT00206102|540607692|FG000|Overall Study|Adverse Event|119|||
149858136|NCT00206102|540607693|FG001|Overall Study|Adverse Event|82|||
149858137|NCT00206102|540607692|FG000|Overall Study|Protocol Violation|0|||
149858138|NCT00206102|540607693|FG001|Overall Study|Protocol Violation|2|||
149858139|NCT00206102|540607692|FG000|Overall Study|Lack of therapeutic response|16|||
149858140|NCT00206102|540607693|FG001|Overall Study|Lack of therapeutic response|11|||
149858141|NCT00206102|540607692|FG000|Overall Study|Lost to Follow-up|95|||
149858142|NCT00206102|540607693|FG001|Overall Study|Lost to Follow-up|66|||
149858143|NCT00206102|540607692|FG000|Overall Study|Withdrawal by Subject|118|||
149858144|NCT00206102|540607693|FG001|Overall Study|Withdrawal by Subject|101|||
149858145|NCT00206102|540607692|FG000|Overall Study|Study-specific discontinuation criteria|18|||
149858146|NCT00206102|540607693|FG001|Overall Study|Study-specific discontinuation criteria|17|||
149858147|NCT00206102|540607692|FG000|Overall Study|None of those categories|42|||
149858148|NCT00206102|540607693|FG001|Overall Study|None of those categories|36|||
149858149|NCT01917968|540607694|FG000|Overall Study|Death|3|||
149858150|NCT01917968|540607695|FG001|Overall Study|Death|2|||
149858151|NCT01917968|540607694|FG000|Overall Study|Lost to Follow-up|21|||
149858152|NCT01917968|540607695|FG001|Overall Study|Lost to Follow-up|39|||
149858153|NCT01917968|540607694|FG000|Overall Study|Physician Decision|1|||
149858154|NCT01917968|540607695|FG001|Overall Study|Physician Decision|2|||
149858155|NCT01917968|540607694|FG000|Overall Study|Withdrawal by Subject|20|||
149858156|NCT01917968|540607695|FG001|Overall Study|Withdrawal by Subject|35|||
149858157|NCT01917968|540607694|FG000|Overall Study|Subject Relocation|5|||
149858158|NCT01917968|540607695|FG001|Overall Study|Subject Relocation|1|||
149858159|NCT01917968|540607694|FG000|Overall Study|36M Missed Visit|3|||
149858160|NCT01917968|540607695|FG001|Overall Study|36M Missed Visit|2|||
149858161|NCT01917968|540607694|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
149858162|NCT01917968|540607695|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
149858163|NCT01917968|540607694|FG000|Overall Study|Change in Family Circumstances|0|||
149858164|NCT01917968|540607695|FG001|Overall Study|Change in Family Circumstances|1|||
149858165|NCT01917968|540607694|FG000|Overall Study|No Data Available|0|||
149858166|NCT01917968|540607695|FG001|Overall Study|No Data Available|2|||
149858167|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
149858168|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
149858169|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
149858170|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
149858171|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
149858172|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
149858173|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
149858174|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
149858175|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
149858176|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
149858177|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
149858178|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
149858179|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
149858180|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
149858181|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
149858182|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
149858183|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
149858184|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
149858185|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
149858186|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
149858187|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
149858188|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
149858189|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
149858190|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
149858191|NCT01435928|540607697|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
149961367|NCT01292473|540992053|FG001|Overall Study|Withdrawal by Subject|4|||
149961368|NCT01292473|540992054|FG002|Overall Study|Withdrawal by Subject|3|||
150290679|NCT05103332|542197804|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290680|NCT05103332|542197805|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149858192|NCT01435928|540607698|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
149858193|NCT01435928|540607699|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
149858194|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
149858195|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
149858196|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
150290681|NCT05103332|542197806|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290682|NCT05103332|542197807|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290683|NCT05103332|542197808|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290684|NCT05103332|542197809|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290685|NCT05103332|542197810|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290686|NCT05103332|542197811|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290687|NCT05103332|542197812|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290688|NCT05103332|542197813|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290689|NCT05103332|542197814|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
150290690|NCT05103332|542197815|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
150290691|NCT05103332|542197816|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
150290692|NCT05103332|542197817|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
150290693|NCT05103332|542197800|FG000|SFU Period (6 Months=168 Days)|Death|0|||
150290694|NCT05103332|542197801|FG001|SFU Period (6 Months=168 Days)|Death|0|||
150290695|NCT05103332|542197802|FG002|SFU Period (6 Months=168 Days)|Death|0|||
150290696|NCT05103332|542197803|FG003|SFU Period (6 Months=168 Days)|Death|0|||
150290697|NCT05103332|542197804|FG004|SFU Period (6 Months=168 Days)|Death|0|||
150290698|NCT05103332|542197805|FG005|SFU Period (6 Months=168 Days)|Death|0|||
150290699|NCT05103332|542197806|FG006|SFU Period (6 Months=168 Days)|Death|0|||
150290700|NCT05103332|542197807|FG007|SFU Period (6 Months=168 Days)|Death|0|||
150290701|NCT05103332|542197808|FG008|SFU Period (6 Months=168 Days)|Death|0|||
150290702|NCT05103332|542197809|FG009|SFU Period (6 Months=168 Days)|Death|0|||
150290703|NCT05103332|542197810|FG010|SFU Period (6 Months=168 Days)|Death|0|||
150290704|NCT05103332|542197811|FG011|SFU Period (6 Months=168 Days)|Death|0|||
150290705|NCT05103332|542197812|FG012|SFU Period (6 Months=168 Days)|Death|0|||
150290706|NCT05103332|542197813|FG013|SFU Period (6 Months=168 Days)|Death|0|||
150290707|NCT05103332|542197814|FG014|SFU Period (6 Months=168 Days)|Death|1|||
150290708|NCT05103332|542197815|FG015|SFU Period (6 Months=168 Days)|Death|0|||
150290709|NCT05103332|542197816|FG016|SFU Period (6 Months=168 Days)|Death|0|||
150290710|NCT05103332|542197817|FG017|SFU Period (6 Months=168 Days)|Death|1|||
150290711|NCT04428476|542197818|FG000|Overall Study|Withdrawal by Subject|1|||
150290712|NCT04428476|542197818|FG000|Overall Study|Still on treatment|12|||
150290713|NCT04042103|542197827|FG000|Overall Study|Lost to Follow-up|1|||
150290714|NCT04042103|542197827|FG000|Overall Study|Withdrawal by Subject|1|||
150290715|NCT02289950|542197829|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
150290716|NCT02289950|542197830|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
150290717|NCT02289950|542197829|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
150290718|NCT02289950|542197830|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
150290719|NCT02289950|542197829|FG000|Overall Study|Lost to Follow-up|1|||
150290720|NCT02289950|542197830|FG001|Overall Study|Lost to Follow-up|0|||
150290721|NCT02289950|542197829|FG000|Overall Study|Physician Decision|9|||
150290722|NCT02289950|542197830|FG001|Overall Study|Physician Decision|3|||
150290723|NCT02289950|542197829|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
150290724|NCT02289950|542197830|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
150290725|NCT02289950|542197829|FG000|Overall Study|Withdrawal by Subject|1|||
150290726|NCT02289950|542197830|FG001|Overall Study|Withdrawal by Subject|3|||
150290727|NCT02289950|542197829|FG000|Overall Study|Test article held for greater than 28 days|0|||
150290728|NCT02289950|542197830|FG001|Overall Study|Test article held for greater than 28 days|1|||
150290729|NCT02289950|542197829|FG000|Overall Study|Adverse Event|11|||
150290730|NCT02289950|542197830|FG001|Overall Study|Adverse Event|3|||
150290731|NCT02289950|542197829|FG000|Overall Study|Death|1|||
150290732|NCT02289950|542197830|FG001|Overall Study|Death|1|||
149858197|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
149858198|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
149858199|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
149858200|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
149858201|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
149858202|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
149858203|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
149858204|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
149858205|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
149961369|NCT01292473|540992055|FG003|Overall Study|Withdrawal by Subject|3|||
150290733|NCT02289950|542197829|FG000|Overall Study|Other|5|||
150290734|NCT02289950|542197830|FG001|Overall Study|Other|2|||
150290735|NCT02289950|542197829|FG000|Overall Study|Not Treated|2|||
150290736|NCT02289950|542197830|FG001|Overall Study|Not Treated|1|||
150290737|NCT04518462|542197831|FG000|Overall Study|Withdrawal by Subject|0|||
150290738|NCT04518462|542197832|FG001|Overall Study|Withdrawal by Subject|0|||
149961370|NCT01292473|540992052|FG000|Overall Study|Physician Decision|0|||
149961371|NCT01292473|540992053|FG001|Overall Study|Physician Decision|1|||
149858206|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
149961372|NCT01292473|540992054|FG002|Overall Study|Physician Decision|0|||
149858207|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
149858208|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
149858209|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
149858210|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
149858211|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
149858212|NCT01435928|540607697|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
149858213|NCT01435928|540607698|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
149858214|NCT01435928|540607699|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
149858215|NCT04232540|540607703|FG000|Overall Study|Lost to Follow-up|1|||
149858216|NCT04232540|540607704|FG001|Overall Study|Lost to Follow-up|0|||
149858217|NCT02105701|540607705|FG000|Overall Study|Lost to Follow-up|1|||
149858218|NCT02105701|540607706|FG001|Overall Study|Lost to Follow-up|0|||
149858219|NCT02105701|540607707|FG002|Overall Study|Lost to Follow-up|2|||
149858220|NCT02105701|540607708|FG003|Overall Study|Lost to Follow-up|1|||
149858221|NCT02105701|540607705|FG000|Overall Study|Protocol Violation|0|||
149858222|NCT02105701|540607706|FG001|Overall Study|Protocol Violation|0|||
149858223|NCT02105701|540607707|FG002|Overall Study|Protocol Violation|1|||
149858224|NCT02105701|540607708|FG003|Overall Study|Protocol Violation|0|||
149858225|NCT02105701|540607705|FG000|Overall Study|Withdrawal by Subject|2|||
149858226|NCT02105701|540607706|FG001|Overall Study|Withdrawal by Subject|1|||
149858227|NCT02105701|540607707|FG002|Overall Study|Withdrawal by Subject|0|||
149858228|NCT02105701|540607708|FG003|Overall Study|Withdrawal by Subject|1|||
149858229|NCT02105701|540607705|FG000|Overall Study|Death|1|||
149858230|NCT02105701|540607706|FG001|Overall Study|Death|0|||
149858231|NCT02105701|540607707|FG002|Overall Study|Death|0|||
149858232|NCT02105701|540607708|FG003|Overall Study|Death|0|||
149858233|NCT03234608|540607709|FG000|Overall Study|Lost to Follow-up|23|||
149858234|NCT03234608|540607710|FG001|Overall Study|Lost to Follow-up|21|||
149858235|NCT01362296|540607711|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
149858236|NCT01362296|540607712|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
149858237|NCT01362296|540607713|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
149858238|NCT01362296|540607714|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
149858239|NCT01362296|540607711|FG000|Randomized Phase (RP)|Physician Decision|1|||
149858240|NCT01362296|540607712|FG001|Randomized Phase (RP)|Physician Decision|9|||
149858241|NCT01362296|540607713|FG002|Randomized Phase (RP)|Physician Decision|0|||
149858242|NCT01362296|540607714|FG003|Randomized Phase (RP)|Physician Decision|0|||
149858243|NCT01362296|540607711|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
149858244|NCT01362296|540607712|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
149858245|NCT01362296|540607713|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
149858246|NCT01362296|540607714|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
149858247|NCT01362296|540607711|FG000|Randomized Phase (RP)|Adverse Event|20|||
149858248|NCT01362296|540607712|FG001|Randomized Phase (RP)|Adverse Event|4|||
149858249|NCT01362296|540607713|FG002|Randomized Phase (RP)|Adverse Event|0|||
149858250|NCT01362296|540607714|FG003|Randomized Phase (RP)|Adverse Event|0|||
149858251|NCT01362296|540607711|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
149858252|NCT01362296|540607712|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
149858253|NCT01362296|540607713|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
149858254|NCT01362296|540607714|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
149858255|NCT01362296|540607711|FG000|Crossover Phase|PD including Death due to PD|0|||
149858256|NCT01362296|540607712|FG001|Crossover Phase|PD including Death due to PD|0|||
149858257|NCT01362296|540607713|FG002|Crossover Phase|PD including Death due to PD|16|||
149858258|NCT01362296|540607714|FG003|Crossover Phase|PD including Death due to PD|1|||
149858259|NCT01362296|540607711|FG000|Crossover Phase|Withdrawal by Subject|0|||
149858260|NCT01362296|540607712|FG001|Crossover Phase|Withdrawal by Subject|0|||
149858261|NCT01362296|540607713|FG002|Crossover Phase|Withdrawal by Subject|2|||
149858262|NCT01362296|540607714|FG003|Crossover Phase|Withdrawal by Subject|1|||
149858263|NCT01362296|540607711|FG000|Crossover Phase|Adverse Event|0|||
149858264|NCT01362296|540607712|FG001|Crossover Phase|Adverse Event|0|||
149858265|NCT01362296|540607713|FG002|Crossover Phase|Adverse Event|4|||
149858266|NCT01362296|540607714|FG003|Crossover Phase|Adverse Event|0|||
149858267|NCT01362296|540607711|FG000|Crossover Phase|Study Closed/Terminated|0|||
150173451|NCT02045836|541771283|FG001|Overall Study|Withdrawal by Subject|1|||
149858268|NCT01362296|540607712|FG001|Crossover Phase|Study Closed/Terminated|0|||
149858269|NCT01362296|540607713|FG002|Crossover Phase|Study Closed/Terminated|1|||
149858270|NCT01362296|540607714|FG003|Crossover Phase|Study Closed/Terminated|0|||
149858271|NCT03693950|540607715|FG000|Overall Study|Withdrawal by Subject|1|||
149858272|NCT03693950|540607716|FG001|Overall Study|Withdrawal by Subject|0|||
149858273|NCT00248170|540607717|FG000|Overall Study|Withdrawal by Subject|71|||
149858274|NCT00248170|540607718|FG001|Overall Study|Withdrawal by Subject|79|||
149858275|NCT00248170|540607717|FG000|Overall Study|Protocol Violation|35|||
149858276|NCT00248170|540607718|FG001|Overall Study|Protocol Violation|30|||
149858277|NCT00248170|540607717|FG000|Overall Study|Lost to Follow-up|28|||
149858278|NCT00248170|540607718|FG001|Overall Study|Lost to Follow-up|35|||
149858279|NCT00248170|540607717|FG000|Overall Study|Disease progression|196|||
149858280|NCT00248170|540607718|FG001|Overall Study|Disease progression|216|||
149858281|NCT00248170|540607717|FG000|Overall Study|Death|28|||
149858282|NCT00248170|540607718|FG001|Overall Study|Death|47|||
149858283|NCT00248170|540607717|FG000|Overall Study|Adverse Event|311|||
149858284|NCT00248170|540607718|FG001|Overall Study|Adverse Event|296|||
149858285|NCT00248170|540607717|FG000|Overall Study|Administrative problems|22|||
149858286|NCT00248170|540607718|FG001|Overall Study|Administrative problems|25|||
149858287|NCT00248170|540607717|FG000|Overall Study|Abnormal test procedure(s) result|49|||
149858288|NCT00248170|540607718|FG001|Overall Study|Abnormal test procedure(s) result|61|||
149858289|NCT00248170|540607717|FG000|Overall Study|Abnormal laboratory values|4|||
149858290|NCT00248170|540607718|FG001|Overall Study|Abnormal laboratory values|0|||
149858291|NCT00248170|540607717|FG000|Overall Study|Protocol deviation|17|||
149858292|NCT00248170|540607718|FG001|Overall Study|Protocol deviation|19|||
149858293|NCT03123783|540607719|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858294|NCT03123783|540607720|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
149858295|NCT03123783|540607721|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858296|NCT03123783|540607722|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858297|NCT03123783|540607723|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858298|NCT03123783|540607724|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858299|NCT03123783|540607725|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
149858300|NCT03123783|540607719|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
149858301|NCT03123783|540607720|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
149858302|NCT03123783|540607721|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
149858303|NCT03123783|540607722|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
149858304|NCT03123783|540607723|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
149858305|NCT03123783|540607724|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
149858306|NCT03123783|540607725|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
149858307|NCT03123783|540607719|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
149858308|NCT03123783|540607720|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
149858309|NCT03123783|540607721|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
149858310|NCT03123783|540607722|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
149858311|NCT03123783|540607723|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
149858312|NCT03123783|540607724|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
149858313|NCT03123783|540607725|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
149961373|NCT01292473|540992055|FG003|Overall Study|Physician Decision|0|||
149961374|NCT01292473|540992052|FG000|Overall Study|Disease Progression|0|||
149961375|NCT01292473|540992053|FG001|Overall Study|Disease Progression|1|||
150040120|NCT01208207|541287304|FG003|Part I|Progressive Disease|0|||
150040121|NCT01208207|541287305|FG004|Part I|Progressive Disease|0|||
150040122|NCT01208207|541287306|FG005|Part I|Progressive Disease|0|||
150040123|NCT01208207|541287307|FG006|Part I|Progressive Disease|0|||
150040124|NCT01208207|541287301|FG000|Part I|Protocol Violation|8|||
150040125|NCT01208207|541287302|FG001|Part I|Protocol Violation|0|||
150040126|NCT01208207|541287303|FG002|Part I|Protocol Violation|2|||
150040127|NCT01208207|541287304|FG003|Part I|Protocol Violation|0|||
150040128|NCT01208207|541287305|FG004|Part I|Protocol Violation|0|||
150040129|NCT01208207|541287306|FG005|Part I|Protocol Violation|0|||
150040130|NCT01208207|541287307|FG006|Part I|Protocol Violation|0|||
150040131|NCT01208207|541287301|FG000|Part I|Withdrawal by Subject|14|||
150040132|NCT01208207|541287302|FG001|Part I|Withdrawal by Subject|4|||
150040133|NCT01208207|541287303|FG002|Part I|Withdrawal by Subject|4|||
150040134|NCT01208207|541287304|FG003|Part I|Withdrawal by Subject|0|||
150040135|NCT01208207|541287305|FG004|Part I|Withdrawal by Subject|0|||
150040136|NCT01208207|541287306|FG005|Part I|Withdrawal by Subject|0|||
150040137|NCT01208207|541287307|FG006|Part I|Withdrawal by Subject|0|||
150040138|NCT01208207|541287301|FG000|Part II|Withdrawal by Subject|0|||
150040139|NCT01208207|541287302|FG001|Part II|Withdrawal by Subject|0|||
150040140|NCT01208207|541287303|FG002|Part II|Withdrawal by Subject|0|||
150040141|NCT01208207|541287304|FG003|Part II|Withdrawal by Subject|10|||
150040142|NCT01208207|541287305|FG004|Part II|Withdrawal by Subject|9|||
150040143|NCT01208207|541287306|FG005|Part II|Withdrawal by Subject|3|||
150040144|NCT01208207|541287307|FG006|Part II|Withdrawal by Subject|5|||
150040145|NCT01208207|541287301|FG000|Part II|Adverse Event|0|||
150040146|NCT01208207|541287302|FG001|Part II|Adverse Event|0|||
150040147|NCT01208207|541287303|FG002|Part II|Adverse Event|0|||
150040148|NCT01208207|541287304|FG003|Part II|Adverse Event|5|||
150040149|NCT01208207|541287305|FG004|Part II|Adverse Event|9|||
150040150|NCT01208207|541287306|FG005|Part II|Adverse Event|4|||
150040151|NCT01208207|541287307|FG006|Part II|Adverse Event|2|||
150040152|NCT01208207|541287301|FG000|Part II|Lack of Efficacy|0|||
150040153|NCT01208207|541287302|FG001|Part II|Lack of Efficacy|0|||
150040154|NCT01208207|541287303|FG002|Part II|Lack of Efficacy|0|||
150040155|NCT01208207|541287304|FG003|Part II|Lack of Efficacy|6|||
150040156|NCT01208207|541287305|FG004|Part II|Lack of Efficacy|4|||
150040157|NCT01208207|541287306|FG005|Part II|Lack of Efficacy|3|||
150040158|NCT01208207|541287307|FG006|Part II|Lack of Efficacy|3|||
150040159|NCT01208207|541287301|FG000|Part II|Lost to Follow-up|0|||
150040160|NCT01208207|541287302|FG001|Part II|Lost to Follow-up|0|||
150040161|NCT01208207|541287303|FG002|Part II|Lost to Follow-up|0|||
150040162|NCT01208207|541287304|FG003|Part II|Lost to Follow-up|4|||
150040163|NCT01208207|541287305|FG004|Part II|Lost to Follow-up|0|||
149858314|NCT03123783|540607719|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
149858315|NCT03123783|540607720|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
149858316|NCT03123783|540607721|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
149858317|NCT03123783|540607722|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
150040164|NCT01208207|541287306|FG005|Part II|Lost to Follow-up|2|||
150040165|NCT01208207|541287307|FG006|Part II|Lost to Follow-up|1|||
150040166|NCT01208207|541287301|FG000|Part II|Non-Compliance With Study Drug|0|||
150040167|NCT01208207|541287302|FG001|Part II|Non-Compliance With Study Drug|0|||
150040168|NCT01208207|541287303|FG002|Part II|Non-Compliance With Study Drug|0|||
150040169|NCT01208207|541287304|FG003|Part II|Non-Compliance With Study Drug|4|||
150040170|NCT01208207|541287305|FG004|Part II|Non-Compliance With Study Drug|1|||
150040171|NCT01208207|541287306|FG005|Part II|Non-Compliance With Study Drug|1|||
150040172|NCT01208207|541287307|FG006|Part II|Non-Compliance With Study Drug|0|||
150040173|NCT01208207|541287301|FG000|Part II|Physician Decision|0|||
150040174|NCT01208207|541287302|FG001|Part II|Physician Decision|0|||
150040175|NCT01208207|541287303|FG002|Part II|Physician Decision|0|||
150040176|NCT01208207|541287304|FG003|Part II|Physician Decision|1|||
150040177|NCT01208207|541287305|FG004|Part II|Physician Decision|0|||
150040178|NCT01208207|541287306|FG005|Part II|Physician Decision|2|||
150040179|NCT01208207|541287307|FG006|Part II|Physician Decision|0|||
150040180|NCT01208207|541287301|FG000|Part II|Protocol Violation|0|||
150040181|NCT01208207|541287302|FG001|Part II|Protocol Violation|0|||
150040182|NCT01208207|541287303|FG002|Part II|Protocol Violation|0|||
150173452|NCT02045836|541771282|FG000|Overall Study|Lost to Follow-up|4|||
150173453|NCT02045836|541771283|FG001|Overall Study|Lost to Follow-up|7|||
150040183|NCT01208207|541287304|FG003|Part II|Protocol Violation|1|||
150040184|NCT01208207|541287305|FG004|Part II|Protocol Violation|0|||
150040185|NCT01208207|541287306|FG005|Part II|Protocol Violation|0|||
150040186|NCT01208207|541287307|FG006|Part II|Protocol Violation|0|||
150040187|NCT01208207|541287301|FG000|Part II|Technical Problems|0|||
150040188|NCT01208207|541287302|FG001|Part II|Technical Problems|0|||
150040189|NCT01208207|541287303|FG002|Part II|Technical Problems|0|||
150040190|NCT01208207|541287304|FG003|Part II|Technical Problems|1|||
150040191|NCT01208207|541287305|FG004|Part II|Technical Problems|0|||
150040192|NCT01208207|541287306|FG005|Part II|Technical Problems|1|||
150040193|NCT01208207|541287307|FG006|Part II|Technical Problems|0|||
149858318|NCT03123783|540607723|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
149858319|NCT03123783|540607724|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
149858320|NCT03123783|540607725|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
149858321|NCT00749411|540607728|FG000|Overall Study|Adverse Event|0|||
149858322|NCT00749411|540607729|FG001|Overall Study|Adverse Event|2|||
149858323|NCT00749411|540607728|FG000|Overall Study|Lack of Efficacy|0|||
149858324|NCT00749411|540607729|FG001|Overall Study|Lack of Efficacy|1|||
149858325|NCT00749411|540607728|FG000|Overall Study|Protocol Violation|1|||
149858326|NCT00749411|540607729|FG001|Overall Study|Protocol Violation|1|||
149858327|NCT00749411|540607728|FG000|Overall Study|Protocol-defined stopping criteria|0|||
149858328|NCT00749411|540607729|FG001|Overall Study|Protocol-defined stopping criteria|1|||
149858329|NCT03581188|540609722|FG000|Overall Study|Inclusion criteria not met|3|||
149858330|NCT03581188|540609723|FG001|Overall Study|Inclusion criteria not met|2|||
149858331|NCT03581188|540609722|FG000|Overall Study|Lost to Follow-up|5|||
149858332|NCT03581188|540609723|FG001|Overall Study|Lost to Follow-up|5|||
149858333|NCT03581188|540609722|FG000|Overall Study|Discontinued intervention|11|||
149858334|NCT03581188|540609723|FG001|Overall Study|Discontinued intervention|8|||
149858335|NCT01619579|540609724|FG000|Overall Study|Withdrawal by Subject|0|||
149858336|NCT01619579|540609725|FG001|Overall Study|Withdrawal by Subject|3|||
149858337|NCT01684215|540609727|FG000|Phase 1, Part 1|Adverse Event|1|||
149858338|NCT01684215|540609728|FG001|Phase 1, Part 1|Adverse Event|0|||
149858339|NCT01684215|540609729|FG002|Phase 1, Part 1|Adverse Event|0|||
149858340|NCT01684215|540609730|FG003|Phase 1, Part 1|Adverse Event|0|||
149858341|NCT01684215|540609727|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
149858342|NCT01684215|540609728|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
149858343|NCT01684215|540609729|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
149858344|NCT01684215|540609730|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
149858345|NCT01684215|540609727|FG000|Phase 1, Part 2|Adverse Event|0|||
149858346|NCT01684215|540609728|FG001|Phase 1, Part 2|Adverse Event|0|||
149858347|NCT01684215|540609729|FG002|Phase 1, Part 2|Adverse Event|1|||
149858348|NCT01684215|540609730|FG003|Phase 1, Part 2|Adverse Event|0|||
149858349|NCT01684215|540609727|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
149858350|NCT01684215|540609728|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
149858351|NCT01684215|540609729|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
149858352|NCT01684215|540609730|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
149858353|NCT01684215|540609727|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
149858354|NCT01684215|540609728|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
149858355|NCT01684215|540609729|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
149858356|NCT01684215|540609730|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
149858357|NCT01684215|540609727|FG000|Phase 2|Death|0|||
149858358|NCT01684215|540609728|FG001|Phase 2|Death|0|||
149858359|NCT01684215|540609729|FG002|Phase 2|Death|0|||
149858360|NCT01684215|540609730|FG003|Phase 2|Death|8|||
149858361|NCT01684215|540609727|FG000|Phase 2|Study terminated by sponsor|0|||
149858362|NCT01684215|540609728|FG001|Phase 2|Study terminated by sponsor|0|||
149858363|NCT01684215|540609729|FG002|Phase 2|Study terminated by sponsor|0|||
149858364|NCT01684215|540609730|FG003|Phase 2|Study terminated by sponsor|30|||
149858365|NCT01684215|540609727|FG000|Phase 2|Enrolled but not treated|0|||
149858366|NCT01684215|540609728|FG001|Phase 2|Enrolled but not treated|0|||
149858367|NCT01684215|540609729|FG002|Phase 2|Enrolled but not treated|0|||
149858368|NCT01684215|540609730|FG003|Phase 2|Enrolled but not treated|1|||
149858369|NCT01684215|540609727|FG000|Phase 2|Lost to Follow-up|0|||
149858370|NCT01684215|540609728|FG001|Phase 2|Lost to Follow-up|0|||
149858371|NCT01684215|540609729|FG002|Phase 2|Lost to Follow-up|0|||
149858372|NCT01684215|540609730|FG003|Phase 2|Lost to Follow-up|4|||
149858373|NCT00983918|540609736|FG000|Overall Study|conversion to open cholecystectomy|0|||
149858374|NCT00983918|540609737|FG001|Overall Study|conversion to open cholecystectomy|2|||
149858375|NCT00983918|540609738|FG002|Overall Study|conversion to open cholecystectomy|2|||
149858376|NCT00983918|540609739|FG003|Overall Study|conversion to open cholecystectomy|2|||
149858377|NCT03346070|540609747|FG000|Overall Study|Death|0|||
149858378|NCT03346070|540609748|FG001|Overall Study|Death|0|||
149858379|NCT03346070|540609749|FG002|Overall Study|Death|0|||
149858380|NCT03346070|540609750|FG003|Overall Study|Death|0|||
149858381|NCT03346070|540609751|FG004|Overall Study|Death|1|||
149858382|NCT03346070|540609747|FG000|Overall Study|Lost to Follow-up|0|||
149858383|NCT03346070|540609748|FG001|Overall Study|Lost to Follow-up|1|||
149858384|NCT03346070|540609749|FG002|Overall Study|Lost to Follow-up|2|||
149858385|NCT03346070|540609750|FG003|Overall Study|Lost to Follow-up|0|||
149858386|NCT03346070|540609751|FG004|Overall Study|Lost to Follow-up|0|||
149858387|NCT03346070|540609747|FG000|Overall Study|Physician Decision|0|||
149858388|NCT03346070|540609748|FG001|Overall Study|Physician Decision|0|||
149858389|NCT03346070|540609749|FG002|Overall Study|Physician Decision|0|||
149858390|NCT03346070|540609750|FG003|Overall Study|Physician Decision|1|||
149858391|NCT03346070|540609751|FG004|Overall Study|Physician Decision|1|||
149858392|NCT03346070|540609747|FG000|Overall Study|Withdrawal by Subject|1|||
149858393|NCT03346070|540609748|FG001|Overall Study|Withdrawal by Subject|0|||
149961376|NCT01292473|540992054|FG002|Overall Study|Disease Progression|3|||
149858394|NCT03346070|540609749|FG002|Overall Study|Withdrawal by Subject|0|||
149858395|NCT03346070|540609750|FG003|Overall Study|Withdrawal by Subject|1|||
149858396|NCT03346070|540609751|FG004|Overall Study|Withdrawal by Subject|0|||
149858397|NCT03346070|540609747|FG000|Overall Study|Study medication not received as planned|2|||
149858398|NCT03346070|540609748|FG001|Overall Study|Study medication not received as planned|3|||
149858399|NCT03346070|540609749|FG002|Overall Study|Study medication not received as planned|2|||
149858400|NCT03346070|540609750|FG003|Overall Study|Study medication not received as planned|3|||
149858401|NCT03346070|540609751|FG004|Overall Study|Study medication not received as planned|2|||
149858402|NCT03346070|540609747|FG000|Overall Study|Screen Failure|0|||
149858403|NCT03346070|540609748|FG001|Overall Study|Screen Failure|0|||
149858404|NCT03346070|540609749|FG002|Overall Study|Screen Failure|0|||
149858405|NCT03346070|540609750|FG003|Overall Study|Screen Failure|1|||
149858406|NCT03346070|540609751|FG004|Overall Study|Screen Failure|1|||
149858407|NCT04086641|540609754|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
149858408|NCT04086641|540609755|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
149858409|NCT00126126|540609756|FG000|Overall Study|Lost to Follow-up|0|||
149858410|NCT00126126|540609757|FG001|Overall Study|Lost to Follow-up|2|||
149858411|NCT00986570|540609761|FG000|Overall Study|Lost to Follow-up|6|||
149858412|NCT00986570|540609761|FG000|Overall Study|Potential bias for objective assessment|1|||
149858413|NCT02225665|540609762|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
149858414|NCT02225665|540609763|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
149858415|NCT02225665|540609762|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
149858416|NCT02225665|540609763|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
149858417|NCT01011556|540609769|FG000|Overall Study|Adverse Event|1|||
149858418|NCT01011556|540609770|FG001|Overall Study|Adverse Event|3|||
149858419|NCT01011556|540609771|FG002|Overall Study|Adverse Event|2|||
149858420|NCT01011556|540609772|FG003|Overall Study|Adverse Event|1|||
150040194|NCT04041414|541287310|FG000|Overall Study|Lost to Follow-up|1|||
150040195|NCT04041414|541287311|FG001|Overall Study|Lost to Follow-up|2|||
150040196|NCT00665652|541287312|FG000|Overall Study|Adverse Event|4|||
150040197|NCT00665652|541287312|FG000|Overall Study|Death|1|||
150040198|NCT00665652|541287312|FG000|Overall Study|No longer met inclusion criteria.|1|||
150040199|NCT02900378|541287321|FG000|Randomization (Visit 2)|Adverse Event|14|||
150040200|NCT02900378|541287322|FG001|Randomization (Visit 2)|Adverse Event|11|||
150040201|NCT02900378|541287321|FG000|Randomization (Visit 2)|Death|1|||
150040202|NCT02900378|541287322|FG001|Randomization (Visit 2)|Death|4|||
150040203|NCT02900378|541287321|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
150040204|NCT02900378|541287322|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
150040205|NCT02900378|541287321|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
150040206|NCT02900378|541287322|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
150040207|NCT02900378|541287321|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
150040208|NCT02900378|541287322|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
150040209|NCT02900378|541287321|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
150040210|NCT02900378|541287322|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
150040211|NCT02900378|541287321|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
150040212|NCT02900378|541287322|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
150040213|NCT01134055|541287324|FG000|Overall Study|Adverse Event|5|||
150040214|NCT01134055|541287325|FG001|Overall Study|Adverse Event|2|||
150040215|NCT01134055|541287326|FG002|Overall Study|Adverse Event|2|||
150040216|NCT01134055|541287327|FG003|Overall Study|Adverse Event|2|||
150040217|NCT01134055|541287328|FG004|Overall Study|Adverse Event|5|||
150040218|NCT01134055|541287329|FG005|Overall Study|Adverse Event|7|||
150040219|NCT01134055|541287330|FG006|Overall Study|Adverse Event|2|||
149858421|NCT01011556|540609769|FG000|Overall Study|Lost to Follow-up|1|||
149858422|NCT01011556|540609770|FG001|Overall Study|Lost to Follow-up|0|||
149858423|NCT01011556|540609771|FG002|Overall Study|Lost to Follow-up|0|||
149858424|NCT01011556|540609772|FG003|Overall Study|Lost to Follow-up|0|||
149858425|NCT01011556|540609769|FG000|Overall Study|Physician Decision|1|||
150040220|NCT01134055|541287324|FG000|Overall Study|Lost to Follow-up|0|||
150040221|NCT01134055|541287325|FG001|Overall Study|Lost to Follow-up|1|||
150040222|NCT01134055|541287326|FG002|Overall Study|Lost to Follow-up|0|||
150040223|NCT01134055|541287327|FG003|Overall Study|Lost to Follow-up|1|||
150040224|NCT01134055|541287328|FG004|Overall Study|Lost to Follow-up|0|||
150040225|NCT01134055|541287329|FG005|Overall Study|Lost to Follow-up|0|||
150040226|NCT01134055|541287330|FG006|Overall Study|Lost to Follow-up|0|||
150040227|NCT01134055|541287324|FG000|Overall Study|Withdrawal by Subject|3|||
150040228|NCT01134055|541287325|FG001|Overall Study|Withdrawal by Subject|3|||
150290739|NCT04518462|542197833|FG002|Overall Study|Withdrawal by Subject|1|||
150290740|NCT04518462|542197831|FG000|Overall Study|Physician Decision|1|||
150290741|NCT04518462|542197832|FG001|Overall Study|Physician Decision|1|||
150290742|NCT04518462|542197833|FG002|Overall Study|Physician Decision|0|||
150290743|NCT01003210|542197834|FG000|Overall Study|Lost to Follow-up|1|||
150290744|NCT01003210|542197835|FG001|Overall Study|Lost to Follow-up|3|||
150290745|NCT00271817|542197836|FG000|Part 1|Adverse Event|68|||
150290746|NCT00271817|542197837|FG001|Part 1|Adverse Event|25|||
150290747|NCT00271817|542197838|FG002|Part 1|Adverse Event|156|||
149858426|NCT01011556|540609770|FG001|Overall Study|Physician Decision|0|||
149858427|NCT01011556|540609771|FG002|Overall Study|Physician Decision|0|||
149858428|NCT01011556|540609772|FG003|Overall Study|Physician Decision|1|||
149858429|NCT01011556|540609769|FG000|Overall Study|Protocol Violation|0|||
149858430|NCT01011556|540609770|FG001|Overall Study|Protocol Violation|1|||
149858431|NCT01011556|540609771|FG002|Overall Study|Protocol Violation|0|||
149858432|NCT01011556|540609772|FG003|Overall Study|Protocol Violation|0|||
149858433|NCT01011556|540609769|FG000|Overall Study|Withdrawal by Subject|1|||
149858434|NCT01011556|540609770|FG001|Overall Study|Withdrawal by Subject|2|||
149858435|NCT01011556|540609771|FG002|Overall Study|Withdrawal by Subject|4|||
149858436|NCT01011556|540609772|FG003|Overall Study|Withdrawal by Subject|4|||
149858437|NCT01011556|540609769|FG000|Overall Study|Sponsor decision|0|||
149858438|NCT01011556|540609770|FG001|Overall Study|Sponsor decision|1|||
149858439|NCT01011556|540609771|FG002|Overall Study|Sponsor decision|1|||
149858440|NCT01011556|540609772|FG003|Overall Study|Sponsor decision|2|||
149858441|NCT01011556|540609769|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
149858442|NCT01011556|540609770|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
149858443|NCT01011556|540609771|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
149858444|NCT01011556|540609772|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
149858445|NCT01098110|540609773|FG000|Overall Study|Withdrawal by Subject|14|||
149858446|NCT01098110|540609774|FG001|Overall Study|Withdrawal by Subject|24|||
149858447|NCT01098110|540609775|FG002|Overall Study|Withdrawal by Subject|19|||
149858448|NCT01098110|540609773|FG000|Overall Study|Adverse Event|30|||
149858449|NCT01098110|540609774|FG001|Overall Study|Adverse Event|32|||
149858450|NCT01098110|540609775|FG002|Overall Study|Adverse Event|43|||
149858451|NCT01098110|540609773|FG000|Overall Study|Lack of Efficacy|13|||
149858452|NCT01098110|540609774|FG001|Overall Study|Lack of Efficacy|9|||
149858453|NCT01098110|540609775|FG002|Overall Study|Lack of Efficacy|27|||
149858454|NCT01098110|540609773|FG000|Overall Study|Other|4|||
149858455|NCT01098110|540609774|FG001|Overall Study|Other|7|||
149858456|NCT01098110|540609775|FG002|Overall Study|Other|5|||
149858457|NCT01098110|540609773|FG000|Overall Study|Untreated|1|||
149858458|NCT01098110|540609774|FG001|Overall Study|Untreated|1|||
149858459|NCT01098110|540609775|FG002|Overall Study|Untreated|0|||
149858460|NCT03920280|540609776|FG000|Overall Study|Adverse Event|2|||
149858461|NCT03920280|540609777|FG001|Overall Study|Adverse Event|3|||
149858462|NCT03920280|540609776|FG000|Overall Study|Lost to Follow-up|0|||
149858463|NCT03920280|540609777|FG001|Overall Study|Lost to Follow-up|1|||
149858464|NCT03920280|540609776|FG000|Overall Study|Withdrawal by Subject|1|||
149858465|NCT03920280|540609777|FG001|Overall Study|Withdrawal by Subject|1|||
149858466|NCT03920280|540609776|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
149858467|NCT03920280|540609777|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
150040229|NCT01134055|541287326|FG002|Overall Study|Withdrawal by Subject|1|||
150040230|NCT01134055|541287327|FG003|Overall Study|Withdrawal by Subject|2|||
149858468|NCT00089076|540609780|FG000|Overall Study|Alternate Therapy|1|||
150290748|NCT00271817|542197836|FG000|Part 1|Lost to Follow-up|6|||
149858469|NCT00089076|540609780|FG000|Overall Study|Withdrawal by Subject|2|||
149858470|NCT00089076|540609780|FG000|Overall Study|Progression|7|||
150290749|NCT00271817|542197837|FG001|Part 1|Lost to Follow-up|8|||
150290750|NCT00271817|542197838|FG002|Part 1|Lost to Follow-up|24|||
150290751|NCT00271817|542197836|FG000|Part 1|Protocol Violation|5|||
150290752|NCT00271817|542197837|FG001|Part 1|Protocol Violation|4|||
150290753|NCT00271817|542197838|FG002|Part 1|Protocol Violation|7|||
150290754|NCT00271817|542197836|FG000|Part 1|Patient Moved|3|||
150290755|NCT00271817|542197837|FG001|Part 1|Patient Moved|1|||
150290756|NCT00271817|542197838|FG002|Part 1|Patient Moved|5|||
150290757|NCT00271817|542197836|FG000|Part 1|Withdrawal by Subject|23|||
150290758|NCT00271817|542197837|FG001|Part 1|Withdrawal by Subject|17|||
150290759|NCT00271817|542197838|FG002|Part 1|Withdrawal by Subject|45|||
150290760|NCT00271817|542197836|FG000|Part 1|LDL < 50 mg/dL|1|||
150290761|NCT00271817|542197837|FG001|Part 1|LDL < 50 mg/dL|4|||
150290762|NCT00271817|542197838|FG002|Part 1|LDL < 50 mg/dL|48|||
150290763|NCT00271817|542197836|FG000|Part 2|Adverse Event|0|||
150290764|NCT00271817|542197837|FG001|Part 2|Adverse Event|17|||
150290765|NCT00271817|542197838|FG002|Part 2|Adverse Event|33|||
150290766|NCT00271817|542197836|FG000|Part 2|Lack of Efficacy|0|||
150290767|NCT00271817|542197837|FG001|Part 2|Lack of Efficacy|1|||
150290768|NCT00271817|542197838|FG002|Part 2|Lack of Efficacy|6|||
150290769|NCT00271817|542197836|FG000|Part 2|Lost to Follow-up|0|||
150290770|NCT00271817|542197837|FG001|Part 2|Lost to Follow-up|6|||
150290771|NCT00271817|542197838|FG002|Part 2|Lost to Follow-up|18|||
150290772|NCT00271817|542197836|FG000|Part 2|Protocol Violation|0|||
150290773|NCT00271817|542197837|FG001|Part 2|Protocol Violation|3|||
150290774|NCT00271817|542197838|FG002|Part 2|Protocol Violation|5|||
150290775|NCT00271817|542197836|FG000|Part 2|Patient Moved|0|||
150290776|NCT00271817|542197837|FG001|Part 2|Patient Moved|0|||
150290777|NCT00271817|542197838|FG002|Part 2|Patient Moved|5|||
150290778|NCT00271817|542197836|FG000|Part 2|Withdrawal by Subject|0|||
150290779|NCT00271817|542197837|FG001|Part 2|Withdrawal by Subject|2|||
150290780|NCT00271817|542197838|FG002|Part 2|Withdrawal by Subject|13|||
149858471|NCT00808509|540609781|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
149858472|NCT00808509|540609782|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
149858473|NCT00808509|540609781|FG000|Randomized Phase|Reduced methotrexate dose|1|||
149858474|NCT00808509|540609782|FG001|Randomized Phase|Reduced methotrexate dose|2|||
149858475|NCT00808509|540609781|FG000|Randomized Phase|Patient refused rescue therapy|0|||
149858476|NCT00808509|540609782|FG001|Randomized Phase|Patient refused rescue therapy|3|||
149858477|NCT03170869|540609785|FG000|Overall Study|Protocol Violation|5|||
149858478|NCT03170869|540609785|FG000|Overall Study|Early study termination|3|||
149858479|NCT01501110|540609791|FG000|Overall Study|Death|0|||
149858480|NCT01501110|540609792|FG001|Overall Study|Death|1|||
149858481|NCT00983476|540609796|FG000|Overall Study|Did not receive intervention|17|||
149858482|NCT00983476|540609797|FG001|Overall Study|Did not receive intervention|22|||
149858483|NCT00983476|540609798|FG002|Overall Study|Did not receive intervention|0|||
149858484|NCT04019054|540609801|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
149858485|NCT04019054|540609802|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
149858486|NCT04019054|540609801|FG000|Overall Study|Withdrawal by Subject|3|||
149858487|NCT04019054|540609802|FG001|Overall Study|Withdrawal by Subject|1|||
149858488|NCT01040793|540609803|FG000|Overall Study|Adverse Event|5|||
149858489|NCT01040793|540609804|FG001|Overall Study|Adverse Event|3|||
149858490|NCT01040793|540609805|FG002|Overall Study|Adverse Event|0|||
149858491|NCT01040793|540609806|FG003|Overall Study|Adverse Event|2|||
149858492|NCT01040793|540609807|FG004|Overall Study|Adverse Event|2|||
149858493|NCT01040793|540609808|FG005|Overall Study|Adverse Event|1|||
149858494|NCT01040793|540609803|FG000|Overall Study|Protocol Violation|1|||
149858495|NCT01040793|540609804|FG001|Overall Study|Protocol Violation|1|||
149858496|NCT01040793|540609805|FG002|Overall Study|Protocol Violation|1|||
149858497|NCT01040793|540609806|FG003|Overall Study|Protocol Violation|0|||
149858498|NCT01040793|540609807|FG004|Overall Study|Protocol Violation|1|||
149858499|NCT01040793|540609808|FG005|Overall Study|Protocol Violation|0|||
149858500|NCT01040793|540609803|FG000|Overall Study|Lost to Follow-up|0|||
149858501|NCT01040793|540609804|FG001|Overall Study|Lost to Follow-up|1|||
149858502|NCT01040793|540609805|FG002|Overall Study|Lost to Follow-up|1|||
149858503|NCT01040793|540609806|FG003|Overall Study|Lost to Follow-up|0|||
149858504|NCT01040793|540609807|FG004|Overall Study|Lost to Follow-up|0|||
149858505|NCT01040793|540609808|FG005|Overall Study|Lost to Follow-up|0|||
149858506|NCT01040793|540609803|FG000|Overall Study|Withdrawal by Subject|0|||
149858507|NCT01040793|540609804|FG001|Overall Study|Withdrawal by Subject|0|||
149858508|NCT01040793|540609805|FG002|Overall Study|Withdrawal by Subject|0|||
149858509|NCT01040793|540609806|FG003|Overall Study|Withdrawal by Subject|2|||
149858510|NCT01040793|540609807|FG004|Overall Study|Withdrawal by Subject|0|||
149858511|NCT01040793|540609808|FG005|Overall Study|Withdrawal by Subject|0|||
149858512|NCT01040793|540609803|FG000|Overall Study|Other reasons not listed above|0|||
149858513|NCT01040793|540609804|FG001|Overall Study|Other reasons not listed above|0|||
149858514|NCT01040793|540609805|FG002|Overall Study|Other reasons not listed above|1|||
150290781|NCT00271817|542197836|FG000|Part 2|LDL < 50 mg/dL|0|||
150290782|NCT00271817|542197837|FG001|Part 2|LDL < 50 mg/dL|3|||
150290783|NCT00271817|542197838|FG002|Part 2|LDL < 50 mg/dL|4|||
150290784|NCT04153188|542197843|FG000|Overall Study|Lost to Follow-up|1|||
150290785|NCT04153188|542197844|FG001|Overall Study|Lost to Follow-up|1|||
150290786|NCT04153188|542197843|FG000|Overall Study|Withdrawal by Subject|2|||
150290787|NCT04153188|542197844|FG001|Overall Study|Withdrawal by Subject|0|||
150290788|NCT04153188|542197843|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
150290789|NCT04153188|542197844|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
150290790|NCT01471782|542197846|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
150290791|NCT01471782|542197847|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
150290792|NCT01471782|542197848|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
150290793|NCT01471782|542197849|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
150290794|NCT01471782|542197850|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
150290795|NCT01471782|542197851|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
150290796|NCT01471782|542197846|FG000|Overall Study|Lack of Efficacy|1|||
149858515|NCT01040793|540609806|FG003|Overall Study|Other reasons not listed above|0|||
149858516|NCT01040793|540609807|FG004|Overall Study|Other reasons not listed above|1|||
150290797|NCT01471782|542197847|FG001|Overall Study|Lack of Efficacy|2|||
149858517|NCT01040793|540609808|FG005|Overall Study|Other reasons not listed above|0|||
149858518|NCT03877926|540609819|FG000|Overall Study|Adverse Event|1|||
149858519|NCT03877926|540609820|FG001|Overall Study|Adverse Event|0|||
149858520|NCT03877926|540609821|FG002|Overall Study|Adverse Event|0|||
149858521|NCT03877926|540609822|FG003|Overall Study|Adverse Event|0|||
149858522|NCT03877926|540609819|FG000|Overall Study|Death|2|||
149858523|NCT03877926|540609820|FG001|Overall Study|Death|2|||
149858524|NCT03877926|540609821|FG002|Overall Study|Death|2|||
149858525|NCT03877926|540609822|FG003|Overall Study|Death|0|||
149858526|NCT03877926|540609819|FG000|Overall Study|Lost to Follow-up|41|||
149858527|NCT03877926|540609820|FG001|Overall Study|Lost to Follow-up|52|||
149858528|NCT03877926|540609821|FG002|Overall Study|Lost to Follow-up|45|||
149858529|NCT03877926|540609822|FG003|Overall Study|Lost to Follow-up|17|||
149858530|NCT03877926|540609819|FG000|Overall Study|Physician Decision|2|||
149858531|NCT03877926|540609820|FG001|Overall Study|Physician Decision|0|||
149858532|NCT03877926|540609821|FG002|Overall Study|Physician Decision|2|||
149858533|NCT03877926|540609822|FG003|Overall Study|Physician Decision|0|||
149858534|NCT03877926|540609819|FG000|Overall Study|Withdrawal by Subject|18|||
149858535|NCT03877926|540609820|FG001|Overall Study|Withdrawal by Subject|21|||
149858536|NCT03877926|540609821|FG002|Overall Study|Withdrawal by Subject|12|||
149858537|NCT03877926|540609822|FG003|Overall Study|Withdrawal by Subject|4|||
149858538|NCT03877926|540609819|FG000|Overall Study|Other - Various|4|||
149858539|NCT03877926|540609820|FG001|Overall Study|Other - Various|1|||
149858540|NCT03877926|540609821|FG002|Overall Study|Other - Various|1|||
149858541|NCT03877926|540609822|FG003|Overall Study|Other - Various|0|||
149858542|NCT03877926|540609819|FG000|Overall Study|Not Treated|3|||
149858543|NCT03877926|540609820|FG001|Overall Study|Not Treated|1|||
149858544|NCT03877926|540609821|FG002|Overall Study|Not Treated|1|||
149858545|NCT03877926|540609822|FG003|Overall Study|Not Treated|0|||
149858546|NCT00588731|540609825|FG000|Overall Study|Withdrawal by Subject|3|||
149858547|NCT00588731|540609826|FG001|Overall Study|Withdrawal by Subject|2|||
149858548|NCT00467831|540609827|FG000|Overall Study|Death|2|||
149858549|NCT00467831|540609827|FG000|Overall Study|Withdrawal by Subject|1|||
149858550|NCT01832402|540609828|FG000|Overall Study|Lost to Follow-up|2|||
149858551|NCT01832402|540609829|FG001|Overall Study|Lost to Follow-up|0|||
149858552|NCT01832402|540609828|FG000|Overall Study|Withdrawal by Subject|3|||
149858553|NCT01832402|540609829|FG001|Overall Study|Withdrawal by Subject|3|||
149858554|NCT01832402|540609828|FG000|Overall Study|Declining Performance status|2|||
149858555|NCT01832402|540609829|FG001|Overall Study|Declining Performance status|1|||
149858556|NCT01198873|540609830|FG000|Overall Study|Adverse Event|4|||
149858557|NCT01198873|540609831|FG001|Overall Study|Adverse Event|7|||
149858558|NCT01198873|540609830|FG000|Overall Study|Study closure|29|||
149858559|NCT01198873|540609831|FG001|Overall Study|Study closure|23|||
149858560|NCT01198873|540609830|FG000|Overall Study|Other than above|4|||
149858561|NCT01198873|540609831|FG001|Overall Study|Other than above|2|||
149858562|NCT00860743|540609832|FG000|Overall Study|Withdrawal by Subject|3|||
149858563|NCT00860743|540609833|FG001|Overall Study|Withdrawal by Subject|0|||
149858564|NCT02776553|540609834|FG000|Overall Study|Lost to Follow-up|1|||
149858565|NCT02776553|540609835|FG001|Overall Study|Lost to Follow-up|0|||
149858566|NCT02776553|540609834|FG000|Overall Study|got liver transplant|1|||
149858567|NCT02776553|540609835|FG001|Overall Study|got liver transplant|2|||
149858568|NCT02776553|540609834|FG000|Overall Study|had other surgery|1|||
149858569|NCT02776553|540609835|FG001|Overall Study|had other surgery|0|||
149858570|NCT02776553|540609834|FG000|Overall Study|Protocol Violation|0|||
150040231|NCT01134055|541287328|FG004|Overall Study|Withdrawal by Subject|0|||
150040232|NCT01134055|541287329|FG005|Overall Study|Withdrawal by Subject|0|||
150040233|NCT01134055|541287330|FG006|Overall Study|Withdrawal by Subject|8|||
150040234|NCT01134055|541287324|FG000|Overall Study|Protocol Violation|0|||
150040235|NCT01134055|541287325|FG001|Overall Study|Protocol Violation|0|||
150040236|NCT01134055|541287326|FG002|Overall Study|Protocol Violation|0|||
149858571|NCT02776553|540609835|FG001|Overall Study|Protocol Violation|1|||
149858572|NCT04569786|540609838|FG000|Overall Study|Lost to Follow-up|1|||
149858573|NCT04569786|540609839|FG001|Overall Study|Lost to Follow-up|0|||
149858574|NCT04569786|540609840|FG002|Overall Study|Lost to Follow-up|4|||
149858575|NCT04569786|540609841|FG003|Overall Study|Lost to Follow-up|1|||
149858576|NCT04569786|540609842|FG004|Overall Study|Lost to Follow-up|0|||
149858577|NCT04569786|540609838|FG000|Overall Study|Withdrawal by Subject|0|||
149858578|NCT04569786|540609839|FG001|Overall Study|Withdrawal by Subject|0|||
149858579|NCT04569786|540609840|FG002|Overall Study|Withdrawal by Subject|0|||
149858580|NCT04569786|540609841|FG003|Overall Study|Withdrawal by Subject|5|||
149858581|NCT04569786|540609842|FG004|Overall Study|Withdrawal by Subject|1|||
149858582|NCT04569786|540609838|FG000|Overall Study|Physician Decision|0|||
149858583|NCT04569786|540609839|FG001|Overall Study|Physician Decision|0|||
150040237|NCT01134055|541287327|FG003|Overall Study|Protocol Violation|1|||
150040238|NCT01134055|541287328|FG004|Overall Study|Protocol Violation|1|||
149858584|NCT04569786|540609840|FG002|Overall Study|Physician Decision|0|||
149858585|NCT04569786|540609841|FG003|Overall Study|Physician Decision|1|||
149858586|NCT04569786|540609842|FG004|Overall Study|Physician Decision|0|||
149858587|NCT01684878|540609843|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
149858588|NCT01684878|540609844|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
149858589|NCT01684878|540609845|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
149858590|NCT01684878|540609846|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
149858591|NCT01684878|540609843|FG000|Part 1: Safety Run in Phase|Death|15|||
149858592|NCT01684878|540609844|FG001|Part 1: Safety Run in Phase|Death|20|||
149858593|NCT01684878|540609845|FG002|Part 1: Safety Run in Phase|Death|0|||
149858594|NCT01684878|540609846|FG003|Part 1: Safety Run in Phase|Death|0|||
149858595|NCT01684878|540609843|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
150040239|NCT01134055|541287329|FG005|Overall Study|Protocol Violation|0|||
150040240|NCT01134055|541287330|FG006|Overall Study|Protocol Violation|0|||
149858596|NCT01684878|540609844|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
149858597|NCT01684878|540609845|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
149858598|NCT01684878|540609846|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
149858599|NCT01684878|540609843|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
149858600|NCT01684878|540609844|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
149858601|NCT01684878|540609845|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
149858602|NCT01684878|540609846|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
149858603|NCT01684878|540609843|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
149858604|NCT01684878|540609844|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
149858605|NCT01684878|540609845|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
149858606|NCT01684878|540609846|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
149858607|NCT01684878|540609843|FG000|Part 2: Randomized Phase|Death|0|||
149858608|NCT01684878|540609844|FG001|Part 2: Randomized Phase|Death|0|||
149858609|NCT01684878|540609845|FG002|Part 2: Randomized Phase|Death|62|||
149858610|NCT01684878|540609846|FG003|Part 2: Randomized Phase|Death|68|||
149858611|NCT01684878|540609843|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
149858612|NCT01684878|540609844|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
149858613|NCT01684878|540609845|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
149858614|NCT01684878|540609846|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
149858615|NCT01684878|540609843|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
149858616|NCT01684878|540609844|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
149858617|NCT01684878|540609845|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
149858618|NCT01684878|540609846|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
149858619|NCT01435031|540609850|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
149858620|NCT01435031|540609850|FG000|ITT at 1 Month|Death|1|||
149858621|NCT01435031|540609850|FG000|ITT at 1 Month|Lost to Follow-up|4|||
150173454|NCT02045836|541771282|FG000|Overall Study|Migrated from study area|0|||
150040241|NCT01134055|541287324|FG000|Overall Study|Physician Decision|0|||
150040242|NCT01134055|541287325|FG001|Overall Study|Physician Decision|0|||
150040243|NCT01134055|541287326|FG002|Overall Study|Physician Decision|0|||
150040244|NCT01134055|541287327|FG003|Overall Study|Physician Decision|0|||
150040245|NCT01134055|541287328|FG004|Overall Study|Physician Decision|0|||
150040246|NCT01134055|541287329|FG005|Overall Study|Physician Decision|0|||
150173455|NCT02045836|541771283|FG001|Overall Study|Migrated from study area|2|||
150290798|NCT01471782|542197848|FG002|Overall Study|Lack of Efficacy|1|||
150290799|NCT01471782|542197849|FG003|Overall Study|Lack of Efficacy|1|||
150290800|NCT01471782|542197850|FG004|Overall Study|Lack of Efficacy|5|||
150290801|NCT01471782|542197851|FG005|Overall Study|Lack of Efficacy|18|||
150290802|NCT01471782|542197846|FG000|Overall Study|Adverse Event|1|||
150290803|NCT01471782|542197847|FG001|Overall Study|Adverse Event|1|||
150290804|NCT01471782|542197848|FG002|Overall Study|Adverse Event|2|||
150290805|NCT01471782|542197849|FG003|Overall Study|Adverse Event|2|||
150290806|NCT01471782|542197850|FG004|Overall Study|Adverse Event|3|||
150290807|NCT01471782|542197851|FG005|Overall Study|Adverse Event|1|||
149858622|NCT01435031|540609850|FG000|ITT at 6 Months|Death|2|||
149858623|NCT01435031|540609850|FG000|ITT at 6 Months|Lost to Follow-up|3|||
149858624|NCT01435031|540609850|FG000|ITT at 1 Year|Death|1|||
149858625|NCT01435031|540609850|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
149858626|NCT01435031|540609850|FG000|ITT at 1 Year|Lost to Follow-up|6|||
149858627|NCT01435031|540609850|FG000|ITT at 2 Years|Death|7|||
149961377|NCT01292473|540992055|FG003|Overall Study|Disease Progression|6|||
149961378|NCT04432298|540992056|FG000|Overall Study|Other than specified|1|||
149961379|NCT04432298|540992057|FG001|Overall Study|Other than specified|0|||
149961380|NCT04432298|540992056|FG000|Overall Study|Lost to Follow-up|0|||
149961381|NCT04432298|540992057|FG001|Overall Study|Lost to Follow-up|1|||
149961382|NCT04432298|540992056|FG000|Overall Study|Death|3|||
149961383|NCT04432298|540992057|FG001|Overall Study|Death|2|||
149961384|NCT04432298|540992056|FG000|Overall Study|Withdrawal by Subject|2|||
149961385|NCT04432298|540992057|FG001|Overall Study|Withdrawal by Subject|0|||
149961386|NCT00348374|540992058|FG000|Overall Study|Adverse Event|1|||
149961387|NCT00348374|540992059|FG001|Overall Study|Adverse Event|4|||
149961388|NCT00348374|540992058|FG000|Overall Study|Lost to Follow-up|1|||
149961389|NCT00348374|540992059|FG001|Overall Study|Lost to Follow-up|3|||
149961390|NCT00348374|540992058|FG000|Overall Study|Withdrawal by Subject|5|||
149961391|NCT00348374|540992059|FG001|Overall Study|Withdrawal by Subject|5|||
149961392|NCT00348374|540992058|FG000|Overall Study|Other|11|||
149961393|NCT00348374|540992059|FG001|Overall Study|Other|12|||
149961394|NCT00348374|540992058|FG000|Overall Study|ongoing at date of cutoff|1|||
149961395|NCT00348374|540992059|FG001|Overall Study|ongoing at date of cutoff|1|||
149961396|NCT00348374|540992058|FG000|Overall Study|randomized but did not receive treatment|0|||
149961397|NCT00348374|540992059|FG001|Overall Study|randomized but did not receive treatment|7|||
149961398|NCT02070380|540992064|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
149961399|NCT02070380|540992065|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
150040247|NCT01134055|541287330|FG006|Overall Study|Physician Decision|1|||
150040248|NCT00380367|541287335|FG000|Overall Study|Lost to Follow-up|1|||
150173456|NCT03920215|541771285|FG000|Overall Study|Lost to Follow-up|1|||
149858628|NCT01435031|540609850|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
149858629|NCT01435031|540609850|FG000|ITT at 2 Years|Lost to Follow-up|4|||
149858630|NCT01435031|540609850|FG000|ITT at 3 Years|Death|5|||
149858631|NCT01435031|540609850|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
149858632|NCT01435031|540609850|FG000|ITT at 3 Years|Lost to Follow-up|4|||
149858633|NCT01435031|540609850|FG000|ITT at 4 Years|Death|4|||
149858634|NCT01435031|540609850|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
149858635|NCT01435031|540609850|FG000|ITT at 4 Years|Lost to Follow-up|1|||
149858636|NCT03942211|540609851|FG000|Overall Study|Death|1|||
149858637|NCT03942211|540609852|FG001|Overall Study|Death|0|||
149858638|NCT03942211|540609851|FG000|Overall Study|Study terminated by sponsor|5|||
149858639|NCT03942211|540609852|FG001|Overall Study|Study terminated by sponsor|3|||
149858640|NCT03942211|540609851|FG000|Overall Study|Adverse Event|0|||
149858641|NCT03942211|540609852|FG001|Overall Study|Adverse Event|1|||
149858642|NCT01955044|540609855|FG000|Overall Study|Death|1|||
149858643|NCT01955044|540609856|FG001|Overall Study|Death|1|||
149858644|NCT01955044|540609857|FG002|Overall Study|Death|0|||
149858645|NCT00104247|540609861|FG000|Overall Study|Withdrawal by Subject|1|||
149858646|NCT00104247|540609862|FG001|Overall Study|Withdrawal by Subject|0|||
149858647|NCT00104247|540609861|FG000|Overall Study|Noncompliant with dosing|0|||
149858648|NCT00104247|540609862|FG001|Overall Study|Noncompliant with dosing|1|||
149858649|NCT00690482|540609863|FG000|Overall Study|Adverse Event|2|||
149858650|NCT00690482|540609864|FG001|Overall Study|Adverse Event|1|||
150290808|NCT01471782|542197846|FG000|Overall Study|Other|0|||
149858651|NCT00690482|540609863|FG000|Overall Study|Incorrect enrolment|0|||
149858652|NCT00690482|540609864|FG001|Overall Study|Incorrect enrolment|1|||
149858653|NCT00690482|540609863|FG000|Overall Study|Study-specific discontinuation criteria|1|||
149858654|NCT00690482|540609864|FG001|Overall Study|Study-specific discontinuation criteria|0|||
149858655|NCT00690482|540609863|FG000|Overall Study|Intake of prohibited medicine|1|||
149858656|NCT00690482|540609864|FG001|Overall Study|Intake of prohibited medicine|0|||
149858657|NCT00690482|540609863|FG000|Overall Study|withdrew consent at rand.day|0|||
149858658|NCT00690482|540609864|FG001|Overall Study|withdrew consent at rand.day|1|||
149858659|NCT04798482|540609867|FG000|Overall Study|Physician Decision|1|||
149858660|NCT04798482|540609867|FG000|Overall Study|Lost eligibility|1|||
149858661|NCT01930175|540609869|FG000|Core Study|Lost to Follow-up|0|||
150290809|NCT01471782|542197847|FG001|Overall Study|Other|0|||
150290810|NCT01471782|542197848|FG002|Overall Study|Other|1|||
150040249|NCT00380367|541287335|FG000|Overall Study|Withdrawal by Subject|1|||
150040250|NCT01605799|541287336|FG000|Overall Study|Withdrawal by Subject|2|||
150290811|NCT01471782|542197849|FG003|Overall Study|Other|1|||
149858662|NCT01930175|540609870|FG001|Core Study|Lost to Follow-up|1|||
149858663|NCT01930175|540609871|FG002|Core Study|Lost to Follow-up|0|||
149858664|NCT01930175|540609869|FG000|Core Study|Adverse Event|0|||
149858665|NCT01930175|540609870|FG001|Core Study|Adverse Event|0|||
149858666|NCT01930175|540609871|FG002|Core Study|Adverse Event|1|||
149858667|NCT00890552|540609873|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
149858668|NCT00890552|540609873|FG000|On-treatment|Early prog disease/ death|10|||
149858669|NCT04965389|540609874|FG000|Overall Study|Other reasons|1|||
150290812|NCT01471782|542197850|FG004|Overall Study|Other|6|||
150290813|NCT01471782|542197851|FG005|Overall Study|Other|5|||
150290814|NCT01471782|542197846|FG000|Overall Study|Change of Chemotherapy|1|||
150290815|NCT01471782|542197847|FG001|Overall Study|Change of Chemotherapy|1|||
150290816|NCT01471782|542197848|FG002|Overall Study|Change of Chemotherapy|0|||
150290817|NCT01471782|542197849|FG003|Overall Study|Change of Chemotherapy|0|||
150290818|NCT01471782|542197850|FG004|Overall Study|Change of Chemotherapy|1|||
150290819|NCT01471782|542197851|FG005|Overall Study|Change of Chemotherapy|4|||
150290820|NCT01471782|542197846|FG000|Overall Study|Disease Relapse|0|||
150290821|NCT01471782|542197847|FG001|Overall Study|Disease Relapse|0|||
150290822|NCT01471782|542197848|FG002|Overall Study|Disease Relapse|0|||
150290823|NCT01471782|542197849|FG003|Overall Study|Disease Relapse|1|||
150290824|NCT01471782|542197850|FG004|Overall Study|Disease Relapse|2|||
150290825|NCT01471782|542197851|FG005|Overall Study|Disease Relapse|1|||
150290826|NCT01471782|542197846|FG000|Overall Study|Physician Decision|0|||
150290827|NCT01471782|542197847|FG001|Overall Study|Physician Decision|0|||
149858670|NCT04965389|540609875|FG001|Overall Study|Other reasons|0|||
149858671|NCT04965389|540609876|FG002|Overall Study|Other reasons|0|||
150040251|NCT01605799|541287337|FG001|Overall Study|Withdrawal by Subject|1|||
150290828|NCT01471782|542197848|FG002|Overall Study|Physician Decision|0|||
150290829|NCT01471782|542197849|FG003|Overall Study|Physician Decision|0|||
150290830|NCT01471782|542197850|FG004|Overall Study|Physician Decision|3|||
150290831|NCT01471782|542197851|FG005|Overall Study|Physician Decision|8|||
149858672|NCT04965389|540609877|FG003|Overall Study|Other reasons|0|||
149858673|NCT04965389|540609874|FG000|Overall Study|Participant withdrew consent|0|||
149858674|NCT04965389|540609875|FG001|Overall Study|Participant withdrew consent|1|||
149858675|NCT04965389|540609876|FG002|Overall Study|Participant withdrew consent|0|||
149858676|NCT04965389|540609877|FG003|Overall Study|Participant withdrew consent|0|||
150040252|NCT00734539|541287340|FG000|Main Study|Death|33|||
150290832|NCT01471782|542197846|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150290833|NCT01471782|542197847|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149858677|NCT04965389|540609874|FG000|Overall Study|Poor/Non-compliance|0|||
149858678|NCT04965389|540609875|FG001|Overall Study|Poor/Non-compliance|1|||
149858679|NCT04965389|540609876|FG002|Overall Study|Poor/Non-compliance|0|||
149858680|NCT04965389|540609877|FG003|Overall Study|Poor/Non-compliance|0|||
149858681|NCT03903159|540609878|FG000|Overall Study|Discharged with Staff Approval|2|||
150040253|NCT00734539|541287341|FG001|Main Study|Death|32|||
150040254|NCT00734539|541287340|FG000|Main Study|Physician Decision|2|||
149858682|NCT03903159|540609878|FG000|Overall Study|Discharged at Staff Request|2|||
149858683|NCT03903159|540609878|FG000|Overall Study|Discharged Against Staff Advice|1|||
149858684|NCT00724373|540609879|FG000|Overall Study|Adverse Event|41|||
149858685|NCT00724373|540609879|FG000|Overall Study|Lack of Efficacy|82|||
149858686|NCT00724373|540609879|FG000|Overall Study|Lost to Follow-up|7|||
149858687|NCT00724373|540609879|FG000|Overall Study|Non-compliance|2|||
149858688|NCT00724373|540609879|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
149858689|NCT00724373|540609879|FG000|Overall Study|Participant moved away|1|||
149858690|NCT00724373|540609879|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
149858691|NCT00724373|540609879|FG000|Overall Study|Only to have 24 week regimen|1|||
149858692|NCT00724373|540609879|FG000|Overall Study|Viral Relapse|1|||
149858693|NCT00724373|540609879|FG000|Overall Study|Acute HCV infection|1|||
149858694|NCT00724373|540609879|FG000|Overall Study|Drug Relapse|1|||
149858695|NCT00724373|540609879|FG000|Overall Study|Tolerability|23|||
149858696|NCT04230876|540609880|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
149858697|NCT04230876|540609881|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
149858698|NCT02093923|540609882|FG000|Overall Study|Lost to Follow-up|0|||
149858699|NCT02093923|540609883|FG001|Overall Study|Lost to Follow-up|0|||
149858700|NCT02093923|540609884|FG002|Overall Study|Lost to Follow-up|0|||
149858701|NCT02093923|540609885|FG003|Overall Study|Lost to Follow-up|1|||
149858702|NCT02093923|540609886|FG004|Overall Study|Lost to Follow-up|0|||
149858703|NCT02093923|540609882|FG000|Overall Study|Screen failure after randomization|0|||
149858704|NCT02093923|540609883|FG001|Overall Study|Screen failure after randomization|0|||
149858705|NCT02093923|540609884|FG002|Overall Study|Screen failure after randomization|0|||
149858706|NCT02093923|540609885|FG003|Overall Study|Screen failure after randomization|1|||
149858707|NCT02093923|540609886|FG004|Overall Study|Screen failure after randomization|0|||
149858708|NCT01662362|540609887|FG000|Overall Study|Lost to Follow-up|38|||
149858709|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
149858710|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
149858711|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
149858712|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
149858713|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
149858714|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
149858715|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
149858716|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
149858717|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
149858718|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
149858719|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
149858720|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
149858721|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Death|0|||
149858722|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Death|1|||
149858723|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Death|0|||
149858724|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Death|0|||
149858725|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
149858726|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
149858727|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
149858728|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
149858729|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
149858730|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
149858731|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
149858732|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
149858733|NCT00545688|540609889|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
149858734|NCT00545688|540609890|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
149858735|NCT00545688|540609891|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
149858736|NCT00545688|540609892|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
149858737|NCT00545688|540609889|FG000|Adjuvant Treatment Period|Disease Progression|3|||
149858738|NCT00545688|540609890|FG001|Adjuvant Treatment Period|Disease Progression|3|||
149858739|NCT00545688|540609891|FG002|Adjuvant Treatment Period|Disease Progression|0|||
149858740|NCT00545688|540609892|FG003|Adjuvant Treatment Period|Disease Progression|7|||
149858741|NCT00545688|540609889|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
149858742|NCT00545688|540609890|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
149858743|NCT00545688|540609891|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
149858744|NCT00545688|540609892|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
149858745|NCT00545688|540609889|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
150040255|NCT00734539|541287341|FG001|Main Study|Physician Decision|0|||
149858746|NCT00545688|540609890|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
149858747|NCT00545688|540609891|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
149858748|NCT00545688|540609892|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
149858749|NCT00545688|540609889|FG000|Adjuvant Treatment Period|Adverse Event|0|||
149858750|NCT00545688|540609890|FG001|Adjuvant Treatment Period|Adverse Event|3|||
149858751|NCT00545688|540609891|FG002|Adjuvant Treatment Period|Adverse Event|2|||
149858752|NCT00545688|540609892|FG003|Adjuvant Treatment Period|Adverse Event|2|||
149858753|NCT00545688|540609889|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
149858754|NCT00545688|540609890|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
149858755|NCT00545688|540609891|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
149858756|NCT00545688|540609892|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
149858757|NCT00545688|540609889|FG000|Follow-Up Period|Death|4|||
149858758|NCT00545688|540609890|FG001|Follow-Up Period|Death|2|||
149858759|NCT00545688|540609891|FG002|Follow-Up Period|Death|2|||
149858760|NCT00545688|540609892|FG003|Follow-Up Period|Death|6|||
149858761|NCT00545688|540609889|FG000|Follow-Up Period|Disease Progression|6|||
149858762|NCT00545688|540609890|FG001|Follow-Up Period|Disease Progression|5|||
149858763|NCT00545688|540609891|FG002|Follow-Up Period|Disease Progression|9|||
149858764|NCT00545688|540609892|FG003|Follow-Up Period|Disease Progression|9|||
149858765|NCT00545688|540609889|FG000|Follow-Up Period|Refused Treatment|6|||
149858766|NCT00545688|540609890|FG001|Follow-Up Period|Refused Treatment|2|||
149858767|NCT00545688|540609891|FG002|Follow-Up Period|Refused Treatment|0|||
149858768|NCT00545688|540609892|FG003|Follow-Up Period|Refused Treatment|2|||
149858769|NCT00545688|540609889|FG000|Follow-Up Period|Lost to Follow-up|3|||
149858770|NCT00545688|540609890|FG001|Follow-Up Period|Lost to Follow-up|3|||
149858771|NCT00545688|540609891|FG002|Follow-Up Period|Lost to Follow-up|3|||
149858772|NCT00545688|540609892|FG003|Follow-Up Period|Lost to Follow-up|1|||
149858773|NCT00545688|540609889|FG000|Follow-Up Period|Unspecified Reason|2|||
149858774|NCT00545688|540609890|FG001|Follow-Up Period|Unspecified Reason|5|||
149858775|NCT00545688|540609891|FG002|Follow-Up Period|Unspecified Reason|6|||
149858776|NCT00545688|540609892|FG003|Follow-Up Period|Unspecified Reason|8|||
149858777|NCT00545688|540609889|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
149858778|NCT00545688|540609890|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
149858779|NCT00545688|540609891|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
149858780|NCT00545688|540609892|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
149858781|NCT01301482|540611365|FG000|Overall Study|Withdrawal by Subject|1|||
149858782|NCT01915940|540611368|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
149858783|NCT01915940|540611369|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
149858784|NCT01915940|540611370|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
149858785|NCT01915940|540611368|FG000|Treatment Period|Decision of Participant|0|||
149858786|NCT01915940|540611369|FG001|Treatment Period|Decision of Participant|1|||
149858787|NCT01915940|540611370|FG002|Treatment Period|Decision of Participant|3|||
149858788|NCT01915940|540611368|FG000|Treatment Period|Adverse Event|0|||
149858789|NCT01915940|540611369|FG001|Treatment Period|Adverse Event|9|||
149858790|NCT01915940|540611370|FG002|Treatment Period|Adverse Event|1|||
149858791|NCT01915940|540611368|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
149858792|NCT01915940|540611369|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
149858793|NCT01915940|540611370|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
149858794|NCT00614926|540611371|FG000|Overall Study|Burden of travel|1|||
149858795|NCT00614926|540611372|FG001|Overall Study|Burden of travel|0|||
149858796|NCT00614926|540611371|FG000|Overall Study|Adverse Event|3|||
149858797|NCT00614926|540611372|FG001|Overall Study|Adverse Event|0|||
149858798|NCT03250299|540611373|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
149858799|NCT03250299|540611374|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
149858800|NCT03250299|540611375|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
149858801|NCT03250299|540611376|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
149858802|NCT03250299|540611377|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
149858803|NCT03250299|540611373|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
149858804|NCT03250299|540611374|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
149858805|NCT03250299|540611375|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
149858806|NCT03250299|540611376|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
149858807|NCT03250299|540611377|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
149858808|NCT03250299|540611373|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
149858809|NCT03250299|540611374|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
149858810|NCT03250299|540611375|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
149858811|NCT03250299|540611376|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
149858812|NCT03250299|540611377|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
149858813|NCT03250299|540611373|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
149858814|NCT03250299|540611374|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
149858815|NCT03250299|540611375|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
149858816|NCT03250299|540611376|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
149858817|NCT03250299|540611377|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
149858818|NCT00706095|540611385|FG000|Overall Study|Progressive Disease|4|||
149858819|NCT00706095|540611386|FG001|Overall Study|Progressive Disease|5|||
149858820|NCT00706095|540611387|FG002|Overall Study|Progressive Disease|3|||
149858821|NCT00706095|540611385|FG000|Overall Study|Clinical Progression|1|||
149858822|NCT00706095|540611386|FG001|Overall Study|Clinical Progression|2|||
149858823|NCT00706095|540611387|FG002|Overall Study|Clinical Progression|2|||
149858824|NCT00706095|540611385|FG000|Overall Study|Withdrawal by Subject|1|||
149858825|NCT00706095|540611386|FG001|Overall Study|Withdrawal by Subject|0|||
149858826|NCT00706095|540611387|FG002|Overall Study|Withdrawal by Subject|0|||
149858827|NCT01005329|540611391|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
149858828|NCT03756883|540611396|FG000|Overall Study|Adverse Event|2|||
149858829|NCT03756883|540611397|FG001|Overall Study|Adverse Event|2|||
149858830|NCT03756883|540611398|FG002|Overall Study|Adverse Event|2|||
150040256|NCT00734539|541287340|FG000|Main Study|Withdrawal by Subject|1|||
150040257|NCT00734539|541287341|FG001|Main Study|Withdrawal by Subject|3|||
150040258|NCT00734539|541287340|FG000|Main Study|Enrolled in error; ineligible|1|||
150040259|NCT00734539|541287341|FG001|Main Study|Enrolled in error; ineligible|0|||
150040260|NCT02504151|541287342|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
150040261|NCT02504151|541287343|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
150040262|NCT02504151|541287342|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
150040263|NCT02504151|541287343|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
150040264|NCT02504151|541287342|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
150040265|NCT02504151|541287343|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
150040266|NCT02504151|541287342|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
150040267|NCT02504151|541287343|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
150040268|NCT05038982|541287344|FG000|Overall Study|Withdrawal by Subject|0|||
150040269|NCT05038982|541287345|FG001|Overall Study|Withdrawal by Subject|2|||
150040270|NCT01454102|541287349|FG000|Overall Study|Continuing in the treatment period|0|||
150040271|NCT01454102|541287350|FG001|Overall Study|Continuing in the treatment period|0|||
150040272|NCT01454102|541287351|FG002|Overall Study|Continuing in the treatment period|0|||
150040273|NCT01454102|541287352|FG003|Overall Study|Continuing in the treatment period|0|||
150040274|NCT01454102|541287353|FG004|Overall Study|Continuing in the treatment period|3|||
150040275|NCT01454102|541287354|FG005|Overall Study|Continuing in the treatment period|3|||
150040276|NCT01454102|541287355|FG006|Overall Study|Continuing in the treatment period|2|||
150040277|NCT01454102|541287356|FG007|Overall Study|Continuing in the treatment period|0|||
149858831|NCT03756883|540611396|FG000|Overall Study|Lack of Efficacy|0|||
149858832|NCT03756883|540611397|FG001|Overall Study|Lack of Efficacy|1|||
149858833|NCT03756883|540611398|FG002|Overall Study|Lack of Efficacy|2|||
149858834|NCT03756883|540611396|FG000|Overall Study|Lost to Follow-up|3|||
149858835|NCT03756883|540611397|FG001|Overall Study|Lost to Follow-up|3|||
149858836|NCT03756883|540611398|FG002|Overall Study|Lost to Follow-up|0|||
149858837|NCT03756883|540611396|FG000|Overall Study|Protocol Violation|2|||
149858838|NCT03756883|540611397|FG001|Overall Study|Protocol Violation|0|||
149858839|NCT03756883|540611398|FG002|Overall Study|Protocol Violation|1|||
149858840|NCT03756883|540611396|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
149858841|NCT03756883|540611397|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
149858842|NCT03756883|540611398|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
149858843|NCT03756883|540611396|FG000|Overall Study|Withdrawal by Subject|4|||
149858844|NCT03756883|540611397|FG001|Overall Study|Withdrawal by Subject|1|||
149858845|NCT03756883|540611398|FG002|Overall Study|Withdrawal by Subject|0|||
149858846|NCT03756883|540611396|FG000|Overall Study|Other Reasons|2|||
149858847|NCT03756883|540611397|FG001|Overall Study|Other Reasons|4|||
149858848|NCT03756883|540611398|FG002|Overall Study|Other Reasons|0|||
149858849|NCT01470417|540611399|FG000|Overall Study|Disease progression|0|||
149858850|NCT01470417|540611400|FG001|Overall Study|Disease progression|2|||
149858851|NCT02973321|540611401|FG000|Overall Study|Other than specified|0|||
149858852|NCT02973321|540611402|FG001|Overall Study|Other than specified|5|||
149858853|NCT02973321|540611403|FG002|Overall Study|Other than specified|3|||
149858854|NCT02973321|540611404|FG003|Overall Study|Other than specified|3|||
149858855|NCT02973321|540611405|FG004|Overall Study|Other than specified|1|||
149858856|NCT02973321|540611401|FG000|Overall Study|Lack of Efficacy|0|||
149858857|NCT02973321|540611402|FG001|Overall Study|Lack of Efficacy|0|||
149858858|NCT02973321|540611403|FG002|Overall Study|Lack of Efficacy|0|||
149858859|NCT02973321|540611404|FG003|Overall Study|Lack of Efficacy|0|||
149858860|NCT02973321|540611405|FG004|Overall Study|Lack of Efficacy|1|||
149858861|NCT02973321|540611401|FG000|Overall Study|Adverse Event|1|||
149858862|NCT02973321|540611402|FG001|Overall Study|Adverse Event|10|||
149858863|NCT02973321|540611403|FG002|Overall Study|Adverse Event|11|||
149858864|NCT02973321|540611404|FG003|Overall Study|Adverse Event|13|||
149858865|NCT02973321|540611405|FG004|Overall Study|Adverse Event|3|||
150040278|NCT01454102|541287357|FG008|Overall Study|Continuing in the treatment period|1|||
149858866|NCT00865514|540611412|FG000|Overall Study|Infusion cost exceeded funding|2|||
150040279|NCT01454102|541287358|FG009|Overall Study|Continuing in the treatment period|0|||
150040280|NCT01454102|541287359|FG010|Overall Study|Continuing in the treatment period|0|||
150173457|NCT03920215|541771286|FG001|Overall Study|Lost to Follow-up|2|||
150173458|NCT03920215|541771287|FG002|Overall Study|Lost to Follow-up|0|||
150173459|NCT03920215|541771288|FG003|Overall Study|Lost to Follow-up|0|||
150173460|NCT03920215|541771285|FG000|Overall Study|Death|0|||
149858867|NCT02865395|540611413|FG000|Overall Study|Physician Decision|6|||
150173461|NCT03920215|541771286|FG001|Overall Study|Death|0|||
149858868|NCT02865395|540611414|FG001|Overall Study|Physician Decision|10|||
149858869|NCT02865395|540611415|FG002|Overall Study|Physician Decision|7|||
149858870|NCT04220775|540611418|FG000|Overall Study|Adverse Event|1|||
149858871|NCT04220775|540611419|FG001|Overall Study|Adverse Event|0|||
149858872|NCT04220775|540611418|FG000|Overall Study|Disease Progression|1|||
149858873|NCT04220775|540611419|FG001|Overall Study|Disease Progression|0|||
149858874|NCT00436917|540611420|FG000|Overall Study|Withdrawal by Subject|13|||
149858875|NCT00436917|540611420|FG000|Overall Study|Adverse Event|2|||
149858876|NCT00436917|540611420|FG000|Overall Study|Physician Decision|1|||
149858877|NCT00436917|540611420|FG000|Overall Study|Death|1|||
150173462|NCT03920215|541771287|FG002|Overall Study|Death|0|||
150173463|NCT03920215|541771288|FG003|Overall Study|Death|1|||
150173464|NCT03024606|541771295|FG000|Overall Study|Withdrawal by Subject|9|||
150173465|NCT03024606|541771296|FG001|Overall Study|Withdrawal by Subject|10|||
150173466|NCT02547922|541771303|FG000|Overall Study|Withdrawal by Subject|9|||
150173467|NCT02547922|541771304|FG001|Overall Study|Withdrawal by Subject|6|||
150173468|NCT02547922|541771305|FG002|Overall Study|Withdrawal by Subject|10|||
150173469|NCT02547922|541771303|FG000|Overall Study|Adverse Event|3|||
150173470|NCT02547922|541771304|FG001|Overall Study|Adverse Event|1|||
150173471|NCT02547922|541771305|FG002|Overall Study|Adverse Event|2|||
150173472|NCT02547922|541771303|FG000|Overall Study|Lost to Follow-up|1|||
150173473|NCT02547922|541771304|FG001|Overall Study|Lost to Follow-up|0|||
150173474|NCT02547922|541771305|FG002|Overall Study|Lost to Follow-up|0|||
150173475|NCT02547922|541771303|FG000|Overall Study|Lack of Efficacy|5|||
150173476|NCT02547922|541771304|FG001|Overall Study|Lack of Efficacy|7|||
150173477|NCT02547922|541771305|FG002|Overall Study|Lack of Efficacy|4|||
150173478|NCT02547922|541771303|FG000|Overall Study|Death|1|||
150173479|NCT02547922|541771304|FG001|Overall Study|Death|0|||
150290834|NCT01471782|542197848|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150290835|NCT01471782|542197849|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
150290836|NCT01471782|542197850|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
150290837|NCT01471782|542197851|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
150290838|NCT01471782|542197846|FG000|Overall Study|Death|0|||
149858878|NCT00436917|540611420|FG000|Overall Study|Lost to Follow-up|1|||
149858879|NCT00436917|540611420|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
149858880|NCT00436917|540611420|FG000|Overall Study|Increased creatinine|1|||
149858881|NCT00436917|540611420|FG000|Overall Study|Personal conflicts of patient|1|||
149858882|NCT02169791|540611421|FG000|Overall Study|Death|6|||
149858883|NCT02169791|540611421|FG000|Overall Study|patient withdrew consent|1|||
149858884|NCT01009515|540611422|FG000|Overall Study|Withdrawal by Subject|3|||
149858885|NCT01439724|540611425|FG000|Overall Study|missing consultation|9|||
149858886|NCT01439724|540611426|FG001|Overall Study|missing consultation|8|||
150173480|NCT02547922|541771305|FG002|Overall Study|Death|0|||
150173481|NCT02547922|541771303|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
150173482|NCT02547922|541771304|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
150173483|NCT02547922|541771305|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
149858887|NCT00271024|540611427|FG000|Overall Study|Lost Interest|3|||
149858888|NCT00271024|540611428|FG001|Overall Study|Lost Interest|4|||
150173484|NCT02547922|541771303|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
150173485|NCT02547922|541771304|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
150173486|NCT02547922|541771305|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
150173487|NCT02547922|541771303|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
150173488|NCT02547922|541771304|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
150173489|NCT02547922|541771305|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
150173490|NCT02547922|541771303|FG000|Overall Study|Physician Decision|2|||
150173491|NCT02547922|541771304|FG001|Overall Study|Physician Decision|1|||
150173492|NCT02547922|541771305|FG002|Overall Study|Physician Decision|2|||
149858889|NCT00271024|540611429|FG002|Overall Study|Lost Interest|2|||
150173493|NCT02547922|541771303|FG000|Overall Study|Patients did not receive IP|1|||
150173494|NCT02547922|541771304|FG001|Overall Study|Patients did not receive IP|1|||
149858890|NCT00271024|540611430|FG003|Overall Study|Lost Interest|3|||
149858891|NCT00271024|540611427|FG000|Overall Study|Unknown/Unspecified|11|||
150290839|NCT01471782|542197847|FG001|Overall Study|Death|0|||
149858892|NCT00271024|540611428|FG001|Overall Study|Unknown/Unspecified|11|||
149858893|NCT00271024|540611429|FG002|Overall Study|Unknown/Unspecified|8|||
149858894|NCT00271024|540611430|FG003|Overall Study|Unknown/Unspecified|4|||
150290840|NCT01471782|542197848|FG002|Overall Study|Death|0|||
149858895|NCT00271024|540611427|FG000|Overall Study|Protocol Violation|1|||
150173495|NCT02547922|541771305|FG002|Overall Study|Patients did not receive IP|0|||
150173496|NCT00102063|541771310|FG000|Overall Study|Lack of Efficacy|5|||
150173497|NCT00102063|541771311|FG001|Overall Study|Lack of Efficacy|1|||
150290841|NCT01471782|542197849|FG003|Overall Study|Death|0|||
149858896|NCT00271024|540611428|FG001|Overall Study|Protocol Violation|6|||
149858897|NCT00271024|540611429|FG002|Overall Study|Protocol Violation|5|||
149858898|NCT00271024|540611430|FG003|Overall Study|Protocol Violation|11|||
149858899|NCT00271024|540611427|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
149858900|NCT00271024|540611428|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
149858901|NCT00271024|540611429|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
149858902|NCT00271024|540611430|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
149858903|NCT00271024|540611427|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
149858904|NCT00271024|540611428|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
149858905|NCT00271024|540611429|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
149858906|NCT00271024|540611430|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
149858907|NCT03573817|540611437|FG000|Overall Study|Adverse Event|0|||
149858908|NCT03573817|540611438|FG001|Overall Study|Adverse Event|2|||
149858909|NCT03573817|540611437|FG000|Overall Study|Protocol Violation|0|||
149858910|NCT03573817|540611438|FG001|Overall Study|Protocol Violation|1|||
149858911|NCT03573817|540611437|FG000|Overall Study|Withdrawal by Subject|1|||
149858912|NCT03573817|540611438|FG001|Overall Study|Withdrawal by Subject|1|||
149858913|NCT01719562|540611439|FG000|Overall Study|Lost to Follow-up|1|||
149858914|NCT01719562|540611440|FG001|Overall Study|Lost to Follow-up|0|||
149858915|NCT01719562|540611439|FG000|Overall Study|Death|1|||
149858916|NCT01719562|540611440|FG001|Overall Study|Death|0|||
149858917|NCT01719562|540611439|FG000|Overall Study|New cancer diagnosis|1|||
149858918|NCT01719562|540611440|FG001|Overall Study|New cancer diagnosis|0|||
149858919|NCT00508027|540611441|FG000|Dose Level 1|Lost to Follow-up|4|||
149858920|NCT00508027|540611441|FG000|Dose Level 1|Withdrawal by Subject|2|||
149858921|NCT00508027|540611441|FG000|Dose Level 1|Physician Decision|2|||
149858922|NCT00508027|540611441|FG000|Dose Level 2|Lost to Follow-up|2|||
149858923|NCT00508027|540611441|FG000|Dose Level 2|Withdrawal by Subject|2|||
149858924|NCT03554317|540611443|FG000|Overall Study|Withdrawal by Subject|1|||
149858925|NCT03554317|540611443|FG000|Overall Study|PSA Progression|3|||
149858926|NCT03554317|540611443|FG000|Overall Study|Radiographic Progression|4|||
149858927|NCT00537199|540611444|FG000|Overall Study|Study Terminated|1|||
149858928|NCT02039063|540611445|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
149858929|NCT02039063|540611446|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
149858930|NCT02039063|540611447|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
149858931|NCT02039063|540611448|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
149858932|NCT02039063|540611445|FG000|Treatment Phase|Progression of disease|0|||
149858933|NCT02039063|540611446|FG001|Treatment Phase|Progression of disease|0|||
149858934|NCT02039063|540611447|FG002|Treatment Phase|Progression of disease|1|||
149858935|NCT02039063|540611448|FG003|Treatment Phase|Progression of disease|1|||
149858936|NCT02039063|540611445|FG000|Extension Phase|Inadequate therapeutic effect|0|||
149858937|NCT02039063|540611446|FG001|Extension Phase|Inadequate therapeutic effect|1|||
149858938|NCT02039063|540611447|FG002|Extension Phase|Inadequate therapeutic effect|2|||
149858939|NCT02039063|540611448|FG003|Extension Phase|Inadequate therapeutic effect|0|||
149858940|NCT02039063|540611445|FG000|Extension Phase|Progression of disease|0|||
149858941|NCT02039063|540611446|FG001|Extension Phase|Progression of disease|0|||
149858942|NCT02039063|540611447|FG002|Extension Phase|Progression of disease|0|||
149858943|NCT02039063|540611448|FG003|Extension Phase|Progression of disease|1|||
149858944|NCT02039063|540611445|FG000|Extension Phase|Adverse Event|0|||
149858945|NCT02039063|540611446|FG001|Extension Phase|Adverse Event|0|||
149858946|NCT02039063|540611447|FG002|Extension Phase|Adverse Event|1|||
149858947|NCT02039063|540611448|FG003|Extension Phase|Adverse Event|0|||
149858948|NCT00612677|540611454|FG000|Overall Study|study closed before treatment started|1|||
149858949|NCT00823199|540611456|FG000|Overall Study|Withdrawal by Subject|2|||
149858950|NCT01640184|540611460|FG000|Overall Study|Death|1|||
149858951|NCT01640184|540611461|FG001|Overall Study|Death|0|||
149858952|NCT01640184|540611462|FG002|Overall Study|Death|0|||
149858953|NCT01640184|540611460|FG000|Overall Study|Lost to Follow-up|4|||
149858954|NCT01640184|540611461|FG001|Overall Study|Lost to Follow-up|1|||
149858955|NCT01640184|540611462|FG002|Overall Study|Lost to Follow-up|0|||
149858956|NCT01640184|540611460|FG000|Overall Study|Physician Decision|3|||
149858957|NCT01640184|540611461|FG001|Overall Study|Physician Decision|0|||
149858958|NCT01640184|540611462|FG002|Overall Study|Physician Decision|0|||
149858959|NCT01640184|540611460|FG000|Overall Study|Withdrawal by Subject|0|||
149858960|NCT01640184|540611461|FG001|Overall Study|Withdrawal by Subject|1|||
149858961|NCT01640184|540611462|FG002|Overall Study|Withdrawal by Subject|1|||
149858962|NCT01640184|540611460|FG000|Overall Study|Protocol Violation|0|||
149858963|NCT01640184|540611461|FG001|Overall Study|Protocol Violation|0|||
149858964|NCT01640184|540611462|FG002|Overall Study|Protocol Violation|1|||
149858965|NCT02927834|540611463|FG000|Overall Study|Lost to Follow-up|1|||
149858966|NCT02927834|540611464|FG001|Overall Study|Lost to Follow-up|2|||
149858967|NCT02927834|540611465|FG002|Overall Study|Lost to Follow-up|2|||
149858968|NCT02492841|540611466|FG000|Overall Study|Lost to Follow-up|34|||
149858969|NCT02492841|540611467|FG001|Overall Study|Lost to Follow-up|31|||
149858970|NCT02492841|540611468|FG002|Overall Study|Lost to Follow-up|35|||
149858971|NCT00613730|540611472|FG000|Overall Study|Disease progression|2|||
149858972|NCT00613730|540611472|FG000|Overall Study|Administrative decision|1|||
149858973|NCT00479388|540611473|FG000|Overall Study|Adverse Event|90|||
149858974|NCT00479388|540611474|FG001|Overall Study|Adverse Event|45|||
149858975|NCT00479388|540611473|FG000|Overall Study|Lost to Follow-up|0|||
149858976|NCT00479388|540611474|FG001|Overall Study|Lost to Follow-up|2|||
149858977|NCT00479388|540611473|FG000|Overall Study|Protocol Violation|10|||
149858978|NCT00479388|540611474|FG001|Overall Study|Protocol Violation|9|||
149858979|NCT00479388|540611473|FG000|Overall Study|Withdrawal by Subject|32|||
149858980|NCT00479388|540611474|FG001|Overall Study|Withdrawal by Subject|17|||
149858981|NCT01876368|540611477|FG000|Overall Study|Adverse Event|2|||
149858982|NCT01876368|540611478|FG001|Overall Study|Adverse Event|5|||
149858983|NCT01876368|540611477|FG000|Overall Study|Lack of Efficacy|1|||
149858984|NCT01876368|540611478|FG001|Overall Study|Lack of Efficacy|0|||
149858985|NCT01876368|540611477|FG000|Overall Study|Lost to Follow-up|0|||
149858986|NCT01876368|540611478|FG001|Overall Study|Lost to Follow-up|1|||
149858987|NCT01876368|540611477|FG000|Overall Study|Non-compliance with study treatment|0|||
149858988|NCT01876368|540611478|FG001|Overall Study|Non-compliance with study treatment|1|||
149858989|NCT01876368|540611477|FG000|Overall Study|Physician Decision|0|||
149858990|NCT01876368|540611478|FG001|Overall Study|Physician Decision|2|||
149858991|NCT01876368|540611477|FG000|Overall Study|Protocol deviation|3|||
149858992|NCT01876368|540611478|FG001|Overall Study|Protocol deviation|3|||
149858993|NCT01876368|540611477|FG000|Overall Study|Subject/guardian decision|3|||
149858994|NCT01876368|540611478|FG001|Overall Study|Subject/guardian decision|1|||
149858995|NCT02563769|540611481|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
149858996|NCT02563769|540611482|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
149858997|NCT02563769|540611483|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
149858998|NCT01644149|540611484|FG000|Overall Study|Withdrawal by Subject|1|||
149858999|NCT01644149|540611485|FG001|Overall Study|Withdrawal by Subject|0|||
149859000|NCT01644149|540611484|FG000|Overall Study|Lost to Follow-up|3|||
149859001|NCT01644149|540611485|FG001|Overall Study|Lost to Follow-up|1|||
149859002|NCT02820740|540611488|FG000|Overall Study|Did not have procedure|2|||
149859003|NCT01436643|540611492|FG000|2-week Pre-treatment|Abnormal test result|0|||
149859004|NCT01436643|540611493|FG001|2-week Pre-treatment|Abnormal test result|0|||
149859005|NCT01436643|540611494|FG002|2-week Pre-treatment|Abnormal test result|0|||
149859006|NCT01436643|540611495|FG003|2-week Pre-treatment|Abnormal test result|1|||
149859007|NCT01436643|540611492|FG000|2-week Pre-treatment|Adverse Event|0|||
149859008|NCT01436643|540611493|FG001|2-week Pre-treatment|Adverse Event|0|||
149859009|NCT01436643|540611494|FG002|2-week Pre-treatment|Adverse Event|0|||
149859010|NCT01436643|540611495|FG003|2-week Pre-treatment|Adverse Event|5|||
149859011|NCT01436643|540611492|FG000|2-week Pre-treatment|Protocol Violation|0|||
149859012|NCT01436643|540611493|FG001|2-week Pre-treatment|Protocol Violation|0|||
149859013|NCT01436643|540611494|FG002|2-week Pre-treatment|Protocol Violation|0|||
149859014|NCT01436643|540611495|FG003|2-week Pre-treatment|Protocol Violation|4|||
149859015|NCT01436643|540611492|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
149859016|NCT01436643|540611493|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
149859017|NCT01436643|540611494|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
149859018|NCT01436643|540611495|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
149859019|NCT01436643|540611492|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
149859020|NCT01436643|540611493|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
149859021|NCT01436643|540611494|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
149859022|NCT01436643|540611495|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
149859023|NCT01436643|540611492|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
149859024|NCT01436643|540611493|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
149859025|NCT01436643|540611494|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
149859026|NCT01436643|540611495|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
149859027|NCT01382251|540611496|FG000|Overall Study|Surgeries cancelled or delayed|16|||
149859028|NCT01382251|540611497|FG001|Overall Study|Surgeries cancelled or delayed|16|||
149859029|NCT01382251|540611496|FG000|Overall Study|Lost to Follow-up|4|||
149859030|NCT01382251|540611497|FG001|Overall Study|Lost to Follow-up|4|||
149859031|NCT01382251|540611496|FG000|Overall Study|Contacted after study closed|1|||
149859032|NCT01382251|540611497|FG001|Overall Study|Contacted after study closed|1|||
149859033|NCT01117987|540611498|FG000|Overall Study|Protocol deviation|0|||
149859034|NCT01117987|540611499|FG001|Overall Study|Protocol deviation|1|||
149859035|NCT01117987|540611498|FG000|Overall Study|Subject no longer requires study drug|1|||
149859036|NCT01117987|540611499|FG001|Overall Study|Subject no longer requires study drug|0|||
149859037|NCT01117987|540611498|FG000|Overall Study|Lost to Follow-up|1|||
149859038|NCT01117987|540611499|FG001|Overall Study|Lost to Follow-up|1|||
149859039|NCT01117987|540611498|FG000|Overall Study|Abnormal test procedure result|2|||
149859040|NCT01117987|540611499|FG001|Overall Study|Abnormal test procedure result|0|||
149859041|NCT01117987|540611498|FG000|Overall Study|Lack of Efficacy|3|||
149859042|NCT01117987|540611499|FG001|Overall Study|Lack of Efficacy|4|||
149859043|NCT01117987|540611498|FG000|Overall Study|Death|5|||
149859044|NCT01117987|540611499|FG001|Overall Study|Death|10|||
149859045|NCT01117987|540611498|FG000|Overall Study|Withdrawal by Subject|5|||
149859046|NCT01117987|540611499|FG001|Overall Study|Withdrawal by Subject|10|||
149859047|NCT01117987|540611498|FG000|Overall Study|Adverse Event|19|||
149859048|NCT01117987|540611499|FG001|Overall Study|Adverse Event|26|||
149859049|NCT01117987|540611498|FG000|Overall Study|Administrative problems|25|||
149859050|NCT01117987|540611499|FG001|Overall Study|Administrative problems|22|||
149859051|NCT04117945|540611500|FG000|Overall Study|Death|1|||
149859052|NCT04117945|540611501|FG001|Overall Study|Death|0|||
149859053|NCT04117945|540611500|FG000|Overall Study|Withdrawal by Subject|3|||
149859054|NCT04117945|540611501|FG001|Overall Study|Withdrawal by Subject|1|||
149859055|NCT04117945|540611500|FG000|Overall Study|Disease Progression|0|||
149859056|NCT04117945|540611501|FG001|Overall Study|Disease Progression|2|||
149859057|NCT04117945|540611500|FG000|Overall Study|Ineligible|8|||
149859058|NCT04117945|540611501|FG001|Overall Study|Ineligible|7|||
149859059|NCT00562120|540611507|FG000|First Intervention Period|Adverse Event|1|||
149859060|NCT00562120|540611508|FG001|First Intervention Period|Adverse Event|0|||
149859061|NCT00562120|540611509|FG002|First Intervention Period|Adverse Event|0|||
149859062|NCT00562120|540611510|FG003|First Intervention Period|Adverse Event|0|||
149859063|NCT00562120|540611507|FG000|First Intervention Period|Randomized but not Treated|1|||
149859064|NCT00562120|540611508|FG001|First Intervention Period|Randomized but not Treated|0|||
149859065|NCT00562120|540611509|FG002|First Intervention Period|Randomized but not Treated|0|||
149859066|NCT00562120|540611510|FG003|First Intervention Period|Randomized but not Treated|0|||
149859067|NCT02148445|540611511|FG000|Overall Study|Death|1|||
149859068|NCT02148445|540611512|FG001|Overall Study|Death|3|||
149859069|NCT03450629|540611513|FG000|Overall Study|Adverse Event|15|||
149859070|NCT03450629|540611514|FG001|Overall Study|Adverse Event|14|||
149859071|NCT03450629|540611513|FG000|Overall Study|Physician Decision|2|||
149859072|NCT03450629|540611514|FG001|Overall Study|Physician Decision|2|||
149859073|NCT03450629|540611513|FG000|Overall Study|Lack of Efficacy|2|||
149859074|NCT03450629|540611514|FG001|Overall Study|Lack of Efficacy|0|||
149859075|NCT03450629|540611513|FG000|Overall Study|Lost to Follow-up|4|||
149961400|NCT02070380|540992066|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
149961401|NCT02070380|540992067|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
149961402|NCT02070380|540992064|FG000|Second Injection|Image sets missing or technically inadeq|0|||
150290842|NCT01471782|542197850|FG004|Overall Study|Death|0|||
150290843|NCT01471782|542197851|FG005|Overall Study|Death|1|||
150290844|NCT00936208|542197852|FG000|Overall Study|Protocol Violation|37|||
150290845|NCT00936208|542197853|FG001|Overall Study|Protocol Violation|22|||
150290846|NCT04818593|542197854|FG000|Overall Study|Low Oocyte Yield|8|||
150290847|NCT04818593|542197855|FG001|Overall Study|Low Oocyte Yield|8|||
150290848|NCT04818593|542197854|FG000|Overall Study|Not ICSI Insemination|7|||
150290849|NCT04818593|542197855|FG001|Overall Study|Not ICSI Insemination|7|||
150290850|NCT04818593|542197854|FG000|Overall Study|Poor Sperm Quality|2|||
150290851|NCT04818593|542197855|FG001|Overall Study|Poor Sperm Quality|2|||
150290852|NCT04818593|542197854|FG000|Overall Study|Withdrawal by Subject|2|||
150290853|NCT04818593|542197855|FG001|Overall Study|Withdrawal by Subject|2|||
150290854|NCT04818593|542197854|FG000|Overall Study|Conversion to IUI due to low response|1|||
150290855|NCT04818593|542197855|FG001|Overall Study|Conversion to IUI due to low response|1|||
150290856|NCT01564862|542197856|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
150290857|NCT01564862|542197857|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
149859076|NCT03450629|540611514|FG001|Overall Study|Lost to Follow-up|2|||
149859077|NCT03450629|540611513|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
149859078|NCT03450629|540611514|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
149859079|NCT03450629|540611513|FG000|Overall Study|Non-Compliance With Study Drug|2|||
149859080|NCT03450629|540611514|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149859081|NCT03450629|540611513|FG000|Overall Study|Protocol Violation|11|||
149859082|NCT03450629|540611514|FG001|Overall Study|Protocol Violation|8|||
149859083|NCT03450629|540611513|FG000|Overall Study|Withdrawal by Subject|12|||
149859084|NCT03450629|540611514|FG001|Overall Study|Withdrawal by Subject|6|||
149859085|NCT03438006|540611516|FG000|Overall Study|Adverse Event|1|||
149859086|NCT03438006|540611516|FG000|Overall Study|Lost to Follow-up|67|||
149961403|NCT02070380|540992065|FG001|Second Injection|Image sets missing or technically inadeq|1|||
149961404|NCT02070380|540992066|FG002|Second Injection|Image sets missing or technically inadeq|0|||
150173498|NCT00102063|541771312|FG002|Overall Study|Lack of Efficacy|1|||
149859087|NCT03438006|540611516|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
149859088|NCT03438006|540611516|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
149859089|NCT01181531|540611525|FG000|Overall Study|Other|17|||
149859090|NCT01181531|540611526|FG001|Overall Study|Other|12|||
149859091|NCT01181531|540611525|FG000|Overall Study|Partial consent by subject withdrawn|0|||
149859092|NCT01181531|540611526|FG001|Overall Study|Partial consent by subject withdrawn|1|||
149859093|NCT01181531|540611525|FG000|Overall Study|Physician Decision|3|||
149859094|NCT01181531|540611526|FG001|Overall Study|Physician Decision|1|||
149859095|NCT01181531|540611525|FG000|Overall Study|Noncompliance|2|||
149859096|NCT01181531|540611526|FG001|Overall Study|Noncompliance|2|||
149859097|NCT01181531|540611525|FG000|Overall Study|Ineligibility determined|1|||
149859098|NCT01181531|540611526|FG001|Overall Study|Ineligibility determined|2|||
149859099|NCT01181531|540611525|FG000|Overall Study|Protocol Specified Criteria|15|||
149859100|NCT01181531|540611526|FG001|Overall Study|Protocol Specified Criteria|8|||
149859101|NCT01181531|540611525|FG000|Overall Study|Pregnancy|0|||
149859102|NCT01181531|540611526|FG001|Overall Study|Pregnancy|1|||
149859103|NCT01181531|540611525|FG000|Overall Study|Withdrawal by Subject|8|||
149859104|NCT01181531|540611526|FG001|Overall Study|Withdrawal by Subject|7|||
149859105|NCT01181531|540611525|FG000|Overall Study|Protocol Violation|6|||
149859106|NCT01181531|540611526|FG001|Overall Study|Protocol Violation|6|||
149859107|NCT01181531|540611525|FG000|Overall Study|Death|9|||
149859108|NCT01181531|540611526|FG001|Overall Study|Death|12|||
149859109|NCT01181531|540611525|FG000|Overall Study|Adverse Event|0|||
149859110|NCT01181531|540611526|FG001|Overall Study|Adverse Event|1|||
149859111|NCT02339090|540611527|FG000|Overall Study|Adverse Event|1|||
149859112|NCT02339090|540611528|FG001|Overall Study|Adverse Event|0|||
149859113|NCT02339090|540611527|FG000|Overall Study|Lost to Follow-up|0|||
149859114|NCT02339090|540611528|FG001|Overall Study|Lost to Follow-up|1|||
149859115|NCT02339090|540611527|FG000|Overall Study|Non-compliance With Study Drug|0|||
149859116|NCT02339090|540611528|FG001|Overall Study|Non-compliance With Study Drug|1|||
149859117|NCT02339090|540611527|FG000|Overall Study|Withdrawal by Subject|2|||
149859118|NCT02339090|540611528|FG001|Overall Study|Withdrawal by Subject|1|||
149859119|NCT02339090|540611527|FG000|Overall Study|Poor Growth|3|||
149859120|NCT02339090|540611528|FG001|Overall Study|Poor Growth|0|||
149859121|NCT02339090|540611527|FG000|Overall Study|Randomized but not treated|0|||
149859122|NCT02339090|540611528|FG001|Overall Study|Randomized but not treated|2|||
149859123|NCT02737592|540611531|FG000|Overall Study|Withdrawal by Subject|1|||
149859124|NCT02792218|540611533|FG000|Overall Study|Patient/guardian decision|15|||
149859125|NCT02792218|540611534|FG001|Overall Study|Patient/guardian decision|42|||
149859126|NCT02792218|540611533|FG000|Overall Study|Adverse Event|15|||
149859127|NCT02792218|540611534|FG001|Overall Study|Adverse Event|14|||
149859128|NCT02792218|540611533|FG000|Overall Study|Lost to Follow-up|10|||
149859129|NCT02792218|540611534|FG001|Overall Study|Lost to Follow-up|5|||
149859130|NCT02792218|540611533|FG000|Overall Study|Lack of Efficacy|1|||
149859131|NCT02792218|540611534|FG001|Overall Study|Lack of Efficacy|12|||
149859132|NCT02792218|540611533|FG000|Overall Study|Physician Decision|4|||
149859133|NCT02792218|540611534|FG001|Overall Study|Physician Decision|4|||
149859134|NCT02792218|540611533|FG000|Overall Study|Protocol deviation|3|||
150040281|NCT01454102|541287360|FG011|Overall Study|Continuing in the treatment period|4|||
149859135|NCT02792218|540611534|FG001|Overall Study|Protocol deviation|2|||
149859136|NCT02792218|540611533|FG000|Overall Study|New therapy for study indication|0|||
149859137|NCT02792218|540611534|FG001|Overall Study|New therapy for study indication|1|||
149859138|NCT02792218|540611533|FG000|Overall Study|Non-compliance with study treatment|0|||
149859139|NCT02792218|540611534|FG001|Overall Study|Non-compliance with study treatment|1|||
149859140|NCT02792218|540611533|FG000|Overall Study|Pregnancy|1|||
149859141|NCT02792218|540611534|FG001|Overall Study|Pregnancy|0|||
149859142|NCT00955721|540611536|FG000|Overall Study|Physician Decision|1|||
149859143|NCT00955721|540611537|FG001|Overall Study|Physician Decision|0|||
149859144|NCT00955721|540611536|FG000|Overall Study|Death|1|||
149859145|NCT00955721|540611537|FG001|Overall Study|Death|0|||
149859146|NCT00955721|540611536|FG000|Overall Study|Withdrawal by Subject|1|||
149859147|NCT00955721|540611537|FG001|Overall Study|Withdrawal by Subject|0|||
149859148|NCT01253317|540611549|FG000|Overall Study|Adverse Event|2|||
149859149|NCT04678817|540613142|FG000|Overall Study|Lost to Follow-up|28|||
149859150|NCT04678817|540613143|FG001|Overall Study|Lost to Follow-up|0|||
149859151|NCT04678817|540613144|FG002|Overall Study|Lost to Follow-up|0|||
149859152|NCT02284347|540613152|FG000|Overall Study|Lost to Follow-up|2|||
149859153|NCT02284347|540613152|FG000|Overall Study|Withdrawn prior to treatment|1|||
149859154|NCT01730040|540613154|FG000|Overall Study|Randomized but not treated|0|||
149859155|NCT01730040|540613155|FG001|Overall Study|Randomized but not treated|0|||
149859156|NCT01730040|540613156|FG002|Overall Study|Randomized but not treated|0|||
149859157|NCT01730040|540613157|FG003|Overall Study|Randomized but not treated|0|||
149859158|NCT01730040|540613158|FG004|Overall Study|Randomized but not treated|0|||
149859159|NCT01730040|540613159|FG005|Overall Study|Randomized but not treated|1|||
149859160|NCT01730040|540613160|FG006|Overall Study|Randomized but not treated|0|||
149859161|NCT01730040|540613154|FG000|Overall Study|Subject moved|0|||
149859162|NCT01730040|540613155|FG001|Overall Study|Subject moved|0|||
149859163|NCT01730040|540613156|FG002|Overall Study|Subject moved|1|||
149859164|NCT01730040|540613157|FG003|Overall Study|Subject moved|0|||
149859165|NCT01730040|540613158|FG004|Overall Study|Subject moved|0|||
149859166|NCT01730040|540613159|FG005|Overall Study|Subject moved|0|||
149859167|NCT01730040|540613160|FG006|Overall Study|Subject moved|1|||
149859168|NCT01730040|540613154|FG000|Overall Study|Physician Decision|0|||
149859169|NCT01730040|540613155|FG001|Overall Study|Physician Decision|0|||
149859170|NCT01730040|540613156|FG002|Overall Study|Physician Decision|0|||
149859171|NCT01730040|540613157|FG003|Overall Study|Physician Decision|0|||
149859172|NCT01730040|540613158|FG004|Overall Study|Physician Decision|0|||
149859173|NCT01730040|540613159|FG005|Overall Study|Physician Decision|1|||
149859174|NCT01730040|540613160|FG006|Overall Study|Physician Decision|1|||
149859175|NCT01730040|540613154|FG000|Overall Study|Other than specified|7|||
149859176|NCT01730040|540613155|FG001|Overall Study|Other than specified|8|||
149859177|NCT01730040|540613156|FG002|Overall Study|Other than specified|5|||
149859178|NCT01730040|540613157|FG003|Overall Study|Other than specified|5|||
149859179|NCT01730040|540613158|FG004|Overall Study|Other than specified|5|||
149859180|NCT01730040|540613159|FG005|Overall Study|Other than specified|4|||
149859181|NCT01730040|540613160|FG006|Overall Study|Other than specified|4|||
149859182|NCT01730040|540613154|FG000|Overall Study|Adverse Event|4|||
149859183|NCT01730040|540613155|FG001|Overall Study|Adverse Event|3|||
149859184|NCT01730040|540613156|FG002|Overall Study|Adverse Event|5|||
149859185|NCT01730040|540613157|FG003|Overall Study|Adverse Event|3|||
149859186|NCT01730040|540613158|FG004|Overall Study|Adverse Event|1|||
149859187|NCT01730040|540613159|FG005|Overall Study|Adverse Event|1|||
149859188|NCT01730040|540613160|FG006|Overall Study|Adverse Event|2|||
149859189|NCT01730040|540613154|FG000|Overall Study|Poor compliance to protocol|2|||
149859190|NCT01730040|540613155|FG001|Overall Study|Poor compliance to protocol|4|||
149859191|NCT01730040|540613156|FG002|Overall Study|Poor compliance to protocol|0|||
149859192|NCT01730040|540613157|FG003|Overall Study|Poor compliance to protocol|0|||
149859193|NCT01730040|540613158|FG004|Overall Study|Poor compliance to protocol|0|||
149859194|NCT01730040|540613159|FG005|Overall Study|Poor compliance to protocol|0|||
149859195|NCT01730040|540613160|FG006|Overall Study|Poor compliance to protocol|1|||
149859196|NCT00544817|540613161|FG000|Combined Modality|Lack of Efficacy|2|||
149859197|NCT00544817|540613161|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
149859198|NCT00544817|540613161|FG000|Combined Modality|Adverse Event|2|||
149859199|NCT00544817|540613161|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
149859200|NCT00544817|540613161|FG000|No Treatment Interval|Lack of Efficacy|8|||
149859201|NCT00544817|540613161|FG000|No Treatment Interval|Physician Decision|3|||
149859202|NCT00544817|540613161|FG000|No Treatment Interval|Adverse Event|1|||
149859203|NCT00544817|540613161|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
149859204|NCT00544817|540613161|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
149859205|NCT00544817|540613161|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
149859206|NCT02999984|540613171|FG000|Overall Study|Treatment Failure|1|||
149859207|NCT00754013|540613174|FG000|Overall Study|Lost to Follow-up|1|||
149859208|NCT00754013|540613175|FG001|Overall Study|Lost to Follow-up|1|||
149859209|NCT00754013|540613174|FG000|Overall Study|didn't return after study termed|3|||
149859210|NCT00754013|540613175|FG001|Overall Study|didn't return after study termed|4|||
149859211|NCT04039919|540613176|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149859212|NCT04039919|540613177|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149859213|NCT04039919|540613178|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149859214|NCT04039919|540613179|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149859215|NCT04039919|540613180|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149859216|NCT04039919|540613176|FG000|Treatment Period 1|Sponsor's decision|0|||
149859217|NCT04039919|540613177|FG001|Treatment Period 1|Sponsor's decision|0|||
149859218|NCT04039919|540613178|FG002|Treatment Period 1|Sponsor's decision|0|||
149859219|NCT04039919|540613179|FG003|Treatment Period 1|Sponsor's decision|0|||
149859220|NCT04039919|540613180|FG004|Treatment Period 1|Sponsor's decision|16|||
149859221|NCT04039919|540613176|FG000|Treatment Period 5|Withdrawal by Subject|1|||
149859222|NCT04039919|540613177|FG001|Treatment Period 5|Withdrawal by Subject|0|||
149859223|NCT04039919|540613178|FG002|Treatment Period 5|Withdrawal by Subject|0|||
149859224|NCT04039919|540613179|FG003|Treatment Period 5|Withdrawal by Subject|0|||
149859225|NCT04039919|540613180|FG004|Treatment Period 5|Withdrawal by Subject|0|||
149859226|NCT02310789|540613181|FG000|Overall Study|Adverse Event|1|||
149859227|NCT01197417|540613182|FG000|Overall Study|Physician Decision|3|||
149859228|NCT01197417|540613183|FG001|Overall Study|Physician Decision|2|||
149859229|NCT01197417|540613182|FG000|Overall Study|Withdrawal by Subject|2|||
149859230|NCT01197417|540613183|FG001|Overall Study|Withdrawal by Subject|4|||
149859231|NCT01197417|540613182|FG000|Overall Study|Site miscommunication|0|||
149859232|NCT01197417|540613183|FG001|Overall Study|Site miscommunication|1|||
149859233|NCT01197417|540613182|FG000|Overall Study|Subject transferred to intensive care|0|||
149859234|NCT01197417|540613183|FG001|Overall Study|Subject transferred to intensive care|1|||
149859235|NCT01197417|540613182|FG000|Overall Study|Not consented in time to receive drug|0|||
149859236|NCT01197417|540613183|FG001|Overall Study|Not consented in time to receive drug|1|||
149859237|NCT01197417|540613182|FG000|Overall Study|Hypotension|1|||
149859238|NCT01197417|540613183|FG001|Overall Study|Hypotension|2|||
149859239|NCT01197417|540613182|FG000|Overall Study|Found to be ineligible|2|||
149859240|NCT01197417|540613183|FG001|Overall Study|Found to be ineligible|5|||
149859241|NCT01197417|540613182|FG000|Overall Study|No 25-hour magnesium level|0|||
149859242|NCT01197417|540613183|FG001|Overall Study|No 25-hour magnesium level|2|||
149859243|NCT02813421|540613188|FG000|Overall Study|Withdrawal by Subject|1|||
149859244|NCT02813421|540613189|FG001|Overall Study|Withdrawal by Subject|2|||
149859245|NCT02813421|540613188|FG000|Overall Study|Lost to Follow-up|1|||
149859246|NCT02813421|540613189|FG001|Overall Study|Lost to Follow-up|1|||
149859247|NCT00977548|540613190|FG000|Overall Study|Ineligible|4|||
149859248|NCT00977548|540613190|FG000|Overall Study|Adverse Event|8|||
149859249|NCT00977548|540613190|FG000|Overall Study|Withdrawal by Subject|1|||
149859250|NCT01546142|540613199|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
149859251|NCT01546142|540613200|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
149859252|NCT01546142|540613199|FG000|Overall Study|Subject Noncompliance|1|||
149859253|NCT01546142|540613200|FG001|Overall Study|Subject Noncompliance|1|||
149859254|NCT01546142|540613199|FG000|Overall Study|Adverse Event|6|||
149859255|NCT01546142|540613200|FG001|Overall Study|Adverse Event|3|||
149859256|NCT01546142|540613199|FG000|Overall Study|Lost to Follow-up|20|||
149859257|NCT01546142|540613200|FG001|Overall Study|Lost to Follow-up|15|||
149859258|NCT01546142|540613199|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
149859259|NCT01546142|540613200|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
149859260|NCT01546142|540613199|FG000|Overall Study|Subject Randomized but Not Treated|1|||
149859261|NCT01546142|540613200|FG001|Overall Study|Subject Randomized but Not Treated|0|||
149859262|NCT01213836|540613201|FG000|Period 1, First Intervention|Adverse Event|2|||
149859263|NCT01213836|540613202|FG001|Period 1, First Intervention|Adverse Event|1|||
149859264|NCT01213836|540613201|FG000|Period 1, First Intervention|Protocol Violation|0|||
149859265|NCT01213836|540613202|FG001|Period 1, First Intervention|Protocol Violation|1|||
149859266|NCT01213836|540613201|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
149859267|NCT01213836|540613202|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
149859268|NCT01311557|540613214|FG000|Overall Study|Serious adverse event|0|||
149859269|NCT01311557|540613215|FG001|Overall Study|Serious adverse event|1|||
149859270|NCT01311557|540613214|FG000|Overall Study|Protocol Violation|4|||
149859271|NCT01311557|540613215|FG001|Overall Study|Protocol Violation|2|||
149859272|NCT01311557|540613214|FG000|Overall Study|Lost to Follow-up|0|||
149859273|NCT01311557|540613215|FG001|Overall Study|Lost to Follow-up|1|||
149859274|NCT01311557|540613214|FG000|Overall Study|Withdrawal by Subject|1|||
149859275|NCT01311557|540613215|FG001|Overall Study|Withdrawal by Subject|2|||
149859276|NCT00608517|540613216|FG000|Overall Study|Death|1|||
149859277|NCT00608517|540613217|FG001|Overall Study|Death|0|||
149859278|NCT00608517|540613218|FG002|Overall Study|Death|0|||
149859279|NCT01333072|540613221|FG000|Overall Study|Lost to Follow-up|3|||
149859280|NCT01333072|540613222|FG001|Overall Study|Lost to Follow-up|0|||
149859281|NCT01333072|540613221|FG000|Overall Study|Adverse Event|2|||
149859282|NCT01333072|540613222|FG001|Overall Study|Adverse Event|4|||
149859283|NCT01333072|540613221|FG000|Overall Study|Physician Decision|1|||
149859284|NCT01333072|540613222|FG001|Overall Study|Physician Decision|0|||
149859285|NCT00619359|540613223|FG000|Overall Study|Adverse Event|32|||
149859286|NCT00619359|540613224|FG001|Overall Study|Adverse Event|36|||
149859287|NCT00619359|540613223|FG000|Overall Study|Lost to Follow-up|12|||
149859288|NCT00619359|540613224|FG001|Overall Study|Lost to Follow-up|16|||
149859289|NCT00619359|540613223|FG000|Overall Study|Physician Decision|0|||
149859290|NCT00619359|540613224|FG001|Overall Study|Physician Decision|7|||
149859291|NCT00619359|540613223|FG000|Overall Study|Protocol Violation|1|||
149859292|NCT00619359|540613224|FG001|Overall Study|Protocol Violation|1|||
149859293|NCT00619359|540613223|FG000|Overall Study|Withdrawal by Subject|19|||
149859294|NCT00619359|540613224|FG001|Overall Study|Withdrawal by Subject|20|||
149859295|NCT00619359|540613223|FG000|Overall Study|Progressive Disease|3|||
149859296|NCT00619359|540613224|FG001|Overall Study|Progressive Disease|1|||
149859297|NCT05212883|540613225|FG000|Overall Study|Invalid test result|125|||
149859298|NCT02075606|540613226|FG000|Overall Study|Adverse Event|5|||
149859299|NCT02075606|540613226|FG000|Overall Study|Withdrawal by Subject|1|||
149859300|NCT02075606|540613226|FG000|Overall Study|Death|1|||
149859301|NCT02075606|540613226|FG000|Overall Study|Investigator's decision|1|||
149859302|NCT02075606|540613226|FG000|Overall Study|Symptom management|1|||
149859303|NCT02075606|540613226|FG000|Overall Study|Increasing Symptoms|1|||
149859304|NCT01261624|540613232|FG000|Week 0 to Week 12|Disease Progression|1|||
149859305|NCT01261624|540613233|FG001|Week 0 to Week 12|Disease Progression|1|||
149859306|NCT01261624|540613232|FG000|Week 0 to Week 12|Insufficient Response|0|||
149859307|NCT01261624|540613233|FG001|Week 0 to Week 12|Insufficient Response|2|||
149859308|NCT01261624|540613232|FG000|Week 13 to Week 24|Insufficient Response|0|||
149859309|NCT01261624|540613233|FG001|Week 13 to Week 24|Insufficient Response|1|||
149859310|NCT02013531|540613236|FG000|Overall Study|Lost to Follow-up|3|||
149859311|NCT02013531|540613236|FG000|Overall Study|Met Withdrawal Criteria|1|||
149859312|NCT02013531|540613236|FG000|Overall Study|Withdrawal by Subject|1|||
149859313|NCT00939627|540613237|FG000|Overall Study|Disease Progression|16|||
149859314|NCT00939627|540613238|FG001|Overall Study|Disease Progression|12|||
149859315|NCT00939627|540613239|FG002|Overall Study|Disease Progression|0|||
149859316|NCT00939627|540613237|FG000|Overall Study|Adverse Event|6|||
149859317|NCT00939627|540613238|FG001|Overall Study|Adverse Event|7|||
149859318|NCT00939627|540613239|FG002|Overall Study|Adverse Event|0|||
149859319|NCT00939627|540613237|FG000|Overall Study|Death|0|||
149859320|NCT00939627|540613238|FG001|Overall Study|Death|2|||
149859321|NCT00939627|540613239|FG002|Overall Study|Death|0|||
149859322|NCT00939627|540613237|FG000|Overall Study|Withdrawal by Subject|2|||
149859323|NCT00939627|540613238|FG001|Overall Study|Withdrawal by Subject|4|||
149859324|NCT00939627|540613239|FG002|Overall Study|Withdrawal by Subject|0|||
149859325|NCT00939627|540613237|FG000|Overall Study|Other complicating disease|1|||
149961405|NCT02070380|540992067|FG003|Second Injection|Image sets missing or technically inadeq|0|||
149961406|NCT02070380|540992064|FG000|Second Injection|Protocol Violation|0|||
149859326|NCT00939627|540613238|FG001|Overall Study|Other complicating disease|1|||
149859327|NCT00939627|540613239|FG002|Overall Study|Other complicating disease|0|||
149859328|NCT00939627|540613237|FG000|Overall Study|Not compliant|2|||
149961407|NCT02070380|540992065|FG001|Second Injection|Protocol Violation|1|||
149859329|NCT00939627|540613238|FG001|Overall Study|Not compliant|0|||
149859330|NCT00939627|540613239|FG002|Overall Study|Not compliant|0|||
149961408|NCT02070380|540992066|FG002|Second Injection|Protocol Violation|1|||
149961409|NCT02070380|540992067|FG003|Second Injection|Protocol Violation|5|||
149859331|NCT00939627|540613237|FG000|Overall Study|No off-tx reason given|0|||
149859332|NCT00939627|540613238|FG001|Overall Study|No off-tx reason given|2|||
149859333|NCT00939627|540613239|FG002|Overall Study|No off-tx reason given|0|||
149859334|NCT00941720|540613244|FG000|Overall Study|Withdrawal by Subject|1|||
149859335|NCT00941720|540613244|FG000|Overall Study|Insurance denied participation|11|||
149859336|NCT00941720|540613244|FG000|Overall Study|ineligible|2|||
149859337|NCT01998243|540613247|FG000|Overall Study|Pregnancy|0|||
149859338|NCT01998243|540613248|FG001|Overall Study|Pregnancy|1|||
149859339|NCT01998243|540613247|FG000|Overall Study|Protocol Violation|5|||
149859340|NCT01998243|540613248|FG001|Overall Study|Protocol Violation|2|||
149859341|NCT01998243|540613247|FG000|Overall Study|Withdrawal by Subject|3|||
149859342|NCT01998243|540613248|FG001|Overall Study|Withdrawal by Subject|4|||
149859343|NCT00268892|540613249|FG000|Overall Study|Adverse Event|14|||
149859344|NCT00268892|540613250|FG001|Overall Study|Adverse Event|17|||
149859345|NCT00268892|540613251|FG002|Overall Study|Adverse Event|20|||
149859346|NCT00268892|540613249|FG000|Overall Study|Lack of Efficacy|1|||
149859347|NCT00268892|540613250|FG001|Overall Study|Lack of Efficacy|3|||
149859348|NCT00268892|540613251|FG002|Overall Study|Lack of Efficacy|0|||
149859349|NCT00268892|540613249|FG000|Overall Study|Withdrawal by Subject|14|||
149859350|NCT00268892|540613250|FG001|Overall Study|Withdrawal by Subject|15|||
149859351|NCT00268892|540613251|FG002|Overall Study|Withdrawal by Subject|13|||
149859352|NCT00268892|540613249|FG000|Overall Study|Physician Decision|0|||
149859353|NCT00268892|540613250|FG001|Overall Study|Physician Decision|1|||
149859354|NCT00268892|540613251|FG002|Overall Study|Physician Decision|0|||
149859355|NCT00268892|540613249|FG000|Overall Study|Lost to Follow-up|5|||
149859356|NCT00268892|540613250|FG001|Overall Study|Lost to Follow-up|2|||
149859357|NCT00268892|540613251|FG002|Overall Study|Lost to Follow-up|4|||
149859358|NCT00268892|540613249|FG000|Overall Study|Protocol Violation|0|||
149859359|NCT00268892|540613250|FG001|Overall Study|Protocol Violation|1|||
149859360|NCT00268892|540613251|FG002|Overall Study|Protocol Violation|0|||
149859361|NCT00268892|540613249|FG000|Overall Study|Disease Progression|1|||
149859362|NCT00268892|540613250|FG001|Overall Study|Disease Progression|1|||
149859363|NCT00268892|540613251|FG002|Overall Study|Disease Progression|0|||
149859364|NCT00268892|540613249|FG000|Overall Study|Trial Site Closed|4|||
149859365|NCT00268892|540613250|FG001|Overall Study|Trial Site Closed|2|||
149859366|NCT00268892|540613251|FG002|Overall Study|Trial Site Closed|2|||
149859367|NCT02244424|540613253|FG000|Overall Study|Lost to Follow-up|20|||
149859368|NCT02244424|540613254|FG001|Overall Study|Lost to Follow-up|10|||
149859369|NCT03366194|540613255|FG000|Overall Study|Lost to Follow-up|2|||
149859370|NCT03183141|540613269|FG000|Overall Study|Withdrawal by Subject|2|||
149859371|NCT03183141|540613270|FG001|Overall Study|Withdrawal by Subject|4|||
149859372|NCT03183141|540613269|FG000|Overall Study|Death|0|||
149859373|NCT03183141|540613270|FG001|Overall Study|Death|8|||
149859374|NCT02756637|540613272|FG000|Overall Study|Not eligible for initial SWOG study|10|||
149859375|NCT02756637|540613273|FG001|Overall Study|Not eligible for initial SWOG study|10|||
149859376|NCT02756637|540613272|FG000|Overall Study|No available NLR value|44|||
149859377|NCT02756637|540613273|FG001|Overall Study|No available NLR value|44|||
149859378|NCT02756637|540613272|FG000|Overall Study|Did not complete curative therapy|33|||
149859379|NCT02756637|540613273|FG001|Overall Study|Did not complete curative therapy|0|||
149859380|NCT01507090|540613276|FG000|Overall Study|incomplete dataset|18|||
149859381|NCT04034355|540613279|FG000|Overall Study|Study terminated by Sponsor|10|||
149859382|NCT04034355|540613280|FG001|Overall Study|Study terminated by Sponsor|17|||
149859383|NCT04034355|540613279|FG000|Overall Study|Withdrawal by Subject|12|||
149859384|NCT04034355|540613280|FG001|Overall Study|Withdrawal by Subject|11|||
149859385|NCT04034355|540613279|FG000|Overall Study|Site terminated by Sponsor|4|||
149859386|NCT04034355|540613280|FG001|Overall Study|Site terminated by Sponsor|5|||
149859387|NCT04034355|540613279|FG000|Overall Study|Adverse Event|2|||
149859388|NCT04034355|540613280|FG001|Overall Study|Adverse Event|0|||
149859389|NCT04034355|540613279|FG000|Overall Study|Death|1|||
149859390|NCT04034355|540613280|FG001|Overall Study|Death|1|||
149859391|NCT04034355|540613279|FG000|Overall Study|Not reported|2|||
149859392|NCT04034355|540613280|FG001|Overall Study|Not reported|0|||
149859393|NCT04034355|540613279|FG000|Overall Study|Lost to Follow-up|1|||
149859394|NCT04034355|540613280|FG001|Overall Study|Lost to Follow-up|0|||
149859395|NCT04034355|540613279|FG000|Overall Study|Physician Decision|1|||
149859396|NCT04034355|540613280|FG001|Overall Study|Physician Decision|0|||
149859397|NCT04034355|540613279|FG000|Overall Study|Protocol Violation|0|||
149859398|NCT04034355|540613280|FG001|Overall Study|Protocol Violation|1|||
149859399|NCT04034355|540613279|FG000|Overall Study|Progressive disease|1|||
149859400|NCT04034355|540613280|FG001|Overall Study|Progressive disease|0|||
149859401|NCT02124902|540614456|FG000|Overall Study|Adverse Event|7|||
149859402|NCT02124902|540614457|FG001|Overall Study|Adverse Event|2|||
149859403|NCT02124902|540614456|FG000|Overall Study|Went to alternative treatment|4|||
149859404|NCT02124902|540614457|FG001|Overall Study|Went to alternative treatment|0|||
149859405|NCT02124902|540614456|FG000|Overall Study|Withdrawal by Subject|2|||
149859406|NCT02124902|540614457|FG001|Overall Study|Withdrawal by Subject|1|||
149859407|NCT02124902|540614456|FG000|Overall Study|Physician Decision|2|||
149859408|NCT02124902|540614457|FG001|Overall Study|Physician Decision|0|||
149859409|NCT02124902|540614456|FG000|Overall Study|Not eligible|1|||
149859410|NCT02124902|540614457|FG001|Overall Study|Not eligible|0|||
149859411|NCT02124902|540614456|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
149859412|NCT02124902|540614457|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
149859413|NCT01961687|540614458|FG000|Overall Study|Lost to Follow-up|19|||
149859414|NCT01961687|540614458|FG000|Overall Study|Re-operation|17|||
149859415|NCT01961687|540614458|FG000|Overall Study|Death|7|||
149859416|NCT01961687|540614458|FG000|Overall Study|Withdrawal by Subject|6|||
149859417|NCT01961687|540614458|FG000|Overall Study|Adverse Event|6|||
149859418|NCT01961687|540614458|FG000|Overall Study|Moved to area without study site|2|||
149859419|NCT01961687|540614458|FG000|Overall Study|Sponsor decision|2|||
149859420|NCT01961687|540614458|FG000|Overall Study|Physician Decision|1|||
149859421|NCT01961687|540614458|FG000|Overall Study|Unable to meet follow-up requirements|1|||
149859422|NCT00546910|540614462|FG000|Overall Study|Adverse Event|2|||
149859423|NCT00546910|540614463|FG001|Overall Study|Adverse Event|3|||
149859424|NCT00546910|540614462|FG000|Overall Study|Lack of Efficacy|5|||
149859425|NCT00546910|540614463|FG001|Overall Study|Lack of Efficacy|7|||
149859426|NCT00546910|540614462|FG000|Overall Study|Physician Decision|0|||
149859427|NCT00546910|540614463|FG001|Overall Study|Physician Decision|1|||
149859428|NCT00546910|540614462|FG000|Overall Study|Withdrawal by Subject|2|||
149859429|NCT00546910|540614463|FG001|Overall Study|Withdrawal by Subject|0|||
149859430|NCT01467479|540614464|FG000|Overall Study|No Study Medication|1|||
149859431|NCT01467479|540614465|FG001|Overall Study|No Study Medication|0|||
149859432|NCT01467479|540614466|FG002|Overall Study|No Study Medication|2|||
149859433|NCT01467479|540614464|FG000|Overall Study|Adverse Event|1|||
149859434|NCT01467479|540614465|FG001|Overall Study|Adverse Event|2|||
149859435|NCT01467479|540614466|FG002|Overall Study|Adverse Event|0|||
149859436|NCT01467479|540614464|FG000|Overall Study|Death|0|||
149859437|NCT01467479|540614465|FG001|Overall Study|Death|0|||
149859438|NCT01467479|540614466|FG002|Overall Study|Death|1|||
149859439|NCT01467479|540614464|FG000|Overall Study|Lost to Follow-up|2|||
149859440|NCT01467479|540614465|FG001|Overall Study|Lost to Follow-up|5|||
149859441|NCT01467479|540614466|FG002|Overall Study|Lost to Follow-up|3|||
149859442|NCT01467479|540614464|FG000|Overall Study|Withdrawal of Consent|3|||
149859443|NCT01467479|540614465|FG001|Overall Study|Withdrawal of Consent|7|||
149859444|NCT01467479|540614466|FG002|Overall Study|Withdrawal of Consent|7|||
149859445|NCT01467479|540614464|FG000|Overall Study|Study Terminated by Sponsor|1|||
149859446|NCT01467479|540614465|FG001|Overall Study|Study Terminated by Sponsor|3|||
149859447|NCT01467479|540614466|FG002|Overall Study|Study Terminated by Sponsor|3|||
149859448|NCT01467479|540614464|FG000|Overall Study|Other|1|||
149859449|NCT01467479|540614465|FG001|Overall Study|Other|0|||
149859450|NCT01467479|540614466|FG002|Overall Study|Other|0|||
149859451|NCT01552369|540614476|FG000|Overall Study|Did not consent to extended follow up|8|||
149859452|NCT01552369|540614477|FG001|Overall Study|Did not consent to extended follow up|9|||
149859453|NCT04213209|540614485|FG000|Overall Study|Protocol Violation|1|||
149859454|NCT04213209|540614486|FG001|Overall Study|Protocol Violation|0|||
149859455|NCT04213209|540614487|FG002|Overall Study|Protocol Violation|0|||
149859456|NCT04213209|540614488|FG003|Overall Study|Protocol Violation|0|||
149859457|NCT04213209|540614489|FG004|Overall Study|Protocol Violation|0|||
149859458|NCT04213209|540614490|FG005|Overall Study|Protocol Violation|0|||
149859459|NCT00892281|540614491|FG000|Overall Study|Adverse Event|65|||
149859460|NCT00892281|540614492|FG001|Overall Study|Adverse Event|8|||
149859461|NCT00892281|540614491|FG000|Overall Study|Lost to Follow-up|81|||
149859462|NCT00892281|540614492|FG001|Overall Study|Lost to Follow-up|8|||
149859463|NCT00892281|540614491|FG000|Overall Study|Pregnancy|1|||
149859464|NCT00892281|540614492|FG001|Overall Study|Pregnancy|0|||
149859465|NCT00892281|540614491|FG000|Overall Study|Protocol Violation|7|||
149859466|NCT00892281|540614492|FG001|Overall Study|Protocol Violation|2|||
149859467|NCT00892281|540614491|FG000|Overall Study|Withdrawal by Subject|86|||
149859468|NCT00892281|540614492|FG001|Overall Study|Withdrawal by Subject|14|||
149859469|NCT00892281|540614491|FG000|Overall Study|Subject failed to return for final visit|2|||
149859470|NCT00892281|540614492|FG001|Overall Study|Subject failed to return for final visit|0|||
149859471|NCT00892281|540614491|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
150040282|NCT01454102|541287361|FG012|Overall Study|Continuing in the treatment period|7|||
150040283|NCT01454102|541287362|FG013|Overall Study|Continuing in the treatment period|4|||
150040284|NCT01454102|541287363|FG014|Overall Study|Continuing in the treatment period|3|||
150040285|NCT01454102|541287364|FG015|Overall Study|Continuing in the treatment period|1|||
150040286|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
150040287|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
150040288|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
150040289|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
150040290|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
150040291|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
150173499|NCT00102063|541771310|FG000|Overall Study|Adverse Event|7|||
149859472|NCT00892281|540614492|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
149859473|NCT00892281|540614491|FG000|Overall Study|Final visit completed 4 weeks late|0|||
149859474|NCT00892281|540614492|FG001|Overall Study|Final visit completed 4 weeks late|1|||
149859475|NCT00892281|540614491|FG000|Overall Study|Subject completed day after study closed|1|||
149859476|NCT00892281|540614492|FG001|Overall Study|Subject completed day after study closed|0|||
149859477|NCT00892281|540614491|FG000|Overall Study|Family emergency|1|||
149859478|NCT00892281|540614492|FG001|Overall Study|Family emergency|0|||
149859479|NCT00892281|540614491|FG000|Overall Study|Last visit not done - death in family|1|||
149859480|NCT00892281|540614492|FG001|Overall Study|Last visit not done - death in family|0|||
149859481|NCT00892281|540614491|FG000|Overall Study|Did not meet incl/excl criteria|1|||
149859482|NCT00892281|540614492|FG001|Overall Study|Did not meet incl/excl criteria|0|||
149859483|NCT00892281|540614491|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
149859484|NCT00892281|540614492|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
149859485|NCT00892281|540614491|FG000|Overall Study|Unable to redeem the drug voucher|1|||
149859486|NCT00892281|540614492|FG001|Overall Study|Unable to redeem the drug voucher|0|||
149859487|NCT00892281|540614491|FG000|Overall Study|Subject not good candidate for study|1|||
149859488|NCT00892281|540614492|FG001|Overall Study|Subject not good candidate for study|0|||
149859489|NCT00892281|540614491|FG000|Overall Study|Subject did not return for any visits|1|||
149859490|NCT00892281|540614492|FG001|Overall Study|Subject did not return for any visits|0|||
149859491|NCT00892281|540614491|FG000|Overall Study|Subject missed several visits/lost meds|1|||
149859492|NCT00892281|540614492|FG001|Overall Study|Subject missed several visits/lost meds|0|||
149859493|NCT00892281|540614491|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
149859494|NCT00892281|540614492|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
149859495|NCT00892281|540614491|FG000|Overall Study|Scheduled for knee replacement|0|||
149859496|NCT00892281|540614492|FG001|Overall Study|Scheduled for knee replacement|1|||
149859497|NCT00892281|540614491|FG000|Overall Study|PI complained of inadequate compensation|3|||
149859498|NCT00892281|540614492|FG001|Overall Study|PI complained of inadequate compensation|0|||
149859499|NCT00892281|540614491|FG000|Overall Study|Subject lost interest in program|0|||
149859500|NCT00892281|540614492|FG001|Overall Study|Subject lost interest in program|1|||
149859501|NCT00892281|540614491|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
149859502|NCT00892281|540614492|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
149859503|NCT00892281|540614491|FG000|Overall Study|Death in family|1|||
149859504|NCT00892281|540614492|FG001|Overall Study|Death in family|0|||
149859505|NCT00892281|540614491|FG000|Overall Study|Lack of efficacy of study product|2|||
149859506|NCT00892281|540614492|FG001|Overall Study|Lack of efficacy of study product|0|||
149859507|NCT00892281|540614491|FG000|Overall Study|Subject not seen by PI at final visit|1|||
149859508|NCT00892281|540614492|FG001|Overall Study|Subject not seen by PI at final visit|0|||
149859509|NCT00892281|540614491|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
149859510|NCT00892281|540614492|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
149859511|NCT00892281|540614491|FG000|Overall Study|Missed multiple visits|1|||
149859512|NCT00892281|540614492|FG001|Overall Study|Missed multiple visits|0|||
149859513|NCT00892281|540614491|FG000|Overall Study|Missed visits rescheduled out of window|1|||
149859514|NCT00892281|540614492|FG001|Overall Study|Missed visits rescheduled out of window|0|||
149859515|NCT00892281|540614491|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
149859516|NCT00892281|540614492|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
149859517|NCT00892281|540614491|FG000|Overall Study|Subject had history of drug abuse|1|||
149859518|NCT00892281|540614492|FG001|Overall Study|Subject had history of drug abuse|0|||
149859519|NCT00892281|540614491|FG000|Overall Study|Rash on hand|1|||
149859520|NCT00892281|540614492|FG001|Overall Study|Rash on hand|0|||
149859521|NCT00892281|540614491|FG000|Overall Study|Visit 4 date out of window|1|||
149859522|NCT00892281|540614492|FG001|Overall Study|Visit 4 date out of window|0|||
149859523|NCT02129647|540614495|FG000|Overall Study|Adverse Event|2|||
149859524|NCT02129647|540614495|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
149859525|NCT01833533|540614496|FG000|Overall Study|Adverse Event|0|||
149859526|NCT01833533|540614497|FG001|Overall Study|Adverse Event|1|||
149859527|NCT01833533|540614496|FG000|Overall Study|Lost to Follow-up|4|||
149859528|NCT01833533|540614497|FG001|Overall Study|Lost to Follow-up|9|||
149859529|NCT01833533|540614496|FG000|Overall Study|To Enter an Extension Study|0|||
149859530|NCT01833533|540614497|FG001|Overall Study|To Enter an Extension Study|4|||
149859531|NCT01833533|540614496|FG000|Overall Study|Other|2|||
149859532|NCT01833533|540614497|FG001|Overall Study|Other|7|||
149859533|NCT00685802|540614500|FG000|Washout Period of 7 Days|Protocol Violation|2|||
149859534|NCT00685802|540614501|FG001|Washout Period of 7 Days|Protocol Violation|0|||
149859535|NCT00685802|540614500|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149859536|NCT00685802|540614501|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149859537|NCT00103038|540614504|FG000|Overall Study|Withdrawal by Subject|8|||
149859538|NCT00103038|540614504|FG000|Overall Study|Screen failure|3|||
149859539|NCT00103038|540614504|FG000|Overall Study|Death|1|||
149859540|NCT00103038|540614504|FG000|Overall Study|Physician Decision|1|||
149859541|NCT02502734|540614505|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
149859542|NCT02502734|540614506|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
149859543|NCT02502734|540614505|FG000|Washout Period|Adverse Event|1|||
149859544|NCT02502734|540614506|FG001|Washout Period|Adverse Event|0|||
149859545|NCT03095118|540614512|FG000|Overall Study|Adverse Event|1|||
149859546|NCT03095118|540614512|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
149859547|NCT01740791|540614513|FG000|Overall Study|Randomized but never treated|5|||
149859548|NCT01740791|540614514|FG001|Overall Study|Randomized but never treated|3|||
149859549|NCT01740791|540614515|FG002|Overall Study|Randomized but never treated|2|||
149859550|NCT01740791|540614516|FG003|Overall Study|Randomized but never treated|2|||
149859551|NCT01740791|540614517|FG004|Overall Study|Randomized but never treated|1|||
149859552|NCT01740791|540614518|FG005|Overall Study|Randomized but never treated|3|||
149859553|NCT01740791|540614513|FG000|Overall Study|Lost to Follow-up|2|||
149859554|NCT01740791|540614514|FG001|Overall Study|Lost to Follow-up|0|||
149859555|NCT01740791|540614515|FG002|Overall Study|Lost to Follow-up|2|||
149859556|NCT01740791|540614516|FG003|Overall Study|Lost to Follow-up|3|||
149859557|NCT01740791|540614517|FG004|Overall Study|Lost to Follow-up|2|||
149859558|NCT01740791|540614518|FG005|Overall Study|Lost to Follow-up|3|||
149859559|NCT01740791|540614513|FG000|Overall Study|Withdrew Consent|4|||
149859560|NCT01740791|540614514|FG001|Overall Study|Withdrew Consent|0|||
149859561|NCT01740791|540614515|FG002|Overall Study|Withdrew Consent|1|||
149859562|NCT01740791|540614516|FG003|Overall Study|Withdrew Consent|2|||
149859563|NCT01740791|540614517|FG004|Overall Study|Withdrew Consent|0|||
149859564|NCT01740791|540614518|FG005|Overall Study|Withdrew Consent|3|||
149859565|NCT01740791|540614513|FG000|Overall Study|Investigator's discretion|1|||
150173500|NCT00102063|541771311|FG001|Overall Study|Adverse Event|4|||
150173501|NCT00102063|541771312|FG002|Overall Study|Adverse Event|2|||
150173502|NCT00102063|541771310|FG000|Overall Study|Withdrawal by Subject|4|||
150173503|NCT00102063|541771311|FG001|Overall Study|Withdrawal by Subject|12|||
149859566|NCT01740791|540614514|FG001|Overall Study|Investigator's discretion|0|||
149859567|NCT01740791|540614515|FG002|Overall Study|Investigator's discretion|1|||
149859568|NCT01740791|540614516|FG003|Overall Study|Investigator's discretion|0|||
149859569|NCT01740791|540614517|FG004|Overall Study|Investigator's discretion|0|||
150173504|NCT00102063|541771312|FG002|Overall Study|Withdrawal by Subject|5|||
150173505|NCT00102063|541771310|FG000|Overall Study|Lost to Follow-up|0|||
150173506|NCT00102063|541771311|FG001|Overall Study|Lost to Follow-up|0|||
150173507|NCT00102063|541771312|FG002|Overall Study|Lost to Follow-up|1|||
150173508|NCT00102063|541771310|FG000|Overall Study|Protocol Violation|0|||
150173509|NCT00102063|541771311|FG001|Overall Study|Protocol Violation|1|||
150173510|NCT00102063|541771312|FG002|Overall Study|Protocol Violation|1|||
150173511|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
150173512|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
150173513|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
150173514|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
150173515|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
150173516|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
150173517|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
150173518|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
150173519|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
150173520|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
150173521|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
150173522|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
150173523|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
150173524|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
150173525|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
150173526|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173527|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173528|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
150173529|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173530|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173531|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173532|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173533|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173534|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173535|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173536|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
150173537|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
150173538|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
150173539|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
150173540|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
150173541|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
149859570|NCT01740791|540614518|FG005|Overall Study|Investigator's discretion|1|||
149859571|NCT01740791|540614513|FG000|Overall Study|Adverse Event|0|||
149859572|NCT01740791|540614514|FG001|Overall Study|Adverse Event|0|||
149859573|NCT01740791|540614515|FG002|Overall Study|Adverse Event|0|||
150173542|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
150290858|NCT01564862|542197858|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
150290859|NCT01564862|542197856|FG000|Overall Study|Major Protocol Deviation|3|||
150290860|NCT01564862|542197857|FG001|Overall Study|Major Protocol Deviation|3|||
149859574|NCT01740791|540614516|FG003|Overall Study|Adverse Event|0|||
149859575|NCT01740791|540614517|FG004|Overall Study|Adverse Event|0|||
149859576|NCT01740791|540614518|FG005|Overall Study|Adverse Event|1|||
149859577|NCT01463982|540614519|FG000|Overall Study|Withdrawal by Subject|0|||
149859578|NCT01463982|540614520|FG001|Overall Study|Withdrawal by Subject|1|||
149859579|NCT01463982|540614521|FG002|Overall Study|Withdrawal by Subject|1|||
149859580|NCT01463982|540614522|FG003|Overall Study|Withdrawal by Subject|0|||
149859581|NCT01463982|540614519|FG000|Overall Study|Treatment delay over 5 week|0|||
149859582|NCT01463982|540614520|FG001|Overall Study|Treatment delay over 5 week|0|||
149859583|NCT01463982|540614521|FG002|Overall Study|Treatment delay over 5 week|1|||
149859584|NCT01463982|540614522|FG003|Overall Study|Treatment delay over 5 week|0|||
149859585|NCT01483625|540614525|FG000|Overall Study|Adverse Event|1|||
149859586|NCT01483625|540614526|FG001|Overall Study|Adverse Event|1|||
149859587|NCT01483625|540614525|FG000|Overall Study|Refused to continue medication|2|||
149859588|NCT01483625|540614526|FG001|Overall Study|Refused to continue medication|1|||
149859589|NCT01483625|540614525|FG000|Overall Study|Due to other reason|1|||
149859590|NCT01483625|540614526|FG001|Overall Study|Due to other reason|0|||
149859591|NCT01731886|540614527|FG000|Overall Study|Death|1|||
149859592|NCT01731886|540614528|FG001|Overall Study|Death|0|||
149859593|NCT01731886|540614527|FG000|Overall Study|Never started treatment|0|||
149859594|NCT01731886|540614528|FG001|Overall Study|Never started treatment|1|||
149859595|NCT01731886|540614527|FG000|Overall Study|Non-compliant|1|||
149859596|NCT01731886|540614528|FG001|Overall Study|Non-compliant|0|||
149859597|NCT02280187|540614529|FG000|Overall Study|Lost to Follow-up|218|||
150040292|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
150040293|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
150040294|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
150040295|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
150040296|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
149859598|NCT02094261|540614530|FG000|Overall Study|Death|24|||
149859599|NCT02094261|540614530|FG000|Overall Study|Lost to Follow-up|1|||
149859600|NCT02094261|540614530|FG000|Overall Study|Withdrawal by Subject|4|||
150040297|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
150040298|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
150040299|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
150040300|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
150040301|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
150040302|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
150040303|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
150040304|NCT03739203|541287369|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
150040305|NCT03739203|541287370|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
150040306|NCT03739203|541287371|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
150040307|NCT03739203|541287369|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
150040308|NCT03739203|541287370|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
150040309|NCT03739203|541287371|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
150040310|NCT03739203|541287369|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
150040311|NCT03739203|541287370|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
150040312|NCT03739203|541287371|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
150040313|NCT03739203|541287369|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
150040314|NCT03739203|541287370|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
150040315|NCT03739203|541287371|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
150040316|NCT03739203|541287369|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
150040317|NCT03739203|541287370|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
150290861|NCT01564862|542197858|FG002|Overall Study|Major Protocol Deviation|4|||
150290862|NCT01564862|542197856|FG000|Overall Study|Lost to Follow-up|10|||
149859601|NCT02094261|540614530|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
149859602|NCT04668274|540614531|FG000|Part 1 Study Period 1|Adverse Event|3|||
150040318|NCT03739203|541287371|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
150040319|NCT01782378|541287372|FG000|First Series|Lost to Follow-up|7|||
150040320|NCT01782378|541287373|FG001|First Series|Lost to Follow-up|8|||
150040321|NCT01782378|541287372|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
150040322|NCT01782378|541287373|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
150040323|NCT01782378|541287372|FG000|Second Series|Lost to Follow-up|8|||
150040324|NCT01782378|541287373|FG001|Second Series|Lost to Follow-up|7|||
150040325|NCT01782378|541287372|FG000|Second Series|Did not choose to complete S2 Optional|18|||
150290863|NCT01564862|542197857|FG001|Overall Study|Lost to Follow-up|8|||
150290864|NCT01564862|542197858|FG002|Overall Study|Lost to Follow-up|6|||
150290865|NCT01564862|542197856|FG000|Overall Study|Voluntary Withdrawal|9|||
150290866|NCT01564862|542197857|FG001|Overall Study|Voluntary Withdrawal|6|||
149859603|NCT04668274|540614532|FG001|Part 1 Study Period 1|Adverse Event|0|||
149859604|NCT04668274|540614533|FG002|Part 1 Study Period 1|Adverse Event|0|||
149859605|NCT04668274|540614534|FG003|Part 1 Study Period 1|Adverse Event|0|||
150290867|NCT01564862|542197858|FG002|Overall Study|Voluntary Withdrawal|8|||
149859606|NCT04668274|540614531|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
149859607|NCT04668274|540614532|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
149859608|NCT04668274|540614533|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
150173543|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
150173544|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
150173545|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
150173546|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
150173547|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
150173548|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
150173549|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
150173550|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173551|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
150173552|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
150290868|NCT01564862|542197856|FG000|Overall Study|Lack of Efficacy|1|||
150290869|NCT01564862|542197857|FG001|Overall Study|Lack of Efficacy|5|||
149859609|NCT04668274|540614534|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
149859610|NCT04668274|540614531|FG000|Part 1 Study Period 2|Other|0|||
149859611|NCT04668274|540614532|FG001|Part 1 Study Period 2|Other|1|||
149859612|NCT04668274|540614533|FG002|Part 1 Study Period 2|Other|0|||
149859613|NCT04668274|540614534|FG003|Part 1 Study Period 2|Other|0|||
149859614|NCT04668274|540614531|FG000|Part 1 Study Period 3|Adverse Event|0|||
149859615|NCT04668274|540614532|FG001|Part 1 Study Period 3|Adverse Event|0|||
149859616|NCT04668274|540614533|FG002|Part 1 Study Period 3|Adverse Event|1|||
149859617|NCT04668274|540614534|FG003|Part 1 Study Period 3|Adverse Event|0|||
149859618|NCT04668274|540614531|FG000|Part 1 Study Period 3|Other|0|||
149859619|NCT04668274|540614532|FG001|Part 1 Study Period 3|Other|0|||
149859620|NCT04668274|540614533|FG002|Part 1 Study Period 3|Other|2|||
149859621|NCT04668274|540614534|FG003|Part 1 Study Period 3|Other|0|||
149859622|NCT04668274|540614531|FG000|Part 2 Study Period 4|Other|0|||
149859623|NCT04668274|540614532|FG001|Part 2 Study Period 4|Other|0|||
149859624|NCT04668274|540614533|FG002|Part 2 Study Period 4|Other|0|||
149859625|NCT04668274|540614534|FG003|Part 2 Study Period 4|Other|1|||
149859626|NCT02363439|540614537|FG000|Overall Study|Lack of Efficacy|4|||
149859627|NCT03417830|540614545|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
149859628|NCT03417830|540614546|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
149859629|NCT03827018|540614551|FG000|Overall Study|Adverse Event|1|||
149859630|NCT03827018|540614552|FG001|Overall Study|Adverse Event|0|||
149859631|NCT03827018|540614551|FG000|Overall Study|Withdrawal by Subject|2|||
149859632|NCT03827018|540614552|FG001|Overall Study|Withdrawal by Subject|2|||
149859633|NCT03827018|540614551|FG000|Overall Study|Lack of Efficacy|0|||
149859634|NCT03827018|540614552|FG001|Overall Study|Lack of Efficacy|1|||
149859635|NCT00775528|540614553|FG000|Overall Study|Protocol Violation|1|||
149859636|NCT02087176|540614554|FG000|Overall Study|Withdrawal by Subject|1|||
149859637|NCT02087176|540614554|FG000|Overall Study|Death|10|||
149859638|NCT02087176|540614554|FG000|Overall Study|Censored|19|||
149859639|NCT02087176|540614554|FG000|Overall Study|Study Terminated by Sponsor|2|||
149859640|NCT03812991|540614555|FG000|Overall Study|Lost to Follow-up|3|||
149859641|NCT03812991|540614556|FG001|Overall Study|Lost to Follow-up|1|||
149859642|NCT01884688|540614559|FG000|Overall Study|Screen Failure|2|||
149859643|NCT00895037|540614567|FG000|Overall Study|Death|0|||
149859644|NCT00895037|540614568|FG001|Overall Study|Death|2|||
149859645|NCT00895037|540614569|FG002|Overall Study|Death|1|||
149859646|NCT02470091|540614576|FG000|Overall Study|Withdrawal by Subject|1|||
149859647|NCT02470091|540614577|FG001|Overall Study|Withdrawal by Subject|0|||
149859648|NCT02470091|540614576|FG000|Overall Study|Ineligible|0|||
149859649|NCT02470091|540614577|FG001|Overall Study|Ineligible|2|||
149859650|NCT01192399|540614580|FG000|Overall Study|Lack of Efficacy|2|||
149859651|NCT01523587|540614582|FG000|Overall Study|Other than listed|5|||
149859652|NCT01523587|540614583|FG001|Overall Study|Other than listed|5|||
149859653|NCT01523587|540614582|FG000|Overall Study|Worsening of underlying cancer disease|19|||
149859654|NCT01523587|540614583|FG001|Overall Study|Worsening of underlying cancer disease|34|||
149859655|NCT01523587|540614582|FG000|Overall Study|Adverse Event|68|||
149859656|NCT01523587|540614583|FG001|Overall Study|Adverse Event|52|||
149859657|NCT01523587|540614582|FG000|Overall Study|Protocol Violation|5|||
149859658|NCT01523587|540614583|FG001|Overall Study|Protocol Violation|3|||
150290870|NCT01564862|542197858|FG002|Overall Study|Lack of Efficacy|6|||
150290871|NCT01564862|542197856|FG000|Overall Study|Other reason(s)|1|||
150290872|NCT01564862|542197857|FG001|Overall Study|Other reason(s)|0|||
150290873|NCT01564862|542197858|FG002|Overall Study|Other reason(s)|0|||
150290874|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
149859659|NCT01523587|540614582|FG000|Overall Study|Lost to Follow-up|2|||
149859660|NCT01523587|540614583|FG001|Overall Study|Lost to Follow-up|2|||
149859661|NCT01523587|540614582|FG000|Overall Study|Withdrawal by Subject|28|||
149859662|NCT01523587|540614583|FG001|Overall Study|Withdrawal by Subject|20|||
149859663|NCT01523587|540614582|FG000|Overall Study|Withdrew due to Progressive disease|265|||
149859664|NCT01523587|540614583|FG001|Overall Study|Withdrew due to Progressive disease|279|||
149859665|NCT01523587|540614582|FG000|Overall Study|Randomised but bot treated|6|||
149859666|NCT01523587|540614583|FG001|Overall Study|Randomised but bot treated|2|||
149859667|NCT01298778|540614584|FG000|Overall Study|Lost to Follow-up|2|||
149859668|NCT01298778|540614585|FG001|Overall Study|Lost to Follow-up|3|||
149859669|NCT01298778|540614584|FG000|Overall Study|Incorrect use of VAS|1|||
149859670|NCT01298778|540614585|FG001|Overall Study|Incorrect use of VAS|0|||
149859671|NCT01298778|540614584|FG000|Overall Study|Withdrawal by Subject|0|||
149859672|NCT01298778|540614585|FG001|Overall Study|Withdrawal by Subject|1|||
149859673|NCT01298778|540614584|FG000|Overall Study|Protocol Violation|0|||
149859674|NCT01298778|540614585|FG001|Overall Study|Protocol Violation|1|||
149859675|NCT01298778|540614584|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
149859676|NCT01298778|540614585|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
149859677|NCT00536484|540614586|FG000|Overall Study|Adverse Event|21|||
149859678|NCT00536484|540614587|FG001|Overall Study|Adverse Event|34|||
149859679|NCT00536484|540614586|FG000|Overall Study|Withdrawal by Subject|11|||
149859680|NCT00536484|540614587|FG001|Overall Study|Withdrawal by Subject|11|||
149859681|NCT00536484|540614586|FG000|Overall Study|Lost to Follow-up|8|||
149859682|NCT00536484|540614587|FG001|Overall Study|Lost to Follow-up|6|||
149859683|NCT00536484|540614586|FG000|Overall Study|Lack of Efficacy|16|||
149859684|NCT00536484|540614587|FG001|Overall Study|Lack of Efficacy|5|||
149859685|NCT00536484|540614586|FG000|Overall Study|Other|4|||
149859686|NCT00536484|540614587|FG001|Overall Study|Other|0|||
149859687|NCT02065713|540615782|FG000|Overall Study|Adverse Event|0|||
149859688|NCT02065713|540615783|FG001|Overall Study|Adverse Event|1|||
149859689|NCT02065713|540615782|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149859690|NCT02065713|540615783|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149859691|NCT01117337|540615790|FG000|Overall Study|Lost to Follow-up|4|||
149859692|NCT01117337|540615791|FG001|Overall Study|Lost to Follow-up|0|||
149859693|NCT01045993|540615792|FG000|Overall Study|Treated-later found eligibility not met|0|||
149859694|NCT01045993|540615793|FG001|Overall Study|Treated-later found eligibility not met|1|||
149859695|NCT01045993|540615794|FG002|Overall Study|Treated-later found eligibility not met|0|||
149859696|NCT01045993|540615795|FG003|Overall Study|Treated-later found eligibility not met|0|||
149859697|NCT01659736|540615796|FG000|Treatment Period|Adverse Event|1|||
149859698|NCT01659736|540615797|FG001|Treatment Period|Adverse Event|1|||
149859699|NCT01659736|540615796|FG000|Treatment Period|Protocol Violation|3|||
149859700|NCT01659736|540615797|FG001|Treatment Period|Protocol Violation|1|||
149859701|NCT01659736|540615796|FG000|Treatment Period|Withdrawal by Subject|1|||
149859702|NCT01659736|540615797|FG001|Treatment Period|Withdrawal by Subject|0|||
149859703|NCT01659736|540615796|FG000|3-month Follow-up|Lost to Follow-up|0|||
149859704|NCT01659736|540615797|FG001|3-month Follow-up|Lost to Follow-up|1|||
149859705|NCT02791893|540615803|FG000|Blinded Phase|Lost to Follow-up|2|||
149859706|NCT02791893|540615804|FG001|Blinded Phase|Lost to Follow-up|2|||
149859707|NCT02791893|540615803|FG000|Blinded Phase|Withdrawal by Subject|1|||
149859708|NCT02791893|540615804|FG001|Blinded Phase|Withdrawal by Subject|2|||
149859709|NCT02791893|540615803|FG000|Open Label Phase|Lost to Follow-up|3|||
149859710|NCT02791893|540615804|FG001|Open Label Phase|Lost to Follow-up|0|||
149859711|NCT02791893|540615803|FG000|Open Label Phase|Withdrawal by Subject|0|||
149859712|NCT02791893|540615804|FG001|Open Label Phase|Withdrawal by Subject|2|||
149859713|NCT01570283|540615805|FG000|Cohort 1: Dose Level 1|Death|0|||
149859714|NCT01570283|540615806|FG001|Cohort 1: Dose Level 1|Death|1|||
149859715|NCT01570283|540615807|FG002|Cohort 1: Dose Level 1|Death|0|||
149859716|NCT01570283|540615808|FG003|Cohort 1: Dose Level 1|Death|0|||
149859717|NCT01570283|540615809|FG004|Cohort 1: Dose Level 1|Death|0|||
149859718|NCT01570283|540615810|FG005|Cohort 1: Dose Level 1|Death|0|||
149859719|NCT01570283|540615805|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
149859720|NCT01570283|540615806|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
150290875|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
149859721|NCT01570283|540615807|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
149859722|NCT01570283|540615808|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
149859723|NCT01570283|540615809|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
149859724|NCT01570283|540615810|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
149859725|NCT01570283|540615805|FG000|Cohort 2: Dose Level 2|Death|0|||
149859726|NCT01570283|540615806|FG001|Cohort 2: Dose Level 2|Death|0|||
149859727|NCT01570283|540615807|FG002|Cohort 2: Dose Level 2|Death|1|||
150290876|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
150290877|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
150290878|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
150290879|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
150290880|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
150290881|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
150290882|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
150290883|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
150290884|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
149859728|NCT01570283|540615808|FG003|Cohort 2: Dose Level 2|Death|0|||
149859729|NCT01570283|540615809|FG004|Cohort 2: Dose Level 2|Death|0|||
149859730|NCT01570283|540615810|FG005|Cohort 2: Dose Level 2|Death|0|||
149961410|NCT01682603|540992070|FG000|Overall Study|Lost to Follow-up|3|||
149859731|NCT01570283|540615805|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
149859732|NCT01570283|540615806|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
149859733|NCT01570283|540615807|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
149859734|NCT01570283|540615808|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
149859735|NCT01570283|540615809|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
149859736|NCT01570283|540615810|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
149859737|NCT01570283|540615805|FG000|Cohort 3: Dose Level 3|Death|0|||
149859738|NCT01570283|540615806|FG001|Cohort 3: Dose Level 3|Death|0|||
149859739|NCT01570283|540615807|FG002|Cohort 3: Dose Level 3|Death|0|||
149859740|NCT01570283|540615808|FG003|Cohort 3: Dose Level 3|Death|0|||
149859741|NCT01570283|540615809|FG004|Cohort 3: Dose Level 3|Death|0|||
149859742|NCT01570283|540615810|FG005|Cohort 3: Dose Level 3|Death|1|||
149859743|NCT01570283|540615805|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
149859744|NCT01570283|540615806|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
149859745|NCT01570283|540615807|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
149859746|NCT01570283|540615808|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
149859747|NCT01570283|540615809|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
149859748|NCT01570283|540615810|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
149859749|NCT02017860|540615814|FG000|Overall Study|Adverse Event|1|||
149859750|NCT02017860|540615814|FG000|Overall Study|Withdrawal by Subject|1|||
149859751|NCT01048502|540615816|FG000|Overall Study|Lost to Follow-up|2|||
149859752|NCT01048502|540615817|FG001|Overall Study|Lost to Follow-up|0|||
150040326|NCT01782378|541287373|FG001|Second Series|Did not choose to complete S2 Optional|0|||
150290885|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
150290886|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
150290887|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
150290888|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
150290889|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
150290890|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
150290891|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
150290892|NCT02600494|542197861|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
150290893|NCT02600494|542197862|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
150290894|NCT02600494|542197863|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
150290895|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
150290896|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
150290897|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
149859753|NCT01048502|540615818|FG002|Overall Study|Lost to Follow-up|0|||
149859754|NCT01048502|540615819|FG003|Overall Study|Lost to Follow-up|0|||
150040327|NCT00830440|541287374|FG000|Overall Study|Protocol Violation|1|||
150040328|NCT00830440|541287375|FG001|Overall Study|Protocol Violation|0|||
150040329|NCT00830440|541287374|FG000|Overall Study|Withdrawal by Subject|1|||
150040330|NCT00830440|541287375|FG001|Overall Study|Withdrawal by Subject|0|||
150040331|NCT00830440|541287374|FG000|Overall Study|unsuccessful procedure|4|||
150040332|NCT00830440|541287375|FG001|Overall Study|unsuccessful procedure|0|||
150040333|NCT00830440|541287374|FG000|Overall Study|Adverse Event|2|||
150040334|NCT00830440|541287375|FG001|Overall Study|Adverse Event|0|||
150040335|NCT02592798|541287376|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
150040336|NCT02592798|541287377|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
150040337|NCT02592798|541287376|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
150040338|NCT02592798|541287377|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
150040339|NCT02592798|541287376|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
150040340|NCT02592798|541287377|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
150040341|NCT02592798|541287376|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
150040342|NCT02592798|541287377|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
150040343|NCT02592798|541287376|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
150040344|NCT02592798|541287377|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
150040345|NCT02592798|541287376|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
150040346|NCT02592798|541287377|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
150040347|NCT02592798|541287376|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
150040348|NCT02592798|541287377|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
150040349|NCT02592798|541287376|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
150040350|NCT02592798|541287377|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
150040351|NCT02592798|541287376|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
150040352|NCT02592798|541287377|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
150040353|NCT02592798|541287376|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
150040354|NCT02592798|541287377|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
150290898|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
149859755|NCT01048502|540615816|FG000|Overall Study|Adverse Event|1|||
149859756|NCT01048502|540615817|FG001|Overall Study|Adverse Event|0|||
149961411|NCT01791205|540992071|FG000|Phase II|Lack of Efficacy|6|||
149961412|NCT01791205|540992072|FG001|Phase II|Lack of Efficacy|0|||
149961413|NCT01791205|540992071|FG000|Phase II|Adverse Event|2|||
149961414|NCT01791205|540992072|FG001|Phase II|Adverse Event|0|||
149961415|NCT01791205|540992071|FG000|Phase II|Safety|1|||
149961416|NCT01791205|540992072|FG001|Phase II|Safety|0|||
149961417|NCT01791205|540992071|FG000|Phase II|Lost to Follow-up|1|||
149961418|NCT01791205|540992072|FG001|Phase II|Lost to Follow-up|0|||
149961419|NCT01791205|540992071|FG000|Phase II|Remission of disease|1|||
149961420|NCT01791205|540992072|FG001|Phase II|Remission of disease|0|||
149961421|NCT01791205|540992071|FG000|Phase II|Physician's decision|1|||
149961422|NCT01791205|540992072|FG001|Phase II|Physician's decision|0|||
149961423|NCT01697501|540992073|FG000|Overall Study|Protocol Violation|2|||
149961424|NCT02242903|540992074|FG000|Overall Study|Withdrawal by Subject|1|||
149961425|NCT02242903|540992075|FG001|Overall Study|Withdrawal by Subject|0|||
149961426|NCT02242903|540992076|FG002|Overall Study|Withdrawal by Subject|0|||
150290899|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
150290900|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
150290901|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
150290902|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
150290903|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
150290904|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
150290905|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
150290906|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
150290907|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
150290908|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
150290909|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
150290910|NCT02600494|542197861|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
150290911|NCT02600494|542197862|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
150290912|NCT02600494|542197863|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
150290913|NCT03124563|542197864|FG000|Overall Study|Lost to Follow-up|1|||
150290914|NCT03124563|542197865|FG001|Overall Study|Lost to Follow-up|1|||
150290915|NCT03124563|542197864|FG000|Overall Study|Withdrawal by Subject|1|||
150290916|NCT03124563|542197865|FG001|Overall Study|Withdrawal by Subject|1|||
150290917|NCT05061719|542197868|FG000|Overall Study|Adverse Event|60|||
150290918|NCT05061719|542197868|FG000|Overall Study|Death|1|||
150290919|NCT05061719|542197868|FG000|Overall Study|Lack of Efficacy|7|||
150290920|NCT05061719|542197868|FG000|Overall Study|Lost to Follow-up|5|||
150290921|NCT05061719|542197868|FG000|Overall Study|Pregnancy|1|||
150290922|NCT05061719|542197868|FG000|Overall Study|Protocol Violation|8|||
150290923|NCT05061719|542197868|FG000|Overall Study|Withdrawal by Subject|41|||
150290924|NCT05061719|542197868|FG000|Overall Study|Site Closure|2|||
150290925|NCT04246372|542200294|FG000|Overall Study|Adverse Event|1|||
150290926|NCT04246372|542200294|FG000|Overall Study|Withdrawal by Subject|1|||
150290927|NCT04246372|542200294|FG000|Overall Study|Protocol Violation|2|||
150290928|NCT04246372|542200294|FG000|Overall Study|Physician Decision|1|||
150290929|NCT02723773|542200306|FG000|Overall Study|Adverse Event|934|||
150290930|NCT02723773|542200307|FG001|Overall Study|Adverse Event|3|||
150290931|NCT02723773|542200308|FG002|Overall Study|Adverse Event|1|||
150290932|NCT02723773|542200309|FG003|Overall Study|Adverse Event|9|||
150290933|NCT02723773|542200306|FG000|Overall Study|Protocol Violation|1|||
149961427|NCT02242903|540992077|FG003|Overall Study|Withdrawal by Subject|0|||
149961428|NCT02242903|540992078|FG004|Overall Study|Withdrawal by Subject|0|||
149961429|NCT02242903|540992079|FG005|Overall Study|Withdrawal by Subject|0|||
149961430|NCT02242903|540992080|FG006|Overall Study|Withdrawal by Subject|0|||
149961431|NCT01063881|540992088|FG000|Overall Study|Adverse Event|12|||
149961432|NCT01063881|540992089|FG001|Overall Study|Adverse Event|2|||
149961433|NCT01063881|540992090|FG002|Overall Study|Adverse Event|0|||
149961434|NCT01063881|540992088|FG000|Overall Study|Lost to Follow-up|13|||
149961435|NCT01063881|540992089|FG001|Overall Study|Lost to Follow-up|7|||
150290934|NCT02723773|542200307|FG001|Overall Study|Protocol Violation|0|||
150290935|NCT02723773|542200308|FG002|Overall Study|Protocol Violation|0|||
150290936|NCT02723773|542200309|FG003|Overall Study|Protocol Violation|0|||
150290937|NCT02723773|542200306|FG000|Overall Study|Withdrawal by Subject|360|||
150290938|NCT02723773|542200307|FG001|Overall Study|Withdrawal by Subject|5|||
150290939|NCT02723773|542200308|FG002|Overall Study|Withdrawal by Subject|6|||
150290940|NCT02723773|542200309|FG003|Overall Study|Withdrawal by Subject|10|||
150290941|NCT02723773|542200306|FG000|Overall Study|Migrated/moved from study area|37|||
150290942|NCT02723773|542200307|FG001|Overall Study|Migrated/moved from study area|0|||
150290943|NCT02723773|542200308|FG002|Overall Study|Migrated/moved from study area|0|||
149961436|NCT01063881|540992090|FG002|Overall Study|Lost to Follow-up|1|||
149961437|NCT01063881|540992088|FG000|Overall Study|Withdrawal by Subject|25|||
149961438|NCT01063881|540992089|FG001|Overall Study|Withdrawal by Subject|1|||
149961439|NCT01063881|540992090|FG002|Overall Study|Withdrawal by Subject|0|||
149859757|NCT01048502|540615818|FG002|Overall Study|Adverse Event|0|||
149859758|NCT01048502|540615819|FG003|Overall Study|Adverse Event|0|||
149859759|NCT01048502|540615816|FG000|Overall Study|Withdrawal by Subject|1|||
149859760|NCT01048502|540615817|FG001|Overall Study|Withdrawal by Subject|4|||
149859761|NCT01048502|540615818|FG002|Overall Study|Withdrawal by Subject|5|||
149859762|NCT01048502|540615819|FG003|Overall Study|Withdrawal by Subject|3|||
149859763|NCT01048502|540615816|FG000|Overall Study|Physician Decision|0|||
149859764|NCT01048502|540615817|FG001|Overall Study|Physician Decision|3|||
149859765|NCT01048502|540615818|FG002|Overall Study|Physician Decision|0|||
149859766|NCT01048502|540615819|FG003|Overall Study|Physician Decision|1|||
150290944|NCT02723773|542200309|FG003|Overall Study|Migrated/moved from study area|1|||
150290945|NCT02723773|542200306|FG000|Overall Study|Lost to Follow-up|198|||
150290946|NCT02723773|542200307|FG001|Overall Study|Lost to Follow-up|0|||
150290947|NCT02723773|542200308|FG002|Overall Study|Lost to Follow-up|0|||
150290948|NCT02723773|542200309|FG003|Overall Study|Lost to Follow-up|0|||
150290949|NCT02723773|542200306|FG000|Overall Study|Other|189|||
150040355|NCT02592798|541287376|FG000|Transition From DB2 to OLE|Other reasons|1|||
150040356|NCT02592798|541287377|FG001|Transition From DB2 to OLE|Other reasons|0|||
150040357|NCT02592798|541287376|FG000|Open Label Period (OLE)|Other reasons|0|||
150040358|NCT02592798|541287377|FG001|Open Label Period (OLE)|Other reasons|2|||
150040359|NCT02592798|541287376|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
150040360|NCT02592798|541287377|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
150040361|NCT02592798|541287376|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
150040362|NCT02592798|541287377|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
150040363|NCT02592798|541287376|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
150040364|NCT02592798|541287377|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
150040365|NCT02592798|541287376|FG000|Open Label Period (OLE)|Adverse Event|0|||
150173553|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173554|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
150173555|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150040366|NCT02592798|541287377|FG001|Open Label Period (OLE)|Adverse Event|1|||
150040367|NCT00705016|541287378|FG000|Overall Study|Adverse Event|6|||
150040368|NCT00705016|541287379|FG001|Overall Study|Adverse Event|11|||
150290950|NCT02723773|542200307|FG001|Overall Study|Other|1|||
150290951|NCT02723773|542200308|FG002|Overall Study|Other|2|||
150290952|NCT02723773|542200309|FG003|Overall Study|Other|2|||
150290953|NCT05168774|542200310|FG000|Overall Study|Lack of Efficacy|1|||
150290954|NCT05168774|542200311|FG001|Overall Study|Lack of Efficacy|2|||
150290955|NCT05168774|542200310|FG000|Overall Study|Withdrawal by Subject|1|||
150290956|NCT05168774|542200311|FG001|Overall Study|Withdrawal by Subject|2|||
150290957|NCT05168774|542200310|FG000|Overall Study|Adverse Event|2|||
150290958|NCT05168774|542200311|FG001|Overall Study|Adverse Event|0|||
150290959|NCT01314703|542200316|FG000|Overall Study|screen failure and closed enrollment|8|||
150290960|NCT04063384|542200317|FG000|Overall Study|placebo manipulation issue|1|||
150290961|NCT04063384|542200318|FG001|Overall Study|placebo manipulation issue|2|||
150290962|NCT04063384|542200319|FG002|Overall Study|placebo manipulation issue|1|||
150290963|NCT04063384|542200320|FG003|Overall Study|placebo manipulation issue|1|||
150290964|NCT03940703|542200322|FG000|Overall Study|Still under treatment|31|||
150290965|NCT03940703|542200323|FG001|Overall Study|Still under treatment|0|||
150290966|NCT03215030|542200324|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
150290967|NCT03215030|542200325|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
150290968|NCT03215030|542200326|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290969|NCT03215030|542200327|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
150290970|NCT03215030|542200328|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
149859767|NCT00493454|540615820|FG000|Overall Study|Withdrawal by Subject|1|||
149859768|NCT02462486|540615823|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
149859769|NCT02462486|540615824|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
150040369|NCT00705016|541287380|FG002|Overall Study|Adverse Event|10|||
150173556|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150290971|NCT03215030|542200329|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290972|NCT03215030|542200330|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290973|NCT03215030|542200331|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
149859770|NCT02462486|540615825|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
150040370|NCT00705016|541287378|FG000|Overall Study|Death|5|||
150290974|NCT03215030|542200332|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290975|NCT03215030|542200333|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290976|NCT03215030|542200334|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
150290977|NCT03215030|542200335|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
149859771|NCT02462486|540615823|FG000|Overall Study|Adverse Event|53|||
150290978|NCT03215030|542200324|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
150290979|NCT03215030|542200325|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290980|NCT03215030|542200326|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290981|NCT03215030|542200327|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
150290982|NCT03215030|542200328|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290983|NCT03215030|542200329|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290984|NCT03215030|542200330|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290985|NCT03215030|542200331|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290986|NCT03215030|542200332|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290987|NCT03215030|542200333|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290988|NCT03215030|542200334|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290989|NCT03215030|542200335|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150290990|NCT03215030|542200324|FG000|Part 1: Dose Escalation|Death|15|||
150290991|NCT03215030|542200325|FG001|Part 1: Dose Escalation|Death|6|||
150290992|NCT03215030|542200326|FG002|Part 1: Dose Escalation|Death|6|||
150290993|NCT03215030|542200327|FG003|Part 1: Dose Escalation|Death|8|||
150290994|NCT03215030|542200328|FG004|Part 1: Dose Escalation|Death|0|||
150290995|NCT03215030|542200329|FG005|Part 1: Dose Escalation|Death|0|||
150290996|NCT03215030|542200330|FG006|Part 1: Dose Escalation|Death|0|||
150290997|NCT03215030|542200331|FG007|Part 1: Dose Escalation|Death|0|||
150290998|NCT03215030|542200332|FG008|Part 1: Dose Escalation|Death|0|||
150290999|NCT03215030|542200333|FG009|Part 1: Dose Escalation|Death|0|||
150291000|NCT03215030|542200334|FG010|Part 1: Dose Escalation|Death|0|||
150291001|NCT03215030|542200335|FG011|Part 1: Dose Escalation|Death|0|||
150291002|NCT03215030|542200324|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
150291003|NCT03215030|542200325|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
150291004|NCT03215030|542200326|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
150291005|NCT03215030|542200327|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
150291006|NCT03215030|542200328|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
150291007|NCT03215030|542200329|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
150291008|NCT03215030|542200330|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
150291009|NCT03215030|542200331|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
150291010|NCT03215030|542200332|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
150291011|NCT03215030|542200333|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
150291012|NCT03215030|542200334|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
150291013|NCT03215030|542200335|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
150291014|NCT03215030|542200324|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291015|NCT03215030|542200325|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291016|NCT03215030|542200326|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291017|NCT03215030|542200327|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291018|NCT03215030|542200328|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291019|NCT03215030|542200329|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291020|NCT03215030|542200330|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291021|NCT03215030|542200331|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
150291022|NCT03215030|542200332|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291023|NCT03215030|542200333|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291024|NCT03215030|542200334|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291025|NCT03215030|542200335|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
150291026|NCT03215030|542200324|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291027|NCT03215030|542200325|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291028|NCT03215030|542200326|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291029|NCT03215030|542200327|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291030|NCT03215030|542200328|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
150291031|NCT03215030|542200329|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
150291032|NCT03215030|542200330|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
150291033|NCT03215030|542200331|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
150291034|NCT03215030|542200332|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291035|NCT03215030|542200333|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291036|NCT03215030|542200334|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291037|NCT03215030|542200335|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150291038|NCT03215030|542200324|FG000|Part 2: Dose Expansion|Death|0|||
150291039|NCT03215030|542200325|FG001|Part 2: Dose Expansion|Death|0|||
150291040|NCT03215030|542200326|FG002|Part 2: Dose Expansion|Death|0|||
150291041|NCT03215030|542200327|FG003|Part 2: Dose Expansion|Death|0|||
150291042|NCT03215030|542200328|FG004|Part 2: Dose Expansion|Death|3|||
150291043|NCT03215030|542200329|FG005|Part 2: Dose Expansion|Death|1|||
150291044|NCT03215030|542200330|FG006|Part 2: Dose Expansion|Death|5|||
150291045|NCT03215030|542200331|FG007|Part 2: Dose Expansion|Death|4|||
150291046|NCT03215030|542200332|FG008|Part 2: Dose Expansion|Death|0|||
150291047|NCT03215030|542200333|FG009|Part 2: Dose Expansion|Death|0|||
150291048|NCT03215030|542200334|FG010|Part 2: Dose Expansion|Death|0|||
150291049|NCT03215030|542200335|FG011|Part 2: Dose Expansion|Death|0|||
150291050|NCT03215030|542200324|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
150291051|NCT03215030|542200325|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
150291052|NCT03215030|542200326|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
150291053|NCT03215030|542200327|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
149859772|NCT02462486|540615824|FG001|Overall Study|Adverse Event|48|||
149859773|NCT02462486|540615825|FG002|Overall Study|Adverse Event|21|||
149859774|NCT02462486|540615823|FG000|Overall Study|Lack of Efficacy|6|||
149859775|NCT02462486|540615824|FG001|Overall Study|Lack of Efficacy|12|||
149859776|NCT02462486|540615825|FG002|Overall Study|Lack of Efficacy|3|||
149859777|NCT02462486|540615823|FG000|Overall Study|Lost to Follow-up|3|||
149961440|NCT01063881|540992088|FG000|Overall Study|Reason for not completed not specified|5|||
149961441|NCT01063881|540992089|FG001|Overall Study|Reason for not completed not specified|1|||
149961442|NCT01063881|540992090|FG002|Overall Study|Reason for not completed not specified|0|||
149961443|NCT01340170|540992091|FG000|Overall Study|Lost to Follow-up|2|||
149961444|NCT01340170|540992092|FG001|Overall Study|Lost to Follow-up|4|||
149961445|NCT01340170|540992093|FG002|Overall Study|Lost to Follow-up|0|||
149961446|NCT01340170|540992091|FG000|Overall Study|Implant failure|1|||
149961447|NCT01340170|540992092|FG001|Overall Study|Implant failure|3|||
149961448|NCT01340170|540992093|FG002|Overall Study|Implant failure|0|||
149961449|NCT00066170|540992094|FG000|Overall Study|Adverse Event|2|||
149961450|NCT00066170|540992095|FG001|Overall Study|Adverse Event|4|||
149961451|NCT00066170|540992096|FG002|Overall Study|Adverse Event|1|||
149961452|NCT00066170|540992097|FG003|Overall Study|Adverse Event|7|||
149961453|NCT00066170|540992094|FG000|Overall Study|Serious Adverse Event|0|||
149961454|NCT00066170|540992095|FG001|Overall Study|Serious Adverse Event|0|||
149961455|NCT00066170|540992096|FG002|Overall Study|Serious Adverse Event|1|||
149961456|NCT00066170|540992097|FG003|Overall Study|Serious Adverse Event|1|||
149961457|NCT00066170|540992094|FG000|Overall Study|Lost to Follow-up|0|||
149961458|NCT00066170|540992095|FG001|Overall Study|Lost to Follow-up|1|||
149961459|NCT00066170|540992096|FG002|Overall Study|Lost to Follow-up|0|||
149961460|NCT00066170|540992097|FG003|Overall Study|Lost to Follow-up|0|||
149961461|NCT00066170|540992094|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
149961462|NCT00066170|540992095|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
149961463|NCT00066170|540992096|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
149961464|NCT00066170|540992097|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
149961465|NCT00066170|540992094|FG000|Overall Study|Protocol Violation|3|||
149961466|NCT00066170|540992095|FG001|Overall Study|Protocol Violation|0|||
149961467|NCT00066170|540992096|FG002|Overall Study|Protocol Violation|0|||
149961468|NCT00066170|540992097|FG003|Overall Study|Protocol Violation|0|||
149961469|NCT00066170|540992094|FG000|Overall Study|Other|1|||
149961470|NCT00066170|540992095|FG001|Overall Study|Other|5|||
149961471|NCT00066170|540992096|FG002|Overall Study|Other|2|||
149961472|NCT00066170|540992097|FG003|Overall Study|Other|0|||
149961473|NCT01370642|540992098|FG000|Overall Study|Adverse Event|2|||
149961474|NCT01370642|540992099|FG001|Overall Study|Adverse Event|1|||
149961475|NCT01370642|540992100|FG002|Overall Study|Adverse Event|1|||
149961476|NCT01370642|540992098|FG000|Overall Study|Detectable HCV RNA|0|||
149961477|NCT01370642|540992099|FG001|Overall Study|Detectable HCV RNA|0|||
149961478|NCT01370642|540992100|FG002|Overall Study|Detectable HCV RNA|22|||
149961479|NCT01370642|540992098|FG000|Overall Study|Lost to Follow-up|0|||
149961480|NCT01370642|540992099|FG001|Overall Study|Lost to Follow-up|0|||
149961481|NCT01370642|540992100|FG002|Overall Study|Lost to Follow-up|1|||
149961482|NCT01370642|540992098|FG000|Overall Study|Physician Decision|4|||
149961483|NCT01370642|540992099|FG001|Overall Study|Physician Decision|1|||
149961484|NCT01370642|540992100|FG002|Overall Study|Physician Decision|2|||
149961485|NCT01370642|540992098|FG000|Overall Study|Withdrawal by Subject|2|||
149961486|NCT01370642|540992099|FG001|Overall Study|Withdrawal by Subject|4|||
149961487|NCT01370642|540992100|FG002|Overall Study|Withdrawal by Subject|3|||
149961488|NCT00987935|540992107|FG000|Overall Study|Progressive disease|3|||
149961489|NCT00987935|540992108|FG001|Overall Study|Progressive disease|2|||
149961490|NCT00987935|540992109|FG002|Overall Study|Progressive disease|3|||
149961491|NCT00987935|540992110|FG003|Overall Study|Progressive disease|2|||
149961492|NCT00987935|540992111|FG004|Overall Study|Progressive disease|5|||
149961493|NCT00987935|540992112|FG005|Overall Study|Progressive disease|3|||
149961494|NCT00987935|540992113|FG006|Overall Study|Progressive disease|9|||
149961495|NCT00987935|540992114|FG007|Overall Study|Progressive disease|48|||
149961496|NCT00987935|540992115|FG008|Overall Study|Progressive disease|23|||
149859778|NCT02462486|540615824|FG001|Overall Study|Lost to Follow-up|4|||
149859779|NCT02462486|540615825|FG002|Overall Study|Lost to Follow-up|2|||
149859780|NCT02462486|540615823|FG000|Overall Study|Withdrawal by Subject|25|||
149961497|NCT00987935|540992107|FG000|Overall Study|Adverse Event|0|||
149961498|NCT00987935|540992108|FG001|Overall Study|Adverse Event|1|||
149961499|NCT00987935|540992109|FG002|Overall Study|Adverse Event|0|||
149859781|NCT02462486|540615824|FG001|Overall Study|Withdrawal by Subject|22|||
149859782|NCT02462486|540615825|FG002|Overall Study|Withdrawal by Subject|19|||
149961500|NCT00987935|540992110|FG003|Overall Study|Adverse Event|1|||
149961501|NCT00987935|540992111|FG004|Overall Study|Adverse Event|1|||
149961502|NCT00987935|540992112|FG005|Overall Study|Adverse Event|0|||
149961503|NCT00987935|540992113|FG006|Overall Study|Adverse Event|2|||
149961504|NCT00987935|540992114|FG007|Overall Study|Adverse Event|10|||
149961505|NCT00987935|540992115|FG008|Overall Study|Adverse Event|6|||
149961506|NCT00987935|540992107|FG000|Overall Study|Refused to continue taking trial med.|1|||
149961507|NCT00987935|540992108|FG001|Overall Study|Refused to continue taking trial med.|0|||
149859783|NCT02462486|540615823|FG000|Overall Study|Protocol Violation|3|||
149859784|NCT02462486|540615824|FG001|Overall Study|Protocol Violation|1|||
149859785|NCT02462486|540615825|FG002|Overall Study|Protocol Violation|1|||
149859786|NCT02462486|540615823|FG000|Overall Study|Reason not Specified|3|||
149859787|NCT02462486|540615824|FG001|Overall Study|Reason not Specified|4|||
149859788|NCT02462486|540615825|FG002|Overall Study|Reason not Specified|3|||
149859789|NCT02310763|540615830|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
149859790|NCT02310763|540615831|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
149859791|NCT02310763|540615832|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
149859792|NCT02310763|540615830|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
149961508|NCT00987935|540992109|FG002|Overall Study|Refused to continue taking trial med.|0|||
150040371|NCT00705016|541287379|FG001|Overall Study|Death|7|||
150291054|NCT03215030|542200328|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
150291055|NCT03215030|542200329|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
150291056|NCT03215030|542200330|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
150291057|NCT03215030|542200331|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
150291058|NCT03215030|542200332|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
150291059|NCT03215030|542200333|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
150291060|NCT03215030|542200334|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
150291061|NCT03215030|542200335|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
150291062|NCT03215030|542200324|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
150291063|NCT03215030|542200325|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
150291064|NCT03215030|542200326|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
150291065|NCT03215030|542200327|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
150291066|NCT03215030|542200328|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
150291067|NCT03215030|542200329|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
150291068|NCT03215030|542200330|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
150291069|NCT03215030|542200331|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
150291070|NCT03215030|542200332|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
150291071|NCT03215030|542200333|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
150291072|NCT03215030|542200334|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
150291073|NCT03215030|542200335|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
150291074|NCT03215030|542200324|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291075|NCT03215030|542200325|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291076|NCT03215030|542200326|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291077|NCT03215030|542200327|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291078|NCT03215030|542200328|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291079|NCT03215030|542200329|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291080|NCT03215030|542200330|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291081|NCT03215030|542200331|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291082|NCT03215030|542200332|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
150291083|NCT03215030|542200333|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
150291084|NCT03215030|542200334|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291085|NCT03215030|542200335|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
150291086|NCT03215030|542200324|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291087|NCT03215030|542200325|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291088|NCT03215030|542200326|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291089|NCT03215030|542200327|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291090|NCT03215030|542200328|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291091|NCT03215030|542200329|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291092|NCT03215030|542200330|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291093|NCT03215030|542200331|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291094|NCT03215030|542200332|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
150291095|NCT03215030|542200333|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
150291096|NCT03215030|542200334|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291097|NCT03215030|542200335|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
150291098|NCT03215030|542200324|FG000|Part 3: Dose Extension|Death|0|||
150291099|NCT03215030|542200325|FG001|Part 3: Dose Extension|Death|0|||
150291100|NCT03215030|542200326|FG002|Part 3: Dose Extension|Death|0|||
150291101|NCT03215030|542200327|FG003|Part 3: Dose Extension|Death|0|||
150291102|NCT03215030|542200328|FG004|Part 3: Dose Extension|Death|0|||
150291103|NCT03215030|542200329|FG005|Part 3: Dose Extension|Death|0|||
150291104|NCT03215030|542200330|FG006|Part 3: Dose Extension|Death|0|||
150291105|NCT03215030|542200331|FG007|Part 3: Dose Extension|Death|0|||
150291106|NCT03215030|542200332|FG008|Part 3: Dose Extension|Death|19|||
150291107|NCT03215030|542200333|FG009|Part 3: Dose Extension|Death|20|||
150291108|NCT03215030|542200334|FG010|Part 3: Dose Extension|Death|0|||
150291109|NCT03215030|542200335|FG011|Part 3: Dose Extension|Death|0|||
150291110|NCT03215030|542200324|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
150291111|NCT03215030|542200325|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
150291112|NCT03215030|542200326|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
150291113|NCT03215030|542200327|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
149859793|NCT02310763|540615831|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
149859794|NCT02310763|540615832|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
149859795|NCT02310763|540615830|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
149859796|NCT02310763|540615831|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
149859797|NCT02310763|540615832|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
149859798|NCT02310763|540615830|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
149859799|NCT02310763|540615831|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
149859800|NCT02310763|540615832|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
149859801|NCT02310763|540615830|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
149859802|NCT02310763|540615831|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
149859803|NCT02310763|540615832|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
149859804|NCT04647383|540615833|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
149859805|NCT04647383|540615834|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
149859806|NCT04647383|540615835|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
149859807|NCT04647383|540615836|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
149859808|NCT04099641|540615837|FG000|Overall Study|Death|46|||
149859809|NCT04099641|540615838|FG001|Overall Study|Death|12|||
149859810|NCT04099641|540615837|FG000|Overall Study|Lost to Follow-up|1|||
149859811|NCT04099641|540615838|FG001|Overall Study|Lost to Follow-up|0|||
149859812|NCT04099641|540615837|FG000|Overall Study|Withdrawal by Subject|2|||
149859813|NCT04099641|540615838|FG001|Overall Study|Withdrawal by Subject|0|||
149859814|NCT00303667|540615849|FG000|Overall Study|Death|0|||
149859815|NCT00303667|540615850|FG001|Overall Study|Death|4|||
149859816|NCT01029392|540615851|FG000|Overall Study|Withdrawal by Subject|18|||
149859817|NCT01029392|540615852|FG001|Overall Study|Withdrawal by Subject|11|||
149859818|NCT01029392|540615851|FG000|Overall Study|Physician Decision|2|||
150291114|NCT03215030|542200328|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
149859819|NCT01029392|540615852|FG001|Overall Study|Physician Decision|0|||
149859820|NCT01103479|540615853|FG000|Overall Study|Up to date with CRC screening|1|||
149859821|NCT01103479|540615854|FG001|Overall Study|Up to date with CRC screening|9|||
149859822|NCT01103479|540615855|FG002|Overall Study|Up to date with CRC screening|12|||
149859823|NCT01103479|540615853|FG000|Overall Study|Family history of CRC|1|||
149859824|NCT01103479|540615854|FG001|Overall Study|Family history of CRC|0|||
149859825|NCT01103479|540615855|FG002|Overall Study|Family history of CRC|2|||
149859826|NCT01103479|540615853|FG000|Overall Study|Active cancer|1|||
149859827|NCT01103479|540615854|FG001|Overall Study|Active cancer|0|||
149859828|NCT01103479|540615855|FG002|Overall Study|Active cancer|0|||
149859829|NCT01103479|540615853|FG000|Overall Study|Saw non-study physician|2|||
149859830|NCT01103479|540615854|FG001|Overall Study|Saw non-study physician|0|||
149859831|NCT01103479|540615855|FG002|Overall Study|Saw non-study physician|0|||
149859832|NCT02549573|540615858|FG000|Overall Study|Withdrawal by Subject|0|||
150291115|NCT03215030|542200329|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
150291116|NCT03215030|542200330|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
149859833|NCT02549573|540615859|FG001|Overall Study|Withdrawal by Subject|2|||
149859834|NCT02549573|540615858|FG000|Overall Study|Protocol Violation|0|||
149859835|NCT02549573|540615859|FG001|Overall Study|Protocol Violation|1|||
149859836|NCT02083926|540615862|FG000|Overall Study|Withdrawal by Subject|1|||
149859837|NCT02083926|540615863|FG001|Overall Study|Withdrawal by Subject|0|||
149859838|NCT02610816|540615864|FG000|Phase 1|Withdrawal by Subject|2|||
149859839|NCT02610816|540615865|FG001|Phase 1|Withdrawal by Subject|6|||
149859840|NCT02610816|540615866|FG002|Phase 1|Withdrawal by Subject|0|||
149859841|NCT02610816|540615867|FG003|Phase 1|Withdrawal by Subject|0|||
149859842|NCT02610816|540615864|FG000|Phase 1|Lost to Follow-up|2|||
149859843|NCT02610816|540615865|FG001|Phase 1|Lost to Follow-up|1|||
149859844|NCT02610816|540615866|FG002|Phase 1|Lost to Follow-up|0|||
149859845|NCT02610816|540615867|FG003|Phase 1|Lost to Follow-up|0|||
149859846|NCT02610816|540615864|FG000|Phase 1|Physician Decision|0|||
149859847|NCT02610816|540615865|FG001|Phase 1|Physician Decision|1|||
149859848|NCT02610816|540615866|FG002|Phase 1|Physician Decision|0|||
149859849|NCT02610816|540615867|FG003|Phase 1|Physician Decision|0|||
149859850|NCT02610816|540615864|FG000|Phase 2|Withdrawal by Subject|0|||
149859851|NCT02610816|540615865|FG001|Phase 2|Withdrawal by Subject|0|||
150291117|NCT03215030|542200331|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
150291118|NCT03215030|542200332|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
149859852|NCT02610816|540615866|FG002|Phase 2|Withdrawal by Subject|9|||
149859853|NCT02610816|540615867|FG003|Phase 2|Withdrawal by Subject|3|||
149859854|NCT02610816|540615864|FG000|Phase 2|Lost to Follow-up|0|||
149859855|NCT02610816|540615865|FG001|Phase 2|Lost to Follow-up|0|||
149859856|NCT02610816|540615866|FG002|Phase 2|Lost to Follow-up|2|||
149859857|NCT02610816|540615867|FG003|Phase 2|Lost to Follow-up|0|||
149859858|NCT02610816|540615864|FG000|Phase 2|Physician Decision|0|||
149859859|NCT02610816|540615865|FG001|Phase 2|Physician Decision|0|||
149859860|NCT02610816|540615866|FG002|Phase 2|Physician Decision|0|||
149859861|NCT02610816|540615867|FG003|Phase 2|Physician Decision|2|||
149859862|NCT02610816|540615864|FG000|Phase 2|Pregnancy|0|||
149859863|NCT02610816|540615865|FG001|Phase 2|Pregnancy|0|||
149859864|NCT02610816|540615866|FG002|Phase 2|Pregnancy|0|||
149859865|NCT02610816|540615867|FG003|Phase 2|Pregnancy|1|||
149859866|NCT00384176|540615870|FG000|Overall Study|Death|239|||
149859867|NCT00384176|540615871|FG001|Overall Study|Death|247|||
149859868|NCT00384176|540615872|FG002|Overall Study|Death|105|||
149859869|NCT00384176|540615870|FG000|Overall Study|Withdrawal by Subject|52|||
149859870|NCT00384176|540615871|FG001|Overall Study|Withdrawal by Subject|48|||
149859871|NCT00384176|540615872|FG002|Overall Study|Withdrawal by Subject|22|||
149859872|NCT00384176|540615870|FG000|Overall Study|Lost to Follow-up|16|||
150291119|NCT03215030|542200333|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
150291120|NCT03215030|542200334|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
150291121|NCT03215030|542200335|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
150291122|NCT03215030|542200324|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291123|NCT03215030|542200325|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291124|NCT03215030|542200326|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291125|NCT03215030|542200327|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291126|NCT03215030|542200328|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291127|NCT03215030|542200329|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291128|NCT03215030|542200330|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291129|NCT03215030|542200331|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291130|NCT03215030|542200332|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291131|NCT03215030|542200333|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
150291132|NCT03215030|542200334|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
150291133|NCT03215030|542200335|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
150291134|NCT05416138|542200336|FG000|Overall Study|Withdrawal by Subject|2|||
150291135|NCT05416138|542200337|FG001|Overall Study|Withdrawal by Subject|1|||
150291136|NCT05804877|542200349|FG000|Overall Study|Lost to Follow-up|1|||
150291137|NCT05804877|542200350|FG001|Overall Study|Lost to Follow-up|3|||
150291138|NCT05804877|542200349|FG000|Overall Study|Withdrawal by Subject|1|||
150291139|NCT05804877|542200350|FG001|Overall Study|Withdrawal by Subject|0|||
150291140|NCT05804877|542200349|FG000|Overall Study|Withdrawal by Subject|1|||
150291141|NCT05804877|542200350|FG001|Overall Study|Withdrawal by Subject|0|||
150291142|NCT03310957|542200351|FG000|Overall Study|Withdrawal by Subject|1|||
150291143|NCT03310957|542200352|FG001|Overall Study|Withdrawal by Subject|1|||
150291144|NCT03310957|542200353|FG002|Overall Study|Withdrawal by Subject|1|||
150291145|NCT03310957|542200354|FG003|Overall Study|Withdrawal by Subject|5|||
150291146|NCT03310957|542200355|FG004|Overall Study|Withdrawal by Subject|0|||
150291147|NCT03310957|542200356|FG005|Overall Study|Withdrawal by Subject|4|||
150291148|NCT03310957|542200357|FG006|Overall Study|Withdrawal by Subject|3|||
150291149|NCT03310957|542200351|FG000|Overall Study|Site Terminated|0|||
150291150|NCT03310957|542200352|FG001|Overall Study|Site Terminated|1|||
150291151|NCT03310957|542200353|FG002|Overall Study|Site Terminated|1|||
150291152|NCT03310957|542200354|FG003|Overall Study|Site Terminated|1|||
150291153|NCT03310957|542200355|FG004|Overall Study|Site Terminated|0|||
150291154|NCT03310957|542200356|FG005|Overall Study|Site Terminated|2|||
150291155|NCT03310957|542200357|FG006|Overall Study|Site Terminated|8|||
150291156|NCT03310957|542200351|FG000|Overall Study|Lost to Follow-up|1|||
150291157|NCT03310957|542200352|FG001|Overall Study|Lost to Follow-up|1|||
150291158|NCT03310957|542200353|FG002|Overall Study|Lost to Follow-up|1|||
150291159|NCT03310957|542200354|FG003|Overall Study|Lost to Follow-up|4|||
150291160|NCT03310957|542200355|FG004|Overall Study|Lost to Follow-up|0|||
150291161|NCT03310957|542200356|FG005|Overall Study|Lost to Follow-up|4|||
150291162|NCT03310957|542200357|FG006|Overall Study|Lost to Follow-up|2|||
150291163|NCT03310957|542200351|FG000|Overall Study|Death|5|||
150291164|NCT03310957|542200352|FG001|Overall Study|Death|8|||
150291165|NCT03310957|542200353|FG002|Overall Study|Death|18|||
150291166|NCT03310957|542200354|FG003|Overall Study|Death|31|||
150291167|NCT03310957|542200355|FG004|Overall Study|Death|1|||
149859873|NCT00384176|540615871|FG001|Overall Study|Lost to Follow-up|18|||
150291168|NCT03310957|542200356|FG005|Overall Study|Death|29|||
150291169|NCT03310957|542200357|FG006|Overall Study|Death|7|||
150291170|NCT03310957|542200351|FG000|Overall Study|Discontinuation per sponsor|0|||
150291171|NCT03310957|542200352|FG001|Overall Study|Discontinuation per sponsor|1|||
150291172|NCT03310957|542200353|FG002|Overall Study|Discontinuation per sponsor|2|||
149859874|NCT00384176|540615872|FG002|Overall Study|Lost to Follow-up|4|||
149859875|NCT00384176|540615870|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
150291173|NCT03310957|542200354|FG003|Overall Study|Discontinuation per sponsor|4|||
150291174|NCT03310957|542200355|FG004|Overall Study|Discontinuation per sponsor|1|||
150291175|NCT03310957|542200356|FG005|Overall Study|Discontinuation per sponsor|9|||
149859876|NCT00384176|540615871|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
149859877|NCT00384176|540615872|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
150291176|NCT03310957|542200357|FG006|Overall Study|Discontinuation per sponsor|12|||
150291177|NCT03310957|542200351|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
150291178|NCT03310957|542200352|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
149961509|NCT00987935|540992110|FG003|Overall Study|Refused to continue taking trial med.|0|||
149961510|NCT00987935|540992111|FG004|Overall Study|Refused to continue taking trial med.|1|||
149961511|NCT00987935|540992112|FG005|Overall Study|Refused to continue taking trial med.|0|||
149961512|NCT00987935|540992113|FG006|Overall Study|Refused to continue taking trial med.|4|||
149961513|NCT00987935|540992114|FG007|Overall Study|Refused to continue taking trial med.|4|||
149961514|NCT00987935|540992115|FG008|Overall Study|Refused to continue taking trial med.|2|||
149961515|NCT00987935|540992107|FG000|Overall Study|Reason other than those specified above|0|||
149961516|NCT00987935|540992108|FG001|Overall Study|Reason other than those specified above|0|||
149961517|NCT00987935|540992109|FG002|Overall Study|Reason other than those specified above|0|||
149961518|NCT00987935|540992110|FG003|Overall Study|Reason other than those specified above|0|||
149961519|NCT00987935|540992111|FG004|Overall Study|Reason other than those specified above|0|||
149961520|NCT00987935|540992112|FG005|Overall Study|Reason other than those specified above|0|||
149961521|NCT00987935|540992113|FG006|Overall Study|Reason other than those specified above|0|||
149961522|NCT00987935|540992114|FG007|Overall Study|Reason other than those specified above|0|||
149961523|NCT00987935|540992115|FG008|Overall Study|Reason other than those specified above|1|||
149961524|NCT00452530|540992116|FG000|Overall Study|Death|1|||
149961525|NCT00452530|540992117|FG001|Overall Study|Death|0|||
149961526|NCT00452530|540992116|FG000|Overall Study|Adverse Event|40|||
149961527|NCT00452530|540992117|FG001|Overall Study|Adverse Event|44|||
149961528|NCT00452530|540992116|FG000|Overall Study|Withdrawal by Subject|68|||
149961529|NCT00452530|540992117|FG001|Overall Study|Withdrawal by Subject|57|||
149961530|NCT00452530|540992116|FG000|Overall Study|Lost to Follow-up|1|||
149961531|NCT00452530|540992117|FG001|Overall Study|Lost to Follow-up|0|||
149961532|NCT00452530|540992116|FG000|Overall Study|Poor compliance/noncompliance|1|||
149961533|NCT00452530|540992117|FG001|Overall Study|Poor compliance/noncompliance|2|||
149961534|NCT00452530|540992116|FG000|Overall Study|No longer met study criteria|18|||
149961535|NCT00452530|540992117|FG001|Overall Study|No longer met study criteria|22|||
149961536|NCT00452530|540992116|FG000|Overall Study|Other|7|||
149961537|NCT00452530|540992117|FG001|Overall Study|Other|11|||
149961538|NCT03888482|540992119|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
149961539|NCT03888482|540992120|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
149961540|NCT03888482|540992119|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
149961541|NCT03888482|540992120|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
149961542|NCT03721107|540992121|FG000|Overall Study|Adverse Event|1|||
149961543|NCT03721107|540992122|FG001|Overall Study|Adverse Event|1|||
149961544|NCT03721107|540992123|FG002|Overall Study|Adverse Event|6|||
149961545|NCT03721107|540992124|FG003|Overall Study|Adverse Event|5|||
149961546|NCT03721107|540992121|FG000|Overall Study|Lost to Follow-up|2|||
149961547|NCT03721107|540992122|FG001|Overall Study|Lost to Follow-up|0|||
149961548|NCT03721107|540992123|FG002|Overall Study|Lost to Follow-up|3|||
149961549|NCT03721107|540992124|FG003|Overall Study|Lost to Follow-up|0|||
149961550|NCT03721107|540992121|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
149961551|NCT03721107|540992122|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
149961552|NCT03721107|540992123|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
149961553|NCT03721107|540992124|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
149961554|NCT03721107|540992121|FG000|Overall Study|Physician Decision|0|||
149961555|NCT03721107|540992122|FG001|Overall Study|Physician Decision|1|||
149961556|NCT03721107|540992123|FG002|Overall Study|Physician Decision|0|||
149961557|NCT03721107|540992124|FG003|Overall Study|Physician Decision|0|||
149961558|NCT03721107|540992121|FG000|Overall Study|Pregnancy|0|||
149961559|NCT03721107|540992122|FG001|Overall Study|Pregnancy|0|||
149961560|NCT03721107|540992123|FG002|Overall Study|Pregnancy|1|||
149961561|NCT03721107|540992124|FG003|Overall Study|Pregnancy|0|||
149961562|NCT03721107|540992121|FG000|Overall Study|Withdrawal by Subject|1|||
149961563|NCT03721107|540992122|FG001|Overall Study|Withdrawal by Subject|1|||
149961564|NCT03721107|540992123|FG002|Overall Study|Withdrawal by Subject|5|||
149961565|NCT03721107|540992124|FG003|Overall Study|Withdrawal by Subject|5|||
149961566|NCT03721107|540992121|FG000|Overall Study|Other|1|||
149961567|NCT03721107|540992122|FG001|Overall Study|Other|0|||
149961568|NCT03721107|540992123|FG002|Overall Study|Other|0|||
149961569|NCT03721107|540992124|FG003|Overall Study|Other|1|||
149961570|NCT02294019|540992125|FG000|Overall Study|Adverse Event|2|||
149961571|NCT02294019|540992125|FG000|Overall Study|Protocol Violation|68|||
149961572|NCT02294019|540992125|FG000|Overall Study|Lost to Follow-up|31|||
149961573|NCT02294019|540992125|FG000|Overall Study|Other|1|||
149961574|NCT02294019|540992125|FG000|Overall Study|Withdrawal by Subject|1|||
149961575|NCT01189227|540992127|FG000|Overall Study|Study terminated due to low accrual|6|||
149961576|NCT01189227|540992128|FG001|Overall Study|Study terminated due to low accrual|3|||
149961577|NCT00968968|540992129|FG000|Overall Study|Study closed/terminated|10|||
149961578|NCT00968968|540992130|FG001|Overall Study|Study closed/terminated|10|||
149961579|NCT00968968|540992129|FG000|Overall Study|Protocol defined stopping criteria|3|||
149961580|NCT00968968|540992130|FG001|Overall Study|Protocol defined stopping criteria|1|||
149859878|NCT00384176|540615870|FG000|Overall Study|Longer QTC as Visit 1|1|||
149859879|NCT00384176|540615871|FG001|Overall Study|Longer QTC as Visit 1|0|||
149859880|NCT00384176|540615872|FG002|Overall Study|Longer QTC as Visit 1|0|||
149859881|NCT00384176|540615870|FG000|Overall Study|Toxicity of treatment|1|||
149859882|NCT00384176|540615871|FG001|Overall Study|Toxicity of treatment|0|||
149859883|NCT00384176|540615872|FG002|Overall Study|Toxicity of treatment|0|||
149859884|NCT00384176|540615870|FG000|Overall Study|Did not receive study treatment|0|||
149859885|NCT00384176|540615871|FG001|Overall Study|Did not receive study treatment|1|||
149859886|NCT00384176|540615872|FG002|Overall Study|Did not receive study treatment|1|||
149859887|NCT00384176|540615870|FG000|Overall Study|Physician Decision|0|||
149859888|NCT00384176|540615871|FG001|Overall Study|Physician Decision|2|||
149859889|NCT00384176|540615872|FG002|Overall Study|Physician Decision|0|||
149859890|NCT00384176|540615870|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
149859891|NCT00384176|540615871|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
149859892|NCT00384176|540615872|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
149859893|NCT00842530|540615873|FG000|Overall Study|Serious adverse event|0|||
149859894|NCT00842530|540615874|FG001|Overall Study|Serious adverse event|6|||
149859895|NCT00842530|540615873|FG000|Overall Study|Other adverse event|6|||
149859896|NCT00842530|540615874|FG001|Overall Study|Other adverse event|1|||
149859897|NCT00842530|540615873|FG000|Overall Study|Protocol Violation|32|||
149859898|NCT00842530|540615874|FG001|Overall Study|Protocol Violation|14|||
149859899|NCT00842530|540615873|FG000|Overall Study|Lost to Follow-up|6|||
149859900|NCT00842530|540615874|FG001|Overall Study|Lost to Follow-up|8|||
149859901|NCT00842530|540615873|FG000|Overall Study|Withdrawal by Subject|73|||
149859902|NCT00842530|540615874|FG001|Overall Study|Withdrawal by Subject|28|||
149859903|NCT02939950|540615875|FG000|Overall Study|Lost to Follow-up|13|||
149859904|NCT02939950|540615876|FG001|Overall Study|Lost to Follow-up|16|||
149859905|NCT02939950|540615875|FG000|Overall Study|Positive slit lamp findings|0|||
149859906|NCT02939950|540615876|FG001|Overall Study|Positive slit lamp findings|1|||
149859907|NCT02939950|540615875|FG000|Overall Study|Chalazion upper lid|0|||
149859908|NCT02939950|540615876|FG001|Overall Study|Chalazion upper lid|1|||
149859909|NCT02939950|540615875|FG000|Overall Study|Lack of motivation|0|||
149859910|NCT02939950|540615876|FG001|Overall Study|Lack of motivation|2|||
149859911|NCT02939950|540615875|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
149859912|NCT02939950|540615876|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
149859913|NCT02939950|540615875|FG000|Overall Study|Military orders|1|||
149859914|NCT02939950|540615876|FG001|Overall Study|Military orders|0|||
149859915|NCT02939950|540615875|FG000|Overall Study|Participant Relocated|5|||
149859916|NCT02939950|540615876|FG001|Overall Study|Participant Relocated|3|||
149859917|NCT02939950|540615875|FG000|Overall Study|Study related symptoms|8|||
149859918|NCT02939950|540615876|FG001|Overall Study|Study related symptoms|8|||
149859919|NCT02939950|540615875|FG000|Overall Study|Unacceptable lens movement|2|||
149859920|NCT02939950|540615876|FG001|Overall Study|Unacceptable lens movement|0|||
149859921|NCT02939950|540615875|FG000|Overall Study|Protocol Violation|6|||
149859922|NCT02939950|540615876|FG001|Overall Study|Protocol Violation|3|||
149859923|NCT02939950|540615875|FG000|Overall Study|Physician Decision|2|||
149859924|NCT02939950|540615876|FG001|Overall Study|Physician Decision|0|||
149859925|NCT02939950|540615875|FG000|Overall Study|Pregnancy|6|||
149859926|NCT02939950|540615876|FG001|Overall Study|Pregnancy|7|||
149859927|NCT02939950|540615875|FG000|Overall Study|Withdrawal by Subject|12|||
149859928|NCT02939950|540615876|FG001|Overall Study|Withdrawal by Subject|28|||
149859929|NCT02939950|540615875|FG000|Overall Study|Adverse Event|7|||
149859930|NCT02939950|540615876|FG001|Overall Study|Adverse Event|3|||
149859931|NCT02939950|540615875|FG000|Overall Study|Randomized, not dispensed|1|||
149859932|NCT02939950|540615876|FG001|Overall Study|Randomized, not dispensed|0|||
149859933|NCT02939950|540615875|FG000|Overall Study|Ineligible at Baseline|2|||
149859934|NCT02939950|540615876|FG001|Overall Study|Ineligible at Baseline|8|||
149859935|NCT00440115|540615877|FG000|Overall Study|Death|7|||
149859936|NCT00440115|540615878|FG001|Overall Study|Death|9|||
149859937|NCT00440115|540615879|FG002|Overall Study|Death|5|||
149859938|NCT00440115|540615877|FG000|Overall Study|Incarceration|0|||
149859939|NCT00440115|540615878|FG001|Overall Study|Incarceration|2|||
149859940|NCT00440115|540615879|FG002|Overall Study|Incarceration|1|||
149859941|NCT02377063|540615880|FG000|Overall Study|Non-compliance|5|||
149859942|NCT01524913|540615881|FG000|Overall Study|Lost to Follow-up|4|||
149859943|NCT01524913|540615882|FG001|Overall Study|Lost to Follow-up|0|||
149859944|NCT01524913|540615883|FG002|Overall Study|Lost to Follow-up|0|||
149859945|NCT00702208|540615884|FG000|Overall Study|Lost to Follow-up|28|||
149859946|NCT00702208|540615884|FG000|Overall Study|Did not self-lavage|1|||
149859947|NCT00702208|540615884|FG000|Overall Study|Unsatisfactory colposcopy|2|||
149859948|NCT00402025|540615886|FG000|Overall Study|Adverse Event|0|||
149859949|NCT00402025|540615887|FG001|Overall Study|Adverse Event|0|||
149859950|NCT00402025|540615888|FG002|Overall Study|Adverse Event|2|||
149859951|NCT00402025|540615886|FG000|Overall Study|Death|0|||
149859952|NCT00402025|540615887|FG001|Overall Study|Death|1|||
149859953|NCT00402025|540615888|FG002|Overall Study|Death|5|||
150291179|NCT03310957|542200353|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
150291180|NCT03310957|542200354|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
150291181|NCT03310957|542200355|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
150291182|NCT03310957|542200356|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
150291183|NCT03310957|542200357|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
150291184|NCT03310957|542200351|FG000|Overall Study|Treatment landscape|0|||
150291185|NCT03310957|542200352|FG001|Overall Study|Treatment landscape|0|||
150291186|NCT03310957|542200353|FG002|Overall Study|Treatment landscape|1|||
150291187|NCT03310957|542200354|FG003|Overall Study|Treatment landscape|1|||
150291188|NCT03310957|542200355|FG004|Overall Study|Treatment landscape|0|||
150291189|NCT03310957|542200356|FG005|Overall Study|Treatment landscape|1|||
150291190|NCT03310957|542200357|FG006|Overall Study|Treatment landscape|0|||
150291191|NCT03310957|542200351|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
149859954|NCT00402025|540615886|FG000|Overall Study|Disease Progression|1|||
149859955|NCT00402025|540615887|FG001|Overall Study|Disease Progression|1|||
149859956|NCT00402025|540615888|FG002|Overall Study|Disease Progression|2|||
149859957|NCT00402025|540615886|FG000|Overall Study|Physician Decision|1|||
149859958|NCT00402025|540615887|FG001|Overall Study|Physician Decision|1|||
149859959|NCT00402025|540615888|FG002|Overall Study|Physician Decision|0|||
149859960|NCT00402025|540615886|FG000|Overall Study|Participant Decision|0|||
149859961|NCT00402025|540615887|FG001|Overall Study|Participant Decision|0|||
149859962|NCT00402025|540615888|FG002|Overall Study|Participant Decision|1|||
149859963|NCT03078478|540615898|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
149859964|NCT03078478|540615899|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
149859965|NCT03078478|540615898|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
149859966|NCT03078478|540615899|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
149859967|NCT03078478|540615898|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
149859968|NCT03078478|540615899|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
149859969|NCT03078478|540615898|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
149859970|NCT03078478|540615899|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
149859971|NCT03078478|540615898|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
149859972|NCT03078478|540615899|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
149859973|NCT03078478|540615898|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
149859974|NCT03078478|540615899|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
149859975|NCT03078478|540615898|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
149859976|NCT03078478|540615899|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
149859977|NCT03078478|540615898|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
149859978|NCT03078478|540615899|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
149859979|NCT01172821|540615902|FG000|Overall Study|Adverse Event|5|||
149859980|NCT01172821|540615903|FG001|Overall Study|Adverse Event|2|||
149859981|NCT01172821|540615904|FG002|Overall Study|Adverse Event|2|||
149859982|NCT01172821|540615905|FG003|Overall Study|Adverse Event|7|||
149859983|NCT01172821|540615902|FG000|Overall Study|Protocol Violation|0|||
149859984|NCT01172821|540615903|FG001|Overall Study|Protocol Violation|2|||
149859985|NCT01172821|540615904|FG002|Overall Study|Protocol Violation|1|||
149859986|NCT01172821|540615905|FG003|Overall Study|Protocol Violation|2|||
149961581|NCT00968968|540992129|FG000|Overall Study|Withdrawal by Subject|2|||
149961582|NCT00968968|540992130|FG001|Overall Study|Withdrawal by Subject|0|||
149961583|NCT00968968|540992129|FG000|Overall Study|Physician Decision|1|||
149961584|NCT00968968|540992130|FG001|Overall Study|Physician Decision|2|||
149961585|NCT00968968|540992129|FG000|Overall Study|Lost to Follow-up|0|||
149961586|NCT00968968|540992130|FG001|Overall Study|Lost to Follow-up|1|||
149961587|NCT00682435|540992141|FG000|Overall Study|Insufficient data|5|||
149961588|NCT00682435|540992141|FG000|Overall Study|Erroneously enrolled twice|2|||
149961589|NCT03760666|540992142|FG000|Overall Study|Adverse Event|2|||
149961590|NCT03760666|540992143|FG001|Overall Study|Adverse Event|4|||
149961591|NCT03760666|540992144|FG002|Overall Study|Adverse Event|1|||
149961592|NCT03760666|540992142|FG000|Overall Study|AML Disease Progression|3|||
150040372|NCT00705016|541287380|FG002|Overall Study|Death|5|||
150040373|NCT00705016|541287378|FG000|Overall Study|Protocol Violation|0|||
150040374|NCT00705016|541287379|FG001|Overall Study|Protocol Violation|1|||
150040375|NCT00705016|541287380|FG002|Overall Study|Protocol Violation|1|||
150040376|NCT00705016|541287378|FG000|Overall Study|Withdrawal by Subject|4|||
150291192|NCT03310957|542200352|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
150291193|NCT03310957|542200353|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
149859987|NCT01172821|540615902|FG000|Overall Study|Lost to Follow-up|4|||
149859988|NCT01172821|540615903|FG001|Overall Study|Lost to Follow-up|1|||
149859989|NCT01172821|540615904|FG002|Overall Study|Lost to Follow-up|2|||
149961593|NCT03760666|540992143|FG001|Overall Study|AML Disease Progression|3|||
149859990|NCT01172821|540615905|FG003|Overall Study|Lost to Follow-up|2|||
149859991|NCT01172821|540615902|FG000|Overall Study|Withdrawal by Subject|2|||
149961594|NCT03760666|540992144|FG002|Overall Study|AML Disease Progression|0|||
149961595|NCT03760666|540992142|FG000|Overall Study|Physician Decision|0|||
149961596|NCT03760666|540992143|FG001|Overall Study|Physician Decision|3|||
150040377|NCT00705016|541287379|FG001|Overall Study|Withdrawal by Subject|3|||
150173557|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173558|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173559|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173560|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173561|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173562|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
150173563|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
150173564|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
150173565|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
150173566|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
150173567|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
150173568|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173569|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173570|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173571|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
149859992|NCT01172821|540615903|FG001|Overall Study|Withdrawal by Subject|3|||
149859993|NCT01172821|540615904|FG002|Overall Study|Withdrawal by Subject|3|||
149859994|NCT01172821|540615905|FG003|Overall Study|Withdrawal by Subject|3|||
149859995|NCT01172821|540615902|FG000|Overall Study|Other|3|||
149859996|NCT01172821|540615903|FG001|Overall Study|Other|4|||
149859997|NCT01172821|540615904|FG002|Overall Study|Other|5|||
149859998|NCT01172821|540615905|FG003|Overall Study|Other|3|||
149859999|NCT02953678|540615908|FG000|Overall Study|Adverse Event|20|||
149860000|NCT02953678|540615908|FG000|Overall Study|Death|7|||
149860001|NCT02953678|540615908|FG000|Overall Study|Physician Decision|23|||
149860002|NCT02953678|540615908|FG000|Overall Study|Progressive Disease of GVHD|7|||
149860003|NCT02953678|540615908|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
149860004|NCT02953678|540615908|FG000|Overall Study|Withdrawal by participant|3|||
149860005|NCT02953678|540615908|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
149860006|NCT02953678|540615908|FG000|Overall Study|Participants were transferred to commercial product.|3|||
149860007|NCT03064438|540618084|FG000|Overall Study|Lost to Follow-up|1|||
149961597|NCT03760666|540992144|FG002|Overall Study|Physician Decision|0|||
149860008|NCT03064438|540618085|FG001|Overall Study|Lost to Follow-up|0|||
149860009|NCT03064438|540618084|FG000|Overall Study|Withdrawal by Subject|0|||
149860010|NCT03064438|540618085|FG001|Overall Study|Withdrawal by Subject|1|||
149860011|NCT01937351|540618086|FG000|Overall Study|Withdrawal by Subject|4|||
149860012|NCT01937351|540618087|FG001|Overall Study|Withdrawal by Subject|2|||
149860013|NCT01937351|540618086|FG000|Overall Study|Death|1|||
149860014|NCT01937351|540618087|FG001|Overall Study|Death|0|||
149860015|NCT01937351|540618086|FG000|Overall Study|Not treated w device, per protocol fail|4|||
149860016|NCT01937351|540618087|FG001|Overall Study|Not treated w device, per protocol fail|0|||
149860017|NCT01432574|540618088|FG000|Overall Study|Moved|2|||
149860018|NCT01432574|540618088|FG000|Overall Study|Not interested|1|||
149860019|NCT01042535|540618089|FG000|Overall Study|disease progression prior to treatment|3|||
149860020|NCT01042535|540618089|FG000|Overall Study|disease progression during treatment|3|||
149860021|NCT01042535|540618089|FG000|Overall Study|complications from other disease|2|||
149860022|NCT00107042|540618092|FG000|Overall Study|Lost to Follow-up|9|||
149860023|NCT00107042|540618093|FG001|Overall Study|Lost to Follow-up|7|||
149860024|NCT00107042|540618092|FG000|Overall Study|Withdrawal by Subject|6|||
149860025|NCT00107042|540618093|FG001|Overall Study|Withdrawal by Subject|1|||
149860026|NCT00107042|540618092|FG000|Overall Study|Moved out of area|5|||
149860027|NCT00107042|540618093|FG001|Overall Study|Moved out of area|3|||
149860028|NCT00107042|540618092|FG000|Overall Study|Pregnancy|1|||
149860029|NCT00107042|540618093|FG001|Overall Study|Pregnancy|1|||
149860030|NCT00107042|540618092|FG000|Overall Study|Inadvertent enrollment|0|||
149860031|NCT00107042|540618093|FG001|Overall Study|Inadvertent enrollment|1|||
149860032|NCT00107042|540618092|FG000|Overall Study|vaccinated outside window|1|||
149860033|NCT00107042|540618093|FG001|Overall Study|vaccinated outside window|1|||
149860034|NCT00107042|540618092|FG000|Overall Study|Disallowed medications|0|||
149860035|NCT00107042|540618093|FG001|Overall Study|Disallowed medications|2|||
149860036|NCT03919448|540618094|FG000|Overall Study|Withdrawal by Subject|1|||
149860037|NCT03919448|540618095|FG001|Overall Study|Withdrawal by Subject|0|||
149860038|NCT03919448|540618096|FG002|Overall Study|Withdrawal by Subject|0|||
149860039|NCT03438539|540618098|FG000|Overall Study|Lost to Follow-up|8|||
149860040|NCT03438539|540618099|FG001|Overall Study|Lost to Follow-up|4|||
149860041|NCT03438539|540618100|FG002|Overall Study|Lost to Follow-up|10|||
149860042|NCT03438539|540618101|FG003|Overall Study|Lost to Follow-up|9|||
149860043|NCT03438539|540618102|FG004|Overall Study|Lost to Follow-up|3|||
149860044|NCT03438539|540618103|FG005|Overall Study|Lost to Follow-up|8|||
149860045|NCT01221090|540618104|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
149860046|NCT01221090|540618105|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
150040378|NCT00705016|541287380|FG002|Overall Study|Withdrawal by Subject|2|||
150040379|NCT00705016|541287378|FG000|Overall Study|Progressive Disease|33|||
150040380|NCT00705016|541287379|FG001|Overall Study|Progressive Disease|29|||
150040381|NCT00705016|541287380|FG002|Overall Study|Progressive Disease|33|||
150040382|NCT00705016|541287378|FG000|Overall Study|Symptomatic Deterioration|3|||
150040383|NCT00705016|541287379|FG001|Overall Study|Symptomatic Deterioration|1|||
150040384|NCT00705016|541287380|FG002|Overall Study|Symptomatic Deterioration|1|||
150040385|NCT00705016|541287378|FG000|Overall Study|Other|9|||
150040386|NCT00705016|541287379|FG001|Overall Study|Other|6|||
149860047|NCT01221090|540618106|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
150040387|NCT00705016|541287380|FG002|Overall Study|Other|6|||
150040388|NCT00942604|541287383|FG000|Overall Study|Protocol Violation|1|||
150040389|NCT00942604|541287384|FG001|Overall Study|Protocol Violation|1|||
150040390|NCT00942604|541287383|FG000|Overall Study|Adverse Event|0|||
150040391|NCT00942604|541287384|FG001|Overall Study|Adverse Event|1|||
150040392|NCT00942604|541287383|FG000|Overall Study|Withdrawal by Subject|0|||
150040393|NCT00942604|541287384|FG001|Overall Study|Withdrawal by Subject|1|||
150040394|NCT00942604|541287383|FG000|Overall Study|Patient relocation|1|||
150040395|NCT00942604|541287384|FG001|Overall Study|Patient relocation|1|||
150040396|NCT01663103|541287385|FG000|Overall Study|Withdrawal by Subject|1|||
150040397|NCT01663103|541287386|FG001|Overall Study|Withdrawal by Subject|2|||
150040398|NCT01663103|541287385|FG000|Overall Study|Adverse Event|1|||
150040399|NCT01663103|541287386|FG001|Overall Study|Adverse Event|0|||
150040400|NCT01663103|541287385|FG000|Overall Study|dog bite|1|||
150040401|NCT01663103|541287386|FG001|Overall Study|dog bite|0|||
150040402|NCT01656408|541287387|FG000|Overall Study|Adverse Event|0|||
150040403|NCT01656408|541287388|FG001|Overall Study|Adverse Event|0|||
150040404|NCT01656408|541287389|FG002|Overall Study|Adverse Event|1|||
150040405|NCT01656408|541287390|FG003|Overall Study|Adverse Event|0|||
150040406|NCT01656408|541287391|FG004|Overall Study|Adverse Event|0|||
150040407|NCT01656408|541287392|FG005|Overall Study|Adverse Event|1|||
150040408|NCT01656408|541287393|FG006|Overall Study|Adverse Event|1|||
150040409|NCT01656408|541287394|FG007|Overall Study|Adverse Event|0|||
150040410|NCT01656408|541287395|FG008|Overall Study|Adverse Event|1|||
150040411|NCT01656408|541287396|FG009|Overall Study|Adverse Event|0|||
150040412|NCT01656408|541287387|FG000|Overall Study|Physician Decision|1|||
150040413|NCT01656408|541287388|FG001|Overall Study|Physician Decision|0|||
150040414|NCT01656408|541287389|FG002|Overall Study|Physician Decision|1|||
150040415|NCT01656408|541287390|FG003|Overall Study|Physician Decision|0|||
150040416|NCT01656408|541287391|FG004|Overall Study|Physician Decision|1|||
150040417|NCT01656408|541287392|FG005|Overall Study|Physician Decision|1|||
150040418|NCT01656408|541287393|FG006|Overall Study|Physician Decision|0|||
150040419|NCT01656408|541287394|FG007|Overall Study|Physician Decision|1|||
150040420|NCT01656408|541287395|FG008|Overall Study|Physician Decision|1|||
150040421|NCT01656408|541287396|FG009|Overall Study|Physician Decision|3|||
150040422|NCT00363480|541287397|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
149860048|NCT01221090|540618107|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
149860049|NCT01221090|540618104|FG000|Overall Study|Withdrawal by Subject|0|||
149860050|NCT01221090|540618105|FG001|Overall Study|Withdrawal by Subject|22|||
149860051|NCT01221090|540618106|FG002|Overall Study|Withdrawal by Subject|27|||
149860052|NCT01221090|540618107|FG003|Overall Study|Withdrawal by Subject|2|||
149860053|NCT00440466|540618108|FG000|Overall Study|Death|3|||
149860054|NCT00440466|540618109|FG001|Overall Study|Death|2|||
149860055|NCT00440466|540618110|FG002|Overall Study|Death|9|||
149860056|NCT00440466|540618108|FG000|Overall Study|Adverse Event|3|||
149860057|NCT00440466|540618109|FG001|Overall Study|Adverse Event|4|||
150040423|NCT00363480|541287397|FG000|Overall Study|Adverse Event|4|||
149860058|NCT00440466|540618110|FG002|Overall Study|Adverse Event|11|||
149860059|NCT00440466|540618108|FG000|Overall Study|Lost to Follow-up|1|||
150040424|NCT00363480|541287397|FG000|Overall Study|Lost to Follow-up|5|||
150040425|NCT00363480|541287397|FG000|Overall Study|Withdrawal by Subject|5|||
150040426|NCT00363480|541287397|FG000|Overall Study|Non-compliance of subject|1|||
150040427|NCT00363480|541287397|FG000|Overall Study|Participant discontinued on its own|1|||
150040428|NCT02420821|541287404|FG000|Overall Study|Lost to Follow-up|6|||
150040429|NCT02420821|541287405|FG001|Overall Study|Lost to Follow-up|6|||
150040430|NCT02420821|541287404|FG000|Overall Study|Non-compliance|0|||
150040431|NCT02420821|541287405|FG001|Overall Study|Non-compliance|2|||
150040432|NCT02420821|541287404|FG000|Overall Study|Physician Decision|6|||
149860060|NCT00440466|540618109|FG001|Overall Study|Lost to Follow-up|0|||
149860061|NCT00440466|540618110|FG002|Overall Study|Lost to Follow-up|2|||
149860062|NCT00440466|540618108|FG000|Overall Study|Physician Decision|2|||
150040433|NCT02420821|541287405|FG001|Overall Study|Physician Decision|2|||
150040434|NCT02420821|541287404|FG000|Overall Study|Withdrawal by Subject|32|||
150040435|NCT02420821|541287405|FG001|Overall Study|Withdrawal by Subject|25|||
150040436|NCT02420821|541287404|FG000|Overall Study|Death|270|||
150040437|NCT02420821|541287405|FG001|Overall Study|Death|263|||
150040438|NCT02420821|541287404|FG000|Overall Study|Study Terminated By Sponsor|145|||
150040439|NCT02420821|541287405|FG001|Overall Study|Study Terminated By Sponsor|149|||
150040440|NCT02420821|541287404|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
150040441|NCT02420821|541287405|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
150040442|NCT02420821|541287404|FG000|Overall Study|Adverse Event|0|||
150040443|NCT02420821|541287405|FG001|Overall Study|Adverse Event|1|||
150040444|NCT02420821|541287404|FG000|Overall Study|Protinuria|0|||
150040445|NCT02420821|541287405|FG001|Overall Study|Protinuria|1|||
150040446|NCT02420821|541287404|FG000|Overall Study|Progressive Disease|1|||
150040447|NCT02420821|541287405|FG001|Overall Study|Progressive Disease|1|||
150040448|NCT02420821|541287404|FG000|Overall Study|Disease Progression|0|||
150040449|NCT02420821|541287405|FG001|Overall Study|Disease Progression|1|||
150040450|NCT02420821|541287404|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
150040451|NCT02420821|541287405|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
150040452|NCT00888940|541287412|FG000|Overall Study|Adverse Event|12|||
150040453|NCT00888940|541287413|FG001|Overall Study|Adverse Event|3|||
150040454|NCT00888940|541287412|FG000|Overall Study|Lost to Follow-up|5|||
150040455|NCT00888940|541287413|FG001|Overall Study|Lost to Follow-up|5|||
150040456|NCT00888940|541287412|FG000|Overall Study|Randomized Not Treated|11|||
150040457|NCT00888940|541287413|FG001|Overall Study|Randomized Not Treated|13|||
150040458|NCT03815929|541287418|FG000|Overall Study|Lost to Follow-up|2|||
150040459|NCT03815929|541287419|FG001|Overall Study|Lost to Follow-up|1|||
150040460|NCT03815929|541287420|FG002|Overall Study|Lost to Follow-up|0|||
150040461|NCT03815929|541287418|FG000|Overall Study|Physician Decision|2|||
150040462|NCT03815929|541287419|FG001|Overall Study|Physician Decision|2|||
150040463|NCT03815929|541287420|FG002|Overall Study|Physician Decision|0|||
150040464|NCT03815929|541287418|FG000|Overall Study|Withdrawal by Subject|0|||
150040465|NCT03815929|541287419|FG001|Overall Study|Withdrawal by Subject|0|||
150040466|NCT03815929|541287420|FG002|Overall Study|Withdrawal by Subject|1|||
150040467|NCT03313037|541287421|FG000|Overall Study|Protocol Violation|4|||
150040468|NCT03313037|541287422|FG001|Overall Study|Protocol Violation|1|||
150040469|NCT03313037|541287421|FG000|Overall Study|Other|1|||
149860063|NCT00440466|540618109|FG001|Overall Study|Physician Decision|0|||
149860064|NCT00440466|540618110|FG002|Overall Study|Physician Decision|1|||
149860065|NCT00440466|540618108|FG000|Overall Study|Protocol Violation|2|||
149860066|NCT00440466|540618109|FG001|Overall Study|Protocol Violation|0|||
149860067|NCT00440466|540618110|FG002|Overall Study|Protocol Violation|4|||
149860068|NCT00440466|540618108|FG000|Overall Study|Withdrawal by Subject|2|||
149860069|NCT00440466|540618109|FG001|Overall Study|Withdrawal by Subject|5|||
149860070|NCT00440466|540618110|FG002|Overall Study|Withdrawal by Subject|9|||
149860071|NCT00440466|540618108|FG000|Overall Study|Began Dialysis|0|||
149860072|NCT00440466|540618109|FG001|Overall Study|Began Dialysis|0|||
149860073|NCT00440466|540618110|FG002|Overall Study|Began Dialysis|1|||
149860074|NCT00440466|540618108|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
149860075|NCT00440466|540618109|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
149860076|NCT00440466|540618110|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
149860077|NCT00655850|540618111|FG000|Overall Study|Death|2|||
149860078|NCT00655850|540618111|FG000|Overall Study|Withdrawal by Subject|1|||
149860079|NCT00140413|540618112|FG000|Overall Study|Lost to Follow-up|1|||
150040470|NCT03313037|541287422|FG001|Overall Study|Other|1|||
150040471|NCT03313037|541287421|FG000|Overall Study|Withdrawal by Subject|4|||
150040472|NCT03313037|541287422|FG001|Overall Study|Withdrawal by Subject|3|||
150040473|NCT03313037|541287421|FG000|Overall Study|No longer meets eligibility criteria|1|||
150040474|NCT03313037|541287422|FG001|Overall Study|No longer meets eligibility criteria|7|||
150040475|NCT03313037|541287421|FG000|Overall Study|Lost to Follow-up|9|||
150040476|NCT03313037|541287422|FG001|Overall Study|Lost to Follow-up|8|||
150040477|NCT03313037|541287421|FG000|Overall Study|Randomized but not treated|1|||
150291194|NCT03310957|542200354|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
150291195|NCT03310957|542200355|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
150291196|NCT03310957|542200356|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
150291197|NCT03310957|542200357|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
150291198|NCT03310957|542200351|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
150291199|NCT03310957|542200352|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
149860080|NCT00140413|540618113|FG001|Overall Study|Lost to Follow-up|0|||
149860081|NCT00140413|540618112|FG000|Overall Study|Withdrawal by Subject|2|||
149860082|NCT00140413|540618113|FG001|Overall Study|Withdrawal by Subject|0|||
149860083|NCT02459665|540618114|FG000|Overall Study|Withdrawal by Subject|0|||
150040478|NCT03313037|541287422|FG001|Overall Study|Randomized but not treated|0|||
150040479|NCT02760498|541287423|FG000|Overall Study|Adverse Event|3|||
150040480|NCT02760498|541287424|FG001|Overall Study|Adverse Event|3|||
150040481|NCT02760498|541287425|FG002|Overall Study|Adverse Event|1|||
150040482|NCT02760498|541287426|FG003|Overall Study|Adverse Event|1|||
150291200|NCT03310957|542200353|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
149860084|NCT02459665|540618115|FG001|Overall Study|Withdrawal by Subject|1|||
149860085|NCT02459665|540618116|FG002|Overall Study|Withdrawal by Subject|1|||
149860086|NCT02459665|540618117|FG003|Overall Study|Withdrawal by Subject|2|||
150040483|NCT02760498|541287427|FG004|Overall Study|Adverse Event|0|||
150173572|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149860087|NCT01223235|540618120|FG000|Overall Study|Withdrawal by Subject|1|||
149860088|NCT00865098|540618122|FG000|Overall Study|Progressive disease|1|||
149860089|NCT00099268|540618123|FG000|Overall Study|Withdrawal by Subject|46|||
149860090|NCT00099268|540618124|FG001|Overall Study|Withdrawal by Subject|28|||
149860091|NCT00099268|540618123|FG000|Overall Study|Adverse Event|19|||
149860092|NCT00099268|540618124|FG001|Overall Study|Adverse Event|19|||
149860093|NCT00099268|540618123|FG000|Overall Study|Protocol Violation|9|||
149860094|NCT00099268|540618124|FG001|Overall Study|Protocol Violation|8|||
149860095|NCT00099268|540618123|FG000|Overall Study|Lost to Follow-up|6|||
149860096|NCT00099268|540618124|FG001|Overall Study|Lost to Follow-up|4|||
149860097|NCT00099268|540618123|FG000|Overall Study|Lack of Efficacy|5|||
149860098|NCT00099268|540618124|FG001|Overall Study|Lack of Efficacy|18|||
149860099|NCT00099268|540618123|FG000|Overall Study|Administrative problems|4|||
149860100|NCT00099268|540618124|FG001|Overall Study|Administrative problems|4|||
149860101|NCT00099268|540618123|FG000|Overall Study|Death|3|||
149860102|NCT00099268|540618124|FG001|Overall Study|Death|1|||
149860103|NCT01360866|540618125|FG000|Overall Study|Lost to Follow-up|11|||
149860104|NCT01360866|540618126|FG001|Overall Study|Lost to Follow-up|28|||
149860105|NCT01360866|540618127|FG002|Overall Study|Lost to Follow-up|41|||
149860106|NCT01360866|540618128|FG003|Overall Study|Lost to Follow-up|0|||
149860107|NCT01360866|540618125|FG000|Overall Study|Adverse Event|56|||
149860108|NCT01360866|540618126|FG001|Overall Study|Adverse Event|61|||
149860109|NCT01360866|540618127|FG002|Overall Study|Adverse Event|134|||
149860110|NCT01360866|540618128|FG003|Overall Study|Adverse Event|6|||
149860111|NCT01360866|540618125|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
149860112|NCT01360866|540618126|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
149860113|NCT01360866|540618127|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
149860114|NCT01360866|540618128|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
149860115|NCT01360866|540618125|FG000|Overall Study|Withdrawn by Investigator|9|||
149860116|NCT01360866|540618126|FG001|Overall Study|Withdrawn by Investigator|8|||
149860117|NCT01360866|540618127|FG002|Overall Study|Withdrawn by Investigator|31|||
149860118|NCT01360866|540618128|FG003|Overall Study|Withdrawn by Investigator|2|||
149860119|NCT01360866|540618125|FG000|Overall Study|Withdrawal by participant|79|||
149860120|NCT01360866|540618126|FG001|Overall Study|Withdrawal by participant|89|||
149860121|NCT01360866|540618127|FG002|Overall Study|Withdrawal by participant|168|||
149860122|NCT01360866|540618128|FG003|Overall Study|Withdrawal by participant|8|||
149860123|NCT01360866|540618125|FG000|Overall Study|Protocol Deviation|25|||
149860124|NCT01360866|540618126|FG001|Overall Study|Protocol Deviation|33|||
149860125|NCT01360866|540618127|FG002|Overall Study|Protocol Deviation|61|||
149860126|NCT01360866|540618128|FG003|Overall Study|Protocol Deviation|2|||
149860127|NCT01360866|540618125|FG000|Overall Study|Lack of Efficacy|30|||
149860128|NCT01360866|540618126|FG001|Overall Study|Lack of Efficacy|40|||
149860129|NCT01360866|540618127|FG002|Overall Study|Lack of Efficacy|30|||
149860130|NCT01360866|540618128|FG003|Overall Study|Lack of Efficacy|4|||
149860131|NCT03702049|540618129|FG000|Overall Study|Lost to Follow-up|4|||
149860132|NCT03702049|540618129|FG000|Overall Study|Physician Decision|1|||
149860133|NCT00918463|540618135|FG000|Overall Study|Death|1|||
149860134|NCT00918463|540618135|FG000|Overall Study|Lack of Efficacy|1|||
149860135|NCT01014624|540618139|FG000|Overall Study|Adverse Event|0|||
149860136|NCT01014624|540618140|FG001|Overall Study|Adverse Event|1|||
149860137|NCT01014624|540618139|FG000|Overall Study|Protocol Violation|1|||
149860138|NCT01014624|540618140|FG001|Overall Study|Protocol Violation|0|||
149860139|NCT01014624|540618139|FG000|Overall Study|Withdrawal by Subject|1|||
150291201|NCT03310957|542200354|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
150291202|NCT03310957|542200355|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
150291203|NCT03310957|542200356|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
150291204|NCT03310957|542200357|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
150291205|NCT03310957|542200351|FG000|Overall Study|Hospice|0|||
149860140|NCT01014624|540618140|FG001|Overall Study|Withdrawal by Subject|0|||
149860141|NCT01715896|540618141|FG000|Overall Study|Lost to Follow-up|0|||
149860142|NCT01715896|540618142|FG001|Overall Study|Lost to Follow-up|2|||
149860143|NCT01715896|540618141|FG000|Overall Study|Withdrawal by Subject|1|||
149860144|NCT01715896|540618142|FG001|Overall Study|Withdrawal by Subject|4|||
149860145|NCT01715896|540618141|FG000|Overall Study|Other|2|||
149860146|NCT01715896|540618142|FG001|Overall Study|Other|5|||
149860147|NCT03336242|540618148|FG000|Overall Study|Adverse Event|0|||
149860148|NCT03336242|540618149|FG001|Overall Study|Adverse Event|1|||
149860149|NCT02457611|540618151|FG000|Overall Study|Lost to Follow-up|3|||
149860150|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
149860151|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
149860152|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
149860153|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
149860154|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
149860155|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
149860156|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
149860157|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
150291206|NCT03310957|542200352|FG001|Overall Study|Hospice|0|||
150040484|NCT02760498|541287428|FG005|Overall Study|Adverse Event|6|||
149860158|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
149860159|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
149860160|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
149860161|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
150291207|NCT03310957|542200353|FG002|Overall Study|Hospice|0|||
150291208|NCT03310957|542200354|FG003|Overall Study|Hospice|0|||
150291209|NCT03310957|542200355|FG004|Overall Study|Hospice|0|||
150291210|NCT03310957|542200356|FG005|Overall Study|Hospice|1|||
150291211|NCT03310957|542200357|FG006|Overall Study|Hospice|0|||
150291212|NCT03310957|542200351|FG000|Overall Study|Progressive|0|||
150291213|NCT03310957|542200352|FG001|Overall Study|Progressive|0|||
150291214|NCT03310957|542200353|FG002|Overall Study|Progressive|1|||
149860162|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
149860163|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
149860164|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
149860165|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
149860166|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
149860167|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
149860168|NCT00384293|540618152|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
149860169|NCT00384293|540618153|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
149860170|NCT00384293|540618154|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
149860171|NCT00384293|540618152|FG000|Post-randomization Period|Adverse Event|0|||
149860172|NCT00384293|540618153|FG001|Post-randomization Period|Adverse Event|23|||
149860173|NCT00384293|540618154|FG002|Post-randomization Period|Adverse Event|7|||
149860174|NCT00384293|540618152|FG000|Post-randomization Period|Lost to Follow-up|0|||
149860175|NCT00384293|540618153|FG001|Post-randomization Period|Lost to Follow-up|2|||
149860176|NCT00384293|540618154|FG002|Post-randomization Period|Lost to Follow-up|1|||
149860177|NCT00384293|540618152|FG000|Post-randomization Period|Protocol Violation|0|||
149860178|NCT00384293|540618153|FG001|Post-randomization Period|Protocol Violation|1|||
149860179|NCT00384293|540618154|FG002|Post-randomization Period|Protocol Violation|0|||
149860180|NCT00384293|540618152|FG000|Post-randomization Period|Withdrawal by Subject|0|||
149860181|NCT00384293|540618153|FG001|Post-randomization Period|Withdrawal by Subject|8|||
149860182|NCT00384293|540618154|FG002|Post-randomization Period|Withdrawal by Subject|6|||
149860183|NCT00384293|540618152|FG000|Post-randomization Period|Trial Termination|0|||
149860184|NCT00384293|540618153|FG001|Post-randomization Period|Trial Termination|180|||
149860185|NCT00384293|540618154|FG002|Post-randomization Period|Trial Termination|204|||
149860186|NCT00384293|540618152|FG000|Post-randomization Period|Patient Randomized in Error|0|||
149860187|NCT00384293|540618153|FG001|Post-randomization Period|Patient Randomized in Error|0|||
149860188|NCT00384293|540618154|FG002|Post-randomization Period|Patient Randomized in Error|1|||
149860189|NCT03005067|540618155|FG000|Overall Study|Withdrawal by Subject|3|||
149860190|NCT03005067|540618156|FG001|Overall Study|Withdrawal by Subject|2|||
149860191|NCT03005067|540618155|FG000|Overall Study|Adverse Event|4|||
149860192|NCT03005067|540618156|FG001|Overall Study|Adverse Event|3|||
149860193|NCT03005067|540618155|FG000|Overall Study|Other (reason not specified)|3|||
149860194|NCT03005067|540618156|FG001|Overall Study|Other (reason not specified)|1|||
149860195|NCT03005067|540618155|FG000|Overall Study|Protocol Violation|0|||
149961598|NCT03760666|540992142|FG000|Overall Study|Withdrawal by Subject|0|||
149961599|NCT03760666|540992143|FG001|Overall Study|Withdrawal by Subject|1|||
149961600|NCT03760666|540992144|FG002|Overall Study|Withdrawal by Subject|0|||
149961601|NCT01800058|540992150|FG000|Overall Study|Lost to Follow-up|1|||
149961602|NCT00800384|540992151|FG000|Overall Study|Withdrawal by Subject|24|||
149961603|NCT00800384|540992152|FG001|Overall Study|Withdrawal by Subject|17|||
149961604|NCT00800384|540992151|FG000|Overall Study|Lost to Follow-up|17|||
149961605|NCT00800384|540992152|FG001|Overall Study|Lost to Follow-up|26|||
149961606|NCT01064622|540992153|FG000|Randomized Phase II|Withdrawal by Subject|2|||
149961607|NCT01064622|540992154|FG001|Randomized Phase II|Withdrawal by Subject|2|||
149961608|NCT01064622|540992153|FG000|Randomized Phase II|Protocol Violation|0|||
149961609|NCT01064622|540992154|FG001|Randomized Phase II|Protocol Violation|1|||
150291215|NCT03310957|542200354|FG003|Overall Study|Progressive|0|||
150291216|NCT03310957|542200355|FG004|Overall Study|Progressive|0|||
150291217|NCT03310957|542200356|FG005|Overall Study|Progressive|0|||
149860196|NCT03005067|540618156|FG001|Overall Study|Protocol Violation|1|||
149860197|NCT00296491|540618157|FG000|Overall Study|Low Pollen Counts|18|||
149961610|NCT02946996|540992157|FG000|Overall Study|non-evaluable|3|||
149961611|NCT02946996|540992158|FG001|Overall Study|non-evaluable|6|||
149961612|NCT02946996|540992159|FG002|Overall Study|non-evaluable|5|||
150040485|NCT02760498|541287423|FG000|Overall Study|Death|7|||
150291218|NCT03310957|542200357|FG006|Overall Study|Progressive|0|||
150291219|NCT04540497|542200359|FG000|Overall Study|Adverse Event|0|||
150291220|NCT04540497|542200360|FG001|Overall Study|Adverse Event|2|||
150291221|NCT04540497|542200359|FG000|Overall Study|Lost to Follow-up|1|||
150291222|NCT04540497|542200360|FG001|Overall Study|Lost to Follow-up|0|||
150291223|NCT04540497|542200359|FG000|Overall Study|Withdrawal by Subject|1|||
150040486|NCT02760498|541287424|FG001|Overall Study|Death|5|||
150040487|NCT02760498|541287425|FG002|Overall Study|Death|5|||
150040488|NCT02760498|541287426|FG003|Overall Study|Death|7|||
150173573|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173574|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173575|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
150173576|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
150173577|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173578|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173579|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173580|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173581|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
150173582|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
150173583|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
150173584|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173585|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173586|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173587|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173588|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
150173589|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
150173590|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
150173591|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
150173592|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
150173593|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
150173594|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
150173595|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
150173596|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
150291224|NCT04540497|542200360|FG001|Overall Study|Withdrawal by Subject|1|||
150040489|NCT02760498|541287427|FG004|Overall Study|Death|0|||
150040490|NCT02760498|541287428|FG005|Overall Study|Death|23|||
150040491|NCT02760498|541287423|FG000|Overall Study|Lost to Follow-up|0|||
150040492|NCT02760498|541287424|FG001|Overall Study|Lost to Follow-up|0|||
150040493|NCT02760498|541287425|FG002|Overall Study|Lost to Follow-up|0|||
150040494|NCT02760498|541287426|FG003|Overall Study|Lost to Follow-up|0|||
150040495|NCT02760498|541287427|FG004|Overall Study|Lost to Follow-up|0|||
150040496|NCT02760498|541287428|FG005|Overall Study|Lost to Follow-up|3|||
150040497|NCT02760498|541287423|FG000|Overall Study|Non-compliance with study drug|0|||
150040498|NCT02760498|541287424|FG001|Overall Study|Non-compliance with study drug|2|||
150040499|NCT02760498|541287425|FG002|Overall Study|Non-compliance with study drug|0|||
150040500|NCT02760498|541287426|FG003|Overall Study|Non-compliance with study drug|0|||
150040501|NCT02760498|541287427|FG004|Overall Study|Non-compliance with study drug|0|||
150040502|NCT02760498|541287428|FG005|Overall Study|Non-compliance with study drug|0|||
150040503|NCT02760498|541287423|FG000|Overall Study|Participant decision|1|||
150040504|NCT02760498|541287424|FG001|Overall Study|Participant decision|4|||
150040505|NCT02760498|541287425|FG002|Overall Study|Participant decision|2|||
150040506|NCT02760498|541287426|FG003|Overall Study|Participant decision|2|||
150040507|NCT02760498|541287427|FG004|Overall Study|Participant decision|1|||
150040508|NCT02760498|541287428|FG005|Overall Study|Participant decision|6|||
150040509|NCT02760498|541287423|FG000|Overall Study|Sponsor decision|0|||
150040510|NCT02760498|541287424|FG001|Overall Study|Sponsor decision|0|||
150040511|NCT02760498|541287425|FG002|Overall Study|Sponsor decision|0|||
150040512|NCT02760498|541287426|FG003|Overall Study|Sponsor decision|3|||
150040513|NCT02760498|541287427|FG004|Overall Study|Sponsor decision|0|||
150040514|NCT02760498|541287428|FG005|Overall Study|Sponsor decision|0|||
150040515|NCT02760498|541287423|FG000|Overall Study|Physician Decision|3|||
150040516|NCT02760498|541287424|FG001|Overall Study|Physician Decision|4|||
150040517|NCT02760498|541287425|FG002|Overall Study|Physician Decision|1|||
150040518|NCT02760498|541287426|FG003|Overall Study|Physician Decision|4|||
150040519|NCT02760498|541287427|FG004|Overall Study|Physician Decision|0|||
150040520|NCT02760498|541287428|FG005|Overall Study|Physician Decision|2|||
150040521|NCT02760498|541287423|FG000|Overall Study|Disease progression|21|||
150040522|NCT02760498|541287424|FG001|Overall Study|Disease progression|19|||
150291225|NCT04540497|542200359|FG000|Overall Study|Miscellaneous|2|||
150291226|NCT04540497|542200360|FG001|Overall Study|Miscellaneous|1|||
150291227|NCT05274815|542200361|FG000|Overall Study|Adverse Event|1|||
150040523|NCT02760498|541287425|FG002|Overall Study|Disease progression|20|||
150040524|NCT02760498|541287426|FG003|Overall Study|Disease progression|18|||
150040525|NCT02760498|541287427|FG004|Overall Study|Disease progression|4|||
150040526|NCT02760498|541287428|FG005|Overall Study|Disease progression|55|||
150173597|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
150291228|NCT05274815|542200361|FG000|Overall Study|Death|2|||
150040527|NCT02760498|541287423|FG000|Overall Study|Withdrawal by Subject|4|||
150040528|NCT02760498|541287424|FG001|Overall Study|Withdrawal by Subject|7|||
150291229|NCT05274815|542200361|FG000|Overall Study|Lost to Follow-up|4|||
150291230|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
149860198|NCT00296491|540618158|FG001|Overall Study|Low Pollen Counts|26|||
149860199|NCT00296491|540618159|FG002|Overall Study|Low Pollen Counts|25|||
149860200|NCT00296491|540618160|FG003|Overall Study|Low Pollen Counts|16|||
149860201|NCT00296491|540618157|FG000|Overall Study|Protocol Violation|4|||
149860202|NCT00296491|540618158|FG001|Overall Study|Protocol Violation|6|||
149860203|NCT00296491|540618159|FG002|Overall Study|Protocol Violation|2|||
149860204|NCT00296491|540618160|FG003|Overall Study|Protocol Violation|3|||
149860205|NCT00296491|540618157|FG000|Overall Study|Adverse Event|1|||
149860206|NCT00296491|540618158|FG001|Overall Study|Adverse Event|3|||
149860207|NCT00296491|540618159|FG002|Overall Study|Adverse Event|1|||
149860208|NCT00296491|540618160|FG003|Overall Study|Adverse Event|4|||
149860209|NCT00296491|540618157|FG000|Overall Study|Withdrawn due to Asthma|0|||
149860210|NCT00296491|540618158|FG001|Overall Study|Withdrawn due to Asthma|0|||
149860211|NCT00296491|540618159|FG002|Overall Study|Withdrawn due to Asthma|0|||
149860212|NCT00296491|540618160|FG003|Overall Study|Withdrawn due to Asthma|4|||
149860213|NCT00296491|540618157|FG000|Overall Study|Withdrawal by Subject|7|||
149860214|NCT00296491|540618158|FG001|Overall Study|Withdrawal by Subject|3|||
149860215|NCT00296491|540618159|FG002|Overall Study|Withdrawal by Subject|3|||
149860216|NCT00296491|540618160|FG003|Overall Study|Withdrawal by Subject|2|||
149860217|NCT00296491|540618157|FG000|Overall Study|Non-Compliance|12|||
149860218|NCT00296491|540618158|FG001|Overall Study|Non-Compliance|13|||
149860219|NCT00296491|540618159|FG002|Overall Study|Non-Compliance|10|||
149860220|NCT00296491|540618160|FG003|Overall Study|Non-Compliance|14|||
149860221|NCT00296491|540618157|FG000|Overall Study|Lost to Follow-up|0|||
149860222|NCT00296491|540618158|FG001|Overall Study|Lost to Follow-up|2|||
149860223|NCT00296491|540618159|FG002|Overall Study|Lost to Follow-up|2|||
149860224|NCT00296491|540618160|FG003|Overall Study|Lost to Follow-up|0|||
149860225|NCT02010255|540618167|FG000|Overall Study|Death|0|||
149860226|NCT02010255|540618168|FG001|Overall Study|Death|1|||
149860227|NCT02010255|540618169|FG002|Overall Study|Death|4|||
149860228|NCT02010255|540618170|FG003|Overall Study|Death|4|||
149860229|NCT02010255|540618171|FG004|Overall Study|Death|2|||
149860230|NCT02010255|540618172|FG005|Overall Study|Death|0|||
149860231|NCT02010255|540618173|FG006|Overall Study|Death|1|||
149860232|NCT02010255|540618174|FG007|Overall Study|Death|1|||
149860233|NCT02010255|540618175|FG008|Overall Study|Death|1|||
149860234|NCT02010255|540618176|FG009|Overall Study|Death|0|||
149860235|NCT02010255|540618177|FG010|Overall Study|Death|1|||
149860236|NCT02010255|540618178|FG011|Overall Study|Death|1|||
149860237|NCT02010255|540618179|FG012|Overall Study|Death|0|||
149860238|NCT02010255|540618180|FG013|Overall Study|Death|0|||
149860239|NCT02010255|540618167|FG000|Overall Study|Lack of Efficacy|4|||
149860240|NCT02010255|540618168|FG001|Overall Study|Lack of Efficacy|1|||
149860241|NCT02010255|540618169|FG002|Overall Study|Lack of Efficacy|2|||
149860242|NCT02010255|540618170|FG003|Overall Study|Lack of Efficacy|1|||
149860243|NCT02010255|540618171|FG004|Overall Study|Lack of Efficacy|1|||
149860244|NCT02010255|540618172|FG005|Overall Study|Lack of Efficacy|0|||
149961613|NCT01245049|540992162|FG000|Overall Study|Migrated/moved from study area|0|||
149961614|NCT01245049|540992163|FG001|Overall Study|Migrated/moved from study area|1|||
149961615|NCT01245049|540992162|FG000|Overall Study|Withdrawal by Subject|0|||
149961616|NCT01245049|540992163|FG001|Overall Study|Withdrawal by Subject|1|||
149961617|NCT01245049|540992162|FG000|Overall Study|Lost to Follow-up|1|||
149961618|NCT01245049|540992163|FG001|Overall Study|Lost to Follow-up|2|||
149961619|NCT00450749|540992164|FG000|Overall Study|Withdrawal by Subject|0|||
149961620|NCT00450749|540992165|FG001|Overall Study|Withdrawal by Subject|0|||
149961621|NCT00450749|540992166|FG002|Overall Study|Withdrawal by Subject|2|||
149961622|NCT00450749|540992164|FG000|Overall Study|Noncompliant|0|||
149961623|NCT00450749|540992165|FG001|Overall Study|Noncompliant|1|||
149961624|NCT00450749|540992166|FG002|Overall Study|Noncompliant|0|||
149961625|NCT02151604|540992167|FG000|Overall Study|Lost to Follow-up|3|||
149961626|NCT02151604|540992167|FG000|Overall Study|Withdrawal by Subject|2|||
149961627|NCT02151604|540992167|FG000|Overall Study|Physician Decision|3|||
149961628|NCT02151604|540992167|FG000|Overall Study|Death|1|||
149961629|NCT00537082|540992168|FG000|Overall Study|Adverse Event|6|||
149961630|NCT00537082|540992169|FG001|Overall Study|Adverse Event|6|||
149961631|NCT00537082|540992170|FG002|Overall Study|Adverse Event|3|||
149961632|NCT00537082|540992168|FG000|Overall Study|Protocol Violation|0|||
149961633|NCT00537082|540992169|FG001|Overall Study|Protocol Violation|2|||
149961634|NCT00537082|540992170|FG002|Overall Study|Protocol Violation|1|||
149961635|NCT00537082|540992168|FG000|Overall Study|Lack of Efficacy|0|||
149961636|NCT00537082|540992169|FG001|Overall Study|Lack of Efficacy|0|||
149961637|NCT00537082|540992170|FG002|Overall Study|Lack of Efficacy|2|||
149961638|NCT00537082|540992168|FG000|Overall Study|Withdrawal by Subject|0|||
149961639|NCT00537082|540992169|FG001|Overall Study|Withdrawal by Subject|1|||
149961640|NCT00537082|540992170|FG002|Overall Study|Withdrawal by Subject|0|||
149961641|NCT00537082|540992168|FG000|Overall Study|Discontinued before initiating treatment|3|||
149961642|NCT00537082|540992169|FG001|Overall Study|Discontinued before initiating treatment|0|||
149961643|NCT00537082|540992170|FG002|Overall Study|Discontinued before initiating treatment|0|||
149961644|NCT02568254|540992172|FG000|Period 2|Adverse Event|0|||
149860245|NCT02010255|540618173|FG006|Overall Study|Lack of Efficacy|0|||
149860246|NCT02010255|540618174|FG007|Overall Study|Lack of Efficacy|0|||
149860247|NCT02010255|540618175|FG008|Overall Study|Lack of Efficacy|0|||
149860248|NCT02010255|540618176|FG009|Overall Study|Lack of Efficacy|0|||
149860249|NCT02010255|540618177|FG010|Overall Study|Lack of Efficacy|1|||
149860250|NCT02010255|540618178|FG011|Overall Study|Lack of Efficacy|0|||
149860251|NCT02010255|540618179|FG012|Overall Study|Lack of Efficacy|0|||
149860252|NCT02010255|540618180|FG013|Overall Study|Lack of Efficacy|0|||
149961645|NCT02568254|540992173|FG001|Period 2|Adverse Event|0|||
149961646|NCT02568254|540992174|FG002|Period 2|Adverse Event|1|||
149961647|NCT02568254|540992175|FG003|Period 2|Adverse Event|0|||
150291231|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
150291232|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
150291233|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
150291234|NCT05274815|542200361|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
150291235|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
150291236|NCT05274815|542200361|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
150291237|NCT05274815|542200361|FG000|Overall Study|Withdrawal by Subject|11|||
150291238|NCT06132659|542200362|FG000|Overall Study|Lost to Follow-up|0|||
150291239|NCT06132659|542200363|FG001|Overall Study|Lost to Follow-up|1|||
150291240|NCT06132659|542200364|FG002|Overall Study|Lost to Follow-up|0|||
150291241|NCT03914326|542200365|FG000|Overall Study|Withdrawal by Subject|27|||
150291242|NCT03914326|542200366|FG001|Overall Study|Withdrawal by Subject|34|||
150291243|NCT03914326|542200365|FG000|Overall Study|Lost to Follow-up|43|||
150291244|NCT03914326|542200366|FG001|Overall Study|Lost to Follow-up|51|||
150291245|NCT03914326|542200365|FG000|Overall Study|Randomised more than once|0|||
150291246|NCT03914326|542200366|FG001|Overall Study|Randomised more than once|1|||
150291247|NCT04478708|542200367|FG000|Overall Study|Lost to Follow-up|0|||
150291248|NCT04478708|542200368|FG001|Overall Study|Lost to Follow-up|0|||
150291249|NCT04478708|542200369|FG002|Overall Study|Lost to Follow-up|0|||
150291250|NCT04478708|542200370|FG003|Overall Study|Lost to Follow-up|0|||
150291251|NCT04478708|542200371|FG004|Overall Study|Lost to Follow-up|0|||
150291252|NCT04478708|542200372|FG005|Overall Study|Lost to Follow-up|0|||
150291253|NCT04478708|542200373|FG006|Overall Study|Lost to Follow-up|0|||
150291254|NCT04478708|542200374|FG007|Overall Study|Lost to Follow-up|0|||
150291255|NCT04478708|542200375|FG008|Overall Study|Lost to Follow-up|1|||
150291256|NCT04478708|542200376|FG009|Overall Study|Lost to Follow-up|1|||
150291257|NCT04478708|542200377|FG010|Overall Study|Lost to Follow-up|1|||
150291258|NCT04478708|542200378|FG011|Overall Study|Lost to Follow-up|2|||
150291259|NCT04478708|542200379|FG012|Overall Study|Lost to Follow-up|1|||
150291260|NCT04478708|542200380|FG013|Overall Study|Lost to Follow-up|0|||
150291261|NCT04478708|542200381|FG014|Overall Study|Lost to Follow-up|0|||
150291262|NCT04478708|542200382|FG015|Overall Study|Lost to Follow-up|0|||
150291263|NCT04478708|542200383|FG016|Overall Study|Lost to Follow-up|0|||
150291264|NCT04478708|542200367|FG000|Overall Study|Withdrawal of consent from study|0|||
150291265|NCT04478708|542200368|FG001|Overall Study|Withdrawal of consent from study|1|||
150291266|NCT04478708|542200369|FG002|Overall Study|Withdrawal of consent from study|2|||
150291267|NCT04478708|542200370|FG003|Overall Study|Withdrawal of consent from study|0|||
150291268|NCT04478708|542200371|FG004|Overall Study|Withdrawal of consent from study|1|||
150291269|NCT04478708|542200372|FG005|Overall Study|Withdrawal of consent from study|1|||
150291270|NCT04478708|542200373|FG006|Overall Study|Withdrawal of consent from study|1|||
150291271|NCT04478708|542200374|FG007|Overall Study|Withdrawal of consent from study|0|||
150291272|NCT04478708|542200375|FG008|Overall Study|Withdrawal of consent from study|0|||
150291273|NCT04478708|542200376|FG009|Overall Study|Withdrawal of consent from study|0|||
150291274|NCT04478708|542200377|FG010|Overall Study|Withdrawal of consent from study|4|||
150291275|NCT04478708|542200378|FG011|Overall Study|Withdrawal of consent from study|3|||
150291276|NCT04478708|542200379|FG012|Overall Study|Withdrawal of consent from study|0|||
150291277|NCT04478708|542200380|FG013|Overall Study|Withdrawal of consent from study|0|||
150291278|NCT04478708|542200381|FG014|Overall Study|Withdrawal of consent from study|1|||
150291279|NCT04478708|542200382|FG015|Overall Study|Withdrawal of consent from study|0|||
150291280|NCT04478708|542200383|FG016|Overall Study|Withdrawal of consent from study|4|||
150291281|NCT01314118|542200384|FG000|Overall Study|Adverse Event|10|||
150291282|NCT01314118|542200384|FG000|Overall Study|Progressive disease|3|||
150291283|NCT01314118|542200384|FG000|Overall Study|Death|8|||
150291284|NCT01314118|542200384|FG000|Overall Study|Physician Decision|13|||
150291285|NCT01314118|542200384|FG000|Overall Study|Sponsor Decision|1|||
150291286|NCT01314118|542200384|FG000|Overall Study|Protocol Violation|2|||
150291287|NCT01314118|542200384|FG000|Overall Study|Withdrawal by Subject|26|||
150291288|NCT01314118|542200384|FG000|Overall Study|Other|21|||
150291289|NCT01869114|542200385|FG000|Overall Study|Death|19|||
150291290|NCT01869114|542200386|FG001|Overall Study|Death|18|||
149860253|NCT02010255|540618167|FG000|Overall Study|Withdrew Consent|1|||
149860254|NCT02010255|540618168|FG001|Overall Study|Withdrew Consent|0|||
149961648|NCT02568254|540992176|FG004|Period 2|Adverse Event|0|||
149961649|NCT02568254|540992177|FG005|Period 2|Adverse Event|0|||
150040529|NCT02760498|541287425|FG002|Overall Study|Withdrawal by Subject|5|||
150040530|NCT02760498|541287426|FG003|Overall Study|Withdrawal by Subject|1|||
150040531|NCT02760498|541287427|FG004|Overall Study|Withdrawal by Subject|0|||
150040532|NCT02760498|541287428|FG005|Overall Study|Withdrawal by Subject|6|||
150040533|NCT02760498|541287423|FG000|Overall Study|Other than specified|1|||
150040534|NCT02760498|541287424|FG001|Overall Study|Other than specified|6|||
150040535|NCT02760498|541287425|FG002|Overall Study|Other than specified|0|||
150040536|NCT02760498|541287426|FG003|Overall Study|Other than specified|3|||
150040537|NCT02760498|541287427|FG004|Overall Study|Other than specified|1|||
150040538|NCT02760498|541287428|FG005|Overall Study|Other than specified|0|||
150040539|NCT02760498|541287423|FG000|Overall Study|Not treated|0|||
150040540|NCT02760498|541287424|FG001|Overall Study|Not treated|0|||
150040541|NCT02760498|541287425|FG002|Overall Study|Not treated|0|||
150040542|NCT02760498|541287426|FG003|Overall Study|Not treated|0|||
150040543|NCT02760498|541287427|FG004|Overall Study|Not treated|0|||
150040544|NCT02760498|541287428|FG005|Overall Study|Not treated|2|||
150040545|NCT02205736|541287429|FG000|Overall Study|Lost to Follow-up|106|||
150040546|NCT02105662|541289084|FG000|Overall Study|Lost to Follow-up|5|||
150040547|NCT02105662|541289084|FG000|Overall Study|Withdrawal by Subject|1|||
150040548|NCT00990704|541289088|FG000|Overall Study|Adverse Event|1|||
150040549|NCT00990704|541289089|FG001|Overall Study|Adverse Event|1|||
150040550|NCT00990704|541289088|FG000|Overall Study|Physician Decision|0|||
150291291|NCT01869114|542200387|FG002|Overall Study|Death|8|||
150291292|NCT01869114|542200385|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
150291293|NCT01869114|542200386|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
150291294|NCT01869114|542200387|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
150291295|NCT01869114|542200385|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
150291296|NCT01869114|542200386|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
150291297|NCT01869114|542200387|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
150291298|NCT01869114|542200385|FG000|Overall Study|Withdrawal by Subject|0|||
149860255|NCT02010255|540618169|FG002|Overall Study|Withdrew Consent|0|||
149860256|NCT02010255|540618170|FG003|Overall Study|Withdrew Consent|1|||
149860257|NCT02010255|540618171|FG004|Overall Study|Withdrew Consent|0|||
149860258|NCT02010255|540618172|FG005|Overall Study|Withdrew Consent|0|||
149860259|NCT02010255|540618173|FG006|Overall Study|Withdrew Consent|0|||
149860260|NCT02010255|540618174|FG007|Overall Study|Withdrew Consent|0|||
149860261|NCT02010255|540618175|FG008|Overall Study|Withdrew Consent|0|||
149860262|NCT02010255|540618176|FG009|Overall Study|Withdrew Consent|0|||
149860263|NCT02010255|540618177|FG010|Overall Study|Withdrew Consent|0|||
149860264|NCT02010255|540618178|FG011|Overall Study|Withdrew Consent|0|||
149860265|NCT02010255|540618179|FG012|Overall Study|Withdrew Consent|0|||
149860266|NCT02010255|540618180|FG013|Overall Study|Withdrew Consent|0|||
149860267|NCT02010255|540618167|FG000|Overall Study|Adverse Event|1|||
149860268|NCT02010255|540618168|FG001|Overall Study|Adverse Event|0|||
149860269|NCT02010255|540618169|FG002|Overall Study|Adverse Event|0|||
149860270|NCT02010255|540618170|FG003|Overall Study|Adverse Event|0|||
150291299|NCT01869114|542200386|FG001|Overall Study|Withdrawal by Subject|3|||
149860271|NCT02010255|540618171|FG004|Overall Study|Adverse Event|0|||
149860272|NCT02010255|540618172|FG005|Overall Study|Adverse Event|0|||
149860273|NCT02010255|540618173|FG006|Overall Study|Adverse Event|0|||
149860274|NCT02010255|540618174|FG007|Overall Study|Adverse Event|0|||
149860275|NCT02010255|540618175|FG008|Overall Study|Adverse Event|0|||
149860276|NCT02010255|540618176|FG009|Overall Study|Adverse Event|0|||
150040551|NCT00990704|541289089|FG001|Overall Study|Physician Decision|1|||
150040552|NCT03252925|541289092|FG000|Overall Study|Withdrawal by Subject|1|||
150040553|NCT03252925|541289093|FG001|Overall Study|Withdrawal by Subject|0|||
150040554|NCT03252925|541289092|FG000|Overall Study|Protocol Violation|6|||
150040555|NCT03252925|541289093|FG001|Overall Study|Protocol Violation|0|||
150040556|NCT03252925|541289092|FG000|Overall Study|Adverse Event|1|||
150040557|NCT03252925|541289093|FG001|Overall Study|Adverse Event|0|||
150040558|NCT03252925|541289092|FG000|Overall Study|Lost to Follow-up|6|||
150040559|NCT03252925|541289093|FG001|Overall Study|Lost to Follow-up|6|||
150040560|NCT01908803|541289098|FG000|Overall Study|Adverse Event|1|||
150040561|NCT01908803|541289099|FG001|Overall Study|Adverse Event|0|||
150040562|NCT01908803|541289098|FG000|Overall Study|Physician Decision|0|||
150040563|NCT01908803|541289099|FG001|Overall Study|Physician Decision|1|||
150291300|NCT01869114|542200387|FG002|Overall Study|Withdrawal by Subject|0|||
149860277|NCT02010255|540618177|FG010|Overall Study|Adverse Event|0|||
149860278|NCT02010255|540618178|FG011|Overall Study|Adverse Event|0|||
149860279|NCT02010255|540618179|FG012|Overall Study|Adverse Event|0|||
149860280|NCT02010255|540618180|FG013|Overall Study|Adverse Event|0|||
149860281|NCT02010255|540618167|FG000|Overall Study|Lost to Follow-up|0|||
149860282|NCT02010255|540618168|FG001|Overall Study|Lost to Follow-up|0|||
150040564|NCT01908803|541289098|FG000|Overall Study|Withdrawal by Subject|1|||
150040565|NCT01908803|541289099|FG001|Overall Study|Withdrawal by Subject|0|||
150040566|NCT01908803|541289098|FG000|Overall Study|Randomization Error|1|||
150040567|NCT01908803|541289099|FG001|Overall Study|Randomization Error|0|||
150040568|NCT01908803|541289098|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
149860283|NCT02010255|540618169|FG002|Overall Study|Lost to Follow-up|1|||
149860284|NCT02010255|540618170|FG003|Overall Study|Lost to Follow-up|0|||
149860285|NCT02010255|540618171|FG004|Overall Study|Lost to Follow-up|1|||
149860286|NCT02010255|540618172|FG005|Overall Study|Lost to Follow-up|0|||
149860287|NCT02010255|540618173|FG006|Overall Study|Lost to Follow-up|0|||
149860288|NCT02010255|540618174|FG007|Overall Study|Lost to Follow-up|0|||
149961650|NCT02568254|540992172|FG000|Period 3|Unstatisfactory Lens fitting|0|||
149961651|NCT02568254|540992173|FG001|Period 3|Unstatisfactory Lens fitting|0|||
149961652|NCT02568254|540992174|FG002|Period 3|Unstatisfactory Lens fitting|0|||
149961653|NCT02568254|540992175|FG003|Period 3|Unstatisfactory Lens fitting|0|||
149860289|NCT02010255|540618175|FG008|Overall Study|Lost to Follow-up|0|||
149961654|NCT02568254|540992176|FG004|Period 3|Unstatisfactory Lens fitting|1|||
149961655|NCT02568254|540992177|FG005|Period 3|Unstatisfactory Lens fitting|0|||
149961656|NCT04495478|540992178|FG000|Overall Study|Withdrawal by Subject|0|||
149860290|NCT02010255|540618176|FG009|Overall Study|Lost to Follow-up|0|||
149860291|NCT02010255|540618177|FG010|Overall Study|Lost to Follow-up|0|||
149860292|NCT02010255|540618178|FG011|Overall Study|Lost to Follow-up|0|||
149860293|NCT02010255|540618179|FG012|Overall Study|Lost to Follow-up|0|||
149860294|NCT02010255|540618180|FG013|Overall Study|Lost to Follow-up|0|||
149860295|NCT02010255|540618167|FG000|Overall Study|Randomized but Not Treated|0|||
149860296|NCT02010255|540618168|FG001|Overall Study|Randomized but Not Treated|0|||
149860297|NCT02010255|540618169|FG002|Overall Study|Randomized but Not Treated|0|||
149860298|NCT02010255|540618170|FG003|Overall Study|Randomized but Not Treated|0|||
149860299|NCT02010255|540618171|FG004|Overall Study|Randomized but Not Treated|0|||
149860300|NCT02010255|540618172|FG005|Overall Study|Randomized but Not Treated|0|||
149860301|NCT02010255|540618173|FG006|Overall Study|Randomized but Not Treated|0|||
149860302|NCT02010255|540618174|FG007|Overall Study|Randomized but Not Treated|0|||
149860303|NCT02010255|540618175|FG008|Overall Study|Randomized but Not Treated|0|||
149860304|NCT02010255|540618176|FG009|Overall Study|Randomized but Not Treated|0|||
149860305|NCT02010255|540618177|FG010|Overall Study|Randomized but Not Treated|0|||
149860306|NCT02010255|540618178|FG011|Overall Study|Randomized but Not Treated|0|||
150040569|NCT01908803|541289099|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
150040570|NCT00098813|541289100|FG000|Overall Study|Death|8|||
150040571|NCT00098813|541289100|FG000|Overall Study|Protocol Violation|1|||
150040572|NCT00098813|541289100|FG000|Overall Study|Withdrawal by Subject|7|||
150040573|NCT00098813|541289100|FG000|Overall Study|Progression of Disease|1|||
150040574|NCT00098813|541289100|FG000|Overall Study|Other complicating disease|1|||
150040575|NCT00098813|541289100|FG000|Overall Study|Reversal of RAI resistance|1|||
150040576|NCT01002339|541289101|FG000|Overall Study|Withdrawal by Subject|0|||
150040577|NCT01002339|541289102|FG001|Overall Study|Withdrawal by Subject|1|||
150040578|NCT01002339|541289103|FG002|Overall Study|Withdrawal by Subject|0|||
150040579|NCT01002339|541289101|FG000|Overall Study|Incorrect treatment assignment|0|||
150040580|NCT01002339|541289102|FG001|Overall Study|Incorrect treatment assignment|0|||
150040581|NCT01002339|541289103|FG002|Overall Study|Incorrect treatment assignment|1|||
150040582|NCT01002339|541289101|FG000|Overall Study|Protocol Violation|0|||
150040583|NCT01002339|541289102|FG001|Overall Study|Protocol Violation|0|||
150040584|NCT01002339|541289103|FG002|Overall Study|Protocol Violation|2|||
150040585|NCT01002339|541289101|FG000|Overall Study|Lung cancer detected before transplant|0|||
150040586|NCT01002339|541289102|FG001|Overall Study|Lung cancer detected before transplant|0|||
150040587|NCT01002339|541289103|FG002|Overall Study|Lung cancer detected before transplant|1|||
150040588|NCT01002339|541289101|FG000|Overall Study|Randomized. Not transplanted|0|||
150040589|NCT01002339|541289102|FG001|Overall Study|Randomized. Not transplanted|0|||
150040590|NCT01002339|541289103|FG002|Overall Study|Randomized. Not transplanted|1|||
150040591|NCT01907854|541289104|FG000|Overall Study|Protocol Violation|1|||
150040592|NCT01907854|541289105|FG001|Overall Study|Protocol Violation|1|||
150040593|NCT01907854|541289104|FG000|Overall Study|Withdrawal by Subject|9|||
150040594|NCT01907854|541289105|FG001|Overall Study|Withdrawal by Subject|7|||
150040595|NCT01907854|541289104|FG000|Overall Study|Lost to Follow-up|2|||
150040596|NCT01907854|541289105|FG001|Overall Study|Lost to Follow-up|2|||
150040597|NCT01907854|541289104|FG000|Overall Study|Unclassified|4|||
149961657|NCT04495478|540992179|FG001|Overall Study|Withdrawal by Subject|0|||
149961658|NCT04495478|540992180|FG002|Overall Study|Withdrawal by Subject|0|||
150040598|NCT01907854|541289105|FG001|Overall Study|Unclassified|3|||
150040599|NCT02215252|541289106|FG000|Overall Study|Adverse Event|1|||
149860307|NCT02010255|540618179|FG012|Overall Study|Randomized but Not Treated|0|||
149860308|NCT02010255|540618180|FG013|Overall Study|Randomized but Not Treated|1|||
150040600|NCT02215252|541289107|FG001|Overall Study|Adverse Event|5|||
149860309|NCT00396331|540618186|FG000|Overall Study|Failed to mobilize - no transplant|8|||
149860310|NCT00396331|540618186|FG000|Overall Study|Did not go on to transplant|5|||
149860311|NCT00396331|540618186|FG000|Overall Study|Lost to Follow-up|3|||
149860312|NCT00396331|540618186|FG000|Overall Study|Death|16|||
149961659|NCT04495478|540992181|FG003|Overall Study|Withdrawal by Subject|1|||
149961660|NCT04495478|540992182|FG004|Overall Study|Withdrawal by Subject|0|||
150040601|NCT02215252|541289108|FG002|Overall Study|Adverse Event|2|||
150040602|NCT02215252|541289106|FG000|Overall Study|Lost to Follow-up|0|||
150040603|NCT02215252|541289107|FG001|Overall Study|Lost to Follow-up|0|||
150040604|NCT02215252|541289108|FG002|Overall Study|Lost to Follow-up|1|||
149860313|NCT00680186|540618187|FG000|Overall Study|Adverse Event|47|||
149860314|NCT00680186|540618188|FG001|Overall Study|Adverse Event|44|||
149860315|NCT00680186|540618187|FG000|Overall Study|Protocol Violation|31|||
149860316|NCT00680186|540618188|FG001|Overall Study|Protocol Violation|26|||
149860317|NCT00680186|540618187|FG000|Overall Study|Lost to Follow-up|11|||
149860318|NCT00680186|540618188|FG001|Overall Study|Lost to Follow-up|6|||
149860319|NCT00680186|540618187|FG000|Overall Study|Withdrawal by Subject|32|||
149860320|NCT00680186|540618188|FG001|Overall Study|Withdrawal by Subject|39|||
149860321|NCT00680186|540618187|FG000|Overall Study|Other|4|||
149860322|NCT00680186|540618188|FG001|Overall Study|Other|1|||
149860323|NCT01351350|540618191|FG000|Overall Study|Disease Progression|5|||
149860324|NCT01351350|540618192|FG001|Overall Study|Disease Progression|13|||
149860325|NCT01351350|540618193|FG002|Overall Study|Disease Progression|6|||
149860326|NCT01351350|540618194|FG003|Overall Study|Disease Progression|8|||
149860327|NCT01351350|540618195|FG004|Overall Study|Disease Progression|5|||
149860328|NCT01351350|540618191|FG000|Overall Study|Adverse Event|1|||
149860329|NCT01351350|540618192|FG001|Overall Study|Adverse Event|10|||
149860330|NCT01351350|540618193|FG002|Overall Study|Adverse Event|1|||
149860331|NCT01351350|540618194|FG003|Overall Study|Adverse Event|2|||
149860332|NCT01351350|540618195|FG004|Overall Study|Adverse Event|0|||
149860333|NCT01351350|540618191|FG000|Overall Study|Participant Decision|2|||
149860334|NCT01351350|540618192|FG001|Overall Study|Participant Decision|6|||
149860335|NCT01351350|540618193|FG002|Overall Study|Participant Decision|3|||
149860336|NCT01351350|540618194|FG003|Overall Study|Participant Decision|3|||
149860337|NCT01351350|540618195|FG004|Overall Study|Participant Decision|2|||
149860338|NCT01351350|540618191|FG000|Overall Study|Enrolled but not Treated|0|||
149860339|NCT01351350|540618192|FG001|Overall Study|Enrolled but not Treated|0|||
149860340|NCT01351350|540618193|FG002|Overall Study|Enrolled but not Treated|1|||
149860341|NCT01351350|540618194|FG003|Overall Study|Enrolled but not Treated|0|||
149860342|NCT01351350|540618195|FG004|Overall Study|Enrolled but not Treated|0|||
149860343|NCT00873119|540618204|FG000|Overall Study|Patient request|4|||
149860344|NCT00873119|540618205|FG001|Overall Study|Patient request|2|||
149860345|NCT00873119|540618204|FG000|Overall Study|Adverse Event|8|||
149860346|NCT00873119|540618205|FG001|Overall Study|Adverse Event|0|||
149860347|NCT00873119|540618204|FG000|Overall Study|Progressive disease|26|||
149860348|NCT00873119|540618205|FG001|Overall Study|Progressive disease|18|||
149860349|NCT00873119|540618204|FG000|Overall Study|Death|2|||
149860350|NCT00873119|540618205|FG001|Overall Study|Death|1|||
149860351|NCT00873119|540618204|FG000|Overall Study|Other|2|||
149860352|NCT00873119|540618205|FG001|Overall Study|Other|5|||
149860353|NCT00873119|540618204|FG000|Overall Study|Not treated|2|||
149860354|NCT00873119|540618205|FG001|Overall Study|Not treated|0|||
149860355|NCT03648879|540618206|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
149860356|NCT00285584|540618207|FG000|Month 3|Lost to Follow-up|3|||
149860357|NCT00285584|540618208|FG001|Month 3|Lost to Follow-up|3|||
149860358|NCT00285584|540618207|FG000|Month 3|Withdrawal by Subject|1|||
149860359|NCT00285584|540618208|FG001|Month 3|Withdrawal by Subject|0|||
149860360|NCT00285584|540618207|FG000|Month 6|Lost to Follow-up|0|||
149860361|NCT00285584|540618208|FG001|Month 6|Lost to Follow-up|1|||
149860362|NCT00466726|540618211|FG000|Overall Study|Not evaluable for response|14|||
149860363|NCT01807117|540618215|FG000|Overall Study|Physician Decision|2|||
149860364|NCT01807117|540618215|FG000|Overall Study|Disease diagnosis not a study disease|1|||
149860365|NCT00834899|540618216|FG000|Overall Study|Withdrawal by Subject|1|||
149860366|NCT00834899|540618217|FG001|Overall Study|Withdrawal by Subject|1|||
149860367|NCT02709486|540618225|FG000|Overall Study|Adverse Event|2|||
149860368|NCT02709486|540618226|FG001|Overall Study|Adverse Event|5|||
149860369|NCT02709486|540618227|FG002|Overall Study|Adverse Event|3|||
149860370|NCT02709486|540618225|FG000|Overall Study|Death|0|||
149860371|NCT02709486|540618226|FG001|Overall Study|Death|0|||
149860372|NCT02709486|540618227|FG002|Overall Study|Death|2|||
149860373|NCT02709486|540618225|FG000|Overall Study|Insufficient clinical response|7|||
149860374|NCT02709486|540618226|FG001|Overall Study|Insufficient clinical response|3|||
149860375|NCT02709486|540618227|FG002|Overall Study|Insufficient clinical response|3|||
149860376|NCT02709486|540618225|FG000|Overall Study|Lost to Follow-up|3|||
149860377|NCT02709486|540618226|FG001|Overall Study|Lost to Follow-up|2|||
149860378|NCT02709486|540618227|FG002|Overall Study|Lost to Follow-up|2|||
149860379|NCT02709486|540618225|FG000|Overall Study|Other|0|||
149860380|NCT02709486|540618226|FG001|Overall Study|Other|2|||
149860381|NCT02709486|540618227|FG002|Overall Study|Other|3|||
149860382|NCT02709486|540618225|FG000|Overall Study|Withdrawal by Subject|32|||
149860383|NCT02709486|540618226|FG001|Overall Study|Withdrawal by Subject|22|||
149860384|NCT02709486|540618227|FG002|Overall Study|Withdrawal by Subject|32|||
149860385|NCT00606502|540618230|FG000|Randomization|Randomized but not treated|3|||
149860386|NCT00606502|540618231|FG001|Randomization|Randomized but not treated|0|||
149860387|NCT00606502|540618230|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
149860388|NCT00606502|540618231|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
149860389|NCT02443545|540618238|FG000|Overall Study|Adverse Event|1|||
149860390|NCT02443545|540618239|FG001|Overall Study|Adverse Event|1|||
149860391|NCT02443545|540618238|FG000|Overall Study|Lost to Follow-up|0|||
149860392|NCT02443545|540618239|FG001|Overall Study|Lost to Follow-up|2|||
149860393|NCT02443545|540618238|FG000|Overall Study|Physician Decision|3|||
149860394|NCT02443545|540618239|FG001|Overall Study|Physician Decision|0|||
149860395|NCT02443545|540618238|FG000|Overall Study|Protocol Violation|8|||
149860396|NCT02443545|540618239|FG001|Overall Study|Protocol Violation|1|||
149860397|NCT02443545|540618238|FG000|Overall Study|Pregnancy|1|||
149860398|NCT02443545|540618239|FG001|Overall Study|Pregnancy|1|||
149860399|NCT02443545|540618238|FG000|Overall Study|Withdrawal by Subject|6|||
149860400|NCT02443545|540618239|FG001|Overall Study|Withdrawal by Subject|3|||
149860401|NCT02443545|540618238|FG000|Overall Study|Termination of study|20|||
149961661|NCT04495478|540992183|FG005|Overall Study|Withdrawal by Subject|0|||
149961662|NCT04495478|540992184|FG006|Overall Study|Withdrawal by Subject|0|||
149961663|NCT04495478|540992178|FG000|Overall Study|Physician Decision|0|||
149961664|NCT04495478|540992179|FG001|Overall Study|Physician Decision|1|||
149961665|NCT04495478|540992180|FG002|Overall Study|Physician Decision|0|||
149961666|NCT04495478|540992181|FG003|Overall Study|Physician Decision|0|||
149961667|NCT04495478|540992182|FG004|Overall Study|Physician Decision|1|||
149961668|NCT04495478|540992183|FG005|Overall Study|Physician Decision|0|||
149961669|NCT04495478|540992184|FG006|Overall Study|Physician Decision|0|||
149961670|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
149961671|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
149961672|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
149961673|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Adverse Event|5|||
149961674|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Adverse Event|1|||
149961675|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Adverse Event|0|||
149961676|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
149961677|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
149961678|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
149961679|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Death|8|||
149961680|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Death|24|||
149961681|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Death|0|||
149961682|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
149961683|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
149961684|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
149961685|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
149961686|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
149961687|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
149961688|NCT02931539|540992185|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
149961689|NCT02931539|540992186|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
149961690|NCT02931539|540992187|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
149961691|NCT02931539|540992185|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
149961692|NCT02931539|540992186|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
149961693|NCT02931539|540992187|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
149961694|NCT03061214|540992190|FG000|Overall Study|Withdrawal by Subject|21|||
149961695|NCT03061214|540992191|FG001|Overall Study|Withdrawal by Subject|26|||
149961696|NCT03061214|540992192|FG002|Overall Study|Withdrawal by Subject|9|||
149961697|NCT03061214|540992190|FG000|Overall Study|Lost to Follow-up|3|||
149961698|NCT03061214|540992191|FG001|Overall Study|Lost to Follow-up|1|||
149961699|NCT03061214|540992192|FG002|Overall Study|Lost to Follow-up|1|||
149961700|NCT03061214|540992190|FG000|Overall Study|Death|1|||
149961701|NCT03061214|540992191|FG001|Overall Study|Death|1|||
149961702|NCT03061214|540992192|FG002|Overall Study|Death|0|||
149961703|NCT00107614|540994045|FG000|Overall Study|Physician Decision|10|||
149961704|NCT00107614|540994045|FG000|Overall Study|Death|2|||
149961705|NCT02457546|540994050|FG000|Overall Study|Other reasons|4|||
149961706|NCT02457546|540994051|FG001|Overall Study|Other reasons|1|||
149961707|NCT02457546|540994050|FG000|Overall Study|Refused to complete study/procedures|1|||
149961708|NCT02457546|540994051|FG001|Overall Study|Refused to complete study/procedures|1|||
149961709|NCT02457546|540994050|FG000|Overall Study|Lost to Follow-up|4|||
149961710|NCT02457546|540994051|FG001|Overall Study|Lost to Follow-up|1|||
149961711|NCT02457546|540994050|FG000|Overall Study|Adverse Event|0|||
149961712|NCT02457546|540994051|FG001|Overall Study|Adverse Event|1|||
149961713|NCT01897896|540994052|FG000|Overall Study|Death|1|||
150040605|NCT02215252|541289106|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
149961714|NCT01897896|540994053|FG001|Overall Study|Death|0|||
149961715|NCT01897896|540994052|FG000|Overall Study|Adverse Event|11|||
149961716|NCT01897896|540994053|FG001|Overall Study|Adverse Event|1|||
149961717|NCT01897896|540994052|FG000|Overall Study|Lost to Follow-up|1|||
149961718|NCT01897896|540994053|FG001|Overall Study|Lost to Follow-up|0|||
149961719|NCT01897896|540994052|FG000|Overall Study|Non-compliance with study drug dosing|1|||
149961720|NCT01897896|540994053|FG001|Overall Study|Non-compliance with study drug dosing|1|||
149961721|NCT01897896|540994052|FG000|Overall Study|Withdrawal by Subject|7|||
149961722|NCT01897896|540994053|FG001|Overall Study|Withdrawal by Subject|1|||
150040606|NCT02215252|541289107|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
149961723|NCT01897896|540994052|FG000|Overall Study|Require drug that interfere with study|1|||
149860402|NCT02443545|540618239|FG001|Overall Study|Termination of study|11|||
149860403|NCT02139124|540618241|FG000|Overall Study|Adverse Event|2|||
149860404|NCT02139124|540618242|FG001|Overall Study|Adverse Event|0|||
149860405|NCT02139124|540618243|FG002|Overall Study|Adverse Event|1|||
149860406|NCT02139124|540618244|FG003|Overall Study|Adverse Event|2|||
149860407|NCT02139124|540618245|FG004|Overall Study|Adverse Event|5|||
149860408|NCT02139124|540618241|FG000|Overall Study|Withdrawal by Subject|2|||
149860409|NCT02139124|540618242|FG001|Overall Study|Withdrawal by Subject|2|||
149860410|NCT02139124|540618243|FG002|Overall Study|Withdrawal by Subject|2|||
149860411|NCT02139124|540618244|FG003|Overall Study|Withdrawal by Subject|2|||
149860412|NCT02139124|540618245|FG004|Overall Study|Withdrawal by Subject|3|||
149860413|NCT02139124|540618241|FG000|Overall Study|Protocol Violation|0|||
149860414|NCT02139124|540618242|FG001|Overall Study|Protocol Violation|0|||
149961724|NCT01897896|540994053|FG001|Overall Study|Require drug that interfere with study|4|||
149961725|NCT01897896|540994052|FG000|Overall Study|Protocol Violation|1|||
149961726|NCT01897896|540994053|FG001|Overall Study|Protocol Violation|1|||
149961727|NCT01897896|540994052|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
149961728|NCT01897896|540994053|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
149961729|NCT01897896|540994052|FG000|Overall Study|Caregiver can no longer participate|0|||
149961730|NCT01897896|540994053|FG001|Overall Study|Caregiver can no longer participate|2|||
149961731|NCT01897896|540994052|FG000|Overall Study|Other than specified|2|||
149961732|NCT01897896|540994053|FG001|Overall Study|Other than specified|1|||
149961733|NCT00363467|540994054|FG000|Overall Study|Physician Decision|1|||
149961734|NCT05069415|540994057|FG000|Overall Study|Withdrawal by Subject|2|||
149961735|NCT05069415|540994058|FG001|Overall Study|Withdrawal by Subject|0|||
149961736|NCT05069415|540994057|FG000|Overall Study|Adverse Event|2|||
149961737|NCT05069415|540994058|FG001|Overall Study|Adverse Event|0|||
149961738|NCT03160573|540994059|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
149961739|NCT03160573|540994060|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
149961740|NCT03160573|540994061|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
149961741|NCT03160573|540994062|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
149961742|NCT00101400|540994063|FG000|Survival Follow-Up|Alive|7|||
149961743|NCT03142451|540994076|FG000|Overall Study|Adverse Event|5|||
149961744|NCT03142451|540994077|FG001|Overall Study|Adverse Event|2|||
149961745|NCT03142451|540994076|FG000|Overall Study|Lost to Follow-up|25|||
149961746|NCT03142451|540994077|FG001|Overall Study|Lost to Follow-up|8|||
149961747|NCT03142451|540994076|FG000|Overall Study|Participant request|24|||
149961748|NCT03142451|540994077|FG001|Overall Study|Participant request|12|||
149961749|NCT03142451|540994076|FG000|Overall Study|Protocol Violation|3|||
149961750|NCT03142451|540994077|FG001|Overall Study|Protocol Violation|1|||
149961751|NCT03142451|540994076|FG000|Overall Study|Other|1|||
149961752|NCT03142451|540994077|FG001|Overall Study|Other|1|||
149961753|NCT00090402|540994078|FG000|Overall Study|Death|1|||
149961754|NCT00090402|540994079|FG001|Overall Study|Death|1|||
149961755|NCT00090402|540994080|FG002|Overall Study|Death|0|||
149961756|NCT00090402|540994078|FG000|Overall Study|subject moved|0|||
149961757|NCT00090402|540994079|FG001|Overall Study|subject moved|1|||
149961758|NCT00090402|540994080|FG002|Overall Study|subject moved|0|||
149961759|NCT00090402|540994078|FG000|Overall Study|stopped taking study medication|1|||
149961760|NCT00090402|540994079|FG001|Overall Study|stopped taking study medication|0|||
149961761|NCT00090402|540994080|FG002|Overall Study|stopped taking study medication|1|||
149961762|NCT00871000|540994085|FG000|Overall Study|Withdrawal by Subject|1|||
149961763|NCT00871000|540994086|FG001|Overall Study|Withdrawal by Subject|0|||
149961764|NCT01052428|540994087|FG000|Overall Study|Death|1|||
149961765|NCT01052428|540994088|FG001|Overall Study|Death|0|||
149961766|NCT01052428|540994087|FG000|Overall Study|Withdrawal by Subject|0|||
149961767|NCT01052428|540994088|FG001|Overall Study|Withdrawal by Subject|1|||
149961768|NCT02168439|540994089|FG000|Overall Study|Protocol Violation|0|||
149961769|NCT02168439|540994090|FG001|Overall Study|Protocol Violation|2|||
149961770|NCT03400787|540994091|FG000|Overall Study|Lost to Follow-up|1|||
150291301|NCT01869114|542200385|FG000|Overall Study|Disease Progression|0|||
150291302|NCT01869114|542200386|FG001|Overall Study|Disease Progression|1|||
150291303|NCT01869114|542200387|FG002|Overall Study|Disease Progression|0|||
150291304|NCT03323502|542200388|FG000|Overall Study|Resident could not be linked to CMS data|594|||
150291305|NCT03323502|542200389|FG001|Overall Study|Resident could not be linked to CMS data|435|||
150291306|NCT03323502|542200388|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
150291307|NCT03323502|542200389|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
150291308|NCT03323502|542200388|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
150291309|NCT03323502|542200389|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
150291310|NCT03323502|542200388|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
150291311|NCT03323502|542200389|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
150291312|NCT03323502|542200388|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
150291313|NCT03323502|542200389|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
150291314|NCT03615326|542200390|FG000|Overall Study|Death|266|||
149860415|NCT02139124|540618243|FG002|Overall Study|Protocol Violation|0|||
149860416|NCT02139124|540618244|FG003|Overall Study|Protocol Violation|1|||
149860417|NCT02139124|540618245|FG004|Overall Study|Protocol Violation|1|||
149860418|NCT02139124|540618241|FG000|Overall Study|non-compliant|1|||
149860419|NCT02139124|540618242|FG001|Overall Study|non-compliant|0|||
149860420|NCT02139124|540618243|FG002|Overall Study|non-compliant|0|||
149860421|NCT02139124|540618244|FG003|Overall Study|non-compliant|2|||
149860422|NCT02139124|540618245|FG004|Overall Study|non-compliant|0|||
149860423|NCT02139124|540618241|FG000|Overall Study|incarceration|0|||
149860424|NCT02139124|540618242|FG001|Overall Study|incarceration|0|||
149860425|NCT02139124|540618243|FG002|Overall Study|incarceration|1|||
149860426|NCT02139124|540618244|FG003|Overall Study|incarceration|0|||
149860427|NCT02139124|540618245|FG004|Overall Study|incarceration|0|||
149860428|NCT02139124|540618241|FG000|Overall Study|subject moved|1|||
149860429|NCT02139124|540618242|FG001|Overall Study|subject moved|0|||
149860430|NCT02139124|540618243|FG002|Overall Study|subject moved|0|||
149860431|NCT02139124|540618244|FG003|Overall Study|subject moved|0|||
149860432|NCT02139124|540618245|FG004|Overall Study|subject moved|0|||
149860433|NCT02139124|540618241|FG000|Overall Study|Lost to Follow-up|3|||
149860434|NCT02139124|540618242|FG001|Overall Study|Lost to Follow-up|2|||
149860435|NCT02139124|540618243|FG002|Overall Study|Lost to Follow-up|0|||
149860436|NCT02139124|540618244|FG003|Overall Study|Lost to Follow-up|5|||
149860437|NCT02139124|540618245|FG004|Overall Study|Lost to Follow-up|4|||
149860438|NCT02691741|540618246|FG000|Overall Study|Adverse Event|0|||
149860439|NCT02691741|540618247|FG001|Overall Study|Adverse Event|2|||
149860440|NCT02691741|540618246|FG000|Overall Study|Lost to Follow-up|1|||
149860441|NCT02691741|540618247|FG001|Overall Study|Lost to Follow-up|0|||
149860442|NCT02691741|540618246|FG000|Overall Study|Physician Decision|0|||
149860443|NCT02691741|540618247|FG001|Overall Study|Physician Decision|1|||
149860444|NCT02691741|540618246|FG000|Overall Study|Withdrawal by Subject|0|||
149860445|NCT02691741|540618247|FG001|Overall Study|Withdrawal by Subject|4|||
149860446|NCT01425528|540618248|FG000|Overall Study|Withdrawal by Subject|1|||
149860447|NCT01425528|540618249|FG001|Overall Study|Withdrawal by Subject|1|||
149860448|NCT00307931|540618250|FG000|Overall Study|Adverse Event|1|||
149860449|NCT02697773|540618251|FG000|Overall Study|Adverse Event|2|||
149860450|NCT02697773|540618252|FG001|Overall Study|Adverse Event|1|||
149860451|NCT02697773|540618253|FG002|Overall Study|Adverse Event|2|||
149860452|NCT02697773|540618251|FG000|Overall Study|Death|0|||
149860453|NCT02697773|540618252|FG001|Overall Study|Death|0|||
149860454|NCT02697773|540618253|FG002|Overall Study|Death|2|||
149860455|NCT02697773|540618251|FG000|Overall Study|Lack of Efficacy|4|||
149860456|NCT02697773|540618252|FG001|Overall Study|Lack of Efficacy|6|||
149860457|NCT02697773|540618253|FG002|Overall Study|Lack of Efficacy|6|||
149860458|NCT02697773|540618251|FG000|Overall Study|Lost to Follow-up|5|||
149860459|NCT02697773|540618252|FG001|Overall Study|Lost to Follow-up|5|||
149860460|NCT02697773|540618253|FG002|Overall Study|Lost to Follow-up|7|||
149860461|NCT02697773|540618251|FG000|Overall Study|Other|15|||
149860462|NCT02697773|540618252|FG001|Overall Study|Other|11|||
149860463|NCT02697773|540618253|FG002|Overall Study|Other|10|||
149860464|NCT02697773|540618251|FG000|Overall Study|Protocol Violation|1|||
149860465|NCT02697773|540618252|FG001|Overall Study|Protocol Violation|1|||
149860466|NCT02697773|540618253|FG002|Overall Study|Protocol Violation|0|||
149860467|NCT02697773|540618251|FG000|Overall Study|Withdrawal by Subject|10|||
150040607|NCT02215252|541289108|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
150173598|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
150291315|NCT03615326|542200391|FG001|Overall Study|Death|286|||
150291316|NCT03615326|542200392|FG002|Overall Study|Death|14|||
150291317|NCT03615326|542200393|FG003|Overall Study|Death|17|||
150291318|NCT03615326|542200390|FG000|Overall Study|Lost to Follow-up|0|||
150291319|NCT03615326|542200391|FG001|Overall Study|Lost to Follow-up|1|||
150291320|NCT03615326|542200392|FG002|Overall Study|Lost to Follow-up|0|||
150291321|NCT03615326|542200393|FG003|Overall Study|Lost to Follow-up|0|||
150291322|NCT03615326|542200390|FG000|Overall Study|Withdrawal by Subject|1|||
150291323|NCT03615326|542200391|FG001|Overall Study|Withdrawal by Subject|3|||
150291324|NCT03615326|542200392|FG002|Overall Study|Withdrawal by Subject|0|||
150291325|NCT03615326|542200393|FG003|Overall Study|Withdrawal by Subject|0|||
150291326|NCT03615326|542200390|FG000|Overall Study|Participants Ongoing|83|||
150291327|NCT03615326|542200391|FG001|Overall Study|Participants Ongoing|58|||
150291328|NCT03615326|542200392|FG002|Overall Study|Participants Ongoing|6|||
150291329|NCT03615326|542200393|FG003|Overall Study|Participants Ongoing|3|||
150291330|NCT03794583|542200394|FG000|Overall Study|Death|8|||
150291331|NCT03794583|542200394|FG000|Overall Study|Study Terminated by Sponsor|24|||
150291332|NCT03794583|542200394|FG000|Overall Study|Withdrawal by Subject|9|||
149860468|NCT02697773|540618252|FG001|Overall Study|Withdrawal by Subject|13|||
149860469|NCT02697773|540618253|FG002|Overall Study|Withdrawal by Subject|13|||
149860470|NCT02697773|540618251|FG000|Overall Study|Randomized but not treated|1|||
149860471|NCT02697773|540618252|FG001|Overall Study|Randomized but not treated|1|||
149860472|NCT02697773|540618253|FG002|Overall Study|Randomized but not treated|0|||
149860473|NCT00613834|540618254|FG000|Overall Study|Withdrawal by Subject|0|||
150291333|NCT04266301|542200398|FG000|Overall Study|Progressive Disease|111|||
149860474|NCT00613834|540618255|FG001|Overall Study|Withdrawal by Subject|3|||
149860475|NCT02243293|540618256|FG000|Overall Study|Adverse Event|1|||
149860476|NCT02243293|540618257|FG001|Overall Study|Adverse Event|0|||
149860477|NCT02243293|540618258|FG002|Overall Study|Adverse Event|0|||
149860478|NCT02243293|540618259|FG003|Overall Study|Adverse Event|0|||
149860479|NCT02243293|540618260|FG004|Overall Study|Adverse Event|0|||
149860480|NCT02243293|540618261|FG005|Overall Study|Adverse Event|0|||
149860481|NCT02243293|540618262|FG006|Overall Study|Adverse Event|0|||
149860482|NCT02243293|540618263|FG007|Overall Study|Adverse Event|0|||
149860483|NCT02243293|540618264|FG008|Overall Study|Adverse Event|0|||
149860484|NCT02243293|540618265|FG009|Overall Study|Adverse Event|0|||
149860485|NCT02243293|540618266|FG010|Overall Study|Adverse Event|0|||
149860486|NCT02243293|540618267|FG011|Overall Study|Adverse Event|0|||
149860487|NCT02243293|540618268|FG012|Overall Study|Adverse Event|0|||
149860488|NCT02243293|540618269|FG013|Overall Study|Adverse Event|0|||
149860489|NCT02243293|540618270|FG014|Overall Study|Adverse Event|0|||
149860490|NCT02243293|540618271|FG015|Overall Study|Adverse Event|1|||
149860491|NCT02243293|540618272|FG016|Overall Study|Adverse Event|0|||
149860492|NCT02243293|540618273|FG017|Overall Study|Adverse Event|0|||
149860493|NCT02243293|540618274|FG018|Overall Study|Adverse Event|0|||
149860494|NCT02243293|540618275|FG019|Overall Study|Adverse Event|0|||
149860495|NCT02243293|540618276|FG020|Overall Study|Adverse Event|1|||
149860496|NCT02243293|540618277|FG021|Overall Study|Adverse Event|0|||
149860497|NCT02243293|540618256|FG000|Overall Study|Withdrawal by Subject|1|||
149860498|NCT02243293|540618257|FG001|Overall Study|Withdrawal by Subject|0|||
149860499|NCT02243293|540618258|FG002|Overall Study|Withdrawal by Subject|0|||
149860500|NCT02243293|540618259|FG003|Overall Study|Withdrawal by Subject|0|||
149860501|NCT02243293|540618260|FG004|Overall Study|Withdrawal by Subject|0|||
149860502|NCT02243293|540618261|FG005|Overall Study|Withdrawal by Subject|0|||
149860503|NCT02243293|540618262|FG006|Overall Study|Withdrawal by Subject|0|||
149860504|NCT02243293|540618263|FG007|Overall Study|Withdrawal by Subject|0|||
149860505|NCT02243293|540618264|FG008|Overall Study|Withdrawal by Subject|0|||
149860506|NCT02243293|540618265|FG009|Overall Study|Withdrawal by Subject|1|||
149860507|NCT02243293|540618266|FG010|Overall Study|Withdrawal by Subject|0|||
149860508|NCT02243293|540618267|FG011|Overall Study|Withdrawal by Subject|1|||
149860509|NCT02243293|540618268|FG012|Overall Study|Withdrawal by Subject|0|||
149860510|NCT02243293|540618269|FG013|Overall Study|Withdrawal by Subject|0|||
149860511|NCT02243293|540618270|FG014|Overall Study|Withdrawal by Subject|0|||
149860512|NCT02243293|540618271|FG015|Overall Study|Withdrawal by Subject|0|||
149860513|NCT02243293|540618272|FG016|Overall Study|Withdrawal by Subject|0|||
149860514|NCT02243293|540618273|FG017|Overall Study|Withdrawal by Subject|0|||
149860515|NCT02243293|540618274|FG018|Overall Study|Withdrawal by Subject|0|||
149860516|NCT02243293|540618275|FG019|Overall Study|Withdrawal by Subject|0|||
149860517|NCT02243293|540618276|FG020|Overall Study|Withdrawal by Subject|0|||
149860518|NCT02243293|540618277|FG021|Overall Study|Withdrawal by Subject|1|||
149860519|NCT02243293|540618256|FG000|Overall Study|Lost to Follow-up|0|||
149860520|NCT02243293|540618257|FG001|Overall Study|Lost to Follow-up|1|||
150291334|NCT04266301|542200399|FG001|Overall Study|Progressive Disease|92|||
150291335|NCT04266301|542200398|FG000|Overall Study|Adverse Event|41|||
150291336|NCT04266301|542200399|FG001|Overall Study|Adverse Event|43|||
150291337|NCT04266301|542200398|FG000|Overall Study|Death|26|||
150291338|NCT04266301|542200399|FG001|Overall Study|Death|35|||
150291339|NCT04266301|542200398|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
150291340|NCT04266301|542200399|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
150291341|NCT04266301|542200398|FG000|Overall Study|Study Terminated by Sponsor|22|||
150291342|NCT04266301|542200399|FG001|Overall Study|Study Terminated by Sponsor|27|||
150291343|NCT04266301|542200398|FG000|Overall Study|Participant Decision|22|||
150291344|NCT04266301|542200399|FG001|Overall Study|Participant Decision|28|||
150291345|NCT04266301|542200398|FG000|Overall Study|Physician Decision|14|||
150291346|NCT04266301|542200399|FG001|Overall Study|Physician Decision|9|||
150291347|NCT04266301|542200398|FG000|Overall Study|New Therapy for Study Indication|2|||
150291348|NCT04266301|542200399|FG001|Overall Study|New Therapy for Study Indication|4|||
150291349|NCT04266301|542200398|FG000|Overall Study|Protocol Deviation|2|||
150291350|NCT04266301|542200399|FG001|Overall Study|Protocol Deviation|4|||
150291351|NCT04266301|542200398|FG000|Overall Study|Guardian Decision|1|||
150291352|NCT04266301|542200399|FG001|Overall Study|Guardian Decision|0|||
150291353|NCT04266301|542200398|FG000|Overall Study|Lost to Follow-up|1|||
150291354|NCT04266301|542200399|FG001|Overall Study|Lost to Follow-up|0|||
150291355|NCT04266301|542200398|FG000|Overall Study|Participants Not Treated|1|||
150291356|NCT04266301|542200399|FG001|Overall Study|Participants Not Treated|1|||
150291357|NCT04079712|542200400|FG000|Overall Study|Disease progression before starting treatment|1|||
150291358|NCT04798781|542200405|FG000|Overall Study|Withdrawal by Subject|1|||
149860521|NCT02243293|540618258|FG002|Overall Study|Lost to Follow-up|1|||
149860522|NCT02243293|540618259|FG003|Overall Study|Lost to Follow-up|1|||
149860523|NCT02243293|540618260|FG004|Overall Study|Lost to Follow-up|0|||
149860524|NCT02243293|540618261|FG005|Overall Study|Lost to Follow-up|0|||
149860525|NCT02243293|540618262|FG006|Overall Study|Lost to Follow-up|3|||
149860526|NCT02243293|540618263|FG007|Overall Study|Lost to Follow-up|0|||
149860527|NCT02243293|540618264|FG008|Overall Study|Lost to Follow-up|0|||
149860528|NCT02243293|540618265|FG009|Overall Study|Lost to Follow-up|0|||
149860529|NCT02243293|540618266|FG010|Overall Study|Lost to Follow-up|0|||
149860530|NCT02243293|540618267|FG011|Overall Study|Lost to Follow-up|2|||
149860531|NCT02243293|540618268|FG012|Overall Study|Lost to Follow-up|0|||
149860532|NCT02243293|540618269|FG013|Overall Study|Lost to Follow-up|0|||
149860533|NCT02243293|540618270|FG014|Overall Study|Lost to Follow-up|0|||
149860534|NCT02243293|540618271|FG015|Overall Study|Lost to Follow-up|0|||
149860535|NCT02243293|540618272|FG016|Overall Study|Lost to Follow-up|3|||
149860536|NCT02243293|540618273|FG017|Overall Study|Lost to Follow-up|1|||
149860537|NCT02243293|540618274|FG018|Overall Study|Lost to Follow-up|0|||
149860538|NCT02243293|540618275|FG019|Overall Study|Lost to Follow-up|0|||
149860539|NCT02243293|540618276|FG020|Overall Study|Lost to Follow-up|1|||
149860540|NCT02243293|540618277|FG021|Overall Study|Lost to Follow-up|2|||
149860541|NCT02243293|540618256|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
149860542|NCT02243293|540618257|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
149860543|NCT02243293|540618258|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
149860544|NCT02243293|540618259|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
149860545|NCT02243293|540618260|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
149860546|NCT02243293|540618261|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
149860547|NCT02243293|540618262|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
149860548|NCT02243293|540618263|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
149860549|NCT02243293|540618264|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
149860550|NCT02243293|540618265|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
149860551|NCT02243293|540618266|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
149860552|NCT02243293|540618267|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
149860553|NCT02243293|540618268|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
149860554|NCT02243293|540618269|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
149860555|NCT02243293|540618270|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
149860556|NCT02243293|540618271|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
149860557|NCT02243293|540618272|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
149961771|NCT03400787|540994092|FG001|Overall Study|Lost to Follow-up|0|||
149961772|NCT03400787|540994091|FG000|Overall Study|Death|1|||
149961773|NCT03400787|540994092|FG001|Overall Study|Death|0|||
149961774|NCT03400787|540994091|FG000|Overall Study|Protocol Violation|0|||
149961775|NCT03400787|540994092|FG001|Overall Study|Protocol Violation|2|||
149961776|NCT03400787|540994091|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
149961777|NCT03400787|540994092|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
149961778|NCT02451007|540994095|FG000|Overall Study|Withdrawal by Subject|4|||
149961779|NCT02451007|540994095|FG000|Overall Study|Adverse Event|1|||
149961780|NCT02451007|540994095|FG000|Overall Study|Disease Progression|2|||
149961781|NCT00449787|540994096|FG000|Overall Study|Lost to Follow-up|10|||
149961782|NCT00449787|540994097|FG001|Overall Study|Lost to Follow-up|8|||
149961783|NCT00449787|540994096|FG000|Overall Study|Did not require medication|95|||
149961784|NCT00449787|540994097|FG001|Overall Study|Did not require medication|92|||
149961785|NCT01716559|540994098|FG000|Overall Study|Adverse Event|11|||
149961786|NCT01716559|540994098|FG000|Overall Study|Death|21|||
149961787|NCT01716559|540994098|FG000|Overall Study|Withdrawal by Subject|4|||
149961788|NCT01716559|540994098|FG000|Overall Study|Other withdrawal reason|75|||
149961789|NCT02595437|540994107|FG000|Triferic Via IV|Withdrawal by Subject|1|||
149961790|NCT02180672|540994112|FG000|Overall Study|Lost to Follow-up|5|||
149961791|NCT02180672|540994113|FG001|Overall Study|Lost to Follow-up|7|||
149961792|NCT03574389|540994114|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
149961793|NCT03574389|540994115|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
149961794|NCT03574389|540994116|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
149961795|NCT03574389|540994117|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
149961796|NCT03574389|540994118|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
149961797|NCT03574389|540994119|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
149961798|NCT03574389|540994120|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
149961799|NCT03574389|540994114|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
149961800|NCT03574389|540994115|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
149961801|NCT03574389|540994116|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
149961802|NCT03574389|540994117|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
149961803|NCT03574389|540994118|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
149961804|NCT03574389|540994119|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
149860558|NCT02243293|540618273|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
149860559|NCT02243293|540618274|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
149860560|NCT02243293|540618275|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
149961805|NCT03574389|540994120|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
149961806|NCT03574389|540994114|FG000|Vaccination Period|Other|6|||
149961807|NCT03574389|540994115|FG001|Vaccination Period|Other|0|||
149860561|NCT02243293|540618276|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
149860562|NCT02243293|540618277|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
149860563|NCT02243293|540618256|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
149860564|NCT02243293|540618257|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
149860565|NCT02243293|540618258|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
149860566|NCT02243293|540618259|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
149860567|NCT02243293|540618260|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
149860568|NCT02243293|540618261|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
149860569|NCT02243293|540618262|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
149961808|NCT03574389|540994116|FG002|Vaccination Period|Other|0|||
149860570|NCT02243293|540618263|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
149961809|NCT03574389|540994117|FG003|Vaccination Period|Other|0|||
149961810|NCT03574389|540994118|FG004|Vaccination Period|Other|0|||
149961811|NCT03574389|540994119|FG005|Vaccination Period|Other|0|||
149961812|NCT03574389|540994120|FG006|Vaccination Period|Other|0|||
149961813|NCT03574389|540994114|FG000|Vaccination Period|Adverse Event|0|||
149961814|NCT03574389|540994115|FG001|Vaccination Period|Adverse Event|1|||
149961815|NCT03574389|540994116|FG002|Vaccination Period|Adverse Event|0|||
149961816|NCT03574389|540994117|FG003|Vaccination Period|Adverse Event|0|||
149961817|NCT03574389|540994118|FG004|Vaccination Period|Adverse Event|0|||
149961818|NCT03574389|540994119|FG005|Vaccination Period|Adverse Event|0|||
149961819|NCT03574389|540994120|FG006|Vaccination Period|Adverse Event|0|||
149961820|NCT03574389|540994114|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
149961821|NCT03574389|540994115|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
149961822|NCT03574389|540994116|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
149961823|NCT03574389|540994117|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
149961824|NCT03574389|540994118|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
149961825|NCT03574389|540994119|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
149961826|NCT03574389|540994120|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
149961827|NCT05166902|540994121|FG000|First Intervention|Lost to Follow-up|0|||
149961828|NCT05166902|540994122|FG001|First Intervention|Lost to Follow-up|1|||
149961829|NCT00779909|540994123|FG000|Overall Study|Lost to Follow-up|1|||
149961830|NCT00779909|540994124|FG001|Overall Study|Lost to Follow-up|0|||
149961831|NCT00779909|540994125|FG002|Overall Study|Lost to Follow-up|0|||
149961832|NCT00779909|540994126|FG003|Overall Study|Lost to Follow-up|1|||
149961833|NCT00779909|540994123|FG000|Overall Study|Withdrawal by Subject|0|||
149961834|NCT00779909|540994124|FG001|Overall Study|Withdrawal by Subject|1|||
149961835|NCT00779909|540994125|FG002|Overall Study|Withdrawal by Subject|0|||
149961836|NCT00779909|540994126|FG003|Overall Study|Withdrawal by Subject|0|||
149961837|NCT03436420|540994127|FG000|Overall Study|Lack of Efficacy|3|||
149961838|NCT01061710|540994129|FG000|Overall Study|Protocol Violation|14|||
149961839|NCT00159874|540994130|FG000|Overall Study|Adverse Event|2|||
149961840|NCT00159874|540994131|FG001|Overall Study|Adverse Event|2|||
149961841|NCT00159874|540994132|FG002|Overall Study|Adverse Event|5|||
149961842|NCT00159874|540994133|FG003|Overall Study|Adverse Event|1|||
149961843|NCT00159874|540994134|FG004|Overall Study|Adverse Event|1|||
149961844|NCT00159874|540994135|FG005|Overall Study|Adverse Event|2|||
149961845|NCT00159874|540994136|FG006|Overall Study|Adverse Event|0|||
149961846|NCT00159874|540994130|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
149961847|NCT00159874|540994131|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
149961848|NCT00159874|540994132|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
149961849|NCT00159874|540994133|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
149961850|NCT00159874|540994134|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
149961851|NCT00159874|540994135|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
149961852|NCT00159874|540994136|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
149961853|NCT00159874|540994130|FG000|Overall Study|Lack of Efficacy|2|||
149961854|NCT00159874|540994131|FG001|Overall Study|Lack of Efficacy|0|||
149961855|NCT00159874|540994132|FG002|Overall Study|Lack of Efficacy|1|||
149961856|NCT00159874|540994133|FG003|Overall Study|Lack of Efficacy|1|||
149961857|NCT00159874|540994134|FG004|Overall Study|Lack of Efficacy|0|||
149961858|NCT00159874|540994135|FG005|Overall Study|Lack of Efficacy|3|||
149860571|NCT02243293|540618264|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
149961859|NCT00159874|540994136|FG006|Overall Study|Lack of Efficacy|0|||
149961860|NCT00159874|540994130|FG000|Overall Study|Lost to Follow-up|1|||
149961861|NCT00159874|540994131|FG001|Overall Study|Lost to Follow-up|0|||
149961862|NCT00159874|540994132|FG002|Overall Study|Lost to Follow-up|3|||
149961863|NCT00159874|540994133|FG003|Overall Study|Lost to Follow-up|0|||
149961864|NCT00159874|540994134|FG004|Overall Study|Lost to Follow-up|1|||
150040608|NCT02215252|541289106|FG000|Overall Study|Protocol Violation|0|||
149961865|NCT00159874|540994135|FG005|Overall Study|Lost to Follow-up|2|||
149961866|NCT00159874|540994136|FG006|Overall Study|Lost to Follow-up|1|||
149961867|NCT00159874|540994130|FG000|Overall Study|Other|8|||
149961868|NCT00159874|540994131|FG001|Overall Study|Other|8|||
149961869|NCT00159874|540994132|FG002|Overall Study|Other|8|||
149961870|NCT00159874|540994133|FG003|Overall Study|Other|0|||
149961871|NCT00159874|540994134|FG004|Overall Study|Other|2|||
149961872|NCT00159874|540994135|FG005|Overall Study|Other|1|||
149860572|NCT02243293|540618265|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
149860573|NCT02243293|540618266|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
149860574|NCT02243293|540618267|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
149860575|NCT02243293|540618268|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
149860576|NCT02243293|540618269|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
149860577|NCT02243293|540618270|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
149860578|NCT02243293|540618271|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
149860579|NCT02243293|540618272|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
149860580|NCT02243293|540618273|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
149860581|NCT02243293|540618274|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
149860582|NCT02243293|540618275|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
149860583|NCT02243293|540618276|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
149860584|NCT02243293|540618277|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
149860585|NCT03069417|540618278|FG000|Overall Study|Lost to Follow-up|2|||
149860586|NCT03069417|540618279|FG001|Overall Study|Lost to Follow-up|0|||
149860587|NCT03069417|540618278|FG000|Overall Study|Reason Unknown|4|||
149860588|NCT03069417|540618279|FG001|Overall Study|Reason Unknown|7|||
149961873|NCT00159874|540994136|FG006|Overall Study|Other|3|||
149961874|NCT00159874|540994130|FG000|Overall Study|Protocol Violation|0|||
149961875|NCT00159874|540994131|FG001|Overall Study|Protocol Violation|5|||
150173599|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
150173600|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
150173601|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
150173602|NCT04707313|541771315|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173603|NCT04707313|541771316|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173604|NCT04707313|541771317|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
150173605|NCT04707313|541771318|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173606|NCT04707313|541771319|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173607|NCT04707313|541771320|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173608|NCT04707313|541771321|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173609|NCT04707313|541771322|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
150173610|NCT04707313|541771323|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173611|NCT04707313|541771324|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173612|NCT04707313|541771325|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173613|NCT04707313|541771326|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173614|NCT04707313|541771327|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
150173615|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149961876|NCT00159874|540994132|FG002|Overall Study|Protocol Violation|2|||
149961877|NCT00159874|540994133|FG003|Overall Study|Protocol Violation|0|||
149961878|NCT00159874|540994134|FG004|Overall Study|Protocol Violation|0|||
149961879|NCT00159874|540994135|FG005|Overall Study|Protocol Violation|0|||
150173616|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173617|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173618|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173619|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150291359|NCT05289830|542200414|FG000|Overall Study|Lost to Follow-up|1|||
150291360|NCT05289830|542200415|FG001|Overall Study|Lost to Follow-up|1|||
150291361|NCT05289830|542200414|FG000|Overall Study|Physician Decision|0|||
150291362|NCT05289830|542200415|FG001|Overall Study|Physician Decision|1|||
150291363|NCT02699697|542200416|FG000|Overall Study|Death|18|||
149961880|NCT00159874|540994136|FG006|Overall Study|Protocol Violation|0|||
149961881|NCT00159874|540994130|FG000|Overall Study|Death|3|||
149961882|NCT00159874|540994131|FG001|Overall Study|Death|8|||
149961883|NCT00159874|540994132|FG002|Overall Study|Death|15|||
150291364|NCT02699697|542200417|FG001|Overall Study|Death|15|||
150291365|NCT02699697|542200416|FG000|Overall Study|Physician Decision|0|||
150291366|NCT02699697|542200417|FG001|Overall Study|Physician Decision|1|||
150291367|NCT02699697|542200416|FG000|Overall Study|Lost to Follow-up|2|||
150291368|NCT02699697|542200417|FG001|Overall Study|Lost to Follow-up|3|||
150291369|NCT02699697|542200416|FG000|Overall Study|Refused to follow up|1|||
150291370|NCT02699697|542200417|FG001|Overall Study|Refused to follow up|1|||
149860589|NCT02516410|540620395|FG000|Overall Study|Adverse Event|0|||
149860590|NCT02516410|540620396|FG001|Overall Study|Adverse Event|1|||
149860591|NCT02516410|540620395|FG000|Overall Study|Withdrawal by Subject|0|||
149860592|NCT02516410|540620396|FG001|Overall Study|Withdrawal by Subject|1|||
149860593|NCT01475253|540620401|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
149860594|NCT01475253|540620402|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
149860595|NCT01475253|540620403|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
149860596|NCT01475253|540620404|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
149860597|NCT01475253|540620401|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
149860598|NCT01475253|540620402|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
149860599|NCT01475253|540620403|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
149860600|NCT01475253|540620404|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
149860601|NCT03135899|540620405|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860602|NCT03135899|540620406|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860603|NCT03135899|540620407|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860604|NCT03135899|540620408|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860605|NCT03135899|540620409|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860606|NCT03135899|540620410|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860607|NCT03135899|540620411|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
149860608|NCT03135899|540620412|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
149860609|NCT03135899|540620405|FG000|Overall Study|Withdrawal by Subject|0|||
149860610|NCT03135899|540620406|FG001|Overall Study|Withdrawal by Subject|0|||
149860611|NCT03135899|540620407|FG002|Overall Study|Withdrawal by Subject|0|||
149860612|NCT03135899|540620408|FG003|Overall Study|Withdrawal by Subject|0|||
149860613|NCT03135899|540620409|FG004|Overall Study|Withdrawal by Subject|0|||
149860614|NCT03135899|540620410|FG005|Overall Study|Withdrawal by Subject|2|||
149860615|NCT03135899|540620411|FG006|Overall Study|Withdrawal by Subject|0|||
149860616|NCT03135899|540620412|FG007|Overall Study|Withdrawal by Subject|0|||
149860617|NCT04146363|540620413|FG000|Induction Period|Adverse Event|1|||
149860618|NCT04146363|540620414|FG001|Induction Period|Adverse Event|2|||
149860619|NCT04146363|540620415|FG002|Induction Period|Adverse Event|0|||
149860620|NCT04146363|540620416|FG003|Induction Period|Adverse Event|0|||
149860621|NCT04146363|540620417|FG004|Induction Period|Adverse Event|0|||
149860622|NCT04146363|540620418|FG005|Induction Period|Adverse Event|0|||
149860623|NCT04146363|540620419|FG006|Induction Period|Adverse Event|0|||
149860624|NCT04146363|540620420|FG007|Induction Period|Adverse Event|0|||
149860625|NCT04146363|540620421|FG008|Induction Period|Adverse Event|0|||
149860626|NCT04146363|540620422|FG009|Induction Period|Adverse Event|0|||
149860627|NCT04146363|540620423|FG010|Induction Period|Adverse Event|0|||
149860628|NCT04146363|540620413|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
149860629|NCT04146363|540620414|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
150040609|NCT02215252|541289107|FG001|Overall Study|Protocol Violation|1|||
150040610|NCT02215252|541289108|FG002|Overall Study|Protocol Violation|0|||
150040611|NCT02215252|541289106|FG000|Overall Study|Withdrawal by Subject|1|||
150040612|NCT02215252|541289107|FG001|Overall Study|Withdrawal by Subject|0|||
150040613|NCT02215252|541289108|FG002|Overall Study|Withdrawal by Subject|0|||
150040614|NCT02215252|541289106|FG000|Overall Study|Other|0|||
150040615|NCT02215252|541289107|FG001|Overall Study|Other|1|||
150040616|NCT02215252|541289108|FG002|Overall Study|Other|1|||
149860630|NCT04146363|540620415|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
149860631|NCT04146363|540620416|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
149860632|NCT04146363|540620417|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
149860633|NCT04146363|540620418|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
149860634|NCT04146363|540620419|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
149860635|NCT04146363|540620420|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
149860636|NCT04146363|540620421|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
149860637|NCT04146363|540620422|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
149860638|NCT04146363|540620423|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
149860639|NCT04146363|540620413|FG000|Induction Period|Lack of Efficacy|7|||
149860640|NCT04146363|540620414|FG001|Induction Period|Lack of Efficacy|2|||
149860641|NCT04146363|540620415|FG002|Induction Period|Lack of Efficacy|0|||
149860642|NCT04146363|540620416|FG003|Induction Period|Lack of Efficacy|0|||
149860643|NCT04146363|540620417|FG004|Induction Period|Lack of Efficacy|0|||
149860644|NCT04146363|540620418|FG005|Induction Period|Lack of Efficacy|0|||
150040617|NCT00892099|541289109|FG000|Overall Study|Death|1|||
149860645|NCT04146363|540620419|FG006|Induction Period|Lack of Efficacy|0|||
149860646|NCT04146363|540620420|FG007|Induction Period|Lack of Efficacy|0|||
150040618|NCT00892099|541289110|FG001|Overall Study|Death|0|||
149860647|NCT04146363|540620421|FG008|Induction Period|Lack of Efficacy|0|||
149860648|NCT04146363|540620422|FG009|Induction Period|Lack of Efficacy|0|||
149860649|NCT04146363|540620423|FG010|Induction Period|Lack of Efficacy|0|||
149860650|NCT04146363|540620413|FG000|Induction Period|Lost to Follow-up|1|||
149860651|NCT04146363|540620414|FG001|Induction Period|Lost to Follow-up|4|||
149860652|NCT04146363|540620415|FG002|Induction Period|Lost to Follow-up|0|||
150040619|NCT00892099|541289111|FG002|Overall Study|Death|1|||
150040620|NCT00892099|541289109|FG000|Overall Study|Adverse Event|1|||
150291371|NCT02699697|542200416|FG000|Overall Study|Entered hospice care|5|||
150291372|NCT02699697|542200417|FG001|Overall Study|Entered hospice care|2|||
150291373|NCT02699697|542200416|FG000|Overall Study|Missing reason for discontinuation|6|||
150291374|NCT02699697|542200417|FG001|Overall Study|Missing reason for discontinuation|5|||
150291375|NCT02362035|542200418|FG000|Overall Study|Death|67|||
149860653|NCT04146363|540620416|FG003|Induction Period|Lost to Follow-up|0|||
149860654|NCT04146363|540620417|FG004|Induction Period|Lost to Follow-up|0|||
149860655|NCT04146363|540620418|FG005|Induction Period|Lost to Follow-up|0|||
149860656|NCT04146363|540620419|FG006|Induction Period|Lost to Follow-up|0|||
149860657|NCT04146363|540620420|FG007|Induction Period|Lost to Follow-up|0|||
149860658|NCT04146363|540620421|FG008|Induction Period|Lost to Follow-up|0|||
149860659|NCT04146363|540620422|FG009|Induction Period|Lost to Follow-up|0|||
149860660|NCT04146363|540620423|FG010|Induction Period|Lost to Follow-up|0|||
149860661|NCT04146363|540620413|FG000|Induction Period|Positive quantiferon test|0|||
149860662|NCT04146363|540620414|FG001|Induction Period|Positive quantiferon test|1|||
149860663|NCT04146363|540620415|FG002|Induction Period|Positive quantiferon test|0|||
150291376|NCT02362035|542200418|FG000|Overall Study|Lost to Follow-up|3|||
150291377|NCT02362035|542200418|FG000|Overall Study|Adverse Event|1|||
149860664|NCT04146363|540620416|FG003|Induction Period|Positive quantiferon test|0|||
149860665|NCT04146363|540620417|FG004|Induction Period|Positive quantiferon test|0|||
149860666|NCT04146363|540620418|FG005|Induction Period|Positive quantiferon test|0|||
149860667|NCT04146363|540620419|FG006|Induction Period|Positive quantiferon test|0|||
149860668|NCT04146363|540620420|FG007|Induction Period|Positive quantiferon test|0|||
149860669|NCT04146363|540620421|FG008|Induction Period|Positive quantiferon test|0|||
149860670|NCT04146363|540620422|FG009|Induction Period|Positive quantiferon test|0|||
149860671|NCT04146363|540620423|FG010|Induction Period|Positive quantiferon test|0|||
149860672|NCT04146363|540620413|FG000|Induction Period|Protocol Deviation|5|||
149860673|NCT04146363|540620414|FG001|Induction Period|Protocol Deviation|6|||
149860674|NCT04146363|540620415|FG002|Induction Period|Protocol Deviation|0|||
149860675|NCT04146363|540620416|FG003|Induction Period|Protocol Deviation|0|||
149860676|NCT04146363|540620417|FG004|Induction Period|Protocol Deviation|0|||
149860677|NCT04146363|540620418|FG005|Induction Period|Protocol Deviation|0|||
149860678|NCT04146363|540620419|FG006|Induction Period|Protocol Deviation|0|||
149860679|NCT04146363|540620420|FG007|Induction Period|Protocol Deviation|0|||
149860680|NCT04146363|540620421|FG008|Induction Period|Protocol Deviation|0|||
149860681|NCT04146363|540620422|FG009|Induction Period|Protocol Deviation|0|||
149860682|NCT04146363|540620423|FG010|Induction Period|Protocol Deviation|0|||
149860683|NCT04146363|540620413|FG000|Induction Period|Withdrawal by Subject|6|||
149860684|NCT04146363|540620414|FG001|Induction Period|Withdrawal by Subject|3|||
149860685|NCT04146363|540620415|FG002|Induction Period|Withdrawal by Subject|0|||
149860686|NCT04146363|540620416|FG003|Induction Period|Withdrawal by Subject|0|||
149860687|NCT04146363|540620417|FG004|Induction Period|Withdrawal by Subject|0|||
149860688|NCT04146363|540620418|FG005|Induction Period|Withdrawal by Subject|0|||
149860689|NCT04146363|540620419|FG006|Induction Period|Withdrawal by Subject|0|||
149860690|NCT04146363|540620420|FG007|Induction Period|Withdrawal by Subject|0|||
149860691|NCT04146363|540620421|FG008|Induction Period|Withdrawal by Subject|0|||
149860692|NCT04146363|540620422|FG009|Induction Period|Withdrawal by Subject|0|||
149961884|NCT00159874|540994133|FG003|Overall Study|Death|0|||
149961885|NCT00159874|540994134|FG004|Overall Study|Death|1|||
149961886|NCT00159874|540994135|FG005|Overall Study|Death|2|||
149961887|NCT00159874|540994136|FG006|Overall Study|Death|0|||
149961888|NCT00159874|540994130|FG000|Overall Study|Withdrawal by Subject|2|||
149961889|NCT00159874|540994131|FG001|Overall Study|Withdrawal by Subject|6|||
149961890|NCT00159874|540994132|FG002|Overall Study|Withdrawal by Subject|8|||
149961891|NCT00159874|540994133|FG003|Overall Study|Withdrawal by Subject|4|||
149961892|NCT00159874|540994134|FG004|Overall Study|Withdrawal by Subject|3|||
150173620|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173621|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173622|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173623|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173624|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
150173625|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
150291378|NCT02362035|542200418|FG000|Overall Study|Physician Decision|1|||
149860693|NCT04146363|540620423|FG010|Induction Period|Withdrawal by Subject|0|||
149860694|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860695|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860696|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860697|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
150173626|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
150291379|NCT02362035|542200418|FG000|Overall Study|Subject started another cancer therapy|10|||
149860698|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860699|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860700|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
149860701|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
149860702|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860703|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860704|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
149860705|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860706|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860707|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860708|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860709|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860710|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860711|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860712|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
149860713|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860714|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860715|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149860716|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860717|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860718|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860719|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860720|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860721|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860722|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
149860723|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
149860724|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860725|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860726|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149860727|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860728|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860729|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
149860730|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860731|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860732|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
149860733|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860734|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860735|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860736|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
150173627|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
150173628|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173629|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173630|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173631|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149860737|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
149860738|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860739|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860740|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860741|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860742|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
149860743|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
149860744|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
149860745|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
149860746|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860747|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860748|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149860749|NCT04146363|540620413|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150173632|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173633|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173634|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149860750|NCT04146363|540620414|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149860751|NCT04146363|540620415|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
149860752|NCT04146363|540620416|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
150040621|NCT00892099|541289110|FG001|Overall Study|Adverse Event|0|||
150173635|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
150173636|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149860753|NCT04146363|540620417|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149860754|NCT04146363|540620418|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
149860755|NCT04146363|540620419|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
149860756|NCT04146363|540620420|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
149860757|NCT04146363|540620421|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149860758|NCT04146363|540620422|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149860759|NCT04146363|540620423|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149860760|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860761|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860762|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860763|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860764|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860765|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860766|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860767|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860768|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
149860769|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
149860770|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
149860771|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860772|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860773|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860774|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860775|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860776|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860777|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860778|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149860779|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
149860780|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
149860781|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
149860782|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860783|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860784|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860785|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860786|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860787|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860788|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860789|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860790|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
149860791|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
149860792|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149860793|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860794|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860795|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
150291380|NCT02362035|542200418|FG000|Overall Study|Study terminated by sponsor|45|||
150291381|NCT02362035|542200418|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
150291382|NCT02362035|542200418|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
150291383|NCT02362035|542200418|FG000|Overall Study|Disease progression|11|||
150291384|NCT02362035|542200418|FG000|Overall Study|Withdrawal by Subject|20|||
150291385|NCT01046825|542200419|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
150291386|NCT01046825|542200420|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
150291387|NCT01046825|542200421|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
150291388|NCT01046825|542200422|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
149860796|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860797|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860798|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860799|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860800|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860801|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
149860802|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
149860803|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
149860804|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860805|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860806|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860807|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150040622|NCT00892099|541289111|FG002|Overall Study|Adverse Event|0|||
150291389|NCT01046825|542200423|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
150173637|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
150173638|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
150173639|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
150173640|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149860808|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860809|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860810|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
150173641|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173642|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173643|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173644|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173645|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173646|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173647|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173648|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173649|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
150173650|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
150173651|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
150173652|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
150173653|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
150173654|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173655|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
150291390|NCT01046825|542200419|FG000|Overall Study|Physician Decision|0|||
150291391|NCT01046825|542200420|FG001|Overall Study|Physician Decision|1|||
150291392|NCT01046825|542200421|FG002|Overall Study|Physician Decision|2|||
150291393|NCT01046825|542200422|FG003|Overall Study|Physician Decision|0|||
150291394|NCT01046825|542200423|FG004|Overall Study|Physician Decision|0|||
150291395|NCT01046825|542200419|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
150291396|NCT01046825|542200420|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
150291397|NCT01046825|542200421|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
150291398|NCT01046825|542200422|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
150291399|NCT01046825|542200423|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
150291400|NCT01046825|542200419|FG000|Overall Study|Found to be ineligible|0|||
150291401|NCT01046825|542200420|FG001|Overall Study|Found to be ineligible|1|||
150291402|NCT01046825|542200421|FG002|Overall Study|Found to be ineligible|0|||
150291403|NCT01046825|542200422|FG003|Overall Study|Found to be ineligible|0|||
150291404|NCT01046825|542200423|FG004|Overall Study|Found to be ineligible|0|||
150291405|NCT01046825|542200419|FG000|Overall Study|Death|0|||
150291406|NCT01046825|542200420|FG001|Overall Study|Death|0|||
150291407|NCT01046825|542200421|FG002|Overall Study|Death|0|||
150291408|NCT01046825|542200422|FG003|Overall Study|Death|1|||
150291409|NCT01046825|542200423|FG004|Overall Study|Death|0|||
150291410|NCT01046825|542200419|FG000|Overall Study|Did not submit biology samples|0|||
150291411|NCT01046825|542200420|FG001|Overall Study|Did not submit biology samples|0|||
150291412|NCT01046825|542200421|FG002|Overall Study|Did not submit biology samples|0|||
150291413|NCT01046825|542200422|FG003|Overall Study|Did not submit biology samples|0|||
150291414|NCT01046825|542200423|FG004|Overall Study|Did not submit biology samples|13|||
150291415|NCT05587296|542200425|FG000|Overall Study|Adverse Event|15|||
150291416|NCT05587296|542200426|FG001|Overall Study|Adverse Event|7|||
150291417|NCT05587296|542200425|FG000|Overall Study|Lack of Efficacy|2|||
150291418|NCT05587296|542200426|FG001|Overall Study|Lack of Efficacy|0|||
150291419|NCT05587296|542200425|FG000|Overall Study|Lost to Follow-up|1|||
150291420|NCT05587296|542200426|FG001|Overall Study|Lost to Follow-up|0|||
150291421|NCT05587296|542200425|FG000|Overall Study|Withdrawal by Subject|14|||
150291422|NCT05587296|542200426|FG001|Overall Study|Withdrawal by Subject|4|||
150291423|NCT05587296|542200425|FG000|Overall Study|miscellaneous|3|||
150291424|NCT05587296|542200426|FG001|Overall Study|miscellaneous|6|||
150291425|NCT05587296|542200425|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
150291426|NCT05587296|542200426|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
149860811|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149860812|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
149860813|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
150291427|NCT05469113|542200427|FG000|Period 2|Adverse Event|0|||
150291428|NCT05469113|542200428|FG001|Period 2|Adverse Event|3|||
150291429|NCT02847624|542200431|FG000|Overall Study|Lost to Follow-up|28|||
150291430|NCT02847624|542200431|FG000|Overall Study|Protocol Violation|98|||
150291431|NCT02847624|542200431|FG000|Overall Study|Case report failures|4|||
150291432|NCT02872311|542200432|FG000|Overall Study|Death|2|||
150291433|NCT02872311|542200433|FG001|Overall Study|Death|0|||
150291434|NCT02872311|542200434|FG002|Overall Study|Death|0|||
149860814|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
150173656|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
149860815|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860816|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860817|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860818|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860819|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860820|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860821|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
150291435|NCT02872311|542200435|FG003|Overall Study|Death|0|||
150291436|NCT02872311|542200436|FG004|Overall Study|Death|0|||
150291437|NCT02872311|542200432|FG000|Overall Study|Lost to Follow-up|2|||
150291438|NCT02872311|542200433|FG001|Overall Study|Lost to Follow-up|0|||
150291439|NCT02872311|542200434|FG002|Overall Study|Lost to Follow-up|0|||
150291440|NCT02872311|542200435|FG003|Overall Study|Lost to Follow-up|0|||
150291441|NCT02872311|542200436|FG004|Overall Study|Lost to Follow-up|0|||
150291442|NCT02872311|542200432|FG000|Overall Study|Protocol Violation|0|||
150291443|NCT02872311|542200433|FG001|Overall Study|Protocol Violation|2|||
150291444|NCT02872311|542200434|FG002|Overall Study|Protocol Violation|1|||
150291445|NCT02872311|542200435|FG003|Overall Study|Protocol Violation|0|||
150291446|NCT02872311|542200436|FG004|Overall Study|Protocol Violation|0|||
150291447|NCT04102098|542200437|FG000|Main Study Period|Ongoing in study|302|||
150291448|NCT04102098|542200438|FG001|Main Study Period|Ongoing in study|291|||
150291449|NCT04102098|542200437|FG000|Main Study Period|Death|20|||
150291450|NCT04102098|542200438|FG001|Main Study Period|Death|27|||
150291451|NCT04102098|542200437|FG000|Main Study Period|Lost to Follow-up|1|||
150291452|NCT04102098|542200438|FG001|Main Study Period|Lost to Follow-up|1|||
150291453|NCT04102098|542200437|FG000|Main Study Period|Physician Decision|0|||
150291454|NCT04102098|542200438|FG001|Main Study Period|Physician Decision|1|||
150291455|NCT04102098|542200437|FG000|Main Study Period|Withdrawal by Subject|11|||
150291456|NCT04102098|542200438|FG001|Main Study Period|Withdrawal by Subject|14|||
150291457|NCT04102098|542200437|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
150291458|NCT04102098|542200438|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
150291459|NCT04102098|542200437|FG000|Crossover: AS Who Crossed Over|Death|11|||
150291460|NCT04102098|542200438|FG001|Crossover: AS Who Crossed Over|Death|0|||
150291461|NCT04102098|542200437|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
150291462|NCT04102098|542200438|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
150291463|NCT04373551|542200439|FG000|Overall Study|Lost to Follow-up|15|||
150291464|NCT04373551|542200439|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
150291465|NCT05617911|542200440|FG000|Overall Study|Withdrawal by Subject|1|||
150291466|NCT05617911|542200441|FG001|Overall Study|Withdrawal by Subject|0|||
150291467|NCT04507126|542200442|FG000|Overall Study|Withdrawal by Subject|3|||
150291468|NCT04507126|542200442|FG000|Overall Study|Protocol Violation|4|||
150291469|NCT03975647|542200450|FG000|Overall Study|Death|71|||
150291470|NCT03975647|542200451|FG001|Overall Study|Death|63|||
150291471|NCT03975647|542200450|FG000|Overall Study|Lost to Follow-up|2|||
150291472|NCT03975647|542200451|FG001|Overall Study|Lost to Follow-up|2|||
150291473|NCT03975647|542200450|FG000|Overall Study|Subject withdrawal of consent|7|||
150291474|NCT03975647|542200451|FG001|Overall Study|Subject withdrawal of consent|11|||
150291475|NCT04868903|542200452|FG000|Overall Study|Adverse Event|0|||
150291476|NCT04868903|542200453|FG001|Overall Study|Adverse Event|0|||
150291477|NCT04868903|542200454|FG002|Overall Study|Adverse Event|0|||
150291478|NCT04868903|542200455|FG003|Overall Study|Adverse Event|1|||
150291479|NCT04868903|542200452|FG000|Overall Study|Withdrawal by Subject|29|||
150291480|NCT04868903|542200453|FG001|Overall Study|Withdrawal by Subject|44|||
150291481|NCT04868903|542200454|FG002|Overall Study|Withdrawal by Subject|17|||
150291482|NCT04868903|542200455|FG003|Overall Study|Withdrawal by Subject|12|||
150291483|NCT04868903|542200452|FG000|Overall Study|Hyperparathyroidism|3|||
150291484|NCT04868903|542200453|FG001|Overall Study|Hyperparathyroidism|5|||
150291485|NCT04868903|542200454|FG002|Overall Study|Hyperparathyroidism|2|||
150291486|NCT04868903|542200455|FG003|Overall Study|Hyperparathyroidism|3|||
150291487|NCT03449901|542200456|FG000|Overall Study|Progression|57|||
150291488|NCT03449901|542200457|FG001|Overall Study|Progression|12|||
149860822|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
150040623|NCT00892099|541289109|FG000|Overall Study|replocated|1|||
150040624|NCT00892099|541289110|FG001|Overall Study|replocated|0|||
150291489|NCT03449901|542200456|FG000|Overall Study|Adverse Event|3|||
150291490|NCT03449901|542200457|FG001|Overall Study|Adverse Event|0|||
150291491|NCT03449901|542200456|FG000|Overall Study|Death|6|||
150291492|NCT03449901|542200457|FG001|Overall Study|Death|2|||
150291493|NCT03449901|542200456|FG000|Overall Study|Withdrawal by Subject|12|||
150291494|NCT03449901|542200457|FG001|Overall Study|Withdrawal by Subject|1|||
150291495|NCT03449901|542200456|FG000|Overall Study|Physician Decision|1|||
150291496|NCT03449901|542200457|FG001|Overall Study|Physician Decision|0|||
150291497|NCT03449901|542200456|FG000|Overall Study|Patient elected for surgical intervention|1|||
150291498|NCT03449901|542200457|FG001|Overall Study|Patient elected for surgical intervention|0|||
150291499|NCT03449901|542200456|FG000|Overall Study|Patient off for other complicating disease|1|||
150291500|NCT03449901|542200457|FG001|Overall Study|Patient off for other complicating disease|0|||
150291501|NCT03150173|542200458|FG000|Overall Study|Lost to Follow-up|13|||
149860823|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860824|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
149860825|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
149860826|NCT04146363|540620413|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860827|NCT04146363|540620414|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860828|NCT04146363|540620415|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860829|NCT04146363|540620416|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860830|NCT04146363|540620417|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860831|NCT04146363|540620418|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
150173657|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173658|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173659|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173660|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
149860832|NCT04146363|540620419|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860833|NCT04146363|540620420|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860834|NCT04146363|540620421|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860835|NCT04146363|540620422|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
149860836|NCT04146363|540620423|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
149860837|NCT02914236|540620428|FG000|Overall Study|Lost to Follow-up|1|||
149860838|NCT04776746|540620429|FG000|Overall Study|Study terminated by sponsor|61|||
149860839|NCT04776746|540620429|FG000|Overall Study|Adverse Event|5|||
150173661|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173662|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173663|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173664|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
149860840|NCT04776746|540620429|FG000|Overall Study|Death|4|||
149860841|NCT04776746|540620429|FG000|Overall Study|Lack of Efficacy|3|||
149860842|NCT04776746|540620429|FG000|Overall Study|Noncompliance with study drug|2|||
149860843|NCT04776746|540620429|FG000|Overall Study|Not related to COVID-19|2|||
149860844|NCT00856830|540620430|FG000|Irinotecan & Bendamustine|Death|0|||
149860845|NCT00856830|540620431|FG001|Irinotecan & Bendamustine|Death|0|||
149860846|NCT00856830|540620432|FG002|Irinotecan & Bendamustine|Death|0|||
149860847|NCT00856830|540620433|FG003|Irinotecan & Bendamustine|Death|2|||
149860848|NCT00856830|540620430|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
149860849|NCT00856830|540620431|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
149860850|NCT00856830|540620432|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
149860851|NCT00856830|540620433|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
149860852|NCT03768726|540620438|FG000|Treatment Phase|Adverse Event|2|||
149860853|NCT03768726|540620439|FG001|Treatment Phase|Adverse Event|2|||
149860854|NCT03768726|540620438|FG000|Treatment Phase|Lost to Follow-up|1|||
150291502|NCT03150173|542200459|FG001|Overall Study|Lost to Follow-up|5|||
150291503|NCT05444556|542200460|FG000|Overall Study|Withdrawal by Subject|0|||
150291504|NCT05444556|542200461|FG001|Overall Study|Withdrawal by Subject|0|||
150291505|NCT05444556|542200462|FG002|Overall Study|Withdrawal by Subject|2|||
150291506|NCT05444556|542200463|FG003|Overall Study|Withdrawal by Subject|1|||
149860855|NCT03768726|540620439|FG001|Treatment Phase|Lost to Follow-up|0|||
149860856|NCT03768726|540620438|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
149860857|NCT03768726|540620439|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
149860858|NCT03768726|540620438|FG000|Treatment Phase|Withdrawal by Subject|3|||
149860859|NCT03768726|540620439|FG001|Treatment Phase|Withdrawal by Subject|1|||
149860860|NCT03768726|540620438|FG000|Follow-Up|Adverse Event|2|||
149860861|NCT03768726|540620439|FG001|Follow-Up|Adverse Event|2|||
149860862|NCT03768726|540620438|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
149860863|NCT03768726|540620439|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
149860864|NCT03768726|540620438|FG000|Follow-Up|Withdrawal by Subject|2|||
150291507|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
150291508|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
150291509|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
150291510|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
150291511|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
149860865|NCT03768726|540620439|FG001|Follow-Up|Withdrawal by Subject|0|||
150173665|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
150173666|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
149860866|NCT03768726|540620438|FG000|Follow-Up|Other|1|||
150291512|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
149860867|NCT03768726|540620439|FG001|Follow-Up|Other|0|||
149860868|NCT02694549|540620443|FG000|Overall Study|screen failures|2|||
149860869|NCT01567826|540620444|FG000|Overall Study|Lost to Follow-up|3|||
149860870|NCT01567826|540620445|FG001|Overall Study|Lost to Follow-up|2|||
149860871|NCT03265288|540620452|FG000|Overall Study|Adverse Event|0|||
149860872|NCT03265288|540620453|FG001|Overall Study|Adverse Event|1|||
150291513|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
149860873|NCT03265288|540620452|FG000|Overall Study|Withdrawal by Subject|13|||
149860874|NCT03265288|540620453|FG001|Overall Study|Withdrawal by Subject|5|||
149860875|NCT03265288|540620452|FG000|Overall Study|Drug Withdrawn|3|||
149860876|NCT03265288|540620453|FG001|Overall Study|Drug Withdrawn|3|||
150291514|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
150291515|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
150291516|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
150291517|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
150291518|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
150291519|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
150291520|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
150291521|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
150291522|NCT03735667|542200466|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
150291523|NCT03735667|542200467|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
150291524|NCT03735667|542200468|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
150291525|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
150291526|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
150291527|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
150291528|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
150291529|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
150291530|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
150291531|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
150291532|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
150291533|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
150291534|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
150291535|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
150291536|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
150291537|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
150291538|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
150291539|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
150291540|NCT03735667|542200466|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
150291541|NCT03735667|542200467|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
150291542|NCT03735667|542200468|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
150291543|NCT02772562|542200470|FG000|Overall Study|Withdrawal by Subject|1|||
150291544|NCT02772562|542200470|FG000|Overall Study|Protocol Violation|1|||
150291545|NCT03755791|542200471|FG000|Overall Study|Did not receive any study treatment|3|||
150291546|NCT03755791|542200472|FG001|Overall Study|Did not receive any study treatment|0|||
150291547|NCT03755791|542200473|FG002|Overall Study|Did not receive any study treatment|10|||
150291548|NCT03755791|542200471|FG000|Overall Study|Radiographic progression|204|||
150291549|NCT03755791|542200472|FG001|Overall Study|Radiographic progression|92|||
150291550|NCT03755791|542200473|FG002|Overall Study|Radiographic progression|115|||
150291551|NCT03755791|542200471|FG000|Overall Study|Adverse Event|140|||
150291552|NCT03755791|542200472|FG001|Overall Study|Adverse Event|60|||
150291553|NCT03755791|542200473|FG002|Overall Study|Adverse Event|51|||
150291554|NCT03755791|542200471|FG000|Overall Study|Lack of Efficacy|12|||
150291555|NCT03755791|542200472|FG001|Overall Study|Lack of Efficacy|6|||
150291556|NCT03755791|542200473|FG002|Overall Study|Lack of Efficacy|6|||
150291557|NCT03755791|542200471|FG000|Overall Study|Withdrawal by Subject|26|||
150291558|NCT03755791|542200472|FG001|Overall Study|Withdrawal by Subject|23|||
150291559|NCT03755791|542200473|FG002|Overall Study|Withdrawal by Subject|24|||
150291560|NCT03755791|542200471|FG000|Overall Study|Sponsor decision,|41|||
150291561|NCT03755791|542200472|FG001|Overall Study|Sponsor decision,|5|||
150291562|NCT03755791|542200473|FG002|Overall Study|Sponsor decision,|7|||
150291563|NCT03755791|542200471|FG000|Overall Study|Lost to Follow-up|1|||
150291564|NCT03755791|542200472|FG001|Overall Study|Lost to Follow-up|0|||
150291565|NCT03755791|542200473|FG002|Overall Study|Lost to Follow-up|2|||
150291566|NCT03755791|542200471|FG000|Overall Study|Protocol Violation|0|||
150291567|NCT03755791|542200472|FG001|Overall Study|Protocol Violation|0|||
150291568|NCT03755791|542200473|FG002|Overall Study|Protocol Violation|2|||
150291569|NCT03755791|542200471|FG000|Overall Study|Other than specified|5|||
149860877|NCT03265288|540620452|FG000|Overall Study|Any Other Reason|7|||
149860878|NCT03265288|540620453|FG001|Overall Study|Any Other Reason|3|||
149860879|NCT03575871|540620461|FG000|Overall Study|Adverse Event|5|||
150040625|NCT00892099|541289111|FG002|Overall Study|replocated|2|||
150291570|NCT03755791|542200472|FG001|Overall Study|Other than specified|2|||
150291571|NCT03755791|542200473|FG002|Overall Study|Other than specified|0|||
150291572|NCT03109847|542200482|FG000|Overall Study|Withdrawal by Subject|1|||
150291573|NCT03109847|542200483|FG001|Overall Study|Withdrawal by Subject|0|||
150291574|NCT04976621|542200484|FG000|Overall Study|Lost to Follow-up|2|||
150291575|NCT04976621|542200485|FG001|Overall Study|Lost to Follow-up|2|||
150291576|NCT04976621|542200484|FG000|Overall Study|Withdrawal by Subject|1|||
150291577|NCT04976621|542200485|FG001|Overall Study|Withdrawal by Subject|1|||
149860880|NCT03575871|540620462|FG001|Overall Study|Adverse Event|5|||
149860881|NCT03575871|540620463|FG002|Overall Study|Adverse Event|8|||
149860882|NCT03575871|540620461|FG000|Overall Study|Death|1|||
149860883|NCT03575871|540620462|FG001|Overall Study|Death|0|||
149860884|NCT03575871|540620463|FG002|Overall Study|Death|0|||
149860885|NCT03575871|540620461|FG000|Overall Study|Lack of Efficacy|5|||
149860886|NCT03575871|540620462|FG001|Overall Study|Lack of Efficacy|4|||
149860887|NCT03575871|540620463|FG002|Overall Study|Lack of Efficacy|7|||
149860888|NCT03575871|540620461|FG000|Overall Study|Lost to Follow-up|1|||
149860889|NCT03575871|540620462|FG001|Overall Study|Lost to Follow-up|1|||
149860890|NCT03575871|540620463|FG002|Overall Study|Lost to Follow-up|1|||
149860891|NCT03575871|540620461|FG000|Overall Study|Protocol Deviation|1|||
149860892|NCT03575871|540620462|FG001|Overall Study|Protocol Deviation|1|||
149860893|NCT03575871|540620463|FG002|Overall Study|Protocol Deviation|1|||
149961893|NCT00159874|540994135|FG005|Overall Study|Withdrawal by Subject|2|||
149961894|NCT00159874|540994136|FG006|Overall Study|Withdrawal by Subject|1|||
149961895|NCT00159874|540994130|FG000|Overall Study|Pregnancy|1|||
149961896|NCT00159874|540994131|FG001|Overall Study|Pregnancy|1|||
149961897|NCT00159874|540994132|FG002|Overall Study|Pregnancy|0|||
149961898|NCT00159874|540994133|FG003|Overall Study|Pregnancy|0|||
149961899|NCT00159874|540994134|FG004|Overall Study|Pregnancy|0|||
149961900|NCT00159874|540994135|FG005|Overall Study|Pregnancy|0|||
149961901|NCT00159874|540994136|FG006|Overall Study|Pregnancy|0|||
149961902|NCT01550965|540994138|FG000|Overall Study|Adverse Event|26|||
149961903|NCT01550965|540994138|FG000|Overall Study|Withdrawal by Subject|10|||
149961904|NCT01550965|540994138|FG000|Overall Study|Lost to Follow-up|2|||
149961905|NCT01550965|540994138|FG000|Overall Study|Lack of Efficacy|59|||
149961906|NCT01550965|540994138|FG000|Overall Study|Other|13|||
149961907|NCT02771145|540994144|FG000|Overall Study|Adverse Event|3|||
149961908|NCT02771145|540994144|FG000|Overall Study|Lost to Follow-up|1|||
149961909|NCT00276380|540994145|FG000|Overall Study|Adverse Event|5|||
149961910|NCT00276380|540994146|FG001|Overall Study|Adverse Event|3|||
150291578|NCT03212170|542200486|FG000|Overall Study|Withdrawal by Subject|1|||
150291579|NCT03205995|542200496|FG000|Overall Study|Adverse Event|1|||
149961911|NCT00276380|540994145|FG000|Overall Study|Lost to Follow-up|1|||
149961912|NCT00276380|540994146|FG001|Overall Study|Lost to Follow-up|1|||
149961913|NCT00276380|540994145|FG000|Overall Study|Withdrawal by Subject|3|||
149961914|NCT00276380|540994146|FG001|Overall Study|Withdrawal by Subject|6|||
149961915|NCT00276380|540994145|FG000|Overall Study|Death|5|||
149961916|NCT00276380|540994146|FG001|Overall Study|Death|3|||
150291580|NCT03205995|542200496|FG000|Overall Study|Death|1|||
150291581|NCT03205995|542200496|FG000|Overall Study|Physician Decision|2|||
150291582|NCT03205995|542200496|FG000|Overall Study|Protocol Violation|2|||
150291583|NCT03892746|542200497|FG000|Overall Study|Withdrawal by Subject|2|||
150291584|NCT03892746|542200498|FG001|Overall Study|Withdrawal by Subject|1|||
150291585|NCT03892746|542200497|FG000|Overall Study|Lost to Follow-up|2|||
150291586|NCT03892746|542200498|FG001|Overall Study|Lost to Follow-up|0|||
150291587|NCT04068610|542200503|FG000|Overall Study|Death|4|||
150291588|NCT04068610|542200504|FG001|Overall Study|Death|8|||
150291589|NCT04068610|542200505|FG002|Overall Study|Death|13|||
150291590|NCT04068610|542200503|FG000|Overall Study|Lost to Follow-up|0|||
150291591|NCT04068610|542200504|FG001|Overall Study|Lost to Follow-up|2|||
150291592|NCT04068610|542200505|FG002|Overall Study|Lost to Follow-up|0|||
150291593|NCT04068610|542200503|FG000|Overall Study|Withdrawal by Subject|0|||
150291594|NCT04068610|542200504|FG001|Overall Study|Withdrawal by Subject|4|||
150291595|NCT04068610|542200505|FG002|Overall Study|Withdrawal by Subject|2|||
150291596|NCT04068610|542200503|FG000|Overall Study|Other|3|||
150291597|NCT04068610|542200504|FG001|Overall Study|Other|12|||
150291598|NCT04068610|542200505|FG002|Overall Study|Other|11|||
150291599|NCT05535972|542200506|FG000|Overall Study|Withdrawal by Subject|31|||
150291600|NCT05535972|542200506|FG000|Overall Study|Lost to Follow-up|5|||
150291601|NCT05535972|542200506|FG000|Overall Study|Adverse Event|6|||
149961917|NCT00276380|540994145|FG000|Overall Study|Abnormal aPPT Levels|0|||
149961918|NCT00276380|540994146|FG001|Overall Study|Abnormal aPPT Levels|1|||
149961919|NCT01651208|540994147|FG000|Overall Study|Lost to Follow-up|14|||
149961920|NCT01651208|540994148|FG001|Overall Study|Lost to Follow-up|16|||
149961921|NCT02067156|540994152|FG000|Overall Study|Lost to Follow-up|4|||
150291602|NCT05535972|542200506|FG000|Overall Study|Protocol Deviation|2|||
150291603|NCT03594994|542200508|FG000|Overall Study|Adverse Event|1|||
150291604|NCT03594994|542200509|FG001|Overall Study|Adverse Event|0|||
150291605|NCT03594994|542200508|FG000|Overall Study|Withdrawal by Subject|0|||
150291606|NCT03594994|542200509|FG001|Overall Study|Withdrawal by Subject|1|||
149860894|NCT03575871|540620461|FG000|Overall Study|Withdrawal by Subject|6|||
149860895|NCT03575871|540620462|FG001|Overall Study|Withdrawal by Subject|1|||
149961922|NCT03596983|540994153|FG000|Overall Study|Withdrawal by Subject|3|||
149961923|NCT03473301|540994154|FG000|Overall Study|Protocol Violation|4|||
149961924|NCT03473301|540994155|FG001|Overall Study|Protocol Violation|0|||
149961925|NCT03473301|540994156|FG002|Overall Study|Protocol Violation|0|||
150291607|NCT02649894|542200510|FG000|Overall Study|Adverse Event|1|||
149961926|NCT03473301|540994154|FG000|Overall Study|Withdrawal by Subject|0|||
149961927|NCT03473301|540994155|FG001|Overall Study|Withdrawal by Subject|1|||
150291608|NCT02649894|542200511|FG001|Overall Study|Adverse Event|0|||
150291609|NCT02649894|542200510|FG000|Overall Study|Physician Decision|0|||
150291610|NCT02649894|542200511|FG001|Overall Study|Physician Decision|1|||
150291611|NCT02649894|542200510|FG000|Overall Study|Withdrawal by Subject|5|||
150291612|NCT02649894|542200511|FG001|Overall Study|Withdrawal by Subject|2|||
150291613|NCT02649894|542200510|FG000|Overall Study|Lost to Follow-up|2|||
150291614|NCT02649894|542200511|FG001|Overall Study|Lost to Follow-up|1|||
150291615|NCT02649894|542200510|FG000|Overall Study|Death|30|||
150291616|NCT02649894|542200511|FG001|Overall Study|Death|7|||
150291617|NCT02649894|542200510|FG000|Overall Study|Other, not specified|6|||
150291618|NCT02649894|542200511|FG001|Overall Study|Other, not specified|0|||
150291619|NCT04590963|542200514|FG000|Overall Study|Death|118|||
150291620|NCT04590963|542200515|FG001|Overall Study|Death|59|||
150291621|NCT04590963|542200514|FG000|Overall Study|Lost to Follow-up|1|||
150291622|NCT04590963|542200515|FG001|Overall Study|Lost to Follow-up|1|||
150291623|NCT04590963|542200514|FG000|Overall Study|Progressive disease|0|||
150291624|NCT04590963|542200515|FG001|Overall Study|Progressive disease|1|||
150291625|NCT04590963|542200514|FG000|Overall Study|Study terminated by sponsor|103|||
150291626|NCT04590963|542200515|FG001|Overall Study|Study terminated by sponsor|50|||
150291627|NCT04590963|542200514|FG000|Overall Study|Withdrawal by Subject|15|||
150291628|NCT04590963|542200515|FG001|Overall Study|Withdrawal by Subject|8|||
150291629|NCT04590963|542200514|FG000|Overall Study|Ongoing at data cut-off|9|||
150291630|NCT04590963|542200515|FG001|Overall Study|Ongoing at data cut-off|4|||
150291631|NCT04590963|542200514|FG000|Overall Study|Screen failure|1|||
150291632|NCT04590963|542200515|FG001|Overall Study|Screen failure|0|||
149860896|NCT03575871|540620463|FG002|Overall Study|Withdrawal by Subject|9|||
149860897|NCT03575871|540620461|FG000|Overall Study|Other than specified|2|||
149860898|NCT03575871|540620462|FG001|Overall Study|Other than specified|2|||
149860899|NCT03575871|540620463|FG002|Overall Study|Other than specified|0|||
149860900|NCT05506358|540620464|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
149860901|NCT05506358|540620465|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
149860902|NCT05506358|540620466|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
149860903|NCT05506358|540620467|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
149860904|NCT05506358|540620468|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
149860905|NCT05506358|540620464|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
149860906|NCT05506358|540620465|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
149860907|NCT05506358|540620466|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
149860908|NCT05506358|540620467|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
149860909|NCT05506358|540620468|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
149860910|NCT05506358|540620464|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
149860911|NCT05506358|540620465|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
149860912|NCT05506358|540620466|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
149860913|NCT05506358|540620467|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
149860914|NCT05506358|540620468|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
149860915|NCT05506358|540620464|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
149860916|NCT05506358|540620465|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
149860917|NCT05506358|540620466|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
149961928|NCT03473301|540994156|FG002|Overall Study|Withdrawal by Subject|0|||
149961929|NCT03473301|540994154|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
149961930|NCT03473301|540994155|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
149961931|NCT03473301|540994156|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
149961932|NCT04829214|540994157|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
149961933|NCT04829214|540994158|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
150291633|NCT04430738|542200516|FG000|Phase 1: Dose Escalation|Death|1|||
150291634|NCT04430738|542200517|FG001|Phase 1: Dose Escalation|Death|4|||
150291635|NCT04430738|542200518|FG002|Phase 1: Dose Escalation|Death|4|||
150291636|NCT04430738|542200519|FG003|Phase 1: Dose Escalation|Death|1|||
149961934|NCT04829214|540994157|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
149961935|NCT04829214|540994158|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
149961936|NCT05287685|540994159|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
149961937|NCT05287685|540994160|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
149961938|NCT05287685|540994159|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
150291637|NCT04430738|542200520|FG004|Phase 1: Dose Escalation|Death|6|||
150291638|NCT04430738|542200521|FG005|Phase 1: Dose Escalation|Death|0|||
150291639|NCT04430738|542200516|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
150291640|NCT04430738|542200517|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
150291641|NCT04430738|542200518|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
150291642|NCT04430738|542200519|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
150291643|NCT04430738|542200520|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
149961939|NCT05287685|540994160|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
149961940|NCT02571244|540994161|FG000|Overall Study|Lost to Follow-up|0|||
149961941|NCT02571244|540994162|FG001|Overall Study|Lost to Follow-up|1|||
149961942|NCT02571244|540994161|FG000|Overall Study|Unable to reach out post discharge|3|||
149961943|NCT02571244|540994162|FG001|Overall Study|Unable to reach out post discharge|0|||
149961944|NCT01696214|540994163|FG000|Overall Study|Lost to Follow-up|1|||
150291644|NCT04430738|542200521|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
150291645|NCT04430738|542200516|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
150291646|NCT04430738|542200517|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
150291647|NCT04430738|542200518|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
150291648|NCT04430738|542200519|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
150291649|NCT04430738|542200520|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
150291650|NCT04430738|542200521|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
150291651|NCT04430738|542200516|FG000|Phase 1: Dose Escalation|Other|1|||
150291652|NCT04430738|542200517|FG001|Phase 1: Dose Escalation|Other|0|||
150291653|NCT04430738|542200518|FG002|Phase 1: Dose Escalation|Other|0|||
150291654|NCT04430738|542200519|FG003|Phase 1: Dose Escalation|Other|0|||
150291655|NCT04430738|542200520|FG004|Phase 1: Dose Escalation|Other|0|||
150291656|NCT04430738|542200521|FG005|Phase 1: Dose Escalation|Other|0|||
150291657|NCT04430738|542200516|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
150291658|NCT04430738|542200517|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
150291659|NCT04430738|542200518|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
150291660|NCT04430738|542200519|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
150291661|NCT04430738|542200520|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
150291662|NCT04430738|542200521|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
150291663|NCT04430738|542200516|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
150291664|NCT04430738|542200517|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
150291665|NCT04430738|542200518|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
150291666|NCT04430738|542200519|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
150291667|NCT04430738|542200520|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
150291668|NCT04430738|542200521|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
150291669|NCT00309985|542201671|FG000|Overall Study|Disease progression|12|||
150291670|NCT00309985|542201672|FG001|Overall Study|Disease progression|0|||
150291671|NCT00309985|542201671|FG000|Overall Study|Adverse Event|30|||
150291672|NCT00309985|542201672|FG001|Overall Study|Adverse Event|0|||
150291673|NCT00309985|542201671|FG000|Overall Study|Death|2|||
150291674|NCT00309985|542201672|FG001|Overall Study|Death|0|||
150291675|NCT00309985|542201671|FG000|Overall Study|Withdrawal by Subject|5|||
150291676|NCT00309985|542201672|FG001|Overall Study|Withdrawal by Subject|1|||
150291677|NCT00309985|542201671|FG000|Overall Study|Physician Decision|3|||
150291678|NCT00309985|542201672|FG001|Overall Study|Physician Decision|0|||
150291679|NCT00309985|542201671|FG000|Overall Study|Never started treatment|7|||
150291680|NCT00309985|542201672|FG001|Overall Study|Never started treatment|0|||
150291681|NCT00309985|542201671|FG000|Overall Study|Complicating disease|1|||
150291682|NCT00309985|542201672|FG001|Overall Study|Complicating disease|0|||
150291683|NCT00309985|542201671|FG000|Overall Study|Non-compliance|1|||
150291684|NCT00309985|542201672|FG001|Overall Study|Non-compliance|0|||
150291685|NCT00309985|542201671|FG000|Overall Study|Chemotherapy discontinued only|1|||
150291686|NCT00309985|542201672|FG001|Overall Study|Chemotherapy discontinued only|0|||
150291687|NCT05575063|542201673|FG000|Overall Study|Withdrawal by Subject|1|||
150291688|NCT03659916|542201674|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
150291689|NCT03659916|542201675|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
150291690|NCT03659916|542201676|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
150291691|NCT03659916|542201674|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
150291692|NCT03659916|542201675|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
150291693|NCT03659916|542201676|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
150291694|NCT03659916|542201674|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
150291695|NCT03659916|542201675|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
150291696|NCT03659916|542201676|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
150291697|NCT03659916|542201674|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
150291698|NCT03659916|542201675|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
150291699|NCT03659916|542201676|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
149961945|NCT01696214|540994164|FG001|Overall Study|Lost to Follow-up|0|||
149961946|NCT01696214|540994165|FG002|Overall Study|Lost to Follow-up|0|||
149961947|NCT01696214|540994166|FG003|Overall Study|Lost to Follow-up|0|||
150291700|NCT03659916|542201674|FG000|Treatment Period (72 Weeks)|Other|1|||
149961948|NCT01570192|540994167|FG000|Overall Study|no qualifying organism|6|||
149961949|NCT01570192|540994168|FG001|Overall Study|no qualifying organism|12|||
149961950|NCT01570192|540994167|FG000|Overall Study|changed to palliative care|1|||
149860918|NCT05506358|540620467|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
149860919|NCT05506358|540620468|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
149860920|NCT05506358|540620464|FG000|Overall Study|HbE trait|0|||
149860921|NCT05506358|540620465|FG001|Overall Study|HbE trait|0|||
149860922|NCT05506358|540620466|FG002|Overall Study|HbE trait|0|||
149860923|NCT05506358|540620467|FG003|Overall Study|HbE trait|1|||
150291701|NCT03659916|542201675|FG001|Treatment Period (72 Weeks)|Other|3|||
150291702|NCT03659916|542201676|FG002|Treatment Period (72 Weeks)|Other|9|||
150291703|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
150291704|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
150291705|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
150291706|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
150291707|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
150291708|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
150291709|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
150291710|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
150291711|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
150291712|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
150291713|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
150291714|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
150291715|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
150291716|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
150291717|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
150291718|NCT03659916|542201674|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
150291719|NCT03659916|542201675|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
150291720|NCT03659916|542201676|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
150291721|NCT04941456|542201677|FG000|Overall Study|Withdrawal by Subject|1|||
150291722|NCT04941456|542201678|FG001|Overall Study|Withdrawal by Subject|0|||
150291723|NCT04941456|542201677|FG000|Overall Study|Protocol Violation|1|||
150291724|NCT04941456|542201678|FG001|Overall Study|Protocol Violation|0|||
150291725|NCT02296684|542201679|FG000|Overall Study|Withdrawal by Subject|0|||
150291726|NCT02296684|542201680|FG001|Overall Study|Withdrawal by Subject|1|||
150291727|NCT02296684|542201681|FG002|Overall Study|Withdrawal by Subject|1|||
150291728|NCT02296684|542201679|FG000|Overall Study|Death|2|||
150291729|NCT02296684|542201680|FG001|Overall Study|Death|0|||
150291730|NCT02296684|542201681|FG002|Overall Study|Death|0|||
150291731|NCT04452344|542201684|FG000|Overall Study|Withdrawal by Subject|3|||
150291732|NCT04452344|542201685|FG001|Overall Study|Withdrawal by Subject|6|||
150291733|NCT04452344|542201684|FG000|Overall Study|Adverse Event|1|||
150291734|NCT04452344|542201685|FG001|Overall Study|Adverse Event|2|||
150291735|NCT04452344|542201684|FG000|Overall Study|Lost to Follow-up|2|||
150291736|NCT04452344|542201685|FG001|Overall Study|Lost to Follow-up|2|||
150291737|NCT04452344|542201684|FG000|Overall Study|No Post-Op Visit|6|||
150291738|NCT04452344|542201685|FG001|Overall Study|No Post-Op Visit|7|||
150291739|NCT05171777|542201688|FG000|Treatment Crossover Period|Adverse Event|9|||
150291740|NCT05171777|542201689|FG001|Treatment Crossover Period|Adverse Event|6|||
150291741|NCT05171777|542201690|FG002|Treatment Crossover Period|Adverse Event|0|||
150291742|NCT05171777|542201691|FG003|Treatment Crossover Period|Adverse Event|0|||
150291743|NCT05171777|542201688|FG000|Treatment Crossover Period|Death|5|||
150291744|NCT05171777|542201689|FG001|Treatment Crossover Period|Death|5|||
150291745|NCT05171777|542201690|FG002|Treatment Crossover Period|Death|0|||
150291746|NCT05171777|542201691|FG003|Treatment Crossover Period|Death|0|||
149860924|NCT05506358|540620468|FG004|Overall Study|HbE trait|0|||
149860925|NCT00252174|540620474|FG000|Overall Study|Withdrawal by Subject|0|||
149860926|NCT00252174|540620475|FG001|Overall Study|Withdrawal by Subject|1|||
149860927|NCT00252174|540620476|FG002|Overall Study|Withdrawal by Subject|0|||
150291747|NCT05171777|542201688|FG000|Treatment Crossover Period|Disease Relapse|1|||
150291748|NCT05171777|542201689|FG001|Treatment Crossover Period|Disease Relapse|0|||
150291749|NCT05171777|542201690|FG002|Treatment Crossover Period|Disease Relapse|0|||
150291750|NCT05171777|542201691|FG003|Treatment Crossover Period|Disease Relapse|0|||
150291751|NCT05171777|542201688|FG000|Treatment Crossover Period|Reason not Specified|1|||
150291752|NCT05171777|542201689|FG001|Treatment Crossover Period|Reason not Specified|1|||
150291753|NCT05171777|542201690|FG002|Treatment Crossover Period|Reason not Specified|0|||
150291754|NCT05171777|542201691|FG003|Treatment Crossover Period|Reason not Specified|0|||
150291755|NCT05171777|542201688|FG000|Treatment Crossover Period|Physician Decision|0|||
150291756|NCT05171777|542201689|FG001|Treatment Crossover Period|Physician Decision|1|||
149860928|NCT02546362|540620477|FG000|4-week Treatment Period|Lost to Follow-up|1|||
149860929|NCT02546362|540620477|FG000|4-week Treatment Period|Change in medication|2|||
150291757|NCT05171777|542201690|FG002|Treatment Crossover Period|Physician Decision|0|||
150291758|NCT05171777|542201691|FG003|Treatment Crossover Period|Physician Decision|0|||
150291759|NCT05171777|542201688|FG000|Treatment Crossover Period|Progressive Disease|14|||
149860930|NCT02546362|540620477|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
149860931|NCT02546362|540620477|FG000|12-week Treatment Period|Lost to Follow-up|2|||
149860932|NCT02546362|540620477|FG000|12-week Treatment Period|Change in medication|1|||
149860933|NCT01138826|540620478|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
149860934|NCT01138826|540620479|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
149860935|NCT01138826|540620480|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
149860936|NCT01138826|540620481|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
149860937|NCT01138826|540620482|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
149860938|NCT01138826|540620483|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
149860939|NCT05206448|540620484|FG000|Overall Study|Lost to Follow-up|2|||
149860940|NCT05206448|540620485|FG001|Overall Study|Lost to Follow-up|2|||
149860941|NCT05206448|540620484|FG000|Overall Study|Withdrawal by Subject|2|||
150291760|NCT05171777|542201689|FG001|Treatment Crossover Period|Progressive Disease|10|||
150291761|NCT05171777|542201690|FG002|Treatment Crossover Period|Progressive Disease|0|||
150291762|NCT05171777|542201691|FG003|Treatment Crossover Period|Progressive Disease|0|||
150291763|NCT05171777|542201688|FG000|Treatment Crossover Period|Protocol Violation|0|||
150291764|NCT05171777|542201689|FG001|Treatment Crossover Period|Protocol Violation|2|||
150291765|NCT05171777|542201690|FG002|Treatment Crossover Period|Protocol Violation|0|||
150291766|NCT05171777|542201691|FG003|Treatment Crossover Period|Protocol Violation|0|||
150291767|NCT05171777|542201688|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
150291768|NCT05171777|542201689|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
150291769|NCT05171777|542201690|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
150291770|NCT05171777|542201691|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
150291771|NCT05171777|542201688|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
150291772|NCT05171777|542201689|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
150291773|NCT05171777|542201690|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
150291774|NCT05171777|542201691|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
150291775|NCT05171777|542201688|FG000|Treatment Continuation Period|Adverse Event|0|||
150291776|NCT05171777|542201689|FG001|Treatment Continuation Period|Adverse Event|0|||
149860942|NCT05206448|540620485|FG001|Overall Study|Withdrawal by Subject|0|||
149860943|NCT05206448|540620484|FG000|Overall Study|found ineligible after randomization|1|||
149860944|NCT05206448|540620485|FG001|Overall Study|found ineligible after randomization|1|||
149860945|NCT05206448|540620484|FG000|Overall Study|unable to complete study due to personal constraints|1|||
149860946|NCT05206448|540620485|FG001|Overall Study|unable to complete study due to personal constraints|0|||
149860947|NCT05206448|540620484|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
149860948|NCT05206448|540620485|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
149860949|NCT00754442|540620489|FG000|Overall Study|Withdrawal by Subject|5|||
149860950|NCT00754442|540620490|FG001|Overall Study|Withdrawal by Subject|3|||
149860951|NCT01557842|540620491|FG000|Overall Study|Lost to Follow-up|0|||
149860952|NCT01557842|540620492|FG001|Overall Study|Lost to Follow-up|1|||
149860953|NCT01557842|540620491|FG000|Overall Study|Death|1|||
149860954|NCT01557842|540620492|FG001|Overall Study|Death|0|||
149860955|NCT01557842|540620491|FG000|Overall Study|Lack of Efficacy|0|||
149860956|NCT01557842|540620492|FG001|Overall Study|Lack of Efficacy|1|||
149860957|NCT01557842|540620491|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
149860958|NCT01557842|540620492|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
149860959|NCT01557842|540620491|FG000|Overall Study|Study Terminated by Sponsor|3|||
149860960|NCT01557842|540620492|FG001|Overall Study|Study Terminated by Sponsor|4|||
149860961|NCT01557842|540620491|FG000|Overall Study|Not Ablated|2|||
149860962|NCT01557842|540620492|FG001|Overall Study|Not Ablated|0|||
149860963|NCT05560763|540620496|FG000|Overall Study|Withdrawal by Subject|4|||
149860964|NCT06972251|540620497|FG000|Overall Study|Withdrawal by Subject|1|||
149860965|NCT06972251|540620498|FG001|Overall Study|Withdrawal by Subject|0|||
149860966|NCT06972251|540620497|FG000|Overall Study|Lost to Follow-up|10|||
149860967|NCT06972251|540620498|FG001|Overall Study|Lost to Follow-up|2|||
149860968|NCT00949988|540620499|FG000|Overall Study|Withdrawal by Subject|3|||
149860969|NCT01929395|540620500|FG000|Overall Study|Did not complete - non-related toxicity|1|||
149860970|NCT01929395|540620501|FG001|Overall Study|Did not complete - non-related toxicity|0|||
149860971|NCT01929395|540620502|FG002|Overall Study|Did not complete - non-related toxicity|0|||
149860972|NCT01929395|540620500|FG000|Overall Study|Withdrawal by Subject|0|||
149860973|NCT01929395|540620501|FG001|Overall Study|Withdrawal by Subject|1|||
150291777|NCT05171777|542201690|FG002|Treatment Continuation Period|Adverse Event|3|||
150291778|NCT05171777|542201691|FG003|Treatment Continuation Period|Adverse Event|6|||
149860974|NCT01929395|540620502|FG002|Overall Study|Withdrawal by Subject|0|||
149860975|NCT01929395|540620500|FG000|Overall Study|Screen Fail|0|||
149860976|NCT01929395|540620501|FG001|Overall Study|Screen Fail|0|||
149860977|NCT01929395|540620502|FG002|Overall Study|Screen Fail|1|||
150291779|NCT05171777|542201688|FG000|Treatment Continuation Period|Death|0|||
150291780|NCT05171777|542201689|FG001|Treatment Continuation Period|Death|0|||
149860978|NCT03604341|540620504|FG000|Overall Study|Withdrawal by Subject|1|||
149860979|NCT03604341|540620505|FG001|Overall Study|Withdrawal by Subject|1|||
149860980|NCT03604341|540620504|FG000|Overall Study|Adverse Event|1|||
149860981|NCT03604341|540620505|FG001|Overall Study|Adverse Event|0|||
149860982|NCT03604341|540620504|FG000|Overall Study|Protocol Violation|0|||
149860983|NCT03604341|540620505|FG001|Overall Study|Protocol Violation|1|||
149860984|NCT00484419|540620506|FG000|Overall Study|Adverse Event|3|||
149860985|NCT00484419|540620507|FG001|Overall Study|Adverse Event|0|||
149860986|NCT00484419|540620508|FG002|Overall Study|Adverse Event|0|||
149860987|NCT00484419|540620506|FG000|Overall Study|Lost to Follow-up|1|||
149860988|NCT00484419|540620507|FG001|Overall Study|Lost to Follow-up|0|||
149860989|NCT00484419|540620508|FG002|Overall Study|Lost to Follow-up|2|||
149860990|NCT00484419|540620506|FG000|Overall Study|Withdrawal by Subject|3|||
149860991|NCT00484419|540620507|FG001|Overall Study|Withdrawal by Subject|1|||
149860992|NCT00484419|540620508|FG002|Overall Study|Withdrawal by Subject|1|||
149860993|NCT00484419|540620506|FG000|Overall Study|subject met discontinuation criteria|2|||
149860994|NCT00484419|540620507|FG001|Overall Study|subject met discontinuation criteria|2|||
149860995|NCT00484419|540620508|FG002|Overall Study|subject met discontinuation criteria|4|||
149860996|NCT00484419|540620506|FG000|Overall Study|required restricted medication|1|||
149860997|NCT00484419|540620507|FG001|Overall Study|required restricted medication|0|||
149860998|NCT00484419|540620508|FG002|Overall Study|required restricted medication|1|||
149860999|NCT00484419|540620506|FG000|Overall Study|Physician Decision|1|||
149861000|NCT00484419|540620507|FG001|Overall Study|Physician Decision|1|||
149861001|NCT00484419|540620508|FG002|Overall Study|Physician Decision|1|||
149861002|NCT00484419|540620506|FG000|Overall Study|subject unable to receive medication|1|||
149861003|NCT00484419|540620507|FG001|Overall Study|subject unable to receive medication|0|||
149861004|NCT00484419|540620508|FG002|Overall Study|subject unable to receive medication|0|||
149861005|NCT00484419|540620506|FG000|Overall Study|subject relocated|0|||
149861006|NCT00484419|540620507|FG001|Overall Study|subject relocated|1|||
149861007|NCT00484419|540620508|FG002|Overall Study|subject relocated|0|||
149861008|NCT00484419|540620506|FG000|Overall Study|sponsor decision, randomized in error|0|||
149861009|NCT00484419|540620507|FG001|Overall Study|sponsor decision, randomized in error|0|||
149861010|NCT00484419|540620508|FG002|Overall Study|sponsor decision, randomized in error|2|||
149861011|NCT01829113|540620510|FG000|Overall Study|Disease Progression|37|||
149861012|NCT01829113|540620511|FG001|Overall Study|Disease Progression|48|||
149861013|NCT01829113|540620510|FG000|Overall Study|Adverse Event|14|||
149861014|NCT01829113|540620511|FG001|Overall Study|Adverse Event|10|||
149861015|NCT01829113|540620510|FG000|Overall Study|Withdrawal by Subject|17|||
149861016|NCT01829113|540620511|FG001|Overall Study|Withdrawal by Subject|10|||
149861017|NCT01829113|540620510|FG000|Overall Study|Death|4|||
149861018|NCT01829113|540620511|FG001|Overall Study|Death|6|||
149861019|NCT01829113|540620510|FG000|Overall Study|Sponsor Decision|1|||
149861020|NCT01829113|540620511|FG001|Overall Study|Sponsor Decision|1|||
149861021|NCT01829113|540620510|FG000|Overall Study|No Study Treatment Received|3|||
149861022|NCT01829113|540620511|FG001|Overall Study|No Study Treatment Received|2|||
149861023|NCT01829113|540620510|FG000|Overall Study|Physician Decision|1|||
149861024|NCT01829113|540620511|FG001|Overall Study|Physician Decision|1|||
149861025|NCT00355472|540620514|FG000|Overall Study|Physician Decision|1|||
149861026|NCT02674386|540620521|FG000|Overall Study|Lost to Follow-up|0|||
149861027|NCT02674386|540620522|FG001|Overall Study|Lost to Follow-up|1|||
149861028|NCT02674386|540620523|FG002|Overall Study|Lost to Follow-up|1|||
149861029|NCT02674386|540620521|FG000|Overall Study|Withdrawal by Subject|0|||
149861030|NCT02674386|540620522|FG001|Overall Study|Withdrawal by Subject|4|||
149861031|NCT02674386|540620523|FG002|Overall Study|Withdrawal by Subject|0|||
149861032|NCT02674386|540620521|FG000|Overall Study|Other|0|||
149861033|NCT02674386|540620522|FG001|Overall Study|Other|1|||
149861034|NCT02674386|540620523|FG002|Overall Study|Other|0|||
149861035|NCT02674386|540620521|FG000|Overall Study|Enrolled but not evaluated|0|||
149861036|NCT02674386|540620522|FG001|Overall Study|Enrolled but not evaluated|4|||
149861037|NCT02674386|540620523|FG002|Overall Study|Enrolled but not evaluated|0|||
149861038|NCT00351351|540620529|FG000|Overall Study|surgical access pbs; device issues|9|||
150040626|NCT00892099|541289109|FG000|Overall Study|Prolonged hospitalization|1|||
150040627|NCT00892099|541289110|FG001|Overall Study|Prolonged hospitalization|0|||
150040628|NCT00892099|541289111|FG002|Overall Study|Prolonged hospitalization|1|||
149861039|NCT00351351|540620530|FG001|Overall Study|surgical access pbs; device issues|4|||
149861040|NCT03891329|540620532|FG000|Overall Study|Death|5|||
149861041|NCT03891329|540620532|FG000|Overall Study|Lost to Follow-up|4|||
149861042|NCT03891329|540620532|FG000|Overall Study|Physician Decision|4|||
149861043|NCT03891329|540620532|FG000|Overall Study|Device explanted|3|||
149861044|NCT03891329|540620532|FG000|Overall Study|No study device implanted|3|||
149861045|NCT03176784|540620533|FG000|Overall Study|Lost to Follow-up|77|||
149861046|NCT03176784|540620534|FG001|Overall Study|Lost to Follow-up|79|||
149861047|NCT03176784|540620535|FG002|Overall Study|Lost to Follow-up|79|||
149861048|NCT03176784|540620536|FG003|Overall Study|Lost to Follow-up|49|||
149861049|NCT03176784|540620533|FG000|Overall Study|Withdrawal by Subject|28|||
149861050|NCT03176784|540620534|FG001|Overall Study|Withdrawal by Subject|34|||
149861051|NCT03176784|540620535|FG002|Overall Study|Withdrawal by Subject|34|||
149861052|NCT03176784|540620536|FG003|Overall Study|Withdrawal by Subject|21|||
149861053|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
150291781|NCT05171777|542201690|FG002|Treatment Continuation Period|Death|1|||
150291782|NCT05171777|542201691|FG003|Treatment Continuation Period|Death|3|||
150291783|NCT05171777|542201688|FG000|Treatment Continuation Period|Disease Relapse|0|||
150291784|NCT05171777|542201689|FG001|Treatment Continuation Period|Disease Relapse|0|||
150291785|NCT05171777|542201690|FG002|Treatment Continuation Period|Disease Relapse|1|||
150291786|NCT05171777|542201691|FG003|Treatment Continuation Period|Disease Relapse|0|||
150291787|NCT05171777|542201688|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
150291788|NCT05171777|542201689|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
150291789|NCT05171777|542201690|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
150291790|NCT05171777|542201691|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
150291791|NCT05171777|542201688|FG000|Treatment Continuation Period|Physician Decision|0|||
150291792|NCT05171777|542201689|FG001|Treatment Continuation Period|Physician Decision|0|||
150291793|NCT05171777|542201690|FG002|Treatment Continuation Period|Physician Decision|0|||
150291794|NCT05171777|542201691|FG003|Treatment Continuation Period|Physician Decision|4|||
150291795|NCT05171777|542201688|FG000|Treatment Continuation Period|Progressive Disease|0|||
150291796|NCT05171777|542201689|FG001|Treatment Continuation Period|Progressive Disease|0|||
150291797|NCT05171777|542201690|FG002|Treatment Continuation Period|Progressive Disease|6|||
150291798|NCT05171777|542201691|FG003|Treatment Continuation Period|Progressive Disease|20|||
150291799|NCT05171777|542201688|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
150291800|NCT05171777|542201689|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
150291801|NCT05171777|542201690|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
150291802|NCT05171777|542201691|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
150291803|NCT05171777|542201688|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
149861054|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
149861055|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
149861056|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
149861057|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
149861058|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
149861059|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
149861060|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
149861061|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
149861062|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
149861063|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
149861064|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
149861065|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
149861066|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
149861067|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
149861068|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
149861069|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
149861070|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
149861071|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
149861072|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
149861073|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
149861074|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
149861075|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
149861076|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
149861077|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
149861078|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
150040629|NCT00892099|541289109|FG000|Overall Study|no further details|1|||
150040630|NCT00892099|541289110|FG001|Overall Study|no further details|0|||
150040631|NCT00892099|541289111|FG002|Overall Study|no further details|1|||
150040632|NCT00892099|541289109|FG000|Overall Study|kidney function recovered|0|||
150040633|NCT00892099|541289110|FG001|Overall Study|kidney function recovered|1|||
150040634|NCT00892099|541289111|FG002|Overall Study|kidney function recovered|0|||
150040635|NCT00892099|541289109|FG000|Overall Study|investigator decision|0|||
150040636|NCT00892099|541289110|FG001|Overall Study|investigator decision|0|||
150040637|NCT00892099|541289111|FG002|Overall Study|investigator decision|1|||
150040638|NCT00892099|541289109|FG000|Overall Study|Lost to Follow-up|0|||
150040639|NCT00892099|541289110|FG001|Overall Study|Lost to Follow-up|0|||
150291804|NCT05171777|542201689|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
150291805|NCT05171777|542201690|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
150291806|NCT05171777|542201691|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
149861079|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
149861080|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
149861081|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Death|0|||
150040640|NCT00892099|541289111|FG002|Overall Study|Lost to Follow-up|1|||
150040641|NCT01657019|541289112|FG000|Overall Study|Withdrawal by Subject|65|||
150291807|NCT05171777|542201688|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
150291808|NCT05171777|542201689|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
150291809|NCT05171777|542201690|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
149861082|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Death|1|||
149861083|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Death|0|||
149861084|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Death|0|||
149861085|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
149861086|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
149861087|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
149861088|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
149861089|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
149861090|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
149861091|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
149861092|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
149861093|NCT02990806|540620537|FG000|Stage 1 (22 Weeks)|Other|1|||
149861094|NCT02990806|540620538|FG001|Stage 1 (22 Weeks)|Other|3|||
149861095|NCT02990806|540620539|FG002|Stage 1 (22 Weeks)|Other|0|||
149861096|NCT02990806|540620540|FG003|Stage 1 (22 Weeks)|Other|0|||
150291810|NCT05171777|542201691|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
149861097|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
149861098|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
149861099|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
149861100|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
149861101|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Death|1|||
149861102|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Death|0|||
149861103|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Death|0|||
149861104|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Death|0|||
149861105|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
149861106|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
149861107|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
149861108|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
149861109|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
149861110|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
149861111|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
149861112|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
149861113|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
149861114|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
149861115|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
149861116|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
149861117|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
149861118|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
149861119|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
150291811|NCT02364713|542201692|FG000|Overall Study|Ineligible|2|||
150291812|NCT02364713|542201693|FG001|Overall Study|Ineligible|2|||
150291813|NCT04686786|542201694|FG000|Overall Study|Adverse Event|9|||
150291814|NCT04686786|542201694|FG000|Overall Study|Death|1|||
150291815|NCT04686786|542201694|FG000|Overall Study|Lack of Efficacy|25|||
150291816|NCT04686786|542201694|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
150291817|NCT04686786|542201694|FG000|Overall Study|Study Terminated by Sponsor|14|||
150291818|NCT04686786|542201694|FG000|Overall Study|Withdrawal by Subject|15|||
150291819|NCT04686786|542201694|FG000|Overall Study|Other than specified|1|||
150291820|NCT05445843|542201695|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
150291821|NCT05445843|542201696|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
150291822|NCT05445843|542201695|FG000|Overall Study|Progressive disease|17|||
150291823|NCT05445843|542201696|FG001|Overall Study|Progressive disease|9|||
150291824|NCT05445843|542201695|FG000|Overall Study|Physician Decision|16|||
150291825|NCT05445843|542201696|FG001|Overall Study|Physician Decision|4|||
149861120|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
149861121|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
150291826|NCT05445843|542201695|FG000|Overall Study|Death|6|||
150291827|NCT05445843|542201696|FG001|Overall Study|Death|3|||
150291828|NCT05445843|542201695|FG000|Overall Study|Subject decision|6|||
150291829|NCT05445843|542201696|FG001|Overall Study|Subject decision|2|||
149861122|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
149861123|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
149861124|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
150291830|NCT05445843|542201695|FG000|Overall Study|Adverse Event|2|||
150291831|NCT05445843|542201696|FG001|Overall Study|Adverse Event|0|||
150291832|NCT05307679|542201697|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
149861125|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
149861126|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
150291833|NCT05307679|542201698|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
150291834|NCT05628103|542201699|FG000|Overall Study|Adverse Event|7|||
150291835|NCT05628103|542201699|FG000|Overall Study|Withdrawal by Subject|3|||
150291836|NCT05628103|542201699|FG000|Overall Study|Lost to Follow-up|3|||
150291837|NCT05628103|542201699|FG000|Overall Study|Lack of Efficacy|1|||
150291838|NCT05628103|542201699|FG000|Overall Study|Non-Compliance With Study Drug|4|||
150291839|NCT04840888|542201700|FG000|Period 1|Withdrawal by Subject|0|||
150291840|NCT04840888|542201701|FG001|Period 1|Withdrawal by Subject|0|||
150291841|NCT04840888|542201702|FG002|Period 1|Withdrawal by Subject|0|||
150291842|NCT04840888|542201703|FG003|Period 1|Withdrawal by Subject|0|||
149861127|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
149861128|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
149861129|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
149861130|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
149861131|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
149861132|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
149861133|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
149861134|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
149861135|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
149861136|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
149861137|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
149861138|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
149861139|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
149861140|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
149861141|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Other|3|||
149861142|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Other|0|||
149861143|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Other|4|||
149861144|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Other|1|||
149861145|NCT02990806|540620537|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
149861146|NCT02990806|540620538|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
149861147|NCT02990806|540620539|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
149861148|NCT02990806|540620540|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
149861149|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
149861150|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
149861151|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
149861152|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
149861153|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
149861154|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
149861155|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
149861156|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
149861157|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
149861158|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
149861159|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
149861160|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
149861161|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
150291843|NCT04840888|542201704|FG004|Period 1|Withdrawal by Subject|1|||
150291844|NCT04840888|542201705|FG005|Period 1|Withdrawal by Subject|0|||
149861162|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
149861163|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
149861164|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
149861165|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
149861166|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
149861167|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
149861168|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
149861169|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
149861170|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
150291845|NCT04840888|542201700|FG000|Period 1|Adverse Event|0|||
150291846|NCT04840888|542201701|FG001|Period 1|Adverse Event|0|||
149861171|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
150291847|NCT04840888|542201702|FG002|Period 1|Adverse Event|1|||
149861172|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
150291848|NCT04840888|542201703|FG003|Period 1|Adverse Event|1|||
149861173|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
149861174|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
149861175|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
150291849|NCT04840888|542201704|FG004|Period 1|Adverse Event|10|||
150291850|NCT04840888|542201705|FG005|Period 1|Adverse Event|1|||
150291851|NCT03924869|542201707|FG000|Overall Study|Death|73|||
149861176|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
149861177|NCT02990806|540620537|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
149861178|NCT02990806|540620538|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
149861179|NCT02990806|540620539|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
149861180|NCT02990806|540620540|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
149861181|NCT01010750|540620541|FG000|Second Intervention|Adverse Event|0|||
149861182|NCT01010750|540620542|FG001|Second Intervention|Adverse Event|1|||
149861183|NCT01010750|540620543|FG002|Second Intervention|Adverse Event|0|||
149861184|NCT01010750|540620544|FG003|Second Intervention|Adverse Event|0|||
149861185|NCT01010750|540620545|FG004|Second Intervention|Adverse Event|0|||
149861186|NCT01010750|540620546|FG005|Second Intervention|Adverse Event|0|||
149861187|NCT00171340|540620549|FG000|Overall Study|Adverse Event|46|||
149861188|NCT00171340|540620550|FG001|Overall Study|Adverse Event|42|||
149861189|NCT00171340|540620549|FG000|Overall Study|Lack of Efficacy|29|||
149861190|NCT00171340|540620550|FG001|Overall Study|Lack of Efficacy|41|||
149861191|NCT00171340|540620549|FG000|Overall Study|Protocol Violation|7|||
149861192|NCT00171340|540620550|FG001|Overall Study|Protocol Violation|8|||
149861193|NCT00171340|540620549|FG000|Overall Study|Withdrawal by Subject|22|||
149861194|NCT00171340|540620550|FG001|Overall Study|Withdrawal by Subject|19|||
149861195|NCT00171340|540620549|FG000|Overall Study|Lost to Follow-up|0|||
149861196|NCT00171340|540620550|FG001|Overall Study|Lost to Follow-up|5|||
149861197|NCT00171340|540620549|FG000|Overall Study|Abnormal Laboratory Results|2|||
149861198|NCT00171340|540620550|FG001|Overall Study|Abnormal Laboratory Results|0|||
149861199|NCT00171340|540620549|FG000|Overall Study|Abnormal Test Procedure Results|6|||
149861200|NCT00171340|540620550|FG001|Overall Study|Abnormal Test Procedure Results|11|||
149861201|NCT00171340|540620549|FG000|Overall Study|No Longer Required Study Drug|1|||
149861202|NCT00171340|540620550|FG001|Overall Study|No Longer Required Study Drug|1|||
149861203|NCT00171340|540620549|FG000|Overall Study|Administrative Problems|5|||
149861204|NCT00171340|540620550|FG001|Overall Study|Administrative Problems|2|||
149861205|NCT00171340|540620549|FG000|Overall Study|Death|6|||
149861206|NCT00171340|540620550|FG001|Overall Study|Death|6|||
149861207|NCT01682148|540620551|FG000|Overall Study|Withdrawal by Subject|2|||
149861208|NCT01682148|540620552|FG001|Overall Study|Withdrawal by Subject|0|||
149861209|NCT01682148|540620551|FG000|Overall Study|Lost to Follow-up|1|||
149861210|NCT01682148|540620552|FG001|Overall Study|Lost to Follow-up|2|||
149861211|NCT01682148|540620551|FG000|Overall Study|Protocol Violation|1|||
149861212|NCT01682148|540620552|FG001|Overall Study|Protocol Violation|1|||
149861213|NCT01056640|540620553|FG000|Overall Study|Withdrawal by Subject|11|||
149861214|NCT01056640|540620554|FG001|Overall Study|Withdrawal by Subject|8|||
149861215|NCT01056640|540620553|FG000|Overall Study|Death|15|||
149861216|NCT01056640|540620554|FG001|Overall Study|Death|4|||
149861217|NCT01803269|540620555|FG000|Overall Study|Withdrawal by Subject|3|||
149861218|NCT01803269|540620556|FG001|Overall Study|Withdrawal by Subject|0|||
149861219|NCT01803269|540620557|FG002|Overall Study|Withdrawal by Subject|0|||
149861220|NCT01202877|540620558|FG000|Overall Study|Disease Progression|0|||
149861221|NCT01202877|540620559|FG001|Overall Study|Disease Progression|1|||
149861222|NCT01202877|540620560|FG002|Overall Study|Disease Progression|2|||
149861223|NCT01202877|540620558|FG000|Overall Study|Adverse Event|0|||
149861224|NCT01202877|540620559|FG001|Overall Study|Adverse Event|0|||
149861225|NCT01202877|540620560|FG002|Overall Study|Adverse Event|2|||
149861226|NCT01202877|540620558|FG000|Overall Study|Withdrawal by Subject|0|||
149861227|NCT01202877|540620559|FG001|Overall Study|Withdrawal by Subject|0|||
149861228|NCT01202877|540620560|FG002|Overall Study|Withdrawal by Subject|1|||
150291852|NCT03924869|542201708|FG001|Overall Study|Death|62|||
150291853|NCT03924869|542201707|FG000|Overall Study|Lost to Follow-up|3|||
150291854|NCT03924869|542201708|FG001|Overall Study|Lost to Follow-up|0|||
150291855|NCT03924869|542201707|FG000|Overall Study|Physician Decision|0|||
150291856|NCT03924869|542201708|FG001|Overall Study|Physician Decision|3|||
149861229|NCT01202877|540620558|FG000|Overall Study|Death|0|||
150291857|NCT03924869|542201707|FG000|Overall Study|Withdrawal by Subject|7|||
150173667|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149861230|NCT01202877|540620559|FG001|Overall Study|Death|0|||
149861231|NCT01202877|540620560|FG002|Overall Study|Death|1|||
149861232|NCT00350402|540620561|FG000|Overall Study|Lost to Follow-up|1|||
150291858|NCT03924869|542201708|FG001|Overall Study|Withdrawal by Subject|3|||
150291859|NCT03924869|542201707|FG000|Overall Study|Study Terminated By Sponsor|144|||
149861233|NCT00350402|540620562|FG001|Overall Study|Lost to Follow-up|1|||
149861234|NCT01376310|540620563|FG000|Overall Study|Study closed/terminated|1|||
149861235|NCT01376310|540620564|FG001|Overall Study|Study closed/terminated|2|||
149861236|NCT01376310|540620563|FG000|Overall Study|Withdrawal by Subject|8|||
149861237|NCT01376310|540620564|FG001|Overall Study|Withdrawal by Subject|2|||
149861238|NCT01376310|540620563|FG000|Overall Study|Physician Decision|26|||
149961951|NCT01570192|540994168|FG001|Overall Study|changed to palliative care|0|||
150291860|NCT03924869|542201708|FG001|Overall Study|Study Terminated By Sponsor|153|||
150291861|NCT05224544|542201709|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
150291862|NCT05224544|542201710|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
150291863|NCT03359759|542201711|FG000|Overall Study|Death|3|||
150291864|NCT03359759|542201711|FG000|Overall Study|Lost to Follow-up|2|||
150291865|NCT06279871|542201712|FG000|Overall Study|Death|0|||
150291866|NCT06279871|542201713|FG001|Overall Study|Death|0|||
150291867|NCT06279871|542201714|FG002|Overall Study|Death|0|||
150291868|NCT06279871|542201715|FG003|Overall Study|Death|0|||
150291869|NCT06279871|542201716|FG004|Overall Study|Death|0|||
150291870|NCT06279871|542201717|FG005|Overall Study|Death|1|||
150291871|NCT06279871|542201718|FG006|Overall Study|Death|0|||
150291872|NCT06279871|542201712|FG000|Overall Study|Other than Specified|1|||
150291873|NCT06279871|542201713|FG001|Overall Study|Other than Specified|0|||
150291874|NCT06279871|542201714|FG002|Overall Study|Other than Specified|4|||
150291875|NCT06279871|542201715|FG003|Overall Study|Other than Specified|0|||
150291876|NCT06279871|542201716|FG004|Overall Study|Other than Specified|0|||
150291877|NCT06279871|542201717|FG005|Overall Study|Other than Specified|0|||
150291878|NCT06279871|542201718|FG006|Overall Study|Other than Specified|0|||
150291879|NCT06279871|542201712|FG000|Overall Study|Withdrawal by Subject|4|||
150291880|NCT06279871|542201713|FG001|Overall Study|Withdrawal by Subject|8|||
149861239|NCT01376310|540620564|FG001|Overall Study|Physician Decision|7|||
149861240|NCT01376310|540620563|FG000|Overall Study|Lost to Follow-up|1|||
149861241|NCT01376310|540620564|FG001|Overall Study|Lost to Follow-up|0|||
149861242|NCT00645944|540620567|FG000|Randomized|Withdrawal by Subject|1|||
149861243|NCT00645944|540620568|FG001|Randomized|Withdrawal by Subject|2|||
149861244|NCT00645944|540620567|FG000|Received Medication|Adverse Event|2|||
149861245|NCT00645944|540620568|FG001|Received Medication|Adverse Event|1|||
149861246|NCT00645944|540620567|FG000|Received Medication|Withdrawal by Subject|1|||
149861247|NCT00645944|540620568|FG001|Received Medication|Withdrawal by Subject|1|||
149861248|NCT00645944|540620567|FG000|Received Medication|Lost to Follow-up|1|||
149861249|NCT00645944|540620568|FG001|Received Medication|Lost to Follow-up|0|||
149861250|NCT00645944|540620567|FG000|Received Medication|Protocol Violation|2|||
149861251|NCT00645944|540620568|FG001|Received Medication|Protocol Violation|1|||
149861252|NCT02339740|540620569|FG000|Overall Study|Death|1|||
149861253|NCT02339740|540620570|FG001|Overall Study|Death|0|||
149861254|NCT02339740|540620569|FG000|Overall Study|Physician Decision|0|||
149861255|NCT02339740|540620570|FG001|Overall Study|Physician Decision|2|||
149861256|NCT02339740|540620569|FG000|Overall Study|Withdrawal by Subject|5|||
149861257|NCT02339740|540620570|FG001|Overall Study|Withdrawal by Subject|1|||
149861258|NCT02339740|540620569|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
149861259|NCT02339740|540620570|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
149861260|NCT00706355|540620571|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
149861261|NCT00706355|540620572|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
149861262|NCT00706355|540620573|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
149861263|NCT00706355|540620574|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
149861264|NCT00706355|540620571|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
149861265|NCT00706355|540620572|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
149861266|NCT00706355|540620573|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
149861267|NCT00706355|540620574|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
149861268|NCT00706355|540620571|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
149861269|NCT00706355|540620572|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
149861270|NCT00706355|540620573|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
150291881|NCT06279871|542201714|FG002|Overall Study|Withdrawal by Subject|4|||
150291882|NCT06279871|542201715|FG003|Overall Study|Withdrawal by Subject|2|||
150291883|NCT06279871|542201716|FG004|Overall Study|Withdrawal by Subject|0|||
150291884|NCT06279871|542201717|FG005|Overall Study|Withdrawal by Subject|0|||
149861271|NCT00706355|540620574|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
149861272|NCT00706355|540620571|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
149861273|NCT00706355|540620572|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
149861274|NCT00706355|540620573|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
149861275|NCT00706355|540620574|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
150291885|NCT06279871|542201718|FG006|Overall Study|Withdrawal by Subject|0|||
150291886|NCT06279871|542201712|FG000|Overall Study|Lost to Follow-up|11|||
150291887|NCT06279871|542201713|FG001|Overall Study|Lost to Follow-up|10|||
150291888|NCT06279871|542201714|FG002|Overall Study|Lost to Follow-up|8|||
150291889|NCT06279871|542201715|FG003|Overall Study|Lost to Follow-up|0|||
150291890|NCT06279871|542201716|FG004|Overall Study|Lost to Follow-up|0|||
149861276|NCT00706355|540620571|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
149861277|NCT00706355|540620572|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
149861278|NCT00706355|540620573|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
149861279|NCT00706355|540620574|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
150291891|NCT06279871|542201717|FG005|Overall Study|Lost to Follow-up|0|||
150291892|NCT06279871|542201718|FG006|Overall Study|Lost to Follow-up|0|||
150291893|NCT06279871|542201712|FG000|Overall Study|Adverse Event|0|||
150291894|NCT06279871|542201713|FG001|Overall Study|Adverse Event|1|||
149861280|NCT00706355|540620571|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
149861281|NCT00706355|540620572|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
149861282|NCT00706355|540620573|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
149861283|NCT00706355|540620574|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
149861284|NCT00706355|540620571|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
149861285|NCT00706355|540620572|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
149861286|NCT00706355|540620573|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
149861287|NCT00706355|540620574|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
149861288|NCT00706355|540620571|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
149861289|NCT00706355|540620572|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
149861290|NCT00706355|540620573|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
149861291|NCT00706355|540620574|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
149861292|NCT00706355|540620571|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
149861293|NCT00706355|540620572|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
149861294|NCT00706355|540620573|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
149861295|NCT00706355|540620574|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
149861296|NCT04179019|540620577|FG000|Overall Study|Lost to Follow-up|2|||
149861297|NCT04179019|540620577|FG000|Overall Study|Physician Decision|2|||
149861298|NCT04179019|540620577|FG000|Overall Study|Withdrawal by Subject|5|||
149861299|NCT04179019|540620577|FG000|Overall Study|Adverse Event|4|||
149861300|NCT01855048|540620578|FG000|Overall Study|Withdrawal by Subject|0|||
149861301|NCT01855048|540620579|FG001|Overall Study|Withdrawal by Subject|1|||
149861302|NCT01855048|540620580|FG002|Overall Study|Withdrawal by Subject|0|||
149861303|NCT01855048|540620581|FG003|Overall Study|Withdrawal by Subject|0|||
149861304|NCT01855048|540620582|FG004|Overall Study|Withdrawal by Subject|1|||
149861305|NCT01855048|540620583|FG005|Overall Study|Withdrawal by Subject|0|||
149861306|NCT03465436|540620584|FG000|Period 1|Protocol Violation|0|||
149861307|NCT03465436|540620585|FG001|Period 1|Protocol Violation|0|||
149861308|NCT03465436|540620586|FG002|Period 1|Protocol Violation|1|||
149861309|NCT03465436|540620587|FG003|Period 1|Protocol Violation|0|||
149861310|NCT03465436|540620584|FG000|Period 2|Protocol Violation|0|||
149861311|NCT03465436|540620585|FG001|Period 2|Protocol Violation|1|||
149861312|NCT03465436|540620586|FG002|Period 2|Protocol Violation|0|||
149861313|NCT03465436|540620587|FG003|Period 2|Protocol Violation|0|||
149861314|NCT03465436|540620584|FG000|Period 3|Protocol Violation|1|||
149861315|NCT03465436|540620585|FG001|Period 3|Protocol Violation|1|||
149861316|NCT03465436|540620586|FG002|Period 3|Protocol Violation|0|||
149861317|NCT03465436|540620587|FG003|Period 3|Protocol Violation|0|||
149861318|NCT03465436|540620584|FG000|Period 4|Protocol Violation|0|||
150173668|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173669|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150291895|NCT06279871|542201714|FG002|Overall Study|Adverse Event|0|||
150291896|NCT06279871|542201715|FG003|Overall Study|Adverse Event|0|||
149861319|NCT03465436|540620585|FG001|Period 4|Protocol Violation|0|||
149861320|NCT03465436|540620586|FG002|Period 4|Protocol Violation|1|||
149861321|NCT03465436|540620587|FG003|Period 4|Protocol Violation|0|||
149861322|NCT01813071|540620588|FG000|Overall Study|Protocol Violation|0|||
149861323|NCT01813071|540620589|FG001|Overall Study|Protocol Violation|0|||
149861324|NCT01813071|540620590|FG002|Overall Study|Protocol Violation|0|||
149861325|NCT01813071|540620591|FG003|Overall Study|Protocol Violation|0|||
149861326|NCT01813071|540620592|FG004|Overall Study|Protocol Violation|1|||
149861327|NCT01813071|540620593|FG005|Overall Study|Protocol Violation|4|||
149861328|NCT01813071|540620594|FG006|Overall Study|Protocol Violation|2|||
149861329|NCT01813071|540620595|FG007|Overall Study|Protocol Violation|4|||
149861330|NCT01813071|540620596|FG008|Overall Study|Protocol Violation|2|||
149861331|NCT01813071|540620588|FG000|Overall Study|Withdrawal by Subject|0|||
149861332|NCT01813071|540620589|FG001|Overall Study|Withdrawal by Subject|0|||
149861333|NCT01813071|540620590|FG002|Overall Study|Withdrawal by Subject|0|||
149861334|NCT01813071|540620591|FG003|Overall Study|Withdrawal by Subject|0|||
149861335|NCT01813071|540620592|FG004|Overall Study|Withdrawal by Subject|0|||
149861336|NCT01813071|540620593|FG005|Overall Study|Withdrawal by Subject|1|||
149861337|NCT01813071|540620594|FG006|Overall Study|Withdrawal by Subject|0|||
149861338|NCT01813071|540620595|FG007|Overall Study|Withdrawal by Subject|0|||
149861339|NCT01813071|540620596|FG008|Overall Study|Withdrawal by Subject|0|||
149861340|NCT01813071|540620588|FG000|Overall Study|Adverse Event|0|||
149861341|NCT01813071|540620589|FG001|Overall Study|Adverse Event|0|||
149861342|NCT01813071|540620590|FG002|Overall Study|Adverse Event|0|||
149861343|NCT01813071|540620591|FG003|Overall Study|Adverse Event|0|||
149861344|NCT01813071|540620592|FG004|Overall Study|Adverse Event|0|||
150173670|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150291897|NCT06279871|542201716|FG004|Overall Study|Adverse Event|0|||
149861345|NCT01813071|540620593|FG005|Overall Study|Adverse Event|1|||
149861346|NCT01813071|540620594|FG006|Overall Study|Adverse Event|0|||
149861347|NCT01813071|540620595|FG007|Overall Study|Adverse Event|0|||
149861348|NCT01813071|540620596|FG008|Overall Study|Adverse Event|0|||
149861349|NCT01813071|540620588|FG000|Overall Study|Physician Decision|0|||
149861350|NCT01813071|540620589|FG001|Overall Study|Physician Decision|0|||
149861351|NCT01813071|540620590|FG002|Overall Study|Physician Decision|0|||
149861352|NCT01813071|540620591|FG003|Overall Study|Physician Decision|0|||
149861353|NCT01813071|540620592|FG004|Overall Study|Physician Decision|0|||
149861354|NCT01813071|540620593|FG005|Overall Study|Physician Decision|0|||
149861355|NCT01813071|540620594|FG006|Overall Study|Physician Decision|1|||
149861356|NCT01813071|540620595|FG007|Overall Study|Physician Decision|0|||
149861357|NCT01813071|540620596|FG008|Overall Study|Physician Decision|0|||
149861358|NCT01813071|540620588|FG000|Overall Study|Met inc/exc criteria|0|||
149861359|NCT01813071|540620589|FG001|Overall Study|Met inc/exc criteria|0|||
149861360|NCT01813071|540620590|FG002|Overall Study|Met inc/exc criteria|0|||
149861361|NCT01813071|540620591|FG003|Overall Study|Met inc/exc criteria|0|||
149861362|NCT01813071|540620592|FG004|Overall Study|Met inc/exc criteria|0|||
149861363|NCT01813071|540620593|FG005|Overall Study|Met inc/exc criteria|1|||
149861364|NCT01813071|540620594|FG006|Overall Study|Met inc/exc criteria|0|||
149861365|NCT01813071|540620595|FG007|Overall Study|Met inc/exc criteria|1|||
149861366|NCT01813071|540620596|FG008|Overall Study|Met inc/exc criteria|1|||
149861367|NCT01688726|540620597|FG000|Overall Study|Adverse Event|1|||
149861368|NCT01688726|540620598|FG001|Overall Study|Adverse Event|0|||
149861369|NCT01688726|540620597|FG000|Overall Study|Relocated abroad|0|||
149861370|NCT01688726|540620598|FG001|Overall Study|Relocated abroad|1|||
149861371|NCT04553913|540620599|FG000|Overall Study|patient's block resolved prior to PACU|1|||
149861372|NCT04553913|540620599|FG000|Overall Study|did not use the device properly|5|||
149861373|NCT00710749|540620601|FG000|First Intervention|Withdrawal by Subject|1|||
149861374|NCT00710749|540620602|FG001|First Intervention|Withdrawal by Subject|0|||
149861375|NCT02985879|540620603|FG000|Overall Study|Adverse Event|7|||
149861376|NCT02985879|540620604|FG001|Overall Study|Adverse Event|9|||
149861377|NCT02985879|540620605|FG002|Overall Study|Adverse Event|7|||
150291898|NCT06279871|542201717|FG005|Overall Study|Adverse Event|0|||
149861378|NCT02985879|540620603|FG000|Overall Study|Withdrew consent|6|||
149861379|NCT02985879|540620604|FG001|Overall Study|Withdrew consent|8|||
149861380|NCT02985879|540620605|FG002|Overall Study|Withdrew consent|10|||
149861381|NCT02985879|540620603|FG000|Overall Study|Lost to Follow-up|1|||
149861382|NCT02985879|540620604|FG001|Overall Study|Lost to Follow-up|0|||
149861383|NCT02985879|540620605|FG002|Overall Study|Lost to Follow-up|2|||
149861384|NCT02985879|540620603|FG000|Overall Study|Other, not specified|62|||
149861385|NCT02985879|540620604|FG001|Overall Study|Other, not specified|58|||
149861386|NCT02985879|540620605|FG002|Overall Study|Other, not specified|58|||
149861387|NCT03821272|540622155|FG000|Overall Study|Death|1|||
149861388|NCT03821272|540622156|FG001|Overall Study|Death|0|||
149861389|NCT03821272|540622155|FG000|Overall Study|Physician Decision|1|||
149861390|NCT03821272|540622156|FG001|Overall Study|Physician Decision|0|||
149861391|NCT03821272|540622155|FG000|Overall Study|Withdrawal by Subject|1|||
149861392|NCT03821272|540622156|FG001|Overall Study|Withdrawal by Subject|0|||
149861393|NCT05904769|540622157|FG000|Overall Study|Physician Decision|0|||
149861394|NCT05904769|540622158|FG001|Overall Study|Physician Decision|6|||
149861395|NCT05626803|540622159|FG000|Overall Study|Lost to Follow-up|0|||
149861396|NCT05626803|540622160|FG001|Overall Study|Lost to Follow-up|1|||
149861397|NCT05626803|540622161|FG002|Overall Study|Lost to Follow-up|0|||
149861398|NCT05626803|540622162|FG003|Overall Study|Lost to Follow-up|0|||
149861399|NCT04974619|540622163|FG000|Overall Study|Lost to Follow-up|0|||
149861400|NCT04974619|540622164|FG001|Overall Study|Lost to Follow-up|0|||
149861401|NCT04974619|540622165|FG002|Overall Study|Lost to Follow-up|1|||
149861402|NCT04974619|540622163|FG000|Overall Study|Withdrawal by Subject|0|||
149861403|NCT04974619|540622164|FG001|Overall Study|Withdrawal by Subject|0|||
149861404|NCT04974619|540622165|FG002|Overall Study|Withdrawal by Subject|1|||
149861405|NCT04974619|540622163|FG000|Overall Study|Protocol Violation|0|||
149861406|NCT04974619|540622164|FG001|Overall Study|Protocol Violation|1|||
149861407|NCT04974619|540622165|FG002|Overall Study|Protocol Violation|0|||
149861408|NCT03959527|540622172|FG000|Overall Study|Withdrawal by Subject|8|||
149861409|NCT03959527|540622173|FG001|Overall Study|Withdrawal by Subject|3|||
149861410|NCT03959527|540622172|FG000|Overall Study|Lost to Follow-up|31|||
149861411|NCT03959527|540622173|FG001|Overall Study|Lost to Follow-up|15|||
149861412|NCT03959527|540622172|FG000|Overall Study|Did not meet eligibility criteria|1|||
149861413|NCT03959527|540622173|FG001|Overall Study|Did not meet eligibility criteria|1|||
149861414|NCT03959527|540622172|FG000|Overall Study|Protocol Violation|10|||
149861415|NCT03959527|540622173|FG001|Overall Study|Protocol Violation|5|||
149861416|NCT01688466|540622174|FG000|Overall Study|Withdrawal by Subject|2|||
149861417|NCT01688466|540622175|FG001|Overall Study|Withdrawal by Subject|1|||
149861418|NCT01688466|540622174|FG000|Overall Study|Death|0|||
149861419|NCT01688466|540622175|FG001|Overall Study|Death|1|||
149861420|NCT01688466|540622174|FG000|Overall Study|Adverse Event|0|||
149861421|NCT01688466|540622175|FG001|Overall Study|Adverse Event|4|||
149861422|NCT01688466|540622174|FG000|Overall Study|Not evaluable|0|||
149861423|NCT01688466|540622175|FG001|Overall Study|Not evaluable|1|||
149861424|NCT01000610|540622180|FG000|Overall Study|Adverse Event|1|||
149861425|NCT01000610|540622180|FG000|Overall Study|Lost to Follow-up|4|||
149861426|NCT01000610|540622180|FG000|Overall Study|Treatment failure|1|||
149861427|NCT02658487|540622187|FG000|Overall Study|Death|2|||
149861428|NCT02658487|540622187|FG000|Overall Study|Disease progression|10|||
149861429|NCT02658487|540622187|FG000|Overall Study|Alternative therapy|1|||
149861430|NCT02658487|540622187|FG000|Overall Study|Adverse Event|1|||
149861431|NCT02658487|540622187|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
149861432|NCT02658487|540622187|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
149861433|NCT01885182|540622188|FG000|Overall Study|Adverse Event|11|||
149861434|NCT01885182|540622189|FG001|Overall Study|Adverse Event|13|||
149861435|NCT01885182|540622188|FG000|Overall Study|Withdrawal by Subject|13|||
149861436|NCT01885182|540622189|FG001|Overall Study|Withdrawal by Subject|6|||
149861437|NCT01885182|540622188|FG000|Overall Study|Lost to Follow-up|2|||
149861438|NCT01885182|540622189|FG001|Overall Study|Lost to Follow-up|2|||
149861439|NCT01885182|540622188|FG000|Overall Study|Lack of Efficacy|8|||
149861440|NCT01885182|540622189|FG001|Overall Study|Lack of Efficacy|1|||
149861441|NCT00380692|540622199|FG000|Study Period II - Double Blind|Adverse Event|1|||
149861442|NCT00380692|540622200|FG001|Study Period II - Double Blind|Adverse Event|0|||
149861443|NCT00380692|540622199|FG000|Study Period II - Double Blind|Protocol Violation|2|||
149861444|NCT00380692|540622200|FG001|Study Period II - Double Blind|Protocol Violation|2|||
149861445|NCT00380692|540622199|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
149861446|NCT00380692|540622200|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
149861447|NCT00380692|540622199|FG000|Study Period II - Double Blind|Physician Decision|0|||
149861448|NCT00380692|540622200|FG001|Study Period II - Double Blind|Physician Decision|1|||
149861449|NCT00380692|540622199|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
149861450|NCT00380692|540622200|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
149861451|NCT00380692|540622199|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
149861452|NCT00380692|540622200|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
149861453|NCT00380692|540622199|FG000|Study Period III - Open Label|Adverse Event|5|||
149861454|NCT00380692|540622200|FG001|Study Period III - Open Label|Adverse Event|3|||
149861455|NCT00380692|540622199|FG000|Study Period III - Open Label|Protocol Violation|0|||
149861456|NCT00380692|540622200|FG001|Study Period III - Open Label|Protocol Violation|0|||
149861457|NCT00380692|540622199|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
149861458|NCT00380692|540622200|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
149861459|NCT00380692|540622199|FG000|Study Period III - Open Label|Physician Decision|0|||
149861460|NCT00380692|540622200|FG001|Study Period III - Open Label|Physician Decision|3|||
149861461|NCT00380692|540622199|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
149861462|NCT00380692|540622200|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
149861463|NCT00380692|540622199|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
149861464|NCT00380692|540622200|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
149861465|NCT02676284|540622201|FG000|Overall Study|Withdrawal by Subject|1|||
149861466|NCT00708708|540622203|FG000|Overall Study|Another therapy instead of Enbrel|141|||
149861467|NCT00708708|540622203|FG000|Overall Study|Lost to Follow-up|52|||
149861468|NCT00708708|540622203|FG000|Overall Study|Withdrawal by Subject|51|||
149861469|NCT00708708|540622203|FG000|Overall Study|Intolerance|42|||
149861470|NCT00708708|540622203|FG000|Overall Study|Another therapy along with Enbrel|15|||
149861471|NCT00708708|540622203|FG000|Overall Study|Other unspecified|11|||
149861472|NCT00708708|540622203|FG000|Overall Study|Good effectiveness|9|||
149861473|NCT00708708|540622203|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
149861474|NCT00708708|540622203|FG000|Overall Study|Administrative reasons|7|||
149861475|NCT00708708|540622203|FG000|Overall Study|Lack of effectiveness|4|||
149861476|NCT00708708|540622203|FG000|Overall Study|Lack of compliance|3|||
149861477|NCT00708708|540622203|FG000|Overall Study|Pregnancy|3|||
149861478|NCT00708708|540622203|FG000|Overall Study|Adverse Event|3|||
149861479|NCT00708708|540622203|FG000|Overall Study|Missing values|392|||
149861480|NCT01286558|540622208|FG000|Overall Study|Adverse Event|1|||
149861481|NCT01286558|540622209|FG001|Overall Study|Adverse Event|1|||
150173671|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150291899|NCT06279871|542201718|FG006|Overall Study|Adverse Event|0|||
150291900|NCT04706507|542201719|FG000|Overall Study|Death|45|||
150291901|NCT04706507|542201720|FG001|Overall Study|Death|22|||
150291902|NCT04706507|542201719|FG000|Overall Study|Unable to adhere|0|||
150291903|NCT04706507|542201720|FG001|Overall Study|Unable to adhere|2|||
150291904|NCT04706507|542201719|FG000|Overall Study|Lost to Follow-up|13|||
150291905|NCT04706507|542201720|FG001|Overall Study|Lost to Follow-up|12|||
149861482|NCT01286558|540622208|FG000|Overall Study|Withdrawal by Subject|0|||
149861483|NCT01286558|540622209|FG001|Overall Study|Withdrawal by Subject|1|||
150291906|NCT04706507|542201719|FG000|Overall Study|Withdrawal of consent|1|||
149861484|NCT01787279|540622211|FG000|Overall Study|Lost to Follow-up|2|||
149861485|NCT01787279|540622211|FG000|Overall Study|Lack of Efficacy|1|||
149861486|NCT02148913|540622212|FG000|Overall Study|Death|0|||
149861487|NCT02148913|540622213|FG001|Overall Study|Death|1|||
149861488|NCT02148913|540622214|FG002|Overall Study|Death|0|||
149861489|NCT02148913|540622215|FG003|Overall Study|Death|0|||
149861490|NCT01287039|540622217|FG000|Overall Study|Noncompliance with study procedures|0|||
149861491|NCT01287039|540622218|FG001|Overall Study|Noncompliance with study procedures|1|||
150291907|NCT04706507|542201720|FG001|Overall Study|Withdrawal of consent|1|||
150291908|NCT04706507|542201719|FG000|Overall Study|Patient or LAR refuses further participation|0|||
150291909|NCT04706507|542201720|FG001|Overall Study|Patient or LAR refuses further participation|3|||
150291910|NCT05568888|542201721|FG000|Overall Study|Physician Decision|1|||
150291911|NCT05568888|542201722|FG001|Overall Study|Physician Decision|0|||
150291912|NCT05568888|542201721|FG000|Overall Study|Protocol Deviation|2|||
150291913|NCT05568888|542201722|FG001|Overall Study|Protocol Deviation|1|||
150291914|NCT05568888|542201721|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
150291915|NCT05568888|542201722|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
150291916|NCT05568888|542201721|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
150291917|NCT05568888|542201722|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
150291918|NCT05568888|542201721|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
150291919|NCT05568888|542201722|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
150291920|NCT02406781|542201724|FG000|Overall Study|Protocol Violation|2|||
150291921|NCT02406781|542201725|FG001|Overall Study|Protocol Violation|2|||
150291922|NCT02406781|542201726|FG002|Overall Study|Protocol Violation|2|||
150291923|NCT02406781|542201727|FG003|Overall Study|Protocol Violation|2|||
150291924|NCT02406781|542201728|FG004|Overall Study|Protocol Violation|1|||
150291925|NCT02406781|542201729|FG005|Overall Study|Protocol Violation|5|||
150291926|NCT02406781|542201730|FG006|Overall Study|Protocol Violation|3|||
150291927|NCT04026711|542201734|FG000|Overall Study|Withdrawal by Subject|1|||
150291928|NCT04026711|542201735|FG001|Overall Study|Withdrawal by Subject|0|||
150291929|NCT04026711|542201734|FG000|Overall Study|mental health crisis|1|||
150291930|NCT04026711|542201735|FG001|Overall Study|mental health crisis|0|||
150291931|NCT05486065|542201736|FG000|Overall Study|Withdrawal by Subject|1|||
150291932|NCT05486065|542201737|FG001|Overall Study|Withdrawal by Subject|5|||
150291933|NCT05486065|542201738|FG002|Overall Study|Withdrawal by Subject|4|||
150291934|NCT05486065|542201739|FG003|Overall Study|Withdrawal by Subject|3|||
150291935|NCT05486065|542201736|FG000|Overall Study|Lost to Follow-up|4|||
150291936|NCT05486065|542201737|FG001|Overall Study|Lost to Follow-up|2|||
149861492|NCT01287039|540622217|FG000|Overall Study|Change of location/residence|0|||
149861493|NCT01287039|540622218|FG001|Overall Study|Change of location/residence|3|||
149861494|NCT01287039|540622217|FG000|Overall Study|Elective surgery|0|||
149861495|NCT01287039|540622218|FG001|Overall Study|Elective surgery|1|||
149861496|NCT01287039|540622217|FG000|Overall Study|Protocol Violation|2|||
149861497|NCT01287039|540622218|FG001|Overall Study|Protocol Violation|3|||
149861498|NCT01287039|540622217|FG000|Overall Study|Excluded medication taken|1|||
149861499|NCT01287039|540622218|FG001|Overall Study|Excluded medication taken|0|||
149861500|NCT01287039|540622217|FG000|Overall Study|Noncompliance with study medication|0|||
149861501|NCT01287039|540622218|FG001|Overall Study|Noncompliance with study medication|1|||
149861502|NCT01287039|540622217|FG000|Overall Study|Problem with travel|0|||
149861503|NCT01287039|540622218|FG001|Overall Study|Problem with travel|1|||
149861504|NCT01287039|540622217|FG000|Overall Study|Death|1|||
149861505|NCT01287039|540622218|FG001|Overall Study|Death|0|||
149861506|NCT01287039|540622217|FG000|Overall Study|Change of residence|1|||
149861507|NCT01287039|540622218|FG001|Overall Study|Change of residence|0|||
149861508|NCT01287039|540622217|FG000|Overall Study|Adverse Event|7|||
149861509|NCT01287039|540622218|FG001|Overall Study|Adverse Event|4|||
149861510|NCT01287039|540622217|FG000|Overall Study|Withdrawal by Subject|14|||
149861511|NCT01287039|540622218|FG001|Overall Study|Withdrawal by Subject|11|||
149861512|NCT01287039|540622217|FG000|Overall Study|Lost to Follow-up|3|||
149861513|NCT01287039|540622218|FG001|Overall Study|Lost to Follow-up|2|||
149861514|NCT05016622|540622219|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
149861515|NCT05016622|540622219|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
149861516|NCT01304693|540622220|FG000|Overall Study|Adverse Event|0|||
149861517|NCT01304693|540622221|FG001|Overall Study|Adverse Event|0|||
149861518|NCT01304693|540622222|FG002|Overall Study|Adverse Event|0|||
150291937|NCT05486065|542201738|FG002|Overall Study|Lost to Follow-up|2|||
150291938|NCT05486065|542201739|FG003|Overall Study|Lost to Follow-up|2|||
149861519|NCT01304693|540622223|FG003|Overall Study|Adverse Event|0|||
149861520|NCT01304693|540622224|FG004|Overall Study|Adverse Event|1|||
149861521|NCT01304693|540622220|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
150291939|NCT05486065|542201736|FG000|Overall Study|Physician Decision|0|||
150291940|NCT05486065|542201737|FG001|Overall Study|Physician Decision|1|||
150291941|NCT05486065|542201738|FG002|Overall Study|Physician Decision|1|||
149861522|NCT01304693|540622221|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
150291942|NCT05486065|542201739|FG003|Overall Study|Physician Decision|0|||
150291943|NCT05486065|542201736|FG000|Overall Study|Failure to meet randomization criteria|0|||
150291944|NCT05486065|542201737|FG001|Overall Study|Failure to meet randomization criteria|0|||
149861523|NCT01304693|540622222|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
149961952|NCT01570192|540994167|FG000|Overall Study|Physician Decision|0|||
150291945|NCT05486065|542201738|FG002|Overall Study|Failure to meet randomization criteria|0|||
150291946|NCT05486065|542201739|FG003|Overall Study|Failure to meet randomization criteria|1|||
150291947|NCT05985395|542201742|FG000|Overall Study|Physician Decision|2|||
150173672|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173673|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173674|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173675|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173676|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
150173677|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
150173678|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173679|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
150173680|NCT04707313|541771315|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173681|NCT04707313|541771316|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173682|NCT04707313|541771317|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173683|NCT04707313|541771318|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173684|NCT04707313|541771319|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173685|NCT04707313|541771320|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173686|NCT04707313|541771321|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173687|NCT04707313|541771322|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173688|NCT04707313|541771323|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
150173689|NCT04707313|541771324|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
150173690|NCT04707313|541771325|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
150173691|NCT04707313|541771326|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
150173692|NCT04707313|541771327|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
150173693|NCT02739035|541771328|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
150173694|NCT02739035|541771329|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
150173695|NCT02739035|541771328|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
150173696|NCT02739035|541771329|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
150173697|NCT02739035|541771328|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
150173698|NCT02739035|541771329|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
150173699|NCT02739035|541771328|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
150173700|NCT02739035|541771329|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
150173701|NCT00940992|541771331|FG000|Overall Study|Adverse Event|2|||
150173702|NCT00940992|541771332|FG001|Overall Study|Adverse Event|0|||
150173703|NCT00940992|541771333|FG002|Overall Study|Adverse Event|1|||
150173704|NCT00940992|541771331|FG000|Overall Study|subject request|2|||
150173705|NCT00940992|541771332|FG001|Overall Study|subject request|1|||
150173706|NCT00940992|541771333|FG002|Overall Study|subject request|0|||
150173707|NCT00940992|541771331|FG000|Overall Study|Lost to Follow-up|0|||
150173708|NCT00940992|541771332|FG001|Overall Study|Lost to Follow-up|1|||
150173709|NCT00940992|541771333|FG002|Overall Study|Lost to Follow-up|1|||
150173710|NCT04221438|541771336|FG000|Overall Study|Adverse Event|1|||
150173711|NCT04221438|541771336|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
150173712|NCT00588770|541771339|FG000|Overall Study|Disease progression|85|||
150173713|NCT00588770|541771340|FG001|Overall Study|Disease progression|68|||
150173714|NCT00588770|541771339|FG000|Overall Study|Adverse Event|29|||
150173715|NCT00588770|541771340|FG001|Overall Study|Adverse Event|58|||
150173716|NCT00588770|541771339|FG000|Overall Study|Death|13|||
150173717|NCT00588770|541771340|FG001|Overall Study|Death|22|||
150173718|NCT00588770|541771339|FG000|Overall Study|Withdrawal by Subject|15|||
150173719|NCT00588770|541771340|FG001|Overall Study|Withdrawal by Subject|25|||
150173720|NCT00588770|541771339|FG000|Overall Study|Alternative therapy|2|||
150173721|NCT00588770|541771340|FG001|Overall Study|Alternative therapy|4|||
150173722|NCT00588770|541771339|FG000|Overall Study|Other complicating disease|3|||
150173723|NCT00588770|541771340|FG001|Overall Study|Other complicating disease|2|||
150173724|NCT00588770|541771339|FG000|Overall Study|Not start protocol therapy|0|||
150173725|NCT00588770|541771340|FG001|Overall Study|Not start protocol therapy|9|||
150291948|NCT05985395|542201743|FG001|Overall Study|Physician Decision|1|||
150291949|NCT05985395|542201742|FG000|Overall Study|Withdrawal by Subject|1|||
149961953|NCT01570192|540994168|FG001|Overall Study|Physician Decision|1|||
149961954|NCT02134028|540994169|FG000|Overall Study|Lack of Efficacy|1|||
149961955|NCT02134028|540994170|FG001|Overall Study|Lack of Efficacy|0|||
149961956|NCT02134028|540994171|FG002|Overall Study|Lack of Efficacy|3|||
149961957|NCT02134028|540994172|FG003|Overall Study|Lack of Efficacy|2|||
149961958|NCT02134028|540994173|FG004|Overall Study|Lack of Efficacy|1|||
149961959|NCT02134028|540994174|FG005|Overall Study|Lack of Efficacy|2|||
149961960|NCT02134028|540994175|FG006|Overall Study|Lack of Efficacy|1|||
150291950|NCT05985395|542201743|FG001|Overall Study|Withdrawal by Subject|0|||
150173726|NCT00588770|541771339|FG000|Overall Study|Lack of Efficacy|8|||
150173727|NCT00588770|541771340|FG001|Overall Study|Lack of Efficacy|10|||
150173728|NCT00588770|541771339|FG000|Overall Study|Physician discretion|2|||
150173729|NCT00588770|541771340|FG001|Overall Study|Physician discretion|0|||
150173730|NCT00588770|541771339|FG000|Overall Study|Patient non-compliance|2|||
150291951|NCT03919162|542201746|FG000|Overall Study|Adverse Event|3|||
149961961|NCT02134028|540994176|FG007|Overall Study|Lack of Efficacy|0|||
150173731|NCT00588770|541771340|FG001|Overall Study|Patient non-compliance|2|||
150291952|NCT03919162|542201747|FG001|Overall Study|Adverse Event|2|||
150173732|NCT00617201|541771345|FG000|Overall Study|Lost to Follow-up|9|||
149861524|NCT01304693|540622223|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
149861525|NCT01304693|540622224|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
149861526|NCT03438396|540622231|FG000|Overall Study|Reason Not Specified|9|||
149861527|NCT03438396|540622231|FG000|Overall Study|Withdrawal by Subject|5|||
149861528|NCT03438396|540622231|FG000|Overall Study|Lost to Follow-up|2|||
149861529|NCT03438396|540622231|FG000|Overall Study|Death|85|||
149861530|NCT03438396|540622231|FG000|Overall Study|Not treated|1|||
149861531|NCT00262041|540622232|FG000|Overall Study|Withdrawal by Subject|0|||
149861532|NCT00262041|540622233|FG001|Overall Study|Withdrawal by Subject|3|||
149861533|NCT00262041|540622234|FG002|Overall Study|Withdrawal by Subject|1|||
149861534|NCT00262041|540622232|FG000|Overall Study|Lost to Follow-up|1|||
149861535|NCT00262041|540622233|FG001|Overall Study|Lost to Follow-up|1|||
149861536|NCT00262041|540622234|FG002|Overall Study|Lost to Follow-up|5|||
149861537|NCT00262041|540622232|FG000|Overall Study|Unable to classify|1|||
149861538|NCT00262041|540622233|FG001|Overall Study|Unable to classify|0|||
149861539|NCT00262041|540622234|FG002|Overall Study|Unable to classify|0|||
149861540|NCT03578237|540622237|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
149861541|NCT03578237|540622238|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
149861542|NCT01173471|540622239|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149861543|NCT01173471|540622240|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149861544|NCT01173471|540622241|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
149861545|NCT01173471|540622242|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
149861546|NCT01173471|540622239|FG000|Overall Study|Condition under investigation worsened|2|||
149861547|NCT01173471|540622240|FG001|Overall Study|Condition under investigation worsened|0|||
149861548|NCT01173471|540622241|FG002|Overall Study|Condition under investigation worsened|0|||
149861549|NCT01173471|540622242|FG003|Overall Study|Condition under investigation worsened|0|||
149861550|NCT01173471|540622239|FG000|Overall Study|Lost to Follow-up|0|||
149861551|NCT01173471|540622240|FG001|Overall Study|Lost to Follow-up|0|||
149861552|NCT01173471|540622241|FG002|Overall Study|Lost to Follow-up|1|||
149861553|NCT01173471|540622242|FG003|Overall Study|Lost to Follow-up|0|||
149861554|NCT01173471|540622239|FG000|Overall Study|Reason given as Other|0|||
149861555|NCT01173471|540622240|FG001|Overall Study|Reason given as Other|0|||
149861556|NCT01173471|540622241|FG002|Overall Study|Reason given as Other|1|||
149861557|NCT01173471|540622242|FG003|Overall Study|Reason given as Other|0|||
149861558|NCT04132336|540622243|FG000|Overall Study|Investigator Decision|0|||
149861559|NCT04132336|540622244|FG001|Overall Study|Investigator Decision|1|||
149861560|NCT04132336|540622245|FG002|Overall Study|Investigator Decision|0|||
149861561|NCT04132336|540622246|FG003|Overall Study|Investigator Decision|0|||
149861562|NCT04132336|540622247|FG004|Overall Study|Investigator Decision|0|||
149861563|NCT04132336|540622248|FG005|Overall Study|Investigator Decision|0|||
149861564|NCT04132336|540622249|FG006|Overall Study|Investigator Decision|0|||
149861565|NCT00584844|540622251|FG000|Overall Study|Withdrawal by Subject|59|||
149861566|NCT00584844|540622251|FG000|Overall Study|Screen Failure|20|||
149861567|NCT02488330|540622252|FG000|Overall Study|Adverse Event|1|||
149861568|NCT02488330|540622252|FG000|Overall Study|Physician Decision|2|||
149861569|NCT02488330|540622252|FG000|Overall Study|Death|2|||
149861570|NCT02488330|540622252|FG000|Overall Study|Disease Progression|3|||
149861571|NCT02488330|540622252|FG000|Overall Study|Study Termination by Sponsor|4|||
149861572|NCT00171301|540622255|FG000|Overall Study|Death|1|||
149861573|NCT00171301|540622256|FG001|Overall Study|Death|2|||
149861574|NCT00171301|540622255|FG000|Overall Study|Adverse Event|1|||
149861575|NCT00171301|540622256|FG001|Overall Study|Adverse Event|2|||
149861576|NCT00171301|540622255|FG000|Overall Study|Lost to Follow-up|6|||
149861577|NCT00171301|540622256|FG001|Overall Study|Lost to Follow-up|2|||
149861578|NCT00171301|540622255|FG000|Overall Study|Protocol Violation|0|||
149861579|NCT00171301|540622256|FG001|Overall Study|Protocol Violation|2|||
150291953|NCT03919162|542201746|FG000|Overall Study|Death|2|||
150291954|NCT03919162|542201747|FG001|Overall Study|Death|0|||
150291955|NCT03919162|542201746|FG000|Overall Study|Lost to Follow-up|1|||
150291956|NCT03919162|542201747|FG001|Overall Study|Lost to Follow-up|0|||
150291957|NCT03919162|542201746|FG000|Overall Study|Withdrawal by Subject|12|||
150291958|NCT03919162|542201747|FG001|Overall Study|Withdrawal by Subject|12|||
150291959|NCT03919162|542201746|FG000|Overall Study|Study terminated by Sponsor|20|||
149861580|NCT00171301|540622255|FG000|Overall Study|Withdrawal by Subject|0|||
149861581|NCT00171301|540622256|FG001|Overall Study|Withdrawal by Subject|1|||
149861582|NCT04319159|540622258|FG000|Overall Study|Screening failure|13|||
149861583|NCT04319159|540622258|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
149861584|NCT04319159|540622258|FG000|Overall Study|Withdrawal by Subject|1|||
149861585|NCT06005597|540622261|FG000|Overall Study|Lost to Follow-up|1|||
150291960|NCT03919162|542201747|FG001|Overall Study|Study terminated by Sponsor|24|||
149861586|NCT06005597|540622262|FG001|Overall Study|Lost to Follow-up|2|||
149861587|NCT06005597|540622263|FG002|Overall Study|Lost to Follow-up|1|||
149861588|NCT06005597|540622264|FG003|Overall Study|Lost to Follow-up|2|||
150291961|NCT03919162|542201746|FG000|Overall Study|Screen failure|1|||
150291962|NCT03919162|542201747|FG001|Overall Study|Screen failure|0|||
150291963|NCT03919162|542201746|FG000|Overall Study|Missing|1|||
150291964|NCT03919162|542201747|FG001|Overall Study|Missing|1|||
150291965|NCT04745689|542201750|FG000|Overall Study|Death|9|||
150291966|NCT04745689|542201751|FG001|Overall Study|Death|6|||
150291967|NCT04745689|542201750|FG000|Overall Study|Lost to Follow-up|1|||
150291968|NCT04745689|542201751|FG001|Overall Study|Lost to Follow-up|0|||
150291969|NCT04745689|542201750|FG000|Overall Study|Withdrawal by Subject|2|||
150291970|NCT04745689|542201751|FG001|Overall Study|Withdrawal by Subject|0|||
150291971|NCT04745689|542201750|FG000|Overall Study|Study terminated by sponsor|10|||
150291972|NCT04745689|542201751|FG001|Overall Study|Study terminated by sponsor|3|||
150291973|NCT05741528|542201752|FG000|Overall Study|Withdrawal by Subject|11|||
149861589|NCT06005597|540622261|FG000|Overall Study|Death|1|||
149861590|NCT06005597|540622262|FG001|Overall Study|Death|1|||
150291974|NCT05741528|542201752|FG000|Overall Study|Lost to Follow-up|3|||
150291975|NCT05741528|542201752|FG000|Overall Study|Adverse Event|2|||
150291976|NCT05741528|542201752|FG000|Overall Study|Non-Compliance With Study Drug|2|||
149861591|NCT06005597|540622263|FG002|Overall Study|Death|1|||
149861592|NCT06005597|540622264|FG003|Overall Study|Death|0|||
149861593|NCT02100319|540622268|FG000|Overall Study|Case Report Forms Uncollected|11|||
149861594|NCT02100319|540622268|FG000|Overall Study|Protocol Deviation|5|||
149861595|NCT02370914|540622271|FG000|Overall Study|Protocol Violation|2|||
149861596|NCT02224573|540622272|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
149861597|NCT02224573|540622273|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
149861598|NCT02224573|540622272|FG000|Treatment Phase|Started on Other IMP|1|||
149861599|NCT02224573|540622273|FG001|Treatment Phase|Started on Other IMP|0|||
150173733|NCT00617201|541771346|FG001|Overall Study|Lost to Follow-up|13|||
150173734|NCT00546871|541771347|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
150173735|NCT00546871|541771348|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
150173736|NCT00546871|541771347|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
150173737|NCT00546871|541771348|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
150173738|NCT00546871|541771347|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
150173739|NCT00546871|541771348|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
150173740|NCT00546871|541771347|FG000|Study Extension Period|Protocol Violation|1|||
150173741|NCT00546871|541771348|FG001|Study Extension Period|Protocol Violation|0|||
150173742|NCT00546871|541771347|FG000|Study Extension Period|Withdrawal by Subject|0|||
150173743|NCT00546871|541771348|FG001|Study Extension Period|Withdrawal by Subject|1|||
150173744|NCT01713946|541771349|FG000|Overall Study|Death|0|||
150173745|NCT01713946|541771350|FG001|Overall Study|Death|2|||
150173746|NCT01713946|541771351|FG002|Overall Study|Death|2|||
150173747|NCT01713946|541771349|FG000|Overall Study|Adverse Event|19|||
150173748|NCT01713946|541771350|FG001|Overall Study|Adverse Event|14|||
150173749|NCT01713946|541771351|FG002|Overall Study|Adverse Event|13|||
150173750|NCT01713946|541771349|FG000|Overall Study|Withdrawal by Subject|12|||
150173751|NCT01713946|541771350|FG001|Overall Study|Withdrawal by Subject|12|||
150173752|NCT01713946|541771351|FG002|Overall Study|Withdrawal by Subject|8|||
150173753|NCT01713946|541771349|FG000|Overall Study|Lack of Efficacy|8|||
150173754|NCT01713946|541771350|FG001|Overall Study|Lack of Efficacy|8|||
150173755|NCT01713946|541771351|FG002|Overall Study|Lack of Efficacy|14|||
150173756|NCT01713946|541771349|FG000|Overall Study|Protocol Violation|2|||
150173757|NCT01713946|541771350|FG001|Overall Study|Protocol Violation|4|||
150173758|NCT01713946|541771351|FG002|Overall Study|Protocol Violation|1|||
150173759|NCT01713946|541771349|FG000|Overall Study|Lost to Follow-up|0|||
150173760|NCT01713946|541771350|FG001|Overall Study|Lost to Follow-up|0|||
150173761|NCT01713946|541771351|FG002|Overall Study|Lost to Follow-up|1|||
150291977|NCT05741528|542201752|FG000|Overall Study|Reason Not Specified|1|||
150291978|NCT04102189|542202557|FG000|Overall Study|Withdrawal by Subject|1|||
149861600|NCT02224573|540622272|FG000|Treatment Phase|Participant Discontinued IMP|0|||
149861601|NCT02224573|540622273|FG001|Treatment Phase|Participant Discontinued IMP|1|||
149861602|NCT02224573|540622272|FG000|Treatment Phase|Lack of Efficacy|15|||
149861603|NCT02224573|540622273|FG001|Treatment Phase|Lack of Efficacy|8|||
150173762|NCT01713946|541771349|FG000|Overall Study|Administrative problems|1|||
150173763|NCT01713946|541771350|FG001|Overall Study|Administrative problems|0|||
150291979|NCT04102189|542202558|FG001|Overall Study|Withdrawal by Subject|2|||
149861604|NCT02224573|540622272|FG000|Treatment Phase|Began Commercial Product|1|||
150173764|NCT01713946|541771351|FG002|Overall Study|Administrative problems|0|||
150173765|NCT01713946|541771349|FG000|Overall Study|Did not continue in Ext|0|||
150173766|NCT01713946|541771350|FG001|Overall Study|Did not continue in Ext|3|||
150291980|NCT04102189|542202557|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150291981|NCT04102189|542202558|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150291982|NCT04102189|542202557|FG000|Overall Study|Lost to Follow-up|1|||
149861605|NCT02224573|540622273|FG001|Treatment Phase|Began Commercial Product|0|||
149861606|NCT02224573|540622272|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
149861607|NCT02224573|540622273|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
150173767|NCT01713946|541771351|FG002|Overall Study|Did not continue in Ext|0|||
150173768|NCT01713946|541771349|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
150173769|NCT01713946|541771350|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
149861608|NCT02224573|540622272|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
149861609|NCT02224573|540622273|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
149861610|NCT02224573|540622272|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
149861611|NCT02224573|540622273|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
149861612|NCT02224573|540622272|FG000|Treatment Phase|Continued Compassionate Use|1|||
149861613|NCT02224573|540622273|FG001|Treatment Phase|Continued Compassionate Use|0|||
149861614|NCT02224573|540622272|FG000|Treatment Phase|Lack of Efficiency|2|||
149861615|NCT02224573|540622273|FG001|Treatment Phase|Lack of Efficiency|1|||
149861616|NCT02224573|540622272|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
149861617|NCT02224573|540622273|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
149861618|NCT02224573|540622272|FG000|Treatment Phase|Participant Moved|2|||
149861619|NCT02224573|540622273|FG001|Treatment Phase|Participant Moved|0|||
149861620|NCT02224573|540622272|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
149861621|NCT02224573|540622273|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
149861622|NCT02224573|540622272|FG000|Treatment Phase|Refused Medication|1|||
149861623|NCT02224573|540622273|FG001|Treatment Phase|Refused Medication|1|||
149861624|NCT02224573|540622272|FG000|Treatment Phase|Adverse Event|26|||
149861625|NCT02224573|540622273|FG001|Treatment Phase|Adverse Event|38|||
149861626|NCT02224573|540622272|FG000|Treatment Phase|Placed in Group Home|0|||
149861627|NCT02224573|540622273|FG001|Treatment Phase|Placed in Group Home|1|||
149861628|NCT02224573|540622272|FG000|Treatment Phase|Pursued Other Trials|1|||
149861629|NCT02224573|540622273|FG001|Treatment Phase|Pursued Other Trials|0|||
149861630|NCT02224573|540622272|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
149861631|NCT02224573|540622273|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
149861632|NCT02224573|540622272|FG000|Treatment Phase|Lost to Follow-up|2|||
149861633|NCT02224573|540622273|FG001|Treatment Phase|Lost to Follow-up|1|||
149861634|NCT02224573|540622272|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
149861635|NCT02224573|540622273|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
149861636|NCT02224573|540622272|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
149861637|NCT02224573|540622273|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
149861638|NCT02224573|540622272|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
149861639|NCT02224573|540622273|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
149861640|NCT02224573|540622272|FG000|Taper Phase|Adverse Event|1|||
149861641|NCT02224573|540622273|FG001|Taper Phase|Adverse Event|1|||
149861642|NCT01790113|540622274|FG000|Overall Study|Adverse Event|2|||
149861643|NCT01790113|540622275|FG001|Overall Study|Adverse Event|7|||
149861644|NCT01790113|540622274|FG000|Overall Study|Study ended due to FDA clearance|1|||
149861645|NCT01790113|540622275|FG001|Overall Study|Study ended due to FDA clearance|68|||
149861646|NCT01341587|540622278|FG000|Overall Study|Lost to Follow-up|2|||
149861647|NCT01341587|540622279|FG001|Overall Study|Lost to Follow-up|0|||
149861648|NCT01341587|540622278|FG000|Overall Study|stopped using the meters|2|||
149861649|NCT01341587|540622279|FG001|Overall Study|stopped using the meters|10|||
149861650|NCT02654587|540622280|FG000|Overall Study|patient alive at end of study|22|||
149861651|NCT02654587|540622281|FG001|Overall Study|patient alive at end of study|8|||
149861652|NCT02654587|540622280|FG000|Overall Study|Withdrawal by Subject|1|||
149861653|NCT02654587|540622281|FG001|Overall Study|Withdrawal by Subject|7|||
149861654|NCT01825837|540622282|FG000|PART I|Withdrawal by Subject|0|||
149861655|NCT01825837|540622283|FG001|PART I|Withdrawal by Subject|0|||
149861656|NCT01825837|540622284|FG002|PART I|Withdrawal by Subject|0|||
149861657|NCT01825837|540622285|FG003|PART I|Withdrawal by Subject|6|||
149861658|NCT01825837|540622282|FG000|PART I|Patient non-compliance|0|||
149861659|NCT01825837|540622283|FG001|PART I|Patient non-compliance|0|||
149861660|NCT01825837|540622284|FG002|PART I|Patient non-compliance|0|||
149861661|NCT01825837|540622285|FG003|PART I|Patient non-compliance|1|||
149861662|NCT01825837|540622282|FG000|PART I|Treatment failure|0|||
149861663|NCT01825837|540622283|FG001|PART I|Treatment failure|0|||
149861664|NCT01825837|540622284|FG002|PART I|Treatment failure|0|||
149861665|NCT01825837|540622285|FG003|PART I|Treatment failure|7|||
149861666|NCT01825837|540622282|FG000|PART I|reason unspecified|0|||
149861667|NCT01825837|540622283|FG001|PART I|reason unspecified|0|||
149861668|NCT01825837|540622284|FG002|PART I|reason unspecified|0|||
149861669|NCT01825837|540622285|FG003|PART I|reason unspecified|3|||
150291983|NCT04102189|542202558|FG001|Overall Study|Lost to Follow-up|0|||
149861670|NCT01825837|540622282|FG000|PART II|Withdrawal by Subject|3|||
149861671|NCT01825837|540622283|FG001|PART II|Withdrawal by Subject|3|||
149861672|NCT01825837|540622284|FG002|PART II|Withdrawal by Subject|7|||
149861673|NCT01825837|540622285|FG003|PART II|Withdrawal by Subject|0|||
149861674|NCT01825837|540622282|FG000|PART II|Patient non-compliance|5|||
149861675|NCT01825837|540622283|FG001|PART II|Patient non-compliance|2|||
149861676|NCT01825837|540622284|FG002|PART II|Patient non-compliance|4|||
149861677|NCT01825837|540622285|FG003|PART II|Patient non-compliance|0|||
149861678|NCT01825837|540622282|FG000|PART II|Adverse Event|3|||
149861679|NCT01825837|540622283|FG001|PART II|Adverse Event|3|||
149861680|NCT01825837|540622284|FG002|PART II|Adverse Event|1|||
149861681|NCT01825837|540622285|FG003|PART II|Adverse Event|0|||
149861682|NCT01825837|540622282|FG000|PART II|Treatment failure|6|||
149861683|NCT01825837|540622283|FG001|PART II|Treatment failure|4|||
150291984|NCT03774082|542202561|FG000|Overall Study|Death|6|||
149861684|NCT01825837|540622284|FG002|PART II|Treatment failure|5|||
149861685|NCT01825837|540622285|FG003|PART II|Treatment failure|0|||
149861686|NCT01825837|540622282|FG000|PART II|reason unspecified|2|||
149861687|NCT01825837|540622283|FG001|PART II|reason unspecified|2|||
149861688|NCT01825837|540622284|FG002|PART II|reason unspecified|2|||
149861689|NCT01825837|540622285|FG003|PART II|reason unspecified|0|||
149861690|NCT00904748|540622286|FG000|Overall Study|Withdrawal by Subject|1|||
149861691|NCT00904748|540622287|FG001|Overall Study|Withdrawal by Subject|1|||
149861692|NCT00904748|540622288|FG002|Overall Study|Withdrawal by Subject|1|||
149861693|NCT00904748|540622289|FG003|Overall Study|Withdrawal by Subject|2|||
149861694|NCT00904748|540622290|FG004|Overall Study|Withdrawal by Subject|0|||
149861695|NCT00904748|540622291|FG005|Overall Study|Withdrawal by Subject|0|||
149861696|NCT00904748|540622286|FG000|Overall Study|Adverse Event|0|||
149861697|NCT00904748|540622287|FG001|Overall Study|Adverse Event|0|||
149861698|NCT00904748|540622288|FG002|Overall Study|Adverse Event|0|||
149861699|NCT00904748|540622289|FG003|Overall Study|Adverse Event|0|||
149861700|NCT00904748|540622290|FG004|Overall Study|Adverse Event|1|||
149861701|NCT00904748|540622291|FG005|Overall Study|Adverse Event|0|||
149861702|NCT04403763|540622292|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
149861703|NCT04403763|540622293|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
149861704|NCT04403763|540622294|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
149861705|NCT04403763|540622295|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
149861706|NCT04403763|540622296|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
149861707|NCT04403763|540622297|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
149861708|NCT04403763|540622298|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
149861709|NCT04403763|540622292|FG000|Stage 1|Early termination due to PK tube failure|0|||
149861710|NCT04403763|540622293|FG001|Stage 1|Early termination due to PK tube failure|0|||
149861711|NCT04403763|540622294|FG002|Stage 1|Early termination due to PK tube failure|1|||
149861712|NCT04403763|540622295|FG003|Stage 1|Early termination due to PK tube failure|0|||
149861713|NCT04403763|540622296|FG004|Stage 1|Early termination due to PK tube failure|0|||
149861714|NCT04403763|540622297|FG005|Stage 1|Early termination due to PK tube failure|0|||
149861715|NCT04403763|540622298|FG006|Stage 1|Early termination due to PK tube failure|0|||
149861716|NCT04403763|540622292|FG000|Stage 2A|Adverse Event|0|||
149861717|NCT04403763|540622293|FG001|Stage 2A|Adverse Event|0|||
149861718|NCT04403763|540622294|FG002|Stage 2A|Adverse Event|0|||
149861719|NCT04403763|540622295|FG003|Stage 2A|Adverse Event|0|||
149861720|NCT04403763|540622296|FG004|Stage 2A|Adverse Event|0|||
149861721|NCT04403763|540622297|FG005|Stage 2A|Adverse Event|0|||
149861722|NCT04403763|540622298|FG006|Stage 2A|Adverse Event|1|||
149861723|NCT01534637|540622299|FG000|Overall Study|Physician Decision|3|||
149861724|NCT01534637|540622299|FG000|Overall Study|Lack of Efficacy|3|||
149861725|NCT01534637|540622299|FG000|Overall Study|Withdrawal by Subject|1|||
149861726|NCT01534637|540622299|FG000|Overall Study|Adverse Event|1|||
149861727|NCT01534637|540622299|FG000|Overall Study|Liver Mets before treatment|1|||
149861728|NCT02377921|540622300|FG000|Overall Study|Subject non-compliance|1|||
149861729|NCT02377921|540622301|FG001|Overall Study|Subject non-compliance|1|||
149861730|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
149861731|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
149861732|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
149861733|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
149861734|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
149861735|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
149861736|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
149861737|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
149861738|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
149861739|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
149861740|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
149861741|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
150173770|NCT01713946|541771351|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
149861742|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
149861743|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
149861744|NCT02510014|540622304|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
149861745|NCT02510014|540622305|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
149861746|NCT02510014|540622304|FG000|Treatment Period|Adverse Event|11|||
150291985|NCT03774082|542202562|FG001|Overall Study|Death|3|||
150291986|NCT03774082|542202563|FG002|Overall Study|Death|2|||
149961962|NCT02134028|540994169|FG000|Overall Study|Poor compliance to protocol|1|||
149861747|NCT02510014|540622305|FG001|Treatment Period|Adverse Event|4|||
149861748|NCT02510014|540622304|FG000|Treatment Period|Withdrawal symptoms|3|||
149861749|NCT02510014|540622305|FG001|Treatment Period|Withdrawal symptoms|0|||
149861750|NCT02510014|540622304|FG000|Treatment Period|Lost to Follow-up|80|||
149861751|NCT02510014|540622305|FG001|Treatment Period|Lost to Follow-up|19|||
149861752|NCT02510014|540622304|FG000|Treatment Period|Physician Decision|5|||
150291987|NCT03774082|542202561|FG000|Overall Study|Subject decision|0|||
150291988|NCT03774082|542202562|FG001|Overall Study|Subject decision|3|||
150291989|NCT03774082|542202563|FG002|Overall Study|Subject decision|0|||
150291990|NCT03774082|542202561|FG000|Overall Study|Lost to Follow-up|2|||
150291991|NCT03774082|542202562|FG001|Overall Study|Lost to Follow-up|0|||
150291992|NCT03774082|542202563|FG002|Overall Study|Lost to Follow-up|0|||
150291993|NCT03774082|542202561|FG000|Overall Study|Guardian decision|0|||
150291994|NCT03774082|542202562|FG001|Overall Study|Guardian decision|0|||
150291995|NCT03774082|542202563|FG002|Overall Study|Guardian decision|1|||
150291996|NCT03774082|542202561|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
150291997|NCT03774082|542202562|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
150291998|NCT03774082|542202563|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
149861753|NCT02510014|540622305|FG001|Treatment Period|Physician Decision|0|||
149861754|NCT02510014|540622304|FG000|Treatment Period|Withdrawal by Subject|67|||
149861755|NCT02510014|540622305|FG001|Treatment Period|Withdrawal by Subject|24|||
149861756|NCT02510014|540622304|FG000|Treatment Period|Withdrawn by the investigator|7|||
149861757|NCT02510014|540622305|FG001|Treatment Period|Withdrawn by the investigator|1|||
149861758|NCT02510014|540622304|FG000|Treatment Period|Protocol Violation|4|||
149861759|NCT02510014|540622305|FG001|Treatment Period|Protocol Violation|4|||
149861760|NCT02510014|540622304|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
149861761|NCT02510014|540622305|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
149861762|NCT01020799|540622306|FG000|Overall Study|Adverse Event|4|||
149861763|NCT01020799|540622307|FG001|Overall Study|Adverse Event|3|||
149861764|NCT01020799|540622308|FG002|Overall Study|Adverse Event|2|||
149861765|NCT01020799|540622306|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
149861766|NCT01020799|540622307|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
149861767|NCT01020799|540622308|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
149861768|NCT01020799|540622306|FG000|Overall Study|Protocol Violation|3|||
149861769|NCT01020799|540622307|FG001|Overall Study|Protocol Violation|2|||
149861770|NCT01020799|540622308|FG002|Overall Study|Protocol Violation|0|||
149861771|NCT01020799|540622306|FG000|Overall Study|Withdrawal by Subject|2|||
149861772|NCT01020799|540622307|FG001|Overall Study|Withdrawal by Subject|2|||
149861773|NCT01020799|540622308|FG002|Overall Study|Withdrawal by Subject|3|||
149861774|NCT01020799|540622306|FG000|Overall Study|Lost to Follow-up|6|||
149861775|NCT01020799|540622307|FG001|Overall Study|Lost to Follow-up|4|||
149861776|NCT01020799|540622308|FG002|Overall Study|Lost to Follow-up|2|||
149861777|NCT00233987|540622314|FG000|Overall Study|Withdrawal by Subject|1|||
149861778|NCT00233987|540622314|FG000|Overall Study|Lack of Efficacy|2|||
149861779|NCT00233987|540622314|FG000|Overall Study|Reason Under Review|1|||
149861780|NCT00233987|540622314|FG000|Overall Study|Other - Not Protocol Specified|5|||
149861781|NCT00233987|540622314|FG000|Overall Study|Eligible but No Treatment Received|2|||
149861782|NCT00233987|540622314|FG000|Overall Study|Ineligible|4|||
149861783|NCT01010126|540623967|FG000|Overall Study|Withdrawal by Subject|1|||
149861784|NCT01010126|540623968|FG001|Overall Study|Withdrawal by Subject|0|||
149861785|NCT01010126|540623969|FG002|Overall Study|Withdrawal by Subject|1|||
149861786|NCT01010126|540623970|FG003|Overall Study|Withdrawal by Subject|0|||
149861787|NCT01010126|540623971|FG004|Overall Study|Withdrawal by Subject|3|||
149861788|NCT01010126|540623972|FG005|Overall Study|Withdrawal by Subject|0|||
149861789|NCT00493246|540623973|FG000|Overall Study|Withdrawal by Subject|0|||
149861790|NCT00493246|540623974|FG001|Overall Study|Withdrawal by Subject|0|||
149861791|NCT00493246|540623975|FG002|Overall Study|Withdrawal by Subject|0|||
149861792|NCT00493246|540623976|FG003|Overall Study|Withdrawal by Subject|0|||
149861793|NCT00493246|540623977|FG004|Overall Study|Withdrawal by Subject|1|||
149861794|NCT00493246|540623978|FG005|Overall Study|Withdrawal by Subject|0|||
149861795|NCT00493246|540623979|FG006|Overall Study|Withdrawal by Subject|0|||
149861796|NCT00493246|540623980|FG007|Overall Study|Withdrawal by Subject|0|||
149861797|NCT00493246|540623973|FG000|Overall Study|No access to draw blood|0|||
149861798|NCT00493246|540623974|FG001|Overall Study|No access to draw blood|0|||
149861799|NCT00493246|540623975|FG002|Overall Study|No access to draw blood|0|||
149861800|NCT00493246|540623976|FG003|Overall Study|No access to draw blood|0|||
149861801|NCT00493246|540623977|FG004|Overall Study|No access to draw blood|0|||
150291999|NCT05478252|542202564|FG000|Overall Study|Withdrawal by Subject|2|||
150292000|NCT05478252|542202565|FG001|Overall Study|Withdrawal by Subject|3|||
150292001|NCT05478252|542202564|FG000|Overall Study|Lost to Follow-up|4|||
150292002|NCT05478252|542202565|FG001|Overall Study|Lost to Follow-up|2|||
149861802|NCT00493246|540623978|FG005|Overall Study|No access to draw blood|1|||
149861803|NCT00493246|540623979|FG006|Overall Study|No access to draw blood|0|||
149861804|NCT00493246|540623980|FG007|Overall Study|No access to draw blood|0|||
149861805|NCT00493246|540623973|FG000|Overall Study|Lost to Follow-up|0|||
149861806|NCT00493246|540623974|FG001|Overall Study|Lost to Follow-up|0|||
149861807|NCT00493246|540623975|FG002|Overall Study|Lost to Follow-up|0|||
149861808|NCT00493246|540623976|FG003|Overall Study|Lost to Follow-up|0|||
149861809|NCT00493246|540623977|FG004|Overall Study|Lost to Follow-up|0|||
149861810|NCT00493246|540623978|FG005|Overall Study|Lost to Follow-up|0|||
149861811|NCT00493246|540623979|FG006|Overall Study|Lost to Follow-up|1|||
149861812|NCT00493246|540623980|FG007|Overall Study|Lost to Follow-up|0|||
149861813|NCT00595335|540623985|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
149861814|NCT00595335|540623986|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
150292003|NCT05478252|542202564|FG000|Overall Study|Physician Decision|1|||
150292004|NCT05478252|542202565|FG001|Overall Study|Physician Decision|1|||
150292005|NCT05478252|542202564|FG000|Overall Study|Death|1|||
150292006|NCT05478252|542202565|FG001|Overall Study|Death|0|||
150292007|NCT02553460|542202566|FG000|Overall Study|Death|3|||
150292008|NCT02553460|542202566|FG000|Overall Study|Withdrawal by Subject|1|||
150292009|NCT02553460|542202566|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
149861815|NCT00595335|540623985|FG000|Baseline to Six Months|Disease Progression|1|||
149861816|NCT00595335|540623986|FG001|Baseline to Six Months|Disease Progression|1|||
149861817|NCT00595335|540623985|FG000|Baseline to Six Months|Adverse Event|1|||
149861818|NCT00595335|540623986|FG001|Baseline to Six Months|Adverse Event|0|||
149861819|NCT00595335|540623985|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
149861820|NCT00595335|540623986|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
149861821|NCT00595335|540623985|FG000|Six Months to Twelve Months|Disease Progression|1|||
149861822|NCT00595335|540623986|FG001|Six Months to Twelve Months|Disease Progression|0|||
149861823|NCT00493779|540624000|FG000|Overall Study|Logistical issue at site|1|||
149861824|NCT01647958|540624001|FG000|Initial Study|Lost to Follow-up|2|||
149861825|NCT01647958|540624002|FG001|Initial Study|Lost to Follow-up|3|||
149861826|NCT01647958|540624001|FG000|Continuation Phase|treatment received during Overall Study|39|||
149861827|NCT01647958|540624002|FG001|Continuation Phase|treatment received during Overall Study|0|||
149861828|NCT01647958|540624001|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
149861829|NCT01647958|540624002|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
149861830|NCT01131299|540624003|FG000|Overall Study|Withdrawal by Subject|4|||
149861831|NCT01131299|540624004|FG001|Overall Study|Withdrawal by Subject|7|||
149861832|NCT01207440|540624012|FG000|Overall Study|Adverse Event|46|||
149861833|NCT01207440|540624013|FG001|Overall Study|Adverse Event|11|||
149861834|NCT01207440|540624014|FG002|Overall Study|Adverse Event|7|||
149861835|NCT01207440|540624015|FG003|Overall Study|Adverse Event|2|||
149861836|NCT01207440|540624016|FG004|Overall Study|Adverse Event|6|||
149861837|NCT01207440|540624017|FG005|Overall Study|Adverse Event|6|||
149861838|NCT01207440|540624018|FG006|Overall Study|Adverse Event|2|||
149861839|NCT01207440|540624012|FG000|Overall Study|Death|6|||
149861840|NCT01207440|540624013|FG001|Overall Study|Death|3|||
149861841|NCT01207440|540624014|FG002|Overall Study|Death|2|||
149861842|NCT01207440|540624015|FG003|Overall Study|Death|2|||
149861843|NCT01207440|540624016|FG004|Overall Study|Death|7|||
149861844|NCT01207440|540624017|FG005|Overall Study|Death|5|||
149861845|NCT01207440|540624018|FG006|Overall Study|Death|1|||
149861846|NCT01207440|540624012|FG000|Overall Study|Lack of Efficacy|13|||
149861847|NCT01207440|540624013|FG001|Overall Study|Lack of Efficacy|2|||
149861848|NCT01207440|540624014|FG002|Overall Study|Lack of Efficacy|5|||
149861849|NCT01207440|540624015|FG003|Overall Study|Lack of Efficacy|1|||
149861850|NCT01207440|540624016|FG004|Overall Study|Lack of Efficacy|2|||
150292010|NCT02553460|542202566|FG000|Overall Study|Relapse or Transplant|14|||
150292011|NCT02553460|542202566|FG000|Overall Study|No response to treatment|2|||
150292012|NCT02553460|542202566|FG000|Overall Study|CAR T cells|2|||
150292013|NCT04823650|542202569|FG000|Overall Study|Withdrawal by Subject|0|||
149861851|NCT01207440|540624017|FG005|Overall Study|Lack of Efficacy|3|||
149861852|NCT01207440|540624018|FG006|Overall Study|Lack of Efficacy|0|||
149861853|NCT01207440|540624012|FG000|Overall Study|Lost to Follow-up|0|||
149861854|NCT01207440|540624013|FG001|Overall Study|Lost to Follow-up|0|||
149861855|NCT01207440|540624014|FG002|Overall Study|Lost to Follow-up|2|||
149861856|NCT01207440|540624015|FG003|Overall Study|Lost to Follow-up|1|||
149861857|NCT01207440|540624016|FG004|Overall Study|Lost to Follow-up|0|||
149861858|NCT01207440|540624017|FG005|Overall Study|Lost to Follow-up|0|||
149861859|NCT01207440|540624018|FG006|Overall Study|Lost to Follow-up|0|||
149861860|NCT01207440|540624012|FG000|Overall Study|Non-compliance with Study Drug|3|||
149861861|NCT01207440|540624013|FG001|Overall Study|Non-compliance with Study Drug|0|||
149861862|NCT01207440|540624014|FG002|Overall Study|Non-compliance with Study Drug|1|||
150292014|NCT04823650|542202570|FG001|Overall Study|Withdrawal by Subject|0|||
149861863|NCT01207440|540624015|FG003|Overall Study|Non-compliance with Study Drug|0|||
149861864|NCT01207440|540624016|FG004|Overall Study|Non-compliance with Study Drug|0|||
149861865|NCT01207440|540624017|FG005|Overall Study|Non-compliance with Study Drug|0|||
149861866|NCT01207440|540624018|FG006|Overall Study|Non-compliance with Study Drug|0|||
149861867|NCT01207440|540624012|FG000|Overall Study|Physician Decision|6|||
149861868|NCT01207440|540624013|FG001|Overall Study|Physician Decision|5|||
149861869|NCT01207440|540624014|FG002|Overall Study|Physician Decision|5|||
149861870|NCT01207440|540624015|FG003|Overall Study|Physician Decision|0|||
150292015|NCT04823650|542202571|FG002|Overall Study|Withdrawal by Subject|0|||
149961963|NCT02134028|540994170|FG001|Overall Study|Poor compliance to protocol|1|||
150292016|NCT04823650|542202572|FG003|Overall Study|Withdrawal by Subject|0|||
150292017|NCT04823650|542202573|FG004|Overall Study|Withdrawal by Subject|1|||
149861871|NCT01207440|540624016|FG004|Overall Study|Physician Decision|1|||
149861872|NCT01207440|540624017|FG005|Overall Study|Physician Decision|0|||
149861873|NCT01207440|540624018|FG006|Overall Study|Physician Decision|0|||
149861874|NCT01207440|540624012|FG000|Overall Study|Progressive Disease|19|||
149861875|NCT01207440|540624013|FG001|Overall Study|Progressive Disease|10|||
149861876|NCT01207440|540624014|FG002|Overall Study|Progressive Disease|19|||
149861877|NCT01207440|540624015|FG003|Overall Study|Progressive Disease|7|||
149861878|NCT01207440|540624016|FG004|Overall Study|Progressive Disease|23|||
149861879|NCT01207440|540624017|FG005|Overall Study|Progressive Disease|27|||
149861880|NCT01207440|540624018|FG006|Overall Study|Progressive Disease|0|||
150292018|NCT04823650|542202574|FG005|Overall Study|Withdrawal by Subject|0|||
150292019|NCT01844986|542202575|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
150292020|NCT01844986|542202576|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
150292021|NCT01844986|542202575|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
150292022|NCT01844986|542202576|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
150292023|NCT01844986|542202575|FG000|Overall Study (Global Cohort)|Death|55|||
150292024|NCT01844986|542202576|FG001|Overall Study (Global Cohort)|Death|26|||
150292025|NCT01844986|542202575|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
150292026|NCT01844986|542202576|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
150292027|NCT01844986|542202575|FG000|Overall Study (China Cohort)|Death|10|||
150292028|NCT01844986|542202576|FG001|Overall Study (China Cohort)|Death|6|||
150292029|NCT04846881|542202577|FG000|Overall Study|Adverse Event|14|||
150292030|NCT04846881|542202578|FG001|Overall Study|Adverse Event|15|||
150292031|NCT04846881|542202577|FG000|Overall Study|Burden of study procedures|7|||
150292032|NCT04846881|542202578|FG001|Overall Study|Burden of study procedures|3|||
150292033|NCT04846881|542202577|FG000|Overall Study|Protocol deviation|6|||
150292034|NCT04846881|542202578|FG001|Overall Study|Protocol deviation|4|||
150292035|NCT04846881|542202577|FG000|Overall Study|Perceived lack of efficacy|5|||
150292036|NCT04846881|542202578|FG001|Overall Study|Perceived lack of efficacy|2|||
150292037|NCT04846881|542202577|FG000|Overall Study|Change of residence|2|||
150292038|NCT04846881|542202578|FG001|Overall Study|Change of residence|0|||
150292039|NCT04846881|542202577|FG000|Overall Study|Technical problems|0|||
150292040|NCT04846881|542202578|FG001|Overall Study|Technical problems|1|||
150292041|NCT04846881|542202577|FG000|Overall Study|Other than listed|3|||
150292042|NCT04846881|542202578|FG001|Overall Study|Other than listed|10|||
150292043|NCT04846881|542202577|FG000|Overall Study|No reason available|1|||
149861881|NCT01207440|540624012|FG000|Overall Study|Protocol Violation|2|||
149861882|NCT01207440|540624013|FG001|Overall Study|Protocol Violation|0|||
149861883|NCT01207440|540624014|FG002|Overall Study|Protocol Violation|0|||
149861884|NCT01207440|540624015|FG003|Overall Study|Protocol Violation|0|||
149861885|NCT01207440|540624016|FG004|Overall Study|Protocol Violation|0|||
149861886|NCT01207440|540624017|FG005|Overall Study|Protocol Violation|0|||
149861887|NCT01207440|540624018|FG006|Overall Study|Protocol Violation|0|||
149861888|NCT01207440|540624012|FG000|Overall Study|Site Terminated by Sponsor|69|||
149861889|NCT01207440|540624013|FG001|Overall Study|Site Terminated by Sponsor|19|||
149861890|NCT01207440|540624014|FG002|Overall Study|Site Terminated by Sponsor|12|||
149861891|NCT01207440|540624015|FG003|Overall Study|Site Terminated by Sponsor|2|||
149861892|NCT01207440|540624016|FG004|Overall Study|Site Terminated by Sponsor|3|||
149861893|NCT01207440|540624017|FG005|Overall Study|Site Terminated by Sponsor|0|||
149861894|NCT01207440|540624018|FG006|Overall Study|Site Terminated by Sponsor|2|||
149861895|NCT01207440|540624012|FG000|Overall Study|Withdrawal by Subject|29|||
149861896|NCT01207440|540624013|FG001|Overall Study|Withdrawal by Subject|4|||
149861897|NCT01207440|540624014|FG002|Overall Study|Withdrawal by Subject|5|||
149861898|NCT01207440|540624015|FG003|Overall Study|Withdrawal by Subject|3|||
149861899|NCT01207440|540624016|FG004|Overall Study|Withdrawal by Subject|2|||
149861900|NCT01207440|540624017|FG005|Overall Study|Withdrawal by Subject|2|||
149861901|NCT01207440|540624018|FG006|Overall Study|Withdrawal by Subject|0|||
149861902|NCT01207440|540624012|FG000|Overall Study|Reason Not Specified|10|||
150292044|NCT04846881|542202578|FG001|Overall Study|No reason available|3|||
150292045|NCT04846881|542202577|FG000|Overall Study|Patient randomised in error|1|||
150292046|NCT04846881|542202578|FG001|Overall Study|Patient randomised in error|0|||
150292047|NCT04560998|542202579|FG000|Overall Study|Withdrawal by Subject|18|||
150292048|NCT04560998|542202580|FG001|Overall Study|Withdrawal by Subject|12|||
149861903|NCT01207440|540624013|FG001|Overall Study|Reason Not Specified|10|||
149861904|NCT01207440|540624014|FG002|Overall Study|Reason Not Specified|7|||
149861905|NCT01207440|540624015|FG003|Overall Study|Reason Not Specified|0|||
149861906|NCT01207440|540624016|FG004|Overall Study|Reason Not Specified|4|||
149861907|NCT01207440|540624017|FG005|Overall Study|Reason Not Specified|3|||
149861908|NCT01207440|540624018|FG006|Overall Study|Reason Not Specified|0|||
149861909|NCT03341000|540624019|FG000|Overall Study|Adverse Event|1|||
149861910|NCT01592721|540624020|FG000|Long-term Follow-up|Death|1|||
150292049|NCT04560998|542202579|FG000|Overall Study|Lost to Follow-up|8|||
150292050|NCT04560998|542202580|FG001|Overall Study|Lost to Follow-up|5|||
150292051|NCT04560998|542202579|FG000|Overall Study|Physician Decision|4|||
150292052|NCT04560998|542202580|FG001|Overall Study|Physician Decision|0|||
150292053|NCT07099521|542202582|FG000|Overall Study|Incompeleted stimulus program|1|||
150292054|NCT07099521|542202583|FG001|Overall Study|Incompeleted stimulus program|0|||
150292055|NCT07099521|542202582|FG000|Overall Study|Non-social anxiety symtpoms|0|||
150292056|NCT07099521|542202583|FG001|Overall Study|Non-social anxiety symtpoms|1|||
150292057|NCT07099521|542202582|FG000|Overall Study|Extreme values|2|||
150292058|NCT07099521|542202583|FG001|Overall Study|Extreme values|4|||
150292059|NCT01950390|542202584|FG000|Overall Study|Never started treatment|3|||
150292060|NCT01950390|542202585|FG001|Overall Study|Never started treatment|2|||
150292061|NCT01950390|542202584|FG000|Overall Study|Disease progression|45|||
149861911|NCT01642914|540624021|FG000|Overall Study|Adverse Event|11|||
149861912|NCT01642914|540624022|FG001|Overall Study|Adverse Event|7|||
149861913|NCT01642914|540624023|FG002|Overall Study|Adverse Event|15|||
149861914|NCT01642914|540624021|FG000|Overall Study|Lack of Efficacy|9|||
149861915|NCT01642914|540624022|FG001|Overall Study|Lack of Efficacy|4|||
149861916|NCT01642914|540624023|FG002|Overall Study|Lack of Efficacy|2|||
149861917|NCT01642914|540624021|FG000|Overall Study|Protocol Violation|15|||
149861918|NCT01642914|540624022|FG001|Overall Study|Protocol Violation|13|||
149861919|NCT01642914|540624023|FG002|Overall Study|Protocol Violation|6|||
149861920|NCT01642914|540624021|FG000|Overall Study|Withdrawal by Subject|5|||
149861921|NCT01642914|540624022|FG001|Overall Study|Withdrawal by Subject|5|||
149861922|NCT01642914|540624023|FG002|Overall Study|Withdrawal by Subject|10|||
149861923|NCT01642914|540624021|FG000|Overall Study|Lost to Follow-up|5|||
149861924|NCT01642914|540624022|FG001|Overall Study|Lost to Follow-up|3|||
149861925|NCT01642914|540624023|FG002|Overall Study|Lost to Follow-up|7|||
149861926|NCT01642914|540624021|FG000|Overall Study|Other Reason|1|||
149861927|NCT01642914|540624022|FG001|Overall Study|Other Reason|0|||
150173771|NCT01713946|541771349|FG000|Overall Study|Patients never switched to everolimus|0|||
150173772|NCT01713946|541771350|FG001|Overall Study|Patients never switched to everolimus|0|||
150173773|NCT01713946|541771351|FG002|Overall Study|Patients never switched to everolimus|5|||
149861928|NCT01642914|540624023|FG002|Overall Study|Other Reason|0|||
149861929|NCT02566993|540624024|FG000|Overall Study|Randomized but not treated|5|||
149861930|NCT02566993|540624025|FG001|Overall Study|Randomized but not treated|16|||
149861931|NCT02566993|540624024|FG000|Overall Study|Progressive disease|213|||
149861932|NCT02566993|540624025|FG001|Overall Study|Progressive disease|152|||
149861933|NCT02566993|540624024|FG000|Overall Study|Withdrawal by Subject|12|||
149861934|NCT02566993|540624025|FG001|Overall Study|Withdrawal by Subject|28|||
149861935|NCT02566993|540624024|FG000|Overall Study|Death|17|||
149861936|NCT02566993|540624025|FG001|Overall Study|Death|23|||
149861937|NCT02566993|540624024|FG000|Overall Study|Physician Decision|10|||
149861938|NCT02566993|540624025|FG001|Overall Study|Physician Decision|17|||
149861939|NCT02566993|540624024|FG000|Overall Study|Study drug-related adverse event|20|||
149861940|NCT02566993|540624025|FG001|Overall Study|Study drug-related adverse event|41|||
149861941|NCT02566993|540624024|FG000|Overall Study|Non study drug-related adverse event|9|||
149861942|NCT02566993|540624025|FG001|Overall Study|Non study drug-related adverse event|9|||
149861943|NCT02566993|540624024|FG000|Overall Study|Symptomatic deterioration|9|||
149861944|NCT02566993|540624025|FG001|Overall Study|Symptomatic deterioration|16|||
149861945|NCT02566993|540624024|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
149861946|NCT02566993|540624025|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
149861947|NCT02566993|540624024|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
149861948|NCT02566993|540624025|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
149861949|NCT02566993|540624024|FG000|Overall Study|Screening failure|2|||
149861950|NCT02566993|540624025|FG001|Overall Study|Screening failure|0|||
149861951|NCT02566993|540624024|FG000|Overall Study|Lost to Follow-up|0|||
149861952|NCT02566993|540624025|FG001|Overall Study|Lost to Follow-up|1|||
149861953|NCT02566993|540624024|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
149861954|NCT02566993|540624025|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
149861955|NCT02589522|540624027|FG000|Overall Study|Physician Decision|1|||
149861956|NCT02589522|540624028|FG001|Overall Study|Physician Decision|2|||
149861957|NCT02589522|540624029|FG002|Overall Study|Physician Decision|0|||
149861958|NCT02589522|540624027|FG000|Overall Study|Did not start treatment|1|||
149861959|NCT02589522|540624028|FG001|Overall Study|Did not start treatment|0|||
149861960|NCT02589522|540624029|FG002|Overall Study|Did not start treatment|0|||
149861961|NCT01478828|540624030|FG000|Overall Study|Adverse Event|1|||
149861962|NCT05611996|540624031|FG000|Overall Study|Ineligible|1|||
149861963|NCT05611996|540624031|FG000|Overall Study|Withdrawal by Subject|9|||
150173774|NCT01286272|541772939|FG000|Overall Study|Ineligible after beginning treatment|1|||
150292062|NCT01950390|542202585|FG001|Overall Study|Disease progression|52|||
150292063|NCT01950390|542202584|FG000|Overall Study|Adverse Event|22|||
149861964|NCT04479475|540624032|FG000|Overall Study|Withdrawal by Subject|7|||
149861965|NCT02025010|540624033|FG000|Overall Study|Symptomatic or radiographic progression|36|||
149861966|NCT02025010|540624033|FG000|Overall Study|Adverse Event|6|||
149861967|NCT02025010|540624033|FG000|Overall Study|Physician Decision|7|||
149861968|NCT02025010|540624033|FG000|Overall Study|Withdrawal by Subject|3|||
149861969|NCT02025010|540624033|FG000|Overall Study|Intercurrent illness|3|||
150173775|NCT01286272|541772940|FG001|Overall Study|Ineligible after beginning treatment|3|||
150292064|NCT01950390|542202585|FG001|Overall Study|Adverse Event|16|||
150292065|NCT01950390|542202584|FG000|Overall Study|Death|5|||
150292066|NCT01950390|542202585|FG001|Overall Study|Death|3|||
150292067|NCT01950390|542202584|FG000|Overall Study|Withdrawal by Subject|5|||
150292068|NCT01950390|542202585|FG001|Overall Study|Withdrawal by Subject|1|||
149861970|NCT02025010|540624033|FG000|Overall Study|Patients still on treatment|3|||
149861971|NCT02025010|540624033|FG000|Overall Study|Never initiate the treatment|2|||
149861972|NCT01300052|540624035|FG000|Overall Study|Adverse Event|3|||
149861973|NCT01300052|540624036|FG001|Overall Study|Adverse Event|0|||
149861974|NCT01300052|540624035|FG000|Overall Study|Withdrawal by Subject|2|||
149861975|NCT01300052|540624036|FG001|Overall Study|Withdrawal by Subject|2|||
149861976|NCT01300052|540624035|FG000|Overall Study|Protocol Violation|1|||
149861977|NCT01300052|540624036|FG001|Overall Study|Protocol Violation|1|||
149861978|NCT04572243|540624037|FG000|Core Study: 14 Weeks|Adverse Event|1|||
149861979|NCT04572243|540624038|FG001|Core Study: 14 Weeks|Adverse Event|2|||
149861980|NCT04572243|540624039|FG002|Core Study: 14 Weeks|Adverse Event|0|||
149861981|NCT04572243|540624040|FG003|Core Study: 14 Weeks|Adverse Event|0|||
149861982|NCT04572243|540624037|FG000|Core Study: 14 Weeks|Subject choice|0|||
149861983|NCT04572243|540624038|FG001|Core Study: 14 Weeks|Subject choice|2|||
149861984|NCT04572243|540624039|FG002|Core Study: 14 Weeks|Subject choice|0|||
149861985|NCT04572243|540624040|FG003|Core Study: 14 Weeks|Subject choice|0|||
149861986|NCT04572243|540624037|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
149861987|NCT04572243|540624038|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
149861988|NCT04572243|540624039|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
149861989|NCT04572243|540624040|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
149861990|NCT04572243|540624037|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
149861991|NCT04572243|540624038|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
149861992|NCT04572243|540624039|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
149861993|NCT04572243|540624040|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
149861994|NCT01661881|540624041|FG000|Overall Study|Disease Progression|1|||
149861995|NCT01231373|540624042|FG000|Overall Study|Withdrew consent prior to randomization|2|||
149861996|NCT01231373|540624043|FG001|Overall Study|Withdrew consent prior to randomization|1|||
149861997|NCT01231373|540624044|FG002|Overall Study|Withdrew consent prior to randomization|0|||
149861998|NCT01231373|540624045|FG003|Overall Study|Withdrew consent prior to randomization|0|||
150292069|NCT01950390|542202584|FG000|Overall Study|Alternative therapy|0|||
150292070|NCT01950390|542202585|FG001|Overall Study|Alternative therapy|3|||
150292071|NCT01950390|542202584|FG000|Overall Study|Complicating disease|1|||
150292072|NCT01950390|542202585|FG001|Overall Study|Complicating disease|0|||
150292073|NCT01950390|542202584|FG000|Overall Study|On treatment|1|||
150292074|NCT01950390|542202585|FG001|Overall Study|On treatment|0|||
150292075|NCT01950390|542202584|FG000|Overall Study|Symptomatic deterioration|2|||
150292076|NCT01950390|542202585|FG001|Overall Study|Symptomatic deterioration|1|||
150292077|NCT01950390|542202584|FG000|Overall Study|Physician Decision|0|||
150292078|NCT01950390|542202585|FG001|Overall Study|Physician Decision|4|||
150292079|NCT01950390|542202584|FG000|Overall Study|Lack of clinical benefit|0|||
150292080|NCT01950390|542202585|FG001|Overall Study|Lack of clinical benefit|1|||
150292081|NCT01950390|542202584|FG000|Overall Study|Maintained PR and moved to observation only|0|||
150292082|NCT01950390|542202585|FG001|Overall Study|Maintained PR and moved to observation only|1|||
150292083|NCT05938920|542202586|FG000|Overall Study|Adverse Event|1|||
150292084|NCT05938920|542202587|FG001|Overall Study|Adverse Event|3|||
150292085|NCT05938920|542202588|FG002|Overall Study|Adverse Event|2|||
150292086|NCT05938920|542202589|FG003|Overall Study|Adverse Event|1|||
150292087|NCT05938920|542202586|FG000|Overall Study|Death|0|||
149861999|NCT01231373|540624042|FG000|Overall Study|Lost to Follow-up|0|||
149862000|NCT01231373|540624043|FG001|Overall Study|Lost to Follow-up|0|||
149862001|NCT01231373|540624044|FG002|Overall Study|Lost to Follow-up|0|||
149862002|NCT01231373|540624045|FG003|Overall Study|Lost to Follow-up|1|||
149862003|NCT01231373|540624042|FG000|Overall Study|Withdrew Consent|1|||
149862004|NCT01231373|540624043|FG001|Overall Study|Withdrew Consent|0|||
149862005|NCT01231373|540624044|FG002|Overall Study|Withdrew Consent|0|||
149862006|NCT01231373|540624045|FG003|Overall Study|Withdrew Consent|0|||
149862007|NCT03451006|540624046|FG000|Overall Study|Withdrawal by Subject|2|||
149862008|NCT03451006|540624047|FG001|Overall Study|Withdrawal by Subject|2|||
149862009|NCT00775606|540624048|FG000|Overall Study|Study sponsor terminated funding|3|||
150173776|NCT03622593|541772942|FG000|Overall Study|Withdrawal by Subject|11|||
150292088|NCT05938920|542202587|FG001|Overall Study|Death|1|||
150292089|NCT05938920|542202588|FG002|Overall Study|Death|0|||
150292090|NCT05938920|542202589|FG003|Overall Study|Death|0|||
150292091|NCT05938920|542202586|FG000|Overall Study|Lost to Follow-up|0|||
150292092|NCT05938920|542202587|FG001|Overall Study|Lost to Follow-up|0|||
149862010|NCT00775606|540624049|FG001|Overall Study|Study sponsor terminated funding|0|||
150292093|NCT05938920|542202588|FG002|Overall Study|Lost to Follow-up|1|||
149862011|NCT02278718|540624050|FG000|Overall Study|Adverse Event|1|||
149862012|NCT02278718|540624051|FG001|Overall Study|Adverse Event|0|||
149862013|NCT02278718|540624050|FG000|Overall Study|Lost to Follow-up|2|||
149862014|NCT02278718|540624051|FG001|Overall Study|Lost to Follow-up|4|||
149862015|NCT02278718|540624050|FG000|Overall Study|Withdrawal by Subject|1|||
150292094|NCT05938920|542202589|FG003|Overall Study|Lost to Follow-up|0|||
149862016|NCT02278718|540624051|FG001|Overall Study|Withdrawal by Subject|4|||
149862017|NCT02278718|540624050|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
149862018|NCT02278718|540624051|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
149862019|NCT02278718|540624050|FG000|Overall Study|Missing|0|||
149862020|NCT02278718|540624051|FG001|Overall Study|Missing|1|||
149862021|NCT04440449|540624052|FG000|Overall Study|Lost to Follow-up|2|||
149862022|NCT04440449|540624053|FG001|Overall Study|Lost to Follow-up|0|||
149862023|NCT02547766|540624054|FG000|Overall Study|Withdrawal by Subject|1|||
149862024|NCT03253744|540624059|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
149862025|NCT03253744|540624060|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
149862026|NCT03253744|540624061|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
149862027|NCT03253744|540624062|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
149862028|NCT05444543|540624063|FG000|Overall Study|Withdrawal by Subject|1|||
149862029|NCT05444543|540624064|FG001|Overall Study|Withdrawal by Subject|0|||
149862030|NCT05444543|540624063|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
149862031|NCT05444543|540624064|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
149862032|NCT05444543|540624063|FG000|Overall Study|Adverse Event|0|||
149862033|NCT05444543|540624064|FG001|Overall Study|Adverse Event|1|||
149862034|NCT05444543|540624063|FG000|Overall Study|Family relocating at a distance from study site|0|||
149862035|NCT05444543|540624064|FG001|Overall Study|Family relocating at a distance from study site|1|||
149862036|NCT03847194|540624065|FG000|Overall Study|Lost to Follow-up|2|||
149862037|NCT03847194|540624066|FG001|Overall Study|Lost to Follow-up|5|||
149862038|NCT03847194|540624065|FG000|Overall Study|Withdrawal by Subject|1|||
149862039|NCT03847194|540624066|FG001|Overall Study|Withdrawal by Subject|2|||
149862040|NCT03847194|540624065|FG000|Overall Study|Death|0|||
149862041|NCT03847194|540624066|FG001|Overall Study|Death|1|||
149862042|NCT01134627|540624067|FG000|Overall Study|Adverse Event|47|||
149862043|NCT01134627|540624068|FG001|Overall Study|Adverse Event|31|||
149862044|NCT01134627|540624067|FG000|Overall Study|Lost to Follow-up|1|||
149862045|NCT01134627|540624068|FG001|Overall Study|Lost to Follow-up|2|||
149862046|NCT01134627|540624067|FG000|Overall Study|Protocol Violation|3|||
149862047|NCT01134627|540624068|FG001|Overall Study|Protocol Violation|5|||
149862048|NCT01134627|540624067|FG000|Overall Study|Lack of Efficacy|2|||
149862049|NCT01134627|540624068|FG001|Overall Study|Lack of Efficacy|12|||
149862050|NCT01134627|540624067|FG000|Overall Study|Withdrawal by Subject|4|||
149862051|NCT01134627|540624068|FG001|Overall Study|Withdrawal by Subject|3|||
149862052|NCT01134627|540624067|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
149862053|NCT01134627|540624068|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
149862054|NCT01134627|540624067|FG000|Overall Study|Other|11|||
149862055|NCT01134627|540624068|FG001|Overall Study|Other|14|||
149862056|NCT01144403|540624070|FG000|Overall Study|Lost to Follow-up|3|||
149862057|NCT01144403|540624070|FG000|Overall Study|Death|1|||
149862058|NCT01144403|540624070|FG000|Overall Study|Adverse Event|1|||
149862059|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
149862060|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
149862061|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
149862062|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
149862063|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
149862064|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
149862065|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
149862066|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
149862067|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
149862068|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
149862069|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
149862070|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
149862071|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
149862072|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
149862073|NCT04740931|540624072|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
149862074|NCT04740931|540624073|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
149862075|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
149862076|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
149862077|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
149862078|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
149862079|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
149862080|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
150292095|NCT05938920|542202586|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
149862081|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
149862082|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
149862083|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
149862084|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
149862085|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
149862086|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
149862087|NCT04740931|540624072|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
149862088|NCT04740931|540624073|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
149862089|NCT02096588|540624074|FG000|Overall Study|Lack of Efficacy|2|||
149862090|NCT02096588|540624075|FG001|Overall Study|Lack of Efficacy|0|||
149862091|NCT02096588|540624074|FG000|Overall Study|Withdrawal by Subject|0|||
149862092|NCT02096588|540624075|FG001|Overall Study|Withdrawal by Subject|1|||
149862093|NCT01949116|540624085|FG000|Overall Study|Death|2|||
149862094|NCT01949116|540624086|FG001|Overall Study|Death|0|||
149862095|NCT01949116|540624085|FG000|Overall Study|Lost to Follow-up|1|||
150292096|NCT05938920|542202587|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
150292097|NCT05938920|542202588|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
150292098|NCT05938920|542202589|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
150292099|NCT05938920|542202586|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
150292100|NCT05938920|542202587|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
150292101|NCT05938920|542202588|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
150292102|NCT05938920|542202589|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
150292103|NCT05938920|542202586|FG000|Overall Study|Participant Refused to Come In|0|||
150292104|NCT05938920|542202587|FG001|Overall Study|Participant Refused to Come In|0|||
150292105|NCT05938920|542202588|FG002|Overall Study|Participant Refused to Come In|1|||
150292106|NCT05938920|542202589|FG003|Overall Study|Participant Refused to Come In|0|||
150292107|NCT01251861|542202590|FG000|Overall Study|Disease progression|6|||
150292108|NCT01251861|542202591|FG001|Overall Study|Disease progression|6|||
150292109|NCT01251861|542202590|FG000|Overall Study|Adverse Event|2|||
150292110|NCT01251861|542202591|FG001|Overall Study|Adverse Event|17|||
150292111|NCT01251861|542202590|FG000|Overall Study|Withdrawal by Subject|2|||
150292112|NCT01251861|542202591|FG001|Overall Study|Withdrawal by Subject|2|||
150292113|NCT01251861|542202590|FG000|Overall Study|Alternative therapy|1|||
150292114|NCT01251861|542202591|FG001|Overall Study|Alternative therapy|0|||
150292115|NCT01251861|542202590|FG000|Overall Study|Other complicating disease|0|||
150292116|NCT01251861|542202591|FG001|Overall Study|Other complicating disease|1|||
150292117|NCT01251861|542202590|FG000|Overall Study|Physician Decision|1|||
150292118|NCT01251861|542202591|FG001|Overall Study|Physician Decision|0|||
150292119|NCT01251861|542202590|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
150292120|NCT01251861|542202591|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
150292121|NCT01251861|542202590|FG000|Overall Study|Other|1|||
150292122|NCT01251861|542202591|FG001|Overall Study|Other|0|||
150292123|NCT01251861|542202590|FG000|Overall Study|Never started therapy|4|||
150292124|NCT01251861|542202591|FG001|Overall Study|Never started therapy|1|||
150292125|NCT01251861|542202590|FG000|Overall Study|Potential interaction of drugs|0|||
150292126|NCT01251861|542202591|FG001|Overall Study|Potential interaction of drugs|1|||
150292127|NCT04381650|542202597|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292128|NCT04381650|542202598|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292129|NCT04381650|542202599|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292130|NCT04381650|542202600|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
150292131|NCT04381650|542202601|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292132|NCT04381650|542202602|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292133|NCT04381650|542202603|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292134|NCT04381650|542202604|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292135|NCT04381650|542202605|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292136|NCT04381650|542202606|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292137|NCT04381650|542202607|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
150292138|NCT04381650|542202597|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292139|NCT04381650|542202598|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292140|NCT04381650|542202599|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292141|NCT04381650|542202600|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
150292142|NCT04381650|542202601|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292143|NCT04381650|542202602|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292144|NCT04381650|542202603|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292145|NCT04381650|542202604|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292146|NCT04381650|542202605|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292147|NCT04381650|542202606|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292148|NCT04381650|542202607|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
150292149|NCT04381650|542202597|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
150292150|NCT04381650|542202598|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
150292151|NCT04381650|542202599|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
149862096|NCT01949116|540624086|FG001|Overall Study|Lost to Follow-up|3|||
149862097|NCT01949116|540624085|FG000|Overall Study|Withdrawal by Subject|5|||
149862098|NCT01949116|540624086|FG001|Overall Study|Withdrawal by Subject|3|||
149862099|NCT01560507|540624095|FG000|Overall Study|Lost to Follow-up|3|||
149862100|NCT01560507|540624096|FG001|Overall Study|Lost to Follow-up|1|||
149862101|NCT01560507|540624097|FG002|Overall Study|Lost to Follow-up|2|||
150292152|NCT04381650|542202600|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
150292153|NCT04381650|542202601|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292154|NCT04381650|542202602|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292155|NCT04381650|542202603|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292156|NCT04381650|542202604|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149862102|NCT01560507|540624095|FG000|Overall Study|Withdrawal by Subject|1|||
149862103|NCT01560507|540624096|FG001|Overall Study|Withdrawal by Subject|1|||
149862104|NCT01560507|540624097|FG002|Overall Study|Withdrawal by Subject|0|||
149862105|NCT01138111|540624098|FG000|Overall Study|Withdrawal by Subject|5|||
149862106|NCT01138111|540624098|FG000|Overall Study|Adverse Event|1|||
149862107|NCT01138111|540624098|FG000|Overall Study|Death|1|||
149862108|NCT01138111|540624098|FG000|Overall Study|Lost to Follow-up|2|||
149862109|NCT00706992|540624099|FG000|Overall Study|Study termination|5|||
149862110|NCT00706992|540624100|FG001|Overall Study|Study termination|5|||
149862111|NCT00706992|540624101|FG002|Overall Study|Study termination|6|||
149862112|NCT00706992|540624102|FG003|Overall Study|Study termination|2|||
149862113|NCT00706992|540624103|FG004|Overall Study|Study termination|3|||
149862114|NCT00706992|540624104|FG005|Overall Study|Study termination|2|||
149862115|NCT00706992|540624105|FG006|Overall Study|Study termination|3|||
149862116|NCT00706992|540624099|FG000|Overall Study|Disease progression before treatment|0|||
149862117|NCT00706992|540624100|FG001|Overall Study|Disease progression before treatment|0|||
149862118|NCT00706992|540624101|FG002|Overall Study|Disease progression before treatment|0|||
149862119|NCT00706992|540624102|FG003|Overall Study|Disease progression before treatment|0|||
149862120|NCT00706992|540624103|FG004|Overall Study|Disease progression before treatment|1|||
149862121|NCT00706992|540624104|FG005|Overall Study|Disease progression before treatment|0|||
149862122|NCT00706992|540624105|FG006|Overall Study|Disease progression before treatment|0|||
149862123|NCT02746627|540624107|FG000|Overall Study|Withdrawal by Subject|1|||
149862124|NCT02746627|540624108|FG001|Overall Study|Withdrawal by Subject|1|||
149862125|NCT02746627|540624109|FG002|Overall Study|Withdrawal by Subject|1|||
149862126|NCT00515034|540624110|FG000|Overall Study|Adverse Event|2|||
149862127|NCT00515034|540624111|FG001|Overall Study|Adverse Event|0|||
149862128|NCT00515034|540624112|FG002|Overall Study|Adverse Event|1|||
149862129|NCT00515034|540624113|FG003|Overall Study|Adverse Event|0|||
149862130|NCT00515034|540624110|FG000|Overall Study|Death|4|||
149862131|NCT00515034|540624111|FG001|Overall Study|Death|2|||
149862132|NCT00515034|540624112|FG002|Overall Study|Death|1|||
149862133|NCT00515034|540624113|FG003|Overall Study|Death|3|||
149862134|NCT00515034|540624110|FG000|Overall Study|Withdrawal by Subject|1|||
149862135|NCT00515034|540624111|FG001|Overall Study|Withdrawal by Subject|0|||
149862136|NCT00515034|540624112|FG002|Overall Study|Withdrawal by Subject|3|||
149862137|NCT00515034|540624113|FG003|Overall Study|Withdrawal by Subject|0|||
149862138|NCT00515034|540624110|FG000|Overall Study|Physician Decision|0|||
149862139|NCT00515034|540624111|FG001|Overall Study|Physician Decision|0|||
149862140|NCT00515034|540624112|FG002|Overall Study|Physician Decision|1|||
149862141|NCT00515034|540624113|FG003|Overall Study|Physician Decision|1|||
149862142|NCT00515034|540624110|FG000|Overall Study|Other|1|||
150292157|NCT04381650|542202605|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292158|NCT04381650|542202606|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292159|NCT04381650|542202607|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
150292160|NCT04381650|542202597|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292161|NCT04381650|542202598|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292162|NCT04381650|542202599|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
149862143|NCT00515034|540624111|FG001|Overall Study|Other|0|||
149862144|NCT00515034|540624112|FG002|Overall Study|Other|2|||
149862145|NCT00515034|540624113|FG003|Overall Study|Other|1|||
149862146|NCT02858726|540624114|FG000|Overall Study|Adverse Event|4|||
149862147|NCT02858726|540624115|FG001|Overall Study|Adverse Event|4|||
149862148|NCT02858726|540624116|FG002|Overall Study|Adverse Event|9|||
149862149|NCT02858726|540624117|FG003|Overall Study|Adverse Event|1|||
149862150|NCT02858726|540624114|FG000|Overall Study|Physician Decision|0|||
149862151|NCT02858726|540624115|FG001|Overall Study|Physician Decision|0|||
149862152|NCT02858726|540624116|FG002|Overall Study|Physician Decision|1|||
149862153|NCT02858726|540624117|FG003|Overall Study|Physician Decision|0|||
149862154|NCT02858726|540624114|FG000|Overall Study|Protocol Violation|0|||
149961964|NCT02134028|540994171|FG002|Overall Study|Poor compliance to protocol|3|||
149961965|NCT02134028|540994172|FG003|Overall Study|Poor compliance to protocol|7|||
149961966|NCT02134028|540994173|FG004|Overall Study|Poor compliance to protocol|1|||
149961967|NCT02134028|540994174|FG005|Overall Study|Poor compliance to protocol|1|||
149961968|NCT02134028|540994175|FG006|Overall Study|Poor compliance to protocol|0|||
149961969|NCT02134028|540994176|FG007|Overall Study|Poor compliance to protocol|0|||
149961970|NCT02134028|540994169|FG000|Overall Study|Other unspecified|4|||
149961971|NCT02134028|540994170|FG001|Overall Study|Other unspecified|22|||
150292163|NCT04381650|542202600|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
150292164|NCT04381650|542202601|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292165|NCT04381650|542202602|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292166|NCT04381650|542202603|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292167|NCT04381650|542202604|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292168|NCT04381650|542202605|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292169|NCT04381650|542202606|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292170|NCT04381650|542202607|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
150292171|NCT04381650|542202597|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292172|NCT04381650|542202598|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
150292173|NCT04381650|542202599|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
150292174|NCT04381650|542202600|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
150292175|NCT04381650|542202601|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292176|NCT04381650|542202602|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292177|NCT04381650|542202603|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149862155|NCT02858726|540624115|FG001|Overall Study|Protocol Violation|0|||
149862156|NCT02858726|540624116|FG002|Overall Study|Protocol Violation|0|||
149862157|NCT02858726|540624117|FG003|Overall Study|Protocol Violation|1|||
149862158|NCT02858726|540624114|FG000|Overall Study|Study Terminated by Sponsor|0|||
149862159|NCT02858726|540624115|FG001|Overall Study|Study Terminated by Sponsor|0|||
149862160|NCT02858726|540624116|FG002|Overall Study|Study Terminated by Sponsor|0|||
149862161|NCT02858726|540624117|FG003|Overall Study|Study Terminated by Sponsor|1|||
149862162|NCT02858726|540624114|FG000|Overall Study|Withdrawal by Subject|1|||
149862163|NCT02858726|540624115|FG001|Overall Study|Withdrawal by Subject|2|||
149862164|NCT02858726|540624116|FG002|Overall Study|Withdrawal by Subject|1|||
149862165|NCT02858726|540624117|FG003|Overall Study|Withdrawal by Subject|0|||
149862166|NCT02858726|540624114|FG000|Overall Study|Noncompliance|0|||
149862167|NCT02858726|540624115|FG001|Overall Study|Noncompliance|1|||
149862168|NCT02858726|540624116|FG002|Overall Study|Noncompliance|0|||
149862169|NCT02858726|540624117|FG003|Overall Study|Noncompliance|0|||
149862170|NCT01481324|540624123|FG000|Overall Study|Missing Data|0|||
149961972|NCT02134028|540994171|FG002|Overall Study|Other unspecified|33|||
149961973|NCT02134028|540994172|FG003|Overall Study|Other unspecified|64|||
149862171|NCT01481324|540624124|FG001|Overall Study|Missing Data|2|||
149862172|NCT01481324|540624125|FG002|Overall Study|Missing Data|2|||
149862173|NCT02698865|540626270|FG000|Overall Study|Other|11|||
149862174|NCT02698865|540626271|FG001|Overall Study|Other|11|||
149862175|NCT02698865|540626270|FG000|Overall Study|Withdrawal by Subject|20|||
149862176|NCT02698865|540626271|FG001|Overall Study|Withdrawal by Subject|16|||
149862177|NCT02698865|540626270|FG000|Overall Study|Physician Decision|0|||
149862178|NCT02698865|540626271|FG001|Overall Study|Physician Decision|4|||
149862179|NCT02698865|540626270|FG000|Overall Study|Lost to Follow-up|4|||
149862180|NCT02698865|540626271|FG001|Overall Study|Lost to Follow-up|2|||
149862181|NCT03861481|540626272|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
149862182|NCT03861481|540626273|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
149862183|NCT03861481|540626272|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
149862184|NCT03861481|540626273|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
149862185|NCT03861481|540626272|FG000|Overall Study|Relapse|1|||
149862186|NCT03861481|540626273|FG001|Overall Study|Relapse|0|||
149862187|NCT03861481|540626272|FG000|Overall Study|Withdrawal by Subject|0|||
149862188|NCT03861481|540626273|FG001|Overall Study|Withdrawal by Subject|1|||
149862189|NCT03861481|540626272|FG000|Overall Study|Lack of Efficacy|4|||
149862190|NCT03861481|540626273|FG001|Overall Study|Lack of Efficacy|5|||
149862191|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
149862192|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
149862193|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
150292178|NCT04381650|542202604|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292179|NCT04381650|542202605|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292180|NCT04381650|542202606|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292181|NCT04381650|542202607|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
150292182|NCT04381650|542202597|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292183|NCT04381650|542202598|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292184|NCT04381650|542202599|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292185|NCT04381650|542202600|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292186|NCT04381650|542202601|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
150292187|NCT04381650|542202602|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
150292188|NCT04381650|542202603|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149862194|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
149961974|NCT02134028|540994173|FG004|Overall Study|Other unspecified|8|||
150292189|NCT04381650|542202604|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149862195|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
149862196|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
149862197|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
149961975|NCT02134028|540994174|FG005|Overall Study|Other unspecified|6|||
149862198|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
149862199|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
149862200|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
149862201|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
150292190|NCT04381650|542202605|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292191|NCT04381650|542202606|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
150292192|NCT04381650|542202607|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
150292193|NCT04381650|542202597|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149862202|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
149862203|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
149862204|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
149862205|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
149862206|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
149862207|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
149862208|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
149862209|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
149862210|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
149862211|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
149862212|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
149862213|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
149862214|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
149862215|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
149862216|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
149862217|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
149862218|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
150292194|NCT04381650|542202598|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150292195|NCT04381650|542202599|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150292196|NCT04381650|542202600|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149862219|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
149862220|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
149862221|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
149862222|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
149862223|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
149862224|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
149862225|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
149862226|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
149862227|NCT00773734|540626274|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
149862228|NCT00773734|540626275|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
149862229|NCT00773734|540626276|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
149862230|NCT00773734|540626277|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
149862231|NCT00773734|540626278|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
149862232|NCT00773734|540626279|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
149862233|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
149862234|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
149862235|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
149862236|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
149862237|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
149862238|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
149862239|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
149862240|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
149862241|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
149862242|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
149862243|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
149862244|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
149862245|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
149862246|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
149862247|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
149862248|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
149862249|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
150173777|NCT03622593|541772943|FG001|Overall Study|Withdrawal by Subject|9|||
150173778|NCT03622593|541772944|FG002|Overall Study|Withdrawal by Subject|13|||
150173779|NCT03622593|541772942|FG000|Overall Study|Death|12|||
150173780|NCT03622593|541772943|FG001|Overall Study|Death|9|||
150292197|NCT04381650|542202601|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150292198|NCT04381650|542202602|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150292199|NCT04381650|542202603|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149862250|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
149862251|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
149862252|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
149862253|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
149862254|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
149862255|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
149862256|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
149862257|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
149862258|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
150292200|NCT04381650|542202604|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149862259|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
149862260|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
149862261|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
149862262|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
149862263|NCT00773734|540626274|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
149862264|NCT00773734|540626275|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
149862265|NCT00773734|540626276|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
149862266|NCT00773734|540626277|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
149862267|NCT00773734|540626278|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
149862268|NCT00773734|540626279|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
149862269|NCT00773734|540626274|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
149961976|NCT02134028|540994175|FG006|Overall Study|Other unspecified|2|||
150173781|NCT03622593|541772944|FG002|Overall Study|Death|10|||
150292201|NCT04381650|542202605|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
150292202|NCT04381650|542202606|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
150292203|NCT04381650|542202607|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150292204|NCT04381650|542202597|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
150292205|NCT04381650|542202598|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
150292206|NCT04381650|542202599|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
150292207|NCT04381650|542202600|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
150292208|NCT04381650|542202601|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
150292209|NCT04381650|542202602|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
150292210|NCT04381650|542202603|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
150292211|NCT04381650|542202604|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
150292212|NCT04381650|542202605|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
150292213|NCT04381650|542202606|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
150292214|NCT04381650|542202607|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
150292215|NCT04381650|542202597|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
150292216|NCT04381650|542202598|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
150292217|NCT04381650|542202599|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
150292218|NCT04381650|542202600|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
150292219|NCT04381650|542202601|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
150292220|NCT04381650|542202602|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
150292221|NCT04381650|542202603|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
150292222|NCT04381650|542202604|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
150292223|NCT04381650|542202605|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
150292224|NCT04381650|542202606|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
150292225|NCT04381650|542202607|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
150173782|NCT03622593|541772942|FG000|Overall Study|Lost to Follow-up|11|||
150292226|NCT04381650|542202597|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292227|NCT04381650|542202598|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149961977|NCT02134028|540994176|FG007|Overall Study|Other unspecified|1|||
149961978|NCT02134028|540994169|FG000|Overall Study|Adverse Event|3|||
150173783|NCT03622593|541772943|FG001|Overall Study|Lost to Follow-up|5|||
150292228|NCT04381650|542202599|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292229|NCT04381650|542202600|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292230|NCT04381650|542202601|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292231|NCT04381650|542202602|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292232|NCT04381650|542202603|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292233|NCT04381650|542202604|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
150292234|NCT04381650|542202605|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292235|NCT04381650|542202606|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
150292236|NCT04381650|542202607|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149862270|NCT00773734|540626275|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
149862271|NCT00773734|540626276|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
149862272|NCT00773734|540626277|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
149862273|NCT00773734|540626278|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
149862274|NCT00773734|540626279|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
149862275|NCT00773734|540626274|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
149862276|NCT00773734|540626275|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
149862277|NCT00773734|540626276|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
149862278|NCT00773734|540626277|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
149862279|NCT00773734|540626278|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
149862280|NCT00773734|540626279|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
149862281|NCT00773734|540626274|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
149862282|NCT00773734|540626275|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
149862283|NCT00773734|540626276|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
149862284|NCT00773734|540626277|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
149862285|NCT00773734|540626278|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
149862286|NCT00773734|540626279|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
149862287|NCT00773734|540626274|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
149862288|NCT00773734|540626275|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
149862289|NCT00773734|540626276|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
149862290|NCT00773734|540626277|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
149862291|NCT00773734|540626278|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
149862292|NCT00773734|540626279|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
149862293|NCT00773734|540626274|FG000|Extension: Active Treatment Week 24-52|Other|0|||
149862294|NCT00773734|540626275|FG001|Extension: Active Treatment Week 24-52|Other|0|||
149862295|NCT00773734|540626276|FG002|Extension: Active Treatment Week 24-52|Other|1|||
149862296|NCT00773734|540626277|FG003|Extension: Active Treatment Week 24-52|Other|2|||
149862297|NCT00773734|540626278|FG004|Extension: Active Treatment Week 24-52|Other|0|||
149862298|NCT00773734|540626279|FG005|Extension: Active Treatment Week 24-52|Other|1|||
149862299|NCT00773734|540626274|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
149862300|NCT00773734|540626275|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
149862301|NCT00773734|540626276|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
149862302|NCT00773734|540626277|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
149862303|NCT00773734|540626278|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
149862304|NCT00773734|540626279|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
149862305|NCT00773734|540626274|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
149862306|NCT00773734|540626275|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
149862307|NCT00773734|540626276|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
149862308|NCT00773734|540626277|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
149862309|NCT00773734|540626278|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
149862310|NCT00773734|540626279|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
149862311|NCT00773734|540626274|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
149961979|NCT02134028|540994170|FG001|Overall Study|Adverse Event|19|||
149961980|NCT02134028|540994171|FG002|Overall Study|Adverse Event|13|||
149961981|NCT02134028|540994172|FG003|Overall Study|Adverse Event|32|||
149961982|NCT02134028|540994173|FG004|Overall Study|Adverse Event|4|||
149961983|NCT02134028|540994174|FG005|Overall Study|Adverse Event|5|||
149862312|NCT00773734|540626275|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
149862313|NCT00773734|540626276|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
149862314|NCT00773734|540626277|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
149862315|NCT00773734|540626278|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
149862316|NCT00773734|540626279|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
149862317|NCT00773734|540626274|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
149862318|NCT00773734|540626275|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
149862319|NCT00773734|540626276|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
149862320|NCT00773734|540626277|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
149862321|NCT00773734|540626278|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
149862322|NCT00773734|540626279|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
149862323|NCT01220297|540626286|FG000|Overall Study|Death|2|||
149862324|NCT01220297|540626286|FG000|Overall Study|Lost to Follow-up|1|||
149862325|NCT02119286|540626288|FG000|Overall Study|Adverse Event|9|||
149862326|NCT02119286|540626289|FG001|Overall Study|Adverse Event|7|||
149862327|NCT02119286|540626290|FG002|Overall Study|Adverse Event|2|||
149862328|NCT02119286|540626288|FG000|Overall Study|Lack of Efficacy|11|||
149862329|NCT02119286|540626289|FG001|Overall Study|Lack of Efficacy|3|||
149862330|NCT02119286|540626290|FG002|Overall Study|Lack of Efficacy|4|||
150040642|NCT01657019|541289112|FG000|Overall Study|Adverse Event|55|||
149862331|NCT02119286|540626288|FG000|Overall Study|Lost to Follow-up|2|||
149862332|NCT02119286|540626289|FG001|Overall Study|Lost to Follow-up|0|||
149862333|NCT02119286|540626290|FG002|Overall Study|Lost to Follow-up|1|||
149862334|NCT02119286|540626288|FG000|Overall Study|Withdrawal by Subject|4|||
149862335|NCT02119286|540626289|FG001|Overall Study|Withdrawal by Subject|1|||
149862336|NCT02119286|540626290|FG002|Overall Study|Withdrawal by Subject|0|||
149862337|NCT04109313|540626291|FG000|Overall Study|Pregnancy|1|||
149862338|NCT04109313|540626291|FG000|Overall Study|Adverse Event|11|||
149862339|NCT04109313|540626291|FG000|Overall Study|Lack of Efficacy|11|||
149862340|NCT04109313|540626291|FG000|Overall Study|Lost to Follow-up|1|||
149862341|NCT04109313|540626291|FG000|Overall Study|Physician Decision|2|||
149862342|NCT04109313|540626291|FG000|Overall Study|Subject Decision|13|||
149862343|NCT04109313|540626291|FG000|Overall Study|Covid-19 situation|2|||
149862344|NCT01272921|540626292|FG000|Overall Study|Protocol Violation|2|||
149862345|NCT01272921|540626293|FG001|Overall Study|Protocol Violation|1|||
149862346|NCT01132664|540626294|FG000|Phase lb|Adverse Event|0|||
149862347|NCT01132664|540626295|FG001|Phase lb|Adverse Event|1|||
149862348|NCT01132664|540626296|FG002|Phase lb|Adverse Event|0|||
149862349|NCT01132664|540626297|FG003|Phase lb|Adverse Event|0|||
149862350|NCT01132664|540626298|FG004|Phase lb|Adverse Event|0|||
149862351|NCT01132664|540626294|FG000|Phase lb|Withdrawal by Subject|1|||
149862352|NCT01132664|540626295|FG001|Phase lb|Withdrawal by Subject|2|||
149862353|NCT01132664|540626296|FG002|Phase lb|Withdrawal by Subject|0|||
149862354|NCT01132664|540626297|FG003|Phase lb|Withdrawal by Subject|0|||
149862355|NCT01132664|540626298|FG004|Phase lb|Withdrawal by Subject|0|||
149862356|NCT01132664|540626294|FG000|Phase lb|Disease Progression|4|||
149862357|NCT01132664|540626295|FG001|Phase lb|Disease Progression|9|||
149862358|NCT01132664|540626296|FG002|Phase lb|Disease Progression|0|||
149862359|NCT01132664|540626297|FG003|Phase lb|Disease Progression|0|||
149862360|NCT01132664|540626298|FG004|Phase lb|Disease Progression|0|||
149862361|NCT01132664|540626294|FG000|Phase ll|Death|0|||
149862362|NCT01132664|540626295|FG001|Phase ll|Death|0|||
149862363|NCT01132664|540626296|FG002|Phase ll|Death|2|||
149862364|NCT01132664|540626297|FG003|Phase ll|Death|0|||
149862365|NCT01132664|540626298|FG004|Phase ll|Death|0|||
149862366|NCT01132664|540626294|FG000|Phase ll|Adverse Event|0|||
149862367|NCT01132664|540626295|FG001|Phase ll|Adverse Event|0|||
149862368|NCT01132664|540626296|FG002|Phase ll|Adverse Event|10|||
150173784|NCT03622593|541772944|FG002|Overall Study|Lost to Follow-up|8|||
150173785|NCT03622593|541772942|FG000|Overall Study|Adverse Event|4|||
149862369|NCT01132664|540626297|FG003|Phase ll|Adverse Event|0|||
149862370|NCT01132664|540626298|FG004|Phase ll|Adverse Event|0|||
149862371|NCT01132664|540626294|FG000|Phase ll|Withdrawal by Subject|0|||
149862372|NCT01132664|540626295|FG001|Phase ll|Withdrawal by Subject|0|||
149862373|NCT01132664|540626296|FG002|Phase ll|Withdrawal by Subject|3|||
149862374|NCT01132664|540626297|FG003|Phase ll|Withdrawal by Subject|0|||
149862375|NCT01132664|540626298|FG004|Phase ll|Withdrawal by Subject|0|||
149862376|NCT01132664|540626294|FG000|Phase ll|Disease progression|0|||
149862377|NCT01132664|540626295|FG001|Phase ll|Disease progression|0|||
149862378|NCT01132664|540626296|FG002|Phase ll|Disease progression|35|||
149862379|NCT01132664|540626297|FG003|Phase ll|Disease progression|0|||
149862380|NCT01132664|540626298|FG004|Phase ll|Disease progression|0|||
149862381|NCT01132664|540626294|FG000|BM Cohort|Disease progression|0|||
149862382|NCT01132664|540626295|FG001|BM Cohort|Disease progression|0|||
149862383|NCT01132664|540626296|FG002|BM Cohort|Disease progression|0|||
149862384|NCT01132664|540626297|FG003|BM Cohort|Disease progression|3|||
149862385|NCT01132664|540626298|FG004|BM Cohort|Disease progression|4|||
149862386|NCT01132664|540626294|FG000|BM Cohort|Adverse Event|0|||
149862387|NCT01132664|540626295|FG001|BM Cohort|Adverse Event|0|||
149862388|NCT01132664|540626296|FG002|BM Cohort|Adverse Event|0|||
149862389|NCT01132664|540626297|FG003|BM Cohort|Adverse Event|0|||
149862390|NCT01132664|540626298|FG004|BM Cohort|Adverse Event|1|||
149862391|NCT01132664|540626294|FG000|BM Cohort|Withdrawal by Subject|0|||
150173786|NCT03622593|541772943|FG001|Overall Study|Adverse Event|5|||
150173787|NCT03622593|541772944|FG002|Overall Study|Adverse Event|6|||
150173788|NCT03622593|541772942|FG000|Overall Study|Physician Decision|2|||
149862392|NCT01132664|540626295|FG001|BM Cohort|Withdrawal by Subject|0|||
149862393|NCT01132664|540626296|FG002|BM Cohort|Withdrawal by Subject|0|||
149862394|NCT01132664|540626297|FG003|BM Cohort|Withdrawal by Subject|0|||
149862395|NCT01132664|540626298|FG004|BM Cohort|Withdrawal by Subject|1|||
149862396|NCT01996332|540626300|FG000|Overall Study|Adverse Event|117|||
149862397|NCT01996332|540626300|FG000|Overall Study|Lack of Efficacy|1245|||
149862398|NCT01996332|540626300|FG000|Overall Study|Death|264|||
149862399|NCT01996332|540626300|FG000|Overall Study|Protocol Violation|9|||
149862400|NCT01996332|540626300|FG000|Overall Study|Withdrawal by Subject|71|||
149862401|NCT01996332|540626300|FG000|Overall Study|Other|20|||
149862402|NCT01996332|540626300|FG000|Overall Study|Clinical Deterioration|28|||
149862403|NCT01996332|540626300|FG000|Overall Study|Physician Decision|17|||
149862404|NCT01996332|540626300|FG000|Overall Study|Lost to Follow-up|34|||
149862405|NCT02113189|540626301|FG000|Overall Study|Lost to follow up|2|||
149862406|NCT02113189|540626302|FG001|Overall Study|Lost to follow up|1|||
149862407|NCT02113189|540626303|FG002|Overall Study|Lost to follow up|3|||
150173789|NCT03622593|541772943|FG001|Overall Study|Physician Decision|1|||
149862408|NCT02954159|540626304|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
149862409|NCT02954159|540626305|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
149862410|NCT02954159|540626304|FG000|Overall Study|Withdrawal by Subject|0|||
149862411|NCT02954159|540626305|FG001|Overall Study|Withdrawal by Subject|1|||
149862412|NCT02581163|540626307|FG000|Overall Study|Failure to return|15|||
149862413|NCT02581163|540626307|FG000|Overall Study|Insufficient virological response|3|||
149862414|NCT02581163|540626307|FG000|Overall Study|Withdrew consent|1|||
149862415|NCT02581163|540626307|FG000|Overall Study|Death|1|||
149862416|NCT02581163|540626307|FG000|Overall Study|Other, not specified|9|||
149862417|NCT01744093|540626311|FG000|Overall Study|Withdrawal by Subject|6|||
149862418|NCT01744093|540626312|FG001|Overall Study|Withdrawal by Subject|1|||
149862419|NCT02006628|540626313|FG000|Overall Study|Adverse Event|1|||
149862420|NCT02006628|540626314|FG001|Overall Study|Adverse Event|1|||
149862421|NCT02006628|540626313|FG000|Overall Study|Withdrawal by Subject|2|||
149862422|NCT02006628|540626314|FG001|Overall Study|Withdrawal by Subject|1|||
149862423|NCT01206816|540626317|FG000|Overall Study|Protocol Violation|0|||
149862424|NCT01206816|540626318|FG001|Overall Study|Protocol Violation|0|||
149862425|NCT01206816|540626319|FG002|Overall Study|Protocol Violation|1|||
149862426|NCT01206816|540626320|FG003|Overall Study|Protocol Violation|0|||
149862427|NCT01206816|540626321|FG004|Overall Study|Protocol Violation|0|||
149862428|NCT01206816|540626322|FG005|Overall Study|Protocol Violation|0|||
149862429|NCT01206816|540626323|FG006|Overall Study|Protocol Violation|0|||
149862430|NCT01206816|540626317|FG000|Overall Study|Withdrawal by Subject|0|||
149862431|NCT01206816|540626318|FG001|Overall Study|Withdrawal by Subject|0|||
149862432|NCT01206816|540626319|FG002|Overall Study|Withdrawal by Subject|1|||
149862433|NCT01206816|540626320|FG003|Overall Study|Withdrawal by Subject|0|||
149862434|NCT01206816|540626321|FG004|Overall Study|Withdrawal by Subject|0|||
149862435|NCT01206816|540626322|FG005|Overall Study|Withdrawal by Subject|0|||
149862436|NCT01206816|540626323|FG006|Overall Study|Withdrawal by Subject|0|||
149862437|NCT01206816|540626317|FG000|Overall Study|Progressive disease|3|||
149862438|NCT01206816|540626318|FG001|Overall Study|Progressive disease|3|||
149862439|NCT01206816|540626319|FG002|Overall Study|Progressive disease|13|||
149862440|NCT01206816|540626320|FG003|Overall Study|Progressive disease|3|||
149862441|NCT01206816|540626321|FG004|Overall Study|Progressive disease|3|||
149862442|NCT01206816|540626322|FG005|Overall Study|Progressive disease|16|||
149862443|NCT01206816|540626323|FG006|Overall Study|Progressive disease|3|||
149961984|NCT02134028|540994175|FG006|Overall Study|Adverse Event|1|||
149961985|NCT02134028|540994176|FG007|Overall Study|Adverse Event|2|||
149961986|NCT02965976|540994177|FG000|Overall Study|Withdrawal by Subject|2|||
149961987|NCT02965976|540994178|FG001|Overall Study|Withdrawal by Subject|0|||
149961988|NCT00806026|540994179|FG000|Overall Study|Death|0|||
149961989|NCT00806026|540994180|FG001|Overall Study|Death|0|||
149961990|NCT00806026|540994181|FG002|Overall Study|Death|0|||
149961991|NCT00806026|540994182|FG003|Overall Study|Death|1|||
149961992|NCT00806026|540994183|FG004|Overall Study|Death|0|||
149961993|NCT00806026|540994184|FG005|Overall Study|Death|0|||
149961994|NCT00806026|540994179|FG000|Overall Study|Did not meet entrance criteria|4|||
149961995|NCT00806026|540994180|FG001|Overall Study|Did not meet entrance criteria|1|||
149961996|NCT00806026|540994181|FG002|Overall Study|Did not meet entrance criteria|2|||
149961997|NCT00806026|540994182|FG003|Overall Study|Did not meet entrance criteria|1|||
149961998|NCT00806026|540994183|FG004|Overall Study|Did not meet entrance criteria|0|||
149961999|NCT00806026|540994184|FG005|Overall Study|Did not meet entrance criteria|0|||
149962000|NCT00806026|540994179|FG000|Overall Study|Lack of Efficacy|5|||
149962001|NCT00806026|540994180|FG001|Overall Study|Lack of Efficacy|18|||
149962002|NCT00806026|540994181|FG002|Overall Study|Lack of Efficacy|13|||
149962003|NCT00806026|540994182|FG003|Overall Study|Lack of Efficacy|4|||
149962004|NCT00806026|540994183|FG004|Overall Study|Lack of Efficacy|8|||
149962005|NCT00806026|540994184|FG005|Overall Study|Lack of Efficacy|7|||
149862444|NCT01206816|540626317|FG000|Overall Study|Other AE|0|||
149862445|NCT01206816|540626318|FG001|Overall Study|Other AE|0|||
149862446|NCT01206816|540626319|FG002|Overall Study|Other AE|4|||
149862447|NCT01206816|540626320|FG003|Overall Study|Other AE|0|||
149962006|NCT00806026|540994179|FG000|Overall Study|Lost to Follow-up|8|||
149962007|NCT00806026|540994180|FG001|Overall Study|Lost to Follow-up|15|||
149962008|NCT00806026|540994181|FG002|Overall Study|Lost to Follow-up|8|||
149962009|NCT00806026|540994182|FG003|Overall Study|Lost to Follow-up|2|||
149862448|NCT01206816|540626321|FG004|Overall Study|Other AE|0|||
149962010|NCT00806026|540994183|FG004|Overall Study|Lost to Follow-up|6|||
149962011|NCT00806026|540994184|FG005|Overall Study|Lost to Follow-up|6|||
149862449|NCT01206816|540626322|FG005|Overall Study|Other AE|3|||
149862450|NCT01206816|540626323|FG006|Overall Study|Other AE|2|||
149862451|NCT01206816|540626317|FG000|Overall Study|other than stated above|0|||
149862452|NCT01206816|540626318|FG001|Overall Study|other than stated above|0|||
149862453|NCT01206816|540626319|FG002|Overall Study|other than stated above|1|||
149862454|NCT01206816|540626320|FG003|Overall Study|other than stated above|0|||
149962012|NCT00806026|540994179|FG000|Overall Study|Withdrawal by Subject|14|||
150173790|NCT03622593|541772944|FG002|Overall Study|Physician Decision|6|||
150173791|NCT03622593|541772942|FG000|Overall Study|Other|2|||
150040643|NCT01657019|541289112|FG000|Overall Study|Lost to Follow-up|48|||
150040644|NCT01657019|541289112|FG000|Overall Study|Protocol Violation|6|||
150040645|NCT01657019|541289112|FG000|Overall Study|Lack of Efficacy|3|||
150040646|NCT01657019|541289112|FG000|Overall Study|Other|58|||
150040647|NCT02346721|541289113|FG000|Overall Study|Withdrew Consent|3|||
150173792|NCT03622593|541772943|FG001|Overall Study|Other|2|||
149862455|NCT01206816|540626321|FG004|Overall Study|other than stated above|0|||
149862456|NCT01206816|540626322|FG005|Overall Study|other than stated above|0|||
149862457|NCT01206816|540626323|FG006|Overall Study|other than stated above|1|||
149862458|NCT01939496|540626324|FG000|Overall Study|Adverse Event|2|||
149862459|NCT01939496|540626325|FG001|Overall Study|Adverse Event|0|||
149862460|NCT01939496|540626326|FG002|Overall Study|Adverse Event|0|||
149862461|NCT01939496|540626324|FG000|Overall Study|Lost to Follow-up|1|||
149862462|NCT01939496|540626325|FG001|Overall Study|Lost to Follow-up|1|||
149862463|NCT01939496|540626326|FG002|Overall Study|Lost to Follow-up|0|||
149862464|NCT01939496|540626324|FG000|Overall Study|Physician Decision|1|||
149862465|NCT01939496|540626325|FG001|Overall Study|Physician Decision|0|||
149862466|NCT01939496|540626326|FG002|Overall Study|Physician Decision|0|||
149862467|NCT01939496|540626324|FG000|Overall Study|Protocol Violation|3|||
149862468|NCT01939496|540626325|FG001|Overall Study|Protocol Violation|0|||
149862469|NCT01939496|540626326|FG002|Overall Study|Protocol Violation|0|||
149862470|NCT01939496|540626324|FG000|Overall Study|Withdrawal by Subject|0|||
149862471|NCT01939496|540626325|FG001|Overall Study|Withdrawal by Subject|1|||
149862472|NCT01939496|540626326|FG002|Overall Study|Withdrawal by Subject|1|||
149862473|NCT01939496|540626324|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
149862474|NCT01939496|540626325|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
149862475|NCT01939496|540626326|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
149862476|NCT01939496|540626324|FG000|Overall Study|Other|2|||
149862477|NCT01939496|540626325|FG001|Overall Study|Other|0|||
149862478|NCT01939496|540626326|FG002|Overall Study|Other|1|||
149862479|NCT02384941|540626327|FG000|Overall Study|Adverse Event|11|||
149862480|NCT02384941|540626328|FG001|Overall Study|Adverse Event|13|||
149862481|NCT02384941|540626329|FG002|Overall Study|Adverse Event|17|||
149862482|NCT02384941|540626327|FG000|Overall Study|Lost to Follow-up|3|||
149862483|NCT02384941|540626328|FG001|Overall Study|Lost to Follow-up|2|||
149862484|NCT02384941|540626329|FG002|Overall Study|Lost to Follow-up|1|||
149862485|NCT02384941|540626327|FG000|Overall Study|Non-Compliance With Study Drug|2|||
149862486|NCT02384941|540626328|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149862487|NCT02384941|540626329|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149862488|NCT02384941|540626327|FG000|Overall Study|Physician Decision|1|||
149862489|NCT02384941|540626328|FG001|Overall Study|Physician Decision|1|||
149862490|NCT02384941|540626329|FG002|Overall Study|Physician Decision|0|||
149862491|NCT02384941|540626327|FG000|Overall Study|Protocol Violation|3|||
149862492|NCT02384941|540626328|FG001|Overall Study|Protocol Violation|0|||
149862493|NCT02384941|540626329|FG002|Overall Study|Protocol Violation|0|||
150040648|NCT02346721|541289113|FG000|Overall Study|Lack of Efficacy|1|||
150173793|NCT03622593|541772944|FG002|Overall Study|Other|3|||
149862494|NCT02384941|540626327|FG000|Overall Study|Withdrawal by Subject|26|||
149862495|NCT02384941|540626328|FG001|Overall Study|Withdrawal by Subject|19|||
149862496|NCT02384941|540626329|FG002|Overall Study|Withdrawal by Subject|20|||
149862497|NCT02384941|540626327|FG000|Overall Study|Pregnancy|0|||
149862498|NCT02384941|540626328|FG001|Overall Study|Pregnancy|0|||
149862499|NCT02384941|540626329|FG002|Overall Study|Pregnancy|1|||
149862500|NCT02384941|540626327|FG000|Overall Study|Other than specified above|4|||
149862501|NCT02384941|540626328|FG001|Overall Study|Other than specified above|0|||
149862502|NCT02384941|540626329|FG002|Overall Study|Other than specified above|1|||
149862503|NCT02493777|540626330|FG000|Overall Study|Lost to Follow-up|0|||
149862504|NCT02493777|540626331|FG001|Overall Study|Lost to Follow-up|1|||
149862505|NCT00468728|540626332|FG000|Treatment|criteria for mITT population|4|||
149862506|NCT00468728|540626333|FG001|Treatment|criteria for mITT population|11|||
149862507|NCT00468728|540626332|FG000|Follow-up|mITT failure|34|||
149862508|NCT00468728|540626333|FG001|Follow-up|mITT failure|31|||
149862509|NCT01705236|540626334|FG000|Overall Study|Lost to Follow-up|1|||
149862510|NCT01705236|540626334|FG000|Overall Study|Administrative problems|2|||
149862511|NCT01705236|540626334|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
149862512|NCT01705236|540626334|FG000|Overall Study|Protocol Violation|3|||
149862513|NCT01705236|540626334|FG000|Overall Study|Abnormal test procedure result(s)|4|||
149862514|NCT01705236|540626334|FG000|Overall Study|Abnormal laboratory value(s)|4|||
149862515|NCT01705236|540626334|FG000|Overall Study|Withdrawal by Subject|5|||
149862516|NCT01705236|540626334|FG000|Overall Study|Adverse Event|5|||
149862517|NCT03028740|540626335|FG000|Overall Study|Did not Receive Study Drug|4|||
149862518|NCT03028740|540626336|FG001|Overall Study|Did not Receive Study Drug|5|||
149862519|NCT03028740|540626335|FG000|Overall Study|Adverse Event|8|||
149862520|NCT03028740|540626336|FG001|Overall Study|Adverse Event|26|||
149862521|NCT03028740|540626335|FG000|Overall Study|Lack of Efficacy|0|||
149862522|NCT03028740|540626336|FG001|Overall Study|Lack of Efficacy|1|||
149862523|NCT03028740|540626335|FG000|Overall Study|Withdrawal by Subject|48|||
149862524|NCT03028740|540626336|FG001|Overall Study|Withdrawal by Subject|101|||
149862525|NCT03028740|540626335|FG000|Overall Study|Lost to Follow-up|30|||
149862526|NCT03028740|540626336|FG001|Overall Study|Lost to Follow-up|54|||
149862527|NCT03028740|540626335|FG000|Overall Study|Physician Decision|4|||
149862528|NCT03028740|540626336|FG001|Overall Study|Physician Decision|11|||
149862529|NCT03028740|540626335|FG000|Overall Study|Protocol Violation|4|||
149862530|NCT03028740|540626336|FG001|Overall Study|Protocol Violation|8|||
149862531|NCT03028740|540626335|FG000|Overall Study|Non-compliance with Study Drug|0|||
149862532|NCT03028740|540626336|FG001|Overall Study|Non-compliance with Study Drug|2|||
149862533|NCT03028740|540626335|FG000|Overall Study|Study Terminated by Sponsor|467|||
149862534|NCT03028740|540626336|FG001|Overall Study|Study Terminated by Sponsor|917|||
149862535|NCT03028740|540626335|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
149862536|NCT03028740|540626336|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
149862537|NCT03028740|540626335|FG000|Overall Study|Reason not Specified|1|||
149862538|NCT03028740|540626336|FG001|Overall Study|Reason not Specified|5|||
149862539|NCT03212794|540626341|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
149862540|NCT03212794|540626342|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
149862541|NCT03212794|540626341|FG000|Overall Study|Lost to Follow-up|5|||
149862542|NCT03212794|540626342|FG001|Overall Study|Lost to Follow-up|6|||
149862543|NCT03212794|540626341|FG000|Overall Study|Incarcerated; unable to participate|2|||
149862544|NCT03212794|540626342|FG001|Overall Study|Incarcerated; unable to participate|0|||
149862545|NCT03212794|540626341|FG000|Overall Study|Withdrawal by Subject|1|||
149862546|NCT03212794|540626342|FG001|Overall Study|Withdrawal by Subject|0|||
149862547|NCT03212794|540626341|FG000|Overall Study|Death|0|||
149862548|NCT03212794|540626342|FG001|Overall Study|Death|1|||
149862549|NCT03212794|540626341|FG000|Overall Study|Found to be ineligible after allocation|0|||
149862550|NCT03212794|540626342|FG001|Overall Study|Found to be ineligible after allocation|1|||
149862551|NCT03212794|540626341|FG000|Overall Study|Relocated out of area|2|||
149862552|NCT03212794|540626342|FG001|Overall Study|Relocated out of area|0|||
149862553|NCT02556307|540626349|FG000|Overall Study|Premature treatment interruption|11|||
149862554|NCT02556307|540626349|FG000|Overall Study|Lost to Follow-up|36|||
149862555|NCT02556307|540626349|FG000|Overall Study|Change to triple therapy|4|||
149862556|NCT02556307|540626349|FG000|Overall Study|Enrolled but not treated|2|||
149862557|NCT03438227|540626350|FG000|Overall Study|Withdrawal by Subject|10|||
149862558|NCT03438227|540626351|FG001|Overall Study|Withdrawal by Subject|5|||
149862559|NCT02039414|540626354|FG000|Overall Study|Delivered|1|||
149862560|NCT02039414|540626355|FG001|Overall Study|Delivered|1|||
149862561|NCT02039414|540626354|FG000|Overall Study|Lost to Follow-up|2|||
149862562|NCT02039414|540626355|FG001|Overall Study|Lost to Follow-up|0|||
149862563|NCT02039414|540626354|FG000|Overall Study|Protocol Violation|3|||
149862564|NCT02039414|540626355|FG001|Overall Study|Protocol Violation|1|||
149862565|NCT02972502|540626358|FG000|Overall Study|Lost to Follow-up|3|||
149862566|NCT02972502|540626359|FG001|Overall Study|Lost to Follow-up|1|||
149862567|NCT02972502|540626358|FG000|Overall Study|Withdrawal by Subject|1|||
149862568|NCT02972502|540626359|FG001|Overall Study|Withdrawal by Subject|1|||
149862569|NCT03832738|540626360|FG000|Overall Study|Withdrawal by Subject|6|||
149862570|NCT03832738|540626361|FG001|Overall Study|Withdrawal by Subject|7|||
149862571|NCT03832738|540626362|FG002|Overall Study|Withdrawal by Subject|16|||
149862572|NCT03832738|540626360|FG000|Overall Study|Physician Decision|0|||
149862573|NCT03832738|540626361|FG001|Overall Study|Physician Decision|1|||
149862574|NCT03832738|540626362|FG002|Overall Study|Physician Decision|2|||
149862575|NCT03832738|540626360|FG000|Overall Study|Adverse Event|2|||
149862576|NCT03832738|540626361|FG001|Overall Study|Adverse Event|3|||
149862577|NCT03832738|540626362|FG002|Overall Study|Adverse Event|1|||
149862578|NCT03832738|540626360|FG000|Overall Study|Pregnancy|0|||
149862579|NCT03832738|540626361|FG001|Overall Study|Pregnancy|1|||
149862580|NCT03832738|540626362|FG002|Overall Study|Pregnancy|0|||
149862581|NCT03852459|540626363|FG000|Overall Study|Adverse Event|2|||
149862582|NCT03852459|540626364|FG001|Overall Study|Adverse Event|2|||
149862583|NCT03852459|540626363|FG000|Overall Study|Withdrawal by Subject|1|||
149862584|NCT03852459|540626364|FG001|Overall Study|Withdrawal by Subject|1|||
149862585|NCT00049842|540626365|FG000|Treatment Phase|Adverse Event|47|||
149862586|NCT00049842|540626366|FG001|Treatment Phase|Adverse Event|12|||
149862587|NCT00049842|540626365|FG000|Treatment Phase|Withdrawal by Subject|35|||
149862588|NCT00049842|540626366|FG001|Treatment Phase|Withdrawal by Subject|46|||
149862589|NCT00049842|540626365|FG000|Treatment Phase|Non-compliance with protocol|7|||
149862590|NCT00049842|540626366|FG001|Treatment Phase|Non-compliance with protocol|8|||
149862591|NCT00049842|540626365|FG000|Treatment Phase|Lost to Follow-up|4|||
149862592|NCT00049842|540626366|FG001|Treatment Phase|Lost to Follow-up|8|||
149862593|NCT00049842|540626365|FG000|Treatment Phase|Administrative|0|||
149862594|NCT00049842|540626366|FG001|Treatment Phase|Administrative|3|||
149862595|NCT00049842|540626365|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
149862596|NCT00049842|540626366|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
149862597|NCT00049842|540626365|FG000|Follow-up Phase|Adverse Event|6|||
149862598|NCT00049842|540626366|FG001|Follow-up Phase|Adverse Event|1|||
149862599|NCT00049842|540626365|FG000|Follow-up Phase|Other|1|||
149862600|NCT00049842|540626366|FG001|Follow-up Phase|Other|4|||
149862601|NCT00430950|540626367|FG000|Overall Study|Adverse Event|7|||
149862602|NCT00430950|540626368|FG001|Overall Study|Adverse Event|6|||
149862603|NCT00430950|540626367|FG000|Overall Study|Withdrawal by Subject|1|||
149862604|NCT00430950|540626368|FG001|Overall Study|Withdrawal by Subject|0|||
149862605|NCT00430950|540626367|FG000|Overall Study|concomitant medication,etc.|5|||
149862606|NCT00430950|540626368|FG001|Overall Study|concomitant medication,etc.|7|||
149862607|NCT00293202|540626371|FG000|Overall Study|Withdrawal by Subject|1|||
149862608|NCT00293202|540626372|FG001|Overall Study|Withdrawal by Subject|2|||
149862609|NCT00293202|540626371|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
149862610|NCT00293202|540626372|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
149862611|NCT00293202|540626371|FG000|Overall Study|on-hold due to fistula maturation time|1|||
149862612|NCT00293202|540626372|FG001|Overall Study|on-hold due to fistula maturation time|0|||
149862613|NCT02442271|540626373|FG000|Overall Study|Adverse Event|1|||
149862614|NCT02442271|540626373|FG000|Overall Study|Withdrew Consent|1|||
149862615|NCT02442271|540626373|FG000|Overall Study|Lost to Follow-up|1|||
149862616|NCT02442271|540626373|FG000|Overall Study|Other|1|||
149862617|NCT00831623|540626379|FG000|Overall Study|Withdrawal by Subject|9|||
149862618|NCT00831623|540626379|FG000|Overall Study|Lost to Follow-up|1|||
149862619|NCT00831623|540626379|FG000|Overall Study|Not 2 years post-treatment|12|||
149862620|NCT01564459|540626381|FG000|Run-In|Adverse Event|7|||
149862621|NCT01564459|540626382|FG001|Run-In|Adverse Event|0|||
149862622|NCT01564459|540626383|FG002|Run-In|Adverse Event|0|||
149862623|NCT01564459|540626381|FG000|Run-In|Lost to Follow-up|1|||
149862624|NCT01564459|540626382|FG001|Run-In|Lost to Follow-up|0|||
149862625|NCT01564459|540626383|FG002|Run-In|Lost to Follow-up|0|||
149862626|NCT01564459|540626381|FG000|Run-In|Non-compliance with study drug|2|||
149862627|NCT01564459|540626382|FG001|Run-In|Non-compliance with study drug|0|||
149862628|NCT01564459|540626383|FG002|Run-In|Non-compliance with study drug|0|||
149862629|NCT01564459|540626381|FG000|Run-In|Protocol Violation|1|||
149862630|NCT01564459|540626382|FG001|Run-In|Protocol Violation|0|||
149862631|NCT01564459|540626383|FG002|Run-In|Protocol Violation|0|||
149862632|NCT01564459|540626381|FG000|Run-In|Withdrawal by Subject|1|||
149862633|NCT01564459|540626382|FG001|Run-In|Withdrawal by Subject|0|||
149862634|NCT01564459|540626383|FG002|Run-In|Withdrawal by Subject|0|||
149862635|NCT01564459|540626381|FG000|Double-blind Treatment|Adverse Event|0|||
149962013|NCT00806026|540994180|FG001|Overall Study|Withdrawal by Subject|17|||
149962014|NCT00806026|540994181|FG002|Overall Study|Withdrawal by Subject|9|||
149962015|NCT00806026|540994182|FG003|Overall Study|Withdrawal by Subject|2|||
149962016|NCT00806026|540994183|FG004|Overall Study|Withdrawal by Subject|5|||
149962017|NCT00806026|540994184|FG005|Overall Study|Withdrawal by Subject|3|||
149962018|NCT00806026|540994179|FG000|Overall Study|Other|3|||
149962019|NCT00806026|540994180|FG001|Overall Study|Other|6|||
149962020|NCT00806026|540994181|FG002|Overall Study|Other|8|||
149962021|NCT00806026|540994182|FG003|Overall Study|Other|2|||
149862636|NCT01564459|540626382|FG001|Double-blind Treatment|Adverse Event|0|||
149862637|NCT01564459|540626383|FG002|Double-blind Treatment|Adverse Event|1|||
149862638|NCT02080832|540626390|FG000|Overall Study|Excluded from analysis by MRI|9|||
149862639|NCT02080832|540626391|FG001|Overall Study|Excluded from analysis by MRI|10|||
149862640|NCT02080832|540626392|FG002|Overall Study|Excluded from analysis by MRI|14|||
149862641|NCT02080832|540626390|FG000|Overall Study|Lost to Follow-up|0|||
149962022|NCT00806026|540994183|FG004|Overall Study|Other|0|||
149962023|NCT00806026|540994184|FG005|Overall Study|Other|4|||
149962024|NCT00806026|540994179|FG000|Overall Study|Protocol Violation|6|||
149862642|NCT02080832|540626391|FG001|Overall Study|Lost to Follow-up|2|||
149862643|NCT02080832|540626392|FG002|Overall Study|Lost to Follow-up|2|||
149862644|NCT00560937|540626396|FG000|Overall Study|Withdrawal by Subject|0|||
149862645|NCT00560937|540626397|FG001|Overall Study|Withdrawal by Subject|1|||
149862646|NCT00560937|540626396|FG000|Overall Study|Physician Decision|1|||
149862647|NCT00560937|540626397|FG001|Overall Study|Physician Decision|1|||
149862648|NCT01118117|540626398|FG000|Overall Study|Death|8|||
149862649|NCT01118117|540626399|FG001|Overall Study|Death|0|||
149862650|NCT01118117|540626398|FG000|Overall Study|Lost to Follow-up|6|||
149862651|NCT01118117|540626399|FG001|Overall Study|Lost to Follow-up|0|||
149862652|NCT01118117|540626398|FG000|Overall Study|Missed 12 Month Visit|7|||
149862653|NCT01118117|540626399|FG001|Overall Study|Missed 12 Month Visit|0|||
149862654|NCT01660022|540626400|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
149862655|NCT01660022|540626401|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
149862656|NCT01660022|540626402|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
149862657|NCT01660022|540626403|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
150040649|NCT00790842|541289114|FG000|Dose Level 1|Adverse Event|1|||
150040650|NCT00790842|541289115|FG001|Dose Level 1|Adverse Event|0|||
150040651|NCT00790842|541289116|FG002|Dose Level 1|Adverse Event|0|||
150040652|NCT00790842|541289117|FG003|Dose Level 1|Adverse Event|2|||
150040653|NCT00790842|541289118|FG004|Dose Level 1|Adverse Event|0|||
150040654|NCT00790842|541289119|FG005|Dose Level 1|Adverse Event|0|||
150040655|NCT00790842|541289120|FG006|Dose Level 1|Adverse Event|0|||
150040656|NCT00790842|541289121|FG007|Dose Level 1|Adverse Event|1|||
150040657|NCT00790842|541289122|FG008|Dose Level 1|Adverse Event|0|||
150040658|NCT00790842|541289123|FG009|Dose Level 1|Adverse Event|0|||
150040659|NCT00790842|541289124|FG010|Dose Level 1|Adverse Event|0|||
150040660|NCT00790842|541289114|FG000|Dose Level 1|Physician Decision|1|||
150040661|NCT00790842|541289115|FG001|Dose Level 1|Physician Decision|0|||
150040662|NCT00790842|541289116|FG002|Dose Level 1|Physician Decision|0|||
150040663|NCT00790842|541289117|FG003|Dose Level 1|Physician Decision|0|||
150040664|NCT00790842|541289118|FG004|Dose Level 1|Physician Decision|0|||
150040665|NCT00790842|541289119|FG005|Dose Level 1|Physician Decision|0|||
150040666|NCT00790842|541289120|FG006|Dose Level 1|Physician Decision|0|||
150040667|NCT00790842|541289121|FG007|Dose Level 1|Physician Decision|1|||
150040668|NCT00790842|541289122|FG008|Dose Level 1|Physician Decision|0|||
150040669|NCT00790842|541289123|FG009|Dose Level 1|Physician Decision|0|||
150040670|NCT00790842|541289124|FG010|Dose Level 1|Physician Decision|0|||
149862658|NCT01660022|540626404|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
149862659|NCT01660022|540626405|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
149862660|NCT01660022|540626400|FG000|First Sequence (7 Days)|Adverse Event|0|||
149862661|NCT01660022|540626401|FG001|First Sequence (7 Days)|Adverse Event|0|||
149862662|NCT01660022|540626402|FG002|First Sequence (7 Days)|Adverse Event|0|||
149862663|NCT01660022|540626403|FG003|First Sequence (7 Days)|Adverse Event|0|||
149862664|NCT01660022|540626404|FG004|First Sequence (7 Days)|Adverse Event|1|||
149862665|NCT01660022|540626405|FG005|First Sequence (7 Days)|Adverse Event|3|||
149862666|NCT01660022|540626400|FG000|First Sequence (7 Days)|Protocol Violation|0|||
149862667|NCT01660022|540626401|FG001|First Sequence (7 Days)|Protocol Violation|0|||
149862668|NCT01660022|540626402|FG002|First Sequence (7 Days)|Protocol Violation|0|||
149862669|NCT01660022|540626403|FG003|First Sequence (7 Days)|Protocol Violation|0|||
149862670|NCT01660022|540626404|FG004|First Sequence (7 Days)|Protocol Violation|0|||
149862671|NCT01660022|540626405|FG005|First Sequence (7 Days)|Protocol Violation|1|||
149862672|NCT03545191|540626407|FG000|Overall Study|Death|1|||
149862673|NCT03545191|540626408|FG001|Overall Study|Death|0|||
149862674|NCT03545191|540626409|FG002|Overall Study|Death|0|||
149862675|NCT03545191|540626407|FG000|Overall Study|Adverse Event|4|||
149862676|NCT03545191|540626408|FG001|Overall Study|Adverse Event|2|||
149862677|NCT03545191|540626409|FG002|Overall Study|Adverse Event|7|||
149862678|NCT03545191|540626407|FG000|Overall Study|Other reasons|3|||
149862679|NCT03545191|540626408|FG001|Overall Study|Other reasons|11|||
149862680|NCT03545191|540626409|FG002|Overall Study|Other reasons|8|||
149862681|NCT03545191|540626407|FG000|Overall Study|Withdrawal by Subject|13|||
149862682|NCT03545191|540626408|FG001|Overall Study|Withdrawal by Subject|10|||
149862683|NCT03545191|540626409|FG002|Overall Study|Withdrawal by Subject|12|||
149862684|NCT03545191|540626407|FG000|Overall Study|Lost to Follow-up|1|||
149862685|NCT03545191|540626408|FG001|Overall Study|Lost to Follow-up|2|||
149862686|NCT03545191|540626409|FG002|Overall Study|Lost to Follow-up|3|||
149862687|NCT01277718|540626413|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
150040671|NCT00790842|541289114|FG000|Dose Level 1|Withdrawal by Subject|1|||
150040672|NCT00790842|541289115|FG001|Dose Level 1|Withdrawal by Subject|0|||
150040673|NCT00790842|541289116|FG002|Dose Level 1|Withdrawal by Subject|0|||
150040674|NCT00790842|541289117|FG003|Dose Level 1|Withdrawal by Subject|0|||
150040675|NCT00790842|541289118|FG004|Dose Level 1|Withdrawal by Subject|0|||
150040676|NCT00790842|541289119|FG005|Dose Level 1|Withdrawal by Subject|0|||
150040677|NCT00790842|541289120|FG006|Dose Level 1|Withdrawal by Subject|0|||
150040678|NCT00790842|541289121|FG007|Dose Level 1|Withdrawal by Subject|0|||
150040679|NCT00790842|541289122|FG008|Dose Level 1|Withdrawal by Subject|0|||
150040680|NCT00790842|541289123|FG009|Dose Level 1|Withdrawal by Subject|0|||
150040681|NCT00790842|541289124|FG010|Dose Level 1|Withdrawal by Subject|0|||
150040682|NCT00790842|541289114|FG000|Dose Level 2|Death|0|||
150040683|NCT00790842|541289115|FG001|Dose Level 2|Death|1|||
150040684|NCT00790842|541289116|FG002|Dose Level 2|Death|0|||
150040685|NCT00790842|541289117|FG003|Dose Level 2|Death|0|||
150040686|NCT00790842|541289118|FG004|Dose Level 2|Death|1|||
150040687|NCT00790842|541289119|FG005|Dose Level 2|Death|0|||
150040688|NCT00790842|541289120|FG006|Dose Level 2|Death|0|||
150040689|NCT00790842|541289121|FG007|Dose Level 2|Death|0|||
150040690|NCT00790842|541289122|FG008|Dose Level 2|Death|0|||
150040691|NCT00790842|541289123|FG009|Dose Level 2|Death|0|||
150040692|NCT00790842|541289124|FG010|Dose Level 2|Death|0|||
150040693|NCT00790842|541289114|FG000|Dose Level 2|Physician Decision|0|||
150040694|NCT00790842|541289115|FG001|Dose Level 2|Physician Decision|1|||
150040695|NCT00790842|541289116|FG002|Dose Level 2|Physician Decision|0|||
150040696|NCT00790842|541289117|FG003|Dose Level 2|Physician Decision|0|||
150040697|NCT00790842|541289118|FG004|Dose Level 2|Physician Decision|0|||
150040698|NCT00790842|541289119|FG005|Dose Level 2|Physician Decision|0|||
150040699|NCT00790842|541289120|FG006|Dose Level 2|Physician Decision|0|||
150040700|NCT00790842|541289121|FG007|Dose Level 2|Physician Decision|0|||
149962025|NCT00806026|540994180|FG001|Overall Study|Protocol Violation|9|||
149962026|NCT00806026|540994181|FG002|Overall Study|Protocol Violation|9|||
149962027|NCT00806026|540994182|FG003|Overall Study|Protocol Violation|0|||
149962028|NCT00806026|540994183|FG004|Overall Study|Protocol Violation|2|||
149962029|NCT00806026|540994184|FG005|Overall Study|Protocol Violation|3|||
149962030|NCT00806026|540994179|FG000|Overall Study|Adverse Event|52|||
149962031|NCT00806026|540994180|FG001|Overall Study|Adverse Event|35|||
149962032|NCT00806026|540994181|FG002|Overall Study|Adverse Event|44|||
149962033|NCT00806026|540994182|FG003|Overall Study|Adverse Event|17|||
149962034|NCT00806026|540994183|FG004|Overall Study|Adverse Event|9|||
149962035|NCT00806026|540994184|FG005|Overall Study|Adverse Event|9|||
149962036|NCT01903733|540994189|FG000|Overall Study|Death|23|||
149962037|NCT01903733|540994190|FG001|Overall Study|Death|54|||
149962038|NCT01903733|540994191|FG002|Overall Study|Death|30|||
149962039|NCT01903733|540994192|FG003|Overall Study|Death|98|||
149962040|NCT01903733|540994189|FG000|Overall Study|Participant refused further follow-up|35|||
149962041|NCT01903733|540994190|FG001|Overall Study|Participant refused further follow-up|38|||
149962042|NCT01903733|540994191|FG002|Overall Study|Participant refused further follow-up|13|||
149962043|NCT01903733|540994192|FG003|Overall Study|Participant refused further follow-up|9|||
149962044|NCT01903733|540994189|FG000|Overall Study|Lost to Follow-up|18|||
149962045|NCT01903733|540994190|FG001|Overall Study|Lost to Follow-up|19|||
149962046|NCT01903733|540994191|FG002|Overall Study|Lost to Follow-up|6|||
149962047|NCT01903733|540994192|FG003|Overall Study|Lost to Follow-up|9|||
149962048|NCT01903733|540994189|FG000|Overall Study|Other|10|||
149962049|NCT01903733|540994190|FG001|Overall Study|Other|15|||
149962050|NCT01903733|540994191|FG002|Overall Study|Other|12|||
149962051|NCT01903733|540994192|FG003|Overall Study|Other|3|||
149962052|NCT01903733|540994189|FG000|Overall Study|Missing|2|||
149962053|NCT01903733|540994190|FG001|Overall Study|Missing|0|||
149962054|NCT01903733|540994191|FG002|Overall Study|Missing|0|||
149962055|NCT01903733|540994192|FG003|Overall Study|Missing|0|||
149962056|NCT01903733|540994189|FG000|Overall Study|Investigator request|18|||
149962057|NCT01903733|540994190|FG001|Overall Study|Investigator request|0|||
149962058|NCT01903733|540994191|FG002|Overall Study|Investigator request|0|||
149962059|NCT01903733|540994192|FG003|Overall Study|Investigator request|0|||
149962060|NCT01248468|540994193|FG000|Overall Study|Administrative problem|1|||
149962061|NCT01248468|540994194|FG001|Overall Study|Administrative problem|0|||
149962062|NCT01248468|540994195|FG002|Overall Study|Administrative problem|0|||
149962063|NCT01248468|540994193|FG000|Overall Study|Lost to Follow-up|9|||
149962064|NCT01248468|540994194|FG001|Overall Study|Lost to Follow-up|12|||
150040701|NCT00790842|541289122|FG008|Dose Level 2|Physician Decision|0|||
150040702|NCT00790842|541289123|FG009|Dose Level 2|Physician Decision|0|||
150040703|NCT00790842|541289124|FG010|Dose Level 2|Physician Decision|0|||
150040704|NCT00790842|541289114|FG000|Dose Level 2|Withdrawal by Subject|0|||
150040705|NCT00790842|541289115|FG001|Dose Level 2|Withdrawal by Subject|1|||
150040706|NCT00790842|541289116|FG002|Dose Level 2|Withdrawal by Subject|0|||
150040707|NCT00790842|541289117|FG003|Dose Level 2|Withdrawal by Subject|0|||
150040708|NCT00790842|541289118|FG004|Dose Level 2|Withdrawal by Subject|0|||
150040709|NCT00790842|541289119|FG005|Dose Level 2|Withdrawal by Subject|0|||
150040710|NCT00790842|541289120|FG006|Dose Level 2|Withdrawal by Subject|0|||
150040711|NCT00790842|541289121|FG007|Dose Level 2|Withdrawal by Subject|0|||
150040712|NCT00790842|541289122|FG008|Dose Level 2|Withdrawal by Subject|0|||
150040713|NCT00790842|541289123|FG009|Dose Level 2|Withdrawal by Subject|0|||
150040714|NCT00790842|541289124|FG010|Dose Level 2|Withdrawal by Subject|0|||
150040715|NCT00790842|541289114|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040716|NCT00790842|541289115|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040717|NCT00790842|541289116|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040718|NCT00790842|541289117|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040719|NCT00790842|541289118|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040720|NCT00790842|541289119|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040721|NCT00790842|541289120|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040722|NCT00790842|541289121|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040723|NCT00790842|541289122|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
150040724|NCT00790842|541289123|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040725|NCT00790842|541289124|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
150040726|NCT00790842|541289114|FG000|Dose Level 3|Adverse Event|0|||
150040727|NCT00790842|541289115|FG001|Dose Level 3|Adverse Event|0|||
150040728|NCT00790842|541289116|FG002|Dose Level 3|Adverse Event|1|||
150040729|NCT00790842|541289117|FG003|Dose Level 3|Adverse Event|0|||
150040730|NCT00790842|541289118|FG004|Dose Level 3|Adverse Event|0|||
150040731|NCT00790842|541289119|FG005|Dose Level 3|Adverse Event|0|||
150040732|NCT00790842|541289120|FG006|Dose Level 3|Adverse Event|0|||
150040733|NCT00790842|541289121|FG007|Dose Level 3|Adverse Event|0|||
150040734|NCT00790842|541289122|FG008|Dose Level 3|Adverse Event|0|||
150040735|NCT00790842|541289123|FG009|Dose Level 3|Adverse Event|0|||
150040736|NCT00790842|541289124|FG010|Dose Level 3|Adverse Event|0|||
150040737|NCT00790842|541289114|FG000|Dose Level 3|Withdrawal by Subject|0|||
150040738|NCT00790842|541289115|FG001|Dose Level 3|Withdrawal by Subject|0|||
150040739|NCT00790842|541289116|FG002|Dose Level 3|Withdrawal by Subject|3|||
150040740|NCT00790842|541289117|FG003|Dose Level 3|Withdrawal by Subject|0|||
150040741|NCT00790842|541289118|FG004|Dose Level 3|Withdrawal by Subject|0|||
150040742|NCT00790842|541289119|FG005|Dose Level 3|Withdrawal by Subject|0|||
150040743|NCT00790842|541289120|FG006|Dose Level 3|Withdrawal by Subject|0|||
150040744|NCT00790842|541289121|FG007|Dose Level 3|Withdrawal by Subject|0|||
150040745|NCT00790842|541289122|FG008|Dose Level 3|Withdrawal by Subject|0|||
150040746|NCT00790842|541289123|FG009|Dose Level 3|Withdrawal by Subject|2|||
150040747|NCT00790842|541289124|FG010|Dose Level 3|Withdrawal by Subject|0|||
150040748|NCT00790842|541289114|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040749|NCT00790842|541289115|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040750|NCT00790842|541289116|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040751|NCT00790842|541289117|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040752|NCT00790842|541289118|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040753|NCT00790842|541289119|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
150040754|NCT00790842|541289120|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040755|NCT00790842|541289121|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040756|NCT00790842|541289122|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040757|NCT00790842|541289123|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040758|NCT00790842|541289124|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
150040759|NCT00790842|541289114|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040760|NCT00790842|541289115|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040761|NCT00790842|541289116|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
150040762|NCT00790842|541289117|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040763|NCT00790842|541289118|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150173794|NCT03622593|541772942|FG000|Overall Study|Protocol Violation|0|||
149862688|NCT01277718|540626414|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
149862689|NCT01277718|540626413|FG000|Period 2 - Second Intervention|Physician Decision|0|||
149862690|NCT01277718|540626414|FG001|Period 2 - Second Intervention|Physician Decision|2|||
149862691|NCT02149121|540626417|FG000|Main Study Period|Lack of Efficacy|2|||
149862692|NCT02149121|540626418|FG001|Main Study Period|Lack of Efficacy|2|||
149862693|NCT02149121|540626419|FG002|Main Study Period|Lack of Efficacy|1|||
149862694|NCT02149121|540626420|FG003|Main Study Period|Lack of Efficacy|0|||
149862695|NCT02149121|540626421|FG004|Main Study Period|Lack of Efficacy|0|||
149862696|NCT02149121|540626422|FG005|Main Study Period|Lack of Efficacy|0|||
149862697|NCT02149121|540626423|FG006|Main Study Period|Lack of Efficacy|0|||
149862698|NCT02149121|540626417|FG000|Main Study Period|Withdrawal by Subject|9|||
149862699|NCT02149121|540626418|FG001|Main Study Period|Withdrawal by Subject|5|||
149862700|NCT02149121|540626419|FG002|Main Study Period|Withdrawal by Subject|1|||
149862701|NCT02149121|540626420|FG003|Main Study Period|Withdrawal by Subject|0|||
149862702|NCT02149121|540626421|FG004|Main Study Period|Withdrawal by Subject|0|||
149862703|NCT02149121|540626422|FG005|Main Study Period|Withdrawal by Subject|0|||
149862704|NCT02149121|540626423|FG006|Main Study Period|Withdrawal by Subject|0|||
149862705|NCT02149121|540626417|FG000|Main Study Period|Adverse Event|2|||
149862706|NCT02149121|540626418|FG001|Main Study Period|Adverse Event|5|||
149862707|NCT02149121|540626419|FG002|Main Study Period|Adverse Event|1|||
149862708|NCT02149121|540626420|FG003|Main Study Period|Adverse Event|0|||
149862709|NCT02149121|540626421|FG004|Main Study Period|Adverse Event|0|||
149862710|NCT02149121|540626422|FG005|Main Study Period|Adverse Event|0|||
149862711|NCT02149121|540626423|FG006|Main Study Period|Adverse Event|0|||
149862712|NCT02149121|540626417|FG000|Main Study Period|Protocol Violation|2|||
149862713|NCT02149121|540626418|FG001|Main Study Period|Protocol Violation|0|||
149862714|NCT02149121|540626419|FG002|Main Study Period|Protocol Violation|0|||
149862715|NCT02149121|540626420|FG003|Main Study Period|Protocol Violation|0|||
149862716|NCT02149121|540626421|FG004|Main Study Period|Protocol Violation|0|||
149862717|NCT02149121|540626422|FG005|Main Study Period|Protocol Violation|0|||
149862718|NCT02149121|540626423|FG006|Main Study Period|Protocol Violation|0|||
149862719|NCT02149121|540626417|FG000|Main Study Period|Lost to Follow-up|2|||
149862720|NCT02149121|540626418|FG001|Main Study Period|Lost to Follow-up|1|||
149862721|NCT02149121|540626419|FG002|Main Study Period|Lost to Follow-up|0|||
149862722|NCT02149121|540626420|FG003|Main Study Period|Lost to Follow-up|0|||
149862723|NCT02149121|540626421|FG004|Main Study Period|Lost to Follow-up|0|||
149962065|NCT01248468|540994195|FG002|Overall Study|Lost to Follow-up|4|||
149962066|NCT01248468|540994193|FG000|Overall Study|Pregnancy|1|||
149962067|NCT01248468|540994194|FG001|Overall Study|Pregnancy|0|||
149962068|NCT01248468|540994195|FG002|Overall Study|Pregnancy|0|||
149962069|NCT01248468|540994193|FG000|Overall Study|Withdrawal by Subject|4|||
149962070|NCT01248468|540994194|FG001|Overall Study|Withdrawal by Subject|2|||
149962071|NCT01248468|540994195|FG002|Overall Study|Withdrawal by Subject|0|||
149962072|NCT00563316|540994196|FG000|Overall Study|Adverse Event|2|||
149962073|NCT00563316|540994196|FG000|Overall Study|Physician Decision|1|||
149962074|NCT00563316|540994196|FG000|Overall Study|Lost to Follow-up|2|||
149962075|NCT00563316|540994196|FG000|Overall Study|Death|1|||
149962076|NCT00563316|540994196|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
149962077|NCT00563316|540994196|FG000|Overall Study|Other|1|||
149962078|NCT00425854|540994198|FG000|Overall Study|Progressive Disease|19|||
149962079|NCT00425854|540994199|FG001|Overall Study|Progressive Disease|12|||
149962080|NCT00425854|540994198|FG000|Overall Study|Dose reduction toxicity AE|8|||
149962081|NCT00425854|540994199|FG001|Overall Study|Dose reduction toxicity AE|7|||
149962082|NCT00425854|540994198|FG000|Overall Study|Other Adverse Event|2|||
149962083|NCT00425854|540994199|FG001|Overall Study|Other Adverse Event|2|||
149962084|NCT01630811|540994205|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
149962085|NCT01630811|540994206|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
149962086|NCT04818086|540994209|FG000|Overall Study|Physician Decision|1|||
149962087|NCT04818086|540994210|FG001|Overall Study|Physician Decision|0|||
149962088|NCT04818086|540994209|FG000|Overall Study|Withdrawal by Subject|0|||
149962089|NCT04818086|540994210|FG001|Overall Study|Withdrawal by Subject|1|||
149962090|NCT06048705|540994212|FG000|Overall Study|Physician Decision|1|||
149962091|NCT06048705|540994213|FG001|Overall Study|Physician Decision|0|||
149962092|NCT06048705|540994214|FG002|Overall Study|Physician Decision|0|||
149962093|NCT06048705|540994212|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
149962094|NCT06048705|540994213|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
150173795|NCT03622593|541772943|FG001|Overall Study|Protocol Violation|0|||
149862724|NCT02149121|540626422|FG005|Main Study Period|Lost to Follow-up|0|||
149862725|NCT02149121|540626423|FG006|Main Study Period|Lost to Follow-up|0|||
149862726|NCT02149121|540626417|FG000|Main Study Period|Death|1|||
149862727|NCT02149121|540626418|FG001|Main Study Period|Death|0|||
149862728|NCT02149121|540626419|FG002|Main Study Period|Death|0|||
149862729|NCT02149121|540626420|FG003|Main Study Period|Death|0|||
149862730|NCT02149121|540626421|FG004|Main Study Period|Death|0|||
149862731|NCT02149121|540626422|FG005|Main Study Period|Death|0|||
149862732|NCT02149121|540626423|FG006|Main Study Period|Death|0|||
149862733|NCT02149121|540626417|FG000|Main Study Period|Physician Decision|1|||
149862734|NCT02149121|540626418|FG001|Main Study Period|Physician Decision|0|||
149862735|NCT02149121|540626419|FG002|Main Study Period|Physician Decision|0|||
149862736|NCT02149121|540626420|FG003|Main Study Period|Physician Decision|0|||
149862737|NCT02149121|540626421|FG004|Main Study Period|Physician Decision|0|||
149862738|NCT02149121|540626422|FG005|Main Study Period|Physician Decision|0|||
149862739|NCT02149121|540626423|FG006|Main Study Period|Physician Decision|0|||
149862740|NCT02149121|540626417|FG000|Main Study Period|Developed any malignancy|0|||
149862741|NCT02149121|540626418|FG001|Main Study Period|Developed any malignancy|1|||
149862742|NCT02149121|540626419|FG002|Main Study Period|Developed any malignancy|1|||
149862743|NCT02149121|540626420|FG003|Main Study Period|Developed any malignancy|0|||
149862744|NCT02149121|540626421|FG004|Main Study Period|Developed any malignancy|0|||
149862745|NCT02149121|540626422|FG005|Main Study Period|Developed any malignancy|0|||
149862746|NCT02149121|540626423|FG006|Main Study Period|Developed any malignancy|0|||
149862747|NCT02149121|540626417|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
149862748|NCT02149121|540626418|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
149862749|NCT02149121|540626419|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
149862750|NCT02149121|540626420|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
149862751|NCT02149121|540626421|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
149862752|NCT02149121|540626422|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
149862753|NCT02149121|540626423|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
149862754|NCT02149121|540626417|FG000|Main Study Period|Disease progression|0|||
149862755|NCT02149121|540626418|FG001|Main Study Period|Disease progression|1|||
149862756|NCT02149121|540626419|FG002|Main Study Period|Disease progression|0|||
149862757|NCT02149121|540626420|FG003|Main Study Period|Disease progression|0|||
149862758|NCT02149121|540626421|FG004|Main Study Period|Disease progression|0|||
149862759|NCT02149121|540626422|FG005|Main Study Period|Disease progression|0|||
149862760|NCT02149121|540626423|FG006|Main Study Period|Disease progression|0|||
149862761|NCT02149121|540626417|FG000|Extension Study Period|Withdrawal by Subject|0|||
149862762|NCT02149121|540626418|FG001|Extension Study Period|Withdrawal by Subject|0|||
149862763|NCT02149121|540626419|FG002|Extension Study Period|Withdrawal by Subject|0|||
149862764|NCT02149121|540626420|FG003|Extension Study Period|Withdrawal by Subject|1|||
149862765|NCT02149121|540626421|FG004|Extension Study Period|Withdrawal by Subject|0|||
149862766|NCT02149121|540626422|FG005|Extension Study Period|Withdrawal by Subject|2|||
149862767|NCT02149121|540626423|FG006|Extension Study Period|Withdrawal by Subject|0|||
149862768|NCT03166124|540626432|FG000|Treatment Period 1|Adverse Event|0|||
149862769|NCT03166124|540626433|FG001|Treatment Period 1|Adverse Event|0|||
149862770|NCT03166124|540626434|FG002|Treatment Period 1|Adverse Event|1|||
149862771|NCT03166124|540626435|FG003|Treatment Period 1|Adverse Event|0|||
149862772|NCT03166124|540626432|FG000|Wash-out Period|Withdrawal by Subject|0|||
149862773|NCT03166124|540626433|FG001|Wash-out Period|Withdrawal by Subject|1|||
149862774|NCT03166124|540626434|FG002|Wash-out Period|Withdrawal by Subject|0|||
149862775|NCT03166124|540626435|FG003|Wash-out Period|Withdrawal by Subject|1|||
149862776|NCT03166124|540626432|FG000|Wash-out Period|Adverse Event|0|||
149862777|NCT03166124|540626433|FG001|Wash-out Period|Adverse Event|1|||
149862778|NCT03166124|540626434|FG002|Wash-out Period|Adverse Event|1|||
149862779|NCT03166124|540626435|FG003|Wash-out Period|Adverse Event|0|||
149862780|NCT00788593|540626438|FG000|Placebo Run-in Phase|Adverse Event|2|||
149862781|NCT00788593|540626439|FG001|Placebo Run-in Phase|Adverse Event|0|||
149862782|NCT00788593|540626440|FG002|Placebo Run-in Phase|Adverse Event|0|||
149862783|NCT00788593|540626438|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
149862784|NCT00788593|540626439|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
149862785|NCT00788593|540626440|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
149862786|NCT00788593|540626438|FG000|Placebo Run-in Phase|Protocol Violation|2|||
149862787|NCT00788593|540626439|FG001|Placebo Run-in Phase|Protocol Violation|0|||
149862788|NCT00788593|540626440|FG002|Placebo Run-in Phase|Protocol Violation|0|||
149962095|NCT06048705|540994214|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
149862789|NCT00788593|540626438|FG000|First Intervention Period|Adverse Event|0|||
149862790|NCT00788593|540626439|FG001|First Intervention Period|Adverse Event|1|||
149862791|NCT00788593|540626440|FG002|First Intervention Period|Adverse Event|0|||
149862792|NCT00788593|540626438|FG000|Second Intervention Period|Lost to Follow-up|0|||
149862793|NCT00788593|540626439|FG001|Second Intervention Period|Lost to Follow-up|1|||
149862794|NCT00788593|540626440|FG002|Second Intervention Period|Lost to Follow-up|0|||
149862795|NCT00788593|540626438|FG000|Second Intervention Period|Other|0|||
149862796|NCT00788593|540626439|FG001|Second Intervention Period|Other|0|||
149862797|NCT00788593|540626440|FG002|Second Intervention Period|Other|1|||
149862798|NCT02655016|540626443|FG000|Overall Study|Disease progression|6|||
149862799|NCT02655016|540626444|FG001|Overall Study|Disease progression|4|||
149862800|NCT02655016|540626443|FG000|Overall Study|Site closed|0|||
149862801|NCT02655016|540626444|FG001|Overall Study|Site closed|1|||
149862802|NCT02655016|540626443|FG000|Overall Study|Death|30|||
149862803|NCT02655016|540626444|FG001|Overall Study|Death|48|||
149862804|NCT02655016|540626443|FG000|Overall Study|Lost to Follow-up|1|||
149862805|NCT02655016|540626444|FG001|Overall Study|Lost to Follow-up|1|||
149862806|NCT02655016|540626443|FG000|Overall Study|Withdrawal by Subject|18|||
149862807|NCT02655016|540626444|FG001|Overall Study|Withdrawal by Subject|36|||
149862808|NCT04459715|540626445|FG000|Overall Study|Adverse Event|3|||
149862809|NCT04459715|540626446|FG001|Overall Study|Adverse Event|3|||
149862810|NCT04459715|540626445|FG000|Overall Study|Death|111|||
149862811|NCT04459715|540626446|FG001|Overall Study|Death|93|||
149862812|NCT04459715|540626445|FG000|Overall Study|Lost to Follow-up|10|||
149862813|NCT04459715|540626446|FG001|Overall Study|Lost to Follow-up|9|||
149862814|NCT04459715|540626445|FG000|Overall Study|Other Reasons|4|||
149862815|NCT04459715|540626446|FG001|Overall Study|Other Reasons|5|||
149862816|NCT04459715|540626445|FG000|Overall Study|PROTOCOL DEVIATION|0|||
149862817|NCT04459715|540626446|FG001|Overall Study|PROTOCOL DEVIATION|1|||
149862818|NCT04459715|540626445|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
149862819|NCT04459715|540626446|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
149862820|NCT04459715|540626445|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
149862821|NCT04459715|540626446|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
149862822|NCT04459715|540626445|FG000|Overall Study|Withdrawal by Subject|22|||
149862823|NCT04459715|540626446|FG001|Overall Study|Withdrawal by Subject|22|||
149862824|NCT00952276|540626447|FG000|Overall Study|Withdrawal by Subject|1|||
149862825|NCT00952276|540626448|FG001|Overall Study|Withdrawal by Subject|0|||
149862826|NCT00952276|540626449|FG002|Overall Study|Withdrawal by Subject|0|||
149862827|NCT00952276|540626450|FG003|Overall Study|Withdrawal by Subject|1|||
149862828|NCT00952276|540626451|FG004|Overall Study|Withdrawal by Subject|0|||
149862829|NCT02427984|540626452|FG000|Overall Study|Lost to Follow-up|13|||
149862830|NCT02427984|540626453|FG001|Overall Study|Lost to Follow-up|5|||
149862831|NCT02427984|540626454|FG002|Overall Study|Lost to Follow-up|18|||
149862832|NCT00897949|540628504|FG000|Overall Study|Adverse Event|1|||
149862833|NCT00897949|540628505|FG001|Overall Study|Adverse Event|1|||
149862834|NCT00897949|540628506|FG002|Overall Study|Adverse Event|0|||
149862835|NCT00897949|540628504|FG000|Overall Study|Lost to Follow-up|0|||
149862836|NCT00897949|540628505|FG001|Overall Study|Lost to Follow-up|2|||
149862837|NCT00897949|540628506|FG002|Overall Study|Lost to Follow-up|1|||
149862838|NCT00897949|540628504|FG000|Overall Study|Protocol Violation|6|||
149862839|NCT00897949|540628505|FG001|Overall Study|Protocol Violation|3|||
149862840|NCT00897949|540628506|FG002|Overall Study|Protocol Violation|1|||
149862841|NCT00897949|540628504|FG000|Overall Study|Withdrawal by Subject|1|||
149862842|NCT00897949|540628505|FG001|Overall Study|Withdrawal by Subject|2|||
149862843|NCT00897949|540628506|FG002|Overall Study|Withdrawal by Subject|0|||
149862844|NCT00897949|540628504|FG000|Overall Study|Patient Uncoorperative|0|||
149862845|NCT00897949|540628505|FG001|Overall Study|Patient Uncoorperative|2|||
149862846|NCT00897949|540628506|FG002|Overall Study|Patient Uncoorperative|1|||
149862847|NCT00897949|540628504|FG000|Overall Study|Lost to Follow-up|30|||
149862848|NCT00897949|540628505|FG001|Overall Study|Lost to Follow-up|23|||
149862849|NCT00897949|540628506|FG002|Overall Study|Lost to Follow-up|17|||
149862850|NCT00897949|540628504|FG000|Overall Study|Withdrawal by Subject|24|||
149862851|NCT00897949|540628505|FG001|Overall Study|Withdrawal by Subject|31|||
149862852|NCT00897949|540628506|FG002|Overall Study|Withdrawal by Subject|17|||
149862853|NCT00897949|540628504|FG000|Overall Study|Abnormal Prestudy Labs|2|||
149862854|NCT00897949|540628505|FG001|Overall Study|Abnormal Prestudy Labs|3|||
149862855|NCT00897949|540628506|FG002|Overall Study|Abnormal Prestudy Labs|4|||
149862856|NCT00897949|540628504|FG000|Overall Study|Abnormal Baseline ECG|2|||
149862857|NCT00897949|540628505|FG001|Overall Study|Abnormal Baseline ECG|2|||
149862858|NCT00897949|540628506|FG002|Overall Study|Abnormal Baseline ECG|4|||
149862859|NCT00897949|540628504|FG000|Overall Study|Need for Concom. Med.|0|||
149862860|NCT00897949|540628505|FG001|Overall Study|Need for Concom. Med.|1|||
149862861|NCT00897949|540628506|FG002|Overall Study|Need for Concom. Med.|1|||
149862862|NCT00897949|540628504|FG000|Overall Study|Lack of Migraine Attack|29|||
149862863|NCT00897949|540628505|FG001|Overall Study|Lack of Migraine Attack|30|||
149862864|NCT00897949|540628506|FG002|Overall Study|Lack of Migraine Attack|19|||
149862865|NCT00897949|540628504|FG000|Overall Study|Did not take study drug|9|||
149862866|NCT00897949|540628505|FG001|Overall Study|Did not take study drug|3|||
149862867|NCT00897949|540628506|FG002|Overall Study|Did not take study drug|4|||
149862868|NCT01763918|540628507|FG000|Overall Study|Withdrawal by Subject|2|||
149862869|NCT01763918|540628508|FG001|Overall Study|Withdrawal by Subject|1|||
149862870|NCT01763918|540628509|FG002|Overall Study|Withdrawal by Subject|1|||
149862871|NCT01763918|540628510|FG003|Overall Study|Withdrawal by Subject|2|||
149862872|NCT01763918|540628507|FG000|Overall Study|Sponsor Decision|4|||
149862873|NCT01763918|540628508|FG001|Overall Study|Sponsor Decision|0|||
149862874|NCT01763918|540628509|FG002|Overall Study|Sponsor Decision|9|||
149862875|NCT01763918|540628510|FG003|Overall Study|Sponsor Decision|0|||
149862876|NCT01553747|540628511|FG000|Overall Study|Protocol Violation|0|||
149862877|NCT01553747|540628512|FG001|Overall Study|Protocol Violation|2|||
149862878|NCT01553747|540628513|FG002|Overall Study|Protocol Violation|0|||
149862879|NCT01553747|540628511|FG000|Overall Study|Voluntarily withdrew|70|||
149862880|NCT01553747|540628512|FG001|Overall Study|Voluntarily withdrew|66|||
149862881|NCT01553747|540628513|FG002|Overall Study|Voluntarily withdrew|74|||
149862882|NCT01553747|540628511|FG000|Overall Study|Adverse event or SAE|32|||
149862883|NCT01553747|540628512|FG001|Overall Study|Adverse event or SAE|28|||
149862884|NCT01553747|540628513|FG002|Overall Study|Adverse event or SAE|19|||
149862885|NCT01553747|540628511|FG000|Overall Study|Physician decision: other|10|||
149862886|NCT01553747|540628512|FG001|Overall Study|Physician decision: other|8|||
149862887|NCT01553747|540628513|FG002|Overall Study|Physician decision: other|7|||
149862888|NCT01553747|540628511|FG000|Overall Study|Lost to Follow-up|11|||
149862889|NCT01553747|540628512|FG001|Overall Study|Lost to Follow-up|5|||
149862890|NCT01553747|540628513|FG002|Overall Study|Lost to Follow-up|6|||
149862891|NCT01553747|540628511|FG000|Overall Study|Sponsor decision, specify|7|||
149862892|NCT01553747|540628512|FG001|Overall Study|Sponsor decision, specify|5|||
149862893|NCT01553747|540628513|FG002|Overall Study|Sponsor decision, specify|0|||
149862894|NCT01553747|540628511|FG000|Overall Study|Physician decision: lack of efficacy|1|||
149862895|NCT01553747|540628512|FG001|Overall Study|Physician decision: lack of efficacy|5|||
149862896|NCT01553747|540628513|FG002|Overall Study|Physician decision: lack of efficacy|3|||
149862897|NCT00102687|540628514|FG000|Initial Period|Withdrawal by Subject|6|||
149862898|NCT00102687|540628515|FG001|Initial Period|Withdrawal by Subject|3|||
149862899|NCT00102687|540628516|FG002|Initial Period|Withdrawal by Subject|5|||
149862900|NCT00102687|540628517|FG003|Initial Period|Withdrawal by Subject|0|||
149862901|NCT00102687|540628518|FG004|Initial Period|Withdrawal by Subject|0|||
149862902|NCT00102687|540628514|FG000|Initial Period|Adverse Event|4|||
149862903|NCT00102687|540628515|FG001|Initial Period|Adverse Event|7|||
149862904|NCT00102687|540628516|FG002|Initial Period|Adverse Event|9|||
149862905|NCT00102687|540628517|FG003|Initial Period|Adverse Event|0|||
149862906|NCT00102687|540628518|FG004|Initial Period|Adverse Event|0|||
149862907|NCT00102687|540628514|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
149862908|NCT00102687|540628515|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
149862909|NCT00102687|540628516|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
149862910|NCT00102687|540628517|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
149862911|NCT00102687|540628518|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
149862912|NCT00102687|540628514|FG000|Initial Period|Protocol Violation|0|||
149862913|NCT00102687|540628515|FG001|Initial Period|Protocol Violation|0|||
149862914|NCT00102687|540628516|FG002|Initial Period|Protocol Violation|2|||
149862915|NCT00102687|540628517|FG003|Initial Period|Protocol Violation|0|||
149862916|NCT00102687|540628518|FG004|Initial Period|Protocol Violation|0|||
149862917|NCT00102687|540628514|FG000|Initial Period|Physician Decision|2|||
149862918|NCT00102687|540628515|FG001|Initial Period|Physician Decision|9|||
149862919|NCT00102687|540628516|FG002|Initial Period|Physician Decision|6|||
149862920|NCT00102687|540628517|FG003|Initial Period|Physician Decision|0|||
149862921|NCT00102687|540628518|FG004|Initial Period|Physician Decision|0|||
149862922|NCT00102687|540628514|FG000|Initial Period|Sponsor's decision|0|||
149862923|NCT00102687|540628515|FG001|Initial Period|Sponsor's decision|1|||
149862924|NCT00102687|540628516|FG002|Initial Period|Sponsor's decision|1|||
149862925|NCT00102687|540628517|FG003|Initial Period|Sponsor's decision|0|||
149862926|NCT00102687|540628518|FG004|Initial Period|Sponsor's decision|0|||
149862927|NCT00102687|540628514|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
149862928|NCT00102687|540628515|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
149862929|NCT00102687|540628516|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
149862930|NCT00102687|540628517|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
149862931|NCT00102687|540628518|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
149862932|NCT00102687|540628514|FG000|Initial Period|Death|1|||
149862933|NCT00102687|540628515|FG001|Initial Period|Death|1|||
149862934|NCT00102687|540628516|FG002|Initial Period|Death|1|||
149862935|NCT00102687|540628517|FG003|Initial Period|Death|0|||
149862936|NCT00102687|540628518|FG004|Initial Period|Death|0|||
149962096|NCT06048705|540994212|FG000|Overall Study|Death prior to lymphodepletion|0|||
149962097|NCT06048705|540994213|FG001|Overall Study|Death prior to lymphodepletion|0|||
149962098|NCT06048705|540994214|FG002|Overall Study|Death prior to lymphodepletion|1|||
149862937|NCT00102687|540628514|FG000|Maintenance Period|Withdrawal by Subject|4|||
149862938|NCT00102687|540628515|FG001|Maintenance Period|Withdrawal by Subject|0|||
149862939|NCT00102687|540628516|FG002|Maintenance Period|Withdrawal by Subject|2|||
149862940|NCT00102687|540628517|FG003|Maintenance Period|Withdrawal by Subject|3|||
149862941|NCT00102687|540628518|FG004|Maintenance Period|Withdrawal by Subject|1|||
149862942|NCT00102687|540628514|FG000|Maintenance Period|Adverse Event|1|||
149862943|NCT00102687|540628515|FG001|Maintenance Period|Adverse Event|0|||
149862944|NCT00102687|540628516|FG002|Maintenance Period|Adverse Event|0|||
149862945|NCT00102687|540628517|FG003|Maintenance Period|Adverse Event|1|||
149862946|NCT00102687|540628518|FG004|Maintenance Period|Adverse Event|3|||
149862947|NCT00102687|540628514|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
149862948|NCT00102687|540628515|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
149862949|NCT00102687|540628516|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
149862950|NCT00102687|540628517|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
149862951|NCT00102687|540628518|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
149862952|NCT00102687|540628514|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
149862953|NCT00102687|540628515|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
149862954|NCT00102687|540628516|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
149862955|NCT00102687|540628517|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
149862956|NCT00102687|540628518|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
149862957|NCT00102687|540628514|FG000|Maintenance Period|Death|0|||
149862958|NCT00102687|540628515|FG001|Maintenance Period|Death|0|||
149862959|NCT00102687|540628516|FG002|Maintenance Period|Death|0|||
149862960|NCT00102687|540628517|FG003|Maintenance Period|Death|1|||
149862961|NCT00102687|540628518|FG004|Maintenance Period|Death|1|||
149862962|NCT00102687|540628514|FG000|Maintenance Period|Physician Decision|1|||
149862963|NCT00102687|540628515|FG001|Maintenance Period|Physician Decision|2|||
149862964|NCT00102687|540628516|FG002|Maintenance Period|Physician Decision|3|||
149862965|NCT00102687|540628517|FG003|Maintenance Period|Physician Decision|0|||
149862966|NCT00102687|540628518|FG004|Maintenance Period|Physician Decision|4|||
149862967|NCT02408120|540628520|FG000|Overall Study|Withdrawal by Subject|0|||
149862968|NCT02408120|540628521|FG001|Overall Study|Withdrawal by Subject|1|||
149862969|NCT02408120|540628520|FG000|Overall Study|Treatment Refusal|1|||
149862970|NCT02408120|540628521|FG001|Overall Study|Treatment Refusal|0|||
149862971|NCT02408120|540628520|FG000|Overall Study|Received Steroids|1|||
149862972|NCT02408120|540628521|FG001|Overall Study|Received Steroids|1|||
149862973|NCT02408120|540628520|FG000|Overall Study|Discharged same day|1|||
149862974|NCT02408120|540628521|FG001|Overall Study|Discharged same day|1|||
149862975|NCT02408120|540628520|FG000|Overall Study|Did not receive insulin|1|||
149862976|NCT02408120|540628521|FG001|Overall Study|Did not receive insulin|2|||
149862977|NCT00977431|540628527|FG000|Overall Study|Other than listed|1|||
149862978|NCT00977431|540628528|FG001|Overall Study|Other than listed|0|||
149862979|NCT00977431|540628529|FG002|Overall Study|Other than listed|0|||
149862980|NCT00977431|540628530|FG003|Overall Study|Other than listed|0|||
149862981|NCT00977431|540628531|FG004|Overall Study|Other than listed|2|||
149862982|NCT00977431|540628527|FG000|Overall Study|Protocol Violation|0|||
149862983|NCT00977431|540628528|FG001|Overall Study|Protocol Violation|0|||
149862984|NCT00977431|540628529|FG002|Overall Study|Protocol Violation|1|||
149862985|NCT00977431|540628530|FG003|Overall Study|Protocol Violation|0|||
149862986|NCT00977431|540628531|FG004|Overall Study|Protocol Violation|0|||
149862987|NCT00977431|540628527|FG000|Overall Study|Adverse Event|3|||
149862988|NCT00977431|540628528|FG001|Overall Study|Adverse Event|0|||
149862989|NCT00977431|540628529|FG002|Overall Study|Adverse Event|4|||
149862990|NCT00977431|540628530|FG003|Overall Study|Adverse Event|0|||
149862991|NCT00977431|540628531|FG004|Overall Study|Adverse Event|6|||
149862992|NCT00977431|540628527|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
149862993|NCT00977431|540628528|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
149862994|NCT00977431|540628529|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
149862995|NCT00977431|540628530|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
149862996|NCT00977431|540628531|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
149862997|NCT00977431|540628527|FG000|Overall Study|Progressive disease|2|||
149862998|NCT00977431|540628528|FG001|Overall Study|Progressive disease|6|||
149862999|NCT00977431|540628529|FG002|Overall Study|Progressive disease|1|||
149863000|NCT00977431|540628530|FG003|Overall Study|Progressive disease|3|||
149863001|NCT00977431|540628531|FG004|Overall Study|Progressive disease|5|||
149863002|NCT03739138|540628532|FG000|Overall Study|Death|0|||
149863003|NCT03739138|540628533|FG001|Overall Study|Death|7|||
149863004|NCT03739138|540628534|FG002|Overall Study|Death|4|||
149863005|NCT03739138|540628535|FG003|Overall Study|Death|13|||
149962099|NCT02113878|540995794|FG000|Overall Study|Adverse Event|1|||
149962100|NCT02113878|540995795|FG001|Overall Study|Adverse Event|0|||
149962101|NCT02113878|540995794|FG000|Overall Study|Withdrawal by Subject|1|||
149863006|NCT03739138|540628536|FG004|Overall Study|Death|0|||
149863007|NCT03739138|540628532|FG000|Overall Study|Lost to Follow-up|0|||
149863008|NCT03739138|540628533|FG001|Overall Study|Lost to Follow-up|0|||
149863009|NCT03739138|540628534|FG002|Overall Study|Lost to Follow-up|1|||
149863010|NCT03739138|540628535|FG003|Overall Study|Lost to Follow-up|0|||
149863011|NCT03739138|540628536|FG004|Overall Study|Lost to Follow-up|0|||
149863012|NCT03739138|540628532|FG000|Overall Study|Study Terminated By Sponsor|0|||
149863013|NCT03739138|540628533|FG001|Overall Study|Study Terminated By Sponsor|0|||
149863014|NCT03739138|540628534|FG002|Overall Study|Study Terminated By Sponsor|0|||
149863015|NCT03739138|540628535|FG003|Overall Study|Study Terminated By Sponsor|4|||
149863016|NCT03739138|540628536|FG004|Overall Study|Study Terminated By Sponsor|0|||
149863017|NCT03739138|540628532|FG000|Overall Study|Withdrawal by Subject|0|||
149863018|NCT03739138|540628533|FG001|Overall Study|Withdrawal by Subject|0|||
149863019|NCT03739138|540628534|FG002|Overall Study|Withdrawal by Subject|0|||
149863020|NCT03739138|540628535|FG003|Overall Study|Withdrawal by Subject|1|||
149863021|NCT03739138|540628536|FG004|Overall Study|Withdrawal by Subject|0|||
149863022|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
149863023|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
149863024|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
149863025|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
149863026|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
149863027|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
149863028|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
149863029|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
149863030|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
149863031|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
149863032|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Subject decision|1|||
149863033|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Subject decision|1|||
149863034|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
149863035|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
149863036|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
149863037|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
149863038|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
149863039|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
149863040|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
149863041|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
149863042|NCT00518882|540628539|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
149863043|NCT00518882|540628540|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
149863044|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
149863045|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
149863046|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
149863047|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
149863048|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
149863049|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
149863050|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
149863051|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
149863052|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
149863053|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
149863054|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
149863055|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
149863056|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
149863057|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
149863058|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
149863059|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
149863060|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
149863061|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
149863062|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
149863063|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
149863064|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
149863065|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
149863066|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
149863067|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
149863068|NCT00518882|540628539|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
149863069|NCT00518882|540628540|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
149863070|NCT02696031|540628542|FG000|Up to Week 24|Adverse Event|2|||
149863071|NCT02696031|540628543|FG001|Up to Week 24|Adverse Event|4|||
149863072|NCT02696031|540628544|FG002|Up to Week 24|Adverse Event|2|||
149863073|NCT02696031|540628545|FG003|Up to Week 24|Adverse Event|0|||
149863074|NCT02696031|540628546|FG004|Up to Week 24|Adverse Event|0|||
149863075|NCT02696031|540628547|FG005|Up to Week 24|Adverse Event|0|||
149863076|NCT02696031|540628542|FG000|Up to Week 24|Lack of Efficacy|2|||
149863077|NCT02696031|540628543|FG001|Up to Week 24|Lack of Efficacy|1|||
149863078|NCT02696031|540628544|FG002|Up to Week 24|Lack of Efficacy|2|||
149863079|NCT02696031|540628545|FG003|Up to Week 24|Lack of Efficacy|0|||
149863080|NCT02696031|540628546|FG004|Up to Week 24|Lack of Efficacy|0|||
149863081|NCT02696031|540628547|FG005|Up to Week 24|Lack of Efficacy|0|||
149863082|NCT02696031|540628542|FG000|Up to Week 24|Lost to Follow-up|0|||
149863083|NCT02696031|540628543|FG001|Up to Week 24|Lost to Follow-up|1|||
149863084|NCT02696031|540628544|FG002|Up to Week 24|Lost to Follow-up|1|||
149863085|NCT02696031|540628545|FG003|Up to Week 24|Lost to Follow-up|0|||
149863086|NCT02696031|540628546|FG004|Up to Week 24|Lost to Follow-up|0|||
149863087|NCT02696031|540628547|FG005|Up to Week 24|Lost to Follow-up|0|||
149863088|NCT02696031|540628542|FG000|Up to Week 24|Physician Decision|1|||
149863089|NCT02696031|540628543|FG001|Up to Week 24|Physician Decision|0|||
149863090|NCT02696031|540628544|FG002|Up to Week 24|Physician Decision|1|||
149863091|NCT02696031|540628545|FG003|Up to Week 24|Physician Decision|0|||
149863092|NCT02696031|540628546|FG004|Up to Week 24|Physician Decision|0|||
149863093|NCT02696031|540628547|FG005|Up to Week 24|Physician Decision|0|||
149863094|NCT02696031|540628542|FG000|Up to Week 24|Protocol Violation|1|||
149863095|NCT02696031|540628543|FG001|Up to Week 24|Protocol Violation|0|||
149863096|NCT02696031|540628544|FG002|Up to Week 24|Protocol Violation|0|||
149863097|NCT02696031|540628545|FG003|Up to Week 24|Protocol Violation|0|||
149863098|NCT02696031|540628546|FG004|Up to Week 24|Protocol Violation|0|||
149863099|NCT02696031|540628547|FG005|Up to Week 24|Protocol Violation|0|||
149863100|NCT02696031|540628542|FG000|Up to Week 24|Withdrawal by Subject|4|||
149863101|NCT02696031|540628543|FG001|Up to Week 24|Withdrawal by Subject|1|||
149863102|NCT02696031|540628544|FG002|Up to Week 24|Withdrawal by Subject|5|||
149863103|NCT02696031|540628545|FG003|Up to Week 24|Withdrawal by Subject|0|||
149863104|NCT02696031|540628546|FG004|Up to Week 24|Withdrawal by Subject|0|||
149863105|NCT02696031|540628547|FG005|Up to Week 24|Withdrawal by Subject|0|||
149863106|NCT02696031|540628542|FG000|Up to Week 52|Adverse Event|4|||
149863107|NCT02696031|540628543|FG001|Up to Week 52|Adverse Event|5|||
149863108|NCT02696031|540628544|FG002|Up to Week 52|Adverse Event|3|||
149863109|NCT02696031|540628545|FG003|Up to Week 52|Adverse Event|0|||
149863110|NCT02696031|540628546|FG004|Up to Week 52|Adverse Event|0|||
149863111|NCT02696031|540628547|FG005|Up to Week 52|Adverse Event|0|||
149863112|NCT02696031|540628542|FG000|Up to Week 52|Lack of Efficacy|10|||
149863113|NCT02696031|540628543|FG001|Up to Week 52|Lack of Efficacy|7|||
149863114|NCT02696031|540628544|FG002|Up to Week 52|Lack of Efficacy|11|||
149863115|NCT02696031|540628545|FG003|Up to Week 52|Lack of Efficacy|0|||
149863116|NCT02696031|540628546|FG004|Up to Week 52|Lack of Efficacy|0|||
149863117|NCT02696031|540628547|FG005|Up to Week 52|Lack of Efficacy|0|||
149863118|NCT02696031|540628542|FG000|Up to Week 52|Lost to Follow-up|1|||
149863119|NCT02696031|540628543|FG001|Up to Week 52|Lost to Follow-up|1|||
149863120|NCT02696031|540628544|FG002|Up to Week 52|Lost to Follow-up|1|||
149863121|NCT02696031|540628545|FG003|Up to Week 52|Lost to Follow-up|0|||
149863122|NCT02696031|540628546|FG004|Up to Week 52|Lost to Follow-up|0|||
149863123|NCT02696031|540628547|FG005|Up to Week 52|Lost to Follow-up|0|||
149863124|NCT02696031|540628542|FG000|Up to Week 52|Physician Decision|1|||
149863125|NCT02696031|540628543|FG001|Up to Week 52|Physician Decision|1|||
149863126|NCT02696031|540628544|FG002|Up to Week 52|Physician Decision|2|||
149863127|NCT02696031|540628545|FG003|Up to Week 52|Physician Decision|0|||
149863128|NCT02696031|540628546|FG004|Up to Week 52|Physician Decision|0|||
149863129|NCT02696031|540628547|FG005|Up to Week 52|Physician Decision|0|||
149863130|NCT02696031|540628542|FG000|Up to Week 52|Pregnancy|0|||
149863131|NCT02696031|540628543|FG001|Up to Week 52|Pregnancy|2|||
149863132|NCT02696031|540628544|FG002|Up to Week 52|Pregnancy|0|||
149863133|NCT02696031|540628545|FG003|Up to Week 52|Pregnancy|0|||
149863134|NCT02696031|540628546|FG004|Up to Week 52|Pregnancy|0|||
149863135|NCT02696031|540628547|FG005|Up to Week 52|Pregnancy|0|||
149863136|NCT02696031|540628542|FG000|Up to Week 52|Protocol Violation|1|||
149863137|NCT02696031|540628543|FG001|Up to Week 52|Protocol Violation|0|||
149863138|NCT02696031|540628544|FG002|Up to Week 52|Protocol Violation|0|||
149863139|NCT02696031|540628545|FG003|Up to Week 52|Protocol Violation|0|||
149863140|NCT02696031|540628546|FG004|Up to Week 52|Protocol Violation|0|||
149863141|NCT02696031|540628547|FG005|Up to Week 52|Protocol Violation|0|||
149863142|NCT02696031|540628542|FG000|Up to Week 52|Withdrawal by Subject|12|||
149863143|NCT02696031|540628543|FG001|Up to Week 52|Withdrawal by Subject|3|||
149863144|NCT02696031|540628544|FG002|Up to Week 52|Withdrawal by Subject|9|||
149863145|NCT02696031|540628545|FG003|Up to Week 52|Withdrawal by Subject|0|||
149863146|NCT02696031|540628546|FG004|Up to Week 52|Withdrawal by Subject|0|||
149962102|NCT02113878|540995795|FG001|Overall Study|Withdrawal by Subject|0|||
150173796|NCT03622593|541772944|FG002|Overall Study|Protocol Violation|1|||
149863147|NCT02696031|540628547|FG005|Up to Week 52|Withdrawal by Subject|0|||
149863148|NCT02696031|540628542|FG000|Up to Week 104|Pregnancy|0|||
149863149|NCT02696031|540628543|FG001|Up to Week 104|Pregnancy|2|||
149863150|NCT02696031|540628544|FG002|Up to Week 104|Pregnancy|1|||
149863151|NCT02696031|540628545|FG003|Up to Week 104|Pregnancy|0|||
149863152|NCT02696031|540628546|FG004|Up to Week 104|Pregnancy|0|||
149863153|NCT02696031|540628547|FG005|Up to Week 104|Pregnancy|0|||
149863154|NCT02696031|540628542|FG000|Up to Week 104|Withdrawal by Subject|15|||
149863155|NCT02696031|540628543|FG001|Up to Week 104|Withdrawal by Subject|10|||
149863156|NCT02696031|540628544|FG002|Up to Week 104|Withdrawal by Subject|16|||
149863157|NCT02696031|540628545|FG003|Up to Week 104|Withdrawal by Subject|0|||
149863158|NCT02696031|540628546|FG004|Up to Week 104|Withdrawal by Subject|0|||
149863159|NCT02696031|540628547|FG005|Up to Week 104|Withdrawal by Subject|0|||
149863160|NCT02696031|540628542|FG000|Up to Week 104|Protocol Violation|1|||
149863161|NCT02696031|540628543|FG001|Up to Week 104|Protocol Violation|0|||
149863162|NCT02696031|540628544|FG002|Up to Week 104|Protocol Violation|0|||
149863163|NCT02696031|540628545|FG003|Up to Week 104|Protocol Violation|0|||
149863164|NCT02696031|540628546|FG004|Up to Week 104|Protocol Violation|0|||
149863165|NCT02696031|540628547|FG005|Up to Week 104|Protocol Violation|0|||
149863166|NCT02696031|540628542|FG000|Up to Week 104|Physician Decision|1|||
149863167|NCT02696031|540628543|FG001|Up to Week 104|Physician Decision|2|||
149863168|NCT02696031|540628544|FG002|Up to Week 104|Physician Decision|3|||
149863169|NCT02696031|540628545|FG003|Up to Week 104|Physician Decision|0|||
149863170|NCT02696031|540628546|FG004|Up to Week 104|Physician Decision|0|||
149863171|NCT02696031|540628547|FG005|Up to Week 104|Physician Decision|0|||
149863172|NCT02696031|540628542|FG000|Up to Week 104|Lost to Follow-up|2|||
149863173|NCT02696031|540628543|FG001|Up to Week 104|Lost to Follow-up|3|||
149863174|NCT02696031|540628544|FG002|Up to Week 104|Lost to Follow-up|1|||
149863175|NCT02696031|540628545|FG003|Up to Week 104|Lost to Follow-up|0|||
149863176|NCT02696031|540628546|FG004|Up to Week 104|Lost to Follow-up|0|||
149863177|NCT02696031|540628547|FG005|Up to Week 104|Lost to Follow-up|0|||
149863178|NCT02696031|540628542|FG000|Up to Week 104|Lack of Efficacy|13|||
149863179|NCT02696031|540628543|FG001|Up to Week 104|Lack of Efficacy|12|||
149863180|NCT02696031|540628544|FG002|Up to Week 104|Lack of Efficacy|11|||
149863181|NCT02696031|540628545|FG003|Up to Week 104|Lack of Efficacy|0|||
149863182|NCT02696031|540628546|FG004|Up to Week 104|Lack of Efficacy|0|||
149863183|NCT02696031|540628547|FG005|Up to Week 104|Lack of Efficacy|0|||
149863184|NCT02696031|540628542|FG000|Up to Week 104|Adverse Event|7|||
149863185|NCT02696031|540628543|FG001|Up to Week 104|Adverse Event|11|||
149863186|NCT02696031|540628544|FG002|Up to Week 104|Adverse Event|5|||
149863187|NCT02696031|540628545|FG003|Up to Week 104|Adverse Event|0|||
149863188|NCT02696031|540628546|FG004|Up to Week 104|Adverse Event|0|||
149863189|NCT02696031|540628547|FG005|Up to Week 104|Adverse Event|0|||
149863190|NCT02696031|540628542|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
149863191|NCT02696031|540628543|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
149863192|NCT02696031|540628544|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
149863193|NCT02696031|540628545|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
149863194|NCT02696031|540628546|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
149863195|NCT02696031|540628547|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
149863196|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
149863197|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
149863198|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
149863199|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
149863200|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
149863201|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
149863202|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
149863203|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
149863204|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
149863205|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
149863206|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
149863207|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
149863208|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
149863209|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
149863210|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
149863211|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
149863212|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
149863213|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
150040764|NCT00790842|541289119|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040765|NCT00790842|541289120|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040766|NCT00790842|541289121|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040767|NCT00790842|541289122|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040768|NCT00790842|541289123|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
150040769|NCT00790842|541289124|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
149863214|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
149863215|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
150040770|NCT00790842|541289114|FG000|Dose Level 4|Adverse Event|0|||
150040771|NCT00790842|541289115|FG001|Dose Level 4|Adverse Event|0|||
150040772|NCT00790842|541289116|FG002|Dose Level 4|Adverse Event|0|||
149863216|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
149863217|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
149863218|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
149863219|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
149863220|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
149863221|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
149863222|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
149863223|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
149863224|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
149863225|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
149863226|NCT02696031|540628542|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
149863227|NCT02696031|540628543|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
149863228|NCT02696031|540628544|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
149863229|NCT02696031|540628545|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
149863230|NCT02696031|540628546|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
149962103|NCT02113878|540995794|FG000|Overall Study|patient non-compliance|1|||
149863231|NCT02696031|540628547|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
149863232|NCT00597116|540628548|FG000|Overall Study|Adverse Event|2|||
149863233|NCT00597116|540628549|FG001|Overall Study|Adverse Event|1|||
149863234|NCT00597116|540628548|FG000|Overall Study|Withdrawal by Subject|0|||
149863235|NCT00597116|540628549|FG001|Overall Study|Withdrawal by Subject|2|||
149863236|NCT00597116|540628548|FG000|Overall Study|Physician Decision|0|||
149863237|NCT00597116|540628549|FG001|Overall Study|Physician Decision|1|||
149863238|NCT00597116|540628548|FG000|Overall Study|Death|0|||
149863239|NCT00597116|540628549|FG001|Overall Study|Death|1|||
149863240|NCT00597116|540628548|FG000|Overall Study|Lost to Follow-up|1|||
149863241|NCT00597116|540628549|FG001|Overall Study|Lost to Follow-up|0|||
149863242|NCT00597116|540628548|FG000|Overall Study|Progressive disease|11|||
149863243|NCT00597116|540628549|FG001|Overall Study|Progressive disease|6|||
149863244|NCT01258101|540628550|FG000|Overall Study|Adverse Event|5|||
149863245|NCT01258101|540628551|FG001|Overall Study|Adverse Event|6|||
149863246|NCT01258101|540628552|FG002|Overall Study|Adverse Event|0|||
149863247|NCT01258101|540628553|FG003|Overall Study|Adverse Event|0|||
149863248|NCT01258101|540628550|FG000|Overall Study|Extra exclusion criterion amended|2|||
149863249|NCT01258101|540628551|FG001|Overall Study|Extra exclusion criterion amended|1|||
149863250|NCT01258101|540628552|FG002|Overall Study|Extra exclusion criterion amended|1|||
149863251|NCT01258101|540628553|FG003|Overall Study|Extra exclusion criterion amended|1|||
149863252|NCT01258101|540628550|FG000|Overall Study|Informed consent has been withdrawn|2|||
149863253|NCT01258101|540628551|FG001|Overall Study|Informed consent has been withdrawn|2|||
149863254|NCT01258101|540628552|FG002|Overall Study|Informed consent has been withdrawn|1|||
149863255|NCT01258101|540628553|FG003|Overall Study|Informed consent has been withdrawn|1|||
149863256|NCT01258101|540628550|FG000|Overall Study|Patient is not able to attend visits|8|||
149863257|NCT01258101|540628551|FG001|Overall Study|Patient is not able to attend visits|9|||
149863258|NCT01258101|540628552|FG002|Overall Study|Patient is not able to attend visits|7|||
149863259|NCT01258101|540628553|FG003|Overall Study|Patient is not able to attend visits|6|||
149863260|NCT01258101|540628550|FG000|Overall Study|Patient´s compliance|4|||
149863261|NCT01258101|540628551|FG001|Overall Study|Patient´s compliance|3|||
149863262|NCT01258101|540628552|FG002|Overall Study|Patient´s compliance|1|||
149863263|NCT01258101|540628553|FG003|Overall Study|Patient´s compliance|2|||
149863264|NCT01258101|540628550|FG000|Overall Study|Lost to Follow-up|5|||
149863265|NCT01258101|540628551|FG001|Overall Study|Lost to Follow-up|5|||
149863266|NCT01258101|540628552|FG002|Overall Study|Lost to Follow-up|0|||
149863267|NCT01258101|540628553|FG003|Overall Study|Lost to Follow-up|6|||
149863268|NCT01258101|540628550|FG000|Overall Study|PCR positive at week 24|0|||
149863269|NCT01258101|540628551|FG001|Overall Study|PCR positive at week 24|0|||
149863270|NCT01258101|540628552|FG002|Overall Study|PCR positive at week 24|0|||
149863271|NCT01258101|540628553|FG003|Overall Study|PCR positive at week 24|1|||
149863272|NCT01258101|540628550|FG000|Overall Study|Other reason|7|||
149863273|NCT01258101|540628551|FG001|Overall Study|Other reason|8|||
149863274|NCT01258101|540628552|FG002|Overall Study|Other reason|1|||
149863275|NCT01258101|540628553|FG003|Overall Study|Other reason|8|||
149863276|NCT00063882|540628556|FG000|Overall Study|Protocol Violation|3|||
149863277|NCT00063882|540628557|FG001|Overall Study|Protocol Violation|3|||
149863278|NCT00063882|540628556|FG000|Overall Study|Withdrawal by Subject|2|||
149863279|NCT00063882|540628557|FG001|Overall Study|Withdrawal by Subject|1|||
149863280|NCT02903238|540628559|FG000|Overall Study|Lost to Follow-up|4|||
149863281|NCT00700817|540628564|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
149863282|NCT00700817|540628565|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
149863283|NCT00700817|540628566|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
149863284|NCT00700817|540628567|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
149863285|NCT00700817|540628568|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
149863286|NCT00700817|540628564|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
149863287|NCT00700817|540628565|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
149863288|NCT00700817|540628566|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
149863289|NCT00700817|540628567|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
149863290|NCT00700817|540628568|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
149863291|NCT00700817|540628564|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
149863292|NCT00700817|540628565|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
149863293|NCT00700817|540628566|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
149863294|NCT00700817|540628567|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
149863295|NCT00700817|540628568|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
149863296|NCT00700817|540628564|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
149863297|NCT00700817|540628565|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
149863298|NCT00700817|540628566|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
149863299|NCT00700817|540628567|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
149863300|NCT00700817|540628568|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
149863301|NCT00700817|540628564|FG000|Week 0-26 (Main Period)|Unclassified|14|||
149863302|NCT00700817|540628565|FG001|Week 0-26 (Main Period)|Unclassified|4|||
149863303|NCT00700817|540628566|FG002|Week 0-26 (Main Period)|Unclassified|8|||
149863304|NCT00700817|540628567|FG003|Week 0-26 (Main Period)|Unclassified|0|||
149863305|NCT00700817|540628568|FG004|Week 0-26 (Main Period)|Unclassified|0|||
149863306|NCT00700817|540628564|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
149863307|NCT00700817|540628565|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
149863308|NCT00700817|540628566|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
149863309|NCT00700817|540628567|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
149863310|NCT00700817|540628568|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
149863311|NCT00700817|540628564|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
149863312|NCT00700817|540628565|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
150040773|NCT00790842|541289117|FG003|Dose Level 4|Adverse Event|0|||
149863313|NCT00700817|540628566|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
149863314|NCT00700817|540628567|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
149863315|NCT00700817|540628568|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
149863316|NCT00700817|540628564|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
149863317|NCT00700817|540628565|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
149863318|NCT00700817|540628566|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
149863319|NCT00700817|540628567|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
149863320|NCT00700817|540628568|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
149863321|NCT00700817|540628564|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
149863322|NCT00700817|540628565|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
149962104|NCT02113878|540995795|FG001|Overall Study|patient non-compliance|0|||
149962105|NCT01251965|540995796|FG000|Overall Study|Participant/physician decision|1|||
149962106|NCT01251965|540995797|FG001|Overall Study|Participant/physician decision|2|||
149962107|NCT01251965|540995798|FG002|Overall Study|Participant/physician decision|0|||
149962108|NCT01251965|540995796|FG000|Overall Study|Death|0|||
149962109|NCT01251965|540995797|FG001|Overall Study|Death|0|||
149962110|NCT01251965|540995798|FG002|Overall Study|Death|11|||
149962111|NCT01027754|540995799|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
149962112|NCT01027754|540995800|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
149962113|NCT01027754|540995799|FG000|Overall Study|Withdrawal by Subject|0|||
149962114|NCT01027754|540995800|FG001|Overall Study|Withdrawal by Subject|5|||
149962115|NCT00530257|540995801|FG000|Overall Study|Lost to Follow-up|1|||
149962116|NCT02562040|540995804|FG000|Overall Study|Lost to Follow-up|20|||
149962117|NCT02562040|540995805|FG001|Overall Study|Lost to Follow-up|28|||
149962118|NCT02562040|540995804|FG000|Overall Study|Withdrawal by Subject|8|||
149962119|NCT02562040|540995805|FG001|Overall Study|Withdrawal by Subject|7|||
149962120|NCT02562040|540995804|FG000|Overall Study|Adverse Event|1|||
149863323|NCT00700817|540628566|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
149863324|NCT00700817|540628567|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
149863325|NCT00700817|540628568|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
149962121|NCT02562040|540995805|FG001|Overall Study|Adverse Event|0|||
149962122|NCT05130281|540995806|FG000|Overall Study|Withdrawal by Subject|0|||
149962123|NCT05130281|540995807|FG001|Overall Study|Withdrawal by Subject|0|||
149962124|NCT05130281|540995808|FG002|Overall Study|Withdrawal by Subject|1|||
149962125|NCT00368849|540995809|FG000|Overall Study|Withdrawal by Subject|0|||
149962126|NCT00368849|540995810|FG001|Overall Study|Withdrawal by Subject|1|||
149962127|NCT00368849|540995809|FG000|Overall Study|Physician Decision|0|||
149962128|NCT00368849|540995810|FG001|Overall Study|Physician Decision|1|||
149863326|NCT00700817|540628564|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
149863327|NCT00700817|540628565|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
149863328|NCT00700817|540628566|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
149863329|NCT00700817|540628567|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
149863330|NCT00700817|540628568|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
149863331|NCT00700817|540628564|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
149863332|NCT00700817|540628565|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
149863333|NCT00700817|540628566|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
149863334|NCT00700817|540628567|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
149863335|NCT00700817|540628568|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
149863336|NCT00700817|540628564|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
149863337|NCT00700817|540628565|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
149962129|NCT01902303|540995815|FG000|Overall Study|Adverse Event|0|||
149962130|NCT01902303|540995816|FG001|Overall Study|Adverse Event|1|||
149962131|NCT01902303|540995815|FG000|Overall Study|Lost to Follow-up|0|||
149962132|NCT01902303|540995816|FG001|Overall Study|Lost to Follow-up|1|||
149962133|NCT01902303|540995815|FG000|Overall Study|Protocol Violation|2|||
149962134|NCT01902303|540995816|FG001|Overall Study|Protocol Violation|2|||
149962135|NCT01902303|540995815|FG000|Overall Study|subject lost investigational product|0|||
149962136|NCT01902303|540995816|FG001|Overall Study|subject lost investigational product|1|||
149962137|NCT01902303|540995815|FG000|Overall Study|Did not develop a cold sore|21|||
149962138|NCT01902303|540995816|FG001|Overall Study|Did not develop a cold sore|19|||
149962139|NCT01699685|540995817|FG000|Period 1|Adverse Event|1|||
149962140|NCT01699685|540995818|FG001|Period 1|Adverse Event|1|||
149962141|NCT01699685|540995817|FG000|Period 1|Medical or ethical, noncompliance|2|||
149962142|NCT01699685|540995818|FG001|Period 1|Medical or ethical, noncompliance|0|||
149962143|NCT01699685|540995817|FG000|Period 1|Other|0|||
149962144|NCT01699685|540995818|FG001|Period 1|Other|1|||
149962145|NCT01699685|540995817|FG000|Period 1|Patient request|0|||
149962146|NCT01699685|540995818|FG001|Period 1|Patient request|1|||
149962147|NCT01699685|540995817|FG000|Period 2|Lost to Follow-up|1|||
149962148|NCT01699685|540995818|FG001|Period 2|Lost to Follow-up|0|||
149962149|NCT05058456|540995819|FG000|Overall Study|Death|1|||
149962150|NCT05058456|540995819|FG000|Overall Study|End of Study data not yet due for release|34|||
149962151|NCT01654250|540995820|FG000|Overall Study|Lost to Follow-up|1|||
149962152|NCT01654250|540995821|FG001|Overall Study|Lost to Follow-up|0|||
149962153|NCT03810365|540995823|FG000|Overall Study|Lost to Follow-up|2|||
149962154|NCT03810365|540995824|FG001|Overall Study|Lost to Follow-up|2|||
149962155|NCT03810365|540995823|FG000|Overall Study|Withdrawal by Subject|4|||
149962156|NCT03810365|540995824|FG001|Overall Study|Withdrawal by Subject|5|||
149962157|NCT02255279|540995831|FG000|Overall Study|Lost to Follow-up|2|||
149962158|NCT02255279|540995832|FG001|Overall Study|Lost to Follow-up|2|||
149962159|NCT02255279|540995831|FG000|Overall Study|Protocol Violation|0|||
149962160|NCT02255279|540995832|FG001|Overall Study|Protocol Violation|1|||
149962161|NCT02255279|540995831|FG000|Overall Study|Withdrawal by Subject|3|||
149962162|NCT02255279|540995832|FG001|Overall Study|Withdrawal by Subject|6|||
150173797|NCT03622593|541772942|FG000|Overall Study|Pregnancy|0|||
150173798|NCT03622593|541772943|FG001|Overall Study|Pregnancy|0|||
149863338|NCT00700817|540628566|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
149962163|NCT01730729|540995834|FG000|Overall Study|Adverse Event|1|||
149962164|NCT01730729|540995834|FG000|Overall Study|Death|1|||
149962165|NCT01730729|540995834|FG000|Overall Study|Progressive Disease|12|||
149962166|NCT02402907|540995839|FG000|Overall Study|Delivered vaginally|9|||
149962167|NCT02402907|540995840|FG001|Overall Study|Delivered vaginally|3|||
149962168|NCT02402907|540995839|FG000|Overall Study|Delivered outside of Sinai|1|||
149962169|NCT02402907|540995840|FG001|Overall Study|Delivered outside of Sinai|1|||
149962170|NCT02402907|540995839|FG000|Overall Study|Lost to follow up after C-Section|10|||
149962171|NCT02402907|540995840|FG001|Overall Study|Lost to follow up after C-Section|23|||
149962172|NCT03701074|540995841|FG000|Overall Study|Physician Decision|1|||
150173799|NCT03622593|541772944|FG002|Overall Study|Pregnancy|1|||
149962173|NCT03701074|540995842|FG001|Overall Study|Physician Decision|0|||
149962174|NCT00661687|540995846|FG000|Overall Study|Study related symptoms and complaints|5|||
149962175|NCT00661687|540995846|FG000|Overall Study|Positive slit lamp findings|4|||
149962176|NCT00661687|540995846|FG000|Overall Study|Inability to maintain wearing schedule|3|||
149962177|NCT00661687|540995846|FG000|Overall Study|Physician Decision|1|||
149962178|NCT00661687|540995846|FG000|Overall Study|Adverse Event|2|||
150173800|NCT03593876|541772950|FG000|Overall Study|Withdrawal by Subject|1|||
149863339|NCT00700817|540628567|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
149863340|NCT00700817|540628568|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
149863341|NCT00700817|540628564|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
149863342|NCT00700817|540628565|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
149863343|NCT00700817|540628566|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
149863344|NCT00700817|540628567|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
149863345|NCT00700817|540628568|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
149863346|NCT00700817|540628564|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
149863347|NCT00700817|540628565|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
149863348|NCT00700817|540628566|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
149863349|NCT00700817|540628567|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
149863350|NCT00700817|540628568|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
149863351|NCT00700817|540628564|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
149863352|NCT00700817|540628565|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
149863353|NCT00700817|540628566|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
149863354|NCT00700817|540628567|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
149863355|NCT00700817|540628568|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
149863356|NCT00767520|540628571|FG000|Overall Study|Participants still on treatment|11|||
149863357|NCT00767520|540628572|FG001|Overall Study|Participants still on treatment|15|||
149863358|NCT00767520|540628571|FG000|Overall Study|Randomized in error and Never treated|0|||
149863359|NCT00767520|540628572|FG001|Overall Study|Randomized in error and Never treated|2|||
149863360|NCT02777918|540628573|FG000|Overall Study|Medical reasons|1|||
149863361|NCT02777918|540628574|FG001|Overall Study|Medical reasons|2|||
149863362|NCT02777918|540628573|FG000|Overall Study|Too busy / stressed|1|||
149863363|NCT02777918|540628574|FG001|Overall Study|Too busy / stressed|1|||
149863364|NCT02777918|540628573|FG000|Overall Study|Withdrawal by Subject|1|||
149863365|NCT02777918|540628574|FG001|Overall Study|Withdrawal by Subject|1|||
149863366|NCT01338987|540628575|FG000|Overall Study|enrolled on new protocol|0|||
149863367|NCT01338987|540628576|FG001|Overall Study|enrolled on new protocol|0|||
149863368|NCT01338987|540628577|FG002|Overall Study|enrolled on new protocol|1|||
149863369|NCT01338987|540628578|FG003|Overall Study|enrolled on new protocol|0|||
149863370|NCT01338987|540628579|FG004|Overall Study|enrolled on new protocol|0|||
149863371|NCT01338987|540628575|FG000|Overall Study|Disease progression on study|2|||
149863372|NCT01338987|540628576|FG001|Overall Study|Disease progression on study|1|||
149863373|NCT01338987|540628577|FG002|Overall Study|Disease progression on study|1|||
149863374|NCT01338987|540628578|FG003|Overall Study|Disease progression on study|0|||
149863375|NCT01338987|540628579|FG004|Overall Study|Disease progression on study|0|||
149863376|NCT00757848|540628580|FG000|Overall Study|Voluntary discontinuation|1|||
149863377|NCT00757848|540628581|FG001|Overall Study|Voluntary discontinuation|0|||
149863378|NCT00757848|540628580|FG000|Overall Study|Adverse Event|1|||
149863379|NCT00757848|540628581|FG001|Overall Study|Adverse Event|2|||
149863380|NCT00757848|540628580|FG000|Overall Study|Incorrect enrolment|1|||
149863381|NCT00757848|540628581|FG001|Overall Study|Incorrect enrolment|0|||
149863382|NCT00058214|540628584|FG000|Overall Study|Adverse Event|1|||
149863383|NCT00958126|540628592|FG000|Overall Study|Serious Adverse Event|0|||
149863384|NCT00958126|540628593|FG001|Overall Study|Serious Adverse Event|2|||
149863385|NCT00958126|540628594|FG002|Overall Study|Serious Adverse Event|0|||
149863386|NCT00958126|540628595|FG003|Overall Study|Serious Adverse Event|0|||
149863387|NCT00958126|540628596|FG004|Overall Study|Serious Adverse Event|0|||
149863388|NCT00958126|540628597|FG005|Overall Study|Serious Adverse Event|0|||
149863389|NCT00958126|540628598|FG006|Overall Study|Serious Adverse Event|1|||
149863390|NCT00958126|540628599|FG007|Overall Study|Serious Adverse Event|0|||
149863391|NCT00958126|540628592|FG000|Overall Study|Withdrawal by Subject|0|||
149863392|NCT00958126|540628593|FG001|Overall Study|Withdrawal by Subject|2|||
149863393|NCT00958126|540628594|FG002|Overall Study|Withdrawal by Subject|0|||
149863394|NCT00958126|540628595|FG003|Overall Study|Withdrawal by Subject|0|||
149863395|NCT00958126|540628596|FG004|Overall Study|Withdrawal by Subject|0|||
149863396|NCT00958126|540628597|FG005|Overall Study|Withdrawal by Subject|0|||
149863397|NCT00958126|540628598|FG006|Overall Study|Withdrawal by Subject|0|||
149863398|NCT00958126|540628599|FG007|Overall Study|Withdrawal by Subject|0|||
149863399|NCT00958126|540628592|FG000|Overall Study|Moved away from study area|0|||
149863400|NCT00958126|540628593|FG001|Overall Study|Moved away from study area|0|||
149863401|NCT00958126|540628594|FG002|Overall Study|Moved away from study area|1|||
149863402|NCT00958126|540628595|FG003|Overall Study|Moved away from study area|1|||
149863403|NCT00958126|540628596|FG004|Overall Study|Moved away from study area|0|||
149863404|NCT00958126|540628597|FG005|Overall Study|Moved away from study area|0|||
149863405|NCT00958126|540628598|FG006|Overall Study|Moved away from study area|0|||
149863406|NCT00958126|540628599|FG007|Overall Study|Moved away from study area|0|||
149863407|NCT00958126|540628592|FG000|Overall Study|Lost to Follow-up|1|||
149863408|NCT00958126|540628593|FG001|Overall Study|Lost to Follow-up|5|||
149863409|NCT00958126|540628594|FG002|Overall Study|Lost to Follow-up|9|||
149863410|NCT00958126|540628595|FG003|Overall Study|Lost to Follow-up|8|||
149863411|NCT00958126|540628596|FG004|Overall Study|Lost to Follow-up|0|||
149863412|NCT00958126|540628597|FG005|Overall Study|Lost to Follow-up|0|||
149863413|NCT00958126|540628598|FG006|Overall Study|Lost to Follow-up|0|||
149863414|NCT00958126|540628599|FG007|Overall Study|Lost to Follow-up|0|||
149863415|NCT00958126|540628592|FG000|Overall Study|Sponsor/Investigator decision|0|||
149863416|NCT00958126|540628593|FG001|Overall Study|Sponsor/Investigator decision|0|||
149863417|NCT00958126|540628594|FG002|Overall Study|Sponsor/Investigator decision|0|||
149863418|NCT00958126|540628595|FG003|Overall Study|Sponsor/Investigator decision|1|||
149863419|NCT00958126|540628596|FG004|Overall Study|Sponsor/Investigator decision|0|||
149863420|NCT00958126|540628597|FG005|Overall Study|Sponsor/Investigator decision|0|||
149863421|NCT00958126|540628598|FG006|Overall Study|Sponsor/Investigator decision|0|||
149863422|NCT00958126|540628599|FG007|Overall Study|Sponsor/Investigator decision|0|||
149863423|NCT00958126|540628592|FG000|Overall Study|Other Reason|0|||
149863424|NCT00958126|540628593|FG001|Overall Study|Other Reason|0|||
149863425|NCT00958126|540628594|FG002|Overall Study|Other Reason|0|||
149863426|NCT00958126|540628595|FG003|Overall Study|Other Reason|1|||
149863427|NCT00958126|540628596|FG004|Overall Study|Other Reason|0|||
149863428|NCT00958126|540628597|FG005|Overall Study|Other Reason|1|||
149863429|NCT00958126|540628598|FG006|Overall Study|Other Reason|0|||
149863430|NCT00958126|540628599|FG007|Overall Study|Other Reason|0|||
149863431|NCT00720226|540628600|FG000|Overall Study|Withdrawal by Subject|7|||
149863432|NCT00720226|540628601|FG001|Overall Study|Withdrawal by Subject|4|||
149863433|NCT00733369|540628602|FG000|Overall Study|Lost to Follow-up|2|||
149863434|NCT00733369|540628603|FG001|Overall Study|Lost to Follow-up|1|||
149863435|NCT00733369|540628602|FG000|Overall Study|Adverse Event|4|||
149863436|NCT00733369|540628603|FG001|Overall Study|Adverse Event|4|||
149863437|NCT00733369|540628602|FG000|Overall Study|Protocol Violation|4|||
149863438|NCT00733369|540628603|FG001|Overall Study|Protocol Violation|4|||
149863439|NCT03401073|540628604|FG000|Overall Study|Lost to Follow-up|1|||
149863440|NCT03401073|540628605|FG001|Overall Study|Lost to Follow-up|2|||
149863441|NCT01470612|540628609|FG000|Overall Study|Adverse Event|20|||
149863442|NCT01470612|540628610|FG001|Overall Study|Adverse Event|80|||
149863443|NCT01470612|540628609|FG000|Overall Study|Death|0|||
149863444|NCT01470612|540628610|FG001|Overall Study|Death|1|||
149863445|NCT01470612|540628609|FG000|Overall Study|Lack of Efficacy|20|||
149863446|NCT01470612|540628610|FG001|Overall Study|Lack of Efficacy|326|||
149863447|NCT01470612|540628609|FG000|Overall Study|Lost to Follow-up|2|||
149863448|NCT01470612|540628610|FG001|Overall Study|Lost to Follow-up|5|||
149863449|NCT01470612|540628609|FG000|Overall Study|Did not meet entrance criteria|0|||
149863450|NCT01470612|540628610|FG001|Overall Study|Did not meet entrance criteria|1|||
149863451|NCT01470612|540628609|FG000|Overall Study|Pregnancy|2|||
149863452|NCT01470612|540628610|FG001|Overall Study|Pregnancy|10|||
149863453|NCT01470612|540628609|FG000|Overall Study|Protocol Violation|2|||
149863454|NCT01470612|540628610|FG001|Overall Study|Protocol Violation|7|||
149863455|NCT01470612|540628609|FG000|Overall Study|Withdrawal by Subject|24|||
149863456|NCT01470612|540628610|FG001|Overall Study|Withdrawal by Subject|79|||
149863457|NCT01470612|540628609|FG000|Overall Study|Other|14|||
149863458|NCT01470612|540628610|FG001|Overall Study|Other|156|||
149863459|NCT03856593|540628613|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
149863460|NCT03856593|540628614|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
149863461|NCT03078582|540628620|FG000|Overall Study|Adverse Event|0|||
149863462|NCT03078582|540628621|FG001|Overall Study|Adverse Event|8|||
149863463|NCT00766831|540628632|FG000|Overall Study|Withdrawal by Subject|4|||
149863464|NCT00766831|540628632|FG000|Overall Study|Lost to Follow-up|3|||
149863465|NCT00766831|540628632|FG000|Overall Study|Adverse Event|20|||
149863466|NCT00766831|540628632|FG000|Overall Study|Protocol Violation|15|||
149863467|NCT00766831|540628632|FG000|Overall Study|Physician Decision|5|||
149863468|NCT00766831|540628632|FG000|Overall Study|Withdrawal of consent|26|||
149863469|NCT00766831|540628632|FG000|Overall Study|Non cooperation by participants|14|||
149863470|NCT00766831|540628632|FG000|Overall Study|Other|28|||
149863471|NCT01392326|540628633|FG000|Overall Study|Death|2|||
149863472|NCT01392326|540628634|FG001|Overall Study|Death|0|||
149863473|NCT01392326|540628635|FG002|Overall Study|Death|0|||
149863474|NCT01392326|540628633|FG000|Overall Study|Withdrawal by Subject|12|||
149863475|NCT01392326|540628634|FG001|Overall Study|Withdrawal by Subject|11|||
149863476|NCT01392326|540628635|FG002|Overall Study|Withdrawal by Subject|15|||
149863477|NCT01392326|540628633|FG000|Overall Study|Protocol Violation|2|||
149863478|NCT01392326|540628634|FG001|Overall Study|Protocol Violation|0|||
149863479|NCT01392326|540628635|FG002|Overall Study|Protocol Violation|0|||
149863480|NCT01392326|540628633|FG000|Overall Study|Pregnancy|0|||
149863481|NCT01392326|540628634|FG001|Overall Study|Pregnancy|0|||
149863482|NCT01392326|540628635|FG002|Overall Study|Pregnancy|1|||
149863483|NCT01392326|540628633|FG000|Overall Study|Physician Decision|7|||
149863484|NCT01392326|540628634|FG001|Overall Study|Physician Decision|5|||
149863485|NCT01392326|540628635|FG002|Overall Study|Physician Decision|2|||
149863486|NCT01392326|540628633|FG000|Overall Study|Lost to Follow-up|1|||
149863487|NCT01392326|540628634|FG001|Overall Study|Lost to Follow-up|3|||
149863488|NCT01392326|540628635|FG002|Overall Study|Lost to Follow-up|4|||
149863489|NCT01392326|540628633|FG000|Overall Study|Lack of Efficacy|14|||
149863490|NCT01392326|540628634|FG001|Overall Study|Lack of Efficacy|10|||
149863491|NCT01392326|540628635|FG002|Overall Study|Lack of Efficacy|15|||
149863492|NCT01392326|540628633|FG000|Overall Study|Adverse Event|9|||
149863493|NCT01392326|540628634|FG001|Overall Study|Adverse Event|6|||
149863494|NCT01392326|540628635|FG002|Overall Study|Adverse Event|11|||
149863495|NCT02340221|540628636|FG000|Overall Study|Death|100|||
149863496|NCT02340221|540628637|FG001|Overall Study|Death|197|||
149863497|NCT02340221|540628636|FG000|Overall Study|Withdrawal by Participant|24|||
149863498|NCT02340221|540628637|FG001|Overall Study|Withdrawal by Participant|37|||
149863499|NCT02340221|540628636|FG000|Overall Study|Lost to Follow-up|4|||
149863500|NCT02340221|540628637|FG001|Overall Study|Lost to Follow-up|15|||
149863501|NCT02340221|540628636|FG000|Overall Study|Reason Not Specified|85|||
149863502|NCT02340221|540628637|FG001|Overall Study|Reason Not Specified|165|||
149863503|NCT02340221|540628636|FG000|Overall Study|Study Terminated by Sponsor|1|||
149863504|NCT02340221|540628637|FG001|Overall Study|Study Terminated by Sponsor|3|||
149863505|NCT00518622|540628638|FG000|Overall Study|Lost to Follow-up|0|||
149863506|NCT00518622|540628639|FG001|Overall Study|Lost to Follow-up|0|||
149863507|NCT00518622|540628640|FG002|Overall Study|Lost to Follow-up|1|||
149863508|NCT00518622|540628641|FG003|Overall Study|Lost to Follow-up|0|||
149863509|NCT00518622|540628642|FG004|Overall Study|Lost to Follow-up|0|||
149863510|NCT00518622|540628643|FG005|Overall Study|Lost to Follow-up|0|||
149863511|NCT00518622|540628644|FG006|Overall Study|Lost to Follow-up|0|||
149863512|NCT00518622|540628645|FG007|Overall Study|Lost to Follow-up|0|||
149863513|NCT00518622|540628638|FG000|Overall Study|Study medication taken incorrectly|0|||
149863514|NCT00518622|540628639|FG001|Overall Study|Study medication taken incorrectly|1|||
149863515|NCT00518622|540628640|FG002|Overall Study|Study medication taken incorrectly|0|||
149863516|NCT00518622|540628641|FG003|Overall Study|Study medication taken incorrectly|0|||
149863517|NCT00518622|540628642|FG004|Overall Study|Study medication taken incorrectly|0|||
149863518|NCT00518622|540628643|FG005|Overall Study|Study medication taken incorrectly|0|||
149863519|NCT00518622|540628644|FG006|Overall Study|Study medication taken incorrectly|0|||
149863520|NCT00518622|540628645|FG007|Overall Study|Study medication taken incorrectly|0|||
149863521|NCT03487848|540628646|FG000|Overall Study|Lost to Follow-up|1|||
149863522|NCT00094094|540628647|FG000|Overall Study|Death|2|||
149863523|NCT00094094|540628647|FG000|Overall Study|Lack of Efficacy|23|||
149863524|NCT00094094|540628647|FG000|Overall Study|Adverse Event|7|||
149863525|NCT06029959|540630203|FG000|Overall Study|Physician Decision|6|||
149863526|NCT00003138|540630204|FG000|Step 1|Reasons off treatment not documented|60|||
149863527|NCT00003138|540630205|FG001|Step 1|Reasons off treatment not documented|57|||
149863528|NCT00003138|540630204|FG000|Step 1|Never started treatment|1|||
149863529|NCT00003138|540630205|FG001|Step 1|Never started treatment|0|||
149863530|NCT00003138|540630204|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
149863531|NCT00003138|540630205|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
149863532|NCT00003138|540630204|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
149863533|NCT00003138|540630205|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
149863534|NCT00003138|540630204|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
149863535|NCT00003138|540630205|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
149863536|NCT00003138|540630204|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
149863537|NCT00003138|540630205|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
149863538|NCT04495283|540630206|FG000|Overall Study|Physician Decision|0|||
149863539|NCT04495283|540630207|FG001|Overall Study|Physician Decision|0|||
149863540|NCT04495283|540630208|FG002|Overall Study|Physician Decision|1|||
149863541|NCT04495283|540630206|FG000|Overall Study|Withdrawal by Subject|0|||
149863542|NCT04495283|540630207|FG001|Overall Study|Withdrawal by Subject|1|||
149863543|NCT04495283|540630208|FG002|Overall Study|Withdrawal by Subject|1|||
149863544|NCT04495283|540630206|FG000|Overall Study|Other|1|||
149863545|NCT04495283|540630207|FG001|Overall Study|Other|0|||
149863546|NCT04495283|540630208|FG002|Overall Study|Other|1|||
149863547|NCT02631876|540630213|FG000|Overall Study|Death|96|||
149863548|NCT02631876|540630214|FG001|Overall Study|Death|50|||
149863549|NCT02631876|540630213|FG000|Overall Study|Investigator's discretion|1|||
149863550|NCT02631876|540630214|FG001|Overall Study|Investigator's discretion|0|||
149863551|NCT02631876|540630213|FG000|Overall Study|Lost to Follow-up|2|||
149863552|NCT02631876|540630214|FG001|Overall Study|Lost to Follow-up|0|||
149863553|NCT02631876|540630213|FG000|Overall Study|Withdrawal by Subject|16|||
149962179|NCT02837952|540995847|FG000|Overall Study|Adverse Event|0|||
149863554|NCT02631876|540630214|FG001|Overall Study|Withdrawal by Subject|9|||
149863555|NCT02631876|540630213|FG000|Overall Study|Other than specified|4|||
149863556|NCT02631876|540630214|FG001|Overall Study|Other than specified|4|||
149863557|NCT01013649|540630217|FG000|First Step|Withdrawal by Subject|36|||
149863558|NCT01013649|540630218|FG001|First Step|Withdrawal by Subject|19|||
149863559|NCT01013649|540630219|FG002|First Step|Withdrawal by Subject|0|||
149962180|NCT02837952|540995848|FG001|Overall Study|Adverse Event|1|||
149863560|NCT01013649|540630220|FG003|First Step|Withdrawal by Subject|0|||
149863561|NCT01013649|540630217|FG000|First Step|Progression|58|||
149863562|NCT01013649|540630218|FG001|First Step|Progression|23|||
149863563|NCT01013649|540630219|FG002|First Step|Progression|0|||
149863564|NCT01013649|540630220|FG003|First Step|Progression|0|||
149863565|NCT01013649|540630217|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
149863566|NCT01013649|540630218|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
149863567|NCT01013649|540630219|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
149863568|NCT01013649|540630220|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
149863569|NCT01013649|540630217|FG000|First Step|Death|3|||
149863570|NCT01013649|540630218|FG001|First Step|Death|4|||
150173801|NCT03593876|541772950|FG000|Overall Study|Discharged home before intervention completion|2|||
150173802|NCT00854906|541772953|FG000|Overall Study|One person had no ocular history|1|||
150173803|NCT00071799|541772954|FG000|Overall Study|Adverse Event|19|||
150173804|NCT00071799|541772955|FG001|Overall Study|Adverse Event|10|||
149863571|NCT01013649|540630219|FG002|First Step|Death|0|||
149863572|NCT01013649|540630220|FG003|First Step|Death|0|||
149863573|NCT01013649|540630217|FG000|First Step|Adverse Event|9|||
149863574|NCT01013649|540630218|FG001|First Step|Adverse Event|5|||
149863575|NCT01013649|540630219|FG002|First Step|Adverse Event|0|||
149863576|NCT01013649|540630220|FG003|First Step|Adverse Event|0|||
149863577|NCT01013649|540630217|FG000|First Step|Other|4|||
149863578|NCT01013649|540630218|FG001|First Step|Other|6|||
149863579|NCT01013649|540630219|FG002|First Step|Other|0|||
149863580|NCT01013649|540630220|FG003|First Step|Other|0|||
150173805|NCT00071799|541772954|FG000|Overall Study|Protocol Violation|1|||
150173806|NCT00071799|541772955|FG001|Overall Study|Protocol Violation|7|||
150173807|NCT00071799|541772954|FG000|Overall Study|Lost to Follow-up|1|||
149863581|NCT04285567|540630221|FG000|Overall Study|Death|3|||
149863582|NCT04285567|540630222|FG001|Overall Study|Death|3|||
150040774|NCT00790842|541289118|FG004|Dose Level 4|Adverse Event|0|||
149863583|NCT04285567|540630221|FG000|Overall Study|Lost to Follow-up|1|||
149863584|NCT04285567|540630222|FG001|Overall Study|Lost to Follow-up|1|||
149863585|NCT04285567|540630221|FG000|Overall Study|Reason Not Specified|1|||
150040775|NCT00790842|541289119|FG005|Dose Level 4|Adverse Event|0|||
150173808|NCT00071799|541772955|FG001|Overall Study|Lost to Follow-up|1|||
149863586|NCT04285567|540630222|FG001|Overall Study|Reason Not Specified|1|||
149863587|NCT04285567|540630221|FG000|Overall Study|Physician Decision|2|||
149863588|NCT04285567|540630222|FG001|Overall Study|Physician Decision|1|||
149863589|NCT04285567|540630221|FG000|Overall Study|Withdrawal by Subject|2|||
149863590|NCT04285567|540630222|FG001|Overall Study|Withdrawal by Subject|6|||
149863591|NCT04285567|540630221|FG000|Overall Study|Adverse Event|1|||
149863592|NCT04285567|540630222|FG001|Overall Study|Adverse Event|0|||
149863593|NCT04285567|540630221|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
149863594|NCT04285567|540630222|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
149863595|NCT01408563|540630223|FG000|Overall Study|Ineligible after consent/ registration|2|||
149863596|NCT02091141|540630229|FG000|Overall Study|Death|280|||
149863597|NCT02091141|540630230|FG001|Overall Study|Death|118|||
149863598|NCT02091141|540630231|FG002|Overall Study|Death|46|||
149863599|NCT02091141|540630232|FG003|Overall Study|Death|13|||
149863600|NCT02091141|540630233|FG004|Overall Study|Death|31|||
149863601|NCT02091141|540630234|FG005|Overall Study|Death|16|||
149863602|NCT02091141|540630235|FG006|Overall Study|Death|12|||
149863603|NCT02091141|540630229|FG000|Overall Study|Withdrawal by Subject|21|||
149863604|NCT02091141|540630230|FG001|Overall Study|Withdrawal by Subject|13|||
149863605|NCT02091141|540630231|FG002|Overall Study|Withdrawal by Subject|3|||
149863606|NCT02091141|540630232|FG003|Overall Study|Withdrawal by Subject|2|||
149863607|NCT02091141|540630233|FG004|Overall Study|Withdrawal by Subject|2|||
149863608|NCT02091141|540630234|FG005|Overall Study|Withdrawal by Subject|3|||
149863609|NCT02091141|540630235|FG006|Overall Study|Withdrawal by Subject|0|||
149863610|NCT02091141|540630229|FG000|Overall Study|Lost to Follow-up|21|||
149863611|NCT02091141|540630230|FG001|Overall Study|Lost to Follow-up|5|||
149863612|NCT02091141|540630231|FG002|Overall Study|Lost to Follow-up|1|||
149863613|NCT02091141|540630232|FG003|Overall Study|Lost to Follow-up|0|||
149863614|NCT02091141|540630233|FG004|Overall Study|Lost to Follow-up|1|||
149863615|NCT02091141|540630234|FG005|Overall Study|Lost to Follow-up|2|||
149863616|NCT02091141|540630235|FG006|Overall Study|Lost to Follow-up|0|||
149863617|NCT02091141|540630229|FG000|Overall Study|Reason Not Specified|6|||
149863618|NCT02091141|540630230|FG001|Overall Study|Reason Not Specified|5|||
149863619|NCT02091141|540630231|FG002|Overall Study|Reason Not Specified|2|||
149863620|NCT02091141|540630232|FG003|Overall Study|Reason Not Specified|0|||
149863621|NCT02091141|540630233|FG004|Overall Study|Reason Not Specified|0|||
149863622|NCT02091141|540630234|FG005|Overall Study|Reason Not Specified|0|||
149863623|NCT02091141|540630235|FG006|Overall Study|Reason Not Specified|1|||
149863624|NCT02091141|540630229|FG000|Overall Study|Study Ended by Sponsor|1|||
149863625|NCT02091141|540630230|FG001|Overall Study|Study Ended by Sponsor|9|||
149863626|NCT02091141|540630231|FG002|Overall Study|Study Ended by Sponsor|0|||
149863627|NCT02091141|540630232|FG003|Overall Study|Study Ended by Sponsor|0|||
149863628|NCT02091141|540630233|FG004|Overall Study|Study Ended by Sponsor|0|||
149863629|NCT02091141|540630234|FG005|Overall Study|Study Ended by Sponsor|0|||
149863630|NCT02091141|540630235|FG006|Overall Study|Study Ended by Sponsor|0|||
149863631|NCT02091141|540630229|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863632|NCT02091141|540630230|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
149863633|NCT02091141|540630231|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863634|NCT02091141|540630232|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863635|NCT02091141|540630233|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863636|NCT02091141|540630234|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863637|NCT02091141|540630235|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
149863638|NCT02246439|540630236|FG000|Overall Study|Adverse Event|3|||
149863639|NCT02246439|540630237|FG001|Overall Study|Adverse Event|0|||
149863640|NCT02246439|540630236|FG000|Overall Study|Lost to Follow-up|7|||
149863641|NCT02246439|540630237|FG001|Overall Study|Lost to Follow-up|5|||
149863642|NCT02246439|540630236|FG000|Overall Study|Protocol Violation|0|||
149863643|NCT02246439|540630237|FG001|Overall Study|Protocol Violation|2|||
149863644|NCT02246439|540630236|FG000|Overall Study|Physician Decision|0|||
149863645|NCT02246439|540630237|FG001|Overall Study|Physician Decision|1|||
149863646|NCT02246439|540630236|FG000|Overall Study|Unkonwn|1|||
149863647|NCT02246439|540630237|FG001|Overall Study|Unkonwn|3|||
149863648|NCT02246439|540630236|FG000|Overall Study|Withdrawal by Subject|1|||
149863649|NCT02246439|540630237|FG001|Overall Study|Withdrawal by Subject|0|||
149863650|NCT03439852|540630238|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
149863651|NCT03439852|540630239|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
149863652|NCT03439852|540630238|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
149863653|NCT03439852|540630239|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
150040776|NCT00790842|541289120|FG006|Dose Level 4|Adverse Event|1|||
149863654|NCT03439852|540630238|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
149863655|NCT03439852|540630239|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
149863656|NCT04271735|540630244|FG000|Overall Study|Physician Decision|2|||
149863657|NCT04271735|540630245|FG001|Overall Study|Physician Decision|0|||
149863658|NCT03197558|540630246|FG000|Overall Study|Tubes not placed|1|||
149863659|NCT00931268|540630257|FG000|Overall Study|Lost to Follow-up|6|||
149863660|NCT02072148|540630258|FG000|Overall Study|withdrew prior to surgery|23|||
149863661|NCT02072148|540630259|FG001|Overall Study|withdrew prior to surgery|0|||
149863662|NCT02072148|540630260|FG002|Overall Study|withdrew prior to surgery|0|||
149863663|NCT02072148|540630258|FG000|Overall Study|Death|0|||
149863664|NCT02072148|540630259|FG001|Overall Study|Death|0|||
149863665|NCT02072148|540630260|FG002|Overall Study|Death|1|||
149863666|NCT02072148|540630258|FG000|Overall Study|Withdrawal by Subject|0|||
149863667|NCT02072148|540630259|FG001|Overall Study|Withdrawal by Subject|13|||
149863668|NCT02072148|540630260|FG002|Overall Study|Withdrawal by Subject|12|||
149863669|NCT00430495|540630262|FG000|Overall Study|Adverse Event|2|||
149863670|NCT00430495|540630263|FG001|Overall Study|Adverse Event|3|||
149863671|NCT00430495|540630264|FG002|Overall Study|Adverse Event|2|||
149863672|NCT00430495|540630265|FG003|Overall Study|Adverse Event|0|||
149863673|NCT00430495|540630262|FG000|Overall Study|Death|0|||
149863674|NCT00430495|540630263|FG001|Overall Study|Death|0|||
149863675|NCT00430495|540630264|FG002|Overall Study|Death|1|||
149863676|NCT00430495|540630265|FG003|Overall Study|Death|0|||
149863677|NCT00430495|540630262|FG000|Overall Study|Lost to Follow-up|0|||
149863678|NCT00430495|540630263|FG001|Overall Study|Lost to Follow-up|1|||
149863679|NCT00430495|540630264|FG002|Overall Study|Lost to Follow-up|4|||
149863680|NCT00430495|540630265|FG003|Overall Study|Lost to Follow-up|0|||
149863681|NCT00430495|540630262|FG000|Overall Study|Protocol Violation|1|||
149863682|NCT00430495|540630263|FG001|Overall Study|Protocol Violation|0|||
149863683|NCT00430495|540630264|FG002|Overall Study|Protocol Violation|1|||
149863684|NCT00430495|540630265|FG003|Overall Study|Protocol Violation|0|||
149863685|NCT00430495|540630262|FG000|Overall Study|Disease Progression|1|||
149863686|NCT00430495|540630263|FG001|Overall Study|Disease Progression|1|||
149863687|NCT00430495|540630264|FG002|Overall Study|Disease Progression|0|||
149863688|NCT00430495|540630265|FG003|Overall Study|Disease Progression|0|||
149863689|NCT00430495|540630262|FG000|Overall Study|Other|8|||
149863690|NCT00430495|540630263|FG001|Overall Study|Other|2|||
149863691|NCT00430495|540630264|FG002|Overall Study|Other|5|||
149863692|NCT00430495|540630265|FG003|Overall Study|Other|4|||
149863693|NCT00430495|540630262|FG000|Overall Study|Randomized but not Treated|2|||
149863694|NCT00430495|540630263|FG001|Overall Study|Randomized but not Treated|0|||
149863695|NCT00430495|540630264|FG002|Overall Study|Randomized but not Treated|0|||
149863696|NCT00430495|540630265|FG003|Overall Study|Randomized but not Treated|0|||
149863697|NCT00158756|540630266|FG000|Overall Study|Withdrawal by Subject|5|||
149863698|NCT00158756|540630267|FG001|Overall Study|Withdrawal by Subject|0|||
149863699|NCT00158756|540630268|FG002|Overall Study|Withdrawal by Subject|6|||
149863700|NCT00158756|540630269|FG003|Overall Study|Withdrawal by Subject|1|||
149863701|NCT00158756|540630270|FG004|Overall Study|Withdrawal by Subject|3|||
149863702|NCT00158756|540630266|FG000|Overall Study|Adverse Event|0|||
149863703|NCT00158756|540630267|FG001|Overall Study|Adverse Event|0|||
149863704|NCT00158756|540630268|FG002|Overall Study|Adverse Event|1|||
149863705|NCT00158756|540630269|FG003|Overall Study|Adverse Event|0|||
149863706|NCT00158756|540630270|FG004|Overall Study|Adverse Event|0|||
149863707|NCT00158756|540630266|FG000|Overall Study|Serious adverse event|0|||
149863708|NCT00158756|540630267|FG001|Overall Study|Serious adverse event|0|||
149863709|NCT00158756|540630268|FG002|Overall Study|Serious adverse event|1|||
149863710|NCT00158756|540630269|FG003|Overall Study|Serious adverse event|0|||
149863711|NCT00158756|540630270|FG004|Overall Study|Serious adverse event|0|||
149863712|NCT02400671|540630271|FG000|Overall Study|Death|5|||
149863713|NCT02400671|540630272|FG001|Overall Study|Death|3|||
149863714|NCT02400671|540630273|FG002|Overall Study|Death|4|||
149863715|NCT02400671|540630271|FG000|Overall Study|Lost to Follow-up|20|||
149863716|NCT02400671|540630272|FG001|Overall Study|Lost to Follow-up|27|||
149863717|NCT02400671|540630273|FG002|Overall Study|Lost to Follow-up|24|||
149863718|NCT02400671|540630271|FG000|Overall Study|Withdrawal by Subject|2|||
149863719|NCT02400671|540630272|FG001|Overall Study|Withdrawal by Subject|2|||
149863720|NCT02400671|540630273|FG002|Overall Study|Withdrawal by Subject|0|||
149863721|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
149863722|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
149863723|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
149863724|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
149863725|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
149863726|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
149863727|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
150040777|NCT00790842|541289121|FG007|Dose Level 4|Adverse Event|0|||
149863728|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
149863729|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
149863730|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
149863731|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
149863732|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
149863733|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
149863734|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
149863735|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
149863736|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
149863737|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
149863738|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
149863739|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
149863740|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
149863741|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
149863742|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
149863743|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
149863744|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
149863745|NCT01421342|540630274|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
149863746|NCT01421342|540630275|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
149863747|NCT01421342|540630276|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
149863748|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
149863749|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
149863750|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
149863751|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
149863752|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
149863753|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
149863754|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
149863755|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
149863756|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
149863757|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
149863758|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
149863759|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
149863760|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
149863761|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
149863762|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
149863763|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
149863764|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
149863765|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
149863766|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
149863767|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
149863768|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
149863769|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
149863770|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
149863771|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
149863772|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
149863773|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
149863774|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
149863775|NCT01421342|540630274|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
149863776|NCT01421342|540630275|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
149863777|NCT01421342|540630276|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
149863778|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
149863779|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
149863780|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
149863781|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
149863782|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
149863783|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
149863784|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
149863785|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
149863786|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
149863787|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
149863788|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
149863789|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
149863790|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
150040778|NCT00790842|541289122|FG008|Dose Level 4|Adverse Event|0|||
150040779|NCT00790842|541289123|FG009|Dose Level 4|Adverse Event|0|||
149863791|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
149863792|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
149863793|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
149863794|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
149863795|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
149863796|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
149863797|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
149863798|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
149863799|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
149863800|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
149863801|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
149863802|NCT01421342|540630274|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
149863803|NCT01421342|540630275|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
149863804|NCT01421342|540630276|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
149863805|NCT03656874|540630279|FG000|Overall Study|Lost to Follow-up|3|||
149863806|NCT03656874|540630280|FG001|Overall Study|Lost to Follow-up|17|||
149863807|NCT03052322|540630282|FG000|Overall Study|Other un-specified|1|||
149863808|NCT03052322|540630283|FG001|Overall Study|Other un-specified|2|||
149863809|NCT03052322|540630282|FG000|Overall Study|Withdrawal by Subject|10|||
149863810|NCT03052322|540630283|FG001|Overall Study|Withdrawal by Subject|9|||
149863811|NCT03052322|540630282|FG000|Overall Study|Death|0|||
149863812|NCT03052322|540630283|FG001|Overall Study|Death|2|||
149863813|NCT03052322|540630282|FG000|Overall Study|Lack of Efficacy|1|||
149863814|NCT03052322|540630283|FG001|Overall Study|Lack of Efficacy|2|||
149863815|NCT03052322|540630282|FG000|Overall Study|Protocol Violation|1|||
149863816|NCT03052322|540630283|FG001|Overall Study|Protocol Violation|0|||
149863817|NCT03052322|540630282|FG000|Overall Study|Lost to Follow-up|2|||
149863818|NCT03052322|540630283|FG001|Overall Study|Lost to Follow-up|4|||
149863819|NCT03052322|540630282|FG000|Overall Study|Adverse Event|6|||
149863820|NCT03052322|540630283|FG001|Overall Study|Adverse Event|13|||
149863821|NCT00973765|540630284|FG000|Overall Study|Lost to Follow-up|8|||
149863822|NCT00973765|540630285|FG001|Overall Study|Lost to Follow-up|14|||
149863823|NCT01892657|540630288|FG000|Overall Study|Withdrawal by Subject|6|||
149863824|NCT01892657|540630288|FG000|Overall Study|Protocol Violation|12|||
149863825|NCT02712333|540630291|FG000|First Period|Withdrawal by Subject|3|||
149863826|NCT02712333|540630292|FG001|First Period|Withdrawal by Subject|2|||
149863827|NCT03463993|540630293|FG000|Overall Study|Lost to Follow-up|7|||
149863828|NCT03463993|540630294|FG001|Overall Study|Lost to Follow-up|8|||
149863829|NCT03463993|540630293|FG000|Overall Study|Withdrawal by Subject|2|||
149863830|NCT03463993|540630294|FG001|Overall Study|Withdrawal by Subject|0|||
149863831|NCT03463993|540630293|FG000|Overall Study|Protocol Violation|4|||
149863832|NCT03463993|540630294|FG001|Overall Study|Protocol Violation|1|||
149863833|NCT03463993|540630293|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
149863834|NCT03463993|540630294|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
149863835|NCT03463993|540630293|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
149863836|NCT03463993|540630294|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
149863837|NCT03977701|540630302|FG000|Overall Study|COVID-19 pandemic|0|||
149863838|NCT03977701|540630303|FG001|Overall Study|COVID-19 pandemic|0|||
149863839|NCT03977701|540630304|FG002|Overall Study|COVID-19 pandemic|0|||
149863840|NCT03977701|540630305|FG003|Overall Study|COVID-19 pandemic|0|||
149863841|NCT03977701|540630306|FG004|Overall Study|COVID-19 pandemic|0|||
149863842|NCT03977701|540630307|FG005|Overall Study|COVID-19 pandemic|1|||
149863843|NCT03977701|540630308|FG006|Overall Study|COVID-19 pandemic|0|||
149863844|NCT03977701|540630309|FG007|Overall Study|COVID-19 pandemic|1|||
149863845|NCT03977701|540630310|FG008|Overall Study|COVID-19 pandemic|0|||
149863846|NCT03977701|540630311|FG009|Overall Study|COVID-19 pandemic|0|||
149863847|NCT02429934|540630312|FG000|Overall Study|Withdrawal by Subject|0|||
149863848|NCT02429934|540630313|FG001|Overall Study|Withdrawal by Subject|2|||
149863849|NCT02429934|540630312|FG000|Overall Study|Adverse Event|2|||
149863850|NCT02429934|540630313|FG001|Overall Study|Adverse Event|0|||
149863851|NCT02429934|540630312|FG000|Overall Study|Lost to Follow-up|1|||
149863852|NCT02429934|540630313|FG001|Overall Study|Lost to Follow-up|1|||
149863853|NCT02429934|540630312|FG000|Overall Study|Physician Decision|1|||
149863854|NCT02429934|540630313|FG001|Overall Study|Physician Decision|0|||
149863855|NCT00869024|540630314|FG000|Overall Study|Death|2|||
149863856|NCT00869024|540630315|FG001|Overall Study|Death|3|||
149863857|NCT00869024|540630314|FG000|Overall Study|Lost to Follow-up|0|||
149863858|NCT00869024|540630315|FG001|Overall Study|Lost to Follow-up|1|||
149863859|NCT00869024|540630314|FG000|Overall Study|Protocol Violation|0|||
149863860|NCT00869024|540630315|FG001|Overall Study|Protocol Violation|1|||
149863861|NCT02025751|540630325|FG000|Overall Study|Lost to Follow-up|1|||
149863862|NCT02025751|540630326|FG001|Overall Study|Lost to Follow-up|0|||
149863863|NCT02025751|540630325|FG000|Overall Study|Adverse Event|0|||
149863864|NCT02025751|540630326|FG001|Overall Study|Adverse Event|1|||
149863865|NCT02025751|540630325|FG000|Overall Study|Physician Decision|0|||
149863866|NCT02025751|540630326|FG001|Overall Study|Physician Decision|1|||
149863867|NCT02025751|540630325|FG000|Overall Study|Withdrawal by Subject|0|||
149863868|NCT02025751|540630326|FG001|Overall Study|Withdrawal by Subject|1|||
149863869|NCT00653991|540630327|FG000|3 Month Follow-up|Participant would not respond|150|||
149863870|NCT00653991|540630328|FG001|3 Month Follow-up|Participant would not respond|157|||
149863871|NCT00653991|540630327|FG000|6 Month Follow-up|Participant would not respond|133|||
149863872|NCT00653991|540630328|FG001|6 Month Follow-up|Participant would not respond|141|||
149863873|NCT02181296|540630329|FG000|Overall Study|Lost to Follow-up|7|||
149863874|NCT02181296|540630330|FG001|Overall Study|Lost to Follow-up|6|||
149863875|NCT01568866|540630331|FG000|Overall Study|Disease Progression|208|||
149863876|NCT01568866|540630332|FG001|Overall Study|Disease Progression|183|||
150040780|NCT00790842|541289124|FG010|Dose Level 4|Adverse Event|0|||
150173809|NCT00071799|541772954|FG000|Overall Study|Withdrawal by Subject|15|||
149863877|NCT01568866|540630331|FG000|Overall Study|Adverse Event|94|||
150173810|NCT00071799|541772955|FG001|Overall Study|Withdrawal by Subject|37|||
149863878|NCT01568866|540630332|FG001|Overall Study|Adverse Event|96|||
149863879|NCT01568866|540630331|FG000|Overall Study|Patient Request|55|||
149863880|NCT01568866|540630332|FG001|Overall Study|Patient Request|71|||
149863881|NCT01568866|540630331|FG000|Overall Study|Physician Decision|40|||
149863882|NCT01568866|540630332|FG001|Overall Study|Physician Decision|32|||
149863883|NCT01568866|540630331|FG000|Overall Study|Withdrawal by Subject|19|||
149863884|NCT01568866|540630332|FG001|Overall Study|Withdrawal by Subject|11|||
149863885|NCT01568866|540630331|FG000|Overall Study|Death|10|||
149863886|NCT01568866|540630332|FG001|Overall Study|Death|18|||
149863887|NCT01568866|540630331|FG000|Overall Study|Protocol Non-compliance|2|||
149863888|NCT01568866|540630332|FG001|Overall Study|Protocol Non-compliance|4|||
149863889|NCT01568866|540630331|FG000|Overall Study|Lost to Follow-up|1|||
149863890|NCT01568866|540630332|FG001|Overall Study|Lost to Follow-up|0|||
149863891|NCT01568866|540630331|FG000|Overall Study|Randomized but Not Dosed|9|||
149863892|NCT01568866|540630332|FG001|Overall Study|Randomized but Not Dosed|1|||
149863893|NCT03864042|540630333|FG000|DDI Phase|Adverse Event|2|||
149863894|NCT03864042|540630334|FG001|DDI Phase|Adverse Event|0|||
149863895|NCT03864042|540630335|FG002|DDI Phase|Adverse Event|0|||
149863896|NCT03864042|540630333|FG000|DDI Phase|Physician Decision|1|||
149863897|NCT03864042|540630334|FG001|DDI Phase|Physician Decision|0|||
149863898|NCT03864042|540630335|FG002|DDI Phase|Physician Decision|0|||
149863899|NCT03864042|540630333|FG000|DDI Phase|Progressive Disease|1|||
149863900|NCT03864042|540630334|FG001|DDI Phase|Progressive Disease|0|||
149863901|NCT03864042|540630335|FG002|DDI Phase|Progressive Disease|0|||
149863902|NCT03864042|540630333|FG000|Post-DDI Phase|Adverse Event|5|||
149863903|NCT03864042|540630334|FG001|Post-DDI Phase|Adverse Event|3|||
149863904|NCT03864042|540630335|FG002|Post-DDI Phase|Adverse Event|2|||
149863905|NCT03864042|540630333|FG000|Post-DDI Phase|Progressive Disease|11|||
149863906|NCT03864042|540630334|FG001|Post-DDI Phase|Progressive Disease|6|||
149863907|NCT03864042|540630335|FG002|Post-DDI Phase|Progressive Disease|13|||
149863908|NCT03864042|540630333|FG000|Post-DDI Phase|Discretion of investigator|1|||
149863909|NCT03864042|540630334|FG001|Post-DDI Phase|Discretion of investigator|1|||
149863910|NCT03864042|540630335|FG002|Post-DDI Phase|Discretion of investigator|0|||
149863911|NCT03864042|540630333|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
149863912|NCT03864042|540630334|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
149863913|NCT03864042|540630335|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
149863914|NCT03864042|540630333|FG000|Post-DDI Phase|Withdrawal of consent|1|||
149863915|NCT03864042|540630334|FG001|Post-DDI Phase|Withdrawal of consent|2|||
149863916|NCT03864042|540630335|FG002|Post-DDI Phase|Withdrawal of consent|0|||
149863917|NCT01698775|540630336|FG000|Phase A|Adverse Event|2|||
149863918|NCT01698775|540630337|FG001|Phase A|Adverse Event|1|||
149863919|NCT01698775|540630336|FG000|Phase A|Death|1|||
149863920|NCT01698775|540630337|FG001|Phase A|Death|1|||
149962181|NCT02837952|540995847|FG000|Overall Study|Withdrawal by Subject|4|||
149863921|NCT01698775|540630336|FG000|Phase A|Lack of Efficacy|1|||
149863922|NCT01698775|540630337|FG001|Phase A|Lack of Efficacy|0|||
149863923|NCT01698775|540630336|FG000|Phase A|Lost to Follow-up|1|||
149863924|NCT01698775|540630337|FG001|Phase A|Lost to Follow-up|2|||
149863925|NCT01698775|540630336|FG000|Phase A|Protocol Violation|1|||
149863926|NCT01698775|540630337|FG001|Phase A|Protocol Violation|0|||
149863927|NCT01698775|540630336|FG000|Phase A|Withdrawal by Subject|3|||
149863928|NCT01698775|540630337|FG001|Phase A|Withdrawal by Subject|4|||
149863929|NCT01698775|540630336|FG000|Phase A|Kidney [transplant]|0|||
149863930|NCT01698775|540630337|FG001|Phase A|Kidney [transplant]|1|||
149863931|NCT01698775|540630336|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
149863932|NCT01698775|540630337|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
149863933|NCT01698775|540630336|FG000|Phase B|Adverse Event|6|||
149863934|NCT01698775|540630337|FG001|Phase B|Adverse Event|3|||
149863935|NCT01698775|540630336|FG000|Phase B|Death|0|||
149863936|NCT01698775|540630337|FG001|Phase B|Death|1|||
149863937|NCT01698775|540630336|FG000|Phase B|Lack of Efficacy|0|||
149863938|NCT01698775|540630337|FG001|Phase B|Lack of Efficacy|1|||
149863939|NCT01698775|540630336|FG000|Phase B|Lost to Follow-up|0|||
149863940|NCT01698775|540630337|FG001|Phase B|Lost to Follow-up|1|||
149863941|NCT01698775|540630336|FG000|Phase B|Physician Decision|1|||
149863942|NCT01698775|540630337|FG001|Phase B|Physician Decision|1|||
149863943|NCT01698775|540630336|FG000|Phase B|Protocol Violation|1|||
149863944|NCT01698775|540630337|FG001|Phase B|Protocol Violation|1|||
149863945|NCT01698775|540630336|FG000|Phase B|Withdrawal by Subject|6|||
149863946|NCT01698775|540630337|FG001|Phase B|Withdrawal by Subject|2|||
149863947|NCT02143583|540630340|FG000|Overall Study|Withdrawal by Subject|1|||
149863948|NCT02143583|540630341|FG001|Overall Study|Withdrawal by Subject|0|||
149863949|NCT02143583|540630342|FG002|Overall Study|Withdrawal by Subject|1|||
149863950|NCT02143583|540630340|FG000|Overall Study|husband illness|0|||
149863951|NCT02143583|540630341|FG001|Overall Study|husband illness|0|||
149863952|NCT02143583|540630342|FG002|Overall Study|husband illness|1|||
149863953|NCT01244061|540630343|FG000|Overall Study|Death|1|||
149863954|NCT01244061|540630344|FG001|Overall Study|Death|0|||
149863955|NCT01244061|540630343|FG000|Overall Study|Did not meet entrance criteria|1|||
149863956|NCT01244061|540630344|FG001|Overall Study|Did not meet entrance criteria|0|||
150173811|NCT00071799|541772954|FG000|Overall Study|Physician Decision|0|||
150173812|NCT00071799|541772955|FG001|Overall Study|Physician Decision|2|||
149863957|NCT01244061|540630343|FG000|Overall Study|Lack of Efficacy|1|||
149863958|NCT01244061|540630344|FG001|Overall Study|Lack of Efficacy|3|||
149863959|NCT01244061|540630343|FG000|Overall Study|Lost to Follow-up|34|||
149863960|NCT01244061|540630344|FG001|Overall Study|Lost to Follow-up|30|||
149863961|NCT01244061|540630343|FG000|Overall Study|Withdrawal by Subject|29|||
149863962|NCT01244061|540630344|FG001|Overall Study|Withdrawal by Subject|46|||
149863963|NCT01244061|540630343|FG000|Overall Study|Other|8|||
149863964|NCT01244061|540630344|FG001|Overall Study|Other|19|||
149863965|NCT01244061|540630343|FG000|Overall Study|Protocol Violation|1|||
149863966|NCT01244061|540630344|FG001|Overall Study|Protocol Violation|1|||
149863967|NCT01244061|540630343|FG000|Overall Study|Adverse Event|5|||
149863968|NCT01244061|540630344|FG001|Overall Study|Adverse Event|2|||
149863969|NCT01244061|540630343|FG000|Overall Study|Randomized but not treated|2|||
149863970|NCT01244061|540630344|FG001|Overall Study|Randomized but not treated|2|||
149863971|NCT03499119|540630347|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
149863972|NCT03499119|540630348|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
149863973|NCT03499119|540630349|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
149863974|NCT03499119|540630350|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
149863975|NCT03499119|540630347|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
149863976|NCT03499119|540630348|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
149863977|NCT03499119|540630349|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
149863978|NCT03499119|540630350|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
149863979|NCT03499119|540630347|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
149863980|NCT03499119|540630348|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
149863981|NCT03499119|540630349|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
149863982|NCT03499119|540630350|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
149863983|NCT03499119|540630347|FG000|Optional Extension Phase|Lost to Follow-up|0|||
149863984|NCT03499119|540630348|FG001|Optional Extension Phase|Lost to Follow-up|0|||
149863985|NCT03499119|540630349|FG002|Optional Extension Phase|Lost to Follow-up|0|||
149863986|NCT03499119|540630350|FG003|Optional Extension Phase|Lost to Follow-up|1|||
149863987|NCT03499119|540630347|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
149863988|NCT03499119|540630348|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
149863989|NCT03499119|540630349|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
149863990|NCT03499119|540630350|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
149863991|NCT03499119|540630347|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
149863992|NCT03499119|540630348|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
149863993|NCT03499119|540630349|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
149863994|NCT03499119|540630350|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
149863995|NCT04718194|540631729|FG000|Overall Study|Withdrawal by Subject|3|||
149863996|NCT04718194|540631730|FG001|Overall Study|Withdrawal by Subject|0|||
149863997|NCT04718194|540631729|FG000|Overall Study|Lost to Follow-up|3|||
149863998|NCT04718194|540631730|FG001|Overall Study|Lost to Follow-up|0|||
149863999|NCT04551911|540631733|FG000|Overall Study|Lost to Follow-up|2|||
149864000|NCT04551911|540631734|FG001|Overall Study|Lost to Follow-up|1|||
149864001|NCT04551911|540631733|FG000|Overall Study|Withdrawal by Subject|10|||
149864002|NCT04551911|540631734|FG001|Overall Study|Withdrawal by Subject|10|||
149864003|NCT04551911|540631733|FG000|Overall Study|Did not receive the study drug|3|||
149864004|NCT04551911|540631734|FG001|Overall Study|Did not receive the study drug|4|||
149864005|NCT01215513|540631735|FG000|Overall Study|Not completed CS42|9|||
149864006|NCT01215513|540631735|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
149864007|NCT01215513|540631735|FG000|Overall Study|Adverse event (CS42A)|2|||
149864008|NCT01215513|540631735|FG000|Overall Study|Physician decision (CS42A)|6|||
149864009|NCT01215513|540631735|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
149864010|NCT01215513|540631735|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
149864011|NCT00821873|540631737|FG000|Overall Study|Lost to Follow-up|4|||
149864012|NCT02177136|540631740|FG000|DB Phase|Withdrawal by Subject|2|||
149864013|NCT02177136|540631741|FG001|DB Phase|Withdrawal by Subject|0|||
149864014|NCT02177136|540631742|FG002|DB Phase|Withdrawal by Subject|0|||
149864015|NCT02177136|540631743|FG003|DB Phase|Withdrawal by Subject|0|||
149864016|NCT02177136|540631740|FG000|DB Phase|Discontinued Due to Pruritus|1|||
149864017|NCT02177136|540631741|FG001|DB Phase|Discontinued Due to Pruritus|3|||
149864018|NCT02177136|540631742|FG002|DB Phase|Discontinued Due to Pruritus|0|||
149864019|NCT02177136|540631743|FG003|DB Phase|Discontinued Due to Pruritus|0|||
149864020|NCT02177136|540631740|FG000|DB Phase|Adverse Event|3|||
149864021|NCT02177136|540631741|FG001|DB Phase|Adverse Event|2|||
149864022|NCT02177136|540631742|FG002|DB Phase|Adverse Event|3|||
149864023|NCT02177136|540631743|FG003|DB Phase|Adverse Event|0|||
149864024|NCT02177136|540631740|FG000|DB Phase|Protocol Violation|0|||
149864025|NCT02177136|540631741|FG001|DB Phase|Protocol Violation|0|||
149864026|NCT02177136|540631742|FG002|DB Phase|Protocol Violation|1|||
149864027|NCT02177136|540631743|FG003|DB Phase|Protocol Violation|0|||
149864028|NCT02177136|540631740|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
149864029|NCT02177136|540631741|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
149864030|NCT02177136|540631742|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
149864031|NCT02177136|540631743|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
149864032|NCT02177136|540631740|FG000|LTSE Phase|Withdrawal by Subject|0|||
149864033|NCT02177136|540631741|FG001|LTSE Phase|Withdrawal by Subject|0|||
149864034|NCT02177136|540631742|FG002|LTSE Phase|Withdrawal by Subject|0|||
149864035|NCT02177136|540631743|FG003|LTSE Phase|Withdrawal by Subject|6|||
149864036|NCT02177136|540631740|FG000|LTSE Phase|Adverse Event|0|||
149864037|NCT02177136|540631741|FG001|LTSE Phase|Adverse Event|0|||
150173813|NCT00071799|541772954|FG000|Overall Study|Lack of Efficacy|11|||
149864038|NCT02177136|540631742|FG002|LTSE Phase|Adverse Event|0|||
149864039|NCT02177136|540631743|FG003|LTSE Phase|Adverse Event|10|||
149864040|NCT02177136|540631740|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
149864041|NCT02177136|540631741|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
149864042|NCT02177136|540631742|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
149864043|NCT02177136|540631743|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
149864044|NCT02177136|540631740|FG000|LTSE Phase|Physician Decision|0|||
149864045|NCT02177136|540631741|FG001|LTSE Phase|Physician Decision|0|||
149864046|NCT02177136|540631742|FG002|LTSE Phase|Physician Decision|0|||
149864047|NCT02177136|540631743|FG003|LTSE Phase|Physician Decision|2|||
149864048|NCT02177136|540631740|FG000|LTSE Phase|Lost to Follow-up|0|||
149864049|NCT02177136|540631741|FG001|LTSE Phase|Lost to Follow-up|0|||
149864050|NCT02177136|540631742|FG002|LTSE Phase|Lost to Follow-up|0|||
149864051|NCT02177136|540631743|FG003|LTSE Phase|Lost to Follow-up|1|||
149864052|NCT02177136|540631740|FG000|LTSE Phase|Participant Moved|0|||
149864053|NCT02177136|540631741|FG001|LTSE Phase|Participant Moved|0|||
149864054|NCT02177136|540631742|FG002|LTSE Phase|Participant Moved|0|||
149864055|NCT02177136|540631743|FG003|LTSE Phase|Participant Moved|1|||
149864056|NCT00729248|540631748|FG000|Overall Study|Physician Decision|2|||
149864057|NCT03573505|540631749|FG000|Overall Study|Adverse Event|1|||
149864058|NCT03573505|540631750|FG001|Overall Study|Adverse Event|1|||
149864059|NCT03573505|540631749|FG000|Overall Study|Consent withdrawn|0|||
149864060|NCT03573505|540631750|FG001|Overall Study|Consent withdrawn|1|||
149864061|NCT03573505|540631749|FG000|Overall Study|Disease progression|0|||
149864062|NCT03573505|540631750|FG001|Overall Study|Disease progression|1|||
149864063|NCT03573505|540631749|FG000|Overall Study|Site Terminated by Sponsor|1|||
149864064|NCT03573505|540631750|FG001|Overall Study|Site Terminated by Sponsor|1|||
149864065|NCT03573505|540631749|FG000|Overall Study|Study terminated by sponsor|50|||
149864066|NCT03573505|540631750|FG001|Overall Study|Study terminated by sponsor|45|||
149864067|NCT03573505|540631749|FG000|Overall Study|Reason not specified|0|||
149864068|NCT03573505|540631750|FG001|Overall Study|Reason not specified|1|||
149864069|NCT03573505|540631749|FG000|Overall Study|Death|0|||
149864070|NCT03573505|540631750|FG001|Overall Study|Death|4|||
149864071|NCT04268316|540631751|FG000|Overall Study|Withdrawal by Subject|2|||
149864072|NCT04268316|540631752|FG001|Overall Study|Withdrawal by Subject|1|||
149864073|NCT04268316|540631753|FG002|Overall Study|Withdrawal by Subject|0|||
149864074|NCT02040779|540631755|FG000|Overall Study|Adverse Event|1|||
149864075|NCT02040779|540631756|FG001|Overall Study|Adverse Event|0|||
149864076|NCT02040779|540631757|FG002|Overall Study|Adverse Event|0|||
149864077|NCT02040779|540631755|FG000|Overall Study|Withdrawal by Subject|4|||
149864078|NCT02040779|540631756|FG001|Overall Study|Withdrawal by Subject|1|||
149864079|NCT02040779|540631757|FG002|Overall Study|Withdrawal by Subject|3|||
149962182|NCT02837952|540995848|FG001|Overall Study|Withdrawal by Subject|5|||
149962183|NCT02837952|540995847|FG000|Overall Study|Medication Error|1|||
149962184|NCT02837952|540995848|FG001|Overall Study|Medication Error|0|||
149864080|NCT02040779|540631755|FG000|Overall Study|Non-compliance|0|||
149864081|NCT02040779|540631756|FG001|Overall Study|Non-compliance|1|||
149864082|NCT02040779|540631757|FG002|Overall Study|Non-compliance|0|||
149864083|NCT02040779|540631755|FG000|Overall Study|Protocol Violation|2|||
149864084|NCT02040779|540631756|FG001|Overall Study|Protocol Violation|1|||
149864085|NCT02040779|540631757|FG002|Overall Study|Protocol Violation|0|||
149864086|NCT02040779|540631755|FG000|Overall Study|Lost to Follow-up|1|||
149864087|NCT02040779|540631756|FG001|Overall Study|Lost to Follow-up|2|||
149864088|NCT02040779|540631757|FG002|Overall Study|Lost to Follow-up|1|||
149864089|NCT02040779|540631755|FG000|Overall Study|Lack of Efficacy|4|||
149864090|NCT02040779|540631756|FG001|Overall Study|Lack of Efficacy|2|||
149864091|NCT02040779|540631757|FG002|Overall Study|Lack of Efficacy|0|||
149864092|NCT02132637|540631758|FG000|Study Period 1|Withdrawal by Subject|0|||
149864093|NCT02132637|540631759|FG001|Study Period 1|Withdrawal by Subject|4|||
149864094|NCT02132637|540631758|FG000|Study Period 1|Physician Decision|1|||
149864095|NCT02132637|540631759|FG001|Study Period 1|Physician Decision|0|||
149864096|NCT02132637|540631758|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
149864097|NCT02132637|540631759|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
149864098|NCT02132637|540631758|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
149864099|NCT02132637|540631759|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
149864100|NCT00866658|540631760|FG000|Overall Study|Adverse Event|5|||
149864101|NCT00866658|540631761|FG001|Overall Study|Adverse Event|14|||
149864102|NCT00866658|540631760|FG000|Overall Study|Lack of Efficacy|2|||
149864103|NCT00866658|540631761|FG001|Overall Study|Lack of Efficacy|1|||
149864104|NCT00866658|540631760|FG000|Overall Study|Withdrawal by Subject|1|||
149864105|NCT00866658|540631761|FG001|Overall Study|Withdrawal by Subject|0|||
149864106|NCT00866658|540631760|FG000|Overall Study|Protocol Violation|1|||
149864107|NCT00866658|540631761|FG001|Overall Study|Protocol Violation|1|||
149864108|NCT00866658|540631760|FG000|Overall Study|Familial and Personal Reasons|4|||
149864109|NCT00866658|540631761|FG001|Overall Study|Familial and Personal Reasons|5|||
149864110|NCT02751359|540631763|FG000|Overall Study|Lost to Follow-up|1|||
149864111|NCT02145026|540631767|FG000|Overall Study|Adverse Event|2|||
149864112|NCT02145026|540631767|FG000|Overall Study|Death|4|||
149864113|NCT02145026|540631767|FG000|Overall Study|Withdrawal by Subject|2|||
149864114|NCT02145026|540631767|FG000|Overall Study|Physician Decision|4|||
149864115|NCT04920916|540631768|FG000|Phase IIa 60 Day Study|Death|2|||
149864116|NCT04920916|540631769|FG001|Phase IIa 60 Day Study|Death|5|||
149864117|NCT04920916|540631768|FG000|1 Year Follow up (Phone Call)|Death|1|||
149864118|NCT04920916|540631769|FG001|1 Year Follow up (Phone Call)|Death|3|||
149864119|NCT04920916|540631768|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
149864120|NCT04920916|540631769|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
149864121|NCT00076804|540631770|FG000|Overall Study|Death|9|||
149864122|NCT00076804|540631771|FG001|Overall Study|Death|20|||
149864123|NCT00076804|540631770|FG000|Overall Study|Lost to Follow-up|9|||
149864124|NCT00076804|540631771|FG001|Overall Study|Lost to Follow-up|9|||
149864125|NCT00076804|540631770|FG000|Overall Study|Withdrawal by Subject|10|||
149864126|NCT00076804|540631771|FG001|Overall Study|Withdrawal by Subject|8|||
149864127|NCT00076804|540631770|FG000|Overall Study|Early study Closure|32|||
149864128|NCT00076804|540631771|FG001|Overall Study|Early study Closure|32|||
149864129|NCT00354341|540631772|FG000|Overall Study|Adverse Event|1|||
149864130|NCT00354341|540631773|FG001|Overall Study|Adverse Event|0|||
149864131|NCT00354341|540631772|FG000|Overall Study|Death|0|||
149864132|NCT00354341|540631773|FG001|Overall Study|Death|2|||
149864133|NCT00354341|540631772|FG000|Overall Study|Refused treatment|1|||
149864134|NCT00354341|540631773|FG001|Overall Study|Refused treatment|2|||
150173814|NCT00071799|541772955|FG001|Overall Study|Lack of Efficacy|18|||
150173815|NCT00071799|541772954|FG000|Overall Study|Disease Progression|23|||
150173816|NCT00071799|541772955|FG001|Overall Study|Disease Progression|20|||
150173817|NCT00071799|541772954|FG000|Overall Study|Different Central+Local Pathology Review|0|||
150173818|NCT00071799|541772955|FG001|Overall Study|Different Central+Local Pathology Review|1|||
150173819|NCT00071799|541772954|FG000|Overall Study|Not Documented|0|||
149864135|NCT00354341|540631772|FG000|Overall Study|Failure to return|0|||
149864136|NCT00354341|540631773|FG001|Overall Study|Failure to return|1|||
149864137|NCT00354341|540631772|FG000|Overall Study|Other|1|||
149864138|NCT00354341|540631773|FG001|Overall Study|Other|2|||
149864139|NCT01546649|540631780|FG000|Overall Study|Adverse Event|4|||
149864140|NCT01546649|540631781|FG001|Overall Study|Adverse Event|5|||
149864141|NCT01546649|540631780|FG000|Overall Study|Protocol Violation|1|||
149864142|NCT01546649|540631781|FG001|Overall Study|Protocol Violation|0|||
149864143|NCT01546649|540631780|FG000|Overall Study|Lack of Efficacy|1|||
149864144|NCT01546649|540631781|FG001|Overall Study|Lack of Efficacy|0|||
149864145|NCT01546649|540631780|FG000|Overall Study|Recurrence|1|||
149864146|NCT01546649|540631781|FG001|Overall Study|Recurrence|1|||
149864147|NCT01546649|540631780|FG000|Overall Study|Discovery of secondary cancer|0|||
149864148|NCT01546649|540631781|FG001|Overall Study|Discovery of secondary cancer|1|||
149864149|NCT01546649|540631780|FG000|Overall Study|Withdrawal by Subject|1|||
150173820|NCT00071799|541772955|FG001|Overall Study|Not Documented|2|||
150173821|NCT04527549|541772958|FG000|Overall Study|Withdrawal by Subject|1|||
149864150|NCT01546649|540631781|FG001|Overall Study|Withdrawal by Subject|2|||
149864151|NCT00038649|540631786|FG000|Overall Study|Adverse Event|9|||
149864152|NCT01901874|540631788|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
149864153|NCT01901874|540631788|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
149864154|NCT01901874|540631788|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
149864155|NCT01901874|540631788|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
149864156|NCT01901874|540631788|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
149864157|NCT01901874|540631788|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
149864158|NCT01347866|540631789|FG000|Overall Study|Death|0|||
149864159|NCT01347866|540631790|FG001|Overall Study|Death|0|||
149864160|NCT01347866|540631791|FG002|Overall Study|Death|0|||
149864161|NCT01347866|540631792|FG003|Overall Study|Death|1|||
149864162|NCT01347866|540631793|FG004|Overall Study|Death|2|||
149864163|NCT01347866|540631794|FG005|Overall Study|Death|2|||
149864164|NCT01347866|540631795|FG006|Overall Study|Death|1|||
149864165|NCT01347866|540631796|FG007|Overall Study|Death|0|||
149864166|NCT01347866|540631797|FG008|Overall Study|Death|4|||
149864167|NCT01347866|540631798|FG009|Overall Study|Death|1|||
149864168|NCT01347866|540631799|FG010|Overall Study|Death|3|||
149864169|NCT01347866|540631800|FG011|Overall Study|Death|1|||
149864170|NCT01347866|540631801|FG012|Overall Study|Death|2|||
149864171|NCT01347866|540631802|FG013|Overall Study|Death|0|||
149864172|NCT01347866|540631803|FG014|Overall Study|Death|0|||
149864173|NCT01347866|540631804|FG015|Overall Study|Death|1|||
149864174|NCT01347866|540631805|FG016|Overall Study|Death|0|||
149864175|NCT01347866|540631789|FG000|Overall Study|Lost to Follow-up|0|||
149864176|NCT01347866|540631790|FG001|Overall Study|Lost to Follow-up|0|||
149864177|NCT01347866|540631791|FG002|Overall Study|Lost to Follow-up|0|||
149864178|NCT01347866|540631792|FG003|Overall Study|Lost to Follow-up|0|||
149864179|NCT01347866|540631793|FG004|Overall Study|Lost to Follow-up|0|||
149864180|NCT01347866|540631794|FG005|Overall Study|Lost to Follow-up|0|||
149864181|NCT01347866|540631795|FG006|Overall Study|Lost to Follow-up|0|||
149864182|NCT01347866|540631796|FG007|Overall Study|Lost to Follow-up|1|||
150173822|NCT04527549|541772959|FG001|Overall Study|Withdrawal by Subject|1|||
150173823|NCT00814346|541772960|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
149864183|NCT01347866|540631797|FG008|Overall Study|Lost to Follow-up|1|||
149864184|NCT01347866|540631798|FG009|Overall Study|Lost to Follow-up|0|||
149864185|NCT01347866|540631799|FG010|Overall Study|Lost to Follow-up|0|||
149864186|NCT01347866|540631800|FG011|Overall Study|Lost to Follow-up|0|||
149864187|NCT01347866|540631801|FG012|Overall Study|Lost to Follow-up|0|||
149864188|NCT01347866|540631802|FG013|Overall Study|Lost to Follow-up|0|||
149864189|NCT01347866|540631803|FG014|Overall Study|Lost to Follow-up|0|||
149864190|NCT01347866|540631804|FG015|Overall Study|Lost to Follow-up|0|||
149864191|NCT01347866|540631805|FG016|Overall Study|Lost to Follow-up|0|||
149864192|NCT01347866|540631789|FG000|Overall Study|Other|3|||
149864193|NCT01347866|540631790|FG001|Overall Study|Other|1|||
149864194|NCT01347866|540631791|FG002|Overall Study|Other|1|||
149864195|NCT01347866|540631792|FG003|Overall Study|Other|4|||
149864196|NCT01347866|540631793|FG004|Overall Study|Other|5|||
149864197|NCT01347866|540631794|FG005|Overall Study|Other|0|||
149864198|NCT01347866|540631795|FG006|Overall Study|Other|5|||
149864199|NCT01347866|540631796|FG007|Overall Study|Other|3|||
149864200|NCT01347866|540631797|FG008|Overall Study|Other|22|||
149864201|NCT01347866|540631798|FG009|Overall Study|Other|5|||
149864202|NCT01347866|540631799|FG010|Overall Study|Other|0|||
149864203|NCT01347866|540631800|FG011|Overall Study|Other|3|||
149864204|NCT01347866|540631801|FG012|Overall Study|Other|4|||
149864205|NCT01347866|540631802|FG013|Overall Study|Other|4|||
149864206|NCT01347866|540631803|FG014|Overall Study|Other|2|||
149864207|NCT01347866|540631804|FG015|Overall Study|Other|3|||
149864208|NCT01347866|540631805|FG016|Overall Study|Other|0|||
149864209|NCT01347866|540631789|FG000|Overall Study|Subject refused further follow-up|2|||
149864210|NCT01347866|540631790|FG001|Overall Study|Subject refused further follow-up|0|||
149864211|NCT01347866|540631791|FG002|Overall Study|Subject refused further follow-up|0|||
149864212|NCT01347866|540631792|FG003|Overall Study|Subject refused further follow-up|2|||
150040781|NCT00790842|541289114|FG000|Dose Level 4|Physician Decision|0|||
149864213|NCT01347866|540631793|FG004|Overall Study|Subject refused further follow-up|0|||
149864214|NCT01347866|540631794|FG005|Overall Study|Subject refused further follow-up|1|||
150040782|NCT00790842|541289115|FG001|Dose Level 4|Physician Decision|0|||
149864215|NCT01347866|540631795|FG006|Overall Study|Subject refused further follow-up|0|||
149864216|NCT01347866|540631796|FG007|Overall Study|Subject refused further follow-up|0|||
149864217|NCT01347866|540631797|FG008|Overall Study|Subject refused further follow-up|4|||
149864218|NCT01347866|540631798|FG009|Overall Study|Subject refused further follow-up|1|||
149864219|NCT01347866|540631799|FG010|Overall Study|Subject refused further follow-up|0|||
149864220|NCT01347866|540631800|FG011|Overall Study|Subject refused further follow-up|0|||
149864221|NCT01347866|540631801|FG012|Overall Study|Subject refused further follow-up|1|||
149864222|NCT01347866|540631802|FG013|Overall Study|Subject refused further follow-up|3|||
149864223|NCT01347866|540631803|FG014|Overall Study|Subject refused further follow-up|1|||
149864224|NCT01347866|540631804|FG015|Overall Study|Subject refused further follow-up|0|||
149864225|NCT01347866|540631805|FG016|Overall Study|Subject refused further follow-up|2|||
149864226|NCT02939014|540631808|FG000|Overall Study|Lost to Follow-up|1|||
149864227|NCT02939014|540631809|FG001|Overall Study|Lost to Follow-up|0|||
149864228|NCT02939014|540631808|FG000|Overall Study|Death|4|||
149864229|NCT02939014|540631809|FG001|Overall Study|Death|3|||
149864230|NCT01641133|540631812|FG000|Overall Study|Protocol Violation|0|||
149864231|NCT01641133|540631813|FG001|Overall Study|Protocol Violation|1|||
149864232|NCT01641133|540631814|FG002|Overall Study|Protocol Violation|1|||
149864233|NCT01641133|540631812|FG000|Overall Study|Migrated/moved from study area|5|||
149864234|NCT01641133|540631813|FG001|Overall Study|Migrated/moved from study area|3|||
149864235|NCT01641133|540631814|FG002|Overall Study|Migrated/moved from study area|1|||
149864236|NCT01641133|540631812|FG000|Overall Study|Adverse Event|0|||
149864237|NCT01641133|540631813|FG001|Overall Study|Adverse Event|0|||
149864238|NCT01641133|540631814|FG002|Overall Study|Adverse Event|1|||
149864239|NCT01641133|540631812|FG000|Overall Study|Withdrawal by Subject|5|||
149864240|NCT01641133|540631813|FG001|Overall Study|Withdrawal by Subject|3|||
149864241|NCT01641133|540631814|FG002|Overall Study|Withdrawal by Subject|3|||
149864242|NCT01641133|540631812|FG000|Overall Study|Lost to Follow-up|0|||
149864243|NCT01641133|540631813|FG001|Overall Study|Lost to Follow-up|2|||
149864244|NCT01641133|540631814|FG002|Overall Study|Lost to Follow-up|2|||
149864245|NCT02220725|540631815|FG000|Overall Study|Lost to Follow-up|0|||
149864246|NCT02220725|540631816|FG001|Overall Study|Lost to Follow-up|0|||
149864247|NCT02220725|540631817|FG002|Overall Study|Lost to Follow-up|0|||
149864248|NCT02220725|540631818|FG003|Overall Study|Lost to Follow-up|1|||
149864249|NCT02220725|540631815|FG000|Overall Study|Withdrawal by Subject|0|||
149864250|NCT02220725|540631816|FG001|Overall Study|Withdrawal by Subject|0|||
149864251|NCT02220725|540631817|FG002|Overall Study|Withdrawal by Subject|0|||
149864252|NCT02220725|540631818|FG003|Overall Study|Withdrawal by Subject|1|||
149864253|NCT03351231|540631819|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
149864254|NCT03351231|540631819|FG000|Combination Therapy Period|Disease progression|2|||
149864255|NCT03351231|540631819|FG000|Combination Therapy Period|Study drug toxicity|1|||
149864256|NCT03351231|540631819|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
149864257|NCT03351231|540631819|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
149864258|NCT03351231|540631819|FG000|Safety Follow-Up Period|Other reason|2|||
149864259|NCT02333487|540631824|FG000|Overall Study|Adverse Event|0|||
149864260|NCT02333487|540631825|FG001|Overall Study|Adverse Event|2|||
149864261|NCT02333487|540631826|FG002|Overall Study|Adverse Event|0|||
149864262|NCT00123955|540631827|FG000|Overall Study|Adverse Event|1|||
149864263|NCT00123955|540631828|FG001|Overall Study|Adverse Event|0|||
149864264|NCT00123955|540631827|FG000|Overall Study|Withdrawal by Subject|4|||
149864265|NCT00123955|540631828|FG001|Overall Study|Withdrawal by Subject|3|||
149864266|NCT00123955|540631827|FG000|Overall Study|Death|0|||
149864267|NCT00123955|540631828|FG001|Overall Study|Death|1|||
149864268|NCT01558297|540631829|FG000|Overall Study|Withdrawal by Subject|2|||
149864269|NCT01558297|540631830|FG001|Overall Study|Withdrawal by Subject|2|||
149864270|NCT01558297|540631831|FG002|Overall Study|Withdrawal by Subject|1|||
149864271|NCT04189445|540633395|FG000|Overall Study|Withdrawal of consent|8|||
149864272|NCT04189445|540633396|FG001|Overall Study|Withdrawal of consent|1|||
149864273|NCT04189445|540633397|FG002|Overall Study|Withdrawal of consent|0|||
149864274|NCT04189445|540633395|FG000|Overall Study|Study Terminated by Sponsor|25|||
149864275|NCT04189445|540633396|FG001|Overall Study|Study Terminated by Sponsor|3|||
149864276|NCT04189445|540633397|FG002|Overall Study|Study Terminated by Sponsor|0|||
149864277|NCT04189445|540633395|FG000|Overall Study|Death|54|||
149864278|NCT04189445|540633396|FG001|Overall Study|Death|24|||
149864279|NCT04189445|540633397|FG002|Overall Study|Death|0|||
149864280|NCT02960893|540633399|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
149864281|NCT02960893|540633400|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
149864282|NCT02960893|540633401|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
149864283|NCT02960893|540633402|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
149864284|NCT02960893|540633399|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
149864285|NCT02960893|540633400|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
149864286|NCT02960893|540633401|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
149864287|NCT02960893|540633402|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
149864288|NCT02960893|540633399|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
149864289|NCT02960893|540633400|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
149864290|NCT02960893|540633401|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
149864291|NCT02960893|540633402|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
149864292|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
149864293|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
149864294|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
149864295|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
149864296|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
149864297|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
149864298|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
150173824|NCT00814346|541772961|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
149864299|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
149864300|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
149864301|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
149864302|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
149864303|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
149864304|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
149864305|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
149864306|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
149864307|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
149864308|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
149864309|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
149864310|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
149864311|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
149864312|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
149864313|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
149864314|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
149864315|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
149864316|NCT02960893|540633399|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
149864317|NCT02960893|540633400|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
149962185|NCT01362530|540995849|FG000|Base Study (Cycle 1)|Adverse Event|2|||
149962186|NCT01362530|540995850|FG001|Base Study (Cycle 1)|Adverse Event|0|||
149962187|NCT01362530|540995849|FG000|Base Study (Cycle 1)|Physician Decision|0|||
149962188|NCT01362530|540995850|FG001|Base Study (Cycle 1)|Physician Decision|1|||
149962189|NCT01362530|540995849|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
149962190|NCT01362530|540995850|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
149962191|NCT01362530|540995849|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
149962192|NCT01362530|540995850|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
149962193|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
149962194|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
150040783|NCT00790842|541289116|FG002|Dose Level 4|Physician Decision|0|||
149864318|NCT02960893|540633401|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
149864319|NCT02960893|540633402|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
149864320|NCT06204887|540633403|FG000|Overall Study|Lost to Follow-up|3|||
149864321|NCT06204887|540633404|FG001|Overall Study|Lost to Follow-up|4|||
149864322|NCT06204887|540633405|FG002|Overall Study|Lost to Follow-up|1|||
149864323|NCT06204887|540633406|FG003|Overall Study|Lost to Follow-up|6|||
149864324|NCT05142566|540633407|FG000|Overall Study|Protocol Violation|1|||
149864325|NCT02054130|540633409|FG000|Overall Study|Withdrawal by Subject|4|||
149864326|NCT02054130|540633410|FG001|Overall Study|Withdrawal by Subject|4|||
149864327|NCT02054130|540633411|FG002|Overall Study|Withdrawal by Subject|7|||
149864328|NCT02054130|540633412|FG003|Overall Study|Withdrawal by Subject|10|||
149864329|NCT02054130|540633409|FG000|Overall Study|Death|0|||
149864330|NCT02054130|540633410|FG001|Overall Study|Death|1|||
149864331|NCT02054130|540633411|FG002|Overall Study|Death|0|||
149864332|NCT02054130|540633412|FG003|Overall Study|Death|0|||
149864333|NCT02054130|540633409|FG000|Overall Study|Lost to Follow-up|0|||
149864334|NCT02054130|540633410|FG001|Overall Study|Lost to Follow-up|0|||
149864335|NCT02054130|540633411|FG002|Overall Study|Lost to Follow-up|1|||
149864336|NCT02054130|540633412|FG003|Overall Study|Lost to Follow-up|2|||
149864337|NCT02054130|540633409|FG000|Overall Study|Missed dose|4|||
149864338|NCT02054130|540633410|FG001|Overall Study|Missed dose|6|||
149864339|NCT02054130|540633411|FG002|Overall Study|Missed dose|7|||
149864340|NCT02054130|540633412|FG003|Overall Study|Missed dose|10|||
149864341|NCT01386684|540633413|FG000|Overall Study|Lost to Follow-up|51|||
149864342|NCT01386684|540633413|FG000|Overall Study|Other|51|||
149864343|NCT01386684|540633413|FG000|Overall Study|Death|47|||
149864344|NCT01386684|540633413|FG000|Overall Study|Withdrawal of Consent|44|||
149864345|NCT01386684|540633413|FG000|Overall Study|Alternative Therapy Required|37|||
149864346|NCT01386684|540633413|FG000|Overall Study|Disease Progression|28|||
149864347|NCT01386684|540633413|FG000|Overall Study|Adverse Event|20|||
149864348|NCT01386684|540633413|FG000|Overall Study|Noncompliance|8|||
149864349|NCT01386684|540633413|FG000|Overall Study|Protocol Violation|4|||
149864350|NCT01386684|540633413|FG000|Overall Study|Missing|3|||
149864351|NCT00094458|540633416|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
149864352|NCT00094458|540633417|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
149864353|NCT00094458|540633418|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
149864354|NCT00094458|540633419|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
149864355|NCT00094458|540633420|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
149864356|NCT00094458|540633421|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
149864357|NCT00094458|540633416|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
149864358|NCT00094458|540633417|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
149864359|NCT00094458|540633418|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
149864360|NCT00094458|540633419|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
149864361|NCT00094458|540633420|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
149864362|NCT00094458|540633421|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
149864363|NCT00094458|540633416|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
149864364|NCT00094458|540633417|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
149864365|NCT00094458|540633418|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
149864366|NCT00094458|540633419|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
149864367|NCT00094458|540633420|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
149864368|NCT00094458|540633421|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
149864369|NCT00094458|540633416|FG000|Main Study: Through Week 30|Adverse Event|38|||
149864370|NCT00094458|540633417|FG001|Main Study: Through Week 30|Adverse Event|20|||
149864371|NCT00094458|540633418|FG002|Main Study: Through Week 30|Adverse Event|28|||
149864372|NCT00094458|540633419|FG003|Main Study: Through Week 30|Adverse Event|0|||
149864373|NCT00094458|540633420|FG004|Main Study: Through Week 30|Adverse Event|0|||
149864374|NCT00094458|540633421|FG005|Main Study: Through Week 30|Adverse Event|0|||
149864375|NCT00094458|540633416|FG000|Main Study: Through Week 30|Death|1|||
149864376|NCT00094458|540633417|FG001|Main Study: Through Week 30|Death|0|||
149864377|NCT00094458|540633418|FG002|Main Study: Through Week 30|Death|0|||
149864378|NCT00094458|540633419|FG003|Main Study: Through Week 30|Death|0|||
149864379|NCT00094458|540633420|FG004|Main Study: Through Week 30|Death|0|||
149864380|NCT00094458|540633421|FG005|Main Study: Through Week 30|Death|0|||
149864381|NCT00094458|540633416|FG000|Main Study: Through Week 30|Other|19|||
149864382|NCT00094458|540633417|FG001|Main Study: Through Week 30|Other|16|||
149864383|NCT00094458|540633418|FG002|Main Study: Through Week 30|Other|9|||
149864384|NCT00094458|540633419|FG003|Main Study: Through Week 30|Other|0|||
149864385|NCT00094458|540633420|FG004|Main Study: Through Week 30|Other|0|||
149864386|NCT00094458|540633421|FG005|Main Study: Through Week 30|Other|0|||
149864387|NCT00094458|540633416|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
149864388|NCT00094458|540633417|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
149864389|NCT00094458|540633418|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
149864390|NCT00094458|540633419|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
149864391|NCT00094458|540633420|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
149864392|NCT00094458|540633421|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
149864393|NCT00094458|540633416|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
149864394|NCT00094458|540633417|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
149864395|NCT00094458|540633418|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
149864396|NCT00094458|540633419|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
149864397|NCT00094458|540633420|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
149864398|NCT00094458|540633421|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
149864399|NCT00094458|540633416|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
149864400|NCT00094458|540633417|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
149864401|NCT00094458|540633418|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
149864402|NCT00094458|540633419|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
149864403|NCT00094458|540633420|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
149864404|NCT00094458|540633421|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
149864405|NCT00094458|540633416|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
149864406|NCT00094458|540633417|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
149864407|NCT00094458|540633418|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
149864408|NCT00094458|540633419|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
149864409|NCT00094458|540633420|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
149864410|NCT00094458|540633421|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
149864411|NCT00094458|540633416|FG000|OLE: Open-Label Extension|Adverse Event|0|||
149864412|NCT00094458|540633417|FG001|OLE: Open-Label Extension|Adverse Event|0|||
149864413|NCT00094458|540633418|FG002|OLE: Open-Label Extension|Adverse Event|0|||
149864414|NCT00094458|540633419|FG003|OLE: Open-Label Extension|Adverse Event|0|||
149864415|NCT00094458|540633420|FG004|OLE: Open-Label Extension|Adverse Event|3|||
149864416|NCT00094458|540633421|FG005|OLE: Open-Label Extension|Adverse Event|4|||
149864417|NCT00094458|540633416|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
149864418|NCT00094458|540633417|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
149864419|NCT00094458|540633418|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
149864420|NCT00094458|540633419|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
149864421|NCT00094458|540633420|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
149864422|NCT00094458|540633421|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
149864423|NCT00094458|540633416|FG000|OLE: Open-Label Extension|Patient decision|0|||
149864424|NCT00094458|540633417|FG001|OLE: Open-Label Extension|Patient decision|0|||
149864425|NCT00094458|540633418|FG002|OLE: Open-Label Extension|Patient decision|0|||
149864426|NCT00094458|540633419|FG003|OLE: Open-Label Extension|Patient decision|0|||
149864427|NCT00094458|540633420|FG004|OLE: Open-Label Extension|Patient decision|1|||
149864428|NCT00094458|540633421|FG005|OLE: Open-Label Extension|Patient decision|0|||
149864429|NCT01995266|540633425|FG000|Overall Study|Death|1|||
149864430|NCT01995266|540633425|FG000|Overall Study|Lack of Efficacy|6|||
149864431|NCT01995266|540633425|FG000|Overall Study|Adverse Event|2|||
149864432|NCT03247517|540633426|FG000|Overall Study|Adverse Event|0|||
149864433|NCT03247517|540633427|FG001|Overall Study|Adverse Event|4|||
149864434|NCT03247517|540633428|FG002|Overall Study|Adverse Event|2|||
149864435|NCT03247517|540633426|FG000|Overall Study|Lost to Follow-up|2|||
149864436|NCT03247517|540633427|FG001|Overall Study|Lost to Follow-up|6|||
149864437|NCT03247517|540633428|FG002|Overall Study|Lost to Follow-up|4|||
149864438|NCT03247517|540633426|FG000|Overall Study|Consent withdrawn by caregiver|1|||
149864439|NCT03247517|540633427|FG001|Overall Study|Consent withdrawn by caregiver|4|||
149864440|NCT03247517|540633428|FG002|Overall Study|Consent withdrawn by caregiver|7|||
149864441|NCT03247517|540633426|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
149864442|NCT03247517|540633427|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
149864443|NCT03247517|540633428|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
149864444|NCT03247517|540633426|FG000|Overall Study|Protocol Violation|0|||
149864445|NCT03247517|540633427|FG001|Overall Study|Protocol Violation|2|||
149864446|NCT03247517|540633428|FG002|Overall Study|Protocol Violation|0|||
149864447|NCT03247517|540633426|FG000|Overall Study|Multiple reasons|3|||
149864448|NCT03247517|540633427|FG001|Overall Study|Multiple reasons|1|||
149864449|NCT03247517|540633428|FG002|Overall Study|Multiple reasons|0|||
149864450|NCT03310411|540633429|FG000|Period 1|Adverse Event|0|||
149864451|NCT03310411|540633430|FG001|Period 1|Adverse Event|0|||
149864452|NCT03310411|540633431|FG002|Period 1|Adverse Event|0|||
149864453|NCT03310411|540633432|FG003|Period 1|Adverse Event|1|||
149864454|NCT00619112|540633433|FG000|Overall Study|Adverse Event|1|||
149864455|NCT00619112|540633434|FG001|Overall Study|Adverse Event|2|||
149864456|NCT03623386|540633437|FG000|Overall Study|Protocol Violation|3|||
149864457|NCT03623386|540633438|FG001|Overall Study|Protocol Violation|2|||
149864458|NCT03623386|540633439|FG002|Overall Study|Protocol Violation|0|||
149864459|NCT03623386|540633437|FG000|Overall Study|Physician Decision|1|||
149864460|NCT03623386|540633438|FG001|Overall Study|Physician Decision|1|||
149864461|NCT03623386|540633439|FG002|Overall Study|Physician Decision|0|||
149864462|NCT03623386|540633437|FG000|Overall Study|Lost to Follow-up|0|||
149864463|NCT03623386|540633438|FG001|Overall Study|Lost to Follow-up|2|||
149864464|NCT03623386|540633439|FG002|Overall Study|Lost to Follow-up|0|||
149864465|NCT03623386|540633437|FG000|Overall Study|COVID-19|0|||
149864466|NCT03623386|540633438|FG001|Overall Study|COVID-19|1|||
149864467|NCT03623386|540633439|FG002|Overall Study|COVID-19|0|||
149864468|NCT00515541|540633442|FG000|Overall Study|Physician Decision|0|||
149864469|NCT00515541|540633443|FG001|Overall Study|Physician Decision|2|||
149864470|NCT00515541|540633444|FG002|Overall Study|Physician Decision|0|||
149864471|NCT00515541|540633445|FG003|Overall Study|Physician Decision|1|||
149864472|NCT00515541|540633442|FG000|Overall Study|No show for appointments|0|||
149864473|NCT00515541|540633443|FG001|Overall Study|No show for appointments|1|||
149864474|NCT00515541|540633444|FG002|Overall Study|No show for appointments|0|||
149864475|NCT00515541|540633445|FG003|Overall Study|No show for appointments|2|||
149864476|NCT00515541|540633442|FG000|Overall Study|Withdrawal by Subject|0|||
149864477|NCT00515541|540633443|FG001|Overall Study|Withdrawal by Subject|2|||
149864478|NCT00515541|540633444|FG002|Overall Study|Withdrawal by Subject|0|||
149864479|NCT00515541|540633445|FG003|Overall Study|Withdrawal by Subject|2|||
149864480|NCT00922272|540633448|FG000|Open-label Phase|Adverse Event|5|||
149864481|NCT00922272|540633449|FG001|Open-label Phase|Adverse Event|0|||
149864482|NCT00922272|540633448|FG000|Open-label Phase|Protocol Violation|1|||
149864483|NCT00922272|540633449|FG001|Open-label Phase|Protocol Violation|0|||
150040784|NCT00790842|541289117|FG003|Dose Level 4|Physician Decision|0|||
150040785|NCT00790842|541289118|FG004|Dose Level 4|Physician Decision|0|||
150040786|NCT00790842|541289119|FG005|Dose Level 4|Physician Decision|0|||
150040787|NCT00790842|541289120|FG006|Dose Level 4|Physician Decision|1|||
149864484|NCT00922272|540633448|FG000|Open-label Phase|Withdrawal by Subject|11|||
149864485|NCT00922272|540633449|FG001|Open-label Phase|Withdrawal by Subject|0|||
150040788|NCT00790842|541289121|FG007|Dose Level 4|Physician Decision|0|||
150040789|NCT00790842|541289122|FG008|Dose Level 4|Physician Decision|0|||
150040790|NCT00790842|541289123|FG009|Dose Level 4|Physician Decision|0|||
150040791|NCT00790842|541289124|FG010|Dose Level 4|Physician Decision|1|||
150040792|NCT00790842|541289114|FG000|Dose Level 4|Withdrawal by Subject|0|||
150040793|NCT00790842|541289115|FG001|Dose Level 4|Withdrawal by Subject|0|||
150040794|NCT00790842|541289116|FG002|Dose Level 4|Withdrawal by Subject|0|||
150040795|NCT00790842|541289117|FG003|Dose Level 4|Withdrawal by Subject|0|||
150040796|NCT00790842|541289118|FG004|Dose Level 4|Withdrawal by Subject|0|||
150040797|NCT00790842|541289119|FG005|Dose Level 4|Withdrawal by Subject|0|||
149864486|NCT00922272|540633448|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
149864487|NCT00922272|540633449|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
149962195|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
149962196|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
149962197|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
149962198|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
149962199|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
149962200|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
149962201|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
149962202|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
149962203|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
149962204|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
149962205|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
149962206|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
150040798|NCT00790842|541289120|FG006|Dose Level 4|Withdrawal by Subject|0|||
150040799|NCT00790842|541289121|FG007|Dose Level 4|Withdrawal by Subject|0|||
150040800|NCT00790842|541289122|FG008|Dose Level 4|Withdrawal by Subject|0|||
150040801|NCT00790842|541289123|FG009|Dose Level 4|Withdrawal by Subject|0|||
150173825|NCT00814346|541772960|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
149864488|NCT00922272|540633448|FG000|Open-label Phase|Withdrawal criteria met|5|||
149864489|NCT00922272|540633449|FG001|Open-label Phase|Withdrawal criteria met|0|||
149864490|NCT00922272|540633448|FG000|Double-blind Phase|Adverse Event|1|||
149864491|NCT00922272|540633449|FG001|Double-blind Phase|Adverse Event|1|||
149864492|NCT00922272|540633448|FG000|Double-blind Phase|Withdrawal by Subject|1|||
149864493|NCT00922272|540633449|FG001|Double-blind Phase|Withdrawal by Subject|1|||
149864494|NCT00922272|540633448|FG000|Double-blind Phase|Lost to Follow-up|2|||
149864495|NCT00922272|540633449|FG001|Double-blind Phase|Lost to Follow-up|1|||
149864496|NCT00922272|540633448|FG000|Double-blind Phase|Withdrawal criteria met|1|||
149864497|NCT00922272|540633449|FG001|Double-blind Phase|Withdrawal criteria met|1|||
149864498|NCT00922272|540633448|FG000|Double-blind Phase|Noncompliance|1|||
149864499|NCT00922272|540633449|FG001|Double-blind Phase|Noncompliance|1|||
149864500|NCT00922272|540633448|FG000|Double-blind Phase|Positive urine drug screen|1|||
149864501|NCT00922272|540633449|FG001|Double-blind Phase|Positive urine drug screen|1|||
149864502|NCT02588950|540633456|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
149864503|NCT02588950|540633457|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
149864504|NCT02588950|540633458|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
149864505|NCT02588950|540633459|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
149864506|NCT02588950|540633456|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
149864507|NCT02588950|540633457|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
149864508|NCT02588950|540633458|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
150173826|NCT00814346|541772961|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
150173827|NCT00814346|541772960|FG000|Open Phase (17 Months)|Adverse Event|5|||
150173828|NCT00814346|541772961|FG001|Open Phase (17 Months)|Adverse Event|0|||
150173829|NCT00814346|541772960|FG000|Open Phase (17 Months)|Consent|2|||
150173830|NCT00814346|541772961|FG001|Open Phase (17 Months)|Consent|0|||
150173831|NCT00814346|541772960|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
150173832|NCT00814346|541772961|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
150173833|NCT00814346|541772960|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
150173834|NCT00814346|541772961|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
150173835|NCT05136443|541772963|FG000|Overall Study|Lost to Follow-up|2|||
150173836|NCT05136443|541772963|FG000|Overall Study|Adverse Event|2|||
150173837|NCT03718767|541772974|FG000|Overall Study|Declined to participate (before treatment started)|0|||
150173838|NCT03718767|541772975|FG001|Overall Study|Declined to participate (before treatment started)|0|||
150173839|NCT03718767|541772976|FG002|Overall Study|Declined to participate (before treatment started)|7|||
150173840|NCT03718767|541772974|FG000|Overall Study|Ineligible|0|||
150173841|NCT03718767|541772975|FG001|Overall Study|Ineligible|0|||
150173842|NCT03718767|541772976|FG002|Overall Study|Ineligible|17|||
150173843|NCT05694065|541772977|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
150173844|NCT05694065|541772977|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
150173845|NCT05694065|541772977|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
149864509|NCT02588950|540633459|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
149864510|NCT00652028|540633460|FG000|Overall Study|Adverse Event|1|||
149864511|NCT00652028|540633461|FG001|Overall Study|Adverse Event|0|||
149864512|NCT00652028|540633462|FG002|Overall Study|Adverse Event|0|||
149864513|NCT00652028|540633463|FG003|Overall Study|Adverse Event|0|||
149864514|NCT00652028|540633460|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
149864515|NCT00652028|540633461|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
149864516|NCT00652028|540633462|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
149864517|NCT00652028|540633463|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
149864518|NCT00652028|540633460|FG000|Overall Study|Physician Decision|0|||
149864519|NCT00652028|540633461|FG001|Overall Study|Physician Decision|0|||
149864520|NCT00652028|540633462|FG002|Overall Study|Physician Decision|1|||
149864521|NCT00652028|540633463|FG003|Overall Study|Physician Decision|0|||
149864522|NCT02072824|540633464|FG000|Overall Study|Insufficient clinical response|1|||
149864523|NCT02072824|540633465|FG001|Overall Study|Insufficient clinical response|0|||
149864524|NCT02072824|540633466|FG002|Overall Study|Insufficient clinical response|1|||
149864525|NCT02072824|540633464|FG000|Overall Study|No longer willing to participate|1|||
149864526|NCT02072824|540633465|FG001|Overall Study|No longer willing to participate|0|||
150173846|NCT00346333|541772978|FG000|Overall Study|Death|1|||
149864527|NCT02072824|540633466|FG002|Overall Study|No longer willing to participate|1|||
149864528|NCT02072824|540633464|FG000|Overall Study|Medication error|0|||
150173847|NCT00346333|541772979|FG001|Overall Study|Death|0|||
150173848|NCT00346333|541772978|FG000|Overall Study|unwilling or unable to continue|4|||
149864529|NCT02072824|540633465|FG001|Overall Study|Medication error|1|||
149864530|NCT02072824|540633466|FG002|Overall Study|Medication error|0|||
149864531|NCT02072824|540633464|FG000|Overall Study|Adverse Event|0|||
149864532|NCT02072824|540633465|FG001|Overall Study|Adverse Event|0|||
149864533|NCT02072824|540633466|FG002|Overall Study|Adverse Event|1|||
149864534|NCT01403064|540633469|FG000|Overall Study|Death|0|||
149864535|NCT01403064|540633470|FG001|Overall Study|Death|0|||
149864536|NCT01403064|540633471|FG002|Overall Study|Death|1|||
149864537|NCT01403064|540633472|FG003|Overall Study|Death|1|||
149864538|NCT01403064|540633469|FG000|Overall Study|Withdrawal by Subject|0|||
149864539|NCT01403064|540633470|FG001|Overall Study|Withdrawal by Subject|0|||
149864540|NCT01403064|540633471|FG002|Overall Study|Withdrawal by Subject|1|||
149864541|NCT01403064|540633472|FG003|Overall Study|Withdrawal by Subject|1|||
149864542|NCT01403064|540633469|FG000|Overall Study|Other|1|||
149864543|NCT01403064|540633470|FG001|Overall Study|Other|0|||
149864544|NCT01403064|540633471|FG002|Overall Study|Other|2|||
149864545|NCT01403064|540633472|FG003|Overall Study|Other|1|||
149864546|NCT02528123|540633473|FG000|Overall Study|Lost to Follow-up|1|||
149864547|NCT03760250|540633474|FG000|Overall Study|Withdrawal by Subject|1|||
149864548|NCT03760250|540633474|FG000|Overall Study|Physician Decision|1|||
149864549|NCT02011113|540633476|FG000|Overall Study|Adverse Event|4|||
149864550|NCT02011113|540633476|FG000|Overall Study|Disease Progression (DP)|16|||
149864551|NCT02011113|540633476|FG000|Overall Study|Death|1|||
149864552|NCT02011113|540633476|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
149864553|NCT02011113|540633476|FG000|Overall Study|Investigator's judgement- DP|3|||
149864554|NCT02011113|540633476|FG000|Overall Study|Study terminated by sponsor|11|||
149864555|NCT02669940|540633479|FG000|Overall Study|Failure to return|0|||
149864556|NCT02669940|540633480|FG001|Overall Study|Failure to return|3|||
149864557|NCT02669940|540633479|FG000|Overall Study|Insufficient follow-up data|1|||
149864558|NCT02669940|540633480|FG001|Overall Study|Insufficient follow-up data|0|||
149864559|NCT05065983|540633489|FG000|Overall Study|Lost to Follow-up|2|||
149864560|NCT00986180|540633490|FG000|Overall Study|Adverse Event|21|||
149864561|NCT00986180|540633491|FG001|Overall Study|Adverse Event|23|||
149864562|NCT00986180|540633490|FG000|Overall Study|Lack of Efficacy|4|||
149864563|NCT00986180|540633491|FG001|Overall Study|Lack of Efficacy|3|||
149864564|NCT00986180|540633490|FG000|Overall Study|Lost to Follow-up|5|||
149864565|NCT00986180|540633491|FG001|Overall Study|Lost to Follow-up|7|||
149864566|NCT00986180|540633490|FG000|Overall Study|Physician Decision|1|||
149864567|NCT00986180|540633491|FG001|Overall Study|Physician Decision|3|||
149864568|NCT00986180|540633490|FG000|Overall Study|Protocol Violation|2|||
149864569|NCT00986180|540633491|FG001|Overall Study|Protocol Violation|0|||
149864570|NCT00986180|540633490|FG000|Overall Study|Withdrawal by Subject|1|||
149864571|NCT00986180|540633491|FG001|Overall Study|Withdrawal by Subject|9|||
149864572|NCT00986180|540633490|FG000|Overall Study|Miscellanies|10|||
149864573|NCT00986180|540633491|FG001|Overall Study|Miscellanies|11|||
149864574|NCT03251963|540633494|FG000|Overall Study|inappropriate Xa level timing|6|||
149864575|NCT03251963|540633495|FG001|Overall Study|inappropriate Xa level timing|3|||
149864576|NCT03251963|540633494|FG000|Overall Study|no peak Xa level drawn|2|||
149864577|NCT03251963|540633495|FG001|Overall Study|no peak Xa level drawn|0|||
149864578|NCT03251963|540633494|FG000|Overall Study|bled prior to Xa level|1|||
149864579|NCT03251963|540633495|FG001|Overall Study|bled prior to Xa level|2|||
149864580|NCT04295135|540633496|FG000|Overall Study|Withdrawal by Subject|2|||
149864581|NCT04295135|540633497|FG001|Overall Study|Withdrawal by Subject|1|||
149864582|NCT04295135|540633496|FG000|Overall Study|Subject left organization|8|||
149864583|NCT04295135|540633497|FG001|Overall Study|Subject left organization|4|||
149864584|NCT01732874|540633499|FG000|Overall Study|Withdrawal by Subject|5|||
149864585|NCT01732874|540633500|FG001|Overall Study|Withdrawal by Subject|1|||
149864586|NCT01732874|540633499|FG000|Overall Study|Death of Infant|3|||
149864587|NCT01732874|540633500|FG001|Overall Study|Death of Infant|2|||
149864588|NCT02923674|540633501|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
149864589|NCT02923674|540633502|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
149864590|NCT02923674|540633503|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
149864591|NCT02923674|540633501|FG000|Overall Study|Lost to Follow-up|7|||
149962207|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
149864592|NCT02923674|540633502|FG001|Overall Study|Lost to Follow-up|12|||
149962208|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
149962209|NCT01362530|540995849|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
149864593|NCT02923674|540633503|FG002|Overall Study|Lost to Follow-up|7|||
149864594|NCT02923674|540633501|FG000|Overall Study|Problem with intervention|2|||
149864595|NCT02923674|540633502|FG001|Overall Study|Problem with intervention|2|||
149864596|NCT02923674|540633503|FG002|Overall Study|Problem with intervention|1|||
149864597|NCT02923674|540633501|FG000|Overall Study|Adverse Event|3|||
149864598|NCT02923674|540633502|FG001|Overall Study|Adverse Event|1|||
149864599|NCT02923674|540633503|FG002|Overall Study|Adverse Event|1|||
149864600|NCT02923674|540633501|FG000|Overall Study|Withdrawal by Subject|2|||
149864601|NCT02923674|540633502|FG001|Overall Study|Withdrawal by Subject|2|||
149864602|NCT02923674|540633503|FG002|Overall Study|Withdrawal by Subject|2|||
149864603|NCT00003875|540633507|FG000|Overall Study|Screen Failed|1|||
149864604|NCT01621191|540633508|FG000|Overall Study|Adverse Event|9|||
149864605|NCT01621191|540633508|FG000|Overall Study|Withdrawal by Subject|8|||
149864606|NCT01621191|540633508|FG000|Overall Study|Lack of Efficacy|6|||
149864607|NCT01621191|540633508|FG000|Overall Study|Lost to Follow-up|1|||
149864608|NCT01621191|540633508|FG000|Overall Study|Site Removed From Study|1|||
149864609|NCT04355663|540633509|FG000|Overall Study|Physician Decision|2|||
149864610|NCT04355663|540633510|FG001|Overall Study|Physician Decision|7|||
149864611|NCT04355663|540633511|FG002|Overall Study|Physician Decision|0|||
149864612|NCT04355663|540633509|FG000|Overall Study|Adverse Event|0|||
149864613|NCT04355663|540633510|FG001|Overall Study|Adverse Event|0|||
149864614|NCT04355663|540633511|FG002|Overall Study|Adverse Event|1|||
149864615|NCT04355663|540633509|FG000|Overall Study|Withdrawal by Subject|0|||
149864616|NCT04355663|540633510|FG001|Overall Study|Withdrawal by Subject|8|||
149864617|NCT04355663|540633511|FG002|Overall Study|Withdrawal by Subject|3|||
149864618|NCT05420012|540633517|FG000|Overall Study|Lost to Follow-up|0|||
149864619|NCT05420012|540633518|FG001|Overall Study|Lost to Follow-up|1|||
149864620|NCT03395639|540633519|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
149864621|NCT03395639|540633520|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
149864622|NCT03395639|540633521|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
149864623|NCT03395639|540633519|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
149864624|NCT03395639|540633520|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
149864625|NCT03395639|540633521|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
149864626|NCT03395639|540633519|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
149864627|NCT03395639|540633520|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
149864628|NCT03395639|540633521|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
150040802|NCT00790842|541289124|FG010|Dose Level 4|Withdrawal by Subject|1|||
150040803|NCT00790842|541289114|FG000|Expansion Cohort|Adverse Event|0|||
150040804|NCT00790842|541289115|FG001|Expansion Cohort|Adverse Event|0|||
149864629|NCT03395639|540633519|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
150040805|NCT00790842|541289116|FG002|Expansion Cohort|Adverse Event|0|||
149864630|NCT03395639|540633520|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
149864631|NCT03395639|540633521|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
149864632|NCT03395639|540633519|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
149864633|NCT03395639|540633520|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
149864634|NCT03395639|540633521|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
149864635|NCT00942331|540633522|FG000|Overall Study|Did not start treatment|15|||
149864636|NCT00942331|540633523|FG001|Overall Study|Did not start treatment|22|||
149864637|NCT00567476|540633527|FG000|Overall Study|Adverse Event|2|||
149864638|NCT00567476|540633528|FG001|Overall Study|Adverse Event|0|||
149864639|NCT00567476|540633527|FG000|Overall Study|Pregnancy|1|||
149864640|NCT00567476|540633528|FG001|Overall Study|Pregnancy|0|||
149864641|NCT00567476|540633527|FG000|Overall Study|Protocol Violation|4|||
149864642|NCT00567476|540633528|FG001|Overall Study|Protocol Violation|1|||
149864643|NCT00567476|540633527|FG000|Overall Study|Lost to Follow-up|0|||
149864644|NCT00567476|540633528|FG001|Overall Study|Lost to Follow-up|1|||
149864645|NCT00567476|540633527|FG000|Overall Study|Administrative issues|1|||
149864646|NCT00567476|540633528|FG001|Overall Study|Administrative issues|0|||
149864647|NCT00567476|540633527|FG000|Overall Study|Medical Decision|0|||
149864648|NCT00567476|540633528|FG001|Overall Study|Medical Decision|1|||
149864649|NCT00567476|540633527|FG000|Overall Study|Non-adherence to protocol|0|||
149864650|NCT00567476|540633528|FG001|Overall Study|Non-adherence to protocol|1|||
149864651|NCT00995085|540633529|FG000|Overall Study|Withdrawal by Subject|5|||
149864652|NCT02595008|540633533|FG000|Overall Study|Enrolled In Error|1|||
149864653|NCT02595008|540633534|FG001|Overall Study|Enrolled In Error|0|||
149864654|NCT03407118|540633535|FG000|Period 2|Withdrawal by Subject|1|||
149864655|NCT03407118|540633536|FG001|Period 2|Withdrawal by Subject|0|||
149864656|NCT01491035|540633546|FG000|Overall Study|Lost to Follow-up|0|||
149864657|NCT01491035|540633547|FG001|Overall Study|Lost to Follow-up|0|||
149864658|NCT01491035|540633548|FG002|Overall Study|Lost to Follow-up|0|||
149864659|NCT01491035|540633549|FG003|Overall Study|Lost to Follow-up|0|||
149864660|NCT01491035|540633550|FG004|Overall Study|Lost to Follow-up|1|||
149864661|NCT01491035|540633551|FG005|Overall Study|Lost to Follow-up|0|||
149864662|NCT01491035|540633552|FG006|Overall Study|Lost to Follow-up|0|||
149864663|NCT01491035|540633553|FG007|Overall Study|Lost to Follow-up|0|||
149864664|NCT02687360|540633556|FG000|Overall Study|Withdrawal by Subject|3|||
149864665|NCT02687360|540633557|FG001|Overall Study|Withdrawal by Subject|0|||
149864666|NCT02999477|540633558|FG000|Overall Study|found ineligible after first dose|0|||
149864667|NCT02999477|540633559|FG001|Overall Study|found ineligible after first dose|1|||
149864668|NCT02999477|540633558|FG000|Overall Study|Withdrawal by Subject|1|||
149864669|NCT02999477|540633559|FG001|Overall Study|Withdrawal by Subject|1|||
149864670|NCT01583218|540633561|FG000|Overall Study|Withdrawal by Subject|43|||
149864671|NCT01583218|540633562|FG001|Overall Study|Withdrawal by Subject|29|||
149864672|NCT01583218|540633561|FG000|Overall Study|Death|206|||
149864673|NCT01583218|540633562|FG001|Overall Study|Death|211|||
149864674|NCT01583218|540633561|FG000|Overall Study|Lost to Follow-up|11|||
149864675|NCT01583218|540633562|FG001|Overall Study|Lost to Follow-up|17|||
149864676|NCT01583218|540633561|FG000|Overall Study|Adverse event or serious adverse event|3|||
149864677|NCT01583218|540633562|FG001|Overall Study|Adverse event or serious adverse event|3|||
149864678|NCT01583218|540633561|FG000|Overall Study|Patient /Family decision|3|||
149864679|NCT01583218|540633562|FG001|Overall Study|Patient /Family decision|0|||
149864680|NCT01583218|540633561|FG000|Overall Study|Cannot contact patient directly|1|||
149962210|NCT01362530|540995850|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
149962211|NCT01517178|540995851|FG000|Period 1|Adverse Event|1|||
149962212|NCT01517178|540995852|FG001|Period 1|Adverse Event|2|||
149962213|NCT01517178|540995851|FG000|Period 1|Lack of Efficacy|0|||
149962214|NCT01517178|540995852|FG001|Period 1|Lack of Efficacy|1|||
149962215|NCT01517178|540995851|FG000|Period 1|E.g. study termination|3|||
149962216|NCT01517178|540995852|FG001|Period 1|E.g. study termination|1|||
149962217|NCT01517178|540995851|FG000|Period 1|Withdrawal by Subject|0|||
149962218|NCT01517178|540995852|FG001|Period 1|Withdrawal by Subject|1|||
149962219|NCT01517178|540995851|FG000|Period 2|Adverse Event|1|||
149962220|NCT01517178|540995852|FG001|Period 2|Adverse Event|0|||
149962221|NCT01517178|540995851|FG000|Period 2|Withdrawal by Subject|3|||
149962222|NCT01517178|540995852|FG001|Period 2|Withdrawal by Subject|0|||
149962223|NCT01517178|540995851|FG000|Period 2|E.g. study termination|2|||
149864681|NCT01583218|540633562|FG001|Overall Study|Cannot contact patient directly|2|||
149962224|NCT01517178|540995852|FG001|Period 2|E.g. study termination|2|||
149962225|NCT01959919|540995853|FG000|Overall Study|Did not meet the eligibility criteria|2|||
149864682|NCT01583218|540633561|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
149864683|NCT01583218|540633562|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
149864684|NCT01583218|540633561|FG000|Overall Study|Patient did not wish to attend visits|0|||
149864685|NCT01583218|540633562|FG001|Overall Study|Patient did not wish to attend visits|1|||
149864686|NCT01583218|540633561|FG000|Overall Study|Patient randomized but not dosed|17|||
149864687|NCT01583218|540633562|FG001|Overall Study|Patient randomized but not dosed|16|||
149962226|NCT02094885|540995855|FG000|Overall Study|Death|1|||
149962227|NCT02094885|540995856|FG001|Overall Study|Death|5|||
149962228|NCT02094885|540995855|FG000|Overall Study|Withdrawn due to age|1|||
149864688|NCT01583218|540633561|FG000|Overall Study|Patient was assessed via phone in person|1|||
149864689|NCT01583218|540633562|FG001|Overall Study|Patient was assessed via phone in person|0|||
149864690|NCT01583218|540633561|FG000|Overall Study|Patient deemed ineligible after random|2|||
149864691|NCT01583218|540633562|FG001|Overall Study|Patient deemed ineligible after random|0|||
149864692|NCT01583218|540633561|FG000|Overall Study|Patient was early terminated from study|0|||
149864693|NCT01583218|540633562|FG001|Overall Study|Patient was early terminated from study|1|||
149864694|NCT01583218|540633561|FG000|Overall Study|Patient was randomized due to mistake|1|||
149864695|NCT01583218|540633562|FG001|Overall Study|Patient was randomized due to mistake|0|||
149864696|NCT01583218|540633561|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
149864697|NCT01583218|540633562|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
149864698|NCT01583218|540633561|FG000|Overall Study|Withdraw of consent on day of random|1|||
149864699|NCT01583218|540633562|FG001|Overall Study|Withdraw of consent on day of random|0|||
149864700|NCT02522403|540635297|FG000|Overall Study|Lost to Follow-up|2|||
149864701|NCT02522403|540635298|FG001|Overall Study|Lost to Follow-up|2|||
149864702|NCT02522403|540635297|FG000|Overall Study|Withdrawal by Subject|2|||
149864703|NCT02522403|540635298|FG001|Overall Study|Withdrawal by Subject|4|||
149864704|NCT00856973|540635299|FG000|Overall Study|Adverse Event|5|||
149864705|NCT00856973|540635300|FG001|Overall Study|Adverse Event|5|||
150173849|NCT00346333|541772979|FG001|Overall Study|unwilling or unable to continue|8|||
150173850|NCT03460756|541772981|FG000|Overall Study|Adverse Event|0|||
150173851|NCT03460756|541772982|FG001|Overall Study|Adverse Event|0|||
149962229|NCT02094885|540995856|FG001|Overall Study|Withdrawn due to age|0|||
149962230|NCT02003898|540995857|FG000|Overall Study|Death|3|||
149962231|NCT02003898|540995857|FG000|Overall Study|Lost to Follow-up|12|||
149962232|NCT02003898|540995857|FG000|Overall Study|Withdrawal by Subject|52|||
149962233|NCT01537432|540995858|FG000|Overall Study|Lost to Follow-up|3|||
149864706|NCT00856973|540635301|FG002|Overall Study|Adverse Event|3|||
149864707|NCT00856973|540635299|FG000|Overall Study|Lost to Follow-up|6|||
149864708|NCT00856973|540635300|FG001|Overall Study|Lost to Follow-up|3|||
149864709|NCT00856973|540635301|FG002|Overall Study|Lost to Follow-up|5|||
149864710|NCT00856973|540635299|FG000|Overall Study|Physician Decision|0|||
149864711|NCT00856973|540635300|FG001|Overall Study|Physician Decision|3|||
149864712|NCT00856973|540635301|FG002|Overall Study|Physician Decision|1|||
149864713|NCT00856973|540635299|FG000|Overall Study|Protocol Violation|1|||
149864714|NCT00856973|540635300|FG001|Overall Study|Protocol Violation|2|||
149864715|NCT00856973|540635301|FG002|Overall Study|Protocol Violation|1|||
149864716|NCT00856973|540635299|FG000|Overall Study|Withdrawal by Subject|13|||
149864717|NCT00856973|540635300|FG001|Overall Study|Withdrawal by Subject|16|||
149864718|NCT00856973|540635301|FG002|Overall Study|Withdrawal by Subject|15|||
149864719|NCT00856973|540635299|FG000|Overall Study|Other|11|||
149864720|NCT00856973|540635300|FG001|Overall Study|Other|12|||
149864721|NCT00856973|540635301|FG002|Overall Study|Other|13|||
149864722|NCT04556552|540635304|FG000|Overall Study|Lost to Follow-up|1|||
149864723|NCT04556552|540635305|FG001|Overall Study|Lost to Follow-up|0|||
149864724|NCT04556552|540635304|FG000|Overall Study|Claustrophobia|0|||
149864725|NCT04556552|540635305|FG001|Overall Study|Claustrophobia|1|||
149864726|NCT04556552|540635304|FG000|Overall Study|Inability to continue|0|||
149864727|NCT04556552|540635305|FG001|Overall Study|Inability to continue|1|||
149864728|NCT00841906|540635308|FG000|Overall Study|Withdrawal by Subject|2|||
149864729|NCT00841906|540635309|FG001|Overall Study|Withdrawal by Subject|0|||
149864730|NCT01196078|540635310|FG000|Overall Study|Withdrawal by Subject|3|||
149864731|NCT01196078|540635311|FG001|Overall Study|Withdrawal by Subject|5|||
149864732|NCT01196078|540635310|FG000|Overall Study|Adverse Event|4|||
149864733|NCT01196078|540635311|FG001|Overall Study|Adverse Event|4|||
149864734|NCT01196078|540635310|FG000|Overall Study|Protocol Violation|2|||
149962234|NCT01537432|540995859|FG001|Overall Study|Lost to Follow-up|1|||
149962235|NCT01537432|540995858|FG000|Overall Study|Withdrawal by Subject|0|||
149962236|NCT01537432|540995859|FG001|Overall Study|Withdrawal by Subject|1|||
149962237|NCT01537432|540995858|FG000|Overall Study|Administrative problems|1|||
149962238|NCT01537432|540995859|FG001|Overall Study|Administrative problems|0|||
149962239|NCT01537432|540995858|FG000|Overall Study|Adverse Event|1|||
149962240|NCT01537432|540995859|FG001|Overall Study|Adverse Event|0|||
149962241|NCT01537432|540995858|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149962242|NCT01537432|540995859|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149962243|NCT01998477|540995860|FG000|Overall Study|Lost to Follow-up|4|||
149962244|NCT01998477|540995861|FG001|Overall Study|Lost to Follow-up|5|||
149962245|NCT01998477|540995860|FG000|Overall Study|Withdrawal by Subject|6|||
149962246|NCT01998477|540995861|FG001|Overall Study|Withdrawal by Subject|0|||
149962247|NCT01104870|540995862|FG000|Overall Study|Adverse Event|1|||
149962248|NCT01104870|540995863|FG001|Overall Study|Adverse Event|1|||
149962249|NCT01104870|540995864|FG002|Overall Study|Adverse Event|0|||
149864735|NCT01196078|540635311|FG001|Overall Study|Protocol Violation|1|||
149864736|NCT01196078|540635310|FG000|Overall Study|Lack of Efficacy|17|||
149864737|NCT01196078|540635311|FG001|Overall Study|Lack of Efficacy|23|||
149864738|NCT01196078|540635310|FG000|Overall Study|Lost to Follow-up|1|||
149864739|NCT01196078|540635311|FG001|Overall Study|Lost to Follow-up|0|||
149864740|NCT01196078|540635310|FG000|Overall Study|Death|6|||
149864741|NCT01196078|540635311|FG001|Overall Study|Death|4|||
149864742|NCT00127036|540635312|FG000|Overall Study|Insufficient Data for Analysis|6|||
149864743|NCT00127036|540635313|FG001|Overall Study|Insufficient Data for Analysis|11|||
149864744|NCT00127036|540635312|FG000|Overall Study|Screen Failure|2|||
149864745|NCT00127036|540635313|FG001|Overall Study|Screen Failure|0|||
149864746|NCT04397445|540635314|FG000|Overall Study|Withdrawal by Subject|1|||
149864747|NCT04397445|540635315|FG001|Overall Study|Withdrawal by Subject|0|||
149864748|NCT04397445|540635316|FG002|Overall Study|Withdrawal by Subject|0|||
149864749|NCT04397445|540635317|FG003|Overall Study|Withdrawal by Subject|0|||
149864750|NCT01429051|540635318|FG000|Titration Phase|Death|1|||
149864751|NCT01429051|540635318|FG000|Titration Phase|Withdrawal by Subject|7|||
149864752|NCT01429051|540635318|FG000|Titration Phase|Physician Decision|1|||
149864753|NCT01429051|540635318|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
149864754|NCT01429051|540635318|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
149864755|NCT01429051|540635318|FG000|Efficacy Phase|Adverse Event|1|||
149864756|NCT01429051|540635318|FG000|Efficacy Phase|Death|1|||
149864757|NCT01429051|540635318|FG000|Tolerability Phase|Death|5|||
149864758|NCT01429051|540635318|FG000|Tolerability Phase|Adverse Event|2|||
149864759|NCT01429051|540635318|FG000|Tolerability Phase|Withdrawal by Subject|5|||
149864760|NCT01429051|540635318|FG000|Tolerability Phase|Physician Decision|1|||
149864761|NCT01429051|540635318|FG000|Tolerability Phase|Other|2|||
149864762|NCT03921151|540635319|FG000|Overall Study|Withdrawal by Subject|11|||
149864763|NCT03921151|540635320|FG001|Overall Study|Withdrawal by Subject|16|||
149864764|NCT00857792|540635322|FG000|Overall Study|inadequate image quality for analysis|12|||
149864765|NCT03001219|540635330|FG000|Proof of Concept|Study Termination by Sponsor|0|||
150040806|NCT00790842|541289117|FG003|Expansion Cohort|Adverse Event|0|||
149864766|NCT03001219|540635331|FG001|Proof of Concept|Study Termination by Sponsor|1|||
149864767|NCT03001219|540635330|FG000|Proof of Concept|Withdrawal by Subject|0|||
149864768|NCT03001219|540635331|FG001|Proof of Concept|Withdrawal by Subject|4|||
149864769|NCT03001219|540635330|FG000|Proof of Concept|Protocol Deviation|0|||
149864770|NCT03001219|540635331|FG001|Proof of Concept|Protocol Deviation|1|||
149864771|NCT03001219|540635330|FG000|Proof of Concept|Adverse Event|1|||
149864772|NCT03001219|540635331|FG001|Proof of Concept|Adverse Event|1|||
149864773|NCT03001219|540635330|FG000|Proof of Concept|Physician Decision|1|||
149864774|NCT03001219|540635331|FG001|Proof of Concept|Physician Decision|0|||
149864775|NCT03001219|540635330|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
149864776|NCT03001219|540635331|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
149864777|NCT03001219|540635330|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
149864778|NCT03001219|540635331|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
149864779|NCT03001219|540635330|FG000|Extension Period Analysis|Physician Decision|0|||
149864780|NCT03001219|540635331|FG001|Extension Period Analysis|Physician Decision|1|||
149864781|NCT03001219|540635330|FG000|Extension Period Analysis|Adverse Event|1|||
149864782|NCT03001219|540635331|FG001|Extension Period Analysis|Adverse Event|1|||
149864783|NCT03001219|540635330|FG000|Extension Period Analysis|Protocol Deviation|0|||
149864784|NCT03001219|540635331|FG001|Extension Period Analysis|Protocol Deviation|1|||
149864785|NCT03001219|540635330|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
149864786|NCT03001219|540635331|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
149864787|NCT01797835|540635332|FG000|Overall Study|Lost to Follow-up|31|||
149864788|NCT01797835|540635333|FG001|Overall Study|Lost to Follow-up|27|||
149864789|NCT03733210|540635334|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
149864790|NCT03733210|540635335|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
149864791|NCT02963441|540635344|FG000|Overall Study|Protocol violation or withdrawn|8|||
149864792|NCT02963441|540635344|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
149864793|NCT02963441|540635344|FG000|Overall Study|IDx-DR insufficient quality|33|||
149864794|NCT04688931|540635345|FG000|Overall Study|Adverse Event|4|||
149864795|NCT04688931|540635346|FG001|Overall Study|Adverse Event|1|||
149864796|NCT04688931|540635345|FG000|Overall Study|Withdrawal by Subject|5|||
149864797|NCT04688931|540635346|FG001|Overall Study|Withdrawal by Subject|16|||
149864798|NCT04688931|540635345|FG000|Overall Study|Physician Decision|3|||
149864799|NCT04688931|540635346|FG001|Overall Study|Physician Decision|5|||
149864800|NCT04688931|540635345|FG000|Overall Study|Noncompliance|0|||
149864801|NCT04688931|540635346|FG001|Overall Study|Noncompliance|1|||
149864802|NCT04688931|540635345|FG000|Overall Study|Lost to Follow-up|1|||
149864803|NCT04688931|540635346|FG001|Overall Study|Lost to Follow-up|3|||
149864804|NCT04688931|540635345|FG000|Overall Study|Randomization Error|3|||
149864805|NCT04688931|540635346|FG001|Overall Study|Randomization Error|0|||
149864806|NCT04688931|540635345|FG000|Overall Study|Not Eligible|1|||
149864807|NCT04688931|540635346|FG001|Overall Study|Not Eligible|3|||
149864808|NCT04688931|540635345|FG000|Overall Study|Disease Progression|0|||
149864809|NCT04688931|540635346|FG001|Overall Study|Disease Progression|2|||
149864810|NCT04688931|540635345|FG000|Overall Study|Sponsor Requirement|1|||
149864811|NCT04688931|540635346|FG001|Overall Study|Sponsor Requirement|1|||
149864812|NCT04688931|540635345|FG000|Overall Study|Other Reason|1|||
149864813|NCT04688931|540635346|FG001|Overall Study|Other Reason|2|||
149864814|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Adverse Event|9|||
149864815|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Adverse Event|4|||
149864816|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Adverse Event|5|||
149864817|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Adverse Event|9|||
149864818|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Adverse Event|8|||
149864819|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Adverse Event|0|||
149864820|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Adverse Event|0|||
149864821|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
149864822|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
149864823|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
149864824|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
149864825|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
149864826|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
149864827|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
149864828|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Death|1|||
149864829|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Death|1|||
149864830|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Death|1|||
149864831|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Death|1|||
149864832|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Death|0|||
149864833|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Death|0|||
149864834|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Death|0|||
149864835|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
149864836|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
149864837|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
149864838|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
149864839|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
149864840|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
149864841|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
149864842|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864843|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864844|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
149864845|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864846|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864847|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864848|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
149864849|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
149864850|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
149864851|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
149864852|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
149864853|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
149864854|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
149864855|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
149864856|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Other|2|||
149864857|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Other|9|||
149864858|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Other|9|||
149864859|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Other|3|||
149864860|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Other|2|||
149864861|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Other|0|||
149864862|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Other|0|||
149864863|NCT00361335|540635347|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
149864864|NCT00361335|540635348|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
149864865|NCT00361335|540635349|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
149864866|NCT00361335|540635350|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
149864867|NCT00361335|540635351|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
149864868|NCT00361335|540635352|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
149864869|NCT00361335|540635353|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
149864870|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
149864871|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
149864872|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
149864873|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
149864874|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
149864875|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
149864876|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
149864877|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
149864878|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
149864879|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
149864880|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
149864881|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
149864882|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
149864883|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
149864884|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Death|0|||
149864885|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Death|0|||
149864886|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Death|0|||
149864887|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Death|0|||
149864888|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Death|0|||
149864889|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Death|0|||
149864890|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Death|1|||
149864891|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
149864892|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
149864893|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
149864894|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
149864895|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
149864896|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
149864897|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
149864898|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Other|1|||
149864899|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Other|0|||
149864900|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Other|0|||
149864901|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Other|1|||
149864902|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Other|0|||
149864903|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Other|1|||
149864904|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Other|2|||
149864905|NCT00361335|540635347|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
149864906|NCT00361335|540635348|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
149864907|NCT00361335|540635349|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
149864908|NCT00361335|540635350|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
149864909|NCT00361335|540635351|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
149864910|NCT00361335|540635352|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
149864911|NCT00361335|540635353|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
149864912|NCT01765582|540635354|FG000|Overall Study|Other|3|||
149864913|NCT01765582|540635355|FG001|Overall Study|Other|6|||
149864914|NCT01765582|540635356|FG002|Overall Study|Other|9|||
149864915|NCT01765582|540635354|FG000|Overall Study|Lost to Follow-up|2|||
149864916|NCT01765582|540635355|FG001|Overall Study|Lost to Follow-up|2|||
149864917|NCT01765582|540635356|FG002|Overall Study|Lost to Follow-up|1|||
149864918|NCT01765582|540635354|FG000|Overall Study|Death|31|||
149864919|NCT01765582|540635355|FG001|Overall Study|Death|36|||
149864920|NCT01765582|540635356|FG002|Overall Study|Death|33|||
149864921|NCT01765582|540635354|FG000|Overall Study|Sponsor Decision|46|||
149864922|NCT01765582|540635355|FG001|Overall Study|Sponsor Decision|42|||
149864923|NCT01765582|540635356|FG002|Overall Study|Sponsor Decision|42|||
149864924|NCT01765582|540635354|FG000|Overall Study|Withdrawal of Consent|11|||
149864925|NCT01765582|540635355|FG001|Overall Study|Withdrawal of Consent|6|||
149864926|NCT01765582|540635356|FG002|Overall Study|Withdrawal of Consent|10|||
149864927|NCT00616941|540635359|FG000|Overall Study|Progressive Disease|1|||
149864928|NCT00616941|540635360|FG001|Overall Study|Progressive Disease|2|||
149864929|NCT00616941|540635361|FG002|Overall Study|Progressive Disease|1|||
149864930|NCT00616941|540635359|FG000|Overall Study|Adverse Event|0|||
149864931|NCT00616941|540635360|FG001|Overall Study|Adverse Event|1|||
149864932|NCT00616941|540635361|FG002|Overall Study|Adverse Event|1|||
149864933|NCT00616941|540635359|FG000|Overall Study|Subject Non-compliance|0|||
149864934|NCT00616941|540635360|FG001|Overall Study|Subject Non-compliance|0|||
149864935|NCT00616941|540635361|FG002|Overall Study|Subject Non-compliance|1|||
149864936|NCT00616941|540635359|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
149864937|NCT00616941|540635360|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
149864938|NCT00616941|540635361|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
149864939|NCT00616941|540635359|FG000|Overall Study|Vaccination Suspended|0|||
149864940|NCT00616941|540635360|FG001|Overall Study|Vaccination Suspended|0|||
149864941|NCT00616941|540635361|FG002|Overall Study|Vaccination Suspended|3|||
149864942|NCT00688376|540635362|FG000|Double-Blind Phase|Adverse Event|4|||
149864943|NCT00688376|540635363|FG001|Double-Blind Phase|Adverse Event|4|||
149864944|NCT00688376|540635362|FG000|Double-Blind Phase|Protocol Violation|1|||
149864945|NCT00688376|540635363|FG001|Double-Blind Phase|Protocol Violation|2|||
149864946|NCT00688376|540635362|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
149864947|NCT00688376|540635363|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
149864948|NCT00688376|540635362|FG000|Double-Blind Phase|Not treated|0|||
149864949|NCT00688376|540635363|FG001|Double-Blind Phase|Not treated|1|||
149864950|NCT00688376|540635362|FG000|Blinded Extension Phase|Adverse Event|3|||
149864951|NCT00688376|540635363|FG001|Blinded Extension Phase|Adverse Event|4|||
149864952|NCT00688376|540635362|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
149864953|NCT00688376|540635363|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
149864954|NCT00688376|540635362|FG000|Blinded Extension Phase|Physician Decision|1|||
149864955|NCT00688376|540635363|FG001|Blinded Extension Phase|Physician Decision|0|||
149864956|NCT00688376|540635362|FG000|Blinded Extension Phase|Other|1|||
149864957|NCT00688376|540635363|FG001|Blinded Extension Phase|Other|0|||
149864958|NCT00557076|540635364|FG000|Overall Study|Unblinding|0|||
149864959|NCT00557076|540635365|FG001|Overall Study|Unblinding|1|||
149864960|NCT02303041|540635369|FG000|Overall Study|Adverse Event|1|||
149864961|NCT02303041|540635370|FG001|Overall Study|Adverse Event|2|||
149864962|NCT00886288|540635371|FG000|Overall Study|no respect of the 12 weeks period|657|||
149864963|NCT00886288|540635372|FG001|Overall Study|no respect of the 12 weeks period|227|||
149864964|NCT00886288|540635371|FG000|Overall Study|Lost to Follow-up|86|||
149864965|NCT00886288|540635372|FG001|Overall Study|Lost to Follow-up|0|||
149864966|NCT00289874|540635373|FG000|Overall Study|Adverse Event|1|||
149864967|NCT00289874|540635374|FG001|Overall Study|Adverse Event|5|||
149864968|NCT00289874|540635373|FG000|Overall Study|Lost to Follow-up|1|||
149864969|NCT00289874|540635374|FG001|Overall Study|Lost to Follow-up|1|||
149864970|NCT00289874|540635373|FG000|Overall Study|Protocol Violation|3|||
149864971|NCT00289874|540635374|FG001|Overall Study|Protocol Violation|2|||
149864972|NCT00289874|540635373|FG000|Overall Study|Did not meet eligibility|1|||
149864973|NCT00289874|540635374|FG001|Overall Study|Did not meet eligibility|0|||
149864974|NCT00136318|540635377|FG000|Overall Study|Adverse Event|5|||
149864975|NCT00136318|540635378|FG001|Overall Study|Adverse Event|5|||
149864976|NCT00136318|540635377|FG000|Overall Study|Withdrawal by Subject|2|||
149864977|NCT00136318|540635378|FG001|Overall Study|Withdrawal by Subject|2|||
149864978|NCT03835325|540635379|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
149864979|NCT03835325|540635379|FG000|Overall Study|Selection failure|1|||
149864980|NCT01370213|540635380|FG000|Overall Study|Early Death|1|||
149864981|NCT01370213|540635381|FG001|Overall Study|Early Death|0|||
149864982|NCT01370213|540635382|FG002|Overall Study|Early Death|0|||
149864983|NCT01370213|540635380|FG000|Overall Study|Not evaluable|0|||
149864984|NCT01370213|540635381|FG001|Overall Study|Not evaluable|2|||
149864985|NCT01370213|540635382|FG002|Overall Study|Not evaluable|0|||
149864986|NCT01550744|540635385|FG000|Open-Label|Lost to Follow-up|7|||
149864987|NCT01550744|540635386|FG001|Open-Label|Lost to Follow-up|0|||
149864988|NCT01550744|540635387|FG002|Open-Label|Lost to Follow-up|0|||
149864989|NCT01550744|540635385|FG000|Open-Label|Withdrawal by Subject|13|||
149864990|NCT01550744|540635386|FG001|Open-Label|Withdrawal by Subject|0|||
149864991|NCT01550744|540635387|FG002|Open-Label|Withdrawal by Subject|0|||
149864992|NCT01550744|540635385|FG000|Open-Label|Adverse Event|11|||
149864993|NCT01550744|540635386|FG001|Open-Label|Adverse Event|0|||
149864994|NCT01550744|540635387|FG002|Open-Label|Adverse Event|0|||
149864995|NCT01550744|540635385|FG000|Open-Label|Lack of Efficacy|4|||
149864996|NCT01550744|540635386|FG001|Open-Label|Lack of Efficacy|0|||
149864997|NCT01550744|540635387|FG002|Open-Label|Lack of Efficacy|0|||
149864998|NCT01550744|540635385|FG000|Open-Label|Protocol Violation|4|||
149864999|NCT01550744|540635386|FG001|Open-Label|Protocol Violation|0|||
149865000|NCT01550744|540635387|FG002|Open-Label|Protocol Violation|0|||
149865001|NCT01550744|540635385|FG000|Open-Label|Not all 3 study drug injections received|2|||
149865002|NCT01550744|540635386|FG001|Open-Label|Not all 3 study drug injections received|0|||
149865003|NCT01550744|540635387|FG002|Open-Label|Not all 3 study drug injections received|0|||
149865004|NCT01550744|540635385|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
149865005|NCT01550744|540635386|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
149865006|NCT01550744|540635387|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
149865007|NCT01550744|540635385|FG000|Open-Label|Other|1|||
149865008|NCT01550744|540635386|FG001|Open-Label|Other|0|||
149865009|NCT01550744|540635387|FG002|Open-Label|Other|0|||
149865010|NCT01550744|540635385|FG000|Double-Blind|Lost to Follow-up|0|||
149865011|NCT01550744|540635386|FG001|Double-Blind|Lost to Follow-up|6|||
149865012|NCT01550744|540635387|FG002|Double-Blind|Lost to Follow-up|12|||
149865013|NCT01550744|540635385|FG000|Double-Blind|Withdrawal by Subject|0|||
149865014|NCT01550744|540635386|FG001|Double-Blind|Withdrawal by Subject|2|||
149865015|NCT01550744|540635387|FG002|Double-Blind|Withdrawal by Subject|15|||
149865016|NCT01550744|540635385|FG000|Double-Blind|Adverse Event|0|||
149865017|NCT01550744|540635386|FG001|Double-Blind|Adverse Event|4|||
149865018|NCT01550744|540635387|FG002|Double-Blind|Adverse Event|15|||
149865019|NCT01550744|540635385|FG000|Double-Blind|Death|0|||
149865020|NCT01550744|540635386|FG001|Double-Blind|Death|1|||
149865021|NCT01550744|540635387|FG002|Double-Blind|Death|0|||
149865022|NCT01550744|540635385|FG000|Double-Blind|Lack of Efficacy|0|||
149865023|NCT01550744|540635386|FG001|Double-Blind|Lack of Efficacy|2|||
149865024|NCT01550744|540635387|FG002|Double-Blind|Lack of Efficacy|8|||
149865025|NCT01550744|540635385|FG000|Double-Blind|Protocol Violation|0|||
149865026|NCT01550744|540635386|FG001|Double-Blind|Protocol Violation|0|||
149865027|NCT01550744|540635387|FG002|Double-Blind|Protocol Violation|4|||
149865028|NCT01550744|540635385|FG000|Double-Blind|Pregnancy|0|||
149865029|NCT01550744|540635386|FG001|Double-Blind|Pregnancy|0|||
149865030|NCT01550744|540635387|FG002|Double-Blind|Pregnancy|3|||
149865031|NCT01550744|540635385|FG000|Double-Blind|Other|0|||
149865032|NCT01550744|540635386|FG001|Double-Blind|Other|2|||
149865033|NCT01550744|540635387|FG002|Double-Blind|Other|10|||
149865034|NCT00706381|540635390|FG000|Overall Study|Lost to Follow-up|0|||
149865035|NCT00706381|540635391|FG001|Overall Study|Lost to Follow-up|1|||
149865036|NCT00706381|540635392|FG002|Overall Study|Lost to Follow-up|1|||
149865037|NCT00706381|540635393|FG003|Overall Study|Lost to Follow-up|0|||
149865038|NCT01782482|540635394|FG000|Overall Study|Adverse Event|2|||
149865039|NCT01782482|540635395|FG001|Overall Study|Adverse Event|1|||
149865040|NCT01782482|540635394|FG000|Overall Study|Lost to Follow-up|2|||
149865041|NCT01782482|540635395|FG001|Overall Study|Lost to Follow-up|3|||
149865042|NCT01782482|540635394|FG000|Overall Study|Physician Decision|1|||
149962250|NCT01104870|540995862|FG000|Overall Study|Death|0|||
149865043|NCT01782482|540635395|FG001|Overall Study|Physician Decision|0|||
149865044|NCT01782482|540635394|FG000|Overall Study|Protocol Violation|1|||
149865045|NCT01782482|540635395|FG001|Overall Study|Protocol Violation|0|||
149865046|NCT01782482|540635394|FG000|Overall Study|Withdrawal by Subject|2|||
149865047|NCT01782482|540635395|FG001|Overall Study|Withdrawal by Subject|3|||
149865048|NCT01782482|540635394|FG000|Overall Study|Randomized in Error|2|||
149962251|NCT01104870|540995863|FG001|Overall Study|Death|0|||
149865049|NCT01782482|540635395|FG001|Overall Study|Randomized in Error|2|||
149865050|NCT01782482|540635394|FG000|Overall Study|Habitually wearing toric lens OS|0|||
149865051|NCT01782482|540635395|FG001|Overall Study|Habitually wearing toric lens OS|1|||
149865052|NCT01194973|540635396|FG000|Screening Period|Screen Failure|3|||
149865053|NCT01194973|540635396|FG000|26 Week Treatment Period|Adverse Event|1|||
149865054|NCT01194973|540635396|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
149865055|NCT01194973|540635396|FG000|26 Week Treatment Period|Pregnancy|1|||
149865056|NCT01846273|540635397|FG000|Overall Study|Adverse Event|9|||
149865057|NCT01846273|540635398|FG001|Overall Study|Adverse Event|7|||
150173852|NCT03460756|541772983|FG002|Overall Study|Adverse Event|0|||
150173853|NCT03460756|541772984|FG003|Overall Study|Adverse Event|1|||
149865058|NCT01846273|540635399|FG002|Overall Study|Adverse Event|0|||
149865059|NCT01846273|540635397|FG000|Overall Study|Subject withdrew consent|5|||
149865060|NCT01846273|540635398|FG001|Overall Study|Subject withdrew consent|8|||
149865061|NCT01846273|540635399|FG002|Overall Study|Subject withdrew consent|0|||
149865062|NCT01846273|540635397|FG000|Overall Study|Lost to Follow-up|2|||
149865063|NCT01846273|540635398|FG001|Overall Study|Lost to Follow-up|1|||
150173854|NCT03460756|541772981|FG000|Overall Study|Lack of Efficacy|0|||
150173855|NCT03460756|541772982|FG001|Overall Study|Lack of Efficacy|0|||
150173856|NCT03460756|541772983|FG002|Overall Study|Lack of Efficacy|0|||
149865064|NCT01846273|540635399|FG002|Overall Study|Lost to Follow-up|0|||
149865065|NCT01846273|540635397|FG000|Overall Study|Administrative problems|1|||
149865066|NCT01846273|540635398|FG001|Overall Study|Administrative problems|0|||
149865067|NCT01846273|540635399|FG002|Overall Study|Administrative problems|0|||
149865068|NCT01846273|540635397|FG000|Overall Study|Death|2|||
149865069|NCT01846273|540635398|FG001|Overall Study|Death|1|||
149865070|NCT01846273|540635399|FG002|Overall Study|Death|0|||
149865071|NCT01846273|540635397|FG000|Overall Study|Disease Progression|0|||
149865072|NCT01846273|540635398|FG001|Overall Study|Disease Progression|4|||
149865073|NCT01846273|540635399|FG002|Overall Study|Disease Progression|0|||
149865074|NCT01846273|540635397|FG000|Overall Study|Protocol Deviation|2|||
149865075|NCT01846273|540635398|FG001|Overall Study|Protocol Deviation|3|||
149865076|NCT01846273|540635399|FG002|Overall Study|Protocol Deviation|0|||
149865077|NCT01846273|540635397|FG000|Overall Study|Physician Decision|1|||
149865078|NCT01846273|540635398|FG001|Overall Study|Physician Decision|2|||
149865079|NCT01846273|540635399|FG002|Overall Study|Physician Decision|0|||
149865080|NCT00891839|540635400|FG000|Overall Study|Adverse Event|2|||
149865081|NCT00891839|540635400|FG000|Overall Study|Withdrawal by Subject|2|||
149865082|NCT00891839|540635400|FG000|Overall Study|Disease progression|3|||
149865083|NCT02037165|540635401|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
149865084|NCT02037165|540635402|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
149865085|NCT02037165|540635403|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
149865086|NCT02037165|540635404|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
149865087|NCT02037165|540635405|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
149865088|NCT02192164|540635411|FG000|Overall Study|Other|8|||
149865089|NCT02192164|540635411|FG000|Overall Study|Withdrawal by Subject|1|||
149865090|NCT02192164|540635411|FG000|Overall Study|Physician Decision|4|||
149865091|NCT02192164|540635411|FG000|Overall Study|Did not meet the exclusion criteria|1|||
149865092|NCT00851643|540635412|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
149865093|NCT00851643|540635413|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
149865094|NCT00851643|540635414|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
149865095|NCT00851643|540635415|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
149865096|NCT00851643|540635416|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
149865097|NCT00851643|540635417|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
149865098|NCT00851643|540635412|FG000|Base Study (Up to 12 Months)|Other|0|||
149865099|NCT00851643|540635413|FG001|Base Study (Up to 12 Months)|Other|0|||
149865100|NCT00851643|540635414|FG002|Base Study (Up to 12 Months)|Other|0|||
149865101|NCT00851643|540635415|FG003|Base Study (Up to 12 Months)|Other|0|||
149865102|NCT00851643|540635416|FG004|Base Study (Up to 12 Months)|Other|0|||
149865103|NCT00851643|540635417|FG005|Base Study (Up to 12 Months)|Other|1|||
149865104|NCT00851643|540635412|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
149865105|NCT00851643|540635413|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
149865106|NCT00851643|540635414|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
149865107|NCT00851643|540635415|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
149865108|NCT00851643|540635416|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
149865109|NCT00851643|540635417|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
149865110|NCT00851643|540635412|FG000|Extension Study (Up to 36 Months)|Moved|0|||
149865111|NCT00851643|540635413|FG001|Extension Study (Up to 36 Months)|Moved|2|||
149865112|NCT00851643|540635414|FG002|Extension Study (Up to 36 Months)|Moved|1|||
149865113|NCT00851643|540635415|FG003|Extension Study (Up to 36 Months)|Moved|1|||
149865114|NCT00851643|540635416|FG004|Extension Study (Up to 36 Months)|Moved|0|||
149865115|NCT00851643|540635417|FG005|Extension Study (Up to 36 Months)|Moved|1|||
149865116|NCT00359788|540635418|FG000|Overall Study|Adverse Event|11|||
149865117|NCT00359788|540635419|FG001|Overall Study|Adverse Event|10|||
149865118|NCT00359788|540635418|FG000|Overall Study|Lack of Efficacy|1|||
149865119|NCT00359788|540635419|FG001|Overall Study|Lack of Efficacy|2|||
149865120|NCT00359788|540635418|FG000|Overall Study|Lost to Follow-up|3|||
149962252|NCT01104870|540995864|FG002|Overall Study|Death|1|||
149962253|NCT01104870|540995862|FG000|Overall Study|Withdrawal by Subject|0|||
149865121|NCT00359788|540635419|FG001|Overall Study|Lost to Follow-up|2|||
149865122|NCT00359788|540635418|FG000|Overall Study|Withdrawal by Subject|4|||
149865123|NCT00359788|540635419|FG001|Overall Study|Withdrawal by Subject|1|||
149865124|NCT00359788|540635418|FG000|Overall Study|Protocol Violation|4|||
149865125|NCT00359788|540635419|FG001|Overall Study|Protocol Violation|2|||
149865126|NCT00673933|540635420|FG000|Overall Study|Withdrawal by Subject|2|||
149962254|NCT01104870|540995863|FG001|Overall Study|Withdrawal by Subject|0|||
149865127|NCT00673933|540635420|FG000|Overall Study|Lost to Follow-up|1|||
149865128|NCT04932941|540635421|FG000|Overall Study|Lost to Follow-up|3|||
149865129|NCT04932941|540635422|FG001|Overall Study|Lost to Follow-up|1|||
149865130|NCT04932941|540635421|FG000|Overall Study|Withdrawal by Subject|7|||
149865131|NCT04932941|540635422|FG001|Overall Study|Withdrawal by Subject|4|||
149865132|NCT04932941|540635421|FG000|Overall Study|Other|4|||
149865133|NCT04932941|540635422|FG001|Overall Study|Other|2|||
149865134|NCT00103402|540635423|FG000|Overall Study|Adverse Event|3|||
149865135|NCT00103402|540635424|FG001|Overall Study|Adverse Event|4|||
149865136|NCT00103402|540635423|FG000|Overall Study|Lost to Follow-up|8|||
149865137|NCT00103402|540635424|FG001|Overall Study|Lost to Follow-up|7|||
149865138|NCT00103402|540635423|FG000|Overall Study|Dissatisfied/No longer interested|6|||
149865139|NCT00103402|540635424|FG001|Overall Study|Dissatisfied/No longer interested|6|||
149865140|NCT00103402|540635423|FG000|Overall Study|Personal constraints/Other|5|||
149865141|NCT00103402|540635424|FG001|Overall Study|Personal constraints/Other|0|||
149865142|NCT01393730|540635425|FG000|Overall Study|Withdrawal by Subject|3|||
149865143|NCT01393730|540635425|FG000|Overall Study|Other|2|||
149865144|NCT01393730|540635425|FG000|Overall Study|Adverse Event|1|||
149865145|NCT01673698|540635426|FG000|Overall Study|Lost to Follow-up|51|||
149865146|NCT01673698|540635427|FG001|Overall Study|Lost to Follow-up|13|||
149865147|NCT01297322|540635428|FG000|Overall Study|Lost to Follow-up|1|||
149865148|NCT01297322|540635429|FG001|Overall Study|Lost to Follow-up|0|||
149865149|NCT01297322|540635428|FG000|Overall Study|Withdrawal by Subject|0|||
149865150|NCT01297322|540635429|FG001|Overall Study|Withdrawal by Subject|1|||
149865151|NCT01297322|540635428|FG000|Overall Study|Protocol Violation|0|||
149865152|NCT01297322|540635429|FG001|Overall Study|Protocol Violation|3|||
149865153|NCT02013375|540635430|FG000|Overall Study|Did not engraft|1|||
149865154|NCT02013375|540635430|FG000|Overall Study|Did not engraft|1|||
149865155|NCT00712985|540635431|FG000|Overall Study|1 withdrew prior to start of drug|1|||
149865156|NCT00712985|540635431|FG000|Overall Study|1 patient moved out of state|1|||
149865157|NCT00712985|540635431|FG000|Overall Study|Lack of Efficacy|3|||
149865158|NCT02674061|540635432|FG000|Overall Study|Death|229|||
149865159|NCT02674061|540635433|FG001|Overall Study|Death|77|||
149865160|NCT02674061|540635432|FG000|Overall Study|Lost to Follow-up|3|||
149865161|NCT02674061|540635433|FG001|Overall Study|Lost to Follow-up|3|||
149865162|NCT02674061|540635432|FG000|Overall Study|Withdrawal by Subject|9|||
149865163|NCT02674061|540635433|FG001|Overall Study|Withdrawal by Subject|1|||
149865164|NCT02674061|540635432|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
149865165|NCT02674061|540635433|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
149865166|NCT03334721|540635438|FG000|Overall Study|Withdrawal by Subject|1|||
149865167|NCT03334721|540635439|FG001|Overall Study|Withdrawal by Subject|0|||
149865168|NCT03334721|540635438|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
149865169|NCT03334721|540635439|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
149865170|NCT01663727|540635440|FG000|Overall Study|Death|161|||
149865171|NCT01663727|540635441|FG001|Overall Study|Death|155|||
149865172|NCT01663727|540635440|FG000|Overall Study|Lost to Follow-up|10|||
149865173|NCT01663727|540635441|FG001|Overall Study|Lost to Follow-up|8|||
149865174|NCT01663727|540635440|FG000|Overall Study|Withdrawal by Subject|18|||
149865175|NCT01663727|540635441|FG001|Overall Study|Withdrawal by Subject|25|||
149865176|NCT01663727|540635440|FG000|Overall Study|Study Terminated|51|||
149865177|NCT01663727|540635441|FG001|Overall Study|Study Terminated|50|||
149865178|NCT01663727|540635440|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
149865179|NCT01663727|540635441|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
149865180|NCT01663727|540635440|FG000|Overall Study|Withdrawal prior to dosing.|1|||
149865181|NCT01663727|540635441|FG001|Overall Study|Withdrawal prior to dosing.|0|||
149865182|NCT01902628|540635442|FG000|Overall Study|Withdrawal of participant's consent|7|||
149865183|NCT01902628|540635442|FG000|Overall Study|Adverse Event|41|||
149865184|NCT01902628|540635442|FG000|Overall Study|Lost to Follow-up|35|||
149865185|NCT01232491|540635443|FG000|Overall Study|Adverse Event|13|||
149865186|NCT01232491|540635444|FG001|Overall Study|Adverse Event|8|||
149865187|NCT01232491|540635443|FG000|Overall Study|Lack of Efficacy|1|||
149865188|NCT01232491|540635444|FG001|Overall Study|Lack of Efficacy|5|||
149865189|NCT01232491|540635443|FG000|Overall Study|Protocol Violation|13|||
149865190|NCT01232491|540635444|FG001|Overall Study|Protocol Violation|11|||
149865191|NCT01232491|540635443|FG000|Overall Study|Withdrawal Criteria|12|||
149865192|NCT01232491|540635444|FG001|Overall Study|Withdrawal Criteria|21|||
149865193|NCT01232491|540635443|FG000|Overall Study|Other|21|||
149865194|NCT01232491|540635444|FG001|Overall Study|Other|18|||
149865195|NCT02932228|540635447|FG000|Overall Study|Death|8|||
149865196|NCT02932228|540635448|FG001|Overall Study|Death|23|||
149865197|NCT02932228|540635447|FG000|Overall Study|not eligible upon chart review|2|||
149865198|NCT02932228|540635448|FG001|Overall Study|not eligible upon chart review|5|||
149865199|NCT01045421|540637033|FG000|Phase 1|Progressive Disease|0|||
149865200|NCT01045421|540637034|FG001|Phase 1|Progressive Disease|0|||
149865201|NCT01045421|540637035|FG002|Phase 1|Progressive Disease|0|||
149865202|NCT01045421|540637036|FG003|Phase 1|Progressive Disease|0|||
149865203|NCT01045421|540637037|FG004|Phase 1|Progressive Disease|1|||
149865204|NCT01045421|540637038|FG005|Phase 1|Progressive Disease|0|||
149865205|NCT01045421|540637039|FG006|Phase 1|Progressive Disease|0|||
149865206|NCT01045421|540637040|FG007|Phase 1|Progressive Disease|0|||
149865207|NCT01045421|540637041|FG008|Phase 1|Progressive Disease|0|||
149865208|NCT01045421|540637042|FG009|Phase 1|Progressive Disease|0|||
149865209|NCT01045421|540637043|FG010|Phase 1|Progressive Disease|0|||
149865210|NCT01045421|540637033|FG000|Phase 1|Withdrawal by Subject|0|||
149865211|NCT01045421|540637034|FG001|Phase 1|Withdrawal by Subject|0|||
149865212|NCT01045421|540637035|FG002|Phase 1|Withdrawal by Subject|0|||
149865213|NCT01045421|540637036|FG003|Phase 1|Withdrawal by Subject|1|||
149865214|NCT01045421|540637037|FG004|Phase 1|Withdrawal by Subject|0|||
149865215|NCT01045421|540637038|FG005|Phase 1|Withdrawal by Subject|0|||
149865216|NCT01045421|540637039|FG006|Phase 1|Withdrawal by Subject|0|||
149865217|NCT01045421|540637040|FG007|Phase 1|Withdrawal by Subject|0|||
149865218|NCT01045421|540637041|FG008|Phase 1|Withdrawal by Subject|0|||
149865219|NCT01045421|540637042|FG009|Phase 1|Withdrawal by Subject|0|||
149865220|NCT01045421|540637043|FG010|Phase 1|Withdrawal by Subject|0|||
149865221|NCT01045421|540637033|FG000|Phase 2|Progressive Disease|0|||
149865222|NCT01045421|540637034|FG001|Phase 2|Progressive Disease|0|||
149865223|NCT01045421|540637035|FG002|Phase 2|Progressive Disease|0|||
149865224|NCT01045421|540637036|FG003|Phase 2|Progressive Disease|0|||
149865225|NCT01045421|540637037|FG004|Phase 2|Progressive Disease|0|||
149865226|NCT01045421|540637038|FG005|Phase 2|Progressive Disease|0|||
149865227|NCT01045421|540637039|FG006|Phase 2|Progressive Disease|0|||
149865228|NCT01045421|540637040|FG007|Phase 2|Progressive Disease|1|||
149865229|NCT01045421|540637041|FG008|Phase 2|Progressive Disease|1|||
149865230|NCT01045421|540637042|FG009|Phase 2|Progressive Disease|1|||
149865231|NCT01045421|540637043|FG010|Phase 2|Progressive Disease|1|||
149865232|NCT01045421|540637033|FG000|Phase 2|Death|0|||
149865233|NCT01045421|540637034|FG001|Phase 2|Death|0|||
149865234|NCT01045421|540637035|FG002|Phase 2|Death|0|||
149865235|NCT01045421|540637036|FG003|Phase 2|Death|0|||
149865236|NCT01045421|540637037|FG004|Phase 2|Death|0|||
149865237|NCT01045421|540637038|FG005|Phase 2|Death|0|||
149865238|NCT01045421|540637039|FG006|Phase 2|Death|0|||
149865239|NCT01045421|540637040|FG007|Phase 2|Death|1|||
149865240|NCT01045421|540637041|FG008|Phase 2|Death|1|||
149865241|NCT01045421|540637042|FG009|Phase 2|Death|2|||
150040807|NCT00790842|541289118|FG004|Expansion Cohort|Adverse Event|0|||
150040808|NCT00790842|541289119|FG005|Expansion Cohort|Adverse Event|0|||
149865242|NCT01045421|540637043|FG010|Phase 2|Death|0|||
149865243|NCT01045421|540637033|FG000|Phase 2|Other|0|||
149865244|NCT01045421|540637034|FG001|Phase 2|Other|0|||
149865245|NCT01045421|540637035|FG002|Phase 2|Other|0|||
149865246|NCT01045421|540637036|FG003|Phase 2|Other|0|||
149865247|NCT01045421|540637037|FG004|Phase 2|Other|0|||
149865248|NCT01045421|540637038|FG005|Phase 2|Other|0|||
149865249|NCT01045421|540637039|FG006|Phase 2|Other|0|||
149865250|NCT01045421|540637040|FG007|Phase 2|Other|3|||
149865251|NCT01045421|540637041|FG008|Phase 2|Other|0|||
149865252|NCT01045421|540637042|FG009|Phase 2|Other|0|||
149865253|NCT01045421|540637043|FG010|Phase 2|Other|1|||
149865254|NCT01553279|540637044|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
149865255|NCT01553279|540637045|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
149865256|NCT01553279|540637044|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
149865257|NCT01553279|540637045|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
149865258|NCT01553279|540637044|FG000|Interim Period|Withdrawal by Subject|2|||
149865259|NCT01553279|540637045|FG001|Interim Period|Withdrawal by Subject|2|||
149865260|NCT01553279|540637044|FG000|Interim Period|Lost to Follow-up|1|||
149865261|NCT01553279|540637045|FG001|Interim Period|Lost to Follow-up|0|||
149865262|NCT01553279|540637044|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
149865263|NCT01553279|540637045|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
149865264|NCT01553279|540637044|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
149865265|NCT01553279|540637045|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
149962255|NCT01104870|540995864|FG002|Overall Study|Withdrawal by Subject|1|||
149865266|NCT00605865|540637046|FG000|Overall Study|Protocol Violation|115|||
149865267|NCT03955471|540637047|FG000|Overall Study|Death|22|||
149865268|NCT03955471|540637047|FG000|Overall Study|Lost to Follow-up|1|||
149865269|NCT03955471|540637047|FG000|Overall Study|Withdrawal by Subject|6|||
149865270|NCT03955471|540637047|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
149865271|NCT01030341|540637050|FG000|Overall Study|Withdrawal by Subject|1|||
149865272|NCT01030341|540637050|FG000|Overall Study|Lost to Follow-up|2|||
149865273|NCT01884311|540637053|FG000|Overall Study|Withdrawal by Subject|3|||
149865274|NCT01884311|540637053|FG000|Overall Study|withdrew consent due to AEs|1|||
149865275|NCT01884311|540637053|FG000|Overall Study|Precautionary measure|1|||
149865276|NCT02856880|540637056|FG000|Overall Study|Withdrawal of consent|1|||
149865277|NCT00793780|540637057|FG000|Overall Study|Withdrawal by Subject|2|||
149865278|NCT00793780|540637058|FG001|Overall Study|Withdrawal by Subject|1|||
149865279|NCT02858492|540637059|FG000|Overall Study|Withdrawal by Subject|0|||
149962256|NCT02150863|540995870|FG000|Overall Study|Lost to Follow-up|0|||
149865280|NCT02858492|540637060|FG001|Overall Study|Withdrawal by Subject|1|||
149865281|NCT02858492|540637061|FG002|Overall Study|Withdrawal by Subject|0|||
149865282|NCT02858492|540637062|FG003|Overall Study|Withdrawal by Subject|1|||
149865283|NCT02858492|540637059|FG000|Overall Study|Adverse Event|0|||
149865284|NCT02858492|540637060|FG001|Overall Study|Adverse Event|0|||
149865285|NCT02858492|540637061|FG002|Overall Study|Adverse Event|0|||
149865286|NCT02858492|540637062|FG003|Overall Study|Adverse Event|3|||
149865287|NCT02858492|540637059|FG000|Overall Study|Lack of Efficacy|0|||
149865288|NCT02858492|540637060|FG001|Overall Study|Lack of Efficacy|0|||
149865289|NCT02858492|540637061|FG002|Overall Study|Lack of Efficacy|0|||
149865290|NCT02858492|540637062|FG003|Overall Study|Lack of Efficacy|1|||
149865291|NCT02858492|540637059|FG000|Overall Study|Protocol defined stopping criteria|0|||
149865292|NCT02858492|540637060|FG001|Overall Study|Protocol defined stopping criteria|0|||
149865293|NCT02858492|540637061|FG002|Overall Study|Protocol defined stopping criteria|0|||
149865294|NCT02858492|540637062|FG003|Overall Study|Protocol defined stopping criteria|1|||
149865295|NCT00573157|540637063|FG000|Overall Study|Adverse Event|3|||
149865296|NCT00573157|540637064|FG001|Overall Study|Adverse Event|1|||
149865297|NCT00573157|540637063|FG000|Overall Study|Other|1|||
149865298|NCT00573157|540637064|FG001|Overall Study|Other|1|||
149865299|NCT01032018|540637067|FG000|Overall Study|Lost to Follow-up|6|||
149865300|NCT01032018|540637068|FG001|Overall Study|Lost to Follow-up|5|||
149865301|NCT01032018|540637067|FG000|Overall Study|Death|0|||
149865302|NCT01032018|540637068|FG001|Overall Study|Death|1|||
149865303|NCT03853148|540637072|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
149865304|NCT03853148|540637073|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
149865305|NCT03853148|540637074|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
149865306|NCT03853148|540637075|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
149865307|NCT00599521|540637078|FG000|Overall Study|Lack of Efficacy|4|||
149865308|NCT00599521|540637079|FG001|Overall Study|Lack of Efficacy|8|||
149865309|NCT00599521|540637078|FG000|Overall Study|Adverse Event|4|||
149865310|NCT00599521|540637079|FG001|Overall Study|Adverse Event|1|||
149865311|NCT00599521|540637078|FG000|Overall Study|Withdrawal by Subject|28|||
149865312|NCT00599521|540637079|FG001|Overall Study|Withdrawal by Subject|34|||
149865313|NCT00599521|540637078|FG000|Overall Study|Protocol Violation|1|||
149865314|NCT00599521|540637079|FG001|Overall Study|Protocol Violation|1|||
149865315|NCT00599521|540637078|FG000|Overall Study|Lost to Follow-up|23|||
149865316|NCT00599521|540637079|FG001|Overall Study|Lost to Follow-up|23|||
149865317|NCT00599521|540637078|FG000|Overall Study|Pregnancy|0|||
149865318|NCT00599521|540637079|FG001|Overall Study|Pregnancy|2|||
149962257|NCT02150863|540995871|FG001|Overall Study|Lost to Follow-up|1|||
149865319|NCT01293539|540637080|FG000|Overall Study|Physician Decision|1|||
149865320|NCT01248013|540637082|FG000|Overall Study|Withdrawal by Subject|14|||
149865321|NCT01388166|540637085|FG000|Overall Study|Adverse Event|16|||
149962258|NCT02150863|540995872|FG002|Overall Study|Lost to Follow-up|0|||
149962259|NCT00511199|540995875|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
149865322|NCT01388166|540637085|FG000|Overall Study|Lost to Follow-up|30|||
149865323|NCT01388166|540637085|FG000|Overall Study|Others than specified above|13|||
149865324|NCT02667288|540637090|FG000|Overall Study|Protocol Violation|5|||
149865325|NCT02667288|540637090|FG000|Overall Study|Lost to Follow-up|3|||
149865326|NCT02667288|540637090|FG000|Overall Study|Withdrawal by Subject|5|||
149865327|NCT00714493|540637098|FG000|Overall Study|Adverse Event|11|||
149865328|NCT00714493|540637098|FG000|Overall Study|Death|3|||
149865329|NCT00714493|540637098|FG000|Overall Study|Lack of Efficacy|10|||
149865330|NCT00714493|540637098|FG000|Overall Study|Lost to Follow-up|3|||
149865331|NCT00714493|540637098|FG000|Overall Study|Protocol Violation|12|||
149865332|NCT00714493|540637098|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
149865333|NCT00714493|540637098|FG000|Overall Study|OTHER|2|||
149865334|NCT04505293|540637099|FG000|Overall Study|Lost to Follow-up|2|||
149865335|NCT04505293|540637099|FG000|Overall Study|Withdrawal by Subject|6|||
149865336|NCT04505293|540637099|FG000|Overall Study|CT scan unreadable|277|||
149865337|NCT00506129|540637100|FG000|Overall Study|Disease Progression/Relapse|15|||
149865338|NCT00506129|540637100|FG000|Overall Study|Death|7|||
149865339|NCT01400919|540637104|FG000|Overall Study|Withdrawal by Subject|4|||
149865340|NCT01400919|540637104|FG000|Overall Study|Lost to Follow-up|2|||
149865341|NCT01400919|540637104|FG000|Overall Study|Missed visit|2|||
149865342|NCT00251719|540637105|FG000|Overall Study|Adverse Event|14|||
149865343|NCT00251719|540637106|FG001|Overall Study|Adverse Event|8|||
149865344|NCT00251719|540637107|FG002|Overall Study|Adverse Event|7|||
149865345|NCT00251719|540637105|FG000|Overall Study|Protocol Violation|1|||
149865346|NCT00251719|540637106|FG001|Overall Study|Protocol Violation|1|||
149865347|NCT00251719|540637107|FG002|Overall Study|Protocol Violation|1|||
149865348|NCT00251719|540637105|FG000|Overall Study|Lost to Follow-up|5|||
149865349|NCT00251719|540637106|FG001|Overall Study|Lost to Follow-up|11|||
149865350|NCT00251719|540637107|FG002|Overall Study|Lost to Follow-up|8|||
149865351|NCT00251719|540637105|FG000|Overall Study|Withdrawal by Subject|14|||
149865352|NCT00251719|540637106|FG001|Overall Study|Withdrawal by Subject|12|||
149865353|NCT00251719|540637107|FG002|Overall Study|Withdrawal by Subject|11|||
149865354|NCT00251719|540637105|FG000|Overall Study|Lack of Efficacy|2|||
149865355|NCT00251719|540637106|FG001|Overall Study|Lack of Efficacy|1|||
149865356|NCT00251719|540637107|FG002|Overall Study|Lack of Efficacy|0|||
149865357|NCT00251719|540637105|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
149865358|NCT00251719|540637106|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
149865359|NCT00251719|540637107|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
149865360|NCT00251719|540637105|FG000|Overall Study|Investigator decision|1|||
149865361|NCT00251719|540637106|FG001|Overall Study|Investigator decision|1|||
149865362|NCT00251719|540637107|FG002|Overall Study|Investigator decision|0|||
149865363|NCT00251719|540637105|FG000|Overall Study|Noncompliance|2|||
149865364|NCT00251719|540637106|FG001|Overall Study|Noncompliance|3|||
149865365|NCT00251719|540637107|FG002|Overall Study|Noncompliance|1|||
149865366|NCT00251719|540637105|FG000|Overall Study|Barrett's esophagus|2|||
149865367|NCT00251719|540637106|FG001|Overall Study|Barrett's esophagus|2|||
149865368|NCT00251719|540637107|FG002|Overall Study|Barrett's esophagus|0|||
149865369|NCT02792959|540637110|FG000|Overall Study|Protocol Violation|1|||
149865370|NCT04392583|540637111|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
149865371|NCT03201250|540637112|FG000|Overall Study|screen failures|3|||
149865372|NCT03201250|540637113|FG001|Overall Study|screen failures|0|||
149865373|NCT03201250|540637114|FG002|Overall Study|screen failures|0|||
149865374|NCT02408068|540637115|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
149865375|NCT02408068|540637116|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
150040809|NCT00790842|541289120|FG006|Expansion Cohort|Adverse Event|1|||
149865376|NCT02408068|540637117|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
149865377|NCT02408068|540637118|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
149865378|NCT02408068|540637119|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
149865379|NCT02408068|540637120|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
149865380|NCT03484117|540637121|FG000|Overall Study|Lost to Follow-up|1|||
149865381|NCT03484117|540637122|FG001|Overall Study|Lost to Follow-up|3|||
149865382|NCT03484117|540637121|FG000|Overall Study|Declined participation in exit assess|1|||
149865383|NCT03484117|540637122|FG001|Overall Study|Declined participation in exit assess|1|||
149865384|NCT01780987|540637123|FG000|Overall Study|Adverse Event|0|||
149865385|NCT01780987|540637124|FG001|Overall Study|Adverse Event|4|||
149865386|NCT01780987|540637123|FG000|Overall Study|Withdrawal by Subject|2|||
149865387|NCT01780987|540637124|FG001|Overall Study|Withdrawal by Subject|0|||
149865388|NCT01780987|540637123|FG000|Overall Study|Request of Changing Hospital|0|||
149865389|NCT01780987|540637124|FG001|Overall Study|Request of Changing Hospital|1|||
149865390|NCT01780987|540637123|FG000|Overall Study|Changing Residence|1|||
149865391|NCT01780987|540637124|FG001|Overall Study|Changing Residence|0|||
149865392|NCT01780987|540637123|FG000|Overall Study|Not Receiving any Study Medication|0|||
149865393|NCT01780987|540637124|FG001|Overall Study|Not Receiving any Study Medication|1|||
149865394|NCT04168190|540637125|FG000|Overall Study|Lost to Follow-up|0|||
149865395|NCT04168190|540637126|FG001|Overall Study|Lost to Follow-up|1|||
149865396|NCT04168190|540637127|FG002|Overall Study|Lost to Follow-up|0|||
149865397|NCT04168190|540637128|FG003|Overall Study|Lost to Follow-up|7|||
149865398|NCT04168190|540637129|FG004|Overall Study|Lost to Follow-up|5|||
149865399|NCT04168190|540637125|FG000|Overall Study|Withdrawal by Subject|1|||
149865400|NCT04168190|540637126|FG001|Overall Study|Withdrawal by Subject|0|||
149865401|NCT04168190|540637127|FG002|Overall Study|Withdrawal by Subject|0|||
149865402|NCT04168190|540637128|FG003|Overall Study|Withdrawal by Subject|2|||
149865403|NCT04168190|540637129|FG004|Overall Study|Withdrawal by Subject|4|||
149865404|NCT04168190|540637125|FG000|Overall Study|Death|0|||
149865405|NCT04168190|540637126|FG001|Overall Study|Death|0|||
149865406|NCT04168190|540637127|FG002|Overall Study|Death|0|||
149865407|NCT04168190|540637128|FG003|Overall Study|Death|1|||
149865408|NCT04168190|540637129|FG004|Overall Study|Death|0|||
149865409|NCT02335983|540637130|FG000|Overall Study|Sponsor Decision|0|||
149865410|NCT02335983|540637131|FG001|Overall Study|Sponsor Decision|0|||
149865411|NCT02335983|540637132|FG002|Overall Study|Sponsor Decision|1|||
149865412|NCT02335983|540637133|FG003|Overall Study|Sponsor Decision|1|||
149865413|NCT02335983|540637134|FG004|Overall Study|Sponsor Decision|0|||
149865414|NCT02335983|540637135|FG005|Overall Study|Sponsor Decision|1|||
149865415|NCT02335983|540637130|FG000|Overall Study|Withdrawal by Subject|3|||
149865416|NCT02335983|540637131|FG001|Overall Study|Withdrawal by Subject|2|||
149865417|NCT02335983|540637132|FG002|Overall Study|Withdrawal by Subject|2|||
149865418|NCT02335983|540637133|FG003|Overall Study|Withdrawal by Subject|1|||
149865419|NCT02335983|540637134|FG004|Overall Study|Withdrawal by Subject|3|||
149865420|NCT02335983|540637135|FG005|Overall Study|Withdrawal by Subject|9|||
149865421|NCT02335983|540637130|FG000|Overall Study|Death|0|||
149865422|NCT02335983|540637131|FG001|Overall Study|Death|0|||
149865423|NCT02335983|540637132|FG002|Overall Study|Death|2|||
149865424|NCT02335983|540637133|FG003|Overall Study|Death|0|||
149865425|NCT02335983|540637134|FG004|Overall Study|Death|0|||
149865426|NCT02335983|540637135|FG005|Overall Study|Death|0|||
149865427|NCT02335983|540637130|FG000|Overall Study|Lost to Follow-up|0|||
149865428|NCT02335983|540637131|FG001|Overall Study|Lost to Follow-up|0|||
149865429|NCT02335983|540637132|FG002|Overall Study|Lost to Follow-up|0|||
149865430|NCT02335983|540637133|FG003|Overall Study|Lost to Follow-up|0|||
149865431|NCT02335983|540637134|FG004|Overall Study|Lost to Follow-up|0|||
149865432|NCT02335983|540637135|FG005|Overall Study|Lost to Follow-up|1|||
149865433|NCT02335983|540637130|FG000|Overall Study|Protocol Specified Criteria|5|||
149865434|NCT02335983|540637131|FG001|Overall Study|Protocol Specified Criteria|7|||
149865435|NCT02335983|540637132|FG002|Overall Study|Protocol Specified Criteria|27|||
149865436|NCT02335983|540637133|FG003|Overall Study|Protocol Specified Criteria|7|||
149865437|NCT02335983|540637134|FG004|Overall Study|Protocol Specified Criteria|5|||
149865438|NCT02335983|540637135|FG005|Overall Study|Protocol Specified Criteria|21|||
149865439|NCT01070771|540637136|FG000|Overall Study|Adverse Event|2|||
149865440|NCT01070771|540637136|FG000|Overall Study|Protocol Violation|1|||
149865441|NCT03127644|540637137|FG000|Overall Study|Study-specific withdrawal criteria|0|||
149865442|NCT03127644|540637138|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149865443|NCT03127644|540637139|FG002|Overall Study|Study-specific withdrawal criteria|2|||
149865444|NCT05070546|540637140|FG000|Overall Study|Death|0|||
149865445|NCT05070546|540637141|FG001|Overall Study|Death|0|||
149865446|NCT05070546|540637142|FG002|Overall Study|Death|0|||
149865447|NCT05070546|540637143|FG003|Overall Study|Death|0|||
149865448|NCT05070546|540637144|FG004|Overall Study|Death|0|||
149865449|NCT05070546|540637145|FG005|Overall Study|Death|1|||
149865450|NCT05070546|540637140|FG000|Overall Study|Lost to Follow-up|8|||
149865451|NCT05070546|540637141|FG001|Overall Study|Lost to Follow-up|2|||
149865452|NCT05070546|540637142|FG002|Overall Study|Lost to Follow-up|7|||
149865453|NCT05070546|540637143|FG003|Overall Study|Lost to Follow-up|1|||
149865454|NCT05070546|540637144|FG004|Overall Study|Lost to Follow-up|2|||
149865455|NCT05070546|540637145|FG005|Overall Study|Lost to Follow-up|0|||
149962260|NCT00511199|540995876|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
149962261|NCT00511199|540995875|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
149865456|NCT05070546|540637140|FG000|Overall Study|Withdrawal by Subject|1|||
149865457|NCT05070546|540637141|FG001|Overall Study|Withdrawal by Subject|1|||
149865458|NCT05070546|540637142|FG002|Overall Study|Withdrawal by Subject|3|||
149865459|NCT05070546|540637143|FG003|Overall Study|Withdrawal by Subject|0|||
149962262|NCT00511199|540995876|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
149865460|NCT05070546|540637144|FG004|Overall Study|Withdrawal by Subject|0|||
149865461|NCT05070546|540637145|FG005|Overall Study|Withdrawal by Subject|0|||
149865462|NCT05070546|540637140|FG000|Overall Study|Other|0|||
150173857|NCT03460756|541772984|FG003|Overall Study|Lack of Efficacy|2|||
149962263|NCT00511199|540995875|FG000|Overall Study|Withdrawal of Informed Consent|19|||
149962264|NCT00511199|540995876|FG001|Overall Study|Withdrawal of Informed Consent|4|||
149962265|NCT00511199|540995875|FG000|Overall Study|Pregnancy|6|||
149962266|NCT00511199|540995876|FG001|Overall Study|Pregnancy|3|||
149962267|NCT00511199|540995875|FG000|Overall Study|Pregnancy Wish|16|||
149962268|NCT00511199|540995876|FG001|Overall Study|Pregnancy Wish|8|||
149962269|NCT00511199|540995875|FG000|Overall Study|Lost to Follow-up|40|||
149962270|NCT00511199|540995876|FG001|Overall Study|Lost to Follow-up|17|||
149962271|NCT00511199|540995875|FG000|Overall Study|Other Reason|78|||
149962272|NCT00511199|540995876|FG001|Overall Study|Other Reason|37|||
149962273|NCT01714063|540995877|FG000|Overall Study|Equipment malfunction|2|||
149962274|NCT03878602|540995878|FG000|Overall Study|cord blood donation|7|||
149962275|NCT03878602|540995879|FG001|Overall Study|cord blood donation|1|||
149962276|NCT03878602|540995878|FG000|Overall Study|incomplete data collection|2|||
149962277|NCT03878602|540995879|FG001|Overall Study|incomplete data collection|0|||
149962278|NCT02191397|540995881|FG000|Overall Study|Adverse Event|28|||
149962279|NCT02191397|540995882|FG001|Overall Study|Adverse Event|17|||
149962280|NCT02191397|540995881|FG000|Overall Study|Lack of Efficacy|10|||
149962281|NCT02191397|540995882|FG001|Overall Study|Lack of Efficacy|5|||
149962282|NCT02191397|540995881|FG000|Overall Study|Protocol Violation|0|||
149962283|NCT02191397|540995882|FG001|Overall Study|Protocol Violation|3|||
149962284|NCT02191397|540995881|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
149962285|NCT02191397|540995882|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
149962286|NCT02191397|540995881|FG000|Overall Study|Lost to Follow-up|10|||
149962287|NCT02191397|540995882|FG001|Overall Study|Lost to Follow-up|11|||
149962288|NCT02191397|540995881|FG000|Overall Study|Physician Decision|8|||
149962289|NCT02191397|540995882|FG001|Overall Study|Physician Decision|3|||
150040810|NCT00790842|541289121|FG007|Expansion Cohort|Adverse Event|0|||
150040811|NCT00790842|541289122|FG008|Expansion Cohort|Adverse Event|0|||
150040812|NCT00790842|541289123|FG009|Expansion Cohort|Adverse Event|0|||
150040813|NCT00790842|541289124|FG010|Expansion Cohort|Adverse Event|0|||
150173858|NCT03460756|541772981|FG000|Overall Study|Lost to Follow-up|0|||
149962290|NCT02191397|540995881|FG000|Overall Study|Withdrawal by Subject|22|||
149962291|NCT02191397|540995882|FG001|Overall Study|Withdrawal by Subject|27|||
150040814|NCT00790842|541289114|FG000|Expansion Cohort|Death|0|||
149865463|NCT05070546|540637141|FG001|Overall Study|Other|0|||
149865464|NCT05070546|540637142|FG002|Overall Study|Other|0|||
149865465|NCT05070546|540637143|FG003|Overall Study|Other|0|||
149865466|NCT05070546|540637144|FG004|Overall Study|Other|3|||
149865467|NCT05070546|540637145|FG005|Overall Study|Other|0|||
149865468|NCT05070546|540637140|FG000|Overall Study|Randomized but not vaccinated|1|||
149865469|NCT05070546|540637141|FG001|Overall Study|Randomized but not vaccinated|0|||
149865470|NCT05070546|540637142|FG002|Overall Study|Randomized but not vaccinated|1|||
149865471|NCT05070546|540637143|FG003|Overall Study|Randomized but not vaccinated|1|||
149865472|NCT05070546|540637144|FG004|Overall Study|Randomized but not vaccinated|3|||
149865473|NCT05070546|540637145|FG005|Overall Study|Randomized but not vaccinated|0|||
149865474|NCT02787408|540637151|FG000|Overall Study|Death|16|||
149865475|NCT02787408|540637151|FG000|Overall Study|Withdrawal by Subject|1|||
149865476|NCT02787408|540637151|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
149865477|NCT03096847|540637153|FG000|Overall Study|Other|2|||
149865478|NCT03096847|540637154|FG001|Overall Study|Other|1|||
149865479|NCT03096847|540637155|FG002|Overall Study|Other|2|||
149865480|NCT03096847|540637153|FG000|Overall Study|Lost to Follow-up|1|||
149865481|NCT03096847|540637154|FG001|Overall Study|Lost to Follow-up|0|||
149865482|NCT03096847|540637155|FG002|Overall Study|Lost to Follow-up|1|||
149865483|NCT03096847|540637153|FG000|Overall Study|Death|6|||
149865484|NCT03096847|540637154|FG001|Overall Study|Death|0|||
149865485|NCT03096847|540637155|FG002|Overall Study|Death|2|||
149865486|NCT03096847|540637153|FG000|Overall Study|Protocol Violation|3|||
149865487|NCT03096847|540637154|FG001|Overall Study|Protocol Violation|0|||
149865488|NCT03096847|540637155|FG002|Overall Study|Protocol Violation|6|||
149865489|NCT03096847|540637153|FG000|Overall Study|Physician Decision|12|||
149865490|NCT03096847|540637154|FG001|Overall Study|Physician Decision|2|||
149865491|NCT03096847|540637155|FG002|Overall Study|Physician Decision|8|||
149865492|NCT03096847|540637153|FG000|Overall Study|Withdrawal by Subject|24|||
149865493|NCT03096847|540637154|FG001|Overall Study|Withdrawal by Subject|1|||
149865494|NCT03096847|540637155|FG002|Overall Study|Withdrawal by Subject|12|||
149865495|NCT03096847|540637153|FG000|Overall Study|Adverse Event|72|||
149865496|NCT03096847|540637154|FG001|Overall Study|Adverse Event|6|||
149865497|NCT03096847|540637155|FG002|Overall Study|Adverse Event|28|||
149865498|NCT03096847|540637153|FG000|Overall Study|Progressive disease|97|||
149865499|NCT03096847|540637154|FG001|Overall Study|Progressive disease|10|||
149865500|NCT03096847|540637155|FG002|Overall Study|Progressive disease|78|||
149865501|NCT03096847|540637153|FG000|Overall Study|Non-compliance with study medication|1|||
149865502|NCT03096847|540637154|FG001|Overall Study|Non-compliance with study medication|0|||
149865503|NCT03096847|540637155|FG002|Overall Study|Non-compliance with study medication|0|||
149865504|NCT03096847|540637153|FG000|Overall Study|New therapy for study indication|1|||
149865505|NCT03096847|540637154|FG001|Overall Study|New therapy for study indication|0|||
149865506|NCT03096847|540637155|FG002|Overall Study|New therapy for study indication|1|||
149865507|NCT02093221|540637158|FG000|Overall Study|Adverse Event|1|||
149865508|NCT02093221|540637159|FG001|Overall Study|Adverse Event|0|||
149865509|NCT02093221|540637160|FG002|Overall Study|Adverse Event|0|||
149865510|NCT02093221|540637161|FG003|Overall Study|Adverse Event|0|||
149865511|NCT02093221|540637162|FG004|Overall Study|Adverse Event|0|||
149865512|NCT02093221|540637158|FG000|Overall Study|Withdrawal by Subject|1|||
149865513|NCT02093221|540637159|FG001|Overall Study|Withdrawal by Subject|1|||
149865514|NCT02093221|540637160|FG002|Overall Study|Withdrawal by Subject|4|||
149865515|NCT02093221|540637161|FG003|Overall Study|Withdrawal by Subject|1|||
149865516|NCT02093221|540637162|FG004|Overall Study|Withdrawal by Subject|1|||
149865517|NCT02093221|540637158|FG000|Overall Study|Lost to Follow-up|2|||
149865518|NCT02093221|540637159|FG001|Overall Study|Lost to Follow-up|0|||
149865519|NCT02093221|540637160|FG002|Overall Study|Lost to Follow-up|1|||
149865520|NCT02093221|540637161|FG003|Overall Study|Lost to Follow-up|1|||
149865521|NCT02093221|540637162|FG004|Overall Study|Lost to Follow-up|0|||
149865522|NCT02093221|540637158|FG000|Overall Study|Death|0|||
149865523|NCT02093221|540637159|FG001|Overall Study|Death|1|||
149865524|NCT02093221|540637160|FG002|Overall Study|Death|0|||
149865525|NCT02093221|540637161|FG003|Overall Study|Death|0|||
149865526|NCT02093221|540637162|FG004|Overall Study|Death|0|||
149865527|NCT02093221|540637158|FG000|Overall Study|Protocol Violation|0|||
149865528|NCT02093221|540637159|FG001|Overall Study|Protocol Violation|1|||
149865529|NCT02093221|540637160|FG002|Overall Study|Protocol Violation|0|||
149865530|NCT02093221|540637161|FG003|Overall Study|Protocol Violation|0|||
149865531|NCT02093221|540637162|FG004|Overall Study|Protocol Violation|0|||
149865532|NCT02093221|540637158|FG000|Overall Study|Study termination|6|||
149865533|NCT02093221|540637159|FG001|Overall Study|Study termination|5|||
149865534|NCT02093221|540637160|FG002|Overall Study|Study termination|4|||
149865535|NCT02093221|540637161|FG003|Overall Study|Study termination|6|||
149865536|NCT02093221|540637162|FG004|Overall Study|Study termination|7|||
149865537|NCT03097588|540637165|FG000|Overall Study|Adverse Event|1|||
149865538|NCT00731549|540637166|FG000|Overall Study|Lost to Follow-up|19|||
149865539|NCT00731549|540637166|FG000|Overall Study|Met withdrawal criteria|24|||
149865540|NCT00731549|540637166|FG000|Overall Study|Physician Decision|16|||
149865541|NCT00731549|540637166|FG000|Overall Study|Withdrawal by Subject|89|||
149865542|NCT00731549|540637166|FG000|Overall Study|Protocol deviation|1|||
149865543|NCT00731549|540637166|FG000|Overall Study|Adverse Event|31|||
149865544|NCT00731549|540637166|FG000|Overall Study|Lack of efficacy with AE|37|||
149865545|NCT00731549|540637166|FG000|Overall Study|Lack of efficacy without AE|6|||
150173859|NCT03460756|541772982|FG001|Overall Study|Lost to Follow-up|1|||
149865546|NCT00588640|540637167|FG000|Overall Study|Physician Decision|1|||
149865547|NCT00588640|540637167|FG000|Overall Study|Ineligible Patient|1|||
149865548|NCT00507546|540637168|FG000|Overall Study|Withdrawal by Subject|1|||
149865549|NCT00507546|540637169|FG001|Overall Study|Withdrawal by Subject|0|||
149865550|NCT00507546|540637168|FG000|Overall Study|Protocol Violation|1|||
149865551|NCT00507546|540637169|FG001|Overall Study|Protocol Violation|0|||
149865552|NCT00507546|540637168|FG000|Overall Study|Physician Decision|0|||
149865553|NCT00507546|540637169|FG001|Overall Study|Physician Decision|1|||
149865554|NCT02384850|540637170|FG000|Overall Study|Withdrawal by Subject|2|||
149865555|NCT02384850|540637171|FG001|Overall Study|Withdrawal by Subject|2|||
149865556|NCT03512262|540637175|FG000|Overall Study|Adverse Event|8|||
149865557|NCT03512262|540637176|FG001|Overall Study|Adverse Event|3|||
149865558|NCT03512262|540637175|FG000|Overall Study|Death (non-treatment emergent)|1|||
149865559|NCT03512262|540637176|FG001|Overall Study|Death (non-treatment emergent)|0|||
149865560|NCT03512262|540637175|FG000|Overall Study|Withdrawal by Subject|17|||
149865561|NCT03512262|540637176|FG001|Overall Study|Withdrawal by Subject|9|||
149865562|NCT03512262|540637175|FG000|Overall Study|Lost to Follow-up|7|||
149865563|NCT03512262|540637176|FG001|Overall Study|Lost to Follow-up|1|||
149865564|NCT03512262|540637175|FG000|Overall Study|Other than Specified|2|||
149865565|NCT03512262|540637176|FG001|Overall Study|Other than Specified|2|||
149865566|NCT00375492|540637178|FG000|Overall Study|Adverse Event|4|||
149865567|NCT00375492|540637179|FG001|Overall Study|Adverse Event|5|||
149865568|NCT00375492|540637178|FG000|Overall Study|Entry Criteria Not Met|0|||
149865569|NCT00375492|540637179|FG001|Overall Study|Entry Criteria Not Met|1|||
149865570|NCT00375492|540637178|FG000|Overall Study|Loss of Glucose Control|0|||
149865571|NCT00375492|540637179|FG001|Overall Study|Loss of Glucose Control|1|||
149865572|NCT00375492|540637178|FG000|Overall Study|Lost to Follow-up|10|||
149865573|NCT00375492|540637179|FG001|Overall Study|Lost to Follow-up|5|||
149865574|NCT00375492|540637178|FG000|Overall Study|Physician Decision|0|||
149865575|NCT00375492|540637179|FG001|Overall Study|Physician Decision|4|||
149865576|NCT00375492|540637178|FG000|Overall Study|Protocol Violation|6|||
149865577|NCT00375492|540637179|FG001|Overall Study|Protocol Violation|3|||
149865578|NCT00375492|540637178|FG000|Overall Study|Sponsor Decision|0|||
149865579|NCT00375492|540637179|FG001|Overall Study|Sponsor Decision|1|||
149865580|NCT00375492|540637178|FG000|Overall Study|Withdrawal by Subject|6|||
149865581|NCT00375492|540637179|FG001|Overall Study|Withdrawal by Subject|6|||
149865582|NCT03303625|540638841|FG000|Overall Study|Withdrawal by Subject|2|||
149865583|NCT03303625|540638842|FG001|Overall Study|Withdrawal by Subject|0|||
149865584|NCT03303625|540638843|FG002|Overall Study|Withdrawal by Subject|0|||
149865585|NCT03303625|540638844|FG003|Overall Study|Withdrawal by Subject|0|||
149865586|NCT04319718|540638845|FG000|Overall Study|Adverse Event|0|||
149865587|NCT04319718|540638846|FG001|Overall Study|Adverse Event|2|||
149865588|NCT04319718|540638845|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
149865589|NCT04319718|540638846|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
149865590|NCT03340064|540638848|FG000|First Period|Adverse Event, non-fatal|2|||
149865591|NCT03340064|540638849|FG001|First Period|Adverse Event, non-fatal|0|||
149865592|NCT03340064|540638848|FG000|First Period|Lack of Efficacy|3|||
149865593|NCT03340064|540638849|FG001|First Period|Lack of Efficacy|0|||
149865594|NCT03340064|540638848|FG000|Second Period|Adverse Event, non-fatal|1|||
149865595|NCT03340064|540638849|FG001|Second Period|Adverse Event, non-fatal|1|||
149865596|NCT03340064|540638848|FG000|Second Period|Lack of Efficacy|11|||
149865597|NCT03340064|540638849|FG001|Second Period|Lack of Efficacy|0|||
149865598|NCT03340064|540638848|FG000|Second Period|Physician Decision|3|||
149865599|NCT03340064|540638849|FG001|Second Period|Physician Decision|0|||
149865600|NCT03340064|540638848|FG000|Second Period|Withdrawal by Subject|2|||
149865601|NCT03340064|540638849|FG001|Second Period|Withdrawal by Subject|1|||
149865602|NCT03340064|540638848|FG000|Second Period|Approved Drug Available For Indication|1|||
149865603|NCT03340064|540638849|FG001|Second Period|Approved Drug Available For Indication|0|||
149865604|NCT03340064|540638848|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
149865605|NCT03340064|540638849|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
149865606|NCT02221037|540638850|FG000|Overall Study|Physician Decision|0|||
149865607|NCT02221037|540638851|FG001|Overall Study|Physician Decision|0|||
149865608|NCT02221037|540638852|FG002|Overall Study|Physician Decision|1|||
149865609|NCT02221037|540638853|FG003|Overall Study|Physician Decision|0|||
149865610|NCT00321828|540638854|FG000|Overall Study|Ineligible|3|||
149865611|NCT00321828|540638854|FG000|Overall Study|No follow up data|1|||
149865612|NCT02307266|540638855|FG000|Overall Study|Adverse Event|3|||
149865613|NCT02307266|540638856|FG001|Overall Study|Adverse Event|1|||
149865614|NCT02307266|540638857|FG002|Overall Study|Adverse Event|5|||
149865615|NCT02307266|540638855|FG000|Overall Study|Withdrawal by Subject|2|||
149865616|NCT02307266|540638856|FG001|Overall Study|Withdrawal by Subject|0|||
149865617|NCT02307266|540638857|FG002|Overall Study|Withdrawal by Subject|1|||
149865618|NCT02307266|540638855|FG000|Overall Study|Lost to Follow-up|3|||
149865619|NCT02307266|540638856|FG001|Overall Study|Lost to Follow-up|0|||
149865620|NCT02307266|540638857|FG002|Overall Study|Lost to Follow-up|0|||
149865621|NCT02944383|540638859|FG000|Overall Study|Lost to Follow-up|0|||
149865622|NCT02944383|540638860|FG001|Overall Study|Lost to Follow-up|0|||
149865623|NCT02944383|540638861|FG002|Overall Study|Lost to Follow-up|1|||
149865624|NCT02944383|540638859|FG000|Overall Study|Withdrawal by Subject|1|||
149865625|NCT02944383|540638860|FG001|Overall Study|Withdrawal by Subject|0|||
149865626|NCT02944383|540638861|FG002|Overall Study|Withdrawal by Subject|0|||
149865627|NCT00858143|540638865|FG000|Overall Study|Adverse Event|16|||
149865628|NCT00858143|540638865|FG000|Overall Study|Lack of Efficacy|4|||
149865629|NCT00858143|540638865|FG000|Overall Study|Death|7|||
149865630|NCT00858143|540638865|FG000|Overall Study|Other|23|||
149865631|NCT00090610|540638866|FG000|Overall Study|Withdrawal by Subject|1|||
149865632|NCT00090610|540638867|FG001|Overall Study|Withdrawal by Subject|1|||
149865633|NCT00609518|540638871|FG000|Overall Study|Death from Study Disease|32|||
149865634|NCT00609518|540638872|FG001|Overall Study|Death from Study Disease|32|||
149865635|NCT00609518|540638871|FG000|Overall Study|Withdrawal by Subject|5|||
149865636|NCT00609518|540638872|FG001|Overall Study|Withdrawal by Subject|3|||
149865637|NCT00609518|540638871|FG000|Overall Study|Lost to Follow-up|3|||
149865638|NCT00609518|540638872|FG001|Overall Study|Lost to Follow-up|0|||
149865639|NCT00609518|540638871|FG000|Overall Study|Physician Decision|1|||
149865640|NCT00609518|540638872|FG001|Overall Study|Physician Decision|3|||
149865641|NCT00609518|540638871|FG000|Overall Study|Death from Adverse Event|2|||
149865642|NCT00609518|540638872|FG001|Overall Study|Death from Adverse Event|2|||
149865643|NCT05855616|540638873|FG000|Overall Study|Lost to Follow-up|1|||
149865644|NCT05855616|540638874|FG001|Overall Study|Lost to Follow-up|2|||
149865645|NCT04032158|540638875|FG000|Overall Study|Study Termination|2|||
149865646|NCT04032158|540638876|FG001|Overall Study|Study Termination|1|||
149865647|NCT00059787|540638877|FG000|Overall Study|Adverse Event|13|||
149865648|NCT00059787|540638877|FG000|Overall Study|disease progression|2|||
149865649|NCT00059787|540638877|FG000|Overall Study|ineligible|1|||
149865650|NCT00059787|540638877|FG000|Overall Study|Other|4|||
149865651|NCT04421586|540638879|FG000|Overall Study|Death|0|||
149865652|NCT04421586|540638880|FG001|Overall Study|Death|1|||
149865653|NCT04421586|540638879|FG000|Overall Study|Lost to Follow-up|2|||
149865654|NCT04421586|540638880|FG001|Overall Study|Lost to Follow-up|2|||
149865655|NCT04421586|540638879|FG000|Overall Study|Withdrawn by PI|1|||
149865656|NCT04421586|540638880|FG001|Overall Study|Withdrawn by PI|0|||
149865657|NCT04421586|540638879|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
149865658|NCT04421586|540638880|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
149865659|NCT01968694|540638881|FG000|Washout (1 Month)|Lost to Follow-up|0|||
149865660|NCT01968694|540638882|FG001|Washout (1 Month)|Lost to Follow-up|1|||
149865661|NCT00846521|540638883|FG000|Overall Study|Withdrawal by Subject|5|||
149865662|NCT00846521|540638883|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
149865663|NCT00846521|540638883|FG000|Overall Study|Protocol Violation|1|||
149865664|NCT03052959|540638890|FG000|Overall Study|Lost to Follow-up|4|||
149962292|NCT02176525|540995884|FG000|Overall Study|Adverse Event|0|||
149865665|NCT03052959|540638891|FG001|Overall Study|Lost to Follow-up|5|||
149962293|NCT02176525|540995885|FG001|Overall Study|Adverse Event|0|||
149865666|NCT02032706|540638892|FG000|Overall Study|Did not qualify|5|||
149962294|NCT02176525|540995886|FG002|Overall Study|Adverse Event|0|||
149865667|NCT02032706|540638892|FG000|Overall Study|Protocol Violation|1|||
149865668|NCT00928707|540638893|FG000|Overall Study|Protocol Violation|1|||
149865669|NCT00928707|540638894|FG001|Overall Study|Protocol Violation|0|||
149865670|NCT00160641|540638896|FG000|Overall Study|Adverse Event|102|||
149865671|NCT00160641|540638896|FG000|Overall Study|Withdrawal by Subject|87|||
149865672|NCT00160641|540638896|FG000|Overall Study|Lost to Follow-up|8|||
149865673|NCT00160641|540638896|FG000|Overall Study|Lack of Efficacy|12|||
149962295|NCT02176525|540995887|FG003|Overall Study|Adverse Event|1|||
149962296|NCT02176525|540995888|FG004|Overall Study|Adverse Event|1|||
149962297|NCT02176525|540995889|FG005|Overall Study|Adverse Event|0|||
149962298|NCT02176525|540995890|FG006|Overall Study|Adverse Event|1|||
149865674|NCT00160641|540638896|FG000|Overall Study|Protocol Violation|3|||
149865675|NCT00160641|540638896|FG000|Overall Study|Other|9|||
149865676|NCT00985712|540638897|FG000|Overall Study|Adverse Event|0|||
149865677|NCT00985712|540638898|FG001|Overall Study|Adverse Event|1|||
149865678|NCT00985712|540638897|FG000|Overall Study|Lost to Follow-up|2|||
149865679|NCT00985712|540638898|FG001|Overall Study|Lost to Follow-up|2|||
149865680|NCT00985712|540638897|FG000|Overall Study|Protocol Violation|0|||
149865681|NCT00985712|540638898|FG001|Overall Study|Protocol Violation|1|||
149865682|NCT00985712|540638897|FG000|Overall Study|Withdrawal by Subject|4|||
149865683|NCT00985712|540638898|FG001|Overall Study|Withdrawal by Subject|1|||
149865684|NCT00985712|540638897|FG000|Overall Study|Sponsor decision|0|||
149865685|NCT00985712|540638898|FG001|Overall Study|Sponsor decision|2|||
149865686|NCT00359632|540638906|FG000|Overall Study|Death|2|||
149865687|NCT00359632|540638907|FG001|Overall Study|Death|0|||
149865688|NCT00359632|540638906|FG000|Overall Study|Adverse Event|1|||
149865689|NCT00359632|540638907|FG001|Overall Study|Adverse Event|0|||
149865690|NCT00359632|540638906|FG000|Overall Study|Non-compliance with visit schedule|1|||
149865691|NCT00359632|540638907|FG001|Overall Study|Non-compliance with visit schedule|0|||
149865692|NCT01875471|540638908|FG000|Overall Study|Adverse Event|0|||
149865693|NCT01875471|540638909|FG001|Overall Study|Adverse Event|1|||
149865694|NCT01875471|540638908|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
149865695|NCT01875471|540638909|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
149865696|NCT03978091|540638912|FG000|Overall Study|Lost to Follow-up|0|||
149865697|NCT03978091|540638913|FG001|Overall Study|Lost to Follow-up|0|||
149962299|NCT02176525|540995891|FG007|Overall Study|Adverse Event|0|||
149962300|NCT02176525|540995884|FG000|Overall Study|not treated|1|||
149962301|NCT02176525|540995885|FG001|Overall Study|not treated|0|||
149962302|NCT02176525|540995886|FG002|Overall Study|not treated|0|||
149865698|NCT03978091|540638914|FG002|Overall Study|Lost to Follow-up|1|||
149962303|NCT02176525|540995887|FG003|Overall Study|not treated|0|||
149865699|NCT03978091|540638915|FG003|Overall Study|Lost to Follow-up|0|||
149865700|NCT03978091|540638916|FG004|Overall Study|Lost to Follow-up|0|||
149865701|NCT03978091|540638917|FG005|Overall Study|Lost to Follow-up|0|||
149865702|NCT03978091|540638912|FG000|Overall Study|Withdrawal by Subject|0|||
149865703|NCT03978091|540638913|FG001|Overall Study|Withdrawal by Subject|0|||
149865704|NCT03978091|540638914|FG002|Overall Study|Withdrawal by Subject|0|||
149865705|NCT03978091|540638915|FG003|Overall Study|Withdrawal by Subject|1|||
149865706|NCT03978091|540638916|FG004|Overall Study|Withdrawal by Subject|1|||
149865707|NCT03978091|540638917|FG005|Overall Study|Withdrawal by Subject|0|||
149865708|NCT04700280|540638925|FG000|Overall Study|Adverse Event|4|||
149865709|NCT04700280|540638926|FG001|Overall Study|Adverse Event|0|||
149865710|NCT04700280|540638925|FG000|Overall Study|Lack of Efficacy|1|||
149865711|NCT04700280|540638926|FG001|Overall Study|Lack of Efficacy|0|||
149865712|NCT04700280|540638925|FG000|Overall Study|Study terminated by sponsor|5|||
149865713|NCT04700280|540638926|FG001|Overall Study|Study terminated by sponsor|3|||
149865714|NCT04700280|540638925|FG000|Overall Study|Other than specified|1|||
149865715|NCT04700280|540638926|FG001|Overall Study|Other than specified|0|||
149865716|NCT01843348|540638927|FG000|Overall Study|Withdrawal by Subject|4|||
149865717|NCT01843348|540638928|FG001|Overall Study|Withdrawal by Subject|16|||
149865718|NCT01843348|540638929|FG002|Overall Study|Withdrawal by Subject|18|||
149865719|NCT01843348|540638927|FG000|Overall Study|Lost to Follow-up|5|||
149865720|NCT01843348|540638928|FG001|Overall Study|Lost to Follow-up|4|||
149865721|NCT01843348|540638929|FG002|Overall Study|Lost to Follow-up|2|||
149865722|NCT01843348|540638927|FG000|Overall Study|Death|5|||
149865723|NCT01843348|540638928|FG001|Overall Study|Death|3|||
149865724|NCT01843348|540638929|FG002|Overall Study|Death|4|||
149865725|NCT01843348|540638927|FG000|Overall Study|Graft loss/retransplantation|5|||
149865726|NCT01843348|540638928|FG001|Overall Study|Graft loss/retransplantation|8|||
149865727|NCT01843348|540638929|FG002|Overall Study|Graft loss/retransplantation|11|||
149865728|NCT01843348|540638927|FG000|Overall Study|Various reasons|4|||
149865729|NCT01843348|540638928|FG001|Overall Study|Various reasons|9|||
149865730|NCT01843348|540638929|FG002|Overall Study|Various reasons|6|||
149865731|NCT00251641|540638930|FG000|Overall Study|Adverse Event|80|||
149865732|NCT00251641|540638931|FG001|Overall Study|Adverse Event|8|||
149865733|NCT00251641|540638930|FG000|Overall Study|Lack of Efficacy|2|||
149865734|NCT00251641|540638931|FG001|Overall Study|Lack of Efficacy|1|||
149865735|NCT00251641|540638930|FG000|Overall Study|Progression of Disease|0|||
149865736|NCT00251641|540638931|FG001|Overall Study|Progression of Disease|2|||
149865737|NCT00251641|540638930|FG000|Overall Study|Lost to Follow-up|3|||
149865738|NCT00251641|540638931|FG001|Overall Study|Lost to Follow-up|3|||
149865739|NCT00251641|540638930|FG000|Overall Study|Withdrawal by Subject|6|||
149865740|NCT00251641|540638931|FG001|Overall Study|Withdrawal by Subject|8|||
149865741|NCT00251641|540638930|FG000|Overall Study|Protocol Violation|10|||
149865742|NCT00251641|540638931|FG001|Overall Study|Protocol Violation|2|||
149865743|NCT00251641|540638930|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
149865744|NCT00251641|540638931|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
149865745|NCT00251641|540638930|FG000|Overall Study|Switched Treatment|9|||
149865746|NCT00251641|540638931|FG001|Overall Study|Switched Treatment|63|||
149865747|NCT00257920|540638932|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
149865748|NCT00257920|540638933|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
149865749|NCT00257920|540638932|FG000|Period: Second Intervention|Other|2|||
149865750|NCT00257920|540638933|FG001|Period: Second Intervention|Other|1|||
149865751|NCT00770692|540638934|FG000|Overall Study|Withdrawal by Subject|7|||
149865752|NCT00770692|540638935|FG001|Overall Study|Withdrawal by Subject|9|||
149865753|NCT00770692|540638936|FG002|Overall Study|Withdrawal by Subject|9|||
149865754|NCT00770692|540638937|FG003|Overall Study|Withdrawal by Subject|6|||
149865755|NCT00770692|540638934|FG000|Overall Study|Adverse Event|3|||
149865756|NCT00770692|540638935|FG001|Overall Study|Adverse Event|0|||
149865757|NCT00770692|540638936|FG002|Overall Study|Adverse Event|4|||
149865758|NCT00770692|540638937|FG003|Overall Study|Adverse Event|4|||
149865759|NCT00770692|540638934|FG000|Overall Study|Investigator judgment|2|||
149865760|NCT00770692|540638935|FG001|Overall Study|Investigator judgment|0|||
149962304|NCT02176525|540995888|FG004|Overall Study|not treated|0|||
149962305|NCT02176525|540995889|FG005|Overall Study|not treated|1|||
149962306|NCT02176525|540995890|FG006|Overall Study|not treated|0|||
149962307|NCT02176525|540995891|FG007|Overall Study|not treated|0|||
149865761|NCT00770692|540638936|FG002|Overall Study|Investigator judgment|1|||
149865762|NCT00770692|540638937|FG003|Overall Study|Investigator judgment|1|||
149865763|NCT01230892|540638938|FG000|Overall Study|Withdrawal by Subject|1|||
149865764|NCT01230892|540638939|FG001|Overall Study|Withdrawal by Subject|1|||
149962308|NCT00478140|540995892|FG000|Overall Study|Clinical Disease Progression|1|||
149962309|NCT01185366|540995897|FG000|First Line Therapy|Insurance Coverage Denied|1|||
150173860|NCT03460756|541772983|FG002|Overall Study|Lost to Follow-up|2|||
149865765|NCT01230892|540638938|FG000|Overall Study|Lost to Follow-up|2|||
149865766|NCT01230892|540638939|FG001|Overall Study|Lost to Follow-up|0|||
149865767|NCT00679913|540638940|FG000|Overall Study|Protocol Violation|18|||
149962310|NCT01185366|540995898|FG001|First Line Therapy|Insurance Coverage Denied|1|||
149865768|NCT00679913|540638941|FG001|Overall Study|Protocol Violation|13|||
149865769|NCT00725621|540638942|FG000|Overall Study|Adverse Event|25|||
149865770|NCT00725621|540638942|FG000|Overall Study|Lack of Efficacy|46|||
149865771|NCT00725621|540638942|FG000|Overall Study|Withdrawal by Subject|57|||
149865772|NCT00725621|540638942|FG000|Overall Study|Physician Decision|19|||
149865773|NCT00725621|540638942|FG000|Overall Study|Lost to Follow-up|52|||
149865774|NCT00725621|540638942|FG000|Overall Study|Non-compliance|8|||
149865775|NCT00725621|540638942|FG000|Overall Study|Continued treatment by other physician|6|||
149865776|NCT00725621|540638942|FG000|Overall Study|Switched to other study|1|||
149865777|NCT00725621|540638942|FG000|Overall Study|Switched to other drug|1|||
149865778|NCT00725621|540638942|FG000|Overall Study|Prepared for elective surgery|1|||
149865779|NCT00725621|540638942|FG000|Overall Study|Reason not specified|55|||
149865780|NCT01189500|540638943|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
149865781|NCT01189500|540638943|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
149865782|NCT00062751|540638944|FG000|Overall Study|Disease progression|24|||
149865783|NCT00062751|540638945|FG001|Overall Study|Disease progression|17|||
149865784|NCT00062751|540638946|FG002|Overall Study|Disease progression|24|||
149865785|NCT00062751|540638947|FG003|Overall Study|Disease progression|2|||
149865786|NCT00062751|540638948|FG004|Overall Study|Disease progression|2|||
149865787|NCT00062751|540638944|FG000|Overall Study|Adverse Event|4|||
149865788|NCT00062751|540638945|FG001|Overall Study|Adverse Event|7|||
149865789|NCT00062751|540638946|FG002|Overall Study|Adverse Event|2|||
149865790|NCT00062751|540638947|FG003|Overall Study|Adverse Event|2|||
149865791|NCT00062751|540638948|FG004|Overall Study|Adverse Event|2|||
149865792|NCT00062751|540638944|FG000|Overall Study|Other|2|||
149865793|NCT00062751|540638945|FG001|Overall Study|Other|3|||
149865794|NCT00062751|540638946|FG002|Overall Study|Other|1|||
149865795|NCT00062751|540638947|FG003|Overall Study|Other|0|||
149865796|NCT00062751|540638948|FG004|Overall Study|Other|1|||
149865797|NCT00062751|540638944|FG000|Overall Study|Withdrawal by Subject|1|||
149865798|NCT00062751|540638945|FG001|Overall Study|Withdrawal by Subject|2|||
149865799|NCT00062751|540638946|FG002|Overall Study|Withdrawal by Subject|2|||
149865800|NCT00062751|540638947|FG003|Overall Study|Withdrawal by Subject|1|||
149865801|NCT00062751|540638948|FG004|Overall Study|Withdrawal by Subject|0|||
149865802|NCT00062751|540638944|FG000|Overall Study|Symptomatic deterioration|1|||
149865803|NCT00062751|540638945|FG001|Overall Study|Symptomatic deterioration|1|||
149865804|NCT00062751|540638946|FG002|Overall Study|Symptomatic deterioration|0|||
149865805|NCT00062751|540638947|FG003|Overall Study|Symptomatic deterioration|0|||
149865806|NCT00062751|540638948|FG004|Overall Study|Symptomatic deterioration|1|||
149865807|NCT00062751|540638944|FG000|Overall Study|Death|1|||
149865808|NCT00062751|540638945|FG001|Overall Study|Death|0|||
149865809|NCT00062751|540638946|FG002|Overall Study|Death|1|||
149865810|NCT00062751|540638947|FG003|Overall Study|Death|0|||
149865811|NCT00062751|540638948|FG004|Overall Study|Death|0|||
149865812|NCT01000493|540638949|FG000|Overall Study|Adverse Event|3|||
149865813|NCT01000493|540638950|FG001|Overall Study|Adverse Event|6|||
149865814|NCT01000493|540638949|FG000|Overall Study|Lack of Efficacy|1|||
149865815|NCT01000493|540638950|FG001|Overall Study|Lack of Efficacy|1|||
149865816|NCT01000493|540638949|FG000|Overall Study|Protocol Violation|1|||
149865817|NCT01000493|540638950|FG001|Overall Study|Protocol Violation|8|||
149865818|NCT01000493|540638949|FG000|Overall Study|Study closed/terminated|25|||
149865819|NCT01000493|540638950|FG001|Overall Study|Study closed/terminated|23|||
149865820|NCT01000493|540638949|FG000|Overall Study|Lost to Follow-up|5|||
149865821|NCT01000493|540638950|FG001|Overall Study|Lost to Follow-up|9|||
149865822|NCT01000493|540638949|FG000|Overall Study|Physician Decision|1|||
149865823|NCT01000493|540638950|FG001|Overall Study|Physician Decision|1|||
149865824|NCT01000493|540638949|FG000|Overall Study|Withdrawal by Subject|3|||
149865825|NCT01000493|540638950|FG001|Overall Study|Withdrawal by Subject|7|||
149865826|NCT03629028|540638951|FG000|Overall Study|Lost to Follow-up|26|||
149865827|NCT03629028|540638952|FG001|Overall Study|Lost to Follow-up|23|||
149865828|NCT03629028|540638951|FG000|Overall Study|Pregnancy|4|||
149865829|NCT03629028|540638952|FG001|Overall Study|Pregnancy|2|||
149865830|NCT03629028|540638951|FG000|Overall Study|intolerance to examination|2|||
149865831|NCT03629028|540638952|FG001|Overall Study|intolerance to examination|0|||
149865832|NCT03828448|540638955|FG000|Overall Study|Sponsor's Discretion|34|||
149865833|NCT05069155|540638956|FG000|Overall Study|Withdrawal by Subject|1|||
149865834|NCT05069155|540638957|FG001|Overall Study|Withdrawal by Subject|3|||
149865835|NCT02206620|540638958|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
149865836|NCT02206620|540638959|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
149865837|NCT02206620|540638958|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
149865838|NCT02206620|540638959|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
149865839|NCT01929031|540638960|FG000|Overall Study|Adverse Event|3|||
149865840|NCT01929031|540638961|FG001|Overall Study|Adverse Event|1|||
149962311|NCT01185366|540995897|FG000|First Line Therapy|Withdrawal by Subject|1|||
149962312|NCT01185366|540995898|FG001|First Line Therapy|Withdrawal by Subject|0|||
149962313|NCT01185366|540995897|FG000|First Line Therapy|Lack of Metastatic Site|1|||
149865841|NCT01929031|540638962|FG002|Overall Study|Adverse Event|1|||
149865842|NCT01929031|540638963|FG003|Overall Study|Adverse Event|0|||
149865843|NCT01929031|540638964|FG004|Overall Study|Adverse Event|0|||
149865844|NCT01929031|540638965|FG005|Overall Study|Adverse Event|0|||
149865845|NCT01929031|540638960|FG000|Overall Study|Protocol Violation|1|||
149865846|NCT01929031|540638961|FG001|Overall Study|Protocol Violation|0|||
149865847|NCT01929031|540638962|FG002|Overall Study|Protocol Violation|0|||
149865848|NCT01929031|540638963|FG003|Overall Study|Protocol Violation|0|||
149865849|NCT01929031|540638964|FG004|Overall Study|Protocol Violation|0|||
149865850|NCT01929031|540638965|FG005|Overall Study|Protocol Violation|1|||
149865851|NCT01929031|540638960|FG000|Overall Study|Reason other than specified above|0|||
149865852|NCT01929031|540638961|FG001|Overall Study|Reason other than specified above|1|||
149865853|NCT01929031|540638962|FG002|Overall Study|Reason other than specified above|0|||
149865854|NCT01929031|540638963|FG003|Overall Study|Reason other than specified above|0|||
149865855|NCT01929031|540638964|FG004|Overall Study|Reason other than specified above|1|||
149865856|NCT01929031|540638965|FG005|Overall Study|Reason other than specified above|0|||
149865857|NCT05816200|540638968|FG000|Overall Study|Lost to Follow-up|2|||
149865858|NCT05816200|540638969|FG001|Overall Study|Lost to Follow-up|1|||
149865859|NCT01366443|540638970|FG000|Overall Study|Lost to Follow-up|2|||
149865860|NCT01366443|540638970|FG000|Overall Study|Under 18 yo|1|||
149865861|NCT02394730|540638971|FG000|Overall Study|Lost to Follow-up|1|||
149865862|NCT02394730|540638972|FG001|Overall Study|Lost to Follow-up|0|||
149865863|NCT02394730|540638971|FG000|Overall Study|Withdrawal by Subject|0|||
149865864|NCT02394730|540638972|FG001|Overall Study|Withdrawal by Subject|1|||
149865865|NCT01111019|540638973|FG000|Overall Study|Withdrew Prematurely|2|||
149865866|NCT01111019|540638973|FG000|Overall Study|Other|1|||
149865867|NCT04062448|540640500|FG000|Overall Study|Lost to Follow-up|1|||
149865868|NCT04062448|540640500|FG000|Overall Study|Withdrawal by Subject|2|||
149865869|NCT04710979|540640501|FG000|Overall Study|Lost to Follow-up|2|||
149865870|NCT04710979|540640502|FG001|Overall Study|Lost to Follow-up|4|||
149865871|NCT04710979|540640501|FG000|Overall Study|Withdrawal by Subject|1|||
149865872|NCT04710979|540640502|FG001|Overall Study|Withdrawal by Subject|0|||
149865873|NCT00912093|540640505|FG000|The Controlled Phase|Death|0|||
149865874|NCT00912093|540640506|FG001|The Controlled Phase|Death|1|||
149865875|NCT00912093|540640507|FG002|The Controlled Phase|Death|0|||
149865876|NCT00912093|540640508|FG003|The Controlled Phase|Death|0|||
149865877|NCT00912093|540640509|FG004|The Controlled Phase|Death|0|||
149865878|NCT00912093|540640505|FG000|The Controlled Phase|Medical Condition|0|||
149865879|NCT00912093|540640506|FG001|The Controlled Phase|Medical Condition|1|||
149865880|NCT00912093|540640507|FG002|The Controlled Phase|Medical Condition|0|||
149865881|NCT00912093|540640508|FG003|The Controlled Phase|Medical Condition|0|||
149865882|NCT00912093|540640509|FG004|The Controlled Phase|Medical Condition|0|||
149865883|NCT00912093|540640505|FG000|The Controlled Phase|Lost to Follow-up|0|||
149865884|NCT00912093|540640506|FG001|The Controlled Phase|Lost to Follow-up|0|||
149865885|NCT00912093|540640507|FG002|The Controlled Phase|Lost to Follow-up|0|||
149865886|NCT00912093|540640508|FG003|The Controlled Phase|Lost to Follow-up|0|||
149865887|NCT00912093|540640509|FG004|The Controlled Phase|Lost to Follow-up|1|||
149865888|NCT00891371|540640512|FG000|Pre-assignment|Inclusion/exclusion|5|||
149865889|NCT00891371|540640512|FG000|Pre-assignment|Consent withdrawal|1|||
149865890|NCT00891371|540640512|FG000|Treatment|Lack of Efficacy|5|||
149865891|NCT00891371|540640512|FG000|Treatment|Adverse Event|2|||
149865892|NCT00891371|540640512|FG000|Treatment|Death|1|||
149865893|NCT00891371|540640512|FG000|Treatment|Lost to Follow-up|1|||
149865894|NCT00307034|540640513|FG000|Overall Study|Adverse Event|1|||
149865895|NCT00307034|540640514|FG001|Overall Study|Adverse Event|2|||
149865896|NCT00307034|540640513|FG000|Overall Study|Withdrawal by Subject|1|||
149865897|NCT00307034|540640514|FG001|Overall Study|Withdrawal by Subject|2|||
149865898|NCT00307034|540640513|FG000|Overall Study|Lost to Follow-up|0|||
149865899|NCT00307034|540640514|FG001|Overall Study|Lost to Follow-up|3|||
149865900|NCT00450619|540640520|FG000|Overall Study|refused treatment after randomization|2|||
149865901|NCT00450619|540640521|FG001|Overall Study|refused treatment after randomization|0|||
149865902|NCT00450619|540640520|FG000|Overall Study|did not progress; refused further trmt|1|||
149865903|NCT00450619|540640521|FG001|Overall Study|did not progress; refused further trmt|1|||
149865904|NCT00450619|540640520|FG000|Overall Study|Adverse Event|1|||
149865905|NCT00450619|540640521|FG001|Overall Study|Adverse Event|0|||
149865906|NCT02034058|540640522|FG000|Overall Study|Death|3|||
149865907|NCT02836496|540640523|FG000|Overall Study|Adverse Event|2|||
149865908|NCT02836496|540640524|FG001|Overall Study|Adverse Event|1|||
149865909|NCT02836496|540640523|FG000|Overall Study|Withdrawal by Subject|0|||
149865910|NCT02836496|540640524|FG001|Overall Study|Withdrawal by Subject|1|||
149865911|NCT03914950|540640533|FG000|Overall Study|Physician Decision|54|||
149865912|NCT02575911|540640536|FG000|Overall Study|Lost to Follow-up|1|||
149865913|NCT03579966|540640537|FG000|Overall Study|Adverse Event|6|||
149865914|NCT03579966|540640537|FG000|Overall Study|Lost to Follow-up|4|||
149865915|NCT03579966|540640537|FG000|Overall Study|Physician Decision|10|||
149865916|NCT03579966|540640537|FG000|Overall Study|Pregnancy|1|||
149865917|NCT03579966|540640537|FG000|Overall Study|Withdrawal by Subject|16|||
149865918|NCT03579966|540640537|FG000|Overall Study|Study terminated by Sponsor|22|||
149865919|NCT03579966|540640537|FG000|Overall Study|Protocol Violation|1|||
149865920|NCT01249365|540640538|FG000|Overall Study|Lost to Follow-up|1|||
149865921|NCT01340768|540640539|FG000|Overall Study|Lost to Follow-up|10|||
149865922|NCT01340768|540640540|FG001|Overall Study|Lost to Follow-up|4|||
149865923|NCT01340768|540640539|FG000|Overall Study|Withdrawal by Subject|5|||
149865924|NCT01340768|540640540|FG001|Overall Study|Withdrawal by Subject|1|||
149865925|NCT01340768|540640539|FG000|Overall Study|Other|2|||
149865926|NCT01340768|540640540|FG001|Overall Study|Other|0|||
149865927|NCT00140426|540640547|FG000|Overall Study|Withdrawal by Subject|0|||
149865928|NCT00140426|540640548|FG001|Overall Study|Withdrawal by Subject|3|||
149865929|NCT00950963|540640549|FG000|Overall Study|Lost to Follow-up|29|||
149865930|NCT00950963|540640550|FG001|Overall Study|Lost to Follow-up|24|||
149865931|NCT01675661|540640551|FG000|Overall Study|Lost to Follow-up|22|||
149865932|NCT01675661|540640552|FG001|Overall Study|Lost to Follow-up|23|||
149865933|NCT01675661|540640551|FG000|Overall Study|Practical problems|9|||
149865934|NCT01675661|540640552|FG001|Overall Study|Practical problems|5|||
149865935|NCT01675661|540640551|FG000|Overall Study|Moved away|5|||
149865936|NCT01675661|540640552|FG001|Overall Study|Moved away|6|||
149865937|NCT01675661|540640551|FG000|Overall Study|Withdrawal by Subject|3|||
149865938|NCT01675661|540640552|FG001|Overall Study|Withdrawal by Subject|7|||
149865939|NCT01675661|540640551|FG000|Overall Study|Physician Decision|0|||
149865940|NCT01675661|540640552|FG001|Overall Study|Physician Decision|2|||
149865941|NCT01675661|540640551|FG000|Overall Study|Death|0|||
149865942|NCT01675661|540640552|FG001|Overall Study|Death|1|||
149865943|NCT01675661|540640551|FG000|Overall Study|Other reason|1|||
149865944|NCT01675661|540640552|FG001|Overall Study|Other reason|2|||
149865945|NCT04765384|540640553|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
149865946|NCT04765384|540640554|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
149865947|NCT04765384|540640555|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
149865948|NCT04765384|540640556|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
149865949|NCT04765384|540640557|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
149865950|NCT04765384|540640558|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
149865951|NCT04765384|540640553|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
149865952|NCT04765384|540640554|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
149865953|NCT04765384|540640555|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
149865954|NCT04765384|540640556|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
149865955|NCT04765384|540640557|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
149865956|NCT04765384|540640558|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
149865957|NCT04765384|540640553|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
149865958|NCT04765384|540640554|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
149865959|NCT04765384|540640555|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
149865960|NCT04765384|540640556|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
149865961|NCT04765384|540640557|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
149865962|NCT04765384|540640558|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
149865963|NCT04765384|540640553|FG000|Post-natal: Neonates and Infants|Death|0|||
149865964|NCT04765384|540640554|FG001|Post-natal: Neonates and Infants|Death|0|||
149865965|NCT04765384|540640555|FG002|Post-natal: Neonates and Infants|Death|0|||
149865966|NCT04765384|540640556|FG003|Post-natal: Neonates and Infants|Death|1|||
149865967|NCT04765384|540640557|FG004|Post-natal: Neonates and Infants|Death|0|||
149962314|NCT01185366|540995898|FG001|First Line Therapy|Lack of Metastatic Site|0|||
149962315|NCT01185366|540995897|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
149962316|NCT01185366|540995898|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
149962317|NCT01185366|540995897|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
149962318|NCT01185366|540995898|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
150040815|NCT00790842|541289115|FG001|Expansion Cohort|Death|0|||
150173861|NCT03460756|541772984|FG003|Overall Study|Lost to Follow-up|1|||
149865968|NCT04765384|540640558|FG005|Post-natal: Neonates and Infants|Death|0|||
149865969|NCT04765384|540640553|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
150173862|NCT03460756|541772981|FG000|Overall Study|Pregnancy|0|||
150173863|NCT03460756|541772982|FG001|Overall Study|Pregnancy|0|||
150173864|NCT03460756|541772983|FG002|Overall Study|Pregnancy|0|||
149865970|NCT04765384|540640554|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
149865971|NCT04765384|540640555|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
149865972|NCT04765384|540640556|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
149865973|NCT04765384|540640557|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
149865974|NCT04765384|540640558|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
149865975|NCT00987389|540640559|FG000|Overall Study|Ineligible|0|||
149865976|NCT00987389|540640560|FG001|Overall Study|Ineligible|3|||
149865977|NCT00987389|540640561|FG002|Overall Study|Ineligible|0|||
149865978|NCT00987389|540640562|FG003|Overall Study|Ineligible|0|||
149865979|NCT00987389|540640559|FG000|Overall Study|Lost to Follow-up|4|||
149865980|NCT00987389|540640560|FG001|Overall Study|Lost to Follow-up|1|||
149865981|NCT00987389|540640561|FG002|Overall Study|Lost to Follow-up|3|||
149865982|NCT00987389|540640562|FG003|Overall Study|Lost to Follow-up|1|||
149865983|NCT00987389|540640559|FG000|Overall Study|Withdrawal by Subject|4|||
149865984|NCT00987389|540640560|FG001|Overall Study|Withdrawal by Subject|3|||
149865985|NCT00987389|540640561|FG002|Overall Study|Withdrawal by Subject|2|||
149865986|NCT00987389|540640562|FG003|Overall Study|Withdrawal by Subject|1|||
149865987|NCT00987389|540640559|FG000|Overall Study|Withdrawn from Treatment|0|||
149865988|NCT00987389|540640560|FG001|Overall Study|Withdrawn from Treatment|1|||
149865989|NCT00987389|540640561|FG002|Overall Study|Withdrawn from Treatment|0|||
149865990|NCT00987389|540640562|FG003|Overall Study|Withdrawn from Treatment|0|||
149865991|NCT00987389|540640559|FG000|Overall Study|Multiple different reasons|1|||
149865992|NCT00987389|540640560|FG001|Overall Study|Multiple different reasons|0|||
149865993|NCT00987389|540640561|FG002|Overall Study|Multiple different reasons|3|||
149865994|NCT00987389|540640562|FG003|Overall Study|Multiple different reasons|1|||
149865995|NCT02992418|540640565|FG000|Overall Study|Withdrawal by Subject|11|||
149865996|NCT02992418|540640566|FG001|Overall Study|Withdrawal by Subject|12|||
149865997|NCT02992418|540640565|FG000|Overall Study|Non-compliance with the protocol|308|||
149865998|NCT02992418|540640566|FG001|Overall Study|Non-compliance with the protocol|308|||
149865999|NCT02992418|540640565|FG000|Overall Study|Lost to Follow-up|27|||
149866000|NCT02992418|540640566|FG001|Overall Study|Lost to Follow-up|22|||
149866001|NCT00289536|540640567|FG000|Period 3|Lost to Follow-up|0|||
149866002|NCT00289536|540640568|FG001|Period 3|Lost to Follow-up|0|||
149866003|NCT00289536|540640569|FG002|Period 3|Lost to Follow-up|1|||
149866004|NCT03246126|540640570|FG000|Overall Study|Withdrawal by Subject|0|||
149866005|NCT03246126|540640571|FG001|Overall Study|Withdrawal by Subject|1|||
149866006|NCT00629265|540640574|FG000|Overall Study|Lost to Follow-up|4|||
149866007|NCT00629265|540640575|FG001|Overall Study|Lost to Follow-up|5|||
149866008|NCT00629265|540640574|FG000|Overall Study|Withdrawal by Subject|11|||
149866009|NCT00629265|540640575|FG001|Overall Study|Withdrawal by Subject|8|||
149866010|NCT00629265|540640574|FG000|Overall Study|Death|1|||
149866011|NCT00629265|540640575|FG001|Overall Study|Death|0|||
149866012|NCT00629265|540640574|FG000|Overall Study|Adverse Event|2|||
149866013|NCT00629265|540640575|FG001|Overall Study|Adverse Event|0|||
149866014|NCT00629265|540640574|FG000|Overall Study|HNC Recurrence|4|||
149866015|NCT00629265|540640575|FG001|Overall Study|HNC Recurrence|0|||
149866016|NCT00629265|540640574|FG000|Overall Study|Other CA Requiring Treatment|1|||
149866017|NCT00629265|540640575|FG001|Overall Study|Other CA Requiring Treatment|3|||
149866018|NCT00629265|540640574|FG000|Overall Study|Needed Esophageal Dilation|4|||
149866019|NCT00629265|540640575|FG001|Overall Study|Needed Esophageal Dilation|1|||
149866020|NCT00629265|540640574|FG000|Overall Study|Unrelated Medical Complications|3|||
149962319|NCT01185366|540995897|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
149962320|NCT01185366|540995898|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
149962321|NCT01185366|540995897|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
150173865|NCT03460756|541772984|FG003|Overall Study|Pregnancy|1|||
149866021|NCT00629265|540640575|FG001|Overall Study|Unrelated Medical Complications|1|||
149866022|NCT00629265|540640574|FG000|Overall Study|Unknown Reason|2|||
149866023|NCT00629265|540640575|FG001|Overall Study|Unknown Reason|2|||
149866024|NCT04465630|540640576|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
149866025|NCT04465630|540640576|FG000|Overall Study|Screen failure|8|||
149866026|NCT04465630|540640576|FG000|Overall Study|Baseline failure|16|||
149866027|NCT01006135|540640577|FG000|Overall Study|Adverse Event|22|||
149866028|NCT01006135|540640577|FG000|Overall Study|Protocol Violation|14|||
149866029|NCT01006135|540640577|FG000|Overall Study|Lost to Follow-up|32|||
149866030|NCT01006135|540640577|FG000|Overall Study|Other|72|||
149866031|NCT01732484|540640581|FG000|Overall Study|Death|7|||
149866032|NCT01732484|540640581|FG000|Overall Study|Lost to Follow-up|14|||
149866033|NCT01732484|540640581|FG000|Overall Study|chronical illness|5|||
149866034|NCT01169532|540640582|FG000|Overall Study|Withdrawal by Subject|1|||
149866035|NCT01087489|540640586|FG000|Overall Study|enrolled in another VA study|0|||
149866036|NCT01087489|540640587|FG001|Overall Study|enrolled in another VA study|1|||
149866037|NCT01087489|540640586|FG000|Overall Study|Death|0|||
149866038|NCT01087489|540640587|FG001|Overall Study|Death|1|||
149866039|NCT01087489|540640586|FG000|Overall Study|unable to survey by telephone|0|||
149866040|NCT01087489|540640587|FG001|Overall Study|unable to survey by telephone|1|||
149866041|NCT00893737|540640595|FG000|Overall Study|Adverse Event|4|||
149866042|NCT00893737|540640595|FG000|Overall Study|Withdrawal by Subject|2|||
149866043|NCT00893737|540640595|FG000|Overall Study|Lost to Follow-up|6|||
149866044|NCT01156142|540640596|FG000|Overall Study|Withdrawal by Subject|8|||
149866045|NCT01156142|540640597|FG001|Overall Study|Withdrawal by Subject|6|||
149866046|NCT01156142|540640596|FG000|Overall Study|Ineligible|0|||
149866047|NCT01156142|540640597|FG001|Overall Study|Ineligible|1|||
149866048|NCT00132028|540640598|FG000|Overall Study|Adverse Event|7|||
149866049|NCT00132028|540640598|FG000|Overall Study|Death|2|||
149866050|NCT00132028|540640598|FG000|Overall Study|Lack of Efficacy|11|||
149866051|NCT00132028|540640598|FG000|Overall Study|Withdrawal by Subject|2|||
149866052|NCT00132028|540640598|FG000|Overall Study|not eligible|2|||
149866053|NCT00132028|540640598|FG000|Overall Study|Physician Decision|3|||
149866054|NCT02140411|540640599|FG000|Overall Study|Adverse Event|1|||
149866055|NCT03981419|540640602|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
149866056|NCT03981419|540640603|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
149866057|NCT01330459|540640607|FG000|Overall Study|Physician Decision|0|||
149866058|NCT01330459|540640608|FG001|Overall Study|Physician Decision|2|||
149866059|NCT02005887|540640610|FG000|Overall Study|Protocol Violation|0|||
149866060|NCT02005887|540640611|FG001|Overall Study|Protocol Violation|2|||
149866061|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
149866062|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
149866063|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
149866064|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
149866065|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
149866066|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
149866067|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
149866068|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
149866069|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
149866070|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
149866071|NCT04771403|540640620|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
149866072|NCT04771403|540640621|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
149866073|NCT04771403|540640620|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
149866074|NCT04771403|540640621|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
149866075|NCT04771403|540640620|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
149866076|NCT04771403|540640621|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
149866077|NCT01615263|540640622|FG000|Overall Study|Post-randomization exclusion|0|||
149866078|NCT01615263|540640623|FG001|Overall Study|Post-randomization exclusion|2|||
149866079|NCT01640873|540640624|FG000|Overall Study|Protocol Violation|2|||
149866080|NCT01640873|540640625|FG001|Overall Study|Protocol Violation|1|||
149866081|NCT01321008|540640626|FG000|Overall Study|Early Study Termination|1|||
149866082|NCT02749292|540640627|FG000|Overall Study|Physician Decision|1|||
149866083|NCT02749292|540640628|FG001|Overall Study|Physician Decision|0|||
149866084|NCT02749292|540640627|FG000|Overall Study|Withdrawal by Subject|5|||
149866085|NCT02749292|540640628|FG001|Overall Study|Withdrawal by Subject|7|||
149866086|NCT02749292|540640627|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
149866087|NCT02749292|540640628|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
149962322|NCT01185366|540995898|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
149962323|NCT02205359|540995899|FG000|Overall Study|Death|293|||
149866088|NCT02749292|540640627|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
149866089|NCT02749292|540640628|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
149866090|NCT02749292|540640627|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
149866091|NCT02749292|540640628|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
149866092|NCT02749292|540640627|FG000|Overall Study|Adverse Event|4|||
149866093|NCT02749292|540640628|FG001|Overall Study|Adverse Event|1|||
149866094|NCT02749292|540640627|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
149866095|NCT02749292|540640628|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
149866096|NCT02749292|540640627|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
149866097|NCT02749292|540640628|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
149866098|NCT02749292|540640627|FG000|Overall Study|Requiring glucocorticoids|0|||
149866099|NCT02749292|540640628|FG001|Overall Study|Requiring glucocorticoids|3|||
149866100|NCT02749292|540640627|FG000|Overall Study|Cancer|1|||
149866101|NCT02749292|540640628|FG001|Overall Study|Cancer|0|||
149866102|NCT00876018|540640629|FG000|Overall Study|Lost to Follow-up|0|||
149866103|NCT00876018|540640630|FG001|Overall Study|Lost to Follow-up|1|||
149866104|NCT00876018|540640631|FG002|Overall Study|Lost to Follow-up|1|||
149866105|NCT00876018|540640629|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
149866106|NCT00876018|540640630|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
149866107|NCT00876018|540640631|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
149866108|NCT01144364|540640638|FG000|Induction Phase|Disease progression|14|||
149866109|NCT01144364|540640639|FG001|Induction Phase|Disease progression|0|||
149866110|NCT01144364|540640640|FG002|Induction Phase|Disease progression|0|||
149866111|NCT01144364|540640638|FG000|Induction Phase|Adverse Event|9|||
149866112|NCT01144364|540640639|FG001|Induction Phase|Adverse Event|0|||
149866113|NCT01144364|540640640|FG002|Induction Phase|Adverse Event|0|||
149866114|NCT01144364|540640638|FG000|Induction Phase|Death|1|||
149866115|NCT01144364|540640639|FG001|Induction Phase|Death|0|||
149866116|NCT01144364|540640640|FG002|Induction Phase|Death|0|||
149866117|NCT01144364|540640638|FG000|Induction Phase|Withdrawal by Subject|1|||
149866118|NCT01144364|540640639|FG001|Induction Phase|Withdrawal by Subject|0|||
149866119|NCT01144364|540640640|FG002|Induction Phase|Withdrawal by Subject|0|||
149866120|NCT01144364|540640638|FG000|Induction Phase|Lost to Follow-up|2|||
149866121|NCT01144364|540640639|FG001|Induction Phase|Lost to Follow-up|0|||
149866122|NCT01144364|540640640|FG002|Induction Phase|Lost to Follow-up|0|||
149866123|NCT01144364|540640638|FG000|Induction Phase|Physician Decision|1|||
149866124|NCT01144364|540640639|FG001|Induction Phase|Physician Decision|0|||
149866125|NCT01144364|540640640|FG002|Induction Phase|Physician Decision|0|||
149866126|NCT01144364|540640638|FG000|Induction Phase|Stable disease|2|||
149866127|NCT01144364|540640639|FG001|Induction Phase|Stable disease|0|||
149866128|NCT01144364|540640640|FG002|Induction Phase|Stable disease|0|||
149866129|NCT01144364|540640638|FG000|Induction Phase|Secondary neoplasia|1|||
149866130|NCT01144364|540640639|FG001|Induction Phase|Secondary neoplasia|0|||
149866131|NCT01144364|540640640|FG002|Induction Phase|Secondary neoplasia|0|||
149866132|NCT01144364|540640638|FG000|Induction Phase|Protocol Violation|1|||
149866133|NCT01144364|540640639|FG001|Induction Phase|Protocol Violation|0|||
149866134|NCT01144364|540640640|FG002|Induction Phase|Protocol Violation|0|||
149866135|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
149866136|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
149866137|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
149866138|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
149866139|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
149866140|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
149866141|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Death|0|||
149866142|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Death|2|||
149866143|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Death|0|||
149866144|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
149866145|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
149866146|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
149866147|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
149866148|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
149866149|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
149866150|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
149866151|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
149866152|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
149866153|NCT01144364|540640638|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
149866154|NCT01144364|540640639|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
149866155|NCT01144364|540640640|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
149866156|NCT03456960|540640641|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
149866157|NCT03456960|540640642|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
149866158|NCT03456960|540640643|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
149866159|NCT03456960|540640644|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
149866160|NCT03456960|540640645|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
149866161|NCT03456960|540640646|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
149866162|NCT03456960|540640641|FG000|Period 2 (1 Day)|Adverse Event|1|||
149866163|NCT03456960|540640642|FG001|Period 2 (1 Day)|Adverse Event|0|||
149866164|NCT03456960|540640643|FG002|Period 2 (1 Day)|Adverse Event|0|||
149866165|NCT03456960|540640644|FG003|Period 2 (1 Day)|Adverse Event|1|||
149866166|NCT03456960|540640645|FG004|Period 2 (1 Day)|Adverse Event|0|||
149866167|NCT03456960|540640646|FG005|Period 2 (1 Day)|Adverse Event|0|||
149866168|NCT01346774|540640647|FG000|Overall Study|Did not take a single dose|6|||
149866169|NCT01346774|540640648|FG001|Overall Study|Did not take a single dose|4|||
149866170|NCT01346774|540640647|FG000|Overall Study|Lost to Follow-up|3|||
149866171|NCT01346774|540640648|FG001|Overall Study|Lost to Follow-up|4|||
149866172|NCT01346774|540640647|FG000|Overall Study|Withdrawal by Subject|1|||
149866173|NCT01346774|540640648|FG001|Overall Study|Withdrawal by Subject|4|||
149866174|NCT01346774|540640647|FG000|Overall Study|Protocol Violation|2|||
149866175|NCT01346774|540640648|FG001|Overall Study|Protocol Violation|3|||
149866176|NCT01346774|540640647|FG000|Overall Study|Adverse Event|1|||
149866177|NCT01346774|540640648|FG001|Overall Study|Adverse Event|2|||
149866178|NCT00609466|540640656|FG000|Overall Study|Withdrawal by Subject|0|||
149866179|NCT00609466|540640657|FG001|Overall Study|Withdrawal by Subject|1|||
149866180|NCT00609466|540640658|FG002|Overall Study|Withdrawal by Subject|1|||
149866181|NCT00609466|540640656|FG000|Overall Study|Adverse Event|2|||
149866182|NCT00609466|540640657|FG001|Overall Study|Adverse Event|3|||
149866183|NCT00609466|540640658|FG002|Overall Study|Adverse Event|1|||
149866184|NCT00609466|540640656|FG000|Overall Study|Lack of Efficacy|0|||
149866185|NCT00609466|540640657|FG001|Overall Study|Lack of Efficacy|2|||
149866186|NCT00609466|540640658|FG002|Overall Study|Lack of Efficacy|2|||
149866187|NCT01299805|540640659|FG000|Overall Study|Adverse Event|2|||
149866188|NCT01299805|540640660|FG001|Overall Study|Adverse Event|0|||
149866189|NCT03510182|540640661|FG000|Overall Study|Withdrawal by Subject|2|||
149866190|NCT01334710|540640668|FG000|Overall Study|Trial was terminated|3|||
149866191|NCT00290251|540640672|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
149866192|NCT00290251|540640673|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
149866193|NCT00290251|540640674|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
149866194|NCT00290251|540640675|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
149866195|NCT00290251|540640676|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
149866196|NCT00290251|540640677|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
149866197|NCT00290251|540640672|FG000|Treatment 1 (Months 2-4)|headache|0|||
149866198|NCT00290251|540640673|FG001|Treatment 1 (Months 2-4)|headache|0|||
149866199|NCT00290251|540640674|FG002|Treatment 1 (Months 2-4)|headache|0|||
149866200|NCT00290251|540640675|FG003|Treatment 1 (Months 2-4)|headache|0|||
149866201|NCT00290251|540640676|FG004|Treatment 1 (Months 2-4)|headache|1|||
149866202|NCT00290251|540640677|FG005|Treatment 1 (Months 2-4)|headache|0|||
149866203|NCT00290251|540640672|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
149866204|NCT00290251|540640673|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
149866205|NCT00290251|540640674|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
149866206|NCT00290251|540640675|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
149866207|NCT00290251|540640676|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
149866208|NCT00290251|540640677|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
149866209|NCT04221789|540642781|FG000|Overall Study|deviation from protoco|22|||
149866210|NCT04221789|540642782|FG001|Overall Study|deviation from protoco|8|||
149866211|NCT04385277|540642783|FG000|Overall Study|Physician Decision|2|||
149866212|NCT04385277|540642783|FG000|Overall Study|Ineligible|1|||
149866213|NCT04385277|540642783|FG000|Overall Study|Patient/Parent Refusal|2|||
149866214|NCT04905290|540642784|FG000|Overall Study|Adverse Event|4|||
149866215|NCT04905290|540642784|FG000|Overall Study|Death|2|||
149866216|NCT04905290|540642784|FG000|Overall Study|Withdrawal by Subject|4|||
149866217|NCT04905290|540642784|FG000|Overall Study|Physician Decision|2|||
149866218|NCT04905290|540642784|FG000|Overall Study|Lost to Follow-up|2|||
149866219|NCT04905290|540642784|FG000|Overall Study|Screen Failure|2|||
149866220|NCT04905290|540642784|FG000|Overall Study|Unsuccessful Procedure|2|||
150040816|NCT00790842|541289116|FG002|Expansion Cohort|Death|2|||
149866221|NCT03295318|540642785|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
149866222|NCT03295318|540642786|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
149866223|NCT03295318|540642787|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
149866224|NCT03295318|540642785|FG000|Overall Study|Death|1|||
149866225|NCT03295318|540642786|FG001|Overall Study|Death|1|||
149866226|NCT03295318|540642787|FG002|Overall Study|Death|1|||
149866227|NCT03295318|540642785|FG000|Overall Study|Protocol Violation|4|||
149866228|NCT03295318|540642786|FG001|Overall Study|Protocol Violation|3|||
149866229|NCT03295318|540642787|FG002|Overall Study|Protocol Violation|3|||
149866230|NCT03295318|540642785|FG000|Overall Study|Withdrawal by Subject|0|||
149866231|NCT03295318|540642786|FG001|Overall Study|Withdrawal by Subject|0|||
149866232|NCT03295318|540642787|FG002|Overall Study|Withdrawal by Subject|1|||
149866233|NCT03295318|540642785|FG000|Overall Study|Subject discontinued due to travel|0|||
150040817|NCT00790842|541289117|FG003|Expansion Cohort|Death|0|||
149866234|NCT03295318|540642786|FG001|Overall Study|Subject discontinued due to travel|1|||
149866235|NCT03295318|540642787|FG002|Overall Study|Subject discontinued due to travel|0|||
149866236|NCT03747601|540642788|FG000|Overall Study|COVID halt to visits|4|||
149866237|NCT03696953|540642792|FG000|Overall Study|Withdrawal by Subject|6|||
149866238|NCT03696953|540642793|FG001|Overall Study|Withdrawal by Subject|1|||
149866239|NCT03696953|540642792|FG000|Overall Study|missed GBS swabs|2|||
149866240|NCT03696953|540642793|FG001|Overall Study|missed GBS swabs|2|||
149866241|NCT03696953|540642792|FG000|Overall Study|lost study bottle containing capsules|2|||
149866242|NCT03696953|540642793|FG001|Overall Study|lost study bottle containing capsules|0|||
149866243|NCT03696953|540642792|FG000|Overall Study|Premature birth|1|||
149866244|NCT03696953|540642793|FG001|Overall Study|Premature birth|4|||
149866245|NCT03696953|540642792|FG000|Overall Study|Gestational hypertension|1|||
149866246|NCT03696953|540642793|FG001|Overall Study|Gestational hypertension|1|||
149866247|NCT03696953|540642792|FG000|Overall Study|Gestational diabetes|2|||
149866248|NCT03696953|540642793|FG001|Overall Study|Gestational diabetes|1|||
149866249|NCT03696953|540642792|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
149866250|NCT03696953|540642793|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
149866251|NCT03696953|540642792|FG000|Overall Study|Changed prenatal provider|1|||
149866252|NCT03696953|540642793|FG001|Overall Study|Changed prenatal provider|1|||
149866253|NCT03502707|540642794|FG000|Overall Study|Adverse Event|0|||
149866254|NCT03502707|540642795|FG001|Overall Study|Adverse Event|0|||
149866255|NCT03502707|540642796|FG002|Overall Study|Adverse Event|0|||
149866256|NCT03502707|540642797|FG003|Overall Study|Adverse Event|0|||
149866257|NCT03502707|540642798|FG004|Overall Study|Adverse Event|0|||
149866258|NCT03502707|540642799|FG005|Overall Study|Adverse Event|0|||
149866259|NCT03502707|540642800|FG006|Overall Study|Adverse Event|0|||
149866260|NCT03502707|540642801|FG007|Overall Study|Adverse Event|0|||
149866261|NCT03502707|540642802|FG008|Overall Study|Adverse Event|0|||
149866262|NCT03502707|540642803|FG009|Overall Study|Adverse Event|0|||
149866263|NCT03502707|540642804|FG010|Overall Study|Adverse Event|0|||
149866264|NCT03502707|540642805|FG011|Overall Study|Adverse Event|0|||
149866265|NCT03502707|540642806|FG012|Overall Study|Adverse Event|0|||
149866266|NCT03502707|540642807|FG013|Overall Study|Adverse Event|0|||
149866267|NCT03502707|540642808|FG014|Overall Study|Adverse Event|0|||
149866268|NCT03502707|540642809|FG015|Overall Study|Adverse Event|1|||
149962324|NCT02205359|540995900|FG001|Overall Study|Death|327|||
149866269|NCT03502707|540642810|FG016|Overall Study|Adverse Event|5|||
149866270|NCT03502707|540642811|FG017|Overall Study|Adverse Event|0|||
149866271|NCT03502707|540642794|FG000|Overall Study|Death|0|||
149866272|NCT03502707|540642795|FG001|Overall Study|Death|0|||
149866273|NCT03502707|540642796|FG002|Overall Study|Death|0|||
149866274|NCT03502707|540642797|FG003|Overall Study|Death|1|||
149866275|NCT03502707|540642798|FG004|Overall Study|Death|0|||
149866276|NCT03502707|540642799|FG005|Overall Study|Death|0|||
149866277|NCT03502707|540642800|FG006|Overall Study|Death|0|||
149866278|NCT03502707|540642801|FG007|Overall Study|Death|0|||
149866279|NCT03502707|540642802|FG008|Overall Study|Death|1|||
149866280|NCT03502707|540642803|FG009|Overall Study|Death|1|||
149866281|NCT03502707|540642804|FG010|Overall Study|Death|0|||
149866282|NCT03502707|540642805|FG011|Overall Study|Death|0|||
149866283|NCT03502707|540642806|FG012|Overall Study|Death|1|||
149866284|NCT03502707|540642807|FG013|Overall Study|Death|0|||
149866285|NCT03502707|540642808|FG014|Overall Study|Death|0|||
149866286|NCT03502707|540642809|FG015|Overall Study|Death|1|||
149866287|NCT03502707|540642810|FG016|Overall Study|Death|0|||
149866288|NCT03502707|540642811|FG017|Overall Study|Death|0|||
149866289|NCT03502707|540642794|FG000|Overall Study|Lost to Follow-up|0|||
149866290|NCT03502707|540642795|FG001|Overall Study|Lost to Follow-up|0|||
149866291|NCT03502707|540642796|FG002|Overall Study|Lost to Follow-up|0|||
149866292|NCT03502707|540642797|FG003|Overall Study|Lost to Follow-up|0|||
149866293|NCT03502707|540642798|FG004|Overall Study|Lost to Follow-up|0|||
149866294|NCT03502707|540642799|FG005|Overall Study|Lost to Follow-up|0|||
149866295|NCT03502707|540642800|FG006|Overall Study|Lost to Follow-up|0|||
149866296|NCT03502707|540642801|FG007|Overall Study|Lost to Follow-up|5|||
149866297|NCT03502707|540642802|FG008|Overall Study|Lost to Follow-up|0|||
149866298|NCT03502707|540642803|FG009|Overall Study|Lost to Follow-up|2|||
149866299|NCT03502707|540642804|FG010|Overall Study|Lost to Follow-up|1|||
149866300|NCT03502707|540642805|FG011|Overall Study|Lost to Follow-up|2|||
149866301|NCT03502707|540642806|FG012|Overall Study|Lost to Follow-up|1|||
149866302|NCT03502707|540642807|FG013|Overall Study|Lost to Follow-up|1|||
149866303|NCT03502707|540642808|FG014|Overall Study|Lost to Follow-up|0|||
149866304|NCT03502707|540642809|FG015|Overall Study|Lost to Follow-up|4|||
149866305|NCT03502707|540642810|FG016|Overall Study|Lost to Follow-up|9|||
149866306|NCT03502707|540642811|FG017|Overall Study|Lost to Follow-up|2|||
149866307|NCT03502707|540642794|FG000|Overall Study|Physician Decision|0|||
149866308|NCT03502707|540642795|FG001|Overall Study|Physician Decision|0|||
149866309|NCT03502707|540642796|FG002|Overall Study|Physician Decision|0|||
149866310|NCT03502707|540642797|FG003|Overall Study|Physician Decision|0|||
149866311|NCT03502707|540642798|FG004|Overall Study|Physician Decision|0|||
149866312|NCT03502707|540642799|FG005|Overall Study|Physician Decision|0|||
149866313|NCT03502707|540642800|FG006|Overall Study|Physician Decision|0|||
150173866|NCT03460756|541772981|FG000|Overall Study|Protocol Violation|0|||
149866314|NCT03502707|540642801|FG007|Overall Study|Physician Decision|0|||
149866315|NCT03502707|540642802|FG008|Overall Study|Physician Decision|2|||
149866316|NCT03502707|540642803|FG009|Overall Study|Physician Decision|1|||
149866317|NCT03502707|540642804|FG010|Overall Study|Physician Decision|0|||
149866318|NCT03502707|540642805|FG011|Overall Study|Physician Decision|0|||
149866319|NCT03502707|540642806|FG012|Overall Study|Physician Decision|0|||
149866320|NCT03502707|540642807|FG013|Overall Study|Physician Decision|0|||
149866321|NCT03502707|540642808|FG014|Overall Study|Physician Decision|1|||
149866322|NCT03502707|540642809|FG015|Overall Study|Physician Decision|3|||
149866323|NCT03502707|540642810|FG016|Overall Study|Physician Decision|0|||
149866324|NCT03502707|540642811|FG017|Overall Study|Physician Decision|0|||
149866325|NCT03502707|540642794|FG000|Overall Study|Protocol Violation|0|||
149866326|NCT03502707|540642795|FG001|Overall Study|Protocol Violation|0|||
149866327|NCT03502707|540642796|FG002|Overall Study|Protocol Violation|0|||
149866328|NCT03502707|540642797|FG003|Overall Study|Protocol Violation|0|||
149866329|NCT03502707|540642798|FG004|Overall Study|Protocol Violation|0|||
149866330|NCT03502707|540642799|FG005|Overall Study|Protocol Violation|0|||
149866331|NCT03502707|540642800|FG006|Overall Study|Protocol Violation|0|||
149866332|NCT03502707|540642801|FG007|Overall Study|Protocol Violation|0|||
149866333|NCT03502707|540642802|FG008|Overall Study|Protocol Violation|0|||
149866334|NCT03502707|540642803|FG009|Overall Study|Protocol Violation|0|||
149866335|NCT03502707|540642804|FG010|Overall Study|Protocol Violation|0|||
149866336|NCT03502707|540642805|FG011|Overall Study|Protocol Violation|0|||
149866337|NCT03502707|540642806|FG012|Overall Study|Protocol Violation|0|||
149866338|NCT03502707|540642807|FG013|Overall Study|Protocol Violation|0|||
149866339|NCT03502707|540642808|FG014|Overall Study|Protocol Violation|0|||
149866340|NCT03502707|540642809|FG015|Overall Study|Protocol Violation|1|||
149866341|NCT03502707|540642810|FG016|Overall Study|Protocol Violation|0|||
149866342|NCT03502707|540642811|FG017|Overall Study|Protocol Violation|0|||
149866343|NCT03502707|540642794|FG000|Overall Study|Withdrawal by Subject|1|||
149866344|NCT03502707|540642795|FG001|Overall Study|Withdrawal by Subject|1|||
149866345|NCT03502707|540642796|FG002|Overall Study|Withdrawal by Subject|0|||
149866346|NCT03502707|540642797|FG003|Overall Study|Withdrawal by Subject|0|||
149866347|NCT03502707|540642798|FG004|Overall Study|Withdrawal by Subject|0|||
149866348|NCT03502707|540642799|FG005|Overall Study|Withdrawal by Subject|2|||
149866349|NCT03502707|540642800|FG006|Overall Study|Withdrawal by Subject|0|||
149866350|NCT03502707|540642801|FG007|Overall Study|Withdrawal by Subject|3|||
149866351|NCT03502707|540642802|FG008|Overall Study|Withdrawal by Subject|1|||
149866352|NCT03502707|540642803|FG009|Overall Study|Withdrawal by Subject|2|||
149866353|NCT03502707|540642804|FG010|Overall Study|Withdrawal by Subject|12|||
149866354|NCT03502707|540642805|FG011|Overall Study|Withdrawal by Subject|23|||
149866355|NCT03502707|540642806|FG012|Overall Study|Withdrawal by Subject|5|||
149866356|NCT03502707|540642807|FG013|Overall Study|Withdrawal by Subject|3|||
149866357|NCT03502707|540642808|FG014|Overall Study|Withdrawal by Subject|3|||
149866358|NCT03502707|540642809|FG015|Overall Study|Withdrawal by Subject|43|||
149866359|NCT03502707|540642810|FG016|Overall Study|Withdrawal by Subject|44|||
149866360|NCT03502707|540642811|FG017|Overall Study|Withdrawal by Subject|18|||
149866361|NCT03502707|540642794|FG000|Overall Study|Sponsor's Decision|1|||
149866362|NCT03502707|540642795|FG001|Overall Study|Sponsor's Decision|0|||
149866363|NCT03502707|540642796|FG002|Overall Study|Sponsor's Decision|0|||
149866364|NCT03502707|540642797|FG003|Overall Study|Sponsor's Decision|0|||
149866365|NCT03502707|540642798|FG004|Overall Study|Sponsor's Decision|0|||
149866366|NCT03502707|540642799|FG005|Overall Study|Sponsor's Decision|0|||
149866367|NCT03502707|540642800|FG006|Overall Study|Sponsor's Decision|0|||
149866368|NCT03502707|540642801|FG007|Overall Study|Sponsor's Decision|0|||
149866369|NCT03502707|540642802|FG008|Overall Study|Sponsor's Decision|0|||
149866370|NCT03502707|540642803|FG009|Overall Study|Sponsor's Decision|1|||
149866371|NCT03502707|540642804|FG010|Overall Study|Sponsor's Decision|0|||
149866372|NCT03502707|540642805|FG011|Overall Study|Sponsor's Decision|0|||
149866373|NCT03502707|540642806|FG012|Overall Study|Sponsor's Decision|0|||
149866374|NCT03502707|540642807|FG013|Overall Study|Sponsor's Decision|0|||
149866375|NCT03502707|540642808|FG014|Overall Study|Sponsor's Decision|0|||
149866376|NCT03502707|540642809|FG015|Overall Study|Sponsor's Decision|2|||
149866377|NCT03502707|540642810|FG016|Overall Study|Sponsor's Decision|1|||
149866378|NCT03502707|540642811|FG017|Overall Study|Sponsor's Decision|0|||
149866379|NCT03502707|540642794|FG000|Overall Study|Initiated Prohibited Medication|0|||
149866380|NCT03502707|540642795|FG001|Overall Study|Initiated Prohibited Medication|0|||
149866381|NCT03502707|540642796|FG002|Overall Study|Initiated Prohibited Medication|0|||
149866382|NCT03502707|540642797|FG003|Overall Study|Initiated Prohibited Medication|0|||
149866383|NCT03502707|540642798|FG004|Overall Study|Initiated Prohibited Medication|0|||
149866384|NCT03502707|540642799|FG005|Overall Study|Initiated Prohibited Medication|0|||
149866385|NCT03502707|540642800|FG006|Overall Study|Initiated Prohibited Medication|0|||
149866386|NCT03502707|540642801|FG007|Overall Study|Initiated Prohibited Medication|0|||
149866387|NCT03502707|540642802|FG008|Overall Study|Initiated Prohibited Medication|0|||
149866388|NCT03502707|540642803|FG009|Overall Study|Initiated Prohibited Medication|0|||
149866389|NCT03502707|540642804|FG010|Overall Study|Initiated Prohibited Medication|0|||
149866390|NCT03502707|540642805|FG011|Overall Study|Initiated Prohibited Medication|0|||
149866391|NCT03502707|540642806|FG012|Overall Study|Initiated Prohibited Medication|0|||
149866392|NCT03502707|540642807|FG013|Overall Study|Initiated Prohibited Medication|0|||
149866393|NCT03502707|540642808|FG014|Overall Study|Initiated Prohibited Medication|0|||
149866394|NCT03502707|540642809|FG015|Overall Study|Initiated Prohibited Medication|0|||
149866395|NCT03502707|540642810|FG016|Overall Study|Initiated Prohibited Medication|1|||
149866396|NCT03502707|540642811|FG017|Overall Study|Initiated Prohibited Medication|0|||
149866397|NCT03502707|540642794|FG000|Overall Study|Other|0|||
149866398|NCT03502707|540642795|FG001|Overall Study|Other|0|||
149866399|NCT03502707|540642796|FG002|Overall Study|Other|0|||
149866400|NCT03502707|540642797|FG003|Overall Study|Other|0|||
149866401|NCT03502707|540642798|FG004|Overall Study|Other|0|||
149866402|NCT03502707|540642799|FG005|Overall Study|Other|0|||
149866403|NCT03502707|540642800|FG006|Overall Study|Other|0|||
149866404|NCT03502707|540642801|FG007|Overall Study|Other|0|||
149866405|NCT03502707|540642802|FG008|Overall Study|Other|1|||
149866406|NCT03502707|540642803|FG009|Overall Study|Other|1|||
149866407|NCT03502707|540642804|FG010|Overall Study|Other|2|||
149866408|NCT03502707|540642805|FG011|Overall Study|Other|0|||
149866409|NCT03502707|540642806|FG012|Overall Study|Other|0|||
149866410|NCT03502707|540642807|FG013|Overall Study|Other|0|||
149866411|NCT03502707|540642808|FG014|Overall Study|Other|0|||
149866412|NCT03502707|540642809|FG015|Overall Study|Other|4|||
149866413|NCT03502707|540642810|FG016|Overall Study|Other|1|||
149866414|NCT03502707|540642811|FG017|Overall Study|Other|0|||
149866415|NCT03502707|540642794|FG000|Overall Study|Randomized but not vaccinated|0|||
149866416|NCT03502707|540642795|FG001|Overall Study|Randomized but not vaccinated|0|||
149866417|NCT03502707|540642796|FG002|Overall Study|Randomized but not vaccinated|0|||
149866418|NCT03502707|540642797|FG003|Overall Study|Randomized but not vaccinated|0|||
149866419|NCT03502707|540642798|FG004|Overall Study|Randomized but not vaccinated|0|||
149866420|NCT03502707|540642799|FG005|Overall Study|Randomized but not vaccinated|0|||
149866421|NCT03502707|540642800|FG006|Overall Study|Randomized but not vaccinated|0|||
149866422|NCT03502707|540642801|FG007|Overall Study|Randomized but not vaccinated|0|||
149866423|NCT03502707|540642802|FG008|Overall Study|Randomized but not vaccinated|0|||
149866424|NCT03502707|540642803|FG009|Overall Study|Randomized but not vaccinated|0|||
149866425|NCT03502707|540642804|FG010|Overall Study|Randomized but not vaccinated|0|||
149866426|NCT03502707|540642805|FG011|Overall Study|Randomized but not vaccinated|1|||
149866427|NCT03502707|540642806|FG012|Overall Study|Randomized but not vaccinated|0|||
149866428|NCT03502707|540642807|FG013|Overall Study|Randomized but not vaccinated|0|||
149866429|NCT03502707|540642808|FG014|Overall Study|Randomized but not vaccinated|0|||
149866430|NCT03502707|540642809|FG015|Overall Study|Randomized but not vaccinated|0|||
149866431|NCT03502707|540642810|FG016|Overall Study|Randomized but not vaccinated|0|||
149866432|NCT03502707|540642811|FG017|Overall Study|Randomized but not vaccinated|1|||
149866433|NCT00461253|540642812|FG000|Overall Study|Death|985|||
149866434|NCT00461253|540642813|FG001|Overall Study|Death|0|||
149866435|NCT00461253|540642812|FG000|Overall Study|Protocol Violation|613|||
149866436|NCT00461253|540642813|FG001|Overall Study|Protocol Violation|236|||
149866437|NCT00461253|540642812|FG000|Overall Study|no response|2609|||
149866438|NCT00461253|540642813|FG001|Overall Study|no response|11789|||
149866439|NCT00461253|540642812|FG000|Overall Study|administrative|773|||
149866440|NCT00461253|540642813|FG001|Overall Study|administrative|7773|||
149866441|NCT00852969|540642816|FG000|Overall Study|Adverse Event|0|||
149866442|NCT00852969|540642817|FG001|Overall Study|Adverse Event|1|||
149866443|NCT00852969|540642816|FG000|Overall Study|Lost to Follow-up|0|||
149866444|NCT00852969|540642817|FG001|Overall Study|Lost to Follow-up|1|||
149866445|NCT02358343|540642820|FG000|Screening Intervention|Death|0|||
149866446|NCT02358343|540642821|FG001|Screening Intervention|Death|2|||
149866447|NCT02358343|540642822|FG002|Screening Intervention|Death|0|||
149866448|NCT02358343|540642823|FG003|Screening Intervention|Death|0|||
149866449|NCT02358343|540642824|FG004|Screening Intervention|Death|0|||
149866450|NCT02358343|540642820|FG000|Screening Intervention|Withdrawal by Subject|1|||
149866451|NCT02358343|540642821|FG001|Screening Intervention|Withdrawal by Subject|0|||
149866452|NCT02358343|540642822|FG002|Screening Intervention|Withdrawal by Subject|0|||
149866453|NCT02358343|540642823|FG003|Screening Intervention|Withdrawal by Subject|0|||
149866454|NCT02358343|540642824|FG004|Screening Intervention|Withdrawal by Subject|0|||
149866455|NCT02358343|540642820|FG000|Screening Intervention|Determined Ineligible|5|||
149866456|NCT02358343|540642821|FG001|Screening Intervention|Determined Ineligible|6|||
149866457|NCT02358343|540642822|FG002|Screening Intervention|Determined Ineligible|0|||
149866458|NCT02358343|540642823|FG003|Screening Intervention|Determined Ineligible|0|||
149866459|NCT02358343|540642824|FG004|Screening Intervention|Determined Ineligible|0|||
149866460|NCT02358343|540642820|FG000|Comparative Efficacy Trial / Observation|Death|0|||
149866461|NCT02358343|540642821|FG001|Comparative Efficacy Trial / Observation|Death|0|||
149866462|NCT02358343|540642822|FG002|Comparative Efficacy Trial / Observation|Death|2|||
149866463|NCT02358343|540642823|FG003|Comparative Efficacy Trial / Observation|Death|0|||
149866464|NCT02358343|540642824|FG004|Comparative Efficacy Trial / Observation|Death|0|||
149866465|NCT02358343|540642820|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
149866466|NCT02358343|540642821|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
149866467|NCT02358343|540642822|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
149866468|NCT02358343|540642823|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
149866469|NCT02358343|540642824|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
149866470|NCT02358343|540642820|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
149866471|NCT02358343|540642821|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
149866472|NCT02358343|540642822|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
149866473|NCT02358343|540642823|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
149866474|NCT02358343|540642824|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
149866475|NCT00807248|540642825|FG000|Overall Study|Adverse Event|1|||
149866476|NCT00807248|540642826|FG001|Overall Study|Adverse Event|2|||
149866477|NCT00807248|540642827|FG002|Overall Study|Adverse Event|2|||
149866478|NCT00807248|540642828|FG003|Overall Study|Adverse Event|6|||
149866479|NCT00807248|540642825|FG000|Overall Study|Lack of Efficacy|14|||
149866480|NCT00807248|540642826|FG001|Overall Study|Lack of Efficacy|4|||
149866481|NCT00807248|540642827|FG002|Overall Study|Lack of Efficacy|8|||
149866482|NCT00807248|540642828|FG003|Overall Study|Lack of Efficacy|3|||
149866483|NCT00807248|540642825|FG000|Overall Study|Protocol Violation|0|||
149866484|NCT00807248|540642826|FG001|Overall Study|Protocol Violation|1|||
149866485|NCT00807248|540642827|FG002|Overall Study|Protocol Violation|1|||
149866486|NCT00807248|540642828|FG003|Overall Study|Protocol Violation|0|||
149866487|NCT00807248|540642825|FG000|Overall Study|Withdrawal of Consent|5|||
149866488|NCT00807248|540642826|FG001|Overall Study|Withdrawal of Consent|5|||
149866489|NCT00807248|540642827|FG002|Overall Study|Withdrawal of Consent|5|||
149866490|NCT00807248|540642828|FG003|Overall Study|Withdrawal of Consent|5|||
149866491|NCT00807248|540642825|FG000|Overall Study|Lost to Follow-up|1|||
149866492|NCT00807248|540642826|FG001|Overall Study|Lost to Follow-up|0|||
149866493|NCT00807248|540642827|FG002|Overall Study|Lost to Follow-up|0|||
149866494|NCT00807248|540642828|FG003|Overall Study|Lost to Follow-up|0|||
149866495|NCT00807248|540642825|FG000|Overall Study|Other Reason|0|||
149866496|NCT00807248|540642826|FG001|Overall Study|Other Reason|0|||
149866497|NCT00807248|540642827|FG002|Overall Study|Other Reason|2|||
149866498|NCT00807248|540642828|FG003|Overall Study|Other Reason|0|||
149866499|NCT00577395|540642829|FG000|Overall Study|Study was terminated early by Sponsor|7|||
149866500|NCT00577395|540642830|FG001|Overall Study|Study was terminated early by Sponsor|6|||
149866501|NCT04322149|540642831|FG000|Overall Study|Adverse Event|1|||
149866502|NCT04322149|540642832|FG001|Overall Study|Adverse Event|1|||
149866503|NCT04322149|540642833|FG002|Overall Study|Adverse Event|0|||
149866504|NCT04322149|540642834|FG003|Overall Study|Adverse Event|0|||
149866505|NCT04322149|540642831|FG000|Overall Study|Withdrawal by Subject|0|||
149866506|NCT04322149|540642832|FG001|Overall Study|Withdrawal by Subject|0|||
149866507|NCT04322149|540642833|FG002|Overall Study|Withdrawal by Subject|0|||
149866508|NCT04322149|540642834|FG003|Overall Study|Withdrawal by Subject|2|||
149866509|NCT04322149|540642831|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
149866510|NCT04322149|540642832|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
149866511|NCT04322149|540642833|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
149866512|NCT04322149|540642834|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
149866513|NCT01700049|540642841|FG000|Overall Study|Withdrawal by Subject|1|||
149866514|NCT03084367|540642844|FG000|Overall Study|Lost to Follow-up|32|||
149866515|NCT03084367|540642844|FG000|Overall Study|Withdrawal by Subject|4|||
149866516|NCT03084367|540642844|FG000|Overall Study|Other|1|||
149866517|NCT01206101|540642845|FG000|Overall Study|Adverse Event|1|||
149866518|NCT01206101|540642846|FG001|Overall Study|Adverse Event|0|||
149866519|NCT01206101|540642845|FG000|Overall Study|Physician Decision|0|||
149866520|NCT01206101|540642846|FG001|Overall Study|Physician Decision|1|||
149866521|NCT01206101|540642845|FG000|Overall Study|Unclassified|1|||
149866522|NCT01206101|540642846|FG001|Overall Study|Unclassified|0|||
149866523|NCT01859130|540642849|FG000|Overall Study|Death|4|||
149866524|NCT01859130|540642849|FG000|Overall Study|Lost to Follow-up|16|||
149866525|NCT01859130|540642849|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
149866526|NCT01859130|540642849|FG000|Overall Study|Physician Decision|6|||
149866527|NCT01859130|540642849|FG000|Overall Study|Withdrawal by Subject|17|||
149866528|NCT01859130|540642849|FG000|Overall Study|Adverse Event|11|||
149866529|NCT04325204|540642850|FG000|Overall Study|Death|0|||
149866530|NCT04325204|540642851|FG001|Overall Study|Death|1|||
149866531|NCT04325204|540642850|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
149866532|NCT04325204|540642851|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
149866533|NCT04325204|540642850|FG000|Overall Study|Lost to Follow-up|8|||
149866534|NCT04325204|540642851|FG001|Overall Study|Lost to Follow-up|8|||
149866535|NCT04325204|540642850|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
149866536|NCT04325204|540642851|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
149866537|NCT00103311|540642858|FG000|Overall Study|Lost to Follow-up|1|||
149866538|NCT00103311|540642859|FG001|Overall Study|Lost to Follow-up|0|||
149866539|NCT00103311|540642858|FG000|Overall Study|Withdrawal by Subject|2|||
149866540|NCT00103311|540642859|FG001|Overall Study|Withdrawal by Subject|1|||
149866541|NCT00103311|540642858|FG000|Overall Study|Adverse Event|1|||
149866542|NCT00103311|540642859|FG001|Overall Study|Adverse Event|0|||
149866543|NCT03827564|540642864|FG000|Overall Study|Discontinued due to Study Termination|1|||
149866544|NCT03827564|540642865|FG001|Overall Study|Discontinued due to Study Termination|0|||
149866545|NCT00270257|540642866|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
149866546|NCT00270257|540642867|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
149866547|NCT01195103|540642868|FG000|Overall Study|Withdrawal by Subject|1|||
149866548|NCT01195103|540642869|FG001|Overall Study|Withdrawal by Subject|0|||
149866549|NCT01195103|540642870|FG002|Overall Study|Withdrawal by Subject|0|||
149866550|NCT02621034|540642871|FG000|Overall Study|Lost to Follow-up|3|||
149866551|NCT02621034|540642872|FG001|Overall Study|Lost to Follow-up|2|||
149866552|NCT02621034|540642873|FG002|Overall Study|Lost to Follow-up|5|||
149866553|NCT03254602|540642880|FG000|Overall Study|Lost to Follow-up|4|||
149866554|NCT02963311|540642883|FG000|Overall Study|Withdrawal by Subject|1|||
149866555|NCT02963311|540642883|FG000|Overall Study|Screen Failure|4|||
149866556|NCT01691820|540642884|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
149866557|NCT01691820|540642885|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
149866558|NCT01691820|540642884|FG000|Overall Study|Migrated/moved from study area|7|||
149866559|NCT01691820|540642885|FG001|Overall Study|Migrated/moved from study area|4|||
149866560|NCT01691820|540642884|FG000|Overall Study|Lost to Follow-up|6|||
149866561|NCT01691820|540642885|FG001|Overall Study|Lost to Follow-up|17|||
149866562|NCT01691820|540642884|FG000|Overall Study|Other (unspecified)|4|||
149866563|NCT01691820|540642885|FG001|Overall Study|Other (unspecified)|1|||
149866564|NCT04442490|540642887|FG000|Overall Study|Withdrawal by Subject|18|||
149866565|NCT04442490|540642888|FG001|Overall Study|Withdrawal by Subject|10|||
149866566|NCT04442490|540642887|FG000|Overall Study|Lost to Follow-up|7|||
149866567|NCT04442490|540642888|FG001|Overall Study|Lost to Follow-up|7|||
149866568|NCT04442490|540642887|FG000|Overall Study|Adverse Event|2|||
149866569|NCT04442490|540642888|FG001|Overall Study|Adverse Event|6|||
149866570|NCT04442490|540642887|FG000|Overall Study|Noncompliance|3|||
149866571|NCT04442490|540642888|FG001|Overall Study|Noncompliance|1|||
149866572|NCT04442490|540642887|FG000|Overall Study|Physician Decision|2|||
149866573|NCT04442490|540642888|FG001|Overall Study|Physician Decision|1|||
149866574|NCT04442490|540642887|FG000|Overall Study|Reason not Specified|2|||
149866575|NCT04442490|540642888|FG001|Overall Study|Reason not Specified|1|||
150173867|NCT03460756|541772982|FG001|Overall Study|Protocol Violation|0|||
150173868|NCT03460756|541772983|FG002|Overall Study|Protocol Violation|0|||
149866576|NCT04442490|540642887|FG000|Overall Study|Randomized but not Treated|3|||
149866577|NCT04442490|540642888|FG001|Overall Study|Randomized but not Treated|3|||
149866578|NCT02372071|540642900|FG000|Overall Study|Protocol Violation|18|||
149866579|NCT01449279|540642901|FG000|Overall Study|Lack of Efficacy|5|||
149866580|NCT01449279|540642901|FG000|Overall Study|Toxicity|2|||
149866581|NCT03347422|540642902|FG000|Part A (26 Weeks)|Adverse Event|3|||
149866582|NCT03347422|540642903|FG001|Part A (26 Weeks)|Adverse Event|0|||
149866583|NCT03347422|540642902|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
149866584|NCT03347422|540642903|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
149866585|NCT03347422|540642902|FG000|Part B (149 Weeks)|Adverse Event|0|||
149866586|NCT03347422|540642903|FG001|Part B (149 Weeks)|Adverse Event|1|||
149866587|NCT03347422|540642902|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
149866588|NCT03347422|540642903|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
149866589|NCT03347422|540642902|FG000|Part B (149 Weeks)|Other|1|||
149866590|NCT03347422|540642903|FG001|Part B (149 Weeks)|Other|0|||
149866591|NCT03709823|540642904|FG000|Overall Study|Adverse Event|0|||
149866592|NCT03709823|540642905|FG001|Overall Study|Adverse Event|0|||
149866593|NCT03709823|540642906|FG002|Overall Study|Adverse Event|1|||
149866594|NCT03709823|540642907|FG003|Overall Study|Adverse Event|0|||
149866595|NCT03709823|540642908|FG004|Overall Study|Adverse Event|0|||
149866596|NCT03709823|540642909|FG005|Overall Study|Adverse Event|0|||
149866597|NCT03709823|540642904|FG000|Overall Study|Lost to Follow-up|2|||
149866598|NCT03709823|540642905|FG001|Overall Study|Lost to Follow-up|2|||
149866599|NCT03709823|540642906|FG002|Overall Study|Lost to Follow-up|2|||
149866600|NCT03709823|540642907|FG003|Overall Study|Lost to Follow-up|1|||
149866601|NCT03709823|540642908|FG004|Overall Study|Lost to Follow-up|1|||
149866602|NCT03709823|540642909|FG005|Overall Study|Lost to Follow-up|0|||
149866603|NCT03709823|540642904|FG000|Overall Study|Withdrawal by Subject|1|||
149866604|NCT03709823|540642905|FG001|Overall Study|Withdrawal by Subject|3|||
149866605|NCT03709823|540642906|FG002|Overall Study|Withdrawal by Subject|0|||
149866606|NCT03709823|540642907|FG003|Overall Study|Withdrawal by Subject|0|||
149866607|NCT03709823|540642908|FG004|Overall Study|Withdrawal by Subject|0|||
149866608|NCT03709823|540642909|FG005|Overall Study|Withdrawal by Subject|0|||
149866609|NCT03709823|540642904|FG000|Overall Study|Other, Not Specified|0|||
149866610|NCT03709823|540642905|FG001|Overall Study|Other, Not Specified|0|||
149866611|NCT03709823|540642906|FG002|Overall Study|Other, Not Specified|0|||
149866612|NCT03709823|540642907|FG003|Overall Study|Other, Not Specified|1|||
149866613|NCT03709823|540642908|FG004|Overall Study|Other, Not Specified|0|||
149866614|NCT03709823|540642909|FG005|Overall Study|Other, Not Specified|0|||
149866615|NCT02038907|540642912|FG000|Overall Study|Protocol Violation|0|||
149866616|NCT02038907|540642913|FG001|Overall Study|Protocol Violation|0|||
149962325|NCT02205359|540995899|FG000|Overall Study|Lost to Follow-up|182|||
149962326|NCT02205359|540995900|FG001|Overall Study|Lost to Follow-up|162|||
149962327|NCT02205359|540995899|FG000|Overall Study|Physician Decision|51|||
149962328|NCT02205359|540995900|FG001|Overall Study|Physician Decision|53|||
149962329|NCT02205359|540995899|FG000|Overall Study|Withdrawal by Subject|167|||
149962330|NCT02205359|540995900|FG001|Overall Study|Withdrawal by Subject|169|||
149962331|NCT01684033|540995903|FG000|Period 1, First 30 Days|Adverse Event|1|||
149962332|NCT01684033|540995904|FG001|Period 1, First 30 Days|Adverse Event|1|||
149962333|NCT01684033|540995903|FG000|Period 1, First 30 Days|Noncompliance|1|||
149962334|NCT01684033|540995904|FG001|Period 1, First 30 Days|Noncompliance|0|||
149962335|NCT01684033|540995903|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
149962336|NCT01684033|540995904|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
149962337|NCT01684033|540995903|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
149962338|NCT01684033|540995904|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
149962339|NCT01684033|540995903|FG000|Period 2, Second 30 Days|Adverse Event|1|||
149962340|NCT01684033|540995904|FG001|Period 2, Second 30 Days|Adverse Event|0|||
149962341|NCT00480025|540995905|FG000|Overall Study|Protocol Violation|12|||
149962342|NCT00480025|540995906|FG001|Overall Study|Protocol Violation|7|||
149962343|NCT00480025|540995905|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
149866617|NCT02038907|540642914|FG002|Overall Study|Protocol Violation|0|||
149866618|NCT02038907|540642915|FG003|Overall Study|Protocol Violation|0|||
149866619|NCT02038907|540642916|FG004|Overall Study|Protocol Violation|0|||
149866620|NCT02038907|540642917|FG005|Overall Study|Protocol Violation|0|||
149866621|NCT02038907|540642918|FG006|Overall Study|Protocol Violation|0|||
149866622|NCT02038907|540642919|FG007|Overall Study|Protocol Violation|0|||
149962344|NCT00480025|540995906|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
149866623|NCT02038907|540642920|FG008|Overall Study|Protocol Violation|0|||
150040818|NCT00790842|541289118|FG004|Expansion Cohort|Death|0|||
150040819|NCT00790842|541289119|FG005|Expansion Cohort|Death|0|||
150040820|NCT00790842|541289120|FG006|Expansion Cohort|Death|0|||
150040821|NCT00790842|541289121|FG007|Expansion Cohort|Death|0|||
150040822|NCT00790842|541289122|FG008|Expansion Cohort|Death|0|||
150040823|NCT00790842|541289123|FG009|Expansion Cohort|Death|0|||
150040824|NCT00790842|541289124|FG010|Expansion Cohort|Death|0|||
150040825|NCT00790842|541289114|FG000|Expansion Cohort|Physician Decision|0|||
150040826|NCT00790842|541289115|FG001|Expansion Cohort|Physician Decision|0|||
150040827|NCT00790842|541289116|FG002|Expansion Cohort|Physician Decision|1|||
150040828|NCT00790842|541289117|FG003|Expansion Cohort|Physician Decision|0|||
149866624|NCT02038907|540642921|FG009|Overall Study|Protocol Violation|0|||
149866625|NCT02038907|540642922|FG010|Overall Study|Protocol Violation|1|||
149866626|NCT02038907|540642923|FG011|Overall Study|Protocol Violation|0|||
149866627|NCT02038907|540642924|FG012|Overall Study|Protocol Violation|0|||
149866628|NCT02038907|540642925|FG013|Overall Study|Protocol Violation|0|||
149866629|NCT02038907|540642912|FG000|Overall Study|Withdrawal by Subject|0|||
149866630|NCT02038907|540642913|FG001|Overall Study|Withdrawal by Subject|0|||
149866631|NCT02038907|540642914|FG002|Overall Study|Withdrawal by Subject|0|||
149866632|NCT02038907|540642915|FG003|Overall Study|Withdrawal by Subject|0|||
149866633|NCT02038907|540642916|FG004|Overall Study|Withdrawal by Subject|0|||
149866634|NCT02038907|540642917|FG005|Overall Study|Withdrawal by Subject|0|||
149866635|NCT02038907|540642918|FG006|Overall Study|Withdrawal by Subject|0|||
149866636|NCT02038907|540642919|FG007|Overall Study|Withdrawal by Subject|0|||
149866637|NCT02038907|540642920|FG008|Overall Study|Withdrawal by Subject|0|||
149866638|NCT02038907|540642921|FG009|Overall Study|Withdrawal by Subject|0|||
149866639|NCT02038907|540642922|FG010|Overall Study|Withdrawal by Subject|1|||
149866640|NCT02038907|540642923|FG011|Overall Study|Withdrawal by Subject|0|||
149866641|NCT02038907|540642924|FG012|Overall Study|Withdrawal by Subject|0|||
149866642|NCT02038907|540642925|FG013|Overall Study|Withdrawal by Subject|0|||
149866643|NCT02618408|540642929|FG000|Overall Study|Withdrawal by Subject|1|||
149866644|NCT02618408|540642930|FG001|Overall Study|Withdrawal by Subject|0|||
149866645|NCT02618408|540642931|FG002|Overall Study|Withdrawal by Subject|4|||
149866646|NCT02618408|540642929|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
149866647|NCT02618408|540642930|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
149866648|NCT02618408|540642931|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
149866649|NCT02618408|540642929|FG000|Overall Study|Lost to Follow-up|4|||
149866650|NCT02618408|540642930|FG001|Overall Study|Lost to Follow-up|2|||
149866651|NCT02618408|540642931|FG002|Overall Study|Lost to Follow-up|6|||
149866652|NCT02618408|540642929|FG000|Overall Study|Adverse Event|4|||
149866653|NCT02618408|540642930|FG001|Overall Study|Adverse Event|0|||
149866654|NCT02618408|540642931|FG002|Overall Study|Adverse Event|10|||
149866655|NCT02618408|540642929|FG000|Overall Study|Physician Decision|1|||
149866656|NCT02618408|540642930|FG001|Overall Study|Physician Decision|1|||
149866657|NCT02618408|540642931|FG002|Overall Study|Physician Decision|2|||
149866658|NCT02618408|540642929|FG000|Overall Study|Protocol Violation|1|||
149866659|NCT02618408|540642930|FG001|Overall Study|Protocol Violation|1|||
149866660|NCT02618408|540642931|FG002|Overall Study|Protocol Violation|2|||
149866661|NCT02618408|540642929|FG000|Overall Study|Other, Multiple Categories|0|||
149866662|NCT02618408|540642930|FG001|Overall Study|Other, Multiple Categories|0|||
149866663|NCT02618408|540642931|FG002|Overall Study|Other, Multiple Categories|4|||
149866664|NCT01246011|540642932|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
149866665|NCT01246011|540642933|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
149866666|NCT01246011|540642934|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
149866667|NCT01246011|540642932|FG000|Overall Study|Withdrawal by Subject|0|||
149866668|NCT01246011|540642933|FG001|Overall Study|Withdrawal by Subject|0|||
149866669|NCT01246011|540642934|FG002|Overall Study|Withdrawal by Subject|1|||
149866670|NCT01155024|540642935|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
149866671|NCT01155024|540642936|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
149866672|NCT01155024|540642935|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
149866673|NCT01155024|540642936|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
149866674|NCT01155024|540642935|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
149866675|NCT01155024|540642936|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
149866676|NCT02397408|540642937|FG000|Overall Study|Physician Decision|4|||
149866677|NCT02397408|540642937|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
149866678|NCT03551496|540642938|FG000|Overall Study|Death|11|||
150040829|NCT00790842|541289118|FG004|Expansion Cohort|Physician Decision|0|||
149866679|NCT03551496|540642939|FG001|Overall Study|Death|7|||
149866680|NCT03551496|540642938|FG000|Overall Study|Withdrawal by Subject|4|||
149866681|NCT03551496|540642939|FG001|Overall Study|Withdrawal by Subject|3|||
149866682|NCT03551496|540642938|FG000|Overall Study|Other Reasons|1|||
150040830|NCT00790842|541289119|FG005|Expansion Cohort|Physician Decision|0|||
150040831|NCT00790842|541289120|FG006|Expansion Cohort|Physician Decision|0|||
150040832|NCT00790842|541289121|FG007|Expansion Cohort|Physician Decision|0|||
150040833|NCT00790842|541289122|FG008|Expansion Cohort|Physician Decision|0|||
149866683|NCT03551496|540642939|FG001|Overall Study|Other Reasons|0|||
149866684|NCT01524679|540642940|FG000|Overall Study|Lost to Follow-up|1|||
149866685|NCT01524679|540642941|FG001|Overall Study|Lost to Follow-up|4|||
149866686|NCT01524679|540642940|FG000|Overall Study|Withdrawal by Subject|4|||
149866687|NCT01524679|540642941|FG001|Overall Study|Withdrawal by Subject|4|||
149866688|NCT01524679|540642940|FG000|Overall Study|Adverse Event|9|||
149866689|NCT01524679|540642941|FG001|Overall Study|Adverse Event|0|||
149866690|NCT01524679|540642940|FG000|Overall Study|Protocol Violation|1|||
149866691|NCT01524679|540642941|FG001|Overall Study|Protocol Violation|0|||
149866692|NCT01524679|540642940|FG000|Overall Study|Lack of Efficacy|2|||
149866693|NCT01524679|540642941|FG001|Overall Study|Lack of Efficacy|0|||
149866694|NCT01524679|540642940|FG000|Overall Study|e.g.wish for children, relocation|6|||
149866695|NCT01524679|540642941|FG001|Overall Study|e.g.wish for children, relocation|1|||
149866696|NCT03321630|540642946|FG000|Overall Study|Adverse Event|1|||
149866697|NCT03321630|540642946|FG000|Overall Study|Investigator Discretion|2|||
149866698|NCT03321630|540642946|FG000|Overall Study|Withdrawal by Subject|1|||
149866699|NCT02458092|540642947|FG000|Overall Study|Withdrawal by Subject|1|||
149866700|NCT02458092|540642948|FG001|Overall Study|Withdrawal by Subject|0|||
149866701|NCT02989168|540642955|FG000|Overall Study|Withdrawal by Subject|2|||
149866702|NCT02989168|540642956|FG001|Overall Study|Withdrawal by Subject|0|||
149866703|NCT02989168|540642955|FG000|Overall Study|Physician Decision|0|||
149866704|NCT02989168|540642956|FG001|Overall Study|Physician Decision|1|||
149866705|NCT02989168|540642955|FG000|Overall Study|Adverse Event|1|||
149866706|NCT02989168|540642956|FG001|Overall Study|Adverse Event|2|||
149866707|NCT02989168|540642955|FG000|Overall Study|Sponsor stopped study.|1|||
149866708|NCT02989168|540642956|FG001|Overall Study|Sponsor stopped study.|0|||
149866709|NCT00532935|540642957|FG000|Overall Study|Adverse Event|11|||
149866710|NCT00532935|540642958|FG001|Overall Study|Adverse Event|12|||
149866711|NCT00532935|540642957|FG000|Overall Study|Lack of Efficacy|0|||
149866712|NCT00532935|540642958|FG001|Overall Study|Lack of Efficacy|3|||
149866713|NCT00532935|540642957|FG000|Overall Study|Lost to Follow-up|10|||
149866714|NCT00532935|540642958|FG001|Overall Study|Lost to Follow-up|6|||
149866715|NCT00532935|540642957|FG000|Overall Study|Physician Decision|4|||
149866716|NCT00532935|540642958|FG001|Overall Study|Physician Decision|5|||
149866717|NCT00532935|540642957|FG000|Overall Study|Pregnancy|1|||
149866718|NCT00532935|540642958|FG001|Overall Study|Pregnancy|0|||
149866719|NCT00532935|540642957|FG000|Overall Study|Protocol Violation|4|||
149866720|NCT00532935|540642958|FG001|Overall Study|Protocol Violation|2|||
149866721|NCT00532935|540642957|FG000|Overall Study|Withdrawal by Subject|10|||
149866722|NCT00532935|540642958|FG001|Overall Study|Withdrawal by Subject|9|||
149866723|NCT00532935|540642957|FG000|Overall Study|Protocol Specific Criteria|11|||
149866724|NCT00532935|540642958|FG001|Overall Study|Protocol Specific Criteria|15|||
149866725|NCT00456495|540642959|FG000|Overall Study|Physician Decision|2|||
149866726|NCT01301508|540642960|FG000|Overall Study|Withdrawal by Subject|1|||
149866727|NCT01301508|540642961|FG001|Overall Study|Withdrawal by Subject|2|||
149866728|NCT01301508|540642960|FG000|Overall Study|Lost to Follow-up|0|||
149866729|NCT01301508|540642961|FG001|Overall Study|Lost to Follow-up|1|||
149866730|NCT01300923|540642962|FG000|Overall Study|Physician Decision|0|||
149866731|NCT01300923|540642963|FG001|Overall Study|Physician Decision|2|||
149866732|NCT01940497|540642966|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
149866733|NCT01940497|540642967|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
149866734|NCT01940497|540642966|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
149866735|NCT01940497|540642967|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
149866736|NCT01940497|540642966|FG000|Overall Study|Violation of Entry Criteria|1|||
149866737|NCT01940497|540642967|FG001|Overall Study|Violation of Entry Criteria|1|||
149866738|NCT01940497|540642966|FG000|Overall Study|Refused Treatment|1|||
149866739|NCT01940497|540642967|FG001|Overall Study|Refused Treatment|3|||
150040834|NCT00790842|541289123|FG009|Expansion Cohort|Physician Decision|0|||
150040835|NCT00790842|541289124|FG010|Expansion Cohort|Physician Decision|0|||
150040836|NCT00790842|541289114|FG000|Expansion Cohort|Withdrawal by Subject|0|||
150040837|NCT00790842|541289115|FG001|Expansion Cohort|Withdrawal by Subject|0|||
150173869|NCT03460756|541772984|FG003|Overall Study|Protocol Violation|1|||
149866740|NCT01940497|540642966|FG000|Overall Study|Withdrew Consent|6|||
149866741|NCT01940497|540642967|FG001|Overall Study|Withdrew Consent|2|||
149866742|NCT01940497|540642966|FG000|Overall Study|Administrative/Other|1|||
149866743|NCT01940497|540642967|FG001|Overall Study|Administrative/Other|1|||
149866744|NCT02707861|540642968|FG000|Overall Study|Went onto commercial drug|30|||
149866745|NCT02707861|540642969|FG001|Overall Study|Went onto commercial drug|23|||
149866746|NCT02707861|540642968|FG000|Overall Study|Adverse Event|2|||
149866747|NCT02707861|540642969|FG001|Overall Study|Adverse Event|3|||
149866748|NCT02707861|540642968|FG000|Overall Study|Death|5|||
149866749|NCT02707861|540642969|FG001|Overall Study|Death|2|||
149866750|NCT02707861|540642968|FG000|Overall Study|Lack of Efficacy|0|||
149866751|NCT02707861|540642969|FG001|Overall Study|Lack of Efficacy|2|||
149866752|NCT02707861|540642968|FG000|Overall Study|Physician Decision|1|||
149866753|NCT02707861|540642969|FG001|Overall Study|Physician Decision|4|||
149866754|NCT02707861|540642968|FG000|Overall Study|Withdrawal by Subject|2|||
149866755|NCT02707861|540642969|FG001|Overall Study|Withdrawal by Subject|1|||
149866756|NCT02707861|540642968|FG000|Overall Study|Lost to Follow-up|1|||
149866757|NCT02707861|540642969|FG001|Overall Study|Lost to Follow-up|3|||
149866758|NCT03123861|540642970|FG000|Overall Study|Protocol Violation|1|||
149866759|NCT03123861|540642971|FG001|Overall Study|Protocol Violation|1|||
149866760|NCT03123861|540642970|FG000|Overall Study|Withdrawal by Subject|2|||
149866761|NCT03123861|540642971|FG001|Overall Study|Withdrawal by Subject|2|||
149866762|NCT00448136|540642976|FG000|Overall Study|Death|3|||
149866763|NCT00448136|540642977|FG001|Overall Study|Death|8|||
149866764|NCT00448136|540642976|FG000|Overall Study|Investigator's decision (progression)|1|||
149866765|NCT00448136|540642977|FG001|Overall Study|Investigator's decision (progression)|0|||
149866766|NCT03407430|540642980|FG000|Washout|Protocol Violation|1|||
149866767|NCT03407430|540642981|FG001|Washout|Protocol Violation|0|||
149866768|NCT00922987|540642983|FG000|Overall Study|Insufficient clinical response|1|||
149866769|NCT00922987|540642983|FG000|Overall Study|Protocol Violation|2|||
149866770|NCT00922987|540642983|FG000|Overall Study|Adverse Event|1|||
149866771|NCT04969861|540642986|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
149866772|NCT04969861|540642987|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
149866773|NCT05101486|540645066|FG000|Overall Study|Death|1|||
149866774|NCT05101486|540645067|FG001|Overall Study|Death|0|||
149866775|NCT05101486|540645068|FG002|Overall Study|Death|1|||
149866776|NCT05101486|540645066|FG000|Overall Study|Lost to Follow-up|12|||
149866777|NCT05101486|540645067|FG001|Overall Study|Lost to Follow-up|8|||
149866778|NCT05101486|540645068|FG002|Overall Study|Lost to Follow-up|17|||
149866779|NCT05101486|540645066|FG000|Overall Study|Physician Decision|1|||
149866780|NCT05101486|540645067|FG001|Overall Study|Physician Decision|0|||
149866781|NCT05101486|540645068|FG002|Overall Study|Physician Decision|0|||
149866782|NCT05101486|540645066|FG000|Overall Study|Protocol Violation|0|||
149866783|NCT05101486|540645067|FG001|Overall Study|Protocol Violation|0|||
149866784|NCT05101486|540645068|FG002|Overall Study|Protocol Violation|1|||
149866785|NCT05101486|540645066|FG000|Overall Study|Withdrawal by Subject|5|||
149866786|NCT05101486|540645067|FG001|Overall Study|Withdrawal by Subject|2|||
149866787|NCT05101486|540645068|FG002|Overall Study|Withdrawal by Subject|4|||
149866788|NCT05101486|540645066|FG000|Overall Study|Randomized but not vaccinated|1|||
149866789|NCT05101486|540645067|FG001|Overall Study|Randomized but not vaccinated|1|||
149866790|NCT05101486|540645068|FG002|Overall Study|Randomized but not vaccinated|1|||
149866791|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
149866792|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
149866793|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
149866794|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
149866795|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
149866796|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
149962345|NCT00480025|540995905|FG000|Overall Study|Disease Progression / Recurrence|449|||
149962346|NCT00480025|540995906|FG001|Overall Study|Disease Progression / Recurrence|224|||
149962347|NCT00480025|540995905|FG000|Overall Study|Adverse Event|44|||
149866797|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
149866798|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
149866799|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
149866800|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
149866801|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
149866802|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
149866803|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
149866804|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
149866805|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
149866806|NCT02788045|540645069|FG000|Main Study (Up to Week 72)|Other|3|||
149866807|NCT02788045|540645070|FG001|Main Study (Up to Week 72)|Other|0|||
149866808|NCT02788045|540645071|FG002|Main Study (Up to Week 72)|Other|0|||
149866809|NCT02788045|540645069|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
149866810|NCT02788045|540645070|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
149866811|NCT02788045|540645071|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
149866812|NCT02788045|540645069|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
149866813|NCT02788045|540645070|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
149866814|NCT02788045|540645071|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
149962348|NCT00480025|540995906|FG001|Overall Study|Adverse Event|12|||
149962349|NCT00480025|540995905|FG000|Overall Study|Other|70|||
149962350|NCT00480025|540995906|FG001|Overall Study|Other|29|||
149962351|NCT00480025|540995905|FG000|Overall Study|SAE including intercurrent illness|76|||
149962352|NCT00480025|540995906|FG001|Overall Study|SAE including intercurrent illness|42|||
149962353|NCT02792257|540995911|FG000|Overall Study|Lost to Follow-up|3|||
149962354|NCT02792257|540995912|FG001|Overall Study|Lost to Follow-up|4|||
149962355|NCT02792257|540995911|FG000|Overall Study|Allergy|0|||
149962356|NCT02792257|540995912|FG001|Overall Study|Allergy|1|||
149962357|NCT02792257|540995911|FG000|Overall Study|Protocol Violation|2|||
149962358|NCT02792257|540995912|FG001|Overall Study|Protocol Violation|0|||
149962359|NCT02792257|540995911|FG000|Overall Study|Excessive Agitation|0|||
149962360|NCT02792257|540995912|FG001|Overall Study|Excessive Agitation|1|||
149962361|NCT02792257|540995911|FG000|Overall Study|Not Feeling Well|0|||
149962362|NCT02792257|540995912|FG001|Overall Study|Not Feeling Well|1|||
149962363|NCT03726879|540995914|FG000|Overall Study|Death|11|||
149962364|NCT03726879|540995915|FG001|Overall Study|Death|13|||
149962365|NCT03726879|540995914|FG000|Overall Study|Physician Decision|0|||
149866815|NCT02788045|540645069|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
149962366|NCT03726879|540995915|FG001|Overall Study|Physician Decision|2|||
149866816|NCT02788045|540645070|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
149866817|NCT02788045|540645071|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
149962367|NCT03726879|540995914|FG000|Overall Study|Protocol Violation|0|||
149962368|NCT03726879|540995915|FG001|Overall Study|Protocol Violation|1|||
149962369|NCT03726879|540995914|FG000|Overall Study|Withdrawal by Subject|5|||
149962370|NCT03726879|540995915|FG001|Overall Study|Withdrawal by Subject|6|||
149866818|NCT00144781|540645072|FG000|Overall Study|Adverse Event|0|||
149866819|NCT00144781|540645073|FG001|Overall Study|Adverse Event|1|||
149866820|NCT00144781|540645074|FG002|Overall Study|Adverse Event|0|||
149866821|NCT00144781|540645075|FG003|Overall Study|Adverse Event|0|||
149866822|NCT00144781|540645072|FG000|Overall Study|Non-compliant|0|||
149866823|NCT00144781|540645073|FG001|Overall Study|Non-compliant|1|||
149866824|NCT00144781|540645074|FG002|Overall Study|Non-compliant|0|||
149866825|NCT00144781|540645075|FG003|Overall Study|Non-compliant|0|||
149866826|NCT04092894|540645076|FG000|Overall Study|Withdrawal by Subject|2|||
149866827|NCT04092894|540645077|FG001|Overall Study|Withdrawal by Subject|4|||
149866828|NCT04092894|540645076|FG000|Overall Study|Discontinued EEG after randomization|10|||
149866829|NCT04092894|540645077|FG001|Overall Study|Discontinued EEG after randomization|6|||
149866830|NCT00541970|540645078|FG000|Month 7|Protocol Violation|9|||
149866831|NCT00541970|540645079|FG001|Month 7|Protocol Violation|13|||
149866832|NCT00541970|540645080|FG002|Month 7|Protocol Violation|11|||
149866833|NCT00541970|540645081|FG003|Month 7|Protocol Violation|5|||
149866834|NCT00541970|540645078|FG000|Month 12|Adverse Event|0|||
149866835|NCT00541970|540645079|FG001|Month 12|Adverse Event|1|||
149866836|NCT00541970|540645080|FG002|Month 12|Adverse Event|1|||
149866837|NCT00541970|540645081|FG003|Month 12|Adverse Event|1|||
149866838|NCT00541970|540645078|FG000|Month 12|Protocol Violation|12|||
149866839|NCT00541970|540645079|FG001|Month 12|Protocol Violation|21|||
149866840|NCT00541970|540645080|FG002|Month 12|Protocol Violation|20|||
149866841|NCT00541970|540645081|FG003|Month 12|Protocol Violation|15|||
149866842|NCT00541970|540645078|FG000|Month 18|Adverse Event|0|||
149866843|NCT00541970|540645079|FG001|Month 18|Adverse Event|1|||
149866844|NCT00541970|540645080|FG002|Month 18|Adverse Event|1|||
149866845|NCT00541970|540645081|FG003|Month 18|Adverse Event|1|||
149866846|NCT00541970|540645078|FG000|Month 18|Protocol Violation|14|||
149866847|NCT00541970|540645079|FG001|Month 18|Protocol Violation|23|||
149866848|NCT00541970|540645080|FG002|Month 18|Protocol Violation|24|||
149866849|NCT00541970|540645081|FG003|Month 18|Protocol Violation|16|||
149866850|NCT00541970|540645078|FG000|Month 24|Adverse Event|0|||
149866851|NCT00541970|540645079|FG001|Month 24|Adverse Event|1|||
149866852|NCT00541970|540645080|FG002|Month 24|Adverse Event|1|||
149866853|NCT00541970|540645081|FG003|Month 24|Adverse Event|1|||
149866854|NCT00541970|540645078|FG000|Month 24|Protocol Violation|29|||
149866855|NCT00541970|540645079|FG001|Month 24|Protocol Violation|31|||
149866856|NCT00541970|540645080|FG002|Month 24|Protocol Violation|31|||
149866857|NCT00541970|540645081|FG003|Month 24|Protocol Violation|21|||
149866858|NCT00541970|540645078|FG000|Month 36|Protocol Violation|61|||
149866859|NCT00541970|540645079|FG001|Month 36|Protocol Violation|66|||
149866860|NCT00541970|540645080|FG002|Month 36|Protocol Violation|66|||
149866861|NCT00541970|540645081|FG003|Month 36|Protocol Violation|60|||
149866862|NCT00541970|540645078|FG000|Month 48|Withdrawal by Subject|2|||
149866863|NCT00541970|540645079|FG001|Month 48|Withdrawal by Subject|4|||
149866864|NCT00541970|540645080|FG002|Month 48|Withdrawal by Subject|4|||
149866865|NCT00541970|540645081|FG003|Month 48|Withdrawal by Subject|2|||
149866866|NCT00541970|540645078|FG000|Month 48|Other|3|||
149866867|NCT00541970|540645079|FG001|Month 48|Other|1|||
149866868|NCT00541970|540645080|FG002|Month 48|Other|1|||
149866869|NCT00541970|540645081|FG003|Month 48|Other|0|||
149866870|NCT00541970|540645078|FG000|Month 48|Lost to Follow-up|66|||
149866871|NCT00541970|540645079|FG001|Month 48|Lost to Follow-up|68|||
149866872|NCT00541970|540645080|FG002|Month 48|Lost to Follow-up|68|||
149866873|NCT00541970|540645081|FG003|Month 48|Lost to Follow-up|73|||
149866874|NCT00541970|540645078|FG000|Month 60|Protocol Violation|78|||
149866875|NCT00541970|540645079|FG001|Month 60|Protocol Violation|77|||
149866876|NCT00541970|540645080|FG002|Month 60|Protocol Violation|82|||
149866877|NCT00541970|540645081|FG003|Month 60|Protocol Violation|72|||
149866878|NCT03107026|540645082|FG000|Overall Study|Adverse Event|2|||
149866879|NCT03107026|540645083|FG001|Overall Study|Adverse Event|14|||
149866880|NCT03107026|540645084|FG002|Overall Study|Adverse Event|23|||
149866881|NCT03107026|540645082|FG000|Overall Study|Lost to Follow-up|12|||
149866882|NCT03107026|540645083|FG001|Overall Study|Lost to Follow-up|12|||
149866883|NCT03107026|540645084|FG002|Overall Study|Lost to Follow-up|13|||
149866884|NCT03107026|540645082|FG000|Overall Study|Protocol Violation|1|||
149866885|NCT03107026|540645083|FG001|Overall Study|Protocol Violation|2|||
149866886|NCT03107026|540645084|FG002|Overall Study|Protocol Violation|0|||
149866887|NCT03107026|540645082|FG000|Overall Study|Pregnancy|1|||
149866888|NCT03107026|540645083|FG001|Overall Study|Pregnancy|0|||
149866889|NCT03107026|540645084|FG002|Overall Study|Pregnancy|0|||
149866890|NCT03107026|540645082|FG000|Overall Study|Withdrawal by Subject|13|||
149866891|NCT03107026|540645083|FG001|Overall Study|Withdrawal by Subject|5|||
149866892|NCT03107026|540645084|FG002|Overall Study|Withdrawal by Subject|17|||
149866893|NCT03107026|540645082|FG000|Overall Study|non compliance with study visits|1|||
149866894|NCT03107026|540645083|FG001|Overall Study|non compliance with study visits|2|||
149866895|NCT03107026|540645084|FG002|Overall Study|non compliance with study visits|0|||
149866896|NCT03107026|540645082|FG000|Overall Study|non-compliance with study drug|2|||
149866897|NCT03107026|540645083|FG001|Overall Study|non-compliance with study drug|2|||
149866898|NCT03107026|540645084|FG002|Overall Study|non-compliance with study drug|3|||
149866899|NCT03107026|540645082|FG000|Overall Study|Physician Decision|0|||
149866900|NCT03107026|540645083|FG001|Overall Study|Physician Decision|1|||
149866901|NCT03107026|540645084|FG002|Overall Study|Physician Decision|0|||
149866902|NCT00062010|540645085|FG000|Overall Study|Ineligible|3|||
149866903|NCT01183221|540645086|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
149866904|NCT01183221|540645087|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
149866905|NCT00678041|540645093|FG000|Overall Study|Physician Decision|5|||
149866906|NCT00678041|540645094|FG001|Overall Study|Physician Decision|5|||
149866907|NCT03596151|540645095|FG000|Overall Study|Withdrawal by Subject|1|||
149866908|NCT02444793|540645097|FG000|Overall Study|Lost to Follow-up|2|||
149866909|NCT02444793|540645098|FG001|Overall Study|Lost to Follow-up|2|||
149866910|NCT02444793|540645099|FG002|Overall Study|Lost to Follow-up|0|||
149866911|NCT02444793|540645100|FG003|Overall Study|Lost to Follow-up|0|||
149866912|NCT02444793|540645097|FG000|Overall Study|Death|0|||
149866913|NCT02444793|540645098|FG001|Overall Study|Death|3|||
149866914|NCT02444793|540645099|FG002|Overall Study|Death|0|||
149866915|NCT02444793|540645100|FG003|Overall Study|Death|0|||
149866916|NCT02444793|540645097|FG000|Overall Study|Other|0|||
149866917|NCT02444793|540645098|FG001|Overall Study|Other|0|||
149866918|NCT02444793|540645099|FG002|Overall Study|Other|2|||
149866919|NCT02444793|540645100|FG003|Overall Study|Other|0|||
149866920|NCT02444793|540645097|FG000|Overall Study|Objective progression or relapse|9|||
149866921|NCT02444793|540645098|FG001|Overall Study|Objective progression or relapse|1|||
149866922|NCT02444793|540645099|FG002|Overall Study|Objective progression or relapse|2|||
149866923|NCT02444793|540645100|FG003|Overall Study|Objective progression or relapse|3|||
149866924|NCT02504671|540645106|FG000|Overall Study|Withdrawal by Subject|1|||
149866925|NCT02504671|540645107|FG001|Overall Study|Withdrawal by Subject|5|||
149962371|NCT03726879|540995914|FG000|Overall Study|TSH result is unstable|0|||
149962372|NCT03726879|540995915|FG001|Overall Study|TSH result is unstable|1|||
149866926|NCT02504671|540645108|FG002|Overall Study|Withdrawal by Subject|4|||
149866927|NCT02504671|540645109|FG003|Overall Study|Withdrawal by Subject|4|||
149866928|NCT02504671|540645110|FG004|Overall Study|Withdrawal by Subject|5|||
149866929|NCT02504671|540645111|FG005|Overall Study|Withdrawal by Subject|3|||
149866930|NCT02504671|540645106|FG000|Overall Study|Lack of Efficacy|1|||
149866931|NCT02504671|540645107|FG001|Overall Study|Lack of Efficacy|3|||
149866932|NCT02504671|540645108|FG002|Overall Study|Lack of Efficacy|1|||
149866933|NCT02504671|540645109|FG003|Overall Study|Lack of Efficacy|0|||
149866934|NCT02504671|540645110|FG004|Overall Study|Lack of Efficacy|4|||
149866935|NCT02504671|540645111|FG005|Overall Study|Lack of Efficacy|4|||
149866936|NCT02504671|540645106|FG000|Overall Study|Adverse Event|1|||
149866937|NCT02504671|540645107|FG001|Overall Study|Adverse Event|1|||
149866938|NCT02504671|540645108|FG002|Overall Study|Adverse Event|0|||
149866939|NCT02504671|540645109|FG003|Overall Study|Adverse Event|1|||
149866940|NCT02504671|540645110|FG004|Overall Study|Adverse Event|0|||
149866941|NCT02504671|540645111|FG005|Overall Study|Adverse Event|2|||
149866942|NCT02504671|540645106|FG000|Overall Study|Protocol Violation|2|||
149866943|NCT02504671|540645107|FG001|Overall Study|Protocol Violation|1|||
149866944|NCT02504671|540645108|FG002|Overall Study|Protocol Violation|0|||
149866945|NCT02504671|540645109|FG003|Overall Study|Protocol Violation|0|||
149866946|NCT02504671|540645110|FG004|Overall Study|Protocol Violation|0|||
149866947|NCT02504671|540645111|FG005|Overall Study|Protocol Violation|1|||
149866948|NCT02504671|540645106|FG000|Overall Study|Lost to Follow-up|0|||
149866949|NCT02504671|540645107|FG001|Overall Study|Lost to Follow-up|0|||
149866950|NCT02504671|540645108|FG002|Overall Study|Lost to Follow-up|2|||
149866951|NCT02504671|540645109|FG003|Overall Study|Lost to Follow-up|0|||
149866952|NCT02504671|540645110|FG004|Overall Study|Lost to Follow-up|0|||
149866953|NCT02504671|540645111|FG005|Overall Study|Lost to Follow-up|1|||
149866954|NCT02504671|540645106|FG000|Overall Study|Protocol defined stopping criteria|7|||
149866955|NCT02504671|540645107|FG001|Overall Study|Protocol defined stopping criteria|4|||
149866956|NCT02504671|540645108|FG002|Overall Study|Protocol defined stopping criteria|3|||
149866957|NCT02504671|540645109|FG003|Overall Study|Protocol defined stopping criteria|5|||
149866958|NCT02504671|540645110|FG004|Overall Study|Protocol defined stopping criteria|3|||
149866959|NCT02504671|540645111|FG005|Overall Study|Protocol defined stopping criteria|3|||
149866960|NCT02518919|540645112|FG000|Overall Study|Protocol Violation|1|||
149866961|NCT02518919|540645113|FG001|Overall Study|Protocol Violation|1|||
149866962|NCT02518919|540645114|FG002|Overall Study|Protocol Violation|2|||
149866963|NCT04498403|540645115|FG000|Overall Study|Adverse Event|1|||
149866964|NCT04498403|540645116|FG001|Overall Study|Adverse Event|0|||
149866965|NCT04498403|540645115|FG000|Overall Study|Study Terminated By Sponsor|29|||
149866966|NCT04498403|540645116|FG001|Overall Study|Study Terminated By Sponsor|10|||
149866967|NCT01951885|540645117|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
149866968|NCT01951885|540645118|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
149866969|NCT01951885|540645117|FG000|Overall Study|Adverse Event|1|||
149866970|NCT01951885|540645118|FG001|Overall Study|Adverse Event|0|||
149866971|NCT01951885|540645117|FG000|Overall Study|Withdrawal by Subject|0|||
149866972|NCT01951885|540645118|FG001|Overall Study|Withdrawal by Subject|1|||
149866973|NCT01951885|540645117|FG000|Overall Study|ineligible due to a change in donor|0|||
149866974|NCT01951885|540645118|FG001|Overall Study|ineligible due to a change in donor|1|||
149866975|NCT01951885|540645117|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
149866976|NCT01951885|540645118|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
149866977|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Death|89|||
149866978|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Death|193|||
149866979|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Death|198|||
149866980|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
149866981|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
149866982|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
149866983|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
149866984|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
149866985|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
149866986|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
149866987|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
149866988|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
149866989|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
149866990|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
149866991|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
149866992|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
149866993|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
149866994|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
149866995|NCT02031458|540645119|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
149866996|NCT02031458|540645120|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
149866997|NCT02031458|540645121|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
149866998|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Death|36|||
149866999|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Death|87|||
149867000|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Death|100|||
149867001|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
149867002|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
149867003|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
149867004|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Physician Decision|0|||
149867005|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Physician Decision|1|||
149867006|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Physician Decision|0|||
149867007|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
149867008|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
149867009|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
149867010|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
149867011|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
149867012|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
149867013|NCT02031458|540645119|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
149867014|NCT02031458|540645120|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
149867015|NCT02031458|540645121|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
149867016|NCT02031458|540645119|FG000|Baseline to May 8, 2015|On Treatment|43|||
149867017|NCT02031458|540645120|FG001|Baseline to May 8, 2015|On Treatment|81|||
149867018|NCT02031458|540645121|FG002|Baseline to May 8, 2015|On Treatment|73|||
149867019|NCT02031458|540645119|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
149867020|NCT02031458|540645120|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
149867021|NCT02031458|540645121|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
149867022|NCT01687478|540645124|FG000|Overall Study|Adverse Event|3|||
149867023|NCT01687478|540645125|FG001|Overall Study|Adverse Event|10|||
149867024|NCT01687478|540645124|FG000|Overall Study|Lost to Follow-up|1|||
149867025|NCT01687478|540645125|FG001|Overall Study|Lost to Follow-up|3|||
149867026|NCT01687478|540645124|FG000|Overall Study|Protocol Violation|0|||
149867027|NCT01687478|540645125|FG001|Overall Study|Protocol Violation|2|||
149867028|NCT01687478|540645124|FG000|Overall Study|Withdrawal by Subject|21|||
149867029|NCT01687478|540645125|FG001|Overall Study|Withdrawal by Subject|19|||
149867030|NCT01687478|540645124|FG000|Overall Study|Physician Decision|1|||
149867031|NCT01687478|540645125|FG001|Overall Study|Physician Decision|3|||
149867032|NCT01687478|540645124|FG000|Overall Study|Entry Criteria Not Met|6|||
149867033|NCT01687478|540645125|FG001|Overall Study|Entry Criteria Not Met|2|||
149867034|NCT03188718|540645126|FG000|Overall Study|Participant noncompliance|4|||
149867035|NCT03188718|540645126|FG000|Overall Study|Withdrawal by Subject|1|||
149867036|NCT03188718|540645126|FG000|Overall Study|Device failure|3|||
149867037|NCT00394524|540645129|FG000|Overall Study|Protocol Violation|2|||
149867038|NCT00394524|540645130|FG001|Overall Study|Protocol Violation|3|||
149867039|NCT00394524|540645129|FG000|Overall Study|Death|1|||
149867040|NCT00394524|540645130|FG001|Overall Study|Death|0|||
149867041|NCT00394524|540645129|FG000|Overall Study|Withdrawal by Subject|0|||
149867042|NCT00394524|540645130|FG001|Overall Study|Withdrawal by Subject|1|||
149867043|NCT01462318|540645131|FG000|Main Study / TP-DI Study|Other|2|||
149867044|NCT01462318|540645132|FG001|Main Study / TP-DI Study|Other|0|||
149867045|NCT01462318|540645133|FG002|Main Study / TP-DI Study|Other|0|||
149867046|NCT01462318|540645131|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
149867047|NCT01462318|540645132|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
149867048|NCT01462318|540645133|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
149867049|NCT01462318|540645131|FG000|Main Study / TP-DI Study|Adverse Event|4|||
149867050|NCT01462318|540645132|FG001|Main Study / TP-DI Study|Adverse Event|0|||
149867051|NCT01462318|540645133|FG002|Main Study / TP-DI Study|Adverse Event|0|||
149867052|NCT01462318|540645131|FG000|Extension Phase|Lost to Follow-up|0|||
149867053|NCT01462318|540645132|FG001|Extension Phase|Lost to Follow-up|0|||
149867054|NCT01462318|540645133|FG002|Extension Phase|Lost to Follow-up|1|||
149867055|NCT01462318|540645131|FG000|Extension Phase|Other|0|||
149867056|NCT01462318|540645132|FG001|Extension Phase|Other|0|||
149867057|NCT01462318|540645133|FG002|Extension Phase|Other|1|||
149867058|NCT01462318|540645131|FG000|Extension Phase|Disease Progression|0|||
149867059|NCT01462318|540645132|FG001|Extension Phase|Disease Progression|0|||
149867060|NCT01462318|540645133|FG002|Extension Phase|Disease Progression|1|||
149867061|NCT01462318|540645131|FG000|Extension Phase|Withdrawal by Subject|0|||
149867062|NCT01462318|540645132|FG001|Extension Phase|Withdrawal by Subject|0|||
149867063|NCT01462318|540645133|FG002|Extension Phase|Withdrawal by Subject|15|||
149867064|NCT01462318|540645131|FG000|Extension Phase|Investigator Decision|0|||
149867065|NCT01462318|540645132|FG001|Extension Phase|Investigator Decision|0|||
149867066|NCT01462318|540645133|FG002|Extension Phase|Investigator Decision|5|||
149867067|NCT01462318|540645131|FG000|Extension Phase|Adverse Event|0|||
149867068|NCT01462318|540645132|FG001|Extension Phase|Adverse Event|0|||
149867069|NCT01462318|540645133|FG002|Extension Phase|Adverse Event|22|||
149867070|NCT02238626|540645134|FG000|Overall Study|Adverse Event|3|||
149867071|NCT02238626|540645135|FG001|Overall Study|Adverse Event|5|||
149867072|NCT02238626|540645136|FG002|Overall Study|Adverse Event|0|||
149867073|NCT02238626|540645137|FG003|Overall Study|Adverse Event|3|||
149867074|NCT02238626|540645134|FG000|Overall Study|Lost to Follow-up|2|||
149867075|NCT02238626|540645135|FG001|Overall Study|Lost to Follow-up|4|||
149867076|NCT02238626|540645136|FG002|Overall Study|Lost to Follow-up|2|||
149867077|NCT02238626|540645137|FG003|Overall Study|Lost to Follow-up|2|||
149867078|NCT02238626|540645134|FG000|Overall Study|Withdrawal by Subject|0|||
149867079|NCT02238626|540645135|FG001|Overall Study|Withdrawal by Subject|3|||
149867080|NCT02238626|540645136|FG002|Overall Study|Withdrawal by Subject|0|||
149867081|NCT02238626|540645137|FG003|Overall Study|Withdrawal by Subject|1|||
149867082|NCT02238626|540645134|FG000|Overall Study|Death|0|||
149867083|NCT02238626|540645135|FG001|Overall Study|Death|0|||
149867084|NCT02238626|540645136|FG002|Overall Study|Death|1|||
149867085|NCT02238626|540645137|FG003|Overall Study|Death|1|||
149867086|NCT02238626|540645134|FG000|Overall Study|Other|0|||
149867087|NCT02238626|540645135|FG001|Overall Study|Other|2|||
149867088|NCT02238626|540645136|FG002|Overall Study|Other|0|||
149867089|NCT02238626|540645137|FG003|Overall Study|Other|0|||
149867090|NCT02227147|540645141|FG000|Controlled Treatment Period|Adverse Event|4|||
149867091|NCT02227147|540645142|FG001|Controlled Treatment Period|Adverse Event|3|||
149867092|NCT02227147|540645141|FG000|Controlled Treatment Period|Other|2|||
149867093|NCT02227147|540645142|FG001|Controlled Treatment Period|Other|0|||
149867094|NCT02227147|540645141|FG000|Follow-up Period|Other|3|||
149867095|NCT02227147|540645142|FG001|Follow-up Period|Other|5|||
149867096|NCT00158600|540645145|FG000|Overall Study|unable to commit time to study|0|||
149867097|NCT00158600|540645146|FG001|Overall Study|unable to commit time to study|1|||
149867098|NCT00158600|540645145|FG000|Overall Study|Adverse Event|2|||
149867099|NCT00158600|540645146|FG001|Overall Study|Adverse Event|1|||
149867100|NCT00158600|540645145|FG000|Overall Study|Death|1|||
149867101|NCT00158600|540645146|FG001|Overall Study|Death|0|||
149867102|NCT00158600|540645145|FG000|Overall Study|Withdrawal by Subject|2|||
149867103|NCT00158600|540645146|FG001|Overall Study|Withdrawal by Subject|2|||
149867104|NCT01593696|540645147|FG000|Dose Escalation|Progressive Disease|2|||
149867105|NCT01593696|540645148|FG001|Dose Escalation|Progressive Disease|0|||
149867106|NCT01593696|540645149|FG002|Dose Escalation|Progressive Disease|0|||
149867107|NCT01593696|540645150|FG003|Dose Escalation|Progressive Disease|0|||
149867108|NCT01593696|540645147|FG000|Dose Expansion|Fungal infection|0|||
149867109|NCT01593696|540645148|FG001|Dose Expansion|Fungal infection|0|||
149867110|NCT01593696|540645149|FG002|Dose Expansion|Fungal infection|1|||
149867111|NCT01593696|540645150|FG003|Dose Expansion|Fungal infection|0|||
149867112|NCT01936623|540645151|FG000|Overall Study|Lost to Follow-up|0|||
149867113|NCT01936623|540645152|FG001|Overall Study|Lost to Follow-up|5|||
149867114|NCT00369655|540645156|FG000|Overall Study|Refusal of further treatment|2|||
149867115|NCT04049617|540645157|FG000|Overall Study|Adverse Event|0|||
149867116|NCT04049617|540645158|FG001|Overall Study|Adverse Event|0|||
149867117|NCT04049617|540645159|FG002|Overall Study|Adverse Event|0|||
149867118|NCT04049617|540645160|FG003|Overall Study|Adverse Event|1|||
149867119|NCT04049617|540645161|FG004|Overall Study|Adverse Event|0|||
149867120|NCT04049617|540645162|FG005|Overall Study|Adverse Event|0|||
149867121|NCT04049617|540645157|FG000|Overall Study|Death|0|||
149867122|NCT04049617|540645158|FG001|Overall Study|Death|0|||
149867123|NCT04049617|540645159|FG002|Overall Study|Death|0|||
149867124|NCT04049617|540645160|FG003|Overall Study|Death|0|||
149867125|NCT04049617|540645161|FG004|Overall Study|Death|0|||
149867126|NCT04049617|540645162|FG005|Overall Study|Death|1|||
149867127|NCT04049617|540645157|FG000|Overall Study|Lost to Follow-up|0|||
149867128|NCT04049617|540645158|FG001|Overall Study|Lost to Follow-up|0|||
149867129|NCT04049617|540645159|FG002|Overall Study|Lost to Follow-up|0|||
149867130|NCT04049617|540645160|FG003|Overall Study|Lost to Follow-up|1|||
149867131|NCT04049617|540645161|FG004|Overall Study|Lost to Follow-up|0|||
150040838|NCT00790842|541289116|FG002|Expansion Cohort|Withdrawal by Subject|3|||
150040839|NCT00790842|541289117|FG003|Expansion Cohort|Withdrawal by Subject|0|||
150040840|NCT00790842|541289118|FG004|Expansion Cohort|Withdrawal by Subject|0|||
150040841|NCT00790842|541289119|FG005|Expansion Cohort|Withdrawal by Subject|0|||
150040842|NCT00790842|541289120|FG006|Expansion Cohort|Withdrawal by Subject|0|||
150040843|NCT00790842|541289121|FG007|Expansion Cohort|Withdrawal by Subject|0|||
150040844|NCT00790842|541289122|FG008|Expansion Cohort|Withdrawal by Subject|0|||
150040845|NCT00790842|541289123|FG009|Expansion Cohort|Withdrawal by Subject|0|||
149867132|NCT04049617|540645162|FG005|Overall Study|Lost to Follow-up|0|||
149867133|NCT04049617|540645157|FG000|Overall Study|Withdrew consent|0|||
149867134|NCT04049617|540645158|FG001|Overall Study|Withdrew consent|0|||
149867135|NCT04049617|540645159|FG002|Overall Study|Withdrew consent|1|||
150040846|NCT00790842|541289124|FG010|Expansion Cohort|Withdrawal by Subject|0|||
149867136|NCT04049617|540645160|FG003|Overall Study|Withdrew consent|0|||
149867137|NCT04049617|540645161|FG004|Overall Study|Withdrew consent|0|||
149867138|NCT04049617|540645162|FG005|Overall Study|Withdrew consent|0|||
149867139|NCT00801099|540645163|FG000|Overall Study|Lost to Follow-up|101|||
149867140|NCT04078126|540645164|FG000|Washout|Study put on hold due to COVID-19|0|||
149867141|NCT04078126|540645165|FG001|Washout|Study put on hold due to COVID-19|2|||
149867142|NCT04078126|540645164|FG000|Period 2|Study put on hold due to COVID-19|1|||
149867143|NCT04078126|540645165|FG001|Period 2|Study put on hold due to COVID-19|1|||
149867144|NCT02669758|540645166|FG000|Overall Study|Withdrawal by Subject|43|||
149867145|NCT02669758|540645166|FG000|Overall Study|Lost to Follow-up|19|||
149867146|NCT02669758|540645166|FG000|Overall Study|Adverse Event|16|||
149867147|NCT02669758|540645166|FG000|Overall Study|Non-Compliance with Study Drug|8|||
149867148|NCT02669758|540645166|FG000|Overall Study|Lack of Efficacy|5|||
149867149|NCT02669758|540645166|FG000|Overall Study|Pregnancy|1|||
149867150|NCT02669758|540645166|FG000|Overall Study|Study noncompliance|1|||
149867151|NCT02669758|540645166|FG000|Overall Study|Protocol Violation|1|||
149867152|NCT02149108|540645167|FG000|Overall Study|Not treated|1|||
149867153|NCT02149108|540645168|FG001|Overall Study|Not treated|2|||
149867154|NCT02149108|540645167|FG000|Overall Study|Progressive Disease (PD)|324|||
149867155|NCT02149108|540645168|FG001|Overall Study|Progressive Disease (PD)|318|||
149867156|NCT02149108|540645167|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
149867157|NCT02149108|540645168|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
149867158|NCT02149108|540645167|FG000|Overall Study|Other Adverse Event (AE)|8|||
149867159|NCT02149108|540645168|FG001|Overall Study|Other Adverse Event (AE)|18|||
150040847|NCT00790842|541289114|FG000|Expansion Cohort|Study Closure|0|||
149867160|NCT02149108|540645167|FG000|Overall Study|Other not defined above|0|||
149867161|NCT02149108|540645168|FG001|Overall Study|Other not defined above|2|||
149867162|NCT02149108|540645167|FG000|Overall Study|Refusal to continue trial medication|15|||
149867163|NCT02149108|540645168|FG001|Overall Study|Refusal to continue trial medication|11|||
149867164|NCT02149108|540645167|FG000|Overall Study|Lost to Follow-up|1|||
149867165|NCT02149108|540645168|FG001|Overall Study|Lost to Follow-up|0|||
149867166|NCT03402750|540645169|FG000|Overall Study|Lost to Follow-up|2|||
149867167|NCT03402750|540645170|FG001|Overall Study|Lost to Follow-up|1|||
149867168|NCT02981303|540645171|FG000|Overall Study|Progressive Disease|17|||
149867169|NCT02981303|540645172|FG001|Overall Study|Progressive Disease|37|||
149867170|NCT02981303|540645171|FG000|Overall Study|Adverse Event|1|||
149867171|NCT02981303|540645172|FG001|Overall Study|Adverse Event|4|||
149867172|NCT02981303|540645171|FG000|Overall Study|Withdrawal by Subject|0|||
149867173|NCT02981303|540645172|FG001|Overall Study|Withdrawal by Subject|1|||
149867174|NCT02325518|540645173|FG000|Overall Study|Adverse Event|4|||
149867175|NCT02325518|540645174|FG001|Overall Study|Adverse Event|1|||
149867176|NCT02325518|540645173|FG000|Overall Study|Physician Decision|0|||
149867177|NCT02325518|540645174|FG001|Overall Study|Physician Decision|1|||
149867178|NCT02325518|540645173|FG000|Overall Study|Withdrawal by Subject|0|||
149867179|NCT02325518|540645174|FG001|Overall Study|Withdrawal by Subject|1|||
149867180|NCT03393806|540645175|FG000|Overall Study|Physician Decision|1|||
149867181|NCT03393806|540645176|FG001|Overall Study|Physician Decision|0|||
149867182|NCT00080938|540645177|FG000|Overall Study|Adverse Event|3|||
149867183|NCT00080938|540645177|FG000|Overall Study|Withdrawal by Subject|6|||
149867184|NCT00080938|540645177|FG000|Overall Study|Death|2|||
149867185|NCT00080938|540645177|FG000|Overall Study|Lack of Efficacy|7|||
149867186|NCT00080938|540645177|FG000|Overall Study|other disease|1|||
149867187|NCT00080938|540645177|FG000|Overall Study|Not started protocol therapy|1|||
149867188|NCT00080938|540645177|FG000|Overall Study|Ineligible|4|||
149867189|NCT00706511|540645182|FG000|Overall Study|Withdrawal by Subject|1|||
149867190|NCT00706511|540645183|FG001|Overall Study|Withdrawal by Subject|0|||
149867191|NCT00706511|540645184|FG002|Overall Study|Withdrawal by Subject|0|||
149867192|NCT00706511|540645185|FG003|Overall Study|Withdrawal by Subject|0|||
149867193|NCT02116608|540645190|FG000|Overall Study|Lost to Follow-up|0|||
149867194|NCT02116608|540645191|FG001|Overall Study|Lost to Follow-up|0|||
149867195|NCT02116608|540645192|FG002|Overall Study|Lost to Follow-up|1|||
149867196|NCT02116608|540645190|FG000|Overall Study|Physician Decision|0|||
149867197|NCT02116608|540645191|FG001|Overall Study|Physician Decision|1|||
149867198|NCT02116608|540645192|FG002|Overall Study|Physician Decision|0|||
149867199|NCT02116608|540645190|FG000|Overall Study|Death|0|||
149867200|NCT02116608|540645191|FG001|Overall Study|Death|1|||
149867201|NCT02116608|540645192|FG002|Overall Study|Death|0|||
149867202|NCT00988442|540645193|FG000|Overall Study|Death|1|||
149867203|NCT00988442|540645194|FG001|Overall Study|Death|2|||
149867204|NCT00988442|540645193|FG000|Overall Study|Lost to Follow-up|0|||
149867205|NCT00988442|540645194|FG001|Overall Study|Lost to Follow-up|1|||
149867206|NCT00988442|540645193|FG000|Overall Study|Early Study Closure|29|||
149867207|NCT00988442|540645194|FG001|Overall Study|Early Study Closure|25|||
149867208|NCT04620135|540645202|FG000|Study Completion|Adverse Event|2|||
149867209|NCT04620135|540645203|FG001|Study Completion|Adverse Event|3|||
149867210|NCT04620135|540645202|FG000|Study Completion|Withdrawal by Subject|2|||
149867211|NCT04620135|540645203|FG001|Study Completion|Withdrawal by Subject|0|||
149867212|NCT02272634|540645204|FG000|Overall Study|Adverse Event|1|||
149867213|NCT02272634|540645205|FG001|Overall Study|Adverse Event|0|||
149867214|NCT02272634|540645206|FG002|Overall Study|Adverse Event|0|||
149867215|NCT02272634|540645204|FG000|Overall Study|Protocol Violation|0|||
149867216|NCT02272634|540645205|FG001|Overall Study|Protocol Violation|0|||
149867217|NCT02272634|540645206|FG002|Overall Study|Protocol Violation|1|||
149867218|NCT02272634|540645204|FG000|Overall Study|Withdrawal by Subject|0|||
149867219|NCT02272634|540645205|FG001|Overall Study|Withdrawal by Subject|1|||
149867220|NCT02272634|540645206|FG002|Overall Study|Withdrawal by Subject|0|||
149867221|NCT01437943|540645207|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
149867222|NCT01437943|540645208|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
149867223|NCT01437943|540645207|FG000|Overall Study|Subject expressed pregnancy plans|1|||
149867224|NCT01437943|540645208|FG001|Overall Study|Subject expressed pregnancy plans|0|||
149867225|NCT01437943|540645207|FG000|Overall Study|Adverse Event|2|||
149867226|NCT01437943|540645208|FG001|Overall Study|Adverse Event|0|||
149867227|NCT01660334|540645213|FG000|Overall Study|Lost to Follow-up|1|||
149867228|NCT00546572|540645214|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
149867229|NCT00546572|540645215|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
149867230|NCT00546572|540645214|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
149867231|NCT00546572|540645215|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
149867232|NCT00546572|540645214|FG000|Vax 1 / Year 0|Protocol Violation|3|||
149867233|NCT00546572|540645215|FG001|Vax 1 / Year 0|Protocol Violation|4|||
149867234|NCT00546572|540645214|FG000|Vax 1 / Year 0|Death|2|||
149867235|NCT00546572|540645215|FG001|Vax 1 / Year 0|Death|2|||
149867236|NCT00546572|540645214|FG000|Vax 1 / Year 0|Adverse Event|0|||
149867237|NCT00546572|540645215|FG001|Vax 1 / Year 0|Adverse Event|1|||
149867238|NCT00546572|540645214|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
149867239|NCT00546572|540645215|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
149867240|NCT00546572|540645214|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
149867241|NCT00546572|540645215|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
149867242|NCT00546572|540645214|FG000|Vax 2 / Year 1|Other|1|||
149867243|NCT00546572|540645215|FG001|Vax 2 / Year 1|Other|1|||
149867244|NCT00546572|540645214|FG000|Vax 2 / Year 1|Adverse Event|1|||
149867245|NCT00546572|540645215|FG001|Vax 2 / Year 1|Adverse Event|0|||
149867246|NCT00546572|540645214|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
149867247|NCT00546572|540645215|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
149867248|NCT00988065|540645216|FG000|Overall Study|Adverse Event|4|||
149867249|NCT00988065|540645217|FG001|Overall Study|Adverse Event|10|||
149867250|NCT00988065|540645218|FG002|Overall Study|Adverse Event|2|||
149867251|NCT00988065|540645216|FG000|Overall Study|Lost to Follow-up|1|||
149867252|NCT00988065|540645217|FG001|Overall Study|Lost to Follow-up|2|||
149867253|NCT00988065|540645218|FG002|Overall Study|Lost to Follow-up|2|||
149867254|NCT00988065|540645216|FG000|Overall Study|Subject withdrew consent|3|||
149867255|NCT00988065|540645217|FG001|Overall Study|Subject withdrew consent|5|||
149867256|NCT00988065|540645218|FG002|Overall Study|Subject withdrew consent|2|||
149867257|NCT00988065|540645216|FG000|Overall Study|Noncompliance with protocol|5|||
149867258|NCT00988065|540645217|FG001|Overall Study|Noncompliance with protocol|6|||
149867259|NCT00988065|540645218|FG002|Overall Study|Noncompliance with protocol|9|||
149867260|NCT03979820|540645219|FG000|Overall Study|Protocol Violation|1|||
149867261|NCT03979820|540645220|FG001|Overall Study|Protocol Violation|0|||
149867262|NCT03979820|540645221|FG002|Overall Study|Protocol Violation|0|||
149867263|NCT03979820|540645222|FG003|Overall Study|Protocol Violation|0|||
149867264|NCT03979820|540645219|FG000|Overall Study|Withdrawal by Subject|0|||
149867265|NCT03979820|540645220|FG001|Overall Study|Withdrawal by Subject|0|||
149867266|NCT03979820|540645221|FG002|Overall Study|Withdrawal by Subject|1|||
149867267|NCT03979820|540645222|FG003|Overall Study|Withdrawal by Subject|0|||
149867268|NCT03979820|540645219|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
149867269|NCT03979820|540645220|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
149867270|NCT03979820|540645221|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
149867271|NCT03979820|540645222|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
149867272|NCT01229735|540645223|FG000|Overall Study|Lack of Efficacy|8|||
149867273|NCT01229735|540645224|FG001|Overall Study|Lack of Efficacy|8|||
149867274|NCT01229735|540645223|FG000|Overall Study|Protocol Violation|13|||
149867275|NCT01229735|540645224|FG001|Overall Study|Protocol Violation|8|||
149867276|NCT01229735|540645223|FG000|Overall Study|Lost to Follow-up|0|||
149962373|NCT03726879|540995914|FG000|Overall Study|Disease relapse|1|||
149962374|NCT03726879|540995915|FG001|Overall Study|Disease relapse|0|||
149962375|NCT03726879|540995914|FG000|Overall Study|Lost to Follow-up|3|||
149962376|NCT03726879|540995915|FG001|Overall Study|Lost to Follow-up|0|||
149867277|NCT01229735|540645224|FG001|Overall Study|Lost to Follow-up|2|||
149867278|NCT01229735|540645223|FG000|Overall Study|Withdrawal by Subject|18|||
149867279|NCT01229735|540645224|FG001|Overall Study|Withdrawal by Subject|17|||
149867280|NCT01229735|540645223|FG000|Overall Study|Other Reason|13|||
149867281|NCT01229735|540645224|FG001|Overall Study|Other Reason|10|||
149867282|NCT01229735|540645223|FG000|Overall Study|SAE, non-fatal|0|||
149867283|NCT01229735|540645224|FG001|Overall Study|SAE, non-fatal|4|||
149867284|NCT01229735|540645223|FG000|Overall Study|AE, non-serious non-fatal|13|||
149867285|NCT01229735|540645224|FG001|Overall Study|AE, non-serious non-fatal|17|||
149867286|NCT01229735|540645223|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149867287|NCT01229735|540645224|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
149867288|NCT02130882|540645225|FG000|Overall Study|Withdrawal by Subject|0|||
149867289|NCT02130882|540645226|FG001|Overall Study|Withdrawal by Subject|1|||
149867290|NCT00502801|540645238|FG000|Treatment Period|Withdrawal by Subject|3|||
149867291|NCT00502801|540645238|FG000|Treatment Period|Adverse Event|7|||
149867292|NCT00502801|540645238|FG000|Treatment Period|Death|14|||
149962377|NCT02766478|540995916|FG000|Overall Study|Withdrawal by Subject|1|||
149867293|NCT00502801|540645238|FG000|Treatment Period|OTHER|30|||
149867294|NCT00502801|540645238|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
149867295|NCT00502801|540645238|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
149867296|NCT00502801|540645238|FG000|End of Therapy to Test of Cure|Death|3|||
149867297|NCT00502801|540645238|FG000|End of Therapy to Test of Cure|OTHER|2|||
149867298|NCT03176459|540645241|FG000|Overall Study|Lost to Follow-up|5|||
149867299|NCT03176459|540645242|FG001|Overall Study|Lost to Follow-up|7|||
149867300|NCT00446199|540645243|FG000|Overall Study|Adverse Event|7|||
149867301|NCT00446199|540645244|FG001|Overall Study|Adverse Event|4|||
149867302|NCT00446199|540645245|FG002|Overall Study|Adverse Event|6|||
149867303|NCT00446199|540645246|FG003|Overall Study|Adverse Event|4|||
149867304|NCT00446199|540645243|FG000|Overall Study|Lost to Follow-up|4|||
149867305|NCT00446199|540645244|FG001|Overall Study|Lost to Follow-up|5|||
149867306|NCT00446199|540645245|FG002|Overall Study|Lost to Follow-up|2|||
149867307|NCT00446199|540645246|FG003|Overall Study|Lost to Follow-up|6|||
149867308|NCT00446199|540645243|FG000|Overall Study|Protocol Violation|1|||
149867309|NCT00446199|540645244|FG001|Overall Study|Protocol Violation|2|||
149867310|NCT00446199|540645245|FG002|Overall Study|Protocol Violation|1|||
149867311|NCT00446199|540645246|FG003|Overall Study|Protocol Violation|3|||
149867312|NCT00446199|540645243|FG000|Overall Study|Withdrawal by Subject|2|||
149867313|NCT00446199|540645244|FG001|Overall Study|Withdrawal by Subject|5|||
149867314|NCT00446199|540645245|FG002|Overall Study|Withdrawal by Subject|9|||
149867315|NCT00446199|540645246|FG003|Overall Study|Withdrawal by Subject|10|||
149867316|NCT00446199|540645243|FG000|Overall Study|Site termination|2|||
149867317|NCT00446199|540645244|FG001|Overall Study|Site termination|0|||
149867318|NCT00446199|540645245|FG002|Overall Study|Site termination|0|||
149867319|NCT00446199|540645246|FG003|Overall Study|Site termination|1|||
149867320|NCT00446199|540645243|FG000|Overall Study|Randomization in Error|2|||
149867321|NCT00446199|540645244|FG001|Overall Study|Randomization in Error|0|||
149867322|NCT00446199|540645245|FG002|Overall Study|Randomization in Error|1|||
149867323|NCT00446199|540645246|FG003|Overall Study|Randomization in Error|1|||
149867324|NCT00446199|540645243|FG000|Overall Study|Lack of Efficacy|1|||
149867325|NCT00446199|540645244|FG001|Overall Study|Lack of Efficacy|0|||
149867326|NCT00446199|540645245|FG002|Overall Study|Lack of Efficacy|0|||
149867327|NCT00446199|540645246|FG003|Overall Study|Lack of Efficacy|1|||
149867328|NCT00446199|540645243|FG000|Overall Study|Non-compliant with study drug|1|||
149867329|NCT00446199|540645244|FG001|Overall Study|Non-compliant with study drug|0|||
149962378|NCT02766478|540995917|FG001|Overall Study|Withdrawal by Subject|1|||
149962379|NCT01093573|540995918|FG000|Overall Study|Physician Decision|0|||
149962380|NCT01093573|540995919|FG001|Overall Study|Physician Decision|0|||
149962381|NCT01093573|540995920|FG002|Overall Study|Physician Decision|1|||
149962382|NCT01093573|540995918|FG000|Overall Study|Insurance Denied|0|||
149962383|NCT01093573|540995919|FG001|Overall Study|Insurance Denied|0|||
150040848|NCT00790842|541289115|FG001|Expansion Cohort|Study Closure|0|||
149867330|NCT00446199|540645245|FG002|Overall Study|Non-compliant with study drug|5|||
149867331|NCT00446199|540645246|FG003|Overall Study|Non-compliant with study drug|0|||
149867332|NCT00446199|540645243|FG000|Overall Study|Non-compliant with visit schedule|1|||
149867333|NCT00446199|540645244|FG001|Overall Study|Non-compliant with visit schedule|1|||
149867334|NCT00446199|540645245|FG002|Overall Study|Non-compliant with visit schedule|1|||
149867335|NCT00446199|540645246|FG003|Overall Study|Non-compliant with visit schedule|2|||
149867336|NCT00446199|540645243|FG000|Overall Study|Hormone fear|0|||
149867337|NCT00446199|540645244|FG001|Overall Study|Hormone fear|0|||
149867338|NCT00446199|540645245|FG002|Overall Study|Hormone fear|0|||
149962384|NCT01093573|540995920|FG002|Overall Study|Insurance Denied|1|||
149962385|NCT00553475|540995921|FG000|Overall Study|Adverse Event|7|||
149962386|NCT00553475|540995922|FG001|Overall Study|Adverse Event|17|||
149867339|NCT00446199|540645246|FG003|Overall Study|Hormone fear|1|||
149867340|NCT00446199|540645243|FG000|Overall Study|Lost interest in study participation|0|||
149867341|NCT00446199|540645244|FG001|Overall Study|Lost interest in study participation|1|||
149867342|NCT00446199|540645245|FG002|Overall Study|Lost interest in study participation|0|||
149867343|NCT00446199|540645246|FG003|Overall Study|Lost interest in study participation|0|||
149867344|NCT00446199|540645243|FG000|Overall Study|In-/Exclusion criterion violated|2|||
149867345|NCT00446199|540645244|FG001|Overall Study|In-/Exclusion criterion violated|1|||
149867346|NCT00446199|540645245|FG002|Overall Study|In-/Exclusion criterion violated|2|||
149867347|NCT00446199|540645246|FG003|Overall Study|In-/Exclusion criterion violated|1|||
149867348|NCT00446199|540645243|FG000|Overall Study|Move|0|||
149867349|NCT00446199|540645244|FG001|Overall Study|Move|1|||
149867350|NCT00446199|540645245|FG002|Overall Study|Move|0|||
149867351|NCT00446199|540645246|FG003|Overall Study|Move|0|||
149867352|NCT06218823|540647381|FG000|Overall Study|Death|3|||
149867353|NCT06218823|540647382|FG001|Overall Study|Death|0|||
149867354|NCT06218823|540647381|FG000|Overall Study|Lost to Follow-up|0|||
149867355|NCT06218823|540647382|FG001|Overall Study|Lost to Follow-up|2|||
149867356|NCT06077487|540647383|FG000|Overall Study|Withdrawal by Subject|0|||
149867357|NCT06077487|540647384|FG001|Overall Study|Withdrawal by Subject|1|||
149867358|NCT04394351|540647385|FG000|Part A (16 Weeks)|Adverse Event|1|||
149867359|NCT04394351|540647386|FG001|Part A (16 Weeks)|Adverse Event|0|||
149867360|NCT04394351|540647387|FG002|Part A (16 Weeks)|Adverse Event|0|||
149867361|NCT04394351|540647388|FG003|Part A (16 Weeks)|Adverse Event|0|||
149867362|NCT04394351|540647389|FG004|Part A (16 Weeks)|Adverse Event|0|||
149867363|NCT04394351|540647390|FG005|Part A (16 Weeks)|Adverse Event|0|||
149867364|NCT04394351|540647391|FG006|Part A (16 Weeks)|Adverse Event|0|||
149867365|NCT04394351|540647392|FG007|Part A (16 Weeks)|Adverse Event|0|||
149867366|NCT04394351|540647385|FG000|Part A (16 Weeks)|Physician Decision|0|||
149867367|NCT04394351|540647386|FG001|Part A (16 Weeks)|Physician Decision|1|||
149867368|NCT04394351|540647387|FG002|Part A (16 Weeks)|Physician Decision|0|||
149867369|NCT04394351|540647388|FG003|Part A (16 Weeks)|Physician Decision|0|||
149867370|NCT04394351|540647389|FG004|Part A (16 Weeks)|Physician Decision|0|||
149867371|NCT04394351|540647390|FG005|Part A (16 Weeks)|Physician Decision|0|||
149867372|NCT04394351|540647391|FG006|Part A (16 Weeks)|Physician Decision|0|||
149867373|NCT04394351|540647392|FG007|Part A (16 Weeks)|Physician Decision|0|||
149867374|NCT04394351|540647385|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867375|NCT04394351|540647386|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
149867376|NCT04394351|540647387|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867377|NCT04394351|540647388|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867378|NCT04394351|540647389|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
150040849|NCT00790842|541289116|FG002|Expansion Cohort|Study Closure|1|||
149867379|NCT04394351|540647390|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867380|NCT04394351|540647391|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867381|NCT04394351|540647392|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
149867382|NCT04394351|540647385|FG000|Part B (36 Weeks)|Adverse Event|0|||
149867383|NCT04394351|540647386|FG001|Part B (36 Weeks)|Adverse Event|0|||
149867384|NCT04394351|540647387|FG002|Part B (36 Weeks)|Adverse Event|0|||
149867385|NCT04394351|540647388|FG003|Part B (36 Weeks)|Adverse Event|0|||
149867386|NCT04394351|540647389|FG004|Part B (36 Weeks)|Adverse Event|0|||
149867387|NCT04394351|540647390|FG005|Part B (36 Weeks)|Adverse Event|0|||
149867388|NCT04394351|540647391|FG006|Part B (36 Weeks)|Adverse Event|1|||
149867389|NCT04394351|540647392|FG007|Part B (36 Weeks)|Adverse Event|0|||
149867390|NCT04394351|540647385|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867391|NCT04394351|540647386|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867392|NCT04394351|540647387|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867393|NCT04394351|540647388|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867394|NCT04394351|540647389|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867395|NCT04394351|540647390|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867396|NCT04394351|540647391|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
149867397|NCT04394351|540647392|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
149867398|NCT04394351|540647385|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867399|NCT04394351|540647386|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867400|NCT04394351|540647387|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867401|NCT04394351|540647388|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867402|NCT04394351|540647389|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867403|NCT04394351|540647390|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867404|NCT04394351|540647391|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
149867405|NCT04394351|540647392|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
149867406|NCT04394351|540647385|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867407|NCT04394351|540647386|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867408|NCT04394351|540647387|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867409|NCT04394351|540647388|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867410|NCT04394351|540647389|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867411|NCT04394351|540647390|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867412|NCT04394351|540647391|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
149867413|NCT04394351|540647392|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
149867414|NCT04394351|540647385|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867415|NCT04394351|540647386|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867416|NCT04394351|540647387|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867417|NCT04394351|540647388|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867418|NCT04394351|540647389|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867419|NCT04394351|540647390|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867420|NCT04394351|540647391|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
149867421|NCT04394351|540647392|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
149867422|NCT01288053|540647393|FG000|Overall Study|Death|1|||
149867423|NCT03188666|540647394|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
149867424|NCT03188666|540647395|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
149867425|NCT03188666|540647396|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
149867426|NCT03188666|540647397|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
149867427|NCT03188666|540647394|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
149867428|NCT03188666|540647395|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
149867429|NCT03188666|540647396|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
149867430|NCT03188666|540647397|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
149867431|NCT03188666|540647394|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
149867432|NCT03188666|540647395|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
149867433|NCT03188666|540647396|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
149867434|NCT03188666|540647397|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
149867435|NCT03188666|540647394|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
149867436|NCT03188666|540647395|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
149867437|NCT03188666|540647396|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
149867438|NCT03188666|540647397|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
149867439|NCT02068092|540647398|FG000|Overall Study|Physician Decision|2|||
149867440|NCT02068092|540647398|FG000|Overall Study|Adverse Event|2|||
149867441|NCT02068092|540647398|FG000|Overall Study|Lost to Follow-up|4|||
149867442|NCT02068092|540647398|FG000|Overall Study|Withdrawal by Subject|2|||
149867443|NCT02799095|540647399|FG000|Part A|Adverse Event|1|||
149867444|NCT02799095|540647400|FG001|Part A|Adverse Event|0|||
149867445|NCT02799095|540647401|FG002|Part A|Adverse Event|1|||
149867446|NCT02799095|540647402|FG003|Part A|Adverse Event|4|||
149867447|NCT02799095|540647403|FG004|Part A|Adverse Event|1|||
149867448|NCT02799095|540647404|FG005|Part A|Adverse Event|0|||
149867449|NCT02799095|540647405|FG006|Part A|Adverse Event|0|||
149867450|NCT02799095|540647406|FG007|Part A|Adverse Event|0|||
149867451|NCT02799095|540647407|FG008|Part A|Adverse Event|0|||
149867452|NCT02799095|540647408|FG009|Part A|Adverse Event|0|||
149867453|NCT02799095|540647409|FG010|Part A|Adverse Event|0|||
149867454|NCT02799095|540647410|FG011|Part A|Adverse Event|0|||
149867455|NCT02799095|540647411|FG012|Part A|Adverse Event|0|||
149867456|NCT02799095|540647412|FG013|Part A|Adverse Event|0|||
149867457|NCT02799095|540647413|FG014|Part A|Adverse Event|0|||
149867458|NCT02799095|540647414|FG015|Part A|Adverse Event|0|||
149867459|NCT02799095|540647415|FG016|Part A|Adverse Event|0|||
149867460|NCT02799095|540647399|FG000|Part A|Death|0|||
149867461|NCT02799095|540647400|FG001|Part A|Death|0|||
149867462|NCT02799095|540647401|FG002|Part A|Death|0|||
149867463|NCT02799095|540647402|FG003|Part A|Death|0|||
149867464|NCT02799095|540647403|FG004|Part A|Death|0|||
149867465|NCT02799095|540647404|FG005|Part A|Death|0|||
149867466|NCT02799095|540647405|FG006|Part A|Death|3|||
149867467|NCT02799095|540647406|FG007|Part A|Death|0|||
149867468|NCT02799095|540647407|FG008|Part A|Death|0|||
149867469|NCT02799095|540647408|FG009|Part A|Death|0|||
149867470|NCT02799095|540647409|FG010|Part A|Death|0|||
149867471|NCT02799095|540647410|FG011|Part A|Death|0|||
149867472|NCT02799095|540647411|FG012|Part A|Death|0|||
149867473|NCT02799095|540647412|FG013|Part A|Death|0|||
149867474|NCT02799095|540647413|FG014|Part A|Death|0|||
149867475|NCT02799095|540647414|FG015|Part A|Death|0|||
149867476|NCT02799095|540647415|FG016|Part A|Death|0|||
149867477|NCT02799095|540647399|FG000|Part A|Lost to Follow-up|0|||
149867478|NCT02799095|540647400|FG001|Part A|Lost to Follow-up|1|||
149867479|NCT02799095|540647401|FG002|Part A|Lost to Follow-up|0|||
149867480|NCT02799095|540647402|FG003|Part A|Lost to Follow-up|0|||
149867481|NCT02799095|540647403|FG004|Part A|Lost to Follow-up|0|||
149867482|NCT02799095|540647404|FG005|Part A|Lost to Follow-up|0|||
149867483|NCT02799095|540647405|FG006|Part A|Lost to Follow-up|1|||
149867484|NCT02799095|540647406|FG007|Part A|Lost to Follow-up|0|||
149867485|NCT02799095|540647407|FG008|Part A|Lost to Follow-up|0|||
149867486|NCT02799095|540647408|FG009|Part A|Lost to Follow-up|0|||
149867487|NCT02799095|540647409|FG010|Part A|Lost to Follow-up|0|||
149867488|NCT02799095|540647410|FG011|Part A|Lost to Follow-up|0|||
149867489|NCT02799095|540647411|FG012|Part A|Lost to Follow-up|0|||
149867490|NCT02799095|540647412|FG013|Part A|Lost to Follow-up|0|||
149867491|NCT02799095|540647413|FG014|Part A|Lost to Follow-up|0|||
149867492|NCT02799095|540647414|FG015|Part A|Lost to Follow-up|0|||
149867493|NCT02799095|540647415|FG016|Part A|Lost to Follow-up|0|||
149867494|NCT02799095|540647399|FG000|Part A|Progressive Disease|3|||
149867495|NCT02799095|540647400|FG001|Part A|Progressive Disease|3|||
149867496|NCT02799095|540647401|FG002|Part A|Progressive Disease|3|||
149867497|NCT02799095|540647402|FG003|Part A|Progressive Disease|2|||
149867498|NCT02799095|540647403|FG004|Part A|Progressive Disease|2|||
149867499|NCT02799095|540647404|FG005|Part A|Progressive Disease|0|||
149867500|NCT02799095|540647405|FG006|Part A|Progressive Disease|0|||
149867501|NCT02799095|540647406|FG007|Part A|Progressive Disease|0|||
149867502|NCT02799095|540647407|FG008|Part A|Progressive Disease|0|||
149867503|NCT02799095|540647408|FG009|Part A|Progressive Disease|0|||
149867504|NCT02799095|540647409|FG010|Part A|Progressive Disease|0|||
149867505|NCT02799095|540647410|FG011|Part A|Progressive Disease|0|||
149867506|NCT02799095|540647411|FG012|Part A|Progressive Disease|0|||
149867507|NCT02799095|540647412|FG013|Part A|Progressive Disease|0|||
149867508|NCT02799095|540647413|FG014|Part A|Progressive Disease|0|||
149867509|NCT02799095|540647414|FG015|Part A|Progressive Disease|0|||
149867510|NCT02799095|540647415|FG016|Part A|Progressive Disease|0|||
149867511|NCT02799095|540647399|FG000|Part A|Clinical Progression|1|||
149867512|NCT02799095|540647400|FG001|Part A|Clinical Progression|0|||
149867513|NCT02799095|540647401|FG002|Part A|Clinical Progression|2|||
149867514|NCT02799095|540647402|FG003|Part A|Clinical Progression|1|||
149867515|NCT02799095|540647403|FG004|Part A|Clinical Progression|5|||
149867516|NCT02799095|540647404|FG005|Part A|Clinical Progression|0|||
149867517|NCT02799095|540647405|FG006|Part A|Clinical Progression|0|||
149867518|NCT02799095|540647406|FG007|Part A|Clinical Progression|0|||
150040850|NCT00790842|541289117|FG003|Expansion Cohort|Study Closure|0|||
149867519|NCT02799095|540647407|FG008|Part A|Clinical Progression|0|||
149867520|NCT02799095|540647408|FG009|Part A|Clinical Progression|0|||
149867521|NCT02799095|540647409|FG010|Part A|Clinical Progression|0|||
149867522|NCT02799095|540647410|FG011|Part A|Clinical Progression|0|||
149867523|NCT02799095|540647411|FG012|Part A|Clinical Progression|0|||
149867524|NCT02799095|540647412|FG013|Part A|Clinical Progression|0|||
149867525|NCT02799095|540647413|FG014|Part A|Clinical Progression|0|||
149867526|NCT02799095|540647414|FG015|Part A|Clinical Progression|0|||
149867527|NCT02799095|540647415|FG016|Part A|Clinical Progression|0|||
149867528|NCT02799095|540647399|FG000|Part A|Protocol Deviation|0|||
149867529|NCT02799095|540647400|FG001|Part A|Protocol Deviation|0|||
149867530|NCT02799095|540647401|FG002|Part A|Protocol Deviation|1|||
149867531|NCT02799095|540647402|FG003|Part A|Protocol Deviation|0|||
149867532|NCT02799095|540647403|FG004|Part A|Protocol Deviation|0|||
149867533|NCT02799095|540647404|FG005|Part A|Protocol Deviation|0|||
149867534|NCT02799095|540647405|FG006|Part A|Protocol Deviation|0|||
149867535|NCT02799095|540647406|FG007|Part A|Protocol Deviation|0|||
149867536|NCT02799095|540647407|FG008|Part A|Protocol Deviation|0|||
149867537|NCT02799095|540647408|FG009|Part A|Protocol Deviation|0|||
149867538|NCT02799095|540647409|FG010|Part A|Protocol Deviation|0|||
149867539|NCT02799095|540647410|FG011|Part A|Protocol Deviation|0|||
149867540|NCT02799095|540647411|FG012|Part A|Protocol Deviation|0|||
149867541|NCT02799095|540647412|FG013|Part A|Protocol Deviation|0|||
149867542|NCT02799095|540647413|FG014|Part A|Protocol Deviation|0|||
149867543|NCT02799095|540647414|FG015|Part A|Protocol Deviation|0|||
149867544|NCT02799095|540647415|FG016|Part A|Protocol Deviation|0|||
149867545|NCT02799095|540647399|FG000|Part A|Withdrawal by Subject|0|||
149867546|NCT02799095|540647400|FG001|Part A|Withdrawal by Subject|0|||
149867547|NCT02799095|540647401|FG002|Part A|Withdrawal by Subject|0|||
149867548|NCT02799095|540647402|FG003|Part A|Withdrawal by Subject|1|||
149867549|NCT02799095|540647403|FG004|Part A|Withdrawal by Subject|3|||
149867550|NCT02799095|540647404|FG005|Part A|Withdrawal by Subject|1|||
149867551|NCT02799095|540647405|FG006|Part A|Withdrawal by Subject|1|||
149867552|NCT02799095|540647406|FG007|Part A|Withdrawal by Subject|0|||
149867553|NCT02799095|540647407|FG008|Part A|Withdrawal by Subject|0|||
149867554|NCT02799095|540647408|FG009|Part A|Withdrawal by Subject|0|||
149867555|NCT02799095|540647409|FG010|Part A|Withdrawal by Subject|0|||
149867556|NCT02799095|540647410|FG011|Part A|Withdrawal by Subject|0|||
149867557|NCT02799095|540647411|FG012|Part A|Withdrawal by Subject|0|||
149867558|NCT02799095|540647412|FG013|Part A|Withdrawal by Subject|0|||
149867559|NCT02799095|540647413|FG014|Part A|Withdrawal by Subject|0|||
149867560|NCT02799095|540647414|FG015|Part A|Withdrawal by Subject|0|||
149867561|NCT02799095|540647415|FG016|Part A|Withdrawal by Subject|0|||
149867562|NCT02799095|540647399|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
149867563|NCT02799095|540647400|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
149867564|NCT02799095|540647401|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
149867565|NCT02799095|540647402|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
149867566|NCT02799095|540647403|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
149867567|NCT02799095|540647404|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
149867568|NCT02799095|540647405|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
149867569|NCT02799095|540647406|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
149867570|NCT02799095|540647407|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
149867571|NCT02799095|540647408|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
149867572|NCT02799095|540647409|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
149867573|NCT02799095|540647410|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
150173870|NCT03460756|541772981|FG000|Overall Study|Withdrawal by Subject|0|||
150173871|NCT03460756|541772982|FG001|Overall Study|Withdrawal by Subject|4|||
150173872|NCT03460756|541772983|FG002|Overall Study|Withdrawal by Subject|7|||
149867574|NCT02799095|540647411|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
149867575|NCT02799095|540647412|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
149867576|NCT02799095|540647413|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
149867577|NCT02799095|540647414|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
149867578|NCT02799095|540647415|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
149867579|NCT02799095|540647399|FG000|Part B|Death|0|||
149867580|NCT02799095|540647400|FG001|Part B|Death|0|||
149867581|NCT02799095|540647401|FG002|Part B|Death|0|||
149867582|NCT02799095|540647402|FG003|Part B|Death|0|||
149867583|NCT02799095|540647403|FG004|Part B|Death|0|||
149867584|NCT02799095|540647404|FG005|Part B|Death|0|||
149867585|NCT02799095|540647405|FG006|Part B|Death|0|||
149867586|NCT02799095|540647406|FG007|Part B|Death|7|||
149867587|NCT02799095|540647407|FG008|Part B|Death|7|||
149867588|NCT02799095|540647408|FG009|Part B|Death|0|||
149867589|NCT02799095|540647409|FG010|Part B|Death|0|||
149867590|NCT02799095|540647410|FG011|Part B|Death|0|||
149867591|NCT02799095|540647411|FG012|Part B|Death|0|||
149867592|NCT02799095|540647412|FG013|Part B|Death|0|||
149867593|NCT02799095|540647413|FG014|Part B|Death|0|||
149867594|NCT02799095|540647414|FG015|Part B|Death|0|||
149867595|NCT02799095|540647415|FG016|Part B|Death|0|||
149867596|NCT02799095|540647399|FG000|Part B|Progressive Disease|0|||
149867597|NCT02799095|540647400|FG001|Part B|Progressive Disease|0|||
149867598|NCT02799095|540647401|FG002|Part B|Progressive Disease|0|||
149867599|NCT02799095|540647402|FG003|Part B|Progressive Disease|0|||
149867600|NCT02799095|540647403|FG004|Part B|Progressive Disease|0|||
149867601|NCT02799095|540647404|FG005|Part B|Progressive Disease|0|||
149867602|NCT02799095|540647405|FG006|Part B|Progressive Disease|0|||
149867603|NCT02799095|540647406|FG007|Part B|Progressive Disease|1|||
149867604|NCT02799095|540647407|FG008|Part B|Progressive Disease|0|||
149867605|NCT02799095|540647408|FG009|Part B|Progressive Disease|0|||
149867606|NCT02799095|540647409|FG010|Part B|Progressive Disease|0|||
149867607|NCT02799095|540647410|FG011|Part B|Progressive Disease|0|||
149867608|NCT02799095|540647411|FG012|Part B|Progressive Disease|0|||
149867609|NCT02799095|540647412|FG013|Part B|Progressive Disease|0|||
149867610|NCT02799095|540647413|FG014|Part B|Progressive Disease|0|||
149867611|NCT02799095|540647414|FG015|Part B|Progressive Disease|0|||
149867612|NCT02799095|540647415|FG016|Part B|Progressive Disease|0|||
149867613|NCT02799095|540647399|FG000|Part B|Withdrawal by Subject|0|||
149867614|NCT02799095|540647400|FG001|Part B|Withdrawal by Subject|0|||
149867615|NCT02799095|540647401|FG002|Part B|Withdrawal by Subject|0|||
149867616|NCT02799095|540647402|FG003|Part B|Withdrawal by Subject|0|||
149867617|NCT02799095|540647403|FG004|Part B|Withdrawal by Subject|0|||
149867618|NCT02799095|540647404|FG005|Part B|Withdrawal by Subject|0|||
149867619|NCT02799095|540647405|FG006|Part B|Withdrawal by Subject|0|||
149867620|NCT02799095|540647406|FG007|Part B|Withdrawal by Subject|10|||
149867621|NCT02799095|540647407|FG008|Part B|Withdrawal by Subject|7|||
149867622|NCT02799095|540647408|FG009|Part B|Withdrawal by Subject|0|||
149867623|NCT02799095|540647409|FG010|Part B|Withdrawal by Subject|0|||
149867624|NCT02799095|540647410|FG011|Part B|Withdrawal by Subject|0|||
149867625|NCT02799095|540647411|FG012|Part B|Withdrawal by Subject|0|||
149867626|NCT02799095|540647412|FG013|Part B|Withdrawal by Subject|0|||
149867627|NCT02799095|540647413|FG014|Part B|Withdrawal by Subject|0|||
149867628|NCT02799095|540647414|FG015|Part B|Withdrawal by Subject|0|||
149867629|NCT02799095|540647415|FG016|Part B|Withdrawal by Subject|0|||
149867630|NCT02799095|540647399|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
149867631|NCT02799095|540647400|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
149867632|NCT02799095|540647401|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
149867633|NCT02799095|540647402|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
149867634|NCT02799095|540647403|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
149867635|NCT02799095|540647404|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
149867636|NCT02799095|540647405|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
149867637|NCT02799095|540647406|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
149867638|NCT02799095|540647407|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
149867639|NCT02799095|540647408|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
150173873|NCT03460756|541772984|FG003|Overall Study|Withdrawal by Subject|3|||
149867640|NCT02799095|540647409|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
149867641|NCT02799095|540647410|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
149867642|NCT02799095|540647411|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
149867643|NCT02799095|540647412|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
149867644|NCT02799095|540647413|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
149867645|NCT02799095|540647414|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
149867646|NCT02799095|540647415|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
149867647|NCT02799095|540647399|FG000|Part C|Adverse Event|0|||
149867648|NCT02799095|540647400|FG001|Part C|Adverse Event|0|||
149867649|NCT02799095|540647401|FG002|Part C|Adverse Event|0|||
149867650|NCT02799095|540647402|FG003|Part C|Adverse Event|0|||
149867651|NCT02799095|540647403|FG004|Part C|Adverse Event|0|||
149867652|NCT02799095|540647404|FG005|Part C|Adverse Event|0|||
149867653|NCT02799095|540647405|FG006|Part C|Adverse Event|0|||
149867654|NCT02799095|540647406|FG007|Part C|Adverse Event|0|||
149867655|NCT02799095|540647407|FG008|Part C|Adverse Event|0|||
149867656|NCT02799095|540647408|FG009|Part C|Adverse Event|0|||
149867657|NCT02799095|540647409|FG010|Part C|Adverse Event|3|||
149867658|NCT02799095|540647410|FG011|Part C|Adverse Event|1|||
149867659|NCT02799095|540647411|FG012|Part C|Adverse Event|0|||
149867660|NCT02799095|540647412|FG013|Part C|Adverse Event|1|||
149867661|NCT02799095|540647413|FG014|Part C|Adverse Event|0|||
149867662|NCT02799095|540647414|FG015|Part C|Adverse Event|0|||
149867663|NCT02799095|540647415|FG016|Part C|Adverse Event|0|||
149867664|NCT02799095|540647399|FG000|Part C|Death|0|||
149867665|NCT02799095|540647400|FG001|Part C|Death|0|||
149867666|NCT02799095|540647401|FG002|Part C|Death|0|||
149867667|NCT02799095|540647402|FG003|Part C|Death|0|||
149867668|NCT02799095|540647403|FG004|Part C|Death|0|||
149867669|NCT02799095|540647404|FG005|Part C|Death|0|||
149867670|NCT02799095|540647405|FG006|Part C|Death|0|||
149867671|NCT02799095|540647406|FG007|Part C|Death|0|||
149867672|NCT02799095|540647407|FG008|Part C|Death|0|||
149867673|NCT02799095|540647408|FG009|Part C|Death|0|||
149867674|NCT02799095|540647409|FG010|Part C|Death|7|||
149867675|NCT02799095|540647410|FG011|Part C|Death|5|||
149867676|NCT02799095|540647411|FG012|Part C|Death|6|||
149867677|NCT02799095|540647412|FG013|Part C|Death|8|||
149867678|NCT02799095|540647413|FG014|Part C|Death|1|||
149867679|NCT02799095|540647414|FG015|Part C|Death|8|||
149867680|NCT02799095|540647415|FG016|Part C|Death|1|||
149867681|NCT02799095|540647399|FG000|Part C|Lost to Follow-up|0|||
149867682|NCT02799095|540647400|FG001|Part C|Lost to Follow-up|0|||
149867683|NCT02799095|540647401|FG002|Part C|Lost to Follow-up|0|||
149867684|NCT02799095|540647402|FG003|Part C|Lost to Follow-up|0|||
149867685|NCT02799095|540647403|FG004|Part C|Lost to Follow-up|0|||
149867686|NCT02799095|540647404|FG005|Part C|Lost to Follow-up|0|||
149867687|NCT02799095|540647405|FG006|Part C|Lost to Follow-up|0|||
149867688|NCT02799095|540647406|FG007|Part C|Lost to Follow-up|0|||
149867689|NCT02799095|540647407|FG008|Part C|Lost to Follow-up|0|||
149867690|NCT02799095|540647408|FG009|Part C|Lost to Follow-up|0|||
149867691|NCT02799095|540647409|FG010|Part C|Lost to Follow-up|1|||
149867692|NCT02799095|540647410|FG011|Part C|Lost to Follow-up|1|||
149867693|NCT02799095|540647411|FG012|Part C|Lost to Follow-up|1|||
149867694|NCT02799095|540647412|FG013|Part C|Lost to Follow-up|3|||
150173874|NCT03946670|541772991|FG000|Overall Study|Progressive Disease|34|||
149867695|NCT02799095|540647413|FG014|Part C|Lost to Follow-up|0|||
149867696|NCT02799095|540647414|FG015|Part C|Lost to Follow-up|0|||
149867697|NCT02799095|540647415|FG016|Part C|Lost to Follow-up|0|||
149867698|NCT02799095|540647399|FG000|Part C|Progressive Disease|0|||
149867699|NCT02799095|540647400|FG001|Part C|Progressive Disease|0|||
149867700|NCT02799095|540647401|FG002|Part C|Progressive Disease|0|||
149867701|NCT02799095|540647402|FG003|Part C|Progressive Disease|0|||
149867702|NCT02799095|540647403|FG004|Part C|Progressive Disease|0|||
149867703|NCT02799095|540647404|FG005|Part C|Progressive Disease|0|||
149867704|NCT02799095|540647405|FG006|Part C|Progressive Disease|0|||
149867705|NCT02799095|540647406|FG007|Part C|Progressive Disease|0|||
149867706|NCT02799095|540647407|FG008|Part C|Progressive Disease|0|||
149867707|NCT02799095|540647408|FG009|Part C|Progressive Disease|2|||
149867708|NCT02799095|540647409|FG010|Part C|Progressive Disease|13|||
149867709|NCT02799095|540647410|FG011|Part C|Progressive Disease|2|||
149867710|NCT02799095|540647411|FG012|Part C|Progressive Disease|0|||
149867711|NCT02799095|540647412|FG013|Part C|Progressive Disease|1|||
149867712|NCT02799095|540647413|FG014|Part C|Progressive Disease|0|||
149867713|NCT02799095|540647414|FG015|Part C|Progressive Disease|0|||
149867714|NCT02799095|540647415|FG016|Part C|Progressive Disease|0|||
149867715|NCT02799095|540647399|FG000|Part C|Clinical Progression|0|||
149867716|NCT02799095|540647400|FG001|Part C|Clinical Progression|0|||
149867717|NCT02799095|540647401|FG002|Part C|Clinical Progression|0|||
149867718|NCT02799095|540647402|FG003|Part C|Clinical Progression|0|||
149867719|NCT02799095|540647403|FG004|Part C|Clinical Progression|0|||
149867720|NCT02799095|540647404|FG005|Part C|Clinical Progression|0|||
149867721|NCT02799095|540647405|FG006|Part C|Clinical Progression|0|||
149867722|NCT02799095|540647406|FG007|Part C|Clinical Progression|0|||
149867723|NCT02799095|540647407|FG008|Part C|Clinical Progression|0|||
149867724|NCT02799095|540647408|FG009|Part C|Clinical Progression|1|||
149867725|NCT02799095|540647409|FG010|Part C|Clinical Progression|3|||
149867726|NCT02799095|540647410|FG011|Part C|Clinical Progression|0|||
149867727|NCT02799095|540647411|FG012|Part C|Clinical Progression|0|||
149867728|NCT02799095|540647412|FG013|Part C|Clinical Progression|1|||
149867729|NCT02799095|540647413|FG014|Part C|Clinical Progression|0|||
149867730|NCT02799095|540647414|FG015|Part C|Clinical Progression|0|||
149867731|NCT02799095|540647415|FG016|Part C|Clinical Progression|0|||
149867732|NCT02799095|540647399|FG000|Part C|Withdrawal by Subject|0|||
149867733|NCT02799095|540647400|FG001|Part C|Withdrawal by Subject|0|||
149867734|NCT02799095|540647401|FG002|Part C|Withdrawal by Subject|0|||
149867735|NCT02799095|540647402|FG003|Part C|Withdrawal by Subject|0|||
149867736|NCT02799095|540647403|FG004|Part C|Withdrawal by Subject|0|||
149867737|NCT02799095|540647404|FG005|Part C|Withdrawal by Subject|0|||
149867738|NCT02799095|540647405|FG006|Part C|Withdrawal by Subject|0|||
149867739|NCT02799095|540647406|FG007|Part C|Withdrawal by Subject|0|||
149867740|NCT02799095|540647407|FG008|Part C|Withdrawal by Subject|0|||
149867741|NCT02799095|540647408|FG009|Part C|Withdrawal by Subject|0|||
149867742|NCT02799095|540647409|FG010|Part C|Withdrawal by Subject|13|||
149867743|NCT02799095|540647410|FG011|Part C|Withdrawal by Subject|15|||
149867744|NCT02799095|540647411|FG012|Part C|Withdrawal by Subject|13|||
149867745|NCT02799095|540647412|FG013|Part C|Withdrawal by Subject|21|||
149867746|NCT02799095|540647413|FG014|Part C|Withdrawal by Subject|0|||
149867747|NCT02799095|540647414|FG015|Part C|Withdrawal by Subject|12|||
149867748|NCT02799095|540647415|FG016|Part C|Withdrawal by Subject|1|||
149867749|NCT02799095|540647399|FG000|Part C|Physician Decision|0|||
149867750|NCT02799095|540647400|FG001|Part C|Physician Decision|0|||
149867751|NCT02799095|540647401|FG002|Part C|Physician Decision|0|||
149867752|NCT02799095|540647402|FG003|Part C|Physician Decision|0|||
149867753|NCT02799095|540647403|FG004|Part C|Physician Decision|0|||
149867754|NCT02799095|540647404|FG005|Part C|Physician Decision|0|||
149867755|NCT02799095|540647405|FG006|Part C|Physician Decision|0|||
149867756|NCT02799095|540647406|FG007|Part C|Physician Decision|0|||
149867757|NCT02799095|540647407|FG008|Part C|Physician Decision|0|||
149867758|NCT02799095|540647408|FG009|Part C|Physician Decision|0|||
149867759|NCT02799095|540647409|FG010|Part C|Physician Decision|1|||
149867760|NCT02799095|540647410|FG011|Part C|Physician Decision|0|||
149867761|NCT02799095|540647411|FG012|Part C|Physician Decision|0|||
149867762|NCT02799095|540647412|FG013|Part C|Physician Decision|0|||
149867763|NCT02799095|540647413|FG014|Part C|Physician Decision|0|||
149867764|NCT02799095|540647414|FG015|Part C|Physician Decision|0|||
149867765|NCT02799095|540647415|FG016|Part C|Physician Decision|0|||
150040851|NCT00790842|541289118|FG004|Expansion Cohort|Study Closure|0|||
150040852|NCT00790842|541289119|FG005|Expansion Cohort|Study Closure|0|||
149867766|NCT02799095|540647399|FG000|Part C|Other|0|||
149867767|NCT02799095|540647400|FG001|Part C|Other|0|||
149867768|NCT02799095|540647401|FG002|Part C|Other|0|||
149867769|NCT02799095|540647402|FG003|Part C|Other|0|||
149867770|NCT02799095|540647403|FG004|Part C|Other|0|||
149867771|NCT02799095|540647404|FG005|Part C|Other|0|||
149867772|NCT02799095|540647405|FG006|Part C|Other|0|||
149867773|NCT02799095|540647406|FG007|Part C|Other|0|||
149867774|NCT02799095|540647407|FG008|Part C|Other|0|||
149867775|NCT02799095|540647408|FG009|Part C|Other|0|||
149867776|NCT02799095|540647409|FG010|Part C|Other|0|||
150040853|NCT00790842|541289120|FG006|Expansion Cohort|Study Closure|0|||
149867777|NCT02799095|540647410|FG011|Part C|Other|2|||
149867778|NCT02799095|540647411|FG012|Part C|Other|2|||
149867779|NCT02799095|540647412|FG013|Part C|Other|0|||
149867780|NCT02799095|540647413|FG014|Part C|Other|0|||
149867781|NCT02799095|540647414|FG015|Part C|Other|0|||
149867782|NCT02799095|540647415|FG016|Part C|Other|0|||
149867783|NCT01933113|540647416|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
149867784|NCT02297438|540647417|FG000|Overall Study|Death|79|||
149867785|NCT02297438|540647418|FG001|Overall Study|Death|86|||
149867786|NCT02297438|540647417|FG000|Overall Study|Lost to Follow-up|9|||
149867787|NCT02297438|540647418|FG001|Overall Study|Lost to Follow-up|7|||
149867788|NCT02297438|540647417|FG000|Overall Study|Withdrawal by Subject|7|||
149867789|NCT02297438|540647418|FG001|Overall Study|Withdrawal by Subject|0|||
150040854|NCT00790842|541289121|FG007|Expansion Cohort|Study Closure|0|||
149867790|NCT02297438|540647417|FG000|Overall Study|Other|9|||
149867791|NCT02297438|540647418|FG001|Overall Study|Other|5|||
149867792|NCT02297438|540647417|FG000|Overall Study|Ongoing|65|||
149867793|NCT02297438|540647418|FG001|Overall Study|Ongoing|73|||
149867794|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
149867795|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
149867796|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
149867797|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
149867798|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
149867799|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
149867800|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
149867801|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
149867802|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
149867803|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
149867804|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
149867805|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
149867806|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
149867807|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
149867808|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
149867809|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
149867810|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
149867811|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
149867812|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
149867813|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
149867814|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
149867815|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
149867816|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
149867817|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
149867818|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
149867819|NCT02935686|540647420|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
149867820|NCT02935686|540647421|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
149867821|NCT02935686|540647422|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
149867822|NCT02935686|540647423|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
149867823|NCT02935686|540647424|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
149867824|NCT02935686|540647420|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
149867825|NCT02935686|540647421|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
149867826|NCT02935686|540647422|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
149867827|NCT02935686|540647423|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
149867828|NCT02935686|540647424|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
149867829|NCT02935686|540647420|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
149867830|NCT02935686|540647421|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
149867831|NCT02935686|540647422|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
149867832|NCT02935686|540647423|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
149867833|NCT02935686|540647424|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
149867834|NCT02935686|540647420|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
149867835|NCT02935686|540647421|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
149867836|NCT02935686|540647422|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
149867837|NCT02935686|540647423|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
149867838|NCT02935686|540647424|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
149867839|NCT02935686|540647420|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
149867840|NCT02935686|540647421|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
149867841|NCT02935686|540647422|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
149867842|NCT02935686|540647423|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
149867843|NCT02935686|540647424|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
149867844|NCT02935686|540647420|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
149867845|NCT02935686|540647421|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
149867846|NCT02935686|540647422|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
149867847|NCT02935686|540647423|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
149867848|NCT02935686|540647424|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
149867849|NCT00759902|540647425|FG000|Overall Study|Adverse Event|0|||
149867850|NCT00759902|540647426|FG001|Overall Study|Adverse Event|1|||
149867851|NCT02128217|540647431|FG000|Overall Study|Lost to Follow-up|0|||
149867852|NCT02128217|540647432|FG001|Overall Study|Lost to Follow-up|1|||
149867853|NCT05071313|540647433|FG000|Overall Study|Lost to Follow-up|17|||
149867854|NCT05071313|540647434|FG001|Overall Study|Lost to Follow-up|10|||
149867855|NCT05071313|540647433|FG000|Overall Study|Physician Decision|1|||
149867856|NCT05071313|540647434|FG001|Overall Study|Physician Decision|6|||
149867857|NCT05071313|540647433|FG000|Overall Study|Death|1|||
149867858|NCT05071313|540647434|FG001|Overall Study|Death|0|||
149867859|NCT05071313|540647433|FG000|Overall Study|Withdrawal by Subject|10|||
149867860|NCT05071313|540647434|FG001|Overall Study|Withdrawal by Subject|15|||
149867861|NCT05071313|540647433|FG000|Overall Study|Other|1|||
149867862|NCT05071313|540647434|FG001|Overall Study|Other|0|||
149867863|NCT05071313|540647433|FG000|Overall Study|Randomized but not vaccinated|4|||
149867864|NCT05071313|540647434|FG001|Overall Study|Randomized but not vaccinated|2|||
149867865|NCT00210249|540647435|FG000|Overall Study|Lost to Follow-up|5|||
149867866|NCT00210249|540647435|FG000|Overall Study|Protocol Violation|11|||
149867867|NCT04280705|540647436|FG000|Overall Study|Enrolled but not treated|4|||
149867868|NCT04280705|540647437|FG001|Overall Study|Enrolled but not treated|10|||
149867869|NCT04280705|540647436|FG000|Overall Study|Physician Decision|1|||
149867870|NCT04280705|540647437|FG001|Overall Study|Physician Decision|0|||
149867871|NCT04280705|540647436|FG000|Overall Study|Withdrawal by Subject|7|||
149867872|NCT04280705|540647437|FG001|Overall Study|Withdrawal by Subject|9|||
149867873|NCT04280705|540647436|FG000|Overall Study|Adverse Event|0|||
149867874|NCT04280705|540647437|FG001|Overall Study|Adverse Event|4|||
149867875|NCT04280705|540647436|FG000|Overall Study|Transferred to another hospital|1|||
149867876|NCT04280705|540647437|FG001|Overall Study|Transferred to another hospital|1|||
149867877|NCT03222583|540647438|FG000|Overall Study|Withdrawal by Subject|3|||
149867878|NCT03222583|540647439|FG001|Overall Study|Withdrawal by Subject|3|||
149867879|NCT03222583|540647438|FG000|Overall Study|Lost to Follow-up|1|||
149867880|NCT03222583|540647439|FG001|Overall Study|Lost to Follow-up|0|||
149867881|NCT03222583|540647438|FG000|Overall Study|Other|1|||
149867882|NCT03222583|540647439|FG001|Overall Study|Other|3|||
149867883|NCT02049450|540647442|FG000|Overall Study|Adverse Event|2|||
149867884|NCT02049450|540647442|FG000|Overall Study|Withdrawal by Subject|1|||
149867885|NCT02049450|540647442|FG000|Overall Study|Patients/guardian decision|1|||
149867886|NCT00292188|540647446|FG000|Single-Blind|Adverse Event|14|||
149867887|NCT00292188|540647447|FG001|Single-Blind|Adverse Event|0|||
149867888|NCT00292188|540647448|FG002|Single-Blind|Adverse Event|0|||
149867889|NCT00292188|540647446|FG000|Single-Blind|Lack of Efficacy|2|||
149867890|NCT00292188|540647447|FG001|Single-Blind|Lack of Efficacy|0|||
149867891|NCT00292188|540647448|FG002|Single-Blind|Lack of Efficacy|0|||
149867892|NCT00292188|540647446|FG000|Single-Blind|Laboratory Abnormality|5|||
149867893|NCT00292188|540647447|FG001|Single-Blind|Laboratory Abnormality|0|||
149867894|NCT00292188|540647448|FG002|Single-Blind|Laboratory Abnormality|0|||
149867895|NCT00292188|540647446|FG000|Single-Blind|Lost to Follow-up|3|||
149867896|NCT00292188|540647447|FG001|Single-Blind|Lost to Follow-up|0|||
149867897|NCT00292188|540647448|FG002|Single-Blind|Lost to Follow-up|0|||
149867898|NCT00292188|540647446|FG000|Single-Blind|Other|77|||
149867899|NCT00292188|540647447|FG001|Single-Blind|Other|0|||
149867900|NCT00292188|540647448|FG002|Single-Blind|Other|0|||
149867901|NCT00292188|540647446|FG000|Single-Blind|Withdrawal by Subject|12|||
149867902|NCT00292188|540647447|FG001|Single-Blind|Withdrawal by Subject|0|||
149867903|NCT00292188|540647448|FG002|Single-Blind|Withdrawal by Subject|0|||
149867904|NCT00292188|540647446|FG000|Single-Blind|Did not receive treatment|1|||
149867905|NCT00292188|540647447|FG001|Single-Blind|Did not receive treatment|0|||
149867906|NCT00292188|540647448|FG002|Single-Blind|Did not receive treatment|0|||
149867907|NCT00292188|540647446|FG000|Double-Blind|Adverse Event|0|||
149867908|NCT00292188|540647447|FG001|Double-Blind|Adverse Event|25|||
149867909|NCT00292188|540647448|FG002|Double-Blind|Adverse Event|9|||
149867910|NCT00292188|540647446|FG000|Double-Blind|Lack of Efficacy|0|||
149867911|NCT00292188|540647447|FG001|Double-Blind|Lack of Efficacy|2|||
149867912|NCT00292188|540647448|FG002|Double-Blind|Lack of Efficacy|12|||
149867913|NCT00292188|540647446|FG000|Double-Blind|Lost to Follow-up|0|||
149867914|NCT00292188|540647447|FG001|Double-Blind|Lost to Follow-up|1|||
149867915|NCT00292188|540647448|FG002|Double-Blind|Lost to Follow-up|0|||
149867916|NCT00292188|540647446|FG000|Double-Blind|Other|0|||
149867917|NCT00292188|540647447|FG001|Double-Blind|Other|3|||
149867918|NCT00292188|540647448|FG002|Double-Blind|Other|4|||
150173875|NCT03946670|541772992|FG001|Overall Study|Progressive Disease|27|||
149867919|NCT00292188|540647446|FG000|Double-Blind|Withdrawal by Subject|0|||
149867920|NCT00292188|540647447|FG001|Double-Blind|Withdrawal by Subject|0|||
149867921|NCT00292188|540647448|FG002|Double-Blind|Withdrawal by Subject|3|||
149867922|NCT00292188|540647446|FG000|Double-Blind|Laboratory Abnormality|0|||
149867923|NCT00292188|540647447|FG001|Double-Blind|Laboratory Abnormality|0|||
149867924|NCT00292188|540647448|FG002|Double-Blind|Laboratory Abnormality|1|||
149867925|NCT04709835|540647449|FG000|Overall Study|Withdrawal by Subject|0|||
149867926|NCT04709835|540647450|FG001|Overall Study|Withdrawal by Subject|1|||
149867927|NCT04709835|540647451|FG002|Overall Study|Withdrawal by Subject|0|||
149867928|NCT00368979|540647453|FG000|Overall Study|Adverse Event|9|||
149867929|NCT00368979|540647454|FG001|Overall Study|Adverse Event|16|||
149867930|NCT00368979|540647453|FG000|Overall Study|Lack of Efficacy|5|||
149867931|NCT00368979|540647454|FG001|Overall Study|Lack of Efficacy|3|||
149867932|NCT00368979|540647453|FG000|Overall Study|Other|3|||
149867933|NCT00368979|540647454|FG001|Overall Study|Other|1|||
149867934|NCT00368979|540647453|FG000|Overall Study|Lost to Follow-up|1|||
149867935|NCT00368979|540647454|FG001|Overall Study|Lost to Follow-up|0|||
149867936|NCT00368979|540647453|FG000|Overall Study|Protocol Violation|2|||
149867937|NCT00368979|540647454|FG001|Overall Study|Protocol Violation|1|||
149867938|NCT00368979|540647453|FG000|Overall Study|Withdrawal by Subject|5|||
149867939|NCT00368979|540647454|FG001|Overall Study|Withdrawal by Subject|9|||
149867940|NCT00974974|540647455|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
149867941|NCT00974974|540647456|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
149867942|NCT00974974|540647455|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
149867943|NCT00974974|540647456|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
149867944|NCT00974974|540647455|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
149867945|NCT00974974|540647456|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
149867946|NCT00974974|540647455|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
149867947|NCT00974974|540647456|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
149867948|NCT00974974|540647455|FG000|IR CD-LD Dose Adjustment|Various|0|||
149867949|NCT00974974|540647456|FG001|IR CD-LD Dose Adjustment|Various|9|||
149867950|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Adverse Event|23|||
149867951|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Adverse Event|0|||
149867952|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Death|2|||
149867953|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Death|0|||
149867954|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
149867955|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
149867956|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
149867957|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
149867958|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Various|3|||
149867959|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Various|0|||
149867960|NCT00974974|540647455|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
149867961|NCT00974974|540647456|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
149867962|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
149867963|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
149867964|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
149867965|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
149867966|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
149867967|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
149867968|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
149867969|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
150173876|NCT03946670|541772991|FG000|Overall Study|Adverse Event|7|||
149867970|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
149867971|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
149867972|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
149962387|NCT00553475|540995923|FG002|Overall Study|Adverse Event|13|||
149867973|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
149867974|NCT00974974|540647455|FG000|Maintenance - Double Blind Treatment|Various|4|||
149867975|NCT00974974|540647456|FG001|Maintenance - Double Blind Treatment|Various|0|||
149867976|NCT01959035|540647457|FG000|Overall Study|Adverse Event|5|||
149867977|NCT01959035|540647457|FG000|Overall Study|Withdrawal by Subject|4|||
149867978|NCT01959035|540647457|FG000|Overall Study|Lost to Follow-up|1|||
149867979|NCT01959035|540647457|FG000|Overall Study|Other (no primary reason given)|1|||
149962388|NCT00553475|540995921|FG000|Overall Study|Lack of Efficacy|7|||
149962389|NCT00553475|540995922|FG001|Overall Study|Lack of Efficacy|1|||
150173877|NCT03946670|541772992|FG001|Overall Study|Adverse Event|10|||
149867980|NCT05183217|540647465|FG000|Overall Study|Withdrawal by Subject|1|||
149867981|NCT05183217|540647466|FG001|Overall Study|Withdrawal by Subject|1|||
149867982|NCT03412396|540647467|FG000|Overall Study|Withdrawal by Subject|2|||
149867983|NCT03412396|540647467|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
149867984|NCT03412396|540647467|FG000|Overall Study|Did not undergo RP|2|||
149867985|NCT00415194|540647473|FG000|Overall Study|Adverse Event|37|||
149867986|NCT00415194|540647474|FG001|Overall Study|Adverse Event|32|||
149867987|NCT00415194|540647473|FG000|Overall Study|Entry Criteria Not Met|4|||
149867988|NCT00415194|540647474|FG001|Overall Study|Entry Criteria Not Met|8|||
149867989|NCT00415194|540647473|FG000|Overall Study|Lost to Follow-up|1|||
149867990|NCT00415194|540647474|FG001|Overall Study|Lost to Follow-up|0|||
149867991|NCT00415194|540647473|FG000|Overall Study|Physician Decision|10|||
149867992|NCT00415194|540647474|FG001|Overall Study|Physician Decision|16|||
149867993|NCT00415194|540647473|FG000|Overall Study|Progressive Disease|180|||
149867994|NCT00415194|540647474|FG001|Overall Study|Progressive Disease|217|||
149867995|NCT00415194|540647473|FG000|Overall Study|Protocol Violation|4|||
149867996|NCT00415194|540647474|FG001|Overall Study|Protocol Violation|2|||
149867997|NCT00415194|540647473|FG000|Overall Study|Withdrawal by Subject|28|||
149867998|NCT00415194|540647474|FG001|Overall Study|Withdrawal by Subject|21|||
149867999|NCT00415194|540647473|FG000|Overall Study|Death Due to Study Disease|26|||
149868000|NCT00415194|540647474|FG001|Overall Study|Death Due to Study Disease|29|||
149868001|NCT00415194|540647473|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
149868002|NCT00415194|540647474|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
149868003|NCT00415194|540647473|FG000|Overall Study|Death Due to Procedural Related AE|0|||
149868004|NCT00415194|540647474|FG001|Overall Study|Death Due to Procedural Related AE|1|||
149868005|NCT00415194|540647473|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
149868006|NCT00415194|540647474|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
149868007|NCT01297465|540647475|FG000|Overall Study|Lack of Ovarian Response|1|||
149868008|NCT01297465|540647476|FG001|Overall Study|Lack of Ovarian Response|1|||
149868009|NCT01297465|540647475|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
149868010|NCT01297465|540647476|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149868011|NCT01297465|540647475|FG000|Overall Study|No Oocytes Retrieved|1|||
149868012|NCT01297465|540647476|FG001|Overall Study|No Oocytes Retrieved|1|||
149868013|NCT01297465|540647475|FG000|Overall Study|Poor oocyte quality|0|||
149868014|NCT01297465|540647476|FG001|Overall Study|Poor oocyte quality|1|||
149868015|NCT01297465|540647475|FG000|Overall Study|No Fertilization|6|||
149868016|NCT01297465|540647476|FG001|Overall Study|No Fertilization|4|||
149868017|NCT01297465|540647475|FG000|Overall Study|All Embryos Discarded|0|||
149868018|NCT01297465|540647476|FG001|Overall Study|All Embryos Discarded|1|||
149868019|NCT01297465|540647475|FG000|Overall Study|Intention to Freeze all Embryos|0|||
149868020|NCT01297465|540647476|FG001|Overall Study|Intention to Freeze all Embryos|1|||
149868021|NCT00969540|540647477|FG000|Overall Study|Lost to Follow-up|1|||
149868022|NCT00969540|540647478|FG001|Overall Study|Lost to Follow-up|1|||
149868023|NCT01259115|540647481|FG000|Period 1|Adverse Event|1|||
149868024|NCT01259115|540647482|FG001|Period 1|Adverse Event|0|||
149868025|NCT01259115|540647481|FG000|Period 1|Protocol Violation|2|||
149868026|NCT01259115|540647482|FG001|Period 1|Protocol Violation|0|||
149868027|NCT01259115|540647481|FG000|Period 1|Lost to Follow-up|0|||
149868028|NCT01259115|540647482|FG001|Period 1|Lost to Follow-up|1|||
149868029|NCT01259115|540647481|FG000|Period 2|Adverse Event|1|||
149868030|NCT01259115|540647482|FG001|Period 2|Adverse Event|0|||
149868031|NCT01971970|540647483|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
149868032|NCT01971970|540647484|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
149868033|NCT01971970|540647483|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
149868034|NCT01971970|540647484|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
149962390|NCT00553475|540995923|FG002|Overall Study|Lack of Efficacy|0|||
149962391|NCT00553475|540995921|FG000|Overall Study|Withdrawal by Subject|1|||
149962392|NCT00553475|540995922|FG001|Overall Study|Withdrawal by Subject|1|||
149962393|NCT00553475|540995923|FG002|Overall Study|Withdrawal by Subject|0|||
149868035|NCT01971970|540647483|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
149868036|NCT01971970|540647484|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
149868037|NCT01971970|540647483|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
149868038|NCT01971970|540647484|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
149868039|NCT01971970|540647483|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
149868040|NCT01971970|540647484|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
149868041|NCT01971970|540647483|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
149868042|NCT01971970|540647484|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
149868043|NCT01971970|540647483|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
149868044|NCT01971970|540647484|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
149962394|NCT00553475|540995921|FG000|Overall Study|Physician Decision|1|||
149868045|NCT00848107|540647485|FG000|Overall Study|Lost to Follow-up|2|||
149868046|NCT00848107|540647485|FG000|Overall Study|Withdrawal by Subject|8|||
149962395|NCT00553475|540995922|FG001|Overall Study|Physician Decision|0|||
149962396|NCT00553475|540995923|FG002|Overall Study|Physician Decision|0|||
149868047|NCT00848107|540647485|FG000|Overall Study|Adverse Event|9|||
149868048|NCT00848107|540647485|FG000|Overall Study|Death|1|||
149868049|NCT00848107|540647485|FG000|Overall Study|Pregnancy|1|||
149868050|NCT01460901|540647486|FG000|Overall Study|Withdrawal by Subject|2|||
149868051|NCT05297578|540647487|FG000|Overall Study|Lost to Follow-up|1|||
149868052|NCT05297578|540647488|FG001|Overall Study|Lost to Follow-up|1|||
149868053|NCT05297578|540647489|FG002|Overall Study|Lost to Follow-up|2|||
149868054|NCT05297578|540647490|FG003|Overall Study|Lost to Follow-up|1|||
149868055|NCT05297578|540647487|FG000|Overall Study|Death|0|||
149868056|NCT05297578|540647488|FG001|Overall Study|Death|1|||
149868057|NCT05297578|540647489|FG002|Overall Study|Death|0|||
149868058|NCT05297578|540647490|FG003|Overall Study|Death|0|||
149868059|NCT05297578|540647487|FG000|Overall Study|Withdrawal by Subject|0|||
149868060|NCT05297578|540647488|FG001|Overall Study|Withdrawal by Subject|0|||
149868061|NCT05297578|540647489|FG002|Overall Study|Withdrawal by Subject|1|||
149868062|NCT05297578|540647490|FG003|Overall Study|Withdrawal by Subject|0|||
149868063|NCT00117325|540647491|FG000|Overall Study|Adverse Event|3|||
149868064|NCT00117325|540647492|FG001|Overall Study|Adverse Event|3|||
149868065|NCT00117325|540647491|FG000|Overall Study|Lost to Follow-up|1|||
149868066|NCT00117325|540647492|FG001|Overall Study|Lost to Follow-up|1|||
149868067|NCT00117325|540647491|FG000|Overall Study|Protocol Violation|2|||
149868068|NCT00117325|540647492|FG001|Overall Study|Protocol Violation|3|||
149868069|NCT00117325|540647491|FG000|Overall Study|Withdrawal by Subject|3|||
149868070|NCT00117325|540647492|FG001|Overall Study|Withdrawal by Subject|2|||
149868071|NCT00117325|540647491|FG000|Overall Study|Lack of Efficacy|1|||
149868072|NCT00117325|540647492|FG001|Overall Study|Lack of Efficacy|0|||
149868073|NCT00117325|540647491|FG000|Overall Study|Use of prohibited medicine|1|||
149868074|NCT00117325|540647492|FG001|Overall Study|Use of prohibited medicine|2|||
149868075|NCT00117325|540647491|FG000|Overall Study|Early termination|1|||
149868076|NCT00117325|540647492|FG001|Overall Study|Early termination|1|||
149868077|NCT00117325|540647491|FG000|Overall Study|Admisnitrative|1|||
149868078|NCT00117325|540647492|FG001|Overall Study|Admisnitrative|0|||
149868079|NCT00895947|540647493|FG000|Overall Study|Adverse Event|3|||
149868080|NCT00895947|540647494|FG001|Overall Study|Adverse Event|4|||
149868081|NCT00895947|540647493|FG000|Overall Study|Lost to Follow-up|3|||
149868082|NCT00895947|540647494|FG001|Overall Study|Lost to Follow-up|4|||
149868083|NCT00895947|540647493|FG000|Overall Study|Protocol Violation|4|||
149868084|NCT00895947|540647494|FG001|Overall Study|Protocol Violation|2|||
149868085|NCT00895947|540647493|FG000|Overall Study|Withdrawal by Subject|2|||
149868086|NCT00895947|540647494|FG001|Overall Study|Withdrawal by Subject|0|||
149868087|NCT02266134|540647495|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
149868088|NCT02266134|540647496|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
149868089|NCT02266134|540647497|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
149868090|NCT02266134|540647498|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
149868091|NCT02266134|540647495|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
149868092|NCT02266134|540647496|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
149868093|NCT02266134|540647497|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
149868094|NCT02266134|540647498|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
149868095|NCT02266134|540647495|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
149868096|NCT02266134|540647496|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
149868097|NCT02266134|540647497|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
149868098|NCT02266134|540647498|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
149868099|NCT02266134|540647495|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
149868100|NCT02266134|540647496|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
149868101|NCT02266134|540647497|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
149868102|NCT02266134|540647498|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
149868103|NCT02266134|540647495|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
149868104|NCT02266134|540647496|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
149868105|NCT02266134|540647497|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
149868106|NCT02266134|540647498|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
149868107|NCT02266134|540647495|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
149868108|NCT02266134|540647496|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
149868109|NCT02266134|540647497|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
149868110|NCT02266134|540647498|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
149868111|NCT04647721|540647503|FG000|Overall Study|Withdrawal by Subject|0|||
149868112|NCT04647721|540647504|FG001|Overall Study|Withdrawal by Subject|2|||
149868113|NCT04647721|540647503|FG000|Overall Study|Lost to Follow-up|2|||
149868114|NCT04647721|540647504|FG001|Overall Study|Lost to Follow-up|0|||
149868115|NCT00857259|540647509|FG000|Overall Study|Protocol Violation|1|||
149868116|NCT00857259|540647510|FG001|Overall Study|Protocol Violation|0|||
149868117|NCT00857259|540647511|FG002|Overall Study|Protocol Violation|1|||
149868118|NCT02701413|540647512|FG000|Overall Study|Withdrawal by Subject|7|||
149868119|NCT02701413|540647513|FG001|Overall Study|Withdrawal by Subject|11|||
149868120|NCT02138136|540647514|FG000|Overall Study|Protocol Violation|4|||
149868121|NCT02138136|540647514|FG000|Overall Study|Physician Decision|7|||
149868122|NCT02138136|540647514|FG000|Overall Study|Lack of Efficacy|35|||
149868123|NCT02138136|540647514|FG000|Overall Study|Pregnancy|2|||
149868124|NCT02138136|540647514|FG000|Overall Study|Adverse Event|18|||
149868125|NCT02138136|540647514|FG000|Overall Study|Withdrawal by Subject|36|||
149868126|NCT02138136|540647514|FG000|Overall Study|Lost to Follow-up|32|||
149868127|NCT02138136|540647514|FG000|Overall Study|Withdrawn by Sponsor|5|||
149868128|NCT01359644|540647515|FG000|Treatment Period|Lack of Efficacy|0|||
149868129|NCT01359644|540647516|FG001|Treatment Period|Lack of Efficacy|1|||
149868130|NCT01359644|540647517|FG002|Treatment Period|Lack of Efficacy|0|||
149868131|NCT01359644|540647518|FG003|Treatment Period|Lack of Efficacy|0|||
149868132|NCT01359644|540647519|FG004|Treatment Period|Lack of Efficacy|0|||
149868133|NCT01359644|540647520|FG005|Treatment Period|Lack of Efficacy|0|||
149868134|NCT01359644|540647521|FG006|Treatment Period|Lack of Efficacy|0|||
149868135|NCT01359644|540647522|FG007|Treatment Period|Lack of Efficacy|0|||
149868136|NCT01359644|540647523|FG008|Treatment Period|Lack of Efficacy|0|||
149868137|NCT01359644|540647524|FG009|Treatment Period|Lack of Efficacy|0|||
149868138|NCT01359644|540647515|FG000|Treatment Period|Adverse Event|0|||
149868139|NCT01359644|540647516|FG001|Treatment Period|Adverse Event|0|||
149868140|NCT01359644|540647517|FG002|Treatment Period|Adverse Event|1|||
149868141|NCT01359644|540647518|FG003|Treatment Period|Adverse Event|0|||
149868142|NCT01359644|540647519|FG004|Treatment Period|Adverse Event|0|||
149868143|NCT01359644|540647520|FG005|Treatment Period|Adverse Event|1|||
149868144|NCT01359644|540647521|FG006|Treatment Period|Adverse Event|0|||
149868145|NCT01359644|540647522|FG007|Treatment Period|Adverse Event|0|||
149868146|NCT01359644|540647523|FG008|Treatment Period|Adverse Event|0|||
149868147|NCT01359644|540647524|FG009|Treatment Period|Adverse Event|0|||
149868148|NCT01359644|540647515|FG000|Treatment Period|Lost to Follow-up|0|||
149868149|NCT01359644|540647516|FG001|Treatment Period|Lost to Follow-up|0|||
149868150|NCT01359644|540647517|FG002|Treatment Period|Lost to Follow-up|0|||
149868151|NCT01359644|540647518|FG003|Treatment Period|Lost to Follow-up|0|||
149868152|NCT01359644|540647519|FG004|Treatment Period|Lost to Follow-up|0|||
149868153|NCT01359644|540647520|FG005|Treatment Period|Lost to Follow-up|1|||
149868154|NCT01359644|540647521|FG006|Treatment Period|Lost to Follow-up|0|||
149868155|NCT01359644|540647522|FG007|Treatment Period|Lost to Follow-up|0|||
149868156|NCT01359644|540647523|FG008|Treatment Period|Lost to Follow-up|0|||
149868157|NCT01359644|540647524|FG009|Treatment Period|Lost to Follow-up|0|||
149868158|NCT01359644|540647515|FG000|Follow-up Period|Withdrawal by Subject|0|||
149868159|NCT01359644|540647516|FG001|Follow-up Period|Withdrawal by Subject|0|||
149868160|NCT01359644|540647517|FG002|Follow-up Period|Withdrawal by Subject|0|||
149868161|NCT01359644|540647518|FG003|Follow-up Period|Withdrawal by Subject|0|||
149868162|NCT01359644|540647519|FG004|Follow-up Period|Withdrawal by Subject|0|||
149868163|NCT01359644|540647520|FG005|Follow-up Period|Withdrawal by Subject|1|||
149868164|NCT01359644|540647521|FG006|Follow-up Period|Withdrawal by Subject|0|||
149868165|NCT01359644|540647522|FG007|Follow-up Period|Withdrawal by Subject|0|||
149868166|NCT01359644|540647523|FG008|Follow-up Period|Withdrawal by Subject|0|||
149868167|NCT01359644|540647524|FG009|Follow-up Period|Withdrawal by Subject|0|||
149868168|NCT01359644|540647515|FG000|Follow-up Period|Lost to Follow-up|0|||
149868169|NCT01359644|540647516|FG001|Follow-up Period|Lost to Follow-up|0|||
149868170|NCT01359644|540647517|FG002|Follow-up Period|Lost to Follow-up|0|||
149868171|NCT01359644|540647518|FG003|Follow-up Period|Lost to Follow-up|0|||
149868172|NCT01359644|540647519|FG004|Follow-up Period|Lost to Follow-up|0|||
149868173|NCT01359644|540647520|FG005|Follow-up Period|Lost to Follow-up|0|||
149868174|NCT01359644|540647521|FG006|Follow-up Period|Lost to Follow-up|1|||
149868175|NCT01359644|540647522|FG007|Follow-up Period|Lost to Follow-up|2|||
149868176|NCT01359644|540647523|FG008|Follow-up Period|Lost to Follow-up|0|||
149868177|NCT01359644|540647524|FG009|Follow-up Period|Lost to Follow-up|0|||
149868178|NCT00311311|540647526|FG000|Overall Study|Adverse Event|3|||
149868179|NCT00311311|540647527|FG001|Overall Study|Adverse Event|2|||
149868180|NCT00311311|540647526|FG000|Overall Study|Withdrawal by Subject|1|||
149868181|NCT00311311|540647527|FG001|Overall Study|Withdrawal by Subject|1|||
149868182|NCT00311311|540647526|FG000|Overall Study|Noncompliance|0|||
149868183|NCT00311311|540647527|FG001|Overall Study|Noncompliance|1|||
149868184|NCT00311311|540647526|FG000|Overall Study|Study Termination by Sponsor|3|||
149868185|NCT00311311|540647527|FG001|Overall Study|Study Termination by Sponsor|4|||
149868186|NCT00311311|540647526|FG000|Overall Study|Death|1|||
149868187|NCT00311311|540647527|FG001|Overall Study|Death|0|||
149868188|NCT00311311|540647526|FG000|Overall Study|Lack of ancillary assistance|0|||
149868189|NCT00311311|540647527|FG001|Overall Study|Lack of ancillary assistance|1|||
149868190|NCT02685202|540647528|FG000|Overall Study|Lost to Follow-up|9|||
150040855|NCT00790842|541289122|FG008|Expansion Cohort|Study Closure|0|||
149868191|NCT02615171|540647533|FG000|Overall Study|Lost to Follow-up|2|||
149868192|NCT02615171|540647534|FG001|Overall Study|Lost to Follow-up|1|||
149868193|NCT00741936|540647545|FG000|Overall Study|Lost to Follow-up|1|||
149868194|NCT00741936|540647546|FG001|Overall Study|Lost to Follow-up|1|||
149868195|NCT00741936|540647545|FG000|Overall Study|Adverse Event|3|||
149868196|NCT00741936|540647546|FG001|Overall Study|Adverse Event|4|||
149868197|NCT00741936|540647545|FG000|Overall Study|Pregnancy|0|||
149868198|NCT00741936|540647546|FG001|Overall Study|Pregnancy|1|||
149868199|NCT00741936|540647545|FG000|Overall Study|Protocol Violation|2|||
149962397|NCT00553475|540995921|FG000|Overall Study|Due to moving|0|||
149868200|NCT00741936|540647546|FG001|Overall Study|Protocol Violation|0|||
149868201|NCT00741936|540647545|FG000|Overall Study|Lack of Efficacy|0|||
149868202|NCT00741936|540647546|FG001|Overall Study|Lack of Efficacy|2|||
149868203|NCT00741936|540647545|FG000|Overall Study|Low compliance|3|||
150173878|NCT03946670|541772991|FG000|Overall Study|Physician Decision|6|||
150173879|NCT03946670|541772992|FG001|Overall Study|Physician Decision|5|||
149868204|NCT00741936|540647546|FG001|Overall Study|Low compliance|0|||
149868205|NCT00369382|540647547|FG000|Overall Study|Death|0|||
149868206|NCT00369382|540647548|FG001|Overall Study|Death|2|||
149868207|NCT00369382|540647547|FG000|Overall Study|Physician Decision|2|||
149868208|NCT00369382|540647548|FG001|Overall Study|Physician Decision|1|||
149868209|NCT00369382|540647547|FG000|Overall Study|Withdrawal by Subject|5|||
149868210|NCT00369382|540647548|FG001|Overall Study|Withdrawal by Subject|0|||
149868211|NCT00369382|540647547|FG000|Overall Study|Randomized, not treated|2|||
149868212|NCT00369382|540647548|FG001|Overall Study|Randomized, not treated|0|||
149868213|NCT00369382|540647547|FG000|Overall Study|Other|1|||
149868214|NCT00369382|540647548|FG001|Overall Study|Other|0|||
149868215|NCT05011123|540649604|FG000|Overall Study|Withdrawal by Subject|4|||
149868216|NCT05011123|540649605|FG001|Overall Study|Withdrawal by Subject|2|||
149868217|NCT05011123|540649604|FG000|Overall Study|Lost to Follow-up|7|||
149868218|NCT05011123|540649605|FG001|Overall Study|Lost to Follow-up|6|||
149868219|NCT05011123|540649604|FG000|Overall Study|Ongoing at the time of DBL date|36|||
149868220|NCT05011123|540649605|FG001|Overall Study|Ongoing at the time of DBL date|10|||
149868221|NCT05011123|540649604|FG000|Overall Study|Randomized but did not receive vaccination|1|||
149868222|NCT05011123|540649605|FG001|Overall Study|Randomized but did not receive vaccination|0|||
149868223|NCT03845296|540649609|FG000|Overall Study|On Treatment|2|||
149868224|NCT03845296|540649610|FG001|Overall Study|On Treatment|1|||
149868225|NCT03845296|540649609|FG000|Overall Study|Adverse Event|4|||
149868226|NCT03845296|540649610|FG001|Overall Study|Adverse Event|11|||
149868227|NCT03845296|540649609|FG000|Overall Study|Refusal unrelated to adverse event|0|||
149868228|NCT03845296|540649610|FG001|Overall Study|Refusal unrelated to adverse event|1|||
149868229|NCT03845296|540649609|FG000|Overall Study|Progression/relapse|14|||
149868230|NCT03845296|540649610|FG001|Overall Study|Progression/relapse|18|||
149868231|NCT03845296|540649609|FG000|Overall Study|Death|4|||
149868232|NCT03845296|540649610|FG001|Overall Study|Death|0|||
149868233|NCT03845296|540649609|FG000|Overall Study|Other - not protocol specified|1|||
149868234|NCT03845296|540649610|FG001|Overall Study|Other - not protocol specified|3|||
149868235|NCT04732221|540649613|FG000|Base Period|Death|2|||
149868236|NCT04732221|540649614|FG001|Base Period|Death|0|||
149868237|NCT04732221|540649615|FG002|Base Period|Death|0|||
149868238|NCT04732221|540649616|FG003|Base Period|Death|0|||
149868239|NCT04732221|540649617|FG004|Base Period|Death|0|||
149962398|NCT00553475|540995922|FG001|Overall Study|Due to moving|1|||
149868240|NCT04732221|540649618|FG005|Base Period|Death|0|||
149868241|NCT04732221|540649619|FG006|Base Period|Death|0|||
149868242|NCT04732221|540649613|FG000|Base Period|Withdrawal by Subject|0|||
149868243|NCT04732221|540649614|FG001|Base Period|Withdrawal by Subject|1|||
149868244|NCT04732221|540649615|FG002|Base Period|Withdrawal by Subject|1|||
149868245|NCT04732221|540649616|FG003|Base Period|Withdrawal by Subject|0|||
149868246|NCT04732221|540649617|FG004|Base Period|Withdrawal by Subject|0|||
149868247|NCT04732221|540649618|FG005|Base Period|Withdrawal by Subject|0|||
149868248|NCT04732221|540649619|FG006|Base Period|Withdrawal by Subject|0|||
149868249|NCT04732221|540649613|FG000|Extension Period|Adverse Event|0|||
149868250|NCT04732221|540649614|FG001|Extension Period|Adverse Event|0|||
149868251|NCT04732221|540649615|FG002|Extension Period|Adverse Event|0|||
149868252|NCT04732221|540649616|FG003|Extension Period|Adverse Event|0|||
149868253|NCT04732221|540649617|FG004|Extension Period|Adverse Event|0|||
149962399|NCT00553475|540995923|FG002|Overall Study|Due to moving|0|||
149962400|NCT02496156|540995924|FG000|Overall Study|Lost to Follow-up|5|||
149962401|NCT02496156|540995925|FG001|Overall Study|Lost to Follow-up|0|||
150173880|NCT03946670|541772991|FG000|Overall Study|Death|5|||
149868254|NCT04732221|540649618|FG005|Extension Period|Adverse Event|1|||
149868255|NCT04732221|540649619|FG006|Extension Period|Adverse Event|0|||
149868256|NCT04732221|540649613|FG000|Extension Period|Death|0|||
149868257|NCT04732221|540649614|FG001|Extension Period|Death|0|||
149868258|NCT04732221|540649615|FG002|Extension Period|Death|0|||
149868259|NCT04732221|540649616|FG003|Extension Period|Death|0|||
149868260|NCT04732221|540649617|FG004|Extension Period|Death|1|||
149868261|NCT04732221|540649618|FG005|Extension Period|Death|0|||
149868262|NCT04732221|540649619|FG006|Extension Period|Death|2|||
149868263|NCT04732221|540649613|FG000|Extension Period|Pregnancy|0|||
149868264|NCT04732221|540649614|FG001|Extension Period|Pregnancy|0|||
149868265|NCT04732221|540649615|FG002|Extension Period|Pregnancy|0|||
149962402|NCT02496156|540995924|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
149962403|NCT02496156|540995925|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
150173881|NCT03946670|541772992|FG001|Overall Study|Death|8|||
149868266|NCT04732221|540649616|FG003|Extension Period|Pregnancy|0|||
149868267|NCT04732221|540649617|FG004|Extension Period|Pregnancy|1|||
149868268|NCT04732221|540649618|FG005|Extension Period|Pregnancy|0|||
149868269|NCT04732221|540649619|FG006|Extension Period|Pregnancy|0|||
149868270|NCT04732221|540649613|FG000|Extension Period|Sponsors Decision|0|||
149868271|NCT04732221|540649614|FG001|Extension Period|Sponsors Decision|0|||
149868272|NCT04732221|540649615|FG002|Extension Period|Sponsors Decision|0|||
149868273|NCT04732221|540649616|FG003|Extension Period|Sponsors Decision|0|||
149868274|NCT04732221|540649617|FG004|Extension Period|Sponsors Decision|41|||
149868275|NCT04732221|540649618|FG005|Extension Period|Sponsors Decision|40|||
149868276|NCT04732221|540649619|FG006|Extension Period|Sponsors Decision|40|||
149868277|NCT04732221|540649613|FG000|Extension Period|Withdrawal by Subject|0|||
149868278|NCT04732221|540649614|FG001|Extension Period|Withdrawal by Subject|0|||
149868279|NCT04732221|540649615|FG002|Extension Period|Withdrawal by Subject|0|||
149868280|NCT04732221|540649616|FG003|Extension Period|Withdrawal by Subject|0|||
149868281|NCT04732221|540649617|FG004|Extension Period|Withdrawal by Subject|1|||
149868282|NCT04732221|540649618|FG005|Extension Period|Withdrawal by Subject|5|||
149868283|NCT04732221|540649619|FG006|Extension Period|Withdrawal by Subject|2|||
149868284|NCT05327816|540649624|FG000|Overall Study|Lost to Follow-up|1|||
149868285|NCT05327816|540649625|FG001|Overall Study|Lost to Follow-up|0|||
149868286|NCT05327816|540649626|FG002|Overall Study|Lost to Follow-up|0|||
149868287|NCT05327816|540649627|FG003|Overall Study|Lost to Follow-up|0|||
149868288|NCT05327816|540649628|FG004|Overall Study|Lost to Follow-up|0|||
149868289|NCT05327816|540649629|FG005|Overall Study|Lost to Follow-up|0|||
149868290|NCT05327816|540649630|FG006|Overall Study|Lost to Follow-up|0|||
149868291|NCT05327816|540649631|FG007|Overall Study|Lost to Follow-up|0|||
149868292|NCT05327816|540649632|FG008|Overall Study|Lost to Follow-up|0|||
149868293|NCT05327816|540649633|FG009|Overall Study|Lost to Follow-up|1|||
149868294|NCT05327816|540649634|FG010|Overall Study|Lost to Follow-up|0|||
149868295|NCT05327816|540649624|FG000|Overall Study|Withdrawal by Subject|0|||
149868296|NCT05327816|540649625|FG001|Overall Study|Withdrawal by Subject|0|||
149868297|NCT05327816|540649626|FG002|Overall Study|Withdrawal by Subject|0|||
149868298|NCT05327816|540649627|FG003|Overall Study|Withdrawal by Subject|0|||
149868299|NCT05327816|540649628|FG004|Overall Study|Withdrawal by Subject|1|||
149868300|NCT05327816|540649629|FG005|Overall Study|Withdrawal by Subject|1|||
149868301|NCT05327816|540649630|FG006|Overall Study|Withdrawal by Subject|0|||
149868302|NCT05327816|540649631|FG007|Overall Study|Withdrawal by Subject|0|||
149868303|NCT05327816|540649632|FG008|Overall Study|Withdrawal by Subject|0|||
149868304|NCT05327816|540649633|FG009|Overall Study|Withdrawal by Subject|0|||
149868305|NCT05327816|540649634|FG010|Overall Study|Withdrawal by Subject|0|||
149868306|NCT05327816|540649624|FG000|Overall Study|Study Terminated by Sponsor|11|||
149868307|NCT05327816|540649625|FG001|Overall Study|Study Terminated by Sponsor|12|||
149868308|NCT05327816|540649626|FG002|Overall Study|Study Terminated by Sponsor|12|||
149868309|NCT05327816|540649627|FG003|Overall Study|Study Terminated by Sponsor|12|||
149868310|NCT05327816|540649628|FG004|Overall Study|Study Terminated by Sponsor|11|||
149868311|NCT05327816|540649629|FG005|Overall Study|Study Terminated by Sponsor|11|||
149868312|NCT05327816|540649630|FG006|Overall Study|Study Terminated by Sponsor|11|||
149868313|NCT05327816|540649631|FG007|Overall Study|Study Terminated by Sponsor|11|||
149868314|NCT05327816|540649632|FG008|Overall Study|Study Terminated by Sponsor|11|||
149868315|NCT05327816|540649633|FG009|Overall Study|Study Terminated by Sponsor|11|||
149868316|NCT05327816|540649634|FG010|Overall Study|Study Terminated by Sponsor|12|||
149868317|NCT05327816|540649624|FG000|Overall Study|Randomized but not treated|0|||
149868318|NCT05327816|540649625|FG001|Overall Study|Randomized but not treated|0|||
149868319|NCT05327816|540649626|FG002|Overall Study|Randomized but not treated|0|||
149868320|NCT05327816|540649627|FG003|Overall Study|Randomized but not treated|0|||
149868321|NCT05327816|540649628|FG004|Overall Study|Randomized but not treated|0|||
149868322|NCT05327816|540649629|FG005|Overall Study|Randomized but not treated|0|||
149868323|NCT05327816|540649630|FG006|Overall Study|Randomized but not treated|1|||
149868324|NCT05327816|540649631|FG007|Overall Study|Randomized but not treated|1|||
149868325|NCT05327816|540649632|FG008|Overall Study|Randomized but not treated|1|||
149868326|NCT05327816|540649633|FG009|Overall Study|Randomized but not treated|0|||
149868327|NCT05327816|540649634|FG010|Overall Study|Randomized but not treated|0|||
149868328|NCT01106014|540649635|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
149868329|NCT01106014|540649636|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
149868330|NCT01106014|540649635|FG000|Overall Study|Adverse Event|78|||
149868331|NCT01106014|540649636|FG001|Overall Study|Adverse Event|42|||
149962404|NCT00089583|540995926|FG000|Overall Study|Adverse Event|0|||
149962405|NCT00089583|540995927|FG001|Overall Study|Adverse Event|3|||
149868332|NCT01106014|540649635|FG000|Overall Study|Withdrawal by Subject|43|||
149868333|NCT01106014|540649636|FG001|Overall Study|Withdrawal by Subject|37|||
149868334|NCT01106014|540649635|FG000|Overall Study|Administrative reason|7|||
149868335|NCT01106014|540649636|FG001|Overall Study|Administrative reason|6|||
149868336|NCT01106014|540649635|FG000|Overall Study|Lost to Follow-up|2|||
149868337|NCT01106014|540649636|FG001|Overall Study|Lost to Follow-up|3|||
149868338|NCT00658658|540649643|FG000|Overall Study|Withdrawal by Subject|0|||
149868339|NCT00658658|540649644|FG001|Overall Study|Withdrawal by Subject|1|||
149868340|NCT00658658|540649645|FG002|Overall Study|Withdrawal by Subject|0|||
149868341|NCT00658658|540649646|FG003|Overall Study|Withdrawal by Subject|0|||
149868342|NCT00658658|540649647|FG004|Overall Study|Withdrawal by Subject|0|||
149868343|NCT00658658|540649643|FG000|Overall Study|Death|4|||
149868344|NCT00658658|540649644|FG001|Overall Study|Death|0|||
149868345|NCT00658658|540649645|FG002|Overall Study|Death|0|||
149868346|NCT00658658|540649646|FG003|Overall Study|Death|1|||
149868347|NCT00658658|540649647|FG004|Overall Study|Death|1|||
149868348|NCT00658658|540649643|FG000|Overall Study|Disease Progression|0|||
149868349|NCT00658658|540649644|FG001|Overall Study|Disease Progression|1|||
149962406|NCT00089583|540995926|FG000|Overall Study|Insufficient Viral Load Response|5|||
149962407|NCT00089583|540995927|FG001|Overall Study|Insufficient Viral Load Response|5|||
149962408|NCT00089583|540995926|FG000|Overall Study|Withdrawal by Subject|0|||
149868350|NCT00658658|540649645|FG002|Overall Study|Disease Progression|0|||
149868351|NCT00658658|540649646|FG003|Overall Study|Disease Progression|1|||
149868352|NCT00658658|540649647|FG004|Overall Study|Disease Progression|3|||
149962409|NCT00089583|540995927|FG001|Overall Study|Withdrawal by Subject|4|||
149962410|NCT00089583|540995926|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
150040856|NCT00790842|541289123|FG009|Expansion Cohort|Study Closure|0|||
149868353|NCT00658658|540649643|FG000|Overall Study|Protocol-specified Criteria|1|||
149868354|NCT00658658|540649644|FG001|Overall Study|Protocol-specified Criteria|0|||
149868355|NCT00658658|540649645|FG002|Overall Study|Protocol-specified Criteria|0|||
149868356|NCT00658658|540649646|FG003|Overall Study|Protocol-specified Criteria|0|||
149868357|NCT00658658|540649647|FG004|Overall Study|Protocol-specified Criteria|0|||
149868358|NCT00658658|540649643|FG000|Overall Study|Other|0|||
149868359|NCT00658658|540649644|FG001|Overall Study|Other|0|||
149868360|NCT00658658|540649645|FG002|Overall Study|Other|0|||
149868361|NCT00658658|540649646|FG003|Overall Study|Other|0|||
149868362|NCT00658658|540649647|FG004|Overall Study|Other|1|||
149868363|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
149868364|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
149868365|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
150040857|NCT00790842|541289124|FG010|Expansion Cohort|Study Closure|0|||
150040858|NCT02968004|541289125|FG000|Main Study Phase|Adverse Event|1|||
150040859|NCT02968004|541289126|FG001|Main Study Phase|Adverse Event|0|||
150040860|NCT02968004|541289125|FG000|Main Study Phase|Withdrawal by Subject|0|||
150040861|NCT02968004|541289126|FG001|Main Study Phase|Withdrawal by Subject|1|||
150040862|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
150040863|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
150040864|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
150040865|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
150040866|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
150040867|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
150040868|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
150040869|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
149868366|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
149868367|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
149868368|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
149868369|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
149868370|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
149868371|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
149868372|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
149868373|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
149868374|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
149868375|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
149868376|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
149868377|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
149868378|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
149868379|NCT03182244|540649649|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
149868380|NCT03182244|540649650|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
149868381|NCT03182244|540649649|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
149868382|NCT03182244|540649650|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
149868383|NCT03182244|540649649|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
149868384|NCT03182244|540649650|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
149868385|NCT03182244|540649649|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
149868386|NCT03182244|540649650|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
149868387|NCT03182244|540649649|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
149868388|NCT03182244|540649650|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
149868389|NCT00824616|540649651|FG000|Overall Study|Adverse Event|2|||
149868390|NCT00824616|540649652|FG001|Overall Study|Adverse Event|1|||
149868391|NCT00824616|540649651|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
149868392|NCT00824616|540649652|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
149868393|NCT00824616|540649651|FG000|Overall Study|Hyperglycemia|1|||
149868394|NCT00824616|540649652|FG001|Overall Study|Hyperglycemia|1|||
149868395|NCT00824616|540649651|FG000|Overall Study|Lack of Efficacy|2|||
149868396|NCT00824616|540649652|FG001|Overall Study|Lack of Efficacy|1|||
149868397|NCT00824616|540649651|FG000|Overall Study|Lost to Follow-up|0|||
149868398|NCT00824616|540649652|FG001|Overall Study|Lost to Follow-up|1|||
149868399|NCT00824616|540649651|FG000|Overall Study|Withdrawal by Subject|1|||
149868400|NCT00824616|540649652|FG001|Overall Study|Withdrawal by Subject|1|||
149868401|NCT04711902|540649653|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
149868402|NCT04711902|540649654|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
149868403|NCT04711902|540649655|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
149868404|NCT04711902|540649656|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
149868405|NCT04711902|540649657|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
149868406|NCT04711902|540649658|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
149868407|NCT01383135|540649667|FG000|Overall Study|Not Scanned / Imaged|1|||
149868408|NCT01383135|540649668|FG001|Overall Study|Not Scanned / Imaged|0|||
149868409|NCT01383135|540649669|FG002|Overall Study|Not Scanned / Imaged|1|||
149868410|NCT01383135|540649670|FG003|Overall Study|Not Scanned / Imaged|0|||
149868411|NCT03167723|540649671|FG000|Overall Study|Protocol Violation|4|||
149868412|NCT03167723|540649672|FG001|Overall Study|Protocol Violation|6|||
149868413|NCT01646138|540649673|FG000|Overall Study|Lost to Follow-up|0|||
149868414|NCT01646138|540649674|FG001|Overall Study|Lost to Follow-up|0|||
149868415|NCT01646138|540649675|FG002|Overall Study|Lost to Follow-up|0|||
149868416|NCT01646138|540649676|FG003|Overall Study|Lost to Follow-up|0|||
149868417|NCT01646138|540649677|FG004|Overall Study|Lost to Follow-up|2|||
149868418|NCT01683838|540649678|FG000|Overall Study|Adverse Event|12|||
149868419|NCT01683838|540649679|FG001|Overall Study|Adverse Event|2|||
149868420|NCT01683838|540649678|FG000|Overall Study|Protocol Violation|3|||
149868421|NCT01683838|540649679|FG001|Overall Study|Protocol Violation|1|||
149868422|NCT01683838|540649678|FG000|Overall Study|Withdrawal by Subject|6|||
149868423|NCT01683838|540649679|FG001|Overall Study|Withdrawal by Subject|5|||
149868424|NCT01683838|540649678|FG000|Overall Study|Lost to Follow-up|1|||
149868425|NCT01683838|540649679|FG001|Overall Study|Lost to Follow-up|1|||
149868426|NCT01683838|540649678|FG000|Overall Study|Other|4|||
149868427|NCT01683838|540649679|FG001|Overall Study|Other|3|||
149868428|NCT03397771|540649680|FG000|Overall Study|2 erroneously randomized, never treated|3|||
149868429|NCT03397771|540649681|FG001|Overall Study|2 erroneously randomized, never treated|1|||
149868430|NCT03397771|540649680|FG000|Overall Study|Withdrawal by Subject|1|||
149868431|NCT03397771|540649681|FG001|Overall Study|Withdrawal by Subject|3|||
149868432|NCT03397771|540649680|FG000|Overall Study|Protocol Violation|2|||
149868433|NCT03397771|540649681|FG001|Overall Study|Protocol Violation|2|||
149868434|NCT03397771|540649680|FG000|Overall Study|Adverse Event|2|||
149868435|NCT03397771|540649681|FG001|Overall Study|Adverse Event|1|||
149868436|NCT02455050|540649685|FG000|Treatment Period 1|Lost to Follow-up|1|||
149868437|NCT02455050|540649686|FG001|Treatment Period 1|Lost to Follow-up|1|||
149868438|NCT02455050|540649687|FG002|Treatment Period 1|Lost to Follow-up|1|||
149868439|NCT02455050|540649688|FG003|Treatment Period 1|Lost to Follow-up|2|||
149868440|NCT02455050|540649685|FG000|Treatment Period 2|Lost to Follow-up|1|||
149868441|NCT02455050|540649686|FG001|Treatment Period 2|Lost to Follow-up|0|||
149868442|NCT02455050|540649687|FG002|Treatment Period 2|Lost to Follow-up|2|||
149868443|NCT02455050|540649688|FG003|Treatment Period 2|Lost to Follow-up|1|||
149868444|NCT01831765|540649689|FG000|Overall Study|Lack of Efficacy|1|||
149868445|NCT01831765|540649690|FG001|Overall Study|Lack of Efficacy|0|||
149868446|NCT01831765|540649691|FG002|Overall Study|Lack of Efficacy|0|||
149868447|NCT01831765|540649689|FG000|Overall Study|Other, sponsor withdrew subject|0|||
149868448|NCT01831765|540649690|FG001|Overall Study|Other, sponsor withdrew subject|1|||
149868449|NCT01831765|540649691|FG002|Overall Study|Other, sponsor withdrew subject|0|||
149868450|NCT01831765|540649689|FG000|Overall Study|Pregnancy|1|||
149868451|NCT01831765|540649690|FG001|Overall Study|Pregnancy|1|||
149868452|NCT01831765|540649691|FG002|Overall Study|Pregnancy|2|||
149868453|NCT01831765|540649689|FG000|Overall Study|Death|0|||
149868454|NCT01831765|540649690|FG001|Overall Study|Death|1|||
149868455|NCT01831765|540649691|FG002|Overall Study|Death|1|||
149868456|NCT01831765|540649689|FG000|Overall Study|Other, site closed|1|||
149868457|NCT01831765|540649690|FG001|Overall Study|Other, site closed|1|||
149868458|NCT01831765|540649691|FG002|Overall Study|Other, site closed|0|||
149868459|NCT01831765|540649689|FG000|Overall Study|Adverse Event|5|||
149868460|NCT01831765|540649690|FG001|Overall Study|Adverse Event|3|||
149868461|NCT01831765|540649691|FG002|Overall Study|Adverse Event|3|||
149868462|NCT01831765|540649689|FG000|Overall Study|Withdrawal by Subject|22|||
149868463|NCT01831765|540649690|FG001|Overall Study|Withdrawal by Subject|7|||
149868464|NCT01831765|540649691|FG002|Overall Study|Withdrawal by Subject|17|||
149868465|NCT01831765|540649689|FG000|Overall Study|Withdrawal criteria|12|||
149868466|NCT01831765|540649690|FG001|Overall Study|Withdrawal criteria|10|||
149868467|NCT01831765|540649691|FG002|Overall Study|Withdrawal criteria|16|||
149868468|NCT01831765|540649689|FG000|Overall Study|Lost to Follow-up|2|||
149962411|NCT00089583|540995927|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
149962412|NCT00089583|540995926|FG000|Overall Study|Participant Refused Study Medication|0|||
149962413|NCT00089583|540995927|FG001|Overall Study|Participant Refused Study Medication|2|||
149962414|NCT00089583|540995926|FG000|Overall Study|Non-Compliance|0|||
149962415|NCT00089583|540995927|FG001|Overall Study|Non-Compliance|4|||
149962416|NCT00089583|540995926|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
149962417|NCT00089583|540995927|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
149962418|NCT00089583|540995926|FG000|Overall Study|Participant Management Criteria Met|0|||
149962419|NCT00089583|540995927|FG001|Overall Study|Participant Management Criteria Met|1|||
149962420|NCT00089583|540995926|FG000|Overall Study|Reason Not Provided|0|||
149962421|NCT00089583|540995927|FG001|Overall Study|Reason Not Provided|1|||
149868469|NCT01831765|540649690|FG001|Overall Study|Lost to Follow-up|3|||
149868470|NCT01831765|540649691|FG002|Overall Study|Lost to Follow-up|3|||
149868471|NCT00859586|540649692|FG000|Overall Study|Donors|4|||
149868472|NCT02524730|540649693|FG000|Overall Study|Lost to Follow-up|5|||
150173882|NCT03946670|541772991|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
149868473|NCT02524730|540649693|FG000|Overall Study|Withdrawal by Subject|18|||
149868474|NCT02524730|540649693|FG000|Overall Study|Death|10|||
149962422|NCT00089583|540995926|FG000|Overall Study|Protocol Violation|0|||
149962423|NCT00089583|540995927|FG001|Overall Study|Protocol Violation|3|||
149868475|NCT02524730|540649693|FG000|Overall Study|Adverse Event|8|||
149868476|NCT02524730|540649693|FG000|Overall Study|Protocol Violation|1|||
149868477|NCT02524730|540649693|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
149868478|NCT00507130|540649694|FG000|Overall Study|Lost to Follow-up|0|||
149868479|NCT00507130|540649695|FG001|Overall Study|Lost to Follow-up|0|||
149868480|NCT00507130|540649696|FG002|Overall Study|Lost to Follow-up|1|||
149868481|NCT00507130|540649697|FG003|Overall Study|Lost to Follow-up|1|||
149868482|NCT00507130|540649694|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
149868483|NCT00507130|540649695|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
149868484|NCT00507130|540649696|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
149868485|NCT00507130|540649697|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
149868486|NCT02605993|540649704|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
149868487|NCT02605993|540649705|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
149868488|NCT02605993|540649706|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
149868489|NCT02605993|540649707|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
149868490|NCT03493386|540649711|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149868491|NCT03493386|540649712|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
149868492|NCT03493386|540649713|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149868493|NCT03493386|540649714|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149868494|NCT04645966|540649715|FG000|Vaccination Phase|Adverse Event|1|||
149868495|NCT04645966|540649716|FG001|Vaccination Phase|Adverse Event|0|||
149868496|NCT04645966|540649717|FG002|Vaccination Phase|Adverse Event|0|||
149868497|NCT04645966|540649718|FG003|Vaccination Phase|Adverse Event|0|||
149868498|NCT04645966|540649719|FG004|Vaccination Phase|Adverse Event|0|||
149868499|NCT04645966|540649720|FG005|Vaccination Phase|Adverse Event|0|||
149868500|NCT04645966|540649721|FG006|Vaccination Phase|Adverse Event|1|||
149868501|NCT04645966|540649722|FG007|Vaccination Phase|Adverse Event|0|||
149868502|NCT04645966|540649723|FG008|Vaccination Phase|Adverse Event|0|||
149868503|NCT04645966|540649715|FG000|Vaccination Phase|Death|0|||
149868504|NCT04645966|540649716|FG001|Vaccination Phase|Death|0|||
149868505|NCT04645966|540649717|FG002|Vaccination Phase|Death|0|||
149868506|NCT04645966|540649718|FG003|Vaccination Phase|Death|0|||
149868507|NCT04645966|540649719|FG004|Vaccination Phase|Death|0|||
149868508|NCT04645966|540649720|FG005|Vaccination Phase|Death|1|||
149868509|NCT04645966|540649721|FG006|Vaccination Phase|Death|0|||
149868510|NCT04645966|540649722|FG007|Vaccination Phase|Death|0|||
149868511|NCT04645966|540649723|FG008|Vaccination Phase|Death|0|||
149868512|NCT04645966|540649715|FG000|Vaccination Phase|Protocol Violation|0|||
149868513|NCT04645966|540649716|FG001|Vaccination Phase|Protocol Violation|0|||
149868514|NCT04645966|540649717|FG002|Vaccination Phase|Protocol Violation|0|||
149868515|NCT04645966|540649718|FG003|Vaccination Phase|Protocol Violation|0|||
149962424|NCT00089583|540995926|FG000|Overall Study|Principal Investigator Decision|0|||
149962425|NCT00089583|540995927|FG001|Overall Study|Principal Investigator Decision|10|||
149962426|NCT00089583|540995926|FG000|Overall Study|Start of Disallowed Medication|0|||
150173883|NCT03946670|541772992|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
149868516|NCT04645966|540649719|FG004|Vaccination Phase|Protocol Violation|1|||
149868517|NCT04645966|540649720|FG005|Vaccination Phase|Protocol Violation|0|||
149868518|NCT04645966|540649721|FG006|Vaccination Phase|Protocol Violation|0|||
149868519|NCT04645966|540649722|FG007|Vaccination Phase|Protocol Violation|0|||
149868520|NCT04645966|540649723|FG008|Vaccination Phase|Protocol Violation|0|||
149868521|NCT04645966|540649715|FG000|Vaccination Phase|Study terminated by sponsor|0|||
150173884|NCT03946670|541772991|FG000|Overall Study|Subject Decision|4|||
150173885|NCT03946670|541772992|FG001|Overall Study|Subject Decision|5|||
150173886|NCT03946670|541772991|FG000|Overall Study|Study Terminated By Sponsor|2|||
149868522|NCT04645966|540649716|FG001|Vaccination Phase|Study terminated by sponsor|0|||
149962427|NCT00089583|540995927|FG001|Overall Study|Start of Disallowed Medication|1|||
150173887|NCT03946670|541772992|FG001|Overall Study|Study Terminated By Sponsor|0|||
149868523|NCT04645966|540649717|FG002|Vaccination Phase|Study terminated by sponsor|14|||
149868524|NCT04645966|540649718|FG003|Vaccination Phase|Study terminated by sponsor|15|||
149868525|NCT04645966|540649719|FG004|Vaccination Phase|Study terminated by sponsor|47|||
149868526|NCT04645966|540649720|FG005|Vaccination Phase|Study terminated by sponsor|43|||
149868527|NCT04645966|540649721|FG006|Vaccination Phase|Study terminated by sponsor|29|||
149868528|NCT04645966|540649722|FG007|Vaccination Phase|Study terminated by sponsor|29|||
149868529|NCT04645966|540649723|FG008|Vaccination Phase|Study terminated by sponsor|12|||
149868530|NCT04645966|540649715|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
149868531|NCT04645966|540649716|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
149868532|NCT04645966|540649717|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
149868533|NCT04645966|540649718|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
149868534|NCT04645966|540649719|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
149868535|NCT04645966|540649720|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
149868536|NCT04645966|540649721|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
149868537|NCT04645966|540649722|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
149868538|NCT04645966|540649723|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
149868539|NCT04645966|540649715|FG000|Vaccination Phase|Other|0|||
149868540|NCT04645966|540649716|FG001|Vaccination Phase|Other|0|||
149868541|NCT04645966|540649717|FG002|Vaccination Phase|Other|0|||
149868542|NCT04645966|540649718|FG003|Vaccination Phase|Other|0|||
149868543|NCT04645966|540649719|FG004|Vaccination Phase|Other|0|||
149868544|NCT04645966|540649720|FG005|Vaccination Phase|Other|2|||
149868545|NCT04645966|540649721|FG006|Vaccination Phase|Other|0|||
149868546|NCT04645966|540649722|FG007|Vaccination Phase|Other|0|||
149868547|NCT04645966|540649723|FG008|Vaccination Phase|Other|0|||
149868548|NCT04645966|540649715|FG000|Vaccination Phase|Lost to Follow-up|0|||
149868549|NCT04645966|540649716|FG001|Vaccination Phase|Lost to Follow-up|0|||
149868550|NCT04645966|540649717|FG002|Vaccination Phase|Lost to Follow-up|0|||
149868551|NCT04645966|540649718|FG003|Vaccination Phase|Lost to Follow-up|0|||
149868552|NCT04645966|540649719|FG004|Vaccination Phase|Lost to Follow-up|0|||
149868553|NCT04645966|540649720|FG005|Vaccination Phase|Lost to Follow-up|0|||
149868554|NCT04645966|540649721|FG006|Vaccination Phase|Lost to Follow-up|0|||
149868555|NCT04645966|540649722|FG007|Vaccination Phase|Lost to Follow-up|1|||
149868556|NCT04645966|540649723|FG008|Vaccination Phase|Lost to Follow-up|0|||
149868557|NCT04645966|540649715|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
149868558|NCT04645966|540649716|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
149868559|NCT04645966|540649717|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
149868560|NCT04645966|540649718|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
149868561|NCT04645966|540649719|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
149868562|NCT04645966|540649720|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
149868563|NCT04645966|540649721|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
149868564|NCT04645966|540649722|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
149868565|NCT04645966|540649723|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
149868566|NCT04645966|540649715|FG000|Follow-up Phase|Lost to Follow-up|0|||
149868567|NCT04645966|540649716|FG001|Follow-up Phase|Lost to Follow-up|0|||
149868568|NCT04645966|540649717|FG002|Follow-up Phase|Lost to Follow-up|0|||
149868569|NCT04645966|540649718|FG003|Follow-up Phase|Lost to Follow-up|0|||
149868570|NCT04645966|540649719|FG004|Follow-up Phase|Lost to Follow-up|0|||
149868571|NCT04645966|540649720|FG005|Follow-up Phase|Lost to Follow-up|0|||
149868572|NCT04645966|540649721|FG006|Follow-up Phase|Lost to Follow-up|0|||
149868573|NCT04645966|540649722|FG007|Follow-up Phase|Lost to Follow-up|1|||
149868574|NCT04645966|540649723|FG008|Follow-up Phase|Lost to Follow-up|0|||
149868575|NCT01468818|540649739|FG000|Overall Study|Death during treatment|2|||
149868576|NCT02731326|540649741|FG000|Overall Study|Withdrawal by Subject|4|||
149868577|NCT02731326|540649742|FG001|Overall Study|Withdrawal by Subject|1|||
149868578|NCT02731326|540649741|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
149868579|NCT02731326|540649742|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
149868580|NCT02731326|540649741|FG000|Overall Study|Discharged without AliveCor|10|||
149868581|NCT02731326|540649742|FG001|Overall Study|Discharged without AliveCor|0|||
149868582|NCT02731326|540649741|FG000|Overall Study|Duplicate Participant|1|||
149868583|NCT02731326|540649742|FG001|Overall Study|Duplicate Participant|1|||
149868584|NCT01442688|540649744|FG000|First Intervention|Withdrawal by Subject|1|||
149868585|NCT01442688|540649745|FG001|First Intervention|Withdrawal by Subject|0|||
149868586|NCT01442688|540649744|FG000|First Intervention|subject incarcerated|1|||
149868587|NCT01442688|540649745|FG001|First Intervention|subject incarcerated|0|||
149868588|NCT01442688|540649744|FG000|Second Intervention|Adverse Event|1|||
149868589|NCT01442688|540649745|FG001|Second Intervention|Adverse Event|0|||
149868590|NCT02643355|540649746|FG000|Overall Study|Withdrawal by Subject|1|||
149868591|NCT02643355|540649747|FG001|Overall Study|Withdrawal by Subject|3|||
149868592|NCT02643355|540649746|FG000|Overall Study|Protocol Violation|0|||
149868593|NCT02643355|540649747|FG001|Overall Study|Protocol Violation|2|||
149868594|NCT01974440|540649750|FG000|Overall Study|Lost to Follow-up|7|||
149868595|NCT01974440|540649751|FG001|Overall Study|Lost to Follow-up|7|||
149868596|NCT01974440|540649750|FG000|Overall Study|Withdrawal by Subject|24|||
149868597|NCT01974440|540649751|FG001|Overall Study|Withdrawal by Subject|20|||
149868598|NCT01974440|540649750|FG000|Overall Study|Sponsor decision|109|||
149868599|NCT01974440|540649751|FG001|Overall Study|Sponsor decision|110|||
149868600|NCT00762437|540649752|FG000|Overall Study|Lost to Follow-up|7|||
149868601|NCT00762437|540649752|FG000|Overall Study|Missed final study visit|11|||
149868602|NCT00762437|540649752|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
149868603|NCT00302081|540649753|FG000|Overall Study|Adverse Event|6|||
149868604|NCT00302081|540649754|FG001|Overall Study|Adverse Event|5|||
149868605|NCT00302081|540649755|FG002|Overall Study|Adverse Event|4|||
149868606|NCT00302081|540649753|FG000|Overall Study|Lost to Follow-up|21|||
149868607|NCT00302081|540649754|FG001|Overall Study|Lost to Follow-up|18|||
149868608|NCT00302081|540649755|FG002|Overall Study|Lost to Follow-up|28|||
149868609|NCT00302081|540649753|FG000|Overall Study|Withdrawal by Subject|8|||
149868610|NCT00302081|540649754|FG001|Overall Study|Withdrawal by Subject|12|||
149868611|NCT00302081|540649755|FG002|Overall Study|Withdrawal by Subject|8|||
149868612|NCT00302081|540649753|FG000|Overall Study|Protocol Violation|5|||
149868613|NCT00302081|540649754|FG001|Overall Study|Protocol Violation|1|||
149868614|NCT00302081|540649755|FG002|Overall Study|Protocol Violation|2|||
149868615|NCT00302081|540649753|FG000|Overall Study|Lack of Efficacy|1|||
149868616|NCT00302081|540649754|FG001|Overall Study|Lack of Efficacy|0|||
149868617|NCT00302081|540649755|FG002|Overall Study|Lack of Efficacy|5|||
149868618|NCT00302081|540649753|FG000|Overall Study|Death|2|||
149868619|NCT00302081|540649754|FG001|Overall Study|Death|1|||
149868620|NCT00302081|540649755|FG002|Overall Study|Death|0|||
149868621|NCT00302081|540649753|FG000|Overall Study|Other|13|||
149868622|NCT00302081|540649754|FG001|Overall Study|Other|6|||
149868623|NCT00302081|540649755|FG002|Overall Study|Other|5|||
149868624|NCT04480710|540649756|FG000|Overall Study|Adverse Event|0|||
149868625|NCT04480710|540649757|FG001|Overall Study|Adverse Event|2|||
149868626|NCT04480710|540649758|FG002|Overall Study|Adverse Event|0|||
149868627|NCT04480710|540649759|FG003|Overall Study|Adverse Event|0|||
149868628|NCT04480710|540649756|FG000|Overall Study|Withdrawal by Subject|0|||
149868629|NCT04480710|540649757|FG001|Overall Study|Withdrawal by Subject|1|||
149868630|NCT04480710|540649758|FG002|Overall Study|Withdrawal by Subject|0|||
149868631|NCT04480710|540649759|FG003|Overall Study|Withdrawal by Subject|0|||
149868632|NCT04480710|540649756|FG000|Overall Study|Physician Decision|0|||
149868633|NCT04480710|540649757|FG001|Overall Study|Physician Decision|0|||
149868634|NCT04480710|540649758|FG002|Overall Study|Physician Decision|1|||
149868635|NCT04480710|540649759|FG003|Overall Study|Physician Decision|0|||
149868636|NCT04480021|540649760|FG000|Overall Study|Lost to Follow-up|3|||
149868637|NCT04480021|540649761|FG001|Overall Study|Lost to Follow-up|4|||
149868638|NCT05084963|540649762|FG000|Overall Study|Withdrawal by Subject|0|||
149868639|NCT05084963|540649763|FG001|Overall Study|Withdrawal by Subject|0|||
149868640|NCT05084963|540649764|FG002|Overall Study|Withdrawal by Subject|1|||
149868641|NCT03569228|540649765|FG000|Overall Study|Withdrawal by PI|0|||
149868642|NCT03569228|540649766|FG001|Overall Study|Withdrawal by PI|0|||
149868643|NCT03569228|540649767|FG002|Overall Study|Withdrawal by PI|2|||
150173888|NCT03946670|541772991|FG000|Overall Study|New Therapy For Study Indication|1|||
149868644|NCT03569228|540649768|FG003|Overall Study|Withdrawal by PI|2|||
149868645|NCT03569228|540649769|FG004|Overall Study|Withdrawal by PI|1|||
149868646|NCT03569228|540649770|FG005|Overall Study|Withdrawal by PI|0|||
149868647|NCT03569228|540649771|FG006|Overall Study|Withdrawal by PI|0|||
149868648|NCT03569228|540649772|FG007|Overall Study|Withdrawal by PI|0|||
149868649|NCT03569228|540649773|FG008|Overall Study|Withdrawal by PI|0|||
149868650|NCT03569228|540649765|FG000|Overall Study|Lost to Follow-up|0|||
149868651|NCT03569228|540649766|FG001|Overall Study|Lost to Follow-up|0|||
149868652|NCT03569228|540649767|FG002|Overall Study|Lost to Follow-up|0|||
149868653|NCT03569228|540649768|FG003|Overall Study|Lost to Follow-up|0|||
149868654|NCT03569228|540649769|FG004|Overall Study|Lost to Follow-up|0|||
149868655|NCT03569228|540649770|FG005|Overall Study|Lost to Follow-up|0|||
149868656|NCT03569228|540649771|FG006|Overall Study|Lost to Follow-up|0|||
149868657|NCT03569228|540649772|FG007|Overall Study|Lost to Follow-up|0|||
149868658|NCT03569228|540649773|FG008|Overall Study|Lost to Follow-up|1|||
149868659|NCT03569228|540649765|FG000|Overall Study|Screen Fail|2|||
149868660|NCT03569228|540649766|FG001|Overall Study|Screen Fail|2|||
149868661|NCT03569228|540649767|FG002|Overall Study|Screen Fail|1|||
149868662|NCT03569228|540649768|FG003|Overall Study|Screen Fail|1|||
149868663|NCT03569228|540649769|FG004|Overall Study|Screen Fail|1|||
149868664|NCT03569228|540649770|FG005|Overall Study|Screen Fail|3|||
149868665|NCT03569228|540649771|FG006|Overall Study|Screen Fail|1|||
149868666|NCT03569228|540649772|FG007|Overall Study|Screen Fail|5|||
149868667|NCT03569228|540649773|FG008|Overall Study|Screen Fail|2|||
149868668|NCT03819049|540649774|FG000|Overall Study|Lost to Follow-up|1|||
149868669|NCT03819049|540649775|FG001|Overall Study|Lost to Follow-up|2|||
149868670|NCT03819049|540649776|FG002|Overall Study|Lost to Follow-up|9|||
149868671|NCT03819049|540649777|FG003|Overall Study|Lost to Follow-up|0|||
149868672|NCT03819049|540649778|FG004|Overall Study|Lost to Follow-up|3|||
149868673|NCT03819049|540649779|FG005|Overall Study|Lost to Follow-up|1|||
149868674|NCT03819049|540649780|FG006|Overall Study|Lost to Follow-up|0|||
149868675|NCT03819049|540649774|FG000|Overall Study|Withdrawal by Subject|0|||
149868676|NCT03819049|540649775|FG001|Overall Study|Withdrawal by Subject|0|||
149868677|NCT03819049|540649776|FG002|Overall Study|Withdrawal by Subject|18|||
149868678|NCT03819049|540649777|FG003|Overall Study|Withdrawal by Subject|0|||
149868679|NCT03819049|540649778|FG004|Overall Study|Withdrawal by Subject|10|||
149868680|NCT03819049|540649779|FG005|Overall Study|Withdrawal by Subject|9|||
149868681|NCT03819049|540649780|FG006|Overall Study|Withdrawal by Subject|1|||
149868682|NCT03819049|540649774|FG000|Overall Study|Ongoing|0|||
149868683|NCT03819049|540649775|FG001|Overall Study|Ongoing|0|||
149868684|NCT03819049|540649776|FG002|Overall Study|Ongoing|75|||
149868685|NCT03819049|540649777|FG003|Overall Study|Ongoing|0|||
149868686|NCT03819049|540649778|FG004|Overall Study|Ongoing|41|||
149868687|NCT03819049|540649779|FG005|Overall Study|Ongoing|0|||
149868688|NCT03819049|540649780|FG006|Overall Study|Ongoing|0|||
149868689|NCT03819049|540649774|FG000|Overall Study|Other|0|||
149868690|NCT03819049|540649775|FG001|Overall Study|Other|0|||
149868691|NCT03819049|540649776|FG002|Overall Study|Other|2|||
149868692|NCT03819049|540649777|FG003|Overall Study|Other|0|||
149868693|NCT03819049|540649778|FG004|Overall Study|Other|0|||
149868694|NCT03819049|540649779|FG005|Overall Study|Other|0|||
149868695|NCT03819049|540649780|FG006|Overall Study|Other|0|||
149868696|NCT03819049|540649774|FG000|Overall Study|Randomized but not vaccinated|0|||
149868697|NCT03819049|540649775|FG001|Overall Study|Randomized but not vaccinated|0|||
149868698|NCT03819049|540649776|FG002|Overall Study|Randomized but not vaccinated|0|||
149868699|NCT03819049|540649777|FG003|Overall Study|Randomized but not vaccinated|1|||
149868700|NCT03819049|540649778|FG004|Overall Study|Randomized but not vaccinated|0|||
149868701|NCT03819049|540649779|FG005|Overall Study|Randomized but not vaccinated|2|||
149868702|NCT03819049|540649780|FG006|Overall Study|Randomized but not vaccinated|1|||
149868703|NCT03819049|540649774|FG000|Overall Study|Physician Decision|0|||
149868704|NCT03819049|540649775|FG001|Overall Study|Physician Decision|0|||
149868705|NCT03819049|540649776|FG002|Overall Study|Physician Decision|0|||
149868706|NCT03819049|540649777|FG003|Overall Study|Physician Decision|0|||
149868707|NCT03819049|540649778|FG004|Overall Study|Physician Decision|0|||
149868708|NCT03819049|540649779|FG005|Overall Study|Physician Decision|0|||
149868709|NCT03819049|540649780|FG006|Overall Study|Physician Decision|1|||
149868710|NCT01986010|540649781|FG000|Overall Study|Adverse Event|0|||
149868711|NCT01986010|540649782|FG001|Overall Study|Adverse Event|1|||
149868712|NCT01986010|540649783|FG002|Overall Study|Adverse Event|0|||
149868713|NCT01986010|540649784|FG003|Overall Study|Adverse Event|0|||
149868714|NCT01986010|540649785|FG004|Overall Study|Adverse Event|0|||
149868715|NCT01986010|540649786|FG005|Overall Study|Adverse Event|0|||
149868716|NCT01986010|540649787|FG006|Overall Study|Adverse Event|0|||
149868717|NCT01986010|540649788|FG007|Overall Study|Adverse Event|0|||
149868718|NCT01986010|540649789|FG008|Overall Study|Adverse Event|0|||
149868719|NCT01986010|540649790|FG009|Overall Study|Adverse Event|0|||
149868720|NCT01986010|540649791|FG010|Overall Study|Adverse Event|0|||
149868721|NCT01986010|540649792|FG011|Overall Study|Adverse Event|0|||
149868722|NCT01986010|540649793|FG012|Overall Study|Adverse Event|0|||
149868723|NCT01986010|540649794|FG013|Overall Study|Adverse Event|0|||
149868724|NCT01986010|540649795|FG014|Overall Study|Adverse Event|0|||
149868725|NCT01986010|540649796|FG015|Overall Study|Adverse Event|1|||
149868726|NCT01986010|540649797|FG016|Overall Study|Adverse Event|0|||
149868727|NCT01986010|540649781|FG000|Overall Study|Lost to Follow-up|2|||
149868728|NCT01986010|540649782|FG001|Overall Study|Lost to Follow-up|1|||
149868729|NCT01986010|540649783|FG002|Overall Study|Lost to Follow-up|2|||
149868730|NCT01986010|540649784|FG003|Overall Study|Lost to Follow-up|2|||
149868731|NCT01986010|540649785|FG004|Overall Study|Lost to Follow-up|2|||
149868732|NCT01986010|540649786|FG005|Overall Study|Lost to Follow-up|2|||
149962428|NCT00089583|540995926|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
149868733|NCT01986010|540649787|FG006|Overall Study|Lost to Follow-up|0|||
149868734|NCT01986010|540649788|FG007|Overall Study|Lost to Follow-up|0|||
149868735|NCT01986010|540649789|FG008|Overall Study|Lost to Follow-up|4|||
149868736|NCT01986010|540649790|FG009|Overall Study|Lost to Follow-up|2|||
149868737|NCT01986010|540649791|FG010|Overall Study|Lost to Follow-up|0|||
149868738|NCT01986010|540649792|FG011|Overall Study|Lost to Follow-up|1|||
149868739|NCT01986010|540649793|FG012|Overall Study|Lost to Follow-up|1|||
149868740|NCT01986010|540649794|FG013|Overall Study|Lost to Follow-up|1|||
149868741|NCT01986010|540649795|FG014|Overall Study|Lost to Follow-up|2|||
149868742|NCT01986010|540649796|FG015|Overall Study|Lost to Follow-up|0|||
149868743|NCT01986010|540649797|FG016|Overall Study|Lost to Follow-up|0|||
149868744|NCT01986010|540649781|FG000|Overall Study|Physician Decision|0|||
149962429|NCT00089583|540995927|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
149868745|NCT01986010|540649782|FG001|Overall Study|Physician Decision|0|||
149868746|NCT01986010|540649783|FG002|Overall Study|Physician Decision|0|||
149868747|NCT01986010|540649784|FG003|Overall Study|Physician Decision|0|||
149868748|NCT01986010|540649785|FG004|Overall Study|Physician Decision|0|||
149868749|NCT01986010|540649786|FG005|Overall Study|Physician Decision|0|||
149868750|NCT01986010|540649787|FG006|Overall Study|Physician Decision|0|||
149868751|NCT01986010|540649788|FG007|Overall Study|Physician Decision|0|||
149868752|NCT01986010|540649789|FG008|Overall Study|Physician Decision|0|||
149868753|NCT01986010|540649790|FG009|Overall Study|Physician Decision|0|||
149868754|NCT01986010|540649791|FG010|Overall Study|Physician Decision|0|||
149868755|NCT01986010|540649792|FG011|Overall Study|Physician Decision|0|||
149868756|NCT01986010|540649793|FG012|Overall Study|Physician Decision|0|||
149868757|NCT01986010|540649794|FG013|Overall Study|Physician Decision|0|||
149868758|NCT01986010|540649795|FG014|Overall Study|Physician Decision|1|||
149868759|NCT01986010|540649796|FG015|Overall Study|Physician Decision|0|||
149868760|NCT01986010|540649797|FG016|Overall Study|Physician Decision|0|||
149868761|NCT01986010|540649781|FG000|Overall Study|Withdrawal by Subject|2|||
149868762|NCT01986010|540649782|FG001|Overall Study|Withdrawal by Subject|2|||
149868763|NCT01986010|540649783|FG002|Overall Study|Withdrawal by Subject|3|||
149868764|NCT01986010|540649784|FG003|Overall Study|Withdrawal by Subject|0|||
149868765|NCT01986010|540649785|FG004|Overall Study|Withdrawal by Subject|2|||
149868766|NCT01986010|540649786|FG005|Overall Study|Withdrawal by Subject|4|||
149868767|NCT01986010|540649787|FG006|Overall Study|Withdrawal by Subject|0|||
149868768|NCT01986010|540649788|FG007|Overall Study|Withdrawal by Subject|0|||
149868769|NCT01986010|540649789|FG008|Overall Study|Withdrawal by Subject|0|||
149868770|NCT01986010|540649790|FG009|Overall Study|Withdrawal by Subject|0|||
149868771|NCT01986010|540649791|FG010|Overall Study|Withdrawal by Subject|0|||
149868772|NCT01986010|540649792|FG011|Overall Study|Withdrawal by Subject|2|||
149868773|NCT01986010|540649793|FG012|Overall Study|Withdrawal by Subject|0|||
149868774|NCT01986010|540649794|FG013|Overall Study|Withdrawal by Subject|1|||
149868775|NCT01986010|540649795|FG014|Overall Study|Withdrawal by Subject|2|||
149868776|NCT01986010|540649796|FG015|Overall Study|Withdrawal by Subject|0|||
149868777|NCT01986010|540649797|FG016|Overall Study|Withdrawal by Subject|0|||
149868778|NCT01986010|540649781|FG000|Overall Study|Status Not Recorded|2|||
149868779|NCT01986010|540649782|FG001|Overall Study|Status Not Recorded|4|||
149868780|NCT01986010|540649783|FG002|Overall Study|Status Not Recorded|2|||
149868781|NCT01986010|540649784|FG003|Overall Study|Status Not Recorded|0|||
149868782|NCT01986010|540649785|FG004|Overall Study|Status Not Recorded|1|||
149868783|NCT01986010|540649786|FG005|Overall Study|Status Not Recorded|2|||
149868784|NCT01986010|540649787|FG006|Overall Study|Status Not Recorded|0|||
149868785|NCT01986010|540649788|FG007|Overall Study|Status Not Recorded|0|||
149868786|NCT01986010|540649789|FG008|Overall Study|Status Not Recorded|2|||
149868787|NCT01986010|540649790|FG009|Overall Study|Status Not Recorded|1|||
149868788|NCT01986010|540649791|FG010|Overall Study|Status Not Recorded|7|||
149868789|NCT01986010|540649792|FG011|Overall Study|Status Not Recorded|7|||
149868790|NCT01986010|540649793|FG012|Overall Study|Status Not Recorded|9|||
149868791|NCT01986010|540649794|FG013|Overall Study|Status Not Recorded|9|||
149868792|NCT01986010|540649795|FG014|Overall Study|Status Not Recorded|5|||
149868793|NCT01986010|540649796|FG015|Overall Study|Status Not Recorded|10|||
149868794|NCT01986010|540649797|FG016|Overall Study|Status Not Recorded|4|||
149868795|NCT01335997|540649800|FG000|Period I and II|Adverse Event|63|||
149868796|NCT01335997|540649801|FG001|Period I and II|Adverse Event|43|||
149868797|NCT01335997|540649800|FG000|Period I and II|Noncompliance with Study Drug|1|||
149868798|NCT01335997|540649801|FG001|Period I and II|Noncompliance with Study Drug|1|||
149868799|NCT01335997|540649800|FG000|Period I and II|Lost to Follow-up|3|||
149868800|NCT01335997|540649801|FG001|Period I and II|Lost to Follow-up|5|||
149868801|NCT01335997|540649800|FG000|Period I and II|Withdrawal by Subject|9|||
149868802|NCT01335997|540649801|FG001|Period I and II|Withdrawal by Subject|4|||
149868803|NCT01335997|540649800|FG000|Period I and II|Study Terminated by Sponsor|406|||
149868804|NCT01335997|540649801|FG001|Period I and II|Study Terminated by Sponsor|415|||
149868805|NCT01335997|540649800|FG000|Period I and II|Protocol Violation|9|||
149868806|NCT01335997|540649801|FG001|Period I and II|Protocol Violation|10|||
149868807|NCT01335997|540649800|FG000|Period I and II|Physician Decision|2|||
149962430|NCT00089583|540995926|FG000|Overall Study|Participant Incarcerated|0|||
149962431|NCT00089583|540995927|FG001|Overall Study|Participant Incarcerated|1|||
150173889|NCT03946670|541772992|FG001|Overall Study|New Therapy For Study Indication|0|||
150173890|NCT03946670|541772991|FG000|Overall Study|Not Treated|1|||
149868808|NCT01335997|540649801|FG001|Period I and II|Physician Decision|1|||
149868809|NCT01335997|540649800|FG000|Period III|Adverse Event|0|||
149868810|NCT01335997|540649801|FG001|Period III|Adverse Event|2|||
149868811|NCT01335997|540649800|FG000|Period III|Study Terminated by Sponsor|77|||
149868812|NCT01335997|540649801|FG001|Period III|Study Terminated by Sponsor|76|||
150173891|NCT03946670|541772992|FG001|Overall Study|Not Treated|1|||
149868813|NCT01335997|540649800|FG000|Period III|Protocol Violation|0|||
149868814|NCT01335997|540649801|FG001|Period III|Protocol Violation|1|||
149868815|NCT01335997|540649800|FG000|Period III|Lost to Follow-up|1|||
149868816|NCT01335997|540649801|FG001|Period III|Lost to Follow-up|0|||
149868817|NCT00536263|540649802|FG000|Overall Study|Adverse Event|5|||
149868818|NCT00536263|540649803|FG001|Overall Study|Adverse Event|5|||
149868819|NCT00536263|540649804|FG002|Overall Study|Adverse Event|7|||
149868820|NCT00536263|540649802|FG000|Overall Study|Lost to Follow-up|3|||
149868821|NCT00536263|540649803|FG001|Overall Study|Lost to Follow-up|4|||
150173892|NCT00057837|541773000|FG000|Overall Study|Progression/relapse|12|||
149868822|NCT00536263|540649804|FG002|Overall Study|Lost to Follow-up|4|||
149868823|NCT00536263|540649802|FG000|Overall Study|Subject withdrew - not treatment related|2|||
149868824|NCT00536263|540649803|FG001|Overall Study|Subject withdrew - not treatment related|0|||
149868825|NCT00536263|540649804|FG002|Overall Study|Subject withdrew - not treatment related|5|||
149868826|NCT00536263|540649802|FG000|Overall Study|Subject withdrew - treatment related|0|||
149868827|NCT00536263|540649803|FG001|Overall Study|Subject withdrew - treatment related|3|||
149868828|NCT00536263|540649804|FG002|Overall Study|Subject withdrew - treatment related|2|||
149868829|NCT00536263|540649802|FG000|Overall Study|Noncompliance with protocol|0|||
149868830|NCT00536263|540649803|FG001|Overall Study|Noncompliance with protocol|0|||
149868831|NCT00536263|540649804|FG002|Overall Study|Noncompliance with protocol|1|||
149868832|NCT00536263|540649802|FG000|Overall Study|Did not meet protocol eligibility|1|||
149868833|NCT00536263|540649803|FG001|Overall Study|Did not meet protocol eligibility|2|||
149868834|NCT00536263|540649804|FG002|Overall Study|Did not meet protocol eligibility|2|||
149868835|NCT00826449|540649805|FG000|Overall Study|Disease Progression|4|||
149868836|NCT00826449|540649805|FG000|Overall Study|Withdrawal by Subject|1|||
149868837|NCT01103466|540649806|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
149868838|NCT01103466|540649807|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
149868839|NCT01103466|540649808|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
149868840|NCT01103466|540649806|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
149868841|NCT01103466|540649807|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
149868842|NCT01103466|540649808|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
149868843|NCT01103466|540649806|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
149868844|NCT01103466|540649807|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
149868845|NCT01103466|540649808|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
149868846|NCT01103466|540649806|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
149868847|NCT01103466|540649807|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
149868848|NCT01103466|540649808|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
149868849|NCT01103466|540649806|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
149868850|NCT01103466|540649807|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
149868851|NCT01103466|540649808|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
149868852|NCT01103466|540649806|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
149868853|NCT01103466|540649807|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
149868854|NCT01103466|540649808|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
149868855|NCT02994940|540649809|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
149868856|NCT02994940|540649810|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
149868857|NCT02994940|540649809|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
149868858|NCT02994940|540649810|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
149868859|NCT02994940|540649809|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
149868860|NCT02994940|540649810|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
149868861|NCT02331368|540649813|FG000|Overall Study|Withdrawal by Subject|3|||
149868862|NCT02302859|540649823|FG000|Overall Study|Lost Phone|1|||
149868863|NCT02302859|540649824|FG001|Overall Study|Lost Phone|1|||
149868864|NCT02302859|540649823|FG000|Overall Study|Withdrawal by Subject|0|||
149868865|NCT02302859|540649824|FG001|Overall Study|Withdrawal by Subject|1|||
149868866|NCT03283761|540649831|FG000|Study Treatment|Patient Non-Compliance|1|||
149868867|NCT03283761|540649831|FG000|Study Treatment|Alternative Cancer Therapy|7|||
149868868|NCT03283761|540649831|FG000|Study Treatment|Disease progression|21|||
149868869|NCT03283761|540649831|FG000|Study Treatment|Adverse Event|3|||
149868870|NCT03283761|540649831|FG000|Study Treatment|Withdrawal by Subject|4|||
149868871|NCT03283761|540649831|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
149868872|NCT03283761|540649831|FG000|Study Treatment|Symptomatic Deterioration|1|||
149868873|NCT03283761|540649831|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
149868874|NCT03283761|540649831|FG000|Follow up|Lost to Follow-up|1|||
149868875|NCT03283761|540649831|FG000|Follow up|Symptomatic Deterioration|1|||
149868876|NCT03283761|540649831|FG000|Follow up|Death|29|||
149868877|NCT03283761|540649831|FG000|Follow up|study terminated|4|||
149868878|NCT03283761|540649831|FG000|Follow up|Primary Investigator Withdrawal|1|||
149868879|NCT03283761|540649831|FG000|Follow up|Switched to alternative therapy|1|||
149868880|NCT03283761|540649831|FG000|Follow up|Subject is now in Hospice|1|||
149868881|NCT01941940|540649832|FG000|Overall Study|Adverse Event|11|||
149868882|NCT01941940|540649832|FG000|Overall Study|Lost to Follow-up|2|||
149868883|NCT01941940|540649832|FG000|Overall Study|Physician Decision|2|||
149868884|NCT01941940|540649832|FG000|Overall Study|Withdrawal by Subject|15|||
149962432|NCT01412983|540995928|FG000|1st Period|Ineligible|0|||
149962433|NCT01412983|540995929|FG001|1st Period|Ineligible|1|||
149962434|NCT01412983|540995928|FG000|1st Period|Positive slit lamp finding|0|||
149868885|NCT01941940|540649832|FG000|Overall Study|Death|1|||
149962435|NCT01412983|540995929|FG001|1st Period|Positive slit lamp finding|1|||
149962436|NCT01412983|540995928|FG000|1st Period|Unacceptable lens movement|0|||
149868886|NCT01941940|540649832|FG000|Overall Study|Other|1|||
149868887|NCT01941940|540649832|FG000|Overall Study|Other|1|||
149868888|NCT03118570|540649834|FG000|Overall Study|Adverse Event|2|||
149868889|NCT03118570|540649835|FG001|Overall Study|Adverse Event|0|||
149868890|NCT03118570|540649836|FG002|Overall Study|Adverse Event|0|||
149868891|NCT03118570|540649837|FG003|Overall Study|Adverse Event|0|||
149868892|NCT03118570|540649838|FG004|Overall Study|Adverse Event|3|||
149868893|NCT03118570|540649834|FG000|Overall Study|Withdrawal by Subject|0|||
149868894|NCT03118570|540649835|FG001|Overall Study|Withdrawal by Subject|1|||
149868895|NCT03118570|540649836|FG002|Overall Study|Withdrawal by Subject|4|||
149868896|NCT03118570|540649837|FG003|Overall Study|Withdrawal by Subject|0|||
149868897|NCT03118570|540649838|FG004|Overall Study|Withdrawal by Subject|1|||
149868898|NCT03118570|540649834|FG000|Overall Study|Lost to Follow-up|2|||
149868899|NCT03118570|540649835|FG001|Overall Study|Lost to Follow-up|3|||
149868900|NCT03118570|540649836|FG002|Overall Study|Lost to Follow-up|1|||
149868901|NCT03118570|540649837|FG003|Overall Study|Lost to Follow-up|0|||
149868902|NCT03118570|540649838|FG004|Overall Study|Lost to Follow-up|1|||
149868903|NCT03118570|540649834|FG000|Overall Study|Other, Not Specified|1|||
149868904|NCT03118570|540649835|FG001|Overall Study|Other, Not Specified|3|||
149868905|NCT03118570|540649836|FG002|Overall Study|Other, Not Specified|0|||
149868906|NCT03118570|540649837|FG003|Overall Study|Other, Not Specified|0|||
149868907|NCT03118570|540649838|FG004|Overall Study|Other, Not Specified|0|||
149868908|NCT00006721|540652056|FG000|Overall Study|Adverse Event|0|||
149868909|NCT00006721|540652057|FG001|Overall Study|Adverse Event|4|||
149868910|NCT00006721|540652058|FG002|Overall Study|Adverse Event|4|||
149868911|NCT00006721|540652056|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149962437|NCT01412983|540995929|FG001|1st Period|Unacceptable lens movement|1|||
149962438|NCT01412983|540995928|FG000|1st Period|Inability to maintain wear|0|||
149962439|NCT01412983|540995929|FG001|1st Period|Inability to maintain wear|1|||
149962440|NCT01623154|540995930|FG000|Overall Study|Did not drink Pranactin Citric|4|||
149962441|NCT00890097|540995931|FG000|Overall Study|Adverse Event|21|||
149962442|NCT00890097|540995932|FG001|Overall Study|Adverse Event|32|||
149962443|NCT00890097|540995933|FG002|Overall Study|Adverse Event|28|||
149962444|NCT00890097|540995931|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
149962445|NCT00890097|540995932|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
149962446|NCT00890097|540995933|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
149962447|NCT00890097|540995931|FG000|Overall Study|Withdrew Consent|9|||
149962448|NCT00890097|540995932|FG001|Overall Study|Withdrew Consent|6|||
149962449|NCT00890097|540995933|FG002|Overall Study|Withdrew Consent|9|||
149962450|NCT00890097|540995931|FG000|Overall Study|Lost to Follow-up|5|||
149962451|NCT00890097|540995932|FG001|Overall Study|Lost to Follow-up|5|||
149868912|NCT00006721|540652057|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
149868913|NCT00006721|540652058|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
149868914|NCT00006721|540652056|FG000|Overall Study|Progression/Relapse|0|||
149868915|NCT00006721|540652057|FG001|Overall Study|Progression/Relapse|1|||
149868916|NCT00006721|540652058|FG002|Overall Study|Progression/Relapse|2|||
149868917|NCT00006721|540652056|FG000|Overall Study|Death|0|||
149962452|NCT00890097|540995933|FG002|Overall Study|Lost to Follow-up|5|||
149962453|NCT00890097|540995931|FG000|Overall Study|Noncompliance|0|||
149962454|NCT00890097|540995932|FG001|Overall Study|Noncompliance|4|||
149962455|NCT00890097|540995933|FG002|Overall Study|Noncompliance|4|||
149962456|NCT00890097|540995931|FG000|Overall Study|Sponsor Decision|7|||
149868918|NCT00006721|540652057|FG001|Overall Study|Death|1|||
149868919|NCT00006721|540652058|FG002|Overall Study|Death|2|||
149868920|NCT00006721|540652056|FG000|Overall Study|Other - Not Protocol Specified|0|||
149868921|NCT00006721|540652057|FG001|Overall Study|Other - Not Protocol Specified|7|||
149868922|NCT00006721|540652058|FG002|Overall Study|Other - Not Protocol Specified|7|||
149868923|NCT00006721|540652056|FG000|Overall Study|Ineligible|2|||
149868924|NCT00006721|540652057|FG001|Overall Study|Ineligible|12|||
149868925|NCT00006721|540652058|FG002|Overall Study|Ineligible|10|||
149868926|NCT00006721|540652056|FG000|Overall Study|Eligible but no Treatment Received|1|||
149868927|NCT00006721|540652057|FG001|Overall Study|Eligible but no Treatment Received|0|||
149868928|NCT00006721|540652058|FG002|Overall Study|Eligible but no Treatment Received|0|||
149868929|NCT03653507|540652059|FG000|Overall Study|Miscellaneous|28|||
149868930|NCT03653507|540652060|FG001|Overall Study|Miscellaneous|19|||
149868931|NCT03653507|540652059|FG000|Overall Study|Withdrawal by Subject|37|||
149868932|NCT03653507|540652060|FG001|Overall Study|Withdrawal by Subject|22|||
149868933|NCT03653507|540652059|FG000|Overall Study|Protocol Deviation|2|||
149868934|NCT03653507|540652060|FG001|Overall Study|Protocol Deviation|1|||
149868935|NCT03653507|540652059|FG000|Overall Study|Progressive disease|117|||
149868936|NCT03653507|540652060|FG001|Overall Study|Progressive disease|168|||
149868937|NCT03653507|540652059|FG000|Overall Study|Lost to Follow-up|1|||
149868938|NCT03653507|540652060|FG001|Overall Study|Lost to Follow-up|1|||
149868939|NCT03653507|540652059|FG000|Overall Study|Death|25|||
149868940|NCT03653507|540652060|FG001|Overall Study|Death|22|||
149868941|NCT03653507|540652059|FG000|Overall Study|Adverse Event|35|||
149868942|NCT03653507|540652060|FG001|Overall Study|Adverse Event|14|||
149868943|NCT03986138|540652071|FG000|First MRI Examination|Physician Decision|0|||
149868944|NCT03986138|540652072|FG001|First MRI Examination|Physician Decision|1|||
149868945|NCT03986138|540652071|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
149868946|NCT03986138|540652072|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
149868947|NCT03986138|540652071|FG000|Washout|Withdrawal by Subject|4|||
149868948|NCT03986138|540652072|FG001|Washout|Withdrawal by Subject|5|||
149868949|NCT03986138|540652071|FG000|Washout|Lost to Follow-up|0|||
149868950|NCT03986138|540652072|FG001|Washout|Lost to Follow-up|2|||
149868951|NCT03986138|540652071|FG000|Washout|Adverse Event|1|||
149868952|NCT03986138|540652072|FG001|Washout|Adverse Event|1|||
149868953|NCT03986138|540652071|FG000|Washout|Other reason|5|||
149868954|NCT03986138|540652072|FG001|Washout|Other reason|5|||
149868955|NCT03986138|540652071|FG000|Second MRI Examination|Withdrawal by Subject|0|||
149868956|NCT03986138|540652072|FG001|Second MRI Examination|Withdrawal by Subject|2|||
149868957|NCT04305587|540652073|FG000|Overall Study|Withdrawal by Subject|0|||
149868958|NCT04305587|540652074|FG001|Overall Study|Withdrawal by Subject|0|||
149868959|NCT04305587|540652075|FG002|Overall Study|Withdrawal by Subject|0|||
149868960|NCT04305587|540652076|FG003|Overall Study|Withdrawal by Subject|1|||
149868961|NCT04305587|540652077|FG004|Overall Study|Withdrawal by Subject|0|||
149868962|NCT04305587|540652078|FG005|Overall Study|Withdrawal by Subject|0|||
149868963|NCT04305587|540652079|FG006|Overall Study|Withdrawal by Subject|0|||
149868964|NCT04305587|540652080|FG007|Overall Study|Withdrawal by Subject|0|||
149868965|NCT04305587|540652081|FG008|Overall Study|Withdrawal by Subject|0|||
149868966|NCT01523457|540652082|FG000|Overall Study|Withdrawal by Subject|7|||
149868967|NCT01523457|540652083|FG001|Overall Study|Withdrawal by Subject|2|||
149868968|NCT01367665|540652084|FG000|Overall Study|Death|102|||
149868969|NCT01367665|540652085|FG001|Overall Study|Death|19|||
149868970|NCT01367665|540652084|FG000|Overall Study|Lost to Follow-up|222|||
149868971|NCT01367665|540652085|FG001|Overall Study|Lost to Follow-up|22|||
149868972|NCT01367665|540652084|FG000|Overall Study|Not Done|118|||
149868973|NCT01367665|540652085|FG001|Overall Study|Not Done|14|||
149868974|NCT02492880|540652086|FG000|Overall Study|Lost to Follow-up|1|||
149868975|NCT02492880|540652086|FG000|Overall Study|Protocol Violation|1|||
149868976|NCT01200992|540652087|FG000|Overall Study|Study terminated early|35|||
149868977|NCT01200992|540652088|FG001|Overall Study|Study terminated early|41|||
149868978|NCT01200992|540652087|FG000|Overall Study|Randomized but not treated|2|||
149868979|NCT01200992|540652088|FG001|Overall Study|Randomized but not treated|0|||
149868980|NCT00792935|540652089|FG000|Overall Study|Adverse Event|2|||
149868981|NCT00792935|540652090|FG001|Overall Study|Adverse Event|1|||
149868982|NCT00792935|540652089|FG000|Overall Study|Lost to Follow-up|0|||
149868983|NCT00792935|540652090|FG001|Overall Study|Lost to Follow-up|1|||
149868984|NCT00792935|540652089|FG000|Overall Study|Protocol Violation|2|||
149868985|NCT00792935|540652090|FG001|Overall Study|Protocol Violation|0|||
149868986|NCT00792935|540652089|FG000|Overall Study|Withdrawal by Subject|0|||
149868987|NCT00792935|540652090|FG001|Overall Study|Withdrawal by Subject|1|||
149868988|NCT03186781|540652091|FG000|Overall Study|Lost to Follow-up|0|||
149868989|NCT03186781|540652092|FG001|Overall Study|Lost to Follow-up|0|||
149868990|NCT03186781|540652093|FG002|Overall Study|Lost to Follow-up|1|||
149868991|NCT03186781|540652094|FG003|Overall Study|Lost to Follow-up|0|||
149868992|NCT03186781|540652095|FG004|Overall Study|Lost to Follow-up|1|||
149868993|NCT03186781|540652096|FG005|Overall Study|Lost to Follow-up|0|||
149868994|NCT03186781|540652091|FG000|Overall Study|Moved from Area|0|||
149868995|NCT03186781|540652092|FG001|Overall Study|Moved from Area|0|||
149868996|NCT03186781|540652093|FG002|Overall Study|Moved from Area|0|||
149868997|NCT03186781|540652094|FG003|Overall Study|Moved from Area|0|||
149868998|NCT03186781|540652095|FG004|Overall Study|Moved from Area|1|||
149868999|NCT03186781|540652096|FG005|Overall Study|Moved from Area|0|||
149869000|NCT03186781|540652091|FG000|Overall Study|Withdrawal by Subject|0|||
149869001|NCT03186781|540652092|FG001|Overall Study|Withdrawal by Subject|0|||
149869002|NCT03186781|540652093|FG002|Overall Study|Withdrawal by Subject|0|||
149869003|NCT03186781|540652094|FG003|Overall Study|Withdrawal by Subject|0|||
149869004|NCT03186781|540652095|FG004|Overall Study|Withdrawal by Subject|1|||
149869005|NCT03186781|540652096|FG005|Overall Study|Withdrawal by Subject|0|||
149869006|NCT02622113|540652101|FG000|Overall Study|Adverse Event|4|||
149869007|NCT02622113|540652102|FG001|Overall Study|Adverse Event|4|||
149869008|NCT02622113|540652101|FG000|Overall Study|Physician Decision|0|||
149869009|NCT02622113|540652102|FG001|Overall Study|Physician Decision|1|||
149869010|NCT02622113|540652101|FG000|Overall Study|Withdrawal by Subject|0|||
149869011|NCT02622113|540652102|FG001|Overall Study|Withdrawal by Subject|2|||
149869012|NCT02622113|540652101|FG000|Overall Study|Stopping Criteria|1|||
149869013|NCT02622113|540652102|FG001|Overall Study|Stopping Criteria|3|||
149869014|NCT00667810|540652103|FG000|Overall Study|Adverse Event|13|||
149869015|NCT00667810|540652104|FG001|Overall Study|Adverse Event|14|||
149869016|NCT00667810|540652105|FG002|Overall Study|Adverse Event|19|||
149869017|NCT00667810|540652106|FG003|Overall Study|Adverse Event|1|||
149869018|NCT00667810|540652103|FG000|Overall Study|Death|1|||
149869019|NCT00667810|540652104|FG001|Overall Study|Death|1|||
149869020|NCT00667810|540652105|FG002|Overall Study|Death|3|||
149869021|NCT00667810|540652106|FG003|Overall Study|Death|0|||
149869022|NCT00667810|540652103|FG000|Overall Study|Lack of Efficacy|1|||
149869023|NCT00667810|540652104|FG001|Overall Study|Lack of Efficacy|0|||
149869024|NCT00667810|540652105|FG002|Overall Study|Lack of Efficacy|2|||
149869025|NCT00667810|540652106|FG003|Overall Study|Lack of Efficacy|0|||
149869026|NCT00667810|540652103|FG000|Overall Study|Lost to Follow-up|1|||
149869027|NCT00667810|540652104|FG001|Overall Study|Lost to Follow-up|4|||
149869028|NCT00667810|540652105|FG002|Overall Study|Lost to Follow-up|2|||
149869029|NCT00667810|540652106|FG003|Overall Study|Lost to Follow-up|0|||
149869030|NCT00667810|540652103|FG000|Overall Study|Physician Decision|1|||
149869031|NCT00667810|540652104|FG001|Overall Study|Physician Decision|1|||
149869032|NCT00667810|540652105|FG002|Overall Study|Physician Decision|2|||
149869033|NCT00667810|540652106|FG003|Overall Study|Physician Decision|0|||
149869034|NCT00667810|540652103|FG000|Overall Study|Protocol Violation|0|||
149869035|NCT00667810|540652104|FG001|Overall Study|Protocol Violation|2|||
149869036|NCT00667810|540652105|FG002|Overall Study|Protocol Violation|0|||
149869037|NCT00667810|540652106|FG003|Overall Study|Protocol Violation|0|||
149869038|NCT00667810|540652103|FG000|Overall Study|Withdrawal by Subject|14|||
149869039|NCT00667810|540652104|FG001|Overall Study|Withdrawal by Subject|20|||
149869040|NCT00667810|540652105|FG002|Overall Study|Withdrawal by Subject|29|||
149869041|NCT00667810|540652106|FG003|Overall Study|Withdrawal by Subject|1|||
149869042|NCT00667810|540652103|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
149869043|NCT00667810|540652104|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
149869044|NCT00667810|540652105|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
149869045|NCT00667810|540652106|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
149869046|NCT00667810|540652103|FG000|Overall Study|Failed to Return|0|||
149869047|NCT00667810|540652104|FG001|Overall Study|Failed to Return|0|||
149869048|NCT00667810|540652105|FG002|Overall Study|Failed to Return|2|||
149869049|NCT00667810|540652106|FG003|Overall Study|Failed to Return|0|||
149869050|NCT00667810|540652103|FG000|Overall Study|Loss of Caregiver|0|||
149869051|NCT00667810|540652104|FG001|Overall Study|Loss of Caregiver|1|||
149869052|NCT00667810|540652105|FG002|Overall Study|Loss of Caregiver|3|||
149869053|NCT00667810|540652106|FG003|Overall Study|Loss of Caregiver|0|||
149869054|NCT00667810|540652103|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
149869055|NCT00667810|540652104|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
149869056|NCT00667810|540652105|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
149869057|NCT00667810|540652106|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
149869058|NCT00667810|540652103|FG000|Overall Study|Other|6|||
149869059|NCT00667810|540652104|FG001|Overall Study|Other|6|||
149869060|NCT00667810|540652105|FG002|Overall Study|Other|5|||
149869061|NCT00667810|540652106|FG003|Overall Study|Other|0|||
149869062|NCT01570686|540652109|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149869063|NCT01570686|540652110|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149869064|NCT01570686|540652109|FG000|Overall Study|Administrative problems|0|||
149869065|NCT01570686|540652110|FG001|Overall Study|Administrative problems|1|||
149869066|NCT01570686|540652109|FG000|Overall Study|Adverse Event|8|||
149869067|NCT01570686|540652110|FG001|Overall Study|Adverse Event|6|||
149869068|NCT01570686|540652109|FG000|Overall Study|Lost to Follow-up|4|||
149869069|NCT01570686|540652110|FG001|Overall Study|Lost to Follow-up|3|||
149869070|NCT01570686|540652109|FG000|Overall Study|Protocol Deviation|3|||
149869071|NCT01570686|540652110|FG001|Overall Study|Protocol Deviation|0|||
149869072|NCT01570686|540652109|FG000|Overall Study|Withdrawal by Subject|4|||
149869073|NCT01570686|540652110|FG001|Overall Study|Withdrawal by Subject|4|||
149869074|NCT01570686|540652109|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149962457|NCT00890097|540995932|FG001|Overall Study|Sponsor Decision|11|||
149962458|NCT00890097|540995933|FG002|Overall Study|Sponsor Decision|7|||
149962459|NCT00890097|540995931|FG000|Overall Study|Did not attend final visit|2|||
149869075|NCT01570686|540652110|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149869076|NCT04112173|540652114|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
149869077|NCT01561430|540652115|FG000|Overall Study|Adverse Event|0|||
149869078|NCT01561430|540652116|FG001|Overall Study|Adverse Event|0|||
149869079|NCT01561430|540652117|FG002|Overall Study|Adverse Event|3|||
149869080|NCT01561430|540652118|FG003|Overall Study|Adverse Event|1|||
149869081|NCT01561430|540652115|FG000|Overall Study|Withdrawal by Subject|0|||
149869082|NCT01561430|540652116|FG001|Overall Study|Withdrawal by Subject|0|||
149869083|NCT01561430|540652117|FG002|Overall Study|Withdrawal by Subject|1|||
149869084|NCT01561430|540652118|FG003|Overall Study|Withdrawal by Subject|0|||
149869085|NCT01561430|540652115|FG000|Overall Study|Physician Decision|0|||
149869086|NCT01561430|540652116|FG001|Overall Study|Physician Decision|1|||
149869087|NCT01561430|540652117|FG002|Overall Study|Physician Decision|0|||
149869088|NCT01561430|540652118|FG003|Overall Study|Physician Decision|0|||
149869089|NCT01561430|540652115|FG000|Overall Study|Sponsor Decision|1|||
149869090|NCT01561430|540652116|FG001|Overall Study|Sponsor Decision|14|||
149869091|NCT01561430|540652117|FG002|Overall Study|Sponsor Decision|13|||
149869092|NCT01561430|540652118|FG003|Overall Study|Sponsor Decision|12|||
149869093|NCT00622466|540652126|FG000|Overall Study|Death|1|||
149869094|NCT00622466|540652126|FG000|Overall Study|Adverse Event|1|||
149869095|NCT00622466|540652126|FG000|Overall Study|Withdrawal by Subject|2|||
149869096|NCT04453202|540652131|FG000|Overall Study|Adverse Event|0|||
149869097|NCT04453202|540652132|FG001|Overall Study|Adverse Event|0|||
149869098|NCT04453202|540652133|FG002|Overall Study|Adverse Event|0|||
149869099|NCT04453202|540652134|FG003|Overall Study|Adverse Event|0|||
149869100|NCT04453202|540652135|FG004|Overall Study|Adverse Event|0|||
149869101|NCT04453202|540652136|FG005|Overall Study|Adverse Event|0|||
149869102|NCT04453202|540652137|FG006|Overall Study|Adverse Event|1|||
149869103|NCT04453202|540652138|FG007|Overall Study|Adverse Event|0|||
149869104|NCT04453202|540652139|FG008|Overall Study|Adverse Event|0|||
149869105|NCT04453202|540652140|FG009|Overall Study|Adverse Event|0|||
149869106|NCT04453202|540652141|FG010|Overall Study|Adverse Event|0|||
149869107|NCT04453202|540652131|FG000|Overall Study|Death|0|||
149869108|NCT04453202|540652132|FG001|Overall Study|Death|0|||
149869109|NCT04453202|540652133|FG002|Overall Study|Death|0|||
149869110|NCT04453202|540652134|FG003|Overall Study|Death|0|||
149869111|NCT04453202|540652135|FG004|Overall Study|Death|0|||
149869112|NCT04453202|540652136|FG005|Overall Study|Death|0|||
149962460|NCT00890097|540995932|FG001|Overall Study|Did not attend final visit|3|||
149962461|NCT00890097|540995933|FG002|Overall Study|Did not attend final visit|0|||
150173893|NCT00057837|541773001|FG001|Overall Study|Progression/relapse|14|||
149869113|NCT04453202|540652137|FG006|Overall Study|Death|0|||
149869114|NCT04453202|540652138|FG007|Overall Study|Death|0|||
149869115|NCT04453202|540652139|FG008|Overall Study|Death|0|||
149869116|NCT04453202|540652140|FG009|Overall Study|Death|1|||
149869117|NCT04453202|540652141|FG010|Overall Study|Death|0|||
149869118|NCT04453202|540652131|FG000|Overall Study|Lost to Follow-up|0|||
149869119|NCT04453202|540652132|FG001|Overall Study|Lost to Follow-up|1|||
149869120|NCT04453202|540652133|FG002|Overall Study|Lost to Follow-up|0|||
149869121|NCT04453202|540652134|FG003|Overall Study|Lost to Follow-up|1|||
149962462|NCT00890097|540995931|FG000|Overall Study|Subject Decision|3|||
149962463|NCT00890097|540995932|FG001|Overall Study|Subject Decision|2|||
149869122|NCT04453202|540652135|FG004|Overall Study|Lost to Follow-up|0|||
149869123|NCT04453202|540652136|FG005|Overall Study|Lost to Follow-up|0|||
149869124|NCT04453202|540652137|FG006|Overall Study|Lost to Follow-up|0|||
149869125|NCT04453202|540652138|FG007|Overall Study|Lost to Follow-up|0|||
149869126|NCT04453202|540652139|FG008|Overall Study|Lost to Follow-up|0|||
149869127|NCT04453202|540652140|FG009|Overall Study|Lost to Follow-up|1|||
149869128|NCT04453202|540652141|FG010|Overall Study|Lost to Follow-up|1|||
149869129|NCT04453202|540652131|FG000|Overall Study|Withdrawal by Subject|1|||
149869130|NCT04453202|540652132|FG001|Overall Study|Withdrawal by Subject|2|||
149869131|NCT04453202|540652133|FG002|Overall Study|Withdrawal by Subject|1|||
149869132|NCT04453202|540652134|FG003|Overall Study|Withdrawal by Subject|2|||
149869133|NCT04453202|540652135|FG004|Overall Study|Withdrawal by Subject|1|||
149869134|NCT04453202|540652136|FG005|Overall Study|Withdrawal by Subject|1|||
149869135|NCT04453202|540652137|FG006|Overall Study|Withdrawal by Subject|0|||
149869136|NCT04453202|540652138|FG007|Overall Study|Withdrawal by Subject|0|||
149869137|NCT04453202|540652139|FG008|Overall Study|Withdrawal by Subject|0|||
149869138|NCT04453202|540652140|FG009|Overall Study|Withdrawal by Subject|1|||
149869139|NCT04453202|540652141|FG010|Overall Study|Withdrawal by Subject|0|||
149869140|NCT04453202|540652131|FG000|Overall Study|Adverse Event|0|||
149869141|NCT04453202|540652132|FG001|Overall Study|Adverse Event|0|||
149869142|NCT04453202|540652133|FG002|Overall Study|Adverse Event|0|||
149869143|NCT04453202|540652134|FG003|Overall Study|Adverse Event|0|||
149869144|NCT04453202|540652135|FG004|Overall Study|Adverse Event|0|||
149869145|NCT04453202|540652136|FG005|Overall Study|Adverse Event|1|||
149869146|NCT04453202|540652137|FG006|Overall Study|Adverse Event|0|||
149962464|NCT00890097|540995933|FG002|Overall Study|Subject Decision|6|||
149962465|NCT00890097|540995931|FG000|Overall Study|Randomization Error|2|||
149962466|NCT00890097|540995932|FG001|Overall Study|Randomization Error|0|||
149962467|NCT00890097|540995933|FG002|Overall Study|Randomization Error|0|||
149962468|NCT00890097|540995931|FG000|Overall Study|Failed inclusion criteria|3|||
149869147|NCT04453202|540652138|FG007|Overall Study|Adverse Event|0|||
149869148|NCT04453202|540652139|FG008|Overall Study|Adverse Event|0|||
149869149|NCT04453202|540652140|FG009|Overall Study|Adverse Event|0|||
149869150|NCT04453202|540652141|FG010|Overall Study|Adverse Event|0|||
149869151|NCT01355159|540652144|FG000|Overall Study|Withdrew consent|39|||
149869152|NCT01355159|540652145|FG001|Overall Study|Withdrew consent|47|||
149869153|NCT01355159|540652144|FG000|Overall Study|No primary outcome data|17|||
149869154|NCT01355159|540652145|FG001|Overall Study|No primary outcome data|11|||
149869155|NCT01355159|540652144|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
149962469|NCT00890097|540995932|FG001|Overall Study|Failed inclusion criteria|4|||
149962470|NCT00890097|540995933|FG002|Overall Study|Failed inclusion criteria|0|||
149962471|NCT00890097|540995931|FG000|Overall Study|Transportation|0|||
149869156|NCT01355159|540652145|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
149869157|NCT01355159|540652144|FG000|Overall Study|Early intrauterine fetal death|6|||
149869158|NCT01355159|540652145|FG001|Overall Study|Early intrauterine fetal death|6|||
149869159|NCT03276221|540652146|FG000|Overall Study|Lost to Follow-up|6|||
149869160|NCT03276221|540652147|FG001|Overall Study|Lost to Follow-up|2|||
149869161|NCT03276221|540652148|FG002|Overall Study|Lost to Follow-up|0|||
149869162|NCT03276221|540652146|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
149869163|NCT03276221|540652147|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
149869164|NCT03276221|540652148|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
149869165|NCT00424775|540652149|FG000|Overall Study|Adverse Event|2|||
149869166|NCT00424775|540652150|FG001|Overall Study|Adverse Event|0|||
149869167|NCT00424775|540652149|FG000|Overall Study|Lack of Efficacy|1|||
149869168|NCT00424775|540652150|FG001|Overall Study|Lack of Efficacy|0|||
149869169|NCT00681590|540652151|FG000|Overall Study|Withdrawal by Subject|2|||
149869170|NCT00681590|540652152|FG001|Overall Study|Withdrawal by Subject|12|||
149869171|NCT02912650|540652153|FG000|Overall Study|Withdrawal by Subject|1|||
149869172|NCT02912650|540652154|FG001|Overall Study|Withdrawal by Subject|0|||
149869173|NCT02912650|540652155|FG002|Overall Study|Withdrawal by Subject|1|||
149869174|NCT02912650|540652156|FG003|Overall Study|Withdrawal by Subject|5|||
149869175|NCT02912650|540652153|FG000|Overall Study|Adverse Event|0|||
149869176|NCT02912650|540652154|FG001|Overall Study|Adverse Event|0|||
149869177|NCT02912650|540652155|FG002|Overall Study|Adverse Event|1|||
149869178|NCT02912650|540652156|FG003|Overall Study|Adverse Event|0|||
149869179|NCT02562482|540652157|FG000|Overall Study|Enrolled, but did not receive product|4|||
149869180|NCT02562482|540652158|FG001|Overall Study|Enrolled, but did not receive product|0|||
149869181|NCT02562482|540652157|FG000|Overall Study|Lost to Follow-up|9|||
149869182|NCT02562482|540652158|FG001|Overall Study|Lost to Follow-up|6|||
149869183|NCT02562482|540652157|FG000|Overall Study|Moved from area|2|||
149869184|NCT02562482|540652158|FG001|Overall Study|Moved from area|3|||
149869185|NCT02562482|540652157|FG000|Overall Study|Withdrawal by Subject|5|||
149869186|NCT02562482|540652158|FG001|Overall Study|Withdrawal by Subject|3|||
149869187|NCT02562482|540652157|FG000|Overall Study|Physician Decision|1|||
149869188|NCT02562482|540652158|FG001|Overall Study|Physician Decision|3|||
149869189|NCT02562482|540652157|FG000|Overall Study|Illness/Injury unrelated to product|0|||
149869190|NCT02562482|540652158|FG001|Overall Study|Illness/Injury unrelated to product|1|||
149869191|NCT00975286|540652164|FG000|Overall Study|Adverse Event|9|||
149869192|NCT00975286|540652165|FG001|Overall Study|Adverse Event|19|||
149869193|NCT00975286|540652164|FG000|Overall Study|Protocol Violation|1|||
149869194|NCT00975286|540652165|FG001|Overall Study|Protocol Violation|2|||
149869195|NCT00975286|540652164|FG000|Overall Study|Withdrawal by Subject|0|||
149869196|NCT00975286|540652165|FG001|Overall Study|Withdrawal by Subject|2|||
149869197|NCT00975286|540652164|FG000|Overall Study|Familial and Personal Reasons|2|||
149869198|NCT00975286|540652165|FG001|Overall Study|Familial and Personal Reasons|2|||
149869199|NCT00975286|540652164|FG000|Overall Study|Poor Compliance to Protocol|0|||
149869200|NCT00975286|540652165|FG001|Overall Study|Poor Compliance to Protocol|2|||
149869201|NCT00975286|540652164|FG000|Overall Study|Sponsor Decision|0|||
149869202|NCT00975286|540652165|FG001|Overall Study|Sponsor Decision|2|||
149869203|NCT02357342|540652166|FG000|First 6 Months|Death|2|||
149869204|NCT02357342|540652167|FG001|First 6 Months|Death|0|||
149869205|NCT01674647|540652168|FG000|Treatment Period|Death|4|||
149869206|NCT01674647|540652169|FG001|Treatment Period|Death|1|||
149869207|NCT01674647|540652168|FG000|Treatment Period|Efficacy outcome reached|0|||
149869208|NCT01674647|540652169|FG001|Treatment Period|Efficacy outcome reached|1|||
149869209|NCT01674647|540652168|FG000|Treatment Period|Physician Decision|3|||
149869210|NCT01674647|540652169|FG001|Treatment Period|Physician Decision|1|||
149869211|NCT01674647|540652168|FG000|Treatment Period|Adverse Event|60|||
149869212|NCT01674647|540652169|FG001|Treatment Period|Adverse Event|22|||
149869213|NCT01674647|540652168|FG000|Treatment Period|Non-compliance with study drug|3|||
149869214|NCT01674647|540652169|FG001|Treatment Period|Non-compliance with study drug|0|||
149962472|NCT00890097|540995932|FG001|Overall Study|Transportation|2|||
149962473|NCT00890097|540995933|FG002|Overall Study|Transportation|0|||
149962474|NCT00890097|540995931|FG000|Overall Study|Subject Moved|0|||
149962475|NCT00890097|540995932|FG001|Overall Study|Subject Moved|4|||
149962476|NCT00890097|540995933|FG002|Overall Study|Subject Moved|0|||
149962477|NCT00890097|540995931|FG000|Overall Study|Protocol Deviation|1|||
149962478|NCT00890097|540995932|FG001|Overall Study|Protocol Deviation|1|||
149962479|NCT00890097|540995933|FG002|Overall Study|Protocol Deviation|1|||
149962480|NCT04349098|540995934|FG000|Overall Study|Death|16|||
149869215|NCT01674647|540652168|FG000|Treatment Period|Lost to Follow-up|1|||
149869216|NCT01674647|540652169|FG001|Treatment Period|Lost to Follow-up|1|||
149869217|NCT01674647|540652168|FG000|Treatment Period|Withdrawal by Subject|19|||
149962481|NCT04349098|540995935|FG001|Overall Study|Death|8|||
149869218|NCT01674647|540652169|FG001|Treatment Period|Withdrawal by Subject|16|||
149869219|NCT01674647|540652168|FG000|Treatment Period|Switching to other therapy|5|||
149962482|NCT04349098|540995934|FG000|Overall Study|Lost to Follow-up|11|||
149962483|NCT04349098|540995935|FG001|Overall Study|Lost to Follow-up|8|||
149962484|NCT04349098|540995934|FG000|Overall Study|Withdrawal by Subject|8|||
149962485|NCT04349098|540995935|FG001|Overall Study|Withdrawal by Subject|5|||
149869220|NCT01674647|540652169|FG001|Treatment Period|Switching to other therapy|2|||
149869221|NCT01674647|540652168|FG000|Treatment Period|Logistical difficulties|5|||
149869222|NCT01674647|540652169|FG001|Treatment Period|Logistical difficulties|8|||
149869223|NCT01674647|540652168|FG000|Treatment Period|Treatment failure|0|||
149869224|NCT01674647|540652169|FG001|Treatment Period|Treatment failure|14|||
149869225|NCT01674647|540652168|FG000|Treatment Period|Protocol Violation|56|||
149869226|NCT01674647|540652169|FG001|Treatment Period|Protocol Violation|36|||
149869227|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Death|3|||
149869228|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Death|2|||
149869229|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
149869230|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
149869231|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
149869232|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
149869233|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
149869234|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
149869235|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
149869236|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
149869237|NCT01674647|540652168|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
149869238|NCT01674647|540652169|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
149869239|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
149869240|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
149869241|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
149869242|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
149869243|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
149869244|NCT01490866|540652171|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
149869245|NCT01490866|540652171|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
149869246|NCT01490866|540652171|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
149869247|NCT01490866|540652171|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
149869248|NCT01490866|540652171|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
149869249|NCT01490866|540652171|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
149869250|NCT04135196|540652172|FG000|Overall Study|Lost to Follow-up|8|||
149869251|NCT04135196|540652173|FG001|Overall Study|Lost to Follow-up|7|||
149869252|NCT04135196|540652174|FG002|Overall Study|Lost to Follow-up|8|||
149869253|NCT04135196|540652175|FG003|Overall Study|Lost to Follow-up|9|||
149869254|NCT04135196|540652176|FG004|Overall Study|Lost to Follow-up|1|||
149869255|NCT04135196|540652172|FG000|Overall Study|Pregnancy|0|||
149869256|NCT04135196|540652173|FG001|Overall Study|Pregnancy|0|||
149869257|NCT04135196|540652174|FG002|Overall Study|Pregnancy|1|||
149869258|NCT04135196|540652175|FG003|Overall Study|Pregnancy|0|||
149869259|NCT04135196|540652176|FG004|Overall Study|Pregnancy|0|||
149869260|NCT04135196|540652172|FG000|Overall Study|Withdrawal by Subject|0|||
149869261|NCT04135196|540652173|FG001|Overall Study|Withdrawal by Subject|0|||
149869262|NCT04135196|540652174|FG002|Overall Study|Withdrawal by Subject|0|||
149869263|NCT04135196|540652175|FG003|Overall Study|Withdrawal by Subject|0|||
149869264|NCT04135196|540652176|FG004|Overall Study|Withdrawal by Subject|1|||
149869265|NCT03212521|540652179|FG000|Overall Study|Adverse Event|1|||
149869266|NCT03212521|540652179|FG000|Overall Study|Lost to Follow-up|4|||
149869267|NCT03212521|540652179|FG000|Overall Study|Withdrawal by Subject|1|||
149869268|NCT03212521|540652179|FG000|Overall Study|Other|1|||
149869269|NCT00444457|540652180|FG000|Infant Series|Other|0|||
149869270|NCT00444457|540652181|FG001|Infant Series|Other|1|||
149869271|NCT00444457|540652182|FG002|Infant Series|Other|0|||
149869272|NCT00444457|540652183|FG003|Infant Series|Other|0|||
149869273|NCT00444457|540652180|FG000|Infant Series|Parent or legal guardian request|18|||
149869274|NCT00444457|540652181|FG001|Infant Series|Parent or legal guardian request|29|||
149869275|NCT00444457|540652182|FG002|Infant Series|Parent or legal guardian request|34|||
149869276|NCT00444457|540652183|FG003|Infant Series|Parent or legal guardian request|14|||
149869277|NCT00444457|540652180|FG000|Infant Series|Lost to Follow-up|10|||
149869278|NCT00444457|540652181|FG001|Infant Series|Lost to Follow-up|11|||
149869279|NCT00444457|540652182|FG002|Infant Series|Lost to Follow-up|7|||
149869280|NCT00444457|540652183|FG003|Infant Series|Lost to Follow-up|6|||
149869281|NCT00444457|540652180|FG000|Infant Series|Protocol Violation|16|||
149869282|NCT00444457|540652181|FG001|Infant Series|Protocol Violation|8|||
149869283|NCT00444457|540652182|FG002|Infant Series|Protocol Violation|6|||
149869284|NCT00444457|540652183|FG003|Infant Series|Protocol Violation|3|||
149869285|NCT00444457|540652180|FG000|Infant Series|Failed to return|5|||
149869286|NCT00444457|540652181|FG001|Infant Series|Failed to return|4|||
149869287|NCT00444457|540652182|FG002|Infant Series|Failed to return|4|||
149869288|NCT00444457|540652183|FG003|Infant Series|Failed to return|2|||
149869289|NCT00444457|540652180|FG000|Infant Series|Investigator request|4|||
149869290|NCT00444457|540652181|FG001|Infant Series|Investigator request|3|||
149869291|NCT00444457|540652182|FG002|Infant Series|Investigator request|3|||
149869292|NCT00444457|540652183|FG003|Infant Series|Investigator request|2|||
149869293|NCT00444457|540652180|FG000|Infant Series|Other|0|||
149869294|NCT00444457|540652181|FG001|Infant Series|Other|2|||
149869295|NCT00444457|540652182|FG002|Infant Series|Other|4|||
149869296|NCT00444457|540652183|FG003|Infant Series|Other|0|||
149869297|NCT00444457|540652180|FG000|Infant Series|Adverse Event|1|||
149869298|NCT00444457|540652181|FG001|Infant Series|Adverse Event|2|||
149869299|NCT00444457|540652182|FG002|Infant Series|Adverse Event|2|||
149869300|NCT00444457|540652183|FG003|Infant Series|Adverse Event|0|||
149869301|NCT00444457|540652180|FG000|Infant Series|Death|0|||
149869302|NCT00444457|540652181|FG001|Infant Series|Death|1|||
149869303|NCT00444457|540652182|FG002|Infant Series|Death|1|||
149869304|NCT00444457|540652183|FG003|Infant Series|Death|1|||
149869305|NCT00444457|540652180|FG000|After Infant Series|Other|0|||
149869306|NCT00444457|540652181|FG001|After Infant Series|Other|1|||
149869307|NCT00444457|540652182|FG002|After Infant Series|Other|1|||
149869308|NCT00444457|540652183|FG003|After Infant Series|Other|1|||
149869309|NCT00444457|540652180|FG000|After Infant Series|Parent or legal guardian request|4|||
149869310|NCT00444457|540652181|FG001|After Infant Series|Parent or legal guardian request|11|||
149869311|NCT00444457|540652182|FG002|After Infant Series|Parent or legal guardian request|6|||
149869312|NCT00444457|540652183|FG003|After Infant Series|Parent or legal guardian request|3|||
149869313|NCT00444457|540652180|FG000|After Infant Series|Failed to return|7|||
149869314|NCT00444457|540652181|FG001|After Infant Series|Failed to return|6|||
149869315|NCT00444457|540652182|FG002|After Infant Series|Failed to return|5|||
149869316|NCT00444457|540652183|FG003|After Infant Series|Failed to return|1|||
149869317|NCT00444457|540652180|FG000|After Infant Series|Lost to Follow-up|5|||
149869318|NCT00444457|540652181|FG001|After Infant Series|Lost to Follow-up|5|||
149869319|NCT00444457|540652182|FG002|After Infant Series|Lost to Follow-up|5|||
149869320|NCT00444457|540652183|FG003|After Infant Series|Lost to Follow-up|2|||
149869321|NCT00444457|540652180|FG000|After Infant Series|Protocol Violation|2|||
149869322|NCT00444457|540652181|FG001|After Infant Series|Protocol Violation|4|||
149869323|NCT00444457|540652182|FG002|After Infant Series|Protocol Violation|2|||
149869324|NCT00444457|540652183|FG003|After Infant Series|Protocol Violation|2|||
149869325|NCT00444457|540652180|FG000|After Infant Series|Adverse Event|2|||
149869326|NCT00444457|540652181|FG001|After Infant Series|Adverse Event|2|||
149869327|NCT00444457|540652182|FG002|After Infant Series|Adverse Event|0|||
149869328|NCT00444457|540652183|FG003|After Infant Series|Adverse Event|0|||
149869329|NCT00444457|540652180|FG000|After Infant Series|Investigator request|0|||
149869330|NCT00444457|540652181|FG001|After Infant Series|Investigator request|0|||
149869331|NCT00444457|540652182|FG002|After Infant Series|Investigator request|0|||
149869332|NCT00444457|540652183|FG003|After Infant Series|Investigator request|1|||
149869333|NCT00444457|540652180|FG000|After Infant Series|Other|0|||
149869334|NCT00444457|540652181|FG001|After Infant Series|Other|1|||
149869335|NCT00444457|540652182|FG002|After Infant Series|Other|0|||
149869336|NCT00444457|540652183|FG003|After Infant Series|Other|0|||
149869337|NCT00444457|540652180|FG000|Toddler Dose|Lost to Follow-up|4|||
149869338|NCT00444457|540652181|FG001|Toddler Dose|Lost to Follow-up|1|||
149869339|NCT00444457|540652182|FG002|Toddler Dose|Lost to Follow-up|1|||
149869340|NCT00444457|540652183|FG003|Toddler Dose|Lost to Follow-up|3|||
149869341|NCT00444457|540652180|FG000|Toddler Dose|Failed to return|2|||
149869342|NCT00444457|540652181|FG001|Toddler Dose|Failed to return|2|||
149869343|NCT00444457|540652182|FG002|Toddler Dose|Failed to return|1|||
149869344|NCT00444457|540652183|FG003|Toddler Dose|Failed to return|3|||
149869345|NCT00444457|540652180|FG000|Toddler Dose|Parent or legal guardian request|0|||
149869346|NCT00444457|540652181|FG001|Toddler Dose|Parent or legal guardian request|3|||
149869347|NCT00444457|540652182|FG002|Toddler Dose|Parent or legal guardian request|2|||
149869348|NCT00444457|540652183|FG003|Toddler Dose|Parent or legal guardian request|1|||
149869349|NCT00444457|540652180|FG000|Toddler Dose|Protocol Violation|1|||
149869350|NCT00444457|540652181|FG001|Toddler Dose|Protocol Violation|0|||
149869351|NCT00444457|540652182|FG002|Toddler Dose|Protocol Violation|0|||
149869352|NCT00444457|540652183|FG003|Toddler Dose|Protocol Violation|1|||
149869353|NCT00914459|540652186|FG000|Overall Study|Protocol Violation|0|||
149869354|NCT00914459|540652187|FG001|Overall Study|Protocol Violation|1|||
149869355|NCT00914459|540652186|FG000|Overall Study|Parent/Legal guardian request|1|||
149869356|NCT00914459|540652187|FG001|Overall Study|Parent/Legal guardian request|0|||
149869357|NCT03201211|540652188|FG000|Overall Study|Adverse Event|1|||
149869358|NCT03201211|540652189|FG001|Overall Study|Adverse Event|0|||
149869359|NCT03201211|540652190|FG002|Overall Study|Adverse Event|0|||
149869360|NCT03201211|540652188|FG000|Overall Study|Protocol Violation|1|||
149869361|NCT03201211|540652189|FG001|Overall Study|Protocol Violation|0|||
149869362|NCT03201211|540652190|FG002|Overall Study|Protocol Violation|0|||
149869363|NCT03201211|540652188|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149869364|NCT03201211|540652189|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149869365|NCT03201211|540652190|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
149869366|NCT03201211|540652188|FG000|Overall Study|OTHER unknown reasons|0|||
149869367|NCT03201211|540652189|FG001|Overall Study|OTHER unknown reasons|1|||
149869368|NCT03201211|540652190|FG002|Overall Study|OTHER unknown reasons|0|||
149869369|NCT01970865|540652191|FG000|Overall Study|Death|3|||
149869370|NCT01970865|540652192|FG001|Overall Study|Death|2|||
149869371|NCT01970865|540652193|FG002|Overall Study|Death|3|||
149869372|NCT01970865|540652194|FG003|Overall Study|Death|6|||
149869373|NCT01970865|540652195|FG004|Overall Study|Death|9|||
149869374|NCT01970865|540652196|FG005|Overall Study|Death|3|||
149869375|NCT01970865|540652197|FG006|Overall Study|Death|2|||
149869376|NCT01970865|540652198|FG007|Overall Study|Death|3|||
149869377|NCT01970865|540652199|FG008|Overall Study|Death|2|||
149869378|NCT01970865|540652200|FG009|Overall Study|Death|2|||
149869379|NCT01970865|540652201|FG010|Overall Study|Death|8|||
149869380|NCT01970865|540652202|FG011|Overall Study|Death|13|||
149869381|NCT01970865|540652203|FG012|Overall Study|Death|25|||
149869382|NCT01970865|540652204|FG013|Overall Study|Death|46|||
149869383|NCT01970865|540652205|FG014|Overall Study|Death|37|||
149869384|NCT01970865|540652206|FG015|Overall Study|Death|22|||
149869385|NCT01970865|540652207|FG016|Overall Study|Death|1|||
149869386|NCT01970865|540652208|FG017|Overall Study|Death|17|||
149869387|NCT01970865|540652191|FG000|Overall Study|Lost to Follow-up|0|||
149869388|NCT01970865|540652192|FG001|Overall Study|Lost to Follow-up|0|||
149869389|NCT01970865|540652193|FG002|Overall Study|Lost to Follow-up|0|||
149869390|NCT01970865|540652194|FG003|Overall Study|Lost to Follow-up|1|||
149869391|NCT01970865|540652195|FG004|Overall Study|Lost to Follow-up|1|||
149869392|NCT01970865|540652196|FG005|Overall Study|Lost to Follow-up|0|||
149869393|NCT01970865|540652197|FG006|Overall Study|Lost to Follow-up|0|||
149869394|NCT01970865|540652198|FG007|Overall Study|Lost to Follow-up|0|||
149869395|NCT01970865|540652199|FG008|Overall Study|Lost to Follow-up|0|||
149869396|NCT01970865|540652200|FG009|Overall Study|Lost to Follow-up|0|||
149869397|NCT01970865|540652201|FG010|Overall Study|Lost to Follow-up|1|||
149869398|NCT01970865|540652202|FG011|Overall Study|Lost to Follow-up|0|||
149869399|NCT01970865|540652203|FG012|Overall Study|Lost to Follow-up|2|||
149869400|NCT01970865|540652204|FG013|Overall Study|Lost to Follow-up|0|||
149869401|NCT01970865|540652205|FG014|Overall Study|Lost to Follow-up|1|||
149869402|NCT01970865|540652206|FG015|Overall Study|Lost to Follow-up|4|||
149869403|NCT01970865|540652207|FG016|Overall Study|Lost to Follow-up|0|||
149869404|NCT01970865|540652208|FG017|Overall Study|Lost to Follow-up|1|||
149869405|NCT01970865|540652191|FG000|Overall Study|Other|0|||
149869406|NCT01970865|540652192|FG001|Overall Study|Other|1|||
149869407|NCT01970865|540652193|FG002|Overall Study|Other|0|||
149869408|NCT01970865|540652194|FG003|Overall Study|Other|1|||
149869409|NCT01970865|540652195|FG004|Overall Study|Other|1|||
149869410|NCT01970865|540652196|FG005|Overall Study|Other|0|||
149869411|NCT01970865|540652197|FG006|Overall Study|Other|1|||
149869412|NCT01970865|540652198|FG007|Overall Study|Other|0|||
149869413|NCT01970865|540652199|FG008|Overall Study|Other|0|||
149869414|NCT01970865|540652200|FG009|Overall Study|Other|0|||
149869415|NCT01970865|540652201|FG010|Overall Study|Other|2|||
149869416|NCT01970865|540652202|FG011|Overall Study|Other|3|||
149869417|NCT01970865|540652203|FG012|Overall Study|Other|8|||
149962486|NCT04349098|540995934|FG000|Overall Study|Other|3|||
149962487|NCT04349098|540995935|FG001|Overall Study|Other|5|||
149962488|NCT01703221|540995936|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
149962489|NCT01703221|540995937|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
149962490|NCT01703221|540995938|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149869418|NCT01970865|540652204|FG013|Overall Study|Other|3|||
149869419|NCT01970865|540652205|FG014|Overall Study|Other|2|||
149869420|NCT01970865|540652206|FG015|Overall Study|Other|3|||
149869421|NCT01970865|540652207|FG016|Overall Study|Other|0|||
149869422|NCT01970865|540652208|FG017|Overall Study|Other|2|||
149869423|NCT01970865|540652191|FG000|Overall Study|Participant refused further follow-up|0|||
149869424|NCT01970865|540652192|FG001|Overall Study|Participant refused further follow-up|0|||
149869425|NCT01970865|540652193|FG002|Overall Study|Participant refused further follow-up|0|||
149869426|NCT01970865|540652194|FG003|Overall Study|Participant refused further follow-up|2|||
149962491|NCT01703221|540995936|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
149869427|NCT01970865|540652195|FG004|Overall Study|Participant refused further follow-up|3|||
149869428|NCT01970865|540652196|FG005|Overall Study|Participant refused further follow-up|0|||
149869429|NCT01970865|540652197|FG006|Overall Study|Participant refused further follow-up|0|||
149869430|NCT01970865|540652198|FG007|Overall Study|Participant refused further follow-up|0|||
149869431|NCT01970865|540652199|FG008|Overall Study|Participant refused further follow-up|0|||
149869432|NCT01970865|540652200|FG009|Overall Study|Participant refused further follow-up|0|||
149869433|NCT01970865|540652201|FG010|Overall Study|Participant refused further follow-up|1|||
149869434|NCT01970865|540652202|FG011|Overall Study|Participant refused further follow-up|4|||
149869435|NCT01970865|540652203|FG012|Overall Study|Participant refused further follow-up|7|||
149869436|NCT01970865|540652204|FG013|Overall Study|Participant refused further follow-up|8|||
149869437|NCT01970865|540652205|FG014|Overall Study|Participant refused further follow-up|3|||
149869438|NCT01970865|540652206|FG015|Overall Study|Participant refused further follow-up|11|||
149869439|NCT01970865|540652207|FG016|Overall Study|Participant refused further follow-up|0|||
149869440|NCT01970865|540652208|FG017|Overall Study|Participant refused further follow-up|6|||
149869441|NCT01661179|540652209|FG000|Overall Study|Death|1|||
149869442|NCT01661179|540652209|FG000|Overall Study|Withdrawal by Subject|1|||
149869443|NCT01661179|540652209|FG000|Overall Study|Other Eligibility criteria|4|||
149869444|NCT01946191|540652210|FG000|Allocation|Did not complete orientation|1|||
149869445|NCT01946191|540652211|FG001|Allocation|Did not complete orientation|1|||
149869446|NCT01946191|540652210|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
149869447|NCT01946191|540652211|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
149869448|NCT01946191|540652210|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
149869449|NCT01946191|540652211|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
149869450|NCT01946191|540652210|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
149869451|NCT01946191|540652211|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
149869452|NCT02041091|540652212|FG000|Treatment|Adverse Event|3|||
149869453|NCT02041091|540652213|FG001|Treatment|Adverse Event|3|||
149869454|NCT02041091|540652212|FG000|Treatment|Withdrawal by Subject|2|||
149869455|NCT02041091|540652213|FG001|Treatment|Withdrawal by Subject|4|||
149869456|NCT02041091|540652212|FG000|Treatment|Physician Decision|1|||
149869457|NCT02041091|540652213|FG001|Treatment|Physician Decision|0|||
149869458|NCT02041091|540652212|FG000|Treatment|Sponsor Decision|15|||
149869459|NCT02041091|540652213|FG001|Treatment|Sponsor Decision|16|||
149869460|NCT02041091|540652212|FG000|Treatment|Lost to Follow-up|1|||
149869461|NCT02041091|540652213|FG001|Treatment|Lost to Follow-up|0|||
149869462|NCT02041091|540652212|FG000|Optional Safety Extension Period|Adverse Event|4|||
149869463|NCT02041091|540652213|FG001|Optional Safety Extension Period|Adverse Event|2|||
149869464|NCT02041091|540652212|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
149869465|NCT02041091|540652213|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
149869466|NCT02041091|540652212|FG000|Optional Safety Extension Period|Protocol Violation|2|||
149869467|NCT02041091|540652213|FG001|Optional Safety Extension Period|Protocol Violation|0|||
149869468|NCT02041091|540652212|FG000|Optional Safety Extension Period|Physician Decision|2|||
149869469|NCT02041091|540652213|FG001|Optional Safety Extension Period|Physician Decision|1|||
149869470|NCT02041091|540652212|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
149869471|NCT02041091|540652213|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
149869472|NCT02041091|540652212|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
149869473|NCT02041091|540652213|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
149869474|NCT01083810|540652214|FG000|Overall Study|Lost to Follow-up|23|||
149869475|NCT01083810|540652215|FG001|Overall Study|Lost to Follow-up|11|||
149869476|NCT01083810|540652216|FG002|Overall Study|Lost to Follow-up|4|||
149869477|NCT01083810|540652214|FG000|Overall Study|Adverse Event|15|||
149869478|NCT01083810|540652215|FG001|Overall Study|Adverse Event|11|||
149869479|NCT01083810|540652216|FG002|Overall Study|Adverse Event|4|||
149869480|NCT01083810|540652214|FG000|Overall Study|Withdrawal by Subject|7|||
149869481|NCT01083810|540652215|FG001|Overall Study|Withdrawal by Subject|2|||
149869482|NCT01083810|540652216|FG002|Overall Study|Withdrawal by Subject|4|||
149869483|NCT01083810|540652214|FG000|Overall Study|Reason not reported|6|||
149869484|NCT01083810|540652215|FG001|Overall Study|Reason not reported|1|||
149869485|NCT01083810|540652216|FG002|Overall Study|Reason not reported|1|||
149869486|NCT01083810|540652214|FG000|Overall Study|Non-compliance|4|||
149869487|NCT01083810|540652215|FG001|Overall Study|Non-compliance|7|||
149869488|NCT01083810|540652216|FG002|Overall Study|Non-compliance|2|||
149869489|NCT01083810|540652214|FG000|Overall Study|Simplification|4|||
149869490|NCT01083810|540652215|FG001|Overall Study|Simplification|1|||
149869491|NCT01083810|540652216|FG002|Overall Study|Simplification|0|||
149869492|NCT01083810|540652214|FG000|Overall Study|Death|2|||
149869493|NCT01083810|540652215|FG001|Overall Study|Death|2|||
149869494|NCT01083810|540652216|FG002|Overall Study|Death|3|||
149869495|NCT01083810|540652214|FG000|Overall Study|Co-morbidities|1|||
149869496|NCT01083810|540652215|FG001|Overall Study|Co-morbidities|0|||
149869497|NCT01083810|540652216|FG002|Overall Study|Co-morbidities|0|||
149869498|NCT01083810|540652214|FG000|Overall Study|Participation in study|1|||
149869499|NCT01083810|540652215|FG001|Overall Study|Participation in study|0|||
149869500|NCT01083810|540652216|FG002|Overall Study|Participation in study|0|||
149869501|NCT01083810|540652214|FG000|Overall Study|Therapy break|1|||
149869502|NCT01083810|540652215|FG001|Overall Study|Therapy break|2|||
149869503|NCT01083810|540652216|FG002|Overall Study|Therapy break|2|||
149869504|NCT01083810|540652214|FG000|Overall Study|Virologic failure|1|||
149869505|NCT01083810|540652215|FG001|Overall Study|Virologic failure|8|||
149869506|NCT01083810|540652216|FG002|Overall Study|Virologic failure|0|||
149869507|NCT01602965|540652217|FG000|Overall Study|Lost to Follow-up|4|||
149869508|NCT01602965|540652218|FG001|Overall Study|Lost to Follow-up|2|||
149869509|NCT03071094|540652222|FG000|Overall Study|Death|1|||
149869510|NCT03071094|540652223|FG001|Overall Study|Death|1|||
149869511|NCT03071094|540652222|FG000|Overall Study|Adverse Event|1|||
149869512|NCT03071094|540652223|FG001|Overall Study|Adverse Event|0|||
149869513|NCT02312063|540652224|FG000|Overall Study|Withdrawal by Subject|0|||
149869514|NCT02312063|540652225|FG001|Overall Study|Withdrawal by Subject|1|||
149869515|NCT00321737|540652231|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
149869516|NCT00321737|540652232|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
149869517|NCT00321737|540652233|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
149869518|NCT00321737|540652231|FG000|Overall Study|Adverse Event|11|||
149869519|NCT00321737|540652232|FG001|Overall Study|Adverse Event|3|||
149869520|NCT00321737|540652233|FG002|Overall Study|Adverse Event|6|||
149869521|NCT00321737|540652231|FG000|Overall Study|Lost to Follow-up|5|||
149869522|NCT00321737|540652232|FG001|Overall Study|Lost to Follow-up|5|||
149962492|NCT01703221|540995937|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
149962493|NCT01703221|540995938|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
149869523|NCT00321737|540652233|FG002|Overall Study|Lost to Follow-up|6|||
149869524|NCT00321737|540652231|FG000|Overall Study|Withdrawal by Subject|19|||
149869525|NCT00321737|540652232|FG001|Overall Study|Withdrawal by Subject|12|||
149869526|NCT00321737|540652233|FG002|Overall Study|Withdrawal by Subject|17|||
149869527|NCT00321737|540652231|FG000|Overall Study|Protocol Violation|0|||
149869528|NCT00321737|540652232|FG001|Overall Study|Protocol Violation|0|||
149869529|NCT00321737|540652233|FG002|Overall Study|Protocol Violation|1|||
149869530|NCT00321737|540652231|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
149869531|NCT00321737|540652232|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
149869532|NCT00321737|540652233|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
149869533|NCT00321737|540652231|FG000|Overall Study|Possible Barrett's Esophagus|2|||
149869534|NCT00321737|540652232|FG001|Overall Study|Possible Barrett's Esophagus|1|||
149869535|NCT00321737|540652233|FG002|Overall Study|Possible Barrett's Esophagus|1|||
149869536|NCT00321737|540652231|FG000|Overall Study|Therapeutic Failure|6|||
149869537|NCT00321737|540652232|FG001|Overall Study|Therapeutic Failure|0|||
149869538|NCT00321737|540652233|FG002|Overall Study|Therapeutic Failure|2|||
149869539|NCT00321737|540652231|FG000|Overall Study|Pregnancy|0|||
149869540|NCT00321737|540652232|FG001|Overall Study|Pregnancy|2|||
149869541|NCT00321737|540652233|FG002|Overall Study|Pregnancy|0|||
149869542|NCT00321737|540652231|FG000|Overall Study|Noncompliance|2|||
149869543|NCT00321737|540652232|FG001|Overall Study|Noncompliance|0|||
149869544|NCT00321737|540652233|FG002|Overall Study|Noncompliance|0|||
149869545|NCT00321737|540652231|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
149869546|NCT00321737|540652232|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
149869547|NCT00321737|540652233|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
149869548|NCT01079832|540652234|FG000|Overall Study|Withdrawal by Subject|1|||
149869549|NCT02283294|540652235|FG000|Overall Study|Lost to Follow-up|1|||
149869550|NCT02283294|540652236|FG001|Overall Study|Lost to Follow-up|1|||
149869551|NCT02283294|540652235|FG000|Overall Study|Withdrawal by Subject|1|||
149869552|NCT02283294|540652236|FG001|Overall Study|Withdrawal by Subject|6|||
149869553|NCT02283294|540652235|FG000|Overall Study|Protocol Violation|1|||
149869554|NCT02283294|540652236|FG001|Overall Study|Protocol Violation|0|||
149869555|NCT02283294|540652235|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
149869556|NCT02283294|540652236|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
149869557|NCT00594646|540652237|FG000|Overall Study|Withdrawal by Subject|1|||
149869558|NCT00594646|540652237|FG000|Overall Study|Lost to Follow-up|15|||
149869559|NCT01769339|540652240|FG000|Overall Study|Lost to Follow-up|42|||
149869560|NCT01769339|540652240|FG000|Overall Study|Adverse Event|1|||
149869561|NCT01195272|540652241|FG000|Overall Study|Adverse Event|1|||
149869562|NCT01195272|540652241|FG000|Overall Study|Lack of Efficacy|3|||
149869563|NCT03548064|540654992|FG000|Overall Study|Withdrawal by Subject|0|||
149869564|NCT03548064|540654993|FG001|Overall Study|Withdrawal by Subject|0|||
149869565|NCT03548064|540654994|FG002|Overall Study|Withdrawal by Subject|0|||
149869566|NCT03548064|540654995|FG003|Overall Study|Withdrawal by Subject|1|||
149869567|NCT03548064|540654996|FG004|Overall Study|Withdrawal by Subject|0|||
149869568|NCT03548064|540654997|FG005|Overall Study|Withdrawal by Subject|0|||
149869569|NCT03548064|540654998|FG006|Overall Study|Withdrawal by Subject|0|||
149869570|NCT03548064|540654999|FG007|Overall Study|Withdrawal by Subject|0|||
149869571|NCT03548064|540654992|FG000|Overall Study|Lost to Follow-up|0|||
149869572|NCT03548064|540654993|FG001|Overall Study|Lost to Follow-up|0|||
149869573|NCT03548064|540654994|FG002|Overall Study|Lost to Follow-up|0|||
149869574|NCT03548064|540654995|FG003|Overall Study|Lost to Follow-up|0|||
149869575|NCT03548064|540654996|FG004|Overall Study|Lost to Follow-up|2|||
149869576|NCT03548064|540654997|FG005|Overall Study|Lost to Follow-up|0|||
149869577|NCT03548064|540654998|FG006|Overall Study|Lost to Follow-up|0|||
149869578|NCT03548064|540654999|FG007|Overall Study|Lost to Follow-up|0|||
149869579|NCT03548064|540654992|FG000|Overall Study|Covid-19 Pandemic|0|||
149869580|NCT03548064|540654993|FG001|Overall Study|Covid-19 Pandemic|0|||
149869581|NCT03548064|540654994|FG002|Overall Study|Covid-19 Pandemic|0|||
149869582|NCT03548064|540654995|FG003|Overall Study|Covid-19 Pandemic|0|||
149869583|NCT03548064|540654996|FG004|Overall Study|Covid-19 Pandemic|10|||
149869584|NCT03548064|540654997|FG005|Overall Study|Covid-19 Pandemic|3|||
149869585|NCT03548064|540654998|FG006|Overall Study|Covid-19 Pandemic|0|||
149869586|NCT03548064|540654999|FG007|Overall Study|Covid-19 Pandemic|0|||
149869587|NCT04941729|540655000|FG000|Overall Study|Death|0|||
150173894|NCT00057837|541773000|FG000|Overall Study|Adverse Event|2|||
150173895|NCT00057837|541773001|FG001|Overall Study|Adverse Event|12|||
149869588|NCT04941729|540655001|FG001|Overall Study|Death|1|||
149869589|NCT04941729|540655000|FG000|Overall Study|Study terminated by sponsor|11|||
149869590|NCT04941729|540655001|FG001|Overall Study|Study terminated by sponsor|10|||
149869591|NCT05424042|540655002|FG000|Overall Study|Withdrawal by Subject|2|||
149869592|NCT05424042|540655003|FG001|Overall Study|Withdrawal by Subject|0|||
149869593|NCT05424042|540655004|FG002|Overall Study|Withdrawal by Subject|4|||
149869594|NCT05424042|540655002|FG000|Overall Study|Lost to Follow-up|0|||
149869595|NCT05424042|540655003|FG001|Overall Study|Lost to Follow-up|0|||
149869596|NCT05424042|540655004|FG002|Overall Study|Lost to Follow-up|1|||
149869597|NCT05091307|540655005|FG000|Overall Study|Death|0|||
149869598|NCT05091307|540655006|FG001|Overall Study|Death|0|||
150173896|NCT00057837|541773000|FG000|Overall Study|Death|5|||
149869599|NCT05091307|540655007|FG002|Overall Study|Death|1|||
149869600|NCT05091307|540655008|FG003|Overall Study|Death|0|||
149869601|NCT05091307|540655005|FG000|Overall Study|Lost to Follow-up|33|||
149869602|NCT05091307|540655006|FG001|Overall Study|Lost to Follow-up|33|||
149869603|NCT05091307|540655007|FG002|Overall Study|Lost to Follow-up|2|||
149869604|NCT05091307|540655008|FG003|Overall Study|Lost to Follow-up|0|||
149869605|NCT05091307|540655005|FG000|Overall Study|Physician Decision|1|||
149869606|NCT05091307|540655006|FG001|Overall Study|Physician Decision|0|||
149869607|NCT05091307|540655007|FG002|Overall Study|Physician Decision|0|||
149869608|NCT05091307|540655008|FG003|Overall Study|Physician Decision|0|||
149869609|NCT05091307|540655005|FG000|Overall Study|Protocol Violation|1|||
149869610|NCT05091307|540655006|FG001|Overall Study|Protocol Violation|0|||
149869611|NCT05091307|540655007|FG002|Overall Study|Protocol Violation|0|||
149869612|NCT05091307|540655008|FG003|Overall Study|Protocol Violation|0|||
149869613|NCT05091307|540655005|FG000|Overall Study|Withdrawal by Subject|16|||
149869614|NCT05091307|540655006|FG001|Overall Study|Withdrawal by Subject|16|||
149869615|NCT05091307|540655007|FG002|Overall Study|Withdrawal by Subject|0|||
149869616|NCT05091307|540655008|FG003|Overall Study|Withdrawal by Subject|1|||
149869617|NCT05091307|540655005|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
149869618|NCT05091307|540655006|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
149869619|NCT05091307|540655007|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
149869620|NCT05091307|540655008|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
149869621|NCT05091307|540655005|FG000|Overall Study|Initiated Prohibited Medication|1|||
149869622|NCT05091307|540655006|FG001|Overall Study|Initiated Prohibited Medication|0|||
149869623|NCT05091307|540655007|FG002|Overall Study|Initiated Prohibited Medication|0|||
149869624|NCT05091307|540655008|FG003|Overall Study|Initiated Prohibited Medication|0|||
149869625|NCT05091307|540655005|FG000|Overall Study|Other|4|||
149869626|NCT05091307|540655006|FG001|Overall Study|Other|4|||
149869627|NCT05091307|540655007|FG002|Overall Study|Other|0|||
149869628|NCT05091307|540655008|FG003|Overall Study|Other|0|||
149869629|NCT05091307|540655005|FG000|Overall Study|Randomized but not vaccinated|0|||
149869630|NCT05091307|540655006|FG001|Overall Study|Randomized but not vaccinated|2|||
149869631|NCT05091307|540655007|FG002|Overall Study|Randomized but not vaccinated|0|||
149869632|NCT05091307|540655008|FG003|Overall Study|Randomized but not vaccinated|0|||
149869633|NCT03611543|540655009|FG000|Overall Study|Withdrawal by Subject|4|||
149869634|NCT03611543|540655010|FG001|Overall Study|Withdrawal by Subject|4|||
149869635|NCT03611543|540655009|FG000|Overall Study|Physician Decision|1|||
149869636|NCT03611543|540655010|FG001|Overall Study|Physician Decision|1|||
149869637|NCT03611543|540655009|FG000|Overall Study|Protocol Violation|2|||
149869638|NCT03611543|540655010|FG001|Overall Study|Protocol Violation|2|||
149869639|NCT03611543|540655009|FG000|Overall Study|Device failure|2|||
149869640|NCT03611543|540655010|FG001|Overall Study|Device failure|2|||
149869641|NCT03611543|540655009|FG000|Overall Study|Missing information|5|||
149869642|NCT03611543|540655010|FG001|Overall Study|Missing information|5|||
149869643|NCT03047473|540655011|FG000|Overall Study|Lost to Follow-up|2|||
149869644|NCT01167257|540655012|FG000|Overall Study|Lost to Follow-up|2|||
149869645|NCT01167257|540655013|FG001|Overall Study|Lost to Follow-up|2|||
149869646|NCT01167257|540655012|FG000|Overall Study|Withdrew consent|1|||
149869647|NCT01167257|540655013|FG001|Overall Study|Withdrew consent|1|||
149869648|NCT02752906|540655014|FG000|Overall Study|Protocol Violation|2|||
149869649|NCT02752906|540655015|FG001|Overall Study|Protocol Violation|1|||
149869650|NCT02752906|540655014|FG000|Overall Study|Withdrawal by Subject|2|||
149869651|NCT02752906|540655015|FG001|Overall Study|Withdrawal by Subject|2|||
149869652|NCT02752906|540655014|FG000|Overall Study|Lost to Follow-up|3|||
149869653|NCT02752906|540655015|FG001|Overall Study|Lost to Follow-up|2|||
149869654|NCT03283319|540655016|FG000|Overall Study|Lost to Follow-up|5|||
149869655|NCT03283319|540655017|FG001|Overall Study|Lost to Follow-up|4|||
149869656|NCT03283319|540655018|FG002|Overall Study|Lost to Follow-up|5|||
149869657|NCT03283319|540655019|FG003|Overall Study|Lost to Follow-up|5|||
149869658|NCT03283319|540655020|FG004|Overall Study|Lost to Follow-up|4|||
149869659|NCT03283319|540655021|FG005|Overall Study|Lost to Follow-up|3|||
149869660|NCT03283319|540655016|FG000|Overall Study|Withdrawal by Subject|2|||
149869661|NCT03283319|540655017|FG001|Overall Study|Withdrawal by Subject|2|||
149869662|NCT03283319|540655018|FG002|Overall Study|Withdrawal by Subject|2|||
149869663|NCT03283319|540655019|FG003|Overall Study|Withdrawal by Subject|1|||
149869664|NCT03283319|540655020|FG004|Overall Study|Withdrawal by Subject|0|||
149869665|NCT03283319|540655021|FG005|Overall Study|Withdrawal by Subject|1|||
149869666|NCT03283319|540655016|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
149869667|NCT03283319|540655017|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
149869668|NCT03283319|540655018|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
150173897|NCT00057837|541773001|FG001|Overall Study|Death|4|||
149869669|NCT03283319|540655019|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
149869670|NCT03283319|540655020|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
149869671|NCT03283319|540655021|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
149869672|NCT00721630|540655023|FG000|Overall Study|Participant found to be ineligible|1|||
149869673|NCT02213510|540655025|FG000|Overall Study|Death|0|||
149869674|NCT02213510|540655026|FG001|Overall Study|Death|1|||
149869675|NCT02213510|540655025|FG000|Overall Study|Lost to Follow-up|1|||
149869676|NCT02213510|540655026|FG001|Overall Study|Lost to Follow-up|0|||
149869677|NCT03954834|540655028|FG000|Overall Study|Adverse Event|1|||
149869678|NCT03954834|540655029|FG001|Overall Study|Adverse Event|3|||
149869679|NCT03954834|540655030|FG002|Overall Study|Adverse Event|1|||
149869680|NCT03954834|540655031|FG003|Overall Study|Adverse Event|1|||
149869681|NCT03954834|540655028|FG000|Overall Study|Death|0|||
149869682|NCT03954834|540655029|FG001|Overall Study|Death|0|||
149869683|NCT03954834|540655030|FG002|Overall Study|Death|0|||
149869684|NCT03954834|540655031|FG003|Overall Study|Death|1|||
149869685|NCT03954834|540655028|FG000|Overall Study|Physician Decision|0|||
149869686|NCT03954834|540655029|FG001|Overall Study|Physician Decision|1|||
149869687|NCT03954834|540655030|FG002|Overall Study|Physician Decision|0|||
149869688|NCT03954834|540655031|FG003|Overall Study|Physician Decision|2|||
149869689|NCT03954834|540655028|FG000|Overall Study|Protocol Violation|1|||
149869690|NCT03954834|540655029|FG001|Overall Study|Protocol Violation|0|||
149869691|NCT03954834|540655030|FG002|Overall Study|Protocol Violation|0|||
149869692|NCT03954834|540655031|FG003|Overall Study|Protocol Violation|1|||
149869693|NCT03954834|540655028|FG000|Overall Study|Withdrawal by Subject|2|||
149869694|NCT03954834|540655029|FG001|Overall Study|Withdrawal by Subject|3|||
149869695|NCT03954834|540655030|FG002|Overall Study|Withdrawal by Subject|13|||
149869696|NCT03954834|540655031|FG003|Overall Study|Withdrawal by Subject|6|||
149869697|NCT03954834|540655028|FG000|Overall Study|Participant left the country|0|||
149869698|NCT03954834|540655029|FG001|Overall Study|Participant left the country|0|||
149869699|NCT03954834|540655030|FG002|Overall Study|Participant left the country|1|||
149869700|NCT03954834|540655031|FG003|Overall Study|Participant left the country|0|||
149869701|NCT03954834|540655028|FG000|Overall Study|Lost to Follow-up|3|||
149869702|NCT03954834|540655029|FG001|Overall Study|Lost to Follow-up|2|||
149869703|NCT03954834|540655030|FG002|Overall Study|Lost to Follow-up|3|||
149869704|NCT03954834|540655031|FG003|Overall Study|Lost to Follow-up|5|||
149869705|NCT00505375|540655045|FG000|Overall Study|Death|1|||
149869706|NCT00505375|540655046|FG001|Overall Study|Death|0|||
149869707|NCT00505375|540655045|FG000|Overall Study|Withdrawal by Subject|2|||
149869708|NCT00505375|540655046|FG001|Overall Study|Withdrawal by Subject|2|||
149869709|NCT00505375|540655045|FG000|Overall Study|Lost to Follow-up|0|||
149869710|NCT00505375|540655046|FG001|Overall Study|Lost to Follow-up|2|||
149869711|NCT00505375|540655045|FG000|Overall Study|Pregnancy|1|||
149869712|NCT00505375|540655046|FG001|Overall Study|Pregnancy|0|||
149869713|NCT00505375|540655045|FG000|Overall Study|Travel issues|0|||
149869714|NCT00505375|540655046|FG001|Overall Study|Travel issues|1|||
149869715|NCT04234984|540655048|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
149869716|NCT04234984|540655048|FG000|Follow-up at the Second Time Point|Death|1|||
149869717|NCT04234984|540655048|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
149869718|NCT01055132|540655051|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
149869719|NCT01055132|540655052|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
149869720|NCT01055132|540655051|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
149869721|NCT01055132|540655052|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
149869722|NCT02746471|540655053|FG000|Overall Study|Death|43|||
149869723|NCT02746471|540655053|FG000|Overall Study|Exited before 36 months|1119|||
149869724|NCT02564211|540655054|FG000|Overall Study|Adverse Event|4|||
149869725|NCT04594707|540655056|FG000|Overall Study|Adverse Event|0|||
149869726|NCT04594707|540655057|FG001|Overall Study|Adverse Event|0|||
149869727|NCT04594707|540655058|FG002|Overall Study|Adverse Event|1|||
149869728|NCT04594707|540655056|FG000|Overall Study|Death|0|||
149869729|NCT04594707|540655057|FG001|Overall Study|Death|2|||
149869730|NCT04594707|540655058|FG002|Overall Study|Death|2|||
149869731|NCT04594707|540655056|FG000|Overall Study|Lung Transplant|0|||
149869732|NCT04594707|540655057|FG001|Overall Study|Lung Transplant|0|||
149869733|NCT04594707|540655058|FG002|Overall Study|Lung Transplant|1|||
149869734|NCT04594707|540655056|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
149962494|NCT01703221|540995936|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
149869735|NCT04594707|540655057|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
149869736|NCT04594707|540655058|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
149869737|NCT04594707|540655056|FG000|Overall Study|Study Terminated By Sponsor|19|||
149869738|NCT04594707|540655057|FG001|Overall Study|Study Terminated By Sponsor|47|||
149869739|NCT04594707|540655058|FG002|Overall Study|Study Terminated By Sponsor|41|||
149869740|NCT04594707|540655056|FG000|Overall Study|Withdrawal by Subject|1|||
149869741|NCT04594707|540655057|FG001|Overall Study|Withdrawal by Subject|0|||
149869742|NCT04594707|540655058|FG002|Overall Study|Withdrawal by Subject|2|||
149869743|NCT02534844|540655059|FG000|Part B|Withdrawal by Subject|0|||
149869744|NCT02534844|540655060|FG001|Part B|Withdrawal by Subject|0|||
149869745|NCT02534844|540655061|FG002|Part B|Withdrawal by Subject|0|||
149869746|NCT02534844|540655062|FG003|Part B|Withdrawal by Subject|0|||
149869747|NCT02534844|540655063|FG004|Part B|Withdrawal by Subject|2|||
149869748|NCT02534844|540655064|FG005|Part B|Withdrawal by Subject|1|||
149869749|NCT00655876|540655065|FG000|Overall Study|Protocol Violation|9|||
149869750|NCT00655876|540655066|FG001|Overall Study|Protocol Violation|7|||
149869751|NCT00326963|540655067|FG000|Overall Study|Adverse Event|2|||
149869752|NCT00326963|540655067|FG000|Overall Study|Injection site reaction|1|||
149869753|NCT00326963|540655067|FG000|Overall Study|Death|1|||
149869754|NCT00326963|540655067|FG000|Overall Study|Failure to return|10|||
149869755|NCT00326963|540655067|FG000|Overall Study|Withdrawal by Subject|10|||
149869756|NCT00326963|540655067|FG000|Overall Study|Refused treatment / did not cooperate|5|||
149869757|NCT00326963|540655067|FG000|Overall Study|Violation of selection criteria at entry|2|||
149869758|NCT00326963|540655067|FG000|Overall Study|Other protocol violation|1|||
149869759|NCT00326963|540655067|FG000|Overall Study|Administrative / other|1|||
149869760|NCT00470067|540655068|FG000|Overall Study|Death|1|||
149869761|NCT00470067|540655068|FG000|Overall Study|Disease Progression|6|||
149869762|NCT00338455|540655072|FG000|Overall Study|Death|2|||
149869763|NCT00338455|540655073|FG001|Overall Study|Death|1|||
149869764|NCT00338455|540655072|FG000|Overall Study|Physician Decision|1|||
149869765|NCT00338455|540655073|FG001|Overall Study|Physician Decision|0|||
149869766|NCT01059344|540655079|FG000|Overall Study|Adverse Event|12|||
149869767|NCT01059344|540655080|FG001|Overall Study|Adverse Event|30|||
149869768|NCT01059344|540655079|FG000|Overall Study|Withdrawal by Subject|6|||
149869769|NCT01059344|540655080|FG001|Overall Study|Withdrawal by Subject|9|||
149869770|NCT01059344|540655079|FG000|Overall Study|Lost to Follow-up|1|||
149869771|NCT01059344|540655080|FG001|Overall Study|Lost to Follow-up|1|||
149869772|NCT01059344|540655079|FG000|Overall Study|Other|3|||
149869773|NCT01059344|540655080|FG001|Overall Study|Other|6|||
149869774|NCT01739348|540655081|FG000|Part I (Base Study)|Adverse Event|41|||
149869775|NCT01739348|540655082|FG001|Part I (Base Study)|Adverse Event|52|||
149869776|NCT01739348|540655083|FG002|Part I (Base Study)|Adverse Event|8|||
149869777|NCT01739348|540655084|FG003|Part I (Base Study)|Adverse Event|33|||
149869778|NCT01739348|540655081|FG000|Part I (Base Study)|Death|10|||
149869779|NCT01739348|540655082|FG001|Part I (Base Study)|Death|7|||
149869780|NCT01739348|540655083|FG002|Part I (Base Study)|Death|2|||
149869781|NCT01739348|540655084|FG003|Part I (Base Study)|Death|8|||
149869782|NCT01739348|540655081|FG000|Part I (Base Study)|Lack of Efficacy|3|||
149869783|NCT01739348|540655082|FG001|Part I (Base Study)|Lack of Efficacy|8|||
149869784|NCT01739348|540655083|FG002|Part I (Base Study)|Lack of Efficacy|0|||
149869785|NCT01739348|540655084|FG003|Part I (Base Study)|Lack of Efficacy|7|||
149869786|NCT01739348|540655081|FG000|Part I (Base Study)|Lost to Follow-up|4|||
149869787|NCT01739348|540655082|FG001|Part I (Base Study)|Lost to Follow-up|2|||
149869788|NCT01739348|540655083|FG002|Part I (Base Study)|Lost to Follow-up|4|||
149869789|NCT01739348|540655084|FG003|Part I (Base Study)|Lost to Follow-up|4|||
149869790|NCT01739348|540655081|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
149869791|NCT01739348|540655082|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
149869792|NCT01739348|540655083|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
149869793|NCT01739348|540655084|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
149869794|NCT01739348|540655081|FG000|Part I (Base Study)|Physician Decision|10|||
149869795|NCT01739348|540655082|FG001|Part I (Base Study)|Physician Decision|7|||
149869796|NCT01739348|540655083|FG002|Part I (Base Study)|Physician Decision|1|||
149869797|NCT01739348|540655084|FG003|Part I (Base Study)|Physician Decision|4|||
149869798|NCT01739348|540655081|FG000|Part I (Base Study)|Protocol Violation|2|||
149869799|NCT01739348|540655082|FG001|Part I (Base Study)|Protocol Violation|0|||
149869800|NCT01739348|540655083|FG002|Part I (Base Study)|Protocol Violation|1|||
149869801|NCT01739348|540655084|FG003|Part I (Base Study)|Protocol Violation|2|||
149869802|NCT01739348|540655081|FG000|Part I (Base Study)|Screen Failure|2|||
149869803|NCT01739348|540655082|FG001|Part I (Base Study)|Screen Failure|0|||
149869804|NCT01739348|540655083|FG002|Part I (Base Study)|Screen Failure|0|||
149962495|NCT01703221|540995937|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149869805|NCT01739348|540655084|FG003|Part I (Base Study)|Screen Failure|0|||
149869806|NCT01739348|540655081|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
149869807|NCT01739348|540655082|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
149869808|NCT01739348|540655083|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
149869809|NCT01739348|540655084|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
149962496|NCT01703221|540995938|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150173898|NCT00057837|541773000|FG000|Overall Study|Withdrawal by Subject|5|||
149869810|NCT01739348|540655081|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
149869811|NCT01739348|540655082|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
149869812|NCT01739348|540655083|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
149869813|NCT01739348|540655084|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
149869814|NCT01739348|540655081|FG000|Part I (Base Study)|Participant Moved|4|||
149869815|NCT01739348|540655082|FG001|Part I (Base Study)|Participant Moved|3|||
149869816|NCT01739348|540655083|FG002|Part I (Base Study)|Participant Moved|1|||
149869817|NCT01739348|540655084|FG003|Part I (Base Study)|Participant Moved|7|||
149869818|NCT01739348|540655081|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
149869819|NCT01739348|540655082|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
149869820|NCT01739348|540655083|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
149869821|NCT01739348|540655084|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
149869822|NCT01739348|540655081|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
149869823|NCT01739348|540655082|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
149869824|NCT01739348|540655083|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
149869825|NCT01739348|540655084|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
149869826|NCT01739348|540655081|FG000|Part II (Extension Study)|Adverse Event|10|||
149869827|NCT01739348|540655082|FG001|Part II (Extension Study)|Adverse Event|11|||
149869828|NCT01739348|540655083|FG002|Part II (Extension Study)|Adverse Event|7|||
149869829|NCT01739348|540655084|FG003|Part II (Extension Study)|Adverse Event|26|||
149869830|NCT01739348|540655081|FG000|Part II (Extension Study)|Death|3|||
149869831|NCT01739348|540655082|FG001|Part II (Extension Study)|Death|3|||
149869832|NCT01739348|540655083|FG002|Part II (Extension Study)|Death|2|||
149869833|NCT01739348|540655084|FG003|Part II (Extension Study)|Death|6|||
149869834|NCT01739348|540655081|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
149869835|NCT01739348|540655082|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
149869836|NCT01739348|540655083|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
149869837|NCT01739348|540655084|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
149869838|NCT01739348|540655081|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
149869839|NCT01739348|540655082|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
149869840|NCT01739348|540655083|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
149869841|NCT01739348|540655084|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
149869842|NCT01739348|540655081|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
149869843|NCT01739348|540655082|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
149869844|NCT01739348|540655083|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
149869845|NCT01739348|540655084|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
149869846|NCT01739348|540655081|FG000|Part II (Extension Study)|Physician Decision|7|||
149869847|NCT01739348|540655082|FG001|Part II (Extension Study)|Physician Decision|11|||
149869848|NCT01739348|540655083|FG002|Part II (Extension Study)|Physician Decision|6|||
149869849|NCT01739348|540655084|FG003|Part II (Extension Study)|Physician Decision|12|||
149869850|NCT01739348|540655081|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
149869851|NCT01739348|540655082|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
149869852|NCT01739348|540655083|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
149869853|NCT01739348|540655084|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
149869854|NCT01739348|540655081|FG000|Part II (Extension Study)|Participant Moved|3|||
149869855|NCT01739348|540655082|FG001|Part II (Extension Study)|Participant Moved|3|||
149869856|NCT01739348|540655083|FG002|Part II (Extension Study)|Participant Moved|0|||
149869857|NCT01739348|540655084|FG003|Part II (Extension Study)|Participant Moved|3|||
149869858|NCT01739348|540655081|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
149869859|NCT01739348|540655082|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
149869860|NCT01739348|540655083|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
149869861|NCT01739348|540655084|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
149869862|NCT01739348|540655081|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
149869863|NCT01739348|540655082|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
149869864|NCT01739348|540655083|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
149869865|NCT01739348|540655084|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
149869866|NCT01447420|540655089|FG000|Overall Study|Adverse Event|2|||
149869867|NCT01447420|540655090|FG001|Overall Study|Adverse Event|4|||
149869868|NCT01447420|540655091|FG002|Overall Study|Adverse Event|2|||
149869869|NCT01447420|540655089|FG000|Overall Study|Protocol Violation|3|||
149869870|NCT01447420|540655090|FG001|Overall Study|Protocol Violation|3|||
149869871|NCT01447420|540655091|FG002|Overall Study|Protocol Violation|0|||
149869872|NCT01447420|540655089|FG000|Overall Study|Withdrawal by Subject|4|||
149962497|NCT01703221|540995936|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
150173899|NCT00057837|541773001|FG001|Overall Study|Withdrawal by Subject|3|||
149869873|NCT01447420|540655090|FG001|Overall Study|Withdrawal by Subject|1|||
149869874|NCT01447420|540655091|FG002|Overall Study|Withdrawal by Subject|0|||
149869875|NCT01447420|540655089|FG000|Overall Study|Lack of Efficacy|1|||
149869876|NCT01447420|540655090|FG001|Overall Study|Lack of Efficacy|19|||
149869877|NCT01447420|540655091|FG002|Overall Study|Lack of Efficacy|8|||
149869878|NCT04562155|540655093|FG000|Overall Study|COVID-19 pandemic|0|||
149869879|NCT04562155|540655094|FG001|Overall Study|COVID-19 pandemic|0|||
149869880|NCT04562155|540655095|FG002|Overall Study|COVID-19 pandemic|0|||
149869881|NCT04562155|540655096|FG003|Overall Study|COVID-19 pandemic|1|||
149869882|NCT04562155|540655093|FG000|Overall Study|Adverse Event|7|||
149869883|NCT04562155|540655094|FG001|Overall Study|Adverse Event|3|||
149869884|NCT04562155|540655095|FG002|Overall Study|Adverse Event|8|||
149869885|NCT04562155|540655096|FG003|Overall Study|Adverse Event|1|||
149869886|NCT04562155|540655093|FG000|Overall Study|Withdrawal by Subject|3|||
149869887|NCT04562155|540655094|FG001|Overall Study|Withdrawal by Subject|6|||
149869888|NCT04562155|540655095|FG002|Overall Study|Withdrawal by Subject|3|||
149869889|NCT04562155|540655096|FG003|Overall Study|Withdrawal by Subject|3|||
149869890|NCT04562155|540655093|FG000|Overall Study|Participant personal reason|1|||
149869891|NCT04562155|540655094|FG001|Overall Study|Participant personal reason|0|||
149869892|NCT04562155|540655095|FG002|Overall Study|Participant personal reason|2|||
149869893|NCT04562155|540655096|FG003|Overall Study|Participant personal reason|1|||
149869894|NCT01085201|540655099|FG000|Overall Study|Scheduling conflict|1|||
149869895|NCT01085201|540655100|FG001|Overall Study|Scheduling conflict|0|||
149869896|NCT01085201|540655101|FG002|Overall Study|Scheduling conflict|1|||
149869897|NCT01085201|540655102|FG003|Overall Study|Scheduling conflict|0|||
149869898|NCT01085201|540655103|FG004|Overall Study|Scheduling conflict|0|||
149869899|NCT01085201|540655099|FG000|Overall Study|Unknown- no study drug|2|||
149869900|NCT01085201|540655100|FG001|Overall Study|Unknown- no study drug|0|||
149869901|NCT01085201|540655101|FG002|Overall Study|Unknown- no study drug|0|||
149869902|NCT01085201|540655102|FG003|Overall Study|Unknown- no study drug|0|||
149869903|NCT01085201|540655103|FG004|Overall Study|Unknown- no study drug|0|||
149869904|NCT01085201|540655099|FG000|Overall Study|Fond ineligible after consent|0|||
149869905|NCT01085201|540655100|FG001|Overall Study|Fond ineligible after consent|1|||
149869906|NCT01085201|540655101|FG002|Overall Study|Fond ineligible after consent|1|||
149869907|NCT01085201|540655102|FG003|Overall Study|Fond ineligible after consent|0|||
149869908|NCT01085201|540655103|FG004|Overall Study|Fond ineligible after consent|0|||
149869909|NCT00528411|540655104|FG000|Overall Study|Adverse Event|4|||
149869910|NCT00528411|540655105|FG001|Overall Study|Adverse Event|0|||
149869911|NCT00528411|540655106|FG002|Overall Study|Adverse Event|1|||
149869912|NCT00528411|540655104|FG000|Overall Study|Incorrect Enrolment|1|||
149869913|NCT00528411|540655105|FG001|Overall Study|Incorrect Enrolment|1|||
149869914|NCT00528411|540655106|FG002|Overall Study|Incorrect Enrolment|0|||
149869915|NCT00528411|540655104|FG000|Overall Study|Severe non-compliance to protocol|0|||
149869916|NCT00528411|540655105|FG001|Overall Study|Severe non-compliance to protocol|1|||
149869917|NCT00528411|540655106|FG002|Overall Study|Severe non-compliance to protocol|0|||
149869918|NCT00528411|540655104|FG000|Overall Study|Prior commitment medication|0|||
149869919|NCT00528411|540655105|FG001|Overall Study|Prior commitment medication|1|||
149869920|NCT00528411|540655106|FG002|Overall Study|Prior commitment medication|0|||
149869921|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
149869922|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
149869923|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869924|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869925|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
149869926|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869927|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869928|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869929|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
149869930|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869931|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
149869932|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869933|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869934|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869935|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869936|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869937|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869938|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
149869939|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869940|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
149869941|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869942|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
149869943|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869944|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869945|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869946|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869947|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149869948|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869949|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
149869950|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869951|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
149869952|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869953|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869954|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869955|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869956|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
149869957|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
149869958|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
149869959|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
149869960|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149869961|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
149869962|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149869963|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149869964|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149869965|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149869966|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869967|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
149869968|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869969|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869970|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869971|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869972|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869973|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869974|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
149869975|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869976|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869977|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869978|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
149869979|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869980|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869981|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869982|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869983|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149869984|NCT03893565|540655107|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869985|NCT03893565|540655108|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
149869986|NCT03893565|540655109|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
149869987|NCT03893565|540655110|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
149869988|NCT03893565|540655111|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869989|NCT03893565|540655112|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869990|NCT03893565|540655113|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869991|NCT03893565|540655114|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869992|NCT03893565|540655115|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
149869993|NCT03893565|540655107|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
149869994|NCT03893565|540655108|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
149869995|NCT03893565|540655109|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
149869996|NCT03893565|540655110|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
149869997|NCT03893565|540655111|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
149869998|NCT03893565|540655112|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
149869999|NCT03893565|540655113|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
149870000|NCT03893565|540655114|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
149870001|NCT03893565|540655115|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
149870002|NCT03893565|540655107|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870003|NCT03893565|540655108|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870004|NCT03893565|540655109|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870005|NCT03893565|540655110|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870006|NCT03893565|540655111|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870007|NCT03893565|540655112|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870008|NCT03893565|540655113|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
149870009|NCT03893565|540655114|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870010|NCT03893565|540655115|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
149870011|NCT03893565|540655107|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870012|NCT03893565|540655108|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870013|NCT03893565|540655109|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870014|NCT03893565|540655110|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870015|NCT03893565|540655111|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870016|NCT03893565|540655112|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
149870017|NCT03893565|540655113|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
149870018|NCT03893565|540655114|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870019|NCT03893565|540655115|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
149870020|NCT03893565|540655107|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
149870021|NCT03893565|540655108|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
149870022|NCT03893565|540655109|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
149870023|NCT03893565|540655110|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
149870024|NCT03893565|540655111|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
149870025|NCT03893565|540655112|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
149870026|NCT03893565|540655113|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
149870027|NCT03893565|540655114|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
149870028|NCT03893565|540655115|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
149870029|NCT03893565|540655107|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870030|NCT03893565|540655108|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870031|NCT03893565|540655109|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870032|NCT03893565|540655110|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870033|NCT03893565|540655111|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870034|NCT03893565|540655112|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870035|NCT03893565|540655113|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870036|NCT03893565|540655114|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
149870037|NCT03893565|540655115|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
149870038|NCT03893565|540655107|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870039|NCT03893565|540655108|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870040|NCT03893565|540655109|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870041|NCT03893565|540655110|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870042|NCT03893565|540655111|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870043|NCT03893565|540655112|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870044|NCT03893565|540655113|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870045|NCT03893565|540655114|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
149870046|NCT03893565|540655115|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
149870047|NCT03893565|540655107|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149962498|NCT01703221|540995937|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149962499|NCT01703221|540995938|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
149962500|NCT01703221|540995936|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149962501|NCT01703221|540995937|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149962502|NCT01703221|540995938|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
149962503|NCT01703221|540995936|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
149962504|NCT01703221|540995937|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
149962505|NCT01703221|540995938|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
149962506|NCT01703221|540995936|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
149962507|NCT01703221|540995937|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
149962508|NCT01703221|540995938|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
149962509|NCT01703221|540995936|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
149962510|NCT01703221|540995937|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
149870048|NCT03893565|540655108|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870049|NCT03893565|540655109|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870050|NCT03893565|540655110|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870051|NCT03893565|540655111|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870052|NCT03893565|540655112|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870053|NCT03893565|540655113|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870054|NCT03893565|540655114|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
149870055|NCT03893565|540655115|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
149870056|NCT03893565|540655107|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870057|NCT03893565|540655108|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870058|NCT03893565|540655109|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870059|NCT03893565|540655110|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870060|NCT03893565|540655111|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870061|NCT03893565|540655112|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870062|NCT03893565|540655113|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870063|NCT03893565|540655114|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
149870064|NCT03893565|540655115|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
149870065|NCT00851318|540655116|FG000|Overall Study|Withdrawal by Subject|7|||
149870066|NCT00851318|540655117|FG001|Overall Study|Withdrawal by Subject|1|||
149870067|NCT00851318|540655118|FG002|Overall Study|Withdrawal by Subject|5|||
149870068|NCT00851318|540655119|FG003|Overall Study|Withdrawal by Subject|3|||
149870069|NCT00851318|540655116|FG000|Overall Study|Adverse Event|13|||
149870070|NCT00851318|540655117|FG001|Overall Study|Adverse Event|2|||
149870071|NCT00851318|540655118|FG002|Overall Study|Adverse Event|9|||
149870072|NCT00851318|540655119|FG003|Overall Study|Adverse Event|12|||
149870073|NCT00851318|540655116|FG000|Overall Study|Pregnancy|0|||
149870074|NCT00851318|540655117|FG001|Overall Study|Pregnancy|0|||
149870075|NCT00851318|540655118|FG002|Overall Study|Pregnancy|1|||
149870076|NCT00851318|540655119|FG003|Overall Study|Pregnancy|1|||
149870077|NCT00851318|540655116|FG000|Overall Study|Lack of Efficacy|8|||
149870078|NCT00851318|540655117|FG001|Overall Study|Lack of Efficacy|2|||
149870079|NCT00851318|540655118|FG002|Overall Study|Lack of Efficacy|4|||
149870080|NCT00851318|540655119|FG003|Overall Study|Lack of Efficacy|2|||
149870081|NCT00851318|540655116|FG000|Overall Study|Non-compliance with Study Procedures|2|||
149870082|NCT00851318|540655117|FG001|Overall Study|Non-compliance with Study Procedures|0|||
149870083|NCT00851318|540655118|FG002|Overall Study|Non-compliance with Study Procedures|1|||
149870084|NCT00851318|540655119|FG003|Overall Study|Non-compliance with Study Procedures|0|||
149870085|NCT00851318|540655116|FG000|Overall Study|Physician Decision|0|||
149870086|NCT00851318|540655117|FG001|Overall Study|Physician Decision|0|||
149870087|NCT00851318|540655118|FG002|Overall Study|Physician Decision|1|||
149870088|NCT00851318|540655119|FG003|Overall Study|Physician Decision|1|||
149870089|NCT05961215|540655120|FG000|Overall Study|Withdrawal by Subject|1|||
149870090|NCT01096368|540655122|FG000|Overall Study|Death|0|||
149870091|NCT01096368|540655123|FG001|Overall Study|Death|1|||
149870092|NCT01096368|540655124|FG002|Overall Study|Death|0|||
149870093|NCT01096368|540655125|FG003|Overall Study|Death|0|||
149870094|NCT01096368|540655126|FG004|Overall Study|Death|0|||
149870095|NCT01096368|540655122|FG000|Overall Study|Physician Decision|0|||
149870096|NCT01096368|540655123|FG001|Overall Study|Physician Decision|13|||
149870097|NCT01096368|540655124|FG002|Overall Study|Physician Decision|2|||
149870098|NCT01096368|540655125|FG003|Overall Study|Physician Decision|4|||
149870099|NCT01096368|540655126|FG004|Overall Study|Physician Decision|6|||
149870100|NCT01096368|540655122|FG000|Overall Study|Withdrawal by Subject|0|||
149870101|NCT01096368|540655123|FG001|Overall Study|Withdrawal by Subject|52|||
149870102|NCT01096368|540655124|FG002|Overall Study|Withdrawal by Subject|0|||
149870103|NCT01096368|540655125|FG003|Overall Study|Withdrawal by Subject|10|||
149870104|NCT01096368|540655126|FG004|Overall Study|Withdrawal by Subject|14|||
149870105|NCT01096368|540655122|FG000|Overall Study|Ineligible|0|||
149870106|NCT01096368|540655123|FG001|Overall Study|Ineligible|3|||
149870107|NCT01096368|540655124|FG002|Overall Study|Ineligible|2|||
149962511|NCT01703221|540995938|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
149962512|NCT05333965|540997640|FG000|First Intervention|Adverse Event|0|||
149962513|NCT05333965|540997641|FG001|First Intervention|Adverse Event|1|||
149962514|NCT05333965|540997640|FG000|First Intervention|Withdrawal by Subject|0|||
149962515|NCT05333965|540997641|FG001|First Intervention|Withdrawal by Subject|1|||
149870108|NCT01096368|540655125|FG003|Overall Study|Ineligible|0|||
149870109|NCT01096368|540655126|FG004|Overall Study|Ineligible|25|||
149870110|NCT01096368|540655122|FG000|Overall Study|Did not start treatment|0|||
149870111|NCT01096368|540655123|FG001|Overall Study|Did not start treatment|4|||
149870112|NCT01096368|540655124|FG002|Overall Study|Did not start treatment|4|||
149870113|NCT01096368|540655125|FG003|Overall Study|Did not start treatment|0|||
149870114|NCT01096368|540655126|FG004|Overall Study|Did not start treatment|0|||
149870115|NCT01096368|540655122|FG000|Overall Study|Progressive disease|0|||
149870116|NCT01096368|540655123|FG001|Overall Study|Progressive disease|6|||
149870117|NCT01096368|540655124|FG002|Overall Study|Progressive disease|0|||
149870118|NCT01096368|540655125|FG003|Overall Study|Progressive disease|10|||
149870119|NCT01096368|540655126|FG004|Overall Study|Progressive disease|3|||
149870120|NCT01096368|540655122|FG000|Overall Study|Other|0|||
149870121|NCT01096368|540655123|FG001|Overall Study|Other|0|||
149870122|NCT01096368|540655124|FG002|Overall Study|Other|1|||
149870123|NCT01096368|540655125|FG003|Overall Study|Other|0|||
149870124|NCT01096368|540655126|FG004|Overall Study|Other|0|||
149870125|NCT01096368|540655122|FG000|Overall Study|Treated with institutional review|0|||
149870126|NCT01096368|540655123|FG001|Overall Study|Treated with institutional review|0|||
149870127|NCT01096368|540655124|FG002|Overall Study|Treated with institutional review|0|||
149870128|NCT01096368|540655125|FG003|Overall Study|Treated with institutional review|0|||
149870129|NCT01096368|540655126|FG004|Overall Study|Treated with institutional review|1|||
149870130|NCT06354998|540655127|FG000|Overall Study|Withdrawal by Subject|3|||
149870131|NCT06354998|540655128|FG001|Overall Study|Withdrawal by Subject|0|||
149870132|NCT05442866|540655129|FG000|Overall Study|Death|1|||
149870133|NCT05442866|540655129|FG000|Overall Study|Lost to Follow-up|9|||
149870134|NCT05442866|540655129|FG000|Overall Study|Protocol Violation|1|||
149870135|NCT01616953|540655131|FG000|Overall Study|Lost to Follow-up|1|||
149870136|NCT01616953|540655132|FG001|Overall Study|Lost to Follow-up|0|||
149870137|NCT01616953|540655131|FG000|Overall Study|lack of bone and soft tissue|1|||
149870138|NCT01616953|540655132|FG001|Overall Study|lack of bone and soft tissue|0|||
149870139|NCT01568320|540655133|FG000|Overall Study|Death|20|||
149870140|NCT01568320|540655133|FG000|Overall Study|Lost to Follow-up|9|||
149870141|NCT01568320|540655133|FG000|Overall Study|Withdrawal by Subject|10|||
149870142|NCT01568320|540655133|FG000|Overall Study|Conversion to open repair|1|||
149870143|NCT01568320|540655133|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
149870144|NCT00816361|540655135|FG000|Overall Study|Withdrawal by Subject|0|||
149870145|NCT00816361|540655136|FG001|Overall Study|Withdrawal by Subject|0|||
149870146|NCT00816361|540655137|FG002|Overall Study|Withdrawal by Subject|0|||
149870147|NCT00816361|540655138|FG003|Overall Study|Withdrawal by Subject|0|||
149870148|NCT00816361|540655139|FG004|Overall Study|Withdrawal by Subject|1|||
149870149|NCT00816361|540655140|FG005|Overall Study|Withdrawal by Subject|2|||
149870150|NCT00816361|540655141|FG006|Overall Study|Withdrawal by Subject|0|||
149870151|NCT00816361|540655142|FG007|Overall Study|Withdrawal by Subject|2|||
149870152|NCT00816361|540655143|FG008|Overall Study|Withdrawal by Subject|1|||
149870153|NCT00816361|540655135|FG000|Overall Study|Death|4|||
149870154|NCT00816361|540655136|FG001|Overall Study|Death|3|||
149870155|NCT00816361|540655137|FG002|Overall Study|Death|3|||
149870156|NCT00816361|540655138|FG003|Overall Study|Death|3|||
149870157|NCT00816361|540655139|FG004|Overall Study|Death|1|||
149870158|NCT00816361|540655140|FG005|Overall Study|Death|1|||
149870159|NCT00816361|540655141|FG006|Overall Study|Death|3|||
149870160|NCT00816361|540655142|FG007|Overall Study|Death|7|||
149870161|NCT00816361|540655143|FG008|Overall Study|Death|8|||
149870162|NCT00816361|540655135|FG000|Overall Study|Other|0|||
149870163|NCT00816361|540655136|FG001|Overall Study|Other|0|||
149870164|NCT00816361|540655137|FG002|Overall Study|Other|0|||
149870165|NCT00816361|540655138|FG003|Overall Study|Other|0|||
149870166|NCT00816361|540655139|FG004|Overall Study|Other|0|||
149870167|NCT00816361|540655140|FG005|Overall Study|Other|0|||
149870168|NCT00816361|540655141|FG006|Overall Study|Other|0|||
149870169|NCT00816361|540655142|FG007|Overall Study|Other|0|||
149870170|NCT00816361|540655143|FG008|Overall Study|Other|1|||
149870171|NCT01394952|540655144|FG000|Overall Study|Lost to Follow-up|0|||
149870172|NCT01394952|540655145|FG001|Overall Study|Lost to Follow-up|5|||
149870173|NCT01394952|540655144|FG000|Overall Study|Withdrawal by Subject|10|||
149870174|NCT01394952|540655145|FG001|Overall Study|Withdrawal by Subject|5|||
149870175|NCT01394952|540655144|FG000|Overall Study|Physician Decision|2|||
149870176|NCT01394952|540655145|FG001|Overall Study|Physician Decision|0|||
149870177|NCT01394952|540655144|FG000|Overall Study|Sponsor Decision|5|||
149870178|NCT01394952|540655145|FG001|Overall Study|Sponsor Decision|7|||
149870179|NCT01763684|540655147|FG000|Overall Study|Study terminated early due to low enrollment|126|||
149870180|NCT01763684|540655148|FG001|Overall Study|Study terminated early due to low enrollment|127|||
149870181|NCT01763684|540655147|FG000|Overall Study|Study surgery not performed|7|||
149870182|NCT01763684|540655148|FG001|Overall Study|Study surgery not performed|6|||
149870183|NCT02987959|540655149|FG000|Overall Study|Grantor stopped supply of drugs|6|||
149870184|NCT02853370|540655151|FG000|Overall Study|Physician Decision|1|||
149870185|NCT02853370|540655151|FG000|Overall Study|Lack of Efficacy|2|||
149870186|NCT02853370|540655151|FG000|Overall Study|Death|1|||
149870187|NCT02853370|540655151|FG000|Overall Study|Adverse Event|4|||
149870188|NCT02853370|540655151|FG000|Overall Study|Withdrawal by Subject|3|||
149870189|NCT00643565|540655153|FG000|Overall Study|Death|12|||
149870190|NCT00643565|540655154|FG001|Overall Study|Death|11|||
149870191|NCT00643565|540655153|FG000|Overall Study|Withdrawal by Subject|4|||
149870192|NCT00643565|540655154|FG001|Overall Study|Withdrawal by Subject|1|||
149870193|NCT00643565|540655153|FG000|Overall Study|Lost to Follow-up|0|||
149870194|NCT00643565|540655154|FG001|Overall Study|Lost to Follow-up|6|||
149870195|NCT00643565|540655153|FG000|Overall Study|Other|7|||
149870196|NCT00643565|540655154|FG001|Overall Study|Other|8|||
149870197|NCT00643565|540655153|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
149870198|NCT00643565|540655154|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
149870199|NCT00643565|540655153|FG000|Overall Study|Recurrence of Disease|2|||
149870200|NCT00643565|540655154|FG001|Overall Study|Recurrence of Disease|1|||
149870201|NCT00643565|540655153|FG000|Overall Study|Progression of Disease|18|||
149870202|NCT00643565|540655154|FG001|Overall Study|Progression of Disease|14|||
149870203|NCT00643565|540655153|FG000|Overall Study|Protocol Violation|3|||
149870204|NCT00643565|540655154|FG001|Overall Study|Protocol Violation|0|||
149870205|NCT00643565|540655153|FG000|Overall Study|Did Not Cooperate|0|||
149870206|NCT00643565|540655154|FG001|Overall Study|Did Not Cooperate|1|||
149870207|NCT00643565|540655153|FG000|Overall Study|Administrative|22|||
149870208|NCT00643565|540655154|FG001|Overall Study|Administrative|16|||
149870209|NCT00643565|540655153|FG000|Overall Study|Adverse Event|5|||
149870210|NCT00643565|540655154|FG001|Overall Study|Adverse Event|8|||
149870211|NCT02317614|540655155|FG000|Overall Study|Lost to Follow-up|1|||
149870212|NCT02317614|540655156|FG001|Overall Study|Lost to Follow-up|1|||
149870213|NCT02317614|540655155|FG000|Overall Study|Withdrawal by Subject|1|||
149870214|NCT02317614|540655156|FG001|Overall Study|Withdrawal by Subject|0|||
149870215|NCT02317614|540655155|FG000|Overall Study|Death|1|||
149870216|NCT02317614|540655156|FG001|Overall Study|Death|1|||
149870217|NCT03285308|540655159|FG000|Overall Study|Adverse Event|3|||
149870218|NCT03285308|540655160|FG001|Overall Study|Adverse Event|7|||
149870219|NCT03285308|540655159|FG000|Overall Study|Withdrawal by Subject|8|||
149870220|NCT03285308|540655160|FG001|Overall Study|Withdrawal by Subject|9|||
149870221|NCT03285308|540655159|FG000|Overall Study|Lost to Follow-up|3|||
149870222|NCT03285308|540655160|FG001|Overall Study|Lost to Follow-up|1|||
149870223|NCT03285308|540655159|FG000|Overall Study|Protocol Deviation|6|||
149870224|NCT03285308|540655160|FG001|Overall Study|Protocol Deviation|5|||
149870225|NCT03285308|540655159|FG000|Overall Study|Reason not Specified|0|||
149870226|NCT03285308|540655160|FG001|Overall Study|Reason not Specified|1|||
149870227|NCT02283983|540655161|FG000|Overall Study|Inclusion criteria not met|0|||
149870228|NCT02283983|540655162|FG001|Overall Study|Inclusion criteria not met|1|||
149870229|NCT02283983|540655161|FG000|Overall Study|Withdrawal by Subject|4|||
149870230|NCT02283983|540655162|FG001|Overall Study|Withdrawal by Subject|2|||
149870231|NCT02283983|540655161|FG000|Overall Study|Protocol Violation|0|||
149870232|NCT02283983|540655162|FG001|Overall Study|Protocol Violation|4|||
149870233|NCT02283983|540655161|FG000|Overall Study|Physician Decision|2|||
149870234|NCT02283983|540655162|FG001|Overall Study|Physician Decision|4|||
149870235|NCT02283983|540655161|FG000|Overall Study|Death|1|||
149870236|NCT02283983|540655162|FG001|Overall Study|Death|0|||
149870237|NCT02283983|540655161|FG000|Overall Study|Adverse Event|1|||
149870238|NCT02283983|540655162|FG001|Overall Study|Adverse Event|0|||
149870239|NCT02283983|540655161|FG000|Overall Study|Lost to Follow-up|9|||
149870240|NCT02283983|540655162|FG001|Overall Study|Lost to Follow-up|8|||
149870241|NCT02283983|540655161|FG000|Overall Study|Relapse|1|||
149870242|NCT02283983|540655162|FG001|Overall Study|Relapse|0|||
149870243|NCT00669071|540655164|FG000|Overall Study|Lost to Follow-up|3|||
149870244|NCT00669071|540655164|FG000|Overall Study|Final visit 40 days out of window|1|||
149870245|NCT01157897|540655167|FG000|Overall Study|Lost to Follow-up|2|||
149870246|NCT01157897|540655168|FG001|Overall Study|Lost to Follow-up|0|||
149870247|NCT01157897|540655169|FG002|Overall Study|Lost to Follow-up|0|||
149870248|NCT01157897|540655170|FG003|Overall Study|Lost to Follow-up|1|||
149870249|NCT01157897|540655167|FG000|Overall Study|Relocated|0|||
149870250|NCT01157897|540655168|FG001|Overall Study|Relocated|2|||
149870251|NCT01157897|540655169|FG002|Overall Study|Relocated|0|||
150173900|NCT00057837|541773000|FG000|Overall Study|Alternative therapy|0|||
149870252|NCT01157897|540655170|FG003|Overall Study|Relocated|0|||
149870253|NCT01791153|540655172|FG000|Part 1: Blinded Period|Adverse Event|7|||
149870254|NCT01791153|540655173|FG001|Part 1: Blinded Period|Adverse Event|3|||
149870255|NCT01791153|540655174|FG002|Part 1: Blinded Period|Adverse Event|2|||
149870256|NCT01791153|540655175|FG003|Part 1: Blinded Period|Adverse Event|0|||
149870257|NCT01791153|540655176|FG004|Part 1: Blinded Period|Adverse Event|0|||
149870258|NCT01791153|540655177|FG005|Part 1: Blinded Period|Adverse Event|0|||
149870259|NCT01791153|540655178|FG006|Part 1: Blinded Period|Adverse Event|0|||
149870260|NCT01791153|540655179|FG007|Part 1: Blinded Period|Adverse Event|0|||
149870261|NCT01791153|540655172|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
149870262|NCT01791153|540655173|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
149870263|NCT01791153|540655174|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
149870264|NCT01791153|540655175|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
149870265|NCT01791153|540655176|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
149870266|NCT01791153|540655177|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
149870267|NCT01791153|540655178|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
150173901|NCT00057837|541773001|FG001|Overall Study|Alternative therapy|1|||
149870268|NCT01791153|540655179|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
149870269|NCT01791153|540655172|FG000|Part 1: Blinded Period|Non-Compliance|1|||
149870270|NCT01791153|540655173|FG001|Part 1: Blinded Period|Non-Compliance|0|||
149870271|NCT01791153|540655174|FG002|Part 1: Blinded Period|Non-Compliance|0|||
149870272|NCT01791153|540655175|FG003|Part 1: Blinded Period|Non-Compliance|0|||
149870273|NCT01791153|540655176|FG004|Part 1: Blinded Period|Non-Compliance|0|||
149870274|NCT01791153|540655177|FG005|Part 1: Blinded Period|Non-Compliance|0|||
149870275|NCT01791153|540655178|FG006|Part 1: Blinded Period|Non-Compliance|0|||
149870276|NCT01791153|540655179|FG007|Part 1: Blinded Period|Non-Compliance|0|||
149870277|NCT01791153|540655172|FG000|Part 1: Blinded Period|Physician Decision|0|||
149870278|NCT01791153|540655173|FG001|Part 1: Blinded Period|Physician Decision|0|||
149870279|NCT01791153|540655174|FG002|Part 1: Blinded Period|Physician Decision|0|||
149870280|NCT01791153|540655175|FG003|Part 1: Blinded Period|Physician Decision|1|||
149870281|NCT01791153|540655176|FG004|Part 1: Blinded Period|Physician Decision|0|||
149870282|NCT01791153|540655177|FG005|Part 1: Blinded Period|Physician Decision|0|||
149870283|NCT01791153|540655178|FG006|Part 1: Blinded Period|Physician Decision|0|||
149870284|NCT01791153|540655179|FG007|Part 1: Blinded Period|Physician Decision|0|||
149870285|NCT01791153|540655172|FG000|Part 1: Blinded Period|Protocol Violation|0|||
149870286|NCT01791153|540655173|FG001|Part 1: Blinded Period|Protocol Violation|0|||
149870287|NCT01791153|540655174|FG002|Part 1: Blinded Period|Protocol Violation|0|||
149870288|NCT01791153|540655175|FG003|Part 1: Blinded Period|Protocol Violation|1|||
149870289|NCT01791153|540655176|FG004|Part 1: Blinded Period|Protocol Violation|0|||
149870290|NCT01791153|540655177|FG005|Part 1: Blinded Period|Protocol Violation|0|||
149870291|NCT01791153|540655178|FG006|Part 1: Blinded Period|Protocol Violation|0|||
149870292|NCT01791153|540655179|FG007|Part 1: Blinded Period|Protocol Violation|0|||
149870293|NCT01791153|540655172|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
149870294|NCT01791153|540655173|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
149870295|NCT01791153|540655174|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
149870296|NCT01791153|540655175|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
149870297|NCT01791153|540655176|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
149870298|NCT01791153|540655177|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
149870299|NCT01791153|540655178|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
149870300|NCT01791153|540655179|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
149870301|NCT01791153|540655172|FG000|Part 2: Open-label Period|Adverse Event|0|||
149870302|NCT01791153|540655173|FG001|Part 2: Open-label Period|Adverse Event|0|||
149870303|NCT01791153|540655174|FG002|Part 2: Open-label Period|Adverse Event|0|||
149870304|NCT01791153|540655175|FG003|Part 2: Open-label Period|Adverse Event|0|||
149870305|NCT01791153|540655176|FG004|Part 2: Open-label Period|Adverse Event|0|||
149870306|NCT01791153|540655177|FG005|Part 2: Open-label Period|Adverse Event|1|||
149870307|NCT01791153|540655178|FG006|Part 2: Open-label Period|Adverse Event|1|||
149870308|NCT01791153|540655179|FG007|Part 2: Open-label Period|Adverse Event|2|||
149870309|NCT01791153|540655172|FG000|Part 2: Open-label Period|Death|0|||
149870310|NCT01791153|540655173|FG001|Part 2: Open-label Period|Death|0|||
149870311|NCT01791153|540655174|FG002|Part 2: Open-label Period|Death|0|||
149870312|NCT01791153|540655175|FG003|Part 2: Open-label Period|Death|0|||
149870313|NCT01791153|540655176|FG004|Part 2: Open-label Period|Death|0|||
149870314|NCT01791153|540655177|FG005|Part 2: Open-label Period|Death|1|||
149870315|NCT01791153|540655178|FG006|Part 2: Open-label Period|Death|1|||
149870316|NCT01791153|540655179|FG007|Part 2: Open-label Period|Death|1|||
149870317|NCT01791153|540655172|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
149870318|NCT01791153|540655173|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
149870319|NCT01791153|540655174|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
149870320|NCT01791153|540655175|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
149870321|NCT01791153|540655176|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
149870322|NCT01791153|540655177|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
149870323|NCT01791153|540655178|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
149870324|NCT01791153|540655179|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
149870325|NCT01791153|540655172|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
149870326|NCT01791153|540655173|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
149870327|NCT01791153|540655174|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
149870328|NCT01791153|540655175|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
149870329|NCT01791153|540655176|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
149870330|NCT01791153|540655177|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
149870331|NCT01791153|540655178|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
149870332|NCT01791153|540655179|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
149870333|NCT01791153|540655172|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
149870334|NCT01791153|540655173|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
149870335|NCT01791153|540655174|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
149870336|NCT01791153|540655175|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
149870337|NCT01791153|540655176|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
149870338|NCT01791153|540655177|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
149870339|NCT01791153|540655178|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
149870340|NCT01791153|540655179|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
149870341|NCT01791153|540655172|FG000|Part 2: Open-label Period|Physician Decision|0|||
149870342|NCT01791153|540655173|FG001|Part 2: Open-label Period|Physician Decision|0|||
149870343|NCT01791153|540655174|FG002|Part 2: Open-label Period|Physician Decision|0|||
149870344|NCT01791153|540655175|FG003|Part 2: Open-label Period|Physician Decision|0|||
149870345|NCT01791153|540655176|FG004|Part 2: Open-label Period|Physician Decision|1|||
149870346|NCT01791153|540655177|FG005|Part 2: Open-label Period|Physician Decision|1|||
149870347|NCT01791153|540655178|FG006|Part 2: Open-label Period|Physician Decision|0|||
149870348|NCT01791153|540655179|FG007|Part 2: Open-label Period|Physician Decision|0|||
149870349|NCT01150890|540655180|FG000|Overall Study|Other|0|||
149870350|NCT01150890|540655181|FG001|Overall Study|Other|1|||
149870351|NCT01150890|540655182|FG002|Overall Study|Other|0|||
149870352|NCT01150890|540655183|FG003|Overall Study|Other|2|||
149870353|NCT01150890|540655180|FG000|Overall Study|Pregnancy|0|||
149870354|NCT01150890|540655181|FG001|Overall Study|Pregnancy|0|||
149870355|NCT01150890|540655182|FG002|Overall Study|Pregnancy|0|||
149870356|NCT01150890|540655183|FG003|Overall Study|Pregnancy|1|||
149870357|NCT01150890|540655180|FG000|Overall Study|Administrative Decision|4|||
149870358|NCT01150890|540655181|FG001|Overall Study|Administrative Decision|4|||
149870359|NCT01150890|540655182|FG002|Overall Study|Administrative Decision|5|||
149870360|NCT01150890|540655183|FG003|Overall Study|Administrative Decision|6|||
149870361|NCT01150890|540655180|FG000|Overall Study|Ineligibility determined|0|||
149870362|NCT01150890|540655181|FG001|Overall Study|Ineligibility determined|1|||
149870363|NCT01150890|540655182|FG002|Overall Study|Ineligibility determined|0|||
149870364|NCT01150890|540655183|FG003|Overall Study|Ineligibility determined|0|||
149870365|NCT01150890|540655180|FG000|Overall Study|Adverse Event|0|||
149870366|NCT01150890|540655181|FG001|Overall Study|Adverse Event|0|||
149870367|NCT01150890|540655182|FG002|Overall Study|Adverse Event|2|||
149870368|NCT01150890|540655183|FG003|Overall Study|Adverse Event|0|||
149870369|NCT01150890|540655180|FG000|Overall Study|Withdrawal by Subject|0|||
149870370|NCT01150890|540655181|FG001|Overall Study|Withdrawal by Subject|0|||
149870371|NCT01150890|540655182|FG002|Overall Study|Withdrawal by Subject|2|||
149870372|NCT01150890|540655183|FG003|Overall Study|Withdrawal by Subject|1|||
149870373|NCT01150890|540655180|FG000|Overall Study|Disease progression|0|||
149870374|NCT01150890|540655181|FG001|Overall Study|Disease progression|7|||
149870375|NCT01150890|540655182|FG002|Overall Study|Disease progression|3|||
149870376|NCT01150890|540655183|FG003|Overall Study|Disease progression|7|||
149870377|NCT03970837|540655184|FG000|Overall Study|Adverse Event|23|||
149870378|NCT03970837|540655185|FG001|Overall Study|Adverse Event|20|||
149870379|NCT03970837|540655186|FG002|Overall Study|Adverse Event|16|||
149870380|NCT03970837|540655187|FG003|Overall Study|Adverse Event|6|||
149870381|NCT03970837|540655188|FG004|Overall Study|Adverse Event|4|||
149870382|NCT03970837|540655189|FG005|Overall Study|Adverse Event|5|||
149870383|NCT03970837|540655190|FG006|Overall Study|Adverse Event|1|||
149870384|NCT03970837|540655191|FG007|Overall Study|Adverse Event|5|||
149870385|NCT03970837|540655192|FG008|Overall Study|Adverse Event|0|||
149870386|NCT03970837|540655193|FG009|Overall Study|Adverse Event|0|||
149870387|NCT03970837|540655194|FG010|Overall Study|Adverse Event|1|||
149870388|NCT03970837|540655195|FG011|Overall Study|Adverse Event|1|||
149870389|NCT03970837|540655184|FG000|Overall Study|Lack of Efficacy|14|||
149870390|NCT03970837|540655185|FG001|Overall Study|Lack of Efficacy|12|||
149870391|NCT03970837|540655186|FG002|Overall Study|Lack of Efficacy|1|||
149870392|NCT03970837|540655187|FG003|Overall Study|Lack of Efficacy|2|||
149870393|NCT03970837|540655188|FG004|Overall Study|Lack of Efficacy|3|||
149870394|NCT03970837|540655189|FG005|Overall Study|Lack of Efficacy|4|||
149870395|NCT03970837|540655190|FG006|Overall Study|Lack of Efficacy|6|||
149870396|NCT03970837|540655191|FG007|Overall Study|Lack of Efficacy|1|||
149870397|NCT03970837|540655192|FG008|Overall Study|Lack of Efficacy|1|||
149870398|NCT03970837|540655193|FG009|Overall Study|Lack of Efficacy|0|||
149870399|NCT03970837|540655194|FG010|Overall Study|Lack of Efficacy|0|||
149870400|NCT03970837|540655195|FG011|Overall Study|Lack of Efficacy|0|||
149870401|NCT03970837|540655184|FG000|Overall Study|Lost to Follow-up|6|||
149870402|NCT03970837|540655185|FG001|Overall Study|Lost to Follow-up|5|||
149870403|NCT03970837|540655186|FG002|Overall Study|Lost to Follow-up|5|||
149870404|NCT03970837|540655187|FG003|Overall Study|Lost to Follow-up|1|||
149870405|NCT03970837|540655188|FG004|Overall Study|Lost to Follow-up|0|||
149870406|NCT03970837|540655189|FG005|Overall Study|Lost to Follow-up|2|||
149870407|NCT03970837|540655190|FG006|Overall Study|Lost to Follow-up|0|||
149870408|NCT03970837|540655191|FG007|Overall Study|Lost to Follow-up|0|||
149870409|NCT03970837|540655192|FG008|Overall Study|Lost to Follow-up|0|||
149870410|NCT03970837|540655193|FG009|Overall Study|Lost to Follow-up|0|||
149870411|NCT03970837|540655194|FG010|Overall Study|Lost to Follow-up|0|||
149870412|NCT03970837|540655195|FG011|Overall Study|Lost to Follow-up|0|||
149870413|NCT03970837|540655184|FG000|Overall Study|Protocol Violation|1|||
149870414|NCT03970837|540655185|FG001|Overall Study|Protocol Violation|0|||
149870415|NCT03970837|540655186|FG002|Overall Study|Protocol Violation|0|||
149870416|NCT03970837|540655187|FG003|Overall Study|Protocol Violation|0|||
149870417|NCT03970837|540655188|FG004|Overall Study|Protocol Violation|0|||
149870418|NCT03970837|540655189|FG005|Overall Study|Protocol Violation|0|||
149870419|NCT03970837|540655190|FG006|Overall Study|Protocol Violation|0|||
149870420|NCT03970837|540655191|FG007|Overall Study|Protocol Violation|0|||
149870421|NCT03970837|540655192|FG008|Overall Study|Protocol Violation|0|||
149870422|NCT03970837|540655193|FG009|Overall Study|Protocol Violation|0|||
149870423|NCT03970837|540655194|FG010|Overall Study|Protocol Violation|0|||
149870424|NCT03970837|540655195|FG011|Overall Study|Protocol Violation|0|||
149870425|NCT03970837|540655184|FG000|Overall Study|Physician Decision|5|||
149870426|NCT03970837|540655185|FG001|Overall Study|Physician Decision|8|||
149870427|NCT03970837|540655186|FG002|Overall Study|Physician Decision|4|||
149870428|NCT03970837|540655187|FG003|Overall Study|Physician Decision|1|||
149870429|NCT03970837|540655188|FG004|Overall Study|Physician Decision|5|||
149870430|NCT03970837|540655189|FG005|Overall Study|Physician Decision|2|||
149870431|NCT03970837|540655190|FG006|Overall Study|Physician Decision|4|||
149870432|NCT03970837|540655191|FG007|Overall Study|Physician Decision|5|||
149870433|NCT03970837|540655192|FG008|Overall Study|Physician Decision|0|||
149870434|NCT03970837|540655193|FG009|Overall Study|Physician Decision|1|||
149870435|NCT03970837|540655194|FG010|Overall Study|Physician Decision|0|||
149870436|NCT03970837|540655195|FG011|Overall Study|Physician Decision|0|||
149870437|NCT03970837|540655184|FG000|Overall Study|Withdrawal by Subject|32|||
149870438|NCT03970837|540655185|FG001|Overall Study|Withdrawal by Subject|35|||
149870439|NCT03970837|540655186|FG002|Overall Study|Withdrawal by Subject|12|||
149870440|NCT03970837|540655187|FG003|Overall Study|Withdrawal by Subject|8|||
149870441|NCT03970837|540655188|FG004|Overall Study|Withdrawal by Subject|6|||
149870442|NCT03970837|540655189|FG005|Overall Study|Withdrawal by Subject|8|||
149870443|NCT03970837|540655190|FG006|Overall Study|Withdrawal by Subject|2|||
149870444|NCT03970837|540655191|FG007|Overall Study|Withdrawal by Subject|3|||
149870445|NCT03970837|540655192|FG008|Overall Study|Withdrawal by Subject|0|||
149870446|NCT03970837|540655193|FG009|Overall Study|Withdrawal by Subject|0|||
149870447|NCT03970837|540655194|FG010|Overall Study|Withdrawal by Subject|0|||
149870448|NCT03970837|540655195|FG011|Overall Study|Withdrawal by Subject|1|||
149870449|NCT03970837|540655184|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
149870450|NCT03970837|540655185|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
149870451|NCT03970837|540655186|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
149870452|NCT03970837|540655187|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149870453|NCT03970837|540655188|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
149870454|NCT03970837|540655189|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
149870455|NCT03970837|540655190|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
149870456|NCT03970837|540655191|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
149870457|NCT03970837|540655192|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
149870458|NCT03970837|540655193|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149870459|NCT03970837|540655194|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149870460|NCT03970837|540655195|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
149870461|NCT03970837|540655184|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870462|NCT03970837|540655185|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870463|NCT03970837|540655186|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870464|NCT03970837|540655187|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870465|NCT03970837|540655188|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870466|NCT03970837|540655189|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149870467|NCT03970837|540655190|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
149870468|NCT03970837|540655191|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
149870469|NCT03970837|540655192|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
149870470|NCT03970837|540655193|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
149870471|NCT03970837|540655194|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
149870472|NCT03970837|540655195|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
149870473|NCT03786718|540657714|FG000|Overall Study|Lost to Follow-up|3|||
149870474|NCT03786718|540657714|FG000|Overall Study|Withdrawal by Subject|1|||
149870475|NCT03786718|540657714|FG000|Overall Study|Did not use the intervention|2|||
149870476|NCT03786718|540657714|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
149962516|NCT00835549|540997644|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
149962517|NCT00835549|540997645|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149962518|NCT00835042|540997646|FG000|First Intervention|Withdrawal by Subject|3|||
149962519|NCT00835042|540997647|FG001|First Intervention|Withdrawal by Subject|0|||
149962520|NCT00835042|540997646|FG000|First Intervention|Adverse Event|1|||
149962521|NCT00835042|540997647|FG001|First Intervention|Adverse Event|2|||
149870477|NCT00372411|540657723|FG000|Overall Study|Withdrawal by Subject|3|||
149870478|NCT00372411|540657724|FG001|Overall Study|Withdrawal by Subject|4|||
149870479|NCT00372411|540657725|FG002|Overall Study|Withdrawal by Subject|1|||
149870480|NCT00372411|540657723|FG000|Overall Study|Death|0|||
149870481|NCT00372411|540657724|FG001|Overall Study|Death|2|||
149962522|NCT00835042|540997646|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
149962523|NCT00835042|540997647|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
149870482|NCT00372411|540657725|FG002|Overall Study|Death|1|||
149870483|NCT00372411|540657723|FG000|Overall Study|Lost to Follow-up|1|||
149870484|NCT00372411|540657724|FG001|Overall Study|Lost to Follow-up|1|||
149870485|NCT00372411|540657725|FG002|Overall Study|Lost to Follow-up|1|||
149870486|NCT00372411|540657723|FG000|Overall Study|Adverse Event|1|||
149870487|NCT00372411|540657724|FG001|Overall Study|Adverse Event|1|||
149870488|NCT00372411|540657725|FG002|Overall Study|Adverse Event|0|||
149870489|NCT01398514|540657726|FG000|Overall Study|Adverse Event|1|||
149870490|NCT01398514|540657727|FG001|Overall Study|Adverse Event|0|||
149870491|NCT01398514|540657726|FG000|Overall Study|Non-compliance with study procedures|2|||
149870492|NCT01398514|540657727|FG001|Overall Study|Non-compliance with study procedures|0|||
149870493|NCT01398514|540657726|FG000|Overall Study|Physiologic non-responsiveness|1|||
149870494|NCT01398514|540657727|FG001|Overall Study|Physiologic non-responsiveness|3|||
149870495|NCT01398514|540657726|FG000|Overall Study|Failure to show a conditioned response|4|||
149870496|NCT01398514|540657727|FG001|Overall Study|Failure to show a conditioned response|3|||
149870497|NCT00754650|540657728|FG000|Overall Study|Disease Progression|2|||
149870498|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
149870499|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
149870500|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
149870501|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
149870502|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
149870503|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
149870504|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
149870505|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
149870506|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
149870507|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
149870508|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
149870509|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
149870510|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
149870511|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
149870512|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
149870513|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
149870514|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
149870515|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
149870516|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
149870517|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
149870518|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
149870519|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
149870520|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
149870521|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
149870522|NCT03514641|540657729|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
149870523|NCT03514641|540657730|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
149870524|NCT03514641|540657731|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
149870525|NCT03514641|540657732|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
149870526|NCT03514641|540657729|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
149870527|NCT03514641|540657730|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
149870528|NCT03514641|540657731|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
149870529|NCT03514641|540657732|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
149870530|NCT03514641|540657729|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
149870531|NCT03514641|540657730|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
149870532|NCT03514641|540657731|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
149870533|NCT03514641|540657732|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
149870534|NCT03514641|540657729|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
149870535|NCT03514641|540657730|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
149870536|NCT03514641|540657731|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
149870537|NCT03514641|540657732|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
149870538|NCT03514641|540657729|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
149870539|NCT03514641|540657730|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
149870540|NCT03514641|540657731|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
149870541|NCT03514641|540657732|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
149870542|NCT03514641|540657729|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
149870543|NCT03514641|540657730|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
149870544|NCT03514641|540657731|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
149962524|NCT04008069|540997648|FG000|Open-Label Period|Adverse Event|1|||
149962525|NCT04008069|540997649|FG001|Open-Label Period|Adverse Event|0|||
149870545|NCT03514641|540657732|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
149870546|NCT01345175|540657733|FG000|Overall Study|Physician Decision|0|||
149870547|NCT01345175|540657734|FG001|Overall Study|Physician Decision|1|||
149870548|NCT01345175|540657733|FG000|Overall Study|Withdrawal by Subject|1|||
149962526|NCT04008069|540997650|FG002|Open-Label Period|Adverse Event|0|||
149870549|NCT01345175|540657734|FG001|Overall Study|Withdrawal by Subject|1|||
149870550|NCT01345175|540657733|FG000|Overall Study|Failed to complete BFI|3|||
149870551|NCT01345175|540657734|FG001|Overall Study|Failed to complete BFI|2|||
149870552|NCT01345175|540657733|FG000|Overall Study|Stopped taking medication|2|||
149870553|NCT01345175|540657734|FG001|Overall Study|Stopped taking medication|2|||
149870554|NCT02906930|540657737|FG000|Overall Study|Withdrawal by Subject|0|||
149870555|NCT02906930|540657738|FG001|Overall Study|Withdrawal by Subject|5|||
149870556|NCT02906930|540657739|FG002|Overall Study|Withdrawal by Subject|5|||
149870557|NCT02906930|540657740|FG003|Overall Study|Withdrawal by Subject|4|||
149870558|NCT02906930|540657737|FG000|Overall Study|Lost to Follow-up|5|||
149870559|NCT02906930|540657738|FG001|Overall Study|Lost to Follow-up|7|||
149870560|NCT02906930|540657739|FG002|Overall Study|Lost to Follow-up|5|||
149870561|NCT02906930|540657740|FG003|Overall Study|Lost to Follow-up|2|||
149870562|NCT02906930|540657737|FG000|Overall Study|Death|0|||
149870563|NCT02906930|540657738|FG001|Overall Study|Death|0|||
149870564|NCT02906930|540657739|FG002|Overall Study|Death|1|||
149870565|NCT02906930|540657740|FG003|Overall Study|Death|0|||
149870566|NCT02906930|540657737|FG000|Overall Study|Other|1|||
149870567|NCT02906930|540657738|FG001|Overall Study|Other|2|||
149870568|NCT02906930|540657739|FG002|Overall Study|Other|1|||
149870569|NCT02906930|540657740|FG003|Overall Study|Other|2|||
149870570|NCT02570113|540657741|FG000|Overall Study|Withdrawal by Subject|3|||
149870571|NCT00910091|540657742|FG000|Pre-assignment|Withdrawal by Subject|0|||
149870572|NCT00910091|540657743|FG001|Pre-assignment|Withdrawal by Subject|2|||
149870573|NCT00910091|540657742|FG000|Treatment and Survival|Withdrawal by Subject|3|||
149870574|NCT00910091|540657743|FG001|Treatment and Survival|Withdrawal by Subject|4|||
149870575|NCT00910091|540657742|FG000|Treatment and Survival|Adverse Event|1|||
149870576|NCT00910091|540657743|FG001|Treatment and Survival|Adverse Event|0|||
149870577|NCT01908816|540657744|FG000|Overall Study|Subject's no longer requires study drug|0|||
149870578|NCT01908816|540657745|FG001|Overall Study|Subject's no longer requires study drug|0|||
149870579|NCT01908816|540657746|FG002|Overall Study|Subject's no longer requires study drug|0|||
149870580|NCT01908816|540657747|FG003|Overall Study|Subject's no longer requires study drug|1|||
149870581|NCT01908816|540657744|FG000|Overall Study|Protocol deviation|1|||
149870582|NCT01908816|540657745|FG001|Overall Study|Protocol deviation|2|||
149870583|NCT01908816|540657746|FG002|Overall Study|Protocol deviation|1|||
149870584|NCT01908816|540657747|FG003|Overall Study|Protocol deviation|1|||
149870585|NCT01908816|540657744|FG000|Overall Study|Withdrawal by Subject|0|||
149870586|NCT01908816|540657745|FG001|Overall Study|Withdrawal by Subject|4|||
149870587|NCT01908816|540657746|FG002|Overall Study|Withdrawal by Subject|2|||
149870588|NCT01908816|540657747|FG003|Overall Study|Withdrawal by Subject|2|||
149870589|NCT01908816|540657744|FG000|Overall Study|Lost to Follow-up|3|||
149870590|NCT01908816|540657745|FG001|Overall Study|Lost to Follow-up|5|||
149870591|NCT01908816|540657746|FG002|Overall Study|Lost to Follow-up|4|||
149870592|NCT01908816|540657747|FG003|Overall Study|Lost to Follow-up|2|||
149870593|NCT01908816|540657744|FG000|Overall Study|Death|1|||
149870594|NCT01908816|540657745|FG001|Overall Study|Death|0|||
149870595|NCT01908816|540657746|FG002|Overall Study|Death|7|||
149870596|NCT01908816|540657747|FG003|Overall Study|Death|1|||
149870597|NCT01908816|540657744|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149870598|NCT01908816|540657745|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
149870599|NCT01908816|540657746|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
149962527|NCT04008069|540997648|FG000|Open-Label Period|Lack of Efficacy|4|||
149962528|NCT04008069|540997649|FG001|Open-Label Period|Lack of Efficacy|0|||
149962529|NCT04008069|540997650|FG002|Open-Label Period|Lack of Efficacy|0|||
149962530|NCT04008069|540997648|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
149962531|NCT04008069|540997649|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
149962532|NCT04008069|540997650|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
149962533|NCT04008069|540997648|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
149962534|NCT04008069|540997649|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
149962535|NCT04008069|540997650|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
149962536|NCT02314247|540997656|FG000|Overall Study|Adverse Event|2|||
149962537|NCT02314247|540997657|FG001|Overall Study|Adverse Event|1|||
149962538|NCT02314247|540997658|FG002|Overall Study|Adverse Event|0|||
149962539|NCT02314247|540997656|FG000|Overall Study|Withdrawal by Subject|1|||
149962540|NCT02314247|540997657|FG001|Overall Study|Withdrawal by Subject|3|||
149870600|NCT01908816|540657747|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149962541|NCT02314247|540997658|FG002|Overall Study|Withdrawal by Subject|1|||
149962542|NCT02314247|540997656|FG000|Overall Study|Progression of Disease|6|||
149870601|NCT01908816|540657744|FG000|Overall Study|Early termination|87|||
149870602|NCT01908816|540657745|FG001|Overall Study|Early termination|60|||
149870603|NCT01908816|540657746|FG002|Overall Study|Early termination|43|||
149870604|NCT01908816|540657747|FG003|Overall Study|Early termination|28|||
149870605|NCT01007942|540657749|FG000|Overall Study|Adverse Event|29|||
149870606|NCT01007942|540657750|FG001|Overall Study|Adverse Event|14|||
149870607|NCT01007942|540657749|FG000|Overall Study|Abnormal test procedure|0|||
149870608|NCT01007942|540657750|FG001|Overall Study|Abnormal test procedure|1|||
149870609|NCT01007942|540657749|FG000|Overall Study|Disease progression|217|||
149870610|NCT01007942|540657750|FG001|Overall Study|Disease progression|242|||
149870611|NCT01007942|540657749|FG000|Overall Study|New cancer therapy|5|||
149870612|NCT01007942|540657750|FG001|Overall Study|New cancer therapy|1|||
149870613|NCT01007942|540657749|FG000|Overall Study|Protocol Violation|1|||
149870614|NCT01007942|540657750|FG001|Overall Study|Protocol Violation|1|||
149870615|NCT01007942|540657749|FG000|Overall Study|Withdrawal by Subject|19|||
149870616|NCT01007942|540657750|FG001|Overall Study|Withdrawal by Subject|14|||
149870617|NCT01007942|540657749|FG000|Overall Study|Lost to Follow-up|1|||
149870618|NCT01007942|540657750|FG001|Overall Study|Lost to Follow-up|0|||
149870619|NCT01007942|540657749|FG000|Overall Study|Administrative problems|2|||
149870620|NCT01007942|540657750|FG001|Overall Study|Administrative problems|0|||
149870621|NCT01007942|540657749|FG000|Overall Study|Death|3|||
149870622|NCT01007942|540657750|FG001|Overall Study|Death|2|||
149870623|NCT01007942|540657749|FG000|Overall Study|Patients untreated|4|||
149870624|NCT01007942|540657750|FG001|Overall Study|Patients untreated|3|||
149870625|NCT04492020|540657751|FG000|Overall Study|Adverse Event|1|||
149870626|NCT04492020|540657752|FG001|Overall Study|Adverse Event|3|||
149870627|NCT04492020|540657751|FG000|Overall Study|Withdrawal by Subject|4|||
149870628|NCT04492020|540657752|FG001|Overall Study|Withdrawal by Subject|3|||
149870629|NCT04492020|540657751|FG000|Overall Study|Lost to Follow-up|4|||
149870630|NCT04492020|540657752|FG001|Overall Study|Lost to Follow-up|3|||
149870631|NCT04492020|540657751|FG000|Overall Study|Protocol Violation|5|||
149870632|NCT04492020|540657752|FG001|Overall Study|Protocol Violation|2|||
149870633|NCT04492020|540657751|FG000|Overall Study|Lack of Qualifying Event|25|||
149870634|NCT04492020|540657752|FG001|Overall Study|Lack of Qualifying Event|27|||
149870635|NCT04492020|540657751|FG000|Overall Study|Non-compliance with Study Drug|2|||
149870636|NCT04492020|540657752|FG001|Overall Study|Non-compliance with Study Drug|1|||
149870637|NCT04585789|540657753|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
149870638|NCT04585789|540657754|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
149870639|NCT04585789|540657755|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
149870640|NCT04585789|540657753|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
149870641|NCT04585789|540657754|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
149870642|NCT04585789|540657755|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
149870643|NCT01175811|540657756|FG000|Overall Study|Adverse Event|1|||
149870644|NCT01175811|540657757|FG001|Overall Study|Adverse Event|1|||
149870645|NCT01175811|540657756|FG000|Overall Study|Entry criteria not met|3|||
149870646|NCT01175811|540657757|FG001|Overall Study|Entry criteria not met|1|||
149870647|NCT01175811|540657756|FG000|Overall Study|Lack of Efficacy|1|||
149870648|NCT01175811|540657757|FG001|Overall Study|Lack of Efficacy|0|||
149870649|NCT01175811|540657756|FG000|Overall Study|Lost to Follow-up|3|||
149870650|NCT01175811|540657757|FG001|Overall Study|Lost to Follow-up|2|||
149870651|NCT01175811|540657756|FG000|Overall Study|Physician Decision|1|||
149870652|NCT01175811|540657757|FG001|Overall Study|Physician Decision|1|||
149870653|NCT01175811|540657756|FG000|Overall Study|Protocol Violation|1|||
149870654|NCT01175811|540657757|FG001|Overall Study|Protocol Violation|2|||
149870655|NCT01175811|540657756|FG000|Overall Study|Withdrawal by Subject|6|||
149870656|NCT01175811|540657757|FG001|Overall Study|Withdrawal by Subject|7|||
149870657|NCT02628743|540657759|FG000|Overall Study|Other|3|||
149870658|NCT02628743|540657759|FG000|Overall Study|Withdrawal by Subject|50|||
149870659|NCT02628743|540657759|FG000|Overall Study|Study Terminated by Sponsor|76|||
149870660|NCT02628743|540657759|FG000|Overall Study|Physician Decision|2|||
149870661|NCT00552578|540657763|FG000|Overall Study|Lost to Follow-up|1|||
149870662|NCT00552578|540657764|FG001|Overall Study|Lost to Follow-up|1|||
149870663|NCT01059539|540657765|FG000|Overall Study|Adverse Event|66|||
149870664|NCT01059539|540657765|FG000|Overall Study|Insufficient Therapeutic Response|26|||
149870665|NCT01059539|540657765|FG000|Overall Study|Protocol Violation|55|||
149870666|NCT01059539|540657765|FG000|Overall Study|Withdrawal of Consent|80|||
149870667|NCT01059539|540657765|FG000|Overall Study|Lost to Follow-up|42|||
149870668|NCT01059539|540657765|FG000|Overall Study|Reason Not Specified|2|||
150173902|NCT00057837|541773000|FG000|Overall Study|Other complicating disease|2|||
149870669|NCT02085135|540657767|FG000|Overall Study|Adverse Event|4|||
149870670|NCT02085135|540657768|FG001|Overall Study|Adverse Event|7|||
149870671|NCT02085135|540657767|FG000|Overall Study|Lost to Follow-up|2|||
149870672|NCT02085135|540657768|FG001|Overall Study|Lost to Follow-up|2|||
149870673|NCT02085135|540657767|FG000|Overall Study|Withdrawal by Subject|3|||
149870674|NCT02085135|540657768|FG001|Overall Study|Withdrawal by Subject|0|||
150173903|NCT00057837|541773001|FG001|Overall Study|Other complicating disease|1|||
149870675|NCT02085135|540657767|FG000|Overall Study|Lack of Efficacy|2|||
149870676|NCT02085135|540657768|FG001|Overall Study|Lack of Efficacy|0|||
149870677|NCT04091659|540657771|FG000|Overall Study|Protocol Violation|3|||
149870678|NCT04091659|540657772|FG001|Overall Study|Protocol Violation|0|||
149870679|NCT04091659|540657771|FG000|Overall Study|Lost to Follow-up|0|||
149870680|NCT04091659|540657772|FG001|Overall Study|Lost to Follow-up|1|||
149870681|NCT00626392|540657773|FG000|Run-in Period|Adverse Event|0|||
149870682|NCT00626392|540657774|FG001|Run-in Period|Adverse Event|0|||
149870683|NCT00626392|540657775|FG002|Run-in Period|Adverse Event|1|||
149870684|NCT00626392|540657776|FG003|Run-in Period|Adverse Event|0|||
149870685|NCT00626392|540657777|FG004|Run-in Period|Adverse Event|1|||
149870686|NCT00626392|540657778|FG005|Run-in Period|Adverse Event|0|||
149870687|NCT00626392|540657773|FG000|Run-in Period|Withdrawal by Subject|0|||
149870688|NCT00626392|540657774|FG001|Run-in Period|Withdrawal by Subject|1|||
149870689|NCT00626392|540657775|FG002|Run-in Period|Withdrawal by Subject|1|||
149870690|NCT00626392|540657776|FG003|Run-in Period|Withdrawal by Subject|1|||
149870691|NCT00626392|540657777|FG004|Run-in Period|Withdrawal by Subject|3|||
149870692|NCT00626392|540657778|FG005|Run-in Period|Withdrawal by Subject|1|||
149870693|NCT00626392|540657773|FG000|Run-in Period|Noncompliance|1|||
149870694|NCT00626392|540657774|FG001|Run-in Period|Noncompliance|0|||
149870695|NCT00626392|540657775|FG002|Run-in Period|Noncompliance|1|||
149870696|NCT00626392|540657776|FG003|Run-in Period|Noncompliance|0|||
149870697|NCT00626392|540657777|FG004|Run-in Period|Noncompliance|0|||
149870698|NCT00626392|540657778|FG005|Run-in Period|Noncompliance|0|||
149870699|NCT00626392|540657773|FG000|Coadministration Period|Adverse Event|3|||
149870700|NCT00626392|540657774|FG001|Coadministration Period|Adverse Event|1|||
149870701|NCT00626392|540657775|FG002|Coadministration Period|Adverse Event|7|||
149870702|NCT00626392|540657776|FG003|Coadministration Period|Adverse Event|4|||
149870703|NCT00626392|540657777|FG004|Coadministration Period|Adverse Event|3|||
149870704|NCT00626392|540657778|FG005|Coadministration Period|Adverse Event|4|||
149870705|NCT00626392|540657773|FG000|Coadministration Period|Withdrawal by Subject|1|||
149870706|NCT00626392|540657774|FG001|Coadministration Period|Withdrawal by Subject|1|||
149870707|NCT00626392|540657775|FG002|Coadministration Period|Withdrawal by Subject|0|||
149870708|NCT00626392|540657776|FG003|Coadministration Period|Withdrawal by Subject|1|||
149962543|NCT02314247|540997657|FG001|Overall Study|Progression of Disease|2|||
149962544|NCT02314247|540997658|FG002|Overall Study|Progression of Disease|0|||
149962545|NCT01953354|540997659|FG000|Overall Study|Withdrawal by Subject|0|||
149870709|NCT00626392|540657777|FG004|Coadministration Period|Withdrawal by Subject|0|||
149870710|NCT00626392|540657778|FG005|Coadministration Period|Withdrawal by Subject|1|||
149870711|NCT00626392|540657773|FG000|Coadministration Period|Protocol Violation|0|||
149870712|NCT00626392|540657774|FG001|Coadministration Period|Protocol Violation|1|||
149870713|NCT00626392|540657775|FG002|Coadministration Period|Protocol Violation|0|||
149870714|NCT00626392|540657776|FG003|Coadministration Period|Protocol Violation|1|||
149870715|NCT00626392|540657777|FG004|Coadministration Period|Protocol Violation|1|||
149870716|NCT00626392|540657778|FG005|Coadministration Period|Protocol Violation|0|||
149870717|NCT00626392|540657773|FG000|Coadministration Period|Other|0|||
149870718|NCT00626392|540657774|FG001|Coadministration Period|Other|2|||
149870719|NCT00626392|540657775|FG002|Coadministration Period|Other|3|||
149870720|NCT00626392|540657776|FG003|Coadministration Period|Other|1|||
149870721|NCT00626392|540657777|FG004|Coadministration Period|Other|1|||
149870722|NCT00626392|540657778|FG005|Coadministration Period|Other|1|||
149870723|NCT03678285|540657782|FG000|Overall Study|Adverse Event|2|||
149870724|NCT03678285|540657782|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
149870725|NCT03678285|540657782|FG000|Overall Study|Dehydrated prior to start of workout|1|||
149870726|NCT01715571|540657785|FG000|Overall Study|Lost to Follow-up|8|||
149870727|NCT01696279|540657794|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
149870728|NCT01696279|540657795|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
149870729|NCT01696279|540657796|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
149962546|NCT01953354|540997660|FG001|Overall Study|Withdrawal by Subject|1|||
149962547|NCT01953354|540997659|FG000|Overall Study|Decision of Sponsor|0|||
149962548|NCT01953354|540997660|FG001|Overall Study|Decision of Sponsor|1|||
149962549|NCT01953354|540997659|FG000|Overall Study|Disease Exacerbation|1|||
149962550|NCT01953354|540997660|FG001|Overall Study|Disease Exacerbation|0|||
149962551|NCT00489359|540997661|FG000|Overall Study|Death|0|||
149962552|NCT00489359|540997662|FG001|Overall Study|Death|2|||
149962553|NCT00489359|540997661|FG000|Overall Study|Progressive Disease|5|||
149870730|NCT01696279|540657797|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
149870731|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
149870732|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
149870733|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
149870734|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
149870735|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
149870736|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
149870737|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
149870738|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
149870739|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
149870740|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
149870741|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
149870742|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
149870743|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
149870744|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
149870745|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
149870746|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
149870747|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
149870748|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
149870749|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
149870750|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
149870751|NCT01696279|540657794|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
149870752|NCT01696279|540657795|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
149870753|NCT01696279|540657796|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
149870754|NCT01696279|540657797|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
149870755|NCT01696279|540657794|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
149870756|NCT01696279|540657795|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
149870757|NCT01696279|540657796|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
149870758|NCT01696279|540657797|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
149870759|NCT01696279|540657794|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
149870760|NCT01696279|540657795|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
149870761|NCT01696279|540657796|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
149870762|NCT01696279|540657797|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
149870763|NCT01696279|540657794|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
149870764|NCT01696279|540657795|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
149870765|NCT01696279|540657796|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
149870766|NCT01696279|540657797|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
149870767|NCT01696279|540657794|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
149870768|NCT01696279|540657795|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
149870769|NCT01696279|540657796|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
149870770|NCT01696279|540657797|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
149870771|NCT04658095|540657798|FG000|Overall Study|Study terminated|5|||
149870772|NCT04658095|540657799|FG001|Overall Study|Study terminated|1|||
149870773|NCT04658095|540657800|FG002|Overall Study|Study terminated|4|||
149870774|NCT05788289|540657801|FG000|Overall Study|Death|3|||
149870775|NCT05187013|540657802|FG000|Overall Study|Withdrawal by Subject|1|||
149870776|NCT05187013|540657803|FG001|Overall Study|Withdrawal by Subject|1|||
149870777|NCT05187013|540657804|FG002|Overall Study|Withdrawal by Subject|0|||
149870778|NCT05187013|540657802|FG000|Overall Study|Death|0|||
149870779|NCT05187013|540657803|FG001|Overall Study|Death|1|||
149870780|NCT05187013|540657804|FG002|Overall Study|Death|0|||
149870781|NCT05187013|540657802|FG000|Overall Study|Lost to Follow-up|20|||
149870782|NCT05187013|540657803|FG001|Overall Study|Lost to Follow-up|17|||
149870783|NCT05187013|540657804|FG002|Overall Study|Lost to Follow-up|0|||
149870784|NCT05187013|540657802|FG000|Overall Study|Ongoing Participants|3|||
149870785|NCT05187013|540657803|FG001|Overall Study|Ongoing Participants|5|||
149870786|NCT05187013|540657804|FG002|Overall Study|Ongoing Participants|0|||
149870787|NCT02387983|540657807|FG000|Overall Study|Adverse Event|4|||
149870788|NCT02387983|540657807|FG000|Overall Study|Protocol Violation|1|||
149870789|NCT02387983|540657807|FG000|Overall Study|Withdrawal by Subject|2|||
149870790|NCT00077857|540657808|FG000|Overall Study|Adverse Event|30|||
149870791|NCT00077857|540657809|FG001|Overall Study|Adverse Event|32|||
149870792|NCT00077857|540657808|FG000|Overall Study|Death|7|||
149870793|NCT00077857|540657809|FG001|Overall Study|Death|3|||
149870794|NCT00077857|540657808|FG000|Overall Study|Insufficient therapeutic response|112|||
149870795|NCT00077857|540657809|FG001|Overall Study|Insufficient therapeutic response|128|||
149962554|NCT00489359|540997662|FG001|Overall Study|Progressive Disease|6|||
149870796|NCT00077857|540657808|FG000|Overall Study|Violation of selection criteria at entry|3|||
149870797|NCT00077857|540657809|FG001|Overall Study|Violation of selection criteria at entry|1|||
149870798|NCT00077857|540657808|FG000|Overall Study|Other protocol violation|0|||
149870799|NCT00077857|540657809|FG001|Overall Study|Other protocol violation|1|||
149870800|NCT00077857|540657808|FG000|Overall Study|Refused treatment|29|||
149870801|NCT00077857|540657809|FG001|Overall Study|Refused treatment|21|||
149870802|NCT00077857|540657808|FG000|Overall Study|Failure to return|5|||
149870803|NCT00077857|540657809|FG001|Overall Study|Failure to return|5|||
149870804|NCT00077857|540657808|FG000|Overall Study|Other|15|||
149870805|NCT00077857|540657809|FG001|Overall Study|Other|13|||
149870806|NCT06187909|540657813|FG000|Overall Study|Withdrawal by Subject|2|||
149870807|NCT06187909|540657814|FG001|Overall Study|Withdrawal by Subject|2|||
149870808|NCT04740814|540657815|FG000|Overall Study|Adverse Event|3|||
149870809|NCT04740814|540657815|FG000|Overall Study|Protocol Violation|2|||
149870810|NCT04740814|540657815|FG000|Overall Study|Lost to Follow-up|2|||
149870811|NCT04740814|540657815|FG000|Overall Study|Withdrawal by Subject|3|||
149870812|NCT00085423|540657816|FG000|Overall Study|Withdrawal by Subject|1|||
149870813|NCT00085423|540657816|FG000|Overall Study|screen failure|1|||
149870814|NCT02440568|540657817|FG000|Overall Study|Death|1|||
149870815|NCT02440568|540657818|FG001|Overall Study|Death|3|||
149870816|NCT02440568|540657819|FG002|Overall Study|Death|4|||
149870817|NCT02440568|540657820|FG003|Overall Study|Death|2|||
149870818|NCT02440568|540657817|FG000|Overall Study|Lack of Efficacy|2|||
149870819|NCT02440568|540657818|FG001|Overall Study|Lack of Efficacy|0|||
149870820|NCT02440568|540657819|FG002|Overall Study|Lack of Efficacy|1|||
149870821|NCT02440568|540657820|FG003|Overall Study|Lack of Efficacy|0|||
149870822|NCT02440568|540657817|FG000|Overall Study|Lost to Follow-up|1|||
149870823|NCT02440568|540657818|FG001|Overall Study|Lost to Follow-up|0|||
149870824|NCT02440568|540657819|FG002|Overall Study|Lost to Follow-up|0|||
149870825|NCT02440568|540657820|FG003|Overall Study|Lost to Follow-up|0|||
149870826|NCT04305496|540657829|FG000|Global Cohort|Withdrawal by Subject|13|||
149870827|NCT04305496|540657830|FG001|Global Cohort|Withdrawal by Subject|6|||
149870828|NCT04305496|540657829|FG000|Global Cohort|Physician Decision|1|||
149870829|NCT04305496|540657830|FG001|Global Cohort|Physician Decision|1|||
149870830|NCT04305496|540657829|FG000|Global Cohort|Subjective disease progression|16|||
149870831|NCT04305496|540657830|FG001|Global Cohort|Subjective disease progression|17|||
149870832|NCT04305496|540657829|FG000|Global Cohort|Condition under investigation worsened|209|||
149870833|NCT04305496|540657830|FG001|Global Cohort|Condition under investigation worsened|273|||
149870834|NCT04305496|540657829|FG000|Global Cohort|Protocol Violation|2|||
149870835|NCT04305496|540657830|FG001|Global Cohort|Protocol Violation|0|||
149870836|NCT04305496|540657829|FG000|Global Cohort|Adverse Event|44|||
149870837|NCT04305496|540657830|FG001|Global Cohort|Adverse Event|6|||
149870838|NCT04305496|540657829|FG000|Global Cohort|Death|3|||
149870839|NCT04305496|540657830|FG001|Global Cohort|Death|2|||
149870840|NCT04305496|540657829|FG000|Global Cohort|Any reason not specifically recorded|4|||
149870841|NCT04305496|540657830|FG001|Global Cohort|Any reason not specifically recorded|5|||
149870842|NCT04305496|540657829|FG000|China Cohort|Any reason not specifically recorded|1|||
149870843|NCT04305496|540657830|FG001|China Cohort|Any reason not specifically recorded|1|||
149870844|NCT04305496|540657829|FG000|China Cohort|Adverse Event|8|||
149870845|NCT04305496|540657830|FG001|China Cohort|Adverse Event|2|||
149870846|NCT04305496|540657829|FG000|China Cohort|Condition under investigation worsened|40|||
149870847|NCT04305496|540657830|FG001|China Cohort|Condition under investigation worsened|47|||
149870848|NCT04305496|540657829|FG000|China Cohort|Subjective disease progression|2|||
149870849|NCT04305496|540657830|FG001|China Cohort|Subjective disease progression|2|||
149870850|NCT04305496|540657829|FG000|China Cohort|Withdrawal by Subject|2|||
149870851|NCT04305496|540657830|FG001|China Cohort|Withdrawal by Subject|1|||
149870852|NCT01181271|540657834|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
149870853|NCT01181271|540657834|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
149870854|NCT01181271|540657834|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
149870855|NCT01181271|540657834|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
149870856|NCT01408628|540657835|FG000|Consented|Withdrawal by Subject|12|||
149870857|NCT01408628|540657835|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
149870858|NCT01408628|540657835|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
149870859|NCT01408628|540657835|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
149870860|NCT02980874|540657836|FG000|Overall Study|Adverse Event|2|||
149870861|NCT02980874|540657837|FG001|Overall Study|Adverse Event|7|||
149870862|NCT02980874|540657836|FG000|Overall Study|Withdrawal by Subject|7|||
149870863|NCT02980874|540657837|FG001|Overall Study|Withdrawal by Subject|2|||
149870864|NCT02980874|540657836|FG000|Overall Study|Lost to Follow-up|5|||
149870865|NCT02980874|540657837|FG001|Overall Study|Lost to Follow-up|5|||
149870866|NCT02980874|540657836|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
149870867|NCT02980874|540657837|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
149870868|NCT02980874|540657836|FG000|Overall Study|Unknown study completion status|1|||
149870869|NCT02980874|540657837|FG001|Overall Study|Unknown study completion status|0|||
149870870|NCT02435836|540657838|FG000|Overall Study|Lost to Follow-up|21|||
149870871|NCT02435836|540657838|FG000|Overall Study|Lack of Efficacy|1|||
149870872|NCT02435836|540657838|FG000|Overall Study|Withdrawal by Subject|236|||
149870873|NCT02435836|540657838|FG000|Overall Study|Insufficient Clinical Response|26|||
149870874|NCT02435836|540657838|FG000|Overall Study|Adverse Event|44|||
149870875|NCT02435836|540657838|FG000|Overall Study|Sponsor discontinued trial|167|||
149870876|NCT02435836|540657838|FG000|Overall Study|Noncompliance|27|||
149870877|NCT02435836|540657838|FG000|Overall Study|Protocol Violation|6|||
149870878|NCT02435836|540657838|FG000|Overall Study|Met Withdrawal Criteria|7|||
149870879|NCT02435836|540657838|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
149870880|NCT01753336|540657839|FG000|Overall Study|Patient decision|12|||
149870881|NCT01753336|540657839|FG000|Overall Study|Lost to Follow-up|3|||
149870882|NCT01753336|540657839|FG000|Overall Study|Physician Decision|2|||
149870883|NCT01753336|540657839|FG000|Overall Study|Sponsor's decision|2|||
149870884|NCT01753336|540657839|FG000|Overall Study|Withdrawal by Subject|1|||
149870885|NCT01121666|540657840|FG000|Overall Study|Protocol Violation|29|||
149870886|NCT01121666|540657841|FG001|Overall Study|Protocol Violation|10|||
149870887|NCT01629966|540657845|FG000|Overall Study|Pregnancy|0|||
149870888|NCT01629966|540657846|FG001|Overall Study|Pregnancy|1|||
149870889|NCT01629966|540657847|FG002|Overall Study|Pregnancy|0|||
149870890|NCT01629966|540657845|FG000|Overall Study|Lost to Follow-up|10|||
149870891|NCT01629966|540657846|FG001|Overall Study|Lost to Follow-up|13|||
149870892|NCT01629966|540657847|FG002|Overall Study|Lost to Follow-up|9|||
149870893|NCT01629966|540657845|FG000|Overall Study|Withdrawal by Subject|8|||
149870894|NCT01629966|540657846|FG001|Overall Study|Withdrawal by Subject|9|||
149870895|NCT01629966|540657847|FG002|Overall Study|Withdrawal by Subject|16|||
149870896|NCT01629966|540657845|FG000|Overall Study|Protocol Violation|7|||
149870897|NCT01629966|540657846|FG001|Overall Study|Protocol Violation|9|||
149870898|NCT01629966|540657847|FG002|Overall Study|Protocol Violation|7|||
149870899|NCT01629966|540657845|FG000|Overall Study|Lack of Efficacy|5|||
149870900|NCT01629966|540657846|FG001|Overall Study|Lack of Efficacy|2|||
149870901|NCT01629966|540657847|FG002|Overall Study|Lack of Efficacy|4|||
149870902|NCT01629966|540657845|FG000|Overall Study|Adverse Event|11|||
149870903|NCT01629966|540657846|FG001|Overall Study|Adverse Event|18|||
149870904|NCT01629966|540657847|FG002|Overall Study|Adverse Event|30|||
149870905|NCT01855074|540657848|FG000|Overall Study|Adverse Event|1|||
149870906|NCT01855074|540657848|FG000|Overall Study|Lost to Follow-up|4|||
149870907|NCT01855074|540657848|FG000|Overall Study|Withdrawal by Subject|8|||
149870908|NCT01855074|540657848|FG000|Overall Study|Started but not treated|1|||
149870909|NCT02991430|540657851|FG000|Treatment Period 1|Adverse Event|1|||
149870910|NCT02991430|540657852|FG001|Treatment Period 1|Adverse Event|0|||
149870911|NCT02991430|540657853|FG002|Treatment Period 1|Adverse Event|2|||
149870912|NCT02991430|540657851|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149870913|NCT02991430|540657852|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149870914|NCT02991430|540657853|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149870915|NCT02991430|540657851|FG000|Treatment Period 2|Study Termination|6|||
149870916|NCT02991430|540657852|FG001|Treatment Period 2|Study Termination|3|||
149870917|NCT02991430|540657853|FG002|Treatment Period 2|Study Termination|3|||
149870918|NCT02991430|540657851|FG000|Treatment Period 2|Lost to Follow-up|0|||
149870919|NCT02991430|540657852|FG001|Treatment Period 2|Lost to Follow-up|0|||
149870920|NCT02991430|540657853|FG002|Treatment Period 2|Lost to Follow-up|1|||
149870921|NCT02991430|540657851|FG000|Post-treatment Observation Period|Study Termination|3|||
149870922|NCT02991430|540657852|FG001|Post-treatment Observation Period|Study Termination|6|||
149870923|NCT02991430|540657853|FG002|Post-treatment Observation Period|Study Termination|5|||
149870924|NCT02132754|540657854|FG000|Overall Study|Adverse Event|0|||
149870925|NCT02132754|540657855|FG001|Overall Study|Adverse Event|0|||
149870926|NCT02132754|540657856|FG002|Overall Study|Adverse Event|0|||
149870927|NCT02132754|540657857|FG003|Overall Study|Adverse Event|0|||
149870928|NCT02132754|540657858|FG004|Overall Study|Adverse Event|0|||
149870929|NCT02132754|540657859|FG005|Overall Study|Adverse Event|0|||
149870930|NCT02132754|540657860|FG006|Overall Study|Adverse Event|0|||
149870931|NCT02132754|540657861|FG007|Overall Study|Adverse Event|0|||
149870932|NCT02132754|540657862|FG008|Overall Study|Adverse Event|0|||
149870933|NCT02132754|540657863|FG009|Overall Study|Adverse Event|0|||
149870934|NCT02132754|540657864|FG010|Overall Study|Adverse Event|0|||
149870935|NCT02132754|540657865|FG011|Overall Study|Adverse Event|0|||
149870936|NCT02132754|540657866|FG012|Overall Study|Adverse Event|0|||
149870937|NCT02132754|540657867|FG013|Overall Study|Adverse Event|0|||
149870938|NCT02132754|540657868|FG014|Overall Study|Adverse Event|0|||
149870939|NCT02132754|540657869|FG015|Overall Study|Adverse Event|0|||
149870940|NCT02132754|540657870|FG016|Overall Study|Adverse Event|0|||
149870941|NCT02132754|540657871|FG017|Overall Study|Adverse Event|1|||
149870942|NCT02132754|540657872|FG018|Overall Study|Adverse Event|0|||
149870943|NCT02132754|540657873|FG019|Overall Study|Adverse Event|0|||
149870944|NCT02132754|540657874|FG020|Overall Study|Adverse Event|0|||
149870945|NCT02132754|540657875|FG021|Overall Study|Adverse Event|0|||
149870946|NCT02132754|540657876|FG022|Overall Study|Adverse Event|0|||
149870947|NCT02132754|540657877|FG023|Overall Study|Adverse Event|0|||
149870948|NCT02132754|540657878|FG024|Overall Study|Adverse Event|0|||
149870949|NCT02132754|540657879|FG025|Overall Study|Adverse Event|1|||
149870950|NCT02132754|540657880|FG026|Overall Study|Adverse Event|1|||
149870951|NCT02132754|540657881|FG027|Overall Study|Adverse Event|0|||
149870952|NCT02132754|540657882|FG028|Overall Study|Adverse Event|0|||
149870953|NCT02132754|540657883|FG029|Overall Study|Adverse Event|0|||
149870954|NCT02132754|540657884|FG030|Overall Study|Adverse Event|1|||
149870955|NCT02132754|540657885|FG031|Overall Study|Adverse Event|0|||
149962555|NCT00489359|540997661|FG000|Overall Study|Lost to Follow-up|1|||
149962556|NCT00489359|540997662|FG001|Overall Study|Lost to Follow-up|0|||
149962557|NCT00489359|540997661|FG000|Overall Study|Withdrawal by Subject|1|||
149962558|NCT00489359|540997662|FG001|Overall Study|Withdrawal by Subject|5|||
149962559|NCT00489359|540997661|FG000|Overall Study|Adverse Event|0|||
149962560|NCT00489359|540997662|FG001|Overall Study|Adverse Event|16|||
149962561|NCT03180138|540997663|FG000|Overall Study|Mobile-phone could not be verified|2|||
149962562|NCT03180138|540997664|FG001|Overall Study|Mobile-phone could not be verified|13|||
149962563|NCT03180138|540997665|FG002|Overall Study|Mobile-phone could not be verified|15|||
149962564|NCT03180138|540997663|FG000|Overall Study|No prior immunization records|17|||
149962565|NCT03180138|540997664|FG001|Overall Study|No prior immunization records|0|||
149962566|NCT03180138|540997665|FG002|Overall Study|No prior immunization records|6|||
149962567|NCT03180138|540997663|FG000|Overall Study|Found to be >24 mon after randomization|3|||
149962568|NCT03180138|540997664|FG001|Overall Study|Found to be >24 mon after randomization|0|||
149962569|NCT03180138|540997665|FG002|Overall Study|Found to be >24 mon after randomization|3|||
149962570|NCT04191733|540997666|FG000|Overall Study|Withdrawn due to study closure|13|||
149962571|NCT04191733|540997667|FG001|Overall Study|Withdrawn due to study closure|14|||
149962572|NCT04191733|540997666|FG000|Overall Study|Withdrawal by Subject|2|||
149962573|NCT04191733|540997667|FG001|Overall Study|Withdrawal by Subject|4|||
149962574|NCT04191733|540997666|FG000|Overall Study|Physician Decision|1|||
149962575|NCT04191733|540997667|FG001|Overall Study|Physician Decision|1|||
149962576|NCT04191733|540997666|FG000|Overall Study|Lost to Follow-up|5|||
149962577|NCT04191733|540997667|FG001|Overall Study|Lost to Follow-up|6|||
149962578|NCT04191733|540997666|FG000|Overall Study|Death|0|||
149962579|NCT04191733|540997667|FG001|Overall Study|Death|1|||
149962580|NCT01260311|540997669|FG000|Overall Study|Adverse Event|11|||
149962581|NCT01260311|540997669|FG000|Overall Study|Lack of Efficacy|4|||
149962582|NCT01260311|540997669|FG000|Overall Study|Lost to Follow-up|25|||
149962583|NCT01260311|540997669|FG000|Overall Study|Withdrawal by Subject|6|||
149962584|NCT01260311|540997669|FG000|Overall Study|Financial Constraints|77|||
149962585|NCT01260311|540997669|FG000|Overall Study|Gone to Province|2|||
149962586|NCT01260311|540997669|FG000|Overall Study|Medication Stopped|1|||
149962587|NCT01260311|540997669|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
149962588|NCT02633527|540997670|FG000|Overall Study|Failed to meet eligibility|0|||
149962589|NCT02633527|540997671|FG001|Overall Study|Failed to meet eligibility|1|||
149962590|NCT02633527|540997672|FG002|Overall Study|Failed to meet eligibility|1|||
149962591|NCT02633527|540997673|FG003|Overall Study|Failed to meet eligibility|0|||
149962592|NCT02633527|540997674|FG004|Overall Study|Failed to meet eligibility|1|||
149962593|NCT02633527|540997670|FG000|Overall Study|Adverse Event|0|||
149962594|NCT02633527|540997671|FG001|Overall Study|Adverse Event|4|||
149962595|NCT02633527|540997672|FG002|Overall Study|Adverse Event|3|||
149962596|NCT02633527|540997673|FG003|Overall Study|Adverse Event|1|||
149962597|NCT02633527|540997674|FG004|Overall Study|Adverse Event|5|||
149962598|NCT02633527|540997670|FG000|Overall Study|Lost to Follow-up|1|||
149962599|NCT02633527|540997671|FG001|Overall Study|Lost to Follow-up|2|||
149962600|NCT02633527|540997672|FG002|Overall Study|Lost to Follow-up|5|||
149962601|NCT02633527|540997673|FG003|Overall Study|Lost to Follow-up|5|||
149870956|NCT02132754|540657886|FG032|Overall Study|Adverse Event|1|||
149962602|NCT02633527|540997674|FG004|Overall Study|Lost to Follow-up|4|||
149962603|NCT02633527|540997670|FG000|Overall Study|Withdrawal by Subject|0|||
149962604|NCT02633527|540997671|FG001|Overall Study|Withdrawal by Subject|3|||
149962605|NCT02633527|540997672|FG002|Overall Study|Withdrawal by Subject|5|||
149962606|NCT02633527|540997673|FG003|Overall Study|Withdrawal by Subject|4|||
149962607|NCT02633527|540997674|FG004|Overall Study|Withdrawal by Subject|4|||
149962608|NCT02633527|540997670|FG000|Overall Study|Protocol Violation|0|||
149962609|NCT02633527|540997671|FG001|Overall Study|Protocol Violation|1|||
149962610|NCT02633527|540997672|FG002|Overall Study|Protocol Violation|1|||
149962611|NCT02633527|540997673|FG003|Overall Study|Protocol Violation|1|||
149962612|NCT02633527|540997674|FG004|Overall Study|Protocol Violation|1|||
149962613|NCT02633527|540997670|FG000|Overall Study|Physician Decision|0|||
149870957|NCT02132754|540657887|FG033|Overall Study|Adverse Event|1|||
149870958|NCT02132754|540657854|FG000|Overall Study|Clinical Progression|0|||
149962614|NCT02633527|540997671|FG001|Overall Study|Physician Decision|0|||
149870959|NCT02132754|540657855|FG001|Overall Study|Clinical Progression|0|||
149870960|NCT02132754|540657856|FG002|Overall Study|Clinical Progression|0|||
149870961|NCT02132754|540657857|FG003|Overall Study|Clinical Progression|0|||
149870962|NCT02132754|540657858|FG004|Overall Study|Clinical Progression|0|||
149870963|NCT02132754|540657859|FG005|Overall Study|Clinical Progression|0|||
149870964|NCT02132754|540657860|FG006|Overall Study|Clinical Progression|0|||
149870965|NCT02132754|540657861|FG007|Overall Study|Clinical Progression|0|||
149870966|NCT02132754|540657862|FG008|Overall Study|Clinical Progression|0|||
149870967|NCT02132754|540657863|FG009|Overall Study|Clinical Progression|1|||
149870968|NCT02132754|540657864|FG010|Overall Study|Clinical Progression|0|||
149870969|NCT02132754|540657865|FG011|Overall Study|Clinical Progression|0|||
149870970|NCT02132754|540657866|FG012|Overall Study|Clinical Progression|0|||
149870971|NCT02132754|540657867|FG013|Overall Study|Clinical Progression|0|||
149870972|NCT02132754|540657868|FG014|Overall Study|Clinical Progression|0|||
149870973|NCT02132754|540657869|FG015|Overall Study|Clinical Progression|0|||
149870974|NCT02132754|540657870|FG016|Overall Study|Clinical Progression|1|||
149870975|NCT02132754|540657871|FG017|Overall Study|Clinical Progression|1|||
149870976|NCT02132754|540657872|FG018|Overall Study|Clinical Progression|0|||
149870977|NCT02132754|540657873|FG019|Overall Study|Clinical Progression|1|||
149870978|NCT02132754|540657874|FG020|Overall Study|Clinical Progression|0|||
149870979|NCT02132754|540657875|FG021|Overall Study|Clinical Progression|0|||
149870980|NCT02132754|540657876|FG022|Overall Study|Clinical Progression|1|||
149962615|NCT02633527|540997672|FG002|Overall Study|Physician Decision|0|||
149962616|NCT02633527|540997673|FG003|Overall Study|Physician Decision|0|||
149962617|NCT02633527|540997674|FG004|Overall Study|Physician Decision|1|||
149962618|NCT02633527|540997670|FG000|Overall Study|Administrative reason|1|||
149962619|NCT02633527|540997671|FG001|Overall Study|Administrative reason|0|||
149962620|NCT02633527|540997672|FG002|Overall Study|Administrative reason|0|||
149962621|NCT02633527|540997673|FG003|Overall Study|Administrative reason|1|||
149962622|NCT02633527|540997674|FG004|Overall Study|Administrative reason|0|||
149962623|NCT02633527|540997670|FG000|Overall Study|Multiple reasons|1|||
149962624|NCT02633527|540997671|FG001|Overall Study|Multiple reasons|0|||
149962625|NCT02633527|540997672|FG002|Overall Study|Multiple reasons|2|||
149962626|NCT02633527|540997673|FG003|Overall Study|Multiple reasons|2|||
149962627|NCT02633527|540997674|FG004|Overall Study|Multiple reasons|1|||
149962628|NCT00728182|540997679|FG000|Overall Study|Adverse Event|1|||
149962629|NCT00728182|540997680|FG001|Overall Study|Adverse Event|0|||
149962630|NCT00728182|540997679|FG000|Overall Study|Lost to Follow-up|2|||
149962631|NCT00728182|540997680|FG001|Overall Study|Lost to Follow-up|0|||
150173904|NCT00057837|541773000|FG000|Overall Study|Physician Decision|1|||
150173905|NCT00057837|541773001|FG001|Overall Study|Physician Decision|0|||
149962632|NCT00728182|540997679|FG000|Overall Study|Death|0|||
149962633|NCT00728182|540997680|FG001|Overall Study|Death|2|||
149962634|NCT00728182|540997679|FG000|Overall Study|Protocol Noncompliance|0|||
149962635|NCT00728182|540997680|FG001|Overall Study|Protocol Noncompliance|1|||
149962636|NCT01898091|540997684|FG000|Overall Study|Lost to Follow-up|1|||
149962637|NCT01898091|540997685|FG001|Overall Study|Lost to Follow-up|1|||
149962638|NCT01898091|540997684|FG000|Overall Study|Withdrawal by Subject|1|||
149962639|NCT01898091|540997685|FG001|Overall Study|Withdrawal by Subject|5|||
149962640|NCT03211832|540997686|FG000|Overall Study|No longer with agency|32|||
149962641|NCT03211832|540997687|FG001|Overall Study|No longer with agency|49|||
149962642|NCT03211832|540997688|FG002|Overall Study|No longer with agency|30|||
149962643|NCT03211832|540997686|FG000|Overall Study|Declined survey|3|||
149962644|NCT03211832|540997687|FG001|Overall Study|Declined survey|3|||
149962645|NCT03211832|540997688|FG002|Overall Study|Declined survey|2|||
149870981|NCT02132754|540657877|FG023|Overall Study|Clinical Progression|0|||
149870982|NCT02132754|540657878|FG024|Overall Study|Clinical Progression|1|||
149870983|NCT02132754|540657879|FG025|Overall Study|Clinical Progression|1|||
149870984|NCT02132754|540657880|FG026|Overall Study|Clinical Progression|0|||
149870985|NCT02132754|540657881|FG027|Overall Study|Clinical Progression|1|||
149870986|NCT02132754|540657882|FG028|Overall Study|Clinical Progression|1|||
149870987|NCT02132754|540657883|FG029|Overall Study|Clinical Progression|0|||
149870988|NCT02132754|540657884|FG030|Overall Study|Clinical Progression|1|||
149870989|NCT02132754|540657885|FG031|Overall Study|Clinical Progression|0|||
149870990|NCT02132754|540657886|FG032|Overall Study|Clinical Progression|0|||
149870991|NCT02132754|540657887|FG033|Overall Study|Clinical Progression|2|||
149962646|NCT03211832|540997686|FG000|Overall Study|Not available during data collection|1|||
149962647|NCT03211832|540997687|FG001|Overall Study|Not available during data collection|0|||
149962648|NCT03211832|540997688|FG002|Overall Study|Not available during data collection|2|||
149962649|NCT02913326|540997698|FG000|Overall Study|Reason not listed|0|||
149962650|NCT02913326|540997699|FG001|Overall Study|Reason not listed|1|||
149962651|NCT02913326|540997698|FG000|Overall Study|Lost to Follow-up|0|||
149962652|NCT02913326|540997699|FG001|Overall Study|Lost to Follow-up|1|||
150173906|NCT00057837|541773000|FG000|Overall Study|Ineligible|3|||
149870992|NCT02132754|540657854|FG000|Overall Study|Death|0|||
149870993|NCT02132754|540657855|FG001|Overall Study|Death|0|||
149870994|NCT02132754|540657856|FG002|Overall Study|Death|0|||
149870995|NCT02132754|540657857|FG003|Overall Study|Death|0|||
149870996|NCT02132754|540657858|FG004|Overall Study|Death|0|||
149870997|NCT02132754|540657859|FG005|Overall Study|Death|0|||
149870998|NCT02132754|540657860|FG006|Overall Study|Death|0|||
149870999|NCT02132754|540657861|FG007|Overall Study|Death|0|||
149871000|NCT02132754|540657862|FG008|Overall Study|Death|0|||
149871001|NCT02132754|540657863|FG009|Overall Study|Death|0|||
149871002|NCT02132754|540657864|FG010|Overall Study|Death|0|||
149962653|NCT02913326|540997698|FG000|Overall Study|Adverse Event|1|||
149962654|NCT02913326|540997699|FG001|Overall Study|Adverse Event|0|||
149962655|NCT01514422|540997700|FG000|Overall Study|Lost to Follow-up|1|||
149962656|NCT01725308|540997701|FG000|Treatment Period I|Did Not Receive Drug|1|||
149962657|NCT01725308|540997702|FG001|Treatment Period I|Did Not Receive Drug|0|||
149962658|NCT01725308|540997703|FG002|Treatment Period I|Did Not Receive Drug|0|||
149962659|NCT01725308|540997701|FG000|Treatment Period I|Adverse Event|5|||
149962660|NCT01725308|540997702|FG001|Treatment Period I|Adverse Event|4|||
149962661|NCT01725308|540997703|FG002|Treatment Period I|Adverse Event|21|||
149962662|NCT01725308|540997701|FG000|Treatment Period I|Insufficient Response|7|||
149962663|NCT01725308|540997702|FG001|Treatment Period I|Insufficient Response|0|||
149962664|NCT01725308|540997703|FG002|Treatment Period I|Insufficient Response|5|||
149962665|NCT01725308|540997701|FG000|Treatment Period I|Worsening of the Target Disease|8|||
149962666|NCT01725308|540997702|FG001|Treatment Period I|Worsening of the Target Disease|0|||
149962667|NCT01725308|540997703|FG002|Treatment Period I|Worsening of the Target Disease|2|||
149962668|NCT01725308|540997701|FG000|Treatment Period I|Changes in the Episodes|3|||
149962669|NCT01725308|540997702|FG001|Treatment Period I|Changes in the Episodes|0|||
149962670|NCT01725308|540997703|FG002|Treatment Period I|Changes in the Episodes|2|||
149962671|NCT01725308|540997701|FG000|Treatment Period I|Withdrawal of Consent|12|||
149962672|NCT01725308|540997702|FG001|Treatment Period I|Withdrawal of Consent|7|||
149962673|NCT01725308|540997703|FG002|Treatment Period I|Withdrawal of Consent|5|||
149962674|NCT01725308|540997701|FG000|Treatment Period I|Lost to Follow-up|3|||
149962675|NCT01725308|540997702|FG001|Treatment Period I|Lost to Follow-up|2|||
149962676|NCT01725308|540997703|FG002|Treatment Period I|Lost to Follow-up|2|||
149962677|NCT01725308|540997701|FG000|Treatment Period I|Protocol Deviations|3|||
149962678|NCT01725308|540997702|FG001|Treatment Period I|Protocol Deviations|1|||
149962679|NCT01725308|540997703|FG002|Treatment Period I|Protocol Deviations|1|||
149962680|NCT01725308|540997701|FG000|Treatment Period I|Miscellaneous|2|||
149962681|NCT01725308|540997702|FG001|Treatment Period I|Miscellaneous|0|||
149962682|NCT01725308|540997703|FG002|Treatment Period I|Miscellaneous|3|||
149962683|NCT01725308|540997701|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
149962684|NCT01725308|540997702|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
149962685|NCT01725308|540997703|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
149962686|NCT01725308|540997701|FG000|Treatment Period II|Did Not Receive Drug|4|||
149962687|NCT01725308|540997702|FG001|Treatment Period II|Did Not Receive Drug|0|||
149962688|NCT01725308|540997703|FG002|Treatment Period II|Did Not Receive Drug|0|||
149962689|NCT01725308|540997701|FG000|Treatment Period II|Adverse Event|13|||
149962690|NCT01725308|540997702|FG001|Treatment Period II|Adverse Event|8|||
149962691|NCT01725308|540997703|FG002|Treatment Period II|Adverse Event|20|||
149962692|NCT01725308|540997701|FG000|Treatment Period II|Insufficient Response|2|||
149962693|NCT01725308|540997702|FG001|Treatment Period II|Insufficient Response|4|||
149962694|NCT01725308|540997703|FG002|Treatment Period II|Insufficient Response|6|||
149962695|NCT01725308|540997701|FG000|Treatment Period II|Worsening of the Target Disease|1|||
149962696|NCT01725308|540997702|FG001|Treatment Period II|Worsening of the Target Disease|4|||
149962697|NCT01725308|540997703|FG002|Treatment Period II|Worsening of the Target Disease|2|||
149962698|NCT01725308|540997701|FG000|Treatment Period II|Changes in the Episodes|1|||
149962699|NCT01725308|540997702|FG001|Treatment Period II|Changes in the Episodes|0|||
149962700|NCT01725308|540997703|FG002|Treatment Period II|Changes in the Episodes|5|||
149962701|NCT01725308|540997701|FG000|Treatment Period II|Withdrawal of Consent|28|||
149871003|NCT02132754|540657865|FG011|Overall Study|Death|0|||
149962702|NCT01725308|540997702|FG001|Treatment Period II|Withdrawal of Consent|2|||
149962703|NCT01725308|540997703|FG002|Treatment Period II|Withdrawal of Consent|16|||
149962704|NCT01725308|540997701|FG000|Treatment Period II|Lost to Follow-up|1|||
149962705|NCT01725308|540997702|FG001|Treatment Period II|Lost to Follow-up|5|||
149962706|NCT01725308|540997703|FG002|Treatment Period II|Lost to Follow-up|3|||
149962707|NCT01725308|540997701|FG000|Treatment Period II|Protocol Deviations|0|||
149962708|NCT01725308|540997702|FG001|Treatment Period II|Protocol Deviations|0|||
149871004|NCT02132754|540657866|FG012|Overall Study|Death|0|||
149962709|NCT01725308|540997703|FG002|Treatment Period II|Protocol Deviations|1|||
149962710|NCT01725308|540997701|FG000|Treatment Period II|Miscellaneous|5|||
149962711|NCT01725308|540997702|FG001|Treatment Period II|Miscellaneous|3|||
149962712|NCT01725308|540997703|FG002|Treatment Period II|Miscellaneous|7|||
149962713|NCT02971137|540997708|FG000|Overall Study|Lost to Follow-up|44|||
149871005|NCT02132754|540657867|FG013|Overall Study|Death|0|||
149871006|NCT02132754|540657868|FG014|Overall Study|Death|0|||
149871007|NCT02132754|540657869|FG015|Overall Study|Death|1|||
149871008|NCT02132754|540657870|FG016|Overall Study|Death|0|||
149871009|NCT02132754|540657871|FG017|Overall Study|Death|0|||
149871010|NCT02132754|540657872|FG018|Overall Study|Death|0|||
149871011|NCT02132754|540657873|FG019|Overall Study|Death|1|||
149871012|NCT02132754|540657874|FG020|Overall Study|Death|0|||
149871013|NCT02132754|540657875|FG021|Overall Study|Death|1|||
149871014|NCT02132754|540657876|FG022|Overall Study|Death|0|||
149871015|NCT02132754|540657877|FG023|Overall Study|Death|0|||
149871016|NCT02132754|540657878|FG024|Overall Study|Death|0|||
149871017|NCT02132754|540657879|FG025|Overall Study|Death|0|||
149871018|NCT02132754|540657880|FG026|Overall Study|Death|1|||
149871019|NCT02132754|540657881|FG027|Overall Study|Death|0|||
149871020|NCT02132754|540657882|FG028|Overall Study|Death|0|||
149871021|NCT02132754|540657883|FG029|Overall Study|Death|0|||
149871022|NCT02132754|540657884|FG030|Overall Study|Death|0|||
149871023|NCT02132754|540657885|FG031|Overall Study|Death|0|||
149871024|NCT02132754|540657886|FG032|Overall Study|Death|0|||
149871025|NCT02132754|540657887|FG033|Overall Study|Death|2|||
149871026|NCT02132754|540657854|FG000|Overall Study|Excluded Medication|0|||
149871027|NCT02132754|540657855|FG001|Overall Study|Excluded Medication|0|||
149871028|NCT02132754|540657856|FG002|Overall Study|Excluded Medication|0|||
149871029|NCT02132754|540657857|FG003|Overall Study|Excluded Medication|0|||
149871030|NCT02132754|540657858|FG004|Overall Study|Excluded Medication|0|||
149871031|NCT02132754|540657859|FG005|Overall Study|Excluded Medication|0|||
149871032|NCT02132754|540657860|FG006|Overall Study|Excluded Medication|0|||
149871033|NCT02132754|540657861|FG007|Overall Study|Excluded Medication|0|||
149871034|NCT02132754|540657862|FG008|Overall Study|Excluded Medication|0|||
149871035|NCT02132754|540657863|FG009|Overall Study|Excluded Medication|0|||
149962714|NCT02971137|540997709|FG001|Overall Study|Lost to Follow-up|56|||
149962715|NCT00215657|540997713|FG000|Overall Study|Adverse Event|5|||
149962716|NCT00215657|540997714|FG001|Overall Study|Adverse Event|1|||
149871036|NCT02132754|540657864|FG010|Overall Study|Excluded Medication|0|||
149871037|NCT02132754|540657865|FG011|Overall Study|Excluded Medication|0|||
149871038|NCT02132754|540657866|FG012|Overall Study|Excluded Medication|0|||
149871039|NCT02132754|540657867|FG013|Overall Study|Excluded Medication|0|||
149962717|NCT00215657|540997715|FG002|Overall Study|Adverse Event|3|||
149962718|NCT00215657|540997716|FG003|Overall Study|Adverse Event|0|||
149871040|NCT02132754|540657868|FG014|Overall Study|Excluded Medication|0|||
149871041|NCT02132754|540657869|FG015|Overall Study|Excluded Medication|0|||
149871042|NCT02132754|540657870|FG016|Overall Study|Excluded Medication|0|||
149871043|NCT02132754|540657871|FG017|Overall Study|Excluded Medication|0|||
149962719|NCT00215657|540997717|FG004|Overall Study|Adverse Event|3|||
149871044|NCT02132754|540657872|FG018|Overall Study|Excluded Medication|0|||
149871045|NCT02132754|540657873|FG019|Overall Study|Excluded Medication|0|||
149871046|NCT02132754|540657874|FG020|Overall Study|Excluded Medication|1|||
149871047|NCT02132754|540657875|FG021|Overall Study|Excluded Medication|0|||
149871048|NCT02132754|540657876|FG022|Overall Study|Excluded Medication|0|||
149871049|NCT02132754|540657877|FG023|Overall Study|Excluded Medication|0|||
149871050|NCT02132754|540657878|FG024|Overall Study|Excluded Medication|0|||
149871051|NCT02132754|540657879|FG025|Overall Study|Excluded Medication|0|||
149871052|NCT02132754|540657880|FG026|Overall Study|Excluded Medication|0|||
149871053|NCT02132754|540657881|FG027|Overall Study|Excluded Medication|0|||
149871054|NCT02132754|540657882|FG028|Overall Study|Excluded Medication|0|||
149871055|NCT02132754|540657883|FG029|Overall Study|Excluded Medication|0|||
149871056|NCT02132754|540657884|FG030|Overall Study|Excluded Medication|0|||
149871057|NCT02132754|540657885|FG031|Overall Study|Excluded Medication|0|||
149871058|NCT02132754|540657886|FG032|Overall Study|Excluded Medication|0|||
149871059|NCT02132754|540657887|FG033|Overall Study|Excluded Medication|1|||
149871060|NCT02132754|540657854|FG000|Overall Study|Physician Decision|0|||
149871061|NCT02132754|540657855|FG001|Overall Study|Physician Decision|0|||
149871062|NCT02132754|540657856|FG002|Overall Study|Physician Decision|0|||
149871063|NCT02132754|540657857|FG003|Overall Study|Physician Decision|0|||
149871064|NCT02132754|540657858|FG004|Overall Study|Physician Decision|0|||
149871065|NCT02132754|540657859|FG005|Overall Study|Physician Decision|0|||
149871066|NCT02132754|540657860|FG006|Overall Study|Physician Decision|0|||
149871067|NCT02132754|540657861|FG007|Overall Study|Physician Decision|0|||
149871068|NCT02132754|540657862|FG008|Overall Study|Physician Decision|0|||
149871069|NCT02132754|540657863|FG009|Overall Study|Physician Decision|1|||
149871070|NCT02132754|540657864|FG010|Overall Study|Physician Decision|0|||
149871071|NCT02132754|540657865|FG011|Overall Study|Physician Decision|1|||
149871072|NCT02132754|540657866|FG012|Overall Study|Physician Decision|1|||
149871073|NCT02132754|540657867|FG013|Overall Study|Physician Decision|0|||
149871074|NCT02132754|540657868|FG014|Overall Study|Physician Decision|0|||
149871075|NCT02132754|540657869|FG015|Overall Study|Physician Decision|1|||
149871076|NCT02132754|540657870|FG016|Overall Study|Physician Decision|0|||
149871077|NCT02132754|540657871|FG017|Overall Study|Physician Decision|0|||
149871078|NCT02132754|540657872|FG018|Overall Study|Physician Decision|0|||
149871079|NCT02132754|540657873|FG019|Overall Study|Physician Decision|0|||
149871080|NCT02132754|540657874|FG020|Overall Study|Physician Decision|0|||
149871081|NCT02132754|540657875|FG021|Overall Study|Physician Decision|0|||
149871082|NCT02132754|540657876|FG022|Overall Study|Physician Decision|0|||
149871083|NCT02132754|540657877|FG023|Overall Study|Physician Decision|0|||
149871084|NCT02132754|540657878|FG024|Overall Study|Physician Decision|1|||
149871085|NCT02132754|540657879|FG025|Overall Study|Physician Decision|0|||
149871086|NCT02132754|540657880|FG026|Overall Study|Physician Decision|0|||
149871087|NCT02132754|540657881|FG027|Overall Study|Physician Decision|0|||
149871088|NCT02132754|540657882|FG028|Overall Study|Physician Decision|0|||
149871089|NCT02132754|540657883|FG029|Overall Study|Physician Decision|0|||
149871090|NCT02132754|540657884|FG030|Overall Study|Physician Decision|0|||
149871091|NCT02132754|540657885|FG031|Overall Study|Physician Decision|1|||
149871092|NCT02132754|540657886|FG032|Overall Study|Physician Decision|0|||
149871093|NCT02132754|540657887|FG033|Overall Study|Physician Decision|3|||
149871094|NCT02132754|540657854|FG000|Overall Study|Progressive Disease|1|||
149871095|NCT02132754|540657855|FG001|Overall Study|Progressive Disease|1|||
149871096|NCT02132754|540657856|FG002|Overall Study|Progressive Disease|1|||
149871097|NCT02132754|540657857|FG003|Overall Study|Progressive Disease|1|||
149871098|NCT02132754|540657858|FG004|Overall Study|Progressive Disease|1|||
149871099|NCT02132754|540657859|FG005|Overall Study|Progressive Disease|1|||
149871100|NCT02132754|540657860|FG006|Overall Study|Progressive Disease|1|||
149871101|NCT02132754|540657861|FG007|Overall Study|Progressive Disease|1|||
149871102|NCT02132754|540657862|FG008|Overall Study|Progressive Disease|1|||
149871103|NCT02132754|540657863|FG009|Overall Study|Progressive Disease|3|||
149871104|NCT02132754|540657864|FG010|Overall Study|Progressive Disease|3|||
149871105|NCT02132754|540657865|FG011|Overall Study|Progressive Disease|2|||
149871106|NCT02132754|540657866|FG012|Overall Study|Progressive Disease|2|||
149871107|NCT02132754|540657867|FG013|Overall Study|Progressive Disease|3|||
149871108|NCT02132754|540657868|FG014|Overall Study|Progressive Disease|2|||
149871109|NCT02132754|540657869|FG015|Overall Study|Progressive Disease|1|||
149871110|NCT02132754|540657870|FG016|Overall Study|Progressive Disease|2|||
149871111|NCT02132754|540657871|FG017|Overall Study|Progressive Disease|1|||
149871112|NCT02132754|540657872|FG018|Overall Study|Progressive Disease|3|||
149871113|NCT02132754|540657873|FG019|Overall Study|Progressive Disease|1|||
149871114|NCT02132754|540657874|FG020|Overall Study|Progressive Disease|1|||
149871115|NCT02132754|540657875|FG021|Overall Study|Progressive Disease|3|||
149871116|NCT02132754|540657876|FG022|Overall Study|Progressive Disease|2|||
149871117|NCT02132754|540657877|FG023|Overall Study|Progressive Disease|3|||
149871118|NCT02132754|540657878|FG024|Overall Study|Progressive Disease|0|||
149871119|NCT02132754|540657879|FG025|Overall Study|Progressive Disease|1|||
149871120|NCT02132754|540657880|FG026|Overall Study|Progressive Disease|2|||
149871121|NCT02132754|540657881|FG027|Overall Study|Progressive Disease|1|||
149871122|NCT02132754|540657882|FG028|Overall Study|Progressive Disease|2|||
149871123|NCT02132754|540657883|FG029|Overall Study|Progressive Disease|3|||
149962720|NCT00215657|540997718|FG005|Overall Study|Adverse Event|1|||
149962721|NCT00215657|540997719|FG006|Overall Study|Adverse Event|0|||
149962722|NCT00215657|540997720|FG007|Overall Study|Adverse Event|3|||
149962723|NCT00215657|540997713|FG000|Overall Study|Withdrawal by Subject|6|||
149962724|NCT00215657|540997714|FG001|Overall Study|Withdrawal by Subject|3|||
149962725|NCT00215657|540997715|FG002|Overall Study|Withdrawal by Subject|3|||
149962726|NCT00215657|540997716|FG003|Overall Study|Withdrawal by Subject|1|||
149962727|NCT00215657|540997717|FG004|Overall Study|Withdrawal by Subject|6|||
149962728|NCT00215657|540997718|FG005|Overall Study|Withdrawal by Subject|1|||
149962729|NCT00215657|540997719|FG006|Overall Study|Withdrawal by Subject|10|||
149962730|NCT00215657|540997720|FG007|Overall Study|Withdrawal by Subject|3|||
149962731|NCT00215657|540997713|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
149962732|NCT00215657|540997714|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
149962733|NCT00215657|540997715|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
149962734|NCT00215657|540997716|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
149962735|NCT00215657|540997717|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
149962736|NCT00215657|540997718|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
149962737|NCT00215657|540997719|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
149962738|NCT00215657|540997720|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
149962739|NCT00215657|540997713|FG000|Overall Study|Insufficient testosterone response|5|||
149962740|NCT00215657|540997714|FG001|Overall Study|Insufficient testosterone response|4|||
149962741|NCT00215657|540997715|FG002|Overall Study|Insufficient testosterone response|1|||
149962742|NCT00215657|540997716|FG003|Overall Study|Insufficient testosterone response|12|||
149962743|NCT00215657|540997717|FG004|Overall Study|Insufficient testosterone response|8|||
149962744|NCT00215657|540997718|FG005|Overall Study|Insufficient testosterone response|12|||
149962745|NCT00215657|540997719|FG006|Overall Study|Insufficient testosterone response|4|||
149962746|NCT00215657|540997720|FG007|Overall Study|Insufficient testosterone response|7|||
149962747|NCT00215657|540997713|FG000|Overall Study|Other|3|||
149962748|NCT00215657|540997714|FG001|Overall Study|Other|1|||
149962749|NCT00215657|540997715|FG002|Overall Study|Other|2|||
149962750|NCT00215657|540997716|FG003|Overall Study|Other|3|||
149962751|NCT00215657|540997717|FG004|Overall Study|Other|5|||
149962752|NCT00215657|540997718|FG005|Overall Study|Other|4|||
149962753|NCT00215657|540997719|FG006|Overall Study|Other|6|||
149962754|NCT00215657|540997720|FG007|Overall Study|Other|1|||
149962755|NCT02614066|540997721|FG000|Overall Study|Death|6|||
149871124|NCT02132754|540657884|FG030|Overall Study|Progressive Disease|1|||
149871125|NCT02132754|540657885|FG031|Overall Study|Progressive Disease|1|||
149871126|NCT02132754|540657886|FG032|Overall Study|Progressive Disease|3|||
149871127|NCT02132754|540657887|FG033|Overall Study|Progressive Disease|6|||
149871128|NCT02132754|540657854|FG000|Overall Study|Screen Failure|0|||
149871129|NCT02132754|540657855|FG001|Overall Study|Screen Failure|0|||
149871130|NCT02132754|540657856|FG002|Overall Study|Screen Failure|0|||
149871131|NCT02132754|540657857|FG003|Overall Study|Screen Failure|0|||
149871132|NCT02132754|540657858|FG004|Overall Study|Screen Failure|0|||
149871133|NCT02132754|540657859|FG005|Overall Study|Screen Failure|0|||
149871134|NCT02132754|540657860|FG006|Overall Study|Screen Failure|0|||
149871135|NCT02132754|540657861|FG007|Overall Study|Screen Failure|0|||
149871136|NCT02132754|540657862|FG008|Overall Study|Screen Failure|0|||
149871137|NCT02132754|540657863|FG009|Overall Study|Screen Failure|0|||
149871138|NCT02132754|540657864|FG010|Overall Study|Screen Failure|0|||
149871139|NCT02132754|540657865|FG011|Overall Study|Screen Failure|0|||
149871140|NCT02132754|540657866|FG012|Overall Study|Screen Failure|0|||
149871141|NCT02132754|540657867|FG013|Overall Study|Screen Failure|0|||
149871142|NCT02132754|540657868|FG014|Overall Study|Screen Failure|0|||
149871143|NCT02132754|540657869|FG015|Overall Study|Screen Failure|0|||
149871144|NCT02132754|540657870|FG016|Overall Study|Screen Failure|0|||
149871145|NCT02132754|540657871|FG017|Overall Study|Screen Failure|0|||
149871146|NCT02132754|540657872|FG018|Overall Study|Screen Failure|0|||
149871147|NCT02132754|540657873|FG019|Overall Study|Screen Failure|1|||
149871148|NCT02132754|540657874|FG020|Overall Study|Screen Failure|0|||
149871149|NCT02132754|540657875|FG021|Overall Study|Screen Failure|1|||
149871150|NCT02132754|540657876|FG022|Overall Study|Screen Failure|0|||
149871151|NCT02132754|540657877|FG023|Overall Study|Screen Failure|0|||
149871152|NCT02132754|540657878|FG024|Overall Study|Screen Failure|0|||
149871153|NCT02132754|540657879|FG025|Overall Study|Screen Failure|0|||
149871154|NCT02132754|540657880|FG026|Overall Study|Screen Failure|0|||
149871155|NCT02132754|540657881|FG027|Overall Study|Screen Failure|0|||
149871156|NCT02132754|540657882|FG028|Overall Study|Screen Failure|0|||
149871157|NCT02132754|540657883|FG029|Overall Study|Screen Failure|0|||
149871158|NCT02132754|540657884|FG030|Overall Study|Screen Failure|0|||
149871159|NCT02132754|540657885|FG031|Overall Study|Screen Failure|0|||
149871160|NCT02132754|540657886|FG032|Overall Study|Screen Failure|0|||
149871161|NCT02132754|540657887|FG033|Overall Study|Screen Failure|0|||
149871162|NCT02132754|540657854|FG000|Overall Study|Transferred to Extension Study|0|||
149871163|NCT02132754|540657855|FG001|Overall Study|Transferred to Extension Study|0|||
149871164|NCT02132754|540657856|FG002|Overall Study|Transferred to Extension Study|0|||
149871165|NCT02132754|540657857|FG003|Overall Study|Transferred to Extension Study|0|||
149871166|NCT02132754|540657858|FG004|Overall Study|Transferred to Extension Study|0|||
149871167|NCT02132754|540657859|FG005|Overall Study|Transferred to Extension Study|0|||
149871168|NCT02132754|540657860|FG006|Overall Study|Transferred to Extension Study|0|||
149871169|NCT02132754|540657861|FG007|Overall Study|Transferred to Extension Study|0|||
149871170|NCT02132754|540657862|FG008|Overall Study|Transferred to Extension Study|0|||
149871171|NCT02132754|540657863|FG009|Overall Study|Transferred to Extension Study|0|||
149871172|NCT02132754|540657864|FG010|Overall Study|Transferred to Extension Study|0|||
149871173|NCT02132754|540657865|FG011|Overall Study|Transferred to Extension Study|0|||
149871174|NCT02132754|540657866|FG012|Overall Study|Transferred to Extension Study|0|||
149871175|NCT02132754|540657867|FG013|Overall Study|Transferred to Extension Study|0|||
149871176|NCT02132754|540657868|FG014|Overall Study|Transferred to Extension Study|0|||
149871177|NCT02132754|540657869|FG015|Overall Study|Transferred to Extension Study|0|||
149871178|NCT02132754|540657870|FG016|Overall Study|Transferred to Extension Study|0|||
149871179|NCT02132754|540657871|FG017|Overall Study|Transferred to Extension Study|0|||
149871180|NCT02132754|540657872|FG018|Overall Study|Transferred to Extension Study|0|||
149871181|NCT02132754|540657873|FG019|Overall Study|Transferred to Extension Study|0|||
149871182|NCT02132754|540657874|FG020|Overall Study|Transferred to Extension Study|0|||
149871183|NCT02132754|540657875|FG021|Overall Study|Transferred to Extension Study|0|||
149871184|NCT02132754|540657876|FG022|Overall Study|Transferred to Extension Study|0|||
149871185|NCT02132754|540657877|FG023|Overall Study|Transferred to Extension Study|0|||
149871186|NCT02132754|540657878|FG024|Overall Study|Transferred to Extension Study|0|||
149871187|NCT02132754|540657879|FG025|Overall Study|Transferred to Extension Study|0|||
149871188|NCT02132754|540657880|FG026|Overall Study|Transferred to Extension Study|0|||
149871189|NCT02132754|540657881|FG027|Overall Study|Transferred to Extension Study|0|||
149871190|NCT02132754|540657882|FG028|Overall Study|Transferred to Extension Study|0|||
149871191|NCT02132754|540657883|FG029|Overall Study|Transferred to Extension Study|0|||
149871192|NCT02132754|540657884|FG030|Overall Study|Transferred to Extension Study|0|||
149871193|NCT02132754|540657885|FG031|Overall Study|Transferred to Extension Study|0|||
149871194|NCT02132754|540657886|FG032|Overall Study|Transferred to Extension Study|0|||
149871195|NCT02132754|540657887|FG033|Overall Study|Transferred to Extension Study|6|||
149871196|NCT02132754|540657854|FG000|Overall Study|Withdrawal by Subject|0|||
149871197|NCT02132754|540657855|FG001|Overall Study|Withdrawal by Subject|0|||
149871198|NCT02132754|540657856|FG002|Overall Study|Withdrawal by Subject|0|||
149871199|NCT02132754|540657857|FG003|Overall Study|Withdrawal by Subject|0|||
149871200|NCT02132754|540657858|FG004|Overall Study|Withdrawal by Subject|0|||
149871201|NCT02132754|540657859|FG005|Overall Study|Withdrawal by Subject|0|||
149871202|NCT02132754|540657860|FG006|Overall Study|Withdrawal by Subject|0|||
149871203|NCT02132754|540657861|FG007|Overall Study|Withdrawal by Subject|0|||
149871204|NCT02132754|540657862|FG008|Overall Study|Withdrawal by Subject|0|||
149871205|NCT02132754|540657863|FG009|Overall Study|Withdrawal by Subject|1|||
149871206|NCT02132754|540657864|FG010|Overall Study|Withdrawal by Subject|0|||
149871207|NCT02132754|540657865|FG011|Overall Study|Withdrawal by Subject|0|||
149871208|NCT02132754|540657866|FG012|Overall Study|Withdrawal by Subject|1|||
149871209|NCT02132754|540657867|FG013|Overall Study|Withdrawal by Subject|0|||
149871210|NCT02132754|540657868|FG014|Overall Study|Withdrawal by Subject|1|||
149871211|NCT02132754|540657869|FG015|Overall Study|Withdrawal by Subject|2|||
149871212|NCT02132754|540657870|FG016|Overall Study|Withdrawal by Subject|1|||
149871213|NCT02132754|540657871|FG017|Overall Study|Withdrawal by Subject|0|||
149871214|NCT02132754|540657872|FG018|Overall Study|Withdrawal by Subject|0|||
149871215|NCT02132754|540657873|FG019|Overall Study|Withdrawal by Subject|0|||
149871216|NCT02132754|540657874|FG020|Overall Study|Withdrawal by Subject|1|||
149871217|NCT02132754|540657875|FG021|Overall Study|Withdrawal by Subject|0|||
149871218|NCT02132754|540657876|FG022|Overall Study|Withdrawal by Subject|0|||
149871219|NCT02132754|540657877|FG023|Overall Study|Withdrawal by Subject|0|||
149871220|NCT02132754|540657878|FG024|Overall Study|Withdrawal by Subject|1|||
149871221|NCT02132754|540657879|FG025|Overall Study|Withdrawal by Subject|0|||
149871222|NCT02132754|540657880|FG026|Overall Study|Withdrawal by Subject|0|||
149871223|NCT02132754|540657881|FG027|Overall Study|Withdrawal by Subject|1|||
149871224|NCT02132754|540657882|FG028|Overall Study|Withdrawal by Subject|0|||
149871225|NCT02132754|540657883|FG029|Overall Study|Withdrawal by Subject|0|||
149871226|NCT02132754|540657884|FG030|Overall Study|Withdrawal by Subject|0|||
149871227|NCT02132754|540657885|FG031|Overall Study|Withdrawal by Subject|1|||
149871228|NCT02132754|540657886|FG032|Overall Study|Withdrawal by Subject|0|||
149871229|NCT02132754|540657887|FG033|Overall Study|Withdrawal by Subject|2|||
149871230|NCT02582866|540657908|FG000|Overall Study|Death|1|||
149871231|NCT02582866|540657908|FG000|Overall Study|Lack of Efficacy|2|||
149871232|NCT02582866|540657908|FG000|Overall Study|Lost to Follow-up|2|||
149871233|NCT02582866|540657908|FG000|Overall Study|Withdrawal by Subject|7|||
149871234|NCT02582866|540657908|FG000|Overall Study|Investigator decision|5|||
149871235|NCT02582866|540657908|FG000|Overall Study|Participant wants to get pregnant|1|||
149871236|NCT02582866|540657908|FG000|Overall Study|Pregnancy|2|||
149871237|NCT02582866|540657908|FG000|Overall Study|Sponsor decision|1|||
149871238|NCT02582866|540657908|FG000|Overall Study|Withdrawal due to personal reasons|1|||
149871239|NCT03190330|540660076|FG000|Overall Study|Adverse Event|2|||
149871240|NCT03190330|540660076|FG000|Overall Study|Death|10|||
149871241|NCT03190330|540660076|FG000|Overall Study|Lost to Follow-up|1|||
149871242|NCT03190330|540660076|FG000|Overall Study|Withdrawal by Subject|6|||
149871243|NCT03190330|540660076|FG000|Overall Study|Progressive Disease|1|||
149871244|NCT02081209|540660077|FG000|Overall Study|Withdrawal by Subject|1|||
149871245|NCT02370329|540660078|FG000|Overall Study|Alternate treatment|1|||
149871246|NCT02370329|540660078|FG000|Overall Study|Adverse Event|1|||
149871247|NCT02370329|540660078|FG000|Overall Study|Disease progression|3|||
149871248|NCT02370329|540660078|FG000|Overall Study|Physician Decision|2|||
149871249|NCT02370329|540660078|FG000|Overall Study|Study closure|4|||
149871250|NCT02022748|540660082|FG000|Overall Study|Adverse Event|1|||
149871251|NCT02022748|540660083|FG001|Overall Study|Adverse Event|1|||
149871252|NCT02022748|540660084|FG002|Overall Study|Adverse Event|0|||
149871253|NCT02022748|540660082|FG000|Overall Study|Withdrawal by Subject|0|||
149871254|NCT02022748|540660083|FG001|Overall Study|Withdrawal by Subject|1|||
149871255|NCT02022748|540660084|FG002|Overall Study|Withdrawal by Subject|0|||
149871256|NCT00633243|540660085|FG000|Overall Study|Withdrawal by Subject|0|||
149962756|NCT02614066|540997722|FG001|Overall Study|Death|14|||
149962757|NCT02614066|540997723|FG002|Overall Study|Death|11|||
149962758|NCT02614066|540997724|FG003|Overall Study|Death|29|||
149962759|NCT02614066|540997721|FG000|Overall Study|Full consent withdrawn|0|||
149962760|NCT02614066|540997722|FG001|Overall Study|Full consent withdrawn|1|||
149962761|NCT02614066|540997723|FG002|Overall Study|Full consent withdrawn|0|||
149962762|NCT02614066|540997724|FG003|Overall Study|Full consent withdrawn|8|||
149962763|NCT02614066|540997721|FG000|Overall Study|Lost to Follow-up|0|||
149962764|NCT02614066|540997722|FG001|Overall Study|Lost to Follow-up|2|||
149962765|NCT02614066|540997723|FG002|Overall Study|Lost to Follow-up|2|||
149962766|NCT02614066|540997724|FG003|Overall Study|Lost to Follow-up|2|||
149962767|NCT02614066|540997721|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
149962768|NCT02614066|540997722|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
149962769|NCT02614066|540997723|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
149962770|NCT02614066|540997724|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
149962771|NCT02614066|540997721|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
149962772|NCT02614066|540997722|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
149962773|NCT02614066|540997723|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
149871257|NCT00633243|540660086|FG001|Overall Study|Withdrawal by Subject|1|||
149871258|NCT00633243|540660085|FG000|Overall Study|incarceration|0|||
149871259|NCT00633243|540660086|FG001|Overall Study|incarceration|2|||
149871260|NCT00633243|540660085|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
149871261|NCT00633243|540660086|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
149871262|NCT00633243|540660085|FG000|Overall Study|Not comfortable with self-injecting|0|||
149871263|NCT00633243|540660086|FG001|Overall Study|Not comfortable with self-injecting|1|||
149871264|NCT00633243|540660085|FG000|Overall Study|Mental Health--Depression|0|||
149871265|NCT00633243|540660086|FG001|Overall Study|Mental Health--Depression|1|||
149871266|NCT00633243|540660085|FG000|Overall Study|Couldn't tolerate side-effects|1|||
149871267|NCT00633243|540660086|FG001|Overall Study|Couldn't tolerate side-effects|1|||
149871268|NCT00379340|540660088|FG000|Overall Study|Death|0|||
149871269|NCT00379340|540660089|FG001|Overall Study|Death|0|||
149871270|NCT00379340|540660090|FG002|Overall Study|Death|0|||
149871271|NCT00379340|540660091|FG003|Overall Study|Death|2|||
149871272|NCT00379340|540660092|FG004|Overall Study|Death|0|||
149871273|NCT00379340|540660088|FG000|Overall Study|Lack of Efficacy|6|||
149871274|NCT00379340|540660089|FG001|Overall Study|Lack of Efficacy|1|||
149871275|NCT00379340|540660090|FG002|Overall Study|Lack of Efficacy|0|||
149871276|NCT00379340|540660091|FG003|Overall Study|Lack of Efficacy|4|||
149871277|NCT00379340|540660092|FG004|Overall Study|Lack of Efficacy|3|||
149871278|NCT00379340|540660088|FG000|Overall Study|Physician Decision|6|||
149871279|NCT00379340|540660089|FG001|Overall Study|Physician Decision|2|||
149871280|NCT00379340|540660090|FG002|Overall Study|Physician Decision|1|||
149871281|NCT00379340|540660091|FG003|Overall Study|Physician Decision|2|||
149871282|NCT00379340|540660092|FG004|Overall Study|Physician Decision|3|||
149871283|NCT00379340|540660088|FG000|Overall Study|Withdrawal by Subject|0|||
149871284|NCT00379340|540660089|FG001|Overall Study|Withdrawal by Subject|0|||
149871285|NCT00379340|540660090|FG002|Overall Study|Withdrawal by Subject|0|||
149871286|NCT00379340|540660091|FG003|Overall Study|Withdrawal by Subject|1|||
149871287|NCT00379340|540660092|FG004|Overall Study|Withdrawal by Subject|0|||
149871288|NCT00379340|540660088|FG000|Overall Study|Refusal of further protocol therapy|1|||
149871289|NCT00379340|540660089|FG001|Overall Study|Refusal of further protocol therapy|0|||
149871290|NCT00379340|540660090|FG002|Overall Study|Refusal of further protocol therapy|1|||
149871291|NCT00379340|540660091|FG003|Overall Study|Refusal of further protocol therapy|1|||
149871292|NCT00379340|540660092|FG004|Overall Study|Refusal of further protocol therapy|7|||
149871293|NCT00379340|540660088|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
149871294|NCT00379340|540660089|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
149871295|NCT00379340|540660090|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
149871296|NCT00379340|540660091|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
149871297|NCT00379340|540660092|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
149871298|NCT00379340|540660088|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
149871299|NCT00379340|540660089|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
149871300|NCT00379340|540660090|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
149871301|NCT00379340|540660091|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
149871302|NCT00379340|540660092|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
149871303|NCT04347122|540660094|FG000|Overall Study|Physician Decision|0|||
149871304|NCT04347122|540660095|FG001|Overall Study|Physician Decision|3|||
149871305|NCT04347122|540660096|FG002|Overall Study|Physician Decision|3|||
149871306|NCT04347122|540660097|FG003|Overall Study|Physician Decision|6|||
149871307|NCT04994483|540660101|FG000|Overall Study|Adverse Event|26|||
149871308|NCT04994483|540660102|FG001|Overall Study|Adverse Event|17|||
149871309|NCT04994483|540660101|FG000|Overall Study|Lost to Follow-up|6|||
149871310|NCT04994483|540660102|FG001|Overall Study|Lost to Follow-up|10|||
149871311|NCT04994483|540660101|FG000|Overall Study|Noncompliance with study drug|8|||
149871312|NCT04994483|540660102|FG001|Overall Study|Noncompliance with study drug|5|||
149871313|NCT04994483|540660101|FG000|Overall Study|Physician Decision|5|||
149871314|NCT04994483|540660102|FG001|Overall Study|Physician Decision|0|||
149871315|NCT04994483|540660101|FG000|Overall Study|Withdrawal by Subject|41|||
149871316|NCT04994483|540660102|FG001|Overall Study|Withdrawal by Subject|38|||
149871317|NCT04994483|540660101|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
149871318|NCT04994483|540660102|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
149871319|NCT04994483|540660101|FG000|Overall Study|Met stopping criteria|1|||
149871320|NCT04994483|540660102|FG001|Overall Study|Met stopping criteria|0|||
149871321|NCT04994483|540660101|FG000|Overall Study|Randomized in error, not treated|4|||
149871322|NCT04994483|540660102|FG001|Overall Study|Randomized in error, not treated|3|||
149871323|NCT04994483|540660101|FG000|Overall Study|Lack of a reliable study partner|0|||
149871324|NCT04994483|540660102|FG001|Overall Study|Lack of a reliable study partner|1|||
149871325|NCT04994483|540660101|FG000|Overall Study|Met MRI exclusion criteria|0|||
149871326|NCT04994483|540660102|FG001|Overall Study|Met MRI exclusion criteria|1|||
149871327|NCT00112866|540660103|FG000|Overall Study|Protocol Violation|1|||
149871328|NCT00112866|540660104|FG001|Overall Study|Protocol Violation|0|||
149871329|NCT00112866|540660103|FG000|Overall Study|did not start treatment post-op|1|||
149871330|NCT00112866|540660104|FG001|Overall Study|did not start treatment post-op|2|||
149871331|NCT04228783|540660107|FG000|Overall Study|Adverse Event|1|||
149962774|NCT02614066|540997724|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
149962775|NCT02614066|540997721|FG000|Overall Study|Reason not specified|0|||
149962776|NCT02614066|540997722|FG001|Overall Study|Reason not specified|2|||
149962777|NCT02614066|540997723|FG002|Overall Study|Reason not specified|1|||
149962778|NCT02614066|540997724|FG003|Overall Study|Reason not specified|1|||
149962779|NCT04565756|540997725|FG000|Overall Study|Withdrawal by Subject|0|||
149962780|NCT04565756|540997726|FG001|Overall Study|Withdrawal by Subject|0|||
149962781|NCT04565756|540997727|FG002|Overall Study|Withdrawal by Subject|0|||
149962782|NCT04565756|540997728|FG003|Overall Study|Withdrawal by Subject|0|||
149962783|NCT04565756|540997729|FG004|Overall Study|Withdrawal by Subject|1|||
149962784|NCT04565756|540997730|FG005|Overall Study|Withdrawal by Subject|0|||
149962785|NCT04565756|540997725|FG000|Overall Study|Protocol Violation|0|||
149962786|NCT04565756|540997726|FG001|Overall Study|Protocol Violation|0|||
149962787|NCT04565756|540997727|FG002|Overall Study|Protocol Violation|0|||
150040870|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
150040871|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
150040872|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
150040873|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
150040874|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
150040875|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
150040876|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
150040877|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
150040878|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
150040879|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
150040880|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
150040881|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
150040882|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
150040883|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
150040884|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
150040885|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
150040886|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
150040887|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
150040888|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
150040889|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
150040890|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
150040891|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
150040892|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
150040893|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
150040894|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
150040895|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
150040896|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
149871332|NCT04228783|540660108|FG001|Overall Study|Adverse Event|0|||
149871333|NCT04228783|540660109|FG002|Overall Study|Adverse Event|2|||
149871334|NCT04228783|540660110|FG003|Overall Study|Adverse Event|0|||
149871335|NCT04228783|540660111|FG004|Overall Study|Adverse Event|0|||
149871336|NCT04228783|540660112|FG005|Overall Study|Adverse Event|1|||
149871337|NCT04228783|540660107|FG000|Overall Study|Death|0|||
149871338|NCT04228783|540660108|FG001|Overall Study|Death|0|||
149871339|NCT04228783|540660109|FG002|Overall Study|Death|0|||
149871340|NCT04228783|540660110|FG003|Overall Study|Death|0|||
149871341|NCT04228783|540660111|FG004|Overall Study|Death|1|||
149871342|NCT04228783|540660112|FG005|Overall Study|Death|0|||
149871343|NCT04228783|540660107|FG000|Overall Study|Lost to Follow-up|36|||
149871344|NCT04228783|540660108|FG001|Overall Study|Lost to Follow-up|36|||
149871345|NCT04228783|540660109|FG002|Overall Study|Lost to Follow-up|28|||
149871346|NCT04228783|540660110|FG003|Overall Study|Lost to Follow-up|6|||
149871347|NCT04228783|540660111|FG004|Overall Study|Lost to Follow-up|14|||
149871348|NCT04228783|540660112|FG005|Overall Study|Lost to Follow-up|3|||
149871349|NCT04228783|540660107|FG000|Overall Study|Physician Decision|1|||
149871350|NCT04228783|540660108|FG001|Overall Study|Physician Decision|2|||
149871351|NCT04228783|540660109|FG002|Overall Study|Physician Decision|0|||
149871352|NCT04228783|540660110|FG003|Overall Study|Physician Decision|0|||
149871353|NCT04228783|540660111|FG004|Overall Study|Physician Decision|0|||
149871354|NCT04228783|540660112|FG005|Overall Study|Physician Decision|0|||
149871355|NCT04228783|540660107|FG000|Overall Study|Protocol Violation|0|||
149871356|NCT04228783|540660108|FG001|Overall Study|Protocol Violation|0|||
149871357|NCT04228783|540660109|FG002|Overall Study|Protocol Violation|0|||
149871358|NCT04228783|540660110|FG003|Overall Study|Protocol Violation|1|||
149871359|NCT04228783|540660111|FG004|Overall Study|Protocol Violation|0|||
149962788|NCT04565756|540997728|FG003|Overall Study|Protocol Violation|0|||
149962789|NCT04565756|540997729|FG004|Overall Study|Protocol Violation|0|||
149962790|NCT04565756|540997730|FG005|Overall Study|Protocol Violation|1|||
149871360|NCT04228783|540660112|FG005|Overall Study|Protocol Violation|0|||
149871361|NCT04228783|540660107|FG000|Overall Study|Withdrawal by Subject|6|||
149871362|NCT04228783|540660108|FG001|Overall Study|Withdrawal by Subject|10|||
149871363|NCT04228783|540660109|FG002|Overall Study|Withdrawal by Subject|19|||
149871364|NCT04228783|540660110|FG003|Overall Study|Withdrawal by Subject|1|||
149871365|NCT04228783|540660111|FG004|Overall Study|Withdrawal by Subject|2|||
149871366|NCT04228783|540660112|FG005|Overall Study|Withdrawal by Subject|0|||
149871367|NCT04228783|540660107|FG000|Overall Study|Other|4|||
149871368|NCT04228783|540660108|FG001|Overall Study|Other|3|||
149871369|NCT04228783|540660109|FG002|Overall Study|Other|2|||
149871370|NCT04228783|540660110|FG003|Overall Study|Other|1|||
149871371|NCT04228783|540660111|FG004|Overall Study|Other|0|||
149871372|NCT04228783|540660112|FG005|Overall Study|Other|0|||
149871373|NCT03151811|540660116|FG000|Overall Study|Randomized But Not Treated|18|||
149871374|NCT03151811|540660117|FG001|Overall Study|Randomized But Not Treated|3|||
149871375|NCT03151811|540660116|FG000|Overall Study|Progressive Disease|130|||
149871376|NCT03151811|540660117|FG001|Overall Study|Progressive Disease|170|||
149871377|NCT03151811|540660116|FG000|Overall Study|Adverse Event|49|||
149871378|NCT03151811|540660117|FG001|Overall Study|Adverse Event|40|||
149871379|NCT03151811|540660116|FG000|Overall Study|Lack of Efficacy|6|||
149871380|NCT03151811|540660117|FG001|Overall Study|Lack of Efficacy|8|||
149871381|NCT03151811|540660116|FG000|Overall Study|Physician Decision|21|||
149871382|NCT03151811|540660117|FG001|Overall Study|Physician Decision|9|||
149871383|NCT03151811|540660116|FG000|Overall Study|Withdrawal by Subject|17|||
149871384|NCT03151811|540660117|FG001|Overall Study|Withdrawal by Subject|7|||
149871385|NCT03151811|540660116|FG000|Overall Study|Lost to Follow-up|0|||
149871386|NCT03151811|540660117|FG001|Overall Study|Lost to Follow-up|1|||
149871387|NCT03151811|540660116|FG000|Overall Study|Study Terminated by Sponsor|5|||
149871388|NCT03151811|540660117|FG001|Overall Study|Study Terminated by Sponsor|11|||
149871389|NCT01085734|540660120|FG000|Overall Study|Adverse Event|0|||
149871390|NCT01085734|540660121|FG001|Overall Study|Adverse Event|2|||
149871391|NCT01085734|540660120|FG000|Overall Study|Death|1|||
149871392|NCT01085734|540660121|FG001|Overall Study|Death|0|||
149871393|NCT01085734|540660120|FG000|Overall Study|Lost to Follow-up|0|||
149871394|NCT01085734|540660121|FG001|Overall Study|Lost to Follow-up|1|||
149871395|NCT01085734|540660120|FG000|Overall Study|Withdrawal by Subject|0|||
149871396|NCT01085734|540660121|FG001|Overall Study|Withdrawal by Subject|1|||
149871397|NCT00123474|540660124|FG000|Randomized to Treatment|Randomized, never treated|1|||
149871398|NCT00123474|540660125|FG001|Randomized to Treatment|Randomized, never treated|4|||
149871399|NCT00123474|540660126|FG002|Randomized to Treatment|Randomized, never treated|2|||
149871400|NCT00123474|540660127|FG003|Randomized to Treatment|Randomized, never treated|1|||
149871401|NCT00123474|540660124|FG000|As Treated at Study Closure|not reported when site closed|1|||
149871402|NCT00123474|540660125|FG001|As Treated at Study Closure|not reported when site closed|0|||
149871403|NCT00123474|540660126|FG002|As Treated at Study Closure|not reported when site closed|1|||
149871404|NCT00123474|540660127|FG003|As Treated at Study Closure|not reported when site closed|0|||
149962791|NCT03688139|540997735|FG000|Overall Study|Lost to Follow-up|2|||
149962792|NCT03688139|540997736|FG001|Overall Study|Lost to Follow-up|0|||
149962793|NCT03688139|540997735|FG000|Overall Study|Physician Decision|0|||
149962794|NCT03688139|540997736|FG001|Overall Study|Physician Decision|1|||
149962795|NCT03688139|540997735|FG000|Overall Study|Withdrawal by Subject|2|||
149962796|NCT03688139|540997736|FG001|Overall Study|Withdrawal by Subject|3|||
149962797|NCT00420056|540997737|FG000|Overall Study|Objective progression or relapse|17|||
149962798|NCT00127933|540997743|FG000|Overall Study|Randomized but not dosed|1|||
149962799|NCT00127933|540997744|FG001|Overall Study|Randomized but not dosed|0|||
149962800|NCT01783938|540997750|FG000|Overall Study|Disease Progression|18|||
149962801|NCT01783938|540997751|FG001|Overall Study|Disease Progression|41|||
149962802|NCT01783938|540997750|FG000|Overall Study|Study Drug Toxicity|27|||
149962803|NCT01783938|540997751|FG001|Overall Study|Study Drug Toxicity|14|||
149962804|NCT01783938|540997750|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
149962805|NCT01783938|540997751|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
149962806|NCT01783938|540997750|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
149962807|NCT01783938|540997751|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
149962808|NCT01783938|540997750|FG000|Overall Study|Participant Withdrew Consent|2|||
149962809|NCT01783938|540997751|FG001|Overall Study|Participant Withdrew Consent|0|||
149871405|NCT00123474|540660124|FG000|As Treated at Study Closure|Adverse Event|10|||
149871406|NCT00123474|540660125|FG001|As Treated at Study Closure|Adverse Event|4|||
149871407|NCT00123474|540660126|FG002|As Treated at Study Closure|Adverse Event|10|||
149962810|NCT01783938|540997750|FG000|Overall Study|Maximum Clinical Benefit|1|||
149962811|NCT01783938|540997751|FG001|Overall Study|Maximum Clinical Benefit|0|||
150173907|NCT00057837|541773001|FG001|Overall Study|Ineligible|3|||
149871408|NCT00123474|540660127|FG003|As Treated at Study Closure|Adverse Event|8|||
149871409|NCT00123474|540660124|FG000|As Treated at Study Closure|Disease Progression|35|||
149871410|NCT00123474|540660125|FG001|As Treated at Study Closure|Disease Progression|42|||
149871411|NCT00123474|540660126|FG002|As Treated at Study Closure|Disease Progression|29|||
149962812|NCT01783938|540997750|FG000|Overall Study|Other Reasons|3|||
149871412|NCT00123474|540660127|FG003|As Treated at Study Closure|Disease Progression|27|||
149871413|NCT00123474|540660124|FG000|As Treated at Study Closure|Investigator Request|12|||
149871414|NCT00123474|540660125|FG001|As Treated at Study Closure|Investigator Request|6|||
149871415|NCT00123474|540660126|FG002|As Treated at Study Closure|Investigator Request|7|||
149871416|NCT00123474|540660127|FG003|As Treated at Study Closure|Investigator Request|5|||
149871417|NCT00123474|540660124|FG000|As Treated at Study Closure|non-specified|54|||
149871418|NCT00123474|540660125|FG001|As Treated at Study Closure|non-specified|47|||
149871419|NCT00123474|540660126|FG002|As Treated at Study Closure|non-specified|57|||
149871420|NCT00123474|540660127|FG003|As Treated at Study Closure|non-specified|60|||
149871421|NCT00123474|540660124|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
149871422|NCT00123474|540660125|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
149871423|NCT00123474|540660126|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
149871424|NCT00123474|540660127|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
149871425|NCT00123474|540660124|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
149871426|NCT00123474|540660125|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
149871427|NCT00123474|540660126|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
149871428|NCT00123474|540660127|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
149871429|NCT00616629|540660128|FG000|Overall Study|Protocol Violation|1|||
149871430|NCT00616629|540660129|FG001|Overall Study|Protocol Violation|2|||
149871431|NCT00616629|540660130|FG002|Overall Study|Protocol Violation|1|||
149871432|NCT00616629|540660131|FG003|Overall Study|Protocol Violation|0|||
149871433|NCT00616629|540660132|FG004|Overall Study|Protocol Violation|0|||
149871434|NCT00616629|540660128|FG000|Overall Study|AV-block|1|||
149871435|NCT00616629|540660129|FG001|Overall Study|AV-block|0|||
149871436|NCT00616629|540660130|FG002|Overall Study|AV-block|0|||
149871437|NCT00616629|540660131|FG003|Overall Study|AV-block|0|||
149871438|NCT00616629|540660132|FG004|Overall Study|AV-block|0|||
149871439|NCT00742924|540660136|FG000|Overall Study|Adverse Event|0|||
149871440|NCT00742924|540660137|FG001|Overall Study|Adverse Event|0|||
149871441|NCT00742924|540660138|FG002|Overall Study|Adverse Event|1|||
149871442|NCT00742924|540660139|FG003|Overall Study|Adverse Event|1|||
149871443|NCT00742924|540660136|FG000|Overall Study|Lack of Efficacy|5|||
149871444|NCT00742924|540660137|FG001|Overall Study|Lack of Efficacy|1|||
149871445|NCT00742924|540660138|FG002|Overall Study|Lack of Efficacy|2|||
149871446|NCT00742924|540660139|FG003|Overall Study|Lack of Efficacy|4|||
149871447|NCT00742924|540660136|FG000|Overall Study|Physician Decision|0|||
149871448|NCT00742924|540660137|FG001|Overall Study|Physician Decision|0|||
149871449|NCT00742924|540660138|FG002|Overall Study|Physician Decision|0|||
149871450|NCT00742924|540660139|FG003|Overall Study|Physician Decision|1|||
149871451|NCT00742924|540660136|FG000|Overall Study|Withdrawal by Subject|0|||
149871452|NCT00742924|540660137|FG001|Overall Study|Withdrawal by Subject|1|||
149871453|NCT00742924|540660138|FG002|Overall Study|Withdrawal by Subject|1|||
149871454|NCT00742924|540660139|FG003|Overall Study|Withdrawal by Subject|0|||
149871455|NCT00660400|540660140|FG000|Overall Study|Lack of insurance approval|1|||
149871456|NCT00660400|540660140|FG000|Overall Study|Suboptimal organ function|1|||
149871457|NCT00660400|540660140|FG000|Overall Study|Intracranial hemorrhage|1|||
149871458|NCT00660400|540660140|FG000|Overall Study|Withdrawal by Subject|1|||
149871459|NCT04005352|540660155|FG000|Overall Study|Adverse Event|4|||
149871460|NCT04005352|540660156|FG001|Overall Study|Adverse Event|5|||
149871461|NCT04005352|540660155|FG000|Overall Study|Death|4|||
149871462|NCT04005352|540660156|FG001|Overall Study|Death|2|||
149871463|NCT04005352|540660155|FG000|Overall Study|Lost to Follow-up|6|||
149871464|NCT04005352|540660156|FG001|Overall Study|Lost to Follow-up|2|||
149871465|NCT04005352|540660155|FG000|Overall Study|Physician Decision|7|||
149871466|NCT04005352|540660156|FG001|Overall Study|Physician Decision|13|||
149871467|NCT04005352|540660155|FG000|Overall Study|Protocol Violation|0|||
149871468|NCT04005352|540660156|FG001|Overall Study|Protocol Violation|1|||
149871469|NCT04005352|540660155|FG000|Overall Study|Withdrawal by Subject|28|||
149871470|NCT04005352|540660156|FG001|Overall Study|Withdrawal by Subject|38|||
149871471|NCT05005312|540660159|FG000|Overall Study|Enrolled, but not treated|0|||
149871472|NCT05005312|540660160|FG001|Overall Study|Enrolled, but not treated|1|||
149871473|NCT01283035|540660161|FG000|Overall Study|Subject later found ineligible|1|||
149871474|NCT02695537|540660171|FG000|Overall Study|Adverse Event|3|||
149871475|NCT02695537|540660171|FG000|Overall Study|Lack of Efficacy|28|||
149871476|NCT02695537|540660171|FG000|Overall Study|Withdrawal by Subject|4|||
149871477|NCT02695537|540660171|FG000|Overall Study|Protocol Violation|3|||
149871478|NCT02792699|540660172|FG000|Overall Study|Adverse Event|1|||
149871479|NCT02792699|540660173|FG001|Overall Study|Adverse Event|2|||
149871480|NCT02792699|540660174|FG002|Overall Study|Adverse Event|4|||
149871481|NCT02792699|540660172|FG000|Overall Study|Withdrawal by Subject|4|||
149871482|NCT02792699|540660173|FG001|Overall Study|Withdrawal by Subject|4|||
149871483|NCT02792699|540660174|FG002|Overall Study|Withdrawal by Subject|3|||
150040897|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
150040898|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
149871484|NCT02792699|540660172|FG000|Overall Study|Lost to Follow-up|0|||
149871485|NCT02792699|540660173|FG001|Overall Study|Lost to Follow-up|1|||
149871486|NCT02792699|540660174|FG002|Overall Study|Lost to Follow-up|2|||
149871487|NCT02792699|540660172|FG000|Overall Study|Physician Decision|2|||
149871488|NCT02792699|540660173|FG001|Overall Study|Physician Decision|0|||
149871489|NCT02792699|540660174|FG002|Overall Study|Physician Decision|0|||
149871490|NCT02792699|540660172|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
149871491|NCT02792699|540660173|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
149871492|NCT02792699|540660174|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
149871493|NCT02792699|540660172|FG000|Overall Study|Other|1|||
150040899|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
149871494|NCT02792699|540660173|FG001|Overall Study|Other|0|||
150040900|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
149871495|NCT02792699|540660174|FG002|Overall Study|Other|0|||
149871496|NCT03870477|540660177|FG000|Overall Study|Early Study Termination|1|||
149871497|NCT02256436|540660180|FG000|Overall Study|Adverse Event|9|||
149871498|NCT02256436|540660181|FG001|Overall Study|Adverse Event|14|||
149871499|NCT02256436|540660180|FG000|Overall Study|Death|216|||
149871500|NCT02256436|540660181|FG001|Overall Study|Death|208|||
149871501|NCT02256436|540660180|FG000|Overall Study|Lost to Follow-up|1|||
149871502|NCT02256436|540660181|FG001|Overall Study|Lost to Follow-up|2|||
149871503|NCT02256436|540660180|FG000|Overall Study|Physician Decision|1|||
149871504|NCT02256436|540660181|FG001|Overall Study|Physician Decision|0|||
149871505|NCT02256436|540660180|FG000|Overall Study|Protocol Violation|0|||
149871506|NCT02256436|540660181|FG001|Overall Study|Protocol Violation|1|||
149871507|NCT02256436|540660180|FG000|Overall Study|Withdrawal by Subject|26|||
149871508|NCT02256436|540660181|FG001|Overall Study|Withdrawal by Subject|10|||
149962813|NCT01783938|540997751|FG001|Overall Study|Other Reasons|1|||
149962814|NCT01390584|540997752|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
149962815|NCT01390584|540997753|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
149962816|NCT01390584|540997754|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
149962817|NCT00498485|540997755|FG000|Overall Study|Adverse Event|1|||
149962818|NCT00498485|540997756|FG001|Overall Study|Adverse Event|5|||
149962819|NCT03072875|540997760|FG000|Overall Study|Lost to Follow-up|1|||
149962820|NCT03111732|540997761|FG000|Overall Study|Enrolled in different study|1|||
149962821|NCT03111732|540997761|FG000|Overall Study|Progressive disease|3|||
149962822|NCT03111732|540997761|FG000|Overall Study|Withdrawal by Subject|1|||
149962823|NCT00401830|540997762|FG000|Overall Study|Adverse Event|10|||
149962824|NCT00401830|540997763|FG001|Overall Study|Adverse Event|18|||
149962825|NCT00401830|540997762|FG000|Overall Study|Lack of Efficacy|11|||
149962826|NCT00401830|540997763|FG001|Overall Study|Lack of Efficacy|5|||
149962827|NCT00401830|540997762|FG000|Overall Study|Withdrawal by Subject|4|||
149962828|NCT00401830|540997763|FG001|Overall Study|Withdrawal by Subject|3|||
149962829|NCT00401830|540997762|FG000|Overall Study|Protocol Violation|3|||
149962830|NCT00401830|540997763|FG001|Overall Study|Protocol Violation|3|||
149962831|NCT00401830|540997762|FG000|Overall Study|Non-compliance with drug study|1|||
149962832|NCT00401830|540997763|FG001|Overall Study|Non-compliance with drug study|0|||
149962833|NCT00401830|540997762|FG000|Overall Study|Lost to Follow-up|1|||
149962834|NCT00401830|540997763|FG001|Overall Study|Lost to Follow-up|3|||
149962835|NCT00401830|540997762|FG000|Overall Study|Other: Personal / Family problems|1|||
149962836|NCT00401830|540997763|FG001|Overall Study|Other: Personal / Family problems|0|||
149962837|NCT01943825|540997764|FG000|Overall Study|Lost to Follow-up|9|||
149962838|NCT01943825|540997765|FG001|Overall Study|Lost to Follow-up|3|||
149962839|NCT01943825|540997766|FG002|Overall Study|Lost to Follow-up|12|||
149962840|NCT01943825|540997767|FG003|Overall Study|Lost to Follow-up|8|||
149962841|NCT01943825|540997764|FG000|Overall Study|Withdrawal by Subject|1|||
149962842|NCT01943825|540997765|FG001|Overall Study|Withdrawal by Subject|0|||
149962843|NCT01943825|540997766|FG002|Overall Study|Withdrawal by Subject|3|||
149962844|NCT01943825|540997767|FG003|Overall Study|Withdrawal by Subject|2|||
149962845|NCT01943825|540997764|FG000|Overall Study|Other than specified above|0|||
149962846|NCT01943825|540997765|FG001|Overall Study|Other than specified above|1|||
149962847|NCT01943825|540997766|FG002|Overall Study|Other than specified above|0|||
149962848|NCT01943825|540997767|FG003|Overall Study|Other than specified above|1|||
149962849|NCT00452400|540997774|FG000|Overall Study|Adverse Event|1|||
149962850|NCT00452400|540997775|FG001|Overall Study|Adverse Event|1|||
149962851|NCT00452400|540997776|FG002|Overall Study|Adverse Event|5|||
149962852|NCT00452400|540997777|FG003|Overall Study|Adverse Event|0|||
149962853|NCT00452400|540997778|FG004|Overall Study|Adverse Event|2|||
149962854|NCT00452400|540997774|FG000|Overall Study|Protocol Violation|0|||
149962855|NCT00452400|540997775|FG001|Overall Study|Protocol Violation|0|||
149962856|NCT00452400|540997776|FG002|Overall Study|Protocol Violation|1|||
149962857|NCT00452400|540997777|FG003|Overall Study|Protocol Violation|0|||
149962858|NCT00452400|540997778|FG004|Overall Study|Protocol Violation|0|||
149962859|NCT00452400|540997774|FG000|Overall Study|Lost to Follow-up|1|||
149962860|NCT00452400|540997775|FG001|Overall Study|Lost to Follow-up|0|||
149962861|NCT00452400|540997776|FG002|Overall Study|Lost to Follow-up|0|||
149962862|NCT00452400|540997777|FG003|Overall Study|Lost to Follow-up|0|||
149962863|NCT00452400|540997778|FG004|Overall Study|Lost to Follow-up|0|||
149962864|NCT00452400|540997774|FG000|Overall Study|Withdrawal by Subject|1|||
149962865|NCT00452400|540997775|FG001|Overall Study|Withdrawal by Subject|0|||
149871509|NCT02256436|540660180|FG000|Overall Study|Transferred to Extension Study|11|||
149871510|NCT02256436|540660181|FG001|Overall Study|Transferred to Extension Study|23|||
149871511|NCT02256436|540660180|FG000|Overall Study|Did Not Continue on Extension Study|8|||
149871512|NCT02256436|540660181|FG001|Overall Study|Did Not Continue on Extension Study|12|||
149871513|NCT02970318|540660183|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
149871514|NCT02970318|540660184|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
149871515|NCT02970318|540660185|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
149871516|NCT02970318|540660186|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
149871517|NCT02970318|540660183|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
149871518|NCT02970318|540660184|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
149871519|NCT02970318|540660185|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
149871520|NCT02970318|540660186|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
149871521|NCT02970318|540660183|FG000|Overall for Arm A & Main for Arm B|Death|41|||
149871522|NCT02970318|540660184|FG001|Overall for Arm A & Main for Arm B|Death|33|||
149871523|NCT02970318|540660185|FG002|Overall for Arm A & Main for Arm B|Death|0|||
149871524|NCT02970318|540660186|FG003|Overall for Arm A & Main for Arm B|Death|0|||
149871525|NCT02970318|540660183|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
149871526|NCT02970318|540660184|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
149871527|NCT02970318|540660185|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
149871528|NCT02970318|540660186|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
149871529|NCT02970318|540660183|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
149871530|NCT02970318|540660184|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
149871531|NCT02970318|540660185|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
149871532|NCT02970318|540660186|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
149871533|NCT02970318|540660183|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
149871534|NCT02970318|540660184|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
149871535|NCT02970318|540660185|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
149871536|NCT02970318|540660186|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
149871537|NCT02970318|540660183|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
149871538|NCT02970318|540660184|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
149871539|NCT02970318|540660185|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
149871540|NCT02970318|540660186|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
149871541|NCT02500641|540660189|FG000|Overall Study|Adverse Event|0|||
149871542|NCT02500641|540660190|FG001|Overall Study|Adverse Event|2|||
149871543|NCT02500641|540660189|FG000|Overall Study|Withdrawal by Subject|4|||
149871544|NCT02500641|540660190|FG001|Overall Study|Withdrawal by Subject|5|||
149871545|NCT02500641|540660189|FG000|Overall Study|Unable to follow study procedures|3|||
149871546|NCT02500641|540660190|FG001|Overall Study|Unable to follow study procedures|2|||
149871547|NCT02500641|540660189|FG000|Overall Study|Protocol Violation|1|||
149871548|NCT02500641|540660190|FG001|Overall Study|Protocol Violation|2|||
149871549|NCT02500641|540660189|FG000|Overall Study|Lost to Follow-up|1|||
149871550|NCT02500641|540660190|FG001|Overall Study|Lost to Follow-up|0|||
149871551|NCT02500641|540660189|FG000|Overall Study|Sponsor decision|1|||
149871552|NCT02500641|540660190|FG001|Overall Study|Sponsor decision|0|||
149871553|NCT02500641|540660189|FG000|Overall Study|Non compliance to study drug|0|||
149871554|NCT02500641|540660190|FG001|Overall Study|Non compliance to study drug|1|||
149871555|NCT03233230|540660191|FG000|Overall Study|Adverse Event|6|||
149871556|NCT03233230|540660192|FG001|Overall Study|Adverse Event|3|||
149871557|NCT03233230|540660193|FG002|Overall Study|Adverse Event|6|||
149871558|NCT03233230|540660194|FG003|Overall Study|Adverse Event|3|||
149871559|NCT03233230|540660191|FG000|Overall Study|Protocol Violation|1|||
149871560|NCT03233230|540660192|FG001|Overall Study|Protocol Violation|2|||
149871561|NCT03233230|540660193|FG002|Overall Study|Protocol Violation|1|||
149871562|NCT03233230|540660194|FG003|Overall Study|Protocol Violation|1|||
149871563|NCT03233230|540660191|FG000|Overall Study|Lack of Efficacy|1|||
149871564|NCT03233230|540660192|FG001|Overall Study|Lack of Efficacy|0|||
149871565|NCT03233230|540660193|FG002|Overall Study|Lack of Efficacy|0|||
149871566|NCT03233230|540660194|FG003|Overall Study|Lack of Efficacy|0|||
149871567|NCT03233230|540660191|FG000|Overall Study|Other|5|||
149871568|NCT03233230|540660192|FG001|Overall Study|Other|5|||
149871569|NCT03233230|540660193|FG002|Overall Study|Other|5|||
149871570|NCT03233230|540660194|FG003|Overall Study|Other|3|||
149871571|NCT03233230|540660191|FG000|Overall Study|Withdrawal by Subject|2|||
149871572|NCT03233230|540660192|FG001|Overall Study|Withdrawal by Subject|2|||
149871573|NCT03233230|540660193|FG002|Overall Study|Withdrawal by Subject|0|||
149871574|NCT03233230|540660194|FG003|Overall Study|Withdrawal by Subject|1|||
149871575|NCT03233230|540660191|FG000|Overall Study|Lost to Follow-up|0|||
149871576|NCT03233230|540660192|FG001|Overall Study|Lost to Follow-up|3|||
149871577|NCT03233230|540660193|FG002|Overall Study|Lost to Follow-up|0|||
149871578|NCT03233230|540660194|FG003|Overall Study|Lost to Follow-up|0|||
149871579|NCT01584843|540660197|FG000|First Treatment Period|Adverse Event|0|||
149871580|NCT01584843|540660198|FG001|First Treatment Period|Adverse Event|0|||
149871581|NCT01584843|540660199|FG002|First Treatment Period|Adverse Event|1|||
149871582|NCT01584843|540660200|FG003|First Treatment Period|Adverse Event|0|||
149871583|NCT01584843|540660201|FG004|First Treatment Period|Adverse Event|0|||
149871584|NCT01584843|540660202|FG005|First Treatment Period|Adverse Event|0|||
150040901|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
150040902|NCT02968004|541289125|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
150040903|NCT02968004|541289126|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
150040904|NCT05029362|541289127|FG000|Overall Study|Lost to Follow-up|9|||
150040905|NCT03722238|541289130|FG000|Overall Study|Protocol Violation|1|||
150040906|NCT03722238|541289131|FG001|Overall Study|Protocol Violation|0|||
150040907|NCT03722238|541289130|FG000|Overall Study|Physician Decision|1|||
150040908|NCT03722238|541289131|FG001|Overall Study|Physician Decision|0|||
150040909|NCT03722238|541289130|FG000|Overall Study|Death|1|||
150040910|NCT03722238|541289131|FG001|Overall Study|Death|0|||
150040911|NCT03722238|541289130|FG000|Overall Study|Lost to Follow-up|6|||
150040912|NCT03722238|541289131|FG001|Overall Study|Lost to Follow-up|0|||
150040913|NCT03722238|541289130|FG000|Overall Study|Partial missing data|44|||
150040914|NCT03722238|541289131|FG001|Overall Study|Partial missing data|1|||
150040915|NCT03722238|541289130|FG000|Overall Study|Withdrawal by Subject|2|||
150040916|NCT03722238|541289131|FG001|Overall Study|Withdrawal by Subject|0|||
150040917|NCT03722238|541289130|FG000|Overall Study|Other|4|||
150173908|NCT00057837|541773000|FG000|Overall Study|Never started treatment|1|||
150173909|NCT00057837|541773001|FG001|Overall Study|Never started treatment|1|||
149871585|NCT01584843|540660197|FG000|First Treatment Period|Protocol Violation|0|||
150040918|NCT03722238|541289131|FG001|Overall Study|Other|0|||
150040919|NCT03722238|541289130|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
149962866|NCT00452400|540997776|FG002|Overall Study|Withdrawal by Subject|1|||
149962867|NCT00452400|540997777|FG003|Overall Study|Withdrawal by Subject|0|||
149962868|NCT00452400|540997778|FG004|Overall Study|Withdrawal by Subject|0|||
149962869|NCT00452400|540997774|FG000|Overall Study|Lack of Efficacy|2|||
149962870|NCT00452400|540997775|FG001|Overall Study|Lack of Efficacy|0|||
149962871|NCT00452400|540997776|FG002|Overall Study|Lack of Efficacy|0|||
149962872|NCT00452400|540997777|FG003|Overall Study|Lack of Efficacy|0|||
149962873|NCT00452400|540997778|FG004|Overall Study|Lack of Efficacy|0|||
149962874|NCT00452400|540997774|FG000|Overall Study|Other reasons not listed above|0|||
149962875|NCT00452400|540997775|FG001|Overall Study|Other reasons not listed above|0|||
149962876|NCT00452400|540997776|FG002|Overall Study|Other reasons not listed above|0|||
149962877|NCT00452400|540997777|FG003|Overall Study|Other reasons not listed above|1|||
149962878|NCT00452400|540997778|FG004|Overall Study|Other reasons not listed above|1|||
149962879|NCT01539525|540997779|FG000|Overall Study|Lost to Follow-up|19|||
149962880|NCT01539525|540997780|FG001|Overall Study|Lost to Follow-up|12|||
149962881|NCT01539525|540997781|FG002|Overall Study|Lost to Follow-up|11|||
149962882|NCT01539525|540997779|FG000|Overall Study|Withdrawal by Subject|0|||
149962883|NCT01539525|540997780|FG001|Overall Study|Withdrawal by Subject|3|||
149962884|NCT01539525|540997781|FG002|Overall Study|Withdrawal by Subject|2|||
149962885|NCT01539525|540997779|FG000|Overall Study|Protocol Violation|1|||
149962886|NCT01539525|540997780|FG001|Overall Study|Protocol Violation|1|||
149962887|NCT01539525|540997781|FG002|Overall Study|Protocol Violation|4|||
149962888|NCT01712074|540997782|FG000|Placebo Run-in Period|Adverse Event|2|||
149962889|NCT01712074|540997783|FG001|Placebo Run-in Period|Adverse Event|0|||
149962890|NCT01712074|540997784|FG002|Placebo Run-in Period|Adverse Event|0|||
149962891|NCT01712074|540997782|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
149962892|NCT01712074|540997783|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
149962893|NCT01712074|540997784|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
149962894|NCT01712074|540997782|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
149962895|NCT01712074|540997783|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
149962896|NCT01712074|540997784|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
149962897|NCT01712074|540997782|FG000|Placebo Run-in Period|Other|1|||
149962898|NCT01712074|540997783|FG001|Placebo Run-in Period|Other|0|||
149962899|NCT01712074|540997784|FG002|Placebo Run-in Period|Other|0|||
149962900|NCT01712074|540997782|FG000|Placebo Run-in Period|No longer willing to participate|1|||
149962901|NCT01712074|540997783|FG001|Placebo Run-in Period|No longer willing to participate|0|||
149962902|NCT01712074|540997784|FG002|Placebo Run-in Period|No longer willing to participate|0|||
149962903|NCT01712074|540997782|FG000|Double Blind Period|Adverse Event|0|||
149962904|NCT01712074|540997783|FG001|Double Blind Period|Adverse Event|2|||
149962905|NCT01712074|540997784|FG002|Double Blind Period|Adverse Event|1|||
149962906|NCT01712074|540997782|FG000|Double Blind Period|No longer willing to participate|0|||
149962907|NCT01712074|540997783|FG001|Double Blind Period|No longer willing to participate|2|||
149962908|NCT01712074|540997784|FG002|Double Blind Period|No longer willing to participate|4|||
150040920|NCT03722238|541289131|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
150040921|NCT03722238|541289130|FG000|Overall Study|Did not meet risk classification group criteria|90|||
150040922|NCT03722238|541289131|FG001|Overall Study|Did not meet risk classification group criteria|0|||
150040923|NCT03722238|541289130|FG000|Overall Study|Did not sign consent|17|||
150040924|NCT03722238|541289131|FG001|Overall Study|Did not sign consent|0|||
150040925|NCT03722238|541289130|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
150040926|NCT03722238|541289131|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
150040927|NCT03722238|541289130|FG000|Overall Study|Not willing to purchase study medication|142|||
150040928|NCT03722238|541289131|FG001|Overall Study|Not willing to purchase study medication|0|||
150040929|NCT03722238|541289130|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
150040930|NCT03722238|541289131|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
150040931|NCT02606643|541289132|FG000|Overall Study|did not meet inclusion criteria|1|||
150040932|NCT02606643|541289133|FG001|Overall Study|did not meet inclusion criteria|3|||
150040933|NCT00561925|541289144|FG000|14 Day Lead-In Period|Adverse Event|38|||
150040934|NCT00561925|541289145|FG001|14 Day Lead-In Period|Adverse Event|0|||
150040935|NCT00561925|541289146|FG002|14 Day Lead-In Period|Adverse Event|0|||
150040936|NCT00561925|541289147|FG003|14 Day Lead-In Period|Adverse Event|0|||
150040937|NCT00561925|541289148|FG004|14 Day Lead-In Period|Adverse Event|0|||
149962909|NCT01712074|540997782|FG000|Double Blind Period|Death|0|||
149962910|NCT01712074|540997783|FG001|Double Blind Period|Death|1|||
149962911|NCT01712074|540997784|FG002|Double Blind Period|Death|0|||
149962912|NCT01712074|540997782|FG000|Double Blind Period|Lost to Follow-up|0|||
149962913|NCT01712074|540997783|FG001|Double Blind Period|Lost to Follow-up|2|||
149962914|NCT01712074|540997784|FG002|Double Blind Period|Lost to Follow-up|1|||
149962915|NCT01712074|540997782|FG000|Double Blind Period|Other|0|||
149962916|NCT01712074|540997783|FG001|Double Blind Period|Other|4|||
149962917|NCT01712074|540997784|FG002|Double Blind Period|Other|1|||
149962918|NCT01712074|540997782|FG000|Double Blind Period|Protocol Violation|0|||
149962919|NCT01712074|540997783|FG001|Double Blind Period|Protocol Violation|0|||
149962920|NCT01712074|540997784|FG002|Double Blind Period|Protocol Violation|1|||
149962921|NCT01712074|540997782|FG000|Double Blind Period|No longer met eligibility criteria|0|||
149962922|NCT01712074|540997783|FG001|Double Blind Period|No longer met eligibility criteria|3|||
149962923|NCT01712074|540997784|FG002|Double Blind Period|No longer met eligibility criteria|0|||
149962924|NCT02268851|540997785|FG000|Overall Study|Death|0|||
149962925|NCT02268851|540997786|FG001|Overall Study|Death|0|||
149962926|NCT02268851|540997787|FG002|Overall Study|Death|0|||
149962927|NCT02268851|540997788|FG003|Overall Study|Death|1|||
149962928|NCT02268851|540997789|FG004|Overall Study|Death|2|||
149962929|NCT02268851|540997790|FG005|Overall Study|Death|1|||
149962930|NCT02268851|540997785|FG000|Overall Study|Adverse Event|0|||
149962931|NCT02268851|540997786|FG001|Overall Study|Adverse Event|0|||
149962932|NCT02268851|540997787|FG002|Overall Study|Adverse Event|0|||
149962933|NCT02268851|540997788|FG003|Overall Study|Adverse Event|0|||
149962934|NCT02268851|540997789|FG004|Overall Study|Adverse Event|2|||
149962935|NCT02268851|540997790|FG005|Overall Study|Adverse Event|2|||
149962936|NCT02268851|540997785|FG000|Overall Study|Withdrawal by Subject|0|||
149962937|NCT02268851|540997786|FG001|Overall Study|Withdrawal by Subject|0|||
149962938|NCT02268851|540997787|FG002|Overall Study|Withdrawal by Subject|0|||
149962939|NCT02268851|540997788|FG003|Overall Study|Withdrawal by Subject|2|||
149962940|NCT02268851|540997789|FG004|Overall Study|Withdrawal by Subject|0|||
149962941|NCT02268851|540997790|FG005|Overall Study|Withdrawal by Subject|1|||
149962942|NCT02268851|540997785|FG000|Overall Study|Progressive Disease|1|||
149962943|NCT02268851|540997786|FG001|Overall Study|Progressive Disease|3|||
149962944|NCT02268851|540997787|FG002|Overall Study|Progressive Disease|0|||
149962945|NCT02268851|540997788|FG003|Overall Study|Progressive Disease|0|||
149962946|NCT02268851|540997789|FG004|Overall Study|Progressive Disease|1|||
149962947|NCT02268851|540997790|FG005|Overall Study|Progressive Disease|4|||
149962948|NCT02268851|540997785|FG000|Overall Study|Physician Decision|0|||
149962949|NCT02268851|540997786|FG001|Overall Study|Physician Decision|0|||
149962950|NCT02268851|540997787|FG002|Overall Study|Physician Decision|1|||
149962951|NCT02268851|540997788|FG003|Overall Study|Physician Decision|0|||
149962952|NCT02268851|540997789|FG004|Overall Study|Physician Decision|0|||
149962953|NCT02268851|540997790|FG005|Overall Study|Physician Decision|1|||
149962954|NCT02268851|540997785|FG000|Overall Study|Patient Compliance|0|||
149962955|NCT02268851|540997786|FG001|Overall Study|Patient Compliance|0|||
149962956|NCT02268851|540997787|FG002|Overall Study|Patient Compliance|0|||
149962957|NCT02268851|540997788|FG003|Overall Study|Patient Compliance|0|||
149962958|NCT02268851|540997789|FG004|Overall Study|Patient Compliance|1|||
149962959|NCT02268851|540997790|FG005|Overall Study|Patient Compliance|1|||
149962960|NCT02268851|540997785|FG000|Overall Study|Co-Morbid Condition|0|||
149962961|NCT02268851|540997786|FG001|Overall Study|Co-Morbid Condition|0|||
149962962|NCT02268851|540997787|FG002|Overall Study|Co-Morbid Condition|0|||
149962963|NCT02268851|540997788|FG003|Overall Study|Co-Morbid Condition|0|||
149962964|NCT02268851|540997789|FG004|Overall Study|Co-Morbid Condition|1|||
149962965|NCT02268851|540997790|FG005|Overall Study|Co-Morbid Condition|1|||
149962966|NCT03378635|540997791|FG000|Overall Study|Adverse Event|1|||
149962967|NCT03378635|540997792|FG001|Overall Study|Adverse Event|0|||
149962968|NCT03378635|540997793|FG002|Overall Study|Adverse Event|0|||
149962969|NCT03378635|540997791|FG000|Overall Study|Withdrawal by Subject|1|||
149962970|NCT03378635|540997792|FG001|Overall Study|Withdrawal by Subject|0|||
149962971|NCT03378635|540997793|FG002|Overall Study|Withdrawal by Subject|0|||
149962972|NCT01472835|540997794|FG000|Overall Study|Lost to Follow-up|2|||
149962973|NCT01472835|540997795|FG001|Overall Study|Lost to Follow-up|0|||
149962974|NCT02413346|540997796|FG000|Overall Study|Adverse Event|6|||
149962975|NCT02413346|540997797|FG001|Overall Study|Adverse Event|6|||
149962976|NCT02413346|540997796|FG000|Overall Study|Withdrawal by Subject|30|||
149962977|NCT02413346|540997797|FG001|Overall Study|Withdrawal by Subject|40|||
149962978|NCT02413346|540997796|FG000|Overall Study|Lost to Follow-up|17|||
149962979|NCT02413346|540997797|FG001|Overall Study|Lost to Follow-up|21|||
149962980|NCT02413346|540997796|FG000|Overall Study|Protocol Violation|2|||
149962981|NCT02413346|540997797|FG001|Overall Study|Protocol Violation|0|||
150173910|NCT02425111|541773002|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
150173911|NCT02425111|541773002|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
150173912|NCT02425111|541773002|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
150173913|NCT02425111|541773002|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
150173914|NCT02425111|541773002|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
150173915|NCT02425111|541773002|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
150173916|NCT00585533|541773003|FG000|Overall Study|objective or symptomatic progression|9|||
150173917|NCT02798835|541773004|FG000|Overall Study|Protocol Violation|0|||
150173918|NCT02798835|541773005|FG001|Overall Study|Protocol Violation|0|||
150173919|NCT02798835|541773006|FG002|Overall Study|Protocol Violation|3|||
150173920|NCT03482011|541773007|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
150173921|NCT03482011|541773008|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
150173922|NCT03482011|541773009|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
150173923|NCT03482011|541773010|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
150173924|NCT03482011|541773011|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
150173925|NCT03482011|541773012|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
150173926|NCT03482011|541773013|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
150173927|NCT03482011|541773014|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
150173928|NCT03482011|541773007|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
150173929|NCT03482011|541773008|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
150173930|NCT03482011|541773009|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173931|NCT03482011|541773010|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173932|NCT03482011|541773011|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173933|NCT03482011|541773012|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173934|NCT03482011|541773013|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173935|NCT03482011|541773014|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150173936|NCT03482011|541773007|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173937|NCT03482011|541773008|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
150173938|NCT03482011|541773009|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173939|NCT03482011|541773010|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173940|NCT03482011|541773011|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173941|NCT03482011|541773012|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173942|NCT03482011|541773013|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173943|NCT03482011|541773014|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
150173944|NCT03482011|541773007|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
150173945|NCT03482011|541773008|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
150173946|NCT03482011|541773009|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
150173947|NCT03482011|541773010|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
150173948|NCT03482011|541773011|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
150173949|NCT03482011|541773012|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
150173950|NCT03482011|541773013|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
150173951|NCT03482011|541773014|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
150173952|NCT03482011|541773007|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
150173953|NCT03482011|541773008|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
149871586|NCT01584843|540660198|FG001|First Treatment Period|Protocol Violation|0|||
149871587|NCT01584843|540660199|FG002|First Treatment Period|Protocol Violation|0|||
149871588|NCT01584843|540660200|FG003|First Treatment Period|Protocol Violation|0|||
149871589|NCT01584843|540660201|FG004|First Treatment Period|Protocol Violation|0|||
149871590|NCT01584843|540660202|FG005|First Treatment Period|Protocol Violation|1|||
149871591|NCT01584843|540660197|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
149871592|NCT01584843|540660198|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
149871593|NCT01584843|540660199|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
149871594|NCT01584843|540660200|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
149871595|NCT01584843|540660201|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
150173954|NCT03482011|541773009|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150173955|NCT03482011|541773010|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150173956|NCT03482011|541773011|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150173957|NCT03482011|541773012|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150173958|NCT03482011|541773013|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149871596|NCT01584843|540660202|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
149871597|NCT01584843|540660197|FG000|Second Treatment Period|Withdrawal by Subject|0|||
149871598|NCT01584843|540660198|FG001|Second Treatment Period|Withdrawal by Subject|0|||
149871599|NCT01584843|540660199|FG002|Second Treatment Period|Withdrawal by Subject|0|||
149871600|NCT01584843|540660200|FG003|Second Treatment Period|Withdrawal by Subject|0|||
149871601|NCT01584843|540660201|FG004|Second Treatment Period|Withdrawal by Subject|0|||
149871602|NCT01584843|540660202|FG005|Second Treatment Period|Withdrawal by Subject|1|||
149871603|NCT04126213|540660203|FG000|Overall Study|Lost to Follow-up|9|||
149871604|NCT04126213|540660204|FG001|Overall Study|Lost to Follow-up|1|||
149871605|NCT04126213|540660205|FG002|Overall Study|Lost to Follow-up|5|||
149871606|NCT04126213|540660206|FG003|Overall Study|Lost to Follow-up|10|||
149871607|NCT04126213|540660207|FG004|Overall Study|Lost to Follow-up|4|||
149871608|NCT04126213|540660208|FG005|Overall Study|Lost to Follow-up|7|||
149871609|NCT04126213|540660203|FG000|Overall Study|Withdrawal by Subject|3|||
149871610|NCT04126213|540660204|FG001|Overall Study|Withdrawal by Subject|2|||
149871611|NCT04126213|540660205|FG002|Overall Study|Withdrawal by Subject|1|||
149871612|NCT04126213|540660206|FG003|Overall Study|Withdrawal by Subject|1|||
149871613|NCT04126213|540660207|FG004|Overall Study|Withdrawal by Subject|1|||
149871614|NCT04126213|540660208|FG005|Overall Study|Withdrawal by Subject|1|||
149871615|NCT04126213|540660203|FG000|Overall Study|Other|0|||
149871616|NCT04126213|540660204|FG001|Overall Study|Other|0|||
149871617|NCT04126213|540660205|FG002|Overall Study|Other|2|||
149871618|NCT04126213|540660206|FG003|Overall Study|Other|2|||
149871619|NCT04126213|540660207|FG004|Overall Study|Other|0|||
149871620|NCT04126213|540660208|FG005|Overall Study|Other|1|||
149871621|NCT04126213|540660203|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149871622|NCT04126213|540660204|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149871623|NCT04126213|540660205|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149871624|NCT04126213|540660206|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149871625|NCT04126213|540660207|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149871626|NCT04126213|540660208|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149871627|NCT02196701|540660211|FG000|Overall Study|Adverse Event|1|||
149871628|NCT02196701|540660211|FG000|Overall Study|Lost to Follow-up|1|||
149871629|NCT02196701|540660211|FG000|Overall Study|Non-adherence to Protocol|1|||
149871630|NCT03275064|540660212|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
149871631|NCT03275064|540660213|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
149871632|NCT03275064|540660214|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
149871633|NCT03275064|540660215|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
149871634|NCT03275064|540660216|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
149871635|NCT03275064|540660212|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
149871636|NCT03275064|540660213|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
149871637|NCT03275064|540660214|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
149871638|NCT03275064|540660215|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
149871639|NCT03275064|540660216|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
149871640|NCT03275064|540660212|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
149871641|NCT03275064|540660213|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
149871642|NCT03275064|540660214|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
149871643|NCT03275064|540660215|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
149871644|NCT03275064|540660216|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
149871645|NCT03275064|540660212|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
149871646|NCT03275064|540660213|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
149871647|NCT03275064|540660214|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
149871648|NCT03275064|540660215|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
149871649|NCT03275064|540660216|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
149871650|NCT03275064|540660212|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
149871651|NCT03275064|540660213|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
149871652|NCT03275064|540660214|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
149871653|NCT03275064|540660215|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
149962982|NCT02413346|540997796|FG000|Overall Study|Other Miscellaneous Reasons|4|||
149871654|NCT03275064|540660216|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
149871655|NCT00620555|540660218|FG000|Overall Study|Adverse Event|4|||
149871656|NCT00620555|540660218|FG000|Overall Study|Protocol Violation|2|||
149871657|NCT00620555|540660218|FG000|Overall Study|Lack of Efficacy|12|||
149871658|NCT00620555|540660218|FG000|Overall Study|Withdrawal by Subject|1|||
149871659|NCT00620555|540660218|FG000|Overall Study|Choice of other treatment|1|||
149871660|NCT00620555|540660218|FG000|Overall Study|Visit failure against planned|1|||
149871661|NCT03796039|540660219|FG000|Overall Study|Death|2|||
149871662|NCT03796039|540660220|FG001|Overall Study|Death|1|||
149871663|NCT03796039|540660219|FG000|Overall Study|Withdrawal by Subject|7|||
149871664|NCT03796039|540660220|FG001|Overall Study|Withdrawal by Subject|4|||
149871665|NCT01140503|540660221|FG000|Overall Study|Withdrawal by Subject|1|||
149871666|NCT00750308|540660222|FG000|First Treatment|Adverse Event|0|||
149871667|NCT00750308|540660223|FG001|First Treatment|Adverse Event|1|||
149871668|NCT00750308|540660224|FG002|First Treatment|Adverse Event|0|||
149871669|NCT00750308|540660225|FG003|First Treatment|Adverse Event|0|||
149871670|NCT00750308|540660226|FG004|First Treatment|Adverse Event|0|||
149871671|NCT00750308|540660227|FG005|First Treatment|Adverse Event|0|||
149871672|NCT00750308|540660228|FG006|First Treatment|Adverse Event|0|||
149871673|NCT00750308|540660229|FG007|First Treatment|Adverse Event|0|||
149871674|NCT00750308|540660230|FG008|First Treatment|Adverse Event|0|||
149871675|NCT00750308|540660231|FG009|First Treatment|Adverse Event|0|||
149871676|NCT00750308|540660232|FG010|First Treatment|Adverse Event|1|||
149871677|NCT00750308|540660233|FG011|First Treatment|Adverse Event|1|||
149871678|NCT00750308|540660222|FG000|First Treatment|Withdrawal by Subject|0|||
149871679|NCT00750308|540660223|FG001|First Treatment|Withdrawal by Subject|0|||
149871680|NCT00750308|540660224|FG002|First Treatment|Withdrawal by Subject|0|||
149871681|NCT00750308|540660225|FG003|First Treatment|Withdrawal by Subject|1|||
149871682|NCT00750308|540660226|FG004|First Treatment|Withdrawal by Subject|0|||
149871683|NCT00750308|540660227|FG005|First Treatment|Withdrawal by Subject|0|||
149871684|NCT00750308|540660228|FG006|First Treatment|Withdrawal by Subject|0|||
149962983|NCT02413346|540997797|FG001|Overall Study|Other Miscellaneous Reasons|3|||
149962984|NCT01835431|540997798|FG000|Overall Study|Adverse Event|1|||
149962985|NCT01835431|540997799|FG001|Overall Study|Adverse Event|0|||
149962986|NCT01835431|540997798|FG000|Overall Study|other|0|||
149962987|NCT01835431|540997799|FG001|Overall Study|other|2|||
149962988|NCT01835431|540997798|FG000|Overall Study|Withdrawal by Subject|6|||
149962989|NCT01835431|540997799|FG001|Overall Study|Withdrawal by Subject|10|||
149962990|NCT01835431|540997798|FG000|Overall Study|Protocol Violation|1|||
149962991|NCT01835431|540997799|FG001|Overall Study|Protocol Violation|0|||
149962992|NCT03810495|540997804|FG000|Overall Study|Lost to Follow-up|2|||
149962993|NCT03810495|540997804|FG000|Overall Study|Withdrawal by Subject|1|||
149962994|NCT00954538|540997808|FG000|Part III|Withdrawal by Subject|0|||
149962995|NCT00954538|540997809|FG001|Part III|Withdrawal by Subject|0|||
149962996|NCT00954538|540997810|FG002|Part III|Withdrawal by Subject|0|||
149962997|NCT00954538|540997811|FG003|Part III|Withdrawal by Subject|0|||
149962998|NCT00954538|540997812|FG004|Part III|Withdrawal by Subject|1|||
149962999|NCT00954538|540997813|FG005|Part III|Withdrawal by Subject|0|||
149963000|NCT01905683|540997816|FG000|Overall Study|Protocol Violation|1|||
149963001|NCT01905683|540997816|FG000|Overall Study|Re-injection criteria not met; others|13|||
149963002|NCT01905683|540997816|FG000|Overall Study|Physician Decision|1|||
149963003|NCT01905683|540997816|FG000|Overall Study|Lack of Efficacy|8|||
149963004|NCT01905683|540997816|FG000|Overall Study|Withdrawal by Subject|20|||
149963005|NCT01905683|540997816|FG000|Overall Study|Adverse Event|4|||
149963006|NCT01905683|540997816|FG000|Overall Study|Lost to Follow-up|4|||
149963007|NCT03439072|540999719|FG000|Overall Study|Withdrawal by Subject|2|||
149963008|NCT03439072|540999720|FG001|Overall Study|Withdrawal by Subject|3|||
149963009|NCT03439072|540999719|FG000|Overall Study|Physician Decision|0|||
149963010|NCT03439072|540999720|FG001|Overall Study|Physician Decision|1|||
149963011|NCT00889005|540999727|FG000|Overall Study|Lost to Follow-up|4|||
149963012|NCT00889005|540999728|FG001|Overall Study|Lost to Follow-up|2|||
149963013|NCT00889005|540999727|FG000|Overall Study|Withdrawal by Subject|4|||
149963014|NCT00889005|540999728|FG001|Overall Study|Withdrawal by Subject|0|||
149963015|NCT00128492|540999729|FG000|Overall Study|AE unrelated to study|2|||
149963016|NCT00128492|540999730|FG001|Overall Study|AE unrelated to study|9|||
149963017|NCT00128492|540999729|FG000|Overall Study|Study drug intolerance (AE)|2|||
149963018|NCT00128492|540999730|FG001|Overall Study|Study drug intolerance (AE)|8|||
149963019|NCT00128492|540999729|FG000|Overall Study|AE related to study|1|||
149963020|NCT00128492|540999730|FG001|Overall Study|AE related to study|4|||
149963021|NCT00128492|540999729|FG000|Overall Study|Death|1|||
149963022|NCT00128492|540999730|FG001|Overall Study|Death|0|||
149963023|NCT00128492|540999729|FG000|Overall Study|Lost to Follow-up|1|||
149963024|NCT00128492|540999730|FG001|Overall Study|Lost to Follow-up|5|||
149963025|NCT00128492|540999729|FG000|Overall Study|Noncompliance|0|||
149871685|NCT00750308|540660229|FG007|First Treatment|Withdrawal by Subject|1|||
149871686|NCT00750308|540660230|FG008|First Treatment|Withdrawal by Subject|0|||
149871687|NCT00750308|540660231|FG009|First Treatment|Withdrawal by Subject|0|||
149963026|NCT00128492|540999730|FG001|Overall Study|Noncompliance|5|||
149963027|NCT00128492|540999729|FG000|Overall Study|Personal or administrative|10|||
149871688|NCT00750308|540660232|FG010|First Treatment|Withdrawal by Subject|0|||
149871689|NCT00750308|540660233|FG011|First Treatment|Withdrawal by Subject|0|||
149871690|NCT00750308|540660222|FG000|Second Treatment|Adverse Event|0|||
149963028|NCT00128492|540999730|FG001|Overall Study|Personal or administrative|22|||
149871691|NCT00750308|540660223|FG001|Second Treatment|Adverse Event|0|||
149871692|NCT00750308|540660224|FG002|Second Treatment|Adverse Event|0|||
149871693|NCT00750308|540660225|FG003|Second Treatment|Adverse Event|0|||
149871694|NCT00750308|540660226|FG004|Second Treatment|Adverse Event|0|||
149871695|NCT00750308|540660227|FG005|Second Treatment|Adverse Event|1|||
149871696|NCT00750308|540660228|FG006|Second Treatment|Adverse Event|0|||
149871697|NCT00750308|540660229|FG007|Second Treatment|Adverse Event|0|||
149871698|NCT00750308|540660230|FG008|Second Treatment|Adverse Event|1|||
149871699|NCT00750308|540660231|FG009|Second Treatment|Adverse Event|0|||
149871700|NCT00750308|540660232|FG010|Second Treatment|Adverse Event|0|||
149871701|NCT00750308|540660233|FG011|Second Treatment|Adverse Event|0|||
149871702|NCT00750308|540660222|FG000|Second Treatment|Withdrawal by Subject|0|||
149871703|NCT00750308|540660223|FG001|Second Treatment|Withdrawal by Subject|0|||
149871704|NCT00750308|540660224|FG002|Second Treatment|Withdrawal by Subject|0|||
149871705|NCT00750308|540660225|FG003|Second Treatment|Withdrawal by Subject|0|||
149871706|NCT00750308|540660226|FG004|Second Treatment|Withdrawal by Subject|1|||
149871707|NCT00750308|540660227|FG005|Second Treatment|Withdrawal by Subject|0|||
149871708|NCT00750308|540660228|FG006|Second Treatment|Withdrawal by Subject|0|||
149871709|NCT00750308|540660229|FG007|Second Treatment|Withdrawal by Subject|0|||
149871710|NCT00750308|540660230|FG008|Second Treatment|Withdrawal by Subject|0|||
149871711|NCT00750308|540660231|FG009|Second Treatment|Withdrawal by Subject|0|||
149871712|NCT00750308|540660232|FG010|Second Treatment|Withdrawal by Subject|0|||
149871713|NCT00750308|540660233|FG011|Second Treatment|Withdrawal by Subject|0|||
149871714|NCT00750308|540660222|FG000|Third Treatment|Withdrawal by Subject|0|||
149871715|NCT00750308|540660223|FG001|Third Treatment|Withdrawal by Subject|1|||
149871716|NCT00750308|540660224|FG002|Third Treatment|Withdrawal by Subject|0|||
149871717|NCT00750308|540660225|FG003|Third Treatment|Withdrawal by Subject|0|||
149871718|NCT00750308|540660226|FG004|Third Treatment|Withdrawal by Subject|0|||
149871719|NCT00750308|540660227|FG005|Third Treatment|Withdrawal by Subject|0|||
149871720|NCT00750308|540660228|FG006|Third Treatment|Withdrawal by Subject|0|||
149871721|NCT00750308|540660229|FG007|Third Treatment|Withdrawal by Subject|0|||
149871722|NCT00750308|540660230|FG008|Third Treatment|Withdrawal by Subject|0|||
149871723|NCT00750308|540660231|FG009|Third Treatment|Withdrawal by Subject|0|||
149871724|NCT00750308|540660232|FG010|Third Treatment|Withdrawal by Subject|0|||
149871725|NCT00750308|540660233|FG011|Third Treatment|Withdrawal by Subject|0|||
149871726|NCT00513682|540660234|FG000|Washout Phase|Adverse Event|2|||
149871727|NCT04156620|540660235|FG000|Overall Study|Adverse event - TP 1|5|||
149871728|NCT04156620|540660236|FG001|Overall Study|Adverse event - TP 1|2|||
150040938|NCT00561925|541289144|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
150040939|NCT00561925|541289145|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
150040940|NCT00561925|541289146|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
150040941|NCT00561925|541289147|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
150040942|NCT00561925|541289148|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
150040943|NCT00561925|541289144|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
150040944|NCT00561925|541289145|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
150040945|NCT00561925|541289146|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
150040946|NCT00561925|541289147|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
150040947|NCT00561925|541289148|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
150040948|NCT00561925|541289144|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
150040949|NCT00561925|541289145|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
150040950|NCT00561925|541289146|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
150040951|NCT00561925|541289147|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
150040952|NCT00561925|541289148|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
150040953|NCT00561925|541289144|FG000|14 Day Lead-In Period|Other|5|||
150040954|NCT00561925|541289145|FG001|14 Day Lead-In Period|Other|0|||
150040955|NCT00561925|541289146|FG002|14 Day Lead-In Period|Other|0|||
150040956|NCT00561925|541289147|FG003|14 Day Lead-In Period|Other|0|||
150040957|NCT00561925|541289148|FG004|14 Day Lead-In Period|Other|0|||
150040958|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
150040959|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
150040960|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
150040961|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
150040962|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
150040963|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
150040964|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
149871729|NCT04156620|540660235|FG000|Overall Study|Lost to follow-up TP 1|1|||
149871730|NCT04156620|540660236|FG001|Overall Study|Lost to follow-up TP 1|1|||
149871731|NCT04156620|540660235|FG000|Overall Study|Progressive disease - TP 1|0|||
149871732|NCT04156620|540660236|FG001|Overall Study|Progressive disease - TP 1|1|||
149871733|NCT04156620|540660235|FG000|Overall Study|Subject decision - TP 1|3|||
149871734|NCT04156620|540660236|FG001|Overall Study|Subject decision - TP 1|5|||
149871735|NCT04156620|540660235|FG000|Overall Study|Adverse event - TP 2|5|||
149871736|NCT04156620|540660236|FG001|Overall Study|Adverse event - TP 2|6|||
150040965|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
150040966|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
149963029|NCT00128492|540999729|FG000|Overall Study|Withdrawal by Subject|3|||
149963030|NCT00128492|540999730|FG001|Overall Study|Withdrawal by Subject|5|||
149963031|NCT00128492|540999729|FG000|Overall Study|Pregnancy|0|||
149963032|NCT00128492|540999730|FG001|Overall Study|Pregnancy|1|||
149963033|NCT00756314|540999734|FG000|Overall Study|Lost to Follow-up|2|||
149963034|NCT00756314|540999735|FG001|Overall Study|Lost to Follow-up|59|||
149963035|NCT02872142|540999737|FG000|Overall Study|Adverse Event|2|||
149963036|NCT02872142|540999737|FG000|Overall Study|Death|1|||
149963037|NCT02872142|540999737|FG000|Overall Study|Participant Decision|3|||
149963038|NCT01903720|540999742|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
149963039|NCT01903720|540999742|FG000|Overall Study|Adverse Event|1|||
149963040|NCT01903720|540999742|FG000|Overall Study|Rescinding of informed consent|2|||
149963041|NCT01903720|540999742|FG000|Overall Study|Lost to Follow-up|2|||
149963042|NCT01903720|540999742|FG000|Overall Study|Treatment with alternative drug|1|||
149963043|NCT03627468|540999743|FG000|Overall Study|Adverse Event|5|||
149963044|NCT03627468|540999744|FG001|Overall Study|Adverse Event|33|||
149963045|NCT03627468|540999743|FG000|Overall Study|Withdrawal by Subject|13|||
149963046|NCT03627468|540999744|FG001|Overall Study|Withdrawal by Subject|23|||
149963047|NCT03627468|540999743|FG000|Overall Study|Physician Decision|1|||
149963048|NCT03627468|540999744|FG001|Overall Study|Physician Decision|0|||
149963049|NCT03627468|540999743|FG000|Overall Study|Protocol Violation|0|||
149963050|NCT03627468|540999744|FG001|Overall Study|Protocol Violation|2|||
149963051|NCT03627468|540999743|FG000|Overall Study|Lost to Follow-up|10|||
149963052|NCT03627468|540999744|FG001|Overall Study|Lost to Follow-up|16|||
150040967|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
150040968|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
150040969|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
150040970|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
150040971|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
150040972|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
150040973|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
150040974|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
150040975|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
150040976|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
150040977|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
150040978|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
150040979|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
150040980|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
150040981|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
150040982|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
150040983|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
150040984|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
150040985|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
150040986|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
150040987|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
150040988|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Death|0|||
150040989|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Death|6|||
150040990|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Death|3|||
150040991|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Death|0|||
150040992|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Death|0|||
150040993|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
150040994|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
150040995|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
150040996|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
150040997|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
150040998|NCT00561925|541289144|FG000|144-week Double-blind, Double-dummy|Other|0|||
150040999|NCT00561925|541289145|FG001|144-week Double-blind, Double-dummy|Other|8|||
150041000|NCT00561925|541289146|FG002|144-week Double-blind, Double-dummy|Other|11|||
150041001|NCT00561925|541289147|FG003|144-week Double-blind, Double-dummy|Other|0|||
150041002|NCT00561925|541289148|FG004|144-week Double-blind, Double-dummy|Other|0|||
149963053|NCT03627468|540999743|FG000|Overall Study|Death|1|||
149963054|NCT03627468|540999744|FG001|Overall Study|Death|0|||
149963055|NCT03627468|540999743|FG000|Overall Study|Pregnancy|1|||
149963056|NCT03627468|540999744|FG001|Overall Study|Pregnancy|1|||
149963057|NCT03627468|540999743|FG000|Overall Study|Lack of Efficacy|0|||
149963058|NCT03627468|540999744|FG001|Overall Study|Lack of Efficacy|2|||
149963059|NCT03627468|540999743|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
150041003|NCT00561925|541289144|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
150041004|NCT00561925|541289145|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
150041005|NCT00561925|541289146|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
150041006|NCT00561925|541289147|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
150041007|NCT00561925|541289148|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
150041008|NCT00684021|541289151|FG000|Overall Study|MRI Contraindicated|1|||
150041009|NCT00684021|541289152|FG001|Overall Study|MRI Contraindicated|1|||
150041010|NCT00684021|541289153|FG002|Overall Study|MRI Contraindicated|1|||
150173959|NCT03482011|541773014|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150173960|NCT03482011|541773007|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
150173961|NCT03482011|541773008|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
150173962|NCT03482011|541773009|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
150173963|NCT03482011|541773010|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
150173964|NCT03482011|541773011|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
150173965|NCT03482011|541773012|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
150173966|NCT03482011|541773013|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
150173967|NCT03482011|541773014|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
150173968|NCT03482011|541773007|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
150173969|NCT03482011|541773008|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
150173970|NCT03482011|541773009|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
150173971|NCT03482011|541773010|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
150173972|NCT03482011|541773011|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
150173973|NCT03482011|541773012|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
150173974|NCT03482011|541773013|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
150173975|NCT03482011|541773014|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
150173976|NCT03482011|541773007|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173977|NCT03482011|541773008|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173978|NCT03482011|541773009|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173979|NCT03482011|541773010|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173980|NCT03482011|541773011|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
150173981|NCT03482011|541773012|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173982|NCT03482011|541773013|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150173983|NCT03482011|541773014|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
150173984|NCT03482011|541773007|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
150173985|NCT03482011|541773008|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
150173986|NCT03482011|541773009|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
150173987|NCT03482011|541773010|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
150173988|NCT03482011|541773011|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
150173989|NCT03482011|541773012|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
150173990|NCT03482011|541773013|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
150173991|NCT03482011|541773014|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
150173992|NCT03482011|541773007|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149871737|NCT04156620|540660235|FG000|Overall Study|Death - TP 2|1|||
149871738|NCT04156620|540660236|FG001|Overall Study|Death - TP 2|0|||
149871739|NCT04156620|540660235|FG000|Overall Study|Lost to follow-up - TP 2|5|||
149871740|NCT04156620|540660236|FG001|Overall Study|Lost to follow-up - TP 2|2|||
150041011|NCT00684021|541289154|FG003|Overall Study|MRI Contraindicated|0|||
150041012|NCT00684021|541289151|FG000|Overall Study|MRI not performed|0|||
150041013|NCT00684021|541289152|FG001|Overall Study|MRI not performed|1|||
150041014|NCT00684021|541289153|FG002|Overall Study|MRI not performed|1|||
150041015|NCT00684021|541289154|FG003|Overall Study|MRI not performed|2|||
150041016|NCT00684021|541289151|FG000|Overall Study|Death|1|||
150041017|NCT00684021|541289152|FG001|Overall Study|Death|0|||
150041018|NCT00684021|541289153|FG002|Overall Study|Death|0|||
150041019|NCT00684021|541289154|FG003|Overall Study|Death|0|||
150041020|NCT00891904|541289155|FG000|Overall Study|Death|1|||
150041021|NCT00891904|541289155|FG000|Overall Study|Adverse Event|1|||
150041022|NCT01046396|541289156|FG000|Overall Study|Withdrawal by Subject|5|||
150041023|NCT02177032|541289157|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
150041024|NCT02177032|541289158|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
150173993|NCT03482011|541773008|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149871741|NCT04156620|540660235|FG000|Overall Study|Physician decision - TP 2|4|||
149871742|NCT04156620|540660236|FG001|Overall Study|Physician decision - TP 2|2|||
150173994|NCT03482011|541773009|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
150173995|NCT03482011|541773010|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
150173996|NCT03482011|541773011|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
150173997|NCT03482011|541773012|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
149871743|NCT04156620|540660235|FG000|Overall Study|Pregnancy - TP 2|1|||
149871744|NCT04156620|540660236|FG001|Overall Study|Pregnancy - TP 2|1|||
150041025|NCT02177032|541289159|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
150041026|NCT02177032|541289160|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
150041027|NCT02177032|541289157|FG000|Overall Study|Lost to Follow-up|0|||
150041028|NCT02177032|541289158|FG001|Overall Study|Lost to Follow-up|2|||
150041029|NCT02177032|541289159|FG002|Overall Study|Lost to Follow-up|0|||
150041030|NCT02177032|541289160|FG003|Overall Study|Lost to Follow-up|0|||
150041031|NCT02177032|541289157|FG000|Overall Study|OTHER|2|||
150041032|NCT02177032|541289158|FG001|Overall Study|OTHER|0|||
149871745|NCT04156620|540660235|FG000|Overall Study|Subject decision - TP 2|11|||
149871746|NCT04156620|540660236|FG001|Overall Study|Subject decision - TP 2|9|||
149871747|NCT04156620|540660235|FG000|Overall Study|New therapy for study indication - TP 2|1|||
149871748|NCT04156620|540660236|FG001|Overall Study|New therapy for study indication - TP 2|0|||
149871749|NCT02450526|540660237|FG000|DB Period (Cycle 1)|Adverse Event|0|||
150041033|NCT02177032|541289159|FG002|Overall Study|OTHER|1|||
150041034|NCT02177032|541289160|FG003|Overall Study|OTHER|0|||
150041035|NCT02177032|541289157|FG000|Overall Study|Withdrawal by Subject|1|||
150041036|NCT02177032|541289158|FG001|Overall Study|Withdrawal by Subject|0|||
150041037|NCT02177032|541289159|FG002|Overall Study|Withdrawal by Subject|1|||
150041038|NCT02177032|541289160|FG003|Overall Study|Withdrawal by Subject|0|||
150041039|NCT02161016|541289161|FG000|Overall Study|withdrawn by IRB|1|||
150041040|NCT02556177|541289162|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
150041041|NCT02556177|541289163|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
150041042|NCT03818321|541289165|FG000|Overall Study|Withdrawal by Subject|1|||
150041043|NCT03818321|541289166|FG001|Overall Study|Withdrawal by Subject|2|||
150041044|NCT01188343|541289178|FG000|Overall Study|Not vaccinated|0|||
150041045|NCT01188343|541289179|FG001|Overall Study|Not vaccinated|2|||
150041046|NCT01188343|541289180|FG002|Overall Study|Not vaccinated|1|||
150041047|NCT01188343|541289178|FG000|Overall Study|Withdrawal by Subject|1|||
150041048|NCT01188343|541289179|FG001|Overall Study|Withdrawal by Subject|24|||
150041049|NCT01188343|541289180|FG002|Overall Study|Withdrawal by Subject|0|||
150041050|NCT01143246|541289181|FG000|Overall Study|Adverse Event|24|||
150041051|NCT01143246|541289182|FG001|Overall Study|Adverse Event|28|||
150041052|NCT01143246|541289181|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
150041053|NCT01143246|541289182|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
150041054|NCT01143246|541289181|FG000|Overall Study|Lost to Follow-up|0|||
150041055|NCT01143246|541289182|FG001|Overall Study|Lost to Follow-up|1|||
150041056|NCT01143246|541289181|FG000|Overall Study|Death|16|||
150041057|NCT01143246|541289182|FG001|Overall Study|Death|15|||
150041058|NCT01143246|541289181|FG000|Overall Study|Reason not Specified|3|||
150041059|NCT01143246|541289182|FG001|Overall Study|Reason not Specified|5|||
150041060|NCT04634253|541289183|FG000|Overall Study|Adverse Event|1|||
150041061|NCT04634253|541289184|FG001|Overall Study|Adverse Event|1|||
150041062|NCT04634253|541289185|FG002|Overall Study|Adverse Event|0|||
150041063|NCT04634253|541289183|FG000|Overall Study|Physician Decision|0|||
150041064|NCT04634253|541289184|FG001|Overall Study|Physician Decision|1|||
150041065|NCT04634253|541289185|FG002|Overall Study|Physician Decision|0|||
150041066|NCT04634253|541289183|FG000|Overall Study|Withdrawal by Subject|1|||
150041067|NCT04634253|541289184|FG001|Overall Study|Withdrawal by Subject|0|||
150041068|NCT04634253|541289185|FG002|Overall Study|Withdrawal by Subject|3|||
150041069|NCT01499355|541289186|FG000|Run-In Period|Study Termination|15|||
150041070|NCT01499355|541289187|FG001|Run-In Period|Study Termination|0|||
150041071|NCT01499355|541289188|FG002|Run-In Period|Study Termination|0|||
150041072|NCT01499355|541289189|FG003|Run-In Period|Study Termination|0|||
150041073|NCT01499355|541289186|FG000|Run-In Period|Other|3|||
150173998|NCT03482011|541773013|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
150041074|NCT01499355|541289187|FG001|Run-In Period|Other|0|||
150041075|NCT01499355|541289188|FG002|Run-In Period|Other|0|||
149871750|NCT02450526|540660238|FG001|DB Period (Cycle 1)|Adverse Event|0|||
149871751|NCT02450526|540660239|FG002|DB Period (Cycle 1)|Adverse Event|2|||
149871752|NCT02450526|540660240|FG003|DB Period (Cycle 1)|Adverse Event|0|||
149871753|NCT02450526|540660241|FG004|DB Period (Cycle 1)|Adverse Event|0|||
149871754|NCT02450526|540660237|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
149871755|NCT02450526|540660238|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
149871756|NCT02450526|540660239|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
149871757|NCT02450526|540660240|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
149871758|NCT02450526|540660241|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
149871759|NCT02450526|540660237|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
149871760|NCT02450526|540660238|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
149871761|NCT02450526|540660239|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
149871762|NCT02450526|540660240|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
149871763|NCT02450526|540660241|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
149871764|NCT02450526|540660237|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
149871765|NCT02450526|540660238|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
149871766|NCT02450526|540660239|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
149871767|NCT02450526|540660240|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
149871768|NCT02450526|540660241|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
149871769|NCT02450526|540660237|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
149871770|NCT02450526|540660238|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
149871771|NCT02450526|540660239|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
149871772|NCT02450526|540660240|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
149871773|NCT02450526|540660241|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
149871774|NCT02450526|540660237|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
149871775|NCT02450526|540660238|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
149871776|NCT02450526|540660239|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
149871777|NCT02450526|540660240|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
149871778|NCT02450526|540660241|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
149871779|NCT02450526|540660237|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
149871780|NCT02450526|540660238|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
149871781|NCT02450526|540660239|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
149871782|NCT02450526|540660240|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
149871783|NCT02450526|540660241|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
149871784|NCT02450526|540660237|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
149871785|NCT02450526|540660238|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
149871786|NCT02450526|540660239|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
149871787|NCT02450526|540660240|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
149871788|NCT02450526|540660241|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
149871789|NCT01672970|540660242|FG000|Overall Study|Lack of Efficacy|12|||
149871790|NCT01672970|540660242|FG000|Overall Study|Adverse Event|18|||
149871791|NCT01672970|540660242|FG000|Overall Study|Withdrawal by Subject|2|||
149871792|NCT01672970|540660242|FG000|Overall Study|Lost to Follow-up|5|||
149871793|NCT01672970|540660242|FG000|Overall Study|Other|9|||
149871794|NCT01672970|540660242|FG000|Overall Study|Enrolled but not treated|1|||
149871795|NCT04568031|540660243|FG000|Overall Study|Lost to Follow-up|1|||
149871796|NCT04568031|540660244|FG001|Overall Study|Lost to Follow-up|0|||
149871797|NCT04568031|540660245|FG002|Overall Study|Lost to Follow-up|0|||
149871798|NCT04568031|540660246|FG003|Overall Study|Lost to Follow-up|0|||
149871799|NCT04568031|540660243|FG000|Overall Study|Physician Decision|1|||
149871800|NCT04568031|540660244|FG001|Overall Study|Physician Decision|0|||
149871801|NCT04568031|540660245|FG002|Overall Study|Physician Decision|1|||
149871802|NCT04568031|540660246|FG003|Overall Study|Physician Decision|0|||
149871803|NCT04568031|540660243|FG000|Overall Study|Withdrawal by Subject|1|||
149871804|NCT04568031|540660244|FG001|Overall Study|Withdrawal by Subject|0|||
149871805|NCT04568031|540660245|FG002|Overall Study|Withdrawal by Subject|4|||
149871806|NCT04568031|540660246|FG003|Overall Study|Withdrawal by Subject|1|||
149871807|NCT04874636|540660247|FG000|Overall Study|Adverse Event|17|||
149871808|NCT04874636|540660248|FG001|Overall Study|Adverse Event|7|||
149871809|NCT04874636|540660247|FG000|Overall Study|Lost to Follow-up|1|||
149871810|NCT04874636|540660248|FG001|Overall Study|Lost to Follow-up|0|||
149871811|NCT04874636|540660247|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149871812|NCT04874636|540660248|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149871813|NCT04874636|540660247|FG000|Overall Study|Physician Decision|1|||
149871814|NCT04874636|540660248|FG001|Overall Study|Physician Decision|0|||
149871815|NCT04874636|540660247|FG000|Overall Study|Withdrawal by Subject|6|||
149871816|NCT04874636|540660248|FG001|Overall Study|Withdrawal by Subject|5|||
149871817|NCT01770392|540660249|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
149871818|NCT00228423|540660250|FG000|Overall Study|Adverse Event|2|||
149871819|NCT00228423|540660251|FG001|Overall Study|Adverse Event|5|||
149871820|NCT00228423|540660250|FG000|Overall Study|Withdrawal by Subject|7|||
149871821|NCT00228423|540660251|FG001|Overall Study|Withdrawal by Subject|3|||
149871822|NCT00228423|540660250|FG000|Overall Study|Protocol Violation|1|||
149871823|NCT00228423|540660251|FG001|Overall Study|Protocol Violation|3|||
149871824|NCT00228423|540660250|FG000|Overall Study|Physician Decision|0|||
149871825|NCT00228423|540660251|FG001|Overall Study|Physician Decision|1|||
149871826|NCT03401450|540660252|FG000|Overall Study|Lost to Follow-up|4|||
149871827|NCT03401450|540660253|FG001|Overall Study|Lost to Follow-up|6|||
149871828|NCT03401450|540660252|FG000|Overall Study|Anesthesia plan changed|2|||
149871829|NCT03401450|540660253|FG001|Overall Study|Anesthesia plan changed|2|||
149871830|NCT03401450|540660252|FG000|Overall Study|Did not complete medication diary|4|||
149871831|NCT03401450|540660253|FG001|Overall Study|Did not complete medication diary|2|||
149871832|NCT03401450|540660252|FG000|Overall Study|post surgery medication change|2|||
149871833|NCT03401450|540660253|FG001|Overall Study|post surgery medication change|1|||
149871834|NCT03401450|540660252|FG000|Overall Study|Cancelled surgery|0|||
149871835|NCT03401450|540660253|FG001|Overall Study|Cancelled surgery|2|||
149871836|NCT03258853|540660259|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
149871837|NCT03258853|540660260|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
149871838|NCT03567382|540660261|FG000|Overall Study|Lost to Follow-up|1|||
149871839|NCT03567382|540660262|FG001|Overall Study|Lost to Follow-up|21|||
149871840|NCT03567382|540660263|FG002|Overall Study|Lost to Follow-up|1|||
149871841|NCT03567382|540660264|FG003|Overall Study|Lost to Follow-up|21|||
149871842|NCT03567382|540660261|FG000|Overall Study|Withdrawal by Subject|2|||
149871843|NCT03567382|540660262|FG001|Overall Study|Withdrawal by Subject|14|||
149871844|NCT03567382|540660263|FG002|Overall Study|Withdrawal by Subject|1|||
149871845|NCT03567382|540660264|FG003|Overall Study|Withdrawal by Subject|12|||
149871846|NCT02011386|540660269|FG000|Overall Study|Non-compliance|2|||
149871847|NCT02011386|540660269|FG000|Overall Study|Lack of Efficacy|3|||
149871848|NCT04555720|540660270|FG000|Overall Study|Lost to Follow-up|2|||
149871849|NCT04555720|540660271|FG001|Overall Study|Lost to Follow-up|0|||
149871850|NCT04555720|540660272|FG002|Overall Study|Lost to Follow-up|0|||
149871851|NCT04555720|540660273|FG003|Overall Study|Lost to Follow-up|0|||
149871852|NCT04555720|540660270|FG000|Overall Study|Withdrawal by Subject|4|||
149871853|NCT04555720|540660271|FG001|Overall Study|Withdrawal by Subject|6|||
149871854|NCT04555720|540660272|FG002|Overall Study|Withdrawal by Subject|0|||
149871855|NCT04555720|540660273|FG003|Overall Study|Withdrawal by Subject|0|||
149871856|NCT03753763|540660274|FG000|Overall Study|Adverse Event|2|||
149871857|NCT03753763|540660275|FG001|Overall Study|Adverse Event|0|||
149871858|NCT03753763|540660274|FG000|Overall Study|Withdrawal by Subject|3|||
149871859|NCT03753763|540660275|FG001|Overall Study|Withdrawal by Subject|1|||
149871860|NCT03753763|540660274|FG000|Overall Study|clinical deterioration|1|||
149871861|NCT03753763|540660275|FG001|Overall Study|clinical deterioration|0|||
149871862|NCT00719849|540660276|FG000|Overall Study|Death|0|||
149871863|NCT00719849|540660277|FG001|Overall Study|Death|1|||
149871864|NCT02201290|540660279|FG000|Overall Study|Withdrawal by Subject|2|||
149871865|NCT02201290|540660279|FG000|Overall Study|Lack of Efficacy|2|||
149871866|NCT02201290|540660279|FG000|Overall Study|Adverse Event|1|||
149871867|NCT03907462|540660280|FG000|Overall Study|Physician Decision|1|||
149871868|NCT03907462|540660281|FG001|Overall Study|Physician Decision|3|||
149871869|NCT03907462|540660282|FG002|Overall Study|Physician Decision|1|||
149871870|NCT03907462|540660280|FG000|Overall Study|Withdrawal by Subject|6|||
149871871|NCT03907462|540660281|FG001|Overall Study|Withdrawal by Subject|3|||
149871872|NCT03907462|540660282|FG002|Overall Study|Withdrawal by Subject|3|||
149871873|NCT03907462|540660280|FG000|Overall Study|Pregnancy|4|||
149871874|NCT03907462|540660281|FG001|Overall Study|Pregnancy|2|||
149871875|NCT03907462|540660282|FG002|Overall Study|Pregnancy|6|||
149871876|NCT03907462|540660280|FG000|Overall Study|Lost to Follow-up|16|||
149871877|NCT03907462|540660281|FG001|Overall Study|Lost to Follow-up|18|||
149871878|NCT03907462|540660282|FG002|Overall Study|Lost to Follow-up|22|||
149871879|NCT03589768|540662662|FG000|Overall Study|Death|1|||
149871880|NCT03589768|540662663|FG001|Overall Study|Death|0|||
149871881|NCT03589768|540662664|FG002|Overall Study|Death|8|||
150041076|NCT01499355|541289189|FG003|Run-In Period|Other|0|||
150041077|NCT01499355|541289186|FG000|Run-In Period|Death|2|||
150041078|NCT01499355|541289187|FG001|Run-In Period|Death|0|||
150041079|NCT01499355|541289188|FG002|Run-In Period|Death|0|||
150041080|NCT01499355|541289189|FG003|Run-In Period|Death|0|||
150041081|NCT01499355|541289186|FG000|Run-In Period|Investigator Decision|2|||
150041082|NCT01499355|541289187|FG001|Run-In Period|Investigator Decision|0|||
150041083|NCT01499355|541289188|FG002|Run-In Period|Investigator Decision|0|||
150041084|NCT01499355|541289189|FG003|Run-In Period|Investigator Decision|0|||
150041085|NCT01499355|541289186|FG000|Run-In Period|Consent Withdrawn|1|||
150041086|NCT01499355|541289187|FG001|Run-In Period|Consent Withdrawn|0|||
150041087|NCT01499355|541289188|FG002|Run-In Period|Consent Withdrawn|0|||
150041088|NCT01499355|541289189|FG003|Run-In Period|Consent Withdrawn|0|||
150041089|NCT01499355|541289186|FG000|Run-In Period|Adverse Event|8|||
150041090|NCT01499355|541289187|FG001|Run-In Period|Adverse Event|0|||
150041091|NCT01499355|541289188|FG002|Run-In Period|Adverse Event|0|||
150041092|NCT01499355|541289189|FG003|Run-In Period|Adverse Event|0|||
150041093|NCT01499355|541289186|FG000|Double-Blind Period|Adverse Event|0|||
150041094|NCT01499355|541289187|FG001|Double-Blind Period|Adverse Event|2|||
150041095|NCT01499355|541289188|FG002|Double-Blind Period|Adverse Event|3|||
150041096|NCT01499355|541289189|FG003|Double-Blind Period|Adverse Event|2|||
150041097|NCT01499355|541289186|FG000|Double-Blind Period|Study Termination|0|||
150041098|NCT01499355|541289187|FG001|Double-Blind Period|Study Termination|18|||
150041099|NCT01499355|541289188|FG002|Double-Blind Period|Study Termination|16|||
150041100|NCT01499355|541289189|FG003|Double-Blind Period|Study Termination|14|||
150041101|NCT01499355|541289186|FG000|Double-Blind Period|Other|0|||
150041102|NCT01499355|541289187|FG001|Double-Blind Period|Other|1|||
150041103|NCT01499355|541289188|FG002|Double-Blind Period|Other|2|||
150041104|NCT01499355|541289189|FG003|Double-Blind Period|Other|2|||
150041105|NCT01499355|541289186|FG000|Double-Blind Period|Death|0|||
150041106|NCT01499355|541289187|FG001|Double-Blind Period|Death|1|||
150041107|NCT01499355|541289188|FG002|Double-Blind Period|Death|0|||
150041108|NCT01499355|541289189|FG003|Double-Blind Period|Death|0|||
150041109|NCT01499355|541289186|FG000|Double-Blind Period|Investigator Decision|0|||
150041110|NCT01499355|541289187|FG001|Double-Blind Period|Investigator Decision|0|||
150041111|NCT01499355|541289188|FG002|Double-Blind Period|Investigator Decision|3|||
150041112|NCT01499355|541289189|FG003|Double-Blind Period|Investigator Decision|3|||
150041113|NCT01499355|541289186|FG000|Double-Blind Period|Consent Withdrawn|0|||
150041114|NCT01499355|541289187|FG001|Double-Blind Period|Consent Withdrawn|0|||
150041115|NCT01499355|541289188|FG002|Double-Blind Period|Consent Withdrawn|1|||
150041116|NCT01499355|541289189|FG003|Double-Blind Period|Consent Withdrawn|2|||
150041117|NCT01499355|541289186|FG000|Double-Blind Period|Lost to Follow-up|0|||
150041118|NCT01499355|541289187|FG001|Double-Blind Period|Lost to Follow-up|1|||
150041119|NCT01499355|541289188|FG002|Double-Blind Period|Lost to Follow-up|0|||
150041120|NCT01499355|541289189|FG003|Double-Blind Period|Lost to Follow-up|0|||
150041121|NCT01457703|541289193|FG000|Overall Study|Screen Failure|5|||
150041122|NCT01457703|541289194|FG001|Overall Study|Screen Failure|7|||
150041123|NCT01457703|541289193|FG000|Overall Study|Withdrawal by Subject|1|||
150041124|NCT01457703|541289194|FG001|Overall Study|Withdrawal by Subject|4|||
150041125|NCT03987503|541289195|FG000|Overall Study|Lost to Follow-up|20|||
150041126|NCT03987503|541289195|FG000|Overall Study|Withdrawal by Subject|2|||
150041127|NCT03133793|541289201|FG000|Overall Study|Withdrawal by Subject|0|||
150041128|NCT03133793|541289202|FG001|Overall Study|Withdrawal by Subject|4|||
150041129|NCT03133793|541289203|FG002|Overall Study|Withdrawal by Subject|2|||
150041130|NCT03133793|541289204|FG003|Overall Study|Withdrawal by Subject|4|||
150041131|NCT03133793|541289201|FG000|Overall Study|Lost to Follow-up|1|||
150041132|NCT03133793|541289202|FG001|Overall Study|Lost to Follow-up|0|||
150041133|NCT03133793|541289203|FG002|Overall Study|Lost to Follow-up|2|||
150041134|NCT03133793|541289204|FG003|Overall Study|Lost to Follow-up|0|||
150041135|NCT03133793|541289201|FG000|Overall Study|Death|0|||
150041136|NCT03133793|541289202|FG001|Overall Study|Death|0|||
150041137|NCT03133793|541289203|FG002|Overall Study|Death|0|||
150041138|NCT03133793|541289204|FG003|Overall Study|Death|1|||
150041139|NCT03486834|541289205|FG000|Overall Study|Withdrawal by Subject|46|||
150041140|NCT03486834|541289206|FG001|Overall Study|Withdrawal by Subject|46|||
150041141|NCT03486834|541289207|FG002|Overall Study|Withdrawal by Subject|52|||
150041142|NCT03486834|541289205|FG000|Overall Study|Adverse Event|8|||
150041143|NCT03486834|541289206|FG001|Overall Study|Adverse Event|7|||
150041144|NCT03486834|541289207|FG002|Overall Study|Adverse Event|0|||
150041145|NCT03486834|541289205|FG000|Overall Study|Lost to Follow-up|41|||
150041146|NCT03486834|541289206|FG001|Overall Study|Lost to Follow-up|24|||
150041147|NCT03486834|541289207|FG002|Overall Study|Lost to Follow-up|39|||
149871882|NCT03589768|540662665|FG003|Overall Study|Death|3|||
149871883|NCT03589768|540662662|FG000|Overall Study|Withdrawal by Subject|2|||
149871884|NCT03589768|540662663|FG001|Overall Study|Withdrawal by Subject|0|||
149871885|NCT03589768|540662664|FG002|Overall Study|Withdrawal by Subject|0|||
149871886|NCT03589768|540662665|FG003|Overall Study|Withdrawal by Subject|0|||
149871887|NCT03589768|540662662|FG000|Overall Study|Protocol Violation|1|||
149871888|NCT03589768|540662663|FG001|Overall Study|Protocol Violation|0|||
149871889|NCT03589768|540662664|FG002|Overall Study|Protocol Violation|0|||
149871890|NCT03589768|540662665|FG003|Overall Study|Protocol Violation|0|||
149871891|NCT04663295|540662666|FG000|Run-in Period|Withdrawal by Subject|3|||
149871892|NCT04663295|540662666|FG000|Overall Study Period|Pregnancy|1|||
149871893|NCT04663295|540662666|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
149871894|NCT00554190|540662667|FG000|Overall Study|Termination forms not completed|10|||
149871895|NCT01502410|540662669|FG000|Overall Study|Adverse Event|1|||
149871896|NCT01502410|540662670|FG001|Overall Study|Adverse Event|2|||
149871897|NCT01502410|540662671|FG002|Overall Study|Adverse Event|0|||
149871898|NCT01502410|540662672|FG003|Overall Study|Adverse Event|0|||
149871899|NCT01502410|540662669|FG000|Overall Study|Lack of Efficacy|7|||
149871900|NCT01502410|540662670|FG001|Overall Study|Lack of Efficacy|7|||
150041148|NCT03486834|541289205|FG000|Overall Study|Non-compliance with Study Drug|2|||
150041149|NCT03486834|541289206|FG001|Overall Study|Non-compliance with Study Drug|2|||
150041150|NCT03486834|541289207|FG002|Overall Study|Non-compliance with Study Drug|0|||
150041151|NCT03486834|541289205|FG000|Overall Study|Physician Decision|5|||
150041152|NCT03486834|541289206|FG001|Overall Study|Physician Decision|2|||
150041153|NCT03486834|541289207|FG002|Overall Study|Physician Decision|3|||
150041154|NCT03486834|541289205|FG000|Overall Study|Pregnancy|10|||
150041155|NCT03486834|541289206|FG001|Overall Study|Pregnancy|12|||
150041156|NCT03486834|541289207|FG002|Overall Study|Pregnancy|12|||
150041157|NCT03486834|541289205|FG000|Overall Study|Protocol Deviation|2|||
150041158|NCT03486834|541289206|FG001|Overall Study|Protocol Deviation|3|||
150041159|NCT03486834|541289207|FG002|Overall Study|Protocol Deviation|3|||
150041160|NCT03486834|541289205|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150041161|NCT03486834|541289206|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
150041162|NCT03486834|541289207|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
150041163|NCT03486834|541289205|FG000|Overall Study|Randomized but not treated|4|||
150041164|NCT03486834|541289206|FG001|Overall Study|Randomized but not treated|4|||
150041165|NCT03486834|541289207|FG002|Overall Study|Randomized but not treated|1|||
150041166|NCT02379091|541289213|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
150041167|NCT02379091|541289214|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
150041168|NCT02379091|541289215|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
150041169|NCT02379091|541289216|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
150041170|NCT02379091|541289213|FG000|Overall Study|Principal Investigator Discretion|0|||
150041171|NCT02379091|541289214|FG001|Overall Study|Principal Investigator Discretion|1|||
150041172|NCT02379091|541289215|FG002|Overall Study|Principal Investigator Discretion|0|||
150041173|NCT02379091|541289216|FG003|Overall Study|Principal Investigator Discretion|0|||
150041174|NCT02379091|541289213|FG000|Overall Study|Lost to Follow-up|0|||
150041175|NCT02379091|541289214|FG001|Overall Study|Lost to Follow-up|0|||
150041176|NCT02379091|541289215|FG002|Overall Study|Lost to Follow-up|0|||
150041177|NCT02379091|541289216|FG003|Overall Study|Lost to Follow-up|1|||
150041178|NCT02379091|541289213|FG000|Overall Study|Voluntary Withdrawal|2|||
150041179|NCT02379091|541289214|FG001|Overall Study|Voluntary Withdrawal|5|||
150041180|NCT02379091|541289215|FG002|Overall Study|Voluntary Withdrawal|2|||
150041181|NCT02379091|541289216|FG003|Overall Study|Voluntary Withdrawal|4|||
150041182|NCT02379091|541289213|FG000|Overall Study|Study Termination|7|||
150041183|NCT02379091|541289214|FG001|Overall Study|Study Termination|2|||
150041184|NCT02379091|541289215|FG002|Overall Study|Study Termination|5|||
150041185|NCT02379091|541289216|FG003|Overall Study|Study Termination|8|||
150041186|NCT02379091|541289213|FG000|Overall Study|Lack of Efficacy|3|||
150041187|NCT02379091|541289214|FG001|Overall Study|Lack of Efficacy|0|||
150041188|NCT02379091|541289215|FG002|Overall Study|Lack of Efficacy|0|||
150041189|NCT02379091|541289216|FG003|Overall Study|Lack of Efficacy|0|||
150041190|NCT03326713|541289218|FG000|Overall Study|Death|2|||
150041191|NCT03326713|541289219|FG001|Overall Study|Death|1|||
150041192|NCT03326713|541289220|FG002|Overall Study|Death|0|||
150041193|NCT03326713|541289218|FG000|Overall Study|Lost to Follow-up|20|||
150041194|NCT03326713|541289219|FG001|Overall Study|Lost to Follow-up|21|||
150041195|NCT03326713|541289220|FG002|Overall Study|Lost to Follow-up|33|||
150041196|NCT03326713|541289218|FG000|Overall Study|Withdrawal by Subject|1|||
150041197|NCT03326713|541289219|FG001|Overall Study|Withdrawal by Subject|2|||
150041198|NCT03326713|541289220|FG002|Overall Study|Withdrawal by Subject|11|||
150041199|NCT03326713|541289218|FG000|Overall Study|Found Ineligible|11|||
150041200|NCT03326713|541289219|FG001|Overall Study|Found Ineligible|11|||
150041201|NCT03326713|541289220|FG002|Overall Study|Found Ineligible|8|||
150041202|NCT00771758|541289221|FG000|Overall Study|Adverse Event|2|||
150041203|NCT00771758|541289222|FG001|Overall Study|Adverse Event|8|||
150041204|NCT00771758|541289223|FG002|Overall Study|Adverse Event|1|||
150041205|NCT00771758|541289221|FG000|Overall Study|Lack of Efficacy|0|||
150041206|NCT00771758|541289222|FG001|Overall Study|Lack of Efficacy|2|||
150041207|NCT00771758|541289223|FG002|Overall Study|Lack of Efficacy|1|||
150041208|NCT00771758|541289221|FG000|Overall Study|Lost to Follow-up|1|||
150041209|NCT00771758|541289222|FG001|Overall Study|Lost to Follow-up|0|||
150041210|NCT00771758|541289223|FG002|Overall Study|Lost to Follow-up|0|||
150041211|NCT00771758|541289221|FG000|Overall Study|Protocol Violation|1|||
150041212|NCT00771758|541289222|FG001|Overall Study|Protocol Violation|0|||
150173999|NCT03482011|541773014|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
150041213|NCT00771758|541289223|FG002|Overall Study|Protocol Violation|0|||
150041214|NCT00771758|541289221|FG000|Overall Study|Withdrawal by Subject|1|||
150041215|NCT00771758|541289222|FG001|Overall Study|Withdrawal by Subject|0|||
150041216|NCT00771758|541289223|FG002|Overall Study|Withdrawal by Subject|0|||
150041217|NCT00771758|541289221|FG000|Overall Study|Other|3|||
150041218|NCT00771758|541289222|FG001|Overall Study|Other|2|||
149871901|NCT01502410|540662671|FG002|Overall Study|Lack of Efficacy|0|||
150041219|NCT00771758|541289223|FG002|Overall Study|Other|0|||
150041220|NCT03067077|541289224|FG000|Overall Study|Did not receive surgery|4|||
150041221|NCT03067077|541289225|FG001|Overall Study|Did not receive surgery|5|||
150041222|NCT03067077|541289224|FG000|Overall Study|Lost to Follow-up|3|||
150041223|NCT03067077|541289225|FG001|Overall Study|Lost to Follow-up|2|||
149871902|NCT01502410|540662672|FG003|Overall Study|Lack of Efficacy|0|||
149871903|NCT01502410|540662669|FG000|Overall Study|Physician Decision|0|||
149871904|NCT01502410|540662670|FG001|Overall Study|Physician Decision|1|||
149871905|NCT01502410|540662671|FG002|Overall Study|Physician Decision|0|||
149871906|NCT01502410|540662672|FG003|Overall Study|Physician Decision|0|||
149871907|NCT01502410|540662669|FG000|Overall Study|Withdrawal by Subject|2|||
149871908|NCT01502410|540662670|FG001|Overall Study|Withdrawal by Subject|0|||
149871909|NCT01502410|540662671|FG002|Overall Study|Withdrawal by Subject|0|||
149871910|NCT01502410|540662672|FG003|Overall Study|Withdrawal by Subject|0|||
149871911|NCT00699283|540662674|FG000|Overall Study|Lack of Efficacy|15|||
149871912|NCT00699283|540662675|FG001|Overall Study|Lack of Efficacy|5|||
149871913|NCT00699283|540662674|FG000|Overall Study|Lost to Follow-up|2|||
149871914|NCT00699283|540662675|FG001|Overall Study|Lost to Follow-up|0|||
149871915|NCT00699283|540662674|FG000|Overall Study|Withdrawal by Subject|1|||
149871916|NCT00699283|540662675|FG001|Overall Study|Withdrawal by Subject|0|||
149871917|NCT00699283|540662674|FG000|Overall Study|Other Reason|5|||
149871918|NCT00699283|540662675|FG001|Overall Study|Other Reason|1|||
149871919|NCT00699283|540662674|FG000|Overall Study|SAE, non-fatal|1|||
149871920|NCT00699283|540662675|FG001|Overall Study|SAE, non-fatal|1|||
149871921|NCT00699283|540662674|FG000|Overall Study|AE, non-serious non-fatal|8|||
149871922|NCT00699283|540662675|FG001|Overall Study|AE, non-serious non-fatal|1|||
149871923|NCT00699283|540662674|FG000|Overall Study|AE of unknown type|1|||
149871924|NCT00699283|540662675|FG001|Overall Study|AE of unknown type|0|||
149871925|NCT00805675|540662676|FG000|Overall Study|Adverse Event|0|||
149963060|NCT03627468|540999744|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
149963061|NCT00692237|540999745|FG000|Overall Study|Withdrawal by Subject|1|||
149963062|NCT00692237|540999746|FG001|Overall Study|Withdrawal by Subject|3|||
149963063|NCT00692237|540999745|FG000|Overall Study|Adverse Event|0|||
149963064|NCT00692237|540999746|FG001|Overall Study|Adverse Event|1|||
149963065|NCT01347086|540999747|FG000|Overall Study|failed screening visit|0|||
149963066|NCT01347086|540999748|FG001|Overall Study|failed screening visit|0|||
149963067|NCT01347086|540999749|FG002|Overall Study|failed screening visit|1|||
149963068|NCT01347086|540999750|FG003|Overall Study|failed screening visit|0|||
149963069|NCT01347086|540999751|FG004|Overall Study|failed screening visit|0|||
149963070|NCT01347086|540999752|FG005|Overall Study|failed screening visit|0|||
149963071|NCT01347086|540999753|FG006|Overall Study|failed screening visit|1|||
149963072|NCT01347086|540999754|FG007|Overall Study|failed screening visit|1|||
149963073|NCT01347086|540999755|FG008|Overall Study|failed screening visit|0|||
149963074|NCT01347086|540999756|FG009|Overall Study|failed screening visit|1|||
149963075|NCT02624687|540999757|FG000|Overall Study|Withdrawal by Subject|1|||
149963076|NCT02624687|540999758|FG001|Overall Study|Withdrawal by Subject|1|||
149963077|NCT02624687|540999757|FG000|Overall Study|medical leave from work|0|||
149963078|NCT02624687|540999758|FG001|Overall Study|medical leave from work|1|||
149963079|NCT03111108|540999759|FG000|Overall Study|Death|0|||
149963080|NCT03111108|540999760|FG001|Overall Study|Death|1|||
149963081|NCT03111108|540999759|FG000|Overall Study|Withdrawal by Subject|1|||
149963082|NCT03111108|540999760|FG001|Overall Study|Withdrawal by Subject|0|||
149963083|NCT01514357|540999761|FG000|Overall Study|Screen failure|2|||
149963084|NCT01514357|540999762|FG001|Overall Study|Screen failure|0|||
149963085|NCT01514357|540999761|FG000|Overall Study|Withdrawal by Subject|2|||
149963086|NCT01514357|540999762|FG001|Overall Study|Withdrawal by Subject|0|||
149963087|NCT00347269|540999763|FG000|Overall Study|Lost to Follow-up|74|||
149963088|NCT00347269|540999764|FG001|Overall Study|Lost to Follow-up|65|||
149963089|NCT00347269|540999763|FG000|Overall Study|Withdrawal by Subject|18|||
149963090|NCT00347269|540999764|FG001|Overall Study|Withdrawal by Subject|38|||
149963091|NCT00347269|540999763|FG000|Overall Study|Death|2|||
149963092|NCT00347269|540999764|FG001|Overall Study|Death|3|||
149963093|NCT01853280|540999765|FG000|Overall Study|Lack of Efficacy|2|||
149963094|NCT01853280|540999766|FG001|Overall Study|Lack of Efficacy|2|||
149963095|NCT01853280|540999765|FG000|Overall Study|Lost to Follow-up|0|||
149963096|NCT01853280|540999766|FG001|Overall Study|Lost to Follow-up|1|||
150041224|NCT00935584|541289226|FG000|Overall Study|Withdrawal by Subject|9|||
149871926|NCT00805675|540662677|FG001|Overall Study|Adverse Event|0|||
149871927|NCT00805675|540662678|FG002|Overall Study|Adverse Event|1|||
149963097|NCT01853280|540999765|FG000|Overall Study|Physician Decision|0|||
150041225|NCT00935584|541289227|FG001|Overall Study|Withdrawal by Subject|0|||
150041226|NCT00935584|541289226|FG000|Overall Study|Death|3|||
150041227|NCT00935584|541289227|FG001|Overall Study|Death|0|||
149871928|NCT02771795|540662679|FG000|Overall Study|Withdrawal by Subject|47|||
149871929|NCT02771795|540662680|FG001|Overall Study|Withdrawal by Subject|37|||
149871930|NCT02771795|540662679|FG000|Overall Study|Termination by premature discontinuation of study|168|||
149963098|NCT01853280|540999766|FG001|Overall Study|Physician Decision|1|||
149963099|NCT01853280|540999765|FG000|Overall Study|Withdrawal by Subject|0|||
149963100|NCT01853280|540999766|FG001|Overall Study|Withdrawal by Subject|1|||
149963101|NCT01853280|540999765|FG000|Overall Study|Ineligible|0|||
149963102|NCT01853280|540999766|FG001|Overall Study|Ineligible|1|||
149963103|NCT00104884|540999767|FG000|Overall Study|Disease progression|4|||
149963104|NCT03032484|540999768|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
149963105|NCT03032484|540999769|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
149963106|NCT03032484|540999768|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
149963107|NCT03032484|540999769|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
149963108|NCT03654326|540999770|FG000|Overall Study|Withdrawal by Subject|5|||
149963109|NCT03654326|540999771|FG001|Overall Study|Withdrawal by Subject|3|||
149963110|NCT03654326|540999770|FG000|Overall Study|Physician Decision|0|||
149963111|NCT03654326|540999771|FG001|Overall Study|Physician Decision|1|||
149963112|NCT03654326|540999770|FG000|Overall Study|Unable to adhere to study schedule|0|||
149963113|NCT03654326|540999771|FG001|Overall Study|Unable to adhere to study schedule|1|||
149963114|NCT03654326|540999770|FG000|Overall Study|Lost to Follow-up|1|||
149963115|NCT03654326|540999771|FG001|Overall Study|Lost to Follow-up|1|||
149963116|NCT01689649|540999772|FG000|Overall Study|Lack of Efficacy|3|||
150041228|NCT00935584|541289226|FG000|Overall Study|Lost to Follow-up|8|||
150041229|NCT00935584|541289227|FG001|Overall Study|Lost to Follow-up|0|||
149871931|NCT02771795|540662680|FG001|Overall Study|Termination by premature discontinuation of study|185|||
149871932|NCT03929757|540662681|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
149871933|NCT03929757|540662682|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
149871934|NCT03929757|540662683|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
149871935|NCT03929757|540662681|FG000|Main Study: Up to Day 365|Other|1|||
149871936|NCT03929757|540662682|FG001|Main Study: Up to Day 365|Other|0|||
149871937|NCT03929757|540662683|FG002|Main Study: Up to Day 365|Other|0|||
149871938|NCT03929757|540662681|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
149871939|NCT03929757|540662682|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
149871940|NCT03929757|540662683|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
149871941|NCT00114166|540662684|FG000|Overall Study|Wrong primary|0|||
149871942|NCT00114166|540662685|FG001|Overall Study|Wrong primary|1|||
149871943|NCT01154816|540662686|FG000|Overall Study|Withdrawal by Subject|1|||
149871944|NCT01154816|540662687|FG001|Overall Study|Withdrawal by Subject|0|||
149871945|NCT01154816|540662688|FG002|Overall Study|Withdrawal by Subject|0|||
149871946|NCT01154816|540662689|FG003|Overall Study|Withdrawal by Subject|1|||
149871947|NCT01154816|540662690|FG004|Overall Study|Withdrawal by Subject|0|||
149871948|NCT01154816|540662691|FG005|Overall Study|Withdrawal by Subject|0|||
149871949|NCT01154816|540662692|FG006|Overall Study|Withdrawal by Subject|0|||
149871950|NCT01154816|540662693|FG007|Overall Study|Withdrawal by Subject|0|||
149871951|NCT01154816|540662694|FG008|Overall Study|Withdrawal by Subject|1|||
149871952|NCT01154816|540662695|FG009|Overall Study|Withdrawal by Subject|3|||
149871953|NCT01154816|540662696|FG010|Overall Study|Withdrawal by Subject|0|||
149871954|NCT01154816|540662697|FG011|Overall Study|Withdrawal by Subject|0|||
149871955|NCT01154816|540662686|FG000|Overall Study|Progressive Disease|13|||
149871956|NCT01154816|540662687|FG001|Overall Study|Progressive Disease|8|||
149871957|NCT01154816|540662688|FG002|Overall Study|Progressive Disease|9|||
149871958|NCT01154816|540662689|FG003|Overall Study|Progressive Disease|9|||
149871959|NCT01154816|540662690|FG004|Overall Study|Progressive Disease|8|||
149871960|NCT01154816|540662691|FG005|Overall Study|Progressive Disease|8|||
149871961|NCT01154816|540662692|FG006|Overall Study|Progressive Disease|5|||
149871962|NCT01154816|540662693|FG007|Overall Study|Progressive Disease|6|||
149871963|NCT01154816|540662694|FG008|Overall Study|Progressive Disease|8|||
150041230|NCT00935584|541289226|FG000|Overall Study|No show|9|||
150041231|NCT00935584|541289227|FG001|Overall Study|No show|0|||
150041232|NCT00935584|541289226|FG000|Overall Study|Relocated|3|||
150041233|NCT00935584|541289227|FG001|Overall Study|Relocated|0|||
150041234|NCT00935584|541289226|FG000|Overall Study|Patient changed provider|3|||
150041235|NCT00935584|541289227|FG001|Overall Study|Patient changed provider|0|||
150041236|NCT00935584|541289226|FG000|Overall Study|Provider dropped out of study|14|||
150041237|NCT00935584|541289227|FG001|Overall Study|Provider dropped out of study|4|||
150041238|NCT01394016|541289234|FG000|Overall Study|Progressive Disease|2|||
150041239|NCT01394016|541289235|FG001|Overall Study|Progressive Disease|0|||
150041240|NCT01394016|541289236|FG002|Overall Study|Progressive Disease|0|||
150041241|NCT01394016|541289237|FG003|Overall Study|Progressive Disease|0|||
150041242|NCT01394016|541289238|FG004|Overall Study|Progressive Disease|0|||
150041243|NCT01394016|541289239|FG005|Overall Study|Progressive Disease|0|||
150041244|NCT01394016|541289240|FG006|Overall Study|Progressive Disease|0|||
150041245|NCT01394016|541289241|FG007|Overall Study|Progressive Disease|0|||
150041246|NCT01394016|541289242|FG008|Overall Study|Progressive Disease|0|||
150041247|NCT01394016|541289243|FG009|Overall Study|Progressive Disease|0|||
150041248|NCT01394016|541289244|FG010|Overall Study|Progressive Disease|0|||
150041249|NCT01394016|541289245|FG011|Overall Study|Progressive Disease|0|||
149871964|NCT01154816|540662695|FG009|Overall Study|Progressive Disease|6|||
150041250|NCT01394016|541289246|FG012|Overall Study|Progressive Disease|0|||
149871965|NCT01154816|540662696|FG010|Overall Study|Progressive Disease|10|||
150041251|NCT01394016|541289247|FG013|Overall Study|Progressive Disease|0|||
149871966|NCT01154816|540662697|FG011|Overall Study|Progressive Disease|3|||
150041252|NCT01394016|541289248|FG014|Overall Study|Progressive Disease|0|||
150041253|NCT01394016|541289249|FG015|Overall Study|Progressive Disease|0|||
149871967|NCT01154816|540662686|FG000|Overall Study|Physician Decision|1|||
149871968|NCT01154816|540662687|FG001|Overall Study|Physician Decision|0|||
149871969|NCT01154816|540662688|FG002|Overall Study|Physician Decision|1|||
149871970|NCT01154816|540662689|FG003|Overall Study|Physician Decision|0|||
149871971|NCT01154816|540662690|FG004|Overall Study|Physician Decision|2|||
149871972|NCT01154816|540662691|FG005|Overall Study|Physician Decision|0|||
149871973|NCT01154816|540662692|FG006|Overall Study|Physician Decision|0|||
149871974|NCT01154816|540662693|FG007|Overall Study|Physician Decision|0|||
149871975|NCT01154816|540662694|FG008|Overall Study|Physician Decision|0|||
149871976|NCT01154816|540662695|FG009|Overall Study|Physician Decision|1|||
149871977|NCT01154816|540662696|FG010|Overall Study|Physician Decision|1|||
149871978|NCT01154816|540662697|FG011|Overall Study|Physician Decision|1|||
149871979|NCT01154816|540662686|FG000|Overall Study|Adverse Event|5|||
149871980|NCT01154816|540662687|FG001|Overall Study|Adverse Event|2|||
149871981|NCT01154816|540662688|FG002|Overall Study|Adverse Event|0|||
149871982|NCT01154816|540662689|FG003|Overall Study|Adverse Event|0|||
149871983|NCT01154816|540662690|FG004|Overall Study|Adverse Event|0|||
149871984|NCT01154816|540662691|FG005|Overall Study|Adverse Event|0|||
149871985|NCT01154816|540662692|FG006|Overall Study|Adverse Event|1|||
149871986|NCT01154816|540662693|FG007|Overall Study|Adverse Event|1|||
149871987|NCT01154816|540662694|FG008|Overall Study|Adverse Event|0|||
149871988|NCT01154816|540662695|FG009|Overall Study|Adverse Event|0|||
149871989|NCT01154816|540662696|FG010|Overall Study|Adverse Event|0|||
149871990|NCT01154816|540662697|FG011|Overall Study|Adverse Event|0|||
149871991|NCT04715932|540662698|FG000|Overall Study|Lost to Follow-up|1|||
149871992|NCT04715932|540662699|FG001|Overall Study|Lost to Follow-up|0|||
149871993|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149871994|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
149871995|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149871996|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149871997|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149871998|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
149871999|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
149872000|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872001|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872002|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872003|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872004|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872005|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149963117|NCT01689649|540999772|FG000|Overall Study|Non-compliance|11|||
149963118|NCT01689649|540999772|FG000|Overall Study|Protocol Violation|3|||
149963119|NCT01689649|540999772|FG000|Overall Study|Lost to Follow-up|5|||
149963120|NCT04893811|540999773|FG000|Vaccination Phase|Death|1|||
149963121|NCT04893811|540999774|FG001|Vaccination Phase|Death|0|||
149963122|NCT04893811|540999773|FG000|Vaccination Phase|Lost to Follow-up|1|||
149963123|NCT04893811|540999774|FG001|Vaccination Phase|Lost to Follow-up|1|||
149963124|NCT04893811|540999773|FG000|Vaccination Phase|Protocol Violation|2|||
149963125|NCT04893811|540999774|FG001|Vaccination Phase|Protocol Violation|0|||
149963126|NCT04893811|540999773|FG000|Vaccination Phase|Withdrawal by Subject|2|||
149963127|NCT04893811|540999774|FG001|Vaccination Phase|Withdrawal by Subject|1|||
149963128|NCT04893811|540999773|FG000|Vaccination Phase|Other|0|||
149963129|NCT04893811|540999774|FG001|Vaccination Phase|Other|1|||
149963130|NCT04893811|540999773|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
149963131|NCT04893811|540999774|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
149963132|NCT04893811|540999773|FG000|Follow-up Phase|Lost to Follow-up|0|||
149963133|NCT04893811|540999774|FG001|Follow-up Phase|Lost to Follow-up|1|||
149963134|NCT03760081|540999788|FG000|Overall Study|Miscellaneous|0|||
149963135|NCT03760081|540999789|FG001|Overall Study|Miscellaneous|1|||
149963136|NCT03760081|540999788|FG000|Overall Study|Progressive Disease|5|||
149963137|NCT03760081|540999789|FG001|Overall Study|Progressive Disease|10|||
149963138|NCT03760081|540999788|FG000|Overall Study|Death|1|||
149963139|NCT03760081|540999789|FG001|Overall Study|Death|1|||
149872006|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872007|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872008|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872009|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872010|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149963140|NCT02662582|540999790|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
149963141|NCT02662582|540999791|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
149963142|NCT02662582|540999790|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
149963143|NCT02662582|540999791|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
149963144|NCT02662582|540999790|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
149963145|NCT02662582|540999791|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
149872011|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872012|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
150174000|NCT03482011|541773007|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
150174001|NCT03482011|541773008|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
150174002|NCT03482011|541773009|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
150174003|NCT03482011|541773010|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
150174004|NCT03482011|541773011|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
150174005|NCT03482011|541773012|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
150174006|NCT03482011|541773013|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
150174007|NCT03482011|541773014|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
150174008|NCT03482011|541773007|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174009|NCT03482011|541773008|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174010|NCT03482011|541773009|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174011|NCT03482011|541773010|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174012|NCT03482011|541773011|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174013|NCT03482011|541773012|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
150174014|NCT03482011|541773013|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
150174015|NCT03482011|541773014|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
150174016|NCT03482011|541773007|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
150174017|NCT03482011|541773008|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
150174018|NCT03482011|541773009|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
150174019|NCT03482011|541773010|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
150174020|NCT03482011|541773011|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
150174021|NCT03482011|541773012|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
150174022|NCT03482011|541773013|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
150174023|NCT03482011|541773014|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
150174024|NCT03482011|541773007|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
149872013|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872014|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872015|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872016|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872017|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
149872018|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872019|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
149872020|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872021|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872022|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872023|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872024|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872025|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872026|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872027|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872028|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872029|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872030|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872031|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872032|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872033|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872034|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872035|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872036|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872037|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872038|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872039|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872040|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872041|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872042|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
149872043|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
149872044|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
149872045|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
149872046|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
150174025|NCT03482011|541773008|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
150174026|NCT03482011|541773009|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
149872047|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
149872048|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
149872049|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
149963146|NCT02662582|540999790|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149963147|NCT02662582|540999791|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149963148|NCT01725282|540999792|FG000|Overall Study|Adverse Event|1|||
149963149|NCT01725282|540999793|FG001|Overall Study|Adverse Event|3|||
149963150|NCT01725282|540999794|FG002|Overall Study|Adverse Event|6|||
149963151|NCT01725282|540999795|FG003|Overall Study|Adverse Event|4|||
149963152|NCT01725282|540999792|FG000|Overall Study|Exacerbation of Target Disease|1|||
149963153|NCT01725282|540999793|FG001|Overall Study|Exacerbation of Target Disease|0|||
149963154|NCT01725282|540999794|FG002|Overall Study|Exacerbation of Target Disease|0|||
149963155|NCT01725282|540999795|FG003|Overall Study|Exacerbation of Target Disease|1|||
149963156|NCT01725282|540999792|FG000|Overall Study|Met Exclusion Criteria|0|||
149963157|NCT01725282|540999793|FG001|Overall Study|Met Exclusion Criteria|0|||
149963158|NCT01725282|540999794|FG002|Overall Study|Met Exclusion Criteria|1|||
149963159|NCT01725282|540999795|FG003|Overall Study|Met Exclusion Criteria|0|||
149963160|NCT01725282|540999792|FG000|Overall Study|Study Site Withdrawal|0|||
149963161|NCT01725282|540999793|FG001|Overall Study|Study Site Withdrawal|1|||
149963162|NCT01725282|540999794|FG002|Overall Study|Study Site Withdrawal|0|||
149963163|NCT01725282|540999795|FG003|Overall Study|Study Site Withdrawal|0|||
149963164|NCT01725282|540999792|FG000|Overall Study|Withdrawal by Subject|0|||
149963165|NCT01725282|540999793|FG001|Overall Study|Withdrawal by Subject|0|||
149963166|NCT01725282|540999794|FG002|Overall Study|Withdrawal by Subject|1|||
149963167|NCT01725282|540999795|FG003|Overall Study|Withdrawal by Subject|1|||
149963168|NCT01725282|540999792|FG000|Overall Study|Lack of Efficacy|0|||
149963169|NCT01725282|540999793|FG001|Overall Study|Lack of Efficacy|1|||
149963170|NCT01725282|540999794|FG002|Overall Study|Lack of Efficacy|0|||
149963171|NCT01725282|540999795|FG003|Overall Study|Lack of Efficacy|1|||
149963172|NCT04064567|540999796|FG000|Overall Study|Lost to Follow-up|23|||
149963173|NCT04064567|540999797|FG001|Overall Study|Lost to Follow-up|22|||
149963174|NCT04064567|540999796|FG000|Overall Study|Withdrawal by Subject|0|||
149963175|NCT04064567|540999797|FG001|Overall Study|Withdrawal by Subject|1|||
149963176|NCT04064567|540999796|FG000|Overall Study|Reincarcerated|7|||
149963177|NCT04064567|540999797|FG001|Overall Study|Reincarcerated|10|||
149963178|NCT04064567|540999796|FG000|Overall Study|Moved out of U.S.|0|||
149963179|NCT04064567|540999797|FG001|Overall Study|Moved out of U.S.|1|||
149963180|NCT02739828|540999802|FG000|Overall Study|Adverse Event|1|||
149963181|NCT02739828|540999802|FG000|Overall Study|Lost to Follow-up|4|||
149963182|NCT01687595|540999803|FG000|Overall Study|Withdrawal by Subject|8|||
149963183|NCT01687595|540999804|FG001|Overall Study|Withdrawal by Subject|0|||
149963184|NCT01687595|540999803|FG000|Overall Study|Lost to Follow-up|3|||
149963185|NCT01687595|540999804|FG001|Overall Study|Lost to Follow-up|1|||
149963186|NCT01687595|540999803|FG000|Overall Study|Investigator's decision|1|||
149963187|NCT01687595|540999804|FG001|Overall Study|Investigator's decision|0|||
149963188|NCT01687595|540999803|FG000|Overall Study|Sponsor's decision|1|||
149963189|NCT01687595|540999804|FG001|Overall Study|Sponsor's decision|0|||
149963190|NCT01687595|540999803|FG000|Overall Study|Noncompliance|1|||
149963191|NCT01687595|540999804|FG001|Overall Study|Noncompliance|2|||
149963192|NCT01687595|540999803|FG000|Overall Study|Other than specified|56|||
149963193|NCT01687595|540999804|FG001|Overall Study|Other than specified|7|||
149963194|NCT05451329|540999807|FG000|Overall Study|Adverse Event|1|||
149963195|NCT05451329|540999808|FG001|Overall Study|Adverse Event|1|||
149963196|NCT05451329|540999809|FG002|Overall Study|Adverse Event|0|||
149963197|NCT05451329|540999807|FG000|Overall Study|Withdrawal by Subject|1|||
149963198|NCT05451329|540999808|FG001|Overall Study|Withdrawal by Subject|0|||
149963199|NCT05451329|540999809|FG002|Overall Study|Withdrawal by Subject|0|||
149963200|NCT05451329|540999807|FG000|Overall Study|Investigational Product Lot exchange|1|||
149963201|NCT05451329|540999808|FG001|Overall Study|Investigational Product Lot exchange|1|||
149963202|NCT05451329|540999809|FG002|Overall Study|Investigational Product Lot exchange|0|||
149963203|NCT02202577|540999812|FG000|Overall Study|Lost to Follow-up|6|||
149963204|NCT02202577|540999813|FG001|Overall Study|Lost to Follow-up|16|||
149963205|NCT02202577|540999812|FG000|Overall Study|Protocol Violation|7|||
149963206|NCT02202577|540999813|FG001|Overall Study|Protocol Violation|3|||
149963207|NCT02369159|540999816|FG000|Overall Study|Adverse Event|0|||
149963208|NCT02369159|540999817|FG001|Overall Study|Adverse Event|1|||
149963209|NCT02369159|540999816|FG000|Overall Study|Lost to Follow-up|1|||
149963210|NCT02369159|540999817|FG001|Overall Study|Lost to Follow-up|1|||
149963211|NCT02369159|540999816|FG000|Overall Study|Withdrawal by Subject|7|||
149963212|NCT02369159|540999817|FG001|Overall Study|Withdrawal by Subject|0|||
149963213|NCT03511209|540999822|FG000|Overall Study|Withdrawal by Subject|2|||
149963214|NCT03511209|540999823|FG001|Overall Study|Withdrawal by Subject|4|||
149963215|NCT03511209|540999822|FG000|Overall Study|Death|1|||
149963216|NCT03511209|540999823|FG001|Overall Study|Death|0|||
149963217|NCT03511209|540999822|FG000|Overall Study|Lost to Follow-up|0|||
149963218|NCT03511209|540999823|FG001|Overall Study|Lost to Follow-up|2|||
149963219|NCT02757963|540999833|FG000|Overall Study|Adverse Event|3|||
149963220|NCT02757963|540999833|FG000|Overall Study|Reached Stopping Criteria|1054|||
149963221|NCT02757963|540999833|FG000|Overall Study|Lost to Follow-up|5|||
149963222|NCT02757963|540999833|FG000|Overall Study|Physician Decision|1|||
150041254|NCT01394016|541289250|FG016|Overall Study|Progressive Disease|0|||
150041255|NCT01394016|541289251|FG017|Overall Study|Progressive Disease|0|||
149872050|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
149872051|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
149872052|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
149872053|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
149872054|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
149872055|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
149872056|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
149872057|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
149872058|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
149872059|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
149872060|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
149872061|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
149872062|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
149872063|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
149872064|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
149872065|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
149872066|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
149872067|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
149872068|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
149872069|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872070|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872071|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872072|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872073|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872074|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872075|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872076|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872077|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872078|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
150041256|NCT01394016|541289252|FG018|Overall Study|Progressive Disease|0|||
149872079|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872080|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872081|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872082|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872083|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872084|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872085|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872086|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872087|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872088|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872089|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872090|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872091|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872092|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
149872093|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872094|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872095|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872096|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872097|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872098|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
149872099|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
149872100|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872101|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872102|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
149872103|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872104|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872105|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872106|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872107|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872108|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872109|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872110|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872111|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872112|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872113|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872114|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872115|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872116|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872117|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
149872118|NCT02393248|540662700|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
150041257|NCT01394016|541289234|FG000|Overall Study|Withdrawal by Subject|0|||
150041258|NCT01394016|541289235|FG001|Overall Study|Withdrawal by Subject|0|||
150041259|NCT01394016|541289236|FG002|Overall Study|Withdrawal by Subject|0|||
150041260|NCT01394016|541289237|FG003|Overall Study|Withdrawal by Subject|0|||
150041261|NCT01394016|541289238|FG004|Overall Study|Withdrawal by Subject|0|||
150041262|NCT01394016|541289239|FG005|Overall Study|Withdrawal by Subject|0|||
150041263|NCT01394016|541289240|FG006|Overall Study|Withdrawal by Subject|0|||
150041264|NCT01394016|541289241|FG007|Overall Study|Withdrawal by Subject|1|||
149872119|NCT02393248|540662701|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872120|NCT02393248|540662702|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872121|NCT02393248|540662703|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872122|NCT02393248|540662704|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872123|NCT02393248|540662705|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872124|NCT02393248|540662706|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
149872125|NCT02393248|540662707|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872126|NCT02393248|540662708|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
150041265|NCT01394016|541289242|FG008|Overall Study|Withdrawal by Subject|1|||
150041266|NCT01394016|541289243|FG009|Overall Study|Withdrawal by Subject|1|||
150041267|NCT01394016|541289244|FG010|Overall Study|Withdrawal by Subject|4|||
150041268|NCT01394016|541289245|FG011|Overall Study|Withdrawal by Subject|0|||
149872127|NCT02393248|540662709|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872128|NCT02393248|540662710|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872129|NCT02393248|540662711|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872130|NCT02393248|540662712|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872131|NCT02393248|540662713|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872132|NCT02393248|540662714|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872133|NCT02393248|540662715|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872134|NCT02393248|540662716|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872135|NCT02393248|540662717|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872136|NCT02393248|540662718|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872137|NCT02393248|540662719|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872138|NCT02393248|540662720|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872139|NCT02393248|540662721|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872140|NCT02393248|540662722|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872141|NCT02393248|540662723|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872142|NCT02393248|540662724|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
149872143|NCT02393248|540662700|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872144|NCT02393248|540662701|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872145|NCT02393248|540662702|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872146|NCT02393248|540662703|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872147|NCT02393248|540662704|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872148|NCT02393248|540662705|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872149|NCT02393248|540662706|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872150|NCT02393248|540662707|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872151|NCT02393248|540662708|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872152|NCT02393248|540662709|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872153|NCT02393248|540662710|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872154|NCT02393248|540662711|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
149872155|NCT02393248|540662712|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
149872156|NCT02393248|540662713|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
149872157|NCT02393248|540662714|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
149872158|NCT02393248|540662715|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872159|NCT02393248|540662716|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872160|NCT02393248|540662717|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872161|NCT02393248|540662718|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872162|NCT02393248|540662719|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872163|NCT02393248|540662720|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872164|NCT02393248|540662721|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872165|NCT02393248|540662722|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872166|NCT02393248|540662723|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872167|NCT02393248|540662724|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
149872168|NCT02393248|540662700|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872169|NCT02393248|540662701|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872170|NCT02393248|540662702|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872171|NCT02393248|540662703|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872172|NCT02393248|540662704|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872173|NCT02393248|540662705|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872174|NCT02393248|540662706|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872175|NCT02393248|540662707|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872176|NCT02393248|540662708|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872177|NCT02393248|540662709|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872178|NCT02393248|540662710|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
149872179|NCT02393248|540662711|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
149872180|NCT02393248|540662712|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872181|NCT02393248|540662713|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872182|NCT02393248|540662714|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872183|NCT02393248|540662715|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
150041269|NCT01394016|541289246|FG012|Overall Study|Withdrawal by Subject|0|||
150041270|NCT01394016|541289247|FG013|Overall Study|Withdrawal by Subject|3|||
150041271|NCT01394016|541289248|FG014|Overall Study|Withdrawal by Subject|1|||
150041272|NCT01394016|541289249|FG015|Overall Study|Withdrawal by Subject|3|||
149872184|NCT02393248|540662716|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872185|NCT02393248|540662717|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872186|NCT02393248|540662718|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872187|NCT02393248|540662719|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872188|NCT02393248|540662720|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872189|NCT02393248|540662721|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872190|NCT02393248|540662722|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872191|NCT02393248|540662723|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872192|NCT02393248|540662724|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
149872193|NCT02393248|540662700|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
149872194|NCT02393248|540662701|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
149872195|NCT02393248|540662702|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
149872196|NCT02393248|540662703|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
149872197|NCT02393248|540662704|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
149872198|NCT02393248|540662705|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
149872199|NCT02393248|540662706|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
149872200|NCT02393248|540662707|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
149872201|NCT02393248|540662708|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
149872202|NCT02393248|540662709|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
149872203|NCT02393248|540662710|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
149872204|NCT02393248|540662711|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
149872205|NCT02393248|540662712|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
149872206|NCT02393248|540662713|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
149872207|NCT02393248|540662714|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
149872208|NCT02393248|540662715|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
149872209|NCT02393248|540662716|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
149872210|NCT02393248|540662717|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
149872211|NCT02393248|540662718|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
149872212|NCT02393248|540662719|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
149872213|NCT02393248|540662720|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
149872214|NCT02393248|540662721|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
149872215|NCT02393248|540662722|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
149872216|NCT02393248|540662723|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
149872217|NCT02393248|540662724|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
149872218|NCT02393248|540662700|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872219|NCT02393248|540662701|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872220|NCT02393248|540662702|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872221|NCT02393248|540662703|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872222|NCT02393248|540662704|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872223|NCT02393248|540662705|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872224|NCT02393248|540662706|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872225|NCT02393248|540662707|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872226|NCT02393248|540662708|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872227|NCT02393248|540662709|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872228|NCT02393248|540662710|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872229|NCT02393248|540662711|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
149872230|NCT02393248|540662712|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872231|NCT02393248|540662713|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
149872232|NCT02393248|540662714|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872233|NCT02393248|540662715|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872234|NCT02393248|540662716|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872235|NCT02393248|540662717|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872236|NCT02393248|540662718|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872237|NCT02393248|540662719|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872238|NCT02393248|540662720|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872239|NCT02393248|540662721|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872240|NCT02393248|540662722|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872241|NCT02393248|540662723|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872242|NCT02393248|540662724|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
149872243|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872244|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872245|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872246|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872247|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872248|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872249|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872250|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872251|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
150041273|NCT01394016|541289250|FG016|Overall Study|Withdrawal by Subject|1|||
150041274|NCT01394016|541289251|FG017|Overall Study|Withdrawal by Subject|1|||
150041275|NCT01394016|541289252|FG018|Overall Study|Withdrawal by Subject|2|||
150041276|NCT01394016|541289234|FG000|Overall Study|Adverse Event|0|||
150041277|NCT01394016|541289235|FG001|Overall Study|Adverse Event|0|||
150041278|NCT01394016|541289236|FG002|Overall Study|Adverse Event|0|||
150041279|NCT01394016|541289237|FG003|Overall Study|Adverse Event|0|||
150041280|NCT01394016|541289238|FG004|Overall Study|Adverse Event|0|||
150041281|NCT01394016|541289239|FG005|Overall Study|Adverse Event|0|||
150041282|NCT01394016|541289240|FG006|Overall Study|Adverse Event|0|||
150041283|NCT01394016|541289241|FG007|Overall Study|Adverse Event|0|||
150041284|NCT01394016|541289242|FG008|Overall Study|Adverse Event|0|||
150041285|NCT01394016|541289243|FG009|Overall Study|Adverse Event|1|||
150041286|NCT01394016|541289244|FG010|Overall Study|Adverse Event|0|||
150041287|NCT01394016|541289245|FG011|Overall Study|Adverse Event|0|||
150041288|NCT01394016|541289246|FG012|Overall Study|Adverse Event|0|||
150041289|NCT01394016|541289247|FG013|Overall Study|Adverse Event|0|||
150041290|NCT01394016|541289248|FG014|Overall Study|Adverse Event|0|||
150041291|NCT01394016|541289249|FG015|Overall Study|Adverse Event|0|||
150041292|NCT01394016|541289250|FG016|Overall Study|Adverse Event|1|||
150041293|NCT01394016|541289251|FG017|Overall Study|Adverse Event|1|||
150041294|NCT01394016|541289252|FG018|Overall Study|Adverse Event|0|||
150041295|NCT01394016|541289234|FG000|Overall Study|Sponsor Decision|0|||
150041296|NCT01394016|541289235|FG001|Overall Study|Sponsor Decision|0|||
150041297|NCT01394016|541289236|FG002|Overall Study|Sponsor Decision|0|||
150041298|NCT01394016|541289237|FG003|Overall Study|Sponsor Decision|0|||
150041299|NCT01394016|541289238|FG004|Overall Study|Sponsor Decision|0|||
150041300|NCT01394016|541289239|FG005|Overall Study|Sponsor Decision|0|||
150041301|NCT01394016|541289240|FG006|Overall Study|Sponsor Decision|0|||
150041302|NCT01394016|541289241|FG007|Overall Study|Sponsor Decision|0|||
149872252|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872253|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872254|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872255|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872256|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872257|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872258|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872259|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872260|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872261|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
149872262|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872263|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
149872264|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
149872265|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872266|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
149872267|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
149872268|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Death|0|||
149872269|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Death|0|||
149872270|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Death|0|||
149872271|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Death|0|||
149872272|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Death|0|||
149872273|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Death|0|||
149872274|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Death|0|||
150041303|NCT01394016|541289242|FG008|Overall Study|Sponsor Decision|0|||
149872275|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Death|0|||
149872276|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Death|0|||
149872277|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Death|0|||
149872278|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Death|0|||
150041304|NCT01394016|541289243|FG009|Overall Study|Sponsor Decision|0|||
150041305|NCT01394016|541289244|FG010|Overall Study|Sponsor Decision|0|||
150041306|NCT01394016|541289245|FG011|Overall Study|Sponsor Decision|0|||
150041307|NCT01394016|541289246|FG012|Overall Study|Sponsor Decision|1|||
150041308|NCT01394016|541289247|FG013|Overall Study|Sponsor Decision|0|||
150041309|NCT01394016|541289248|FG014|Overall Study|Sponsor Decision|0|||
149872279|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Death|0|||
149872280|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Death|0|||
149872281|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Death|0|||
149872282|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Death|0|||
149872283|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Death|1|||
149872284|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Death|7|||
149872285|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Death|5|||
150041310|NCT01394016|541289249|FG015|Overall Study|Sponsor Decision|0|||
150041311|NCT01394016|541289250|FG016|Overall Study|Sponsor Decision|0|||
150041312|NCT01394016|541289251|FG017|Overall Study|Sponsor Decision|0|||
150041313|NCT01394016|541289252|FG018|Overall Study|Sponsor Decision|0|||
150041314|NCT01394016|541289234|FG000|Overall Study|Lost to Follow-up|0|||
150041315|NCT01394016|541289235|FG001|Overall Study|Lost to Follow-up|0|||
150041316|NCT01394016|541289236|FG002|Overall Study|Lost to Follow-up|0|||
150041317|NCT01394016|541289237|FG003|Overall Study|Lost to Follow-up|0|||
150041318|NCT01394016|541289238|FG004|Overall Study|Lost to Follow-up|0|||
150041319|NCT01394016|541289239|FG005|Overall Study|Lost to Follow-up|0|||
150041320|NCT01394016|541289240|FG006|Overall Study|Lost to Follow-up|0|||
150041321|NCT01394016|541289241|FG007|Overall Study|Lost to Follow-up|0|||
150041322|NCT01394016|541289242|FG008|Overall Study|Lost to Follow-up|0|||
150041323|NCT01394016|541289243|FG009|Overall Study|Lost to Follow-up|0|||
150041324|NCT01394016|541289244|FG010|Overall Study|Lost to Follow-up|0|||
150041325|NCT01394016|541289245|FG011|Overall Study|Lost to Follow-up|0|||
150041326|NCT01394016|541289246|FG012|Overall Study|Lost to Follow-up|0|||
150041327|NCT01394016|541289247|FG013|Overall Study|Lost to Follow-up|0|||
150041328|NCT01394016|541289248|FG014|Overall Study|Lost to Follow-up|0|||
150041329|NCT01394016|541289249|FG015|Overall Study|Lost to Follow-up|0|||
150041330|NCT01394016|541289250|FG016|Overall Study|Lost to Follow-up|0|||
150041331|NCT01394016|541289251|FG017|Overall Study|Lost to Follow-up|0|||
150041332|NCT01394016|541289252|FG018|Overall Study|Lost to Follow-up|1|||
150041333|NCT00174187|541289256|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
150041334|NCT00174187|541289257|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
150041335|NCT00174187|541289258|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
150041336|NCT00174187|541289256|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
150041337|NCT00174187|541289257|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
150041338|NCT00174187|541289258|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
150041339|NCT00174187|541289256|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
150041340|NCT00174187|541289257|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
150041341|NCT00174187|541289258|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
150041342|NCT00174187|541289256|FG000|Period 1 (up to 3 Years)|Other|0|||
150041343|NCT00174187|541289257|FG001|Period 1 (up to 3 Years)|Other|1|||
150041344|NCT00174187|541289258|FG002|Period 1 (up to 3 Years)|Other|0|||
150041345|NCT00174187|541289256|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
150041346|NCT00174187|541289257|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
150041347|NCT00174187|541289258|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
150041348|NCT00174187|541289256|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
150041349|NCT00174187|541289257|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
150041350|NCT00174187|541289258|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
150041351|NCT00174187|541289256|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
150041352|NCT00174187|541289257|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
150041353|NCT00174187|541289258|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
150041354|NCT00174187|541289256|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
150041355|NCT00174187|541289257|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
150041356|NCT00174187|541289258|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
150041357|NCT00174187|541289256|FG000|Period 2 (After 3 Years)|Other|0|||
150041358|NCT00174187|541289257|FG001|Period 2 (After 3 Years)|Other|0|||
150041359|NCT00174187|541289258|FG002|Period 2 (After 3 Years)|Other|5|||
150041360|NCT01198977|541289260|FG000|Overall Study|Lost to Follow-up|1|||
150041361|NCT01198977|541289261|FG001|Overall Study|Lost to Follow-up|0|||
149872286|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Death|5|||
150041362|NCT01285557|541289262|FG000|Overall Study|Death|173|||
150174027|NCT03482011|541773010|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
149872287|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Death|3|||
149872288|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Death|7|||
150041363|NCT01285557|541289263|FG001|Overall Study|Death|90|||
150041364|NCT01285557|541289262|FG000|Overall Study|Lost to Follow-up|6|||
150041365|NCT01285557|541289263|FG001|Overall Study|Lost to Follow-up|2|||
150041366|NCT01285557|541289262|FG000|Overall Study|Withdrew Consent|6|||
150041367|NCT01285557|541289263|FG001|Overall Study|Withdrew Consent|1|||
150041368|NCT01285557|541289262|FG000|Overall Study|Sponsor Study Termination|23|||
150041369|NCT01285557|541289263|FG001|Overall Study|Sponsor Study Termination|13|||
150041370|NCT01285557|541289262|FG000|Overall Study|Randomized but not treated|1|||
150041371|NCT01285557|541289263|FG001|Overall Study|Randomized but not treated|1|||
150041372|NCT01285557|541289262|FG000|Overall Study|Study follow-up ongoing|28|||
150041373|NCT01285557|541289263|FG001|Overall Study|Study follow-up ongoing|14|||
150041374|NCT01285557|541289262|FG000|Overall Study|Sponsor Decision|2|||
150041375|NCT01285557|541289263|FG001|Overall Study|Sponsor Decision|1|||
150041376|NCT05786651|541289274|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
150041377|NCT01987453|541290615|FG000|Overall Study|Death|0|||
150041378|NCT01987453|541290616|FG001|Overall Study|Death|0|||
150041379|NCT01987453|541290617|FG002|Overall Study|Death|1|||
150041380|NCT01987453|541290615|FG000|Overall Study|Lack of Efficacy|1|||
150041381|NCT01987453|541290616|FG001|Overall Study|Lack of Efficacy|12|||
150041382|NCT01987453|541290617|FG002|Overall Study|Lack of Efficacy|0|||
150041383|NCT01590888|541290618|FG000|Overall Study|Adverse Event|3|||
150041384|NCT01590888|541290619|FG001|Overall Study|Adverse Event|0|||
150041385|NCT01590888|541290620|FG002|Overall Study|Adverse Event|1|||
150041386|NCT01590888|541290618|FG000|Overall Study|Lost to Follow-up|1|||
150041387|NCT01590888|541290619|FG001|Overall Study|Lost to Follow-up|0|||
150041388|NCT01590888|541290620|FG002|Overall Study|Lost to Follow-up|0|||
150041389|NCT04953728|541290621|FG000|Overall Study|Withdrawal by Subject|3|||
150041390|NCT04953728|541290621|FG000|Overall Study|Physician Decision|1|||
150041391|NCT02331277|541290622|FG000|Overall Study|Withdrawal by Subject|1|||
150041392|NCT02331277|541290623|FG001|Overall Study|Withdrawal by Subject|0|||
150041393|NCT01399372|541290625|FG000|Overall Study|Protocol Violation|3|||
150041394|NCT01399372|541290626|FG001|Overall Study|Protocol Violation|1|||
150041395|NCT01376804|541290627|FG000|Treatment Period|Withdrawal by Subject|1|||
150041396|NCT01376804|541290627|FG000|Treatment Period|Adverse Event|6|||
150041397|NCT01376804|541290627|FG000|Treatment Period|Patient did not receive study drug|1|||
150041398|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
150041399|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
150041400|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Patient requirement|20|||
150041401|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Death|5|||
150041402|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Change of therapy|6|||
150041403|NCT01071798|541290628|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
150041404|NCT01071798|541290628|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
150041405|NCT01071798|541290628|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
150041406|NCT01071798|541290628|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
149872289|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Death|5|||
149872290|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Death|6|||
149872291|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Death|3|||
149872292|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Death|0|||
149872293|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872294|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872295|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872296|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
150041407|NCT01071798|541290628|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
149872297|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872298|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872299|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872300|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872301|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872302|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872303|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872304|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872305|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872306|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872307|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
150041408|NCT01705509|541290636|FG000|Inclusion CPET|Screen Failure|5|||
149872308|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872309|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872310|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
149872311|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
149872312|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
149872313|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
149872314|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
150041409|NCT01705509|541290636|FG000|Inclusion CPET|Withdrawal by Subject|2|||
150041410|NCT01705509|541290636|FG000|CPET w/ Ranexa|Screen Failure|2|||
150041411|NCT02736890|541290637|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
150041412|NCT02736890|541290638|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
150041413|NCT02736890|541290637|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
150041414|NCT02736890|541290638|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
150041415|NCT02904954|541290639|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
150041416|NCT02904954|541290640|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
150041417|NCT02904954|541290639|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
150041418|NCT02904954|541290640|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
150041419|NCT02904954|541290639|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
150041420|NCT02904954|541290640|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
149872315|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
149872316|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
149872317|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
149872318|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Disease Progression|0|||
149872319|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Disease Progression|0|||
150041421|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Recurrence|2|||
150041422|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Recurrence|0|||
150041423|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Adverse Event|2|||
150041424|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Adverse Event|6|||
149872320|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Disease Progression|0|||
149872321|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Disease Progression|0|||
149872322|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Disease Progression|0|||
149872323|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Disease Progression|0|||
149872324|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Disease Progression|0|||
149872325|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Disease Progression|0|||
149872326|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Disease Progression|0|||
149872327|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Disease Progression|0|||
149872328|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Disease Progression|0|||
149872329|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Disease Progression|0|||
149872330|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Disease Progression|0|||
149872331|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Disease Progression|0|||
149872332|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Disease Progression|0|||
149872333|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Disease Progression|0|||
149872334|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Disease Progression|0|||
149872335|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Disease Progression|0|||
149872336|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Disease Progression|0|||
149872337|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Disease Progression|0|||
149872338|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Disease Progression|2|||
149872339|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Disease Progression|1|||
149872340|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Disease Progression|0|||
149872341|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Disease Progression|0|||
149872342|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Disease Progression|0|||
150174028|NCT03482011|541773011|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
149872343|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872344|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872345|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872346|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872347|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872348|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872349|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872350|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872351|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872352|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872353|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872354|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872355|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872356|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872357|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872358|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872359|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872360|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872361|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872362|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872363|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
149872364|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
149872365|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872366|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872367|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
149872368|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149963223|NCT02757963|540999833|FG000|Overall Study|Withdrawal by Subject|34|||
149872369|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872370|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872371|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872372|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872373|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872374|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872375|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872376|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872377|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872378|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872379|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872380|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149963224|NCT00911157|540999834|FG000|Overall Study|Adverse Event|4|||
149963225|NCT00911157|540999835|FG001|Overall Study|Adverse Event|1|||
149963226|NCT00911157|540999834|FG000|Overall Study|Withdrawal by Subject|1|||
149963227|NCT00911157|540999835|FG001|Overall Study|Withdrawal by Subject|1|||
149963228|NCT00911157|540999834|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
149963229|NCT00911157|540999835|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
149963230|NCT00911157|540999834|FG000|Overall Study|Need to treat for lung cancer|1|||
149963231|NCT00911157|540999835|FG001|Overall Study|Need to treat for lung cancer|0|||
149963232|NCT03769467|540999836|FG000|Overall Study|Adverse Event|1|||
149963233|NCT03769467|540999837|FG001|Overall Study|Adverse Event|1|||
149963234|NCT03769467|540999838|FG002|Overall Study|Adverse Event|0|||
149963235|NCT03769467|540999836|FG000|Overall Study|Death|3|||
149963236|NCT03769467|540999837|FG001|Overall Study|Death|3|||
149963237|NCT03769467|540999838|FG002|Overall Study|Death|0|||
149963238|NCT03769467|540999836|FG000|Overall Study|Study Terminated By Sponsor|2|||
149963239|NCT03769467|540999837|FG001|Overall Study|Study Terminated By Sponsor|1|||
149963240|NCT03769467|540999838|FG002|Overall Study|Study Terminated By Sponsor|0|||
149963241|NCT03769467|540999836|FG000|Overall Study|Withdrawal by Subject|0|||
149963242|NCT03769467|540999837|FG001|Overall Study|Withdrawal by Subject|1|||
149963243|NCT03769467|540999838|FG002|Overall Study|Withdrawal by Subject|0|||
149963244|NCT05259722|540999839|FG000|Overall Study|Adverse Event|2|||
149963245|NCT05259722|540999840|FG001|Overall Study|Adverse Event|24|||
149963246|NCT05259722|540999839|FG000|Overall Study|Lost to Follow-up|5|||
149963247|NCT05259722|540999840|FG001|Overall Study|Lost to Follow-up|1|||
149963248|NCT05259722|540999839|FG000|Overall Study|Lack of Efficacy|8|||
149963249|NCT05259722|540999840|FG001|Overall Study|Lack of Efficacy|26|||
149963250|NCT05259722|540999839|FG000|Overall Study|Withdrawal by Subject|15|||
149963251|NCT05259722|540999840|FG001|Overall Study|Withdrawal by Subject|33|||
149963252|NCT05259722|540999839|FG000|Overall Study|Various reasons|3|||
149963253|NCT05259722|540999840|FG001|Overall Study|Various reasons|9|||
149963254|NCT05259722|540999839|FG000|Overall Study|Not exposed to IMP|1|||
149963255|NCT05259722|540999840|FG001|Overall Study|Not exposed to IMP|12|||
149963256|NCT05259722|540999839|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
149963257|NCT05259722|540999840|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
149963258|NCT01887600|540999841|FG000|Overall Study|Death|39|||
149963259|NCT01887600|540999842|FG001|Overall Study|Death|16|||
149963260|NCT01887600|540999841|FG000|Overall Study|Lack of Efficacy|3|||
149963261|NCT01887600|540999842|FG001|Overall Study|Lack of Efficacy|26|||
149963262|NCT01887600|540999841|FG000|Overall Study|Lost to Follow-up|5|||
149963263|NCT01887600|540999842|FG001|Overall Study|Lost to Follow-up|1|||
149963264|NCT01887600|540999841|FG000|Overall Study|Physician Decision|7|||
149963265|NCT01887600|540999842|FG001|Overall Study|Physician Decision|8|||
149963266|NCT01887600|540999841|FG000|Overall Study|Protocol Deviation|3|||
149963267|NCT01887600|540999842|FG001|Overall Study|Protocol Deviation|0|||
149963268|NCT01887600|540999841|FG000|Overall Study|Withdrawal by Subject|58|||
149963269|NCT01887600|540999842|FG001|Overall Study|Withdrawal by Subject|52|||
149963270|NCT01887600|540999841|FG000|Overall Study|Adverse Event|21|||
149963271|NCT01887600|540999842|FG001|Overall Study|Adverse Event|9|||
149963272|NCT01887600|540999841|FG000|Overall Study|Non-compliance with study drug|3|||
149963273|NCT01887600|540999842|FG001|Overall Study|Non-compliance with study drug|0|||
149963274|NCT01887600|540999841|FG000|Overall Study|Miscellaneous|6|||
149963275|NCT01887600|540999842|FG001|Overall Study|Miscellaneous|2|||
149963276|NCT01887600|540999841|FG000|Overall Study|Progressive Disease|1|||
149963277|NCT01887600|540999842|FG001|Overall Study|Progressive Disease|0|||
149963278|NCT00962650|540999843|FG000|Overall Study|Transgastric DP was not completed|2|||
149963279|NCT00231465|540999844|FG000|Overall Study|Completed only one cycle|1|||
149963280|NCT00231465|540999844|FG000|Overall Study|Did not have follow up CT scans|1|||
149963281|NCT02539394|540999852|FG000|Overall Study|Protocol Violation|1|||
149963282|NCT02539394|540999853|FG001|Overall Study|Protocol Violation|3|||
149963283|NCT02539394|540999852|FG000|Overall Study|Lost to Follow-up|1|||
149872381|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
150041425|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Participant wishes|12|||
150041426|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Participant wishes|7|||
150041427|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Physician Decision|2|||
150041428|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Physician Decision|1|||
150041429|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
150041430|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
150041431|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Death|0|||
150041432|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Death|1|||
150041433|NCT02904954|541290639|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
150041434|NCT02904954|541290640|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
150041435|NCT05097963|541290641|FG000|Overall Study|Protocol Violation|13|||
150041436|NCT05097963|541290641|FG000|Overall Study|Withdrawal by Subject|21|||
150041437|NCT01554241|541290644|FG000|Overall Study|Death|3|||
150041438|NCT01554241|541290645|FG001|Overall Study|Death|1|||
150041439|NCT01554241|541290646|FG002|Overall Study|Death|1|||
150041440|NCT01554241|541290647|FG003|Overall Study|Death|0|||
150041441|NCT01554241|541290644|FG000|Overall Study|protocol specified renal stone|0|||
150041442|NCT01554241|541290645|FG001|Overall Study|protocol specified renal stone|0|||
150041443|NCT01554241|541290646|FG002|Overall Study|protocol specified renal stone|0|||
150041444|NCT01554241|541290647|FG003|Overall Study|protocol specified renal stone|1|||
150041445|NCT01554241|541290644|FG000|Overall Study|protocol specified change in eGFR|0|||
150041446|NCT01554241|541290645|FG001|Overall Study|protocol specified change in eGFR|0|||
150041447|NCT01554241|541290646|FG002|Overall Study|protocol specified change in eGFR|1|||
150041448|NCT01554241|541290647|FG003|Overall Study|protocol specified change in eGFR|0|||
150041449|NCT01554241|541290644|FG000|Overall Study|Withdrawal by Subject|0|||
150041450|NCT01554241|541290645|FG001|Overall Study|Withdrawal by Subject|0|||
150041451|NCT01554241|541290646|FG002|Overall Study|Withdrawal by Subject|2|||
150041452|NCT01554241|541290647|FG003|Overall Study|Withdrawal by Subject|0|||
150041453|NCT02118961|541290648|FG000|Overall Study|Withdrawal by Subject|1|||
150041454|NCT02118961|541290649|FG001|Overall Study|Withdrawal by Subject|0|||
150041455|NCT02745119|541290650|FG000|Overall Study|Adverse Event|1|||
150041456|NCT02745119|541290651|FG001|Overall Study|Adverse Event|0|||
150041457|NCT02745119|541290652|FG002|Overall Study|Adverse Event|1|||
150041458|NCT02745119|541290653|FG003|Overall Study|Adverse Event|3|||
150041459|NCT02745119|541290650|FG000|Overall Study|Death|3|||
150041460|NCT02745119|541290651|FG001|Overall Study|Death|3|||
150041461|NCT02745119|541290652|FG002|Overall Study|Death|0|||
150041462|NCT02745119|541290653|FG003|Overall Study|Death|4|||
150041463|NCT02745119|541290650|FG000|Overall Study|Lost to Follow-up|0|||
150041464|NCT02745119|541290651|FG001|Overall Study|Lost to Follow-up|0|||
150041465|NCT02745119|541290652|FG002|Overall Study|Lost to Follow-up|0|||
150041466|NCT02745119|541290653|FG003|Overall Study|Lost to Follow-up|1|||
150041467|NCT02745119|541290650|FG000|Overall Study|Protocol Deviation|0|||
150041468|NCT02745119|541290651|FG001|Overall Study|Protocol Deviation|0|||
150041469|NCT02745119|541290652|FG002|Overall Study|Protocol Deviation|0|||
150041470|NCT02745119|541290653|FG003|Overall Study|Protocol Deviation|1|||
150041471|NCT02745119|541290650|FG000|Overall Study|Withdrawal by Subject|7|||
150041472|NCT02745119|541290651|FG001|Overall Study|Withdrawal by Subject|15|||
150174029|NCT03482011|541773012|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
150041473|NCT02745119|541290652|FG002|Overall Study|Withdrawal by Subject|8|||
150041474|NCT02745119|541290653|FG003|Overall Study|Withdrawal by Subject|14|||
150041475|NCT02745119|541290650|FG000|Overall Study|Study Terminated by Sponsor|134|||
150041476|NCT02745119|541290651|FG001|Overall Study|Study Terminated by Sponsor|252|||
150041477|NCT02745119|541290652|FG002|Overall Study|Study Terminated by Sponsor|135|||
150041478|NCT02745119|541290653|FG003|Overall Study|Study Terminated by Sponsor|251|||
150041479|NCT02745119|541290650|FG000|Overall Study|Physician Decision|0|||
150041480|NCT02745119|541290651|FG001|Overall Study|Physician Decision|2|||
150041481|NCT02745119|541290652|FG002|Overall Study|Physician Decision|2|||
150041482|NCT02745119|541290653|FG003|Overall Study|Physician Decision|2|||
150041483|NCT02745119|541290650|FG000|Overall Study|Reason Not Specified|0|||
150041484|NCT02745119|541290651|FG001|Overall Study|Reason Not Specified|2|||
150041485|NCT02745119|541290652|FG002|Overall Study|Reason Not Specified|0|||
150041486|NCT02745119|541290653|FG003|Overall Study|Reason Not Specified|1|||
150041487|NCT00432172|541290654|FG000|Overall Study|Physician Decision|0|||
150174030|NCT03482011|541773013|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
150041488|NCT00432172|541290655|FG001|Overall Study|Physician Decision|0|||
150041489|NCT00432172|541290656|FG002|Overall Study|Physician Decision|2|||
150041490|NCT00432172|541290657|FG003|Overall Study|Physician Decision|0|||
150041491|NCT00432172|541290654|FG000|Overall Study|Adverse Event|4|||
150041492|NCT00432172|541290655|FG001|Overall Study|Adverse Event|2|||
150041493|NCT00432172|541290656|FG002|Overall Study|Adverse Event|4|||
150041494|NCT00432172|541290657|FG003|Overall Study|Adverse Event|3|||
150174031|NCT03482011|541773014|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
150174032|NCT03482011|541773007|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174033|NCT03482011|541773008|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174034|NCT03482011|541773009|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174035|NCT03482011|541773010|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174036|NCT03482011|541773011|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174037|NCT03482011|541773012|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174038|NCT03482011|541773013|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150174039|NCT03482011|541773014|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
150174040|NCT00468052|541773015|FG000|Overall Study|Protocol Violation|7|||
150174041|NCT00468052|541773016|FG001|Overall Study|Protocol Violation|8|||
150174042|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
150174043|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
150174044|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
150174045|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
150174046|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
150041495|NCT00432172|541290654|FG000|Overall Study|Disease progression|0|||
150041496|NCT00432172|541290655|FG001|Overall Study|Disease progression|2|||
150041497|NCT00432172|541290656|FG002|Overall Study|Disease progression|5|||
150041498|NCT00432172|541290657|FG003|Overall Study|Disease progression|1|||
150041499|NCT00432172|541290654|FG000|Overall Study|Withdrawal by Subject|0|||
150041500|NCT00432172|541290655|FG001|Overall Study|Withdrawal by Subject|1|||
149963284|NCT02539394|540999853|FG001|Overall Study|Lost to Follow-up|2|||
149963285|NCT02539394|540999852|FG000|Overall Study|Incomplete dataset|6|||
149963286|NCT02539394|540999853|FG001|Overall Study|Incomplete dataset|6|||
149963287|NCT03425188|540999873|FG000|Overall Study|Withdrawal by Subject|1|||
149963288|NCT01316900|540999874|FG000|Overall Study|Adverse Event|10|||
149963289|NCT01316900|540999875|FG001|Overall Study|Adverse Event|10|||
149963290|NCT01316900|540999876|FG002|Overall Study|Adverse Event|15|||
149963291|NCT01316900|540999877|FG003|Overall Study|Adverse Event|9|||
149963292|NCT01316900|540999874|FG000|Overall Study|Lack of Efficacy|17|||
149963293|NCT01316900|540999875|FG001|Overall Study|Lack of Efficacy|9|||
149963294|NCT01316900|540999876|FG002|Overall Study|Lack of Efficacy|5|||
149963295|NCT01316900|540999877|FG003|Overall Study|Lack of Efficacy|7|||
149963296|NCT01316900|540999874|FG000|Overall Study|Protocol Violation|7|||
149963297|NCT01316900|540999875|FG001|Overall Study|Protocol Violation|1|||
149963298|NCT01316900|540999876|FG002|Overall Study|Protocol Violation|4|||
149963299|NCT01316900|540999877|FG003|Overall Study|Protocol Violation|0|||
149963300|NCT01316900|540999874|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
149963301|NCT01316900|540999875|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
149963302|NCT01316900|540999876|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
149963303|NCT01316900|540999877|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
149963304|NCT01316900|540999874|FG000|Overall Study|Lost to Follow-up|1|||
149963305|NCT01316900|540999875|FG001|Overall Study|Lost to Follow-up|0|||
150041501|NCT00432172|541290656|FG002|Overall Study|Withdrawal by Subject|0|||
150041502|NCT00432172|541290657|FG003|Overall Study|Withdrawal by Subject|2|||
150041503|NCT00432172|541290654|FG000|Overall Study|No treatment received|2|||
150041504|NCT00432172|541290655|FG001|Overall Study|No treatment received|2|||
150041505|NCT00432172|541290656|FG002|Overall Study|No treatment received|0|||
150041506|NCT00432172|541290657|FG003|Overall Study|No treatment received|1|||
150041507|NCT02536963|541290658|FG000|Overall Study|Withdrawal by Subject|18|||
150041508|NCT00687193|541290659|FG000|Overall Study|Adverse Event|0|||
150041509|NCT00687193|541290660|FG001|Overall Study|Adverse Event|1|||
150041510|NCT00687193|541290661|FG002|Overall Study|Adverse Event|2|||
150041511|NCT00687193|541290662|FG003|Overall Study|Adverse Event|3|||
150041512|NCT00687193|541290663|FG004|Overall Study|Adverse Event|0|||
150041513|NCT00687193|541290664|FG005|Overall Study|Adverse Event|2|||
150041514|NCT00687193|541290659|FG000|Overall Study|Lack of Efficacy|1|||
150041515|NCT00687193|541290660|FG001|Overall Study|Lack of Efficacy|1|||
150041516|NCT00687193|541290661|FG002|Overall Study|Lack of Efficacy|0|||
150041517|NCT00687193|541290662|FG003|Overall Study|Lack of Efficacy|0|||
150041518|NCT00687193|541290663|FG004|Overall Study|Lack of Efficacy|0|||
150041519|NCT00687193|541290664|FG005|Overall Study|Lack of Efficacy|2|||
150041520|NCT00687193|541290659|FG000|Overall Study|Protocol Violation|1|||
150041521|NCT00687193|541290660|FG001|Overall Study|Protocol Violation|2|||
150041522|NCT00687193|541290661|FG002|Overall Study|Protocol Violation|0|||
150041523|NCT00687193|541290662|FG003|Overall Study|Protocol Violation|1|||
150041524|NCT00687193|541290663|FG004|Overall Study|Protocol Violation|2|||
150041525|NCT00687193|541290664|FG005|Overall Study|Protocol Violation|0|||
150041526|NCT02129699|541290665|FG000|Overall Study|Did not start treatment|3|||
150041527|NCT02129699|541290666|FG001|Overall Study|Did not start treatment|2|||
150041528|NCT02447003|541290667|FG000|Overall Study|Other|0|||
150041529|NCT02447003|541290668|FG001|Overall Study|Other|4|||
150041530|NCT02447003|541290667|FG000|Overall Study|Site discontinued|0|||
150041531|NCT02447003|541290668|FG001|Overall Study|Site discontinued|2|||
150041532|NCT02447003|541290667|FG000|Overall Study|Physician Decision|0|||
150041533|NCT02447003|541290668|FG001|Overall Study|Physician Decision|1|||
150041534|NCT02447003|541290667|FG000|Overall Study|Withdrawal by Subject|4|||
150041535|NCT02447003|541290668|FG001|Overall Study|Withdrawal by Subject|3|||
150041536|NCT02447003|541290667|FG000|Overall Study|Sponsor Decision|6|||
150041537|NCT02447003|541290668|FG001|Overall Study|Sponsor Decision|11|||
150041538|NCT02447003|541290667|FG000|Overall Study|Progressive Disease|1|||
150041539|NCT02447003|541290668|FG001|Overall Study|Progressive Disease|0|||
150041540|NCT02447003|541290667|FG000|Overall Study|Lost to Follow-up|5|||
150041541|NCT02447003|541290668|FG001|Overall Study|Lost to Follow-up|0|||
150041542|NCT02447003|541290667|FG000|Overall Study|Death|154|||
150041543|NCT02447003|541290668|FG001|Overall Study|Death|63|||
150041544|NCT03534804|541290669|FG000|Overall Study|Withdrawal by Subject|1|||
150041545|NCT04161157|541290670|FG000|Overall Study|Lost to Follow-up|4|||
150041546|NCT04161157|541290670|FG000|Overall Study|Death|3|||
150041547|NCT04161157|541290670|FG000|Overall Study|Ineligible|2|||
150041548|NCT04161157|541290670|FG000|Overall Study|Withdrawal by Subject|4|||
150041549|NCT01648751|541290686|FG000|Overall Study|Withdrawal by Subject|2|||
150041550|NCT01648751|541290687|FG001|Overall Study|Withdrawal by Subject|3|||
150041551|NCT05673876|541290689|FG000|Overall Study|Death|3|||
150041552|NCT05673876|541290690|FG001|Overall Study|Death|1|||
150041553|NCT05673876|541290689|FG000|Overall Study|Study Terminated by Sponsor|0|||
150041554|NCT05673876|541290690|FG001|Overall Study|Study Terminated by Sponsor|1|||
150041555|NCT05673876|541290689|FG000|Overall Study|Physician Decision|0|||
150041556|NCT05673876|541290690|FG001|Overall Study|Physician Decision|1|||
150041557|NCT03529422|541290691|FG000|Overall Study|Withdrawal by Subject|1|||
150041558|NCT03529422|541290691|FG000|Overall Study|Protocol Violation|1|||
150041559|NCT03529422|541290691|FG000|Overall Study|Disease progression|2|||
150041560|NCT02000115|541290692|FG000|Overall Study|Death|56|||
150041561|NCT02000115|541290693|FG001|Overall Study|Death|45|||
150041562|NCT02000115|541290694|FG002|Overall Study|Death|0|||
150041563|NCT02000115|541290695|FG003|Overall Study|Death|0|||
150041564|NCT02000115|541290692|FG000|Overall Study|Missed Visit|6|||
150041565|NCT02000115|541290693|FG001|Overall Study|Missed Visit|8|||
150041566|NCT02000115|541290694|FG002|Overall Study|Missed Visit|1|||
150041567|NCT02000115|541290695|FG003|Overall Study|Missed Visit|0|||
150041568|NCT02000115|541290692|FG000|Overall Study|Protocol Violation|2|||
150041569|NCT02000115|541290693|FG001|Overall Study|Protocol Violation|1|||
150041570|NCT02000115|541290694|FG002|Overall Study|Protocol Violation|0|||
150041571|NCT02000115|541290695|FG003|Overall Study|Protocol Violation|0|||
150041572|NCT02000115|541290692|FG000|Overall Study|Physician Decision|2|||
150041573|NCT02000115|541290693|FG001|Overall Study|Physician Decision|0|||
149963306|NCT01316900|540999876|FG002|Overall Study|Lost to Follow-up|1|||
149963307|NCT01316900|540999877|FG003|Overall Study|Lost to Follow-up|1|||
149963308|NCT01316900|540999874|FG000|Overall Study|Withdrawal by Subject|7|||
149963309|NCT01316900|540999875|FG001|Overall Study|Withdrawal by Subject|8|||
149963310|NCT01316900|540999876|FG002|Overall Study|Withdrawal by Subject|6|||
149963311|NCT01316900|540999877|FG003|Overall Study|Withdrawal by Subject|9|||
149963312|NCT00562861|540999878|FG000|Overall Study|Adverse Event|1|||
149963313|NCT00562861|540999879|FG001|Overall Study|Adverse Event|1|||
149963314|NCT00562861|540999878|FG000|Overall Study|Lack of Efficacy|5|||
149963315|NCT00562861|540999879|FG001|Overall Study|Lack of Efficacy|5|||
149963316|NCT00562861|540999878|FG000|Overall Study|noncompliance, moved|7|||
149963317|NCT00562861|540999879|FG001|Overall Study|noncompliance, moved|2|||
149963318|NCT00562861|540999878|FG000|Overall Study|Lost to Follow-up|7|||
149963319|NCT00562861|540999879|FG001|Overall Study|Lost to Follow-up|3|||
149963320|NCT01152385|540999881|FG000|Overall Study|Withdrawal by Subject|3|||
149963321|NCT01152385|540999882|FG001|Overall Study|Withdrawal by Subject|1|||
149963322|NCT01152385|540999883|FG002|Overall Study|Withdrawal by Subject|1|||
149963323|NCT01152385|540999884|FG003|Overall Study|Withdrawal by Subject|1|||
149963324|NCT01152385|540999881|FG000|Overall Study|Protocol Violation|0|||
149963325|NCT01152385|540999882|FG001|Overall Study|Protocol Violation|0|||
149963326|NCT01152385|540999883|FG002|Overall Study|Protocol Violation|0|||
149963327|NCT01152385|540999884|FG003|Overall Study|Protocol Violation|1|||
149963328|NCT01152385|540999881|FG000|Overall Study|Adverse Event|1|||
149963329|NCT01152385|540999882|FG001|Overall Study|Adverse Event|1|||
149963330|NCT01152385|540999883|FG002|Overall Study|Adverse Event|0|||
149963331|NCT01152385|540999884|FG003|Overall Study|Adverse Event|0|||
149963332|NCT01152385|540999881|FG000|Overall Study|Study-specific withdrawal criteria|1|||
149963333|NCT01152385|540999882|FG001|Overall Study|Study-specific withdrawal criteria|1|||
149963334|NCT01152385|540999883|FG002|Overall Study|Study-specific withdrawal criteria|2|||
149963335|NCT01152385|540999884|FG003|Overall Study|Study-specific withdrawal criteria|0|||
149963336|NCT01152385|540999881|FG000|Overall Study|Other|4|||
149963337|NCT01152385|540999882|FG001|Overall Study|Other|3|||
149963338|NCT01152385|540999883|FG002|Overall Study|Other|2|||
149963339|NCT01152385|540999884|FG003|Overall Study|Other|3|||
149963340|NCT02656173|540999885|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
149963341|NCT02656173|540999886|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
149963342|NCT02656173|540999885|FG000|Overall Study|Adverse Event|7|||
149963343|NCT02656173|540999886|FG001|Overall Study|Adverse Event|5|||
149963344|NCT02656173|540999885|FG000|Overall Study|Withdrawal by Subject|1|||
149963345|NCT02656173|540999886|FG001|Overall Study|Withdrawal by Subject|3|||
150174047|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
149872382|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872383|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872384|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872385|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872386|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872387|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872388|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
149872389|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872390|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872391|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872392|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
149872393|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Adverse Event|0|||
149872394|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Adverse Event|0|||
149872395|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Adverse Event|0|||
149872396|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Adverse Event|0|||
149872397|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Adverse Event|0|||
149872398|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Adverse Event|0|||
149872399|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Adverse Event|0|||
149872400|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Adverse Event|0|||
149872401|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Adverse Event|0|||
149872402|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Adverse Event|0|||
149872403|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Adverse Event|0|||
149872404|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Adverse Event|0|||
149872405|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Adverse Event|0|||
149963346|NCT02656173|540999885|FG000|Overall Study|Protocol Violation|0|||
149963347|NCT02656173|540999886|FG001|Overall Study|Protocol Violation|1|||
149963348|NCT02656173|540999885|FG000|Overall Study|Miscellaneous|2|||
149963349|NCT02656173|540999886|FG001|Overall Study|Miscellaneous|0|||
149963350|NCT03449147|540999887|FG000|52-week Treatment Period|Death|0|||
149963351|NCT03449147|540999888|FG001|52-week Treatment Period|Death|1|||
149963352|NCT03449147|540999889|FG002|52-week Treatment Period|Death|0|||
149963353|NCT03449147|540999887|FG000|52-week Treatment Period|Lost to Follow-up|6|||
149963354|NCT03449147|540999888|FG001|52-week Treatment Period|Lost to Follow-up|2|||
149963355|NCT03449147|540999889|FG002|52-week Treatment Period|Lost to Follow-up|5|||
149963356|NCT03449147|540999887|FG000|52-week Treatment Period|Other|0|||
149963357|NCT03449147|540999888|FG001|52-week Treatment Period|Other|1|||
149963358|NCT03449147|540999889|FG002|52-week Treatment Period|Other|2|||
149963359|NCT03449147|540999887|FG000|52-week Treatment Period|Physician Decision|1|||
149963360|NCT03449147|540999888|FG001|52-week Treatment Period|Physician Decision|0|||
149963361|NCT03449147|540999889|FG002|52-week Treatment Period|Physician Decision|3|||
149963362|NCT03449147|540999887|FG000|52-week Treatment Period|Screen Failure|1|||
149963363|NCT03449147|540999888|FG001|52-week Treatment Period|Screen Failure|2|||
149963364|NCT03449147|540999889|FG002|52-week Treatment Period|Screen Failure|0|||
149963365|NCT03449147|540999887|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
149963366|NCT03449147|540999888|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
149963367|NCT03449147|540999889|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
149963368|NCT03449147|540999887|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
149963369|NCT03449147|540999888|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
149963370|NCT03449147|540999889|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
149872406|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Adverse Event|0|||
149872407|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Adverse Event|0|||
149872408|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Adverse Event|0|||
149872409|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Adverse Event|0|||
149872410|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Adverse Event|0|||
149872411|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Adverse Event|0|||
149872412|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Adverse Event|0|||
149872413|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Adverse Event|0|||
149872414|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Adverse Event|0|||
149872415|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Adverse Event|0|||
149872416|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Adverse Event|1|||
149872417|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Adverse Event|0|||
150041574|NCT02000115|541290694|FG002|Overall Study|Physician Decision|0|||
150041575|NCT02000115|541290695|FG003|Overall Study|Physician Decision|0|||
150041576|NCT02000115|541290692|FG000|Overall Study|Withdrawal by Subject|11|||
150041577|NCT02000115|541290693|FG001|Overall Study|Withdrawal by Subject|11|||
150041578|NCT02000115|541290694|FG002|Overall Study|Withdrawal by Subject|0|||
150041579|NCT02000115|541290695|FG003|Overall Study|Withdrawal by Subject|0|||
150041580|NCT02000115|541290692|FG000|Overall Study|Lost to Follow-up|0|||
150041581|NCT02000115|541290693|FG001|Overall Study|Lost to Follow-up|1|||
150041582|NCT02000115|541290694|FG002|Overall Study|Lost to Follow-up|0|||
150041583|NCT02000115|541290695|FG003|Overall Study|Lost to Follow-up|0|||
150041584|NCT02000115|541290692|FG000|Overall Study|Non-compliance|2|||
150041585|NCT02000115|541290693|FG001|Overall Study|Non-compliance|1|||
150041586|NCT02000115|541290694|FG002|Overall Study|Non-compliance|0|||
150041587|NCT02000115|541290695|FG003|Overall Study|Non-compliance|0|||
150041588|NCT02000115|541290692|FG000|Overall Study|Withdrawn on day of randomization|0|||
150041589|NCT02000115|541290693|FG001|Overall Study|Withdrawn on day of randomization|1|||
150041590|NCT02000115|541290694|FG002|Overall Study|Withdrawn on day of randomization|0|||
150041591|NCT02000115|541290695|FG003|Overall Study|Withdrawn on day of randomization|0|||
150041592|NCT02000115|541290692|FG000|Overall Study|Still on Study|0|||
150041593|NCT02000115|541290693|FG001|Overall Study|Still on Study|0|||
150041594|NCT02000115|541290694|FG002|Overall Study|Still on Study|0|||
150041595|NCT02000115|541290695|FG003|Overall Study|Still on Study|53|||
150041596|NCT05006573|541290698|FG000|Double-blind Treatment Period|Physician Decision|2|||
150041597|NCT05006573|541290699|FG001|Double-blind Treatment Period|Physician Decision|0|||
150041598|NCT05006573|541290698|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
150041599|NCT05006573|541290699|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
150041600|NCT05006573|541290698|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
150041601|NCT05006573|541290699|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
150041602|NCT05006573|541290698|FG000|Double-blind Treatment Period|Protocol Violation|2|||
149872418|NCT02393248|540662700|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
150041603|NCT05006573|541290699|FG001|Double-blind Treatment Period|Protocol Violation|0|||
150041604|NCT05006573|541290698|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
150041605|NCT05006573|541290699|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
150041606|NCT05006573|541290698|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
150041607|NCT05006573|541290699|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
150041608|NCT02484391|541290703|FG000|Overall Study|Lack of Efficacy|15|||
150041609|NCT02484391|541290704|FG001|Overall Study|Lack of Efficacy|14|||
150041610|NCT02484391|541290705|FG002|Overall Study|Lack of Efficacy|3|||
150041611|NCT02484391|541290703|FG000|Overall Study|Lost to Follow-up|0|||
150041612|NCT02484391|541290704|FG001|Overall Study|Lost to Follow-up|0|||
150041613|NCT02484391|541290705|FG002|Overall Study|Lost to Follow-up|2|||
150041614|NCT02484391|541290703|FG000|Overall Study|Physician Decision|1|||
150041615|NCT02484391|541290704|FG001|Overall Study|Physician Decision|3|||
150041616|NCT02484391|541290705|FG002|Overall Study|Physician Decision|0|||
150041617|NCT02484391|541290703|FG000|Overall Study|Went to Transplant|5|||
150041618|NCT02484391|541290704|FG001|Overall Study|Went to Transplant|3|||
150041619|NCT02484391|541290705|FG002|Overall Study|Went to Transplant|2|||
150041620|NCT04922216|541290708|FG000|Overall Study|Withdrawal by Subject|0|||
150041621|NCT04922216|541290709|FG001|Overall Study|Withdrawal by Subject|1|||
150041622|NCT04922216|541290710|FG002|Overall Study|Withdrawal by Subject|0|||
150041623|NCT04922216|541290711|FG003|Overall Study|Withdrawal by Subject|0|||
150041624|NCT04922216|541290712|FG004|Overall Study|Withdrawal by Subject|0|||
150041625|NCT04922216|541290713|FG005|Overall Study|Withdrawal by Subject|0|||
150041626|NCT04922216|541290714|FG006|Overall Study|Withdrawal by Subject|0|||
150041627|NCT04922216|541290715|FG007|Overall Study|Withdrawal by Subject|2|||
150041628|NCT04922216|541290716|FG008|Overall Study|Withdrawal by Subject|0|||
150041629|NCT04922216|541290717|FG009|Overall Study|Withdrawal by Subject|0|||
150041630|NCT04922216|541290718|FG010|Overall Study|Withdrawal by Subject|0|||
150041631|NCT04922216|541290719|FG011|Overall Study|Withdrawal by Subject|0|||
150041632|NCT04922216|541290720|FG012|Overall Study|Withdrawal by Subject|1|||
150041633|NCT04922216|541290721|FG013|Overall Study|Withdrawal by Subject|1|||
150041634|NCT04922216|541290722|FG014|Overall Study|Withdrawal by Subject|1|||
150041635|NCT04922216|541290723|FG015|Overall Study|Withdrawal by Subject|0|||
150041636|NCT04922216|541290724|FG016|Overall Study|Withdrawal by Subject|0|||
150041637|NCT04922216|541290725|FG017|Overall Study|Withdrawal by Subject|1|||
150041638|NCT04922216|541290726|FG018|Overall Study|Withdrawal by Subject|1|||
150041639|NCT04922216|541290727|FG019|Overall Study|Withdrawal by Subject|1|||
150041640|NCT04922216|541290728|FG020|Overall Study|Withdrawal by Subject|1|||
150041641|NCT04922216|541290729|FG021|Overall Study|Withdrawal by Subject|0|||
150041642|NCT04922216|541290730|FG022|Overall Study|Withdrawal by Subject|0|||
150041643|NCT04922216|541290731|FG023|Overall Study|Withdrawal by Subject|2|||
150041644|NCT04922216|541290732|FG024|Overall Study|Withdrawal by Subject|0|||
150041645|NCT04922216|541290733|FG025|Overall Study|Withdrawal by Subject|0|||
150041646|NCT04922216|541290734|FG026|Overall Study|Withdrawal by Subject|1|||
150041647|NCT04922216|541290735|FG027|Overall Study|Withdrawal by Subject|0|||
150041648|NCT04922216|541290736|FG028|Overall Study|Withdrawal by Subject|0|||
150041649|NCT04922216|541290737|FG029|Overall Study|Withdrawal by Subject|0|||
150041650|NCT04922216|541290738|FG030|Overall Study|Withdrawal by Subject|1|||
150041651|NCT04922216|541290739|FG031|Overall Study|Withdrawal by Subject|0|||
150041652|NCT04922216|541290708|FG000|Overall Study|Lost to Follow-up|1|||
150041653|NCT04922216|541290709|FG001|Overall Study|Lost to Follow-up|0|||
150041654|NCT04922216|541290710|FG002|Overall Study|Lost to Follow-up|2|||
150041655|NCT04922216|541290711|FG003|Overall Study|Lost to Follow-up|0|||
150041656|NCT04922216|541290712|FG004|Overall Study|Lost to Follow-up|0|||
150041657|NCT04922216|541290713|FG005|Overall Study|Lost to Follow-up|2|||
150041658|NCT04922216|541290714|FG006|Overall Study|Lost to Follow-up|0|||
150041659|NCT04922216|541290715|FG007|Overall Study|Lost to Follow-up|1|||
150041660|NCT04922216|541290716|FG008|Overall Study|Lost to Follow-up|1|||
150041661|NCT04922216|541290717|FG009|Overall Study|Lost to Follow-up|2|||
150041662|NCT04922216|541290718|FG010|Overall Study|Lost to Follow-up|2|||
150041663|NCT04922216|541290719|FG011|Overall Study|Lost to Follow-up|1|||
150041664|NCT04922216|541290720|FG012|Overall Study|Lost to Follow-up|1|||
150041665|NCT04922216|541290721|FG013|Overall Study|Lost to Follow-up|0|||
150041666|NCT04922216|541290722|FG014|Overall Study|Lost to Follow-up|1|||
150041667|NCT04922216|541290723|FG015|Overall Study|Lost to Follow-up|0|||
150041668|NCT04922216|541290724|FG016|Overall Study|Lost to Follow-up|0|||
150041669|NCT04922216|541290725|FG017|Overall Study|Lost to Follow-up|2|||
150174048|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
150174049|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
150174050|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
150041670|NCT04922216|541290726|FG018|Overall Study|Lost to Follow-up|1|||
150041671|NCT04922216|541290727|FG019|Overall Study|Lost to Follow-up|0|||
150041672|NCT04922216|541290728|FG020|Overall Study|Lost to Follow-up|1|||
150041673|NCT04922216|541290729|FG021|Overall Study|Lost to Follow-up|0|||
150041674|NCT04922216|541290730|FG022|Overall Study|Lost to Follow-up|2|||
150041675|NCT04922216|541290731|FG023|Overall Study|Lost to Follow-up|1|||
150041676|NCT04922216|541290732|FG024|Overall Study|Lost to Follow-up|0|||
150041677|NCT04922216|541290733|FG025|Overall Study|Lost to Follow-up|2|||
150041678|NCT04922216|541290734|FG026|Overall Study|Lost to Follow-up|0|||
150041679|NCT04922216|541290735|FG027|Overall Study|Lost to Follow-up|0|||
150041680|NCT04922216|541290736|FG028|Overall Study|Lost to Follow-up|1|||
150174051|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
150041681|NCT04922216|541290737|FG029|Overall Study|Lost to Follow-up|0|||
150041682|NCT04922216|541290738|FG030|Overall Study|Lost to Follow-up|2|||
150041683|NCT04922216|541290739|FG031|Overall Study|Lost to Follow-up|1|||
150041684|NCT04949490|541290740|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
150041685|NCT04949490|541290741|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
150041686|NCT04949490|541290742|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
150041687|NCT04949490|541290743|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
150041688|NCT04949490|541290744|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
150041689|NCT04949490|541290745|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
150041690|NCT04949490|541290740|FG000|Group A and Group B|Withdrawal by Subject|0|||
150041691|NCT04949490|541290741|FG001|Group A and Group B|Withdrawal by Subject|0|||
150041692|NCT04949490|541290742|FG002|Group A and Group B|Withdrawal by Subject|1|||
150041693|NCT04949490|541290743|FG003|Group A and Group B|Withdrawal by Subject|0|||
150041694|NCT04949490|541290744|FG004|Group A and Group B|Withdrawal by Subject|0|||
150041695|NCT04949490|541290745|FG005|Group A and Group B|Withdrawal by Subject|0|||
150041696|NCT04949490|541290740|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
150041697|NCT04949490|541290741|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
150041698|NCT04949490|541290742|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
150041699|NCT04949490|541290743|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
150041700|NCT04949490|541290744|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
150041701|NCT04949490|541290745|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
150041702|NCT04949490|541290740|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
150041703|NCT04949490|541290741|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
150041704|NCT04949490|541290742|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
150041705|NCT04949490|541290743|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
150041706|NCT04949490|541290744|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
150041707|NCT04949490|541290745|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
150041708|NCT03278249|541290746|FG000|Overall Study|Withdrawal by Subject|2|||
150041709|NCT03278249|541290746|FG000|Overall Study|Lost to Follow-up|1|||
150041710|NCT02017405|541290747|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
150041711|NCT02017405|541290748|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
150041712|NCT02017405|541290749|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
150041713|NCT02017405|541290750|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
150041714|NCT02017405|541290751|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
149872419|NCT02393248|540662701|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872420|NCT02393248|540662702|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872421|NCT02393248|540662703|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872422|NCT02393248|540662704|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872423|NCT02393248|540662705|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149963371|NCT03449147|540999887|FG000|12-Week Off-Treatment Durability Period|Other|0|||
149963372|NCT03449147|540999888|FG001|12-Week Off-Treatment Durability Period|Other|1|||
149963373|NCT03449147|540999889|FG002|12-Week Off-Treatment Durability Period|Other|0|||
149963374|NCT00992394|540999891|FG000|Overall Study|Lack of Efficacy|6|||
149963375|NCT00992394|540999892|FG001|Overall Study|Lack of Efficacy|3|||
149963376|NCT00992394|540999891|FG000|Overall Study|Adverse Event|4|||
149963377|NCT00992394|540999892|FG001|Overall Study|Adverse Event|5|||
149963378|NCT00992394|540999891|FG000|Overall Study|Withdrawal by Subject|8|||
150041715|NCT02017405|541290752|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
150041716|NCT02017405|541290747|FG000|Open-label Phase|Adverse Event|1|||
150041717|NCT02017405|541290748|FG001|Open-label Phase|Adverse Event|1|||
150041718|NCT02017405|541290749|FG002|Open-label Phase|Adverse Event|0|||
150041719|NCT02017405|541290750|FG003|Open-label Phase|Adverse Event|0|||
149872424|NCT02393248|540662706|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872425|NCT02393248|540662707|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872426|NCT02393248|540662708|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872427|NCT02393248|540662709|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872428|NCT02393248|540662710|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872429|NCT02393248|540662711|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872430|NCT02393248|540662712|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872431|NCT02393248|540662713|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872432|NCT02393248|540662714|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872433|NCT02393248|540662715|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872434|NCT02393248|540662716|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872435|NCT02393248|540662717|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872436|NCT02393248|540662718|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872437|NCT02393248|540662719|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872438|NCT02393248|540662720|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149963379|NCT00992394|540999892|FG001|Overall Study|Withdrawal by Subject|2|||
149963380|NCT00992394|540999891|FG000|Overall Study|Physician Decision|1|||
149963381|NCT00992394|540999892|FG001|Overall Study|Physician Decision|0|||
149963382|NCT00992394|540999891|FG000|Overall Study|Protocol Violation|2|||
150041720|NCT02017405|541290751|FG004|Open-label Phase|Adverse Event|0|||
150041721|NCT02017405|541290752|FG005|Open-label Phase|Adverse Event|0|||
150041722|NCT00905164|541290756|FG000|Period 1|Protocol Violation|0|||
150041723|NCT00905164|541290757|FG001|Period 1|Protocol Violation|1|||
150041724|NCT04730804|541290758|FG000|Overall Study|Physician Decision|0|||
150041725|NCT04730804|541290759|FG001|Overall Study|Physician Decision|0|||
150041726|NCT04730804|541290760|FG002|Overall Study|Physician Decision|0|||
150041727|NCT04730804|541290761|FG003|Overall Study|Physician Decision|0|||
150041728|NCT04730804|541290762|FG004|Overall Study|Physician Decision|0|||
150041729|NCT04730804|541290763|FG005|Overall Study|Physician Decision|1|||
150041730|NCT04730804|541290758|FG000|Overall Study|Withdrawal by Subject|0|||
150041731|NCT04730804|541290759|FG001|Overall Study|Withdrawal by Subject|0|||
150041732|NCT04730804|541290760|FG002|Overall Study|Withdrawal by Subject|0|||
150041733|NCT04730804|541290761|FG003|Overall Study|Withdrawal by Subject|0|||
150041734|NCT04730804|541290762|FG004|Overall Study|Withdrawal by Subject|1|||
150041735|NCT04730804|541290763|FG005|Overall Study|Withdrawal by Subject|2|||
150041736|NCT03349034|541291942|FG000|Overall Study|catheters dislodged during transport|2|||
150041737|NCT03349034|541291943|FG001|Overall Study|catheters dislodged during transport|0|||
150041738|NCT03349034|541291942|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
150041739|NCT03349034|541291943|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
150041740|NCT03349034|541291942|FG000|Overall Study|soft tissue flap used|1|||
150041741|NCT03349034|541291943|FG001|Overall Study|soft tissue flap used|0|||
150041742|NCT03349034|541291942|FG000|Overall Study|Other|0|||
150041743|NCT03349034|541291943|FG001|Overall Study|Other|1|||
150041744|NCT01039376|541291944|FG000|Overall Study|Lost to Follow-up|5|||
150041745|NCT01039376|541291945|FG001|Overall Study|Lost to Follow-up|12|||
150041746|NCT01039376|541291944|FG000|Overall Study|Physician Decision|15|||
150041747|NCT01039376|541291945|FG001|Overall Study|Physician Decision|10|||
150041748|NCT01039376|541291944|FG000|Overall Study|Withdrawal by Subject|20|||
150041749|NCT01039376|541291945|FG001|Overall Study|Withdrawal by Subject|32|||
150041750|NCT01039376|541291944|FG000|Overall Study|Study terminated by Sponsor|90|||
150041751|NCT01039376|541291945|FG001|Overall Study|Study terminated by Sponsor|72|||
150041752|NCT00123422|541291946|FG000|Overall Study|Physician Decision|2|||
150041753|NCT00123422|541291947|FG001|Overall Study|Physician Decision|2|||
150041754|NCT00123422|541291948|FG002|Overall Study|Physician Decision|6|||
150041755|NCT00123422|541291946|FG000|Overall Study|Withdrawal by Subject|1|||
150041756|NCT00123422|541291947|FG001|Overall Study|Withdrawal by Subject|2|||
150041757|NCT00123422|541291948|FG002|Overall Study|Withdrawal by Subject|2|||
150041758|NCT00123422|541291946|FG000|Overall Study|Lost to Follow-up|1|||
150041759|NCT00123422|541291947|FG001|Overall Study|Lost to Follow-up|2|||
150041760|NCT00123422|541291948|FG002|Overall Study|Lost to Follow-up|2|||
150041761|NCT04555616|541291949|FG000|Overall Study|Death|1|||
150041762|NCT04555616|541291950|FG001|Overall Study|Death|0|||
150041763|NCT04555616|541291951|FG002|Overall Study|Death|1|||
150041764|NCT04555616|541291949|FG000|Overall Study|Withdrawal by Subject|2|||
150041765|NCT04555616|541291950|FG001|Overall Study|Withdrawal by Subject|1|||
150041766|NCT04555616|541291951|FG002|Overall Study|Withdrawal by Subject|0|||
150041767|NCT01938716|541291952|FG000|Overall Study|Physician Decision|2|||
150041768|NCT01938716|541291952|FG000|Overall Study|Withdrawal by Subject|2|||
150041769|NCT04455815|541291954|FG000|Randomisation Phase|Adverse Event|1|||
150041770|NCT04455815|541291955|FG001|Randomisation Phase|Adverse Event|0|||
150041771|NCT04455815|541291954|FG000|Treatment Phase|Adverse Event|0|||
150041772|NCT04455815|541291955|FG001|Treatment Phase|Adverse Event|1|||
150041773|NCT04455815|541291954|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
150041774|NCT04455815|541291955|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
150041775|NCT04455815|541291954|FG000|Treatment Phase|Withdrawal by Subject|1|||
150041776|NCT04455815|541291955|FG001|Treatment Phase|Withdrawal by Subject|1|||
150041777|NCT03219528|541291956|FG000|Overall Study|Lost to Follow-up|5|||
150041778|NCT03219528|541291957|FG001|Overall Study|Lost to Follow-up|4|||
150041779|NCT03219528|541291956|FG000|Overall Study|Withdrawal by Subject|4|||
150041780|NCT03219528|541291957|FG001|Overall Study|Withdrawal by Subject|4|||
150041781|NCT02120898|541291958|FG000|Overall Study|Withdrawal by Subject|4|||
150174052|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
149872439|NCT02393248|540662721|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872440|NCT02393248|540662722|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872441|NCT02393248|540662723|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
149872442|NCT02393248|540662724|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
149872443|NCT03560986|540662725|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
149872444|NCT03560986|540662726|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
150041782|NCT02120898|541291959|FG001|Overall Study|Withdrawal by Subject|2|||
150041783|NCT02120898|541291960|FG002|Overall Study|Withdrawal by Subject|2|||
150041784|NCT02120898|541291958|FG000|Overall Study|Non-compliance with study drug|3|||
150041785|NCT02120898|541291959|FG001|Overall Study|Non-compliance with study drug|0|||
150041786|NCT02120898|541291960|FG002|Overall Study|Non-compliance with study drug|0|||
150041787|NCT02120898|541291958|FG000|Overall Study|Adverse Event|1|||
150041788|NCT02120898|541291959|FG001|Overall Study|Adverse Event|2|||
150041789|NCT02120898|541291960|FG002|Overall Study|Adverse Event|1|||
150041790|NCT02120898|541291958|FG000|Overall Study|Protocol Violation|1|||
150041791|NCT02120898|541291959|FG001|Overall Study|Protocol Violation|2|||
150041792|NCT02120898|541291960|FG002|Overall Study|Protocol Violation|0|||
150041793|NCT02120898|541291958|FG000|Overall Study|Lost to Follow-up|0|||
150041794|NCT02120898|541291959|FG001|Overall Study|Lost to Follow-up|0|||
150041795|NCT02120898|541291960|FG002|Overall Study|Lost to Follow-up|1|||
150041796|NCT00927953|541291961|FG000|Overall Study|Death|2|||
150041797|NCT00927953|541291962|FG001|Overall Study|Death|1|||
150041798|NCT00724698|541291963|FG000|Overall Study|Adverse Event|9|||
150041799|NCT00724698|541291963|FG000|Overall Study|Failure of Therapy|4|||
150041800|NCT00724698|541291963|FG000|Overall Study|Poor Compliance|16|||
150041801|NCT00724698|541291963|FG000|Overall Study|Lost to Follow-up|36|||
150041802|NCT00724698|541291963|FG000|Overall Study|No Info|25|||
150041803|NCT05021978|541291966|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
150041804|NCT05021978|541291967|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
150041805|NCT05021978|541291968|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
150041806|NCT05021978|541291969|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
150041807|NCT05021978|541291966|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
150041808|NCT05021978|541291967|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
150041809|NCT05021978|541291968|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
150041810|NCT05021978|541291969|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
150041811|NCT00196313|541291970|FG000|Overall Study|Protocol Violation|2|||
150041812|NCT00196313|541291971|FG001|Overall Study|Protocol Violation|3|||
150041813|NCT00196313|541291970|FG000|Overall Study|Withdrawal by Subject|3|||
150041814|NCT00196313|541291971|FG001|Overall Study|Withdrawal by Subject|1|||
150041815|NCT00196313|541291970|FG000|Overall Study|Adverse Event|3|||
150041816|NCT00196313|541291971|FG001|Overall Study|Adverse Event|1|||
150041817|NCT00196313|541291970|FG000|Overall Study|Subject Pregnant|1|||
150041818|NCT00196313|541291971|FG001|Overall Study|Subject Pregnant|1|||
150041819|NCT00196313|541291970|FG000|Overall Study|Lost to Follow-up|2|||
150041820|NCT00196313|541291971|FG001|Overall Study|Lost to Follow-up|2|||
150041821|NCT01411891|541291974|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
150041822|NCT01411891|541291975|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
150041823|NCT00414596|541291977|FG000|Overall Study|Protocol Violation|2|||
150041824|NCT04614974|541291978|FG000|Overall Study|Lost to Follow-up|14|||
150041825|NCT04614974|541291979|FG001|Overall Study|Lost to Follow-up|11|||
150041826|NCT00658359|541291980|FG000|Overall Study|Death|3|||
149872445|NCT03560986|540662725|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
149872446|NCT03560986|540662726|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
149872447|NCT03560986|540662725|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
149872448|NCT03560986|540662726|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
149872449|NCT03560986|540662725|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
149872450|NCT03560986|540662726|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
149872451|NCT03560986|540662725|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
149872452|NCT03560986|540662726|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
149872453|NCT03560986|540662725|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
149872454|NCT03560986|540662726|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
150041827|NCT00658359|541291981|FG001|Overall Study|Death|1|||
150041828|NCT00658359|541291982|FG002|Overall Study|Death|2|||
150041829|NCT00658359|541291980|FG000|Overall Study|Adverse Event|13|||
150041830|NCT00658359|541291981|FG001|Overall Study|Adverse Event|6|||
150041831|NCT00658359|541291982|FG002|Overall Study|Adverse Event|9|||
149872455|NCT03560986|540662725|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
149872456|NCT03560986|540662726|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
149872457|NCT02603393|540662727|FG000|Overall Study|Patient/guardian decision|32|||
149872458|NCT02603393|540662728|FG001|Overall Study|Patient/guardian decision|18|||
149872459|NCT02603393|540662727|FG000|Overall Study|Adverse Event|17|||
149872460|NCT02603393|540662728|FG001|Overall Study|Adverse Event|15|||
149872461|NCT02603393|540662727|FG000|Overall Study|Technical problems|4|||
149872462|NCT02603393|540662728|FG001|Overall Study|Technical problems|7|||
149872463|NCT02603393|540662727|FG000|Overall Study|Lack of Efficacy|7|||
149872464|NCT02603393|540662728|FG001|Overall Study|Lack of Efficacy|2|||
149872465|NCT02603393|540662727|FG000|Overall Study|Death|3|||
149872466|NCT02603393|540662728|FG001|Overall Study|Death|4|||
149872467|NCT02603393|540662727|FG000|Overall Study|Physician Decision|3|||
149872468|NCT02603393|540662728|FG001|Overall Study|Physician Decision|3|||
149872469|NCT02603393|540662727|FG000|Overall Study|Protocol deviation|2|||
149872470|NCT02603393|540662728|FG001|Overall Study|Protocol deviation|3|||
149872471|NCT02603393|540662727|FG000|Overall Study|Lost to Follow-up|1|||
149872472|NCT02603393|540662728|FG001|Overall Study|Lost to Follow-up|2|||
150174053|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
150174054|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149872473|NCT02603393|540662727|FG000|Overall Study|Non-compliance with study treatment|1|||
149872474|NCT02603393|540662728|FG001|Overall Study|Non-compliance with study treatment|0|||
149872475|NCT02603393|540662727|FG000|Overall Study|Sponsor decision|1|||
149872476|NCT02603393|540662728|FG001|Overall Study|Sponsor decision|0|||
149872477|NCT01868893|540662729|FG000|Overall Study|Adverse Event|2|||
149872478|NCT01868893|540662729|FG000|Overall Study|Commercial availability of study drug|17|||
149872479|NCT01868893|540662729|FG000|Overall Study|Neutropenia|1|||
149872480|NCT01857271|540662730|FG000|Overall Study|Lost to Follow-up|1|||
149872481|NCT01783548|540662731|FG000|Overall Study|Adverse Event|8|||
149872482|NCT01783548|540662732|FG001|Overall Study|Adverse Event|4|||
149872483|NCT01783548|540662731|FG000|Overall Study|Withdrawal by Subject|11|||
149872484|NCT01783548|540662732|FG001|Overall Study|Withdrawal by Subject|8|||
149872485|NCT01783548|540662731|FG000|Overall Study|Non-compliance|4|||
149872486|NCT01783548|540662732|FG001|Overall Study|Non-compliance|0|||
149872487|NCT01783548|540662731|FG000|Overall Study|Protocol Violation|2|||
149872488|NCT01783548|540662732|FG001|Overall Study|Protocol Violation|2|||
149872489|NCT01783548|540662731|FG000|Overall Study|Lost to Follow-up|8|||
149872490|NCT01783548|540662732|FG001|Overall Study|Lost to Follow-up|3|||
149872491|NCT01783548|540662731|FG000|Overall Study|Lack of Efficacy|1|||
149872492|NCT01783548|540662732|FG001|Overall Study|Lack of Efficacy|1|||
149872493|NCT03825341|540662733|FG000|Overall Study|Withdrawal by Subject|0|||
149872494|NCT03825341|540662734|FG001|Overall Study|Withdrawal by Subject|1|||
149872495|NCT04053465|540662740|FG000|Overall Study|Withdrawal by Subject|4|||
149872496|NCT04053465|540662741|FG001|Overall Study|Withdrawal by Subject|4|||
149872497|NCT02885181|540662742|FG000|Overall Study|Investigator's Discretion|0|||
149963383|NCT00992394|540999892|FG001|Overall Study|Protocol Violation|4|||
149963384|NCT00992394|540999891|FG000|Overall Study|Lost to Follow-up|2|||
149963385|NCT00992394|540999892|FG001|Overall Study|Lost to Follow-up|0|||
149963386|NCT00992394|540999891|FG000|Overall Study|Other event|1|||
149963387|NCT00992394|540999892|FG001|Overall Study|Other event|0|||
149963388|NCT00561821|540999893|FG000|Overall Study|Not treated|0|||
149963389|NCT00561821|540999894|FG001|Overall Study|Not treated|0|||
149963390|NCT00561821|540999895|FG002|Overall Study|Not treated|1|||
149963391|NCT00561821|540999896|FG003|Overall Study|Not treated|0|||
149963392|NCT00561821|540999893|FG000|Overall Study|Withdrawal by Subject|0|||
149963393|NCT00561821|540999894|FG001|Overall Study|Withdrawal by Subject|1|||
149963394|NCT00561821|540999895|FG002|Overall Study|Withdrawal by Subject|0|||
149963395|NCT00561821|540999896|FG003|Overall Study|Withdrawal by Subject|2|||
149963396|NCT00561821|540999893|FG000|Overall Study|Reasons not related to trial|2|||
149963397|NCT00561821|540999894|FG001|Overall Study|Reasons not related to trial|1|||
149963398|NCT00561821|540999895|FG002|Overall Study|Reasons not related to trial|0|||
149963399|NCT00561821|540999896|FG003|Overall Study|Reasons not related to trial|0|||
149963400|NCT00561821|540999893|FG000|Overall Study|Other (reason not specified)|1|||
149963401|NCT00561821|540999894|FG001|Overall Study|Other (reason not specified)|1|||
149963402|NCT00561821|540999895|FG002|Overall Study|Other (reason not specified)|0|||
150041832|NCT00658359|541291980|FG000|Overall Study|Protocol Violation|1|||
149872498|NCT02885181|540662743|FG001|Overall Study|Investigator's Discretion|1|||
149963403|NCT00561821|540999896|FG003|Overall Study|Other (reason not specified)|0|||
149963404|NCT00561821|540999893|FG000|Overall Study|Adverse Event|2|||
149872499|NCT02885181|540662744|FG002|Overall Study|Investigator's Discretion|0|||
149872500|NCT02885181|540662745|FG003|Overall Study|Investigator's Discretion|1|||
149872501|NCT02885181|540662742|FG000|Overall Study|Adverse Event|0|||
149872502|NCT02885181|540662743|FG001|Overall Study|Adverse Event|0|||
149872503|NCT02885181|540662744|FG002|Overall Study|Adverse Event|0|||
149872504|NCT02885181|540662745|FG003|Overall Study|Adverse Event|1|||
149872505|NCT02885181|540662742|FG000|Overall Study|Withdrawal by Subject|0|||
149872506|NCT02885181|540662743|FG001|Overall Study|Withdrawal by Subject|0|||
150041833|NCT00658359|541291981|FG001|Overall Study|Protocol Violation|0|||
150041834|NCT00658359|541291982|FG002|Overall Study|Protocol Violation|0|||
150041835|NCT00658359|541291980|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
150041836|NCT00658359|541291981|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
150041837|NCT00658359|541291982|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
150041838|NCT00658359|541291980|FG000|Overall Study|Withdrawal by Subject|7|||
150041839|NCT00658359|541291981|FG001|Overall Study|Withdrawal by Subject|4|||
150041840|NCT00658359|541291982|FG002|Overall Study|Withdrawal by Subject|2|||
150041841|NCT00658359|541291980|FG000|Overall Study|Lost to Follow-up|2|||
150041842|NCT00658359|541291981|FG001|Overall Study|Lost to Follow-up|2|||
150041843|NCT00658359|541291982|FG002|Overall Study|Lost to Follow-up|4|||
150041844|NCT00658359|541291980|FG000|Overall Study|Lack of Efficacy|0|||
150041845|NCT00658359|541291981|FG001|Overall Study|Lack of Efficacy|1|||
150041846|NCT00658359|541291982|FG002|Overall Study|Lack of Efficacy|0|||
150041847|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Adverse Event|9|||
149872507|NCT02885181|540662744|FG002|Overall Study|Withdrawal by Subject|0|||
149872508|NCT02885181|540662745|FG003|Overall Study|Withdrawal by Subject|1|||
150041848|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Adverse Event|3|||
149872509|NCT03317834|540662746|FG000|Overall Study|Death|2|||
149872510|NCT03317834|540662746|FG000|Overall Study|Device Revision|5|||
149872511|NCT03317834|540662746|FG000|Overall Study|Withdrawal by Subject|13|||
150041849|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Death|7|||
149872512|NCT03317834|540662746|FG000|Overall Study|Lost to Follow-up|13|||
150041850|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Death|7|||
150041851|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
150041852|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
150041853|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Physician Decision|1|||
150041854|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Physician Decision|0|||
150041855|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
150041856|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
150041857|NCT02558296|541291983|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
150041858|NCT02558296|541291984|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
150041859|NCT02558296|541291983|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
150041860|NCT02558296|541291984|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
150041861|NCT02558296|541291983|FG000|Completed the Study|Adverse Event|14|||
150041862|NCT02558296|541291984|FG001|Completed the Study|Adverse Event|5|||
150041863|NCT02558296|541291983|FG000|Completed the Study|Death|39|||
150041864|NCT02558296|541291984|FG001|Completed the Study|Death|25|||
150041865|NCT02558296|541291983|FG000|Completed the Study|Lost to Follow-up|31|||
150041866|NCT02558296|541291984|FG001|Completed the Study|Lost to Follow-up|23|||
150041867|NCT02558296|541291983|FG000|Completed the Study|Physician Decision|6|||
150041868|NCT02558296|541291984|FG001|Completed the Study|Physician Decision|0|||
150041869|NCT02558296|541291983|FG000|Completed the Study|Protocol Violation|2|||
150041870|NCT02558296|541291984|FG001|Completed the Study|Protocol Violation|1|||
150041871|NCT02558296|541291983|FG000|Completed the Study|Withdrawal by Subject|53|||
150041872|NCT02558296|541291984|FG001|Completed the Study|Withdrawal by Subject|31|||
150041873|NCT02558296|541291983|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
150041874|NCT02558296|541291984|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
150041875|NCT02919995|541291987|FG000|Overall Study|Adverse Event|0|||
150041876|NCT02919995|541291988|FG001|Overall Study|Adverse Event|0|||
150041877|NCT02919995|541291989|FG002|Overall Study|Adverse Event|0|||
150041878|NCT02919995|541291990|FG003|Overall Study|Adverse Event|0|||
150041879|NCT02919995|541291991|FG004|Overall Study|Adverse Event|0|||
150041880|NCT02919995|541291992|FG005|Overall Study|Adverse Event|1|||
150041881|NCT03967444|541291994|FG000|Overall Study|Lost to Follow-up|1|||
150041882|NCT03967444|541291995|FG001|Overall Study|Lost to Follow-up|2|||
150041883|NCT01821118|541292001|FG000|Overall Study|Death|0|||
150041884|NCT01821118|541292002|FG001|Overall Study|Death|1|||
150041885|NCT00318643|541292003|FG000|Overall Study|Adverse Event|0|||
150041886|NCT00318643|541292004|FG001|Overall Study|Adverse Event|0|||
150041887|NCT00318643|541292005|FG002|Overall Study|Adverse Event|0|||
150041888|NCT00318643|541292006|FG003|Overall Study|Adverse Event|0|||
150041889|NCT00318643|541292007|FG004|Overall Study|Adverse Event|1|||
150041890|NCT00318643|541292003|FG000|Overall Study|Participant's Decision|0|||
150041891|NCT00318643|541292004|FG001|Overall Study|Participant's Decision|0|||
150041892|NCT00318643|541292005|FG002|Overall Study|Participant's Decision|0|||
150041893|NCT00318643|541292006|FG003|Overall Study|Participant's Decision|0|||
150041894|NCT00318643|541292007|FG004|Overall Study|Participant's Decision|1|||
150041895|NCT00318643|541292003|FG000|Overall Study|Investigator's Decision|0|||
150041896|NCT00318643|541292004|FG001|Overall Study|Investigator's Decision|0|||
150041897|NCT00318643|541292005|FG002|Overall Study|Investigator's Decision|0|||
150041898|NCT00318643|541292006|FG003|Overall Study|Investigator's Decision|0|||
150041899|NCT00318643|541292007|FG004|Overall Study|Investigator's Decision|1|||
150041900|NCT01812252|541292008|FG000|Overall Study|Persistent Disease|1|||
150041901|NCT01812252|541292009|FG001|Overall Study|Persistent Disease|0|||
150041902|NCT01812252|541292008|FG000|Overall Study|Not transplanted|11|||
150041903|NCT01812252|541292009|FG001|Overall Study|Not transplanted|11|||
150041904|NCT01812252|541292008|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
150041905|NCT01812252|541292009|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
150041906|NCT01812252|541292008|FG000|Overall Study|Withdrawal by Subject|1|||
150041907|NCT01812252|541292009|FG001|Overall Study|Withdrawal by Subject|1|||
150041908|NCT01812252|541292008|FG000|Overall Study|Screen Failure|1|||
150041909|NCT01812252|541292009|FG001|Overall Study|Screen Failure|0|||
150041910|NCT02557139|541292010|FG000|Overall Study|Significant liver elevation|1|||
150041911|NCT02557139|541292011|FG001|Overall Study|Significant liver elevation|0|||
150041912|NCT02557139|541292012|FG002|Overall Study|Significant liver elevation|1|||
150041913|NCT02557139|541292010|FG000|Overall Study|Withdrawal by Subject|1|||
150041914|NCT02557139|541292011|FG001|Overall Study|Withdrawal by Subject|0|||
150041915|NCT02557139|541292012|FG002|Overall Study|Withdrawal by Subject|0|||
150041916|NCT02557139|541292010|FG000|Overall Study|Illness of prohibited medication|0|||
150041917|NCT02557139|541292011|FG001|Overall Study|Illness of prohibited medication|0|||
150174055|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
150041918|NCT02557139|541292012|FG002|Overall Study|Illness of prohibited medication|1|||
150041919|NCT01519921|541292014|FG000|Overall Study|Adverse Event|10|||
150041920|NCT01519921|541292015|FG001|Overall Study|Adverse Event|9|||
150041921|NCT01519921|541292014|FG000|Overall Study|Lack of Efficacy|4|||
150041922|NCT01519921|541292015|FG001|Overall Study|Lack of Efficacy|3|||
150041923|NCT01519921|541292014|FG000|Overall Study|Withdrawal by Subject|3|||
150041924|NCT01519921|541292015|FG001|Overall Study|Withdrawal by Subject|0|||
150041925|NCT01519921|541292014|FG000|Overall Study|Lost to Follow-up|2|||
150041926|NCT01519921|541292015|FG001|Overall Study|Lost to Follow-up|1|||
150041927|NCT01519921|541292014|FG000|Overall Study|Treatment refusal|2|||
150041928|NCT01519921|541292015|FG001|Overall Study|Treatment refusal|1|||
150041929|NCT01519921|541292014|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
150041930|NCT01519921|541292015|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
150041931|NCT01216189|541292016|FG000|Overall Study|Lost to Follow-up|21|||
150041932|NCT01216189|541292017|FG001|Overall Study|Lost to Follow-up|3|||
150041933|NCT01216189|541292016|FG000|Overall Study|Death|4|||
150041934|NCT01216189|541292017|FG001|Overall Study|Death|2|||
150041935|NCT01146795|541292018|FG000|Overall Study|Withdrawal by Subject|4|||
150041936|NCT01146795|541292018|FG000|Overall Study|Adverse Event|6|||
150041937|NCT01146795|541292018|FG000|Overall Study|Still in treatment at study closure|10|||
150041938|NCT05375760|541292019|FG000|Overall Study|Adverse Event|1|||
150041939|NCT05375760|541292020|FG001|Overall Study|Adverse Event|0|||
150041940|NCT05375760|541292019|FG000|Overall Study|Death|0|||
150041941|NCT05375760|541292020|FG001|Overall Study|Death|1|||
150041942|NCT05375760|541292019|FG000|Overall Study|Lost to Follow-up|6|||
150041943|NCT05375760|541292020|FG001|Overall Study|Lost to Follow-up|6|||
150041944|NCT05375760|541292019|FG000|Overall Study|Withdrawal by Subject|17|||
150041945|NCT05375760|541292020|FG001|Overall Study|Withdrawal by Subject|19|||
150041946|NCT05375760|541292019|FG000|Overall Study|Dosing halted by FDA|96|||
150041947|NCT05375760|541292020|FG001|Overall Study|Dosing halted by FDA|100|||
150041948|NCT05375760|541292019|FG000|Overall Study|Not compliant with study visit|2|||
150041949|NCT05375760|541292020|FG001|Overall Study|Not compliant with study visit|0|||
150041950|NCT05375760|541292019|FG000|Overall Study|Physician Decision|1|||
150041951|NCT05375760|541292020|FG001|Overall Study|Physician Decision|0|||
150041952|NCT05375760|541292019|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
150041953|NCT05375760|541292020|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
150041954|NCT05375760|541292019|FG000|Overall Study|Participant moved|1|||
150041955|NCT05375760|541292020|FG001|Overall Study|Participant moved|0|||
150041956|NCT03853109|541292021|FG000|Overall Study|Withdrawal by Subject|0|||
150041957|NCT03853109|541292022|FG001|Overall Study|Withdrawal by Subject|0|||
150041958|NCT03853109|541292023|FG002|Overall Study|Withdrawal by Subject|1|||
150041959|NCT03853109|541292024|FG003|Overall Study|Withdrawal by Subject|2|||
150041960|NCT03853109|541292025|FG004|Overall Study|Withdrawal by Subject|1|||
150041961|NCT03853109|541292026|FG005|Overall Study|Withdrawal by Subject|4|||
150041962|NCT03853109|541292027|FG006|Overall Study|Withdrawal by Subject|5|||
150041963|NCT03853109|541292028|FG007|Overall Study|Withdrawal by Subject|3|||
150041964|NCT03853109|541292021|FG000|Overall Study|Decision by Sponsor|0|||
150041965|NCT03853109|541292022|FG001|Overall Study|Decision by Sponsor|0|||
150041966|NCT03853109|541292023|FG002|Overall Study|Decision by Sponsor|1|||
150041967|NCT03853109|541292024|FG003|Overall Study|Decision by Sponsor|0|||
150041968|NCT03853109|541292025|FG004|Overall Study|Decision by Sponsor|1|||
150041969|NCT03853109|541292026|FG005|Overall Study|Decision by Sponsor|1|||
150041970|NCT03853109|541292027|FG006|Overall Study|Decision by Sponsor|10|||
150041971|NCT03853109|541292028|FG007|Overall Study|Decision by Sponsor|2|||
150041972|NCT03853109|541292021|FG000|Overall Study|Lost to Follow-up|0|||
150041973|NCT03853109|541292022|FG001|Overall Study|Lost to Follow-up|0|||
150041974|NCT03853109|541292023|FG002|Overall Study|Lost to Follow-up|0|||
150041975|NCT03853109|541292024|FG003|Overall Study|Lost to Follow-up|0|||
150041976|NCT03853109|541292025|FG004|Overall Study|Lost to Follow-up|1|||
150041977|NCT03853109|541292026|FG005|Overall Study|Lost to Follow-up|3|||
150041978|NCT03853109|541292027|FG006|Overall Study|Lost to Follow-up|0|||
150041979|NCT03853109|541292028|FG007|Overall Study|Lost to Follow-up|0|||
150041980|NCT03853109|541292021|FG000|Overall Study|Death|2|||
150041981|NCT03853109|541292022|FG001|Overall Study|Death|5|||
150041982|NCT03853109|541292023|FG002|Overall Study|Death|8|||
150041983|NCT03853109|541292024|FG003|Overall Study|Death|10|||
150041984|NCT03853109|541292025|FG004|Overall Study|Death|3|||
150041985|NCT03853109|541292026|FG005|Overall Study|Death|20|||
150041986|NCT03853109|541292027|FG006|Overall Study|Death|10|||
150041987|NCT03853109|541292028|FG007|Overall Study|Death|5|||
150041988|NCT01721044|541292029|FG000|Treatment Period|Adverse Event|7|||
150041989|NCT01721044|541292030|FG001|Treatment Period|Adverse Event|7|||
149963405|NCT00561821|540999894|FG001|Overall Study|Adverse Event|3|||
150041990|NCT01721044|541292031|FG002|Treatment Period|Adverse Event|10|||
150041991|NCT01721044|541292029|FG000|Treatment Period|Death|0|||
150041992|NCT01721044|541292030|FG001|Treatment Period|Death|0|||
150041993|NCT01721044|541292031|FG002|Treatment Period|Death|1|||
150041994|NCT01721044|541292029|FG000|Treatment Period|Lack of Efficacy|16|||
150041995|NCT01721044|541292030|FG001|Treatment Period|Lack of Efficacy|4|||
150041996|NCT01721044|541292031|FG002|Treatment Period|Lack of Efficacy|4|||
150041997|NCT01721044|541292029|FG000|Treatment Period|Lost to Follow-up|0|||
150041998|NCT01721044|541292030|FG001|Treatment Period|Lost to Follow-up|0|||
150041999|NCT01721044|541292031|FG002|Treatment Period|Lost to Follow-up|1|||
150042000|NCT01721044|541292029|FG000|Treatment Period|Physician Decision|1|||
150042001|NCT01721044|541292030|FG001|Treatment Period|Physician Decision|0|||
150042002|NCT01721044|541292031|FG002|Treatment Period|Physician Decision|2|||
150042003|NCT01721044|541292029|FG000|Treatment Period|Protocol Violation|1|||
150042004|NCT01721044|541292030|FG001|Treatment Period|Protocol Violation|0|||
150042005|NCT01721044|541292031|FG002|Treatment Period|Protocol Violation|0|||
150042006|NCT01721044|541292029|FG000|Treatment Period|Withdrawal by Subject|7|||
150042007|NCT01721044|541292030|FG001|Treatment Period|Withdrawal by Subject|6|||
150042008|NCT01721044|541292031|FG002|Treatment Period|Withdrawal by Subject|1|||
150042009|NCT04032093|541292034|FG000|Overall Study|Lost to Follow-up|7|||
150042010|NCT04032093|541292035|FG001|Overall Study|Lost to Follow-up|7|||
150042011|NCT04032093|541292036|FG002|Overall Study|Lost to Follow-up|6|||
150042012|NCT04032093|541292037|FG003|Overall Study|Lost to Follow-up|10|||
150042013|NCT04032093|541292038|FG004|Overall Study|Lost to Follow-up|13|||
149963406|NCT00561821|540999895|FG002|Overall Study|Adverse Event|1|||
150042014|NCT04032093|541292039|FG005|Overall Study|Lost to Follow-up|7|||
150042015|NCT04032093|541292040|FG006|Overall Study|Lost to Follow-up|7|||
150042016|NCT04032093|541292041|FG007|Overall Study|Lost to Follow-up|5|||
150042017|NCT04032093|541292042|FG008|Overall Study|Lost to Follow-up|9|||
150042018|NCT04032093|541292043|FG009|Overall Study|Lost to Follow-up|12|||
150042019|NCT04032093|541292034|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
150042020|NCT04032093|541292035|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150042021|NCT04032093|541292036|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
150042022|NCT04032093|541292037|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
150042023|NCT04032093|541292038|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
150042024|NCT04032093|541292039|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
150042025|NCT04032093|541292040|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
149963407|NCT00561821|540999896|FG003|Overall Study|Adverse Event|1|||
149963408|NCT01657942|540999897|FG000|Overall Study|Alternative Treatment|7|||
149963409|NCT01657942|540999897|FG000|Overall Study|Lost to Follow-up|1|||
149963410|NCT01197300|541001375|FG000|Overall Study|Lost to Follow-up|0|||
149963411|NCT01197300|541001376|FG001|Overall Study|Lost to Follow-up|1|||
149963412|NCT01197300|541001375|FG000|Overall Study|Protocol Violation|0|||
149963413|NCT01197300|541001376|FG001|Overall Study|Protocol Violation|1|||
149963414|NCT04744831|541001377|FG000|Overall Study|Progressive Disease|31|||
149963415|NCT04744831|541001378|FG001|Overall Study|Progressive Disease|27|||
149963416|NCT04744831|541001379|FG002|Overall Study|Progressive Disease|25|||
149963417|NCT04744831|541001377|FG000|Overall Study|Adverse Event|3|||
149963418|NCT04744831|541001378|FG001|Overall Study|Adverse Event|3|||
149963419|NCT04744831|541001379|FG002|Overall Study|Adverse Event|3|||
149963420|NCT04744831|541001377|FG000|Overall Study|Clinical Progression|3|||
149963421|NCT04744831|541001378|FG001|Overall Study|Clinical Progression|2|||
149963422|NCT04744831|541001379|FG002|Overall Study|Clinical Progression|5|||
149963423|NCT04744831|541001377|FG000|Overall Study|Other|0|||
149963424|NCT04744831|541001378|FG001|Overall Study|Other|2|||
149963425|NCT04744831|541001379|FG002|Overall Study|Other|1|||
149963426|NCT04744831|541001377|FG000|Overall Study|Death|0|||
149963427|NCT04744831|541001378|FG001|Overall Study|Death|2|||
149963428|NCT04744831|541001379|FG002|Overall Study|Death|1|||
149963429|NCT03443401|541001390|FG000|Overall Study|Lost to Follow-up|13|||
149963430|NCT03443401|541001390|FG000|Overall Study|Influential outlier|1|||
149963431|NCT02363283|541001391|FG000|Overall Study|Withdrawal by Subject|1|||
149963432|NCT02363283|541001391|FG000|Overall Study|Not eligible due to transaminitis|1|||
150174056|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149963433|NCT01394185|541001398|FG000|Overall Study|Withdrawal by Subject|2|||
149963434|NCT01394185|541001399|FG001|Overall Study|Withdrawal by Subject|0|||
149963435|NCT01394185|541001400|FG002|Overall Study|Withdrawal by Subject|0|||
149963436|NCT01394185|541001401|FG003|Overall Study|Withdrawal by Subject|0|||
150042026|NCT04032093|541292041|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
150042027|NCT04032093|541292042|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
149963437|NCT01394185|541001402|FG004|Overall Study|Withdrawal by Subject|1|||
150042028|NCT04032093|541292043|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
150042029|NCT04032093|541292034|FG000|Overall Study|Other|1|||
150042030|NCT04032093|541292035|FG001|Overall Study|Other|0|||
150042031|NCT04032093|541292036|FG002|Overall Study|Other|0|||
150042032|NCT04032093|541292037|FG003|Overall Study|Other|1|||
150042033|NCT04032093|541292038|FG004|Overall Study|Other|1|||
150042034|NCT04032093|541292039|FG005|Overall Study|Other|0|||
150042035|NCT04032093|541292040|FG006|Overall Study|Other|0|||
150042036|NCT04032093|541292041|FG007|Overall Study|Other|0|||
150042037|NCT04032093|541292042|FG008|Overall Study|Other|0|||
150042038|NCT04032093|541292043|FG009|Overall Study|Other|1|||
150042039|NCT04032093|541292034|FG000|Overall Study|Withdrawal by Subject|1|||
150042040|NCT04032093|541292035|FG001|Overall Study|Withdrawal by Subject|3|||
150042041|NCT04032093|541292036|FG002|Overall Study|Withdrawal by Subject|2|||
150042042|NCT04032093|541292037|FG003|Overall Study|Withdrawal by Subject|2|||
150042043|NCT04032093|541292038|FG004|Overall Study|Withdrawal by Subject|3|||
150042044|NCT04032093|541292039|FG005|Overall Study|Withdrawal by Subject|0|||
149872513|NCT01517373|540662749|FG000|Run-in Period|Death|1|||
149872514|NCT01517373|540662750|FG001|Run-in Period|Death|0|||
149872515|NCT01517373|540662751|FG002|Run-in Period|Death|0|||
149872516|NCT01517373|540662752|FG003|Run-in Period|Death|0|||
149872517|NCT01517373|540662753|FG004|Run-in Period|Death|0|||
149872518|NCT01517373|540662754|FG005|Run-in Period|Death|0|||
149872519|NCT01517373|540662749|FG000|Run-in Period|Adverse Event|5|||
149872520|NCT01517373|540662750|FG001|Run-in Period|Adverse Event|0|||
149872521|NCT01517373|540662751|FG002|Run-in Period|Adverse Event|0|||
149872522|NCT01517373|540662752|FG003|Run-in Period|Adverse Event|0|||
149872523|NCT01517373|540662753|FG004|Run-in Period|Adverse Event|0|||
149872524|NCT01517373|540662754|FG005|Run-in Period|Adverse Event|0|||
150042045|NCT04032093|541292040|FG006|Overall Study|Withdrawal by Subject|0|||
150042046|NCT04032093|541292041|FG007|Overall Study|Withdrawal by Subject|0|||
150042047|NCT04032093|541292042|FG008|Overall Study|Withdrawal by Subject|0|||
150042048|NCT04032093|541292043|FG009|Overall Study|Withdrawal by Subject|0|||
150042049|NCT04032093|541292034|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149872525|NCT01517373|540662749|FG000|Run-in Period|Did not meet eligibility criteria|34|||
149872526|NCT01517373|540662750|FG001|Run-in Period|Did not meet eligibility criteria|0|||
149872527|NCT01517373|540662751|FG002|Run-in Period|Did not meet eligibility criteria|0|||
150042050|NCT04032093|541292035|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150042051|NCT04032093|541292036|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150042052|NCT04032093|541292037|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149872528|NCT01517373|540662752|FG003|Run-in Period|Did not meet eligibility criteria|0|||
149872529|NCT01517373|540662753|FG004|Run-in Period|Did not meet eligibility criteria|0|||
149872530|NCT01517373|540662754|FG005|Run-in Period|Did not meet eligibility criteria|0|||
149872531|NCT01517373|540662749|FG000|Run-in Period|Lost to Follow-up|1|||
149872532|NCT01517373|540662750|FG001|Run-in Period|Lost to Follow-up|0|||
149872533|NCT01517373|540662751|FG002|Run-in Period|Lost to Follow-up|0|||
149872534|NCT01517373|540662752|FG003|Run-in Period|Lost to Follow-up|0|||
149872535|NCT01517373|540662753|FG004|Run-in Period|Lost to Follow-up|0|||
149872536|NCT01517373|540662754|FG005|Run-in Period|Lost to Follow-up|0|||
149963438|NCT01394185|541001403|FG005|Overall Study|Withdrawal by Subject|0|||
149963439|NCT01394185|541001398|FG000|Overall Study|Change in protocol|3|||
149963440|NCT01394185|541001399|FG001|Overall Study|Change in protocol|0|||
149963441|NCT01394185|541001400|FG002|Overall Study|Change in protocol|0|||
149963442|NCT01394185|541001401|FG003|Overall Study|Change in protocol|0|||
149963443|NCT01394185|541001402|FG004|Overall Study|Change in protocol|3|||
149963444|NCT01394185|541001403|FG005|Overall Study|Change in protocol|0|||
149963445|NCT01394185|541001398|FG000|Overall Study|Protocol Violation|1|||
149963446|NCT01394185|541001399|FG001|Overall Study|Protocol Violation|0|||
149963447|NCT01394185|541001400|FG002|Overall Study|Protocol Violation|0|||
149963448|NCT01394185|541001401|FG003|Overall Study|Protocol Violation|1|||
149963449|NCT01394185|541001402|FG004|Overall Study|Protocol Violation|0|||
149963450|NCT01394185|541001403|FG005|Overall Study|Protocol Violation|1|||
149963451|NCT05401409|541001404|FG000|Overall Study|Lost to Follow-up|1|||
149963452|NCT05401409|541001405|FG001|Overall Study|Lost to Follow-up|0|||
149963453|NCT02371889|541001406|FG000|Overall Study|Adverse medication effect|11|||
149963454|NCT02371889|541001407|FG001|Overall Study|Adverse medication effect|2|||
149963455|NCT02371889|541001406|FG000|Overall Study|Lost to Follow-up|6|||
149963456|NCT02371889|541001407|FG001|Overall Study|Lost to Follow-up|5|||
149963457|NCT02371889|541001406|FG000|Overall Study|Personal time constraints|2|||
149963458|NCT02371889|541001407|FG001|Overall Study|Personal time constraints|4|||
149963459|NCT02371889|541001406|FG000|Overall Study|Lack of Efficacy|0|||
149963460|NCT02371889|541001407|FG001|Overall Study|Lack of Efficacy|2|||
149963461|NCT02371889|541001406|FG000|Overall Study|Relapse|0|||
149963462|NCT02371889|541001407|FG001|Overall Study|Relapse|1|||
149963463|NCT06844812|541001408|FG000|Overall Study|Lost to Follow-up|5|||
149963464|NCT06844812|541001408|FG000|Overall Study|stigmatization concerns|2|||
149963465|NCT06844812|541001408|FG000|Overall Study|medication refusal|2|||
149963466|NCT06844812|541001408|FG000|Overall Study|concerns about possible side effects|2|||
149963467|NCT06844812|541001408|FG000|Overall Study|wanting to seek another specialist opinion|2|||
149963468|NCT06844812|541001408|FG000|Overall Study|side effects (dizziness)|1|||
149963469|NCT05520333|541001409|FG000|Overall Study|Lost to Follow-up|3|||
149963470|NCT05520333|541001410|FG001|Overall Study|Lost to Follow-up|6|||
149963471|NCT02410200|541001413|FG000|Overall Study|Adverse Event|2|||
149963472|NCT02144337|541001434|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
150042053|NCT04032093|541292038|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
150042054|NCT04032093|541292039|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
150042055|NCT04032093|541292040|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
150042056|NCT04032093|541292041|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
150042057|NCT04032093|541292042|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
150042058|NCT04032093|541292043|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
150042059|NCT04032093|541292034|FG000|Overall Study|Adverse Event|0|||
150042060|NCT04032093|541292035|FG001|Overall Study|Adverse Event|0|||
150042061|NCT04032093|541292036|FG002|Overall Study|Adverse Event|0|||
150042062|NCT04032093|541292037|FG003|Overall Study|Adverse Event|0|||
150042063|NCT04032093|541292038|FG004|Overall Study|Adverse Event|0|||
150042064|NCT04032093|541292039|FG005|Overall Study|Adverse Event|0|||
150042065|NCT04032093|541292040|FG006|Overall Study|Adverse Event|0|||
150042066|NCT04032093|541292041|FG007|Overall Study|Adverse Event|0|||
150042067|NCT04032093|541292042|FG008|Overall Study|Adverse Event|0|||
150042068|NCT04032093|541292043|FG009|Overall Study|Adverse Event|1|||
150042069|NCT04032093|541292034|FG000|Overall Study|Physician Decision|0|||
150042070|NCT04032093|541292035|FG001|Overall Study|Physician Decision|0|||
150042071|NCT04032093|541292036|FG002|Overall Study|Physician Decision|0|||
150042072|NCT04032093|541292037|FG003|Overall Study|Physician Decision|0|||
150042073|NCT04032093|541292038|FG004|Overall Study|Physician Decision|0|||
150042074|NCT04032093|541292039|FG005|Overall Study|Physician Decision|1|||
150042075|NCT04032093|541292040|FG006|Overall Study|Physician Decision|0|||
150042076|NCT04032093|541292041|FG007|Overall Study|Physician Decision|0|||
150042077|NCT04032093|541292042|FG008|Overall Study|Physician Decision|0|||
150042078|NCT04032093|541292043|FG009|Overall Study|Physician Decision|0|||
150042079|NCT00960999|541292048|FG000|Overall Study|Withdrawal by Subject|1|||
150042080|NCT00960999|541292049|FG001|Overall Study|Withdrawal by Subject|0|||
150042081|NCT00960999|541292048|FG000|Overall Study|Protocol Violation|5|||
150042082|NCT00960999|541292049|FG001|Overall Study|Protocol Violation|2|||
150042083|NCT00960999|541292048|FG000|Overall Study|RT dose constraints not met|2|||
150042084|NCT00960999|541292049|FG001|Overall Study|RT dose constraints not met|0|||
150042085|NCT00515619|541292050|FG000|Overall Study|Adverse Event|34|||
150042086|NCT00515619|541292050|FG000|Overall Study|Lack of Efficacy|92|||
150042087|NCT00515619|541292050|FG000|Overall Study|Withdrawal by Subject|66|||
150042088|NCT00515619|541292050|FG000|Overall Study|Protocol Violation|3|||
150042089|NCT00515619|541292050|FG000|Overall Study|Lost to Follow-up|4|||
150042090|NCT00515619|541292050|FG000|Overall Study|Unsatisfactory compliance|6|||
150042091|NCT00515619|541292050|FG000|Overall Study|Other: Site discontinuing trials|2|||
150042092|NCT00515619|541292050|FG000|Overall Study|Other: Subject cannot attend visits|2|||
150042093|NCT00515619|541292050|FG000|Overall Study|Other: Subject required surgery|1|||
150042094|NCT00515619|541292050|FG000|Overall Study|Other: Subject moved to another country|1|||
150042095|NCT00515619|541292050|FG000|Overall Study|Other: Investigator decision|1|||
150042096|NCT00515619|541292050|FG000|Overall Study|Other: Subject became pregnant|1|||
150042097|NCT00515619|541292050|FG000|Overall Study|Other: Request from sponsor|1|||
150042098|NCT00515619|541292050|FG000|Overall Study|Other: Drug available on license|1|||
150042099|NCT00515619|541292050|FG000|Overall Study|Other: Subject interested in other AED|1|||
150042100|NCT04721977|541292059|FG000|Overall Study|Death|15|||
150042101|NCT04721977|541292059|FG000|Overall Study|Ongoing|51|||
150042102|NCT02864394|541292060|FG000|Overall Study|Death|184|||
150042103|NCT02864394|541292061|FG001|Overall Study|Death|189|||
150042104|NCT02864394|541292060|FG000|Overall Study|Lost to Follow-up|0|||
150042105|NCT02864394|541292061|FG001|Overall Study|Lost to Follow-up|2|||
150042106|NCT02864394|541292060|FG000|Overall Study|Sponsor Decision|26|||
150042107|NCT02864394|541292061|FG001|Overall Study|Sponsor Decision|11|||
150042108|NCT02864394|541292060|FG000|Overall Study|Withdrawal by Subject|3|||
150042109|NCT02864394|541292061|FG001|Overall Study|Withdrawal by Subject|10|||
150042110|NCT02374450|541292062|FG000|Overall Study|Protocol Violation|0|||
150042111|NCT02374450|541292063|FG001|Overall Study|Protocol Violation|1|||
150042112|NCT02374450|541292064|FG002|Overall Study|Protocol Violation|0|||
150042113|NCT02374450|541292062|FG000|Overall Study|Withdrawal by Subject|91|||
150042114|NCT02374450|541292063|FG001|Overall Study|Withdrawal by Subject|110|||
150042115|NCT02374450|541292064|FG002|Overall Study|Withdrawal by Subject|4|||
150174057|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
150042116|NCT02374450|541292062|FG000|Overall Study|Lost to Follow-up|168|||
150042117|NCT02374450|541292063|FG001|Overall Study|Lost to Follow-up|194|||
150042118|NCT02374450|541292064|FG002|Overall Study|Lost to Follow-up|138|||
150042119|NCT02374450|541292062|FG000|Overall Study|Death|173|||
150042120|NCT02374450|541292063|FG001|Overall Study|Death|185|||
150174058|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
150042121|NCT02374450|541292064|FG002|Overall Study|Death|81|||
150042122|NCT02374450|541292062|FG000|Overall Study|Migrated from the study area|538|||
150042123|NCT02374450|541292063|FG001|Overall Study|Migrated from the study area|648|||
150042124|NCT02374450|541292064|FG002|Overall Study|Migrated from the study area|181|||
150042125|NCT02374450|541292062|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
150042126|NCT02374450|541292063|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
149872537|NCT01517373|540662749|FG000|Run-in Period|Withdrawal by Subject|12|||
149872538|NCT01517373|540662750|FG001|Run-in Period|Withdrawal by Subject|0|||
150042127|NCT02374450|541292064|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
150042128|NCT02374450|541292062|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
150042129|NCT02374450|541292063|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
150042130|NCT02374450|541292064|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
149872539|NCT01517373|540662751|FG002|Run-in Period|Withdrawal by Subject|0|||
150042131|NCT02374450|541292062|FG000|Overall Study|Other|0|||
150042132|NCT02374450|541292063|FG001|Overall Study|Other|21|||
150042133|NCT02374450|541292064|FG002|Overall Study|Other|79|||
150042134|NCT03207763|541293649|FG000|Overall Study|Lost to Follow-up|1|||
150042135|NCT03207763|541293650|FG001|Overall Study|Lost to Follow-up|0|||
150042136|NCT01177397|541293652|FG000|Overall Study|Protocol Violation|0|||
150042137|NCT01177397|541293653|FG001|Overall Study|Protocol Violation|0|||
150042138|NCT01177397|541293654|FG002|Overall Study|Protocol Violation|0|||
150042139|NCT01177397|541293655|FG003|Overall Study|Protocol Violation|0|||
150042140|NCT01177397|541293656|FG004|Overall Study|Protocol Violation|0|||
150042141|NCT01177397|541293657|FG005|Overall Study|Protocol Violation|1|||
150042142|NCT01177397|541293658|FG006|Overall Study|Protocol Violation|0|||
150042143|NCT01177397|541293659|FG007|Overall Study|Protocol Violation|0|||
150042144|NCT01177397|541293660|FG008|Overall Study|Protocol Violation|0|||
150042145|NCT01177397|541293661|FG009|Overall Study|Protocol Violation|0|||
150042146|NCT01177397|541293662|FG010|Overall Study|Protocol Violation|0|||
150042147|NCT01177397|541293663|FG011|Overall Study|Protocol Violation|0|||
150042148|NCT01177397|541293652|FG000|Overall Study|Lost to Follow-up|0|||
150042149|NCT01177397|541293653|FG001|Overall Study|Lost to Follow-up|0|||
150042150|NCT01177397|541293654|FG002|Overall Study|Lost to Follow-up|0|||
150042151|NCT01177397|541293655|FG003|Overall Study|Lost to Follow-up|0|||
150042152|NCT01177397|541293656|FG004|Overall Study|Lost to Follow-up|1|||
150042153|NCT01177397|541293657|FG005|Overall Study|Lost to Follow-up|0|||
150042154|NCT01177397|541293658|FG006|Overall Study|Lost to Follow-up|0|||
150042155|NCT01177397|541293659|FG007|Overall Study|Lost to Follow-up|2|||
150042156|NCT01177397|541293660|FG008|Overall Study|Lost to Follow-up|0|||
150042157|NCT01177397|541293661|FG009|Overall Study|Lost to Follow-up|0|||
150042158|NCT01177397|541293662|FG010|Overall Study|Lost to Follow-up|0|||
150042159|NCT01177397|541293663|FG011|Overall Study|Lost to Follow-up|0|||
150042160|NCT01177397|541293652|FG000|Overall Study|Death|0|||
150042161|NCT01177397|541293653|FG001|Overall Study|Death|0|||
150174059|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
150174060|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
150174061|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
149872540|NCT01517373|540662752|FG003|Run-in Period|Withdrawal by Subject|0|||
150042162|NCT01177397|541293654|FG002|Overall Study|Death|1|||
150042163|NCT01177397|541293655|FG003|Overall Study|Death|1|||
150042164|NCT01177397|541293656|FG004|Overall Study|Death|0|||
150042165|NCT01177397|541293657|FG005|Overall Study|Death|0|||
150042166|NCT01177397|541293658|FG006|Overall Study|Death|0|||
149872541|NCT01517373|540662753|FG004|Run-in Period|Withdrawal by Subject|0|||
149872542|NCT01517373|540662754|FG005|Run-in Period|Withdrawal by Subject|0|||
149872543|NCT01517373|540662749|FG000|Run-in Period|Sponsor Decision|3|||
149872544|NCT01517373|540662750|FG001|Run-in Period|Sponsor Decision|0|||
149872545|NCT01517373|540662751|FG002|Run-in Period|Sponsor Decision|0|||
149872546|NCT01517373|540662752|FG003|Run-in Period|Sponsor Decision|0|||
149872547|NCT01517373|540662753|FG004|Run-in Period|Sponsor Decision|0|||
149963473|NCT02144337|541001435|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
149963474|NCT02144337|541001434|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
150042167|NCT01177397|541293659|FG007|Overall Study|Death|5|||
150042168|NCT01177397|541293660|FG008|Overall Study|Death|2|||
150042169|NCT01177397|541293661|FG009|Overall Study|Death|1|||
150042170|NCT01177397|541293662|FG010|Overall Study|Death|0|||
150042171|NCT01177397|541293663|FG011|Overall Study|Death|0|||
150042172|NCT01177397|541293652|FG000|Overall Study|Withdrawal by Subject|0|||
150042173|NCT01177397|541293653|FG001|Overall Study|Withdrawal by Subject|0|||
150042174|NCT01177397|541293654|FG002|Overall Study|Withdrawal by Subject|1|||
150042175|NCT01177397|541293655|FG003|Overall Study|Withdrawal by Subject|1|||
150042176|NCT01177397|541293656|FG004|Overall Study|Withdrawal by Subject|1|||
149963475|NCT02144337|541001435|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
149963476|NCT02144337|541001434|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
149963477|NCT02144337|541001435|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
149963478|NCT02144337|541001434|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
149963479|NCT02144337|541001435|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
149963480|NCT02144337|541001434|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
149963481|NCT02144337|541001435|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
149963482|NCT00203242|541001436|FG000|Overall Study|Lost to Follow-up|1|||
149963483|NCT00866775|541001437|FG000|Overall Study|Adverse Event|5|||
149963484|NCT00866775|541001438|FG001|Overall Study|Adverse Event|19|||
149963485|NCT00866775|541001437|FG000|Overall Study|Death|1|||
150042177|NCT01177397|541293657|FG005|Overall Study|Withdrawal by Subject|2|||
150042178|NCT01177397|541293658|FG006|Overall Study|Withdrawal by Subject|0|||
150042179|NCT01177397|541293659|FG007|Overall Study|Withdrawal by Subject|5|||
150042180|NCT01177397|541293660|FG008|Overall Study|Withdrawal by Subject|9|||
150042181|NCT01177397|541293661|FG009|Overall Study|Withdrawal by Subject|1|||
150042182|NCT01177397|541293662|FG010|Overall Study|Withdrawal by Subject|1|||
149963486|NCT00866775|541001438|FG001|Overall Study|Death|0|||
150042183|NCT01177397|541293663|FG011|Overall Study|Withdrawal by Subject|0|||
150042184|NCT01177397|541293652|FG000|Overall Study|Adverse Event|0|||
150042185|NCT01177397|541293653|FG001|Overall Study|Adverse Event|0|||
150042186|NCT01177397|541293654|FG002|Overall Study|Adverse Event|1|||
150042187|NCT01177397|541293655|FG003|Overall Study|Adverse Event|2|||
150042188|NCT01177397|541293656|FG004|Overall Study|Adverse Event|0|||
150042189|NCT01177397|541293657|FG005|Overall Study|Adverse Event|12|||
150042190|NCT01177397|541293658|FG006|Overall Study|Adverse Event|1|||
150042191|NCT01177397|541293659|FG007|Overall Study|Adverse Event|14|||
150042192|NCT01177397|541293660|FG008|Overall Study|Adverse Event|8|||
150042193|NCT01177397|541293661|FG009|Overall Study|Adverse Event|6|||
150042194|NCT01177397|541293662|FG010|Overall Study|Adverse Event|3|||
150042195|NCT01177397|541293663|FG011|Overall Study|Adverse Event|7|||
150042196|NCT01177397|541293652|FG000|Overall Study|Disease progression|1|||
150042197|NCT01177397|541293653|FG001|Overall Study|Disease progression|2|||
150042198|NCT01177397|541293654|FG002|Overall Study|Disease progression|5|||
150042199|NCT01177397|541293655|FG003|Overall Study|Disease progression|5|||
150042200|NCT01177397|541293656|FG004|Overall Study|Disease progression|4|||
150042201|NCT01177397|541293657|FG005|Overall Study|Disease progression|10|||
150042202|NCT01177397|541293658|FG006|Overall Study|Disease progression|10|||
150042203|NCT01177397|541293659|FG007|Overall Study|Disease progression|21|||
150042204|NCT01177397|541293660|FG008|Overall Study|Disease progression|18|||
150042205|NCT01177397|541293661|FG009|Overall Study|Disease progression|12|||
150042206|NCT01177397|541293662|FG010|Overall Study|Disease progression|10|||
149872548|NCT01517373|540662754|FG005|Run-in Period|Sponsor Decision|0|||
150042207|NCT01177397|541293663|FG011|Overall Study|Disease progression|8|||
150042208|NCT01177397|541293652|FG000|Overall Study|Other reasons|0|||
150042209|NCT01177397|541293653|FG001|Overall Study|Other reasons|0|||
150042210|NCT01177397|541293654|FG002|Overall Study|Other reasons|1|||
150042211|NCT01177397|541293655|FG003|Overall Study|Other reasons|0|||
150042212|NCT01177397|541293656|FG004|Overall Study|Other reasons|1|||
150042213|NCT01177397|541293657|FG005|Overall Study|Other reasons|1|||
150042214|NCT01177397|541293658|FG006|Overall Study|Other reasons|2|||
150042215|NCT01177397|541293659|FG007|Overall Study|Other reasons|6|||
150042216|NCT01177397|541293660|FG008|Overall Study|Other reasons|10|||
150042217|NCT01177397|541293661|FG009|Overall Study|Other reasons|8|||
150042218|NCT01177397|541293662|FG010|Overall Study|Other reasons|0|||
150042219|NCT01177397|541293663|FG011|Overall Study|Other reasons|2|||
150042220|NCT01358721|541293666|FG000|Overall Study|Withdrawal by Subject|0|||
149872549|NCT01517373|540662749|FG000|Run-in Period|Other|1|||
149872550|NCT01517373|540662750|FG001|Run-in Period|Other|0|||
150042221|NCT01358721|541293667|FG001|Overall Study|Withdrawal by Subject|0|||
150042222|NCT01358721|541293668|FG002|Overall Study|Withdrawal by Subject|0|||
150042223|NCT01358721|541293669|FG003|Overall Study|Withdrawal by Subject|1|||
150042224|NCT01358721|541293666|FG000|Overall Study|Death|0|||
150042225|NCT01358721|541293667|FG001|Overall Study|Death|2|||
150042226|NCT01358721|541293668|FG002|Overall Study|Death|0|||
150042227|NCT01358721|541293669|FG003|Overall Study|Death|0|||
150042228|NCT01358721|541293666|FG000|Overall Study|Study Drug Toxicity|1|||
150042229|NCT01358721|541293667|FG001|Overall Study|Study Drug Toxicity|3|||
150042230|NCT01358721|541293668|FG002|Overall Study|Study Drug Toxicity|4|||
150042231|NCT01358721|541293669|FG003|Overall Study|Study Drug Toxicity|5|||
150042232|NCT01358721|541293666|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
150042233|NCT01358721|541293667|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
150042234|NCT01358721|541293668|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
150042235|NCT01358721|541293669|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
150042236|NCT01358721|541293666|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
150042237|NCT01358721|541293667|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
150042238|NCT01358721|541293668|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
150042239|NCT01358721|541293669|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
150042240|NCT01358721|541293666|FG000|Overall Study|Adverse Event related to study drug|1|||
150042241|NCT01358721|541293667|FG001|Overall Study|Adverse Event related to study drug|0|||
150042242|NCT01358721|541293668|FG002|Overall Study|Adverse Event related to study drug|0|||
150042243|NCT01358721|541293669|FG003|Overall Study|Adverse Event related to study drug|1|||
150042244|NCT01358721|541293666|FG000|Overall Study|Disease Progression|19|||
150042245|NCT01358721|541293667|FG001|Overall Study|Disease Progression|15|||
150042246|NCT01358721|541293668|FG002|Overall Study|Disease Progression|17|||
150042247|NCT01358721|541293669|FG003|Overall Study|Disease Progression|15|||
150042248|NCT01358721|541293666|FG000|Overall Study|Out of State/Unmet Criteria|0|||
150042249|NCT01358721|541293667|FG001|Overall Study|Out of State/Unmet Criteria|0|||
150042250|NCT01358721|541293668|FG002|Overall Study|Out of State/Unmet Criteria|1|||
150042251|NCT01358721|541293669|FG003|Overall Study|Out of State/Unmet Criteria|0|||
150042252|NCT02446899|541293674|FG000|Overall Study|Adverse Event|4|||
150042253|NCT02446899|541293675|FG001|Overall Study|Adverse Event|7|||
150042254|NCT02446899|541293674|FG000|Overall Study|Condition Under Investigation Worsened|1|||
150042255|NCT02446899|541293675|FG001|Overall Study|Condition Under Investigation Worsened|4|||
150042256|NCT02446899|541293674|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
150042257|NCT02446899|541293675|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
150042258|NCT02446899|541293674|FG000|Overall Study|Lack of Efficacy|2|||
150042259|NCT02446899|541293675|FG001|Overall Study|Lack of Efficacy|8|||
150042260|NCT02446899|541293674|FG000|Overall Study|Lost to Follow-up|1|||
150042261|NCT02446899|541293675|FG001|Overall Study|Lost to Follow-up|3|||
150042262|NCT02446899|541293674|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
150042263|NCT02446899|541293675|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
150042264|NCT02446899|541293674|FG000|Overall Study|Withdrawal by Subject|11|||
150042265|NCT02446899|541293675|FG001|Overall Study|Withdrawal by Subject|19|||
150042266|NCT02446899|541293674|FG000|Overall Study|Miscellaneous|5|||
150042267|NCT02446899|541293675|FG001|Overall Study|Miscellaneous|4|||
150042268|NCT02446899|541293674|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
150042269|NCT02446899|541293675|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
150042270|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
150042271|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
150042272|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
150042273|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
149872551|NCT01517373|540662751|FG002|Run-in Period|Other|0|||
149872552|NCT01517373|540662752|FG003|Run-in Period|Other|0|||
149872553|NCT01517373|540662753|FG004|Run-in Period|Other|0|||
149872554|NCT01517373|540662754|FG005|Run-in Period|Other|0|||
149872555|NCT01517373|540662749|FG000|Treatment Period|Adverse Event|0|||
149872556|NCT01517373|540662750|FG001|Treatment Period|Adverse Event|0|||
149872557|NCT01517373|540662751|FG002|Treatment Period|Adverse Event|0|||
149872558|NCT01517373|540662752|FG003|Treatment Period|Adverse Event|0|||
149872559|NCT01517373|540662753|FG004|Treatment Period|Adverse Event|0|||
150042274|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
150042275|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
150042276|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
150042277|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
150042278|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
149872560|NCT01517373|540662754|FG005|Treatment Period|Adverse Event|2|||
149872561|NCT01517373|540662749|FG000|Treatment Period|Lost to Follow-up|0|||
149872562|NCT01517373|540662750|FG001|Treatment Period|Lost to Follow-up|0|||
150042279|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
150042280|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
150042281|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
149872563|NCT01517373|540662751|FG002|Treatment Period|Lost to Follow-up|1|||
149872564|NCT01517373|540662752|FG003|Treatment Period|Lost to Follow-up|1|||
149872565|NCT01517373|540662753|FG004|Treatment Period|Lost to Follow-up|0|||
149872566|NCT01517373|540662754|FG005|Treatment Period|Lost to Follow-up|0|||
149872567|NCT01517373|540662749|FG000|Treatment Period|Withdrawal by Subject|0|||
149872568|NCT01517373|540662750|FG001|Treatment Period|Withdrawal by Subject|3|||
149872569|NCT01517373|540662751|FG002|Treatment Period|Withdrawal by Subject|2|||
149872570|NCT01517373|540662752|FG003|Treatment Period|Withdrawal by Subject|2|||
149872571|NCT01517373|540662753|FG004|Treatment Period|Withdrawal by Subject|2|||
149872572|NCT01517373|540662754|FG005|Treatment Period|Withdrawal by Subject|3|||
149872573|NCT01517373|540662749|FG000|Treatment Period|Other|0|||
149872574|NCT01517373|540662750|FG001|Treatment Period|Other|0|||
149872575|NCT01517373|540662751|FG002|Treatment Period|Other|0|||
149872576|NCT01517373|540662752|FG003|Treatment Period|Other|0|||
149872577|NCT01517373|540662753|FG004|Treatment Period|Other|1|||
149872578|NCT01517373|540662754|FG005|Treatment Period|Other|0|||
149872579|NCT01517373|540662749|FG000|Treatment Period|Protocol Violation|0|||
149872580|NCT01517373|540662750|FG001|Treatment Period|Protocol Violation|0|||
149872581|NCT01517373|540662751|FG002|Treatment Period|Protocol Violation|0|||
149872582|NCT01517373|540662752|FG003|Treatment Period|Protocol Violation|0|||
149872583|NCT01517373|540662753|FG004|Treatment Period|Protocol Violation|1|||
149872584|NCT01517373|540662754|FG005|Treatment Period|Protocol Violation|0|||
149872585|NCT01517373|540662749|FG000|Treatment Period|Lack of Efficacy|0|||
149872586|NCT01517373|540662750|FG001|Treatment Period|Lack of Efficacy|1|||
149872587|NCT01517373|540662751|FG002|Treatment Period|Lack of Efficacy|1|||
149872588|NCT01517373|540662752|FG003|Treatment Period|Lack of Efficacy|3|||
149872589|NCT01517373|540662753|FG004|Treatment Period|Lack of Efficacy|2|||
149872590|NCT01517373|540662754|FG005|Treatment Period|Lack of Efficacy|0|||
149872591|NCT01517373|540662749|FG000|Treatment Period|Medication error without AEs|0|||
149872592|NCT01517373|540662750|FG001|Treatment Period|Medication error without AEs|0|||
149872593|NCT01517373|540662751|FG002|Treatment Period|Medication error without AEs|2|||
149872594|NCT01517373|540662752|FG003|Treatment Period|Medication error without AEs|1|||
149872595|NCT01517373|540662753|FG004|Treatment Period|Medication error without AEs|0|||
149872596|NCT01517373|540662754|FG005|Treatment Period|Medication error without AEs|2|||
149872597|NCT04015908|540662755|FG000|Overall Study|Lost to Follow-up|0|||
149872598|NCT04015908|540662756|FG001|Overall Study|Lost to Follow-up|1|||
149872599|NCT04154631|540662758|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
149872600|NCT04154631|540662759|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
149872601|NCT01441947|540662760|FG000|Overall Study|Withdrawal by Subject|3|||
149872602|NCT01441947|540662761|FG001|Overall Study|Withdrawal by Subject|0|||
149872603|NCT03384654|540662762|FG000|Overall Study|Withdrawal by Subject|0|||
149872604|NCT03384654|540662763|FG001|Overall Study|Withdrawal by Subject|0|||
149872605|NCT03384654|540662764|FG002|Overall Study|Withdrawal by Subject|1|||
149872606|NCT03384654|540662765|FG003|Overall Study|Withdrawal by Subject|0|||
149872607|NCT02927366|540662766|FG000|Overall Study|Adverse Event|1|||
149872608|NCT02927366|540662767|FG001|Overall Study|Adverse Event|0|||
149872609|NCT02927366|540662766|FG000|Overall Study|Patient schedule|1|||
149872610|NCT02927366|540662767|FG001|Overall Study|Patient schedule|0|||
149872611|NCT00724048|540662768|FG000|Overall Study|Adverse Event|1|||
149872612|NCT00724048|540662769|FG001|Overall Study|Adverse Event|1|||
149872613|NCT00724048|540662770|FG002|Overall Study|Adverse Event|1|||
149872614|NCT00724048|540662771|FG003|Overall Study|Adverse Event|0|||
149872615|NCT00724048|540662768|FG000|Overall Study|Lost to Follow-up|0|||
149872616|NCT00724048|540662769|FG001|Overall Study|Lost to Follow-up|1|||
149872617|NCT00724048|540662770|FG002|Overall Study|Lost to Follow-up|0|||
149872618|NCT00724048|540662771|FG003|Overall Study|Lost to Follow-up|0|||
149872619|NCT00724048|540662768|FG000|Overall Study|Withdrawal by Subject|1|||
149872620|NCT00724048|540662769|FG001|Overall Study|Withdrawal by Subject|2|||
149872621|NCT00724048|540662770|FG002|Overall Study|Withdrawal by Subject|1|||
149872622|NCT00724048|540662771|FG003|Overall Study|Withdrawal by Subject|2|||
149872623|NCT00724048|540662768|FG000|Overall Study|Investigator decision|0|||
149872624|NCT00724048|540662769|FG001|Overall Study|Investigator decision|0|||
149872625|NCT00724048|540662770|FG002|Overall Study|Investigator decision|1|||
149872626|NCT00724048|540662771|FG003|Overall Study|Investigator decision|0|||
149872627|NCT00724048|540662768|FG000|Overall Study|Did not tolerate study drug|0|||
149872628|NCT00724048|540662769|FG001|Overall Study|Did not tolerate study drug|0|||
149872629|NCT00724048|540662770|FG002|Overall Study|Did not tolerate study drug|0|||
149872630|NCT00724048|540662771|FG003|Overall Study|Did not tolerate study drug|1|||
149872631|NCT00724048|540662768|FG000|Overall Study|Other than specified|1|||
149872632|NCT00724048|540662769|FG001|Overall Study|Other than specified|1|||
149872633|NCT00724048|540662770|FG002|Overall Study|Other than specified|0|||
149872634|NCT00724048|540662771|FG003|Overall Study|Other than specified|0|||
149872635|NCT00587990|540662772|FG000|Overall Study|Death|0|||
149872636|NCT00587990|540662773|FG001|Overall Study|Death|0|||
149872637|NCT00587990|540662774|FG002|Overall Study|Death|1|||
149872638|NCT00206323|540662775|FG000|Overall Study|Lack of Efficacy|4|||
149872639|NCT00206323|540662776|FG001|Overall Study|Lack of Efficacy|1|||
150042282|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
150042283|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
150042284|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
150042285|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
150042286|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
150042287|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
150042288|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
150042289|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
150042290|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
150042291|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
150042292|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
150042293|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
150042294|NCT01106690|541293683|FG000|Core Period: Baseline to Week 26|Other|10|||
150042295|NCT01106690|541293684|FG001|Core Period: Baseline to Week 26|Other|2|||
150042296|NCT01106690|541293685|FG002|Core Period: Baseline to Week 26|Other|6|||
150042297|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
150042298|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
150042299|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
150042300|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
150042301|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
150042302|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
150042303|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
150042304|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
150042305|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
150042306|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
150042307|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
149872640|NCT00206323|540662775|FG000|Overall Study|Adverse Event|1|||
149872641|NCT00206323|540662776|FG001|Overall Study|Adverse Event|1|||
149872642|NCT00206323|540662775|FG000|Overall Study|Lost to Follow-up|1|||
149872643|NCT00206323|540662776|FG001|Overall Study|Lost to Follow-up|1|||
149872644|NCT03334617|540662777|FG000|Overall Study|Adverse Event|0|||
149872645|NCT03334617|540662778|FG001|Overall Study|Adverse Event|0|||
149872646|NCT03334617|540662779|FG002|Overall Study|Adverse Event|0|||
149872647|NCT03334617|540662780|FG003|Overall Study|Adverse Event|0|||
149872648|NCT03334617|540662781|FG004|Overall Study|Adverse Event|0|||
149872649|NCT03334617|540662782|FG005|Overall Study|Adverse Event|0|||
149872650|NCT03334617|540662783|FG006|Overall Study|Adverse Event|0|||
149872651|NCT03334617|540662784|FG007|Overall Study|Adverse Event|0|||
149872652|NCT03334617|540662785|FG008|Overall Study|Adverse Event|1|||
149872653|NCT03334617|540662786|FG009|Overall Study|Adverse Event|0|||
149872654|NCT03334617|540662787|FG010|Overall Study|Adverse Event|0|||
149872655|NCT03334617|540662788|FG011|Overall Study|Adverse Event|0|||
149872656|NCT03334617|540662789|FG012|Overall Study|Adverse Event|1|||
149872657|NCT03334617|540662790|FG013|Overall Study|Adverse Event|0|||
149872658|NCT03334617|540662791|FG014|Overall Study|Adverse Event|0|||
149872659|NCT03334617|540662792|FG015|Overall Study|Adverse Event|0|||
149872660|NCT03334617|540662793|FG016|Overall Study|Adverse Event|0|||
149872661|NCT03334617|540662794|FG017|Overall Study|Adverse Event|0|||
149872662|NCT03334617|540662795|FG018|Overall Study|Adverse Event|0|||
149872663|NCT03334617|540662796|FG019|Overall Study|Adverse Event|0|||
149872664|NCT03334617|540662797|FG020|Overall Study|Adverse Event|0|||
149872665|NCT03334617|540662798|FG021|Overall Study|Adverse Event|0|||
149872666|NCT03334617|540662777|FG000|Overall Study|Death|18|||
149872667|NCT03334617|540662778|FG001|Overall Study|Death|18|||
149872668|NCT03334617|540662779|FG002|Overall Study|Death|20|||
149872669|NCT03334617|540662780|FG003|Overall Study|Death|21|||
149872670|NCT03334617|540662781|FG004|Overall Study|Death|20|||
149872671|NCT03334617|540662782|FG005|Overall Study|Death|16|||
149872672|NCT03334617|540662783|FG006|Overall Study|Death|28|||
149872673|NCT03334617|540662784|FG007|Overall Study|Death|35|||
149872674|NCT03334617|540662785|FG008|Overall Study|Death|47|||
149872675|NCT03334617|540662786|FG009|Overall Study|Death|0|||
149872676|NCT03334617|540662787|FG010|Overall Study|Death|19|||
149872677|NCT03334617|540662788|FG011|Overall Study|Death|6|||
150042308|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
149872678|NCT03334617|540662789|FG012|Overall Study|Death|20|||
149872679|NCT03334617|540662790|FG013|Overall Study|Death|22|||
149872680|NCT03334617|540662791|FG014|Overall Study|Death|17|||
149872681|NCT03334617|540662792|FG015|Overall Study|Death|18|||
149872682|NCT03334617|540662793|FG016|Overall Study|Death|12|||
149872683|NCT03334617|540662794|FG017|Overall Study|Death|15|||
149872684|NCT03334617|540662795|FG018|Overall Study|Death|16|||
149872685|NCT03334617|540662796|FG019|Overall Study|Death|27|||
149872686|NCT03334617|540662797|FG020|Overall Study|Death|14|||
149872687|NCT03334617|540662798|FG021|Overall Study|Death|27|||
149872688|NCT03334617|540662777|FG000|Overall Study|Lost to Follow-up|0|||
149872689|NCT03334617|540662778|FG001|Overall Study|Lost to Follow-up|0|||
149872690|NCT03334617|540662779|FG002|Overall Study|Lost to Follow-up|0|||
149872691|NCT03334617|540662780|FG003|Overall Study|Lost to Follow-up|1|||
149872692|NCT03334617|540662781|FG004|Overall Study|Lost to Follow-up|0|||
149872693|NCT03334617|540662782|FG005|Overall Study|Lost to Follow-up|1|||
149872694|NCT03334617|540662783|FG006|Overall Study|Lost to Follow-up|0|||
149872695|NCT03334617|540662784|FG007|Overall Study|Lost to Follow-up|0|||
149872696|NCT03334617|540662785|FG008|Overall Study|Lost to Follow-up|1|||
149872697|NCT03334617|540662786|FG009|Overall Study|Lost to Follow-up|0|||
149872698|NCT03334617|540662787|FG010|Overall Study|Lost to Follow-up|0|||
149872699|NCT03334617|540662788|FG011|Overall Study|Lost to Follow-up|0|||
149872700|NCT03334617|540662789|FG012|Overall Study|Lost to Follow-up|0|||
149872701|NCT03334617|540662790|FG013|Overall Study|Lost to Follow-up|0|||
149872702|NCT03334617|540662791|FG014|Overall Study|Lost to Follow-up|0|||
149872703|NCT03334617|540662792|FG015|Overall Study|Lost to Follow-up|0|||
149872704|NCT03334617|540662793|FG016|Overall Study|Lost to Follow-up|0|||
149872705|NCT03334617|540662794|FG017|Overall Study|Lost to Follow-up|0|||
149872706|NCT03334617|540662795|FG018|Overall Study|Lost to Follow-up|0|||
149872707|NCT03334617|540662796|FG019|Overall Study|Lost to Follow-up|0|||
149872708|NCT03334617|540662797|FG020|Overall Study|Lost to Follow-up|0|||
149872709|NCT03334617|540662798|FG021|Overall Study|Lost to Follow-up|0|||
149872710|NCT03334617|540662777|FG000|Overall Study|Withdrawal by Subject|0|||
149872711|NCT03334617|540662778|FG001|Overall Study|Withdrawal by Subject|1|||
149872712|NCT03334617|540662779|FG002|Overall Study|Withdrawal by Subject|0|||
149872713|NCT03334617|540662780|FG003|Overall Study|Withdrawal by Subject|0|||
149872714|NCT03334617|540662781|FG004|Overall Study|Withdrawal by Subject|1|||
149872715|NCT03334617|540662782|FG005|Overall Study|Withdrawal by Subject|1|||
149872716|NCT03334617|540662783|FG006|Overall Study|Withdrawal by Subject|1|||
149872717|NCT03334617|540662784|FG007|Overall Study|Withdrawal by Subject|2|||
149872718|NCT03334617|540662785|FG008|Overall Study|Withdrawal by Subject|0|||
149872719|NCT03334617|540662786|FG009|Overall Study|Withdrawal by Subject|0|||
149872720|NCT03334617|540662787|FG010|Overall Study|Withdrawal by Subject|0|||
149872721|NCT03334617|540662788|FG011|Overall Study|Withdrawal by Subject|1|||
149872722|NCT03334617|540662789|FG012|Overall Study|Withdrawal by Subject|1|||
149872723|NCT03334617|540662790|FG013|Overall Study|Withdrawal by Subject|0|||
149872724|NCT03334617|540662791|FG014|Overall Study|Withdrawal by Subject|2|||
149872725|NCT03334617|540662792|FG015|Overall Study|Withdrawal by Subject|1|||
149872726|NCT03334617|540662793|FG016|Overall Study|Withdrawal by Subject|0|||
149872727|NCT03334617|540662794|FG017|Overall Study|Withdrawal by Subject|1|||
149872728|NCT03334617|540662795|FG018|Overall Study|Withdrawal by Subject|1|||
149872729|NCT03334617|540662796|FG019|Overall Study|Withdrawal by Subject|1|||
149872730|NCT03334617|540662797|FG020|Overall Study|Withdrawal by Subject|0|||
149872731|NCT03334617|540662798|FG021|Overall Study|Withdrawal by Subject|1|||
149872732|NCT03334617|540662777|FG000|Overall Study|Other|1|||
149872733|NCT03334617|540662778|FG001|Overall Study|Other|2|||
149872734|NCT03334617|540662779|FG002|Overall Study|Other|0|||
149872735|NCT03334617|540662780|FG003|Overall Study|Other|1|||
149872736|NCT03334617|540662781|FG004|Overall Study|Other|1|||
149872737|NCT03334617|540662782|FG005|Overall Study|Other|0|||
149872738|NCT03334617|540662783|FG006|Overall Study|Other|2|||
149872739|NCT03334617|540662784|FG007|Overall Study|Other|1|||
149872740|NCT03334617|540662785|FG008|Overall Study|Other|8|||
149872741|NCT03334617|540662786|FG009|Overall Study|Other|0|||
149872742|NCT03334617|540662787|FG010|Overall Study|Other|3|||
149872743|NCT03334617|540662788|FG011|Overall Study|Other|1|||
149872744|NCT03334617|540662789|FG012|Overall Study|Other|3|||
149872745|NCT03334617|540662790|FG013|Overall Study|Other|1|||
149872746|NCT03334617|540662791|FG014|Overall Study|Other|1|||
149872747|NCT03334617|540662792|FG015|Overall Study|Other|3|||
149872748|NCT03334617|540662793|FG016|Overall Study|Other|3|||
149872749|NCT03334617|540662794|FG017|Overall Study|Other|3|||
149963487|NCT00866775|541001437|FG000|Overall Study|Lost to Follow-up|0|||
149872750|NCT03334617|540662795|FG018|Overall Study|Other|7|||
149872751|NCT03334617|540662796|FG019|Overall Study|Other|4|||
149872752|NCT03334617|540662797|FG020|Overall Study|Other|1|||
149872753|NCT03334617|540662798|FG021|Overall Study|Other|4|||
149872754|NCT03334617|540662777|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
149872755|NCT03334617|540662778|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
149872756|NCT03334617|540662779|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
149872757|NCT03334617|540662780|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
149872758|NCT03334617|540662781|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
149872759|NCT03334617|540662782|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
149872760|NCT03334617|540662783|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
149963488|NCT00866775|541001438|FG001|Overall Study|Lost to Follow-up|4|||
149872761|NCT03334617|540662784|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
149872762|NCT03334617|540662785|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
149872763|NCT03334617|540662786|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
149872764|NCT03334617|540662787|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
149872765|NCT03334617|540662788|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
149872766|NCT03334617|540662789|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
149872767|NCT03334617|540662790|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
149872768|NCT03334617|540662791|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
149872769|NCT03334617|540662792|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
149872770|NCT03334617|540662793|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
149872771|NCT03334617|540662794|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
149872772|NCT03334617|540662795|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
149872773|NCT03334617|540662796|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
149872774|NCT03334617|540662797|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
149872775|NCT03334617|540662798|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
149872776|NCT03657342|540662799|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
149872777|NCT03657342|540662800|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
149872778|NCT03657342|540662799|FG000|Overall Study|Withdrawal by Subject|4|||
149872779|NCT03657342|540662800|FG001|Overall Study|Withdrawal by Subject|4|||
149872780|NCT03657342|540662799|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
149872781|NCT03657342|540662800|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
149872782|NCT03657342|540662799|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
149872783|NCT03657342|540662800|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
149872784|NCT00827632|540662801|FG000|Overall Study|Lost to Follow-up|8|||
149872785|NCT00827632|540662802|FG001|Overall Study|Lost to Follow-up|12|||
149872786|NCT00827632|540662801|FG000|Overall Study|Early withdrawal|14|||
149872787|NCT00827632|540662802|FG001|Overall Study|Early withdrawal|11|||
149872788|NCT03734666|540662804|FG000|Overall Study|Other|7|||
149872789|NCT03734666|540662805|FG001|Overall Study|Other|4|||
149872790|NCT03734666|540662804|FG000|Overall Study|Lost to Follow-up|12|||
149872791|NCT03734666|540662805|FG001|Overall Study|Lost to Follow-up|12|||
149872792|NCT01910389|540662808|FG000|Overall Study|Withdrawal by Subject|2|||
149872793|NCT01910389|540662809|FG001|Overall Study|Withdrawal by Subject|0|||
149872794|NCT01910389|540662808|FG000|Overall Study|Study Closed|13|||
149872795|NCT01910389|540662809|FG001|Overall Study|Study Closed|8|||
149872796|NCT01898650|540662810|FG000|Overall Study|the subject would not lie still for imaging|1|||
149872797|NCT05896202|540662812|FG000|Overall Study|Lost to Follow-up|2|||
149872798|NCT05896202|540662813|FG001|Overall Study|Lost to Follow-up|2|||
149872799|NCT03923530|540662814|FG000|Overall Study|Withdrawal by Subject|1|||
149872800|NCT03923530|540662814|FG000|Overall Study|screen failure|3|||
149872801|NCT00407758|540662815|FG000|Overall Study|ineligible -improper prior treatment|1|||
149872802|NCT04669691|540662826|FG000|Overall Study|Death|0|||
149872803|NCT04669691|540662827|FG001|Overall Study|Death|1|||
149872804|NCT04669691|540662828|FG002|Overall Study|Death|0|||
149872805|NCT04669691|540662829|FG003|Overall Study|Death|0|||
149872806|NCT04669691|540662830|FG004|Overall Study|Death|0|||
149872807|NCT04669691|540662831|FG005|Overall Study|Death|0|||
149872808|NCT02722148|540662832|FG000|Overall Study|Lost to Follow-up|2|||
149872809|NCT02722148|540662832|FG000|Overall Study|Non compliant with treatment regimen|3|||
149872810|NCT00855803|540662834|FG000|Overall Study|Death|2|||
149872811|NCT00855803|540662834|FG000|Overall Study|Lost to Follow-up|2|||
149872812|NCT00855803|540662834|FG000|Overall Study|Technical inability to undergo procedure|2|||
149872813|NCT00855803|540662834|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
149872814|NCT00855803|540662834|FG000|Overall Study|Withdrawal by Subject|3|||
149872815|NCT00855803|540662834|FG000|Overall Study|Physician Decision|3|||
149872816|NCT00809159|540662835|FG000|Part 1|Adverse Event|1|||
149872817|NCT00809159|540662836|FG001|Part 1|Adverse Event|1|||
149872818|NCT00809159|540662837|FG002|Part 1|Adverse Event|0|||
149872819|NCT00809159|540662838|FG003|Part 1|Adverse Event|0|||
149872820|NCT00809159|540662839|FG004|Part 1|Adverse Event|0|||
149872821|NCT00809159|540662840|FG005|Part 1|Adverse Event|0|||
149872822|NCT00809159|540662835|FG000|Part 1|Lost to Follow-up|1|||
149872823|NCT00809159|540662836|FG001|Part 1|Lost to Follow-up|0|||
149872824|NCT00809159|540662837|FG002|Part 1|Lost to Follow-up|0|||
149872825|NCT00809159|540662838|FG003|Part 1|Lost to Follow-up|0|||
149872826|NCT00809159|540662839|FG004|Part 1|Lost to Follow-up|0|||
149963489|NCT00866775|541001437|FG000|Overall Study|Physician Decision|0|||
149872827|NCT00809159|540662840|FG005|Part 1|Lost to Follow-up|0|||
149872828|NCT00809159|540662835|FG000|Part 1|Withdrawal by Subject|3|||
149872829|NCT00809159|540662836|FG001|Part 1|Withdrawal by Subject|1|||
149963490|NCT00866775|541001438|FG001|Overall Study|Physician Decision|3|||
149963491|NCT00866775|541001437|FG000|Overall Study|Protocol Violation|3|||
149963492|NCT00866775|541001438|FG001|Overall Study|Protocol Violation|4|||
149963493|NCT00866775|541001437|FG000|Overall Study|Withdrawal by Subject|4|||
149872830|NCT00809159|540662837|FG002|Part 1|Withdrawal by Subject|0|||
149872831|NCT00809159|540662838|FG003|Part 1|Withdrawal by Subject|0|||
149872832|NCT00809159|540662839|FG004|Part 1|Withdrawal by Subject|0|||
149872833|NCT00809159|540662840|FG005|Part 1|Withdrawal by Subject|0|||
149872834|NCT00809159|540662835|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
149872835|NCT00809159|540662836|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
149872836|NCT00809159|540662837|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
149872837|NCT00809159|540662838|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
149872838|NCT00809159|540662839|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
149872839|NCT00809159|540662840|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
149872840|NCT00809159|540662835|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
149872841|NCT00809159|540662836|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
149872842|NCT00809159|540662837|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
149872843|NCT00809159|540662838|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
149872844|NCT00809159|540662839|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
149872845|NCT00809159|540662840|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
149872846|NCT00809159|540662835|FG000|Part 1 and 2|Administrative problems|0|||
149872847|NCT00809159|540662836|FG001|Part 1 and 2|Administrative problems|0|||
149872848|NCT00809159|540662837|FG002|Part 1 and 2|Administrative problems|0|||
149872849|NCT00809159|540662838|FG003|Part 1 and 2|Administrative problems|1|||
149872850|NCT00809159|540662839|FG004|Part 1 and 2|Administrative problems|0|||
149963494|NCT00866775|541001438|FG001|Overall Study|Withdrawal by Subject|4|||
149963495|NCT00866775|541001437|FG000|Overall Study|met exit criteria|23|||
149963496|NCT00866775|541001438|FG001|Overall Study|met exit criteria|17|||
149963497|NCT00866775|541001437|FG000|Overall Study|discontinued due to communication error|0|||
149963498|NCT00866775|541001438|FG001|Overall Study|discontinued due to communication error|1|||
149963499|NCT01500135|541001439|FG000|Overall Study|Withdrawal of Consent|4|||
149963500|NCT01500135|541001440|FG001|Overall Study|Withdrawal of Consent|0|||
149963501|NCT01500135|541001439|FG000|Overall Study|Lost to Follow-up|6|||
149963502|NCT01500135|541001440|FG001|Overall Study|Lost to Follow-up|4|||
149963503|NCT01500135|541001439|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
149963504|NCT01500135|541001440|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
149963505|NCT01500135|541001439|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
149963506|NCT01500135|541001440|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
149963507|NCT01500135|541001439|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
149963508|NCT01500135|541001440|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
149963509|NCT01500135|541001439|FG000|Overall Study|Participant was a Safety Concern|1|||
149963510|NCT01500135|541001440|FG001|Overall Study|Participant was a Safety Concern|0|||
149963511|NCT01500135|541001439|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
149963512|NCT01500135|541001440|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
149963513|NCT01661595|541001441|FG000|Phase 1: Week 0-4|Adverse Event|1|||
149963514|NCT01661595|541001442|FG001|Phase 1: Week 0-4|Adverse Event|0|||
149963515|NCT01661595|541001443|FG002|Phase 1: Week 0-4|Adverse Event|0|||
149963516|NCT01661595|541001444|FG003|Phase 1: Week 0-4|Adverse Event|0|||
149963517|NCT01661595|541001441|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
149963518|NCT01661595|541001442|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
149963519|NCT01661595|541001443|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
149963520|NCT01661595|541001444|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
149963521|NCT00912509|541001445|FG000|Overall Study|Lost to Follow-up|1|||
149963522|NCT00912509|541001446|FG001|Overall Study|Lost to Follow-up|0|||
149963523|NCT00912509|541001445|FG000|Overall Study|Lack of Efficacy|4|||
149963524|NCT00912509|541001446|FG001|Overall Study|Lack of Efficacy|3|||
149963525|NCT05538728|541001447|FG000|Overall Study|Withdrawal by Subject|1|||
149963526|NCT05538728|541001448|FG001|Overall Study|Withdrawal by Subject|1|||
149963527|NCT01034657|541001450|FG000|Core Phase|Withdrawal by Subject|1|||
149963528|NCT01034657|541001451|FG001|Core Phase|Withdrawal by Subject|0|||
149963529|NCT01034657|541001452|FG002|Core Phase|Withdrawal by Subject|0|||
149963530|NCT01034657|541001450|FG000|Core Phase|Lack of Efficacy|2|||
149963531|NCT01034657|541001451|FG001|Core Phase|Lack of Efficacy|0|||
149963532|NCT01034657|541001452|FG002|Core Phase|Lack of Efficacy|0|||
150042309|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
150042310|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
149872851|NCT00809159|540662840|FG005|Part 1 and 2|Administrative problems|0|||
149872852|NCT00809159|540662835|FG000|Part 1 and 2|Adverse Event|0|||
149872853|NCT00809159|540662836|FG001|Part 1 and 2|Adverse Event|0|||
149872854|NCT00809159|540662837|FG002|Part 1 and 2|Adverse Event|1|||
149872855|NCT00809159|540662838|FG003|Part 1 and 2|Adverse Event|0|||
149872856|NCT00809159|540662839|FG004|Part 1 and 2|Adverse Event|1|||
149872857|NCT00809159|540662840|FG005|Part 1 and 2|Adverse Event|1|||
149963533|NCT01034657|541001450|FG000|Core Phase|Abnormal laboratory value|1|||
149963534|NCT01034657|541001451|FG001|Core Phase|Abnormal laboratory value|0|||
149963535|NCT01034657|541001452|FG002|Core Phase|Abnormal laboratory value|0|||
149963536|NCT01034657|541001450|FG000|Core Phase|Adverse Event|8|||
149872858|NCT00809159|540662835|FG000|Part 1 and 2|Lost to Follow-up|0|||
149872859|NCT00809159|540662836|FG001|Part 1 and 2|Lost to Follow-up|0|||
149872860|NCT00809159|540662837|FG002|Part 1 and 2|Lost to Follow-up|1|||
149872861|NCT00809159|540662838|FG003|Part 1 and 2|Lost to Follow-up|1|||
149872862|NCT00809159|540662839|FG004|Part 1 and 2|Lost to Follow-up|0|||
149872863|NCT00809159|540662840|FG005|Part 1 and 2|Lost to Follow-up|0|||
149872864|NCT00809159|540662835|FG000|Part 1 and 2|Withdrawal by Subject|0|||
149872865|NCT00809159|540662836|FG001|Part 1 and 2|Withdrawal by Subject|0|||
149872866|NCT00809159|540662837|FG002|Part 1 and 2|Withdrawal by Subject|4|||
149872867|NCT00809159|540662838|FG003|Part 1 and 2|Withdrawal by Subject|0|||
149872868|NCT00809159|540662839|FG004|Part 1 and 2|Withdrawal by Subject|0|||
149872869|NCT00809159|540662840|FG005|Part 1 and 2|Withdrawal by Subject|1|||
149872870|NCT04430855|540662846|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
149872871|NCT04430855|540662847|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
149872872|NCT04430855|540662846|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
149872873|NCT04430855|540662847|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
149872874|NCT04430855|540662846|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
149872875|NCT04430855|540662847|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
149872876|NCT04430855|540662846|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
149872877|NCT04430855|540662847|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
149872878|NCT04430855|540662846|FG000|Period 1 (Weeks 1-12)|Other|0|||
149872879|NCT04430855|540662847|FG001|Period 1 (Weeks 1-12)|Other|1|||
149963537|NCT01034657|541001451|FG001|Core Phase|Adverse Event|0|||
149963538|NCT01034657|541001452|FG002|Core Phase|Adverse Event|0|||
149963539|NCT01034657|541001450|FG000|Core Phase|Protocol Violation|2|||
149963540|NCT01034657|541001451|FG001|Core Phase|Protocol Violation|0|||
149963541|NCT01034657|541001452|FG002|Core Phase|Protocol Violation|0|||
149963542|NCT01034657|541001450|FG000|Randomized Phase|Withdrawal by Subject|0|||
149963543|NCT01034657|541001451|FG001|Randomized Phase|Withdrawal by Subject|2|||
149963544|NCT01034657|541001452|FG002|Randomized Phase|Withdrawal by Subject|0|||
149963545|NCT01034657|541001450|FG000|Randomized Phase|Lack of Efficacy|5|||
149963546|NCT01034657|541001451|FG001|Randomized Phase|Lack of Efficacy|1|||
149963547|NCT01034657|541001452|FG002|Randomized Phase|Lack of Efficacy|0|||
149963548|NCT01034657|541001450|FG000|Randomized Phase|Abnormal laboratory value|0|||
149963549|NCT01034657|541001451|FG001|Randomized Phase|Abnormal laboratory value|1|||
149963550|NCT01034657|541001452|FG002|Randomized Phase|Abnormal laboratory value|0|||
149963551|NCT01034657|541001450|FG000|Randomized Phase|Adverse Event|0|||
149963552|NCT01034657|541001451|FG001|Randomized Phase|Adverse Event|2|||
149963553|NCT01034657|541001452|FG002|Randomized Phase|Adverse Event|1|||
149963554|NCT02715856|541001453|FG000|Overall Study|Software Issues|12|||
149963555|NCT02715856|541001454|FG001|Overall Study|Software Issues|7|||
149963556|NCT02715856|541001453|FG000|Overall Study|Death|6|||
149963557|NCT02715856|541001454|FG001|Overall Study|Death|5|||
149963558|NCT02715856|541001453|FG000|Overall Study|Non- Compliant|0|||
149963559|NCT02715856|541001454|FG001|Overall Study|Non- Compliant|40|||
149963560|NCT01050218|541001455|FG000|Overall Study|Adverse Event|37|||
149963561|NCT01050218|541001455|FG000|Overall Study|Lack of Efficacy|8|||
149963562|NCT01050218|541001455|FG000|Overall Study|Protocol Violation|3|||
149963563|NCT01050218|541001455|FG000|Overall Study|Withdrawal by Subject|18|||
149963564|NCT01050218|541001455|FG000|Overall Study|Discontinued by sponsor|18|||
149963565|NCT01050218|541001455|FG000|Overall Study|Compliance|2|||
149963566|NCT01050218|541001455|FG000|Overall Study|Failed to return|7|||
149963567|NCT01050218|541001455|FG000|Overall Study|Serious Adverse Event|1|||
149963568|NCT01050218|541001455|FG000|Overall Study|Family emergency|1|||
149963569|NCT02336555|541001456|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149963570|NCT02336555|541001457|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
149963571|NCT02336555|541001456|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
149963572|NCT02336555|541001457|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
149963573|NCT02336555|541001456|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
149963574|NCT02336555|541001457|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
149963575|NCT01772693|541001458|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
149963576|NCT01772693|541001459|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
149963577|NCT01772693|541001458|FG000|Overall Study|Withdrawal by Subject|2|||
149963578|NCT01772693|541001459|FG001|Overall Study|Withdrawal by Subject|0|||
149963579|NCT01772693|541001458|FG000|Overall Study|Alternative Treatment|2|||
149963580|NCT01772693|541001459|FG001|Overall Study|Alternative Treatment|0|||
149963581|NCT01633112|541001462|FG000|Overall Study|Lack of Efficacy|1|||
149963582|NCT01633112|541001463|FG001|Overall Study|Lack of Efficacy|6|||
149963583|NCT01633112|541001464|FG002|Overall Study|Lack of Efficacy|13|||
149963584|NCT01633112|541001462|FG000|Overall Study|Abnormal laboratory value(s)|3|||
149963585|NCT01633112|541001463|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149963586|NCT01633112|541001464|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149963587|NCT01633112|541001462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149963588|NCT01633112|541001463|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149872880|NCT04430855|540662846|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
149872881|NCT04430855|540662847|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
149872882|NCT04430855|540662846|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
149872883|NCT04430855|540662847|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
149872884|NCT04430855|540662846|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
149872885|NCT04430855|540662847|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
149872886|NCT00186043|540662848|FG000|Overall Study|Lack of Efficacy|1|||
149872887|NCT00186043|540662849|FG001|Overall Study|Lack of Efficacy|3|||
149872888|NCT00186043|540662848|FG000|Overall Study|Lost to Follow-up|4|||
149872889|NCT00186043|540662849|FG001|Overall Study|Lost to Follow-up|6|||
149872890|NCT00186043|540662848|FG000|Overall Study|Withdrawal by Subject|1|||
149872891|NCT00186043|540662849|FG001|Overall Study|Withdrawal by Subject|0|||
149872892|NCT00186043|540662848|FG000|Overall Study|Adverse Event|7|||
149872893|NCT00186043|540662849|FG001|Overall Study|Adverse Event|3|||
149872894|NCT00186043|540662848|FG000|Overall Study|Protocol Violation|2|||
149872895|NCT00186043|540662849|FG001|Overall Study|Protocol Violation|1|||
149872896|NCT04188301|540662852|FG000|Month 3|Lost to Follow-up|0|||
149872897|NCT04188301|540662853|FG001|Month 3|Lost to Follow-up|0|||
149872898|NCT04188301|540662854|FG002|Month 3|Lost to Follow-up|1|||
149872899|NCT04188301|540662852|FG000|Month 12|Lost to Follow-up|0|||
149872900|NCT04188301|540662853|FG001|Month 12|Lost to Follow-up|0|||
149872901|NCT04188301|540662854|FG002|Month 12|Lost to Follow-up|2|||
149872902|NCT04188301|540662852|FG000|Month 12|Death|1|||
149872903|NCT04188301|540662853|FG001|Month 12|Death|1|||
149872904|NCT04188301|540662854|FG002|Month 12|Death|0|||
149872905|NCT04188301|540662852|FG000|Month 18|Lost to Follow-up|6|||
149872906|NCT04188301|540662853|FG001|Month 18|Lost to Follow-up|0|||
149872907|NCT04188301|540662854|FG002|Month 18|Lost to Follow-up|0|||
149872908|NCT01709838|540662857|FG000|Overall Study|Withdrawal by Subject|21|||
149872909|NCT01709838|540662857|FG000|Overall Study|Lost to Follow-up|16|||
149872910|NCT01709838|540662857|FG000|Overall Study|Pregnancy|10|||
149872911|NCT01709838|540662857|FG000|Overall Study|Subject/guardian decision|8|||
149872912|NCT01709838|540662857|FG000|Overall Study|Adverse Event|4|||
149872913|NCT01709838|540662857|FG000|Overall Study|Physician Decision|4|||
149872914|NCT01709838|540662857|FG000|Overall Study|Death|3|||
149872915|NCT01709838|540662857|FG000|Overall Study|Protocol Violation|1|||
149872916|NCT00620659|540662858|FG000|Treatment Period 1|Adverse Event|1|||
149872917|NCT00620659|540662859|FG001|Treatment Period 1|Adverse Event|0|||
149872918|NCT00620659|540662860|FG002|Treatment Period 1|Adverse Event|0|||
149872919|NCT00620659|540662861|FG003|Treatment Period 1|Adverse Event|3|||
149872920|NCT00620659|540662862|FG004|Treatment Period 1|Adverse Event|0|||
149872921|NCT00620659|540662863|FG005|Treatment Period 1|Adverse Event|0|||
149872922|NCT00620659|540662858|FG000|Treatment Period 1|Protocol Violation|1|||
149872923|NCT00620659|540662859|FG001|Treatment Period 1|Protocol Violation|0|||
149872924|NCT00620659|540662860|FG002|Treatment Period 1|Protocol Violation|0|||
149872925|NCT00620659|540662861|FG003|Treatment Period 1|Protocol Violation|0|||
149872926|NCT00620659|540662862|FG004|Treatment Period 1|Protocol Violation|0|||
149872927|NCT00620659|540662863|FG005|Treatment Period 1|Protocol Violation|0|||
149872928|NCT00620659|540662858|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149872929|NCT00620659|540662859|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149872930|NCT00620659|540662860|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149872931|NCT00620659|540662861|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149872932|NCT00620659|540662862|FG004|Treatment Period 1|Withdrawal by Subject|1|||
149872933|NCT00620659|540662863|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149872934|NCT00620659|540662858|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
149872935|NCT00620659|540662859|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
149872936|NCT00620659|540662860|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
149872937|NCT00620659|540662861|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
149872938|NCT00620659|540662862|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
150174062|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
150174063|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149872939|NCT00620659|540662863|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
149872940|NCT00620659|540662858|FG000|Treatment Period 2|Adverse Event|0|||
149872941|NCT00620659|540662859|FG001|Treatment Period 2|Adverse Event|3|||
149872942|NCT00620659|540662860|FG002|Treatment Period 2|Adverse Event|0|||
149872943|NCT00620659|540662861|FG003|Treatment Period 2|Adverse Event|0|||
149872944|NCT00620659|540662862|FG004|Treatment Period 2|Adverse Event|2|||
149872945|NCT00620659|540662863|FG005|Treatment Period 2|Adverse Event|0|||
150174064|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
150174065|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
150174066|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149872946|NCT00620659|540662858|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149872947|NCT00620659|540662859|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150174067|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
149872948|NCT00620659|540662860|FG002|Treatment Period 2|Withdrawal by Subject|1|||
149872949|NCT00620659|540662861|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149872950|NCT00620659|540662862|FG004|Treatment Period 2|Withdrawal by Subject|3|||
149872951|NCT00620659|540662863|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149872952|NCT00620659|540662858|FG000|Placebo Washout Period 2|Adverse Event|2|||
149872953|NCT00620659|540662859|FG001|Placebo Washout Period 2|Adverse Event|0|||
149872954|NCT00620659|540662860|FG002|Placebo Washout Period 2|Adverse Event|0|||
149872955|NCT00620659|540662861|FG003|Placebo Washout Period 2|Adverse Event|0|||
149872956|NCT00620659|540662862|FG004|Placebo Washout Period 2|Adverse Event|0|||
149872957|NCT00620659|540662863|FG005|Placebo Washout Period 2|Adverse Event|0|||
149872958|NCT00620659|540662858|FG000|Treatment Period 3|Adverse Event|0|||
149872959|NCT00620659|540662859|FG001|Treatment Period 3|Adverse Event|2|||
149872960|NCT00620659|540662860|FG002|Treatment Period 3|Adverse Event|0|||
149872961|NCT00620659|540662861|FG003|Treatment Period 3|Adverse Event|0|||
149872962|NCT00620659|540662862|FG004|Treatment Period 3|Adverse Event|0|||
149963589|NCT01633112|541001464|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149963590|NCT01633112|541001462|FG000|Overall Study|Administrative problems|1|||
149963591|NCT01633112|541001463|FG001|Overall Study|Administrative problems|2|||
149963592|NCT01633112|541001464|FG002|Overall Study|Administrative problems|5|||
149963593|NCT01633112|541001462|FG000|Overall Study|Adverse Event|16|||
149963594|NCT01633112|541001463|FG001|Overall Study|Adverse Event|18|||
149963595|NCT01633112|541001464|FG002|Overall Study|Adverse Event|20|||
149963596|NCT01633112|541001462|FG000|Overall Study|Lost to Follow-up|7|||
149963597|NCT01633112|541001463|FG001|Overall Study|Lost to Follow-up|19|||
149963598|NCT01633112|541001464|FG002|Overall Study|Lost to Follow-up|6|||
149963599|NCT01633112|541001462|FG000|Overall Study|Protocol Violation|4|||
149963600|NCT01633112|541001463|FG001|Overall Study|Protocol Violation|0|||
149963601|NCT01633112|541001464|FG002|Overall Study|Protocol Violation|2|||
149963602|NCT01633112|541001462|FG000|Overall Study|Subject no longer requires study drug|0|||
149963603|NCT01633112|541001463|FG001|Overall Study|Subject no longer requires study drug|0|||
149963604|NCT01633112|541001464|FG002|Overall Study|Subject no longer requires study drug|1|||
149963605|NCT01633112|541001462|FG000|Overall Study|Withdrawal by Subject|20|||
149963606|NCT01633112|541001463|FG001|Overall Study|Withdrawal by Subject|12|||
149963607|NCT01633112|541001464|FG002|Overall Study|Withdrawal by Subject|41|||
149963608|NCT01633112|541001462|FG000|Overall Study|missing Study Completion CRF|1|||
149963609|NCT01633112|541001463|FG001|Overall Study|missing Study Completion CRF|1|||
149963610|NCT01633112|541001464|FG002|Overall Study|missing Study Completion CRF|4|||
149963611|NCT03682367|541001467|FG000|Overall Study|Protocol Violation|2|||
149963612|NCT03682367|541001468|FG001|Overall Study|Protocol Violation|1|||
149963613|NCT03682367|541001467|FG000|Overall Study|Closed Study Early|0|||
149963614|NCT03682367|541001468|FG001|Overall Study|Closed Study Early|3|||
149963615|NCT02605967|541001471|FG000|Overall Study|subject / guardian decision|1|||
149963616|NCT02605967|541001472|FG001|Overall Study|subject / guardian decision|2|||
149963617|NCT02605967|541001471|FG000|Overall Study|Physician Decision|10|||
149963618|NCT02605967|541001472|FG001|Overall Study|Physician Decision|1|||
149963619|NCT02605967|541001471|FG000|Overall Study|Death|4|||
149963620|NCT02605967|541001472|FG001|Overall Study|Death|2|||
149963621|NCT02605967|541001471|FG000|Overall Study|Adverse Event|1|||
149963622|NCT02605967|541001472|FG001|Overall Study|Adverse Event|0|||
149963623|NCT02605967|541001471|FG000|Overall Study|progressive disease|66|||
149963624|NCT02605967|541001472|FG001|Overall Study|progressive disease|35|||
149963625|NCT04576481|541001484|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
149963626|NCT04576481|541001485|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
149963627|NCT04576481|541001486|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
149963628|NCT04576481|541001487|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
149963629|NCT03464461|541001490|FG000|Overall Study|exclusionary medication given ,|1|||
149963630|NCT03464461|541001491|FG001|Overall Study|exclusionary medication given ,|2|||
149963631|NCT03464461|541001492|FG002|Overall Study|exclusionary medication given ,|0|||
149963632|NCT03464461|541001490|FG000|Overall Study|Physician Decision|0|||
149963633|NCT03464461|541001491|FG001|Overall Study|Physician Decision|1|||
149963634|NCT03464461|541001492|FG002|Overall Study|Physician Decision|0|||
149963635|NCT05524948|541001493|FG000|Overall Study|Withdrawal by Subject|1|||
149963636|NCT05524948|541001494|FG001|Overall Study|Withdrawal by Subject|0|||
149963637|NCT05524948|541001493|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
149963638|NCT05524948|541001494|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
149963639|NCT05261490|541001498|FG000|Overall Study|Other|1|||
149872963|NCT00620659|540662863|FG005|Treatment Period 3|Adverse Event|0|||
149963640|NCT05261490|541001499|FG001|Overall Study|Other|0|||
149963641|NCT05261490|541001500|FG002|Overall Study|Other|0|||
149872964|NCT00620659|540662858|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149872965|NCT00620659|540662859|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149963642|NCT05261490|541001498|FG000|Overall Study|Study Terminated by Sponsor|1|||
149963643|NCT05261490|541001499|FG001|Overall Study|Study Terminated by Sponsor|1|||
149963644|NCT05261490|541001500|FG002|Overall Study|Study Terminated by Sponsor|4|||
149872966|NCT00620659|540662860|FG002|Treatment Period 3|Withdrawal by Subject|0|||
149872967|NCT00620659|540662861|FG003|Treatment Period 3|Withdrawal by Subject|1|||
149872968|NCT00620659|540662862|FG004|Treatment Period 3|Withdrawal by Subject|0|||
149872969|NCT00620659|540662863|FG005|Treatment Period 3|Withdrawal by Subject|0|||
149872970|NCT01193127|540662864|FG000|Randomized|Surgery Cancelled|0|||
149872971|NCT01193127|540662865|FG001|Randomized|Surgery Cancelled|0|||
150042311|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
150042312|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Other|8|||
150042313|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Other|3|||
150042314|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Other|4|||
150042315|NCT01106690|541293683|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
150042316|NCT01106690|541293684|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
150042317|NCT01106690|541293685|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
150042318|NCT00998296|541293686|FG000|Overall Study|Progressive disease|0|||
150042319|NCT00998296|541293687|FG001|Overall Study|Progressive disease|1|||
150042320|NCT00998296|541293688|FG002|Overall Study|Progressive disease|0|||
150042321|NCT00998296|541293689|FG003|Overall Study|Progressive disease|0|||
150042322|NCT00998296|541293690|FG004|Overall Study|Progressive disease|0|||
149872972|NCT01193127|540662866|FG002|Randomized|Surgery Cancelled|0|||
149872973|NCT01193127|540662867|FG003|Randomized|Surgery Cancelled|1|||
149872974|NCT01193127|540662864|FG000|Treated|Withdrawal by Subject|0|||
149872975|NCT01193127|540662865|FG001|Treated|Withdrawal by Subject|0|||
149872976|NCT01193127|540662866|FG002|Treated|Withdrawal by Subject|0|||
149872977|NCT01193127|540662867|FG003|Treated|Withdrawal by Subject|1|||
149872978|NCT03246646|540662872|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
149872979|NCT03246646|540662873|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
149872980|NCT03246646|540662872|FG000|Overall Study|Withdrawal by Subject|3|||
149872981|NCT03246646|540662873|FG001|Overall Study|Withdrawal by Subject|0|||
149872982|NCT03246646|540662872|FG000|Overall Study|Lost to Follow-up|7|||
149872983|NCT03246646|540662873|FG001|Overall Study|Lost to Follow-up|0|||
149872984|NCT02352779|540662876|FG000|Overall Study|Personal Issues|1|||
149872985|NCT02352779|540662877|FG001|Overall Study|Personal Issues|1|||
149872986|NCT02352779|540662878|FG002|Overall Study|Personal Issues|0|||
149872987|NCT02352779|540662876|FG000|Overall Study|Too Many Forms|2|||
149872988|NCT02352779|540662877|FG001|Overall Study|Too Many Forms|0|||
149872989|NCT02352779|540662878|FG002|Overall Study|Too Many Forms|0|||
149872990|NCT02352779|540662876|FG000|Overall Study|Feeling Overwhelmed|1|||
149872991|NCT02352779|540662877|FG001|Overall Study|Feeling Overwhelmed|0|||
149872992|NCT02352779|540662878|FG002|Overall Study|Feeling Overwhelmed|0|||
149872993|NCT02352779|540662876|FG000|Overall Study|Disliked Intervention|1|||
149872994|NCT02352779|540662877|FG001|Overall Study|Disliked Intervention|0|||
149872995|NCT02352779|540662878|FG002|Overall Study|Disliked Intervention|0|||
149872996|NCT02352779|540662876|FG000|Overall Study|Changed Mind|1|||
149872997|NCT02352779|540662877|FG001|Overall Study|Changed Mind|0|||
149872998|NCT02352779|540662878|FG002|Overall Study|Changed Mind|0|||
149872999|NCT02352779|540662876|FG000|Overall Study|Study Related Symptoms|1|||
149873000|NCT02352779|540662877|FG001|Overall Study|Study Related Symptoms|0|||
149873001|NCT02352779|540662878|FG002|Overall Study|Study Related Symptoms|0|||
149873002|NCT02352779|540662876|FG000|Overall Study|Absence of Symptoms|1|||
149873003|NCT02352779|540662877|FG001|Overall Study|Absence of Symptoms|0|||
149873004|NCT02352779|540662878|FG002|Overall Study|Absence of Symptoms|0|||
149873005|NCT02352779|540662876|FG000|Overall Study|Other Medical Reason|0|||
149873006|NCT02352779|540662877|FG001|Overall Study|Other Medical Reason|0|||
149873007|NCT02352779|540662878|FG002|Overall Study|Other Medical Reason|1|||
149873008|NCT02352779|540662876|FG000|Overall Study|No Reason|0|||
149873009|NCT02352779|540662877|FG001|Overall Study|No Reason|0|||
149873010|NCT02352779|540662878|FG002|Overall Study|No Reason|1|||
149873011|NCT00968799|540662881|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
149873012|NCT01104779|540662884|FG000|Overall Study|Protocol Violation|1|||
149873013|NCT01104779|540662885|FG001|Overall Study|Protocol Violation|2|||
149873014|NCT01104779|540662886|FG002|Overall Study|Protocol Violation|2|||
149873015|NCT01104779|540662884|FG000|Overall Study|Lack of Efficacy|26|||
149873016|NCT01104779|540662885|FG001|Overall Study|Lack of Efficacy|12|||
149873017|NCT01104779|540662886|FG002|Overall Study|Lack of Efficacy|13|||
149873018|NCT01104779|540662884|FG000|Overall Study|Adverse Event|13|||
149873019|NCT01104779|540662885|FG001|Overall Study|Adverse Event|14|||
149873020|NCT01104779|540662886|FG002|Overall Study|Adverse Event|13|||
149873021|NCT01104779|540662884|FG000|Overall Study|Did not meet inc/exc criteria|1|||
149873022|NCT01104779|540662885|FG001|Overall Study|Did not meet inc/exc criteria|1|||
149873023|NCT01104779|540662886|FG002|Overall Study|Did not meet inc/exc criteria|1|||
149873024|NCT01104779|540662884|FG000|Overall Study|Other reasons|0|||
149873025|NCT01104779|540662885|FG001|Overall Study|Other reasons|1|||
149873026|NCT01104779|540662886|FG002|Overall Study|Other reasons|0|||
150042323|NCT00998296|541293691|FG005|Overall Study|Progressive disease|0|||
149873027|NCT01104779|540662884|FG000|Overall Study|Lost to Follow-up|2|||
149873028|NCT01104779|540662885|FG001|Overall Study|Lost to Follow-up|0|||
149873029|NCT01104779|540662886|FG002|Overall Study|Lost to Follow-up|1|||
149873030|NCT01104779|540662884|FG000|Overall Study|Withdrawal by Subject|16|||
149873031|NCT01104779|540662885|FG001|Overall Study|Withdrawal by Subject|25|||
149873032|NCT01104779|540662886|FG002|Overall Study|Withdrawal by Subject|32|||
149873033|NCT01372774|540662889|FG000|Overall Study|Withdrawal prior to treatment|4|||
149873034|NCT01372774|540662890|FG001|Overall Study|Withdrawal prior to treatment|5|||
149873035|NCT00389831|540662891|FG000|Overall Study|Lack of Efficacy|0|||
149873036|NCT00389831|540662892|FG001|Overall Study|Lack of Efficacy|2|||
149873037|NCT00389831|540662891|FG000|Overall Study|Did not receive treatment.|0|||
149873038|NCT00389831|540662892|FG001|Overall Study|Did not receive treatment.|2|||
149873039|NCT00389831|540662891|FG000|Overall Study|Other reasons|0|||
149873040|NCT00389831|540662892|FG001|Overall Study|Other reasons|2|||
149873041|NCT00389831|540662891|FG000|Overall Study|Lost to Follow-up|0|||
149873042|NCT00389831|540662892|FG001|Overall Study|Lost to Follow-up|1|||
149873043|NCT04639713|540662899|FG000|Overall Study|Protocol Noncompliance|2|||
149873044|NCT04639713|540662899|FG000|Overall Study|Withdrawal by Subject|1|||
149873045|NCT02903030|540664959|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
149873046|NCT02903030|540664960|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
149873047|NCT04345601|540664961|FG000|Overall Study|Death|0|||
149873048|NCT04345601|540664962|FG001|Overall Study|Death|3|||
149873049|NCT04345601|540664963|FG002|Overall Study|Death|2|||
149873050|NCT04345601|540664961|FG000|Overall Study|Lost to Follow-up|0|||
149873051|NCT04345601|540664962|FG001|Overall Study|Lost to Follow-up|0|||
149873052|NCT04345601|540664963|FG002|Overall Study|Lost to Follow-up|2|||
149873053|NCT03610516|540664964|FG000|Treatment Epoch|Adverse Event|3|||
149873054|NCT03610516|540664965|FG001|Treatment Epoch|Adverse Event|1|||
149873055|NCT03610516|540664964|FG000|Treatment Epoch|Death|1|||
149873056|NCT03610516|540664965|FG001|Treatment Epoch|Death|0|||
149873057|NCT03610516|540664964|FG000|Treatment Epoch|Lack of Efficacy|0|||
149873058|NCT03610516|540664965|FG001|Treatment Epoch|Lack of Efficacy|1|||
149873059|NCT03610516|540664964|FG000|Treatment Epoch|No longer requires treatment|1|||
149873060|NCT03610516|540664965|FG001|Treatment Epoch|No longer requires treatment|0|||
149873061|NCT03610516|540664964|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
149873062|NCT03610516|540664965|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
149873063|NCT03610516|540664964|FG000|Treatment Epoch|Physician Decision|8|||
149873064|NCT03610516|540664965|FG001|Treatment Epoch|Physician Decision|5|||
149873065|NCT03610516|540664964|FG000|Treatment Epoch|Protocol Deviation|1|||
149873066|NCT03610516|540664965|FG001|Treatment Epoch|Protocol Deviation|0|||
149873067|NCT03610516|540664964|FG000|Treatment Epoch|Withdrawal by Subject|3|||
149873068|NCT03610516|540664965|FG001|Treatment Epoch|Withdrawal by Subject|1|||
149873069|NCT03610516|540664964|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
149873070|NCT03610516|540664965|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
149873071|NCT03610516|540664964|FG000|Post-Treatment Follow-up|Death|1|||
149873072|NCT03610516|540664965|FG001|Post-Treatment Follow-up|Death|0|||
149873073|NCT03700385|540664966|FG000|Overall Study|Lost to Follow-up|1|||
149873074|NCT01555671|540664972|FG000|Overall Study|Physician Decision|20|||
149873075|NCT01555671|540664973|FG001|Overall Study|Physician Decision|25|||
149873076|NCT04590040|540664979|FG000|Treatment Period|Lost to Follow-up|2|||
149873077|NCT04590040|540664980|FG001|Treatment Period|Lost to Follow-up|5|||
149873078|NCT04590040|540664981|FG002|Treatment Period|Lost to Follow-up|0|||
149873079|NCT04590040|540664979|FG000|Treatment Period|Physician Decision|0|||
149873080|NCT04590040|540664980|FG001|Treatment Period|Physician Decision|0|||
149873081|NCT04590040|540664981|FG002|Treatment Period|Physician Decision|2|||
149873082|NCT00000378|540664984|FG000|Overall Study|Lack of Efficacy|16|||
149873083|NCT00000378|540664985|FG001|Overall Study|Lack of Efficacy|14|||
149873084|NCT01284361|540664988|FG000|Overall Study|Withdrawal by Subject|1|||
149873085|NCT01284361|540664988|FG000|Overall Study|Protocol Violation|5|||
149873086|NCT01284361|540664988|FG000|Overall Study|Adverse Event|1|||
149873087|NCT01284361|540664988|FG000|Overall Study|Lost to Follow-up|2|||
149873088|NCT01957397|540664992|FG000|Test Period 1|sudden leakage/small bag|1|||
149873089|NCT01957397|540664993|FG001|Test Period 1|sudden leakage/small bag|1|||
149873090|NCT01957397|540664992|FG000|Test Period 1|Withdrawal by Subject|1|||
149873091|NCT01957397|540664993|FG001|Test Period 1|Withdrawal by Subject|0|||
149873092|NCT01957397|540664992|FG000|Test Period 2|Adverse Event|0|||
149873093|NCT01957397|540664993|FG001|Test Period 2|Adverse Event|1|||
149873094|NCT01957397|540664992|FG000|Test Period 3|Adverse Event|1|||
149873095|NCT01957397|540664993|FG001|Test Period 3|Adverse Event|2|||
149873096|NCT01957397|540664992|FG000|Test Period 3|the adhesive did not work|1|||
149873097|NCT01957397|540664993|FG001|Test Period 3|the adhesive did not work|0|||
149873098|NCT00540293|540664994|FG000|Overall Study|Adverse event related to study drug|10|||
149873099|NCT00540293|540664994|FG000|Overall Study|Adverse event not related to study drug|7|||
149873100|NCT00540293|540664994|FG000|Overall Study|Withdrawal by Subject|6|||
149963645|NCT05261490|541001498|FG000|Overall Study|Death|1|||
149963646|NCT05261490|541001499|FG001|Overall Study|Death|2|||
149963647|NCT05261490|541001500|FG002|Overall Study|Death|0|||
149873101|NCT00540293|540664994|FG000|Overall Study|Protocol violation, & subject schedule|12|||
149873102|NCT03537599|540664995|FG000|Overall Study|Disease Progression|2|||
149963648|NCT02100644|541001506|FG000|LTG Escalation Phase|Adverse Event|9|||
149873103|NCT03537599|540664996|FG001|Overall Study|Disease Progression|1|||
150174068|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
150174069|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149873104|NCT03537599|540664995|FG000|Overall Study|Death|0|||
149873105|NCT03537599|540664996|FG001|Overall Study|Death|1|||
149873106|NCT00325195|540664999|FG000|Randomized|Not dosed|5|||
149873107|NCT00325195|540665000|FG001|Randomized|Not dosed|5|||
149873108|NCT00325195|540665001|FG002|Randomized|Not dosed|3|||
149873109|NCT00325195|540664999|FG000|Received Intervention: ITT Population|Adverse Event|15|||
149873110|NCT00325195|540665000|FG001|Received Intervention: ITT Population|Adverse Event|17|||
149873111|NCT00325195|540665001|FG002|Received Intervention: ITT Population|Adverse Event|1|||
149873112|NCT00325195|540664999|FG000|Received Intervention: ITT Population|Death|3|||
149873113|NCT00325195|540665000|FG001|Received Intervention: ITT Population|Death|1|||
149873114|NCT00325195|540665001|FG002|Received Intervention: ITT Population|Death|0|||
149873115|NCT00325195|540664999|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
149873116|NCT00325195|540665000|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
149873117|NCT00325195|540665001|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
149873118|NCT00325195|540664999|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
149873119|NCT00325195|540665000|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
149873120|NCT00325195|540665001|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
149873121|NCT00325195|540664999|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
149873122|NCT00325195|540665000|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
149873123|NCT00325195|540665001|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
149873124|NCT00806286|540665002|FG000|Overall Study|Adverse Event|5|||
149873125|NCT00806286|540665003|FG001|Overall Study|Adverse Event|2|||
149873126|NCT00806286|540665004|FG002|Overall Study|Adverse Event|0|||
149873127|NCT00806286|540665002|FG000|Overall Study|Disease progression|31|||
149873128|NCT00806286|540665003|FG001|Overall Study|Disease progression|38|||
149873129|NCT00806286|540665004|FG002|Overall Study|Disease progression|1|||
149873130|NCT00806286|540665002|FG000|Overall Study|Death|1|||
149873131|NCT00806286|540665003|FG001|Overall Study|Death|6|||
149873132|NCT00806286|540665004|FG002|Overall Study|Death|0|||
149873133|NCT00806286|540665002|FG000|Overall Study|Lost to Follow-up|0|||
149873134|NCT00806286|540665003|FG001|Overall Study|Lost to Follow-up|1|||
149873135|NCT00806286|540665004|FG002|Overall Study|Lost to Follow-up|0|||
149873136|NCT00806286|540665002|FG000|Overall Study|Withdrawal by Subject|8|||
149873137|NCT00806286|540665003|FG001|Overall Study|Withdrawal by Subject|3|||
149873138|NCT00806286|540665004|FG002|Overall Study|Withdrawal by Subject|1|||
149873139|NCT00806286|540665002|FG000|Overall Study|Physician Decision|2|||
149873140|NCT00806286|540665003|FG001|Overall Study|Physician Decision|2|||
149873141|NCT00806286|540665004|FG002|Overall Study|Physician Decision|0|||
149873142|NCT00806286|540665002|FG000|Overall Study|Due to a variety of reasons|7|||
149873143|NCT00806286|540665003|FG001|Overall Study|Due to a variety of reasons|2|||
149873144|NCT00806286|540665004|FG002|Overall Study|Due to a variety of reasons|1|||
149873145|NCT00977379|540665017|FG000|Overall Study|Withdrawal by Subject|1|||
149873146|NCT00977379|540665018|FG001|Overall Study|Withdrawal by Subject|1|||
149873147|NCT00977379|540665017|FG000|Overall Study|Death|7|||
149873148|NCT00977379|540665018|FG001|Overall Study|Death|9|||
149873149|NCT00977379|540665017|FG000|Overall Study|Premature Study Termination|4|||
149873150|NCT00977379|540665018|FG001|Overall Study|Premature Study Termination|0|||
149873151|NCT00977379|540665017|FG000|Overall Study|Participant Moving House|0|||
149873152|NCT00977379|540665018|FG001|Overall Study|Participant Moving House|1|||
149873153|NCT00977379|540665017|FG000|Overall Study|Randomization Error|0|||
149963649|NCT02100644|541001507|FG001|LTG Escalation Phase|Adverse Event|0|||
149963650|NCT02100644|541001508|FG002|LTG Escalation Phase|Adverse Event|0|||
149963651|NCT02100644|541001506|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
149963652|NCT02100644|541001507|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
149963653|NCT02100644|541001508|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
149963654|NCT02100644|541001506|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
149963655|NCT02100644|541001507|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
149963656|NCT02100644|541001508|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
149963657|NCT03478787|541001512|FG000|Overall Study|Adverse Event|5|||
149963658|NCT03478787|541001513|FG001|Overall Study|Adverse Event|1|||
149963659|NCT03478787|541001512|FG000|Overall Study|Protocol Violation|3|||
149963660|NCT03478787|541001513|FG001|Overall Study|Protocol Violation|0|||
149963661|NCT03478787|541001512|FG000|Overall Study|Lack of Efficacy|7|||
149963662|NCT03478787|541001513|FG001|Overall Study|Lack of Efficacy|1|||
149963663|NCT03478787|541001512|FG000|Overall Study|Lost to Follow-up|9|||
149963664|NCT03478787|541001513|FG001|Overall Study|Lost to Follow-up|5|||
150042324|NCT00998296|541293692|FG006|Overall Study|Progressive disease|1|||
149873154|NCT00977379|540665018|FG001|Overall Study|Randomization Error|1|||
149873155|NCT00699374|540665019|FG000|Overall Study|Death|93|||
149873156|NCT00699374|540665020|FG001|Overall Study|Death|83|||
149873157|NCT00699374|540665019|FG000|Overall Study|Adverse Event|70|||
149873158|NCT00699374|540665020|FG001|Overall Study|Adverse Event|67|||
150042325|NCT00998296|541293693|FG007|Overall Study|Progressive disease|0|||
150042326|NCT00998296|541293694|FG008|Overall Study|Progressive disease|0|||
150042327|NCT00998296|541293695|FG009|Overall Study|Progressive disease|14|||
150042328|NCT00998296|541293696|FG010|Overall Study|Progressive disease|5|||
150042329|NCT00998296|541293686|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042330|NCT00998296|541293687|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042331|NCT00998296|541293688|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042332|NCT00998296|541293689|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042333|NCT00998296|541293690|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
150042334|NCT00998296|541293691|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042335|NCT00998296|541293692|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042336|NCT00998296|541293693|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
150042337|NCT00998296|541293694|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
150042338|NCT00998296|541293695|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042339|NCT00998296|541293696|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
150042340|NCT00998296|541293686|FG000|Overall Study|Other adverse event|0|||
150042341|NCT00998296|541293687|FG001|Overall Study|Other adverse event|0|||
150042342|NCT00998296|541293688|FG002|Overall Study|Other adverse event|0|||
149873159|NCT00699374|540665019|FG000|Overall Study|Global deterioration of health status|7|||
150042343|NCT00998296|541293689|FG003|Overall Study|Other adverse event|0|||
150042344|NCT00998296|541293690|FG004|Overall Study|Other adverse event|1|||
150042345|NCT00998296|541293691|FG005|Overall Study|Other adverse event|0|||
150042346|NCT00998296|541293692|FG006|Overall Study|Other adverse event|0|||
150042347|NCT00998296|541293693|FG007|Overall Study|Other adverse event|0|||
150042348|NCT00998296|541293694|FG008|Overall Study|Other adverse event|0|||
150042349|NCT00998296|541293695|FG009|Overall Study|Other adverse event|1|||
150042350|NCT00998296|541293696|FG010|Overall Study|Other adverse event|2|||
150042351|NCT00998296|541293686|FG000|Overall Study|Refused to continue taking trial med.|0|||
150042352|NCT00998296|541293687|FG001|Overall Study|Refused to continue taking trial med.|0|||
150042353|NCT00998296|541293688|FG002|Overall Study|Refused to continue taking trial med.|0|||
150042354|NCT00998296|541293689|FG003|Overall Study|Refused to continue taking trial med.|0|||
150042355|NCT00998296|541293690|FG004|Overall Study|Refused to continue taking trial med.|0|||
150042356|NCT00998296|541293691|FG005|Overall Study|Refused to continue taking trial med.|0|||
150042357|NCT00998296|541293692|FG006|Overall Study|Refused to continue taking trial med.|0|||
150042358|NCT00998296|541293693|FG007|Overall Study|Refused to continue taking trial med.|0|||
150042359|NCT00998296|541293694|FG008|Overall Study|Refused to continue taking trial med.|0|||
150042360|NCT00998296|541293695|FG009|Overall Study|Refused to continue taking trial med.|2|||
150042361|NCT00998296|541293696|FG010|Overall Study|Refused to continue taking trial med.|0|||
150042362|NCT00998296|541293686|FG000|Overall Study|Reason other than those specified above|0|||
149873160|NCT00699374|540665020|FG001|Overall Study|Global deterioration of health status|8|||
149873161|NCT00699374|540665019|FG000|Overall Study|Lost to Follow-up|3|||
149873162|NCT00699374|540665020|FG001|Overall Study|Lost to Follow-up|5|||
149873163|NCT00699374|540665019|FG000|Overall Study|Withdrawal by Subject|34|||
149873164|NCT00699374|540665020|FG001|Overall Study|Withdrawal by Subject|44|||
149873165|NCT00699374|540665019|FG000|Overall Study|Objective progression or relapse|281|||
149873166|NCT00699374|540665020|FG001|Overall Study|Objective progression or relapse|277|||
149873167|NCT00699374|540665019|FG000|Overall Study|Other|18|||
149873168|NCT00699374|540665020|FG001|Overall Study|Other|15|||
149873169|NCT00699374|540665019|FG000|Overall Study|Protocol Violation|2|||
149873170|NCT00699374|540665020|FG001|Overall Study|Protocol Violation|6|||
150042363|NCT00998296|541293687|FG001|Overall Study|Reason other than those specified above|0|||
150042364|NCT00998296|541293688|FG002|Overall Study|Reason other than those specified above|0|||
150042365|NCT00998296|541293689|FG003|Overall Study|Reason other than those specified above|0|||
149873171|NCT00699374|540665019|FG000|Overall Study|Study terminated by sponsor|13|||
150042366|NCT00998296|541293690|FG004|Overall Study|Reason other than those specified above|0|||
150042367|NCT00998296|541293691|FG005|Overall Study|Reason other than those specified above|0|||
150042368|NCT00998296|541293692|FG006|Overall Study|Reason other than those specified above|0|||
150042369|NCT00998296|541293693|FG007|Overall Study|Reason other than those specified above|0|||
150042370|NCT00998296|541293694|FG008|Overall Study|Reason other than those specified above|0|||
150042371|NCT00998296|541293695|FG009|Overall Study|Reason other than those specified above|1|||
150042372|NCT00998296|541293696|FG010|Overall Study|Reason other than those specified above|0|||
150042373|NCT04396639|541293697|FG000|Overall Study|Withdrawal by Subject|1|||
150042374|NCT04396639|541293697|FG000|Overall Study|Other|1|||
150042375|NCT01544335|541293698|FG000|Overall Study|Lost to Follow-up|27|||
149873172|NCT00699374|540665020|FG001|Overall Study|Study terminated by sponsor|28|||
149873173|NCT00699374|540665019|FG000|Overall Study|Randomized but not treated|4|||
149873174|NCT00699374|540665020|FG001|Overall Study|Randomized but not treated|2|||
149963665|NCT03478787|541001512|FG000|Overall Study|Withdrawal by Subject|2|||
149963666|NCT03478787|541001513|FG001|Overall Study|Withdrawal by Subject|6|||
149963667|NCT03478787|541001512|FG000|Overall Study|Other, Not Specified|3|||
149963668|NCT03478787|541001513|FG001|Overall Study|Other, Not Specified|0|||
149963669|NCT00655356|541001516|FG000|Overall Study|Withdrawal by Subject|3|||
149963670|NCT00655356|541001517|FG001|Overall Study|Withdrawal by Subject|4|||
149963671|NCT00655356|541001516|FG000|Overall Study|Sponsor Request|10|||
149963672|NCT00655356|541001517|FG001|Overall Study|Sponsor Request|4|||
149963673|NCT00655356|541001516|FG000|Overall Study|Adverse Event|1|||
149963674|NCT00655356|541001517|FG001|Overall Study|Adverse Event|1|||
149963675|NCT00655356|541001516|FG000|Overall Study|Protocol Violation|2|||
149963676|NCT00655356|541001517|FG001|Overall Study|Protocol Violation|1|||
149963677|NCT00655356|541001516|FG000|Overall Study|Other Reason|1|||
149963678|NCT00655356|541001517|FG001|Overall Study|Other Reason|0|||
149963679|NCT01044459|541001518|FG000|Overall Study|Withdrawal by Subject|21|||
149963680|NCT01044459|541001519|FG001|Overall Study|Withdrawal by Subject|28|||
149963681|NCT01044459|541001518|FG000|Overall Study|Terminated by Sponsor|22|||
149873175|NCT00699374|540665019|FG000|Overall Study|Died 28 days after last dose|5|||
149873176|NCT00699374|540665020|FG001|Overall Study|Died 28 days after last dose|9|||
149873177|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
149873178|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
149873179|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
149873180|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
149873181|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
149873182|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
149873183|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
149873184|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
149873185|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
149873186|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
149873187|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
149873188|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
149873189|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
149873190|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
149873191|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
149873192|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
149873193|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
149873194|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
149873195|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
149873196|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
149873197|NCT00593736|540665027|FG000|Screening Period and Placebo Run-in|Various|0|||
149873198|NCT00593736|540665028|FG001|Screening Period and Placebo Run-in|Various|0|||
149963682|NCT01044459|541001519|FG001|Overall Study|Terminated by Sponsor|21|||
149963683|NCT01044459|541001518|FG000|Overall Study|Adverse Event|22|||
150042376|NCT01544335|541293698|FG000|Overall Study|Death|4|||
149873199|NCT00593736|540665029|FG002|Screening Period and Placebo Run-in|Various|0|||
150042377|NCT01544335|541293698|FG000|Overall Study|Disease progression|3|||
150042378|NCT01544335|541293698|FG000|Overall Study|Baseline Measurements not Available|19|||
150042379|NCT02106390|541293701|FG000|Overall Study|Withdrawal by Subject|15|||
150042380|NCT02106390|541293702|FG001|Overall Study|Withdrawal by Subject|16|||
150042381|NCT02106390|541293703|FG002|Overall Study|Withdrawal by Subject|15|||
150042382|NCT02106390|541293701|FG000|Overall Study|Lost to Follow-up|25|||
150042383|NCT02106390|541293702|FG001|Overall Study|Lost to Follow-up|20|||
150042384|NCT02106390|541293703|FG002|Overall Study|Lost to Follow-up|13|||
150042385|NCT02106390|541293701|FG000|Overall Study|Other: Administrative Reason|8|||
150042386|NCT02106390|541293702|FG001|Overall Study|Other: Administrative Reason|5|||
150042387|NCT02106390|541293703|FG002|Overall Study|Other: Administrative Reason|12|||
150042388|NCT02106390|541293701|FG000|Overall Study|Other: Unspecified|1|||
150042389|NCT02106390|541293702|FG001|Overall Study|Other: Unspecified|4|||
150042390|NCT02106390|541293703|FG002|Overall Study|Other: Unspecified|2|||
150042391|NCT02106390|541293701|FG000|Overall Study|Adverse Event|0|||
150042392|NCT02106390|541293702|FG001|Overall Study|Adverse Event|2|||
150042393|NCT02106390|541293703|FG002|Overall Study|Adverse Event|1|||
150042394|NCT02106390|541293701|FG000|Overall Study|Protocol Violation|0|||
150042395|NCT02106390|541293702|FG001|Overall Study|Protocol Violation|1|||
150042396|NCT02106390|541293703|FG002|Overall Study|Protocol Violation|0|||
150042397|NCT03809104|541293710|FG000|Overall Study|Withdrawal by Subject|3|||
150042398|NCT01532986|541293711|FG000|Overall Study|Death|9|||
150042399|NCT01532986|541293712|FG001|Overall Study|Death|9|||
150042400|NCT01532986|541293711|FG000|Overall Study|Withdrawal by Subject|7|||
150042401|NCT01532986|541293712|FG001|Overall Study|Withdrawal by Subject|10|||
150042402|NCT01532986|541293711|FG000|Overall Study|Physician Decision|7|||
150042403|NCT01532986|541293712|FG001|Overall Study|Physician Decision|5|||
150042404|NCT04313244|541293713|FG000|Overall Study|Withdrawal of Consent|3|||
150042405|NCT04313244|541293714|FG001|Overall Study|Withdrawal of Consent|3|||
150042406|NCT04313244|541293713|FG000|Overall Study|Met Exclusion Criteria|1|||
150042407|NCT04313244|541293714|FG001|Overall Study|Met Exclusion Criteria|0|||
150042408|NCT04313244|541293713|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
150042409|NCT04313244|541293714|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
150042410|NCT02976038|541293715|FG000|Overall Study|Physician Decision|22|||
150042411|NCT02976038|541293715|FG000|Overall Study|Withdrawal by Subject|3|||
150042412|NCT02976038|541293715|FG000|Overall Study|Lost to Follow-up|2|||
150042413|NCT02976038|541293715|FG000|Overall Study|Adverse Event|1|||
150042414|NCT03096288|541293717|FG000|Overall Study|Withdrawal by Subject|0|||
150042415|NCT03096288|541293718|FG001|Overall Study|Withdrawal by Subject|1|||
150042416|NCT03096288|541293719|FG002|Overall Study|Withdrawal by Subject|0|||
150042417|NCT03096288|541293720|FG003|Overall Study|Withdrawal by Subject|1|||
150042418|NCT02004093|541293724|FG000|Overall Study|Death|2|||
150042419|NCT02004093|541293725|FG001|Overall Study|Death|1|||
150042420|NCT02004093|541293724|FG000|Overall Study|Lack of Efficacy|66|||
150042421|NCT02004093|541293725|FG001|Overall Study|Lack of Efficacy|62|||
150042422|NCT02004093|541293724|FG000|Overall Study|Protocol Violation|0|||
150042423|NCT02004093|541293725|FG001|Overall Study|Protocol Violation|1|||
150042424|NCT02004093|541293724|FG000|Overall Study|Lost to Follow-up|0|||
149873200|NCT00593736|540665030|FG003|Screening Period and Placebo Run-in|Various|25|||
149873201|NCT00593736|540665027|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
149873202|NCT00593736|540665028|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
149873203|NCT00593736|540665029|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
149873204|NCT00593736|540665030|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
149873205|NCT00593736|540665027|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
149873206|NCT00593736|540665028|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
150042425|NCT02004093|541293725|FG001|Overall Study|Lost to Follow-up|1|||
150042426|NCT02004093|541293724|FG000|Overall Study|Withdrawal by Subject|3|||
150042427|NCT02004093|541293725|FG001|Overall Study|Withdrawal by Subject|7|||
150042428|NCT02004093|541293724|FG000|Overall Study|Other|3|||
150042429|NCT02004093|541293725|FG001|Overall Study|Other|1|||
150042430|NCT04085289|541293726|FG000|Overall Study|Withdrawal by Subject|0|||
150042431|NCT04085289|541293727|FG001|Overall Study|Withdrawal by Subject|0|||
150042432|NCT04085289|541293728|FG002|Overall Study|Withdrawal by Subject|1|||
150042433|NCT01995838|541293729|FG000|Overall Study|Lost to Follow-up|0|||
150042434|NCT01995838|541293730|FG001|Overall Study|Lost to Follow-up|1|||
150042435|NCT01995838|541293731|FG002|Overall Study|Lost to Follow-up|0|||
150042436|NCT01995838|541293732|FG003|Overall Study|Lost to Follow-up|0|||
150042437|NCT01995838|541293733|FG004|Overall Study|Lost to Follow-up|0|||
150042438|NCT01995838|541293734|FG005|Overall Study|Lost to Follow-up|0|||
150042439|NCT01995838|541293735|FG006|Overall Study|Lost to Follow-up|1|||
150042440|NCT01995838|541293729|FG000|Overall Study|Participant choice|2|||
150042441|NCT01995838|541293730|FG001|Overall Study|Participant choice|0|||
150042442|NCT01995838|541293731|FG002|Overall Study|Participant choice|0|||
150042443|NCT01995838|541293732|FG003|Overall Study|Participant choice|0|||
150042444|NCT01995838|541293733|FG004|Overall Study|Participant choice|0|||
150042445|NCT01995838|541293734|FG005|Overall Study|Participant choice|1|||
150042446|NCT01995838|541293735|FG006|Overall Study|Participant choice|1|||
150042447|NCT01995838|541293729|FG000|Overall Study|Adverse Event|0|||
150042448|NCT01995838|541293730|FG001|Overall Study|Adverse Event|0|||
150042449|NCT01995838|541293731|FG002|Overall Study|Adverse Event|0|||
149873207|NCT00593736|540665029|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
150042450|NCT01995838|541293732|FG003|Overall Study|Adverse Event|0|||
150042451|NCT01995838|541293733|FG004|Overall Study|Adverse Event|0|||
150042452|NCT01995838|541293734|FG005|Overall Study|Adverse Event|0|||
150042453|NCT01995838|541293735|FG006|Overall Study|Adverse Event|1|||
150042454|NCT01995838|541293729|FG000|Overall Study|Withdrawal by Subject|0|||
150042455|NCT01995838|541293730|FG001|Overall Study|Withdrawal by Subject|0|||
150174070|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
150174071|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149873208|NCT00593736|540665030|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
149873209|NCT00593736|540665027|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
150174072|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
150174073|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149873210|NCT00593736|540665028|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
149873211|NCT00593736|540665029|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
149873212|NCT00593736|540665030|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
149873213|NCT00593736|540665027|FG000|Treatment Period and Placebo Run-out|Various|1|||
149873214|NCT00593736|540665028|FG001|Treatment Period and Placebo Run-out|Various|1|||
149873215|NCT00593736|540665029|FG002|Treatment Period and Placebo Run-out|Various|1|||
149873216|NCT00593736|540665030|FG003|Treatment Period and Placebo Run-out|Various|0|||
149873217|NCT04283500|540665033|FG000|Overall Study|Lost to Follow-up|8|||
149873218|NCT04283500|540665033|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
149873219|NCT02006693|540665037|FG000|Overall Study|No Reason Specified|6|||
149873220|NCT02006693|540665038|FG001|Overall Study|No Reason Specified|8|||
149873221|NCT02006693|540665037|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
149873222|NCT02006693|540665038|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
149873223|NCT02006693|540665037|FG000|Overall Study|XEN Implant Explantation|0|||
149873224|NCT02006693|540665038|FG001|Overall Study|XEN Implant Explantation|1|||
149873225|NCT02006693|540665037|FG000|Overall Study|Death|2|||
149873226|NCT02006693|540665038|FG001|Overall Study|Death|2|||
149873227|NCT02006693|540665037|FG000|Overall Study|Lost to Follow-up|4|||
149873228|NCT02006693|540665038|FG001|Overall Study|Lost to Follow-up|1|||
149873229|NCT02006693|540665037|FG000|Overall Study|Patient Decision|4|||
149873230|NCT02006693|540665038|FG001|Overall Study|Patient Decision|0|||
150042456|NCT01995838|541293731|FG002|Overall Study|Withdrawal by Subject|0|||
150042457|NCT01995838|541293732|FG003|Overall Study|Withdrawal by Subject|0|||
150042458|NCT01995838|541293733|FG004|Overall Study|Withdrawal by Subject|1|||
150042459|NCT01995838|541293734|FG005|Overall Study|Withdrawal by Subject|0|||
150174074|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149873231|NCT01119508|540665041|FG000|Overall Study|Adverse Event|56|||
150042460|NCT01995838|541293735|FG006|Overall Study|Withdrawal by Subject|0|||
150042461|NCT01995838|541293729|FG000|Overall Study|Other|3|||
150042462|NCT01995838|541293730|FG001|Overall Study|Other|1|||
149873232|NCT01119508|540665041|FG000|Overall Study|Withdrawal by Subject|2|||
149873233|NCT01119508|540665041|FG000|Overall Study|Died before tumor response evaluation|1|||
150042463|NCT01995838|541293731|FG002|Overall Study|Other|0|||
150042464|NCT01995838|541293732|FG003|Overall Study|Other|2|||
150042465|NCT01995838|541293733|FG004|Overall Study|Other|1|||
150042466|NCT01995838|541293734|FG005|Overall Study|Other|1|||
150042467|NCT01995838|541293735|FG006|Overall Study|Other|2|||
150042468|NCT00275509|541293740|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
150042469|NCT00275509|541293741|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
150042470|NCT01967576|541293742|FG000|Overall Study|Withdrawal by Subject|3|||
150042471|NCT01967576|541293742|FG000|Overall Study|Progressed/Removed from treatment|1|||
150042472|NCT01967576|541293742|FG000|Overall Study|Study closing at site|1|||
150042473|NCT01967576|541293742|FG000|Overall Study|Adverse Event|1|||
150042474|NCT01967576|541293742|FG000|Overall Study|Refused further treatment|1|||
150042475|NCT02819804|541293745|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
150042476|NCT03196349|541293746|FG000|Overall Study|Did not receive study drug|0|||
150042477|NCT03196349|541293747|FG001|Overall Study|Did not receive study drug|1|||
150042478|NCT03196349|541293748|FG002|Overall Study|Did not receive study drug|2|||
150042479|NCT03196349|541293746|FG000|Overall Study|No data entered|2|||
150042480|NCT03196349|541293747|FG001|Overall Study|No data entered|4|||
150042481|NCT03196349|541293748|FG002|Overall Study|No data entered|0|||
150042482|NCT03196349|541293746|FG000|Overall Study|Study Terminated early|15|||
150042483|NCT03196349|541293747|FG001|Overall Study|Study Terminated early|9|||
150042484|NCT03196349|541293748|FG002|Overall Study|Study Terminated early|11|||
150042485|NCT03388164|541293753|FG000|Overall Study|Withdrawal by Subject|3|||
150042486|NCT03388164|541293754|FG001|Overall Study|Withdrawal by Subject|1|||
149873234|NCT00265395|540665042|FG000|Overall Study|Adverse Event|3|||
149873235|NCT00265395|540665043|FG001|Overall Study|Adverse Event|6|||
149873236|NCT00265395|540665042|FG000|Overall Study|Lost to Follow-up|2|||
150042487|NCT00345358|541293756|FG000|Primary Vaccination Phase|Other|0|||
150042488|NCT00345358|541293757|FG001|Primary Vaccination Phase|Other|1|||
150042489|NCT00345358|541293758|FG002|Primary Vaccination Phase|Other|1|||
150042490|NCT00345358|541293759|FG003|Primary Vaccination Phase|Other|0|||
150042491|NCT00345358|541293756|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
150042492|NCT00345358|541293757|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
149873237|NCT00265395|540665043|FG001|Overall Study|Lost to Follow-up|1|||
149873238|NCT00265395|540665042|FG000|Overall Study|Withdrawal by Subject|1|||
149873239|NCT00265395|540665043|FG001|Overall Study|Withdrawal by Subject|6|||
150042493|NCT00345358|541293758|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
150042494|NCT00345358|541293759|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
150042495|NCT00345358|541293756|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
150042496|NCT00345358|541293757|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
150042497|NCT00345358|541293758|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
150042498|NCT00345358|541293759|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
150042499|NCT00345358|541293756|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
150042500|NCT00345358|541293757|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
150042501|NCT00345358|541293758|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
150042502|NCT00345358|541293759|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
150042503|NCT00345358|541293756|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
150042504|NCT00345358|541293757|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
150042505|NCT00345358|541293758|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
150042506|NCT00345358|541293759|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
150042507|NCT00345358|541293756|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
150174075|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
150174076|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149873240|NCT00265395|540665042|FG000|Overall Study|Protocol Violation|2|||
149873241|NCT00265395|540665043|FG001|Overall Study|Protocol Violation|2|||
149873242|NCT00265395|540665042|FG000|Overall Study|Lack of Efficacy|0|||
149873243|NCT00265395|540665043|FG001|Overall Study|Lack of Efficacy|1|||
149873244|NCT00265395|540665042|FG000|Overall Study|Administrative|0|||
149873245|NCT00265395|540665043|FG001|Overall Study|Administrative|1|||
149873246|NCT02563106|540665046|FG000|Overall Study|Withdrawal by Subject|7|||
149873247|NCT02563106|540665047|FG001|Overall Study|Withdrawal by Subject|8|||
149873248|NCT02563106|540665046|FG000|Overall Study|Adverse Event|17|||
150042508|NCT00345358|541293757|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
150042509|NCT00345358|541293758|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
150042510|NCT00345358|541293759|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
150042511|NCT02892448|541293761|FG000|Overall Study|Screening failure|2|||
150042512|NCT02892448|541293762|FG001|Overall Study|Screening failure|2|||
150042513|NCT02892448|541293763|FG002|Overall Study|Screening failure|1|||
149873249|NCT02563106|540665047|FG001|Overall Study|Adverse Event|15|||
150042514|NCT00499083|541293764|FG000|Overall Study|Not evaluable|3|||
150042515|NCT01254422|541293765|FG000|Overall Study|Protocol Violation|1|||
150042516|NCT01254422|541293766|FG001|Overall Study|Protocol Violation|0|||
149873250|NCT02563106|540665046|FG000|Overall Study|Protocol Violation|1|||
149873251|NCT02563106|540665047|FG001|Overall Study|Protocol Violation|0|||
149873252|NCT02563106|540665046|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
150174077|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
149873253|NCT02563106|540665047|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
149873254|NCT02563106|540665046|FG000|Overall Study|Lost to Follow-up|3|||
149873255|NCT02563106|540665047|FG001|Overall Study|Lost to Follow-up|2|||
149873256|NCT02563106|540665046|FG000|Overall Study|Physician Decision|3|||
149873257|NCT02563106|540665047|FG001|Overall Study|Physician Decision|1|||
149873258|NCT02563106|540665046|FG000|Overall Study|Other reason - not specified|2|||
149873259|NCT02563106|540665047|FG001|Overall Study|Other reason - not specified|1|||
149873260|NCT04729309|540665048|FG000|Period 1|Subject unable to return for Period 2|3|||
149873261|NCT04729309|540665049|FG001|Period 1|Subject unable to return for Period 2|0|||
149873262|NCT04729309|540665048|FG000|Period 1|Lost to Follow-up|1|||
149873263|NCT04729309|540665049|FG001|Period 1|Lost to Follow-up|0|||
149873264|NCT01212588|540665050|FG000|Overall Study|Physician Decision|0|||
149873265|NCT01212588|540665051|FG001|Overall Study|Physician Decision|1|||
149873266|NCT01212588|540665050|FG000|Overall Study|Protocol Violation|1|||
149873267|NCT01212588|540665051|FG001|Overall Study|Protocol Violation|1|||
149873268|NCT01136967|540665052|FG000|Overall Study|Adverse Event|9|||
149873269|NCT01136967|540665053|FG001|Overall Study|Adverse Event|12|||
149873270|NCT01136967|540665052|FG000|Overall Study|Participant Choice|8|||
149873271|NCT01136967|540665053|FG001|Overall Study|Participant Choice|3|||
149873272|NCT01136967|540665052|FG000|Overall Study|Lost to Follow-up|0|||
149873273|NCT01136967|540665053|FG001|Overall Study|Lost to Follow-up|1|||
149873274|NCT01136967|540665052|FG000|Overall Study|Withdrawal by Subject|1|||
149873275|NCT01136967|540665053|FG001|Overall Study|Withdrawal by Subject|2|||
149873276|NCT01136967|540665052|FG000|Overall Study|Clinical Progression|3|||
149873277|NCT01136967|540665053|FG001|Overall Study|Clinical Progression|5|||
149873278|NCT01136967|540665052|FG000|Overall Study|Radiation|1|||
149873279|NCT01136967|540665053|FG001|Overall Study|Radiation|0|||
149873280|NCT01136967|540665052|FG000|Overall Study|Non-compliance|1|||
149873281|NCT01136967|540665053|FG001|Overall Study|Non-compliance|0|||
149873282|NCT01136967|540665052|FG000|Overall Study|Investigator's Choice|1|||
149873283|NCT01136967|540665053|FG001|Overall Study|Investigator's Choice|1|||
149873284|NCT01136967|540665052|FG000|Overall Study|Increase in Lesion Size|0|||
149873285|NCT01136967|540665053|FG001|Overall Study|Increase in Lesion Size|2|||
149873286|NCT01136967|540665052|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
149873287|NCT01136967|540665053|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
149873288|NCT01716715|540665057|FG000|Overall Study|Never Treated|2|||
149873289|NCT01716715|540665058|FG001|Overall Study|Never Treated|4|||
149873290|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
149873291|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
149873292|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
149873293|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
149873294|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
149873295|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
149873296|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
149873297|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
149873298|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
149873299|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
149873300|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Death|1|||
149873301|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Death|0|||
149873302|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Death|0|||
149873303|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Death|0|||
149873304|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Death|0|||
149873305|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
149873306|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
149873307|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
149873308|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
149873309|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
149873310|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
149873311|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
149873312|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
149873313|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
149963684|NCT01044459|541001519|FG001|Overall Study|Adverse Event|20|||
149873314|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
149873315|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
149873316|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
149873317|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
149873318|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
149873319|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
149873320|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
149873321|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
149963685|NCT01044459|541001518|FG000|Overall Study|Lack of Efficacy|23|||
150042517|NCT01254422|541293765|FG000|Overall Study|Adverse Event|1|||
150042518|NCT01254422|541293766|FG001|Overall Study|Adverse Event|0|||
150042519|NCT01254422|541293765|FG000|Overall Study|Serious adverse event|0|||
150042520|NCT01254422|541293766|FG001|Overall Study|Serious adverse event|1|||
150042521|NCT01254422|541293765|FG000|Overall Study|Lost to Follow-up|1|||
150042522|NCT01254422|541293766|FG001|Overall Study|Lost to Follow-up|0|||
150042523|NCT00643162|541293767|FG000|Overall Study|Withdrawal by Subject|1|||
150042524|NCT00643162|541293768|FG001|Overall Study|Withdrawal by Subject|1|||
150042525|NCT00949702|541293774|FG000|Overall Study|Death|40|||
150042526|NCT00949702|541293774|FG000|Overall Study|Disease progression|7|||
150042527|NCT00949702|541293774|FG000|Overall Study|Withdrawal of consent|1|||
150042528|NCT01654302|541293775|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
150042529|NCT01654302|541293776|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
150042530|NCT04139018|541293781|FG000|Overall Study|Screen fail|1|||
150042531|NCT04139018|541293782|FG001|Overall Study|Screen fail|0|||
150042532|NCT04139018|541293781|FG000|Overall Study|Withdrawal by Subject|2|||
150042533|NCT04139018|541293782|FG001|Overall Study|Withdrawal by Subject|0|||
150042534|NCT04139018|541293781|FG000|Overall Study|Lost to Follow-up|0|||
150042535|NCT04139018|541293782|FG001|Overall Study|Lost to Follow-up|1|||
150042536|NCT02565108|541293783|FG000|Overall Study|Adverse Event|1|||
150042537|NCT02565108|541293784|FG001|Overall Study|Adverse Event|0|||
150042538|NCT02565108|541293783|FG000|Overall Study|Withdrew Consent|1|||
150042539|NCT02565108|541293784|FG001|Overall Study|Withdrew Consent|0|||
150042540|NCT03614156|541293785|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
150042541|NCT03614156|541293786|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
150042542|NCT03614156|541293787|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
150042543|NCT03614156|541293788|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
150042544|NCT03614156|541293785|FG000|Open-Label Treatment Period|Adverse Event|7|||
150042545|NCT03614156|541293786|FG001|Open-Label Treatment Period|Adverse Event|0|||
150042546|NCT03614156|541293787|FG002|Open-Label Treatment Period|Adverse Event|0|||
150042547|NCT03614156|541293788|FG003|Open-Label Treatment Period|Adverse Event|0|||
150042548|NCT03614156|541293785|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
150042549|NCT03614156|541293786|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
150042550|NCT03614156|541293787|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
150042551|NCT03614156|541293788|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
150042552|NCT03614156|541293785|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
150042553|NCT03614156|541293786|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
150042554|NCT03614156|541293787|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
150042555|NCT03614156|541293788|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
150042556|NCT03614156|541293785|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
150042557|NCT03614156|541293786|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
150042558|NCT03614156|541293787|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
149873322|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
149873323|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
149873324|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149873325|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
150174078|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
150174079|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
150174080|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
150174081|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
150174082|NCT02709655|541773017|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
149873326|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149873327|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149873328|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149873329|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149873330|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Other|4|||
150042559|NCT03614156|541293788|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
150042560|NCT03614156|541293785|FG000|Open-Label Treatment Period|Protocol Violation|2|||
150042561|NCT03614156|541293786|FG001|Open-Label Treatment Period|Protocol Violation|0|||
150174083|NCT02709655|541773018|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
150174084|NCT02709655|541773019|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
150174085|NCT02709655|541773020|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
150042562|NCT03614156|541293787|FG002|Open-Label Treatment Period|Protocol Violation|0|||
150042563|NCT03614156|541293788|FG003|Open-Label Treatment Period|Protocol Violation|0|||
150042564|NCT03614156|541293785|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
150042565|NCT03614156|541293786|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
150042566|NCT03614156|541293787|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
150042567|NCT03614156|541293788|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
150042568|NCT03614156|541293785|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
150042569|NCT03614156|541293786|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
150042570|NCT03614156|541293787|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
150042571|NCT03614156|541293788|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
150042572|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
149873331|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Other|4|||
149873332|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Other|3|||
149873333|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Other|1|||
149873334|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Other|0|||
149873335|NCT01081834|540665063|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
149873336|NCT01081834|540665064|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
149873337|NCT01081834|540665065|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
149873338|NCT01081834|540665066|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
149873339|NCT01081834|540665067|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
149873340|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
149873341|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
149873342|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
149873343|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
149873344|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
149873345|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Death|1|||
149873346|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Death|0|||
149873347|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Death|0|||
149873348|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Death|0|||
149873349|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Death|0|||
149873350|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
149963686|NCT01044459|541001519|FG001|Overall Study|Lack of Efficacy|12|||
149963687|NCT01044459|541001518|FG000|Overall Study|Protocol Violation|11|||
149963688|NCT01044459|541001519|FG001|Overall Study|Protocol Violation|16|||
149963689|NCT01044459|541001518|FG000|Overall Study|Other Reason|7|||
149963690|NCT01044459|541001519|FG001|Overall Study|Other Reason|14|||
149963691|NCT01044459|541001518|FG000|Overall Study|COPD exacerbation|9|||
149963692|NCT01044459|541001519|FG001|Overall Study|COPD exacerbation|8|||
149963693|NCT01044459|541001518|FG000|Overall Study|Lost to Follow-up|18|||
149963694|NCT01044459|541001519|FG001|Overall Study|Lost to Follow-up|12|||
149963695|NCT04105725|541001520|FG000|Primary Intervention|Lost to Follow-up|0|||
149963696|NCT04105725|541001521|FG001|Primary Intervention|Lost to Follow-up|2|||
149963697|NCT04105725|541001520|FG000|Primary Intervention|Withdrawal by Subject|0|||
149963698|NCT04105725|541001521|FG001|Primary Intervention|Withdrawal by Subject|1|||
149963699|NCT05346640|541001522|FG000|Overall Study|Lack of Efficacy|2|||
149963700|NCT05346640|541001522|FG000|Overall Study|Lost to Follow-up|14|||
149963701|NCT05346640|541001522|FG000|Overall Study|Protocol Violation|4|||
149963702|NCT05346640|541001522|FG000|Overall Study|Withdrawal by Subject|2|||
149963703|NCT05346640|541001522|FG000|Overall Study|Physiological Complications|3|||
149963704|NCT05346640|541001522|FG000|Overall Study|Other Reason|3|||
149963705|NCT04634331|541001523|FG000|Overall Study|Withdrawal by Subject|2|||
149963706|NCT04634331|541001524|FG001|Overall Study|Withdrawal by Subject|2|||
149963707|NCT05626686|541001525|FG000|Overall Study|Protocol Violation|3|||
149963708|NCT05626686|541001525|FG000|Overall Study|Withdrawal by Subject|3|||
149963709|NCT00289900|541001526|FG000|Overall Study|Adverse Event|28|||
149963710|NCT00289900|541001527|FG001|Overall Study|Adverse Event|40|||
149963711|NCT00289900|541001528|FG002|Overall Study|Adverse Event|13|||
149963712|NCT00289900|541001529|FG003|Overall Study|Adverse Event|19|||
149963713|NCT00289900|541001530|FG004|Overall Study|Adverse Event|20|||
149963714|NCT00289900|541001531|FG005|Overall Study|Adverse Event|33|||
149963715|NCT00289900|541001526|FG000|Overall Study|Lost to Follow-up|7|||
149963716|NCT00289900|541001527|FG001|Overall Study|Lost to Follow-up|7|||
149963717|NCT00289900|541001528|FG002|Overall Study|Lost to Follow-up|8|||
150042573|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
150174086|NCT02709655|541773021|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
150174087|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
150174088|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
149873351|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
149963718|NCT00289900|541001529|FG003|Overall Study|Lost to Follow-up|8|||
149963719|NCT00289900|541001530|FG004|Overall Study|Lost to Follow-up|4|||
149963720|NCT00289900|541001531|FG005|Overall Study|Lost to Follow-up|8|||
149963721|NCT00289900|541001526|FG000|Overall Study|Participant had flushing|18|||
149963722|NCT00289900|541001527|FG001|Overall Study|Participant had flushing|42|||
149963723|NCT00289900|541001528|FG002|Overall Study|Participant had flushing|1|||
149963724|NCT00289900|541001529|FG003|Overall Study|Participant had flushing|2|||
149963725|NCT00289900|541001530|FG004|Overall Study|Participant had flushing|0|||
149963726|NCT00289900|541001531|FG005|Overall Study|Participant had flushing|4|||
149963727|NCT00289900|541001526|FG000|Overall Study|Other|0|||
149963728|NCT00289900|541001527|FG001|Overall Study|Other|0|||
149963729|NCT00289900|541001528|FG002|Overall Study|Other|0|||
150042574|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
149963730|NCT00289900|541001529|FG003|Overall Study|Other|5|||
149873352|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149873353|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149873354|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149873355|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149873356|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149873357|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149873358|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149873359|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149873360|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149873361|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
149873362|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
149873363|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
149873364|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
149873365|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
149963731|NCT00289900|541001530|FG004|Overall Study|Other|1|||
149963732|NCT00289900|541001531|FG005|Overall Study|Other|0|||
149963733|NCT00289900|541001526|FG000|Overall Study|Participant moved|1|||
149963734|NCT00289900|541001527|FG001|Overall Study|Participant moved|0|||
149963735|NCT00289900|541001528|FG002|Overall Study|Participant moved|0|||
149963736|NCT00289900|541001529|FG003|Overall Study|Participant moved|1|||
149963737|NCT00289900|541001530|FG004|Overall Study|Participant moved|1|||
149963738|NCT00289900|541001531|FG005|Overall Study|Participant moved|1|||
149963739|NCT00289900|541001526|FG000|Overall Study|Withdrawal by Subject|10|||
149963740|NCT00289900|541001527|FG001|Overall Study|Withdrawal by Subject|21|||
149963741|NCT00289900|541001528|FG002|Overall Study|Withdrawal by Subject|8|||
149963742|NCT00289900|541001529|FG003|Overall Study|Withdrawal by Subject|18|||
149963743|NCT00289900|541001530|FG004|Overall Study|Withdrawal by Subject|12|||
149963744|NCT00289900|541001531|FG005|Overall Study|Withdrawal by Subject|11|||
149963745|NCT00289900|541001526|FG000|Overall Study|Protocol Violation|3|||
149963746|NCT00289900|541001527|FG001|Overall Study|Protocol Violation|9|||
149963747|NCT00289900|541001528|FG002|Overall Study|Protocol Violation|2|||
149963748|NCT00289900|541001529|FG003|Overall Study|Protocol Violation|6|||
149963749|NCT00289900|541001530|FG004|Overall Study|Protocol Violation|7|||
149963750|NCT00289900|541001531|FG005|Overall Study|Protocol Violation|4|||
149963751|NCT00289900|541001526|FG000|Overall Study|site terminated|1|||
149963752|NCT00289900|541001527|FG001|Overall Study|site terminated|0|||
149963753|NCT00289900|541001528|FG002|Overall Study|site terminated|1|||
149963754|NCT00289900|541001529|FG003|Overall Study|site terminated|0|||
149963755|NCT00289900|541001530|FG004|Overall Study|site terminated|0|||
149963756|NCT00289900|541001531|FG005|Overall Study|site terminated|0|||
149963757|NCT00289900|541001526|FG000|Overall Study|Not treated|0|||
149963758|NCT00289900|541001527|FG001|Overall Study|Not treated|1|||
149963759|NCT00289900|541001528|FG002|Overall Study|Not treated|0|||
149963760|NCT00289900|541001529|FG003|Overall Study|Not treated|0|||
149963761|NCT00289900|541001530|FG004|Overall Study|Not treated|0|||
149963762|NCT00289900|541001531|FG005|Overall Study|Not treated|0|||
149963763|NCT03927846|541001535|FG000|Overall Study|Lost to Follow-up|10|||
149963764|NCT03927846|541001536|FG001|Overall Study|Lost to Follow-up|11|||
149963765|NCT03878069|541001537|FG000|Overall Study|Death|0|||
149963766|NCT03878069|541001538|FG001|Overall Study|Death|1|||
149963767|NCT03878069|541001539|FG002|Overall Study|Death|0|||
149963768|NCT00834587|541001540|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
149963769|NCT00834587|541001541|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
149963770|NCT00176254|541001542|FG000|Overall Study|Lost to Follow-up|1|||
149963771|NCT03289741|541001543|FG000|Overall Study|Adverse Event|1|||
149963772|NCT03289741|541001544|FG001|Overall Study|Adverse Event|1|||
149963773|NCT03289741|541001543|FG000|Overall Study|Physician Decision|2|||
149963774|NCT03289741|541001544|FG001|Overall Study|Physician Decision|2|||
149963775|NCT03289741|541001543|FG000|Overall Study|Withdrawal by Subject|1|||
149963776|NCT03289741|541001544|FG001|Overall Study|Withdrawal by Subject|0|||
149963777|NCT02536339|541001546|FG000|Overall Study|Death|20|||
149963778|NCT02536339|541001546|FG000|Overall Study|Withdrawal by Subject|3|||
149963779|NCT02536339|541001546|FG000|Overall Study|Lost to Follow-up|2|||
149963780|NCT02536339|541001546|FG000|Overall Study|Treatment discontinued|2|||
149963781|NCT02536339|541001546|FG000|Overall Study|Physician Decision|1|||
150174089|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
149963782|NCT02037984|541001547|FG000|Overall Study|Lack of Efficacy|0|||
149963783|NCT02037984|541001548|FG001|Overall Study|Lack of Efficacy|0|||
149873366|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149873367|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
149873368|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149873369|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149873370|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
149873371|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
149873372|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
149873373|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
149873374|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
149873375|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Other|4|||
149873376|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Other|5|||
149873377|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Other|4|||
149873378|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Other|0|||
149873379|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Other|0|||
149873380|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
149873381|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
149873382|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
149873383|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
149873384|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
149873385|NCT01081834|540665063|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149873386|NCT01081834|540665064|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
149873387|NCT01081834|540665065|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149873388|NCT01081834|540665066|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149873389|NCT01081834|540665067|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149873390|NCT01161407|540665068|FG000|Overall Study|Protocol Violation|3|||
149873391|NCT01161407|540665069|FG001|Overall Study|Protocol Violation|1|||
149873392|NCT01777620|540665070|FG000|Overall Study|Subject Withdrawal|1|||
149873393|NCT01777620|540665071|FG001|Overall Study|Subject Withdrawal|0|||
149873394|NCT01756079|540665083|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
149873395|NCT01756079|540665083|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
149873396|NCT01756079|540665083|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
149873397|NCT01756079|540665083|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
149873398|NCT01756079|540665083|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
149873399|NCT03597529|540665084|FG000|Overall Study|Lost to Follow-up|10|||
149873400|NCT03597529|540665085|FG001|Overall Study|Lost to Follow-up|12|||
149873401|NCT03597529|540665084|FG000|Overall Study|Physician Decision|3|||
149873402|NCT03597529|540665085|FG001|Overall Study|Physician Decision|1|||
149873403|NCT03597529|540665084|FG000|Overall Study|Withdrawal by Subject|6|||
149873404|NCT03597529|540665085|FG001|Overall Study|Withdrawal by Subject|3|||
149873405|NCT03597529|540665084|FG000|Overall Study|Non-compliant with study activities|1|||
149873406|NCT03597529|540665085|FG001|Overall Study|Non-compliant with study activities|2|||
149873407|NCT03464630|540665088|FG000|Overall Study|Lost to Follow-up|62|||
149873408|NCT03464630|540665089|FG001|Overall Study|Lost to Follow-up|52|||
149873409|NCT03464630|540665088|FG000|Overall Study|Withdrawal by Subject|16|||
149873410|NCT03464630|540665089|FG001|Overall Study|Withdrawal by Subject|10|||
149873411|NCT03464630|540665088|FG000|Overall Study|Passive Disengagement|8|||
149873412|NCT03464630|540665089|FG001|Overall Study|Passive Disengagement|4|||
149873413|NCT04524364|540665090|FG000|Overall Study|Physician Decision|3|||
149873414|NCT04524364|540665091|FG001|Overall Study|Physician Decision|6|||
149873415|NCT04524364|540665090|FG000|Overall Study|Adverse Event|0|||
149873416|NCT04524364|540665091|FG001|Overall Study|Adverse Event|1|||
149873417|NCT04524364|540665090|FG000|Overall Study|Investigational device deficiency|0|||
149873418|NCT04524364|540665091|FG001|Overall Study|Investigational device deficiency|1|||
149873419|NCT04524364|540665090|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
149873420|NCT04524364|540665091|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
149873421|NCT04524364|540665090|FG000|Overall Study|Device unavailability|0|||
149873422|NCT04524364|540665091|FG001|Overall Study|Device unavailability|2|||
149873423|NCT04524364|540665090|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
149873424|NCT04524364|540665091|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
149873425|NCT04524364|540665090|FG000|Overall Study|Low International normalized ratio (INR)|1|||
149873426|NCT04524364|540665091|FG001|Overall Study|Low International normalized ratio (INR)|0|||
149873427|NCT00998309|540665096|FG000|Overall Study|Protocol Violation|4|||
150174090|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
150174091|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
149873428|NCT00735397|540665098|FG000|Overall Study|Adverse Event|194|||
149873429|NCT00735397|540665098|FG000|Overall Study|Lost to Follow-up|33|||
149873430|NCT00735397|540665098|FG000|Overall Study|Participant choice|252|||
149873431|NCT00735397|540665098|FG000|Overall Study|Inadequate therapeutic effect|202|||
149873432|NCT00735397|540665098|FG000|Overall Study|Administrative/Other|502|||
149873433|NCT00380744|540665099|FG000|Overall Study|Death|0|||
149873434|NCT00380744|540665100|FG001|Overall Study|Death|0|||
149873435|NCT00380744|540665101|FG002|Overall Study|Death|0|||
149873436|NCT00380744|540665102|FG003|Overall Study|Death|0|||
149873437|NCT00380744|540665103|FG004|Overall Study|Death|0|||
149873438|NCT00380744|540665104|FG005|Overall Study|Death|0|||
149873439|NCT00380744|540665105|FG006|Overall Study|Death|1|||
149873440|NCT00380744|540665099|FG000|Overall Study|Withdrawal by Subject|1|||
149873441|NCT00380744|540665100|FG001|Overall Study|Withdrawal by Subject|0|||
149873442|NCT00380744|540665101|FG002|Overall Study|Withdrawal by Subject|0|||
149873443|NCT00380744|540665102|FG003|Overall Study|Withdrawal by Subject|0|||
149873444|NCT00380744|540665103|FG004|Overall Study|Withdrawal by Subject|0|||
149873445|NCT00380744|540665104|FG005|Overall Study|Withdrawal by Subject|0|||
149873446|NCT00380744|540665105|FG006|Overall Study|Withdrawal by Subject|0|||
149873447|NCT02865460|540665106|FG000|Overall Study|Adverse Event|1|||
149873448|NCT02865460|540665107|FG001|Overall Study|Adverse Event|0|||
149873449|NCT02865460|540665106|FG000|Overall Study|Withdrawal by Subject|1|||
149873450|NCT02865460|540665107|FG001|Overall Study|Withdrawal by Subject|1|||
149873451|NCT02865460|540665106|FG000|Overall Study|Lost to Follow-up|7|||
149873452|NCT02865460|540665107|FG001|Overall Study|Lost to Follow-up|4|||
149873453|NCT02865460|540665106|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
149873454|NCT02865460|540665107|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
149873455|NCT00901576|540665112|FG000|Second Intervention|Withdrawal by Subject|0|||
149873456|NCT00901576|540665113|FG001|Second Intervention|Withdrawal by Subject|0|||
149873457|NCT00901576|540665114|FG002|Second Intervention|Withdrawal by Subject|0|||
149873458|NCT00901576|540665115|FG003|Second Intervention|Withdrawal by Subject|1|||
149873459|NCT00901576|540665116|FG004|Second Intervention|Withdrawal by Subject|0|||
149873460|NCT00901576|540665117|FG005|Second Intervention|Withdrawal by Subject|1|||
149873461|NCT00901576|540665112|FG000|Second Intervention|Physician Decision|1|||
149873462|NCT00901576|540665113|FG001|Second Intervention|Physician Decision|0|||
149873463|NCT00901576|540665114|FG002|Second Intervention|Physician Decision|0|||
149873464|NCT00901576|540665115|FG003|Second Intervention|Physician Decision|0|||
149873465|NCT00901576|540665116|FG004|Second Intervention|Physician Decision|0|||
149873466|NCT00901576|540665117|FG005|Second Intervention|Physician Decision|0|||
149873467|NCT00171951|540665120|FG000|Overall Study|Adverse Event|1|||
149873468|NCT00171951|540665120|FG000|Overall Study|Abnormal Laboratory Values|2|||
149873469|NCT00171951|540665120|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149873470|NCT00171951|540665120|FG000|Overall Study|Participants Withdrew Consent|3|||
149873471|NCT00171951|540665120|FG000|Overall Study|New Cancer Therapy|5|||
149873472|NCT00171951|540665120|FG000|Overall Study|Reason not Specified|2|||
149873473|NCT06077149|540665121|FG000|Overall Study|Death|1|||
149873474|NCT06077149|540665122|FG001|Overall Study|Death|0|||
149873475|NCT06077149|540665121|FG000|Overall Study|Withdrawal by Subject|2|||
149873476|NCT06077149|540665122|FG001|Overall Study|Withdrawal by Subject|0|||
149873477|NCT06077149|540665121|FG000|Overall Study|RSV infection before vaccination|3|||
149873478|NCT06077149|540665122|FG001|Overall Study|RSV infection before vaccination|0|||
149873479|NCT02238795|540665123|FG000|Overall Study|Patient without purpura fulminans|1|||
149873480|NCT04159935|540665127|FG000|Overall Study|Study terminated due to COVID-19|1|||
149873481|NCT04159935|540665128|FG001|Overall Study|Study terminated due to COVID-19|3|||
149873482|NCT01341782|540665129|FG000|Overall Study|Adverse Event|1|||
149873483|NCT01341782|540665130|FG001|Overall Study|Adverse Event|1|||
149873484|NCT01341782|540665129|FG000|Overall Study|Withdrawal by Subject|6|||
149873485|NCT01341782|540665130|FG001|Overall Study|Withdrawal by Subject|5|||
149873486|NCT01341782|540665129|FG000|Overall Study|Missed 3 consecutive doses|0|||
149873487|NCT01341782|540665130|FG001|Overall Study|Missed 3 consecutive doses|4|||
149873488|NCT01341782|540665129|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
149873489|NCT01341782|540665130|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
149873490|NCT01341782|540665129|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
149873491|NCT01341782|540665130|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
150174092|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
150174093|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
150174094|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
150174095|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
150174096|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
150174097|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
150174098|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
150174099|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
150174100|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
150174101|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
150174102|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
150174103|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
150174104|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
150174105|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
150174106|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
150174107|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
150174108|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
150174109|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
150174110|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
150174111|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
150174112|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
150174113|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
150174114|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
150042575|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
150042576|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
150042577|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
150042578|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
150042579|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
150042580|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150042581|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150042582|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
150042583|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
150042584|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
150042585|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
150042586|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
150042587|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
150042588|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
150042589|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
150042590|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
150042591|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
150042592|NCT03614156|541293785|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
150042593|NCT03614156|541293786|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
150042594|NCT03614156|541293787|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
150042595|NCT03614156|541293788|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
150042596|NCT03614156|541293785|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
150042597|NCT03614156|541293786|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
150042598|NCT03614156|541293787|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
150042599|NCT03614156|541293788|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
150042600|NCT03614156|541293785|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
150174115|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
150174116|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
150174117|NCT02709655|541773017|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
150174118|NCT02709655|541773018|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
150174119|NCT02709655|541773019|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
150174120|NCT02709655|541773020|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
150174121|NCT02709655|541773021|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
150174122|NCT02459899|541773023|FG000|Overall Study|Adverse Event|1|||
150174123|NCT02459899|541773024|FG001|Overall Study|Adverse Event|1|||
150174124|NCT02459899|541773025|FG002|Overall Study|Adverse Event|0|||
150174125|NCT02459899|541773026|FG003|Overall Study|Adverse Event|0|||
150174126|NCT02459899|541773023|FG000|Overall Study|Lost to Follow-up|1|||
150174127|NCT02459899|541773024|FG001|Overall Study|Lost to Follow-up|2|||
150174128|NCT02459899|541773025|FG002|Overall Study|Lost to Follow-up|0|||
149873492|NCT01341782|540665129|FG000|Overall Study|Other|5|||
149873493|NCT01341782|540665130|FG001|Overall Study|Other|0|||
149873494|NCT02036775|540665131|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
149873495|NCT02036775|540665132|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
149873496|NCT02036775|540665133|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
149873497|NCT02036775|540665134|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
149873498|NCT02036775|540665135|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
149873499|NCT02036775|540665136|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
149873500|NCT02329847|540665143|FG000|Overall Study|Death|4|||
149873501|NCT02329847|540665144|FG001|Overall Study|Death|4|||
149873502|NCT02329847|540665145|FG002|Overall Study|Death|22|||
149873503|NCT02329847|540665146|FG003|Overall Study|Death|12|||
149873504|NCT02329847|540665147|FG004|Overall Study|Death|20|||
149873505|NCT02329847|540665148|FG005|Overall Study|Death|13|||
149873506|NCT02329847|540665143|FG000|Overall Study|Lost to Follow-up|0|||
149873507|NCT02329847|540665144|FG001|Overall Study|Lost to Follow-up|0|||
149873508|NCT02329847|540665145|FG002|Overall Study|Lost to Follow-up|2|||
149873509|NCT02329847|540665146|FG003|Overall Study|Lost to Follow-up|3|||
149873510|NCT02329847|540665147|FG004|Overall Study|Lost to Follow-up|0|||
149873511|NCT02329847|540665148|FG005|Overall Study|Lost to Follow-up|1|||
149873512|NCT02329847|540665143|FG000|Overall Study|Physician Decision|0|||
149873513|NCT02329847|540665144|FG001|Overall Study|Physician Decision|0|||
149873514|NCT02329847|540665145|FG002|Overall Study|Physician Decision|0|||
149873515|NCT02329847|540665146|FG003|Overall Study|Physician Decision|0|||
149873516|NCT02329847|540665147|FG004|Overall Study|Physician Decision|1|||
149873517|NCT02329847|540665148|FG005|Overall Study|Physician Decision|0|||
149873518|NCT02329847|540665143|FG000|Overall Study|Withdrawal by Subject|2|||
149873519|NCT02329847|540665144|FG001|Overall Study|Withdrawal by Subject|1|||
149873520|NCT02329847|540665145|FG002|Overall Study|Withdrawal by Subject|5|||
149873521|NCT02329847|540665146|FG003|Overall Study|Withdrawal by Subject|7|||
149873522|NCT02329847|540665147|FG004|Overall Study|Withdrawal by Subject|8|||
149873523|NCT02329847|540665148|FG005|Overall Study|Withdrawal by Subject|3|||
149873524|NCT02329847|540665143|FG000|Overall Study|Other|1|||
149873525|NCT02329847|540665144|FG001|Overall Study|Other|2|||
149873526|NCT02329847|540665145|FG002|Overall Study|Other|6|||
149873527|NCT02329847|540665146|FG003|Overall Study|Other|13|||
150174129|NCT02459899|541773026|FG003|Overall Study|Lost to Follow-up|1|||
149873528|NCT02329847|540665147|FG004|Overall Study|Other|10|||
149873529|NCT02329847|540665148|FG005|Overall Study|Other|3|||
149873530|NCT01822275|540665150|FG000|Overall Study|Withdrawal by Subject|3|||
149873531|NCT01822275|540665150|FG000|Overall Study|Adverse Event|3|||
149963784|NCT02037984|541001549|FG002|Overall Study|Lack of Efficacy|3|||
149963785|NCT02037984|541001550|FG003|Overall Study|Lack of Efficacy|10|||
149963786|NCT02037984|541001551|FG004|Overall Study|Lack of Efficacy|2|||
149963787|NCT02037984|541001552|FG005|Overall Study|Lack of Efficacy|2|||
149963788|NCT02037984|541001553|FG006|Overall Study|Lack of Efficacy|4|||
149963789|NCT02037984|541001554|FG007|Overall Study|Lack of Efficacy|3|||
149963790|NCT02037984|541001547|FG000|Overall Study|Lost to Follow-up|1|||
149963791|NCT02037984|541001548|FG001|Overall Study|Lost to Follow-up|0|||
149873532|NCT01822275|540665150|FG000|Overall Study|Progression|14|||
149963792|NCT02037984|541001549|FG002|Overall Study|Lost to Follow-up|3|||
149963793|NCT02037984|541001550|FG003|Overall Study|Lost to Follow-up|5|||
149963794|NCT02037984|541001551|FG004|Overall Study|Lost to Follow-up|2|||
149963795|NCT02037984|541001552|FG005|Overall Study|Lost to Follow-up|2|||
149963796|NCT02037984|541001553|FG006|Overall Study|Lost to Follow-up|2|||
149963797|NCT02037984|541001554|FG007|Overall Study|Lost to Follow-up|4|||
149963798|NCT02037984|541001547|FG000|Overall Study|Physician Decision|0|||
149873533|NCT01822275|540665150|FG000|Overall Study|Physician Decision|2|||
149873534|NCT00911807|540665152|FG000|Overall Study|Adverse Event|2|||
149873535|NCT00911807|540665153|FG001|Overall Study|Adverse Event|1|||
149873536|NCT00911807|540665154|FG002|Overall Study|Adverse Event|5|||
149873537|NCT00911807|540665152|FG000|Overall Study|Death|0|||
149873538|NCT00911807|540665153|FG001|Overall Study|Death|0|||
149873539|NCT00911807|540665154|FG002|Overall Study|Death|1|||
149873540|NCT00911807|540665152|FG000|Overall Study|Protocol Violation|6|||
149873541|NCT00911807|540665153|FG001|Overall Study|Protocol Violation|4|||
149963799|NCT02037984|541001548|FG001|Overall Study|Physician Decision|0|||
149873542|NCT00911807|540665154|FG002|Overall Study|Protocol Violation|9|||
149873543|NCT00911807|540665152|FG000|Overall Study|Withdrawal by Subject|8|||
149873544|NCT00911807|540665153|FG001|Overall Study|Withdrawal by Subject|10|||
149873545|NCT00911807|540665154|FG002|Overall Study|Withdrawal by Subject|7|||
149873546|NCT00911807|540665152|FG000|Overall Study|Organizational reasons|1|||
149873547|NCT00911807|540665153|FG001|Overall Study|Organizational reasons|3|||
149873548|NCT00911807|540665154|FG002|Overall Study|Organizational reasons|1|||
149873549|NCT03918109|540665155|FG000|Overall Study|Withdrawal by Subject|0|||
149873550|NCT03918109|540665156|FG001|Overall Study|Withdrawal by Subject|0|||
149873551|NCT03918109|540665157|FG002|Overall Study|Withdrawal by Subject|2|||
149873552|NCT03918109|540665158|FG003|Overall Study|Withdrawal by Subject|1|||
149873553|NCT03918109|540665155|FG000|Overall Study|Lost to Follow-up|0|||
149873554|NCT03918109|540665156|FG001|Overall Study|Lost to Follow-up|0|||
149873555|NCT03918109|540665157|FG002|Overall Study|Lost to Follow-up|0|||
149873556|NCT03918109|540665158|FG003|Overall Study|Lost to Follow-up|1|||
149873557|NCT00871741|540665159|FG000|Overall Study|Premature study termination|9|||
149873558|NCT00871741|540665160|FG001|Overall Study|Premature study termination|7|||
149873559|NCT05323123|540665161|FG000|Overall Study|Withdrawal by Subject|2|||
149873560|NCT05323123|540665162|FG001|Overall Study|Withdrawal by Subject|1|||
149873561|NCT05323123|540665161|FG000|Overall Study|Lost to Follow-up|4|||
149873562|NCT05323123|540665162|FG001|Overall Study|Lost to Follow-up|2|||
149873563|NCT05323123|540665161|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
149873564|NCT05323123|540665162|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
149873565|NCT05529472|540665163|FG000|Overall Study|Withdrawal by Subject|1|||
149873566|NCT05529472|540665164|FG001|Overall Study|Withdrawal by Subject|1|||
149873567|NCT03510598|540667073|FG000|Overall Study|Withdrawal by Subject|1|||
149873568|NCT04240392|540667075|FG000|Overall Study|Withdrawal by Subject|13|||
149873569|NCT04240392|540667076|FG001|Overall Study|Withdrawal by Subject|4|||
149873570|NCT04240392|540667075|FG000|Overall Study|Lost to Follow-up|11|||
149873571|NCT04240392|540667076|FG001|Overall Study|Lost to Follow-up|12|||
149873572|NCT00191113|540667077|FG000|Core Study|Withdrawal by Subject|25|||
149873573|NCT00191113|540667078|FG001|Core Study|Withdrawal by Subject|9|||
149873574|NCT00191113|540667077|FG000|Core Study|Protocol Violation|6|||
149873575|NCT00191113|540667078|FG001|Core Study|Protocol Violation|2|||
149873576|NCT00191113|540667077|FG000|Core Study|Lost to Follow-up|3|||
149873577|NCT00191113|540667078|FG001|Core Study|Lost to Follow-up|0|||
149873578|NCT00191113|540667077|FG000|Core Study|Adverse Event|0|||
149873579|NCT00191113|540667078|FG001|Core Study|Adverse Event|2|||
149873580|NCT00191113|540667077|FG000|Core Study|Lack of Efficacy|0|||
149873581|NCT00191113|540667078|FG001|Core Study|Lack of Efficacy|2|||
149873582|NCT00191113|540667077|FG000|Core Study|Death|1|||
149873583|NCT00191113|540667078|FG001|Core Study|Death|0|||
149873584|NCT04241315|540667080|FG000|Overall Study|Withdrawal by Subject|0|||
149873585|NCT04241315|540667081|FG001|Overall Study|Withdrawal by Subject|1|||
149873586|NCT03047330|540667082|FG000|Sleep Block 1|Withdrawal by Subject|3|||
149873587|NCT00631657|540667083|FG000|6-Month Treatment Period|Adverse Event|47|||
149873588|NCT00631657|540667084|FG001|6-Month Treatment Period|Adverse Event|0|||
149873589|NCT00631657|540667085|FG002|6-Month Treatment Period|Adverse Event|7|||
149873590|NCT00631657|540667083|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
149873591|NCT00631657|540667084|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
149873592|NCT00631657|540667085|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
149873593|NCT00631657|540667083|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
149873594|NCT00631657|540667084|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
149873595|NCT00631657|540667085|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
149873596|NCT00631657|540667083|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
149873597|NCT00631657|540667084|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
149873598|NCT00631657|540667085|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
149873599|NCT00631657|540667083|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
149873600|NCT00631657|540667084|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
149873601|NCT00631657|540667085|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
149873602|NCT00631657|540667083|FG000|6-Month Treatment Period|Other|16|||
149873603|NCT00631657|540667084|FG001|6-Month Treatment Period|Other|0|||
149873604|NCT00631657|540667085|FG002|6-Month Treatment Period|Other|4|||
149873605|NCT00631657|540667083|FG000|6-Month Treatment Period|Not Treated|2|||
149873606|NCT00631657|540667084|FG001|6-Month Treatment Period|Not Treated|0|||
149873607|NCT00631657|540667085|FG002|6-Month Treatment Period|Not Treated|1|||
149873608|NCT00631657|540667083|FG000|7-Day Discontinuation Period|Not Treated|1|||
149873609|NCT00631657|540667084|FG001|7-Day Discontinuation Period|Not Treated|1|||
149873610|NCT00631657|540667085|FG002|7-Day Discontinuation Period|Not Treated|1|||
149873611|NCT00631657|540667083|FG000|7-Day Discontinuation Period|Other|1|||
149873612|NCT00631657|540667084|FG001|7-Day Discontinuation Period|Other|0|||
149873613|NCT00631657|540667085|FG002|7-Day Discontinuation Period|Other|0|||
149873614|NCT05083585|540667104|FG000|Overall Study|Death|1|||
149873615|NCT05083585|540667105|FG001|Overall Study|Death|1|||
150042601|NCT03614156|541293786|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
150042602|NCT03614156|541293787|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
150042603|NCT03614156|541293788|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
150042604|NCT03614156|541293785|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
150042605|NCT03614156|541293786|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
150042606|NCT03614156|541293787|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
150042607|NCT03614156|541293788|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
150042608|NCT01310075|541293789|FG000|Overall Study|Lost to Follow-up|1|||
150042609|NCT01310075|541293790|FG001|Overall Study|Lost to Follow-up|0|||
150042610|NCT01310075|541293789|FG000|Overall Study|Physician Decision|10|||
150042611|NCT01310075|541293790|FG001|Overall Study|Physician Decision|7|||
150042612|NCT01310075|541293789|FG000|Overall Study|Protocol Violation|2|||
150042613|NCT01310075|541293790|FG001|Overall Study|Protocol Violation|2|||
150042614|NCT01310075|541293789|FG000|Overall Study|Withdrawal by Subject|1|||
150042615|NCT01310075|541293790|FG001|Overall Study|Withdrawal by Subject|1|||
150042616|NCT01587924|541293792|FG000|Overall Study|Adverse Event|0|||
150042617|NCT01587924|541293793|FG001|Overall Study|Adverse Event|2|||
150042618|NCT01587924|541293794|FG002|Overall Study|Adverse Event|0|||
150042619|NCT01587924|541293795|FG003|Overall Study|Adverse Event|0|||
149873616|NCT05083585|540667104|FG000|Overall Study|Lost to Follow-up|1|||
149873617|NCT05083585|540667105|FG001|Overall Study|Lost to Follow-up|1|||
149873618|NCT05083585|540667104|FG000|Overall Study|Withdrawal by Subject|2|||
149873619|NCT05083585|540667105|FG001|Overall Study|Withdrawal by Subject|0|||
149873620|NCT05083585|540667104|FG000|Overall Study|Randomized but not vaccinated|2|||
149873621|NCT05083585|540667105|FG001|Overall Study|Randomized but not vaccinated|0|||
149873622|NCT03469336|540667106|FG000|Overall Study|Adverse Event|1|||
149873623|NCT00686075|540667108|FG000|Overall Study|Withdrawal by Subject|4|||
149873624|NCT00686075|540667109|FG001|Overall Study|Withdrawal by Subject|3|||
149873625|NCT00686075|540667110|FG002|Overall Study|Withdrawal by Subject|3|||
149873626|NCT00686075|540667111|FG003|Overall Study|Withdrawal by Subject|7|||
149873627|NCT00686075|540667112|FG004|Overall Study|Withdrawal by Subject|1|||
149873628|NCT00686075|540667113|FG005|Overall Study|Withdrawal by Subject|0|||
149873629|NCT00686075|540667114|FG006|Overall Study|Withdrawal by Subject|0|||
149873630|NCT00686075|540667115|FG007|Overall Study|Withdrawal by Subject|2|||
149873631|NCT00686075|540667116|FG008|Overall Study|Withdrawal by Subject|4|||
149873632|NCT00686075|540667117|FG009|Overall Study|Withdrawal by Subject|6|||
149873633|NCT00686075|540667108|FG000|Overall Study|Lost to Follow-up|3|||
149873634|NCT00686075|540667109|FG001|Overall Study|Lost to Follow-up|6|||
149873635|NCT00686075|540667110|FG002|Overall Study|Lost to Follow-up|3|||
149873636|NCT00686075|540667111|FG003|Overall Study|Lost to Follow-up|2|||
149873637|NCT00686075|540667112|FG004|Overall Study|Lost to Follow-up|3|||
149873638|NCT00686075|540667113|FG005|Overall Study|Lost to Follow-up|3|||
149873639|NCT00686075|540667114|FG006|Overall Study|Lost to Follow-up|0|||
149873640|NCT00686075|540667115|FG007|Overall Study|Lost to Follow-up|0|||
149873641|NCT00686075|540667116|FG008|Overall Study|Lost to Follow-up|2|||
149873642|NCT00686075|540667117|FG009|Overall Study|Lost to Follow-up|3|||
149873643|NCT00686075|540667108|FG000|Overall Study|Other|1|||
149873644|NCT00686075|540667109|FG001|Overall Study|Other|1|||
149873645|NCT00686075|540667110|FG002|Overall Study|Other|0|||
149873646|NCT00686075|540667111|FG003|Overall Study|Other|0|||
149873647|NCT00686075|540667112|FG004|Overall Study|Other|0|||
149873648|NCT00686075|540667113|FG005|Overall Study|Other|0|||
149873649|NCT00686075|540667114|FG006|Overall Study|Other|0|||
149873650|NCT00686075|540667115|FG007|Overall Study|Other|0|||
149873651|NCT00686075|540667116|FG008|Overall Study|Other|0|||
149873652|NCT00686075|540667117|FG009|Overall Study|Other|1|||
149873653|NCT02740699|540667118|FG000|Overall Study|Lost to Follow-up|5|||
150042620|NCT01587924|541293792|FG000|Overall Study|Protocol Violation|2|||
150042621|NCT01587924|541293793|FG001|Overall Study|Protocol Violation|1|||
150042622|NCT01587924|541293794|FG002|Overall Study|Protocol Violation|2|||
150042623|NCT01587924|541293795|FG003|Overall Study|Protocol Violation|1|||
150042624|NCT01587924|541293792|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
150042625|NCT01587924|541293793|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
149873654|NCT02740699|540667118|FG000|Overall Study|Withdrawal by Subject|14|||
149873655|NCT02740699|540667118|FG000|Overall Study|Physician Decision|5|||
149873656|NCT02585934|540667120|FG000|Overall Study|Lost to Follow-up|2|||
149873657|NCT02585934|540667121|FG001|Overall Study|Lost to Follow-up|2|||
149873658|NCT02585934|540667120|FG000|Overall Study|Protocol Violation|14|||
149873659|NCT02585934|540667121|FG001|Overall Study|Protocol Violation|11|||
149873660|NCT02585934|540667120|FG000|Overall Study|Adverse Event|21|||
149873661|NCT02585934|540667121|FG001|Overall Study|Adverse Event|22|||
149873662|NCT02585934|540667120|FG000|Overall Study|Physician Decision|3|||
150042626|NCT01587924|541293794|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
150042627|NCT01587924|541293795|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
149873663|NCT02585934|540667121|FG001|Overall Study|Physician Decision|2|||
150042628|NCT01587924|541293792|FG000|Overall Study|Withdrawal by Subject|0|||
150042629|NCT01587924|541293793|FG001|Overall Study|Withdrawal by Subject|1|||
150042630|NCT01587924|541293794|FG002|Overall Study|Withdrawal by Subject|1|||
150042631|NCT01587924|541293795|FG003|Overall Study|Withdrawal by Subject|0|||
150042632|NCT01696188|541293796|FG000|Overall Study|Protocol Violation|1|||
150042633|NCT01696188|541293797|FG001|Overall Study|Protocol Violation|1|||
150042634|NCT02668393|541293798|FG000|Overall Study|Progressive disease|6|||
150042635|NCT02668393|541293799|FG001|Overall Study|Progressive disease|3|||
150042636|NCT02668393|541293798|FG000|Overall Study|Adverse Event|0|||
150042637|NCT02668393|541293799|FG001|Overall Study|Adverse Event|2|||
150042638|NCT02668393|541293798|FG000|Overall Study|Withdrawal from the trial|0|||
150042639|NCT02668393|541293799|FG001|Overall Study|Withdrawal from the trial|1|||
150042640|NCT02668393|541293798|FG000|Overall Study|Lack of benefit and side effects|1|||
150042641|NCT02668393|541293799|FG001|Overall Study|Lack of benefit and side effects|0|||
150042642|NCT02141204|541293800|FG000|Overall Study|Lost to Follow-up|2|||
150042643|NCT02141204|541293801|FG001|Overall Study|Lost to Follow-up|1|||
150042644|NCT02141204|541293800|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
150042645|NCT02141204|541293801|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
150042646|NCT02141204|541293800|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
150042647|NCT02141204|541293801|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
150042648|NCT02141204|541293800|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
150042649|NCT02141204|541293801|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
150042650|NCT03848728|541293807|FG000|Overall Study|Death|16|||
149873664|NCT02585934|540667120|FG000|Overall Study|Withdrawal by Subject|7|||
149873665|NCT02585934|540667121|FG001|Overall Study|Withdrawal by Subject|21|||
149873666|NCT02585934|540667120|FG000|Overall Study|Lack of Efficacy|2|||
149873667|NCT02585934|540667121|FG001|Overall Study|Lack of Efficacy|1|||
149873668|NCT02585934|540667120|FG000|Overall Study|Death|2|||
149873669|NCT02585934|540667121|FG001|Overall Study|Death|0|||
149873670|NCT02585934|540667120|FG000|Overall Study|Caregiver Withdrew Consent|7|||
149873671|NCT02585934|540667121|FG001|Overall Study|Caregiver Withdrew Consent|7|||
149873672|NCT02585934|540667120|FG000|Overall Study|Sponsor Termination|1|||
150042651|NCT03848728|541293808|FG001|Overall Study|Death|13|||
150042652|NCT03848728|541293807|FG000|Overall Study|Outmigrated to non-study community|98|||
150042653|NCT03848728|541293808|FG001|Overall Study|Outmigrated to non-study community|106|||
150042654|NCT03848728|541293807|FG000|Overall Study|Transfered to non-study clinic|32|||
150042655|NCT03848728|541293808|FG001|Overall Study|Transfered to non-study clinic|48|||
150042656|NCT03848728|541293807|FG000|Overall Study|Withdrawal by Subject|1|||
150042657|NCT03848728|541293808|FG001|Overall Study|Withdrawal by Subject|0|||
150042658|NCT00536744|541293811|FG000|Overall Study|Adverse Event|13|||
150042659|NCT00536744|541293812|FG001|Overall Study|Adverse Event|10|||
150042660|NCT00536744|541293811|FG000|Overall Study|Death|2|||
150042661|NCT00536744|541293812|FG001|Overall Study|Death|1|||
150042662|NCT00536744|541293811|FG000|Overall Study|Physician Decision|3|||
150042663|NCT00536744|541293812|FG001|Overall Study|Physician Decision|1|||
150042664|NCT00536744|541293811|FG000|Overall Study|Lost to Follow-up|3|||
150042665|NCT00536744|541293812|FG001|Overall Study|Lost to Follow-up|5|||
150042666|NCT00536744|541293811|FG000|Overall Study|Withdrawal by Subject|7|||
150042667|NCT00536744|541293812|FG001|Overall Study|Withdrawal by Subject|8|||
150042668|NCT00536744|541293811|FG000|Overall Study|PI tried alternative treatment|1|||
150042669|NCT00536744|541293812|FG001|Overall Study|PI tried alternative treatment|3|||
150042670|NCT02581410|541293813|FG000|Vaccination Phase|Adverse Event|2|||
150042671|NCT02581410|541293814|FG001|Vaccination Phase|Adverse Event|1|||
150042672|NCT02581410|541293813|FG000|Vaccination Phase|Withdrawal by Subject|0|||
149873673|NCT02585934|540667121|FG001|Overall Study|Sponsor Termination|2|||
149873674|NCT02585934|540667120|FG000|Overall Study|Another Reason|10|||
149873675|NCT02585934|540667121|FG001|Overall Study|Another Reason|5|||
150042673|NCT02581410|541293814|FG001|Vaccination Phase|Withdrawal by Subject|1|||
149873676|NCT04713553|540667122|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
149873677|NCT04713553|540667123|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
149873678|NCT04713553|540667124|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
149873679|NCT04713553|540667125|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
149873680|NCT04713553|540667126|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
149873681|NCT04713553|540667127|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
149873682|NCT04713553|540667128|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
149873683|NCT04713553|540667122|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
150042674|NCT02581410|541293813|FG000|Vaccination Phase|Migrated/moved from study area|0|||
150042675|NCT02581410|541293814|FG001|Vaccination Phase|Migrated/moved from study area|1|||
150042676|NCT02581410|541293813|FG000|End of Study Phase|Adverse Event|4|||
150042677|NCT02581410|541293814|FG001|End of Study Phase|Adverse Event|3|||
150042678|NCT02581410|541293813|FG000|End of Study Phase|Withdrawal by Subject|1|||
150042679|NCT02581410|541293814|FG001|End of Study Phase|Withdrawal by Subject|2|||
150042680|NCT02581410|541293813|FG000|End of Study Phase|Migrated/moved from study area|0|||
150042681|NCT02581410|541293814|FG001|End of Study Phase|Migrated/moved from study area|3|||
149873684|NCT04713553|540667123|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
149873685|NCT04713553|540667124|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
149873686|NCT04713553|540667125|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
150042682|NCT02581410|541293813|FG000|End of Study Phase|Lost to Follow-up|0|||
150042683|NCT02581410|541293814|FG001|End of Study Phase|Lost to Follow-up|2|||
150042684|NCT02581410|541293813|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
150042685|NCT02581410|541293814|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
150042686|NCT00670748|541293815|FG000|Overall Study|Death during treatment|1|||
150042687|NCT00670748|541293816|FG001|Overall Study|Death during treatment|1|||
150042688|NCT00670748|541293817|FG002|Overall Study|Death during treatment|1|||
150042689|NCT00670748|541293818|FG003|Overall Study|Death during treatment|0|||
150042690|NCT00670748|541293815|FG000|Overall Study|Not off study|2|||
150042691|NCT00670748|541293816|FG001|Overall Study|Not off study|1|||
150042692|NCT00670748|541293817|FG002|Overall Study|Not off study|1|||
150042693|NCT00670748|541293818|FG003|Overall Study|Not off study|1|||
150042694|NCT02876601|541293819|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
150042695|NCT02876601|541293820|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
150042696|NCT02876601|541293821|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
150042697|NCT02876601|541293822|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
150042698|NCT03863080|541293823|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
150042699|NCT03863080|541293824|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
150042700|NCT03863080|541293825|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
150042701|NCT03863080|541293826|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
150042702|NCT03863080|541293823|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
150042703|NCT03863080|541293824|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
150042704|NCT03863080|541293825|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
150042705|NCT03863080|541293826|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
150042706|NCT03863080|541293823|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
150042707|NCT03863080|541293824|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
150042708|NCT03863080|541293825|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
150042709|NCT03863080|541293826|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
150042710|NCT02991768|541293828|FG000|Overall Study|Physician Decision|4|||
150042711|NCT03467750|541293829|FG000|Overall Study|Surgery canceled|1|||
150042712|NCT03467750|541293830|FG001|Overall Study|Surgery canceled|0|||
150042713|NCT03467750|541293829|FG000|Overall Study|Protocol Violation|1|||
150042714|NCT03467750|541293830|FG001|Overall Study|Protocol Violation|1|||
150042715|NCT03467750|541293829|FG000|Overall Study|Withdrawal by Subject|0|||
150042716|NCT03467750|541293830|FG001|Overall Study|Withdrawal by Subject|1|||
150042717|NCT00742235|541295534|FG000|Overall Study|Lost to Follow-up|0|||
150042718|NCT00742235|541295535|FG001|Overall Study|Lost to Follow-up|31|||
150042719|NCT00433004|541295536|FG000|Overall Study|Lost to Follow-up|5|||
150042720|NCT00433004|541295537|FG001|Overall Study|Lost to Follow-up|7|||
150042721|NCT05661409|541295538|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
150042722|NCT05661409|541295539|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
150042723|NCT05661409|541295540|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
150042724|NCT05661409|541295541|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
150042725|NCT05661409|541295542|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
150042726|NCT05661409|541295543|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
150042727|NCT05661409|541295538|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
150042728|NCT05661409|541295539|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
150042729|NCT05661409|541295540|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
150042730|NCT05661409|541295541|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
150042731|NCT05661409|541295542|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
150042732|NCT05661409|541295543|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
150042733|NCT05661409|541295538|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
150042734|NCT05661409|541295539|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
149873687|NCT04713553|540667126|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
149873688|NCT04713553|540667127|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
149873689|NCT04713553|540667128|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
149873690|NCT04713553|540667122|FG000|Primary Study (2 Months)|Other|1|||
149873691|NCT04713553|540667123|FG001|Primary Study (2 Months)|Other|2|||
149873692|NCT04713553|540667124|FG002|Primary Study (2 Months)|Other|0|||
149873693|NCT04713553|540667125|FG003|Primary Study (2 Months)|Other|0|||
149873694|NCT04713553|540667126|FG004|Primary Study (2 Months)|Other|1|||
149873695|NCT04713553|540667127|FG005|Primary Study (2 Months)|Other|0|||
149873696|NCT04713553|540667128|FG006|Primary Study (2 Months)|Other|0|||
149873697|NCT04713553|540667122|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
150174130|NCT02459899|541773023|FG000|Overall Study|Non-compliance with the treatment|0|||
150174131|NCT02459899|541773024|FG001|Overall Study|Non-compliance with the treatment|0|||
149873698|NCT04713553|540667123|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
150042735|NCT05661409|541295540|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
150042736|NCT05661409|541295541|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
150042737|NCT05661409|541295542|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
150042738|NCT05661409|541295543|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
150042739|NCT05661409|541295538|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
149873699|NCT04713553|540667124|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
149873700|NCT04713553|540667125|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
149873701|NCT04713553|540667126|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
149873702|NCT04713553|540667127|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
149873703|NCT04713553|540667128|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
149873704|NCT04713553|540667122|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873705|NCT04713553|540667123|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873706|NCT04713553|540667124|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
149873707|NCT04713553|540667125|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873708|NCT04713553|540667126|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873709|NCT04713553|540667127|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873710|NCT04713553|540667128|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
149873711|NCT01359969|540667130|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
149873712|NCT02338193|540667133|FG000|Overall Study|Withdrawal by Subject|0|||
149873713|NCT02338193|540667134|FG001|Overall Study|Withdrawal by Subject|0|||
149873714|NCT02338193|540667135|FG002|Overall Study|Withdrawal by Subject|2|||
149873715|NCT02338193|540667133|FG000|Overall Study|Pregnancy|0|||
149873716|NCT02338193|540667134|FG001|Overall Study|Pregnancy|1|||
149873717|NCT02338193|540667135|FG002|Overall Study|Pregnancy|1|||
149873718|NCT02338193|540667133|FG000|Overall Study|Noncompliant with visits|2|||
149873719|NCT02338193|540667134|FG001|Overall Study|Noncompliant with visits|2|||
149873720|NCT02338193|540667135|FG002|Overall Study|Noncompliant with visits|7|||
149873721|NCT02338193|540667133|FG000|Overall Study|moved out of state|0|||
149873722|NCT02338193|540667134|FG001|Overall Study|moved out of state|1|||
149873723|NCT02338193|540667135|FG002|Overall Study|moved out of state|0|||
149873724|NCT02338193|540667133|FG000|Overall Study|intolerant of side effects|1|||
149873725|NCT02338193|540667134|FG001|Overall Study|intolerant of side effects|0|||
149873726|NCT02338193|540667135|FG002|Overall Study|intolerant of side effects|0|||
149873727|NCT01735955|540667140|FG000|Overall Study|Administrative problems|1|||
149873728|NCT01735955|540667140|FG000|Overall Study|Patient/guardian decision|1|||
149873729|NCT01735955|540667140|FG000|Overall Study|Patient withdrew consent|2|||
149873730|NCT01735955|540667140|FG000|Overall Study|Physician Decision|4|||
149873731|NCT01735955|540667140|FG000|Overall Study|Disease progression|24|||
149873732|NCT01735955|540667140|FG000|Overall Study|Adverse Event|5|||
149873733|NCT00936897|540667146|FG000|Overall Study|Withdrawal by Subject|9|||
149873734|NCT00936897|540667147|FG001|Overall Study|Withdrawal by Subject|19|||
149873735|NCT00936897|540667146|FG000|Overall Study|Adverse Event|4|||
149873736|NCT00936897|540667147|FG001|Overall Study|Adverse Event|13|||
149873737|NCT00936897|540667146|FG000|Overall Study|Other|3|||
149873738|NCT00936897|540667147|FG001|Overall Study|Other|9|||
149873739|NCT00936897|540667146|FG000|Overall Study|Lost to Follow-up|1|||
149873740|NCT00936897|540667147|FG001|Overall Study|Lost to Follow-up|10|||
149873741|NCT00936897|540667146|FG000|Overall Study|Administrative Decision|1|||
149873742|NCT00936897|540667147|FG001|Overall Study|Administrative Decision|2|||
149873743|NCT00936897|540667146|FG000|Overall Study|Protocol Violation|1|||
149873744|NCT00936897|540667147|FG001|Overall Study|Protocol Violation|1|||
149873745|NCT00936897|540667146|FG000|Overall Study|Ineligibility Determined|0|||
149873746|NCT00936897|540667147|FG001|Overall Study|Ineligibility Determined|3|||
149873747|NCT00936897|540667146|FG000|Overall Study|Noncompliance|0|||
149873748|NCT00936897|540667147|FG001|Overall Study|Noncompliance|2|||
149873749|NCT00936897|540667146|FG000|Overall Study|Death|0|||
149873750|NCT00936897|540667147|FG001|Overall Study|Death|1|||
149873751|NCT00417170|540667148|FG000|Overall Study|Adverse Event|1|||
150042740|NCT05661409|541295539|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
150042741|NCT05661409|541295540|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
150042742|NCT05661409|541295541|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
149873752|NCT00417170|540667149|FG001|Overall Study|Adverse Event|1|||
149873753|NCT00417170|540667148|FG000|Overall Study|Withdrawal by Subject|1|||
149873754|NCT00417170|540667149|FG001|Overall Study|Withdrawal by Subject|1|||
150042743|NCT05661409|541295542|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
150042744|NCT05661409|541295543|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
149873755|NCT00417170|540667148|FG000|Overall Study|Lost to Follow-up|0|||
149873756|NCT00417170|540667149|FG001|Overall Study|Lost to Follow-up|1|||
149873757|NCT04058067|540667150|FG000|Overall Study|Adverse Event|2|||
149873758|NCT04058067|540667151|FG001|Overall Study|Adverse Event|0|||
149873759|NCT04058067|540667150|FG000|Overall Study|Death|0|||
149873760|NCT04058067|540667151|FG001|Overall Study|Death|1|||
149873761|NCT04058067|540667150|FG000|Overall Study|Physician Decision|3|||
149873762|NCT04058067|540667151|FG001|Overall Study|Physician Decision|1|||
149873763|NCT04058067|540667150|FG000|Overall Study|Protocol Violation|0|||
149873764|NCT04058067|540667151|FG001|Overall Study|Protocol Violation|1|||
149873765|NCT04058067|540667150|FG000|Overall Study|Withdrawal by Subject|7|||
149873766|NCT04058067|540667151|FG001|Overall Study|Withdrawal by Subject|8|||
149873767|NCT00927394|540667152|FG000|Overall Study|Adverse Event|14|||
150174132|NCT02459899|541773025|FG002|Overall Study|Non-compliance with the treatment|0|||
150174133|NCT02459899|541773026|FG003|Overall Study|Non-compliance with the treatment|1|||
150174134|NCT02459899|541773023|FG000|Overall Study|Withdrawal by Subject|1|||
150174135|NCT02459899|541773024|FG001|Overall Study|Withdrawal by Subject|3|||
149873768|NCT00927394|540667153|FG001|Overall Study|Adverse Event|9|||
149873769|NCT00927394|540667152|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
149873770|NCT00927394|540667153|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
149873771|NCT00927394|540667152|FG000|Overall Study|Withdrawal by Subject|20|||
149873772|NCT00927394|540667153|FG001|Overall Study|Withdrawal by Subject|24|||
149873773|NCT00927394|540667152|FG000|Overall Study|Lost to Follow-up|8|||
149873774|NCT00927394|540667153|FG001|Overall Study|Lost to Follow-up|14|||
149873775|NCT00927394|540667152|FG000|Overall Study|Administrative Problem|1|||
149873776|NCT00927394|540667153|FG001|Overall Study|Administrative Problem|0|||
149873777|NCT00927394|540667152|FG000|Overall Study|Death|1|||
149873778|NCT00927394|540667153|FG001|Overall Study|Death|1|||
149873779|NCT00927394|540667152|FG000|Overall Study|Protocol deviation|16|||
149873780|NCT00927394|540667153|FG001|Overall Study|Protocol deviation|13|||
149873781|NCT00927394|540667152|FG000|Overall Study|Randomized in error|0|||
149873782|NCT00927394|540667153|FG001|Overall Study|Randomized in error|1|||
149873783|NCT01221363|540667154|FG000|Overall Study|Pregnancy|1|||
149873784|NCT01221363|540667155|FG001|Overall Study|Pregnancy|0|||
149873785|NCT01221363|540667154|FG000|Overall Study|Withdrawal by Subject|11|||
149873786|NCT01221363|540667155|FG001|Overall Study|Withdrawal by Subject|5|||
149873787|NCT04628793|540667156|FG000|Overall Study|Study terminated by sponsor|0|||
149873788|NCT04628793|540667157|FG001|Overall Study|Study terminated by sponsor|0|||
149873789|NCT04628793|540667158|FG002|Overall Study|Study terminated by sponsor|8|||
149873790|NCT04628793|540667156|FG000|Overall Study|Withdrawal by Subject|2|||
149873791|NCT04628793|540667157|FG001|Overall Study|Withdrawal by Subject|3|||
149873792|NCT04628793|540667158|FG002|Overall Study|Withdrawal by Subject|0|||
149873793|NCT04628793|540667156|FG000|Overall Study|Lost to Follow-up|0|||
149873794|NCT04628793|540667157|FG001|Overall Study|Lost to Follow-up|1|||
149873795|NCT04628793|540667158|FG002|Overall Study|Lost to Follow-up|0|||
149873796|NCT01329549|540667162|FG000|Overall Study|Withdrawal by Subject|1|||
149873797|NCT01329549|540667162|FG000|Overall Study|Adverse Event|1|||
149873798|NCT04623086|540667163|FG000|Overall Study|Withdrawal by Subject|0|||
149873799|NCT04623086|540667164|FG001|Overall Study|Withdrawal by Subject|0|||
149873800|NCT04623086|540667165|FG002|Overall Study|Withdrawal by Subject|10|||
149873801|NCT01755767|540667166|FG000|Overall Study|Progressive Disease|8|||
149873802|NCT01755767|540667167|FG001|Overall Study|Progressive Disease|7|||
149873803|NCT01755767|540667168|FG002|Overall Study|Progressive Disease|91|||
149873804|NCT01755767|540667169|FG003|Overall Study|Progressive Disease|43|||
149873805|NCT01755767|540667166|FG000|Overall Study|Clinical Disease Progression|4|||
149873806|NCT01755767|540667167|FG001|Overall Study|Clinical Disease Progression|2|||
149873807|NCT01755767|540667168|FG002|Overall Study|Clinical Disease Progression|29|||
149873808|NCT01755767|540667169|FG003|Overall Study|Clinical Disease Progression|20|||
150174136|NCT02459899|541773025|FG002|Overall Study|Withdrawal by Subject|0|||
150174137|NCT02459899|541773026|FG003|Overall Study|Withdrawal by Subject|0|||
150174138|NCT00630786|541773034|FG000|Overall Study|Physician Decision|0|||
150174139|NCT00630786|541773035|FG001|Overall Study|Physician Decision|0|||
150174140|NCT00630786|541773036|FG002|Overall Study|Physician Decision|1|||
150174141|NCT00630786|541773034|FG000|Overall Study|Withdrawal by Subject|0|||
149873809|NCT01755767|540667166|FG000|Overall Study|Radiographic Disease Progression|9|||
149873810|NCT01755767|540667167|FG001|Overall Study|Radiographic Disease Progression|4|||
149873811|NCT01755767|540667168|FG002|Overall Study|Radiographic Disease Progression|44|||
149873812|NCT01755767|540667169|FG003|Overall Study|Radiographic Disease Progression|27|||
149873813|NCT01755767|540667166|FG000|Overall Study|Adverse Event|6|||
149873814|NCT01755767|540667167|FG001|Overall Study|Adverse Event|0|||
149873815|NCT01755767|540667168|FG002|Overall Study|Adverse Event|28|||
149873816|NCT01755767|540667169|FG003|Overall Study|Adverse Event|11|||
149873817|NCT01755767|540667166|FG000|Overall Study|Death|1|||
149873818|NCT01755767|540667167|FG001|Overall Study|Death|2|||
149873819|NCT01755767|540667168|FG002|Overall Study|Death|15|||
149873820|NCT01755767|540667169|FG003|Overall Study|Death|4|||
149873821|NCT01755767|540667166|FG000|Overall Study|Subject Decision|0|||
149963800|NCT02037984|541001549|FG002|Overall Study|Physician Decision|0|||
149963801|NCT02037984|541001550|FG003|Overall Study|Physician Decision|0|||
149963802|NCT02037984|541001551|FG004|Overall Study|Physician Decision|0|||
149963803|NCT02037984|541001552|FG005|Overall Study|Physician Decision|0|||
149963804|NCT02037984|541001553|FG006|Overall Study|Physician Decision|1|||
149963805|NCT02037984|541001554|FG007|Overall Study|Physician Decision|0|||
149963806|NCT02037984|541001547|FG000|Overall Study|Protocol Violation|0|||
149963807|NCT02037984|541001548|FG001|Overall Study|Protocol Violation|0|||
149963808|NCT02037984|541001549|FG002|Overall Study|Protocol Violation|0|||
149963809|NCT02037984|541001550|FG003|Overall Study|Protocol Violation|0|||
149873822|NCT01755767|540667167|FG001|Overall Study|Subject Decision|0|||
149873823|NCT01755767|540667168|FG002|Overall Study|Subject Decision|10|||
149873824|NCT01755767|540667169|FG003|Overall Study|Subject Decision|3|||
150174142|NCT00630786|541773035|FG001|Overall Study|Withdrawal by Subject|1|||
150042745|NCT05661409|541295538|FG000|Overall Study|Miscommu-nication about administration|0|||
149873825|NCT01755767|540667166|FG000|Overall Study|Withdrawal by Subject|0|||
149873826|NCT01755767|540667167|FG001|Overall Study|Withdrawal by Subject|0|||
149873827|NCT01755767|540667168|FG002|Overall Study|Withdrawal by Subject|2|||
149873828|NCT01755767|540667169|FG003|Overall Study|Withdrawal by Subject|1|||
149873829|NCT01755767|540667166|FG000|Overall Study|Other|0|||
149873830|NCT01755767|540667167|FG001|Overall Study|Other|0|||
149873831|NCT01755767|540667168|FG002|Overall Study|Other|2|||
149873832|NCT01755767|540667169|FG003|Overall Study|Other|3|||
149873833|NCT01755767|540667166|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
149873834|NCT01755767|540667167|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
149873835|NCT01755767|540667168|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
149873836|NCT01755767|540667169|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
149873837|NCT00191165|540667170|FG000|Overall Study|Adverse Event|2|||
149873838|NCT00191165|540667171|FG001|Overall Study|Adverse Event|0|||
149873839|NCT00191165|540667170|FG000|Overall Study|Protocol Violation|0|||
149873840|NCT00191165|540667171|FG001|Overall Study|Protocol Violation|1|||
149873841|NCT00191165|540667170|FG000|Overall Study|Participant Moved Away|0|||
149873842|NCT00191165|540667171|FG001|Overall Study|Participant Moved Away|1|||
149873843|NCT00715624|540667172|FG000|Overall Study|Adverse Event|12|||
149873844|NCT00715624|540667173|FG001|Overall Study|Adverse Event|37|||
149873845|NCT00715624|540667172|FG000|Overall Study|Lack of Efficacy|11|||
149873846|NCT00715624|540667173|FG001|Overall Study|Lack of Efficacy|11|||
149873847|NCT00715624|540667172|FG000|Overall Study|Lost to Follow-up|1|||
149873848|NCT00715624|540667173|FG001|Overall Study|Lost to Follow-up|2|||
149873849|NCT00715624|540667172|FG000|Overall Study|Protocol Violation|1|||
149873850|NCT00715624|540667173|FG001|Overall Study|Protocol Violation|0|||
149873851|NCT00715624|540667172|FG000|Overall Study|Withdrawal by Subject|11|||
149873852|NCT00715624|540667173|FG001|Overall Study|Withdrawal by Subject|25|||
149873853|NCT00715624|540667172|FG000|Overall Study|Familial and personal reasons|10|||
149873854|NCT00715624|540667173|FG001|Overall Study|Familial and personal reasons|22|||
149873855|NCT00715624|540667172|FG000|Overall Study|Poor compliance|6|||
149873856|NCT00715624|540667173|FG001|Overall Study|Poor compliance|13|||
149873857|NCT00715624|540667172|FG000|Overall Study|Sponsor decision|0|||
149873858|NCT00715624|540667173|FG001|Overall Study|Sponsor decision|4|||
149873859|NCT00715624|540667172|FG000|Overall Study|Incorrect randomization (not treated)|0|||
149873860|NCT00715624|540667173|FG001|Overall Study|Incorrect randomization (not treated)|1|||
149873861|NCT00715624|540667172|FG000|Overall Study|Other|0|||
149873862|NCT00715624|540667173|FG001|Overall Study|Other|1|||
149873863|NCT03200912|540667174|FG000|Overall Study|Adverse Event|3|||
149873864|NCT03200912|540667175|FG001|Overall Study|Adverse Event|0|||
149873865|NCT03200912|540667176|FG002|Overall Study|Adverse Event|0|||
149873866|NCT03200912|540667174|FG000|Overall Study|Withdrawal by Subject|1|||
149873867|NCT03200912|540667175|FG001|Overall Study|Withdrawal by Subject|2|||
149873868|NCT03200912|540667176|FG002|Overall Study|Withdrawal by Subject|4|||
149873869|NCT03200912|540667174|FG000|Overall Study|Non-compliance with study drug|0|||
149873870|NCT03200912|540667175|FG001|Overall Study|Non-compliance with study drug|1|||
149873871|NCT03200912|540667176|FG002|Overall Study|Non-compliance with study drug|0|||
149873872|NCT03196635|540667178|FG000|Overall Study|Withdrawal by Subject|1|||
149873873|NCT00229723|540667181|FG000|Concomitant Phase|Adverse Event|4|||
149873874|NCT00229723|540667182|FG001|Concomitant Phase|Adverse Event|2|||
149873875|NCT00229723|540667183|FG002|Concomitant Phase|Adverse Event|5|||
149873876|NCT00229723|540667184|FG003|Concomitant Phase|Adverse Event|2|||
149873877|NCT00229723|540667185|FG004|Concomitant Phase|Adverse Event|0|||
149873878|NCT00229723|540667186|FG005|Concomitant Phase|Adverse Event|1|||
149873879|NCT00229723|540667187|FG006|Concomitant Phase|Adverse Event|2|||
149873880|NCT00229723|540667181|FG000|Concomitant Phase|Objective disease progression|0|||
149873881|NCT00229723|540667182|FG001|Concomitant Phase|Objective disease progression|0|||
149873882|NCT00229723|540667183|FG002|Concomitant Phase|Objective disease progression|0|||
150042746|NCT05661409|541295539|FG001|Overall Study|Miscommu-nication about administration|0|||
150042747|NCT05661409|541295540|FG002|Overall Study|Miscommu-nication about administration|0|||
150042748|NCT05661409|541295541|FG003|Overall Study|Miscommu-nication about administration|0|||
150042749|NCT05661409|541295542|FG004|Overall Study|Miscommu-nication about administration|0|||
150042750|NCT05661409|541295543|FG005|Overall Study|Miscommu-nication about administration|1|||
150042751|NCT04730271|541295544|FG000|Overall Study|Adverse Event|0|||
149873883|NCT00229723|540667184|FG003|Concomitant Phase|Objective disease progression|0|||
149873884|NCT00229723|540667185|FG004|Concomitant Phase|Objective disease progression|0|||
149873885|NCT00229723|540667186|FG005|Concomitant Phase|Objective disease progression|0|||
149873886|NCT00229723|540667187|FG006|Concomitant Phase|Objective disease progression|0|||
149873887|NCT00229723|540667181|FG000|Concomitant Phase|Clinical progression|0|||
149873888|NCT00229723|540667182|FG001|Concomitant Phase|Clinical progression|0|||
149873889|NCT00229723|540667183|FG002|Concomitant Phase|Clinical progression|0|||
149873890|NCT00229723|540667184|FG003|Concomitant Phase|Clinical progression|0|||
149873891|NCT00229723|540667185|FG004|Concomitant Phase|Clinical progression|0|||
149873892|NCT00229723|540667186|FG005|Concomitant Phase|Clinical progression|0|||
150042752|NCT04730271|541295545|FG001|Overall Study|Adverse Event|2|||
150042753|NCT04730271|541295544|FG000|Overall Study|Withdrawal by Subject|1|||
150042754|NCT04730271|541295545|FG001|Overall Study|Withdrawal by Subject|1|||
150042755|NCT04730271|541295544|FG000|Overall Study|Protocol Violation|7|||
150042756|NCT04730271|541295545|FG001|Overall Study|Protocol Violation|13|||
150042757|NCT04730271|541295544|FG000|Overall Study|Lost to Follow-up|3|||
150042758|NCT04730271|541295545|FG001|Overall Study|Lost to Follow-up|3|||
150042759|NCT04730271|541295544|FG000|Overall Study|Death|1|||
150042760|NCT04730271|541295545|FG001|Overall Study|Death|0|||
150042761|NCT02223858|541295548|FG000|Overall Study|Death|1|||
150042762|NCT02223858|541295549|FG001|Overall Study|Death|1|||
150042763|NCT02223858|541295548|FG000|Overall Study|Lost to Follow-up|6|||
150042764|NCT02223858|541295549|FG001|Overall Study|Lost to Follow-up|11|||
150042765|NCT02223858|541295548|FG000|Overall Study|Withdrawal by Subject|8|||
150042766|NCT02223858|541295549|FG001|Overall Study|Withdrawal by Subject|5|||
150042767|NCT02223858|541295548|FG000|Overall Study|Refused|9|||
150042768|NCT02223858|541295549|FG001|Overall Study|Refused|9|||
150042769|NCT03198507|541295550|FG000|Overall Study|Withdrawal by Subject|1|||
150042770|NCT03198507|541295551|FG001|Overall Study|Withdrawal by Subject|0|||
150042771|NCT00241839|541295552|FG000|Overall Study|Withdrawal by Subject|18|||
150042772|NCT00241839|541295553|FG001|Overall Study|Withdrawal by Subject|17|||
150042773|NCT00241839|541295552|FG000|Overall Study|Adverse Event|1|||
150042774|NCT00241839|541295553|FG001|Overall Study|Adverse Event|1|||
150042775|NCT00831181|541295560|FG000|Overall Study|Adverse Event|12|||
150042776|NCT00043979|541295561|FG000|Period 1|recipient with progressive disease|7|||
150042777|NCT00043979|541295562|FG001|Period 1|recipient with progressive disease|4|||
150042778|NCT00043979|541295563|FG002|Period 1|recipient with progressive disease|3|||
150042779|NCT04639258|541295564|FG000|Overall Study|Screen failure|5|||
150042780|NCT04639258|541295564|FG000|Overall Study|Physician Decision|2|||
150042781|NCT04639258|541295564|FG000|Overall Study|Early study termination|3|||
150042782|NCT04639258|541295564|FG000|Overall Study|Withdrawal by Subject|1|||
150042783|NCT01635153|541295566|FG000|Overall Study|Lost to Follow-up|40|||
149873893|NCT00229723|540667187|FG006|Concomitant Phase|Clinical progression|1|||
149873894|NCT00229723|540667181|FG000|Concomitant Phase|Lost to Follow-up|0|||
149873895|NCT00229723|540667182|FG001|Concomitant Phase|Lost to Follow-up|0|||
149873896|NCT00229723|540667183|FG002|Concomitant Phase|Lost to Follow-up|0|||
149873897|NCT00229723|540667184|FG003|Concomitant Phase|Lost to Follow-up|0|||
149873898|NCT00229723|540667185|FG004|Concomitant Phase|Lost to Follow-up|1|||
149873899|NCT00229723|540667186|FG005|Concomitant Phase|Lost to Follow-up|0|||
149873900|NCT00229723|540667187|FG006|Concomitant Phase|Lost to Follow-up|0|||
149873901|NCT00229723|540667181|FG000|Concomitant Phase|Informed consent withdrawn|3|||
149873902|NCT00229723|540667182|FG001|Concomitant Phase|Informed consent withdrawn|2|||
149873903|NCT00229723|540667183|FG002|Concomitant Phase|Informed consent withdrawn|0|||
149873904|NCT00229723|540667184|FG003|Concomitant Phase|Informed consent withdrawn|2|||
149873905|NCT00229723|540667185|FG004|Concomitant Phase|Informed consent withdrawn|0|||
149873906|NCT00229723|540667186|FG005|Concomitant Phase|Informed consent withdrawn|0|||
149873907|NCT00229723|540667187|FG006|Concomitant Phase|Informed consent withdrawn|0|||
149873908|NCT00229723|540667181|FG000|Concomitant Phase|Severe non-compliance|0|||
149873909|NCT00229723|540667182|FG001|Concomitant Phase|Severe non-compliance|1|||
149873910|NCT00229723|540667183|FG002|Concomitant Phase|Severe non-compliance|0|||
149873911|NCT00229723|540667184|FG003|Concomitant Phase|Severe non-compliance|0|||
149873912|NCT00229723|540667185|FG004|Concomitant Phase|Severe non-compliance|1|||
149873913|NCT00229723|540667186|FG005|Concomitant Phase|Severe non-compliance|0|||
149873914|NCT00229723|540667187|FG006|Concomitant Phase|Severe non-compliance|0|||
149873915|NCT00229723|540667181|FG000|Concomitant Phase|Other|3|||
149873916|NCT00229723|540667182|FG001|Concomitant Phase|Other|0|||
150042784|NCT01635153|541295567|FG001|Overall Study|Lost to Follow-up|43|||
150042785|NCT02560558|541295569|FG000|Overall Study|Adverse Event|1|||
150042786|NCT02560558|541295570|FG001|Overall Study|Adverse Event|0|||
150042787|NCT02560558|541295569|FG000|Overall Study|Death|0|||
150042788|NCT02560558|541295570|FG001|Overall Study|Death|2|||
150042789|NCT02560558|541295569|FG000|Overall Study|Lost to Follow-up|0|||
150042790|NCT02560558|541295570|FG001|Overall Study|Lost to Follow-up|4|||
149873917|NCT00229723|540667183|FG002|Concomitant Phase|Other|1|||
149873918|NCT00229723|540667184|FG003|Concomitant Phase|Other|1|||
149873919|NCT00229723|540667185|FG004|Concomitant Phase|Other|0|||
149873920|NCT00229723|540667186|FG005|Concomitant Phase|Other|2|||
149873921|NCT00229723|540667187|FG006|Concomitant Phase|Other|0|||
149873922|NCT00229723|540667181|FG000|Maintenance Phase|Adverse Event|7|||
150042791|NCT02560558|541295569|FG000|Overall Study|Protocol Violation|3|||
150042792|NCT02560558|541295570|FG001|Overall Study|Protocol Violation|0|||
150042793|NCT02560558|541295569|FG000|Overall Study|Withdrawal by Subject|3|||
150042794|NCT02560558|541295570|FG001|Overall Study|Withdrawal by Subject|0|||
150042795|NCT01189032|541295575|FG000|Overall Study|Adverse Event|1|||
150042796|NCT01189032|541295576|FG001|Overall Study|Adverse Event|3|||
150042797|NCT01189032|541295577|FG002|Overall Study|Adverse Event|4|||
150042798|NCT01189032|541295575|FG000|Overall Study|Lack of Efficacy|2|||
150042799|NCT01189032|541295576|FG001|Overall Study|Lack of Efficacy|3|||
150042800|NCT01189032|541295577|FG002|Overall Study|Lack of Efficacy|0|||
149873923|NCT00229723|540667182|FG001|Maintenance Phase|Adverse Event|2|||
149873924|NCT00229723|540667183|FG002|Maintenance Phase|Adverse Event|1|||
149873925|NCT00229723|540667184|FG003|Maintenance Phase|Adverse Event|4|||
150042801|NCT01189032|541295575|FG000|Overall Study|Withdrawal by Subject|1|||
150042802|NCT01189032|541295576|FG001|Overall Study|Withdrawal by Subject|0|||
150042803|NCT01189032|541295577|FG002|Overall Study|Withdrawal by Subject|1|||
149873926|NCT00229723|540667185|FG004|Maintenance Phase|Adverse Event|7|||
149873927|NCT00229723|540667186|FG005|Maintenance Phase|Adverse Event|5|||
149873928|NCT00229723|540667187|FG006|Maintenance Phase|Adverse Event|2|||
149873929|NCT00229723|540667181|FG000|Maintenance Phase|Objective disease progression|5|||
149873930|NCT00229723|540667182|FG001|Maintenance Phase|Objective disease progression|5|||
149873931|NCT00229723|540667183|FG002|Maintenance Phase|Objective disease progression|3|||
149873932|NCT00229723|540667184|FG003|Maintenance Phase|Objective disease progression|6|||
149873933|NCT00229723|540667185|FG004|Maintenance Phase|Objective disease progression|2|||
149873934|NCT00229723|540667186|FG005|Maintenance Phase|Objective disease progression|9|||
149873935|NCT00229723|540667187|FG006|Maintenance Phase|Objective disease progression|5|||
149873936|NCT00229723|540667181|FG000|Maintenance Phase|Clinical progression|4|||
149873937|NCT00229723|540667182|FG001|Maintenance Phase|Clinical progression|1|||
149873938|NCT00229723|540667183|FG002|Maintenance Phase|Clinical progression|2|||
149873939|NCT00229723|540667184|FG003|Maintenance Phase|Clinical progression|2|||
149873940|NCT00229723|540667185|FG004|Maintenance Phase|Clinical progression|1|||
149873941|NCT00229723|540667186|FG005|Maintenance Phase|Clinical progression|1|||
149873942|NCT00229723|540667187|FG006|Maintenance Phase|Clinical progression|1|||
149873943|NCT00229723|540667181|FG000|Maintenance Phase|Lost to Follow-up|0|||
149873944|NCT00229723|540667182|FG001|Maintenance Phase|Lost to Follow-up|1|||
150042804|NCT01189032|541295575|FG000|Overall Study|Protocol Violation|1|||
150042805|NCT01189032|541295576|FG001|Overall Study|Protocol Violation|1|||
150042806|NCT01189032|541295577|FG002|Overall Study|Protocol Violation|1|||
150042807|NCT01470326|541295578|FG000|Overall Study|Protocol Violation|32|||
150042808|NCT01470326|541295578|FG000|Overall Study|No Drug Administration Information|2|||
150042809|NCT01470326|541295578|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
150042810|NCT01166282|541295579|FG000|Open-label Period|Adverse Event|0|||
150042811|NCT01166282|541295580|FG001|Open-label Period|Adverse Event|0|||
150042812|NCT01166282|541295581|FG002|Open-label Period|Adverse Event|6|||
150042813|NCT01166282|541295579|FG000|Open-label Period|Withdrawal by Subject|0|||
150042814|NCT01166282|541295580|FG001|Open-label Period|Withdrawal by Subject|0|||
150042815|NCT01166282|541295581|FG002|Open-label Period|Withdrawal by Subject|4|||
150042816|NCT01166282|541295579|FG000|Open-label Period|Lack of Efficacy|0|||
149873945|NCT00229723|540667183|FG002|Maintenance Phase|Lost to Follow-up|2|||
149873946|NCT00229723|540667184|FG003|Maintenance Phase|Lost to Follow-up|2|||
149873947|NCT00229723|540667185|FG004|Maintenance Phase|Lost to Follow-up|0|||
149873948|NCT00229723|540667186|FG005|Maintenance Phase|Lost to Follow-up|0|||
149873949|NCT00229723|540667187|FG006|Maintenance Phase|Lost to Follow-up|1|||
149873950|NCT00229723|540667181|FG000|Maintenance Phase|Informed consent withdrawn|1|||
149873951|NCT00229723|540667182|FG001|Maintenance Phase|Informed consent withdrawn|0|||
149873952|NCT00229723|540667183|FG002|Maintenance Phase|Informed consent withdrawn|0|||
149873953|NCT00229723|540667184|FG003|Maintenance Phase|Informed consent withdrawn|1|||
149873954|NCT00229723|540667185|FG004|Maintenance Phase|Informed consent withdrawn|1|||
149873955|NCT00229723|540667186|FG005|Maintenance Phase|Informed consent withdrawn|1|||
149873956|NCT00229723|540667187|FG006|Maintenance Phase|Informed consent withdrawn|0|||
149873957|NCT00229723|540667181|FG000|Maintenance Phase|Severe non-compliance|3|||
149873958|NCT00229723|540667182|FG001|Maintenance Phase|Severe non-compliance|1|||
149873959|NCT00229723|540667183|FG002|Maintenance Phase|Severe non-compliance|0|||
149873960|NCT00229723|540667184|FG003|Maintenance Phase|Severe non-compliance|0|||
149873961|NCT00229723|540667185|FG004|Maintenance Phase|Severe non-compliance|1|||
149873962|NCT00229723|540667186|FG005|Maintenance Phase|Severe non-compliance|0|||
149873963|NCT00229723|540667187|FG006|Maintenance Phase|Severe non-compliance|0|||
150042817|NCT01166282|541295580|FG001|Open-label Period|Lack of Efficacy|0|||
150042818|NCT01166282|541295581|FG002|Open-label Period|Lack of Efficacy|2|||
150042819|NCT01166282|541295579|FG000|Open-label Period|Remission|0|||
150042820|NCT01166282|541295580|FG001|Open-label Period|Remission|0|||
150042821|NCT01166282|541295581|FG002|Open-label Period|Remission|4|||
150042822|NCT01166282|541295579|FG000|Open-label Period|Irregular Compliance|0|||
149873964|NCT00229723|540667181|FG000|Maintenance Phase|Other|5|||
149873965|NCT00229723|540667182|FG001|Maintenance Phase|Other|4|||
149873966|NCT00229723|540667183|FG002|Maintenance Phase|Other|1|||
149873967|NCT00229723|540667184|FG003|Maintenance Phase|Other|2|||
149873968|NCT00229723|540667185|FG004|Maintenance Phase|Other|3|||
149873969|NCT00229723|540667186|FG005|Maintenance Phase|Other|3|||
149873970|NCT00229723|540667187|FG006|Maintenance Phase|Other|1|||
149873971|NCT02309138|540667188|FG000|Overall Study|Withdrawal by Subject|44|||
149873972|NCT02309138|540667189|FG001|Overall Study|Withdrawal by Subject|15|||
149873973|NCT02309138|540667188|FG000|Overall Study|Protocol Violation|4|||
149873974|NCT02309138|540667189|FG001|Overall Study|Protocol Violation|2|||
150042823|NCT01166282|541295580|FG001|Open-label Period|Irregular Compliance|0|||
150042824|NCT01166282|541295581|FG002|Open-label Period|Irregular Compliance|1|||
150042825|NCT02577718|541295582|FG000|Overall Study|Death|6|||
150042826|NCT02577718|541295582|FG000|Overall Study|Withdrawal by Subject|2|||
149873975|NCT02309138|540667188|FG000|Overall Study|delivered before visit 2|0|||
149873976|NCT02309138|540667189|FG001|Overall Study|delivered before visit 2|1|||
149873977|NCT02677714|540667192|FG000|Overall Study|Withdrawal by Subject|2|||
149873978|NCT02677714|540667193|FG001|Overall Study|Withdrawal by Subject|0|||
149873979|NCT00477295|540667198|FG000|Overall Study|Adverse Event|31|||
149873980|NCT00477295|540667199|FG001|Overall Study|Adverse Event|35|||
149873981|NCT00477295|540667198|FG000|Overall Study|Withdrawal by Subject|35|||
149873982|NCT00477295|540667199|FG001|Overall Study|Withdrawal by Subject|24|||
149873983|NCT00477295|540667198|FG000|Overall Study|Lack of Efficacy|23|||
149873984|NCT00477295|540667199|FG001|Overall Study|Lack of Efficacy|23|||
150042827|NCT00346697|541295583|FG000|Overall Study|Lost to Follow-up|0|||
150042828|NCT00346697|541295584|FG001|Overall Study|Lost to Follow-up|1|||
150042829|NCT00686686|541295585|FG000|Overall Study|Non-compliance|1|||
150042830|NCT00686686|541295585|FG000|Overall Study|Adverse Event|2|||
150042831|NCT00686686|541295585|FG000|Overall Study|Lost to Follow-up|3|||
150042832|NCT01012440|541295586|FG000|Overall Study|Withdrawal by Subject|2|||
150042833|NCT00131248|541295588|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
150042834|NCT00131248|541295589|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
150042835|NCT00477386|541295597|FG000|Overall Study|Adverse Event|4|||
150042836|NCT00477386|541295598|FG001|Overall Study|Adverse Event|8|||
149873985|NCT00477295|540667198|FG000|Overall Study|Protocol Violation|3|||
149873986|NCT00477295|540667199|FG001|Overall Study|Protocol Violation|8|||
149873987|NCT00477295|540667198|FG000|Overall Study|Physician Decision|4|||
149873988|NCT00477295|540667199|FG001|Overall Study|Physician Decision|5|||
149873989|NCT00477295|540667198|FG000|Overall Study|Lost to Follow-up|21|||
149873990|NCT00477295|540667199|FG001|Overall Study|Lost to Follow-up|11|||
149873991|NCT00477295|540667198|FG000|Overall Study|Other|4|||
149873992|NCT00477295|540667199|FG001|Overall Study|Other|3|||
149873993|NCT03276780|540667202|FG000|Overall Study|Withdrawal by Subject|5|||
149873994|NCT03276780|540667203|FG001|Overall Study|Withdrawal by Subject|3|||
149873995|NCT03276780|540667202|FG000|Overall Study|Lost to Follow-up|3|||
149873996|NCT03276780|540667203|FG001|Overall Study|Lost to Follow-up|5|||
149873997|NCT03276780|540667202|FG000|Overall Study|Moved out of state|1|||
149873998|NCT03276780|540667203|FG001|Overall Study|Moved out of state|1|||
149873999|NCT03276780|540667202|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
149874000|NCT03276780|540667203|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
149874001|NCT03276780|540667202|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
149874002|NCT03276780|540667203|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
149874003|NCT02304458|540667204|FG000|Overall Study|Adverse Event|0|||
149874004|NCT02304458|540667205|FG001|Overall Study|Adverse Event|0|||
149874005|NCT02304458|540667206|FG002|Overall Study|Adverse Event|7|||
149874006|NCT02304458|540667207|FG003|Overall Study|Adverse Event|0|||
149874007|NCT02304458|540667208|FG004|Overall Study|Adverse Event|0|||
150042837|NCT00477386|541295597|FG000|Overall Study|Disease progression, relapse|3|||
150042838|NCT00477386|541295598|FG001|Overall Study|Disease progression, relapse|4|||
150042839|NCT00477386|541295597|FG000|Overall Study|Disease progression, refractory|1|||
150042840|NCT00477386|541295598|FG001|Overall Study|Disease progression, refractory|3|||
150042841|NCT00477386|541295597|FG000|Overall Study|Other|1|||
150042842|NCT00477386|541295598|FG001|Overall Study|Other|2|||
150042843|NCT00477386|541295597|FG000|Overall Study|Physician Decision|1|||
150042844|NCT00477386|541295598|FG001|Overall Study|Physician Decision|0|||
150042845|NCT00477386|541295597|FG000|Overall Study|Withdrawal by Subject|1|||
150042846|NCT00477386|541295598|FG001|Overall Study|Withdrawal by Subject|0|||
150042847|NCT02691507|541295599|FG000|Overall Study|Missed Visit 3|0|||
150042848|NCT02691507|541295600|FG001|Overall Study|Missed Visit 3|1|||
150042849|NCT03023397|541295601|FG000|Run-In|Failed screening allergen challenge|1|||
150042850|NCT03023397|541295602|FG001|Run-In|Failed screening allergen challenge|0|||
150042851|NCT03023397|541295603|FG002|Run-In|Failed screening allergen challenge|0|||
150042852|NCT03023397|541295601|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
149874008|NCT02304458|540667209|FG005|Overall Study|Adverse Event|0|||
150042853|NCT03023397|541295602|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
150174143|NCT00630786|541773036|FG002|Overall Study|Withdrawal by Subject|1|||
149874009|NCT02304458|540667210|FG006|Overall Study|Adverse Event|3|||
149874010|NCT02304458|540667211|FG007|Overall Study|Adverse Event|4|||
149874011|NCT02304458|540667204|FG000|Overall Study|Death|0|||
149874012|NCT02304458|540667205|FG001|Overall Study|Death|0|||
149874013|NCT02304458|540667206|FG002|Overall Study|Death|2|||
149874014|NCT02304458|540667207|FG003|Overall Study|Death|0|||
149874015|NCT02304458|540667208|FG004|Overall Study|Death|0|||
149874016|NCT02304458|540667209|FG005|Overall Study|Death|0|||
150042854|NCT03023397|541295603|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
150042855|NCT02284243|541295607|FG000|Overall Study|Lack of Efficacy|3|||
150042856|NCT02284243|541295608|FG001|Overall Study|Lack of Efficacy|3|||
150042857|NCT02284243|541295607|FG000|Overall Study|Adverse Event|1|||
149874017|NCT02304458|540667210|FG006|Overall Study|Death|1|||
149874018|NCT02304458|540667211|FG007|Overall Study|Death|0|||
149874019|NCT02304458|540667204|FG000|Overall Study|Lack of Efficacy|4|||
149874020|NCT02304458|540667205|FG001|Overall Study|Lack of Efficacy|6|||
149874021|NCT02304458|540667206|FG002|Overall Study|Lack of Efficacy|38|||
149874022|NCT02304458|540667207|FG003|Overall Study|Lack of Efficacy|5|||
149874023|NCT02304458|540667208|FG004|Overall Study|Lack of Efficacy|6|||
149874024|NCT02304458|540667209|FG005|Overall Study|Lack of Efficacy|6|||
149874025|NCT02304458|540667210|FG006|Overall Study|Lack of Efficacy|21|||
149874026|NCT02304458|540667211|FG007|Overall Study|Lack of Efficacy|4|||
149874027|NCT02304458|540667204|FG000|Overall Study|Physician Decision|2|||
149874028|NCT02304458|540667205|FG001|Overall Study|Physician Decision|0|||
149874029|NCT02304458|540667206|FG002|Overall Study|Physician Decision|16|||
149874030|NCT02304458|540667207|FG003|Overall Study|Physician Decision|1|||
149874031|NCT02304458|540667208|FG004|Overall Study|Physician Decision|0|||
149874032|NCT02304458|540667209|FG005|Overall Study|Physician Decision|0|||
149874033|NCT02304458|540667210|FG006|Overall Study|Physician Decision|3|||
149874034|NCT02304458|540667211|FG007|Overall Study|Physician Decision|0|||
149874035|NCT02304458|540667204|FG000|Overall Study|Protocol Violation|0|||
149874036|NCT02304458|540667205|FG001|Overall Study|Protocol Violation|0|||
149874037|NCT02304458|540667206|FG002|Overall Study|Protocol Violation|1|||
149874038|NCT02304458|540667207|FG003|Overall Study|Protocol Violation|0|||
149874039|NCT02304458|540667208|FG004|Overall Study|Protocol Violation|0|||
149874040|NCT02304458|540667209|FG005|Overall Study|Protocol Violation|0|||
149874041|NCT02304458|540667210|FG006|Overall Study|Protocol Violation|0|||
149874042|NCT02304458|540667211|FG007|Overall Study|Protocol Violation|0|||
149874043|NCT02304458|540667204|FG000|Overall Study|Withdrawal by Subject|1|||
149874044|NCT02304458|540667205|FG001|Overall Study|Withdrawal by Subject|0|||
149874045|NCT02304458|540667206|FG002|Overall Study|Withdrawal by Subject|7|||
149874046|NCT02304458|540667207|FG003|Overall Study|Withdrawal by Subject|0|||
149874047|NCT02304458|540667208|FG004|Overall Study|Withdrawal by Subject|0|||
149874048|NCT02304458|540667209|FG005|Overall Study|Withdrawal by Subject|0|||
149874049|NCT02304458|540667210|FG006|Overall Study|Withdrawal by Subject|1|||
149874050|NCT02304458|540667211|FG007|Overall Study|Withdrawal by Subject|0|||
149874051|NCT01425723|540667212|FG000|Overall Study|Lack of Efficacy|0|||
149874052|NCT01425723|540667213|FG001|Overall Study|Lack of Efficacy|1|||
149874053|NCT01425723|540667212|FG000|Overall Study|Withdrawal by Subject|1|||
149874054|NCT01425723|540667213|FG001|Overall Study|Withdrawal by Subject|4|||
149874055|NCT01425723|540667212|FG000|Overall Study|Lost to Follow-up|0|||
149874056|NCT01425723|540667213|FG001|Overall Study|Lost to Follow-up|3|||
149874057|NCT01425723|540667212|FG000|Overall Study|Physician Decision|2|||
149874058|NCT01425723|540667213|FG001|Overall Study|Physician Decision|0|||
149874059|NCT01425723|540667212|FG000|Overall Study|Other|1|||
149874060|NCT01425723|540667213|FG001|Overall Study|Other|10|||
149874061|NCT00390221|540667214|FG000|Overall Study|Lost to Follow-up|0|||
149874062|NCT00390221|540667215|FG001|Overall Study|Lost to Follow-up|3|||
149874063|NCT00390221|540667216|FG002|Overall Study|Lost to Follow-up|0|||
149874064|NCT00390221|540667214|FG000|Overall Study|Adverse Event|1|||
149874065|NCT00390221|540667215|FG001|Overall Study|Adverse Event|4|||
149874066|NCT00390221|540667216|FG002|Overall Study|Adverse Event|3|||
149874067|NCT00390221|540667214|FG000|Overall Study|Investigator Decision|0|||
149874068|NCT00390221|540667215|FG001|Overall Study|Investigator Decision|0|||
149874069|NCT00390221|540667216|FG002|Overall Study|Investigator Decision|1|||
149874070|NCT00390221|540667214|FG000|Overall Study|Withdrawal by Subject|13|||
149874071|NCT00390221|540667215|FG001|Overall Study|Withdrawal by Subject|9|||
149874072|NCT00390221|540667216|FG002|Overall Study|Withdrawal by Subject|7|||
149874073|NCT00390221|540667214|FG000|Overall Study|Subject Non-compliance|1|||
149874074|NCT00390221|540667215|FG001|Overall Study|Subject Non-compliance|0|||
149874075|NCT00390221|540667216|FG002|Overall Study|Subject Non-compliance|2|||
150042858|NCT02284243|541295608|FG001|Overall Study|Adverse Event|0|||
150042859|NCT00541385|541295610|FG000|Overall Study|Adverse Event|6|||
150042860|NCT00541385|541295611|FG001|Overall Study|Adverse Event|3|||
149874076|NCT00390221|540667214|FG000|Overall Study|Other|3|||
149874077|NCT00390221|540667215|FG001|Overall Study|Other|4|||
149874078|NCT00390221|540667216|FG002|Overall Study|Other|2|||
149874079|NCT03365011|540667221|FG000|Overall Study|Withdrawal by Subject|1|||
149874080|NCT03365011|540667222|FG001|Overall Study|Withdrawal by Subject|2|||
150042861|NCT00541385|541295610|FG000|Overall Study|Withdrawal by Subject|2|||
149874081|NCT03582826|540667223|FG000|Overall Study|Lost to Follow-up|39|||
149874082|NCT03582826|540667224|FG001|Overall Study|Lost to Follow-up|0|||
149874083|NCT03582826|540667223|FG000|Overall Study|Withdrawal by Subject|2|||
150042862|NCT00541385|541295611|FG001|Overall Study|Withdrawal by Subject|2|||
149874084|NCT03582826|540667224|FG001|Overall Study|Withdrawal by Subject|0|||
149874085|NCT00319982|540667225|FG000|Overall Study|Withdrawal by Subject|1|||
149874086|NCT00319982|540667226|FG001|Overall Study|Withdrawal by Subject|0|||
149874087|NCT00761865|540667227|FG000|Overall Study|Lost to Follow-up|8|||
149874088|NCT00761865|540667228|FG001|Overall Study|Lost to Follow-up|7|||
149874089|NCT00758680|540667229|FG000|Overall Study|Adverse Event|0|||
149874090|NCT00758680|540667230|FG001|Overall Study|Adverse Event|0|||
150042863|NCT00541385|541295610|FG000|Overall Study|Lost to Follow-up|6|||
150042864|NCT00541385|541295611|FG001|Overall Study|Lost to Follow-up|1|||
150042865|NCT00541385|541295610|FG000|Overall Study|Parasite reappearance/malaria|67|||
150042866|NCT00541385|541295611|FG001|Overall Study|Parasite reappearance/malaria|32|||
150042867|NCT01733680|541295612|FG000|Overall Study|Withdrawal by Subject|0|||
150042868|NCT01733680|541295613|FG001|Overall Study|Withdrawal by Subject|1|||
149874091|NCT00758680|540667231|FG002|Overall Study|Adverse Event|0|||
150042869|NCT01932437|541295614|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
150042870|NCT01932437|541295615|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
150042871|NCT01932437|541295616|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
150042872|NCT01932437|541295617|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
150042873|NCT01932437|541295618|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
150042874|NCT01932437|541295619|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
149874092|NCT00758680|540667232|FG003|Overall Study|Adverse Event|0|||
149874093|NCT00758680|540667233|FG004|Overall Study|Adverse Event|0|||
149874094|NCT00758680|540667234|FG005|Overall Study|Adverse Event|0|||
149874095|NCT00758680|540667235|FG006|Overall Study|Adverse Event|0|||
149874096|NCT00758680|540667236|FG007|Overall Study|Adverse Event|1|||
149874097|NCT00758680|540667237|FG008|Overall Study|Adverse Event|0|||
149874098|NCT00758680|540667238|FG009|Overall Study|Adverse Event|1|||
149874099|NCT00758680|540667229|FG000|Overall Study|Laboratory Adverse Event|0|||
149874100|NCT00758680|540667230|FG001|Overall Study|Laboratory Adverse Event|0|||
150042875|NCT04269889|541295623|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
149874101|NCT00758680|540667231|FG002|Overall Study|Laboratory Adverse Event|0|||
149874102|NCT00758680|540667232|FG003|Overall Study|Laboratory Adverse Event|0|||
149874103|NCT00758680|540667233|FG004|Overall Study|Laboratory Adverse Event|0|||
149874104|NCT00758680|540667234|FG005|Overall Study|Laboratory Adverse Event|0|||
149874105|NCT00758680|540667235|FG006|Overall Study|Laboratory Adverse Event|0|||
149874106|NCT00758680|540667236|FG007|Overall Study|Laboratory Adverse Event|0|||
149874107|NCT00758680|540667237|FG008|Overall Study|Laboratory Adverse Event|1|||
149874108|NCT00758680|540667238|FG009|Overall Study|Laboratory Adverse Event|0|||
149874109|NCT00758680|540667229|FG000|Overall Study|Withdrawal by Subject|0|||
149874110|NCT00758680|540667230|FG001|Overall Study|Withdrawal by Subject|0|||
149874111|NCT00758680|540667231|FG002|Overall Study|Withdrawal by Subject|0|||
149874112|NCT00758680|540667232|FG003|Overall Study|Withdrawal by Subject|0|||
149874113|NCT00758680|540667233|FG004|Overall Study|Withdrawal by Subject|0|||
149874114|NCT00758680|540667234|FG005|Overall Study|Withdrawal by Subject|0|||
149874115|NCT00758680|540667235|FG006|Overall Study|Withdrawal by Subject|1|||
149874116|NCT00758680|540667236|FG007|Overall Study|Withdrawal by Subject|0|||
149874117|NCT00758680|540667237|FG008|Overall Study|Withdrawal by Subject|1|||
149874118|NCT00758680|540667238|FG009|Overall Study|Withdrawal by Subject|0|||
149874119|NCT01565850|540667246|FG000|Overall Study|Adverse Event|0|||
149874120|NCT01565850|540667247|FG001|Overall Study|Adverse Event|1|||
149874121|NCT01565850|540667246|FG000|Overall Study|Lost to Follow-up|12|||
149874122|NCT01565850|540667247|FG001|Overall Study|Lost to Follow-up|4|||
149874123|NCT01565850|540667246|FG000|Overall Study|Investigator's Discretion|2|||
149874124|NCT01565850|540667247|FG001|Overall Study|Investigator's Discretion|1|||
149874125|NCT01565850|540667246|FG000|Overall Study|Participant noncompliance|2|||
149874126|NCT01565850|540667247|FG001|Overall Study|Participant noncompliance|0|||
149874127|NCT01565850|540667246|FG000|Overall Study|Withdrew Consent|4|||
149874128|NCT01565850|540667247|FG001|Overall Study|Withdrew Consent|2|||
149874129|NCT05065567|540667248|FG000|Overall Study|Lost to Follow-up|10|||
149874130|NCT05065567|540667249|FG001|Overall Study|Lost to Follow-up|9|||
149874131|NCT05065567|540667250|FG002|Overall Study|Lost to Follow-up|6|||
149874132|NCT03665441|540669327|FG000|Overall Study|survival follow up ongoing|23|||
149874133|NCT03665441|540669328|FG001|Overall Study|survival follow up ongoing|0|||
149874134|NCT03665441|540669327|FG000|Overall Study|Patients ongoing on treatment|9|||
149874135|NCT03665441|540669328|FG001|Overall Study|Patients ongoing on treatment|6|||
149874136|NCT03665441|540669327|FG000|Overall Study|Randomized but not treated|7|||
149874137|NCT03665441|540669328|FG001|Overall Study|Randomized but not treated|11|||
149874138|NCT00663026|540669331|FG000|Overall Study|Lost to Follow-up|1|||
149874139|NCT00663026|540669332|FG001|Overall Study|Lost to Follow-up|0|||
149874140|NCT00663026|540669333|FG002|Overall Study|Lost to Follow-up|0|||
149874141|NCT00663026|540669331|FG000|Overall Study|Other|1|||
149874142|NCT00663026|540669332|FG001|Overall Study|Other|2|||
149874143|NCT00663026|540669333|FG002|Overall Study|Other|0|||
149874144|NCT00663026|540669331|FG000|Overall Study|Adverse Event|0|||
149874145|NCT00663026|540669332|FG001|Overall Study|Adverse Event|2|||
149874146|NCT00663026|540669333|FG002|Overall Study|Adverse Event|3|||
149874147|NCT00663026|540669331|FG000|Overall Study|Caregiver Request|0|||
149874148|NCT00663026|540669332|FG001|Overall Study|Caregiver Request|2|||
149874149|NCT00663026|540669333|FG002|Overall Study|Caregiver Request|0|||
149874150|NCT00663026|540669331|FG000|Overall Study|Withdrawal by Subject|0|||
149874151|NCT00663026|540669332|FG001|Overall Study|Withdrawal by Subject|0|||
149874152|NCT00663026|540669333|FG002|Overall Study|Withdrawal by Subject|1|||
149874153|NCT03783039|540669347|FG000|Overall Study|Death|2|||
149874154|NCT03783039|540669348|FG001|Overall Study|Death|1|||
149874155|NCT00918138|540669349|FG000|Overall Study|Subject withdrew consent|1|||
149874156|NCT00918138|540669350|FG001|Overall Study|Subject withdrew consent|1|||
149874157|NCT00918138|540669349|FG000|Overall Study|Death|1|||
149874158|NCT00918138|540669350|FG001|Overall Study|Death|0|||
149874159|NCT03972163|540669351|FG000|Overall Study|Death|0|||
149874160|NCT03972163|540669352|FG001|Overall Study|Death|1|||
149874161|NCT00837473|540669353|FG000|Overall Study|Lost to Follow-up|1|||
149874162|NCT00837473|540669353|FG000|Overall Study|Withdrawal by Subject|2|||
149874163|NCT03400943|540669354|FG000|Treatment Period 1|Adverse Event|0|||
149874164|NCT03400943|540669355|FG001|Treatment Period 1|Adverse Event|0|||
149874165|NCT03400943|540669356|FG002|Treatment Period 1|Adverse Event|0|||
149874166|NCT03400943|540669357|FG003|Treatment Period 1|Adverse Event|1|||
149874167|NCT03400943|540669354|FG000|Treatment Period 1|Lost to Follow-up|1|||
149874168|NCT03400943|540669355|FG001|Treatment Period 1|Lost to Follow-up|0|||
149874169|NCT03400943|540669356|FG002|Treatment Period 1|Lost to Follow-up|0|||
149874170|NCT03400943|540669357|FG003|Treatment Period 1|Lost to Follow-up|0|||
149874171|NCT03400943|540669354|FG000|Treatment Period 1|Protocol Violation|0|||
149874172|NCT03400943|540669355|FG001|Treatment Period 1|Protocol Violation|1|||
149874173|NCT03400943|540669356|FG002|Treatment Period 1|Protocol Violation|1|||
149874174|NCT03400943|540669357|FG003|Treatment Period 1|Protocol Violation|0|||
149874175|NCT03400943|540669354|FG000|Treatment Period 1|Study terminated by sponsor|2|||
149874176|NCT03400943|540669355|FG001|Treatment Period 1|Study terminated by sponsor|0|||
149874177|NCT03400943|540669356|FG002|Treatment Period 1|Study terminated by sponsor|0|||
149874178|NCT03400943|540669357|FG003|Treatment Period 1|Study terminated by sponsor|1|||
149874179|NCT03400943|540669354|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149874180|NCT03400943|540669355|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149874181|NCT03400943|540669356|FG002|Treatment Period 1|Withdrawal by Subject|3|||
149874182|NCT03400943|540669357|FG003|Treatment Period 1|Withdrawal by Subject|1|||
149874183|NCT03400943|540669354|FG000|Treatment Period 1|Other|2|||
149874184|NCT03400943|540669355|FG001|Treatment Period 1|Other|1|||
149874185|NCT03400943|540669356|FG002|Treatment Period 1|Other|2|||
149874186|NCT03400943|540669357|FG003|Treatment Period 1|Other|2|||
149874187|NCT03400943|540669354|FG000|Post-treatment Period 1|Adverse Event|2|||
149874188|NCT03400943|540669355|FG001|Post-treatment Period 1|Adverse Event|0|||
149874189|NCT03400943|540669356|FG002|Post-treatment Period 1|Adverse Event|0|||
149874190|NCT03400943|540669357|FG003|Post-treatment Period 1|Adverse Event|0|||
149874191|NCT03400943|540669354|FG000|Post-treatment Period 1|Protocol Violation|1|||
149874192|NCT03400943|540669355|FG001|Post-treatment Period 1|Protocol Violation|0|||
149874193|NCT03400943|540669356|FG002|Post-treatment Period 1|Protocol Violation|0|||
149874194|NCT03400943|540669357|FG003|Post-treatment Period 1|Protocol Violation|0|||
149874195|NCT03400943|540669354|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
149874196|NCT03400943|540669355|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
149874197|NCT03400943|540669356|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
149874198|NCT03400943|540669357|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
149874199|NCT03400943|540669354|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
149874200|NCT03400943|540669355|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
149874201|NCT03400943|540669356|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
149874202|NCT03400943|540669357|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
149874203|NCT03400943|540669354|FG000|Post-treatment Period 1|Other|2|||
150042876|NCT01526733|541295624|FG000|Phase 1|Protocol Violation|1|||
150042877|NCT01526733|541295625|FG001|Phase 1|Protocol Violation|0|||
149874204|NCT03400943|540669355|FG001|Post-treatment Period 1|Other|0|||
149874205|NCT03400943|540669356|FG002|Post-treatment Period 1|Other|4|||
149874206|NCT03400943|540669357|FG003|Post-treatment Period 1|Other|5|||
149874207|NCT03400943|540669354|FG000|Treatment Period 2|Study terminated by sponsor|0|||
150042878|NCT01526733|541295624|FG000|Phase 1|Withdrawal by Subject|1|||
150042879|NCT01526733|541295625|FG001|Phase 1|Withdrawal by Subject|1|||
149874208|NCT03400943|540669355|FG001|Treatment Period 2|Study terminated by sponsor|1|||
149874209|NCT03400943|540669356|FG002|Treatment Period 2|Study terminated by sponsor|0|||
150042880|NCT02699749|541295631|FG000|Overall Study|Other|0|||
150042881|NCT02699749|541295632|FG001|Overall Study|Other|0|||
150042882|NCT02699749|541295633|FG002|Overall Study|Other|2|||
150042883|NCT02699749|541295634|FG003|Overall Study|Other|0|||
149874210|NCT03400943|540669357|FG003|Treatment Period 2|Study terminated by sponsor|0|||
149874211|NCT03400943|540669354|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149874212|NCT03400943|540669355|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149874213|NCT03400943|540669356|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149874214|NCT03400943|540669357|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149874215|NCT03400943|540669354|FG000|Treatment Period 2|Other|1|||
149874216|NCT03400943|540669355|FG001|Treatment Period 2|Other|6|||
149874217|NCT03400943|540669356|FG002|Treatment Period 2|Other|0|||
149874218|NCT03400943|540669357|FG003|Treatment Period 2|Other|0|||
149874219|NCT03400943|540669354|FG000|Follow-up Period|Withdrawal by Subject|1|||
149874220|NCT03400943|540669355|FG001|Follow-up Period|Withdrawal by Subject|0|||
149874221|NCT03400943|540669356|FG002|Follow-up Period|Withdrawal by Subject|0|||
149874222|NCT03400943|540669357|FG003|Follow-up Period|Withdrawal by Subject|0|||
149874223|NCT00537303|540669358|FG000|Overall Study|Adverse Event|1|||
149874224|NCT00537303|540669359|FG001|Overall Study|Adverse Event|4|||
149874225|NCT00537303|540669358|FG000|Overall Study|Lack of Efficacy|6|||
149874226|NCT00537303|540669359|FG001|Overall Study|Lack of Efficacy|7|||
149874227|NCT00537303|540669358|FG000|Overall Study|Protocol Violation|8|||
149874228|NCT00537303|540669359|FG001|Overall Study|Protocol Violation|4|||
149874229|NCT00537303|540669358|FG000|Overall Study|Withdrawal criteria|3|||
149874230|NCT00537303|540669359|FG001|Overall Study|Withdrawal criteria|3|||
149874231|NCT00537303|540669358|FG000|Overall Study|Unclassified|8|||
149874232|NCT00537303|540669359|FG001|Overall Study|Unclassified|7|||
149874233|NCT03839823|540669360|FG000|Overall Study|Adverse Event|8|||
149874234|NCT03839823|540669361|FG001|Overall Study|Adverse Event|4|||
149874235|NCT03839823|540669360|FG000|Overall Study|Death|1|||
149874236|NCT03839823|540669361|FG001|Overall Study|Death|0|||
149874237|NCT03839823|540669360|FG000|Overall Study|Physician Decision|1|||
149874238|NCT03839823|540669361|FG001|Overall Study|Physician Decision|5|||
149874239|NCT03839823|540669360|FG000|Overall Study|Progressive Disease (PD)|65|||
149874240|NCT03839823|540669361|FG001|Overall Study|Progressive Disease (PD)|65|||
149874241|NCT03839823|540669360|FG000|Overall Study|Subject Decision|2|||
149874242|NCT03839823|540669361|FG001|Overall Study|Subject Decision|9|||
149874243|NCT03839823|540669360|FG000|Overall Study|Not Treated|0|||
149874244|NCT03839823|540669361|FG001|Overall Study|Not Treated|10|||
149874245|NCT03327792|540669362|FG000|Overall Study|Adverse Event|4|||
149874246|NCT03327792|540669363|FG001|Overall Study|Adverse Event|0|||
149874247|NCT03327792|540669362|FG000|Overall Study|Family/Personal issues|3|||
149874248|NCT03327792|540669363|FG001|Overall Study|Family/Personal issues|2|||
150042884|NCT02699749|541295635|FG004|Overall Study|Other|0|||
150042885|NCT02699749|541295636|FG005|Overall Study|Other|1|||
150042886|NCT02699749|541295637|FG006|Overall Study|Other|1|||
150042887|NCT02699749|541295638|FG007|Overall Study|Other|0|||
150042888|NCT02699749|541295639|FG008|Overall Study|Other|0|||
150042889|NCT02699749|541295640|FG009|Overall Study|Other|0|||
150042890|NCT02699749|541295641|FG010|Overall Study|Other|1|||
150042891|NCT02699749|541295642|FG011|Overall Study|Other|0|||
150042892|NCT02699749|541295643|FG012|Overall Study|Other|0|||
150042893|NCT02699749|541295644|FG013|Overall Study|Other|0|||
150042894|NCT02699749|541295631|FG000|Overall Study|Progressive Disease|3|||
150042895|NCT02699749|541295632|FG001|Overall Study|Progressive Disease|3|||
150042896|NCT02699749|541295633|FG002|Overall Study|Progressive Disease|14|||
150042897|NCT02699749|541295634|FG003|Overall Study|Progressive Disease|3|||
150042898|NCT02699749|541295635|FG004|Overall Study|Progressive Disease|3|||
150042899|NCT02699749|541295636|FG005|Overall Study|Progressive Disease|7|||
150042900|NCT02699749|541295637|FG006|Overall Study|Progressive Disease|5|||
150042901|NCT02699749|541295638|FG007|Overall Study|Progressive Disease|5|||
150042902|NCT02699749|541295639|FG008|Overall Study|Progressive Disease|6|||
149874249|NCT03327792|540669362|FG000|Overall Study|Lost to Follow-up|0|||
149874250|NCT03327792|540669363|FG001|Overall Study|Lost to Follow-up|1|||
149874251|NCT03511326|540669365|FG000|Overall Study|Withdrawal by Subject|1|||
149874252|NCT01305044|540669366|FG000|Overall Study|Withdrawal by Subject|3|||
149874253|NCT01305044|540669367|FG001|Overall Study|Withdrawal by Subject|6|||
149874254|NCT00849186|540669372|FG000|Overall Study|Adverse Event|2|||
149874255|NCT00849186|540669372|FG000|Overall Study|Withdrawal by Subject|1|||
149874256|NCT00849186|540669372|FG000|Overall Study|not treated|6|||
149874257|NCT00849186|540669372|FG000|Overall Study|Other|1|||
149874258|NCT00492024|540669373|FG000|Treatment|Adverse Event|3|||
149874259|NCT00492024|540669374|FG001|Treatment|Adverse Event|1|||
149874260|NCT00492024|540669373|FG000|Treatment|Lack of Efficacy|21|||
149874261|NCT00492024|540669374|FG001|Treatment|Lack of Efficacy|20|||
150042903|NCT02699749|541295640|FG009|Overall Study|Progressive Disease|6|||
150042904|NCT02699749|541295641|FG010|Overall Study|Progressive Disease|5|||
150042905|NCT02699749|541295642|FG011|Overall Study|Progressive Disease|4|||
150042906|NCT02699749|541295643|FG012|Overall Study|Progressive Disease|3|||
150042907|NCT02699749|541295644|FG013|Overall Study|Progressive Disease|5|||
150042908|NCT02699749|541295631|FG000|Overall Study|Death|0|||
150042909|NCT02699749|541295632|FG001|Overall Study|Death|0|||
150042910|NCT02699749|541295633|FG002|Overall Study|Death|0|||
149874262|NCT00492024|540669373|FG000|Treatment|Lost to Follow-up|3|||
149874263|NCT00492024|540669374|FG001|Treatment|Lost to Follow-up|1|||
149874264|NCT00492024|540669373|FG000|Treatment|Withdrawal by Subject|2|||
149874265|NCT00492024|540669374|FG001|Treatment|Withdrawal by Subject|0|||
149874266|NCT00492024|540669373|FG000|Follow up|Lack of Efficacy|0|||
149874267|NCT00492024|540669374|FG001|Follow up|Lack of Efficacy|1|||
149874268|NCT00492024|540669373|FG000|Follow up|Lost to Follow-up|1|||
149874269|NCT00492024|540669374|FG001|Follow up|Lost to Follow-up|1|||
149874270|NCT00867503|540669383|FG000|Overall Study|Withdrawal by Subject|1|||
149874271|NCT02704403|540669384|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
149874272|NCT02704403|540669385|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
149874273|NCT02704403|540669384|FG000|Overall Study|Administrative reasons by sponsor|1251|||
149874274|NCT02704403|540669385|FG001|Overall Study|Administrative reasons by sponsor|616|||
149874275|NCT02704403|540669384|FG000|Overall Study|Death|4|||
149874276|NCT02704403|540669385|FG001|Overall Study|Death|3|||
149874277|NCT02704403|540669384|FG000|Overall Study|Endpoint event|52|||
149874278|NCT02704403|540669385|FG001|Overall Study|Endpoint event|24|||
149874279|NCT02704403|540669384|FG000|Overall Study|Lost to Follow-up|22|||
149874280|NCT02704403|540669385|FG001|Overall Study|Lost to Follow-up|11|||
149874281|NCT02704403|540669384|FG000|Overall Study|Protocol Violation|15|||
149874282|NCT02704403|540669385|FG001|Overall Study|Protocol Violation|15|||
149874283|NCT02704403|540669384|FG000|Overall Study|Adverse Event|2|||
149874284|NCT02704403|540669385|FG001|Overall Study|Adverse Event|0|||
149874285|NCT02704403|540669384|FG000|Overall Study|Withdrawal by Subject|85|||
149874286|NCT02704403|540669385|FG001|Overall Study|Withdrawal by Subject|45|||
149874287|NCT02704403|540669384|FG000|Overall Study|Investigator decision|1|||
149874288|NCT02704403|540669385|FG001|Overall Study|Investigator decision|1|||
149874289|NCT02704403|540669384|FG000|Overall Study|Follow-up not possible|1|||
149874290|NCT02704403|540669385|FG001|Overall Study|Follow-up not possible|2|||
149874291|NCT01844856|540669394|FG000|Overall Study|Lost to Follow-up|15|||
149874292|NCT01844856|540669395|FG001|Overall Study|Lost to Follow-up|3|||
149874293|NCT01844856|540669394|FG000|Overall Study|Adverse Event|3|||
149963810|NCT02037984|541001551|FG004|Overall Study|Protocol Violation|0|||
149963811|NCT02037984|541001552|FG005|Overall Study|Protocol Violation|1|||
149963812|NCT02037984|541001553|FG006|Overall Study|Protocol Violation|2|||
149963813|NCT02037984|541001554|FG007|Overall Study|Protocol Violation|0|||
149963814|NCT02037984|541001547|FG000|Overall Study|Technical Problems|0|||
149963815|NCT02037984|541001548|FG001|Overall Study|Technical Problems|0|||
149963816|NCT02037984|541001549|FG002|Overall Study|Technical Problems|3|||
149963817|NCT02037984|541001550|FG003|Overall Study|Technical Problems|3|||
149963818|NCT02037984|541001551|FG004|Overall Study|Technical Problems|2|||
149963819|NCT02037984|541001552|FG005|Overall Study|Technical Problems|3|||
149963820|NCT02037984|541001553|FG006|Overall Study|Technical Problems|4|||
149963821|NCT02037984|541001554|FG007|Overall Study|Technical Problems|2|||
149963822|NCT02037984|541001547|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149963823|NCT02037984|541001548|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149963824|NCT02037984|541001549|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
149963825|NCT02037984|541001550|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
149963826|NCT02037984|541001551|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
149963827|NCT02037984|541001552|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
149963828|NCT02037984|541001553|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
149963829|NCT02037984|541001554|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
149963830|NCT02037984|541001547|FG000|Overall Study|Withdrawal by Subject|0|||
149963831|NCT02037984|541001548|FG001|Overall Study|Withdrawal by Subject|0|||
149963832|NCT02037984|541001549|FG002|Overall Study|Withdrawal by Subject|0|||
149963833|NCT02037984|541001550|FG003|Overall Study|Withdrawal by Subject|1|||
149874294|NCT01844856|540669395|FG001|Overall Study|Adverse Event|6|||
149874295|NCT01844856|540669394|FG000|Overall Study|Withdrawal by Subject|3|||
149963834|NCT02037984|541001551|FG004|Overall Study|Withdrawal by Subject|1|||
149963835|NCT02037984|541001552|FG005|Overall Study|Withdrawal by Subject|3|||
149963836|NCT02037984|541001553|FG006|Overall Study|Withdrawal by Subject|0|||
149963837|NCT02037984|541001554|FG007|Overall Study|Withdrawal by Subject|1|||
149963838|NCT00974233|541001558|FG000|Induction Chemoimmunotherapy|Death|2|||
149874296|NCT01844856|540669395|FG001|Overall Study|Withdrawal by Subject|2|||
149874297|NCT01844856|540669394|FG000|Overall Study|Noncompliance|2|||
149874298|NCT01844856|540669395|FG001|Overall Study|Noncompliance|3|||
149874299|NCT01844856|540669394|FG000|Overall Study|Enterococcus Resistant|0|||
149874300|NCT01844856|540669395|FG001|Overall Study|Enterococcus Resistant|1|||
149874301|NCT01844856|540669394|FG000|Overall Study|Inadvertently Not Scheduled|1|||
149874302|NCT01844856|540669395|FG001|Overall Study|Inadvertently Not Scheduled|0|||
149874303|NCT01844856|540669394|FG000|Overall Study|Randomized but was a Screen Failure|0|||
149874304|NCT01844856|540669395|FG001|Overall Study|Randomized but was a Screen Failure|1|||
149874305|NCT01001988|540669396|FG000|Overall Study|Protocol Violation|84|||
149874306|NCT01001988|540669396|FG000|Overall Study|Withdrawal by Subject|18|||
149874307|NCT01001988|540669396|FG000|Overall Study|Lost to Follow-up|15|||
149874308|NCT03421730|540669400|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874309|NCT03421730|540669401|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
149874310|NCT03421730|540669402|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874311|NCT03421730|540669403|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874312|NCT03421730|540669404|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874313|NCT03421730|540669405|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874314|NCT03421730|540669406|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874315|NCT03421730|540669407|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874316|NCT03421730|540669408|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874317|NCT03421730|540669409|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874318|NCT03421730|540669410|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874319|NCT03421730|540669411|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
149874320|NCT03421730|540669400|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874321|NCT03421730|540669401|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874322|NCT03421730|540669402|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874323|NCT03421730|540669403|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874324|NCT03421730|540669404|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
149874325|NCT03421730|540669405|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874326|NCT03421730|540669406|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874327|NCT03421730|540669407|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874328|NCT03421730|540669408|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874329|NCT03421730|540669409|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874330|NCT03421730|540669410|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874331|NCT03421730|540669411|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
149874332|NCT02901548|540669412|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
149874333|NCT01338870|540669420|FG000|Overall Study|Lost to Follow-up|0|||
149874334|NCT01338870|540669421|FG001|Overall Study|Lost to Follow-up|0|||
149874335|NCT01338870|540669422|FG002|Overall Study|Lost to Follow-up|1|||
149963839|NCT00974233|541001558|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
149963840|NCT00974233|541001558|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
149963841|NCT00974233|541001558|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
149963842|NCT00974233|541001558|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
150042911|NCT02699749|541295634|FG003|Overall Study|Death|0|||
150042912|NCT02699749|541295635|FG004|Overall Study|Death|0|||
150042913|NCT02699749|541295636|FG005|Overall Study|Death|0|||
150042914|NCT02699749|541295637|FG006|Overall Study|Death|0|||
150042915|NCT02699749|541295638|FG007|Overall Study|Death|0|||
150042916|NCT02699749|541295639|FG008|Overall Study|Death|0|||
150042917|NCT02699749|541295640|FG009|Overall Study|Death|0|||
150042918|NCT02699749|541295641|FG010|Overall Study|Death|0|||
150042919|NCT02699749|541295642|FG011|Overall Study|Death|0|||
150042920|NCT02699749|541295643|FG012|Overall Study|Death|0|||
150042921|NCT02699749|541295644|FG013|Overall Study|Death|1|||
150042922|NCT02699749|541295631|FG000|Overall Study|Lost to Follow-up|0|||
150042923|NCT02699749|541295632|FG001|Overall Study|Lost to Follow-up|0|||
150042924|NCT02699749|541295633|FG002|Overall Study|Lost to Follow-up|0|||
150042925|NCT02699749|541295634|FG003|Overall Study|Lost to Follow-up|0|||
150042926|NCT02699749|541295635|FG004|Overall Study|Lost to Follow-up|0|||
150042927|NCT02699749|541295636|FG005|Overall Study|Lost to Follow-up|1|||
150042928|NCT02699749|541295637|FG006|Overall Study|Lost to Follow-up|0|||
150042929|NCT02699749|541295638|FG007|Overall Study|Lost to Follow-up|1|||
150042930|NCT02699749|541295639|FG008|Overall Study|Lost to Follow-up|0|||
150042931|NCT02699749|541295640|FG009|Overall Study|Lost to Follow-up|0|||
150042932|NCT02699749|541295641|FG010|Overall Study|Lost to Follow-up|0|||
149874336|NCT01338870|540669423|FG003|Overall Study|Lost to Follow-up|0|||
149874337|NCT01338870|540669424|FG004|Overall Study|Lost to Follow-up|1|||
149874338|NCT01338870|540669425|FG005|Overall Study|Lost to Follow-up|0|||
149874339|NCT01338870|540669420|FG000|Overall Study|Withdrawal by Subject|2|||
149874340|NCT01338870|540669421|FG001|Overall Study|Withdrawal by Subject|3|||
149874341|NCT01338870|540669422|FG002|Overall Study|Withdrawal by Subject|4|||
149874342|NCT01338870|540669423|FG003|Overall Study|Withdrawal by Subject|0|||
149874343|NCT01338870|540669424|FG004|Overall Study|Withdrawal by Subject|0|||
149874344|NCT01338870|540669425|FG005|Overall Study|Withdrawal by Subject|2|||
149874345|NCT01338870|540669420|FG000|Overall Study|Other|3|||
149874346|NCT01338870|540669421|FG001|Overall Study|Other|3|||
149874347|NCT01338870|540669422|FG002|Overall Study|Other|3|||
149874348|NCT01338870|540669423|FG003|Overall Study|Other|2|||
149874349|NCT01338870|540669424|FG004|Overall Study|Other|0|||
149874350|NCT01338870|540669425|FG005|Overall Study|Other|2|||
149874351|NCT01338870|540669420|FG000|Overall Study|Protocol Violation|0|||
149874352|NCT01338870|540669421|FG001|Overall Study|Protocol Violation|2|||
149874353|NCT01338870|540669422|FG002|Overall Study|Protocol Violation|2|||
149874354|NCT01338870|540669423|FG003|Overall Study|Protocol Violation|2|||
149874355|NCT01338870|540669424|FG004|Overall Study|Protocol Violation|1|||
149874356|NCT01338870|540669425|FG005|Overall Study|Protocol Violation|1|||
149874357|NCT01338870|540669420|FG000|Overall Study|Adverse Event|4|||
149874358|NCT01338870|540669421|FG001|Overall Study|Adverse Event|4|||
149874359|NCT01338870|540669422|FG002|Overall Study|Adverse Event|1|||
149874360|NCT01338870|540669423|FG003|Overall Study|Adverse Event|5|||
149874361|NCT01338870|540669424|FG004|Overall Study|Adverse Event|4|||
149874362|NCT01338870|540669425|FG005|Overall Study|Adverse Event|1|||
149874363|NCT01955083|540669428|FG000|Overall Study|Lost to Follow-up|1|||
149874364|NCT01955083|540669429|FG001|Overall Study|Lost to Follow-up|1|||
149874365|NCT01559389|540669440|FG000|Overall Study|Withdrawal by Subject|20|||
149874366|NCT01559389|540669441|FG001|Overall Study|Withdrawal by Subject|20|||
149874367|NCT02871492|540669442|FG000|Overall Study|Lost to Follow-up|6|||
149874368|NCT02871492|540669443|FG001|Overall Study|Lost to Follow-up|3|||
149874369|NCT02871492|540669444|FG002|Overall Study|Lost to Follow-up|5|||
149874370|NCT02871492|540669442|FG000|Overall Study|Withdrawal by Subject|0|||
149874371|NCT02871492|540669443|FG001|Overall Study|Withdrawal by Subject|0|||
149874372|NCT02871492|540669444|FG002|Overall Study|Withdrawal by Subject|1|||
149874373|NCT04546724|540669445|FG000|Overall Study|Withdrawal by Subject|145|||
149874374|NCT04546724|540669446|FG001|Overall Study|Withdrawal by Subject|41|||
149874375|NCT04546724|540669445|FG000|Overall Study|Adverse Event|1|||
149874376|NCT04546724|540669446|FG001|Overall Study|Adverse Event|1|||
149874377|NCT04546724|540669445|FG000|Overall Study|Lost to Follow-up|186|||
149874378|NCT04546724|540669446|FG001|Overall Study|Lost to Follow-up|63|||
149874379|NCT04546724|540669445|FG000|Overall Study|Physician Decision|8|||
149874380|NCT04546724|540669446|FG001|Overall Study|Physician Decision|2|||
149874381|NCT04546724|540669445|FG000|Overall Study|Death|2|||
150042933|NCT02699749|541295642|FG011|Overall Study|Lost to Follow-up|0|||
150042934|NCT02699749|541295643|FG012|Overall Study|Lost to Follow-up|0|||
150042935|NCT02699749|541295644|FG013|Overall Study|Lost to Follow-up|0|||
150042936|NCT02377817|541295645|FG000|Overall Study|Transportation/childcare barriers.|2|||
150042937|NCT02377817|541295646|FG001|Overall Study|Transportation/childcare barriers.|0|||
150042938|NCT02377817|541295645|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
150042939|NCT02377817|541295646|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
150042940|NCT02839200|541295647|FG000|Overall Study|Withdrawal by Subject|2|||
149874382|NCT04546724|540669446|FG001|Overall Study|Death|1|||
149874383|NCT04546724|540669445|FG000|Overall Study|subject has been out of town|1|||
149874384|NCT04546724|540669446|FG001|Overall Study|subject has been out of town|0|||
149874385|NCT04546724|540669445|FG000|Overall Study|subject is incarcerated|2|||
149874386|NCT04546724|540669446|FG001|Overall Study|subject is incarcerated|0|||
149874387|NCT04546724|540669445|FG000|Overall Study|subject is relocating|12|||
149874388|NCT04546724|540669446|FG001|Overall Study|subject is relocating|4|||
150174144|NCT00630786|541773034|FG000|Overall Study|Lost to Follow-up|0|||
150174145|NCT00630786|541773035|FG001|Overall Study|Lost to Follow-up|1|||
149874389|NCT04546724|540669445|FG000|Overall Study|Subject in another study|1|||
149874390|NCT04546724|540669446|FG001|Overall Study|Subject in another study|1|||
149874391|NCT03583086|540669447|FG000|Overall Study|Death|2|||
149874392|NCT03583086|540669448|FG001|Overall Study|Death|6|||
149874393|NCT03583086|540669449|FG002|Overall Study|Death|12|||
149874394|NCT03583086|540669450|FG003|Overall Study|Death|10|||
149874395|NCT03583086|540669451|FG004|Overall Study|Death|14|||
149874396|NCT03583086|540669452|FG005|Overall Study|Death|14|||
149874397|NCT03583086|540669453|FG006|Overall Study|Death|4|||
149874398|NCT03583086|540669447|FG000|Overall Study|Withdrawal by Subject|0|||
149874399|NCT03583086|540669448|FG001|Overall Study|Withdrawal by Subject|0|||
149874400|NCT03583086|540669449|FG002|Overall Study|Withdrawal by Subject|1|||
149874401|NCT03583086|540669450|FG003|Overall Study|Withdrawal by Subject|0|||
149874402|NCT03583086|540669451|FG004|Overall Study|Withdrawal by Subject|0|||
149874403|NCT03583086|540669452|FG005|Overall Study|Withdrawal by Subject|0|||
149874404|NCT03583086|540669453|FG006|Overall Study|Withdrawal by Subject|1|||
149874405|NCT03583086|540669447|FG000|Overall Study|Refused follow-up|0|||
149874406|NCT03583086|540669448|FG001|Overall Study|Refused follow-up|0|||
149874407|NCT03583086|540669449|FG002|Overall Study|Refused follow-up|1|||
149874408|NCT03583086|540669450|FG003|Overall Study|Refused follow-up|0|||
149874409|NCT03583086|540669451|FG004|Overall Study|Refused follow-up|1|||
149874410|NCT03583086|540669452|FG005|Overall Study|Refused follow-up|0|||
149874411|NCT03583086|540669453|FG006|Overall Study|Refused follow-up|0|||
149874412|NCT03583086|540669447|FG000|Overall Study|Declining Performance Status|0|||
149874413|NCT03583086|540669448|FG001|Overall Study|Declining Performance Status|0|||
149874414|NCT03583086|540669449|FG002|Overall Study|Declining Performance Status|1|||
149874415|NCT03583086|540669450|FG003|Overall Study|Declining Performance Status|0|||
149874416|NCT03583086|540669451|FG004|Overall Study|Declining Performance Status|0|||
149874417|NCT03583086|540669452|FG005|Overall Study|Declining Performance Status|0|||
149874418|NCT03583086|540669453|FG006|Overall Study|Declining Performance Status|0|||
149874419|NCT03583086|540669447|FG000|Overall Study|Still on study|0|||
149874420|NCT03583086|540669448|FG001|Overall Study|Still on study|0|||
149874421|NCT03583086|540669449|FG002|Overall Study|Still on study|0|||
149874422|NCT03583086|540669450|FG003|Overall Study|Still on study|1|||
149874423|NCT03583086|540669451|FG004|Overall Study|Still on study|0|||
149874424|NCT03583086|540669452|FG005|Overall Study|Still on study|0|||
149874425|NCT03583086|540669453|FG006|Overall Study|Still on study|1|||
149874426|NCT03583086|540669447|FG000|Overall Study|Disease progression|0|||
149874427|NCT03583086|540669448|FG001|Overall Study|Disease progression|0|||
149874428|NCT03583086|540669449|FG002|Overall Study|Disease progression|0|||
149874429|NCT03583086|540669450|FG003|Overall Study|Disease progression|0|||
149874430|NCT03583086|540669451|FG004|Overall Study|Disease progression|0|||
149874431|NCT03583086|540669452|FG005|Overall Study|Disease progression|0|||
149874432|NCT03583086|540669453|FG006|Overall Study|Disease progression|1|||
149874433|NCT03583086|540669447|FG000|Overall Study|Undergoing radiation therapy|0|||
149874434|NCT03583086|540669448|FG001|Overall Study|Undergoing radiation therapy|0|||
149874435|NCT03583086|540669449|FG002|Overall Study|Undergoing radiation therapy|0|||
149874436|NCT03583086|540669450|FG003|Overall Study|Undergoing radiation therapy|0|||
149874437|NCT03583086|540669451|FG004|Overall Study|Undergoing radiation therapy|0|||
149874438|NCT03583086|540669452|FG005|Overall Study|Undergoing radiation therapy|0|||
149874439|NCT03583086|540669453|FG006|Overall Study|Undergoing radiation therapy|1|||
149874440|NCT03583086|540669447|FG000|Overall Study|Lost to Follow-up|0|||
149874441|NCT03583086|540669448|FG001|Overall Study|Lost to Follow-up|0|||
149874442|NCT03583086|540669449|FG002|Overall Study|Lost to Follow-up|0|||
149874443|NCT03583086|540669450|FG003|Overall Study|Lost to Follow-up|0|||
149874444|NCT03583086|540669451|FG004|Overall Study|Lost to Follow-up|0|||
149874445|NCT03583086|540669452|FG005|Overall Study|Lost to Follow-up|1|||
149874446|NCT03583086|540669453|FG006|Overall Study|Lost to Follow-up|0|||
149874447|NCT03583086|540669447|FG000|Overall Study|Adverse Event|0|||
149874448|NCT03583086|540669448|FG001|Overall Study|Adverse Event|0|||
149874449|NCT03583086|540669449|FG002|Overall Study|Adverse Event|0|||
149874450|NCT03583086|540669450|FG003|Overall Study|Adverse Event|0|||
149874451|NCT03583086|540669451|FG004|Overall Study|Adverse Event|0|||
149874452|NCT03583086|540669452|FG005|Overall Study|Adverse Event|1|||
149874453|NCT03583086|540669453|FG006|Overall Study|Adverse Event|0|||
149874454|NCT00396812|540669457|FG000|Overall Study|Physician Decision|1|||
149963843|NCT00974233|541001558|FG000|Maintenance Lenalidomide|Adverse Event|8|||
149963844|NCT01691092|541001559|FG000|Overall Study|Lost to Follow-up|10|||
149874455|NCT03201445|540669459|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
149874456|NCT03201445|540669460|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
149874457|NCT03201445|540669459|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
149874458|NCT03201445|540669460|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
149874459|NCT03201445|540669459|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
149874460|NCT03201445|540669460|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
149874461|NCT03201445|540669459|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
149874462|NCT03201445|540669460|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
149874463|NCT03201445|540669459|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
149874464|NCT03201445|540669460|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
149874465|NCT03201445|540669459|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
149874466|NCT03201445|540669460|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
149874467|NCT03201445|540669459|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
149874468|NCT03201445|540669460|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
149874469|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
149874470|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
149874471|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
149874472|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
149874473|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
149874474|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
149874475|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
149874476|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
149874477|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
149874478|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
149874479|NCT03201445|540669459|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
149874480|NCT03201445|540669460|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
149874481|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
149874482|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
149874483|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
149874484|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
149874485|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
149874486|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
149874487|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
149874488|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
149874489|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
149874490|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
149874491|NCT03201445|540669459|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
149874492|NCT03201445|540669460|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
149874493|NCT03201445|540669459|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
149874494|NCT03201445|540669460|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
149874495|NCT03201445|540669459|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
149874496|NCT03201445|540669460|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
149874497|NCT01228019|540669461|FG000|Overall Study|Dose Violation|70|||
149874498|NCT01228019|540669461|FG000|Overall Study|Duplicate enrollment|1|||
149874499|NCT01228019|540669461|FG000|Overall Study|Missing pre-treatment data|72|||
149874500|NCT01228019|540669461|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
149874501|NCT01228019|540669461|FG000|Overall Study|Violation of Entry Criterion|9|||
149874502|NCT01346293|540669464|FG000|Overall Study|Protocol Violation|30|||
149874503|NCT01346293|540669465|FG001|Overall Study|Protocol Violation|9|||
149874504|NCT01346293|540669464|FG000|Overall Study|Lost to Follow-up|21|||
149874505|NCT01346293|540669465|FG001|Overall Study|Lost to Follow-up|8|||
149874506|NCT01346293|540669464|FG000|Overall Study|Withdrawal by Subject|15|||
149874507|NCT01346293|540669465|FG001|Overall Study|Withdrawal by Subject|4|||
149874508|NCT01346293|540669464|FG000|Overall Study|Other|1|||
149874509|NCT01346293|540669465|FG001|Overall Study|Other|0|||
149874510|NCT01844505|540669468|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
149874511|NCT01844505|540669469|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
149874512|NCT01844505|540669470|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
149874513|NCT01844505|540669468|FG000|Treatment Period|Other Reasons|120|||
149874514|NCT01844505|540669469|FG001|Treatment Period|Other Reasons|136|||
149874515|NCT01844505|540669470|FG002|Treatment Period|Other Reasons|58|||
149874516|NCT01844505|540669468|FG000|Treatment Period|Lost to Follow-up|9|||
149874517|NCT01844505|540669469|FG001|Treatment Period|Lost to Follow-up|11|||
149874518|NCT01844505|540669470|FG002|Treatment Period|Lost to Follow-up|6|||
149874519|NCT01844505|540669468|FG000|Treatment Period|Death|175|||
149874520|NCT01844505|540669469|FG001|Treatment Period|Death|154|||
149874521|NCT01844505|540669470|FG002|Treatment Period|Death|228|||
149874522|NCT02730351|540669471|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
149874523|NCT02730351|540669472|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
149874524|NCT02730351|540669471|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
149874525|NCT02730351|540669472|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
149874526|NCT02730351|540669471|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
149874527|NCT02730351|540669472|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
149874528|NCT02730351|540669471|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
149874529|NCT02730351|540669472|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
149874530|NCT02730351|540669471|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
149874531|NCT02730351|540669472|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
149874532|NCT00128830|540669473|FG000|Overall Study|Adverse Event|10|||
149874533|NCT00128830|540669473|FG000|Overall Study|Withdrawal by Subject|14|||
149874534|NCT00128830|540669473|FG000|Overall Study|Lost to Follow-up|4|||
149874535|NCT00128830|540669473|FG000|Overall Study|Reached a virologic endpoint|29|||
149874536|NCT00128830|540669473|FG000|Overall Study|Non-compliant|4|||
149874537|NCT00128830|540669473|FG000|Overall Study|Discontinued or ineligible for study|2|||
149874538|NCT00128830|540669473|FG000|Overall Study|Other|9|||
149874539|NCT00311402|540669474|FG000|Overall Study|Adverse Event|118|||
149874540|NCT00311402|540669475|FG001|Overall Study|Adverse Event|105|||
149874541|NCT00311402|540669474|FG000|Overall Study|Lost to Follow-up|0|||
149874542|NCT00311402|540669475|FG001|Overall Study|Lost to Follow-up|3|||
149874543|NCT00311402|540669474|FG000|Overall Study|Withdrawal by Subject|17|||
149874544|NCT00311402|540669475|FG001|Overall Study|Withdrawal by Subject|18|||
149874545|NCT00311402|540669474|FG000|Overall Study|Lack of Efficacy|58|||
149874546|NCT00311402|540669475|FG001|Overall Study|Lack of Efficacy|42|||
149874547|NCT00311402|540669474|FG000|Overall Study|Protocol Violation|7|||
149874548|NCT00311402|540669475|FG001|Overall Study|Protocol Violation|6|||
149874549|NCT00311402|540669474|FG000|Overall Study|IRB's rejection etc.|10|||
149874550|NCT00311402|540669475|FG001|Overall Study|IRB's rejection etc.|3|||
149874551|NCT00838435|540669476|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
149874552|NCT00838435|540669476|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
149874553|NCT00838435|540669476|FG000|Part 2 (7 Years)|Adverse Event|2|||
149874554|NCT00838435|540669476|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
149874555|NCT00838435|540669476|FG000|Part 2 (7 Years)|Physician Decision|1|||
149874556|NCT00838435|540669476|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
149874557|NCT00838435|540669476|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
149874558|NCT02640053|540669477|FG000|Overall Study|Withdrawal by Subject|2|||
149874559|NCT02640053|540669478|FG001|Overall Study|Withdrawal by Subject|1|||
149874560|NCT02640053|540669477|FG000|Overall Study|Adverse Event|1|||
149874561|NCT02640053|540669478|FG001|Overall Study|Adverse Event|1|||
149874562|NCT02640053|540669477|FG000|Overall Study|Alternative Therapy|1|||
149874563|NCT02640053|540669478|FG001|Overall Study|Alternative Therapy|1|||
149874564|NCT02640053|540669477|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
149874565|NCT02640053|540669478|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
149874566|NCT01268501|540669480|FG000|Overall Study|Lost to Follow-up|1|||
149874567|NCT01268501|540669480|FG000|Overall Study|Withdrawal by Subject|3|||
149874568|NCT01268501|540669480|FG000|Overall Study|Unacceptable Subjective Vision|3|||
149874569|NCT01268501|540669480|FG000|Overall Study|Handling Difficulties|2|||
149874570|NCT02754856|540669484|FG000|Overall Study|Withdrawal by Subject|1|||
149874571|NCT04874155|540669485|FG000|Overall Study|Lost to Follow-up|1|||
149874572|NCT04874155|540669486|FG001|Overall Study|Lost to Follow-up|1|||
149874573|NCT04874155|540669485|FG000|Overall Study|Withdrawal by Subject|2|||
149874574|NCT04874155|540669486|FG001|Overall Study|Withdrawal by Subject|2|||
149874575|NCT00530218|540669489|FG000|Overall Study|CMV Not Detected|13|||
149874576|NCT00530218|540669489|FG000|Overall Study|Death|12|||
149874577|NCT00678886|540669490|FG000|Overall Study|Withdrawal by Subject|0|||
149874578|NCT00678886|540669491|FG001|Overall Study|Withdrawal by Subject|0|||
149874579|NCT00678886|540669492|FG002|Overall Study|Withdrawal by Subject|4|||
149874580|NCT00678886|540669493|FG003|Overall Study|Withdrawal by Subject|6|||
149874581|NCT00678886|540669490|FG000|Overall Study|Physician Decision|0|||
149874582|NCT00678886|540669491|FG001|Overall Study|Physician Decision|0|||
149874583|NCT00678886|540669492|FG002|Overall Study|Physician Decision|1|||
149874584|NCT00678886|540669493|FG003|Overall Study|Physician Decision|1|||
149874585|NCT00678886|540669490|FG000|Overall Study|Lost to Follow-up|0|||
149874586|NCT00678886|540669491|FG001|Overall Study|Lost to Follow-up|0|||
149874587|NCT00678886|540669492|FG002|Overall Study|Lost to Follow-up|3|||
149874588|NCT00678886|540669493|FG003|Overall Study|Lost to Follow-up|2|||
149874589|NCT00678886|540669490|FG000|Overall Study|Other|0|||
149874590|NCT00678886|540669491|FG001|Overall Study|Other|0|||
149874591|NCT00678886|540669492|FG002|Overall Study|Other|1|||
149874592|NCT00678886|540669493|FG003|Overall Study|Other|0|||
149874593|NCT03477903|540669494|FG000|Overall Study|Study Terminated by Sponsor|1|||
149874594|NCT01147107|540669495|FG000|Overall Study|Lack of Efficacy|5|||
149874595|NCT01147107|540669496|FG001|Overall Study|Lack of Efficacy|0|||
149874596|NCT01147107|540669495|FG000|Overall Study|Withdrawal by Subject|1|||
149874597|NCT01147107|540669496|FG001|Overall Study|Withdrawal by Subject|1|||
149874598|NCT03480386|540669499|FG000|Overall Study|Did not complete measures at 3-months|17|||
149874599|NCT03480386|540669500|FG001|Overall Study|Did not complete measures at 3-months|14|||
149874600|NCT03480386|540669499|FG000|Overall Study|No baseline measures|11|||
149874601|NCT03480386|540669500|FG001|Overall Study|No baseline measures|14|||
149874602|NCT03480386|540669499|FG000|Overall Study|Death|0|||
149874603|NCT03480386|540669500|FG001|Overall Study|Death|5|||
149874604|NCT03480386|540669499|FG000|Overall Study|Withdrawal by Subject|12|||
149874605|NCT03480386|540669500|FG001|Overall Study|Withdrawal by Subject|8|||
149874606|NCT03480386|540669499|FG000|Overall Study|Lost to Follow-up|2|||
149874607|NCT03480386|540669500|FG001|Overall Study|Lost to Follow-up|1|||
149874608|NCT03480386|540669499|FG000|Overall Study|Complicating disease|0|||
149874609|NCT03480386|540669500|FG001|Overall Study|Complicating disease|1|||
149874610|NCT03480386|540669499|FG000|Overall Study|Disease progression|3|||
149874611|NCT03480386|540669500|FG001|Overall Study|Disease progression|0|||
149874612|NCT03480386|540669499|FG000|Overall Study|Became ineligible|0|||
149874613|NCT03480386|540669500|FG001|Overall Study|Became ineligible|2|||
149874614|NCT00574912|540669501|FG000|Overall Study|Could not place IV lines.|3|||
149874615|NCT00574912|540669501|FG000|Overall Study|scheduling conflicts|3|||
149874616|NCT00574912|540669501|FG000|Overall Study|Physician Decision|2|||
149874617|NCT04730349|540669504|FG000|Overall Study|Participant withdrew consent|1|||
149874618|NCT04730349|540669505|FG001|Overall Study|Participant withdrew consent|0|||
149874619|NCT04730349|540669504|FG000|Overall Study|Disease progression|6|||
149874620|NCT04730349|540669505|FG001|Overall Study|Disease progression|4|||
149874621|NCT04730349|540669504|FG000|Overall Study|Study drug toxicity|0|||
149874622|NCT04730349|540669505|FG001|Overall Study|Study drug toxicity|1|||
149874623|NCT03155945|540669508|FG000|Overall Study|Lost to Follow-up|0|||
149963845|NCT01691092|541001559|FG000|Overall Study|Physician Decision|4|||
149963846|NCT01691092|541001559|FG000|Overall Study|Withdrawal by Subject|3|||
149963847|NCT01691092|541001559|FG000|Overall Study|non-compliance|3|||
149963848|NCT01691092|541001559|FG000|Overall Study|used for different study|2|||
149874624|NCT03155945|540669509|FG001|Overall Study|Lost to Follow-up|1|||
149963849|NCT01691092|541001559|FG000|Overall Study|screen fail|19|||
149874625|NCT03155945|540669508|FG000|Overall Study|Withdrawal by Subject|0|||
149874626|NCT03155945|540669509|FG001|Overall Study|Withdrawal by Subject|1|||
149874627|NCT03155945|540669508|FG000|Overall Study|Other Reason|0|||
149874628|NCT03155945|540669509|FG001|Overall Study|Other Reason|1|||
149874629|NCT02013674|540669510|FG000|Overall Study|Death|0|||
149963850|NCT00590317|541003111|FG000|Overall Study|Lack of Efficacy|1|||
149874630|NCT02013674|540669511|FG001|Overall Study|Death|1|||
149874631|NCT02013674|540669510|FG000|Overall Study|Lost to Follow-up|1|||
149874632|NCT02013674|540669511|FG001|Overall Study|Lost to Follow-up|0|||
149874633|NCT03433755|540669515|FG000|Overall Study|Lost to Follow-up|1|||
149874634|NCT03433755|540669516|FG001|Overall Study|Lost to Follow-up|0|||
149874635|NCT03433755|540669517|FG002|Overall Study|Lost to Follow-up|0|||
149874636|NCT03433755|540669518|FG003|Overall Study|Lost to Follow-up|0|||
149874637|NCT03433755|540669515|FG000|Overall Study|Decision by Sponsor|1|||
149874638|NCT03433755|540669516|FG001|Overall Study|Decision by Sponsor|0|||
149874639|NCT03433755|540669517|FG002|Overall Study|Decision by Sponsor|0|||
149874640|NCT03433755|540669518|FG003|Overall Study|Decision by Sponsor|0|||
149874641|NCT05307510|540671404|FG000|Overall Study|Lost to Follow-up|3|||
149874642|NCT05307510|540671405|FG001|Overall Study|Lost to Follow-up|6|||
149874643|NCT05307510|540671404|FG000|Overall Study|Withdrawal by Subject|0|||
149874644|NCT05307510|540671405|FG001|Overall Study|Withdrawal by Subject|1|||
149874645|NCT04003896|540671406|FG000|Overall Study|Withdrawal by Subject|3|||
149874646|NCT04003896|540671406|FG000|Overall Study|Physician Decision|1|||
149874647|NCT01682863|540671407|FG000|Overall Study|Subject/guardian decision|19|||
149874648|NCT01682863|540671408|FG001|Overall Study|Subject/guardian decision|12|||
149874649|NCT01682863|540671409|FG002|Overall Study|Subject/guardian decision|10|||
149874650|NCT01682863|540671407|FG000|Overall Study|Lost to Follow-up|5|||
149874651|NCT01682863|540671408|FG001|Overall Study|Lost to Follow-up|1|||
149874652|NCT01682863|540671409|FG002|Overall Study|Lost to Follow-up|6|||
149874653|NCT01682863|540671407|FG000|Overall Study|Death|1|||
149874654|NCT01682863|540671408|FG001|Overall Study|Death|3|||
149874655|NCT01682863|540671409|FG002|Overall Study|Death|4|||
149874656|NCT01682863|540671407|FG000|Overall Study|Protocol deviation|1|||
149874657|NCT01682863|540671408|FG001|Overall Study|Protocol deviation|0|||
149874658|NCT01682863|540671409|FG002|Overall Study|Protocol deviation|1|||
149874659|NCT01682863|540671407|FG000|Overall Study|Technical problems|1|||
149874660|NCT01682863|540671408|FG001|Overall Study|Technical problems|0|||
149874661|NCT01682863|540671409|FG002|Overall Study|Technical problems|0|||
149874662|NCT01682863|540671407|FG000|Overall Study|Adverse Event|0|||
149874663|NCT01682863|540671408|FG001|Overall Study|Adverse Event|1|||
149874664|NCT01682863|540671409|FG002|Overall Study|Adverse Event|2|||
149874665|NCT01682863|540671407|FG000|Overall Study|Physician Decision|0|||
149874666|NCT01682863|540671408|FG001|Overall Study|Physician Decision|0|||
149874667|NCT01682863|540671409|FG002|Overall Study|Physician Decision|1|||
149874668|NCT02315196|540671410|FG000|Overall Study|Withdrew consent|9|||
149874669|NCT01635218|540671411|FG000|Overall Study|Lost to Follow-up|3|||
149874670|NCT01635218|540671412|FG001|Overall Study|Lost to Follow-up|7|||
149874671|NCT01635218|540671413|FG002|Overall Study|Lost to Follow-up|6|||
149874672|NCT04576923|540671414|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
149874673|NCT01475097|540671415|FG000|Overall Study|Protocol Violation|1|||
149874674|NCT01475097|540671416|FG001|Overall Study|Protocol Violation|1|||
149874675|NCT01635283|540671417|FG000|Overall Study|Tumor Progression|3|||
149874676|NCT01635283|540671417|FG000|Overall Study|Lost to Follow-up|1|||
149874677|NCT04516759|540671418|FG000|Overall Study|Withdrawal by Subject|1|||
149874678|NCT04516759|540671419|FG001|Overall Study|Withdrawal by Subject|1|||
149874679|NCT04516759|540671418|FG000|Overall Study|Other|0|||
149874680|NCT04516759|540671419|FG001|Overall Study|Other|1|||
149874681|NCT01994291|540671420|FG000|Overall Study|Adverse Event|4|||
149874682|NCT01994291|540671421|FG001|Overall Study|Adverse Event|1|||
149874683|NCT01994291|540671422|FG002|Overall Study|Adverse Event|3|||
149874684|NCT01994291|540671420|FG000|Overall Study|Lost to Follow-up|1|||
149874685|NCT01994291|540671421|FG001|Overall Study|Lost to Follow-up|1|||
149874686|NCT01994291|540671422|FG002|Overall Study|Lost to Follow-up|0|||
149874687|NCT01994291|540671420|FG000|Overall Study|Does not meet entrance criteria|1|||
149874688|NCT01994291|540671421|FG001|Overall Study|Does not meet entrance criteria|0|||
149874689|NCT01994291|540671422|FG002|Overall Study|Does not meet entrance criteria|0|||
149874690|NCT01994291|540671420|FG000|Overall Study|Medication error without associated AE|1|||
149874691|NCT01994291|540671421|FG001|Overall Study|Medication error without associated AE|0|||
149874692|NCT01994291|540671422|FG002|Overall Study|Medication error without associated AE|1|||
149874693|NCT01994291|540671420|FG000|Overall Study|Protocol Violation|1|||
149874694|NCT01994291|540671421|FG001|Overall Study|Protocol Violation|0|||
149874695|NCT01994291|540671422|FG002|Overall Study|Protocol Violation|0|||
149874696|NCT01994291|540671420|FG000|Overall Study|Withdrawal by Subject|6|||
149874697|NCT01994291|540671421|FG001|Overall Study|Withdrawal by Subject|3|||
149874698|NCT01994291|540671422|FG002|Overall Study|Withdrawal by Subject|5|||
149874699|NCT01994291|540671420|FG000|Overall Study|Other|1|||
149874700|NCT01994291|540671421|FG001|Overall Study|Other|2|||
149874701|NCT01994291|540671422|FG002|Overall Study|Other|0|||
149874702|NCT01775189|540671423|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874703|NCT01775189|540671424|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
149874704|NCT01775189|540671425|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874705|NCT01775189|540671426|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874706|NCT01775189|540671427|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874707|NCT01775189|540671428|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874708|NCT01775189|540671429|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
149874709|NCT01775189|540671423|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874710|NCT01775189|540671424|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
149874711|NCT01775189|540671425|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874712|NCT01775189|540671426|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874713|NCT01775189|540671427|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874714|NCT01775189|540671428|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874715|NCT01775189|540671429|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
149874716|NCT01775189|540671423|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
149874717|NCT01775189|540671424|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
149874718|NCT01775189|540671425|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
149874719|NCT01775189|540671426|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
149874720|NCT01775189|540671427|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
149874721|NCT01775189|540671428|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
149874722|NCT01775189|540671429|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
149874723|NCT01775189|540671423|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874724|NCT01775189|540671424|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874725|NCT01775189|540671425|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874726|NCT01775189|540671426|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874727|NCT01775189|540671427|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874728|NCT01775189|540671428|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
149874729|NCT01775189|540671429|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
149874730|NCT01775189|540671423|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874731|NCT01775189|540671424|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874732|NCT01775189|540671425|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874733|NCT01775189|540671426|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
149874734|NCT01775189|540671427|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874735|NCT01775189|540671428|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874736|NCT01775189|540671429|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
149874737|NCT01775189|540671423|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
149874738|NCT01775189|540671424|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
149874739|NCT01775189|540671425|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
149874740|NCT01775189|540671426|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
149874741|NCT01775189|540671427|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
149874742|NCT01775189|540671428|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
149874743|NCT01775189|540671429|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
149874744|NCT00856375|540671430|FG000|Overall Study|Other|0|||
149874745|NCT00856375|540671431|FG001|Overall Study|Other|1|||
149874746|NCT00856375|540671430|FG000|Overall Study|Death|32|||
149874747|NCT00856375|540671431|FG001|Overall Study|Death|30|||
149874748|NCT00856375|540671430|FG000|Overall Study|Sponsor Terminated Study|7|||
149874749|NCT00856375|540671431|FG001|Overall Study|Sponsor Terminated Study|7|||
149874750|NCT00856375|540671430|FG000|Overall Study|Withdrawal by Subject|2|||
149874751|NCT00856375|540671431|FG001|Overall Study|Withdrawal by Subject|1|||
149874752|NCT00856375|540671430|FG000|Overall Study|Lost to Follow-up|1|||
149874753|NCT00856375|540671431|FG001|Overall Study|Lost to Follow-up|2|||
149874754|NCT02227446|540671432|FG000|Overall Study|not eligible post randomization|18|||
150174146|NCT00630786|541773036|FG002|Overall Study|Lost to Follow-up|0|||
149874755|NCT02227446|540671433|FG001|Overall Study|not eligible post randomization|29|||
149874756|NCT02227446|540671432|FG000|Overall Study|Withdrawal by Subject|4|||
149874757|NCT02227446|540671433|FG001|Overall Study|Withdrawal by Subject|5|||
149874758|NCT02121392|540671434|FG000|Prior to Intervention|Protocol Violation|40|||
149874759|NCT02121392|540671435|FG001|Prior to Intervention|Protocol Violation|35|||
149874760|NCT02121392|540671434|FG000|Prior to Intervention|Withdrawal by Subject|8|||
149874761|NCT02121392|540671435|FG001|Prior to Intervention|Withdrawal by Subject|6|||
149874762|NCT02121392|540671434|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
149963851|NCT00590317|541003112|FG001|Overall Study|Lack of Efficacy|5|||
149963852|NCT04280783|541003113|FG000|Overall Study|Family issues unrelated to the study.|1|||
149963853|NCT04280783|541003114|FG001|Overall Study|Family issues unrelated to the study.|0|||
149963854|NCT04280783|541003113|FG000|Overall Study|Withdrawal by Subject|0|||
149963855|NCT04280783|541003114|FG001|Overall Study|Withdrawal by Subject|1|||
149963856|NCT04616196|541003115|FG000|Overall Study|Progressive Disease|3|||
149963857|NCT04616196|541003116|FG001|Overall Study|Progressive Disease|0|||
149963858|NCT04616196|541003117|FG002|Overall Study|Progressive Disease|4|||
149963859|NCT04616196|541003118|FG003|Overall Study|Progressive Disease|1|||
149963860|NCT04616196|541003115|FG000|Overall Study|Death|2|||
150174147|NCT00630786|541773034|FG000|Overall Study|Other|1|||
150174148|NCT00630786|541773035|FG001|Overall Study|Other|0|||
150174149|NCT00630786|541773036|FG002|Overall Study|Other|0|||
149963861|NCT04616196|541003116|FG001|Overall Study|Death|4|||
149963862|NCT04616196|541003117|FG002|Overall Study|Death|1|||
150174150|NCT01585558|541773039|FG000|Overall Study|Withdrawal by Subject|4|||
149874763|NCT02121392|540671435|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
149874764|NCT02121392|540671434|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
149874765|NCT02121392|540671435|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
149874766|NCT01352416|540671436|FG000|Overall Study|Physician Decision|1|||
149874767|NCT01352416|540671437|FG001|Overall Study|Physician Decision|2|||
149874768|NCT01352416|540671438|FG002|Overall Study|Physician Decision|2|||
149874769|NCT01352416|540671439|FG003|Overall Study|Physician Decision|1|||
149874770|NCT03016975|540671453|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
149874771|NCT03016975|540671454|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
149874772|NCT03016975|540671455|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
149874773|NCT03016975|540671453|FG000|At 6 Months Follow-up|Death|2|||
149874774|NCT03016975|540671454|FG001|At 6 Months Follow-up|Death|0|||
149874775|NCT03016975|540671455|FG002|At 6 Months Follow-up|Death|0|||
149874776|NCT03016975|540671453|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
149874777|NCT03016975|540671454|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
149874778|NCT03016975|540671455|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
149874779|NCT03016975|540671453|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
149874780|NCT03016975|540671454|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
149874781|NCT03016975|540671455|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
149874782|NCT03016975|540671453|FG000|At 6 Months Follow-up|Aborted implant|1|||
149874783|NCT03016975|540671454|FG001|At 6 Months Follow-up|Aborted implant|0|||
149874784|NCT03016975|540671455|FG002|At 6 Months Follow-up|Aborted implant|0|||
149874785|NCT03016975|540671453|FG000|At 2 Year Follow-up|Death|1|||
149874786|NCT03016975|540671454|FG001|At 2 Year Follow-up|Death|0|||
149874787|NCT03016975|540671455|FG002|At 2 Year Follow-up|Death|0|||
149874788|NCT03016975|540671453|FG000|At 3 Year Follow-up|Death|1|||
149874789|NCT03016975|540671454|FG001|At 3 Year Follow-up|Death|0|||
149874790|NCT03016975|540671455|FG002|At 3 Year Follow-up|Death|0|||
149874791|NCT03016975|540671453|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
149874792|NCT03016975|540671454|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
149874793|NCT03016975|540671455|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
149874794|NCT03016975|540671453|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
149874795|NCT03016975|540671454|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
149874796|NCT03016975|540671455|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
149963863|NCT04616196|541003118|FG003|Overall Study|Death|0|||
149963864|NCT04616196|541003115|FG000|Overall Study|Withdrawal by Subject|0|||
149963865|NCT04616196|541003116|FG001|Overall Study|Withdrawal by Subject|2|||
149963866|NCT04616196|541003117|FG002|Overall Study|Withdrawal by Subject|0|||
149963867|NCT04616196|541003118|FG003|Overall Study|Withdrawal by Subject|0|||
149963868|NCT04616196|541003115|FG000|Overall Study|Lost to Follow-up|1|||
149963869|NCT04616196|541003116|FG001|Overall Study|Lost to Follow-up|0|||
149963870|NCT04616196|541003117|FG002|Overall Study|Lost to Follow-up|0|||
149963871|NCT04616196|541003118|FG003|Overall Study|Lost to Follow-up|0|||
149874797|NCT01661062|540671456|FG000|Overall Study|Completed Treatment Off Study|3|||
149874798|NCT01661062|540671456|FG000|Overall Study|Withdrawal by Subject|2|||
149874799|NCT02348723|540671459|FG000|Overall Study|No ablation|21|||
149874800|NCT02348723|540671460|FG001|Overall Study|No ablation|20|||
149963872|NCT04616196|541003115|FG000|Overall Study|Sponsor request|2|||
149963873|NCT04616196|541003116|FG001|Overall Study|Sponsor request|1|||
149963874|NCT04616196|541003117|FG002|Overall Study|Sponsor request|1|||
149963875|NCT04616196|541003118|FG003|Overall Study|Sponsor request|2|||
149963876|NCT02904265|541003119|FG000|Overall Study|Physician Decision|1|||
149963877|NCT02904265|541003120|FG001|Overall Study|Physician Decision|2|||
149963878|NCT00185614|541003121|FG000|Inter-treatment Period|Physician Decision|1|||
149963879|NCT00185614|541003121|FG000|Inter-treatment Period|Relapse|2|||
150174151|NCT01585558|541773040|FG001|Overall Study|Withdrawal by Subject|5|||
149874801|NCT02348723|540671459|FG000|Overall Study|Non-compliant with Protocol|1|||
149874802|NCT02348723|540671460|FG001|Overall Study|Non-compliant with Protocol|0|||
149874803|NCT02348723|540671459|FG000|Overall Study|Lost to Follow-up|1|||
149874804|NCT02348723|540671460|FG001|Overall Study|Lost to Follow-up|1|||
149874805|NCT02348723|540671459|FG000|Overall Study|Consent withdrawn|1|||
149874806|NCT02348723|540671460|FG001|Overall Study|Consent withdrawn|3|||
149874807|NCT02348723|540671459|FG000|Overall Study|Reason other than specified|1|||
149874808|NCT02348723|540671460|FG001|Overall Study|Reason other than specified|1|||
149874809|NCT02348723|540671459|FG000|Overall Study|Adverse Event|3|||
149874810|NCT02348723|540671460|FG001|Overall Study|Adverse Event|1|||
149874811|NCT02910063|540671463|FG000|Phase 2|Withdrawal by Subject|3|||
149874812|NCT02910063|540671464|FG001|Phase 2|Withdrawal by Subject|0|||
149874813|NCT02910063|540671465|FG002|Phase 2|Withdrawal by Subject|0|||
149874814|NCT02910063|540671463|FG000|Phase 2|Lost to Follow-up|1|||
149874815|NCT02910063|540671464|FG001|Phase 2|Lost to Follow-up|0|||
149874816|NCT02910063|540671465|FG002|Phase 2|Lost to Follow-up|0|||
149874817|NCT02910063|540671463|FG000|Phase 2|Death|24|||
149874818|NCT02910063|540671464|FG001|Phase 2|Death|0|||
149874819|NCT02910063|540671465|FG002|Phase 2|Death|0|||
149874820|NCT03496610|540671466|FG000|Overall Study|Lost to Follow-up|3|||
149874821|NCT03496610|540671467|FG001|Overall Study|Lost to Follow-up|2|||
149874822|NCT03496610|540671466|FG000|Overall Study|Physician Decision|1|||
149874823|NCT03496610|540671467|FG001|Overall Study|Physician Decision|0|||
149874824|NCT03496610|540671466|FG000|Overall Study|Withdrawal by Subject|1|||
149874825|NCT03496610|540671467|FG001|Overall Study|Withdrawal by Subject|0|||
149874826|NCT04435184|540671468|FG000|Overall Study|follow-up blood draws missing|3|||
149874827|NCT04435184|540671469|FG001|Overall Study|follow-up blood draws missing|5|||
149874828|NCT04693416|540671470|FG000|Overall Study|Lost to Follow-up|13|||
149874829|NCT04693416|540671471|FG001|Overall Study|Lost to Follow-up|0|||
149874830|NCT00474266|540671474|FG000|Overall Study|Withdrawal by Subject|7|||
149874831|NCT00474266|540671475|FG001|Overall Study|Withdrawal by Subject|20|||
149874832|NCT00474266|540671476|FG002|Overall Study|Withdrawal by Subject|4|||
149874833|NCT00474266|540671477|FG003|Overall Study|Withdrawal by Subject|7|||
149874834|NCT02774642|540671479|FG000|Overall Study|Lost to Follow-up|9|||
149874835|NCT02774642|540671480|FG001|Overall Study|Lost to Follow-up|7|||
149874836|NCT05330468|540671484|FG000|Overall Study|Death|6|||
149874837|NCT05330468|540671484|FG000|Overall Study|Withdrawal by Subject|4|||
149874838|NCT05330468|540671484|FG000|Overall Study|Lost to Follow-up|4|||
149874839|NCT00369317|540671485|FG000|Overall Study|Adverse Event|3|||
149874840|NCT00369317|540671485|FG000|Overall Study|Death|1|||
149874841|NCT00369317|540671485|FG000|Overall Study|Lack of Efficacy|5|||
149874842|NCT00369317|540671485|FG000|Overall Study|Physician Decision|2|||
149874843|NCT00369317|540671485|FG000|Overall Study|Withdrawal by Subject|8|||
149874844|NCT00369317|540671485|FG000|Overall Study|Ineligible|1|||
149874845|NCT02365558|540671486|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
149874846|NCT02365558|540671487|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
149874847|NCT02365558|540671486|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
149874848|NCT02365558|540671487|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
149874849|NCT06281171|540671505|FG000|Timepoint 2|Lost to Follow-up|6|||
149874850|NCT06281171|540671506|FG001|Timepoint 2|Lost to Follow-up|4|||
149874851|NCT06281171|540671505|FG000|Timepoint 3|Lost to Follow-up|0|||
149874852|NCT06281171|540671506|FG001|Timepoint 3|Lost to Follow-up|5|||
149874853|NCT00073021|540671511|FG000|Overall Study|Protocol Violation|2|||
149874854|NCT00073021|540671512|FG001|Overall Study|Protocol Violation|1|||
149874855|NCT00073021|540671511|FG000|Overall Study|Adverse Event|4|||
149874856|NCT00073021|540671512|FG001|Overall Study|Adverse Event|4|||
149874857|NCT00073021|540671511|FG000|Overall Study|Withdrawal by Subject|6|||
149874858|NCT00073021|540671512|FG001|Overall Study|Withdrawal by Subject|5|||
149874859|NCT00073021|540671511|FG000|Overall Study|Physician Decision|3|||
149874860|NCT00073021|540671512|FG001|Overall Study|Physician Decision|1|||
149874861|NCT00073021|540671511|FG000|Overall Study|Lack of Efficacy|11|||
149874862|NCT00073021|540671512|FG001|Overall Study|Lack of Efficacy|5|||
149874863|NCT01458106|540671513|FG000|Overall Study|Withdrawal by Subject|2|||
149874864|NCT01458106|540671514|FG001|Overall Study|Withdrawal by Subject|0|||
149874865|NCT01458106|540671513|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
149874866|NCT01458106|540671514|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
149874867|NCT01458106|540671513|FG000|Overall Study|Withdrawn Per Protocol|0|||
149874868|NCT01458106|540671514|FG001|Overall Study|Withdrawn Per Protocol|1|||
149874869|NCT03835221|540671515|FG000|Methafilcon A|Withdrawal by Subject|1|||
149874870|NCT00861198|540671517|FG000|Overall Study|SpyGlass Failed|5|||
149874871|NCT02288182|540671518|FG000|Overall Study|Adverse Event|0|||
149874872|NCT02288182|540671519|FG001|Overall Study|Adverse Event|1|||
149874873|NCT02288182|540671518|FG000|Overall Study|Lost to Follow-up|0|||
149874874|NCT02288182|540671519|FG001|Overall Study|Lost to Follow-up|1|||
149874875|NCT02823652|540671523|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
149874876|NCT02823652|540671524|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
150174152|NCT01585558|541773041|FG002|Overall Study|Withdrawal by Subject|8|||
149874877|NCT02823652|540671525|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
149874878|NCT02823652|540671523|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
149874879|NCT02823652|540671524|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
149874880|NCT02823652|540671525|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
149874881|NCT02823652|540671523|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
149874882|NCT02823652|540671524|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
149874883|NCT02823652|540671525|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
149874884|NCT02823652|540671523|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
149874885|NCT02823652|540671524|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
149874886|NCT02823652|540671525|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
149874887|NCT04619992|540671526|FG000|Overall Study|Withdrawal by Subject|1|||
149874888|NCT04619992|540671527|FG001|Overall Study|Withdrawal by Subject|0|||
149874889|NCT01197755|540671528|FG000|Overall Study|Adverse Event|8|||
149874890|NCT01197755|540671529|FG001|Overall Study|Adverse Event|10|||
149874891|NCT01197755|540671530|FG002|Overall Study|Adverse Event|10|||
149874892|NCT01197755|540671528|FG000|Overall Study|Study-specific discontinuation criteria|2|||
149874893|NCT01197755|540671529|FG001|Overall Study|Study-specific discontinuation criteria|1|||
149874894|NCT01197755|540671530|FG002|Overall Study|Study-specific discontinuation criteria|0|||
149874895|NCT01197755|540671528|FG000|Overall Study|Entered the long-term extension study|18|||
149874896|NCT01197755|540671529|FG001|Overall Study|Entered the long-term extension study|21|||
149874897|NCT01197755|540671530|FG002|Overall Study|Entered the long-term extension study|35|||
149874898|NCT01197755|540671528|FG000|Overall Study|Lack of therapeutic response|0|||
149874899|NCT01197755|540671529|FG001|Overall Study|Lack of therapeutic response|7|||
149874900|NCT01197755|540671530|FG002|Overall Study|Lack of therapeutic response|4|||
149874901|NCT01197755|540671528|FG000|Overall Study|Severe non-compliance to the protocol|2|||
149874902|NCT01197755|540671529|FG001|Overall Study|Severe non-compliance to the protocol|1|||
149874903|NCT01197755|540671530|FG002|Overall Study|Severe non-compliance to the protocol|2|||
149874904|NCT01197755|540671528|FG000|Overall Study|Withdrawal by Subject|1|||
149874905|NCT01197755|540671529|FG001|Overall Study|Withdrawal by Subject|0|||
149874906|NCT01197755|540671530|FG002|Overall Study|Withdrawal by Subject|0|||
149874907|NCT01197755|540671528|FG000|Overall Study|Lost to Follow-up|0|||
149874908|NCT01197755|540671529|FG001|Overall Study|Lost to Follow-up|0|||
149874909|NCT01197755|540671530|FG002|Overall Study|Lost to Follow-up|1|||
149874910|NCT01197755|540671528|FG000|Overall Study|eg, change in circumstances|7|||
149874911|NCT01197755|540671529|FG001|Overall Study|eg, change in circumstances|3|||
149874912|NCT01197755|540671530|FG002|Overall Study|eg, change in circumstances|2|||
149874913|NCT04428333|540671531|FG000|Overall Study|Physician Decision|5|||
149874914|NCT04428333|540671532|FG001|Overall Study|Physician Decision|6|||
149874915|NCT04428333|540671531|FG000|Overall Study|Withdrawal by Subject|1|||
149874916|NCT04428333|540671532|FG001|Overall Study|Withdrawal by Subject|3|||
149874917|NCT04428333|540671531|FG000|Overall Study|Study Terminated By Sponsor|14|||
149874918|NCT04428333|540671532|FG001|Overall Study|Study Terminated By Sponsor|16|||
149874919|NCT00499174|540671533|FG000|Overall Study|Physician Decision|78|||
149874920|NCT00499174|540671534|FG001|Overall Study|Physician Decision|9|||
149874921|NCT02269163|540671535|FG000|Overall Study|Lost to Follow-up|1|||
149874922|NCT02269163|540671536|FG001|Overall Study|Lost to Follow-up|0|||
149874923|NCT02269163|540671535|FG000|Overall Study|Major protocol violation|0|||
149874924|NCT02269163|540671536|FG001|Overall Study|Major protocol violation|1|||
149874925|NCT02269163|540671535|FG000|Overall Study|Other|2|||
149874926|NCT02269163|540671536|FG001|Overall Study|Other|2|||
149874927|NCT02269163|540671535|FG000|Overall Study|Withdrawal by Subject|0|||
149874928|NCT02269163|540671536|FG001|Overall Study|Withdrawal by Subject|3|||
149874929|NCT02269163|540671535|FG000|Overall Study|Physician Decision|0|||
149874930|NCT02269163|540671536|FG001|Overall Study|Physician Decision|1|||
149874931|NCT01214915|540671538|FG000|Overall Study|Adverse Event|8|||
149874932|NCT01214915|540671538|FG000|Overall Study|Lack of Efficacy|3|||
149874933|NCT02351960|540671541|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
149874934|NCT02351960|540671542|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
149874935|NCT02351960|540671541|FG000|Overall Study|Voluntary Withdrawal|5|||
149874936|NCT02351960|540671542|FG001|Overall Study|Voluntary Withdrawal|4|||
149874937|NCT02351960|540671541|FG000|Overall Study|Significant Protocol Deviation|0|||
149874938|NCT02351960|540671542|FG001|Overall Study|Significant Protocol Deviation|5|||
149874939|NCT03866902|540671543|FG000|Overall Study|Lost to Follow-up|98|||
149874940|NCT03866902|540671544|FG001|Overall Study|Lost to Follow-up|82|||
149874941|NCT03866902|540671543|FG000|Overall Study|Pregnancy|18|||
149874942|NCT03866902|540671544|FG001|Overall Study|Pregnancy|24|||
149874943|NCT00638027|540671548|FG000|Overall Study|Adverse Event|0|||
149874944|NCT00638027|540671549|FG001|Overall Study|Adverse Event|2|||
149874945|NCT02377427|540671550|FG000|Part A (Up to Week 20)|Physician Decision|1|||
149874946|NCT02377427|540671551|FG001|Part A (Up to Week 20)|Physician Decision|0|||
149874947|NCT02377427|540671552|FG002|Part A (Up to Week 20)|Physician Decision|0|||
149874948|NCT02377427|540671553|FG003|Part A (Up to Week 20)|Physician Decision|0|||
149874949|NCT02377427|540671554|FG004|Part A (Up to Week 20)|Physician Decision|0|||
149874950|NCT02377427|540671550|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
149874951|NCT02377427|540671551|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
149963880|NCT00185614|541003121|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
149874952|NCT02377427|540671552|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
149874953|NCT02377427|540671553|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
149874954|NCT02377427|540671554|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
149874955|NCT02377427|540671550|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
149874956|NCT02377427|540671551|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
149874957|NCT02377427|540671552|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
149874958|NCT02377427|540671553|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
149874959|NCT02377427|540671554|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
149874960|NCT02377427|540671550|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
149874961|NCT02377427|540671551|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
149874962|NCT02377427|540671552|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
149874963|NCT02377427|540671553|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
149874964|NCT02377427|540671554|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
149874965|NCT02886624|540673200|FG000|12-week Post Treatment Follow-up|Death|1|||
149874966|NCT02886624|540673200|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
149874967|NCT03151408|540673202|FG000|Overall Study|Adverse Event|24|||
149874968|NCT03151408|540673203|FG001|Overall Study|Adverse Event|23|||
149874969|NCT03151408|540673202|FG000|Overall Study|Death|46|||
149874970|NCT03151408|540673203|FG001|Overall Study|Death|26|||
149874971|NCT03151408|540673202|FG000|Overall Study|Physician Decision|13|||
149874972|NCT03151408|540673203|FG001|Overall Study|Physician Decision|19|||
149874973|NCT03151408|540673202|FG000|Overall Study|Withdrawal by Subject|16|||
149874974|NCT03151408|540673203|FG001|Overall Study|Withdrawal by Subject|20|||
149874975|NCT03151408|540673202|FG000|Overall Study|Progressive disease|45|||
149874976|NCT03151408|540673203|FG001|Overall Study|Progressive disease|61|||
149874977|NCT03151408|540673202|FG000|Overall Study|non-compliance by patient|1|||
149874978|NCT03151408|540673203|FG001|Overall Study|non-compliance by patient|0|||
149874979|NCT03151408|540673202|FG000|Overall Study|other reasons|56|||
149874980|NCT03151408|540673203|FG001|Overall Study|other reasons|52|||
149874981|NCT03151408|540673202|FG000|Overall Study|randomized and not treated|2|||
149874982|NCT03151408|540673203|FG001|Overall Study|randomized and not treated|2|||
149874983|NCT03262038|540673208|FG000|Overall Study|Withdrawal by Subject|0|||
149874984|NCT03262038|540673209|FG001|Overall Study|Withdrawal by Subject|1|||
149874985|NCT04933968|540673210|FG000|Overall Study|Adverse Event|0|||
149874986|NCT04933968|540673211|FG001|Overall Study|Adverse Event|0|||
149874987|NCT04933968|540673212|FG002|Overall Study|Adverse Event|1|||
149874988|NCT04933968|540673213|FG003|Overall Study|Adverse Event|1|||
149874989|NCT04933968|540673214|FG004|Overall Study|Adverse Event|0|||
149874990|NCT04933968|540673215|FG005|Overall Study|Adverse Event|0|||
149874991|NCT04933968|540673210|FG000|Overall Study|Lost to Follow-up|1|||
149874992|NCT04933968|540673211|FG001|Overall Study|Lost to Follow-up|0|||
149874993|NCT04933968|540673212|FG002|Overall Study|Lost to Follow-up|1|||
149874994|NCT04933968|540673213|FG003|Overall Study|Lost to Follow-up|0|||
149874995|NCT04933968|540673214|FG004|Overall Study|Lost to Follow-up|0|||
149874996|NCT04933968|540673215|FG005|Overall Study|Lost to Follow-up|0|||
149874997|NCT04933968|540673210|FG000|Overall Study|Randomized not treated|1|||
149874998|NCT04933968|540673211|FG001|Overall Study|Randomized not treated|0|||
149874999|NCT04933968|540673212|FG002|Overall Study|Randomized not treated|0|||
149875000|NCT04933968|540673213|FG003|Overall Study|Randomized not treated|0|||
149875001|NCT04933968|540673214|FG004|Overall Study|Randomized not treated|0|||
149875002|NCT04933968|540673215|FG005|Overall Study|Randomized not treated|0|||
149875003|NCT04933968|540673210|FG000|Overall Study|Sponsor terminated study|0|||
149875004|NCT04933968|540673211|FG001|Overall Study|Sponsor terminated study|0|||
149875005|NCT04933968|540673212|FG002|Overall Study|Sponsor terminated study|0|||
149875006|NCT04933968|540673213|FG003|Overall Study|Sponsor terminated study|1|||
149875007|NCT04933968|540673214|FG004|Overall Study|Sponsor terminated study|2|||
149875008|NCT04933968|540673215|FG005|Overall Study|Sponsor terminated study|0|||
149875009|NCT04933968|540673210|FG000|Overall Study|Other|0|||
149875010|NCT04933968|540673211|FG001|Overall Study|Other|0|||
149875011|NCT04933968|540673212|FG002|Overall Study|Other|0|||
149875012|NCT04933968|540673213|FG003|Overall Study|Other|1|||
149875013|NCT04933968|540673214|FG004|Overall Study|Other|0|||
149875014|NCT04933968|540673215|FG005|Overall Study|Other|0|||
149963881|NCT00003907|541003129|FG000|Overall Study|Adverse Event|2|||
149963882|NCT00003907|541003130|FG001|Overall Study|Adverse Event|11|||
149875015|NCT04933968|540673210|FG000|Overall Study|Missing|1|||
149963883|NCT00003907|541003129|FG000|Overall Study|Death|2|||
149875016|NCT04933968|540673211|FG001|Overall Study|Missing|3|||
149875017|NCT04933968|540673212|FG002|Overall Study|Missing|2|||
149875018|NCT04933968|540673213|FG003|Overall Study|Missing|1|||
149875019|NCT04933968|540673214|FG004|Overall Study|Missing|1|||
149875020|NCT04933968|540673215|FG005|Overall Study|Missing|0|||
149963884|NCT00003907|541003130|FG001|Overall Study|Death|0|||
149875021|NCT01724489|540673216|FG000|Overall Study|Adverse Event|8|||
149875022|NCT01724489|540673217|FG001|Overall Study|Adverse Event|3|||
149875023|NCT01724489|540673216|FG000|Overall Study|Surgery, medication|1|||
149875024|NCT01724489|540673217|FG001|Overall Study|Surgery, medication|1|||
149875025|NCT01724489|540673216|FG000|Overall Study|Lost to Follow-up|1|||
149875026|NCT01724489|540673217|FG001|Overall Study|Lost to Follow-up|2|||
149875027|NCT01724489|540673216|FG000|Overall Study|Withdrawal by Subject|6|||
149875028|NCT01724489|540673217|FG001|Overall Study|Withdrawal by Subject|6|||
149875029|NCT01664130|540673220|FG000|Overall Study|competing secondary disease|2|||
149875030|NCT01473524|540673221|FG000|DB Phase|Adverse Event|4|||
149875031|NCT01473524|540673222|FG001|DB Phase|Adverse Event|8|||
149875032|NCT01473524|540673223|FG002|DB Phase|Adverse Event|2|||
149875033|NCT01473524|540673224|FG003|DB Phase|Adverse Event|0|||
149875034|NCT01473524|540673225|FG004|DB Phase|Adverse Event|0|||
149875035|NCT01473524|540673226|FG005|DB Phase|Adverse Event|0|||
149875036|NCT01473524|540673221|FG000|DB Phase|Death|1|||
149875037|NCT01473524|540673222|FG001|DB Phase|Death|0|||
149875038|NCT01473524|540673223|FG002|DB Phase|Death|0|||
149875039|NCT01473524|540673224|FG003|DB Phase|Death|0|||
149875040|NCT01473524|540673225|FG004|DB Phase|Death|0|||
149875041|NCT01473524|540673226|FG005|DB Phase|Death|0|||
149875042|NCT01473524|540673221|FG000|DB Phase|Withdrawal by Subject|2|||
149875043|NCT01473524|540673222|FG001|DB Phase|Withdrawal by Subject|1|||
149875044|NCT01473524|540673223|FG002|DB Phase|Withdrawal by Subject|1|||
149875045|NCT01473524|540673224|FG003|DB Phase|Withdrawal by Subject|0|||
149875046|NCT01473524|540673225|FG004|DB Phase|Withdrawal by Subject|0|||
149875047|NCT01473524|540673226|FG005|DB Phase|Withdrawal by Subject|0|||
149875048|NCT01473524|540673221|FG000|LTSE Phase|Withdrawal by Subject|0|||
149875049|NCT01473524|540673222|FG001|LTSE Phase|Withdrawal by Subject|0|||
149875050|NCT01473524|540673223|FG002|LTSE Phase|Withdrawal by Subject|0|||
149875051|NCT01473524|540673224|FG003|LTSE Phase|Withdrawal by Subject|3|||
149875052|NCT01473524|540673225|FG004|LTSE Phase|Withdrawal by Subject|3|||
149875053|NCT01473524|540673226|FG005|LTSE Phase|Withdrawal by Subject|6|||
149875054|NCT01473524|540673221|FG000|LTSE Phase|Death|0|||
149875055|NCT01473524|540673222|FG001|LTSE Phase|Death|0|||
149875056|NCT01473524|540673223|FG002|LTSE Phase|Death|0|||
149875057|NCT01473524|540673224|FG003|LTSE Phase|Death|0|||
149875058|NCT01473524|540673225|FG004|LTSE Phase|Death|1|||
149875059|NCT01473524|540673226|FG005|LTSE Phase|Death|0|||
149875060|NCT01473524|540673221|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
149875061|NCT01473524|540673222|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
149875062|NCT01473524|540673223|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
149875063|NCT01473524|540673224|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
149875064|NCT01473524|540673225|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
149875065|NCT01473524|540673226|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
149875066|NCT01473524|540673221|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
149875067|NCT01473524|540673222|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
149875068|NCT01473524|540673223|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
149875069|NCT01473524|540673224|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
149875070|NCT01473524|540673225|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
149875071|NCT01473524|540673226|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
149875072|NCT01473524|540673221|FG000|LTSE Phase|Lost to Follow-up|0|||
149875073|NCT01473524|540673222|FG001|LTSE Phase|Lost to Follow-up|0|||
149875074|NCT01473524|540673223|FG002|LTSE Phase|Lost to Follow-up|0|||
149875075|NCT01473524|540673224|FG003|LTSE Phase|Lost to Follow-up|1|||
149875076|NCT01473524|540673225|FG004|LTSE Phase|Lost to Follow-up|3|||
149875077|NCT01473524|540673226|FG005|LTSE Phase|Lost to Follow-up|2|||
149875078|NCT01473524|540673221|FG000|LTSE Phase|Principal Investigator Decision|0|||
149875079|NCT01473524|540673222|FG001|LTSE Phase|Principal Investigator Decision|0|||
149875080|NCT01473524|540673223|FG002|LTSE Phase|Principal Investigator Decision|0|||
149963885|NCT00003907|541003129|FG000|Overall Study|Withdrawal by Subject|1|||
149963886|NCT00003907|541003130|FG001|Overall Study|Withdrawal by Subject|3|||
149963887|NCT00003907|541003129|FG000|Overall Study|Progressive disease|4|||
149963888|NCT00003907|541003130|FG001|Overall Study|Progressive disease|4|||
149875081|NCT01473524|540673224|FG003|LTSE Phase|Principal Investigator Decision|1|||
149875082|NCT01473524|540673225|FG004|LTSE Phase|Principal Investigator Decision|1|||
149875083|NCT01473524|540673226|FG005|LTSE Phase|Principal Investigator Decision|3|||
149875084|NCT01473524|540673221|FG000|LTSE Phase|Liver Transplantation|0|||
149875085|NCT01473524|540673222|FG001|LTSE Phase|Liver Transplantation|0|||
149875086|NCT01473524|540673223|FG002|LTSE Phase|Liver Transplantation|0|||
149875087|NCT01473524|540673224|FG003|LTSE Phase|Liver Transplantation|0|||
149875088|NCT01473524|540673225|FG004|LTSE Phase|Liver Transplantation|0|||
149875089|NCT01473524|540673226|FG005|LTSE Phase|Liver Transplantation|1|||
149875090|NCT01473524|540673221|FG000|LTSE Phase|Pregnancy|0|||
149875091|NCT01473524|540673222|FG001|LTSE Phase|Pregnancy|0|||
149875092|NCT01473524|540673223|FG002|LTSE Phase|Pregnancy|0|||
149875093|NCT01473524|540673224|FG003|LTSE Phase|Pregnancy|1|||
149875094|NCT01473524|540673225|FG004|LTSE Phase|Pregnancy|0|||
149963889|NCT00003907|541003129|FG000|Overall Study|Complicating disease|1|||
149963890|NCT00003907|541003130|FG001|Overall Study|Complicating disease|0|||
149875095|NCT01473524|540673226|FG005|LTSE Phase|Pregnancy|0|||
149875096|NCT01473524|540673221|FG000|LTSE Phase|Protocol Violation|0|||
149875097|NCT01473524|540673222|FG001|LTSE Phase|Protocol Violation|0|||
149875098|NCT01473524|540673223|FG002|LTSE Phase|Protocol Violation|0|||
149875099|NCT01473524|540673224|FG003|LTSE Phase|Protocol Violation|0|||
149875100|NCT01473524|540673225|FG004|LTSE Phase|Protocol Violation|0|||
149875101|NCT01473524|540673226|FG005|LTSE Phase|Protocol Violation|1|||
149875102|NCT02045147|540673227|FG000|Overall Study|Withdrawal by Subject|2|||
149875103|NCT02045147|540673228|FG001|Overall Study|Withdrawal by Subject|0|||
149875104|NCT02045147|540673229|FG002|Overall Study|Withdrawal by Subject|0|||
149875105|NCT02045147|540673230|FG003|Overall Study|Withdrawal by Subject|0|||
149875106|NCT02045147|540673231|FG004|Overall Study|Withdrawal by Subject|0|||
149875107|NCT02045147|540673232|FG005|Overall Study|Withdrawal by Subject|0|||
149875108|NCT02045147|540673233|FG006|Overall Study|Withdrawal by Subject|0|||
149875109|NCT02045147|540673234|FG007|Overall Study|Withdrawal by Subject|1|||
149875110|NCT02045147|540673227|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
149875111|NCT02045147|540673228|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
149875112|NCT02045147|540673229|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
149875113|NCT02045147|540673230|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
149875114|NCT02045147|540673231|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
149875115|NCT02045147|540673232|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
149875116|NCT02045147|540673233|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
149875117|NCT02045147|540673234|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
149875118|NCT04839692|540673235|FG000|Overall Study|Withdrawal by Subject|0|||
149875119|NCT04839692|540673236|FG001|Overall Study|Withdrawal by Subject|3|||
149875120|NCT04839692|540673235|FG000|Overall Study|Physician Decision|1|||
149875121|NCT04839692|540673236|FG001|Overall Study|Physician Decision|0|||
149875122|NCT03146962|540673237|FG000|Overall Study|Lost to Follow-up|1|||
149875123|NCT03146962|540673238|FG001|Overall Study|Lost to Follow-up|1|||
149875124|NCT03146962|540673239|FG002|Overall Study|Lost to Follow-up|0|||
149875125|NCT03146962|540673240|FG003|Overall Study|Lost to Follow-up|0|||
149875126|NCT03146962|540673241|FG004|Overall Study|Lost to Follow-up|0|||
149875127|NCT03146962|540673242|FG005|Overall Study|Lost to Follow-up|0|||
149875128|NCT03146962|540673243|FG006|Overall Study|Lost to Follow-up|0|||
149875129|NCT03146962|540673244|FG007|Overall Study|Lost to Follow-up|0|||
149875130|NCT03146962|540673245|FG008|Overall Study|Lost to Follow-up|0|||
149875131|NCT03146962|540673246|FG009|Overall Study|Lost to Follow-up|0|||
149875132|NCT03146962|540673237|FG000|Overall Study|Adverse Event|0|||
149963891|NCT00003907|541003129|FG000|Overall Study|Other|1|||
149963892|NCT00003907|541003130|FG001|Overall Study|Other|3|||
149963893|NCT00003907|541003129|FG000|Overall Study|ineligible or not treated|2|||
149875133|NCT03146962|540673238|FG001|Overall Study|Adverse Event|3|||
149875134|NCT03146962|540673239|FG002|Overall Study|Adverse Event|0|||
149875135|NCT03146962|540673240|FG003|Overall Study|Adverse Event|0|||
149875136|NCT03146962|540673241|FG004|Overall Study|Adverse Event|0|||
149963894|NCT00003907|541003130|FG001|Overall Study|ineligible or not treated|2|||
149875137|NCT03146962|540673242|FG005|Overall Study|Adverse Event|0|||
149875138|NCT03146962|540673243|FG006|Overall Study|Adverse Event|0|||
149875139|NCT03146962|540673244|FG007|Overall Study|Adverse Event|1|||
149875140|NCT03146962|540673245|FG008|Overall Study|Adverse Event|0|||
149875141|NCT03146962|540673246|FG009|Overall Study|Adverse Event|0|||
149875142|NCT03146962|540673237|FG000|Overall Study|Withdrawal by Subject|0|||
149875143|NCT03146962|540673238|FG001|Overall Study|Withdrawal by Subject|0|||
149875144|NCT03146962|540673239|FG002|Overall Study|Withdrawal by Subject|0|||
149875145|NCT03146962|540673240|FG003|Overall Study|Withdrawal by Subject|0|||
149875146|NCT03146962|540673241|FG004|Overall Study|Withdrawal by Subject|1|||
149875147|NCT03146962|540673242|FG005|Overall Study|Withdrawal by Subject|0|||
149875148|NCT03146962|540673243|FG006|Overall Study|Withdrawal by Subject|0|||
149875149|NCT03146962|540673244|FG007|Overall Study|Withdrawal by Subject|0|||
149875150|NCT03146962|540673245|FG008|Overall Study|Withdrawal by Subject|0|||
149875151|NCT03146962|540673246|FG009|Overall Study|Withdrawal by Subject|0|||
149875152|NCT03146962|540673237|FG000|Overall Study|Death|0|||
149875153|NCT03146962|540673238|FG001|Overall Study|Death|1|||
149875154|NCT03146962|540673239|FG002|Overall Study|Death|0|||
149875155|NCT03146962|540673240|FG003|Overall Study|Death|0|||
149875156|NCT03146962|540673241|FG004|Overall Study|Death|0|||
149875157|NCT03146962|540673242|FG005|Overall Study|Death|0|||
149875158|NCT03146962|540673243|FG006|Overall Study|Death|0|||
149875159|NCT03146962|540673244|FG007|Overall Study|Death|0|||
149875160|NCT03146962|540673245|FG008|Overall Study|Death|0|||
149875161|NCT03146962|540673246|FG009|Overall Study|Death|0|||
149875162|NCT03146962|540673237|FG000|Overall Study|COVID Precautions|1|||
149875163|NCT03146962|540673238|FG001|Overall Study|COVID Precautions|0|||
149875164|NCT03146962|540673239|FG002|Overall Study|COVID Precautions|0|||
149875165|NCT03146962|540673240|FG003|Overall Study|COVID Precautions|0|||
149875166|NCT03146962|540673241|FG004|Overall Study|COVID Precautions|0|||
149875167|NCT03146962|540673242|FG005|Overall Study|COVID Precautions|0|||
149875168|NCT03146962|540673243|FG006|Overall Study|COVID Precautions|0|||
149875169|NCT03146962|540673244|FG007|Overall Study|COVID Precautions|0|||
149875170|NCT03146962|540673245|FG008|Overall Study|COVID Precautions|0|||
149875171|NCT03146962|540673246|FG009|Overall Study|COVID Precautions|0|||
149875172|NCT03146962|540673237|FG000|Overall Study|Physician Decision|0|||
149963895|NCT01557569|541003131|FG000|Overall Study|Adverse Event|2|||
149963896|NCT01557569|541003132|FG001|Overall Study|Adverse Event|0|||
149963897|NCT01557569|541003131|FG000|Overall Study|high blood pressure|0|||
149963898|NCT01557569|541003132|FG001|Overall Study|high blood pressure|1|||
149963899|NCT01557569|541003131|FG000|Overall Study|Withdrawal by Subject|3|||
149963900|NCT01557569|541003132|FG001|Overall Study|Withdrawal by Subject|5|||
149875173|NCT03146962|540673238|FG001|Overall Study|Physician Decision|0|||
149875174|NCT03146962|540673239|FG002|Overall Study|Physician Decision|0|||
149875175|NCT03146962|540673240|FG003|Overall Study|Physician Decision|0|||
149875176|NCT03146962|540673241|FG004|Overall Study|Physician Decision|0|||
149875177|NCT03146962|540673242|FG005|Overall Study|Physician Decision|0|||
149875178|NCT03146962|540673243|FG006|Overall Study|Physician Decision|0|||
149875179|NCT03146962|540673244|FG007|Overall Study|Physician Decision|0|||
149963901|NCT01557569|541003131|FG000|Overall Study|noncompliance with rules of residential|0|||
149875180|NCT03146962|540673245|FG008|Overall Study|Physician Decision|0|||
149875181|NCT03146962|540673246|FG009|Overall Study|Physician Decision|1|||
149875182|NCT03146962|540673237|FG000|Overall Study|Started New Treatment|0|||
149875183|NCT03146962|540673238|FG001|Overall Study|Started New Treatment|1|||
149875184|NCT03146962|540673239|FG002|Overall Study|Started New Treatment|0|||
149875185|NCT03146962|540673240|FG003|Overall Study|Started New Treatment|0|||
149875186|NCT03146962|540673241|FG004|Overall Study|Started New Treatment|0|||
149875187|NCT03146962|540673242|FG005|Overall Study|Started New Treatment|0|||
149875188|NCT03146962|540673243|FG006|Overall Study|Started New Treatment|0|||
149875189|NCT03146962|540673244|FG007|Overall Study|Started New Treatment|0|||
149875190|NCT03146962|540673245|FG008|Overall Study|Started New Treatment|0|||
149875191|NCT03146962|540673246|FG009|Overall Study|Started New Treatment|0|||
149875192|NCT02383810|540673247|FG000|Overall Study|Physician Decision|1|||
149875193|NCT02383810|540673248|FG001|Overall Study|Physician Decision|1|||
149875194|NCT02383810|540673249|FG002|Overall Study|Physician Decision|0|||
149875195|NCT02383810|540673250|FG003|Overall Study|Physician Decision|0|||
149875196|NCT02383810|540673251|FG004|Overall Study|Physician Decision|0|||
149875197|NCT02383810|540673252|FG005|Overall Study|Physician Decision|0|||
149875198|NCT02383810|540673253|FG006|Overall Study|Physician Decision|0|||
149875199|NCT02383810|540673254|FG007|Overall Study|Physician Decision|0|||
149875200|NCT02383810|540673247|FG000|Overall Study|Withdrawal by Subject|2|||
149875201|NCT02383810|540673248|FG001|Overall Study|Withdrawal by Subject|3|||
149875202|NCT02383810|540673249|FG002|Overall Study|Withdrawal by Subject|3|||
149875203|NCT02383810|540673250|FG003|Overall Study|Withdrawal by Subject|3|||
149875204|NCT02383810|540673251|FG004|Overall Study|Withdrawal by Subject|0|||
149875205|NCT02383810|540673252|FG005|Overall Study|Withdrawal by Subject|0|||
149875206|NCT02383810|540673253|FG006|Overall Study|Withdrawal by Subject|0|||
149875207|NCT02383810|540673254|FG007|Overall Study|Withdrawal by Subject|0|||
149875208|NCT02383810|540673247|FG000|Overall Study|Adverse Event|0|||
149875209|NCT02383810|540673248|FG001|Overall Study|Adverse Event|2|||
149875210|NCT02383810|540673249|FG002|Overall Study|Adverse Event|4|||
149875211|NCT02383810|540673250|FG003|Overall Study|Adverse Event|5|||
149875212|NCT02383810|540673251|FG004|Overall Study|Adverse Event|0|||
149875213|NCT02383810|540673252|FG005|Overall Study|Adverse Event|1|||
149875214|NCT02383810|540673253|FG006|Overall Study|Adverse Event|1|||
149875215|NCT02383810|540673254|FG007|Overall Study|Adverse Event|0|||
149875216|NCT02383810|540673247|FG000|Overall Study|Lost to Follow-up|0|||
149875217|NCT02383810|540673248|FG001|Overall Study|Lost to Follow-up|1|||
149875218|NCT02383810|540673249|FG002|Overall Study|Lost to Follow-up|0|||
149875219|NCT02383810|540673250|FG003|Overall Study|Lost to Follow-up|1|||
149875220|NCT02383810|540673251|FG004|Overall Study|Lost to Follow-up|0|||
149875221|NCT02383810|540673252|FG005|Overall Study|Lost to Follow-up|0|||
149875222|NCT02383810|540673253|FG006|Overall Study|Lost to Follow-up|0|||
149875223|NCT02383810|540673254|FG007|Overall Study|Lost to Follow-up|0|||
149875224|NCT02383810|540673247|FG000|Overall Study|other|0|||
149875225|NCT02383810|540673248|FG001|Overall Study|other|0|||
149875226|NCT02383810|540673249|FG002|Overall Study|other|0|||
149875227|NCT02383810|540673250|FG003|Overall Study|other|2|||
149875228|NCT02383810|540673251|FG004|Overall Study|other|0|||
149875229|NCT02383810|540673252|FG005|Overall Study|other|0|||
149875230|NCT02383810|540673253|FG006|Overall Study|other|0|||
149875231|NCT02383810|540673254|FG007|Overall Study|other|0|||
149875232|NCT02383810|540673247|FG000|Overall Study|subject did not receive study treatment|0|||
149875233|NCT02383810|540673248|FG001|Overall Study|subject did not receive study treatment|1|||
149875234|NCT02383810|540673249|FG002|Overall Study|subject did not receive study treatment|0|||
149875235|NCT02383810|540673250|FG003|Overall Study|subject did not receive study treatment|0|||
149875236|NCT02383810|540673251|FG004|Overall Study|subject did not receive study treatment|0|||
149875237|NCT02383810|540673252|FG005|Overall Study|subject did not receive study treatment|0|||
149875238|NCT02383810|540673253|FG006|Overall Study|subject did not receive study treatment|0|||
149875239|NCT02383810|540673254|FG007|Overall Study|subject did not receive study treatment|0|||
149875240|NCT03247816|540673257|FG000|Overall Study|Adverse Event|12|||
149875241|NCT03247816|540673257|FG000|Overall Study|Physician Decision|3|||
149875242|NCT03247816|540673257|FG000|Overall Study|Lack of Efficacy|1|||
149875243|NCT03247816|540673257|FG000|Overall Study|Lost to Follow-up|10|||
149875244|NCT03247816|540673257|FG000|Overall Study|Missing Feraccru stop date|3|||
149875245|NCT02861014|540673258|FG000|Primary Analysis|Adverse Event|7|||
149875246|NCT02861014|540673258|FG000|Primary Analysis|Death|1|||
149963902|NCT01557569|541003132|FG001|Overall Study|noncompliance with rules of residential|1|||
149963903|NCT02254460|541003133|FG000|Overall Study|Adverse Event|1|||
149875247|NCT02861014|540673258|FG000|Primary Analysis|Lack of Efficacy|3|||
149875248|NCT02861014|540673258|FG000|Primary Analysis|Physician Decision|2|||
149875249|NCT02861014|540673258|FG000|Primary Analysis|Pregnancy|4|||
149875250|NCT02861014|540673258|FG000|Primary Analysis|Protocol Violation|2|||
149963904|NCT02254460|541003134|FG001|Overall Study|Adverse Event|0|||
149875251|NCT02861014|540673258|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
149875252|NCT02861014|540673258|FG000|Primary Analysis|Withdrawal by Subject|14|||
149875253|NCT02861014|540673258|FG000|Primary Analysis|Commercial ocrelizumab|3|||
149875254|NCT02861014|540673258|FG000|Safety Follow-up|Adverse Event|1|||
149875255|NCT02861014|540673258|FG000|Safety Follow-up|Pregnancy|1|||
149875256|NCT02861014|540673258|FG000|Safety Follow-up|Withdrawal by Subject|9|||
149875257|NCT02861014|540673258|FG000|Safety Follow-up|Study terminated by sponsor|1|||
149875258|NCT02861014|540673258|FG000|Safety Follow-up|Physician Decision|1|||
149875259|NCT02861014|540673258|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
149875260|NCT02861014|540673258|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
149875261|NCT00926783|540673261|FG000|Overall Study|Incomplete CFAE Procedures|3|||
149875262|NCT00926783|540673262|FG001|Overall Study|Incomplete CFAE Procedures|3|||
149875263|NCT00696787|540673263|FG000|Overall Study|Adverse Event|1|||
149875264|NCT00696787|540673264|FG001|Overall Study|Adverse Event|0|||
149875265|NCT00696787|540673265|FG002|Overall Study|Adverse Event|6|||
149875266|NCT00696787|540673263|FG000|Overall Study|Discontinuation by Sponsor|9|||
149875267|NCT00696787|540673264|FG001|Overall Study|Discontinuation by Sponsor|13|||
149875268|NCT00696787|540673265|FG002|Overall Study|Discontinuation by Sponsor|14|||
149875269|NCT00696787|540673263|FG000|Overall Study|Lack of Efficacy|0|||
149875270|NCT00696787|540673264|FG001|Overall Study|Lack of Efficacy|1|||
149875271|NCT00696787|540673265|FG002|Overall Study|Lack of Efficacy|0|||
149875272|NCT00696787|540673263|FG000|Overall Study|Lost to Follow-up|4|||
149875273|NCT00696787|540673264|FG001|Overall Study|Lost to Follow-up|0|||
149875274|NCT00696787|540673265|FG002|Overall Study|Lost to Follow-up|3|||
149875275|NCT00696787|540673263|FG000|Overall Study|Withdrawal by Subject|0|||
149875276|NCT00696787|540673264|FG001|Overall Study|Withdrawal by Subject|3|||
149875277|NCT00696787|540673265|FG002|Overall Study|Withdrawal by Subject|2|||
149875278|NCT00696787|540673263|FG000|Overall Study|Failed to return|1|||
149875279|NCT00696787|540673264|FG001|Overall Study|Failed to return|3|||
149875280|NCT00696787|540673265|FG002|Overall Study|Failed to return|1|||
149875281|NCT02278055|540673266|FG000|Overall Study|Adverse Event|1|||
149875282|NCT02278055|540673266|FG000|Overall Study|Lost to Follow-up|1|||
149875283|NCT02278055|540673266|FG000|Overall Study|Withdrawal by Subject|2|||
149875284|NCT02278055|540673266|FG000|Overall Study|Progressive Disease|4|||
149875285|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
149875286|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
149875287|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
149875288|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
149875289|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
149875290|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
149875291|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
149875292|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
149875293|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
149875294|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
149875295|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
149875296|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
149875297|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
149875298|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
149875299|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
149875300|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
149875301|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
149875302|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
149875303|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
149875304|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
149875305|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
149875306|NCT04040192|540673267|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
149963905|NCT00993473|541003135|FG000|Overall Study|Adverse Event|0|||
149963906|NCT00993473|541003136|FG001|Overall Study|Adverse Event|2|||
149963907|NCT00993473|541003135|FG000|Overall Study|Protocol Violation|1|||
149963908|NCT00993473|541003136|FG001|Overall Study|Protocol Violation|2|||
149963909|NCT00993473|541003135|FG000|Overall Study|Lost to Follow-up|1|||
149963910|NCT00993473|541003136|FG001|Overall Study|Lost to Follow-up|0|||
149875307|NCT04040192|540673268|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
149875308|NCT04040192|540673269|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
149875309|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
149875310|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
149875311|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
149963911|NCT00993473|541003135|FG000|Overall Study|Withdrawal by Subject|1|||
149963912|NCT00993473|541003136|FG001|Overall Study|Withdrawal by Subject|5|||
149963913|NCT00993473|541003135|FG000|Overall Study|Technical problem with CGM device|0|||
149875312|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
149875313|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
149875314|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
149875315|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
149875316|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
149875317|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
149875318|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
149875319|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
149875320|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
149875321|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
149875322|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
149875323|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
149875324|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
149875325|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
149875326|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
149875327|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
149875328|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
149875329|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
149875330|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
149875331|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
149875332|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
149875333|NCT04040192|540673267|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
149875334|NCT04040192|540673268|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
149875335|NCT04040192|540673269|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
149875336|NCT00469144|540673270|FG000|Overall Study|Death|0|||
149875337|NCT00469144|540673271|FG001|Overall Study|Death|1|||
149875338|NCT00469144|540673270|FG000|Overall Study|No Response|5|||
149875339|NCT00469144|540673271|FG001|Overall Study|No Response|5|||
149875340|NCT00469144|540673270|FG000|Overall Study|Progressive Disease|1|||
149875341|NCT00469144|540673271|FG001|Overall Study|Progressive Disease|0|||
149875342|NCT01292226|540673273|FG000|Overall Study|Adverse Event|5|||
149875343|NCT01292226|540673273|FG000|Overall Study|Death|1|||
149875344|NCT01292226|540673273|FG000|Overall Study|Graft loss|1|||
149875345|NCT01292226|540673273|FG000|Overall Study|Protocol Violation|3|||
149875346|NCT01292226|540673273|FG000|Overall Study|Withdrawal by Subject|1|||
149875347|NCT01292226|540673273|FG000|Overall Study|Other|2|||
149875348|NCT04106661|540673274|FG000|Overall Study|Protocol Violation|3|||
149875349|NCT04106661|540673275|FG001|Overall Study|Protocol Violation|0|||
149875350|NCT04106661|540673274|FG000|Overall Study|Scheduling difficulties|1|||
149875351|NCT04106661|540673275|FG001|Overall Study|Scheduling difficulties|1|||
149875352|NCT00233402|540673276|FG000|Overall Study|No pathology data|12|||
149875353|NCT00233402|540673277|FG001|Overall Study|No pathology data|9|||
149875354|NCT00233402|540673276|FG000|Overall Study|No Ta/T1|89|||
149875355|NCT00233402|540673277|FG001|Overall Study|No Ta/T1|94|||
149875356|NCT00233402|540673276|FG000|Overall Study|Lost to follow up etc|3|||
149875357|NCT00233402|540673277|FG001|Overall Study|Lost to follow up etc|21|||
149875358|NCT03503864|540673278|FG000|Overall Study|Protocol Violation|6|||
149875359|NCT03503864|540673278|FG000|Overall Study|Withdrawal by Subject|7|||
149875360|NCT00426361|540673279|FG000|Overall Study|Lost to Follow-up|3|||
149875361|NCT00426361|540673280|FG001|Overall Study|Lost to Follow-up|2|||
149875362|NCT00426361|540673281|FG002|Overall Study|Lost to Follow-up|5|||
149875363|NCT00426361|540673279|FG000|Overall Study|Withdrawal by Subject|1|||
149875364|NCT00426361|540673280|FG001|Overall Study|Withdrawal by Subject|3|||
149875365|NCT00426361|540673281|FG002|Overall Study|Withdrawal by Subject|0|||
149875366|NCT02828241|540673282|FG000|Overall Study|Adverse Event|7|||
149875367|NCT02828241|540673283|FG001|Overall Study|Adverse Event|2|||
149875368|NCT02828241|540673282|FG000|Overall Study|Protocol Violation|1|||
149875369|NCT02828241|540673283|FG001|Overall Study|Protocol Violation|0|||
149875370|NCT04572893|540673289|FG000|Part A|Adverse Event|1|||
149875371|NCT04572893|540673290|FG001|Part A|Adverse Event|0|||
149875372|NCT04572893|540673291|FG002|Part A|Adverse Event|0|||
149875373|NCT04572893|540673292|FG003|Part A|Adverse Event|0|||
149875374|NCT04572893|540673293|FG004|Part A|Adverse Event|0|||
149875375|NCT04572893|540673294|FG005|Part A|Adverse Event|0|||
149875376|NCT04572893|540673295|FG006|Part A|Adverse Event|0|||
149875377|NCT04572893|540673289|FG000|Part B|Withdrawal by Subject|0|||
149875378|NCT04572893|540673290|FG001|Part B|Withdrawal by Subject|0|||
149875379|NCT04572893|540673291|FG002|Part B|Withdrawal by Subject|0|||
149875380|NCT04572893|540673292|FG003|Part B|Withdrawal by Subject|0|||
149875381|NCT04572893|540673293|FG004|Part B|Withdrawal by Subject|0|||
149875382|NCT04572893|540673294|FG005|Part B|Withdrawal by Subject|1|||
149875383|NCT04572893|540673295|FG006|Part B|Withdrawal by Subject|0|||
149875384|NCT04572893|540673289|FG000|Part B|Study terminated by sponsor|0|||
149875385|NCT04572893|540673290|FG001|Part B|Study terminated by sponsor|0|||
149875386|NCT04572893|540673291|FG002|Part B|Study terminated by sponsor|0|||
149875387|NCT04572893|540673292|FG003|Part B|Study terminated by sponsor|0|||
149875388|NCT04572893|540673293|FG004|Part B|Study terminated by sponsor|7|||
149875389|NCT04572893|540673294|FG005|Part B|Study terminated by sponsor|5|||
149875390|NCT04572893|540673295|FG006|Part B|Study terminated by sponsor|3|||
149875391|NCT04572893|540673289|FG000|Part B|Lost to Follow-up|0|||
149875392|NCT04572893|540673290|FG001|Part B|Lost to Follow-up|0|||
149875393|NCT04572893|540673291|FG002|Part B|Lost to Follow-up|0|||
149875394|NCT04572893|540673292|FG003|Part B|Lost to Follow-up|0|||
149875395|NCT04572893|540673293|FG004|Part B|Lost to Follow-up|0|||
149875396|NCT04572893|540673294|FG005|Part B|Lost to Follow-up|0|||
149875397|NCT04572893|540673295|FG006|Part B|Lost to Follow-up|1|||
149875398|NCT04572893|540673289|FG000|Part B|Adverse Event|0|||
149875399|NCT04572893|540673290|FG001|Part B|Adverse Event|0|||
149875400|NCT04572893|540673291|FG002|Part B|Adverse Event|0|||
149875401|NCT04572893|540673292|FG003|Part B|Adverse Event|0|||
149875402|NCT04572893|540673293|FG004|Part B|Adverse Event|1|||
149875403|NCT04572893|540673294|FG005|Part B|Adverse Event|1|||
149875404|NCT04572893|540673295|FG006|Part B|Adverse Event|0|||
149875405|NCT05038800|540673296|FG000|Overall Study|Death|1|||
149875406|NCT05038800|540673297|FG001|Overall Study|Death|1|||
149875407|NCT05038800|540673298|FG002|Overall Study|Death|5|||
149875408|NCT05038800|540673299|FG003|Overall Study|Death|3|||
149875409|NCT05038800|540673300|FG004|Overall Study|Death|1|||
149963914|NCT00993473|541003136|FG001|Overall Study|Technical problem with CGM device|1|||
149963915|NCT00993473|541003135|FG000|Overall Study|Family event|1|||
149963916|NCT00993473|541003136|FG001|Overall Study|Family event|0|||
149963917|NCT00129974|541003137|FG000|Overall Study|Other|1|||
149963918|NCT05122143|541003138|FG000|Overall Study|Adverse Event|1|||
149963919|NCT05122143|541003139|FG001|Overall Study|Adverse Event|0|||
149963920|NCT05122143|541003140|FG002|Overall Study|Adverse Event|0|||
149963921|NCT05122143|541003141|FG003|Overall Study|Adverse Event|0|||
149963922|NCT05122143|541003142|FG004|Overall Study|Adverse Event|1|||
149963923|NCT05122143|541003143|FG005|Overall Study|Adverse Event|0|||
149963924|NCT05122143|541003138|FG000|Overall Study|Protocol non-compliance|0|||
149963925|NCT05122143|541003139|FG001|Overall Study|Protocol non-compliance|0|||
149963926|NCT05122143|541003140|FG002|Overall Study|Protocol non-compliance|1|||
149963927|NCT05122143|541003141|FG003|Overall Study|Protocol non-compliance|0|||
149963928|NCT05122143|541003142|FG004|Overall Study|Protocol non-compliance|0|||
149963929|NCT05122143|541003143|FG005|Overall Study|Protocol non-compliance|0|||
149963930|NCT05122143|541003138|FG000|Overall Study|Covid contact|0|||
149875410|NCT05038800|540673296|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149875411|NCT05038800|540673297|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149875412|NCT05038800|540673298|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149875413|NCT05038800|540673299|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149875414|NCT05038800|540673300|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149875415|NCT05038800|540673296|FG000|Overall Study|Lack of Efficacy|0|||
149875416|NCT05038800|540673297|FG001|Overall Study|Lack of Efficacy|0|||
149875417|NCT05038800|540673298|FG002|Overall Study|Lack of Efficacy|0|||
149875418|NCT05038800|540673299|FG003|Overall Study|Lack of Efficacy|0|||
149875419|NCT05038800|540673300|FG004|Overall Study|Lack of Efficacy|1|||
149875420|NCT00121134|540673301|FG000|Overall Study|Progression of Disease|5|||
149875421|NCT00121134|540673302|FG001|Overall Study|Progression of Disease|3|||
149875422|NCT00121134|540673303|FG002|Overall Study|Progression of Disease|4|||
149875423|NCT00121134|540673304|FG003|Overall Study|Progression of Disease|2|||
149875424|NCT00121134|540673301|FG000|Overall Study|Toxicity|4|||
149875425|NCT00121134|540673302|FG001|Overall Study|Toxicity|7|||
149875426|NCT00121134|540673303|FG002|Overall Study|Toxicity|13|||
149875427|NCT00121134|540673304|FG003|Overall Study|Toxicity|5|||
149875428|NCT00121134|540673301|FG000|Overall Study|Physician Decision|6|||
149875429|NCT00121134|540673302|FG001|Overall Study|Physician Decision|4|||
149875430|NCT00121134|540673303|FG002|Overall Study|Physician Decision|4|||
149875431|NCT00121134|540673304|FG003|Overall Study|Physician Decision|1|||
149875432|NCT00121134|540673301|FG000|Overall Study|Treatment Delay|1|||
149875433|NCT00121134|540673302|FG001|Overall Study|Treatment Delay|0|||
149875434|NCT00121134|540673303|FG002|Overall Study|Treatment Delay|0|||
149875435|NCT00121134|540673304|FG003|Overall Study|Treatment Delay|0|||
149875436|NCT00121134|540673301|FG000|Overall Study|Intercurrent Illness|0|||
149875437|NCT00121134|540673302|FG001|Overall Study|Intercurrent Illness|0|||
149875438|NCT00121134|540673303|FG002|Overall Study|Intercurrent Illness|0|||
149875439|NCT00121134|540673304|FG003|Overall Study|Intercurrent Illness|1|||
149875440|NCT00121134|540673301|FG000|Overall Study|Patient Personal Reasons|0|||
149875441|NCT00121134|540673302|FG001|Overall Study|Patient Personal Reasons|1|||
149875442|NCT00121134|540673303|FG002|Overall Study|Patient Personal Reasons|0|||
149875443|NCT00121134|540673304|FG003|Overall Study|Patient Personal Reasons|0|||
149875444|NCT03050060|540673312|FG000|Overall Study|Adverse Event|7|||
149875445|NCT03050060|540673312|FG000|Overall Study|Withdrawal by Subject|1|||
149875446|NCT03050060|540673312|FG000|Overall Study|Progression|7|||
149875447|NCT00510289|540673313|FG000|Overall Study|Withdrawal by Subject|7|||
149875448|NCT00510289|540673313|FG000|Overall Study|Refused bone marrow biopsy|2|||
149875449|NCT00510289|540673313|FG000|Overall Study|Lost to Follow-up|1|||
149963931|NCT05122143|541003139|FG001|Overall Study|Covid contact|0|||
149963932|NCT05122143|541003140|FG002|Overall Study|Covid contact|0|||
149963933|NCT05122143|541003141|FG003|Overall Study|Covid contact|0|||
149963934|NCT05122143|541003142|FG004|Overall Study|Covid contact|1|||
150042941|NCT02839200|541295648|FG001|Overall Study|Withdrawal by Subject|0|||
150042942|NCT02839200|541295649|FG002|Overall Study|Withdrawal by Subject|1|||
149875450|NCT00510289|540673313|FG000|Overall Study|Progressed prior to starting drug|2|||
149875451|NCT04853992|540673316|FG000|Treatment Period A|Adverse Event|0|||
149875452|NCT04853992|540673317|FG001|Treatment Period A|Adverse Event|1|||
149875453|NCT04853992|540673316|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
149875454|NCT04853992|540673317|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
149875455|NCT01094886|540673318|FG000|Overall Study|Adverse Event|2|||
149875456|NCT01094886|540673318|FG000|Overall Study|Withdrawal by Subject|5|||
149875457|NCT00371397|540673323|FG000|Session 1|Withdrawal by Subject|1|||
149875458|NCT00371397|540673324|FG001|Session 1|Withdrawal by Subject|0|||
149875459|NCT00371397|540673325|FG002|Session 1|Withdrawal by Subject|0|||
149875460|NCT00371397|540673326|FG003|Session 1|Withdrawal by Subject|0|||
149963935|NCT05122143|541003143|FG005|Overall Study|Covid contact|0|||
150042943|NCT02839200|541295650|FG003|Overall Study|Withdrawal by Subject|0|||
149875461|NCT00371397|540673327|FG004|Session 1|Withdrawal by Subject|0|||
149875462|NCT00371397|540673328|FG005|Session 1|Withdrawal by Subject|0|||
149875463|NCT00371397|540673329|FG006|Session 1|Withdrawal by Subject|0|||
149875464|NCT00371397|540673330|FG007|Session 1|Withdrawal by Subject|1|||
149875465|NCT00371397|540673331|FG008|Session 1|Withdrawal by Subject|0|||
149875466|NCT00371397|540673332|FG009|Session 1|Withdrawal by Subject|0|||
150042944|NCT02839200|541295651|FG004|Overall Study|Withdrawal by Subject|0|||
150042945|NCT02839200|541295652|FG005|Overall Study|Withdrawal by Subject|1|||
150042946|NCT02839200|541295647|FG000|Overall Study|Lost to Follow-up|2|||
150042947|NCT02839200|541295648|FG001|Overall Study|Lost to Follow-up|0|||
150042948|NCT02839200|541295649|FG002|Overall Study|Lost to Follow-up|0|||
150042949|NCT02839200|541295650|FG003|Overall Study|Lost to Follow-up|0|||
150042950|NCT02839200|541295651|FG004|Overall Study|Lost to Follow-up|1|||
149875467|NCT00371397|540673333|FG010|Session 1|Withdrawal by Subject|0|||
149875468|NCT00371397|540673334|FG011|Session 1|Withdrawal by Subject|0|||
149875469|NCT01284621|540673335|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
149875470|NCT01284621|540673336|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
149875471|NCT01284621|540673337|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
149875472|NCT01284621|540673338|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
149875473|NCT01284621|540673339|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
149875474|NCT01284621|540673340|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
149875475|NCT02342639|540673343|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
149875476|NCT02342639|540673344|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
149875477|NCT02342639|540673343|FG000|Overall Study|Protocol Violation|0|||
149875478|NCT02342639|540673344|FG001|Overall Study|Protocol Violation|2|||
149875479|NCT02293863|540673345|FG000|Overall Study|Death|4|||
149875480|NCT02293863|540673346|FG001|Overall Study|Death|6|||
149875481|NCT02293863|540673347|FG002|Overall Study|Death|4|||
149963936|NCT01475825|541003144|FG000|Overall Study|Adverse Event|41|||
149963937|NCT01475825|541003145|FG001|Overall Study|Adverse Event|15|||
149963938|NCT01475825|541003146|FG002|Overall Study|Adverse Event|27|||
149963939|NCT01475825|541003147|FG003|Overall Study|Adverse Event|11|||
149963940|NCT01475825|541003144|FG000|Overall Study|Death|1|||
149963941|NCT01475825|541003145|FG001|Overall Study|Death|0|||
149963942|NCT01475825|541003146|FG002|Overall Study|Death|1|||
149963943|NCT01475825|541003147|FG003|Overall Study|Death|0|||
149963944|NCT01475825|541003144|FG000|Overall Study|Lack of Efficacy|0|||
149963945|NCT01475825|541003145|FG001|Overall Study|Lack of Efficacy|0|||
149963946|NCT01475825|541003146|FG002|Overall Study|Lack of Efficacy|1|||
149963947|NCT01475825|541003147|FG003|Overall Study|Lack of Efficacy|0|||
149963948|NCT01475825|541003144|FG000|Overall Study|Lost to Follow-up|0|||
149963949|NCT01475825|541003145|FG001|Overall Study|Lost to Follow-up|0|||
149963950|NCT01475825|541003146|FG002|Overall Study|Lost to Follow-up|3|||
149963951|NCT01475825|541003147|FG003|Overall Study|Lost to Follow-up|1|||
149963952|NCT01475825|541003144|FG000|Overall Study|Non-compliance with Study Drug|1|||
149963953|NCT01475825|541003145|FG001|Overall Study|Non-compliance with Study Drug|2|||
149963954|NCT01475825|541003146|FG002|Overall Study|Non-compliance with Study Drug|4|||
149963955|NCT01475825|541003147|FG003|Overall Study|Non-compliance with Study Drug|0|||
149963956|NCT01475825|541003144|FG000|Overall Study|Other: Not available|0|||
149963957|NCT01475825|541003145|FG001|Overall Study|Other: Not available|0|||
149963958|NCT01475825|541003146|FG002|Overall Study|Other: Not available|2|||
149963959|NCT01475825|541003147|FG003|Overall Study|Other: Not available|0|||
149963960|NCT01475825|541003144|FG000|Overall Study|Protocol Violation|1|||
150042951|NCT02839200|541295652|FG005|Overall Study|Lost to Follow-up|0|||
150042952|NCT02839200|541295647|FG000|Overall Study|Adverse Event|0|||
150042953|NCT02839200|541295648|FG001|Overall Study|Adverse Event|0|||
149875482|NCT02293863|540673345|FG000|Overall Study|Lost to Follow-up|2|||
149963961|NCT01475825|541003145|FG001|Overall Study|Protocol Violation|0|||
149963962|NCT01475825|541003146|FG002|Overall Study|Protocol Violation|0|||
149963963|NCT01475825|541003147|FG003|Overall Study|Protocol Violation|0|||
149963964|NCT01475825|541003144|FG000|Overall Study|Physician Decision|0|||
149875483|NCT02293863|540673346|FG001|Overall Study|Lost to Follow-up|2|||
149875484|NCT02293863|540673347|FG002|Overall Study|Lost to Follow-up|2|||
149875485|NCT02293863|540673345|FG000|Overall Study|Withdrawal by Subject|3|||
149875486|NCT02293863|540673346|FG001|Overall Study|Withdrawal by Subject|3|||
149875487|NCT02293863|540673347|FG002|Overall Study|Withdrawal by Subject|1|||
150042954|NCT02839200|541295649|FG002|Overall Study|Adverse Event|0|||
150042955|NCT02839200|541295650|FG003|Overall Study|Adverse Event|0|||
150042956|NCT02839200|541295651|FG004|Overall Study|Adverse Event|1|||
149875488|NCT02293863|540673345|FG000|Overall Study|Reason Not Specified|0|||
149875489|NCT02293863|540673346|FG001|Overall Study|Reason Not Specified|2|||
149875490|NCT02293863|540673347|FG002|Overall Study|Reason Not Specified|2|||
149875491|NCT00416884|540673350|FG000|Overall Study|Study terminated due to low accrual|1|||
149875492|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
149875493|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
149875494|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875495|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875496|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875497|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875498|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875499|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875500|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875501|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875502|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875503|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875504|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875505|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
149875506|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
149875507|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
149875508|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875509|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875510|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875511|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875512|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875513|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875514|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875515|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875516|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875517|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875518|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875519|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
149875520|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
149875521|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
149875522|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875523|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875524|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875525|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
150042957|NCT02839200|541295652|FG005|Overall Study|Adverse Event|0|||
150042958|NCT02839200|541295647|FG000|Overall Study|Randomized in error|0|||
150042959|NCT02839200|541295648|FG001|Overall Study|Randomized in error|1|||
150042960|NCT02839200|541295649|FG002|Overall Study|Randomized in error|0|||
150042961|NCT02839200|541295650|FG003|Overall Study|Randomized in error|0|||
150042962|NCT02839200|541295651|FG004|Overall Study|Randomized in error|0|||
150042963|NCT02839200|541295652|FG005|Overall Study|Randomized in error|0|||
150042964|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
150042965|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
150042966|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
150042967|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
149875526|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875527|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875528|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875529|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875530|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875531|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875532|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875533|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
149875534|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
149875535|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
149875536|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875537|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875538|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875539|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875540|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875541|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875542|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875543|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875544|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875545|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875546|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875547|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
149875548|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
149875549|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
149875550|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875551|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875552|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875553|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875554|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875555|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875556|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875557|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875558|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875559|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875560|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875561|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
149875562|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
149875563|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
149875564|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875565|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875566|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875567|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
150042968|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
150042969|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
150042970|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
150042971|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
150042972|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
150042973|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
150042974|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
150042975|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
150042976|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
150042977|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
149875568|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875569|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875570|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875571|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875572|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875573|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875574|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149875575|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
149963965|NCT01475825|541003145|FG001|Overall Study|Physician Decision|1|||
149875576|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
149875577|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
149875578|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875579|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875580|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875581|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875582|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875583|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875584|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875585|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875586|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875587|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875588|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875589|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
149875590|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
149875591|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
149875592|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875593|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875594|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875595|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875596|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875597|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875598|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875599|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875600|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875601|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875602|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875603|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
149875604|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
149875605|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
149875606|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875607|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875608|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875609|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875610|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875611|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875612|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875613|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875614|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875615|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875616|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875617|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
149875618|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
149875619|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
149963966|NCT01475825|541003146|FG002|Overall Study|Physician Decision|0|||
149963967|NCT01475825|541003147|FG003|Overall Study|Physician Decision|0|||
149963968|NCT01475825|541003144|FG000|Overall Study|Withdrawal by Subject|8|||
149963969|NCT01475825|541003145|FG001|Overall Study|Withdrawal by Subject|3|||
149963970|NCT01475825|541003146|FG002|Overall Study|Withdrawal by Subject|11|||
149963971|NCT01475825|541003147|FG003|Overall Study|Withdrawal by Subject|7|||
149963972|NCT01475825|541003144|FG000|Overall Study|Did not enter OLC|15|||
149963973|NCT01475825|541003145|FG001|Overall Study|Did not enter OLC|11|||
149963974|NCT01475825|541003146|FG002|Overall Study|Did not enter OLC|15|||
149963975|NCT01475825|541003147|FG003|Overall Study|Did not enter OLC|11|||
149963976|NCT00160563|541003148|FG000|Overall Study|Adverse Event|1|||
149963977|NCT00160563|541003149|FG001|Overall Study|Adverse Event|1|||
149963978|NCT00160563|541003150|FG002|Overall Study|Adverse Event|1|||
149963979|NCT00160563|541003148|FG000|Overall Study|Lost to Follow-up|1|||
149963980|NCT00160563|541003149|FG001|Overall Study|Lost to Follow-up|1|||
149963981|NCT00160563|541003150|FG002|Overall Study|Lost to Follow-up|2|||
149963982|NCT00160563|541003148|FG000|Overall Study|Protocol Violation|0|||
149963983|NCT00160563|541003149|FG001|Overall Study|Protocol Violation|0|||
149963984|NCT00160563|541003150|FG002|Overall Study|Protocol Violation|3|||
149963985|NCT00160563|541003148|FG000|Overall Study|Withdrawal by Subject|1|||
149963986|NCT00160563|541003149|FG001|Overall Study|Withdrawal by Subject|2|||
149963987|NCT00160563|541003150|FG002|Overall Study|Withdrawal by Subject|3|||
149963988|NCT00160563|541003148|FG000|Overall Study|Other (listed in the study report)|48|||
149963989|NCT00160563|541003149|FG001|Overall Study|Other (listed in the study report)|40|||
150174153|NCT01585558|541773039|FG000|Overall Study|Lost to Follow-up|2|||
149875620|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875621|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875622|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875623|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875624|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875625|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875626|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875627|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875628|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875629|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875630|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875631|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
149875632|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
149875633|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
149875634|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875635|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875636|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875637|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875638|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875639|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875640|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875641|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875642|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875643|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875644|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875645|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
149875646|NCT03982199|540673351|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
149875647|NCT03982199|540673352|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
149875648|NCT03982199|540673353|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875649|NCT03982199|540673354|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875650|NCT03982199|540673355|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875651|NCT03982199|540673356|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875652|NCT03982199|540673357|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875653|NCT03982199|540673358|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875654|NCT03982199|540673359|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875655|NCT03982199|540673360|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875656|NCT03982199|540673361|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875657|NCT03982199|540673362|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875658|NCT03982199|540673363|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875659|NCT03982199|540673364|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
149875660|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875661|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875662|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875663|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
149875664|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875665|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875666|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875667|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875668|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875669|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875670|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875671|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875672|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875673|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
149875674|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875675|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875676|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
149875677|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875678|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875679|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149963990|NCT00160563|541003150|FG002|Overall Study|Other (listed in the study report)|81|||
149963991|NCT00160563|541003148|FG000|Overall Study|Missing reason|0|||
149875680|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875681|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875682|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875683|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875684|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875685|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875686|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875687|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
149875688|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875689|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875690|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
149875691|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875692|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875693|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875694|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875695|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875696|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875697|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875698|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875699|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875700|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875701|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
149875702|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875703|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875704|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
150042978|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
150042979|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
150042980|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
150042981|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
150042982|NCT02952820|541295653|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
149875705|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
149875706|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875707|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875708|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875709|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875710|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875711|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875712|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875713|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875714|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875715|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
149875716|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875717|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875718|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875719|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
149875720|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875721|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875722|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875723|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875724|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875725|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875726|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875727|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875728|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875729|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
149875730|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875731|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875732|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
149875733|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
149875734|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
150042983|NCT02952820|541295654|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
149875735|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875736|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875737|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875738|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875739|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875740|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875741|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875742|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875743|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
149875744|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875745|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875746|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875747|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875748|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875749|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875750|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875751|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875752|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
149875753|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875754|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875755|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875756|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875757|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
149875758|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875759|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875760|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875761|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875762|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875763|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875764|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875765|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875766|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
149875767|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875768|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875769|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875770|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875771|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
149875772|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875773|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875774|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875775|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875776|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875777|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875778|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875779|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875780|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
149875781|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875782|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875783|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875784|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875785|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
149875786|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875787|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875788|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875789|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875790|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875791|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875792|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875793|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875794|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
149875795|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875796|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149963992|NCT00160563|541003149|FG001|Overall Study|Missing reason|1|||
150174154|NCT01585558|541773040|FG001|Overall Study|Lost to Follow-up|0|||
150174155|NCT01585558|541773041|FG002|Overall Study|Lost to Follow-up|3|||
150042984|NCT02952820|541295655|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
150042985|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
150042986|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
150042987|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
150042988|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
150042989|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
150042990|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
150042991|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
150042992|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
150042993|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
150174156|NCT01585558|541773039|FG000|Overall Study|Adverse Event|3|||
150174157|NCT01585558|541773040|FG001|Overall Study|Adverse Event|4|||
150174158|NCT01585558|541773041|FG002|Overall Study|Adverse Event|1|||
149875797|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875798|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875799|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
149875800|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875801|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875802|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875803|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875804|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875805|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875806|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875807|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875808|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
149875809|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875810|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875811|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875812|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
149875813|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
150042994|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
150174159|NCT01585558|541773039|FG000|Overall Study|Protocol Violation|4|||
150174160|NCT01585558|541773040|FG001|Overall Study|Protocol Violation|3|||
149875814|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875815|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875816|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875817|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875818|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875819|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
149875820|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875821|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
149875822|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
149875823|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875824|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875825|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875826|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875827|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
149875828|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875829|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875830|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875831|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875832|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875833|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875834|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875835|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875836|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
149875837|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875838|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875839|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875840|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875841|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
149875842|NCT03982199|540673351|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875843|NCT03982199|540673352|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875844|NCT03982199|540673353|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875845|NCT03982199|540673354|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875846|NCT03982199|540673355|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875847|NCT03982199|540673356|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
149875848|NCT03982199|540673357|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875849|NCT03982199|540673358|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
149875850|NCT03982199|540673359|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
149875851|NCT03982199|540673360|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875852|NCT03982199|540673361|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875853|NCT03982199|540673362|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875854|NCT03982199|540673363|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875855|NCT03982199|540673364|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
149875856|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875857|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875858|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875859|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875860|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875861|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149963993|NCT00160563|541003150|FG002|Overall Study|Missing reason|0|||
149963994|NCT04157738|541003151|FG000|Overall Study|Moved out of state|0|||
149875862|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875863|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875864|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
149875865|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
149875866|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
149875867|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
149875868|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
149875869|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
149875870|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875871|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875872|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875873|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875874|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875875|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875876|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875877|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875878|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875879|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
149875880|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875881|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875882|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875883|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
149875884|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875885|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875886|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875887|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875888|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875889|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875890|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875891|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875892|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875893|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875894|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875895|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875896|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149875897|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
149875898|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875899|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875900|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875901|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875902|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875903|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875904|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875905|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875906|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875907|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875908|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
149875909|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
149875910|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
149875911|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
149875912|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875913|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875914|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875915|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875916|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875917|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875918|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875919|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875920|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875921|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875922|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875923|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875924|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
149875925|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
149875926|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875927|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875928|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875929|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875930|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875931|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875932|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875933|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875934|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875935|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149963995|NCT04157738|541003152|FG001|Overall Study|Moved out of state|2|||
149963996|NCT04157738|541003151|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
149963997|NCT04157738|541003152|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
149963998|NCT00309946|541003153|FG000|Overall Study|Withdrawal by Subject|1|||
149963999|NCT02244957|541003157|FG000|Overall Study|Lack of Efficacy|1|||
149964000|NCT02244957|541003158|FG001|Overall Study|Lack of Efficacy|0|||
149964001|NCT00395447|541003162|FG000|Overall Study|Death|37|||
149964002|NCT00395447|541003163|FG001|Overall Study|Death|32|||
149964003|NCT00395447|541003162|FG000|Overall Study|Lost to Follow-up|52|||
149964004|NCT00395447|541003163|FG001|Overall Study|Lost to Follow-up|43|||
149964005|NCT00395447|541003162|FG000|Overall Study|Withdrawal by Subject|24|||
149964006|NCT00395447|541003163|FG001|Overall Study|Withdrawal by Subject|19|||
149964007|NCT00395447|541003162|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
149964008|NCT00395447|541003163|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
149964009|NCT03766906|541003164|FG000|Overall Study|Withdrawal by Subject|6|||
149964010|NCT04691115|541003168|FG000|Overall Study|Withdrawal by Subject|0|||
149964011|NCT04691115|541003169|FG001|Overall Study|Withdrawal by Subject|0|||
149964012|NCT04691115|541003170|FG002|Overall Study|Withdrawal by Subject|0|||
149964013|NCT04691115|541003171|FG003|Overall Study|Withdrawal by Subject|0|||
149964014|NCT04691115|541003172|FG004|Overall Study|Withdrawal by Subject|0|||
149964015|NCT04691115|541003173|FG005|Overall Study|Withdrawal by Subject|1|||
149964016|NCT04691115|541003174|FG006|Overall Study|Withdrawal by Subject|0|||
149964017|NCT04691115|541003175|FG007|Overall Study|Withdrawal by Subject|0|||
149964018|NCT04691115|541003176|FG008|Overall Study|Withdrawal by Subject|0|||
149964019|NCT04691115|541003177|FG009|Overall Study|Withdrawal by Subject|0|||
149964020|NCT04691115|541003178|FG010|Overall Study|Withdrawal by Subject|0|||
149964021|NCT04691115|541003179|FG011|Overall Study|Withdrawal by Subject|0|||
149964022|NCT04691115|541003180|FG012|Overall Study|Withdrawal by Subject|0|||
149964023|NCT04691115|541003181|FG013|Overall Study|Withdrawal by Subject|0|||
149964024|NCT01047540|541003185|FG000|Overall Study|Protocol Violation|1|||
149964025|NCT01047540|541003186|FG001|Overall Study|Protocol Violation|0|||
149964026|NCT01047540|541003187|FG002|Overall Study|Protocol Violation|0|||
150042995|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
149964027|NCT01047540|541003188|FG003|Overall Study|Protocol Violation|0|||
149964028|NCT01047540|541003189|FG004|Overall Study|Protocol Violation|0|||
149964029|NCT01047540|541003185|FG000|Overall Study|Lost to Follow-up|1|||
149964030|NCT01047540|541003186|FG001|Overall Study|Lost to Follow-up|0|||
149964031|NCT01047540|541003187|FG002|Overall Study|Lost to Follow-up|0|||
149964032|NCT01047540|541003188|FG003|Overall Study|Lost to Follow-up|0|||
150174161|NCT01585558|541773041|FG002|Overall Study|Protocol Violation|2|||
150174162|NCT01585558|541773039|FG000|Overall Study|Lack of Efficacy|0|||
150174163|NCT01585558|541773040|FG001|Overall Study|Lack of Efficacy|0|||
150174164|NCT01585558|541773041|FG002|Overall Study|Lack of Efficacy|1|||
150174165|NCT01350804|541773044|FG000|Core Study|Withdrawal by Subject|11|||
150174166|NCT01350804|541773045|FG001|Core Study|Withdrawal by Subject|17|||
150174167|NCT01350804|541773046|FG002|Core Study|Withdrawal by Subject|16|||
150174168|NCT01350804|541773047|FG003|Core Study|Withdrawal by Subject|7|||
150174169|NCT01350804|541773044|FG000|Core Study|Study terminated by Sponsor|0|||
150174170|NCT01350804|541773045|FG001|Core Study|Study terminated by Sponsor|0|||
150174171|NCT01350804|541773046|FG002|Core Study|Study terminated by Sponsor|0|||
150174172|NCT01350804|541773047|FG003|Core Study|Study terminated by Sponsor|2|||
150174173|NCT01350804|541773044|FG000|Core Study|Protocol deviation|1|||
150174174|NCT01350804|541773045|FG001|Core Study|Protocol deviation|0|||
150174175|NCT01350804|541773046|FG002|Core Study|Protocol deviation|1|||
150174176|NCT01350804|541773047|FG003|Core Study|Protocol deviation|0|||
150174177|NCT01350804|541773044|FG000|Core Study|Physician Decision|1|||
150174178|NCT01350804|541773045|FG001|Core Study|Physician Decision|0|||
150174179|NCT01350804|541773046|FG002|Core Study|Physician Decision|1|||
150174180|NCT01350804|541773047|FG003|Core Study|Physician Decision|3|||
150174181|NCT01350804|541773044|FG000|Core Study|Lost to Follow-up|3|||
150174182|NCT01350804|541773045|FG001|Core Study|Lost to Follow-up|0|||
150174183|NCT01350804|541773046|FG002|Core Study|Lost to Follow-up|2|||
150174184|NCT01350804|541773047|FG003|Core Study|Lost to Follow-up|1|||
150174185|NCT01350804|541773044|FG000|Core Study|Lack of Efficacy|16|||
150174186|NCT01350804|541773045|FG001|Core Study|Lack of Efficacy|19|||
150174187|NCT01350804|541773046|FG002|Core Study|Lack of Efficacy|18|||
150174188|NCT01350804|541773047|FG003|Core Study|Lack of Efficacy|5|||
150174189|NCT01350804|541773044|FG000|Core Study|Death|1|||
150174190|NCT01350804|541773045|FG001|Core Study|Death|1|||
150174191|NCT01350804|541773046|FG002|Core Study|Death|1|||
150174192|NCT01350804|541773047|FG003|Core Study|Death|0|||
150174193|NCT01350804|541773044|FG000|Core Study|Adverse Event|8|||
150174194|NCT01350804|541773045|FG001|Core Study|Adverse Event|10|||
150174195|NCT01350804|541773046|FG002|Core Study|Adverse Event|8|||
150174196|NCT01350804|541773047|FG003|Core Study|Adverse Event|8|||
150174197|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
150174198|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
149875936|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875937|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
149875938|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
149875939|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
149875940|NCT03982199|540673351|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875941|NCT03982199|540673352|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875942|NCT03982199|540673353|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875943|NCT03982199|540673354|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875944|NCT03982199|540673355|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875945|NCT03982199|540673356|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875946|NCT03982199|540673357|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875947|NCT03982199|540673358|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875948|NCT03982199|540673359|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875949|NCT03982199|540673360|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875950|NCT03982199|540673361|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875951|NCT03982199|540673362|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
150174199|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
150174200|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
150174201|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
150174202|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
150174203|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
150174204|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
150174205|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
150174206|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
150174207|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
149875952|NCT03982199|540673363|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
149875953|NCT03982199|540673364|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
149875954|NCT03395405|540674761|FG000|Overall Study|Death|0|||
149875955|NCT03395405|540674762|FG001|Overall Study|Death|2|||
149875956|NCT03395405|540674761|FG000|Overall Study|Lost to Follow-up|0|||
149875957|NCT03395405|540674762|FG001|Overall Study|Lost to Follow-up|1|||
149875958|NCT03395405|540674761|FG000|Overall Study|Protocol Violation|0|||
149875959|NCT03395405|540674762|FG001|Overall Study|Protocol Violation|1|||
149875960|NCT03395405|540674761|FG000|Overall Study|Withdrawal by Subject|3|||
149875961|NCT03395405|540674762|FG001|Overall Study|Withdrawal by Subject|1|||
149875962|NCT03395405|540674761|FG000|Overall Study|COVID-19 Pandemic|1|||
149875963|NCT03395405|540674762|FG001|Overall Study|COVID-19 Pandemic|0|||
149875964|NCT00450801|540674765|FG000|Overall Study|Death|1|||
149875965|NCT05048329|540674766|FG000|Overall Study|Withdrawal by Subject|1|||
149875966|NCT05048329|540674766|FG000|Overall Study|Screenfail|1|||
149875967|NCT00324649|540674767|FG000|Overall Study|Adverse Event|1|||
149875968|NCT00324649|540674768|FG001|Overall Study|Adverse Event|4|||
149875969|NCT00324649|540674767|FG000|Overall Study|Withdrawal by Subject|0|||
149875970|NCT00324649|540674768|FG001|Overall Study|Withdrawal by Subject|1|||
149875971|NCT00324649|540674767|FG000|Overall Study|Noncompliance|1|||
149875972|NCT00324649|540674768|FG001|Overall Study|Noncompliance|0|||
149875973|NCT01396512|540674771|FG000|Overall Study|Withdrawal by Subject|0|||
149875974|NCT01396512|540674772|FG001|Overall Study|Withdrawal by Subject|1|||
149875975|NCT02152605|540674773|FG000|Overall Study|Adverse Event|6|||
149875976|NCT02152605|540674774|FG001|Overall Study|Adverse Event|8|||
149875977|NCT02152605|540674773|FG000|Overall Study|Lack of Efficacy|7|||
149875978|NCT02152605|540674774|FG001|Overall Study|Lack of Efficacy|4|||
149875979|NCT02152605|540674773|FG000|Overall Study|Protocol deviation|1|||
149875980|NCT02152605|540674774|FG001|Overall Study|Protocol deviation|4|||
149875981|NCT02152605|540674773|FG000|Overall Study|Lost to Follow-up|1|||
149875982|NCT02152605|540674774|FG001|Overall Study|Lost to Follow-up|0|||
149875983|NCT02152605|540674773|FG000|Overall Study|Withdrew consent|4|||
149964033|NCT01047540|541003189|FG004|Overall Study|Lost to Follow-up|0|||
149964034|NCT01047540|541003185|FG000|Overall Study|Withdrawal by Subject|1|||
149964035|NCT01047540|541003186|FG001|Overall Study|Withdrawal by Subject|0|||
149964036|NCT01047540|541003187|FG002|Overall Study|Withdrawal by Subject|3|||
149964037|NCT01047540|541003188|FG003|Overall Study|Withdrawal by Subject|0|||
149964038|NCT01047540|541003189|FG004|Overall Study|Withdrawal by Subject|1|||
149964039|NCT01047540|541003185|FG000|Overall Study|Pregnancy|1|||
149964040|NCT01047540|541003186|FG001|Overall Study|Pregnancy|0|||
149964041|NCT01047540|541003187|FG002|Overall Study|Pregnancy|0|||
149964042|NCT01047540|541003188|FG003|Overall Study|Pregnancy|0|||
149964043|NCT01047540|541003189|FG004|Overall Study|Pregnancy|0|||
149964044|NCT01047540|541003185|FG000|Overall Study|Adverse Event|1|||
149875984|NCT02152605|540674774|FG001|Overall Study|Withdrew consent|2|||
149875985|NCT01564537|540674779|FG000|Overall Study|Site Terminated by Sponsor|1|||
149875986|NCT01564537|540674780|FG001|Overall Study|Site Terminated by Sponsor|0|||
149875987|NCT01564537|540674779|FG000|Overall Study|Withdrawal by Subject|12|||
149875988|NCT01564537|540674780|FG001|Overall Study|Withdrawal by Subject|14|||
149875989|NCT01564537|540674779|FG000|Overall Study|Lost to Follow-up|7|||
149875990|NCT01564537|540674780|FG001|Overall Study|Lost to Follow-up|3|||
149875991|NCT01564537|540674779|FG000|Overall Study|Reason not specified|81|||
149875992|NCT01564537|540674780|FG001|Overall Study|Reason not specified|82|||
149875993|NCT05776862|540674781|FG000|Overall Study|Adverse Event|0|||
149875994|NCT05776862|540674782|FG001|Overall Study|Adverse Event|1|||
149875995|NCT05776862|540674781|FG000|Overall Study|non-compliance|1|||
149875996|NCT05776862|540674782|FG001|Overall Study|non-compliance|0|||
149875997|NCT02448706|540674783|FG000|Overall Study|Withdrawal by Subject|4|||
149875998|NCT02448706|540674784|FG001|Overall Study|Withdrawal by Subject|3|||
149875999|NCT02448706|540674783|FG000|Overall Study|Protocol Violation|1|||
149876000|NCT02448706|540674784|FG001|Overall Study|Protocol Violation|1|||
149876001|NCT01199471|540674785|FG000|Overall Study|Protocol Violation|4|||
149876002|NCT01199471|540674785|FG000|Overall Study|Withdrawal by Subject|1|||
149876003|NCT01199471|540674785|FG000|Overall Study|Physician Decision|1|||
149876004|NCT02065700|540674786|FG000|Overall Study|Adverse Event|165|||
149876005|NCT02065700|540674787|FG001|Overall Study|Adverse Event|101|||
149964045|NCT01047540|541003186|FG001|Overall Study|Adverse Event|0|||
149964046|NCT01047540|541003187|FG002|Overall Study|Adverse Event|0|||
149876006|NCT02065700|540674786|FG000|Overall Study|Withdrawal by Subject|90|||
149876007|NCT02065700|540674787|FG001|Overall Study|Withdrawal by Subject|29|||
149876008|NCT02065700|540674786|FG000|Overall Study|Lost to Follow-up|12|||
149876009|NCT02065700|540674787|FG001|Overall Study|Lost to Follow-up|9|||
149964047|NCT01047540|541003188|FG003|Overall Study|Adverse Event|0|||
149964048|NCT01047540|541003189|FG004|Overall Study|Adverse Event|0|||
149964049|NCT02758626|541003195|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
149876010|NCT02065700|540674786|FG000|Overall Study|Physician Decision|2|||
149876011|NCT02065700|540674787|FG001|Overall Study|Physician Decision|0|||
149876012|NCT02065700|540674786|FG000|Overall Study|Sponsor Request|38|||
149876013|NCT02065700|540674787|FG001|Overall Study|Sponsor Request|15|||
149876014|NCT02065700|540674786|FG000|Overall Study|Treatment Failure|3|||
149876015|NCT02065700|540674787|FG001|Overall Study|Treatment Failure|2|||
149876016|NCT02065700|540674786|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
149876017|NCT02065700|540674787|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
149876018|NCT02065700|540674786|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
149876019|NCT02065700|540674787|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
149876020|NCT02065700|540674786|FG000|Overall Study|Non-compliance with Study Procedures|2|||
149876021|NCT02065700|540674787|FG001|Overall Study|Non-compliance with Study Procedures|0|||
149876022|NCT02065700|540674786|FG000|Overall Study|Not Defined|21|||
149876023|NCT02065700|540674787|FG001|Overall Study|Not Defined|3|||
149964050|NCT02758626|541003196|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
149964051|NCT02758626|541003195|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
149964052|NCT02758626|541003196|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
149964053|NCT02758626|541003195|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
149964054|NCT02758626|541003196|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
149964055|NCT02758626|541003195|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
149964056|NCT02758626|541003196|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
149964057|NCT01682720|541003199|FG000|Overall Study|Randomized but Not Treated|0|||
149876024|NCT00554606|540674791|FG000|Overall Study|Adverse Event|3|||
149876025|NCT00554606|540674791|FG000|Overall Study|Abnormal laboratory values|1|||
149876026|NCT00554606|540674791|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
149876027|NCT00554606|540674791|FG000|Overall Study|Subject withdrew consent|2|||
149876028|NCT00554606|540674791|FG000|Overall Study|Lost to Follow-up|2|||
149876029|NCT00554606|540674791|FG000|Overall Study|Administrative problems|60|||
149876030|NCT00554606|540674791|FG000|Overall Study|Death|1|||
149876031|NCT00554606|540674791|FG000|Overall Study|Protocol deviation|2|||
149876032|NCT03323437|540674792|FG000|Overall Study|Withdrawal by Subject|0|||
149876033|NCT03323437|540674793|FG001|Overall Study|Withdrawal by Subject|4|||
149876034|NCT01544179|540674799|FG000|Overall Study|Death|50|||
149876035|NCT01544179|540674800|FG001|Overall Study|Death|37|||
149876036|NCT01544179|540674799|FG000|Overall Study|Lost to Follow-up|0|||
149876037|NCT01544179|540674800|FG001|Overall Study|Lost to Follow-up|1|||
149876038|NCT01544179|540674799|FG000|Overall Study|Adverse Event|0|||
149876039|NCT01544179|540674800|FG001|Overall Study|Adverse Event|1|||
149876040|NCT01544179|540674799|FG000|Overall Study|Withdrawal by Subject|12|||
149876041|NCT01544179|540674800|FG001|Overall Study|Withdrawal by Subject|7|||
149876042|NCT01544179|540674799|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
149876043|NCT01544179|540674800|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149876044|NCT00049530|540674803|FG000|Overall Study|Lack of Efficacy|25|||
149876045|NCT00049530|540674803|FG000|Overall Study|Adverse Event|2|||
149876046|NCT00049530|540674803|FG000|Overall Study|Death|1|||
149876047|NCT00049530|540674803|FG000|Overall Study|symptomatic deterioration|1|||
149876048|NCT00049530|540674803|FG000|Overall Study|ineligible|3|||
149876049|NCT00282919|540674804|FG000|Overall Study|Lack of Efficacy|4|||
149876050|NCT00282919|540674804|FG000|Overall Study|Withdrawal by Subject|1|||
149876051|NCT00282919|540674804|FG000|Overall Study|Asymptomatic Parasitemia|2|||
149876052|NCT01439009|540674808|FG000|Overall Study|Physician Decision|5|||
149876053|NCT01439009|540674809|FG001|Overall Study|Physician Decision|3|||
149876054|NCT01439009|540674808|FG000|Overall Study|Protocol Violation|2|||
149876055|NCT01439009|540674809|FG001|Overall Study|Protocol Violation|0|||
149876056|NCT01439009|540674808|FG000|Overall Study|Deviation of exclusion criteria|1|||
149876057|NCT01439009|540674809|FG001|Overall Study|Deviation of exclusion criteria|0|||
149876058|NCT03257865|540674810|FG000|Overall Study|Adverse Event|4|||
149876059|NCT03257865|540674811|FG001|Overall Study|Adverse Event|8|||
149876060|NCT03257865|540674810|FG000|Overall Study|Lack of Efficacy|1|||
149876061|NCT03257865|540674811|FG001|Overall Study|Lack of Efficacy|2|||
149876062|NCT03257865|540674810|FG000|Overall Study|Non-compliance with Study Drug|0|||
149876063|NCT03257865|540674811|FG001|Overall Study|Non-compliance with Study Drug|2|||
149876064|NCT03257865|540674810|FG000|Overall Study|Withdrawal by Subject|23|||
149876065|NCT03257865|540674811|FG001|Overall Study|Withdrawal by Subject|17|||
149876066|NCT03257865|540674810|FG000|Overall Study|Physician Decision|3|||
149876067|NCT03257865|540674811|FG001|Overall Study|Physician Decision|1|||
149876068|NCT03257865|540674810|FG000|Overall Study|Other|0|||
149876069|NCT03257865|540674811|FG001|Overall Study|Other|1|||
149876070|NCT03257865|540674810|FG000|Overall Study|Lost to Follow-up|4|||
149876071|NCT03257865|540674811|FG001|Overall Study|Lost to Follow-up|4|||
149876072|NCT01934335|540674819|FG000|Overall Study|Withdrawal by Subject|1|||
149876073|NCT01934335|540674820|FG001|Overall Study|Withdrawal by Subject|1|||
149876074|NCT05384171|540674821|FG000|Overall Study|Lost to Follow-up|9|||
149876075|NCT05384171|540674822|FG001|Overall Study|Lost to Follow-up|9|||
149876076|NCT05384171|540674821|FG000|Overall Study|Withdrawal by Subject|3|||
149876077|NCT05384171|540674822|FG001|Overall Study|Withdrawal by Subject|0|||
149876078|NCT01421511|540674823|FG000|Overall Study|Lost to Follow-up|11|||
149876079|NCT01421511|540674824|FG001|Overall Study|Lost to Follow-up|14|||
149876080|NCT01421511|540674823|FG000|Overall Study|Randomized but didn't receive study drug|1|||
149876081|NCT01421511|540674824|FG001|Overall Study|Randomized but didn't receive study drug|7|||
149876082|NCT01421511|540674823|FG000|Overall Study|Physician Decision|0|||
149876083|NCT01421511|540674824|FG001|Overall Study|Physician Decision|1|||
149876084|NCT01421511|540674823|FG000|Overall Study|Withdrawal by Subject|6|||
149876085|NCT01421511|540674824|FG001|Overall Study|Withdrawal by Subject|5|||
149876086|NCT01421511|540674823|FG000|Overall Study|Death|1|||
149876087|NCT01421511|540674824|FG001|Overall Study|Death|1|||
149876088|NCT01111825|540674825|FG000|Overall Study|Withdrawal by Subject|0|||
149876089|NCT01111825|540674826|FG001|Overall Study|Withdrawal by Subject|0|||
149876090|NCT01111825|540674827|FG002|Overall Study|Withdrawal by Subject|1|||
149876091|NCT01111825|540674828|FG003|Overall Study|Withdrawal by Subject|0|||
149876092|NCT01111825|540674825|FG000|Overall Study|Lost to Follow-up|0|||
149876093|NCT01111825|540674826|FG001|Overall Study|Lost to Follow-up|0|||
149876094|NCT01111825|540674827|FG002|Overall Study|Lost to Follow-up|3|||
149876095|NCT01111825|540674828|FG003|Overall Study|Lost to Follow-up|1|||
149876096|NCT01111825|540674825|FG000|Overall Study|Adverse Event|2|||
149876097|NCT01111825|540674826|FG001|Overall Study|Adverse Event|1|||
149876098|NCT01111825|540674827|FG002|Overall Study|Adverse Event|4|||
149876099|NCT01111825|540674828|FG003|Overall Study|Adverse Event|0|||
149876100|NCT01111825|540674825|FG000|Overall Study|Disease Progression|1|||
149876101|NCT01111825|540674826|FG001|Overall Study|Disease Progression|0|||
149876102|NCT01111825|540674827|FG002|Overall Study|Disease Progression|0|||
149876103|NCT01111825|540674828|FG003|Overall Study|Disease Progression|0|||
149876104|NCT01111825|540674825|FG000|Overall Study|Discontinuation by Sponsor|0|||
149876105|NCT01111825|540674826|FG001|Overall Study|Discontinuation by Sponsor|0|||
149876106|NCT01111825|540674827|FG002|Overall Study|Discontinuation by Sponsor|0|||
149876107|NCT01111825|540674828|FG003|Overall Study|Discontinuation by Sponsor|20|||
149876108|NCT01377987|540674829|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
149876109|NCT01377987|540674830|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
149876110|NCT04893018|540674835|FG000|Overall Study|Lost to Follow-up|1|||
149876111|NCT04893018|540674836|FG001|Overall Study|Lost to Follow-up|0|||
149876112|NCT04893018|540674835|FG000|Overall Study|Withdrawal by Subject|2|||
149876113|NCT04893018|540674836|FG001|Overall Study|Withdrawal by Subject|0|||
149876114|NCT04893018|540674835|FG000|Overall Study|Study Terminated|1|||
149876115|NCT04893018|540674836|FG001|Overall Study|Study Terminated|2|||
149876116|NCT00195338|540674837|FG000|Overall Study|Lost to Follow-up|2|||
149876117|NCT00195338|540674837|FG000|Overall Study|Adverse Event|5|||
149876118|NCT00195338|540674837|FG000|Overall Study|Lack of Efficacy|1|||
149876119|NCT00195338|540674837|FG000|Overall Study|Early closure of the site|4|||
149964058|NCT01682720|541003200|FG001|Overall Study|Randomized but Not Treated|1|||
149964059|NCT01682720|541003201|FG002|Overall Study|Randomized but Not Treated|1|||
149964060|NCT01682720|541003202|FG003|Overall Study|Randomized but Not Treated|0|||
149964061|NCT01682720|541003199|FG000|Overall Study|Terminated by Sponsor|83|||
149964062|NCT01682720|541003200|FG001|Overall Study|Terminated by Sponsor|0|||
149964063|NCT01682720|541003201|FG002|Overall Study|Terminated by Sponsor|0|||
149964064|NCT01682720|541003202|FG003|Overall Study|Terminated by Sponsor|0|||
149964065|NCT01682720|541003199|FG000|Overall Study|Efficacy Failure|0|||
149964066|NCT01682720|541003200|FG001|Overall Study|Efficacy Failure|3|||
149964067|NCT01682720|541003201|FG002|Overall Study|Efficacy Failure|3|||
149964068|NCT01682720|541003202|FG003|Overall Study|Efficacy Failure|30|||
149964069|NCT01682720|541003199|FG000|Overall Study|Lost to Follow-up|1|||
149964070|NCT01682720|541003200|FG001|Overall Study|Lost to Follow-up|1|||
149964071|NCT01682720|541003201|FG002|Overall Study|Lost to Follow-up|0|||
149964072|NCT01682720|541003202|FG003|Overall Study|Lost to Follow-up|6|||
149964073|NCT01682720|541003199|FG000|Overall Study|Subject Withdrew Consent|0|||
149964074|NCT01682720|541003200|FG001|Overall Study|Subject Withdrew Consent|0|||
149964075|NCT01682720|541003201|FG002|Overall Study|Subject Withdrew Consent|2|||
149964076|NCT01682720|541003202|FG003|Overall Study|Subject Withdrew Consent|2|||
149964077|NCT01682720|541003199|FG000|Overall Study|Adverse Event|1|||
149964078|NCT01682720|541003200|FG001|Overall Study|Adverse Event|0|||
150042996|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
149876120|NCT00811928|540674838|FG000|Overall Study|AEs and SAEs Including Death|7|||
149876121|NCT00811928|540674839|FG001|Overall Study|AEs and SAEs Including Death|11|||
149876122|NCT00811928|540674838|FG000|Overall Study|Withdrawal by Subject|18|||
149876123|NCT00811928|540674839|FG001|Overall Study|Withdrawal by Subject|12|||
149876124|NCT00811928|540674838|FG000|Overall Study|Did Not Take Study Drug|3|||
149964079|NCT01682720|541003201|FG002|Overall Study|Adverse Event|1|||
149876125|NCT00811928|540674839|FG001|Overall Study|Did Not Take Study Drug|0|||
149876126|NCT00811928|540674838|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
149876127|NCT00811928|540674839|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
149876128|NCT00811928|540674838|FG000|Overall Study|Investigator Decision|2|||
149876129|NCT00811928|540674839|FG001|Overall Study|Investigator Decision|1|||
149876130|NCT00811928|540674838|FG000|Overall Study|Poor Compliance|2|||
149876131|NCT00811928|540674839|FG001|Overall Study|Poor Compliance|5|||
149876132|NCT00423319|540674844|FG000|Overall Study|Death|2|||
149876133|NCT00423319|540674845|FG001|Overall Study|Death|0|||
149876134|NCT00423319|540674844|FG000|Overall Study|Adverse Event|93|||
149876135|NCT00423319|540674845|FG001|Overall Study|Adverse Event|112|||
149876136|NCT00423319|540674844|FG000|Overall Study|Withdrawal by Subject|86|||
149876137|NCT00423319|540674845|FG001|Overall Study|Withdrawal by Subject|99|||
149876138|NCT00423319|540674844|FG000|Overall Study|Lost to Follow-up|4|||
149876139|NCT00423319|540674845|FG001|Overall Study|Lost to Follow-up|3|||
149876140|NCT00423319|540674844|FG000|Overall Study|Poor compliance or noncompliance|1|||
149876141|NCT00423319|540674845|FG001|Overall Study|Poor compliance or noncompliance|1|||
149876142|NCT00423319|540674844|FG000|Overall Study|No longer meets study criteria|15|||
149876143|NCT00423319|540674845|FG001|Overall Study|No longer meets study criteria|15|||
149876144|NCT00423319|540674844|FG000|Overall Study|Other|23|||
149876145|NCT00423319|540674845|FG001|Overall Study|Other|22|||
149876146|NCT02639052|540674846|FG000|Overall Study|Lost to Follow-up|1|||
149876147|NCT02087189|540674848|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
149876148|NCT01671332|540674849|FG000|Overall Study|Withdrawal by Subject|1|||
149876149|NCT01671332|540674850|FG001|Overall Study|Withdrawal by Subject|1|||
149876150|NCT02533375|540674857|FG000|Overall Study|Lack of Efficacy|3|||
149876151|NCT02533375|540674857|FG000|Overall Study|Adverse Event|2|||
149876152|NCT00673387|540674858|FG000|Overall Study|Withdrawal by Subject|15|||
149876153|NCT00673387|540674859|FG001|Overall Study|Withdrawal by Subject|16|||
149876154|NCT00673387|540674860|FG002|Overall Study|Withdrawal by Subject|20|||
149876155|NCT00673387|540674861|FG003|Overall Study|Withdrawal by Subject|16|||
149876156|NCT00673387|540674862|FG004|Overall Study|Withdrawal by Subject|18|||
149876157|NCT00673387|540674863|FG005|Overall Study|Withdrawal by Subject|21|||
149876158|NCT00673387|540674864|FG006|Overall Study|Withdrawal by Subject|15|||
149876159|NCT00673387|540674865|FG007|Overall Study|Withdrawal by Subject|21|||
149876160|NCT00673387|540674858|FG000|Overall Study|Adverse Event|3|||
149876161|NCT00673387|540674859|FG001|Overall Study|Adverse Event|1|||
149876162|NCT00673387|540674860|FG002|Overall Study|Adverse Event|5|||
149876163|NCT00673387|540674861|FG003|Overall Study|Adverse Event|2|||
149876164|NCT00673387|540674862|FG004|Overall Study|Adverse Event|6|||
149876165|NCT00673387|540674863|FG005|Overall Study|Adverse Event|2|||
149876166|NCT00673387|540674864|FG006|Overall Study|Adverse Event|5|||
149876167|NCT00673387|540674865|FG007|Overall Study|Adverse Event|5|||
149876168|NCT00673387|540674858|FG000|Overall Study|Physician Decision|0|||
149876169|NCT00673387|540674859|FG001|Overall Study|Physician Decision|0|||
149876170|NCT00673387|540674860|FG002|Overall Study|Physician Decision|0|||
149876171|NCT00673387|540674861|FG003|Overall Study|Physician Decision|0|||
149876172|NCT00673387|540674862|FG004|Overall Study|Physician Decision|0|||
149876173|NCT00673387|540674863|FG005|Overall Study|Physician Decision|5|||
149876174|NCT00673387|540674864|FG006|Overall Study|Physician Decision|1|||
149876175|NCT00673387|540674865|FG007|Overall Study|Physician Decision|1|||
149876176|NCT00673387|540674858|FG000|Overall Study|Protocol Violation|3|||
149876177|NCT00673387|540674859|FG001|Overall Study|Protocol Violation|0|||
149876178|NCT00673387|540674860|FG002|Overall Study|Protocol Violation|1|||
149876179|NCT00673387|540674861|FG003|Overall Study|Protocol Violation|2|||
149876180|NCT00673387|540674862|FG004|Overall Study|Protocol Violation|0|||
149876181|NCT00673387|540674863|FG005|Overall Study|Protocol Violation|1|||
149876182|NCT00673387|540674864|FG006|Overall Study|Protocol Violation|1|||
149876183|NCT00673387|540674865|FG007|Overall Study|Protocol Violation|3|||
149876184|NCT00673387|540674858|FG000|Overall Study|Lost to Follow-up|8|||
149876185|NCT00673387|540674859|FG001|Overall Study|Lost to Follow-up|6|||
149876186|NCT00673387|540674860|FG002|Overall Study|Lost to Follow-up|5|||
149876187|NCT00673387|540674861|FG003|Overall Study|Lost to Follow-up|6|||
149876188|NCT00673387|540674862|FG004|Overall Study|Lost to Follow-up|6|||
149876189|NCT00673387|540674863|FG005|Overall Study|Lost to Follow-up|5|||
149876190|NCT00673387|540674864|FG006|Overall Study|Lost to Follow-up|8|||
149876191|NCT00673387|540674865|FG007|Overall Study|Lost to Follow-up|5|||
149876192|NCT00960115|540674866|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
149876193|NCT00960115|540674867|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
149876194|NCT00418821|540674868|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
149876195|NCT02092467|540674871|FG000|Overall Study|Death|49|||
149876196|NCT02092467|540674872|FG001|Overall Study|Death|66|||
149876197|NCT02092467|540674873|FG002|Overall Study|Death|38|||
149876198|NCT02092467|540674871|FG000|Overall Study|Lost to Follow-up|38|||
149876199|NCT02092467|540674872|FG001|Overall Study|Lost to Follow-up|35|||
149876200|NCT02092467|540674873|FG002|Overall Study|Lost to Follow-up|40|||
149876201|NCT02092467|540674871|FG000|Overall Study|Global Deterioration of Health Status|1|||
149876202|NCT02092467|540674872|FG001|Overall Study|Global Deterioration of Health Status|0|||
150042997|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
149964080|NCT01682720|541003202|FG003|Overall Study|Adverse Event|1|||
149964081|NCT04204902|541003203|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
149964082|NCT04204902|541003204|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
149964083|NCT01646216|541003207|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
149964084|NCT01646216|541003208|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
149964085|NCT01646216|541003207|FG000|Overall Study|Did not complete training|0|||
149964086|NCT01646216|541003208|FG001|Overall Study|Did not complete training|2|||
149964087|NCT01646216|541003207|FG000|Overall Study|Investigator decision|1|||
149964088|NCT01646216|541003208|FG001|Overall Study|Investigator decision|1|||
149964089|NCT00113373|541003209|FG000|Overall Study|Ineligible: wrong primary|1|||
149964090|NCT00113373|541003209|FG000|Overall Study|Ineligible: second primary|1|||
149964091|NCT00113373|541003209|FG000|Overall Study|Never Treated|1|||
149964092|NCT02395627|541003210|FG000|Overall Study|Withdrawal by Subject|0|||
149964093|NCT02395627|541003211|FG001|Overall Study|Withdrawal by Subject|2|||
149876203|NCT02092467|540674873|FG002|Overall Study|Global Deterioration of Health Status|0|||
149876204|NCT02092467|540674871|FG000|Overall Study|Other|32|||
149876205|NCT02092467|540674872|FG001|Overall Study|Other|30|||
149876206|NCT02092467|540674873|FG002|Overall Study|Other|24|||
149876207|NCT02092467|540674871|FG000|Overall Study|Withdrawal by Subject|282|||
149876208|NCT02092467|540674872|FG001|Overall Study|Withdrawal by Subject|327|||
149876209|NCT02092467|540674873|FG002|Overall Study|Withdrawal by Subject|289|||
149876210|NCT02092467|540674871|FG000|Overall Study|Randomized but not treated|2|||
149876211|NCT02092467|540674872|FG001|Overall Study|Randomized but not treated|1|||
149876212|NCT02092467|540674873|FG002|Overall Study|Randomized but not treated|7|||
149876213|NCT03014180|540674874|FG000|Overall Study|Protocol Violation|2|||
149876214|NCT02099682|540674875|FG000|Overall Study|Data Not Available|51|||
149876215|NCT02099682|540674875|FG000|Overall Study|Lost to Follow-up|31|||
149876216|NCT02099682|540674875|FG000|Overall Study|Other|29|||
149876217|NCT02802631|540674876|FG000|Overall Study|Withdrawal by Subject|1|||
149876218|NCT02802631|540674877|FG001|Overall Study|Withdrawal by Subject|0|||
149876219|NCT02802631|540674878|FG002|Overall Study|Withdrawal by Subject|0|||
149876220|NCT02802631|540674879|FG003|Overall Study|Withdrawal by Subject|0|||
149876221|NCT02802631|540674880|FG004|Overall Study|Withdrawal by Subject|0|||
149876222|NCT02802631|540674881|FG005|Overall Study|Withdrawal by Subject|0|||
149876223|NCT02802631|540674882|FG006|Overall Study|Withdrawal by Subject|0|||
149876224|NCT02802631|540674883|FG007|Overall Study|Withdrawal by Subject|0|||
149876225|NCT02802631|540674876|FG000|Overall Study|Physician Decision|1|||
149876226|NCT02802631|540674877|FG001|Overall Study|Physician Decision|0|||
149876227|NCT02802631|540674878|FG002|Overall Study|Physician Decision|0|||
149876228|NCT02802631|540674879|FG003|Overall Study|Physician Decision|0|||
149876229|NCT02802631|540674880|FG004|Overall Study|Physician Decision|0|||
149876230|NCT02802631|540674881|FG005|Overall Study|Physician Decision|0|||
149876231|NCT02802631|540674882|FG006|Overall Study|Physician Decision|1|||
149876232|NCT02802631|540674883|FG007|Overall Study|Physician Decision|0|||
149876233|NCT02802631|540674876|FG000|Overall Study|Adverse Event|0|||
149876234|NCT02802631|540674877|FG001|Overall Study|Adverse Event|2|||
149876235|NCT02802631|540674878|FG002|Overall Study|Adverse Event|0|||
149876236|NCT02802631|540674879|FG003|Overall Study|Adverse Event|1|||
149876237|NCT02802631|540674880|FG004|Overall Study|Adverse Event|6|||
149876238|NCT02802631|540674881|FG005|Overall Study|Adverse Event|1|||
149876239|NCT02802631|540674882|FG006|Overall Study|Adverse Event|4|||
149876240|NCT02802631|540674883|FG007|Overall Study|Adverse Event|0|||
149876241|NCT02802631|540674876|FG000|Overall Study|Sponsor Decision|0|||
149876242|NCT02802631|540674877|FG001|Overall Study|Sponsor Decision|0|||
149876243|NCT02802631|540674878|FG002|Overall Study|Sponsor Decision|6|||
149876244|NCT02802631|540674879|FG003|Overall Study|Sponsor Decision|0|||
149876245|NCT02802631|540674880|FG004|Overall Study|Sponsor Decision|2|||
149876246|NCT02802631|540674881|FG005|Overall Study|Sponsor Decision|0|||
149876247|NCT02802631|540674882|FG006|Overall Study|Sponsor Decision|0|||
149876248|NCT02802631|540674883|FG007|Overall Study|Sponsor Decision|4|||
149876249|NCT02212379|540674884|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
149876250|NCT02212379|540674884|FG000|From Baseline to Week 48|Adverse Event|7|||
149876251|NCT02212379|540674884|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
149876252|NCT02212379|540674884|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
149876253|NCT02212379|540674884|FG000|From Week 48 to Week 96|Adverse Event|1|||
149876254|NCT02212379|540674884|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
149876255|NCT00704730|540674885|FG000|Overall Study|Adverse Event|35|||
149876256|NCT00704730|540674886|FG001|Overall Study|Adverse Event|9|||
149876257|NCT00704730|540674885|FG000|Overall Study|Death|11|||
149876258|NCT00704730|540674886|FG001|Overall Study|Death|5|||
149876259|NCT00704730|540674885|FG000|Overall Study|Physician Decision|2|||
149876260|NCT00704730|540674886|FG001|Overall Study|Physician Decision|0|||
149876261|NCT00704730|540674885|FG000|Overall Study|Did not receive drug|5|||
149876262|NCT00704730|540674886|FG001|Overall Study|Did not receive drug|2|||
149876263|NCT00704730|540674885|FG000|Overall Study|Disease progression per PI|58|||
149876264|NCT00704730|540674886|FG001|Overall Study|Disease progression per PI|67|||
149876265|NCT00704730|540674885|FG000|Overall Study|data unavailable|1|||
149876266|NCT00704730|540674886|FG001|Overall Study|data unavailable|0|||
149876267|NCT00704730|540674885|FG000|Overall Study|Withdrawal by Subject|9|||
149876268|NCT00704730|540674886|FG001|Overall Study|Withdrawal by Subject|13|||
149876269|NCT00213135|540676626|FG000|Overall Study|Adverse Event|9|||
149876270|NCT00213135|540676627|FG001|Overall Study|Adverse Event|5|||
149876271|NCT00213135|540676628|FG002|Overall Study|Adverse Event|5|||
149876272|NCT00213135|540676626|FG000|Overall Study|Lost to Follow-up|11|||
149876273|NCT00213135|540676627|FG001|Overall Study|Lost to Follow-up|8|||
149876274|NCT00213135|540676628|FG002|Overall Study|Lost to Follow-up|4|||
149876275|NCT00213135|540676626|FG000|Overall Study|Protocol Violation|4|||
149876276|NCT00213135|540676627|FG001|Overall Study|Protocol Violation|4|||
149876277|NCT00213135|540676628|FG002|Overall Study|Protocol Violation|10|||
149876278|NCT00213135|540676626|FG000|Overall Study|Death|1|||
149876279|NCT00213135|540676627|FG001|Overall Study|Death|1|||
149876280|NCT00213135|540676628|FG002|Overall Study|Death|2|||
149876281|NCT00213135|540676626|FG000|Overall Study|Disease progression|4|||
149876282|NCT00213135|540676627|FG001|Overall Study|Disease progression|5|||
149876283|NCT00213135|540676628|FG002|Overall Study|Disease progression|21|||
149876284|NCT00213135|540676626|FG000|Overall Study|Other|21|||
149876285|NCT00213135|540676627|FG001|Overall Study|Other|12|||
149876286|NCT00213135|540676628|FG002|Overall Study|Other|15|||
149876287|NCT01908907|540676629|FG000|Overall Study|Physician Decision|1|||
149876288|NCT01908907|540676630|FG001|Overall Study|Physician Decision|0|||
149876289|NCT01908907|540676629|FG000|Overall Study|Protocol Violation|1|||
149876290|NCT01908907|540676630|FG001|Overall Study|Protocol Violation|0|||
149876291|NCT00660907|540676631|FG000|Overall Study|Incorrect Enrollment|1|||
149876292|NCT00660907|540676632|FG001|Overall Study|Incorrect Enrollment|1|||
149876293|NCT00660907|540676631|FG000|Overall Study|Adverse Event|33|||
149876294|NCT00660907|540676632|FG001|Overall Study|Adverse Event|19|||
149876295|NCT00660907|540676631|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
149876296|NCT00660907|540676632|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
149876297|NCT00660907|540676631|FG000|Overall Study|Withdrawal by Subject|23|||
149876298|NCT00660907|540676632|FG001|Overall Study|Withdrawal by Subject|32|||
149876299|NCT00660907|540676631|FG000|Overall Study|Lost to Follow-up|3|||
149876300|NCT00660907|540676632|FG001|Overall Study|Lost to Follow-up|3|||
149876301|NCT00660907|540676631|FG000|Overall Study|Poor/Non-Compliance|5|||
149876302|NCT00660907|540676632|FG001|Overall Study|Poor/Non-Compliance|1|||
149876303|NCT00660907|540676631|FG000|Overall Study|Safety|1|||
149876304|NCT00660907|540676632|FG001|Overall Study|Safety|0|||
149876305|NCT00660907|540676631|FG000|Overall Study|Death|1|||
149876306|NCT00660907|540676632|FG001|Overall Study|Death|3|||
149876307|NCT00660907|540676631|FG000|Overall Study|Various|11|||
149876308|NCT00660907|540676632|FG001|Overall Study|Various|8|||
149876309|NCT04975191|540676633|FG000|Overall Study|Protocol Violation|1|||
149876310|NCT04975191|540676634|FG001|Overall Study|Protocol Violation|2|||
149876311|NCT04975191|540676635|FG002|Overall Study|Protocol Violation|2|||
149876312|NCT04975191|540676636|FG003|Overall Study|Protocol Violation|2|||
149876313|NCT04975191|540676633|FG000|Overall Study|Lost to Follow-up|13|||
149876314|NCT04975191|540676634|FG001|Overall Study|Lost to Follow-up|3|||
149876315|NCT04975191|540676635|FG002|Overall Study|Lost to Follow-up|8|||
149876316|NCT04975191|540676636|FG003|Overall Study|Lost to Follow-up|8|||
149876317|NCT00761657|540676639|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
149876318|NCT00761657|540676640|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
149876319|NCT00761657|540676641|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
150042998|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
149876320|NCT00761657|540676642|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
149876321|NCT00761657|540676643|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
149876322|NCT00761657|540676644|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
149876323|NCT00761657|540676645|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
149876324|NCT00761657|540676646|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
149876325|NCT00761657|540676647|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
149876326|NCT00761657|540676639|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876327|NCT00761657|540676640|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876328|NCT00761657|540676641|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
149876329|NCT00761657|540676642|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
149876330|NCT00761657|540676643|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876331|NCT00761657|540676644|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876332|NCT00761657|540676645|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876333|NCT00761657|540676646|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876334|NCT00761657|540676647|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
149876335|NCT00761657|540676639|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
149876336|NCT00761657|540676640|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
149876337|NCT00761657|540676641|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
149876338|NCT00761657|540676642|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
149876339|NCT00761657|540676643|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
149876340|NCT00761657|540676644|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
149876341|NCT00761657|540676645|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
149876342|NCT00761657|540676646|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
149876343|NCT00761657|540676647|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
149876344|NCT00761657|540676639|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
149876345|NCT00761657|540676640|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
149876346|NCT00761657|540676641|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
149876347|NCT00761657|540676642|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
149964094|NCT02395627|541003212|FG002|Overall Study|Withdrawal by Subject|0|||
149964095|NCT02395627|541003210|FG000|Overall Study|Did not receive pembrolizumab|3|||
149964096|NCT02395627|541003211|FG001|Overall Study|Did not receive pembrolizumab|1|||
149964097|NCT02395627|541003212|FG002|Overall Study|Did not receive pembrolizumab|0|||
149964098|NCT06091956|541003213|FG000|Overall Study|Withdrawal by Subject|1|||
149964099|NCT06091956|541003213|FG000|Overall Study|Complicating Disease|1|||
149964100|NCT01681849|541003223|FG000|Overall Study|Protocol Violation|2|||
149964101|NCT01681849|541003224|FG001|Overall Study|Protocol Violation|0|||
149964102|NCT01681849|541003225|FG002|Overall Study|Protocol Violation|0|||
149964103|NCT01681849|541003223|FG000|Overall Study|Withdrawal by Subject|3|||
149964104|NCT01681849|541003224|FG001|Overall Study|Withdrawal by Subject|5|||
149964105|NCT01681849|541003225|FG002|Overall Study|Withdrawal by Subject|33|||
149964106|NCT01681849|541003223|FG000|Overall Study|Lost to Follow-up|3|||
149964107|NCT01681849|541003224|FG001|Overall Study|Lost to Follow-up|2|||
149964108|NCT01681849|541003225|FG002|Overall Study|Lost to Follow-up|6|||
149964109|NCT02852005|541003228|FG000|Overall Study|Lost to Follow-up|0|||
149964110|NCT02852005|541003229|FG001|Overall Study|Lost to Follow-up|0|||
149964111|NCT02852005|541003230|FG002|Overall Study|Lost to Follow-up|0|||
149964112|NCT02852005|541003231|FG003|Overall Study|Lost to Follow-up|0|||
149964113|NCT02852005|541003232|FG004|Overall Study|Lost to Follow-up|1|||
149964114|NCT02852005|541003228|FG000|Overall Study|Withdrawal by Subject|1|||
149964115|NCT02852005|541003229|FG001|Overall Study|Withdrawal by Subject|0|||
149964116|NCT02852005|541003230|FG002|Overall Study|Withdrawal by Subject|0|||
149964117|NCT02852005|541003231|FG003|Overall Study|Withdrawal by Subject|0|||
149964118|NCT02852005|541003232|FG004|Overall Study|Withdrawal by Subject|0|||
149964119|NCT04629521|541003233|FG000|Overall Study|Death|1|||
149964120|NCT04629521|541003233|FG000|Overall Study|Lost to Follow-up|3|||
150174208|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
149964121|NCT04629521|541003233|FG000|Overall Study|Subject withdrew consent|3|||
149964122|NCT04629521|541003233|FG000|Overall Study|Enrolled in error|1|||
149964123|NCT01618708|541003234|FG000|Overall Study|Adverse Event|10|||
149964124|NCT01618708|541003235|FG001|Overall Study|Adverse Event|10|||
149964125|NCT01618708|541003234|FG000|Overall Study|Lost to Follow-up|3|||
149964126|NCT01618708|541003235|FG001|Overall Study|Lost to Follow-up|3|||
149876348|NCT00761657|540676643|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
149876349|NCT00761657|540676644|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
149876350|NCT00761657|540676645|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
149876351|NCT00761657|540676646|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
149876352|NCT00761657|540676647|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
149876353|NCT00359801|540676655|FG000|Overall Study|Lost to Follow-up|72|||
149876354|NCT00359801|540676656|FG001|Overall Study|Lost to Follow-up|58|||
149876355|NCT00359801|540676655|FG000|Overall Study|Withdrawal by Subject|143|||
149876356|NCT00359801|540676656|FG001|Overall Study|Withdrawal by Subject|96|||
149876357|NCT00359801|540676655|FG000|Overall Study|Other|66|||
149876358|NCT00359801|540676656|FG001|Overall Study|Other|46|||
149876359|NCT00359801|540676655|FG000|Overall Study|Final Status Unknown: missing data|7|||
149876360|NCT00359801|540676656|FG001|Overall Study|Final Status Unknown: missing data|4|||
149876361|NCT00359801|540676655|FG000|Overall Study|Sponsor Decision|17|||
149876362|NCT00359801|540676656|FG001|Overall Study|Sponsor Decision|16|||
149876363|NCT02929056|540676661|FG000|Overall Study|Lost to Follow-up|0|||
149876364|NCT02929056|540676662|FG001|Overall Study|Lost to Follow-up|1|||
149876365|NCT02245412|540676666|FG000|Treatment Period|Death|1|||
149876366|NCT02245412|540676667|FG001|Treatment Period|Death|1|||
149876367|NCT02245412|540676668|FG002|Treatment Period|Death|0|||
149876368|NCT02245412|540676666|FG000|Treatment Period|Physician Decision|1|||
149876369|NCT02245412|540676667|FG001|Treatment Period|Physician Decision|1|||
149876370|NCT02245412|540676668|FG002|Treatment Period|Physician Decision|0|||
149876371|NCT02245412|540676666|FG000|Treatment Period|Withdrawal by Subject|2|||
149876372|NCT02245412|540676667|FG001|Treatment Period|Withdrawal by Subject|1|||
149876373|NCT02245412|540676668|FG002|Treatment Period|Withdrawal by Subject|0|||
149876374|NCT02245412|540676666|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
149876375|NCT02245412|540676667|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
149876376|NCT02245412|540676668|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
149876377|NCT02245412|540676666|FG000|Follow-Up Period|Death|4|||
149876378|NCT02245412|540676667|FG001|Follow-Up Period|Death|2|||
149876379|NCT02245412|540676668|FG002|Follow-Up Period|Death|1|||
149876380|NCT02245412|540676666|FG000|Follow-Up Period|Physician Decision|1|||
149876381|NCT02245412|540676667|FG001|Follow-Up Period|Physician Decision|0|||
149876382|NCT02245412|540676668|FG002|Follow-Up Period|Physician Decision|0|||
149876383|NCT02245412|540676666|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
149876384|NCT02245412|540676667|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
149876385|NCT02245412|540676668|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
149876386|NCT01056289|540676669|FG000|Open-label Phase|Adverse Event|29|||
149876387|NCT01056289|540676670|FG001|Open-label Phase|Adverse Event|0|||
149876388|NCT01056289|540676671|FG002|Open-label Phase|Adverse Event|0|||
149876389|NCT01056289|540676672|FG003|Open-label Phase|Adverse Event|0|||
149876390|NCT01056289|540676669|FG000|Open-label Phase|Lost to Follow-up|30|||
149876391|NCT01056289|540676670|FG001|Open-label Phase|Lost to Follow-up|0|||
149876392|NCT01056289|540676671|FG002|Open-label Phase|Lost to Follow-up|0|||
149876393|NCT01056289|540676672|FG003|Open-label Phase|Lost to Follow-up|0|||
149876394|NCT01056289|540676669|FG000|Open-label Phase|Other|9|||
149876395|NCT01056289|540676670|FG001|Open-label Phase|Other|0|||
149876396|NCT01056289|540676671|FG002|Open-label Phase|Other|0|||
149876397|NCT01056289|540676672|FG003|Open-label Phase|Other|0|||
149876398|NCT01056289|540676669|FG000|Open-label Phase|Protocol Violation|6|||
149876399|NCT01056289|540676670|FG001|Open-label Phase|Protocol Violation|0|||
149876400|NCT01056289|540676671|FG002|Open-label Phase|Protocol Violation|0|||
149876401|NCT01056289|540676672|FG003|Open-label Phase|Protocol Violation|0|||
149964127|NCT01618708|541003234|FG000|Overall Study|Withdrawal by Subject|17|||
149964128|NCT01618708|541003235|FG001|Overall Study|Withdrawal by Subject|22|||
149964129|NCT01618708|541003234|FG000|Overall Study|Lack of Efficacy|8|||
149964130|NCT01618708|541003235|FG001|Overall Study|Lack of Efficacy|8|||
149964131|NCT01618708|541003234|FG000|Overall Study|Technical problems|2|||
149964132|NCT01618708|541003235|FG001|Overall Study|Technical problems|0|||
149964133|NCT01618708|541003234|FG000|Overall Study|Other than specified above|1|||
149876402|NCT01056289|540676669|FG000|Open-label Phase|Withdrawal by Subject|26|||
149876403|NCT01056289|540676670|FG001|Open-label Phase|Withdrawal by Subject|0|||
149876404|NCT01056289|540676671|FG002|Open-label Phase|Withdrawal by Subject|0|||
149964134|NCT01618708|541003235|FG001|Overall Study|Other than specified above|1|||
149876405|NCT01056289|540676672|FG003|Open-label Phase|Withdrawal by Subject|0|||
149876406|NCT01056289|540676669|FG000|Open-label Phase|Lack of Efficacy|18|||
149876407|NCT01056289|540676670|FG001|Open-label Phase|Lack of Efficacy|0|||
149876408|NCT01056289|540676671|FG002|Open-label Phase|Lack of Efficacy|0|||
149876409|NCT01056289|540676672|FG003|Open-label Phase|Lack of Efficacy|0|||
149876410|NCT01056289|540676669|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
149964135|NCT01618708|541003234|FG000|Overall Study|Randomized but not treated|3|||
149964136|NCT01618708|541003235|FG001|Overall Study|Randomized but not treated|2|||
149964137|NCT02554474|541003236|FG000|Overall Study|Protocol Violation|1|||
150174209|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149876411|NCT01056289|540676670|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
149876412|NCT01056289|540676671|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
149876413|NCT01056289|540676672|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
149876414|NCT01056289|540676669|FG000|Double-blind Phase|Adverse Event|0|||
149876415|NCT01056289|540676670|FG001|Double-blind Phase|Adverse Event|1|||
149876416|NCT01056289|540676671|FG002|Double-blind Phase|Adverse Event|2|||
149876417|NCT01056289|540676672|FG003|Double-blind Phase|Adverse Event|1|||
149876418|NCT01056289|540676669|FG000|Double-blind Phase|Lost to Follow-up|0|||
149876419|NCT01056289|540676670|FG001|Double-blind Phase|Lost to Follow-up|2|||
149876420|NCT01056289|540676671|FG002|Double-blind Phase|Lost to Follow-up|2|||
149876421|NCT01056289|540676672|FG003|Double-blind Phase|Lost to Follow-up|2|||
149876422|NCT01056289|540676669|FG000|Double-blind Phase|Other|0|||
149876423|NCT01056289|540676670|FG001|Double-blind Phase|Other|0|||
149876424|NCT01056289|540676671|FG002|Double-blind Phase|Other|1|||
149876425|NCT01056289|540676672|FG003|Double-blind Phase|Other|2|||
149876426|NCT01056289|540676669|FG000|Double-blind Phase|Protocol Violation|0|||
149876427|NCT01056289|540676670|FG001|Double-blind Phase|Protocol Violation|0|||
149876428|NCT01056289|540676671|FG002|Double-blind Phase|Protocol Violation|1|||
149876429|NCT01056289|540676672|FG003|Double-blind Phase|Protocol Violation|1|||
149876430|NCT01056289|540676669|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149876431|NCT01056289|540676670|FG001|Double-blind Phase|Withdrawal by Subject|0|||
149876432|NCT01056289|540676671|FG002|Double-blind Phase|Withdrawal by Subject|4|||
149876433|NCT01056289|540676672|FG003|Double-blind Phase|Withdrawal by Subject|2|||
149876434|NCT01056289|540676669|FG000|Double-blind Phase|Discontinuation symptom|0|||
149876435|NCT01056289|540676670|FG001|Double-blind Phase|Discontinuation symptom|1|||
149876436|NCT01056289|540676671|FG002|Double-blind Phase|Discontinuation symptom|2|||
149876437|NCT01056289|540676672|FG003|Double-blind Phase|Discontinuation symptom|2|||
149876438|NCT01056289|540676669|FG000|Double-blind Phase|Physician Decision|0|||
149876439|NCT01056289|540676670|FG001|Double-blind Phase|Physician Decision|0|||
149876440|NCT01056289|540676671|FG002|Double-blind Phase|Physician Decision|1|||
149876441|NCT01056289|540676672|FG003|Double-blind Phase|Physician Decision|0|||
149876442|NCT00402116|540676679|FG000|Overall Study|Jaw infection after surgery-other|1|||
149876443|NCT00402116|540676680|FG001|Overall Study|Jaw infection after surgery-other|0|||
149876444|NCT00402116|540676681|FG002|Overall Study|Jaw infection after surgery-other|0|||
149876445|NCT00402116|540676679|FG000|Overall Study|Withdrawal by Subject|1|||
149876446|NCT00402116|540676680|FG001|Overall Study|Withdrawal by Subject|0|||
149876447|NCT00402116|540676681|FG002|Overall Study|Withdrawal by Subject|5|||
149876448|NCT00402116|540676679|FG000|Overall Study|Treatment completed per protocol|1|||
149876449|NCT00402116|540676680|FG001|Overall Study|Treatment completed per protocol|1|||
149876450|NCT00402116|540676681|FG002|Overall Study|Treatment completed per protocol|2|||
149964138|NCT02554474|541003237|FG001|Overall Study|Protocol Violation|1|||
149964139|NCT02554474|541003236|FG000|Overall Study|Health issue not related to the study|1|||
149964140|NCT02554474|541003237|FG001|Overall Study|Health issue not related to the study|0|||
149964141|NCT02554474|541003236|FG000|Overall Study|Withdrawal by Subject|1|||
149964142|NCT02554474|541003237|FG001|Overall Study|Withdrawal by Subject|1|||
149964143|NCT00489476|541003241|FG000|Overall Study|Lost to Follow-up|0|||
149964144|NCT00489476|541003242|FG001|Overall Study|Lost to Follow-up|1|||
149964145|NCT00489476|541003243|FG002|Overall Study|Lost to Follow-up|0|||
149964146|NCT00489476|541003244|FG003|Overall Study|Lost to Follow-up|0|||
149964147|NCT03769116|541003247|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
149964148|NCT03769116|541003248|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
149964149|NCT03769116|541003247|FG000|Part 3 - Open Label|Physician Decision|1|||
149876451|NCT00402116|540676679|FG000|Overall Study|other complicating disease|0|||
149876452|NCT00402116|540676680|FG001|Overall Study|other complicating disease|0|||
149876453|NCT00402116|540676681|FG002|Overall Study|other complicating disease|2|||
149876454|NCT00402116|540676679|FG000|Overall Study|Disease Progression|0|||
149964150|NCT03769116|541003248|FG001|Part 3 - Open Label|Physician Decision|0|||
149964151|NCT03769116|541003247|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
149964152|NCT03769116|541003248|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
149964153|NCT02181413|541003251|FG000|Overall Study|Withdrawal by Subject|45|||
149876455|NCT00402116|540676680|FG001|Overall Study|Disease Progression|4|||
149876456|NCT00402116|540676681|FG002|Overall Study|Disease Progression|38|||
149876457|NCT00402116|540676679|FG000|Overall Study|mistaken thrombocytopenia|0|||
149876458|NCT00402116|540676680|FG001|Overall Study|mistaken thrombocytopenia|0|||
149876459|NCT00402116|540676681|FG002|Overall Study|mistaken thrombocytopenia|1|||
149876460|NCT00402116|540676679|FG000|Overall Study|decline related hyponatremia/tumor|0|||
149876461|NCT00402116|540676680|FG001|Overall Study|decline related hyponatremia/tumor|0|||
149876462|NCT00402116|540676681|FG002|Overall Study|decline related hyponatremia/tumor|1|||
149876463|NCT00402116|540676679|FG000|Overall Study|Adverse Event|0|||
149876464|NCT00402116|540676680|FG001|Overall Study|Adverse Event|1|||
149876465|NCT00402116|540676681|FG002|Overall Study|Adverse Event|6|||
149876466|NCT00270855|540676682|FG000|Overall Study|Withdrawal by Subject|8|||
149876467|NCT00270855|540676683|FG001|Overall Study|Withdrawal by Subject|8|||
149876468|NCT02618759|540676688|FG000|Overall Study|Lost to Follow-up|0|||
149876469|NCT02618759|540676689|FG001|Overall Study|Lost to Follow-up|1|||
149876470|NCT02618759|540676688|FG000|Overall Study|Withdrawal by Subject|1|||
149876471|NCT02618759|540676689|FG001|Overall Study|Withdrawal by Subject|0|||
149876472|NCT02618759|540676688|FG000|Overall Study|Other Reasons|1|||
149876473|NCT02618759|540676689|FG001|Overall Study|Other Reasons|4|||
149876474|NCT02500043|540676692|FG000|Overall Study|Randomized, but not Treated|2|||
149876475|NCT02500043|540676693|FG001|Overall Study|Randomized, but not Treated|2|||
149876476|NCT02500043|540676692|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
149876477|NCT02500043|540676693|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
149876478|NCT02500043|540676692|FG000|Overall Study|Adverse Event|33|||
149876479|NCT02500043|540676693|FG001|Overall Study|Adverse Event|11|||
149876480|NCT02500043|540676692|FG000|Overall Study|Clinical Progression|54|||
149876481|NCT02500043|540676693|FG001|Overall Study|Clinical Progression|35|||
149876482|NCT02500043|540676692|FG000|Overall Study|Radiological Progression|192|||
149876483|NCT02500043|540676693|FG001|Overall Study|Radiological Progression|110|||
149876484|NCT02500043|540676692|FG000|Overall Study|Physician's Decision|11|||
149876485|NCT02500043|540676693|FG001|Overall Study|Physician's Decision|3|||
149876486|NCT02500043|540676692|FG000|Overall Study|Withdrawal by Subject|14|||
149876487|NCT02500043|540676693|FG001|Overall Study|Withdrawal by Subject|4|||
149876488|NCT02500043|540676692|FG000|Overall Study|Death|11|||
149876489|NCT02500043|540676693|FG001|Overall Study|Death|2|||
149876490|NCT02500043|540676692|FG000|Overall Study|Protocol Deviation|1|||
149876491|NCT02500043|540676693|FG001|Overall Study|Protocol Deviation|0|||
149876492|NCT01371747|540676694|FG000|Overall Study|Adverse Event|4|||
149876493|NCT01371747|540676695|FG001|Overall Study|Adverse Event|2|||
149876494|NCT01371747|540676696|FG002|Overall Study|Adverse Event|7|||
149876495|NCT01371747|540676697|FG003|Overall Study|Adverse Event|2|||
149876496|NCT01371747|540676698|FG004|Overall Study|Adverse Event|2|||
149876497|NCT01371747|540676699|FG005|Overall Study|Adverse Event|2|||
149876498|NCT01371747|540676694|FG000|Overall Study|Death|1|||
149876499|NCT01371747|540676695|FG001|Overall Study|Death|0|||
149876500|NCT01371747|540676696|FG002|Overall Study|Death|4|||
149876501|NCT01371747|540676697|FG003|Overall Study|Death|1|||
149876502|NCT01371747|540676698|FG004|Overall Study|Death|2|||
149876503|NCT01371747|540676699|FG005|Overall Study|Death|0|||
149876504|NCT01371747|540676694|FG000|Overall Study|Abnormal Renal Function|0|||
149876505|NCT01371747|540676695|FG001|Overall Study|Abnormal Renal Function|2|||
149876506|NCT01371747|540676696|FG002|Overall Study|Abnormal Renal Function|0|||
149876507|NCT01371747|540676697|FG003|Overall Study|Abnormal Renal Function|1|||
149876508|NCT01371747|540676698|FG004|Overall Study|Abnormal Renal Function|0|||
149876509|NCT01371747|540676699|FG005|Overall Study|Abnormal Renal Function|1|||
149876510|NCT01371747|540676694|FG000|Overall Study|High Serum Potassium Results|1|||
149876511|NCT01371747|540676695|FG001|Overall Study|High Serum Potassium Results|1|||
149876512|NCT01371747|540676696|FG002|Overall Study|High Serum Potassium Results|1|||
149876513|NCT01371747|540676697|FG003|Overall Study|High Serum Potassium Results|2|||
149876514|NCT01371747|540676698|FG004|Overall Study|High Serum Potassium Results|0|||
149876515|NCT01371747|540676699|FG005|Overall Study|High Serum Potassium Results|2|||
149876516|NCT01371747|540676694|FG000|Overall Study|Low Serum Potassium Results|1|||
149876517|NCT01371747|540676695|FG001|Overall Study|Low Serum Potassium Results|1|||
149876518|NCT01371747|540676696|FG002|Overall Study|Low Serum Potassium Results|1|||
149876519|NCT01371747|540676697|FG003|Overall Study|Low Serum Potassium Results|1|||
149876520|NCT01371747|540676698|FG004|Overall Study|Low Serum Potassium Results|0|||
149876521|NCT01371747|540676699|FG005|Overall Study|Low Serum Potassium Results|3|||
149876522|NCT01371747|540676694|FG000|Overall Study|Protocol Violation|0|||
149876523|NCT01371747|540676695|FG001|Overall Study|Protocol Violation|0|||
149876524|NCT01371747|540676696|FG002|Overall Study|Protocol Violation|1|||
149876525|NCT01371747|540676697|FG003|Overall Study|Protocol Violation|0|||
149876526|NCT01371747|540676698|FG004|Overall Study|Protocol Violation|0|||
149876527|NCT01371747|540676699|FG005|Overall Study|Protocol Violation|0|||
149876528|NCT01371747|540676694|FG000|Overall Study|Non-Compliance|3|||
149876529|NCT01371747|540676695|FG001|Overall Study|Non-Compliance|4|||
149876530|NCT01371747|540676696|FG002|Overall Study|Non-Compliance|3|||
149876531|NCT01371747|540676697|FG003|Overall Study|Non-Compliance|0|||
150042999|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
149876532|NCT01371747|540676698|FG004|Overall Study|Non-Compliance|0|||
149876533|NCT01371747|540676699|FG005|Overall Study|Non-Compliance|1|||
149876534|NCT01371747|540676694|FG000|Overall Study|Physician Decision|0|||
149876535|NCT01371747|540676695|FG001|Overall Study|Physician Decision|0|||
149876536|NCT01371747|540676696|FG002|Overall Study|Physician Decision|0|||
149876537|NCT01371747|540676697|FG003|Overall Study|Physician Decision|0|||
149876538|NCT01371747|540676698|FG004|Overall Study|Physician Decision|1|||
149876539|NCT01371747|540676699|FG005|Overall Study|Physician Decision|0|||
149876540|NCT01371747|540676694|FG000|Overall Study|Withdrawal by Subject|6|||
149876541|NCT01371747|540676695|FG001|Overall Study|Withdrawal by Subject|12|||
149876542|NCT01371747|540676696|FG002|Overall Study|Withdrawal by Subject|5|||
149876543|NCT01371747|540676697|FG003|Overall Study|Withdrawal by Subject|2|||
149876544|NCT01371747|540676698|FG004|Overall Study|Withdrawal by Subject|2|||
149876545|NCT01371747|540676699|FG005|Overall Study|Withdrawal by Subject|4|||
149876546|NCT01371747|540676694|FG000|Overall Study|Other Reasons|2|||
149876547|NCT01371747|540676695|FG001|Overall Study|Other Reasons|1|||
149876548|NCT01371747|540676696|FG002|Overall Study|Other Reasons|2|||
149876549|NCT01371747|540676697|FG003|Overall Study|Other Reasons|0|||
149876550|NCT01371747|540676698|FG004|Overall Study|Other Reasons|0|||
149876551|NCT01371747|540676699|FG005|Overall Study|Other Reasons|1|||
149876552|NCT02094417|540676700|FG000|Overall Study|Adverse Event|0|||
149876553|NCT02094417|540676701|FG001|Overall Study|Adverse Event|0|||
149876554|NCT02094417|540676702|FG002|Overall Study|Adverse Event|0|||
149876555|NCT02094417|540676703|FG003|Overall Study|Adverse Event|1|||
149876556|NCT02094417|540676700|FG000|Overall Study|Eligibility criteria|0|||
149876557|NCT02094417|540676701|FG001|Overall Study|Eligibility criteria|1|||
149876558|NCT02094417|540676702|FG002|Overall Study|Eligibility criteria|0|||
149876559|NCT02094417|540676703|FG003|Overall Study|Eligibility criteria|0|||
149876560|NCT02094417|540676700|FG000|Overall Study|No responder|4|||
149876561|NCT02094417|540676701|FG001|Overall Study|No responder|4|||
149876562|NCT02094417|540676702|FG002|Overall Study|No responder|4|||
149876563|NCT02094417|540676703|FG003|Overall Study|No responder|3|||
149876564|NCT02094417|540676700|FG000|Overall Study|Unable to conduct observations or assess|0|||
149876565|NCT02094417|540676701|FG001|Overall Study|Unable to conduct observations or assess|1|||
149876566|NCT02094417|540676702|FG002|Overall Study|Unable to conduct observations or assess|0|||
149876567|NCT02094417|540676703|FG003|Overall Study|Unable to conduct observations or assess|0|||
149876568|NCT02094417|540676700|FG000|Overall Study|Withdrawal by Subject|1|||
149876569|NCT02094417|540676701|FG001|Overall Study|Withdrawal by Subject|2|||
149876570|NCT02094417|540676702|FG002|Overall Study|Withdrawal by Subject|1|||
149876571|NCT02094417|540676703|FG003|Overall Study|Withdrawal by Subject|3|||
149876572|NCT03022084|540676704|FG000|Overall Study|Lost to Follow-up|2|||
149876573|NCT03022084|540676705|FG001|Overall Study|Lost to Follow-up|3|||
149876574|NCT02932306|540676709|FG000|Overall Study|Withdrawal by Subject|16|||
149876575|NCT02932306|540676710|FG001|Overall Study|Withdrawal by Subject|25|||
149876576|NCT02932306|540676709|FG000|Overall Study|Adverse Event|3|||
149876577|NCT02932306|540676710|FG001|Overall Study|Adverse Event|0|||
149876578|NCT02932306|540676709|FG000|Overall Study|Pregnancy|2|||
149876579|NCT02932306|540676710|FG001|Overall Study|Pregnancy|0|||
149876580|NCT02932306|540676709|FG000|Overall Study|Protocol Violation|1|||
149876581|NCT02932306|540676710|FG001|Overall Study|Protocol Violation|1|||
149876582|NCT02932306|540676709|FG000|Overall Study|Noncompliance with Study Drug|1|||
149876583|NCT02932306|540676710|FG001|Overall Study|Noncompliance with Study Drug|1|||
149876584|NCT02932306|540676709|FG000|Overall Study|Lost to Follow-up|36|||
149876585|NCT02932306|540676710|FG001|Overall Study|Lost to Follow-up|40|||
149876586|NCT02932306|540676709|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
149876587|NCT02932306|540676710|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
149876588|NCT02932306|540676709|FG000|Overall Study|Lack of Efficacy|0|||
149876589|NCT02932306|540676710|FG001|Overall Study|Lack of Efficacy|2|||
149876590|NCT02932306|540676709|FG000|Overall Study|Worsening condition|2|||
149876591|NCT02932306|540676710|FG001|Overall Study|Worsening condition|0|||
149876592|NCT02932306|540676709|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
149876593|NCT02932306|540676710|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
150043000|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
150043001|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
150043002|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
150043003|NCT02952820|541295653|FG000|Active Treatment Period (6 Months)|Not treated|0|||
150043004|NCT02952820|541295654|FG001|Active Treatment Period (6 Months)|Not treated|0|||
150043005|NCT02952820|541295655|FG002|Active Treatment Period (6 Months)|Not treated|1|||
149876594|NCT03559400|540676715|FG000|Overall Study|Lost to Follow-up|9|||
149876595|NCT03559400|540676716|FG001|Overall Study|Lost to Follow-up|7|||
149876596|NCT03559400|540676715|FG000|Overall Study|Death|0|||
149876597|NCT03559400|540676716|FG001|Overall Study|Death|2|||
149876598|NCT00509366|540676717|FG000|Overall Study|Not Treated (Screen Failure)|1|||
149876599|NCT00509366|540676718|FG001|Overall Study|Not Treated (Screen Failure)|1|||
149876600|NCT00509366|540676719|FG002|Overall Study|Not Treated (Screen Failure)|1|||
149876601|NCT00509366|540676720|FG003|Overall Study|Not Treated (Screen Failure)|0|||
149876602|NCT00509366|540676721|FG004|Overall Study|Not Treated (Screen Failure)|0|||
149876603|NCT02119819|540676722|FG000|Overall Study|Adverse Event|3|||
149876604|NCT02119819|540676723|FG001|Overall Study|Adverse Event|1|||
149876605|NCT02119819|540676724|FG002|Overall Study|Adverse Event|2|||
149876606|NCT02119819|540676725|FG003|Overall Study|Adverse Event|3|||
149876607|NCT02119819|540676726|FG004|Overall Study|Adverse Event|0|||
149876608|NCT02119819|540676727|FG005|Overall Study|Adverse Event|1|||
149876609|NCT02119819|540676722|FG000|Overall Study|Lack of Efficacy|0|||
149876610|NCT02119819|540676723|FG001|Overall Study|Lack of Efficacy|0|||
149876611|NCT02119819|540676724|FG002|Overall Study|Lack of Efficacy|0|||
149876612|NCT02119819|540676725|FG003|Overall Study|Lack of Efficacy|0|||
149876613|NCT02119819|540676726|FG004|Overall Study|Lack of Efficacy|0|||
149876614|NCT02119819|540676727|FG005|Overall Study|Lack of Efficacy|1|||
149876615|NCT02119819|540676722|FG000|Overall Study|Lost to Follow-up|0|||
149876616|NCT02119819|540676723|FG001|Overall Study|Lost to Follow-up|0|||
149876617|NCT02119819|540676724|FG002|Overall Study|Lost to Follow-up|1|||
149876618|NCT02119819|540676725|FG003|Overall Study|Lost to Follow-up|2|||
149876619|NCT02119819|540676726|FG004|Overall Study|Lost to Follow-up|1|||
149876620|NCT02119819|540676727|FG005|Overall Study|Lost to Follow-up|2|||
149876621|NCT02119819|540676722|FG000|Overall Study|Physician Decision|1|||
149876622|NCT02119819|540676723|FG001|Overall Study|Physician Decision|1|||
149876623|NCT02119819|540676724|FG002|Overall Study|Physician Decision|0|||
149876624|NCT02119819|540676725|FG003|Overall Study|Physician Decision|0|||
149876625|NCT02119819|540676726|FG004|Overall Study|Physician Decision|0|||
149876626|NCT02119819|540676727|FG005|Overall Study|Physician Decision|1|||
149876627|NCT02119819|540676722|FG000|Overall Study|Withdrawal by Subject|5|||
149876628|NCT02119819|540676723|FG001|Overall Study|Withdrawal by Subject|3|||
149876629|NCT02119819|540676724|FG002|Overall Study|Withdrawal by Subject|0|||
149876630|NCT02119819|540676725|FG003|Overall Study|Withdrawal by Subject|0|||
149876631|NCT02119819|540676726|FG004|Overall Study|Withdrawal by Subject|6|||
149876632|NCT02119819|540676727|FG005|Overall Study|Withdrawal by Subject|10|||
149876633|NCT02119819|540676722|FG000|Overall Study|Jury Duty|0|||
149876634|NCT02119819|540676723|FG001|Overall Study|Jury Duty|0|||
149876635|NCT02119819|540676724|FG002|Overall Study|Jury Duty|1|||
149876636|NCT02119819|540676725|FG003|Overall Study|Jury Duty|0|||
149876637|NCT02119819|540676726|FG004|Overall Study|Jury Duty|0|||
149876638|NCT02119819|540676727|FG005|Overall Study|Jury Duty|0|||
149876639|NCT02119819|540676722|FG000|Overall Study|Protocol Violation|0|||
149876640|NCT02119819|540676723|FG001|Overall Study|Protocol Violation|0|||
149876641|NCT02119819|540676724|FG002|Overall Study|Protocol Violation|0|||
149876642|NCT02119819|540676725|FG003|Overall Study|Protocol Violation|1|||
149876643|NCT02119819|540676726|FG004|Overall Study|Protocol Violation|0|||
149876644|NCT02119819|540676727|FG005|Overall Study|Protocol Violation|0|||
149876645|NCT02119819|540676722|FG000|Overall Study|Left the city to get a job|0|||
149876646|NCT02119819|540676723|FG001|Overall Study|Left the city to get a job|0|||
149876647|NCT02119819|540676724|FG002|Overall Study|Left the city to get a job|0|||
149876648|NCT02119819|540676725|FG003|Overall Study|Left the city to get a job|1|||
149876649|NCT02119819|540676726|FG004|Overall Study|Left the city to get a job|0|||
149876650|NCT02119819|540676727|FG005|Overall Study|Left the city to get a job|0|||
149876651|NCT04497948|540676728|FG000|Overall Study|Death|2|||
149876652|NCT00314951|540676734|FG000|Treatment|Didn't meet criteria for mITT population|16|||
149876653|NCT00314951|540676735|FG001|Treatment|Didn't meet criteria for mITT population|11|||
149876654|NCT00314951|540676734|FG000|Follow-up|mITT failure|44|||
150043006|NCT01108185|541295676|FG000|Overall Study|Non-compliance|15|||
150043007|NCT01108185|541295676|FG000|Overall Study|Lost to Follow-up|12|||
150043008|NCT02908672|541295679|FG000|Run-in Period|Death|12|||
150043009|NCT02908672|541295680|FG001|Run-in Period|Death|10|||
150043010|NCT02908672|541295681|FG002|Run-in Period|Death|0|||
150043011|NCT02908672|541295682|FG003|Run-in Period|Death|0|||
149876655|NCT00314951|540676735|FG001|Follow-up|mITT failure|34|||
149876656|NCT02015065|540676741|FG000|Overall Study|Death on study|1|||
149876657|NCT02015065|540676742|FG001|Overall Study|Death on study|2|||
149876658|NCT02015065|540676743|FG002|Overall Study|Death on study|1|||
149876659|NCT03280381|540676744|FG000|Overall Study|Physician Decision|0|||
149876660|NCT03280381|540676745|FG001|Overall Study|Physician Decision|2|||
149876661|NCT00468650|540676748|FG000|Overall Study|Lost to Follow-up|4|||
149876662|NCT00468650|540676748|FG000|Overall Study|Withdrawal by Subject|2|||
149876663|NCT00468650|540676748|FG000|Overall Study|Protocol Violation|1|||
149876664|NCT02655666|540676749|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
149876665|NCT00478426|540676750|FG000|Overall Study|Withdrawal by Subject|1|||
149876666|NCT00789737|540676755|FG000|Overall Study|Withdrawal by Subject|13|||
149876667|NCT00789737|540676756|FG001|Overall Study|Withdrawal by Subject|22|||
149876668|NCT00789737|540676755|FG000|Overall Study|Lost to Follow-up|10|||
149876669|NCT00789737|540676756|FG001|Overall Study|Lost to Follow-up|14|||
149876670|NCT00789737|540676755|FG000|Overall Study|Adverse Event|8|||
149876671|NCT00789737|540676756|FG001|Overall Study|Adverse Event|8|||
149876672|NCT00789737|540676755|FG000|Overall Study|Protocol Violation|3|||
149876673|NCT00789737|540676756|FG001|Overall Study|Protocol Violation|0|||
149876674|NCT00789737|540676755|FG000|Overall Study|Lack of Efficacy|3|||
149876675|NCT00789737|540676756|FG001|Overall Study|Lack of Efficacy|0|||
149876676|NCT00789737|540676755|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
149876677|NCT00789737|540676756|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
149876678|NCT00789737|540676755|FG000|Overall Study|Other|11|||
149876679|NCT00789737|540676756|FG001|Overall Study|Other|7|||
149876680|NCT01189487|540676757|FG000|Overall Study|Lack of Efficacy|2|||
149876681|NCT01189487|540676757|FG000|Overall Study|Adverse Event|1|||
149876682|NCT04630158|540676758|FG000|Overall Study|Adverse Event|1|||
149876683|NCT04630158|540676759|FG001|Overall Study|Adverse Event|1|||
149876684|NCT04630158|540676760|FG002|Overall Study|Adverse Event|1|||
149876685|NCT04630158|540676758|FG000|Overall Study|Physician Decision|0|||
149876686|NCT04630158|540676759|FG001|Overall Study|Physician Decision|2|||
149876687|NCT04630158|540676760|FG002|Overall Study|Physician Decision|0|||
149876688|NCT04630158|540676758|FG000|Overall Study|Protocol Violation|1|||
149876689|NCT04630158|540676759|FG001|Overall Study|Protocol Violation|0|||
149876690|NCT04630158|540676760|FG002|Overall Study|Protocol Violation|1|||
149876691|NCT04630158|540676758|FG000|Overall Study|Withdrawal by Subject|2|||
149876692|NCT04630158|540676759|FG001|Overall Study|Withdrawal by Subject|1|||
149876693|NCT04630158|540676760|FG002|Overall Study|Withdrawal by Subject|2|||
149876694|NCT03136965|540676763|FG000|Overall Study|Lost to Follow-up|0|||
149876695|NCT03136965|540676764|FG001|Overall Study|Lost to Follow-up|1|||
149876696|NCT03136965|540676765|FG002|Overall Study|Lost to Follow-up|0|||
149876697|NCT01210612|540676768|FG000|Overall Study|Withdrawal by Subject|0|||
149876698|NCT01210612|540676769|FG001|Overall Study|Withdrawal by Subject|2|||
149876699|NCT02290223|540676770|FG000|6 Months|Lost to Follow-up|9|||
149876700|NCT02290223|540676771|FG001|6 Months|Lost to Follow-up|6|||
149876701|NCT02290223|540676770|FG000|6 Months|Withdrawal by Subject|5|||
149876702|NCT02290223|540676771|FG001|6 Months|Withdrawal by Subject|0|||
149876703|NCT02290223|540676770|FG000|6 Months|deceased (not related to study)|2|||
149876704|NCT02290223|540676771|FG001|6 Months|deceased (not related to study)|0|||
149876705|NCT02290223|540676770|FG000|12 Months|Lost to Follow-up|16|||
149876706|NCT02290223|540676771|FG001|12 Months|Lost to Follow-up|10|||
149876707|NCT02290223|540676770|FG000|12 Months|Refusal|0|||
149876708|NCT02290223|540676771|FG001|12 Months|Refusal|1|||
149876709|NCT05293639|540676772|FG000|Overall Study|Withdrawal by Subject|1|||
149876710|NCT05293639|540676773|FG001|Overall Study|Withdrawal by Subject|1|||
149876711|NCT05293639|540676774|FG002|Overall Study|Withdrawal by Subject|2|||
149876712|NCT05293639|540676772|FG000|Overall Study|Death|0|||
149876713|NCT05293639|540676773|FG001|Overall Study|Death|1|||
149876714|NCT05293639|540676774|FG002|Overall Study|Death|0|||
149876715|NCT05293639|540676772|FG000|Overall Study|Lost to Follow-up|0|||
149876716|NCT05293639|540676773|FG001|Overall Study|Lost to Follow-up|0|||
149876717|NCT05293639|540676774|FG002|Overall Study|Lost to Follow-up|5|||
149876718|NCT05293639|540676772|FG000|Overall Study|Other|0|||
149876719|NCT05293639|540676773|FG001|Overall Study|Other|0|||
149876720|NCT05293639|540676774|FG002|Overall Study|Other|1|||
149876721|NCT00813800|540676780|FG000|Overall Study|Screen Failure after Consent|2|||
149876722|NCT00813800|540676780|FG000|Overall Study|Adverse Event|1|||
149876723|NCT00813800|540676780|FG000|Overall Study|Worsening of depression|2|||
149876724|NCT00813800|540676780|FG000|Overall Study|Physician Decision|1|||
149876725|NCT01860677|540676781|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
149876726|NCT01860677|540676782|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
149876727|NCT00642278|540676785|FG000|Overall Study|Adverse Event|2|||
149876728|NCT00642278|540676786|FG001|Overall Study|Adverse Event|1|||
149876729|NCT00642278|540676787|FG002|Overall Study|Adverse Event|3|||
149876730|NCT00642278|540676788|FG003|Overall Study|Adverse Event|1|||
149964154|NCT02181413|541003252|FG001|Overall Study|Withdrawal by Subject|61|||
149964155|NCT02181413|541003251|FG000|Overall Study|Reason Not Specified|2|||
149964156|NCT02181413|541003252|FG001|Overall Study|Reason Not Specified|5|||
150174210|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
150174211|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149876731|NCT00642278|540676789|FG004|Overall Study|Adverse Event|2|||
149964157|NCT02181413|541003251|FG000|Overall Study|Lost to Follow-up|8|||
150174212|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149876732|NCT00642278|540676790|FG005|Overall Study|Adverse Event|2|||
149876733|NCT00642278|540676791|FG006|Overall Study|Adverse Event|0|||
149876734|NCT00642278|540676785|FG000|Overall Study|Lack of Efficacy|0|||
149876735|NCT00642278|540676786|FG001|Overall Study|Lack of Efficacy|1|||
149876736|NCT00642278|540676787|FG002|Overall Study|Lack of Efficacy|0|||
149876737|NCT00642278|540676788|FG003|Overall Study|Lack of Efficacy|0|||
149876738|NCT00642278|540676789|FG004|Overall Study|Lack of Efficacy|0|||
149876739|NCT00642278|540676790|FG005|Overall Study|Lack of Efficacy|0|||
149964158|NCT02181413|541003252|FG001|Overall Study|Lost to Follow-up|7|||
149876740|NCT00642278|540676791|FG006|Overall Study|Lack of Efficacy|0|||
149876741|NCT00642278|540676785|FG000|Overall Study|Lost to Follow-up|5|||
149876742|NCT00642278|540676786|FG001|Overall Study|Lost to Follow-up|1|||
149876743|NCT00642278|540676787|FG002|Overall Study|Lost to Follow-up|0|||
149876744|NCT00642278|540676788|FG003|Overall Study|Lost to Follow-up|1|||
149876745|NCT00642278|540676789|FG004|Overall Study|Lost to Follow-up|0|||
149876746|NCT00642278|540676790|FG005|Overall Study|Lost to Follow-up|1|||
149876747|NCT00642278|540676791|FG006|Overall Study|Lost to Follow-up|1|||
149876748|NCT00642278|540676785|FG000|Overall Study|Physician Decision|0|||
149876749|NCT00642278|540676786|FG001|Overall Study|Physician Decision|0|||
149876750|NCT00642278|540676787|FG002|Overall Study|Physician Decision|0|||
149876751|NCT00642278|540676788|FG003|Overall Study|Physician Decision|1|||
149876752|NCT00642278|540676789|FG004|Overall Study|Physician Decision|0|||
149876753|NCT00642278|540676790|FG005|Overall Study|Physician Decision|0|||
149876754|NCT00642278|540676791|FG006|Overall Study|Physician Decision|0|||
149876755|NCT00642278|540676785|FG000|Overall Study|Protocol Violation|0|||
149876756|NCT00642278|540676786|FG001|Overall Study|Protocol Violation|0|||
149876757|NCT00642278|540676787|FG002|Overall Study|Protocol Violation|1|||
149876758|NCT00642278|540676788|FG003|Overall Study|Protocol Violation|1|||
149876759|NCT00642278|540676789|FG004|Overall Study|Protocol Violation|0|||
149876760|NCT00642278|540676790|FG005|Overall Study|Protocol Violation|1|||
149876761|NCT00642278|540676791|FG006|Overall Study|Protocol Violation|2|||
149876762|NCT00642278|540676785|FG000|Overall Study|Withdrawal by Subject|1|||
149876763|NCT00642278|540676786|FG001|Overall Study|Withdrawal by Subject|1|||
149876764|NCT00642278|540676787|FG002|Overall Study|Withdrawal by Subject|1|||
149876765|NCT00642278|540676788|FG003|Overall Study|Withdrawal by Subject|3|||
149876766|NCT00642278|540676789|FG004|Overall Study|Withdrawal by Subject|6|||
149876767|NCT00642278|540676790|FG005|Overall Study|Withdrawal by Subject|2|||
149876768|NCT00642278|540676791|FG006|Overall Study|Withdrawal by Subject|2|||
149876769|NCT00642278|540676785|FG000|Overall Study|Noncompliance with study drug regimen|0|||
149876770|NCT00642278|540676786|FG001|Overall Study|Noncompliance with study drug regimen|0|||
149876771|NCT00642278|540676787|FG002|Overall Study|Noncompliance with study drug regimen|0|||
149876772|NCT00642278|540676788|FG003|Overall Study|Noncompliance with study drug regimen|1|||
149876773|NCT00642278|540676789|FG004|Overall Study|Noncompliance with study drug regimen|0|||
149876774|NCT00642278|540676790|FG005|Overall Study|Noncompliance with study drug regimen|0|||
149876775|NCT00642278|540676791|FG006|Overall Study|Noncompliance with study drug regimen|0|||
149876776|NCT00642278|540676785|FG000|Overall Study|Other|2|||
149876777|NCT00642278|540676786|FG001|Overall Study|Other|1|||
149876778|NCT00642278|540676787|FG002|Overall Study|Other|0|||
149876779|NCT00642278|540676788|FG003|Overall Study|Other|1|||
149876780|NCT00642278|540676789|FG004|Overall Study|Other|0|||
149876781|NCT00642278|540676790|FG005|Overall Study|Other|1|||
149876782|NCT00642278|540676791|FG006|Overall Study|Other|0|||
149876783|NCT00090363|540676792|FG000|Overall Study|Lost to Follow-up|1|||
149876784|NCT00090363|540676793|FG001|Overall Study|Lost to Follow-up|2|||
149876785|NCT00090363|540676794|FG002|Overall Study|Lost to Follow-up|1|||
149876786|NCT00090363|540676792|FG000|Overall Study|Withdrawal by Subject|7|||
149876787|NCT00090363|540676793|FG001|Overall Study|Withdrawal by Subject|7|||
149876788|NCT00090363|540676794|FG002|Overall Study|Withdrawal by Subject|6|||
149876789|NCT00090363|540676792|FG000|Overall Study|Study-specific discontinuation criteria|75|||
149876790|NCT00090363|540676793|FG001|Overall Study|Study-specific discontinuation criteria|74|||
149876791|NCT00090363|540676794|FG002|Overall Study|Study-specific discontinuation criteria|62|||
149876792|NCT00090363|540676792|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149876793|NCT00090363|540676793|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149876794|NCT00090363|540676794|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
149876795|NCT00090363|540676792|FG000|Overall Study|Consent expired|7|||
149876796|NCT00090363|540676793|FG001|Overall Study|Consent expired|10|||
149876797|NCT00090363|540676794|FG002|Overall Study|Consent expired|9|||
149876798|NCT00090363|540676792|FG000|Overall Study|Reasons not specified|2|||
149876799|NCT00090363|540676793|FG001|Overall Study|Reasons not specified|1|||
149876800|NCT00090363|540676794|FG002|Overall Study|Reasons not specified|1|||
149876801|NCT00090363|540676792|FG000|Overall Study|Continuing on study off treatment|14|||
149876802|NCT00090363|540676793|FG001|Overall Study|Continuing on study off treatment|13|||
149876803|NCT00090363|540676794|FG002|Overall Study|Continuing on study off treatment|16|||
149876804|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
149876805|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
149876806|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
149876807|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
149876808|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
149876809|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
149876810|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
149876811|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
149876812|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
149876813|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
149876814|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
149876815|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
149876816|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
149964159|NCT04003142|541003253|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
149876817|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
149876818|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
149876819|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
149876820|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149876821|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149876822|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149876823|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149876824|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
149876825|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
149876826|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
149876827|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
149876828|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
149876829|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
149876830|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
149876831|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
149876832|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
149876833|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
149876834|NCT03713619|540676795|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
149876835|NCT03713619|540676796|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
149876836|NCT03713619|540676797|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
149876837|NCT03713619|540676798|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
149876838|NCT03713619|540676799|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
149876839|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
149876840|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
149876841|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
149876842|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
149876843|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
149876844|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
149876845|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149876846|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149876847|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
149876848|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149876849|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
149876850|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
149876851|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
149876852|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
149876853|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
149876854|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
149876855|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
149876856|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
149876857|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
149876858|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
149876859|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
149876860|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
149876861|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
149876862|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
149876863|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
149876864|NCT03713619|540676795|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
149876865|NCT03713619|540676796|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
149876866|NCT03713619|540676797|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
149876867|NCT03713619|540676798|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
149876868|NCT03713619|540676799|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
149876869|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
149876870|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
149876871|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
149876872|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
149876873|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
149876874|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
149876875|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
149876876|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
149876877|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
149876878|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
149876879|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
149876880|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
149876881|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
149876882|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
149876883|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
149876884|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
149876885|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
149876886|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
149876887|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
149876888|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
149876889|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
149876890|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
149876891|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
149876892|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
149876893|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
149876894|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
149876895|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
149876896|NCT02552212|540676802|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
149876897|NCT02552212|540676803|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
149876898|NCT02552212|540676804|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
149876899|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
149876900|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
149876901|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
149876902|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
149876903|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
149876904|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
149876905|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
149876906|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
149876907|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
149876908|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
149876909|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
149876910|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
149876911|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
149876912|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
149876913|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
149876914|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
149876915|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
149876916|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
149876917|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
149876918|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
149876919|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
149876920|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
149876921|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
149876922|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
149876923|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
149876924|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
149876925|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
149876926|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
149876927|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
149876928|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
149876929|NCT02552212|540676802|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
149876930|NCT02552212|540676803|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
149876931|NCT02552212|540676804|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
149876932|NCT04400682|540676810|FG000|Period 1|Withdrawal by Subject|1|||
149876933|NCT04400682|540676811|FG001|Period 1|Withdrawal by Subject|4|||
149876934|NCT02105974|540676812|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
149876935|NCT02105974|540676813|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
149876936|NCT02105974|540676814|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
149876937|NCT02105974|540676812|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
149876938|NCT02105974|540676813|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
149876939|NCT02105974|540676814|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
149876940|NCT02105974|540676812|FG000|2 Week Run-in Period|Adverse Event|6|||
149876941|NCT02105974|540676813|FG001|2 Week Run-in Period|Adverse Event|0|||
149876942|NCT02105974|540676814|FG002|2 Week Run-in Period|Adverse Event|0|||
149876943|NCT02105974|540676812|FG000|2 Week Run-in Period|Study closed/terminated|1|||
149876944|NCT02105974|540676813|FG001|2 Week Run-in Period|Study closed/terminated|0|||
149876945|NCT02105974|540676814|FG002|2 Week Run-in Period|Study closed/terminated|0|||
149876946|NCT02105974|540676812|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
149876947|NCT02105974|540676813|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
149876948|NCT02105974|540676814|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
149876949|NCT02105974|540676812|FG000|2 Week Run-in Period|Withdrew consent|23|||
149876950|NCT02105974|540676813|FG001|2 Week Run-in Period|Withdrew consent|0|||
149876951|NCT02105974|540676814|FG002|2 Week Run-in Period|Withdrew consent|0|||
149876952|NCT02105974|540676812|FG000|2 Week Run-in Period|Investigator discretion|8|||
149876953|NCT02105974|540676813|FG001|2 Week Run-in Period|Investigator discretion|0|||
149876954|NCT02105974|540676814|FG002|2 Week Run-in Period|Investigator discretion|0|||
149876955|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
149876956|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
149876957|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
149876958|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
149876959|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
149876960|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
149876961|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
149876962|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
149876963|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
149876964|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
149876965|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
149876966|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
149876967|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
149876968|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
149876969|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
149876970|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
149876971|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
149876972|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
149876973|NCT02105974|540676812|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
149876974|NCT02105974|540676813|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
149876975|NCT02105974|540676814|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
149876976|NCT00477633|540676815|FG000|Overall Study|Did not receive treatment|23|||
149876977|NCT00477633|540676815|FG000|Overall Study|Adverse Event|143|||
149876978|NCT00477633|540676815|FG000|Overall Study|Pregnancy|23|||
149876979|NCT00477633|540676815|FG000|Overall Study|Lost to Follow-up|271|||
149876980|NCT00477633|540676815|FG000|Overall Study|Withdrawal by Subject|149|||
149876981|NCT00477633|540676815|FG000|Overall Study|Protocol Violation|25|||
149876982|NCT00477633|540676815|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
149876983|NCT02968849|540676816|FG000|Overall Study|Death|8|||
149876984|NCT02968849|540676817|FG001|Overall Study|Death|10|||
149876985|NCT02968849|540676816|FG000|Overall Study|Lost to Follow-up|31|||
149876986|NCT02968849|540676817|FG001|Overall Study|Lost to Follow-up|29|||
149876987|NCT02968849|540676816|FG000|Overall Study|Withdrawal by Subject|73|||
149876988|NCT02968849|540676817|FG001|Overall Study|Withdrawal by Subject|64|||
149876989|NCT02968849|540676816|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
149876990|NCT02968849|540676817|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
150043012|NCT02908672|541295679|FG000|Run-in Period|Lost to Follow-up|1|||
150043013|NCT02908672|541295680|FG001|Run-in Period|Lost to Follow-up|1|||
150043014|NCT02908672|541295681|FG002|Run-in Period|Lost to Follow-up|0|||
150043015|NCT02908672|541295682|FG003|Run-in Period|Lost to Follow-up|0|||
150043016|NCT02908672|541295679|FG000|Run-in Period|Reason Not Specified|2|||
150043017|NCT02908672|541295680|FG001|Run-in Period|Reason Not Specified|0|||
150043018|NCT02908672|541295681|FG002|Run-in Period|Reason Not Specified|0|||
150043019|NCT02908672|541295682|FG003|Run-in Period|Reason Not Specified|0|||
150043020|NCT02908672|541295679|FG000|Run-in Period|Protocol Violation|1|||
150043021|NCT02908672|541295680|FG001|Run-in Period|Protocol Violation|1|||
150043022|NCT02908672|541295681|FG002|Run-in Period|Protocol Violation|0|||
150043023|NCT02908672|541295682|FG003|Run-in Period|Protocol Violation|0|||
150043024|NCT02908672|541295679|FG000|Run-in Period|Study Ended by Sponsor|5|||
150043025|NCT02908672|541295680|FG001|Run-in Period|Study Ended by Sponsor|1|||
150043026|NCT02908672|541295681|FG002|Run-in Period|Study Ended by Sponsor|0|||
150043027|NCT02908672|541295682|FG003|Run-in Period|Study Ended by Sponsor|0|||
150043028|NCT02908672|541295679|FG000|Run-in Period|Withdrawal by Subject|3|||
150043029|NCT02908672|541295680|FG001|Run-in Period|Withdrawal by Subject|9|||
150043030|NCT02908672|541295681|FG002|Run-in Period|Withdrawal by Subject|0|||
150043031|NCT02908672|541295682|FG003|Run-in Period|Withdrawal by Subject|0|||
150043032|NCT02908672|541295679|FG000|Triple Combination Period|Death|0|||
150043033|NCT02908672|541295680|FG001|Triple Combination Period|Death|0|||
150043034|NCT02908672|541295681|FG002|Triple Combination Period|Death|150|||
150043035|NCT02908672|541295682|FG003|Triple Combination Period|Death|127|||
150043036|NCT02908672|541295679|FG000|Triple Combination Period|Lost to Follow-up|0|||
150043037|NCT02908672|541295680|FG001|Triple Combination Period|Lost to Follow-up|0|||
150043038|NCT02908672|541295681|FG002|Triple Combination Period|Lost to Follow-up|6|||
150043039|NCT02908672|541295682|FG003|Triple Combination Period|Lost to Follow-up|8|||
150043040|NCT02908672|541295679|FG000|Triple Combination Period|Reason Not Specified|0|||
150043041|NCT02908672|541295680|FG001|Triple Combination Period|Reason Not Specified|0|||
150043042|NCT02908672|541295681|FG002|Triple Combination Period|Reason Not Specified|0|||
150043043|NCT02908672|541295682|FG003|Triple Combination Period|Reason Not Specified|1|||
150043044|NCT02908672|541295679|FG000|Triple Combination Period|Physician Decision|0|||
150043045|NCT02908672|541295680|FG001|Triple Combination Period|Physician Decision|0|||
150043046|NCT02908672|541295681|FG002|Triple Combination Period|Physician Decision|1|||
150043047|NCT02908672|541295682|FG003|Triple Combination Period|Physician Decision|1|||
150043048|NCT02908672|541295679|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
150043049|NCT02908672|541295680|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
150043050|NCT02908672|541295681|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
150043051|NCT02908672|541295682|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
150043052|NCT02908672|541295679|FG000|Triple Combination Period|Withdrawal by Subject|0|||
150043053|NCT02908672|541295680|FG001|Triple Combination Period|Withdrawal by Subject|0|||
150043054|NCT02908672|541295681|FG002|Triple Combination Period|Withdrawal by Subject|13|||
150043055|NCT02908672|541295682|FG003|Triple Combination Period|Withdrawal by Subject|16|||
150043056|NCT01185080|541295686|FG000|Overall Study|Adverse Event|1|||
150043057|NCT01185080|541295687|FG001|Overall Study|Adverse Event|1|||
150043058|NCT01185080|541295688|FG002|Overall Study|Adverse Event|0|||
150043059|NCT01185080|541295686|FG000|Overall Study|Personal reasons|0|||
150043060|NCT01185080|541295687|FG001|Overall Study|Personal reasons|0|||
150043061|NCT01185080|541295688|FG002|Overall Study|Personal reasons|1|||
150043062|NCT00759941|541295689|FG000|Overall Study|Use of medication|1|||
150043063|NCT00759941|541295690|FG001|Overall Study|Use of medication|0|||
150043064|NCT00759941|541295689|FG000|Overall Study|Adverse Event|1|||
150043065|NCT00759941|541295690|FG001|Overall Study|Adverse Event|0|||
150043066|NCT00759941|541295689|FG000|Overall Study|Exited in error by site|1|||
150043067|NCT00759941|541295690|FG001|Overall Study|Exited in error by site|1|||
150043068|NCT05615922|541295694|FG000|Overall Study|Lost to Follow-up|1|||
150043069|NCT06083506|541295695|FG000|Overall Study|Physician Decision|2|||
150043070|NCT06083506|541295695|FG000|Overall Study|Lack of Efficacy|1|||
150043071|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
150043072|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
150043073|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
150043074|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
150174213|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
150043075|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
150051995|NCT00717236|541332847|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
149876991|NCT02968849|540676816|FG000|Overall Study|Physician Decision|6|||
149876992|NCT02968849|540676817|FG001|Overall Study|Physician Decision|9|||
149876993|NCT02968849|540676816|FG000|Overall Study|Other|16|||
149876994|NCT02968849|540676817|FG001|Overall Study|Other|10|||
149876995|NCT01200069|540678674|FG000|Overall Study|Withdrawal by Subject|0|||
149876996|NCT01200069|540678675|FG001|Overall Study|Withdrawal by Subject|1|||
149876997|NCT03408639|540678676|FG000|Overall Study|Death|5|||
149876998|NCT03408639|540678677|FG001|Overall Study|Death|5|||
149876999|NCT03408639|540678676|FG000|Overall Study|Lost to Follow-up|1|||
149877000|NCT03408639|540678677|FG001|Overall Study|Lost to Follow-up|4|||
149877001|NCT03408639|540678676|FG000|Overall Study|Withdrawal by Subject|2|||
149877002|NCT03408639|540678677|FG001|Overall Study|Withdrawal by Subject|7|||
149877003|NCT03408639|540678676|FG000|Overall Study|Physician Decision|3|||
149877004|NCT03408639|540678677|FG001|Overall Study|Physician Decision|6|||
149877005|NCT04998851|540678678|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
149877006|NCT04998851|540678679|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
149877007|NCT04998851|540678678|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
149877008|NCT04998851|540678679|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
149877009|NCT00070499|540678680|FG000|Overall Study|Adverse Event|6|||
149877010|NCT00070499|540678681|FG001|Overall Study|Adverse Event|6|||
149877011|NCT00070499|540678682|FG002|Overall Study|Adverse Event|19|||
149877012|NCT00070499|540678683|FG003|Overall Study|Adverse Event|15|||
149877013|NCT00070499|540678680|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
149877014|NCT00070499|540678681|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
149877015|NCT00070499|540678682|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
149877016|NCT00070499|540678683|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
149877017|NCT00070499|540678680|FG000|Overall Study|Progression/relapse|4|||
149877018|NCT00070499|540678681|FG001|Overall Study|Progression/relapse|2|||
149877019|NCT00070499|540678682|FG002|Overall Study|Progression/relapse|1|||
149877020|NCT00070499|540678683|FG003|Overall Study|Progression/relapse|4|||
149877021|NCT00070499|540678680|FG000|Overall Study|Death|1|||
149877022|NCT00070499|540678681|FG001|Overall Study|Death|1|||
149877023|NCT00070499|540678682|FG002|Overall Study|Death|1|||
149877024|NCT00070499|540678683|FG003|Overall Study|Death|2|||
149877025|NCT00070499|540678680|FG000|Overall Study|Other - not protocol specified|7|||
149877026|NCT00070499|540678681|FG001|Overall Study|Other - not protocol specified|3|||
149877027|NCT00070499|540678682|FG002|Overall Study|Other - not protocol specified|12|||
149877028|NCT00070499|540678683|FG003|Overall Study|Other - not protocol specified|20|||
149877029|NCT00070499|540678680|FG000|Overall Study|Still on protocol treatment|10|||
149877030|NCT00070499|540678681|FG001|Overall Study|Still on protocol treatment|4|||
149877031|NCT00070499|540678682|FG002|Overall Study|Still on protocol treatment|79|||
149877032|NCT00070499|540678683|FG003|Overall Study|Still on protocol treatment|57|||
149877033|NCT00070499|540678680|FG000|Overall Study|Did not start treatment|1|||
149877034|NCT00070499|540678681|FG001|Overall Study|Did not start treatment|0|||
149877035|NCT00070499|540678682|FG002|Overall Study|Did not start treatment|0|||
149877036|NCT00070499|540678683|FG003|Overall Study|Did not start treatment|2|||
149877037|NCT00070499|540678680|FG000|Overall Study|Not eligible|2|||
149877038|NCT00070499|540678681|FG001|Overall Study|Not eligible|5|||
149877039|NCT00070499|540678682|FG002|Overall Study|Not eligible|3|||
149877040|NCT00070499|540678683|FG003|Overall Study|Not eligible|2|||
149877041|NCT00805467|540678684|FG000|Overall Study|Lack of Efficacy|0|||
149877042|NCT00805467|540678685|FG001|Overall Study|Lack of Efficacy|8|||
149877043|NCT00805467|540678686|FG002|Overall Study|Lack of Efficacy|13|||
149877044|NCT00805467|540678687|FG003|Overall Study|Lack of Efficacy|86|||
149877045|NCT00805467|540678684|FG000|Overall Study|Lost to Follow-up|0|||
149877046|NCT00805467|540678685|FG001|Overall Study|Lost to Follow-up|1|||
149877047|NCT00805467|540678686|FG002|Overall Study|Lost to Follow-up|7|||
149877048|NCT00805467|540678687|FG003|Overall Study|Lost to Follow-up|21|||
149877049|NCT00805467|540678684|FG000|Overall Study|Withdrawal by Subject|0|||
149877050|NCT00805467|540678685|FG001|Overall Study|Withdrawal by Subject|6|||
149877051|NCT00805467|540678686|FG002|Overall Study|Withdrawal by Subject|45|||
149877052|NCT00805467|540678687|FG003|Overall Study|Withdrawal by Subject|50|||
149877053|NCT00805467|540678684|FG000|Overall Study|Protocol Violation|0|||
149877054|NCT00805467|540678685|FG001|Overall Study|Protocol Violation|3|||
149877055|NCT00805467|540678686|FG002|Overall Study|Protocol Violation|0|||
149877056|NCT00805467|540678687|FG003|Overall Study|Protocol Violation|5|||
149877057|NCT00805467|540678684|FG000|Overall Study|Adverse Event|0|||
149877058|NCT00805467|540678685|FG001|Overall Study|Adverse Event|13|||
149877059|NCT00805467|540678686|FG002|Overall Study|Adverse Event|26|||
149877060|NCT00805467|540678687|FG003|Overall Study|Adverse Event|57|||
149877061|NCT00805467|540678684|FG000|Overall Study|Death|0|||
149877062|NCT00805467|540678685|FG001|Overall Study|Death|2|||
149877063|NCT00805467|540678686|FG002|Overall Study|Death|7|||
149877064|NCT00805467|540678687|FG003|Overall Study|Death|5|||
149877065|NCT00805467|540678684|FG000|Overall Study|Physician Decision|0|||
149877066|NCT00805467|540678685|FG001|Overall Study|Physician Decision|1|||
149877067|NCT00805467|540678686|FG002|Overall Study|Physician Decision|2|||
149877068|NCT00805467|540678687|FG003|Overall Study|Physician Decision|6|||
149877069|NCT00805467|540678684|FG000|Overall Study|Not reported|0|||
149877070|NCT00805467|540678685|FG001|Overall Study|Not reported|0|||
149877071|NCT00805467|540678686|FG002|Overall Study|Not reported|3|||
149877072|NCT00805467|540678687|FG003|Overall Study|Not reported|7|||
149877073|NCT00478244|540678692|FG000|Overall Study|Did not receive transplant|1|||
149877074|NCT00459043|540678693|FG000|Overall Study|Withdrawal by Subject|1|||
149877075|NCT00459043|540678694|FG001|Overall Study|Withdrawal by Subject|0|||
149877076|NCT01392963|540678695|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
149877077|NCT01392963|540678696|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
149877078|NCT01392963|540678695|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
149877079|NCT01392963|540678696|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
149877080|NCT01392963|540678695|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
149877081|NCT01392963|540678696|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
149877082|NCT02856555|540678702|FG000|Overall Study|Adverse Event|1|||
149877083|NCT02856555|540678703|FG001|Overall Study|Adverse Event|0|||
149877084|NCT02856555|540678704|FG002|Overall Study|Adverse Event|0|||
149877085|NCT02856555|540678702|FG000|Overall Study|Lost to Follow-up|1|||
149877086|NCT02856555|540678703|FG001|Overall Study|Lost to Follow-up|3|||
149877087|NCT02856555|540678704|FG002|Overall Study|Lost to Follow-up|0|||
149877088|NCT02856555|540678702|FG000|Overall Study|Withdrawal by Subject|3|||
149877089|NCT02856555|540678703|FG001|Overall Study|Withdrawal by Subject|0|||
149877090|NCT02856555|540678704|FG002|Overall Study|Withdrawal by Subject|0|||
149877091|NCT02856555|540678702|FG000|Overall Study|Randomized but Never Treated|0|||
149964160|NCT04003142|541003254|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
149964161|NCT04003142|541003255|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
149964162|NCT04003142|541003256|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
149964163|NCT04003142|541003257|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
149964164|NCT04003142|541003253|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
149877092|NCT02856555|540678703|FG001|Overall Study|Randomized but Never Treated|1|||
149877093|NCT02856555|540678704|FG002|Overall Study|Randomized but Never Treated|0|||
149877094|NCT00580788|540678705|FG000|Overall Study|Adverse Event|0|||
149877095|NCT00580788|540678706|FG001|Overall Study|Adverse Event|0|||
149877096|NCT00580788|540678707|FG002|Overall Study|Adverse Event|0|||
149877097|NCT00580788|540678708|FG003|Overall Study|Adverse Event|1|||
149877098|NCT03301649|540678711|FG000|Overall Study|Need alternate therapy due to live lice|17|||
149964165|NCT04003142|541003254|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
149964166|NCT04003142|541003255|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
149877099|NCT03301649|540678712|FG001|Overall Study|Need alternate therapy due to live lice|25|||
149877100|NCT03301649|540678713|FG002|Overall Study|Need alternate therapy due to live lice|81|||
149877101|NCT03301649|540678711|FG000|Overall Study|Lost to Follow-up|11|||
149877102|NCT03301649|540678712|FG001|Overall Study|Lost to Follow-up|11|||
149877103|NCT03301649|540678713|FG002|Overall Study|Lost to Follow-up|3|||
149877104|NCT03301649|540678711|FG000|Overall Study|Protocol Violation|0|||
149877105|NCT03301649|540678712|FG001|Overall Study|Protocol Violation|1|||
149877106|NCT03301649|540678713|FG002|Overall Study|Protocol Violation|1|||
149877107|NCT03301649|540678711|FG000|Overall Study|Withdrawal by Subject|10|||
149877108|NCT03301649|540678712|FG001|Overall Study|Withdrawal by Subject|4|||
149877109|NCT03301649|540678713|FG002|Overall Study|Withdrawal by Subject|0|||
149877110|NCT03301649|540678711|FG000|Overall Study|Other than specified|5|||
149877111|NCT03301649|540678712|FG001|Overall Study|Other than specified|3|||
149877112|NCT03301649|540678713|FG002|Overall Study|Other than specified|0|||
149877113|NCT01403051|540678714|FG000|Overall Study|Protocol Violation|2|||
149877114|NCT01403051|540678715|FG001|Overall Study|Protocol Violation|0|||
149877115|NCT01403051|540678714|FG000|Overall Study|Death|1|||
149877116|NCT01403051|540678715|FG001|Overall Study|Death|0|||
149877117|NCT01403051|540678714|FG000|Overall Study|Withdrawal by Subject|2|||
149877118|NCT01403051|540678715|FG001|Overall Study|Withdrawal by Subject|1|||
149877119|NCT01403051|540678714|FG000|Overall Study|Lost to Follow-up|5|||
149877120|NCT01403051|540678715|FG001|Overall Study|Lost to Follow-up|5|||
149877121|NCT00887289|540678720|FG000|Overall Study|Lack of Efficacy|14|||
149877122|NCT00887289|540678720|FG000|Overall Study|Adverse Event|27|||
149877123|NCT00887289|540678720|FG000|Overall Study|Withdrawal by Subject|26|||
149877124|NCT00887289|540678720|FG000|Overall Study|Lost to Follow-up|8|||
149877125|NCT00887289|540678720|FG000|Overall Study|Other|20|||
149877126|NCT00591773|540678721|FG000|Overall Study|Adverse Event|9|||
149877127|NCT00591773|540678722|FG001|Overall Study|Adverse Event|9|||
149877128|NCT00591773|540678723|FG002|Overall Study|Adverse Event|6|||
149877129|NCT00591773|540678721|FG000|Overall Study|Protocol Violation|2|||
149877130|NCT00591773|540678722|FG001|Overall Study|Protocol Violation|3|||
149877131|NCT00591773|540678723|FG002|Overall Study|Protocol Violation|0|||
149877132|NCT00591773|540678721|FG000|Overall Study|Lost to Follow-up|1|||
149877133|NCT00591773|540678722|FG001|Overall Study|Lost to Follow-up|4|||
149877134|NCT00591773|540678723|FG002|Overall Study|Lost to Follow-up|1|||
149877135|NCT00591773|540678721|FG000|Overall Study|Withdrawal by Subject|2|||
149877136|NCT00591773|540678722|FG001|Overall Study|Withdrawal by Subject|5|||
149877137|NCT00591773|540678723|FG002|Overall Study|Withdrawal by Subject|3|||
149877138|NCT00591773|540678721|FG000|Overall Study|Lack of Efficacy|1|||
149877139|NCT00591773|540678722|FG001|Overall Study|Lack of Efficacy|2|||
149877140|NCT00591773|540678723|FG002|Overall Study|Lack of Efficacy|2|||
149877141|NCT00591773|540678721|FG000|Overall Study|Other|1|||
149877142|NCT00591773|540678722|FG001|Overall Study|Other|1|||
149877143|NCT00591773|540678723|FG002|Overall Study|Other|4|||
149877144|NCT02135614|540678724|FG000|Overall Study|Randomized but Not Treated|2|||
149877145|NCT02135614|540678725|FG001|Overall Study|Randomized but Not Treated|1|||
149877146|NCT02135614|540678724|FG000|Overall Study|Adverse Event|0|||
149877147|NCT02135614|540678725|FG001|Overall Study|Adverse Event|1|||
149877148|NCT02135614|540678724|FG000|Overall Study|Death|1|||
149877149|NCT02135614|540678725|FG001|Overall Study|Death|0|||
149877150|NCT02135614|540678724|FG000|Overall Study|Investigator's Discretion|0|||
149877151|NCT02135614|540678725|FG001|Overall Study|Investigator's Discretion|1|||
149964167|NCT04003142|541003256|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
149964168|NCT04003142|541003257|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
149964169|NCT04003142|541003253|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
149964170|NCT04003142|541003254|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
149964171|NCT04003142|541003255|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
149964172|NCT04003142|541003256|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
149964173|NCT04003142|541003257|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
149877152|NCT02135614|540678724|FG000|Overall Study|Withdrew Consent|2|||
149964174|NCT04003142|541003253|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
149877153|NCT02135614|540678725|FG001|Overall Study|Withdrew Consent|2|||
149877154|NCT02135614|540678724|FG000|Overall Study|Lost to Follow-up|3|||
149877155|NCT02135614|540678725|FG001|Overall Study|Lost to Follow-up|0|||
149877156|NCT02679235|540678732|FG000|Overall Study|Withdrawal by Subject|3|||
149877157|NCT02679235|540678732|FG000|Overall Study|Adverse Event|1|||
149877158|NCT00923273|540678733|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
149877159|NCT00923273|540678734|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
149877160|NCT00923273|540678735|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
149964175|NCT04003142|541003254|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
149964176|NCT04003142|541003255|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
149877161|NCT00923273|540678736|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
149877162|NCT00923273|540678737|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
149877163|NCT00923273|540678733|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
149877164|NCT00923273|540678734|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
149877165|NCT00923273|540678735|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
149877166|NCT00923273|540678736|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
149877167|NCT00923273|540678737|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
149877168|NCT00605540|540678738|FG000|Overall Study|Death|15|||
149877169|NCT00605540|540678738|FG000|Overall Study|Lost to Follow-up|23|||
149877170|NCT01438996|540678741|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
149877171|NCT01438996|540678742|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
149877172|NCT01438996|540678743|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
149877173|NCT01433549|540678744|FG000|Phase 2: Second Study Product|Adverse Event|0|||
149877174|NCT01433549|540678745|FG001|Phase 2: Second Study Product|Adverse Event|1|||
149877175|NCT02246114|540678748|FG000|Overall Study|miscarriage|1|||
149877176|NCT02246114|540678749|FG001|Overall Study|miscarriage|0|||
149877177|NCT01696058|540678756|FG000|Overall Study|Adverse Event|21|||
149877178|NCT01696058|540678757|FG001|Overall Study|Adverse Event|11|||
149877179|NCT01696058|540678756|FG000|Overall Study|Lack of Efficacy|2|||
149877180|NCT01696058|540678757|FG001|Overall Study|Lack of Efficacy|3|||
149877181|NCT01696058|540678756|FG000|Overall Study|Protocol Violation|9|||
149877182|NCT01696058|540678757|FG001|Overall Study|Protocol Violation|3|||
149877183|NCT01696058|540678756|FG000|Overall Study|Lost to Follow-up|2|||
149877184|NCT01696058|540678757|FG001|Overall Study|Lost to Follow-up|5|||
149877185|NCT01696058|540678756|FG000|Overall Study|Withdrawal by Subject|4|||
149877186|NCT01696058|540678757|FG001|Overall Study|Withdrawal by Subject|6|||
149877187|NCT01696058|540678756|FG000|Overall Study|Other reason prematurely discontinued|5|||
149877188|NCT01696058|540678757|FG001|Overall Study|Other reason prematurely discontinued|3|||
149877189|NCT02186834|540678759|FG000|Dose Escalation|Death|0|||
149877190|NCT02186834|540678760|FG001|Dose Escalation|Death|0|||
149877191|NCT02186834|540678761|FG002|Dose Escalation|Death|0|||
149877192|NCT02186834|540678762|FG003|Dose Escalation|Death|1|||
149877193|NCT02186834|540678763|FG004|Dose Escalation|Death|0|||
149877194|NCT02186834|540678764|FG005|Dose Escalation|Death|0|||
149877195|NCT02186834|540678759|FG000|Treatment at RP2D|Died prior to treatment|0|||
149877196|NCT02186834|540678760|FG001|Treatment at RP2D|Died prior to treatment|0|||
149877197|NCT02186834|540678761|FG002|Treatment at RP2D|Died prior to treatment|0|||
149877198|NCT02186834|540678762|FG003|Treatment at RP2D|Died prior to treatment|0|||
149877199|NCT02186834|540678763|FG004|Treatment at RP2D|Died prior to treatment|0|||
149877200|NCT02186834|540678764|FG005|Treatment at RP2D|Died prior to treatment|1|||
149877201|NCT00749892|540678765|FG000|Overall Study|Withdrawal by Subject|3|||
149877202|NCT04581369|540678766|FG000|Overall Study|Death|7|||
149877203|NCT04581369|540678767|FG001|Overall Study|Death|6|||
149877204|NCT04581369|540678768|FG002|Overall Study|Death|0|||
149877205|NCT04581369|540678766|FG000|Overall Study|Lost to Follow-up|7|||
149877206|NCT04581369|540678767|FG001|Overall Study|Lost to Follow-up|3|||
149877207|NCT04581369|540678768|FG002|Overall Study|Lost to Follow-up|0|||
149877208|NCT04581369|540678766|FG000|Overall Study|liver transplant|2|||
149877209|NCT04581369|540678767|FG001|Overall Study|liver transplant|2|||
149877210|NCT04581369|540678768|FG002|Overall Study|liver transplant|0|||
149877211|NCT04581369|540678766|FG000|Overall Study|transitioned to hospice care|0|||
149877212|NCT04581369|540678767|FG001|Overall Study|transitioned to hospice care|5|||
149877213|NCT04581369|540678768|FG002|Overall Study|transitioned to hospice care|0|||
149877214|NCT00780910|540678769|FG000|Overall Study|Adverse Event|2|||
149877215|NCT00106964|540678773|FG000|Overall Study|Lost to Follow-up|8|||
149877216|NCT00106964|540678774|FG001|Overall Study|Lost to Follow-up|6|||
149877217|NCT00106964|540678775|FG002|Overall Study|Lost to Follow-up|2|||
149877218|NCT00106964|540678773|FG000|Overall Study|Pregnancy|2|||
149877219|NCT00106964|540678774|FG001|Overall Study|Pregnancy|3|||
149877220|NCT00106964|540678775|FG002|Overall Study|Pregnancy|2|||
149877221|NCT00106964|540678773|FG000|Overall Study|Death|1|||
149877222|NCT00106964|540678774|FG001|Overall Study|Death|1|||
149877223|NCT00106964|540678775|FG002|Overall Study|Death|0|||
149877224|NCT00106964|540678773|FG000|Overall Study|Incarceration|0|||
149877225|NCT00106964|540678774|FG001|Overall Study|Incarceration|1|||
149877226|NCT00106964|540678775|FG002|Overall Study|Incarceration|0|||
149877227|NCT00106964|540678773|FG000|Overall Study|Site Funding Terminated|0|||
149877228|NCT00106964|540678774|FG001|Overall Study|Site Funding Terminated|1|||
149877229|NCT00106964|540678775|FG002|Overall Study|Site Funding Terminated|1|||
149877230|NCT00106964|540678773|FG000|Overall Study|Failure to adhere|2|||
149877231|NCT00106964|540678774|FG001|Overall Study|Failure to adhere|0|||
149877232|NCT00106964|540678775|FG002|Overall Study|Failure to adhere|0|||
149877233|NCT00106964|540678773|FG000|Overall Study|Did not meet eligibility criteria|0|||
149877234|NCT00106964|540678774|FG001|Overall Study|Did not meet eligibility criteria|2|||
149877235|NCT00106964|540678775|FG002|Overall Study|Did not meet eligibility criteria|2|||
149877236|NCT00106964|540678773|FG000|Overall Study|Required disallowed medication|0|||
149877237|NCT00106964|540678774|FG001|Overall Study|Required disallowed medication|1|||
149877238|NCT00106964|540678775|FG002|Overall Study|Required disallowed medication|0|||
149877239|NCT04746794|540678776|FG000|Overall Study|Did not complete any study assessment|50303|||
149877240|NCT04746794|540678777|FG001|Overall Study|Did not complete any study assessment|44997|||
149877241|NCT03207243|540678778|FG000|Overall Study|Adverse Event|2|||
149877242|NCT03207243|540678779|FG001|Overall Study|Adverse Event|2|||
149877243|NCT03207243|540678778|FG000|Overall Study|Loss of Asthma Control|47|||
149877244|NCT03207243|540678779|FG001|Overall Study|Loss of Asthma Control|31|||
149877245|NCT03207243|540678778|FG000|Overall Study|Withdrawal by Subject|2|||
149877246|NCT03207243|540678779|FG001|Overall Study|Withdrawal by Subject|4|||
149877247|NCT03207243|540678778|FG000|Overall Study|Physician Decision|1|||
149877248|NCT03207243|540678779|FG001|Overall Study|Physician Decision|1|||
149877249|NCT03207243|540678778|FG000|Overall Study|Lost to Follow-up|0|||
149877250|NCT03207243|540678779|FG001|Overall Study|Lost to Follow-up|1|||
149877251|NCT03207243|540678778|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
149877252|NCT03207243|540678779|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
149877253|NCT03207243|540678778|FG000|Overall Study|Protocol Violation|0|||
149877254|NCT03207243|540678779|FG001|Overall Study|Protocol Violation|3|||
149877255|NCT01422187|540678784|FG000|Overall Study|Personal reason|1|||
149877256|NCT01422187|540678785|FG001|Overall Study|Personal reason|0|||
149877257|NCT01422187|540678786|FG002|Overall Study|Personal reason|0|||
149877258|NCT01422187|540678784|FG000|Overall Study|Lost to Follow-up|0|||
149877259|NCT01422187|540678785|FG001|Overall Study|Lost to Follow-up|1|||
149877260|NCT01422187|540678786|FG002|Overall Study|Lost to Follow-up|0|||
149877261|NCT00168818|540678787|FG000|Overall Study|Adverse Event|23|||
149877262|NCT00168818|540678788|FG001|Overall Study|Adverse Event|29|||
149877263|NCT00168818|540678789|FG002|Overall Study|Adverse Event|31|||
149877264|NCT00168818|540678787|FG000|Overall Study|Protocol Violation|16|||
149877265|NCT00168818|540678788|FG001|Overall Study|Protocol Violation|11|||
149877266|NCT00168818|540678789|FG002|Overall Study|Protocol Violation|11|||
149877267|NCT00168818|540678787|FG000|Overall Study|Lost to Follow-up|13|||
149877268|NCT00168818|540678788|FG001|Overall Study|Lost to Follow-up|4|||
149877269|NCT00168818|540678789|FG002|Overall Study|Lost to Follow-up|15|||
149877270|NCT00168818|540678787|FG000|Overall Study|Withdrawal by Subject|43|||
149877271|NCT00168818|540678788|FG001|Overall Study|Withdrawal by Subject|41|||
149877272|NCT00168818|540678789|FG002|Overall Study|Withdrawal by Subject|37|||
149877273|NCT00168818|540678787|FG000|Overall Study|Other|22|||
149877274|NCT00168818|540678788|FG001|Overall Study|Other|24|||
149877275|NCT00168818|540678789|FG002|Overall Study|Other|30|||
149877276|NCT00168818|540678787|FG000|Treatment|Adverse Event|77|||
149877277|NCT00168818|540678788|FG001|Treatment|Adverse Event|89|||
149877278|NCT00168818|540678789|FG002|Treatment|Adverse Event|68|||
149877279|NCT00168818|540678787|FG000|Treatment|Protocol Violation|8|||
149877280|NCT00168818|540678788|FG001|Treatment|Protocol Violation|11|||
149877281|NCT00168818|540678789|FG002|Treatment|Protocol Violation|11|||
149877282|NCT00168818|540678787|FG000|Treatment|Lost to Follow-up|0|||
149877283|NCT00168818|540678788|FG001|Treatment|Lost to Follow-up|2|||
149877284|NCT00168818|540678789|FG002|Treatment|Lost to Follow-up|1|||
149877285|NCT00168818|540678787|FG000|Treatment|Withdrawal by Subject|25|||
149877286|NCT00168818|540678788|FG001|Treatment|Withdrawal by Subject|20|||
149964177|NCT04003142|541003256|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
149964178|NCT04003142|541003257|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
149964179|NCT04003142|541003253|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
149964180|NCT04003142|541003254|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
149964181|NCT04003142|541003255|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
149964182|NCT04003142|541003256|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
149964183|NCT04003142|541003257|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
149964184|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
149964185|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
149964186|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
149964187|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
149877287|NCT00168818|540678789|FG002|Treatment|Withdrawal by Subject|22|||
149877288|NCT00168818|540678787|FG000|Treatment|Other|23|||
149877289|NCT00168818|540678788|FG001|Treatment|Other|29|||
149877290|NCT00168818|540678789|FG002|Treatment|Other|31|||
149877291|NCT00603837|540678792|FG000|Overall Study|Physician Decision|3|||
149877292|NCT00603837|540678793|FG001|Overall Study|Physician Decision|0|||
149877293|NCT04611529|540678794|FG000|2-day Follow up|Lost to Follow-up|5|||
149877294|NCT04611529|540678795|FG001|2-day Follow up|Lost to Follow-up|6|||
149877295|NCT04611529|540678796|FG002|2-day Follow up|Lost to Follow-up|3|||
149877296|NCT02538965|540678860|FG000|Treatment Period|Other = Death due to disease progression|1|||
149877297|NCT02538965|540678860|FG000|Treatment Period|Adverse Event|2|||
149877298|NCT02538965|540678860|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
149877299|NCT02538965|540678860|FG000|Treatment Period|Treatment Failure|9|||
149877300|NCT02538965|540678860|FG000|Treatment Period|Disease Progression|1|||
149964188|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
149964189|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Death|0|||
149877301|NCT02538965|540678860|FG000|Treatment Period|Physician Decision|2|||
149877302|NCT02538965|540678860|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
149877303|NCT02538965|540678860|FG000|Follow-Up Period|Withdrawal by Parent|4|||
149877304|NCT02960490|540678861|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
149877305|NCT02960490|540678862|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
149877306|NCT02960490|540678863|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877307|NCT02960490|540678864|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877308|NCT02960490|540678865|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877309|NCT02960490|540678866|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877310|NCT02960490|540678867|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877311|NCT02960490|540678868|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877312|NCT02960490|540678869|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877313|NCT02960490|540678870|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
149877314|NCT02960490|540678861|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877315|NCT02960490|540678862|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
149877316|NCT02960490|540678863|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877317|NCT02960490|540678864|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877318|NCT02960490|540678865|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877319|NCT02960490|540678866|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877320|NCT02960490|540678867|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877321|NCT02960490|540678868|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877322|NCT02960490|540678869|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877323|NCT02960490|540678870|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
149877324|NCT02960490|540678861|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
149877325|NCT02960490|540678862|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
149877326|NCT02960490|540678863|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877327|NCT02960490|540678864|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877328|NCT02960490|540678865|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877329|NCT02960490|540678866|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877330|NCT02960490|540678867|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877331|NCT02960490|540678868|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877332|NCT02960490|540678869|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877333|NCT02960490|540678870|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
149877334|NCT02960490|540678861|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
149877335|NCT02960490|540678862|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
149877336|NCT02960490|540678863|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877337|NCT02960490|540678864|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877338|NCT02960490|540678865|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877339|NCT02960490|540678866|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877340|NCT02960490|540678867|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877341|NCT02960490|540678868|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877342|NCT02960490|540678869|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877343|NCT02960490|540678870|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
149877344|NCT02960490|540678861|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877345|NCT02960490|540678862|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877346|NCT02960490|540678863|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
149877347|NCT02960490|540678864|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
149877348|NCT02960490|540678865|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877349|NCT02960490|540678866|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
149877350|NCT02960490|540678867|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877351|NCT02960490|540678868|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877352|NCT02960490|540678869|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877353|NCT02960490|540678870|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
149877354|NCT02960490|540678861|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877355|NCT02960490|540678862|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877356|NCT02960490|540678863|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
149877357|NCT02960490|540678864|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877358|NCT02960490|540678865|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
149877359|NCT02960490|540678866|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877360|NCT02960490|540678867|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877361|NCT02960490|540678868|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877362|NCT02960490|540678869|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877363|NCT02960490|540678870|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
149877364|NCT02960490|540678861|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
149877365|NCT02960490|540678862|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
149877366|NCT02960490|540678863|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
149877367|NCT02960490|540678864|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
149877368|NCT02960490|540678865|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
149877369|NCT02960490|540678866|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
149877370|NCT02960490|540678867|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
149877371|NCT02960490|540678868|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
149877372|NCT02960490|540678869|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
149877373|NCT02960490|540678870|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
149877374|NCT02960490|540678861|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877375|NCT02960490|540678862|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877376|NCT02960490|540678863|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877377|NCT02960490|540678864|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877378|NCT02960490|540678865|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877379|NCT02960490|540678866|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877380|NCT02960490|540678867|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
149877381|NCT02960490|540678868|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
149877382|NCT02960490|540678869|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
149877383|NCT02960490|540678870|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
149877384|NCT02960490|540678861|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877385|NCT02960490|540678862|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877386|NCT02960490|540678863|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877387|NCT02960490|540678864|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877388|NCT02960490|540678865|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877389|NCT02960490|540678866|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877390|NCT02960490|540678867|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877391|NCT02960490|540678868|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
149877392|NCT02960490|540678869|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877393|NCT02960490|540678870|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
149877394|NCT02960490|540678861|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877395|NCT02960490|540678862|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877396|NCT02960490|540678863|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877397|NCT02960490|540678864|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877398|NCT02960490|540678865|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877399|NCT02960490|540678866|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
149877400|NCT02960490|540678867|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
149877401|NCT02960490|540678868|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
149877402|NCT02960490|540678869|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
149877403|NCT02960490|540678870|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
149877404|NCT02960490|540678861|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877405|NCT02960490|540678862|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877406|NCT02960490|540678863|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877407|NCT02960490|540678864|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877408|NCT02960490|540678865|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877409|NCT02960490|540678866|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877410|NCT02960490|540678867|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
149877411|NCT02960490|540678868|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877412|NCT02960490|540678869|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877413|NCT02960490|540678870|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
149877414|NCT02960490|540678861|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877415|NCT02960490|540678862|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877416|NCT02960490|540678863|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877417|NCT02960490|540678864|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877418|NCT02960490|540678865|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877419|NCT02960490|540678866|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877420|NCT02960490|540678867|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877421|NCT02960490|540678868|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
149877422|NCT02960490|540678869|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877423|NCT02960490|540678870|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
149877424|NCT04642365|540678873|FG000|Overall Study|Death|3|||
149877425|NCT04642365|540678874|FG001|Overall Study|Death|2|||
149877426|NCT04642365|540678875|FG002|Overall Study|Death|4|||
149877427|NCT04642365|540678876|FG003|Overall Study|Death|5|||
149877428|NCT04642365|540678877|FG004|Overall Study|Death|5|||
149877429|NCT04642365|540678878|FG005|Overall Study|Death|3|||
149877430|NCT04642365|540678879|FG006|Overall Study|Death|2|||
149877431|NCT04642365|540678880|FG007|Overall Study|Death|1|||
149877432|NCT04642365|540678873|FG000|Overall Study|Physician Decision|1|||
149877433|NCT04642365|540678874|FG001|Overall Study|Physician Decision|0|||
149877434|NCT04642365|540678875|FG002|Overall Study|Physician Decision|0|||
149877435|NCT04642365|540678876|FG003|Overall Study|Physician Decision|0|||
149877436|NCT04642365|540678877|FG004|Overall Study|Physician Decision|0|||
149877437|NCT04642365|540678878|FG005|Overall Study|Physician Decision|0|||
149877438|NCT04642365|540678879|FG006|Overall Study|Physician Decision|0|||
149877439|NCT04642365|540678880|FG007|Overall Study|Physician Decision|0|||
149877440|NCT04642365|540678873|FG000|Overall Study|Progressive Disease|1|||
149877441|NCT04642365|540678874|FG001|Overall Study|Progressive Disease|1|||
149877442|NCT04642365|540678875|FG002|Overall Study|Progressive Disease|1|||
149877443|NCT04642365|540678876|FG003|Overall Study|Progressive Disease|0|||
149877444|NCT04642365|540678877|FG004|Overall Study|Progressive Disease|0|||
149877445|NCT04642365|540678878|FG005|Overall Study|Progressive Disease|0|||
149877446|NCT04642365|540678879|FG006|Overall Study|Progressive Disease|1|||
149877447|NCT04642365|540678880|FG007|Overall Study|Progressive Disease|0|||
149877448|NCT04642365|540678873|FG000|Overall Study|Study Terminated By Sponsor|0|||
149877449|NCT04642365|540678874|FG001|Overall Study|Study Terminated By Sponsor|2|||
149877450|NCT04642365|540678875|FG002|Overall Study|Study Terminated By Sponsor|1|||
149877451|NCT04642365|540678876|FG003|Overall Study|Study Terminated By Sponsor|1|||
149877452|NCT04642365|540678877|FG004|Overall Study|Study Terminated By Sponsor|1|||
149877453|NCT04642365|540678878|FG005|Overall Study|Study Terminated By Sponsor|2|||
149877454|NCT04642365|540678879|FG006|Overall Study|Study Terminated By Sponsor|2|||
149877455|NCT04642365|540678880|FG007|Overall Study|Study Terminated By Sponsor|1|||
149877456|NCT04642365|540678873|FG000|Overall Study|Symptomatic Deterioration|1|||
149877457|NCT04642365|540678874|FG001|Overall Study|Symptomatic Deterioration|1|||
149877458|NCT04642365|540678875|FG002|Overall Study|Symptomatic Deterioration|0|||
149877459|NCT04642365|540678876|FG003|Overall Study|Symptomatic Deterioration|0|||
149877460|NCT04642365|540678877|FG004|Overall Study|Symptomatic Deterioration|0|||
149877461|NCT04642365|540678878|FG005|Overall Study|Symptomatic Deterioration|1|||
149877462|NCT04642365|540678879|FG006|Overall Study|Symptomatic Deterioration|0|||
149877463|NCT04642365|540678880|FG007|Overall Study|Symptomatic Deterioration|0|||
149877464|NCT04642365|540678873|FG000|Overall Study|Withdrawal by Subject|0|||
149877465|NCT04642365|540678874|FG001|Overall Study|Withdrawal by Subject|0|||
149877466|NCT04642365|540678875|FG002|Overall Study|Withdrawal by Subject|1|||
149877467|NCT04642365|540678876|FG003|Overall Study|Withdrawal by Subject|1|||
149877468|NCT04642365|540678877|FG004|Overall Study|Withdrawal by Subject|0|||
149877469|NCT04642365|540678878|FG005|Overall Study|Withdrawal by Subject|0|||
149877470|NCT04642365|540678879|FG006|Overall Study|Withdrawal by Subject|2|||
149877471|NCT04642365|540678880|FG007|Overall Study|Withdrawal by Subject|0|||
149877472|NCT04642365|540678873|FG000|Overall Study|Adverse Event|0|||
149877473|NCT04642365|540678874|FG001|Overall Study|Adverse Event|0|||
149877474|NCT04642365|540678875|FG002|Overall Study|Adverse Event|0|||
149877475|NCT04642365|540678876|FG003|Overall Study|Adverse Event|0|||
149877476|NCT04642365|540678877|FG004|Overall Study|Adverse Event|0|||
149877477|NCT04642365|540678878|FG005|Overall Study|Adverse Event|0|||
149877478|NCT04642365|540678879|FG006|Overall Study|Adverse Event|0|||
149877479|NCT04642365|540678880|FG007|Overall Study|Adverse Event|1|||
149877480|NCT02728843|540678881|FG000|Overall Study|Adverse Event|0|||
149877481|NCT02728843|540678882|FG001|Overall Study|Adverse Event|2|||
149877482|NCT02728843|540678883|FG002|Overall Study|Adverse Event|3|||
149877483|NCT02728843|540678884|FG003|Overall Study|Adverse Event|1|||
149877484|NCT02728843|540678885|FG004|Overall Study|Adverse Event|2|||
149877485|NCT02728843|540678881|FG000|Overall Study|Lack of Efficacy|0|||
149877486|NCT02728843|540678882|FG001|Overall Study|Lack of Efficacy|1|||
149877487|NCT02728843|540678883|FG002|Overall Study|Lack of Efficacy|1|||
149877488|NCT02728843|540678884|FG003|Overall Study|Lack of Efficacy|0|||
149877489|NCT02728843|540678885|FG004|Overall Study|Lack of Efficacy|0|||
149877490|NCT02728843|540678881|FG000|Overall Study|Protocol Violation|2|||
149877491|NCT02728843|540678882|FG001|Overall Study|Protocol Violation|0|||
149877492|NCT02728843|540678883|FG002|Overall Study|Protocol Violation|4|||
149877493|NCT02728843|540678884|FG003|Overall Study|Protocol Violation|2|||
149877494|NCT02728843|540678885|FG004|Overall Study|Protocol Violation|2|||
149877495|NCT02728843|540678881|FG000|Overall Study|Withdrawal by Subject|1|||
149877496|NCT02728843|540678882|FG001|Overall Study|Withdrawal by Subject|0|||
149877497|NCT02728843|540678883|FG002|Overall Study|Withdrawal by Subject|0|||
149877498|NCT02728843|540678884|FG003|Overall Study|Withdrawal by Subject|1|||
149877499|NCT02728843|540678885|FG004|Overall Study|Withdrawal by Subject|0|||
149877500|NCT02728843|540678881|FG000|Overall Study|Use of rescue medication|0|||
149877501|NCT02728843|540678882|FG001|Overall Study|Use of rescue medication|2|||
149877502|NCT02728843|540678883|FG002|Overall Study|Use of rescue medication|0|||
149877503|NCT02728843|540678884|FG003|Overall Study|Use of rescue medication|2|||
149877504|NCT02728843|540678885|FG004|Overall Study|Use of rescue medication|1|||
149877505|NCT02478320|540678886|FG000|Overall Study|Adverse Event|2|||
149877506|NCT02478320|540678887|FG001|Overall Study|Adverse Event|0|||
149877507|NCT02478320|540678886|FG000|Overall Study|Death|1|||
149877508|NCT02478320|540678887|FG001|Overall Study|Death|0|||
149877509|NCT02478320|540678886|FG000|Overall Study|Lack of Efficacy|4|||
149877510|NCT02478320|540678887|FG001|Overall Study|Lack of Efficacy|0|||
149877511|NCT02478320|540678886|FG000|Overall Study|Withdrawal by Subject|2|||
149877512|NCT02478320|540678887|FG001|Overall Study|Withdrawal by Subject|0|||
149877513|NCT02478320|540678886|FG000|Overall Study|Screen Failure|3|||
149877514|NCT02478320|540678887|FG001|Overall Study|Screen Failure|0|||
149877515|NCT02952898|540678890|FG000|Overall Study|Withdrawal by Subject|10|||
149877516|NCT02952898|540678891|FG001|Overall Study|Withdrawal by Subject|8|||
149877517|NCT02952898|540678892|FG002|Overall Study|Withdrawal by Subject|8|||
149877518|NCT02952898|540678890|FG000|Overall Study|Adverse Event|8|||
149877519|NCT02952898|540678891|FG001|Overall Study|Adverse Event|8|||
149877520|NCT02952898|540678892|FG002|Overall Study|Adverse Event|3|||
149877521|NCT02952898|540678890|FG000|Overall Study|Lost to Follow-up|3|||
149877522|NCT02952898|540678891|FG001|Overall Study|Lost to Follow-up|2|||
149877523|NCT02952898|540678892|FG002|Overall Study|Lost to Follow-up|2|||
149877524|NCT02952898|540678890|FG000|Overall Study|Non-compliance with study drug|1|||
149877525|NCT02952898|540678891|FG001|Overall Study|Non-compliance with study drug|1|||
149877526|NCT02952898|540678892|FG002|Overall Study|Non-compliance with study drug|2|||
149877527|NCT04844762|540678895|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877528|NCT04844762|540678896|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877529|NCT04844762|540678897|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
149877530|NCT04844762|540678898|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877531|NCT04844762|540678899|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877532|NCT04844762|540678900|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877533|NCT04844762|540678895|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
149877534|NCT04844762|540678896|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
149877535|NCT04844762|540678897|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
149877536|NCT04844762|540678898|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
149877537|NCT04844762|540678899|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
149877538|NCT04844762|540678900|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
149877539|NCT04844762|540678895|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877540|NCT04844762|540678896|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877541|NCT04844762|540678897|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
149877542|NCT04844762|540678898|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
149877543|NCT04844762|540678899|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877544|NCT04844762|540678900|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
149877545|NCT04844762|540678895|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877546|NCT04844762|540678896|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877547|NCT04844762|540678897|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
149877548|NCT04844762|540678898|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
149877549|NCT04844762|540678899|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
149877550|NCT04844762|540678900|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877551|NCT04844762|540678895|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
149877552|NCT04844762|540678896|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
149877553|NCT04844762|540678897|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877554|NCT04844762|540678898|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877555|NCT04844762|540678899|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877556|NCT04844762|540678900|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877557|NCT04844762|540678895|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
149877558|NCT04844762|540678896|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877559|NCT04844762|540678897|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877560|NCT04844762|540678898|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877561|NCT04844762|540678899|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877562|NCT04844762|540678900|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877563|NCT04844762|540678895|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
150043076|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
150043077|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
150043078|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
150043079|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
150043080|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
149877564|NCT04844762|540678896|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877565|NCT04844762|540678897|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877566|NCT04844762|540678898|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877567|NCT04844762|540678899|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
149877568|NCT04844762|540678900|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
149877569|NCT04844762|540678895|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
149877570|NCT04844762|540678896|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877571|NCT04844762|540678897|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877572|NCT04844762|540678898|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877573|NCT04844762|540678899|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877574|NCT04844762|540678900|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
149877575|NCT04844762|540678895|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
149877576|NCT04844762|540678896|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877577|NCT04844762|540678897|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877578|NCT04844762|540678898|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877579|NCT04844762|540678899|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
149877580|NCT04844762|540678900|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
149877581|NCT04844762|540678895|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
149877582|NCT04844762|540678896|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
149877583|NCT04844762|540678897|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
149877584|NCT04844762|540678898|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
149877585|NCT04844762|540678899|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
149877586|NCT04844762|540678900|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
149877587|NCT04844762|540678895|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
149877588|NCT04844762|540678896|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
149877589|NCT04844762|540678897|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
149877590|NCT04844762|540678898|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
149877591|NCT04844762|540678899|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
149877592|NCT04844762|540678900|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
149877593|NCT04051619|540678901|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
149877594|NCT04051619|540678902|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
149877595|NCT04051619|540678901|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
149877596|NCT04051619|540678902|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
149877597|NCT02899195|540680758|FG000|Concurrent Durvalumab|Adverse Event|4|||
149877598|NCT02899195|540680758|FG000|Concurrent Durvalumab|Physician Decision|1|||
149877599|NCT02899195|540680758|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
149877600|NCT02899195|540680758|FG000|Concurrent Durvalumab|Progressive Disease|5|||
149877601|NCT02899195|540680758|FG000|Maintenance Durvalumab|Adverse Event|1|||
149877602|NCT02899195|540680758|FG000|Maintenance Durvalumab|Physician Decision|1|||
149877603|NCT02899195|540680758|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
149877604|NCT02899195|540680758|FG000|Maintenance Durvalumab|Progressive Disease|31|||
149877605|NCT03156504|540680760|FG000|Overall Study|Withdrawal by Subject|1|||
149877606|NCT04778904|540680761|FG000|Overall Study|Protocol Violation|1|||
149877607|NCT04778904|540680762|FG001|Overall Study|Protocol Violation|0|||
149877608|NCT04778904|540680763|FG002|Overall Study|Protocol Violation|0|||
149877609|NCT04778904|540680764|FG003|Overall Study|Protocol Violation|0|||
149877610|NCT04778904|540680761|FG000|Overall Study|Withdrawal by Subject|0|||
149877611|NCT04778904|540680762|FG001|Overall Study|Withdrawal by Subject|0|||
149877612|NCT04778904|540680763|FG002|Overall Study|Withdrawal by Subject|1|||
149877613|NCT04778904|540680764|FG003|Overall Study|Withdrawal by Subject|0|||
149877614|NCT03452137|540680765|FG000|Overall Study|Death|67|||
149877615|NCT03452137|540680766|FG001|Overall Study|Death|70|||
149877616|NCT03452137|540680765|FG000|Overall Study|Lost to Follow-up|4|||
149877617|NCT03452137|540680766|FG001|Overall Study|Lost to Follow-up|2|||
149877618|NCT03452137|540680765|FG000|Overall Study|Physician Decision|0|||
149877619|NCT03452137|540680766|FG001|Overall Study|Physician Decision|1|||
149877620|NCT03452137|540680765|FG000|Overall Study|Study Terminated by Sponsor|120|||
149877621|NCT03452137|540680766|FG001|Overall Study|Study Terminated by Sponsor|121|||
149877622|NCT03452137|540680765|FG000|Overall Study|Withdrawal by Subject|12|||
149877623|NCT03452137|540680766|FG001|Overall Study|Withdrawal by Subject|9|||
149877624|NCT04138043|540680767|FG000|Overall Study|Withdrawal by Subject|0|||
149877625|NCT04138043|540680768|FG001|Overall Study|Withdrawal by Subject|1|||
149877626|NCT03772717|540680769|FG000|Overall Study|Withdrawal by Subject|2|||
149877627|NCT02856802|540680770|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
149877628|NCT02856802|540680771|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
149877629|NCT02856802|540680770|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
149877630|NCT02856802|540680771|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
149877631|NCT02856802|540680770|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
149877632|NCT02856802|540680771|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
149877633|NCT02856802|540680770|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
149964190|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Death|0|||
149877634|NCT02856802|540680771|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
149877635|NCT02856802|540680770|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
149877636|NCT02856802|540680771|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
149877637|NCT02856802|540680770|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
149877638|NCT02856802|540680771|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
149877639|NCT00587860|540680772|FG000|Overall Study|Lost to Follow-up|2|||
149877640|NCT00587860|540680773|FG001|Overall Study|Lost to Follow-up|2|||
149877641|NCT00587860|540680772|FG000|Overall Study|Withdrawal by Subject|3|||
149877642|NCT00587860|540680773|FG001|Overall Study|Withdrawal by Subject|3|||
149877643|NCT01659125|540680774|FG000|Overall Study|Withdrawal by Subject|2|||
149877644|NCT01659125|540680774|FG000|Overall Study|Lost to Follow-up|7|||
149877645|NCT01659125|540680774|FG000|Overall Study|Technical Problem|1|||
149877646|NCT01659125|540680774|FG000|Overall Study|Time Constraints|2|||
149877647|NCT01659125|540680774|FG000|Overall Study|Failed to Start Treatment|2|||
149877648|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
149877649|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
149877650|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
149877651|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
149877652|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
149964191|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Death|0|||
149964192|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Death|0|||
149964193|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Death|1|||
149964194|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
149964195|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
149964196|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
149964197|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
149877653|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
149877654|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
149877655|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
149964198|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
149964199|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
150043081|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
150043082|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
150043083|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
149877656|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
149877657|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
149877658|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
149877659|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
149877660|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
149877661|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
149877662|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
150174214|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
150174215|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
150174216|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
150174217|NCT01350804|541773044|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
150174218|NCT01350804|541773045|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
150174219|NCT01350804|541773046|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
150174220|NCT01350804|541773047|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
150174221|NCT03516942|541773048|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
150174222|NCT03516942|541773048|FG000|Registration through baseline survey com|Death|8|||
150174223|NCT03516942|541773048|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
150174224|NCT03516942|541773048|FG000|T0: Baseline|LOST|13|||
150174225|NCT03516942|541773048|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
150174226|NCT03516942|541773048|FG000|T1: 3 Months Survey|Death|10|||
150174227|NCT03516942|541773048|FG000|T1: 3 Months Survey|Lost|163|||
150174228|NCT03516942|541773048|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
149877663|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
149877664|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
149877665|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
149877666|NCT00261443|540680775|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
149877667|NCT00261443|540680776|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
149877668|NCT00261443|540680777|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
150174229|NCT03516942|541773048|FG000|T2: 6 Month Survey|Death|14|||
150174230|NCT03516942|541773048|FG000|T2: 6 Month Survey|Lost|180|||
150043084|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
150043085|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
150043086|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
150043087|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
150043088|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
150043089|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
150043090|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
150043091|NCT05307692|541295697|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
150043092|NCT05307692|541295698|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
150043093|NCT05307692|541295699|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
150043094|NCT05307692|541295700|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
150043095|NCT05307692|541295697|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
150043096|NCT05307692|541295698|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
150043097|NCT05307692|541295699|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
150043098|NCT05307692|541295700|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
150043099|NCT05307692|541295697|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
150043100|NCT05307692|541295698|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
150043101|NCT05307692|541295699|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
150043102|NCT05307692|541295700|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
150043103|NCT04500158|541295701|FG000|Overall Study|Physician Decision|17|||
150043104|NCT04500158|541295702|FG001|Overall Study|Physician Decision|11|||
150043105|NCT01967238|541295703|FG000|Overall Study|Adverse Event|1|||
150043106|NCT01967238|541295704|FG001|Overall Study|Adverse Event|1|||
150043107|NCT01967238|541295705|FG002|Overall Study|Adverse Event|0|||
150043108|NCT01967238|541295703|FG000|Overall Study|Lost to Follow-up|1|||
150043109|NCT01967238|541295704|FG001|Overall Study|Lost to Follow-up|0|||
150043110|NCT01967238|541295705|FG002|Overall Study|Lost to Follow-up|1|||
150043111|NCT01967238|541295703|FG000|Overall Study|Withdrawal by Subject|0|||
150043112|NCT01967238|541295704|FG001|Overall Study|Withdrawal by Subject|0|||
150043113|NCT01967238|541295705|FG002|Overall Study|Withdrawal by Subject|1|||
150043114|NCT04774094|541295708|FG000|Overall Study|Other|2|||
150043115|NCT04774094|541295708|FG000|Overall Study|Withdrawal by Subject|9|||
150043116|NCT04774094|541295708|FG000|Overall Study|Lost to Follow-up|7|||
150043117|NCT04774094|541295708|FG000|Overall Study|Lack of Efficacy|5|||
150043118|NCT04774094|541295708|FG000|Overall Study|Death|17|||
150043119|NCT04774094|541295708|FG000|Overall Study|Adverse Event|4|||
150043120|NCT05232682|541295711|FG000|Overall Study|Lost to Follow-up|2|||
150043121|NCT02605122|541297081|FG000|Overall Study|Withdrawal by Subject|4|||
150043122|NCT02605122|541297082|FG001|Overall Study|Withdrawal by Subject|1|||
150043123|NCT02605122|541297081|FG000|Overall Study|Lost to Follow-up|1|||
150043124|NCT02605122|541297082|FG001|Overall Study|Lost to Follow-up|1|||
150043125|NCT03751657|541297083|FG000|Overall Study|Physician Decision|0|||
150043126|NCT03751657|541297084|FG001|Overall Study|Physician Decision|1|||
150043127|NCT03751657|541297083|FG000|Overall Study|Withdrawal by Subject|1|||
150043128|NCT03751657|541297084|FG001|Overall Study|Withdrawal by Subject|1|||
150043129|NCT03751657|541297083|FG000|Overall Study|Lost to Follow-up|2|||
150043130|NCT03751657|541297084|FG001|Overall Study|Lost to Follow-up|1|||
150043131|NCT02139592|541297086|FG000|Overall Study|Case Report Forms Uncollected|8|||
150043132|NCT02754440|541297092|FG000|Overall Study|Protocol Violation|3|||
149877669|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
149877670|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
149877671|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
150043133|NCT02754440|541297093|FG001|Overall Study|Protocol Violation|2|||
150043134|NCT02754440|541297094|FG002|Overall Study|Protocol Violation|2|||
149877672|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
150043135|NCT02754440|541297095|FG003|Overall Study|Protocol Violation|6|||
150043136|NCT02754440|541297092|FG000|Overall Study|Adverse Event|3|||
150043137|NCT02754440|541297093|FG001|Overall Study|Adverse Event|1|||
150043138|NCT02754440|541297094|FG002|Overall Study|Adverse Event|0|||
150043139|NCT02754440|541297095|FG003|Overall Study|Adverse Event|9|||
150043140|NCT02754440|541297092|FG000|Overall Study|Withdrawal by Subject|0|||
150043141|NCT02754440|541297093|FG001|Overall Study|Withdrawal by Subject|0|||
150043142|NCT02754440|541297094|FG002|Overall Study|Withdrawal by Subject|0|||
150043143|NCT02754440|541297095|FG003|Overall Study|Withdrawal by Subject|1|||
150043144|NCT02754440|541297092|FG000|Overall Study|Equipment failure|0|||
150043145|NCT02754440|541297093|FG001|Overall Study|Equipment failure|5|||
149877673|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
149877674|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
149877675|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
149877676|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
149877677|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
149877678|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
149877679|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
149877680|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
149877681|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
149877682|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
149877683|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
149877684|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
149877685|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
149877686|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
149877687|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
149877688|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
149877689|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
149877690|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
149877691|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
149877692|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
149877693|NCT00261443|540680775|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
149877694|NCT00261443|540680776|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
149877695|NCT00261443|540680777|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
149877696|NCT00261443|540680775|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
149877697|NCT00261443|540680776|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
149877698|NCT00261443|540680777|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
149877699|NCT00261443|540680775|FG000|3: Assessment of Relapse|Adverse Event|0|||
149877700|NCT00261443|540680776|FG001|3: Assessment of Relapse|Adverse Event|15|||
149877701|NCT00261443|540680777|FG002|3: Assessment of Relapse|Adverse Event|19|||
149877702|NCT00261443|540680775|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
149877703|NCT00261443|540680776|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
149877704|NCT00261443|540680777|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
149877705|NCT00261443|540680775|FG000|3: Assessment of Relapse|Death|0|||
150043146|NCT02754440|541297094|FG002|Overall Study|Equipment failure|5|||
150043147|NCT02754440|541297095|FG003|Overall Study|Equipment failure|7|||
150043148|NCT02754440|541297092|FG000|Overall Study|Subject issues not resulting in AE|0|||
150043149|NCT02754440|541297093|FG001|Overall Study|Subject issues not resulting in AE|0|||
150043150|NCT02754440|541297094|FG002|Overall Study|Subject issues not resulting in AE|0|||
150043151|NCT02754440|541297095|FG003|Overall Study|Subject issues not resulting in AE|12|||
150043152|NCT00297258|541297106|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
150043153|NCT00297258|541297106|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
150043154|NCT00297258|541297106|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
150043155|NCT00297258|541297106|FG000|Overall Study|Intercurrent Illness|3|||
150043156|NCT00297258|541297106|FG000|Overall Study|Intercurrent Death|2|||
150043157|NCT00297258|541297106|FG000|Overall Study|Deteriorization of General Condition|1|||
150043158|NCT00297258|541297106|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
150043159|NCT00297258|541297106|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
150043160|NCT00297258|541297106|FG000|Overall Study|Switch to Commercial Treatment|1|||
150174231|NCT03516942|541773048|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
150043161|NCT00297258|541297106|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
150043162|NCT01263197|541297107|FG000|First Intervention (Period 1)|Adverse Event|0|||
150174232|NCT03516942|541773048|FG000|T3: 12 Month Survey|Death|19|||
149964200|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
149964201|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
149964202|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
149964203|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
149964204|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
149964205|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
149964206|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
149964207|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
149964208|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
150174233|NCT03516942|541773048|FG000|T3: 12 Month Survey|Lost|209|||
149964209|NCT04003142|541003253|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
149964210|NCT04003142|541003254|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
149964211|NCT04003142|541003255|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
149964212|NCT04003142|541003256|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
149964213|NCT04003142|541003257|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
149964214|NCT04755231|541003265|FG000|Overall Study|Lost to Follow-up|5|||
149964215|NCT04755231|541003265|FG000|Overall Study|Withdrawal by Subject|5|||
149964216|NCT03624036|541003266|FG000|Overall Study|Death|2|||
149964217|NCT03624036|541003267|FG001|Overall Study|Death|3|||
149964218|NCT03624036|541003268|FG002|Overall Study|Death|0|||
149964219|NCT03624036|541003269|FG003|Overall Study|Death|1|||
149964220|NCT03624036|541003266|FG000|Overall Study|Withdrawal by Subject|1|||
149964221|NCT03624036|541003267|FG001|Overall Study|Withdrawal by Subject|0|||
149964222|NCT03624036|541003268|FG002|Overall Study|Withdrawal by Subject|1|||
149964223|NCT03624036|541003269|FG003|Overall Study|Withdrawal by Subject|0|||
149964224|NCT03624036|541003266|FG000|Overall Study|Enrolled but Never Treated|1|||
149964225|NCT03624036|541003267|FG001|Overall Study|Enrolled but Never Treated|0|||
149964226|NCT03624036|541003268|FG002|Overall Study|Enrolled but Never Treated|0|||
149964227|NCT03624036|541003269|FG003|Overall Study|Enrolled but Never Treated|0|||
150174234|NCT03215927|541774380|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
150174235|NCT03215927|541774381|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
150174236|NCT03215927|541774380|FG000|Open Label Extension|Adverse Event|1|||
150174237|NCT03215927|541774381|FG001|Open Label Extension|Adverse Event|0|||
150174238|NCT03215927|541774380|FG000|Open Label Extension|Lack of Efficacy|1|||
150174239|NCT03215927|541774381|FG001|Open Label Extension|Lack of Efficacy|0|||
150174240|NCT03215927|541774380|FG000|Open Label Extension|Death|0|||
150174241|NCT03215927|541774381|FG001|Open Label Extension|Death|1|||
150174242|NCT03779048|541774382|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
150174243|NCT03779048|541774383|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
150174244|NCT03779048|541774384|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
150174245|NCT03779048|541774382|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
150174246|NCT03779048|541774383|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
150174247|NCT03779048|541774384|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
150174248|NCT03779048|541774382|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
150174249|NCT03779048|541774383|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
150174250|NCT03779048|541774384|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
150174251|NCT01134562|541774385|FG000|Overall Study|Adverse Event|0|||
150174252|NCT01134562|541774386|FG001|Overall Study|Adverse Event|1|||
150174253|NCT01134562|541774387|FG002|Overall Study|Adverse Event|0|||
150174254|NCT01134562|541774388|FG003|Overall Study|Adverse Event|0|||
150174255|NCT01134562|541774389|FG004|Overall Study|Adverse Event|0|||
150174256|NCT00768664|541774390|FG000|Overall Study|Death|57|||
150174257|NCT00768664|541774390|FG000|Overall Study|Lost to Follow-up|2|||
150174258|NCT00768664|541774390|FG000|Overall Study|Other|9|||
150174259|NCT00768664|541774390|FG000|Overall Study|Participant refused|1|||
150174260|NCT02544152|541774391|FG000|Overall Study|Adverse Event|0|||
150174261|NCT02544152|541774392|FG001|Overall Study|Adverse Event|4|||
150174262|NCT02544152|541774391|FG000|Overall Study|Withdrawal by Subject|0|||
150174263|NCT02544152|541774392|FG001|Overall Study|Withdrawal by Subject|3|||
150174264|NCT02544152|541774391|FG000|Overall Study|Other|1|||
150174265|NCT02544152|541774392|FG001|Overall Study|Other|0|||
150174266|NCT00423098|541774393|FG000|Overall Study|Adverse Event|1|||
150174267|NCT00423098|541774394|FG001|Overall Study|Adverse Event|2|||
150174268|NCT00423098|541774393|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150174269|NCT00423098|541774394|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150174270|NCT00423098|541774393|FG000|Overall Study|Administrative problems|0|||
149964228|NCT03624036|541003266|FG000|Overall Study|Reason not Specified|3|||
149964229|NCT03624036|541003267|FG001|Overall Study|Reason not Specified|0|||
149877706|NCT00261443|540680776|FG001|3: Assessment of Relapse|Death|0|||
149877707|NCT00261443|540680777|FG002|3: Assessment of Relapse|Death|1|||
149877708|NCT00261443|540680775|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
149877709|NCT00261443|540680776|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
149877710|NCT00261443|540680777|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
149877711|NCT00261443|540680775|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
149877712|NCT00261443|540680776|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
149877713|NCT00261443|540680777|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
149877714|NCT00261443|540680775|FG000|3: Assessment of Relapse|Pregnancy|0|||
149877715|NCT00261443|540680776|FG001|3: Assessment of Relapse|Pregnancy|2|||
149877716|NCT00261443|540680777|FG002|3: Assessment of Relapse|Pregnancy|1|||
149877717|NCT00261443|540680775|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
149877718|NCT00261443|540680776|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
149877719|NCT00261443|540680777|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
149877720|NCT00261443|540680775|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
149877721|NCT00261443|540680776|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
149877722|NCT00261443|540680777|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
149877723|NCT00261443|540680775|FG000|3: Assessment of Relapse|Other Reasons|0|||
149877724|NCT00261443|540680776|FG001|3: Assessment of Relapse|Other Reasons|4|||
149877725|NCT00261443|540680777|FG002|3: Assessment of Relapse|Other Reasons|3|||
149877726|NCT00261443|540680775|FG000|4: Extension Phase|Adverse Event|0|||
149877727|NCT00261443|540680776|FG001|4: Extension Phase|Adverse Event|1|||
149877728|NCT00261443|540680777|FG002|4: Extension Phase|Adverse Event|0|||
149877729|NCT00261443|540680775|FG000|4: Extension Phase|Withdrawal by Subject|0|||
149877730|NCT00261443|540680776|FG001|4: Extension Phase|Withdrawal by Subject|1|||
149877731|NCT00261443|540680777|FG002|4: Extension Phase|Withdrawal by Subject|2|||
149877732|NCT00261443|540680775|FG000|4: Extension Phase|Lost to Follow-up|0|||
149877733|NCT00261443|540680776|FG001|4: Extension Phase|Lost to Follow-up|1|||
149877734|NCT00261443|540680777|FG002|4: Extension Phase|Lost to Follow-up|0|||
149877735|NCT02755649|540680778|FG000|Overall Study|Transitioned into OLE study|99|||
149877736|NCT02755649|540680779|FG001|Overall Study|Transitioned into OLE study|98|||
149877737|NCT02755649|540680780|FG002|Overall Study|Transitioned into OLE study|100|||
149877738|NCT02755649|540680778|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
149877739|NCT02755649|540680779|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
149877740|NCT02755649|540680780|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
149877741|NCT02755649|540680778|FG000|Overall Study|Physician Decision|0|||
149877742|NCT02755649|540680779|FG001|Overall Study|Physician Decision|0|||
149877743|NCT02755649|540680780|FG002|Overall Study|Physician Decision|2|||
149877744|NCT02755649|540680778|FG000|Overall Study|Withdrawal by Subject|0|||
149877745|NCT02755649|540680779|FG001|Overall Study|Withdrawal by Subject|1|||
149877746|NCT02755649|540680780|FG002|Overall Study|Withdrawal by Subject|0|||
149877747|NCT02755649|540680778|FG000|Overall Study|Undecided|1|||
149877748|NCT02755649|540680779|FG001|Overall Study|Undecided|0|||
149877749|NCT02755649|540680780|FG002|Overall Study|Undecided|0|||
149877750|NCT01286753|540680781|FG000|Overall Study|Adverse Event|7|||
149877751|NCT01286753|540680782|FG001|Overall Study|Adverse Event|6|||
149877752|NCT01286753|540680781|FG000|Overall Study|Progression|11|||
149877753|NCT01286753|540680782|FG001|Overall Study|Progression|13|||
149877754|NCT01286753|540680781|FG000|Overall Study|Refused Treatment|1|||
149877755|NCT01286753|540680782|FG001|Overall Study|Refused Treatment|0|||
149877756|NCT01286753|540680781|FG000|Overall Study|Withdrawal of Consent|0|||
149877757|NCT01286753|540680782|FG001|Overall Study|Withdrawal of Consent|2|||
150043163|NCT01263197|541297108|FG001|First Intervention (Period 1)|Adverse Event|0|||
149877758|NCT01286753|540680781|FG000|Overall Study|Discontinued to Join Extension Study|6|||
149877759|NCT01286753|540680782|FG001|Overall Study|Discontinued to Join Extension Study|4|||
150174271|NCT00423098|541774394|FG001|Overall Study|Administrative problems|1|||
149877760|NCT01286753|540680781|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
149877761|NCT01286753|540680782|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
150174272|NCT00423098|541774393|FG000|Overall Study|Death|2|||
150174273|NCT00423098|541774394|FG001|Overall Study|Death|0|||
149877762|NCT02126826|540680786|FG000|Overall Study|Withdrawal by Subject|0|||
149877763|NCT02126826|540680787|FG001|Overall Study|Withdrawal by Subject|0|||
149877764|NCT02126826|540680788|FG002|Overall Study|Withdrawal by Subject|0|||
149877765|NCT02126826|540680789|FG003|Overall Study|Withdrawal by Subject|1|||
149877766|NCT02126826|540680790|FG004|Overall Study|Withdrawal by Subject|0|||
149877767|NCT02126826|540680791|FG005|Overall Study|Withdrawal by Subject|0|||
149877768|NCT02126826|540680792|FG006|Overall Study|Withdrawal by Subject|0|||
149877769|NCT03092219|540680793|FG000|Overall Study|Protocol Violation|7|||
149877770|NCT03092219|540680794|FG001|Overall Study|Protocol Violation|4|||
149877771|NCT03278626|540680795|FG000|Overall Study|Death|2|||
149877772|NCT03278626|540680795|FG000|Overall Study|Toxicity|1|||
149877773|NCT03278626|540680795|FG000|Overall Study|Disease Progression|2|||
149877774|NCT03333941|540680796|FG000|Overall Study|Lost to Follow-up|10|||
149877775|NCT03333941|540680796|FG000|Overall Study|Death|2|||
150043164|NCT01263197|541297109|FG002|First Intervention (Period 1)|Adverse Event|0|||
150043165|NCT01263197|541297110|FG003|First Intervention (Period 1)|Adverse Event|0|||
150043166|NCT01263197|541297111|FG004|First Intervention (Period 1)|Adverse Event|0|||
150043167|NCT01263197|541297112|FG005|First Intervention (Period 1)|Adverse Event|1|||
150043168|NCT01263197|541297107|FG000|Washout Period 1|Protocol Violation|0|||
150043169|NCT01263197|541297108|FG001|Washout Period 1|Protocol Violation|0|||
150043170|NCT01263197|541297109|FG002|Washout Period 1|Protocol Violation|0|||
150043171|NCT01263197|541297110|FG003|Washout Period 1|Protocol Violation|0|||
150043172|NCT01263197|541297111|FG004|Washout Period 1|Protocol Violation|1|||
150043173|NCT01263197|541297112|FG005|Washout Period 1|Protocol Violation|0|||
150043174|NCT01263197|541297107|FG000|Washout Period 2|Physician Decision|0|||
150043175|NCT01263197|541297108|FG001|Washout Period 2|Physician Decision|0|||
150043176|NCT01263197|541297109|FG002|Washout Period 2|Physician Decision|0|||
150043177|NCT01263197|541297110|FG003|Washout Period 2|Physician Decision|0|||
150043178|NCT01263197|541297111|FG004|Washout Period 2|Physician Decision|0|||
150043179|NCT01263197|541297112|FG005|Washout Period 2|Physician Decision|1|||
150174274|NCT02320123|541774395|FG000|Overall Study|Lost to Follow-up|4|||
150174275|NCT02320123|541774396|FG001|Overall Study|Lost to Follow-up|6|||
150174276|NCT02320123|541774395|FG000|Overall Study|Death|6|||
150174277|NCT02320123|541774396|FG001|Overall Study|Death|5|||
150174278|NCT04480827|541774397|FG000|Overall Study|Adverse Event|0|||
150174279|NCT04480827|541774398|FG001|Overall Study|Adverse Event|0|||
150174280|NCT04480827|541774399|FG002|Overall Study|Adverse Event|0|||
150174281|NCT04480827|541774400|FG003|Overall Study|Adverse Event|0|||
150174282|NCT04480827|541774401|FG004|Overall Study|Adverse Event|0|||
150174283|NCT04480827|541774402|FG005|Overall Study|Adverse Event|1|||
150174284|NCT04480827|541774403|FG006|Overall Study|Adverse Event|0|||
150174285|NCT00465816|541774404|FG000|Overall Study|Lost to Follow-up|0|||
150174286|NCT00465816|541774405|FG001|Overall Study|Lost to Follow-up|0|||
150174287|NCT00465816|541774406|FG002|Overall Study|Lost to Follow-up|2|||
150174288|NCT01426269|541774409|FG000|Period 1: 12 Weeks|Adverse Event|5|||
150174289|NCT01426269|541774410|FG001|Period 1: 12 Weeks|Adverse Event|0|||
150174290|NCT01426269|541774411|FG002|Period 1: 12 Weeks|Adverse Event|0|||
150174291|NCT01426269|541774409|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
150174292|NCT01426269|541774410|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
150174293|NCT01426269|541774411|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
150174294|NCT01426269|541774409|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
150174295|NCT01426269|541774410|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
150174296|NCT01426269|541774411|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
150174297|NCT01426269|541774409|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
150174298|NCT01426269|541774410|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
150174299|NCT01426269|541774411|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
150174300|NCT01426269|541774409|FG000|Period 1: 12 Weeks|Pregnancy|1|||
150174301|NCT01426269|541774410|FG001|Period 1: 12 Weeks|Pregnancy|0|||
150174302|NCT01426269|541774411|FG002|Period 1: 12 Weeks|Pregnancy|0|||
150174303|NCT01426269|541774409|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
150174304|NCT01426269|541774410|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
150174305|NCT01426269|541774411|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
150174306|NCT01426269|541774409|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
150174307|NCT01426269|541774410|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
150174308|NCT01426269|541774411|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
150174309|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Adverse Event|0|||
150174310|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Adverse Event|1|||
150174311|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Adverse Event|2|||
150174312|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
150174313|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
150174314|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
150174315|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
150174316|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
150174317|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
150174318|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
150174319|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
150174320|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
150174321|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Site closed|0|||
150174322|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Site closed|6|||
150174323|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Site closed|5|||
150174324|NCT01426269|541774409|FG000|Period 2: 40 Weeks|Relapsed|0|||
150174325|NCT01426269|541774410|FG001|Period 2: 40 Weeks|Relapsed|9|||
150174326|NCT01426269|541774411|FG002|Period 2: 40 Weeks|Relapsed|18|||
150174327|NCT00799396|541774413|FG000|Clopidogrel Treatment|Adverse Event|6|||
150174328|NCT00799396|541774413|FG000|Clopidogrel Treatment|Physician Decision|5|||
150174329|NCT00799396|541774413|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
150174330|NCT00799396|541774413|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
150174331|NCT00799396|541774413|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
150174332|NCT01867216|541774414|FG000|Overall Study|Withdrawal by Subject|2|||
150174333|NCT01867216|541774415|FG001|Overall Study|Withdrawal by Subject|0|||
150174334|NCT01867216|541774416|FG002|Overall Study|Withdrawal by Subject|0|||
150174335|NCT01867216|541774417|FG003|Overall Study|Withdrawal by Subject|0|||
150174336|NCT01867216|541774418|FG004|Overall Study|Withdrawal by Subject|1|||
150174337|NCT01867216|541774419|FG005|Overall Study|Withdrawal by Subject|0|||
150174338|NCT01867216|541774420|FG006|Overall Study|Withdrawal by Subject|1|||
150174339|NCT01867216|541774414|FG000|Overall Study|Physician Decision|1|||
150174340|NCT01867216|541774415|FG001|Overall Study|Physician Decision|0|||
150174341|NCT01867216|541774416|FG002|Overall Study|Physician Decision|0|||
150174342|NCT01867216|541774417|FG003|Overall Study|Physician Decision|0|||
150174343|NCT01867216|541774418|FG004|Overall Study|Physician Decision|0|||
150174344|NCT01867216|541774419|FG005|Overall Study|Physician Decision|0|||
150174345|NCT01867216|541774420|FG006|Overall Study|Physician Decision|0|||
150174346|NCT01867216|541774414|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
150174347|NCT01867216|541774415|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150174348|NCT01867216|541774416|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150043180|NCT01263197|541297107|FG000|Washout Period 2|Protocol Violation|0|||
150043181|NCT01263197|541297108|FG001|Washout Period 2|Protocol Violation|0|||
150043182|NCT01263197|541297109|FG002|Washout Period 2|Protocol Violation|0|||
150043183|NCT01263197|541297110|FG003|Washout Period 2|Protocol Violation|1|||
150043184|NCT01263197|541297111|FG004|Washout Period 2|Protocol Violation|0|||
150043185|NCT01263197|541297112|FG005|Washout Period 2|Protocol Violation|0|||
150043186|NCT01263197|541297107|FG000|Third Intervention (Period 3)|Adverse Event|0|||
150043187|NCT01263197|541297108|FG001|Third Intervention (Period 3)|Adverse Event|1|||
150043188|NCT01263197|541297109|FG002|Third Intervention (Period 3)|Adverse Event|0|||
150043189|NCT01263197|541297110|FG003|Third Intervention (Period 3)|Adverse Event|0|||
150043190|NCT01263197|541297111|FG004|Third Intervention (Period 3)|Adverse Event|0|||
150043191|NCT01263197|541297112|FG005|Third Intervention (Period 3)|Adverse Event|0|||
150043192|NCT00473382|541297113|FG000|Core Study|Adverse Event|3|||
150043193|NCT00473382|541297114|FG001|Core Study|Adverse Event|1|||
150043194|NCT00473382|541297115|FG002|Core Study|Adverse Event|1|||
150043195|NCT00473382|541297113|FG000|Core Study|Death|3|||
150174349|NCT01867216|541774417|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150174350|NCT01867216|541774418|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150174351|NCT01867216|541774419|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150174352|NCT01867216|541774420|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
150043196|NCT00473382|541297114|FG001|Core Study|Death|5|||
150043197|NCT00473382|541297115|FG002|Core Study|Death|10|||
150043198|NCT00473382|541297113|FG000|Core Study|Lost to Follow-up|3|||
149877776|NCT03333941|540680796|FG000|Overall Study|Adverse Event|1|||
149877777|NCT04971187|540680797|FG000|Overall Study|Screen failures|2|||
149877778|NCT01207583|540680805|FG000|Overall Study|Withdrawal by Subject|0|||
150043199|NCT00473382|541297114|FG001|Core Study|Lost to Follow-up|3|||
150043200|NCT00473382|541297115|FG002|Core Study|Lost to Follow-up|3|||
150043201|NCT00473382|541297113|FG000|Core Study|Physician Decision|1|||
149877779|NCT01207583|540680806|FG001|Overall Study|Withdrawal by Subject|3|||
150043202|NCT00473382|541297114|FG001|Core Study|Physician Decision|2|||
150043203|NCT00473382|541297115|FG002|Core Study|Physician Decision|2|||
150043204|NCT00473382|541297113|FG000|Core Study|Subject non-compliance|5|||
150043205|NCT00473382|541297114|FG001|Core Study|Subject non-compliance|2|||
150043206|NCT00473382|541297115|FG002|Core Study|Subject non-compliance|1|||
150043207|NCT00473382|541297113|FG000|Core Study|Subject needed other treatment|1|||
150043208|NCT00473382|541297114|FG001|Core Study|Subject needed other treatment|3|||
150043209|NCT00473382|541297115|FG002|Core Study|Subject needed other treatment|2|||
150043210|NCT00473382|541297113|FG000|Core Study|Subject's decision|12|||
150043211|NCT00473382|541297114|FG001|Core Study|Subject's decision|11|||
150043212|NCT00473382|541297115|FG002|Core Study|Subject's decision|10|||
150043213|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
150043214|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
150043215|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
150043216|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Death|1|||
150043217|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Death|3|||
150043218|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Death|3|||
150043219|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
150043220|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
150043221|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
150043222|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
150174353|NCT01765543|541774429|FG000|Overall Study|Death|1|||
150174354|NCT01765543|541774429|FG000|Overall Study|Withdrawal by Subject|2|||
150174355|NCT03454529|541774430|FG000|Overall Study|Did not receive treatment|6|||
150174356|NCT03454529|541774430|FG000|Overall Study|Received < 80% doses|1|||
150174357|NCT04956575|541774431|FG000|Overall Study|Death|1|||
150174358|NCT04956575|541774432|FG001|Overall Study|Death|0|||
150043223|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
150043224|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
150043225|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
150043226|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
150043227|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
150043228|NCT00473382|541297113|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
150043229|NCT00473382|541297114|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
150043230|NCT00473382|541297115|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
150043231|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
150043232|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
150174359|NCT04956575|541774433|FG002|Overall Study|Death|0|||
150174360|NCT04956575|541774434|FG003|Overall Study|Death|0|||
149964230|NCT03624036|541003268|FG002|Overall Study|Reason not Specified|2|||
149964231|NCT03624036|541003269|FG003|Overall Study|Reason not Specified|2|||
149964232|NCT02916433|541003270|FG000|Overall Study|Withdrawal by Subject|1|||
149964233|NCT02916433|541003271|FG001|Overall Study|Withdrawal by Subject|0|||
149964234|NCT02916433|541003270|FG000|Overall Study|Physician Decision|1|||
149964235|NCT02916433|541003271|FG001|Overall Study|Physician Decision|0|||
150174361|NCT04956575|541774435|FG004|Overall Study|Death|0|||
150174362|NCT04956575|541774436|FG005|Overall Study|Death|0|||
150174363|NCT04956575|541774437|FG006|Overall Study|Death|0|||
150174364|NCT04956575|541774438|FG007|Overall Study|Death|1|||
150174365|NCT04956575|541774439|FG008|Overall Study|Death|0|||
150174366|NCT04956575|541774440|FG009|Overall Study|Death|1|||
150174367|NCT04956575|541774441|FG010|Overall Study|Death|0|||
150174368|NCT04956575|541774442|FG011|Overall Study|Death|0|||
150174369|NCT04956575|541774431|FG000|Overall Study|Lost to Follow-up|3|||
150174370|NCT04956575|541774432|FG001|Overall Study|Lost to Follow-up|4|||
150174371|NCT04956575|541774433|FG002|Overall Study|Lost to Follow-up|2|||
150174372|NCT04956575|541774434|FG003|Overall Study|Lost to Follow-up|3|||
150174373|NCT04956575|541774435|FG004|Overall Study|Lost to Follow-up|1|||
150174374|NCT04956575|541774436|FG005|Overall Study|Lost to Follow-up|10|||
150174375|NCT04956575|541774437|FG006|Overall Study|Lost to Follow-up|11|||
150174376|NCT04956575|541774438|FG007|Overall Study|Lost to Follow-up|7|||
150174377|NCT04956575|541774439|FG008|Overall Study|Lost to Follow-up|4|||
150174378|NCT04956575|541774440|FG009|Overall Study|Lost to Follow-up|2|||
150174379|NCT04956575|541774441|FG010|Overall Study|Lost to Follow-up|3|||
150174380|NCT04956575|541774442|FG011|Overall Study|Lost to Follow-up|8|||
150174381|NCT04956575|541774431|FG000|Overall Study|Withdrawal by Subject|1|||
150174382|NCT04956575|541774432|FG001|Overall Study|Withdrawal by Subject|2|||
150174383|NCT04956575|541774433|FG002|Overall Study|Withdrawal by Subject|1|||
150174384|NCT04956575|541774434|FG003|Overall Study|Withdrawal by Subject|4|||
150174385|NCT04956575|541774435|FG004|Overall Study|Withdrawal by Subject|2|||
150174386|NCT04956575|541774436|FG005|Overall Study|Withdrawal by Subject|8|||
150174387|NCT04956575|541774437|FG006|Overall Study|Withdrawal by Subject|5|||
150174388|NCT04956575|541774438|FG007|Overall Study|Withdrawal by Subject|1|||
150174389|NCT04956575|541774439|FG008|Overall Study|Withdrawal by Subject|1|||
150174390|NCT04956575|541774440|FG009|Overall Study|Withdrawal by Subject|0|||
150174391|NCT04956575|541774441|FG010|Overall Study|Withdrawal by Subject|3|||
150174392|NCT04956575|541774442|FG011|Overall Study|Withdrawal by Subject|1|||
150174393|NCT00507689|541774445|FG000|Pre-Randomization Period|Adverse Event|1|||
150174394|NCT00507689|541774446|FG001|Pre-Randomization Period|Adverse Event|0|||
150174395|NCT00507689|541774445|FG000|Pre-Randomization Period|Physician Decision|1|||
150043233|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
150043234|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Death|1|||
150043235|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Death|7|||
150043236|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Death|4|||
150043237|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
150043238|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
150043239|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
150043240|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
150043241|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
150043242|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
150043243|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
150043244|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
150043245|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
150043246|NCT00473382|541297113|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
150043247|NCT00473382|541297114|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
150043248|NCT00473382|541297115|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
150043249|NCT03155841|541297116|FG000|Overall Study|Protocol Violation|3|||
150043250|NCT03155841|541297117|FG001|Overall Study|Protocol Violation|4|||
150043251|NCT03070964|541297120|FG000|Overall Study|Progressive disease|8|||
150043252|NCT03070964|541297120|FG000|Overall Study|Treatment-unrelated adverse event|2|||
150043253|NCT03070964|541297120|FG000|Overall Study|Never treated|1|||
150043254|NCT03070964|541297120|FG000|Overall Study|Physician Decision|1|||
150174396|NCT00507689|541774446|FG001|Pre-Randomization Period|Physician Decision|0|||
150174397|NCT00507689|541774445|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
150174398|NCT00507689|541774446|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
150174399|NCT00507689|541774445|FG000|Randomized Period|Adverse Event|1|||
150174400|NCT00507689|541774446|FG001|Randomized Period|Adverse Event|1|||
150174401|NCT00507689|541774445|FG000|Randomized Period|Withdrawal by Subject|0|||
150174402|NCT00507689|541774446|FG001|Randomized Period|Withdrawal by Subject|1|||
150174403|NCT00831415|541774447|FG000|Overall Study|Adverse Event|14|||
150043255|NCT03070964|541297120|FG000|Overall Study|Withdrawal by Subject|1|||
150043256|NCT03070964|541297120|FG000|Overall Study|Adverse Event|1|||
150043257|NCT01094119|541297121|FG000|Overall Study|Lack of Efficacy|2|||
150043258|NCT01094119|541297122|FG001|Overall Study|Lack of Efficacy|4|||
150043259|NCT00834093|541297123|FG000|Overall Study|Progressive Disease|3|||
150043260|NCT00834093|541297123|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
150043261|NCT01626872|541297124|FG000|Overall Study|Physician Decision|13|||
150043262|NCT01626872|541297125|FG001|Overall Study|Physician Decision|9|||
150043263|NCT01626872|541297126|FG002|Overall Study|Physician Decision|6|||
150043264|NCT01626872|541297124|FG000|Overall Study|Withdrawal by Subject|19|||
150043265|NCT01626872|541297125|FG001|Overall Study|Withdrawal by Subject|27|||
150043266|NCT01626872|541297126|FG002|Overall Study|Withdrawal by Subject|8|||
150043267|NCT01626872|541297124|FG000|Overall Study|Adverse Event (including Death)|20|||
150043268|NCT01626872|541297125|FG001|Overall Study|Adverse Event (including Death)|28|||
150043269|NCT01626872|541297126|FG002|Overall Study|Adverse Event (including Death)|8|||
150043270|NCT01626872|541297124|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
150043271|NCT01626872|541297125|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
150043272|NCT01626872|541297126|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
150043273|NCT01578486|541297127|FG000|Overall Study|Physician Decision|3|||
150043274|NCT01578486|541297127|FG000|Overall Study|Withdrawal by Subject|2|||
150043275|NCT02425943|541297128|FG000|Overall Study|Adverse Event|3|||
150043276|NCT02425943|541297129|FG001|Overall Study|Adverse Event|1|||
150174404|NCT00831415|541774447|FG000|Overall Study|Failed to return|3|||
150043277|NCT02425943|541297128|FG000|Overall Study|Lost to Follow-up|59|||
150043278|NCT02425943|541297129|FG001|Overall Study|Lost to Follow-up|37|||
150043279|NCT02425943|541297128|FG000|Overall Study|Protocol Violation|4|||
150043280|NCT02425943|541297129|FG001|Overall Study|Protocol Violation|1|||
150043281|NCT02425943|541297128|FG000|Overall Study|Withdrawal by Subject|64|||
150043282|NCT02425943|541297129|FG001|Overall Study|Withdrawal by Subject|31|||
150043283|NCT02425943|541297128|FG000|Overall Study|Other|6|||
150043284|NCT02425943|541297129|FG001|Overall Study|Other|0|||
150043285|NCT01106248|541297131|FG000|Overall Study|Adverse Event|1|||
150043286|NCT01106248|541297131|FG000|Overall Study|Administrative|2|||
150043287|NCT00357903|541297132|FG000|Overall Study|Adverse Event|87|||
150043288|NCT00357903|541297133|FG001|Overall Study|Adverse Event|4|||
150043289|NCT00357903|541297132|FG000|Overall Study|Death|33|||
150043290|NCT00357903|541297133|FG001|Overall Study|Death|0|||
150043291|NCT00357903|541297132|FG000|Overall Study|Lost to Follow-up|23|||
150043292|NCT00357903|541297133|FG001|Overall Study|Lost to Follow-up|4|||
150043293|NCT00357903|541297132|FG000|Overall Study|Physician Decision|39|||
150043294|NCT00357903|541297133|FG001|Overall Study|Physician Decision|5|||
150043295|NCT00357903|541297132|FG000|Overall Study|Withdrawal by Subject|57|||
150043296|NCT00357903|541297133|FG001|Overall Study|Withdrawal by Subject|7|||
150043297|NCT00357903|541297132|FG000|Overall Study|Completed month 12 only|0|||
150043298|NCT00357903|541297133|FG001|Overall Study|Completed month 12 only|1|||
150043299|NCT00357903|541297132|FG000|Overall Study|Protocol issues|14|||
150043300|NCT00357903|541297133|FG001|Overall Study|Protocol issues|3|||
150043301|NCT00357903|541297132|FG000|Overall Study|Response status|61|||
150043302|NCT00357903|541297133|FG001|Overall Study|Response status|9|||
150043303|NCT00357903|541297132|FG000|Overall Study|Other|49|||
150043304|NCT00357903|541297133|FG001|Overall Study|Other|10|||
150043305|NCT00606593|541297134|FG000|Overall Study|Adverse Event|0|||
150043306|NCT00606593|541297135|FG001|Overall Study|Adverse Event|0|||
150043307|NCT00606593|541297136|FG002|Overall Study|Adverse Event|0|||
150043308|NCT00606593|541297137|FG003|Overall Study|Adverse Event|1|||
150043309|NCT00606593|541297138|FG004|Overall Study|Adverse Event|1|||
150043310|NCT00606593|541297139|FG005|Overall Study|Adverse Event|0|||
150043311|NCT00606593|541297140|FG006|Overall Study|Adverse Event|1|||
150043312|NCT00606593|541297141|FG007|Overall Study|Adverse Event|2|||
150043313|NCT00606593|541297142|FG008|Overall Study|Adverse Event|1|||
150043314|NCT00606593|541297143|FG009|Overall Study|Adverse Event|0|||
150043315|NCT00606593|541297134|FG000|Overall Study|Withdrawal of consent|1|||
150043316|NCT00606593|541297135|FG001|Overall Study|Withdrawal of consent|0|||
150043317|NCT00606593|541297136|FG002|Overall Study|Withdrawal of consent|1|||
150043318|NCT00606593|541297137|FG003|Overall Study|Withdrawal of consent|0|||
150043319|NCT00606593|541297138|FG004|Overall Study|Withdrawal of consent|0|||
150043320|NCT00606593|541297139|FG005|Overall Study|Withdrawal of consent|0|||
150043321|NCT00606593|541297140|FG006|Overall Study|Withdrawal of consent|0|||
150043322|NCT00606593|541297141|FG007|Overall Study|Withdrawal of consent|0|||
150043323|NCT00606593|541297142|FG008|Overall Study|Withdrawal of consent|0|||
150043324|NCT00606593|541297143|FG009|Overall Study|Withdrawal of consent|0|||
150043325|NCT00606593|541297134|FG000|Overall Study|Administrative/Other|0|||
150043326|NCT00606593|541297135|FG001|Overall Study|Administrative/Other|0|||
150043327|NCT00606593|541297136|FG002|Overall Study|Administrative/Other|1|||
150043328|NCT00606593|541297137|FG003|Overall Study|Administrative/Other|0|||
150043329|NCT00606593|541297138|FG004|Overall Study|Administrative/Other|0|||
150043330|NCT00606593|541297139|FG005|Overall Study|Administrative/Other|0|||
150043331|NCT00606593|541297140|FG006|Overall Study|Administrative/Other|0|||
150043332|NCT00606593|541297141|FG007|Overall Study|Administrative/Other|0|||
150043333|NCT00606593|541297142|FG008|Overall Study|Administrative/Other|0|||
150043334|NCT00606593|541297143|FG009|Overall Study|Administrative/Other|0|||
150043335|NCT03181529|541297144|FG000|Overall Study|Withdrawal by Subject|1|||
150043336|NCT03181529|541297145|FG001|Overall Study|Withdrawal by Subject|1|||
150043337|NCT03181529|541297144|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
150043338|NCT03181529|541297145|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
150043339|NCT01209325|541297148|FG000|Overall Study|Lost to Follow-up|24|||
150043340|NCT01209325|541297148|FG000|Overall Study|Adverse Event|1|||
150043341|NCT01209325|541297148|FG000|Overall Study|Relocated|3|||
150043342|NCT01209325|541297148|FG000|Overall Study|Refusal after starting therapy|8|||
150043343|NCT01209325|541297148|FG000|Overall Study|Protocol Violation|4|||
150043344|NCT01209325|541297148|FG000|Overall Study|Refusal prior to therapy|1|||
150043345|NCT01209325|541297148|FG000|Overall Study|Incarceration|2|||
150043346|NCT00607373|541297149|FG000|Treatment Period|Adverse Event|0|||
150043347|NCT00607373|541297150|FG001|Treatment Period|Adverse Event|4|||
150043348|NCT00607373|541297149|FG000|Treatment Period|Physician Decision|0|||
150043349|NCT00607373|541297150|FG001|Treatment Period|Physician Decision|1|||
150043350|NCT00607373|541297149|FG000|Treatment Period|Withdrawal by Subject|0|||
150043351|NCT00607373|541297150|FG001|Treatment Period|Withdrawal by Subject|1|||
150043352|NCT00607373|541297149|FG000|Follow-up Period|Other|0|||
150043353|NCT00607373|541297150|FG001|Follow-up Period|Other|1|||
150043354|NCT00607373|541297149|FG000|Follow-up Period|Protocol Violation|0|||
150043355|NCT00607373|541297150|FG001|Follow-up Period|Protocol Violation|1|||
150043356|NCT00607373|541297149|FG000|Follow-up Period|Withdrawal by Subject|1|||
150043357|NCT00607373|541297150|FG001|Follow-up Period|Withdrawal by Subject|3|||
150043358|NCT01160822|541297153|FG000|Overall Study|Adverse Event|0|||
150043359|NCT01160822|541297154|FG001|Overall Study|Adverse Event|0|||
150043360|NCT01160822|541297155|FG002|Overall Study|Adverse Event|0|||
150043361|NCT01160822|541297156|FG003|Overall Study|Adverse Event|0|||
150043362|NCT01160822|541297157|FG004|Overall Study|Adverse Event|1|||
150043363|NCT01160822|541297158|FG005|Overall Study|Adverse Event|2|||
150043364|NCT01160822|541297159|FG006|Overall Study|Adverse Event|5|||
150043365|NCT01160822|541297153|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150043366|NCT01160822|541297154|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150043367|NCT01160822|541297155|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
150043368|NCT01160822|541297156|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
150043369|NCT01160822|541297157|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
150043370|NCT01160822|541297158|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
150043371|NCT01160822|541297159|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
150043372|NCT01160822|541297153|FG000|Overall Study|Withdrawal by Subject|0|||
150043373|NCT01160822|541297154|FG001|Overall Study|Withdrawal by Subject|0|||
150043374|NCT01160822|541297155|FG002|Overall Study|Withdrawal by Subject|0|||
150043375|NCT01160822|541297156|FG003|Overall Study|Withdrawal by Subject|0|||
150043376|NCT01160822|541297157|FG004|Overall Study|Withdrawal by Subject|0|||
150043377|NCT01160822|541297158|FG005|Overall Study|Withdrawal by Subject|0|||
150043378|NCT01160822|541297159|FG006|Overall Study|Withdrawal by Subject|1|||
150043379|NCT01160822|541297153|FG000|Overall Study|Lost to Follow-up|0|||
150043380|NCT01160822|541297154|FG001|Overall Study|Lost to Follow-up|0|||
150043381|NCT01160822|541297155|FG002|Overall Study|Lost to Follow-up|0|||
150043382|NCT01160822|541297156|FG003|Overall Study|Lost to Follow-up|0|||
150043383|NCT01160822|541297157|FG004|Overall Study|Lost to Follow-up|1|||
150043384|NCT01160822|541297158|FG005|Overall Study|Lost to Follow-up|0|||
150043385|NCT01160822|541297159|FG006|Overall Study|Lost to Follow-up|0|||
150043386|NCT01160822|541297153|FG000|Overall Study|Administrative problems|0|||
150043387|NCT01160822|541297154|FG001|Overall Study|Administrative problems|0|||
150043388|NCT01160822|541297155|FG002|Overall Study|Administrative problems|0|||
150043389|NCT01160822|541297156|FG003|Overall Study|Administrative problems|0|||
150043390|NCT01160822|541297157|FG004|Overall Study|Administrative problems|1|||
150043391|NCT01160822|541297158|FG005|Overall Study|Administrative problems|0|||
150043392|NCT01160822|541297159|FG006|Overall Study|Administrative problems|0|||
150043393|NCT01160822|541297153|FG000|Overall Study|Protocol deviation|0|||
150043394|NCT01160822|541297154|FG001|Overall Study|Protocol deviation|0|||
150043395|NCT01160822|541297155|FG002|Overall Study|Protocol deviation|0|||
150043396|NCT01160822|541297156|FG003|Overall Study|Protocol deviation|0|||
150043397|NCT01160822|541297157|FG004|Overall Study|Protocol deviation|2|||
150043398|NCT01160822|541297158|FG005|Overall Study|Protocol deviation|0|||
150043399|NCT01160822|541297159|FG006|Overall Study|Protocol deviation|0|||
150043400|NCT00314795|541297162|FG000|Overall Study|Adverse Event|8|||
150043401|NCT00314795|541297162|FG000|Overall Study|Death|4|||
150043402|NCT00314795|541297162|FG000|Overall Study|Reason not Specified|3|||
150043403|NCT00314795|541297162|FG000|Overall Study|Renal Transplant|3|||
150043404|NCT00314795|541297162|FG000|Overall Study|Participants Withdrew Consent|2|||
150043405|NCT02170077|541297167|FG000|Overall Study|Withdrawal by Subject|3|||
150043406|NCT02170077|541297168|FG001|Overall Study|Withdrawal by Subject|4|||
150043407|NCT02170077|541297169|FG002|Overall Study|Withdrawal by Subject|2|||
150043408|NCT02170077|541297167|FG000|Overall Study|Adverse Event|4|||
150174405|NCT00831415|541774447|FG000|Overall Study|Physician Decision|6|||
150043409|NCT02170077|541297168|FG001|Overall Study|Adverse Event|4|||
150043410|NCT02170077|541297169|FG002|Overall Study|Adverse Event|4|||
150043411|NCT02170077|541297167|FG000|Overall Study|Lost to Follow-up|0|||
150174406|NCT00831415|541774447|FG000|Overall Study|Lost to Follow-up|9|||
150043412|NCT02170077|541297168|FG001|Overall Study|Lost to Follow-up|1|||
150043413|NCT02170077|541297169|FG002|Overall Study|Lost to Follow-up|0|||
150043414|NCT02170077|541297167|FG000|Overall Study|Exclusion criteria|2|||
150043415|NCT02170077|541297168|FG001|Overall Study|Exclusion criteria|2|||
150043416|NCT02170077|541297169|FG002|Overall Study|Exclusion criteria|5|||
150043417|NCT02170077|541297167|FG000|Overall Study|Exacerbation of seizures|0|||
150043418|NCT02170077|541297168|FG001|Overall Study|Exacerbation of seizures|2|||
150043419|NCT02170077|541297169|FG002|Overall Study|Exacerbation of seizures|1|||
150043420|NCT01780974|541297174|FG000|Overall Study|Death|1|||
150043421|NCT01780974|541297175|FG001|Overall Study|Death|0|||
150043422|NCT01780974|541297174|FG000|Overall Study|Adverse Event|1|||
150174407|NCT00831415|541774447|FG000|Overall Study|Protocol Violation|3|||
149877780|NCT01207583|540680807|FG002|Overall Study|Withdrawal by Subject|1|||
149877781|NCT01207583|540680805|FG000|Overall Study|Participant failed to return|1|||
149877782|NCT01207583|540680806|FG001|Overall Study|Participant failed to return|0|||
149877783|NCT01207583|540680807|FG002|Overall Study|Participant failed to return|0|||
149877784|NCT01207583|540680805|FG000|Overall Study|Lost to Follow-up|0|||
149877785|NCT01207583|540680806|FG001|Overall Study|Lost to Follow-up|2|||
149877786|NCT01207583|540680807|FG002|Overall Study|Lost to Follow-up|0|||
149877787|NCT02549027|540680809|FG000|Washout After Period 4|Withdrawal by Subject|0|||
149877788|NCT02549027|540680810|FG001|Washout After Period 4|Withdrawal by Subject|1|||
149964236|NCT00581100|541004472|FG000|Overall Study|Death|1|||
149964237|NCT00581100|541004473|FG001|Overall Study|Death|0|||
150174408|NCT00831415|541774447|FG000|Overall Study|Withdrawal by Subject|35|||
150174409|NCT00831415|541774447|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
150174410|NCT00831415|541774447|FG000|Overall Study|Death|1|||
150174411|NCT00424762|541774453|FG000|Overall Study|Withdrawal by Subject|18|||
150174412|NCT00424762|541774454|FG001|Overall Study|Withdrawal by Subject|19|||
150174413|NCT00424762|541774453|FG000|Overall Study|Lost to Follow-up|2|||
150174414|NCT00424762|541774454|FG001|Overall Study|Lost to Follow-up|3|||
150174415|NCT01145885|541774455|FG000|Overall Study|Progressive Disease|7|||
150174416|NCT05299606|541774456|FG000|Overall Study|Death|1|||
149877789|NCT02549027|540680811|FG002|Washout After Period 4|Withdrawal by Subject|1|||
149877790|NCT02549027|540680812|FG003|Washout After Period 4|Withdrawal by Subject|1|||
150174417|NCT00723450|541774457|FG000|Open-Label Phase|Adverse Event|26|||
150174418|NCT00723450|541774458|FG001|Open-Label Phase|Adverse Event|0|||
150174419|NCT00723450|541774459|FG002|Open-Label Phase|Adverse Event|0|||
150174420|NCT00723450|541774457|FG000|Open-Label Phase|Lack of Efficacy|18|||
150174421|NCT00723450|541774458|FG001|Open-Label Phase|Lack of Efficacy|0|||
150174422|NCT00723450|541774459|FG002|Open-Label Phase|Lack of Efficacy|0|||
150174423|NCT00723450|541774457|FG000|Open-Label Phase|Protocol Violation|35|||
150174424|NCT00723450|541774458|FG001|Open-Label Phase|Protocol Violation|0|||
150174425|NCT00723450|541774459|FG002|Open-Label Phase|Protocol Violation|0|||
150174426|NCT00723450|541774457|FG000|Open-Label Phase|Lost to Follow-up|7|||
150174427|NCT00723450|541774458|FG001|Open-Label Phase|Lost to Follow-up|0|||
150174428|NCT00723450|541774459|FG002|Open-Label Phase|Lost to Follow-up|0|||
150174429|NCT00723450|541774457|FG000|Open-Label Phase|Physician Decision|2|||
150174430|NCT00723450|541774458|FG001|Open-Label Phase|Physician Decision|0|||
150174431|NCT00723450|541774459|FG002|Open-Label Phase|Physician Decision|0|||
150174432|NCT00723450|541774457|FG000|Open-Label Phase|Withdrawal by Subject|37|||
150174433|NCT00723450|541774458|FG001|Open-Label Phase|Withdrawal by Subject|0|||
150174434|NCT00723450|541774459|FG002|Open-Label Phase|Withdrawal by Subject|0|||
150174435|NCT00723450|541774457|FG000|Randomized Phase|Adverse Event|0|||
150174436|NCT00723450|541774458|FG001|Randomized Phase|Adverse Event|26|||
149877791|NCT02549027|540680813|FG004|Washout After Period 4|Withdrawal by Subject|0|||
149877792|NCT02549027|540680814|FG005|Washout After Period 4|Withdrawal by Subject|0|||
149877793|NCT02549027|540680809|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
150174437|NCT00723450|541774459|FG002|Randomized Phase|Adverse Event|17|||
149877794|NCT02549027|540680810|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
150174438|NCT00723450|541774457|FG000|Randomized Phase|Lack of Efficacy|0|||
150174439|NCT00723450|541774458|FG001|Randomized Phase|Lack of Efficacy|11|||
150174440|NCT00723450|541774459|FG002|Randomized Phase|Lack of Efficacy|11|||
149877795|NCT02549027|540680811|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
149877796|NCT02549027|540680812|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
149877797|NCT02549027|540680813|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
149877798|NCT02549027|540680814|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
149877799|NCT02242045|540680815|FG000|Overall Study|Investigator's Discretion|1|||
149877800|NCT02242045|540680815|FG000|Overall Study|Progressive Disease|2|||
149877801|NCT02242045|540680815|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
149877802|NCT02242045|540680815|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
149877803|NCT00875797|540680819|FG000|Overall Study|Protocol Violation|6|||
149877804|NCT00875797|540680820|FG001|Overall Study|Protocol Violation|3|||
149877805|NCT00741286|540680822|FG000|Overall Study|Lost to Follow-up|15|||
149877806|NCT00741286|540680823|FG001|Overall Study|Lost to Follow-up|10|||
149877807|NCT00741286|540680822|FG000|Overall Study|Adverse Event|1|||
149877808|NCT00741286|540680823|FG001|Overall Study|Adverse Event|6|||
149877809|NCT00741286|540680822|FG000|Overall Study|Protocol Violation|3|||
149877810|NCT00741286|540680823|FG001|Overall Study|Protocol Violation|2|||
149877811|NCT00741286|540680822|FG000|Overall Study|Primary Outcome|1|||
149877812|NCT00741286|540680823|FG001|Overall Study|Primary Outcome|1|||
149877813|NCT00425373|540680826|FG000|Overall Study|Adverse Event|2|||
149964238|NCT00581100|541004472|FG000|Overall Study|Adverse Event|2|||
149877814|NCT00425373|540680827|FG001|Overall Study|Adverse Event|2|||
149877815|NCT00425373|540680828|FG002|Overall Study|Adverse Event|0|||
149877816|NCT00425373|540680829|FG003|Overall Study|Adverse Event|1|||
149964239|NCT00581100|541004473|FG001|Overall Study|Adverse Event|1|||
149964240|NCT00581100|541004472|FG000|Overall Study|Withdrawal by Subject|1|||
149964241|NCT00581100|541004473|FG001|Overall Study|Withdrawal by Subject|4|||
149964242|NCT00581100|541004472|FG000|Overall Study|Other|3|||
149877817|NCT00425373|540680830|FG004|Overall Study|Adverse Event|4|||
149877818|NCT00425373|540680831|FG005|Overall Study|Adverse Event|6|||
149877819|NCT00425373|540680832|FG006|Overall Study|Adverse Event|2|||
149877820|NCT00425373|540680833|FG007|Overall Study|Adverse Event|3|||
149877821|NCT00425373|540680834|FG008|Overall Study|Adverse Event|8|||
149964243|NCT00581100|541004473|FG001|Overall Study|Other|0|||
149877822|NCT00425373|540680826|FG000|Overall Study|Lost to Follow-up|0|||
150043423|NCT01780974|541297175|FG001|Overall Study|Adverse Event|3|||
150043424|NCT01724346|541297176|FG000|Overall Study|Death|42|||
150043425|NCT01724346|541297177|FG001|Overall Study|Death|42|||
150043426|NCT01724346|541297176|FG000|Overall Study|Lost to Follow-up|5|||
149877823|NCT00425373|540680827|FG001|Overall Study|Lost to Follow-up|1|||
150043427|NCT01724346|541297177|FG001|Overall Study|Lost to Follow-up|1|||
150043428|NCT01724346|541297176|FG000|Overall Study|Withdrawal by Subject|27|||
150043429|NCT01724346|541297177|FG001|Overall Study|Withdrawal by Subject|19|||
149877824|NCT00425373|540680828|FG002|Overall Study|Lost to Follow-up|0|||
149877825|NCT00425373|540680829|FG003|Overall Study|Lost to Follow-up|0|||
149877826|NCT00425373|540680830|FG004|Overall Study|Lost to Follow-up|1|||
149877827|NCT00425373|540680831|FG005|Overall Study|Lost to Follow-up|0|||
149877828|NCT00425373|540680832|FG006|Overall Study|Lost to Follow-up|0|||
149877829|NCT00425373|540680833|FG007|Overall Study|Lost to Follow-up|0|||
149877830|NCT00425373|540680834|FG008|Overall Study|Lost to Follow-up|0|||
149877831|NCT00425373|540680826|FG000|Overall Study|Protocol Violation|1|||
149877832|NCT00425373|540680827|FG001|Overall Study|Protocol Violation|0|||
149877833|NCT00425373|540680828|FG002|Overall Study|Protocol Violation|1|||
149877834|NCT00425373|540680829|FG003|Overall Study|Protocol Violation|0|||
149877835|NCT00425373|540680830|FG004|Overall Study|Protocol Violation|0|||
149877836|NCT00425373|540680831|FG005|Overall Study|Protocol Violation|0|||
149877837|NCT00425373|540680832|FG006|Overall Study|Protocol Violation|0|||
149877838|NCT00425373|540680833|FG007|Overall Study|Protocol Violation|5|||
149877839|NCT00425373|540680834|FG008|Overall Study|Protocol Violation|3|||
149877840|NCT00425373|540680826|FG000|Overall Study|Withdrawal by Subject|2|||
149877841|NCT00425373|540680827|FG001|Overall Study|Withdrawal by Subject|0|||
149877842|NCT00425373|540680828|FG002|Overall Study|Withdrawal by Subject|2|||
149877843|NCT00425373|540680829|FG003|Overall Study|Withdrawal by Subject|1|||
149877844|NCT00425373|540680830|FG004|Overall Study|Withdrawal by Subject|4|||
149877845|NCT00425373|540680831|FG005|Overall Study|Withdrawal by Subject|0|||
149877846|NCT00425373|540680832|FG006|Overall Study|Withdrawal by Subject|2|||
149877847|NCT00425373|540680833|FG007|Overall Study|Withdrawal by Subject|2|||
149877848|NCT00425373|540680834|FG008|Overall Study|Withdrawal by Subject|2|||
149877849|NCT00425373|540680826|FG000|Overall Study|Lack of Efficacy|0|||
149877850|NCT00425373|540680827|FG001|Overall Study|Lack of Efficacy|0|||
149877851|NCT00425373|540680828|FG002|Overall Study|Lack of Efficacy|0|||
149877852|NCT00425373|540680829|FG003|Overall Study|Lack of Efficacy|0|||
149877853|NCT00425373|540680830|FG004|Overall Study|Lack of Efficacy|1|||
149877854|NCT00425373|540680831|FG005|Overall Study|Lack of Efficacy|3|||
149877855|NCT00425373|540680832|FG006|Overall Study|Lack of Efficacy|3|||
149877856|NCT00425373|540680833|FG007|Overall Study|Lack of Efficacy|0|||
149877857|NCT00425373|540680834|FG008|Overall Study|Lack of Efficacy|5|||
149877858|NCT01590797|540680836|FG000|Overall Study|Adverse Event|4|||
149877859|NCT01590797|540680837|FG001|Overall Study|Adverse Event|3|||
149877860|NCT01590797|540680836|FG000|Overall Study|Lack of Efficacy|0|||
149877861|NCT01590797|540680837|FG001|Overall Study|Lack of Efficacy|2|||
149877862|NCT01590797|540680836|FG000|Overall Study|Lost to Follow-up|0|||
149877863|NCT01590797|540680837|FG001|Overall Study|Lost to Follow-up|1|||
149877864|NCT01590797|540680836|FG000|Overall Study|Protocol Violation|4|||
149877865|NCT01590797|540680837|FG001|Overall Study|Protocol Violation|1|||
149877866|NCT01590797|540680836|FG000|Overall Study|Withdrawal by Subject|7|||
149877867|NCT01590797|540680837|FG001|Overall Study|Withdrawal by Subject|5|||
149877868|NCT01590797|540680836|FG000|Overall Study|Other Protocol Specified Criteria|2|||
149877869|NCT01590797|540680837|FG001|Overall Study|Other Protocol Specified Criteria|4|||
149877870|NCT01085357|540680844|FG000|Overall Study|Adverse Event|1|||
150043430|NCT01724346|541297176|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
150043431|NCT01724346|541297177|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
150043432|NCT00525161|541297180|FG000|Overall Study|Adverse Event|1|||
149877871|NCT01085357|540680845|FG001|Overall Study|Adverse Event|1|||
149877872|NCT01085357|540680844|FG000|Overall Study|Subject Decision|4|||
149877873|NCT01085357|540680845|FG001|Overall Study|Subject Decision|3|||
149877874|NCT01085357|540680844|FG000|Overall Study|Investigator Decision|1|||
149877875|NCT01085357|540680845|FG001|Overall Study|Investigator Decision|1|||
149877876|NCT01085357|540680844|FG000|Overall Study|Death|11|||
149877877|NCT01085357|540680845|FG001|Overall Study|Death|1|||
149877878|NCT01085357|540680844|FG000|Overall Study|Lost to Follow-up|2|||
149877879|NCT01085357|540680845|FG001|Overall Study|Lost to Follow-up|0|||
149877880|NCT02910011|540680850|FG000|Overall Study|Physician Decision|2|||
149877881|NCT00920790|540680851|FG000|Overall Study|aggravation of general condition|14|||
149877882|NCT02460679|540680852|FG000|Overall Study|Investigator Decision|1|||
149877883|NCT02460679|540680852|FG000|Overall Study|Withdrawal by Subject|4|||
149877884|NCT04411914|540680853|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
149877885|NCT04411914|540680854|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
149877886|NCT00339144|540680892|FG000|Overall Study|Disease progression|5|||
149877887|NCT00339144|540680893|FG001|Overall Study|Disease progression|2|||
149877888|NCT00339144|540680894|FG002|Overall Study|Disease progression|2|||
149877889|NCT00339144|540680892|FG000|Overall Study|Study drug toxicity|3|||
149877890|NCT00339144|540680893|FG001|Overall Study|Study drug toxicity|1|||
149877891|NCT00339144|540680894|FG002|Overall Study|Study drug toxicity|1|||
149877892|NCT00339144|540680892|FG000|Overall Study|Participant's request to discontinuation|1|||
149877893|NCT00339144|540680893|FG001|Overall Study|Participant's request to discontinuation|0|||
149877894|NCT00339144|540680894|FG002|Overall Study|Participant's request to discontinuation|1|||
149877895|NCT00895414|540680897|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
149877896|NCT00895414|540680898|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
149877897|NCT00895414|540680897|FG000|First Intervention (14 Days)|Physician Decision|0|||
149877898|NCT00895414|540680898|FG001|First Intervention (14 Days)|Physician Decision|1|||
149877899|NCT02181790|540680901|FG000|Overall Study|study terminated|2|||
149877900|NCT02181790|540680902|FG001|Overall Study|study terminated|0|||
149877901|NCT02752087|540680905|FG000|Washout|Physician Decision|1|||
149877902|NCT02752087|540680906|FG001|Washout|Physician Decision|0|||
149877903|NCT02458287|540680907|FG000|Overall Study|Adverse Event|0|||
149877904|NCT02458287|540680908|FG001|Overall Study|Adverse Event|0|||
149877905|NCT02458287|540680909|FG002|Overall Study|Adverse Event|0|||
149877906|NCT02458287|540680910|FG003|Overall Study|Adverse Event|1|||
149877907|NCT02458287|540680907|FG000|Overall Study|Lost to Follow-up|0|||
149877908|NCT02458287|540680908|FG001|Overall Study|Lost to Follow-up|1|||
149877909|NCT02458287|540680909|FG002|Overall Study|Lost to Follow-up|1|||
149877910|NCT02458287|540680910|FG003|Overall Study|Lost to Follow-up|0|||
149877911|NCT02458287|540680907|FG000|Overall Study|Protocol Violation|0|||
149877912|NCT02458287|540680908|FG001|Overall Study|Protocol Violation|1|||
149877913|NCT02458287|540680909|FG002|Overall Study|Protocol Violation|0|||
149877914|NCT02458287|540680910|FG003|Overall Study|Protocol Violation|0|||
149877915|NCT02458287|540680907|FG000|Overall Study|Withdrawal by Subject|0|||
149877916|NCT02458287|540680908|FG001|Overall Study|Withdrawal by Subject|2|||
149877917|NCT02458287|540680909|FG002|Overall Study|Withdrawal by Subject|2|||
149877918|NCT02458287|540680910|FG003|Overall Study|Withdrawal by Subject|1|||
149877919|NCT02458287|540680907|FG000|Overall Study|Relocated Out of State|0|||
149877920|NCT02458287|540680908|FG001|Overall Study|Relocated Out of State|0|||
149877921|NCT02458287|540680909|FG002|Overall Study|Relocated Out of State|0|||
149877922|NCT02458287|540680910|FG003|Overall Study|Relocated Out of State|1|||
149877923|NCT00843635|540680911|FG000|Overall Study|Adverse Event|2|||
149877924|NCT00843635|540680912|FG001|Overall Study|Adverse Event|2|||
149877925|NCT00843635|540680913|FG002|Overall Study|Adverse Event|0|||
149877926|NCT02785952|540680914|FG000|Overall Study|Adverse Event|31|||
149877927|NCT02785952|540680915|FG001|Overall Study|Adverse Event|19|||
149877928|NCT02785952|540680914|FG000|Overall Study|Refusal unrelated to adverse events|10|||
149877929|NCT02785952|540680915|FG001|Overall Study|Refusal unrelated to adverse events|5|||
149877930|NCT02785952|540680914|FG000|Overall Study|Disease progression/relapse|61|||
149877931|NCT02785952|540680915|FG001|Overall Study|Disease progression/relapse|89|||
149877932|NCT02785952|540680914|FG000|Overall Study|Death|11|||
149877933|NCT02785952|540680915|FG001|Overall Study|Death|7|||
149877934|NCT02785952|540680914|FG000|Overall Study|Other- not protocol specified|6|||
149877935|NCT02785952|540680915|FG001|Overall Study|Other- not protocol specified|4|||
149877936|NCT02785952|540680914|FG000|Overall Study|On protocol treatment|6|||
149877937|NCT02785952|540680915|FG001|Overall Study|On protocol treatment|3|||
149877938|NCT01144715|540680916|FG000|Overall Study|Lost to Follow-up|2|||
149877939|NCT01144715|540680917|FG001|Overall Study|Lost to Follow-up|1|||
149964244|NCT04129398|541004474|FG000|Overall Study|Physician Decision|2|||
149964245|NCT04110145|541004475|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
149964246|NCT04110145|541004476|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
149964247|NCT04110145|541004477|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
149964248|NCT04110145|541004478|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
149964249|NCT04110145|541004479|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
149964250|NCT02579759|541004480|FG000|Overall Study|Protocol Violation|2|||
149964251|NCT02579759|541004481|FG001|Overall Study|Protocol Violation|0|||
149964252|NCT02579759|541004482|FG002|Overall Study|Protocol Violation|0|||
149877940|NCT01144715|540680916|FG000|Overall Study|Withdrawal by Subject|2|||
149877941|NCT01144715|540680917|FG001|Overall Study|Withdrawal by Subject|1|||
149877942|NCT01144715|540680916|FG000|Overall Study|Adverse Event|0|||
149877943|NCT01144715|540680917|FG001|Overall Study|Adverse Event|1|||
149877944|NCT03553576|540680918|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
149877945|NCT03553576|540680919|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
149877946|NCT03553576|540680918|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
149877947|NCT03553576|540680919|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
149877948|NCT03553576|540680918|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
149877949|NCT03553576|540680919|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
149877950|NCT03553576|540680918|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
149877951|NCT03553576|540680919|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
149877952|NCT03553576|540680918|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
149877953|NCT03553576|540680919|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
149877954|NCT03553576|540680918|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
149877955|NCT03553576|540680919|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
149877956|NCT03553576|540680918|FG000|Overall Study|Physician Decision|2|||
149877957|NCT03553576|540680919|FG001|Overall Study|Physician Decision|5|||
149877958|NCT00351533|540680924|FG000|Overall Study|Extubated before first BAL|1|||
149877959|NCT00351533|540680925|FG001|Overall Study|Extubated before first BAL|0|||
149877960|NCT00351533|540680924|FG000|Overall Study|Lost to Follow-up|1|||
149877961|NCT00351533|540680925|FG001|Overall Study|Lost to Follow-up|3|||
149877962|NCT00351533|540680924|FG000|Overall Study|Physician Decision|0|||
149877963|NCT00351533|540680925|FG001|Overall Study|Physician Decision|1|||
149877964|NCT00351533|540680924|FG000|Overall Study|Withdrawal by Subject|0|||
149877965|NCT00351533|540680925|FG001|Overall Study|Withdrawal by Subject|1|||
149877966|NCT03185013|540680926|FG000|Overall Study|Withdrawal by Subject|5|||
149877967|NCT03185013|540680927|FG001|Overall Study|Withdrawal by Subject|3|||
149877968|NCT03185013|540680926|FG000|Overall Study|Adverse Event|1|||
149877969|NCT03185013|540680927|FG001|Overall Study|Adverse Event|0|||
149877970|NCT03185013|540680926|FG000|Overall Study|Progressive Disease|1|||
149877971|NCT03185013|540680927|FG001|Overall Study|Progressive Disease|0|||
149877972|NCT03185013|540680926|FG000|Overall Study|Lost to Follow-up|8|||
149877973|NCT03185013|540680927|FG001|Overall Study|Lost to Follow-up|2|||
149877974|NCT03185013|540680926|FG000|Overall Study|Physician Decision|1|||
149877975|NCT03185013|540680927|FG001|Overall Study|Physician Decision|0|||
149877976|NCT03185013|540680926|FG000|Overall Study|Protocol Deviation|2|||
149877977|NCT03185013|540680927|FG001|Overall Study|Protocol Deviation|0|||
149877978|NCT03185013|540680926|FG000|Overall Study|Reason not Specified|3|||
149877979|NCT03185013|540680927|FG001|Overall Study|Reason not Specified|2|||
149877980|NCT03185013|540680926|FG000|Overall Study|Death|1|||
149877981|NCT03185013|540680927|FG001|Overall Study|Death|0|||
149877982|NCT00197496|540680931|FG000|Baseline to Discharge|not interested|1|||
149877983|NCT00197496|540680932|FG001|Baseline to Discharge|not interested|0|||
149877984|NCT00197496|540680931|FG000|Baseline to Discharge|MRSA|1|||
149877985|NCT00197496|540680932|FG001|Baseline to Discharge|MRSA|0|||
149877986|NCT00197496|540680931|FG000|Baseline to Discharge|Physician Decision|0|||
149877987|NCT00197496|540680932|FG001|Baseline to Discharge|Physician Decision|1|||
149877988|NCT00197496|540680931|FG000|Baseline to Discharge|Protocol Violation|0|||
149877989|NCT00197496|540680932|FG001|Baseline to Discharge|Protocol Violation|1|||
149877990|NCT00197496|540680931|FG000|Follow-up|Lost to Follow-up|2|||
149877991|NCT00197496|540680932|FG001|Follow-up|Lost to Follow-up|1|||
149877992|NCT00857584|540680935|FG000|Overall Study|Lack of Efficacy|1|||
149877993|NCT00857584|540680936|FG001|Overall Study|Lack of Efficacy|2|||
149877994|NCT00857584|540680935|FG000|Overall Study|Adverse Event|2|||
149877995|NCT00857584|540680936|FG001|Overall Study|Adverse Event|2|||
149877996|NCT00857584|540680935|FG000|Overall Study|Physician Decision|1|||
149877997|NCT00857584|540680936|FG001|Overall Study|Physician Decision|1|||
149877998|NCT01102374|540680937|FG000|Overall Study|Death|9|||
149877999|NCT01102374|540680938|FG001|Overall Study|Death|13|||
149878000|NCT01102374|540680937|FG000|Overall Study|Lost to Follow-up|7|||
149878001|NCT01102374|540680938|FG001|Overall Study|Lost to Follow-up|6|||
149878002|NCT00658021|540680941|FG000|28-Week Treatment Period|Adverse Event|3|||
149878003|NCT00658021|540680942|FG001|28-Week Treatment Period|Adverse Event|1|||
149878004|NCT00658021|540680943|FG002|28-Week Treatment Period|Adverse Event|0|||
149878005|NCT00658021|540680941|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
149878006|NCT00658021|540680942|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
149878007|NCT00658021|540680943|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
149878008|NCT00658021|540680941|FG000|28-Week Treatment Period|Protocol Violation|0|||
149878009|NCT00658021|540680942|FG001|28-Week Treatment Period|Protocol Violation|2|||
149878010|NCT00658021|540680943|FG002|28-Week Treatment Period|Protocol Violation|1|||
149878011|NCT00658021|540680941|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
149878012|NCT00658021|540680942|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
149878013|NCT00658021|540680943|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
149878014|NCT00658021|540680941|FG000|28-Week Treatment Period|Physician Decision|1|||
149878015|NCT00658021|540680942|FG001|28-Week Treatment Period|Physician Decision|2|||
149878016|NCT00658021|540680943|FG002|28-Week Treatment Period|Physician Decision|1|||
149878017|NCT00658021|540680941|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
149878018|NCT00658021|540680942|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
149878019|NCT00658021|540680943|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
149878020|NCT00658021|540680941|FG000|28-Week Treatment Period|Loss of glucose control|1|||
149878021|NCT00658021|540680942|FG001|28-Week Treatment Period|Loss of glucose control|1|||
149878022|NCT00658021|540680943|FG002|28-Week Treatment Period|Loss of glucose control|10|||
149878023|NCT00658021|540680941|FG000|28-Week Treatment Period|Other|2|||
149878024|NCT00658021|540680942|FG001|28-Week Treatment Period|Other|3|||
149878025|NCT00658021|540680943|FG002|28-Week Treatment Period|Other|1|||
149878026|NCT00658021|540680941|FG000|28-Week Treatment Period|Did not receive treatment|2|||
149878027|NCT00658021|540680942|FG001|28-Week Treatment Period|Did not receive treatment|0|||
149878028|NCT00658021|540680943|FG002|28-Week Treatment Period|Did not receive treatment|0|||
149878029|NCT00658021|540680941|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
149878030|NCT00658021|540680942|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
149878031|NCT00658021|540680943|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
149878032|NCT00658021|540680941|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
149878033|NCT00658021|540680942|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
149878034|NCT00658021|540680943|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
149878035|NCT01806506|540680944|FG000|Overall Study|Lost to Follow-up|2|||
149878036|NCT01806506|540680945|FG001|Overall Study|Lost to Follow-up|1|||
149878037|NCT02542605|540680948|FG000|Part B: Challenge Phase|Sponsor decision|1|||
149878038|NCT02542605|540680949|FG001|Part B: Challenge Phase|Sponsor decision|0|||
149878039|NCT02542605|540680950|FG002|Part B: Challenge Phase|Sponsor decision|0|||
149878040|NCT02542605|540680948|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
149878041|NCT02542605|540680949|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
149878042|NCT02542605|540680950|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
149878043|NCT04324073|540682540|FG000|Overall Study|withdrew consent|0|||
149878044|NCT04324073|540682541|FG001|Overall Study|withdrew consent|4|||
149878045|NCT04324073|540682542|FG002|Overall Study|withdrew consent|2|||
149878046|NCT04324073|540682543|FG003|Overall Study|withdrew consent|8|||
149878047|NCT01924754|540682552|FG000|Overall Study|Lost to Follow-up|1|||
149878048|NCT01924754|540682553|FG001|Overall Study|Lost to Follow-up|2|||
149878049|NCT01924754|540682554|FG002|Overall Study|Lost to Follow-up|1|||
149878050|NCT01924754|540682552|FG000|Overall Study|Pregnancy|0|||
149878051|NCT01924754|540682553|FG001|Overall Study|Pregnancy|1|||
149878052|NCT01924754|540682554|FG002|Overall Study|Pregnancy|2|||
149878053|NCT03132155|540682555|FG000|Overall Study|Lack of Efficacy|6|||
149878054|NCT03132155|540682555|FG000|Overall Study|Lost to Follow-up|1|||
150043433|NCT01076361|541297181|FG000|Overall Study|22 leads were excluded from analysis|21|||
150043434|NCT00750438|541297186|FG000|Overall Study|Protocol Violation|4|||
149878055|NCT03132155|540682555|FG000|Overall Study|Withdrawal by Subject|1|||
149878056|NCT02925403|540682561|FG000|Overall Study|Lost to Follow-up|0|||
149878057|NCT02925403|540682562|FG001|Overall Study|Lost to Follow-up|1|||
149878058|NCT05013008|540682566|FG000|Overall Study|Exclusion from mBFAS|5|||
149878059|NCT05013008|540682567|FG001|Overall Study|Exclusion from mBFAS|25|||
149878060|NCT01443728|540682568|FG000|Overall Study|Lost to Follow-up|2|||
149878061|NCT01443728|540682569|FG001|Overall Study|Lost to Follow-up|0|||
149878062|NCT01443728|540682568|FG000|Overall Study|Withdrawal by Subject|1|||
149878063|NCT01443728|540682569|FG001|Overall Study|Withdrawal by Subject|1|||
149878064|NCT01443728|540682568|FG000|Overall Study|Adverse Event|0|||
149878065|NCT01443728|540682569|FG001|Overall Study|Adverse Event|2|||
149878066|NCT00264550|540682570|FG000|Overall Study|Death|0|||
149878067|NCT00264550|540682571|FG001|Overall Study|Death|3|||
149878068|NCT00264550|540682572|FG002|Overall Study|Death|0|||
149878069|NCT00264550|540682573|FG003|Overall Study|Death|0|||
149878070|NCT00264550|540682570|FG000|Overall Study|Lost to Follow-up|3|||
149878071|NCT00264550|540682571|FG001|Overall Study|Lost to Follow-up|1|||
149878072|NCT00264550|540682572|FG002|Overall Study|Lost to Follow-up|1|||
149878073|NCT00264550|540682573|FG003|Overall Study|Lost to Follow-up|1|||
149878074|NCT00264550|540682570|FG000|Overall Study|Adverse Event|23|||
149878075|NCT00264550|540682571|FG001|Overall Study|Adverse Event|18|||
149878076|NCT00264550|540682572|FG002|Overall Study|Adverse Event|9|||
149878077|NCT00264550|540682573|FG003|Overall Study|Adverse Event|14|||
149878078|NCT00264550|540682570|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149878079|NCT00264550|540682571|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
149878080|NCT00264550|540682572|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
149878081|NCT00264550|540682573|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
149878082|NCT00264550|540682570|FG000|Overall Study|Discontinued oral study agent|0|||
149878083|NCT00264550|540682571|FG001|Overall Study|Discontinued oral study agent|1|||
149878084|NCT00264550|540682572|FG002|Overall Study|Discontinued oral study agent|0|||
149878085|NCT00264550|540682573|FG003|Overall Study|Discontinued oral study agent|0|||
149878086|NCT00264550|540682570|FG000|Overall Study|Other|13|||
149878087|NCT00264550|540682571|FG001|Overall Study|Other|7|||
149878088|NCT00264550|540682572|FG002|Overall Study|Other|3|||
149878089|NCT00264550|540682573|FG003|Overall Study|Other|9|||
149878090|NCT00129389|540682574|FG000|Overall Study|Adverse Event|19|||
149878091|NCT00129389|540682575|FG001|Overall Study|Adverse Event|87|||
149878092|NCT00129389|540682574|FG000|Overall Study|Death|0|||
149878093|NCT00129389|540682575|FG001|Overall Study|Death|1|||
149878094|NCT00129389|540682574|FG000|Overall Study|Lost to Follow-up|2|||
149878095|NCT00129389|540682575|FG001|Overall Study|Lost to Follow-up|1|||
149878096|NCT00129389|540682574|FG000|Overall Study|Physician Decision|0|||
149964253|NCT02579759|541004480|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
149964254|NCT02579759|541004481|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
149964255|NCT02579759|541004482|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
149964256|NCT02579759|541004480|FG000|Overall Study|BfArM hold|13|||
149964257|NCT02579759|541004481|FG001|Overall Study|BfArM hold|12|||
149964258|NCT02579759|541004482|FG002|Overall Study|BfArM hold|12|||
149964259|NCT02579759|541004480|FG000|Overall Study|Sponsor stopped Dose 2|0|||
149964260|NCT02579759|541004481|FG001|Overall Study|Sponsor stopped Dose 2|41|||
149964261|NCT02579759|541004482|FG002|Overall Study|Sponsor stopped Dose 2|0|||
149964262|NCT02579759|541004480|FG000|Overall Study|Non compliance|0|||
149964263|NCT02579759|541004481|FG001|Overall Study|Non compliance|1|||
149964264|NCT02579759|541004482|FG002|Overall Study|Non compliance|0|||
149964265|NCT02579759|541004480|FG000|Overall Study|Pregnancy|0|||
149964266|NCT02579759|541004481|FG001|Overall Study|Pregnancy|1|||
149964267|NCT02579759|541004482|FG002|Overall Study|Pregnancy|0|||
149964268|NCT02579759|541004480|FG000|Overall Study|Inclusion/exclusion criteria|0|||
149964269|NCT02579759|541004481|FG001|Overall Study|Inclusion/exclusion criteria|0|||
149964270|NCT02579759|541004482|FG002|Overall Study|Inclusion/exclusion criteria|1|||
149964271|NCT02579759|541004480|FG000|Overall Study|Adverse Event|4|||
149964272|NCT02579759|541004481|FG001|Overall Study|Adverse Event|3|||
149964273|NCT02579759|541004482|FG002|Overall Study|Adverse Event|1|||
149964274|NCT02579759|541004480|FG000|Overall Study|Withdrawal by Subject|3|||
149964275|NCT02579759|541004481|FG001|Overall Study|Withdrawal by Subject|3|||
149964276|NCT02579759|541004482|FG002|Overall Study|Withdrawal by Subject|5|||
149964277|NCT02579759|541004480|FG000|Overall Study|Lost to Follow-up|2|||
149964278|NCT02579759|541004481|FG001|Overall Study|Lost to Follow-up|2|||
149878097|NCT00129389|540682575|FG001|Overall Study|Physician Decision|4|||
149878098|NCT00129389|540682574|FG000|Overall Study|Protocol Violation|0|||
149878099|NCT00129389|540682575|FG001|Overall Study|Protocol Violation|6|||
149878100|NCT00129389|540682574|FG000|Overall Study|Withdrawal by Subject|9|||
149878101|NCT00129389|540682575|FG001|Overall Study|Withdrawal by Subject|23|||
149878102|NCT00129389|540682574|FG000|Overall Study|Relapse|1|||
149878103|NCT00129389|540682575|FG001|Overall Study|Relapse|0|||
149964279|NCT02579759|541004482|FG002|Overall Study|Lost to Follow-up|2|||
149964280|NCT00770679|541004501|FG000|Overall Study|Lost to Follow-up|3|||
149964281|NCT00770679|541004501|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
149878104|NCT00129389|540682574|FG000|Overall Study|Not eligible|1|||
149878105|NCT00129389|540682575|FG001|Overall Study|Not eligible|2|||
149878106|NCT00129389|540682574|FG000|Overall Study|Crossed to the other arm|1|||
149878107|NCT00129389|540682575|FG001|Overall Study|Crossed to the other arm|16|||
149878108|NCT01831258|540682580|FG000|Overall Study|Withdrawal by Subject|2|||
149878109|NCT01831258|540682581|FG001|Overall Study|Withdrawal by Subject|1|||
149878110|NCT01831258|540682580|FG000|Overall Study|Lost to Follow-up|3|||
149878111|NCT01831258|540682581|FG001|Overall Study|Lost to Follow-up|2|||
149878112|NCT02564887|540682590|FG000|Overall Study|Lost to Follow-up|6|||
149878113|NCT02564887|540682591|FG001|Overall Study|Lost to Follow-up|0|||
149878114|NCT01199016|540682592|FG000|Overall Study|No longer meets eligibility criteria|4|||
149878115|NCT01199016|540682592|FG000|Overall Study|Entrance criteria|5|||
149878116|NCT01199016|540682592|FG000|Overall Study|Protocol Violation|9|||
149878117|NCT01199016|540682592|FG000|Overall Study|Other|13|||
149878118|NCT01199016|540682592|FG000|Overall Study|Withdrawal by Subject|21|||
149878119|NCT01199016|540682592|FG000|Overall Study|Lost to Follow-up|25|||
149878120|NCT02842073|540682603|FG000|Overall Study|Withdrawal by Subject|1|||
149878121|NCT01333397|540682606|FG000|Overall Study|Lost to Follow-up|1|||
149878122|NCT01333397|540682607|FG001|Overall Study|Lost to Follow-up|0|||
149878123|NCT01333397|540682608|FG002|Overall Study|Lost to Follow-up|0|||
149878124|NCT01333397|540682609|FG003|Overall Study|Lost to Follow-up|1|||
149878125|NCT01333397|540682610|FG004|Overall Study|Lost to Follow-up|0|||
149878126|NCT05320887|540682613|FG000|Overall Study|Lost to Follow-up|0|||
149878127|NCT05320887|540682614|FG001|Overall Study|Lost to Follow-up|3|||
149878128|NCT05320887|540682615|FG002|Overall Study|Lost to Follow-up|0|||
149878129|NCT05320887|540682616|FG003|Overall Study|Lost to Follow-up|0|||
149878130|NCT01994850|540682621|FG000|Overall Study|Physician Decision|1|||
149878131|NCT01994850|540682621|FG000|Overall Study|Withdrawal by Subject|1|||
149878132|NCT00182325|540682626|FG000|Overall Study|Lost to Follow-up|7|||
149878133|NCT00182325|540682627|FG001|Overall Study|Lost to Follow-up|7|||
149878134|NCT00182325|540682626|FG000|Overall Study|Miscarriage|5|||
149878135|NCT00182325|540682627|FG001|Overall Study|Miscarriage|3|||
149878136|NCT00182325|540682626|FG000|Overall Study|Did not complete survey|22|||
149964282|NCT01935947|541004509|FG000|Overall Study|Adverse Event|0|||
149964283|NCT01935947|541004510|FG001|Overall Study|Adverse Event|2|||
149964284|NCT01935947|541004511|FG002|Overall Study|Adverse Event|0|||
149964285|NCT01935947|541004509|FG000|Overall Study|Diease Progression|2|||
149964286|NCT01935947|541004510|FG001|Overall Study|Diease Progression|2|||
149964287|NCT01935947|541004511|FG002|Overall Study|Diease Progression|2|||
149964288|NCT01935947|541004509|FG000|Overall Study|Death|1|||
149964289|NCT01935947|541004510|FG001|Overall Study|Death|0|||
149964290|NCT01935947|541004511|FG002|Overall Study|Death|0|||
149964291|NCT00752219|541004512|FG000|Overall Study|Clinical failure|0|||
149964292|NCT00752219|541004513|FG001|Overall Study|Clinical failure|1|||
149964293|NCT00752219|541004512|FG000|Overall Study|Adverse Event|5|||
149964294|NCT00752219|541004513|FG001|Overall Study|Adverse Event|3|||
149964295|NCT00752219|541004512|FG000|Overall Study|Protocol deviation|1|||
149964296|NCT00752219|541004513|FG001|Overall Study|Protocol deviation|0|||
149964297|NCT00752219|541004512|FG000|Overall Study|Lost to Follow-up|1|||
149964298|NCT00752219|541004513|FG001|Overall Study|Lost to Follow-up|2|||
149964299|NCT00752219|541004512|FG000|Overall Study|Randomized but not treated|1|||
149964300|NCT00752219|541004513|FG001|Overall Study|Randomized but not treated|0|||
149964301|NCT00752219|541004512|FG000|Overall Study|Other|3|||
149964302|NCT00752219|541004513|FG001|Overall Study|Other|0|||
149964303|NCT00830336|541004516|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
149964304|NCT00830336|541004517|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
149964305|NCT00867334|541004518|FG000|Overall Study|Withdrawal by Subject|0|||
149964306|NCT00867334|541004519|FG001|Overall Study|Withdrawal by Subject|1|||
149964307|NCT00867334|541004518|FG000|Overall Study|Withdrawal by Subject|1|||
149964308|NCT00867334|541004519|FG001|Overall Study|Withdrawal by Subject|0|||
149964309|NCT00867334|541004518|FG000|Overall Study|Withdrawal by Subject|1|||
149964310|NCT00867334|541004519|FG001|Overall Study|Withdrawal by Subject|0|||
149964311|NCT01148771|541004522|FG000|Washout Period|Withdrawal by Subject|0|||
149964312|NCT01148771|541004523|FG001|Washout Period|Withdrawal by Subject|1|||
149964313|NCT01437189|541004524|FG000|Overall Study|Adverse Event|3|||
149964314|NCT01437189|541004524|FG000|Overall Study|Lack of Efficacy|4|||
149964315|NCT01437189|541004524|FG000|Overall Study|Withdrawal by Subject|8|||
149964316|NCT05463952|541004531|FG000|Treatment|Progressive disease|4|||
149964317|NCT05463952|541004531|FG000|Treatment|Ongoing|2|||
150043435|NCT00750438|541297187|FG001|Overall Study|Protocol Violation|1|||
149878137|NCT00182325|540682627|FG001|Overall Study|Did not complete survey|43|||
149878138|NCT01420965|540682631|FG000|Overall Study|Withdrawal by Subject|1|||
149964318|NCT00595075|541004532|FG000|Overall Study|Withdrawal by Subject|1|||
149964319|NCT00595075|541004533|FG001|Overall Study|Withdrawal by Subject|0|||
149964320|NCT00456365|541004544|FG000|Overall Study|Lost to Follow-up|1|||
149964321|NCT00456365|541004545|FG001|Overall Study|Lost to Follow-up|3|||
149964322|NCT00456365|541004544|FG000|Overall Study|Withdrawal by Subject|4|||
149964323|NCT00456365|541004545|FG001|Overall Study|Withdrawal by Subject|7|||
149878139|NCT01420965|540682632|FG001|Overall Study|Withdrawal by Subject|0|||
149878140|NCT01420965|540682633|FG002|Overall Study|Withdrawal by Subject|0|||
149878141|NCT01420965|540682631|FG000|Overall Study|Adverse Event|0|||
149878142|NCT01420965|540682632|FG001|Overall Study|Adverse Event|1|||
149878143|NCT01420965|540682633|FG002|Overall Study|Adverse Event|0|||
149878144|NCT03485365|540682634|FG000|Overall Study|Protocol Violation|0|||
149878145|NCT03485365|540682635|FG001|Overall Study|Protocol Violation|0|||
149878146|NCT03485365|540682636|FG002|Overall Study|Protocol Violation|0|||
149878147|NCT03485365|540682637|FG003|Overall Study|Protocol Violation|1|||
149878148|NCT03485365|540682638|FG004|Overall Study|Protocol Violation|0|||
149878149|NCT03485365|540682639|FG005|Overall Study|Protocol Violation|0|||
149878150|NCT03485365|540682640|FG006|Overall Study|Protocol Violation|1|||
149878151|NCT03485365|540682641|FG007|Overall Study|Protocol Violation|0|||
149878152|NCT03485365|540682642|FG008|Overall Study|Protocol Violation|0|||
149878153|NCT00205803|540682643|FG000|Infant Series|Lost to Follow-up|10|||
149878154|NCT00205803|540682644|FG001|Infant Series|Lost to Follow-up|4|||
149878155|NCT00205803|540682643|FG000|Infant Series|Withdrawal by Subject|2|||
149878156|NCT00205803|540682644|FG001|Infant Series|Withdrawal by Subject|5|||
149878157|NCT00205803|540682643|FG000|Infant Series|Physician Decision|3|||
149878158|NCT00205803|540682644|FG001|Infant Series|Physician Decision|1|||
149878159|NCT00205803|540682643|FG000|Infant Series|Protocol Violation|1|||
149878160|NCT00205803|540682644|FG001|Infant Series|Protocol Violation|0|||
149878161|NCT00205803|540682643|FG000|Infant Series|Lost Kaiser coverage|0|||
149878162|NCT00205803|540682644|FG001|Infant Series|Lost Kaiser coverage|1|||
149878163|NCT00205803|540682643|FG000|Infant Series|Non-compliant|1|||
149878164|NCT00205803|540682644|FG001|Infant Series|Non-compliant|0|||
149878165|NCT00205803|540682643|FG000|Infant Series|Sponsor request|1|||
149878166|NCT00205803|540682644|FG001|Infant Series|Sponsor request|0|||
149878167|NCT00205803|540682643|FG000|After Infant Series|Adverse Event|1|||
149878168|NCT00205803|540682644|FG001|After Infant Series|Adverse Event|1|||
149878169|NCT00205803|540682643|FG000|After Infant Series|Protocol Violation|1|||
149878170|NCT00205803|540682644|FG001|After Infant Series|Protocol Violation|1|||
149878171|NCT00205803|540682643|FG000|After Infant Series|Lost to Follow-up|2|||
149878172|NCT00205803|540682644|FG001|After Infant Series|Lost to Follow-up|1|||
149878173|NCT00205803|540682643|FG000|After Infant Series|Physician Decision|3|||
149878174|NCT00205803|540682644|FG001|After Infant Series|Physician Decision|2|||
149878175|NCT00205803|540682643|FG000|After Infant Series|Withdrawal by Subject|1|||
149878176|NCT00205803|540682644|FG001|After Infant Series|Withdrawal by Subject|4|||
149878177|NCT00205803|540682643|FG000|After Infant Series|Other|10|||
149878178|NCT00205803|540682644|FG001|After Infant Series|Other|4|||
149878179|NCT00205803|540682643|FG000|Toddler Dose|Lost to Follow-up|2|||
149878180|NCT00205803|540682644|FG001|Toddler Dose|Lost to Follow-up|3|||
149878181|NCT01104792|540682648|FG000|Overall Study|Adverse Event|77|||
149878182|NCT01104792|540682648|FG000|Overall Study|Insufficient Therapeutic Response|22|||
149878183|NCT01104792|540682648|FG000|Overall Study|Protocol Violation|45|||
149878184|NCT01104792|540682648|FG000|Overall Study|Withdrawal of Consent|179|||
149878185|NCT01104792|540682648|FG000|Overall Study|Lost to Follow-up|43|||
149878186|NCT01104792|540682648|FG000|Overall Study|Reasons Not Specified|27|||
149878187|NCT01104792|540682648|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
149878188|NCT03255655|540682649|FG000|Overall Study|Lost to Follow-up|7|||
149878189|NCT03255655|540682650|FG001|Overall Study|Lost to Follow-up|4|||
149878190|NCT02056392|540682651|FG000|Overall Study|Lost to Follow-up|0|||
149878191|NCT02056392|540682652|FG001|Overall Study|Lost to Follow-up|1|||
149878192|NCT02056392|540682653|FG002|Overall Study|Lost to Follow-up|2|||
149878193|NCT02056392|540682654|FG003|Overall Study|Lost to Follow-up|0|||
149878194|NCT02056392|540682655|FG004|Overall Study|Lost to Follow-up|0|||
149878195|NCT02056392|540682656|FG005|Overall Study|Lost to Follow-up|0|||
149878196|NCT02056392|540682651|FG000|Overall Study|Protocol Violation|1|||
149878197|NCT02056392|540682652|FG001|Overall Study|Protocol Violation|0|||
149878198|NCT02056392|540682653|FG002|Overall Study|Protocol Violation|1|||
149878199|NCT02056392|540682654|FG003|Overall Study|Protocol Violation|0|||
149878200|NCT02056392|540682655|FG004|Overall Study|Protocol Violation|0|||
150174441|NCT00723450|541774457|FG000|Randomized Phase|Protocol Violation|0|||
149878201|NCT02056392|540682656|FG005|Overall Study|Protocol Violation|0|||
149878202|NCT02056392|540682651|FG000|Overall Study|Withdrawal by Subject|1|||
149878203|NCT02056392|540682652|FG001|Overall Study|Withdrawal by Subject|0|||
149878204|NCT02056392|540682653|FG002|Overall Study|Withdrawal by Subject|0|||
149878205|NCT02056392|540682654|FG003|Overall Study|Withdrawal by Subject|0|||
149878206|NCT02056392|540682655|FG004|Overall Study|Withdrawal by Subject|1|||
149878207|NCT02056392|540682656|FG005|Overall Study|Withdrawal by Subject|0|||
149878208|NCT05819203|540682663|FG000|Overall Study|Protocol Violation|1|||
149878209|NCT05819203|540682664|FG001|Overall Study|Protocol Violation|2|||
149878210|NCT05819203|540682663|FG000|Overall Study|Withdrawal by Subject|1|||
149878211|NCT05819203|540682664|FG001|Overall Study|Withdrawal by Subject|0|||
149878212|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
149878213|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
149878214|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878215|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878216|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878217|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878218|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878219|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878220|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878221|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
149878222|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
149878223|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
149878224|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878225|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878226|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878227|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878228|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878229|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878230|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878231|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149878232|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878233|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
149878234|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878235|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878236|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878237|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878238|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878239|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878240|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878241|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
149878242|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
149878243|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878244|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878245|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878246|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878247|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878248|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878249|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878250|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878251|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
149878252|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
149878253|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
150043436|NCT00750438|541297186|FG000|Overall Study|Physician Decision|2|||
150043437|NCT00750438|541297187|FG001|Overall Study|Physician Decision|2|||
150043438|NCT00750438|541297186|FG000|Overall Study|Withdrawal by Subject|1|||
150043439|NCT00750438|541297187|FG001|Overall Study|Withdrawal by Subject|1|||
150043440|NCT00787644|541297188|FG000|Overall Study|Lost to Follow-up|1|||
150043441|NCT00787644|541297189|FG001|Overall Study|Lost to Follow-up|1|||
150043442|NCT00787644|541297188|FG000|Overall Study|Withdrawal by Subject|1|||
150043443|NCT00787644|541297189|FG001|Overall Study|Withdrawal by Subject|1|||
150043444|NCT01642589|541297193|FG000|Overall Study|Withdrawal by Subject|1|||
150043445|NCT01642589|541297194|FG001|Overall Study|Withdrawal by Subject|1|||
150043446|NCT02736578|541297197|FG000|Overall Study|Adverse Event|1|||
150043447|NCT02736578|541297198|FG001|Overall Study|Adverse Event|0|||
150043448|NCT01442103|541298618|FG000|Overall Study|Lost to Follow-up|2|||
150043449|NCT00807001|541298626|FG000|Overall Study|Non-compliance|0|||
150043450|NCT00807001|541298627|FG001|Overall Study|Non-compliance|1|||
150043451|NCT00807001|541298628|FG002|Overall Study|Non-compliance|0|||
150043452|NCT00807001|541298629|FG003|Overall Study|Non-compliance|0|||
150043453|NCT00807001|541298630|FG004|Overall Study|Non-compliance|0|||
150043454|NCT02269267|541298644|FG000|Overall Study|Death|5|||
150043455|NCT03773796|541298645|FG000|Overall Study|Adverse Event|1|||
149878254|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878255|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878256|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878257|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878258|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878259|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878260|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878261|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
149878262|NCT04784533|540682667|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
149878263|NCT04784533|540682668|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
149878264|NCT04784533|540682669|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878265|NCT04784533|540682670|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878266|NCT04784533|540682671|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878267|NCT04784533|540682672|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878268|NCT04784533|540682673|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878269|NCT04784533|540682674|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878270|NCT04784533|540682675|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878271|NCT04784533|540682676|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
149878272|NCT04784533|540682667|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878273|NCT04784533|540682668|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878274|NCT04784533|540682669|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
149878275|NCT04784533|540682670|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878276|NCT04784533|540682671|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878277|NCT04784533|540682672|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878278|NCT04784533|540682673|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878279|NCT04784533|540682674|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878280|NCT04784533|540682675|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878281|NCT04784533|540682676|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
149878282|NCT04784533|540682667|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878283|NCT04784533|540682668|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878284|NCT04784533|540682669|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878285|NCT04784533|540682670|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878286|NCT04784533|540682671|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878287|NCT04784533|540682672|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878288|NCT04784533|540682673|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878289|NCT04784533|540682674|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878290|NCT04784533|540682675|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
149878291|NCT04784533|540682676|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
149878292|NCT04784533|540682667|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878293|NCT04784533|540682668|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878294|NCT04784533|540682669|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878295|NCT04784533|540682670|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878296|NCT04784533|540682671|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878297|NCT04784533|540682672|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878298|NCT04784533|540682673|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878299|NCT04784533|540682674|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
149878300|NCT04784533|540682675|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
149878301|NCT04784533|540682676|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
149878302|NCT04123561|540682681|FG000|Overall Study|Lost to Follow-up|20|||
149878303|NCT04123561|540682682|FG001|Overall Study|Lost to Follow-up|12|||
149878304|NCT04123561|540682683|FG002|Overall Study|Lost to Follow-up|5|||
149878305|NCT04123561|540682681|FG000|Overall Study|Withdrawal by Subject|9|||
149878306|NCT04123561|540682682|FG001|Overall Study|Withdrawal by Subject|7|||
149878307|NCT04123561|540682683|FG002|Overall Study|Withdrawal by Subject|9|||
149878308|NCT04123561|540682681|FG000|Overall Study|Lack of Efficacy|7|||
149878309|NCT04123561|540682682|FG001|Overall Study|Lack of Efficacy|8|||
149964324|NCT00456365|541004544|FG000|Overall Study|Pregnancy|1|||
149964325|NCT00456365|541004545|FG001|Overall Study|Pregnancy|1|||
149964326|NCT00456365|541004544|FG000|Overall Study|oncologic diagnosis|1|||
149964327|NCT00456365|541004545|FG001|Overall Study|oncologic diagnosis|1|||
149964328|NCT03579719|541004547|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
149964329|NCT04525183|541004548|FG000|Overall Study|Withdrawal by Subject|0|||
149964330|NCT04525183|541004549|FG001|Overall Study|Withdrawal by Subject|0|||
149878310|NCT04123561|540682683|FG002|Overall Study|Lack of Efficacy|6|||
149878311|NCT04123561|540682681|FG000|Overall Study|Adverse Event|5|||
149878312|NCT04123561|540682682|FG001|Overall Study|Adverse Event|2|||
149878313|NCT04123561|540682683|FG002|Overall Study|Adverse Event|3|||
149878314|NCT04123561|540682681|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
149964331|NCT04525183|541004550|FG002|Overall Study|Withdrawal by Subject|3|||
149964332|NCT04525183|541004548|FG000|Overall Study|Study non-compliance|0|||
149878315|NCT04123561|540682682|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
149878316|NCT04123561|540682683|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
149878317|NCT04123561|540682681|FG000|Overall Study|Death|0|||
149878318|NCT04123561|540682682|FG001|Overall Study|Death|0|||
149878319|NCT04123561|540682683|FG002|Overall Study|Death|1|||
149878320|NCT04123561|540682681|FG000|Overall Study|Protocol Violation|0|||
149878321|NCT04123561|540682682|FG001|Overall Study|Protocol Violation|1|||
149878322|NCT04123561|540682683|FG002|Overall Study|Protocol Violation|0|||
149878323|NCT02203331|540682688|FG000|Overall Study|Pregnancy|1|||
149878324|NCT02203331|540682689|FG001|Overall Study|Pregnancy|0|||
149878325|NCT02203331|540682690|FG002|Overall Study|Pregnancy|0|||
149878326|NCT02203331|540682691|FG003|Overall Study|Pregnancy|0|||
149878327|NCT02203331|540682692|FG004|Overall Study|Pregnancy|2|||
149878328|NCT02203331|540682693|FG005|Overall Study|Pregnancy|0|||
149878329|NCT02203331|540682688|FG000|Overall Study|Withdrawal by Subject|1|||
149878330|NCT02203331|540682689|FG001|Overall Study|Withdrawal by Subject|0|||
149878331|NCT02203331|540682690|FG002|Overall Study|Withdrawal by Subject|1|||
149878332|NCT02203331|540682691|FG003|Overall Study|Withdrawal by Subject|0|||
149878333|NCT02203331|540682692|FG004|Overall Study|Withdrawal by Subject|0|||
149878334|NCT02203331|540682693|FG005|Overall Study|Withdrawal by Subject|3|||
149878335|NCT02203331|540682688|FG000|Overall Study|Adverse Event|4|||
149878336|NCT02203331|540682689|FG001|Overall Study|Adverse Event|8|||
149878337|NCT02203331|540682690|FG002|Overall Study|Adverse Event|3|||
149878338|NCT02203331|540682691|FG003|Overall Study|Adverse Event|4|||
149878339|NCT02203331|540682692|FG004|Overall Study|Adverse Event|3|||
149878340|NCT02203331|540682693|FG005|Overall Study|Adverse Event|3|||
149878341|NCT02203331|540682688|FG000|Overall Study|Other Reasons|1|||
149878342|NCT02203331|540682689|FG001|Overall Study|Other Reasons|2|||
149878343|NCT02203331|540682690|FG002|Overall Study|Other Reasons|0|||
149878344|NCT02203331|540682691|FG003|Overall Study|Other Reasons|2|||
149878345|NCT02203331|540682692|FG004|Overall Study|Other Reasons|0|||
149878346|NCT02203331|540682693|FG005|Overall Study|Other Reasons|0|||
149878347|NCT02203331|540682688|FG000|Overall Study|Lack of Efficacy|0|||
149878348|NCT02203331|540682689|FG001|Overall Study|Lack of Efficacy|2|||
149878349|NCT02203331|540682690|FG002|Overall Study|Lack of Efficacy|1|||
149878350|NCT02203331|540682691|FG003|Overall Study|Lack of Efficacy|0|||
149878351|NCT02203331|540682692|FG004|Overall Study|Lack of Efficacy|0|||
149878352|NCT02203331|540682693|FG005|Overall Study|Lack of Efficacy|1|||
149878353|NCT02203331|540682688|FG000|Overall Study|Protocol Violation|0|||
149878354|NCT02203331|540682689|FG001|Overall Study|Protocol Violation|2|||
149878355|NCT02203331|540682690|FG002|Overall Study|Protocol Violation|0|||
149878356|NCT02203331|540682691|FG003|Overall Study|Protocol Violation|1|||
149878357|NCT02203331|540682692|FG004|Overall Study|Protocol Violation|1|||
149878358|NCT02203331|540682693|FG005|Overall Study|Protocol Violation|0|||
149878359|NCT02203331|540682688|FG000|Overall Study|Lost to Follow-up|0|||
149878360|NCT02203331|540682689|FG001|Overall Study|Lost to Follow-up|0|||
149878361|NCT02203331|540682690|FG002|Overall Study|Lost to Follow-up|0|||
149878362|NCT02203331|540682691|FG003|Overall Study|Lost to Follow-up|0|||
149878363|NCT02203331|540682692|FG004|Overall Study|Lost to Follow-up|1|||
149878364|NCT02203331|540682693|FG005|Overall Study|Lost to Follow-up|0|||
149878365|NCT02682927|540682703|FG000|Overall Study|Adverse Event|0|||
149878366|NCT02682927|540682704|FG001|Overall Study|Adverse Event|0|||
149878367|NCT02682927|540682705|FG002|Overall Study|Adverse Event|5|||
149878368|NCT02682927|540682706|FG003|Overall Study|Adverse Event|1|||
149878369|NCT02682927|540682707|FG004|Overall Study|Adverse Event|0|||
149878370|NCT02682927|540682708|FG005|Overall Study|Adverse Event|2|||
149878371|NCT02682927|540682703|FG000|Overall Study|Death|0|||
149964333|NCT04525183|541004549|FG001|Overall Study|Study non-compliance|0|||
149878372|NCT02682927|540682704|FG001|Overall Study|Death|0|||
149878373|NCT02682927|540682705|FG002|Overall Study|Death|0|||
149878374|NCT02682927|540682706|FG003|Overall Study|Death|1|||
149878375|NCT02682927|540682707|FG004|Overall Study|Death|0|||
149878376|NCT02682927|540682708|FG005|Overall Study|Death|0|||
149878377|NCT02682927|540682703|FG000|Overall Study|Lack of Efficacy|1|||
149878378|NCT02682927|540682704|FG001|Overall Study|Lack of Efficacy|0|||
149878379|NCT02682927|540682705|FG002|Overall Study|Lack of Efficacy|0|||
149878380|NCT02682927|540682706|FG003|Overall Study|Lack of Efficacy|1|||
149878381|NCT02682927|540682707|FG004|Overall Study|Lack of Efficacy|0|||
149878382|NCT02682927|540682708|FG005|Overall Study|Lack of Efficacy|0|||
149964334|NCT04525183|541004550|FG002|Overall Study|Study non-compliance|1|||
149964335|NCT04525183|541004548|FG000|Overall Study|Recurrent disease before starting on study|0|||
149878383|NCT02682927|540682703|FG000|Overall Study|Other|0|||
149878384|NCT02682927|540682704|FG001|Overall Study|Other|0|||
149878385|NCT02682927|540682705|FG002|Overall Study|Other|0|||
149878386|NCT02682927|540682706|FG003|Overall Study|Other|2|||
149878387|NCT02682927|540682707|FG004|Overall Study|Other|0|||
149878388|NCT02682927|540682708|FG005|Overall Study|Other|0|||
149878389|NCT02682927|540682703|FG000|Overall Study|Withdrawal by Subject|2|||
149878390|NCT02682927|540682704|FG001|Overall Study|Withdrawal by Subject|0|||
149878391|NCT02682927|540682705|FG002|Overall Study|Withdrawal by Subject|1|||
149878392|NCT02682927|540682706|FG003|Overall Study|Withdrawal by Subject|0|||
149878393|NCT02682927|540682707|FG004|Overall Study|Withdrawal by Subject|1|||
149878394|NCT02682927|540682708|FG005|Overall Study|Withdrawal by Subject|1|||
149878395|NCT03462459|540682712|FG000|Overall Study|Death|1|||
149878396|NCT03462459|540682713|FG001|Overall Study|Death|0|||
149878397|NCT03462459|540682712|FG000|Overall Study|Lack of Efficacy|2|||
149878398|NCT03462459|540682713|FG001|Overall Study|Lack of Efficacy|4|||
149878399|NCT03462459|540682712|FG000|Overall Study|Lost to Follow-up|1|||
149878400|NCT03462459|540682713|FG001|Overall Study|Lost to Follow-up|3|||
149878401|NCT03462459|540682712|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
149878402|NCT03462459|540682713|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
149878403|NCT03462459|540682712|FG000|Overall Study|Withdrawal by Subject|3|||
149878404|NCT03462459|540682713|FG001|Overall Study|Withdrawal by Subject|2|||
149878405|NCT03462459|540682712|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
149878406|NCT03462459|540682713|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
149878407|NCT02551666|540682715|FG000|Overall Study|Withdrawal by Subject|1|||
149878408|NCT02551666|540682716|FG001|Overall Study|Withdrawal by Subject|3|||
149878409|NCT01177059|540682717|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
149878410|NCT01177059|540682717|FG000|Overall Study|Withdrew consent|2|||
149878411|NCT01177059|540682717|FG000|Overall Study|Lost to Follow-up|18|||
149878412|NCT05833139|540684190|FG000|Study Period 2|Adverse Event|1|||
149878413|NCT00369486|540684195|FG000|4-Week Visit|Missed visit|2|||
149878414|NCT00369486|540684196|FG001|4-Week Visit|Missed visit|2|||
149878415|NCT00369486|540684197|FG002|4-Week Visit|Missed visit|0|||
149878416|NCT00369486|540684198|FG003|4-Week Visit|Missed visit|2|||
149878417|NCT00369486|540684199|FG004|4-Week Visit|Missed visit|1|||
149878418|NCT00369486|540684195|FG000|4-Week Visit|Dropped|0|||
149878419|NCT00369486|540684196|FG001|4-Week Visit|Dropped|0|||
149878420|NCT00369486|540684197|FG002|4-Week Visit|Dropped|1|||
149878421|NCT00369486|540684198|FG003|4-Week Visit|Dropped|0|||
149878422|NCT00369486|540684199|FG004|4-Week Visit|Dropped|0|||
149878423|NCT00369486|540684195|FG000|8-Week Visit|Missed visit|0|||
149878424|NCT00369486|540684196|FG001|8-Week Visit|Missed visit|1|||
149878425|NCT00369486|540684197|FG002|8-Week Visit|Missed visit|0|||
149878426|NCT00369486|540684198|FG003|8-Week Visit|Missed visit|0|||
149878427|NCT00369486|540684199|FG004|8-Week Visit|Missed visit|1|||
149878428|NCT00369486|540684195|FG000|8-Week Visit|Dropped|0|||
149878429|NCT00369486|540684196|FG001|8-Week Visit|Dropped|0|||
149878430|NCT00369486|540684197|FG002|8-Week Visit|Dropped|0|||
149878431|NCT00369486|540684198|FG003|8-Week Visit|Dropped|1|||
149878432|NCT00369486|540684199|FG004|8-Week Visit|Dropped|0|||
149878433|NCT00369486|540684195|FG000|17-Week Visit|Missed visit|0|||
149878434|NCT00369486|540684196|FG001|17-Week Visit|Missed visit|0|||
149878435|NCT00369486|540684197|FG002|17-Week Visit|Missed visit|1|||
149878436|NCT00369486|540684198|FG003|17-Week Visit|Missed visit|1|||
149878437|NCT00369486|540684199|FG004|17-Week Visit|Missed visit|1|||
149878438|NCT00369486|540684195|FG000|34-Week Visit|Dropped|0|||
149878439|NCT00369486|540684196|FG001|34-Week Visit|Dropped|1|||
149878440|NCT00369486|540684197|FG002|34-Week Visit|Dropped|1|||
149878441|NCT00369486|540684198|FG003|34-Week Visit|Dropped|3|||
149878442|NCT00369486|540684199|FG004|34-Week Visit|Dropped|3|||
149878443|NCT04981717|540684200|FG000|Overall Study|Protocol Violation|0|||
149878444|NCT04981717|540684201|FG001|Overall Study|Protocol Violation|3|||
149878445|NCT04981717|540684200|FG000|Overall Study|Adverse Event|1|||
149878446|NCT04981717|540684201|FG001|Overall Study|Adverse Event|3|||
149878447|NCT04981717|540684200|FG000|Overall Study|Pregnancy|1|||
149878448|NCT04981717|540684201|FG001|Overall Study|Pregnancy|0|||
149878449|NCT04981717|540684200|FG000|Overall Study|Physician Decision|1|||
149878450|NCT04981717|540684201|FG001|Overall Study|Physician Decision|0|||
149878451|NCT04981717|540684200|FG000|Overall Study|Sponsor Request|157|||
149878452|NCT04981717|540684201|FG001|Overall Study|Sponsor Request|172|||
149878453|NCT04981717|540684200|FG000|Overall Study|Lost to Follow-up|4|||
149878454|NCT04981717|540684201|FG001|Overall Study|Lost to Follow-up|5|||
149878455|NCT04981717|540684200|FG000|Overall Study|Withdrawal by Subject|50|||
149878456|NCT04981717|540684201|FG001|Overall Study|Withdrawal by Subject|37|||
149878457|NCT00974922|540684202|FG000|Overall Study|study terminated|24|||
149878458|NCT00287586|540684203|FG000|Overall Study|Withdrew Consent|19|||
149878459|NCT00287586|540684204|FG001|Overall Study|Withdrew Consent|30|||
149878460|NCT00287586|540684203|FG000|Overall Study|Lost to Follow-up|5|||
149878461|NCT00287586|540684204|FG001|Overall Study|Lost to Follow-up|4|||
149878462|NCT00287586|540684203|FG000|Overall Study|Death|2|||
149878463|NCT00287586|540684204|FG001|Overall Study|Death|3|||
149878464|NCT00287586|540684203|FG000|Overall Study|Elevated Hematocrit|3|||
149878465|NCT00287586|540684204|FG001|Overall Study|Elevated Hematocrit|0|||
149878466|NCT00287586|540684203|FG000|Overall Study|Rash|3|||
149878467|NCT00287586|540684204|FG001|Overall Study|Rash|0|||
149878468|NCT00287586|540684203|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
149878469|NCT00287586|540684204|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
149878470|NCT00287586|540684203|FG000|Overall Study|Stroke|2|||
149878471|NCT00287586|540684204|FG001|Overall Study|Stroke|0|||
149878472|NCT00287586|540684203|FG000|Overall Study|Myocardial Infarction|1|||
149878473|NCT00287586|540684204|FG001|Overall Study|Myocardial Infarction|0|||
149878474|NCT00287586|540684203|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
149878475|NCT00287586|540684204|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
149878476|NCT00287586|540684203|FG000|Overall Study|Cognitive Impairment|1|||
149878477|NCT00287586|540684204|FG001|Overall Study|Cognitive Impairment|0|||
149878478|NCT00287586|540684203|FG000|Overall Study|Pancreatic Cancer|1|||
149878479|NCT00287586|540684204|FG001|Overall Study|Pancreatic Cancer|3|||
149878480|NCT00287586|540684203|FG000|Overall Study|Sleep Apnea|1|||
149878481|NCT00287586|540684204|FG001|Overall Study|Sleep Apnea|0|||
149878482|NCT00287586|540684203|FG000|Overall Study|Shoulder Pain|1|||
149878483|NCT00287586|540684204|FG001|Overall Study|Shoulder Pain|0|||
149878484|NCT00287586|540684203|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
149878485|NCT00287586|540684204|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
149878486|NCT00287586|540684203|FG000|Overall Study|Nonadherence|1|||
149878487|NCT00287586|540684204|FG001|Overall Study|Nonadherence|1|||
149878488|NCT00287586|540684203|FG000|Overall Study|Enrolled in Another Study|1|||
149878489|NCT00287586|540684204|FG001|Overall Study|Enrolled in Another Study|0|||
149878490|NCT00287586|540684203|FG000|Overall Study|Major Depression|0|||
149878491|NCT00287586|540684204|FG001|Overall Study|Major Depression|2|||
149878492|NCT00287586|540684203|FG000|Overall Study|Lung Cancer|0|||
149878493|NCT00287586|540684204|FG001|Overall Study|Lung Cancer|2|||
149878494|NCT00287586|540684203|FG000|Overall Study|Elevated IPSS Score|0|||
149878495|NCT00287586|540684204|FG001|Overall Study|Elevated IPSS Score|1|||
149878496|NCT00287586|540684203|FG000|Overall Study|Retroperitoneal Cancer|0|||
149878497|NCT00287586|540684204|FG001|Overall Study|Retroperitoneal Cancer|1|||
149878498|NCT00287586|540684203|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
149878499|NCT00287586|540684204|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
149878500|NCT00287586|540684203|FG000|Overall Study|Mood Swings and Irritability|0|||
149878501|NCT00287586|540684204|FG001|Overall Study|Mood Swings and Irritability|1|||
149878502|NCT00287586|540684203|FG000|Overall Study|Bradycardia|0|||
149878503|NCT00287586|540684204|FG001|Overall Study|Bradycardia|1|||
149878504|NCT00287586|540684203|FG000|Overall Study|Itchy Swollen Eyes|0|||
149878505|NCT00287586|540684204|FG001|Overall Study|Itchy Swollen Eyes|1|||
149964336|NCT04525183|541004549|FG001|Overall Study|Recurrent disease before starting on study|0|||
149964337|NCT04525183|541004550|FG002|Overall Study|Recurrent disease before starting on study|1|||
149964338|NCT01166646|541004551|FG000|Overall Study|Protocol Violation|0|||
149964339|NCT01166646|541004552|FG001|Overall Study|Protocol Violation|1|||
149964340|NCT01166646|541004551|FG000|Overall Study|Adverse Event|1|||
149964341|NCT01166646|541004552|FG001|Overall Study|Adverse Event|0|||
149878506|NCT00287586|540684203|FG000|Overall Study|Recurrent Melanoma|0|||
149878507|NCT00287586|540684204|FG001|Overall Study|Recurrent Melanoma|1|||
149878508|NCT02640482|540684206|FG000|Overall Study|Lost to Follow-up|3|||
149878509|NCT02640482|540684207|FG001|Overall Study|Lost to Follow-up|0|||
149878510|NCT00517881|540684208|FG000|Overall Study|Protocol Violation|2|||
149878511|NCT00517881|540684208|FG000|Overall Study|Adverse Event|1|||
149878512|NCT00517881|540684208|FG000|Overall Study|Renal transplantation|2|||
149878513|NCT00113763|540684209|FG000|Overall Study|Adverse Event|5|||
149878514|NCT00113763|540684210|FG001|Overall Study|Adverse Event|2|||
149878515|NCT00113763|540684209|FG000|Overall Study|Disease Progression|28|||
149878516|NCT00113763|540684210|FG001|Overall Study|Disease Progression|14|||
149878517|NCT00113763|540684209|FG000|Overall Study|Lost to Follow-up|10|||
149878518|NCT00113763|540684210|FG001|Overall Study|Lost to Follow-up|0|||
149878519|NCT00113763|540684209|FG000|Overall Study|Withdrawal by Subject|1|||
149878520|NCT00113763|540684210|FG001|Overall Study|Withdrawal by Subject|4|||
149964342|NCT01335685|541004555|FG000|Overall Study|Study Terminated by Sponsor|2|||
149964343|NCT01335685|541004556|FG001|Overall Study|Study Terminated by Sponsor|1|||
149878521|NCT00113763|540684209|FG000|Overall Study|Other|27|||
149878522|NCT00113763|540684210|FG001|Overall Study|Other|6|||
149878523|NCT00113763|540684209|FG000|Overall Study|Non-compliance|1|||
149878524|NCT00113763|540684210|FG001|Overall Study|Non-compliance|0|||
149878525|NCT00113763|540684209|FG000|Overall Study|Ongoing|1|||
149878526|NCT00113763|540684210|FG001|Overall Study|Ongoing|0|||
149878527|NCT03743415|540684211|FG000|Overall Study|Death|5|||
149878528|NCT03743415|540684212|FG001|Overall Study|Death|3|||
149878529|NCT03743415|540684213|FG002|Overall Study|Death|1|||
149878530|NCT03743415|540684214|FG003|Overall Study|Death|4|||
149878531|NCT03743415|540684215|FG004|Overall Study|Death|0|||
149878532|NCT03743415|540684216|FG005|Overall Study|Death|0|||
149878533|NCT03743415|540684217|FG006|Overall Study|Death|0|||
149878534|NCT03743415|540684218|FG007|Overall Study|Death|0|||
149878535|NCT03743415|540684219|FG008|Overall Study|Death|1|||
149964344|NCT01335685|541004557|FG002|Overall Study|Study Terminated by Sponsor|1|||
149964345|NCT01335685|541004558|FG003|Overall Study|Study Terminated by Sponsor|10|||
149964346|NCT01335685|541004559|FG004|Overall Study|Study Terminated by Sponsor|0|||
149964347|NCT01335685|541004560|FG005|Overall Study|Study Terminated by Sponsor|4|||
149964348|NCT01335685|541004561|FG006|Overall Study|Study Terminated by Sponsor|2|||
149964349|NCT01335685|541004562|FG007|Overall Study|Study Terminated by Sponsor|3|||
149878536|NCT03743415|540684220|FG009|Overall Study|Death|0|||
149878537|NCT03743415|540684211|FG000|Overall Study|Withdrawal by Subject|1|||
149878538|NCT03743415|540684212|FG001|Overall Study|Withdrawal by Subject|0|||
149878539|NCT03743415|540684213|FG002|Overall Study|Withdrawal by Subject|4|||
149878540|NCT03743415|540684214|FG003|Overall Study|Withdrawal by Subject|5|||
149878541|NCT03743415|540684215|FG004|Overall Study|Withdrawal by Subject|5|||
149878542|NCT03743415|540684216|FG005|Overall Study|Withdrawal by Subject|2|||
149878543|NCT03743415|540684217|FG006|Overall Study|Withdrawal by Subject|2|||
149878544|NCT03743415|540684218|FG007|Overall Study|Withdrawal by Subject|5|||
149878545|NCT03743415|540684219|FG008|Overall Study|Withdrawal by Subject|9|||
149878546|NCT03743415|540684220|FG009|Overall Study|Withdrawal by Subject|10|||
149878547|NCT03743415|540684211|FG000|Overall Study|Lost to Follow-up|2|||
149878548|NCT03743415|540684212|FG001|Overall Study|Lost to Follow-up|0|||
149878549|NCT03743415|540684213|FG002|Overall Study|Lost to Follow-up|2|||
149878550|NCT03743415|540684214|FG003|Overall Study|Lost to Follow-up|1|||
149878551|NCT03743415|540684215|FG004|Overall Study|Lost to Follow-up|1|||
149878552|NCT03743415|540684216|FG005|Overall Study|Lost to Follow-up|0|||
149878553|NCT03743415|540684217|FG006|Overall Study|Lost to Follow-up|1|||
149878554|NCT03743415|540684218|FG007|Overall Study|Lost to Follow-up|4|||
149878555|NCT03743415|540684219|FG008|Overall Study|Lost to Follow-up|13|||
149878556|NCT03743415|540684220|FG009|Overall Study|Lost to Follow-up|13|||
149878557|NCT00094861|540684223|FG000|Overall Study|Adverse Event|5|||
149878558|NCT00094861|540684224|FG001|Overall Study|Adverse Event|2|||
149878559|NCT00094861|540684223|FG000|Overall Study|Withdrawal by Subject|5|||
149878560|NCT00094861|540684224|FG001|Overall Study|Withdrawal by Subject|3|||
149878561|NCT00094861|540684223|FG000|Overall Study|Physician Decision|1|||
149878562|NCT00094861|540684224|FG001|Overall Study|Physician Decision|1|||
149878563|NCT00094861|540684223|FG000|Overall Study|Lost to Follow-up|0|||
149878564|NCT00094861|540684224|FG001|Overall Study|Lost to Follow-up|1|||
149878565|NCT00094861|540684223|FG000|Overall Study|Death|4|||
149878566|NCT00094861|540684224|FG001|Overall Study|Death|2|||
149878567|NCT00094861|540684223|FG000|Overall Study|Other|3|||
149878568|NCT00094861|540684224|FG001|Overall Study|Other|0|||
149878569|NCT02540850|540684225|FG000|Overall Study|Lost to Follow-up|69|||
149878570|NCT02540850|540684226|FG001|Overall Study|Lost to Follow-up|66|||
149878571|NCT02540850|540684227|FG002|Overall Study|Lost to Follow-up|34|||
149878572|NCT00576316|540684232|FG000|Overall Study|Adverse Event|9|||
149878573|NCT00576316|540684232|FG000|Overall Study|Withdrawal by Subject|2|||
149878574|NCT00576316|540684232|FG000|Overall Study|Protocol Violation|9|||
149878575|NCT02794246|540684235|FG000|Overall Study|Withdrawal by Subject|2|||
149878576|NCT02794246|540684235|FG000|Overall Study|Physician Decision|4|||
149878577|NCT00253448|540684238|FG000|Overall Study|Withdrawal by Subject|1|||
149878578|NCT02052011|540684240|FG000|Overall Study|Lost to Follow-up|3|||
149878579|NCT02052011|540684241|FG001|Overall Study|Lost to Follow-up|0|||
149878580|NCT02052011|540684240|FG000|Overall Study|Withdrawal by Subject|1|||
149878581|NCT02052011|540684241|FG001|Overall Study|Withdrawal by Subject|2|||
149878582|NCT00000620|540684242|FG000|Overall Study|Death|86|||
149878583|NCT00000620|540684243|FG001|Overall Study|Death|67|||
149878584|NCT00000620|540684244|FG002|Overall Study|Death|112|||
149878585|NCT00000620|540684245|FG003|Overall Study|Death|126|||
149878586|NCT00000620|540684246|FG004|Overall Study|Death|64|||
149878587|NCT00000620|540684247|FG005|Overall Study|Death|77|||
149878588|NCT00000620|540684248|FG006|Overall Study|Death|91|||
149878589|NCT00000620|540684249|FG007|Overall Study|Death|95|||
149878590|NCT00000620|540684242|FG000|Overall Study|Lost to Follow-up|14|||
149878591|NCT00000620|540684243|FG001|Overall Study|Lost to Follow-up|14|||
149878592|NCT00000620|540684244|FG002|Overall Study|Lost to Follow-up|14|||
149878593|NCT00000620|540684245|FG003|Overall Study|Lost to Follow-up|14|||
149878594|NCT00000620|540684246|FG004|Overall Study|Lost to Follow-up|15|||
149878595|NCT00000620|540684247|FG005|Overall Study|Lost to Follow-up|15|||
149878596|NCT00000620|540684248|FG006|Overall Study|Lost to Follow-up|13|||
149878597|NCT00000620|540684249|FG007|Overall Study|Lost to Follow-up|14|||
149878598|NCT00000620|540684242|FG000|Overall Study|Withdrawal by Subject|40|||
149878599|NCT00000620|540684243|FG001|Overall Study|Withdrawal by Subject|27|||
149878600|NCT00000620|540684244|FG002|Overall Study|Withdrawal by Subject|28|||
149878601|NCT00000620|540684245|FG003|Overall Study|Withdrawal by Subject|27|||
149878602|NCT00000620|540684246|FG004|Overall Study|Withdrawal by Subject|30|||
149878603|NCT00000620|540684247|FG005|Overall Study|Withdrawal by Subject|32|||
149878604|NCT00000620|540684248|FG006|Overall Study|Withdrawal by Subject|32|||
149878605|NCT00000620|540684249|FG007|Overall Study|Withdrawal by Subject|21|||
149878606|NCT00000620|540684242|FG000|Overall Study|missed closeout visit|22|||
149878607|NCT00000620|540684243|FG001|Overall Study|missed closeout visit|28|||
149878608|NCT00000620|540684244|FG002|Overall Study|missed closeout visit|16|||
149878609|NCT00000620|540684245|FG003|Overall Study|missed closeout visit|11|||
149878610|NCT00000620|540684246|FG004|Overall Study|missed closeout visit|26|||
149878611|NCT00000620|540684247|FG005|Overall Study|missed closeout visit|28|||
149878612|NCT00000620|540684248|FG006|Overall Study|missed closeout visit|13|||
149878613|NCT00000620|540684249|FG007|Overall Study|missed closeout visit|16|||
149878614|NCT01851330|540684251|FG000|Overall Study|Lack of Efficacy|10|||
149878615|NCT01851330|540684252|FG001|Overall Study|Lack of Efficacy|9|||
149878616|NCT01851330|540684253|FG002|Overall Study|Lack of Efficacy|2|||
149878617|NCT01851330|540684251|FG000|Overall Study|Lost to Follow-up|1|||
149878618|NCT01851330|540684252|FG001|Overall Study|Lost to Follow-up|6|||
149878619|NCT01851330|540684253|FG002|Overall Study|Lost to Follow-up|9|||
149878620|NCT01851330|540684251|FG000|Overall Study|Withdrew Consent|2|||
149878621|NCT01851330|540684252|FG001|Overall Study|Withdrew Consent|1|||
149878622|NCT01851330|540684253|FG002|Overall Study|Withdrew Consent|0|||
149878623|NCT01851330|540684251|FG000|Overall Study|Investigator's Discretion|0|||
149878624|NCT01851330|540684252|FG001|Overall Study|Investigator's Discretion|0|||
149878625|NCT01851330|540684253|FG002|Overall Study|Investigator's Discretion|1|||
149878626|NCT02648932|540684254|FG000|Overall Study|No transplant|3|||
149878627|NCT02648932|540684255|FG001|Overall Study|No transplant|1|||
149878628|NCT02368314|540684256|FG000|Overall Study|Withdrawal by Subject|2|||
149878629|NCT02368314|540684257|FG001|Overall Study|Withdrawal by Subject|1|||
149878630|NCT02368314|540684256|FG000|Overall Study|Adverse Event|1|||
149878631|NCT02368314|540684257|FG001|Overall Study|Adverse Event|2|||
149878632|NCT01266031|540684258|FG000|Overall Study|Not treated|0|||
149878633|NCT01266031|540684259|FG001|Overall Study|Not treated|3|||
149878634|NCT01266031|540684260|FG002|Overall Study|Not treated|2|||
149964350|NCT01335685|541004555|FG000|Overall Study|Withdrawal by Subject|1|||
149878635|NCT03106987|540684263|FG000|Overall Study|Death|37|||
149964351|NCT01335685|541004556|FG001|Overall Study|Withdrawal by Subject|0|||
149964352|NCT01335685|541004557|FG002|Overall Study|Withdrawal by Subject|0|||
149964353|NCT01335685|541004558|FG003|Overall Study|Withdrawal by Subject|1|||
149964354|NCT01335685|541004559|FG004|Overall Study|Withdrawal by Subject|0|||
149964355|NCT01335685|541004560|FG005|Overall Study|Withdrawal by Subject|0|||
149878636|NCT03106987|540684264|FG001|Overall Study|Death|22|||
149964356|NCT01335685|541004561|FG006|Overall Study|Withdrawal by Subject|0|||
149964357|NCT01335685|541004562|FG007|Overall Study|Withdrawal by Subject|0|||
149964358|NCT01335685|541004555|FG000|Overall Study|Reason not Specified|0|||
149964359|NCT01335685|541004556|FG001|Overall Study|Reason not Specified|0|||
149878637|NCT03106987|540684265|FG002|Overall Study|Death|12|||
149878638|NCT03106987|540684266|FG003|Overall Study|Death|8|||
149878639|NCT03106987|540684263|FG000|Overall Study|Lost to Follow-up|2|||
149878640|NCT03106987|540684264|FG001|Overall Study|Lost to Follow-up|0|||
149878641|NCT03106987|540684265|FG002|Overall Study|Lost to Follow-up|2|||
149878642|NCT03106987|540684266|FG003|Overall Study|Lost to Follow-up|2|||
149878643|NCT03106987|540684263|FG000|Overall Study|Withdrawal by Subject|5|||
149878644|NCT03106987|540684264|FG001|Overall Study|Withdrawal by Subject|1|||
149878645|NCT03106987|540684265|FG002|Overall Study|Withdrawal by Subject|4|||
149878646|NCT03106987|540684266|FG003|Overall Study|Withdrawal by Subject|1|||
149878647|NCT01307111|540684267|FG000|IUD Insertion|Lost to Follow-up|2|||
149878648|NCT01307111|540684268|FG001|IUD Insertion|Lost to Follow-up|0|||
149878649|NCT01307111|540684267|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
149878650|NCT01307111|540684268|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
149878651|NCT03336528|540684269|FG000|Overall Study|Protocol Violation|1|||
149878652|NCT03336528|540684270|FG001|Overall Study|Protocol Violation|1|||
149878653|NCT03336528|540684269|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
149878654|NCT03336528|540684270|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
149878655|NCT03336528|540684269|FG000|Overall Study|Did not receive study medication|1|||
149878656|NCT03336528|540684270|FG001|Overall Study|Did not receive study medication|2|||
149878657|NCT00005957|540684278|FG000|Overall Study|No treated|3|||
149878658|NCT00005957|540684279|FG001|Overall Study|No treated|9|||
149878659|NCT00005957|540684278|FG000|Overall Study|Crossover to the other arm|5|||
149878660|NCT00005957|540684279|FG001|Overall Study|Crossover to the other arm|19|||
149878661|NCT02047734|540684280|FG000|Overall Study|Adverse Event|18|||
149878662|NCT02047734|540684281|FG001|Overall Study|Adverse Event|13|||
149878663|NCT02047734|540684282|FG002|Overall Study|Adverse Event|13|||
149878664|NCT02047734|540684280|FG000|Overall Study|Lack of Efficacy|4|||
149878665|NCT02047734|540684281|FG001|Overall Study|Lack of Efficacy|5|||
149878666|NCT02047734|540684282|FG002|Overall Study|Lack of Efficacy|1|||
149878667|NCT02047734|540684280|FG000|Overall Study|Protocol Violation|3|||
149878668|NCT02047734|540684281|FG001|Overall Study|Protocol Violation|1|||
149878669|NCT02047734|540684282|FG002|Overall Study|Protocol Violation|1|||
149878670|NCT02047734|540684280|FG000|Overall Study|Lost to Follow-up|1|||
149878671|NCT02047734|540684281|FG001|Overall Study|Lost to Follow-up|4|||
149878672|NCT02047734|540684282|FG002|Overall Study|Lost to Follow-up|0|||
149878673|NCT02047734|540684280|FG000|Overall Study|Death|0|||
149878674|NCT02047734|540684281|FG001|Overall Study|Death|1|||
149878675|NCT02047734|540684282|FG002|Overall Study|Death|0|||
149878676|NCT02047734|540684280|FG000|Overall Study|Withdrawal by Subject|30|||
149878677|NCT02047734|540684281|FG001|Overall Study|Withdrawal by Subject|31|||
149878678|NCT02047734|540684282|FG002|Overall Study|Withdrawal by Subject|19|||
149878679|NCT02047734|540684280|FG000|Overall Study|Physician Decision|7|||
149878680|NCT02047734|540684281|FG001|Overall Study|Physician Decision|6|||
149878681|NCT02047734|540684282|FG002|Overall Study|Physician Decision|5|||
149878682|NCT02047734|540684280|FG000|Overall Study|Miscellaneous|2|||
149878683|NCT02047734|540684281|FG001|Overall Study|Miscellaneous|4|||
149878684|NCT02047734|540684282|FG002|Overall Study|Miscellaneous|6|||
149878685|NCT02047734|540684280|FG000|Overall Study|Did Not Receive Study Drug|2|||
149878686|NCT02047734|540684281|FG001|Overall Study|Did Not Receive Study Drug|4|||
149878687|NCT02047734|540684282|FG002|Overall Study|Did Not Receive Study Drug|1|||
149878688|NCT00582010|540684285|FG000|Overall Study|Death|0|||
149878689|NCT00582010|540684286|FG001|Overall Study|Death|1|||
149878690|NCT00958893|540684287|FG000|Overall Study|Study prematurely terminated|4|||
149878691|NCT01890434|540684288|FG000|Overall Study|Adverse Event|8|||
149878692|NCT01890434|540684288|FG000|Overall Study|PCI at external hospital|1|||
149878693|NCT01890434|540684288|FG000|Overall Study|Assessment discrepancy|1|||
149878694|NCT01890434|540684288|FG000|Overall Study|CRC didn't contact participant for FU|1|||
149878695|NCT01890434|540684288|FG000|Overall Study|Could not get whole set of images|1|||
149878696|NCT01890434|540684288|FG000|Overall Study|Decline to return for GSPECT|1|||
149878697|NCT01890434|540684288|FG000|Overall Study|GSPECT at rest was not done|1|||
149878698|NCT01890434|540684288|FG000|Overall Study|Participant didn't complete MRI|1|||
149878699|NCT01890434|540684288|FG000|Overall Study|Uncontactable by phone|1|||
149878700|NCT01890434|540684288|FG000|Overall Study|Moved out of position|1|||
149878701|NCT01890434|540684288|FG000|Overall Study|Unable to contact|1|||
149878702|NCT01890434|540684288|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
149878703|NCT01267994|540684290|FG000|Overall Study|Adverse Event|2|||
149878704|NCT05199090|540684293|FG000|Overall Study|Adverse Event|1|||
149878705|NCT05199090|540684294|FG001|Overall Study|Adverse Event|4|||
149878706|NCT05199090|540684295|FG002|Overall Study|Adverse Event|0|||
149878707|NCT05199090|540684296|FG003|Overall Study|Adverse Event|0|||
149878708|NCT05199090|540684297|FG004|Overall Study|Adverse Event|0|||
149878709|NCT05199090|540684298|FG005|Overall Study|Adverse Event|0|||
149878710|NCT05199090|540684293|FG000|Overall Study|Lost to Follow-up|1|||
149878711|NCT05199090|540684294|FG001|Overall Study|Lost to Follow-up|0|||
149878712|NCT05199090|540684295|FG002|Overall Study|Lost to Follow-up|1|||
149878713|NCT05199090|540684296|FG003|Overall Study|Lost to Follow-up|4|||
149878714|NCT05199090|540684297|FG004|Overall Study|Lost to Follow-up|0|||
149878715|NCT05199090|540684298|FG005|Overall Study|Lost to Follow-up|5|||
149878716|NCT05199090|540684293|FG000|Overall Study|Physician Decision|0|||
149878717|NCT05199090|540684294|FG001|Overall Study|Physician Decision|0|||
149878718|NCT05199090|540684295|FG002|Overall Study|Physician Decision|0|||
149878719|NCT05199090|540684296|FG003|Overall Study|Physician Decision|0|||
149878720|NCT05199090|540684297|FG004|Overall Study|Physician Decision|0|||
149878721|NCT05199090|540684298|FG005|Overall Study|Physician Decision|1|||
149878722|NCT05199090|540684293|FG000|Overall Study|Study terminated by sponsor|0|||
149878723|NCT05199090|540684294|FG001|Overall Study|Study terminated by sponsor|6|||
149878724|NCT05199090|540684295|FG002|Overall Study|Study terminated by sponsor|0|||
149878725|NCT05199090|540684296|FG003|Overall Study|Study terminated by sponsor|0|||
149878726|NCT05199090|540684297|FG004|Overall Study|Study terminated by sponsor|0|||
149878727|NCT05199090|540684298|FG005|Overall Study|Study terminated by sponsor|5|||
149878728|NCT05199090|540684293|FG000|Overall Study|Subject decision|0|||
149878729|NCT05199090|540684294|FG001|Overall Study|Subject decision|4|||
149878730|NCT05199090|540684295|FG002|Overall Study|Subject decision|0|||
149878731|NCT05199090|540684296|FG003|Overall Study|Subject decision|2|||
149878732|NCT05199090|540684297|FG004|Overall Study|Subject decision|5|||
149878733|NCT05199090|540684298|FG005|Overall Study|Subject decision|2|||
149878734|NCT04868968|540684299|FG000|Overall Study|Lost to Follow-up|1|||
149878735|NCT03276078|540684300|FG000|Overall Study|Adverse Event|1|||
149878736|NCT02552732|540684301|FG000|Overall Study|Lost to Follow-up|2|||
149878737|NCT02552732|540684301|FG000|Overall Study|Physician Decision|1|||
149878738|NCT02552732|540684301|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
149964360|NCT01335685|541004557|FG002|Overall Study|Reason not Specified|1|||
149964361|NCT01335685|541004558|FG003|Overall Study|Reason not Specified|0|||
149964362|NCT01335685|541004559|FG004|Overall Study|Reason not Specified|0|||
149964363|NCT01335685|541004560|FG005|Overall Study|Reason not Specified|1|||
149964364|NCT01335685|541004561|FG006|Overall Study|Reason not Specified|0|||
149964365|NCT01335685|541004562|FG007|Overall Study|Reason not Specified|0|||
149964366|NCT03777020|541004565|FG000|Overall Study|Withdrawal by Subject|4|||
149964367|NCT03777020|541004566|FG001|Overall Study|Withdrawal by Subject|4|||
149964368|NCT03777020|541004565|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
149964369|NCT03777020|541004566|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
149964370|NCT03460704|541004567|FG000|Overall Study|Withdrawal by Subject|11|||
149964371|NCT03460704|541004568|FG001|Overall Study|Withdrawal by Subject|14|||
149878739|NCT02552732|540684301|FG000|Overall Study|Withdrawal by Subject|6|||
149878740|NCT01275430|540684306|FG000|Overall Study|Adverse Event|1|||
149878741|NCT01275430|540684306|FG000|Overall Study|No Contrast Injection|6|||
149878742|NCT01275430|540684306|FG000|Overall Study|Device Malfunction|1|||
149878743|NCT01275430|540684306|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
149878744|NCT04988087|540684307|FG000|Overall Study|Adverse Event|4|||
149878745|NCT04988087|540684308|FG001|Overall Study|Adverse Event|0|||
149878746|NCT04988087|540684309|FG002|Overall Study|Adverse Event|0|||
149878747|NCT04988087|540684310|FG003|Overall Study|Adverse Event|0|||
149878748|NCT04988087|540684307|FG000|Overall Study|Withdrawal by Subject|1|||
149878749|NCT04988087|540684308|FG001|Overall Study|Withdrawal by Subject|1|||
149964372|NCT03460704|541004567|FG000|Overall Study|Study terminated by the Sponsor|29|||
149964373|NCT03460704|541004568|FG001|Overall Study|Study terminated by the Sponsor|19|||
149964374|NCT03460704|541004567|FG000|Overall Study|Adverse Event|10|||
149878750|NCT04988087|540684309|FG002|Overall Study|Withdrawal by Subject|0|||
149878751|NCT04988087|540684310|FG003|Overall Study|Withdrawal by Subject|0|||
149878752|NCT04988087|540684307|FG000|Overall Study|Technical problems|7|||
149878753|NCT04988087|540684308|FG001|Overall Study|Technical problems|9|||
149878754|NCT04988087|540684309|FG002|Overall Study|Technical problems|1|||
149964375|NCT03460704|541004568|FG001|Overall Study|Adverse Event|5|||
149878755|NCT04988087|540684310|FG003|Overall Study|Technical problems|2|||
149878756|NCT02613182|540684311|FG000|Overall Study|Death|6|||
149878757|NCT02613182|540684311|FG000|Overall Study|Physician Decision|1|||
149878758|NCT02613182|540684311|FG000|Overall Study|Study Terminated by Sponsor|21|||
149878759|NCT02613182|540684311|FG000|Overall Study|Withdrawal by Subject|6|||
149878760|NCT02714426|540684312|FG000|Overall Study|Withdrawal by Subject|2|||
149878761|NCT02714426|540684313|FG001|Overall Study|Withdrawal by Subject|2|||
149878762|NCT00025259|540684317|FG000|Overall Study|Death|1|||
149878763|NCT00025259|540684318|FG001|Overall Study|Death|3|||
149878764|NCT00025259|540684319|FG002|Overall Study|Death|0|||
149878765|NCT00025259|540684320|FG003|Overall Study|Death|3|||
149878766|NCT00025259|540684321|FG004|Overall Study|Death|0|||
149878767|NCT00025259|540684322|FG005|Overall Study|Death|1|||
149878768|NCT00025259|540684323|FG006|Overall Study|Death|2|||
149878769|NCT00025259|540684317|FG000|Overall Study|Lack of Efficacy|2|||
149878770|NCT00025259|540684318|FG001|Overall Study|Lack of Efficacy|46|||
149878771|NCT00025259|540684319|FG002|Overall Study|Lack of Efficacy|60|||
149878772|NCT00025259|540684320|FG003|Overall Study|Lack of Efficacy|78|||
149878773|NCT00025259|540684321|FG004|Overall Study|Lack of Efficacy|11|||
149878774|NCT00025259|540684322|FG005|Overall Study|Lack of Efficacy|30|||
149878775|NCT00025259|540684323|FG006|Overall Study|Lack of Efficacy|38|||
149878776|NCT00025259|540684317|FG000|Overall Study|Lost to Follow-up|2|||
149878777|NCT00025259|540684318|FG001|Overall Study|Lost to Follow-up|9|||
149878778|NCT00025259|540684319|FG002|Overall Study|Lost to Follow-up|13|||
149878779|NCT00025259|540684320|FG003|Overall Study|Lost to Follow-up|13|||
149878780|NCT00025259|540684321|FG004|Overall Study|Lost to Follow-up|1|||
149964376|NCT03460704|541004567|FG000|Overall Study|Death|3|||
149964377|NCT03460704|541004568|FG001|Overall Study|Death|2|||
149964378|NCT03460704|541004567|FG000|Overall Study|Non-Compliance with Study Drug|3|||
149964379|NCT03460704|541004568|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149964380|NCT03460704|541004567|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149964381|NCT03460704|541004568|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
149964382|NCT03460704|541004567|FG000|Overall Study|Other|2|||
149964383|NCT03460704|541004568|FG001|Overall Study|Other|1|||
149964384|NCT01767857|541004569|FG000|Overall Study|Adverse Event|27|||
149964385|NCT01767857|541004570|FG001|Overall Study|Adverse Event|7|||
149964386|NCT01767857|541004569|FG000|Overall Study|Death|28|||
149964387|NCT01767857|541004570|FG001|Overall Study|Death|13|||
149964388|NCT01767857|541004569|FG000|Overall Study|Lack of Efficacy|299|||
149964389|NCT01767857|541004570|FG001|Overall Study|Lack of Efficacy|151|||
149964390|NCT01767857|541004569|FG000|Overall Study|Lost to Follow-up|1|||
149964391|NCT01767857|541004570|FG001|Overall Study|Lost to Follow-up|1|||
149964392|NCT01767857|541004569|FG000|Overall Study|Withdrawal by Subject|38|||
149964393|NCT01767857|541004570|FG001|Overall Study|Withdrawal by Subject|18|||
149964394|NCT01767857|541004569|FG000|Overall Study|Physician Decision|17|||
149964395|NCT01767857|541004570|FG001|Overall Study|Physician Decision|10|||
149964396|NCT01767857|541004569|FG000|Overall Study|Protocol Terminated|1|||
149964397|NCT01767857|541004570|FG001|Overall Study|Protocol Terminated|0|||
149964398|NCT01767857|541004569|FG000|Overall Study|Randomized But Never Treated|19|||
149964399|NCT01767857|541004570|FG001|Overall Study|Randomized But Never Treated|13|||
149964400|NCT01421459|541004571|FG000|Overall Study|Adverse Event|6|||
149964401|NCT01421459|541004572|FG001|Overall Study|Adverse Event|10|||
149964402|NCT01421459|541004571|FG000|Overall Study|Death|1|||
149964403|NCT01421459|541004572|FG001|Overall Study|Death|1|||
149878781|NCT00025259|540684322|FG005|Overall Study|Lost to Follow-up|3|||
149878782|NCT00025259|540684323|FG006|Overall Study|Lost to Follow-up|1|||
149878783|NCT00025259|540684317|FG000|Overall Study|Physician Decision|12|||
149878784|NCT00025259|540684318|FG001|Overall Study|Physician Decision|1|||
150043456|NCT03773796|541298645|FG000|Overall Study|Withdrawal by Subject|1|||
149878785|NCT00025259|540684319|FG002|Overall Study|Physician Decision|0|||
149878786|NCT00025259|540684320|FG003|Overall Study|Physician Decision|5|||
149878787|NCT00025259|540684321|FG004|Overall Study|Physician Decision|4|||
149964404|NCT01421459|541004571|FG000|Overall Study|Lack of Efficacy|1|||
149964405|NCT01421459|541004572|FG001|Overall Study|Lack of Efficacy|2|||
149878788|NCT00025259|540684322|FG005|Overall Study|Physician Decision|2|||
149878789|NCT00025259|540684323|FG006|Overall Study|Physician Decision|1|||
149878790|NCT00025259|540684317|FG000|Overall Study|Protocol Violation|3|||
149878791|NCT00025259|540684318|FG001|Overall Study|Protocol Violation|2|||
149878792|NCT00025259|540684319|FG002|Overall Study|Protocol Violation|2|||
149878793|NCT00025259|540684320|FG003|Overall Study|Protocol Violation|1|||
149878794|NCT00025259|540684321|FG004|Overall Study|Protocol Violation|2|||
149878795|NCT00025259|540684322|FG005|Overall Study|Protocol Violation|1|||
149878796|NCT00025259|540684323|FG006|Overall Study|Protocol Violation|3|||
149878797|NCT00025259|540684317|FG000|Overall Study|Withdrawal by Subject|9|||
149878798|NCT00025259|540684318|FG001|Overall Study|Withdrawal by Subject|27|||
150043457|NCT03773796|541298645|FG000|Overall Study|Lack of Efficacy|1|||
150043458|NCT03805659|541298647|FG000|Overall Study|Withdrawal by Subject|0|||
149878799|NCT00025259|540684319|FG002|Overall Study|Withdrawal by Subject|6|||
149878800|NCT00025259|540684320|FG003|Overall Study|Withdrawal by Subject|14|||
149878801|NCT00025259|540684321|FG004|Overall Study|Withdrawal by Subject|11|||
149878802|NCT00025259|540684322|FG005|Overall Study|Withdrawal by Subject|8|||
149878803|NCT00025259|540684323|FG006|Overall Study|Withdrawal by Subject|3|||
149878804|NCT00025259|540684317|FG000|Overall Study|Ineligible|14|||
150043459|NCT03805659|541298648|FG001|Overall Study|Withdrawal by Subject|1|||
149878805|NCT00025259|540684318|FG001|Overall Study|Ineligible|1|||
149878806|NCT00025259|540684319|FG002|Overall Study|Ineligible|0|||
149878807|NCT00025259|540684320|FG003|Overall Study|Ineligible|0|||
149878808|NCT00025259|540684321|FG004|Overall Study|Ineligible|6|||
149878809|NCT00025259|540684322|FG005|Overall Study|Ineligible|0|||
149878810|NCT00025259|540684323|FG006|Overall Study|Ineligible|1|||
149878811|NCT00025259|540684317|FG000|Overall Study|Randomization error|1|||
149878812|NCT00025259|540684318|FG001|Overall Study|Randomization error|0|||
149878813|NCT00025259|540684319|FG002|Overall Study|Randomization error|0|||
149878814|NCT00025259|540684320|FG003|Overall Study|Randomization error|0|||
149878815|NCT00025259|540684321|FG004|Overall Study|Randomization error|1|||
149878816|NCT00025259|540684322|FG005|Overall Study|Randomization error|7|||
149878817|NCT00025259|540684323|FG006|Overall Study|Randomization error|2|||
149878818|NCT00025259|540684317|FG000|Overall Study|Adverse Event|1|||
149878819|NCT00025259|540684318|FG001|Overall Study|Adverse Event|0|||
149878820|NCT00025259|540684319|FG002|Overall Study|Adverse Event|0|||
149878821|NCT00025259|540684320|FG003|Overall Study|Adverse Event|0|||
149878822|NCT00025259|540684321|FG004|Overall Study|Adverse Event|0|||
149878823|NCT00025259|540684322|FG005|Overall Study|Adverse Event|0|||
150043460|NCT02273596|541298650|FG000|24-Week Treatment Period|Adverse Event|3|||
150043461|NCT02273596|541298650|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
150043462|NCT02273596|541298650|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
149878824|NCT00025259|540684323|FG006|Overall Study|Adverse Event|0|||
150174442|NCT00723450|541774458|FG001|Randomized Phase|Protocol Violation|9|||
150174443|NCT00723450|541774459|FG002|Randomized Phase|Protocol Violation|13|||
150174444|NCT00723450|541774457|FG000|Randomized Phase|Lost to Follow-up|0|||
150174445|NCT00723450|541774458|FG001|Randomized Phase|Lost to Follow-up|2|||
150174446|NCT00723450|541774459|FG002|Randomized Phase|Lost to Follow-up|3|||
150174447|NCT00723450|541774457|FG000|Randomized Phase|Physician Decision|0|||
150174448|NCT00723450|541774458|FG001|Randomized Phase|Physician Decision|3|||
150174449|NCT00723450|541774459|FG002|Randomized Phase|Physician Decision|1|||
150174450|NCT00723450|541774457|FG000|Randomized Phase|Withdrawal by Subject|0|||
150174451|NCT00723450|541774458|FG001|Randomized Phase|Withdrawal by Subject|14|||
150174452|NCT00723450|541774459|FG002|Randomized Phase|Withdrawal by Subject|22|||
149878825|NCT00863772|540684324|FG000|Overall Study|Adverse Event|1|||
149878826|NCT00863772|540684325|FG001|Overall Study|Adverse Event|4|||
149878827|NCT00863772|540684326|FG002|Overall Study|Adverse Event|0|||
149878828|NCT00863772|540684324|FG000|Overall Study|Lack of Efficacy|4|||
149878829|NCT00863772|540684325|FG001|Overall Study|Lack of Efficacy|2|||
149878830|NCT00863772|540684326|FG002|Overall Study|Lack of Efficacy|4|||
149878831|NCT00863772|540684324|FG000|Overall Study|Lost to Follow-up|5|||
149878832|NCT00863772|540684325|FG001|Overall Study|Lost to Follow-up|1|||
149878833|NCT00863772|540684326|FG002|Overall Study|Lost to Follow-up|1|||
149878834|NCT00863772|540684324|FG000|Overall Study|Protocol Violation|2|||
149878835|NCT00863772|540684325|FG001|Overall Study|Protocol Violation|0|||
149964406|NCT01421459|541004571|FG000|Overall Study|Lost to Follow-up|8|||
149964407|NCT01421459|541004572|FG001|Overall Study|Lost to Follow-up|9|||
149964408|NCT01421459|541004571|FG000|Overall Study|Physician Decision|9|||
150174453|NCT00189202|541774460|FG000|Overall Study|Physician Decision|5|||
150174454|NCT01135511|541774461|FG000|Overall Study|Adverse Event|0|||
150174455|NCT01135511|541774462|FG001|Overall Study|Adverse Event|1|||
149964409|NCT01421459|541004572|FG001|Overall Study|Physician Decision|9|||
149964410|NCT01421459|541004571|FG000|Overall Study|Protocol Violation|8|||
149964411|NCT01421459|541004572|FG001|Overall Study|Protocol Violation|5|||
150174456|NCT01135511|541774463|FG002|Overall Study|Adverse Event|2|||
150174457|NCT01135511|541774464|FG003|Overall Study|Adverse Event|0|||
150174458|NCT01135511|541774465|FG004|Overall Study|Adverse Event|0|||
150174459|NCT01135511|541774466|FG005|Overall Study|Adverse Event|1|||
150174460|NCT01135511|541774467|FG006|Overall Study|Adverse Event|0|||
150174461|NCT01135511|541774468|FG007|Overall Study|Adverse Event|1|||
150174462|NCT01135511|541774469|FG008|Overall Study|Adverse Event|0|||
150174463|NCT01135511|541774461|FG000|Overall Study|Lack of Efficacy|0|||
149878836|NCT00863772|540684326|FG002|Overall Study|Protocol Violation|2|||
149878837|NCT00863772|540684324|FG000|Overall Study|Withdrawal by Subject|4|||
150174464|NCT01135511|541774462|FG001|Overall Study|Lack of Efficacy|1|||
150174465|NCT01135511|541774463|FG002|Overall Study|Lack of Efficacy|1|||
149878838|NCT00863772|540684325|FG001|Overall Study|Withdrawal by Subject|7|||
150174466|NCT01135511|541774464|FG003|Overall Study|Lack of Efficacy|2|||
149964412|NCT01421459|541004571|FG000|Overall Study|Withdrawal by Subject|12|||
149878839|NCT00863772|540684326|FG002|Overall Study|Withdrawal by Subject|5|||
149878840|NCT00863772|540684324|FG000|Overall Study|Study terminated by sponsor|44|||
149878841|NCT00863772|540684325|FG001|Overall Study|Study terminated by sponsor|45|||
149878842|NCT00863772|540684326|FG002|Overall Study|Study terminated by sponsor|36|||
149878843|NCT00863772|540684324|FG000|Overall Study|Entered extension study|6|||
149878844|NCT00863772|540684325|FG001|Overall Study|Entered extension study|4|||
149878845|NCT00863772|540684326|FG002|Overall Study|Entered extension study|9|||
149878846|NCT00863772|540684324|FG000|Overall Study|Other|1|||
149878847|NCT00863772|540684325|FG001|Overall Study|Other|2|||
149878848|NCT00863772|540684326|FG002|Overall Study|Other|4|||
149878849|NCT00863772|540684324|FG000|Overall Study|Randomized but not Treated|1|||
149878850|NCT00863772|540684325|FG001|Overall Study|Randomized but not Treated|0|||
149878851|NCT00863772|540684326|FG002|Overall Study|Randomized but not Treated|0|||
149878852|NCT00086281|540684327|FG000|Phase 1|Adverse Event|0|||
149878853|NCT00086281|540684328|FG001|Phase 1|Adverse Event|0|||
149878854|NCT00086281|540684329|FG002|Phase 1|Adverse Event|0|||
149878855|NCT00086281|540684330|FG003|Phase 1|Adverse Event|0|||
149878856|NCT00086281|540684331|FG004|Phase 1|Adverse Event|0|||
149878857|NCT00086281|540684332|FG005|Phase 1|Adverse Event|0|||
149878858|NCT00086281|540684333|FG006|Phase 1|Adverse Event|0|||
149878859|NCT00086281|540684334|FG007|Phase 1|Adverse Event|0|||
149878860|NCT00086281|540684335|FG008|Phase 1|Adverse Event|0|||
149878861|NCT00086281|540684336|FG009|Phase 1|Adverse Event|1|||
149878862|NCT00086281|540684337|FG010|Phase 1|Adverse Event|2|||
149878863|NCT00086281|540684338|FG011|Phase 1|Adverse Event|1|||
149878864|NCT00086281|540684339|FG012|Phase 1|Adverse Event|1|||
149878865|NCT00086281|540684340|FG013|Phase 1|Adverse Event|1|||
149878866|NCT00086281|540684341|FG014|Phase 1|Adverse Event|2|||
149878867|NCT00086281|540684327|FG000|Phase 1|Protocol Violation|0|||
149878868|NCT00086281|540684328|FG001|Phase 1|Protocol Violation|0|||
149878869|NCT00086281|540684329|FG002|Phase 1|Protocol Violation|0|||
149878870|NCT00086281|540684330|FG003|Phase 1|Protocol Violation|0|||
149878871|NCT00086281|540684331|FG004|Phase 1|Protocol Violation|0|||
149878872|NCT00086281|540684332|FG005|Phase 1|Protocol Violation|0|||
149878873|NCT00086281|540684333|FG006|Phase 1|Protocol Violation|0|||
149878874|NCT00086281|540684334|FG007|Phase 1|Protocol Violation|0|||
149878875|NCT00086281|540684335|FG008|Phase 1|Protocol Violation|0|||
150043463|NCT02273596|541298650|FG000|24-Week Treatment Period|Physician Decision|1|||
150043464|NCT02273596|541298650|FG000|24-Week Treatment Period|Protocol Deviation|1|||
150043465|NCT02273596|541298650|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
150043466|NCT02273596|541298650|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
150043467|NCT02273596|541298650|FG000|Extension Period|Lost to Follow-up|1|||
149878876|NCT00086281|540684336|FG009|Phase 1|Protocol Violation|0|||
149878877|NCT00086281|540684337|FG010|Phase 1|Protocol Violation|1|||
149878878|NCT00086281|540684338|FG011|Phase 1|Protocol Violation|0|||
149878879|NCT00086281|540684339|FG012|Phase 1|Protocol Violation|0|||
149878880|NCT00086281|540684340|FG013|Phase 1|Protocol Violation|0|||
149878881|NCT00086281|540684341|FG014|Phase 1|Protocol Violation|0|||
149878882|NCT00086281|540684327|FG000|Phase 1|Serious Adverse Event|0|||
149878883|NCT00086281|540684328|FG001|Phase 1|Serious Adverse Event|0|||
149878884|NCT00086281|540684329|FG002|Phase 1|Serious Adverse Event|0|||
149878885|NCT00086281|540684330|FG003|Phase 1|Serious Adverse Event|0|||
149878886|NCT00086281|540684331|FG004|Phase 1|Serious Adverse Event|0|||
149878887|NCT00086281|540684332|FG005|Phase 1|Serious Adverse Event|0|||
149878888|NCT00086281|540684333|FG006|Phase 1|Serious Adverse Event|0|||
149878889|NCT00086281|540684334|FG007|Phase 1|Serious Adverse Event|0|||
149878890|NCT00086281|540684335|FG008|Phase 1|Serious Adverse Event|0|||
149964413|NCT01421459|541004572|FG001|Overall Study|Withdrawal by Subject|16|||
149964414|NCT04126174|541004573|FG000|Overall Study|Lost to Follow-up|3|||
149964415|NCT04126174|541004574|FG001|Overall Study|Lost to Follow-up|3|||
149964416|NCT01422382|541004577|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
149964417|NCT04754399|541004578|FG000|Overall Study|Adverse Event|5|||
149964418|NCT04754399|541004578|FG000|Overall Study|Withdrawal by Subject|6|||
149964419|NCT00025233|541004581|FG000|Overall Study|Ineligible: wrong cell type|1|||
149964420|NCT00025233|541004581|FG000|Overall Study|Ineligible: wrong primary|1|||
149964421|NCT00025233|541004581|FG000|Overall Study|Ineligible: improper prior treatment|1|||
150043468|NCT02273596|541298650|FG000|Extension Period|Protocol Deviation|1|||
150043469|NCT02604160|541298651|FG000|Overall Study|Protocol Violation|0|||
150043470|NCT02604160|541298652|FG001|Overall Study|Protocol Violation|1|||
150043471|NCT02604160|541298651|FG000|Overall Study|Physician Decision|0|||
150043472|NCT02604160|541298652|FG001|Overall Study|Physician Decision|1|||
150043473|NCT01069900|541298653|FG000|Overall Study|Technical problems|0|||
150043474|NCT01069900|541298654|FG001|Overall Study|Technical problems|1|||
150043475|NCT01069900|541298653|FG000|Overall Study|Lost to Follow-up|7|||
150043476|NCT01069900|541298654|FG001|Overall Study|Lost to Follow-up|1|||
150043477|NCT01069900|541298653|FG000|Overall Study|Withdrawal by Subject|6|||
150043478|NCT01069900|541298654|FG001|Overall Study|Withdrawal by Subject|1|||
150174467|NCT01135511|541774465|FG004|Overall Study|Lack of Efficacy|0|||
150043479|NCT01069900|541298653|FG000|Overall Study|Protocol Violation|4|||
150043480|NCT01069900|541298654|FG001|Overall Study|Protocol Violation|1|||
150043481|NCT01069900|541298653|FG000|Overall Study|Insufficient Therapeutic effect|1|||
149878891|NCT00086281|540684336|FG009|Phase 1|Serious Adverse Event|0|||
149878892|NCT00086281|540684337|FG010|Phase 1|Serious Adverse Event|0|||
149878893|NCT00086281|540684338|FG011|Phase 1|Serious Adverse Event|0|||
149878894|NCT00086281|540684339|FG012|Phase 1|Serious Adverse Event|0|||
149878895|NCT00086281|540684340|FG013|Phase 1|Serious Adverse Event|0|||
149878896|NCT00086281|540684341|FG014|Phase 1|Serious Adverse Event|1|||
149878897|NCT00086281|540684327|FG000|Phase 2|Adverse Event|0|||
149878898|NCT00086281|540684328|FG001|Phase 2|Adverse Event|0|||
149878899|NCT00086281|540684329|FG002|Phase 2|Adverse Event|0|||
149878900|NCT00086281|540684330|FG003|Phase 2|Adverse Event|0|||
149878901|NCT00086281|540684331|FG004|Phase 2|Adverse Event|0|||
149878902|NCT00086281|540684332|FG005|Phase 2|Adverse Event|0|||
149878903|NCT00086281|540684333|FG006|Phase 2|Adverse Event|0|||
149878904|NCT00086281|540684334|FG007|Phase 2|Adverse Event|0|||
149878905|NCT00086281|540684335|FG008|Phase 2|Adverse Event|0|||
149878906|NCT00086281|540684336|FG009|Phase 2|Adverse Event|0|||
149878907|NCT00086281|540684337|FG010|Phase 2|Adverse Event|0|||
149878908|NCT00086281|540684338|FG011|Phase 2|Adverse Event|0|||
149878909|NCT00086281|540684339|FG012|Phase 2|Adverse Event|1|||
149878910|NCT00086281|540684340|FG013|Phase 2|Adverse Event|1|||
149878911|NCT00086281|540684341|FG014|Phase 2|Adverse Event|0|||
149878912|NCT03456453|540684342|FG000|Overall Study|Withdrawal by Subject|2|||
149878913|NCT03456453|540684343|FG001|Overall Study|Withdrawal by Subject|0|||
149878914|NCT03456453|540684342|FG000|Overall Study|Not released to community|1|||
149878915|NCT03456453|540684343|FG001|Overall Study|Not released to community|5|||
149878916|NCT03456453|540684342|FG000|Overall Study|Lost to Follow-up|0|||
149878917|NCT03456453|540684343|FG001|Overall Study|Lost to Follow-up|2|||
149878918|NCT00896480|540684344|FG000|Overall Study|Disease progression/recurrence|21|||
149878919|NCT02071849|540684347|FG000|6-month Primary Endpoint|Did not receive device|4|||
149878920|NCT02071849|540684347|FG000|6-month Primary Endpoint|Adverse Event|1|||
149878921|NCT02071849|540684347|FG000|2-year Extended Follow-up|Adverse Event|1|||
149878922|NCT00103610|540684348|FG000|Overall Study|Entered Rescue Procedure|10|||
149878923|NCT00103610|540684349|FG001|Overall Study|Entered Rescue Procedure|52|||
149878924|NCT00103610|540684348|FG000|Overall Study|Death|16|||
149878925|NCT00103610|540684349|FG001|Overall Study|Death|12|||
149878926|NCT00103610|540684348|FG000|Overall Study|Elective Withdrawal|4|||
149878927|NCT00103610|540684349|FG001|Overall Study|Elective Withdrawal|0|||
149878928|NCT00103610|540684348|FG000|Overall Study|Lost to Follow-up|3|||
149878929|NCT00103610|540684349|FG001|Overall Study|Lost to Follow-up|1|||
149878930|NCT00103610|540684348|FG000|Overall Study|Adverse Event|2|||
149964422|NCT00025233|541004581|FG000|Overall Study|Never treated|1|||
149964423|NCT01720602|541004582|FG000|Overall Study|Adverse Event|3|||
149964424|NCT01720602|541004582|FG000|Overall Study|Progressive disease on therapy|2|||
149964425|NCT00507507|541004585|FG000|Treatment Period|Lost to Follow-up|0|||
149964426|NCT00507507|541004586|FG001|Treatment Period|Lost to Follow-up|2|||
149964427|NCT00507507|541004585|FG000|Treatment Period|Physician Decision|4|||
149964428|NCT00507507|541004586|FG001|Treatment Period|Physician Decision|1|||
149964429|NCT00507507|541004585|FG000|Treatment Period|Protocol Violation|1|||
149964430|NCT00507507|541004586|FG001|Treatment Period|Protocol Violation|2|||
149964431|NCT00507507|541004585|FG000|Treatment Period|Adverse Event|1|||
149964432|NCT00507507|541004586|FG001|Treatment Period|Adverse Event|1|||
149964433|NCT00507507|541004585|FG000|Treatment Period|Withdrawal by Subject|46|||
149964434|NCT00507507|541004586|FG001|Treatment Period|Withdrawal by Subject|47|||
149964435|NCT00507507|541004585|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
149964436|NCT00507507|541004586|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
149964437|NCT00507507|541004585|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
149964438|NCT00507507|541004586|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
149964439|NCT00507507|541004585|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
149964440|NCT00507507|541004586|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
149964441|NCT01694771|541004587|FG000|Overall Study|Adverse Event|18|||
149964442|NCT01694771|541004588|FG001|Overall Study|Adverse Event|16|||
149964443|NCT01694771|541004587|FG000|Overall Study|Lack of Efficacy|1|||
149964444|NCT01694771|541004588|FG001|Overall Study|Lack of Efficacy|0|||
149964445|NCT01694771|541004587|FG000|Overall Study|Non compliance protocol|7|||
149878931|NCT00103610|540684349|FG001|Overall Study|Adverse Event|2|||
149878932|NCT00103610|540684348|FG000|Overall Study|Other|2|||
149878933|NCT00103610|540684349|FG001|Overall Study|Other|7|||
149878934|NCT00103610|540684348|FG000|Overall Study|Failed mobilization|1|||
149878935|NCT00103610|540684349|FG001|Overall Study|Failed mobilization|5|||
149878936|NCT00103610|540684348|FG000|Overall Study|Noncompliance|0|||
149878937|NCT00103610|540684349|FG001|Overall Study|Noncompliance|1|||
149878938|NCT01680497|540684353|FG000|Overall Study|Lost to Follow-up|2|||
149878939|NCT00725205|540684354|FG000|Overall Study|Adverse Event|22|||
149878940|NCT00725205|540684354|FG000|Overall Study|Investigator Discontinued|1|||
149878941|NCT00725205|540684354|FG000|Overall Study|Non-compliance With Protocol|14|||
149878942|NCT00725205|540684354|FG000|Overall Study|Other|8|||
149878943|NCT00725205|540684354|FG000|Overall Study|Protocol Defined Clinical Event|1|||
149964446|NCT01694771|541004588|FG001|Overall Study|Non compliance protocol|6|||
149964447|NCT01694771|541004587|FG000|Overall Study|Lost to Follow-up|2|||
149878944|NCT00725205|540684354|FG000|Overall Study|Treatment Failure|41|||
149878945|NCT02260570|540685779|FG000|Overall Study|Withdrawal by Subject|2|||
149878946|NCT02260570|540685780|FG001|Overall Study|Withdrawal by Subject|1|||
149878947|NCT02260570|540685779|FG000|Overall Study|Physician Decision|1|||
149878948|NCT02260570|540685780|FG001|Overall Study|Physician Decision|1|||
149878949|NCT03996447|540685781|FG000|First MRI Examination|Adverse Event|2|||
149878950|NCT03996447|540685782|FG001|First MRI Examination|Adverse Event|0|||
149878951|NCT03996447|540685781|FG000|First MRI Examination|Withdrawal by Subject|1|||
149878952|NCT03996447|540685782|FG001|First MRI Examination|Withdrawal by Subject|2|||
149878953|NCT03996447|540685781|FG000|First MRI Examination|Protocol Violation|0|||
149878954|NCT03996447|540685782|FG001|First MRI Examination|Protocol Violation|1|||
149878955|NCT03996447|540685781|FG000|Washout|Adverse Event|2|||
149878956|NCT03996447|540685782|FG001|Washout|Adverse Event|0|||
149878957|NCT03996447|540685781|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
149878958|NCT03996447|540685782|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
149878959|NCT03996447|540685781|FG000|Washout|Withdrawal by Subject|0|||
149878960|NCT03996447|540685782|FG001|Washout|Withdrawal by Subject|1|||
149878961|NCT03996447|540685781|FG000|Washout|Other reason|1|||
149878962|NCT03996447|540685782|FG001|Washout|Other reason|1|||
149878963|NCT01810302|540685790|FG000|Overall Study|Death|1|||
149878964|NCT01810302|540685791|FG001|Overall Study|Death|0|||
149878965|NCT01810302|540685790|FG000|Overall Study|Physician Decision|0|||
149878966|NCT01810302|540685791|FG001|Overall Study|Physician Decision|1|||
149878967|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #1|24|||
149878968|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #1|0|||
149878969|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
149878970|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
149878971|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149878972|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149878973|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
149878974|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
149964448|NCT01694771|541004588|FG001|Overall Study|Lost to Follow-up|3|||
149964449|NCT01694771|541004587|FG000|Overall Study|Consent withdrawn|7|||
149964450|NCT01694771|541004588|FG001|Overall Study|Consent withdrawn|9|||
149964451|NCT01694771|541004587|FG000|Overall Study|Other reasons|5|||
149964452|NCT01694771|541004588|FG001|Overall Study|Other reasons|6|||
149964453|NCT00137449|541006644|FG000|Overall Study|Disease Progression|8|||
149964454|NCT00137449|541006645|FG001|Overall Study|Disease Progression|13|||
149964455|NCT00137449|541006644|FG000|Overall Study|Death|4|||
149964456|NCT00137449|541006645|FG001|Overall Study|Death|3|||
149964457|NCT00137449|541006644|FG000|Overall Study|Adverse Event|3|||
149964458|NCT00137449|541006645|FG001|Overall Study|Adverse Event|1|||
149964459|NCT00137449|541006644|FG000|Overall Study|Withdrawal by Subject|1|||
150043482|NCT01069900|541298654|FG001|Overall Study|Insufficient Therapeutic effect|0|||
149964460|NCT00137449|541006645|FG001|Overall Study|Withdrawal by Subject|1|||
149964461|NCT01356940|541006648|FG000|First Intervention (28 Days)|Adverse Event|1|||
149964462|NCT01356940|541006649|FG001|First Intervention (28 Days)|Adverse Event|0|||
149878975|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
149878976|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
149878977|NCT03888066|540685792|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149878978|NCT03888066|540685793|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149878979|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149878980|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149878981|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
149878982|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
149878983|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149878984|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149878985|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
149878986|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149878987|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #2|5|||
149878988|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #2|0|||
149878989|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
149878990|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
149878991|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
149878992|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
149878993|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
149878994|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
149878995|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #3|11|||
149878996|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #3|0|||
149878997|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
149878998|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
149878999|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
149879000|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
149879001|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149879002|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149879003|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #4|3|||
149879004|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #4|0|||
149879005|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
149879006|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
149879007|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
149879008|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
149879009|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
149879010|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
149879011|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
149879012|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
149879013|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
149879014|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149879015|NCT03888066|540685792|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
149879016|NCT03888066|540685793|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
149879017|NCT03888066|540685792|FG000|Run-in Phase|AE (Adverse Event)|17|||
149879018|NCT03888066|540685793|FG001|Run-in Phase|AE (Adverse Event)|0|||
149879019|NCT03888066|540685792|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
149879020|NCT03888066|540685793|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
149879021|NCT03888066|540685792|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149879022|NCT03888066|540685793|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149879023|NCT03888066|540685792|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
149879024|NCT03888066|540685793|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
149879025|NCT03888066|540685792|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
150043483|NCT00145158|541298655|FG000|Overall Study|premature withdrawal|2|||
150043484|NCT00145158|541298656|FG001|Overall Study|premature withdrawal|3|||
150043485|NCT02873702|541298659|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
150043486|NCT02873702|541298660|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
150043487|NCT02873702|541298661|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
149964463|NCT01356940|541006648|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
149964464|NCT01356940|541006649|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
149964465|NCT00668642|541006650|FG000|First Off-cycle|Cancer progression|1|||
149964466|NCT00668642|541006651|FG001|First Off-cycle|Cancer progression|0|||
149964467|NCT00668642|541006650|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
149964468|NCT00668642|541006651|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
149964469|NCT03283241|541006652|FG000|Overall Study|Adverse Event|4|||
149964470|NCT03283241|541006653|FG001|Overall Study|Adverse Event|1|||
149964471|NCT03283241|541006652|FG000|Overall Study|Withdrawal by Subject|0|||
149964472|NCT03283241|541006653|FG001|Overall Study|Withdrawal by Subject|1|||
149964473|NCT03283241|541006652|FG000|Overall Study|Subject relocated to Finland|0|||
149964474|NCT03283241|541006653|FG001|Overall Study|Subject relocated to Finland|1|||
149964475|NCT00666263|541006656|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
149964476|NCT00666263|541006657|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
149964477|NCT00666263|541006656|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
149964478|NCT00666263|541006657|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
149964479|NCT00666263|541006656|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
149964480|NCT00666263|541006657|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
149964481|NCT02439957|541006658|FG000|Overall Study|Study Terminated|3|||
149964482|NCT02439957|541006659|FG001|Overall Study|Study Terminated|3|||
149964483|NCT00586157|541006660|FG000|First Intervention|Worsening behavior|1|||
149964484|NCT00586157|541006661|FG001|First Intervention|Worsening behavior|0|||
149964485|NCT00586157|541006660|FG000|Second Intervention|Withdrawal by Subject|1|||
149964486|NCT00586157|541006661|FG001|Second Intervention|Withdrawal by Subject|0|||
149964487|NCT00586157|541006660|FG000|Second Intervention|Worsening behavior|1|||
149964488|NCT00586157|541006661|FG001|Second Intervention|Worsening behavior|0|||
149964489|NCT00586157|541006660|FG000|Second Intervention|Adverse Event|0|||
149964490|NCT00586157|541006661|FG001|Second Intervention|Adverse Event|1|||
149964491|NCT00831389|541006664|FG000|Overall Study|Withdrawal by Subject|0|||
149964492|NCT00831389|541006665|FG001|Overall Study|Withdrawal by Subject|1|||
149964493|NCT00278161|541006667|FG000|Overall Study|Death|11|||
149964494|NCT01817777|541006668|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
149964495|NCT01817777|541006669|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
149964496|NCT01817777|541006670|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
149964497|NCT01817777|541006668|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
149964498|NCT01817777|541006669|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
149964499|NCT01817777|541006670|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
149879026|NCT03888066|540685793|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
149879027|NCT03888066|540685792|FG000|Run-in Phase|Withdrawal by Subject|43|||
149879028|NCT03888066|540685793|FG001|Run-in Phase|Withdrawal by Subject|0|||
149879029|NCT03888066|540685792|FG000|Run-in Phase|AE; Physician Decision|1|||
149879030|NCT03888066|540685793|FG001|Run-in Phase|AE; Physician Decision|0|||
149879031|NCT03888066|540685792|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
149879032|NCT03888066|540685793|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
150043488|NCT02873702|541298662|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
150043489|NCT02873702|541298659|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
149879033|NCT03888066|540685792|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
149879034|NCT03888066|540685793|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
150043490|NCT02873702|541298660|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
150043491|NCT02873702|541298661|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
149879035|NCT03888066|540685792|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
150043492|NCT02873702|541298662|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
150043493|NCT02873702|541298659|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
150174468|NCT01135511|541774466|FG005|Overall Study|Lack of Efficacy|0|||
149964500|NCT01817777|541006668|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
149964501|NCT01817777|541006669|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
149964502|NCT01817777|541006670|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
149964503|NCT01817777|541006668|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
149964504|NCT01817777|541006669|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
149964505|NCT01817777|541006670|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
149964506|NCT01817777|541006668|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
149964507|NCT01817777|541006669|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
149964508|NCT01817777|541006670|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
149964509|NCT03242434|541006671|FG000|Overall Study|Death|0|||
149964510|NCT03242434|541006672|FG001|Overall Study|Death|2|||
149964511|NCT00414609|541006673|FG000|Core Study|Adverse Event|9|||
149964512|NCT00414609|541006674|FG001|Core Study|Adverse Event|11|||
149964513|NCT00414609|541006675|FG002|Core Study|Adverse Event|0|||
150174469|NCT01135511|541774467|FG006|Overall Study|Lack of Efficacy|0|||
149964514|NCT00414609|541006673|FG000|Core Study|Abnormal laboratory values|0|||
149964515|NCT00414609|541006674|FG001|Core Study|Abnormal laboratory values|1|||
149964516|NCT00414609|541006675|FG002|Core Study|Abnormal laboratory values|0|||
150174470|NCT01135511|541774468|FG007|Overall Study|Lack of Efficacy|0|||
150043494|NCT02873702|541298660|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
150043495|NCT02873702|541298661|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
150043496|NCT02873702|541298662|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
150043497|NCT02873702|541298659|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
150043498|NCT02873702|541298660|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
150043499|NCT02873702|541298661|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
150043500|NCT02873702|541298662|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
150043501|NCT02873702|541298659|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
150043502|NCT02873702|541298660|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
150043503|NCT02873702|541298661|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
150043504|NCT02873702|541298662|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
150043505|NCT01255436|541298672|FG000|Overall Study|Lost to Follow-up|178|||
150043506|NCT01255436|541298673|FG001|Overall Study|Lost to Follow-up|191|||
150043507|NCT01255436|541298672|FG000|Overall Study|Death, stroke, or MI|4|||
150043508|NCT01255436|541298673|FG001|Overall Study|Death, stroke, or MI|3|||
150043509|NCT04816669|541298674|FG000|Part 1|Adverse Event|1|||
150043510|NCT04816669|541298675|FG001|Part 1|Adverse Event|1|||
150043511|NCT04816669|541298676|FG002|Part 1|Adverse Event|0|||
150043512|NCT04816669|541298677|FG003|Part 1|Adverse Event|0|||
150043513|NCT04816669|541298674|FG000|Part 1|Lost to Follow-up|2|||
149964517|NCT00414609|541006673|FG000|Core Study|Abnormal test procedure results|1|||
149964518|NCT00414609|541006674|FG001|Core Study|Abnormal test procedure results|1|||
149964519|NCT00414609|541006675|FG002|Core Study|Abnormal test procedure results|0|||
149964520|NCT00414609|541006673|FG000|Core Study|Protocol deviation|0|||
149964521|NCT00414609|541006674|FG001|Core Study|Protocol deviation|1|||
149964522|NCT00414609|541006675|FG002|Core Study|Protocol deviation|0|||
149964523|NCT00414609|541006673|FG000|Core Study|Patient withdrew consent|10|||
149964524|NCT00414609|541006674|FG001|Core Study|Patient withdrew consent|11|||
149964525|NCT00414609|541006675|FG002|Core Study|Patient withdrew consent|0|||
149964526|NCT00414609|541006673|FG000|Core Study|Lost to Follow-up|7|||
149964527|NCT00414609|541006674|FG001|Core Study|Lost to Follow-up|4|||
149964528|NCT00414609|541006675|FG002|Core Study|Lost to Follow-up|0|||
149964529|NCT00414609|541006673|FG000|Core Study|Administrative problems|0|||
149964530|NCT00414609|541006674|FG001|Core Study|Administrative problems|2|||
149964531|NCT00414609|541006675|FG002|Core Study|Administrative problems|0|||
149964532|NCT00414609|541006673|FG000|Core Study|Death|7|||
149964533|NCT00414609|541006674|FG001|Core Study|Death|14|||
149964534|NCT00414609|541006675|FG002|Core Study|Death|0|||
149964535|NCT00414609|541006673|FG000|Extension Study|Adverse Event|0|||
149964536|NCT00414609|541006674|FG001|Extension Study|Adverse Event|0|||
149964537|NCT00414609|541006675|FG002|Extension Study|Adverse Event|14|||
149964538|NCT00414609|541006673|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
149964539|NCT00414609|541006674|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
149964540|NCT00414609|541006675|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
149964541|NCT00414609|541006673|FG000|Extension Study|Withdrawal by Subject|0|||
149964542|NCT00414609|541006674|FG001|Extension Study|Withdrawal by Subject|0|||
149964543|NCT00414609|541006675|FG002|Extension Study|Withdrawal by Subject|13|||
149964544|NCT00414609|541006673|FG000|Extension Study|Lost to Follow-up|0|||
149964545|NCT00414609|541006674|FG001|Extension Study|Lost to Follow-up|0|||
149964546|NCT00414609|541006675|FG002|Extension Study|Lost to Follow-up|10|||
149964547|NCT00414609|541006673|FG000|Extension Study|Administrative problems|0|||
149964548|NCT00414609|541006674|FG001|Extension Study|Administrative problems|0|||
149964549|NCT00414609|541006675|FG002|Extension Study|Administrative problems|1|||
149879036|NCT03888066|540685793|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
149879037|NCT03888066|540685792|FG000|Run-in Phase|Death|1|||
149879038|NCT03888066|540685793|FG001|Run-in Phase|Death|0|||
149879039|NCT03888066|540685792|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
149879040|NCT03888066|540685793|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
149879041|NCT03888066|540685792|FG000|Run-in Phase|Physician Decision|1|||
149879042|NCT03888066|540685793|FG001|Run-in Phase|Physician Decision|0|||
149879043|NCT03888066|540685792|FG000|Run-in Phase|Protocol Violation|13|||
149879044|NCT03888066|540685793|FG001|Run-in Phase|Protocol Violation|0|||
149879045|NCT03888066|540685792|FG000|Run-in Phase|Sponsor Request|34|||
149879046|NCT03888066|540685793|FG001|Run-in Phase|Sponsor Request|0|||
149879047|NCT03888066|540685792|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
149879048|NCT03888066|540685793|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
149879049|NCT03888066|540685792|FG000|Run-in Phase|Withdrawal Of Consent|1|||
149879050|NCT03888066|540685793|FG001|Run-in Phase|Withdrawal Of Consent|0|||
149879051|NCT03888066|540685792|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
149879052|NCT03888066|540685793|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
149879053|NCT03888066|540685792|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
149879054|NCT03888066|540685793|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
149879055|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
149879056|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
149879057|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
149879058|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
149879059|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
149879060|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
149879061|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
149879062|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
149879063|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
149964550|NCT00414609|541006673|FG000|Extension Study|Death|0|||
149964551|NCT00414609|541006674|FG001|Extension Study|Death|0|||
149964552|NCT00414609|541006675|FG002|Extension Study|Death|17|||
149964553|NCT00266032|541006676|FG000|Treatment|Adverse Event|42|||
149964554|NCT00266032|541006677|FG001|Treatment|Adverse Event|26|||
149964555|NCT00266032|541006678|FG002|Treatment|Adverse Event|10|||
149964556|NCT00266032|541006676|FG000|Treatment|Lost to Follow-up|19|||
149964557|NCT00266032|541006677|FG001|Treatment|Lost to Follow-up|4|||
150043514|NCT04816669|541298675|FG001|Part 1|Lost to Follow-up|2|||
150043515|NCT04816669|541298676|FG002|Part 1|Lost to Follow-up|0|||
150043516|NCT04816669|541298677|FG003|Part 1|Lost to Follow-up|0|||
150043517|NCT04816669|541298674|FG000|Part 1|Protocol Violation|0|||
149964558|NCT00266032|541006678|FG002|Treatment|Lost to Follow-up|2|||
149964559|NCT00266032|541006676|FG000|Treatment|Pregnancy|3|||
149964560|NCT00266032|541006677|FG001|Treatment|Pregnancy|2|||
149964561|NCT00266032|541006678|FG002|Treatment|Pregnancy|2|||
150174471|NCT01135511|541774469|FG008|Overall Study|Lack of Efficacy|0|||
149964562|NCT00266032|541006676|FG000|Treatment|Protocol Violation|6|||
149964563|NCT00266032|541006677|FG001|Treatment|Protocol Violation|14|||
149964564|NCT00266032|541006678|FG002|Treatment|Protocol Violation|13|||
149879064|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
149879065|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
149879066|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
149879067|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
149879068|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
149879069|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
149879070|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
149879071|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
149879072|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
149879073|NCT03888066|540685792|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
149879074|NCT03888066|540685793|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
150174472|NCT01135511|541774461|FG000|Overall Study|Protocol Violation|0|||
149879075|NCT02207634|540685794|FG000|Overall Study|Withdrawal by Subject|21|||
149879076|NCT02207634|540685795|FG001|Overall Study|Withdrawal by Subject|31|||
149879077|NCT02207634|540685794|FG000|Overall Study|Lost to Follow-up|1|||
149879078|NCT02207634|540685795|FG001|Overall Study|Lost to Follow-up|0|||
149879079|NCT02077140|540685796|FG000|Overall Study|Lost to Follow-up|4|||
149879080|NCT02077140|540685797|FG001|Overall Study|Lost to Follow-up|1|||
149879081|NCT02077140|540685798|FG002|Overall Study|Lost to Follow-up|2|||
149879082|NCT02077140|540685799|FG003|Overall Study|Lost to Follow-up|2|||
149879083|NCT02077140|540685800|FG004|Overall Study|Lost to Follow-up|3|||
149879084|NCT02077140|540685796|FG000|Overall Study|Withdrawal by Subject|0|||
149879085|NCT02077140|540685797|FG001|Overall Study|Withdrawal by Subject|1|||
149879086|NCT02077140|540685798|FG002|Overall Study|Withdrawal by Subject|0|||
149879087|NCT02077140|540685799|FG003|Overall Study|Withdrawal by Subject|2|||
149879088|NCT02077140|540685800|FG004|Overall Study|Withdrawal by Subject|2|||
149879089|NCT02129608|540685801|FG000|Overall Study|Lost to Follow-up|0|||
149879090|NCT02129608|540685802|FG001|Overall Study|Lost to Follow-up|1|||
149879091|NCT02129608|540685803|FG002|Overall Study|Lost to Follow-up|1|||
149879092|NCT02129608|540685801|FG000|Overall Study|Withdrawal by Subject|0|||
149879093|NCT02129608|540685802|FG001|Overall Study|Withdrawal by Subject|0|||
149879094|NCT02129608|540685803|FG002|Overall Study|Withdrawal by Subject|2|||
149879095|NCT00451204|540685804|FG000|Overall Study|Adverse Event|4|||
149879096|NCT00451204|540685805|FG001|Overall Study|Adverse Event|6|||
149879097|NCT00451204|540685804|FG000|Overall Study|Lack of Efficacy|4|||
149879098|NCT00451204|540685805|FG001|Overall Study|Lack of Efficacy|4|||
149879099|NCT00451204|540685804|FG000|Overall Study|Lost to Follow-up|4|||
149879100|NCT00451204|540685805|FG001|Overall Study|Lost to Follow-up|4|||
149879101|NCT00451204|540685804|FG000|Overall Study|Protocol Violation|1|||
149879102|NCT00451204|540685805|FG001|Overall Study|Protocol Violation|0|||
149879103|NCT00451204|540685804|FG000|Overall Study|Patient refusal|8|||
149879104|NCT00451204|540685805|FG001|Overall Study|Patient refusal|4|||
149879105|NCT00451204|540685804|FG000|Overall Study|Other|1|||
149879106|NCT00451204|540685805|FG001|Overall Study|Other|2|||
149879107|NCT03760185|540685806|FG000|Overall Study|Lost to Follow-up|1|||
149879108|NCT03760185|540685807|FG001|Overall Study|Lost to Follow-up|1|||
149879109|NCT02473523|540685808|FG000|Overall Study|Death|1|||
149879110|NCT02473523|540685808|FG000|Overall Study|Lost to Follow-up|1|||
149879111|NCT00976911|540685812|FG000|Overall Study|Withdrawal by Subject|4|||
149879112|NCT00976911|540685813|FG001|Overall Study|Withdrawal by Subject|6|||
149879113|NCT00976911|540685812|FG000|Overall Study|Death|138|||
149964565|NCT00266032|541006676|FG000|Treatment|Withdrawal by Subject|28|||
149964566|NCT00266032|541006677|FG001|Treatment|Withdrawal by Subject|13|||
149964567|NCT00266032|541006678|FG002|Treatment|Withdrawal by Subject|12|||
149964568|NCT00266032|541006676|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
149964569|NCT00266032|541006677|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
149964570|NCT00266032|541006678|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
149964571|NCT00266032|541006676|FG000|Open-label Safety Extension|Adverse Event|5|||
149964572|NCT00266032|541006677|FG001|Open-label Safety Extension|Adverse Event|0|||
149964573|NCT00266032|541006678|FG002|Open-label Safety Extension|Adverse Event|4|||
149964574|NCT00266032|541006676|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
149964575|NCT00266032|541006677|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
149964576|NCT00266032|541006678|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
149964577|NCT00266032|541006676|FG000|Open-label Safety Extension|Pregnancy|4|||
149964578|NCT00266032|541006677|FG001|Open-label Safety Extension|Pregnancy|1|||
149964579|NCT00266032|541006678|FG002|Open-label Safety Extension|Pregnancy|2|||
149964580|NCT00266032|541006676|FG000|Open-label Safety Extension|Protocol Violation|1|||
149964581|NCT00266032|541006677|FG001|Open-label Safety Extension|Protocol Violation|3|||
149964582|NCT00266032|541006678|FG002|Open-label Safety Extension|Protocol Violation|2|||
149879114|NCT00976911|540685813|FG001|Overall Study|Death|126|||
149879115|NCT00976911|540685812|FG000|Overall Study|Adverse Event|0|||
149879116|NCT00976911|540685813|FG001|Overall Study|Adverse Event|1|||
149879117|NCT00976911|540685812|FG000|Overall Study|Protocol Violation|2|||
149964583|NCT00266032|541006676|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
149964584|NCT00266032|541006677|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
149879118|NCT00976911|540685813|FG001|Overall Study|Protocol Violation|0|||
149879119|NCT00976911|540685812|FG000|Overall Study|Other|8|||
149879120|NCT00976911|540685813|FG001|Overall Study|Other|9|||
150043518|NCT04816669|541298675|FG001|Part 1|Protocol Violation|1|||
150043519|NCT04816669|541298676|FG002|Part 1|Protocol Violation|0|||
150043520|NCT04816669|541298677|FG003|Part 1|Protocol Violation|0|||
150043521|NCT04816669|541298674|FG000|Part 1|Withdrawal by Subject|1|||
150043522|NCT04816669|541298675|FG001|Part 1|Withdrawal by Subject|2|||
150043523|NCT04816669|541298676|FG002|Part 1|Withdrawal by Subject|0|||
150043524|NCT04816669|541298677|FG003|Part 1|Withdrawal by Subject|0|||
150043525|NCT04816669|541298674|FG000|Part 2|Other|0|||
150043526|NCT04816669|541298675|FG001|Part 2|Other|0|||
150043527|NCT04816669|541298676|FG002|Part 2|Other|1|||
150043528|NCT04816669|541298677|FG003|Part 2|Other|0|||
150043529|NCT04816669|541298674|FG000|Part 2|Withdrawal by Subject|0|||
150043530|NCT04816669|541298675|FG001|Part 2|Withdrawal by Subject|0|||
150043531|NCT04816669|541298676|FG002|Part 2|Withdrawal by Subject|0|||
150043532|NCT04816669|541298677|FG003|Part 2|Withdrawal by Subject|1|||
150043533|NCT04816669|541298674|FG000|Part 2|Lost to Follow-up|0|||
150043534|NCT04816669|541298675|FG001|Part 2|Lost to Follow-up|0|||
150043535|NCT04816669|541298676|FG002|Part 2|Lost to Follow-up|1|||
150043536|NCT04816669|541298677|FG003|Part 2|Lost to Follow-up|0|||
150043537|NCT01229267|541298678|FG000|Overall Study|Adverse Event|4|||
150043538|NCT01229267|541298679|FG001|Overall Study|Adverse Event|6|||
150043539|NCT01229267|541298680|FG002|Overall Study|Adverse Event|3|||
150043540|NCT01229267|541298681|FG003|Overall Study|Adverse Event|2|||
149879121|NCT00976911|540685812|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
150043541|NCT01229267|541298682|FG004|Overall Study|Adverse Event|10|||
149879122|NCT00976911|540685813|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
150043542|NCT01229267|541298678|FG000|Overall Study|Death|40|||
149879123|NCT01191944|540685814|FG000|Overall Study|Adverse Event|11|||
149879124|NCT01191944|540685815|FG001|Overall Study|Adverse Event|12|||
150174473|NCT01135511|541774462|FG001|Overall Study|Protocol Violation|0|||
150174474|NCT01135511|541774463|FG002|Overall Study|Protocol Violation|3|||
150174475|NCT01135511|541774464|FG003|Overall Study|Protocol Violation|0|||
150174476|NCT01135511|541774465|FG004|Overall Study|Protocol Violation|0|||
149879125|NCT01191944|540685814|FG000|Overall Study|Protocol Violation|1|||
149879126|NCT01191944|540685815|FG001|Overall Study|Protocol Violation|2|||
149879127|NCT01191944|540685814|FG000|Overall Study|Withdrawal by Subject|4|||
149879128|NCT01191944|540685815|FG001|Overall Study|Withdrawal by Subject|2|||
149879129|NCT01191944|540685814|FG000|Overall Study|Other|1|||
149879130|NCT01191944|540685815|FG001|Overall Study|Other|3|||
149879131|NCT02954991|540685818|FG000|Overall Study|Death|92|||
149879132|NCT02954991|540685819|FG001|Overall Study|Death|11|||
149879133|NCT02954991|540685820|FG002|Overall Study|Death|2|||
149879134|NCT02954991|540685818|FG000|Overall Study|Lost to Follow-up|3|||
149879135|NCT02954991|540685819|FG001|Overall Study|Lost to Follow-up|2|||
149879136|NCT02954991|540685820|FG002|Overall Study|Lost to Follow-up|0|||
149879137|NCT02954991|540685818|FG000|Overall Study|Withdrawal by Subject|9|||
149879138|NCT02954991|540685819|FG001|Overall Study|Withdrawal by Subject|8|||
149879139|NCT02954991|540685820|FG002|Overall Study|Withdrawal by Subject|1|||
149879140|NCT02954991|540685818|FG000|Overall Study|Study Terminated by Sponsor|18|||
149879141|NCT02954991|540685819|FG001|Overall Study|Study Terminated by Sponsor|10|||
149879142|NCT02954991|540685820|FG002|Overall Study|Study Terminated by Sponsor|1|||
149879143|NCT02954991|540685818|FG000|Overall Study|Miscellaneous|2|||
149879144|NCT02954991|540685819|FG001|Overall Study|Miscellaneous|1|||
149879145|NCT02954991|540685820|FG002|Overall Study|Miscellaneous|1|||
149879146|NCT02552303|540685821|FG000|Allocation|Withdrawal by Subject|2|||
149879147|NCT02552303|540685822|FG001|Allocation|Withdrawal by Subject|1|||
149879148|NCT02552303|540685823|FG002|Allocation|Withdrawal by Subject|1|||
149879149|NCT02552303|540685824|FG003|Allocation|Withdrawal by Subject|1|||
149879150|NCT02552303|540685821|FG000|Allocation|ineligible|1|||
149879151|NCT02552303|540685822|FG001|Allocation|ineligible|1|||
149879152|NCT02552303|540685823|FG002|Allocation|ineligible|0|||
149879153|NCT02552303|540685824|FG003|Allocation|ineligible|0|||
149879154|NCT02552303|540685821|FG000|Follow-Up|Lost to Follow-up|0|||
149879155|NCT02552303|540685822|FG001|Follow-Up|Lost to Follow-up|0|||
149879156|NCT02552303|540685823|FG002|Follow-Up|Lost to Follow-up|1|||
149879157|NCT02552303|540685824|FG003|Follow-Up|Lost to Follow-up|0|||
149879158|NCT02552303|540685821|FG000|Follow-Up|ineligible|0|||
149879159|NCT02552303|540685822|FG001|Follow-Up|ineligible|2|||
149879160|NCT02552303|540685823|FG002|Follow-Up|ineligible|0|||
149879161|NCT02552303|540685824|FG003|Follow-Up|ineligible|0|||
149879162|NCT04602546|540685827|FG000|Overall Study|Training|2|||
150174477|NCT01135511|541774466|FG005|Overall Study|Protocol Violation|0|||
149879163|NCT04602546|540685828|FG001|Overall Study|Training|2|||
149879164|NCT04602546|540685829|FG002|Overall Study|Training|1|||
149879165|NCT04602546|540685830|FG003|Overall Study|Training|2|||
149879166|NCT04602546|540685831|FG004|Overall Study|Training|0|||
149879167|NCT04602546|540685827|FG000|Overall Study|Randomized with disqualified data|2|||
149879168|NCT04602546|540685828|FG001|Overall Study|Randomized with disqualified data|0|||
150043543|NCT01229267|541298679|FG001|Overall Study|Death|37|||
149879169|NCT04602546|540685829|FG002|Overall Study|Randomized with disqualified data|2|||
149879170|NCT04602546|540685830|FG003|Overall Study|Randomized with disqualified data|5|||
149879171|NCT04602546|540685831|FG004|Overall Study|Randomized with disqualified data|3|||
149879172|NCT02114385|540685832|FG000|Overall Study|Withdrawal by Subject|3|||
149879173|NCT02114385|540685833|FG001|Overall Study|Withdrawal by Subject|2|||
149879174|NCT02114385|540685832|FG000|Overall Study|Lost to Follow-up|0|||
149879175|NCT02114385|540685833|FG001|Overall Study|Lost to Follow-up|6|||
149879176|NCT01609023|540685837|FG000|Overall Study|Lack of Efficacy|3|||
149879177|NCT01609023|540685837|FG000|Overall Study|Withdrawal by Subject|4|||
149879178|NCT01609023|540685837|FG000|Overall Study|Lost to Follow-up|8|||
149879179|NCT01609023|540685837|FG000|Overall Study|Toxicity|3|||
149879180|NCT01609023|540685837|FG000|Overall Study|Disease progression|10|||
149879181|NCT01609023|540685837|FG000|Overall Study|Physician Decision|2|||
149879182|NCT01609023|540685837|FG000|Overall Study|Death|2|||
149879183|NCT01609023|540685837|FG000|Overall Study|Personal reasons|1|||
149879184|NCT01174043|540685838|FG000|Overall Study|Disease progression|5|||
149879185|NCT01174043|540685838|FG000|Overall Study|Adverse Event|3|||
149879186|NCT01174043|540685838|FG000|Overall Study|Death|1|||
149879187|NCT01174043|540685838|FG000|Overall Study|Withdrawal by Subject|2|||
149879188|NCT04172597|540685842|FG000|Overall Study|Disease Progression|0|||
149879189|NCT04172597|540685843|FG001|Overall Study|Disease Progression|0|||
149879190|NCT04172597|540685844|FG002|Overall Study|Disease Progression|0|||
149879191|NCT04172597|540685845|FG003|Overall Study|Disease Progression|0|||
149964585|NCT00266032|541006678|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
149964586|NCT00266032|541006676|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
149964587|NCT00266032|541006677|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
149964588|NCT00266032|541006678|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
149964589|NCT00124657|541006679|FG000|Overall Study|Toxicity|0|||
149964590|NCT00124657|541006680|FG001|Overall Study|Toxicity|0|||
149964591|NCT00124657|541006681|FG002|Overall Study|Toxicity|1|||
149964592|NCT00124657|541006679|FG000|Overall Study|Non-compliance|1|||
149964593|NCT00124657|541006680|FG001|Overall Study|Non-compliance|0|||
149964594|NCT00124657|541006681|FG002|Overall Study|Non-compliance|4|||
149964595|NCT00124657|541006679|FG000|Overall Study|Progressive disease|14|||
149964596|NCT00124657|541006680|FG001|Overall Study|Progressive disease|5|||
149964597|NCT00124657|541006681|FG002|Overall Study|Progressive disease|27|||
149964598|NCT00124657|541006679|FG000|Overall Study|Intercurrent illness|1|||
149964599|NCT00124657|541006680|FG001|Overall Study|Intercurrent illness|0|||
149964600|NCT00124657|541006681|FG002|Overall Study|Intercurrent illness|0|||
149964601|NCT00814983|541006684|FG000|Overall Study|Screen failure|1|||
150043544|NCT01229267|541298680|FG002|Overall Study|Death|35|||
149964602|NCT00814983|541006685|FG001|Overall Study|Screen failure|0|||
150043545|NCT01229267|541298681|FG003|Overall Study|Death|13|||
150043546|NCT01229267|541298682|FG004|Overall Study|Death|103|||
149964603|NCT00814983|541006684|FG000|Overall Study|Withdrawal by Subject|1|||
149964604|NCT00814983|541006685|FG001|Overall Study|Withdrawal by Subject|0|||
149964605|NCT00814983|541006684|FG000|Overall Study|Graft failure|1|||
149964606|NCT00814983|541006685|FG001|Overall Study|Graft failure|0|||
149964607|NCT02096354|541006690|FG000|Overall Study|Physician Decision|4|||
149964608|NCT02096354|541006691|FG001|Overall Study|Physician Decision|5|||
149964609|NCT02096354|541006692|FG002|Overall Study|Physician Decision|0|||
149964610|NCT02096354|541006690|FG000|Overall Study|Withdrawal by Subject|3|||
149964611|NCT02096354|541006691|FG001|Overall Study|Withdrawal by Subject|1|||
149964612|NCT02096354|541006692|FG002|Overall Study|Withdrawal by Subject|0|||
149964613|NCT02096354|541006690|FG000|Overall Study|Adverse Event|7|||
149964614|NCT02096354|541006691|FG001|Overall Study|Adverse Event|4|||
149964615|NCT02096354|541006692|FG002|Overall Study|Adverse Event|0|||
149964616|NCT02096354|541006690|FG000|Overall Study|Ineligible|0|||
149964617|NCT02096354|541006691|FG001|Overall Study|Ineligible|0|||
149964618|NCT02096354|541006692|FG002|Overall Study|Ineligible|11|||
150043547|NCT01229267|541298678|FG000|Overall Study|Withdrawal by Subject|23|||
150043548|NCT01229267|541298679|FG001|Overall Study|Withdrawal by Subject|22|||
150043549|NCT01229267|541298680|FG002|Overall Study|Withdrawal by Subject|32|||
150043550|NCT01229267|541298681|FG003|Overall Study|Withdrawal by Subject|14|||
150043551|NCT01229267|541298682|FG004|Overall Study|Withdrawal by Subject|59|||
150043552|NCT01229267|541298678|FG000|Overall Study|Protocol Violation|0|||
150043553|NCT01229267|541298679|FG001|Overall Study|Protocol Violation|1|||
150043554|NCT01229267|541298680|FG002|Overall Study|Protocol Violation|0|||
150043555|NCT01229267|541298681|FG003|Overall Study|Protocol Violation|0|||
150043556|NCT01229267|541298682|FG004|Overall Study|Protocol Violation|0|||
150043557|NCT01229267|541298678|FG000|Overall Study|Progressive disease|0|||
150043558|NCT01229267|541298679|FG001|Overall Study|Progressive disease|0|||
150043559|NCT01229267|541298680|FG002|Overall Study|Progressive disease|0|||
150043560|NCT01229267|541298681|FG003|Overall Study|Progressive disease|0|||
150043561|NCT01229267|541298682|FG004|Overall Study|Progressive disease|1|||
150043562|NCT01229267|541298678|FG000|Overall Study|Physician Decision|8|||
150043563|NCT01229267|541298679|FG001|Overall Study|Physician Decision|11|||
150043564|NCT01229267|541298680|FG002|Overall Study|Physician Decision|8|||
150043565|NCT01229267|541298681|FG003|Overall Study|Physician Decision|3|||
150043566|NCT01229267|541298682|FG004|Overall Study|Physician Decision|25|||
150043567|NCT01229267|541298678|FG000|Overall Study|Lost to Follow-up|6|||
150043568|NCT01229267|541298679|FG001|Overall Study|Lost to Follow-up|5|||
150043569|NCT01229267|541298680|FG002|Overall Study|Lost to Follow-up|8|||
150043570|NCT01229267|541298681|FG003|Overall Study|Lost to Follow-up|3|||
150043571|NCT01229267|541298682|FG004|Overall Study|Lost to Follow-up|22|||
150043572|NCT00001213|541298683|FG000|Overall Study|Death|18|||
150043573|NCT01499277|541298686|FG000|Overall Study|Adverse Event|3|||
150043574|NCT01499277|541298687|FG001|Overall Study|Adverse Event|6|||
150043575|NCT01499277|541298686|FG000|Overall Study|Death|3|||
150043576|NCT01499277|541298687|FG001|Overall Study|Death|2|||
150043577|NCT01499277|541298686|FG000|Overall Study|Lost to Follow-up|15|||
150043578|NCT01499277|541298687|FG001|Overall Study|Lost to Follow-up|8|||
150043579|NCT01499277|541298686|FG000|Overall Study|Protocol Violation|2|||
150043580|NCT01499277|541298687|FG001|Overall Study|Protocol Violation|3|||
150043581|NCT01499277|541298686|FG000|Overall Study|Withdrawal by Subject|16|||
150043582|NCT01499277|541298687|FG001|Overall Study|Withdrawal by Subject|6|||
150043583|NCT01499277|541298686|FG000|Overall Study|Lack of therapeutic response and other|8|||
150043584|NCT01499277|541298687|FG001|Overall Study|Lack of therapeutic response and other|7|||
150043585|NCT00859456|541298688|FG000|Overall Study|Adverse Event|3|||
150043586|NCT00859456|541298688|FG000|Overall Study|Progressive disease|2|||
150043587|NCT00859456|541298688|FG000|Overall Study|Non-compliance|3|||
150043588|NCT02636595|541298689|FG000|Overall Study|Lost to Follow-up|1|||
150043589|NCT02636595|541298689|FG000|Overall Study|Other|1|||
150043590|NCT02015637|541298694|FG000|Overall Study|Lost to Follow-up|3|||
150043591|NCT02015637|541298695|FG001|Overall Study|Lost to Follow-up|5|||
150043592|NCT02015637|541298694|FG000|Overall Study|Adverse Event|3|||
150043593|NCT02015637|541298695|FG001|Overall Study|Adverse Event|0|||
149964619|NCT02951819|541006693|FG000|Overall Study|Death|9|||
149964620|NCT02951819|541006694|FG001|Overall Study|Death|7|||
149964621|NCT02951819|541006693|FG000|Overall Study|Withdrawal by Subject|3|||
149964622|NCT02951819|541006694|FG001|Overall Study|Withdrawal by Subject|0|||
149964623|NCT02951819|541006693|FG000|Overall Study|Adverse Event|1|||
149964624|NCT02951819|541006694|FG001|Overall Study|Adverse Event|0|||
149964625|NCT02951819|541006693|FG000|Overall Study|Lack of Efficacy|4|||
149964626|NCT02951819|541006694|FG001|Overall Study|Lack of Efficacy|0|||
149964627|NCT02951819|541006693|FG000|Overall Study|Lost to Follow-up|1|||
149964628|NCT02951819|541006694|FG001|Overall Study|Lost to Follow-up|0|||
149964629|NCT02951819|541006693|FG000|Overall Study|Progressive Disease|1|||
149964630|NCT02951819|541006694|FG001|Overall Study|Progressive Disease|0|||
149964631|NCT02951819|541006693|FG000|Overall Study|Other|9|||
149964632|NCT02951819|541006694|FG001|Overall Study|Other|0|||
149964633|NCT03715829|541006695|FG000|Dose Ranging Period|Adverse Event|2|||
149964634|NCT03715829|541006696|FG001|Dose Ranging Period|Adverse Event|4|||
149964635|NCT03715829|541006697|FG002|Dose Ranging Period|Adverse Event|5|||
149964636|NCT03715829|541006698|FG003|Dose Ranging Period|Adverse Event|2|||
149964637|NCT03715829|541006699|FG004|Dose Ranging Period|Adverse Event|3|||
149964638|NCT03715829|541006700|FG005|Dose Ranging Period|Adverse Event|3|||
149964639|NCT03715829|541006701|FG006|Dose Ranging Period|Adverse Event|0|||
149964640|NCT03715829|541006702|FG007|Dose Ranging Period|Adverse Event|0|||
149964641|NCT03715829|541006703|FG008|Dose Ranging Period|Adverse Event|0|||
149964642|NCT03715829|541006704|FG009|Dose Ranging Period|Adverse Event|0|||
149964643|NCT03715829|541006705|FG010|Dose Ranging Period|Adverse Event|0|||
149964644|NCT03715829|541006695|FG000|Dose Ranging Period|Lack of Efficacy|0|||
149964645|NCT03715829|541006696|FG001|Dose Ranging Period|Lack of Efficacy|1|||
149964646|NCT03715829|541006697|FG002|Dose Ranging Period|Lack of Efficacy|0|||
149964647|NCT03715829|541006698|FG003|Dose Ranging Period|Lack of Efficacy|1|||
149964648|NCT03715829|541006699|FG004|Dose Ranging Period|Lack of Efficacy|0|||
149964649|NCT03715829|541006700|FG005|Dose Ranging Period|Lack of Efficacy|0|||
149964650|NCT03715829|541006701|FG006|Dose Ranging Period|Lack of Efficacy|0|||
149964651|NCT03715829|541006702|FG007|Dose Ranging Period|Lack of Efficacy|0|||
150043594|NCT02015637|541298694|FG000|Overall Study|Did not take study drug|2|||
150043595|NCT02015637|541298695|FG001|Overall Study|Did not take study drug|0|||
149964652|NCT03715829|541006703|FG008|Dose Ranging Period|Lack of Efficacy|0|||
149964653|NCT03715829|541006704|FG009|Dose Ranging Period|Lack of Efficacy|0|||
149964654|NCT03715829|541006705|FG010|Dose Ranging Period|Lack of Efficacy|0|||
149964655|NCT03715829|541006695|FG000|Dose Ranging Period|Lost to Follow-up|2|||
150043596|NCT05782179|541298699|FG000|Overall Study|Adverse Event|0|||
149964656|NCT03715829|541006696|FG001|Dose Ranging Period|Lost to Follow-up|0|||
149964657|NCT03715829|541006697|FG002|Dose Ranging Period|Lost to Follow-up|1|||
149964658|NCT03715829|541006698|FG003|Dose Ranging Period|Lost to Follow-up|1|||
149964659|NCT03715829|541006699|FG004|Dose Ranging Period|Lost to Follow-up|1|||
149964660|NCT03715829|541006700|FG005|Dose Ranging Period|Lost to Follow-up|2|||
149964661|NCT03715829|541006701|FG006|Dose Ranging Period|Lost to Follow-up|0|||
150174478|NCT01135511|541774467|FG006|Overall Study|Protocol Violation|0|||
150174479|NCT01135511|541774468|FG007|Overall Study|Protocol Violation|0|||
150174480|NCT01135511|541774469|FG008|Overall Study|Protocol Violation|0|||
150174481|NCT01135511|541774461|FG000|Overall Study|Pregnancy|0|||
150174482|NCT01135511|541774462|FG001|Overall Study|Pregnancy|0|||
150174483|NCT01135511|541774463|FG002|Overall Study|Pregnancy|0|||
150174484|NCT01135511|541774464|FG003|Overall Study|Pregnancy|1|||
150174485|NCT01135511|541774465|FG004|Overall Study|Pregnancy|0|||
150174486|NCT01135511|541774466|FG005|Overall Study|Pregnancy|0|||
150174487|NCT01135511|541774467|FG006|Overall Study|Pregnancy|0|||
150174488|NCT01135511|541774468|FG007|Overall Study|Pregnancy|0|||
150174489|NCT01135511|541774469|FG008|Overall Study|Pregnancy|0|||
150174490|NCT01135511|541774461|FG000|Overall Study|could not visit the clinic|0|||
150174491|NCT01135511|541774462|FG001|Overall Study|could not visit the clinic|1|||
150174492|NCT01135511|541774463|FG002|Overall Study|could not visit the clinic|2|||
150174493|NCT01135511|541774464|FG003|Overall Study|could not visit the clinic|0|||
150174494|NCT01135511|541774465|FG004|Overall Study|could not visit the clinic|0|||
150174495|NCT01135511|541774466|FG005|Overall Study|could not visit the clinic|0|||
150174496|NCT01135511|541774467|FG006|Overall Study|could not visit the clinic|0|||
150174497|NCT01135511|541774468|FG007|Overall Study|could not visit the clinic|0|||
150174498|NCT01135511|541774469|FG008|Overall Study|could not visit the clinic|0|||
150174499|NCT01135511|541774461|FG000|Overall Study|noncompliance with study drug taken|0|||
150174500|NCT01135511|541774462|FG001|Overall Study|noncompliance with study drug taken|0|||
150174501|NCT01135511|541774463|FG002|Overall Study|noncompliance with study drug taken|0|||
150174502|NCT01135511|541774464|FG003|Overall Study|noncompliance with study drug taken|0|||
150174503|NCT01135511|541774465|FG004|Overall Study|noncompliance with study drug taken|1|||
150174504|NCT01135511|541774466|FG005|Overall Study|noncompliance with study drug taken|0|||
150174505|NCT01135511|541774467|FG006|Overall Study|noncompliance with study drug taken|0|||
150174506|NCT01135511|541774468|FG007|Overall Study|noncompliance with study drug taken|0|||
150174507|NCT01135511|541774469|FG008|Overall Study|noncompliance with study drug taken|0|||
150174508|NCT01135511|541774461|FG000|Overall Study|Withdrawal by Subject|0|||
150174509|NCT01135511|541774462|FG001|Overall Study|Withdrawal by Subject|0|||
150174510|NCT01135511|541774463|FG002|Overall Study|Withdrawal by Subject|0|||
150174511|NCT01135511|541774464|FG003|Overall Study|Withdrawal by Subject|0|||
150174512|NCT01135511|541774465|FG004|Overall Study|Withdrawal by Subject|0|||
150174513|NCT01135511|541774466|FG005|Overall Study|Withdrawal by Subject|0|||
150174514|NCT01135511|541774467|FG006|Overall Study|Withdrawal by Subject|1|||
150174515|NCT01135511|541774468|FG007|Overall Study|Withdrawal by Subject|0|||
150174516|NCT01135511|541774469|FG008|Overall Study|Withdrawal by Subject|1|||
150174517|NCT02880241|541774470|FG000|Overall Study|Lack of Efficacy|1|||
150174518|NCT02880241|541774471|FG001|Overall Study|Lack of Efficacy|0|||
150174519|NCT02880241|541774472|FG002|Overall Study|Lack of Efficacy|0|||
150174520|NCT02880241|541774473|FG003|Overall Study|Lack of Efficacy|0|||
150174521|NCT02880241|541774474|FG004|Overall Study|Lack of Efficacy|0|||
150174522|NCT02880241|541774475|FG005|Overall Study|Lack of Efficacy|0|||
150043597|NCT05782179|541298700|FG001|Overall Study|Adverse Event|0|||
150043598|NCT05782179|541298701|FG002|Overall Study|Adverse Event|2|||
150043599|NCT05782179|541298702|FG003|Overall Study|Adverse Event|0|||
150043600|NCT05782179|541298703|FG004|Overall Study|Adverse Event|0|||
150043601|NCT05782179|541298704|FG005|Overall Study|Adverse Event|0|||
150043602|NCT06170242|541298705|FG000|Overall Study|Lost to Follow-up|0|||
150043603|NCT06170242|541298706|FG001|Overall Study|Lost to Follow-up|0|||
150043604|NCT06170242|541298707|FG002|Overall Study|Lost to Follow-up|1|||
150043605|NCT06170242|541298708|FG003|Overall Study|Lost to Follow-up|1|||
150043606|NCT02863419|541298709|FG000|Overall Study|Lost to Follow-up|0|||
150043607|NCT02863419|541298710|FG001|Overall Study|Lost to Follow-up|1|||
150043608|NCT02863419|541298711|FG002|Overall Study|Lost to Follow-up|4|||
150043609|NCT02863419|541298709|FG000|Overall Study|Withdrawal by Subject|5|||
150043610|NCT02863419|541298710|FG001|Overall Study|Withdrawal by Subject|5|||
150043611|NCT02863419|541298711|FG002|Overall Study|Withdrawal by Subject|3|||
150043612|NCT02863419|541298709|FG000|Overall Study|Died|3|||
150043613|NCT02863419|541298710|FG001|Overall Study|Died|4|||
150043614|NCT02863419|541298711|FG002|Overall Study|Died|1|||
150043615|NCT02362282|541298712|FG000|Overall Study|Withdrawal by Subject|1|||
150043616|NCT02362282|541298713|FG001|Overall Study|Withdrawal by Subject|0|||
150043617|NCT02207088|541298714|FG000|Overall Study|Adverse Event|2|||
150043618|NCT00074490|541298719|FG000|Overall Study|Progressive malignancy|0|||
150043619|NCT00074490|541298720|FG001|Overall Study|Progressive malignancy|7|||
150043620|NCT00074490|541298721|FG002|Overall Study|Progressive malignancy|0|||
150043621|NCT00074490|541298722|FG003|Overall Study|Progressive malignancy|0|||
150043622|NCT00074490|541298723|FG004|Overall Study|Progressive malignancy|3|||
150174523|NCT02537522|541774476|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
150043623|NCT00074490|541298724|FG005|Overall Study|Progressive malignancy|0|||
150043624|NCT04139798|541298725|FG000|Overall Study|Withdrawal by Subject|6|||
150043625|NCT04139798|541298726|FG001|Overall Study|Withdrawal by Subject|5|||
150043626|NCT04139798|541298725|FG000|Overall Study|Lost to Follow-up|2|||
150043627|NCT04139798|541298726|FG001|Overall Study|Lost to Follow-up|5|||
150043628|NCT04139798|541298725|FG000|Overall Study|Discontinued|4|||
150043629|NCT04139798|541298726|FG001|Overall Study|Discontinued|2|||
150174524|NCT02537522|541774477|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
150174525|NCT02537522|541774478|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
150174526|NCT02537522|541774479|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
150174527|NCT02537522|541774476|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
150174528|NCT02537522|541774477|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
150174529|NCT02537522|541774478|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
150174530|NCT02537522|541774479|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
150174531|NCT02537522|541774476|FG000|Phase I - Contralateral|incorrect randomization|0|||
150174532|NCT02537522|541774477|FG001|Phase I - Contralateral|incorrect randomization|1|||
150174533|NCT02537522|541774478|FG002|Phase I - Contralateral|incorrect randomization|0|||
150174534|NCT02537522|541774479|FG003|Phase I - Contralateral|incorrect randomization|0|||
150174535|NCT02537522|541774476|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
150174536|NCT02537522|541774477|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
150174537|NCT02537522|541774478|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
150174538|NCT02537522|541774479|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
150174539|NCT02537522|541774476|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
150174540|NCT02537522|541774477|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
150174541|NCT02537522|541774478|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
150174542|NCT02537522|541774479|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
150174543|NCT02570711|541774481|FG000|Overall Study|Death|1|||
150174544|NCT02570711|541774482|FG001|Overall Study|Death|0|||
150174545|NCT02570711|541774481|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
150174546|NCT02570711|541774482|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
150174547|NCT02248480|541774483|FG000|Overall Study|Lack of Efficacy|4|||
150174548|NCT02248480|541774484|FG001|Overall Study|Lack of Efficacy|6|||
150174549|NCT02248480|541774483|FG000|Overall Study|Adverse Event|11|||
150174550|NCT02248480|541774484|FG001|Overall Study|Adverse Event|2|||
150174551|NCT02248480|541774483|FG000|Overall Study|Withdrawal by Subject|2|||
150174552|NCT02248480|541774484|FG001|Overall Study|Withdrawal by Subject|4|||
150174553|NCT02248480|541774483|FG000|Overall Study|Entry Criteria Not Met|0|||
150174554|NCT02248480|541774484|FG001|Overall Study|Entry Criteria Not Met|1|||
150174555|NCT02248480|541774483|FG000|Overall Study|Other:Physician Decision|0|||
150174556|NCT02248480|541774484|FG001|Overall Study|Other:Physician Decision|1|||
150174557|NCT01595321|541774485|FG000|Overall Study|Adverse Event|1|||
150174558|NCT01595321|541774486|FG001|Overall Study|Adverse Event|1|||
150174559|NCT01595321|541774487|FG002|Overall Study|Adverse Event|1|||
150174560|NCT01595321|541774485|FG000|Overall Study|Lack of Efficacy|0|||
150174561|NCT01595321|541774486|FG001|Overall Study|Lack of Efficacy|0|||
150174562|NCT01595321|541774487|FG002|Overall Study|Lack of Efficacy|4|||
150174563|NCT04795752|541774488|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
150174564|NCT04795752|541774489|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
150174565|NCT04795752|541774488|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
150174566|NCT04795752|541774489|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
150174567|NCT04795752|541774488|FG000|Primary Endpoint Phase|Physician Decision|2|||
150174568|NCT04795752|541774489|FG001|Primary Endpoint Phase|Physician Decision|0|||
150174569|NCT04795752|541774488|FG000|Primary Endpoint Phase|Other|4|||
150174570|NCT04795752|541774489|FG001|Primary Endpoint Phase|Other|1|||
150174571|NCT04795752|541774488|FG000|Primary Endpoint Phase|Protocol Violation|1|||
150174572|NCT04795752|541774489|FG001|Primary Endpoint Phase|Protocol Violation|0|||
150174573|NCT04795752|541774488|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
150174574|NCT04795752|541774489|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
150174575|NCT04795752|541774488|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
149879192|NCT04172597|540685846|FG004|Overall Study|Disease Progression|1|||
150174576|NCT04795752|541774489|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
150174577|NCT04795752|541774488|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
150174578|NCT04795752|541774489|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
150174579|NCT04795752|541774488|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
150174580|NCT04795752|541774489|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
149879193|NCT02289456|540685854|FG000|Induction Period|Death|2|||
150174581|NCT04795752|541774488|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
150174582|NCT04795752|541774489|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
150174583|NCT00792948|541774490|FG000|Overall Study|Adverse Event|6|||
150174584|NCT00792948|541774490|FG000|Overall Study|Death|4|||
150174585|NCT00792948|541774490|FG000|Overall Study|Withdrawal by Subject|3|||
150174586|NCT00792948|541774490|FG000|Overall Study|Ineligible|2|||
150174587|NCT00792948|541774490|FG000|Overall Study|Insurance denial - not treated|1|||
150174588|NCT00792948|541774490|FG000|Overall Study|Physician Decision|11|||
150174589|NCT00792948|541774490|FG000|Overall Study|Protocol Violation|1|||
150174590|NCT06129045|541774491|FG000|Overall Study|Lost to Follow-up|1|||
150174591|NCT06129045|541774492|FG001|Overall Study|Lost to Follow-up|1|||
150174592|NCT06129045|541774493|FG002|Overall Study|Lost to Follow-up|4|||
150174593|NCT01582269|541774496|FG000|Overall Study|Withdrawal by Subject|1|||
150174594|NCT01582269|541774497|FG001|Overall Study|Withdrawal by Subject|0|||
150174595|NCT01582269|541774498|FG002|Overall Study|Withdrawal by Subject|0|||
150174596|NCT06218251|541774499|FG000|Overall Study|Lost to Follow-up|4|||
150174597|NCT05076266|541774500|FG000|Overall Study|Survey not complete - Participant refusal|2|||
150174598|NCT05076266|541774501|FG001|Overall Study|Survey not complete - Participant refusal|0|||
149801794|NCT04338685|540402440|FG002|Overall Study|Study terminated by Sponsor|1|||
150174599|NCT00997386|541774502|FG000|Overall Study|Death|7|||
150174600|NCT03785782|541775905|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
150174601|NCT03785782|541775906|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
150174602|NCT03785782|541775905|FG000|Overall Study|Withdrawal by Subject|1|||
150174603|NCT03785782|541775906|FG001|Overall Study|Withdrawal by Subject|1|||
150174604|NCT03785782|541775905|FG000|Overall Study|insufficient image quality.|3|||
150174605|NCT03785782|541775906|FG001|Overall Study|insufficient image quality.|0|||
150174606|NCT00818454|541775907|FG000|Treatment Period 1|Adverse Event|0|||
150174607|NCT00818454|541775908|FG001|Treatment Period 1|Adverse Event|1|||
150174608|NCT00818454|541775909|FG002|Treatment Period 1|Adverse Event|0|||
150174609|NCT00818454|541775910|FG003|Treatment Period 1|Adverse Event|0|||
150174610|NCT00818454|541775907|FG000|Treatment Period 1|Other|3|||
150174611|NCT00818454|541775908|FG001|Treatment Period 1|Other|0|||
150174612|NCT00818454|541775909|FG002|Treatment Period 1|Other|0|||
150174613|NCT00818454|541775910|FG003|Treatment Period 1|Other|0|||
150174614|NCT00818454|541775907|FG000|Washout Period of 1 Week|Adverse Event|1|||
150174615|NCT00818454|541775908|FG001|Washout Period of 1 Week|Adverse Event|1|||
150174616|NCT00818454|541775909|FG002|Washout Period of 1 Week|Adverse Event|0|||
150174617|NCT00818454|541775910|FG003|Washout Period of 1 Week|Adverse Event|0|||
150174618|NCT00818454|541775907|FG000|Washout Period of 1 Week|Protocol Violation|2|||
150174619|NCT00818454|541775908|FG001|Washout Period of 1 Week|Protocol Violation|0|||
150174620|NCT00818454|541775909|FG002|Washout Period of 1 Week|Protocol Violation|0|||
150174621|NCT00818454|541775910|FG003|Washout Period of 1 Week|Protocol Violation|0|||
150174622|NCT00818454|541775907|FG000|Washout Period of 1 Week|Other|1|||
150174623|NCT00818454|541775908|FG001|Washout Period of 1 Week|Other|2|||
150174624|NCT00818454|541775909|FG002|Washout Period of 1 Week|Other|0|||
150174625|NCT00818454|541775910|FG003|Washout Period of 1 Week|Other|0|||
150174626|NCT00818454|541775907|FG000|Treatment Period 2|Other|2|||
150174627|NCT00818454|541775908|FG001|Treatment Period 2|Other|1|||
150174628|NCT00818454|541775909|FG002|Treatment Period 2|Other|0|||
150174629|NCT00818454|541775910|FG003|Treatment Period 2|Other|0|||
150174630|NCT00818454|541775907|FG000|Treatment Period 3|Adverse Event|0|||
150174631|NCT00818454|541775908|FG001|Treatment Period 3|Adverse Event|0|||
150174632|NCT00818454|541775909|FG002|Treatment Period 3|Adverse Event|0|||
150174633|NCT00818454|541775910|FG003|Treatment Period 3|Adverse Event|1|||
150174634|NCT01307267|541775915|FG000|Overall Study|Death|4|||
150174635|NCT01307267|541775916|FG001|Overall Study|Death|3|||
150174636|NCT01307267|541775917|FG002|Overall Study|Death|5|||
150174637|NCT01307267|541775918|FG003|Overall Study|Death|3|||
150174638|NCT01307267|541775919|FG004|Overall Study|Death|1|||
150174639|NCT01307267|541775920|FG005|Overall Study|Death|26|||
150174640|NCT01307267|541775921|FG006|Overall Study|Death|2|||
150174641|NCT01307267|541775922|FG007|Overall Study|Death|2|||
150174642|NCT01307267|541775923|FG008|Overall Study|Death|21|||
150174643|NCT01307267|541775924|FG009|Overall Study|Death|2|||
150174644|NCT01307267|541775925|FG010|Overall Study|Death|3|||
150174645|NCT01307267|541775926|FG011|Overall Study|Death|9|||
150174646|NCT01307267|541775927|FG012|Overall Study|Death|0|||
150174647|NCT01307267|541775928|FG013|Overall Study|Death|0|||
150174648|NCT01307267|541775929|FG014|Overall Study|Death|0|||
150174649|NCT01307267|541775930|FG015|Overall Study|Death|0|||
150174650|NCT01307267|541775931|FG016|Overall Study|Death|1|||
150174651|NCT01307267|541775932|FG017|Overall Study|Death|1|||
150174652|NCT01307267|541775933|FG018|Overall Study|Death|2|||
150174653|NCT01307267|541775934|FG019|Overall Study|Death|8|||
150174654|NCT01307267|541775935|FG020|Overall Study|Death|1|||
150174655|NCT01307267|541775936|FG021|Overall Study|Death|2|||
150174656|NCT01307267|541775937|FG022|Overall Study|Death|2|||
149964662|NCT03715829|541006702|FG007|Dose Ranging Period|Lost to Follow-up|0|||
149964663|NCT03715829|541006703|FG008|Dose Ranging Period|Lost to Follow-up|0|||
149964664|NCT03715829|541006704|FG009|Dose Ranging Period|Lost to Follow-up|0|||
149964665|NCT03715829|541006705|FG010|Dose Ranging Period|Lost to Follow-up|0|||
149964666|NCT03715829|541006695|FG000|Dose Ranging Period|Protocol Violation|0|||
149964667|NCT03715829|541006696|FG001|Dose Ranging Period|Protocol Violation|0|||
149964668|NCT03715829|541006697|FG002|Dose Ranging Period|Protocol Violation|0|||
150174657|NCT01307267|541775915|FG000|Overall Study|Lost to Follow-up|0|||
150174658|NCT01307267|541775916|FG001|Overall Study|Lost to Follow-up|0|||
150174659|NCT01307267|541775917|FG002|Overall Study|Lost to Follow-up|0|||
150043630|NCT04139798|541298725|FG000|Overall Study|Adverse Event|1|||
149964669|NCT03715829|541006698|FG003|Dose Ranging Period|Protocol Violation|1|||
149964670|NCT03715829|541006699|FG004|Dose Ranging Period|Protocol Violation|0|||
149964671|NCT03715829|541006700|FG005|Dose Ranging Period|Protocol Violation|0|||
149964672|NCT03715829|541006701|FG006|Dose Ranging Period|Protocol Violation|0|||
149964673|NCT03715829|541006702|FG007|Dose Ranging Period|Protocol Violation|0|||
149964674|NCT03715829|541006703|FG008|Dose Ranging Period|Protocol Violation|0|||
149964675|NCT03715829|541006704|FG009|Dose Ranging Period|Protocol Violation|0|||
149964676|NCT03715829|541006705|FG010|Dose Ranging Period|Protocol Violation|0|||
149964677|NCT03715829|541006695|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
149964678|NCT03715829|541006696|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
149964679|NCT03715829|541006697|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
149964680|NCT03715829|541006698|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
150043631|NCT04139798|541298726|FG001|Overall Study|Adverse Event|3|||
149964681|NCT03715829|541006699|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
149964682|NCT03715829|541006700|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
149964683|NCT03715829|541006701|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
150043632|NCT04139798|541298725|FG000|Overall Study|Protocol Violation|1|||
150043633|NCT04139798|541298726|FG001|Overall Study|Protocol Violation|0|||
149964684|NCT03715829|541006702|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
149964685|NCT03715829|541006703|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
149964686|NCT03715829|541006704|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
149964687|NCT03715829|541006705|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
149964688|NCT03715829|541006695|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
150174660|NCT01307267|541775918|FG003|Overall Study|Lost to Follow-up|0|||
149964689|NCT03715829|541006696|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964690|NCT03715829|541006697|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
150043634|NCT04411667|541298729|FG000|Overall Study|Physician Decision|1|||
150174661|NCT01307267|541775919|FG004|Overall Study|Lost to Follow-up|0|||
150174662|NCT01307267|541775920|FG005|Overall Study|Lost to Follow-up|7|||
150174663|NCT01307267|541775921|FG006|Overall Study|Lost to Follow-up|0|||
150174664|NCT01307267|541775922|FG007|Overall Study|Lost to Follow-up|0|||
150174665|NCT01307267|541775923|FG008|Overall Study|Lost to Follow-up|1|||
150174666|NCT01307267|541775924|FG009|Overall Study|Lost to Follow-up|2|||
150174667|NCT01307267|541775925|FG010|Overall Study|Lost to Follow-up|1|||
150174668|NCT01307267|541775926|FG011|Overall Study|Lost to Follow-up|0|||
150174669|NCT01307267|541775927|FG012|Overall Study|Lost to Follow-up|0|||
150174670|NCT01307267|541775928|FG013|Overall Study|Lost to Follow-up|0|||
150174671|NCT01307267|541775929|FG014|Overall Study|Lost to Follow-up|0|||
150174672|NCT01307267|541775930|FG015|Overall Study|Lost to Follow-up|0|||
150174673|NCT01307267|541775931|FG016|Overall Study|Lost to Follow-up|0|||
150174674|NCT01307267|541775932|FG017|Overall Study|Lost to Follow-up|0|||
150174675|NCT01307267|541775933|FG018|Overall Study|Lost to Follow-up|0|||
150174676|NCT01307267|541775934|FG019|Overall Study|Lost to Follow-up|2|||
150174677|NCT01307267|541775935|FG020|Overall Study|Lost to Follow-up|0|||
150174678|NCT01307267|541775936|FG021|Overall Study|Lost to Follow-up|0|||
150174679|NCT01307267|541775937|FG022|Overall Study|Lost to Follow-up|0|||
150174680|NCT01307267|541775915|FG000|Overall Study|Withdrawal by Subject|0|||
150174681|NCT01307267|541775916|FG001|Overall Study|Withdrawal by Subject|0|||
150174682|NCT01307267|541775917|FG002|Overall Study|Withdrawal by Subject|0|||
150174683|NCT01307267|541775918|FG003|Overall Study|Withdrawal by Subject|0|||
150174684|NCT01307267|541775919|FG004|Overall Study|Withdrawal by Subject|0|||
150174685|NCT01307267|541775920|FG005|Overall Study|Withdrawal by Subject|1|||
150174686|NCT01307267|541775921|FG006|Overall Study|Withdrawal by Subject|0|||
150174687|NCT01307267|541775922|FG007|Overall Study|Withdrawal by Subject|1|||
150174688|NCT01307267|541775923|FG008|Overall Study|Withdrawal by Subject|5|||
150174689|NCT01307267|541775924|FG009|Overall Study|Withdrawal by Subject|1|||
150174690|NCT01307267|541775925|FG010|Overall Study|Withdrawal by Subject|1|||
150174691|NCT01307267|541775926|FG011|Overall Study|Withdrawal by Subject|1|||
150174692|NCT01307267|541775927|FG012|Overall Study|Withdrawal by Subject|0|||
150174693|NCT01307267|541775928|FG013|Overall Study|Withdrawal by Subject|0|||
150174694|NCT01307267|541775929|FG014|Overall Study|Withdrawal by Subject|0|||
150174695|NCT01307267|541775930|FG015|Overall Study|Withdrawal by Subject|0|||
150174696|NCT01307267|541775931|FG016|Overall Study|Withdrawal by Subject|0|||
150174697|NCT01307267|541775932|FG017|Overall Study|Withdrawal by Subject|0|||
150174698|NCT01307267|541775933|FG018|Overall Study|Withdrawal by Subject|0|||
150174699|NCT01307267|541775934|FG019|Overall Study|Withdrawal by Subject|3|||
150174700|NCT01307267|541775935|FG020|Overall Study|Withdrawal by Subject|0|||
150174701|NCT01307267|541775936|FG021|Overall Study|Withdrawal by Subject|0|||
150174702|NCT01307267|541775937|FG022|Overall Study|Withdrawal by Subject|0|||
150174703|NCT01307267|541775915|FG000|Overall Study|Other|0|||
150174704|NCT01307267|541775916|FG001|Overall Study|Other|0|||
150174705|NCT01307267|541775917|FG002|Overall Study|Other|0|||
150174706|NCT01307267|541775918|FG003|Overall Study|Other|0|||
150174707|NCT01307267|541775919|FG004|Overall Study|Other|0|||
150174708|NCT01307267|541775920|FG005|Overall Study|Other|7|||
150174709|NCT01307267|541775921|FG006|Overall Study|Other|0|||
150174710|NCT01307267|541775922|FG007|Overall Study|Other|1|||
150174711|NCT01307267|541775923|FG008|Overall Study|Other|3|||
150174712|NCT01307267|541775924|FG009|Overall Study|Other|0|||
150174713|NCT01307267|541775925|FG010|Overall Study|Other|1|||
150174714|NCT01307267|541775926|FG011|Overall Study|Other|1|||
150174715|NCT01307267|541775927|FG012|Overall Study|Other|1|||
150174716|NCT01307267|541775928|FG013|Overall Study|Other|0|||
150174717|NCT01307267|541775929|FG014|Overall Study|Other|2|||
150174718|NCT01307267|541775930|FG015|Overall Study|Other|1|||
150174719|NCT01307267|541775931|FG016|Overall Study|Other|0|||
150174720|NCT01307267|541775932|FG017|Overall Study|Other|0|||
150174721|NCT01307267|541775933|FG018|Overall Study|Other|0|||
150174722|NCT01307267|541775934|FG019|Overall Study|Other|19|||
150174723|NCT01307267|541775935|FG020|Overall Study|Other|2|||
150174724|NCT01307267|541775936|FG021|Overall Study|Other|3|||
150174725|NCT01307267|541775937|FG022|Overall Study|Other|2|||
150174726|NCT01786564|541775942|FG000|Overall Study|Lost to Follow-up|47|||
150174727|NCT01786564|541775942|FG000|Overall Study|Ineligible|17|||
150174728|NCT00494442|541775943|FG000|Overall Study|Death|1|||
150174729|NCT00494442|541775944|FG001|Overall Study|Death|1|||
150174730|NCT00494442|541775943|FG000|Overall Study|Lack of Efficacy|16|||
150174731|NCT00494442|541775944|FG001|Overall Study|Lack of Efficacy|10|||
150174732|NCT00494442|541775943|FG000|Overall Study|Adverse Event|0|||
150174733|NCT00494442|541775944|FG001|Overall Study|Adverse Event|2|||
150174734|NCT00494442|541775943|FG000|Overall Study|Physician Decision|0|||
150174735|NCT00494442|541775944|FG001|Overall Study|Physician Decision|1|||
150174736|NCT00494442|541775943|FG000|Overall Study|Non-compliance|0|||
150174737|NCT00494442|541775944|FG001|Overall Study|Non-compliance|1|||
150174738|NCT00494442|541775943|FG000|Overall Study|Intercurrent illness|0|||
150174739|NCT00494442|541775944|FG001|Overall Study|Intercurrent illness|1|||
150174740|NCT01241292|541775945|FG000|Overall Study|Administrative Reason by Sponsor|1|||
150174741|NCT01241292|541775946|FG001|Overall Study|Administrative Reason by Sponsor|0|||
150174742|NCT01241292|541775945|FG000|Overall Study|Disease Progression|2|||
150174743|NCT01241292|541775946|FG001|Overall Study|Disease Progression|0|||
150174744|NCT01241292|541775945|FG000|Overall Study|Study Drug Toxicity|0|||
150174745|NCT01241292|541775946|FG001|Overall Study|Study Drug Toxicity|1|||
150174746|NCT01241292|541775945|FG000|Overall Study|Participant Discontinued Treatment|0|||
150174747|NCT01241292|541775946|FG001|Overall Study|Participant Discontinued Treatment|2|||
150174748|NCT03034915|541775947|FG000|Overall Study|Adverse Event|29|||
149879194|NCT02289456|540685854|FG000|Induction Period|Adverse Event|11|||
150174749|NCT03034915|541775948|FG001|Overall Study|Adverse Event|32|||
150174750|NCT03034915|541775949|FG002|Overall Study|Adverse Event|22|||
150174751|NCT03034915|541775947|FG000|Overall Study|Lost to Follow-up|5|||
150174752|NCT03034915|541775948|FG001|Overall Study|Lost to Follow-up|13|||
150174753|NCT03034915|541775949|FG002|Overall Study|Lost to Follow-up|3|||
150174754|NCT03034915|541775947|FG000|Overall Study|Withdrawal by Subject|29|||
150174755|NCT03034915|541775948|FG001|Overall Study|Withdrawal by Subject|46|||
150174756|NCT03034915|541775949|FG002|Overall Study|Withdrawal by Subject|41|||
150174757|NCT03034915|541775947|FG000|Overall Study|Protocol Deviation|2|||
150174758|NCT03034915|541775948|FG001|Overall Study|Protocol Deviation|14|||
150174759|NCT03034915|541775949|FG002|Overall Study|Protocol Deviation|7|||
150174760|NCT03034915|541775947|FG000|Overall Study|Lack of Efficacy|8|||
150174761|NCT03034915|541775948|FG001|Overall Study|Lack of Efficacy|16|||
150174762|NCT03034915|541775949|FG002|Overall Study|Lack of Efficacy|18|||
149964691|NCT03715829|541006698|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964692|NCT03715829|541006699|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964693|NCT03715829|541006700|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964694|NCT03715829|541006701|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964695|NCT03715829|541006702|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964696|NCT03715829|541006703|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964697|NCT03715829|541006704|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964698|NCT03715829|541006705|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
149964699|NCT03715829|541006695|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964700|NCT03715829|541006696|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
150174763|NCT03034915|541775947|FG000|Overall Study|Site closed|2|||
150174764|NCT03034915|541775948|FG001|Overall Study|Site closed|2|||
150174765|NCT03034915|541775949|FG002|Overall Study|Site closed|4|||
150174766|NCT03034915|541775947|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
150174767|NCT03034915|541775948|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
150174768|NCT03034915|541775949|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
150174769|NCT03034915|541775947|FG000|Overall Study|Physician Decision|1|||
150174770|NCT03034915|541775948|FG001|Overall Study|Physician Decision|5|||
150174771|NCT03034915|541775949|FG002|Overall Study|Physician Decision|2|||
150174772|NCT03861767|541775952|FG000|Overall Study|Withdrawal by Subject|2|||
150174773|NCT03861767|541775953|FG001|Overall Study|Withdrawal by Subject|1|||
150174774|NCT03861767|541775954|FG002|Overall Study|Withdrawal by Subject|0|||
150174775|NCT03861767|541775955|FG003|Overall Study|Withdrawal by Subject|5|||
150174776|NCT03861767|541775956|FG004|Overall Study|Withdrawal by Subject|2|||
150174777|NCT03861767|541775957|FG005|Overall Study|Withdrawal by Subject|1|||
150174778|NCT03861767|541775958|FG006|Overall Study|Withdrawal by Subject|3|||
150174779|NCT03861767|541775959|FG007|Overall Study|Withdrawal by Subject|1|||
150174780|NCT03861767|541775960|FG008|Overall Study|Withdrawal by Subject|0|||
150174781|NCT03861767|541775961|FG009|Overall Study|Withdrawal by Subject|5|||
150174782|NCT03184558|541775962|FG000|Overall Study|Withdrawal by Subject|2|||
150174783|NCT03184558|541775962|FG000|Overall Study|Death|16|||
149964701|NCT03715829|541006697|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
150043635|NCT04411667|541298730|FG001|Overall Study|Physician Decision|0|||
150174784|NCT03184558|541775962|FG000|Overall Study|Lost to Follow-up|2|||
150174785|NCT03184558|541775962|FG000|Overall Study|Other|9|||
150174786|NCT01254019|541775963|FG000|Overall Study|Adverse Event|0|||
150174787|NCT01254019|541775964|FG001|Overall Study|Adverse Event|2|||
150174788|NCT01254019|541775963|FG000|Overall Study|Protocol Violation|1|||
150174789|NCT01254019|541775964|FG001|Overall Study|Protocol Violation|0|||
150174790|NCT01254019|541775963|FG000|Overall Study|Withdrawal by Subject|0|||
150174791|NCT01254019|541775964|FG001|Overall Study|Withdrawal by Subject|2|||
150174792|NCT03061474|541775965|FG000|Overall Study|Adverse Event|2|||
150174793|NCT03061474|541775966|FG001|Overall Study|Adverse Event|0|||
150174794|NCT03061474|541775965|FG000|Overall Study|Safety Risk|0|||
150174795|NCT03061474|541775966|FG001|Overall Study|Safety Risk|1|||
150174796|NCT03061474|541775965|FG000|Overall Study|Participant unwilling or unable to participate|0|||
150174797|NCT03061474|541775966|FG001|Overall Study|Participant unwilling or unable to participate|2|||
150174798|NCT03061474|541775965|FG000|Overall Study|Lost to Follow-up|0|||
150174799|NCT03061474|541775966|FG001|Overall Study|Lost to Follow-up|1|||
150174800|NCT01391130|541775967|FG000|Overall Study|Withdrawal by Subject|3|||
150174801|NCT01391130|541775968|FG001|Overall Study|Withdrawal by Subject|2|||
150174802|NCT01391130|541775967|FG000|Overall Study|Physician Decision|2|||
150174803|NCT01391130|541775968|FG001|Overall Study|Physician Decision|3|||
150174804|NCT01391130|541775967|FG000|Overall Study|Did not Receive Drug|1|||
150174805|NCT01391130|541775968|FG001|Overall Study|Did not Receive Drug|1|||
150174806|NCT05001945|541775971|FG000|Overall Study|Adverse Event|0|||
150174807|NCT05001945|541775972|FG001|Overall Study|Adverse Event|0|||
150174808|NCT05001945|541775973|FG002|Overall Study|Adverse Event|0|||
150174809|NCT05001945|541775974|FG003|Overall Study|Adverse Event|1|||
150174810|NCT05001945|541775975|FG004|Overall Study|Adverse Event|0|||
150174811|NCT05001945|541775976|FG005|Overall Study|Adverse Event|0|||
150174812|NCT05001945|541775977|FG006|Overall Study|Adverse Event|0|||
150174813|NCT05001945|541775978|FG007|Overall Study|Adverse Event|0|||
150174814|NCT05001945|541775971|FG000|Overall Study|Lost to Follow-up|0|||
150174815|NCT05001945|541775972|FG001|Overall Study|Lost to Follow-up|1|||
150174816|NCT05001945|541775973|FG002|Overall Study|Lost to Follow-up|1|||
150174817|NCT05001945|541775974|FG003|Overall Study|Lost to Follow-up|2|||
150174818|NCT05001945|541775975|FG004|Overall Study|Lost to Follow-up|0|||
150174819|NCT05001945|541775976|FG005|Overall Study|Lost to Follow-up|1|||
150174820|NCT05001945|541775977|FG006|Overall Study|Lost to Follow-up|0|||
150174821|NCT05001945|541775978|FG007|Overall Study|Lost to Follow-up|0|||
150174822|NCT05001945|541775971|FG000|Overall Study|Protocol Violation|1|||
150174823|NCT05001945|541775972|FG001|Overall Study|Protocol Violation|0|||
150174824|NCT05001945|541775973|FG002|Overall Study|Protocol Violation|1|||
150174825|NCT05001945|541775974|FG003|Overall Study|Protocol Violation|1|||
150174826|NCT05001945|541775975|FG004|Overall Study|Protocol Violation|0|||
150174827|NCT05001945|541775976|FG005|Overall Study|Protocol Violation|1|||
150174828|NCT05001945|541775977|FG006|Overall Study|Protocol Violation|0|||
150174829|NCT05001945|541775978|FG007|Overall Study|Protocol Violation|0|||
150174830|NCT05001945|541775971|FG000|Overall Study|Withdrawal by Subject|0|||
150174831|NCT05001945|541775972|FG001|Overall Study|Withdrawal by Subject|0|||
150174832|NCT05001945|541775973|FG002|Overall Study|Withdrawal by Subject|0|||
150174833|NCT05001945|541775974|FG003|Overall Study|Withdrawal by Subject|1|||
150174834|NCT05001945|541775975|FG004|Overall Study|Withdrawal by Subject|1|||
150174835|NCT05001945|541775976|FG005|Overall Study|Withdrawal by Subject|1|||
150174836|NCT05001945|541775977|FG006|Overall Study|Withdrawal by Subject|0|||
150174837|NCT05001945|541775978|FG007|Overall Study|Withdrawal by Subject|1|||
150174838|NCT05001945|541775971|FG000|Overall Study|Not specified by Investigator|0|||
150174839|NCT05001945|541775972|FG001|Overall Study|Not specified by Investigator|3|||
150174840|NCT05001945|541775973|FG002|Overall Study|Not specified by Investigator|0|||
150174841|NCT05001945|541775974|FG003|Overall Study|Not specified by Investigator|0|||
150174842|NCT05001945|541775975|FG004|Overall Study|Not specified by Investigator|1|||
150174843|NCT05001945|541775976|FG005|Overall Study|Not specified by Investigator|0|||
150174844|NCT05001945|541775977|FG006|Overall Study|Not specified by Investigator|0|||
150174845|NCT05001945|541775978|FG007|Overall Study|Not specified by Investigator|0|||
149879195|NCT02289456|540685854|FG000|Induction Period|Progressive Disease (PD)|4|||
149879196|NCT02289456|540685854|FG000|Induction Period|Symptomatic Deterioration|4|||
149879197|NCT02289456|540685854|FG000|Induction Period|Withdrawal by Subject|2|||
149879198|NCT02289456|540685854|FG000|Induction Period|Miscellaneous|1|||
149879199|NCT02289456|540685854|FG000|Monotherapy Period|Death|1|||
150174846|NCT00545077|541775979|FG000|Overall Study|Treatment not received|5|||
149964702|NCT03715829|541006698|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964703|NCT03715829|541006699|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
149964704|NCT03715829|541006700|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964705|NCT03715829|541006701|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964706|NCT03715829|541006702|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964707|NCT03715829|541006703|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964708|NCT03715829|541006704|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964709|NCT03715829|541006705|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
149964710|NCT03715829|541006695|FG000|Dose Ranging Period|Other|0|||
149964711|NCT03715829|541006696|FG001|Dose Ranging Period|Other|0|||
149964712|NCT03715829|541006697|FG002|Dose Ranging Period|Other|2|||
149964713|NCT03715829|541006698|FG003|Dose Ranging Period|Other|0|||
149964714|NCT03715829|541006699|FG004|Dose Ranging Period|Other|0|||
149964715|NCT03715829|541006700|FG005|Dose Ranging Period|Other|3|||
149964716|NCT03715829|541006701|FG006|Dose Ranging Period|Other|0|||
149964717|NCT03715829|541006702|FG007|Dose Ranging Period|Other|0|||
149964718|NCT03715829|541006703|FG008|Dose Ranging Period|Other|0|||
149964719|NCT03715829|541006704|FG009|Dose Ranging Period|Other|0|||
149964720|NCT03715829|541006705|FG010|Dose Ranging Period|Other|0|||
149964721|NCT03715829|541006695|FG000|Extension Period|Adverse Event|0|||
149964722|NCT03715829|541006696|FG001|Extension Period|Adverse Event|0|||
149964723|NCT03715829|541006697|FG002|Extension Period|Adverse Event|0|||
149964724|NCT03715829|541006698|FG003|Extension Period|Adverse Event|0|||
149964725|NCT03715829|541006699|FG004|Extension Period|Adverse Event|0|||
149964726|NCT03715829|541006700|FG005|Extension Period|Adverse Event|0|||
149964727|NCT03715829|541006701|FG006|Extension Period|Adverse Event|3|||
149964728|NCT03715829|541006702|FG007|Extension Period|Adverse Event|1|||
149964729|NCT03715829|541006703|FG008|Extension Period|Adverse Event|6|||
149964730|NCT03715829|541006704|FG009|Extension Period|Adverse Event|0|||
149964731|NCT03715829|541006705|FG010|Extension Period|Adverse Event|0|||
149964732|NCT03715829|541006695|FG000|Extension Period|Lack of Efficacy|0|||
149964733|NCT03715829|541006696|FG001|Extension Period|Lack of Efficacy|0|||
149964734|NCT03715829|541006697|FG002|Extension Period|Lack of Efficacy|0|||
149964735|NCT03715829|541006698|FG003|Extension Period|Lack of Efficacy|0|||
149964736|NCT03715829|541006699|FG004|Extension Period|Lack of Efficacy|0|||
149964737|NCT03715829|541006700|FG005|Extension Period|Lack of Efficacy|0|||
149964738|NCT03715829|541006701|FG006|Extension Period|Lack of Efficacy|1|||
149964739|NCT03715829|541006702|FG007|Extension Period|Lack of Efficacy|9|||
149964740|NCT03715829|541006703|FG008|Extension Period|Lack of Efficacy|2|||
149964741|NCT03715829|541006704|FG009|Extension Period|Lack of Efficacy|0|||
149964742|NCT03715829|541006705|FG010|Extension Period|Lack of Efficacy|0|||
149964743|NCT03715829|541006695|FG000|Extension Period|Lost to Follow-up|0|||
149964744|NCT03715829|541006696|FG001|Extension Period|Lost to Follow-up|0|||
149964745|NCT03715829|541006697|FG002|Extension Period|Lost to Follow-up|0|||
149964746|NCT03715829|541006698|FG003|Extension Period|Lost to Follow-up|0|||
149964747|NCT03715829|541006699|FG004|Extension Period|Lost to Follow-up|0|||
149964748|NCT03715829|541006700|FG005|Extension Period|Lost to Follow-up|0|||
149964749|NCT03715829|541006701|FG006|Extension Period|Lost to Follow-up|0|||
149964750|NCT03715829|541006702|FG007|Extension Period|Lost to Follow-up|0|||
149964751|NCT03715829|541006703|FG008|Extension Period|Lost to Follow-up|2|||
149964752|NCT03715829|541006704|FG009|Extension Period|Lost to Follow-up|0|||
149964753|NCT03715829|541006705|FG010|Extension Period|Lost to Follow-up|0|||
149964754|NCT03715829|541006695|FG000|Extension Period|Protocol Violation|0|||
149964755|NCT03715829|541006696|FG001|Extension Period|Protocol Violation|0|||
149964756|NCT03715829|541006697|FG002|Extension Period|Protocol Violation|0|||
149964757|NCT03715829|541006698|FG003|Extension Period|Protocol Violation|0|||
149964758|NCT03715829|541006699|FG004|Extension Period|Protocol Violation|0|||
150043636|NCT00714870|541298731|FG000|Overall Study|Lost to Follow-up|22|||
149964759|NCT03715829|541006700|FG005|Extension Period|Protocol Violation|0|||
149964760|NCT03715829|541006701|FG006|Extension Period|Protocol Violation|0|||
149964761|NCT03715829|541006702|FG007|Extension Period|Protocol Violation|0|||
150174847|NCT00545077|541775980|FG001|Overall Study|Treatment not received|1|||
150174848|NCT00545077|541775979|FG000|Overall Study|Disease Progression|131|||
150174849|NCT00545077|541775980|FG001|Overall Study|Disease Progression|98|||
150174850|NCT00545077|541775979|FG000|Overall Study|Withdrawal by Subject|3|||
150174851|NCT00545077|541775980|FG001|Overall Study|Withdrawal by Subject|14|||
150174852|NCT00545077|541775979|FG000|Overall Study|Physician Decision|6|||
150174853|NCT00545077|541775980|FG001|Overall Study|Physician Decision|3|||
150174854|NCT00545077|541775979|FG000|Overall Study|Lost to Follow-up|2|||
150174855|NCT00545077|541775980|FG001|Overall Study|Lost to Follow-up|0|||
150174856|NCT00545077|541775979|FG000|Overall Study|Protocol Violation|1|||
150174857|NCT00545077|541775980|FG001|Overall Study|Protocol Violation|0|||
150174858|NCT00545077|541775979|FG000|Overall Study|Adverse Event|0|||
150174859|NCT00545077|541775980|FG001|Overall Study|Adverse Event|31|||
150174860|NCT00545077|541775979|FG000|Overall Study|Death|0|||
150174861|NCT00545077|541775980|FG001|Overall Study|Death|8|||
150174862|NCT01179334|541775981|FG000|Treatment Period|Adverse Event|1|||
150174863|NCT01179334|541775982|FG001|Treatment Period|Adverse Event|0|||
150174864|NCT01179334|541775981|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
149964762|NCT03715829|541006703|FG008|Extension Period|Protocol Violation|1|||
149964763|NCT03715829|541006704|FG009|Extension Period|Protocol Violation|0|||
149964764|NCT03715829|541006705|FG010|Extension Period|Protocol Violation|0|||
149964765|NCT03715829|541006695|FG000|Extension Period|Withdrawal by Subject|0|||
150174865|NCT01179334|541775982|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
150174866|NCT01179334|541775981|FG000|Long-term Extension (LTE) Period|Death|3|||
150174867|NCT01179334|541775982|FG001|Long-term Extension (LTE) Period|Death|0|||
150174868|NCT01179334|541775981|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
149964766|NCT03715829|541006696|FG001|Extension Period|Withdrawal by Subject|0|||
150174869|NCT01179334|541775982|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
150174870|NCT04177394|541775983|FG000|Overall Study|Death|16|||
149964767|NCT03715829|541006697|FG002|Extension Period|Withdrawal by Subject|0|||
149964768|NCT03715829|541006698|FG003|Extension Period|Withdrawal by Subject|0|||
149964769|NCT03715829|541006699|FG004|Extension Period|Withdrawal by Subject|0|||
149964770|NCT03715829|541006700|FG005|Extension Period|Withdrawal by Subject|0|||
149964771|NCT03715829|541006701|FG006|Extension Period|Withdrawal by Subject|3|||
149964772|NCT03715829|541006702|FG007|Extension Period|Withdrawal by Subject|3|||
149964773|NCT03715829|541006703|FG008|Extension Period|Withdrawal by Subject|12|||
150043637|NCT00714870|541298732|FG001|Overall Study|Lost to Follow-up|5|||
149964774|NCT03715829|541006704|FG009|Extension Period|Withdrawal by Subject|3|||
149964775|NCT03715829|541006705|FG010|Extension Period|Withdrawal by Subject|0|||
149964776|NCT03715829|541006695|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964777|NCT03715829|541006696|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964778|NCT03715829|541006697|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964779|NCT03715829|541006698|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964780|NCT03715829|541006699|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964781|NCT03715829|541006700|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964782|NCT03715829|541006701|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964783|NCT03715829|541006702|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
149964784|NCT03715829|541006703|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
149964785|NCT03715829|541006704|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964786|NCT03715829|541006705|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
149964787|NCT03715829|541006695|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964788|NCT03715829|541006696|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964789|NCT03715829|541006697|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964790|NCT03715829|541006698|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964791|NCT03715829|541006699|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964792|NCT03715829|541006700|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964793|NCT03715829|541006701|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964794|NCT03715829|541006702|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964795|NCT03715829|541006703|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
149964796|NCT03715829|541006704|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964797|NCT03715829|541006705|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
149964798|NCT03715829|541006695|FG000|Extension Period|Other|0|||
149964799|NCT03715829|541006696|FG001|Extension Period|Other|0|||
149964800|NCT03715829|541006697|FG002|Extension Period|Other|0|||
149964801|NCT03715829|541006698|FG003|Extension Period|Other|0|||
149964802|NCT03715829|541006699|FG004|Extension Period|Other|0|||
149964803|NCT03715829|541006700|FG005|Extension Period|Other|0|||
149964804|NCT03715829|541006701|FG006|Extension Period|Other|1|||
149964805|NCT03715829|541006702|FG007|Extension Period|Other|2|||
149964806|NCT03715829|541006703|FG008|Extension Period|Other|4|||
149964807|NCT03715829|541006704|FG009|Extension Period|Other|0|||
149964808|NCT03715829|541006705|FG010|Extension Period|Other|0|||
149964809|NCT00069953|541006707|FG000|Overall Study|Protocol Violation|2|||
149964810|NCT03253627|541006710|FG000|Overall Study|Lost to Follow-up|1|||
149964811|NCT03253627|541006711|FG001|Overall Study|Lost to Follow-up|2|||
149964812|NCT03253627|541006710|FG000|Overall Study|Withdrawal by Subject|0|||
149964813|NCT03253627|541006711|FG001|Overall Study|Withdrawal by Subject|2|||
149964814|NCT03253627|541006710|FG000|Overall Study|Inability to complete MRI|1|||
149964815|NCT03253627|541006711|FG001|Overall Study|Inability to complete MRI|0|||
149964816|NCT03829683|541006712|FG000|Overall Study|Lost to Follow-up|1|||
149964817|NCT03829683|541006713|FG001|Overall Study|Lost to Follow-up|0|||
149964818|NCT03829683|541006712|FG000|Overall Study|Physician Decision|3|||
149964819|NCT03829683|541006713|FG001|Overall Study|Physician Decision|1|||
149964820|NCT03829683|541006712|FG000|Overall Study|Withdrawal by Subject|0|||
149964821|NCT03829683|541006713|FG001|Overall Study|Withdrawal by Subject|1|||
149964822|NCT03829683|541006712|FG000|Overall Study|Discharge from hospital|1|||
150174871|NCT04177394|541775983|FG000|Overall Study|Withdrawal by Subject|19|||
150174872|NCT04177394|541775983|FG000|Overall Study|Missed visits|61|||
150174873|NCT04177394|541775983|FG000|Overall Study|Expected Visits|15|||
150174874|NCT00843882|541775984|FG000|Step 1|Lack of Efficacy|14|||
150174875|NCT00843882|541775985|FG001|Step 1|Lack of Efficacy|10|||
150174876|NCT00843882|541775986|FG002|Step 1|Lack of Efficacy|21|||
150174877|NCT00843882|541775984|FG000|Step 1|Adverse Event|8|||
150174878|NCT00843882|541775985|FG001|Step 1|Adverse Event|17|||
150174879|NCT00843882|541775986|FG002|Step 1|Adverse Event|20|||
150174880|NCT00843882|541775984|FG000|Step 1|Death|1|||
150174881|NCT00843882|541775985|FG001|Step 1|Death|2|||
150174882|NCT00843882|541775986|FG002|Step 1|Death|4|||
150174883|NCT00843882|541775984|FG000|Step 1|Withdrawal by Subject|6|||
150174884|NCT00843882|541775985|FG001|Step 1|Withdrawal by Subject|12|||
150174885|NCT00843882|541775986|FG002|Step 1|Withdrawal by Subject|9|||
150174886|NCT00843882|541775984|FG000|Step 1|Physician Decision|0|||
150174887|NCT00843882|541775985|FG001|Step 1|Physician Decision|5|||
150174888|NCT00843882|541775986|FG002|Step 1|Physician Decision|1|||
150174889|NCT00843882|541775984|FG000|Step 1|Patient and physician's decision|0|||
150174890|NCT00843882|541775985|FG001|Step 1|Patient and physician's decision|0|||
150174891|NCT00843882|541775986|FG002|Step 1|Patient and physician's decision|1|||
150174892|NCT00843882|541775984|FG000|Step 1|Other complicating disease|1|||
150174893|NCT00843882|541775985|FG001|Step 1|Other complicating disease|3|||
150174894|NCT00843882|541775986|FG002|Step 1|Other complicating disease|4|||
150174895|NCT00843882|541775984|FG000|Step 1|Alternative therapy|0|||
150174896|NCT00843882|541775985|FG001|Step 1|Alternative therapy|1|||
150174897|NCT00843882|541775986|FG002|Step 1|Alternative therapy|1|||
150174898|NCT00843882|541775984|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
150174899|NCT00843882|541775985|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
150174900|NCT00843882|541775986|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
150174901|NCT00843882|541775984|FG000|Step 1|Off treatment reason unknown|0|||
150174902|NCT00843882|541775985|FG001|Step 1|Off treatment reason unknown|1|||
150174903|NCT00843882|541775986|FG002|Step 1|Off treatment reason unknown|4|||
150174904|NCT00843882|541775984|FG000|Step 1|Never started treatment|2|||
150174905|NCT00843882|541775985|FG001|Step 1|Never started treatment|0|||
150174906|NCT00843882|541775986|FG002|Step 1|Never started treatment|0|||
150174907|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
150174908|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
150174909|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
150174910|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
150174911|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
150174912|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
150174913|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
150174914|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
150174915|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
150174916|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
150174917|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
150174918|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
150174919|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
150174920|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
150174921|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
150174922|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
150174923|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
150174924|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
150174925|NCT00843882|541775984|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
150174926|NCT00843882|541775985|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
150174927|NCT00843882|541775986|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
150174928|NCT00256243|541775987|FG000|Overall Study|Lost to Follow-up|2|||
150174929|NCT00256243|541775987|FG000|Overall Study|Death|7|||
150174930|NCT00256243|541775987|FG000|Overall Study|Not treated|1|||
150174931|NCT05797155|541775988|FG000|Overall Study|Lost to Follow-up|33|||
150174932|NCT05797155|541775989|FG001|Overall Study|Lost to Follow-up|12|||
150174933|NCT00026312|541775990|FG000|Overall Study|Adverse Event|0|||
150174934|NCT00026312|541775991|FG001|Overall Study|Adverse Event|32|||
150174935|NCT00026312|541775990|FG000|Overall Study|Death|1|||
150174936|NCT00026312|541775991|FG001|Overall Study|Death|7|||
150174937|NCT00026312|541775990|FG000|Overall Study|Lack of Efficacy|19|||
150174938|NCT00026312|541775991|FG001|Overall Study|Lack of Efficacy|114|||
150174939|NCT00026312|541775990|FG000|Overall Study|Lost to Follow-up|0|||
150174940|NCT00026312|541775991|FG001|Overall Study|Lost to Follow-up|5|||
149879200|NCT02289456|540685854|FG000|Monotherapy Period|Adverse Event|1|||
149964823|NCT03829683|541006713|FG001|Overall Study|Discharge from hospital|0|||
149964824|NCT03163667|541006714|FG000|Overall Study|Death|15|||
149964825|NCT03163667|541006715|FG001|Overall Study|Death|27|||
149964826|NCT03163667|541006714|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
149964827|NCT03163667|541006715|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
149964828|NCT00979407|541006716|FG000|Overall Study|Withdrawal by Subject|3|||
149964829|NCT00979407|541006717|FG001|Overall Study|Withdrawal by Subject|4|||
149964830|NCT00979407|541006716|FG000|Overall Study|Lost to Follow-up|3|||
149964831|NCT00979407|541006717|FG001|Overall Study|Lost to Follow-up|3|||
149964832|NCT02420314|541006718|FG000|Overall Study|Withdrawal by Subject|1|||
149964833|NCT02420314|541006718|FG000|Overall Study|Protocol Violation|1|||
149964834|NCT03760068|541006719|FG000|Overall Study|Withdrawal by Subject|7|||
149964835|NCT03760068|541006720|FG001|Overall Study|Withdrawal by Subject|8|||
149964836|NCT03760068|541006719|FG000|Overall Study|Adverse Event|1|||
149964837|NCT03760068|541006720|FG001|Overall Study|Adverse Event|2|||
149964838|NCT03760068|541006719|FG000|Overall Study|Administrative Decision by Sponsor|0|||
149964839|NCT03760068|541006720|FG001|Overall Study|Administrative Decision by Sponsor|2|||
149964840|NCT03760068|541006719|FG000|Overall Study|Physician Decision|1|||
149964841|NCT03760068|541006720|FG001|Overall Study|Physician Decision|2|||
149964842|NCT03760068|541006719|FG000|Overall Study|Lost to Follow-up|4|||
149964843|NCT03760068|541006720|FG001|Overall Study|Lost to Follow-up|9|||
149964844|NCT03760068|541006719|FG000|Overall Study|Subject Moved Out of State|1|||
149964845|NCT03760068|541006720|FG001|Overall Study|Subject Moved Out of State|0|||
149964846|NCT05430919|541006721|FG000|Overall Study|Protocol Violation|0|||
149964847|NCT05430919|541006722|FG001|Overall Study|Protocol Violation|0|||
149964848|NCT05430919|541006723|FG002|Overall Study|Protocol Violation|1|||
149964849|NCT05430919|541006724|FG003|Overall Study|Protocol Violation|0|||
149964850|NCT05430919|541006721|FG000|Overall Study|Lost to Follow-up|0|||
149964851|NCT05430919|541006722|FG001|Overall Study|Lost to Follow-up|1|||
149964852|NCT05430919|541006723|FG002|Overall Study|Lost to Follow-up|0|||
149964853|NCT05430919|541006724|FG003|Overall Study|Lost to Follow-up|0|||
149964854|NCT05430919|541006721|FG000|Overall Study|Withdrawal by Subject|3|||
149964855|NCT05430919|541006722|FG001|Overall Study|Withdrawal by Subject|0|||
149964856|NCT05430919|541006723|FG002|Overall Study|Withdrawal by Subject|0|||
149964857|NCT05430919|541006724|FG003|Overall Study|Withdrawal by Subject|1|||
149964858|NCT00855166|541006727|FG000|Overall Study|Adverse Event|0|||
149964859|NCT00855166|541006728|FG001|Overall Study|Adverse Event|2|||
149964860|NCT00855166|541006727|FG000|Overall Study|Death|0|||
149964861|NCT00855166|541006728|FG001|Overall Study|Death|1|||
149964862|NCT00855166|541006727|FG000|Overall Study|Withdrawal by Subject|1|||
149964863|NCT00855166|541006728|FG001|Overall Study|Withdrawal by Subject|4|||
149964864|NCT00855166|541006727|FG000|Overall Study|Poor/non-compliance|2|||
149964865|NCT00855166|541006728|FG001|Overall Study|Poor/non-compliance|0|||
149964866|NCT00855166|541006727|FG000|Overall Study|Administrative reasons by sponsor|1|||
149964867|NCT00855166|541006728|FG001|Overall Study|Administrative reasons by sponsor|0|||
149964868|NCT00855166|541006727|FG000|Overall Study|Subject no longer meets study criteria|1|||
149964869|NCT00855166|541006728|FG001|Overall Study|Subject no longer meets study criteria|1|||
149964870|NCT00803049|541006729|FG000|Overall Study|Adverse Event|21|||
149964871|NCT00803049|541006730|FG001|Overall Study|Adverse Event|33|||
149964872|NCT00803049|541006731|FG002|Overall Study|Adverse Event|13|||
149964873|NCT00803049|541006732|FG003|Overall Study|Adverse Event|27|||
149964874|NCT00803049|541006729|FG000|Overall Study|Lack of Efficacy|10|||
149964875|NCT00803049|541006730|FG001|Overall Study|Lack of Efficacy|19|||
149964876|NCT00803049|541006731|FG002|Overall Study|Lack of Efficacy|6|||
149964877|NCT00803049|541006732|FG003|Overall Study|Lack of Efficacy|13|||
149964878|NCT00803049|541006729|FG000|Overall Study|Lost to Follow-up|0|||
150043638|NCT00714870|541298731|FG000|Overall Study|patient unable to come b/c back pain|1|||
149964879|NCT00803049|541006730|FG001|Overall Study|Lost to Follow-up|2|||
149964880|NCT00803049|541006731|FG002|Overall Study|Lost to Follow-up|0|||
149964881|NCT00803049|541006732|FG003|Overall Study|Lost to Follow-up|3|||
149964882|NCT00803049|541006729|FG000|Overall Study|Death|2|||
149964883|NCT00803049|541006730|FG001|Overall Study|Death|1|||
150043639|NCT00714870|541298732|FG001|Overall Study|patient unable to come b/c back pain|0|||
150043640|NCT00714870|541298731|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
150043641|NCT00714870|541298732|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
150043642|NCT03399552|541298733|FG000|Overall Study|No evidence of disease|1|||
150043643|NCT03399552|541298733|FG000|Overall Study|Unevaluable|1|||
150043644|NCT02357368|541298734|FG000|Overall Study|Lost to Follow-up|0|||
150043645|NCT02357368|541298735|FG001|Overall Study|Lost to Follow-up|0|||
150043646|NCT02357368|541298736|FG002|Overall Study|Lost to Follow-up|0|||
150043647|NCT02357368|541298737|FG003|Overall Study|Lost to Follow-up|1|||
150043648|NCT02357368|541298734|FG000|Overall Study|Pregnancy|3|||
150043649|NCT02357368|541298735|FG001|Overall Study|Pregnancy|2|||
149964884|NCT00803049|541006731|FG002|Overall Study|Death|0|||
149964885|NCT00803049|541006732|FG003|Overall Study|Death|2|||
149964886|NCT00803049|541006729|FG000|Overall Study|Progressive Disease|6|||
150043650|NCT02357368|541298736|FG002|Overall Study|Pregnancy|0|||
150043651|NCT02357368|541298737|FG003|Overall Study|Pregnancy|0|||
150043652|NCT02357368|541298734|FG000|Overall Study|Withdrawal by Subject|3|||
150043653|NCT02357368|541298735|FG001|Overall Study|Withdrawal by Subject|1|||
150043654|NCT02357368|541298736|FG002|Overall Study|Withdrawal by Subject|1|||
150043655|NCT02357368|541298737|FG003|Overall Study|Withdrawal by Subject|2|||
150043656|NCT03895840|541298738|FG000|Overall Study|Withdrawal by Subject|21|||
150043657|NCT01931566|541298739|FG000|Overall Study|Randomized But Not Treated|6|||
150043658|NCT01931566|541298740|FG001|Overall Study|Randomized But Not Treated|9|||
150043659|NCT01931566|541298741|FG002|Overall Study|Randomized But Not Treated|14|||
150043660|NCT01931566|541298739|FG000|Overall Study|Adverse Event|37|||
150043661|NCT01931566|541298740|FG001|Overall Study|Adverse Event|167|||
150043662|NCT01931566|541298741|FG002|Overall Study|Adverse Event|132|||
149964887|NCT00803049|541006730|FG001|Overall Study|Progressive Disease|10|||
149964888|NCT00803049|541006731|FG002|Overall Study|Progressive Disease|6|||
149964889|NCT00803049|541006732|FG003|Overall Study|Progressive Disease|6|||
149964890|NCT00803049|541006729|FG000|Overall Study|Withdrawal by Subject|19|||
149964891|NCT00803049|541006730|FG001|Overall Study|Withdrawal by Subject|43|||
149964892|NCT00803049|541006731|FG002|Overall Study|Withdrawal by Subject|16|||
149964893|NCT00803049|541006732|FG003|Overall Study|Withdrawal by Subject|44|||
150043663|NCT01931566|541298739|FG000|Overall Study|Major Protocol Deviation|5|||
150043664|NCT01931566|541298740|FG001|Overall Study|Major Protocol Deviation|14|||
150043665|NCT01931566|541298741|FG002|Overall Study|Major Protocol Deviation|21|||
150043666|NCT01931566|541298739|FG000|Overall Study|Lost to Follow-up|3|||
150043667|NCT01931566|541298740|FG001|Overall Study|Lost to Follow-up|26|||
150043668|NCT01931566|541298741|FG002|Overall Study|Lost to Follow-up|23|||
150043669|NCT01931566|541298739|FG000|Overall Study|Voluntary Withdrawal|78|||
149964894|NCT00803049|541006729|FG000|Overall Study|Protocol Violation|0|||
149964895|NCT00803049|541006730|FG001|Overall Study|Protocol Violation|1|||
149964896|NCT00803049|541006731|FG002|Overall Study|Protocol Violation|1|||
149964897|NCT00803049|541006732|FG003|Overall Study|Protocol Violation|0|||
149964898|NCT00803049|541006729|FG000|Overall Study|Randomized and Not Treated|0|||
149964899|NCT00803049|541006730|FG001|Overall Study|Randomized and Not Treated|0|||
149964900|NCT00803049|541006731|FG002|Overall Study|Randomized and Not Treated|0|||
149964901|NCT00803049|541006732|FG003|Overall Study|Randomized and Not Treated|2|||
149964902|NCT00803049|541006729|FG000|Overall Study|Other than Specified Above|3|||
149964903|NCT00803049|541006730|FG001|Overall Study|Other than Specified Above|9|||
149964904|NCT00803049|541006731|FG002|Overall Study|Other than Specified Above|2|||
149964905|NCT00803049|541006732|FG003|Overall Study|Other than Specified Above|5|||
149964906|NCT01272219|541006743|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
149964907|NCT01272219|541006744|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
149964908|NCT01272219|541006745|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
149964909|NCT01272219|541006746|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
149964910|NCT01272219|541006747|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
149964911|NCT01272219|541006748|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
149964912|NCT01272219|541006743|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
149964913|NCT01272219|541006744|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
149964914|NCT01272219|541006745|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
149964915|NCT01272219|541006746|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
149964916|NCT01272219|541006747|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
149964917|NCT01272219|541006748|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
149964918|NCT01272219|541006743|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
149964919|NCT01272219|541006744|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
149964920|NCT01272219|541006745|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
149964921|NCT01272219|541006746|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
149964922|NCT01272219|541006747|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
149964923|NCT01272219|541006748|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
149964924|NCT01272219|541006743|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
149964925|NCT01272219|541006744|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
149964926|NCT01272219|541006745|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
149964927|NCT01272219|541006746|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
149964928|NCT01272219|541006747|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
149964929|NCT01272219|541006748|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
149964930|NCT01272219|541006743|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
149964931|NCT01272219|541006744|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
149964932|NCT01272219|541006745|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
149964933|NCT01272219|541006746|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
149964934|NCT01272219|541006747|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
149964935|NCT01272219|541006748|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
149964936|NCT01272219|541006743|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
149964937|NCT01272219|541006744|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
149964938|NCT01272219|541006745|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
149964939|NCT01272219|541006746|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
149964940|NCT01272219|541006747|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
149964941|NCT01272219|541006748|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
149964942|NCT01272219|541006743|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
149964943|NCT01272219|541006744|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
149964944|NCT01272219|541006745|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
149964945|NCT01272219|541006746|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
149964946|NCT01272219|541006747|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
149964947|NCT01272219|541006748|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
149964948|NCT01272219|541006743|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
150043670|NCT01931566|541298740|FG001|Overall Study|Voluntary Withdrawal|245|||
150174941|NCT00026312|541775990|FG000|Overall Study|Physician Decision|1|||
150174942|NCT00026312|541775991|FG001|Overall Study|Physician Decision|37|||
150174943|NCT00026312|541775990|FG000|Overall Study|Protocol Violation|0|||
150174944|NCT00026312|541775991|FG001|Overall Study|Protocol Violation|3|||
150174945|NCT00026312|541775990|FG000|Overall Study|Withdrawal by Subject|1|||
150174946|NCT00026312|541775991|FG001|Overall Study|Withdrawal by Subject|6|||
150174947|NCT00026312|541775990|FG000|Overall Study|Ineligible|4|||
150174948|NCT00026312|541775991|FG001|Overall Study|Ineligible|5|||
150174949|NCT00026312|541775990|FG000|Overall Study|Entry onto another COG study|0|||
150174950|NCT00026312|541775991|FG001|Overall Study|Entry onto another COG study|1|||
150174951|NCT00026312|541775990|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
150174952|NCT00026312|541775991|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
150174953|NCT02445391|541775992|FG000|Overall Study|No active protocol treatment|3|||
149879201|NCT02289456|540685854|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
149879202|NCT02289456|540685854|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
150043671|NCT01931566|541298741|FG002|Overall Study|Voluntary Withdrawal|225|||
150043672|NCT01931566|541298739|FG000|Overall Study|Study Termination|289|||
150043673|NCT01931566|541298740|FG001|Overall Study|Study Termination|968|||
150043674|NCT01931566|541298741|FG002|Overall Study|Study Termination|1037|||
150043675|NCT01931566|541298739|FG000|Overall Study|Reason Not Specified|11|||
150174954|NCT02445391|541775993|FG001|Overall Study|No active protocol treatment|0|||
150174955|NCT02445391|541775994|FG002|Overall Study|No active protocol treatment|0|||
150174956|NCT02445391|541775992|FG000|Overall Study|Adverse Event|0|||
150174957|NCT02445391|541775993|FG001|Overall Study|Adverse Event|21|||
150174958|NCT02445391|541775994|FG002|Overall Study|Adverse Event|12|||
150174959|NCT02445391|541775992|FG000|Overall Study|Alternative therapy|0|||
150174960|NCT02445391|541775993|FG001|Overall Study|Alternative therapy|0|||
150174961|NCT02445391|541775994|FG002|Overall Study|Alternative therapy|1|||
149964949|NCT01272219|541006744|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
149964950|NCT01272219|541006745|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
149964951|NCT01272219|541006746|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
149964952|NCT01272219|541006747|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
149964953|NCT01272219|541006748|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
149964954|NCT01272219|541006743|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
149964955|NCT01272219|541006744|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
149964956|NCT01272219|541006745|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
149964957|NCT01272219|541006746|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
149964958|NCT01272219|541006747|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
150174962|NCT02445391|541775992|FG000|Overall Study|Disease progression|0|||
150174963|NCT02445391|541775993|FG001|Overall Study|Disease progression|7|||
150174964|NCT02445391|541775994|FG002|Overall Study|Disease progression|22|||
149964959|NCT01272219|541006748|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
150174965|NCT02445391|541775992|FG000|Overall Study|Complicating disease|0|||
150174966|NCT02445391|541775993|FG001|Overall Study|Complicating disease|2|||
150174967|NCT02445391|541775994|FG002|Overall Study|Complicating disease|1|||
150174968|NCT02445391|541775992|FG000|Overall Study|Withdrawal by Subject|0|||
150174969|NCT02445391|541775993|FG001|Overall Study|Withdrawal by Subject|4|||
150043676|NCT01931566|541298740|FG001|Overall Study|Reason Not Specified|47|||
150043677|NCT01931566|541298741|FG002|Overall Study|Reason Not Specified|53|||
150043678|NCT01931566|541298739|FG000|Overall Study|Missing|0|||
150043679|NCT01931566|541298740|FG001|Overall Study|Missing|0|||
150043680|NCT01931566|541298741|FG002|Overall Study|Missing|1|||
150043681|NCT00760617|541298743|FG000|Overall Study|Adverse Event|5|||
150043682|NCT00760617|541298744|FG001|Overall Study|Adverse Event|2|||
150043683|NCT00760617|541298745|FG002|Overall Study|Adverse Event|0|||
150043684|NCT00760617|541298743|FG000|Overall Study|Lost to Follow-up|0|||
150043685|NCT00760617|541298744|FG001|Overall Study|Lost to Follow-up|0|||
150043686|NCT00760617|541298745|FG002|Overall Study|Lost to Follow-up|5|||
150043687|NCT04476797|541298746|FG000|Overall Study|Withdrawal by Subject|1|||
150043688|NCT04476797|541298747|FG001|Overall Study|Withdrawal by Subject|0|||
150043689|NCT04476797|541298748|FG002|Overall Study|Withdrawal by Subject|0|||
149964960|NCT01272219|541006743|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
149964961|NCT01272219|541006744|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
149964962|NCT01272219|541006745|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
149964963|NCT01272219|541006746|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
149964964|NCT01272219|541006747|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
149964965|NCT01272219|541006748|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
149964966|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
149964967|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
150043690|NCT04476797|541298746|FG000|Overall Study|Death|0|||
150043691|NCT04476797|541298747|FG001|Overall Study|Death|1|||
150043692|NCT04476797|541298748|FG002|Overall Study|Death|2|||
149879203|NCT02289456|540685854|FG000|Monotherapy Period|Withdrawal by Subject|2|||
149879204|NCT02289456|540685854|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
149879205|NCT02289456|540685854|FG000|Monotherapy Period|Miscellaneous|1|||
149879206|NCT02681510|540685855|FG000|Overall Study|Withdrawal by Subject|1|||
149879207|NCT02681510|540685855|FG000|Overall Study|Lost to Follow-up|9|||
149879208|NCT01721317|540685857|FG000|Overall Study|Study Closed / Terminated|2|||
149879209|NCT01721317|540685858|FG001|Overall Study|Study Closed / Terminated|2|||
149879210|NCT01721317|540685857|FG000|Overall Study|Physician Decision|0|||
149879211|NCT01721317|540685858|FG001|Overall Study|Physician Decision|1|||
149879212|NCT01721317|540685857|FG000|Overall Study|Withdrawal by Subject|0|||
149879213|NCT01721317|540685858|FG001|Overall Study|Withdrawal by Subject|1|||
149879214|NCT02806024|540685865|FG000|Overall Study|Night Delivery|1|||
149879215|NCT02806024|540685866|FG001|Overall Study|Night Delivery|1|||
149879216|NCT02806024|540685865|FG000|Overall Study|DVT during antepartum admission|0|||
149879217|NCT02806024|540685866|FG001|Overall Study|DVT during antepartum admission|1|||
149964968|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
149964969|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
149964970|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
149964971|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
149964972|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
149964973|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
149964974|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
149964975|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
149964976|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
150043693|NCT04476797|541298746|FG000|Overall Study|Sponsor Terminated Study|0|||
150043694|NCT04476797|541298747|FG001|Overall Study|Sponsor Terminated Study|18|||
150043695|NCT04476797|541298748|FG002|Overall Study|Sponsor Terminated Study|17|||
150043696|NCT04625101|541298751|FG000|Overall Study|Withdrawal by Subject|0|||
150043697|NCT04625101|541298752|FG001|Overall Study|Withdrawal by Subject|1|||
150043698|NCT04625101|541298751|FG000|Overall Study|Protocol Deviation|1|||
150043699|NCT04625101|541298752|FG001|Overall Study|Protocol Deviation|0|||
150043700|NCT02991040|541298753|FG000|Overall Study|Withdrawal by Subject|2|||
150043701|NCT02991040|541298753|FG000|Overall Study|Lost to Follow-up|2|||
150043702|NCT04287517|541298754|FG000|Overall Study|Withdrawal by Subject|1|||
150043703|NCT04287517|541298755|FG001|Overall Study|Withdrawal by Subject|1|||
150043704|NCT03857867|541298757|FG000|Overall Study|Physician Decision|1|||
150043705|NCT01869764|541298758|FG000|Overall Study|Withdrawal by Subject|0|||
150043706|NCT01869764|541298759|FG001|Overall Study|Withdrawal by Subject|2|||
150043707|NCT01286480|541298760|FG000|Overall Study|Withdrawal by Subject|5|||
150043708|NCT01286480|541298761|FG001|Overall Study|Withdrawal by Subject|3|||
150043709|NCT01918306|541298762|FG000|Overall Study|progresive disease|4|||
150043710|NCT01918306|541298763|FG001|Overall Study|progresive disease|0|||
150043711|NCT01918306|541298764|FG002|Overall Study|progresive disease|1|||
150043712|NCT01918306|541298765|FG003|Overall Study|progresive disease|1|||
150043713|NCT01918306|541298762|FG000|Overall Study|Withdrawal by Subject|0|||
150043714|NCT01918306|541298763|FG001|Overall Study|Withdrawal by Subject|0|||
150043715|NCT01918306|541298764|FG002|Overall Study|Withdrawal by Subject|0|||
150043716|NCT01918306|541298765|FG003|Overall Study|Withdrawal by Subject|2|||
150043717|NCT01918306|541298762|FG000|Overall Study|neutropenia|1|||
150043718|NCT01918306|541298763|FG001|Overall Study|neutropenia|0|||
150043719|NCT01918306|541298764|FG002|Overall Study|neutropenia|0|||
150043720|NCT01918306|541298765|FG003|Overall Study|neutropenia|0|||
150043721|NCT01918306|541298762|FG000|Overall Study|Lack of Efficacy|1|||
150043722|NCT01918306|541298763|FG001|Overall Study|Lack of Efficacy|0|||
150043723|NCT01918306|541298764|FG002|Overall Study|Lack of Efficacy|0|||
150043724|NCT01918306|541298765|FG003|Overall Study|Lack of Efficacy|0|||
150043725|NCT01918306|541298762|FG000|Overall Study|progress disease, crossover|0|||
150043726|NCT01918306|541298763|FG001|Overall Study|progress disease, crossover|0|||
150043727|NCT01918306|541298764|FG002|Overall Study|progress disease, crossover|1|||
150043728|NCT01918306|541298765|FG003|Overall Study|progress disease, crossover|0|||
150043729|NCT02506244|541298768|FG000|Overall Study|Did not undergo active monitoring|458|||
149964977|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
149964978|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
149964979|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
149964980|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
149964981|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
149964982|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
149964983|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
149964984|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
149964985|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
149964986|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
149964987|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
149964988|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
149964989|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
149964990|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
149964991|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
150043730|NCT02506244|541298769|FG001|Overall Study|Did not undergo active monitoring|459|||
150043731|NCT02506244|541298770|FG002|Overall Study|Did not undergo active monitoring|0|||
150043732|NCT04717336|541298772|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
150043733|NCT04717336|541298773|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
150043734|NCT04717336|541298772|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
150043735|NCT04717336|541298773|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
150043736|NCT02039843|541298774|FG000|Randomization and Observation Period|Adverse Event|2|||
150043737|NCT02039843|541298775|FG001|Randomization and Observation Period|Adverse Event|0|||
150043738|NCT02039843|541298774|FG000|Randomization and Observation Period|Death|1|||
150043739|NCT02039843|541298775|FG001|Randomization and Observation Period|Death|0|||
150043740|NCT02039843|541298774|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
150043741|NCT02039843|541298775|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
150043742|NCT02039843|541298774|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
150043743|NCT02039843|541298775|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
150043744|NCT02039843|541298774|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
150043745|NCT02039843|541298775|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
150043746|NCT02039843|541298774|FG000|Pairing With a Study Dog|Death|1|||
150043747|NCT02039843|541298775|FG001|Pairing With a Study Dog|Death|0|||
150043748|NCT02039843|541298774|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
150043749|NCT02039843|541298775|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
150043750|NCT02039843|541298774|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
150043751|NCT02039843|541298775|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
150043752|NCT02039843|541298774|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
149964992|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
149964993|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
149964994|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
149964995|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
149964996|NCT01272219|541006743|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
149964997|NCT01272219|541006744|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
149964998|NCT01272219|541006745|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
150043753|NCT02039843|541298775|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
149964999|NCT01272219|541006746|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
149965000|NCT01272219|541006747|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
149965001|NCT01272219|541006748|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
149965002|NCT01491919|541006749|FG000|Overall Study|Insufficient PK sampling|1|||
149965003|NCT01491919|541006750|FG001|Overall Study|Insufficient PK sampling|2|||
149965004|NCT01491919|541006751|FG002|Overall Study|Insufficient PK sampling|1|||
149965005|NCT04003389|541006752|FG000|Overall Study|Adverse Event|27|||
149965006|NCT04003389|541006753|FG001|Overall Study|Adverse Event|34|||
149965007|NCT04003389|541006754|FG002|Overall Study|Adverse Event|28|||
149965008|NCT04003389|541006752|FG000|Overall Study|Lost to Follow-up|39|||
149965009|NCT04003389|541006753|FG001|Overall Study|Lost to Follow-up|30|||
149965010|NCT04003389|541006754|FG002|Overall Study|Lost to Follow-up|33|||
149965011|NCT04003389|541006752|FG000|Overall Study|Protocol Violation|1|||
149965012|NCT04003389|541006753|FG001|Overall Study|Protocol Violation|6|||
149965013|NCT04003389|541006754|FG002|Overall Study|Protocol Violation|5|||
149965014|NCT04003389|541006752|FG000|Overall Study|Withdrawal by Subject|119|||
149965015|NCT04003389|541006753|FG001|Overall Study|Withdrawal by Subject|79|||
149965016|NCT04003389|541006754|FG002|Overall Study|Withdrawal by Subject|85|||
149965017|NCT04003389|541006752|FG000|Overall Study|Miscellaneous|14|||
149965018|NCT04003389|541006753|FG001|Overall Study|Miscellaneous|11|||
149965019|NCT04003389|541006754|FG002|Overall Study|Miscellaneous|14|||
149965020|NCT04003389|541006752|FG000|Overall Study|Participant did not receive study drug|1|||
149965021|NCT04003389|541006753|FG001|Overall Study|Participant did not receive study drug|0|||
150174970|NCT02445391|541775994|FG002|Overall Study|Withdrawal by Subject|9|||
150174971|NCT02445391|541775992|FG000|Overall Study|Financial issue|0|||
149965022|NCT04003389|541006754|FG002|Overall Study|Participant did not receive study drug|0|||
149965023|NCT04439903|541006757|FG000|Overall Study|Withdrawal by Subject|2|||
149965024|NCT04439903|541006757|FG000|Overall Study|Screen Failure|1|||
150043754|NCT01958164|541298776|FG000|Overall Study|Adverse Event|0|||
150043755|NCT01958164|541298777|FG001|Overall Study|Adverse Event|2|||
150043756|NCT01958164|541298776|FG000|Overall Study|Lost to Follow-up|2|||
150043757|NCT01958164|541298777|FG001|Overall Study|Lost to Follow-up|3|||
150043758|NCT02807402|541298780|FG000|Overall Study|Failure to Return|1|||
150043759|NCT02807402|541298780|FG000|Overall Study|Death|3|||
150043760|NCT02807402|541298780|FG000|Overall Study|Other|2|||
150043761|NCT02102204|541300668|FG000|Overall Study|Withdrawal by Subject|137|||
150043762|NCT02102204|541300668|FG000|Overall Study|Death|92|||
150174972|NCT02445391|541775993|FG001|Overall Study|Financial issue|0|||
150043763|NCT02102204|541300668|FG000|Overall Study|Lost to Follow-up|65|||
150043764|NCT02102204|541300668|FG000|Overall Study|Sponsor Decision|5|||
150043765|NCT02102204|541300668|FG000|Overall Study|Ongoing|5|||
150043766|NCT03894813|541300669|FG000|Overall Study|Adverse Event|1|||
150043767|NCT03894813|541300670|FG001|Overall Study|Adverse Event|1|||
150043768|NCT03894813|541300669|FG000|Overall Study|Lack of Efficacy|3|||
150043769|NCT03894813|541300670|FG001|Overall Study|Lack of Efficacy|3|||
150043770|NCT03894813|541300669|FG000|Overall Study|Lost to Follow-up|1|||
150043771|NCT03894813|541300670|FG001|Overall Study|Lost to Follow-up|0|||
150043772|NCT03894813|541300669|FG000|Overall Study|Pregnancy|2|||
150043773|NCT03894813|541300670|FG001|Overall Study|Pregnancy|1|||
150043774|NCT03894813|541300669|FG000|Overall Study|Protocol Violation|3|||
150043775|NCT03894813|541300670|FG001|Overall Study|Protocol Violation|7|||
150043776|NCT03894813|541300669|FG000|Overall Study|Withdrawal by Subject|1|||
150043777|NCT03894813|541300670|FG001|Overall Study|Withdrawal by Subject|3|||
150043778|NCT03894813|541300669|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
150043779|NCT03894813|541300670|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
150043780|NCT02656693|541300671|FG000|Overall Study|Pregnancy|1|||
150043781|NCT02656693|541300672|FG001|Overall Study|Pregnancy|1|||
150043782|NCT02656693|541300673|FG002|Overall Study|Pregnancy|1|||
150043783|NCT02656693|541300671|FG000|Overall Study|Bariatric surgery|0|||
150043784|NCT02656693|541300672|FG001|Overall Study|Bariatric surgery|1|||
150043785|NCT02656693|541300673|FG002|Overall Study|Bariatric surgery|2|||
150043786|NCT01596062|541300676|FG000|Overall Study|Adverse Event|1|||
150043787|NCT01596062|541300677|FG001|Overall Study|Adverse Event|0|||
150043788|NCT01596062|541300678|FG002|Overall Study|Adverse Event|2|||
150043789|NCT01596062|541300676|FG000|Overall Study|Lack of Efficacy|0|||
149965025|NCT02899754|541006758|FG000|Overall Study|Lost to Follow-up|7|||
149965026|NCT02899754|541006759|FG001|Overall Study|Lost to Follow-up|9|||
149965027|NCT04818229|541006762|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
149965028|NCT04818229|541006763|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
149965029|NCT04818229|541006764|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
149965030|NCT04818229|541006762|FG000|Overall Study|Adverse Event|3|||
149965031|NCT04818229|541006763|FG001|Overall Study|Adverse Event|1|||
149965032|NCT04818229|541006764|FG002|Overall Study|Adverse Event|1|||
149965033|NCT04818229|541006762|FG000|Overall Study|Withdrawal by Subject|0|||
149965034|NCT04818229|541006763|FG001|Overall Study|Withdrawal by Subject|0|||
149965035|NCT04818229|541006764|FG002|Overall Study|Withdrawal by Subject|2|||
149965036|NCT04818229|541006762|FG000|Overall Study|Lost to Follow-up|0|||
149965037|NCT04818229|541006763|FG001|Overall Study|Lost to Follow-up|0|||
149965038|NCT04818229|541006764|FG002|Overall Study|Lost to Follow-up|1|||
149965039|NCT04082364|541006765|FG000|Overall Study|Death|23|||
149965040|NCT04082364|541006766|FG001|Overall Study|Death|1|||
149965041|NCT04082364|541006767|FG002|Overall Study|Death|1|||
149965042|NCT04082364|541006768|FG003|Overall Study|Death|2|||
149965043|NCT04082364|541006769|FG004|Overall Study|Death|1|||
149965044|NCT04082364|541006765|FG000|Overall Study|Lost to Follow-up|1|||
149965045|NCT04082364|541006766|FG001|Overall Study|Lost to Follow-up|0|||
149965046|NCT04082364|541006767|FG002|Overall Study|Lost to Follow-up|0|||
149965047|NCT04082364|541006768|FG003|Overall Study|Lost to Follow-up|0|||
149965048|NCT04082364|541006769|FG004|Overall Study|Lost to Follow-up|1|||
149965049|NCT04082364|541006765|FG000|Overall Study|Physician Decision|1|||
149965050|NCT04082364|541006766|FG001|Overall Study|Physician Decision|1|||
149965051|NCT04082364|541006767|FG002|Overall Study|Physician Decision|0|||
149965052|NCT04082364|541006768|FG003|Overall Study|Physician Decision|2|||
149965053|NCT04082364|541006769|FG004|Overall Study|Physician Decision|1|||
149965054|NCT04082364|541006765|FG000|Overall Study|Withdrawal by Subject|1|||
149965055|NCT04082364|541006766|FG001|Overall Study|Withdrawal by Subject|1|||
149965056|NCT04082364|541006767|FG002|Overall Study|Withdrawal by Subject|0|||
149965057|NCT04082364|541006768|FG003|Overall Study|Withdrawal by Subject|0|||
149965058|NCT04082364|541006769|FG004|Overall Study|Withdrawal by Subject|1|||
149965059|NCT04082364|541006765|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
149965060|NCT04082364|541006766|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
149965061|NCT04082364|541006767|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
149965062|NCT04082364|541006768|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
149965063|NCT04082364|541006769|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
149965064|NCT04082364|541006765|FG000|Overall Study|Disease progression|0|||
149965065|NCT04082364|541006766|FG001|Overall Study|Disease progression|0|||
149965066|NCT04082364|541006767|FG002|Overall Study|Disease progression|0|||
149965067|NCT04082364|541006768|FG003|Overall Study|Disease progression|1|||
149965068|NCT04082364|541006769|FG004|Overall Study|Disease progression|0|||
149965069|NCT03186378|541006770|FG000|Overall Study|Lost to Follow-up|1|||
149965070|NCT03186378|541006771|FG001|Overall Study|Lost to Follow-up|0|||
149965071|NCT02514746|541006778|FG000|Overall Study|Chronically Ill|1|||
149965072|NCT02514746|541006779|FG001|Overall Study|Chronically Ill|2|||
149965073|NCT02514746|541006778|FG000|Overall Study|Physician Decision|4|||
149965074|NCT02514746|541006779|FG001|Overall Study|Physician Decision|2|||
149965075|NCT02514746|541006778|FG000|Overall Study|Withdrawal by Subject|12|||
149879218|NCT02892149|540685867|FG000|Overall Study|Death|262|||
149879219|NCT02892149|540685868|FG001|Overall Study|Death|278|||
149879220|NCT02892149|540685867|FG000|Overall Study|Withdrawal by Subject|53|||
149879221|NCT02892149|540685868|FG001|Overall Study|Withdrawal by Subject|47|||
149879222|NCT02892149|540685867|FG000|Overall Study|Lost to Follow-up|37|||
149879223|NCT02892149|540685868|FG001|Overall Study|Lost to Follow-up|31|||
149879224|NCT01098474|540685869|FG000|Active Phase|Other|0|||
149879225|NCT01098474|540685870|FG001|Active Phase|Other|0|||
149879226|NCT01098474|540685871|FG002|Active Phase|Other|3|||
149879227|NCT01098474|540685872|FG003|Active Phase|Other|0|||
149879228|NCT01098474|540685873|FG004|Active Phase|Other|0|||
149879229|NCT01098474|540685874|FG005|Active Phase|Other|0|||
149879230|NCT01098474|540685869|FG000|Active Phase|Withdrawal by Subject|1|||
149879231|NCT01098474|540685870|FG001|Active Phase|Withdrawal by Subject|1|||
149879232|NCT01098474|540685871|FG002|Active Phase|Withdrawal by Subject|2|||
149879233|NCT01098474|540685872|FG003|Active Phase|Withdrawal by Subject|0|||
149879234|NCT01098474|540685873|FG004|Active Phase|Withdrawal by Subject|0|||
149879235|NCT01098474|540685874|FG005|Active Phase|Withdrawal by Subject|0|||
149879236|NCT01098474|540685869|FG000|Active Phase|Lost to Follow-up|1|||
149879237|NCT01098474|540685870|FG001|Active Phase|Lost to Follow-up|0|||
149879238|NCT01098474|540685871|FG002|Active Phase|Lost to Follow-up|0|||
149879239|NCT01098474|540685872|FG003|Active Phase|Lost to Follow-up|0|||
149879240|NCT01098474|540685873|FG004|Active Phase|Lost to Follow-up|0|||
149879241|NCT01098474|540685874|FG005|Active Phase|Lost to Follow-up|0|||
149879242|NCT01098474|540685869|FG000|Follow Up Phase|Travelled out of study area|0|||
149879243|NCT01098474|540685870|FG001|Follow Up Phase|Travelled out of study area|0|||
149879244|NCT01098474|540685871|FG002|Follow Up Phase|Travelled out of study area|0|||
149879245|NCT01098474|540685872|FG003|Follow Up Phase|Travelled out of study area|0|||
149879246|NCT01098474|540685873|FG004|Follow Up Phase|Travelled out of study area|1|||
149879247|NCT01098474|540685874|FG005|Follow Up Phase|Travelled out of study area|0|||
149879248|NCT01098474|540685869|FG000|Follow Up Phase|Other|0|||
149879249|NCT01098474|540685870|FG001|Follow Up Phase|Other|0|||
149879250|NCT01098474|540685871|FG002|Follow Up Phase|Other|0|||
149879251|NCT01098474|540685872|FG003|Follow Up Phase|Other|0|||
149879252|NCT01098474|540685873|FG004|Follow Up Phase|Other|0|||
149879253|NCT01098474|540685874|FG005|Follow Up Phase|Other|4|||
149879254|NCT01098474|540685869|FG000|Follow Up Phase|Withdrawal by Subject|0|||
149965076|NCT02514746|541006779|FG001|Overall Study|Withdrawal by Subject|10|||
149965077|NCT02514746|541006778|FG000|Overall Study|Other|5|||
149965078|NCT02514746|541006779|FG001|Overall Study|Other|1|||
149965079|NCT04042311|541006781|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
150174973|NCT02445391|541775994|FG002|Overall Study|Financial issue|2|||
150174974|NCT02445391|541775992|FG000|Overall Study|Still on treatment|0|||
149879255|NCT01098474|540685870|FG001|Follow Up Phase|Withdrawal by Subject|0|||
149879256|NCT01098474|540685871|FG002|Follow Up Phase|Withdrawal by Subject|0|||
150174975|NCT02445391|541775993|FG001|Overall Study|Still on treatment|7|||
149879257|NCT01098474|540685872|FG003|Follow Up Phase|Withdrawal by Subject|2|||
149879258|NCT01098474|540685873|FG004|Follow Up Phase|Withdrawal by Subject|0|||
149879259|NCT01098474|540685874|FG005|Follow Up Phase|Withdrawal by Subject|1|||
149879260|NCT01098474|540685869|FG000|Follow Up Phase|Lost to Follow-up|0|||
149879261|NCT01098474|540685870|FG001|Follow Up Phase|Lost to Follow-up|0|||
149965080|NCT04042311|541006781|FG000|Overall Study|Unable to tolerate|4|||
149965081|NCT04042311|541006781|FG000|Overall Study|Concurrent illness|2|||
149965082|NCT04042311|541006781|FG000|Overall Study|Adverse Event|2|||
149965083|NCT04042311|541006781|FG000|Overall Study|No longer meeting inclusion criteria|2|||
149879262|NCT01098474|540685871|FG002|Follow Up Phase|Lost to Follow-up|0|||
149879263|NCT01098474|540685872|FG003|Follow Up Phase|Lost to Follow-up|0|||
149879264|NCT01098474|540685873|FG004|Follow Up Phase|Lost to Follow-up|1|||
149879265|NCT01098474|540685874|FG005|Follow Up Phase|Lost to Follow-up|0|||
149965084|NCT04042311|541006781|FG000|Overall Study|No reason given|1|||
150174976|NCT02445391|541775994|FG002|Overall Study|Still on treatment|16|||
149879266|NCT00711880|540685875|FG000|Overall Study|Adverse Event|11|||
149879267|NCT00711880|540685876|FG001|Overall Study|Adverse Event|2|||
149879268|NCT00711880|540685875|FG000|Overall Study|Patient non-compliance|1|||
149879269|NCT00711880|540685876|FG001|Overall Study|Patient non-compliance|0|||
149879270|NCT00711880|540685875|FG000|Overall Study|Lack of Efficacy|1|||
149879271|NCT00711880|540685876|FG001|Overall Study|Lack of Efficacy|5|||
149879272|NCT04841577|540685877|FG000|Overall Study|Adverse Event|5|||
149879273|NCT04841577|540685878|FG001|Overall Study|Adverse Event|10|||
149879274|NCT04841577|540685877|FG000|Overall Study|Lost to Follow-up|8|||
149879275|NCT04841577|540685878|FG001|Overall Study|Lost to Follow-up|7|||
149879276|NCT04841577|540685877|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
149879277|NCT04841577|540685878|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
149879278|NCT04841577|540685877|FG000|Overall Study|Other|0|||
149879279|NCT04841577|540685878|FG001|Overall Study|Other|1|||
149879280|NCT00652340|540685883|FG000|Overall Study|Had not progressed.|4|||
149879281|NCT00652340|540685884|FG001|Overall Study|Had not progressed.|3|||
149879282|NCT03682107|540685885|FG000|Overall Study|Withdrawal by Subject|0|||
149879283|NCT03682107|540685886|FG001|Overall Study|Withdrawal by Subject|1|||
149879284|NCT03682107|540685887|FG002|Overall Study|Withdrawal by Subject|0|||
149879285|NCT03682107|540685888|FG003|Overall Study|Withdrawal by Subject|0|||
149879286|NCT03682107|540685889|FG004|Overall Study|Withdrawal by Subject|0|||
149879287|NCT00879411|540685890|FG000|Overall Study|lost to follow-up (non-AE)|162|||
149879288|NCT03837743|540685891|FG000|Overall Study|Adverse Event|1|||
149879289|NCT03837743|540685891|FG000|Overall Study|Withdrawal by Subject|2|||
149879290|NCT02257385|540685892|FG000|Overall Study|Adverse Event|12|||
149879291|NCT02257385|540685893|FG001|Overall Study|Adverse Event|8|||
149879292|NCT02257385|540685892|FG000|Overall Study|Lack of Efficacy|1|||
149879293|NCT02257385|540685893|FG001|Overall Study|Lack of Efficacy|2|||
149879294|NCT02257385|540685892|FG000|Overall Study|Protocol Violation|5|||
149879295|NCT02257385|540685893|FG001|Overall Study|Protocol Violation|7|||
149879296|NCT02257385|540685892|FG000|Overall Study|Lost to Follow-up|0|||
149879297|NCT02257385|540685893|FG001|Overall Study|Lost to Follow-up|1|||
149879298|NCT02257385|540685892|FG000|Overall Study|Withdrawal by Subject|4|||
149879299|NCT02257385|540685893|FG001|Overall Study|Withdrawal by Subject|4|||
149879300|NCT03489109|540685896|FG000|Overall Study|Lost to Follow-up|1|||
149879301|NCT03489109|540685897|FG001|Overall Study|Lost to Follow-up|2|||
149879302|NCT01547130|540685898|FG000|Overall Study|Lost to Follow-up|9|||
149879303|NCT01547130|540685899|FG001|Overall Study|Lost to Follow-up|5|||
149879304|NCT03968978|540685900|FG000|Overall Study|Adverse Event|1|||
149879305|NCT03968978|540685901|FG001|Overall Study|Adverse Event|0|||
149879306|NCT00908310|540685907|FG000|Overall Study|Death|37|||
149879307|NCT00908310|540685907|FG000|Overall Study|Withdrawal by Subject|7|||
149879308|NCT00908310|540685907|FG000|Overall Study|Lost to Follow-up|7|||
149879309|NCT00908310|540685907|FG000|Overall Study|Screening failure|5|||
149879310|NCT00908310|540685907|FG000|Overall Study|Other reasons|4|||
149879311|NCT01004003|540685908|FG000|Overall Study|Progressive disease|2|||
149879312|NCT01004003|540685909|FG001|Overall Study|Progressive disease|1|||
149879313|NCT01004003|540685910|FG002|Overall Study|Progressive disease|1|||
149879314|NCT01004003|540685911|FG003|Overall Study|Progressive disease|0|||
149879315|NCT01004003|540685912|FG004|Overall Study|Progressive disease|2|||
149879316|NCT01004003|540685913|FG005|Overall Study|Progressive disease|1|||
149879317|NCT01004003|540685914|FG006|Overall Study|Progressive disease|1|||
149965085|NCT04042311|541006781|FG000|Overall Study|Withdrawal by Subject|4|||
149965086|NCT03382873|541006782|FG000|Overall Study|Lost to Follow-up|9|||
149965087|NCT03382873|541006783|FG001|Overall Study|Lost to Follow-up|10|||
149965088|NCT03382873|541006782|FG000|Overall Study|Withdrawal by Subject|6|||
149965089|NCT03382873|541006783|FG001|Overall Study|Withdrawal by Subject|11|||
149965090|NCT03382873|541006782|FG000|Overall Study|Visit not completed due to pandemic|16|||
149965091|NCT03382873|541006783|FG001|Overall Study|Visit not completed due to pandemic|41|||
149965092|NCT05021224|541006784|FG000|Overall Study|Did not complete all survey items|4|||
149879318|NCT01004003|540685915|FG007|Overall Study|Progressive disease|39|||
149879319|NCT01004003|540685916|FG008|Overall Study|Progressive disease|22|||
149879320|NCT01004003|540685908|FG000|Overall Study|Adverse Event|4|||
149879321|NCT01004003|540685909|FG001|Overall Study|Adverse Event|2|||
149879322|NCT01004003|540685910|FG002|Overall Study|Adverse Event|3|||
149879323|NCT01004003|540685911|FG003|Overall Study|Adverse Event|3|||
149879324|NCT01004003|540685912|FG004|Overall Study|Adverse Event|2|||
149879325|NCT01004003|540685913|FG005|Overall Study|Adverse Event|2|||
149879326|NCT01004003|540685914|FG006|Overall Study|Adverse Event|7|||
149879327|NCT01004003|540685915|FG007|Overall Study|Adverse Event|21|||
149879328|NCT01004003|540685916|FG008|Overall Study|Adverse Event|6|||
149965093|NCT05021224|541006785|FG001|Overall Study|Did not complete all survey items|1|||
149879329|NCT01004003|540685908|FG000|Overall Study|Refused to continue taking trial med.|0|||
149879330|NCT01004003|540685909|FG001|Overall Study|Refused to continue taking trial med.|0|||
149965094|NCT05021224|541006786|FG002|Overall Study|Did not complete all survey items|0|||
149965095|NCT05021224|541006787|FG003|Overall Study|Did not complete all survey items|2|||
149965096|NCT03996395|541006788|FG000|Overall Study|Lost to Follow-up|4|||
149965097|NCT03996395|541006788|FG000|Overall Study|Withdrawal by Subject|1|||
149965098|NCT03996395|541006788|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
149879331|NCT01004003|540685910|FG002|Overall Study|Refused to continue taking trial med.|0|||
149879332|NCT01004003|540685911|FG003|Overall Study|Refused to continue taking trial med.|0|||
149879333|NCT01004003|540685912|FG004|Overall Study|Refused to continue taking trial med.|0|||
149879334|NCT01004003|540685913|FG005|Overall Study|Refused to continue taking trial med.|0|||
149879335|NCT01004003|540685914|FG006|Overall Study|Refused to continue taking trial med.|0|||
149879336|NCT01004003|540685915|FG007|Overall Study|Refused to continue taking trial med.|0|||
149879337|NCT01004003|540685916|FG008|Overall Study|Refused to continue taking trial med.|2|||
149879338|NCT01004003|540685908|FG000|Overall Study|Other|0|||
149879339|NCT01004003|540685909|FG001|Overall Study|Other|0|||
149879340|NCT01004003|540685910|FG002|Overall Study|Other|0|||
149879341|NCT01004003|540685911|FG003|Overall Study|Other|0|||
149879342|NCT01004003|540685912|FG004|Overall Study|Other|0|||
149879343|NCT01004003|540685913|FG005|Overall Study|Other|1|||
149879344|NCT01004003|540685914|FG006|Overall Study|Other|0|||
149879345|NCT01004003|540685915|FG007|Overall Study|Other|0|||
149879346|NCT01004003|540685916|FG008|Overall Study|Other|0|||
149879347|NCT00315731|540685919|FG000|Overall Study|Lost to Follow-up|1|||
149879348|NCT00315731|540685919|FG000|Overall Study|Death|5|||
149879349|NCT03597464|540685920|FG000|Overall Study|Withdrawal by Subject|4|||
149879350|NCT03597464|540685921|FG001|Overall Study|Withdrawal by Subject|5|||
149879351|NCT03597464|540685920|FG000|Overall Study|Lost to Follow-up|3|||
149879352|NCT03597464|540685921|FG001|Overall Study|Lost to Follow-up|1|||
149879353|NCT03597464|540685920|FG000|Overall Study|Pregnancy|3|||
149879354|NCT03597464|540685921|FG001|Overall Study|Pregnancy|1|||
149879355|NCT03597464|540685920|FG000|Overall Study|Lack of Efficacy|2|||
149879356|NCT03597464|540685921|FG001|Overall Study|Lack of Efficacy|0|||
149879357|NCT03597464|540685920|FG000|Overall Study|Physician Decision|2|||
149879358|NCT03597464|540685921|FG001|Overall Study|Physician Decision|2|||
149879359|NCT03597464|540685920|FG000|Overall Study|Protocol Violation|1|||
149879360|NCT03597464|540685921|FG001|Overall Study|Protocol Violation|1|||
149879361|NCT03597464|540685920|FG000|Overall Study|Adverse Event|0|||
149879362|NCT03597464|540685921|FG001|Overall Study|Adverse Event|2|||
149879363|NCT03597464|540685920|FG000|Overall Study|Death|0|||
149879364|NCT03597464|540685921|FG001|Overall Study|Death|3|||
149879365|NCT01243775|540685925|FG000|Overall Study|Withdrawal by Subject|2|||
149879366|NCT01753297|540688600|FG000|Overall Study|Lost to Follow-up|7|||
149879367|NCT01753297|540688601|FG001|Overall Study|Lost to Follow-up|2|||
149879368|NCT01753297|540688600|FG000|Overall Study|Withdrawal by Subject|26|||
149879369|NCT01753297|540688601|FG001|Overall Study|Withdrawal by Subject|23|||
149879370|NCT01753297|540688600|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
149879371|NCT01753297|540688601|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
149879372|NCT01753297|540688600|FG000|Overall Study|Death|0|||
149879373|NCT01753297|540688601|FG001|Overall Study|Death|2|||
149879374|NCT01753297|540688600|FG000|Overall Study|Did not attend end of study visit|7|||
149879375|NCT01753297|540688601|FG001|Overall Study|Did not attend end of study visit|8|||
149879376|NCT00230178|540688602|FG000|Overall Study|Adverse Event|1|||
149879377|NCT00230178|540688603|FG001|Overall Study|Adverse Event|5|||
149965099|NCT05375929|541006789|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
149965100|NCT05375929|541006790|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
149965101|NCT05375929|541006791|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
149965102|NCT05375929|541006792|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
149965103|NCT05375929|541006789|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
149965104|NCT05375929|541006790|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
149965105|NCT05375929|541006791|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
149965106|NCT05375929|541006792|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
149965107|NCT05375929|541006789|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
149965108|NCT05375929|541006790|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
149965109|NCT05375929|541006791|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
149965110|NCT05375929|541006792|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
149965111|NCT05375929|541006789|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
149879378|NCT00230178|540688604|FG002|Overall Study|Adverse Event|2|||
149879379|NCT00230178|540688602|FG000|Overall Study|Withdrawal by Subject|0|||
149879380|NCT00230178|540688603|FG001|Overall Study|Withdrawal by Subject|0|||
149879381|NCT00230178|540688604|FG002|Overall Study|Withdrawal by Subject|1|||
149879382|NCT00230178|540688602|FG000|Overall Study|Various other reasons|3|||
149879383|NCT00230178|540688603|FG001|Overall Study|Various other reasons|2|||
149879384|NCT00230178|540688604|FG002|Overall Study|Various other reasons|4|||
149879385|NCT01275729|540688605|FG000|Overall Study|Death|3|||
149879386|NCT01275729|540688605|FG000|Overall Study|Withdrawal by Subject|1|||
149879387|NCT02252406|540688606|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
149879388|NCT02252406|540688607|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
149879389|NCT02252406|540688606|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
149879390|NCT02252406|540688607|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
149879391|NCT02252406|540688606|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
149879392|NCT02252406|540688607|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
149879393|NCT02252406|540688606|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
149879394|NCT02252406|540688607|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
149879395|NCT02252406|540688606|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
149879396|NCT02252406|540688607|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
149879397|NCT02533180|540688608|FG000|Overall Study|Death|0|||
149879398|NCT02533180|540688609|FG001|Overall Study|Death|2|||
149879399|NCT02533180|540688608|FG000|Overall Study|Lost to Follow-up|0|||
149879400|NCT02533180|540688609|FG001|Overall Study|Lost to Follow-up|1|||
149879401|NCT02533180|540688608|FG000|Overall Study|Physician Decision|0|||
149879402|NCT02533180|540688609|FG001|Overall Study|Physician Decision|1|||
149879403|NCT02533180|540688608|FG000|Overall Study|Withdrawal by Subject|2|||
149879404|NCT02533180|540688609|FG001|Overall Study|Withdrawal by Subject|5|||
149879405|NCT02533180|540688608|FG000|Overall Study|Screen Failure|37|||
149879406|NCT02533180|540688609|FG001|Overall Study|Screen Failure|0|||
149879407|NCT02533180|540688608|FG000|Overall Study|Protocol Deviation|0|||
149879408|NCT02533180|540688609|FG001|Overall Study|Protocol Deviation|1|||
149879409|NCT02533180|540688608|FG000|Overall Study|Non-compliance|0|||
149879410|NCT02533180|540688609|FG001|Overall Study|Non-compliance|1|||
149879411|NCT00447876|540688610|FG000|Overall Study|Withdrawal by Subject|1|||
149879412|NCT00447876|540688611|FG001|Overall Study|Withdrawal by Subject|4|||
149879413|NCT00447876|540688610|FG000|Overall Study|Lost to Follow-up|1|||
149879414|NCT00447876|540688611|FG001|Overall Study|Lost to Follow-up|0|||
149879415|NCT00447876|540688610|FG000|Overall Study|Deterioration of symptomology|1|||
149879416|NCT00447876|540688611|FG001|Overall Study|Deterioration of symptomology|0|||
149879417|NCT03717012|540688624|FG000|Overall Study|Due to trial termination|1|||
149879418|NCT03717012|540688625|FG001|Overall Study|Due to trial termination|2|||
149879419|NCT03717012|540688624|FG000|Overall Study|Protocol Violation|0|||
149879420|NCT03717012|540688625|FG001|Overall Study|Protocol Violation|2|||
149879421|NCT03717012|540688624|FG000|Overall Study|Adverse Event|0|||
149879422|NCT03717012|540688625|FG001|Overall Study|Adverse Event|1|||
149879423|NCT03717012|540688624|FG000|Overall Study|Lung transplant|0|||
149879424|NCT03717012|540688625|FG001|Overall Study|Lung transplant|1|||
149879425|NCT00789035|540688626|FG000|Overall Study|Adverse Event|0|||
149879426|NCT00789035|540688627|FG001|Overall Study|Adverse Event|2|||
149879427|NCT00789035|540688628|FG002|Overall Study|Adverse Event|0|||
149879428|NCT00789035|540688629|FG003|Overall Study|Adverse Event|1|||
149879429|NCT00789035|540688630|FG004|Overall Study|Adverse Event|3|||
149879430|NCT00789035|540688626|FG000|Overall Study|Lack of Efficacy|3|||
150043790|NCT01596062|541300677|FG001|Overall Study|Lack of Efficacy|0|||
149879431|NCT00789035|540688627|FG001|Overall Study|Lack of Efficacy|0|||
149879432|NCT00789035|540688628|FG002|Overall Study|Lack of Efficacy|0|||
149879433|NCT00789035|540688629|FG003|Overall Study|Lack of Efficacy|0|||
150043791|NCT01596062|541300678|FG002|Overall Study|Lack of Efficacy|1|||
149879434|NCT00789035|540688630|FG004|Overall Study|Lack of Efficacy|2|||
149879435|NCT00789035|540688626|FG000|Overall Study|Protocol Violation|1|||
149879436|NCT00789035|540688627|FG001|Overall Study|Protocol Violation|0|||
149879437|NCT00789035|540688628|FG002|Overall Study|Protocol Violation|0|||
149879438|NCT00789035|540688629|FG003|Overall Study|Protocol Violation|0|||
149879439|NCT00789035|540688630|FG004|Overall Study|Protocol Violation|0|||
149879440|NCT00789035|540688626|FG000|Overall Study|Withdrawal by Subject|0|||
149879441|NCT00789035|540688627|FG001|Overall Study|Withdrawal by Subject|2|||
149879442|NCT00789035|540688628|FG002|Overall Study|Withdrawal by Subject|0|||
149879443|NCT00789035|540688629|FG003|Overall Study|Withdrawal by Subject|0|||
149879444|NCT00789035|540688630|FG004|Overall Study|Withdrawal by Subject|0|||
149879445|NCT00789035|540688626|FG000|Overall Study|Other reason not defined above|2|||
149879446|NCT00789035|540688627|FG001|Overall Study|Other reason not defined above|3|||
149879447|NCT00789035|540688628|FG002|Overall Study|Other reason not defined above|1|||
149879448|NCT00789035|540688629|FG003|Overall Study|Other reason not defined above|0|||
149879449|NCT00789035|540688630|FG004|Overall Study|Other reason not defined above|1|||
149879450|NCT01520870|540688631|FG000|Overall Study|Withdrawal by Subject|2|||
149879451|NCT02463357|540688632|FG000|Overall Study|Withdrawal by Subject|1|||
149879452|NCT02463357|540688633|FG001|Overall Study|Withdrawal by Subject|0|||
149879453|NCT02463357|540688634|FG002|Overall Study|Withdrawal by Subject|0|||
149879454|NCT02463357|540688635|FG003|Overall Study|Withdrawal by Subject|0|||
149879455|NCT02463357|540688636|FG004|Overall Study|Withdrawal by Subject|0|||
149879456|NCT02463357|540688632|FG000|Overall Study|Withdrawal by Subject|0|||
149879457|NCT02463357|540688633|FG001|Overall Study|Withdrawal by Subject|0|||
149879458|NCT02463357|540688634|FG002|Overall Study|Withdrawal by Subject|0|||
149879459|NCT02463357|540688635|FG003|Overall Study|Withdrawal by Subject|0|||
149879460|NCT02463357|540688636|FG004|Overall Study|Withdrawal by Subject|1|||
149879461|NCT01371539|540688639|FG000|Period One: One Week|Lost to Follow-up|0|||
149879462|NCT01371539|540688640|FG001|Period One: One Week|Lost to Follow-up|1|||
149879463|NCT01371539|540688639|FG000|Period Two: One Week|Lost to Follow-up|0|||
149879464|NCT01371539|540688640|FG001|Period Two: One Week|Lost to Follow-up|1|||
149879465|NCT01371539|540688639|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
149879466|NCT01371539|540688640|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
149879467|NCT01371539|540688639|FG000|Period Two: One Week|Time/job conflict|0|||
149879468|NCT01371539|540688640|FG001|Period Two: One Week|Time/job conflict|1|||
149879469|NCT01399658|540688641|FG000|Overall Study|Ineligible|1|||
149879470|NCT01399658|540688641|FG000|Overall Study|Machine Technical Issue|3|||
149879471|NCT01399658|540688641|FG000|Overall Study|Alternative therapy|1|||
149879472|NCT01399658|540688641|FG000|Overall Study|No reason given|1|||
149879473|NCT02620579|540688642|FG000|Overall Study|Physician Decision|0|||
149879474|NCT02620579|540688643|FG001|Overall Study|Physician Decision|0|||
149879475|NCT02620579|540688644|FG002|Overall Study|Physician Decision|0|||
149879476|NCT02620579|540688645|FG003|Overall Study|Physician Decision|1|||
149879477|NCT02620579|540688642|FG000|Overall Study|Withdrawal by Subject|0|||
149879478|NCT02620579|540688643|FG001|Overall Study|Withdrawal by Subject|1|||
149879479|NCT02620579|540688644|FG002|Overall Study|Withdrawal by Subject|1|||
149879480|NCT02620579|540688645|FG003|Overall Study|Withdrawal by Subject|0|||
149879481|NCT00796107|540688651|FG000|Overall Study|Lack of Efficacy|1|||
149879482|NCT00796107|540688651|FG000|Overall Study|Progressive Disease|5|||
149879483|NCT00378573|540688654|FG000|Treatment Period|Adverse Event|9|||
149879484|NCT00378573|540688654|FG000|Treatment Period|Physician Decision|1|||
149879485|NCT00378573|540688654|FG000|Treatment Period|Withdrawal by Subject|2|||
149879486|NCT00378573|540688654|FG000|Treatment Period|Disease Progression|4|||
149879487|NCT00378573|540688654|FG000|Treatment Period|Sponsor decision to close study|1|||
149879488|NCT00378573|540688654|FG000|Follow-up|Death|12|||
149879489|NCT00378573|540688654|FG000|Follow-up|Lost to Follow-up|1|||
149879490|NCT00378573|540688654|FG000|Follow-up|Withdrawal by Subject|1|||
149879491|NCT03066258|540688661|FG000|Overall Study|Death|1|||
149879492|NCT03066258|540688662|FG001|Overall Study|Death|0|||
149879493|NCT03066258|540688663|FG002|Overall Study|Death|0|||
149879494|NCT03066258|540688664|FG003|Overall Study|Death|0|||
149879495|NCT03066258|540688665|FG004|Overall Study|Death|1|||
149879496|NCT02165735|540688666|FG000|Overall Study|Lost to Follow-up|12|||
149879497|NCT02165735|540688667|FG001|Overall Study|Lost to Follow-up|10|||
149879498|NCT02165735|540688666|FG000|Overall Study|Withdrawal by Subject|3|||
149879499|NCT02165735|540688667|FG001|Overall Study|Withdrawal by Subject|0|||
149879500|NCT02165735|540688666|FG000|Overall Study|Participant indicated lack of time|1|||
149879501|NCT02165735|540688667|FG001|Overall Study|Participant indicated lack of time|3|||
149879502|NCT02165735|540688666|FG000|Overall Study|Protocol Violation|0|||
149879503|NCT02165735|540688667|FG001|Overall Study|Protocol Violation|1|||
149879504|NCT02784795|540688668|FG000|Overall Study|Progressive Disease|2|||
149879505|NCT02784795|540688669|FG001|Overall Study|Progressive Disease|1|||
149879506|NCT02784795|540688670|FG002|Overall Study|Progressive Disease|1|||
149879507|NCT02784795|540688671|FG003|Overall Study|Progressive Disease|0|||
149879508|NCT02784795|540688672|FG004|Overall Study|Progressive Disease|2|||
149879509|NCT02784795|540688673|FG005|Overall Study|Progressive Disease|0|||
149879510|NCT02784795|540688674|FG006|Overall Study|Progressive Disease|2|||
149879511|NCT02784795|540688675|FG007|Overall Study|Progressive Disease|0|||
149879512|NCT02784795|540688676|FG008|Overall Study|Progressive Disease|0|||
149879513|NCT02784795|540688677|FG009|Overall Study|Progressive Disease|0|||
149879514|NCT02784795|540688678|FG010|Overall Study|Progressive Disease|1|||
149879515|NCT02784795|540688679|FG011|Overall Study|Progressive Disease|0|||
149879516|NCT02784795|540688668|FG000|Overall Study|Adverse Event|1|||
149879517|NCT02784795|540688669|FG001|Overall Study|Adverse Event|0|||
149879518|NCT02784795|540688670|FG002|Overall Study|Adverse Event|0|||
149879519|NCT02784795|540688671|FG003|Overall Study|Adverse Event|1|||
149879520|NCT02784795|540688672|FG004|Overall Study|Adverse Event|0|||
149879521|NCT02784795|540688673|FG005|Overall Study|Adverse Event|0|||
149879522|NCT02784795|540688674|FG006|Overall Study|Adverse Event|1|||
149879523|NCT02784795|540688675|FG007|Overall Study|Adverse Event|0|||
149879524|NCT02784795|540688676|FG008|Overall Study|Adverse Event|0|||
149879525|NCT02784795|540688677|FG009|Overall Study|Adverse Event|0|||
149879526|NCT02784795|540688678|FG010|Overall Study|Adverse Event|0|||
149879527|NCT02784795|540688679|FG011|Overall Study|Adverse Event|2|||
149879528|NCT02784795|540688668|FG000|Overall Study|Withdrawal by Subject|1|||
149879529|NCT02784795|540688669|FG001|Overall Study|Withdrawal by Subject|0|||
149879530|NCT02784795|540688670|FG002|Overall Study|Withdrawal by Subject|2|||
149879531|NCT02784795|540688671|FG003|Overall Study|Withdrawal by Subject|1|||
149879532|NCT02784795|540688672|FG004|Overall Study|Withdrawal by Subject|3|||
149879533|NCT02784795|540688673|FG005|Overall Study|Withdrawal by Subject|0|||
150043792|NCT02255435|541300679|FG000|Overall Study|Patient's Limited Time Availability|0|||
150043793|NCT02255435|541300680|FG001|Overall Study|Patient's Limited Time Availability|0|||
150043794|NCT02255435|541300681|FG002|Overall Study|Patient's Limited Time Availability|0|||
149879534|NCT02784795|540688674|FG006|Overall Study|Withdrawal by Subject|0|||
149879535|NCT02784795|540688675|FG007|Overall Study|Withdrawal by Subject|1|||
149879536|NCT02784795|540688676|FG008|Overall Study|Withdrawal by Subject|0|||
149879537|NCT02784795|540688677|FG009|Overall Study|Withdrawal by Subject|0|||
149879538|NCT02784795|540688678|FG010|Overall Study|Withdrawal by Subject|0|||
149879539|NCT02784795|540688679|FG011|Overall Study|Withdrawal by Subject|2|||
149879540|NCT02784795|540688668|FG000|Overall Study|Death|0|||
149879541|NCT02784795|540688669|FG001|Overall Study|Death|0|||
149879542|NCT02784795|540688670|FG002|Overall Study|Death|0|||
149879543|NCT02784795|540688671|FG003|Overall Study|Death|0|||
149879544|NCT02784795|540688672|FG004|Overall Study|Death|1|||
149879545|NCT02784795|540688673|FG005|Overall Study|Death|0|||
149879546|NCT02784795|540688674|FG006|Overall Study|Death|0|||
149879547|NCT02784795|540688675|FG007|Overall Study|Death|0|||
149879548|NCT02784795|540688676|FG008|Overall Study|Death|0|||
149879549|NCT02784795|540688677|FG009|Overall Study|Death|0|||
149879550|NCT02784795|540688678|FG010|Overall Study|Death|0|||
149879551|NCT02784795|540688679|FG011|Overall Study|Death|0|||
149879552|NCT02784795|540688668|FG000|Overall Study|Physician Decision|0|||
149879553|NCT02784795|540688669|FG001|Overall Study|Physician Decision|0|||
149879554|NCT02784795|540688670|FG002|Overall Study|Physician Decision|0|||
149879555|NCT02784795|540688671|FG003|Overall Study|Physician Decision|0|||
149879556|NCT02784795|540688672|FG004|Overall Study|Physician Decision|0|||
149879557|NCT02784795|540688673|FG005|Overall Study|Physician Decision|0|||
149879558|NCT02784795|540688674|FG006|Overall Study|Physician Decision|1|||
149879559|NCT02784795|540688675|FG007|Overall Study|Physician Decision|0|||
149879560|NCT02784795|540688676|FG008|Overall Study|Physician Decision|0|||
149879561|NCT02784795|540688677|FG009|Overall Study|Physician Decision|0|||
149879562|NCT02784795|540688678|FG010|Overall Study|Physician Decision|0|||
149879563|NCT02784795|540688679|FG011|Overall Study|Physician Decision|0|||
149879564|NCT00626561|540688680|FG000|Overall Study|Withdrawal by Subject|2|||
149879565|NCT00626561|540688680|FG000|Overall Study|Disease Progression|2|||
149879566|NCT00595309|540688681|FG000|Overall Study|Lost to Follow-up|1|||
149879567|NCT00595309|540688681|FG000|Overall Study|planned vaccination against yellow fever|1|||
149879568|NCT00595309|540688681|FG000|Overall Study|acute infection after V0|1|||
149879569|NCT00595309|540688681|FG000|Overall Study|personal reason|1|||
149879570|NCT00101283|540688682|FG000|Overall Study|Withdrawal by Subject|0|||
149879571|NCT00101283|540688683|FG001|Overall Study|Withdrawal by Subject|1|||
149879572|NCT00101283|540688682|FG000|Overall Study|Insurance Refusal|0|||
149879573|NCT00101283|540688683|FG001|Overall Study|Insurance Refusal|1|||
149879574|NCT00101283|540688682|FG000|Overall Study|Prostate Cancer Recurrence|0|||
150043795|NCT02255435|541300682|FG003|Overall Study|Patient's Limited Time Availability|0|||
149879575|NCT00101283|540688683|FG001|Overall Study|Prostate Cancer Recurrence|1|||
149879576|NCT02797171|540688684|FG000|Overall Study|Lost to Follow-up|2|||
149879577|NCT02797171|540688685|FG001|Overall Study|Lost to Follow-up|0|||
149879578|NCT02797171|540688686|FG002|Overall Study|Lost to Follow-up|2|||
149879579|NCT02797171|540688687|FG003|Overall Study|Lost to Follow-up|1|||
149879580|NCT02797171|540688688|FG004|Overall Study|Lost to Follow-up|2|||
149879581|NCT02797171|540688689|FG005|Overall Study|Lost to Follow-up|0|||
149879582|NCT02797171|540688684|FG000|Overall Study|Withdrawal by Subject|1|||
149879583|NCT02797171|540688685|FG001|Overall Study|Withdrawal by Subject|1|||
149879584|NCT02797171|540688686|FG002|Overall Study|Withdrawal by Subject|0|||
149879585|NCT02797171|540688687|FG003|Overall Study|Withdrawal by Subject|0|||
149879586|NCT02797171|540688688|FG004|Overall Study|Withdrawal by Subject|0|||
149879587|NCT02797171|540688689|FG005|Overall Study|Withdrawal by Subject|0|||
149879588|NCT02797171|540688684|FG000|Overall Study|Protocol Violation|1|||
149879589|NCT02797171|540688685|FG001|Overall Study|Protocol Violation|0|||
149879590|NCT02797171|540688686|FG002|Overall Study|Protocol Violation|0|||
149879591|NCT02797171|540688687|FG003|Overall Study|Protocol Violation|0|||
149879592|NCT02797171|540688688|FG004|Overall Study|Protocol Violation|0|||
149879593|NCT02797171|540688689|FG005|Overall Study|Protocol Violation|0|||
149879594|NCT02797171|540688684|FG000|Overall Study|Participant unable to adhere|0|||
149879595|NCT02797171|540688685|FG001|Overall Study|Participant unable to adhere|1|||
149879596|NCT02797171|540688686|FG002|Overall Study|Participant unable to adhere|0|||
149879597|NCT02797171|540688687|FG003|Overall Study|Participant unable to adhere|0|||
149879598|NCT02797171|540688688|FG004|Overall Study|Participant unable to adhere|0|||
149879599|NCT02797171|540688689|FG005|Overall Study|Participant unable to adhere|0|||
149879600|NCT02797171|540688684|FG000|Overall Study|Not Randomized|0|||
149879601|NCT02797171|540688685|FG001|Overall Study|Not Randomized|0|||
149879602|NCT02797171|540688686|FG002|Overall Study|Not Randomized|0|||
149879603|NCT02797171|540688687|FG003|Overall Study|Not Randomized|0|||
149879604|NCT02797171|540688688|FG004|Overall Study|Not Randomized|0|||
149879605|NCT02797171|540688689|FG005|Overall Study|Not Randomized|1|||
149879606|NCT03993379|540688690|FG000|Overall Study|The study was terminated early due to business decision.|0|||
149879607|NCT03993379|540688691|FG001|Overall Study|The study was terminated early due to business decision.|2|||
149879608|NCT03993379|540688692|FG002|Overall Study|The study was terminated early due to business decision.|0|||
149879609|NCT03993379|540688693|FG003|Overall Study|The study was terminated early due to business decision.|0|||
149879610|NCT03993379|540688690|FG000|Overall Study|Withdrawal by Subject|0|||
149879611|NCT03993379|540688691|FG001|Overall Study|Withdrawal by Subject|1|||
149879612|NCT03993379|540688692|FG002|Overall Study|Withdrawal by Subject|0|||
149879613|NCT03993379|540688693|FG003|Overall Study|Withdrawal by Subject|0|||
149879614|NCT00704132|540688699|FG000|Overall Study|Clinical Adverse Experience|1|||
149879615|NCT00704132|540688700|FG001|Overall Study|Clinical Adverse Experience|0|||
149879616|NCT00704132|540688699|FG000|Overall Study|Lack of Efficacy|0|||
149879617|NCT00704132|540688700|FG001|Overall Study|Lack of Efficacy|1|||
149879618|NCT00704132|540688699|FG000|Overall Study|Withdrawal by Subject|0|||
149879619|NCT00704132|540688700|FG001|Overall Study|Withdrawal by Subject|1|||
149879620|NCT00442962|540688701|FG000|Overall Study|Pregnancy|1|||
149879621|NCT00442962|540688701|FG000|Overall Study|Lost to Follow-up|7|||
149879622|NCT03348163|540688702|FG000|Overall Study|Withdrawal by Subject|2|||
149879623|NCT03348163|540688703|FG001|Overall Study|Withdrawal by Subject|0|||
149879624|NCT02756208|540688704|FG000|Overall Study|Withdrawal by Subject|1|||
149879625|NCT02756208|540688705|FG001|Overall Study|Withdrawal by Subject|0|||
149879626|NCT02756208|540688706|FG002|Overall Study|Withdrawal by Subject|1|||
149879627|NCT02756208|540688707|FG003|Overall Study|Withdrawal by Subject|3|||
149879628|NCT02756208|540688704|FG000|Overall Study|Lost to Follow-up|3|||
149879629|NCT02756208|540688705|FG001|Overall Study|Lost to Follow-up|1|||
149879630|NCT02756208|540688706|FG002|Overall Study|Lost to Follow-up|1|||
149879631|NCT02756208|540688707|FG003|Overall Study|Lost to Follow-up|1|||
149879632|NCT02756208|540688704|FG000|Overall Study|Physician Decision|1|||
149879633|NCT02756208|540688705|FG001|Overall Study|Physician Decision|0|||
149879634|NCT02756208|540688706|FG002|Overall Study|Physician Decision|0|||
149879635|NCT02756208|540688707|FG003|Overall Study|Physician Decision|0|||
149879636|NCT02756208|540688704|FG000|Overall Study|Protocol Violation|0|||
149879637|NCT02756208|540688705|FG001|Overall Study|Protocol Violation|1|||
149879638|NCT02756208|540688706|FG002|Overall Study|Protocol Violation|0|||
149879639|NCT02756208|540688707|FG003|Overall Study|Protocol Violation|0|||
149879640|NCT02585778|540688708|FG000|Overall Study|Adverse Event|17|||
149879641|NCT02585778|540688709|FG001|Overall Study|Adverse Event|4|||
149879642|NCT02585778|540688708|FG000|Overall Study|Participant did not wish to continue|9|||
149879643|NCT02585778|540688709|FG001|Overall Study|Participant did not wish to continue|4|||
149879644|NCT02585778|540688708|FG000|Overall Study|Poor compliance to study protocol|0|||
149879645|NCT02585778|540688709|FG001|Overall Study|Poor compliance to study protocol|2|||
149879646|NCT02585778|540688708|FG000|Overall Study|Death|0|||
149879647|NCT02585778|540688709|FG001|Overall Study|Death|1|||
149879648|NCT02585778|540688708|FG000|Overall Study|Randomized but not treated|1|||
149879649|NCT02585778|540688709|FG001|Overall Study|Randomized but not treated|2|||
149879650|NCT02585778|540688708|FG000|Overall Study|Other than specified above|6|||
149879651|NCT02585778|540688709|FG001|Overall Study|Other than specified above|2|||
149879652|NCT00356525|540688710|FG000|Overall Study|Progressive Disease|8|||
149879653|NCT00356525|540688711|FG001|Overall Study|Progressive Disease|5|||
149879654|NCT00356525|540688712|FG002|Overall Study|Progressive Disease|4|||
149879655|NCT00356525|540688713|FG003|Overall Study|Progressive Disease|2|||
149879656|NCT00356525|540688710|FG000|Overall Study|Adverse Event|1|||
149879657|NCT00356525|540688711|FG001|Overall Study|Adverse Event|3|||
149879658|NCT00356525|540688712|FG002|Overall Study|Adverse Event|1|||
149879659|NCT00356525|540688713|FG003|Overall Study|Adverse Event|1|||
149879660|NCT00356525|540688710|FG000|Overall Study|Lost to Follow-up|1|||
149879661|NCT00356525|540688711|FG001|Overall Study|Lost to Follow-up|0|||
149879662|NCT00356525|540688712|FG002|Overall Study|Lost to Follow-up|0|||
149879663|NCT00356525|540688713|FG003|Overall Study|Lost to Follow-up|0|||
149879664|NCT00356525|540688710|FG000|Overall Study|Physician Decision|2|||
149879665|NCT00356525|540688711|FG001|Overall Study|Physician Decision|2|||
149879666|NCT00356525|540688712|FG002|Overall Study|Physician Decision|2|||
149879667|NCT00356525|540688713|FG003|Overall Study|Physician Decision|1|||
149879668|NCT00356525|540688710|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
149879669|NCT00356525|540688711|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
149879670|NCT00356525|540688712|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
149879671|NCT00356525|540688713|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
149879672|NCT00356525|540688710|FG000|Overall Study|Withdrawal by Subject|1|||
149879673|NCT00356525|540688711|FG001|Overall Study|Withdrawal by Subject|1|||
149879674|NCT00356525|540688712|FG002|Overall Study|Withdrawal by Subject|0|||
149879675|NCT00356525|540688713|FG003|Overall Study|Withdrawal by Subject|3|||
149879676|NCT00356525|540688710|FG000|Overall Study|Death|0|||
149879677|NCT00356525|540688711|FG001|Overall Study|Death|0|||
149879678|NCT00356525|540688712|FG002|Overall Study|Death|0|||
149879679|NCT00356525|540688713|FG003|Overall Study|Death|1|||
149879680|NCT00356525|540688710|FG000|Overall Study|Sponsor Decision|0|||
149879681|NCT00356525|540688711|FG001|Overall Study|Sponsor Decision|0|||
149879682|NCT00356525|540688712|FG002|Overall Study|Sponsor Decision|0|||
149879683|NCT00356525|540688713|FG003|Overall Study|Sponsor Decision|1|||
149879684|NCT00214383|540688719|FG000|Overall Study|Lost to Follow-up|16|||
149879685|NCT00214383|540688720|FG001|Overall Study|Lost to Follow-up|26|||
149879686|NCT00252239|540688729|FG000|Overall Study|Withdrawal by Subject|1|||
149879687|NCT00252239|540688730|FG001|Overall Study|Withdrawal by Subject|0|||
149879688|NCT00252239|540688731|FG002|Overall Study|Withdrawal by Subject|0|||
149879689|NCT00252239|540688732|FG003|Overall Study|Withdrawal by Subject|1|||
149879690|NCT00252239|540688729|FG000|Overall Study|Lost to Follow-up|0|||
149879691|NCT00252239|540688730|FG001|Overall Study|Lost to Follow-up|0|||
149879692|NCT00252239|540688731|FG002|Overall Study|Lost to Follow-up|2|||
149879693|NCT00252239|540688732|FG003|Overall Study|Lost to Follow-up|0|||
149879694|NCT01685840|540688742|FG000|Overall Study|Death|77|||
149879695|NCT01685840|540688743|FG001|Overall Study|Death|66|||
149879696|NCT01685840|540688742|FG000|Overall Study|Lost to Follow-up|27|||
149879697|NCT01685840|540688743|FG001|Overall Study|Lost to Follow-up|25|||
149879698|NCT01685840|540688742|FG000|Overall Study|Physician Decision|3|||
149879699|NCT01685840|540688743|FG001|Overall Study|Physician Decision|7|||
149879700|NCT01685840|540688742|FG000|Overall Study|Withdrawal by Subject|14|||
149879701|NCT01685840|540688743|FG001|Overall Study|Withdrawal by Subject|17|||
149879702|NCT01685840|540688742|FG000|Overall Study|Futility|197|||
149879703|NCT01685840|540688743|FG001|Overall Study|Futility|200|||
149879704|NCT01685840|540688742|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
149879705|NCT01685840|540688743|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
149879706|NCT00710866|540688744|FG000|Overall Study|Protocol Violation|5|||
149879707|NCT00710866|540688745|FG001|Overall Study|Protocol Violation|4|||
149879708|NCT00710866|540688744|FG000|Overall Study|Withdrawal by Subject|2|||
149879709|NCT00710866|540688745|FG001|Overall Study|Withdrawal by Subject|1|||
149965112|NCT05375929|541006790|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
149879710|NCT00710866|540688744|FG000|Overall Study|Lost to Follow-up|1|||
149879711|NCT00710866|540688745|FG001|Overall Study|Lost to Follow-up|0|||
149879712|NCT00710866|540688744|FG000|Overall Study|Failed to meet eligibility|1|||
149879713|NCT00710866|540688745|FG001|Overall Study|Failed to meet eligibility|1|||
149879714|NCT00534404|540688750|FG000|Overall Study|Death|0|||
149879715|NCT00534404|540688751|FG001|Overall Study|Death|0|||
149879716|NCT00534404|540688752|FG002|Overall Study|Death|2|||
149965113|NCT05375929|541006791|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
149879717|NCT00534404|540688750|FG000|Overall Study|Withdrawal by Subject|8|||
149879718|NCT00534404|540688751|FG001|Overall Study|Withdrawal by Subject|2|||
149879719|NCT00534404|540688752|FG002|Overall Study|Withdrawal by Subject|38|||
149879720|NCT00534404|540688750|FG000|Overall Study|Removed by study staff|2|||
149879721|NCT00534404|540688751|FG001|Overall Study|Removed by study staff|3|||
150043796|NCT02255435|541300683|FG004|Overall Study|Patient's Limited Time Availability|0|||
150043797|NCT02255435|541300684|FG005|Overall Study|Patient's Limited Time Availability|0|||
150043798|NCT02255435|541300685|FG006|Overall Study|Patient's Limited Time Availability|0|||
150043799|NCT02255435|541300686|FG007|Overall Study|Patient's Limited Time Availability|1|||
150043800|NCT02255435|541300687|FG008|Overall Study|Patient's Limited Time Availability|0|||
150043801|NCT02255435|541300688|FG009|Overall Study|Patient's Limited Time Availability|0|||
150043802|NCT02255435|541300679|FG000|Overall Study|Withdrawal by Subject|0|||
150043803|NCT02255435|541300680|FG001|Overall Study|Withdrawal by Subject|0|||
150043804|NCT02255435|541300681|FG002|Overall Study|Withdrawal by Subject|0|||
149879722|NCT00534404|540688752|FG002|Overall Study|Removed by study staff|1|||
149879723|NCT00534404|540688750|FG000|Overall Study|Lost to Follow-up|170|||
149879724|NCT00534404|540688751|FG001|Overall Study|Lost to Follow-up|138|||
149879725|NCT00534404|540688752|FG002|Overall Study|Lost to Follow-up|201|||
149879726|NCT02996487|540688755|FG000|Overall Study|Lost to Follow-up|1|||
149879727|NCT02996487|540688756|FG001|Overall Study|Lost to Follow-up|1|||
149879728|NCT02996487|540688757|FG002|Overall Study|Lost to Follow-up|0|||
149879729|NCT02996487|540688755|FG000|Overall Study|Death|0|||
149879730|NCT02996487|540688756|FG001|Overall Study|Death|1|||
149879731|NCT02996487|540688757|FG002|Overall Study|Death|0|||
149879732|NCT02996487|540688755|FG000|Overall Study|Withdrawal by Subject|2|||
149879733|NCT02996487|540688756|FG001|Overall Study|Withdrawal by Subject|3|||
149879734|NCT02996487|540688757|FG002|Overall Study|Withdrawal by Subject|0|||
149879735|NCT02027428|540688758|FG000|Induction|Never treated|7|||
149879736|NCT02027428|540688759|FG001|Induction|Never treated|0|||
149879737|NCT02027428|540688760|FG002|Induction|Never treated|0|||
149879738|NCT02027428|540688758|FG000|Induction|Progressive disease|77|||
149879739|NCT02027428|540688759|FG001|Induction|Progressive disease|0|||
149879740|NCT02027428|540688760|FG002|Induction|Progressive disease|0|||
149879741|NCT02027428|540688758|FG000|Induction|Adverse Event|51|||
149879742|NCT02027428|540688759|FG001|Induction|Adverse Event|0|||
149879743|NCT02027428|540688760|FG002|Induction|Adverse Event|0|||
149965114|NCT05375929|541006792|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
149965115|NCT05375929|541006789|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
149965116|NCT05375929|541006790|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
149965117|NCT05375929|541006791|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
149965118|NCT05375929|541006792|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
149965119|NCT05375929|541006789|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
149965120|NCT05375929|541006790|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
149965121|NCT05375929|541006791|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
149965122|NCT05375929|541006792|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
149965123|NCT05375929|541006789|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
149965124|NCT05375929|541006790|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
150043805|NCT02255435|541300682|FG003|Overall Study|Withdrawal by Subject|0|||
150043806|NCT02255435|541300683|FG004|Overall Study|Withdrawal by Subject|0|||
150043807|NCT02255435|541300684|FG005|Overall Study|Withdrawal by Subject|0|||
150043808|NCT02255435|541300685|FG006|Overall Study|Withdrawal by Subject|0|||
150043809|NCT02255435|541300686|FG007|Overall Study|Withdrawal by Subject|0|||
150043810|NCT02255435|541300687|FG008|Overall Study|Withdrawal by Subject|1|||
150043811|NCT02255435|541300688|FG009|Overall Study|Withdrawal by Subject|4|||
150043812|NCT02255435|541300679|FG000|Overall Study|Administrative reasons|0|||
150043813|NCT02255435|541300680|FG001|Overall Study|Administrative reasons|0|||
150043814|NCT02255435|541300681|FG002|Overall Study|Administrative reasons|0|||
150043815|NCT02255435|541300682|FG003|Overall Study|Administrative reasons|0|||
150043816|NCT02255435|541300683|FG004|Overall Study|Administrative reasons|0|||
150043817|NCT02255435|541300684|FG005|Overall Study|Administrative reasons|0|||
149879744|NCT02027428|540688758|FG000|Induction|Withdrawal by Subject|22|||
149879745|NCT02027428|540688759|FG001|Induction|Withdrawal by Subject|0|||
150043818|NCT02255435|541300685|FG006|Overall Study|Administrative reasons|0|||
149879746|NCT02027428|540688760|FG002|Induction|Withdrawal by Subject|0|||
149879747|NCT02027428|540688758|FG000|Induction|Death|21|||
149879748|NCT02027428|540688759|FG001|Induction|Death|0|||
150043819|NCT02255435|541300686|FG007|Overall Study|Administrative reasons|0|||
149879749|NCT02027428|540688760|FG002|Induction|Death|0|||
149879750|NCT02027428|540688758|FG000|Induction|Symptomatic deterioration|16|||
149879751|NCT02027428|540688759|FG001|Induction|Symptomatic deterioration|0|||
149879752|NCT02027428|540688760|FG002|Induction|Symptomatic deterioration|0|||
149879753|NCT02027428|540688758|FG000|Induction|Study terminated by sponsor|12|||
149879754|NCT02027428|540688759|FG001|Induction|Study terminated by sponsor|0|||
149879755|NCT02027428|540688760|FG002|Induction|Study terminated by sponsor|0|||
150043820|NCT02255435|541300687|FG008|Overall Study|Administrative reasons|0|||
150043821|NCT02255435|541300688|FG009|Overall Study|Administrative reasons|2|||
150043822|NCT02741518|541300691|FG000|Overall Study|Withdrawal by Subject|1|||
150043823|NCT02741518|541300692|FG001|Overall Study|Withdrawal by Subject|1|||
150043824|NCT00476008|541300693|FG000|Overall Study|Adverse Event|4|||
150043825|NCT00476008|541300694|FG001|Overall Study|Adverse Event|4|||
150043826|NCT00476008|541300693|FG000|Overall Study|Placebo concerns|2|||
149879756|NCT02027428|540688758|FG000|Induction|Protocol Violation|1|||
149879757|NCT02027428|540688759|FG001|Induction|Protocol Violation|0|||
149879758|NCT02027428|540688760|FG002|Induction|Protocol Violation|0|||
149879759|NCT02027428|540688758|FG000|Induction|Miscellaneous|14|||
149879760|NCT02027428|540688759|FG001|Induction|Miscellaneous|0|||
149879761|NCT02027428|540688760|FG002|Induction|Miscellaneous|0|||
149879762|NCT02027428|540688758|FG000|Induction|Induction Treatment Ongoing|4|||
149879763|NCT02027428|540688759|FG001|Induction|Induction Treatment Ongoing|0|||
149879764|NCT02027428|540688760|FG002|Induction|Induction Treatment Ongoing|0|||
149879765|NCT02027428|540688758|FG000|Maintenance|Death|0|||
149879766|NCT02027428|540688759|FG001|Maintenance|Death|3|||
149879767|NCT02027428|540688760|FG002|Maintenance|Death|2|||
149879768|NCT02027428|540688758|FG000|Maintenance|Adverse Event|0|||
149879769|NCT02027428|540688759|FG001|Maintenance|Adverse Event|21|||
149879770|NCT02027428|540688760|FG002|Maintenance|Adverse Event|1|||
149879771|NCT02027428|540688758|FG000|Maintenance|Progressive disease|0|||
149879772|NCT02027428|540688759|FG001|Maintenance|Progressive disease|84|||
149879773|NCT02027428|540688760|FG002|Maintenance|Progressive disease|47|||
149879774|NCT02027428|540688758|FG000|Maintenance|Symptomatic deterioration|0|||
149879775|NCT02027428|540688759|FG001|Maintenance|Symptomatic deterioration|4|||
149879776|NCT02027428|540688760|FG002|Maintenance|Symptomatic deterioration|1|||
149879777|NCT02027428|540688758|FG000|Maintenance|Withdrawal by Subject|0|||
149879778|NCT02027428|540688759|FG001|Maintenance|Withdrawal by Subject|6|||
149879779|NCT02027428|540688760|FG002|Maintenance|Withdrawal by Subject|5|||
149879780|NCT02027428|540688758|FG000|Maintenance|Protocol Violation|0|||
149879781|NCT02027428|540688759|FG001|Maintenance|Protocol Violation|0|||
149879782|NCT02027428|540688760|FG002|Maintenance|Protocol Violation|1|||
149879783|NCT02027428|540688758|FG000|Maintenance|Other|0|||
149879784|NCT02027428|540688759|FG001|Maintenance|Other|6|||
149879785|NCT02027428|540688760|FG002|Maintenance|Other|3|||
149879786|NCT02027428|540688758|FG000|Survival Follow-up|Death|0|||
149879787|NCT02027428|540688759|FG001|Survival Follow-up|Death|78|||
149879788|NCT02027428|540688760|FG002|Survival Follow-up|Death|45|||
149879789|NCT02027428|540688758|FG000|Survival Follow-up|Lost to Follow-up|0|||
149879790|NCT02027428|540688759|FG001|Survival Follow-up|Lost to Follow-up|1|||
149879791|NCT02027428|540688760|FG002|Survival Follow-up|Lost to Follow-up|1|||
149879792|NCT01128543|540688761|FG000|Overall Study|Withdrawal by Subject|3|||
149879793|NCT01128543|540688761|FG000|Overall Study|Protocol Violation|1|||
149879794|NCT02676765|540688762|FG000|Overall Study|Lost to Follow-up|0|||
149879795|NCT02676765|540688763|FG001|Overall Study|Lost to Follow-up|1|||
149879796|NCT03340974|540688764|FG000|Completion of Study -Long Term Follow up|Death|8|||
149879797|NCT03340974|540688765|FG001|Completion of Study -Long Term Follow up|Death|5|||
149879798|NCT03340974|540688766|FG002|Completion of Study -Long Term Follow up|Death|5|||
149879799|NCT03340974|540688767|FG003|Completion of Study -Long Term Follow up|Death|7|||
149879800|NCT03340974|540688764|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
149879801|NCT03340974|540688765|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
149879802|NCT03340974|540688766|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
149879803|NCT03340974|540688767|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
149879804|NCT03340974|540688764|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
149879805|NCT03340974|540688765|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
149879806|NCT03340974|540688766|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
149879807|NCT03340974|540688767|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
149879808|NCT03340974|540688764|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
149879809|NCT03340974|540688765|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
149879810|NCT03340974|540688766|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
149879811|NCT03340974|540688767|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
149879812|NCT02374346|540688768|FG000|Overall Study|operated or discharged during weekend|48|||
149879813|NCT03097991|540688771|FG000|Overall Study|Didn't meet study criteria|8|||
150043827|NCT00476008|541300694|FG001|Overall Study|Placebo concerns|2|||
149879814|NCT03097991|540688772|FG001|Overall Study|Didn't meet study criteria|0|||
149879815|NCT03097991|540688771|FG000|Overall Study|Withdrawal by Subject|12|||
150043828|NCT00476008|541300693|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
149879816|NCT03097991|540688772|FG001|Overall Study|Withdrawal by Subject|6|||
149879817|NCT03097991|540688771|FG000|Overall Study|Death of Baby|3|||
149879818|NCT03097991|540688772|FG001|Overall Study|Death of Baby|1|||
149879819|NCT03097991|540688771|FG000|Overall Study|Lost to Follow-up|24|||
149879820|NCT03097991|540688772|FG001|Overall Study|Lost to Follow-up|38|||
149879821|NCT03097991|540688771|FG000|Overall Study|Adverse Event|3|||
150043829|NCT00476008|541300694|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
149879822|NCT03097991|540688772|FG001|Overall Study|Adverse Event|5|||
149879823|NCT00246324|540688773|FG000|Overall Study|Withdrawal by Subject|1|||
149879824|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
149879825|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
149879826|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
149879827|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Death|1|||
149879828|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Death|3|||
149879829|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Death|1|||
149879830|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
149879831|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
149879832|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
149879833|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
149879834|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
149879835|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
149879836|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
149879837|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
149879838|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
149879839|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
149879840|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
149879841|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
149879842|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
149879843|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
149879844|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
149879845|NCT00299130|540688774|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
149879846|NCT00299130|540688775|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
149879847|NCT00299130|540688776|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
149879848|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
149879849|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
149879850|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
149879851|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
149879852|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
149879853|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
149879854|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
149879855|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
149879856|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
149879857|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
149879858|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
149879859|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
149879860|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
149879861|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
149879862|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
149879863|NCT00299130|540688774|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
149879864|NCT00299130|540688775|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
149879865|NCT00299130|540688776|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
149879866|NCT00299130|540688774|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
149879867|NCT00299130|540688775|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
149879868|NCT00299130|540688776|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
149879869|NCT00299130|540688774|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
149879870|NCT00299130|540688775|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
149879871|NCT00299130|540688776|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
149879872|NCT00299130|540688774|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
149879873|NCT00299130|540688775|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
149879874|NCT00299130|540688776|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
149879875|NCT01374269|540688779|FG000|Overall Study|Withdrawal by Subject|4|||
149879876|NCT01374269|540688780|FG001|Overall Study|Withdrawal by Subject|0|||
149879877|NCT01374269|540688779|FG000|Overall Study|Lost to Follow-up|1|||
149879878|NCT01374269|540688780|FG001|Overall Study|Lost to Follow-up|3|||
150174977|NCT02445391|541775992|FG000|Overall Study|Not start protocol therapy|0|||
150174978|NCT02445391|541775993|FG001|Overall Study|Not start protocol therapy|12|||
150174979|NCT02445391|541775994|FG002|Overall Study|Not start protocol therapy|9|||
150174980|NCT03889925|541777004|FG000|Overall Study|Lost to Follow-up|11|||
149879879|NCT01374269|540688779|FG000|Overall Study|closed research|1|||
149879880|NCT01374269|540688780|FG001|Overall Study|closed research|2|||
149879881|NCT03316547|540688786|FG000|Overall Study|Death|3|||
149879882|NCT03316547|540688787|FG001|Overall Study|Death|1|||
149879883|NCT03316547|540688786|FG000|Overall Study|Lost to Follow-up|6|||
149879884|NCT03316547|540688787|FG001|Overall Study|Lost to Follow-up|6|||
149879885|NCT03316547|540688786|FG000|Overall Study|Withdrawal by Subject|3|||
149879886|NCT03316547|540688787|FG001|Overall Study|Withdrawal by Subject|2|||
149879887|NCT03316547|540688786|FG000|Overall Study|Transfer to another hospital|6|||
149879888|NCT03316547|540688787|FG001|Overall Study|Transfer to another hospital|4|||
149879889|NCT00996892|540688788|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
149879890|NCT00996892|540688789|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
149879891|NCT00996892|540688790|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
149879892|NCT00996892|540688791|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
149879893|NCT00996892|540688792|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
149879894|NCT00996892|540688793|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
149879895|NCT00996892|540688794|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
149879896|NCT00996892|540688795|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
149879897|NCT00996892|540688796|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
149879898|NCT00996892|540688797|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
149879899|NCT00996892|540688798|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
149879900|NCT00996892|540688799|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
149879901|NCT00996892|540688800|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
149879902|NCT00996892|540688801|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
149879903|NCT00996892|540688802|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
149879904|NCT00996892|540688803|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
149879905|NCT00996892|540688804|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
149879906|NCT00996892|540688805|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
149879907|NCT00996892|540688806|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
149879908|NCT00996892|540688807|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
149879909|NCT00996892|540688788|FG000|Dose-Escalation Stage 1|Death|1|||
149879910|NCT00996892|540688789|FG001|Dose-Escalation Stage 1|Death|0|||
149879911|NCT00996892|540688790|FG002|Dose-Escalation Stage 1|Death|0|||
149879912|NCT00996892|540688791|FG003|Dose-Escalation Stage 1|Death|0|||
149879913|NCT00996892|540688792|FG004|Dose-Escalation Stage 1|Death|0|||
149879914|NCT00996892|540688793|FG005|Dose-Escalation Stage 1|Death|1|||
149879915|NCT00996892|540688794|FG006|Dose-Escalation Stage 1|Death|0|||
149879916|NCT00996892|540688795|FG007|Dose-Escalation Stage 1|Death|0|||
149879917|NCT00996892|540688796|FG008|Dose-Escalation Stage 1|Death|0|||
149879918|NCT00996892|540688797|FG009|Dose-Escalation Stage 1|Death|0|||
149879919|NCT00996892|540688798|FG010|Dose-Escalation Stage 1|Death|0|||
149879920|NCT00996892|540688799|FG011|Dose-Escalation Stage 1|Death|0|||
149879921|NCT00996892|540688800|FG012|Dose-Escalation Stage 1|Death|0|||
149879922|NCT00996892|540688801|FG013|Dose-Escalation Stage 1|Death|0|||
149879923|NCT00996892|540688802|FG014|Dose-Escalation Stage 1|Death|0|||
149879924|NCT00996892|540688803|FG015|Dose-Escalation Stage 1|Death|0|||
149879925|NCT00996892|540688804|FG016|Dose-Escalation Stage 1|Death|0|||
149879926|NCT00996892|540688805|FG017|Dose-Escalation Stage 1|Death|0|||
149879927|NCT00996892|540688806|FG018|Dose-Escalation Stage 1|Death|0|||
149879928|NCT00996892|540688807|FG019|Dose-Escalation Stage 1|Death|0|||
149879929|NCT00996892|540688788|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
149879930|NCT00996892|540688789|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
149879931|NCT00996892|540688790|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
149879932|NCT00996892|540688791|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
149879933|NCT00996892|540688792|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
149879934|NCT00996892|540688793|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
149879935|NCT00996892|540688794|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
149879936|NCT00996892|540688795|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
149965125|NCT05375929|541006791|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
149965126|NCT05375929|541006792|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
149965127|NCT05375929|541006789|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
149965128|NCT05375929|541006790|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
149965129|NCT05375929|541006791|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
149879937|NCT00996892|540688796|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
149879938|NCT00996892|540688797|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
149879939|NCT00996892|540688798|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
149879940|NCT00996892|540688799|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
149879941|NCT00996892|540688800|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
149879942|NCT00996892|540688801|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
149879943|NCT00996892|540688802|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
149879944|NCT00996892|540688803|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
149879945|NCT00996892|540688804|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
149879946|NCT00996892|540688805|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
149879947|NCT00996892|540688806|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
149879948|NCT00996892|540688807|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
149879949|NCT00996892|540688788|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879950|NCT00996892|540688789|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
149879951|NCT00996892|540688790|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879952|NCT00996892|540688791|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
149879953|NCT00996892|540688792|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
149879954|NCT00996892|540688793|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
149879955|NCT00996892|540688794|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
149879956|NCT00996892|540688795|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879957|NCT00996892|540688796|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879958|NCT00996892|540688797|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879959|NCT00996892|540688798|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879960|NCT00996892|540688799|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879961|NCT00996892|540688800|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879962|NCT00996892|540688801|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879963|NCT00996892|540688802|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879964|NCT00996892|540688803|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879965|NCT00996892|540688804|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879966|NCT00996892|540688805|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879967|NCT00996892|540688806|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879968|NCT00996892|540688807|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
149879969|NCT00996892|540688788|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
149879970|NCT00996892|540688789|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
149879971|NCT00996892|540688790|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
149879972|NCT00996892|540688791|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
149879973|NCT00996892|540688792|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
149879974|NCT00996892|540688793|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
149879975|NCT00996892|540688794|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
149879976|NCT00996892|540688795|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
149879977|NCT00996892|540688796|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
149879978|NCT00996892|540688797|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
149879979|NCT00996892|540688798|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
149879980|NCT00996892|540688799|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
149879981|NCT00996892|540688800|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
149879982|NCT00996892|540688801|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
149879983|NCT00996892|540688802|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
149879984|NCT00996892|540688803|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
149879985|NCT00996892|540688804|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
149879986|NCT00996892|540688805|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
149879987|NCT00996892|540688806|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
149879988|NCT00996892|540688807|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
149879989|NCT00996892|540688788|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
149879990|NCT00996892|540688789|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
149879991|NCT00996892|540688790|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
149879992|NCT00996892|540688791|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
149879993|NCT00996892|540688792|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
149879994|NCT00996892|540688793|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
149879995|NCT00996892|540688794|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
149879996|NCT00996892|540688795|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
149879997|NCT00996892|540688796|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
149879998|NCT00996892|540688797|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
149879999|NCT00996892|540688798|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
149880000|NCT00996892|540688799|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
149880001|NCT00996892|540688800|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
149880002|NCT00996892|540688801|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
149880003|NCT00996892|540688802|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
149880004|NCT00996892|540688803|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
149880005|NCT00996892|540688804|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
149880006|NCT00996892|540688805|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
149880007|NCT00996892|540688806|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
149880008|NCT00996892|540688807|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
149880009|NCT00996892|540688788|FG000|Dose-Escalation Stage 1A|Death|0|||
149880010|NCT00996892|540688789|FG001|Dose-Escalation Stage 1A|Death|0|||
149880011|NCT00996892|540688790|FG002|Dose-Escalation Stage 1A|Death|0|||
149880012|NCT00996892|540688791|FG003|Dose-Escalation Stage 1A|Death|0|||
149880013|NCT00996892|540688792|FG004|Dose-Escalation Stage 1A|Death|0|||
149880014|NCT00996892|540688793|FG005|Dose-Escalation Stage 1A|Death|0|||
149880015|NCT00996892|540688794|FG006|Dose-Escalation Stage 1A|Death|0|||
149880016|NCT00996892|540688795|FG007|Dose-Escalation Stage 1A|Death|0|||
149880017|NCT00996892|540688796|FG008|Dose-Escalation Stage 1A|Death|0|||
149880018|NCT00996892|540688797|FG009|Dose-Escalation Stage 1A|Death|2|||
149880019|NCT00996892|540688798|FG010|Dose-Escalation Stage 1A|Death|0|||
149880020|NCT00996892|540688799|FG011|Dose-Escalation Stage 1A|Death|1|||
149880021|NCT00996892|540688800|FG012|Dose-Escalation Stage 1A|Death|1|||
149880022|NCT00996892|540688801|FG013|Dose-Escalation Stage 1A|Death|0|||
149880023|NCT00996892|540688802|FG014|Dose-Escalation Stage 1A|Death|0|||
149880024|NCT00996892|540688803|FG015|Dose-Escalation Stage 1A|Death|0|||
149880025|NCT00996892|540688804|FG016|Dose-Escalation Stage 1A|Death|0|||
149880026|NCT00996892|540688805|FG017|Dose-Escalation Stage 1A|Death|0|||
149880027|NCT00996892|540688806|FG018|Dose-Escalation Stage 1A|Death|0|||
149880028|NCT00996892|540688807|FG019|Dose-Escalation Stage 1A|Death|0|||
149880029|NCT00996892|540688788|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
149880030|NCT00996892|540688789|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
149880031|NCT00996892|540688790|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
149880032|NCT00996892|540688791|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
149880033|NCT00996892|540688792|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
149880034|NCT00996892|540688793|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
149880035|NCT00996892|540688794|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
149880036|NCT00996892|540688795|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
149880037|NCT00996892|540688796|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
149880038|NCT00996892|540688797|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
149880039|NCT00996892|540688798|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
149880040|NCT00996892|540688799|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
149880041|NCT00996892|540688800|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
149880042|NCT00996892|540688801|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
149880043|NCT00996892|540688802|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
149880044|NCT00996892|540688803|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
149880045|NCT00996892|540688804|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
149880046|NCT00996892|540688805|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
149880047|NCT00996892|540688806|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
149880048|NCT00996892|540688807|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
149880049|NCT00996892|540688788|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880050|NCT00996892|540688789|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880051|NCT00996892|540688790|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880052|NCT00996892|540688791|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880053|NCT00996892|540688792|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880054|NCT00996892|540688793|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880055|NCT00996892|540688794|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880056|NCT00996892|540688795|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880057|NCT00996892|540688796|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880058|NCT00996892|540688797|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
149880059|NCT00996892|540688798|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
149880060|NCT00996892|540688799|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
149880061|NCT00996892|540688800|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
149880062|NCT00996892|540688801|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149965130|NCT05375929|541006792|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
149965131|NCT05375929|541006789|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
149965132|NCT05375929|541006790|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
149965133|NCT05375929|541006791|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
149965134|NCT05375929|541006792|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
149965135|NCT05375929|541006789|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
149965136|NCT05375929|541006790|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
149965137|NCT05375929|541006791|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
149965138|NCT05375929|541006792|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
149880063|NCT00996892|540688802|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149965139|NCT03973489|541006793|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
149880064|NCT00996892|540688803|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880065|NCT00996892|540688804|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880066|NCT00996892|540688805|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880067|NCT00996892|540688806|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880068|NCT00996892|540688807|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
149880069|NCT00996892|540688788|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
149880070|NCT00996892|540688789|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
149880071|NCT00996892|540688790|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
149880072|NCT00996892|540688791|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
149880073|NCT00996892|540688792|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
149880074|NCT00996892|540688793|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
149880075|NCT00996892|540688794|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
149880076|NCT00996892|540688795|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
149880077|NCT00996892|540688796|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
149880078|NCT00996892|540688797|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
149880079|NCT00996892|540688798|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
149880080|NCT00996892|540688799|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
149880081|NCT00996892|540688800|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
149880082|NCT00996892|540688801|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
149880083|NCT00996892|540688802|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
149880084|NCT00996892|540688803|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
149880085|NCT00996892|540688804|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
149880086|NCT00996892|540688805|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
149880087|NCT00996892|540688806|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
149880088|NCT00996892|540688807|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
149880089|NCT00996892|540688788|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
149880090|NCT00996892|540688789|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
149880091|NCT00996892|540688790|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
149880092|NCT00996892|540688791|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
149880093|NCT00996892|540688792|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
149880094|NCT00996892|540688793|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
149880095|NCT00996892|540688794|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
149880096|NCT00996892|540688795|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
149880097|NCT00996892|540688796|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
149880098|NCT00996892|540688797|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
149880099|NCT00996892|540688798|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
149880100|NCT00996892|540688799|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
149880101|NCT00996892|540688800|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
149880102|NCT00996892|540688801|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
149880103|NCT00996892|540688802|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
149880104|NCT00996892|540688803|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
149880105|NCT00996892|540688804|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
149880106|NCT00996892|540688805|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
149880107|NCT00996892|540688806|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
149880108|NCT00996892|540688807|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
149880109|NCT00996892|540688788|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
149880110|NCT00996892|540688789|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
149880111|NCT00996892|540688790|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
149880112|NCT00996892|540688791|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
149880113|NCT00996892|540688792|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
149880114|NCT00996892|540688793|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
149880115|NCT00996892|540688794|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
149880116|NCT00996892|540688795|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
149880117|NCT00996892|540688796|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
149880118|NCT00996892|540688797|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
149880119|NCT00996892|540688798|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
149880120|NCT00996892|540688799|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
149880121|NCT00996892|540688800|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
149880122|NCT00996892|540688801|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
149880123|NCT00996892|540688802|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
149880124|NCT00996892|540688803|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
149880125|NCT00996892|540688804|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
149880126|NCT00996892|540688805|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
149880127|NCT00996892|540688806|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
149880128|NCT00996892|540688807|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
149880129|NCT00996892|540688788|FG000|Expansion Stage 2|Adverse Event|0|||
149880130|NCT00996892|540688789|FG001|Expansion Stage 2|Adverse Event|0|||
149880131|NCT00996892|540688790|FG002|Expansion Stage 2|Adverse Event|0|||
149880132|NCT00996892|540688791|FG003|Expansion Stage 2|Adverse Event|0|||
149880133|NCT00996892|540688792|FG004|Expansion Stage 2|Adverse Event|0|||
149880134|NCT00996892|540688793|FG005|Expansion Stage 2|Adverse Event|0|||
149880135|NCT00996892|540688794|FG006|Expansion Stage 2|Adverse Event|0|||
149880136|NCT00996892|540688795|FG007|Expansion Stage 2|Adverse Event|0|||
149880137|NCT00996892|540688796|FG008|Expansion Stage 2|Adverse Event|0|||
149880138|NCT00996892|540688797|FG009|Expansion Stage 2|Adverse Event|0|||
149880139|NCT00996892|540688798|FG010|Expansion Stage 2|Adverse Event|0|||
149880140|NCT00996892|540688799|FG011|Expansion Stage 2|Adverse Event|0|||
149880141|NCT00996892|540688800|FG012|Expansion Stage 2|Adverse Event|0|||
149880142|NCT00996892|540688801|FG013|Expansion Stage 2|Adverse Event|0|||
149880143|NCT00996892|540688802|FG014|Expansion Stage 2|Adverse Event|0|||
149880144|NCT00996892|540688803|FG015|Expansion Stage 2|Adverse Event|0|||
149880145|NCT00996892|540688804|FG016|Expansion Stage 2|Adverse Event|0|||
149880146|NCT00996892|540688805|FG017|Expansion Stage 2|Adverse Event|0|||
149880147|NCT00996892|540688806|FG018|Expansion Stage 2|Adverse Event|3|||
149965140|NCT03973489|541006794|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149965141|NCT03973489|541006795|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149965142|NCT03973489|541006796|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149965143|NCT03973489|541006797|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
149965144|NCT03973489|541006798|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149965145|NCT03973489|541006799|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149965146|NCT03973489|541006800|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
149880148|NCT00996892|540688807|FG019|Expansion Stage 2|Adverse Event|0|||
149880149|NCT00996892|540688788|FG000|Expansion Stage 2|Death|0|||
149880150|NCT00996892|540688789|FG001|Expansion Stage 2|Death|0|||
149880151|NCT00996892|540688790|FG002|Expansion Stage 2|Death|0|||
149880152|NCT00996892|540688791|FG003|Expansion Stage 2|Death|0|||
149880153|NCT00996892|540688792|FG004|Expansion Stage 2|Death|0|||
149880154|NCT00996892|540688793|FG005|Expansion Stage 2|Death|0|||
149880155|NCT00996892|540688794|FG006|Expansion Stage 2|Death|0|||
149880156|NCT00996892|540688795|FG007|Expansion Stage 2|Death|0|||
149880157|NCT00996892|540688796|FG008|Expansion Stage 2|Death|0|||
149880158|NCT00996892|540688797|FG009|Expansion Stage 2|Death|0|||
149880159|NCT00996892|540688798|FG010|Expansion Stage 2|Death|0|||
149880160|NCT00996892|540688799|FG011|Expansion Stage 2|Death|0|||
149880161|NCT00996892|540688800|FG012|Expansion Stage 2|Death|0|||
149880162|NCT00996892|540688801|FG013|Expansion Stage 2|Death|0|||
149880163|NCT00996892|540688802|FG014|Expansion Stage 2|Death|0|||
149880164|NCT00996892|540688803|FG015|Expansion Stage 2|Death|0|||
149880165|NCT00996892|540688804|FG016|Expansion Stage 2|Death|0|||
149880166|NCT00996892|540688805|FG017|Expansion Stage 2|Death|0|||
149880167|NCT00996892|540688806|FG018|Expansion Stage 2|Death|2|||
149880168|NCT00996892|540688807|FG019|Expansion Stage 2|Death|0|||
149880169|NCT00996892|540688788|FG000|Expansion Stage 2|Physician Decision|0|||
149965147|NCT03973489|541006793|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965148|NCT03973489|541006794|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965149|NCT03973489|541006795|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965150|NCT03973489|541006796|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
149965151|NCT03973489|541006797|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
149965152|NCT03973489|541006798|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965153|NCT03973489|541006799|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965154|NCT03973489|541006800|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
149965155|NCT03973489|541006793|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
149880170|NCT00996892|540688789|FG001|Expansion Stage 2|Physician Decision|0|||
149880171|NCT00996892|540688790|FG002|Expansion Stage 2|Physician Decision|0|||
149880172|NCT00996892|540688791|FG003|Expansion Stage 2|Physician Decision|0|||
149880173|NCT00996892|540688792|FG004|Expansion Stage 2|Physician Decision|0|||
149880174|NCT00996892|540688793|FG005|Expansion Stage 2|Physician Decision|0|||
149880175|NCT00996892|540688794|FG006|Expansion Stage 2|Physician Decision|0|||
149880176|NCT00996892|540688795|FG007|Expansion Stage 2|Physician Decision|0|||
149880177|NCT00996892|540688796|FG008|Expansion Stage 2|Physician Decision|0|||
149880178|NCT00996892|540688797|FG009|Expansion Stage 2|Physician Decision|0|||
149880179|NCT00996892|540688798|FG010|Expansion Stage 2|Physician Decision|0|||
149880180|NCT00996892|540688799|FG011|Expansion Stage 2|Physician Decision|0|||
149880181|NCT00996892|540688800|FG012|Expansion Stage 2|Physician Decision|0|||
149880182|NCT00996892|540688801|FG013|Expansion Stage 2|Physician Decision|0|||
149880183|NCT00996892|540688802|FG014|Expansion Stage 2|Physician Decision|0|||
149880184|NCT00996892|540688803|FG015|Expansion Stage 2|Physician Decision|0|||
149880185|NCT00996892|540688804|FG016|Expansion Stage 2|Physician Decision|0|||
149880186|NCT00996892|540688805|FG017|Expansion Stage 2|Physician Decision|0|||
149880187|NCT00996892|540688806|FG018|Expansion Stage 2|Physician Decision|1|||
149880188|NCT00996892|540688807|FG019|Expansion Stage 2|Physician Decision|0|||
149880189|NCT00996892|540688788|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
149880190|NCT00996892|540688789|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
149880191|NCT00996892|540688790|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
149880192|NCT00996892|540688791|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
149880193|NCT00996892|540688792|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
149880194|NCT00996892|540688793|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
149880195|NCT00996892|540688794|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
149965156|NCT03973489|541006794|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
149880196|NCT00996892|540688795|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
149880197|NCT00996892|540688796|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
149880198|NCT00996892|540688797|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
149965157|NCT03973489|541006795|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
149965158|NCT03973489|541006796|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
149880199|NCT00996892|540688798|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
149880200|NCT00996892|540688799|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
149880201|NCT00996892|540688800|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
149880202|NCT00996892|540688801|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
149880203|NCT00996892|540688802|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
149880204|NCT00996892|540688803|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
149880205|NCT00996892|540688804|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
149880206|NCT00996892|540688805|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
149880207|NCT00996892|540688806|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
149880208|NCT00996892|540688807|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
149880209|NCT00996892|540688788|FG000|Expansion Stage 2|Disease Progression|0|||
149880210|NCT00996892|540688789|FG001|Expansion Stage 2|Disease Progression|0|||
149880211|NCT00996892|540688790|FG002|Expansion Stage 2|Disease Progression|0|||
149880212|NCT00996892|540688791|FG003|Expansion Stage 2|Disease Progression|0|||
149880213|NCT00996892|540688792|FG004|Expansion Stage 2|Disease Progression|0|||
149880214|NCT00996892|540688793|FG005|Expansion Stage 2|Disease Progression|0|||
149880215|NCT00996892|540688794|FG006|Expansion Stage 2|Disease Progression|0|||
149880216|NCT00996892|540688795|FG007|Expansion Stage 2|Disease Progression|0|||
149880217|NCT00996892|540688796|FG008|Expansion Stage 2|Disease Progression|0|||
149880218|NCT00996892|540688797|FG009|Expansion Stage 2|Disease Progression|0|||
149880219|NCT00996892|540688798|FG010|Expansion Stage 2|Disease Progression|0|||
149880220|NCT00996892|540688799|FG011|Expansion Stage 2|Disease Progression|0|||
149880221|NCT00996892|540688800|FG012|Expansion Stage 2|Disease Progression|0|||
149880222|NCT00996892|540688801|FG013|Expansion Stage 2|Disease Progression|0|||
149880223|NCT00996892|540688802|FG014|Expansion Stage 2|Disease Progression|0|||
149880224|NCT00996892|540688803|FG015|Expansion Stage 2|Disease Progression|0|||
149880225|NCT00996892|540688804|FG016|Expansion Stage 2|Disease Progression|0|||
149880226|NCT00996892|540688805|FG017|Expansion Stage 2|Disease Progression|0|||
149880227|NCT00996892|540688806|FG018|Expansion Stage 2|Disease Progression|28|||
149880228|NCT00996892|540688807|FG019|Expansion Stage 2|Disease Progression|0|||
149880229|NCT00996892|540688788|FG000|Expansion Stage 2A|Adverse Event|0|||
149880230|NCT00996892|540688789|FG001|Expansion Stage 2A|Adverse Event|0|||
149880231|NCT00996892|540688790|FG002|Expansion Stage 2A|Adverse Event|0|||
149880232|NCT00996892|540688791|FG003|Expansion Stage 2A|Adverse Event|0|||
149880233|NCT00996892|540688792|FG004|Expansion Stage 2A|Adverse Event|0|||
149880234|NCT00996892|540688793|FG005|Expansion Stage 2A|Adverse Event|0|||
149880235|NCT00996892|540688794|FG006|Expansion Stage 2A|Adverse Event|0|||
149880236|NCT00996892|540688795|FG007|Expansion Stage 2A|Adverse Event|0|||
149880237|NCT00996892|540688796|FG008|Expansion Stage 2A|Adverse Event|0|||
149880238|NCT00996892|540688797|FG009|Expansion Stage 2A|Adverse Event|0|||
149880239|NCT00996892|540688798|FG010|Expansion Stage 2A|Adverse Event|0|||
149880240|NCT00996892|540688799|FG011|Expansion Stage 2A|Adverse Event|0|||
149880241|NCT00996892|540688800|FG012|Expansion Stage 2A|Adverse Event|0|||
149880242|NCT00996892|540688801|FG013|Expansion Stage 2A|Adverse Event|0|||
149880243|NCT00996892|540688802|FG014|Expansion Stage 2A|Adverse Event|0|||
149880244|NCT00996892|540688803|FG015|Expansion Stage 2A|Adverse Event|0|||
149880245|NCT00996892|540688804|FG016|Expansion Stage 2A|Adverse Event|0|||
149880246|NCT00996892|540688805|FG017|Expansion Stage 2A|Adverse Event|0|||
149880247|NCT00996892|540688806|FG018|Expansion Stage 2A|Adverse Event|0|||
149880248|NCT00996892|540688807|FG019|Expansion Stage 2A|Adverse Event|8|||
149880249|NCT00996892|540688788|FG000|Expansion Stage 2A|Physician Decision|0|||
149880250|NCT00996892|540688789|FG001|Expansion Stage 2A|Physician Decision|0|||
149880251|NCT00996892|540688790|FG002|Expansion Stage 2A|Physician Decision|0|||
149880252|NCT00996892|540688791|FG003|Expansion Stage 2A|Physician Decision|0|||
149880253|NCT00996892|540688792|FG004|Expansion Stage 2A|Physician Decision|0|||
149880254|NCT00996892|540688793|FG005|Expansion Stage 2A|Physician Decision|0|||
149880255|NCT00996892|540688794|FG006|Expansion Stage 2A|Physician Decision|0|||
149880256|NCT00996892|540688795|FG007|Expansion Stage 2A|Physician Decision|0|||
149880257|NCT00996892|540688796|FG008|Expansion Stage 2A|Physician Decision|0|||
149880258|NCT00996892|540688797|FG009|Expansion Stage 2A|Physician Decision|0|||
149880259|NCT00996892|540688798|FG010|Expansion Stage 2A|Physician Decision|0|||
149880260|NCT00996892|540688799|FG011|Expansion Stage 2A|Physician Decision|0|||
149880261|NCT00996892|540688800|FG012|Expansion Stage 2A|Physician Decision|0|||
149880262|NCT00996892|540688801|FG013|Expansion Stage 2A|Physician Decision|0|||
149880263|NCT00996892|540688802|FG014|Expansion Stage 2A|Physician Decision|0|||
149880264|NCT00996892|540688803|FG015|Expansion Stage 2A|Physician Decision|0|||
149880265|NCT00996892|540688804|FG016|Expansion Stage 2A|Physician Decision|0|||
149880266|NCT00996892|540688805|FG017|Expansion Stage 2A|Physician Decision|0|||
149880267|NCT00996892|540688806|FG018|Expansion Stage 2A|Physician Decision|0|||
149880268|NCT00996892|540688807|FG019|Expansion Stage 2A|Physician Decision|2|||
149880269|NCT00996892|540688788|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
149880270|NCT00996892|540688789|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
149880271|NCT00996892|540688790|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
149880272|NCT00996892|540688791|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
149965159|NCT03973489|541006797|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
149965160|NCT03973489|541006798|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
149965161|NCT03973489|541006799|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
149965162|NCT03973489|541006800|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
149965163|NCT03973489|541006793|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
149880273|NCT00996892|540688792|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
149880274|NCT00996892|540688793|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
149880275|NCT00996892|540688794|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
149880276|NCT00996892|540688795|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
149880277|NCT00996892|540688796|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
149880278|NCT00996892|540688797|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
149880279|NCT00996892|540688798|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
149880280|NCT00996892|540688799|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
149880281|NCT00996892|540688800|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
149880282|NCT00996892|540688801|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
149880283|NCT00996892|540688802|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
149880284|NCT00996892|540688803|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
149880285|NCT00996892|540688804|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
149880286|NCT00996892|540688805|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
149880287|NCT00996892|540688806|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
149880288|NCT00996892|540688807|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
149880289|NCT00996892|540688788|FG000|Expansion Stage 2A|Disease Progression|0|||
149965164|NCT03973489|541006794|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965165|NCT03973489|541006795|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965166|NCT03973489|541006796|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
149965167|NCT03973489|541006797|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965168|NCT03973489|541006798|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965169|NCT03973489|541006799|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965170|NCT03973489|541006800|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
149965171|NCT03973489|541006793|FG000|Second Intervention (1 Day)|Adverse Event|0|||
149965172|NCT03973489|541006794|FG001|Second Intervention (1 Day)|Adverse Event|0|||
149965173|NCT03973489|541006795|FG002|Second Intervention (1 Day)|Adverse Event|0|||
149965174|NCT03973489|541006796|FG003|Second Intervention (1 Day)|Adverse Event|1|||
149965175|NCT03973489|541006797|FG004|Second Intervention (1 Day)|Adverse Event|0|||
149965176|NCT03973489|541006798|FG005|Second Intervention (1 Day)|Adverse Event|0|||
149965177|NCT03973489|541006799|FG006|Second Intervention (1 Day)|Adverse Event|0|||
149880290|NCT00996892|540688789|FG001|Expansion Stage 2A|Disease Progression|0|||
149880291|NCT00996892|540688790|FG002|Expansion Stage 2A|Disease Progression|0|||
149880292|NCT00996892|540688791|FG003|Expansion Stage 2A|Disease Progression|0|||
149880293|NCT00996892|540688792|FG004|Expansion Stage 2A|Disease Progression|0|||
149880294|NCT00996892|540688793|FG005|Expansion Stage 2A|Disease Progression|0|||
149880295|NCT00996892|540688794|FG006|Expansion Stage 2A|Disease Progression|0|||
149880296|NCT00996892|540688795|FG007|Expansion Stage 2A|Disease Progression|0|||
149880297|NCT00996892|540688796|FG008|Expansion Stage 2A|Disease Progression|0|||
149880298|NCT00996892|540688797|FG009|Expansion Stage 2A|Disease Progression|0|||
149880299|NCT00996892|540688798|FG010|Expansion Stage 2A|Disease Progression|0|||
149880300|NCT00996892|540688799|FG011|Expansion Stage 2A|Disease Progression|0|||
149880301|NCT00996892|540688800|FG012|Expansion Stage 2A|Disease Progression|0|||
149880302|NCT00996892|540688801|FG013|Expansion Stage 2A|Disease Progression|0|||
149880303|NCT00996892|540688802|FG014|Expansion Stage 2A|Disease Progression|0|||
149880304|NCT00996892|540688803|FG015|Expansion Stage 2A|Disease Progression|0|||
149880305|NCT00996892|540688804|FG016|Expansion Stage 2A|Disease Progression|0|||
149880306|NCT00996892|540688805|FG017|Expansion Stage 2A|Disease Progression|0|||
149880307|NCT00996892|540688806|FG018|Expansion Stage 2A|Disease Progression|0|||
149880308|NCT00996892|540688807|FG019|Expansion Stage 2A|Disease Progression|31|||
149880309|NCT01653912|540688808|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
149880310|NCT01653912|540688809|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
149880311|NCT01653912|540688810|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
149880312|NCT01653912|540688811|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
149880313|NCT01653912|540688812|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
149965178|NCT03973489|541006800|FG007|Second Intervention (1 Day)|Adverse Event|0|||
149965179|NCT03301415|541006801|FG000|Overall Study|Lost to Follow-up|2|||
149880314|NCT01653912|540688813|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
149880315|NCT01653912|540688808|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
149880316|NCT01653912|540688809|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
149880317|NCT01653912|540688810|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
149880318|NCT01653912|540688811|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
149880319|NCT01653912|540688812|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
149880320|NCT01653912|540688813|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
149880321|NCT01653912|540688808|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
149880322|NCT01653912|540688809|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
149880323|NCT01653912|540688810|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
149880324|NCT01653912|540688811|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
149880325|NCT01653912|540688812|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
149880326|NCT01653912|540688813|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
149880327|NCT01653912|540688808|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880328|NCT01653912|540688809|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880329|NCT01653912|540688810|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880330|NCT01653912|540688811|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
149880331|NCT01653912|540688812|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880332|NCT01653912|540688813|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880333|NCT01653912|540688808|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
149880334|NCT01653912|540688809|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
149880335|NCT01653912|540688810|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
149880336|NCT01653912|540688811|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
149880337|NCT01653912|540688812|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
149965180|NCT03301415|541006801|FG000|Overall Study|Unable to comply with visit schedule|2|||
149965181|NCT03247673|541006802|FG000|Overall Study|Withdrawal by Subject|1|||
149965182|NCT03247673|541006803|FG001|Overall Study|Withdrawal by Subject|0|||
149965183|NCT03247673|541006804|FG002|Overall Study|Withdrawal by Subject|3|||
149965184|NCT03247673|541006802|FG000|Overall Study|Lost to Follow-up|0|||
149965185|NCT03247673|541006803|FG001|Overall Study|Lost to Follow-up|0|||
149965186|NCT03247673|541006804|FG002|Overall Study|Lost to Follow-up|1|||
149965187|NCT00392288|541006805|FG000|Overall Study|Adverse Event|17|||
149965188|NCT00392288|541006806|FG001|Overall Study|Adverse Event|7|||
149965189|NCT00392288|541006807|FG002|Overall Study|Adverse Event|8|||
149965190|NCT00392288|541006805|FG000|Overall Study|Lack of Efficacy|8|||
149965191|NCT00392288|541006806|FG001|Overall Study|Lack of Efficacy|5|||
149965192|NCT00392288|541006807|FG002|Overall Study|Lack of Efficacy|3|||
149965193|NCT00392288|541006805|FG000|Overall Study|Protocol Violation|1|||
149965194|NCT00392288|541006806|FG001|Overall Study|Protocol Violation|3|||
149965195|NCT00392288|541006807|FG002|Overall Study|Protocol Violation|1|||
149965196|NCT00392288|541006805|FG000|Overall Study|Lost to Follow-up|1|||
149965197|NCT00392288|541006806|FG001|Overall Study|Lost to Follow-up|1|||
149965198|NCT00392288|541006807|FG002|Overall Study|Lost to Follow-up|1|||
149965199|NCT00392288|541006805|FG000|Overall Study|Withdrawal by Subject|1|||
149965200|NCT00392288|541006806|FG001|Overall Study|Withdrawal by Subject|0|||
149965201|NCT00392288|541006807|FG002|Overall Study|Withdrawal by Subject|2|||
149965202|NCT00392288|541006805|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
149965203|NCT00392288|541006806|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
149965204|NCT00392288|541006807|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
149965205|NCT00392288|541006805|FG000|Overall Study|Other|3|||
149965206|NCT00392288|541006806|FG001|Overall Study|Other|4|||
149965207|NCT00392288|541006807|FG002|Overall Study|Other|1|||
149965208|NCT02184442|541006811|FG000|Overall Study|Death|61|||
149965209|NCT02184442|541006812|FG001|Overall Study|Death|65|||
149965210|NCT02184442|541006811|FG000|Overall Study|Withdrawal by Subject|3|||
149965211|NCT02184442|541006812|FG001|Overall Study|Withdrawal by Subject|11|||
149965212|NCT02691494|541006815|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
149965213|NCT02691494|541006816|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
149965214|NCT02691494|541006817|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
149965215|NCT02691494|541006815|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
149965216|NCT02691494|541006816|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
149965217|NCT02691494|541006817|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
149965218|NCT02691494|541006815|FG000|Post-Treatment Follow-Up Period|Other|2|||
149965219|NCT02691494|541006816|FG001|Post-Treatment Follow-Up Period|Other|1|||
149965220|NCT02691494|541006817|FG002|Post-Treatment Follow-Up Period|Other|1|||
149965221|NCT02691494|541006815|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
149965222|NCT02691494|541006816|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
149965223|NCT02691494|541006817|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
149965224|NCT02691494|541006815|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
149880338|NCT01653912|540688813|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
149880339|NCT01653912|540688808|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
149880340|NCT01653912|540688809|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
149880341|NCT01653912|540688810|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
149880342|NCT01653912|540688811|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
149880343|NCT01653912|540688812|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
149880344|NCT01653912|540688813|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
149880345|NCT01653912|540688808|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880346|NCT01653912|540688809|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880347|NCT01653912|540688810|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880348|NCT01653912|540688811|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880349|NCT01653912|540688812|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
149880350|NCT01653912|540688813|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
149880351|NCT00708227|540688814|FG000|Overall Study|Physician Decision|0|||
149880352|NCT00708227|540688815|FG001|Overall Study|Physician Decision|3|||
149880353|NCT00708227|540688816|FG002|Overall Study|Physician Decision|1|||
149880354|NCT00708227|540688817|FG003|Overall Study|Physician Decision|2|||
149880355|NCT00708227|540688814|FG000|Overall Study|Withdrawal by Subject|1|||
149880356|NCT00708227|540688815|FG001|Overall Study|Withdrawal by Subject|2|||
149880357|NCT00708227|540688816|FG002|Overall Study|Withdrawal by Subject|0|||
149880358|NCT00708227|540688817|FG003|Overall Study|Withdrawal by Subject|1|||
149880359|NCT04007991|540688818|FG000|Overall Study|Withdrawal by Subject|1|||
149880360|NCT04007991|540688819|FG001|Overall Study|Withdrawal by Subject|1|||
149880361|NCT04007991|540688818|FG000|Overall Study|Physician Decision|1|||
149880362|NCT04007991|540688819|FG001|Overall Study|Physician Decision|1|||
149880363|NCT04007991|540688818|FG000|Overall Study|Non-compliance with Study Drug|0|||
149880364|NCT04007991|540688819|FG001|Overall Study|Non-compliance with Study Drug|1|||
149880365|NCT04007991|540688818|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
149880366|NCT04007991|540688819|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
149880367|NCT04007991|540688818|FG000|Overall Study|Adverse event, non-fatal|5|||
149880368|NCT04007991|540688819|FG001|Overall Study|Adverse event, non-fatal|0|||
149880369|NCT04007991|540688818|FG000|Overall Study|Lost to Follow-up|2|||
149880370|NCT04007991|540688819|FG001|Overall Study|Lost to Follow-up|1|||
149880371|NCT01987479|540688820|FG000|Overall Study|Protocol Violation|1|||
149880372|NCT01987479|540688820|FG000|Overall Study|Physician Decision|2|||
149880373|NCT01987479|540688820|FG000|Overall Study|Participant/legal guardian decision|1|||
149880374|NCT01987479|540688820|FG000|Overall Study|Other|5|||
149880375|NCT01987479|540688820|FG000|Overall Study|Lost to Follow-up|1|||
149880376|NCT01987479|540688820|FG000|Overall Study|Adverse Event|7|||
149880377|NCT00278889|540688821|FG000|Overall Study|Withdrawal by Subject|0|||
149880378|NCT00278889|540688822|FG001|Overall Study|Withdrawal by Subject|5|||
149880379|NCT00278889|540688823|FG002|Overall Study|Withdrawal by Subject|3|||
149880380|NCT00278889|540688821|FG000|Overall Study|Lost to Follow-up|1|||
149880381|NCT00278889|540688822|FG001|Overall Study|Lost to Follow-up|1|||
149880382|NCT00278889|540688823|FG002|Overall Study|Lost to Follow-up|0|||
149880383|NCT00278889|540688821|FG000|Overall Study|Death|24|||
149880384|NCT00278889|540688822|FG001|Overall Study|Death|21|||
149880385|NCT00278889|540688823|FG002|Overall Study|Death|17|||
149880386|NCT03654599|540688824|FG000|Overall Study|Lost to Follow-up|14|||
149880387|NCT03654599|540688825|FG001|Overall Study|Lost to Follow-up|12|||
149880388|NCT03654599|540688824|FG000|Overall Study|Death|8|||
149880389|NCT03654599|540688825|FG001|Overall Study|Death|6|||
149880390|NCT03654599|540688824|FG000|Overall Study|Withdrawal by Subject|6|||
149880391|NCT03654599|540688825|FG001|Overall Study|Withdrawal by Subject|4|||
149880392|NCT05314816|540688826|FG000|Overall Study|Lost to Follow-up|5|||
149880393|NCT05314816|540688827|FG001|Overall Study|Lost to Follow-up|0|||
149880394|NCT05314816|540688828|FG002|Overall Study|Lost to Follow-up|1|||
149880395|NCT05314816|540688826|FG000|Overall Study|Protocol Violation|13|||
149880396|NCT05314816|540688827|FG001|Overall Study|Protocol Violation|8|||
149880397|NCT05314816|540688828|FG002|Overall Study|Protocol Violation|0|||
149880398|NCT04042376|540688829|FG000|Overall Study|Withdrawal by Subject|1|||
149880399|NCT04042376|540688829|FG000|Overall Study|Death|3|||
149880400|NCT02017015|540691183|FG000|Overall Study|Adverse Event|9|||
149880401|NCT02017015|540691183|FG000|Overall Study|Withdrawal by Subject|21|||
149880402|NCT02017015|540691183|FG000|Overall Study|Death|4|||
149880403|NCT02017015|540691183|FG000|Overall Study|Progressive Disease|31|||
149880404|NCT02017015|540691183|FG000|Overall Study|Non-compliance with study drug|2|||
149880405|NCT02017015|540691183|FG000|Overall Study|Physician Decision|2|||
149880406|NCT01762800|540691188|FG000|Overall Study|Adverse Event|8|||
149880407|NCT01762800|540691189|FG001|Overall Study|Adverse Event|13|||
149880408|NCT01762800|540691188|FG000|Overall Study|Lack of Efficacy|3|||
149880409|NCT01762800|540691189|FG001|Overall Study|Lack of Efficacy|2|||
149880410|NCT01762800|540691188|FG000|Overall Study|Study Closed/Terminated|0|||
149880411|NCT01762800|540691189|FG001|Overall Study|Study Closed/Terminated|1|||
149880412|NCT01762800|540691188|FG000|Overall Study|Physician Decision|1|||
149880413|NCT01762800|540691189|FG001|Overall Study|Physician Decision|1|||
149880414|NCT01762800|540691188|FG000|Overall Study|Withdrawal by Subject|7|||
149880415|NCT01762800|540691189|FG001|Overall Study|Withdrawal by Subject|4|||
149880416|NCT02847260|540691190|FG000|Overall Study|Adverse Event|3|||
149880417|NCT02847260|540691190|FG000|Overall Study|Withdrawal by Subject|2|||
149880418|NCT02847260|540691190|FG000|Overall Study|Clinical Deterioration|1|||
149880419|NCT02847260|540691190|FG000|Overall Study|Physician Decision|1|||
149880420|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
149880421|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
149880422|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
149880423|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
149880424|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
149880425|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
149880426|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
149880427|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
149880428|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
149880429|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
149880430|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
149880431|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
149880432|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
149880433|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
149880434|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
149880435|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
149880436|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
149880437|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
149880438|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
149880439|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
149880440|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
149880441|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
149880442|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
149880443|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
149880444|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
149880445|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
149880446|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
149880447|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
149880448|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
149880449|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
149880450|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
149965225|NCT02691494|541006816|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
149965226|NCT02691494|541006817|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
149965227|NCT03249558|541006821|FG000|Overall Study|Lost to Follow-up|2|||
149965228|NCT03249558|541006822|FG001|Overall Study|Lost to Follow-up|1|||
149965229|NCT03249558|541006823|FG002|Overall Study|Lost to Follow-up|4|||
149965230|NCT03249558|541006821|FG000|Overall Study|Physician Decision|1|||
149965231|NCT03249558|541006822|FG001|Overall Study|Physician Decision|0|||
149880451|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
149880452|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
149880453|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
149880454|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
149880455|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
149880456|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
149880457|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
149965232|NCT03249558|541006823|FG002|Overall Study|Physician Decision|0|||
149880458|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
149880459|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
149880460|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880461|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880462|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880463|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
149880464|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880465|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880466|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880467|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880468|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880469|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
149880470|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
149880471|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
149880472|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
149880473|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
149880474|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
149880475|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
149880476|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
149880477|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
149880478|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
149880479|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
149880480|NCT03104400|540691191|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880481|NCT03104400|540691192|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880482|NCT03104400|540691193|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880483|NCT03104400|540691194|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
149880484|NCT03104400|540691195|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880485|NCT03104400|540691196|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880486|NCT03104400|540691197|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880487|NCT03104400|540691198|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880488|NCT03104400|540691199|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880489|NCT03104400|540691200|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
149880490|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
149880491|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
149880492|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
149880493|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
149880494|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
149880495|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
149880496|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
149880497|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
149880498|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
149880499|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
149880500|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
149880501|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
149880502|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
149880503|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
149965233|NCT03249558|541006821|FG000|Overall Study|Withdrawal by Subject|6|||
149965234|NCT03249558|541006822|FG001|Overall Study|Withdrawal by Subject|5|||
149965235|NCT03249558|541006823|FG002|Overall Study|Withdrawal by Subject|7|||
149965236|NCT03249558|541006821|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
149965237|NCT03249558|541006822|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
149965238|NCT03249558|541006823|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
149965239|NCT03249558|541006821|FG000|Overall Study|Protocol Violation|1|||
149965240|NCT03249558|541006822|FG001|Overall Study|Protocol Violation|1|||
149965241|NCT03249558|541006823|FG002|Overall Study|Protocol Violation|2|||
149965242|NCT02657356|541007815|FG000|Overall Study|Death|1|||
149880504|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
149965243|NCT02657356|541007816|FG001|Overall Study|Death|0|||
149965244|NCT02657356|541007815|FG000|Overall Study|Withdrawal by Subject|5|||
149965245|NCT02657356|541007816|FG001|Overall Study|Withdrawal by Subject|6|||
149880505|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
149880506|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
149880507|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
149880508|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
149880509|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
149880510|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
149880511|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
149880512|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
149880513|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
149880514|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
149880515|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
149880516|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
149880517|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
149880518|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
149880519|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
149880520|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
149880521|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
149880522|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
149880523|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
149880524|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
149880525|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
149880526|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
149880527|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
149880528|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
149880529|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
149880530|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880531|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880532|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880533|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880534|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880535|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880536|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
149880537|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
149880538|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
149880539|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
149880540|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880541|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880542|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880543|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880544|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880545|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880546|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880547|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
149880548|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
149880549|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
149880550|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
149880551|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
149880552|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
149880553|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
149880554|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
149880555|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
149880556|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
149880557|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
149880558|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
149880559|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
149880560|NCT03104400|540691191|FG000|Period 2 Week 56 - 260)|Other|0|||
149880561|NCT03104400|540691192|FG001|Period 2 Week 56 - 260)|Other|0|||
149880562|NCT03104400|540691193|FG002|Period 2 Week 56 - 260)|Other|0|||
149880563|NCT03104400|540691194|FG003|Period 2 Week 56 - 260)|Other|0|||
149880564|NCT03104400|540691195|FG004|Period 2 Week 56 - 260)|Other|0|||
149880565|NCT03104400|540691196|FG005|Period 2 Week 56 - 260)|Other|0|||
149880566|NCT03104400|540691197|FG006|Period 2 Week 56 - 260)|Other|0|||
149965246|NCT02657356|541007815|FG000|Overall Study|Terminated by Sponsor|8|||
149880567|NCT03104400|540691198|FG007|Period 2 Week 56 - 260)|Other|0|||
149880568|NCT03104400|540691199|FG008|Period 2 Week 56 - 260)|Other|1|||
149880569|NCT03104400|540691200|FG009|Period 2 Week 56 - 260)|Other|1|||
149880570|NCT02906358|540691201|FG000|Overall Study|Withdrawal by Subject|10|||
149880571|NCT02906358|540691202|FG001|Overall Study|Withdrawal by Subject|7|||
149880572|NCT02906358|540691201|FG000|Overall Study|Lost to Follow-up|12|||
149880573|NCT02906358|540691202|FG001|Overall Study|Lost to Follow-up|15|||
149880574|NCT02699684|540691203|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
149880575|NCT02699684|540691204|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
149965247|NCT02657356|541007816|FG001|Overall Study|Terminated by Sponsor|5|||
149880576|NCT00492778|540691207|FG000|Overall Study|Ineligible by Pathology Review|8|||
149880577|NCT00492778|540691208|FG001|Overall Study|Ineligible by Pathology Review|1|||
149880578|NCT00362336|540691211|FG000|Overall Study|Serious Adverse Event|1|||
149880579|NCT00362336|540691212|FG001|Overall Study|Serious Adverse Event|0|||
149880580|NCT00362336|540691213|FG002|Overall Study|Serious Adverse Event|1|||
149880581|NCT00362336|540691211|FG000|Overall Study|Protocol Violation|0|||
149880582|NCT00362336|540691212|FG001|Overall Study|Protocol Violation|0|||
149880583|NCT00362336|540691213|FG002|Overall Study|Protocol Violation|1|||
149880584|NCT00362336|540691211|FG000|Overall Study|Lost to Follow-up|6|||
149880585|NCT00362336|540691212|FG001|Overall Study|Lost to Follow-up|4|||
149880586|NCT00362336|540691213|FG002|Overall Study|Lost to Follow-up|0|||
149880587|NCT00362336|540691211|FG000|Overall Study|Withdrawal by Subject|3|||
149880588|NCT00362336|540691212|FG001|Overall Study|Withdrawal by Subject|3|||
149880589|NCT00362336|540691213|FG002|Overall Study|Withdrawal by Subject|1|||
149880590|NCT04414618|540691214|FG000|Overall Study|Death|3|||
149880591|NCT04414618|540691215|FG001|Overall Study|Death|3|||
149880592|NCT04414618|540691214|FG000|Overall Study|Withdrawal by Subject|2|||
149880593|NCT04414618|540691215|FG001|Overall Study|Withdrawal by Subject|1|||
149880594|NCT04414618|540691214|FG000|Overall Study|Lost to Follow-up|2|||
149880595|NCT04414618|540691215|FG001|Overall Study|Lost to Follow-up|3|||
149880596|NCT04414618|540691214|FG000|Overall Study|Physician Decision|1|||
149880597|NCT04414618|540691215|FG001|Overall Study|Physician Decision|0|||
149880598|NCT00658879|540691216|FG000|Overall Study|Protocol Violation|1|||
149880599|NCT02640690|540691217|FG000|Overall Study|Lost to Follow-up|7|||
149880600|NCT02640690|540691218|FG001|Overall Study|Lost to Follow-up|7|||
149880601|NCT02640690|540691217|FG000|Overall Study|Withdrawal by Subject|16|||
149880602|NCT02640690|540691218|FG001|Overall Study|Withdrawal by Subject|20|||
149880603|NCT02640690|540691217|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
149880604|NCT02640690|540691218|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
149880605|NCT01118975|540691219|FG000|Overall Study|Adverse Event|0|||
149965248|NCT02657356|541007815|FG000|Overall Study|Rolled over to EAP study|6|||
149880606|NCT01118975|540691220|FG001|Overall Study|Adverse Event|1|||
149880607|NCT01645787|540691221|FG000|Washout (2 Weeks)|Adverse Event|1|||
149880608|NCT01645787|540691222|FG001|Washout (2 Weeks)|Adverse Event|0|||
149880609|NCT04315506|540691231|FG000|Overall Study|Lost to Follow-up|74|||
149880610|NCT04315506|540691232|FG001|Overall Study|Lost to Follow-up|82|||
149880611|NCT04315506|540691231|FG000|Overall Study|Withdrawal by Subject|8|||
149880612|NCT04315506|540691232|FG001|Overall Study|Withdrawal by Subject|8|||
149880613|NCT04315506|540691231|FG000|Overall Study|Physician Decision|0|||
149880614|NCT04315506|540691232|FG001|Overall Study|Physician Decision|1|||
149880615|NCT02661217|540691233|FG000|Overall Study|Physician Decision|12|||
149880616|NCT02661217|540691234|FG001|Overall Study|Physician Decision|15|||
149880617|NCT02661217|540691233|FG000|Overall Study|Lost to Follow-up|1|||
149880618|NCT02661217|540691234|FG001|Overall Study|Lost to Follow-up|4|||
149880619|NCT02661217|540691233|FG000|Overall Study|Protocol Deviation|0|||
149880620|NCT02661217|540691234|FG001|Overall Study|Protocol Deviation|4|||
149880621|NCT02661217|540691233|FG000|Overall Study|Non-compliance with study treatment|5|||
149880622|NCT02661217|540691234|FG001|Overall Study|Non-compliance with study treatment|5|||
149880623|NCT02661217|540691233|FG000|Overall Study|Death|21|||
149880624|NCT02661217|540691234|FG001|Overall Study|Death|15|||
149880625|NCT02661217|540691233|FG000|Overall Study|Adverse Event|10|||
149880626|NCT02661217|540691234|FG001|Overall Study|Adverse Event|8|||
149880627|NCT02661217|540691233|FG000|Overall Study|Withdrawal by Subject|15|||
149880628|NCT02661217|540691234|FG001|Overall Study|Withdrawal by Subject|19|||
149880629|NCT02661217|540691233|FG000|Overall Study|Did not enter follow-up epoch|7|||
149880630|NCT02661217|540691234|FG001|Overall Study|Did not enter follow-up epoch|10|||
149880631|NCT02661217|540691233|FG000|Overall Study|Death - no study drug received|1|||
149880632|NCT02661217|540691234|FG001|Overall Study|Death - no study drug received|2|||
149880633|NCT02661217|540691233|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
149880634|NCT02661217|540691234|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
149880635|NCT04238650|540691246|FG000|Overall Study|Withdrawal by Subject|0|||
149880636|NCT04238650|540691247|FG001|Overall Study|Withdrawal by Subject|1|||
149880637|NCT03633825|540691248|FG000|Enrollment|Did not post on network|5066|||
149880638|NCT03633825|540691249|FG001|Enrollment|Did not post on network|5080|||
149880639|NCT03633825|540691248|FG000|Enrollment|Post not classified as crisis|13967|||
149880640|NCT03633825|540691249|FG001|Enrollment|Post not classified as crisis|13757|||
149880641|NCT03633825|540691248|FG000|Follow up|Lost to Follow-up|478|||
149880642|NCT03633825|540691249|FG001|Follow up|Lost to Follow-up|450|||
149880643|NCT05246670|540691250|FG000|Overall Study|Withdrawal by Subject|2|||
149880644|NCT05246670|540691251|FG001|Overall Study|Withdrawal by Subject|3|||
149880645|NCT05246670|540691252|FG002|Overall Study|Withdrawal by Subject|0|||
149880646|NCT05246670|540691253|FG003|Overall Study|Withdrawal by Subject|1|||
149880647|NCT05246670|540691250|FG000|Overall Study|Adverse Event|0|||
149880648|NCT05246670|540691251|FG001|Overall Study|Adverse Event|0|||
149880649|NCT05246670|540691252|FG002|Overall Study|Adverse Event|1|||
149880650|NCT05246670|540691253|FG003|Overall Study|Adverse Event|0|||
149880651|NCT05246670|540691250|FG000|Overall Study|Physician Decision|1|||
149880652|NCT05246670|540691251|FG001|Overall Study|Physician Decision|0|||
149880653|NCT05246670|540691252|FG002|Overall Study|Physician Decision|0|||
149880654|NCT05246670|540691253|FG003|Overall Study|Physician Decision|0|||
149880655|NCT05246670|540691250|FG000|Overall Study|Protocol Violation|1|||
149880656|NCT05246670|540691251|FG001|Overall Study|Protocol Violation|0|||
149880657|NCT05246670|540691252|FG002|Overall Study|Protocol Violation|0|||
149880658|NCT05246670|540691253|FG003|Overall Study|Protocol Violation|0|||
149880659|NCT04152291|540691256|FG000|Overall Study|Covid-19 restrictions|27|||
149880660|NCT04152291|540691256|FG000|Overall Study|Withdrawal by Subject|3|||
149880661|NCT03597295|540691257|FG000|Overall Study|Death|70|||
149880662|NCT03597295|540691257|FG000|Overall Study|Lost to Follow-up|7|||
149880663|NCT05124691|540691258|FG000|Phase II|Eligibility criteria|0|||
149880664|NCT05124691|540691259|FG001|Phase II|Eligibility criteria|1|||
149880665|NCT05124691|540691260|FG002|Phase II|Eligibility criteria|0|||
149880666|NCT05124691|540691258|FG000|Phase II|Withdrawal by Subject|6|||
149880667|NCT05124691|540691259|FG001|Phase II|Withdrawal by Subject|2|||
149880668|NCT05124691|540691260|FG002|Phase II|Withdrawal by Subject|3|||
149880669|NCT05124691|540691258|FG000|Phase III|Withdrawal by Subject|6|||
149880670|NCT05124691|540691259|FG001|Phase III|Withdrawal by Subject|4|||
149880671|NCT05124691|540691260|FG002|Phase III|Withdrawal by Subject|4|||
149880672|NCT05124691|540691258|FG000|Phase III|Lost to Follow-up|1|||
149880673|NCT05124691|540691259|FG001|Phase III|Lost to Follow-up|0|||
149880674|NCT05124691|540691260|FG002|Phase III|Lost to Follow-up|0|||
149880675|NCT05211726|540691261|FG000|Overall Study|Withdrawal by Subject|2|||
149880676|NCT05211726|540691262|FG001|Overall Study|Withdrawal by Subject|3|||
149880677|NCT05211726|540691261|FG000|Overall Study|Protocol Violation|0|||
149880678|NCT05211726|540691262|FG001|Overall Study|Protocol Violation|1|||
149880679|NCT03509467|540691263|FG000|Overall Study|Withdrawal by Subject|5|||
149880680|NCT03509467|540691264|FG001|Overall Study|Withdrawal by Subject|1|||
149880681|NCT03509467|540691265|FG002|Overall Study|Withdrawal by Subject|6|||
149880682|NCT03509467|540691266|FG003|Overall Study|Withdrawal by Subject|7|||
149880683|NCT03509467|540691267|FG004|Overall Study|Withdrawal by Subject|10|||
149880684|NCT03509467|540691268|FG005|Overall Study|Withdrawal by Subject|10|||
149880685|NCT03509467|540691269|FG006|Overall Study|Withdrawal by Subject|10|||
149880686|NCT03509467|540691270|FG007|Overall Study|Withdrawal by Subject|10|||
149880687|NCT03509467|540691263|FG000|Overall Study|Death|0|||
149880688|NCT03509467|540691264|FG001|Overall Study|Death|0|||
149880689|NCT03509467|540691265|FG002|Overall Study|Death|2|||
149880690|NCT03509467|540691266|FG003|Overall Study|Death|2|||
149880691|NCT03509467|540691267|FG004|Overall Study|Death|1|||
149880692|NCT03509467|540691268|FG005|Overall Study|Death|0|||
149880693|NCT03509467|540691269|FG006|Overall Study|Death|1|||
149880694|NCT03509467|540691270|FG007|Overall Study|Death|0|||
149880695|NCT03509467|540691263|FG000|Overall Study|Proxy Withdrawal|0|||
149880696|NCT03509467|540691264|FG001|Overall Study|Proxy Withdrawal|0|||
149880697|NCT03509467|540691265|FG002|Overall Study|Proxy Withdrawal|0|||
149880698|NCT03509467|540691266|FG003|Overall Study|Proxy Withdrawal|0|||
149880699|NCT03509467|540691267|FG004|Overall Study|Proxy Withdrawal|0|||
149880700|NCT03509467|540691268|FG005|Overall Study|Proxy Withdrawal|0|||
149880701|NCT03509467|540691269|FG006|Overall Study|Proxy Withdrawal|0|||
149880702|NCT03509467|540691270|FG007|Overall Study|Proxy Withdrawal|1|||
149880703|NCT00428116|540691271|FG000|Overall Study|Death|1|||
149880704|NCT00428116|540691272|FG001|Overall Study|Death|0|||
149880705|NCT00428116|540691271|FG000|Overall Study|Withdrawal by Subject|1|||
149880706|NCT00428116|540691272|FG001|Overall Study|Withdrawal by Subject|0|||
149880707|NCT00428116|540691271|FG000|Overall Study|Lost to Follow-up|1|||
149880708|NCT00428116|540691272|FG001|Overall Study|Lost to Follow-up|0|||
149880709|NCT01038297|540691273|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
149965249|NCT02657356|541007816|FG001|Overall Study|Rolled over to EAP study|4|||
149965250|NCT03379870|541007817|FG000|Overall Study|Lost to Follow-up|1|||
149965251|NCT03379870|541007818|FG001|Overall Study|Lost to Follow-up|0|||
149965252|NCT03379870|541007817|FG000|Overall Study|Protocol Violation|1|||
149965253|NCT03379870|541007818|FG001|Overall Study|Protocol Violation|1|||
149965254|NCT03768336|541007819|FG000|Overall Study|Lost to Follow-up|3|||
149965255|NCT03768336|541007820|FG001|Overall Study|Lost to Follow-up|2|||
149965256|NCT03768336|541007819|FG000|Overall Study|Became Ineligible|2|||
149965257|NCT03768336|541007820|FG001|Overall Study|Became Ineligible|0|||
149965258|NCT03768336|541007819|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
149965259|NCT03768336|541007820|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
149965260|NCT03768336|541007819|FG000|Overall Study|Missed final survey (post-treatment|0|||
149965261|NCT03768336|541007820|FG001|Overall Study|Missed final survey (post-treatment|1|||
149965262|NCT00980044|541007821|FG000|Overall Study|Withdrawal by Subject|5|||
149965263|NCT00980044|541007822|FG001|Overall Study|Withdrawal by Subject|7|||
149965264|NCT00980044|541007823|FG002|Overall Study|Withdrawal by Subject|3|||
149965265|NCT00980044|541007821|FG000|Overall Study|Protocol Violation|0|||
149965266|NCT00980044|541007822|FG001|Overall Study|Protocol Violation|0|||
149965267|NCT00980044|541007823|FG002|Overall Study|Protocol Violation|2|||
149965268|NCT01444781|541007824|FG000|Overall Study|Lost to Follow-up|0|||
149965269|NCT01444781|541007825|FG001|Overall Study|Lost to Follow-up|3|||
149965270|NCT01444781|541007826|FG002|Overall Study|Lost to Follow-up|1|||
149965271|NCT01444781|541007824|FG000|Overall Study|Withdrawal by Subject|3|||
149965272|NCT01444781|541007825|FG001|Overall Study|Withdrawal by Subject|1|||
149965273|NCT01444781|541007826|FG002|Overall Study|Withdrawal by Subject|2|||
149965274|NCT02254291|541007827|FG000|Overall Study|Withdrawal by Subject|0|||
149965275|NCT02254291|541007828|FG001|Overall Study|Withdrawal by Subject|3|||
149965276|NCT02254291|541007829|FG002|Overall Study|Withdrawal by Subject|1|||
149965277|NCT02254291|541007827|FG000|Overall Study|Missing follow-up information|0|||
149965278|NCT02254291|541007828|FG001|Overall Study|Missing follow-up information|0|||
149965279|NCT02254291|541007829|FG002|Overall Study|Missing follow-up information|1|||
149965280|NCT06790303|541007832|FG000|Overall Study|Study Terminated by sponsor|4|||
149965281|NCT06790303|541007832|FG000|Overall Study|Death|4|||
149965282|NCT00833703|541007838|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
149965283|NCT00833703|541007839|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
149965284|NCT01904279|541007842|FG000|Overall Study|Lack of Efficacy|2|||
149965285|NCT01904279|541007843|FG001|Overall Study|Lack of Efficacy|3|||
149965286|NCT01904279|541007842|FG000|Overall Study|Withdrawal by Subject|1|||
149965287|NCT01904279|541007843|FG001|Overall Study|Withdrawal by Subject|0|||
149965288|NCT03257657|541007851|FG000|Overall Study|Lost to Follow-up|0|||
149880710|NCT01038297|540691274|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
149880711|NCT01038297|540691275|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
149880712|NCT01141205|540691276|FG000|Overall Study|Physician Decision|1|||
149880713|NCT01141205|540691277|FG001|Overall Study|Physician Decision|1|||
149880714|NCT01141205|540691276|FG000|Overall Study|Lost to Follow-up|1|||
149880715|NCT01141205|540691277|FG001|Overall Study|Lost to Follow-up|0|||
149880716|NCT01141205|540691276|FG000|Overall Study|Withdrawal by Subject|1|||
149880717|NCT01141205|540691277|FG001|Overall Study|Withdrawal by Subject|1|||
149880718|NCT01822366|540691280|FG000|Overall Study|Lost to Follow-up|5|||
149880719|NCT01822366|540691281|FG001|Overall Study|Lost to Follow-up|1|||
149880720|NCT01822366|540691282|FG002|Overall Study|Lost to Follow-up|5|||
149880721|NCT01822366|540691283|FG003|Overall Study|Lost to Follow-up|1|||
149880722|NCT01822366|540691280|FG000|Overall Study|Withdrawal by Subject|0|||
149880723|NCT01822366|540691281|FG001|Overall Study|Withdrawal by Subject|6|||
149880724|NCT01822366|540691282|FG002|Overall Study|Withdrawal by Subject|0|||
149880725|NCT01822366|540691283|FG003|Overall Study|Withdrawal by Subject|6|||
149880726|NCT01822366|540691280|FG000|Overall Study|Partial Intervention Completion|0|||
149880727|NCT01822366|540691281|FG001|Overall Study|Partial Intervention Completion|15|||
149880728|NCT01822366|540691282|FG002|Overall Study|Partial Intervention Completion|0|||
149880729|NCT01822366|540691283|FG003|Overall Study|Partial Intervention Completion|15|||
149880730|NCT00384930|540691284|FG000|Overall Study|Adverse Event|5|||
149880731|NCT00384930|540691285|FG001|Overall Study|Adverse Event|4|||
149880732|NCT00384930|540691286|FG002|Overall Study|Adverse Event|12|||
149965289|NCT03257657|541007852|FG001|Overall Study|Lost to Follow-up|3|||
149965290|NCT03257657|541007851|FG000|Overall Study|Withdrawn|0|||
149965291|NCT03257657|541007852|FG001|Overall Study|Withdrawn|1|||
149965292|NCT03257657|541007851|FG000|Overall Study|Noted not eligible right after enrolled|0|||
149880733|NCT00384930|540691287|FG003|Overall Study|Adverse Event|11|||
149880734|NCT00384930|540691288|FG004|Overall Study|Adverse Event|14|||
149880735|NCT00384930|540691284|FG000|Overall Study|Entry Criteria Not Met|2|||
149880736|NCT00384930|540691285|FG001|Overall Study|Entry Criteria Not Met|6|||
149880737|NCT00384930|540691286|FG002|Overall Study|Entry Criteria Not Met|7|||
149880738|NCT00384930|540691287|FG003|Overall Study|Entry Criteria Not Met|8|||
149880739|NCT00384930|540691288|FG004|Overall Study|Entry Criteria Not Met|4|||
149965293|NCT03257657|541007852|FG001|Overall Study|Noted not eligible right after enrolled|1|||
149965294|NCT02801578|541007853|FG000|Overall Study|Adverse Event|2|||
149880740|NCT00384930|540691284|FG000|Overall Study|Lack of Efficacy|1|||
149880741|NCT00384930|540691285|FG001|Overall Study|Lack of Efficacy|1|||
149880742|NCT00384930|540691286|FG002|Overall Study|Lack of Efficacy|2|||
149880743|NCT00384930|540691287|FG003|Overall Study|Lack of Efficacy|1|||
149880744|NCT00384930|540691288|FG004|Overall Study|Lack of Efficacy|2|||
149880745|NCT00384930|540691284|FG000|Overall Study|Lost to Follow-up|5|||
149880746|NCT00384930|540691285|FG001|Overall Study|Lost to Follow-up|3|||
149880747|NCT00384930|540691286|FG002|Overall Study|Lost to Follow-up|0|||
149965295|NCT03412591|541007859|FG000|Overall Study|Withdrawal by Subject|1|||
149965296|NCT03412591|541007860|FG001|Overall Study|Withdrawal by Subject|8|||
149965297|NCT03412591|541007859|FG000|Overall Study|Adverse Event|0|||
149965298|NCT03412591|541007860|FG001|Overall Study|Adverse Event|1|||
149965299|NCT02272985|541007861|FG000|Overall Study|Withdrawal by Subject|1|||
149965300|NCT02272985|541007861|FG000|Overall Study|hip fracture|1|||
149965301|NCT02272985|541007861|FG000|Overall Study|kidney transplantation|1|||
149965302|NCT02489279|541007866|FG000|Overall Study|Lost to Follow-up|12|||
149965303|NCT02489279|541007867|FG001|Overall Study|Lost to Follow-up|10|||
149965304|NCT02263547|541007868|FG000|Overall Study|Adverse Event|1|||
149965305|NCT02263547|541007868|FG000|Overall Study|Lost to Follow-up|2|||
149965306|NCT00505687|541007871|FG000|Overall Study|Important protocol violation|2|||
149965307|NCT00505687|541007871|FG000|Overall Study|Lack of Efficacy|15|||
149965308|NCT00505687|541007871|FG000|Overall Study|Adverse Event|48|||
149965309|NCT00505687|541007871|FG000|Overall Study|Subject withdrew consent|15|||
149965310|NCT00505687|541007871|FG000|Overall Study|Lost to Follow-up|1|||
149965311|NCT00505687|541007871|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
149965312|NCT00505687|541007871|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
149965313|NCT00505687|541007871|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
149965314|NCT00505687|541007871|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
149965315|NCT00505687|541007871|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
149965316|NCT00505687|541007871|FG000|Overall Study|Other: Disease Progression|1|||
149965317|NCT00505687|541007871|FG000|Overall Study|Other: As Per Sponsor|8|||
149965318|NCT03707821|541007872|FG000|Overall Study|Protocol Violation|0|||
149965319|NCT03707821|541007873|FG001|Overall Study|Protocol Violation|1|||
149965320|NCT03707821|541007872|FG000|Overall Study|Unsatisfactory Visual Response|1|||
149965321|NCT03707821|541007873|FG001|Overall Study|Unsatisfactory Visual Response|0|||
149965322|NCT03707821|541007872|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
149965323|NCT03707821|541007873|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
149965324|NCT00836901|541007874|FG000|First Intervention|Withdrawal by Subject|1|||
149965325|NCT00836901|541007875|FG001|First Intervention|Withdrawal by Subject|0|||
149965326|NCT01229111|541007876|FG000|Overall Study|Death|1|||
149965327|NCT04102514|541007877|FG000|Overall Study|Death|3|||
149965328|NCT04102514|541007878|FG001|Overall Study|Death|0|||
149965329|NCT04102514|541007879|FG002|Overall Study|Death|0|||
149965330|NCT04102514|541007880|FG003|Overall Study|Death|0|||
149965331|NCT04102514|541007877|FG000|Overall Study|Lost to Follow-up|0|||
149965332|NCT04102514|541007878|FG001|Overall Study|Lost to Follow-up|0|||
149965333|NCT04102514|541007879|FG002|Overall Study|Lost to Follow-up|3|||
149965334|NCT04102514|541007880|FG003|Overall Study|Lost to Follow-up|0|||
149965335|NCT04102514|541007877|FG000|Overall Study|Physician Decision|0|||
149965336|NCT04102514|541007878|FG001|Overall Study|Physician Decision|0|||
149965337|NCT04102514|541007879|FG002|Overall Study|Physician Decision|1|||
149965338|NCT04102514|541007880|FG003|Overall Study|Physician Decision|0|||
149965339|NCT04102514|541007877|FG000|Overall Study|Withdrawal by Subject|7|||
149965340|NCT04102514|541007878|FG001|Overall Study|Withdrawal by Subject|13|||
149965341|NCT04102514|541007879|FG002|Overall Study|Withdrawal by Subject|7|||
149965342|NCT04102514|541007880|FG003|Overall Study|Withdrawal by Subject|14|||
149965343|NCT04102514|541007877|FG000|Overall Study|Moved to longterm care facility|6|||
149965344|NCT04102514|541007878|FG001|Overall Study|Moved to longterm care facility|0|||
149965345|NCT04102514|541007879|FG002|Overall Study|Moved to longterm care facility|4|||
149965346|NCT04102514|541007880|FG003|Overall Study|Moved to longterm care facility|0|||
149965347|NCT03268499|541007881|FG000|Overall Study|Withdrawal by Subject|2|||
149965348|NCT03268499|541007882|FG001|Overall Study|Withdrawal by Subject|1|||
149965349|NCT00619918|541007883|FG000|Overall Study|Withdrawal by Subject|4|||
149965350|NCT00619918|541007884|FG001|Overall Study|Withdrawal by Subject|3|||
149965351|NCT00619918|541007883|FG000|Overall Study|Physician Decision|2|||
149965352|NCT00619918|541007884|FG001|Overall Study|Physician Decision|4|||
149965353|NCT00619918|541007883|FG000|Overall Study|Transfer to outside facility|3|||
149965354|NCT00619918|541007884|FG001|Overall Study|Transfer to outside facility|3|||
149965355|NCT00619918|541007883|FG000|Overall Study|Left before receiving first dose|7|||
149965356|NCT00619918|541007884|FG001|Overall Study|Left before receiving first dose|6|||
149965357|NCT00619918|541007883|FG000|Overall Study|ICU admission|4|||
149965358|NCT00619918|541007884|FG001|Overall Study|ICU admission|6|||
149965359|NCT03533491|541007889|FG000|Overall Study|Lost to Follow-up|2|||
149965360|NCT05071027|541007897|FG000|Overall Study|Lost to Follow-up|1|||
149965361|NCT05071027|541007898|FG001|Overall Study|Lost to Follow-up|4|||
149965362|NCT05418426|541007899|FG000|Overall Study|Adverse Event|0|||
149965363|NCT05418426|541007900|FG001|Overall Study|Adverse Event|1|||
149880748|NCT00384930|540691287|FG003|Overall Study|Lost to Follow-up|4|||
149880749|NCT00384930|540691288|FG004|Overall Study|Lost to Follow-up|6|||
149880750|NCT00384930|540691284|FG000|Overall Study|Physician Decision|0|||
149880751|NCT00384930|540691285|FG001|Overall Study|Physician Decision|1|||
149880752|NCT00384930|540691286|FG002|Overall Study|Physician Decision|1|||
149880753|NCT00384930|540691287|FG003|Overall Study|Physician Decision|0|||
149880754|NCT00384930|540691288|FG004|Overall Study|Physician Decision|1|||
149880755|NCT00384930|540691284|FG000|Overall Study|Protocol Violation|1|||
149880756|NCT00384930|540691285|FG001|Overall Study|Protocol Violation|0|||
149880757|NCT00384930|540691286|FG002|Overall Study|Protocol Violation|1|||
149880758|NCT00384930|540691287|FG003|Overall Study|Protocol Violation|6|||
149880759|NCT00384930|540691288|FG004|Overall Study|Protocol Violation|4|||
149880760|NCT00384930|540691284|FG000|Overall Study|Sponsor Decision|3|||
149880761|NCT00384930|540691285|FG001|Overall Study|Sponsor Decision|4|||
149880762|NCT00384930|540691286|FG002|Overall Study|Sponsor Decision|0|||
149880763|NCT00384930|540691287|FG003|Overall Study|Sponsor Decision|5|||
149880764|NCT00384930|540691288|FG004|Overall Study|Sponsor Decision|0|||
149880765|NCT00384930|540691284|FG000|Overall Study|Withdrawal by Subject|9|||
149880766|NCT00384930|540691285|FG001|Overall Study|Withdrawal by Subject|7|||
149880767|NCT00384930|540691286|FG002|Overall Study|Withdrawal by Subject|7|||
149880768|NCT00384930|540691287|FG003|Overall Study|Withdrawal by Subject|6|||
149880769|NCT00384930|540691288|FG004|Overall Study|Withdrawal by Subject|16|||
149880770|NCT00384930|540691284|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
149880771|NCT00384930|540691285|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
149880772|NCT00384930|540691286|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
149880773|NCT00384930|540691287|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
149880774|NCT00384930|540691288|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
149880775|NCT01449370|540691291|FG000|Overall Study|Disease Progression|5|||
149880776|NCT01449370|540691292|FG001|Overall Study|Disease Progression|4|||
150174981|NCT03889925|541777005|FG001|Overall Study|Lost to Follow-up|10|||
150174982|NCT03762668|541777006|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
150174983|NCT03762668|541777007|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
149880777|NCT01449370|540691293|FG002|Overall Study|Disease Progression|8|||
150174984|NCT05764161|541777010|FG000|12-week DBVC Period|Lack of Efficacy|2|||
149880778|NCT01449370|540691294|FG003|Overall Study|Disease Progression|3|||
149880779|NCT01449370|540691295|FG004|Overall Study|Disease Progression|3|||
149880780|NCT01449370|540691296|FG005|Overall Study|Disease Progression|3|||
149880781|NCT01449370|540691297|FG006|Overall Study|Disease Progression|3|||
149880782|NCT01449370|540691298|FG007|Overall Study|Disease Progression|2|||
149880783|NCT01449370|540691299|FG008|Overall Study|Disease Progression|9|||
149880784|NCT01449370|540691300|FG009|Overall Study|Disease Progression|1|||
149880785|NCT01449370|540691301|FG010|Overall Study|Disease Progression|3|||
149880786|NCT01449370|540691302|FG011|Overall Study|Disease Progression|3|||
149880787|NCT01449370|540691303|FG012|Overall Study|Disease Progression|2|||
149880788|NCT01449370|540691304|FG013|Overall Study|Disease Progression|8|||
149880789|NCT01449370|540691305|FG014|Overall Study|Disease Progression|3|||
149880790|NCT01449370|540691306|FG015|Overall Study|Disease Progression|1|||
149880791|NCT01449370|540691307|FG016|Overall Study|Disease Progression|4|||
149880792|NCT01449370|540691308|FG017|Overall Study|Disease Progression|3|||
149880793|NCT01449370|540691309|FG018|Overall Study|Disease Progression|1|||
149880794|NCT01449370|540691310|FG019|Overall Study|Disease Progression|2|||
149880795|NCT01449370|540691311|FG020|Overall Study|Disease Progression|5|||
149880796|NCT01449370|540691312|FG021|Overall Study|Disease Progression|2|||
149880797|NCT01449370|540691313|FG022|Overall Study|Disease Progression|3|||
149880798|NCT01449370|540691314|FG023|Overall Study|Disease Progression|7|||
149880799|NCT01449370|540691315|FG024|Overall Study|Disease Progression|3|||
149880800|NCT01449370|540691291|FG000|Overall Study|Adverse Event|1|||
149880801|NCT01449370|540691292|FG001|Overall Study|Adverse Event|2|||
149880802|NCT01449370|540691293|FG002|Overall Study|Adverse Event|0|||
149880803|NCT01449370|540691294|FG003|Overall Study|Adverse Event|1|||
149880804|NCT01449370|540691295|FG004|Overall Study|Adverse Event|0|||
149880805|NCT01449370|540691296|FG005|Overall Study|Adverse Event|0|||
149880806|NCT01449370|540691297|FG006|Overall Study|Adverse Event|0|||
149880807|NCT01449370|540691298|FG007|Overall Study|Adverse Event|0|||
149880808|NCT01449370|540691299|FG008|Overall Study|Adverse Event|1|||
149880809|NCT01449370|540691300|FG009|Overall Study|Adverse Event|1|||
149880810|NCT01449370|540691301|FG010|Overall Study|Adverse Event|0|||
149880811|NCT01449370|540691302|FG011|Overall Study|Adverse Event|0|||
149880812|NCT01449370|540691303|FG012|Overall Study|Adverse Event|0|||
149880813|NCT01449370|540691304|FG013|Overall Study|Adverse Event|2|||
149880814|NCT01449370|540691305|FG014|Overall Study|Adverse Event|0|||
149880815|NCT01449370|540691306|FG015|Overall Study|Adverse Event|1|||
149880816|NCT01449370|540691307|FG016|Overall Study|Adverse Event|0|||
149880817|NCT01449370|540691308|FG017|Overall Study|Adverse Event|0|||
149880818|NCT01449370|540691309|FG018|Overall Study|Adverse Event|1|||
149880819|NCT01449370|540691310|FG019|Overall Study|Adverse Event|1|||
149880820|NCT01449370|540691311|FG020|Overall Study|Adverse Event|0|||
149880821|NCT01449370|540691312|FG021|Overall Study|Adverse Event|1|||
149880822|NCT01449370|540691313|FG022|Overall Study|Adverse Event|0|||
149880823|NCT01449370|540691314|FG023|Overall Study|Adverse Event|1|||
149880824|NCT01449370|540691315|FG024|Overall Study|Adverse Event|3|||
149880825|NCT01449370|540691291|FG000|Overall Study|Participant Decision|0|||
149880826|NCT01449370|540691292|FG001|Overall Study|Participant Decision|0|||
149880827|NCT01449370|540691293|FG002|Overall Study|Participant Decision|0|||
149880828|NCT01449370|540691294|FG003|Overall Study|Participant Decision|0|||
149880829|NCT01449370|540691295|FG004|Overall Study|Participant Decision|0|||
149880830|NCT01449370|540691296|FG005|Overall Study|Participant Decision|0|||
149880831|NCT01449370|540691297|FG006|Overall Study|Participant Decision|0|||
149880832|NCT01449370|540691298|FG007|Overall Study|Participant Decision|1|||
149880833|NCT01449370|540691299|FG008|Overall Study|Participant Decision|1|||
149880834|NCT01449370|540691300|FG009|Overall Study|Participant Decision|0|||
149880835|NCT01449370|540691301|FG010|Overall Study|Participant Decision|0|||
149880836|NCT01449370|540691302|FG011|Overall Study|Participant Decision|0|||
149880837|NCT01449370|540691303|FG012|Overall Study|Participant Decision|1|||
149880838|NCT01449370|540691304|FG013|Overall Study|Participant Decision|1|||
149880839|NCT01449370|540691305|FG014|Overall Study|Participant Decision|0|||
149880840|NCT01449370|540691306|FG015|Overall Study|Participant Decision|1|||
149880841|NCT01449370|540691307|FG016|Overall Study|Participant Decision|3|||
149880842|NCT01449370|540691308|FG017|Overall Study|Participant Decision|0|||
149880843|NCT01449370|540691309|FG018|Overall Study|Participant Decision|1|||
149880844|NCT01449370|540691310|FG019|Overall Study|Participant Decision|0|||
149880845|NCT01449370|540691311|FG020|Overall Study|Participant Decision|0|||
149880846|NCT01449370|540691312|FG021|Overall Study|Participant Decision|1|||
149880847|NCT01449370|540691313|FG022|Overall Study|Participant Decision|0|||
149880848|NCT01449370|540691314|FG023|Overall Study|Participant Decision|0|||
149880849|NCT01449370|540691315|FG024|Overall Study|Participant Decision|1|||
149880850|NCT01449370|540691291|FG000|Overall Study|Lost to Follow-up|0|||
149880851|NCT01449370|540691292|FG001|Overall Study|Lost to Follow-up|0|||
149880852|NCT01449370|540691293|FG002|Overall Study|Lost to Follow-up|0|||
149880853|NCT01449370|540691294|FG003|Overall Study|Lost to Follow-up|0|||
149880854|NCT01449370|540691295|FG004|Overall Study|Lost to Follow-up|0|||
149880855|NCT01449370|540691296|FG005|Overall Study|Lost to Follow-up|0|||
149880856|NCT01449370|540691297|FG006|Overall Study|Lost to Follow-up|0|||
149880857|NCT01449370|540691298|FG007|Overall Study|Lost to Follow-up|0|||
149880858|NCT01449370|540691299|FG008|Overall Study|Lost to Follow-up|0|||
149880859|NCT01449370|540691300|FG009|Overall Study|Lost to Follow-up|0|||
149880860|NCT01449370|540691301|FG010|Overall Study|Lost to Follow-up|0|||
149880861|NCT01449370|540691302|FG011|Overall Study|Lost to Follow-up|0|||
149880862|NCT01449370|540691303|FG012|Overall Study|Lost to Follow-up|0|||
149880863|NCT01449370|540691304|FG013|Overall Study|Lost to Follow-up|0|||
149880864|NCT01449370|540691305|FG014|Overall Study|Lost to Follow-up|0|||
149880865|NCT01449370|540691306|FG015|Overall Study|Lost to Follow-up|0|||
149880866|NCT01449370|540691307|FG016|Overall Study|Lost to Follow-up|0|||
149880867|NCT01449370|540691308|FG017|Overall Study|Lost to Follow-up|0|||
149880868|NCT01449370|540691309|FG018|Overall Study|Lost to Follow-up|0|||
149880869|NCT01449370|540691310|FG019|Overall Study|Lost to Follow-up|0|||
149880870|NCT01449370|540691311|FG020|Overall Study|Lost to Follow-up|1|||
149880871|NCT01449370|540691312|FG021|Overall Study|Lost to Follow-up|0|||
149880872|NCT01449370|540691313|FG022|Overall Study|Lost to Follow-up|0|||
149880873|NCT01449370|540691314|FG023|Overall Study|Lost to Follow-up|0|||
149880874|NCT01449370|540691315|FG024|Overall Study|Lost to Follow-up|0|||
149880875|NCT01449370|540691291|FG000|Overall Study|Other|0|||
149880876|NCT01449370|540691292|FG001|Overall Study|Other|0|||
149880877|NCT01449370|540691293|FG002|Overall Study|Other|0|||
149880878|NCT01449370|540691294|FG003|Overall Study|Other|0|||
149880879|NCT01449370|540691295|FG004|Overall Study|Other|0|||
149880880|NCT01449370|540691296|FG005|Overall Study|Other|0|||
149880881|NCT01449370|540691297|FG006|Overall Study|Other|0|||
149880882|NCT01449370|540691298|FG007|Overall Study|Other|0|||
149880883|NCT01449370|540691299|FG008|Overall Study|Other|1|||
149880884|NCT01449370|540691300|FG009|Overall Study|Other|1|||
149880885|NCT01449370|540691301|FG010|Overall Study|Other|0|||
149880886|NCT01449370|540691302|FG011|Overall Study|Other|0|||
149880887|NCT01449370|540691303|FG012|Overall Study|Other|0|||
149880888|NCT01449370|540691304|FG013|Overall Study|Other|0|||
149880889|NCT01449370|540691305|FG014|Overall Study|Other|0|||
149880890|NCT01449370|540691306|FG015|Overall Study|Other|0|||
149880891|NCT01449370|540691307|FG016|Overall Study|Other|0|||
149880892|NCT01449370|540691308|FG017|Overall Study|Other|0|||
149880893|NCT01449370|540691309|FG018|Overall Study|Other|0|||
149880894|NCT01449370|540691310|FG019|Overall Study|Other|0|||
149880895|NCT01449370|540691311|FG020|Overall Study|Other|0|||
149880896|NCT01449370|540691312|FG021|Overall Study|Other|0|||
149880897|NCT01449370|540691313|FG022|Overall Study|Other|1|||
149880898|NCT01449370|540691314|FG023|Overall Study|Other|1|||
149880899|NCT01449370|540691315|FG024|Overall Study|Other|0|||
149880900|NCT01449370|540691291|FG000|Overall Study|Medication Prohibited by Protocol|0|||
149880901|NCT01449370|540691292|FG001|Overall Study|Medication Prohibited by Protocol|0|||
149880902|NCT01449370|540691293|FG002|Overall Study|Medication Prohibited by Protocol|0|||
149880903|NCT01449370|540691294|FG003|Overall Study|Medication Prohibited by Protocol|0|||
149880904|NCT01449370|540691295|FG004|Overall Study|Medication Prohibited by Protocol|0|||
149880905|NCT01449370|540691296|FG005|Overall Study|Medication Prohibited by Protocol|0|||
149880906|NCT01449370|540691297|FG006|Overall Study|Medication Prohibited by Protocol|0|||
149880907|NCT01449370|540691298|FG007|Overall Study|Medication Prohibited by Protocol|0|||
149880908|NCT01449370|540691299|FG008|Overall Study|Medication Prohibited by Protocol|0|||
149880909|NCT01449370|540691300|FG009|Overall Study|Medication Prohibited by Protocol|0|||
149880910|NCT01449370|540691301|FG010|Overall Study|Medication Prohibited by Protocol|0|||
149880911|NCT01449370|540691302|FG011|Overall Study|Medication Prohibited by Protocol|0|||
149880912|NCT01449370|540691303|FG012|Overall Study|Medication Prohibited by Protocol|0|||
149880913|NCT01449370|540691304|FG013|Overall Study|Medication Prohibited by Protocol|0|||
149880914|NCT01449370|540691305|FG014|Overall Study|Medication Prohibited by Protocol|0|||
149880915|NCT01449370|540691306|FG015|Overall Study|Medication Prohibited by Protocol|0|||
149880916|NCT01449370|540691307|FG016|Overall Study|Medication Prohibited by Protocol|0|||
149880917|NCT01449370|540691308|FG017|Overall Study|Medication Prohibited by Protocol|0|||
149880918|NCT01449370|540691309|FG018|Overall Study|Medication Prohibited by Protocol|0|||
149880919|NCT01449370|540691310|FG019|Overall Study|Medication Prohibited by Protocol|0|||
149880920|NCT01449370|540691311|FG020|Overall Study|Medication Prohibited by Protocol|0|||
149880921|NCT01449370|540691312|FG021|Overall Study|Medication Prohibited by Protocol|0|||
149880922|NCT01449370|540691313|FG022|Overall Study|Medication Prohibited by Protocol|0|||
149880923|NCT01449370|540691314|FG023|Overall Study|Medication Prohibited by Protocol|1|||
149880924|NCT01449370|540691315|FG024|Overall Study|Medication Prohibited by Protocol|0|||
149880925|NCT01449370|540691291|FG000|Overall Study|Death|0|||
149880926|NCT01449370|540691292|FG001|Overall Study|Death|0|||
149880927|NCT01449370|540691293|FG002|Overall Study|Death|0|||
149880928|NCT01449370|540691294|FG003|Overall Study|Death|0|||
149880929|NCT01449370|540691295|FG004|Overall Study|Death|0|||
149880930|NCT01449370|540691296|FG005|Overall Study|Death|0|||
149880931|NCT01449370|540691297|FG006|Overall Study|Death|0|||
149880932|NCT01449370|540691298|FG007|Overall Study|Death|0|||
149880933|NCT01449370|540691299|FG008|Overall Study|Death|0|||
149880934|NCT01449370|540691300|FG009|Overall Study|Death|0|||
149880935|NCT01449370|540691301|FG010|Overall Study|Death|0|||
149880936|NCT01449370|540691302|FG011|Overall Study|Death|0|||
149880937|NCT01449370|540691303|FG012|Overall Study|Death|0|||
149880938|NCT01449370|540691304|FG013|Overall Study|Death|0|||
149880939|NCT01449370|540691305|FG014|Overall Study|Death|0|||
149880940|NCT01449370|540691306|FG015|Overall Study|Death|0|||
149880941|NCT01449370|540691307|FG016|Overall Study|Death|0|||
149880942|NCT01449370|540691308|FG017|Overall Study|Death|0|||
149880943|NCT01449370|540691309|FG018|Overall Study|Death|0|||
149880944|NCT01449370|540691310|FG019|Overall Study|Death|0|||
149880945|NCT01449370|540691311|FG020|Overall Study|Death|0|||
149880946|NCT01449370|540691312|FG021|Overall Study|Death|0|||
149880947|NCT01449370|540691313|FG022|Overall Study|Death|0|||
149880948|NCT01449370|540691314|FG023|Overall Study|Death|0|||
149880949|NCT01449370|540691315|FG024|Overall Study|Death|1|||
149880950|NCT04487067|540691327|FG000|Overall Study|Adverse Event|3|||
149880951|NCT04487067|540691327|FG000|Overall Study|Death Other Than Progressive Disease|60|||
150043830|NCT00476008|541300693|FG000|Overall Study|Withdrawal by Subject|0|||
149880952|NCT04487067|540691327|FG000|Overall Study|Death Due To Progressive Disease|40|||
149880953|NCT04487067|540691327|FG000|Overall Study|Lost to Follow-up|3|||
149880954|NCT04487067|540691327|FG000|Overall Study|Progressive Disease|1|||
149880955|NCT04487067|540691327|FG000|Overall Study|Protocol Violation|3|||
149880956|NCT04487067|540691327|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
149880957|NCT04487067|540691327|FG000|Overall Study|Withdrawal by Subject|15|||
149880958|NCT01098487|540691329|FG000|Overall Study|Adverse Event|22|||
149880959|NCT01098487|540691329|FG000|Overall Study|Lack of Efficacy|11|||
149880960|NCT01098487|540691329|FG000|Overall Study|Withdrawal by Subject|7|||
149880961|NCT01098487|540691329|FG000|Overall Study|Lost to Follow-up|3|||
149880962|NCT01098487|540691329|FG000|Overall Study|Physician Decision|1|||
149880963|NCT00345631|540691330|FG000|Overall Study|Withdrawal by Subject|1|||
149880964|NCT00345631|540691331|FG001|Overall Study|Withdrawal by Subject|0|||
149880965|NCT00345631|540691332|FG002|Overall Study|Withdrawal by Subject|1|||
149880966|NCT00345631|540691330|FG000|Overall Study|Adverse Event|0|||
149880967|NCT00345631|540691331|FG001|Overall Study|Adverse Event|1|||
149880968|NCT00345631|540691332|FG002|Overall Study|Adverse Event|0|||
149880969|NCT00345631|540691330|FG000|Overall Study|Lost to Follow-up|3|||
149880970|NCT00345631|540691331|FG001|Overall Study|Lost to Follow-up|7|||
149880971|NCT00345631|540691332|FG002|Overall Study|Lost to Follow-up|4|||
149880972|NCT00345631|540691330|FG000|Overall Study|Other reasons|0|||
149880973|NCT00345631|540691331|FG001|Overall Study|Other reasons|0|||
149880974|NCT00345631|540691332|FG002|Overall Study|Other reasons|1|||
149880975|NCT01885195|540691335|FG000|Overall Study|Adverse Event|29|||
149880976|NCT01885195|540691335|FG000|Overall Study|Death|1|||
149880977|NCT01885195|540691335|FG000|Overall Study|Disease Progression|67|||
149880978|NCT01885195|540691335|FG000|Overall Study|Protocol Deviation|2|||
149880979|NCT01885195|540691335|FG000|Overall Study|Physician Decision|3|||
149880980|NCT01885195|540691335|FG000|Overall Study|Patient/guardian decision|8|||
149880981|NCT03390426|540691336|FG000|Overall Study|Protocol Violation|0|||
149880982|NCT03390426|540691337|FG001|Overall Study|Protocol Violation|1|||
149880983|NCT00259272|540691344|FG000|Overall Study|Adverse Event|2|||
149880984|NCT00259272|540691345|FG001|Overall Study|Adverse Event|1|||
149880985|NCT00259272|540691346|FG002|Overall Study|Adverse Event|0|||
149880986|NCT00259272|540691347|FG003|Overall Study|Adverse Event|3|||
149880987|NCT00259272|540691344|FG000|Overall Study|Lack of Efficacy|5|||
149880988|NCT00259272|540691345|FG001|Overall Study|Lack of Efficacy|1|||
149880989|NCT00259272|540691346|FG002|Overall Study|Lack of Efficacy|2|||
149880990|NCT00259272|540691347|FG003|Overall Study|Lack of Efficacy|6|||
149880991|NCT00259272|540691344|FG000|Overall Study|Physician Decision|1|||
149880992|NCT00259272|540691345|FG001|Overall Study|Physician Decision|2|||
149880993|NCT00259272|540691346|FG002|Overall Study|Physician Decision|1|||
149880994|NCT00259272|540691347|FG003|Overall Study|Physician Decision|3|||
149880995|NCT00259272|540691344|FG000|Overall Study|Protocol Violation|2|||
149880996|NCT00259272|540691345|FG001|Overall Study|Protocol Violation|0|||
149880997|NCT00259272|540691346|FG002|Overall Study|Protocol Violation|0|||
149880998|NCT00259272|540691347|FG003|Overall Study|Protocol Violation|1|||
149880999|NCT00259272|540691344|FG000|Overall Study|Sponsor Decision|0|||
149881000|NCT00259272|540691345|FG001|Overall Study|Sponsor Decision|1|||
149881001|NCT00259272|540691346|FG002|Overall Study|Sponsor Decision|0|||
149881002|NCT00259272|540691347|FG003|Overall Study|Sponsor Decision|0|||
149881003|NCT00259272|540691344|FG000|Overall Study|Withdrawal by Subject|4|||
149881004|NCT00259272|540691345|FG001|Overall Study|Withdrawal by Subject|2|||
149881005|NCT00259272|540691346|FG002|Overall Study|Withdrawal by Subject|2|||
149965364|NCT05418426|541007901|FG002|Overall Study|Adverse Event|0|||
149965365|NCT05418426|541007899|FG000|Overall Study|Withdrawal by Subject|0|||
149965366|NCT05418426|541007900|FG001|Overall Study|Withdrawal by Subject|1|||
149965367|NCT05418426|541007901|FG002|Overall Study|Withdrawal by Subject|0|||
149965368|NCT05418426|541007899|FG000|Overall Study|Protocol Violation|0|||
149965369|NCT05418426|541007900|FG001|Overall Study|Protocol Violation|0|||
149965370|NCT05418426|541007901|FG002|Overall Study|Protocol Violation|1|||
149965371|NCT04661839|541007904|FG000|Overall Study|Not Treated|0|||
149965372|NCT04661839|541007905|FG001|Overall Study|Not Treated|0|||
149965373|NCT04661839|541007906|FG002|Overall Study|Not Treated|1|||
149965374|NCT04661839|541007907|FG003|Overall Study|Not Treated|0|||
149881006|NCT00259272|540691347|FG003|Overall Study|Withdrawal by Subject|7|||
149881007|NCT00259272|540691344|FG000|Overall Study|Lost to Follow-up|1|||
149881008|NCT00259272|540691345|FG001|Overall Study|Lost to Follow-up|0|||
149881009|NCT00259272|540691346|FG002|Overall Study|Lost to Follow-up|0|||
149881010|NCT00259272|540691347|FG003|Overall Study|Lost to Follow-up|1|||
149881011|NCT03301623|540691348|FG000|Overall Study|Death|3|||
149881012|NCT03301623|540691349|FG001|Overall Study|Death|1|||
149881013|NCT03301623|540691348|FG000|Overall Study|Withdrawal by Subject|11|||
149881014|NCT03301623|540691349|FG001|Overall Study|Withdrawal by Subject|13|||
149881015|NCT03301623|540691348|FG000|Overall Study|Lost to Follow-up|3|||
149881016|NCT03301623|540691349|FG001|Overall Study|Lost to Follow-up|1|||
149965375|NCT04661839|541007904|FG000|Overall Study|Lost to Follow-up|1|||
149965376|NCT04661839|541007905|FG001|Overall Study|Lost to Follow-up|0|||
149881017|NCT02516553|540691350|FG000|Overall Study|Progressive disease|2|||
149881018|NCT02516553|540691351|FG001|Overall Study|Progressive disease|2|||
149881019|NCT02516553|540691352|FG002|Overall Study|Progressive disease|3|||
149965377|NCT04661839|541007906|FG002|Overall Study|Lost to Follow-up|0|||
149881020|NCT02516553|540691353|FG003|Overall Study|Progressive disease|5|||
149881021|NCT02516553|540691354|FG004|Overall Study|Progressive disease|3|||
149881022|NCT02516553|540691355|FG005|Overall Study|Progressive disease|0|||
149881023|NCT02516553|540691356|FG006|Overall Study|Progressive disease|5|||
149881024|NCT02516553|540691357|FG007|Overall Study|Progressive disease|5|||
149881025|NCT02516553|540691358|FG008|Overall Study|Progressive disease|11|||
149881026|NCT02516553|540691359|FG009|Overall Study|Progressive disease|3|||
149881027|NCT02516553|540691360|FG010|Overall Study|Progressive disease|10|||
149881028|NCT02516553|540691361|FG011|Overall Study|Progressive disease|8|||
149881029|NCT02516553|540691362|FG012|Overall Study|Progressive disease|8|||
149881030|NCT02516553|540691363|FG013|Overall Study|Progressive disease|2|||
149881031|NCT02516553|540691364|FG014|Overall Study|Progressive disease|2|||
149881032|NCT02516553|540691365|FG015|Overall Study|Progressive disease|2|||
149881033|NCT02516553|540691366|FG016|Overall Study|Progressive disease|1|||
149881034|NCT02516553|540691367|FG017|Overall Study|Progressive disease|9|||
149881035|NCT02516553|540691368|FG018|Overall Study|Progressive disease|12|||
149881036|NCT02516553|540691369|FG019|Overall Study|Progressive disease|7|||
149881037|NCT02516553|540691370|FG020|Overall Study|Progressive disease|16|||
149881038|NCT02516553|540691371|FG021|Overall Study|Progressive disease|18|||
149881039|NCT02516553|540691350|FG000|Overall Study|Dose limiting toxicity|0|||
149881040|NCT02516553|540691351|FG001|Overall Study|Dose limiting toxicity|0|||
149881041|NCT02516553|540691352|FG002|Overall Study|Dose limiting toxicity|0|||
149881042|NCT02516553|540691353|FG003|Overall Study|Dose limiting toxicity|0|||
149881043|NCT02516553|540691354|FG004|Overall Study|Dose limiting toxicity|3|||
149881044|NCT02516553|540691355|FG005|Overall Study|Dose limiting toxicity|1|||
149881045|NCT02516553|540691356|FG006|Overall Study|Dose limiting toxicity|1|||
149881046|NCT02516553|540691357|FG007|Overall Study|Dose limiting toxicity|0|||
149881047|NCT02516553|540691358|FG008|Overall Study|Dose limiting toxicity|1|||
149881048|NCT02516553|540691359|FG009|Overall Study|Dose limiting toxicity|0|||
149881049|NCT02516553|540691360|FG010|Overall Study|Dose limiting toxicity|0|||
149881050|NCT02516553|540691361|FG011|Overall Study|Dose limiting toxicity|1|||
149881051|NCT02516553|540691362|FG012|Overall Study|Dose limiting toxicity|0|||
149881052|NCT02516553|540691363|FG013|Overall Study|Dose limiting toxicity|1|||
149881053|NCT02516553|540691364|FG014|Overall Study|Dose limiting toxicity|0|||
149881054|NCT02516553|540691365|FG015|Overall Study|Dose limiting toxicity|0|||
149881055|NCT02516553|540691366|FG016|Overall Study|Dose limiting toxicity|1|||
149881056|NCT02516553|540691367|FG017|Overall Study|Dose limiting toxicity|1|||
149881057|NCT02516553|540691368|FG018|Overall Study|Dose limiting toxicity|0|||
149881058|NCT02516553|540691369|FG019|Overall Study|Dose limiting toxicity|2|||
149881059|NCT02516553|540691370|FG020|Overall Study|Dose limiting toxicity|0|||
149881060|NCT02516553|540691371|FG021|Overall Study|Dose limiting toxicity|0|||
149881061|NCT02516553|540691350|FG000|Overall Study|Other Adverse Events|0|||
149881062|NCT02516553|540691351|FG001|Overall Study|Other Adverse Events|0|||
149881063|NCT02516553|540691352|FG002|Overall Study|Other Adverse Events|0|||
149881064|NCT02516553|540691353|FG003|Overall Study|Other Adverse Events|1|||
149881065|NCT02516553|540691354|FG004|Overall Study|Other Adverse Events|0|||
149881066|NCT02516553|540691355|FG005|Overall Study|Other Adverse Events|1|||
149881067|NCT02516553|540691356|FG006|Overall Study|Other Adverse Events|0|||
149881068|NCT02516553|540691357|FG007|Overall Study|Other Adverse Events|0|||
149881069|NCT02516553|540691358|FG008|Overall Study|Other Adverse Events|0|||
149881070|NCT02516553|540691359|FG009|Overall Study|Other Adverse Events|1|||
149881071|NCT02516553|540691360|FG010|Overall Study|Other Adverse Events|3|||
149881072|NCT02516553|540691361|FG011|Overall Study|Other Adverse Events|2|||
149881073|NCT02516553|540691362|FG012|Overall Study|Other Adverse Events|0|||
149881074|NCT02516553|540691363|FG013|Overall Study|Other Adverse Events|1|||
149881075|NCT02516553|540691364|FG014|Overall Study|Other Adverse Events|0|||
149881076|NCT02516553|540691365|FG015|Overall Study|Other Adverse Events|0|||
149881077|NCT02516553|540691366|FG016|Overall Study|Other Adverse Events|0|||
149881078|NCT02516553|540691367|FG017|Overall Study|Other Adverse Events|2|||
149881079|NCT02516553|540691368|FG018|Overall Study|Other Adverse Events|1|||
149881080|NCT02516553|540691369|FG019|Overall Study|Other Adverse Events|2|||
149881081|NCT02516553|540691370|FG020|Overall Study|Other Adverse Events|2|||
149881082|NCT02516553|540691371|FG021|Overall Study|Other Adverse Events|1|||
149881083|NCT02516553|540691350|FG000|Overall Study|Refused to continue trial medication|0|||
149881084|NCT02516553|540691351|FG001|Overall Study|Refused to continue trial medication|0|||
150043831|NCT00476008|541300694|FG001|Overall Study|Withdrawal by Subject|1|||
150043832|NCT00476008|541300693|FG000|Overall Study|Death|1|||
149881085|NCT02516553|540691352|FG002|Overall Study|Refused to continue trial medication|0|||
149881086|NCT02516553|540691353|FG003|Overall Study|Refused to continue trial medication|0|||
149881087|NCT02516553|540691354|FG004|Overall Study|Refused to continue trial medication|0|||
149881088|NCT02516553|540691355|FG005|Overall Study|Refused to continue trial medication|0|||
149881089|NCT02516553|540691356|FG006|Overall Study|Refused to continue trial medication|0|||
149881090|NCT02516553|540691357|FG007|Overall Study|Refused to continue trial medication|0|||
150043833|NCT00476008|541300694|FG001|Overall Study|Death|0|||
150043834|NCT01227018|541300695|FG000|Overall Study|Disease progression|9|||
150043835|NCT01227018|541300695|FG000|Overall Study|Toxicity|2|||
149881091|NCT02516553|540691358|FG008|Overall Study|Refused to continue trial medication|0|||
149881092|NCT02516553|540691359|FG009|Overall Study|Refused to continue trial medication|0|||
149881093|NCT02516553|540691360|FG010|Overall Study|Refused to continue trial medication|1|||
149881094|NCT02516553|540691361|FG011|Overall Study|Refused to continue trial medication|0|||
149881095|NCT02516553|540691362|FG012|Overall Study|Refused to continue trial medication|0|||
149881096|NCT02516553|540691363|FG013|Overall Study|Refused to continue trial medication|0|||
149881097|NCT02516553|540691364|FG014|Overall Study|Refused to continue trial medication|0|||
149881098|NCT02516553|540691365|FG015|Overall Study|Refused to continue trial medication|0|||
149881099|NCT02516553|540691366|FG016|Overall Study|Refused to continue trial medication|0|||
149881100|NCT02516553|540691367|FG017|Overall Study|Refused to continue trial medication|0|||
149881101|NCT02516553|540691368|FG018|Overall Study|Refused to continue trial medication|1|||
149881102|NCT02516553|540691369|FG019|Overall Study|Refused to continue trial medication|0|||
149881103|NCT02516553|540691370|FG020|Overall Study|Refused to continue trial medication|0|||
149881104|NCT02516553|540691371|FG021|Overall Study|Refused to continue trial medication|1|||
149881105|NCT02516553|540691350|FG000|Overall Study|other reasons than listed|0|||
149881106|NCT02516553|540691351|FG001|Overall Study|other reasons than listed|0|||
149881107|NCT02516553|540691352|FG002|Overall Study|other reasons than listed|0|||
149881108|NCT02516553|540691353|FG003|Overall Study|other reasons than listed|0|||
149881109|NCT02516553|540691354|FG004|Overall Study|other reasons than listed|0|||
149881110|NCT02516553|540691355|FG005|Overall Study|other reasons than listed|0|||
149881111|NCT02516553|540691356|FG006|Overall Study|other reasons than listed|0|||
149881112|NCT02516553|540691357|FG007|Overall Study|other reasons than listed|1|||
149881113|NCT02516553|540691358|FG008|Overall Study|other reasons than listed|1|||
149881114|NCT02516553|540691359|FG009|Overall Study|other reasons than listed|0|||
149881115|NCT02516553|540691360|FG010|Overall Study|other reasons than listed|1|||
149881116|NCT02516553|540691361|FG011|Overall Study|other reasons than listed|1|||
149881117|NCT02516553|540691362|FG012|Overall Study|other reasons than listed|0|||
149881118|NCT02516553|540691363|FG013|Overall Study|other reasons than listed|0|||
149881119|NCT02516553|540691364|FG014|Overall Study|other reasons than listed|0|||
149881120|NCT02516553|540691365|FG015|Overall Study|other reasons than listed|0|||
149881121|NCT02516553|540691366|FG016|Overall Study|other reasons than listed|0|||
149881122|NCT02516553|540691367|FG017|Overall Study|other reasons than listed|0|||
149881123|NCT02516553|540691368|FG018|Overall Study|other reasons than listed|0|||
149881124|NCT02516553|540691369|FG019|Overall Study|other reasons than listed|0|||
149881125|NCT02516553|540691370|FG020|Overall Study|other reasons than listed|2|||
149881126|NCT02516553|540691371|FG021|Overall Study|other reasons than listed|2|||
149881127|NCT04614246|540691373|FG000|Overall Study|Adverse Event|0|||
149881128|NCT04614246|540691374|FG001|Overall Study|Adverse Event|1|||
149881129|NCT04614246|540691375|FG002|Overall Study|Adverse Event|1|||
149881130|NCT04614246|540691376|FG003|Overall Study|Adverse Event|2|||
149881131|NCT04614246|540691377|FG004|Overall Study|Adverse Event|1|||
149881132|NCT04614246|540691373|FG000|Overall Study|Lost to Follow-up|0|||
149881133|NCT04614246|540691374|FG001|Overall Study|Lost to Follow-up|1|||
149881134|NCT04614246|540691375|FG002|Overall Study|Lost to Follow-up|0|||
149881135|NCT04614246|540691376|FG003|Overall Study|Lost to Follow-up|1|||
149881136|NCT04614246|540691377|FG004|Overall Study|Lost to Follow-up|3|||
149881137|NCT04614246|540691373|FG000|Overall Study|Other reason|0|||
149881138|NCT04614246|540691374|FG001|Overall Study|Other reason|1|||
149881139|NCT04614246|540691375|FG002|Overall Study|Other reason|2|||
149881140|NCT04614246|540691376|FG003|Overall Study|Other reason|0|||
149881141|NCT04614246|540691377|FG004|Overall Study|Other reason|0|||
149881142|NCT04614246|540691373|FG000|Overall Study|Withdrawal by Subject|4|||
149881143|NCT04614246|540691374|FG001|Overall Study|Withdrawal by Subject|2|||
149881144|NCT04614246|540691375|FG002|Overall Study|Withdrawal by Subject|4|||
149881145|NCT04614246|540691376|FG003|Overall Study|Withdrawal by Subject|3|||
149881146|NCT04614246|540691377|FG004|Overall Study|Withdrawal by Subject|4|||
149881147|NCT04614246|540691373|FG000|Overall Study|Physician Decision|0|||
149881148|NCT04614246|540691374|FG001|Overall Study|Physician Decision|2|||
149965378|NCT04661839|541007907|FG003|Overall Study|Lost to Follow-up|1|||
150174985|NCT05764161|541777011|FG001|12-week DBVC Period|Lack of Efficacy|1|||
149881149|NCT04614246|540691375|FG002|Overall Study|Physician Decision|1|||
149881150|NCT04614246|540691376|FG003|Overall Study|Physician Decision|0|||
149881151|NCT04614246|540691377|FG004|Overall Study|Physician Decision|0|||
149881152|NCT04614246|540691373|FG000|Overall Study|Study terminated by sponsor|10|||
149881153|NCT04614246|540691374|FG001|Overall Study|Study terminated by sponsor|15|||
149881154|NCT04614246|540691375|FG002|Overall Study|Study terminated by sponsor|12|||
149881155|NCT04614246|540691376|FG003|Overall Study|Study terminated by sponsor|13|||
149881156|NCT04614246|540691377|FG004|Overall Study|Study terminated by sponsor|9|||
149881157|NCT04614246|540691373|FG000|Overall Study|Pregnancy|2|||
149881158|NCT04614246|540691374|FG001|Overall Study|Pregnancy|0|||
149881159|NCT04614246|540691375|FG002|Overall Study|Pregnancy|1|||
149881160|NCT04614246|540691376|FG003|Overall Study|Pregnancy|0|||
149881161|NCT04614246|540691377|FG004|Overall Study|Pregnancy|0|||
149881162|NCT02521376|540691378|FG000|Overall Study|Enrolled, But Not Treated|1|||
149881163|NCT02521376|540691379|FG001|Overall Study|Enrolled, But Not Treated|0|||
149881164|NCT02521376|540691380|FG002|Overall Study|Enrolled, But Not Treated|0|||
149881165|NCT02521376|540691381|FG003|Overall Study|Enrolled, But Not Treated|0|||
149881166|NCT00340678|540691383|FG000|Overall Study|Lost to Follow-up|1|||
149881167|NCT00340678|540691384|FG001|Overall Study|Lost to Follow-up|0|||
149881168|NCT00340678|540691385|FG002|Overall Study|Lost to Follow-up|0|||
149881169|NCT00340678|540691386|FG003|Overall Study|Lost to Follow-up|0|||
149881170|NCT02759692|540691389|FG000|Period 1|Test article no longer available|1|||
149881171|NCT02759692|540691390|FG001|Period 1|Test article no longer available|1|||
149881172|NCT02759692|540691389|FG000|Period 1|No longer meets eligibility criteria.|1|||
149881173|NCT02759692|540691390|FG001|Period 1|No longer meets eligibility criteria.|0|||
149881174|NCT02759692|540691389|FG000|Period 1|Miss-Randomized|1|||
149881175|NCT02759692|540691390|FG001|Period 1|Miss-Randomized|1|||
149881176|NCT02759692|540691389|FG000|Period 2|Lost to Follow-up|1|||
149881177|NCT02759692|540691390|FG001|Period 2|Lost to Follow-up|0|||
149881178|NCT02759692|540691389|FG000|Period 2|Test article no longer available|0|||
149881179|NCT02759692|540691390|FG001|Period 2|Test article no longer available|1|||
149881180|NCT01954745|540691396|FG000|Overall Study|Radiological Progression|11|||
149881181|NCT01954745|540691396|FG000|Overall Study|Clinical Progression|5|||
149881182|NCT01954745|540691396|FG000|Overall Study|Adverse Event|2|||
149881183|NCT01954745|540691396|FG000|Overall Study|Death|1|||
149881184|NCT05292183|540693006|FG000|Overall Study|Adverse Event|1|||
149881185|NCT03922529|540693010|FG000|Overall Study|Withdrawal by Subject|13|||
149881186|NCT03922529|540693011|FG001|Overall Study|Withdrawal by Subject|12|||
149881187|NCT03922529|540693010|FG000|Overall Study|Death|7|||
149881188|NCT03922529|540693011|FG001|Overall Study|Death|12|||
149881189|NCT03922529|540693010|FG000|Overall Study|Lost to Follow-up|12|||
149881190|NCT03922529|540693011|FG001|Overall Study|Lost to Follow-up|19|||
149881191|NCT03922529|540693010|FG000|Overall Study|Adverse Event|1|||
149881192|NCT03922529|540693011|FG001|Overall Study|Adverse Event|0|||
149881193|NCT03922529|540693010|FG000|Overall Study|Death after withdrawal|1|||
149881194|NCT03922529|540693011|FG001|Overall Study|Death after withdrawal|0|||
149881195|NCT03922529|540693010|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
149881196|NCT03922529|540693011|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
149881197|NCT03922529|540693010|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
149881198|NCT03922529|540693011|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
149881199|NCT01277601|540693012|FG000|Overall Study|Adverse Event|5|||
149881200|NCT01277601|540693013|FG001|Overall Study|Adverse Event|3|||
149881201|NCT01277601|540693014|FG002|Overall Study|Adverse Event|0|||
149881202|NCT01277601|540693015|FG003|Overall Study|Adverse Event|7|||
149881203|NCT01277601|540693012|FG000|Overall Study|Withdrawal by Subject|18|||
149881204|NCT01277601|540693013|FG001|Overall Study|Withdrawal by Subject|21|||
149881205|NCT01277601|540693014|FG002|Overall Study|Withdrawal by Subject|8|||
149881206|NCT01277601|540693015|FG003|Overall Study|Withdrawal by Subject|17|||
149881207|NCT01277601|540693012|FG000|Overall Study|Lost to Follow-up|7|||
149881208|NCT01277601|540693013|FG001|Overall Study|Lost to Follow-up|9|||
149965379|NCT03647137|541007908|FG000|Overall Study|Scan Limitation|2|||
149965380|NCT03647137|541007909|FG001|Overall Study|Scan Limitation|1|||
149965381|NCT03647137|541007910|FG002|Overall Study|Scan Limitation|1|||
149965382|NCT03647137|541007911|FG003|Overall Study|Scan Limitation|2|||
149965383|NCT01443026|541007912|FG000|Overall Study|Physician Decision|1|||
149965384|NCT01443026|541007913|FG001|Overall Study|Physician Decision|0|||
149965385|NCT01443026|541007912|FG000|Overall Study|Death|0|||
149881209|NCT01277601|540693014|FG002|Overall Study|Lost to Follow-up|4|||
149881210|NCT01277601|540693015|FG003|Overall Study|Lost to Follow-up|2|||
149965386|NCT01443026|541007913|FG001|Overall Study|Death|1|||
149881211|NCT01277601|540693012|FG000|Overall Study|Physician Decision|3|||
149881212|NCT01277601|540693013|FG001|Overall Study|Physician Decision|5|||
149881213|NCT01277601|540693014|FG002|Overall Study|Physician Decision|1|||
149881214|NCT01277601|540693015|FG003|Overall Study|Physician Decision|6|||
149881215|NCT01277601|540693012|FG000|Overall Study|Pregnancy|2|||
149881216|NCT01277601|540693013|FG001|Overall Study|Pregnancy|2|||
149881217|NCT01277601|540693014|FG002|Overall Study|Pregnancy|4|||
149881218|NCT01277601|540693015|FG003|Overall Study|Pregnancy|1|||
149881219|NCT01277601|540693012|FG000|Overall Study|Noncompliance with Study Drug|1|||
149881220|NCT01277601|540693013|FG001|Overall Study|Noncompliance with Study Drug|3|||
149881221|NCT01277601|540693014|FG002|Overall Study|Noncompliance with Study Drug|2|||
149881222|NCT01277601|540693015|FG003|Overall Study|Noncompliance with Study Drug|0|||
149881223|NCT01277601|540693012|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
149881224|NCT01277601|540693013|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
149881225|NCT01277601|540693014|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
149881226|NCT01277601|540693015|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
149881227|NCT01277601|540693012|FG000|Overall Study|Protocol Violation|0|||
149881228|NCT01277601|540693013|FG001|Overall Study|Protocol Violation|2|||
149881229|NCT01277601|540693014|FG002|Overall Study|Protocol Violation|5|||
149881230|NCT01277601|540693015|FG003|Overall Study|Protocol Violation|0|||
149881231|NCT01277601|540693012|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
149881232|NCT01277601|540693013|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
149881233|NCT01277601|540693014|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
149881234|NCT01277601|540693015|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
149881235|NCT04034927|540693016|FG000|Overall Study|Adverse Event|4|||
149881236|NCT04034927|540693017|FG001|Overall Study|Adverse Event|9|||
149881237|NCT04034927|540693016|FG000|Overall Study|Death|0|||
149881238|NCT04034927|540693017|FG001|Overall Study|Death|1|||
149881239|NCT04034927|540693016|FG000|Overall Study|Withdrawal by Subject|0|||
149881240|NCT04034927|540693017|FG001|Overall Study|Withdrawal by Subject|3|||
149881241|NCT04034927|540693016|FG000|Overall Study|Still on Treatment|2|||
149881242|NCT04034927|540693017|FG001|Overall Study|Still on Treatment|1|||
149881243|NCT04034927|540693016|FG000|Overall Study|Other|1|||
149881244|NCT04034927|540693017|FG001|Overall Study|Other|1|||
149881245|NCT02291510|540693018|FG000|Overall Study|Adverse Event|0|||
149881246|NCT02291510|540693019|FG001|Overall Study|Adverse Event|0|||
149881247|NCT02291510|540693020|FG002|Overall Study|Adverse Event|0|||
149881248|NCT02291510|540693021|FG003|Overall Study|Adverse Event|1|||
149881249|NCT00459355|540693022|FG000|Overall Study|Subject no longer met inc criteria|20|||
149881250|NCT00459355|540693023|FG001|Overall Study|Subject no longer met inc criteria|18|||
149881251|NCT01173120|540693025|FG000|Overall Study|Lack of Efficacy|2|||
149881252|NCT01173120|540693025|FG000|Overall Study|Lost to Follow-up|1|||
149881253|NCT01173120|540693025|FG000|Overall Study|Participant Decision|2|||
149881254|NCT01173120|540693025|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
149881255|NCT01173120|540693025|FG000|Overall Study|Switch-Participant Decision|12|||
149881256|NCT01173120|540693025|FG000|Overall Study|Switch-Difficulty With Device|12|||
149881257|NCT01383707|540693034|FG000|Overall Study|Consent withdrawal|6|||
149881258|NCT01383707|540693034|FG000|Overall Study|Death|19|||
149881259|NCT01383707|540693034|FG000|Overall Study|Other|8|||
149881260|NCT01383707|540693034|FG000|Overall Study|Sponsor's decision|2|||
149881261|NCT01383707|540693034|FG000|Overall Study|Adverse Event|14|||
149881262|NCT01383707|540693034|FG000|Overall Study|Progressive disease|23|||
149881263|NCT01977417|540693036|FG000|Overall Study|Adverse Event|1|||
149881264|NCT01977417|540693037|FG001|Overall Study|Adverse Event|0|||
149881265|NCT01977417|540693036|FG000|Overall Study|Withdrawal by Subject|2|||
149881266|NCT01977417|540693037|FG001|Overall Study|Withdrawal by Subject|4|||
149881267|NCT01977417|540693036|FG000|Overall Study|Female enrollment goal met|0|||
149881268|NCT01977417|540693037|FG001|Overall Study|Female enrollment goal met|2|||
149881269|NCT02013817|540693038|FG000|Overall Study|Adverse Event|12|||
149881270|NCT02013817|540693038|FG000|Overall Study|Withdrawal by Subject|4|||
149881271|NCT02013817|540693038|FG000|Overall Study|Death|2|||
149881272|NCT02013817|540693038|FG000|Overall Study|Other|9|||
149881273|NCT01145508|540693039|FG000|Overall Study|Adverse Event|1|||
149881274|NCT01145508|540693040|FG001|Overall Study|Adverse Event|0|||
149881275|NCT01145508|540693039|FG000|Overall Study|Death|1|||
149881276|NCT01145508|540693040|FG001|Overall Study|Death|0|||
149881277|NCT01145508|540693039|FG000|Overall Study|Physician Decision|2|||
149881278|NCT01145508|540693040|FG001|Overall Study|Physician Decision|1|||
149881279|NCT01145508|540693039|FG000|Overall Study|Never started treatment|1|||
149881280|NCT01145508|540693040|FG001|Overall Study|Never started treatment|1|||
149881281|NCT02111603|540693052|FG000|Overall Study|Withdrawal by Subject|1|||
149881282|NCT01582152|540693053|FG000|Overall Study|Disease Progression|4|||
149881283|NCT01582152|540693054|FG001|Overall Study|Disease Progression|5|||
149881284|NCT01582152|540693053|FG000|Overall Study|Adverse Event|2|||
149881285|NCT01582152|540693054|FG001|Overall Study|Adverse Event|1|||
149881286|NCT03055624|540693055|FG000|Overall Study|Study closed|9|||
149881287|NCT01434810|540693056|FG000|Overall Study|Did not receive treatment|11|||
149881288|NCT01434810|540693057|FG001|Overall Study|Did not receive treatment|3|||
149881289|NCT01434810|540693056|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
149881290|NCT01434810|540693057|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
149881291|NCT02437903|540693062|FG000|Overall Study|Adverse Event|1|||
149881292|NCT02437903|540693062|FG000|Overall Study|Withdrawal by Subject|1|||
149881293|NCT02437903|540693062|FG000|Overall Study|Lost to Follow-up|3|||
149881294|NCT00799825|540693074|FG000|Overall Study|Adverse Event|1|||
149881295|NCT00799825|540693074|FG000|Overall Study|Withdrawal by Subject|6|||
149881296|NCT00799825|540693074|FG000|Overall Study|Lost to Follow-up|38|||
149881297|NCT00799825|540693074|FG000|Overall Study|Pregnancy|3|||
149881298|NCT00794339|540693075|FG000|Overall Study|Withdrawal by Subject|3|||
149881299|NCT00794339|540693075|FG000|Overall Study|Ineligible|4|||
149881300|NCT00794339|540693075|FG000|Overall Study|Tx prior to ATSM|3|||
149881301|NCT00794339|540693075|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
149881302|NCT00794339|540693075|FG000|Overall Study|Tx not per protocol|1|||
149881303|NCT01611857|540693076|FG000|Overall Study|Withdrawal by Subject|0|||
149881304|NCT01611857|540693077|FG001|Overall Study|Withdrawal by Subject|2|||
149881305|NCT02439970|540693081|FG000|Overall Study|Study Terminated|2|||
149881306|NCT02439970|540693082|FG001|Overall Study|Study Terminated|3|||
149881307|NCT02952586|540693085|FG000|Lead-In Phase (7 Days)|Death|0|||
149881308|NCT02952586|540693086|FG001|Lead-In Phase (7 Days)|Death|1|||
149881309|NCT02952586|540693085|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
149881310|NCT02952586|540693086|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
149881311|NCT02952586|540693085|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
149881312|NCT02952586|540693086|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
149881313|NCT02952586|540693085|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
149881314|NCT02952586|540693086|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
149881315|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
149881316|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
149881317|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
149881318|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
149881319|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
149881320|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
149881321|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
149881322|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
149881323|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
149881324|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
149881325|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
149881326|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
149881327|NCT02952586|540693085|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
149881328|NCT02952586|540693086|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
149881329|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Death|3|||
149881330|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Death|8|||
149881331|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
149881332|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
149881333|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
149881334|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
149881335|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
149881336|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
149881337|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
149881338|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
149881339|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
149881340|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
149881341|NCT02952586|540693085|FG000|CRT for Cisplatin (63 Days)|Other|1|||
149881342|NCT02952586|540693086|FG001|CRT for Cisplatin (63 Days)|Other|1|||
149881343|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Death|5|||
149881344|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Death|8|||
149881345|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
149881346|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
149881347|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
149881348|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
149881349|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
149965387|NCT01443026|541007912|FG000|Overall Study|Withdrawal by Subject|0|||
149965388|NCT01443026|541007913|FG001|Overall Study|Withdrawal by Subject|3|||
149965389|NCT01443026|541007912|FG000|Overall Study|Lost to Follow-up|2|||
149965390|NCT01443026|541007913|FG001|Overall Study|Lost to Follow-up|1|||
149965391|NCT00829868|541007914|FG000|Washout|Physician Decision|1|||
149965392|NCT00829868|541007915|FG001|Washout|Physician Decision|0|||
149881350|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
150174986|NCT05764161|541777010|FG000|12-week DBVC Period|Lost to Follow-up|0|||
149881351|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
149881352|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
149881353|NCT02952586|540693085|FG000|CRT for IMRT (63 Days)|Other|1|||
149881354|NCT02952586|540693086|FG001|CRT for IMRT (63 Days)|Other|0|||
149881355|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Death|17|||
149881356|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Death|11|||
150174987|NCT05764161|541777011|FG001|12-week DBVC Period|Lost to Follow-up|2|||
149965393|NCT03773562|541007918|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
149965394|NCT03773562|541007918|FG000|Overall Study|Lost to Follow-up|10|||
149965395|NCT03773562|541007918|FG000|Overall Study|Withdrawal by Subject|1|||
149965396|NCT03131479|541007919|FG000|Overall Study|Adverse Event|0|||
149965397|NCT03131479|541007920|FG001|Overall Study|Adverse Event|0|||
149965398|NCT03131479|541007921|FG002|Overall Study|Adverse Event|1|||
149965399|NCT03131479|541007922|FG003|Overall Study|Adverse Event|1|||
149965400|NCT03131479|541007923|FG004|Overall Study|Adverse Event|0|||
149965401|NCT03131479|541007919|FG000|Overall Study|Subject/Guardian Decision|0|||
149965402|NCT03131479|541007920|FG001|Overall Study|Subject/Guardian Decision|0|||
149965403|NCT03131479|541007921|FG002|Overall Study|Subject/Guardian Decision|0|||
149965404|NCT03131479|541007922|FG003|Overall Study|Subject/Guardian Decision|1|||
149965405|NCT03131479|541007923|FG004|Overall Study|Subject/Guardian Decision|0|||
149965406|NCT04806373|541007927|FG000|Overall Study|Withdrawal by Subject|1|||
149965407|NCT04806373|541007928|FG001|Overall Study|Withdrawal by Subject|1|||
149965408|NCT00908141|541007931|FG000|Overall Study|Withdrawal by Subject|0|||
149965409|NCT00908141|541007932|FG001|Overall Study|Withdrawal by Subject|1|||
149965410|NCT03058952|541009500|FG000|Overall Study|Adverse Event|1|||
149965411|NCT03058952|541009501|FG001|Overall Study|Adverse Event|0|||
149965412|NCT03058952|541009500|FG000|Overall Study|Lost to Follow-up|15|||
149881357|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
149881358|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
149881359|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
149881360|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
149881361|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
149881362|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
149881363|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
149881364|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
149881365|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
149881366|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
149881367|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
149881368|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
149881369|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
149881370|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
149881371|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Other|2|||
149881372|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Other|1|||
149881373|NCT02952586|540693085|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
149881374|NCT02952586|540693086|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
149881375|NCT02952586|540693085|FG000|Follow-Up Phase (90 Days)|Death|12|||
149881376|NCT02952586|540693086|FG001|Follow-Up Phase (90 Days)|Death|10|||
149881377|NCT02952586|540693085|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
149881378|NCT02952586|540693086|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
149881379|NCT02952586|540693085|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
149881380|NCT02952586|540693086|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
149881381|NCT02952586|540693085|FG000|Follow-Up Phase (90 Days)|Other|7|||
149881382|NCT02952586|540693086|FG001|Follow-Up Phase (90 Days)|Other|5|||
149881383|NCT02952586|540693085|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
149881384|NCT02952586|540693086|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
149881385|NCT02952586|540693085|FG000|LT Follow-up (up to 45 Months)|Death|51|||
149881386|NCT02952586|540693086|FG001|LT Follow-up (up to 45 Months)|Death|31|||
149881387|NCT02952586|540693085|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
149881388|NCT02952586|540693086|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
149881389|NCT02952586|540693085|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
149881390|NCT02952586|540693086|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
149881391|NCT02952586|540693085|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
149881392|NCT02952586|540693086|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
149881393|NCT02075515|540693090|FG000|Overall Study|Serious Adverse Event|1|||
149881394|NCT02075515|540693091|FG001|Overall Study|Serious Adverse Event|1|||
149881395|NCT02075515|540693092|FG002|Overall Study|Serious Adverse Event|1|||
149881396|NCT02075515|540693090|FG000|Overall Study|Non-Serious Adverse Event|0|||
149881397|NCT02075515|540693091|FG001|Overall Study|Non-Serious Adverse Event|1|||
149881398|NCT02075515|540693092|FG002|Overall Study|Non-Serious Adverse Event|0|||
149881399|NCT02075515|540693090|FG000|Overall Study|Withdrawal by Subject|2|||
149965413|NCT03058952|541009501|FG001|Overall Study|Lost to Follow-up|15|||
149965414|NCT03058952|541009500|FG000|Overall Study|Withdrawal by Subject|7|||
149965415|NCT03058952|541009501|FG001|Overall Study|Withdrawal by Subject|11|||
149881400|NCT02075515|540693091|FG001|Overall Study|Withdrawal by Subject|0|||
149881401|NCT02075515|540693092|FG002|Overall Study|Withdrawal by Subject|1|||
149881402|NCT02075515|540693090|FG000|Overall Study|Lost to Follow-up|1|||
149881403|NCT02075515|540693091|FG001|Overall Study|Lost to Follow-up|3|||
149881404|NCT02075515|540693092|FG002|Overall Study|Lost to Follow-up|6|||
149881405|NCT00741338|540693095|FG000|Overall Study|Adverse Event|0|||
149881406|NCT00741338|540693096|FG001|Overall Study|Adverse Event|1|||
149881407|NCT03593395|540693097|FG000|Overall Study|Lost to Follow-up|48|||
149881408|NCT03593395|540693098|FG001|Overall Study|Lost to Follow-up|3|||
149881409|NCT03593395|540693097|FG000|Overall Study|Withdrawal by Subject|5|||
149881410|NCT03593395|540693098|FG001|Overall Study|Withdrawal by Subject|24|||
149881411|NCT03593395|540693097|FG000|Overall Study|Death|2|||
149881412|NCT03593395|540693098|FG001|Overall Study|Death|3|||
149881413|NCT03593395|540693097|FG000|Overall Study|Physician Decision|0|||
149881414|NCT03593395|540693098|FG001|Overall Study|Physician Decision|6|||
149881415|NCT03593395|540693097|FG000|Overall Study|Participant Relocated|19|||
149881416|NCT03593395|540693098|FG001|Overall Study|Participant Relocated|3|||
149881417|NCT03593395|540693097|FG000|Overall Study|No Information|1|||
149881418|NCT03593395|540693098|FG001|Overall Study|No Information|7|||
149881419|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
149881420|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
149881421|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
149881422|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
149881423|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
149881424|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
149881425|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
149881426|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
149881427|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
149881428|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
149881429|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
149881430|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
149881431|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
149881432|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
149881433|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
149881434|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
149881435|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
149881436|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
149881437|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
149881438|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
149881439|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
149881440|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149881441|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
150043836|NCT01227018|541300695|FG000|Overall Study|Withdrew after beginning treatment|4|||
149881442|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149881443|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
149881444|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
149881445|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
149881446|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
149881447|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
149881448|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
149881449|NCT03713632|540693099|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
149881450|NCT03713632|540693100|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
149881451|NCT03713632|540693101|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
149881452|NCT03713632|540693102|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
149881453|NCT03713632|540693103|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
149881454|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
149881455|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
149881456|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
149881457|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
149881458|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
149881459|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
149881460|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
149881461|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
149881462|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
149881463|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
149881464|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
149881465|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
149881466|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
149881467|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
149881468|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
149881469|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
149881470|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
149881471|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
149881472|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
149881473|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
149881474|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
149881475|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
149881476|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
149881477|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
149881478|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
149881479|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
149881480|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
149881481|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
149881482|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
149881483|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
149881484|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Death|0|||
149881485|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Death|1|||
149881486|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Death|0|||
149881487|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Death|0|||
149881488|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Death|0|||
149881489|NCT03713632|540693099|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149881490|NCT03713632|540693100|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
149881491|NCT03713632|540693101|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149881492|NCT03713632|540693102|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149881493|NCT03713632|540693103|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
149881494|NCT01524978|540693104|FG000|Overall Study|Other|16|||
149881495|NCT01524978|540693105|FG001|Overall Study|Other|2|||
149881496|NCT01524978|540693106|FG002|Overall Study|Other|1|||
149881497|NCT01524978|540693107|FG003|Overall Study|Other|2|||
149881498|NCT01524978|540693108|FG004|Overall Study|Other|1|||
149881499|NCT01524978|540693109|FG005|Overall Study|Other|3|||
149881500|NCT01524978|540693110|FG006|Overall Study|Other|17|||
149881501|NCT01524978|540693111|FG007|Overall Study|Other|1|||
149881502|NCT01524978|540693112|FG008|Overall Study|Other|2|||
149881503|NCT01524978|540693113|FG009|Overall Study|Other|2|||
149881504|NCT01524978|540693114|FG010|Overall Study|Other|5|||
149881505|NCT01524978|540693104|FG000|Overall Study|Withdrawal by Subject|12|||
149881506|NCT01524978|540693105|FG001|Overall Study|Withdrawal by Subject|0|||
149881507|NCT01524978|540693106|FG002|Overall Study|Withdrawal by Subject|1|||
149881508|NCT01524978|540693107|FG003|Overall Study|Withdrawal by Subject|1|||
149881509|NCT01524978|540693108|FG004|Overall Study|Withdrawal by Subject|3|||
149881510|NCT01524978|540693109|FG005|Overall Study|Withdrawal by Subject|1|||
149881511|NCT01524978|540693110|FG006|Overall Study|Withdrawal by Subject|6|||
149881512|NCT01524978|540693111|FG007|Overall Study|Withdrawal by Subject|2|||
149881513|NCT01524978|540693112|FG008|Overall Study|Withdrawal by Subject|4|||
149881514|NCT01524978|540693113|FG009|Overall Study|Withdrawal by Subject|0|||
149881515|NCT01524978|540693114|FG010|Overall Study|Withdrawal by Subject|5|||
149881516|NCT01524978|540693104|FG000|Overall Study|Lost to Follow-up|0|||
149881517|NCT01524978|540693105|FG001|Overall Study|Lost to Follow-up|0|||
149881518|NCT01524978|540693106|FG002|Overall Study|Lost to Follow-up|3|||
149881519|NCT01524978|540693107|FG003|Overall Study|Lost to Follow-up|0|||
149881520|NCT01524978|540693108|FG004|Overall Study|Lost to Follow-up|1|||
149881521|NCT01524978|540693109|FG005|Overall Study|Lost to Follow-up|1|||
149881522|NCT01524978|540693110|FG006|Overall Study|Lost to Follow-up|2|||
149881523|NCT01524978|540693111|FG007|Overall Study|Lost to Follow-up|0|||
149881524|NCT01524978|540693112|FG008|Overall Study|Lost to Follow-up|1|||
149881525|NCT01524978|540693113|FG009|Overall Study|Lost to Follow-up|1|||
149881526|NCT01524978|540693114|FG010|Overall Study|Lost to Follow-up|1|||
149881527|NCT01524978|540693104|FG000|Overall Study|Death|34|||
149965416|NCT05654181|541009504|FG000|Overall Study|Adverse Event|1|||
149965417|NCT05654181|541009505|FG001|Overall Study|Adverse Event|0|||
149881528|NCT01524978|540693105|FG001|Overall Study|Death|2|||
149881529|NCT01524978|540693106|FG002|Overall Study|Death|5|||
149881530|NCT01524978|540693107|FG003|Overall Study|Death|24|||
149881531|NCT01524978|540693108|FG004|Overall Study|Death|4|||
149881532|NCT01524978|540693109|FG005|Overall Study|Death|4|||
149965418|NCT05654181|541009506|FG002|Overall Study|Adverse Event|0|||
149881533|NCT01524978|540693110|FG006|Overall Study|Death|1|||
149965419|NCT05654181|541009507|FG003|Overall Study|Adverse Event|0|||
149965420|NCT05654181|541009508|FG004|Overall Study|Adverse Event|0|||
149965421|NCT05654181|541009509|FG005|Overall Study|Adverse Event|0|||
149965422|NCT05654181|541009510|FG006|Overall Study|Adverse Event|0|||
149881534|NCT01524978|540693111|FG007|Overall Study|Death|9|||
149881535|NCT01524978|540693112|FG008|Overall Study|Death|5|||
149881536|NCT01524978|540693113|FG009|Overall Study|Death|6|||
149881537|NCT01524978|540693114|FG010|Overall Study|Death|17|||
149881538|NCT01372748|540693126|FG000|Overall Study|Lost to Follow-up|16|||
149881539|NCT01372748|540693127|FG001|Overall Study|Lost to Follow-up|34|||
149881540|NCT01372748|540693126|FG000|Overall Study|Withdrawal by Subject|7|||
149881541|NCT01372748|540693127|FG001|Overall Study|Withdrawal by Subject|5|||
149881542|NCT00134901|540693128|FG000|Overall Study|Lost to Follow-up|5|||
149881543|NCT00134901|540693129|FG001|Overall Study|Lost to Follow-up|5|||
149881544|NCT00134901|540693128|FG000|Overall Study|discontinued intervention|12|||
149881545|NCT00134901|540693129|FG001|Overall Study|discontinued intervention|10|||
149881546|NCT00606632|540693130|FG000|Overall Study|Withdrawal by Subject|13|||
149881547|NCT00606632|540693130|FG000|Overall Study|Miscellaneous reasons|9|||
149881548|NCT03908437|540693131|FG000|Overall Study|Death|0|||
149881549|NCT03908437|540693132|FG001|Overall Study|Death|1|||
149881550|NCT03908437|540693131|FG000|Overall Study|Lost to Follow-up|31|||
149881551|NCT03908437|540693132|FG001|Overall Study|Lost to Follow-up|24|||
149881552|NCT00396565|540693133|FG000|Overall Study|Physician Decision|3|||
149881553|NCT00396565|540693134|FG001|Overall Study|Physician Decision|1|||
149881554|NCT00396565|540693135|FG002|Overall Study|Physician Decision|2|||
149881555|NCT00396565|540693133|FG000|Overall Study|Adverse Event|5|||
149881556|NCT00396565|540693134|FG001|Overall Study|Adverse Event|13|||
149881557|NCT00396565|540693135|FG002|Overall Study|Adverse Event|3|||
149881558|NCT00396565|540693133|FG000|Overall Study|Withdrawal by Subject|8|||
149881559|NCT00396565|540693134|FG001|Overall Study|Withdrawal by Subject|13|||
149881560|NCT00396565|540693135|FG002|Overall Study|Withdrawal by Subject|1|||
149881561|NCT00396565|540693133|FG000|Overall Study|Lack of Efficacy|32|||
149881562|NCT00396565|540693134|FG001|Overall Study|Lack of Efficacy|64|||
149881563|NCT00396565|540693135|FG002|Overall Study|Lack of Efficacy|11|||
149965423|NCT05654181|541009511|FG007|Overall Study|Adverse Event|1|||
149965424|NCT05654181|541009512|FG008|Overall Study|Adverse Event|0|||
149965425|NCT05654181|541009513|FG009|Overall Study|Adverse Event|0|||
149965426|NCT05654181|541009504|FG000|Overall Study|Withdrawal by Subject|0|||
149965427|NCT05654181|541009505|FG001|Overall Study|Withdrawal by Subject|0|||
149965428|NCT05654181|541009506|FG002|Overall Study|Withdrawal by Subject|0|||
149965429|NCT05654181|541009507|FG003|Overall Study|Withdrawal by Subject|0|||
149965430|NCT05654181|541009508|FG004|Overall Study|Withdrawal by Subject|0|||
149965431|NCT05654181|541009509|FG005|Overall Study|Withdrawal by Subject|0|||
149965432|NCT05654181|541009510|FG006|Overall Study|Withdrawal by Subject|0|||
149965433|NCT05654181|541009511|FG007|Overall Study|Withdrawal by Subject|1|||
150043837|NCT02948634|541300696|FG000|Overall Study|Lack of efficacy and study suspended|10|||
150043838|NCT02948634|541300697|FG001|Overall Study|Lack of efficacy and study suspended|2|||
150043839|NCT00499616|541300700|FG000|Overall Study|Death|1|||
150043840|NCT00499616|541300701|FG001|Overall Study|Death|5|||
150043841|NCT00499616|541300702|FG002|Overall Study|Death|3|||
150043842|NCT00499616|541300703|FG003|Overall Study|Death|1|||
150043843|NCT00499616|541300700|FG000|Overall Study|Lack of Efficacy|5|||
150043844|NCT00499616|541300701|FG001|Overall Study|Lack of Efficacy|0|||
150043845|NCT00499616|541300702|FG002|Overall Study|Lack of Efficacy|19|||
150043846|NCT00499616|541300703|FG003|Overall Study|Lack of Efficacy|0|||
150043847|NCT00499616|541300700|FG000|Overall Study|Lost to Follow-up|0|||
150043848|NCT00499616|541300701|FG001|Overall Study|Lost to Follow-up|0|||
150043849|NCT00499616|541300702|FG002|Overall Study|Lost to Follow-up|1|||
150043850|NCT00499616|541300703|FG003|Overall Study|Lost to Follow-up|0|||
150043851|NCT00499616|541300700|FG000|Overall Study|Physician Decision|6|||
150043852|NCT00499616|541300701|FG001|Overall Study|Physician Decision|16|||
150043853|NCT00499616|541300702|FG002|Overall Study|Physician Decision|9|||
150043854|NCT00499616|541300703|FG003|Overall Study|Physician Decision|0|||
150043855|NCT00499616|541300700|FG000|Overall Study|Withdrawal by Subject|1|||
150043856|NCT00499616|541300701|FG001|Overall Study|Withdrawal by Subject|0|||
150043857|NCT00499616|541300702|FG002|Overall Study|Withdrawal by Subject|1|||
150043858|NCT00499616|541300703|FG003|Overall Study|Withdrawal by Subject|0|||
150043859|NCT00499616|541300700|FG000|Overall Study|Ineligible|1|||
150043860|NCT00499616|541300701|FG001|Overall Study|Ineligible|2|||
150043861|NCT00499616|541300702|FG002|Overall Study|Ineligible|0|||
150043862|NCT00499616|541300703|FG003|Overall Study|Ineligible|15|||
150043863|NCT00499616|541300700|FG000|Overall Study|Not evaluable|0|||
149881564|NCT03516513|540693136|FG000|Overall Study|Withdrawal by Subject|2|||
149881565|NCT03516513|540693137|FG001|Overall Study|Withdrawal by Subject|2|||
149881566|NCT03516513|540693138|FG002|Overall Study|Withdrawal by Subject|0|||
149881567|NCT03516513|540693139|FG003|Overall Study|Withdrawal by Subject|0|||
149881568|NCT01589497|540693140|FG000|Overall Study|Withdrawal by Subject|0|||
149881569|NCT01589497|540693141|FG001|Overall Study|Withdrawal by Subject|1|||
149965434|NCT05654181|541009512|FG008|Overall Study|Withdrawal by Subject|0|||
149965435|NCT05654181|541009513|FG009|Overall Study|Withdrawal by Subject|0|||
150043864|NCT00499616|541300701|FG001|Overall Study|Not evaluable|0|||
150043865|NCT00499616|541300702|FG002|Overall Study|Not evaluable|0|||
150043866|NCT00499616|541300703|FG003|Overall Study|Not evaluable|41|||
150043867|NCT00499616|541300700|FG000|Overall Study|Patient/Parent Refusal|1|||
150043868|NCT00499616|541300701|FG001|Overall Study|Patient/Parent Refusal|5|||
150043869|NCT00499616|541300702|FG002|Overall Study|Patient/Parent Refusal|3|||
149965436|NCT05654181|541009504|FG000|Overall Study|Other|0|||
149965437|NCT05654181|541009505|FG001|Overall Study|Other|0|||
149965438|NCT05654181|541009506|FG002|Overall Study|Other|0|||
149965439|NCT05654181|541009507|FG003|Overall Study|Other|0|||
149965440|NCT05654181|541009508|FG004|Overall Study|Other|1|||
149965441|NCT05654181|541009509|FG005|Overall Study|Other|1|||
149965442|NCT05654181|541009510|FG006|Overall Study|Other|0|||
149965443|NCT05654181|541009511|FG007|Overall Study|Other|0|||
149965444|NCT05654181|541009512|FG008|Overall Study|Other|0|||
149965445|NCT05654181|541009513|FG009|Overall Study|Other|0|||
149965446|NCT04101331|541009514|FG000|Overall Study|Adverse Event|9|||
149965447|NCT04101331|541009514|FG000|Overall Study|Disease progression|82|||
149881570|NCT01589497|540693142|FG002|Overall Study|Withdrawal by Subject|0|||
149881571|NCT01589497|540693143|FG003|Overall Study|Withdrawal by Subject|1|||
149881572|NCT01589497|540693140|FG000|Overall Study|Death|1|||
149881573|NCT01589497|540693141|FG001|Overall Study|Death|0|||
149881574|NCT01589497|540693142|FG002|Overall Study|Death|0|||
149881575|NCT01589497|540693143|FG003|Overall Study|Death|0|||
149881576|NCT01589497|540693140|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
149881577|NCT01589497|540693141|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
149881578|NCT01589497|540693142|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
149881579|NCT01589497|540693143|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
149881580|NCT03052127|540693146|FG000|Overall Study|Withdrawal by Subject|0|||
149881581|NCT03052127|540693147|FG001|Overall Study|Withdrawal by Subject|0|||
149881582|NCT03052127|540693148|FG002|Overall Study|Withdrawal by Subject|0|||
149881583|NCT03052127|540693149|FG003|Overall Study|Withdrawal by Subject|0|||
149881584|NCT03052127|540693150|FG004|Overall Study|Withdrawal by Subject|0|||
149881585|NCT03052127|540693151|FG005|Overall Study|Withdrawal by Subject|0|||
149881586|NCT03052127|540693152|FG006|Overall Study|Withdrawal by Subject|0|||
149881587|NCT03052127|540693153|FG007|Overall Study|Withdrawal by Subject|1|||
149881588|NCT03052127|540693154|FG008|Overall Study|Withdrawal by Subject|1|||
149881589|NCT03052127|540693155|FG009|Overall Study|Withdrawal by Subject|1|||
149881590|NCT03052127|540693156|FG010|Overall Study|Withdrawal by Subject|0|||
149881591|NCT03052127|540693157|FG011|Overall Study|Withdrawal by Subject|0|||
149881592|NCT03052127|540693146|FG000|Overall Study|Discontinuation by Sponsor|0|||
149881593|NCT03052127|540693147|FG001|Overall Study|Discontinuation by Sponsor|0|||
149881594|NCT03052127|540693148|FG002|Overall Study|Discontinuation by Sponsor|0|||
149881595|NCT03052127|540693149|FG003|Overall Study|Discontinuation by Sponsor|0|||
149881596|NCT03052127|540693150|FG004|Overall Study|Discontinuation by Sponsor|0|||
149881597|NCT03052127|540693151|FG005|Overall Study|Discontinuation by Sponsor|0|||
149881598|NCT03052127|540693152|FG006|Overall Study|Discontinuation by Sponsor|0|||
149881599|NCT03052127|540693153|FG007|Overall Study|Discontinuation by Sponsor|0|||
149881600|NCT03052127|540693154|FG008|Overall Study|Discontinuation by Sponsor|4|||
149881601|NCT03052127|540693155|FG009|Overall Study|Discontinuation by Sponsor|2|||
149881602|NCT03052127|540693156|FG010|Overall Study|Discontinuation by Sponsor|5|||
149881603|NCT03052127|540693157|FG011|Overall Study|Discontinuation by Sponsor|13|||
149881604|NCT03052127|540693146|FG000|Overall Study|Inability to comply with trial requirements|0|||
149881605|NCT03052127|540693147|FG001|Overall Study|Inability to comply with trial requirements|0|||
149881606|NCT03052127|540693148|FG002|Overall Study|Inability to comply with trial requirements|1|||
149881607|NCT03052127|540693149|FG003|Overall Study|Inability to comply with trial requirements|0|||
149881608|NCT03052127|540693150|FG004|Overall Study|Inability to comply with trial requirements|0|||
149881609|NCT03052127|540693151|FG005|Overall Study|Inability to comply with trial requirements|0|||
149881610|NCT03052127|540693152|FG006|Overall Study|Inability to comply with trial requirements|0|||
149881611|NCT03052127|540693153|FG007|Overall Study|Inability to comply with trial requirements|0|||
149881612|NCT03052127|540693154|FG008|Overall Study|Inability to comply with trial requirements|0|||
149965448|NCT04101331|541009514|FG000|Overall Study|Withdrawal by Subject|1|||
149965449|NCT04101331|541009514|FG000|Overall Study|Investigator decision|6|||
149965450|NCT04101331|541009514|FG000|Overall Study|Death|6|||
149965451|NCT04101331|541009514|FG000|Overall Study|Allogenic transplant|1|||
149965452|NCT00500331|541009516|FG000|Overall Study|Adverse Event|0|||
149965453|NCT00500331|541009517|FG001|Overall Study|Adverse Event|2|||
149965454|NCT00500331|541009518|FG002|Overall Study|Adverse Event|0|||
149965455|NCT00500331|541009519|FG003|Overall Study|Adverse Event|1|||
149965456|NCT00500331|541009520|FG004|Overall Study|Adverse Event|2|||
149965457|NCT00500331|541009521|FG005|Overall Study|Adverse Event|2|||
149965458|NCT00500331|541009522|FG006|Overall Study|Adverse Event|0|||
149965459|NCT00500331|541009516|FG000|Overall Study|Lost to Follow-up|1|||
149881613|NCT03052127|540693155|FG009|Overall Study|Inability to comply with trial requirements|0|||
149881614|NCT03052127|540693156|FG010|Overall Study|Inability to comply with trial requirements|0|||
149881615|NCT03052127|540693157|FG011|Overall Study|Inability to comply with trial requirements|0|||
149881616|NCT03052127|540693146|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
149881617|NCT03052127|540693147|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149965460|NCT00500331|541009517|FG001|Overall Study|Lost to Follow-up|1|||
149965461|NCT00500331|541009518|FG002|Overall Study|Lost to Follow-up|1|||
149965462|NCT00500331|541009519|FG003|Overall Study|Lost to Follow-up|2|||
149965463|NCT00500331|541009520|FG004|Overall Study|Lost to Follow-up|1|||
149965464|NCT00500331|541009521|FG005|Overall Study|Lost to Follow-up|0|||
149881618|NCT03052127|540693148|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881619|NCT03052127|540693149|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881620|NCT03052127|540693150|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
149881621|NCT03052127|540693151|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
149881622|NCT03052127|540693152|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
149881623|NCT03052127|540693153|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881624|NCT03052127|540693154|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881625|NCT03052127|540693155|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881626|NCT03052127|540693156|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881627|NCT03052127|540693157|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
149881628|NCT03694327|540693158|FG000|Overall Study|Lost to Follow-up|13|||
149881629|NCT03694327|540693159|FG001|Overall Study|Lost to Follow-up|23|||
149881630|NCT01862484|540693162|FG000|Overall Study|Lack of Efficacy|1|||
149881631|NCT01862484|540693163|FG001|Overall Study|Lack of Efficacy|1|||
149881632|NCT01862484|540693162|FG000|Overall Study|Lost to Follow-up|1|||
149881633|NCT01862484|540693163|FG001|Overall Study|Lost to Follow-up|2|||
149881634|NCT01862484|540693162|FG000|Overall Study|Protocol Violation|0|||
149881635|NCT01862484|540693163|FG001|Overall Study|Protocol Violation|2|||
149881636|NCT01862484|540693162|FG000|Overall Study|Withdrawal by Subject|0|||
149881637|NCT01862484|540693163|FG001|Overall Study|Withdrawal by Subject|3|||
149881638|NCT00721227|540693164|FG000|Overall Study|Lost to Follow-up|3|||
149881639|NCT00721227|540693165|FG001|Overall Study|Lost to Follow-up|0|||
149881640|NCT00721227|540693164|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
149881641|NCT00721227|540693165|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
149881642|NCT05026177|540694853|FG000|Overall Study|Adverse Event|33|||
149881643|NCT05026177|540694854|FG001|Overall Study|Adverse Event|33|||
149881644|NCT05026177|540694855|FG002|Overall Study|Adverse Event|17|||
149881645|NCT05026177|540694853|FG000|Overall Study|Lost to Follow-up|7|||
149881646|NCT05026177|540694854|FG001|Overall Study|Lost to Follow-up|6|||
149881647|NCT05026177|540694855|FG002|Overall Study|Lost to Follow-up|8|||
149881648|NCT05026177|540694853|FG000|Overall Study|Noncompliance with study drug|6|||
149881649|NCT05026177|540694854|FG001|Overall Study|Noncompliance with study drug|2|||
149881650|NCT05026177|540694855|FG002|Overall Study|Noncompliance with study drug|1|||
149881651|NCT05026177|540694853|FG000|Overall Study|Physician Decision|4|||
149881652|NCT05026177|540694854|FG001|Overall Study|Physician Decision|1|||
149881653|NCT05026177|540694855|FG002|Overall Study|Physician Decision|0|||
149881654|NCT05026177|540694853|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
149881655|NCT05026177|540694854|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
149881656|NCT05026177|540694855|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
149881657|NCT05026177|540694853|FG000|Overall Study|Withdrawal by Subject|53|||
149881658|NCT05026177|540694854|FG001|Overall Study|Withdrawal by Subject|51|||
149881659|NCT05026177|540694855|FG002|Overall Study|Withdrawal by Subject|55|||
149965465|NCT00500331|541009522|FG006|Overall Study|Lost to Follow-up|0|||
149965466|NCT00500331|541009516|FG000|Overall Study|Protocol Violation|3|||
149965467|NCT00500331|541009517|FG001|Overall Study|Protocol Violation|1|||
149965468|NCT00500331|541009518|FG002|Overall Study|Protocol Violation|1|||
149965469|NCT00500331|541009519|FG003|Overall Study|Protocol Violation|0|||
149965470|NCT00500331|541009520|FG004|Overall Study|Protocol Violation|1|||
149965471|NCT00500331|541009521|FG005|Overall Study|Protocol Violation|1|||
149965472|NCT00500331|541009522|FG006|Overall Study|Protocol Violation|1|||
149965473|NCT00500331|541009516|FG000|Overall Study|Withdrawal by Subject|4|||
149965474|NCT00500331|541009517|FG001|Overall Study|Withdrawal by Subject|0|||
149965475|NCT00500331|541009518|FG002|Overall Study|Withdrawal by Subject|1|||
149965476|NCT00500331|541009519|FG003|Overall Study|Withdrawal by Subject|5|||
149965477|NCT00500331|541009520|FG004|Overall Study|Withdrawal by Subject|0|||
149965478|NCT00500331|541009521|FG005|Overall Study|Withdrawal by Subject|1|||
149965479|NCT00500331|541009522|FG006|Overall Study|Withdrawal by Subject|1|||
149965480|NCT00500331|541009516|FG000|Overall Study|Lack of Efficacy|3|||
149965481|NCT00500331|541009517|FG001|Overall Study|Lack of Efficacy|1|||
149965482|NCT00500331|541009518|FG002|Overall Study|Lack of Efficacy|0|||
149965483|NCT00500331|541009519|FG003|Overall Study|Lack of Efficacy|0|||
149965484|NCT00500331|541009520|FG004|Overall Study|Lack of Efficacy|0|||
149965485|NCT00500331|541009521|FG005|Overall Study|Lack of Efficacy|0|||
149965486|NCT00500331|541009522|FG006|Overall Study|Lack of Efficacy|0|||
149965487|NCT00500331|541009516|FG000|Overall Study|Liver function test abnormality|0|||
149965488|NCT00500331|541009517|FG001|Overall Study|Liver function test abnormality|0|||
149965489|NCT00500331|541009518|FG002|Overall Study|Liver function test abnormality|1|||
149965490|NCT00500331|541009519|FG003|Overall Study|Liver function test abnormality|0|||
149881660|NCT05026177|540694853|FG000|Overall Study|Protocol Violation|0|||
149881661|NCT05026177|540694854|FG001|Overall Study|Protocol Violation|1|||
149881662|NCT05026177|540694855|FG002|Overall Study|Protocol Violation|0|||
149881663|NCT05026177|540694853|FG000|Overall Study|Study terminated by sponsor|70|||
149881664|NCT05026177|540694854|FG001|Overall Study|Study terminated by sponsor|74|||
149965491|NCT00500331|541009520|FG004|Overall Study|Liver function test abnormality|0|||
149881665|NCT05026177|540694855|FG002|Overall Study|Study terminated by sponsor|67|||
149881666|NCT05026177|540694853|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
149881667|NCT05026177|540694854|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
149881668|NCT05026177|540694855|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
149881669|NCT05026177|540694853|FG000|Overall Study|Starting alternative treatment|0|||
149881670|NCT05026177|540694854|FG001|Overall Study|Starting alternative treatment|1|||
149881671|NCT05026177|540694855|FG002|Overall Study|Starting alternative treatment|1|||
149881672|NCT05026177|540694853|FG000|Overall Study|Noncompliance with study procedures|0|||
149881673|NCT05026177|540694854|FG001|Overall Study|Noncompliance with study procedures|1|||
149881674|NCT05026177|540694855|FG002|Overall Study|Noncompliance with study procedures|1|||
149881675|NCT05026177|540694853|FG000|Overall Study|Met stopping criteria|0|||
149881676|NCT05026177|540694854|FG001|Overall Study|Met stopping criteria|0|||
149881677|NCT05026177|540694855|FG002|Overall Study|Met stopping criteria|1|||
149881678|NCT05026177|540694853|FG000|Overall Study|Health issues preventing continuation|0|||
149881679|NCT05026177|540694854|FG001|Overall Study|Health issues preventing continuation|0|||
149881680|NCT05026177|540694855|FG002|Overall Study|Health issues preventing continuation|1|||
149881681|NCT05026177|540694853|FG000|Overall Study|Randomized in error, not treated|0|||
149881682|NCT05026177|540694854|FG001|Overall Study|Randomized in error, not treated|0|||
149881683|NCT05026177|540694855|FG002|Overall Study|Randomized in error, not treated|2|||
149881684|NCT03355469|540694860|FG000|Overall Study|COVID-19|3|||
149881685|NCT03355469|540694861|FG001|Overall Study|COVID-19|2|||
149881686|NCT03355469|540694862|FG002|Overall Study|COVID-19|3|||
149881687|NCT03355469|540694863|FG003|Overall Study|COVID-19|3|||
149881688|NCT03355469|540694860|FG000|Overall Study|Lost to Follow-up|1|||
149881689|NCT03355469|540694861|FG001|Overall Study|Lost to Follow-up|0|||
149881690|NCT03355469|540694862|FG002|Overall Study|Lost to Follow-up|1|||
149881691|NCT03355469|540694863|FG003|Overall Study|Lost to Follow-up|0|||
149881692|NCT03355469|540694860|FG000|Overall Study|Withdrawal by Subject|2|||
149881693|NCT03355469|540694861|FG001|Overall Study|Withdrawal by Subject|1|||
149881694|NCT03355469|540694862|FG002|Overall Study|Withdrawal by Subject|0|||
149881695|NCT03355469|540694863|FG003|Overall Study|Withdrawal by Subject|3|||
149881696|NCT02731638|540694864|FG000|Overall Study|Lost to Follow-up|6|||
149881697|NCT02731638|540694865|FG001|Overall Study|Lost to Follow-up|9|||
149881698|NCT04158245|540694866|FG000|Overall Study|Lost to Follow-up|1|||
149881699|NCT02454608|540694867|FG000|Double-Blind Period|Lack of Efficacy|0|||
149881700|NCT02454608|540694868|FG001|Double-Blind Period|Lack of Efficacy|2|||
149881701|NCT02454608|540694869|FG002|Double-Blind Period|Lack of Efficacy|0|||
149881702|NCT02454608|540694867|FG000|Open Label Period|Lost to Follow-up|0|||
149881703|NCT02454608|540694868|FG001|Open Label Period|Lost to Follow-up|0|||
149881704|NCT02454608|540694869|FG002|Open Label Period|Lost to Follow-up|11|||
149881705|NCT02454608|540694867|FG000|Open Label Period|Withdrawal by Subject|0|||
149881706|NCT02454608|540694868|FG001|Open Label Period|Withdrawal by Subject|0|||
149881707|NCT02454608|540694869|FG002|Open Label Period|Withdrawal by Subject|8|||
149881708|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
149881709|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
149881710|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
149881711|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
149881712|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
149881713|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
149881714|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
149881715|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
149881716|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
149881717|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
149881718|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
149881719|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
149881720|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
149881721|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
149881722|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
149881723|NCT04856930|540694876|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
149881724|NCT04856930|540694877|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
149881725|NCT04856930|540694878|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
149881726|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
149881727|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
149881728|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
149881729|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
149965492|NCT00500331|541009521|FG005|Overall Study|Liver function test abnormality|0|||
149965493|NCT00500331|541009522|FG006|Overall Study|Liver function test abnormality|0|||
149881730|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
149965494|NCT00500331|541009516|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
149965495|NCT00500331|541009517|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
149881731|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
149881732|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
149881733|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
149881734|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
149881735|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
149881736|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
149881737|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
149881738|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
149881739|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
149881740|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
149881741|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
149881742|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
149881743|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
149881744|NCT04856930|540694876|FG000|Extension Period (16 Weeks)|Other than specified|0|||
149881745|NCT04856930|540694877|FG001|Extension Period (16 Weeks)|Other than specified|0|||
149881746|NCT04856930|540694878|FG002|Extension Period (16 Weeks)|Other than specified|1|||
149881747|NCT04856930|540694876|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
149881748|NCT04856930|540694877|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
149881749|NCT04856930|540694878|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
149881750|NCT04856930|540694876|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
149881751|NCT04856930|540694877|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
149881752|NCT04856930|540694878|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
149881753|NCT04856930|540694876|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
149881754|NCT04856930|540694877|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
149881755|NCT04856930|540694878|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
149881756|NCT04856930|540694876|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
149881757|NCT04856930|540694877|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
149881758|NCT04856930|540694878|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
149881759|NCT01433055|540694880|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
149881760|NCT01433055|540694881|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
149881761|NCT01433055|540694880|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
149881762|NCT01433055|540694881|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
149881763|NCT00678210|540694887|FG000|Overall Study|Adverse Event|1|||
149881764|NCT00678210|540694888|FG001|Overall Study|Adverse Event|2|||
149881765|NCT00678210|540694889|FG002|Overall Study|Adverse Event|3|||
149881766|NCT00678210|540694890|FG003|Overall Study|Adverse Event|3|||
149881767|NCT00678210|540694887|FG000|Overall Study|Lack of Efficacy|2|||
149881768|NCT00678210|540694888|FG001|Overall Study|Lack of Efficacy|3|||
149881769|NCT00678210|540694889|FG002|Overall Study|Lack of Efficacy|1|||
149881770|NCT00678210|540694890|FG003|Overall Study|Lack of Efficacy|9|||
149881771|NCT00678210|540694887|FG000|Overall Study|Lost to Follow-up|4|||
149881772|NCT00678210|540694888|FG001|Overall Study|Lost to Follow-up|2|||
149881773|NCT00678210|540694889|FG002|Overall Study|Lost to Follow-up|0|||
149881774|NCT00678210|540694890|FG003|Overall Study|Lost to Follow-up|1|||
149881775|NCT00678210|540694887|FG000|Overall Study|Withdrawal by Subject|3|||
149881776|NCT00678210|540694888|FG001|Overall Study|Withdrawal by Subject|4|||
149881777|NCT00678210|540694889|FG002|Overall Study|Withdrawal by Subject|1|||
149881778|NCT00678210|540694890|FG003|Overall Study|Withdrawal by Subject|7|||
149881779|NCT00678210|540694887|FG000|Overall Study|Other|1|||
149881780|NCT00678210|540694888|FG001|Overall Study|Other|0|||
149881781|NCT00678210|540694889|FG002|Overall Study|Other|1|||
149881782|NCT00678210|540694890|FG003|Overall Study|Other|0|||
149881783|NCT04825912|540694891|FG000|Overall Study|Death|3|||
149881784|NCT04825912|540694891|FG000|Overall Study|Withdrawal by Subject|1|||
149881785|NCT01009814|540694894|FG000|Overall Study|No longer met study criteria|1|||
149881786|NCT01009814|540694895|FG001|Overall Study|No longer met study criteria|1|||
149881787|NCT01009814|540694896|FG002|Overall Study|No longer met study criteria|0|||
149881788|NCT01009814|540694897|FG003|Overall Study|No longer met study criteria|0|||
149881789|NCT01009814|540694898|FG004|Overall Study|No longer met study criteria|0|||
149881790|NCT00618371|540694899|FG000|Overall Study|Withdrawal by Subject|2|||
149881791|NCT03965689|540694900|FG000|Overall Study|Too sick to get study intervention|2|||
149881792|NCT02090725|540694901|FG000|Overall Study|Withdrawal by Subject|1|||
149881793|NCT02090725|540694901|FG000|Overall Study|participants moved from area|3|||
149881794|NCT01214655|540694902|FG000|Part A|Progressive Disease|7|||
149881795|NCT01214655|540694903|FG001|Part A|Progressive Disease|0|||
149881796|NCT01214655|540694904|FG002|Part A|Progressive Disease|0|||
149881797|NCT01214655|540694902|FG000|Part A|Physician Decision|1|||
149881798|NCT01214655|540694903|FG001|Part A|Physician Decision|0|||
149881799|NCT01214655|540694904|FG002|Part A|Physician Decision|0|||
149881800|NCT01214655|540694902|FG000|Part B|Progressive disease|0|||
149881801|NCT01214655|540694903|FG001|Part B|Progressive disease|10|||
149881802|NCT01214655|540694904|FG002|Part B|Progressive disease|0|||
149881803|NCT01214655|540694902|FG000|Part B|Death|0|||
149881804|NCT01214655|540694903|FG001|Part B|Death|1|||
149881805|NCT01214655|540694904|FG002|Part B|Death|0|||
149881806|NCT01214655|540694902|FG000|Part B|Withdrawal by Subject|0|||
149881807|NCT01214655|540694903|FG001|Part B|Withdrawal by Subject|2|||
149881808|NCT01214655|540694904|FG002|Part B|Withdrawal by Subject|0|||
149881809|NCT01214655|540694902|FG000|Part C|Progressive Disease|0|||
149881810|NCT01214655|540694903|FG001|Part C|Progressive Disease|0|||
149881811|NCT01214655|540694904|FG002|Part C|Progressive Disease|5|||
149881812|NCT01214655|540694902|FG000|Part C|Death|0|||
149881813|NCT01214655|540694903|FG001|Part C|Death|0|||
149881814|NCT01214655|540694904|FG002|Part C|Death|1|||
149881815|NCT01214655|540694902|FG000|Part C|Physician Decision|0|||
149881816|NCT01214655|540694903|FG001|Part C|Physician Decision|0|||
149881817|NCT01214655|540694904|FG002|Part C|Physician Decision|1|||
149881818|NCT05256134|540694908|FG000|Overall Study|Study Terminated by Sponsor|11|||
149881819|NCT05256134|540694909|FG001|Overall Study|Study Terminated by Sponsor|10|||
149881820|NCT05256134|540694908|FG000|Overall Study|Withdrawal by Subject|1|||
149881821|NCT05256134|540694909|FG001|Overall Study|Withdrawal by Subject|3|||
149881822|NCT04974749|540694910|FG000|Overall Study|Withdrawal by Subject|2|||
149881823|NCT04974749|540694910|FG000|Overall Study|Gestation|1|||
149881824|NCT01121562|540694911|FG000|Overall Study|Objective progression or relapse|8|||
149881825|NCT01121562|540694911|FG000|Overall Study|Withdrawal by Subject|1|||
149881826|NCT01121562|540694911|FG000|Overall Study|Adverse Event|1|||
149881827|NCT01121562|540694911|FG000|Overall Study|Sponsor Decision|1|||
149881828|NCT01121562|540694911|FG000|Overall Study|Met study discontinuation criteria|1|||
149881829|NCT02540083|540694917|FG000|Overall Study|Withdrawal by Subject|16|||
149881830|NCT02301390|540694920|FG000|Overall Study|Withdrawal by Subject|3|||
149881831|NCT02301390|540694921|FG001|Overall Study|Withdrawal by Subject|5|||
149881832|NCT02301390|540694920|FG000|Overall Study|Protocol Violation|1|||
149881833|NCT02301390|540694921|FG001|Overall Study|Protocol Violation|0|||
149881834|NCT02301390|540694920|FG000|Overall Study|Physician Decision|1|||
149881835|NCT02301390|540694921|FG001|Overall Study|Physician Decision|0|||
149881836|NCT02301390|540694920|FG000|Overall Study|Lost to Follow-up|0|||
149881837|NCT02301390|540694921|FG001|Overall Study|Lost to Follow-up|1|||
149881838|NCT02301390|540694920|FG000|Overall Study|Death|2|||
149881839|NCT02301390|540694921|FG001|Overall Study|Death|2|||
149881840|NCT02301390|540694920|FG000|Overall Study|Procedure not completed|0|||
149881841|NCT02301390|540694921|FG001|Overall Study|Procedure not completed|4|||
149881842|NCT02301390|540694920|FG000|Overall Study|Missed multiple visits|1|||
149881843|NCT02301390|540694921|FG001|Overall Study|Missed multiple visits|1|||
149881844|NCT02301390|540694920|FG000|Overall Study|study terminated|2|||
149881845|NCT02301390|540694921|FG001|Overall Study|study terminated|0|||
149881846|NCT00185588|540694922|FG000|Overall Study|Adverse Event|3|||
149881847|NCT00185588|540694923|FG001|Overall Study|Adverse Event|1|||
149881848|NCT00185588|540694924|FG002|Overall Study|Adverse Event|4|||
149881849|NCT00185588|540694925|FG003|Overall Study|Adverse Event|2|||
149881850|NCT00185588|540694922|FG000|Overall Study|Lost to Follow-up|0|||
149881851|NCT00185588|540694923|FG001|Overall Study|Lost to Follow-up|0|||
149881852|NCT00185588|540694924|FG002|Overall Study|Lost to Follow-up|1|||
149881853|NCT00185588|540694925|FG003|Overall Study|Lost to Follow-up|2|||
149881854|NCT00185588|540694922|FG000|Overall Study|Withdrawal by Subject|0|||
149881855|NCT00185588|540694923|FG001|Overall Study|Withdrawal by Subject|1|||
149881856|NCT00185588|540694924|FG002|Overall Study|Withdrawal by Subject|0|||
149881857|NCT00185588|540694925|FG003|Overall Study|Withdrawal by Subject|0|||
149881858|NCT00185588|540694922|FG000|Overall Study|Physician Decision|0|||
149881859|NCT00185588|540694923|FG001|Overall Study|Physician Decision|0|||
149881860|NCT00185588|540694924|FG002|Overall Study|Physician Decision|1|||
149881861|NCT00185588|540694925|FG003|Overall Study|Physician Decision|0|||
149881862|NCT02604407|540694926|FG000|Overall Study|Adverse Event|0|||
149881863|NCT02604407|540694927|FG001|Overall Study|Adverse Event|7|||
149881864|NCT02604407|540694928|FG002|Overall Study|Adverse Event|5|||
149881865|NCT02604407|540694926|FG000|Overall Study|Protocol Violation|2|||
149881866|NCT02604407|540694927|FG001|Overall Study|Protocol Violation|0|||
149881867|NCT02604407|540694928|FG002|Overall Study|Protocol Violation|0|||
149881868|NCT02604407|540694926|FG000|Overall Study|Withdrawal by Subject|3|||
149881869|NCT02604407|540694927|FG001|Overall Study|Withdrawal by Subject|3|||
149881870|NCT02604407|540694928|FG002|Overall Study|Withdrawal by Subject|5|||
149881871|NCT02604407|540694926|FG000|Overall Study|Lost to Follow-up|2|||
149881872|NCT02604407|540694927|FG001|Overall Study|Lost to Follow-up|1|||
149881873|NCT02604407|540694928|FG002|Overall Study|Lost to Follow-up|2|||
149881874|NCT02604407|540694926|FG000|Overall Study|Lack of Efficacy|1|||
149881875|NCT02604407|540694927|FG001|Overall Study|Lack of Efficacy|0|||
149881876|NCT02604407|540694928|FG002|Overall Study|Lack of Efficacy|0|||
149881877|NCT02604407|540694926|FG000|Overall Study|Other|3|||
149881878|NCT02604407|540694927|FG001|Overall Study|Other|1|||
149881879|NCT02604407|540694928|FG002|Overall Study|Other|4|||
149881880|NCT00398866|540694929|FG000|Overall Study|Adverse Event|1|||
149881881|NCT00398866|540694930|FG001|Overall Study|Adverse Event|0|||
149881882|NCT00398866|540694931|FG002|Overall Study|Adverse Event|0|||
149881883|NCT00398866|540694929|FG000|Overall Study|Lack of Efficacy|0|||
149881884|NCT00398866|540694930|FG001|Overall Study|Lack of Efficacy|0|||
149881885|NCT00398866|540694931|FG002|Overall Study|Lack of Efficacy|1|||
149881886|NCT00398866|540694929|FG000|Overall Study|Lost to Follow-up|7|||
149881887|NCT00398866|540694930|FG001|Overall Study|Lost to Follow-up|6|||
149881888|NCT00398866|540694931|FG002|Overall Study|Lost to Follow-up|4|||
149881889|NCT00398866|540694929|FG000|Overall Study|Withdrawal by Subject|5|||
149881890|NCT00398866|540694930|FG001|Overall Study|Withdrawal by Subject|1|||
149881891|NCT00398866|540694931|FG002|Overall Study|Withdrawal by Subject|2|||
149881892|NCT00398866|540694929|FG000|Overall Study|Unable to complete requirements of study|1|||
149881893|NCT00398866|540694930|FG001|Overall Study|Unable to complete requirements of study|1|||
149881894|NCT00398866|540694931|FG002|Overall Study|Unable to complete requirements of study|1|||
149881895|NCT02481869|540694934|FG000|Overall Study|Lost to Follow-up|3|||
149881896|NCT02481869|540694935|FG001|Overall Study|Lost to Follow-up|4|||
149881897|NCT02481869|540694934|FG000|Overall Study|Withdrawal by Subject|2|||
149881898|NCT02481869|540694935|FG001|Overall Study|Withdrawal by Subject|0|||
149881899|NCT05445492|540694938|FG000|Overall Study|Physician Decision|1|||
149881900|NCT00191191|540694939|FG000|Overall Study|Entry Criteria Exclusion|2|||
149881901|NCT00191191|540694940|FG001|Overall Study|Entry Criteria Exclusion|0|||
149881902|NCT00191191|540694939|FG000|Overall Study|Treated with Another Systemic Agent|1|||
149881903|NCT00191191|540694940|FG001|Overall Study|Treated with Another Systemic Agent|1|||
149881904|NCT00191191|540694939|FG000|Overall Study|Adverse Event|11|||
149881905|NCT00191191|540694940|FG001|Overall Study|Adverse Event|21|||
149881906|NCT00191191|540694939|FG000|Overall Study|Progressive Disease|84|||
149881907|NCT00191191|540694940|FG001|Overall Study|Progressive Disease|72|||
149881908|NCT00191191|540694939|FG000|Overall Study|Toxicity After Dose Reduction|7|||
149881909|NCT00191191|540694940|FG001|Overall Study|Toxicity After Dose Reduction|8|||
149881910|NCT00191191|540694939|FG000|Overall Study|Family/Caregiver Decision|5|||
149881911|NCT00191191|540694940|FG001|Overall Study|Family/Caregiver Decision|7|||
149881912|NCT00191191|540694939|FG000|Overall Study|Lost to Follow-up|1|||
149881913|NCT00191191|540694940|FG001|Overall Study|Lost to Follow-up|0|||
149881914|NCT00191191|540694939|FG000|Overall Study|Physician Decision|3|||
149881915|NCT00191191|540694940|FG001|Overall Study|Physician Decision|2|||
149881916|NCT00191191|540694939|FG000|Overall Study|Good Clinical Practice Violation|0|||
149881917|NCT00191191|540694940|FG001|Overall Study|Good Clinical Practice Violation|1|||
149881918|NCT04289363|540694942|FG000|Overall Study|Lost to Follow-up|14|||
149881919|NCT04289363|540694943|FG001|Overall Study|Lost to Follow-up|0|||
149881920|NCT03790657|540694947|FG000|Overall Study|Adverse Event|1|||
149881921|NCT03790657|540694948|FG001|Overall Study|Adverse Event|1|||
149881922|NCT03790657|540694947|FG000|Overall Study|Withdrawal by Subject|1|||
149881923|NCT03790657|540694948|FG001|Overall Study|Withdrawal by Subject|1|||
149881924|NCT03126435|540694949|FG000|Overall Study|Death|90|||
149881925|NCT03126435|540694950|FG001|Overall Study|Death|84|||
149881926|NCT03126435|540694949|FG000|Overall Study|Lost to Follow-up|4|||
149881927|NCT03126435|540694950|FG001|Overall Study|Lost to Follow-up|3|||
149881928|NCT03126435|540694949|FG000|Overall Study|Physician Decision|0|||
149881929|NCT03126435|540694950|FG001|Overall Study|Physician Decision|1|||
149881930|NCT03126435|540694949|FG000|Overall Study|Withdrawal by Subject|6|||
149881931|NCT03126435|540694950|FG001|Overall Study|Withdrawal by Subject|12|||
149881932|NCT03126435|540694949|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
149881933|NCT03126435|540694950|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
149881934|NCT03971474|540694951|FG000|Overall Study|Adverse Event|11|||
149881935|NCT03971474|540694952|FG001|Overall Study|Adverse Event|7|||
149881936|NCT03971474|540694951|FG000|Overall Study|Refusal unrelated to adverse event|5|||
149881937|NCT03971474|540694952|FG001|Overall Study|Refusal unrelated to adverse event|1|||
149881938|NCT03971474|540694951|FG000|Overall Study|Progression/relapse|40|||
149881939|NCT03971474|540694952|FG001|Overall Study|Progression/relapse|47|||
149881940|NCT03971474|540694951|FG000|Overall Study|Death|6|||
149881941|NCT03971474|540694952|FG001|Overall Study|Death|3|||
149881942|NCT03971474|540694951|FG000|Overall Study|Other - not protocol specified|5|||
149881943|NCT03971474|540694952|FG001|Overall Study|Other - not protocol specified|4|||
149881944|NCT03971474|540694951|FG000|Overall Study|On treatment|0|||
149881945|NCT03971474|540694952|FG001|Overall Study|On treatment|7|||
149881946|NCT02370238|540694959|FG000|Overall Study|Death|42|||
149881947|NCT02370238|540694960|FG001|Overall Study|Death|35|||
149881948|NCT02370238|540694959|FG000|Overall Study|Lost to Follow-up|1|||
149881949|NCT02370238|540694960|FG001|Overall Study|Lost to Follow-up|3|||
149881950|NCT02370238|540694959|FG000|Overall Study|Withdrawal by Subject|2|||
149881951|NCT02370238|540694960|FG001|Overall Study|Withdrawal by Subject|6|||
149881952|NCT02370238|540694959|FG000|Overall Study|Other|2|||
149881953|NCT02370238|540694960|FG001|Overall Study|Other|1|||
149881954|NCT01807065|540694961|FG000|Overall Study|Receive no sip-T due to IV access|1|||
149881955|NCT01807065|540694962|FG001|Overall Study|Receive no sip-T due to IV access|1|||
149881956|NCT01153425|540694963|FG000|Overall Study|Withdrawal by Subject|3|||
149881957|NCT01153425|540694964|FG001|Overall Study|Withdrawal by Subject|3|||
149881958|NCT01482312|540694965|FG000|Period 1, 90 Minutes of Wear|Other|1|||
149881959|NCT01482312|540694966|FG001|Period 1, 90 Minutes of Wear|Other|0|||
149881960|NCT01482312|540694967|FG002|Period 1, 90 Minutes of Wear|Other|0|||
149881961|NCT01482312|540694965|FG000|Period 2, 90 Minutes of Wear|Other|1|||
149881962|NCT01482312|540694966|FG001|Period 2, 90 Minutes of Wear|Other|0|||
149881963|NCT01482312|540694967|FG002|Period 2, 90 Minutes of Wear|Other|0|||
149881964|NCT01699815|540694968|FG000|Overall Study|Protocol Violation|4|||
149881965|NCT01699815|540694969|FG001|Overall Study|Protocol Violation|7|||
149881966|NCT01699815|540694968|FG000|Overall Study|record could not be located|1|||
149881967|NCT01699815|540694969|FG001|Overall Study|record could not be located|0|||
149881968|NCT01699815|540694968|FG000|Overall Study|Adverse Event|0|||
149881969|NCT01699815|540694969|FG001|Overall Study|Adverse Event|1|||
149881970|NCT01295320|540694970|FG000|Overall Study|Adverse Event|2|||
149881971|NCT01295320|540694970|FG000|Overall Study|Lost to Follow-up|4|||
149881972|NCT01295320|540694970|FG000|Overall Study|Withdrawal by Subject|2|||
149881973|NCT01295320|540694970|FG000|Overall Study|Subject was bedridden|1|||
149881974|NCT01295320|540694970|FG000|Overall Study|Unable to travel|1|||
149881975|NCT04759768|540694971|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
149881976|NCT04759768|540694972|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
149881977|NCT04759768|540694971|FG000|Washout (7 Days)|Physician Decision|0|||
149881978|NCT04759768|540694972|FG001|Washout (7 Days)|Physician Decision|1|||
149881979|NCT04324021|540694976|FG000|Overall Study|Adverse Event|1|||
149881980|NCT04324021|540694977|FG001|Overall Study|Adverse Event|0|||
149881981|NCT04324021|540694978|FG002|Overall Study|Adverse Event|0|||
149881982|NCT04324021|540694976|FG000|Overall Study|Lack of Efficacy|0|||
149881983|NCT04324021|540694977|FG001|Overall Study|Lack of Efficacy|0|||
149881984|NCT04324021|540694978|FG002|Overall Study|Lack of Efficacy|1|||
149881985|NCT04324021|540694976|FG000|Overall Study|Death|1|||
149881986|NCT04324021|540694977|FG001|Overall Study|Death|1|||
149881987|NCT04324021|540694978|FG002|Overall Study|Death|0|||
149881988|NCT02006732|540694979|FG000|Overall Study|Adverse Event|10|||
149881989|NCT02006732|540694980|FG001|Overall Study|Adverse Event|7|||
149881990|NCT02006732|540694981|FG002|Overall Study|Adverse Event|4|||
149881991|NCT02006732|540694982|FG003|Overall Study|Adverse Event|2|||
149881992|NCT02006732|540694979|FG000|Overall Study|Lack of Efficacy|6|||
149881993|NCT02006732|540694980|FG001|Overall Study|Lack of Efficacy|3|||
149881994|NCT02006732|540694981|FG002|Overall Study|Lack of Efficacy|1|||
149881995|NCT02006732|540694982|FG003|Overall Study|Lack of Efficacy|1|||
149881996|NCT02006732|540694979|FG000|Overall Study|Protocol Violation|1|||
149881997|NCT02006732|540694980|FG001|Overall Study|Protocol Violation|1|||
149881998|NCT02006732|540694981|FG002|Overall Study|Protocol Violation|0|||
149881999|NCT02006732|540694982|FG003|Overall Study|Protocol Violation|0|||
149882000|NCT02006732|540694979|FG000|Overall Study|Lost to Follow-up|0|||
149882001|NCT02006732|540694980|FG001|Overall Study|Lost to Follow-up|1|||
149882002|NCT02006732|540694981|FG002|Overall Study|Lost to Follow-up|0|||
149882003|NCT02006732|540694982|FG003|Overall Study|Lost to Follow-up|0|||
149882004|NCT02006732|540694979|FG000|Overall Study|Withdrawal by Subject|3|||
149882005|NCT02006732|540694980|FG001|Overall Study|Withdrawal by Subject|0|||
149882006|NCT02006732|540694981|FG002|Overall Study|Withdrawal by Subject|4|||
149882007|NCT02006732|540694982|FG003|Overall Study|Withdrawal by Subject|1|||
149882008|NCT02211417|540694983|FG000|Overall Study|Withdrawal by Subject|11|||
149882009|NCT02211417|540694984|FG001|Overall Study|Withdrawal by Subject|8|||
149882010|NCT02211417|540694983|FG000|Overall Study|Protocol Violation|1|||
149882011|NCT02211417|540694984|FG001|Overall Study|Protocol Violation|0|||
149882012|NCT02211417|540694983|FG000|Overall Study|Pregnancy|0|||
149882013|NCT02211417|540694984|FG001|Overall Study|Pregnancy|1|||
149882014|NCT02211417|540694983|FG000|Overall Study|Lost to Follow-up|2|||
149882015|NCT02211417|540694984|FG001|Overall Study|Lost to Follow-up|3|||
149882016|NCT02211417|540694983|FG000|Overall Study|Adverse Event|1|||
149882017|NCT02211417|540694984|FG001|Overall Study|Adverse Event|4|||
149882018|NCT01198132|540694985|FG000|Overall Study|Withdrawal by Subject|4|||
149882019|NCT01198132|540694986|FG001|Overall Study|Withdrawal by Subject|5|||
149882020|NCT01198132|540694985|FG000|Overall Study|Physician Decision|5|||
149882021|NCT01198132|540694986|FG001|Overall Study|Physician Decision|4|||
149882022|NCT01198132|540694985|FG000|Overall Study|Other Unspecified|3|||
149882023|NCT01198132|540694986|FG001|Overall Study|Other Unspecified|6|||
149882024|NCT01198132|540694985|FG000|Overall Study|Lack of Efficacy|2|||
149882025|NCT01198132|540694986|FG001|Overall Study|Lack of Efficacy|3|||
149882026|NCT01198132|540694985|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
149882027|NCT01198132|540694986|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
149882028|NCT01198132|540694985|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
149882029|NCT01198132|540694986|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
149882030|NCT01198132|540694985|FG000|Overall Study|Adverse Event|0|||
149882031|NCT01198132|540694986|FG001|Overall Study|Adverse Event|1|||
149882032|NCT01198132|540694985|FG000|Overall Study|Protocol Violation|1|||
149882033|NCT01198132|540694986|FG001|Overall Study|Protocol Violation|0|||
149882034|NCT01277211|540694987|FG000|Overall Study|Adverse Event|60|||
149882035|NCT01277211|540694988|FG001|Overall Study|Adverse Event|22|||
149882036|NCT01277211|540694987|FG000|Overall Study|Pregnancy|9|||
149882037|NCT01277211|540694988|FG001|Overall Study|Pregnancy|4|||
149882038|NCT01277211|540694987|FG000|Overall Study|Lost to Follow-up|14|||
149882039|NCT01277211|540694988|FG001|Overall Study|Lost to Follow-up|9|||
149882040|NCT01277211|540694987|FG000|Overall Study|Did not wish to continue|17|||
149882041|NCT01277211|540694988|FG001|Overall Study|Did not wish to continue|0|||
149882042|NCT01277211|540694987|FG000|Overall Study|Withdrew Consent|9|||
149882043|NCT01277211|540694988|FG001|Overall Study|Withdrew Consent|9|||
149882044|NCT01277211|540694987|FG000|Overall Study|Non-compliance with protocol|13|||
149882045|NCT01277211|540694988|FG001|Overall Study|Non-compliance with protocol|4|||
149882046|NCT01277211|540694987|FG000|Overall Study|Did not meet protocol eligibility|1|||
149882047|NCT01277211|540694988|FG001|Overall Study|Did not meet protocol eligibility|0|||
149882048|NCT01277211|540694987|FG000|Overall Study|Administrative|3|||
149882049|NCT01277211|540694988|FG001|Overall Study|Administrative|0|||
149882050|NCT01277211|540694987|FG000|Overall Study|Pregnancy wish|0|||
149882051|NCT01277211|540694988|FG001|Overall Study|Pregnancy wish|2|||
149882052|NCT01277211|540694987|FG000|Overall Study|Discontinued prior to treatment|24|||
149882053|NCT01277211|540694988|FG001|Overall Study|Discontinued prior to treatment|13|||
149882054|NCT01130597|540694996|FG000|Overall Study|Protocol-specified (High K+)|1|||
149882055|NCT01130597|540694996|FG000|Overall Study|Adverse Event|4|||
149882056|NCT01130597|540694996|FG000|Overall Study|Death|1|||
149882057|NCT01130597|540694996|FG000|Overall Study|Protocol Violation|1|||
149882058|NCT03371459|540694997|FG000|Washout|Lost to Follow-up|0|||
149882059|NCT03371459|540694998|FG001|Washout|Lost to Follow-up|1|||
149882060|NCT03071276|540694999|FG000|Overall Study|Adverse Event|1|||
149882061|NCT03071276|540694999|FG000|Overall Study|Lack of Efficacy|14|||
149882062|NCT01290302|540697000|FG000|Overall Study|Adverse Event|2|||
149882063|NCT01290302|540697001|FG001|Overall Study|Adverse Event|0|||
149882064|NCT01290302|540697000|FG000|Overall Study|Withdrawal by Subject|1|||
149882065|NCT01290302|540697001|FG001|Overall Study|Withdrawal by Subject|0|||
149882066|NCT01290302|540697000|FG000|Overall Study|Physician Decision|0|||
149882067|NCT01290302|540697001|FG001|Overall Study|Physician Decision|2|||
149882068|NCT01290302|540697000|FG000|Overall Study|Expiration of time for screening window|1|||
149882069|NCT01290302|540697001|FG001|Overall Study|Expiration of time for screening window|0|||
149882070|NCT01496976|540697002|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
149882071|NCT05938621|540697003|FG000|Overall Study|Lost to Follow-up|1|||
149882072|NCT05938621|540697004|FG001|Overall Study|Lost to Follow-up|5|||
149882073|NCT05938621|540697005|FG002|Overall Study|Lost to Follow-up|2|||
149882074|NCT05938621|540697006|FG003|Overall Study|Lost to Follow-up|2|||
149882075|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
149882076|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
149882077|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
149882078|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
149882079|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
149882080|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
149882081|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
149882082|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
149882083|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
149882084|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
149882085|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
149882086|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
149882087|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
149882088|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
149882089|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
149882090|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
149882091|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
149882092|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
149882093|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
149882094|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
149882095|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
149882096|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882097|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882098|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882099|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882100|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882101|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
149882102|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
149882103|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
149882104|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
149882105|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882106|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882107|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882108|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882109|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882110|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
149882111|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
149882112|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
149882113|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
149882114|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
149882115|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
149882116|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
149882117|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
149882118|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
149882119|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
149882120|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
149882121|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882122|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882123|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882124|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882125|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882126|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882127|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882128|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
149882129|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882130|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
149882131|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882132|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882133|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882134|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882135|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882136|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882137|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882138|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882139|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882140|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
149882141|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882142|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882143|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882144|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882145|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882146|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
149882147|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
149882148|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882149|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882150|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882151|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882152|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882153|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882154|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882155|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
149882156|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
149882157|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882158|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882159|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882160|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882161|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882162|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882163|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882164|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
149882165|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
149882166|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882167|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882168|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882169|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882170|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882171|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882172|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882173|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
149882174|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882175|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
149882176|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
149882177|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882178|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882179|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882180|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882181|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882182|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
149882183|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
149882184|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
149882185|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882186|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882187|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882188|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882189|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882190|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882191|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
149882192|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882193|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
149882194|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882195|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882196|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882197|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882198|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882199|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882200|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
149882201|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882202|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
149882203|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882204|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882205|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882206|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882207|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882208|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882209|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
149882210|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882211|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882212|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
149882213|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882214|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882215|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882216|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882217|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882218|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
149882219|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
150043870|NCT00499616|541300703|FG003|Overall Study|Patient/Parent Refusal|0|||
150043871|NCT03085797|541300709|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
149882220|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882221|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
149882222|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882223|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882224|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882225|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882226|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882227|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
149882228|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882229|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882230|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
149882231|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882232|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882233|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882234|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882235|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882236|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
149882237|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882238|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882239|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882240|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882241|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882242|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882243|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
149882244|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882245|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
149882246|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
149882247|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
149882248|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882249|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882250|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882251|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882252|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882253|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882254|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
149882255|NCT03598790|540697007|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882256|NCT03598790|540697008|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882257|NCT03598790|540697009|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
149882258|NCT03598790|540697010|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882259|NCT03598790|540697011|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882260|NCT03598790|540697012|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882261|NCT03598790|540697013|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882262|NCT03598790|540697014|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882263|NCT03598790|540697015|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
149882264|NCT03598790|540697007|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882265|NCT03598790|540697008|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882266|NCT03598790|540697009|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882267|NCT03598790|540697010|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
150043872|NCT03085797|541300710|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
150174988|NCT05764161|541777010|FG000|12-week DBVC Period|Protocol Violation|2|||
149882268|NCT03598790|540697011|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
149882269|NCT03598790|540697012|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
149882270|NCT03598790|540697013|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882271|NCT03598790|540697014|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882272|NCT03598790|540697015|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149882273|NCT03598790|540697007|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882274|NCT03598790|540697008|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882275|NCT03598790|540697009|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882276|NCT03598790|540697010|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
149882277|NCT03598790|540697011|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882278|NCT03598790|540697012|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882279|NCT03598790|540697013|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882280|NCT03598790|540697014|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882281|NCT03598790|540697015|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
149882282|NCT03598790|540697007|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882283|NCT03598790|540697008|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882284|NCT03598790|540697009|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882285|NCT03598790|540697010|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
149882286|NCT03598790|540697011|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882287|NCT03598790|540697012|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882288|NCT03598790|540697013|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882289|NCT03598790|540697014|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882290|NCT03598790|540697015|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149882291|NCT03598790|540697007|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882292|NCT03598790|540697008|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882293|NCT03598790|540697009|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882294|NCT03598790|540697010|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
149882295|NCT03598790|540697011|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
149882296|NCT03598790|540697012|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882297|NCT03598790|540697013|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882298|NCT03598790|540697014|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882299|NCT03598790|540697015|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
149882300|NCT03598790|540697007|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882301|NCT03598790|540697008|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882302|NCT03598790|540697009|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882303|NCT03598790|540697010|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
149882304|NCT03598790|540697011|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882305|NCT03598790|540697012|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882306|NCT03598790|540697013|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882307|NCT03598790|540697014|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882308|NCT03598790|540697015|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
149882309|NCT01059786|540697019|FG000|Overall Study|Did not receive 6 cycles.|0|||
149882310|NCT01059786|540697020|FG001|Overall Study|Did not receive 6 cycles.|0|||
149882311|NCT01059786|540697021|FG002|Overall Study|Did not receive 6 cycles.|4|||
149882312|NCT01059786|540697022|FG003|Overall Study|Did not receive 6 cycles.|1|||
149882313|NCT01059786|540697023|FG004|Overall Study|Did not receive 6 cycles.|0|||
149882314|NCT04205812|540697024|FG000|Randomized Treatment Period|Ongoing|28|||
149882315|NCT04205812|540697025|FG001|Randomized Treatment Period|Ongoing|138|||
149882316|NCT04205812|540697024|FG000|Randomized Treatment Period|Death|94|||
149882317|NCT04205812|540697025|FG001|Randomized Treatment Period|Death|226|||
149882318|NCT04205812|540697024|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
149882319|NCT04205812|540697025|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
149882320|NCT04205812|540697024|FG000|Randomized Treatment Period|Physician Decision|1|||
149882321|NCT04205812|540697025|FG001|Randomized Treatment Period|Physician Decision|4|||
149882322|NCT04205812|540697024|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
149882323|NCT04205812|540697025|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
149882324|NCT04205812|540697024|FG000|Randomized Treatment Period|Progressive Disease|0|||
149882325|NCT04205812|540697025|FG001|Randomized Treatment Period|Progressive Disease|1|||
149882326|NCT04205812|540697024|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
149882327|NCT04205812|540697025|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
149882328|NCT04205812|540697024|FG000|Monotherapy Treatment Period|Ongoing|17|||
149882329|NCT04205812|540697025|FG001|Monotherapy Treatment Period|Ongoing|0|||
149882330|NCT04205812|540697024|FG000|Monotherapy Treatment Period|Death|39|||
149882331|NCT04205812|540697025|FG001|Monotherapy Treatment Period|Death|0|||
149882332|NCT04205812|540697024|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
150043873|NCT03085797|541300709|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
149882333|NCT04205812|540697025|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
149882334|NCT04205812|540697024|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
149882335|NCT04205812|540697025|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
149882336|NCT04559347|540697026|FG000|Overall Study|Death|1|||
149882337|NCT04559347|540697027|FG001|Overall Study|Death|0|||
149882338|NCT04559347|540697026|FG000|Overall Study|Thoracotomy conversion|1|||
149882339|NCT04559347|540697027|FG001|Overall Study|Thoracotomy conversion|1|||
149882340|NCT04559347|540697026|FG000|Overall Study|Provider unavailable|2|||
149882341|NCT04559347|540697027|FG001|Overall Study|Provider unavailable|1|||
149882342|NCT04559347|540697026|FG000|Overall Study|Other|2|||
149882343|NCT04559347|540697027|FG001|Overall Study|Other|1|||
149882344|NCT00371033|540697028|FG000|Overall Study|Lost to Follow-up|3|||
149882345|NCT00371033|540697029|FG001|Overall Study|Lost to Follow-up|2|||
149882346|NCT00371033|540697028|FG000|Overall Study|No longer interested|2|||
149882347|NCT00371033|540697029|FG001|Overall Study|No longer interested|0|||
149882348|NCT00371033|540697028|FG000|Overall Study|Uknown|3|||
149882349|NCT00371033|540697029|FG001|Overall Study|Uknown|1|||
149882350|NCT05929651|540697036|FG000|Overall Study|Protocol Deviation|1|||
149882351|NCT05929651|540697036|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
149882352|NCT00733005|540697039|FG000|Overall Study|Adverse Event|0|||
149882353|NCT00733005|540697040|FG001|Overall Study|Adverse Event|1|||
149882354|NCT00733005|540697039|FG000|Overall Study|Treatment Failure|0|||
149882355|NCT00733005|540697040|FG001|Overall Study|Treatment Failure|1|||
149882356|NCT00733005|540697039|FG000|Overall Study|Withdrawal by Subject|0|||
149882357|NCT00733005|540697040|FG001|Overall Study|Withdrawal by Subject|1|||
149882358|NCT00733005|540697039|FG000|Overall Study|Protocol Violation|2|||
149882359|NCT00733005|540697040|FG001|Overall Study|Protocol Violation|0|||
149882360|NCT01769456|540697041|FG000|Overall Study|Lost to Follow-up|19|||
149882361|NCT01769456|540697041|FG000|Overall Study|Withdrawal by Subject|3|||
149882362|NCT01769456|540697041|FG000|Overall Study|Did not receive PCC intervention|6|||
149882363|NCT01769456|540697041|FG000|Overall Study|Moved out of the area|3|||
149882364|NCT01769456|540697041|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
149882365|NCT01769456|540697041|FG000|Overall Study|Parental request to youth to withdraw|1|||
149882366|NCT02465398|540697048|FG000|Overall Study|Death|7|||
149882367|NCT02465398|540697048|FG000|Overall Study|Revision|7|||
149882368|NCT02465398|540697048|FG000|Overall Study|did not receive study device|1|||
149882369|NCT02465398|540697048|FG000|Overall Study|Withdrawal by Subject|1|||
149882370|NCT02465398|540697048|FG000|Overall Study|Lost to Follow-up|14|||
149882371|NCT05244122|540697053|FG000|Overall Study|Withdrawal by Subject|318|||
149882372|NCT01692626|540697056|FG000|Overall Study|Death|0|||
149882373|NCT01692626|540697057|FG001|Overall Study|Death|1|||
149882374|NCT01692626|540697056|FG000|Overall Study|Adverse Event|2|||
149882375|NCT01692626|540697057|FG001|Overall Study|Adverse Event|3|||
149882376|NCT01692626|540697056|FG000|Overall Study|Protocol Violation|1|||
149882377|NCT01692626|540697057|FG001|Overall Study|Protocol Violation|2|||
149882378|NCT01692626|540697056|FG000|Overall Study|Withdrawal by Subject|1|||
149882379|NCT01692626|540697057|FG001|Overall Study|Withdrawal by Subject|0|||
149882380|NCT00855894|540697058|FG000|Overall Study|Death|31|||
149882381|NCT00855894|540697058|FG000|Overall Study|Patient's decision|1|||
149882382|NCT00855894|540697058|FG000|Overall Study|Disease progression|1|||
149882383|NCT02794870|540697071|FG000|Overall Study|Withdrawal by Subject|2|||
149882384|NCT02794870|540697072|FG001|Overall Study|Withdrawal by Subject|0|||
149882385|NCT01625988|540697074|FG000|Overall Study|Lost to Follow-up|5|||
149882386|NCT01625988|540697075|FG001|Overall Study|Lost to Follow-up|6|||
149882387|NCT01625988|540697074|FG000|Overall Study|Withdrawal by Subject|8|||
149882388|NCT01625988|540697075|FG001|Overall Study|Withdrawal by Subject|3|||
149882389|NCT01625988|540697074|FG000|Overall Study|Adverse Event|0|||
149882390|NCT01625988|540697075|FG001|Overall Study|Adverse Event|1|||
149882391|NCT01625988|540697074|FG000|Overall Study|Lack of Efficacy|0|||
149882392|NCT01625988|540697075|FG001|Overall Study|Lack of Efficacy|1|||
149882393|NCT01625988|540697074|FG000|Overall Study|Randomized Inappropriately|1|||
149882394|NCT01625988|540697075|FG001|Overall Study|Randomized Inappropriately|0|||
149882395|NCT01625988|540697074|FG000|Overall Study|Protocol Violation|0|||
149882396|NCT01625988|540697075|FG001|Overall Study|Protocol Violation|2|||
150043874|NCT03085797|541300710|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
149882397|NCT00616421|540697076|FG000|Overall Study|Withdrawal by Subject|9|||
149882398|NCT00616421|540697077|FG001|Overall Study|Withdrawal by Subject|11|||
149882399|NCT00616421|540697078|FG002|Overall Study|Withdrawal by Subject|8|||
149882400|NCT00616421|540697076|FG000|Overall Study|Lost to Follow-up|12|||
149882401|NCT00616421|540697077|FG001|Overall Study|Lost to Follow-up|26|||
149882402|NCT00616421|540697078|FG002|Overall Study|Lost to Follow-up|30|||
149882403|NCT00616421|540697076|FG000|Overall Study|Inappropriate enrollment|3|||
149882404|NCT00616421|540697077|FG001|Overall Study|Inappropriate enrollment|0|||
149882405|NCT00616421|540697078|FG002|Overall Study|Inappropriate enrollment|1|||
149882406|NCT00616421|540697076|FG000|Overall Study|Administrative reason|1|||
149882407|NCT00616421|540697077|FG001|Overall Study|Administrative reason|0|||
149882408|NCT00616421|540697078|FG002|Overall Study|Administrative reason|0|||
149882409|NCT00616421|540697076|FG000|Overall Study|Protocol Violation|0|||
149882410|NCT00616421|540697077|FG001|Overall Study|Protocol Violation|1|||
149882411|NCT00616421|540697078|FG002|Overall Study|Protocol Violation|2|||
149882412|NCT00616421|540697076|FG000|Overall Study|Unable to classify|1|||
149882413|NCT00616421|540697077|FG001|Overall Study|Unable to classify|0|||
149882414|NCT00616421|540697078|FG002|Overall Study|Unable to classify|0|||
149882415|NCT01495702|540697079|FG000|Randomized Phase|Randomized But Not Treated|1|||
149882416|NCT01495702|540697080|FG001|Randomized Phase|Randomized But Not Treated|4|||
149882417|NCT01495702|540697079|FG000|Randomized Phase|Adverse Event|2|||
149882418|NCT01495702|540697080|FG001|Randomized Phase|Adverse Event|2|||
149882419|NCT01495702|540697079|FG000|Randomized Phase|Death|1|||
149882420|NCT01495702|540697080|FG001|Randomized Phase|Death|0|||
149882421|NCT01495702|540697079|FG000|Randomized Phase|Lack of Efficacy|2|||
149882422|NCT01495702|540697080|FG001|Randomized Phase|Lack of Efficacy|0|||
149882423|NCT01495702|540697079|FG000|Randomized Phase|Investigators Discretion|2|||
149882424|NCT01495702|540697080|FG001|Randomized Phase|Investigators Discretion|0|||
149882425|NCT01495702|540697079|FG000|Randomized Phase|Withdrew Consent|10|||
149882426|NCT01495702|540697080|FG001|Randomized Phase|Withdrew Consent|18|||
149882427|NCT01495702|540697079|FG000|Randomized Phase|Lost to Follow-up|4|||
149882428|NCT01495702|540697080|FG001|Randomized Phase|Lost to Follow-up|3|||
149882429|NCT01495702|540697079|FG000|Randomized Phase|Participant Noncompliance|1|||
149882430|NCT01495702|540697080|FG001|Randomized Phase|Participant Noncompliance|0|||
149882431|NCT01495702|540697079|FG000|Randomized Phase|Protocol Violation|3|||
149882432|NCT01495702|540697080|FG001|Randomized Phase|Protocol Violation|1|||
149882433|NCT01427608|540697081|FG000|Overall Study|Death|1|||
149882434|NCT01427608|540697082|FG001|Overall Study|Death|0|||
149882435|NCT01427608|540697081|FG000|Overall Study|Withdrawal by Subject|7|||
149882436|NCT01427608|540697082|FG001|Overall Study|Withdrawal by Subject|3|||
149882437|NCT01427608|540697081|FG000|Overall Study|Relapsed-all cause|13|||
149882438|NCT01427608|540697082|FG001|Overall Study|Relapsed-all cause|34|||
149882439|NCT01427608|540697081|FG000|Overall Study|Events not attributed to study meds|0|||
149882440|NCT01427608|540697082|FG001|Overall Study|Events not attributed to study meds|1|||
149882441|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
149882442|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
149882443|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
149882444|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
149882445|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
149882446|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
149882447|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
149882448|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
149882449|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
149882450|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
149882451|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
149882452|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
149882453|NCT02422797|540697083|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
149882454|NCT02422797|540697084|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
149882455|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
149882456|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
149882457|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
149882458|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
149882459|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
149882460|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
149882461|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
149882462|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
149882463|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
149882464|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
149882465|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
149882466|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
149882467|NCT02422797|540697083|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
149882468|NCT02422797|540697084|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
149882469|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
149882470|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
149882471|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
149882472|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
149882473|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
149882474|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
149965496|NCT00500331|541009518|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
149965497|NCT00500331|541009519|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
149965498|NCT00500331|541009520|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
149965499|NCT00500331|541009521|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
149965500|NCT00500331|541009522|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
149965501|NCT00500331|541009516|FG000|Overall Study|Didn't return for continuation of study|1|||
149965502|NCT00500331|541009517|FG001|Overall Study|Didn't return for continuation of study|0|||
149965503|NCT00500331|541009518|FG002|Overall Study|Didn't return for continuation of study|0|||
149965504|NCT00500331|541009519|FG003|Overall Study|Didn't return for continuation of study|0|||
149965505|NCT00500331|541009520|FG004|Overall Study|Didn't return for continuation of study|0|||
149965506|NCT00500331|541009521|FG005|Overall Study|Didn't return for continuation of study|0|||
149965507|NCT00500331|541009522|FG006|Overall Study|Didn't return for continuation of study|0|||
149965508|NCT00500331|541009516|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
149965509|NCT00500331|541009517|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965510|NCT00500331|541009518|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965511|NCT00500331|541009519|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965512|NCT00500331|541009520|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965513|NCT00500331|541009521|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965514|NCT00500331|541009522|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
149965515|NCT00500331|541009516|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
149965516|NCT00500331|541009517|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
149965517|NCT00500331|541009518|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
149965518|NCT00500331|541009519|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
149965519|NCT00500331|541009520|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
149965520|NCT00500331|541009521|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
149965521|NCT00500331|541009522|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
149965522|NCT00500331|541009516|FG000|Overall Study|Participant was randomized by mistake|1|||
149965523|NCT00500331|541009517|FG001|Overall Study|Participant was randomized by mistake|0|||
149965524|NCT00500331|541009518|FG002|Overall Study|Participant was randomized by mistake|0|||
149965525|NCT00500331|541009519|FG003|Overall Study|Participant was randomized by mistake|0|||
149965526|NCT00500331|541009520|FG004|Overall Study|Participant was randomized by mistake|0|||
149965527|NCT00500331|541009521|FG005|Overall Study|Participant was randomized by mistake|0|||
149965528|NCT00500331|541009522|FG006|Overall Study|Participant was randomized by mistake|0|||
149882475|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
149882476|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
149882477|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
149882478|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
149882479|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
149882480|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
149882481|NCT02422797|540697083|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
149882482|NCT02422797|540697084|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
149882483|NCT04071405|540697085|FG000|Overall Study|Protocol Violation|3|||
149882484|NCT01937871|540697091|FG000|Overall Study|Adverse Event|6|||
149882485|NCT01937871|540697092|FG001|Overall Study|Adverse Event|6|||
149882486|NCT01937871|540697093|FG002|Overall Study|Adverse Event|2|||
149882487|NCT01937871|540697091|FG000|Overall Study|Lost to Follow-up|8|||
149882488|NCT01937871|540697092|FG001|Overall Study|Lost to Follow-up|2|||
149965529|NCT00500331|541009516|FG000|Overall Study|Diabetologist nurse in the study|0|||
149965530|NCT00500331|541009517|FG001|Overall Study|Diabetologist nurse in the study|0|||
149965531|NCT00500331|541009518|FG002|Overall Study|Diabetologist nurse in the study|1|||
149965532|NCT00500331|541009519|FG003|Overall Study|Diabetologist nurse in the study|0|||
149965533|NCT00500331|541009520|FG004|Overall Study|Diabetologist nurse in the study|0|||
149965534|NCT00500331|541009521|FG005|Overall Study|Diabetologist nurse in the study|0|||
149965535|NCT00500331|541009522|FG006|Overall Study|Diabetologist nurse in the study|0|||
149965536|NCT00500331|541009516|FG000|Overall Study|State ban of biological samples export|0|||
149965537|NCT00500331|541009517|FG001|Overall Study|State ban of biological samples export|0|||
149965538|NCT00500331|541009518|FG002|Overall Study|State ban of biological samples export|0|||
149965539|NCT00500331|541009519|FG003|Overall Study|State ban of biological samples export|1|||
149965540|NCT00500331|541009520|FG004|Overall Study|State ban of biological samples export|0|||
149882489|NCT01937871|540697093|FG002|Overall Study|Lost to Follow-up|4|||
149882490|NCT01937871|540697091|FG000|Overall Study|Withdrawal by Subject|9|||
149882491|NCT01937871|540697092|FG001|Overall Study|Withdrawal by Subject|6|||
149882492|NCT01937871|540697093|FG002|Overall Study|Withdrawal by Subject|4|||
149882493|NCT01937871|540697091|FG000|Overall Study|Physician Decision|0|||
149965541|NCT00500331|541009521|FG005|Overall Study|State ban of biological samples export|0|||
149965542|NCT00500331|541009522|FG006|Overall Study|State ban of biological samples export|0|||
149965543|NCT00500331|541009516|FG000|Overall Study|Protocol violated|0|||
149882494|NCT01937871|540697092|FG001|Overall Study|Physician Decision|1|||
149882495|NCT01937871|540697093|FG002|Overall Study|Physician Decision|0|||
149882496|NCT01937871|540697091|FG000|Overall Study|Entry Criteria Not Met|1|||
149882497|NCT01937871|540697092|FG001|Overall Study|Entry Criteria Not Met|2|||
149882498|NCT01937871|540697093|FG002|Overall Study|Entry Criteria Not Met|1|||
149882499|NCT03154125|540697094|FG000|Overall Study|Lost to Follow-up|11|||
149882500|NCT03154125|540697095|FG001|Overall Study|Lost to Follow-up|11|||
149882501|NCT03154125|540697096|FG002|Overall Study|Lost to Follow-up|0|||
149882502|NCT03154125|540697094|FG000|Overall Study|Withdrawal by Subject|49|||
149882503|NCT03154125|540697095|FG001|Overall Study|Withdrawal by Subject|55|||
149882504|NCT03154125|540697096|FG002|Overall Study|Withdrawal by Subject|8|||
149882505|NCT03154125|540697094|FG000|Overall Study|Physician Decision|13|||
149882506|NCT03154125|540697095|FG001|Overall Study|Physician Decision|6|||
149882507|NCT03154125|540697096|FG002|Overall Study|Physician Decision|0|||
149882508|NCT03154125|540697094|FG000|Overall Study|Protocol Violation|3|||
149882509|NCT03154125|540697095|FG001|Overall Study|Protocol Violation|5|||
149882510|NCT03154125|540697096|FG002|Overall Study|Protocol Violation|0|||
149882511|NCT00810511|540697097|FG000|Overall Study|Protocol Violation|0|||
149882512|NCT00810511|540697098|FG001|Overall Study|Protocol Violation|1|||
149882513|NCT00810511|540697097|FG000|Overall Study|Lack of Efficacy|9|||
149882514|NCT00810511|540697098|FG001|Overall Study|Lack of Efficacy|1|||
149882515|NCT00810511|540697097|FG000|Overall Study|death in the family|0|||
149882516|NCT00810511|540697098|FG001|Overall Study|death in the family|1|||
149882517|NCT00810511|540697097|FG000|Overall Study|Lost to Follow-up|1|||
149882518|NCT00810511|540697098|FG001|Overall Study|Lost to Follow-up|0|||
149882519|NCT00810511|540697097|FG000|Overall Study|deposits on contact lens|0|||
149882520|NCT00810511|540697098|FG001|Overall Study|deposits on contact lens|1|||
149882521|NCT00462904|540697099|FG000|Overall Study|Lost to Follow-up|1|||
149882522|NCT02652949|540697100|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
149882523|NCT02652949|540697100|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
149882524|NCT02652949|540697100|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
149882525|NCT02652949|540697100|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
149882526|NCT02652949|540697100|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
149882527|NCT02652949|540697100|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
149882528|NCT02652949|540697100|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
149882529|NCT02652949|540697100|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
149882530|NCT02652949|540697100|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
149882531|NCT02652949|540697100|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
149882532|NCT02652949|540697100|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
149882533|NCT02652949|540697100|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
149882534|NCT02652949|540697100|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
149882535|NCT02652949|540697100|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
149882536|NCT02652949|540697100|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
149882537|NCT02652949|540697100|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
149882538|NCT02652949|540697100|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
149882539|NCT00699816|540697101|FG000|Overall Study|Protocol Violation|1|||
149882540|NCT00699816|540697102|FG001|Overall Study|Protocol Violation|3|||
149882541|NCT01569295|540697103|FG000|Overall Study|Progressive Disease|75|||
149882542|NCT01569295|540697104|FG001|Overall Study|Progressive Disease|139|||
149882543|NCT01569295|540697103|FG000|Overall Study|Adverse Event|39|||
149882544|NCT01569295|540697104|FG001|Overall Study|Adverse Event|14|||
149882545|NCT01569295|540697103|FG000|Overall Study|Withdrawal by Subject|25|||
149882546|NCT01569295|540697104|FG001|Overall Study|Withdrawal by Subject|12|||
149882547|NCT01569295|540697103|FG000|Overall Study|Death|19|||
149882548|NCT01569295|540697104|FG001|Overall Study|Death|15|||
149882549|NCT01569295|540697103|FG000|Overall Study|Physician Decision|13|||
149882550|NCT01569295|540697104|FG001|Overall Study|Physician Decision|18|||
149882551|NCT01569295|540697103|FG000|Overall Study|Study Terminated by Sponsor|24|||
149882552|NCT01569295|540697104|FG001|Overall Study|Study Terminated by Sponsor|2|||
149882553|NCT01569295|540697103|FG000|Overall Study|Other Reason not Specified|3|||
149882554|NCT01569295|540697104|FG001|Overall Study|Other Reason not Specified|5|||
149882555|NCT01569295|540697103|FG000|Overall Study|Non-Compliance with Study Drug|6|||
149882556|NCT01569295|540697104|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149882557|NCT01569295|540697103|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
149882558|NCT01569295|540697104|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
149882559|NCT01569295|540697103|FG000|Overall Study|Lost to Follow-up|1|||
149882560|NCT01569295|540697104|FG001|Overall Study|Lost to Follow-up|1|||
149882561|NCT01973595|540697108|FG000|Washout|Withdrawal by Subject|1|||
149882562|NCT01973595|540697109|FG001|Washout|Withdrawal by Subject|0|||
149882563|NCT01973595|540697110|FG002|Washout|Withdrawal by Subject|1|||
149882564|NCT01973595|540697111|FG003|Washout|Withdrawal by Subject|0|||
149965544|NCT00500331|541009517|FG001|Overall Study|Protocol violated|0|||
149882565|NCT02508935|540697112|FG000|Overall Study|Withdrawal by Subject|1|||
149882566|NCT02508935|540697112|FG000|Overall Study|Withdrawal by Caregiver|8|||
149882567|NCT02508935|540697112|FG000|Overall Study|Pain Score <4|1|||
149882568|NCT02508935|540697112|FG000|Overall Study|Emesis|3|||
149882569|NCT02508935|540697112|FG000|Overall Study|Adverse Event|3|||
149882570|NCT02508935|540697112|FG000|Overall Study|Protocol Violation|1|||
149882571|NCT02508935|540697112|FG000|Overall Study|Physician Decision|1|||
149882572|NCT02508935|540697112|FG000|Overall Study|Trial terminated by sponsor|5|||
149882573|NCT02125877|540697113|FG000|Overall Study|Physician Decision|1|||
149882574|NCT02125877|540697114|FG001|Overall Study|Physician Decision|0|||
149882575|NCT02125877|540697113|FG000|Overall Study|Death|0|||
149882576|NCT02125877|540697114|FG001|Overall Study|Death|1|||
149882577|NCT02125877|540697113|FG000|Overall Study|Administrative problems|0|||
149882578|NCT02125877|540697114|FG001|Overall Study|Administrative problems|1|||
149882579|NCT02125877|540697113|FG000|Overall Study|Participant/guardian decision|0|||
149882580|NCT02125877|540697114|FG001|Overall Study|Participant/guardian decision|2|||
149882581|NCT02125877|540697113|FG000|Overall Study|Withdrawal by Subject|2|||
149882582|NCT02125877|540697114|FG001|Overall Study|Withdrawal by Subject|1|||
149882583|NCT02125877|540697113|FG000|Overall Study|Protocol deviation|4|||
149882584|NCT02125877|540697114|FG001|Overall Study|Protocol deviation|1|||
149882585|NCT02125877|540697113|FG000|Overall Study|Adverse Event|6|||
149882586|NCT02125877|540697114|FG001|Overall Study|Adverse Event|4|||
149882587|NCT03138655|540697121|FG000|Overall Study|Adverse Event|2|||
149882588|NCT03138655|540697122|FG001|Overall Study|Adverse Event|1|||
149882589|NCT03138655|540697123|FG002|Overall Study|Adverse Event|2|||
149882590|NCT03138655|540697124|FG003|Overall Study|Adverse Event|1|||
149882591|NCT03138655|540697125|FG004|Overall Study|Adverse Event|1|||
149882592|NCT03138655|540697126|FG005|Overall Study|Adverse Event|4|||
149882593|NCT03138655|540697127|FG006|Overall Study|Adverse Event|2|||
149882594|NCT03138655|540697128|FG007|Overall Study|Adverse Event|2|||
149882595|NCT03138655|540697121|FG000|Overall Study|Withdrawal by Subject|0|||
149882596|NCT03138655|540697122|FG001|Overall Study|Withdrawal by Subject|1|||
149882597|NCT03138655|540697123|FG002|Overall Study|Withdrawal by Subject|0|||
149882598|NCT03138655|540697124|FG003|Overall Study|Withdrawal by Subject|0|||
149882599|NCT03138655|540697125|FG004|Overall Study|Withdrawal by Subject|0|||
149882600|NCT03138655|540697126|FG005|Overall Study|Withdrawal by Subject|0|||
149882601|NCT03138655|540697127|FG006|Overall Study|Withdrawal by Subject|1|||
149882602|NCT03138655|540697128|FG007|Overall Study|Withdrawal by Subject|0|||
149882603|NCT03138655|540697121|FG000|Overall Study|Reason not Specified|1|||
149882604|NCT03138655|540697122|FG001|Overall Study|Reason not Specified|0|||
149882605|NCT03138655|540697123|FG002|Overall Study|Reason not Specified|0|||
149882606|NCT03138655|540697124|FG003|Overall Study|Reason not Specified|2|||
149882607|NCT03138655|540697125|FG004|Overall Study|Reason not Specified|1|||
149882608|NCT03138655|540697126|FG005|Overall Study|Reason not Specified|1|||
149882609|NCT03138655|540697127|FG006|Overall Study|Reason not Specified|0|||
149882610|NCT03138655|540697128|FG007|Overall Study|Reason not Specified|0|||
149882611|NCT02800642|540697129|FG000|Overall Study|Death|3|||
149882612|NCT02800642|540697129|FG000|Overall Study|Other|10|||
149882613|NCT02800642|540697129|FG000|Overall Study|Physician Decision|2|||
149882614|NCT02800642|540697129|FG000|Overall Study|Adverse Event|6|||
149882615|NCT02800642|540697129|FG000|Overall Study|Withdrawal by Subject|3|||
149882616|NCT02800642|540697129|FG000|Overall Study|Lost to Follow-up|1|||
149882617|NCT04868500|540697130|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
149882618|NCT04868500|540697131|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
149882619|NCT04868500|540697130|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
149882620|NCT04868500|540697131|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
149882621|NCT02859142|540697132|FG000|Overall Study|Adverse Event|1|||
149882622|NCT02859142|540697133|FG001|Overall Study|Adverse Event|2|||
149882623|NCT02859142|540697132|FG000|Overall Study|Lost to Follow-up|1|||
149882624|NCT02859142|540697133|FG001|Overall Study|Lost to Follow-up|4|||
149882625|NCT02859142|540697132|FG000|Overall Study|Withdrawal by Subject|2|||
149882626|NCT02859142|540697133|FG001|Overall Study|Withdrawal by Subject|0|||
149882627|NCT02859142|540697132|FG000|Overall Study|Scheduling difficulties|0|||
149882628|NCT02859142|540697133|FG001|Overall Study|Scheduling difficulties|3|||
149882629|NCT03290079|540697134|FG000|Overall Study|Death|2|||
149965545|NCT00500331|541009518|FG002|Overall Study|Protocol violated|0|||
149882630|NCT01941498|540697138|FG000|Overall Study|Relocated out of state|1|||
149965546|NCT00500331|541009519|FG003|Overall Study|Protocol violated|1|||
149882631|NCT05299528|540697143|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149882632|NCT05299528|540697144|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
149882633|NCT05299528|540697145|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149882634|NCT05299528|540697146|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149882635|NCT05299528|540697147|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149882636|NCT05299528|540697148|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149882637|NCT05299528|540697149|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
149965547|NCT00500331|541009520|FG004|Overall Study|Protocol violated|0|||
149965548|NCT00500331|541009521|FG005|Overall Study|Protocol violated|0|||
149965549|NCT00500331|541009522|FG006|Overall Study|Protocol violated|0|||
150043875|NCT03085797|541300709|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
149882638|NCT05299528|540697143|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882639|NCT05299528|540697144|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882640|NCT05299528|540697145|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882641|NCT05299528|540697146|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882642|NCT05299528|540697147|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882643|NCT05299528|540697148|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
149882644|NCT05299528|540697149|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
149882645|NCT05299528|540697143|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
149882646|NCT05299528|540697144|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
149882647|NCT05299528|540697145|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
149882648|NCT05299528|540697146|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
149882649|NCT05299528|540697147|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
149882650|NCT05299528|540697148|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
149882651|NCT05299528|540697149|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
149882652|NCT04877457|540697150|FG000|Overall Study|Early termination of study due to low enrollment|2|||
149882653|NCT04877457|540697151|FG001|Overall Study|Early termination of study due to low enrollment|1|||
149882654|NCT01755091|540697152|FG000|Overall Study|Withdrawal by Subject|6|||
149882655|NCT01755091|540697153|FG001|Overall Study|Withdrawal by Subject|1|||
149882656|NCT01755091|540697154|FG002|Overall Study|Withdrawal by Subject|3|||
149882657|NCT01755091|540697152|FG000|Overall Study|Adverse Event|1|||
149882658|NCT01755091|540697153|FG001|Overall Study|Adverse Event|1|||
149882659|NCT01755091|540697154|FG002|Overall Study|Adverse Event|1|||
149882660|NCT01755091|540697152|FG000|Overall Study|Lost to Follow-up|1|||
149882661|NCT01755091|540697153|FG001|Overall Study|Lost to Follow-up|0|||
149882662|NCT01755091|540697154|FG002|Overall Study|Lost to Follow-up|1|||
149882663|NCT01755091|540697152|FG000|Overall Study|Physician Decision|1|||
149882664|NCT01755091|540697153|FG001|Overall Study|Physician Decision|1|||
149882665|NCT01755091|540697154|FG002|Overall Study|Physician Decision|2|||
149882666|NCT00490841|540697155|FG000|Overall Study|Death|5|||
149882667|NCT00490841|540697155|FG000|Overall Study|Withdrawal by Subject|4|||
149882668|NCT00490841|540697155|FG000|Overall Study|Lost to Follow-up|1|||
149882669|NCT00490841|540697155|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
149882670|NCT03452943|540697156|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
149882671|NCT03452943|540697157|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
149882672|NCT03452943|540697156|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
149882673|NCT03452943|540697157|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
149882674|NCT03452943|540697156|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
149882675|NCT03452943|540697157|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
149882676|NCT03452943|540697156|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
149882677|NCT03452943|540697157|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
149882678|NCT03452943|540697156|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
149882679|NCT03452943|540697157|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
149882680|NCT03452943|540697156|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
149882681|NCT03452943|540697157|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
149882682|NCT02185053|540697158|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
149882683|NCT02185053|540697159|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
149882684|NCT02185053|540697160|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
149882685|NCT02185053|540697158|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
149882686|NCT02185053|540697159|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
149882687|NCT02185053|540697160|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
149882688|NCT02185053|540697158|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
149882689|NCT02185053|540697159|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
149882690|NCT02185053|540697160|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
149882691|NCT02185053|540697158|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
149882692|NCT02185053|540697159|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
149882693|NCT02185053|540697160|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
149882694|NCT02185053|540697158|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
149882695|NCT02185053|540697159|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
149882696|NCT02185053|540697160|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
149882697|NCT02185053|540697158|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
149882698|NCT02185053|540697159|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
149882699|NCT02185053|540697160|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
149882700|NCT02185053|540697158|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
149882701|NCT02185053|540697159|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
149882702|NCT02185053|540697160|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
149882703|NCT02185053|540697158|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
149882704|NCT02185053|540697159|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
150043876|NCT03085797|541300710|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
150043877|NCT00867815|541300711|FG000|Overall Study|Lost to Follow-up|1|||
150043878|NCT04050202|541300712|FG000|Overall Study|Lost to Follow-up|2|||
150043879|NCT00372593|541300715|FG000|Overall Study|Adverse Event|43|||
150043880|NCT00372593|541300716|FG001|Overall Study|Adverse Event|45|||
150043881|NCT00372593|541300717|FG002|Overall Study|Adverse Event|0|||
150043882|NCT00372593|541300715|FG000|Overall Study|Death|16|||
150043883|NCT00372593|541300716|FG001|Overall Study|Death|20|||
149882705|NCT02185053|540697160|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
149882706|NCT00307437|540697161|FG000|Controlled Period|Adverse Event|7|||
149882707|NCT00307437|540697162|FG001|Controlled Period|Adverse Event|2|||
149882708|NCT00307437|540697163|FG002|Controlled Period|Adverse Event|5|||
149882709|NCT00307437|540697164|FG003|Controlled Period|Adverse Event|0|||
149882710|NCT00307437|540697165|FG004|Controlled Period|Adverse Event|0|||
149882711|NCT00307437|540697166|FG005|Controlled Period|Adverse Event|0|||
149882712|NCT00307437|540697167|FG006|Controlled Period|Adverse Event|0|||
149882713|NCT00307437|540697161|FG000|Controlled Period|Death|0|||
149882714|NCT00307437|540697162|FG001|Controlled Period|Death|0|||
149882715|NCT00307437|540697163|FG002|Controlled Period|Death|1|||
149882716|NCT00307437|540697164|FG003|Controlled Period|Death|0|||
149882717|NCT00307437|540697165|FG004|Controlled Period|Death|0|||
149882718|NCT00307437|540697166|FG005|Controlled Period|Death|0|||
149882719|NCT00307437|540697167|FG006|Controlled Period|Death|0|||
149882720|NCT00307437|540697161|FG000|Controlled Period|Lack of Efficacy|2|||
149882721|NCT00307437|540697162|FG001|Controlled Period|Lack of Efficacy|0|||
149882722|NCT00307437|540697163|FG002|Controlled Period|Lack of Efficacy|0|||
149882723|NCT00307437|540697164|FG003|Controlled Period|Lack of Efficacy|0|||
149882724|NCT00307437|540697165|FG004|Controlled Period|Lack of Efficacy|0|||
149882725|NCT00307437|540697166|FG005|Controlled Period|Lack of Efficacy|0|||
149882726|NCT00307437|540697167|FG006|Controlled Period|Lack of Efficacy|0|||
149882727|NCT00307437|540697161|FG000|Controlled Period|Lost to Follow-up|2|||
149882728|NCT00307437|540697162|FG001|Controlled Period|Lost to Follow-up|3|||
149882729|NCT00307437|540697163|FG002|Controlled Period|Lost to Follow-up|0|||
149882730|NCT00307437|540697164|FG003|Controlled Period|Lost to Follow-up|0|||
149882731|NCT00307437|540697165|FG004|Controlled Period|Lost to Follow-up|0|||
149882732|NCT00307437|540697166|FG005|Controlled Period|Lost to Follow-up|0|||
149882733|NCT00307437|540697167|FG006|Controlled Period|Lost to Follow-up|0|||
149882734|NCT00307437|540697161|FG000|Controlled Period|Other|5|||
149882735|NCT00307437|540697162|FG001|Controlled Period|Other|1|||
149882736|NCT00307437|540697163|FG002|Controlled Period|Other|3|||
149882737|NCT00307437|540697164|FG003|Controlled Period|Other|0|||
149882738|NCT00307437|540697165|FG004|Controlled Period|Other|0|||
149882739|NCT00307437|540697166|FG005|Controlled Period|Other|0|||
149882740|NCT00307437|540697167|FG006|Controlled Period|Other|0|||
149882741|NCT00307437|540697161|FG000|After Controlled Period|Adverse Event|0|||
149882742|NCT00307437|540697162|FG001|After Controlled Period|Adverse Event|0|||
149882743|NCT00307437|540697163|FG002|After Controlled Period|Adverse Event|0|||
149882744|NCT00307437|540697164|FG003|After Controlled Period|Adverse Event|18|||
149882745|NCT00307437|540697165|FG004|After Controlled Period|Adverse Event|16|||
149882746|NCT00307437|540697166|FG005|After Controlled Period|Adverse Event|31|||
149882747|NCT00307437|540697167|FG006|After Controlled Period|Adverse Event|40|||
149882748|NCT00307437|540697161|FG000|After Controlled Period|Death|0|||
149882749|NCT00307437|540697162|FG001|After Controlled Period|Death|0|||
149882750|NCT00307437|540697163|FG002|After Controlled Period|Death|0|||
149882751|NCT00307437|540697164|FG003|After Controlled Period|Death|3|||
149882752|NCT00307437|540697165|FG004|After Controlled Period|Death|1|||
149882753|NCT00307437|540697166|FG005|After Controlled Period|Death|1|||
149882754|NCT00307437|540697167|FG006|After Controlled Period|Death|3|||
149882755|NCT00307437|540697161|FG000|After Controlled Period|Lack of Efficacy|0|||
149882756|NCT00307437|540697162|FG001|After Controlled Period|Lack of Efficacy|0|||
149882757|NCT00307437|540697163|FG002|After Controlled Period|Lack of Efficacy|0|||
149882758|NCT00307437|540697164|FG003|After Controlled Period|Lack of Efficacy|15|||
149882759|NCT00307437|540697165|FG004|After Controlled Period|Lack of Efficacy|17|||
149882760|NCT00307437|540697166|FG005|After Controlled Period|Lack of Efficacy|37|||
149882761|NCT00307437|540697167|FG006|After Controlled Period|Lack of Efficacy|24|||
149882762|NCT00307437|540697161|FG000|After Controlled Period|Lost to Follow-up|0|||
149882763|NCT00307437|540697162|FG001|After Controlled Period|Lost to Follow-up|0|||
149882764|NCT00307437|540697163|FG002|After Controlled Period|Lost to Follow-up|0|||
149882765|NCT00307437|540697164|FG003|After Controlled Period|Lost to Follow-up|7|||
149882766|NCT00307437|540697165|FG004|After Controlled Period|Lost to Follow-up|12|||
149882767|NCT00307437|540697166|FG005|After Controlled Period|Lost to Follow-up|13|||
150043884|NCT00372593|541300717|FG002|Overall Study|Death|1|||
149882768|NCT00307437|540697167|FG006|After Controlled Period|Lost to Follow-up|18|||
149882769|NCT00307437|540697161|FG000|After Controlled Period|Other|0|||
149882770|NCT00307437|540697162|FG001|After Controlled Period|Other|0|||
149882771|NCT00307437|540697163|FG002|After Controlled Period|Other|0|||
149882772|NCT00307437|540697164|FG003|After Controlled Period|Other|15|||
149882773|NCT00307437|540697165|FG004|After Controlled Period|Other|9|||
150043885|NCT00372593|541300715|FG000|Overall Study|Lack of Efficacy|82|||
149882774|NCT00307437|540697166|FG005|After Controlled Period|Other|40|||
149882775|NCT00307437|540697167|FG006|After Controlled Period|Other|28|||
149882776|NCT00338728|540697173|FG000|Overall Study|Screen Failure|14|||
149882777|NCT02933255|540697180|FG000|Overall Study|Discontinued due to study closure.|1|||
149882778|NCT02933255|540697181|FG001|Overall Study|Discontinued due to study closure.|0|||
149882779|NCT04380961|540697182|FG000|Overall Study|Lost to Follow-up|17|||
149882780|NCT04380961|540697183|FG001|Overall Study|Lost to Follow-up|11|||
149882781|NCT04380961|540697182|FG000|Overall Study|Withdrawal by Subject|3|||
149882782|NCT04380961|540697183|FG001|Overall Study|Withdrawal by Subject|0|||
149882783|NCT04380961|540697182|FG000|Overall Study|Death|22|||
149882784|NCT04380961|540697183|FG001|Overall Study|Death|16|||
149882785|NCT04380961|540697182|FG000|Overall Study|Other|1|||
149882786|NCT04380961|540697183|FG001|Overall Study|Other|0|||
149882787|NCT04380961|540697182|FG000|Overall Study|Randomized but Not Treated|1|||
149882788|NCT04380961|540697183|FG001|Overall Study|Randomized but Not Treated|2|||
149882789|NCT04803305|540697184|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
149882790|NCT04803305|540697185|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
149882791|NCT04803305|540697184|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
149882792|NCT04803305|540697185|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
149882793|NCT04803305|540697184|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
149882794|NCT04803305|540697185|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
149882795|NCT04803305|540697184|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
149882796|NCT04803305|540697185|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
149882797|NCT04803305|540697184|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
149882798|NCT04803305|540697185|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
149882799|NCT04803305|540697184|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
149882800|NCT04803305|540697185|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
149882801|NCT04803305|540697184|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
149882802|NCT04803305|540697185|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
149882803|NCT04803305|540697184|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
149882804|NCT04803305|540697185|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
149882805|NCT03207867|540697186|FG000|Overall Study|Adverse Event|1|||
149882806|NCT03207867|540697187|FG001|Overall Study|Adverse Event|0|||
149882807|NCT03207867|540697188|FG002|Overall Study|Adverse Event|1|||
149882808|NCT03207867|540697189|FG003|Overall Study|Adverse Event|0|||
149882809|NCT03207867|540697190|FG004|Overall Study|Adverse Event|0|||
149882810|NCT03207867|540697191|FG005|Overall Study|Adverse Event|2|||
149882811|NCT03207867|540697192|FG006|Overall Study|Adverse Event|1|||
149882812|NCT03207867|540697193|FG007|Overall Study|Adverse Event|1|||
149882813|NCT03207867|540697194|FG008|Overall Study|Adverse Event|2|||
149882814|NCT03207867|540697195|FG009|Overall Study|Adverse Event|2|||
149882815|NCT03207867|540697196|FG010|Overall Study|Adverse Event|0|||
149882816|NCT03207867|540697197|FG011|Overall Study|Adverse Event|0|||
149882817|NCT03207867|540697198|FG012|Overall Study|Adverse Event|0|||
149882818|NCT03207867|540697199|FG013|Overall Study|Adverse Event|0|||
149882819|NCT03207867|540697200|FG014|Overall Study|Adverse Event|0|||
149882820|NCT03207867|540697201|FG015|Overall Study|Adverse Event|0|||
149882821|NCT03207867|540697202|FG016|Overall Study|Adverse Event|3|||
149882822|NCT03207867|540697203|FG017|Overall Study|Adverse Event|1|||
149882823|NCT03207867|540697204|FG018|Overall Study|Adverse Event|2|||
149882824|NCT03207867|540697205|FG019|Overall Study|Adverse Event|1|||
149882825|NCT03207867|540697206|FG020|Overall Study|Adverse Event|0|||
149882826|NCT03207867|540697207|FG021|Overall Study|Adverse Event|0|||
149882827|NCT03207867|540697208|FG022|Overall Study|Adverse Event|0|||
149882828|NCT03207867|540697209|FG023|Overall Study|Adverse Event|0|||
149882829|NCT03207867|540697186|FG000|Overall Study|Death|0|||
149882830|NCT03207867|540697187|FG001|Overall Study|Death|0|||
149882831|NCT03207867|540697188|FG002|Overall Study|Death|0|||
149882832|NCT03207867|540697189|FG003|Overall Study|Death|0|||
149882833|NCT03207867|540697190|FG004|Overall Study|Death|0|||
149882834|NCT03207867|540697191|FG005|Overall Study|Death|1|||
149882835|NCT03207867|540697192|FG006|Overall Study|Death|0|||
149882836|NCT03207867|540697193|FG007|Overall Study|Death|3|||
149965550|NCT03345550|541009523|FG000|Overall Study|Withdrawal by Subject|1|||
149965551|NCT03345550|541009524|FG001|Overall Study|Withdrawal by Subject|0|||
149882837|NCT03207867|540697194|FG008|Overall Study|Death|1|||
149965552|NCT03345550|541009523|FG000|Overall Study|Lost to Follow-up|4|||
149965553|NCT03345550|541009524|FG001|Overall Study|Lost to Follow-up|5|||
149965554|NCT03033784|541009529|FG000|Overall Study|Anxiety related to MRI scanner|0|||
149965555|NCT03033784|541009530|FG001|Overall Study|Anxiety related to MRI scanner|1|||
149965556|NCT03033784|541009531|FG002|Overall Study|Anxiety related to MRI scanner|0|||
149882838|NCT03207867|540697195|FG009|Overall Study|Death|2|||
149882839|NCT03207867|540697196|FG010|Overall Study|Death|0|||
149882840|NCT03207867|540697197|FG011|Overall Study|Death|1|||
149882841|NCT03207867|540697198|FG012|Overall Study|Death|0|||
149882842|NCT03207867|540697199|FG013|Overall Study|Death|1|||
149882843|NCT03207867|540697200|FG014|Overall Study|Death|0|||
149882844|NCT03207867|540697201|FG015|Overall Study|Death|0|||
150043886|NCT00372593|541300716|FG001|Overall Study|Lack of Efficacy|71|||
150043887|NCT00372593|541300717|FG002|Overall Study|Lack of Efficacy|2|||
150043888|NCT00372593|541300715|FG000|Overall Study|Lost to Follow-up|1|||
150043889|NCT00372593|541300716|FG001|Overall Study|Lost to Follow-up|0|||
150043890|NCT00372593|541300717|FG002|Overall Study|Lost to Follow-up|0|||
150043891|NCT00372593|541300715|FG000|Overall Study|Physician Decision|42|||
150043892|NCT00372593|541300716|FG001|Overall Study|Physician Decision|41|||
150043893|NCT00372593|541300717|FG002|Overall Study|Physician Decision|0|||
150043894|NCT00372593|541300715|FG000|Overall Study|Ineligible|20|||
150043895|NCT00372593|541300716|FG001|Overall Study|Ineligible|21|||
150043896|NCT00372593|541300717|FG002|Overall Study|Ineligible|1|||
150043897|NCT02974543|541300718|FG000|Overall Study|Withdrawal by Subject|1|||
150043898|NCT02974543|541300719|FG001|Overall Study|Withdrawal by Subject|0|||
150043899|NCT03534180|541300720|FG000|Overall Study|Withdrawal by Subject|1|||
149882845|NCT03207867|540697202|FG016|Overall Study|Death|0|||
149882846|NCT03207867|540697203|FG017|Overall Study|Death|2|||
149882847|NCT03207867|540697204|FG018|Overall Study|Death|0|||
149882848|NCT03207867|540697205|FG019|Overall Study|Death|1|||
149882849|NCT03207867|540697206|FG020|Overall Study|Death|0|||
149882850|NCT03207867|540697207|FG021|Overall Study|Death|0|||
149882851|NCT03207867|540697208|FG022|Overall Study|Death|0|||
149882852|NCT03207867|540697209|FG023|Overall Study|Death|0|||
149882853|NCT03207867|540697186|FG000|Overall Study|Physician Decision|3|||
149882854|NCT03207867|540697187|FG001|Overall Study|Physician Decision|5|||
149882855|NCT03207867|540697188|FG002|Overall Study|Physician Decision|0|||
149882856|NCT03207867|540697189|FG003|Overall Study|Physician Decision|3|||
149882857|NCT03207867|540697190|FG004|Overall Study|Physician Decision|2|||
149882858|NCT03207867|540697191|FG005|Overall Study|Physician Decision|0|||
149882859|NCT03207867|540697192|FG006|Overall Study|Physician Decision|0|||
149882860|NCT03207867|540697193|FG007|Overall Study|Physician Decision|0|||
149882861|NCT03207867|540697194|FG008|Overall Study|Physician Decision|4|||
149882862|NCT03207867|540697195|FG009|Overall Study|Physician Decision|2|||
149882863|NCT03207867|540697196|FG010|Overall Study|Physician Decision|0|||
149882864|NCT03207867|540697197|FG011|Overall Study|Physician Decision|4|||
149882865|NCT03207867|540697198|FG012|Overall Study|Physician Decision|0|||
149882866|NCT03207867|540697199|FG013|Overall Study|Physician Decision|0|||
149882867|NCT03207867|540697200|FG014|Overall Study|Physician Decision|2|||
149882868|NCT03207867|540697201|FG015|Overall Study|Physician Decision|1|||
149882869|NCT03207867|540697202|FG016|Overall Study|Physician Decision|1|||
149882870|NCT03207867|540697203|FG017|Overall Study|Physician Decision|2|||
149882871|NCT03207867|540697204|FG018|Overall Study|Physician Decision|1|||
149882872|NCT03207867|540697205|FG019|Overall Study|Physician Decision|3|||
149882873|NCT03207867|540697206|FG020|Overall Study|Physician Decision|0|||
149882874|NCT03207867|540697207|FG021|Overall Study|Physician Decision|0|||
149882875|NCT03207867|540697208|FG022|Overall Study|Physician Decision|0|||
149882876|NCT03207867|540697209|FG023|Overall Study|Physician Decision|0|||
149882877|NCT03207867|540697186|FG000|Overall Study|Progressive Disease|7|||
149965557|NCT03033784|541009532|FG003|Overall Study|Anxiety related to MRI scanner|0|||
149965558|NCT03033784|541009533|FG004|Overall Study|Anxiety related to MRI scanner|0|||
149965559|NCT03033784|541009534|FG005|Overall Study|Anxiety related to MRI scanner|0|||
149965560|NCT03033784|541009535|FG006|Overall Study|Anxiety related to MRI scanner|0|||
149965561|NCT03033784|541009536|FG007|Overall Study|Anxiety related to MRI scanner|0|||
149965562|NCT03033784|541009537|FG008|Overall Study|Anxiety related to MRI scanner|0|||
149965563|NCT03033784|541009538|FG009|Overall Study|Anxiety related to MRI scanner|0|||
149965564|NCT03033784|541009539|FG010|Overall Study|Anxiety related to MRI scanner|0|||
149965565|NCT03033784|541009540|FG011|Overall Study|Anxiety related to MRI scanner|0|||
149965566|NCT03033784|541009541|FG012|Overall Study|Anxiety related to MRI scanner|0|||
149965567|NCT03033784|541009529|FG000|Overall Study|Withdrawal by Subject|0|||
149965568|NCT03033784|541009530|FG001|Overall Study|Withdrawal by Subject|0|||
149965569|NCT03033784|541009531|FG002|Overall Study|Withdrawal by Subject|0|||
149965570|NCT03033784|541009532|FG003|Overall Study|Withdrawal by Subject|0|||
149965571|NCT03033784|541009533|FG004|Overall Study|Withdrawal by Subject|0|||
150174989|NCT05764161|541777011|FG001|12-week DBVC Period|Protocol Violation|4|||
150174990|NCT05764161|541777010|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
149882878|NCT03207867|540697187|FG001|Overall Study|Progressive Disease|7|||
149882879|NCT03207867|540697188|FG002|Overall Study|Progressive Disease|9|||
149882880|NCT03207867|540697189|FG003|Overall Study|Progressive Disease|10|||
149882881|NCT03207867|540697190|FG004|Overall Study|Progressive Disease|11|||
149882882|NCT03207867|540697191|FG005|Overall Study|Progressive Disease|10|||
149882883|NCT03207867|540697192|FG006|Overall Study|Progressive Disease|9|||
149882884|NCT03207867|540697193|FG007|Overall Study|Progressive Disease|8|||
149882885|NCT03207867|540697194|FG008|Overall Study|Progressive Disease|19|||
149882886|NCT03207867|540697195|FG009|Overall Study|Progressive Disease|23|||
149882887|NCT03207867|540697196|FG010|Overall Study|Progressive Disease|2|||
149882888|NCT03207867|540697197|FG011|Overall Study|Progressive Disease|24|||
149965572|NCT03033784|541009534|FG005|Overall Study|Withdrawal by Subject|0|||
149965573|NCT03033784|541009535|FG006|Overall Study|Withdrawal by Subject|0|||
150043900|NCT00220636|541300721|FG000|Overall Study|Withdrawal by Subject|4|||
149882889|NCT03207867|540697198|FG012|Overall Study|Progressive Disease|3|||
149882890|NCT03207867|540697199|FG013|Overall Study|Progressive Disease|11|||
149882891|NCT03207867|540697200|FG014|Overall Study|Progressive Disease|9|||
149882892|NCT03207867|540697201|FG015|Overall Study|Progressive Disease|5|||
149882893|NCT03207867|540697202|FG016|Overall Study|Progressive Disease|10|||
149882894|NCT03207867|540697203|FG017|Overall Study|Progressive Disease|14|||
149882895|NCT03207867|540697204|FG018|Overall Study|Progressive Disease|13|||
149882896|NCT03207867|540697205|FG019|Overall Study|Progressive Disease|14|||
149882897|NCT03207867|540697206|FG020|Overall Study|Progressive Disease|6|||
149882898|NCT03207867|540697207|FG021|Overall Study|Progressive Disease|3|||
149882899|NCT03207867|540697208|FG022|Overall Study|Progressive Disease|3|||
149882900|NCT03207867|540697209|FG023|Overall Study|Progressive Disease|3|||
149882901|NCT03207867|540697186|FG000|Overall Study|Patient/guardian Decision|0|||
149882902|NCT03207867|540697187|FG001|Overall Study|Patient/guardian Decision|0|||
149882903|NCT03207867|540697188|FG002|Overall Study|Patient/guardian Decision|1|||
149882904|NCT03207867|540697189|FG003|Overall Study|Patient/guardian Decision|1|||
149882905|NCT03207867|540697190|FG004|Overall Study|Patient/guardian Decision|1|||
149882906|NCT03207867|540697191|FG005|Overall Study|Patient/guardian Decision|2|||
149882907|NCT03207867|540697192|FG006|Overall Study|Patient/guardian Decision|1|||
149882908|NCT03207867|540697193|FG007|Overall Study|Patient/guardian Decision|0|||
149882909|NCT03207867|540697194|FG008|Overall Study|Patient/guardian Decision|1|||
149882910|NCT03207867|540697195|FG009|Overall Study|Patient/guardian Decision|0|||
149882911|NCT03207867|540697196|FG010|Overall Study|Patient/guardian Decision|0|||
149882912|NCT03207867|540697197|FG011|Overall Study|Patient/guardian Decision|1|||
149882913|NCT03207867|540697198|FG012|Overall Study|Patient/guardian Decision|0|||
149882914|NCT03207867|540697199|FG013|Overall Study|Patient/guardian Decision|1|||
149882915|NCT03207867|540697200|FG014|Overall Study|Patient/guardian Decision|2|||
149882916|NCT03207867|540697201|FG015|Overall Study|Patient/guardian Decision|0|||
149882917|NCT03207867|540697202|FG016|Overall Study|Patient/guardian Decision|1|||
149882918|NCT03207867|540697203|FG017|Overall Study|Patient/guardian Decision|3|||
149882919|NCT03207867|540697204|FG018|Overall Study|Patient/guardian Decision|4|||
149882920|NCT03207867|540697205|FG019|Overall Study|Patient/guardian Decision|1|||
149882921|NCT03207867|540697206|FG020|Overall Study|Patient/guardian Decision|0|||
149882922|NCT03207867|540697207|FG021|Overall Study|Patient/guardian Decision|0|||
149882923|NCT03207867|540697208|FG022|Overall Study|Patient/guardian Decision|0|||
149882924|NCT03207867|540697209|FG023|Overall Study|Patient/guardian Decision|0|||
149882925|NCT03816878|540698615|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
149882926|NCT03816878|540698616|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
149882927|NCT03816878|540698615|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
149882928|NCT03816878|540698616|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
149882929|NCT05626231|540698617|FG000|Provider Enrollment|Worked part-time|4|||
149882930|NCT05626231|540698617|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
149882931|NCT05626231|540698617|FG000|Provider Enrollment|Non-clinical employee|1|||
149882932|NCT05626231|540698617|FG000|Provider Enrollment|Provider does not see clients|3|||
149882933|NCT05626231|540698617|FG000|Provider Enrollment|Other|5|||
149882934|NCT03765788|540698619|FG000|Overall Study|Subject decision|2|||
149882935|NCT03765788|540698620|FG001|Overall Study|Subject decision|3|||
149882936|NCT03765788|540698619|FG000|Overall Study|Physician Decision|2|||
149882937|NCT03765788|540698620|FG001|Overall Study|Physician Decision|4|||
149882938|NCT03765788|540698619|FG000|Overall Study|Death|0|||
149882939|NCT03765788|540698620|FG001|Overall Study|Death|1|||
149882940|NCT03765788|540698619|FG000|Overall Study|Lost to Follow-up|1|||
149882941|NCT03765788|540698620|FG001|Overall Study|Lost to Follow-up|0|||
149882942|NCT03203850|540698621|FG000|Overall Study|Subject/guardian decision|4|||
149882943|NCT03203850|540698622|FG001|Overall Study|Subject/guardian decision|3|||
149882944|NCT03203850|540698621|FG000|Overall Study|Adverse Event|3|||
149882945|NCT03203850|540698622|FG001|Overall Study|Adverse Event|0|||
149882946|NCT03203850|540698621|FG000|Overall Study|Death|1|||
149882947|NCT03203850|540698622|FG001|Overall Study|Death|0|||
149882948|NCT02717455|540698623|FG000|Overall Study|Adverse Event|1|||
149882949|NCT02717455|540698624|FG001|Overall Study|Adverse Event|0|||
149882950|NCT02717455|540698625|FG002|Overall Study|Adverse Event|0|||
149882951|NCT02717455|540698626|FG003|Overall Study|Adverse Event|2|||
149882952|NCT02717455|540698627|FG004|Overall Study|Adverse Event|2|||
149882953|NCT02717455|540698628|FG005|Overall Study|Adverse Event|2|||
149882954|NCT02717455|540698623|FG000|Overall Study|Withdrawal by Subject|1|||
149882955|NCT02717455|540698624|FG001|Overall Study|Withdrawal by Subject|1|||
149882956|NCT02717455|540698625|FG002|Overall Study|Withdrawal by Subject|0|||
149882957|NCT02717455|540698626|FG003|Overall Study|Withdrawal by Subject|2|||
149882958|NCT02717455|540698627|FG004|Overall Study|Withdrawal by Subject|2|||
149882959|NCT02717455|540698628|FG005|Overall Study|Withdrawal by Subject|1|||
149882960|NCT02717455|540698623|FG000|Overall Study|Death|1|||
149882961|NCT02717455|540698624|FG001|Overall Study|Death|0|||
149882962|NCT02717455|540698625|FG002|Overall Study|Death|0|||
149882963|NCT02717455|540698626|FG003|Overall Study|Death|0|||
149882964|NCT02717455|540698627|FG004|Overall Study|Death|1|||
149882965|NCT02717455|540698628|FG005|Overall Study|Death|0|||
149882966|NCT02717455|540698623|FG000|Overall Study|Did not receive study drug|0|||
149882967|NCT02717455|540698624|FG001|Overall Study|Did not receive study drug|0|||
149882968|NCT02717455|540698625|FG002|Overall Study|Did not receive study drug|0|||
149882969|NCT02717455|540698626|FG003|Overall Study|Did not receive study drug|1|||
149882970|NCT02717455|540698627|FG004|Overall Study|Did not receive study drug|0|||
149882971|NCT02717455|540698628|FG005|Overall Study|Did not receive study drug|1|||
149882972|NCT02717455|540698623|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
149882973|NCT02717455|540698624|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
149882974|NCT02717455|540698625|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
149882975|NCT02717455|540698626|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
149882976|NCT02717455|540698627|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
149882977|NCT02717455|540698628|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
149882978|NCT02717455|540698623|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
149882979|NCT02717455|540698624|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
149882980|NCT02717455|540698625|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
149882981|NCT02717455|540698626|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
149882982|NCT02717455|540698627|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
149882983|NCT02717455|540698628|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
149882984|NCT00615199|540698631|FG000|Overall Study|Adverse Event|3|||
149882985|NCT00615199|540698632|FG001|Overall Study|Adverse Event|1|||
149882986|NCT00615199|540698633|FG002|Overall Study|Adverse Event|1|||
149882987|NCT00615199|540698634|FG003|Overall Study|Adverse Event|0|||
149882988|NCT00615199|540698631|FG000|Overall Study|Lack of Efficacy|2|||
149882989|NCT00615199|540698632|FG001|Overall Study|Lack of Efficacy|0|||
149882990|NCT00615199|540698633|FG002|Overall Study|Lack of Efficacy|0|||
149882991|NCT00615199|540698634|FG003|Overall Study|Lack of Efficacy|1|||
149882992|NCT00615199|540698631|FG000|Overall Study|Lost to Follow-up|1|||
149882993|NCT00615199|540698632|FG001|Overall Study|Lost to Follow-up|0|||
149882994|NCT00615199|540698633|FG002|Overall Study|Lost to Follow-up|0|||
149882995|NCT00615199|540698634|FG003|Overall Study|Lost to Follow-up|0|||
149882996|NCT00615199|540698631|FG000|Overall Study|Other|0|||
149882997|NCT00615199|540698632|FG001|Overall Study|Other|0|||
149882998|NCT00615199|540698633|FG002|Overall Study|Other|0|||
149882999|NCT00615199|540698634|FG003|Overall Study|Other|1|||
149883000|NCT00615199|540698631|FG000|Overall Study|Withdrawal by Subject|2|||
149883001|NCT00615199|540698632|FG001|Overall Study|Withdrawal by Subject|1|||
149883002|NCT00615199|540698633|FG002|Overall Study|Withdrawal by Subject|0|||
149883003|NCT00615199|540698634|FG003|Overall Study|Withdrawal by Subject|0|||
149883004|NCT02653625|540698635|FG000|Overall Study|Adverse Event|1|||
149883005|NCT02653625|540698635|FG000|Overall Study|Non-compliance with Study Drug|1|||
149883006|NCT02653625|540698635|FG000|Overall Study|Protocol Violation|1|||
149965574|NCT03033784|541009536|FG007|Overall Study|Withdrawal by Subject|0|||
149883007|NCT02653625|540698635|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
149883008|NCT00064987|540698638|FG000|Overall Study|Physician Decision|3|||
149883009|NCT00064987|540698639|FG001|Overall Study|Physician Decision|0|||
149883010|NCT02969382|540698640|FG000|Overall Study|Adverse Event|8|||
149883011|NCT02969382|540698641|FG001|Overall Study|Adverse Event|10|||
149965575|NCT03033784|541009537|FG008|Overall Study|Withdrawal by Subject|0|||
149883012|NCT02969382|540698640|FG000|Overall Study|Lack of Efficacy|4|||
149883013|NCT02969382|540698641|FG001|Overall Study|Lack of Efficacy|5|||
149883014|NCT02969382|540698640|FG000|Overall Study|Death|0|||
149883015|NCT02969382|540698641|FG001|Overall Study|Death|1|||
149883016|NCT02969382|540698640|FG000|Overall Study|PROTOCOL DEVIATION|0|||
149883017|NCT02969382|540698641|FG001|Overall Study|PROTOCOL DEVIATION|1|||
149883018|NCT02969382|540698640|FG000|Overall Study|Withdrawal by Subject|14|||
149883019|NCT02969382|540698641|FG001|Overall Study|Withdrawal by Subject|9|||
149883020|NCT04152863|540698644|FG000|Overall Study|Death|13|||
149883021|NCT04152863|540698645|FG001|Overall Study|Death|12|||
149883022|NCT04152863|540698646|FG002|Overall Study|Death|7|||
149883023|NCT04152863|540698644|FG000|Overall Study|Physician Decision|1|||
149883024|NCT04152863|540698645|FG001|Overall Study|Physician Decision|1|||
149883025|NCT04152863|540698646|FG002|Overall Study|Physician Decision|1|||
149883026|NCT04152863|540698644|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
149883027|NCT04152863|540698645|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
149883028|NCT04152863|540698646|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
149883029|NCT04152863|540698644|FG000|Overall Study|Withdrawal by Subject|2|||
149883030|NCT04152863|540698645|FG001|Overall Study|Withdrawal by Subject|1|||
149883031|NCT04152863|540698646|FG002|Overall Study|Withdrawal by Subject|3|||
149883032|NCT01644617|540698647|FG000|Overall Study|Withdrawal by Subject|3|||
149883033|NCT01644617|540698648|FG001|Overall Study|Withdrawal by Subject|4|||
149883034|NCT01644617|540698649|FG002|Overall Study|Withdrawal by Subject|1|||
149883035|NCT01644617|540698647|FG000|Overall Study|Lost to Follow-up|0|||
149883036|NCT01644617|540698648|FG001|Overall Study|Lost to Follow-up|1|||
149883037|NCT01644617|540698649|FG002|Overall Study|Lost to Follow-up|0|||
149883038|NCT01644617|540698647|FG000|Overall Study|Adverse Event|3|||
149883039|NCT01644617|540698648|FG001|Overall Study|Adverse Event|0|||
149883040|NCT01644617|540698649|FG002|Overall Study|Adverse Event|6|||
149883041|NCT02276807|540698650|FG000|Overall Study|Withdrawal by Subject|8|||
149883042|NCT02276807|540698651|FG001|Overall Study|Withdrawal by Subject|7|||
149883043|NCT02276807|540698650|FG000|Overall Study|Lost to Follow-up|10|||
149883044|NCT02276807|540698651|FG001|Overall Study|Lost to Follow-up|10|||
149883045|NCT00799058|540698659|FG000|Overall Study|Withdrawal by Subject|2|||
149883046|NCT00799058|540698660|FG001|Overall Study|Withdrawal by Subject|2|||
149883047|NCT00799058|540698661|FG002|Overall Study|Withdrawal by Subject|2|||
149883048|NCT00799058|540698659|FG000|Overall Study|Lost to Follow-up|1|||
149883049|NCT00799058|540698660|FG001|Overall Study|Lost to Follow-up|2|||
149883050|NCT00799058|540698661|FG002|Overall Study|Lost to Follow-up|1|||
149883051|NCT00799058|540698659|FG000|Overall Study|Adverse Event|0|||
149883052|NCT00799058|540698660|FG001|Overall Study|Adverse Event|2|||
149883053|NCT00799058|540698661|FG002|Overall Study|Adverse Event|0|||
149883054|NCT00799058|540698659|FG000|Overall Study|Pregnancy|1|||
149883055|NCT00799058|540698660|FG001|Overall Study|Pregnancy|0|||
149883056|NCT00799058|540698661|FG002|Overall Study|Pregnancy|0|||
149883057|NCT00799058|540698659|FG000|Overall Study|Not adherent|3|||
149883058|NCT00799058|540698660|FG001|Overall Study|Not adherent|2|||
149883059|NCT00799058|540698661|FG002|Overall Study|Not adherent|1|||
149883060|NCT00799058|540698659|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
149883061|NCT00799058|540698660|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
149883062|NCT00799058|540698661|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
149883063|NCT00799058|540698659|FG000|Overall Study|IP dispensing error|1|||
149883064|NCT00799058|540698660|FG001|Overall Study|IP dispensing error|0|||
149883065|NCT00799058|540698661|FG002|Overall Study|IP dispensing error|0|||
149883066|NCT00799058|540698659|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
149883067|NCT00799058|540698660|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
149883068|NCT00799058|540698661|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
149883069|NCT00799058|540698659|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
149883070|NCT00799058|540698660|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
149883071|NCT00799058|540698661|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
149883072|NCT00799058|540698659|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
149883073|NCT00799058|540698660|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
149965576|NCT03033784|541009538|FG009|Overall Study|Withdrawal by Subject|0|||
149965577|NCT03033784|541009539|FG010|Overall Study|Withdrawal by Subject|0|||
149965578|NCT03033784|541009540|FG011|Overall Study|Withdrawal by Subject|0|||
149965579|NCT03033784|541009541|FG012|Overall Study|Withdrawal by Subject|2|||
149965580|NCT00267488|541009542|FG000|Overall Study|Sponsor Terminated Study|9|||
149965581|NCT00267488|541009542|FG000|Overall Study|Protocol Violation|1|||
149965582|NCT00267488|541009542|FG000|Overall Study|Other (Disease Progression)|1|||
149883074|NCT00799058|540698661|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
149883075|NCT00799058|540698659|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
149883076|NCT00799058|540698660|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
149883077|NCT00799058|540698661|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
149883078|NCT02088697|540698664|FG000|Period I|Physician Decision|1|||
149883079|NCT02088697|540698665|FG001|Period I|Physician Decision|4|||
149883080|NCT02088697|540698664|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
149883081|NCT02088697|540698665|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
149883082|NCT00247676|540698668|FG000|Overall Study|Death|5|||
149883083|NCT00247676|540698668|FG000|Overall Study|Adverse Event|11|||
149883084|NCT00247676|540698668|FG000|Overall Study|Lack of Efficacy|15|||
149883085|NCT00247676|540698668|FG000|Overall Study|Other|3|||
149883086|NCT00247676|540698668|FG000|Overall Study|Withdrawal by Subject|2|||
149883087|NCT04342819|540698670|FG000|Overall Study|Declined|4|||
149883088|NCT04342819|540698670|FG000|Overall Study|Not meeeting selection criteria|1|||
149883089|NCT00911300|540698671|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
149883090|NCT00911300|540698672|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
149883091|NCT00911300|540698671|FG000|Overall Study|Death|1|||
149883092|NCT00911300|540698672|FG001|Overall Study|Death|0|||
149883093|NCT00911300|540698671|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
149883094|NCT00911300|540698672|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
149883095|NCT00911300|540698671|FG000|Overall Study|Adverse Event|14|||
149883096|NCT00911300|540698672|FG001|Overall Study|Adverse Event|6|||
149883097|NCT00911300|540698671|FG000|Overall Study|Protocol Violation|3|||
149883098|NCT00911300|540698672|FG001|Overall Study|Protocol Violation|2|||
149883099|NCT00911300|540698671|FG000|Overall Study|Consent Withdrawn|4|||
149883100|NCT00911300|540698672|FG001|Overall Study|Consent Withdrawn|12|||
149883101|NCT00911300|540698671|FG000|Overall Study|Coronary Angiography Performed|1|||
149883102|NCT00911300|540698672|FG001|Overall Study|Coronary Angiography Performed|0|||
149883103|NCT00911300|540698671|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
149883104|NCT00911300|540698672|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
149883105|NCT00911300|540698671|FG000|Overall Study|Received Commercial Treatment|1|||
149883106|NCT00911300|540698672|FG001|Overall Study|Received Commercial Treatment|0|||
149883107|NCT00911300|540698671|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
149883108|NCT00911300|540698672|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
149883109|NCT00911300|540698671|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
149883110|NCT00911300|540698672|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
149883111|NCT00911300|540698671|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
149883112|NCT00911300|540698672|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
149883113|NCT00911300|540698671|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
149883114|NCT00911300|540698672|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
149883115|NCT00911300|540698671|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
149883116|NCT00911300|540698672|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
149883117|NCT00911300|540698671|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
149883118|NCT00911300|540698672|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
149883119|NCT00911300|540698671|FG000|Overall Study|International Normalized Ratio Too High|0|||
149883120|NCT00911300|540698672|FG001|Overall Study|International Normalized Ratio Too High|1|||
149883121|NCT00911300|540698671|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
149883122|NCT00911300|540698672|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
149883123|NCT00911300|540698671|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
149883124|NCT00911300|540698672|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
149883125|NCT00911300|540698671|FG000|Overall Study|Physician Decision|0|||
149883126|NCT00911300|540698672|FG001|Overall Study|Physician Decision|1|||
149883127|NCT00911300|540698671|FG000|Overall Study|Treatment Stopped by Mistake|0|||
149883128|NCT00911300|540698672|FG001|Overall Study|Treatment Stopped by Mistake|1|||
149883129|NCT00911300|540698671|FG000|Overall Study|Randomized; No Study Medication Received|0|||
149883130|NCT00911300|540698672|FG001|Overall Study|Randomized; No Study Medication Received|2|||
149883131|NCT02455518|540698673|FG000|Overall Study|Protocol Violation|0|||
149883132|NCT02455518|540698674|FG001|Overall Study|Protocol Violation|1|||
149883133|NCT02455518|540698675|FG002|Overall Study|Protocol Violation|1|||
149883134|NCT02455518|540698676|FG003|Overall Study|Protocol Violation|3|||
149883135|NCT04759703|540698682|FG000|Overall Study|Withdrawal by Subject|4|||
149883136|NCT04759703|540698683|FG001|Overall Study|Withdrawal by Subject|9|||
149883137|NCT04759703|540698682|FG000|Overall Study|Adverse Event|1|||
149883138|NCT04759703|540698683|FG001|Overall Study|Adverse Event|0|||
149883139|NCT04759703|540698682|FG000|Overall Study|Lost to Follow-up|2|||
149883140|NCT04759703|540698683|FG001|Overall Study|Lost to Follow-up|0|||
149883141|NCT01107197|540698688|FG000|Overall Study|Death|12|||
149883142|NCT01107197|540698689|FG001|Overall Study|Death|10|||
149883143|NCT01107197|540698688|FG000|Overall Study|Lost to Follow-up|5|||
149883144|NCT01107197|540698689|FG001|Overall Study|Lost to Follow-up|8|||
149883145|NCT01107197|540698688|FG000|Overall Study|Withdrawal by Subject|3|||
149883146|NCT01107197|540698689|FG001|Overall Study|Withdrawal by Subject|5|||
149883147|NCT04697069|540698690|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
149883148|NCT04697069|540698691|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
149883149|NCT04697069|540698690|FG000|Overall Study|Study termination|2|||
149965583|NCT01149460|541009543|FG000|Overall Study|Withdrawal by Subject|0|||
149965584|NCT01149460|541009544|FG001|Overall Study|Withdrawal by Subject|2|||
149883150|NCT04697069|540698691|FG001|Overall Study|Study termination|1|||
149883151|NCT05180227|540698692|FG000|Overall Study|Hypertension at screening|1|||
149883152|NCT05180227|540698692|FG000|Overall Study|Lost to Follow-up|1|||
149883153|NCT02779855|540698693|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
149883154|NCT02779855|540698694|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
149883155|NCT02779855|540698695|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
149883156|NCT01301729|540698696|FG000|Overall Study|Withdrawal by Subject|2|||
149883157|NCT01301729|540698696|FG000|Overall Study|Participant did not Return for Treatment|1|||
149883158|NCT01301729|540698696|FG000|Overall Study|Violated Selection Criteria|1|||
149883159|NCT05794503|540698697|FG000|Overall Study|Operation Cancelled|2|||
149883160|NCT05794503|540698698|FG001|Overall Study|Operation Cancelled|0|||
149883161|NCT05794503|540698697|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
149883162|NCT05794503|540698698|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
149883163|NCT05794503|540698697|FG000|Overall Study|Protocol Violation|1|||
149883164|NCT05794503|540698698|FG001|Overall Study|Protocol Violation|0|||
149883165|NCT00509795|540698699|FG000|Overall Study|Adverse Event|4|||
149883166|NCT00509795|540698700|FG001|Overall Study|Adverse Event|3|||
149883167|NCT00509795|540698701|FG002|Overall Study|Adverse Event|5|||
149883168|NCT00509795|540698702|FG003|Overall Study|Adverse Event|4|||
149883169|NCT00509795|540698699|FG000|Overall Study|Death|3|||
149883170|NCT00509795|540698700|FG001|Overall Study|Death|1|||
149883171|NCT00509795|540698701|FG002|Overall Study|Death|2|||
149883172|NCT00509795|540698702|FG003|Overall Study|Death|7|||
149883173|NCT00509795|540698699|FG000|Overall Study|Lack of Efficacy|0|||
149883174|NCT00509795|540698700|FG001|Overall Study|Lack of Efficacy|0|||
149883175|NCT00509795|540698701|FG002|Overall Study|Lack of Efficacy|2|||
149883176|NCT00509795|540698702|FG003|Overall Study|Lack of Efficacy|2|||
149883177|NCT00509795|540698699|FG000|Overall Study|Lost to Follow-up|1|||
149883178|NCT00509795|540698700|FG001|Overall Study|Lost to Follow-up|2|||
149883179|NCT00509795|540698701|FG002|Overall Study|Lost to Follow-up|4|||
149883180|NCT00509795|540698702|FG003|Overall Study|Lost to Follow-up|4|||
149883181|NCT00509795|540698699|FG000|Overall Study|OTHER|1|||
149883182|NCT00509795|540698700|FG001|Overall Study|OTHER|0|||
149883183|NCT00509795|540698701|FG002|Overall Study|OTHER|4|||
149883184|NCT00509795|540698702|FG003|Overall Study|OTHER|1|||
149883185|NCT00509795|540698699|FG000|Overall Study|Protocol Violation|3|||
149883186|NCT00509795|540698700|FG001|Overall Study|Protocol Violation|0|||
149883187|NCT00509795|540698701|FG002|Overall Study|Protocol Violation|3|||
149883188|NCT00509795|540698702|FG003|Overall Study|Protocol Violation|1|||
149883189|NCT00509795|540698699|FG000|Overall Study|Withdrawal by Subject|10|||
149883190|NCT00509795|540698700|FG001|Overall Study|Withdrawal by Subject|5|||
149883191|NCT00509795|540698701|FG002|Overall Study|Withdrawal by Subject|7|||
149883192|NCT00509795|540698702|FG003|Overall Study|Withdrawal by Subject|8|||
149883193|NCT00143247|540698704|FG000|Overall Study|Death|8|||
149883194|NCT00143247|540698704|FG000|Overall Study|Adverse Event|19|||
149883195|NCT00143247|540698704|FG000|Overall Study|Lack of Efficacy|3|||
149883196|NCT00143247|540698704|FG000|Overall Study|Withdrawal by Subject|55|||
149883197|NCT00143247|540698704|FG000|Overall Study|Study terminated by sponsor|31|||
149883198|NCT00143247|540698704|FG000|Overall Study|Protocol Violation|15|||
149883199|NCT00143247|540698704|FG000|Overall Study|Lost to Follow-up|12|||
149883200|NCT00143247|540698704|FG000|Overall Study|following inaccurate lab adverse event|1|||
149883201|NCT00143247|540698704|FG000|Overall Study|Other|12|||
149883202|NCT02766283|540698705|FG000|Overall Study|Lost to Follow-up|27|||
149883203|NCT00805961|540698706|FG000|Modality Therapy|Withdrawal by Subject|1|||
149883204|NCT00805961|540698706|FG000|Modality Therapy|Adverse Event|1|||
149883205|NCT00805961|540698706|FG000|Modality Therapy|Disease Progression|2|||
149883206|NCT00805961|540698706|FG000|Treatment-Free Interval|Adverse Event|3|||
149883207|NCT00805961|540698706|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
149883208|NCT00805961|540698706|FG000|Treatment-Free Interval|Physician Decision|1|||
149883209|NCT00805961|540698706|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
149883210|NCT00805961|540698706|FG000|Maintenance Treatment|Lack of Efficacy|13|||
149965585|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
149883211|NCT00805961|540698706|FG000|Maintenance Treatment|Intercurrent Illness|7|||
149883212|NCT00805961|540698706|FG000|Maintenance Treatment|Adverse Event|6|||
149883213|NCT00805961|540698706|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
149883214|NCT00805961|540698706|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
149883215|NCT00805961|540698706|FG000|Maintenance Treatment|Withdrawn Consent|1|||
149883216|NCT02447744|540698709|FG000|Overall Study|Withdrawal by Subject|3|||
149883217|NCT02447744|540698710|FG001|Overall Study|Withdrawal by Subject|1|||
149883218|NCT02447744|540698709|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
149883219|NCT02447744|540698710|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
149883220|NCT00912912|540698711|FG000|Overall Study|Withdrawal by Subject|1|||
149883221|NCT00912912|540698711|FG000|Overall Study|Disease Progression|3|||
149883222|NCT00306995|540698712|FG000|Study Part I|Withdrawal by Subject|0|||
149883223|NCT00306995|540698713|FG001|Study Part I|Withdrawal by Subject|0|||
149883224|NCT00306995|540698714|FG002|Study Part I|Withdrawal by Subject|0|||
149883225|NCT00306995|540698715|FG003|Study Part I|Withdrawal by Subject|0|||
149883226|NCT00306995|540698716|FG004|Study Part I|Withdrawal by Subject|0|||
149883227|NCT00306995|540698717|FG005|Study Part I|Withdrawal by Subject|0|||
149883228|NCT00306995|540698718|FG006|Study Part I|Withdrawal by Subject|1|||
149883229|NCT00306995|540698712|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
149883230|NCT00306995|540698713|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
149883231|NCT00306995|540698714|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
149883232|NCT00306995|540698715|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
149883233|NCT00306995|540698716|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
149883234|NCT00306995|540698717|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
149883235|NCT00306995|540698718|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
149883236|NCT05422625|540698719|FG000|Overall Study|Withdrawal by Subject|1|||
149883237|NCT05422625|540698720|FG001|Overall Study|Withdrawal by Subject|0|||
149883238|NCT02287922|540700394|FG000|Overall Study|Adverse Event|1|||
149883239|NCT02287922|540700395|FG001|Overall Study|Adverse Event|1|||
149883240|NCT02287922|540700396|FG002|Overall Study|Adverse Event|3|||
149883241|NCT02287922|540700397|FG003|Overall Study|Adverse Event|4|||
149883242|NCT02287922|540700394|FG000|Overall Study|Withdrawal by Subject|1|||
149883243|NCT02287922|540700395|FG001|Overall Study|Withdrawal by Subject|1|||
149883244|NCT02287922|540700396|FG002|Overall Study|Withdrawal by Subject|1|||
149883245|NCT02287922|540700397|FG003|Overall Study|Withdrawal by Subject|2|||
149883246|NCT02287922|540700394|FG000|Overall Study|Lost to Follow-up|0|||
149883247|NCT02287922|540700395|FG001|Overall Study|Lost to Follow-up|0|||
149883248|NCT02287922|540700396|FG002|Overall Study|Lost to Follow-up|1|||
149883249|NCT02287922|540700397|FG003|Overall Study|Lost to Follow-up|0|||
149883250|NCT02287922|540700394|FG000|Overall Study|Sponsor's decision|0|||
149883251|NCT02287922|540700395|FG001|Overall Study|Sponsor's decision|0|||
149883252|NCT02287922|540700396|FG002|Overall Study|Sponsor's decision|0|||
149883253|NCT02287922|540700397|FG003|Overall Study|Sponsor's decision|1|||
149883254|NCT02287922|540700394|FG000|Overall Study|Other|1|||
149883255|NCT02287922|540700395|FG001|Overall Study|Other|0|||
149883256|NCT02287922|540700396|FG002|Overall Study|Other|2|||
149883257|NCT02287922|540700397|FG003|Overall Study|Other|0|||
149883258|NCT00668317|540700398|FG000|Overall Study|Adverse Event|2|||
149883259|NCT03668808|540700404|FG000|First Intervention|Withdrawal by Subject|2|||
149883260|NCT03668808|540700405|FG001|First Intervention|Withdrawal by Subject|2|||
149883261|NCT01526655|540700408|FG000|Overall Study|Withdrawal by Subject|0|||
149883262|NCT01526655|540700409|FG001|Overall Study|Withdrawal by Subject|1|||
149883263|NCT00280735|540700410|FG000|Overall Study|Adverse Event|5|||
149883264|NCT00280735|540700410|FG000|Overall Study|Lack of Efficacy|3|||
149883265|NCT00280735|540700410|FG000|Overall Study|Withdrawal by Subject|8|||
149883266|NCT00280735|540700410|FG000|Overall Study|Intercurrent Illness|2|||
149883267|NCT04753216|540700411|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
149883268|NCT04753216|540700411|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
149883269|NCT04753216|540700411|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
149883270|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
149883271|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Death|1|||
149883272|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
149883273|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
149883274|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
149883275|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
150174991|NCT05764161|541777011|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
150174992|NCT05764161|541777010|FG000|40-week OLE Period|Lack of Efficacy|0|||
149883276|NCT02001987|540700413|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
149883277|NCT02001987|540700413|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
149883278|NCT02001987|540700413|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
149883279|NCT02001987|540700413|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
149883280|NCT02001987|540700413|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
149883281|NCT02001987|540700413|FG000|LTE Period (52 Weeks)|Other|3|||
149883282|NCT01965860|540700414|FG000|Overall Study|Pregnancy|1|||
149883283|NCT01965860|540700415|FG001|Overall Study|Pregnancy|0|||
149883284|NCT01965860|540700416|FG002|Overall Study|Pregnancy|1|||
149883285|NCT01965860|540700414|FG000|Overall Study|Logistics|1|||
149883286|NCT01965860|540700415|FG001|Overall Study|Logistics|0|||
149883287|NCT01965860|540700416|FG002|Overall Study|Logistics|0|||
149883288|NCT01895777|540700417|FG000|Overall Study|Adverse Event|1|||
149883289|NCT01895777|540700418|FG001|Overall Study|Adverse Event|2|||
149883290|NCT01895777|540700417|FG000|Overall Study|Lost to Follow-up|2|||
149883291|NCT01895777|540700418|FG001|Overall Study|Lost to Follow-up|0|||
149883292|NCT01895777|540700417|FG000|Overall Study|Not treated|1|||
149883293|NCT01895777|540700418|FG001|Overall Study|Not treated|0|||
149883294|NCT01895777|540700417|FG000|Overall Study|Other reasons|3|||
149883295|NCT01895777|540700418|FG001|Overall Study|Other reasons|2|||
149883296|NCT01895777|540700417|FG000|Overall Study|Non-compliance with the CTP|2|||
149883297|NCT01895777|540700418|FG001|Overall Study|Non-compliance with the CTP|1|||
149883298|NCT02064296|540700422|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
149883299|NCT02064296|540700423|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
149883300|NCT02064296|540700424|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
149883301|NCT02064296|540700422|FG000|Intervention|Withdrawal by Subject|0|||
149883302|NCT02064296|540700423|FG001|Intervention|Withdrawal by Subject|1|||
149883303|NCT02064296|540700424|FG002|Intervention|Withdrawal by Subject|2|||
149883304|NCT02288325|540700438|FG000|Run-in Period|Adverse Event|48|||
149883305|NCT02288325|540700439|FG001|Run-in Period|Adverse Event|0|||
149883306|NCT02288325|540700440|FG002|Run-in Period|Adverse Event|0|||
149883307|NCT02288325|540700438|FG000|Run-in Period|Lack of Efficacy|16|||
149883308|NCT02288325|540700439|FG001|Run-in Period|Lack of Efficacy|0|||
149883309|NCT02288325|540700440|FG002|Run-in Period|Lack of Efficacy|0|||
149883310|NCT02288325|540700438|FG000|Run-in Period|Withdrawal of Consent|28|||
149883311|NCT02288325|540700439|FG001|Run-in Period|Withdrawal of Consent|0|||
149883312|NCT02288325|540700440|FG002|Run-in Period|Withdrawal of Consent|0|||
149883313|NCT02288325|540700438|FG000|Run-in Period|Lost to Follow-up|25|||
149883314|NCT02288325|540700439|FG001|Run-in Period|Lost to Follow-up|0|||
149883315|NCT02288325|540700440|FG002|Run-in Period|Lost to Follow-up|0|||
149883316|NCT02288325|540700438|FG000|Run-in Period|Protocol Violation|17|||
149883317|NCT02288325|540700439|FG001|Run-in Period|Protocol Violation|0|||
149883318|NCT02288325|540700440|FG002|Run-in Period|Protocol Violation|0|||
149883319|NCT02288325|540700438|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
149883320|NCT02288325|540700439|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
149883321|NCT02288325|540700440|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
149883322|NCT02288325|540700438|FG000|Run-in Period|Reason not Specified|8|||
149883323|NCT02288325|540700439|FG001|Run-in Period|Reason not Specified|0|||
149883324|NCT02288325|540700440|FG002|Run-in Period|Reason not Specified|0|||
149883325|NCT02288325|540700438|FG000|Stabilization Period|Adverse Event|13|||
149883326|NCT02288325|540700439|FG001|Stabilization Period|Adverse Event|0|||
149883327|NCT02288325|540700440|FG002|Stabilization Period|Adverse Event|0|||
149883328|NCT02288325|540700438|FG000|Stabilization Period|Lack of Efficacy|22|||
149883329|NCT02288325|540700439|FG001|Stabilization Period|Lack of Efficacy|0|||
149883330|NCT02288325|540700440|FG002|Stabilization Period|Lack of Efficacy|0|||
149883331|NCT02288325|540700438|FG000|Stabilization Period|Withdrawal of Consent|23|||
149883332|NCT02288325|540700439|FG001|Stabilization Period|Withdrawal of Consent|0|||
149883333|NCT02288325|540700440|FG002|Stabilization Period|Withdrawal of Consent|0|||
149883334|NCT02288325|540700438|FG000|Stabilization Period|Lost to Follow-up|12|||
149883335|NCT02288325|540700439|FG001|Stabilization Period|Lost to Follow-up|0|||
149883336|NCT02288325|540700440|FG002|Stabilization Period|Lost to Follow-up|0|||
149965586|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
149883337|NCT02288325|540700438|FG000|Stabilization Period|Protocol Violation|8|||
149883338|NCT02288325|540700439|FG001|Stabilization Period|Protocol Violation|0|||
149883339|NCT02288325|540700440|FG002|Stabilization Period|Protocol Violation|0|||
149883340|NCT02288325|540700438|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
149883341|NCT02288325|540700439|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
149883342|NCT02288325|540700440|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
149883343|NCT02288325|540700438|FG000|Stabilization Period|Reason not Specified|15|||
149883344|NCT02288325|540700439|FG001|Stabilization Period|Reason not Specified|0|||
149883345|NCT02288325|540700440|FG002|Stabilization Period|Reason not Specified|0|||
149883346|NCT02288325|540700438|FG000|Double-blind Treatment Period|Adverse Event|0|||
149883347|NCT02288325|540700439|FG001|Double-blind Treatment Period|Adverse Event|2|||
149883348|NCT02288325|540700440|FG002|Double-blind Treatment Period|Adverse Event|5|||
149883349|NCT02288325|540700438|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
149883350|NCT02288325|540700439|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
149883351|NCT02288325|540700440|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
149883352|NCT02288325|540700438|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149883353|NCT02288325|540700439|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
149883354|NCT02288325|540700440|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
149883355|NCT02288325|540700438|FG000|Double-blind Treatment Period|Protocol Violation|0|||
149883356|NCT02288325|540700439|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149883357|NCT02288325|540700440|FG002|Double-blind Treatment Period|Protocol Violation|2|||
149883358|NCT02288325|540700438|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
149883359|NCT02288325|540700439|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
149883360|NCT02288325|540700440|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
149883361|NCT02288325|540700438|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
149883362|NCT02288325|540700439|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
149883363|NCT02288325|540700440|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
149883364|NCT03607487|540700443|FG000|Overall Study|Withdrawal by Subject|2|||
149883365|NCT03607487|540700444|FG001|Overall Study|Withdrawal by Subject|0|||
149883366|NCT03607487|540700445|FG002|Overall Study|Withdrawal by Subject|0|||
149883367|NCT03607487|540700446|FG003|Overall Study|Withdrawal by Subject|1|||
149883368|NCT01884337|540700447|FG000|Treatment|Adverse Event|2|||
149883369|NCT01884337|540700448|FG001|Treatment|Adverse Event|2|||
149965587|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
149965588|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
149965589|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
149965590|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
149965591|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
149883370|NCT01884337|540700447|FG000|Treatment|Subj. request to discont. treatment|2|||
149883371|NCT01884337|540700448|FG001|Treatment|Subj. request to discont. treatment|0|||
149883372|NCT01884337|540700447|FG000|Follow-up Period|Lost to Follow-up|1|||
149883373|NCT01884337|540700448|FG001|Follow-up Period|Lost to Follow-up|1|||
149883374|NCT04223752|540700450|FG000|Overall Study|Participant enrolled in error|0|||
149883375|NCT04223752|540700451|FG001|Overall Study|Participant enrolled in error|0|||
149883376|NCT04223752|540700452|FG002|Overall Study|Participant enrolled in error|0|||
149883377|NCT04223752|540700453|FG003|Overall Study|Participant enrolled in error|0|||
149883378|NCT04223752|540700454|FG004|Overall Study|Participant enrolled in error|1|||
149883379|NCT04223752|540700450|FG000|Overall Study|Death|0|||
149883380|NCT04223752|540700451|FG001|Overall Study|Death|0|||
149883381|NCT04223752|540700452|FG002|Overall Study|Death|0|||
149883382|NCT04223752|540700453|FG003|Overall Study|Death|2|||
149883383|NCT04223752|540700454|FG004|Overall Study|Death|1|||
149883384|NCT04186845|540700462|FG000|Overall Study|Death|2|||
149883385|NCT04186845|540700462|FG000|Overall Study|Lost to Follow-up|1|||
149883386|NCT04186845|540700462|FG000|Overall Study|Physician Decision|1|||
149883387|NCT04186845|540700462|FG000|Overall Study|Protocol Violation|1|||
149883388|NCT04186845|540700462|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
149883389|NCT04186845|540700462|FG000|Overall Study|Biopsy ordered but not done|1|||
149883390|NCT04186845|540700462|FG000|Overall Study|It was previously confirmed|1|||
149883391|NCT04186845|540700462|FG000|Overall Study|Patient cancelled scheduled scans|2|||
149883392|NCT04186845|540700462|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
149883393|NCT04186845|540700462|FG000|Overall Study|Subject refused confirmatory imaging|1|||
149883394|NCT04186845|540700462|FG000|Overall Study|Too small to biopsy|1|||
149883395|NCT05061420|540700463|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
149883396|NCT05061420|540700464|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
149883397|NCT05061420|540700465|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
149883398|NCT05061420|540700463|FG000|Overall Study|Progressive disease|11|||
149883399|NCT05061420|540700464|FG001|Overall Study|Progressive disease|15|||
149883400|NCT05061420|540700465|FG002|Overall Study|Progressive disease|14|||
149883401|NCT05061420|540700463|FG000|Overall Study|Withdrawal by Subject|2|||
149883402|NCT05061420|540700464|FG001|Overall Study|Withdrawal by Subject|0|||
149883403|NCT05061420|540700465|FG002|Overall Study|Withdrawal by Subject|1|||
149883404|NCT05061420|540700463|FG000|Overall Study|Not related to COVID-19|2|||
149883405|NCT05061420|540700464|FG001|Overall Study|Not related to COVID-19|0|||
149883406|NCT05061420|540700465|FG002|Overall Study|Not related to COVID-19|0|||
149883407|NCT01814553|540700466|FG000|Overall Study|PD per clinical progression|6|||
149883408|NCT01814553|540700467|FG001|Overall Study|PD per clinical progression|8|||
149883409|NCT01814553|540700466|FG000|Overall Study|Other Adverse Event|4|||
149883410|NCT01814553|540700467|FG001|Overall Study|Other Adverse Event|5|||
149883411|NCT01814553|540700466|FG000|Overall Study|Withdrawal by Subject|1|||
149883412|NCT01814553|540700467|FG001|Overall Study|Withdrawal by Subject|1|||
149883413|NCT01814553|540700466|FG000|Overall Study|Other than stated|7|||
149883414|NCT01814553|540700467|FG001|Overall Study|Other than stated|8|||
149883415|NCT04138823|540700468|FG000|Overall Study|Clinical disease progression|0|||
149883416|NCT04138823|540700469|FG001|Overall Study|Clinical disease progression|0|||
149883417|NCT04138823|540700470|FG002|Overall Study|Clinical disease progression|1|||
149883418|NCT04138823|540700468|FG000|Overall Study|Objective disease progression|3|||
149883419|NCT04138823|540700469|FG001|Overall Study|Objective disease progression|2|||
149883420|NCT04138823|540700470|FG002|Overall Study|Objective disease progression|5|||
149883421|NCT04036110|540700471|FG000|Overall Study|Lost to Follow-up|3|||
149883422|NCT04036110|540700472|FG001|Overall Study|Lost to Follow-up|2|||
149883423|NCT04036110|540700473|FG002|Overall Study|Lost to Follow-up|1|||
149883424|NCT04036110|540700471|FG000|Overall Study|Study Suspended|4|||
150043901|NCT01237899|541300724|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
149883425|NCT04036110|540700472|FG001|Overall Study|Study Suspended|5|||
149883426|NCT04036110|540700473|FG002|Overall Study|Study Suspended|1|||
149883427|NCT02466685|540700474|FG000|Overall Study|Adverse Event|5|||
149883428|NCT02466685|540700475|FG001|Overall Study|Adverse Event|2|||
149883429|NCT02466685|540700474|FG000|Overall Study|Lost to Follow-up|1|||
149883430|NCT02466685|540700475|FG001|Overall Study|Lost to Follow-up|1|||
149883431|NCT02466685|540700474|FG000|Overall Study|Withdrawal by Subject|1|||
149883432|NCT02466685|540700475|FG001|Overall Study|Withdrawal by Subject|0|||
149883433|NCT02466685|540700474|FG000|Overall Study|Physician Decision|1|||
149883434|NCT02466685|540700475|FG001|Overall Study|Physician Decision|1|||
149883435|NCT00796757|540700476|FG000|Overall Study|Withdrawal by Subject|14|||
149883436|NCT00796757|540700476|FG000|Overall Study|Death|61|||
149883437|NCT00796757|540700476|FG000|Overall Study|Protocol Violation|1|||
150174993|NCT05764161|541777011|FG001|40-week OLE Period|Lack of Efficacy|1|||
149883438|NCT00796757|540700476|FG000|Overall Study|Participant noncompliance|1|||
149883439|NCT00796757|540700476|FG000|Overall Study|Investigator's decision|2|||
150174994|NCT05764161|541777010|FG000|40-week OLE Period|Lost to Follow-up|1|||
150174995|NCT05764161|541777011|FG001|40-week OLE Period|Lost to Follow-up|4|||
149883440|NCT00796757|540700476|FG000|Overall Study|Other|7|||
149883441|NCT02593110|540700477|FG000|Overall Study|Withdrawal by Subject|0|||
149883442|NCT02593110|540700478|FG001|Overall Study|Withdrawal by Subject|3|||
149883443|NCT02593110|540700479|FG002|Overall Study|Withdrawal by Subject|3|||
149883444|NCT02593110|540700480|FG003|Overall Study|Withdrawal by Subject|2|||
149883445|NCT02593110|540700477|FG000|Overall Study|Death|0|||
149883446|NCT02593110|540700478|FG001|Overall Study|Death|0|||
149883447|NCT02593110|540700479|FG002|Overall Study|Death|1|||
149883448|NCT02593110|540700480|FG003|Overall Study|Death|0|||
149883449|NCT03548337|540700481|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
149883450|NCT03548337|540700482|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
149883451|NCT03548337|540700481|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
149883452|NCT03548337|540700482|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
149883453|NCT03548337|540700481|FG000|Infant Series|Lost to Follow-up|2|||
149883454|NCT03548337|540700482|FG001|Infant Series|Lost to Follow-up|1|||
149883455|NCT03548337|540700481|FG000|Infant Series|Adverse Event|0|||
149883456|NCT03548337|540700482|FG001|Infant Series|Adverse Event|2|||
149883457|NCT03548337|540700481|FG000|Infant Series|Randomized but Not Vaccinated|1|||
149883458|NCT03548337|540700482|FG001|Infant Series|Randomized but Not Vaccinated|0|||
149883459|NCT03548337|540700481|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
149883460|NCT03548337|540700482|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
149883461|NCT01911273|540700485|FG000|Overall Study|Progression of Disease|1|||
149883462|NCT01911273|540700486|FG001|Overall Study|Progression of Disease|0|||
149965592|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
149965593|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
149965594|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
149965595|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
149965596|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
149965597|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
149965598|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
149965599|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
149965600|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
149965601|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
149965602|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
149965603|NCT01432444|541009545|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
149883463|NCT01911273|540700485|FG000|Overall Study|Withdrawal by Subject|0|||
149883464|NCT01911273|540700486|FG001|Overall Study|Withdrawal by Subject|2|||
149883465|NCT00447993|540700489|FG000|Overall Study|Lost to Follow-up|0|||
149883466|NCT00447993|540700490|FG001|Overall Study|Lost to Follow-up|0|||
149883467|NCT00447993|540700491|FG002|Overall Study|Lost to Follow-up|2|||
149883468|NCT00447993|540700492|FG003|Overall Study|Lost to Follow-up|2|||
149883469|NCT00447993|540700489|FG000|Overall Study|Withdrawal by Subject|0|||
149883470|NCT00447993|540700490|FG001|Overall Study|Withdrawal by Subject|0|||
149883471|NCT00447993|540700491|FG002|Overall Study|Withdrawal by Subject|2|||
149883472|NCT00447993|540700492|FG003|Overall Study|Withdrawal by Subject|2|||
149883473|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
149883474|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Off-label use|283|||
149883475|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
149883476|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
149883477|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
149883478|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
149883479|NCT01070953|540700497|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
149883480|NCT01070953|540700497|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
149883481|NCT01070953|540700497|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
149883482|NCT01070953|540700497|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
149883483|NCT02503787|540700498|FG000|Enrollment|Withdrawal by Subject|6|||
149883484|NCT02503787|540700498|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
149883485|NCT02503787|540700498|FG000|Enrollment|Physician Decision|2|||
149883486|NCT02503787|540700498|FG000|Enrollment|Insurance issue|2|||
149883487|NCT02503787|540700498|FG000|Enrollment|Lost to Follow-up|1|||
149883488|NCT02503787|540700498|FG000|Enrollment|Study closure|1|||
149883489|NCT02503787|540700498|FG000|Enrollment|Adverse Event|1|||
149883490|NCT02503787|540700498|FG000|Enrollment|Protocol Violation|1|||
149883491|NCT02503787|540700498|FG000|Enrollment|Inability to implant system|1|||
149883492|NCT02503787|540700498|FG000|Enrollment|Unable to be programmed|1|||
149883493|NCT02503787|540700498|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
149883494|NCT02503787|540700498|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
149883495|NCT02503787|540700498|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
149883496|NCT02503787|540700498|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
149883497|NCT02503787|540700498|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
149883498|NCT02503787|540700498|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
149883499|NCT04700137|540700499|FG000|Overall Study|Lost to Follow-up|1|||
149883500|NCT04700137|540700500|FG001|Overall Study|Lost to Follow-up|6|||
149883501|NCT04700137|540700501|FG002|Overall Study|Lost to Follow-up|1|||
149883502|NCT04700137|540700502|FG003|Overall Study|Lost to Follow-up|1|||
149883503|NCT04700137|540700499|FG000|Overall Study|Withdrawal by Subject|0|||
149965604|NCT01432444|541009546|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
150043902|NCT01237899|541300725|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
149883504|NCT04700137|540700500|FG001|Overall Study|Withdrawal by Subject|0|||
149883505|NCT04700137|540700501|FG002|Overall Study|Withdrawal by Subject|1|||
149883506|NCT04700137|540700502|FG003|Overall Study|Withdrawal by Subject|0|||
149883507|NCT04700137|540700499|FG000|Overall Study|Death|0|||
149883508|NCT04700137|540700500|FG001|Overall Study|Death|0|||
149883509|NCT04700137|540700501|FG002|Overall Study|Death|1|||
149883510|NCT04700137|540700502|FG003|Overall Study|Death|0|||
149883511|NCT04787627|540700503|FG000|Overall Study|Withdrawal by Subject|3|||
149883512|NCT04787627|540700504|FG001|Overall Study|Withdrawal by Subject|0|||
149883513|NCT04787627|540700503|FG000|Overall Study|Physician Decision|2|||
149883514|NCT04787627|540700504|FG001|Overall Study|Physician Decision|0|||
149883515|NCT04787627|540700503|FG000|Overall Study|Excluded|0|||
149883516|NCT04787627|540700504|FG001|Overall Study|Excluded|1|||
149883517|NCT00548093|540700505|FG000|Overall Study|Death|33|||
149883518|NCT00548093|540700506|FG001|Overall Study|Death|13|||
149883519|NCT00548093|540700505|FG000|Overall Study|Lost to Follow-up|3|||
149883520|NCT00548093|540700506|FG001|Overall Study|Lost to Follow-up|1|||
149883521|NCT00548093|540700505|FG000|Overall Study|Objective progression or relapse|1|||
149883522|NCT00548093|540700506|FG001|Overall Study|Objective progression or relapse|1|||
149883523|NCT00548093|540700505|FG000|Overall Study|Other|11|||
149883524|NCT00548093|540700506|FG001|Overall Study|Other|1|||
149883525|NCT00548093|540700505|FG000|Overall Study|Withdrawal by Subject|1|||
149883526|NCT00548093|540700506|FG001|Overall Study|Withdrawal by Subject|0|||
149883527|NCT00548093|540700505|FG000|Overall Study|Completed post-treatment follow-up|1|||
149883528|NCT00548093|540700506|FG001|Overall Study|Completed post-treatment follow-up|0|||
149883529|NCT02924727|540700507|FG000|Overall Study|Withdrawal by Subject|2|||
149883530|NCT02924727|540700508|FG001|Overall Study|Withdrawal by Subject|4|||
149883531|NCT02924727|540700507|FG000|Overall Study|Lost to Follow-up|2|||
149883532|NCT02924727|540700508|FG001|Overall Study|Lost to Follow-up|5|||
149965605|NCT01432444|541009547|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
149965606|NCT01432444|541009545|FG000|Treatment Phase|Lost to Follow-up|0|||
149965607|NCT01432444|541009546|FG001|Treatment Phase|Lost to Follow-up|33|||
149965608|NCT01432444|541009547|FG002|Treatment Phase|Lost to Follow-up|0|||
149965609|NCT01432444|541009545|FG000|Treatment Phase|Adverse Event|0|||
149965610|NCT01432444|541009546|FG001|Treatment Phase|Adverse Event|37|||
149965611|NCT01432444|541009547|FG002|Treatment Phase|Adverse Event|0|||
149965612|NCT01432444|541009545|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
149965613|NCT01432444|541009546|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
149965614|NCT01432444|541009547|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
149965615|NCT01432444|541009545|FG000|Treatment Phase|Physician Decision|0|||
149965616|NCT01432444|541009546|FG001|Treatment Phase|Physician Decision|5|||
149965617|NCT01432444|541009547|FG002|Treatment Phase|Physician Decision|0|||
149965618|NCT01432444|541009545|FG000|Treatment Phase|Withdrawal by Subject|0|||
149965619|NCT01432444|541009546|FG001|Treatment Phase|Withdrawal by Subject|41|||
149965620|NCT01432444|541009547|FG002|Treatment Phase|Withdrawal by Subject|0|||
149965621|NCT01432444|541009545|FG000|Treatment Phase|Protocol Deviation|0|||
149965622|NCT01432444|541009546|FG001|Treatment Phase|Protocol Deviation|3|||
149965623|NCT01432444|541009547|FG002|Treatment Phase|Protocol Deviation|0|||
149965624|NCT01432444|541009545|FG000|Treatment Phase|Lack of Efficacy|0|||
149965625|NCT01432444|541009546|FG001|Treatment Phase|Lack of Efficacy|10|||
149965626|NCT01432444|541009547|FG002|Treatment Phase|Lack of Efficacy|0|||
149965627|NCT01432444|541009545|FG000|Extension Phase|Lost to Follow-up|0|||
149965628|NCT01432444|541009546|FG001|Extension Phase|Lost to Follow-up|0|||
149965629|NCT01432444|541009547|FG002|Extension Phase|Lost to Follow-up|17|||
149965630|NCT01432444|541009545|FG000|Extension Phase|Adverse Event|0|||
149965631|NCT01432444|541009546|FG001|Extension Phase|Adverse Event|0|||
149965632|NCT01432444|541009547|FG002|Extension Phase|Adverse Event|10|||
149965633|NCT01432444|541009545|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
149965634|NCT01432444|541009546|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
149965635|NCT01432444|541009547|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
149965636|NCT01432444|541009545|FG000|Extension Phase|Met Withdrawal Criteria|0|||
149965637|NCT01432444|541009546|FG001|Extension Phase|Met Withdrawal Criteria|0|||
149965638|NCT01432444|541009547|FG002|Extension Phase|Met Withdrawal Criteria|144|||
149965639|NCT01432444|541009545|FG000|Extension Phase|Physician Decision|0|||
149965640|NCT01432444|541009546|FG001|Extension Phase|Physician Decision|0|||
150043903|NCT01237899|541300726|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
150043904|NCT01237899|541300727|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
150043905|NCT01237899|541300728|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
150043906|NCT01237899|541300729|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
150043907|NCT01237899|541300730|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
150043908|NCT01237899|541300731|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
150043909|NCT01237899|541300732|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
150043910|NCT01237899|541300733|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
150043911|NCT01237899|541300734|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
150043912|NCT00790088|541300735|FG000|Overall Study|Protocol Violation|11|||
150043913|NCT00790088|541300735|FG000|Overall Study|Withdrawal by Subject|17|||
150043914|NCT00790088|541300735|FG000|Overall Study|Lost to Follow-up|7|||
150043915|NCT00790088|541300735|FG000|Overall Study|Physician Decision|4|||
150043916|NCT04269265|541300736|FG000|Overall Study|Physician Decision|1|||
150043917|NCT04269265|541300736|FG000|Overall Study|Withdrawal by Subject|1|||
150043918|NCT04269265|541300736|FG000|Overall Study|Overenrolled (sample size reached)|4|||
150174996|NCT05764161|541777010|FG000|40-week OLE Period|Withdrawal by Subject|2|||
149965641|NCT01432444|541009547|FG002|Extension Phase|Physician Decision|1|||
149965642|NCT01432444|541009545|FG000|Extension Phase|Withdrawal by Subject|0|||
149965643|NCT01432444|541009546|FG001|Extension Phase|Withdrawal by Subject|0|||
149965644|NCT01432444|541009547|FG002|Extension Phase|Withdrawal by Subject|13|||
149965645|NCT01225952|541009549|FG000|Overall Study|Lost to Follow-up|1|||
149965646|NCT01225952|541009550|FG001|Overall Study|Lost to Follow-up|0|||
149965647|NCT01225952|541009551|FG002|Overall Study|Lost to Follow-up|0|||
149965648|NCT01225952|541009549|FG000|Overall Study|Study Eye Explanted|0|||
149965649|NCT01225952|541009550|FG001|Overall Study|Study Eye Explanted|0|||
149965650|NCT01225952|541009551|FG002|Overall Study|Study Eye Explanted|1|||
149965651|NCT01225952|541009549|FG000|Overall Study|Withdrawal by Subject|4|||
149965652|NCT01225952|541009550|FG001|Overall Study|Withdrawal by Subject|4|||
149965653|NCT01225952|541009551|FG002|Overall Study|Withdrawal by Subject|5|||
149965654|NCT01225952|541009549|FG000|Overall Study|Surgical complications|1|||
149965655|NCT01225952|541009550|FG001|Overall Study|Surgical complications|0|||
149965656|NCT01225952|541009551|FG002|Overall Study|Surgical complications|0|||
149965657|NCT02014467|541009552|FG000|Overall Study|Adverse Event|4|||
149965658|NCT02014467|541009553|FG001|Overall Study|Adverse Event|0|||
149965659|NCT02014467|541009552|FG000|Overall Study|Protocol Violation|3|||
149965660|NCT02014467|541009553|FG001|Overall Study|Protocol Violation|0|||
149965661|NCT02014467|541009552|FG000|Overall Study|Physician Decision|2|||
149965662|NCT02014467|541009553|FG001|Overall Study|Physician Decision|3|||
149965663|NCT02014467|541009552|FG000|Overall Study|Withdrawal by Subject|16|||
149965664|NCT02014467|541009553|FG001|Overall Study|Withdrawal by Subject|4|||
149965665|NCT01230060|541009554|FG000|Overall Study|Withdrawal by Subject|1|||
149965666|NCT03802916|541009555|FG000|Overall Study|Adverse Event|0|||
149965667|NCT03802916|541009556|FG001|Overall Study|Adverse Event|1|||
149965668|NCT03802916|541009555|FG000|Overall Study|Withdrawal by Subject|0|||
149965669|NCT03802916|541009556|FG001|Overall Study|Withdrawal by Subject|1|||
149965670|NCT00480532|541009557|FG000|Overall Study|Withdrawal by Subject|2|||
149965671|NCT00480532|541009558|FG001|Overall Study|Withdrawal by Subject|4|||
149965672|NCT00480532|541009559|FG002|Overall Study|Withdrawal by Subject|3|||
149965673|NCT00480532|541009560|FG003|Overall Study|Withdrawal by Subject|1|||
149965674|NCT00480532|541009557|FG000|Overall Study|Protocol Violation|0|||
149965675|NCT00480532|541009558|FG001|Overall Study|Protocol Violation|0|||
149965676|NCT00480532|541009559|FG002|Overall Study|Protocol Violation|1|||
149965677|NCT00480532|541009560|FG003|Overall Study|Protocol Violation|0|||
149965678|NCT00443456|541009561|FG000|Overall Study|Adverse Event|16|||
149965679|NCT00443456|541009561|FG000|Overall Study|Move|1|||
149965680|NCT00443456|541009561|FG000|Overall Study|Withdrawal by Subject|1|||
150043919|NCT04439136|541300737|FG000|Overall Study|Ineligible|1|||
150043920|NCT04439136|541300737|FG000|Overall Study|Never Started Treatment|2|||
149965681|NCT02157610|541009562|FG000|Overall Study|Death|4|||
150174997|NCT05764161|541777011|FG001|40-week OLE Period|Withdrawal by Subject|7|||
150174998|NCT05764161|541777010|FG000|40-week OLE Period|Extended Travel|0|||
149883533|NCT02924727|540700507|FG000|Overall Study|Death|221|||
149883534|NCT02924727|540700508|FG001|Overall Study|Death|247|||
149883535|NCT02924727|540700507|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
149883536|NCT02924727|540700508|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
149883537|NCT01464931|540700513|FG000|Overall Study|Withdrawal by Subject|1|||
149883538|NCT01464931|540700514|FG001|Overall Study|Withdrawal by Subject|0|||
149883539|NCT01982812|540700517|FG000|Overall Study|Death|1|||
149883540|NCT01982812|540700518|FG001|Overall Study|Death|5|||
149883541|NCT01982812|540700517|FG000|Overall Study|Adverse Event|0|||
149883542|NCT01982812|540700518|FG001|Overall Study|Adverse Event|5|||
149883543|NCT00174954|540700520|FG000|Overall Study|Adverse Event|2|||
149883544|NCT00174954|540700520|FG000|Overall Study|No tophi found in MRI|1|||
149883545|NCT00174954|540700520|FG000|Overall Study|Physician Decision|1|||
149883546|NCT00839254|540700521|FG000|Overall Study|Protocol Violation|0|||
149965682|NCT02157610|541009563|FG001|Overall Study|Death|4|||
149883547|NCT00839254|540700522|FG001|Overall Study|Protocol Violation|1|||
149883548|NCT00839254|540700523|FG002|Overall Study|Protocol Violation|1|||
149883549|NCT00839254|540700524|FG003|Overall Study|Protocol Violation|1|||
149883550|NCT00839254|540700525|FG004|Overall Study|Protocol Violation|0|||
149883551|NCT00839254|540700526|FG005|Overall Study|Protocol Violation|0|||
149883552|NCT00839254|540700527|FG006|Overall Study|Protocol Violation|1|||
149883553|NCT00839254|540700528|FG007|Overall Study|Protocol Violation|2|||
149883554|NCT00839254|540700521|FG000|Overall Study|Physician Decision|0|||
149883555|NCT00839254|540700522|FG001|Overall Study|Physician Decision|1|||
149883556|NCT00839254|540700523|FG002|Overall Study|Physician Decision|0|||
149883557|NCT00839254|540700524|FG003|Overall Study|Physician Decision|0|||
149883558|NCT00839254|540700525|FG004|Overall Study|Physician Decision|0|||
149883559|NCT00839254|540700526|FG005|Overall Study|Physician Decision|0|||
149883560|NCT00839254|540700527|FG006|Overall Study|Physician Decision|0|||
149883561|NCT00839254|540700528|FG007|Overall Study|Physician Decision|1|||
149883562|NCT00839254|540700521|FG000|Overall Study|Wrong treatment number allocation|0|||
149883563|NCT00839254|540700522|FG001|Overall Study|Wrong treatment number allocation|1|||
149883564|NCT00839254|540700523|FG002|Overall Study|Wrong treatment number allocation|0|||
149883565|NCT00839254|540700524|FG003|Overall Study|Wrong treatment number allocation|0|||
149883566|NCT00839254|540700525|FG004|Overall Study|Wrong treatment number allocation|0|||
149883567|NCT00839254|540700526|FG005|Overall Study|Wrong treatment number allocation|1|||
149883568|NCT00839254|540700527|FG006|Overall Study|Wrong treatment number allocation|0|||
149883569|NCT00839254|540700528|FG007|Overall Study|Wrong treatment number allocation|0|||
149883570|NCT00839254|540700521|FG000|Overall Study|Adverse Event|12|||
149883571|NCT00839254|540700522|FG001|Overall Study|Adverse Event|6|||
149883572|NCT00839254|540700523|FG002|Overall Study|Adverse Event|3|||
149883573|NCT00839254|540700524|FG003|Overall Study|Adverse Event|5|||
149883574|NCT00839254|540700525|FG004|Overall Study|Adverse Event|2|||
149883575|NCT00839254|540700526|FG005|Overall Study|Adverse Event|1|||
149883576|NCT00839254|540700527|FG006|Overall Study|Adverse Event|0|||
149883577|NCT00839254|540700528|FG007|Overall Study|Adverse Event|1|||
149883578|NCT00839254|540700521|FG000|Overall Study|Withdrawal by Subject|87|||
149883579|NCT00839254|540700522|FG001|Overall Study|Withdrawal by Subject|53|||
149883580|NCT00839254|540700523|FG002|Overall Study|Withdrawal by Subject|54|||
149883581|NCT00839254|540700524|FG003|Overall Study|Withdrawal by Subject|32|||
149883582|NCT00839254|540700525|FG004|Overall Study|Withdrawal by Subject|27|||
149883583|NCT00839254|540700526|FG005|Overall Study|Withdrawal by Subject|15|||
149965683|NCT01592747|541009564|FG000|Overall Study|Loss of Therapeutic Response|107|||
149883584|NCT00839254|540700527|FG006|Overall Study|Withdrawal by Subject|22|||
149883585|NCT00839254|540700528|FG007|Overall Study|Withdrawal by Subject|9|||
149965684|NCT01592747|541009565|FG001|Overall Study|Loss of Therapeutic Response|108|||
149883586|NCT00839254|540700521|FG000|Overall Study|Wrong group allocation|0|||
149883587|NCT00839254|540700522|FG001|Overall Study|Wrong group allocation|0|||
150043921|NCT04439136|541300737|FG000|Overall Study|Adverse Event|4|||
149883588|NCT00839254|540700523|FG002|Overall Study|Wrong group allocation|0|||
149883589|NCT00839254|540700524|FG003|Overall Study|Wrong group allocation|0|||
149883590|NCT00839254|540700525|FG004|Overall Study|Wrong group allocation|0|||
149883591|NCT00839254|540700526|FG005|Overall Study|Wrong group allocation|0|||
149883592|NCT00839254|540700527|FG006|Overall Study|Wrong group allocation|1|||
149883593|NCT00839254|540700528|FG007|Overall Study|Wrong group allocation|0|||
149883594|NCT00839254|540700521|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
149883595|NCT00839254|540700522|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883596|NCT00839254|540700523|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883597|NCT00839254|540700524|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883598|NCT00839254|540700525|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883599|NCT00839254|540700526|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
149883600|NCT00839254|540700527|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883601|NCT00839254|540700528|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
149883602|NCT00839254|540700521|FG000|Overall Study|Withdrawn due to non-compliance|2|||
149883603|NCT00839254|540700522|FG001|Overall Study|Withdrawn due to non-compliance|0|||
149883604|NCT00839254|540700523|FG002|Overall Study|Withdrawn due to non-compliance|0|||
149883605|NCT00839254|540700524|FG003|Overall Study|Withdrawn due to non-compliance|0|||
149883606|NCT00839254|540700525|FG004|Overall Study|Withdrawn due to non-compliance|0|||
149883607|NCT00839254|540700526|FG005|Overall Study|Withdrawn due to non-compliance|0|||
149883608|NCT00839254|540700527|FG006|Overall Study|Withdrawn due to non-compliance|0|||
149883609|NCT00839254|540700528|FG007|Overall Study|Withdrawn due to non-compliance|0|||
149883610|NCT00839254|540700521|FG000|Overall Study|Lost to Follow-up|51|||
149883611|NCT00839254|540700522|FG001|Overall Study|Lost to Follow-up|30|||
149883612|NCT00839254|540700523|FG002|Overall Study|Lost to Follow-up|32|||
149883613|NCT00839254|540700524|FG003|Overall Study|Lost to Follow-up|24|||
149883614|NCT00839254|540700525|FG004|Overall Study|Lost to Follow-up|8|||
150043922|NCT04439136|541300737|FG000|Overall Study|Death|3|||
150043923|NCT04439136|541300737|FG000|Overall Study|Disease Progression|27|||
150043924|NCT04439136|541300737|FG000|Overall Study|Alternative Therapy|1|||
150043925|NCT04439136|541300737|FG000|Overall Study|Increased Tumor Burden|1|||
150043926|NCT04439136|541300737|FG000|Overall Study|Symptomatic Detrioration|1|||
150043927|NCT02910986|541300738|FG000|Overall Study|non-Latina|14|||
150043928|NCT02910986|541300739|FG001|Overall Study|non-Latina|13|||
150043929|NCT02910986|541300740|FG002|Overall Study|non-Latina|12|||
150043930|NCT02910986|541300738|FG000|Overall Study|Failure to return T! survey|72|||
150043931|NCT02910986|541300739|FG001|Overall Study|Failure to return T! survey|84|||
150043932|NCT02910986|541300740|FG002|Overall Study|Failure to return T! survey|72|||
150043933|NCT02910986|541300738|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
150043934|NCT02910986|541300739|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
150043935|NCT02910986|541300740|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
150043936|NCT02910986|541300738|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
150174999|NCT05764161|541777011|FG001|40-week OLE Period|Extended Travel|1|||
150175000|NCT05764161|541777010|FG000|40-week OLE Period|Ongoing|66|||
150175001|NCT05764161|541777011|FG001|40-week OLE Period|Ongoing|59|||
149883615|NCT00839254|540700526|FG005|Overall Study|Lost to Follow-up|8|||
149883616|NCT00839254|540700527|FG006|Overall Study|Lost to Follow-up|4|||
149883617|NCT00839254|540700528|FG007|Overall Study|Lost to Follow-up|2|||
149883618|NCT04597632|540700531|FG000|Overall Study|Withdrawal by Subject|10|||
149883619|NCT04597632|540700531|FG000|Overall Study|Lost to Follow-up|1|||
150043937|NCT02910986|541300739|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
150043938|NCT02910986|541300740|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
150043939|NCT03682770|541300756|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
149883620|NCT04597632|540700531|FG000|Overall Study|Death|1|||
149883621|NCT04597632|540700531|FG000|Overall Study|Adverse Event|5|||
149883622|NCT00993421|540700537|FG000|Overall Study|Adverse Event|2|||
149883623|NCT00993421|540700538|FG001|Overall Study|Adverse Event|7|||
149883624|NCT00993421|540700539|FG002|Overall Study|Adverse Event|6|||
149883625|NCT00993421|540700540|FG003|Overall Study|Adverse Event|9|||
149883626|NCT00993421|540700541|FG004|Overall Study|Adverse Event|5|||
149883627|NCT00993421|540700542|FG005|Overall Study|Adverse Event|7|||
149883628|NCT00993421|540700543|FG006|Overall Study|Adverse Event|1|||
149883629|NCT00993421|540700537|FG000|Overall Study|Sponsor Decision|36|||
149883630|NCT00993421|540700538|FG001|Overall Study|Sponsor Decision|31|||
149883631|NCT00993421|540700539|FG002|Overall Study|Sponsor Decision|28|||
149883632|NCT00993421|540700540|FG003|Overall Study|Sponsor Decision|30|||
149883633|NCT00993421|540700541|FG004|Overall Study|Sponsor Decision|38|||
149883634|NCT00993421|540700542|FG005|Overall Study|Sponsor Decision|30|||
149883635|NCT00993421|540700543|FG006|Overall Study|Sponsor Decision|29|||
149883636|NCT00993421|540700537|FG000|Overall Study|Lost to Follow-up|3|||
149883637|NCT00993421|540700538|FG001|Overall Study|Lost to Follow-up|5|||
149883638|NCT00993421|540700539|FG002|Overall Study|Lost to Follow-up|5|||
149883639|NCT00993421|540700540|FG003|Overall Study|Lost to Follow-up|0|||
149883640|NCT00993421|540700541|FG004|Overall Study|Lost to Follow-up|0|||
149883641|NCT00993421|540700542|FG005|Overall Study|Lost to Follow-up|0|||
149883642|NCT00993421|540700543|FG006|Overall Study|Lost to Follow-up|6|||
149883643|NCT00993421|540700537|FG000|Overall Study|Withdrawal by Subject|3|||
149883644|NCT00993421|540700538|FG001|Overall Study|Withdrawal by Subject|2|||
149883645|NCT00993421|540700539|FG002|Overall Study|Withdrawal by Subject|3|||
149883646|NCT00993421|540700540|FG003|Overall Study|Withdrawal by Subject|3|||
149883647|NCT00993421|540700541|FG004|Overall Study|Withdrawal by Subject|3|||
149883648|NCT00993421|540700542|FG005|Overall Study|Withdrawal by Subject|5|||
149883649|NCT00993421|540700543|FG006|Overall Study|Withdrawal by Subject|3|||
149883650|NCT00993421|540700537|FG000|Overall Study|Death|0|||
149883651|NCT00993421|540700538|FG001|Overall Study|Death|0|||
149883652|NCT00993421|540700539|FG002|Overall Study|Death|0|||
149883653|NCT00993421|540700540|FG003|Overall Study|Death|0|||
149883654|NCT00993421|540700541|FG004|Overall Study|Death|0|||
149883655|NCT00993421|540700542|FG005|Overall Study|Death|0|||
149883656|NCT00993421|540700543|FG006|Overall Study|Death|1|||
149883657|NCT00993421|540700537|FG000|Overall Study|Entry Criteria Exclusion|0|||
149883658|NCT00993421|540700538|FG001|Overall Study|Entry Criteria Exclusion|0|||
149883659|NCT00993421|540700539|FG002|Overall Study|Entry Criteria Exclusion|1|||
149883660|NCT00993421|540700540|FG003|Overall Study|Entry Criteria Exclusion|3|||
149883661|NCT00993421|540700541|FG004|Overall Study|Entry Criteria Exclusion|0|||
149883662|NCT00993421|540700542|FG005|Overall Study|Entry Criteria Exclusion|1|||
149883663|NCT00993421|540700543|FG006|Overall Study|Entry Criteria Exclusion|0|||
149883664|NCT00993421|540700537|FG000|Overall Study|Physician Decision|0|||
149883665|NCT00993421|540700538|FG001|Overall Study|Physician Decision|0|||
149883666|NCT00993421|540700539|FG002|Overall Study|Physician Decision|0|||
149883667|NCT00993421|540700540|FG003|Overall Study|Physician Decision|0|||
149883668|NCT00993421|540700541|FG004|Overall Study|Physician Decision|0|||
149883669|NCT00993421|540700542|FG005|Overall Study|Physician Decision|1|||
149883670|NCT00993421|540700543|FG006|Overall Study|Physician Decision|1|||
149883671|NCT00993421|540700537|FG000|Overall Study|Protocol Violation|0|||
149883672|NCT00993421|540700538|FG001|Overall Study|Protocol Violation|0|||
149883673|NCT00993421|540700539|FG002|Overall Study|Protocol Violation|0|||
149883674|NCT00993421|540700540|FG003|Overall Study|Protocol Violation|0|||
149883675|NCT00993421|540700541|FG004|Overall Study|Protocol Violation|0|||
149883676|NCT00993421|540700542|FG005|Overall Study|Protocol Violation|2|||
149883677|NCT00993421|540700543|FG006|Overall Study|Protocol Violation|1|||
149883678|NCT00352417|540700544|FG000|Overall Study|Adverse Event|1|||
149883679|NCT00352417|540700545|FG001|Overall Study|Adverse Event|0|||
149883680|NCT00352417|540700544|FG000|Overall Study|Protocol Violation|0|||
149883681|NCT00352417|540700545|FG001|Overall Study|Protocol Violation|2|||
149965685|NCT01592747|541009566|FG002|Overall Study|Loss of Therapeutic Response|100|||
149965686|NCT01592747|541009564|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
149965687|NCT01592747|541009565|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
149965688|NCT01592747|541009566|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
149965689|NCT01592747|541009564|FG000|Overall Study|Adverse Event|1|||
149965690|NCT01592747|541009565|FG001|Overall Study|Adverse Event|0|||
149965691|NCT01592747|541009566|FG002|Overall Study|Adverse Event|0|||
149965692|NCT01592747|541009564|FG000|Overall Study|Protocol Violation|4|||
149965693|NCT01592747|541009565|FG001|Overall Study|Protocol Violation|0|||
149965694|NCT01592747|541009566|FG002|Overall Study|Protocol Violation|4|||
149965695|NCT01592747|541009564|FG000|Overall Study|Lack of Efficacy|0|||
149965696|NCT01592747|541009565|FG001|Overall Study|Lack of Efficacy|1|||
149965697|NCT01592747|541009566|FG002|Overall Study|Lack of Efficacy|0|||
149965698|NCT01592747|541009564|FG000|Overall Study|Withdrawal by Subject|2|||
149965699|NCT01592747|541009565|FG001|Overall Study|Withdrawal by Subject|0|||
149965700|NCT01592747|541009566|FG002|Overall Study|Withdrawal by Subject|2|||
149965701|NCT01592747|541009564|FG000|Overall Study|Lost to Follow-up|1|||
149965702|NCT01592747|541009565|FG001|Overall Study|Lost to Follow-up|0|||
149965703|NCT01592747|541009566|FG002|Overall Study|Lost to Follow-up|1|||
149965704|NCT01592747|541009564|FG000|Overall Study|Other Reasons|1|||
149965705|NCT01592747|541009565|FG001|Overall Study|Other Reasons|1|||
149965706|NCT01592747|541009566|FG002|Overall Study|Other Reasons|0|||
149965707|NCT01602484|541009567|FG000|Overall Study|Airway issues unrelated to study|0|||
149965708|NCT01602484|541009568|FG001|Overall Study|Airway issues unrelated to study|1|||
149965709|NCT00425555|541009574|FG000|Overall Study|Withdrawal by Subject|11|||
149965710|NCT00425555|541009575|FG001|Overall Study|Withdrawal by Subject|8|||
149965711|NCT00425555|541009574|FG000|Overall Study|Lost to Follow-up|0|||
149965712|NCT00425555|541009575|FG001|Overall Study|Lost to Follow-up|1|||
149965713|NCT00425555|541009574|FG000|Overall Study|Administrative problems|3|||
149965714|NCT00425555|541009575|FG001|Overall Study|Administrative problems|0|||
149965715|NCT00425555|541009574|FG000|Overall Study|Death|1|||
149965716|NCT00425555|541009575|FG001|Overall Study|Death|2|||
149965717|NCT00425555|541009574|FG000|Overall Study|New cancer therapy|2|||
149965718|NCT00425555|541009575|FG001|Overall Study|New cancer therapy|1|||
149965719|NCT00425555|541009574|FG000|Overall Study|Disease progression|36|||
149965720|NCT00425555|541009575|FG001|Overall Study|Disease progression|33|||
149965721|NCT00425555|541009574|FG000|Overall Study|Adverse Event|25|||
149965722|NCT00425555|541009575|FG001|Overall Study|Adverse Event|15|||
149965723|NCT00425555|541009574|FG000|Overall Study|Protocol Violation|1|||
149965724|NCT00425555|541009575|FG001|Overall Study|Protocol Violation|0|||
149965725|NCT03729609|541009576|FG000|Overall Study|Protocol Violation|1|||
149965726|NCT01969409|541009578|FG000|Overall Study|Death|2|||
149965727|NCT01969409|541009579|FG001|Overall Study|Death|2|||
149965728|NCT01969409|541009578|FG000|Overall Study|Transplant|1|||
149965729|NCT01969409|541009579|FG001|Overall Study|Transplant|1|||
149965730|NCT01969409|541009578|FG000|Overall Study|Withdrawal by Subject|0|||
149965731|NCT01969409|541009579|FG001|Overall Study|Withdrawal by Subject|1|||
149965732|NCT02799043|541009580|FG000|Overall Study|Adverse Event|0|||
149965733|NCT02799043|541009581|FG001|Overall Study|Adverse Event|1|||
149965734|NCT02799043|541009580|FG000|Overall Study|Death|1|||
149965735|NCT02799043|541009581|FG001|Overall Study|Death|1|||
149965736|NCT02799043|541009580|FG000|Overall Study|Lost to Follow-up|3|||
149965737|NCT02799043|541009581|FG001|Overall Study|Lost to Follow-up|6|||
149965738|NCT02799043|541009580|FG000|Overall Study|Withdrawal by Subject|4|||
149965739|NCT02799043|541009581|FG001|Overall Study|Withdrawal by Subject|4|||
149965740|NCT02799043|541009580|FG000|Overall Study|Moved to different country|0|||
149965741|NCT02799043|541009581|FG001|Overall Study|Moved to different country|1|||
149965742|NCT02799043|541009580|FG000|Overall Study|Trial Screen Failure|1|||
149965743|NCT02799043|541009581|FG001|Overall Study|Trial Screen Failure|0|||
149965744|NCT02799043|541009580|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
149965745|NCT02799043|541009581|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
150043940|NCT03682770|541300757|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
150175002|NCT02613871|541777012|FG000|Overall Study|Death|2|||
150175003|NCT02613871|541777012|FG000|Overall Study|Withdrew Consent|1|||
150175004|NCT01831791|541777015|FG000|Overall Study|Withdrawal by Subject|10|||
150175005|NCT00494780|541777016|FG000|Overall Study|Adverse Event|1|||
149965746|NCT01554904|541009584|FG000|Overall Study|Withdrawal by Subject|3|||
149965747|NCT01554904|541009584|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
149965748|NCT01051661|541009587|FG000|Overall Study|Adverse Event|1|||
149965749|NCT01051661|541009588|FG001|Overall Study|Adverse Event|1|||
149965750|NCT01051661|541009589|FG002|Overall Study|Adverse Event|1|||
149965751|NCT01051661|541009590|FG003|Overall Study|Adverse Event|1|||
149965752|NCT01051661|541009591|FG004|Overall Study|Adverse Event|0|||
149965753|NCT01051661|541009592|FG005|Overall Study|Adverse Event|0|||
149965754|NCT01051661|541009587|FG000|Overall Study|Lost to Follow-up|13|||
149965755|NCT01051661|541009588|FG001|Overall Study|Lost to Follow-up|22|||
149965756|NCT01051661|541009589|FG002|Overall Study|Lost to Follow-up|15|||
149965757|NCT01051661|541009590|FG003|Overall Study|Lost to Follow-up|17|||
149965758|NCT01051661|541009591|FG004|Overall Study|Lost to Follow-up|10|||
149883682|NCT00352417|540700544|FG000|Overall Study|Withdrawal by Subject|1|||
149883683|NCT00352417|540700545|FG001|Overall Study|Withdrawal by Subject|2|||
149883684|NCT00352417|540700544|FG000|Overall Study|Lost to Follow-up|1|||
149883685|NCT00352417|540700545|FG001|Overall Study|Lost to Follow-up|0|||
149883686|NCT00352417|540700544|FG000|Overall Study|Schedule Change|2|||
149883687|NCT00352417|540700545|FG001|Overall Study|Schedule Change|1|||
149883688|NCT03130777|540703050|FG000|Overall Study|Death|0|||
149883689|NCT03130777|540703051|FG001|Overall Study|Death|1|||
149883690|NCT03130777|540703050|FG000|Overall Study|Did not meet eligibility criteria|1|||
149883691|NCT03130777|540703051|FG001|Overall Study|Did not meet eligibility criteria|0|||
149883692|NCT02586688|540703052|FG000|Overall Study|Lost to Follow-up|2|||
149883693|NCT02586688|540703053|FG001|Overall Study|Lost to Follow-up|1|||
149883694|NCT02586688|540703052|FG000|Overall Study|Withdrawal by Subject|1|||
149883695|NCT02586688|540703053|FG001|Overall Study|Withdrawal by Subject|1|||
149883696|NCT02586688|540703052|FG000|Overall Study|Adverse Event|3|||
149883697|NCT02586688|540703053|FG001|Overall Study|Adverse Event|1|||
149883698|NCT02498613|540703054|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
149883699|NCT02498613|540703055|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
149883700|NCT02498613|540703056|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
149883701|NCT02498613|540703057|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
149883702|NCT02498613|540703054|FG000|Overall Study|Withdrawal by Subject|3|||
149883703|NCT02498613|540703055|FG001|Overall Study|Withdrawal by Subject|1|||
149883704|NCT02498613|540703056|FG002|Overall Study|Withdrawal by Subject|0|||
149883705|NCT02498613|540703057|FG003|Overall Study|Withdrawal by Subject|0|||
149883706|NCT05109611|540703059|FG000|Overall Study|Adverse Event|13|||
149883707|NCT05109611|540703060|FG001|Overall Study|Adverse Event|10|||
149883708|NCT05109611|540703059|FG000|Overall Study|Withdrawal by Subject|1|||
149883709|NCT05109611|540703060|FG001|Overall Study|Withdrawal by Subject|0|||
149883710|NCT05109611|540703059|FG000|Overall Study|Lost to Follow-up|1|||
149883711|NCT05109611|540703060|FG001|Overall Study|Lost to Follow-up|2|||
149883712|NCT05109611|540703059|FG000|Overall Study|Protocol Violation|0|||
149883713|NCT05109611|540703060|FG001|Overall Study|Protocol Violation|4|||
149883714|NCT05109611|540703059|FG000|Overall Study|Information unavailable|1|||
149883715|NCT05109611|540703060|FG001|Overall Study|Information unavailable|1|||
149883716|NCT03631199|540703061|FG000|Overall Study|Progressive disease|9|||
149883717|NCT03631199|540703062|FG001|Overall Study|Progressive disease|5|||
149883718|NCT03631199|540703063|FG002|Overall Study|Progressive disease|5|||
149883719|NCT03631199|540703064|FG003|Overall Study|Progressive disease|149|||
149883720|NCT03631199|540703065|FG004|Overall Study|Progressive disease|148|||
149883721|NCT03631199|540703061|FG000|Overall Study|Physician Decision|0|||
149883722|NCT03631199|540703062|FG001|Overall Study|Physician Decision|2|||
149883723|NCT03631199|540703063|FG002|Overall Study|Physician Decision|3|||
149883724|NCT03631199|540703064|FG003|Overall Study|Physician Decision|19|||
149883725|NCT03631199|540703065|FG004|Overall Study|Physician Decision|13|||
149883726|NCT03631199|540703061|FG000|Overall Study|Adverse Event|1|||
149883727|NCT03631199|540703062|FG001|Overall Study|Adverse Event|1|||
149883728|NCT03631199|540703063|FG002|Overall Study|Adverse Event|0|||
149883729|NCT03631199|540703064|FG003|Overall Study|Adverse Event|28|||
149883730|NCT03631199|540703065|FG004|Overall Study|Adverse Event|29|||
149883731|NCT03631199|540703061|FG000|Overall Study|Death|0|||
149883732|NCT03631199|540703062|FG001|Overall Study|Death|1|||
149883733|NCT03631199|540703063|FG002|Overall Study|Death|0|||
149883734|NCT03631199|540703064|FG003|Overall Study|Death|35|||
149883735|NCT03631199|540703065|FG004|Overall Study|Death|48|||
149883736|NCT03631199|540703061|FG000|Overall Study|Subject decision|0|||
149883737|NCT03631199|540703062|FG001|Overall Study|Subject decision|1|||
149883738|NCT03631199|540703063|FG002|Overall Study|Subject decision|0|||
149965759|NCT01051661|541009592|FG005|Overall Study|Lost to Follow-up|24|||
149965760|NCT01051661|541009587|FG000|Overall Study|Migrated/moved from study area|1|||
149883739|NCT03631199|540703064|FG003|Overall Study|Subject decision|12|||
149965761|NCT01051661|541009588|FG001|Overall Study|Migrated/moved from study area|6|||
149883740|NCT03631199|540703065|FG004|Overall Study|Subject decision|12|||
149883741|NCT03631199|540703061|FG000|Overall Study|No treated|0|||
149965762|NCT01051661|541009589|FG002|Overall Study|Migrated/moved from study area|6|||
149883742|NCT03631199|540703062|FG001|Overall Study|No treated|0|||
149883743|NCT03631199|540703063|FG002|Overall Study|No treated|0|||
149883744|NCT03631199|540703064|FG003|Overall Study|No treated|0|||
149883745|NCT03631199|540703065|FG004|Overall Study|No treated|1|||
149883746|NCT03631199|540703061|FG000|Overall Study|Treatment ongoing|0|||
149883747|NCT03631199|540703062|FG001|Overall Study|Treatment ongoing|1|||
149883748|NCT03631199|540703063|FG002|Overall Study|Treatment ongoing|1|||
149883749|NCT03631199|540703064|FG003|Overall Study|Treatment ongoing|76|||
149883750|NCT03631199|540703065|FG004|Overall Study|Treatment ongoing|71|||
149883751|NCT03631199|540703061|FG000|Overall Study|Guardian decision|0|||
149883752|NCT03631199|540703062|FG001|Overall Study|Guardian decision|0|||
149883753|NCT03631199|540703063|FG002|Overall Study|Guardian decision|0|||
149883754|NCT03631199|540703064|FG003|Overall Study|Guardian decision|1|||
149883755|NCT03631199|540703065|FG004|Overall Study|Guardian decision|1|||
149883756|NCT03573830|540703068|FG000|Overall Study|Dropped without completing treatment|0|||
149883757|NCT03573830|540703069|FG001|Overall Study|Dropped without completing treatment|7|||
149883758|NCT03573830|540703068|FG000|Overall Study|Lost to Follow-up|4|||
149883759|NCT03573830|540703069|FG001|Overall Study|Lost to Follow-up|0|||
149883760|NCT00233948|540703070|FG000|Overall Study|Adverse Event|1|||
149883761|NCT00233948|540703071|FG001|Overall Study|Adverse Event|0|||
149883762|NCT00233948|540703072|FG002|Overall Study|Adverse Event|0|||
149883763|NCT00233948|540703073|FG003|Overall Study|Adverse Event|0|||
149883764|NCT00233948|540703074|FG004|Overall Study|Adverse Event|0|||
149883765|NCT00233948|540703075|FG005|Overall Study|Adverse Event|0|||
149883766|NCT03284723|540703076|FG000|Overall Study|Death|0|||
149883767|NCT03284723|540703077|FG001|Overall Study|Death|0|||
149883768|NCT03284723|540703078|FG002|Overall Study|Death|0|||
149883769|NCT03284723|540703079|FG003|Overall Study|Death|1|||
149883770|NCT03284723|540703080|FG004|Overall Study|Death|0|||
149883771|NCT03284723|540703081|FG005|Overall Study|Death|0|||
149883772|NCT03284723|540703082|FG006|Overall Study|Death|1|||
149883773|NCT03284723|540703083|FG007|Overall Study|Death|0|||
149883774|NCT03284723|540703084|FG008|Overall Study|Death|0|||
149883775|NCT03284723|540703085|FG009|Overall Study|Death|2|||
149883776|NCT03284723|540703086|FG010|Overall Study|Death|1|||
149883777|NCT03284723|540703087|FG011|Overall Study|Death|0|||
149883778|NCT03284723|540703076|FG000|Overall Study|Lost to Follow-up|0|||
149883779|NCT03284723|540703077|FG001|Overall Study|Lost to Follow-up|0|||
149883780|NCT03284723|540703078|FG002|Overall Study|Lost to Follow-up|0|||
149883781|NCT03284723|540703079|FG003|Overall Study|Lost to Follow-up|0|||
149883782|NCT03284723|540703080|FG004|Overall Study|Lost to Follow-up|0|||
149883783|NCT03284723|540703081|FG005|Overall Study|Lost to Follow-up|2|||
149883784|NCT03284723|540703082|FG006|Overall Study|Lost to Follow-up|1|||
149883785|NCT03284723|540703083|FG007|Overall Study|Lost to Follow-up|0|||
149883786|NCT03284723|540703084|FG008|Overall Study|Lost to Follow-up|0|||
149883787|NCT03284723|540703085|FG009|Overall Study|Lost to Follow-up|2|||
149883788|NCT03284723|540703086|FG010|Overall Study|Lost to Follow-up|0|||
149883789|NCT03284723|540703087|FG011|Overall Study|Lost to Follow-up|0|||
149883790|NCT03284723|540703076|FG000|Overall Study|Study Terminated By Sponsor|0|||
149883791|NCT03284723|540703077|FG001|Overall Study|Study Terminated By Sponsor|0|||
149883792|NCT03284723|540703078|FG002|Overall Study|Study Terminated By Sponsor|0|||
149883793|NCT03284723|540703079|FG003|Overall Study|Study Terminated By Sponsor|0|||
149883794|NCT03284723|540703080|FG004|Overall Study|Study Terminated By Sponsor|1|||
149883795|NCT03284723|540703081|FG005|Overall Study|Study Terminated By Sponsor|0|||
149883796|NCT03284723|540703082|FG006|Overall Study|Study Terminated By Sponsor|0|||
149883797|NCT03284723|540703083|FG007|Overall Study|Study Terminated By Sponsor|0|||
149883798|NCT03284723|540703084|FG008|Overall Study|Study Terminated By Sponsor|1|||
149883799|NCT03284723|540703085|FG009|Overall Study|Study Terminated By Sponsor|1|||
149883800|NCT03284723|540703086|FG010|Overall Study|Study Terminated By Sponsor|1|||
149883801|NCT03284723|540703087|FG011|Overall Study|Study Terminated By Sponsor|1|||
149883802|NCT03284723|540703076|FG000|Overall Study|Withdrawal by Subject|0|||
149883803|NCT03284723|540703077|FG001|Overall Study|Withdrawal by Subject|0|||
149883804|NCT03284723|540703078|FG002|Overall Study|Withdrawal by Subject|0|||
149883805|NCT03284723|540703079|FG003|Overall Study|Withdrawal by Subject|0|||
149883806|NCT03284723|540703080|FG004|Overall Study|Withdrawal by Subject|5|||
149883807|NCT03284723|540703081|FG005|Overall Study|Withdrawal by Subject|3|||
149883808|NCT03284723|540703082|FG006|Overall Study|Withdrawal by Subject|1|||
149883809|NCT03284723|540703083|FG007|Overall Study|Withdrawal by Subject|0|||
149883810|NCT03284723|540703084|FG008|Overall Study|Withdrawal by Subject|6|||
149883811|NCT03284723|540703085|FG009|Overall Study|Withdrawal by Subject|0|||
149883812|NCT03284723|540703086|FG010|Overall Study|Withdrawal by Subject|3|||
149883813|NCT03284723|540703087|FG011|Overall Study|Withdrawal by Subject|1|||
149883814|NCT03284723|540703076|FG000|Overall Study|Other|1|||
149883815|NCT03284723|540703077|FG001|Overall Study|Other|0|||
149883816|NCT03284723|540703078|FG002|Overall Study|Other|1|||
149883817|NCT03284723|540703079|FG003|Overall Study|Other|0|||
149883818|NCT03284723|540703080|FG004|Overall Study|Other|1|||
149883819|NCT03284723|540703081|FG005|Overall Study|Other|0|||
149883820|NCT03284723|540703082|FG006|Overall Study|Other|0|||
149883821|NCT03284723|540703083|FG007|Overall Study|Other|0|||
149883822|NCT03284723|540703084|FG008|Overall Study|Other|0|||
149883823|NCT03284723|540703085|FG009|Overall Study|Other|0|||
149883824|NCT03284723|540703086|FG010|Overall Study|Other|1|||
149883825|NCT03284723|540703087|FG011|Overall Study|Other|0|||
149883826|NCT03284723|540703076|FG000|Overall Study|Adverse Event|0|||
149883827|NCT03284723|540703077|FG001|Overall Study|Adverse Event|0|||
149883828|NCT03284723|540703078|FG002|Overall Study|Adverse Event|0|||
149883829|NCT03284723|540703079|FG003|Overall Study|Adverse Event|0|||
149883830|NCT03284723|540703080|FG004|Overall Study|Adverse Event|0|||
149883831|NCT03284723|540703081|FG005|Overall Study|Adverse Event|0|||
149883832|NCT03284723|540703082|FG006|Overall Study|Adverse Event|0|||
149883833|NCT03284723|540703083|FG007|Overall Study|Adverse Event|0|||
149883834|NCT03284723|540703084|FG008|Overall Study|Adverse Event|1|||
149883835|NCT03284723|540703085|FG009|Overall Study|Adverse Event|0|||
150043941|NCT03682770|541300758|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
149883836|NCT03284723|540703086|FG010|Overall Study|Adverse Event|0|||
149883837|NCT03284723|540703087|FG011|Overall Study|Adverse Event|0|||
149883838|NCT00764881|540703088|FG000|Overall Study|Adverse Event|5|||
149883839|NCT00764881|540703089|FG001|Overall Study|Adverse Event|1|||
149883840|NCT00764881|540703088|FG000|Overall Study|Withdrawal by Subject|1|||
149883841|NCT00764881|540703089|FG001|Overall Study|Withdrawal by Subject|3|||
149883842|NCT00764881|540703088|FG000|Overall Study|Protocol Violation|2|||
149883843|NCT00764881|540703089|FG001|Overall Study|Protocol Violation|2|||
149883844|NCT00764881|540703088|FG000|Overall Study|Lost to Follow-up|2|||
149883845|NCT00764881|540703089|FG001|Overall Study|Lost to Follow-up|0|||
149883846|NCT00764881|540703088|FG000|Overall Study|Noncompliant|1|||
149883847|NCT00764881|540703089|FG001|Overall Study|Noncompliant|0|||
149883848|NCT00764881|540703088|FG000|Overall Study|Accidentally discontinued study drug|1|||
149883849|NCT00764881|540703089|FG001|Overall Study|Accidentally discontinued study drug|0|||
149883850|NCT00764881|540703088|FG000|Overall Study|Wished to become pregnant|1|||
149883851|NCT00764881|540703089|FG001|Overall Study|Wished to become pregnant|0|||
149883852|NCT00764881|540703088|FG000|Overall Study|Carcinoma detected|1|||
149883853|NCT00764881|540703089|FG001|Overall Study|Carcinoma detected|0|||
149883854|NCT00764881|540703088|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
149883855|NCT00764881|540703089|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
149883856|NCT00764881|540703088|FG000|Overall Study|no treatment or no observation|2|||
149883857|NCT00764881|540703089|FG001|Overall Study|no treatment or no observation|2|||
149883858|NCT01567462|540703093|FG000|Overall Study|Withdrawal by Subject|4|||
149883859|NCT01567462|540703094|FG001|Overall Study|Withdrawal by Subject|7|||
149883860|NCT00886015|540703097|FG000|Overall Study|Death|0|||
149883861|NCT00886015|540703098|FG001|Overall Study|Death|2|||
149883862|NCT00196326|540703101|FG000|Overall Study|Did not meet protocol requirements|64|||
149883863|NCT00196326|540703101|FG000|Overall Study|Non-compliance with the protocol|81|||
149883864|NCT00196326|540703101|FG000|Overall Study|Physician Decision|3|||
150043942|NCT03682770|541300759|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
150043943|NCT03682770|541300760|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
149883865|NCT00196326|540703101|FG000|Overall Study|Withdrawal by Subject|225|||
149883866|NCT00196326|540703101|FG000|Overall Study|Adverse Event|253|||
149883867|NCT00196326|540703101|FG000|Overall Study|Pregnancy|34|||
149883868|NCT00196326|540703101|FG000|Overall Study|Lost to Follow-up|304|||
149883869|NCT00196326|540703101|FG000|Overall Study|Other|22|||
149883870|NCT01473407|540703102|FG000|Overall Study|Physician Decision|1|||
149883871|NCT01473407|540703103|FG001|Overall Study|Physician Decision|4|||
149883872|NCT01473407|540703102|FG000|Overall Study|Lost to Follow-up|10|||
150043944|NCT03682770|541300761|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
149883873|NCT01473407|540703103|FG001|Overall Study|Lost to Follow-up|4|||
149883874|NCT01473407|540703102|FG000|Overall Study|Adverse Event|8|||
149883875|NCT01473407|540703103|FG001|Overall Study|Adverse Event|8|||
149883876|NCT01473407|540703102|FG000|Overall Study|Randomization Error|3|||
149883877|NCT01473407|540703103|FG001|Overall Study|Randomization Error|1|||
149883878|NCT01473407|540703102|FG000|Overall Study|Withdrawal by Subject|4|||
149883879|NCT01473407|540703103|FG001|Overall Study|Withdrawal by Subject|7|||
149883880|NCT01473407|540703102|FG000|Overall Study|Kidney Transplant|7|||
149883881|NCT01473407|540703103|FG001|Overall Study|Kidney Transplant|6|||
149883882|NCT01473407|540703102|FG000|Overall Study|Vacation/Travel|1|||
149883883|NCT01473407|540703103|FG001|Overall Study|Vacation/Travel|1|||
149883884|NCT01473407|540703102|FG000|Overall Study|Elevated Hemoglobin|1|||
149883885|NCT01473407|540703103|FG001|Overall Study|Elevated Hemoglobin|0|||
149883886|NCT01473407|540703102|FG000|Overall Study|Patient Received Aranesp|1|||
149883887|NCT01473407|540703103|FG001|Overall Study|Patient Received Aranesp|0|||
149883888|NCT01473407|540703102|FG000|Overall Study|Patient Lost Green Card Status|1|||
149883889|NCT01473407|540703103|FG001|Overall Study|Patient Lost Green Card Status|0|||
149883890|NCT01473407|540703102|FG000|Overall Study|Temperature Excursion|2|||
149883891|NCT01473407|540703103|FG001|Overall Study|Temperature Excursion|3|||
149883892|NCT01473407|540703102|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
149883893|NCT01473407|540703103|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
149883894|NCT01473407|540703102|FG000|Overall Study|Sponsor's Decision|10|||
149883895|NCT01473407|540703103|FG001|Overall Study|Sponsor's Decision|10|||
149883896|NCT01473407|540703102|FG000|Overall Study|Site Closure|1|||
149883897|NCT01473407|540703103|FG001|Overall Study|Site Closure|0|||
149883898|NCT05223920|540703104|FG000|Overall Study|Adverse Event|6|||
149883899|NCT05223920|540703105|FG001|Overall Study|Adverse Event|3|||
149883900|NCT05223920|540703104|FG000|Overall Study|Death|2|||
149883901|NCT05223920|540703105|FG001|Overall Study|Death|0|||
149883902|NCT05223920|540703104|FG000|Overall Study|Disease Progression|1|||
149883903|NCT05223920|540703105|FG001|Overall Study|Disease Progression|2|||
149883904|NCT05223920|540703104|FG000|Overall Study|Physician Decision|1|||
149883905|NCT05223920|540703105|FG001|Overall Study|Physician Decision|2|||
149883906|NCT05223920|540703104|FG000|Overall Study|Sponsor decision|11|||
149883907|NCT05223920|540703105|FG001|Overall Study|Sponsor decision|9|||
149883908|NCT05223920|540703104|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
149883909|NCT05223920|540703105|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
149965763|NCT01051661|541009590|FG003|Overall Study|Migrated/moved from study area|8|||
149965764|NCT01051661|541009591|FG004|Overall Study|Migrated/moved from study area|7|||
149965765|NCT01051661|541009592|FG005|Overall Study|Migrated/moved from study area|3|||
149965766|NCT01051661|541009587|FG000|Overall Study|Refused blood sampling|0|||
150175006|NCT00494780|541777017|FG001|Overall Study|Adverse Event|0|||
150175007|NCT00494780|541777016|FG000|Overall Study|Withdrew before Dosed|0|||
150175008|NCT00494780|541777017|FG001|Overall Study|Withdrew before Dosed|1|||
150175009|NCT00494780|541777016|FG000|Overall Study|Progression of Study Disease|7|||
150175010|NCT00494780|541777017|FG001|Overall Study|Progression of Study Disease|8|||
150175011|NCT00494780|541777016|FG000|Overall Study|New Treatment|2|||
150175012|NCT00494780|541777017|FG001|Overall Study|New Treatment|2|||
150175013|NCT00494780|541777016|FG000|Overall Study|Non-compliance|1|||
150175014|NCT00494780|541777017|FG001|Overall Study|Non-compliance|0|||
150175015|NCT00494780|541777016|FG000|Overall Study|Residual Tumour Mass|0|||
150175016|NCT00494780|541777017|FG001|Overall Study|Residual Tumour Mass|1|||
150175017|NCT00494780|541777016|FG000|Overall Study|Insurance Issues|0|||
150175018|NCT00494780|541777017|FG001|Overall Study|Insurance Issues|1|||
150175019|NCT01190007|541777018|FG000|Overall Study|Withdrawal by Subject|4|||
150175020|NCT01190007|541777018|FG000|Overall Study|Adverse Event|8|||
150175021|NCT01190007|541777018|FG000|Overall Study|Difficulty of visit for complications|1|||
150175022|NCT01190007|541777018|FG000|Overall Study|Participant was arrested|1|||
150175023|NCT00845832|541777025|FG000|Treatment Period|Adverse Event|0|||
150175024|NCT00845832|541777026|FG001|Treatment Period|Adverse Event|2|||
150175025|NCT00845832|541777027|FG002|Treatment Period|Adverse Event|0|||
150175026|NCT00845832|541777025|FG000|Treatment Period|Protocol Violation|1|||
150175027|NCT00845832|541777026|FG001|Treatment Period|Protocol Violation|1|||
150175028|NCT00845832|541777027|FG002|Treatment Period|Protocol Violation|0|||
150175029|NCT00845832|541777025|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
149883910|NCT05223920|540703104|FG000|Overall Study|Subject decision|1|||
149883911|NCT05223920|540703105|FG001|Overall Study|Subject decision|0|||
149965767|NCT01051661|541009588|FG001|Overall Study|Refused blood sampling|0|||
150175030|NCT00845832|541777026|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
150175031|NCT00845832|541777027|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
150175032|NCT00845832|541777025|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
150175033|NCT00845832|541777026|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
150175034|NCT00845832|541777027|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
149883912|NCT05223920|540703104|FG000|Overall Study|Withdrawal by Subject|1|||
149883913|NCT05223920|540703105|FG001|Overall Study|Withdrawal by Subject|6|||
149883914|NCT00369941|540703106|FG000|Overall Study|Never Treated|1|||
149883915|NCT00369941|540703107|FG001|Overall Study|Never Treated|2|||
149883916|NCT00369941|540703106|FG000|Overall Study|Adverse Event|14|||
150175035|NCT03260140|541777032|FG000|Overall Study|Death|4|||
150175036|NCT03260140|541777033|FG001|Overall Study|Death|1|||
150175037|NCT03260140|541777032|FG000|Overall Study|Withdrawal by Subject|1|||
150175038|NCT03260140|541777033|FG001|Overall Study|Withdrawal by Subject|4|||
150175039|NCT00463788|541777034|FG000|Overall Study|Progressive Disease|86|||
150175040|NCT00463788|541777035|FG001|Overall Study|Progressive Disease|42|||
150175041|NCT00463788|541777034|FG000|Overall Study|Adverse Event|6|||
150175042|NCT00463788|541777035|FG001|Overall Study|Adverse Event|2|||
150175043|NCT00463788|541777034|FG000|Overall Study|Withdrawal by Subject|6|||
150175044|NCT00463788|541777035|FG001|Overall Study|Withdrawal by Subject|2|||
150175045|NCT00463788|541777034|FG000|Overall Study|Death|4|||
150175046|NCT00463788|541777035|FG001|Overall Study|Death|3|||
150175047|NCT00463788|541777034|FG000|Overall Study|Symptomatic Deterioration|2|||
150175048|NCT00463788|541777035|FG001|Overall Study|Symptomatic Deterioration|3|||
150175049|NCT00463788|541777034|FG000|Overall Study|Lost to Follow-up|1|||
150175050|NCT00463788|541777035|FG001|Overall Study|Lost to Follow-up|0|||
150175051|NCT00463788|541777034|FG000|Overall Study|Protocol Violation|0|||
150175052|NCT00463788|541777035|FG001|Overall Study|Protocol Violation|1|||
150175053|NCT00463788|541777034|FG000|Overall Study|Other|3|||
150175054|NCT00463788|541777035|FG001|Overall Study|Other|0|||
150175055|NCT00463788|541777034|FG000|Overall Study|Randomized but not treated|1|||
150175056|NCT00463788|541777035|FG001|Overall Study|Randomized but not treated|1|||
150175057|NCT00360698|541777036|FG000|Run-In|Physician Decision|0|||
150175058|NCT00360698|541777037|FG001|Run-In|Physician Decision|1|||
150175059|NCT00360698|541777036|FG000|Run-In|Withdrawal by Subject|0|||
150175060|NCT00360698|541777037|FG001|Run-In|Withdrawal by Subject|2|||
150175061|NCT00360698|541777036|FG000|Run-In|Non compliance with treatment procedure|0|||
150175062|NCT00360698|541777037|FG001|Run-In|Non compliance with treatment procedure|1|||
150175063|NCT00360698|541777036|FG000|Run-In|Sponsor request|0|||
150175064|NCT00360698|541777037|FG001|Run-In|Sponsor request|2|||
150175065|NCT00360698|541777036|FG000|Run-In|Patient did not meet inclusion criteria|0|||
150175066|NCT00360698|541777037|FG001|Run-In|Patient did not meet inclusion criteria|1|||
150175067|NCT00360698|541777036|FG000|Run-In|Patient personal reasons|0|||
150175068|NCT00360698|541777037|FG001|Run-In|Patient personal reasons|2|||
150175069|NCT00360698|541777036|FG000|Run-In|Need of insulin with meals|0|||
150175070|NCT00360698|541777037|FG001|Run-In|Need of insulin with meals|1|||
150175071|NCT00360698|541777036|FG000|Treatment Period|Non compliance with treatment procedure|1|||
150175072|NCT00360698|541777037|FG001|Treatment Period|Non compliance with treatment procedure|0|||
150175073|NCT00360698|541777036|FG000|Treatment Period|Early termination by error|0|||
150175074|NCT00360698|541777037|FG001|Treatment Period|Early termination by error|1|||
150175075|NCT01692938|541777047|FG000|Overall Study|Protocol Deviation|1|||
150175076|NCT01692938|541777048|FG001|Overall Study|Protocol Deviation|1|||
150175077|NCT01692938|541777047|FG000|Overall Study|Study completed prior to site completion|3|||
150175078|NCT01692938|541777048|FG001|Overall Study|Study completed prior to site completion|3|||
150175079|NCT02423291|541777049|FG000|Overall Study|Lack of Efficacy|14|||
150175080|NCT02423291|541777049|FG000|Overall Study|Adverse Event|1|||
150175081|NCT05283395|541777052|FG000|Overall Study|Adverse Event|4|||
150175082|NCT05283395|541777053|FG001|Overall Study|Adverse Event|4|||
150175083|NCT05283395|541777054|FG002|Overall Study|Adverse Event|0|||
150175084|NCT05283395|541777052|FG000|Overall Study|Patient Lost to Follow-Up|0|||
150175085|NCT05283395|541777053|FG001|Overall Study|Patient Lost to Follow-Up|0|||
150175086|NCT05283395|541777054|FG002|Overall Study|Patient Lost to Follow-Up|1|||
150175087|NCT05283395|541777052|FG000|Overall Study|Patient Withdrawal|2|||
150175088|NCT05283395|541777053|FG001|Overall Study|Patient Withdrawal|4|||
150175089|NCT05283395|541777054|FG002|Overall Study|Patient Withdrawal|2|||
150175090|NCT05283395|541777052|FG000|Overall Study|Investigator Decision|1|||
149965768|NCT01051661|541009589|FG002|Overall Study|Refused blood sampling|0|||
149965769|NCT01051661|541009590|FG003|Overall Study|Refused blood sampling|0|||
149965770|NCT01051661|541009591|FG004|Overall Study|Refused blood sampling|0|||
149965771|NCT01051661|541009592|FG005|Overall Study|Refused blood sampling|1|||
149965772|NCT01051661|541009587|FG000|Overall Study|Data not reliable|1|||
149965773|NCT01051661|541009588|FG001|Overall Study|Data not reliable|0|||
149965774|NCT01051661|541009589|FG002|Overall Study|Data not reliable|0|||
150175091|NCT05283395|541777053|FG001|Overall Study|Investigator Decision|0|||
150175092|NCT05283395|541777054|FG002|Overall Study|Investigator Decision|1|||
150175093|NCT05283395|541777052|FG000|Overall Study|Enrolled in error|0|||
150175094|NCT05283395|541777053|FG001|Overall Study|Enrolled in error|0|||
150175095|NCT05283395|541777054|FG002|Overall Study|Enrolled in error|1|||
150175096|NCT01063972|541777055|FG000|Overall Study|Death|12|||
150175097|NCT01063972|541777056|FG001|Overall Study|Death|11|||
150175098|NCT01063972|541777055|FG000|Overall Study|Incarcerated|2|||
150175099|NCT01063972|541777056|FG001|Overall Study|Incarcerated|1|||
150175100|NCT00712335|541777058|FG000|Overall Study|Withdrawal by Subject|0|||
150175101|NCT00712335|541777059|FG001|Overall Study|Withdrawal by Subject|7|||
150175102|NCT00712335|541777060|FG002|Overall Study|Withdrawal by Subject|2|||
149965775|NCT01051661|541009590|FG003|Overall Study|Data not reliable|0|||
150175103|NCT00712335|541777061|FG003|Overall Study|Withdrawal by Subject|3|||
150175104|NCT00712335|541777062|FG004|Overall Study|Withdrawal by Subject|0|||
150175105|NCT00712335|541777058|FG000|Overall Study|Lost to Follow-up|2|||
150175106|NCT00712335|541777059|FG001|Overall Study|Lost to Follow-up|5|||
150175107|NCT00712335|541777060|FG002|Overall Study|Lost to Follow-up|0|||
150175108|NCT00712335|541777061|FG003|Overall Study|Lost to Follow-up|1|||
150175109|NCT00712335|541777062|FG004|Overall Study|Lost to Follow-up|0|||
150175110|NCT00712335|541777058|FG000|Overall Study|Protocol Violation|1|||
150175111|NCT00712335|541777059|FG001|Overall Study|Protocol Violation|2|||
150175112|NCT00712335|541777060|FG002|Overall Study|Protocol Violation|1|||
150175113|NCT00712335|541777061|FG003|Overall Study|Protocol Violation|0|||
150175114|NCT00712335|541777062|FG004|Overall Study|Protocol Violation|0|||
150175115|NCT00712335|541777058|FG000|Overall Study|Lack of Efficacy|0|||
150175116|NCT00712335|541777059|FG001|Overall Study|Lack of Efficacy|0|||
150175117|NCT00712335|541777060|FG002|Overall Study|Lack of Efficacy|1|||
150175118|NCT00712335|541777061|FG003|Overall Study|Lack of Efficacy|1|||
150175119|NCT00712335|541777062|FG004|Overall Study|Lack of Efficacy|0|||
150175120|NCT00712335|541777058|FG000|Overall Study|Other Reason|0|||
150175121|NCT00712335|541777059|FG001|Overall Study|Other Reason|3|||
150175122|NCT00712335|541777060|FG002|Overall Study|Other Reason|1|||
150175123|NCT00712335|541777061|FG003|Overall Study|Other Reason|0|||
150175124|NCT00712335|541777062|FG004|Overall Study|Other Reason|0|||
150175125|NCT03401112|541777063|FG000|Overall Study|Adverse Event|1|||
150175126|NCT03401112|541777064|FG001|Overall Study|Adverse Event|2|||
150175127|NCT03401112|541777065|FG002|Overall Study|Adverse Event|3|||
150175128|NCT03401112|541777066|FG003|Overall Study|Adverse Event|2|||
150175129|NCT03401112|541777067|FG004|Overall Study|Adverse Event|0|||
150175130|NCT03401112|541777063|FG000|Overall Study|Lost to Follow-up|1|||
150175131|NCT03401112|541777064|FG001|Overall Study|Lost to Follow-up|0|||
150175132|NCT03401112|541777065|FG002|Overall Study|Lost to Follow-up|0|||
150175133|NCT03401112|541777066|FG003|Overall Study|Lost to Follow-up|0|||
150175134|NCT03401112|541777067|FG004|Overall Study|Lost to Follow-up|0|||
150175135|NCT03401112|541777063|FG000|Overall Study|Noncompliance|1|||
150175136|NCT03401112|541777064|FG001|Overall Study|Noncompliance|2|||
150175137|NCT03401112|541777065|FG002|Overall Study|Noncompliance|3|||
150175138|NCT03401112|541777066|FG003|Overall Study|Noncompliance|0|||
150175139|NCT03401112|541777067|FG004|Overall Study|Noncompliance|0|||
150175140|NCT03401112|541777063|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
150175141|NCT03401112|541777064|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
150175142|NCT03401112|541777065|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
150175143|NCT03401112|541777066|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
150175144|NCT03401112|541777067|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
150175145|NCT03401112|541777063|FG000|Overall Study|Withdrawal by Subject|0|||
150175146|NCT03401112|541777064|FG001|Overall Study|Withdrawal by Subject|3|||
150175147|NCT03401112|541777065|FG002|Overall Study|Withdrawal by Subject|2|||
150175148|NCT03401112|541777066|FG003|Overall Study|Withdrawal by Subject|1|||
150175149|NCT03401112|541777067|FG004|Overall Study|Withdrawal by Subject|0|||
150175150|NCT03401112|541777063|FG000|Overall Study|Physician Decision|0|||
150175151|NCT03401112|541777064|FG001|Overall Study|Physician Decision|0|||
150175152|NCT03401112|541777065|FG002|Overall Study|Physician Decision|0|||
150175153|NCT03401112|541777066|FG003|Overall Study|Physician Decision|2|||
150175154|NCT03401112|541777067|FG004|Overall Study|Physician Decision|0|||
150175155|NCT03401112|541777063|FG000|Overall Study|Study was Terminated by Sponsor|0|||
150175156|NCT03401112|541777064|FG001|Overall Study|Study was Terminated by Sponsor|0|||
150175157|NCT03401112|541777065|FG002|Overall Study|Study was Terminated by Sponsor|0|||
150175158|NCT03401112|541777066|FG003|Overall Study|Study was Terminated by Sponsor|1|||
150175159|NCT03401112|541777067|FG004|Overall Study|Study was Terminated by Sponsor|0|||
150175160|NCT03401112|541777063|FG000|Overall Study|Day 1 Assessment not Done|1|||
150175161|NCT03401112|541777064|FG001|Overall Study|Day 1 Assessment not Done|0|||
149965776|NCT01051661|541009591|FG004|Overall Study|Data not reliable|0|||
149965777|NCT01051661|541009592|FG005|Overall Study|Data not reliable|1|||
149965778|NCT01051661|541009587|FG000|Overall Study|Unable to attend visit(s)|2|||
149965779|NCT01051661|541009588|FG001|Overall Study|Unable to attend visit(s)|4|||
149965780|NCT01051661|541009589|FG002|Overall Study|Unable to attend visit(s)|2|||
149965781|NCT01051661|541009590|FG003|Overall Study|Unable to attend visit(s)|1|||
149965782|NCT01051661|541009591|FG004|Overall Study|Unable to attend visit(s)|3|||
149965783|NCT01051661|541009592|FG005|Overall Study|Unable to attend visit(s)|2|||
149965784|NCT01051661|541009587|FG000|Overall Study|Consent not received from both parents|0|||
150175162|NCT03401112|541777065|FG002|Overall Study|Day 1 Assessment not Done|0|||
150175163|NCT03401112|541777066|FG003|Overall Study|Day 1 Assessment not Done|0|||
150175164|NCT03401112|541777067|FG004|Overall Study|Day 1 Assessment not Done|0|||
150175165|NCT03401112|541777063|FG000|Overall Study|Not Dosed|0|||
150175166|NCT03401112|541777064|FG001|Overall Study|Not Dosed|0|||
150175167|NCT03401112|541777065|FG002|Overall Study|Not Dosed|1|||
150175168|NCT03401112|541777066|FG003|Overall Study|Not Dosed|0|||
150175169|NCT03401112|541777067|FG004|Overall Study|Not Dosed|0|||
150175170|NCT03401112|541777063|FG000|Overall Study|Missed Clinical Visit|0|||
150175171|NCT03401112|541777064|FG001|Overall Study|Missed Clinical Visit|0|||
150175172|NCT03401112|541777065|FG002|Overall Study|Missed Clinical Visit|1|||
149883917|NCT00369941|540703107|FG001|Overall Study|Adverse Event|28|||
149883918|NCT00369941|540703106|FG000|Overall Study|Lack of Efficacy|6|||
149883919|NCT00369941|540703107|FG001|Overall Study|Lack of Efficacy|10|||
149883920|NCT00369941|540703106|FG000|Overall Study|Lost to Follow-up|12|||
149883921|NCT00369941|540703107|FG001|Overall Study|Lost to Follow-up|22|||
149883922|NCT00369941|540703106|FG000|Overall Study|Protocol Violation|5|||
149883923|NCT00369941|540703107|FG001|Overall Study|Protocol Violation|3|||
149883924|NCT00369941|540703106|FG000|Overall Study|Withdrawal by Subject|5|||
149883925|NCT00369941|540703107|FG001|Overall Study|Withdrawal by Subject|18|||
149883926|NCT00369941|540703106|FG000|Overall Study|Pregnancy|4|||
149883927|NCT00369941|540703107|FG001|Overall Study|Pregnancy|2|||
149883928|NCT00369941|540703106|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
149883929|NCT00369941|540703107|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
149883930|NCT00369941|540703106|FG000|Overall Study|Moved|11|||
149883931|NCT00369941|540703107|FG001|Overall Study|Moved|5|||
149883932|NCT00369941|540703106|FG000|Overall Study|Treatment with Prohibited Medication|3|||
149883933|NCT00369941|540703107|FG001|Overall Study|Treatment with Prohibited Medication|1|||
149883934|NCT00369941|540703106|FG000|Overall Study|Employment Interfered with Study Visits|1|||
149883935|NCT00369941|540703107|FG001|Overall Study|Employment Interfered with Study Visits|0|||
149883936|NCT00369941|540703106|FG000|Overall Study|Study Site Terminated|2|||
149883937|NCT00369941|540703107|FG001|Overall Study|Study Site Terminated|0|||
149883938|NCT00369941|540703106|FG000|Overall Study|Miscellaneous|3|||
149883939|NCT00369941|540703107|FG001|Overall Study|Miscellaneous|3|||
149883940|NCT01027702|540703108|FG000|Overall Study|Received subsequent therapy|1|||
149883941|NCT01027702|540703109|FG001|Overall Study|Received subsequent therapy|2|||
149883942|NCT01027702|540703110|FG002|Overall Study|Received subsequent therapy|0|||
149883943|NCT01027702|540703111|FG003|Overall Study|Received subsequent therapy|4|||
149883944|NCT01027702|540703112|FG004|Overall Study|Received subsequent therapy|1|||
149883945|NCT01027702|540703113|FG005|Overall Study|Received subsequent therapy|0|||
149883946|NCT01027702|540703114|FG006|Overall Study|Received subsequent therapy|1|||
149883947|NCT01027702|540703108|FG000|Overall Study|Death|0|||
149883948|NCT01027702|540703109|FG001|Overall Study|Death|0|||
149883949|NCT01027702|540703110|FG002|Overall Study|Death|1|||
149883950|NCT01027702|540703111|FG003|Overall Study|Death|0|||
149883951|NCT01027702|540703112|FG004|Overall Study|Death|0|||
149883952|NCT01027702|540703113|FG005|Overall Study|Death|0|||
149883953|NCT01027702|540703114|FG006|Overall Study|Death|0|||
149883954|NCT00403585|540703115|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
149883955|NCT00403585|540703115|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
149883956|NCT00403585|540703115|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
149883957|NCT02964312|540703116|FG000|Overall Study|Lost to Follow-up|28|||
149883958|NCT02964312|540703116|FG000|Overall Study|Withdrawal by Subject|11|||
149883959|NCT02964312|540703116|FG000|Overall Study|Lack of Efficacy|10|||
150043945|NCT03682770|541300762|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
150043946|NCT03682770|541300756|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
150043947|NCT03682770|541300757|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
150043948|NCT03682770|541300758|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
150043949|NCT03682770|541300759|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
150043950|NCT03682770|541300760|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
150043951|NCT03682770|541300761|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
150043952|NCT03682770|541300762|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
150043953|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
150043954|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
150043955|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
150043956|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
150043957|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
150043958|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
150043959|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
150043960|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
150043961|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
150043962|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
150043963|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
150175173|NCT03401112|541777066|FG003|Overall Study|Missed Clinical Visit|0|||
149883960|NCT02964312|540703116|FG000|Overall Study|Did not consent to long-term FU|14|||
149883961|NCT02964312|540703116|FG000|Overall Study|Death|1|||
149883962|NCT02862730|540703125|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883963|NCT02862730|540703126|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883964|NCT02862730|540703127|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
149883965|NCT02862730|540703128|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883966|NCT02862730|540703129|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883967|NCT02862730|540703130|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883968|NCT02862730|540703131|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
149883969|NCT02862730|540703125|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
149883970|NCT02862730|540703126|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883971|NCT02862730|540703127|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883972|NCT02862730|540703128|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883973|NCT02862730|540703129|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883974|NCT02862730|540703130|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883975|NCT02862730|540703131|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
149883976|NCT02862730|540703125|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
149883977|NCT02862730|540703126|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
149883978|NCT02862730|540703127|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
149883979|NCT02862730|540703128|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
149883980|NCT02862730|540703129|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
149883981|NCT02862730|540703130|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
149883982|NCT02862730|540703131|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
149883983|NCT02862730|540703125|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883984|NCT02862730|540703126|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883985|NCT02862730|540703127|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883986|NCT02862730|540703128|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
149883987|NCT02862730|540703129|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883988|NCT02862730|540703130|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883989|NCT02862730|540703131|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
149883990|NCT03685344|540703132|FG000|Overall Study|Withdrawal by Subject|1|||
149883991|NCT03685344|540703133|FG001|Overall Study|Withdrawal by Subject|1|||
149883992|NCT03685344|540703134|FG002|Overall Study|Withdrawal by Subject|2|||
149883993|NCT03685344|540703135|FG003|Overall Study|Withdrawal by Subject|0|||
149883994|NCT03685344|540703132|FG000|Overall Study|Physician Decision|1|||
149883995|NCT03685344|540703133|FG001|Overall Study|Physician Decision|1|||
149883996|NCT03685344|540703134|FG002|Overall Study|Physician Decision|5|||
149883997|NCT03685344|540703135|FG003|Overall Study|Physician Decision|0|||
149883998|NCT03685344|540703132|FG000|Overall Study|Death|1|||
149883999|NCT03685344|540703133|FG001|Overall Study|Death|1|||
149884000|NCT03685344|540703134|FG002|Overall Study|Death|0|||
149884001|NCT03685344|540703135|FG003|Overall Study|Death|0|||
149884002|NCT02121652|540703138|FG000|Overall Study|Lost to Follow-up|2|||
149884003|NCT02121652|540703139|FG001|Overall Study|Lost to Follow-up|1|||
149884004|NCT02121652|540703138|FG000|Overall Study|Death|1|||
149965785|NCT01051661|541009588|FG001|Overall Study|Consent not received from both parents|0|||
149965786|NCT01051661|541009589|FG002|Overall Study|Consent not received from both parents|0|||
150175174|NCT03401112|541777067|FG004|Overall Study|Missed Clinical Visit|0|||
150175175|NCT03401112|541777063|FG000|Overall Study|Missed Doses|0|||
150175176|NCT03401112|541777064|FG001|Overall Study|Missed Doses|0|||
149884005|NCT02121652|540703139|FG001|Overall Study|Death|0|||
149884006|NCT02121652|540703138|FG000|Overall Study|Withdrawal by Subject|3|||
149884007|NCT02121652|540703139|FG001|Overall Study|Withdrawal by Subject|3|||
149884008|NCT00261950|540703141|FG000|Overall Study|Lost to Follow-up|2|||
149884009|NCT00261950|540703141|FG000|Overall Study|Death|6|||
149884010|NCT00261950|540703141|FG000|Overall Study|Withdrawal by Subject|5|||
149884011|NCT00261950|540703141|FG000|Overall Study|Other|1|||
149884012|NCT00261950|540703141|FG000|Overall Study|Physician Decision|1|||
149884013|NCT00261950|540703141|FG000|Overall Study|Protocol specified Criteria|11|||
149884014|NCT01023035|540703142|FG000|Treatment Period|Adverse Event|27|||
149884015|NCT01023035|540703143|FG001|Treatment Period|Adverse Event|32|||
149884016|NCT01023035|540703144|FG002|Treatment Period|Adverse Event|50|||
149884017|NCT01023035|540703142|FG000|Treatment Period|Non-Medical Reasons|19|||
149884018|NCT01023035|540703143|FG001|Treatment Period|Non-Medical Reasons|22|||
149884019|NCT01023035|540703144|FG002|Treatment Period|Non-Medical Reasons|44|||
149884020|NCT01023035|540703142|FG000|Treatment Period|Treatment Failure|26|||
149884021|NCT01023035|540703143|FG001|Treatment Period|Treatment Failure|31|||
149884022|NCT01023035|540703144|FG002|Treatment Period|Treatment Failure|24|||
149884023|NCT01023035|540703142|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
149884024|NCT01023035|540703143|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
149884025|NCT01023035|540703144|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
149884026|NCT01023035|540703142|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
149884027|NCT01023035|540703143|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
149884028|NCT01023035|540703144|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
149884029|NCT00445432|540703149|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
149884030|NCT00445432|540703150|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
149884031|NCT00445432|540703151|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
149884032|NCT00445432|540703152|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
149884033|NCT00445432|540703149|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
149884034|NCT00445432|540703150|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
149965787|NCT01051661|541009590|FG003|Overall Study|Consent not received from both parents|0|||
149965788|NCT01051661|541009591|FG004|Overall Study|Consent not received from both parents|0|||
149965789|NCT01051661|541009592|FG005|Overall Study|Consent not received from both parents|1|||
149965790|NCT01051661|541009587|FG000|Overall Study|Failure to comply with protocol|0|||
149965791|NCT01051661|541009588|FG001|Overall Study|Failure to comply with protocol|0|||
149965792|NCT01051661|541009589|FG002|Overall Study|Failure to comply with protocol|2|||
149965793|NCT01051661|541009590|FG003|Overall Study|Failure to comply with protocol|0|||
149965794|NCT01051661|541009591|FG004|Overall Study|Failure to comply with protocol|0|||
149965795|NCT01051661|541009592|FG005|Overall Study|Failure to comply with protocol|0|||
149965796|NCT01051661|541009587|FG000|Overall Study|Subject lost legal representation|0|||
150043964|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
150043965|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
150175177|NCT03401112|541777065|FG002|Overall Study|Missed Doses|1|||
149965797|NCT01051661|541009588|FG001|Overall Study|Subject lost legal representation|0|||
149965798|NCT01051661|541009589|FG002|Overall Study|Subject lost legal representation|0|||
149965799|NCT01051661|541009590|FG003|Overall Study|Subject lost legal representation|0|||
149965800|NCT01051661|541009591|FG004|Overall Study|Subject lost legal representation|1|||
149965801|NCT01051661|541009592|FG005|Overall Study|Subject lost legal representation|0|||
149965802|NCT01051661|541009587|FG000|Overall Study|Protocol Violation|0|||
149965803|NCT01051661|541009588|FG001|Overall Study|Protocol Violation|0|||
149965804|NCT01051661|541009589|FG002|Overall Study|Protocol Violation|0|||
149965805|NCT01051661|541009590|FG003|Overall Study|Protocol Violation|1|||
149965806|NCT01051661|541009591|FG004|Overall Study|Protocol Violation|2|||
150043966|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
149965807|NCT01051661|541009592|FG005|Overall Study|Protocol Violation|1|||
150043967|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
150043968|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
150043969|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
150043970|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
150043971|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
150043972|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
150043973|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
150175178|NCT03401112|541777066|FG003|Overall Study|Missed Doses|0|||
150175179|NCT03401112|541777067|FG004|Overall Study|Missed Doses|0|||
149884035|NCT00445432|540703151|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
149884036|NCT00445432|540703152|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
149884037|NCT00445432|540703149|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
149884038|NCT00445432|540703150|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
149884039|NCT00445432|540703151|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
149884040|NCT00445432|540703152|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
149884041|NCT00445432|540703149|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
149884042|NCT00445432|540703150|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
149884043|NCT00445432|540703151|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
149884044|NCT00445432|540703152|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
149884045|NCT00445432|540703149|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
149884046|NCT00445432|540703150|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
149884047|NCT00445432|540703151|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
149884048|NCT00445432|540703152|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
149884049|NCT00445432|540703149|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
149884050|NCT00445432|540703150|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
149884051|NCT00445432|540703151|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
149884052|NCT00445432|540703152|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
149884053|NCT00445432|540703149|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
149884054|NCT00445432|540703150|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
149884055|NCT00445432|540703151|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
149884056|NCT00445432|540703152|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
149884057|NCT02789137|540703153|FG000|Overall Study|Dropped out/Died|58|||
149884058|NCT01090414|540703154|FG000|Study 101-99|Progressive Disease|28|||
149884059|NCT01090414|540703155|FG001|Study 101-99|Progressive Disease|48|||
149884060|NCT01090414|540703156|FG002|Study 101-99|Progressive Disease|10|||
149884061|NCT01090414|540703157|FG003|Study 101-99|Progressive Disease|4|||
149884062|NCT01090414|540703154|FG000|Study 101-99|Adverse Event|10|||
149884063|NCT01090414|540703155|FG001|Study 101-99|Adverse Event|28|||
149884064|NCT01090414|540703156|FG002|Study 101-99|Adverse Event|18|||
149884065|NCT01090414|540703157|FG003|Study 101-99|Adverse Event|0|||
149884066|NCT01090414|540703154|FG000|Study 101-99|Investigator Request|1|||
149884067|NCT01090414|540703155|FG001|Study 101-99|Investigator Request|11|||
149884068|NCT01090414|540703156|FG002|Study 101-99|Investigator Request|4|||
149884069|NCT01090414|540703157|FG003|Study 101-99|Investigator Request|0|||
149884070|NCT01090414|540703154|FG000|Study 101-99|Death|3|||
149884071|NCT01090414|540703155|FG001|Study 101-99|Death|8|||
149884072|NCT01090414|540703156|FG002|Study 101-99|Death|1|||
149884073|NCT01090414|540703157|FG003|Study 101-99|Death|0|||
149884074|NCT01090414|540703154|FG000|Study 101-99|Sponsor Discontinued Study|0|||
149884075|NCT01090414|540703155|FG001|Study 101-99|Sponsor Discontinued Study|7|||
149884076|NCT01090414|540703156|FG002|Study 101-99|Sponsor Discontinued Study|5|||
149884077|NCT01090414|540703157|FG003|Study 101-99|Sponsor Discontinued Study|0|||
149884078|NCT01090414|540703154|FG000|Study 101-99|Other (Unknown Reasons)|3|||
149884079|NCT01090414|540703155|FG001|Study 101-99|Other (Unknown Reasons)|3|||
149884080|NCT01090414|540703156|FG002|Study 101-99|Other (Unknown Reasons)|0|||
149884081|NCT01090414|540703157|FG003|Study 101-99|Other (Unknown Reasons)|0|||
149884082|NCT01090414|540703154|FG000|Study 101-99|Withdrew Consent|0|||
149884083|NCT01090414|540703155|FG001|Study 101-99|Withdrew Consent|2|||
149884084|NCT01090414|540703156|FG002|Study 101-99|Withdrew Consent|3|||
149884085|NCT01090414|540703157|FG003|Study 101-99|Withdrew Consent|1|||
149884086|NCT01090414|540703154|FG000|Study 101-99|Participant Request|3|||
149884087|NCT01090414|540703155|FG001|Study 101-99|Participant Request|1|||
149884088|NCT01090414|540703156|FG002|Study 101-99|Participant Request|0|||
149884089|NCT01090414|540703157|FG003|Study 101-99|Participant Request|0|||
149884090|NCT03594071|540703158|FG000|Overall Study|Re-operation|3|||
149884091|NCT03594071|540703158|FG000|Overall Study|Missed visit|2|||
149884092|NCT05219448|540703159|FG000|Overall Study|Lost to Follow-up|9|||
149884093|NCT05219448|540703160|FG001|Overall Study|Lost to Follow-up|0|||
149884094|NCT03022370|540703161|FG000|Overall Study|Death|6|||
149884095|NCT03022370|540703162|FG001|Overall Study|Death|12|||
149884096|NCT03022370|540703161|FG000|Overall Study|Lost to Follow-up|174|||
149884097|NCT03022370|540703162|FG001|Overall Study|Lost to Follow-up|109|||
149884098|NCT00560391|540703163|FG000|Overall Study|Still on treatment|0|||
149884099|NCT00560391|540703164|FG001|Overall Study|Still on treatment|0|||
149884100|NCT00560391|540703165|FG002|Overall Study|Still on treatment|0|||
149884101|NCT00560391|540703166|FG003|Overall Study|Still on treatment|1|||
149884102|NCT00560391|540703167|FG004|Overall Study|Still on treatment|2|||
149884103|NCT02829918|540703185|FG000|Overall Study|Death|2|||
149884104|NCT02829918|540703185|FG000|Overall Study|Withdrawal by Subject|4|||
149884105|NCT02829918|540703185|FG000|Overall Study|Adverse Event|1|||
149884106|NCT02829918|540703185|FG000|Overall Study|Progression|1|||
149884107|NCT02359994|540703190|FG000|Overall Population Study|Adverse Event|1|||
149884108|NCT02359994|540703191|FG001|Overall Population Study|Adverse Event|1|||
149884109|NCT02359994|540703190|FG000|Overall Population Study|Death|1|||
149884110|NCT02359994|540703191|FG001|Overall Population Study|Death|5|||
149884111|NCT02359994|540703190|FG000|Overall Population Study|Lost to Follow-up|1|||
149884112|NCT02359994|540703191|FG001|Overall Population Study|Lost to Follow-up|1|||
149884113|NCT02359994|540703190|FG000|Overall Population Study|Withdrawal by Subject|1|||
149884114|NCT02359994|540703191|FG001|Overall Population Study|Withdrawal by Subject|0|||
149884115|NCT02359994|540703190|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
149884116|NCT02359994|540703191|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
149884117|NCT02359994|540703190|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
149884118|NCT02359994|540703191|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
149884119|NCT02359994|540703190|FG000|Extended Oncology 24-Month Survival|Death|19|||
149884120|NCT02359994|540703191|FG001|Extended Oncology 24-Month Survival|Death|21|||
149884121|NCT02359994|540703190|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
149884122|NCT02359994|540703191|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
149884123|NCT01823835|540703192|FG000|Overall Study|Adverse Event|0|||
149884124|NCT01823835|540703193|FG001|Overall Study|Adverse Event|0|||
149884125|NCT01823835|540703194|FG002|Overall Study|Adverse Event|0|||
149884126|NCT01823835|540703195|FG003|Overall Study|Adverse Event|0|||
149884127|NCT01823835|540703196|FG004|Overall Study|Adverse Event|1|||
149884128|NCT01823835|540703197|FG005|Overall Study|Adverse Event|0|||
149884129|NCT01823835|540703198|FG006|Overall Study|Adverse Event|1|||
149884130|NCT01823835|540703199|FG007|Overall Study|Adverse Event|0|||
149884131|NCT01823835|540703200|FG008|Overall Study|Adverse Event|0|||
149884132|NCT01823835|540703201|FG009|Overall Study|Adverse Event|0|||
149884133|NCT01823835|540703202|FG010|Overall Study|Adverse Event|1|||
149884134|NCT01823835|540703203|FG011|Overall Study|Adverse Event|2|||
149884135|NCT01823835|540703204|FG012|Overall Study|Adverse Event|0|||
149884136|NCT01823835|540703205|FG013|Overall Study|Adverse Event|0|||
149884137|NCT01823835|540703206|FG014|Overall Study|Adverse Event|0|||
149884138|NCT01823835|540703192|FG000|Overall Study|Physician Decision|0|||
149884139|NCT01823835|540703193|FG001|Overall Study|Physician Decision|0|||
149884140|NCT01823835|540703194|FG002|Overall Study|Physician Decision|0|||
149884141|NCT01823835|540703195|FG003|Overall Study|Physician Decision|0|||
149884142|NCT01823835|540703196|FG004|Overall Study|Physician Decision|0|||
149884143|NCT01823835|540703197|FG005|Overall Study|Physician Decision|0|||
149884144|NCT01823835|540703198|FG006|Overall Study|Physician Decision|0|||
149884145|NCT01823835|540703199|FG007|Overall Study|Physician Decision|0|||
149884146|NCT01823835|540703200|FG008|Overall Study|Physician Decision|0|||
149884147|NCT01823835|540703201|FG009|Overall Study|Physician Decision|0|||
149884148|NCT01823835|540703202|FG010|Overall Study|Physician Decision|0|||
149884149|NCT01823835|540703203|FG011|Overall Study|Physician Decision|2|||
149884150|NCT01823835|540703204|FG012|Overall Study|Physician Decision|0|||
149884151|NCT01823835|540703205|FG013|Overall Study|Physician Decision|0|||
149884152|NCT01823835|540703206|FG014|Overall Study|Physician Decision|0|||
149884153|NCT01823835|540703192|FG000|Overall Study|Progressive Disease|3|||
149884154|NCT01823835|540703193|FG001|Overall Study|Progressive Disease|4|||
149884155|NCT01823835|540703194|FG002|Overall Study|Progressive Disease|3|||
149884156|NCT01823835|540703195|FG003|Overall Study|Progressive Disease|6|||
149884157|NCT01823835|540703196|FG004|Overall Study|Progressive Disease|4|||
149884158|NCT01823835|540703197|FG005|Overall Study|Progressive Disease|6|||
149884159|NCT01823835|540703198|FG006|Overall Study|Progressive Disease|5|||
149884160|NCT01823835|540703199|FG007|Overall Study|Progressive Disease|3|||
149884161|NCT01823835|540703200|FG008|Overall Study|Progressive Disease|3|||
149884162|NCT01823835|540703201|FG009|Overall Study|Progressive Disease|18|||
149884163|NCT01823835|540703202|FG010|Overall Study|Progressive Disease|8|||
149884164|NCT01823835|540703203|FG011|Overall Study|Progressive Disease|46|||
149884165|NCT01823835|540703204|FG012|Overall Study|Progressive Disease|18|||
149884166|NCT01823835|540703205|FG013|Overall Study|Progressive Disease|4|||
149884167|NCT01823835|540703206|FG014|Overall Study|Progressive Disease|6|||
149884168|NCT01823835|540703192|FG000|Overall Study|Study Termination|0|||
149884169|NCT01823835|540703193|FG001|Overall Study|Study Termination|0|||
149884170|NCT01823835|540703194|FG002|Overall Study|Study Termination|0|||
149884171|NCT01823835|540703195|FG003|Overall Study|Study Termination|0|||
149884172|NCT01823835|540703196|FG004|Overall Study|Study Termination|1|||
149884173|NCT01823835|540703197|FG005|Overall Study|Study Termination|0|||
149884174|NCT01823835|540703198|FG006|Overall Study|Study Termination|0|||
149884175|NCT01823835|540703199|FG007|Overall Study|Study Termination|0|||
149884176|NCT01823835|540703200|FG008|Overall Study|Study Termination|0|||
149884177|NCT01823835|540703201|FG009|Overall Study|Study Termination|0|||
149884178|NCT01823835|540703202|FG010|Overall Study|Study Termination|0|||
149884179|NCT01823835|540703203|FG011|Overall Study|Study Termination|1|||
149884180|NCT01823835|540703204|FG012|Overall Study|Study Termination|0|||
149884181|NCT01823835|540703205|FG013|Overall Study|Study Termination|0|||
149884182|NCT01823835|540703206|FG014|Overall Study|Study Termination|0|||
149884183|NCT01823835|540703192|FG000|Overall Study|Withdrawal by Subject|0|||
149884184|NCT01823835|540703193|FG001|Overall Study|Withdrawal by Subject|0|||
149884185|NCT01823835|540703194|FG002|Overall Study|Withdrawal by Subject|1|||
149884186|NCT01823835|540703195|FG003|Overall Study|Withdrawal by Subject|0|||
149884187|NCT01823835|540703196|FG004|Overall Study|Withdrawal by Subject|0|||
149884188|NCT01823835|540703197|FG005|Overall Study|Withdrawal by Subject|0|||
149884189|NCT01823835|540703198|FG006|Overall Study|Withdrawal by Subject|0|||
149884190|NCT01823835|540703199|FG007|Overall Study|Withdrawal by Subject|0|||
149884191|NCT01823835|540703200|FG008|Overall Study|Withdrawal by Subject|0|||
149884192|NCT01823835|540703201|FG009|Overall Study|Withdrawal by Subject|1|||
149884193|NCT01823835|540703202|FG010|Overall Study|Withdrawal by Subject|1|||
149884194|NCT01823835|540703203|FG011|Overall Study|Withdrawal by Subject|2|||
149884195|NCT01823835|540703204|FG012|Overall Study|Withdrawal by Subject|1|||
149884196|NCT01823835|540703205|FG013|Overall Study|Withdrawal by Subject|0|||
149884197|NCT01823835|540703206|FG014|Overall Study|Withdrawal by Subject|0|||
149884198|NCT03017612|540703207|FG000|Overall Study|Adverse Event|2|||
149884199|NCT01320150|540703208|FG000|Overall Study|Protocol Violation|15|||
149884200|NCT01320150|540703208|FG000|Overall Study|Withdrawal by Subject|5|||
149884201|NCT01320150|540703208|FG000|Overall Study|Death|2|||
149884202|NCT01320150|540703208|FG000|Overall Study|Lost to Follow-up|44|||
149965808|NCT01051661|541009587|FG000|Overall Study|Withdrawal by Subject|16|||
149965809|NCT01051661|541009588|FG001|Overall Study|Withdrawal by Subject|30|||
149965810|NCT01051661|541009589|FG002|Overall Study|Withdrawal by Subject|13|||
149965811|NCT01051661|541009590|FG003|Overall Study|Withdrawal by Subject|28|||
149965812|NCT01051661|541009591|FG004|Overall Study|Withdrawal by Subject|12|||
149965813|NCT01051661|541009592|FG005|Overall Study|Withdrawal by Subject|34|||
149965814|NCT01922895|541009593|FG000|Overall Study|Death|0|||
149965815|NCT01922895|541009594|FG001|Overall Study|Death|1|||
149884203|NCT04895982|540703209|FG000|Overall Study|Withdrawal by Subject|0|||
149884204|NCT04895982|540703210|FG001|Overall Study|Withdrawal by Subject|0|||
149884205|NCT04895982|540703211|FG002|Overall Study|Withdrawal by Subject|0|||
149884206|NCT04895982|540703212|FG003|Overall Study|Withdrawal by Subject|0|||
149884207|NCT04895982|540703213|FG004|Overall Study|Withdrawal by Subject|0|||
149884208|NCT04895982|540703214|FG005|Overall Study|Withdrawal by Subject|1|||
149884209|NCT04895982|540703215|FG006|Overall Study|Withdrawal by Subject|1|||
149884210|NCT04895982|540703216|FG007|Overall Study|Withdrawal by Subject|0|||
149884211|NCT04895982|540703217|FG008|Overall Study|Withdrawal by Subject|0|||
149884212|NCT04895982|540703218|FG009|Overall Study|Withdrawal by Subject|1|||
149965816|NCT01922895|541009593|FG000|Overall Study|Withdrawal by Subject|1|||
149884213|NCT04895982|540703219|FG010|Overall Study|Withdrawal by Subject|0|||
149884214|NCT04895982|540703220|FG011|Overall Study|Withdrawal by Subject|1|||
149884215|NCT04895982|540703209|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149884216|NCT04895982|540703210|FG001|Overall Study|Withdrawal by parent/guardian|3|||
149884217|NCT04895982|540703211|FG002|Overall Study|Withdrawal by parent/guardian|3|||
149884218|NCT04895982|540703212|FG003|Overall Study|Withdrawal by parent/guardian|1|||
149884219|NCT04895982|540703213|FG004|Overall Study|Withdrawal by parent/guardian|3|||
149884220|NCT04895982|540703214|FG005|Overall Study|Withdrawal by parent/guardian|2|||
149884221|NCT04895982|540703215|FG006|Overall Study|Withdrawal by parent/guardian|1|||
149884222|NCT04895982|540703216|FG007|Overall Study|Withdrawal by parent/guardian|0|||
149884223|NCT04895982|540703217|FG008|Overall Study|Withdrawal by parent/guardian|3|||
149884224|NCT04895982|540703218|FG009|Overall Study|Withdrawal by parent/guardian|0|||
149884225|NCT04895982|540703219|FG010|Overall Study|Withdrawal by parent/guardian|0|||
149884226|NCT04895982|540703220|FG011|Overall Study|Withdrawal by parent/guardian|0|||
149884227|NCT04895982|540703209|FG000|Overall Study|Other|0|||
149884228|NCT04895982|540703210|FG001|Overall Study|Other|0|||
149884229|NCT04895982|540703211|FG002|Overall Study|Other|1|||
149884230|NCT04895982|540703212|FG003|Overall Study|Other|1|||
149884231|NCT04895982|540703213|FG004|Overall Study|Other|0|||
149884232|NCT04895982|540703214|FG005|Overall Study|Other|0|||
149884233|NCT04895982|540703215|FG006|Overall Study|Other|0|||
149884234|NCT04895982|540703216|FG007|Overall Study|Other|0|||
149884235|NCT04895982|540703217|FG008|Overall Study|Other|0|||
149884236|NCT04895982|540703218|FG009|Overall Study|Other|1|||
149884237|NCT04895982|540703219|FG010|Overall Study|Other|0|||
149884238|NCT04895982|540703220|FG011|Overall Study|Other|0|||
149884239|NCT04895982|540703209|FG000|Overall Study|Protocol Violation|0|||
149884240|NCT04895982|540703210|FG001|Overall Study|Protocol Violation|0|||
149884241|NCT04895982|540703211|FG002|Overall Study|Protocol Violation|1|||
149884242|NCT04895982|540703212|FG003|Overall Study|Protocol Violation|1|||
149884243|NCT04895982|540703213|FG004|Overall Study|Protocol Violation|1|||
149884244|NCT04895982|540703214|FG005|Overall Study|Protocol Violation|0|||
149884245|NCT04895982|540703215|FG006|Overall Study|Protocol Violation|0|||
149884246|NCT04895982|540703216|FG007|Overall Study|Protocol Violation|1|||
149884247|NCT04895982|540703217|FG008|Overall Study|Protocol Violation|0|||
149884248|NCT04895982|540703218|FG009|Overall Study|Protocol Violation|0|||
149884249|NCT04895982|540703219|FG010|Overall Study|Protocol Violation|0|||
149884250|NCT04895982|540703220|FG011|Overall Study|Protocol Violation|0|||
149884251|NCT04895982|540703209|FG000|Overall Study|Lost to Follow-up|0|||
149884252|NCT04895982|540703210|FG001|Overall Study|Lost to Follow-up|0|||
149884253|NCT04895982|540703211|FG002|Overall Study|Lost to Follow-up|1|||
149884254|NCT04895982|540703212|FG003|Overall Study|Lost to Follow-up|0|||
149884255|NCT04895982|540703213|FG004|Overall Study|Lost to Follow-up|0|||
149884256|NCT04895982|540703214|FG005|Overall Study|Lost to Follow-up|1|||
149884257|NCT04895982|540703215|FG006|Overall Study|Lost to Follow-up|0|||
149884258|NCT04895982|540703216|FG007|Overall Study|Lost to Follow-up|0|||
149884259|NCT04895982|540703217|FG008|Overall Study|Lost to Follow-up|1|||
149884260|NCT04895982|540703218|FG009|Overall Study|Lost to Follow-up|0|||
149884261|NCT04895982|540703219|FG010|Overall Study|Lost to Follow-up|0|||
149884262|NCT04895982|540703220|FG011|Overall Study|Lost to Follow-up|0|||
149884263|NCT04895982|540703209|FG000|Overall Study|Refused further study procedures|0|||
149884264|NCT04895982|540703210|FG001|Overall Study|Refused further study procedures|0|||
149884265|NCT04895982|540703211|FG002|Overall Study|Refused further study procedures|1|||
149884266|NCT04895982|540703212|FG003|Overall Study|Refused further study procedures|0|||
149884267|NCT04895982|540703213|FG004|Overall Study|Refused further study procedures|0|||
149884268|NCT04895982|540703214|FG005|Overall Study|Refused further study procedures|0|||
149884269|NCT04895982|540703215|FG006|Overall Study|Refused further study procedures|0|||
149884270|NCT04895982|540703216|FG007|Overall Study|Refused further study procedures|0|||
149884271|NCT04895982|540703217|FG008|Overall Study|Refused further study procedures|0|||
149884272|NCT04895982|540703218|FG009|Overall Study|Refused further study procedures|0|||
149884273|NCT04895982|540703219|FG010|Overall Study|Refused further study procedures|0|||
149884274|NCT04895982|540703220|FG011|Overall Study|Refused further study procedures|0|||
149884275|NCT00919854|540703221|FG000|Overall Study|Adverse Event|1|||
149965817|NCT01922895|541009594|FG001|Overall Study|Withdrawal by Subject|2|||
149965818|NCT01922895|541009593|FG000|Overall Study|Lost to Follow-up|5|||
149884276|NCT00985491|540703224|FG000|Overall Study|Adverse Event|8|||
149884277|NCT00985491|540703224|FG000|Overall Study|device migration|7|||
149884278|NCT00985491|540703224|FG000|Overall Study|Withdrawal by Subject|1|||
149884279|NCT00985491|540703224|FG000|Overall Study|implant failure|3|||
149884280|NCT01893346|540703227|FG000|Overall Study|Lost to Follow-up|0|||
149884281|NCT01893346|540703228|FG001|Overall Study|Lost to Follow-up|1|||
149965819|NCT01922895|541009594|FG001|Overall Study|Lost to Follow-up|11|||
149884282|NCT01893346|540703229|FG002|Overall Study|Lost to Follow-up|0|||
149884283|NCT01893346|540703230|FG003|Overall Study|Lost to Follow-up|0|||
149884284|NCT01893346|540703227|FG000|Overall Study|Protocol Violation|1|||
149884285|NCT01893346|540703228|FG001|Overall Study|Protocol Violation|0|||
149884286|NCT01893346|540703229|FG002|Overall Study|Protocol Violation|0|||
149884287|NCT01893346|540703230|FG003|Overall Study|Protocol Violation|0|||
149884288|NCT01893346|540703227|FG000|Overall Study|Withdrawal by Subject|2|||
149884289|NCT01893346|540703228|FG001|Overall Study|Withdrawal by Subject|0|||
149884290|NCT01893346|540703229|FG002|Overall Study|Withdrawal by Subject|0|||
149884291|NCT01893346|540703230|FG003|Overall Study|Withdrawal by Subject|0|||
149884292|NCT04386616|540703234|FG000|Overall Study|Death|22|||
149884293|NCT04386616|540703235|FG001|Overall Study|Death|22|||
149884294|NCT04386616|540703236|FG002|Overall Study|Death|21|||
149884295|NCT04386616|540703234|FG000|Overall Study|Lost to Follow-up|5|||
149884296|NCT04386616|540703235|FG001|Overall Study|Lost to Follow-up|8|||
149884297|NCT04386616|540703236|FG002|Overall Study|Lost to Follow-up|6|||
149884298|NCT04386616|540703234|FG000|Overall Study|Withdrawal by Subject|2|||
149884299|NCT04386616|540703235|FG001|Overall Study|Withdrawal by Subject|4|||
149884300|NCT04386616|540703236|FG002|Overall Study|Withdrawal by Subject|1|||
149884301|NCT04386616|540703234|FG000|Overall Study|Adverse Event|1|||
149884302|NCT04386616|540703235|FG001|Overall Study|Adverse Event|1|||
149884303|NCT04386616|540703236|FG002|Overall Study|Adverse Event|0|||
149884304|NCT01377012|540703237|FG000|Core Study|Study terminated by Sponsor|47|||
149884305|NCT01377012|540703238|FG001|Core Study|Study terminated by Sponsor|54|||
149884306|NCT01377012|540703239|FG002|Core Study|Study terminated by Sponsor|46|||
149884307|NCT01377012|540703237|FG000|Core Study|Technical problems|1|||
149884308|NCT01377012|540703238|FG001|Core Study|Technical problems|0|||
149884309|NCT01377012|540703239|FG002|Core Study|Technical problems|0|||
149884310|NCT01377012|540703237|FG000|Core Study|Withdrawal by Subject|15|||
149884311|NCT01377012|540703238|FG001|Core Study|Withdrawal by Subject|23|||
149884312|NCT01377012|540703239|FG002|Core Study|Withdrawal by Subject|18|||
149884313|NCT01377012|540703237|FG000|Core Study|Protocol Violation|7|||
149884314|NCT01377012|540703238|FG001|Core Study|Protocol Violation|3|||
149884315|NCT01377012|540703239|FG002|Core Study|Protocol Violation|2|||
149884316|NCT01377012|540703237|FG000|Core Study|Pregnancy|0|||
149884317|NCT01377012|540703238|FG001|Core Study|Pregnancy|0|||
149884318|NCT01377012|540703239|FG002|Core Study|Pregnancy|1|||
149884319|NCT01377012|540703237|FG000|Core Study|Physician Decision|5|||
149884320|NCT01377012|540703238|FG001|Core Study|Physician Decision|4|||
149884321|NCT01377012|540703239|FG002|Core Study|Physician Decision|10|||
149884322|NCT01377012|540703237|FG000|Core Study|Non-Compliant with study treatment|0|||
149884323|NCT01377012|540703238|FG001|Core Study|Non-Compliant with study treatment|0|||
149884324|NCT01377012|540703239|FG002|Core Study|Non-Compliant with study treatment|1|||
149884325|NCT01377012|540703237|FG000|Core Study|No Longer require treatment|0|||
149884326|NCT01377012|540703238|FG001|Core Study|No Longer require treatment|0|||
149884327|NCT01377012|540703239|FG002|Core Study|No Longer require treatment|1|||
149884328|NCT01377012|540703237|FG000|Core Study|Lost to Follow-up|7|||
149884329|NCT01377012|540703238|FG001|Core Study|Lost to Follow-up|5|||
149884330|NCT01377012|540703239|FG002|Core Study|Lost to Follow-up|4|||
149884331|NCT01377012|540703237|FG000|Core Study|Lack of Efficacy|41|||
149884332|NCT01377012|540703238|FG001|Core Study|Lack of Efficacy|28|||
149884333|NCT01377012|540703239|FG002|Core Study|Lack of Efficacy|37|||
149884334|NCT01377012|540703237|FG000|Core Study|Death|1|||
149884335|NCT01377012|540703238|FG001|Core Study|Death|1|||
149884336|NCT01377012|540703239|FG002|Core Study|Death|1|||
149965820|NCT01916226|541009595|FG000|Overall Study|Adverse Event|1|||
149884337|NCT01377012|540703237|FG000|Core Study|Adverse Event|10|||
149884338|NCT01377012|540703238|FG001|Core Study|Adverse Event|14|||
149884339|NCT01377012|540703239|FG002|Core Study|Adverse Event|13|||
149884340|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
149884341|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
149884342|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
149884343|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
149884344|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
149884345|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
149884346|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
149884347|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
149884348|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
149884349|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
149965821|NCT01916226|541009596|FG001|Overall Study|Adverse Event|0|||
149884350|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
149884351|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
149884352|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
149884353|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
149884354|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
149884355|NCT01377012|540703237|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
149884356|NCT01377012|540703238|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
149884357|NCT01377012|540703239|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
149884358|NCT03086551|540703266|FG000|First Intervention|Failure to meet inclusion criterion|1|||
149884359|NCT03086551|540703267|FG001|First Intervention|Failure to meet inclusion criterion|0|||
149884360|NCT03086551|540703266|FG000|First Intervention|Lost to Follow-up|0|||
149884361|NCT03086551|540703267|FG001|First Intervention|Lost to Follow-up|1|||
149884362|NCT03086551|540703266|FG000|Washout|Lost to Follow-up|1|||
149884363|NCT03086551|540703267|FG001|Washout|Lost to Follow-up|2|||
149884364|NCT03086551|540703266|FG000|Washout|Withdrawal by Subject|2|||
149884365|NCT03086551|540703267|FG001|Washout|Withdrawal by Subject|1|||
149884366|NCT02215967|540703273|FG000|Overall Study|Patient became ineligible for treatment|0|||
149884367|NCT02215967|540703274|FG001|Overall Study|Patient became ineligible for treatment|0|||
149884368|NCT02215967|540703275|FG002|Overall Study|Patient became ineligible for treatment|0|||
149884369|NCT02215967|540703276|FG003|Overall Study|Patient became ineligible for treatment|3|||
149884370|NCT02215967|540703273|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
149884371|NCT02215967|540703274|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
149884372|NCT02215967|540703275|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
149884373|NCT02215967|540703276|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
149884374|NCT03514017|540703277|FG000|Overall Study|Death|1|||
149884375|NCT03514017|540703277|FG000|Overall Study|Adverse Event|1|||
149884376|NCT05221320|540705233|FG000|Overall Study|Lack of Efficacy|3|||
149884377|NCT05221320|540705234|FG001|Overall Study|Lack of Efficacy|7|||
149884378|NCT05221320|540705235|FG002|Overall Study|Lack of Efficacy|10|||
149884379|NCT05221320|540705236|FG003|Overall Study|Lack of Efficacy|1|||
149884380|NCT05221320|540705237|FG004|Overall Study|Lack of Efficacy|0|||
149884381|NCT05221320|540705238|FG005|Overall Study|Lack of Efficacy|0|||
149884382|NCT05221320|540705233|FG000|Overall Study|Physician Decision|1|||
149884383|NCT05221320|540705234|FG001|Overall Study|Physician Decision|0|||
149884384|NCT05221320|540705235|FG002|Overall Study|Physician Decision|3|||
149884385|NCT05221320|540705236|FG003|Overall Study|Physician Decision|1|||
149884386|NCT05221320|540705237|FG004|Overall Study|Physician Decision|0|||
149884387|NCT05221320|540705238|FG005|Overall Study|Physician Decision|0|||
149884388|NCT05221320|540705233|FG000|Overall Study|Withdrawal by Subject|0|||
149884389|NCT05221320|540705234|FG001|Overall Study|Withdrawal by Subject|3|||
149884390|NCT05221320|540705235|FG002|Overall Study|Withdrawal by Subject|1|||
149884391|NCT05221320|540705236|FG003|Overall Study|Withdrawal by Subject|0|||
149884392|NCT05221320|540705237|FG004|Overall Study|Withdrawal by Subject|0|||
149884393|NCT05221320|540705238|FG005|Overall Study|Withdrawal by Subject|0|||
149884394|NCT05221320|540705233|FG000|Overall Study|Death|0|||
149884395|NCT05221320|540705234|FG001|Overall Study|Death|5|||
149884396|NCT05221320|540705235|FG002|Overall Study|Death|6|||
149884397|NCT05221320|540705236|FG003|Overall Study|Death|0|||
149884398|NCT05221320|540705237|FG004|Overall Study|Death|1|||
149884399|NCT05221320|540705238|FG005|Overall Study|Death|0|||
149884400|NCT06473519|540705239|FG000|Overall Study|Lost to Follow-up|2|||
149884401|NCT06473519|540705240|FG001|Overall Study|Lost to Follow-up|5|||
149884402|NCT06473519|540705239|FG000|Overall Study|Withdrawal by Subject|1|||
149884403|NCT06473519|540705240|FG001|Overall Study|Withdrawal by Subject|4|||
149884404|NCT06473519|540705239|FG000|Overall Study|Randomized but not vaccinated|1|||
149884405|NCT06473519|540705240|FG001|Overall Study|Randomized but not vaccinated|2|||
149884406|NCT02514447|540705244|FG000|Overall Study|Withdrawal by Subject|3|||
149884407|NCT02514447|540705245|FG001|Overall Study|Withdrawal by Subject|1|||
149884408|NCT02514447|540705246|FG002|Overall Study|Withdrawal by Subject|1|||
149884409|NCT02514447|540705247|FG003|Overall Study|Withdrawal by Subject|0|||
149884410|NCT02514447|540705248|FG004|Overall Study|Withdrawal by Subject|0|||
149884411|NCT02514447|540705249|FG005|Overall Study|Withdrawal by Subject|0|||
149884412|NCT02514447|540705250|FG006|Overall Study|Withdrawal by Subject|0|||
149884413|NCT02514447|540705251|FG007|Overall Study|Withdrawal by Subject|1|||
149965822|NCT01916226|541009597|FG002|Overall Study|Adverse Event|1|||
149965823|NCT01916226|541009598|FG003|Overall Study|Adverse Event|1|||
149965824|NCT01916226|541009595|FG000|Overall Study|Lack of Efficacy|0|||
149965825|NCT01916226|541009596|FG001|Overall Study|Lack of Efficacy|0|||
149965826|NCT01916226|541009597|FG002|Overall Study|Lack of Efficacy|2|||
149965827|NCT01916226|541009598|FG003|Overall Study|Lack of Efficacy|1|||
149965828|NCT01916226|541009595|FG000|Overall Study|Protocol Violation|0|||
149965829|NCT01916226|541009596|FG001|Overall Study|Protocol Violation|1|||
149965830|NCT01916226|541009597|FG002|Overall Study|Protocol Violation|0|||
149965831|NCT01916226|541009598|FG003|Overall Study|Protocol Violation|1|||
149965832|NCT01916226|541009595|FG000|Overall Study|Physician Decision|0|||
149965833|NCT01916226|541009596|FG001|Overall Study|Physician Decision|0|||
149965834|NCT01916226|541009597|FG002|Overall Study|Physician Decision|0|||
149965835|NCT01916226|541009598|FG003|Overall Study|Physician Decision|1|||
149965836|NCT05142306|541009599|FG000|Overall Study|Withdrawal by Subject|0|||
149884414|NCT02514447|540705252|FG008|Overall Study|Withdrawal by Subject|1|||
149884415|NCT02514447|540705244|FG000|Overall Study|Death|24|||
149884416|NCT02514447|540705245|FG001|Overall Study|Death|28|||
149965837|NCT05142306|541009600|FG001|Overall Study|Withdrawal by Subject|0|||
149965838|NCT05142306|541009601|FG002|Overall Study|Withdrawal by Subject|1|||
149965839|NCT05305651|541009607|FG000|Overall Study|Death|1|||
149965840|NCT05305651|541009607|FG000|Overall Study|Withdrawal by Subject|4|||
149965841|NCT05305651|541009607|FG000|Overall Study|Lost to Follow-up|4|||
149965842|NCT00967499|541009612|FG000|Overall Study|Adverse Event|0|||
149965843|NCT00967499|541009613|FG001|Overall Study|Adverse Event|1|||
149965844|NCT00967499|541009612|FG000|Overall Study|Protocol Violation|1|||
149965845|NCT00967499|541009613|FG001|Overall Study|Protocol Violation|0|||
149965846|NCT00967499|541009612|FG000|Overall Study|Sponsor Decision|1|||
149965847|NCT00967499|541009613|FG001|Overall Study|Sponsor Decision|0|||
149965848|NCT00967499|541009612|FG000|Overall Study|Randomized but not treated|63|||
149965849|NCT00967499|541009613|FG001|Overall Study|Randomized but not treated|59|||
149965850|NCT02412436|541009616|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
149965851|NCT02412436|541009616|FG000|Overall Study|Lost to Follow-up|6|||
149965852|NCT02412436|541009616|FG000|Overall Study|Unable to get to clinic|3|||
149965853|NCT02412436|541009616|FG000|Overall Study|Death|1|||
149965854|NCT02412436|541009616|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
149965855|NCT02544763|541009617|FG000|Overall Study|Adverse Event|8|||
149965856|NCT02544763|541009618|FG001|Overall Study|Adverse Event|8|||
149965857|NCT02544763|541009619|FG002|Overall Study|Adverse Event|0|||
149965858|NCT02544763|541009617|FG000|Overall Study|Withdrawn by parent/guardian|1|||
149965859|NCT02544763|541009618|FG001|Overall Study|Withdrawn by parent/guardian|1|||
149965860|NCT02544763|541009619|FG002|Overall Study|Withdrawn by parent/guardian|1|||
149965861|NCT02544763|541009617|FG000|Overall Study|Met withdrawal criteria|0|||
149965862|NCT02544763|541009618|FG001|Overall Study|Met withdrawal criteria|2|||
149965863|NCT02544763|541009619|FG002|Overall Study|Met withdrawal criteria|0|||
149965864|NCT02544763|541009617|FG000|Overall Study|Physician Decision|0|||
149965865|NCT02544763|541009618|FG001|Overall Study|Physician Decision|1|||
149965866|NCT02544763|541009619|FG002|Overall Study|Physician Decision|0|||
149965867|NCT02544763|541009617|FG000|Overall Study|Difficulties taking IMP|1|||
149965868|NCT02544763|541009618|FG001|Overall Study|Difficulties taking IMP|0|||
149965869|NCT02544763|541009619|FG002|Overall Study|Difficulties taking IMP|0|||
149965870|NCT04091438|541009621|FG000|Treatment Period 1 (1 Day)|Other|1|||
149965871|NCT04091438|541009622|FG001|Treatment Period 1 (1 Day)|Other|0|||
149965872|NCT04091438|541009621|FG000|Washout Period (1 Day)|Protocol deviation|0|||
149965873|NCT04091438|541009622|FG001|Washout Period (1 Day)|Protocol deviation|1|||
149965874|NCT04091438|541009621|FG000|Washout Period (1 Day)|Other|0|||
149965875|NCT04091438|541009622|FG001|Washout Period (1 Day)|Other|1|||
149965876|NCT00787800|541009625|FG000|Overall Study|Withdrawal by Subject|3|||
149965877|NCT00787800|541009626|FG001|Overall Study|Withdrawal by Subject|5|||
149965878|NCT00787800|541009625|FG000|Overall Study|Death|0|||
149965879|NCT00787800|541009626|FG001|Overall Study|Death|2|||
149965880|NCT04309500|541009628|FG000|Overall Study|Lost to Follow-up|1|||
149965881|NCT04309500|541009629|FG001|Overall Study|Lost to Follow-up|0|||
149965882|NCT04309500|541009630|FG002|Overall Study|Lost to Follow-up|0|||
149965883|NCT04309500|541009631|FG003|Overall Study|Lost to Follow-up|0|||
149965884|NCT00773461|541009633|FG000|Overall Study|Adverse Event|1|||
149965885|NCT00773461|541009634|FG001|Overall Study|Adverse Event|3|||
149965886|NCT00773461|541009633|FG000|Overall Study|Withdrawal by Subject|4|||
149965887|NCT00773461|541009634|FG001|Overall Study|Withdrawal by Subject|1|||
149965888|NCT00913835|541009635|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
149965889|NCT00913835|541009636|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
149965890|NCT00913835|541009635|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
149965891|NCT00913835|541009636|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
149965892|NCT00913835|541009635|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
149965893|NCT00913835|541009636|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
149965894|NCT00913835|541009635|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
149965895|NCT00913835|541009636|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
149965896|NCT00913835|541009635|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
149965897|NCT00913835|541009636|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
149965898|NCT00637156|541009639|FG000|Overall Study|Withdrawal by Subject|0|||
149965899|NCT00637156|541009640|FG001|Overall Study|Withdrawal by Subject|7|||
149965900|NCT00637156|541009639|FG000|Overall Study|Death|0|||
149965901|NCT00637156|541009640|FG001|Overall Study|Death|1|||
149965902|NCT00637156|541009639|FG000|Overall Study|Lost to Follow-up|10|||
149965903|NCT00637156|541009640|FG001|Overall Study|Lost to Follow-up|16|||
149965904|NCT02471144|541011115|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
149965905|NCT02471144|541011116|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
149965906|NCT02471144|541011117|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
149965907|NCT02471144|541011118|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
149965908|NCT02471144|541011119|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
149965909|NCT02471144|541011120|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
149965910|NCT02471144|541011121|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
149965911|NCT02471144|541011122|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
149965912|NCT02471144|541011123|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
149965913|NCT02471144|541011124|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
149965914|NCT02471144|541011125|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
149965915|NCT02471144|541011115|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965916|NCT02471144|541011116|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965917|NCT02471144|541011117|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965918|NCT02471144|541011118|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
149965919|NCT02471144|541011119|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965920|NCT02471144|541011120|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965921|NCT02471144|541011121|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965922|NCT02471144|541011122|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965923|NCT02471144|541011123|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965924|NCT02471144|541011124|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965925|NCT02471144|541011125|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
149965926|NCT02471144|541011115|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965927|NCT02471144|541011116|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965928|NCT02471144|541011117|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
149965929|NCT02471144|541011118|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965930|NCT02471144|541011119|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965931|NCT02471144|541011120|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965932|NCT02471144|541011121|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965933|NCT02471144|541011122|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965934|NCT02471144|541011123|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965935|NCT02471144|541011124|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965936|NCT02471144|541011125|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
149965937|NCT02471144|541011115|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
149965938|NCT02471144|541011116|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
149965939|NCT02471144|541011117|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965940|NCT02471144|541011118|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149884417|NCT02514447|540705246|FG002|Overall Study|Death|29|||
149884418|NCT02514447|540705247|FG003|Overall Study|Death|0|||
149884419|NCT02514447|540705248|FG004|Overall Study|Death|3|||
149884420|NCT02514447|540705249|FG005|Overall Study|Death|4|||
149884421|NCT02514447|540705250|FG006|Overall Study|Death|8|||
149884422|NCT02514447|540705251|FG007|Overall Study|Death|6|||
149884423|NCT02514447|540705252|FG008|Overall Study|Death|5|||
149884424|NCT02514447|540705244|FG000|Overall Study|Lost to Follow-up|1|||
149884425|NCT02514447|540705245|FG001|Overall Study|Lost to Follow-up|0|||
149884426|NCT02514447|540705246|FG002|Overall Study|Lost to Follow-up|0|||
149884427|NCT02514447|540705247|FG003|Overall Study|Lost to Follow-up|0|||
149884428|NCT02514447|540705248|FG004|Overall Study|Lost to Follow-up|0|||
149884429|NCT02514447|540705249|FG005|Overall Study|Lost to Follow-up|0|||
149884430|NCT02514447|540705250|FG006|Overall Study|Lost to Follow-up|0|||
149884431|NCT02514447|540705251|FG007|Overall Study|Lost to Follow-up|0|||
149884432|NCT02514447|540705252|FG008|Overall Study|Lost to Follow-up|1|||
149884433|NCT02514447|540705244|FG000|Overall Study|Sponsor Termination of Study|0|||
149884434|NCT02514447|540705245|FG001|Overall Study|Sponsor Termination of Study|1|||
149884435|NCT02514447|540705246|FG002|Overall Study|Sponsor Termination of Study|1|||
149884436|NCT02514447|540705247|FG003|Overall Study|Sponsor Termination of Study|0|||
149884437|NCT02514447|540705248|FG004|Overall Study|Sponsor Termination of Study|0|||
149884438|NCT02514447|540705249|FG005|Overall Study|Sponsor Termination of Study|0|||
149884439|NCT02514447|540705250|FG006|Overall Study|Sponsor Termination of Study|0|||
149884440|NCT02514447|540705251|FG007|Overall Study|Sponsor Termination of Study|0|||
149884441|NCT02514447|540705252|FG008|Overall Study|Sponsor Termination of Study|0|||
149884442|NCT02514447|540705244|FG000|Overall Study|Study completion per Investigator|1|||
149884443|NCT02514447|540705245|FG001|Overall Study|Study completion per Investigator|0|||
149884444|NCT02514447|540705246|FG002|Overall Study|Study completion per Investigator|1|||
149884445|NCT02514447|540705247|FG003|Overall Study|Study completion per Investigator|2|||
149965941|NCT02471144|541011119|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965942|NCT02471144|541011120|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965943|NCT02471144|541011121|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965944|NCT02471144|541011122|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965945|NCT02471144|541011123|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149884446|NCT02514447|540705248|FG004|Overall Study|Study completion per Investigator|0|||
149884447|NCT02514447|540705249|FG005|Overall Study|Study completion per Investigator|0|||
149884448|NCT02514447|540705250|FG006|Overall Study|Study completion per Investigator|0|||
149884449|NCT02514447|540705251|FG007|Overall Study|Study completion per Investigator|0|||
149884450|NCT02514447|540705252|FG008|Overall Study|Study completion per Investigator|1|||
149884451|NCT06419907|540705254|FG000|Overall Study|Protocol Violation|0|||
149884452|NCT06419907|540705255|FG001|Overall Study|Protocol Violation|3|||
149884453|NCT06419907|540705256|FG002|Overall Study|Protocol Violation|0|||
149884454|NCT06419907|540705257|FG003|Overall Study|Protocol Violation|1|||
149884455|NCT06419907|540705254|FG000|Overall Study|Lost to Follow-up|0|||
149884456|NCT06419907|540705255|FG001|Overall Study|Lost to Follow-up|0|||
149884457|NCT06419907|540705256|FG002|Overall Study|Lost to Follow-up|2|||
149884458|NCT06419907|540705257|FG003|Overall Study|Lost to Follow-up|1|||
149884459|NCT04856917|540705259|FG000|Overall Study|Withdrawal by Subject|4|||
149884460|NCT04856917|540705260|FG001|Overall Study|Withdrawal by Subject|3|||
149884461|NCT04856917|540705261|FG002|Overall Study|Withdrawal by Subject|1|||
149884462|NCT04856917|540705259|FG000|Overall Study|Lost to Follow-up|3|||
149884463|NCT04856917|540705260|FG001|Overall Study|Lost to Follow-up|1|||
149884464|NCT04856917|540705261|FG002|Overall Study|Lost to Follow-up|1|||
149884465|NCT04856917|540705259|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
149884466|NCT04856917|540705260|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
149884467|NCT04856917|540705261|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
149884468|NCT04856917|540705259|FG000|Overall Study|Other|1|||
149884469|NCT04856917|540705260|FG001|Overall Study|Other|1|||
149884470|NCT04856917|540705261|FG002|Overall Study|Other|0|||
149884471|NCT03560037|540705262|FG000|Overall Study|Protocol Violation|1|||
149884472|NCT03560037|540705263|FG001|Overall Study|Protocol Violation|0|||
149884473|NCT03560037|540705262|FG000|Overall Study|Physician Decision|0|||
149884474|NCT03560037|540705263|FG001|Overall Study|Physician Decision|1|||
149884475|NCT03620708|540705264|FG000|Overall Study|Lost to Follow-up|1|||
149884476|NCT03620708|540705265|FG001|Overall Study|Lost to Follow-up|1|||
149884477|NCT03620708|540705266|FG002|Overall Study|Lost to Follow-up|2|||
149884478|NCT03620708|540705264|FG000|Overall Study|Withdrawal by Subject|0|||
149884479|NCT03620708|540705265|FG001|Overall Study|Withdrawal by Subject|0|||
149884480|NCT03620708|540705266|FG002|Overall Study|Withdrawal by Subject|1|||
149884481|NCT05168202|540705267|FG000|Overall Study|Progressive Disease|4|||
149884482|NCT05168202|540705268|FG001|Overall Study|Progressive Disease|4|||
149884483|NCT05168202|540705269|FG002|Overall Study|Progressive Disease|2|||
149884484|NCT05168202|540705270|FG003|Overall Study|Progressive Disease|3|||
149884485|NCT05168202|540705271|FG004|Overall Study|Progressive Disease|2|||
149884486|NCT05168202|540705272|FG005|Overall Study|Progressive Disease|3|||
149884487|NCT05168202|540705273|FG006|Overall Study|Progressive Disease|2|||
149884488|NCT05168202|540705267|FG000|Overall Study|Adverse Event|2|||
149884489|NCT05168202|540705268|FG001|Overall Study|Adverse Event|1|||
149884490|NCT05168202|540705269|FG002|Overall Study|Adverse Event|4|||
149884491|NCT05168202|540705270|FG003|Overall Study|Adverse Event|4|||
149884492|NCT05168202|540705271|FG004|Overall Study|Adverse Event|3|||
149884493|NCT05168202|540705272|FG005|Overall Study|Adverse Event|2|||
149884494|NCT05168202|540705273|FG006|Overall Study|Adverse Event|0|||
149884495|NCT05168202|540705267|FG000|Overall Study|Lack of Efficacy|0|||
149884496|NCT05168202|540705268|FG001|Overall Study|Lack of Efficacy|1|||
149884497|NCT05168202|540705269|FG002|Overall Study|Lack of Efficacy|1|||
149884498|NCT05168202|540705270|FG003|Overall Study|Lack of Efficacy|0|||
149884499|NCT05168202|540705271|FG004|Overall Study|Lack of Efficacy|1|||
149884500|NCT05168202|540705272|FG005|Overall Study|Lack of Efficacy|2|||
149884501|NCT05168202|540705273|FG006|Overall Study|Lack of Efficacy|2|||
149884502|NCT05168202|540705267|FG000|Overall Study|Withdrawal by Subject|0|||
149884503|NCT05168202|540705268|FG001|Overall Study|Withdrawal by Subject|0|||
149884504|NCT05168202|540705269|FG002|Overall Study|Withdrawal by Subject|1|||
149884505|NCT05168202|540705270|FG003|Overall Study|Withdrawal by Subject|1|||
149884506|NCT05168202|540705271|FG004|Overall Study|Withdrawal by Subject|1|||
149884507|NCT05168202|540705272|FG005|Overall Study|Withdrawal by Subject|1|||
149884508|NCT05168202|540705273|FG006|Overall Study|Withdrawal by Subject|0|||
149884509|NCT05168202|540705267|FG000|Overall Study|Disease Relapse|0|||
149884510|NCT05168202|540705268|FG001|Overall Study|Disease Relapse|1|||
149884511|NCT05168202|540705269|FG002|Overall Study|Disease Relapse|0|||
149884512|NCT05168202|540705270|FG003|Overall Study|Disease Relapse|1|||
149884513|NCT05168202|540705271|FG004|Overall Study|Disease Relapse|1|||
150175180|NCT01264679|541777068|FG000|Overall Study|Participation in Another Clinical Trial|1|||
150175181|NCT01264679|541777068|FG000|Overall Study|Physician Decision|1|||
150175182|NCT01264679|541777068|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
150175183|NCT01264679|541777068|FG000|Overall Study|Withdrawal by Subject|1|||
149884514|NCT05168202|540705272|FG005|Overall Study|Disease Relapse|0|||
149884515|NCT05168202|540705273|FG006|Overall Study|Disease Relapse|0|||
149884516|NCT05168202|540705267|FG000|Overall Study|Other Reasons|0|||
149884517|NCT05168202|540705268|FG001|Overall Study|Other Reasons|0|||
149884518|NCT05168202|540705269|FG002|Overall Study|Other Reasons|0|||
149884519|NCT05168202|540705270|FG003|Overall Study|Other Reasons|0|||
149884520|NCT05168202|540705271|FG004|Overall Study|Other Reasons|0|||
149884521|NCT05168202|540705272|FG005|Overall Study|Other Reasons|2|||
149884522|NCT05168202|540705273|FG006|Overall Study|Other Reasons|1|||
149884523|NCT05168202|540705267|FG000|Overall Study|Physician Decision|0|||
149884524|NCT05168202|540705268|FG001|Overall Study|Physician Decision|1|||
149884525|NCT05168202|540705269|FG002|Overall Study|Physician Decision|1|||
149884526|NCT05168202|540705270|FG003|Overall Study|Physician Decision|0|||
149884527|NCT05168202|540705271|FG004|Overall Study|Physician Decision|0|||
149884528|NCT05168202|540705272|FG005|Overall Study|Physician Decision|0|||
149884529|NCT05168202|540705273|FG006|Overall Study|Physician Decision|0|||
149884530|NCT05168202|540705267|FG000|Overall Study|Study Terminated by Sponsor|0|||
149884531|NCT05168202|540705268|FG001|Overall Study|Study Terminated by Sponsor|0|||
149884532|NCT05168202|540705269|FG002|Overall Study|Study Terminated by Sponsor|0|||
149884533|NCT05168202|540705270|FG003|Overall Study|Study Terminated by Sponsor|1|||
149884534|NCT05168202|540705271|FG004|Overall Study|Study Terminated by Sponsor|0|||
149884535|NCT05168202|540705272|FG005|Overall Study|Study Terminated by Sponsor|0|||
149884536|NCT05168202|540705273|FG006|Overall Study|Study Terminated by Sponsor|0|||
149884537|NCT04011722|540705277|FG000|30 Days|Death|5|||
149884538|NCT04011722|540705278|FG001|30 Days|Death|1|||
149884539|NCT04011722|540705277|FG000|1 Year|Death|13|||
149884540|NCT04011722|540705278|FG001|1 Year|Death|5|||
149884541|NCT04011722|540705277|FG000|1 Year|Withdrawal by Subject|8|||
149884542|NCT04011722|540705278|FG001|1 Year|Withdrawal by Subject|2|||
149884543|NCT04011722|540705277|FG000|1 Year|Missed Visit|6|||
149884544|NCT04011722|540705278|FG001|1 Year|Missed Visit|1|||
149884545|NCT04011722|540705277|FG000|1 Year|Pending Visit|0|||
149884546|NCT04011722|540705278|FG001|1 Year|Pending Visit|11|||
149884547|NCT04011722|540705277|FG000|1 Year|Not Yet Due|0|||
149884548|NCT04011722|540705278|FG001|1 Year|Not Yet Due|9|||
149884549|NCT04011722|540705277|FG000|2 Year|Death|16|||
149884550|NCT04011722|540705278|FG001|2 Year|Death|1|||
149884551|NCT04011722|540705277|FG000|2 Year|Withdrawal by Subject|10|||
149884552|NCT04011722|540705278|FG001|2 Year|Withdrawal by Subject|1|||
149884553|NCT04011722|540705277|FG000|2 Year|Missed Visit|9|||
149884554|NCT04011722|540705278|FG001|2 Year|Missed Visit|0|||
149884555|NCT04011722|540705277|FG000|2 Year|Visit Pending|1|||
149884556|NCT04011722|540705278|FG001|2 Year|Visit Pending|3|||
149884557|NCT04011722|540705277|FG000|2 Year|Not Yet Due|43|||
149884558|NCT04011722|540705278|FG001|2 Year|Not Yet Due|54|||
149884559|NCT04011722|540705277|FG000|3 Year|Death|10|||
149884560|NCT04011722|540705278|FG001|3 Year|Death|0|||
149884561|NCT04011722|540705277|FG000|3 Year|Withdrawal by Subject|2|||
149884562|NCT04011722|540705278|FG001|3 Year|Withdrawal by Subject|0|||
149884563|NCT04011722|540705277|FG000|3 Year|Missed Visit|2|||
149884564|NCT04011722|540705278|FG001|3 Year|Missed Visit|0|||
149884565|NCT04011722|540705277|FG000|3 Year|Pending Visit|34|||
149884566|NCT04011722|540705278|FG001|3 Year|Pending Visit|0|||
149884567|NCT04011722|540705277|FG000|3 Year|Not Yet Due|99|||
149884568|NCT04011722|540705278|FG001|3 Year|Not Yet Due|0|||
149884569|NCT06195930|540705284|FG000|Overall Study|Adverse Event|4|||
149884570|NCT03999996|540705285|FG000|Prior to Booster|Adverse Event|2|||
149884571|NCT03999996|540705286|FG001|Prior to Booster|Adverse Event|0|||
149884572|NCT03999996|540705287|FG002|Prior to Booster|Adverse Event|0|||
149884573|NCT03999996|540705288|FG003|Prior to Booster|Adverse Event|0|||
149884574|NCT03999996|540705285|FG000|Prior to Booster|Lost to Follow-up|17|||
149884575|NCT03999996|540705286|FG001|Prior to Booster|Lost to Follow-up|22|||
149884576|NCT03999996|540705287|FG002|Prior to Booster|Lost to Follow-up|0|||
149884577|NCT03999996|540705288|FG003|Prior to Booster|Lost to Follow-up|0|||
149884578|NCT03999996|540705285|FG000|Prior to Booster|Withdrawal of Consent|51|||
149884579|NCT03999996|540705286|FG001|Prior to Booster|Withdrawal of Consent|8|||
149884580|NCT03999996|540705287|FG002|Prior to Booster|Withdrawal of Consent|0|||
149884581|NCT03999996|540705288|FG003|Prior to Booster|Withdrawal of Consent|0|||
149884582|NCT03999996|540705285|FG000|Prior to Booster|Death|0|||
149884583|NCT03999996|540705286|FG001|Prior to Booster|Death|1|||
149884584|NCT03999996|540705287|FG002|Prior to Booster|Death|0|||
149884585|NCT03999996|540705288|FG003|Prior to Booster|Death|0|||
149884586|NCT03999996|540705285|FG000|Prior to Booster|Reason Not Specified|27|||
149884587|NCT03999996|540705286|FG001|Prior to Booster|Reason Not Specified|4|||
149884588|NCT03999996|540705287|FG002|Prior to Booster|Reason Not Specified|0|||
149884589|NCT03999996|540705288|FG003|Prior to Booster|Reason Not Specified|0|||
149884590|NCT03999996|540705285|FG000|Booster Phase|Lost to Follow-up|0|||
149884591|NCT03999996|540705286|FG001|Booster Phase|Lost to Follow-up|0|||
149884592|NCT03999996|540705287|FG002|Booster Phase|Lost to Follow-up|3|||
149884593|NCT03999996|540705288|FG003|Booster Phase|Lost to Follow-up|3|||
149884594|NCT03999996|540705285|FG000|Booster Phase|Withdrawal of Consent|0|||
149884595|NCT03999996|540705286|FG001|Booster Phase|Withdrawal of Consent|0|||
149884596|NCT03999996|540705287|FG002|Booster Phase|Withdrawal of Consent|0|||
149884597|NCT03999996|540705288|FG003|Booster Phase|Withdrawal of Consent|1|||
149884598|NCT03999996|540705285|FG000|Booster Phase|Reason Not Specified|0|||
149884599|NCT03999996|540705286|FG001|Booster Phase|Reason Not Specified|0|||
149884600|NCT03999996|540705287|FG002|Booster Phase|Reason Not Specified|0|||
149884601|NCT03999996|540705288|FG003|Booster Phase|Reason Not Specified|1|||
149884602|NCT03690388|540705289|FG000|Overall Study|Adverse Event|8|||
149884603|NCT03690388|540705290|FG001|Overall Study|Adverse Event|1|||
149884604|NCT03690388|540705289|FG000|Overall Study|Radiographic Progression|14|||
149884605|NCT03690388|540705290|FG001|Overall Study|Radiographic Progression|29|||
149884606|NCT03690388|540705289|FG000|Overall Study|Clinical deterioration|10|||
149884607|NCT03690388|540705290|FG001|Overall Study|Clinical deterioration|6|||
149884608|NCT03690388|540705289|FG000|Overall Study|Withdrawal by Subject|2|||
149884609|NCT03690388|540705290|FG001|Overall Study|Withdrawal by Subject|0|||
149884610|NCT03690388|540705289|FG000|Overall Study|Lack of Efficacy|1|||
149884611|NCT03690388|540705290|FG001|Overall Study|Lack of Efficacy|0|||
149884612|NCT03690388|540705289|FG000|Overall Study|Lost to Follow-up|1|||
149884613|NCT03690388|540705290|FG001|Overall Study|Lost to Follow-up|0|||
149884614|NCT00266630|540705295|FG000|Overall Study|Adverse Event|8|||
149884615|NCT00266630|540705296|FG001|Overall Study|Adverse Event|6|||
149884616|NCT00266630|540705295|FG000|Overall Study|Lack of Efficacy|1|||
149884617|NCT00266630|540705296|FG001|Overall Study|Lack of Efficacy|4|||
149884618|NCT00266630|540705295|FG000|Overall Study|Entry Criteria not met|1|||
149884619|NCT00266630|540705296|FG001|Overall Study|Entry Criteria not met|0|||
149884620|NCT00266630|540705295|FG000|Overall Study|Protocol Violation|1|||
149884621|NCT00266630|540705296|FG001|Overall Study|Protocol Violation|3|||
149884622|NCT00266630|540705295|FG000|Overall Study|Physician Decision|1|||
149884623|NCT00266630|540705296|FG001|Overall Study|Physician Decision|2|||
149884624|NCT00266630|540705295|FG000|Overall Study|Withdrawal by Subject|10|||
149884625|NCT00266630|540705296|FG001|Overall Study|Withdrawal by Subject|2|||
149965946|NCT02471144|541011124|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149884626|NCT00266630|540705295|FG000|Overall Study|Lost to Follow-up|1|||
149884627|NCT00266630|540705296|FG001|Overall Study|Lost to Follow-up|0|||
149884628|NCT00266630|540705295|FG000|Overall Study|Other|19|||
149884629|NCT00266630|540705296|FG001|Overall Study|Other|11|||
149884630|NCT05377749|540705301|FG000|3 Weeks|Lost to Follow-up|2|||
149884631|NCT05377749|540705302|FG001|3 Weeks|Lost to Follow-up|4|||
149884632|NCT05377749|540705301|FG000|3 Weeks|Withdrawal by Subject|1|||
149884633|NCT05377749|540705302|FG001|3 Weeks|Withdrawal by Subject|1|||
149884634|NCT04909853|540705303|FG000|Part 1|Assigned but not treated|0|||
149884635|NCT04909853|540705304|FG001|Part 1|Assigned but not treated|0|||
149884636|NCT04909853|540705305|FG002|Part 1|Assigned but not treated|1|||
149884637|NCT04909853|540705306|FG003|Part 1|Assigned but not treated|0|||
149884638|NCT04909853|540705303|FG000|Part 2|Adverse Event|0|||
149884639|NCT04909853|540705304|FG001|Part 2|Adverse Event|0|||
149884640|NCT04909853|540705305|FG002|Part 2|Adverse Event|0|||
149884641|NCT04909853|540705306|FG003|Part 2|Adverse Event|1|||
149884642|NCT00077207|540705309|FG000|Overall Study|Adverse Event|5|||
149965947|NCT02471144|541011125|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
149965948|NCT02471144|541011115|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149884643|NCT00077207|540705309|FG000|Overall Study|Lack of Efficacy|12|||
149884644|NCT00077207|540705309|FG000|Overall Study|Physician Decision|6|||
150043974|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
150043975|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
150043976|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
150043977|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
150043978|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
150043979|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
150043980|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
149884645|NCT00077207|540705309|FG000|Overall Study|Withdrawal by Subject|6|||
149884646|NCT00077207|540705309|FG000|Overall Study|Ineligible|1|||
149884647|NCT01720225|540705320|FG000|Overall Study|Withdrawal by Subject|0|||
149884648|NCT01720225|540705321|FG001|Overall Study|Withdrawal by Subject|1|||
149884649|NCT01720225|540705320|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
149884650|NCT01720225|540705321|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
149884651|NCT02738138|540705322|FG000|Overall Study|Adverse Event|0|||
149965949|NCT02471144|541011116|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149965950|NCT02471144|541011117|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149884652|NCT02738138|540705323|FG001|Overall Study|Adverse Event|1|||
149884653|NCT02738138|540705322|FG000|Overall Study|Lost to Follow-up|2|||
149884654|NCT02738138|540705323|FG001|Overall Study|Lost to Follow-up|0|||
149884655|NCT02738138|540705322|FG000|Overall Study|Other - not further specified|1|||
149884656|NCT02738138|540705323|FG001|Overall Study|Other - not further specified|0|||
149884657|NCT03571828|540705334|FG000|Overall Study|Withdrawal by Subject|1|||
149884658|NCT03571828|540705335|FG001|Overall Study|Withdrawal by Subject|0|||
149884659|NCT03571828|540705334|FG000|Overall Study|Decision by sponsor|5|||
149884660|NCT03571828|540705335|FG001|Overall Study|Decision by sponsor|1|||
149884661|NCT03571828|540705334|FG000|Overall Study|Death|2|||
150043981|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150043982|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150043983|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
149884662|NCT03571828|540705335|FG001|Overall Study|Death|0|||
149884663|NCT00666328|540705336|FG000|Overall Study|Death|2|||
149884664|NCT00666328|540705336|FG000|Overall Study|Lost to Follow-up|2|||
149884665|NCT00666328|540705336|FG000|Overall Study|No longer met eligibility criteria|1|||
149884666|NCT02441686|540705337|FG000|Induction|Adverse Event|4|||
149884667|NCT02441686|540705337|FG000|Induction|Complicating disease|1|||
149884668|NCT02441686|540705337|FG000|Induction|Physician Decision|1|||
149884669|NCT02441686|540705337|FG000|Induction|Withdrawal by Subject|1|||
149884670|NCT02441686|540705337|FG000|Induction|Did not receive treatment|1|||
149884671|NCT02441686|540705337|FG000|Maintenance|Remaining on Treatment|23|||
149884672|NCT02441686|540705337|FG000|Maintenance|Physician Decision|1|||
149884673|NCT02441686|540705337|FG000|Maintenance|Adverse Event|3|||
149884674|NCT02441686|540705337|FG000|Maintenance|Progressive Disease|10|||
149884675|NCT02441686|540705337|FG000|Maintenance|Withdrawal by Subject|1|||
149884676|NCT03762239|540705338|FG000|Overall Study|Appointment to the doctor|1|||
149884677|NCT03762239|540705339|FG001|Overall Study|Appointment to the doctor|1|||
149884678|NCT04471428|540705340|FG000|Overall Study|Withdrawal by Subject|29|||
149884679|NCT04471428|540705341|FG001|Overall Study|Withdrawal by Subject|1|||
149884680|NCT04471428|540705340|FG000|Overall Study|Physician Decision|0|||
149884681|NCT04471428|540705341|FG001|Overall Study|Physician Decision|1|||
149884682|NCT04471428|540705340|FG000|Overall Study|Reason Not Specified|0|||
149884683|NCT04471428|540705341|FG001|Overall Study|Reason Not Specified|2|||
149884684|NCT04471428|540705340|FG000|Overall Study|Death|106|||
149884685|NCT04471428|540705341|FG001|Overall Study|Death|114|||
149884686|NCT04471428|540705340|FG000|Overall Study|Ongoing in the study|45|||
149884687|NCT04471428|540705341|FG001|Overall Study|Ongoing in the study|68|||
149884688|NCT03151304|540705342|FG000|Overall Study|Termination of study by Sponsor|23|||
149884689|NCT03151304|540705342|FG000|Overall Study|missing|3|||
149884690|NCT03151304|540705342|FG000|Overall Study|Withdrawal by Subject|8|||
149884691|NCT03151304|540705342|FG000|Overall Study|multiple reasons|30|||
149884692|NCT01137071|540705344|FG000|Overall Study|Disease Progression|11|||
149884693|NCT01137071|540705344|FG000|Overall Study|Withdrawal by Subject|2|||
149884694|NCT01137071|540705344|FG000|Overall Study|Wrongly Included|1|||
149884695|NCT02565511|540705345|FG000|Overall Study|Study terminated by Sponsor|35|||
149884696|NCT02565511|540705346|FG001|Overall Study|Study terminated by Sponsor|22|||
149884697|NCT02565511|540705347|FG002|Overall Study|Study terminated by Sponsor|235|||
149884698|NCT02565511|540705348|FG003|Overall Study|Study terminated by Sponsor|156|||
150043984|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150043985|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150043986|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150175184|NCT03475316|541777069|FG000|6 Month Intervention|Adverse Event|2|||
149884699|NCT02565511|540705345|FG000|Overall Study|Withdrawal by Subject|3|||
149884700|NCT02565511|540705346|FG001|Overall Study|Withdrawal by Subject|0|||
149884701|NCT02565511|540705347|FG002|Overall Study|Withdrawal by Subject|12|||
149884702|NCT02565511|540705348|FG003|Overall Study|Withdrawal by Subject|5|||
149884703|NCT02565511|540705345|FG000|Overall Study|Adverse Event|0|||
149884704|NCT02565511|540705346|FG001|Overall Study|Adverse Event|0|||
149884705|NCT02565511|540705347|FG002|Overall Study|Adverse Event|1|||
149884706|NCT02565511|540705348|FG003|Overall Study|Adverse Event|1|||
149884707|NCT02565511|540705345|FG000|Overall Study|Lost to Follow-up|4|||
149884708|NCT02565511|540705346|FG001|Overall Study|Lost to Follow-up|1|||
149884709|NCT02565511|540705347|FG002|Overall Study|Lost to Follow-up|0|||
149884710|NCT02565511|540705348|FG003|Overall Study|Lost to Follow-up|1|||
149884711|NCT02565511|540705345|FG000|Overall Study|Physician Decision|0|||
149884712|NCT02565511|540705346|FG001|Overall Study|Physician Decision|0|||
149884713|NCT02565511|540705347|FG002|Overall Study|Physician Decision|0|||
149884714|NCT02565511|540705348|FG003|Overall Study|Physician Decision|1|||
149884715|NCT02565511|540705345|FG000|Overall Study|Protocol deviation|0|||
149884716|NCT02565511|540705346|FG001|Overall Study|Protocol deviation|0|||
149884717|NCT02565511|540705347|FG002|Overall Study|Protocol deviation|3|||
149884718|NCT02565511|540705348|FG003|Overall Study|Protocol deviation|0|||
149884719|NCT04807400|540705349|FG000|Overall Study|Adverse Event|2|||
149884720|NCT04807400|540705350|FG001|Overall Study|Adverse Event|3|||
149884721|NCT04807400|540705351|FG002|Overall Study|Adverse Event|3|||
149884722|NCT04807400|540705349|FG000|Overall Study|Death|2|||
149884723|NCT04807400|540705350|FG001|Overall Study|Death|0|||
149884724|NCT04807400|540705351|FG002|Overall Study|Death|0|||
149884725|NCT04807400|540705349|FG000|Overall Study|Lost to Follow-up|8|||
149884726|NCT04807400|540705350|FG001|Overall Study|Lost to Follow-up|6|||
149884727|NCT04807400|540705351|FG002|Overall Study|Lost to Follow-up|6|||
149884728|NCT04807400|540705349|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149884729|NCT04807400|540705350|FG001|Overall Study|Non-Compliance With Study Drug|4|||
149884730|NCT04807400|540705351|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149884731|NCT04807400|540705349|FG000|Overall Study|Participant Decision|20|||
149884732|NCT04807400|540705350|FG001|Overall Study|Participant Decision|19|||
149884733|NCT04807400|540705351|FG002|Overall Study|Participant Decision|26|||
149884734|NCT04807400|540705349|FG000|Overall Study|Physician Decision|0|||
149884735|NCT04807400|540705350|FG001|Overall Study|Physician Decision|1|||
149884736|NCT04807400|540705351|FG002|Overall Study|Physician Decision|0|||
149884737|NCT04807400|540705349|FG000|Overall Study|Protocol Violation|4|||
149884738|NCT04807400|540705350|FG001|Overall Study|Protocol Violation|3|||
149884739|NCT04807400|540705351|FG002|Overall Study|Protocol Violation|7|||
149884740|NCT04807400|540705349|FG000|Overall Study|Withdrawal by Subject|13|||
149884741|NCT04807400|540705350|FG001|Overall Study|Withdrawal by Subject|9|||
149884742|NCT04807400|540705351|FG002|Overall Study|Withdrawal by Subject|20|||
149884743|NCT04807400|540705349|FG000|Overall Study|Mis-randomized|1|||
149884744|NCT04807400|540705350|FG001|Overall Study|Mis-randomized|0|||
149884745|NCT04807400|540705351|FG002|Overall Study|Mis-randomized|0|||
149965951|NCT02471144|541011118|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149884746|NCT03656744|540705352|FG000|Overall Study|Adverse Event|1|||
149884747|NCT03656744|540705353|FG001|Overall Study|Adverse Event|4|||
149884748|NCT03656744|540705354|FG002|Overall Study|Adverse Event|1|||
149884749|NCT03656744|540705352|FG000|Overall Study|Protocol Violation|1|||
149884750|NCT03656744|540705353|FG001|Overall Study|Protocol Violation|0|||
149884751|NCT03656744|540705354|FG002|Overall Study|Protocol Violation|0|||
149884752|NCT03656744|540705352|FG000|Overall Study|Lost to Follow-up|2|||
149884753|NCT03656744|540705353|FG001|Overall Study|Lost to Follow-up|2|||
149884754|NCT03656744|540705354|FG002|Overall Study|Lost to Follow-up|0|||
149884755|NCT03656744|540705352|FG000|Overall Study|Withdrawal by Subject|0|||
149884756|NCT03656744|540705353|FG001|Overall Study|Withdrawal by Subject|1|||
149884757|NCT03656744|540705354|FG002|Overall Study|Withdrawal by Subject|0|||
149884758|NCT03656744|540705352|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
149884759|NCT03656744|540705353|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
149884760|NCT03656744|540705354|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
149884761|NCT01332292|540705358|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
149884762|NCT01332292|540705359|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
149884763|NCT01332292|540705358|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
149884764|NCT01332292|540705359|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
150043987|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
150043988|NCT03682770|541300756|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043989|NCT03682770|541300757|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043990|NCT03682770|541300758|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043991|NCT03682770|541300759|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
150043992|NCT03682770|541300760|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043993|NCT03682770|541300761|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043994|NCT03682770|541300762|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
150043995|NCT03682770|541300756|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
150043996|NCT03682770|541300757|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
150043997|NCT03682770|541300758|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
150043998|NCT03682770|541300759|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
150043999|NCT03682770|541300760|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
150175185|NCT03475316|541777070|FG001|6 Month Intervention|Adverse Event|1|||
150175186|NCT03475316|541777069|FG000|6 Month Intervention|Withdrawal by Subject|2|||
150175187|NCT03475316|541777070|FG001|6 Month Intervention|Withdrawal by Subject|0|||
149884765|NCT01332292|540705358|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
149884766|NCT01332292|540705359|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
149884767|NCT00098774|540705361|FG000|Overall Study|Adverse Event|2|||
150044000|NCT03682770|541300761|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
150175188|NCT03475316|541777069|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
149884768|NCT00098774|540705361|FG000|Overall Study|Disease Progression|9|||
149884769|NCT00098774|540705361|FG000|Overall Study|Withdrawal by Subject|1|||
149884770|NCT00098774|540705361|FG000|Overall Study|Failed (to respond) during induction|4|||
149884771|NCT00098774|540705361|FG000|Overall Study|Physician Decision|2|||
149884772|NCT03910673|540705362|FG000|Overall Study|Adverse Event|0|||
149884773|NCT03910673|540705363|FG001|Overall Study|Adverse Event|0|||
149884774|NCT03910673|540705364|FG002|Overall Study|Adverse Event|0|||
149884775|NCT03910673|540705365|FG003|Overall Study|Adverse Event|2|||
149884776|NCT03910673|540705366|FG004|Overall Study|Adverse Event|0|||
149884777|NCT00489827|540705371|FG000|Overall Study|Intraoperative exclusion criteria|1|||
149884778|NCT00489827|540705372|FG001|Overall Study|Intraoperative exclusion criteria|1|||
149884779|NCT00489827|540705371|FG000|Overall Study|Intraoperative exclusion criteria|1|||
149884780|NCT00489827|540705372|FG001|Overall Study|Intraoperative exclusion criteria|1|||
149884781|NCT02296931|540705373|FG000|Overall Study|Protocol Violation|0|||
149884782|NCT02296931|540705374|FG001|Overall Study|Protocol Violation|2|||
149884783|NCT01590277|540705375|FG000|Overall Study|Withdrawal by Subject|3|||
149884784|NCT01590277|540705375|FG000|Overall Study|Withdrawal by Subject|2|||
149884785|NCT01590277|540705375|FG000|Overall Study|Withdrawal by Subject|1|||
149884786|NCT01590277|540705375|FG000|Overall Study|Withdrawal by Subject|1|||
149884787|NCT01632280|540705378|FG000|Overall Study|Withdrawal by Subject|1|||
149884788|NCT01632280|540705379|FG001|Overall Study|Withdrawal by Subject|0|||
149884789|NCT03736031|540705380|FG000|Overall Study|Death|2|||
149884790|NCT03736031|540705381|FG001|Overall Study|Death|4|||
149884791|NCT03736031|540705380|FG000|Overall Study|Lost to Follow-up|21|||
149884792|NCT03736031|540705381|FG001|Overall Study|Lost to Follow-up|2|||
149884793|NCT03736031|540705380|FG000|Overall Study|Withdrawal by Subject|9|||
149884794|NCT03736031|540705381|FG001|Overall Study|Withdrawal by Subject|0|||
149884795|NCT05022212|540705382|FG000|Overall Study|Lost to Follow-up|0|||
149884796|NCT05022212|540705383|FG001|Overall Study|Lost to Follow-up|2|||
149884797|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
149884798|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
149884799|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
149884800|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
149884801|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
149884802|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
149884803|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
149884804|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
149884805|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
149884806|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
149884807|NCT00451178|540705384|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
149884808|NCT00451178|540705385|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
149884809|NCT00451178|540705384|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
149884810|NCT00451178|540705385|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
149884811|NCT00451178|540705384|FG000|Prior to Maintenance Therapy|PD|2|||
149884812|NCT00451178|540705385|FG001|Prior to Maintenance Therapy|PD|0|||
149884813|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
149884814|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
149884815|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
149884816|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
149884817|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
149884818|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
149884819|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
149884820|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
149884821|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
149884822|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
149884823|NCT00451178|540705384|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
149884824|NCT00451178|540705385|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
149884825|NCT00451178|540705384|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
149884826|NCT00451178|540705385|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
149884827|NCT02729909|540705386|FG000|Overall Study|Lost to Follow-up|0|||
149884828|NCT02729909|540705387|FG001|Overall Study|Lost to Follow-up|1|||
149884829|NCT02729909|540705386|FG000|Overall Study|Lack of Efficacy|0|||
149884830|NCT02729909|540705387|FG001|Overall Study|Lack of Efficacy|2|||
149884831|NCT02729909|540705386|FG000|Overall Study|Significant Protocol Deviation|0|||
149884832|NCT02729909|540705387|FG001|Overall Study|Significant Protocol Deviation|2|||
149884833|NCT02729909|540705386|FG000|Overall Study|Voluntary Withdrawal|1|||
149884834|NCT02729909|540705387|FG001|Overall Study|Voluntary Withdrawal|0|||
149884835|NCT01260701|540705388|FG000|Overall Study|Adverse Event|9|||
149884836|NCT01260701|540705388|FG000|Overall Study|Withdrawal by Subject|2|||
149884837|NCT01260701|540705388|FG000|Overall Study|Progression|53|||
149884838|NCT01260701|540705388|FG000|Overall Study|Death|2|||
149884839|NCT01260701|540705388|FG000|Overall Study|Not protocol specified|3|||
149884840|NCT01260701|540705388|FG000|Overall Study|Under review|1|||
149884841|NCT01260701|540705388|FG000|Overall Study|Ineligible|4|||
149884842|NCT01260701|540705388|FG000|Overall Study|Did not begin protocol therapy|1|||
149884843|NCT03300817|540706979|FG000|Overall Study|Withdrawal by Subject|1|||
149884844|NCT03300817|540706979|FG000|Overall Study|Adverse Event|1|||
149884845|NCT03300817|540706979|FG000|Overall Study|Subject Found to be Ineligible|2|||
149884846|NCT03729596|540706981|FG000|Overall Study|Death|3|||
149884847|NCT03729596|540706982|FG001|Overall Study|Death|5|||
149884848|NCT03729596|540706983|FG002|Overall Study|Death|4|||
149884849|NCT03729596|540706984|FG003|Overall Study|Death|1|||
149884850|NCT03729596|540706985|FG004|Overall Study|Death|0|||
149884851|NCT03729596|540706986|FG005|Overall Study|Death|34|||
149884852|NCT03729596|540706987|FG006|Overall Study|Death|18|||
149884853|NCT03729596|540706988|FG007|Overall Study|Death|14|||
149884854|NCT03729596|540706989|FG008|Overall Study|Death|19|||
149884855|NCT03729596|540706990|FG009|Overall Study|Death|9|||
149884856|NCT03729596|540706981|FG000|Overall Study|Lost to Follow-up|0|||
149884857|NCT03729596|540706982|FG001|Overall Study|Lost to Follow-up|0|||
149884858|NCT03729596|540706983|FG002|Overall Study|Lost to Follow-up|0|||
149884859|NCT03729596|540706984|FG003|Overall Study|Lost to Follow-up|0|||
149884860|NCT03729596|540706985|FG004|Overall Study|Lost to Follow-up|0|||
149884861|NCT03729596|540706986|FG005|Overall Study|Lost to Follow-up|0|||
149884862|NCT03729596|540706987|FG006|Overall Study|Lost to Follow-up|1|||
149884863|NCT03729596|540706988|FG007|Overall Study|Lost to Follow-up|0|||
149884864|NCT03729596|540706989|FG008|Overall Study|Lost to Follow-up|0|||
149884865|NCT03729596|540706990|FG009|Overall Study|Lost to Follow-up|1|||
149884866|NCT03729596|540706981|FG000|Overall Study|protocol amendment|0|||
149884867|NCT03729596|540706982|FG001|Overall Study|protocol amendment|1|||
149884868|NCT03729596|540706983|FG002|Overall Study|protocol amendment|3|||
149884869|NCT03729596|540706984|FG003|Overall Study|protocol amendment|6|||
149884870|NCT03729596|540706985|FG004|Overall Study|protocol amendment|5|||
149884871|NCT03729596|540706986|FG005|Overall Study|protocol amendment|0|||
149884872|NCT03729596|540706987|FG006|Overall Study|protocol amendment|0|||
149884873|NCT03729596|540706988|FG007|Overall Study|protocol amendment|0|||
149884874|NCT03729596|540706989|FG008|Overall Study|protocol amendment|0|||
149884875|NCT03729596|540706990|FG009|Overall Study|protocol amendment|0|||
149884876|NCT03729596|540706981|FG000|Overall Study|Withdrawal by Subject|0|||
149884877|NCT03729596|540706982|FG001|Overall Study|Withdrawal by Subject|0|||
149884878|NCT03729596|540706983|FG002|Overall Study|Withdrawal by Subject|0|||
149884879|NCT03729596|540706984|FG003|Overall Study|Withdrawal by Subject|0|||
149884880|NCT03729596|540706985|FG004|Overall Study|Withdrawal by Subject|0|||
149884881|NCT03729596|540706986|FG005|Overall Study|Withdrawal by Subject|4|||
149884882|NCT03729596|540706987|FG006|Overall Study|Withdrawal by Subject|2|||
149884883|NCT03729596|540706988|FG007|Overall Study|Withdrawal by Subject|3|||
149884884|NCT03729596|540706989|FG008|Overall Study|Withdrawal by Subject|2|||
149884885|NCT03729596|540706990|FG009|Overall Study|Withdrawal by Subject|3|||
149884886|NCT03729596|540706981|FG000|Overall Study|study terminated by sponsor|0|||
149884887|NCT03729596|540706982|FG001|Overall Study|study terminated by sponsor|0|||
149884888|NCT03729596|540706983|FG002|Overall Study|study terminated by sponsor|0|||
149884889|NCT03729596|540706984|FG003|Overall Study|study terminated by sponsor|0|||
150044001|NCT03682770|541300762|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
149884890|NCT03729596|540706985|FG004|Overall Study|study terminated by sponsor|1|||
149884891|NCT03729596|540706986|FG005|Overall Study|study terminated by sponsor|3|||
149884892|NCT03729596|540706987|FG006|Overall Study|study terminated by sponsor|0|||
149884893|NCT03729596|540706988|FG007|Overall Study|study terminated by sponsor|1|||
149884894|NCT03729596|540706989|FG008|Overall Study|study terminated by sponsor|0|||
149884895|NCT03729596|540706990|FG009|Overall Study|study terminated by sponsor|0|||
149884896|NCT01499095|540706991|FG000|Overall Study|Randomized But Not Treated|1|||
149884897|NCT01499095|540706992|FG001|Overall Study|Randomized But Not Treated|1|||
149884898|NCT01499095|540706991|FG000|Overall Study|Adverse Event|12|||
149884899|NCT01499095|540706992|FG001|Overall Study|Adverse Event|7|||
149884900|NCT01499095|540706991|FG000|Overall Study|Lack of Efficacy|2|||
149884901|NCT01499095|540706992|FG001|Overall Study|Lack of Efficacy|1|||
149884902|NCT01499095|540706991|FG000|Overall Study|Protocol Violation|6|||
149884903|NCT01499095|540706992|FG001|Overall Study|Protocol Violation|7|||
149884904|NCT01499095|540706991|FG000|Overall Study|Received Rescue Therapy|32|||
149884905|NCT01499095|540706992|FG001|Overall Study|Received Rescue Therapy|40|||
149884906|NCT01499095|540706991|FG000|Overall Study|Diverse Reasons|22|||
149884907|NCT01499095|540706992|FG001|Overall Study|Diverse Reasons|25|||
149884908|NCT01499095|540706991|FG000|Overall Study|Lost to Follow-up|6|||
149884909|NCT01499095|540706992|FG001|Overall Study|Lost to Follow-up|4|||
149884910|NCT01499095|540706991|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
149884911|NCT01499095|540706992|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
149884912|NCT01499095|540706991|FG000|Overall Study|Hypoglycemia|3|||
149884913|NCT01499095|540706992|FG001|Overall Study|Hypoglycemia|1|||
149884914|NCT01499095|540706991|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
149884915|NCT01499095|540706992|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
149884916|NCT01499095|540706991|FG000|Overall Study|Change in Injection Schedule|2|||
149884917|NCT01499095|540706992|FG001|Overall Study|Change in Injection Schedule|0|||
149884918|NCT01499095|540706991|FG000|Overall Study|Perceived Lack of Efficacy|1|||
149884919|NCT01499095|540706992|FG001|Overall Study|Perceived Lack of Efficacy|1|||
149884920|NCT02548156|540706994|FG000|Washout Period 1|Lost to Follow-up|0|||
149884921|NCT02548156|540706995|FG001|Washout Period 1|Lost to Follow-up|0|||
149884922|NCT02548156|540706996|FG002|Washout Period 1|Lost to Follow-up|0|||
149884923|NCT02548156|540706997|FG003|Washout Period 1|Lost to Follow-up|0|||
149884924|NCT02548156|540706998|FG004|Washout Period 1|Lost to Follow-up|1|||
149884925|NCT02548156|540706999|FG005|Washout Period 1|Lost to Follow-up|0|||
149884926|NCT03052751|540707000|FG000|Dosing Period 1|Adverse Event|0|||
149884927|NCT03052751|540707001|FG001|Dosing Period 1|Adverse Event|1|||
149884928|NCT03052751|540707002|FG002|Dosing Period 1|Adverse Event|0|||
149884929|NCT03052751|540707003|FG003|Dosing Period 1|Adverse Event|0|||
149884930|NCT03052751|540707004|FG004|Dosing Period 1|Adverse Event|0|||
149884931|NCT03052751|540707005|FG005|Dosing Period 1|Adverse Event|0|||
149884932|NCT03052751|540707000|FG000|Dosing Period 2|Adverse Event|0|||
149884933|NCT03052751|540707001|FG001|Dosing Period 2|Adverse Event|0|||
149884934|NCT03052751|540707002|FG002|Dosing Period 2|Adverse Event|3|||
149884935|NCT03052751|540707003|FG003|Dosing Period 2|Adverse Event|0|||
149884936|NCT03052751|540707004|FG004|Dosing Period 2|Adverse Event|0|||
149884937|NCT03052751|540707005|FG005|Dosing Period 2|Adverse Event|0|||
149884938|NCT03052751|540707000|FG000|Observation Period|Adverse Event|0|||
149884939|NCT03052751|540707001|FG001|Observation Period|Adverse Event|0|||
149884940|NCT03052751|540707002|FG002|Observation Period|Adverse Event|0|||
149884941|NCT03052751|540707003|FG003|Observation Period|Adverse Event|0|||
149884942|NCT03052751|540707004|FG004|Observation Period|Adverse Event|1|||
149884943|NCT03052751|540707005|FG005|Observation Period|Adverse Event|0|||
149884944|NCT00444587|540707008|FG000|Overall Study|Death|2|||
149884945|NCT00444587|540707009|FG001|Overall Study|Death|1|||
149884946|NCT00444587|540707008|FG000|Overall Study|Progression of the disease|73|||
149884947|NCT00444587|540707009|FG001|Overall Study|Progression of the disease|8|||
149884948|NCT00444587|540707008|FG000|Overall Study|Refused treatment/did not cooperate|4|||
149884949|NCT00444587|540707009|FG001|Overall Study|Refused treatment/did not cooperate|1|||
149884950|NCT00444587|540707008|FG000|Overall Study|Investigator decision|3|||
149884951|NCT00444587|540707009|FG001|Overall Study|Investigator decision|0|||
149884952|NCT00444587|540707008|FG000|Overall Study|Protocol Violation|1|||
149884953|NCT00444587|540707009|FG001|Overall Study|Protocol Violation|0|||
149884954|NCT00444587|540707008|FG000|Overall Study|Missing|0|||
149884955|NCT00444587|540707009|FG001|Overall Study|Missing|5|||
149884956|NCT00661193|540707021|FG000|Overall Study|Adverse Event|2|||
149884957|NCT00661193|540707022|FG001|Overall Study|Adverse Event|1|||
149884958|NCT00661193|540707021|FG000|Overall Study|Withdrawal by Subject|3|||
149884959|NCT00661193|540707022|FG001|Overall Study|Withdrawal by Subject|1|||
149884960|NCT00661193|540707021|FG000|Overall Study|Progression|27|||
149884961|NCT00661193|540707022|FG001|Overall Study|Progression|24|||
149884962|NCT00661193|540707021|FG000|Overall Study|Not protocol specified|1|||
149884963|NCT00661193|540707022|FG001|Overall Study|Not protocol specified|0|||
149884964|NCT01811472|540707023|FG000|Overall Study|Adverse Event|1|||
149884965|NCT01811472|540707024|FG001|Overall Study|Adverse Event|0|||
149884966|NCT01811472|540707025|FG002|Overall Study|Adverse Event|4|||
149884967|NCT01811472|540707023|FG000|Overall Study|Lost to Follow-up|0|||
149884968|NCT01811472|540707024|FG001|Overall Study|Lost to Follow-up|0|||
149884969|NCT01811472|540707025|FG002|Overall Study|Lost to Follow-up|1|||
149884970|NCT01811472|540707023|FG000|Overall Study|Subject/guardian decision|1|||
149884971|NCT01811472|540707024|FG001|Overall Study|Subject/guardian decision|0|||
149884972|NCT01811472|540707025|FG002|Overall Study|Subject/guardian decision|0|||
149884973|NCT03288714|540707026|FG000|Overall Study|Lost to Follow-up|2|||
149884974|NCT03288714|540707027|FG001|Overall Study|Lost to Follow-up|1|||
149884975|NCT03288714|540707026|FG000|Overall Study|Non-compliance with study schedule|2|||
149884976|NCT03288714|540707027|FG001|Overall Study|Non-compliance with study schedule|0|||
149884977|NCT03288714|540707026|FG000|Overall Study|Withdrawal by Subject|3|||
149884978|NCT03288714|540707027|FG001|Overall Study|Withdrawal by Subject|1|||
149884979|NCT03288714|540707026|FG000|Overall Study|Clinical Worsening|2|||
149884980|NCT03288714|540707027|FG001|Overall Study|Clinical Worsening|1|||
149884981|NCT03288714|540707026|FG000|Overall Study|Adverse Event|1|||
149884982|NCT03288714|540707027|FG001|Overall Study|Adverse Event|0|||
149884983|NCT03280264|540707028|FG000|Overall Study|Adverse Event|1|||
149884984|NCT03280264|540707028|FG000|Overall Study|Physician Decision|1|||
149884985|NCT03280264|540707028|FG000|Overall Study|Withdrawal by Subject|1|||
149884986|NCT00524420|540707036|FG000|Overall Study|Lack of Efficacy|1|||
149884987|NCT00524420|540707037|FG001|Overall Study|Lack of Efficacy|0|||
149884988|NCT00577863|540707038|FG000|Overall Study|Adverse Event|4|||
149884989|NCT00577863|540707039|FG001|Overall Study|Adverse Event|2|||
149884990|NCT00577863|540707038|FG000|Overall Study|Death|1|||
149884991|NCT00577863|540707039|FG001|Overall Study|Death|0|||
149884992|NCT00577863|540707038|FG000|Overall Study|Lost to Follow-up|2|||
149884993|NCT00577863|540707039|FG001|Overall Study|Lost to Follow-up|2|||
149884994|NCT00577863|540707038|FG000|Overall Study|Entry Criteria Exclusion|1|||
149884995|NCT00577863|540707039|FG001|Overall Study|Entry Criteria Exclusion|0|||
149965952|NCT02471144|541011119|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
149965953|NCT02471144|541011120|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149965954|NCT02471144|541011121|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
149965955|NCT02471144|541011122|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149965956|NCT02471144|541011123|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
149965957|NCT02471144|541011124|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149965958|NCT02471144|541011125|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
149965959|NCT02471144|541011115|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965960|NCT02471144|541011116|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965961|NCT02471144|541011117|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965962|NCT02471144|541011118|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965963|NCT02471144|541011119|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965964|NCT02471144|541011120|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
149965965|NCT02471144|541011121|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965966|NCT02471144|541011122|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965967|NCT02471144|541011123|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
149965968|NCT02471144|541011124|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965969|NCT02471144|541011125|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
149965970|NCT02471144|541011115|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965971|NCT02471144|541011116|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965972|NCT02471144|541011117|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965973|NCT02471144|541011118|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965974|NCT02471144|541011119|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965975|NCT02471144|541011120|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965976|NCT02471144|541011121|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965977|NCT02471144|541011122|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965978|NCT02471144|541011123|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
150175189|NCT03475316|541777070|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
149884996|NCT00577863|540707038|FG000|Overall Study|Withdrawal by Subject|0|||
149884997|NCT00577863|540707039|FG001|Overall Study|Withdrawal by Subject|2|||
149884998|NCT00577863|540707038|FG000|Overall Study|Sponsor Decision|2|||
149884999|NCT00577863|540707039|FG001|Overall Study|Sponsor Decision|7|||
149885000|NCT00577863|540707038|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
149885001|NCT00577863|540707039|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
149885002|NCT03639779|540707052|FG000|Overall Study|Lost to Follow-up|1|||
149885003|NCT02413229|540707055|FG000|Overall Study|Adverse Event|0|||
149885004|NCT02413229|540707056|FG001|Overall Study|Adverse Event|0|||
149885005|NCT02413229|540707057|FG002|Overall Study|Adverse Event|0|||
149885006|NCT02413229|540707058|FG003|Overall Study|Adverse Event|1|||
149885007|NCT02413229|540707059|FG004|Overall Study|Adverse Event|0|||
149885008|NCT02413229|540707060|FG005|Overall Study|Adverse Event|0|||
149885009|NCT02413229|540707061|FG006|Overall Study|Adverse Event|0|||
149885010|NCT02413229|540707062|FG007|Overall Study|Adverse Event|1|||
149885011|NCT02413229|540707055|FG000|Overall Study|Lost to Follow-up|0|||
149885012|NCT02413229|540707056|FG001|Overall Study|Lost to Follow-up|0|||
149885013|NCT02413229|540707057|FG002|Overall Study|Lost to Follow-up|1|||
149885014|NCT02413229|540707058|FG003|Overall Study|Lost to Follow-up|0|||
149885015|NCT02413229|540707059|FG004|Overall Study|Lost to Follow-up|2|||
149885016|NCT02413229|540707060|FG005|Overall Study|Lost to Follow-up|0|||
149885017|NCT02413229|540707061|FG006|Overall Study|Lost to Follow-up|0|||
149885018|NCT02413229|540707062|FG007|Overall Study|Lost to Follow-up|0|||
149885019|NCT02413229|540707055|FG000|Overall Study|Withdrawal by Subject|1|||
149885020|NCT02413229|540707056|FG001|Overall Study|Withdrawal by Subject|1|||
149885021|NCT02413229|540707057|FG002|Overall Study|Withdrawal by Subject|0|||
149885022|NCT02413229|540707058|FG003|Overall Study|Withdrawal by Subject|0|||
149885023|NCT02413229|540707059|FG004|Overall Study|Withdrawal by Subject|1|||
149885024|NCT02413229|540707060|FG005|Overall Study|Withdrawal by Subject|0|||
149885025|NCT02413229|540707061|FG006|Overall Study|Withdrawal by Subject|0|||
149885026|NCT02413229|540707062|FG007|Overall Study|Withdrawal by Subject|2|||
149885027|NCT02413229|540707055|FG000|Overall Study|Progressive Disease|0|||
149885028|NCT02413229|540707056|FG001|Overall Study|Progressive Disease|0|||
149885029|NCT02413229|540707057|FG002|Overall Study|Progressive Disease|0|||
149885030|NCT02413229|540707058|FG003|Overall Study|Progressive Disease|0|||
149885031|NCT02413229|540707059|FG004|Overall Study|Progressive Disease|0|||
149885032|NCT02413229|540707060|FG005|Overall Study|Progressive Disease|0|||
149885033|NCT02413229|540707061|FG006|Overall Study|Progressive Disease|0|||
149885034|NCT02413229|540707062|FG007|Overall Study|Progressive Disease|1|||
149885035|NCT02932462|540707063|FG000|Overall Study|Adverse Event|1|||
149885036|NCT02932462|540707064|FG001|Overall Study|Adverse Event|2|||
149885037|NCT02932462|540707063|FG000|Overall Study|Lost to Follow-up|4|||
149885038|NCT02932462|540707064|FG001|Overall Study|Lost to Follow-up|1|||
149885039|NCT02932462|540707063|FG000|Overall Study|Protocol Violation|0|||
149885040|NCT02932462|540707064|FG001|Overall Study|Protocol Violation|5|||
149885041|NCT02932462|540707063|FG000|Overall Study|Withdrawal by Subject|1|||
149885042|NCT02932462|540707064|FG001|Overall Study|Withdrawal by Subject|4|||
149885043|NCT02932462|540707063|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149885044|NCT02932462|540707064|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149885045|NCT02932462|540707063|FG000|Overall Study|Progressive Disease|1|||
149885046|NCT02932462|540707064|FG001|Overall Study|Progressive Disease|0|||
149885047|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Other|34|||
149885048|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Other|0|||
149885049|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Other|0|||
149885050|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Other|0|||
149885051|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Death|14|||
149885052|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Death|0|||
149885053|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Death|0|||
149885054|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Death|0|||
149885055|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
149885056|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
149885057|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
149885058|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
149885059|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
149885060|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
149885061|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
149885062|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
149885063|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
149885064|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
149885065|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
149885066|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
149885067|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
149885068|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
149885069|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
149885070|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
149885071|NCT01995513|540707065|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
149885072|NCT01995513|540707066|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
149885073|NCT01995513|540707067|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
149885074|NCT01995513|540707068|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
149885075|NCT01995513|540707065|FG000|Period 1: Second Open Label Treatment|Other|0|||
149885076|NCT01995513|540707066|FG001|Period 1: Second Open Label Treatment|Other|2|||
149885077|NCT01995513|540707067|FG002|Period 1: Second Open Label Treatment|Other|0|||
149885078|NCT01995513|540707068|FG003|Period 1: Second Open Label Treatment|Other|0|||
149885079|NCT01995513|540707065|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
149885080|NCT01995513|540707066|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
149885081|NCT01995513|540707067|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
149885082|NCT01995513|540707068|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
149885083|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Death|0|||
149885084|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Death|0|||
149885085|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Death|0|||
149885086|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Death|1|||
149885087|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Other|0|||
149885088|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Other|0|||
149885089|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Other|3|||
149885090|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Other|3|||
149885091|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
149885092|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
149885093|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
149885094|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
149885095|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
149885096|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
149885097|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
149885098|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
149885099|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
149885100|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
149885101|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
149885102|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
149885103|NCT01995513|540707065|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
149885104|NCT01995513|540707066|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
149885105|NCT01995513|540707067|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
149885106|NCT01995513|540707068|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
149885107|NCT01232452|540707069|FG000|Overall Study|Adverse Event|17|||
149885108|NCT01232452|540707070|FG001|Overall Study|Adverse Event|15|||
149885109|NCT01232452|540707069|FG000|Overall Study|Withdrawal by Subject|11|||
149885110|NCT01232452|540707070|FG001|Overall Study|Withdrawal by Subject|8|||
149885111|NCT01232452|540707069|FG000|Overall Study|Physician Decision|8|||
149885112|NCT01232452|540707070|FG001|Overall Study|Physician Decision|12|||
149885113|NCT01232452|540707069|FG000|Overall Study|Protocol entry criterion not met|0|||
149885114|NCT01232452|540707070|FG001|Overall Study|Protocol entry criterion not met|2|||
149885115|NCT01232452|540707069|FG000|Overall Study|Sponsor Decision|3|||
149885116|NCT01232452|540707070|FG001|Overall Study|Sponsor Decision|1|||
149885117|NCT01232452|540707069|FG000|Overall Study|Protocol Violation|0|||
149885118|NCT01232452|540707070|FG001|Overall Study|Protocol Violation|1|||
149885119|NCT01750190|540707075|FG000|Overall Study|Adverse Event|47|||
149885120|NCT01750190|540707076|FG001|Overall Study|Adverse Event|19|||
149885121|NCT01750190|540707075|FG000|Overall Study|Death|38|||
149885122|NCT01750190|540707076|FG001|Overall Study|Death|11|||
149885123|NCT01750190|540707075|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
149885124|NCT01750190|540707076|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
149885125|NCT01750190|540707075|FG000|Overall Study|Lost to Follow-up|28|||
149885126|NCT01750190|540707076|FG001|Overall Study|Lost to Follow-up|7|||
149885127|NCT01750190|540707075|FG000|Overall Study|Physician Decision|16|||
149885128|NCT01750190|540707076|FG001|Overall Study|Physician Decision|17|||
149885129|NCT01750190|540707075|FG000|Overall Study|Protocol Violation|6|||
149885130|NCT01750190|540707076|FG001|Overall Study|Protocol Violation|5|||
150175190|NCT03475316|541777069|FG000|9 Months|Study stopped due to COVID pandemic|3|||
150175191|NCT03475316|541777070|FG001|9 Months|Study stopped due to COVID pandemic|4|||
150175192|NCT00424645|541777071|FG000|Overall Study|Death|1|||
149885131|NCT01750190|540707075|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
149885132|NCT01750190|540707076|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
149885133|NCT01750190|540707075|FG000|Overall Study|Withdrawal by Subject|83|||
149885134|NCT01750190|540707076|FG001|Overall Study|Withdrawal by Subject|89|||
149885135|NCT01750190|540707075|FG000|Overall Study|Kidney Transplant|8|||
149885136|NCT01750190|540707076|FG001|Overall Study|Kidney Transplant|4|||
149885137|NCT01750190|540707075|FG000|Overall Study|Dialysis|22|||
149885138|NCT01750190|540707076|FG001|Overall Study|Dialysis|8|||
149885139|NCT01750190|540707075|FG000|Overall Study|Other than Specified|13|||
149885140|NCT01750190|540707076|FG001|Overall Study|Other than Specified|4|||
149885141|NCT02009722|540707083|FG000|Overall Study|Protocol Violation|1|||
149885142|NCT02009722|540707084|FG001|Overall Study|Protocol Violation|2|||
149885143|NCT02009722|540707083|FG000|Overall Study|Did not receive intervention|0|||
149885144|NCT02009722|540707084|FG001|Overall Study|Did not receive intervention|1|||
149885145|NCT02955212|540707085|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
149885146|NCT02955212|540707086|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
149885147|NCT02955212|540707085|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
149885148|NCT02955212|540707086|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
149885149|NCT02955212|540707085|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
149885150|NCT02955212|540707086|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
149885151|NCT02955212|540707085|FG000|Period 1: Double-blind Treatment Period|Other|3|||
149885152|NCT02955212|540707086|FG001|Period 1: Double-blind Treatment Period|Other|2|||
149885153|NCT02955212|540707085|FG000|Period 2: Open-label Extension|Adverse Event|11|||
149885154|NCT02955212|540707086|FG001|Period 2: Open-label Extension|Adverse Event|7|||
149885155|NCT02955212|540707085|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
149885156|NCT02955212|540707086|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
149885157|NCT02955212|540707085|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
149885158|NCT02955212|540707086|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
149885159|NCT02955212|540707085|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
149885160|NCT02955212|540707086|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
149885161|NCT02955212|540707085|FG000|Period 2: Open-label Extension|Other|2|||
149885162|NCT02955212|540707086|FG001|Period 2: Open-label Extension|Other|4|||
149885163|NCT02454933|540707091|FG000|Overall Study|Progressive disease|10|||
149885164|NCT02454933|540707092|FG001|Overall Study|Progressive disease|7|||
149885165|NCT02454933|540707091|FG000|Overall Study|Adverse Event|1|||
149885166|NCT02454933|540707092|FG001|Overall Study|Adverse Event|1|||
149885167|NCT02454933|540707091|FG000|Overall Study|Withdrawal by Subject|0|||
149885168|NCT02454933|540707092|FG001|Overall Study|Withdrawal by Subject|3|||
149885169|NCT02454933|540707091|FG000|Overall Study|Lost to Follow-up|1|||
149885170|NCT02454933|540707092|FG001|Overall Study|Lost to Follow-up|0|||
149885171|NCT02071225|540707095|FG000|Overall Study|Withdrawal of Consent|2|||
149885172|NCT02071225|540707095|FG000|Overall Study|Protocol Deviation|1|||
149885173|NCT02071225|540707095|FG000|Overall Study|Lost to Follow-up|2|||
149885174|NCT02071225|540707095|FG000|Overall Study|Death|25|||
149885175|NCT01342081|540707096|FG000|Overall Study|Did not receive allocated intervention|0|||
149885176|NCT01342081|540707097|FG001|Overall Study|Did not receive allocated intervention|0|||
149885177|NCT01342081|540707098|FG002|Overall Study|Did not receive allocated intervention|1|||
149885178|NCT01342081|540707096|FG000|Overall Study|Adverse Event|1|||
149885179|NCT01342081|540707097|FG001|Overall Study|Adverse Event|0|||
149885180|NCT01342081|540707098|FG002|Overall Study|Adverse Event|0|||
149885181|NCT01342081|540707096|FG000|Overall Study|Physician Decision|0|||
149885182|NCT01342081|540707097|FG001|Overall Study|Physician Decision|1|||
149885183|NCT01342081|540707098|FG002|Overall Study|Physician Decision|0|||
149885184|NCT01342081|540707096|FG000|Overall Study|Withdrawal by Subject|1|||
149885185|NCT01342081|540707097|FG001|Overall Study|Withdrawal by Subject|1|||
149885186|NCT01342081|540707098|FG002|Overall Study|Withdrawal by Subject|0|||
149885187|NCT01973439|540707099|FG000|Overall Study|Lost samples from one PK Day|2|||
149885188|NCT01973439|540707099|FG000|Overall Study|Vomiting after commencing once daily|1|||
149885189|NCT01973439|540707099|FG000|Overall Study|PK curve incomplete|2|||
149885190|NCT02232984|540707104|FG000|Overall Study|Withdrawal by Subject|5|||
149885191|NCT02232984|540707104|FG000|Overall Study|Death|1|||
149885192|NCT02232984|540707104|FG000|Overall Study|Investigator withdrawal|10|||
149885193|NCT02232984|540707104|FG000|Overall Study|Device implant unsuccessful|53|||
149885194|NCT02232984|540707104|FG000|Overall Study|not disclosed by site|7|||
150175193|NCT00424645|541777072|FG001|Overall Study|Death|0|||
149885195|NCT02232984|540707104|FG000|Overall Study|Protocol Violation|1|||
149885196|NCT00769379|540707107|FG000|Overall Study|No follow up data mapped to Other.|3|||
149885197|NCT00769379|540707108|FG001|Overall Study|No follow up data mapped to Other.|13|||
149885198|NCT03934541|540707109|FG000|Overall Study|Study Terminated by Sponsor|0|||
149885199|NCT03934541|540707110|FG001|Overall Study|Study Terminated by Sponsor|1|||
149885200|NCT03934541|540707111|FG002|Overall Study|Study Terminated by Sponsor|0|||
149885201|NCT03934541|540707112|FG003|Overall Study|Study Terminated by Sponsor|0|||
149885202|NCT02673775|540707113|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
149885203|NCT02673775|540707114|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
149885204|NCT02673775|540707113|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
149885205|NCT02673775|540707114|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
149885206|NCT02673775|540707113|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
149885207|NCT02673775|540707114|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
149885208|NCT02673775|540707113|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
149885209|NCT02673775|540707114|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
149885210|NCT00535405|540707115|FG000|Overall Study|Adverse Event|6|||
149885211|NCT00535405|540707116|FG001|Overall Study|Adverse Event|8|||
149885212|NCT00535405|540707117|FG002|Overall Study|Adverse Event|3|||
149885213|NCT00535405|540707118|FG003|Overall Study|Adverse Event|8|||
149885214|NCT00535405|540707119|FG004|Overall Study|Adverse Event|6|||
149885215|NCT00535405|540707115|FG000|Overall Study|Lost to Follow-up|1|||
149885216|NCT00535405|540707116|FG001|Overall Study|Lost to Follow-up|3|||
149885217|NCT00535405|540707117|FG002|Overall Study|Lost to Follow-up|3|||
149885218|NCT00535405|540707118|FG003|Overall Study|Lost to Follow-up|2|||
149885219|NCT00535405|540707119|FG004|Overall Study|Lost to Follow-up|1|||
149885220|NCT00535405|540707115|FG000|Overall Study|Physician Decision|3|||
149885221|NCT00535405|540707116|FG001|Overall Study|Physician Decision|2|||
149885222|NCT00535405|540707117|FG002|Overall Study|Physician Decision|0|||
149885223|NCT00535405|540707118|FG003|Overall Study|Physician Decision|1|||
149885224|NCT00535405|540707119|FG004|Overall Study|Physician Decision|1|||
149885225|NCT00535405|540707115|FG000|Overall Study|Protocol Violation|2|||
149885226|NCT00535405|540707116|FG001|Overall Study|Protocol Violation|2|||
149885227|NCT00535405|540707117|FG002|Overall Study|Protocol Violation|2|||
149885228|NCT00535405|540707118|FG003|Overall Study|Protocol Violation|1|||
149885229|NCT00535405|540707119|FG004|Overall Study|Protocol Violation|0|||
149885230|NCT00535405|540707115|FG000|Overall Study|Withdrawal by Subject|5|||
149885231|NCT00535405|540707116|FG001|Overall Study|Withdrawal by Subject|11|||
149885232|NCT00535405|540707117|FG002|Overall Study|Withdrawal by Subject|10|||
149885233|NCT00535405|540707118|FG003|Overall Study|Withdrawal by Subject|10|||
149885234|NCT00535405|540707119|FG004|Overall Study|Withdrawal by Subject|8|||
149885235|NCT03519087|540707120|FG000|Clinic Evaluation|Physician Decision|15|||
150044002|NCT03682770|541300756|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150044003|NCT03682770|541300757|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150044004|NCT03682770|541300758|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150044005|NCT03682770|541300759|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150044006|NCT03682770|541300760|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
150044007|NCT03682770|541300761|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150044008|NCT03682770|541300762|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
150175194|NCT01595061|541777073|FG000|Overall Study|Never Treated|3|||
150175195|NCT01595061|541777073|FG000|Overall Study|Inadequate Pathology|1|||
149885236|NCT03519087|540707121|FG001|Clinic Evaluation|Physician Decision|18|||
149885237|NCT03519087|540707122|FG002|Clinic Evaluation|Physician Decision|0|||
149885238|NCT03519087|540707123|FG003|Clinic Evaluation|Physician Decision|0|||
149885239|NCT03519087|540707124|FG004|Clinic Evaluation|Physician Decision|0|||
149885240|NCT03519087|540707120|FG000|Clinic Evaluation|Protocol Violation|1|||
149885241|NCT03519087|540707121|FG001|Clinic Evaluation|Protocol Violation|0|||
149885242|NCT03519087|540707122|FG002|Clinic Evaluation|Protocol Violation|0|||
149885243|NCT03519087|540707123|FG003|Clinic Evaluation|Protocol Violation|0|||
149885244|NCT03519087|540707124|FG004|Clinic Evaluation|Protocol Violation|0|||
149885245|NCT03519087|540707120|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
149885246|NCT03519087|540707121|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
150175196|NCT03194958|541777076|FG000|Overall Study|Death|0|||
149885247|NCT03519087|540707122|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
149885248|NCT03519087|540707123|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
149885249|NCT03519087|540707124|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
149885250|NCT03519087|540707120|FG000|Re-randomization for Treatment|Not appropriate|2|||
149885251|NCT03519087|540707121|FG001|Re-randomization for Treatment|Not appropriate|3|||
149885252|NCT03519087|540707122|FG002|Re-randomization for Treatment|Not appropriate|0|||
149885253|NCT03519087|540707123|FG003|Re-randomization for Treatment|Not appropriate|0|||
149885254|NCT03519087|540707124|FG004|Re-randomization for Treatment|Not appropriate|0|||
149885255|NCT03519087|540707120|FG000|Laboratory Testing|Lost to Follow-up|0|||
149885256|NCT03519087|540707121|FG001|Laboratory Testing|Lost to Follow-up|0|||
149885257|NCT03519087|540707122|FG002|Laboratory Testing|Lost to Follow-up|2|||
149885258|NCT03519087|540707123|FG003|Laboratory Testing|Lost to Follow-up|3|||
149885259|NCT03519087|540707124|FG004|Laboratory Testing|Lost to Follow-up|6|||
149885260|NCT03519087|540707120|FG000|Laboratory Testing|Protocol Violation|0|||
149885261|NCT03519087|540707121|FG001|Laboratory Testing|Protocol Violation|0|||
149885262|NCT03519087|540707122|FG002|Laboratory Testing|Protocol Violation|0|||
149885263|NCT03519087|540707123|FG003|Laboratory Testing|Protocol Violation|1|||
149885264|NCT03519087|540707124|FG004|Laboratory Testing|Protocol Violation|0|||
149885265|NCT03076775|540707125|FG000|Overall Study|Lost to Follow-up|1|||
149885266|NCT03076775|540707126|FG001|Overall Study|Lost to Follow-up|0|||
149885267|NCT00104572|540707127|FG000|Overall Study|Withdrawal by Subject|3|||
149885268|NCT00104572|540707128|FG001|Overall Study|Withdrawal by Subject|3|||
149885269|NCT00104572|540707129|FG002|Overall Study|Withdrawal by Subject|0|||
149885270|NCT02290405|540707130|FG000|Overall Study|Withdrawal by Subject|1|||
149885271|NCT02290405|540707131|FG001|Overall Study|Withdrawal by Subject|0|||
149885272|NCT02016183|540707132|FG000|Overall Study|Case Report Forms Uncollected|13|||
149885273|NCT02016183|540707132|FG000|Overall Study|Protocol Violation|52|||
149885274|NCT03142191|540707133|FG000|Placebo Controlled Period|Death|0|||
149885275|NCT03142191|540707134|FG001|Placebo Controlled Period|Death|1|||
149885276|NCT03142191|540707135|FG002|Placebo Controlled Period|Death|1|||
149885277|NCT03142191|540707136|FG003|Placebo Controlled Period|Death|0|||
149885278|NCT03142191|540707137|FG004|Placebo Controlled Period|Death|0|||
149885279|NCT03142191|540707133|FG000|Placebo Controlled Period|Adverse Event|4|||
149885280|NCT03142191|540707134|FG001|Placebo Controlled Period|Adverse Event|5|||
149885281|NCT03142191|540707135|FG002|Placebo Controlled Period|Adverse Event|1|||
149885282|NCT03142191|540707136|FG003|Placebo Controlled Period|Adverse Event|0|||
149885283|NCT03142191|540707137|FG004|Placebo Controlled Period|Adverse Event|0|||
149885284|NCT03142191|540707133|FG000|Placebo Controlled Period|Progressive Disease|1|||
149885285|NCT03142191|540707134|FG001|Placebo Controlled Period|Progressive Disease|0|||
149885286|NCT03142191|540707135|FG002|Placebo Controlled Period|Progressive Disease|1|||
149885287|NCT03142191|540707136|FG003|Placebo Controlled Period|Progressive Disease|0|||
149885288|NCT03142191|540707137|FG004|Placebo Controlled Period|Progressive Disease|0|||
149885289|NCT03142191|540707133|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
149885290|NCT03142191|540707134|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
149885291|NCT03142191|540707135|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
149885292|NCT03142191|540707136|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
149885293|NCT03142191|540707137|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
149885294|NCT03142191|540707133|FG000|Placebo Controlled Period|Other Reasons|1|||
149885295|NCT03142191|540707134|FG001|Placebo Controlled Period|Other Reasons|0|||
149885296|NCT03142191|540707135|FG002|Placebo Controlled Period|Other Reasons|0|||
149885297|NCT03142191|540707136|FG003|Placebo Controlled Period|Other Reasons|0|||
149885298|NCT03142191|540707137|FG004|Placebo Controlled Period|Other Reasons|0|||
149885299|NCT03142191|540707133|FG000|Active Treatment Extension Period|Death|2|||
149885300|NCT03142191|540707134|FG001|Active Treatment Extension Period|Death|1|||
149885301|NCT03142191|540707135|FG002|Active Treatment Extension Period|Death|1|||
149885302|NCT03142191|540707136|FG003|Active Treatment Extension Period|Death|1|||
149885303|NCT03142191|540707137|FG004|Active Treatment Extension Period|Death|0|||
149885304|NCT03142191|540707133|FG000|Active Treatment Extension Period|Adverse Event|6|||
149885305|NCT03142191|540707134|FG001|Active Treatment Extension Period|Adverse Event|5|||
149885306|NCT03142191|540707135|FG002|Active Treatment Extension Period|Adverse Event|4|||
149885307|NCT03142191|540707136|FG003|Active Treatment Extension Period|Adverse Event|1|||
149885308|NCT03142191|540707137|FG004|Active Treatment Extension Period|Adverse Event|0|||
149885309|NCT03142191|540707133|FG000|Active Treatment Extension Period|Progressive Disease|10|||
149885310|NCT03142191|540707134|FG001|Active Treatment Extension Period|Progressive Disease|5|||
149885311|NCT03142191|540707135|FG002|Active Treatment Extension Period|Progressive Disease|4|||
149885312|NCT03142191|540707136|FG003|Active Treatment Extension Period|Progressive Disease|1|||
149885313|NCT03142191|540707137|FG004|Active Treatment Extension Period|Progressive Disease|2|||
149885314|NCT03142191|540707133|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
149885315|NCT03142191|540707134|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
149885316|NCT03142191|540707135|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
149885317|NCT03142191|540707136|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
149885318|NCT03142191|540707137|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
149885319|NCT03142191|540707133|FG000|Active Treatment Extension Period|Physician Decision|2|||
149885320|NCT03142191|540707134|FG001|Active Treatment Extension Period|Physician Decision|0|||
149885321|NCT03142191|540707135|FG002|Active Treatment Extension Period|Physician Decision|0|||
149885322|NCT03142191|540707136|FG003|Active Treatment Extension Period|Physician Decision|0|||
149885323|NCT03142191|540707137|FG004|Active Treatment Extension Period|Physician Decision|0|||
150044009|NCT03682770|541300756|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
150175197|NCT03194958|541777077|FG001|Overall Study|Death|1|||
149885324|NCT03142191|540707133|FG000|Active Treatment Extension Period|Other Reasons|3|||
149885325|NCT03142191|540707134|FG001|Active Treatment Extension Period|Other Reasons|3|||
149885326|NCT03142191|540707135|FG002|Active Treatment Extension Period|Other Reasons|3|||
149885327|NCT03142191|540707136|FG003|Active Treatment Extension Period|Other Reasons|8|||
149885328|NCT03142191|540707137|FG004|Active Treatment Extension Period|Other Reasons|3|||
149885329|NCT03142191|540707133|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
149885330|NCT03142191|540707134|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
149885331|NCT03142191|540707135|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
149885332|NCT03142191|540707136|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
149885333|NCT03142191|540707137|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
149885334|NCT00770328|540707153|FG000|Overall Study|Adverse Event|11|||
149885335|NCT00770328|540707154|FG001|Overall Study|Adverse Event|2|||
149885336|NCT00770328|540707153|FG000|Overall Study|Lost to Follow-up|2|||
149885337|NCT00770328|540707154|FG001|Overall Study|Lost to Follow-up|2|||
149885338|NCT01130493|540707155|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
149885339|NCT01130493|540707156|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
149885340|NCT01130493|540707157|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
149885341|NCT01130493|540707155|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
149885342|NCT01130493|540707156|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
149885343|NCT01130493|540707157|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
149885344|NCT01130493|540707155|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
149885345|NCT01130493|540707156|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
149885346|NCT01130493|540707157|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
149885347|NCT01130493|540707155|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
149885348|NCT01130493|540707156|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
149885349|NCT01130493|540707157|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
149885350|NCT01130493|540707155|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
149885351|NCT01130493|540707156|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
149885352|NCT01130493|540707157|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
149965979|NCT02471144|541011124|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965980|NCT02471144|541011125|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
149965981|NCT02471144|541011115|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965982|NCT02471144|541011116|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965983|NCT02471144|541011117|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965984|NCT02471144|541011118|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965985|NCT02471144|541011119|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965986|NCT02471144|541011120|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965987|NCT02471144|541011121|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965988|NCT02471144|541011122|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
149965989|NCT02471144|541011123|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
149965990|NCT02471144|541011124|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965991|NCT02471144|541011125|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
149965992|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965993|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965994|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965995|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965996|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965997|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965998|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149965999|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149966000|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
149966001|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
149966002|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
149966003|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966004|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966005|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966006|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966007|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149885353|NCT01130493|540707155|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
149966008|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966009|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966010|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
150044010|NCT03682770|541300757|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
149885354|NCT01130493|540707156|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
149885355|NCT01130493|540707157|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
149885356|NCT01130493|540707155|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
149885357|NCT01130493|540707156|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
149885358|NCT01130493|540707157|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
149885359|NCT01130493|540707155|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
149885360|NCT01130493|540707156|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
149885361|NCT01130493|540707157|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
149885362|NCT01130493|540707155|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
149885363|NCT01130493|540707156|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
150044011|NCT03682770|541300758|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
150044012|NCT03682770|541300759|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
150044013|NCT03682770|541300760|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
150044014|NCT03682770|541300761|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
150044015|NCT03682770|541300762|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
150044016|NCT03682770|541300756|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
150044017|NCT03682770|541300757|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
150044018|NCT03682770|541300758|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
150044019|NCT03682770|541300759|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
150044020|NCT03682770|541300760|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
150044021|NCT03682770|541300761|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
150044022|NCT03682770|541300762|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
150044023|NCT01491607|541300763|FG000|Overall Study|Lost to Follow-up|7|||
150044024|NCT01491607|541300763|FG000|Overall Study|Withdrawal by Subject|3|||
150044025|NCT01317277|541300764|FG000|Overall Study|Lost to Follow-up|3|||
150044026|NCT01317277|541300765|FG001|Overall Study|Lost to Follow-up|1|||
150044027|NCT01317277|541300764|FG000|Overall Study|Lost MEMS|1|||
150044028|NCT01317277|541300765|FG001|Overall Study|Lost MEMS|1|||
150044029|NCT01317277|541300764|FG000|Overall Study|Unable to comply with intervention|1|||
150044030|NCT01317277|541300765|FG001|Overall Study|Unable to comply with intervention|0|||
150044031|NCT01317277|541300764|FG000|Overall Study|Withdrawal by Subject|1|||
150044032|NCT01317277|541300765|FG001|Overall Study|Withdrawal by Subject|0|||
150044033|NCT01317277|541300764|FG000|Overall Study|Adverse Event|1|||
150044034|NCT01317277|541300765|FG001|Overall Study|Adverse Event|0|||
150044035|NCT00774566|541300766|FG000|Overall Study|Protocol Violation|18|||
150044036|NCT00774566|541300767|FG001|Overall Study|Protocol Violation|15|||
150044037|NCT04896073|541300774|FG000|Overall Study|Screen failure|0|||
150044038|NCT04896073|541300775|FG001|Overall Study|Screen failure|2|||
149885364|NCT01130493|540707157|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
149885365|NCT01130493|540707155|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
149885366|NCT01130493|540707156|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
149885367|NCT01130493|540707157|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
149885368|NCT01130493|540707155|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
149885369|NCT01130493|540707156|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
150044039|NCT04896073|541300774|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
150044040|NCT04896073|541300775|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
150044041|NCT02454517|541300777|FG000|Overall Study|Withdrawal by Subject|3|||
150044042|NCT02454517|541300778|FG001|Overall Study|Withdrawal by Subject|0|||
150044043|NCT02454517|541300777|FG000|Overall Study|Lost to Follow-up|4|||
150044044|NCT02454517|541300778|FG001|Overall Study|Lost to Follow-up|7|||
149885370|NCT01130493|540707157|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
149885371|NCT01130493|540707155|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
149885372|NCT01130493|540707156|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
149885373|NCT01130493|540707157|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
149885374|NCT01130493|540707155|FG000|Part 2: OLE|Adverse Event|0|||
149885375|NCT01130493|540707156|FG001|Part 2: OLE|Adverse Event|2|||
149885376|NCT01130493|540707157|FG002|Part 2: OLE|Adverse Event|1|||
149885377|NCT01130493|540707155|FG000|Part 2: OLE|Withdrawal by Subject|0|||
149885378|NCT01130493|540707156|FG001|Part 2: OLE|Withdrawal by Subject|1|||
149885379|NCT01130493|540707157|FG002|Part 2: OLE|Withdrawal by Subject|4|||
149885380|NCT00879086|540707162|FG000|Overall Study|Adverse Event|3|||
149885381|NCT00879086|540707163|FG001|Overall Study|Adverse Event|15|||
149885382|NCT00879086|540707162|FG000|Overall Study|Participant choice|2|||
149885383|NCT00879086|540707163|FG001|Overall Study|Participant choice|2|||
149885384|NCT00879086|540707162|FG000|Overall Study|Progression of disease|40|||
149885385|NCT00879086|540707163|FG001|Overall Study|Progression of disease|26|||
149885386|NCT00879086|540707162|FG000|Overall Study|Withdrawal of consent|2|||
149885387|NCT00879086|540707163|FG001|Overall Study|Withdrawal of consent|1|||
149885388|NCT00879086|540707162|FG000|Overall Study|Other|4|||
149885389|NCT00879086|540707163|FG001|Overall Study|Other|6|||
149885390|NCT00879086|540707162|FG000|Overall Study|Death|1|||
149885391|NCT00879086|540707163|FG001|Overall Study|Death|2|||
149885392|NCT02969044|540707164|FG000|Overall Study|Withdrawal by Subject|2|||
149885393|NCT02969044|540707165|FG001|Overall Study|Withdrawal by Subject|6|||
149885394|NCT02969044|540707164|FG000|Overall Study|Adverse Event|3|||
149885395|NCT02969044|540707165|FG001|Overall Study|Adverse Event|0|||
149885396|NCT04728802|540707166|FG000|Overall Study|Withdrawal by Subject|4|||
149885397|NCT04728802|540707167|FG001|Overall Study|Withdrawal by Subject|20|||
149885398|NCT04728802|540707166|FG000|Overall Study|Physician Decision|7|||
149885399|NCT04728802|540707167|FG001|Overall Study|Physician Decision|7|||
149885400|NCT04728802|540707166|FG000|Overall Study|Protocol Violation|10|||
149885401|NCT04728802|540707167|FG001|Overall Study|Protocol Violation|4|||
149885402|NCT04728802|540707166|FG000|Overall Study|Transfer|1|||
149885403|NCT04728802|540707167|FG001|Overall Study|Transfer|0|||
149885404|NCT04728802|540707166|FG000|Overall Study|Death|4|||
149885405|NCT04728802|540707167|FG001|Overall Study|Death|5|||
149885406|NCT04728802|540707166|FG000|Overall Study|Other|3|||
149885407|NCT04728802|540707167|FG001|Overall Study|Other|0|||
149885408|NCT04650204|540707168|FG000|Overall Study|Study was Terminated|2|||
149966011|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966012|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
149966013|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
149966014|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966015|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
150044045|NCT02454517|541300777|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
150044046|NCT02454517|541300778|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
150044047|NCT03565497|541300779|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
150044048|NCT03565497|541300780|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
150044049|NCT03565497|541300781|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
150044050|NCT03565497|541300779|FG000|Overall Study|Lost to Follow-up|1|||
150044051|NCT03565497|541300780|FG001|Overall Study|Lost to Follow-up|1|||
150044052|NCT03565497|541300781|FG002|Overall Study|Lost to Follow-up|2|||
150044053|NCT03565497|541300779|FG000|Overall Study|Withdrawal by Subject|1|||
150044054|NCT03565497|541300780|FG001|Overall Study|Withdrawal by Subject|1|||
150044055|NCT03565497|541300781|FG002|Overall Study|Withdrawal by Subject|1|||
149885409|NCT04650204|540707169|FG001|Overall Study|Study was Terminated|1|||
149885410|NCT01330303|540707170|FG000|Period 1|Adverse Event|1|||
149885411|NCT01330303|540707171|FG001|Period 1|Adverse Event|0|||
149885412|NCT01330303|540707170|FG000|Period 1|Protocol Violation|0|||
149885413|NCT01330303|540707171|FG001|Period 1|Protocol Violation|1|||
149885414|NCT01330303|540707170|FG000|Period 1|Withdrawal by Subject|0|||
149885415|NCT01330303|540707171|FG001|Period 1|Withdrawal by Subject|1|||
149885416|NCT02517463|540707173|FG000|Overall Study|Lost to Follow-up|5|||
149885417|NCT02517463|540707174|FG001|Overall Study|Lost to Follow-up|2|||
149885418|NCT03180645|540707175|FG000|Overall Study|Adverse Event|0|||
149966016|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966017|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966018|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966019|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966020|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966021|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966022|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149966023|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
149885419|NCT03180645|540707176|FG001|Overall Study|Adverse Event|1|||
149885420|NCT03180645|540707177|FG002|Overall Study|Adverse Event|2|||
149885421|NCT04208750|540707178|FG000|Overall Study|Lost to Follow-up|16|||
150044056|NCT02999672|541300782|FG000|Overall Study|Death|0|||
150044057|NCT02999672|541300783|FG001|Overall Study|Death|1|||
150044058|NCT02999672|541300782|FG000|Overall Study|Study Terminated by Sponsor|0|||
150044059|NCT02999672|541300783|FG001|Overall Study|Study Terminated by Sponsor|1|||
150044060|NCT02999672|541300782|FG000|Overall Study|Progressive Disease|9|||
150044061|NCT02999672|541300783|FG001|Overall Study|Progressive Disease|5|||
150044062|NCT02999672|541300782|FG000|Overall Study|Adverse Event|4|||
149885422|NCT04208750|540707179|FG001|Overall Study|Lost to Follow-up|15|||
149885423|NCT02201277|540707183|FG000|Overall Study|Death|3|||
149885424|NCT02201277|540707184|FG001|Overall Study|Death|4|||
149885425|NCT02201277|540707183|FG000|Overall Study|Lost to Follow-up|2|||
149885426|NCT02201277|540707184|FG001|Overall Study|Lost to Follow-up|1|||
150044063|NCT02999672|541300783|FG001|Overall Study|Adverse Event|0|||
150044064|NCT01075685|541300784|FG000|Overall Study|Protocol Violation|9|||
150044065|NCT01075685|541300785|FG001|Overall Study|Protocol Violation|1|||
150044066|NCT01075685|541300784|FG000|Overall Study|Withdrawal by Subject|20|||
150044067|NCT01075685|541300785|FG001|Overall Study|Withdrawal by Subject|5|||
150044068|NCT01075685|541300784|FG000|Overall Study|Lost to Follow-up|563|||
150044069|NCT01075685|541300785|FG001|Overall Study|Lost to Follow-up|220|||
150044070|NCT02858362|541300788|FG000|Overall Study|Protocol Violation|0|||
150044071|NCT02858362|541300789|FG001|Overall Study|Protocol Violation|1|||
150044072|NCT02858362|541300790|FG002|Overall Study|Protocol Violation|0|||
150044073|NCT02858362|541300788|FG000|Overall Study|Withdrawal by Subject|1|||
150044074|NCT02858362|541300789|FG001|Overall Study|Withdrawal by Subject|0|||
150175198|NCT03194958|541777078|FG002|Overall Study|Death|1|||
150175199|NCT03194958|541777079|FG003|Overall Study|Death|1|||
149885427|NCT02201277|540707183|FG000|Overall Study|Failed retrieval|1|||
150044075|NCT02858362|541300790|FG002|Overall Study|Withdrawal by Subject|0|||
150044076|NCT02858362|541300788|FG000|Overall Study|Early Study Termination|0|||
150175200|NCT03194958|541777076|FG000|Overall Study|Withdrawal by Subject|24|||
150044077|NCT02858362|541300789|FG001|Overall Study|Early Study Termination|0|||
150044078|NCT02858362|541300790|FG002|Overall Study|Early Study Termination|3|||
150044079|NCT02858362|541300788|FG000|Overall Study|Lost to Follow-up|1|||
149885428|NCT02201277|540707184|FG001|Overall Study|Failed retrieval|0|||
149885429|NCT02201277|540707183|FG000|Overall Study|Physician Decision|1|||
150044080|NCT02858362|541300789|FG001|Overall Study|Lost to Follow-up|0|||
150175201|NCT03194958|541777077|FG001|Overall Study|Withdrawal by Subject|27|||
149885430|NCT02201277|540707184|FG001|Overall Study|Physician Decision|0|||
149885431|NCT00940316|540708605|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
149885432|NCT00940316|540708606|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
149885433|NCT00940316|540708607|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
149885434|NCT00940316|540708605|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
149885435|NCT00940316|540708606|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
149885436|NCT00940316|540708607|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
149885437|NCT00940316|540708605|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
149885438|NCT00940316|540708606|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
149885439|NCT00940316|540708607|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
149885440|NCT00940316|540708605|FG000|Treated After Cycle 5|Adverse Event|0|||
149885441|NCT00940316|540708606|FG001|Treated After Cycle 5|Adverse Event|0|||
149885442|NCT00940316|540708607|FG002|Treated After Cycle 5|Adverse Event|1|||
149885443|NCT00940316|540708605|FG000|Treated After Cycle 5|Progressive disease|0|||
149885444|NCT00940316|540708606|FG001|Treated After Cycle 5|Progressive disease|1|||
149885445|NCT00940316|540708607|FG002|Treated After Cycle 5|Progressive disease|0|||
149885446|NCT02324582|540708608|FG000|Overall Study|Screen Failures|0|||
149885447|NCT02324582|540708609|FG001|Overall Study|Screen Failures|5|||
149885448|NCT00129545|540708611|FG000|Overall Study|Death|5|||
149885449|NCT00129545|540708612|FG001|Overall Study|Death|60|||
149885450|NCT00129545|540708613|FG002|Overall Study|Death|44|||
149885451|NCT00129545|540708611|FG000|Overall Study|Withdrawal by Subject|3|||
149885452|NCT00129545|540708612|FG001|Overall Study|Withdrawal by Subject|18|||
149885453|NCT00129545|540708613|FG002|Overall Study|Withdrawal by Subject|44|||
149885454|NCT00129545|540708611|FG000|Overall Study|Lost to Follow-up|2|||
149885455|NCT00129545|540708612|FG001|Overall Study|Lost to Follow-up|22|||
149885456|NCT00129545|540708613|FG002|Overall Study|Lost to Follow-up|13|||
149885457|NCT00129545|540708611|FG000|Overall Study|Physician Decision|0|||
149885458|NCT00129545|540708612|FG001|Overall Study|Physician Decision|3|||
149885459|NCT00129545|540708613|FG002|Overall Study|Physician Decision|10|||
149885460|NCT00129545|540708611|FG000|Overall Study|Device not implanted|16|||
149885461|NCT00129545|540708612|FG001|Overall Study|Device not implanted|61|||
149885462|NCT00129545|540708613|FG002|Overall Study|Device not implanted|0|||
149885463|NCT02286843|540708620|FG000|Overall Study|Not Treated|4|||
149885464|NCT02286843|540708620|FG000|Overall Study|Protocol Violation|1|||
149885465|NCT02286843|540708620|FG000|Overall Study|Withdrawal by Subject|1|||
149885466|NCT02536846|540708621|FG000|Overall Study|Withdrawal by Subject|1|||
149885467|NCT03164616|540708622|FG000|Overall Study|Death|250|||
149885468|NCT03164616|540708623|FG001|Overall Study|Death|264|||
149885469|NCT03164616|540708624|FG002|Overall Study|Death|279|||
149885470|NCT03164616|540708622|FG000|Overall Study|Lost to Follow-up|2|||
149885471|NCT03164616|540708623|FG001|Overall Study|Lost to Follow-up|2|||
149885472|NCT03164616|540708624|FG002|Overall Study|Lost to Follow-up|2|||
149885473|NCT03164616|540708622|FG000|Overall Study|Withdrawal by Subject|6|||
149885474|NCT03164616|540708623|FG001|Overall Study|Withdrawal by Subject|7|||
149885475|NCT03164616|540708624|FG002|Overall Study|Withdrawal by Subject|16|||
149885476|NCT04388553|540708625|FG000|Overall Study|Protocol Violation|1|||
149885477|NCT04388553|540708626|FG001|Overall Study|Protocol Violation|0|||
149885478|NCT02123446|540708627|FG000|Washout Period (1 Day)|Physician Decision|1|||
149885479|NCT02123446|540708628|FG001|Washout Period (1 Day)|Physician Decision|0|||
149885480|NCT04604795|540708629|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
149885481|NCT04604795|540708630|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
149885482|NCT04604795|540708631|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885483|NCT04604795|540708632|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885484|NCT04604795|540708633|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885485|NCT04604795|540708634|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885486|NCT04604795|540708635|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885487|NCT04604795|540708636|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885488|NCT04604795|540708637|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885489|NCT04604795|540708638|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
149885490|NCT04604795|540708629|FG000|Part B: Up to Day 14|Adverse Event|0|||
149885491|NCT04604795|540708630|FG001|Part B: Up to Day 14|Adverse Event|0|||
149885492|NCT04604795|540708631|FG002|Part B: Up to Day 14|Adverse Event|0|||
149885493|NCT04604795|540708632|FG003|Part B: Up to Day 14|Adverse Event|0|||
149885494|NCT04604795|540708633|FG004|Part B: Up to Day 14|Adverse Event|2|||
149885495|NCT04604795|540708634|FG005|Part B: Up to Day 14|Adverse Event|1|||
149885496|NCT04604795|540708635|FG006|Part B: Up to Day 14|Adverse Event|0|||
149885497|NCT04604795|540708636|FG007|Part B: Up to Day 14|Adverse Event|0|||
149885498|NCT04604795|540708637|FG008|Part B: Up to Day 14|Adverse Event|0|||
149885499|NCT04604795|540708638|FG009|Part B: Up to Day 14|Adverse Event|0|||
149885500|NCT04604795|540708629|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885501|NCT04604795|540708630|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885502|NCT04604795|540708631|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885503|NCT04604795|540708632|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
150175202|NCT03194958|541777078|FG002|Overall Study|Withdrawal by Subject|7|||
150175203|NCT03194958|541777079|FG003|Overall Study|Withdrawal by Subject|22|||
150175204|NCT03194958|541777076|FG000|Overall Study|Lost to Follow-up|168|||
150175205|NCT03194958|541777077|FG001|Overall Study|Lost to Follow-up|196|||
149885504|NCT04604795|540708633|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885505|NCT04604795|540708634|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885506|NCT04604795|540708635|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885507|NCT04604795|540708636|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149885508|NCT04604795|540708637|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
150175206|NCT03194958|541777078|FG002|Overall Study|Lost to Follow-up|174|||
150175207|NCT03194958|541777079|FG003|Overall Study|Lost to Follow-up|186|||
149885509|NCT04604795|540708638|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
149885510|NCT04604795|540708629|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885511|NCT04604795|540708630|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885512|NCT04604795|540708631|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885513|NCT04604795|540708632|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885514|NCT04604795|540708633|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885515|NCT04604795|540708634|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885516|NCT04604795|540708635|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885517|NCT04604795|540708636|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885518|NCT04604795|540708637|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
149966024|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
149966025|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
150175208|NCT00959946|541777081|FG000|Overall Study|Adverse Event|0|||
149966026|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966027|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966028|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966029|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966030|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966031|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966032|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966033|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
149966034|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
149966035|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
149966036|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966037|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966038|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966039|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966040|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966041|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966042|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
150175209|NCT00959946|541777082|FG001|Overall Study|Adverse Event|0|||
150175210|NCT00959946|541777083|FG002|Overall Study|Adverse Event|2|||
150175211|NCT00959946|541777084|FG003|Overall Study|Adverse Event|1|||
150175212|NCT00959946|541777085|FG004|Overall Study|Adverse Event|0|||
150175213|NCT00959946|541777086|FG005|Overall Study|Adverse Event|1|||
149885519|NCT04604795|540708638|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
149885520|NCT04604795|540708629|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885521|NCT04604795|540708630|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885522|NCT04604795|540708631|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885523|NCT04604795|540708632|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885524|NCT04604795|540708633|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885525|NCT04604795|540708634|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885526|NCT04604795|540708635|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885527|NCT04604795|540708636|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885528|NCT04604795|540708637|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
149885529|NCT04604795|540708638|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
149885530|NCT04604795|540708629|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885531|NCT04604795|540708630|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885532|NCT04604795|540708631|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885533|NCT04604795|540708632|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885534|NCT04604795|540708633|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
149966043|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966044|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149966045|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
149966046|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
149885535|NCT04604795|540708634|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885536|NCT04604795|540708635|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885537|NCT04604795|540708636|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885538|NCT04604795|540708637|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
149966047|NCT02471144|541011115|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966048|NCT02471144|541011116|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966049|NCT02471144|541011117|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966050|NCT02471144|541011118|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966051|NCT02471144|541011119|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966052|NCT02471144|541011120|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966053|NCT02471144|541011121|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966054|NCT02471144|541011122|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966055|NCT02471144|541011123|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
149966056|NCT02471144|541011124|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
149966057|NCT02471144|541011125|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
149966058|NCT00851084|541011126|FG000|Overall Study|Randomized but not treated|1|||
149966059|NCT00851084|541011127|FG001|Overall Study|Randomized but not treated|0|||
149966060|NCT00851084|541011126|FG000|Overall Study|Adverse Event|26|||
149966061|NCT00851084|541011127|FG001|Overall Study|Adverse Event|36|||
149966062|NCT00851084|541011126|FG000|Overall Study|Disease progression|52|||
149966063|NCT00851084|541011127|FG001|Overall Study|Disease progression|47|||
149966064|NCT00851084|541011126|FG000|Overall Study|Poor compliance to protocol|1|||
149966065|NCT00851084|541011127|FG001|Overall Study|Poor compliance to protocol|1|||
150175214|NCT00959946|541777087|FG006|Overall Study|Adverse Event|0|||
150175215|NCT00959946|541777088|FG007|Overall Study|Adverse Event|0|||
150175216|NCT00959946|541777081|FG000|Overall Study|Death|0|||
150175217|NCT00959946|541777082|FG001|Overall Study|Death|0|||
150175218|NCT00959946|541777083|FG002|Overall Study|Death|0|||
150175219|NCT00959946|541777084|FG003|Overall Study|Death|0|||
150175220|NCT00959946|541777085|FG004|Overall Study|Death|0|||
150175221|NCT00959946|541777086|FG005|Overall Study|Death|1|||
150175222|NCT00959946|541777087|FG006|Overall Study|Death|0|||
150175223|NCT00959946|541777088|FG007|Overall Study|Death|0|||
150175224|NCT00959946|541777081|FG000|Overall Study|Disease Progression|2|||
150175225|NCT00959946|541777082|FG001|Overall Study|Disease Progression|4|||
150175226|NCT00959946|541777083|FG002|Overall Study|Disease Progression|2|||
150175227|NCT00959946|541777084|FG003|Overall Study|Disease Progression|4|||
150175228|NCT00959946|541777085|FG004|Overall Study|Disease Progression|4|||
150175229|NCT00959946|541777086|FG005|Overall Study|Disease Progression|6|||
150175230|NCT00959946|541777087|FG006|Overall Study|Disease Progression|2|||
150175231|NCT00959946|541777088|FG007|Overall Study|Disease Progression|2|||
150175232|NCT00959946|541777081|FG000|Overall Study|Withdrawal by Subject|0|||
150175233|NCT00959946|541777082|FG001|Overall Study|Withdrawal by Subject|0|||
150175234|NCT00959946|541777083|FG002|Overall Study|Withdrawal by Subject|0|||
150175235|NCT00959946|541777084|FG003|Overall Study|Withdrawal by Subject|0|||
150175236|NCT00959946|541777085|FG004|Overall Study|Withdrawal by Subject|0|||
150175237|NCT00959946|541777086|FG005|Overall Study|Withdrawal by Subject|1|||
150175238|NCT00959946|541777087|FG006|Overall Study|Withdrawal by Subject|0|||
150175239|NCT00959946|541777088|FG007|Overall Study|Withdrawal by Subject|0|||
150175240|NCT00356265|541777089|FG000|Overall Study|Withdrawal by Subject|0|||
149885539|NCT04604795|540708638|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
149885540|NCT04502212|540708645|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
149885541|NCT04502212|540708645|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
149885542|NCT02096744|540708650|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
149885543|NCT02096744|540708651|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
149885544|NCT02096744|540708650|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
149885545|NCT02096744|540708651|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
149885546|NCT02096744|540708650|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
149885547|NCT02096744|540708651|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
149885548|NCT02445963|540708653|FG000|Overall Study|Lost to Follow-up|1|||
149885549|NCT02445963|540708654|FG001|Overall Study|Lost to Follow-up|0|||
149885550|NCT02445963|540708655|FG002|Overall Study|Lost to Follow-up|0|||
149885551|NCT02445963|540708656|FG003|Overall Study|Lost to Follow-up|0|||
149885552|NCT02445963|540708653|FG000|Overall Study|Change in employment|1|||
149885553|NCT02445963|540708654|FG001|Overall Study|Change in employment|0|||
149885554|NCT02445963|540708655|FG002|Overall Study|Change in employment|0|||
149885555|NCT02445963|540708656|FG003|Overall Study|Change in employment|0|||
149885556|NCT02445963|540708653|FG000|Overall Study|Symptoms post-vaccination|0|||
149885557|NCT02445963|540708654|FG001|Overall Study|Symptoms post-vaccination|0|||
149885558|NCT02445963|540708655|FG002|Overall Study|Symptoms post-vaccination|1|||
149885559|NCT02445963|540708656|FG003|Overall Study|Symptoms post-vaccination|0|||
149885560|NCT01957176|540708660|FG000|Overall Study|Adverse Event|2|||
149885561|NCT01957176|540708661|FG001|Overall Study|Adverse Event|0|||
149885562|NCT01957176|540708660|FG000|Overall Study|Physician Decision|2|||
149885563|NCT01957176|540708661|FG001|Overall Study|Physician Decision|1|||
149885564|NCT01957176|540708660|FG000|Overall Study|Withdrawal by Subject|1|||
149885565|NCT01957176|540708661|FG001|Overall Study|Withdrawal by Subject|0|||
149885566|NCT00625872|540708664|FG000|Overall Study|Withdrawal by Subject|1|||
149885567|NCT00625872|540708665|FG001|Overall Study|Withdrawal by Subject|0|||
149885568|NCT00625872|540708664|FG000|Overall Study|Does not meet inclusion criteria|1|||
149885569|NCT00625872|540708665|FG001|Overall Study|Does not meet inclusion criteria|0|||
149885570|NCT00625872|540708664|FG000|Overall Study|Terminated by sponsor|2|||
149885571|NCT00625872|540708665|FG001|Overall Study|Terminated by sponsor|5|||
149885572|NCT00625872|540708664|FG000|Overall Study|Randomized but not treated|0|||
149885573|NCT00625872|540708665|FG001|Overall Study|Randomized but not treated|1|||
149885574|NCT01512160|540708666|FG000|Overall Study|Lost to Follow-up|1|||
149885575|NCT01512160|540708667|FG001|Overall Study|Lost to Follow-up|0|||
149885576|NCT01512160|540708668|FG002|Overall Study|Lost to Follow-up|0|||
149885577|NCT01512160|540708669|FG003|Overall Study|Lost to Follow-up|0|||
150175241|NCT00356265|541777090|FG001|Overall Study|Withdrawal by Subject|0|||
150175242|NCT00356265|541777091|FG002|Overall Study|Withdrawal by Subject|1|||
150175243|NCT01152190|541777095|FG000|Overall Study|Adverse Event|2|||
150175244|NCT01152190|541777096|FG001|Overall Study|Adverse Event|4|||
150175245|NCT01152190|541777095|FG000|Overall Study|Death|1|||
150175246|NCT01152190|541777096|FG001|Overall Study|Death|0|||
150175247|NCT01152190|541777095|FG000|Overall Study|Protocol Violation|1|||
150175248|NCT01152190|541777096|FG001|Overall Study|Protocol Violation|1|||
150175249|NCT01152190|541777095|FG000|Overall Study|Withdrawal by Subject|1|||
149885578|NCT01512160|540708666|FG000|Overall Study|Withdrawal by Subject|1|||
149885579|NCT01512160|540708667|FG001|Overall Study|Withdrawal by Subject|0|||
149885580|NCT01512160|540708668|FG002|Overall Study|Withdrawal by Subject|0|||
149885581|NCT01512160|540708669|FG003|Overall Study|Withdrawal by Subject|1|||
149885582|NCT02905032|540708672|FG000|Overall Study|Withdrawal by Subject|2|||
149885583|NCT02905032|540708673|FG001|Overall Study|Withdrawal by Subject|0|||
149885584|NCT02905032|540708674|FG002|Overall Study|Withdrawal by Subject|0|||
149885585|NCT02905032|540708672|FG000|Overall Study|Protocol Violation|6|||
149885586|NCT02905032|540708673|FG001|Overall Study|Protocol Violation|12|||
149885587|NCT02905032|540708674|FG002|Overall Study|Protocol Violation|0|||
149885588|NCT00739063|540708675|FG000|Overall Study|Screen failures|8|||
149885589|NCT00866359|540708677|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
149885590|NCT00866359|540708678|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
149885591|NCT00866359|540708679|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
149885592|NCT00866359|540708680|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
149885593|NCT00866359|540708677|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
149885594|NCT00866359|540708678|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
149885595|NCT00866359|540708679|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
149885596|NCT00866359|540708680|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
149885597|NCT00866359|540708677|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
149885598|NCT00866359|540708678|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
149885599|NCT00866359|540708679|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
149885600|NCT00866359|540708680|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
149885601|NCT00866359|540708677|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
149885602|NCT00866359|540708678|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
149885603|NCT00866359|540708679|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
149885604|NCT00866359|540708680|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
149885605|NCT00866359|540708677|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
149885606|NCT00866359|540708678|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
149966066|NCT00851084|541011126|FG000|Overall Study|Physician Decision|13|||
149966067|NCT00851084|541011127|FG001|Overall Study|Physician Decision|14|||
149966068|NCT00851084|541011126|FG000|Overall Study|Consent withdrawn|0|||
149966069|NCT00851084|541011127|FG001|Overall Study|Consent withdrawn|2|||
149966070|NCT00851084|541011126|FG000|Overall Study|Withdrawal by Subject|11|||
149966071|NCT00851084|541011127|FG001|Overall Study|Withdrawal by Subject|12|||
149966072|NCT00851084|541011126|FG000|Overall Study|Metastatic surgery|6|||
149966073|NCT00851084|541011127|FG001|Overall Study|Metastatic surgery|6|||
149966074|NCT00851084|541011126|FG000|Overall Study|Other|7|||
149966075|NCT00851084|541011127|FG001|Overall Study|Other|1|||
149966076|NCT00734032|541011128|FG000|Overall Study|Adverse Event|0|||
149966077|NCT00734032|541011129|FG001|Overall Study|Adverse Event|1|||
149966078|NCT00734032|541011130|FG002|Overall Study|Adverse Event|0|||
149966079|NCT00734032|541011131|FG003|Overall Study|Adverse Event|0|||
149966080|NCT03787615|541011135|FG000|Overall Study|Withdrawal by Subject|2|||
149966081|NCT03787615|541011135|FG000|Overall Study|Lost to Follow-up|2|||
149966082|NCT03412929|541011137|FG000|Overall Study|Protocol Violation|3|||
149966083|NCT01674062|541011139|FG000|Overall Study|Insufficient Therapeutic Response|56|||
149966084|NCT01674062|541011140|FG001|Overall Study|Insufficient Therapeutic Response|26|||
149966085|NCT01674062|541011139|FG000|Overall Study|Other|8|||
149966086|NCT01674062|541011140|FG001|Overall Study|Other|1|||
149966087|NCT01674062|541011139|FG000|Overall Study|Adverse Event|1|||
149966088|NCT01674062|541011140|FG001|Overall Study|Adverse Event|1|||
149966089|NCT01674062|541011139|FG000|Overall Study|Death|0|||
149966090|NCT01674062|541011140|FG001|Overall Study|Death|1|||
149966091|NCT01674062|541011139|FG000|Overall Study|Programming Error|1|||
149966092|NCT01674062|541011140|FG001|Overall Study|Programming Error|0|||
149966093|NCT01946880|541011141|FG000|Overall Study|Lost to Follow-up|1|||
149966094|NCT01946880|541011142|FG001|Overall Study|Lost to Follow-up|0|||
149885607|NCT00866359|540708679|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
149885608|NCT00866359|540708680|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
149885609|NCT00866359|540708677|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
149966095|NCT01946880|541011141|FG000|Overall Study|Physician Decision|1|||
149966096|NCT01946880|541011142|FG001|Overall Study|Physician Decision|1|||
149966097|NCT01946880|541011141|FG000|Overall Study|Withdrawal by Subject|3|||
149966098|NCT01946880|541011142|FG001|Overall Study|Withdrawal by Subject|2|||
149966099|NCT01946880|541011141|FG000|Overall Study|Met Primary Endpoint|1|||
149885610|NCT00866359|540708678|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
149885611|NCT00866359|540708679|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
149885612|NCT00866359|540708680|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
149885613|NCT01625091|540708681|FG000|Intervention|Death|1|||
149885614|NCT01625091|540708682|FG001|Intervention|Death|1|||
149885615|NCT01625091|540708681|FG000|Intervention|Withdrawal by Subject|4|||
149885616|NCT01625091|540708682|FG001|Intervention|Withdrawal by Subject|1|||
149885617|NCT01625091|540708681|FG000|Intervention|Adverse Event|0|||
149885618|NCT01625091|540708682|FG001|Intervention|Adverse Event|2|||
149885619|NCT01625091|540708681|FG000|Intervention|Lost to Follow-up|4|||
149885620|NCT01625091|540708682|FG001|Intervention|Lost to Follow-up|4|||
149885621|NCT01625091|540708681|FG000|Intervention|Study termination|2|||
149885622|NCT01625091|540708682|FG001|Intervention|Study termination|3|||
149885623|NCT01625091|540708681|FG000|Post-intervention|Death|0|||
149885624|NCT01625091|540708682|FG001|Post-intervention|Death|1|||
149885625|NCT01625091|540708681|FG000|Post-intervention|Lost to Follow-up|2|||
149885626|NCT01625091|540708682|FG001|Post-intervention|Lost to Follow-up|0|||
149885627|NCT01625091|540708681|FG000|Post-intervention|Study termination|2|||
149885628|NCT01625091|540708682|FG001|Post-intervention|Study termination|1|||
149885629|NCT02163057|540708683|FG000|Overall Study|Participant Refusal to Continue|2|||
149885630|NCT02163057|540708684|FG001|Overall Study|Participant Refusal to Continue|2|||
149885631|NCT02163057|540708683|FG000|Overall Study|Participant Significant Noncompliance|0|||
149885632|NCT02163057|540708684|FG001|Overall Study|Participant Significant Noncompliance|1|||
149885633|NCT02163057|540708683|FG000|Overall Study|Progression of Disease|1|||
149885634|NCT02163057|540708684|FG001|Overall Study|Progression of Disease|2|||
149885635|NCT00768248|540708688|FG000|Overall Study|Research coordinator didn't collect data|1|||
149885636|NCT00768248|540708689|FG001|Overall Study|Research coordinator didn't collect data|1|||
149885637|NCT01547390|540708693|FG000|Overall Study|Withdrawal by Subject|10|||
149885638|NCT01547390|540708694|FG001|Overall Study|Withdrawal by Subject|7|||
149885639|NCT01547390|540708693|FG000|Overall Study|termination of pregnancy|0|||
149885640|NCT01547390|540708694|FG001|Overall Study|termination of pregnancy|1|||
149885641|NCT01547390|540708693|FG000|Overall Study|Lost to Follow-up|0|||
149885642|NCT01547390|540708694|FG001|Overall Study|Lost to Follow-up|2|||
149885643|NCT01547390|540708693|FG000|Overall Study|Adverse Event|3|||
149885644|NCT01547390|540708694|FG001|Overall Study|Adverse Event|0|||
149885645|NCT01959295|540708697|FG000|Overall Study|Adverse Event|2|||
149885646|NCT01959295|540708698|FG001|Overall Study|Adverse Event|0|||
149885647|NCT01959295|540708697|FG000|Overall Study|Lost to Follow-up|0|||
149885648|NCT01959295|540708698|FG001|Overall Study|Lost to Follow-up|2|||
149885649|NCT01959295|540708697|FG000|Overall Study|Physician Decision|2|||
149885650|NCT01959295|540708698|FG001|Overall Study|Physician Decision|3|||
149885651|NCT01959295|540708697|FG000|Overall Study|Protocol Violation|16|||
149885652|NCT01959295|540708698|FG001|Overall Study|Protocol Violation|5|||
149885653|NCT01959295|540708697|FG000|Overall Study|Withdrawal by Subject|3|||
149885654|NCT01959295|540708698|FG001|Overall Study|Withdrawal by Subject|1|||
149885655|NCT01959295|540708697|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
150175250|NCT01152190|541777096|FG001|Overall Study|Withdrawal by Subject|3|||
150175251|NCT00258895|541777097|FG000|Overall Study|Lost to Follow-up|3|||
150175252|NCT00258895|541777098|FG001|Overall Study|Lost to Follow-up|1|||
150175253|NCT00258895|541777097|FG000|Overall Study|Protocol Violation|6|||
150175254|NCT00258895|541777098|FG001|Overall Study|Protocol Violation|2|||
150175255|NCT00258895|541777097|FG000|Overall Study|Withdrawal by Subject|1|||
150175256|NCT00258895|541777098|FG001|Overall Study|Withdrawal by Subject|0|||
150175257|NCT00547118|541777101|FG000|Overall Study|Did not qualify prior to starting drug|1|||
150175258|NCT00547118|541777102|FG001|Overall Study|Did not qualify prior to starting drug|1|||
150175259|NCT00547118|541777101|FG000|Overall Study|Study suspended|7|||
150175260|NCT00547118|541777102|FG001|Overall Study|Study suspended|8|||
150175261|NCT00834834|541777103|FG000|Overall Study|Withdrawal by Subject|4|||
150175262|NCT00834834|541777104|FG001|Overall Study|Withdrawal by Subject|3|||
150175263|NCT00373529|541777105|FG000|Overall Study|Physician Decision|19|||
150175264|NCT00373529|541777105|FG000|Overall Study|Withdrawal by Subject|7|||
150175265|NCT00373529|541777105|FG000|Overall Study|Adverse Event|7|||
150175266|NCT00373529|541777105|FG000|Overall Study|Treatment failure|36|||
150175267|NCT00373529|541777105|FG000|Overall Study|Disease recurrence|10|||
150175268|NCT00373529|541777105|FG000|Overall Study|Death|16|||
150175269|NCT00373529|541777105|FG000|Overall Study|Need for treatment prohibited by study|1|||
150175270|NCT00373529|541777105|FG000|Overall Study|Other|8|||
150175271|NCT00373529|541777105|FG000|Overall Study|Failed independent confirmation of AML|3|||
150175272|NCT00373529|541777105|FG000|Overall Study|Consent violation|1|||
150175273|NCT01810263|541777128|FG000|Overall Study|Lost to Follow-up|8|||
150175274|NCT01810263|541777129|FG001|Overall Study|Lost to Follow-up|7|||
150175275|NCT01390402|541777130|FG000|Overall Study|Death|1|||
150175276|NCT01390402|541777130|FG000|Overall Study|Disease Progression|4|||
149885656|NCT01959295|540708698|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
149885657|NCT04917861|540708700|FG000|Main Study (196 Days)|Adverse Event|0|||
149885658|NCT04917861|540708701|FG001|Main Study (196 Days)|Adverse Event|1|||
149885659|NCT04917861|540708702|FG002|Main Study (196 Days)|Adverse Event|0|||
149885660|NCT04917861|540708703|FG003|Main Study (196 Days)|Adverse Event|0|||
149885661|NCT04917861|540708700|FG000|Main Study (196 Days)|Death|0|||
149885662|NCT04917861|540708701|FG001|Main Study (196 Days)|Death|0|||
149885663|NCT04917861|540708702|FG002|Main Study (196 Days)|Death|0|||
149885664|NCT04917861|540708703|FG003|Main Study (196 Days)|Death|1|||
149885665|NCT04917861|540708700|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
149885666|NCT04917861|540708701|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
149885667|NCT04917861|540708702|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
149885668|NCT04917861|540708703|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
149885669|NCT04917861|540708700|FG000|Main Study (196 Days)|Physician Decision|0|||
149885670|NCT04917861|540708701|FG001|Main Study (196 Days)|Physician Decision|0|||
149885671|NCT04917861|540708702|FG002|Main Study (196 Days)|Physician Decision|0|||
149885672|NCT04917861|540708703|FG003|Main Study (196 Days)|Physician Decision|1|||
149885673|NCT04917861|540708700|FG000|Main Study (196 Days)|Pregnancy|1|||
149885674|NCT04917861|540708701|FG001|Main Study (196 Days)|Pregnancy|1|||
149885675|NCT04917861|540708702|FG002|Main Study (196 Days)|Pregnancy|0|||
149885676|NCT04917861|540708703|FG003|Main Study (196 Days)|Pregnancy|0|||
149885677|NCT04917861|540708700|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
149885678|NCT04917861|540708701|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
149885679|NCT04917861|540708702|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
149885680|NCT04917861|540708703|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
149885681|NCT04917861|540708700|FG000|Main Study (196 Days)|Other Than Specified|1|||
149885682|NCT04917861|540708701|FG001|Main Study (196 Days)|Other Than Specified|0|||
149885683|NCT04917861|540708702|FG002|Main Study (196 Days)|Other Than Specified|1|||
149885684|NCT04917861|540708703|FG003|Main Study (196 Days)|Other Than Specified|2|||
150175277|NCT01170026|541778462|FG000|Overall Study|Lost to Follow-up|4|||
150175278|NCT01170026|541778463|FG001|Overall Study|Lost to Follow-up|2|||
150175279|NCT05777785|541778464|FG000|Overall Study|Withdrawal by Subject|5|||
150175280|NCT05777785|541778464|FG000|Overall Study|Lost to Follow-up|1|||
150175281|NCT05644444|541778469|FG000|Tolerance Phase|Adverse Event|0|||
150175282|NCT05644444|541778470|FG001|Tolerance Phase|Adverse Event|2|||
150175283|NCT05644444|541778469|FG000|Treatment Phase|Adverse Event|0|||
149885685|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
149885686|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
149885687|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
150175284|NCT05644444|541778470|FG001|Treatment Phase|Adverse Event|2|||
150175285|NCT04817670|541778471|FG000|Overall Study|Withdrawal by Subject|1|||
150175286|NCT04817670|541778472|FG001|Overall Study|Withdrawal by Subject|0|||
150175287|NCT04817670|541778473|FG002|Overall Study|Withdrawal by Subject|0|||
150175288|NCT04817670|541778474|FG003|Overall Study|Withdrawal by Subject|0|||
150175289|NCT04817670|541778475|FG004|Overall Study|Withdrawal by Subject|0|||
150175290|NCT04817670|541778471|FG000|Overall Study|Lost to Follow-up|0|||
150175291|NCT04817670|541778472|FG001|Overall Study|Lost to Follow-up|0|||
150175292|NCT04817670|541778473|FG002|Overall Study|Lost to Follow-up|1|||
149885688|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
149885689|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
149885690|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
149885691|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
149885692|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
149885693|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
149885694|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
149885695|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
149885696|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
149885697|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
149885698|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
149885699|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
149885700|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
149885701|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
149885702|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
149885703|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
149885704|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
149885705|NCT04917861|540708700|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
149885706|NCT04917861|540708701|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
149885707|NCT04917861|540708702|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
149885708|NCT04917861|540708703|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
149885709|NCT01128179|540708705|FG000|Overall Study|Death|1|||
149885710|NCT01128179|540708706|FG001|Overall Study|Death|0|||
149885711|NCT01128179|540708705|FG000|Overall Study|Protocol Violation|1|||
149885712|NCT01128179|540708706|FG001|Overall Study|Protocol Violation|0|||
149885713|NCT01682811|540708707|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885714|NCT01682811|540708708|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885715|NCT01682811|540708709|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885716|NCT01682811|540708710|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885717|NCT01682811|540708711|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
149885718|NCT01682811|540708712|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885719|NCT01682811|540708713|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
149885720|NCT01682811|540708707|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
149885721|NCT01682811|540708708|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
149885722|NCT01682811|540708709|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
149885723|NCT01682811|540708710|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
149966100|NCT01946880|541011142|FG001|Overall Study|Met Primary Endpoint|0|||
149966101|NCT01946880|541011141|FG000|Overall Study|Personal and Family Issues|1|||
149966102|NCT01946880|541011142|FG001|Overall Study|Personal and Family Issues|0|||
149966103|NCT02034565|541011143|FG000|Overall Study|Adverse Event|1|||
149966104|NCT02034565|541011144|FG001|Overall Study|Adverse Event|0|||
149966105|NCT00581919|541011145|FG000|Overall Study|Adverse Event|8|||
149966106|NCT00581919|541011145|FG000|Overall Study|Death|1|||
149966107|NCT00581919|541011145|FG000|Overall Study|Disease Progression|10|||
149966108|NCT00581919|541011145|FG000|Overall Study|Physician Decision|1|||
149966109|NCT00581919|541011145|FG000|Overall Study|Other Complicating Disease|1|||
149885724|NCT01682811|540708711|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
149885725|NCT01682811|540708712|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
149885726|NCT01682811|540708713|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
149885727|NCT01682811|540708707|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
149966110|NCT00581919|541011145|FG000|Overall Study|Started Non-Protocol Therapy|2|||
149966111|NCT00581919|541011145|FG000|Overall Study|Withdrawal by Subject|1|||
149885728|NCT01682811|540708708|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
149885729|NCT01682811|540708709|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
149885730|NCT01682811|540708710|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
149885731|NCT01682811|540708711|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
149885732|NCT01682811|540708712|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
149885733|NCT01682811|540708713|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
149885734|NCT01682811|540708707|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885735|NCT01682811|540708708|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885736|NCT01682811|540708709|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885737|NCT01682811|540708710|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885738|NCT01682811|540708711|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885739|NCT01682811|540708712|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
149885740|NCT01682811|540708713|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
149885741|NCT02694328|540708714|FG000|Overall Study|Adverse Event|27|||
149885742|NCT02694328|540708715|FG001|Overall Study|Adverse Event|33|||
149885743|NCT02694328|540708714|FG000|Overall Study|Withdrawal by Subject|27|||
149885744|NCT02694328|540708715|FG001|Overall Study|Withdrawal by Subject|23|||
149885745|NCT02694328|540708714|FG000|Overall Study|Lost to Follow-up|26|||
149885746|NCT02694328|540708715|FG001|Overall Study|Lost to Follow-up|22|||
149885747|NCT02694328|540708714|FG000|Overall Study|Noncompliant with study drug|11|||
149885748|NCT02694328|540708715|FG001|Overall Study|Noncompliant with study drug|8|||
149885749|NCT02694328|540708714|FG000|Overall Study|Incarceration|1|||
149885750|NCT02694328|540708715|FG001|Overall Study|Incarceration|1|||
149885751|NCT02694328|540708714|FG000|Overall Study|Lack of Efficacy|1|||
149885752|NCT02694328|540708715|FG001|Overall Study|Lack of Efficacy|2|||
149885753|NCT02694328|540708714|FG000|Overall Study|Pregnancy|1|||
149885754|NCT02694328|540708715|FG001|Overall Study|Pregnancy|1|||
149885755|NCT02694328|540708714|FG000|Overall Study|Protocol Violation|6|||
149885756|NCT02694328|540708715|FG001|Overall Study|Protocol Violation|5|||
149885757|NCT02694328|540708714|FG000|Overall Study|Abnormal Laboratory Value|0|||
149885758|NCT02694328|540708715|FG001|Overall Study|Abnormal Laboratory Value|3|||
149885759|NCT00720382|540708719|FG000|Overall Study|Adverse Event|54|||
149885760|NCT00720382|540708720|FG001|Overall Study|Adverse Event|17|||
149885761|NCT00720382|540708719|FG000|Overall Study|Lack of Efficacy|18|||
149885762|NCT00720382|540708720|FG001|Overall Study|Lack of Efficacy|7|||
149885763|NCT00720382|540708719|FG000|Overall Study|Non-Compliance|15|||
149885764|NCT00720382|540708720|FG001|Overall Study|Non-Compliance|5|||
149885765|NCT00720382|540708719|FG000|Overall Study|Withdrawal by Subject|47|||
149885766|NCT00720382|540708720|FG001|Overall Study|Withdrawal by Subject|11|||
149885767|NCT00720382|540708719|FG000|Overall Study|Lost to Follow-up|28|||
149885768|NCT00720382|540708720|FG001|Overall Study|Lost to Follow-up|14|||
149885769|NCT00720382|540708719|FG000|Overall Study|administrative|14|||
149885770|NCT00720382|540708720|FG001|Overall Study|administrative|5|||
149885771|NCT05192889|540708721|FG000|Block 1: All Eligible Patients|Death|2|||
149885772|NCT05192889|540708722|FG001|Block 1: All Eligible Patients|Death|0|||
149885773|NCT05192889|540708723|FG002|Block 1: All Eligible Patients|Death|0|||
149885774|NCT05192889|540708721|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
149885775|NCT05192889|540708722|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
149885776|NCT05192889|540708723|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
149885777|NCT05192889|540708721|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
149885778|NCT05192889|540708722|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
149885779|NCT05192889|540708723|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
149885780|NCT00265759|540711119|FG000|Overall Study|Withdrawal by Subject|0|||
149885781|NCT00265759|540711120|FG001|Overall Study|Withdrawal by Subject|1|||
149885782|NCT00265759|540711121|FG002|Overall Study|Withdrawal by Subject|2|||
149885783|NCT00265759|540711122|FG003|Overall Study|Withdrawal by Subject|2|||
149885784|NCT00265759|540711119|FG000|Overall Study|Cancel|0|||
149885785|NCT00265759|540711120|FG001|Overall Study|Cancel|0|||
149885786|NCT00265759|540711121|FG002|Overall Study|Cancel|0|||
149885787|NCT00265759|540711122|FG003|Overall Study|Cancel|3|||
149885788|NCT00265759|540711119|FG000|Overall Study|Ineligible|0|||
149885789|NCT00265759|540711120|FG001|Overall Study|Ineligible|0|||
149885790|NCT00265759|540711121|FG002|Overall Study|Ineligible|0|||
149885791|NCT00265759|540711122|FG003|Overall Study|Ineligible|1|||
149885792|NCT00265759|540711119|FG000|Overall Study|Bilateral disease|0|||
149885793|NCT00265759|540711120|FG001|Overall Study|Bilateral disease|0|||
149885794|NCT00265759|540711121|FG002|Overall Study|Bilateral disease|0|||
149885795|NCT00265759|540711122|FG003|Overall Study|Bilateral disease|2|||
149885796|NCT00265759|540711119|FG000|Overall Study|Discontinued due to intolerability|0|||
149885797|NCT00265759|540711120|FG001|Overall Study|Discontinued due to intolerability|0|||
149885798|NCT00265759|540711121|FG002|Overall Study|Discontinued due to intolerability|0|||
149885799|NCT00265759|540711122|FG003|Overall Study|Discontinued due to intolerability|1|||
149885800|NCT03713593|540711123|FG000|Overall Study|Sponsor Decision|73|||
149885801|NCT03713593|540711124|FG001|Overall Study|Sponsor Decision|41|||
149885802|NCT03713593|540711123|FG000|Overall Study|Lost to Follow-up|2|||
149885803|NCT03713593|540711124|FG001|Overall Study|Lost to Follow-up|1|||
149885804|NCT03713593|540711123|FG000|Overall Study|Death|314|||
149885805|NCT03713593|540711124|FG001|Overall Study|Death|349|||
149885806|NCT03713593|540711123|FG000|Overall Study|Withdrawal by Subject|6|||
149885807|NCT03713593|540711124|FG001|Overall Study|Withdrawal by Subject|8|||
149885808|NCT05061134|540711125|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
149885809|NCT05061134|540711126|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
149885810|NCT05061134|540711127|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
149885811|NCT05061134|540711125|FG000|Overall Study|Subject not treated|0|||
149885812|NCT05061134|540711126|FG001|Overall Study|Subject not treated|0|||
149885813|NCT05061134|540711127|FG002|Overall Study|Subject not treated|2|||
149885814|NCT05061134|540711125|FG000|Overall Study|Other|0|||
149885815|NCT05061134|540711126|FG001|Overall Study|Other|0|||
149885816|NCT05061134|540711127|FG002|Overall Study|Other|9|||
149885817|NCT05061134|540711125|FG000|Overall Study|Withdrawal by Subject|9|||
149885818|NCT05061134|540711126|FG001|Overall Study|Withdrawal by Subject|8|||
149885819|NCT05061134|540711127|FG002|Overall Study|Withdrawal by Subject|5|||
149885820|NCT05061134|540711125|FG000|Overall Study|Study Terminated by Sponsor|22|||
149885821|NCT05061134|540711126|FG001|Overall Study|Study Terminated by Sponsor|14|||
149885822|NCT05061134|540711127|FG002|Overall Study|Study Terminated by Sponsor|7|||
149885823|NCT05061134|540711125|FG000|Overall Study|Progressive Disease|1|||
149885824|NCT05061134|540711126|FG001|Overall Study|Progressive Disease|2|||
149885825|NCT05061134|540711127|FG002|Overall Study|Progressive Disease|0|||
149885826|NCT05061134|540711125|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
149885827|NCT05061134|540711126|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
149885828|NCT05061134|540711127|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
149885829|NCT05061134|540711125|FG000|Overall Study|Lost to Follow-up|1|||
149885830|NCT05061134|540711126|FG001|Overall Study|Lost to Follow-up|0|||
149885831|NCT05061134|540711127|FG002|Overall Study|Lost to Follow-up|0|||
149885832|NCT05061134|540711125|FG000|Overall Study|Physician Decision|1|||
149885833|NCT05061134|540711126|FG001|Overall Study|Physician Decision|1|||
150044081|NCT02858362|541300790|FG002|Overall Study|Lost to Follow-up|0|||
150044082|NCT02194985|541300792|FG000|Overall Study|Adverse Event|1|||
150044083|NCT02194985|541300792|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
150044084|NCT02194985|541300792|FG000|Overall Study|Physician Decision|4|||
150044085|NCT02194985|541300792|FG000|Overall Study|Lost to Follow-up|1|||
150044086|NCT02194985|541300792|FG000|Overall Study|Withdrawal by Subject|2|||
150044087|NCT02561832|541300795|FG000|Overall Study|Withdrawal by Subject|1|||
150044088|NCT02561832|541300796|FG001|Overall Study|Withdrawal by Subject|1|||
150044089|NCT02561832|541300795|FG000|Overall Study|Adverse Event|3|||
150044090|NCT02561832|541300796|FG001|Overall Study|Adverse Event|0|||
150044091|NCT02561832|541300795|FG000|Overall Study|Disease progression|3|||
150044092|NCT02561832|541300796|FG001|Overall Study|Disease progression|3|||
150044093|NCT02304367|541300803|FG000|Overall Study|Lack of Response to Bruosumab|1|||
150044094|NCT02304367|541300803|FG000|Overall Study|Sponsor Decision|3|||
150044095|NCT02304367|541300803|FG000|Overall Study|Death|2|||
150044096|NCT02304367|541300803|FG000|Overall Study|Physician Decision|1|||
150044097|NCT02304367|541300803|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
150044098|NCT00594815|541300804|FG000|Overall Study|Never Treated|3|||
150044099|NCT00594815|541300804|FG000|Overall Study|Withdrawal by Subject|2|||
150044100|NCT00594815|541300804|FG000|Overall Study|Toxicity|4|||
150044101|NCT03527732|541300805|FG000|Overall Study|Lost to Follow-up|21|||
150044102|NCT03527732|541300806|FG001|Overall Study|Lost to Follow-up|23|||
150044103|NCT03527732|541300807|FG002|Overall Study|Lost to Follow-up|80|||
150044104|NCT03527732|541300808|FG003|Overall Study|Lost to Follow-up|62|||
150044105|NCT03527732|541300809|FG004|Overall Study|Lost to Follow-up|12|||
150044106|NCT03527732|541300810|FG005|Overall Study|Lost to Follow-up|20|||
150044107|NCT03599089|541300811|FG000|Overall Study|Lost to Follow-up|1|||
150044108|NCT03599089|541300812|FG001|Overall Study|Lost to Follow-up|0|||
150044109|NCT03599089|541300813|FG002|Overall Study|Lost to Follow-up|0|||
150044110|NCT03599089|541300814|FG003|Overall Study|Lost to Follow-up|0|||
150044111|NCT03599089|541300811|FG000|Overall Study|Withdrawal by Subject|2|||
150044112|NCT03599089|541300812|FG001|Overall Study|Withdrawal by Subject|1|||
149885834|NCT05061134|540711127|FG002|Overall Study|Physician Decision|0|||
149885835|NCT05061134|540711125|FG000|Overall Study|Disease progression|1|||
150044113|NCT03599089|541300813|FG002|Overall Study|Withdrawal by Subject|0|||
150044114|NCT03599089|541300814|FG003|Overall Study|Withdrawal by Subject|0|||
150044115|NCT03599089|541300811|FG000|Overall Study|Lack of Efficacy|0|||
149885836|NCT05061134|540711126|FG001|Overall Study|Disease progression|0|||
149885837|NCT05061134|540711127|FG002|Overall Study|Disease progression|0|||
149885838|NCT05061134|540711125|FG000|Overall Study|Death|43|||
149885839|NCT05061134|540711126|FG001|Overall Study|Death|23|||
149885840|NCT05061134|540711127|FG002|Overall Study|Death|14|||
149885841|NCT05061134|540711125|FG000|Overall Study|Database lock|2|||
149885842|NCT05061134|540711126|FG001|Overall Study|Database lock|0|||
149885843|NCT05061134|540711127|FG002|Overall Study|Database lock|0|||
150044116|NCT03599089|541300812|FG001|Overall Study|Lack of Efficacy|0|||
150044117|NCT03599089|541300813|FG002|Overall Study|Lack of Efficacy|1|||
150044118|NCT03599089|541300814|FG003|Overall Study|Lack of Efficacy|2|||
149885844|NCT00001521|540711128|FG000|Overall Study|Withdrawal by Subject|3|||
150044119|NCT03214666|541300815|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
150044120|NCT03214666|541300816|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
150175293|NCT04817670|541778474|FG003|Overall Study|Lost to Follow-up|0|||
150175294|NCT04817670|541778475|FG004|Overall Study|Lost to Follow-up|0|||
150175295|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
150175296|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
150175297|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
150175298|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
149885845|NCT00001521|540711129|FG001|Overall Study|Withdrawal by Subject|3|||
149885846|NCT00001521|540711128|FG000|Overall Study|Physician Decision|1|||
149885847|NCT00001521|540711129|FG001|Overall Study|Physician Decision|1|||
149885848|NCT00001521|540711128|FG000|Overall Study|Noncompliant|6|||
149885849|NCT00001521|540711129|FG001|Overall Study|Noncompliant|3|||
149885850|NCT03176134|540711130|FG000|Overall Study|Lost to Follow-up|0|||
149885851|NCT03176134|540711131|FG001|Overall Study|Lost to Follow-up|2|||
149885852|NCT03176134|540711132|FG002|Overall Study|Lost to Follow-up|0|||
149885853|NCT03176134|540711133|FG003|Overall Study|Lost to Follow-up|0|||
149885854|NCT03176134|540711134|FG004|Overall Study|Lost to Follow-up|0|||
149885855|NCT03176134|540711135|FG005|Overall Study|Lost to Follow-up|0|||
149885856|NCT03176134|540711136|FG006|Overall Study|Lost to Follow-up|0|||
149885857|NCT03176134|540711137|FG007|Overall Study|Lost to Follow-up|0|||
149885858|NCT03176134|540711130|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149885859|NCT03176134|540711131|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149885860|NCT03176134|540711132|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
149885861|NCT03176134|540711133|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149885862|NCT03176134|540711134|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149885863|NCT03176134|540711135|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149885864|NCT03176134|540711136|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
149885865|NCT03176134|540711137|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
149885866|NCT03410056|540711142|FG000|Overall Study|Decision by Sponsor|0|||
149885867|NCT03410056|540711143|FG001|Overall Study|Decision by Sponsor|0|||
149885868|NCT03410056|540711144|FG002|Overall Study|Decision by Sponsor|3|||
149885869|NCT03410056|540711145|FG003|Overall Study|Decision by Sponsor|0|||
149885870|NCT03410056|540711146|FG004|Overall Study|Decision by Sponsor|0|||
149885871|NCT03410056|540711147|FG005|Overall Study|Decision by Sponsor|0|||
149885872|NCT03410056|540711148|FG006|Overall Study|Decision by Sponsor|0|||
149885873|NCT03410056|540711142|FG000|Overall Study|Withdrawal by Subject|0|||
149885874|NCT03410056|540711143|FG001|Overall Study|Withdrawal by Subject|2|||
149885875|NCT03410056|540711144|FG002|Overall Study|Withdrawal by Subject|5|||
149885876|NCT03410056|540711145|FG003|Overall Study|Withdrawal by Subject|5|||
149885877|NCT03410056|540711146|FG004|Overall Study|Withdrawal by Subject|0|||
149885878|NCT03410056|540711147|FG005|Overall Study|Withdrawal by Subject|0|||
149885879|NCT03410056|540711148|FG006|Overall Study|Withdrawal by Subject|0|||
149885880|NCT00443729|540711153|FG000|Overall Study|Never Treated|0|||
149885881|NCT00443729|540711154|FG001|Overall Study|Never Treated|1|||
149885882|NCT00443729|540711153|FG000|Overall Study|Lack of Efficacy|4|||
149885883|NCT00443729|540711154|FG001|Overall Study|Lack of Efficacy|2|||
149885884|NCT00443729|540711153|FG000|Overall Study|Lost to Follow-up|0|||
149885885|NCT00443729|540711154|FG001|Overall Study|Lost to Follow-up|1|||
149885886|NCT00443729|540711153|FG000|Overall Study|Physician Decision|2|||
149885887|NCT00443729|540711154|FG001|Overall Study|Physician Decision|1|||
149885888|NCT00443729|540711153|FG000|Overall Study|Protocol Violation|1|||
149966112|NCT02655601|541011146|FG000|Overall Study|Adverse Event|0|||
149885889|NCT00443729|540711154|FG001|Overall Study|Protocol Violation|1|||
149885890|NCT00443729|540711153|FG000|Overall Study|Withdrawal by Subject|3|||
149885891|NCT00443729|540711154|FG001|Overall Study|Withdrawal by Subject|1|||
149966113|NCT02655601|541011147|FG001|Overall Study|Adverse Event|0|||
149885892|NCT03718832|540711158|FG000|Analysis Sample|Withdrawal by Subject|18|||
149885893|NCT03718832|540711159|FG001|Analysis Sample|Withdrawal by Subject|15|||
149885894|NCT03718832|540711158|FG000|Analysis Sample|Legal hold on data|1|||
149885895|NCT03718832|540711159|FG001|Analysis Sample|Legal hold on data|0|||
149885896|NCT03718832|540711158|FG000|Analysis Sample|Participant from treated household|0|||
149885897|NCT03718832|540711159|FG001|Analysis Sample|Participant from treated household|1|||
149885898|NCT03718832|540711158|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
149966114|NCT02655601|541011148|FG002|Overall Study|Adverse Event|0|||
149885899|NCT03718832|540711159|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
149885900|NCT01996241|540711160|FG000|Overall Study|Lost to Follow-up|252|||
149885901|NCT01996241|540711161|FG001|Overall Study|Lost to Follow-up|235|||
149885902|NCT04182490|540711162|FG000|Overall Study|Withdrawal by Subject|3|||
149966115|NCT02655601|541011149|FG003|Overall Study|Adverse Event|1|||
149966116|NCT02655601|541011150|FG004|Overall Study|Adverse Event|1|||
149966117|NCT02655601|541011151|FG005|Overall Study|Adverse Event|0|||
149966118|NCT02655601|541011146|FG000|Overall Study|Physician Decision|0|||
149966119|NCT02655601|541011147|FG001|Overall Study|Physician Decision|0|||
149966120|NCT02655601|541011148|FG002|Overall Study|Physician Decision|0|||
149966121|NCT02655601|541011149|FG003|Overall Study|Physician Decision|0|||
149966122|NCT02655601|541011150|FG004|Overall Study|Physician Decision|1|||
149966123|NCT02655601|541011151|FG005|Overall Study|Physician Decision|1|||
149966124|NCT02655601|541011146|FG000|Overall Study|Withdrawal by Subject|0|||
149966125|NCT02655601|541011147|FG001|Overall Study|Withdrawal by Subject|0|||
149966126|NCT02655601|541011148|FG002|Overall Study|Withdrawal by Subject|0|||
149966127|NCT02655601|541011149|FG003|Overall Study|Withdrawal by Subject|0|||
149966128|NCT02655601|541011150|FG004|Overall Study|Withdrawal by Subject|4|||
149966129|NCT02655601|541011151|FG005|Overall Study|Withdrawal by Subject|8|||
149966130|NCT02655601|541011146|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
149966131|NCT02655601|541011147|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
149966132|NCT02655601|541011148|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
149966133|NCT02655601|541011149|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
149966134|NCT02655601|541011150|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
149966135|NCT02655601|541011151|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
149966136|NCT02796651|541011158|FG000|Overall Study|Adverse Event|6|||
149966137|NCT02796651|541011158|FG000|Overall Study|Lost to Follow-up|1|||
149966138|NCT02796651|541011158|FG000|Overall Study|Withdrawal by Subject|4|||
149966139|NCT02796651|541011158|FG000|Overall Study|Protocol Violation|4|||
149966140|NCT02796651|541011158|FG000|Overall Study|Lack of Efficacy|1|||
149966141|NCT02796651|541011158|FG000|Overall Study|Other|10|||
149966142|NCT04079920|541011162|FG000|Overall Study|Adverse event, not related to study drug|2|||
149966143|NCT04079920|541011162|FG000|Overall Study|Adverse event related to study drug|10|||
149966144|NCT04079920|541011162|FG000|Overall Study|Death|2|||
149966145|NCT04079920|541011162|FG000|Overall Study|Lost to Follow-up|22|||
149966146|NCT04079920|541011162|FG000|Overall Study|Physician Decision|1|||
149966147|NCT04079920|541011162|FG000|Overall Study|Withdrawal by Subject|11|||
149966148|NCT00050011|541011165|FG000|Overall Study|Adverse Event|41|||
149966149|NCT00050011|541011166|FG001|Overall Study|Adverse Event|46|||
149966150|NCT00050011|541011165|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149966151|NCT00050011|541011166|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149966152|NCT00050011|541011165|FG000|Overall Study|Abnormal test procedure results|0|||
149966153|NCT00050011|541011166|FG001|Overall Study|Abnormal test procedure results|1|||
149966154|NCT00050011|541011165|FG000|Overall Study|Lack of Efficacy|16|||
149966155|NCT00050011|541011166|FG001|Overall Study|Lack of Efficacy|21|||
149966156|NCT00050011|541011165|FG000|Overall Study|Participant condition no longer required|1|||
149966157|NCT00050011|541011166|FG001|Overall Study|Participant condition no longer required|0|||
149966158|NCT00050011|541011165|FG000|Overall Study|Protocol Violation|4|||
149966159|NCT00050011|541011166|FG001|Overall Study|Protocol Violation|10|||
149966160|NCT00050011|541011165|FG000|Overall Study|Withdrawal by Subject|34|||
149966161|NCT00050011|541011166|FG001|Overall Study|Withdrawal by Subject|26|||
149966162|NCT00050011|541011165|FG000|Overall Study|Lost to Follow-up|7|||
149966163|NCT00050011|541011166|FG001|Overall Study|Lost to Follow-up|9|||
149966164|NCT00050011|541011165|FG000|Overall Study|Administrative problems|10|||
149966165|NCT00050011|541011166|FG001|Overall Study|Administrative problems|6|||
149966166|NCT00050011|541011165|FG000|Overall Study|Death|7|||
149966167|NCT00050011|541011166|FG001|Overall Study|Death|4|||
149966168|NCT00050011|541011165|FG000|Overall Study|Unknown - Reason is missing|0|||
149966169|NCT00050011|541011166|FG001|Overall Study|Unknown - Reason is missing|2|||
149966170|NCT04197583|541011169|FG000|Overall Study|Study Stent Replacement|34|||
149966171|NCT04197583|541011170|FG001|Overall Study|Study Stent Replacement|8|||
149966172|NCT04197583|541011169|FG000|Overall Study|Lost to Follow-up|14|||
149966173|NCT04197583|541011170|FG001|Overall Study|Lost to Follow-up|3|||
150044121|NCT03214666|541300817|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
150044122|NCT03214666|541300818|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
149966174|NCT04197583|541011169|FG000|Overall Study|Death|3|||
149966175|NCT04197583|541011170|FG001|Overall Study|Death|0|||
149966176|NCT04197583|541011169|FG000|Overall Study|Physician Decision|1|||
149966177|NCT04197583|541011170|FG001|Overall Study|Physician Decision|0|||
150044123|NCT03214666|541300819|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
149885903|NCT04182490|540711163|FG001|Overall Study|Withdrawal by Subject|3|||
149885904|NCT04182490|540711162|FG000|Overall Study|Lost to Follow-up|0|||
149885905|NCT04182490|540711163|FG001|Overall Study|Lost to Follow-up|1|||
149885906|NCT04182490|540711162|FG000|Overall Study|Physician Decision|0|||
149885907|NCT04182490|540711163|FG001|Overall Study|Physician Decision|1|||
149885908|NCT04882241|540711164|FG000|Overall Study|Ongoing in study|46|||
149885909|NCT04882241|540711165|FG001|Overall Study|Ongoing in study|48|||
149885910|NCT04882241|540711166|FG002|Overall Study|Ongoing in study|0|||
149885911|NCT04882241|540711167|FG003|Overall Study|Ongoing in study|0|||
149885912|NCT04882241|540711164|FG000|Overall Study|Death|13|||
149885913|NCT04882241|540711165|FG001|Overall Study|Death|13|||
149885914|NCT04882241|540711166|FG002|Overall Study|Death|0|||
149885915|NCT04882241|540711167|FG003|Overall Study|Death|0|||
149885916|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
149885917|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
149885918|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
149885919|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885920|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
149966178|NCT04197583|541011169|FG000|Overall Study|Withdrawal by Subject|1|||
149966179|NCT04197583|541011170|FG001|Overall Study|Withdrawal by Subject|1|||
149966180|NCT04197583|541011169|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
149966181|NCT04197583|541011170|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
149966182|NCT04197583|541011169|FG000|Overall Study|Screen Failure|0|||
149966183|NCT04197583|541011170|FG001|Overall Study|Screen Failure|20|||
149966184|NCT04134936|541011171|FG000|Overall Study|Adverse Event|3|||
149966185|NCT04134936|541011172|FG001|Overall Study|Adverse Event|2|||
149966186|NCT04134936|541011171|FG000|Overall Study|Withdrawal by Subject|2|||
149966187|NCT04134936|541011172|FG001|Overall Study|Withdrawal by Subject|3|||
149966188|NCT04134936|541011171|FG000|Overall Study|Physician Decision|0|||
149966189|NCT04134936|541011172|FG001|Overall Study|Physician Decision|1|||
149966190|NCT04134936|541011171|FG000|Overall Study|Progressive disease, joined another trial|1|||
149966191|NCT04134936|541011172|FG001|Overall Study|Progressive disease, joined another trial|0|||
149966192|NCT04134936|541011171|FG000|Overall Study|Progressive disease|1|||
149966193|NCT04134936|541011172|FG001|Overall Study|Progressive disease|0|||
149966194|NCT03518060|541011173|FG000|Overall Study|Death|1|||
149966195|NCT03518060|541011173|FG000|Overall Study|Poor adherence|1|||
149966196|NCT03518060|541011173|FG000|Overall Study|Withdrawal of informed consent|2|||
149966197|NCT03518060|541011173|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
149966198|NCT03518060|541011173|FG000|Overall Study|Physician Decision|7|||
149966199|NCT03518060|541011173|FG000|Overall Study|Adverse drug reactions|23|||
149966200|NCT03518060|541011173|FG000|Overall Study|Withdrawal by Subject|25|||
149966201|NCT03518060|541011173|FG000|Overall Study|Lost to Follow-up|13|||
149966202|NCT04629196|541011175|FG000|Overall Study|Subject discontinued study drug|1|||
149966203|NCT04629196|541011176|FG001|Overall Study|Subject discontinued study drug|0|||
149966204|NCT04629196|541011175|FG000|Overall Study|Subject study drug dosing increased|1|||
149966205|NCT04629196|541011176|FG001|Overall Study|Subject study drug dosing increased|1|||
149966206|NCT04629196|541011175|FG000|Overall Study|Withdrawal by Subject|1|||
149966207|NCT04629196|541011176|FG001|Overall Study|Withdrawal by Subject|2|||
149966208|NCT05810597|541011180|FG000|Period 1|Adverse Event|2|||
149966209|NCT05810597|541011181|FG001|Period 1|Adverse Event|0|||
149966210|NCT05810597|541011180|FG000|Period 1|Physician Decision|1|||
149966211|NCT05810597|541011181|FG001|Period 1|Physician Decision|0|||
149966212|NCT01450631|541011182|FG000|Overall Study|Lost to Follow-up|2|||
149966213|NCT01450631|541011183|FG001|Overall Study|Lost to Follow-up|4|||
149966214|NCT01450631|541011182|FG000|Overall Study|Withdrawal by Subject|1|||
149966215|NCT01450631|541011183|FG001|Overall Study|Withdrawal by Subject|0|||
149966216|NCT02061085|541011188|FG000|Overall Study|Adverse Event|8|||
149966217|NCT04903093|541011189|FG000|Overall Study|Withdrawal by Subject|0|||
149966218|NCT04903093|541011190|FG001|Overall Study|Withdrawal by Subject|0|||
149966219|NCT04903093|541011191|FG002|Overall Study|Withdrawal by Subject|0|||
149885921|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
149966220|NCT04903093|541011192|FG003|Overall Study|Withdrawal by Subject|1|||
149966221|NCT04903093|541011193|FG004|Overall Study|Withdrawal by Subject|0|||
149966222|NCT04903093|541011194|FG005|Overall Study|Withdrawal by Subject|0|||
149966223|NCT03204812|541011204|FG000|Overall Study|Adverse Event|3|||
149966224|NCT01027351|541011205|FG000|Overall Study|Withdrawal by Subject|1|||
149966225|NCT01027351|541011206|FG001|Overall Study|Withdrawal by Subject|0|||
149966226|NCT01027351|541011207|FG002|Overall Study|Withdrawal by Subject|1|||
149966227|NCT01027351|541011208|FG003|Overall Study|Withdrawal by Subject|0|||
149966228|NCT01027351|541011209|FG004|Overall Study|Withdrawal by Subject|3|||
149966229|NCT01027351|541011210|FG005|Overall Study|Withdrawal by Subject|5|||
149885922|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885923|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885924|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885925|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885926|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885927|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885928|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885929|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885930|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885931|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885932|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
149885933|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
149885934|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885935|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
149885936|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
149885937|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
149885938|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
149885939|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885940|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885941|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885942|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885943|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885944|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885945|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885946|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885947|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885948|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885949|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
149885950|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
149885951|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
149885952|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
149885953|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
149885954|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
149885955|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
149885956|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885957|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885958|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885959|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885960|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885961|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885962|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885963|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885964|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885965|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885966|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
149885967|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885968|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
150175299|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
150175300|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
149885969|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
149885970|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885971|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
149885972|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
149885973|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885974|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885975|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885976|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885977|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885978|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885979|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885980|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885981|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885982|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885983|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
149885984|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885985|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885986|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
149885987|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
149966230|NCT01027351|541011205|FG000|Overall Study|Lost to Follow-up|1|||
149966231|NCT01027351|541011206|FG001|Overall Study|Lost to Follow-up|1|||
149966232|NCT01027351|541011207|FG002|Overall Study|Lost to Follow-up|0|||
149966233|NCT01027351|541011208|FG003|Overall Study|Lost to Follow-up|1|||
149966234|NCT01027351|541011209|FG004|Overall Study|Lost to Follow-up|6|||
149966235|NCT01027351|541011210|FG005|Overall Study|Lost to Follow-up|0|||
149966236|NCT01027351|541011205|FG000|Overall Study|Inappropriate enrollment|0|||
149966237|NCT01027351|541011206|FG001|Overall Study|Inappropriate enrollment|0|||
149966238|NCT01027351|541011207|FG002|Overall Study|Inappropriate enrollment|0|||
149966239|NCT01027351|541011208|FG003|Overall Study|Inappropriate enrollment|0|||
149966240|NCT01027351|541011209|FG004|Overall Study|Inappropriate enrollment|1|||
149966241|NCT01027351|541011210|FG005|Overall Study|Inappropriate enrollment|0|||
149966242|NCT01027351|541011205|FG000|Overall Study|Protocol Violation|1|||
149966243|NCT01027351|541011206|FG001|Overall Study|Protocol Violation|0|||
149966244|NCT01027351|541011207|FG002|Overall Study|Protocol Violation|0|||
149966245|NCT01027351|541011208|FG003|Overall Study|Protocol Violation|1|||
149885988|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149966246|NCT01027351|541011209|FG004|Overall Study|Protocol Violation|1|||
149966247|NCT01027351|541011210|FG005|Overall Study|Protocol Violation|0|||
149966248|NCT04090749|541011214|FG000|Open Label Pilot|Lost to Follow-up|1|||
149966249|NCT04090749|541011215|FG001|Open Label Pilot|Lost to Follow-up|0|||
149966250|NCT04090749|541011216|FG002|Open Label Pilot|Lost to Follow-up|0|||
149966251|NCT04090749|541011214|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
149966252|NCT04090749|541011215|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
149966253|NCT04090749|541011216|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
149966254|NCT04090749|541011214|FG000|Pilot Trial|Lost to Follow-up|0|||
149966255|NCT04090749|541011215|FG001|Pilot Trial|Lost to Follow-up|1|||
149966256|NCT04090749|541011216|FG002|Pilot Trial|Lost to Follow-up|1|||
149966257|NCT02528305|541011217|FG000|Overall Study|Withdrawal by Subject|1|||
149966258|NCT02528305|541011217|FG000|Overall Study|Adverse Event|1|||
149966259|NCT02528305|541011217|FG000|Overall Study|Physician Decision|1|||
149966260|NCT01852214|541011218|FG000|Period 1|Adverse Event|1|||
149966261|NCT01852214|541011219|FG001|Period 1|Adverse Event|2|||
149966262|NCT01852214|541011218|FG000|Period 1|Withdrawal by Subject|0|||
149966263|NCT01852214|541011219|FG001|Period 1|Withdrawal by Subject|1|||
149966264|NCT01852214|541011218|FG000|Washout Period|Withdrawal by Subject|0|||
149966265|NCT01852214|541011219|FG001|Washout Period|Withdrawal by Subject|1|||
149966266|NCT00421408|541011220|FG000|Overall Study|Lost to Follow-up|30|||
149885989|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885990|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885991|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885992|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885993|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885994|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885995|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885996|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885997|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149966267|NCT00421408|541011221|FG001|Overall Study|Lost to Follow-up|20|||
149966268|NCT00421408|541011220|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
149966269|NCT00421408|541011221|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
149966270|NCT02679274|541011226|FG000|Overall Study|Withdrawal by Subject|1|||
149966271|NCT02679274|541011227|FG001|Overall Study|Withdrawal by Subject|0|||
149966272|NCT00461812|541011228|FG000|Overall Study|study terminated|10|||
149966273|NCT01308788|541011229|FG000|2-year Treatment|medication change by treating physician|4|||
149966274|NCT01308788|541011230|FG001|2-year Treatment|medication change by treating physician|11|||
149966275|NCT00322218|541011231|FG000|Overall Study|Death|3|||
149966276|NCT00322218|541011232|FG001|Overall Study|Death|6|||
149966277|NCT03193437|541011239|FG000|Overall Study|Adverse Event|4|||
149966278|NCT03193437|541011239|FG000|Overall Study|Withdrawal by Subject|2|||
149966279|NCT03193437|541011239|FG000|Overall Study|Disease Progression|2|||
149966280|NCT04976855|541011240|FG000|Part I|Withdrawal by Subject|0|||
149966281|NCT04976855|541011241|FG001|Part I|Withdrawal by Subject|1|||
149966282|NCT04976855|541011242|FG002|Part I|Withdrawal by Subject|0|||
149966283|NCT04976855|541011243|FG003|Part I|Withdrawal by Subject|0|||
149966284|NCT04976855|541011244|FG004|Part I|Withdrawal by Subject|0|||
149966285|NCT04976855|541011245|FG005|Part I|Withdrawal by Subject|0|||
149966286|NCT04976855|541011246|FG006|Part I|Withdrawal by Subject|0|||
149966287|NCT04976855|541011240|FG000|Part II|Adverse Event|0|||
149966288|NCT04976855|541011241|FG001|Part II|Adverse Event|0|||
149966289|NCT04976855|541011242|FG002|Part II|Adverse Event|0|||
149966290|NCT04976855|541011243|FG003|Part II|Adverse Event|1|||
149966291|NCT04976855|541011244|FG004|Part II|Adverse Event|0|||
149966292|NCT04976855|541011245|FG005|Part II|Adverse Event|0|||
149966293|NCT04976855|541011246|FG006|Part II|Adverse Event|0|||
149966294|NCT04976855|541011240|FG000|Part II|Withdrawal by Subject|0|||
149966295|NCT04976855|541011241|FG001|Part II|Withdrawal by Subject|0|||
149966296|NCT04976855|541011242|FG002|Part II|Withdrawal by Subject|0|||
149966297|NCT04976855|541011243|FG003|Part II|Withdrawal by Subject|0|||
149966298|NCT04976855|541011244|FG004|Part II|Withdrawal by Subject|1|||
149966299|NCT04976855|541011245|FG005|Part II|Withdrawal by Subject|0|||
149966300|NCT04976855|541011246|FG006|Part II|Withdrawal by Subject|0|||
149966301|NCT04976855|541011240|FG000|Part II|Lost to Follow-up|0|||
149966302|NCT04976855|541011241|FG001|Part II|Lost to Follow-up|0|||
149966303|NCT04976855|541011242|FG002|Part II|Lost to Follow-up|0|||
149966304|NCT04976855|541011243|FG003|Part II|Lost to Follow-up|0|||
149966305|NCT04976855|541011244|FG004|Part II|Lost to Follow-up|0|||
150044124|NCT03214666|541300820|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
150044125|NCT02500797|541300823|FG000|Overall Study|Cancel (rapid disease progression)|0|||
149966306|NCT04976855|541011245|FG005|Part II|Lost to Follow-up|1|||
149966307|NCT04976855|541011246|FG006|Part II|Lost to Follow-up|0|||
149966308|NCT05487378|541011247|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
149966309|NCT05487378|541011248|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
149966310|NCT05487378|541011247|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
149966311|NCT05487378|541011248|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
149966312|NCT01385995|541011258|FG000|Period 1, 2 Months|Physician Decision|1|||
149885998|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149885999|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149886000|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
149886001|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886002|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886003|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886004|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886005|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
149886006|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886007|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886008|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886009|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886010|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
150044126|NCT02500797|541300824|FG001|Overall Study|Cancel (rapid disease progression)|0|||
150044127|NCT02500797|541300825|FG002|Overall Study|Cancel (rapid disease progression)|0|||
150044128|NCT02500797|541300826|FG003|Overall Study|Cancel (rapid disease progression)|0|||
150044129|NCT02500797|541300827|FG004|Overall Study|Cancel (rapid disease progression)|1|||
150044130|NCT02500797|541300828|FG005|Overall Study|Cancel (rapid disease progression)|1|||
150044131|NCT02500797|541300829|FG006|Overall Study|Cancel (rapid disease progression)|0|||
150044132|NCT02500797|541300830|FG007|Overall Study|Cancel (rapid disease progression)|0|||
150044133|NCT02500797|541300823|FG000|Overall Study|Withdrawal by Subject|1|||
150044134|NCT02500797|541300824|FG001|Overall Study|Withdrawal by Subject|0|||
150044135|NCT02500797|541300825|FG002|Overall Study|Withdrawal by Subject|0|||
150044136|NCT02500797|541300826|FG003|Overall Study|Withdrawal by Subject|0|||
150044137|NCT02500797|541300827|FG004|Overall Study|Withdrawal by Subject|0|||
150044138|NCT02500797|541300828|FG005|Overall Study|Withdrawal by Subject|0|||
150044139|NCT02500797|541300829|FG006|Overall Study|Withdrawal by Subject|0|||
150044140|NCT02500797|541300830|FG007|Overall Study|Withdrawal by Subject|0|||
150044141|NCT00060840|541300831|FG000|Overall Study|Change in surgical plan|2|||
150044142|NCT00060840|541300832|FG001|Overall Study|Change in surgical plan|6|||
150044143|NCT00060840|541300831|FG000|Overall Study|Death|0|||
150044144|NCT00060840|541300832|FG001|Overall Study|Death|1|||
150044145|NCT00060840|541300831|FG000|Overall Study|Withdrawal by Subject|0|||
150044146|NCT00060840|541300832|FG001|Overall Study|Withdrawal by Subject|1|||
150044147|NCT00060840|541300831|FG000|Overall Study|Subinvestigator unavailable|0|||
149886011|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886012|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886013|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
150044148|NCT00060840|541300832|FG001|Overall Study|Subinvestigator unavailable|1|||
150044149|NCT00060840|541300831|FG000|Overall Study|Physician Decision|1|||
150044150|NCT00060840|541300832|FG001|Overall Study|Physician Decision|0|||
149886014|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886015|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886016|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886017|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
149886018|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886019|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
149886020|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886021|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886022|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886023|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886024|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886025|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886026|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886027|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886028|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886029|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886030|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886031|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886032|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886033|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886034|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
149886035|NCT00758524|540711181|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886036|NCT00758524|540711182|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
149886037|NCT00758524|540711183|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886038|NCT00758524|540711184|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886039|NCT00758524|540711185|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149966313|NCT01385995|541011259|FG001|Period 1, 2 Months|Physician Decision|0|||
149966314|NCT02414841|541011260|FG000|Overall Study|Withdrawal by Subject|7|||
149966315|NCT02414841|541011261|FG001|Overall Study|Withdrawal by Subject|5|||
149966316|NCT02414841|541011260|FG000|Overall Study|Lost to Follow-up|13|||
149966317|NCT02414841|541011261|FG001|Overall Study|Lost to Follow-up|6|||
149966318|NCT02414841|541011260|FG000|Overall Study|Death|17|||
149966319|NCT02414841|541011261|FG001|Overall Study|Death|14|||
149966320|NCT02414841|541011260|FG000|Overall Study|Received a Kidney Transplant|13|||
149966321|NCT02414841|541011261|FG001|Overall Study|Received a Kidney Transplant|4|||
149966322|NCT02414841|541011260|FG000|Overall Study|Randomized But Not Treated|6|||
149966323|NCT02414841|541011261|FG001|Overall Study|Randomized But Not Treated|4|||
149966324|NCT00112385|541011262|FG000|Overall Study|Lost to Follow-up|1|||
149966325|NCT00112385|541011263|FG001|Overall Study|Lost to Follow-up|0|||
149966326|NCT00112385|541011262|FG000|Overall Study|Withdrawal by Subject|0|||
149886040|NCT00758524|540711186|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886041|NCT00758524|540711187|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886042|NCT00758524|540711188|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886043|NCT00758524|540711189|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886044|NCT00758524|540711190|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886045|NCT00758524|540711191|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886046|NCT00758524|540711192|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886047|NCT00758524|540711193|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886048|NCT00758524|540711194|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886049|NCT00758524|540711195|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886050|NCT00758524|540711196|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886051|NCT00758524|540711197|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
149886052|NCT00758524|540711181|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886053|NCT00758524|540711182|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886054|NCT00758524|540711183|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886055|NCT00758524|540711184|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886056|NCT00758524|540711185|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886057|NCT00758524|540711186|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886058|NCT00758524|540711187|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886059|NCT00758524|540711188|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886060|NCT00758524|540711189|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
149886061|NCT00758524|540711190|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886062|NCT00758524|540711191|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886063|NCT00758524|540711192|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886064|NCT00758524|540711193|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886065|NCT00758524|540711194|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886066|NCT00758524|540711195|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149966327|NCT00112385|541011263|FG001|Overall Study|Withdrawal by Subject|1|||
149966328|NCT03673176|541013081|FG000|Overall Study|Death prior to intervention|1|||
149966329|NCT03673176|541013081|FG000|Overall Study|Death following intervention|3|||
149966330|NCT03673176|541013081|FG000|Overall Study|Withdrawal by Subject|1|||
149966331|NCT02301897|541013082|FG000|Treatment Course 1|Non-Compliance|0|||
149966332|NCT02301897|541013083|FG001|Treatment Course 1|Non-Compliance|0|||
149966333|NCT02301897|541013084|FG002|Treatment Course 1|Non-Compliance|1|||
149966334|NCT02301897|541013082|FG000|Treatment Course 1|Adverse Event|1|||
149966335|NCT02301897|541013083|FG001|Treatment Course 1|Adverse Event|1|||
149966336|NCT02301897|541013084|FG002|Treatment Course 1|Adverse Event|0|||
149966337|NCT02301897|541013082|FG000|Treatment Course 1|Lost to Follow-up|1|||
149966338|NCT02301897|541013083|FG001|Treatment Course 1|Lost to Follow-up|2|||
149966339|NCT02301897|541013084|FG002|Treatment Course 1|Lost to Follow-up|1|||
149966340|NCT02301897|541013082|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
149966341|NCT02301897|541013083|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
149966342|NCT02301897|541013084|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
149966343|NCT02301897|541013082|FG000|Treatment Course 1|Withdrawal by Subject|0|||
150044151|NCT00060840|541300831|FG000|Overall Study|Other|1|||
149886067|NCT00758524|540711196|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149886068|NCT00758524|540711197|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
149966344|NCT02301897|541013083|FG001|Treatment Course 1|Withdrawal by Subject|0|||
150044152|NCT00060840|541300832|FG001|Overall Study|Other|0|||
150044153|NCT00357006|541300837|FG000|Overall Study|Lost to Follow-up|1|||
149886069|NCT00758524|540711181|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149966345|NCT02301897|541013084|FG002|Treatment Course 1|Withdrawal by Subject|2|||
149966346|NCT02301897|541013082|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
149966347|NCT02301897|541013083|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
150044154|NCT00357006|541300838|FG001|Overall Study|Lost to Follow-up|2|||
150044155|NCT00357006|541300839|FG002|Overall Study|Lost to Follow-up|1|||
150044156|NCT00357006|541300837|FG000|Overall Study|Withdrawal by Subject|1|||
150044157|NCT00357006|541300838|FG001|Overall Study|Withdrawal by Subject|3|||
150044158|NCT00357006|541300839|FG002|Overall Study|Withdrawal by Subject|2|||
150044159|NCT00976560|541300840|FG000|Overall Study|Adverse Event|5|||
150044160|NCT00976560|541300841|FG001|Overall Study|Adverse Event|5|||
150044161|NCT00976560|541300840|FG000|Overall Study|Lack of Efficacy|3|||
150044162|NCT00976560|541300841|FG001|Overall Study|Lack of Efficacy|5|||
150044163|NCT00976560|541300840|FG000|Overall Study|Protocol Violation|1|||
150044164|NCT00976560|541300841|FG001|Overall Study|Protocol Violation|0|||
149886070|NCT00758524|540711182|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886071|NCT00758524|540711183|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886072|NCT00758524|540711184|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886073|NCT00758524|540711185|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886074|NCT00758524|540711186|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886075|NCT00758524|540711187|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
149886076|NCT00758524|540711188|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886077|NCT00758524|540711189|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886078|NCT00758524|540711190|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886079|NCT00758524|540711191|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886080|NCT00758524|540711192|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886081|NCT00758524|540711193|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886082|NCT00758524|540711194|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886083|NCT00758524|540711195|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886084|NCT00758524|540711196|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886085|NCT00758524|540711197|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
149886086|NCT04176250|540711198|FG000|Overall Study|Adverse Event|0|||
149886087|NCT04176250|540711199|FG001|Overall Study|Adverse Event|1|||
149886088|NCT04176250|540711200|FG002|Overall Study|Adverse Event|0|||
149886089|NCT04176250|540711201|FG003|Overall Study|Adverse Event|1|||
149886090|NCT04176250|540711202|FG004|Overall Study|Adverse Event|0|||
149886091|NCT04176250|540711203|FG005|Overall Study|Adverse Event|1|||
149886092|NCT04176250|540711198|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
149886093|NCT04176250|540711199|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
149886094|NCT04176250|540711200|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
149886095|NCT04176250|540711201|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
149886096|NCT04176250|540711202|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
149886097|NCT04176250|540711203|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
149886098|NCT04176250|540711198|FG000|Overall Study|Withdrawal by Subject|0|||
149886099|NCT04176250|540711199|FG001|Overall Study|Withdrawal by Subject|0|||
149886100|NCT04176250|540711200|FG002|Overall Study|Withdrawal by Subject|0|||
149886101|NCT04176250|540711201|FG003|Overall Study|Withdrawal by Subject|0|||
149886102|NCT04176250|540711202|FG004|Overall Study|Withdrawal by Subject|0|||
149886103|NCT04176250|540711203|FG005|Overall Study|Withdrawal by Subject|1|||
149886104|NCT04176250|540711198|FG000|Overall Study|Randomized in error|0|||
149886105|NCT04176250|540711199|FG001|Overall Study|Randomized in error|0|||
149886106|NCT04176250|540711200|FG002|Overall Study|Randomized in error|0|||
149886107|NCT04176250|540711201|FG003|Overall Study|Randomized in error|0|||
149886108|NCT04176250|540711202|FG004|Overall Study|Randomized in error|1|||
149886109|NCT04176250|540711203|FG005|Overall Study|Randomized in error|0|||
149886110|NCT04747470|540711209|FG000|Overall Study|Death|0|||
149886111|NCT04747470|540711210|FG001|Overall Study|Death|3|||
149886112|NCT04747470|540711211|FG002|Overall Study|Death|2|||
149886113|NCT04747470|540711212|FG003|Overall Study|Death|2|||
149886114|NCT04747470|540711213|FG004|Overall Study|Death|2|||
149886115|NCT04747470|540711214|FG005|Overall Study|Death|0|||
149886116|NCT04747470|540711215|FG006|Overall Study|Death|0|||
149886117|NCT04747470|540711216|FG007|Overall Study|Death|0|||
149886118|NCT04747470|540711217|FG008|Overall Study|Death|0|||
150044165|NCT00976560|541300840|FG000|Overall Study|Lost to Follow-up|1|||
150044166|NCT00976560|541300841|FG001|Overall Study|Lost to Follow-up|0|||
150044167|NCT00976560|541300840|FG000|Overall Study|Physician Decision|2|||
149886119|NCT04747470|540711218|FG009|Overall Study|Death|0|||
150044168|NCT00976560|541300841|FG001|Overall Study|Physician Decision|0|||
150044169|NCT00976560|541300840|FG000|Overall Study|Withdrawal by Subject|2|||
150044170|NCT00976560|541300841|FG001|Overall Study|Withdrawal by Subject|3|||
150044171|NCT03710161|541300842|FG000|Overall Study|Study halted due to COVID pandemic|3|||
150044172|NCT03710161|541300843|FG001|Overall Study|Study halted due to COVID pandemic|2|||
150044173|NCT01469377|541300851|FG000|Overall Study|Protocol Deviation|7|||
150044174|NCT01469377|541300852|FG001|Overall Study|Protocol Deviation|10|||
149886120|NCT04747470|540711219|FG010|Overall Study|Death|0|||
149886121|NCT04747470|540711209|FG000|Overall Study|Withdrew Consent|0|||
149886122|NCT04747470|540711210|FG001|Overall Study|Withdrew Consent|0|||
149886123|NCT04747470|540711211|FG002|Overall Study|Withdrew Consent|0|||
149886124|NCT04747470|540711212|FG003|Overall Study|Withdrew Consent|1|||
149886125|NCT04747470|540711213|FG004|Overall Study|Withdrew Consent|0|||
149886126|NCT04747470|540711214|FG005|Overall Study|Withdrew Consent|0|||
149886127|NCT04747470|540711215|FG006|Overall Study|Withdrew Consent|0|||
149886128|NCT04747470|540711216|FG007|Overall Study|Withdrew Consent|0|||
149886129|NCT04747470|540711217|FG008|Overall Study|Withdrew Consent|0|||
149886130|NCT04747470|540711218|FG009|Overall Study|Withdrew Consent|0|||
149886131|NCT04747470|540711219|FG010|Overall Study|Withdrew Consent|0|||
149886132|NCT04747470|540711209|FG000|Overall Study|Study Terminated by Sponsor|0|||
149886133|NCT04747470|540711210|FG001|Overall Study|Study Terminated by Sponsor|0|||
149886134|NCT04747470|540711211|FG002|Overall Study|Study Terminated by Sponsor|1|||
149886135|NCT04747470|540711212|FG003|Overall Study|Study Terminated by Sponsor|0|||
149886136|NCT04747470|540711213|FG004|Overall Study|Study Terminated by Sponsor|2|||
149886137|NCT04747470|540711214|FG005|Overall Study|Study Terminated by Sponsor|0|||
149886138|NCT04747470|540711215|FG006|Overall Study|Study Terminated by Sponsor|0|||
149886139|NCT04747470|540711216|FG007|Overall Study|Study Terminated by Sponsor|0|||
149886140|NCT04747470|540711217|FG008|Overall Study|Study Terminated by Sponsor|0|||
149886141|NCT04747470|540711218|FG009|Overall Study|Study Terminated by Sponsor|0|||
149886142|NCT04747470|540711219|FG010|Overall Study|Study Terminated by Sponsor|0|||
149886143|NCT04720053|540711223|FG000|Overall Study|Lost to Follow-up|12|||
149886144|NCT01960257|540711224|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
149886145|NCT01960257|540711225|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
149886146|NCT01960257|540711226|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
149886147|NCT01960257|540711224|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
149886148|NCT01960257|540711225|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
149886149|NCT01960257|540711226|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
149886150|NCT01960257|540711224|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
149886151|NCT01960257|540711225|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
149886152|NCT01960257|540711226|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
149886153|NCT01942993|540711227|FG000|Overall Study|Lost to Follow-up|1|||
149886154|NCT01942993|540711227|FG000|Overall Study|Physician Decision|1|||
149886155|NCT01350271|540711231|FG000|Overall Study|Lost to Follow-up|21|||
149886156|NCT01350271|540711232|FG001|Overall Study|Lost to Follow-up|17|||
149886157|NCT01350271|540711233|FG002|Overall Study|Lost to Follow-up|26|||
149886158|NCT02906670|540711234|FG000|Cohort 1, QW|Radiological Progression|1|||
149886159|NCT02906670|540711235|FG001|Cohort 1, QW|Radiological Progression|0|||
149886160|NCT02906670|540711236|FG002|Cohort 1, QW|Radiological Progression|0|||
149886161|NCT02906670|540711237|FG003|Cohort 1, QW|Radiological Progression|0|||
149886162|NCT02906670|540711238|FG004|Cohort 1, QW|Radiological Progression|0|||
149886163|NCT02906670|540711239|FG005|Cohort 1, QW|Radiological Progression|0|||
149886164|NCT02906670|540711240|FG006|Cohort 1, QW|Radiological Progression|0|||
149886165|NCT02906670|540711241|FG007|Cohort 1, QW|Radiological Progression|0|||
149886166|NCT02906670|540711242|FG008|Cohort 1, QW|Radiological Progression|0|||
149886167|NCT02906670|540711243|FG009|Cohort 1, QW|Radiological Progression|0|||
149886168|NCT02906670|540711234|FG000|Cohort 2, QW|Radiological Progression|0|||
149886169|NCT02906670|540711235|FG001|Cohort 2, QW|Radiological Progression|1|||
149886170|NCT02906670|540711236|FG002|Cohort 2, QW|Radiological Progression|0|||
149886171|NCT02906670|540711237|FG003|Cohort 2, QW|Radiological Progression|0|||
149886172|NCT02906670|540711238|FG004|Cohort 2, QW|Radiological Progression|0|||
149886173|NCT02906670|540711239|FG005|Cohort 2, QW|Radiological Progression|0|||
149886174|NCT02906670|540711240|FG006|Cohort 2, QW|Radiological Progression|0|||
149886175|NCT02906670|540711241|FG007|Cohort 2, QW|Radiological Progression|0|||
149886176|NCT02906670|540711242|FG008|Cohort 2, QW|Radiological Progression|0|||
149886177|NCT02906670|540711243|FG009|Cohort 2, QW|Radiological Progression|0|||
149886178|NCT02906670|540711234|FG000|Cohort 3, QW|Radiological Progression|0|||
149886179|NCT02906670|540711235|FG001|Cohort 3, QW|Radiological Progression|0|||
149886180|NCT02906670|540711236|FG002|Cohort 3, QW|Radiological Progression|2|||
149886181|NCT02906670|540711237|FG003|Cohort 3, QW|Radiological Progression|0|||
149886182|NCT02906670|540711238|FG004|Cohort 3, QW|Radiological Progression|0|||
149886183|NCT02906670|540711239|FG005|Cohort 3, QW|Radiological Progression|0|||
149886184|NCT02906670|540711240|FG006|Cohort 3, QW|Radiological Progression|0|||
149886185|NCT02906670|540711241|FG007|Cohort 3, QW|Radiological Progression|0|||
149886186|NCT02906670|540711242|FG008|Cohort 3, QW|Radiological Progression|0|||
149886187|NCT02906670|540711243|FG009|Cohort 3, QW|Radiological Progression|0|||
149886188|NCT02906670|540711234|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886189|NCT02906670|540711235|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886190|NCT02906670|540711236|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
149886191|NCT02906670|540711237|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886192|NCT02906670|540711238|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886193|NCT02906670|540711239|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886194|NCT02906670|540711240|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886195|NCT02906670|540711241|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886196|NCT02906670|540711242|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886197|NCT02906670|540711243|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
149886198|NCT02906670|540711234|FG000|Cohort 4, Q2W|Radiological Progression|0|||
149886199|NCT02906670|540711235|FG001|Cohort 4, Q2W|Radiological Progression|0|||
149886200|NCT02906670|540711236|FG002|Cohort 4, Q2W|Radiological Progression|0|||
149886201|NCT02906670|540711237|FG003|Cohort 4, Q2W|Radiological Progression|0|||
149886202|NCT02906670|540711238|FG004|Cohort 4, Q2W|Radiological Progression|0|||
149886203|NCT02906670|540711239|FG005|Cohort 4, Q2W|Radiological Progression|1|||
149886204|NCT02906670|540711240|FG006|Cohort 4, Q2W|Radiological Progression|0|||
149886205|NCT02906670|540711241|FG007|Cohort 4, Q2W|Radiological Progression|0|||
149886206|NCT02906670|540711242|FG008|Cohort 4, Q2W|Radiological Progression|0|||
149886207|NCT02906670|540711243|FG009|Cohort 4, Q2W|Radiological Progression|0|||
149886208|NCT02906670|540711234|FG000|Cohort 4, Q2W|Clinical Progression|0|||
149886209|NCT02906670|540711235|FG001|Cohort 4, Q2W|Clinical Progression|0|||
149886210|NCT02906670|540711236|FG002|Cohort 4, Q2W|Clinical Progression|0|||
149886211|NCT02906670|540711237|FG003|Cohort 4, Q2W|Clinical Progression|0|||
149886212|NCT02906670|540711238|FG004|Cohort 4, Q2W|Clinical Progression|0|||
149886213|NCT02906670|540711239|FG005|Cohort 4, Q2W|Clinical Progression|2|||
149886214|NCT02906670|540711240|FG006|Cohort 4, Q2W|Clinical Progression|0|||
149886215|NCT02906670|540711241|FG007|Cohort 4, Q2W|Clinical Progression|0|||
149886216|NCT02906670|540711242|FG008|Cohort 4, Q2W|Clinical Progression|0|||
149886217|NCT02906670|540711243|FG009|Cohort 4, Q2W|Clinical Progression|0|||
149886218|NCT02906670|540711234|FG000|Cohort 5, Q2W|Radiological Progression|0|||
149886219|NCT02906670|540711235|FG001|Cohort 5, Q2W|Radiological Progression|0|||
149886220|NCT02906670|540711236|FG002|Cohort 5, Q2W|Radiological Progression|0|||
149886221|NCT02906670|540711237|FG003|Cohort 5, Q2W|Radiological Progression|0|||
149886222|NCT02906670|540711238|FG004|Cohort 5, Q2W|Radiological Progression|0|||
149886223|NCT02906670|540711239|FG005|Cohort 5, Q2W|Radiological Progression|0|||
149886224|NCT02906670|540711240|FG006|Cohort 5, Q2W|Radiological Progression|4|||
149886225|NCT02906670|540711241|FG007|Cohort 5, Q2W|Radiological Progression|0|||
149886226|NCT02906670|540711242|FG008|Cohort 5, Q2W|Radiological Progression|0|||
149886227|NCT02906670|540711243|FG009|Cohort 5, Q2W|Radiological Progression|0|||
149886228|NCT02906670|540711234|FG000|Cohort 5, Q2W|Clinical Progression|0|||
149886229|NCT02906670|540711235|FG001|Cohort 5, Q2W|Clinical Progression|0|||
149886230|NCT02906670|540711236|FG002|Cohort 5, Q2W|Clinical Progression|0|||
149886231|NCT02906670|540711237|FG003|Cohort 5, Q2W|Clinical Progression|0|||
149886232|NCT02906670|540711238|FG004|Cohort 5, Q2W|Clinical Progression|0|||
149886233|NCT02906670|540711239|FG005|Cohort 5, Q2W|Clinical Progression|0|||
149886234|NCT02906670|540711240|FG006|Cohort 5, Q2W|Clinical Progression|1|||
149886235|NCT02906670|540711241|FG007|Cohort 5, Q2W|Clinical Progression|0|||
149886236|NCT02906670|540711242|FG008|Cohort 5, Q2W|Clinical Progression|0|||
149886237|NCT02906670|540711243|FG009|Cohort 5, Q2W|Clinical Progression|0|||
149886238|NCT02906670|540711234|FG000|Cohort 5, Q2W|Adverse Event|0|||
149886239|NCT02906670|540711235|FG001|Cohort 5, Q2W|Adverse Event|0|||
149886240|NCT02906670|540711236|FG002|Cohort 5, Q2W|Adverse Event|0|||
149886241|NCT02906670|540711237|FG003|Cohort 5, Q2W|Adverse Event|0|||
149886242|NCT02906670|540711238|FG004|Cohort 5, Q2W|Adverse Event|0|||
149886243|NCT02906670|540711239|FG005|Cohort 5, Q2W|Adverse Event|0|||
149886244|NCT02906670|540711240|FG006|Cohort 5, Q2W|Adverse Event|1|||
149886245|NCT02906670|540711241|FG007|Cohort 5, Q2W|Adverse Event|0|||
149886246|NCT02906670|540711242|FG008|Cohort 5, Q2W|Adverse Event|0|||
149886247|NCT02906670|540711243|FG009|Cohort 5, Q2W|Adverse Event|0|||
149886248|NCT02906670|540711234|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886249|NCT02906670|540711235|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886250|NCT02906670|540711236|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886251|NCT02906670|540711237|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886252|NCT02906670|540711238|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886253|NCT02906670|540711239|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886254|NCT02906670|540711240|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
149886255|NCT02906670|540711241|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886256|NCT02906670|540711242|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886257|NCT02906670|540711243|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
149886258|NCT02906670|540711234|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
149886259|NCT02906670|540711235|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
149886260|NCT02906670|540711236|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
149886261|NCT02906670|540711237|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
149886262|NCT02906670|540711238|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
149886263|NCT02906670|540711239|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
149886264|NCT02906670|540711240|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
149886265|NCT02906670|540711241|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
149886266|NCT02906670|540711242|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
149886267|NCT02906670|540711243|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
149886268|NCT02906670|540711234|FG000|Cohort 5P, Q2W|Adverse Event|0|||
149886269|NCT02906670|540711235|FG001|Cohort 5P, Q2W|Adverse Event|0|||
149886270|NCT02906670|540711236|FG002|Cohort 5P, Q2W|Adverse Event|0|||
149886271|NCT02906670|540711237|FG003|Cohort 5P, Q2W|Adverse Event|0|||
149966348|NCT02301897|541013084|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
149966349|NCT02301897|541013082|FG000|Treatment Course 2|Lost to Follow-up|0|||
149966350|NCT02301897|541013083|FG001|Treatment Course 2|Lost to Follow-up|2|||
149966351|NCT02301897|541013084|FG002|Treatment Course 2|Lost to Follow-up|0|||
149966352|NCT02301897|541013082|FG000|Treatment Course 2|Pregnancy|0|||
149966353|NCT02301897|541013083|FG001|Treatment Course 2|Pregnancy|1|||
149966354|NCT02301897|541013084|FG002|Treatment Course 2|Pregnancy|1|||
149966355|NCT02301897|541013082|FG000|Treatment Course 2|Withdrawal by Subject|0|||
149966356|NCT02301897|541013083|FG001|Treatment Course 2|Withdrawal by Subject|2|||
149966357|NCT02301897|541013084|FG002|Treatment Course 2|Withdrawal by Subject|0|||
149966358|NCT02301897|541013082|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
149966359|NCT02301897|541013083|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
149966360|NCT02301897|541013084|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
149966361|NCT00337168|541013085|FG000|Overall Study|Death|5|||
149966362|NCT00337168|541013085|FG000|Overall Study|Not protocol specified|2|||
149966363|NCT00337168|541013085|FG000|Overall Study|Did not start therapy|1|||
149966364|NCT02378480|541013086|FG000|Overall Study|Physician Decision|1|||
149966365|NCT02378480|541013087|FG001|Overall Study|Physician Decision|1|||
149966366|NCT02378480|541013086|FG000|Overall Study|Death|1|||
149966367|NCT02378480|541013087|FG001|Overall Study|Death|2|||
149966368|NCT02378480|541013086|FG000|Overall Study|Randomized, but Not Treated|6|||
149966369|NCT02378480|541013087|FG001|Overall Study|Randomized, but Not Treated|4|||
149966370|NCT02378480|541013086|FG000|Overall Study|Adverse Event|0|||
149966371|NCT02378480|541013087|FG001|Overall Study|Adverse Event|1|||
149966372|NCT02378480|541013086|FG000|Overall Study|Missed EOT/PTE Visit|1|||
149966373|NCT02378480|541013087|FG001|Overall Study|Missed EOT/PTE Visit|2|||
149966374|NCT02378480|541013086|FG000|Overall Study|Withdrawal by Subject|9|||
149966375|NCT02378480|541013087|FG001|Overall Study|Withdrawal by Subject|4|||
149966376|NCT02378480|541013086|FG000|Overall Study|Lost to Follow-up|10|||
149966377|NCT02378480|541013087|FG001|Overall Study|Lost to Follow-up|18|||
149966378|NCT01217892|541013092|FG000|Overall Study|Adverse Event|1|||
149966379|NCT01217892|541013093|FG001|Overall Study|Adverse Event|1|||
149966380|NCT01217892|541013094|FG002|Overall Study|Adverse Event|1|||
149966381|NCT01217892|541013095|FG003|Overall Study|Adverse Event|0|||
149966382|NCT01217892|541013092|FG000|Overall Study|Withdrawal by Subject|0|||
149966383|NCT01217892|541013093|FG001|Overall Study|Withdrawal by Subject|2|||
149966384|NCT01217892|541013094|FG002|Overall Study|Withdrawal by Subject|1|||
149966385|NCT01217892|541013095|FG003|Overall Study|Withdrawal by Subject|0|||
149966386|NCT01217892|541013092|FG000|Overall Study|Lab value|1|||
149966387|NCT01217892|541013093|FG001|Overall Study|Lab value|0|||
149886272|NCT02906670|540711238|FG004|Cohort 5P, Q2W|Adverse Event|0|||
149886273|NCT02906670|540711239|FG005|Cohort 5P, Q2W|Adverse Event|0|||
149886274|NCT02906670|540711240|FG006|Cohort 5P, Q2W|Adverse Event|0|||
149886275|NCT02906670|540711241|FG007|Cohort 5P, Q2W|Adverse Event|1|||
149966388|NCT01217892|541013094|FG002|Overall Study|Lab value|1|||
149966389|NCT01217892|541013095|FG003|Overall Study|Lab value|0|||
149966390|NCT01217892|541013092|FG000|Overall Study|Subject no longer meets study criteria|5|||
149966391|NCT01217892|541013093|FG001|Overall Study|Subject no longer meets study criteria|2|||
149966392|NCT01217892|541013094|FG002|Overall Study|Subject no longer meets study criteria|4|||
149966393|NCT01217892|541013095|FG003|Overall Study|Subject no longer meets study criteria|8|||
149886276|NCT02906670|540711242|FG008|Cohort 5P, Q2W|Adverse Event|0|||
149886277|NCT02906670|540711243|FG009|Cohort 5P, Q2W|Adverse Event|0|||
149886278|NCT02906670|540711234|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
149886279|NCT02906670|540711235|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
149886280|NCT02906670|540711236|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
149886281|NCT02906670|540711237|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
149886282|NCT02906670|540711238|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
149886283|NCT02906670|540711239|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
149886284|NCT02906670|540711240|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
149886285|NCT02906670|540711241|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
149886286|NCT02906670|540711242|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
149886287|NCT02906670|540711243|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
149886288|NCT02906670|540711234|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
149886289|NCT02906670|540711235|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
149886290|NCT02906670|540711236|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
149886291|NCT02906670|540711237|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
149886292|NCT02906670|540711238|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
149886293|NCT02906670|540711239|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
149886294|NCT02906670|540711240|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
149886295|NCT02906670|540711241|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
149886296|NCT02906670|540711242|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
149886297|NCT02906670|540711243|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
149886298|NCT02906670|540711234|FG000|Cohort 4P, QW|Radiological Progression|0|||
149886299|NCT02906670|540711235|FG001|Cohort 4P, QW|Radiological Progression|0|||
149886300|NCT02906670|540711236|FG002|Cohort 4P, QW|Radiological Progression|0|||
149886301|NCT02906670|540711237|FG003|Cohort 4P, QW|Radiological Progression|3|||
149886302|NCT02906670|540711238|FG004|Cohort 4P, QW|Radiological Progression|0|||
149886303|NCT02906670|540711239|FG005|Cohort 4P, QW|Radiological Progression|0|||
149886304|NCT02906670|540711240|FG006|Cohort 4P, QW|Radiological Progression|0|||
149886305|NCT02906670|540711241|FG007|Cohort 4P, QW|Radiological Progression|0|||
149886306|NCT02906670|540711242|FG008|Cohort 4P, QW|Radiological Progression|0|||
149886307|NCT02906670|540711243|FG009|Cohort 4P, QW|Radiological Progression|0|||
149886308|NCT02906670|540711234|FG000|Cohort 7P, Q2W|Adverse Event|0|||
149886309|NCT02906670|540711235|FG001|Cohort 7P, Q2W|Adverse Event|0|||
149886310|NCT02906670|540711236|FG002|Cohort 7P, Q2W|Adverse Event|0|||
149886311|NCT02906670|540711237|FG003|Cohort 7P, Q2W|Adverse Event|0|||
149886312|NCT02906670|540711238|FG004|Cohort 7P, Q2W|Adverse Event|0|||
149886313|NCT02906670|540711239|FG005|Cohort 7P, Q2W|Adverse Event|0|||
149886314|NCT02906670|540711240|FG006|Cohort 7P, Q2W|Adverse Event|0|||
149886315|NCT02906670|540711241|FG007|Cohort 7P, Q2W|Adverse Event|0|||
149886316|NCT02906670|540711242|FG008|Cohort 7P, Q2W|Adverse Event|0|||
149886317|NCT02906670|540711243|FG009|Cohort 7P, Q2W|Adverse Event|1|||
149886318|NCT02906670|540711234|FG000|Cohort 7P, Q2W|Physician Decision|0|||
149886319|NCT02906670|540711235|FG001|Cohort 7P, Q2W|Physician Decision|0|||
149886320|NCT02906670|540711236|FG002|Cohort 7P, Q2W|Physician Decision|0|||
149886321|NCT02906670|540711237|FG003|Cohort 7P, Q2W|Physician Decision|0|||
149886322|NCT02906670|540711238|FG004|Cohort 7P, Q2W|Physician Decision|0|||
149886323|NCT02906670|540711239|FG005|Cohort 7P, Q2W|Physician Decision|0|||
149886324|NCT02906670|540711240|FG006|Cohort 7P, Q2W|Physician Decision|0|||
149886325|NCT02906670|540711241|FG007|Cohort 7P, Q2W|Physician Decision|0|||
149886326|NCT02906670|540711242|FG008|Cohort 7P, Q2W|Physician Decision|0|||
149886327|NCT02906670|540711243|FG009|Cohort 7P, Q2W|Physician Decision|1|||
149886328|NCT02906670|540711234|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886329|NCT02906670|540711235|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886330|NCT02906670|540711236|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886331|NCT02906670|540711237|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886332|NCT02906670|540711238|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886333|NCT02906670|540711239|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886334|NCT02906670|540711240|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886335|NCT02906670|540711241|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886336|NCT02906670|540711242|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
149886337|NCT02906670|540711243|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
149886338|NCT02906670|540711234|FG000|Cohort 5P, QW|Radiological Progression|0|||
149886339|NCT02906670|540711235|FG001|Cohort 5P, QW|Radiological Progression|0|||
149886340|NCT02906670|540711236|FG002|Cohort 5P, QW|Radiological Progression|0|||
149886341|NCT02906670|540711237|FG003|Cohort 5P, QW|Radiological Progression|0|||
149886342|NCT02906670|540711238|FG004|Cohort 5P, QW|Radiological Progression|3|||
149886343|NCT02906670|540711239|FG005|Cohort 5P, QW|Radiological Progression|0|||
149886344|NCT02906670|540711240|FG006|Cohort 5P, QW|Radiological Progression|0|||
149886345|NCT02906670|540711241|FG007|Cohort 5P, QW|Radiological Progression|0|||
149886346|NCT02906670|540711242|FG008|Cohort 5P, QW|Radiological Progression|0|||
149886347|NCT02906670|540711243|FG009|Cohort 5P, QW|Radiological Progression|0|||
149886348|NCT01349192|540711244|FG000|Overall Study|Protocol Violation|0|||
149886349|NCT01349192|540711245|FG001|Overall Study|Protocol Violation|1|||
149886350|NCT01349192|540711244|FG000|Overall Study|Withdrawal by Subject|0|||
149886351|NCT01349192|540711245|FG001|Overall Study|Withdrawal by Subject|2|||
149886352|NCT01349192|540711244|FG000|Overall Study|Lost to Follow-up|1|||
149886353|NCT01349192|540711245|FG001|Overall Study|Lost to Follow-up|3|||
149886354|NCT01349192|540711244|FG000|Overall Study|Failure to adhere to Protocol|2|||
149886355|NCT01349192|540711245|FG001|Overall Study|Failure to adhere to Protocol|0|||
149886356|NCT03749330|540711246|FG000|Overall Study|Clinicians left work in the CICU|0|||
149886357|NCT03749330|540711247|FG001|Overall Study|Clinicians left work in the CICU|2|||
149966394|NCT01217892|541013092|FG000|Overall Study|Incorrect enrollment|0|||
149966395|NCT01217892|541013093|FG001|Overall Study|Incorrect enrollment|1|||
149966396|NCT01217892|541013094|FG002|Overall Study|Incorrect enrollment|1|||
149966397|NCT01217892|541013095|FG003|Overall Study|Incorrect enrollment|0|||
149966398|NCT01217892|541013092|FG000|Overall Study|Poor/Non-Compliance|0|||
149966399|NCT01217892|541013093|FG001|Overall Study|Poor/Non-Compliance|0|||
149966400|NCT01217892|541013094|FG002|Overall Study|Poor/Non-Compliance|1|||
149966401|NCT01217892|541013095|FG003|Overall Study|Poor/Non-Compliance|0|||
149966402|NCT01052779|541013097|FG000|Overall Study|Adverse Event|1|||
149966403|NCT01052779|541013098|FG001|Overall Study|Adverse Event|4|||
149966404|NCT01052779|541013097|FG000|Overall Study|Withdrawal by Subject|1|||
149966405|NCT01052779|541013098|FG001|Overall Study|Withdrawal by Subject|2|||
149966406|NCT01052779|541013097|FG000|Overall Study|Other-Protocol Violation|1|||
149966407|NCT01052779|541013098|FG001|Overall Study|Other-Protocol Violation|1|||
149966408|NCT01052779|541013097|FG000|Overall Study|Other-Surgery|0|||
149966409|NCT01052779|541013098|FG001|Overall Study|Other-Surgery|2|||
149966410|NCT01052779|541013097|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
149966411|NCT01052779|541013098|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
149966412|NCT03663582|541013099|FG000|Overall Study|Physician Decision|1|||
149966413|NCT01285102|541013100|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
149966414|NCT00557440|541013110|FG000|Treatment Period 1|Adverse Event|0|||
149966415|NCT00557440|541013111|FG001|Treatment Period 1|Adverse Event|0|||
149966416|NCT00557440|541013112|FG002|Treatment Period 1|Adverse Event|1|||
149966417|NCT03524157|541013113|FG000|Overall Study|cytology not readable|0|||
149966418|NCT03524157|541013114|FG001|Overall Study|cytology not readable|0|||
149966419|NCT03524157|541013115|FG002|Overall Study|cytology not readable|1|||
149966420|NCT04507763|541013116|FG000|Overall Study|Participants did not meet entrance criteria|201|||
149966421|NCT03322566|541013117|FG000|Overall Study|Death|34|||
149966422|NCT03322566|541013118|FG001|Overall Study|Death|35|||
149966423|NCT03322566|541013119|FG002|Overall Study|Death|23|||
149966424|NCT03322566|541013117|FG000|Overall Study|Physician Decision|6|||
149966425|NCT03322566|541013118|FG001|Overall Study|Physician Decision|7|||
149966426|NCT03322566|541013119|FG002|Overall Study|Physician Decision|2|||
149966427|NCT03322566|541013117|FG000|Overall Study|Withdrawal by Subject|4|||
149966428|NCT03322566|541013118|FG001|Overall Study|Withdrawal by Subject|3|||
149966429|NCT03322566|541013119|FG002|Overall Study|Withdrawal by Subject|6|||
149966430|NCT03322566|541013117|FG000|Overall Study|Lost to Follow-up|0|||
149966431|NCT03322566|541013118|FG001|Overall Study|Lost to Follow-up|0|||
149966432|NCT03322566|541013119|FG002|Overall Study|Lost to Follow-up|1|||
149966433|NCT03322566|541013117|FG000|Overall Study|Study terminated by sponsor|1|||
149966434|NCT03322566|541013118|FG001|Overall Study|Study terminated by sponsor|0|||
149966435|NCT03322566|541013119|FG002|Overall Study|Study terminated by sponsor|1|||
149966436|NCT02367885|541013120|FG000|Overall Study|Lost to Follow-up|1|||
149966437|NCT02367885|541013121|FG001|Overall Study|Lost to Follow-up|0|||
149886358|NCT03749330|540711248|FG002|Overall Study|Clinicians left work in the CICU|0|||
149886359|NCT03749330|540711249|FG003|Overall Study|Clinicians left work in the CICU|0|||
149886360|NCT03749330|540711250|FG004|Overall Study|Clinicians left work in the CICU|0|||
149966438|NCT02367885|541013122|FG002|Overall Study|Lost to Follow-up|0|||
149966439|NCT02367885|541013120|FG000|Overall Study|Withdrawal by Subject|1|||
149966440|NCT02367885|541013121|FG001|Overall Study|Withdrawal by Subject|0|||
149966441|NCT02367885|541013122|FG002|Overall Study|Withdrawal by Subject|0|||
149966442|NCT01378195|541013123|FG000|Overall Study|Lost to Follow-up|29|||
149966443|NCT01378195|541013124|FG001|Overall Study|Lost to Follow-up|18|||
149966444|NCT03427619|541013125|FG000|Overall Study|Physician Decision|3|||
149966445|NCT03427619|541013125|FG000|Overall Study|Withdrawal by Subject|4|||
149966446|NCT03427619|541013125|FG000|Overall Study|Lost to Follow-up|5|||
149966447|NCT03427619|541013125|FG000|Overall Study|Administrative|4|||
149886361|NCT03749330|540711251|FG005|Overall Study|Clinicians left work in the CICU|0|||
149886362|NCT02038010|540711255|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
149886363|NCT02038010|540711256|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
149886364|NCT02038010|540711257|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
149886365|NCT02038010|540711258|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
149886366|NCT02038010|540711255|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
149886367|NCT02038010|540711256|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
149886368|NCT02038010|540711257|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
149886369|NCT02038010|540711258|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
149886370|NCT02038010|540711255|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
149886371|NCT02038010|540711256|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
149886372|NCT02038010|540711257|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
149886373|NCT02038010|540711258|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
149886374|NCT02038010|540711255|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
150044175|NCT01469377|541300853|FG002|Overall Study|Protocol Deviation|10|||
150044176|NCT01469377|541300851|FG000|Overall Study|Lost to Follow-up|3|||
150044177|NCT01469377|541300852|FG001|Overall Study|Lost to Follow-up|2|||
150044178|NCT01469377|541300853|FG002|Overall Study|Lost to Follow-up|5|||
150044179|NCT01469377|541300851|FG000|Overall Study|Withdrawal of Consent|12|||
150044180|NCT01469377|541300852|FG001|Overall Study|Withdrawal of Consent|14|||
150044181|NCT01469377|541300853|FG002|Overall Study|Withdrawal of Consent|15|||
150044182|NCT01469377|541300851|FG000|Overall Study|Adverse Event|8|||
150044183|NCT01469377|541300852|FG001|Overall Study|Adverse Event|18|||
150044184|NCT01469377|541300853|FG002|Overall Study|Adverse Event|36|||
150044185|NCT01469377|541300851|FG000|Overall Study|Insufficient Therapeutic Response|3|||
150044186|NCT01469377|541300852|FG001|Overall Study|Insufficient Therapeutic Response|4|||
150044187|NCT01469377|541300853|FG002|Overall Study|Insufficient Therapeutic Response|0|||
150044188|NCT01469377|541300851|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150044189|NCT01469377|541300852|FG001|Overall Study|Other Miscellaneous Reasons|0|||
150044190|NCT01469377|541300853|FG002|Overall Study|Other Miscellaneous Reasons|0|||
150044191|NCT04939415|541300854|FG000|Overall Study|Withdrawal by Subject|1|||
150044192|NCT04939415|541300855|FG001|Overall Study|Withdrawal by Subject|3|||
150044193|NCT04939415|541300854|FG000|Overall Study|Lost to Follow-up|0|||
150044194|NCT04939415|541300855|FG001|Overall Study|Lost to Follow-up|2|||
150044195|NCT04308291|541300856|FG000|Run-In Phase|Withdrawal by Subject|4|||
150044196|NCT04308291|541300856|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
150044197|NCT04308291|541300856|FG000|Study Phase 6-M|Physician Decision|2|||
150044198|NCT04308291|541300856|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
150044199|NCT04308291|541300856|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
150044200|NCT04308291|541300856|FG000|Study Phase 12-M|Physician Decision|2|||
150175301|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
150175302|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
150175303|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
150175304|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
150175305|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
150175306|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
150175307|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
150175308|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
150175309|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
150175310|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
150175311|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
150175312|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
150175313|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
150175314|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
150175315|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
150175316|NCT00304031|541778477|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
150175317|NCT00304031|541778478|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
150175318|NCT00304031|541778479|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
150175319|NCT00304031|541778477|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
150175320|NCT00304031|541778478|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
150175321|NCT00304031|541778479|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
150175322|NCT01188655|541778483|FG000|Overall Study|Lack of Efficacy|1|||
150175323|NCT01188655|541778483|FG000|Overall Study|Lost to Follow-up|1|||
150175324|NCT01188655|541778483|FG000|Overall Study|Other|11|||
150175325|NCT00493649|541778484|FG000|Overall Study|Adverse Event|44|||
150175326|NCT00493649|541778484|FG000|Overall Study|Patient Request|21|||
150175327|NCT00493649|541778484|FG000|Overall Study|Investigator Request|2|||
150175328|NCT00493649|541778484|FG000|Overall Study|Disease Progression|1|||
150175329|NCT00493649|541778484|FG000|Overall Study|Lost to Follow-up|1|||
150175330|NCT00493649|541778484|FG000|Overall Study|Other|13|||
150175331|NCT00925899|541778487|FG000|Part 1|Death|1|||
150175332|NCT00925899|541778488|FG001|Part 1|Death|2|||
150175333|NCT00925899|541778487|FG000|Part 1|Withdrawal by Subject|10|||
150175334|NCT00925899|541778488|FG001|Part 1|Withdrawal by Subject|9|||
150175335|NCT00683696|541778489|FG000|Overall Study|Withdrawn due to study closure|337|||
150175336|NCT00683696|541778490|FG001|Overall Study|Withdrawn due to study closure|338|||
150175337|NCT00683696|541778489|FG000|Overall Study|Withdrawn prior to study closure|13|||
150175338|NCT00683696|541778490|FG001|Overall Study|Withdrawn prior to study closure|28|||
150175339|NCT00683696|541778489|FG000|Overall Study|Lost to Follow-up|5|||
150175340|NCT00683696|541778490|FG001|Overall Study|Lost to Follow-up|6|||
150175341|NCT00683696|541778489|FG000|Overall Study|Vital status follow-up only|3|||
150175342|NCT00683696|541778490|FG001|Overall Study|Vital status follow-up only|3|||
150175343|NCT00683696|541778489|FG000|Overall Study|Death|46|||
150175344|NCT00683696|541778490|FG001|Overall Study|Death|30|||
150175345|NCT00089544|541778491|FG000|Overall Study|Ineligible|1|||
150175346|NCT00089544|541778492|FG001|Overall Study|Ineligible|0|||
150175347|NCT02396316|541778495|FG000|Overall Study|Physician Decision|1|||
150175348|NCT02396316|541778496|FG001|Overall Study|Physician Decision|0|||
150175349|NCT02396316|541778495|FG000|Overall Study|Progressive disease|6|||
150175350|NCT02396316|541778496|FG001|Overall Study|Progressive disease|3|||
150175351|NCT02396316|541778495|FG000|Overall Study|Protocol Violation|0|||
149966448|NCT03427619|541013125|FG000|Overall Study|Other|2|||
150175352|NCT02396316|541778496|FG001|Overall Study|Protocol Violation|1|||
150175353|NCT02396316|541778495|FG000|Overall Study|Treatment unblinded|0|||
150175354|NCT02396316|541778496|FG001|Overall Study|Treatment unblinded|1|||
150175355|NCT01823536|541778497|FG000|Overall Study|Lost to Follow-up|1|||
150175356|NCT01823536|541778498|FG001|Overall Study|Lost to Follow-up|0|||
149966449|NCT03427619|541013125|FG000|Overall Study|Unknown or Missing Completion Status|48|||
149966450|NCT05763381|541013128|FG000|Overall Study|Lost to Follow-up|2|||
149966451|NCT05763381|541013129|FG001|Overall Study|Lost to Follow-up|3|||
149966452|NCT05763381|541013128|FG000|Overall Study|Withdrawal by Subject|1|||
149966453|NCT05763381|541013129|FG001|Overall Study|Withdrawal by Subject|2|||
149966454|NCT02853136|541013130|FG000|Wash-out|Adverse Event|0|||
149966455|NCT02853136|541013131|FG001|Wash-out|Adverse Event|0|||
149966456|NCT02853136|541013132|FG002|Wash-out|Adverse Event|0|||
149966457|NCT02853136|541013133|FG003|Wash-out|Adverse Event|1|||
149966458|NCT00841815|541013134|FG000|Washout|Withdrawal by Subject|0|||
149966459|NCT00841815|541013135|FG001|Washout|Withdrawal by Subject|1|||
149966460|NCT00605189|541013139|FG000|Overall Study|Adverse Event|1|||
149966461|NCT00605189|541013140|FG001|Overall Study|Adverse Event|0|||
149966462|NCT00605189|541013141|FG002|Overall Study|Adverse Event|0|||
150175357|NCT01823536|541778499|FG002|Overall Study|Lost to Follow-up|0|||
150175358|NCT01823536|541778500|FG003|Overall Study|Lost to Follow-up|1|||
150175359|NCT01823536|541778501|FG004|Overall Study|Lost to Follow-up|1|||
150175360|NCT01823536|541778502|FG005|Overall Study|Lost to Follow-up|0|||
150175361|NCT01823536|541778497|FG000|Overall Study|Protocol Violation|0|||
149886375|NCT02038010|540711256|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
149886376|NCT02038010|540711257|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
149886377|NCT02038010|540711258|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
149886378|NCT02038010|540711255|FG000|Follow Up|Death|4|||
149886379|NCT02038010|540711256|FG001|Follow Up|Death|3|||
149886380|NCT02038010|540711257|FG002|Follow Up|Death|0|||
149886381|NCT02038010|540711258|FG003|Follow Up|Death|0|||
149886382|NCT02038010|540711255|FG000|Follow Up|Other|3|||
149886383|NCT02038010|540711256|FG001|Follow Up|Other|0|||
149886384|NCT02038010|540711257|FG002|Follow Up|Other|0|||
149886385|NCT02038010|540711258|FG003|Follow Up|Other|0|||
149886386|NCT03908125|540711259|FG000|Overall Study|Withdrawal by Subject|92|||
149886387|NCT03908125|540711259|FG000|Overall Study|Lost to Follow-up|8|||
149886388|NCT02262325|540711260|FG000|Overall Study|Death|16|||
149886389|NCT02262325|540711260|FG000|Overall Study|Lost to Follow-up|1|||
149886390|NCT02815995|540711261|FG000|Overall Study|Disease Progression|3|||
149886391|NCT02815995|540711262|FG001|Overall Study|Disease Progression|7|||
149886392|NCT02815995|540711263|FG002|Overall Study|Disease Progression|2|||
149886393|NCT02815995|540711264|FG003|Overall Study|Disease Progression|4|||
149886394|NCT02815995|540711265|FG004|Overall Study|Disease Progression|3|||
149886395|NCT02815995|540711266|FG005|Overall Study|Disease Progression|9|||
149886396|NCT02815995|540711267|FG006|Overall Study|Disease Progression|3|||
149886397|NCT02815995|540711268|FG007|Overall Study|Disease Progression|1|||
149886398|NCT02815995|540711261|FG000|Overall Study|Adverse Event|1|||
149886399|NCT02815995|540711262|FG001|Overall Study|Adverse Event|2|||
149966463|NCT00605189|541013139|FG000|Overall Study|Other|2|||
149966464|NCT00605189|541013140|FG001|Overall Study|Other|2|||
149966465|NCT00605189|541013141|FG002|Overall Study|Other|0|||
149966466|NCT02697448|541013142|FG000|Overall Study|Protocol Violation|2|||
149966467|NCT02697448|541013143|FG001|Overall Study|Protocol Violation|4|||
149966468|NCT02697448|541013142|FG000|Overall Study|Clinical concerns during ablation|1|||
149966469|NCT02697448|541013143|FG001|Overall Study|Clinical concerns during ablation|1|||
149966470|NCT02697448|541013142|FG000|Overall Study|No data collected|2|||
149966471|NCT02697448|541013143|FG001|Overall Study|No data collected|0|||
149966472|NCT03411044|541013147|FG000|Overall Study|Death|30|||
149966473|NCT03411044|541013147|FG000|Overall Study|Withdrawal by Subject|48|||
150044201|NCT04308291|541300856|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
150044202|NCT01599637|541300861|FG000|Overall Study|administrative problems|0|||
150044203|NCT01599637|541300862|FG001|Overall Study|administrative problems|2|||
150044204|NCT01599637|541300863|FG002|Overall Study|administrative problems|0|||
150044205|NCT01599637|541300861|FG000|Overall Study|Adverse Event|1|||
150044206|NCT01599637|541300862|FG001|Overall Study|Adverse Event|0|||
150044207|NCT01599637|541300863|FG002|Overall Study|Adverse Event|0|||
150044208|NCT00354432|541300865|FG000|Overall Study|Adverse Event|3|||
150044209|NCT00354432|541300866|FG001|Overall Study|Adverse Event|1|||
150044210|NCT00354432|541300867|FG002|Overall Study|Adverse Event|5|||
150044211|NCT00354432|541300868|FG003|Overall Study|Adverse Event|5|||
150044212|NCT00354432|541300865|FG000|Overall Study|Off/Toxicity|3|||
150044213|NCT00354432|541300866|FG001|Overall Study|Off/Toxicity|7|||
150044214|NCT00354432|541300867|FG002|Overall Study|Off/Toxicity|5|||
150044215|NCT00354432|541300868|FG003|Overall Study|Off/Toxicity|5|||
150044216|NCT00802945|541300869|FG000|Overall Study|Death|27|||
150044217|NCT00802945|541300870|FG001|Overall Study|Death|23|||
150044218|NCT00802945|541300869|FG000|Overall Study|Terminated by sponsor|8|||
150044219|NCT00802945|541300870|FG001|Overall Study|Terminated by sponsor|12|||
150044220|NCT03493464|541300871|FG000|Overall Study|Surgery not performed|1|||
150044221|NCT01788358|541302434|FG000|Overall Study|Other|11|||
150044222|NCT01788358|541302434|FG000|Overall Study|Logistical difficulties|1|||
150044223|NCT01788358|541302434|FG000|Overall Study|Lost to Follow-up|5|||
150044224|NCT01788358|541302434|FG000|Overall Study|Protocol Violation|3|||
150044225|NCT01788358|541302434|FG000|Overall Study|Withdrawal by Subject|26|||
150044226|NCT01788358|541302434|FG000|Overall Study|Lack of Efficacy|1|||
150044227|NCT01788358|541302434|FG000|Overall Study|Adverse Event|51|||
150044228|NCT01168219|541302435|FG000|Overall Study|off study before starting treatment|2|||
150044229|NCT01168219|541302435|FG000|Overall Study|withdrew before transplant|1|||
150044230|NCT01168219|541302435|FG000|Overall Study|ineligible due to CML|2|||
149886400|NCT02815995|540711263|FG002|Overall Study|Adverse Event|2|||
149886401|NCT02815995|540711264|FG003|Overall Study|Adverse Event|0|||
149886402|NCT02815995|540711265|FG004|Overall Study|Adverse Event|0|||
149886403|NCT02815995|540711266|FG005|Overall Study|Adverse Event|1|||
149886404|NCT02815995|540711267|FG006|Overall Study|Adverse Event|0|||
149886405|NCT02815995|540711268|FG007|Overall Study|Adverse Event|0|||
149886406|NCT02815995|540711261|FG000|Overall Study|Pregnancy|0|||
149886407|NCT02815995|540711262|FG001|Overall Study|Pregnancy|0|||
149966474|NCT03411044|541013147|FG000|Overall Study|Lost to Follow-up|78|||
149966475|NCT03411044|541013147|FG000|Overall Study|Adverse Event|30|||
149966476|NCT03411044|541013147|FG000|Overall Study|Missing status|4|||
150044231|NCT01413204|541302436|FG000|Overall Study|Adverse Event|1|||
150044232|NCT01413204|541302437|FG001|Overall Study|Adverse Event|2|||
150044233|NCT01413204|541302438|FG002|Overall Study|Adverse Event|2|||
149886408|NCT02815995|540711263|FG002|Overall Study|Pregnancy|0|||
149886409|NCT02815995|540711264|FG003|Overall Study|Pregnancy|0|||
149886410|NCT02815995|540711265|FG004|Overall Study|Pregnancy|0|||
149886411|NCT02815995|540711266|FG005|Overall Study|Pregnancy|0|||
149886412|NCT02815995|540711267|FG006|Overall Study|Pregnancy|1|||
149886413|NCT02815995|540711268|FG007|Overall Study|Pregnancy|0|||
149886414|NCT01071915|540711269|FG000|Overall Study|Adverse Event|3|||
149886415|NCT01071915|540711269|FG000|Overall Study|Physician Decision|2|||
149886416|NCT01071915|540711269|FG000|Overall Study|Withdrawal by Subject|2|||
149886417|NCT01071915|540711269|FG000|Overall Study|Miscellaneous Reasons|2|||
149886418|NCT01125189|540711270|FG000|Treatment Period|Lack of Efficacy|15|||
149886419|NCT01125189|540711271|FG001|Treatment Period|Lack of Efficacy|18|||
149886420|NCT01125189|540711272|FG002|Treatment Period|Lack of Efficacy|25|||
149886421|NCT01125189|540711270|FG000|Treatment Period|Adverse Event|7|||
149886422|NCT01125189|540711271|FG001|Treatment Period|Adverse Event|8|||
149886423|NCT01125189|540711272|FG002|Treatment Period|Adverse Event|8|||
149886424|NCT01125189|540711270|FG000|Treatment Period|Withdrawal by Subject|3|||
149886425|NCT01125189|540711271|FG001|Treatment Period|Withdrawal by Subject|1|||
149886426|NCT01125189|540711272|FG002|Treatment Period|Withdrawal by Subject|1|||
149886427|NCT01125189|540711270|FG000|Treatment Period|Death|1|||
149886428|NCT01125189|540711271|FG001|Treatment Period|Death|0|||
149886429|NCT01125189|540711272|FG002|Treatment Period|Death|0|||
149886430|NCT01125189|540711270|FG000|Treatment Period|Lost to Follow-up|1|||
149886431|NCT01125189|540711271|FG001|Treatment Period|Lost to Follow-up|2|||
149886432|NCT01125189|540711272|FG002|Treatment Period|Lost to Follow-up|1|||
149886433|NCT01125189|540711270|FG000|Treatment Period|Poor compliance/noncompliance|0|||
149886434|NCT01125189|540711271|FG001|Treatment Period|Poor compliance/noncompliance|1|||
149886435|NCT01125189|540711272|FG002|Treatment Period|Poor compliance/noncompliance|0|||
149886436|NCT01125189|540711270|FG000|Treatment Period|Participants requested to discontinue|1|||
149886437|NCT01125189|540711271|FG001|Treatment Period|Participants requested to discontinue|3|||
149886438|NCT01125189|540711272|FG002|Treatment Period|Participants requested to discontinue|4|||
149886439|NCT01125189|540711270|FG000|Treatment Period|Other reasons|1|||
149886440|NCT01125189|540711271|FG001|Treatment Period|Other reasons|1|||
149886441|NCT01125189|540711272|FG002|Treatment Period|Other reasons|0|||
149886442|NCT01125189|540711270|FG000|Treatment Period|Completed 24 week treatment period only|2|||
149886443|NCT01125189|540711271|FG001|Treatment Period|Completed 24 week treatment period only|1|||
149886444|NCT01125189|540711272|FG002|Treatment Period|Completed 24 week treatment period only|2|||
149886445|NCT01125189|540711270|FG000|Follow up Period|Withdrawal by Subject|3|||
149886446|NCT01125189|540711271|FG001|Follow up Period|Withdrawal by Subject|2|||
149886447|NCT01125189|540711272|FG002|Follow up Period|Withdrawal by Subject|5|||
149886448|NCT01125189|540711270|FG000|Follow up Period|Death|1|||
149886449|NCT01125189|540711271|FG001|Follow up Period|Death|0|||
149886450|NCT01125189|540711272|FG002|Follow up Period|Death|0|||
149886451|NCT01125189|540711270|FG000|Follow up Period|Lost to Follow-up|12|||
149966477|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
149886452|NCT01125189|540711271|FG001|Follow up Period|Lost to Follow-up|9|||
149886453|NCT01125189|540711272|FG002|Follow up Period|Lost to Follow-up|6|||
149886454|NCT01125189|540711270|FG000|Follow up Period|Other reasons|4|||
149886455|NCT01125189|540711271|FG001|Follow up Period|Other reasons|4|||
149886456|NCT01125189|540711272|FG002|Follow up Period|Other reasons|5|||
149966478|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
149886457|NCT00114140|540711273|FG000|Overall Study|Protocol Violation|7|||
149886458|NCT00110396|540711274|FG000|Overall Study|Adverse Event|15|||
149886459|NCT00110396|540711274|FG000|Overall Study|Lost to Follow-up|1|||
149886460|NCT00110396|540711274|FG000|Overall Study|Administration of plasmapheresis|1|||
149886461|NCT00110396|540711274|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
149886462|NCT00110396|540711274|FG000|Overall Study|Lack of Efficacy|1|||
149886463|NCT00110396|540711274|FG000|Overall Study|Decided not to continue treatment|1|||
149886464|NCT00110396|540711274|FG000|Overall Study|Patient non-compliance|1|||
149886465|NCT00110396|540711274|FG000|Overall Study|Patient refused to continue|1|||
149886466|NCT00110396|540711274|FG000|Overall Study|Patient refused to participate|1|||
149886467|NCT00110396|540711274|FG000|Overall Study|Patient will|1|||
149886468|NCT00110396|540711274|FG000|Overall Study|Patient's decision|1|||
149886469|NCT00110396|540711274|FG000|Overall Study|Participation in MS vaccine study|1|||
149886470|NCT00110396|540711274|FG000|Overall Study|Pregnancy|1|||
149886471|NCT00110396|540711274|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
149886472|NCT00110396|540711274|FG000|Overall Study|Protocol Violation|2|||
149966479|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
149966480|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
149966481|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
149966482|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
149966483|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
149966484|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
149966485|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
149886473|NCT00110396|540711274|FG000|Overall Study|Patient refused to come back|1|||
149886474|NCT00110396|540711274|FG000|Overall Study|The patient has refused|2|||
150044234|NCT01413204|541302436|FG000|Overall Study|Physician Decision|3|||
149886475|NCT00110396|540711274|FG000|Overall Study|The patient has refused to visit site|1|||
149886476|NCT00110396|540711274|FG000|Overall Study|Patient is to be administered copaxone|1|||
149886477|NCT02414958|540711277|FG000|Overall Study|Adverse Event|6|||
149886478|NCT02414958|540711278|FG001|Overall Study|Adverse Event|6|||
149886479|NCT02414958|540711279|FG002|Overall Study|Adverse Event|3|||
149886480|NCT02414958|540711277|FG000|Overall Study|Protocol Violation|10|||
149886481|NCT02414958|540711278|FG001|Overall Study|Protocol Violation|3|||
149886482|NCT02414958|540711279|FG002|Overall Study|Protocol Violation|1|||
149886483|NCT02414958|540711277|FG000|Overall Study|Lost to Follow-up|7|||
149886484|NCT02414958|540711278|FG001|Overall Study|Lost to Follow-up|4|||
149886485|NCT02414958|540711279|FG002|Overall Study|Lost to Follow-up|0|||
149886486|NCT02414958|540711277|FG000|Overall Study|Withdrawal by Subject|5|||
149886487|NCT02414958|540711278|FG001|Overall Study|Withdrawal by Subject|3|||
149886488|NCT02414958|540711279|FG002|Overall Study|Withdrawal by Subject|5|||
149886489|NCT02414958|540711277|FG000|Overall Study|Other than specified|4|||
149886490|NCT02414958|540711278|FG001|Overall Study|Other than specified|4|||
149886491|NCT02414958|540711279|FG002|Overall Study|Other than specified|5|||
149886492|NCT00245466|540711281|FG000|Overall Study|Adverse Event|2|||
149886493|NCT00245466|540711282|FG001|Overall Study|Adverse Event|8|||
149886494|NCT00245466|540711283|FG002|Overall Study|Adverse Event|4|||
149886495|NCT00245466|540711281|FG000|Overall Study|Low prostate specific antigen suppr|16|||
149886496|NCT00245466|540711282|FG001|Overall Study|Low prostate specific antigen suppr|14|||
149886497|NCT00245466|540711283|FG002|Overall Study|Low prostate specific antigen suppr|5|||
149886498|NCT00245466|540711281|FG000|Overall Study|Insufficient testosterone suppr|12|||
149886499|NCT00245466|540711282|FG001|Overall Study|Insufficient testosterone suppr|12|||
149886500|NCT00245466|540711283|FG002|Overall Study|Insufficient testosterone suppr|21|||
149966486|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
149966487|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
149966488|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
149966489|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
149966490|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
149966491|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
149966492|NCT05014919|541013154|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
149966493|NCT05014919|541013155|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
149966494|NCT05014919|541013156|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
149966495|NCT05014919|541013154|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
149966496|NCT05014919|541013155|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
149966497|NCT05014919|541013156|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
149966498|NCT05014919|541013154|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
149966499|NCT05014919|541013155|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
149966500|NCT05014919|541013156|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
149966501|NCT00680914|541013157|FG000|Overall Study|Consent withdrawal|6|||
149966502|NCT00680914|541013158|FG001|Overall Study|Consent withdrawal|3|||
149966503|NCT00680914|541013157|FG000|Overall Study|Lost to Follow-up|4|||
149966504|NCT00680914|541013158|FG001|Overall Study|Lost to Follow-up|0|||
149966505|NCT00680914|541013157|FG000|Overall Study|serious adverse event (SAE)|0|||
149966506|NCT00680914|541013158|FG001|Overall Study|serious adverse event (SAE)|1|||
149966507|NCT02971163|541013159|FG000|Overall Study|Lost to Follow-up|4|||
149966508|NCT02971163|541013160|FG001|Overall Study|Lost to Follow-up|2|||
149966509|NCT01848457|541013161|FG000|Overall Study|Death|1|||
149966510|NCT01848457|541013162|FG001|Overall Study|Death|0|||
149886501|NCT00245466|540711281|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
149886502|NCT00245466|540711282|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
149886503|NCT00245466|540711283|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
149886504|NCT00245466|540711281|FG000|Overall Study|Withdrawal by Subject|2|||
149886505|NCT00245466|540711282|FG001|Overall Study|Withdrawal by Subject|2|||
149886506|NCT00245466|540711283|FG002|Overall Study|Withdrawal by Subject|1|||
149886507|NCT00245466|540711281|FG000|Overall Study|Lost to Follow-up|3|||
149886508|NCT00245466|540711282|FG001|Overall Study|Lost to Follow-up|0|||
149886509|NCT00245466|540711283|FG002|Overall Study|Lost to Follow-up|0|||
149886510|NCT00245466|540711281|FG000|Overall Study|Disease progression|0|||
149886511|NCT00245466|540711282|FG001|Overall Study|Disease progression|3|||
149886512|NCT00245466|540711283|FG002|Overall Study|Disease progression|1|||
149886513|NCT00245466|540711281|FG000|Overall Study|Protocol Violation|1|||
149886514|NCT00245466|540711282|FG001|Overall Study|Protocol Violation|2|||
149886515|NCT00245466|540711283|FG002|Overall Study|Protocol Violation|2|||
149886516|NCT00245466|540711281|FG000|Overall Study|Death|0|||
149886517|NCT00245466|540711282|FG001|Overall Study|Death|2|||
149886518|NCT00245466|540711283|FG002|Overall Study|Death|0|||
149886519|NCT00245466|540711281|FG000|Overall Study|Administrative reasons|0|||
149886520|NCT00245466|540711282|FG001|Overall Study|Administrative reasons|1|||
149886521|NCT00245466|540711283|FG002|Overall Study|Administrative reasons|0|||
149886522|NCT03885661|540711284|FG000|Overall Study|Withdrawal by Subject|0|||
149886523|NCT03885661|540711285|FG001|Overall Study|Withdrawal by Subject|1|||
149886524|NCT03885661|540711284|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
149886525|NCT03885661|540711285|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
149886526|NCT05064397|540711286|FG000|Overall Study|Adverse Event|4|||
149886527|NCT05064397|540711286|FG000|Overall Study|Lack of Efficacy|12|||
149886528|NCT05064397|540711286|FG000|Overall Study|Withdrawal by Subject|3|||
149886529|NCT05064397|540711286|FG000|Overall Study|Lost to Follow-up|1|||
149886530|NCT05064397|540711286|FG000|Overall Study|Other reasons|3|||
149886531|NCT00344448|540711291|FG000|Screening|Withdrawal by Subject|0|||
149886532|NCT00344448|540711292|FG001|Screening|Withdrawal by Subject|1|||
149886533|NCT00344448|540711291|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
149886534|NCT00344448|540711292|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
149886535|NCT00344448|540711291|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
149886536|NCT00344448|540711292|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
149886537|NCT00344448|540711291|FG000|Open Label|Withdrawal by Subject|1|||
149886538|NCT00344448|540711292|FG001|Open Label|Withdrawal by Subject|1|||
149886539|NCT00344448|540711291|FG000|Open Label|Study terminated|1|||
149886540|NCT00344448|540711292|FG001|Open Label|Study terminated|0|||
150175362|NCT01823536|541778498|FG001|Overall Study|Protocol Violation|1|||
150175363|NCT01823536|541778499|FG002|Overall Study|Protocol Violation|0|||
150175364|NCT01823536|541778500|FG003|Overall Study|Protocol Violation|0|||
150175365|NCT01823536|541778501|FG004|Overall Study|Protocol Violation|0|||
149886541|NCT04194645|540711295|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886542|NCT04194645|540711296|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886543|NCT04194645|540711297|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886544|NCT04194645|540711298|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886545|NCT04194645|540711299|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886546|NCT04194645|540711300|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886547|NCT04194645|540711301|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886548|NCT04194645|540711302|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886549|NCT04194645|540711303|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149966511|NCT01848457|541013163|FG002|Overall Study|Death|0|||
149966512|NCT01848457|541013164|FG003|Overall Study|Death|0|||
149886550|NCT04194645|540711304|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
149886551|NCT04194645|540711305|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886552|NCT04194645|540711306|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886553|NCT04194645|540711307|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886554|NCT04194645|540711308|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886555|NCT04194645|540711309|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
149886556|NCT00996489|540711313|FG000|Overall Study|Device failure|45|||
149886557|NCT00996489|540711313|FG000|Overall Study|Discontinued|116|||
149886558|NCT03541317|540711319|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
149886559|NCT03541317|540711320|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
149886560|NCT03541317|540711321|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
149886561|NCT03541317|540711322|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
149886562|NCT03541317|540711323|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
149886563|NCT03541317|540711324|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
149886564|NCT00111241|540711325|FG000|Overall Study|Lost to Follow-up|1|||
149886565|NCT00111241|540711326|FG001|Overall Study|Lost to Follow-up|0|||
149886566|NCT00111241|540711325|FG000|Overall Study|Withdrawal by Subject|4|||
149886567|NCT00111241|540711326|FG001|Overall Study|Withdrawal by Subject|0|||
149886568|NCT00111241|540711325|FG000|Overall Study|Protocol Violation|9|||
149886569|NCT00111241|540711326|FG001|Overall Study|Protocol Violation|8|||
149886570|NCT00111241|540711325|FG000|Overall Study|Adverse Event|1|||
149886571|NCT00111241|540711326|FG001|Overall Study|Adverse Event|0|||
149886572|NCT01449812|540711339|FG000|Overall Study|Migrated/moved from study area|1|||
149886573|NCT01449812|540711340|FG001|Overall Study|Migrated/moved from study area|0|||
149886574|NCT01449812|540711341|FG002|Overall Study|Migrated/moved from study area|0|||
149886575|NCT01449812|540711339|FG000|Overall Study|Withdrawal by Subject|0|||
149886576|NCT01449812|540711340|FG001|Overall Study|Withdrawal by Subject|0|||
149886577|NCT01449812|540711341|FG002|Overall Study|Withdrawal by Subject|1|||
149886578|NCT01449812|540711339|FG000|Overall Study|Lost to Follow-up|1|||
150175366|NCT01823536|541778502|FG005|Overall Study|Protocol Violation|0|||
150175367|NCT01823536|541778497|FG000|Overall Study|Withdrawal by Subject|1|||
149886579|NCT01449812|540711340|FG001|Overall Study|Lost to Follow-up|0|||
149886580|NCT01449812|540711341|FG002|Overall Study|Lost to Follow-up|0|||
149966513|NCT02940223|541013169|FG000|Overall Study|Failed Requirement|2|||
149966514|NCT02940223|541013170|FG001|Overall Study|Failed Requirement|0|||
149966515|NCT00526799|541013171|FG000|Overall Study|Withdrawal by Subject|1|||
149966516|NCT00526799|541013172|FG001|Overall Study|Withdrawal by Subject|0|||
149966517|NCT00526799|541013171|FG000|Overall Study|Intercurrent Complicating Disease|0|||
149966518|NCT00526799|541013172|FG001|Overall Study|Intercurrent Complicating Disease|1|||
149966519|NCT00522379|541013173|FG000|Overall Study|Adverse Event|12|||
149966520|NCT00522379|541013174|FG001|Overall Study|Adverse Event|15|||
149966521|NCT00522379|541013175|FG002|Overall Study|Adverse Event|12|||
149966522|NCT00522379|541013176|FG003|Overall Study|Adverse Event|5|||
149966523|NCT00522379|541013177|FG004|Overall Study|Adverse Event|17|||
149966524|NCT00522379|541013173|FG000|Overall Study|Lack of Efficacy|3|||
149966525|NCT00522379|541013174|FG001|Overall Study|Lack of Efficacy|0|||
149966526|NCT00522379|541013175|FG002|Overall Study|Lack of Efficacy|2|||
149966527|NCT00522379|541013176|FG003|Overall Study|Lack of Efficacy|2|||
149966528|NCT00522379|541013177|FG004|Overall Study|Lack of Efficacy|7|||
149966529|NCT00522379|541013173|FG000|Overall Study|Withdrawal by Subject|2|||
149966530|NCT00522379|541013174|FG001|Overall Study|Withdrawal by Subject|3|||
149966531|NCT00522379|541013175|FG002|Overall Study|Withdrawal by Subject|1|||
149966532|NCT00522379|541013176|FG003|Overall Study|Withdrawal by Subject|2|||
149966533|NCT00522379|541013177|FG004|Overall Study|Withdrawal by Subject|0|||
149966534|NCT00522379|541013173|FG000|Overall Study|Protocol Violation|1|||
149966535|NCT00522379|541013174|FG001|Overall Study|Protocol Violation|1|||
149966536|NCT00522379|541013175|FG002|Overall Study|Protocol Violation|2|||
149966537|NCT00522379|541013176|FG003|Overall Study|Protocol Violation|0|||
149966538|NCT00522379|541013177|FG004|Overall Study|Protocol Violation|0|||
149966539|NCT00522379|541013173|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
149966540|NCT00522379|541013174|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
149966541|NCT00522379|541013175|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
149966542|NCT00522379|541013176|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
149966543|NCT00522379|541013177|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
149966544|NCT00522379|541013173|FG000|Overall Study|Lost to Follow-up|1|||
149966545|NCT00522379|541013174|FG001|Overall Study|Lost to Follow-up|0|||
149966546|NCT00522379|541013175|FG002|Overall Study|Lost to Follow-up|4|||
149966547|NCT00522379|541013176|FG003|Overall Study|Lost to Follow-up|2|||
149966548|NCT00522379|541013177|FG004|Overall Study|Lost to Follow-up|2|||
149966549|NCT00522379|541013173|FG000|Overall Study|Randomization error|0|||
149966550|NCT00522379|541013174|FG001|Overall Study|Randomization error|0|||
149966551|NCT00522379|541013175|FG002|Overall Study|Randomization error|0|||
149966552|NCT00522379|541013176|FG003|Overall Study|Randomization error|0|||
150044235|NCT01413204|541302437|FG001|Overall Study|Physician Decision|0|||
150044236|NCT01413204|541302438|FG002|Overall Study|Physician Decision|2|||
150175368|NCT01823536|541778498|FG001|Overall Study|Withdrawal by Subject|1|||
150175369|NCT01823536|541778499|FG002|Overall Study|Withdrawal by Subject|0|||
150175370|NCT01823536|541778500|FG003|Overall Study|Withdrawal by Subject|0|||
150044237|NCT01413204|541302436|FG000|Overall Study|Withdrawal by Subject|1|||
150044238|NCT01413204|541302437|FG001|Overall Study|Withdrawal by Subject|4|||
150044239|NCT01413204|541302438|FG002|Overall Study|Withdrawal by Subject|4|||
150044240|NCT01413204|541302436|FG000|Overall Study|Clearly not eligible for the study|0|||
150044241|NCT01413204|541302437|FG001|Overall Study|Clearly not eligible for the study|0|||
150044242|NCT01413204|541302438|FG002|Overall Study|Clearly not eligible for the study|1|||
150044243|NCT01413204|541302436|FG000|Overall Study|Fasting plasma glucose level increased|1|||
150044244|NCT01413204|541302437|FG001|Overall Study|Fasting plasma glucose level increased|0|||
150044245|NCT01413204|541302438|FG002|Overall Study|Fasting plasma glucose level increased|10|||
150044246|NCT00753649|541302439|FG000|Overall Study|Migrated/moved from study area|1|||
150044247|NCT00753649|541302440|FG001|Overall Study|Migrated/moved from study area|0|||
150044248|NCT00753649|541302439|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
150044249|NCT00753649|541302440|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
150044250|NCT00753649|541302439|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
150044251|NCT00753649|541302440|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
150044252|NCT00753649|541302439|FG000|Overall Study|Protocol Violation|2|||
150044253|NCT00753649|541302440|FG001|Overall Study|Protocol Violation|0|||
150044254|NCT04849559|541302442|FG000|Overall Study|Withdrawal by Subject|2|||
150044255|NCT04849559|541302443|FG001|Overall Study|Withdrawal by Subject|1|||
150044256|NCT01662102|541302444|FG000|Overall Study|Sponsor's decision|1|||
150044257|NCT01662102|541302445|FG001|Overall Study|Sponsor's decision|0|||
150044258|NCT02586207|541302446|FG000|Overall Study|Physician Decision|1|||
150044259|NCT02586207|541302446|FG000|Overall Study|Withdrawal by Subject|1|||
149886581|NCT03449446|540711342|FG000|Overall Study|Randomized but Never Treated|0|||
150044260|NCT00392769|541302447|FG000|Overall Study|Clinical Deterioration|9|||
150044261|NCT00392769|541302447|FG000|Overall Study|Adverse Event|1|||
150044262|NCT00439517|541302448|FG000|Overall Study|Subject on treatment|1|||
150044263|NCT00439517|541302449|FG001|Overall Study|Subject on treatment|0|||
150175371|NCT01823536|541778501|FG004|Overall Study|Withdrawal by Subject|0|||
150044264|NCT00439517|541302448|FG000|Overall Study|Subject in survival follow-up|1|||
150044265|NCT00439517|541302449|FG001|Overall Study|Subject in survival follow-up|0|||
150044266|NCT01262989|541302452|FG000|Period 1|Lost to Follow-up|1|||
150044267|NCT01262989|541302453|FG001|Period 1|Lost to Follow-up|1|||
150044268|NCT01262989|541302452|FG000|Period 1|Intercurrent disease|0|||
150175372|NCT01823536|541778502|FG005|Overall Study|Withdrawal by Subject|0|||
149886582|NCT03449446|540711343|FG001|Overall Study|Randomized but Never Treated|0|||
150044269|NCT01262989|541302453|FG001|Period 1|Intercurrent disease|1|||
150044270|NCT01262989|541302452|FG000|Period 1|Positive answer for exclusion criteria|0|||
149886583|NCT03449446|540711344|FG002|Overall Study|Randomized but Never Treated|1|||
149886584|NCT03449446|540711345|FG003|Overall Study|Randomized but Never Treated|1|||
149886585|NCT03449446|540711346|FG004|Overall Study|Randomized but Never Treated|1|||
149886586|NCT03449446|540711347|FG005|Overall Study|Randomized but Never Treated|0|||
149886587|NCT03449446|540711348|FG006|Overall Study|Randomized but Never Treated|0|||
149886588|NCT03449446|540711342|FG000|Overall Study|Unknown Reason|33|||
149886589|NCT03449446|540711343|FG001|Overall Study|Unknown Reason|1|||
149886590|NCT03449446|540711344|FG002|Overall Study|Unknown Reason|1|||
149886591|NCT03449446|540711345|FG003|Overall Study|Unknown Reason|1|||
149886592|NCT03449446|540711346|FG004|Overall Study|Unknown Reason|2|||
149886593|NCT03449446|540711347|FG005|Overall Study|Unknown Reason|2|||
149886594|NCT03449446|540711348|FG006|Overall Study|Unknown Reason|0|||
149886595|NCT03449446|540711342|FG000|Overall Study|Withdrew Consent|1|||
149886596|NCT03449446|540711343|FG001|Overall Study|Withdrew Consent|3|||
149886597|NCT03449446|540711344|FG002|Overall Study|Withdrew Consent|1|||
149886598|NCT03449446|540711345|FG003|Overall Study|Withdrew Consent|4|||
149886599|NCT03449446|540711346|FG004|Overall Study|Withdrew Consent|4|||
149886600|NCT03449446|540711347|FG005|Overall Study|Withdrew Consent|4|||
149886601|NCT03449446|540711348|FG006|Overall Study|Withdrew Consent|1|||
149886602|NCT03449446|540711342|FG000|Overall Study|Adverse Event|1|||
149886603|NCT03449446|540711343|FG001|Overall Study|Adverse Event|2|||
149886604|NCT03449446|540711344|FG002|Overall Study|Adverse Event|1|||
149886605|NCT03449446|540711345|FG003|Overall Study|Adverse Event|0|||
149886606|NCT03449446|540711346|FG004|Overall Study|Adverse Event|0|||
149886607|NCT03449446|540711347|FG005|Overall Study|Adverse Event|2|||
149886608|NCT03449446|540711348|FG006|Overall Study|Adverse Event|0|||
149886609|NCT03449446|540711342|FG000|Overall Study|Lost to Follow-up|0|||
149886610|NCT03449446|540711343|FG001|Overall Study|Lost to Follow-up|0|||
149886611|NCT03449446|540711344|FG002|Overall Study|Lost to Follow-up|2|||
149886612|NCT03449446|540711345|FG003|Overall Study|Lost to Follow-up|1|||
149886613|NCT03449446|540711346|FG004|Overall Study|Lost to Follow-up|3|||
149886614|NCT03449446|540711347|FG005|Overall Study|Lost to Follow-up|0|||
149886615|NCT03449446|540711348|FG006|Overall Study|Lost to Follow-up|0|||
149886616|NCT03449446|540711342|FG000|Overall Study|Investigator's Discretion|0|||
149886617|NCT03449446|540711343|FG001|Overall Study|Investigator's Discretion|1|||
149886618|NCT03449446|540711344|FG002|Overall Study|Investigator's Discretion|1|||
149886619|NCT03449446|540711345|FG003|Overall Study|Investigator's Discretion|2|||
149886620|NCT03449446|540711346|FG004|Overall Study|Investigator's Discretion|0|||
149886621|NCT03449446|540711347|FG005|Overall Study|Investigator's Discretion|0|||
150044271|NCT01262989|541302453|FG001|Period 1|Positive answer for exclusion criteria|1|||
150044272|NCT01262989|541302452|FG000|Period 2|Intercurrent disease|0|||
150044273|NCT01262989|541302453|FG001|Period 2|Intercurrent disease|1|||
150044274|NCT00470275|541302454|FG000|Overall Study|Death|1|||
150044275|NCT00470275|541302454|FG000|Overall Study|Lack of Efficacy|7|||
150044276|NCT00470275|541302454|FG000|Overall Study|Withdrawal by Subject|2|||
150044277|NCT00526071|541302455|FG000|Overall Study|Adverse Event|1|||
150044278|NCT00526071|541302455|FG000|Overall Study|Withdrawal by Subject|1|||
150044279|NCT00526071|541302455|FG000|Overall Study|Lack of Response to Study Drug|4|||
150044280|NCT01339052|541302456|FG000|Overall Study|Disease progression|13|||
149886622|NCT03449446|540711348|FG006|Overall Study|Investigator's Discretion|0|||
149886623|NCT03449446|540711342|FG000|Overall Study|Non Compliance with Study Drug|1|||
149886624|NCT03449446|540711343|FG001|Overall Study|Non Compliance with Study Drug|0|||
149886625|NCT03449446|540711344|FG002|Overall Study|Non Compliance with Study Drug|0|||
149886626|NCT03449446|540711345|FG003|Overall Study|Non Compliance with Study Drug|0|||
149886627|NCT03449446|540711346|FG004|Overall Study|Non Compliance with Study Drug|0|||
149886628|NCT03449446|540711347|FG005|Overall Study|Non Compliance with Study Drug|0|||
149886629|NCT03449446|540711348|FG006|Overall Study|Non Compliance with Study Drug|0|||
149886630|NCT03449446|540711342|FG000|Overall Study|Protocol Violation|0|||
149886631|NCT03449446|540711343|FG001|Overall Study|Protocol Violation|0|||
149886632|NCT03449446|540711344|FG002|Overall Study|Protocol Violation|0|||
149886633|NCT03449446|540711345|FG003|Overall Study|Protocol Violation|0|||
150044281|NCT01339052|541302457|FG001|Overall Study|Disease progression|46|||
150044282|NCT01339052|541302456|FG000|Overall Study|Adverse Event|1|||
149886634|NCT03449446|540711346|FG004|Overall Study|Protocol Violation|1|||
149886635|NCT03449446|540711347|FG005|Overall Study|Protocol Violation|1|||
149886636|NCT03449446|540711348|FG006|Overall Study|Protocol Violation|0|||
149886637|NCT03449446|540711342|FG000|Overall Study|Death|0|||
149886638|NCT03449446|540711343|FG001|Overall Study|Death|0|||
149886639|NCT03449446|540711344|FG002|Overall Study|Death|0|||
149886640|NCT03449446|540711345|FG003|Overall Study|Death|0|||
149886641|NCT03449446|540711346|FG004|Overall Study|Death|1|||
149886642|NCT03449446|540711347|FG005|Overall Study|Death|0|||
149886643|NCT03449446|540711348|FG006|Overall Study|Death|0|||
149886644|NCT02108912|540711353|FG000|Overall Study|Lost to Follow-up|1|||
149886645|NCT02108912|540711354|FG001|Overall Study|Lost to Follow-up|1|||
149886646|NCT02108912|540711353|FG000|Overall Study|lack of transportation|1|||
149886647|NCT02108912|540711354|FG001|Overall Study|lack of transportation|0|||
149886648|NCT02108912|540711353|FG000|Overall Study|high blood pressure|1|||
149886649|NCT02108912|540711354|FG001|Overall Study|high blood pressure|0|||
149886650|NCT05101343|540711360|FG000|Overall Study|Withdrawal by Subject|2|||
149886651|NCT05101343|540711361|FG001|Overall Study|Withdrawal by Subject|1|||
149886652|NCT04779879|540711362|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
149886653|NCT04779879|540711363|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
149886654|NCT04779879|540711364|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
149886655|NCT04779879|540711365|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
149886656|NCT04779879|540711366|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
149886657|NCT04779879|540711367|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
149886658|NCT04779879|540711362|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
149886659|NCT04779879|540711363|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
149886660|NCT04779879|540711364|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
149886661|NCT04779879|540711365|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
149886662|NCT04779879|540711366|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
149886663|NCT04779879|540711367|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
149886664|NCT04779879|540711362|FG000|Part C: Up to Week 36|Death|0|||
149886665|NCT04779879|540711363|FG001|Part C: Up to Week 36|Death|0|||
149886666|NCT04779879|540711364|FG002|Part C: Up to Week 36|Death|0|||
150175373|NCT01823536|541778497|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
150175374|NCT01823536|541778498|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
150175375|NCT01823536|541778499|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
150175376|NCT01823536|541778500|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149886667|NCT04779879|540711365|FG003|Part C: Up to Week 36|Death|0|||
149886668|NCT04779879|540711366|FG004|Part C: Up to Week 36|Death|0|||
149886669|NCT04779879|540711367|FG005|Part C: Up to Week 36|Death|1|||
149886670|NCT04779879|540711362|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
149966553|NCT00522379|541013177|FG004|Overall Study|Randomization error|1|||
149966554|NCT00522379|541013173|FG000|Overall Study|Dispensing error|1|||
149966555|NCT00522379|541013174|FG001|Overall Study|Dispensing error|0|||
149966556|NCT00522379|541013175|FG002|Overall Study|Dispensing error|0|||
149966557|NCT00522379|541013176|FG003|Overall Study|Dispensing error|1|||
149966558|NCT00522379|541013177|FG004|Overall Study|Dispensing error|0|||
149966559|NCT00522379|541013173|FG000|Overall Study|Subject Moved|1|||
149966560|NCT00522379|541013174|FG001|Overall Study|Subject Moved|1|||
149966561|NCT00522379|541013175|FG002|Overall Study|Subject Moved|0|||
149966562|NCT00522379|541013176|FG003|Overall Study|Subject Moved|0|||
149966563|NCT00522379|541013177|FG004|Overall Study|Subject Moved|0|||
149966564|NCT00522379|541013173|FG000|Overall Study|Sponsor Request|0|||
149966565|NCT00522379|541013174|FG001|Overall Study|Sponsor Request|1|||
149966566|NCT00522379|541013175|FG002|Overall Study|Sponsor Request|0|||
149966567|NCT00522379|541013176|FG003|Overall Study|Sponsor Request|0|||
149966568|NCT00522379|541013177|FG004|Overall Study|Sponsor Request|0|||
149966569|NCT00522379|541013173|FG000|Overall Study|Family Problem|0|||
149966570|NCT00522379|541013174|FG001|Overall Study|Family Problem|0|||
149966571|NCT00522379|541013175|FG002|Overall Study|Family Problem|1|||
149966572|NCT00522379|541013176|FG003|Overall Study|Family Problem|0|||
149966573|NCT00522379|541013177|FG004|Overall Study|Family Problem|0|||
149966574|NCT00522379|541013173|FG000|Overall Study|Site Closed|0|||
149966575|NCT00522379|541013174|FG001|Overall Study|Site Closed|0|||
149966576|NCT00522379|541013175|FG002|Overall Study|Site Closed|0|||
149966577|NCT00522379|541013176|FG003|Overall Study|Site Closed|1|||
149966578|NCT00522379|541013177|FG004|Overall Study|Site Closed|0|||
149966579|NCT00522379|541013173|FG000|Overall Study|Subject Withdrawal|0|||
149966580|NCT00522379|541013174|FG001|Overall Study|Subject Withdrawal|0|||
149966581|NCT00522379|541013175|FG002|Overall Study|Subject Withdrawal|0|||
149966582|NCT00522379|541013176|FG003|Overall Study|Subject Withdrawal|1|||
149966583|NCT00522379|541013177|FG004|Overall Study|Subject Withdrawal|0|||
149966584|NCT02298946|541013181|FG000|Overall Study|Did not receive treatment|2|||
149966585|NCT02298946|541013182|FG001|Overall Study|Did not receive treatment|0|||
149966586|NCT02298946|541013181|FG000|Overall Study|Unevaluable|2|||
149966587|NCT02298946|541013182|FG001|Overall Study|Unevaluable|1|||
149966588|NCT00323622|541013183|FG000|Overall Study|Other|30|||
149966589|NCT00323622|541013184|FG001|Overall Study|Other|91|||
150044283|NCT01339052|541302457|FG001|Overall Study|Adverse Event|1|||
150044284|NCT01339052|541302456|FG000|Overall Study|Withdrawal by Subject|0|||
150044285|NCT01339052|541302457|FG001|Overall Study|Withdrawal by Subject|3|||
150044286|NCT01339052|541302456|FG000|Overall Study|Physician Decision|1|||
150044287|NCT01339052|541302457|FG001|Overall Study|Physician Decision|0|||
150044288|NCT02637037|541302458|FG000|Overall Study|Positive drug screen at admission|1|||
150044289|NCT02637037|541302459|FG001|Overall Study|Positive drug screen at admission|0|||
150044290|NCT02637037|541302458|FG000|Overall Study|Withdrawal by Subject|2|||
150044291|NCT02637037|541302459|FG001|Overall Study|Withdrawal by Subject|1|||
150044292|NCT02637037|541302458|FG000|Overall Study|Adverse Event|1|||
150044293|NCT02637037|541302459|FG001|Overall Study|Adverse Event|0|||
150044294|NCT03610269|541302460|FG000|Overall Study|Physician Decision|10|||
150044295|NCT03610269|541302460|FG000|Overall Study|Protocol Violation|1|||
150044296|NCT03610269|541302460|FG000|Overall Study|Unable to draw blood|1|||
150044297|NCT03610269|541302460|FG000|Overall Study|Screen fail|4|||
150044298|NCT00611026|541302463|FG000|Randomized to Double-blind Treatment|Not treated|2|||
150044299|NCT00611026|541302464|FG001|Randomized to Double-blind Treatment|Not treated|1|||
150044300|NCT00611026|541302465|FG002|Randomized to Double-blind Treatment|Not treated|3|||
150044301|NCT00611026|541302463|FG000|Double-blind Treatment Period|Death|1|||
150044302|NCT00611026|541302464|FG001|Double-blind Treatment Period|Death|0|||
150044303|NCT00611026|541302465|FG002|Double-blind Treatment Period|Death|0|||
149886671|NCT04779879|540711363|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
149886672|NCT04779879|540711364|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
149886673|NCT04779879|540711365|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
149886674|NCT04779879|540711366|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
149886675|NCT04779879|540711367|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
149886676|NCT02603146|540713602|FG000|Overall Study|Lost to Follow-up|5|||
149886677|NCT02603146|540713603|FG001|Overall Study|Lost to Follow-up|6|||
149886678|NCT02603146|540713602|FG000|Overall Study|Withdrawal by Subject|8|||
149886679|NCT02603146|540713603|FG001|Overall Study|Withdrawal by Subject|10|||
149886680|NCT02603146|540713602|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
149886681|NCT02603146|540713603|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
149886682|NCT02603146|540713602|FG000|Overall Study|Participant moved|2|||
149886683|NCT02603146|540713603|FG001|Overall Study|Participant moved|0|||
149886684|NCT02603146|540713602|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
149886685|NCT02603146|540713603|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
149886686|NCT01368497|540713607|FG000|Overall Study|Lost to Follow-up|2|||
149886687|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
149886688|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
149886689|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
149886690|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
149886691|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
149886692|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
149886693|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
149886694|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
149886695|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
149886696|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
149886697|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
149886698|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
149886699|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
149886700|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
150044304|NCT00611026|541302463|FG000|Double-blind Treatment Period|Adverse Event|9|||
150044305|NCT00611026|541302464|FG001|Double-blind Treatment Period|Adverse Event|28|||
150044306|NCT00611026|541302465|FG002|Double-blind Treatment Period|Adverse Event|46|||
150044307|NCT00611026|541302463|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
150044308|NCT00611026|541302464|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
150044309|NCT00611026|541302465|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
150044310|NCT00611026|541302463|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
150044311|NCT00611026|541302464|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
150044312|NCT00611026|541302465|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
150044313|NCT00611026|541302463|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
149886701|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
149886702|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
150044314|NCT00611026|541302464|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
150044315|NCT00611026|541302465|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
149886703|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
149886704|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
149886705|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
149886706|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
149886707|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
149886708|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
149886709|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
149886710|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
149886711|NCT01130532|540713608|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
149886712|NCT01130532|540713609|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
149886713|NCT01130532|540713610|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
149886714|NCT01130532|540713611|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
149886715|NCT01130532|540713608|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
149886716|NCT01130532|540713609|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
149886717|NCT01130532|540713610|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
149886718|NCT01130532|540713611|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
149886719|NCT01130532|540713608|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
149886720|NCT01130532|540713609|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
149886721|NCT01130532|540713610|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
149886722|NCT01130532|540713611|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
149886723|NCT01130532|540713608|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
149886724|NCT01130532|540713609|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
149886725|NCT01130532|540713610|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
149886726|NCT01130532|540713611|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
149886727|NCT01130532|540713608|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
149886728|NCT01130532|540713609|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
149886729|NCT01130532|540713610|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
149886730|NCT01130532|540713611|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
149886731|NCT02762929|540713612|FG000|Overall Study|Adverse Event|0|||
149886732|NCT02762929|540713613|FG001|Overall Study|Adverse Event|0|||
149886733|NCT02762929|540713614|FG002|Overall Study|Adverse Event|0|||
149886734|NCT02762929|540713615|FG003|Overall Study|Adverse Event|1|||
149886735|NCT02762929|540713616|FG004|Overall Study|Adverse Event|0|||
149886736|NCT02762929|540713617|FG005|Overall Study|Adverse Event|0|||
149886737|NCT02762929|540713612|FG000|Overall Study|Lost to Follow-up|1|||
149886738|NCT02762929|540713613|FG001|Overall Study|Lost to Follow-up|2|||
149886739|NCT02762929|540713614|FG002|Overall Study|Lost to Follow-up|0|||
149886740|NCT02762929|540713615|FG003|Overall Study|Lost to Follow-up|1|||
149886741|NCT02762929|540713616|FG004|Overall Study|Lost to Follow-up|0|||
149886742|NCT02762929|540713617|FG005|Overall Study|Lost to Follow-up|0|||
149886743|NCT02762929|540713612|FG000|Overall Study|Withdrawal by Subject|0|||
149886744|NCT02762929|540713613|FG001|Overall Study|Withdrawal by Subject|1|||
149886745|NCT02762929|540713614|FG002|Overall Study|Withdrawal by Subject|0|||
149886746|NCT02762929|540713615|FG003|Overall Study|Withdrawal by Subject|0|||
149886747|NCT02762929|540713616|FG004|Overall Study|Withdrawal by Subject|0|||
149886748|NCT02762929|540713617|FG005|Overall Study|Withdrawal by Subject|0|||
149886749|NCT02762929|540713612|FG000|Overall Study|exclusionary medication disclosed late|0|||
149886750|NCT02762929|540713613|FG001|Overall Study|exclusionary medication disclosed late|0|||
149886751|NCT02762929|540713614|FG002|Overall Study|exclusionary medication disclosed late|0|||
149886752|NCT02762929|540713615|FG003|Overall Study|exclusionary medication disclosed late|1|||
149886753|NCT02762929|540713616|FG004|Overall Study|exclusionary medication disclosed late|0|||
149886754|NCT02762929|540713617|FG005|Overall Study|exclusionary medication disclosed late|0|||
149886755|NCT02656303|540713619|FG000|Overall Study|Adverse Event|3|||
149886756|NCT02656303|540713620|FG001|Overall Study|Adverse Event|2|||
149886757|NCT02656303|540713621|FG002|Overall Study|Adverse Event|0|||
149886758|NCT02656303|540713619|FG000|Overall Study|Death|12|||
149886759|NCT02656303|540713620|FG001|Overall Study|Death|4|||
149886760|NCT02656303|540713621|FG002|Overall Study|Death|1|||
149886761|NCT02656303|540713619|FG000|Overall Study|Lack of Efficacy|1|||
149886762|NCT02656303|540713620|FG001|Overall Study|Lack of Efficacy|0|||
149886763|NCT02656303|540713621|FG002|Overall Study|Lack of Efficacy|0|||
149886764|NCT02656303|540713619|FG000|Overall Study|Non-Compliance with Study|1|||
149886765|NCT02656303|540713620|FG001|Overall Study|Non-Compliance with Study|1|||
149886766|NCT02656303|540713621|FG002|Overall Study|Non-Compliance with Study|0|||
149886767|NCT02656303|540713619|FG000|Overall Study|Investigator Decision|2|||
149886768|NCT02656303|540713620|FG001|Overall Study|Investigator Decision|1|||
149886769|NCT02656303|540713621|FG002|Overall Study|Investigator Decision|0|||
149886770|NCT02656303|540713619|FG000|Overall Study|Progressive Disease|25|||
149886771|NCT02656303|540713620|FG001|Overall Study|Progressive Disease|14|||
149966590|NCT00323622|541013185|FG002|Overall Study|Other|4|||
149886772|NCT02656303|540713621|FG002|Overall Study|Progressive Disease|10|||
149886773|NCT02656303|540713619|FG000|Overall Study|Study Terminated by Sponsor|20|||
149886774|NCT02656303|540713620|FG001|Overall Study|Study Terminated by Sponsor|7|||
149886775|NCT02656303|540713621|FG002|Overall Study|Study Terminated by Sponsor|5|||
149886776|NCT02656303|540713619|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
149886777|NCT02656303|540713620|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
149886778|NCT02656303|540713621|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
149886779|NCT02656303|540713619|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
149886780|NCT02656303|540713620|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
149886781|NCT02656303|540713621|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
149886782|NCT02656303|540713619|FG000|Overall Study|Reason not Specified|1|||
149886783|NCT02656303|540713620|FG001|Overall Study|Reason not Specified|1|||
149886784|NCT02656303|540713621|FG002|Overall Study|Reason not Specified|2|||
149886785|NCT03041311|540713624|FG000|Overall Study|Death|39|||
149886786|NCT03041311|540713625|FG001|Overall Study|Death|42|||
149886787|NCT03041311|540713624|FG000|Overall Study|Lost to Follow-up|0|||
149886788|NCT03041311|540713625|FG001|Overall Study|Lost to Follow-up|1|||
149886789|NCT03041311|540713624|FG000|Overall Study|Withdrawal by Subject|8|||
149886790|NCT03041311|540713625|FG001|Overall Study|Withdrawal by Subject|5|||
149886791|NCT03041311|540713624|FG000|Overall Study|Sponsor Terminated Study|2|||
149886792|NCT03041311|540713625|FG001|Overall Study|Sponsor Terminated Study|4|||
149886793|NCT03041311|540713624|FG000|Overall Study|Disease Progression|3|||
149886794|NCT03041311|540713625|FG001|Overall Study|Disease Progression|1|||
149886795|NCT03041311|540713624|FG000|Overall Study|Randomized in error, did not receive drug|2|||
149886796|NCT03041311|540713625|FG001|Overall Study|Randomized in error, did not receive drug|0|||
149886797|NCT01842438|540713626|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
149886798|NCT01842438|540713627|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
149886799|NCT01842438|540713626|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
149886800|NCT01842438|540713627|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
149886801|NCT01842438|540713626|FG000|T2: 6month Follow-up|Death|0|||
149886802|NCT01842438|540713627|FG001|T2: 6month Follow-up|Death|1|||
149886803|NCT00782626|540713631|FG000|Overall Study|Adverse Event|1|||
149886804|NCT00782626|540713631|FG000|Overall Study|Progressive Disease|5|||
149966591|NCT00323622|541013186|FG003|Overall Study|Other|12|||
149966592|NCT00323622|541013187|FG004|Overall Study|Other|32|||
149966593|NCT00323622|541013188|FG005|Overall Study|Other|74|||
149966594|NCT00323622|541013189|FG006|Overall Study|Other|5|||
149966595|NCT00323622|541013190|FG007|Overall Study|Other|13|||
150175377|NCT01823536|541778501|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
150175378|NCT01823536|541778502|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
150175379|NCT01823536|541778497|FG000|Overall Study|Met exclusion criterion No 6|0|||
150175380|NCT01823536|541778498|FG001|Overall Study|Met exclusion criterion No 6|0|||
149966596|NCT00323622|541013183|FG000|Overall Study|Death|1|||
149966597|NCT00323622|541013184|FG001|Overall Study|Death|1|||
149966598|NCT00323622|541013185|FG002|Overall Study|Death|0|||
149966599|NCT00323622|541013186|FG003|Overall Study|Death|0|||
149966600|NCT00323622|541013187|FG004|Overall Study|Death|7|||
149966601|NCT00323622|541013188|FG005|Overall Study|Death|0|||
149966602|NCT00323622|541013189|FG006|Overall Study|Death|0|||
149966603|NCT00323622|541013190|FG007|Overall Study|Death|2|||
149966604|NCT00835354|541013191|FG000|First Intervention|Adverse Event|0|||
150175381|NCT01823536|541778499|FG002|Overall Study|Met exclusion criterion No 6|0|||
149886805|NCT00782626|540713631|FG000|Overall Study|Other Complicating Disease|1|||
149886806|NCT04054765|540713632|FG000|Baseline|Withdrawal by Subject|5|||
149886807|NCT04054765|540713633|FG001|Baseline|Withdrawal by Subject|3|||
149886808|NCT04054765|540713632|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
149886809|NCT04054765|540713633|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
149886810|NCT04054765|540713632|FG000|3-month Follow up|Withdrawal by Subject|0|||
149886811|NCT04054765|540713633|FG001|3-month Follow up|Withdrawal by Subject|3|||
149886812|NCT04054765|540713632|FG000|6-month Follow up|Lost to Follow-up|32|||
149886813|NCT04054765|540713633|FG001|6-month Follow up|Lost to Follow-up|32|||
149886814|NCT02366689|540713640|FG000|Overall Study|Withdrawal by Subject|1|||
149886815|NCT02366689|540713641|FG001|Overall Study|Withdrawal by Subject|0|||
149966605|NCT00835354|541013192|FG001|First Intervention|Adverse Event|1|||
149966606|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
149966607|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149966608|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149886816|NCT02366689|540713642|FG002|Overall Study|Withdrawal by Subject|1|||
149886817|NCT02366689|540713640|FG000|Overall Study|Lost to Follow-up|3|||
149886818|NCT02366689|540713641|FG001|Overall Study|Lost to Follow-up|2|||
149886819|NCT02366689|540713642|FG002|Overall Study|Lost to Follow-up|0|||
149886820|NCT02366689|540713640|FG000|Overall Study|Pregnancy|0|||
149886821|NCT02366689|540713641|FG001|Overall Study|Pregnancy|1|||
149886822|NCT02366689|540713642|FG002|Overall Study|Pregnancy|1|||
149886823|NCT01290068|540713643|FG000|Overall Study|Adverse Event|1|||
149886824|NCT01290068|540713644|FG001|Overall Study|Adverse Event|3|||
149886825|NCT01290068|540713643|FG000|Overall Study|Lost to Follow-up|3|||
149886826|NCT01290068|540713644|FG001|Overall Study|Lost to Follow-up|0|||
149886827|NCT01290068|540713643|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
149886828|NCT01290068|540713644|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
149886829|NCT01290068|540713643|FG000|Overall Study|Other|3|||
149886830|NCT01290068|540713644|FG001|Overall Study|Other|1|||
149886831|NCT04515147|540713647|FG000|Overall Study|Withdrawal by Subject|1|||
149886832|NCT04515147|540713648|FG001|Overall Study|Withdrawal by Subject|0|||
149886833|NCT04515147|540713649|FG002|Overall Study|Withdrawal by Subject|10|||
149886834|NCT04515147|540713650|FG003|Overall Study|Withdrawal by Subject|18|||
149886835|NCT04515147|540713651|FG004|Overall Study|Withdrawal by Subject|1|||
149886836|NCT04515147|540713652|FG005|Overall Study|Withdrawal by Subject|8|||
149886837|NCT04515147|540713647|FG000|Overall Study|Lost to Follow-up|0|||
149886838|NCT04515147|540713648|FG001|Overall Study|Lost to Follow-up|1|||
149886839|NCT04515147|540713649|FG002|Overall Study|Lost to Follow-up|5|||
149886840|NCT04515147|540713650|FG003|Overall Study|Lost to Follow-up|6|||
149966609|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149966610|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149966611|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
149966612|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149966613|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149966614|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149966615|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149966616|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
149966617|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149966618|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149966619|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149966620|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149966621|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
149966622|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
149966623|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
149966624|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
149966625|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
149966626|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
149966627|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
149966628|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
149966629|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
149966630|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
149966631|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
149966632|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
149966633|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
149966634|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
149966635|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
149966636|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
149966637|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149966638|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
150044316|NCT00611026|541302463|FG000|Double-blind Treatment Period|Other|13|||
150044317|NCT00611026|541302464|FG001|Double-blind Treatment Period|Other|20|||
149966639|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149966640|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
150044318|NCT00611026|541302465|FG002|Double-blind Treatment Period|Other|18|||
150044319|NCT02395081|541302466|FG000|Overall Study|Withdrawal by Subject|1|||
150044320|NCT02395081|541302467|FG001|Overall Study|Withdrawal by Subject|1|||
149886841|NCT04515147|540713651|FG004|Overall Study|Lost to Follow-up|2|||
149886842|NCT04515147|540713652|FG005|Overall Study|Lost to Follow-up|1|||
149886843|NCT04515147|540713647|FG000|Overall Study|Adverse Event|0|||
149886844|NCT04515147|540713648|FG001|Overall Study|Adverse Event|0|||
149886845|NCT04515147|540713649|FG002|Overall Study|Adverse Event|0|||
149886846|NCT04515147|540713650|FG003|Overall Study|Adverse Event|2|||
149886847|NCT04515147|540713651|FG004|Overall Study|Adverse Event|0|||
149886848|NCT04515147|540713652|FG005|Overall Study|Adverse Event|0|||
149886849|NCT04515147|540713647|FG000|Overall Study|Miscellaneous|0|||
149886850|NCT04515147|540713648|FG001|Overall Study|Miscellaneous|0|||
149886851|NCT04515147|540713649|FG002|Overall Study|Miscellaneous|0|||
149886852|NCT04515147|540713650|FG003|Overall Study|Miscellaneous|1|||
149886853|NCT04515147|540713651|FG004|Overall Study|Miscellaneous|0|||
149886854|NCT04515147|540713652|FG005|Overall Study|Miscellaneous|1|||
149886855|NCT01068262|540713658|FG000|Overall Study|Adverse Event|2|||
149886856|NCT01068262|540713659|FG001|Overall Study|Adverse Event|0|||
149886857|NCT01068262|540713660|FG002|Overall Study|Adverse Event|1|||
149886858|NCT01068262|540713661|FG003|Overall Study|Adverse Event|0|||
149886859|NCT01068262|540713658|FG000|Overall Study|Protocol Violation|1|||
149886860|NCT01068262|540713659|FG001|Overall Study|Protocol Violation|0|||
149886861|NCT01068262|540713660|FG002|Overall Study|Protocol Violation|0|||
149886862|NCT01068262|540713661|FG003|Overall Study|Protocol Violation|0|||
149886863|NCT01068262|540713658|FG000|Overall Study|Withdrawal by Subject|0|||
149886864|NCT01068262|540713659|FG001|Overall Study|Withdrawal by Subject|1|||
149886865|NCT01068262|540713660|FG002|Overall Study|Withdrawal by Subject|0|||
149886866|NCT01068262|540713661|FG003|Overall Study|Withdrawal by Subject|0|||
149886867|NCT00853099|540713662|FG000|Double-blind Period|Adverse Event|7|||
149886868|NCT00853099|540713663|FG001|Double-blind Period|Adverse Event|9|||
149886869|NCT00853099|540713664|FG002|Double-blind Period|Adverse Event|13|||
149886870|NCT00853099|540713665|FG003|Double-blind Period|Adverse Event|0|||
149886871|NCT00853099|540713662|FG000|Double-blind Period|Withdrawal by Subject|2|||
149886872|NCT00853099|540713663|FG001|Double-blind Period|Withdrawal by Subject|3|||
149886873|NCT00853099|540713664|FG002|Double-blind Period|Withdrawal by Subject|0|||
149886874|NCT00853099|540713665|FG003|Double-blind Period|Withdrawal by Subject|0|||
149886875|NCT00853099|540713662|FG000|Double-blind Period|Lack of Efficacy|14|||
149886876|NCT00853099|540713663|FG001|Double-blind Period|Lack of Efficacy|17|||
149886877|NCT00853099|540713664|FG002|Double-blind Period|Lack of Efficacy|16|||
149886878|NCT00853099|540713665|FG003|Double-blind Period|Lack of Efficacy|0|||
149886879|NCT00853099|540713662|FG000|Double-blind Period|Other|0|||
149886880|NCT00853099|540713663|FG001|Double-blind Period|Other|0|||
149886881|NCT00853099|540713664|FG002|Double-blind Period|Other|1|||
149886882|NCT00853099|540713665|FG003|Double-blind Period|Other|0|||
149886883|NCT00853099|540713662|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
149886884|NCT00853099|540713663|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
149886885|NCT00853099|540713664|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
149886886|NCT00853099|540713665|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
149886887|NCT00853099|540713662|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
149886888|NCT00853099|540713663|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
149886889|NCT00853099|540713664|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
150044321|NCT02395081|541302468|FG002|Overall Study|Withdrawal by Subject|0|||
149886890|NCT00853099|540713665|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
149886891|NCT00853099|540713662|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
149886892|NCT00853099|540713663|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
149886893|NCT00853099|540713664|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
149886894|NCT00853099|540713665|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
149886895|NCT00853099|540713662|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
149886896|NCT00853099|540713663|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
149886897|NCT00853099|540713664|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
149886898|NCT00853099|540713665|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
149886899|NCT00853099|540713662|FG000|Double-blind + Open-label Periods|Other|0|||
149886900|NCT00853099|540713663|FG001|Double-blind + Open-label Periods|Other|0|||
149886901|NCT00853099|540713664|FG002|Double-blind + Open-label Periods|Other|0|||
149886902|NCT00853099|540713665|FG003|Double-blind + Open-label Periods|Other|6|||
149886903|NCT02719184|540713672|FG000|Overall Study|Other than listed|1|||
149886904|NCT02719184|540713673|FG001|Overall Study|Other than listed|12|||
149886905|NCT02719184|540713674|FG002|Overall Study|Other than listed|13|||
149886906|NCT02719184|540713675|FG003|Overall Study|Other than listed|22|||
149886907|NCT02719184|540713676|FG004|Overall Study|Other than listed|9|||
149886908|NCT02719184|540713672|FG000|Overall Study|Withdrawal by Subject|5|||
149886909|NCT02719184|540713673|FG001|Overall Study|Withdrawal by Subject|3|||
149886910|NCT02719184|540713674|FG002|Overall Study|Withdrawal by Subject|6|||
149886911|NCT02719184|540713675|FG003|Overall Study|Withdrawal by Subject|6|||
149886912|NCT02719184|540713676|FG004|Overall Study|Withdrawal by Subject|0|||
149886913|NCT02719184|540713672|FG000|Overall Study|Lost to Follow-up|0|||
149886914|NCT02719184|540713673|FG001|Overall Study|Lost to Follow-up|4|||
149886915|NCT02719184|540713674|FG002|Overall Study|Lost to Follow-up|1|||
149886916|NCT02719184|540713675|FG003|Overall Study|Lost to Follow-up|3|||
149886917|NCT02719184|540713676|FG004|Overall Study|Lost to Follow-up|0|||
149886918|NCT02719184|540713672|FG000|Overall Study|Protocol Violation|0|||
149886919|NCT02719184|540713673|FG001|Overall Study|Protocol Violation|3|||
149886920|NCT02719184|540713674|FG002|Overall Study|Protocol Violation|0|||
149886921|NCT02719184|540713675|FG003|Overall Study|Protocol Violation|2|||
149886922|NCT02719184|540713676|FG004|Overall Study|Protocol Violation|0|||
149886923|NCT02719184|540713672|FG000|Overall Study|Adverse Event|0|||
149886924|NCT02719184|540713673|FG001|Overall Study|Adverse Event|0|||
149886925|NCT02719184|540713674|FG002|Overall Study|Adverse Event|0|||
149886926|NCT02719184|540713675|FG003|Overall Study|Adverse Event|3|||
149886927|NCT02719184|540713676|FG004|Overall Study|Adverse Event|0|||
149886928|NCT00470535|540713681|FG000|Overall Study|Disease Progression|13|||
149886929|NCT00470535|540713681|FG000|Overall Study|Withdrawal by Subject|1|||
149886930|NCT00470535|540713681|FG000|Overall Study|Adverse Event|1|||
149886931|NCT00470535|540713681|FG000|Overall Study|Death|1|||
149886932|NCT00470535|540713681|FG000|Overall Study|Other|2|||
149886933|NCT04108299|540713682|FG000|Overall Study|Not interested in participating|2|||
149966641|NCT01111552|541013197|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
149966642|NCT01111552|541013198|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
149966643|NCT01111552|541013199|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
149966644|NCT01111552|541013200|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
149966645|NCT01111552|541013201|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
149966646|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149966647|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149966648|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149966649|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
149966650|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149966651|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
149966652|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149966653|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
149966654|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
149966655|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149966656|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
149966657|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
149966658|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
149886934|NCT04108299|540713683|FG001|Overall Study|Not interested in participating|1|||
149886935|NCT04108299|540713684|FG002|Overall Study|Not interested in participating|2|||
149886936|NCT04108299|540713685|FG003|Overall Study|Not interested in participating|1|||
149886937|NCT04123405|540713686|FG000|Overall Study|Adverse Event|1|||
149886938|NCT04123405|540713687|FG001|Overall Study|Adverse Event|2|||
149886939|NCT04123405|540713688|FG002|Overall Study|Adverse Event|3|||
149886940|NCT04123405|540713689|FG003|Overall Study|Adverse Event|3|||
149886941|NCT04123405|540713686|FG000|Overall Study|Exclusion criteria met|1|||
149886942|NCT04123405|540713687|FG001|Overall Study|Exclusion criteria met|2|||
149886943|NCT04123405|540713688|FG002|Overall Study|Exclusion criteria met|0|||
149886944|NCT04123405|540713689|FG003|Overall Study|Exclusion criteria met|2|||
149886945|NCT04123405|540713686|FG000|Overall Study|Withdrawal by Subject|1|||
149886946|NCT04123405|540713687|FG001|Overall Study|Withdrawal by Subject|3|||
149886947|NCT04123405|540713688|FG002|Overall Study|Withdrawal by Subject|0|||
149886948|NCT04123405|540713689|FG003|Overall Study|Withdrawal by Subject|2|||
149886949|NCT04123405|540713686|FG000|Overall Study|Contact to subject lost|0|||
149886950|NCT04123405|540713687|FG001|Overall Study|Contact to subject lost|0|||
149886951|NCT04123405|540713688|FG002|Overall Study|Contact to subject lost|0|||
149886952|NCT04123405|540713689|FG003|Overall Study|Contact to subject lost|1|||
149886953|NCT04123405|540713686|FG000|Overall Study|screening failure|1|||
149886954|NCT04123405|540713687|FG001|Overall Study|screening failure|0|||
149886955|NCT04123405|540713688|FG002|Overall Study|screening failure|0|||
149886956|NCT04123405|540713689|FG003|Overall Study|screening failure|0|||
149886957|NCT05024747|540713690|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
149886958|NCT05024747|540713691|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
149886959|NCT05024747|540713690|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
149886960|NCT05024747|540713691|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
149886961|NCT05024747|540713690|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
149886962|NCT05024747|540713691|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
149886963|NCT00662649|540713693|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
149886964|NCT00662649|540713694|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
149886965|NCT00662649|540713695|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
149886966|NCT00662649|540713696|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
149886967|NCT00662649|540713697|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
149886968|NCT00662649|540713693|FG000|Core Study (24 Months)|Adverse Event|22|||
149886969|NCT00662649|540713694|FG001|Core Study (24 Months)|Adverse Event|13|||
149886970|NCT00662649|540713695|FG002|Core Study (24 Months)|Adverse Event|18|||
149886971|NCT00662649|540713696|FG003|Core Study (24 Months)|Adverse Event|0|||
149886972|NCT00662649|540713697|FG004|Core Study (24 Months)|Adverse Event|0|||
149886973|NCT00662649|540713693|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
149886974|NCT00662649|540713694|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
149886975|NCT00662649|540713695|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
149886976|NCT00662649|540713696|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
149886977|NCT00662649|540713697|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
149886978|NCT00662649|540713693|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
149886979|NCT00662649|540713694|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
149886980|NCT00662649|540713695|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
149886981|NCT00662649|540713696|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
149886982|NCT00662649|540713697|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
149886983|NCT00662649|540713693|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
149886984|NCT00662649|540713694|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
149886985|NCT00662649|540713695|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
149886986|NCT00662649|540713696|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
149886987|NCT00662649|540713697|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
150044322|NCT02395081|541302466|FG000|Overall Study|Moved where blood couldn't be collected|4|||
150044323|NCT02395081|541302467|FG001|Overall Study|Moved where blood couldn't be collected|1|||
150044324|NCT02395081|541302468|FG002|Overall Study|Moved where blood couldn't be collected|3|||
150044325|NCT02395081|541302466|FG000|Overall Study|Fetal Loss|2|||
150044326|NCT02395081|541302467|FG001|Overall Study|Fetal Loss|3|||
150044327|NCT02395081|541302468|FG002|Overall Study|Fetal Loss|1|||
150175382|NCT01823536|541778500|FG003|Overall Study|Met exclusion criterion No 6|1|||
150175383|NCT01823536|541778501|FG004|Overall Study|Met exclusion criterion No 6|0|||
149886988|NCT00662649|540713693|FG000|Core Study (24 Months)|Protocol Violation|5|||
149886989|NCT00662649|540713694|FG001|Core Study (24 Months)|Protocol Violation|5|||
149886990|NCT00662649|540713695|FG002|Core Study (24 Months)|Protocol Violation|4|||
149886991|NCT00662649|540713696|FG003|Core Study (24 Months)|Protocol Violation|0|||
149886992|NCT00662649|540713697|FG004|Core Study (24 Months)|Protocol Violation|0|||
149886993|NCT00662649|540713693|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
149886994|NCT00662649|540713694|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
149886995|NCT00662649|540713695|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
149886996|NCT00662649|540713696|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
149886997|NCT00662649|540713697|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
149886998|NCT00662649|540713693|FG000|Core Study (24 Months)|Death|1|||
149886999|NCT00662649|540713694|FG001|Core Study (24 Months)|Death|0|||
149887000|NCT00662649|540713695|FG002|Core Study (24 Months)|Death|2|||
149887001|NCT00662649|540713696|FG003|Core Study (24 Months)|Death|0|||
149887002|NCT00662649|540713697|FG004|Core Study (24 Months)|Death|0|||
149887003|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
150044328|NCT01147874|541302470|FG000|Overall Study|Adverse Event|5|||
149887004|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
149887005|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
149887006|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
149887007|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
149887008|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
149887009|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
149887010|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
149887011|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
149887012|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
149887013|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
149887014|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
149887015|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
149887016|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
149887017|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
149887018|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
149887019|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
149887020|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
149887021|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
149887022|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
149887023|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
149887024|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
149887025|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
149887026|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
149887027|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
149887028|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
149887029|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
149887030|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
149887031|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
149887032|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
149887033|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
150044329|NCT01147874|541302470|FG000|Overall Study|Investigator's Request|1|||
150044330|NCT01147874|541302470|FG000|Overall Study|Lost to Follow-up|25|||
150044331|NCT01147874|541302470|FG000|Overall Study|Other|5|||
150044332|NCT01147874|541302470|FG000|Overall Study|Protocol Violation|5|||
150044333|NCT01147874|541302470|FG000|Overall Study|Sponsor's Decision|2|||
150044334|NCT01147874|541302470|FG000|Overall Study|Withdrawal by Subject|24|||
150044335|NCT02721966|541302475|FG000|Overall Study|Protocol Violation|1|||
150044336|NCT02721966|541302476|FG001|Overall Study|Protocol Violation|0|||
150044337|NCT02721966|541302477|FG002|Overall Study|Protocol Violation|0|||
150044338|NCT02721966|541302478|FG003|Overall Study|Protocol Violation|0|||
150044339|NCT02721966|541302479|FG004|Overall Study|Protocol Violation|0|||
150044340|NCT02721966|541302475|FG000|Overall Study|Withdrawal by Subject|9|||
150044341|NCT02721966|541302476|FG001|Overall Study|Withdrawal by Subject|2|||
150044342|NCT02721966|541302477|FG002|Overall Study|Withdrawal by Subject|3|||
150044343|NCT02721966|541302478|FG003|Overall Study|Withdrawal by Subject|7|||
150044344|NCT02721966|541302479|FG004|Overall Study|Withdrawal by Subject|0|||
150044345|NCT02721966|541302475|FG000|Overall Study|Adverse Event|4|||
150044346|NCT02721966|541302476|FG001|Overall Study|Adverse Event|4|||
150044347|NCT02721966|541302477|FG002|Overall Study|Adverse Event|3|||
150044348|NCT02721966|541302478|FG003|Overall Study|Adverse Event|0|||
150175384|NCT01823536|541778502|FG005|Overall Study|Met exclusion criterion No 6|0|||
149887034|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
149887035|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
149887036|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
149887037|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
150044349|NCT02721966|541302479|FG004|Overall Study|Adverse Event|0|||
150044350|NCT02721966|541302475|FG000|Overall Study|Death|1|||
150044351|NCT02721966|541302476|FG001|Overall Study|Death|0|||
149887038|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
149887039|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
149887040|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
149887041|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
149887042|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
149887043|NCT00662649|540713693|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
149887044|NCT00662649|540713694|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
149887045|NCT00662649|540713695|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
149887046|NCT00662649|540713696|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
149887047|NCT00662649|540713697|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
149966659|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
149887048|NCT01026194|540713698|FG000|Period 1：Double Blind Period|Adverse Event|2|||
149887049|NCT01026194|540713699|FG001|Period 1：Double Blind Period|Adverse Event|1|||
149887050|NCT01026194|540713698|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
149887051|NCT01026194|540713699|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
149887052|NCT01026194|540713698|FG000|Period 1：Double Blind Period|Physician Decision|0|||
149887053|NCT01026194|540713699|FG001|Period 1：Double Blind Period|Physician Decision|4|||
149887054|NCT01026194|540713698|FG000|Period 2：Open-label Period|Adverse Event|4|||
149887055|NCT01026194|540713699|FG001|Period 2：Open-label Period|Adverse Event|5|||
149887056|NCT01026194|540713698|FG000|Period 2：Open-label Period|Physician Decision|3|||
149887057|NCT01026194|540713699|FG001|Period 2：Open-label Period|Physician Decision|1|||
149887058|NCT01026194|540713698|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
149887059|NCT01026194|540713699|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
149887060|NCT04428034|540713702|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
149887061|NCT02556801|540713705|FG000|Overall Study|Lost to Follow-up|1|||
149887062|NCT02556801|540713706|FG001|Overall Study|Lost to Follow-up|0|||
149887063|NCT02556801|540713707|FG002|Overall Study|Lost to Follow-up|2|||
149887064|NCT02556801|540713708|FG003|Overall Study|Lost to Follow-up|0|||
149887065|NCT02556801|540713705|FG000|Overall Study|Withdrawal by Subject|1|||
149887066|NCT02556801|540713706|FG001|Overall Study|Withdrawal by Subject|1|||
149887067|NCT02556801|540713707|FG002|Overall Study|Withdrawal by Subject|1|||
149887068|NCT02556801|540713708|FG003|Overall Study|Withdrawal by Subject|0|||
149887069|NCT02556801|540713705|FG000|Overall Study|Protocol Violation|0|||
149887070|NCT02556801|540713706|FG001|Overall Study|Protocol Violation|3|||
149887071|NCT02556801|540713707|FG002|Overall Study|Protocol Violation|1|||
149887072|NCT02556801|540713708|FG003|Overall Study|Protocol Violation|1|||
149887073|NCT02556801|540713705|FG000|Overall Study|Adverse Event|0|||
149887074|NCT02556801|540713706|FG001|Overall Study|Adverse Event|2|||
149887075|NCT02556801|540713707|FG002|Overall Study|Adverse Event|0|||
149887076|NCT02556801|540713708|FG003|Overall Study|Adverse Event|3|||
149887077|NCT02556801|540713705|FG000|Overall Study|Pregnancy|0|||
149887078|NCT02556801|540713706|FG001|Overall Study|Pregnancy|1|||
149887079|NCT02556801|540713707|FG002|Overall Study|Pregnancy|0|||
149966660|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
149966661|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
149966662|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
150044352|NCT02721966|541302477|FG002|Overall Study|Death|0|||
149887080|NCT02556801|540713708|FG003|Overall Study|Pregnancy|0|||
149887081|NCT02556801|540713705|FG000|Overall Study|Personal reasons patient|0|||
149887082|NCT02556801|540713706|FG001|Overall Study|Personal reasons patient|0|||
149887083|NCT02556801|540713707|FG002|Overall Study|Personal reasons patient|0|||
149887084|NCT02556801|540713708|FG003|Overall Study|Personal reasons patient|1|||
149887085|NCT02515331|540713711|FG000|Overall Study|Withdrawal by Subject|0|||
149887086|NCT02515331|540713712|FG001|Overall Study|Withdrawal by Subject|0|||
149887087|NCT02515331|540713713|FG002|Overall Study|Withdrawal by Subject|1|||
149887088|NCT02515331|540713711|FG000|Overall Study|Protocol deviation|0|||
149887089|NCT02515331|540713712|FG001|Overall Study|Protocol deviation|0|||
149887090|NCT02515331|540713713|FG002|Overall Study|Protocol deviation|3|||
149887091|NCT02515331|540713711|FG000|Overall Study|Adverse Event|2|||
149887092|NCT02515331|540713712|FG001|Overall Study|Adverse Event|0|||
149887093|NCT02515331|540713713|FG002|Overall Study|Adverse Event|0|||
149887094|NCT00124748|540713714|FG000|Overall Study|Adverse Event|8|||
149887095|NCT00124748|540713715|FG001|Overall Study|Adverse Event|39|||
149887096|NCT00124748|540713714|FG000|Overall Study|Abnormal laboratory Value|2|||
149887097|NCT00124748|540713715|FG001|Overall Study|Abnormal laboratory Value|2|||
149887098|NCT00124748|540713714|FG000|Overall Study|Abnormal Procedure|0|||
149887099|NCT00124748|540713715|FG001|Overall Study|Abnormal Procedure|1|||
149887100|NCT00124748|540713714|FG000|Overall Study|Lack of Efficacy|20|||
149887101|NCT00124748|540713715|FG001|Overall Study|Lack of Efficacy|41|||
149887102|NCT00124748|540713714|FG000|Overall Study|No longer requires study drug|1|||
149887103|NCT00124748|540713715|FG001|Overall Study|No longer requires study drug|1|||
149887104|NCT00124748|540713714|FG000|Overall Study|Protocol Violation|3|||
149887105|NCT00124748|540713715|FG001|Overall Study|Protocol Violation|1|||
149887106|NCT00124748|540713714|FG000|Overall Study|Withdrawal by Subject|5|||
149887107|NCT00124748|540713715|FG001|Overall Study|Withdrawal by Subject|15|||
149887108|NCT00124748|540713714|FG000|Overall Study|Lost to Follow-up|2|||
149887109|NCT00124748|540713715|FG001|Overall Study|Lost to Follow-up|7|||
149887110|NCT00124748|540713714|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
149887111|NCT00124748|540713715|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
149887112|NCT00124748|540713714|FG000|Overall Study|Death|1|||
149887113|NCT00124748|540713715|FG001|Overall Study|Death|3|||
149887114|NCT00322712|540713716|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
149887115|NCT01431079|540713723|FG000|Overall Study|Lost to Follow-up|35|||
149887116|NCT01431079|540713724|FG001|Overall Study|Lost to Follow-up|39|||
149887117|NCT01202175|540713725|FG000|Overall Study|Lost to Follow-up|2|||
149887118|NCT01202175|540713725|FG000|Overall Study|Withdrawal by Subject|1|||
149887119|NCT01202175|540713725|FG000|Overall Study|Adverse Event|2|||
149887120|NCT01783886|540713728|FG000|Overall Study|Lost to Follow-up|0|||
149887121|NCT01783886|540713729|FG001|Overall Study|Lost to Follow-up|3|||
149887122|NCT01783886|540713730|FG002|Overall Study|Lost to Follow-up|0|||
149887123|NCT01783886|540713728|FG000|Overall Study|Protocol deviation|0|||
149887124|NCT01783886|540713729|FG001|Overall Study|Protocol deviation|0|||
149887125|NCT01783886|540713730|FG002|Overall Study|Protocol deviation|2|||
149887126|NCT01783886|540713728|FG000|Overall Study|Withdrawal of consent by participant|1|||
149887127|NCT01783886|540713729|FG001|Overall Study|Withdrawal of consent by participant|3|||
149887128|NCT01783886|540713730|FG002|Overall Study|Withdrawal of consent by participant|4|||
149887129|NCT01783886|540713728|FG000|Overall Study|Adverse Event|4|||
149887130|NCT01783886|540713729|FG001|Overall Study|Adverse Event|5|||
149887131|NCT01783886|540713730|FG002|Overall Study|Adverse Event|4|||
149887132|NCT01640249|540713731|FG000|Period 1|Withdrawal by Subject|1|||
149887133|NCT01640249|540713732|FG001|Period 1|Withdrawal by Subject|0|||
149887134|NCT01640249|540713733|FG002|Period 1|Withdrawal by Subject|0|||
149887135|NCT01640249|540713734|FG003|Period 1|Withdrawal by Subject|0|||
149887136|NCT01640249|540713735|FG004|Period 1|Withdrawal by Subject|0|||
149887137|NCT01640249|540713736|FG005|Period 1|Withdrawal by Subject|1|||
149887138|NCT01640249|540713737|FG006|Period 1|Withdrawal by Subject|0|||
149887139|NCT02273388|540713738|FG000|Overall Study|Adverse Event|0|||
149887140|NCT02273388|540713739|FG001|Overall Study|Adverse Event|0|||
149887141|NCT02273388|540713740|FG002|Overall Study|Adverse Event|0|||
149887142|NCT02273388|540713741|FG003|Overall Study|Adverse Event|0|||
149887143|NCT02273388|540713742|FG004|Overall Study|Adverse Event|0|||
149887144|NCT02273388|540713743|FG005|Overall Study|Adverse Event|0|||
149887145|NCT02273388|540713744|FG006|Overall Study|Adverse Event|1|||
149887146|NCT02273388|540713745|FG007|Overall Study|Adverse Event|2|||
149887147|NCT02273388|540713746|FG008|Overall Study|Adverse Event|0|||
149887148|NCT02273388|540713747|FG009|Overall Study|Adverse Event|0|||
149887149|NCT02273388|540713748|FG010|Overall Study|Adverse Event|0|||
149887150|NCT02273388|540713749|FG011|Overall Study|Adverse Event|0|||
149887151|NCT02273388|540713738|FG000|Overall Study|Adverse Event study disease worse|4|||
149887152|NCT02273388|540713739|FG001|Overall Study|Adverse Event study disease worse|3|||
149887153|NCT02273388|540713740|FG002|Overall Study|Adverse Event study disease worse|3|||
149887154|NCT02273388|540713741|FG003|Overall Study|Adverse Event study disease worse|2|||
149887155|NCT02273388|540713742|FG004|Overall Study|Adverse Event study disease worse|4|||
149887156|NCT02273388|540713743|FG005|Overall Study|Adverse Event study disease worse|3|||
149887157|NCT02273388|540713744|FG006|Overall Study|Adverse Event study disease worse|14|||
149887158|NCT02273388|540713745|FG007|Overall Study|Adverse Event study disease worse|6|||
149887159|NCT02273388|540713746|FG008|Overall Study|Adverse Event study disease worse|6|||
149887160|NCT02273388|540713747|FG009|Overall Study|Adverse Event study disease worse|5|||
149887161|NCT02273388|540713748|FG010|Overall Study|Adverse Event study disease worse|10|||
149887162|NCT02273388|540713749|FG011|Overall Study|Adverse Event study disease worse|1|||
149887163|NCT02273388|540713738|FG000|Overall Study|Sponsor decision|0|||
149887164|NCT02273388|540713739|FG001|Overall Study|Sponsor decision|0|||
149887165|NCT02273388|540713740|FG002|Overall Study|Sponsor decision|0|||
149887166|NCT02273388|540713741|FG003|Overall Study|Sponsor decision|0|||
149887167|NCT02273388|540713742|FG004|Overall Study|Sponsor decision|0|||
149887168|NCT02273388|540713743|FG005|Overall Study|Sponsor decision|0|||
149887169|NCT02273388|540713744|FG006|Overall Study|Sponsor decision|0|||
149887170|NCT02273388|540713745|FG007|Overall Study|Sponsor decision|0|||
149887171|NCT02273388|540713746|FG008|Overall Study|Sponsor decision|0|||
149887172|NCT02273388|540713747|FG009|Overall Study|Sponsor decision|0|||
149887173|NCT02273388|540713748|FG010|Overall Study|Sponsor decision|0|||
149887174|NCT02273388|540713749|FG011|Overall Study|Sponsor decision|1|||
149887175|NCT01855828|540713750|FG000|Overall Study|Adverse Event|1|||
149887176|NCT01855828|540713750|FG000|Overall Study|Withdrawal by Subject|1|||
149887177|NCT04239027|540713751|FG000|Overall Study|Adverse Event|4|||
149887178|NCT04239027|540713751|FG000|Overall Study|Withdrawal by Subject|9|||
149887179|NCT04239027|540713751|FG000|Overall Study|Death|1|||
149887180|NCT04239027|540713751|FG000|Overall Study|Physician Decision|9|||
149887181|NCT04239027|540713751|FG000|Overall Study|Lost to Follow-up|2|||
149887182|NCT04239027|540713751|FG000|Overall Study|Lack of Efficacy|1|||
149887183|NCT01184079|540713752|FG000|Overall Study|Lost to Follow-up|14|||
149887184|NCT01184079|540713753|FG001|Overall Study|Lost to Follow-up|2|||
149887185|NCT03172494|540713754|FG000|Overall Study|Adverse Event|5|||
149887186|NCT03172494|540713755|FG001|Overall Study|Adverse Event|1|||
149887187|NCT03172494|540713756|FG002|Overall Study|Adverse Event|15|||
149887188|NCT03172494|540713754|FG000|Overall Study|Protocol Violation|3|||
149887189|NCT03172494|540713755|FG001|Overall Study|Protocol Violation|2|||
149887190|NCT03172494|540713756|FG002|Overall Study|Protocol Violation|1|||
149887191|NCT03172494|540713754|FG000|Overall Study|Lack of Efficacy|0|||
149887192|NCT03172494|540713755|FG001|Overall Study|Lack of Efficacy|0|||
149887193|NCT03172494|540713756|FG002|Overall Study|Lack of Efficacy|4|||
149887194|NCT03172494|540713754|FG000|Overall Study|Pregnancy|0|||
149887195|NCT03172494|540713755|FG001|Overall Study|Pregnancy|1|||
149966663|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
149887196|NCT03172494|540713756|FG002|Overall Study|Pregnancy|0|||
149887197|NCT03172494|540713754|FG000|Overall Study|Withdrawal by Subject|10|||
150044353|NCT02721966|541302478|FG003|Overall Study|Death|0|||
149887198|NCT03172494|540713755|FG001|Overall Study|Withdrawal by Subject|8|||
149887199|NCT03172494|540713756|FG002|Overall Study|Withdrawal by Subject|8|||
149887200|NCT03172494|540713754|FG000|Overall Study|Severe hypoglycaemic episode|0|||
149887201|NCT03172494|540713755|FG001|Overall Study|Severe hypoglycaemic episode|0|||
149887202|NCT03172494|540713756|FG002|Overall Study|Severe hypoglycaemic episode|1|||
149887203|NCT03172494|540713754|FG000|Overall Study|Non-compliance towards treatment|2|||
149887204|NCT03172494|540713755|FG001|Overall Study|Non-compliance towards treatment|0|||
149887205|NCT03172494|540713756|FG002|Overall Study|Non-compliance towards treatment|0|||
149887206|NCT04233073|540713757|FG000|Overall Study|Death|5|||
149887207|NCT00143390|540713758|FG000|Overall Study|Death|2|||
149887208|NCT00143390|540713759|FG001|Overall Study|Death|0|||
149887209|NCT00143390|540713758|FG000|Overall Study|Not meeting entry criteria|2|||
149887210|NCT00143390|540713759|FG001|Overall Study|Not meeting entry criteria|5|||
150044354|NCT02721966|541302479|FG004|Overall Study|Death|0|||
150044355|NCT02721966|541302475|FG000|Overall Study|Lack of Efficacy|7|||
150044356|NCT02721966|541302476|FG001|Overall Study|Lack of Efficacy|4|||
150044357|NCT02721966|541302477|FG002|Overall Study|Lack of Efficacy|0|||
150044358|NCT02721966|541302478|FG003|Overall Study|Lack of Efficacy|0|||
150044359|NCT02721966|541302479|FG004|Overall Study|Lack of Efficacy|0|||
150044360|NCT02721966|541302475|FG000|Overall Study|Lost to Follow-up|0|||
150044361|NCT02721966|541302476|FG001|Overall Study|Lost to Follow-up|0|||
150044362|NCT02721966|541302477|FG002|Overall Study|Lost to Follow-up|3|||
149887211|NCT00143390|540713758|FG000|Overall Study|Withdrawal by Subject|4|||
149887212|NCT00143390|540713759|FG001|Overall Study|Withdrawal by Subject|4|||
149887213|NCT00143390|540713758|FG000|Overall Study|Progressive disease|119|||
149887214|NCT00143390|540713759|FG001|Overall Study|Progressive disease|115|||
149887215|NCT00143390|540713758|FG000|Overall Study|Protocol Violation|2|||
149887216|NCT00143390|540713759|FG001|Overall Study|Protocol Violation|0|||
149887217|NCT00143390|540713758|FG000|Overall Study|Study termination|10|||
149887218|NCT00143390|540713759|FG001|Overall Study|Study termination|15|||
149887219|NCT00143390|540713758|FG000|Overall Study|Adverse Event|9|||
149887220|NCT00143390|540713759|FG001|Overall Study|Adverse Event|8|||
149887221|NCT00143390|540713758|FG000|Overall Study|Other|1|||
150044363|NCT02721966|541302478|FG003|Overall Study|Lost to Follow-up|0|||
150044364|NCT02721966|541302479|FG004|Overall Study|Lost to Follow-up|0|||
150044365|NCT02721966|541302475|FG000|Overall Study|Physician Decision|1|||
150044366|NCT02721966|541302476|FG001|Overall Study|Physician Decision|1|||
150044367|NCT02721966|541302477|FG002|Overall Study|Physician Decision|0|||
150044368|NCT02721966|541302478|FG003|Overall Study|Physician Decision|0|||
150044369|NCT02721966|541302479|FG004|Overall Study|Physician Decision|0|||
149887222|NCT00143390|540713759|FG001|Overall Study|Other|2|||
149887223|NCT02764151|540713762|FG000|Overall Study|Subject refused further follow-up|0|||
149887224|NCT02764151|540713763|FG001|Overall Study|Subject refused further follow-up|0|||
150044370|NCT02721966|541302475|FG000|Overall Study|Pregnancy|1|||
150044371|NCT02721966|541302476|FG001|Overall Study|Pregnancy|0|||
149887225|NCT02764151|540713764|FG002|Overall Study|Subject refused further follow-up|0|||
149887226|NCT02764151|540713765|FG003|Overall Study|Subject refused further follow-up|1|||
149887227|NCT02764151|540713762|FG000|Overall Study|Other|0|||
150044372|NCT02721966|541302477|FG002|Overall Study|Pregnancy|0|||
150044373|NCT02721966|541302478|FG003|Overall Study|Pregnancy|0|||
150044374|NCT02721966|541302479|FG004|Overall Study|Pregnancy|0|||
149887228|NCT02764151|540713763|FG001|Overall Study|Other|0|||
149887229|NCT02764151|540713764|FG002|Overall Study|Other|0|||
149887230|NCT02764151|540713765|FG003|Overall Study|Other|2|||
149887231|NCT01450683|540713766|FG000|Overall Study|Adverse Event|2|||
149887232|NCT01523002|540713772|FG000|Period 1|Withdrawal by Subject|1|||
149887233|NCT01523002|540713773|FG001|Period 1|Withdrawal by Subject|3|||
149887234|NCT01523002|540713772|FG000|Period 1|Lost to Follow-up|1|||
149887235|NCT01523002|540713773|FG001|Period 1|Lost to Follow-up|0|||
149887236|NCT01523002|540713772|FG000|Period 1|Adverse Event|0|||
149887237|NCT01523002|540713773|FG001|Period 1|Adverse Event|8|||
149887238|NCT01523002|540713772|FG000|Period 2|Withdrawal by Subject|4|||
149887239|NCT01523002|540713773|FG001|Period 2|Withdrawal by Subject|1|||
149887240|NCT01523002|540713772|FG000|Period 2|Adverse Event|2|||
149887241|NCT01523002|540713773|FG001|Period 2|Adverse Event|5|||
149887242|NCT01523002|540713772|FG000|Period 3|Withdrawal by Subject|1|||
149887243|NCT01523002|540713773|FG001|Period 3|Withdrawal by Subject|0|||
149887244|NCT01523002|540713772|FG000|Period 3|Adverse Event|3|||
149887245|NCT01523002|540713773|FG001|Period 3|Adverse Event|0|||
149887246|NCT01256502|540713774|FG000|Overall Study|Had scaffold removed|4|||
149887247|NCT01256502|540713774|FG000|Overall Study|Personal reasons|5|||
149887248|NCT01256502|540713774|FG000|Overall Study|Protocol deviation|1|||
149887249|NCT00852202|540713777|FG000|Overall Study|Adverse Event|2|||
149887250|NCT00852202|540713778|FG001|Overall Study|Adverse Event|3|||
149887251|NCT00852202|540713779|FG002|Overall Study|Adverse Event|7|||
149887252|NCT00852202|540713777|FG000|Overall Study|Lack of Efficacy|4|||
149887253|NCT00852202|540713778|FG001|Overall Study|Lack of Efficacy|1|||
149887254|NCT00852202|540713779|FG002|Overall Study|Lack of Efficacy|2|||
149887255|NCT00852202|540713777|FG000|Overall Study|Protocol Violation|2|||
149887256|NCT00852202|540713778|FG001|Overall Study|Protocol Violation|2|||
149887257|NCT00852202|540713779|FG002|Overall Study|Protocol Violation|7|||
149887258|NCT00852202|540713777|FG000|Overall Study|Withdrawal by Subject|3|||
149887259|NCT00852202|540713778|FG001|Overall Study|Withdrawal by Subject|1|||
149887260|NCT00852202|540713779|FG002|Overall Study|Withdrawal by Subject|2|||
149887261|NCT00852202|540713777|FG000|Overall Study|Lost to Follow-up|5|||
149887262|NCT00852202|540713778|FG001|Overall Study|Lost to Follow-up|5|||
149887263|NCT00852202|540713779|FG002|Overall Study|Lost to Follow-up|6|||
149887264|NCT00852202|540713777|FG000|Overall Study|pregnancy,moving away and surgery|1|||
149887265|NCT00852202|540713778|FG001|Overall Study|pregnancy,moving away and surgery|0|||
149887266|NCT00852202|540713779|FG002|Overall Study|pregnancy,moving away and surgery|2|||
149887267|NCT02854527|540713780|FG000|Overall Study|Adverse Event|0|||
150175385|NCT01823536|541778497|FG000|Overall Study|Subject moved out of the state|0|||
149887268|NCT02854527|540713781|FG001|Overall Study|Adverse Event|0|||
149887269|NCT02854527|540713782|FG002|Overall Study|Adverse Event|0|||
149887270|NCT02854527|540713783|FG003|Overall Study|Adverse Event|0|||
149887271|NCT02854527|540713784|FG004|Overall Study|Adverse Event|1|||
149887272|NCT02854527|540713785|FG005|Overall Study|Adverse Event|0|||
149887273|NCT02854527|540713786|FG006|Overall Study|Adverse Event|0|||
149887274|NCT02854527|540713787|FG007|Overall Study|Adverse Event|0|||
149887275|NCT02854527|540713788|FG008|Overall Study|Adverse Event|0|||
149887276|NCT02854527|540713789|FG009|Overall Study|Adverse Event|0|||
149887277|NCT02854527|540713780|FG000|Overall Study|Lost to Follow-up|0|||
149887278|NCT02854527|540713781|FG001|Overall Study|Lost to Follow-up|0|||
149887279|NCT02854527|540713782|FG002|Overall Study|Lost to Follow-up|0|||
149887280|NCT02854527|540713783|FG003|Overall Study|Lost to Follow-up|1|||
149887281|NCT02854527|540713784|FG004|Overall Study|Lost to Follow-up|0|||
149887282|NCT02854527|540713785|FG005|Overall Study|Lost to Follow-up|0|||
149887283|NCT02854527|540713786|FG006|Overall Study|Lost to Follow-up|0|||
149887284|NCT02854527|540713787|FG007|Overall Study|Lost to Follow-up|0|||
149887285|NCT02854527|540713788|FG008|Overall Study|Lost to Follow-up|0|||
149887286|NCT02854527|540713789|FG009|Overall Study|Lost to Follow-up|0|||
149887287|NCT06082843|540715777|FG000|Overall Study|Withdrawal by Subject|0|||
149887288|NCT06082843|540715778|FG001|Overall Study|Withdrawal by Subject|2|||
149887289|NCT06082843|540715777|FG000|Overall Study|Study terminated by sponsor|12|||
149887290|NCT06082843|540715778|FG001|Overall Study|Study terminated by sponsor|8|||
149887291|NCT02848001|540715782|FG000|Overall Study|other reasons|0|||
149887292|NCT02848001|540715783|FG001|Overall Study|other reasons|0|||
149887293|NCT02848001|540715784|FG002|Overall Study|other reasons|1|||
149887294|NCT02848001|540715785|FG003|Overall Study|other reasons|0|||
149887295|NCT02848001|540715786|FG004|Overall Study|other reasons|4|||
149887296|NCT02848001|540715787|FG005|Overall Study|other reasons|1|||
149887297|NCT02848001|540715788|FG006|Overall Study|other reasons|0|||
149887298|NCT02848001|540715789|FG007|Overall Study|other reasons|2|||
149887299|NCT02848001|540715790|FG008|Overall Study|other reasons|2|||
149887300|NCT02848001|540715791|FG009|Overall Study|other reasons|3|||
149887301|NCT02848001|540715792|FG010|Overall Study|other reasons|0|||
149887302|NCT02848001|540715793|FG011|Overall Study|other reasons|1|||
149887303|NCT02848001|540715794|FG012|Overall Study|other reasons|1|||
149887304|NCT02848001|540715795|FG013|Overall Study|other reasons|0|||
149887305|NCT02848001|540715796|FG014|Overall Study|other reasons|0|||
149887306|NCT02848001|540715797|FG015|Overall Study|other reasons|2|||
149887307|NCT02848001|540715798|FG016|Overall Study|other reasons|1|||
149887308|NCT02848001|540715782|FG000|Overall Study|Lack of Efficacy|0|||
149887309|NCT02848001|540715783|FG001|Overall Study|Lack of Efficacy|1|||
149887310|NCT02848001|540715784|FG002|Overall Study|Lack of Efficacy|1|||
149887311|NCT02848001|540715785|FG003|Overall Study|Lack of Efficacy|2|||
149887312|NCT02848001|540715786|FG004|Overall Study|Lack of Efficacy|3|||
149887313|NCT02848001|540715787|FG005|Overall Study|Lack of Efficacy|0|||
149887314|NCT02848001|540715788|FG006|Overall Study|Lack of Efficacy|1|||
149887315|NCT02848001|540715789|FG007|Overall Study|Lack of Efficacy|0|||
149887316|NCT02848001|540715790|FG008|Overall Study|Lack of Efficacy|0|||
149887317|NCT02848001|540715791|FG009|Overall Study|Lack of Efficacy|1|||
149887318|NCT02848001|540715792|FG010|Overall Study|Lack of Efficacy|0|||
149887319|NCT02848001|540715793|FG011|Overall Study|Lack of Efficacy|2|||
149887320|NCT02848001|540715794|FG012|Overall Study|Lack of Efficacy|0|||
149887321|NCT02848001|540715795|FG013|Overall Study|Lack of Efficacy|2|||
149887322|NCT02848001|540715796|FG014|Overall Study|Lack of Efficacy|2|||
149887323|NCT02848001|540715797|FG015|Overall Study|Lack of Efficacy|0|||
149887324|NCT02848001|540715798|FG016|Overall Study|Lack of Efficacy|0|||
149887325|NCT02848001|540715782|FG000|Overall Study|Progressive Disease|2|||
149887326|NCT02848001|540715783|FG001|Overall Study|Progressive Disease|1|||
149887327|NCT02848001|540715784|FG002|Overall Study|Progressive Disease|0|||
149887328|NCT02848001|540715785|FG003|Overall Study|Progressive Disease|4|||
149887329|NCT02848001|540715786|FG004|Overall Study|Progressive Disease|3|||
149887330|NCT02848001|540715787|FG005|Overall Study|Progressive Disease|0|||
149887331|NCT02848001|540715788|FG006|Overall Study|Progressive Disease|4|||
149887332|NCT02848001|540715789|FG007|Overall Study|Progressive Disease|1|||
149887333|NCT02848001|540715790|FG008|Overall Study|Progressive Disease|0|||
149887334|NCT02848001|540715791|FG009|Overall Study|Progressive Disease|2|||
149887335|NCT02848001|540715792|FG010|Overall Study|Progressive Disease|3|||
149887336|NCT02848001|540715793|FG011|Overall Study|Progressive Disease|2|||
149887337|NCT02848001|540715794|FG012|Overall Study|Progressive Disease|1|||
149887338|NCT02848001|540715795|FG013|Overall Study|Progressive Disease|0|||
149887339|NCT02848001|540715796|FG014|Overall Study|Progressive Disease|2|||
149887340|NCT02848001|540715797|FG015|Overall Study|Progressive Disease|4|||
149887341|NCT02848001|540715798|FG016|Overall Study|Progressive Disease|0|||
149887342|NCT02848001|540715782|FG000|Overall Study|Adverse Event|0|||
149887343|NCT02848001|540715783|FG001|Overall Study|Adverse Event|0|||
149887344|NCT02848001|540715784|FG002|Overall Study|Adverse Event|0|||
149887345|NCT02848001|540715785|FG003|Overall Study|Adverse Event|0|||
149887346|NCT02848001|540715786|FG004|Overall Study|Adverse Event|2|||
149887347|NCT02848001|540715787|FG005|Overall Study|Adverse Event|0|||
149887348|NCT02848001|540715788|FG006|Overall Study|Adverse Event|0|||
149887349|NCT02848001|540715789|FG007|Overall Study|Adverse Event|0|||
149966664|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
150175386|NCT01823536|541778498|FG001|Overall Study|Subject moved out of the state|0|||
149887350|NCT02848001|540715790|FG008|Overall Study|Adverse Event|0|||
149887351|NCT02848001|540715791|FG009|Overall Study|Adverse Event|1|||
149887352|NCT02848001|540715792|FG010|Overall Study|Adverse Event|0|||
149887353|NCT02848001|540715793|FG011|Overall Study|Adverse Event|1|||
149887354|NCT02848001|540715794|FG012|Overall Study|Adverse Event|1|||
149887355|NCT02848001|540715795|FG013|Overall Study|Adverse Event|0|||
149887356|NCT02848001|540715796|FG014|Overall Study|Adverse Event|2|||
149887357|NCT02848001|540715797|FG015|Overall Study|Adverse Event|0|||
149887358|NCT02848001|540715798|FG016|Overall Study|Adverse Event|0|||
149966665|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
149887359|NCT02848001|540715782|FG000|Overall Study|Death|0|||
149887360|NCT02848001|540715783|FG001|Overall Study|Death|0|||
149887361|NCT02848001|540715784|FG002|Overall Study|Death|0|||
149887362|NCT02848001|540715785|FG003|Overall Study|Death|1|||
149887363|NCT02848001|540715786|FG004|Overall Study|Death|3|||
149887364|NCT02848001|540715787|FG005|Overall Study|Death|1|||
149887365|NCT02848001|540715788|FG006|Overall Study|Death|2|||
149887366|NCT02848001|540715789|FG007|Overall Study|Death|3|||
149887367|NCT02848001|540715790|FG008|Overall Study|Death|4|||
149887368|NCT02848001|540715791|FG009|Overall Study|Death|1|||
149887369|NCT02848001|540715792|FG010|Overall Study|Death|0|||
149887370|NCT02848001|540715793|FG011|Overall Study|Death|1|||
149887371|NCT02848001|540715794|FG012|Overall Study|Death|3|||
149887372|NCT02848001|540715795|FG013|Overall Study|Death|0|||
149887373|NCT02848001|540715796|FG014|Overall Study|Death|2|||
149887374|NCT02848001|540715797|FG015|Overall Study|Death|3|||
149887375|NCT02848001|540715798|FG016|Overall Study|Death|0|||
149887376|NCT02848001|540715782|FG000|Overall Study|Physician Decision|0|||
149887377|NCT02848001|540715783|FG001|Overall Study|Physician Decision|0|||
149887378|NCT02848001|540715784|FG002|Overall Study|Physician Decision|0|||
149887379|NCT02848001|540715785|FG003|Overall Study|Physician Decision|0|||
149887380|NCT02848001|540715786|FG004|Overall Study|Physician Decision|0|||
149887381|NCT02848001|540715787|FG005|Overall Study|Physician Decision|0|||
149887382|NCT02848001|540715788|FG006|Overall Study|Physician Decision|0|||
149887383|NCT02848001|540715789|FG007|Overall Study|Physician Decision|0|||
149887384|NCT02848001|540715790|FG008|Overall Study|Physician Decision|1|||
149887385|NCT02848001|540715791|FG009|Overall Study|Physician Decision|1|||
149887386|NCT02848001|540715792|FG010|Overall Study|Physician Decision|0|||
149887387|NCT02848001|540715793|FG011|Overall Study|Physician Decision|0|||
149887388|NCT02848001|540715794|FG012|Overall Study|Physician Decision|2|||
149887389|NCT02848001|540715795|FG013|Overall Study|Physician Decision|0|||
149887390|NCT02848001|540715796|FG014|Overall Study|Physician Decision|0|||
149887391|NCT02848001|540715797|FG015|Overall Study|Physician Decision|0|||
149887392|NCT02848001|540715798|FG016|Overall Study|Physician Decision|0|||
149887393|NCT02848001|540715782|FG000|Overall Study|Withdrawal by Subject|0|||
149887394|NCT02848001|540715783|FG001|Overall Study|Withdrawal by Subject|0|||
149887395|NCT02848001|540715784|FG002|Overall Study|Withdrawal by Subject|0|||
149887396|NCT02848001|540715785|FG003|Overall Study|Withdrawal by Subject|0|||
149887397|NCT02848001|540715786|FG004|Overall Study|Withdrawal by Subject|0|||
149887398|NCT02848001|540715787|FG005|Overall Study|Withdrawal by Subject|1|||
149887399|NCT02848001|540715788|FG006|Overall Study|Withdrawal by Subject|1|||
149887400|NCT02848001|540715789|FG007|Overall Study|Withdrawal by Subject|1|||
149887401|NCT02848001|540715790|FG008|Overall Study|Withdrawal by Subject|0|||
149887402|NCT02848001|540715791|FG009|Overall Study|Withdrawal by Subject|0|||
149887403|NCT02848001|540715792|FG010|Overall Study|Withdrawal by Subject|0|||
149887404|NCT02848001|540715793|FG011|Overall Study|Withdrawal by Subject|0|||
149887405|NCT02848001|540715794|FG012|Overall Study|Withdrawal by Subject|0|||
149887406|NCT02848001|540715795|FG013|Overall Study|Withdrawal by Subject|0|||
149887407|NCT02848001|540715796|FG014|Overall Study|Withdrawal by Subject|0|||
149887408|NCT02848001|540715797|FG015|Overall Study|Withdrawal by Subject|0|||
149887409|NCT02848001|540715798|FG016|Overall Study|Withdrawal by Subject|0|||
149887410|NCT04358081|540715799|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
149887411|NCT04358081|540715800|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
149887412|NCT04358081|540715801|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
149887413|NCT04358081|540715799|FG000|Treatment Phase of Study|Adverse Event|1|||
149966666|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
149966667|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
149966668|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
149966669|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
149966670|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
149966671|NCT01111552|541013197|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149966672|NCT01111552|541013198|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149966673|NCT01111552|541013199|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
149966674|NCT01111552|541013200|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149966675|NCT01111552|541013201|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149966676|NCT02097225|541013202|FG000|Dose Level 4|Adverse Event|0|||
149966677|NCT02097225|541013203|FG001|Dose Level 4|Adverse Event|0|||
149966678|NCT02097225|541013204|FG002|Dose Level 4|Adverse Event|0|||
149966679|NCT02097225|541013205|FG003|Dose Level 4|Adverse Event|0|||
149966680|NCT02097225|541013206|FG004|Dose Level 4|Adverse Event|1|||
149966681|NCT04650893|541013207|FG000|Overall Study|Lost to Follow-up|11|||
149966682|NCT04650893|541013208|FG001|Overall Study|Lost to Follow-up|10|||
149887414|NCT04358081|540715800|FG001|Treatment Phase of Study|Adverse Event|0|||
149887415|NCT04358081|540715801|FG002|Treatment Phase of Study|Adverse Event|1|||
149887416|NCT04358081|540715799|FG000|Treatment Phase of Study|Physician Decision|2|||
149887417|NCT04358081|540715800|FG001|Treatment Phase of Study|Physician Decision|0|||
149887418|NCT04358081|540715801|FG002|Treatment Phase of Study|Physician Decision|1|||
149887419|NCT04358081|540715799|FG000|Treatment Phase of Study|Protocol Violation|1|||
149887420|NCT04358081|540715800|FG001|Treatment Phase of Study|Protocol Violation|0|||
149887421|NCT04358081|540715801|FG002|Treatment Phase of Study|Protocol Violation|0|||
149887422|NCT04358081|540715799|FG000|Study Completion Phase|Death|0|||
149887423|NCT04358081|540715800|FG001|Study Completion Phase|Death|0|||
149887424|NCT04358081|540715801|FG002|Study Completion Phase|Death|1|||
149887425|NCT04358081|540715799|FG000|Study Completion Phase|Lost to Follow-up|1|||
149887426|NCT04358081|540715800|FG001|Study Completion Phase|Lost to Follow-up|0|||
149887427|NCT04358081|540715801|FG002|Study Completion Phase|Lost to Follow-up|1|||
149887428|NCT03283566|540715806|FG000|Overall Study|Lost to Follow-up|1|||
149887429|NCT03283566|540715807|FG001|Overall Study|Lost to Follow-up|2|||
149887430|NCT02760004|540715808|FG000|Overall Study|Lost to Follow-up|13|||
149887431|NCT02760004|540715809|FG001|Overall Study|Lost to Follow-up|22|||
149887432|NCT00545714|540715810|FG000|Induction Phase (6 Months)|Physician Decision|3|||
149887433|NCT00545714|540715810|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
149887434|NCT00545714|540715810|FG000|Induction Phase (6 Months)|Disease Progression|1|||
149887435|NCT00545714|540715810|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
149887436|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
149887437|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
149887438|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
149887439|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
149887440|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
149887441|NCT00545714|540715810|FG000|Maintenance Phase (36 Months)|Death|2|||
149887442|NCT03889886|540715813|FG000|Overall Study|Other|0|||
149887443|NCT03889886|540715814|FG001|Overall Study|Other|1|||
149887444|NCT03889886|540715815|FG002|Overall Study|Other|0|||
149887445|NCT03889886|540715816|FG003|Overall Study|Other|1|||
149887446|NCT03889886|540715813|FG000|Overall Study|Withdrawal by Subject|0|||
149887447|NCT03889886|540715814|FG001|Overall Study|Withdrawal by Subject|0|||
149887448|NCT03889886|540715815|FG002|Overall Study|Withdrawal by Subject|1|||
149887449|NCT03889886|540715816|FG003|Overall Study|Withdrawal by Subject|0|||
149887450|NCT03889886|540715813|FG000|Overall Study|Adverse Event|0|||
149887451|NCT03889886|540715814|FG001|Overall Study|Adverse Event|0|||
149887452|NCT03889886|540715815|FG002|Overall Study|Adverse Event|0|||
149887453|NCT03889886|540715816|FG003|Overall Study|Adverse Event|6|||
149887454|NCT00276484|540715817|FG000|Overall Study|Adverse Event|4|||
149887455|NCT00276484|540715818|FG001|Overall Study|Adverse Event|7|||
149887456|NCT00276484|540715817|FG000|Overall Study|Lost to Follow-up|1|||
149887457|NCT00276484|540715818|FG001|Overall Study|Lost to Follow-up|1|||
149887458|NCT00276484|540715817|FG000|Overall Study|Protocol Violation|0|||
149887459|NCT00276484|540715818|FG001|Overall Study|Protocol Violation|1|||
149887460|NCT00276484|540715817|FG000|Overall Study|Withdrawal by Subject|4|||
149887461|NCT00276484|540715818|FG001|Overall Study|Withdrawal by Subject|3|||
149887462|NCT00276484|540715817|FG000|Overall Study|Could not take time off work|0|||
149887463|NCT00276484|540715818|FG001|Overall Study|Could not take time off work|1|||
149887464|NCT02790437|540715828|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
149887465|NCT02790437|540715829|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
149887466|NCT02790437|540715828|FG000|Overall Study|Adverse Event|1|||
149887467|NCT02790437|540715829|FG001|Overall Study|Adverse Event|0|||
149887468|NCT02790437|540715828|FG000|Overall Study|Withdrawal by Subject|1|||
149887469|NCT02790437|540715829|FG001|Overall Study|Withdrawal by Subject|0|||
149887470|NCT04688671|540715832|FG000|Overall Study|Adverse Event|3|||
149887471|NCT04688671|540715833|FG001|Overall Study|Adverse Event|1|||
149887472|NCT04688671|540715832|FG000|Overall Study|Withdrawal by Subject|3|||
149887473|NCT04688671|540715833|FG001|Overall Study|Withdrawal by Subject|1|||
149887474|NCT04688671|540715832|FG000|Overall Study|Lack of Efficacy|1|||
149887475|NCT04688671|540715833|FG001|Overall Study|Lack of Efficacy|1|||
149887476|NCT04688671|540715832|FG000|Overall Study|Protocol Violation|1|||
149887477|NCT04688671|540715833|FG001|Overall Study|Protocol Violation|0|||
149887478|NCT04688671|540715832|FG000|Overall Study|Lost to Follow-up|0|||
149887479|NCT04688671|540715833|FG001|Overall Study|Lost to Follow-up|1|||
149887480|NCT01626690|540715834|FG000|Overall Study|Protocol Violation|1|||
149887481|NCT01626690|540715835|FG001|Overall Study|Protocol Violation|0|||
149887482|NCT01626690|540715834|FG000|Overall Study|Adverse Event|1|||
149887483|NCT01626690|540715835|FG001|Overall Study|Adverse Event|0|||
149887484|NCT02105467|540715842|FG000|Period 1|Lost to Follow-up|1|||
149887485|NCT02105467|540715843|FG001|Period 1|Lost to Follow-up|0|||
149887486|NCT02105467|540715842|FG000|Period 1|Death|1|||
149887487|NCT02105467|540715843|FG001|Period 1|Death|0|||
149887488|NCT02105467|540715842|FG000|Period 2|Lost to Follow-up|1|||
149887489|NCT02105467|540715843|FG001|Period 2|Lost to Follow-up|0|||
149887490|NCT02105467|540715842|FG000|Period 2|Death|1|||
149887491|NCT02105467|540715843|FG001|Period 2|Death|0|||
149887492|NCT02105467|540715842|FG000|Period 2|Withdrawal by Subject|0|||
149887493|NCT02105467|540715843|FG001|Period 2|Withdrawal by Subject|2|||
149887494|NCT02105467|540715842|FG000|Period 3|Lost to Follow-up|0|||
149887495|NCT02105467|540715843|FG001|Period 3|Lost to Follow-up|1|||
149887496|NCT02676882|540715846|FG000|Overall Study|Adverse Event|1|||
149887497|NCT02676882|540715847|FG001|Overall Study|Adverse Event|0|||
149887498|NCT02676882|540715846|FG000|Overall Study|Lost to Follow-up|1|||
149887499|NCT02676882|540715847|FG001|Overall Study|Lost to Follow-up|0|||
149887500|NCT02676882|540715846|FG000|Overall Study|Withdrawal by Subject|1|||
149887501|NCT02676882|540715847|FG001|Overall Study|Withdrawal by Subject|2|||
149887502|NCT00958828|540715852|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
149887503|NCT00958828|540715853|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
149887504|NCT00958828|540715852|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
149887505|NCT00958828|540715853|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
149887506|NCT01518322|540715854|FG000|Overall Study|FeNO measurement was missing|13|||
149887507|NCT01269918|540715855|FG000|Overall Study|Did not receive study drug|0|||
149887508|NCT01269918|540715856|FG001|Overall Study|Did not receive study drug|3|||
149887509|NCT00811733|540715860|FG000|Overall Study|Investigator Discretion|10|||
149887510|NCT00811733|540715861|FG001|Overall Study|Investigator Discretion|8|||
149887511|NCT00811733|540715860|FG000|Overall Study|Withdrawal by Subject|1|||
149887512|NCT00811733|540715861|FG001|Overall Study|Withdrawal by Subject|2|||
149887513|NCT02500589|540715862|FG000|Overall Study|Withdrawal by Subject|11|||
149887514|NCT02500589|540715863|FG001|Overall Study|Withdrawal by Subject|14|||
149887515|NCT02500589|540715862|FG000|Overall Study|Lost to Follow-up|10|||
149887516|NCT02500589|540715863|FG001|Overall Study|Lost to Follow-up|12|||
149887517|NCT02500589|540715862|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
149887518|NCT02500589|540715863|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
149887519|NCT02500589|540715862|FG000|Overall Study|Death|7|||
149887520|NCT02500589|540715863|FG001|Overall Study|Death|5|||
149887521|NCT00856193|540715864|FG000|Period 2|Abnormal test procedure results|0|||
149887522|NCT00856193|540715865|FG001|Period 2|Abnormal test procedure results|1|||
149887523|NCT00856193|540715864|FG000|Period 2|Lost to Follow-up|0|||
149887524|NCT00856193|540715865|FG001|Period 2|Lost to Follow-up|1|||
149887525|NCT04542057|540715868|FG000|Overall Study|Death|3|||
149887526|NCT04542057|540715869|FG001|Overall Study|Death|1|||
149887527|NCT04542057|540715868|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
149887528|NCT04542057|540715869|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
149887529|NCT04542057|540715868|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
149887530|NCT04542057|540715869|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
149966683|NCT04650893|541013209|FG002|Overall Study|Lost to Follow-up|11|||
149966684|NCT00835172|541013215|FG000|Washout|Protocol Violation|0|||
149966685|NCT00835172|541013216|FG001|Washout|Protocol Violation|1|||
149966686|NCT02613507|541013225|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
149966687|NCT02613507|541013226|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
149966688|NCT02613507|541013225|FG000|Pre-Treamtent|Participant withdrew consent|0|||
149966689|NCT02613507|541013226|FG001|Pre-Treamtent|Participant withdrew consent|4|||
149966690|NCT02613507|541013225|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
149966691|NCT02613507|541013226|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
149966692|NCT02613507|541013225|FG000|Treatment|Not reported|3|||
149966693|NCT02613507|541013226|FG001|Treatment|Not reported|0|||
149966694|NCT02613507|541013225|FG000|Treatment|Other reasons|8|||
149966695|NCT02613507|541013226|FG001|Treatment|Other reasons|0|||
149966696|NCT02613507|541013225|FG000|Treatment|Participant no longer meets criteria|3|||
149966697|NCT02613507|541013226|FG001|Treatment|Participant no longer meets criteria|0|||
149966698|NCT02613507|541013225|FG000|Treatment|Maximum clinical benefit|5|||
149966699|NCT02613507|541013226|FG001|Treatment|Maximum clinical benefit|10|||
149887531|NCT04542057|540715868|FG000|Overall Study|Adverse Event|15|||
149887532|NCT04542057|540715869|FG001|Overall Study|Adverse Event|6|||
149887533|NCT04542057|540715868|FG000|Overall Study|COVID-19 adverse event|6|||
149887534|NCT04542057|540715869|FG001|Overall Study|COVID-19 adverse event|4|||
149887535|NCT04542057|540715868|FG000|Overall Study|Lack of Efficacy|2|||
149966700|NCT02613507|541013225|FG000|Treatment|Lost to Follow-up|1|||
149966701|NCT02613507|541013226|FG001|Treatment|Lost to Follow-up|0|||
149966702|NCT02613507|541013225|FG000|Treatment|Participant withdrew consent|0|||
149966703|NCT02613507|541013226|FG001|Treatment|Participant withdrew consent|2|||
149966704|NCT02613507|541013225|FG000|Treatment|Participant request to discontinue study treatment|13|||
149966705|NCT02613507|541013226|FG001|Treatment|Participant request to discontinue study treatment|17|||
149966706|NCT02613507|541013225|FG000|Treatment|Adverse event unrelated to study drug|20|||
149887536|NCT04542057|540715869|FG001|Overall Study|Lack of Efficacy|5|||
149887537|NCT04542057|540715868|FG000|Overall Study|Study terminated by sponsor|1|||
149887538|NCT04542057|540715869|FG001|Overall Study|Study terminated by sponsor|0|||
149887539|NCT04542057|540715868|FG000|Overall Study|Investigator discretion|2|||
149887540|NCT04542057|540715869|FG001|Overall Study|Investigator discretion|1|||
149887541|NCT04542057|540715868|FG000|Overall Study|Withdrawal by Subject|52|||
149887542|NCT04542057|540715869|FG001|Overall Study|Withdrawal by Subject|30|||
149966707|NCT02613507|541013226|FG001|Treatment|Adverse event unrelated to study drug|3|||
149887543|NCT04542057|540715868|FG000|Overall Study|Lost to Follow-up|8|||
149887544|NCT04542057|540715869|FG001|Overall Study|Lost to Follow-up|11|||
149887545|NCT04542057|540715868|FG000|Overall Study|Other|2|||
149887546|NCT04542057|540715869|FG001|Overall Study|Other|2|||
149887547|NCT03404674|540715871|FG000|Overall Study|Inability to Attend Future Visits|0|||
149887548|NCT03404674|540715872|FG001|Overall Study|Inability to Attend Future Visits|1|||
149887549|NCT03404674|540715873|FG002|Overall Study|Inability to Attend Future Visits|1|||
149966708|NCT02613507|541013225|FG000|Treatment|Death|2|||
149966709|NCT02613507|541013226|FG001|Treatment|Death|0|||
149966710|NCT02613507|541013225|FG000|Treatment|Study drug toxicity|19|||
149966711|NCT02613507|541013226|FG001|Treatment|Study drug toxicity|14|||
149966712|NCT02613507|541013225|FG000|Treatment|Disease progression|263|||
149966713|NCT02613507|541013226|FG001|Treatment|Disease progression|110|||
149966714|NCT03941093|541013227|FG000|Overall Study|Protocol Violation|0|||
149966715|NCT03941093|541013228|FG001|Overall Study|Protocol Violation|1|||
149966716|NCT03941093|541013227|FG000|Overall Study|Withdrawal by Subject|9|||
149966717|NCT03941093|541013228|FG001|Overall Study|Withdrawal by Subject|6|||
149966718|NCT03648372|541013243|FG000|Overall Study|Withdrawal by Subject|2|||
149966719|NCT03648372|541013244|FG001|Overall Study|Withdrawal by Subject|0|||
149966720|NCT03648372|541013245|FG002|Overall Study|Withdrawal by Subject|0|||
150044375|NCT02721966|541302475|FG000|Overall Study|Did not continue to period 2|5|||
150044376|NCT02721966|541302476|FG001|Overall Study|Did not continue to period 2|12|||
150044377|NCT02721966|541302477|FG002|Overall Study|Did not continue to period 2|0|||
150044378|NCT02721966|541302478|FG003|Overall Study|Did not continue to period 2|0|||
150044379|NCT02721966|541302479|FG004|Overall Study|Did not continue to period 2|5|||
150044380|NCT02175030|541302483|FG000|Overall Study|Failed screen after consent|7|||
150044381|NCT02175030|541302484|FG001|Overall Study|Failed screen after consent|6|||
150044382|NCT02175030|541302483|FG000|Overall Study|Failed IUD Insertion|20|||
150044383|NCT02175030|541302484|FG001|Overall Study|Failed IUD Insertion|21|||
150044384|NCT02175030|541302483|FG000|Overall Study|Physician Decision|1|||
150044385|NCT02175030|541302484|FG001|Overall Study|Physician Decision|1|||
150044386|NCT02175030|541302483|FG000|Overall Study|Lost to Follow-up|6|||
150044387|NCT02175030|541302484|FG001|Overall Study|Lost to Follow-up|6|||
150044388|NCT02175030|541302483|FG000|Overall Study|Withdrawal by Subject|1|||
150044389|NCT02175030|541302484|FG001|Overall Study|Withdrawal by Subject|4|||
150044390|NCT02533453|541302485|FG000|Overall Study|Adverse Event|6|||
150044391|NCT02533453|541302485|FG000|Overall Study|Protocol Violation|1|||
150044392|NCT02533453|541302485|FG000|Overall Study|Withdrawal by Subject|2|||
150044393|NCT02453711|541302486|FG000|Overall Study|Withdrawal by Subject|5|||
150044394|NCT02453711|541302487|FG001|Overall Study|Withdrawal by Subject|4|||
150044395|NCT02453711|541302488|FG002|Overall Study|Withdrawal by Subject|6|||
150044396|NCT02453711|541302489|FG003|Overall Study|Withdrawal by Subject|4|||
150044397|NCT02453711|541302490|FG004|Overall Study|Withdrawal by Subject|1|||
150044398|NCT02453711|541302491|FG005|Overall Study|Withdrawal by Subject|1|||
150044399|NCT02453711|541302492|FG006|Overall Study|Withdrawal by Subject|0|||
150044400|NCT02453711|541302493|FG007|Overall Study|Withdrawal by Subject|1|||
150044401|NCT02453711|541302494|FG008|Overall Study|Withdrawal by Subject|7|||
150044402|NCT02453711|541302486|FG000|Overall Study|Lost to Follow-up|5|||
150044403|NCT02453711|541302487|FG001|Overall Study|Lost to Follow-up|3|||
150044404|NCT02453711|541302488|FG002|Overall Study|Lost to Follow-up|2|||
150044405|NCT02453711|541302489|FG003|Overall Study|Lost to Follow-up|3|||
150044406|NCT02453711|541302490|FG004|Overall Study|Lost to Follow-up|1|||
150044407|NCT02453711|541302491|FG005|Overall Study|Lost to Follow-up|5|||
150044408|NCT02453711|541302492|FG006|Overall Study|Lost to Follow-up|2|||
150044409|NCT02453711|541302493|FG007|Overall Study|Lost to Follow-up|6|||
150044410|NCT02453711|541302494|FG008|Overall Study|Lost to Follow-up|6|||
150044411|NCT02453711|541302486|FG000|Overall Study|Death|0|||
150044412|NCT02453711|541302487|FG001|Overall Study|Death|0|||
150044413|NCT02453711|541302488|FG002|Overall Study|Death|0|||
150044414|NCT02453711|541302489|FG003|Overall Study|Death|0|||
150044415|NCT02453711|541302490|FG004|Overall Study|Death|0|||
150044416|NCT02453711|541302491|FG005|Overall Study|Death|0|||
150044417|NCT02453711|541302492|FG006|Overall Study|Death|1|||
150044418|NCT02453711|541302493|FG007|Overall Study|Death|0|||
150044419|NCT02453711|541302494|FG008|Overall Study|Death|0|||
150044420|NCT02453711|541302486|FG000|Overall Study|Unclassified|1|||
150044421|NCT02453711|541302487|FG001|Overall Study|Unclassified|0|||
149966721|NCT03648372|541013246|FG003|Overall Study|Withdrawal by Subject|0|||
150044422|NCT02453711|541302488|FG002|Overall Study|Unclassified|1|||
150044423|NCT02453711|541302489|FG003|Overall Study|Unclassified|0|||
150044424|NCT02453711|541302490|FG004|Overall Study|Unclassified|0|||
150044425|NCT02453711|541302491|FG005|Overall Study|Unclassified|0|||
150175387|NCT01823536|541778499|FG002|Overall Study|Subject moved out of the state|0|||
149966722|NCT03648372|541013247|FG004|Overall Study|Withdrawal by Subject|0|||
149966723|NCT03648372|541013248|FG005|Overall Study|Withdrawal by Subject|1|||
150044426|NCT02453711|541302492|FG006|Overall Study|Unclassified|0|||
150044427|NCT02453711|541302493|FG007|Overall Study|Unclassified|0|||
150044428|NCT02453711|541302494|FG008|Overall Study|Unclassified|0|||
150044429|NCT03695367|541302497|FG000|Overall Study|Missed the Day 28 visit.|1|||
150044430|NCT03695367|541302498|FG001|Overall Study|Missed the Day 28 visit.|0|||
149966724|NCT03648372|541013249|FG006|Overall Study|Withdrawal by Subject|2|||
149966725|NCT03648372|541013250|FG007|Overall Study|Withdrawal by Subject|0|||
149966726|NCT03648372|541013251|FG008|Overall Study|Withdrawal by Subject|0|||
150044431|NCT03695367|541302497|FG000|Overall Study|Lost to Follow-up|0|||
150044432|NCT03695367|541302498|FG001|Overall Study|Lost to Follow-up|1|||
150175388|NCT01823536|541778500|FG003|Overall Study|Subject moved out of the state|0|||
149887550|NCT03404674|540715874|FG003|Overall Study|Inability to Attend Future Visits|0|||
149887551|NCT03404674|540715875|FG004|Overall Study|Inability to Attend Future Visits|0|||
149887552|NCT03404674|540715876|FG005|Overall Study|Inability to Attend Future Visits|0|||
149887553|NCT03404674|540715871|FG000|Overall Study|Behavioral Problems|0|||
149887554|NCT03404674|540715872|FG001|Overall Study|Behavioral Problems|0|||
149887555|NCT03404674|540715873|FG002|Overall Study|Behavioral Problems|1|||
149887556|NCT03404674|540715874|FG003|Overall Study|Behavioral Problems|0|||
149887557|NCT03404674|540715875|FG004|Overall Study|Behavioral Problems|0|||
149887558|NCT03404674|540715876|FG005|Overall Study|Behavioral Problems|0|||
149887559|NCT03404674|540715871|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
149887560|NCT03404674|540715872|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
149887561|NCT03404674|540715873|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
149887562|NCT03404674|540715874|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
149887563|NCT03404674|540715875|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
149887564|NCT03404674|540715876|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
149887565|NCT03624192|540715881|FG000|Overall Study|Lost to Follow-up|1|||
149887566|NCT03624192|540715882|FG001|Overall Study|Lost to Follow-up|1|||
149887567|NCT04660331|540715883|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
149887568|NCT04660331|540715884|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
149887569|NCT04660331|540715885|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
149887570|NCT01487525|540715888|FG000|Overall Study|Withdrawal by Subject|0|||
149887571|NCT01487525|540715889|FG001|Overall Study|Withdrawal by Subject|1|||
149887572|NCT01870778|540715890|FG000|Overall Study|Withdrawal by Subject|8|||
149887573|NCT01870778|540715891|FG001|Overall Study|Withdrawal by Subject|7|||
149887574|NCT01870778|540715890|FG000|Overall Study|Lost to Follow-up|0|||
149887575|NCT01870778|540715891|FG001|Overall Study|Lost to Follow-up|2|||
149887576|NCT00065156|540715892|FG000|Overall Study|Adverse Event|37|||
149887577|NCT00065156|540715892|FG000|Overall Study|Lack of Efficacy|52|||
149887578|NCT00065156|540715892|FG000|Overall Study|Withdrawal by Subject|8|||
149887579|NCT00065156|540715892|FG000|Overall Study|Lost to Follow-up|1|||
149887580|NCT00065156|540715892|FG000|Overall Study|Death|11|||
149887581|NCT00065156|540715892|FG000|Overall Study|Study Closed by Sponsor|2|||
149887582|NCT00065156|540715892|FG000|Overall Study|Disease Progression|7|||
149887583|NCT00065156|540715892|FG000|Overall Study|Investigator Decision|2|||
149887584|NCT00065156|540715892|FG000|Overall Study|Non-Compliance|2|||
149887585|NCT00065156|540715892|FG000|Overall Study|Loss of Response|1|||
149887586|NCT00065156|540715892|FG000|Overall Study|Secondary Malign Disease|1|||
149887587|NCT01215136|540715893|FG000|Overall Study|Adverse Event|2|||
149887588|NCT01215136|540715894|FG001|Overall Study|Adverse Event|9|||
149887589|NCT01215136|540715893|FG000|Overall Study|Disease Progression|3|||
149887590|NCT01215136|540715894|FG001|Overall Study|Disease Progression|14|||
149887591|NCT01215136|540715893|FG000|Overall Study|Symptomatic Deterioration|1|||
149887592|NCT01215136|540715894|FG001|Overall Study|Symptomatic Deterioration|1|||
149887593|NCT01215136|540715893|FG000|Overall Study|Death|0|||
149887594|NCT01215136|540715894|FG001|Overall Study|Death|2|||
149887595|NCT01215136|540715893|FG000|Overall Study|Withdrawal by Subject|0|||
149887596|NCT01215136|540715894|FG001|Overall Study|Withdrawal by Subject|1|||
149887597|NCT02308124|540715895|FG000|Overall Study|Lost to Follow-up|6|||
149887598|NCT02308124|540715896|FG001|Overall Study|Lost to Follow-up|6|||
149887599|NCT02308124|540715897|FG002|Overall Study|Lost to Follow-up|6|||
149887600|NCT02308124|540715895|FG000|Overall Study|Adverse Event|0|||
149887601|NCT02308124|540715896|FG001|Overall Study|Adverse Event|2|||
149966727|NCT03648372|541013252|FG009|Overall Study|Withdrawal by Subject|0|||
149966728|NCT03648372|541013253|FG010|Overall Study|Withdrawal by Subject|2|||
149966729|NCT03648372|541013254|FG011|Overall Study|Withdrawal by Subject|0|||
149966730|NCT03648372|541013255|FG012|Overall Study|Withdrawal by Subject|2|||
149966731|NCT03648372|541013256|FG013|Overall Study|Withdrawal by Subject|0|||
149966732|NCT03648372|541013257|FG014|Overall Study|Withdrawal by Subject|0|||
149966733|NCT03648372|541013258|FG015|Overall Study|Withdrawal by Subject|0|||
149966734|NCT03648372|541013259|FG016|Overall Study|Withdrawal by Subject|1|||
149966735|NCT03648372|541013260|FG017|Overall Study|Withdrawal by Subject|0|||
149887602|NCT02308124|540715897|FG002|Overall Study|Adverse Event|2|||
149887603|NCT01329900|540715913|FG000|Overall Study|Elevated creatinine/renal function|1|||
149887604|NCT01866098|540715914|FG000|Overall Study|Lost to Follow-up|11|||
149887605|NCT01866098|540715915|FG001|Overall Study|Lost to Follow-up|18|||
149966736|NCT03648372|541013261|FG018|Overall Study|Withdrawal by Subject|0|||
149966737|NCT03648372|541013262|FG019|Overall Study|Withdrawal by Subject|0|||
149887606|NCT01866098|540715916|FG002|Overall Study|Lost to Follow-up|13|||
149887607|NCT01866098|540715914|FG000|Overall Study|Physician Decision|0|||
149887608|NCT01866098|540715915|FG001|Overall Study|Physician Decision|1|||
149887609|NCT01866098|540715916|FG002|Overall Study|Physician Decision|2|||
149887610|NCT01866098|540715914|FG000|Overall Study|Adverse Event|1|||
149887611|NCT01866098|540715915|FG001|Overall Study|Adverse Event|5|||
149887612|NCT01866098|540715916|FG002|Overall Study|Adverse Event|4|||
149887613|NCT01866098|540715914|FG000|Overall Study|Protocol Violation|1|||
149887614|NCT01866098|540715915|FG001|Overall Study|Protocol Violation|0|||
149887615|NCT01866098|540715916|FG002|Overall Study|Protocol Violation|0|||
149887616|NCT01866098|540715914|FG000|Overall Study|Withdrawal by Subject|1|||
149887617|NCT01866098|540715915|FG001|Overall Study|Withdrawal by Subject|2|||
149887618|NCT01866098|540715916|FG002|Overall Study|Withdrawal by Subject|0|||
149887619|NCT01866098|540715914|FG000|Overall Study|Unrelated Hospitalization|2|||
149887620|NCT01866098|540715915|FG001|Overall Study|Unrelated Hospitalization|0|||
149887621|NCT01866098|540715916|FG002|Overall Study|Unrelated Hospitalization|1|||
149887622|NCT01866098|540715914|FG000|Overall Study|Non-compliance|1|||
149887623|NCT01866098|540715915|FG001|Overall Study|Non-compliance|0|||
149887624|NCT01866098|540715916|FG002|Overall Study|Non-compliance|1|||
149887625|NCT01866098|540715914|FG000|Overall Study|Pregnancy|2|||
149887626|NCT01866098|540715915|FG001|Overall Study|Pregnancy|0|||
149887627|NCT01866098|540715916|FG002|Overall Study|Pregnancy|0|||
149887628|NCT01866098|540715914|FG000|Overall Study|Death|0|||
149887629|NCT01866098|540715915|FG001|Overall Study|Death|1|||
149887630|NCT01866098|540715916|FG002|Overall Study|Death|0|||
149887631|NCT00489255|540715930|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
149887632|NCT00489255|540715931|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
149887633|NCT00489255|540715930|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
149887634|NCT00489255|540715931|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
149887635|NCT00489255|540715930|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
149887636|NCT00489255|540715931|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
149887637|NCT00489255|540715930|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
149887638|NCT00489255|540715931|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
149887639|NCT00489255|540715930|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
149887640|NCT00489255|540715931|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
149887641|NCT00489255|540715930|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
149887642|NCT00489255|540715931|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
149887643|NCT00489255|540715930|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
149887644|NCT00489255|540715931|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
149887645|NCT00489255|540715930|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
149887646|NCT00489255|540715931|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
149887647|NCT00489255|540715930|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
149887648|NCT00489255|540715931|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
149887649|NCT00489255|540715930|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
149887650|NCT00489255|540715931|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
149887651|NCT01982955|540715934|FG000|Overall Study|Randomized but not treated|0|||
149887652|NCT01982955|540715935|FG001|Overall Study|Randomized but not treated|0|||
149887653|NCT01982955|540715936|FG002|Overall Study|Randomized but not treated|0|||
149887654|NCT01982955|540715937|FG003|Overall Study|Randomized but not treated|1|||
149887655|NCT01982955|540715938|FG004|Overall Study|Randomized but not treated|0|||
149887656|NCT03493685|540717287|FG000|Overall Study|Death|4|||
149887657|NCT03493685|540717288|FG001|Overall Study|Death|3|||
149887658|NCT03493685|540717287|FG000|Overall Study|Lost to Follow-up|3|||
149887659|NCT03493685|540717288|FG001|Overall Study|Lost to Follow-up|2|||
149887660|NCT03493685|540717287|FG000|Overall Study|Physician Decision|2|||
149887661|NCT03493685|540717288|FG001|Overall Study|Physician Decision|0|||
149887662|NCT03493685|540717287|FG000|Overall Study|Withdrawal by Subject|7|||
149887663|NCT03493685|540717288|FG001|Overall Study|Withdrawal by Subject|11|||
149887664|NCT04452669|540717289|FG000|Overall Study|Death|1|||
149887665|NCT04452669|540717290|FG001|Overall Study|Death|4|||
149887666|NCT05126693|540717295|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
149887667|NCT05126693|540717296|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
149887668|NCT05126693|540717295|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
149887669|NCT05126693|540717296|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
149887670|NCT05126693|540717295|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
149887671|NCT05126693|540717296|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
149887672|NCT05525520|540717297|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
149887673|NCT05525520|540717298|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
149887674|NCT05525520|540717297|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
149887675|NCT05525520|540717298|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
149887676|NCT05878093|540717299|FG000|Overall Study|Withdrawal by Subject|3|||
149887677|NCT05878093|540717300|FG001|Overall Study|Withdrawal by Subject|1|||
149887678|NCT02721732|540717301|FG000|Overall Study|Adverse Event|2|||
149887679|NCT02721732|540717302|FG001|Overall Study|Adverse Event|0|||
149887680|NCT02721732|540717303|FG002|Overall Study|Adverse Event|2|||
149887681|NCT02721732|540717304|FG003|Overall Study|Adverse Event|0|||
149887682|NCT02721732|540717305|FG004|Overall Study|Adverse Event|1|||
149887683|NCT02721732|540717306|FG005|Overall Study|Adverse Event|0|||
149887684|NCT02721732|540717307|FG006|Overall Study|Adverse Event|1|||
149887685|NCT02721732|540717308|FG007|Overall Study|Adverse Event|0|||
149887686|NCT02721732|540717309|FG008|Overall Study|Adverse Event|1|||
149887687|NCT02721732|540717310|FG009|Overall Study|Adverse Event|1|||
149887688|NCT02721732|540717301|FG000|Overall Study|Death|0|||
149887689|NCT02721732|540717302|FG001|Overall Study|Death|0|||
149887690|NCT02721732|540717303|FG002|Overall Study|Death|0|||
149887691|NCT02721732|540717304|FG003|Overall Study|Death|0|||
149887692|NCT02721732|540717305|FG004|Overall Study|Death|1|||
149887693|NCT02721732|540717306|FG005|Overall Study|Death|0|||
149887694|NCT02721732|540717307|FG006|Overall Study|Death|1|||
149887695|NCT02721732|540717308|FG007|Overall Study|Death|0|||
149887696|NCT02721732|540717309|FG008|Overall Study|Death|0|||
149887697|NCT02721732|540717310|FG009|Overall Study|Death|1|||
149887698|NCT02721732|540717301|FG000|Overall Study|Lack of Efficacy|12|||
149887699|NCT02721732|540717302|FG001|Overall Study|Lack of Efficacy|11|||
149887700|NCT02721732|540717303|FG002|Overall Study|Lack of Efficacy|18|||
149887701|NCT02721732|540717304|FG003|Overall Study|Lack of Efficacy|5|||
149887702|NCT02721732|540717305|FG004|Overall Study|Lack of Efficacy|21|||
149887703|NCT02721732|540717306|FG005|Overall Study|Lack of Efficacy|2|||
149887704|NCT02721732|540717307|FG006|Overall Study|Lack of Efficacy|8|||
149887705|NCT02721732|540717308|FG007|Overall Study|Lack of Efficacy|11|||
149887706|NCT02721732|540717309|FG008|Overall Study|Lack of Efficacy|10|||
149887707|NCT02721732|540717310|FG009|Overall Study|Lack of Efficacy|20|||
149887708|NCT02721732|540717301|FG000|Overall Study|Physician Decision|0|||
149887709|NCT02721732|540717302|FG001|Overall Study|Physician Decision|0|||
149887710|NCT02721732|540717303|FG002|Overall Study|Physician Decision|1|||
149966738|NCT03648372|541013263|FG020|Overall Study|Withdrawal by Subject|0|||
149966739|NCT03648372|541013243|FG000|Overall Study|Progressive Disease|2|||
149966740|NCT03648372|541013244|FG001|Overall Study|Progressive Disease|3|||
149887711|NCT02721732|540717304|FG003|Overall Study|Physician Decision|0|||
149887712|NCT02721732|540717305|FG004|Overall Study|Physician Decision|0|||
149887713|NCT02721732|540717306|FG005|Overall Study|Physician Decision|0|||
149887714|NCT02721732|540717307|FG006|Overall Study|Physician Decision|0|||
149887715|NCT02721732|540717308|FG007|Overall Study|Physician Decision|0|||
149887716|NCT02721732|540717309|FG008|Overall Study|Physician Decision|0|||
149887717|NCT02721732|540717310|FG009|Overall Study|Physician Decision|0|||
149887718|NCT02721732|540717301|FG000|Overall Study|Withdrawal by Subject|1|||
149887719|NCT02721732|540717302|FG001|Overall Study|Withdrawal by Subject|0|||
149887720|NCT02721732|540717303|FG002|Overall Study|Withdrawal by Subject|0|||
149966741|NCT03648372|541013245|FG002|Overall Study|Progressive Disease|4|||
149966742|NCT03648372|541013246|FG003|Overall Study|Progressive Disease|3|||
149887721|NCT02721732|540717304|FG003|Overall Study|Withdrawal by Subject|0|||
149887722|NCT02721732|540717305|FG004|Overall Study|Withdrawal by Subject|3|||
149887723|NCT02721732|540717306|FG005|Overall Study|Withdrawal by Subject|0|||
149887724|NCT02721732|540717307|FG006|Overall Study|Withdrawal by Subject|1|||
149887725|NCT02721732|540717308|FG007|Overall Study|Withdrawal by Subject|1|||
149887726|NCT02721732|540717309|FG008|Overall Study|Withdrawal by Subject|0|||
149887727|NCT02721732|540717310|FG009|Overall Study|Withdrawal by Subject|1|||
149887728|NCT02721732|540717301|FG000|Overall Study|Participant Choice|1|||
149887729|NCT02721732|540717302|FG001|Overall Study|Participant Choice|0|||
149887730|NCT02721732|540717303|FG002|Overall Study|Participant Choice|0|||
149887731|NCT02721732|540717304|FG003|Overall Study|Participant Choice|0|||
149887732|NCT02721732|540717305|FG004|Overall Study|Participant Choice|0|||
149887733|NCT02721732|540717306|FG005|Overall Study|Participant Choice|0|||
149887734|NCT02721732|540717307|FG006|Overall Study|Participant Choice|0|||
149887735|NCT02721732|540717308|FG007|Overall Study|Participant Choice|0|||
149887736|NCT02721732|540717309|FG008|Overall Study|Participant Choice|0|||
149887737|NCT02721732|540717310|FG009|Overall Study|Participant Choice|1|||
149887738|NCT02721732|540717301|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887739|NCT02721732|540717302|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887740|NCT02721732|540717303|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
149887741|NCT02721732|540717304|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887742|NCT02721732|540717305|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887743|NCT02721732|540717306|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887744|NCT02721732|540717307|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887745|NCT02721732|540717308|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887746|NCT02721732|540717309|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887747|NCT02721732|540717310|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
149887748|NCT02721732|540717301|FG000|Overall Study|Progression and withdrew consent|1|||
149887749|NCT02721732|540717302|FG001|Overall Study|Progression and withdrew consent|1|||
149887750|NCT02721732|540717303|FG002|Overall Study|Progression and withdrew consent|0|||
149887751|NCT02721732|540717304|FG003|Overall Study|Progression and withdrew consent|0|||
149887752|NCT02721732|540717305|FG004|Overall Study|Progression and withdrew consent|0|||
149887753|NCT02721732|540717306|FG005|Overall Study|Progression and withdrew consent|0|||
149887754|NCT02721732|540717307|FG006|Overall Study|Progression and withdrew consent|0|||
149887755|NCT02721732|540717308|FG007|Overall Study|Progression and withdrew consent|0|||
149887756|NCT02721732|540717309|FG008|Overall Study|Progression and withdrew consent|0|||
149887757|NCT02721732|540717310|FG009|Overall Study|Progression and withdrew consent|1|||
149887758|NCT02721732|540717301|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
149887759|NCT02721732|540717302|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
149887760|NCT02721732|540717303|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
149887761|NCT02721732|540717304|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
149887762|NCT02721732|540717305|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
149887763|NCT02721732|540717306|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
149887764|NCT02721732|540717307|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
150044433|NCT03695367|541302497|FG000|Overall Study|Withdrawal by Subject|0|||
150044434|NCT03695367|541302498|FG001|Overall Study|Withdrawal by Subject|1|||
150044435|NCT03695367|541302497|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
150044436|NCT03695367|541302498|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
150044437|NCT00068419|541302501|FG000|Overall Study|Adverse Event|3|||
150044438|NCT00068419|541302501|FG000|Overall Study|Lack of Efficacy|24|||
150044439|NCT00068419|541302501|FG000|Overall Study|Lost to Follow-up|1|||
150044440|NCT00068419|541302501|FG000|Overall Study|Physician Decision|7|||
150044441|NCT00068419|541302501|FG000|Overall Study|Withdrawal by Subject|14|||
150175389|NCT01823536|541778501|FG004|Overall Study|Subject moved out of the state|1|||
150175390|NCT01823536|541778502|FG005|Overall Study|Subject moved out of the state|0|||
150175391|NCT03648762|541778506|FG000|Overall Study|Lost to Follow-up|1|||
150175392|NCT03648762|541778507|FG001|Overall Study|Lost to Follow-up|2|||
150175393|NCT03648762|541778508|FG002|Overall Study|Lost to Follow-up|0|||
150175394|NCT03648762|541778506|FG000|Overall Study|Withdrawal by Subject|5|||
150175395|NCT03648762|541778507|FG001|Overall Study|Withdrawal by Subject|2|||
150175396|NCT03648762|541778508|FG002|Overall Study|Withdrawal by Subject|1|||
150175397|NCT01662336|541778518|FG000|Overall Study|Adverse Event|1|||
149887765|NCT02721732|540717308|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
149887766|NCT02721732|540717309|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
149887767|NCT02721732|540717310|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
149887768|NCT04100018|540717314|FG000|Pre-Treatment Period|Not Reported|0|||
149887769|NCT04100018|540717315|FG001|Pre-Treatment Period|Not Reported|4|||
149887770|NCT04100018|540717314|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
149887771|NCT04100018|540717315|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
150044442|NCT00068419|541302501|FG000|Overall Study|Ineligible|11|||
150044443|NCT00396253|541302507|FG000|Overall Study|Protocol Violation|1|||
149887772|NCT04100018|540717314|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
149887773|NCT04100018|540717315|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
149887774|NCT04100018|540717314|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
149887775|NCT04100018|540717315|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
149887776|NCT04100018|540717314|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
149887777|NCT04100018|540717315|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
149887778|NCT04100018|540717314|FG000|Treatment Period|Ongoing Treatment|1|||
149887779|NCT04100018|540717315|FG001|Treatment Period|Ongoing Treatment|0|||
149887780|NCT04100018|540717314|FG000|Treatment Period|Other Reason|26|||
149887781|NCT04100018|540717315|FG001|Treatment Period|Other Reason|37|||
149887782|NCT04100018|540717314|FG000|Treatment Period|Completed treatment as per protocol|1|||
149887783|NCT04100018|540717315|FG001|Treatment Period|Completed treatment as per protocol|2|||
149887784|NCT04100018|540717314|FG000|Treatment Period|Maximum clinical benefit|3|||
149887785|NCT04100018|540717315|FG001|Treatment Period|Maximum clinical benefit|0|||
149887786|NCT04100018|540717314|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
149887787|NCT04100018|540717315|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
149887788|NCT04100018|540717314|FG000|Treatment Period|Study drug toxicity|67|||
149887789|NCT04100018|540717315|FG001|Treatment Period|Study drug toxicity|28|||
149887790|NCT04100018|540717314|FG000|Treatment Period|Disease Progression|284|||
149887791|NCT04100018|540717315|FG001|Treatment Period|Disease Progression|327|||
149887792|NCT04100018|540717314|FG000|Treatment Period|Administrative reasons by sponsor|16|||
149887793|NCT04100018|540717315|FG001|Treatment Period|Administrative reasons by sponsor|30|||
149887794|NCT04100018|540717314|FG000|Treatment Period|Poor/Non-Compliance|1|||
149887795|NCT04100018|540717315|FG001|Treatment Period|Poor/Non-Compliance|0|||
149887796|NCT04100018|540717314|FG000|Treatment Period|Lost to Follow-up|2|||
149887797|NCT04100018|540717315|FG001|Treatment Period|Lost to Follow-up|2|||
149887798|NCT04100018|540717314|FG000|Treatment Period|Death|16|||
149887799|NCT04100018|540717315|FG001|Treatment Period|Death|11|||
149887800|NCT04100018|540717314|FG000|Treatment Period|Participant withdrew consent|10|||
149966743|NCT03648372|541013247|FG004|Overall Study|Progressive Disease|2|||
149966744|NCT03648372|541013248|FG005|Overall Study|Progressive Disease|2|||
149966745|NCT03648372|541013249|FG006|Overall Study|Progressive Disease|3|||
149966746|NCT03648372|541013250|FG007|Overall Study|Progressive Disease|3|||
149966747|NCT03648372|541013251|FG008|Overall Study|Progressive Disease|5|||
149966748|NCT03648372|541013252|FG009|Overall Study|Progressive Disease|5|||
149966749|NCT03648372|541013253|FG010|Overall Study|Progressive Disease|2|||
149966750|NCT03648372|541013254|FG011|Overall Study|Progressive Disease|3|||
149966751|NCT03648372|541013255|FG012|Overall Study|Progressive Disease|3|||
149966752|NCT03648372|541013256|FG013|Overall Study|Progressive Disease|3|||
149966753|NCT03648372|541013257|FG014|Overall Study|Progressive Disease|6|||
149966754|NCT03648372|541013258|FG015|Overall Study|Progressive Disease|0|||
149966755|NCT03648372|541013259|FG016|Overall Study|Progressive Disease|0|||
149966756|NCT03648372|541013260|FG017|Overall Study|Progressive Disease|0|||
149966757|NCT03648372|541013261|FG018|Overall Study|Progressive Disease|0|||
149966758|NCT03648372|541013262|FG019|Overall Study|Progressive Disease|0|||
149966759|NCT03648372|541013263|FG020|Overall Study|Progressive Disease|0|||
149966760|NCT03648372|541013243|FG000|Overall Study|Other|0|||
149966761|NCT03648372|541013244|FG001|Overall Study|Other|0|||
149966762|NCT03648372|541013245|FG002|Overall Study|Other|0|||
149966763|NCT03648372|541013246|FG003|Overall Study|Other|0|||
149966764|NCT03648372|541013247|FG004|Overall Study|Other|1|||
149966765|NCT03648372|541013248|FG005|Overall Study|Other|0|||
149966766|NCT03648372|541013249|FG006|Overall Study|Other|0|||
149887801|NCT04100018|540717315|FG001|Treatment Period|Participant withdrew consent|10|||
149887802|NCT04100018|540717314|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
149887803|NCT04100018|540717315|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
149887804|NCT04100018|540717314|FG000|Treatment Period|Adverse Event|14|||
149887805|NCT04100018|540717315|FG001|Treatment Period|Adverse Event|6|||
149887806|NCT04100018|540717314|FG000|Treatment Period|Lack of Efficacy|4|||
149887807|NCT04100018|540717315|FG001|Treatment Period|Lack of Efficacy|2|||
149887808|NCT00118157|540717319|FG000|Overall Study|Adverse Event|2|||
149887809|NCT00118157|540717319|FG000|Overall Study|Death|8|||
149966767|NCT03648372|541013250|FG007|Overall Study|Other|0|||
149966768|NCT03648372|541013251|FG008|Overall Study|Other|0|||
149966769|NCT03648372|541013252|FG009|Overall Study|Other|0|||
149966770|NCT03648372|541013253|FG010|Overall Study|Other|1|||
149887810|NCT00118157|540717319|FG000|Overall Study|Withdrawal by Subject|2|||
149966771|NCT03648372|541013254|FG011|Overall Study|Other|2|||
149966772|NCT03648372|541013255|FG012|Overall Study|Other|1|||
149966773|NCT03648372|541013256|FG013|Overall Study|Other|3|||
149966774|NCT03648372|541013257|FG014|Overall Study|Other|0|||
149966775|NCT03648372|541013258|FG015|Overall Study|Other|5|||
149966776|NCT03648372|541013259|FG016|Overall Study|Other|1|||
149966777|NCT03648372|541013260|FG017|Overall Study|Other|5|||
149966778|NCT03648372|541013261|FG018|Overall Study|Other|0|||
149966779|NCT03648372|541013262|FG019|Overall Study|Other|1|||
149966780|NCT03648372|541013263|FG020|Overall Study|Other|0|||
149966781|NCT03648372|541013243|FG000|Overall Study|Lost to Follow-up|0|||
149887811|NCT00696423|540717320|FG000|Overall Study|Lost to Follow-up|0|||
149887812|NCT00696423|540717321|FG001|Overall Study|Lost to Follow-up|5|||
149887813|NCT03989102|540717322|FG000|Year 1|Withdrawal by Subject|6|||
149887814|NCT03989102|540717323|FG001|Year 1|Withdrawal by Subject|2|||
149887815|NCT03989102|540717324|FG002|Year 1|Withdrawal by Subject|7|||
149887816|NCT03989102|540717322|FG000|Year 1|Lost to Follow-up|5|||
149887817|NCT03989102|540717323|FG001|Year 1|Lost to Follow-up|2|||
149887818|NCT03989102|540717324|FG002|Year 1|Lost to Follow-up|5|||
149966782|NCT03648372|541013244|FG001|Overall Study|Lost to Follow-up|0|||
149966783|NCT03648372|541013245|FG002|Overall Study|Lost to Follow-up|0|||
149887819|NCT03989102|540717322|FG000|Year 1|Subject met withdrawal criteria|1|||
149887820|NCT03989102|540717323|FG001|Year 1|Subject met withdrawal criteria|0|||
149887821|NCT03989102|540717324|FG002|Year 1|Subject met withdrawal criteria|1|||
149966784|NCT03648372|541013246|FG003|Overall Study|Lost to Follow-up|0|||
149966785|NCT03648372|541013247|FG004|Overall Study|Lost to Follow-up|0|||
149887822|NCT03989102|540717322|FG000|Year 2|Lost to Follow-up|7|||
149887823|NCT03989102|540717323|FG001|Year 2|Lost to Follow-up|3|||
149887824|NCT03989102|540717324|FG002|Year 2|Lost to Follow-up|4|||
149887825|NCT03989102|540717322|FG000|Year 2|Withdrawal by Subject|3|||
149887826|NCT03989102|540717323|FG001|Year 2|Withdrawal by Subject|1|||
149887827|NCT03989102|540717324|FG002|Year 2|Withdrawal by Subject|2|||
149887828|NCT03989102|540717322|FG000|Year 2|Subject non-compliant|3|||
149887829|NCT03989102|540717323|FG001|Year 2|Subject non-compliant|2|||
149887830|NCT03989102|540717324|FG002|Year 2|Subject non-compliant|0|||
149887831|NCT03989102|540717322|FG000|Year 2|Travel|1|||
149887832|NCT03989102|540717323|FG001|Year 2|Travel|0|||
149887833|NCT03989102|540717324|FG002|Year 2|Travel|1|||
149887834|NCT03989102|540717322|FG000|Year 2|P16 missing|4|||
149887835|NCT03989102|540717323|FG001|Year 2|P16 missing|2|||
149887836|NCT03989102|540717324|FG002|Year 2|P16 missing|1|||
149887837|NCT03989102|540717322|FG000|Year 2|P11 missing|1|||
149887838|NCT03989102|540717323|FG001|Year 2|P11 missing|3|||
149966786|NCT03648372|541013248|FG005|Overall Study|Lost to Follow-up|0|||
150044444|NCT00396253|541302507|FG000|Overall Study|Withdrawal by Subject|7|||
149966787|NCT03648372|541013249|FG006|Overall Study|Lost to Follow-up|0|||
149966788|NCT03648372|541013250|FG007|Overall Study|Lost to Follow-up|0|||
149966789|NCT03648372|541013251|FG008|Overall Study|Lost to Follow-up|0|||
149966790|NCT03648372|541013252|FG009|Overall Study|Lost to Follow-up|0|||
149966791|NCT03648372|541013253|FG010|Overall Study|Lost to Follow-up|0|||
149966792|NCT03648372|541013254|FG011|Overall Study|Lost to Follow-up|0|||
149966793|NCT03648372|541013255|FG012|Overall Study|Lost to Follow-up|0|||
149966794|NCT03648372|541013256|FG013|Overall Study|Lost to Follow-up|1|||
149966795|NCT03648372|541013257|FG014|Overall Study|Lost to Follow-up|0|||
149966796|NCT03648372|541013258|FG015|Overall Study|Lost to Follow-up|1|||
149966797|NCT03648372|541013259|FG016|Overall Study|Lost to Follow-up|0|||
149966798|NCT03648372|541013260|FG017|Overall Study|Lost to Follow-up|1|||
149966799|NCT03648372|541013261|FG018|Overall Study|Lost to Follow-up|0|||
149966800|NCT03648372|541013262|FG019|Overall Study|Lost to Follow-up|0|||
149966801|NCT03648372|541013263|FG020|Overall Study|Lost to Follow-up|0|||
149966802|NCT03648372|541013243|FG000|Overall Study|Start of a New Systemic Treatment|0|||
149966803|NCT03648372|541013244|FG001|Overall Study|Start of a New Systemic Treatment|0|||
149966804|NCT03648372|541013245|FG002|Overall Study|Start of a New Systemic Treatment|0|||
149966805|NCT03648372|541013246|FG003|Overall Study|Start of a New Systemic Treatment|0|||
149966806|NCT03648372|541013247|FG004|Overall Study|Start of a New Systemic Treatment|0|||
149966807|NCT03648372|541013248|FG005|Overall Study|Start of a New Systemic Treatment|0|||
149966808|NCT03648372|541013249|FG006|Overall Study|Start of a New Systemic Treatment|0|||
149966809|NCT03648372|541013250|FG007|Overall Study|Start of a New Systemic Treatment|2|||
149966810|NCT03648372|541013251|FG008|Overall Study|Start of a New Systemic Treatment|0|||
149966811|NCT03648372|541013252|FG009|Overall Study|Start of a New Systemic Treatment|0|||
149966812|NCT03648372|541013253|FG010|Overall Study|Start of a New Systemic Treatment|1|||
149966813|NCT03648372|541013254|FG011|Overall Study|Start of a New Systemic Treatment|0|||
149966814|NCT03648372|541013255|FG012|Overall Study|Start of a New Systemic Treatment|0|||
149966815|NCT03648372|541013256|FG013|Overall Study|Start of a New Systemic Treatment|0|||
149966816|NCT03648372|541013257|FG014|Overall Study|Start of a New Systemic Treatment|0|||
149966817|NCT03648372|541013258|FG015|Overall Study|Start of a New Systemic Treatment|0|||
149966818|NCT03648372|541013259|FG016|Overall Study|Start of a New Systemic Treatment|0|||
149966819|NCT03648372|541013260|FG017|Overall Study|Start of a New Systemic Treatment|0|||
149966820|NCT03648372|541013261|FG018|Overall Study|Start of a New Systemic Treatment|0|||
149966821|NCT03648372|541013262|FG019|Overall Study|Start of a New Systemic Treatment|0|||
149966822|NCT03648372|541013263|FG020|Overall Study|Start of a New Systemic Treatment|0|||
149966823|NCT03514134|541014599|FG000|Overall Study|Lost to Follow-up|0|||
149966824|NCT03514134|541014600|FG001|Overall Study|Lost to Follow-up|1|||
149966825|NCT00363298|541014611|FG000|First Study Week|Lack of Efficacy|6|||
150044445|NCT00396253|541302507|FG000|Overall Study|Death|3|||
149887839|NCT03989102|540717324|FG002|Year 2|P11 missing|7|||
149887840|NCT03989102|540717322|FG000|Year 2|Definitive displacement outside the study site|0|||
149887841|NCT03989102|540717323|FG001|Year 2|Definitive displacement outside the study site|1|||
149966826|NCT00363298|541014612|FG001|First Study Week|Lack of Efficacy|5|||
149966827|NCT00363298|541014611|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
149966828|NCT00363298|541014612|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
149966829|NCT03332056|541014614|FG000|Overall Study|Incomplete questionnaires|8|||
149966830|NCT03332056|541014615|FG001|Overall Study|Incomplete questionnaires|9|||
149966831|NCT03332056|541014614|FG000|Overall Study|Passed stone prior to surgery date|1|||
149887842|NCT03989102|540717324|FG002|Year 2|Definitive displacement outside the study site|0|||
149887843|NCT03989102|540717322|FG000|Year 2|Subject missed last study visit|0|||
149887844|NCT03989102|540717323|FG001|Year 2|Subject missed last study visit|1|||
149887845|NCT03989102|540717324|FG002|Year 2|Subject missed last study visit|0|||
149887846|NCT03989102|540717322|FG000|Year 2|Death|0|||
149887847|NCT03989102|540717323|FG001|Year 2|Death|1|||
149887848|NCT03989102|540717324|FG002|Year 2|Death|0|||
149887849|NCT03989102|540717322|FG000|Year 2|Subject not reachable|0|||
150044446|NCT00396253|541302507|FG000|Overall Study|Physician Decision|1|||
150044447|NCT00396253|541302507|FG000|Overall Study|Change in eligibility status|1|||
150044448|NCT05340478|541302510|FG000|Overall Study|Scheduling Issues|10|||
150044449|NCT05340478|541302511|FG001|Overall Study|Scheduling Issues|4|||
150044450|NCT05340478|541302510|FG000|Overall Study|Neither member of dyad started treatment|2|||
150044451|NCT05340478|541302511|FG001|Overall Study|Neither member of dyad started treatment|2|||
150044452|NCT05340478|541302510|FG000|Overall Study|Withdrawn from study|2|||
150044453|NCT05340478|541302511|FG001|Overall Study|Withdrawn from study|2|||
150044454|NCT05340478|541302510|FG000|Overall Study|Lost to Follow-up|1|||
150044455|NCT05340478|541302511|FG001|Overall Study|Lost to Follow-up|4|||
150044456|NCT00092443|541302512|FG000|Overall Study|Adverse Event|9|||
150044457|NCT00092443|541302513|FG001|Overall Study|Adverse Event|13|||
150044458|NCT00092443|541302512|FG000|Overall Study|Lost to Follow-up|7|||
150044459|NCT00092443|541302513|FG001|Overall Study|Lost to Follow-up|3|||
150044460|NCT00092443|541302512|FG000|Overall Study|Protocol Violation|11|||
150044461|NCT00092443|541302513|FG001|Overall Study|Protocol Violation|9|||
150044462|NCT00092443|541302512|FG000|Overall Study|Withdrawal by Subject|9|||
150044463|NCT00092443|541302513|FG001|Overall Study|Withdrawal by Subject|11|||
150044464|NCT00092443|541302512|FG000|Overall Study|Moved|5|||
150044465|NCT00092443|541302513|FG001|Overall Study|Moved|5|||
150044466|NCT00092443|541302512|FG000|Overall Study|Other|17|||
150044467|NCT00092443|541302513|FG001|Overall Study|Other|13|||
150044468|NCT01500720|541302518|FG000|Overall Study|Randomized But Not Treated|1|||
150044469|NCT01500720|541302519|FG001|Overall Study|Randomized But Not Treated|1|||
150044470|NCT01500720|541302518|FG000|Overall Study|Other|4|||
150044471|NCT01500720|541302519|FG001|Overall Study|Other|8|||
150044472|NCT00740857|541302521|FG000|Overall Study|Withdrawal by Subject|1|||
150044473|NCT00740857|541302522|FG001|Overall Study|Withdrawal by Subject|0|||
150044474|NCT00740857|541302523|FG002|Overall Study|Withdrawal by Subject|0|||
150044475|NCT02963506|541302524|FG000|Double-Blind Period|Adverse Event|0|||
150044476|NCT02963506|541302525|FG001|Double-Blind Period|Adverse Event|0|||
150044477|NCT02963506|541302526|FG002|Double-Blind Period|Adverse Event|1|||
150044478|NCT02963506|541302527|FG003|Double-Blind Period|Adverse Event|0|||
150044479|NCT02963506|541302528|FG004|Double-Blind Period|Adverse Event|0|||
150044480|NCT02963506|541302529|FG005|Double-Blind Period|Adverse Event|0|||
150044481|NCT02963506|541302530|FG006|Double-Blind Period|Adverse Event|0|||
149887850|NCT03989102|540717323|FG001|Year 2|Subject not reachable|0|||
149887851|NCT03989102|540717324|FG002|Year 2|Subject not reachable|1|||
149887852|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
150044482|NCT02963506|541302531|FG007|Double-Blind Period|Adverse Event|0|||
150044483|NCT02963506|541302532|FG008|Double-Blind Period|Adverse Event|0|||
150044484|NCT02963506|541302533|FG009|Double-Blind Period|Adverse Event|0|||
150044485|NCT02963506|541302534|FG010|Double-Blind Period|Adverse Event|0|||
150044486|NCT02963506|541302535|FG011|Double-Blind Period|Adverse Event|0|||
150044487|NCT02963506|541302536|FG012|Double-Blind Period|Adverse Event|0|||
150044488|NCT02963506|541302524|FG000|Double-Blind Period|Death|0|||
150044489|NCT02963506|541302525|FG001|Double-Blind Period|Death|0|||
150044490|NCT02963506|541302526|FG002|Double-Blind Period|Death|0|||
150044491|NCT02963506|541302527|FG003|Double-Blind Period|Death|1|||
150044492|NCT02963506|541302528|FG004|Double-Blind Period|Death|0|||
150044493|NCT02963506|541302529|FG005|Double-Blind Period|Death|0|||
150044494|NCT02963506|541302530|FG006|Double-Blind Period|Death|0|||
150044495|NCT02963506|541302531|FG007|Double-Blind Period|Death|0|||
150044496|NCT02963506|541302532|FG008|Double-Blind Period|Death|0|||
150044497|NCT02963506|541302533|FG009|Double-Blind Period|Death|0|||
150044498|NCT02963506|541302534|FG010|Double-Blind Period|Death|0|||
150044499|NCT02963506|541302535|FG011|Double-Blind Period|Death|0|||
150044500|NCT02963506|541302536|FG012|Double-Blind Period|Death|0|||
150175398|NCT01662336|541778518|FG000|Overall Study|No longer on LPV/r|30|||
149887853|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
149887854|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
150044501|NCT02963506|541302524|FG000|Double-Blind Period|Lost to Follow-up|0|||
150044502|NCT02963506|541302525|FG001|Double-Blind Period|Lost to Follow-up|1|||
150044503|NCT02963506|541302526|FG002|Double-Blind Period|Lost to Follow-up|0|||
149887855|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
150044504|NCT02963506|541302527|FG003|Double-Blind Period|Lost to Follow-up|0|||
150044505|NCT02963506|541302528|FG004|Double-Blind Period|Lost to Follow-up|0|||
150044506|NCT02963506|541302529|FG005|Double-Blind Period|Lost to Follow-up|0|||
150044507|NCT02963506|541302530|FG006|Double-Blind Period|Lost to Follow-up|0|||
150175399|NCT01662336|541778518|FG000|Overall Study|Other|29|||
150175400|NCT01662336|541778518|FG000|Overall Study|Withdrawal by Subject|6|||
150175401|NCT02189252|541778519|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
150175402|NCT02189252|541778520|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
150175403|NCT02189252|541778521|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
150175404|NCT02189252|541778522|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
150175405|NCT02189252|541778519|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
150175406|NCT02189252|541778520|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
150175407|NCT02189252|541778521|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
150175408|NCT02189252|541778522|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
150175409|NCT00566735|541778523|FG000|Overall Study|Withdrawal by Subject|0|||
150175410|NCT00566735|541778524|FG001|Overall Study|Withdrawal by Subject|1|||
150175411|NCT00566735|541778523|FG000|Overall Study|Refused neuropsychological testing|2|||
150175412|NCT00566735|541778524|FG001|Overall Study|Refused neuropsychological testing|5|||
150175413|NCT00566735|541778523|FG000|Overall Study|Switched into a manic episode|0|||
150175414|NCT00566735|541778524|FG001|Overall Study|Switched into a manic episode|1|||
150175415|NCT04603924|541778525|FG000|Overall Study|Not Dosed|2|||
150175416|NCT04603924|541778526|FG001|Overall Study|Not Dosed|1|||
150175417|NCT04603924|541778525|FG000|Overall Study|Withdrawal by Subject|6|||
150175418|NCT04603924|541778526|FG001|Overall Study|Withdrawal by Subject|6|||
150175419|NCT04603924|541778525|FG000|Overall Study|Adverse Event|2|||
150175420|NCT04603924|541778526|FG001|Overall Study|Adverse Event|2|||
150175421|NCT00686855|541778532|FG000|Overall Study|Lost to Follow-up|1|||
150175422|NCT00686855|541778533|FG001|Overall Study|Lost to Follow-up|0|||
150175423|NCT00686855|541778532|FG000|Overall Study|Progressive GVHD|0|||
150175424|NCT00686855|541778533|FG001|Overall Study|Progressive GVHD|1|||
150175425|NCT02731755|541778536|FG000|First Intervention|Withdrawal by Subject|0|||
150175426|NCT02731755|541778537|FG001|First Intervention|Withdrawal by Subject|2|||
150175427|NCT01460446|541778538|FG000|Overall Study|Non-compliance|2|||
150175428|NCT01460446|541778539|FG001|Overall Study|Non-compliance|9|||
150175429|NCT01460446|541778538|FG000|Overall Study|Consent Withdrawn|0|||
150175430|NCT01460446|541778539|FG001|Overall Study|Consent Withdrawn|4|||
150175431|NCT01460446|541778538|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
150175432|NCT01460446|541778539|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
150175433|NCT01460446|541778538|FG000|Overall Study|Surgery/Illness|1|||
150175434|NCT01460446|541778539|FG001|Overall Study|Surgery/Illness|1|||
150175435|NCT01460446|541778538|FG000|Overall Study|Pregnancy|1|||
150175436|NCT01460446|541778539|FG001|Overall Study|Pregnancy|0|||
150175437|NCT01460446|541778538|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
150175438|NCT01460446|541778539|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
150175439|NCT02139046|541778540|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
150175440|NCT02139046|541778541|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
150175441|NCT02139046|541778542|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
150175442|NCT02139046|541778543|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
150175443|NCT02139046|541778544|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
150175444|NCT02139046|541778540|FG000|Overall Study|Major Protocol Deviation|9|||
150175445|NCT02139046|541778541|FG001|Overall Study|Major Protocol Deviation|10|||
150175446|NCT02139046|541778542|FG002|Overall Study|Major Protocol Deviation|16|||
150175447|NCT02139046|541778543|FG003|Overall Study|Major Protocol Deviation|12|||
150175448|NCT02139046|541778544|FG004|Overall Study|Major Protocol Deviation|6|||
150175449|NCT02139046|541778540|FG000|Overall Study|Lost to Follow-up|13|||
150175450|NCT02139046|541778541|FG001|Overall Study|Lost to Follow-up|16|||
150175451|NCT02139046|541778542|FG002|Overall Study|Lost to Follow-up|16|||
150175452|NCT02139046|541778543|FG003|Overall Study|Lost to Follow-up|18|||
150175453|NCT02139046|541778544|FG004|Overall Study|Lost to Follow-up|13|||
150175454|NCT02139046|541778540|FG000|Overall Study|Voluntary Withdrawal|20|||
150175455|NCT02139046|541778541|FG001|Overall Study|Voluntary Withdrawal|8|||
150175456|NCT02139046|541778542|FG002|Overall Study|Voluntary Withdrawal|10|||
149887856|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
149887857|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
149887858|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
149887859|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
150175457|NCT02139046|541778543|FG003|Overall Study|Voluntary Withdrawal|15|||
150175458|NCT02139046|541778544|FG004|Overall Study|Voluntary Withdrawal|16|||
150175459|NCT02139046|541778540|FG000|Overall Study|Lack of Efficacy|0|||
150175460|NCT02139046|541778541|FG001|Overall Study|Lack of Efficacy|1|||
150175461|NCT02139046|541778542|FG002|Overall Study|Lack of Efficacy|2|||
150175462|NCT02139046|541778543|FG003|Overall Study|Lack of Efficacy|1|||
149887860|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
150175463|NCT02139046|541778544|FG004|Overall Study|Lack of Efficacy|2|||
150175464|NCT02139046|541778540|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
150175465|NCT02139046|541778541|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
150175466|NCT02139046|541778542|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
150175467|NCT02139046|541778543|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
150175468|NCT02139046|541778544|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
150175469|NCT02139046|541778540|FG000|Overall Study|Other Miscellaneous Reasons|10|||
149887861|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
149887862|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
149887863|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
149887864|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
149887865|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
149887866|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
149887867|NCT03989102|540717322|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
149887868|NCT03989102|540717323|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
149887869|NCT03989102|540717324|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
149887870|NCT00818766|540717325|FG000|Overall Study|Could not be Contacted on Day 28|11|||
149887871|NCT00818766|540717326|FG001|Overall Study|Could not be Contacted on Day 28|10|||
149887872|NCT00818766|540717325|FG000|Overall Study|Death|1|||
149887873|NCT00818766|540717326|FG001|Overall Study|Death|0|||
149887874|NCT00818766|540717325|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
149887875|NCT00818766|540717326|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
149887876|NCT00970593|540717327|FG000|Overall Study|Adverse Event|1|||
149887877|NCT00970593|540717328|FG001|Overall Study|Adverse Event|1|||
149887878|NCT00970593|540717329|FG002|Overall Study|Adverse Event|0|||
149887879|NCT00970593|540717330|FG003|Overall Study|Adverse Event|0|||
149887880|NCT00970593|540717331|FG004|Overall Study|Adverse Event|0|||
149887881|NCT00970593|540717332|FG005|Overall Study|Adverse Event|0|||
149887882|NCT00970593|540717333|FG006|Overall Study|Adverse Event|0|||
149887883|NCT00970593|540717327|FG000|Overall Study|Discontinuation of study by sponsor|0|||
149887884|NCT00970593|540717328|FG001|Overall Study|Discontinuation of study by sponsor|0|||
149887885|NCT00970593|540717329|FG002|Overall Study|Discontinuation of study by sponsor|5|||
149887886|NCT00970593|540717330|FG003|Overall Study|Discontinuation of study by sponsor|0|||
149887887|NCT00970593|540717331|FG004|Overall Study|Discontinuation of study by sponsor|0|||
149887888|NCT00970593|540717332|FG005|Overall Study|Discontinuation of study by sponsor|0|||
149887889|NCT00970593|540717333|FG006|Overall Study|Discontinuation of study by sponsor|2|||
149887890|NCT00970593|540717327|FG000|Overall Study|Withdrawal by Subject|0|||
149887891|NCT00970593|540717328|FG001|Overall Study|Withdrawal by Subject|0|||
149887892|NCT00970593|540717329|FG002|Overall Study|Withdrawal by Subject|1|||
149887893|NCT00970593|540717330|FG003|Overall Study|Withdrawal by Subject|0|||
149887894|NCT00970593|540717331|FG004|Overall Study|Withdrawal by Subject|0|||
149887895|NCT00970593|540717332|FG005|Overall Study|Withdrawal by Subject|0|||
149887896|NCT00970593|540717333|FG006|Overall Study|Withdrawal by Subject|0|||
149887897|NCT00942357|540717347|FG000|Overall Study|Ineligible|37|||
149887898|NCT00942357|540717348|FG001|Overall Study|Ineligible|40|||
149887899|NCT01321879|540717349|FG000|Overall Study|Lack of Efficacy|5|||
149966832|NCT03332056|541014615|FG001|Overall Study|Passed stone prior to surgery date|0|||
149966833|NCT03332056|541014614|FG000|Overall Study|Did not require a ureteral stent|0|||
149966834|NCT03332056|541014615|FG001|Overall Study|Did not require a ureteral stent|1|||
149966835|NCT02374255|541014616|FG000|Overall Study|Withdrawal by Subject|2|||
149966836|NCT02374255|541014617|FG001|Overall Study|Withdrawal by Subject|0|||
149966837|NCT02374255|541014618|FG002|Overall Study|Withdrawal by Subject|0|||
149966838|NCT02374255|541014619|FG003|Overall Study|Withdrawal by Subject|0|||
149966839|NCT02093520|541014620|FG000|Overall Study|Not treated|6|||
149966840|NCT02093520|541014621|FG001|Overall Study|Not treated|22|||
149966841|NCT03014089|541014622|FG000|Overall Study|Withdrawal by Subject|0|||
149966842|NCT03014089|541014623|FG001|Overall Study|Withdrawal by Subject|1|||
149966843|NCT03014089|541014624|FG002|Overall Study|Withdrawal by Subject|1|||
149966844|NCT03014089|541014625|FG003|Overall Study|Withdrawal by Subject|1|||
149966845|NCT03014089|541014622|FG000|Overall Study|Lost to Follow-up|1|||
149966846|NCT03014089|541014623|FG001|Overall Study|Lost to Follow-up|0|||
149966847|NCT03014089|541014624|FG002|Overall Study|Lost to Follow-up|0|||
149966848|NCT03014089|541014625|FG003|Overall Study|Lost to Follow-up|0|||
149966849|NCT03014089|541014622|FG000|Overall Study|Adverse Event|1|||
149966850|NCT03014089|541014623|FG001|Overall Study|Adverse Event|0|||
149966851|NCT03014089|541014624|FG002|Overall Study|Adverse Event|1|||
149966852|NCT03014089|541014625|FG003|Overall Study|Adverse Event|0|||
149966853|NCT00321932|541014626|FG000|Overall Study|Death|3|||
149966854|NCT00321932|541014627|FG001|Overall Study|Death|6|||
149966855|NCT00321932|541014626|FG000|Overall Study|Withdrawal by Subject|3|||
149966856|NCT00321932|541014627|FG001|Overall Study|Withdrawal by Subject|6|||
149966857|NCT00321932|541014626|FG000|Overall Study|Early relapse|2|||
149966858|NCT00321932|541014627|FG001|Overall Study|Early relapse|8|||
149966859|NCT00321932|541014626|FG000|Overall Study|Missing data|2|||
149966860|NCT00321932|541014627|FG001|Overall Study|Missing data|1|||
149966861|NCT03360344|541014630|FG000|Overall Study|Withdrawal by Subject|0|||
149966862|NCT03360344|541014631|FG001|Overall Study|Withdrawal by Subject|1|||
149966863|NCT03360344|541014632|FG002|Overall Study|Withdrawal by Subject|1|||
149966864|NCT00133705|541014637|FG000|Overall Study|Withdrawal by Subject|2|||
149966865|NCT00133705|541014638|FG001|Overall Study|Withdrawal by Subject|3|||
149966866|NCT01892189|541014647|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
149966867|NCT01892189|541014648|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
149966868|NCT01892189|541014649|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
149966869|NCT01892189|541014650|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
149966870|NCT01892189|541014651|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
149966871|NCT01892189|541014652|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
149966872|NCT01892189|541014653|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
149966873|NCT01892189|541014654|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
149966874|NCT01892189|541014655|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
150044508|NCT02963506|541302531|FG007|Double-Blind Period|Lost to Follow-up|0|||
149887900|NCT01321879|540717349|FG000|Overall Study|Adverse Event|5|||
149887901|NCT01321879|540717349|FG000|Overall Study|Death|3|||
149887902|NCT01321879|540717349|FG000|Overall Study|Withdrawal by Subject|1|||
149887903|NCT00793871|540717350|FG000|Overall Study|Death|50|||
149887904|NCT00793871|540717350|FG000|Overall Study|Lost to Follow-up|3|||
149887905|NCT00793871|540717350|FG000|Overall Study|Study terminated by the Sponsor|7|||
149887906|NCT05767905|540717351|FG000|Overall Study|Adverse Event|0|||
149966875|NCT01892189|541014647|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149966876|NCT01892189|541014648|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149966877|NCT01892189|541014649|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
149966878|NCT01892189|541014650|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149966879|NCT01892189|541014651|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149887907|NCT05767905|540717352|FG001|Overall Study|Adverse Event|0|||
149887908|NCT05767905|540717353|FG002|Overall Study|Adverse Event|1|||
149887909|NCT03125798|540717354|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
149887910|NCT03125798|540717355|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
149887911|NCT03125798|540717354|FG000|Overall Study|Conversion to thoracotomy|7|||
149887912|NCT03125798|540717355|FG001|Overall Study|Conversion to thoracotomy|7|||
149887913|NCT02635984|540717356|FG000|Overall Study|Lost to Follow-up|2|||
149887914|NCT02635984|540717357|FG001|Overall Study|Lost to Follow-up|4|||
149887915|NCT02635984|540717356|FG000|Overall Study|Study Arm Closed|1|||
149887916|NCT02635984|540717357|FG001|Overall Study|Study Arm Closed|0|||
149887917|NCT00307086|540717358|FG000|Overall Study|ineligible|5|||
149887918|NCT00100828|540717359|FG000|Overall Study|Physician Decision|6|||
149887919|NCT01176513|540717360|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
149887920|NCT04583735|540717361|FG000|Double-masked Treatment Period|Adverse Event|0|||
149887921|NCT04583735|540717362|FG001|Double-masked Treatment Period|Adverse Event|1|||
149887922|NCT04583735|540717361|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
149887923|NCT04583735|540717362|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
149887924|NCT04583735|540717361|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
149887925|NCT04583735|540717362|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
149887926|NCT04583735|540717361|FG000|Open-label Treatment Period|Adverse Event|1|||
149887927|NCT04583735|540717362|FG001|Open-label Treatment Period|Adverse Event|1|||
149887928|NCT04583735|540717361|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
149887929|NCT04583735|540717362|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
149887930|NCT04583735|540717361|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
149887931|NCT04583735|540717362|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
149887932|NCT01125917|540717363|FG000|Overall Study|Adverse Event|43|||
149887933|NCT01125917|540717363|FG000|Overall Study|Lost to Follow-up|23|||
149887934|NCT01125917|540717363|FG000|Overall Study|Withdrawal by Subject|31|||
149887935|NCT01125917|540717363|FG000|Overall Study|Administrative|223|||
149887936|NCT01125917|540717363|FG000|Overall Study|Lack of Efficacy|19|||
149887937|NCT01197911|540717364|FG000|Overall Study|Adverse Event|0|||
149887938|NCT01197911|540717365|FG001|Overall Study|Adverse Event|0|||
149887939|NCT01197911|540717366|FG002|Overall Study|Adverse Event|1|||
149887940|NCT00786409|540717372|FG000|Overall Study|Withdrawal by Subject|2|||
149887941|NCT00786409|540717372|FG000|Overall Study|Adverse Event|2|||
149887942|NCT00786409|540717372|FG000|Overall Study|Pregnancy|2|||
149887943|NCT00786409|540717372|FG000|Overall Study|Lost to Follow-up|1|||
149887944|NCT00610129|540717373|FG000|Overall Study|Not treated since patients ineligible|3|||
149887945|NCT01042093|540717376|FG000|Overall Study|Protocol Violation|2|||
149887946|NCT01042093|540717377|FG001|Overall Study|Protocol Violation|2|||
149887947|NCT01042093|540717378|FG002|Overall Study|Protocol Violation|2|||
149887948|NCT01042093|540717379|FG003|Overall Study|Protocol Violation|3|||
149887949|NCT01042093|540717376|FG000|Overall Study|Withdrawal by Subject|0|||
149887950|NCT01042093|540717377|FG001|Overall Study|Withdrawal by Subject|0|||
149887951|NCT01042093|540717378|FG002|Overall Study|Withdrawal by Subject|0|||
149887952|NCT01042093|540717379|FG003|Overall Study|Withdrawal by Subject|1|||
149887953|NCT04331808|540717380|FG000|Overall Study|Withdrew consent|1|||
149887954|NCT04331808|540717381|FG001|Overall Study|Withdrew consent|0|||
149887955|NCT04331808|540717382|FG002|Overall Study|Withdrew consent|2|||
149887956|NCT04331808|540717383|FG003|Overall Study|Withdrew consent|3|||
149887957|NCT00952731|540717384|FG000|Overall Study|Drug supply expired|1|||
149887958|NCT00952731|540717385|FG001|Overall Study|Drug supply expired|0|||
149887959|NCT00243412|540717387|FG000|Overall Study|Death|0|||
149887960|NCT00243412|540717388|FG001|Overall Study|Death|1|||
149887961|NCT00243412|540717387|FG000|Overall Study|Adverse Event|4|||
149887962|NCT00243412|540717388|FG001|Overall Study|Adverse Event|2|||
149887963|NCT00243412|540717387|FG000|Overall Study|Lost to Follow-up|0|||
149887964|NCT00243412|540717388|FG001|Overall Study|Lost to Follow-up|1|||
149887965|NCT00243412|540717387|FG000|Overall Study|Physician Decision|1|||
149887966|NCT00243412|540717388|FG001|Overall Study|Physician Decision|1|||
149887967|NCT00243412|540717387|FG000|Overall Study|Withdrawal by Subject|4|||
149887968|NCT00243412|540717388|FG001|Overall Study|Withdrawal by Subject|5|||
149887969|NCT00243412|540717387|FG000|Overall Study|Other|1|||
149887970|NCT00243412|540717388|FG001|Overall Study|Other|1|||
149887971|NCT00041132|540717389|FG000|Overall Study|Adverse Event|19|||
149887972|NCT00041132|540717389|FG000|Overall Study|Death|1|||
149887973|NCT00041132|540717389|FG000|Overall Study|Not Eligible|7|||
149887974|NCT00041132|540717389|FG000|Overall Study|Withdrawal by Subject|1|||
149887975|NCT00041132|540717389|FG000|Overall Study|Physician Decision|2|||
149887976|NCT00995774|540717393|FG000|Training Period 2|Withdrawal by Subject|2|||
149887977|NCT00995774|540717394|FG001|Training Period 2|Withdrawal by Subject|0|||
149887978|NCT01808573|540717395|FG000|Overall Study|Death|212|||
149887979|NCT01808573|540717396|FG001|Overall Study|Death|240|||
149887980|NCT01808573|540717395|FG000|Overall Study|Withdrawal by Subject|12|||
149887981|NCT01808573|540717396|FG001|Overall Study|Withdrawal by Subject|10|||
149887982|NCT01808573|540717395|FG000|Overall Study|Lost to Follow-up|3|||
149887983|NCT01808573|540717396|FG001|Overall Study|Lost to Follow-up|0|||
149887984|NCT01808573|540717395|FG000|Overall Study|Discontinuation of study by sponsor|79|||
149887985|NCT01808573|540717396|FG001|Overall Study|Discontinuation of study by sponsor|64|||
149966880|NCT01892189|541014652|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
150175470|NCT02139046|541778541|FG001|Overall Study|Other Miscellaneous Reasons|9|||
150175471|NCT02139046|541778542|FG002|Overall Study|Other Miscellaneous Reasons|4|||
150175472|NCT02139046|541778543|FG003|Overall Study|Other Miscellaneous Reasons|9|||
150175473|NCT02139046|541778544|FG004|Overall Study|Other Miscellaneous Reasons|12|||
150175474|NCT01582100|541778548|FG000|Overall Study|Adverse Event|1|||
150175475|NCT01582100|541778548|FG000|Overall Study|Withdrawal by Subject|1|||
150175476|NCT01040689|541778549|FG000|Overall Study|Adverse Event|0|||
150175477|NCT01040689|541778550|FG001|Overall Study|Adverse Event|0|||
150175478|NCT01040689|541778551|FG002|Overall Study|Adverse Event|2|||
150175479|NCT01040689|541778552|FG003|Overall Study|Adverse Event|4|||
150175480|NCT01040689|541778549|FG000|Overall Study|Lack of Efficacy|0|||
150175481|NCT01040689|541778550|FG001|Overall Study|Lack of Efficacy|0|||
150175482|NCT01040689|541778551|FG002|Overall Study|Lack of Efficacy|1|||
150175483|NCT01040689|541778552|FG003|Overall Study|Lack of Efficacy|0|||
150175484|NCT01040689|541778549|FG000|Overall Study|Lost to Follow-up|1|||
150175485|NCT01040689|541778550|FG001|Overall Study|Lost to Follow-up|0|||
150175486|NCT01040689|541778551|FG002|Overall Study|Lost to Follow-up|0|||
150175487|NCT01040689|541778552|FG003|Overall Study|Lost to Follow-up|0|||
150175488|NCT01040689|541778549|FG000|Overall Study|Withdrawal by Subject|2|||
150175489|NCT01040689|541778550|FG001|Overall Study|Withdrawal by Subject|1|||
150175490|NCT01040689|541778551|FG002|Overall Study|Withdrawal by Subject|1|||
150175491|NCT01040689|541778552|FG003|Overall Study|Withdrawal by Subject|0|||
150175492|NCT01040689|541778549|FG000|Overall Study|Other reasons not listed above|0|||
150175493|NCT01040689|541778550|FG001|Overall Study|Other reasons not listed above|1|||
150175494|NCT01040689|541778551|FG002|Overall Study|Other reasons not listed above|0|||
150175495|NCT01040689|541778552|FG003|Overall Study|Other reasons not listed above|0|||
150175496|NCT05876949|541778553|FG000|Overall Study|Withdrawal by Subject|1|||
150175497|NCT05876949|541778554|FG001|Overall Study|Withdrawal by Subject|3|||
150175498|NCT05876949|541778553|FG000|Overall Study|Physician Decision|0|||
150175499|NCT05876949|541778554|FG001|Overall Study|Physician Decision|2|||
150175500|NCT05876949|541778553|FG000|Overall Study|Death|0|||
150175501|NCT05876949|541778554|FG001|Overall Study|Death|1|||
150175502|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
150175503|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
150175504|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
150175505|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
150175506|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
150175507|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
150175508|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
149966881|NCT01892189|541014653|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149966882|NCT01892189|541014654|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149966883|NCT01892189|541014655|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149966884|NCT01892189|541014647|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966885|NCT01892189|541014648|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966886|NCT01892189|541014649|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966887|NCT01892189|541014650|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966888|NCT01892189|541014651|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966889|NCT01892189|541014652|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
149966890|NCT01892189|541014653|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966891|NCT01892189|541014654|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966892|NCT01892189|541014655|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
149966893|NCT01992757|541014658|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
149966894|NCT03440411|541014659|FG000|Overall Study|Adverse Event|0|||
150175509|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
150175510|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
150175511|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
150175512|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
150175513|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
149966895|NCT03440411|541014660|FG001|Overall Study|Adverse Event|0|||
149887986|NCT01808573|540717395|FG000|Overall Study|Randomized in Error|1|||
149887987|NCT01808573|540717396|FG001|Overall Study|Randomized in Error|0|||
149887988|NCT03953612|540717399|FG000|Overall Study|Randomized but did not start|1|||
149887989|NCT03953612|540717400|FG001|Overall Study|Randomized but did not start|1|||
149887990|NCT03953612|540717401|FG002|Overall Study|Randomized but did not start|1|||
149887991|NCT03953612|540717399|FG000|Overall Study|Withdrawal by Subject|2|||
149887992|NCT03953612|540717400|FG001|Overall Study|Withdrawal by Subject|1|||
150044509|NCT02963506|541302532|FG008|Double-Blind Period|Lost to Follow-up|0|||
150044510|NCT02963506|541302533|FG009|Double-Blind Period|Lost to Follow-up|0|||
149887993|NCT03953612|540717401|FG002|Overall Study|Withdrawal by Subject|0|||
149887994|NCT03485352|540717402|FG000|Overall Study|Lost to Follow-up|9|||
149887995|NCT00141778|540717413|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
149887996|NCT00141778|540717414|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
149887997|NCT00141778|540717415|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
149887998|NCT00141778|540717413|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
149887999|NCT00141778|540717414|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
149888000|NCT00141778|540717415|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
149888001|NCT00141778|540717413|FG000|Started Study Medication|Withdrawal by Subject|0|||
149888002|NCT00141778|540717414|FG001|Started Study Medication|Withdrawal by Subject|2|||
149888003|NCT00141778|540717415|FG002|Started Study Medication|Withdrawal by Subject|0|||
149888004|NCT00141778|540717413|FG000|Started Study Medication|Difficulty Swallowing|0|||
149888005|NCT00141778|540717414|FG001|Started Study Medication|Difficulty Swallowing|1|||
149888006|NCT00141778|540717415|FG002|Started Study Medication|Difficulty Swallowing|0|||
149888007|NCT00141778|540717413|FG000|Started Study Medication|Chest Discomfort|0|||
149888008|NCT00141778|540717414|FG001|Started Study Medication|Chest Discomfort|0|||
149966896|NCT03440411|541014661|FG002|Overall Study|Adverse Event|1|||
149888009|NCT00141778|540717415|FG002|Started Study Medication|Chest Discomfort|1|||
149966897|NCT03440411|541014662|FG003|Overall Study|Adverse Event|0|||
149888010|NCT05655546|540719103|FG000|Overall Study|Withdrawal by Subject|2|||
149888011|NCT05655546|540719104|FG001|Overall Study|Withdrawal by Subject|4|||
149888012|NCT04576507|540719105|FG000|Overall Study|Adverse Event|4|||
149888013|NCT04576507|540719105|FG000|Overall Study|Withdrawal by Subject|1|||
149888014|NCT04467840|540719106|FG000|Overall Study|Death|35|||
149888015|NCT04467840|540719107|FG001|Overall Study|Death|39|||
149888016|NCT04467840|540719106|FG000|Overall Study|Withdrawal by Subject|8|||
149888017|NCT04467840|540719107|FG001|Overall Study|Withdrawal by Subject|4|||
149888018|NCT04467840|540719106|FG000|Overall Study|Adverse Event|2|||
149888019|NCT04467840|540719107|FG001|Overall Study|Adverse Event|0|||
149888020|NCT04467840|540719106|FG000|Overall Study|Lost to Follow-up|1|||
149888021|NCT04467840|540719107|FG001|Overall Study|Lost to Follow-up|3|||
149888022|NCT04467840|540719106|FG000|Overall Study|Physician Decision|1|||
149888023|NCT04467840|540719107|FG001|Overall Study|Physician Decision|0|||
149888024|NCT04467840|540719106|FG000|Overall Study|Other|1|||
149888025|NCT04467840|540719107|FG001|Overall Study|Other|5|||
149888026|NCT04467840|540719106|FG000|Overall Study|Missing study completion status|3|||
149888027|NCT04467840|540719107|FG001|Overall Study|Missing study completion status|1|||
149888028|NCT00711243|540719112|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
149888029|NCT00711243|540719113|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
149888030|NCT00711243|540719114|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
149888031|NCT00711243|540719115|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
149888032|NCT00711243|540719116|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
149888033|NCT00711243|540719117|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
149888034|NCT00711243|540719112|FG000|Reached First Response/4 Cycles|Death|0|||
149888035|NCT00711243|540719113|FG001|Reached First Response/4 Cycles|Death|0|||
149888036|NCT00711243|540719114|FG002|Reached First Response/4 Cycles|Death|0|||
149888037|NCT00711243|540719115|FG003|Reached First Response/4 Cycles|Death|0|||
149888038|NCT00711243|540719116|FG004|Reached First Response/4 Cycles|Death|0|||
149888039|NCT00711243|540719117|FG005|Reached First Response/4 Cycles|Death|2|||
149888040|NCT00711243|540719112|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
149888041|NCT00711243|540719113|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
149888042|NCT00711243|540719114|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
149888043|NCT00711243|540719115|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
149888044|NCT00711243|540719116|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
149888045|NCT00711243|540719117|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
149888046|NCT00711243|540719112|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
149888047|NCT00711243|540719113|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
149888048|NCT00711243|540719114|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
149888049|NCT00711243|540719115|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
149888050|NCT00711243|540719116|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
149888051|NCT00711243|540719117|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
149888052|NCT00711243|540719112|FG000|Treated Cycle 5 After First Response|Death|0|||
149888053|NCT00711243|540719113|FG001|Treated Cycle 5 After First Response|Death|0|||
149888054|NCT00711243|540719114|FG002|Treated Cycle 5 After First Response|Death|0|||
149888055|NCT00711243|540719115|FG003|Treated Cycle 5 After First Response|Death|0|||
149888056|NCT00711243|540719116|FG004|Treated Cycle 5 After First Response|Death|0|||
149888057|NCT00711243|540719117|FG005|Treated Cycle 5 After First Response|Death|2|||
149888058|NCT00711243|540719112|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
149888059|NCT00711243|540719113|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
149888060|NCT00711243|540719114|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
149888061|NCT00711243|540719115|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
149888062|NCT00711243|540719116|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
149888063|NCT00711243|540719117|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
149888064|NCT00711243|540719112|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
149888065|NCT00711243|540719113|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
149888066|NCT00711243|540719114|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
149888067|NCT00711243|540719115|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
149888068|NCT00711243|540719116|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
149888069|NCT00711243|540719117|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
149888070|NCT05989672|540719118|FG000|Overall Study|Adverse Event|3|||
149888071|NCT05989672|540719119|FG001|Overall Study|Adverse Event|0|||
149888072|NCT05989672|540719120|FG002|Overall Study|Adverse Event|0|||
149888073|NCT01962103|540719124|FG000|Phase 1|Adverse Event|4|||
149888074|NCT01962103|540719125|FG001|Phase 1|Adverse Event|0|||
149888075|NCT01962103|540719126|FG002|Phase 1|Adverse Event|2|||
149888076|NCT01962103|540719127|FG003|Phase 1|Adverse Event|1|||
149888077|NCT01962103|540719128|FG004|Phase 1|Adverse Event|2|||
149888078|NCT01962103|540719129|FG005|Phase 1|Adverse Event|2|||
149888079|NCT01962103|540719130|FG006|Phase 1|Adverse Event|0|||
149888080|NCT01962103|540719131|FG007|Phase 1|Adverse Event|0|||
149888081|NCT01962103|540719132|FG008|Phase 1|Adverse Event|0|||
149888082|NCT01962103|540719124|FG000|Phase 1|Progressive Disease|8|||
149888083|NCT01962103|540719125|FG001|Phase 1|Progressive Disease|6|||
150044511|NCT02963506|541302534|FG010|Double-Blind Period|Lost to Follow-up|0|||
150044512|NCT02963506|541302535|FG011|Double-Blind Period|Lost to Follow-up|0|||
150044513|NCT02963506|541302536|FG012|Double-Blind Period|Lost to Follow-up|0|||
150044514|NCT02963506|541302524|FG000|Double-Blind Period|Withdrawal by Subject|0|||
150044515|NCT02963506|541302525|FG001|Double-Blind Period|Withdrawal by Subject|0|||
150044516|NCT02963506|541302526|FG002|Double-Blind Period|Withdrawal by Subject|1|||
150044517|NCT02963506|541302527|FG003|Double-Blind Period|Withdrawal by Subject|1|||
150044518|NCT02963506|541302528|FG004|Double-Blind Period|Withdrawal by Subject|0|||
150044519|NCT02963506|541302529|FG005|Double-Blind Period|Withdrawal by Subject|0|||
150044520|NCT02963506|541302530|FG006|Double-Blind Period|Withdrawal by Subject|0|||
150044521|NCT02963506|541302531|FG007|Double-Blind Period|Withdrawal by Subject|0|||
150044522|NCT02963506|541302532|FG008|Double-Blind Period|Withdrawal by Subject|0|||
150044523|NCT02963506|541302533|FG009|Double-Blind Period|Withdrawal by Subject|0|||
150044524|NCT02963506|541302534|FG010|Double-Blind Period|Withdrawal by Subject|0|||
150044525|NCT02963506|541302535|FG011|Double-Blind Period|Withdrawal by Subject|0|||
150044526|NCT02963506|541302536|FG012|Double-Blind Period|Withdrawal by Subject|0|||
150044527|NCT02963506|541302524|FG000|Double-Blind Period|No compliance|0|||
150044528|NCT02963506|541302525|FG001|Double-Blind Period|No compliance|1|||
150044529|NCT02963506|541302526|FG002|Double-Blind Period|No compliance|0|||
150044530|NCT02963506|541302527|FG003|Double-Blind Period|No compliance|0|||
150044531|NCT02963506|541302528|FG004|Double-Blind Period|No compliance|0|||
150044532|NCT02963506|541302529|FG005|Double-Blind Period|No compliance|0|||
150044533|NCT02963506|541302530|FG006|Double-Blind Period|No compliance|0|||
150044534|NCT02963506|541302531|FG007|Double-Blind Period|No compliance|0|||
150044535|NCT02963506|541302532|FG008|Double-Blind Period|No compliance|0|||
150044536|NCT02963506|541302533|FG009|Double-Blind Period|No compliance|0|||
150044537|NCT02963506|541302534|FG010|Double-Blind Period|No compliance|0|||
150044538|NCT02963506|541302535|FG011|Double-Blind Period|No compliance|0|||
150044539|NCT02963506|541302536|FG012|Double-Blind Period|No compliance|0|||
150044540|NCT02963506|541302524|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044541|NCT02963506|541302525|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
150044542|NCT02963506|541302526|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044543|NCT02963506|541302527|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044544|NCT02963506|541302528|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044545|NCT02963506|541302529|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044546|NCT02963506|541302530|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044547|NCT02963506|541302531|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044548|NCT02963506|541302532|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044549|NCT02963506|541302533|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
149888084|NCT01962103|540719126|FG002|Phase 1|Progressive Disease|8|||
149888085|NCT01962103|540719127|FG003|Phase 1|Progressive Disease|4|||
149888086|NCT01962103|540719128|FG004|Phase 1|Progressive Disease|5|||
150044550|NCT02963506|541302534|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
149888087|NCT01962103|540719129|FG005|Phase 1|Progressive Disease|4|||
149888088|NCT01962103|540719130|FG006|Phase 1|Progressive Disease|0|||
149888089|NCT01962103|540719131|FG007|Phase 1|Progressive Disease|0|||
150044551|NCT02963506|541302535|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044552|NCT02963506|541302536|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
150044553|NCT02963506|541302524|FG000|Dose-Blind Period|Adverse Event|0|||
150044554|NCT02963506|541302525|FG001|Dose-Blind Period|Adverse Event|0|||
150044555|NCT02963506|541302526|FG002|Dose-Blind Period|Adverse Event|0|||
150175514|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
149888090|NCT01962103|540719132|FG008|Phase 1|Progressive Disease|0|||
149888091|NCT01962103|540719124|FG000|Phase 1|Withdrawal by Subject|0|||
149888092|NCT01962103|540719125|FG001|Phase 1|Withdrawal by Subject|0|||
149888093|NCT01962103|540719126|FG002|Phase 1|Withdrawal by Subject|0|||
149888094|NCT01962103|540719127|FG003|Phase 1|Withdrawal by Subject|2|||
149888095|NCT01962103|540719128|FG004|Phase 1|Withdrawal by Subject|0|||
149888096|NCT01962103|540719129|FG005|Phase 1|Withdrawal by Subject|0|||
149888097|NCT01962103|540719130|FG006|Phase 1|Withdrawal by Subject|0|||
149888098|NCT01962103|540719131|FG007|Phase 1|Withdrawal by Subject|0|||
149888099|NCT01962103|540719132|FG008|Phase 1|Withdrawal by Subject|0|||
149888100|NCT01962103|540719124|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
149888101|NCT01962103|540719125|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
149888102|NCT01962103|540719126|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
149888103|NCT01962103|540719127|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
149888104|NCT01962103|540719128|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
149888105|NCT01962103|540719129|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
149888106|NCT01962103|540719130|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
149888107|NCT01962103|540719131|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
149888108|NCT01962103|540719132|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
149888109|NCT01962103|540719124|FG000|Phase 1|Physician Decision|0|||
149888110|NCT01962103|540719125|FG001|Phase 1|Physician Decision|0|||
149888111|NCT01962103|540719126|FG002|Phase 1|Physician Decision|0|||
149888112|NCT01962103|540719127|FG003|Phase 1|Physician Decision|1|||
149888113|NCT01962103|540719128|FG004|Phase 1|Physician Decision|0|||
149888114|NCT01962103|540719129|FG005|Phase 1|Physician Decision|0|||
149888115|NCT01962103|540719130|FG006|Phase 1|Physician Decision|0|||
149888116|NCT01962103|540719131|FG007|Phase 1|Physician Decision|0|||
149888117|NCT01962103|540719132|FG008|Phase 1|Physician Decision|0|||
149888118|NCT01962103|540719124|FG000|Phase 1|Symptomatic Deterioration|3|||
149888119|NCT01962103|540719125|FG001|Phase 1|Symptomatic Deterioration|2|||
149888120|NCT01962103|540719126|FG002|Phase 1|Symptomatic Deterioration|2|||
150175515|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
150175516|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
150175517|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
150175518|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
150175519|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
150175520|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
149888121|NCT01962103|540719127|FG003|Phase 1|Symptomatic Deterioration|2|||
149888122|NCT01962103|540719128|FG004|Phase 1|Symptomatic Deterioration|1|||
149888123|NCT01962103|540719129|FG005|Phase 1|Symptomatic Deterioration|1|||
149888124|NCT01962103|540719130|FG006|Phase 1|Symptomatic Deterioration|0|||
149888125|NCT01962103|540719131|FG007|Phase 1|Symptomatic Deterioration|0|||
150175521|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
150175522|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
150175523|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
150175524|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
150175525|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
150175526|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
150175527|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
149888126|NCT01962103|540719132|FG008|Phase 1|Symptomatic Deterioration|0|||
149888127|NCT01962103|540719124|FG000|Phase 1|Miscellaneous|1|||
149888128|NCT01962103|540719125|FG001|Phase 1|Miscellaneous|0|||
149888129|NCT01962103|540719126|FG002|Phase 1|Miscellaneous|0|||
149888130|NCT01962103|540719127|FG003|Phase 1|Miscellaneous|0|||
150175528|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
150175529|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
149888131|NCT01962103|540719128|FG004|Phase 1|Miscellaneous|0|||
149888132|NCT01962103|540719129|FG005|Phase 1|Miscellaneous|0|||
149888133|NCT01962103|540719130|FG006|Phase 1|Miscellaneous|0|||
149888134|NCT01962103|540719131|FG007|Phase 1|Miscellaneous|0|||
149888135|NCT01962103|540719132|FG008|Phase 1|Miscellaneous|0|||
149888136|NCT01962103|540719124|FG000|Phase 2|Adverse Event|0|||
149888137|NCT01962103|540719125|FG001|Phase 2|Adverse Event|0|||
149888138|NCT01962103|540719126|FG002|Phase 2|Adverse Event|0|||
149888139|NCT01962103|540719127|FG003|Phase 2|Adverse Event|0|||
149888140|NCT01962103|540719128|FG004|Phase 2|Adverse Event|0|||
149888141|NCT01962103|540719129|FG005|Phase 2|Adverse Event|0|||
149888142|NCT01962103|540719130|FG006|Phase 2|Adverse Event|1|||
149888143|NCT01962103|540719131|FG007|Phase 2|Adverse Event|0|||
149888144|NCT01962103|540719132|FG008|Phase 2|Adverse Event|3|||
150175530|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
150175531|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
150175532|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
150175533|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
150175534|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
150175535|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
150175536|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
150175537|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
150175538|NCT03593213|541778559|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
150175539|NCT03593213|541778560|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
150175540|NCT03593213|541778561|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
150175541|NCT03593213|541778562|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
150175542|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
150175543|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
150175544|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
150175545|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
150175546|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
150175547|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
150175548|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
150175549|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
150175550|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
150175551|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
150175552|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
150175553|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
150175554|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
150175555|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
150175556|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
150175557|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
150175558|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
150175559|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
150175560|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
150175561|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
150175562|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
150175563|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
150175564|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
150175565|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
150175566|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
150175567|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
150175568|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
150175569|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
150175570|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
150175571|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
150175572|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
150175573|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
150175574|NCT03593213|541778559|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
150175575|NCT03593213|541778560|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
150175576|NCT03593213|541778561|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
150175577|NCT03593213|541778562|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
150175578|NCT00668863|541778563|FG000|Overall Study|Objective Progression or Relapse|42|||
150175579|NCT00668863|541778563|FG000|Overall Study|Adverse Event|13|||
150175580|NCT00668863|541778563|FG000|Overall Study|Study Terminated by Sponsor|8|||
150175581|NCT00668863|541778563|FG000|Overall Study|Global Deterioration of Health Status|4|||
150175582|NCT00668863|541778563|FG000|Overall Study|Withdrawal by Subject|1|||
150175583|NCT00668863|541778563|FG000|Overall Study|Surgery|1|||
150175584|NCT00668863|541778563|FG000|Overall Study|Subject's work scheduling problem|1|||
150175585|NCT00668863|541778563|FG000|Overall Study|Physician Decision|1|||
150175586|NCT00869323|541778566|FG000|Maintenance Therapy|concurrent illness|1|||
150175587|NCT01068743|541778567|FG000|Period 3|Adverse Event|0|||
150175588|NCT01068743|541778568|FG001|Period 3|Adverse Event|1|||
150175589|NCT01068743|541778569|FG002|Period 3|Adverse Event|0|||
150175590|NCT01068743|541778570|FG003|Period 3|Adverse Event|0|||
150175591|NCT00638963|541778571|FG000|Overall Study|Withdrawal by Subject|1|||
149888145|NCT01962103|540719124|FG000|Phase 2|Progressive Disease|0|||
149888146|NCT01962103|540719125|FG001|Phase 2|Progressive Disease|0|||
149888147|NCT01962103|540719126|FG002|Phase 2|Progressive Disease|0|||
149888148|NCT01962103|540719127|FG003|Phase 2|Progressive Disease|0|||
149888149|NCT01962103|540719128|FG004|Phase 2|Progressive Disease|0|||
149888150|NCT01962103|540719129|FG005|Phase 2|Progressive Disease|0|||
149888151|NCT01962103|540719130|FG006|Phase 2|Progressive Disease|11|||
149888152|NCT01962103|540719131|FG007|Phase 2|Progressive Disease|12|||
149888153|NCT01962103|540719132|FG008|Phase 2|Progressive Disease|11|||
149888154|NCT01962103|540719124|FG000|Phase 2|Symptomatic Deterioration|0|||
149888155|NCT01962103|540719125|FG001|Phase 2|Symptomatic Deterioration|0|||
149966898|NCT03440411|541014659|FG000|Overall Study|PD|2|||
149966899|NCT03440411|541014660|FG001|Overall Study|PD|1|||
149966900|NCT03440411|541014661|FG002|Overall Study|PD|1|||
149966901|NCT03440411|541014662|FG003|Overall Study|PD|1|||
149966902|NCT03440411|541014659|FG000|Overall Study|Withdrawal by Subject|1|||
149966903|NCT03440411|541014660|FG001|Overall Study|Withdrawal by Subject|0|||
149966904|NCT03440411|541014661|FG002|Overall Study|Withdrawal by Subject|0|||
149966905|NCT03440411|541014662|FG003|Overall Study|Withdrawal by Subject|0|||
149966906|NCT03440411|541014659|FG000|Overall Study|Closed study by sponsor|0|||
149966907|NCT03440411|541014660|FG001|Overall Study|Closed study by sponsor|0|||
149966908|NCT03440411|541014661|FG002|Overall Study|Closed study by sponsor|0|||
149966909|NCT03440411|541014662|FG003|Overall Study|Closed study by sponsor|1|||
149966910|NCT00688740|541014663|FG000|Overall Study|Adverse Event|45|||
149966911|NCT00688740|541014664|FG001|Overall Study|Adverse Event|8|||
149966912|NCT00688740|541014663|FG000|Overall Study|Death|2|||
149966913|NCT00688740|541014664|FG001|Overall Study|Death|2|||
149966914|NCT00688740|541014663|FG000|Overall Study|Lost to Follow-up|0|||
149966915|NCT00688740|541014664|FG001|Overall Study|Lost to Follow-up|1|||
149966916|NCT00688740|541014663|FG000|Overall Study|Consent Withdrawn|17|||
149966917|NCT00688740|541014664|FG001|Overall Study|Consent Withdrawn|17|||
149966918|NCT00688740|541014663|FG000|Overall Study|Breast Cancer Relapse|1|||
149966919|NCT00688740|541014664|FG001|Overall Study|Breast Cancer Relapse|4|||
149966920|NCT00688740|541014663|FG000|Overall Study|Violation of Inclusion Criteria|1|||
149966921|NCT00688740|541014664|FG001|Overall Study|Violation of Inclusion Criteria|3|||
149966922|NCT01344356|541014665|FG000|Overall Study|Physician Decision|0|||
149966923|NCT01344356|541014666|FG001|Overall Study|Physician Decision|3|||
149966924|NCT01344356|541014665|FG000|Overall Study|Lost to Follow-up|0|||
149966925|NCT01344356|541014666|FG001|Overall Study|Lost to Follow-up|6|||
149966926|NCT00095576|541014667|FG000|Overall Study|Adverse Event|5|||
149966927|NCT00095576|541014668|FG001|Overall Study|Adverse Event|3|||
149966928|NCT00095576|541014667|FG000|Overall Study|Lost to Follow-up|233|||
149966929|NCT00095576|541014668|FG001|Overall Study|Lost to Follow-up|229|||
149966930|NCT00095576|541014667|FG000|Overall Study|Protocol Violation|1|||
149966931|NCT00095576|541014668|FG001|Overall Study|Protocol Violation|0|||
149966932|NCT00095576|541014667|FG000|Overall Study|Withdrawal by Subject|34|||
149966933|NCT00095576|541014668|FG001|Overall Study|Withdrawal by Subject|47|||
149966934|NCT00095576|541014667|FG000|Overall Study|Option to switch to a rollover study|1097|||
149966935|NCT00095576|541014668|FG001|Overall Study|Option to switch to a rollover study|1099|||
149966936|NCT00095576|541014667|FG000|Overall Study|Site terminated|75|||
149966937|NCT00095576|541014668|FG001|Overall Study|Site terminated|67|||
149966938|NCT00095576|541014667|FG000|Overall Study|Subject moved|30|||
149966939|NCT00095576|541014668|FG001|Overall Study|Subject moved|36|||
149966940|NCT00856557|541014671|FG000|Overall Study|No patients with contextual flags|12|||
149966941|NCT00856557|541014672|FG001|Overall Study|No patients with contextual flags|16|||
149966942|NCT02327169|541014673|FG000|Overall Study|Progressive Disease|1|||
149966943|NCT02327169|541014674|FG001|Overall Study|Progressive Disease|3|||
149966944|NCT02327169|541014675|FG002|Overall Study|Progressive Disease|4|||
149966945|NCT02327169|541014676|FG003|Overall Study|Progressive Disease|3|||
149966946|NCT02327169|541014677|FG004|Overall Study|Progressive Disease|4|||
149966947|NCT02327169|541014678|FG005|Overall Study|Progressive Disease|3|||
150044556|NCT02963506|541302527|FG003|Dose-Blind Period|Adverse Event|0|||
149888156|NCT01962103|540719126|FG002|Phase 2|Symptomatic Deterioration|0|||
149888157|NCT01962103|540719127|FG003|Phase 2|Symptomatic Deterioration|0|||
149888158|NCT01962103|540719128|FG004|Phase 2|Symptomatic Deterioration|0|||
149888159|NCT01962103|540719129|FG005|Phase 2|Symptomatic Deterioration|0|||
149888160|NCT01962103|540719130|FG006|Phase 2|Symptomatic Deterioration|2|||
149966948|NCT02327169|541014679|FG006|Overall Study|Progressive Disease|3|||
149966949|NCT02327169|541014680|FG007|Overall Study|Progressive Disease|3|||
149966950|NCT02327169|541014681|FG008|Overall Study|Progressive Disease|4|||
149966951|NCT02327169|541014682|FG009|Overall Study|Progressive Disease|4|||
149966952|NCT02327169|541014683|FG010|Overall Study|Progressive Disease|4|||
149966953|NCT02327169|541014684|FG011|Overall Study|Progressive Disease|3|||
149966954|NCT02327169|541014685|FG012|Overall Study|Progressive Disease|1|||
149966955|NCT02327169|541014686|FG013|Overall Study|Progressive Disease|3|||
149966956|NCT02327169|541014687|FG014|Overall Study|Progressive Disease|3|||
149966957|NCT02327169|541014673|FG000|Overall Study|Adverse Event|2|||
149966958|NCT02327169|541014674|FG001|Overall Study|Adverse Event|0|||
149888161|NCT01962103|540719131|FG007|Phase 2|Symptomatic Deterioration|2|||
149966959|NCT02327169|541014675|FG002|Overall Study|Adverse Event|1|||
149888162|NCT01962103|540719132|FG008|Phase 2|Symptomatic Deterioration|0|||
149888163|NCT01321749|540719133|FG000|Overall Study|Lost to Follow-up|4|||
149888164|NCT01321749|540719134|FG001|Overall Study|Lost to Follow-up|11|||
149888165|NCT01321749|540719133|FG000|Overall Study|Protocol Violation|4|||
149888166|NCT01321749|540719134|FG001|Overall Study|Protocol Violation|7|||
149888167|NCT01321749|540719133|FG000|Overall Study|Withdrawal by Subject|5|||
149888168|NCT01321749|540719134|FG001|Overall Study|Withdrawal by Subject|4|||
149888169|NCT04179838|540719138|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
149888170|NCT04179838|540719139|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
149888171|NCT04179838|540719138|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
149888172|NCT04179838|540719139|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
149888173|NCT02763046|540719144|FG000|Overall Study|Adverse Event|5|||
149888174|NCT02763046|540719145|FG001|Overall Study|Adverse Event|4|||
149888175|NCT02763046|540719146|FG002|Overall Study|Adverse Event|0|||
149888176|NCT02763046|540719144|FG000|Overall Study|Lack of Efficacy|1|||
149888177|NCT02763046|540719145|FG001|Overall Study|Lack of Efficacy|1|||
149888178|NCT02763046|540719146|FG002|Overall Study|Lack of Efficacy|3|||
149888179|NCT02763046|540719144|FG000|Overall Study|Physician Decision|1|||
149888180|NCT02763046|540719145|FG001|Overall Study|Physician Decision|0|||
149888181|NCT02763046|540719146|FG002|Overall Study|Physician Decision|1|||
149888182|NCT02763046|540719144|FG000|Overall Study|Subject/guardian decision|2|||
149888183|NCT02763046|540719145|FG001|Overall Study|Subject/guardian decision|0|||
149966960|NCT02327169|541014676|FG003|Overall Study|Adverse Event|0|||
149966961|NCT02327169|541014677|FG004|Overall Study|Adverse Event|1|||
149966962|NCT02327169|541014678|FG005|Overall Study|Adverse Event|0|||
149966963|NCT02327169|541014679|FG006|Overall Study|Adverse Event|0|||
149966964|NCT02327169|541014680|FG007|Overall Study|Adverse Event|0|||
149966965|NCT02327169|541014681|FG008|Overall Study|Adverse Event|0|||
149966966|NCT02327169|541014682|FG009|Overall Study|Adverse Event|2|||
149966967|NCT02327169|541014683|FG010|Overall Study|Adverse Event|0|||
149966968|NCT02327169|541014684|FG011|Overall Study|Adverse Event|3|||
149966969|NCT02327169|541014685|FG012|Overall Study|Adverse Event|0|||
149966970|NCT02327169|541014686|FG013|Overall Study|Adverse Event|2|||
149966971|NCT02327169|541014687|FG014|Overall Study|Adverse Event|1|||
149966972|NCT02327169|541014673|FG000|Overall Study|Symptomatic Deterioration|0|||
149966973|NCT02327169|541014674|FG001|Overall Study|Symptomatic Deterioration|0|||
149966974|NCT02327169|541014675|FG002|Overall Study|Symptomatic Deterioration|1|||
149966975|NCT02327169|541014676|FG003|Overall Study|Symptomatic Deterioration|0|||
149966976|NCT02327169|541014677|FG004|Overall Study|Symptomatic Deterioration|1|||
149966977|NCT02327169|541014678|FG005|Overall Study|Symptomatic Deterioration|1|||
149966978|NCT02327169|541014679|FG006|Overall Study|Symptomatic Deterioration|0|||
149966979|NCT02327169|541014680|FG007|Overall Study|Symptomatic Deterioration|0|||
149966980|NCT02327169|541014681|FG008|Overall Study|Symptomatic Deterioration|2|||
149966981|NCT02327169|541014682|FG009|Overall Study|Symptomatic Deterioration|1|||
149966982|NCT02327169|541014683|FG010|Overall Study|Symptomatic Deterioration|0|||
149966983|NCT02327169|541014684|FG011|Overall Study|Symptomatic Deterioration|0|||
149966984|NCT02327169|541014685|FG012|Overall Study|Symptomatic Deterioration|0|||
149966985|NCT02327169|541014686|FG013|Overall Study|Symptomatic Deterioration|2|||
149966986|NCT02327169|541014687|FG014|Overall Study|Symptomatic Deterioration|1|||
149966987|NCT02327169|541014673|FG000|Overall Study|Reason Not Specified|0|||
149966988|NCT02327169|541014674|FG001|Overall Study|Reason Not Specified|0|||
149966989|NCT02327169|541014675|FG002|Overall Study|Reason Not Specified|1|||
149966990|NCT02327169|541014676|FG003|Overall Study|Reason Not Specified|0|||
149966991|NCT02327169|541014677|FG004|Overall Study|Reason Not Specified|0|||
149966992|NCT02327169|541014678|FG005|Overall Study|Reason Not Specified|0|||
149966993|NCT02327169|541014679|FG006|Overall Study|Reason Not Specified|0|||
149966994|NCT02327169|541014680|FG007|Overall Study|Reason Not Specified|0|||
149966995|NCT02327169|541014681|FG008|Overall Study|Reason Not Specified|0|||
149966996|NCT02327169|541014682|FG009|Overall Study|Reason Not Specified|1|||
149966997|NCT02327169|541014683|FG010|Overall Study|Reason Not Specified|2|||
149966998|NCT02327169|541014684|FG011|Overall Study|Reason Not Specified|1|||
149966999|NCT02327169|541014685|FG012|Overall Study|Reason Not Specified|0|||
149967000|NCT02327169|541014686|FG013|Overall Study|Reason Not Specified|0|||
149967001|NCT02327169|541014687|FG014|Overall Study|Reason Not Specified|2|||
149967002|NCT02327169|541014673|FG000|Overall Study|Withdrawal by Subject|1|||
149967003|NCT02327169|541014674|FG001|Overall Study|Withdrawal by Subject|0|||
149967004|NCT02327169|541014675|FG002|Overall Study|Withdrawal by Subject|0|||
149888184|NCT02763046|540719146|FG002|Overall Study|Subject/guardian decision|4|||
149888185|NCT00086684|540719149|FG000|Overall Study|Adverse Event|12|||
149888186|NCT00086684|540719150|FG001|Overall Study|Adverse Event|17|||
149888187|NCT00086684|540719151|FG002|Overall Study|Adverse Event|14|||
149888188|NCT00086684|540719149|FG000|Overall Study|Lack of Efficacy|6|||
149888189|NCT00086684|540719150|FG001|Overall Study|Lack of Efficacy|6|||
149888190|NCT00086684|540719151|FG002|Overall Study|Lack of Efficacy|5|||
149888191|NCT00086684|540719149|FG000|Overall Study|Lost to Follow-up|15|||
149888192|NCT00086684|540719150|FG001|Overall Study|Lost to Follow-up|8|||
149888193|NCT00086684|540719151|FG002|Overall Study|Lost to Follow-up|10|||
149888194|NCT00086684|540719149|FG000|Overall Study|Protocol Violation|8|||
149888195|NCT00086684|540719150|FG001|Overall Study|Protocol Violation|3|||
149888196|NCT00086684|540719151|FG002|Overall Study|Protocol Violation|0|||
149888197|NCT00086684|540719149|FG000|Overall Study|Withdrawal by Subject|0|||
149888198|NCT00086684|540719150|FG001|Overall Study|Withdrawal by Subject|4|||
149888199|NCT00086684|540719151|FG002|Overall Study|Withdrawal by Subject|10|||
149888200|NCT00086684|540719149|FG000|Overall Study|NONCOMPLIANCE|5|||
149888201|NCT00086684|540719150|FG001|Overall Study|NONCOMPLIANCE|7|||
149888202|NCT00086684|540719151|FG002|Overall Study|NONCOMPLIANCE|6|||
149888203|NCT00086684|540719149|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149888204|NCT00086684|540719150|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
149888205|NCT00086684|540719151|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
149888206|NCT00086684|540719149|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
149888207|NCT00086684|540719150|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
149888208|NCT00086684|540719151|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
149888209|NCT00086684|540719149|FG000|Overall Study|Other|4|||
149888210|NCT00086684|540719150|FG001|Overall Study|Other|2|||
149888211|NCT00086684|540719151|FG002|Overall Study|Other|3|||
149888212|NCT01067105|540719154|FG000|Overall Study|Adverse Event|14|||
149888213|NCT01067105|540719154|FG000|Overall Study|Protocol Violation|48|||
149888214|NCT01067105|540719154|FG000|Overall Study|Withdrawal by Subject|36|||
149888215|NCT01067105|540719154|FG000|Overall Study|Lost to Follow-up|6|||
149888216|NCT01067105|540719154|FG000|Overall Study|Physician Decision|6|||
149888217|NCT01067105|540719154|FG000|Overall Study|Other|31|||
149888218|NCT02203357|540719158|FG000|Overall Study|Lost to Follow-up|58|||
149888219|NCT02203357|540719159|FG001|Overall Study|Lost to Follow-up|66|||
149888220|NCT02203357|540719160|FG002|Overall Study|Lost to Follow-up|70|||
149888221|NCT02288312|540719161|FG000|Overall Study|Pregnancy|1|||
149888222|NCT02288312|540719162|FG001|Overall Study|Pregnancy|0|||
149888223|NCT02288312|540719163|FG002|Overall Study|Pregnancy|0|||
149888224|NCT01276041|540719164|FG000|Overall Study|Adverse Event|2|||
149888225|NCT01276041|540719164|FG000|Overall Study|Protocol Violation|1|||
149888226|NCT01495000|540719165|FG000|Overall Study|Lost to Follow-up|2|||
149888227|NCT01495000|540719166|FG001|Overall Study|Lost to Follow-up|2|||
149888228|NCT01495000|540719165|FG000|Overall Study|Protocol Violation|1|||
149888229|NCT01495000|540719166|FG001|Overall Study|Protocol Violation|0|||
149888230|NCT01495000|540719165|FG000|Overall Study|Withdrawal by Subject|10|||
149888231|NCT01495000|540719166|FG001|Overall Study|Withdrawal by Subject|10|||
149888232|NCT02070965|540719167|FG000|Overall Study|Lost to Follow-up|0|||
149888233|NCT02070965|540719168|FG001|Overall Study|Lost to Follow-up|1|||
149888234|NCT02070965|540719169|FG002|Overall Study|Lost to Follow-up|0|||
149888235|NCT02070965|540719167|FG000|Overall Study|Withdrawal by Subject|1|||
149888236|NCT02070965|540719168|FG001|Overall Study|Withdrawal by Subject|1|||
149888237|NCT02070965|540719169|FG002|Overall Study|Withdrawal by Subject|1|||
149888238|NCT02070965|540719167|FG000|Overall Study|Subject moved|1|||
149888239|NCT02070965|540719168|FG001|Overall Study|Subject moved|0|||
149888240|NCT02070965|540719169|FG002|Overall Study|Subject moved|0|||
149888241|NCT03347110|540719171|FG000|Overall Study|Other (Participant is incarcerated)|1|||
149888242|NCT03347110|540719171|FG000|Overall Study|Withdrawal by Subject|9|||
149888243|NCT03347110|540719171|FG000|Overall Study|Lost to Follow-up|1|||
149888244|NCT03347110|540719171|FG000|Overall Study|Lack of Efficacy|2|||
149888245|NCT03347110|540719171|FG000|Overall Study|Adverse Event, non-fatal|9|||
149888246|NCT00116779|540719172|FG000|Overall Study|Adverse Event|4|||
149888247|NCT00116779|540719173|FG001|Overall Study|Adverse Event|2|||
149888248|NCT00116779|540719172|FG000|Overall Study|Protocol Violation|1|||
149888249|NCT00116779|540719173|FG001|Overall Study|Protocol Violation|4|||
149888250|NCT00116779|540719172|FG000|Overall Study|Withdrawal by Subject|4|||
149888251|NCT00116779|540719173|FG001|Overall Study|Withdrawal by Subject|1|||
149888252|NCT00116779|540719172|FG000|Overall Study|Inadequate testosterone suppression|7|||
149888253|NCT00116779|540719173|FG001|Overall Study|Inadequate testosterone suppression|9|||
149888254|NCT00116779|540719172|FG000|Overall Study|Physician Decision|3|||
149888255|NCT00116779|540719173|FG001|Overall Study|Physician Decision|1|||
149888256|NCT00116779|540719172|FG000|Overall Study|Elevated PSA levels|2|||
149888257|NCT00116779|540719173|FG001|Overall Study|Elevated PSA levels|2|||
149888258|NCT00707239|540719175|FG000|Overall Study|Adverse Event|5|||
149888259|NCT00707239|540719176|FG001|Overall Study|Adverse Event|3|||
149888260|NCT00707239|540719177|FG002|Overall Study|Adverse Event|2|||
149888261|NCT00707239|540719175|FG000|Overall Study|Death|3|||
149888262|NCT00707239|540719176|FG001|Overall Study|Death|1|||
149888263|NCT00707239|540719177|FG002|Overall Study|Death|3|||
149888264|NCT00707239|540719175|FG000|Overall Study|Physician Decision|1|||
149888265|NCT00707239|540719176|FG001|Overall Study|Physician Decision|1|||
149888266|NCT00707239|540719177|FG002|Overall Study|Physician Decision|2|||
149888267|NCT00707239|540719175|FG000|Overall Study|Protocol Violation|0|||
149888268|NCT00707239|540719176|FG001|Overall Study|Protocol Violation|0|||
149888269|NCT00707239|540719177|FG002|Overall Study|Protocol Violation|1|||
149888270|NCT00707239|540719175|FG000|Overall Study|Lack of Efficacy|1|||
149888271|NCT00707239|540719176|FG001|Overall Study|Lack of Efficacy|2|||
149888272|NCT00707239|540719177|FG002|Overall Study|Lack of Efficacy|0|||
149888273|NCT00707239|540719175|FG000|Overall Study|Randomized, but not treated|1|||
149888274|NCT00707239|540719176|FG001|Overall Study|Randomized, but not treated|1|||
149888275|NCT00707239|540719177|FG002|Overall Study|Randomized, but not treated|1|||
149888276|NCT00707239|540719175|FG000|Overall Study|Other|8|||
149888277|NCT00707239|540719176|FG001|Overall Study|Other|3|||
149888278|NCT00707239|540719177|FG002|Overall Study|Other|5|||
149888279|NCT01778530|540719178|FG000|Overall Study|Progression on study|1|||
149888280|NCT01778530|540719178|FG000|Overall Study|Adverse event/side effect|1|||
149888281|NCT03442751|540719181|FG000|Overall Study|Withdrawal by Subject|3|||
149888282|NCT03442751|540719182|FG001|Overall Study|Withdrawal by Subject|1|||
149888283|NCT03442751|540719181|FG000|Overall Study|Lost to Follow-up|3|||
149888284|NCT03442751|540719182|FG001|Overall Study|Lost to Follow-up|0|||
149888285|NCT01928472|540719183|FG000|Overall Study|Death|0|||
149888286|NCT01928472|540719184|FG001|Overall Study|Death|0|||
149888287|NCT01928472|540719185|FG002|Overall Study|Death|1|||
149888288|NCT01928472|540719186|FG003|Overall Study|Death|0|||
149888289|NCT01928472|540719183|FG000|Overall Study|Withdrawal by Subject|4|||
149888290|NCT01928472|540719184|FG001|Overall Study|Withdrawal by Subject|4|||
149888291|NCT01928472|540719185|FG002|Overall Study|Withdrawal by Subject|1|||
149888292|NCT01928472|540719186|FG003|Overall Study|Withdrawal by Subject|2|||
149888293|NCT01928472|540719183|FG000|Overall Study|Lost to Follow-up|2|||
149888294|NCT01928472|540719184|FG001|Overall Study|Lost to Follow-up|3|||
149888295|NCT01928472|540719185|FG002|Overall Study|Lost to Follow-up|4|||
149888296|NCT01928472|540719186|FG003|Overall Study|Lost to Follow-up|0|||
149888297|NCT01928472|540719183|FG000|Overall Study|Administrative Reason|2|||
149888298|NCT01928472|540719184|FG001|Overall Study|Administrative Reason|1|||
149888299|NCT01928472|540719185|FG002|Overall Study|Administrative Reason|0|||
149888300|NCT01928472|540719186|FG003|Overall Study|Administrative Reason|0|||
149888301|NCT01928472|540719183|FG000|Overall Study|Unclassified|0|||
149888302|NCT01928472|540719184|FG001|Overall Study|Unclassified|0|||
149888303|NCT01928472|540719185|FG002|Overall Study|Unclassified|1|||
149888304|NCT01928472|540719186|FG003|Overall Study|Unclassified|0|||
149888305|NCT00312338|540719193|FG000|Overall Study|Adverse Event|7|||
149888306|NCT00312338|540719194|FG001|Overall Study|Adverse Event|2|||
149888307|NCT00312338|540719193|FG000|Overall Study|Lost to Follow-up|9|||
149888308|NCT00312338|540719194|FG001|Overall Study|Lost to Follow-up|1|||
149888309|NCT00312338|540719193|FG000|Overall Study|Withdrawal by Subject|4|||
149888310|NCT00312338|540719194|FG001|Overall Study|Withdrawal by Subject|0|||
149888311|NCT00312338|540719193|FG000|Overall Study|Subsequent infection|2|||
150044557|NCT02963506|541302528|FG004|Dose-Blind Period|Adverse Event|0|||
149888312|NCT00312338|540719194|FG001|Overall Study|Subsequent infection|0|||
150044558|NCT02963506|541302529|FG005|Dose-Blind Period|Adverse Event|1|||
150044559|NCT02963506|541302530|FG006|Dose-Blind Period|Adverse Event|3|||
150044560|NCT02963506|541302531|FG007|Dose-Blind Period|Adverse Event|2|||
150044561|NCT02963506|541302532|FG008|Dose-Blind Period|Adverse Event|2|||
150044562|NCT02963506|541302533|FG009|Dose-Blind Period|Adverse Event|2|||
150044563|NCT02963506|541302534|FG010|Dose-Blind Period|Adverse Event|1|||
150175592|NCT00638963|541778572|FG001|Overall Study|Withdrawal by Subject|0|||
150175593|NCT02755116|541778579|FG000|Overall Study|surgery converted to open, pt admitted|3|||
150175594|NCT02755116|541778580|FG001|Overall Study|surgery converted to open, pt admitted|1|||
149967005|NCT02327169|541014676|FG003|Overall Study|Withdrawal by Subject|0|||
149967006|NCT02327169|541014677|FG004|Overall Study|Withdrawal by Subject|1|||
149967007|NCT02327169|541014678|FG005|Overall Study|Withdrawal by Subject|0|||
149967008|NCT02327169|541014679|FG006|Overall Study|Withdrawal by Subject|0|||
149967009|NCT02327169|541014680|FG007|Overall Study|Withdrawal by Subject|1|||
149967010|NCT02327169|541014681|FG008|Overall Study|Withdrawal by Subject|0|||
149967011|NCT02327169|541014682|FG009|Overall Study|Withdrawal by Subject|0|||
149967012|NCT02327169|541014683|FG010|Overall Study|Withdrawal by Subject|0|||
149967013|NCT02327169|541014684|FG011|Overall Study|Withdrawal by Subject|0|||
149967014|NCT02327169|541014685|FG012|Overall Study|Withdrawal by Subject|0|||
149967015|NCT02327169|541014686|FG013|Overall Study|Withdrawal by Subject|0|||
149967016|NCT02327169|541014687|FG014|Overall Study|Withdrawal by Subject|3|||
149967017|NCT02327169|541014673|FG000|Overall Study|Lost to Follow-up|0|||
149967018|NCT02327169|541014674|FG001|Overall Study|Lost to Follow-up|0|||
149967019|NCT02327169|541014675|FG002|Overall Study|Lost to Follow-up|0|||
149967020|NCT02327169|541014676|FG003|Overall Study|Lost to Follow-up|0|||
149967021|NCT02327169|541014677|FG004|Overall Study|Lost to Follow-up|1|||
149967022|NCT02327169|541014678|FG005|Overall Study|Lost to Follow-up|0|||
149967023|NCT02327169|541014679|FG006|Overall Study|Lost to Follow-up|0|||
149967024|NCT02327169|541014680|FG007|Overall Study|Lost to Follow-up|0|||
149967025|NCT02327169|541014681|FG008|Overall Study|Lost to Follow-up|0|||
149967026|NCT02327169|541014682|FG009|Overall Study|Lost to Follow-up|0|||
149967027|NCT02327169|541014683|FG010|Overall Study|Lost to Follow-up|0|||
149967028|NCT02327169|541014684|FG011|Overall Study|Lost to Follow-up|0|||
149967029|NCT02327169|541014685|FG012|Overall Study|Lost to Follow-up|0|||
149967030|NCT02327169|541014686|FG013|Overall Study|Lost to Follow-up|0|||
149967031|NCT02327169|541014687|FG014|Overall Study|Lost to Follow-up|0|||
149967032|NCT02743221|541014691|FG000|Overall Study|Progressive disease|29|||
149967033|NCT02743221|541014692|FG001|Overall Study|Progressive disease|38|||
149967034|NCT02743221|541014691|FG000|Overall Study|Adverse Event|17|||
149967035|NCT02743221|541014692|FG001|Overall Study|Adverse Event|14|||
149967036|NCT02743221|541014691|FG000|Overall Study|non medical reason|8|||
149967037|NCT02743221|541014692|FG001|Overall Study|non medical reason|2|||
149967038|NCT02743221|541014691|FG000|Overall Study|Physician Decision|2|||
149967039|NCT02743221|541014692|FG001|Overall Study|Physician Decision|5|||
149967040|NCT02743221|541014691|FG000|Overall Study|Patient not eligible, not treated|0|||
149967041|NCT02743221|541014692|FG001|Overall Study|Patient not eligible, not treated|1|||
149967042|NCT03528902|541014693|FG000|Overall Study|Adverse Event|1|||
149967043|NCT03528902|541014694|FG001|Overall Study|Adverse Event|0|||
149967044|NCT04620668|541014696|FG000|Overall Study|Withdrawal by Subject|2|||
149967045|NCT04620668|541014697|FG001|Overall Study|Withdrawal by Subject|0|||
149967046|NCT04620668|541014696|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
149967047|NCT04620668|541014697|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
149967048|NCT04620668|541014696|FG000|Overall Study|Removed before analysis: missing data|2|||
150044564|NCT02963506|541302535|FG011|Dose-Blind Period|Adverse Event|1|||
149967049|NCT04620668|541014697|FG001|Overall Study|Removed before analysis: missing data|0|||
149967050|NCT04620668|541014696|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
150044565|NCT02963506|541302536|FG012|Dose-Blind Period|Adverse Event|6|||
150175595|NCT02200770|541778581|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
150175596|NCT02200770|541778582|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
150175597|NCT02200770|541778581|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
150175598|NCT02200770|541778582|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
150175599|NCT02200770|541778581|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
150175600|NCT02200770|541778582|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
150175601|NCT02200770|541778581|FG000|Randomized-controlled Period (RCP)|Other|1|||
150175602|NCT02200770|541778582|FG001|Randomized-controlled Period (RCP)|Other|2|||
150175603|NCT02200770|541778581|FG000|Open-label Period (OLP)|Adverse Event|1|||
150175604|NCT02200770|541778582|FG001|Open-label Period (OLP)|Adverse Event|2|||
150175605|NCT02200770|541778581|FG000|Open-label Period (OLP)|Death|1|||
150175606|NCT02200770|541778582|FG001|Open-label Period (OLP)|Death|2|||
150175607|NCT02200770|541778581|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
150175608|NCT02200770|541778582|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
150175609|NCT02200770|541778581|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
150175610|NCT02200770|541778582|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
150175611|NCT02200770|541778581|FG000|Open-label Period (OLP)|Other|6|||
150175612|NCT02200770|541778582|FG001|Open-label Period (OLP)|Other|15|||
150175613|NCT01124734|541778584|FG000|Overall Study|Disease progression|13|||
150175614|NCT01124734|541778584|FG000|Overall Study|Adverse Event|1|||
150175615|NCT01124734|541778584|FG000|Overall Study|Withdrawal by Subject|1|||
150175616|NCT01124734|541778584|FG000|Overall Study|Elected for alternative treatment|2|||
150175617|NCT01510717|541778586|FG000|Overall Study|Adverse Event|1|||
150175618|NCT01510717|541778587|FG001|Overall Study|Adverse Event|2|||
150175619|NCT01510717|541778586|FG000|Overall Study|Death|1|||
150175620|NCT01510717|541778587|FG001|Overall Study|Death|0|||
150175621|NCT01510717|541778586|FG000|Overall Study|Lost to Follow-up|0|||
150175622|NCT01510717|541778587|FG001|Overall Study|Lost to Follow-up|1|||
150175623|NCT01510717|541778586|FG000|Overall Study|Withdrawal by Subject|0|||
150175624|NCT01510717|541778587|FG001|Overall Study|Withdrawal by Subject|2|||
150175625|NCT02555215|541778590|FG000|Overall Study|Other|1|||
150175626|NCT02555215|541778590|FG000|Overall Study|Investigator Decision|2|||
150175627|NCT00529789|541778591|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
150175628|NCT00529789|541778591|FG000|Study Period II/III|Adverse Event|3|||
150175629|NCT00529789|541778591|FG000|Study Period II/III|Lack of Efficacy|2|||
150044566|NCT02963506|541302524|FG000|Dose-Blind Period|Lack of Efficacy|0|||
150044567|NCT02963506|541302525|FG001|Dose-Blind Period|Lack of Efficacy|0|||
150044568|NCT02963506|541302526|FG002|Dose-Blind Period|Lack of Efficacy|0|||
150044569|NCT02963506|541302527|FG003|Dose-Blind Period|Lack of Efficacy|0|||
150044570|NCT02963506|541302528|FG004|Dose-Blind Period|Lack of Efficacy|0|||
150044571|NCT02963506|541302529|FG005|Dose-Blind Period|Lack of Efficacy|0|||
150044572|NCT02963506|541302530|FG006|Dose-Blind Period|Lack of Efficacy|0|||
150044573|NCT02963506|541302531|FG007|Dose-Blind Period|Lack of Efficacy|1|||
150044574|NCT02963506|541302532|FG008|Dose-Blind Period|Lack of Efficacy|0|||
150044575|NCT02963506|541302533|FG009|Dose-Blind Period|Lack of Efficacy|1|||
150044576|NCT02963506|541302534|FG010|Dose-Blind Period|Lack of Efficacy|0|||
150044577|NCT02963506|541302535|FG011|Dose-Blind Period|Lack of Efficacy|0|||
150044578|NCT02963506|541302536|FG012|Dose-Blind Period|Lack of Efficacy|0|||
150044579|NCT02963506|541302524|FG000|Dose-Blind Period|Lost to Follow-up|0|||
150044580|NCT02963506|541302525|FG001|Dose-Blind Period|Lost to Follow-up|0|||
150044581|NCT02963506|541302526|FG002|Dose-Blind Period|Lost to Follow-up|0|||
150044582|NCT02963506|541302527|FG003|Dose-Blind Period|Lost to Follow-up|0|||
150044583|NCT02963506|541302528|FG004|Dose-Blind Period|Lost to Follow-up|0|||
150044584|NCT02963506|541302529|FG005|Dose-Blind Period|Lost to Follow-up|1|||
150044585|NCT02963506|541302530|FG006|Dose-Blind Period|Lost to Follow-up|0|||
150044586|NCT02963506|541302531|FG007|Dose-Blind Period|Lost to Follow-up|0|||
150044587|NCT02963506|541302532|FG008|Dose-Blind Period|Lost to Follow-up|1|||
150044588|NCT02963506|541302533|FG009|Dose-Blind Period|Lost to Follow-up|0|||
150044589|NCT02963506|541302534|FG010|Dose-Blind Period|Lost to Follow-up|0|||
150044590|NCT02963506|541302535|FG011|Dose-Blind Period|Lost to Follow-up|1|||
150044591|NCT02963506|541302536|FG012|Dose-Blind Period|Lost to Follow-up|0|||
150044592|NCT02963506|541302524|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
150044593|NCT02963506|541302525|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
150044594|NCT02963506|541302526|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
150044595|NCT02963506|541302527|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
150044596|NCT02963506|541302528|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
150044597|NCT02963506|541302529|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
150044598|NCT02963506|541302530|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
150044599|NCT02963506|541302531|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
150044600|NCT02963506|541302532|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
150044601|NCT02963506|541302533|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
150044602|NCT02963506|541302534|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
150044603|NCT02963506|541302535|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
150044604|NCT02963506|541302536|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
149888313|NCT00262028|540719195|FG000|Overall Study|Withdrawal by Subject|6|||
149888314|NCT00262028|540719196|FG001|Overall Study|Withdrawal by Subject|3|||
149888315|NCT00262028|540719197|FG002|Overall Study|Withdrawal by Subject|6|||
149888316|NCT00262028|540719198|FG003|Overall Study|Withdrawal by Subject|5|||
149888317|NCT00262028|540719199|FG004|Overall Study|Withdrawal by Subject|2|||
149888318|NCT00262028|540719200|FG005|Overall Study|Withdrawal by Subject|3|||
149888319|NCT00262028|540719201|FG006|Overall Study|Withdrawal by Subject|5|||
149888320|NCT00262028|540719202|FG007|Overall Study|Withdrawal by Subject|7|||
149888321|NCT00262028|540719203|FG008|Overall Study|Withdrawal by Subject|2|||
149888322|NCT00262028|540719195|FG000|Overall Study|Lost to Follow-up|7|||
149888323|NCT00262028|540719196|FG001|Overall Study|Lost to Follow-up|7|||
149967051|NCT04620668|541014697|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
149967052|NCT04620668|541014696|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
149967053|NCT04620668|541014697|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
149967054|NCT03685149|541014698|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
150175630|NCT00529789|541778591|FG000|Study Period II/III|Withdrawal by Subject|1|||
150175631|NCT00529789|541778591|FG000|Study Period II/III|Protocol Violation|3|||
150175632|NCT00529789|541778591|FG000|Study Period II/III|Physician Decision|3|||
149888324|NCT00262028|540719197|FG002|Overall Study|Lost to Follow-up|5|||
149967055|NCT03685149|541014699|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
149967056|NCT03685149|541014698|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149967057|NCT03685149|541014699|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149967058|NCT03685149|541014698|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
149967059|NCT03685149|541014699|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
149967060|NCT02609503|541014700|FG000|Overall Study|Adverse Event|1|||
149967061|NCT02609503|541014700|FG000|Overall Study|Death|1|||
149967062|NCT02609503|541014700|FG000|Overall Study|Withdrawal by Subject|1|||
149967063|NCT02609503|541014700|FG000|Overall Study|Disease progression|1|||
149967064|NCT03900650|541014707|FG000|Overall Study|Withdrawal by Subject|1|||
149967065|NCT03900650|541014708|FG001|Overall Study|Withdrawal by Subject|1|||
149967066|NCT03900650|541014709|FG002|Overall Study|Withdrawal by Subject|0|||
149967067|NCT03900650|541014710|FG003|Overall Study|Withdrawal by Subject|0|||
149967068|NCT03900650|541014707|FG000|Overall Study|Withdrawn by staff|1|||
149967069|NCT03900650|541014708|FG001|Overall Study|Withdrawn by staff|0|||
149967070|NCT03900650|541014709|FG002|Overall Study|Withdrawn by staff|0|||
149967071|NCT03900650|541014710|FG003|Overall Study|Withdrawn by staff|0|||
149967072|NCT02014376|541014713|FG000|Overall Study|Adverse Event|1|||
149967073|NCT02014376|541014714|FG001|Overall Study|Adverse Event|1|||
149967074|NCT02014376|541014715|FG002|Overall Study|Adverse Event|0|||
149888325|NCT00262028|540719198|FG003|Overall Study|Lost to Follow-up|5|||
149888326|NCT00262028|540719199|FG004|Overall Study|Lost to Follow-up|4|||
149888327|NCT00262028|540719200|FG005|Overall Study|Lost to Follow-up|3|||
149967075|NCT02014376|541014713|FG000|Overall Study|Lost to Follow-up|2|||
149967076|NCT02014376|541014714|FG001|Overall Study|Lost to Follow-up|0|||
149967077|NCT02014376|541014715|FG002|Overall Study|Lost to Follow-up|0|||
150175633|NCT00529789|541778591|FG000|Study Period II/III|Lost to Follow-up|3|||
150175634|NCT00529789|541778591|FG000|Study Period IV|Parent/Caregiver Decision|1|||
149888328|NCT00262028|540719201|FG006|Overall Study|Lost to Follow-up|3|||
149888329|NCT00262028|540719202|FG007|Overall Study|Lost to Follow-up|5|||
149888330|NCT00262028|540719203|FG008|Overall Study|Lost to Follow-up|6|||
149888331|NCT00262028|540719195|FG000|Overall Study|Administrative Reason|11|||
149888332|NCT00262028|540719196|FG001|Overall Study|Administrative Reason|14|||
149888333|NCT00262028|540719197|FG002|Overall Study|Administrative Reason|9|||
149888334|NCT00262028|540719198|FG003|Overall Study|Administrative Reason|12|||
149888335|NCT00262028|540719199|FG004|Overall Study|Administrative Reason|6|||
149888336|NCT00262028|540719200|FG005|Overall Study|Administrative Reason|7|||
149888337|NCT00262028|540719201|FG006|Overall Study|Administrative Reason|4|||
149888338|NCT00262028|540719202|FG007|Overall Study|Administrative Reason|6|||
149888339|NCT00262028|540719203|FG008|Overall Study|Administrative Reason|10|||
149888340|NCT00262028|540719195|FG000|Overall Study|Protocol Violation|0|||
149888341|NCT00262028|540719196|FG001|Overall Study|Protocol Violation|0|||
149888342|NCT00262028|540719197|FG002|Overall Study|Protocol Violation|0|||
149888343|NCT00262028|540719198|FG003|Overall Study|Protocol Violation|1|||
149888344|NCT00262028|540719199|FG004|Overall Study|Protocol Violation|0|||
149888345|NCT00262028|540719200|FG005|Overall Study|Protocol Violation|0|||
149888346|NCT00262028|540719201|FG006|Overall Study|Protocol Violation|0|||
149888347|NCT00262028|540719202|FG007|Overall Study|Protocol Violation|0|||
149888348|NCT00262028|540719203|FG008|Overall Study|Protocol Violation|0|||
149888349|NCT00262028|540719195|FG000|Overall Study|Unable to classify|0|||
149888350|NCT00262028|540719196|FG001|Overall Study|Unable to classify|3|||
149888351|NCT00262028|540719197|FG002|Overall Study|Unable to classify|0|||
149888352|NCT00262028|540719198|FG003|Overall Study|Unable to classify|0|||
149967078|NCT00721110|541014722|FG000|Overall Study|Ultram use|1|||
149888353|NCT00262028|540719199|FG004|Overall Study|Unable to classify|0|||
149888354|NCT00262028|540719200|FG005|Overall Study|Unable to classify|0|||
149888355|NCT00262028|540719201|FG006|Overall Study|Unable to classify|0|||
149888356|NCT00262028|540719202|FG007|Overall Study|Unable to classify|0|||
149967079|NCT00721110|541014723|FG001|Overall Study|Ultram use|0|||
149888357|NCT00262028|540719203|FG008|Overall Study|Unable to classify|1|||
149888358|NCT01515423|540719204|FG000|Open Label Phase|Adverse Event|57|||
149888359|NCT01515423|540719205|FG001|Open Label Phase|Adverse Event|0|||
149967080|NCT00721110|541014724|FG002|Overall Study|Ultram use|0|||
149888360|NCT01515423|540719206|FG002|Open Label Phase|Adverse Event|0|||
149888361|NCT01515423|540719204|FG000|Open Label Phase|Death|2|||
149888362|NCT01515423|540719205|FG001|Open Label Phase|Death|0|||
149967081|NCT00721110|541014725|FG003|Overall Study|Ultram use|0|||
149888363|NCT01515423|540719206|FG002|Open Label Phase|Death|0|||
149888364|NCT01515423|540719204|FG000|Open Label Phase|Lack of Efficacy|117|||
149888365|NCT01515423|540719205|FG001|Open Label Phase|Lack of Efficacy|0|||
149888366|NCT01515423|540719206|FG002|Open Label Phase|Lack of Efficacy|0|||
149888367|NCT01515423|540719204|FG000|Open Label Phase|Lost to Follow-up|21|||
149888368|NCT01515423|540719205|FG001|Open Label Phase|Lost to Follow-up|0|||
149888369|NCT01515423|540719206|FG002|Open Label Phase|Lost to Follow-up|0|||
149888370|NCT01515423|540719204|FG000|Open Label Phase|Withdrawal by Subject|118|||
149888371|NCT01515423|540719205|FG001|Open Label Phase|Withdrawal by Subject|0|||
149888372|NCT01515423|540719206|FG002|Open Label Phase|Withdrawal by Subject|0|||
149888373|NCT01515423|540719204|FG000|Open Label Phase|excluded from DB Phase|70|||
149888374|NCT01515423|540719205|FG001|Open Label Phase|excluded from DB Phase|0|||
149888375|NCT01515423|540719206|FG002|Open Label Phase|excluded from DB Phase|0|||
149888376|NCT01515423|540719204|FG000|Open Label Phase|Other|28|||
149888377|NCT01515423|540719205|FG001|Open Label Phase|Other|0|||
149888378|NCT01515423|540719206|FG002|Open Label Phase|Other|0|||
149888379|NCT01515423|540719204|FG000|DOUBLE BLIND|Adverse Event|0|||
149888380|NCT01515423|540719205|FG001|DOUBLE BLIND|Adverse Event|15|||
149888381|NCT01515423|540719206|FG002|DOUBLE BLIND|Adverse Event|13|||
149888382|NCT01515423|540719204|FG000|DOUBLE BLIND|Death|0|||
149888383|NCT01515423|540719205|FG001|DOUBLE BLIND|Death|1|||
149888384|NCT01515423|540719206|FG002|DOUBLE BLIND|Death|2|||
149888385|NCT01515423|540719204|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
149888386|NCT01515423|540719205|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
149888387|NCT01515423|540719206|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
149888388|NCT01515423|540719204|FG000|DOUBLE BLIND|Pregnancy|0|||
149888389|NCT01515423|540719205|FG001|DOUBLE BLIND|Pregnancy|2|||
149888390|NCT01515423|540719206|FG002|DOUBLE BLIND|Pregnancy|0|||
149888391|NCT01515423|540719204|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
149888392|NCT01515423|540719205|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
149888393|NCT01515423|540719206|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
149888394|NCT01515423|540719204|FG000|DOUBLE BLIND|Other|0|||
149888395|NCT01515423|540719205|FG001|DOUBLE BLIND|Other|6|||
149888396|NCT01515423|540719206|FG002|DOUBLE BLIND|Other|12|||
149888397|NCT01515423|540719204|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
149888398|NCT01515423|540719205|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
149888399|NCT01515423|540719206|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
149888400|NCT04421131|540719214|FG000|Overall Study|Lost to Follow-up|1|||
149888401|NCT04421131|540719214|FG000|Overall Study|Protocol Violation|2|||
149888402|NCT04421131|540719214|FG000|Overall Study|App crashed|5|||
149888403|NCT00613171|540719217|FG000|Overall Study|Adverse Event|7|||
149888404|NCT00613171|540719217|FG000|Overall Study|Withdrawal by Subject|3|||
149888405|NCT00613171|540719217|FG000|Overall Study|Reason not Specified|4|||
149888406|NCT02501928|540719218|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
149888407|NCT02501928|540719219|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
149888408|NCT02501928|540719220|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
149888409|NCT02501928|540719221|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
149888410|NCT02501928|540719222|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
149888411|NCT02501928|540719223|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
149888412|NCT00951496|540719226|FG000|Overall Study|Did not initiate study treatment|10|||
149888413|NCT00951496|540719227|FG001|Overall Study|Did not initiate study treatment|8|||
149888414|NCT00951496|540719228|FG002|Overall Study|Did not initiate study treatment|13|||
149888415|NCT00838526|540719230|FG000|Overall Study|Adverse Event|3|||
149888416|NCT00838526|540719231|FG001|Overall Study|Adverse Event|12|||
149888417|NCT00838526|540719230|FG000|Overall Study|Lost to Follow-up|4|||
149888418|NCT00838526|540719231|FG001|Overall Study|Lost to Follow-up|12|||
149888419|NCT00838526|540719230|FG000|Overall Study|Withdrawal by Subject|4|||
149888420|NCT00838526|540719231|FG001|Overall Study|Withdrawal by Subject|5|||
149888421|NCT00838526|540719230|FG000|Overall Study|Lack of Efficacy|2|||
149888422|NCT00838526|540719231|FG001|Overall Study|Lack of Efficacy|3|||
149888423|NCT00838526|540719230|FG000|Overall Study|Other|11|||
149888424|NCT00838526|540719231|FG001|Overall Study|Other|7|||
149888425|NCT01526057|540719232|FG000|Overall Study|Withdrawal by Subject|3|||
149888426|NCT01526057|540719233|FG001|Overall Study|Withdrawal by Subject|2|||
149888427|NCT01526057|540719234|FG002|Overall Study|Withdrawal by Subject|2|||
149888428|NCT01526057|540719232|FG000|Overall Study|Adverse Event|3|||
149888429|NCT01526057|540719233|FG001|Overall Study|Adverse Event|1|||
149888430|NCT01526057|540719234|FG002|Overall Study|Adverse Event|1|||
149888431|NCT01526057|540719232|FG000|Overall Study|Death|1|||
149888432|NCT01526057|540719233|FG001|Overall Study|Death|0|||
149888433|NCT01526057|540719234|FG002|Overall Study|Death|0|||
149888434|NCT01526057|540719232|FG000|Overall Study|Lost to Follow-up|1|||
149888435|NCT01526057|540719233|FG001|Overall Study|Lost to Follow-up|0|||
149888436|NCT01526057|540719234|FG002|Overall Study|Lost to Follow-up|1|||
149888437|NCT01526057|540719232|FG000|Overall Study|Other|1|||
149888438|NCT01526057|540719233|FG001|Overall Study|Other|0|||
149888439|NCT01526057|540719234|FG002|Overall Study|Other|1|||
149888440|NCT01526057|540719232|FG000|Overall Study|Protocol Violation|0|||
149888441|NCT01526057|540719233|FG001|Overall Study|Protocol Violation|0|||
149888442|NCT01526057|540719234|FG002|Overall Study|Protocol Violation|1|||
149888443|NCT01169350|540719247|FG000|Overall Study|Physician Decision|3|||
149888444|NCT01169350|540719247|FG000|Overall Study|Lost to Follow-up|2|||
149888445|NCT02553772|540719250|FG000|Overall Study|Adverse Event|2|||
149888446|NCT02553772|540719251|FG001|Overall Study|Adverse Event|3|||
149888447|NCT02553772|540719250|FG000|Overall Study|Lost to Follow-up|2|||
149888448|NCT02553772|540719251|FG001|Overall Study|Lost to Follow-up|1|||
149888449|NCT02553772|540719250|FG000|Overall Study|Withdrawal of Consent|1|||
149967082|NCT00721110|541014722|FG000|Overall Study|vertical incision|0|||
149888450|NCT02553772|540719251|FG001|Overall Study|Withdrawal of Consent|1|||
149888451|NCT02553772|540719250|FG000|Overall Study|Lack of Efficacy|1|||
149888452|NCT02553772|540719251|FG001|Overall Study|Lack of Efficacy|0|||
149888453|NCT02553772|540719250|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149888454|NCT02553772|540719251|FG001|Overall Study|Other Miscellaneous Reasons|1|||
149888455|NCT05724589|540719252|FG000|Overall Study|Lost to Follow-up|1|||
149888456|NCT02466321|540719253|FG000|Overall Study|Death|26|||
149888457|NCT02466321|540719253|FG000|Overall Study|Revision|6|||
149888458|NCT02466321|540719253|FG000|Overall Study|Lost to Follow-up|60|||
149888459|NCT02466321|540719253|FG000|Overall Study|Did not receive study device|1|||
149888460|NCT03629184|540719259|FG000|Overall Study|Withdrawal by Subject|2|||
149888461|NCT03629184|540719260|FG001|Overall Study|Withdrawal by Subject|1|||
149888462|NCT03629184|540719259|FG000|Overall Study|Physician Decision|1|||
150175635|NCT00529789|541778591|FG000|Study Period IV|Adverse Event|1|||
149888463|NCT03629184|540719260|FG001|Overall Study|Physician Decision|0|||
149888464|NCT01461538|540719261|FG000|Overall Study|Death|15|||
149888465|NCT01461538|540719262|FG001|Overall Study|Death|6|||
149888466|NCT01461538|540719263|FG002|Overall Study|Death|2|||
149967083|NCT00721110|541014723|FG001|Overall Study|vertical incision|0|||
149967084|NCT00721110|541014724|FG002|Overall Study|vertical incision|1|||
149967085|NCT00721110|541014725|FG003|Overall Study|vertical incision|0|||
149967086|NCT02457065|541014727|FG000|Overall Study|Lost to Follow-up|9|||
149967087|NCT02457065|541014728|FG001|Overall Study|Lost to Follow-up|11|||
149967088|NCT04642079|541014734|FG000|Overall Study|Lost to Follow-up|2|||
149967089|NCT04642079|541014735|FG001|Overall Study|Lost to Follow-up|5|||
149967090|NCT04642079|541014736|FG002|Overall Study|Lost to Follow-up|2|||
149967091|NCT04642079|541014737|FG003|Overall Study|Lost to Follow-up|0|||
149888467|NCT01461538|540719261|FG000|Overall Study|Study Stopped by Sponsor|2|||
149888468|NCT01461538|540719262|FG001|Overall Study|Study Stopped by Sponsor|1|||
149888469|NCT01461538|540719263|FG002|Overall Study|Study Stopped by Sponsor|0|||
149888470|NCT01461538|540719261|FG000|Overall Study|Withdrawal by Subject|1|||
149888471|NCT01461538|540719262|FG001|Overall Study|Withdrawal by Subject|1|||
149888472|NCT01461538|540719263|FG002|Overall Study|Withdrawal by Subject|0|||
149888473|NCT04075487|540720943|FG000|Overall Study|Withdrawal by Subject|1|||
149888474|NCT05016960|540720946|FG000|Overall Study|Withdrawal by Subject|1|||
149888475|NCT05016960|540720947|FG001|Overall Study|Withdrawal by Subject|9|||
149888476|NCT05201794|540720956|FG000|Overall Study|Withdrawal by Subject|13|||
149888477|NCT05201794|540720957|FG001|Overall Study|Withdrawal by Subject|12|||
149888478|NCT05201794|540720958|FG002|Overall Study|Withdrawal by Subject|14|||
149888479|NCT05201794|540720959|FG003|Overall Study|Withdrawal by Subject|0|||
149888480|NCT05201794|540720956|FG000|Overall Study|Adverse Event|5|||
149888481|NCT05201794|540720957|FG001|Overall Study|Adverse Event|5|||
149888482|NCT05201794|540720958|FG002|Overall Study|Adverse Event|4|||
149888483|NCT05201794|540720959|FG003|Overall Study|Adverse Event|0|||
149888484|NCT05201794|540720956|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
149888485|NCT05201794|540720957|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
149888486|NCT05201794|540720958|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
149888487|NCT05201794|540720959|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149888488|NCT05201794|540720956|FG000|Overall Study|Non-Compliance With Study Drug|2|||
149888489|NCT05201794|540720957|FG001|Overall Study|Non-Compliance With Study Drug|3|||
149888490|NCT05201794|540720958|FG002|Overall Study|Non-Compliance With Study Drug|3|||
149888491|NCT05201794|540720959|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149888492|NCT05201794|540720956|FG000|Overall Study|Physician Decision|1|||
149888493|NCT05201794|540720957|FG001|Overall Study|Physician Decision|3|||
149967092|NCT04642079|541014734|FG000|Overall Study|Withdrawal by Subject|0|||
149967093|NCT04642079|541014735|FG001|Overall Study|Withdrawal by Subject|4|||
149967094|NCT04642079|541014736|FG002|Overall Study|Withdrawal by Subject|1|||
149967095|NCT04642079|541014737|FG003|Overall Study|Withdrawal by Subject|2|||
149967096|NCT04642079|541014734|FG000|Overall Study|Other|0|||
149967097|NCT04642079|541014735|FG001|Overall Study|Other|0|||
149967098|NCT04642079|541014736|FG002|Overall Study|Other|0|||
149967099|NCT04642079|541014737|FG003|Overall Study|Other|1|||
149967100|NCT04642079|541014734|FG000|Overall Study|No longer met eligibility criteria|1|||
149967101|NCT04642079|541014735|FG001|Overall Study|No longer met eligibility criteria|0|||
149967102|NCT04642079|541014736|FG002|Overall Study|No longer met eligibility criteria|1|||
149967103|NCT04642079|541014737|FG003|Overall Study|No longer met eligibility criteria|1|||
149967104|NCT02226653|541014738|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
149967105|NCT02226653|541014739|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
149967106|NCT02226653|541014738|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
149967107|NCT02226653|541014739|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
149967108|NCT00759395|541014741|FG000|Overall Study|Adverse Event|1|||
149967109|NCT00759395|541014742|FG001|Overall Study|Adverse Event|0|||
149967110|NCT00759395|541014741|FG000|Overall Study|Withdrawal by Subject|1|||
149967111|NCT00759395|541014742|FG001|Overall Study|Withdrawal by Subject|0|||
149967112|NCT00759395|541014741|FG000|Overall Study|Lack of Efficacy|0|||
149967113|NCT00759395|541014742|FG001|Overall Study|Lack of Efficacy|2|||
149967114|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
149967115|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
149967116|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
149967117|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
149967118|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
149967119|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
149967120|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
149967121|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
149967122|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
149967123|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
149967124|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
149888494|NCT05201794|540720958|FG002|Overall Study|Physician Decision|2|||
149888495|NCT05201794|540720959|FG003|Overall Study|Physician Decision|0|||
149967125|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
150044605|NCT02963506|541302524|FG000|Dose-Blind Period|Sponsor decision|0|||
149888496|NCT05201794|540720956|FG000|Overall Study|Lost to Follow-up|2|||
149888497|NCT05201794|540720957|FG001|Overall Study|Lost to Follow-up|2|||
149967126|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
149967127|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
149967128|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
150044606|NCT02963506|541302525|FG001|Dose-Blind Period|Sponsor decision|0|||
149888498|NCT05201794|540720958|FG002|Overall Study|Lost to Follow-up|0|||
149967129|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
149967130|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
150044607|NCT02963506|541302526|FG002|Dose-Blind Period|Sponsor decision|0|||
149888499|NCT05201794|540720959|FG003|Overall Study|Lost to Follow-up|0|||
149888500|NCT05201794|540720956|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
149888501|NCT05201794|540720957|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
149888502|NCT05201794|540720958|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
149888503|NCT05201794|540720959|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
149888504|NCT05201794|540720956|FG000|Overall Study|Protocol Violation|2|||
149888505|NCT05201794|540720957|FG001|Overall Study|Protocol Violation|0|||
149888506|NCT05201794|540720958|FG002|Overall Study|Protocol Violation|1|||
149888507|NCT05201794|540720959|FG003|Overall Study|Protocol Violation|0|||
149888508|NCT05201794|540720956|FG000|Overall Study|Death|1|||
149888509|NCT05201794|540720957|FG001|Overall Study|Death|0|||
149888510|NCT05201794|540720958|FG002|Overall Study|Death|0|||
149888511|NCT05201794|540720959|FG003|Overall Study|Death|0|||
149888512|NCT05201794|540720956|FG000|Overall Study|Site Terminated By Sponsor|0|||
149888513|NCT05201794|540720957|FG001|Overall Study|Site Terminated By Sponsor|1|||
149967131|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
149967132|NCT00086515|541014743|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
149967133|NCT00086515|541014744|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
149967134|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
149967135|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
149967136|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
149967137|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
149967138|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
149967139|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
149967140|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
149967141|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
149967142|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
149967143|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
149967144|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
149967145|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
149967146|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
149967147|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
149967148|NCT00086515|541014743|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
149967149|NCT00086515|541014744|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
149967150|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
149967151|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
149967152|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
149967153|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
149967154|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
149967155|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
149967156|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
149967157|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
149967158|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
149967159|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
149967160|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
149967161|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
149967162|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
149967163|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
149967164|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
149967165|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
149967166|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
149967167|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
149967168|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
149967169|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
149967170|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
149967171|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
149967172|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
150044608|NCT02963506|541302527|FG003|Dose-Blind Period|Sponsor decision|0|||
149888514|NCT05201794|540720958|FG002|Overall Study|Site Terminated By Sponsor|0|||
150175636|NCT00529789|541778591|FG000|Study Period IV|Lack of Efficacy|1|||
150175637|NCT00529789|541778591|FG000|Study Period IV|Lost to Follow-up|3|||
149888515|NCT05201794|540720959|FG003|Overall Study|Site Terminated By Sponsor|0|||
149888516|NCT05201794|540720956|FG000|Overall Study|Other|3|||
149888517|NCT05201794|540720957|FG001|Overall Study|Other|3|||
149888518|NCT05201794|540720958|FG002|Overall Study|Other|3|||
149888519|NCT05201794|540720959|FG003|Overall Study|Other|0|||
149888520|NCT05201794|540720956|FG000|Overall Study|Randomized But Not Treated|1|||
149888521|NCT05201794|540720957|FG001|Overall Study|Randomized But Not Treated|2|||
149888522|NCT05201794|540720958|FG002|Overall Study|Randomized But Not Treated|1|||
149888523|NCT05201794|540720959|FG003|Overall Study|Randomized But Not Treated|0|||
149888524|NCT04653454|540720962|FG000|Overall Study|Withdrawal by Subject|1|||
149888525|NCT04653454|540720962|FG000|Overall Study|Physician Decision|40|||
149888526|NCT02439216|540720963|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
149888527|NCT02439216|540720964|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888528|NCT02439216|540720965|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888529|NCT02439216|540720966|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888530|NCT02439216|540720967|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888531|NCT02439216|540720968|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888532|NCT02439216|540720969|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888533|NCT02439216|540720970|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888534|NCT02439216|540720971|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
149888535|NCT02439216|540720963|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888536|NCT02439216|540720964|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888537|NCT02439216|540720965|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888538|NCT02439216|540720966|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888539|NCT02439216|540720967|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888540|NCT02439216|540720968|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888541|NCT02439216|540720969|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888542|NCT02439216|540720970|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
149888543|NCT02439216|540720971|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
149888544|NCT02439216|540720963|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888545|NCT02439216|540720964|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888546|NCT02439216|540720965|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888547|NCT02439216|540720966|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888548|NCT02439216|540720967|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888549|NCT02439216|540720968|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888550|NCT02439216|540720969|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
149888551|NCT02439216|540720970|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
149888552|NCT02439216|540720971|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
149888553|NCT02439216|540720963|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888554|NCT02439216|540720964|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888555|NCT02439216|540720965|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888556|NCT02439216|540720966|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888557|NCT02439216|540720967|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888558|NCT02439216|540720968|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888559|NCT02439216|540720969|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888560|NCT02439216|540720970|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
149888561|NCT02439216|540720971|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
150044609|NCT02963506|541302528|FG004|Dose-Blind Period|Sponsor decision|0|||
150044610|NCT02963506|541302529|FG005|Dose-Blind Period|Sponsor decision|1|||
150044611|NCT02963506|541302530|FG006|Dose-Blind Period|Sponsor decision|0|||
150044612|NCT02963506|541302531|FG007|Dose-Blind Period|Sponsor decision|0|||
150175638|NCT01202955|541778592|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
150175639|NCT01202955|541778593|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
149967173|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
149967174|NCT00086515|541014743|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
149967175|NCT00086515|541014744|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
149967176|NCT05360784|541014748|FG000|Overall Study|Discontinued|25|||
149967177|NCT05360784|541014749|FG001|Overall Study|Discontinued|11|||
149967178|NCT02251041|541014750|FG000|Overall Study|Did not receive intervention|15|||
149967179|NCT02251041|541014751|FG001|Overall Study|Did not receive intervention|4|||
149967180|NCT04918771|541014752|FG000|Overall Study|Withdrawal by Subject|4|||
150175640|NCT01278394|541778597|FG000|Overall Study|Lost to Follow-up|1|||
150175641|NCT02115139|541778600|FG000|Overall Study|Protocol Violation|1|||
149967181|NCT04918771|541014753|FG001|Overall Study|Withdrawal by Subject|5|||
149967182|NCT04918771|541014752|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
150175642|NCT02115139|541778600|FG000|Overall Study|treatment discontinuation|6|||
150175643|NCT00468910|541778601|FG000|Overall Study|Lost to Follow-up|2|||
150175644|NCT00468910|541778602|FG001|Overall Study|Lost to Follow-up|1|||
150175645|NCT00468910|541778601|FG000|Overall Study|Withdrawal by Subject|2|||
150175646|NCT00468910|541778602|FG001|Overall Study|Withdrawal by Subject|1|||
150175647|NCT00468910|541778601|FG000|Overall Study|Medical Contraindication|0|||
150175648|NCT00468910|541778602|FG001|Overall Study|Medical Contraindication|1|||
150175649|NCT01909778|541778603|FG000|Overall Study|failed screening|1|||
150175650|NCT01121549|541778604|FG000|Overall Study|Adverse Event|10|||
150175651|NCT01121549|541778604|FG000|Overall Study|Lack of Efficacy|11|||
150175652|NCT01121549|541778604|FG000|Overall Study|Lost to Follow-up|12|||
150175653|NCT01121549|541778604|FG000|Overall Study|Did not meet entrance criteria|9|||
150175654|NCT01121549|541778604|FG000|Overall Study|Study terminated by sponsor|197|||
150175655|NCT01121549|541778604|FG000|Overall Study|Pregnancy|1|||
150175656|NCT01121549|541778604|FG000|Overall Study|Protocol Violation|33|||
150175657|NCT01121549|541778604|FG000|Overall Study|Withdrawal by Subject|16|||
150175658|NCT01121549|541778604|FG000|Overall Study|Other|58|||
150175659|NCT04789408|541778605|FG000|Overall Study|Death|4|||
150175660|NCT04789408|541778606|FG001|Overall Study|Death|3|||
150175661|NCT04789408|541778607|FG002|Overall Study|Death|6|||
150175662|NCT04789408|541778605|FG000|Overall Study|Did not meet eligibility criteria|1|||
150175663|NCT04789408|541778606|FG001|Overall Study|Did not meet eligibility criteria|0|||
150175664|NCT04789408|541778607|FG002|Overall Study|Did not meet eligibility criteria|0|||
150175665|NCT04789408|541778605|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
150175666|NCT04789408|541778606|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
150175667|NCT04789408|541778607|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
150175668|NCT01391832|541779872|FG000|Overall Study|Withdrawal by Subject|21|||
150175669|NCT01391832|541779873|FG001|Overall Study|Withdrawal by Subject|22|||
150175670|NCT01391832|541779872|FG000|Overall Study|Lost to Follow-up|0|||
150175671|NCT01391832|541779873|FG001|Overall Study|Lost to Follow-up|1|||
150175672|NCT03345901|541779879|FG000|Overall Study|The study was terminated|18|||
150175673|NCT00722046|541779880|FG000|Overall Study|Adverse Event|0|||
150175674|NCT00722046|541779881|FG001|Overall Study|Adverse Event|1|||
150175675|NCT00722046|541779882|FG002|Overall Study|Adverse Event|2|||
150175676|NCT00722046|541779883|FG003|Overall Study|Adverse Event|1|||
150175677|NCT00722046|541779884|FG004|Overall Study|Adverse Event|2|||
150175678|NCT00722046|541779885|FG005|Overall Study|Adverse Event|1|||
150175679|NCT00722046|541779886|FG006|Overall Study|Adverse Event|0|||
150175680|NCT00722046|541779880|FG000|Overall Study|Death|0|||
150175681|NCT00722046|541779881|FG001|Overall Study|Death|1|||
150175682|NCT00722046|541779882|FG002|Overall Study|Death|0|||
149967183|NCT04918771|541014753|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
150175683|NCT00722046|541779883|FG003|Overall Study|Death|0|||
150175684|NCT00722046|541779884|FG004|Overall Study|Death|0|||
150175685|NCT00722046|541779885|FG005|Overall Study|Death|0|||
150175686|NCT00722046|541779886|FG006|Overall Study|Death|2|||
150175687|NCT00722046|541779880|FG000|Overall Study|Protocol Violation|1|||
150175688|NCT00722046|541779881|FG001|Overall Study|Protocol Violation|0|||
150175689|NCT00722046|541779882|FG002|Overall Study|Protocol Violation|0|||
150175690|NCT00722046|541779883|FG003|Overall Study|Protocol Violation|0|||
150175691|NCT00722046|541779884|FG004|Overall Study|Protocol Violation|0|||
150175692|NCT00722046|541779885|FG005|Overall Study|Protocol Violation|1|||
149967184|NCT01299961|541014761|FG000|Overall Study|Adverse Event|3|||
149967185|NCT01299961|541014761|FG000|Overall Study|Lack of Efficacy|2|||
149967186|NCT01299961|541014761|FG000|Overall Study|Lost to Follow-up|1|||
149967187|NCT01813357|541014762|FG000|Overall Study|Lost to Follow-up|5|||
149967188|NCT01813357|541014763|FG001|Overall Study|Lost to Follow-up|6|||
149967189|NCT00003645|541016176|FG000|Overall Study|Death|4|||
149967190|NCT00003645|541016177|FG001|Overall Study|Death|1|||
149967191|NCT00003645|541016176|FG000|Overall Study|Lost to Follow-up|7|||
149967192|NCT00003645|541016177|FG001|Overall Study|Lost to Follow-up|8|||
149967193|NCT00003645|541016176|FG000|Overall Study|Withdrawal by Subject|1|||
149967194|NCT00003645|541016177|FG001|Overall Study|Withdrawal by Subject|3|||
149967195|NCT00462826|541016178|FG000|Overall Study|Ineligible - second primary|1|||
150175693|NCT00722046|541779886|FG006|Overall Study|Protocol Violation|0|||
150175694|NCT00722046|541779880|FG000|Overall Study|Withdrawal by Subject|3|||
149967196|NCT00462826|541016178|FG000|Overall Study|Ineligible - wrong cell type|1|||
150175695|NCT00722046|541779881|FG001|Overall Study|Withdrawal by Subject|3|||
150175696|NCT00722046|541779882|FG002|Overall Study|Withdrawal by Subject|4|||
149967197|NCT00462826|541016178|FG000|Overall Study|Ineligible - wrong primary|2|||
149967198|NCT00462826|541016178|FG000|Overall Study|Never treated|1|||
150044613|NCT02963506|541302532|FG008|Dose-Blind Period|Sponsor decision|0|||
150175697|NCT00722046|541779883|FG003|Overall Study|Withdrawal by Subject|4|||
150175698|NCT00722046|541779884|FG004|Overall Study|Withdrawal by Subject|4|||
150175699|NCT00722046|541779885|FG005|Overall Study|Withdrawal by Subject|7|||
150175700|NCT00722046|541779886|FG006|Overall Study|Withdrawal by Subject|3|||
150175701|NCT00722046|541779880|FG000|Overall Study|Randomized, but not treated|1|||
150175702|NCT00722046|541779881|FG001|Overall Study|Randomized, but not treated|1|||
149888562|NCT02439216|540720963|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888563|NCT02439216|540720964|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888564|NCT02439216|540720965|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888565|NCT02439216|540720966|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888566|NCT02439216|540720967|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888567|NCT02439216|540720968|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888568|NCT02439216|540720969|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
149888569|NCT02439216|540720970|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
149888570|NCT02439216|540720971|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
149888571|NCT02094300|540720972|FG000|Overall Study|Death|7|||
149888572|NCT02094300|540720972|FG000|Overall Study|Lost to Follow-up|10|||
149888573|NCT02094300|540720972|FG000|Overall Study|Still be eligible for follow-up|3|||
149888574|NCT01866826|540720977|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
149888575|NCT01866826|540720978|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
149888576|NCT01866826|540720977|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
149888577|NCT01866826|540720978|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
149888578|NCT01866826|540720977|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
149888579|NCT01866826|540720978|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
149888580|NCT02493660|540720979|FG000|Overall Study|Physician Decision|0|||
149888581|NCT02493660|540720980|FG001|Overall Study|Physician Decision|1|||
149888582|NCT02493660|540720979|FG000|Overall Study|Adverse Event|4|||
149888583|NCT02493660|540720980|FG001|Overall Study|Adverse Event|2|||
150175703|NCT00722046|541779882|FG002|Overall Study|Randomized, but not treated|0|||
150175704|NCT00722046|541779883|FG003|Overall Study|Randomized, but not treated|2|||
150175705|NCT00722046|541779884|FG004|Overall Study|Randomized, but not treated|0|||
150175706|NCT00722046|541779885|FG005|Overall Study|Randomized, but not treated|0|||
150175707|NCT00722046|541779886|FG006|Overall Study|Randomized, but not treated|0|||
149888584|NCT02493660|540720979|FG000|Overall Study|Withdrawal by Subject|2|||
149888585|NCT02493660|540720980|FG001|Overall Study|Withdrawal by Subject|3|||
149888586|NCT02493660|540720979|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
150044614|NCT02963506|541302533|FG009|Dose-Blind Period|Sponsor decision|0|||
149888587|NCT02493660|540720980|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
149888588|NCT02493660|540720979|FG000|Overall Study|Protocol Violation|0|||
149888589|NCT02493660|540720980|FG001|Overall Study|Protocol Violation|1|||
149888590|NCT02493660|540720979|FG000|Overall Study|Death|0|||
149888591|NCT02493660|540720980|FG001|Overall Study|Death|1|||
149888592|NCT02493660|540720979|FG000|Overall Study|Lost to Follow-up|2|||
149888593|NCT02493660|540720980|FG001|Overall Study|Lost to Follow-up|4|||
149888594|NCT01050530|540720983|FG000|Overall Study|Adverse Event|6|||
149888595|NCT01050530|540720984|FG001|Overall Study|Adverse Event|3|||
149888596|NCT01050530|540720983|FG000|Overall Study|Lack of Efficacy|1|||
149888597|NCT01050530|540720984|FG001|Overall Study|Lack of Efficacy|4|||
149888598|NCT01050530|540720983|FG000|Overall Study|Withdrawal by Subject|0|||
149888599|NCT01050530|540720984|FG001|Overall Study|Withdrawal by Subject|3|||
149888600|NCT01050530|540720983|FG000|Overall Study|Protocol Violation|1|||
149888601|NCT01050530|540720984|FG001|Overall Study|Protocol Violation|0|||
149888602|NCT00725491|540720987|FG000|Overall Study|Adverse Event|3|||
149888603|NCT00725491|540720988|FG001|Overall Study|Adverse Event|2|||
149888604|NCT00725491|540720987|FG000|Overall Study|Pregnancy|0|||
149888605|NCT00725491|540720988|FG001|Overall Study|Pregnancy|3|||
149888606|NCT00725491|540720987|FG000|Overall Study|Risk for hyperstimulation|2|||
149888607|NCT00725491|540720988|FG001|Overall Study|Risk for hyperstimulation|9|||
149888608|NCT00725491|540720987|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
149888609|NCT00725491|540720988|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
149888610|NCT00725491|540720987|FG000|Overall Study|Fertilization failure|0|||
149888611|NCT00725491|540720988|FG001|Overall Study|Fertilization failure|1|||
149888612|NCT00725491|540720987|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
149888613|NCT00725491|540720988|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
149888614|NCT02687451|540720997|FG000|Overall Study|Withdrawal by Subject|1|||
149888615|NCT02687451|540720998|FG001|Overall Study|Withdrawal by Subject|0|||
149888616|NCT02687451|540720999|FG002|Overall Study|Withdrawal by Subject|0|||
149888617|NCT02687451|540721000|FG003|Overall Study|Withdrawal by Subject|0|||
149888618|NCT02687451|540721001|FG004|Overall Study|Withdrawal by Subject|0|||
149888619|NCT02687451|540721002|FG005|Overall Study|Withdrawal by Subject|1|||
149888620|NCT03472014|540721003|FG000|Overall Study|Lost to Follow-up|4|||
149888621|NCT03652051|540721008|FG000|Stage 1|Adverse Event|0|||
149888622|NCT03652051|540721009|FG001|Stage 1|Adverse Event|5|||
149967199|NCT02296476|541016180|FG000|Overall Study|Disease Progression|6|||
149967200|NCT02296476|541016181|FG001|Overall Study|Disease Progression|4|||
149967201|NCT02296476|541016182|FG002|Overall Study|Disease Progression|2|||
149967202|NCT00488293|541016183|FG000|Overall Study|Lost to Follow-up|28|||
149967203|NCT00488293|541016184|FG001|Overall Study|Lost to Follow-up|25|||
149967204|NCT00488293|541016183|FG000|Overall Study|Withdrawal by Subject|5|||
149967205|NCT00488293|541016184|FG001|Overall Study|Withdrawal by Subject|3|||
149967206|NCT00488293|541016183|FG000|Overall Study|Death|2|||
149967207|NCT00488293|541016184|FG001|Overall Study|Death|1|||
149967208|NCT00488293|541016183|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
149967209|NCT00488293|541016184|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
149967210|NCT03436732|541016185|FG000|Overall Study|Not treated-enrolled in different study|1|||
149967211|NCT03436732|541016186|FG001|Overall Study|Not treated-enrolled in different study|0|||
149967212|NCT03436732|541016185|FG000|Overall Study|Off study after cycle 1|1|||
149967213|NCT03436732|541016186|FG001|Overall Study|Off study after cycle 1|0|||
149967214|NCT03436732|541016185|FG000|Overall Study|Adverse Event|2|||
149967215|NCT03436732|541016186|FG001|Overall Study|Adverse Event|0|||
149967216|NCT03436732|541016185|FG000|Overall Study|Death|0|||
149967217|NCT03436732|541016186|FG001|Overall Study|Death|1|||
149967218|NCT00939185|541016187|FG000|Overall Study|Adverse Event|3|||
149967219|NCT00939185|541016187|FG000|Overall Study|Lack of Efficacy|1|||
149967220|NCT00939185|541016187|FG000|Overall Study|Lost to Follow-up|6|||
149967221|NCT00939185|541016187|FG000|Overall Study|Other|3|||
149967222|NCT00939185|541016187|FG000|Overall Study|Withdrawal by Subject|2|||
149967223|NCT00939185|541016187|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
149967224|NCT00836706|541016190|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
149967225|NCT00836706|541016191|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
149967226|NCT02989857|541016192|FG000|Randomization Phase|Not Treated|3|||
149967227|NCT02989857|541016193|FG001|Randomization Phase|Not Treated|2|||
149967228|NCT02989857|541016194|FG002|Randomization Phase|Not Treated|0|||
149967229|NCT02332928|541016196|FG000|Overall Study|Withdrawal by Subject|0|||
149967230|NCT02332928|541016197|FG001|Overall Study|Withdrawal by Subject|2|||
149967231|NCT02332928|541016196|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
149967232|NCT02332928|541016197|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
149967233|NCT04484857|541016198|FG000|Overall Study|Adverse Event|2|||
149967234|NCT04484857|541016198|FG000|Overall Study|Death|10|||
149967235|NCT04484857|541016198|FG000|Overall Study|Withdrawal by Subject|3|||
149967236|NCT04484857|541016198|FG000|Overall Study|Transferred/Relocation|5|||
149967237|NCT04484857|541016198|FG000|Overall Study|Kidney Transplant|7|||
149967238|NCT04484857|541016198|FG000|Overall Study|Other than specified|4|||
149967239|NCT04484857|541016198|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
149967240|NCT01425814|541016199|FG000|Period 1|Stability criteria not fulfilled|0|||
149967241|NCT01425814|541016200|FG001|Period 1|Stability criteria not fulfilled|1|||
149967242|NCT01425814|541016201|FG002|Period 1|Stability criteria not fulfilled|0|||
149967243|NCT01425814|541016202|FG003|Period 1|Stability criteria not fulfilled|0|||
149967244|NCT01425814|541016203|FG004|Period 1|Stability criteria not fulfilled|0|||
149967245|NCT01425814|541016204|FG005|Period 1|Stability criteria not fulfilled|0|||
149967246|NCT01425814|541016199|FG000|Period 2|Stability criteria not fulfilled|0|||
149967247|NCT01425814|541016200|FG001|Period 2|Stability criteria not fulfilled|1|||
149888623|NCT03652051|540721010|FG002|Stage 1|Adverse Event|7|||
149888624|NCT03652051|540721011|FG003|Stage 1|Adverse Event|1|||
149888625|NCT03652051|540721008|FG000|Stage 1|Withdrawal by Subject|0|||
149888626|NCT03652051|540721009|FG001|Stage 1|Withdrawal by Subject|0|||
149888627|NCT03652051|540721010|FG002|Stage 1|Withdrawal by Subject|1|||
149888628|NCT03652051|540721011|FG003|Stage 1|Withdrawal by Subject|0|||
149888629|NCT03652051|540721008|FG000|Stage 2|Adverse Event|0|||
149888630|NCT03652051|540721009|FG001|Stage 2|Adverse Event|2|||
149888631|NCT03652051|540721010|FG002|Stage 2|Adverse Event|1|||
149888632|NCT03652051|540721011|FG003|Stage 2|Adverse Event|0|||
149888633|NCT03652051|540721008|FG000|Stage 2|Protocol Violation|0|||
149888634|NCT03652051|540721009|FG001|Stage 2|Protocol Violation|1|||
149888635|NCT03652051|540721010|FG002|Stage 2|Protocol Violation|6|||
149888636|NCT03652051|540721011|FG003|Stage 2|Protocol Violation|0|||
149888637|NCT03652051|540721008|FG000|Stage 2|Lost to Follow-up|0|||
149888638|NCT03652051|540721009|FG001|Stage 2|Lost to Follow-up|2|||
149888639|NCT03652051|540721010|FG002|Stage 2|Lost to Follow-up|0|||
149888640|NCT03652051|540721011|FG003|Stage 2|Lost to Follow-up|3|||
149888641|NCT03652051|540721008|FG000|Stage 2|Withdrawal by Subject|0|||
149888642|NCT03652051|540721009|FG001|Stage 2|Withdrawal by Subject|11|||
149888643|NCT03652051|540721010|FG002|Stage 2|Withdrawal by Subject|9|||
149888644|NCT03652051|540721011|FG003|Stage 2|Withdrawal by Subject|3|||
149888645|NCT02394600|540721014|FG000|Overall Study|Adverse Event|3|||
149888646|NCT02394600|540721015|FG001|Overall Study|Adverse Event|0|||
149888647|NCT02394600|540721014|FG000|Overall Study|Lost to Follow-up|0|||
149888648|NCT02394600|540721015|FG001|Overall Study|Lost to Follow-up|1|||
149888649|NCT02394600|540721014|FG000|Overall Study|Withdrawal by Subject|0|||
149888650|NCT02394600|540721015|FG001|Overall Study|Withdrawal by Subject|1|||
149888651|NCT02394600|540721014|FG000|Overall Study|Protocol Violation|1|||
149888652|NCT02394600|540721015|FG001|Overall Study|Protocol Violation|0|||
149888653|NCT02569801|540721016|FG000|Overall Study|Withdrawal by Subject|9|||
149888654|NCT02569801|540721017|FG001|Overall Study|Withdrawal by Subject|9|||
149888655|NCT02569801|540721016|FG000|Overall Study|Sponsor Decision|13|||
149888656|NCT02569801|540721017|FG001|Overall Study|Sponsor Decision|14|||
149888657|NCT02569801|540721016|FG000|Overall Study|Progressive Disease|2|||
149888658|NCT02569801|540721017|FG001|Overall Study|Progressive Disease|7|||
149888659|NCT02569801|540721016|FG000|Overall Study|Lost to Follow-up|0|||
149888660|NCT02569801|540721017|FG001|Overall Study|Lost to Follow-up|1|||
149888661|NCT02569801|540721016|FG000|Overall Study|Death|12|||
149888662|NCT02569801|540721017|FG001|Overall Study|Death|4|||
149888663|NCT00428246|540721018|FG000|Overall Study|Withdrawal by Subject|0|||
149888664|NCT00428246|540721019|FG001|Overall Study|Withdrawal by Subject|0|||
149888665|NCT00428246|540721020|FG002|Overall Study|Withdrawal by Subject|1|||
149888666|NCT00428246|540721018|FG000|Overall Study|Adverse Event|1|||
149888667|NCT00428246|540721019|FG001|Overall Study|Adverse Event|0|||
149888668|NCT00428246|540721020|FG002|Overall Study|Adverse Event|0|||
149888669|NCT01308424|540721028|FG000|Baseline Eligibility|Screen Failures|71|||
149888670|NCT01308424|540721029|FG001|Baseline Eligibility|Screen Failures|0|||
149888671|NCT01308424|540721030|FG002|Baseline Eligibility|Screen Failures|0|||
149888672|NCT01308424|540721028|FG000|Randomization|Adverse Event|0|||
149888673|NCT01308424|540721029|FG001|Randomization|Adverse Event|1|||
149888674|NCT01308424|540721030|FG002|Randomization|Adverse Event|1|||
149967248|NCT01425814|541016201|FG002|Period 2|Stability criteria not fulfilled|0|||
149967249|NCT01425814|541016202|FG003|Period 2|Stability criteria not fulfilled|0|||
149967250|NCT01425814|541016203|FG004|Period 2|Stability criteria not fulfilled|0|||
149967251|NCT01425814|541016204|FG005|Period 2|Stability criteria not fulfilled|0|||
149888675|NCT01308424|540721028|FG000|Randomization|Lost to Follow-up|0|||
149888676|NCT01308424|540721029|FG001|Randomization|Lost to Follow-up|1|||
149888677|NCT01308424|540721030|FG002|Randomization|Lost to Follow-up|0|||
149888678|NCT01308424|540721028|FG000|Randomization|Physician Decision|0|||
149967252|NCT01425814|541016199|FG000|Period 3|Adverse Event|0|||
149888679|NCT01308424|540721029|FG001|Randomization|Physician Decision|1|||
149888680|NCT01308424|540721030|FG002|Randomization|Physician Decision|1|||
149888681|NCT00948155|540721031|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
149888682|NCT00948155|540721032|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
149888683|NCT00948155|540721031|FG000|Washout 14 Days|Lost to Follow-up|1|||
149888684|NCT00948155|540721032|FG001|Washout 14 Days|Lost to Follow-up|2|||
149888685|NCT04870710|540721036|FG000|Overall Study|Lost to Follow-up|3|||
149888686|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
149888687|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
150175708|NCT00722046|541779880|FG000|Overall Study|Other|0|||
149967253|NCT01425814|541016200|FG001|Period 3|Adverse Event|0|||
150175709|NCT00722046|541779881|FG001|Overall Study|Other|0|||
150175710|NCT00722046|541779882|FG002|Overall Study|Other|1|||
150175711|NCT00722046|541779883|FG003|Overall Study|Other|1|||
150175712|NCT00722046|541779884|FG004|Overall Study|Other|3|||
150175713|NCT00722046|541779885|FG005|Overall Study|Other|2|||
150175714|NCT00722046|541779886|FG006|Overall Study|Other|1|||
150175715|NCT00925587|541779887|FG000|Overall Study|Protocol Specified Criteria|6|||
150175716|NCT00925587|541779888|FG001|Overall Study|Protocol Specified Criteria|6|||
149967254|NCT01425814|541016201|FG002|Period 3|Adverse Event|0|||
149967255|NCT01425814|541016202|FG003|Period 3|Adverse Event|0|||
149967256|NCT01425814|541016203|FG004|Period 3|Adverse Event|0|||
149967257|NCT01425814|541016204|FG005|Period 3|Adverse Event|1|||
149967258|NCT01425814|541016199|FG000|Period 4|Adverse Event|1|||
149967259|NCT01425814|541016200|FG001|Period 4|Adverse Event|0|||
149967260|NCT01425814|541016201|FG002|Period 4|Adverse Event|1|||
149967261|NCT01425814|541016202|FG003|Period 4|Adverse Event|0|||
149967262|NCT01425814|541016203|FG004|Period 4|Adverse Event|0|||
149967263|NCT01425814|541016204|FG005|Period 4|Adverse Event|0|||
149967264|NCT01425814|541016199|FG000|Period 5|Stability criteria not fulfilled|0|||
149967265|NCT01425814|541016200|FG001|Period 5|Stability criteria not fulfilled|0|||
149967266|NCT01425814|541016201|FG002|Period 5|Stability criteria not fulfilled|1|||
149967267|NCT01425814|541016202|FG003|Period 5|Stability criteria not fulfilled|0|||
149967268|NCT01425814|541016203|FG004|Period 5|Stability criteria not fulfilled|0|||
149967269|NCT01425814|541016204|FG005|Period 5|Stability criteria not fulfilled|1|||
149967270|NCT00863304|541016205|FG000|Overall Study|Adverse Event|10|||
149967271|NCT00863304|541016206|FG001|Overall Study|Adverse Event|4|||
149967272|NCT00863304|541016207|FG002|Overall Study|Adverse Event|14|||
149967273|NCT00863304|541016208|FG003|Overall Study|Adverse Event|16|||
149967274|NCT00863304|541016205|FG000|Overall Study|Lost to Follow-up|1|||
149967275|NCT00863304|541016206|FG001|Overall Study|Lost to Follow-up|5|||
149967276|NCT00863304|541016207|FG002|Overall Study|Lost to Follow-up|4|||
149967277|NCT00863304|541016208|FG003|Overall Study|Lost to Follow-up|2|||
149967278|NCT00863304|541016205|FG000|Overall Study|Lack of Efficacy|57|||
149967279|NCT00863304|541016206|FG001|Overall Study|Lack of Efficacy|26|||
149967280|NCT00863304|541016207|FG002|Overall Study|Lack of Efficacy|30|||
149967281|NCT00863304|541016208|FG003|Overall Study|Lack of Efficacy|28|||
149967282|NCT00863304|541016205|FG000|Overall Study|Withdrawal by Subject|19|||
149967283|NCT00863304|541016206|FG001|Overall Study|Withdrawal by Subject|14|||
149967284|NCT00863304|541016207|FG002|Overall Study|Withdrawal by Subject|20|||
149967285|NCT00863304|541016208|FG003|Overall Study|Withdrawal by Subject|18|||
149967286|NCT00863304|541016205|FG000|Overall Study|Other|1|||
149967287|NCT00863304|541016206|FG001|Overall Study|Other|0|||
149967288|NCT00863304|541016207|FG002|Overall Study|Other|0|||
149967289|NCT00863304|541016208|FG003|Overall Study|Other|1|||
149967290|NCT00863304|541016205|FG000|Overall Study|Protocol Violation|2|||
149967291|NCT00863304|541016206|FG001|Overall Study|Protocol Violation|6|||
149967292|NCT00863304|541016207|FG002|Overall Study|Protocol Violation|2|||
149967293|NCT00863304|541016208|FG003|Overall Study|Protocol Violation|0|||
149967294|NCT00863304|541016205|FG000|Overall Study|Randomized, but not Treated|3|||
149967295|NCT00863304|541016206|FG001|Overall Study|Randomized, but not Treated|1|||
149967296|NCT00863304|541016207|FG002|Overall Study|Randomized, but not Treated|4|||
149967297|NCT00863304|541016208|FG003|Overall Study|Randomized, but not Treated|1|||
149967298|NCT00863304|541016205|FG000|Overall Study|Entered extension study|101|||
149967299|NCT00863304|541016206|FG001|Overall Study|Entered extension study|129|||
149967300|NCT00863304|541016207|FG002|Overall Study|Entered extension study|113|||
149967301|NCT00863304|541016208|FG003|Overall Study|Entered extension study|125|||
149967302|NCT03931330|541016209|FG000|Overall Study|Physician Decision|1|||
149967303|NCT01182350|541016210|FG000|Overall Study|Adverse Event|5|||
149967304|NCT01182350|541016211|FG001|Overall Study|Adverse Event|0|||
149967305|NCT01182350|541016212|FG002|Overall Study|Adverse Event|0|||
149967306|NCT01182350|541016213|FG003|Overall Study|Adverse Event|0|||
149967307|NCT01182350|541016214|FG004|Overall Study|Adverse Event|0|||
149967308|NCT01182350|541016210|FG000|Overall Study|Disease Progression|15|||
149967309|NCT01182350|541016211|FG001|Overall Study|Disease Progression|12|||
149967310|NCT01182350|541016212|FG002|Overall Study|Disease Progression|0|||
149967311|NCT01182350|541016213|FG003|Overall Study|Disease Progression|1|||
149967312|NCT01182350|541016214|FG004|Overall Study|Disease Progression|0|||
149967313|NCT01182350|541016210|FG000|Overall Study|Death|0|||
149967314|NCT01182350|541016211|FG001|Overall Study|Death|1|||
149967315|NCT01182350|541016212|FG002|Overall Study|Death|1|||
149967316|NCT01182350|541016213|FG003|Overall Study|Death|0|||
149967317|NCT01182350|541016214|FG004|Overall Study|Death|0|||
149967318|NCT01182350|541016210|FG000|Overall Study|Withdrawal by Subject|3|||
149967319|NCT01182350|541016211|FG001|Overall Study|Withdrawal by Subject|1|||
149967320|NCT01182350|541016212|FG002|Overall Study|Withdrawal by Subject|0|||
149967321|NCT01182350|541016213|FG003|Overall Study|Withdrawal by Subject|1|||
149967322|NCT01182350|541016214|FG004|Overall Study|Withdrawal by Subject|0|||
149967323|NCT01182350|541016210|FG000|Overall Study|Alternative Therapy|2|||
149967324|NCT01182350|541016211|FG001|Overall Study|Alternative Therapy|0|||
149967325|NCT01182350|541016212|FG002|Overall Study|Alternative Therapy|1|||
149967326|NCT01182350|541016213|FG003|Overall Study|Alternative Therapy|0|||
149967327|NCT01182350|541016214|FG004|Overall Study|Alternative Therapy|0|||
149967328|NCT01182350|541016210|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
150175717|NCT00925587|541779887|FG000|Overall Study|Physician Decision|4|||
149967329|NCT01182350|541016211|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
149967330|NCT01182350|541016212|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
149967331|NCT01182350|541016213|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
149967332|NCT01182350|541016214|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
150044615|NCT02963506|541302534|FG010|Dose-Blind Period|Sponsor decision|0|||
150044616|NCT02963506|541302535|FG011|Dose-Blind Period|Sponsor decision|0|||
150044617|NCT02963506|541302536|FG012|Dose-Blind Period|Sponsor decision|0|||
150044618|NCT02963506|541302524|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044619|NCT02963506|541302525|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044620|NCT02963506|541302526|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044621|NCT02963506|541302527|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044622|NCT02963506|541302528|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044623|NCT02963506|541302529|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044624|NCT02963506|541302530|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044625|NCT02963506|541302531|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044626|NCT02963506|541302532|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044627|NCT02963506|541302533|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044628|NCT02963506|541302534|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044629|NCT02963506|541302535|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
150044630|NCT02963506|541302536|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
150044631|NCT00630838|541302541|FG000|Overall Study|Death|0|||
150044632|NCT00630838|541302542|FG001|Overall Study|Death|1|||
150044633|NCT00630838|541302541|FG000|Overall Study|Lost to Follow-up|0|||
150044634|NCT00630838|541302542|FG001|Overall Study|Lost to Follow-up|1|||
150044635|NCT00928408|541302543|FG000|Overall Study|Other|2|||
150044636|NCT00928408|541302543|FG000|Overall Study|Withdrawal by Subject|4|||
150044637|NCT00928408|541302543|FG000|Overall Study|Death|5|||
150044638|NCT00928408|541302543|FG000|Overall Study|Lost to Follow-up|12|||
150044639|NCT00256997|541302544|FG000|Overall Study|Protocol Violation|1|||
150044640|NCT00256997|541302545|FG001|Overall Study|Protocol Violation|4|||
150044641|NCT00256997|541302544|FG000|Overall Study|Lack of Efficacy|1|||
150044642|NCT00256997|541302545|FG001|Overall Study|Lack of Efficacy|4|||
150044643|NCT00256997|541302544|FG000|Overall Study|Death|2|||
150044644|NCT00256997|541302545|FG001|Overall Study|Death|0|||
150044645|NCT00256997|541302544|FG000|Overall Study|Adverse Event|4|||
150044646|NCT00256997|541302545|FG001|Overall Study|Adverse Event|0|||
150044647|NCT00256997|541302544|FG000|Overall Study|Lost to Follow-up|3|||
150044648|NCT00256997|541302545|FG001|Overall Study|Lost to Follow-up|5|||
149888688|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
149888689|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
149888690|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
149888691|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
149888692|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
149888693|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
149888694|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
149888695|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
149888696|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
149888697|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
149888698|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
149888699|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
149888700|NCT04338022|540721037|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
149888701|NCT04338022|540721038|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
149888702|NCT04338022|540721037|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
150044649|NCT00256997|541302544|FG000|Overall Study|Withdrawal by Subject|13|||
150044650|NCT00256997|541302545|FG001|Overall Study|Withdrawal by Subject|3|||
150044651|NCT00256997|541302544|FG000|Overall Study|Started but not treated|2|||
150044652|NCT00256997|541302545|FG001|Overall Study|Started but not treated|0|||
150044653|NCT00256997|541302544|FG000|Overall Study|Other|5|||
150044654|NCT00256997|541302545|FG001|Overall Study|Other|8|||
150044655|NCT00256997|541302544|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
150044656|NCT00256997|541302545|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
150044657|NCT00256997|541302544|FG000|Overall Study|Participant Non-compliant|3|||
150044658|NCT00256997|541302545|FG001|Overall Study|Participant Non-compliant|6|||
150044659|NCT00256997|541302544|FG000|Overall Study|Investigator Withdrew Participant|2|||
150044660|NCT00256997|541302545|FG001|Overall Study|Investigator Withdrew Participant|1|||
150044661|NCT03843541|541302548|FG000|Overall Study|Adverse Event|4|||
150044662|NCT03843541|541302549|FG001|Overall Study|Adverse Event|2|||
150044663|NCT03843541|541302550|FG002|Overall Study|Adverse Event|3|||
150044664|NCT03843541|541302548|FG000|Overall Study|Death|1|||
150044665|NCT03843541|541302549|FG001|Overall Study|Death|0|||
150044666|NCT03843541|541302550|FG002|Overall Study|Death|0|||
150044667|NCT03843541|541302548|FG000|Overall Study|Lack of adherence to study medication|0|||
149967333|NCT01182350|541016210|FG000|Overall Study|Unevaluable for Biopsy|0|||
149967334|NCT01182350|541016211|FG001|Overall Study|Unevaluable for Biopsy|0|||
149967335|NCT01182350|541016212|FG002|Overall Study|Unevaluable for Biopsy|0|||
149967336|NCT01182350|541016213|FG003|Overall Study|Unevaluable for Biopsy|0|||
149967337|NCT01182350|541016214|FG004|Overall Study|Unevaluable for Biopsy|3|||
149967338|NCT05473715|541016219|FG000|Overall Study|Trial terminate|2|||
149967339|NCT05473715|541016220|FG001|Overall Study|Trial terminate|1|||
149967340|NCT02919618|541016223|FG000|Overall Study|Death|1|||
149967341|NCT02592863|541016224|FG000|Overall Study|Withdrawal by Subject|2|||
149967342|NCT02592863|541016225|FG001|Overall Study|Withdrawal by Subject|2|||
149967343|NCT02592863|541016224|FG000|Overall Study|Lost to Follow-up|1|||
149967344|NCT02592863|541016225|FG001|Overall Study|Lost to Follow-up|1|||
149967345|NCT03559530|541016226|FG000|Overall Study|non-location of medical records|44|||
149967346|NCT03559530|541016227|FG001|Overall Study|non-location of medical records|0|||
149967347|NCT03559530|541016226|FG000|Overall Study|culture results not considered for treat|29|||
149967348|NCT03559530|541016227|FG001|Overall Study|culture results not considered for treat|0|||
149967349|NCT03559530|541016226|FG000|Overall Study|duplicate cases|8|||
149967350|NCT03559530|541016227|FG001|Overall Study|duplicate cases|0|||
149967351|NCT03559530|541016226|FG000|Overall Study|other species of Acinetobacte|7|||
149967352|NCT03559530|541016227|FG001|Overall Study|other species of Acinetobacte|0|||
150044668|NCT03843541|541302549|FG001|Overall Study|Lack of adherence to study medication|0|||
150044669|NCT03843541|541302550|FG002|Overall Study|Lack of adherence to study medication|1|||
150044670|NCT03843541|541302548|FG000|Overall Study|Physician Decision|1|||
150044671|NCT03843541|541302549|FG001|Overall Study|Physician Decision|2|||
150044672|NCT03843541|541302550|FG002|Overall Study|Physician Decision|2|||
150044673|NCT03843541|541302548|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
150044674|NCT03843541|541302549|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
150044675|NCT03843541|541302550|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
150044676|NCT03843541|541302548|FG000|Overall Study|Withdrawal by Subject|6|||
150044677|NCT03843541|541302549|FG001|Overall Study|Withdrawal by Subject|9|||
150044678|NCT03843541|541302550|FG002|Overall Study|Withdrawal by Subject|7|||
150044679|NCT03843541|541302548|FG000|Overall Study|Administration of rescue mucolytic|0|||
150044680|NCT03843541|541302549|FG001|Overall Study|Administration of rescue mucolytic|0|||
150044681|NCT03843541|541302550|FG002|Overall Study|Administration of rescue mucolytic|1|||
150044682|NCT03843541|541302548|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
150044683|NCT03843541|541302549|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
150044684|NCT03843541|541302550|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
150044685|NCT04163016|541302552|FG000|Enrollment|Adverse Event|1|||
150044686|NCT04163016|541302553|FG001|Enrollment|Adverse Event|0|||
150044687|NCT04163016|541302554|FG002|Enrollment|Adverse Event|0|||
150044688|NCT04163016|541302555|FG003|Enrollment|Adverse Event|0|||
150044689|NCT04163016|541302552|FG000|Treatment|Adverse Event|0|||
150044690|NCT04163016|541302553|FG001|Treatment|Adverse Event|1|||
150044691|NCT04163016|541302554|FG002|Treatment|Adverse Event|0|||
150044692|NCT04163016|541302555|FG003|Treatment|Adverse Event|0|||
150044693|NCT04163016|541302552|FG000|Treatment|Withdrawal by Subject|0|||
150044694|NCT04163016|541302553|FG001|Treatment|Withdrawal by Subject|2|||
150044695|NCT04163016|541302554|FG002|Treatment|Withdrawal by Subject|0|||
150044696|NCT04163016|541302555|FG003|Treatment|Withdrawal by Subject|0|||
150044697|NCT04163016|541302552|FG000|Treatment|Indeterminate TB-test|0|||
150044698|NCT04163016|541302553|FG001|Treatment|Indeterminate TB-test|0|||
150044699|NCT04163016|541302554|FG002|Treatment|Indeterminate TB-test|0|||
150044700|NCT04163016|541302555|FG003|Treatment|Indeterminate TB-test|1|||
150044701|NCT04163016|541302552|FG000|Treatment|Participant did not want to continue in study|0|||
150044702|NCT04163016|541302553|FG001|Treatment|Participant did not want to continue in study|0|||
150044703|NCT04163016|541302554|FG002|Treatment|Participant did not want to continue in study|0|||
149967353|NCT03559530|541016226|FG000|Overall Study|contamination / colonization|3|||
150044704|NCT04163016|541302555|FG003|Treatment|Participant did not want to continue in study|1|||
150044705|NCT02930018|541302559|FG000|Overall Study|Lost to Follow-up|1|||
150044706|NCT02930018|541302560|FG001|Overall Study|Lost to Follow-up|1|||
150044707|NCT02930018|541302559|FG000|Overall Study|Withdrawal by Subject|5|||
150044708|NCT02930018|541302560|FG001|Overall Study|Withdrawal by Subject|2|||
150044709|NCT01104311|541302561|FG000|Overall Study|Withdrawal by Subject|6|||
150044710|NCT01104311|541302562|FG001|Overall Study|Withdrawal by Subject|6|||
150044711|NCT01104311|541302561|FG000|Overall Study|Protocol Violation|0|||
150044712|NCT01104311|541302562|FG001|Overall Study|Protocol Violation|1|||
150044713|NCT01104311|541302561|FG000|Overall Study|Physician Decision|2|||
150044714|NCT01104311|541302562|FG001|Overall Study|Physician Decision|2|||
150044715|NCT01104311|541302561|FG000|Overall Study|low compliance|1|||
150044716|NCT01104311|541302562|FG001|Overall Study|low compliance|1|||
149967354|NCT03559530|541016227|FG001|Overall Study|contamination / colonization|0|||
149967355|NCT00023595|541016228|FG000|5 Year Follow up|Lost to Follow-up|2|||
150044717|NCT01104311|541302561|FG000|Overall Study|Adverse Event|1|||
150044718|NCT01104311|541302562|FG001|Overall Study|Adverse Event|2|||
149888703|NCT04338022|540721038|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
149888704|NCT04338022|540721037|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
149888705|NCT04338022|540721038|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
149888706|NCT04338022|540721037|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
149888707|NCT04338022|540721038|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
149888708|NCT04338022|540721037|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
149888709|NCT04338022|540721038|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
149888710|NCT04338022|540721037|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
149888711|NCT04338022|540721038|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
149888712|NCT04338022|540721037|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
150044719|NCT04193189|541302564|FG000|Overall Study|Lost to Follow-up|9|||
150044720|NCT04193189|541302565|FG001|Overall Study|Lost to Follow-up|7|||
150044721|NCT04193189|541302566|FG002|Overall Study|Lost to Follow-up|9|||
150044722|NCT04193189|541302567|FG003|Overall Study|Lost to Follow-up|0|||
150044723|NCT04193189|541302564|FG000|Overall Study|Withdrawal by Subject|1|||
150044724|NCT04193189|541302565|FG001|Overall Study|Withdrawal by Subject|2|||
150044725|NCT04193189|541302566|FG002|Overall Study|Withdrawal by Subject|2|||
150044726|NCT04193189|541302567|FG003|Overall Study|Withdrawal by Subject|0|||
150044727|NCT04193189|541302564|FG000|Overall Study|Death|1|||
150044728|NCT04193189|541302565|FG001|Overall Study|Death|1|||
150044729|NCT04193189|541302566|FG002|Overall Study|Death|0|||
150044730|NCT04193189|541302567|FG003|Overall Study|Death|0|||
150044731|NCT04193189|541302564|FG000|Overall Study|Protocol Violation|0|||
150044732|NCT04193189|541302565|FG001|Overall Study|Protocol Violation|0|||
150044733|NCT04193189|541302566|FG002|Overall Study|Protocol Violation|0|||
150044734|NCT04193189|541302567|FG003|Overall Study|Protocol Violation|1|||
150044735|NCT00684060|541304152|FG000|Overall Study|Lost to Follow-up|1|||
150044736|NCT00684060|541304153|FG001|Overall Study|Lost to Follow-up|0|||
150044737|NCT00684060|541304152|FG000|Overall Study|New stenosis identified|1|||
150044738|NCT00684060|541304153|FG001|Overall Study|New stenosis identified|0|||
150044739|NCT00684060|541304152|FG000|Overall Study|Unable to collect MRI|1|||
150044740|NCT00684060|541304153|FG001|Overall Study|Unable to collect MRI|2|||
150044741|NCT00684060|541304152|FG000|Overall Study|Death|0|||
150044742|NCT00684060|541304153|FG001|Overall Study|Death|1|||
150044743|NCT00702715|541304154|FG000|Overall Study|Lost to Follow-up|1|||
150044744|NCT00702715|541304155|FG001|Overall Study|Lost to Follow-up|0|||
150044745|NCT01677377|541304156|FG000|Overall Study|Protocol Violation|1|||
150044746|NCT01677377|541304157|FG001|Overall Study|Protocol Violation|0|||
150044747|NCT01677377|541304158|FG002|Overall Study|Protocol Violation|0|||
150044748|NCT01677377|541304156|FG000|Overall Study|Lost to Follow-up|0|||
150044749|NCT01677377|541304157|FG001|Overall Study|Lost to Follow-up|1|||
150044750|NCT01677377|541304158|FG002|Overall Study|Lost to Follow-up|1|||
150044751|NCT01677377|541304156|FG000|Overall Study|Withdrawal by Subject|0|||
150044752|NCT01677377|541304157|FG001|Overall Study|Withdrawal by Subject|0|||
150044753|NCT01677377|541304158|FG002|Overall Study|Withdrawal by Subject|3|||
150044754|NCT01677377|541304156|FG000|Overall Study|Lack of Efficacy|0|||
150044755|NCT01677377|541304157|FG001|Overall Study|Lack of Efficacy|0|||
150044756|NCT01677377|541304158|FG002|Overall Study|Lack of Efficacy|1|||
150044757|NCT01677377|541304156|FG000|Overall Study|Pregnancy|0|||
150044758|NCT01677377|541304157|FG001|Overall Study|Pregnancy|0|||
150044759|NCT01677377|541304158|FG002|Overall Study|Pregnancy|1|||
150044760|NCT02260180|541304159|FG000|Overall Study|Adverse Event|2|||
150044761|NCT02260180|541304160|FG001|Overall Study|Adverse Event|0|||
150044762|NCT02260180|541304161|FG002|Overall Study|Adverse Event|1|||
150044763|NCT03544333|541304171|FG000|Overall Study|Withdrawal by Subject|1|||
150044764|NCT03544333|541304172|FG001|Overall Study|Withdrawal by Subject|0|||
150044765|NCT00243269|541304178|FG000|Overall Study|Protocol Violation|2|||
150044766|NCT00243269|541304179|FG001|Overall Study|Protocol Violation|1|||
150044767|NCT00243269|541304180|FG002|Overall Study|Protocol Violation|0|||
150044768|NCT00243269|541304181|FG003|Overall Study|Protocol Violation|1|||
150044769|NCT00243269|541304178|FG000|Overall Study|Lost to Follow-up|1|||
150044770|NCT00243269|541304179|FG001|Overall Study|Lost to Follow-up|0|||
150044771|NCT00243269|541304180|FG002|Overall Study|Lost to Follow-up|1|||
150044772|NCT00243269|541304181|FG003|Overall Study|Lost to Follow-up|3|||
150044773|NCT01837823|541304182|FG000|Overall Study|Lost to Follow-up|6|||
150044774|NCT00555061|541304183|FG000|Overall Study|Adverse Event|3|||
150044775|NCT00555061|541304183|FG000|Overall Study|Protocol Violation|1|||
150044776|NCT00555061|541304183|FG000|Overall Study|Lost to Follow-up|2|||
150044777|NCT00555061|541304183|FG000|Overall Study|Withdrawal by Subject|2|||
150044778|NCT00555061|541304183|FG000|Overall Study|Participant enrolled, but never treated|1|||
150044779|NCT01864603|541304184|FG000|Stage 2|DSMB design modification|86056|||
150044780|NCT01864603|541304185|FG001|Stage 2|DSMB design modification|92558|||
150044781|NCT03830892|541304189|FG000|Overall Study|Physician Decision|2|||
150044782|NCT03830892|541304190|FG001|Overall Study|Physician Decision|3|||
150175718|NCT00925587|541779888|FG001|Overall Study|Physician Decision|1|||
149888713|NCT04338022|540721038|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
149888714|NCT02189837|540721039|FG000|Overall Study|Withdrawal by Subject|2|||
149888715|NCT02189837|540721040|FG001|Overall Study|Withdrawal by Subject|1|||
149888716|NCT02189837|540721041|FG002|Overall Study|Withdrawal by Subject|3|||
149888717|NCT02189837|540721042|FG003|Overall Study|Withdrawal by Subject|1|||
149888718|NCT02189837|540721039|FG000|Overall Study|Sponsor Decision|0|||
149888719|NCT02189837|540721040|FG001|Overall Study|Sponsor Decision|0|||
149888720|NCT02189837|540721041|FG002|Overall Study|Sponsor Decision|0|||
149888721|NCT02189837|540721042|FG003|Overall Study|Sponsor Decision|1|||
149888722|NCT02198963|540721043|FG000|Overall Study|Adverse Event|1|||
149888723|NCT02198963|540721043|FG000|Overall Study|Withdrawal by Subject|6|||
149888724|NCT01876446|540721044|FG000|Overall Study|Death|0|||
149888725|NCT01876446|540721045|FG001|Overall Study|Death|1|||
149888726|NCT01876446|540721044|FG000|Overall Study|Withdrawal by Subject|1|||
149888727|NCT01876446|540721045|FG001|Overall Study|Withdrawal by Subject|2|||
149888728|NCT01876446|540721044|FG000|Overall Study|Physician Decision|1|||
149888729|NCT01876446|540721045|FG001|Overall Study|Physician Decision|3|||
149888730|NCT00822692|540721048|FG000|Overall Study|Lost to Follow-up|17|||
149888731|NCT00822692|540721049|FG001|Overall Study|Lost to Follow-up|25|||
149888732|NCT00683657|540721053|FG000|Overall Study|Adverse Event|0|||
149888733|NCT00683657|540721054|FG001|Overall Study|Adverse Event|1|||
149888734|NCT00683657|540721053|FG000|Overall Study|Subject Withdrew Consent|1|||
149888735|NCT00683657|540721054|FG001|Overall Study|Subject Withdrew Consent|0|||
149888736|NCT03200717|540721057|FG000|Overall Study|Progressive disease|24|||
149888737|NCT03200717|540721058|FG001|Overall Study|Progressive disease|5|||
149888738|NCT03200717|540721057|FG000|Overall Study|Adverse Event|11|||
149888739|NCT03200717|540721058|FG001|Overall Study|Adverse Event|8|||
149888740|NCT03200717|540721057|FG000|Overall Study|Physician Decision|3|||
149888741|NCT03200717|540721058|FG001|Overall Study|Physician Decision|2|||
149888742|NCT03200717|540721057|FG000|Overall Study|Death|2|||
149888743|NCT03200717|540721058|FG001|Overall Study|Death|0|||
149888744|NCT03200717|540721057|FG000|Overall Study|Subject/Guardian Decision|1|||
149888745|NCT03200717|540721058|FG001|Overall Study|Subject/Guardian Decision|0|||
149888746|NCT03552380|540721060|FG000|Study Treatment|Disease Progression|3|||
149888747|NCT03552380|540721061|FG001|Study Treatment|Disease Progression|4|||
149888748|NCT03552380|540721060|FG000|Study Treatment|Adverse Event|2|||
149888749|NCT03552380|540721061|FG001|Study Treatment|Adverse Event|2|||
149888750|NCT03552380|540721060|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
149888751|NCT03552380|540721061|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
149888752|NCT03552380|540721060|FG000|Follow up|Death|3|||
149888753|NCT03552380|540721061|FG001|Follow up|Death|4|||
149888754|NCT03552380|540721060|FG000|Follow up|Site IRB terminated|0|||
149888755|NCT03552380|540721061|FG001|Follow up|Site IRB terminated|1|||
149888756|NCT03447743|540721062|FG000|Overall Study|Withdrawal by Subject|2|||
149888757|NCT03447743|540721062|FG000|Overall Study|Lost to Follow-up|3|||
149888758|NCT03447743|540721062|FG000|Overall Study|Adverse Event|1|||
149888759|NCT03447743|540721062|FG000|Overall Study|Did not meet criteria to continue|1|||
149888760|NCT02046603|540721063|FG000|Overall Study|Other|11|||
149888761|NCT02046603|540721064|FG001|Overall Study|Other|66|||
149888762|NCT02046603|540721063|FG000|Overall Study|Protocol Violation|0|||
149888763|NCT02046603|540721064|FG001|Overall Study|Protocol Violation|1|||
149888764|NCT02046603|540721063|FG000|Overall Study|Participant/legal guardian decision|1|||
149888765|NCT02046603|540721064|FG001|Overall Study|Participant/legal guardian decision|3|||
149888766|NCT02046603|540721063|FG000|Overall Study|Physician Decision|2|||
149888767|NCT02046603|540721064|FG001|Overall Study|Physician Decision|1|||
149888768|NCT02046603|540721063|FG000|Overall Study|Lost to Follow-up|1|||
149888769|NCT02046603|540721064|FG001|Overall Study|Lost to Follow-up|2|||
149888770|NCT02046603|540721063|FG000|Overall Study|Death|0|||
149888771|NCT02046603|540721064|FG001|Overall Study|Death|1|||
149888772|NCT02046603|540721063|FG000|Overall Study|Adverse Event|0|||
149888773|NCT02046603|540721064|FG001|Overall Study|Adverse Event|1|||
149888774|NCT02461160|540721065|FG000|Overall Study|Lost to Follow-up|0|||
149888775|NCT02461160|540721066|FG001|Overall Study|Lost to Follow-up|0|||
149888776|NCT02461160|540721067|FG002|Overall Study|Lost to Follow-up|0|||
149888777|NCT02461160|540721068|FG003|Overall Study|Lost to Follow-up|0|||
149888778|NCT02461160|540721069|FG004|Overall Study|Lost to Follow-up|0|||
149888779|NCT02461160|540721070|FG005|Overall Study|Lost to Follow-up|0|||
149888780|NCT02461160|540721071|FG006|Overall Study|Lost to Follow-up|0|||
149888781|NCT02461160|540721072|FG007|Overall Study|Lost to Follow-up|1|||
149888782|NCT02461160|540721073|FG008|Overall Study|Lost to Follow-up|0|||
149888783|NCT02461160|540721074|FG009|Overall Study|Lost to Follow-up|0|||
149888784|NCT02461160|540721075|FG010|Overall Study|Lost to Follow-up|0|||
149888785|NCT02461160|540721076|FG011|Overall Study|Lost to Follow-up|0|||
149888786|NCT02461160|540721077|FG012|Overall Study|Lost to Follow-up|0|||
149888787|NCT01112059|540721078|FG000|Overall Study|Withdrawal by Subject|1|||
149888788|NCT01112059|540721079|FG001|Overall Study|Withdrawal by Subject|0|||
149888789|NCT03567980|540721082|FG000|Overall Study|Adverse Event|1|||
149888790|NCT02575833|540721083|FG000|Overall Study|Withdrawal by Subject|0|||
149888791|NCT02575833|540721084|FG001|Overall Study|Withdrawal by Subject|1|||
149888792|NCT02575833|540721083|FG000|Overall Study|Lost to Follow-up|1|||
149888793|NCT02575833|540721084|FG001|Overall Study|Lost to Follow-up|0|||
149888794|NCT02633787|540721087|FG000|Overall Study|Withdrawal by Subject|1|||
149888795|NCT01742897|540721088|FG000|Overall Study|Adverse Event|3|||
150044783|NCT03830892|541304189|FG000|Overall Study|Study terminated due to COVID|4|||
149888796|NCT01742897|540721088|FG000|Overall Study|Withdrawal by Subject|1|||
149888797|NCT01742897|540721088|FG000|Overall Study|Other|1|||
149888798|NCT00967330|540721091|FG000|Overall Study|Protocol Violation|3|||
149888799|NCT00967330|540721092|FG001|Overall Study|Protocol Violation|4|||
149888800|NCT00967330|540721091|FG000|Overall Study|Regular|10|||
149888801|NCT00967330|540721092|FG001|Overall Study|Regular|3|||
149888802|NCT00967330|540721091|FG000|Overall Study|Withdrawal by Subject|6|||
149888803|NCT00967330|540721092|FG001|Overall Study|Withdrawal by Subject|0|||
149888804|NCT00967330|540721091|FG000|Overall Study|Lost to Follow-up|1|||
149888805|NCT00967330|540721092|FG001|Overall Study|Lost to Follow-up|1|||
149888806|NCT00967330|540721091|FG000|Overall Study|Death|102|||
149888807|NCT00967330|540721092|FG001|Overall Study|Death|51|||
149888808|NCT00967330|540721091|FG000|Overall Study|Severe protocol deviation|0|||
149888809|NCT00967330|540721092|FG001|Overall Study|Severe protocol deviation|1|||
149888810|NCT02698163|540721093|FG000|Overall Study|Lost to Follow-up|0|||
149888811|NCT02698163|540721094|FG001|Overall Study|Lost to Follow-up|1|||
149888812|NCT01133067|540721095|FG000|Overall Study|Death|136|||
149888813|NCT01133067|540721095|FG000|Overall Study|Lost to Follow-up|3|||
149888814|NCT00752128|540721099|FG000|Overall Study|Withdrawal by Subject|4|||
149888815|NCT04135937|540721100|FG000|Overall Study|Lost to Follow-up|2|||
149888816|NCT04135937|540721100|FG000|Overall Study|Withdrawal by Subject|1|||
149888817|NCT02548143|540721101|FG000|Overall Study|Adverse Event|1|||
149888818|NCT02548143|540721102|FG001|Overall Study|Adverse Event|0|||
149888819|NCT02548143|540721101|FG000|Overall Study|Withdrawal by Subject|0|||
149888820|NCT02548143|540721102|FG001|Overall Study|Withdrawal by Subject|1|||
149888821|NCT04871776|540721103|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
149888822|NCT04871776|540721104|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
149888823|NCT04871776|540721105|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
149888824|NCT04871776|540721103|FG000|Overall Study|Did not meet eligibility criteria|1|||
149888825|NCT04871776|540721104|FG001|Overall Study|Did not meet eligibility criteria|1|||
149888826|NCT04871776|540721105|FG002|Overall Study|Did not meet eligibility criteria|1|||
149967356|NCT00023595|541016229|FG001|5 Year Follow up|Lost to Follow-up|2|||
149967357|NCT00023595|541016230|FG002|5 Year Follow up|Lost to Follow-up|1|||
149967358|NCT00023595|541016231|FG003|5 Year Follow up|Lost to Follow-up|7|||
149967359|NCT00023595|541016232|FG004|5 Year Follow up|Lost to Follow-up|3|||
149967360|NCT00023595|541016228|FG000|10 Year Follow up|Lost to Follow-up|12|||
149967361|NCT00023595|541016229|FG001|10 Year Follow up|Lost to Follow-up|10|||
149967362|NCT00023595|541016230|FG002|10 Year Follow up|Lost to Follow-up|3|||
149967363|NCT00023595|541016231|FG003|10 Year Follow up|Lost to Follow-up|0|||
149967364|NCT00023595|541016232|FG004|10 Year Follow up|Lost to Follow-up|0|||
149967365|NCT05889468|541016233|FG000|Overall Study|Lost to Follow-up|9|||
149967366|NCT05889468|541016234|FG001|Overall Study|Lost to Follow-up|2|||
149967367|NCT05889468|541016233|FG000|Overall Study|Withdrawal by Subject|2|||
149967368|NCT05889468|541016234|FG001|Overall Study|Withdrawal by Subject|2|||
149967369|NCT01309230|541016235|FG000|Overall Study|Withdrawal by Subject|0|||
149967370|NCT01309230|541016236|FG001|Overall Study|Withdrawal by Subject|2|||
149967371|NCT01309230|541016235|FG000|Overall Study|Observation arm closed|0|||
149967372|NCT01309230|541016236|FG001|Overall Study|Observation arm closed|2|||
149967373|NCT00427700|541016239|FG000|Overall Study|Lost to Follow-up|2|||
149967374|NCT00427700|541016240|FG001|Overall Study|Lost to Follow-up|5|||
149967375|NCT00427700|541016239|FG000|Overall Study|no induction of menses|1|||
149967376|NCT00427700|541016240|FG001|Overall Study|no induction of menses|4|||
149967377|NCT00427700|541016239|FG000|Overall Study|Pregnancy|0|||
149967378|NCT00427700|541016240|FG001|Overall Study|Pregnancy|2|||
149967379|NCT03038087|541016243|FG000|Overall Study|lost data|1|||
149967380|NCT01435356|541016248|FG000|Overall Study|Adverse Event|2|||
149967381|NCT01435356|541016249|FG001|Overall Study|Adverse Event|0|||
149967382|NCT01435356|541016248|FG000|Overall Study|Disease progression/recurrence|17|||
149967383|NCT01435356|541016249|FG001|Overall Study|Disease progression/recurrence|10|||
149967384|NCT01435356|541016248|FG000|Overall Study|Protocol Violation|0|||
149967385|NCT01435356|541016249|FG001|Overall Study|Protocol Violation|1|||
149967386|NCT01435356|541016248|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
149967387|NCT01435356|541016249|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
149967388|NCT01435356|541016248|FG000|Overall Study|Withdrawal by Subject|1|||
149967389|NCT01435356|541016249|FG001|Overall Study|Withdrawal by Subject|1|||
149967390|NCT01435356|541016248|FG000|Overall Study|Facial palsy|1|||
149967391|NCT01435356|541016249|FG001|Overall Study|Facial palsy|0|||
149967392|NCT01435356|541016248|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
149967393|NCT01435356|541016249|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
149967394|NCT01435356|541016248|FG000|Overall Study|Physician Decision|1|||
149967395|NCT01435356|541016249|FG001|Overall Study|Physician Decision|0|||
149967396|NCT01435356|541016248|FG000|Overall Study|Patient decision|3|||
149967397|NCT01435356|541016249|FG001|Overall Study|Patient decision|0|||
149967398|NCT01435356|541016248|FG000|Overall Study|Patient moved to another city|1|||
149967399|NCT01435356|541016249|FG001|Overall Study|Patient moved to another city|1|||
149967400|NCT00209131|541016250|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
149967401|NCT00209131|541016251|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
149967402|NCT02871219|541016254|FG000|Overall Study|Adverse Event|15|||
149967403|NCT02871219|541016254|FG000|Overall Study|Death|3|||
149967404|NCT02871219|541016254|FG000|Overall Study|Progression|3|||
149967405|NCT02871219|541016254|FG000|Overall Study|Infections|7|||
149967406|NCT02871219|541016254|FG000|Overall Study|Infusion Related|4|||
149967407|NCT05081843|541016255|FG000|Overall Study|Lost to Follow-up|135|||
149967408|NCT05081843|541016256|FG001|Overall Study|Lost to Follow-up|145|||
149967409|NCT03034044|541016257|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
149967410|NCT03211416|541016262|FG000|Overall Study|Adverse Event|7|||
149967411|NCT03211416|541016262|FG000|Overall Study|Lack of Efficacy|2|||
149967412|NCT03211416|541016262|FG000|Overall Study|Physician Decision|1|||
149967413|NCT03709472|541016266|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
149967414|NCT03709472|541016267|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
149967415|NCT03709472|541016266|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
149967416|NCT03709472|541016267|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
149967417|NCT03559556|541016268|FG000|Overall Study|Withdrawal by Subject|1|||
149967418|NCT01969058|541016270|FG000|Overall Study|Withdrawal by Subject|2|||
149967419|NCT01969058|541016271|FG001|Overall Study|Withdrawal by Subject|0|||
149967420|NCT01969058|541016270|FG000|Overall Study|Adverse Event|1|||
149967421|NCT01969058|541016271|FG001|Overall Study|Adverse Event|0|||
149967422|NCT02038036|541016277|FG000|Core Study|Adverse Event|7|||
149967423|NCT02038036|541016278|FG001|Core Study|Adverse Event|7|||
149967424|NCT02038036|541016277|FG000|Core Study|Death|1|||
149967425|NCT02038036|541016278|FG001|Core Study|Death|1|||
149967426|NCT02038036|541016277|FG000|Core Study|Disease progression|2|||
149967427|NCT02038036|541016278|FG001|Core Study|Disease progression|2|||
149967428|NCT02038036|541016277|FG000|Core Study|Lost to Follow-up|0|||
149967429|NCT02038036|541016278|FG001|Core Study|Lost to Follow-up|1|||
149967430|NCT02038036|541016277|FG000|Core Study|Physician Decision|2|||
149967431|NCT02038036|541016278|FG001|Core Study|Physician Decision|1|||
149967432|NCT02038036|541016277|FG000|Core Study|Subject/guardian decision|0|||
149967433|NCT02038036|541016278|FG001|Core Study|Subject/guardian decision|1|||
149888827|NCT00725283|540722721|FG000|Overall Study|Missing Code|3|||
149888828|NCT00725283|540722721|FG000|Overall Study|Death|5|||
149888829|NCT00725283|540722721|FG000|Overall Study|Other|6|||
149888830|NCT00725283|540722721|FG000|Overall Study|Withdrawal by Subject|10|||
149888831|NCT00711087|540722722|FG000|Overall Study|Lost to Follow-up|1|||
149888832|NCT00711087|540722723|FG001|Overall Study|Lost to Follow-up|0|||
149888833|NCT01958437|540722724|FG000|Overall Study|Incidental MRI findings|0|||
149888834|NCT01958437|540722725|FG001|Overall Study|Incidental MRI findings|0|||
149888835|NCT01958437|540722726|FG002|Overall Study|Incidental MRI findings|1|||
149888836|NCT01958437|540722727|FG003|Overall Study|Incidental MRI findings|1|||
149888837|NCT02603887|540722728|FG000|Stage 1|Adverse Event|4|||
149888838|NCT02603887|540722728|FG000|Stage 1|Disease progression|1|||
149888839|NCT02603887|540722728|FG000|Stage 2|FDA guidance|1|||
149888840|NCT04620746|540722729|FG000|Overall Study|Adverse Event|2|||
149888841|NCT04620746|540722730|FG001|Overall Study|Adverse Event|0|||
149888842|NCT04620746|540722729|FG000|Overall Study|Uniterpretable skin test|1|||
149888843|NCT04620746|540722730|FG001|Overall Study|Uniterpretable skin test|0|||
149888844|NCT04620746|540722729|FG000|Overall Study|Withdrawal by Subject|0|||
149888845|NCT04620746|540722730|FG001|Overall Study|Withdrawal by Subject|1|||
149967434|NCT02038036|541016277|FG000|Core Study|Withdrawal by Subject|3|||
149967435|NCT02038036|541016278|FG001|Core Study|Withdrawal by Subject|1|||
149967436|NCT02038036|541016277|FG000|Crossover Period|Withdrawal by Subject|0|||
149967437|NCT02038036|541016278|FG001|Crossover Period|Withdrawal by Subject|3|||
149967438|NCT02038036|541016277|FG000|Crossover Period|Adverse Event|0|||
149888846|NCT03473925|540722731|FG000|Overall Study|Death|48|||
149888847|NCT03473925|540722732|FG001|Overall Study|Death|44|||
149888848|NCT03473925|540722731|FG000|Overall Study|Sponsor Decision|2|||
149888849|NCT03473925|540722732|FG001|Overall Study|Sponsor Decision|7|||
149967439|NCT02038036|541016278|FG001|Crossover Period|Adverse Event|9|||
149967440|NCT02038036|541016277|FG000|Crossover Period|Death|0|||
149967441|NCT02038036|541016278|FG001|Crossover Period|Death|2|||
149967442|NCT02038036|541016277|FG000|Crossover Period|Disease progression|0|||
149888850|NCT03473925|540722731|FG000|Overall Study|Withdrawal by Subject|1|||
149888851|NCT03473925|540722732|FG001|Overall Study|Withdrawal by Subject|3|||
149888852|NCT03473925|540722731|FG000|Overall Study|Not Treated|1|||
149888853|NCT03473925|540722732|FG001|Overall Study|Not Treated|1|||
149888854|NCT03411863|540722733|FG000|Overall Study|Withdrawal by Subject|3|||
149888855|NCT03411863|540722734|FG001|Overall Study|Withdrawal by Subject|1|||
149888856|NCT03411863|540722733|FG000|Overall Study|Physician Decision|0|||
149888857|NCT03411863|540722734|FG001|Overall Study|Physician Decision|1|||
149888858|NCT03535740|540722737|FG000|Overall Study|Death|44|||
149888859|NCT03535740|540722737|FG000|Overall Study|Lost to Follow-up|1|||
149888860|NCT03535740|540722737|FG000|Overall Study|Withdrawal by Subject|13|||
149888861|NCT03535740|540722737|FG000|Overall Study|Site terminated by Sponsor|45|||
149888862|NCT05198518|540722740|FG000|Screening Visit|Deemed unable to participate|58|||
149888863|NCT05198518|540722741|FG001|Screening Visit|Deemed unable to participate|0|||
149888864|NCT05198518|540722742|FG002|Screening Visit|Deemed unable to participate|0|||
149888865|NCT01841593|540722746|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
149888866|NCT01841593|540722747|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
149888867|NCT01841593|540722746|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
149888868|NCT01841593|540722747|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
149888869|NCT00124917|540722755|FG000|Overall Study|Physician Decision|3|||
149888870|NCT03518008|540722756|FG000|Period 2, Second Week of Wear|Family emergency|0|||
149888871|NCT03518008|540722757|FG001|Period 2, Second Week of Wear|Family emergency|1|||
149888872|NCT03164551|540722758|FG000|Overall Study|Imaging discontinued prior completion|8|||
149888873|NCT03164551|540722759|FG001|Overall Study|Imaging discontinued prior completion|0|||
149888874|NCT03164551|540722758|FG000|Overall Study|Participant was non-compliant|1|||
149888875|NCT03164551|540722759|FG001|Overall Study|Participant was non-compliant|0|||
149888876|NCT03164551|540722758|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
149888877|NCT03164551|540722759|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
149888878|NCT03164551|540722758|FG000|Overall Study|Other|8|||
149888879|NCT03164551|540722759|FG001|Overall Study|Other|2|||
149888880|NCT04782076|540722766|FG000|Overall Study|Family Emergency|1|||
149888881|NCT00729937|540722773|FG000|Overall Study|Lost to Follow-up|49|||
149888882|NCT00729937|540722774|FG001|Overall Study|Lost to Follow-up|58|||
149888883|NCT00729937|540722775|FG002|Overall Study|Lost to Follow-up|18|||
149888884|NCT00729937|540722776|FG003|Overall Study|Lost to Follow-up|33|||
149888885|NCT00729937|540722777|FG004|Overall Study|Lost to Follow-up|18|||
149888886|NCT00729937|540722778|FG005|Overall Study|Lost to Follow-up|23|||
149888887|NCT00729937|540722773|FG000|Overall Study|Physician Decision|7|||
149967443|NCT02038036|541016278|FG001|Crossover Period|Disease progression|3|||
149967444|NCT02038036|541016277|FG000|Crossover Period|Lost to Follow-up|0|||
149967445|NCT02038036|541016278|FG001|Crossover Period|Lost to Follow-up|1|||
149967446|NCT02038036|541016277|FG000|Crossover Period|Physician Decision|0|||
149967447|NCT02038036|541016278|FG001|Crossover Period|Physician Decision|2|||
149967448|NCT01373281|541017891|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
149888888|NCT00729937|540722774|FG001|Overall Study|Physician Decision|16|||
149888889|NCT00729937|540722775|FG002|Overall Study|Physician Decision|2|||
149888890|NCT00729937|540722776|FG003|Overall Study|Physician Decision|0|||
149888891|NCT00729937|540722777|FG004|Overall Study|Physician Decision|5|||
149888892|NCT00729937|540722778|FG005|Overall Study|Physician Decision|8|||
149888893|NCT00729937|540722773|FG000|Overall Study|Death|1|||
149888894|NCT00729937|540722774|FG001|Overall Study|Death|0|||
149888895|NCT00729937|540722775|FG002|Overall Study|Death|1|||
149888896|NCT00729937|540722776|FG003|Overall Study|Death|0|||
149888897|NCT00729937|540722777|FG004|Overall Study|Death|0|||
149888898|NCT00729937|540722778|FG005|Overall Study|Death|1|||
149888899|NCT00729937|540722773|FG000|Overall Study|Withdrawal by Subject|3|||
149967449|NCT01373281|541017892|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
149967450|NCT01373281|541017891|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
149967451|NCT01373281|541017892|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
149888900|NCT00729937|540722774|FG001|Overall Study|Withdrawal by Subject|5|||
149967452|NCT01373281|541017891|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
149967453|NCT01373281|541017892|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
149967454|NCT01373281|541017891|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
149967455|NCT01373281|541017892|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
149967456|NCT01373281|541017891|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
149967457|NCT01373281|541017892|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
149967458|NCT01373281|541017891|FG000|Surveillance Expansion Period|Protocol Violation|9|||
149967459|NCT01373281|541017892|FG001|Surveillance Expansion Period|Protocol Violation|1|||
149967460|NCT01373281|541017891|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
149967461|NCT01373281|541017892|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
149888901|NCT00729937|540722775|FG002|Overall Study|Withdrawal by Subject|6|||
149888902|NCT00729937|540722776|FG003|Overall Study|Withdrawal by Subject|0|||
149967462|NCT01373281|541017891|FG000|Surveillance Expansion Period|Serious adverse event|3|||
149967463|NCT01373281|541017892|FG001|Surveillance Expansion Period|Serious adverse event|4|||
149967464|NCT01397253|541017893|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
149967465|NCT01397253|541017894|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
150175719|NCT00925587|541779887|FG000|Overall Study|Protocol Violation|6|||
149888903|NCT00729937|540722777|FG004|Overall Study|Withdrawal by Subject|4|||
149888904|NCT00729937|540722778|FG005|Overall Study|Withdrawal by Subject|2|||
149888905|NCT00729937|540722773|FG000|Overall Study|Randomized but not treated|12|||
149888906|NCT00729937|540722774|FG001|Overall Study|Randomized but not treated|6|||
149888907|NCT00729937|540722775|FG002|Overall Study|Randomized but not treated|1|||
149888908|NCT00729937|540722776|FG003|Overall Study|Randomized but not treated|0|||
149888909|NCT00729937|540722777|FG004|Overall Study|Randomized but not treated|1|||
149888910|NCT00729937|540722778|FG005|Overall Study|Randomized but not treated|3|||
149888911|NCT00729937|540722773|FG000|Overall Study|Did not meet eligibility criteria|2|||
149888912|NCT00729937|540722774|FG001|Overall Study|Did not meet eligibility criteria|1|||
149888913|NCT00729937|540722775|FG002|Overall Study|Did not meet eligibility criteria|0|||
149888914|NCT00729937|540722776|FG003|Overall Study|Did not meet eligibility criteria|0|||
149888915|NCT00729937|540722777|FG004|Overall Study|Did not meet eligibility criteria|0|||
149888916|NCT00729937|540722778|FG005|Overall Study|Did not meet eligibility criteria|0|||
149888917|NCT00729937|540722773|FG000|Overall Study|Incarcerated|0|||
149888918|NCT00729937|540722774|FG001|Overall Study|Incarcerated|2|||
150044784|NCT03830892|541304190|FG001|Overall Study|Study terminated due to COVID|0|||
150044785|NCT03830892|541304189|FG000|Overall Study|Protocol Violation|0|||
150044786|NCT03830892|541304190|FG001|Overall Study|Protocol Violation|1|||
150044787|NCT03830892|541304189|FG000|Overall Study|Withdrawal by Subject|0|||
150044788|NCT03830892|541304190|FG001|Overall Study|Withdrawal by Subject|2|||
150044789|NCT00330967|541304191|FG000|Overall Study|Withdrawal by Subject|0|||
150044790|NCT00330967|541304192|FG001|Overall Study|Withdrawal by Subject|5|||
150044791|NCT00330967|541304191|FG000|Overall Study|Physician Decision|0|||
150044792|NCT00330967|541304192|FG001|Overall Study|Physician Decision|9|||
150044793|NCT00337675|541304193|FG000|Overall Study|Adverse Event|10|||
149888919|NCT00729937|540722775|FG002|Overall Study|Incarcerated|1|||
149888920|NCT00729937|540722776|FG003|Overall Study|Incarcerated|1|||
149888921|NCT00729937|540722777|FG004|Overall Study|Incarcerated|0|||
149888922|NCT00729937|540722778|FG005|Overall Study|Incarcerated|0|||
149888923|NCT00281957|540722782|FG000|Overall Study|Adverse Event|7|||
149888924|NCT00281957|540722783|FG001|Overall Study|Adverse Event|2|||
149888925|NCT00281957|540722782|FG000|Overall Study|Death|1|||
149888926|NCT00281957|540722783|FG001|Overall Study|Death|0|||
149888927|NCT00281957|540722782|FG000|Overall Study|Progression/relapse|47|||
149888928|NCT00281957|540722783|FG001|Overall Study|Progression/relapse|35|||
149888929|NCT00281957|540722782|FG000|Overall Study|Not protocol specified|8|||
149888930|NCT00281957|540722783|FG001|Overall Study|Not protocol specified|1|||
149888931|NCT00281957|540722782|FG000|Overall Study|Not eligible|1|||
149888932|NCT00281957|540722783|FG001|Overall Study|Not eligible|2|||
149888933|NCT00281957|540722782|FG000|Overall Study|Did not start treatment|3|||
149888934|NCT00281957|540722783|FG001|Overall Study|Did not start treatment|1|||
149888935|NCT00281957|540722782|FG000|Overall Study|Refusal unrelated to adverse events|0|||
149888936|NCT00281957|540722783|FG001|Overall Study|Refusal unrelated to adverse events|1|||
149888937|NCT03281876|540722791|FG000|Overall Study|Adverse Event|4|||
149888938|NCT03281876|540722792|FG001|Overall Study|Adverse Event|15|||
149888939|NCT03281876|540722791|FG000|Overall Study|Lost to Follow-up|1|||
149888940|NCT03281876|540722792|FG001|Overall Study|Lost to Follow-up|4|||
149888941|NCT03281876|540722791|FG000|Overall Study|Withdrawal by Subject|11|||
149888942|NCT03281876|540722792|FG001|Overall Study|Withdrawal by Subject|15|||
149888943|NCT03281876|540722791|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149888944|NCT03281876|540722792|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149888945|NCT03281876|540722791|FG000|Overall Study|OTHER|5|||
149888946|NCT03281876|540722792|FG001|Overall Study|OTHER|5|||
150044794|NCT00337675|541304194|FG001|Overall Study|Adverse Event|9|||
150044795|NCT00337675|541304195|FG002|Overall Study|Adverse Event|19|||
150044796|NCT00337675|541304193|FG000|Overall Study|Lack of Efficacy|10|||
149888947|NCT02208089|540722793|FG000|Overall Study|Withdrawal by Subject|1|||
149888948|NCT02208089|540722794|FG001|Overall Study|Withdrawal by Subject|0|||
149888949|NCT02208089|540722793|FG000|Overall Study|Lost to Follow-up|6|||
149888950|NCT02208089|540722794|FG001|Overall Study|Lost to Follow-up|0|||
149888951|NCT02443740|540722795|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888952|NCT02443740|540722796|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888953|NCT02443740|540722797|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
150044797|NCT00337675|541304194|FG001|Overall Study|Lack of Efficacy|7|||
150044798|NCT00337675|541304195|FG002|Overall Study|Lack of Efficacy|9|||
150044799|NCT00337675|541304193|FG000|Overall Study|Lost to Follow-up|22|||
149888954|NCT02443740|540722798|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888955|NCT02443740|540722799|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888956|NCT02443740|540722800|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
149888957|NCT02443740|540722801|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888958|NCT02443740|540722802|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888959|NCT02443740|540722803|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888960|NCT02443740|540722804|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888961|NCT02443740|540722805|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
149888962|NCT02443740|540722795|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
149888963|NCT02443740|540722796|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888964|NCT02443740|540722797|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888965|NCT02443740|540722798|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888966|NCT02443740|540722799|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888967|NCT02443740|540722800|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888968|NCT02443740|540722801|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
149888969|NCT02443740|540722802|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149967466|NCT03502681|541017897|FG000|Overall Study|Adverse Event|1|||
149967467|NCT03502681|541017898|FG001|Overall Study|Adverse Event|1|||
149967468|NCT03502681|541017897|FG000|Overall Study|Disease Progression|2|||
149967469|NCT03502681|541017898|FG001|Overall Study|Disease Progression|1|||
149967470|NCT03468998|541017899|FG000|Overall Study|Withdrawal by Subject|1|||
149967471|NCT03468998|541017900|FG001|Overall Study|Withdrawal by Subject|1|||
149888970|NCT02443740|540722803|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888971|NCT02443740|540722804|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888972|NCT02443740|540722805|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
149888973|NCT02443740|540722795|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888974|NCT02443740|540722796|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888975|NCT02443740|540722797|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888976|NCT02443740|540722798|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888977|NCT02443740|540722799|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888978|NCT02443740|540722800|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
149888979|NCT02443740|540722801|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888980|NCT02443740|540722802|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888981|NCT02443740|540722803|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888982|NCT02443740|540722804|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888983|NCT02443740|540722805|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
149888984|NCT00456300|540722806|FG000|Overall Study|Adverse Event|1|||
149888985|NCT00456300|540722807|FG001|Overall Study|Adverse Event|0|||
149888986|NCT02452476|540722808|FG000|Overall Study|Death|4|||
149888987|NCT02452476|540722809|FG001|Overall Study|Death|7|||
149888988|NCT02452476|540722808|FG000|Overall Study|Lost to Follow-up|1|||
149888989|NCT02452476|540722809|FG001|Overall Study|Lost to Follow-up|1|||
149888990|NCT02452476|540722808|FG000|Overall Study|Physician Decision|1|||
149888991|NCT02452476|540722809|FG001|Overall Study|Physician Decision|1|||
149888992|NCT02452476|540722808|FG000|Overall Study|Not treated|5|||
149888993|NCT02452476|540722809|FG001|Overall Study|Not treated|1|||
149888994|NCT01074944|540722815|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
149888995|NCT01074944|540722816|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
149888996|NCT01074944|540722817|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
149888997|NCT01074944|540722818|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
149888998|NCT01074944|540722819|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
150044800|NCT00337675|541304194|FG001|Overall Study|Lost to Follow-up|19|||
150044801|NCT00337675|541304195|FG002|Overall Study|Lost to Follow-up|17|||
150044802|NCT00337675|541304193|FG000|Overall Study|Physician Decision|9|||
150044803|NCT00337675|541304194|FG001|Overall Study|Physician Decision|17|||
150044804|NCT00337675|541304195|FG002|Overall Study|Physician Decision|14|||
150044805|NCT00337675|541304193|FG000|Overall Study|Protocol Violation|21|||
149888999|NCT01074944|540722815|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
149889000|NCT01074944|540722816|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
149889001|NCT01074944|540722817|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
149889002|NCT01074944|540722818|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
149889003|NCT01074944|540722819|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
149967472|NCT03468998|541017901|FG002|Overall Study|Withdrawal by Subject|0|||
149967473|NCT03468998|541017902|FG003|Overall Study|Withdrawal by Subject|4|||
149967474|NCT03468998|541017903|FG004|Overall Study|Withdrawal by Subject|1|||
149967475|NCT03468998|541017904|FG005|Overall Study|Withdrawal by Subject|0|||
149967476|NCT00959049|541017905|FG000|Overall Study|Adverse Event|1|||
149967477|NCT00959049|541017906|FG001|Overall Study|Adverse Event|0|||
149967478|NCT00959049|541017907|FG002|Overall Study|Adverse Event|0|||
149967479|NCT00959049|541017908|FG003|Overall Study|Adverse Event|0|||
149967480|NCT00959049|541017909|FG004|Overall Study|Adverse Event|0|||
149967481|NCT00959049|541017910|FG005|Overall Study|Adverse Event|0|||
149967482|NCT00959049|541017905|FG000|Overall Study|Lost to Follow-up|17|||
149967483|NCT00959049|541017906|FG001|Overall Study|Lost to Follow-up|5|||
149967484|NCT00959049|541017907|FG002|Overall Study|Lost to Follow-up|1|||
149967485|NCT00959049|541017908|FG003|Overall Study|Lost to Follow-up|10|||
149967486|NCT00959049|541017909|FG004|Overall Study|Lost to Follow-up|9|||
149967487|NCT00959049|541017910|FG005|Overall Study|Lost to Follow-up|1|||
149967488|NCT00959049|541017905|FG000|Overall Study|Contraindicated medication|0|||
149967489|NCT00959049|541017906|FG001|Overall Study|Contraindicated medication|0|||
149967490|NCT00959049|541017907|FG002|Overall Study|Contraindicated medication|0|||
149967491|NCT00959049|541017908|FG003|Overall Study|Contraindicated medication|1|||
149967492|NCT00959049|541017909|FG004|Overall Study|Contraindicated medication|0|||
149967493|NCT00959049|541017910|FG005|Overall Study|Contraindicated medication|0|||
149967494|NCT00959049|541017905|FG000|Overall Study|Withdrawal by Subject|0|||
149967495|NCT00959049|541017906|FG001|Overall Study|Withdrawal by Subject|2|||
149967496|NCT00959049|541017907|FG002|Overall Study|Withdrawal by Subject|0|||
149967497|NCT00959049|541017908|FG003|Overall Study|Withdrawal by Subject|0|||
149967498|NCT00959049|541017909|FG004|Overall Study|Withdrawal by Subject|0|||
149967499|NCT00959049|541017910|FG005|Overall Study|Withdrawal by Subject|0|||
149967500|NCT01905540|541017913|FG000|Period 3|Other|1|||
149967501|NCT01905540|541017914|FG001|Period 3|Other|0|||
149967502|NCT01905540|541017915|FG002|Period 3|Other|1|||
149967503|NCT01905540|541017916|FG003|Period 3|Other|1|||
149967504|NCT03847519|541017917|FG000|Overall Study|Death|5|||
149967505|NCT03847519|541017918|FG001|Overall Study|Death|8|||
149967506|NCT03847519|541017919|FG002|Overall Study|Death|1|||
150044806|NCT00337675|541304194|FG001|Overall Study|Protocol Violation|24|||
149889004|NCT01074944|540722815|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
149889005|NCT01074944|540722816|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
149889006|NCT01074944|540722817|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
149889007|NCT01074944|540722818|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
149889008|NCT01074944|540722819|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
149889009|NCT01074944|540722815|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
149889010|NCT01074944|540722816|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
149889011|NCT01074944|540722817|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
149889012|NCT01074944|540722818|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
149889013|NCT01074944|540722819|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
149889014|NCT01074944|540722815|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
149889015|NCT01074944|540722816|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
149889016|NCT01074944|540722817|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
149889017|NCT01074944|540722818|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
149889018|NCT01074944|540722819|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
149889019|NCT01074944|540722815|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
149889020|NCT01074944|540722816|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
149889021|NCT01074944|540722817|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
149889022|NCT01074944|540722818|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
149889023|NCT01074944|540722819|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
149889024|NCT01074944|540722815|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
149889025|NCT01074944|540722816|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
149889026|NCT01074944|540722817|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
149889027|NCT01074944|540722818|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
149889028|NCT01074944|540722819|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
149889029|NCT01074944|540722815|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
149967507|NCT03847519|541017917|FG000|Overall Study|Lost to Follow-up|1|||
149967508|NCT03847519|541017918|FG001|Overall Study|Lost to Follow-up|2|||
149967509|NCT03847519|541017919|FG002|Overall Study|Lost to Follow-up|0|||
149967510|NCT03847519|541017917|FG000|Overall Study|Study Terminated by Sponsor|0|||
149889030|NCT01074944|540722816|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
149889031|NCT01074944|540722817|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
149967511|NCT03847519|541017918|FG001|Overall Study|Study Terminated by Sponsor|3|||
149967512|NCT03847519|541017919|FG002|Overall Study|Study Terminated by Sponsor|2|||
149967513|NCT02743962|541017920|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
149967514|NCT02743962|541017921|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
149967515|NCT00725985|541017925|FG000|ITP- Treatment Disposition|Adverse Event|20|||
149967516|NCT00725985|541017926|FG001|ITP- Treatment Disposition|Adverse Event|10|||
149889032|NCT01074944|540722818|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
149889033|NCT01074944|540722819|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
149889034|NCT01074944|540722815|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
149889035|NCT01074944|540722816|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
149889036|NCT01074944|540722817|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
149889037|NCT01074944|540722818|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
149889038|NCT01074944|540722819|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
149889039|NCT01074944|540722815|FG000|Long Term Treatment|Adverse Event|0|||
149889040|NCT01074944|540722816|FG001|Long Term Treatment|Adverse Event|0|||
149889041|NCT01074944|540722817|FG002|Long Term Treatment|Adverse Event|0|||
149889042|NCT01074944|540722818|FG003|Long Term Treatment|Adverse Event|3|||
149889043|NCT01074944|540722819|FG004|Long Term Treatment|Adverse Event|0|||
149889044|NCT01074944|540722815|FG000|Long Term Treatment|Lost to Follow-up|0|||
149889045|NCT01074944|540722816|FG001|Long Term Treatment|Lost to Follow-up|0|||
149889046|NCT01074944|540722817|FG002|Long Term Treatment|Lost to Follow-up|0|||
149889047|NCT01074944|540722818|FG003|Long Term Treatment|Lost to Follow-up|2|||
149889048|NCT01074944|540722819|FG004|Long Term Treatment|Lost to Follow-up|0|||
149889049|NCT01074944|540722815|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
149889050|NCT01074944|540722816|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
149889051|NCT01074944|540722817|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
149889052|NCT01074944|540722818|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
149889053|NCT01074944|540722819|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
149889054|NCT01074944|540722815|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
149889055|NCT01074944|540722816|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
149889056|NCT01074944|540722817|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
149889057|NCT01074944|540722818|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
149889058|NCT01074944|540722819|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
149967517|NCT00725985|541017927|FG002|ITP- Treatment Disposition|Adverse Event|5|||
149967518|NCT00725985|541017928|FG003|ITP- Treatment Disposition|Adverse Event|0|||
149889059|NCT01074944|540722815|FG000|Long Term Treatment|Withdrawal by Subject|0|||
149889060|NCT01074944|540722816|FG001|Long Term Treatment|Withdrawal by Subject|0|||
149967519|NCT00725985|541017929|FG004|ITP- Treatment Disposition|Adverse Event|0|||
149967520|NCT00725985|541017930|FG005|ITP- Treatment Disposition|Adverse Event|0|||
149967521|NCT00725985|541017931|FG006|ITP- Treatment Disposition|Adverse Event|0|||
149967522|NCT00725985|541017932|FG007|ITP- Treatment Disposition|Adverse Event|0|||
149967523|NCT00725985|541017933|FG008|ITP- Treatment Disposition|Adverse Event|0|||
149967524|NCT00725985|541017934|FG009|ITP- Treatment Disposition|Adverse Event|0|||
149967525|NCT00725985|541017935|FG010|ITP- Treatment Disposition|Adverse Event|0|||
149967526|NCT00725985|541017936|FG011|ITP- Treatment Disposition|Adverse Event|0|||
149967527|NCT00725985|541017925|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967528|NCT00725985|541017926|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967529|NCT00725985|541017927|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
150044807|NCT00337675|541304195|FG002|Overall Study|Protocol Violation|19|||
150044808|NCT00337675|541304193|FG000|Overall Study|Withdrawal by Subject|25|||
150044809|NCT00337675|541304194|FG001|Overall Study|Withdrawal by Subject|25|||
150044810|NCT00337675|541304195|FG002|Overall Study|Withdrawal by Subject|19|||
150044811|NCT00337675|541304193|FG000|Overall Study|Progressive Disease|0|||
150044812|NCT00337675|541304194|FG001|Overall Study|Progressive Disease|2|||
150044813|NCT00337675|541304195|FG002|Overall Study|Progressive Disease|0|||
150044814|NCT00337675|541304193|FG000|Overall Study|Trial Terminated|0|||
150044815|NCT00337675|541304194|FG001|Overall Study|Trial Terminated|0|||
150044816|NCT00337675|541304195|FG002|Overall Study|Trial Terminated|2|||
150044817|NCT02136069|541304196|FG000|Overall Study|UC flare-up|1|||
150044818|NCT02136069|541304197|FG001|Overall Study|UC flare-up|0|||
150044819|NCT02136069|541304196|FG000|Overall Study|Adverse Event|6|||
150044820|NCT02136069|541304197|FG001|Overall Study|Adverse Event|8|||
150044821|NCT02136069|541304196|FG000|Overall Study|Death|0|||
150044822|NCT02136069|541304197|FG001|Overall Study|Death|1|||
150044823|NCT02136069|541304196|FG000|Overall Study|Lack of Efficacy|10|||
150044824|NCT02136069|541304197|FG001|Overall Study|Lack of Efficacy|4|||
149889061|NCT01074944|540722817|FG002|Long Term Treatment|Withdrawal by Subject|0|||
149967530|NCT00725985|541017928|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967531|NCT00725985|541017929|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967532|NCT00725985|541017930|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
150044825|NCT02136069|541304196|FG000|Overall Study|Lost to Follow-up|1|||
150044826|NCT02136069|541304197|FG001|Overall Study|Lost to Follow-up|0|||
150044827|NCT02136069|541304196|FG000|Overall Study|Non-Compliance|1|||
150044828|NCT02136069|541304197|FG001|Overall Study|Non-Compliance|0|||
149889062|NCT01074944|540722818|FG003|Long Term Treatment|Withdrawal by Subject|2|||
149889063|NCT01074944|540722819|FG004|Long Term Treatment|Withdrawal by Subject|0|||
149889064|NCT01074944|540722815|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
149889065|NCT01074944|540722816|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
149889066|NCT01074944|540722817|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
149889067|NCT01074944|540722818|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
149889068|NCT01074944|540722819|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
149889069|NCT01074944|540722815|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
149889070|NCT01074944|540722816|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
149889071|NCT01074944|540722817|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
149889072|NCT01074944|540722818|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
149889073|NCT01074944|540722819|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
149889074|NCT02348112|540722821|FG000|Overall Study|Withdrawal by Subject|32|||
149889075|NCT02348112|540722822|FG001|Overall Study|Withdrawal by Subject|29|||
149889076|NCT02348112|540722821|FG000|Overall Study|Lost to Follow-up|24|||
149889077|NCT02348112|540722822|FG001|Overall Study|Lost to Follow-up|20|||
149889078|NCT02348112|540722821|FG000|Overall Study|Physician Decision|17|||
149889079|NCT02348112|540722822|FG001|Overall Study|Physician Decision|15|||
149889080|NCT02348112|540722821|FG000|Overall Study|Site closed due to PI leaving|0|||
149889081|NCT02348112|540722822|FG001|Overall Study|Site closed due to PI leaving|30|||
149889082|NCT02348112|540722821|FG000|Overall Study|Sponsor withdrawal|0|||
149889083|NCT02348112|540722822|FG001|Overall Study|Sponsor withdrawal|7|||
149889084|NCT02348112|540722821|FG000|Overall Study|Death|0|||
149889085|NCT02348112|540722822|FG001|Overall Study|Death|1|||
149889086|NCT01998841|540722827|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
149889087|NCT01998841|540722828|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
149889088|NCT01998841|540722829|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
149889089|NCT01998841|540722830|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
149889090|NCT01998841|540722831|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
149889091|NCT01998841|540722827|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
150044829|NCT02136069|541304196|FG000|Overall Study|Physician Decision|5|||
150044830|NCT02136069|541304197|FG001|Overall Study|Physician Decision|4|||
150044831|NCT02136069|541304196|FG000|Overall Study|Withdrawal by Subject|10|||
150175720|NCT00925587|541779888|FG001|Overall Study|Protocol Violation|4|||
150044832|NCT02136069|541304197|FG001|Overall Study|Withdrawal by Subject|11|||
150044833|NCT04693234|541304198|FG000|Overall Study|Death|79|||
150044834|NCT04693234|541304199|FG001|Overall Study|Death|19|||
150044835|NCT04693234|541304198|FG000|Overall Study|Sponsor Ended Study|47|||
150044836|NCT04693234|541304199|FG001|Overall Study|Sponsor Ended Study|18|||
150044837|NCT04693234|541304198|FG000|Overall Study|Withdrawal by Subject|10|||
150044838|NCT04693234|541304199|FG001|Overall Study|Withdrawal by Subject|2|||
150044839|NCT04693234|541304198|FG000|Overall Study|Lost to Follow-up|2|||
150044840|NCT04693234|541304199|FG001|Overall Study|Lost to Follow-up|1|||
150044841|NCT02578706|541304202|FG000|Overall Study|Withdrawal by Subject|1|||
150044842|NCT02578706|541304203|FG001|Overall Study|Withdrawal by Subject|0|||
150044843|NCT02578706|541304204|FG002|Overall Study|Withdrawal by Subject|0|||
150044844|NCT02578706|541304202|FG000|Overall Study|Lost to Follow-up|0|||
150044845|NCT02578706|541304203|FG001|Overall Study|Lost to Follow-up|4|||
150044846|NCT02578706|541304204|FG002|Overall Study|Lost to Follow-up|0|||
150044847|NCT02578706|541304202|FG000|Overall Study|Physician Decision|0|||
150044848|NCT02578706|541304203|FG001|Overall Study|Physician Decision|1|||
150044849|NCT02578706|541304204|FG002|Overall Study|Physician Decision|0|||
150044850|NCT03048578|541304210|FG000|Overall Study|Withdrawal by Subject|5|||
150044851|NCT03048578|541304211|FG001|Overall Study|Withdrawal by Subject|6|||
150044852|NCT03048578|541304210|FG000|Overall Study|Lost to Follow-up|22|||
150044853|NCT03048578|541304211|FG001|Overall Study|Lost to Follow-up|10|||
150044854|NCT03048578|541304210|FG000|Overall Study|Adverse Event|1|||
150044855|NCT03048578|541304211|FG001|Overall Study|Adverse Event|2|||
150044856|NCT03048578|541304210|FG000|Overall Study|Terminated|3|||
150044857|NCT03048578|541304211|FG001|Overall Study|Terminated|2|||
150044858|NCT00459186|541304212|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
150044859|NCT00459186|541304212|FG000|PET Imaging and Assessment|Adverse Event|3|||
150044860|NCT02920242|541304213|FG000|Overall Study|Withdrawal by Subject|1|||
150044861|NCT02920242|541304214|FG001|Overall Study|Withdrawal by Subject|0|||
150044862|NCT02920242|541304215|FG002|Overall Study|Withdrawal by Subject|1|||
150044863|NCT02920242|541304213|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
150044864|NCT02920242|541304214|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
150044865|NCT02920242|541304215|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
150044866|NCT01409811|541304216|FG000|Overall Study|Insurance denial|1|||
150044867|NCT00634101|541304217|FG000|Overall Study|Study Terminated|3|||
150044868|NCT00634101|541304218|FG001|Overall Study|Study Terminated|3|||
150044869|NCT00634101|541304217|FG000|Overall Study|Lost to Follow-up|2|||
150044870|NCT00634101|541304218|FG001|Overall Study|Lost to Follow-up|0|||
150044871|NCT03306173|541304220|FG000|Overall Study|Lost to Follow-up|16|||
150044872|NCT03306173|541304221|FG001|Overall Study|Lost to Follow-up|23|||
150044873|NCT03306173|541304220|FG000|Overall Study|Withdrawal by Subject|4|||
150044874|NCT03306173|541304221|FG001|Overall Study|Withdrawal by Subject|3|||
150044875|NCT03306173|541304220|FG000|Overall Study|Discontinued|4|||
150044876|NCT03306173|541304221|FG001|Overall Study|Discontinued|4|||
150044877|NCT00573144|541304222|FG000|Overall Study|Withdrawal by Subject|2|||
150044878|NCT00573144|541304223|FG001|Overall Study|Withdrawal by Subject|3|||
150044879|NCT03051178|541304224|FG000|Overall Study|Withdrawal by Subject|5|||
150044880|NCT02813577|541304225|FG000|Overall Study|Study terminated|4|||
150044881|NCT00125164|541304228|FG000|Overall Study|Adverse Event|0|||
150044882|NCT00125164|541304229|FG001|Overall Study|Adverse Event|0|||
150044883|NCT00125164|541304230|FG002|Overall Study|Adverse Event|2|||
150044884|NCT00125164|541304231|FG003|Overall Study|Adverse Event|4|||
150044885|NCT00125164|541304228|FG000|Overall Study|Lost to Follow-up|0|||
150044886|NCT00125164|541304229|FG001|Overall Study|Lost to Follow-up|0|||
150044887|NCT00125164|541304230|FG002|Overall Study|Lost to Follow-up|1|||
150044888|NCT00125164|541304231|FG003|Overall Study|Lost to Follow-up|1|||
150044889|NCT00125164|541304228|FG000|Overall Study|Withdrawal by Subject|2|||
150044890|NCT00125164|541304229|FG001|Overall Study|Withdrawal by Subject|0|||
150044891|NCT00125164|541304230|FG002|Overall Study|Withdrawal by Subject|1|||
150044892|NCT00125164|541304231|FG003|Overall Study|Withdrawal by Subject|1|||
150044893|NCT03339219|541304235|FG000|Overall Study|Death|12|||
150044894|NCT03339219|541304235|FG000|Overall Study|Site Terminated by Sponsor|22|||
150044895|NCT03339219|541304235|FG000|Overall Study|Withdrawal by Subject|1|||
150044896|NCT02023697|541304237|FG000|Treatment Period|Radiological progression|13|||
150044897|NCT02023697|541304238|FG001|Treatment Period|Radiological progression|17|||
150044898|NCT02023697|541304239|FG002|Treatment Period|Radiological progression|26|||
150044899|NCT02023697|541304237|FG000|Treatment Period|Never Treated|5|||
150044900|NCT02023697|541304238|FG001|Treatment Period|Never Treated|6|||
150044901|NCT02023697|541304239|FG002|Treatment Period|Never Treated|10|||
150044902|NCT02023697|541304237|FG000|Treatment Period|Adverse Event|13|||
150044903|NCT02023697|541304238|FG001|Treatment Period|Adverse Event|25|||
150044904|NCT02023697|541304239|FG002|Treatment Period|Adverse Event|23|||
150044905|NCT02023697|541304237|FG000|Treatment Period|Logistical difficulties|1|||
150044906|NCT02023697|541304238|FG001|Treatment Period|Logistical difficulties|1|||
150044907|NCT02023697|541304239|FG002|Treatment Period|Logistical difficulties|1|||
150044908|NCT02023697|541304237|FG000|Treatment Period|Clinical progression|10|||
149889092|NCT01998841|540722828|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
149889093|NCT01998841|540722829|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
149889094|NCT01998841|540722830|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
149889095|NCT01998841|540722831|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
149889096|NCT00972595|540722832|FG000|Period 1|Adverse Event|1|||
149889097|NCT00972595|540722833|FG001|Period 1|Adverse Event|0|||
149889098|NCT04211831|540722835|FG000|Overall Study|Withdrawal by Subject|4|||
149889099|NCT04211831|540722836|FG001|Overall Study|Withdrawal by Subject|1|||
149889100|NCT04211831|540722837|FG002|Overall Study|Withdrawal by Subject|1|||
149889101|NCT04211831|540722835|FG000|Overall Study|Protocol Violation|0|||
149889102|NCT04211831|540722836|FG001|Overall Study|Protocol Violation|0|||
149889103|NCT04211831|540722837|FG002|Overall Study|Protocol Violation|1|||
149889104|NCT04211831|540722835|FG000|Overall Study|Adverse Event|0|||
149889105|NCT04211831|540722836|FG001|Overall Study|Adverse Event|1|||
149889106|NCT04211831|540722837|FG002|Overall Study|Adverse Event|0|||
149889107|NCT04211831|540722835|FG000|Overall Study|Lack of Efficacy|0|||
149889108|NCT04211831|540722836|FG001|Overall Study|Lack of Efficacy|0|||
149889109|NCT04211831|540722837|FG002|Overall Study|Lack of Efficacy|1|||
149889110|NCT04211831|540722835|FG000|Overall Study|Lost to Follow-up|0|||
149889111|NCT04211831|540722836|FG001|Overall Study|Lost to Follow-up|0|||
149889112|NCT04211831|540722837|FG002|Overall Study|Lost to Follow-up|2|||
149889113|NCT04211831|540722835|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
149889114|NCT04211831|540722836|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
149889115|NCT04211831|540722837|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
149889116|NCT04211831|540722835|FG000|Overall Study|Other|0|||
149889117|NCT04211831|540722836|FG001|Overall Study|Other|1|||
149889118|NCT04211831|540722837|FG002|Overall Study|Other|0|||
149889119|NCT05373108|540722841|FG000|Overall Study|Withdrawal by Subject|2|||
149889120|NCT00349973|540722842|FG000|Overall Study|Adverse Event|3|||
149889121|NCT00349973|540722843|FG001|Overall Study|Adverse Event|3|||
149889122|NCT00349973|540722842|FG000|Overall Study|Withdrawal by Subject|1|||
149889123|NCT00349973|540722843|FG001|Overall Study|Withdrawal by Subject|0|||
149889124|NCT05620082|540722847|FG000|Overall Study|Discharged before study end|1|||
149889125|NCT05620082|540722848|FG001|Overall Study|Discharged before study end|4|||
149889126|NCT05620082|540722849|FG002|Overall Study|Discharged before study end|0|||
149889127|NCT05620082|540722847|FG000|Overall Study|Moved to a different ward|1|||
149889128|NCT05620082|540722848|FG001|Overall Study|Moved to a different ward|0|||
149889129|NCT05620082|540722849|FG002|Overall Study|Moved to a different ward|0|||
149889130|NCT05620082|540722847|FG000|Overall Study|Feeling too unwell|1|||
149889131|NCT05620082|540722848|FG001|Overall Study|Feeling too unwell|0|||
149889132|NCT05620082|540722849|FG002|Overall Study|Feeling too unwell|0|||
149889133|NCT00625820|540722854|FG000|Overall Study|Withdrawal by Subject|1|||
149889134|NCT00070564|540725130|FG000|Overall Study|Progression|2|||
149889135|NCT00070564|540725131|FG001|Overall Study|Progression|4|||
149889136|NCT00070564|540725132|FG002|Overall Study|Progression|7|||
149889137|NCT00070564|540725133|FG003|Overall Study|Progression|7|||
149889138|NCT00070564|540725134|FG004|Overall Study|Progression|1|||
149889139|NCT00070564|540725135|FG005|Overall Study|Progression|0|||
149889140|NCT00070564|540725130|FG000|Overall Study|Delinquent|1|||
149889141|NCT00070564|540725131|FG001|Overall Study|Delinquent|4|||
149889142|NCT00070564|540725132|FG002|Overall Study|Delinquent|2|||
149889143|NCT00070564|540725133|FG003|Overall Study|Delinquent|0|||
149889144|NCT00070564|540725134|FG004|Overall Study|Delinquent|0|||
150175721|NCT00925587|541779887|FG000|Overall Study|Withdrawal by Subject|9|||
150175722|NCT00925587|541779888|FG001|Overall Study|Withdrawal by Subject|6|||
150175723|NCT00925587|541779887|FG000|Overall Study|Death|5|||
150175724|NCT00925587|541779888|FG001|Overall Study|Death|5|||
149889145|NCT00070564|540725135|FG005|Overall Study|Delinquent|0|||
149889146|NCT00070564|540725130|FG000|Overall Study|Adverse Event|150|||
149889147|NCT00070564|540725131|FG001|Overall Study|Adverse Event|142|||
149889148|NCT00070564|540725132|FG002|Overall Study|Adverse Event|120|||
149889149|NCT00070564|540725133|FG003|Overall Study|Adverse Event|108|||
149889150|NCT00070564|540725134|FG004|Overall Study|Adverse Event|63|||
149889151|NCT00070564|540725135|FG005|Overall Study|Adverse Event|36|||
149889152|NCT00070564|540725130|FG000|Overall Study|Death|4|||
149889153|NCT00070564|540725131|FG001|Overall Study|Death|1|||
149889154|NCT00070564|540725132|FG002|Overall Study|Death|5|||
149889155|NCT00070564|540725133|FG003|Overall Study|Death|3|||
149889156|NCT00070564|540725134|FG004|Overall Study|Death|0|||
149889157|NCT00070564|540725135|FG005|Overall Study|Death|1|||
149889158|NCT00070564|540725130|FG000|Overall Study|Other, not protocol specified|17|||
149889159|NCT00070564|540725131|FG001|Overall Study|Other, not protocol specified|15|||
149889160|NCT00070564|540725132|FG002|Overall Study|Other, not protocol specified|14|||
149889161|NCT00070564|540725133|FG003|Overall Study|Other, not protocol specified|19|||
149889162|NCT00070564|540725134|FG004|Overall Study|Other, not protocol specified|6|||
149889163|NCT00070564|540725135|FG005|Overall Study|Other, not protocol specified|7|||
149889164|NCT00070564|540725130|FG000|Overall Study|Withdrawal by Subject|26|||
149889165|NCT00070564|540725131|FG001|Overall Study|Withdrawal by Subject|37|||
149889166|NCT00070564|540725132|FG002|Overall Study|Withdrawal by Subject|23|||
149889167|NCT00070564|540725133|FG003|Overall Study|Withdrawal by Subject|30|||
149889168|NCT00070564|540725134|FG004|Overall Study|Withdrawal by Subject|8|||
149889169|NCT00070564|540725135|FG005|Overall Study|Withdrawal by Subject|8|||
149889170|NCT00070564|540725130|FG000|Overall Study|Not reported|0|||
149889171|NCT00070564|540725131|FG001|Overall Study|Not reported|0|||
149889172|NCT00070564|540725132|FG002|Overall Study|Not reported|0|||
149889173|NCT00070564|540725133|FG003|Overall Study|Not reported|0|||
149889174|NCT00070564|540725134|FG004|Overall Study|Not reported|1|||
149889175|NCT00070564|540725135|FG005|Overall Study|Not reported|0|||
149889176|NCT04796961|540725136|FG000|Overall Study|Lost to Follow-up|10|||
149889177|NCT04796961|540725136|FG000|Overall Study|Withdrawal by Subject|3|||
149889178|NCT04796961|540725136|FG000|Overall Study|Left Organization|10|||
149889179|NCT01168232|540725137|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
149889180|NCT01168232|540725137|FG000|Overall Study|Ineligible- Wrong cell type|6|||
149889181|NCT01168232|540725137|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
149889182|NCT03018288|540725138|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
149889183|NCT03018288|540725139|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
149889184|NCT03018288|540725140|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
149889185|NCT03018288|540725141|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
149889186|NCT03018288|540725138|FG000|Overall Study|Participant withdrew consent.|0|||
149889187|NCT03018288|540725139|FG001|Overall Study|Participant withdrew consent.|0|||
149889188|NCT03018288|540725140|FG002|Overall Study|Participant withdrew consent.|1|||
149889189|NCT03018288|540725141|FG003|Overall Study|Participant withdrew consent.|0|||
149889190|NCT03018288|540725138|FG000|Overall Study|Switched to alternative treatment.|0|||
149889191|NCT03018288|540725139|FG001|Overall Study|Switched to alternative treatment.|0|||
149889192|NCT03018288|540725140|FG002|Overall Study|Switched to alternative treatment.|1|||
149889193|NCT03018288|540725141|FG003|Overall Study|Switched to alternative treatment.|0|||
149889194|NCT03018288|540725138|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
149889195|NCT03018288|540725139|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
149889196|NCT03018288|540725140|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
149889197|NCT03018288|540725141|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
149889198|NCT03018288|540725138|FG000|Overall Study|Screen failures|0|||
149889199|NCT03018288|540725139|FG001|Overall Study|Screen failures|0|||
149889200|NCT03018288|540725140|FG002|Overall Study|Screen failures|0|||
149889201|NCT03018288|540725141|FG003|Overall Study|Screen failures|51|||
149889202|NCT03018288|540725138|FG000|Overall Study|Chose treatment outside of UNC|0|||
149889203|NCT03018288|540725139|FG001|Overall Study|Chose treatment outside of UNC|0|||
149889204|NCT03018288|540725140|FG002|Overall Study|Chose treatment outside of UNC|0|||
149889205|NCT03018288|540725141|FG003|Overall Study|Chose treatment outside of UNC|1|||
149889206|NCT03018288|540725138|FG000|Overall Study|Unable to comply with protocol requirements|1|||
149889207|NCT03018288|540725139|FG001|Overall Study|Unable to comply with protocol requirements|1|||
149889208|NCT03018288|540725140|FG002|Overall Study|Unable to comply with protocol requirements|0|||
149889209|NCT03018288|540725141|FG003|Overall Study|Unable to comply with protocol requirements|1|||
149889210|NCT03018288|540725138|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
149889211|NCT03018288|540725139|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
149889212|NCT03018288|540725140|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
149889213|NCT03018288|540725141|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
149889214|NCT03018288|540725138|FG000|Overall Study|Physician Decision|0|||
150044909|NCT02023697|541304238|FG001|Treatment Period|Clinical progression|8|||
150175725|NCT00925587|541779887|FG000|Overall Study|Adverse Event|6|||
149889215|NCT03018288|540725139|FG001|Overall Study|Physician Decision|0|||
149889216|NCT03018288|540725140|FG002|Overall Study|Physician Decision|0|||
149889217|NCT03018288|540725141|FG003|Overall Study|Physician Decision|1|||
149889218|NCT01490086|540725145|FG000|Overall Study|Consent withdrawn|4|||
149889219|NCT01490086|540725146|FG001|Overall Study|Consent withdrawn|4|||
149889220|NCT01490086|540725147|FG002|Overall Study|Consent withdrawn|3|||
149889221|NCT01490086|540725148|FG003|Overall Study|Consent withdrawn|0|||
149889222|NCT01490086|540725149|FG004|Overall Study|Consent withdrawn|1|||
149889223|NCT01490086|540725145|FG000|Overall Study|Non-compliance|0|||
149889224|NCT01490086|540725146|FG001|Overall Study|Non-compliance|1|||
149889225|NCT01490086|540725147|FG002|Overall Study|Non-compliance|0|||
150175726|NCT00925587|541779888|FG001|Overall Study|Adverse Event|2|||
150175727|NCT00925587|541779887|FG000|Overall Study|Lost to Follow-up|0|||
150175728|NCT00925587|541779888|FG001|Overall Study|Lost to Follow-up|1|||
150175729|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
150175730|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
149889226|NCT01490086|540725148|FG003|Overall Study|Non-compliance|0|||
149889227|NCT01490086|540725149|FG004|Overall Study|Non-compliance|0|||
149889228|NCT01490086|540725145|FG000|Overall Study|Abnormal laboratory findings|1|||
149889229|NCT01490086|540725146|FG001|Overall Study|Abnormal laboratory findings|0|||
149889230|NCT01490086|540725147|FG002|Overall Study|Abnormal laboratory findings|0|||
149889231|NCT01490086|540725148|FG003|Overall Study|Abnormal laboratory findings|0|||
149889232|NCT01490086|540725149|FG004|Overall Study|Abnormal laboratory findings|0|||
149889233|NCT01490086|540725145|FG000|Overall Study|Lost to Follow-up|0|||
149889234|NCT01490086|540725146|FG001|Overall Study|Lost to Follow-up|0|||
149889235|NCT01490086|540725147|FG002|Overall Study|Lost to Follow-up|0|||
149889236|NCT01490086|540725148|FG003|Overall Study|Lost to Follow-up|0|||
149889237|NCT01490086|540725149|FG004|Overall Study|Lost to Follow-up|1|||
149889238|NCT01490086|540725145|FG000|Overall Study|Physician Decision|3|||
149889239|NCT01490086|540725146|FG001|Overall Study|Physician Decision|4|||
149889240|NCT01490086|540725147|FG002|Overall Study|Physician Decision|2|||
149889241|NCT01490086|540725148|FG003|Overall Study|Physician Decision|3|||
149889242|NCT01490086|540725149|FG004|Overall Study|Physician Decision|1|||
149889243|NCT01490086|540725145|FG000|Overall Study|Adverse Event|0|||
149889244|NCT01490086|540725146|FG001|Overall Study|Adverse Event|0|||
149889245|NCT01490086|540725147|FG002|Overall Study|Adverse Event|1|||
149889246|NCT01490086|540725148|FG003|Overall Study|Adverse Event|2|||
149889247|NCT01490086|540725149|FG004|Overall Study|Adverse Event|0|||
149889248|NCT01490086|540725145|FG000|Overall Study|Lack of Efficacy|0|||
149889249|NCT01490086|540725146|FG001|Overall Study|Lack of Efficacy|3|||
149889250|NCT01490086|540725147|FG002|Overall Study|Lack of Efficacy|1|||
149889251|NCT01490086|540725148|FG003|Overall Study|Lack of Efficacy|0|||
149889252|NCT01490086|540725149|FG004|Overall Study|Lack of Efficacy|8|||
149889253|NCT01490086|540725145|FG000|Overall Study|Worsening of symptoms|0|||
149889254|NCT01490086|540725146|FG001|Overall Study|Worsening of symptoms|1|||
149889255|NCT01490086|540725147|FG002|Overall Study|Worsening of symptoms|0|||
149889256|NCT01490086|540725148|FG003|Overall Study|Worsening of symptoms|1|||
149889257|NCT01490086|540725149|FG004|Overall Study|Worsening of symptoms|0|||
149889258|NCT01490086|540725145|FG000|Overall Study|Subject uncontrollable and abusive|0|||
149889259|NCT01490086|540725146|FG001|Overall Study|Subject uncontrollable and abusive|1|||
149889260|NCT01490086|540725147|FG002|Overall Study|Subject uncontrollable and abusive|0|||
149889261|NCT01490086|540725148|FG003|Overall Study|Subject uncontrollable and abusive|0|||
149889262|NCT01490086|540725149|FG004|Overall Study|Subject uncontrollable and abusive|0|||
149889263|NCT01490086|540725145|FG000|Overall Study|Subject left hospital|0|||
149889264|NCT01490086|540725146|FG001|Overall Study|Subject left hospital|1|||
149889265|NCT01490086|540725147|FG002|Overall Study|Subject left hospital|0|||
149889266|NCT01490086|540725148|FG003|Overall Study|Subject left hospital|1|||
149889267|NCT01490086|540725149|FG004|Overall Study|Subject left hospital|0|||
150175731|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
149889268|NCT04510090|540725152|FG000|FE-HS|Withdrawal by Subject|0|||
149889269|NCT04510090|540725153|FG001|FE-HS|Withdrawal by Subject|0|||
149889270|NCT04510090|540725154|FG002|FE-HS|Withdrawal by Subject|0|||
149889271|NCT04510090|540725155|FG003|FE-HS|Withdrawal by Subject|0|||
149889272|NCT04510090|540725156|FG004|FE-HS|Withdrawal by Subject|1|||
149889273|NCT04510090|540725157|FG005|FE-HS|Withdrawal by Subject|0|||
149889274|NCT04510090|540725158|FG006|FE-HS|Withdrawal by Subject|0|||
149889275|NCT04510090|540725159|FG007|FE-HS|Withdrawal by Subject|0|||
149889276|NCT05825404|540725160|FG000|First Intervention (Weeks 2-5)|Death|0|||
149889277|NCT05825404|540725161|FG001|First Intervention (Weeks 2-5)|Death|1|||
149889278|NCT05825404|540725160|FG000|Second Intervention (Weeks 8-11)|Death|0|||
149889279|NCT05825404|540725161|FG001|Second Intervention (Weeks 8-11)|Death|1|||
149889280|NCT01127256|540725162|FG000|Overall Study|Adverse Event|13|||
149889281|NCT01127256|540725163|FG001|Overall Study|Adverse Event|13|||
149889282|NCT01127256|540725162|FG000|Overall Study|Lack of Efficacy|4|||
149889283|NCT01127256|540725163|FG001|Overall Study|Lack of Efficacy|0|||
149889284|NCT01127256|540725162|FG000|Overall Study|Lost to Follow-up|16|||
149889285|NCT01127256|540725163|FG001|Overall Study|Lost to Follow-up|17|||
149889286|NCT01127256|540725162|FG000|Overall Study|Withdrawal by Subject|5|||
149889287|NCT01127256|540725163|FG001|Overall Study|Withdrawal by Subject|9|||
149889288|NCT01127256|540725162|FG000|Overall Study|Protocol Violation|1|||
150175732|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
149889289|NCT01127256|540725163|FG001|Overall Study|Protocol Violation|0|||
149889290|NCT01749826|540725164|FG000|Overall Study|Study Terminated|20|||
149889291|NCT01749826|540725165|FG001|Overall Study|Study Terminated|0|||
149889292|NCT01922037|540725166|FG000|Overall Study|Withdrawal by Subject|2|||
149889293|NCT01922037|540725167|FG001|Overall Study|Withdrawal by Subject|44|||
149889294|NCT01922037|540725166|FG000|Overall Study|Adverse Event|1|||
150175733|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
149889295|NCT01922037|540725167|FG001|Overall Study|Adverse Event|7|||
149889296|NCT01922037|540725166|FG000|Overall Study|Death|0|||
149889297|NCT01922037|540725167|FG001|Overall Study|Death|5|||
149889298|NCT01922037|540725166|FG000|Overall Study|Pregnancy|0|||
149889299|NCT01922037|540725167|FG001|Overall Study|Pregnancy|2|||
149889300|NCT01922037|540725166|FG000|Overall Study|Participant non-compliance|4|||
149889301|NCT01922037|540725167|FG001|Overall Study|Participant non-compliance|46|||
149889302|NCT01922037|540725166|FG000|Overall Study|Investigator/Sponsor decision|1|||
149889303|NCT01922037|540725167|FG001|Overall Study|Investigator/Sponsor decision|4|||
149889304|NCT01922037|540725166|FG000|Overall Study|Other unspecified|2|||
149889305|NCT01922037|540725167|FG001|Overall Study|Other unspecified|66|||
149889306|NCT00679211|540725168|FG000|Overall Study|Progressive disease|82|||
149889307|NCT00679211|540725168|FG000|Overall Study|Adverse Event|7|||
149889308|NCT00679211|540725168|FG000|Overall Study|Withdrawal by Subject|2|||
149889309|NCT00679211|540725168|FG000|Overall Study|Physician Decision|5|||
149889310|NCT00679211|540725168|FG000|Overall Study|Refused to undergo protocol procedures|1|||
149889311|NCT00679211|540725168|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
149889312|NCT00679211|540725168|FG000|Overall Study|Other|1|||
149889313|NCT00931528|540725169|FG000|Overall Study|Protocol Violation|9|||
149889314|NCT00931528|540725170|FG001|Overall Study|Protocol Violation|12|||
149889315|NCT00931528|540725169|FG000|Overall Study|Withdrawal by Subject|4|||
149889316|NCT00931528|540725170|FG001|Overall Study|Withdrawal by Subject|12|||
149889317|NCT00931528|540725169|FG000|Overall Study|Lost to Follow-up|6|||
149889318|NCT00931528|540725170|FG001|Overall Study|Lost to Follow-up|13|||
149889319|NCT00931528|540725169|FG000|Overall Study|Assessment outside of Time Frame|22|||
149889320|NCT00931528|540725170|FG001|Overall Study|Assessment outside of Time Frame|23|||
149889321|NCT01730053|540725171|FG000|Overall Study|Participant moved|0|||
149889322|NCT01730053|540725172|FG001|Overall Study|Participant moved|0|||
149889323|NCT01730053|540725173|FG002|Overall Study|Participant moved|1|||
149889324|NCT01730053|540725174|FG003|Overall Study|Participant moved|0|||
149889325|NCT01730053|540725175|FG004|Overall Study|Participant moved|0|||
149889326|NCT01730053|540725176|FG005|Overall Study|Participant moved|0|||
149889327|NCT01730053|540725171|FG000|Overall Study|Physician Decision|0|||
149889328|NCT01730053|540725172|FG001|Overall Study|Physician Decision|0|||
149889329|NCT01730053|540725173|FG002|Overall Study|Physician Decision|0|||
149889330|NCT01730053|540725174|FG003|Overall Study|Physician Decision|1|||
149889331|NCT01730053|540725175|FG004|Overall Study|Physician Decision|0|||
149889332|NCT01730053|540725176|FG005|Overall Study|Physician Decision|0|||
149889333|NCT01730053|540725171|FG000|Overall Study|Adverse Event|2|||
149889334|NCT01730053|540725172|FG001|Overall Study|Adverse Event|6|||
149889335|NCT01730053|540725173|FG002|Overall Study|Adverse Event|3|||
149889336|NCT01730053|540725174|FG003|Overall Study|Adverse Event|3|||
149889337|NCT01730053|540725175|FG004|Overall Study|Adverse Event|2|||
149889338|NCT01730053|540725176|FG005|Overall Study|Adverse Event|2|||
149889339|NCT01730053|540725171|FG000|Overall Study|Poor compliance to protocol|1|||
149889340|NCT01730053|540725172|FG001|Overall Study|Poor compliance to protocol|2|||
149889341|NCT01730053|540725173|FG002|Overall Study|Poor compliance to protocol|2|||
149889342|NCT01730053|540725174|FG003|Overall Study|Poor compliance to protocol|0|||
149889343|NCT01730053|540725175|FG004|Overall Study|Poor compliance to protocol|0|||
149889344|NCT01730053|540725176|FG005|Overall Study|Poor compliance to protocol|2|||
149889345|NCT01730053|540725171|FG000|Overall Study|Other than specified|2|||
149889346|NCT01730053|540725172|FG001|Overall Study|Other than specified|6|||
149889347|NCT01730053|540725173|FG002|Overall Study|Other than specified|5|||
149889348|NCT01730053|540725174|FG003|Overall Study|Other than specified|4|||
149889349|NCT01730053|540725175|FG004|Overall Study|Other than specified|7|||
149889350|NCT01730053|540725176|FG005|Overall Study|Other than specified|9|||
149889351|NCT01470248|540725177|FG000|Overall Study|Withdrawal by Subject|1|||
149889352|NCT05085834|540725178|FG000|Overall Study|Lost to Follow-up|9|||
149967533|NCT00725985|541017931|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967534|NCT00725985|541017932|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967535|NCT00725985|541017933|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967536|NCT00725985|541017934|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967537|NCT00725985|541017935|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967538|NCT00725985|541017936|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
149967539|NCT00725985|541017925|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
149889353|NCT05085834|540725179|FG001|Overall Study|Lost to Follow-up|2|||
149889354|NCT05085834|540725178|FG000|Overall Study|Adverse Event|6|||
149889355|NCT05085834|540725179|FG001|Overall Study|Adverse Event|0|||
149889356|NCT05085834|540725178|FG000|Overall Study|Death|1|||
149889357|NCT05085834|540725179|FG001|Overall Study|Death|0|||
149889358|NCT05085834|540725178|FG000|Overall Study|Inability to swallow the pill|0|||
149889359|NCT05085834|540725179|FG001|Overall Study|Inability to swallow the pill|1|||
149889360|NCT05842967|540725182|FG000|Period 1: SSA|Adverse Event|1|||
149889361|NCT05842967|540725183|FG001|Period 1: SSA|Adverse Event|1|||
149889362|NCT05842967|540725184|FG002|Period 1: SSA|Adverse Event|0|||
149889363|NCT05842967|540725185|FG003|Period 1: SSA|Adverse Event|0|||
149889364|NCT05842967|540725182|FG000|Period 1: SSA|Death|1|||
149889365|NCT05842967|540725183|FG001|Period 1: SSA|Death|0|||
149889366|NCT05842967|540725184|FG002|Period 1: SSA|Death|0|||
150175734|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
150175735|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
150175736|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
150175737|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
150175738|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
150175739|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
150175740|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
150175741|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
150175742|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
150175743|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
150175744|NCT00516321|541779896|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
150175745|NCT00516321|541779897|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
150175746|NCT00516321|541779898|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
150175747|NCT00516321|541779896|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
150175748|NCT00516321|541779897|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
149889367|NCT05842967|540725185|FG003|Period 1: SSA|Death|0|||
149889368|NCT05842967|540725182|FG000|Period 1: SSA|Lost to Follow-up|16|||
149889369|NCT05842967|540725183|FG001|Period 1: SSA|Lost to Follow-up|4|||
149889370|NCT05842967|540725184|FG002|Period 1: SSA|Lost to Follow-up|0|||
149889371|NCT05842967|540725185|FG003|Period 1: SSA|Lost to Follow-up|0|||
149889372|NCT05842967|540725182|FG000|Period 1: SSA|Physician Decision|1|||
149889373|NCT05842967|540725183|FG001|Period 1: SSA|Physician Decision|0|||
149889374|NCT05842967|540725184|FG002|Period 1: SSA|Physician Decision|0|||
149889375|NCT05842967|540725185|FG003|Period 1: SSA|Physician Decision|0|||
149889376|NCT05842967|540725182|FG000|Period 1: SSA|Withdrawal by Subject|2|||
149889377|NCT05842967|540725183|FG001|Period 1: SSA|Withdrawal by Subject|2|||
149889378|NCT05842967|540725184|FG002|Period 1: SSA|Withdrawal by Subject|0|||
149889379|NCT05842967|540725185|FG003|Period 1: SSA|Withdrawal by Subject|0|||
149889380|NCT05842967|540725182|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
149889381|NCT05842967|540725183|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
149889382|NCT05842967|540725184|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
149889383|NCT05842967|540725185|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
149889384|NCT05842967|540725182|FG000|Period 2: SSB|Adverse Event|0|||
150175749|NCT00516321|541779898|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
149967540|NCT00725985|541017926|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
149889385|NCT05842967|540725183|FG001|Period 2: SSB|Adverse Event|0|||
149889386|NCT05842967|540725184|FG002|Period 2: SSB|Adverse Event|2|||
149889387|NCT05842967|540725185|FG003|Period 2: SSB|Adverse Event|0|||
149889388|NCT05842967|540725182|FG000|Period 2: SSB|Lost to Follow-up|0|||
149889389|NCT05842967|540725183|FG001|Period 2: SSB|Lost to Follow-up|0|||
149889390|NCT05842967|540725184|FG002|Period 2: SSB|Lost to Follow-up|4|||
149889391|NCT05842967|540725185|FG003|Period 2: SSB|Lost to Follow-up|3|||
149889392|NCT05842967|540725182|FG000|Period 2: SSB|Withdrawal by Subject|0|||
149889393|NCT05842967|540725183|FG001|Period 2: SSB|Withdrawal by Subject|0|||
149889394|NCT05842967|540725184|FG002|Period 2: SSB|Withdrawal by Subject|1|||
149889395|NCT05842967|540725185|FG003|Period 2: SSB|Withdrawal by Subject|0|||
149889396|NCT05842967|540725182|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
149889397|NCT05842967|540725183|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
149889398|NCT05842967|540725184|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
149889399|NCT05842967|540725185|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
149889400|NCT05842967|540725182|FG000|Period 2: SSB|Protocol Violation|0|||
149889401|NCT05842967|540725183|FG001|Period 2: SSB|Protocol Violation|0|||
149889402|NCT05842967|540725184|FG002|Period 2: SSB|Protocol Violation|0|||
149889403|NCT05842967|540725185|FG003|Period 2: SSB|Protocol Violation|1|||
149889404|NCT03657797|540725193|FG000|Overall Study|Lost to Follow-up|0|||
149889405|NCT03657797|540725194|FG001|Overall Study|Lost to Follow-up|1|||
149889406|NCT03657797|540725195|FG002|Overall Study|Lost to Follow-up|1|||
149889407|NCT03657797|540725196|FG003|Overall Study|Lost to Follow-up|0|||
149889408|NCT03657797|540725193|FG000|Overall Study|Physician Decision|0|||
149889409|NCT03657797|540725194|FG001|Overall Study|Physician Decision|1|||
149889410|NCT03657797|540725195|FG002|Overall Study|Physician Decision|0|||
149889411|NCT03657797|540725196|FG003|Overall Study|Physician Decision|0|||
149967541|NCT00725985|541017927|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
149967542|NCT00725985|541017928|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
149967543|NCT00725985|541017929|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
149967544|NCT00725985|541017930|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
149967545|NCT00725985|541017931|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
149967546|NCT00725985|541017932|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
149967547|NCT00725985|541017933|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
150175750|NCT00516321|541779896|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
149889412|NCT03657797|540725193|FG000|Overall Study|Withdrawal by Subject|0|||
149889413|NCT03657797|540725194|FG001|Overall Study|Withdrawal by Subject|1|||
149889414|NCT03657797|540725195|FG002|Overall Study|Withdrawal by Subject|2|||
149889415|NCT03657797|540725196|FG003|Overall Study|Withdrawal by Subject|0|||
149967548|NCT00725985|541017934|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
149967549|NCT00725985|541017935|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
149967550|NCT00725985|541017936|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
149967551|NCT00725985|541017925|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
149967552|NCT00725985|541017926|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
149967553|NCT00725985|541017927|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
149967554|NCT00725985|541017928|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
149967555|NCT00725985|541017929|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
149967556|NCT00725985|541017930|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
149967557|NCT00725985|541017931|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
149967558|NCT00725985|541017932|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
149967559|NCT00725985|541017933|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
149967560|NCT00725985|541017934|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
149967561|NCT00725985|541017935|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
149967562|NCT00725985|541017936|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
149967563|NCT00725985|541017925|FG000|ITP- Treatment Disposition|Other|50|||
149967564|NCT00725985|541017926|FG001|ITP- Treatment Disposition|Other|38|||
149967565|NCT00725985|541017927|FG002|ITP- Treatment Disposition|Other|24|||
149967566|NCT00725985|541017928|FG003|ITP- Treatment Disposition|Other|0|||
149967567|NCT00725985|541017929|FG004|ITP- Treatment Disposition|Other|0|||
149967568|NCT00725985|541017930|FG005|ITP- Treatment Disposition|Other|0|||
149967569|NCT00725985|541017931|FG006|ITP- Treatment Disposition|Other|0|||
149967570|NCT00725985|541017932|FG007|ITP- Treatment Disposition|Other|0|||
149967571|NCT00725985|541017933|FG008|ITP- Treatment Disposition|Other|0|||
149967572|NCT00725985|541017934|FG009|ITP- Treatment Disposition|Other|0|||
149967573|NCT00725985|541017935|FG010|ITP- Treatment Disposition|Other|0|||
149967574|NCT00725985|541017936|FG011|ITP- Treatment Disposition|Other|0|||
149967575|NCT00725985|541017925|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149967576|NCT00725985|541017926|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149967577|NCT00725985|541017927|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149967578|NCT00725985|541017928|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
149967579|NCT00725985|541017929|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
149967580|NCT00725985|541017930|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
149967581|NCT00725985|541017931|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
150175751|NCT00516321|541779897|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
149889416|NCT03657797|540725193|FG000|Overall Study|Adverse Event|0|||
149889417|NCT03657797|540725194|FG001|Overall Study|Adverse Event|0|||
149889418|NCT03657797|540725195|FG002|Overall Study|Adverse Event|2|||
149889419|NCT03657797|540725196|FG003|Overall Study|Adverse Event|0|||
149889420|NCT03103087|540725197|FG000|Overall Study|Did not receive any study drug|1|||
149889421|NCT03103087|540725198|FG001|Overall Study|Did not receive any study drug|0|||
149889422|NCT03103087|540725199|FG002|Overall Study|Did not receive any study drug|0|||
149889423|NCT03103087|540725197|FG000|Overall Study|Protocol Violation|1|||
149889424|NCT03103087|540725198|FG001|Overall Study|Protocol Violation|2|||
149889425|NCT03103087|540725199|FG002|Overall Study|Protocol Violation|1|||
149889426|NCT03103087|540725197|FG000|Overall Study|Lack of Efficacy|2|||
149889427|NCT03103087|540725198|FG001|Overall Study|Lack of Efficacy|1|||
149889428|NCT03103087|540725199|FG002|Overall Study|Lack of Efficacy|1|||
149889429|NCT03103087|540725197|FG000|Overall Study|Pregnancy|0|||
149889430|NCT03103087|540725198|FG001|Overall Study|Pregnancy|0|||
149889431|NCT03103087|540725199|FG002|Overall Study|Pregnancy|1|||
149889432|NCT03103087|540725197|FG000|Overall Study|Adverse Event|2|||
149889433|NCT03103087|540725198|FG001|Overall Study|Adverse Event|15|||
149889434|NCT03103087|540725199|FG002|Overall Study|Adverse Event|6|||
149889435|NCT03103087|540725197|FG000|Overall Study|Withdrawal by Subject|13|||
149889436|NCT03103087|540725198|FG001|Overall Study|Withdrawal by Subject|6|||
149889437|NCT03103087|540725199|FG002|Overall Study|Withdrawal by Subject|6|||
149889438|NCT03103087|540725197|FG000|Overall Study|Lost to Follow-up|4|||
149889439|NCT03103087|540725198|FG001|Overall Study|Lost to Follow-up|2|||
149889440|NCT03103087|540725199|FG002|Overall Study|Lost to Follow-up|7|||
149889441|NCT03103087|540725197|FG000|Overall Study|Other reason not reported|1|||
149889442|NCT03103087|540725198|FG001|Overall Study|Other reason not reported|3|||
149889443|NCT03103087|540725199|FG002|Overall Study|Other reason not reported|5|||
149889444|NCT00413699|540725200|FG000|Initial Period|Death|25|||
149889445|NCT00413699|540725201|FG001|Initial Period|Death|30|||
149889446|NCT00413699|540725202|FG002|Initial Period|Death|0|||
149889447|NCT00413699|540725200|FG000|Initial Period|Lack of Efficacy|59|||
149889448|NCT00413699|540725201|FG001|Initial Period|Lack of Efficacy|115|||
149889449|NCT00413699|540725202|FG002|Initial Period|Lack of Efficacy|0|||
149889450|NCT00413699|540725200|FG000|Initial Period|Lost to Follow-up|31|||
149889451|NCT00413699|540725201|FG001|Initial Period|Lost to Follow-up|101|||
149889452|NCT00413699|540725202|FG002|Initial Period|Lost to Follow-up|0|||
149889453|NCT00413699|540725200|FG000|Initial Period|Protocol Violation|38|||
149889454|NCT00413699|540725201|FG001|Initial Period|Protocol Violation|89|||
149889455|NCT00413699|540725202|FG002|Initial Period|Protocol Violation|0|||
149889456|NCT00413699|540725200|FG000|Initial Period|Pregnancy|10|||
149889457|NCT00413699|540725201|FG001|Initial Period|Pregnancy|8|||
149889458|NCT00413699|540725202|FG002|Initial Period|Pregnancy|0|||
149889459|NCT00413699|540725200|FG000|Initial Period|Did not meet entrance criteria|2|||
149889460|NCT00413699|540725201|FG001|Initial Period|Did not meet entrance criteria|2|||
149889461|NCT00413699|540725202|FG002|Initial Period|Did not meet entrance criteria|0|||
149889462|NCT00413699|540725200|FG000|Initial Period|Medication error without adverse event|0|||
149889463|NCT00413699|540725201|FG001|Initial Period|Medication error without adverse event|1|||
149889464|NCT00413699|540725202|FG002|Initial Period|Medication error without adverse event|0|||
149889465|NCT00413699|540725200|FG000|Initial Period|Study terminated by Sponsor|0|||
149889466|NCT00413699|540725201|FG001|Initial Period|Study terminated by Sponsor|1|||
149889467|NCT00413699|540725202|FG002|Initial Period|Study terminated by Sponsor|0|||
149889468|NCT00413699|540725200|FG000|Initial Period|Other|67|||
149889469|NCT00413699|540725201|FG001|Initial Period|Other|211|||
149889470|NCT00413699|540725202|FG002|Initial Period|Other|0|||
149889471|NCT00413699|540725200|FG000|Initial Period|Adverse event related to study drug|178|||
149889472|NCT00413699|540725201|FG001|Initial Period|Adverse event related to study drug|527|||
149889473|NCT00413699|540725202|FG002|Initial Period|Adverse event related to study drug|0|||
149889474|NCT00413699|540725200|FG000|Initial Period|Adverse event not related to study drug|113|||
149889475|NCT00413699|540725201|FG001|Initial Period|Adverse event not related to study drug|248|||
149889476|NCT00413699|540725202|FG002|Initial Period|Adverse event not related to study drug|0|||
149889477|NCT00413699|540725200|FG000|Initial Period|Missing end of study page|0|||
149889478|NCT00413699|540725201|FG001|Initial Period|Missing end of study page|4|||
149967582|NCT00725985|541017932|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149889479|NCT00413699|540725202|FG002|Initial Period|Missing end of study page|0|||
149889480|NCT00413699|540725200|FG000|Initial Period|No longer willing to participate|116|||
149967583|NCT00725985|541017933|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149967584|NCT00725985|541017934|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149967585|NCT00725985|541017935|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149889481|NCT00413699|540725201|FG001|Initial Period|No longer willing to participate|368|||
149889482|NCT00413699|540725202|FG002|Initial Period|No longer willing to participate|0|||
149889483|NCT00413699|540725200|FG000|Extension Period|No Longer Willing to Participate|0|||
149889484|NCT00413699|540725201|FG001|Extension Period|No Longer Willing to Participate|0|||
149967586|NCT00725985|541017936|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
149889485|NCT00413699|540725202|FG002|Extension Period|No Longer Willing to Participate|2|||
149889486|NCT00413699|540725200|FG000|Extension Period|Protocol Violation|0|||
149889487|NCT00413699|540725201|FG001|Extension Period|Protocol Violation|0|||
149889488|NCT00413699|540725202|FG002|Extension Period|Protocol Violation|1|||
149889489|NCT00413699|540725200|FG000|Extension Period|Adverse Event|0|||
149889490|NCT00413699|540725201|FG001|Extension Period|Adverse Event|0|||
149889491|NCT00413699|540725202|FG002|Extension Period|Adverse Event|2|||
149889492|NCT02115269|540725204|FG000|Overall Study|Lost to Follow-up|43|||
149889493|NCT02115269|540725204|FG000|Overall Study|Did not complete patient diary|3|||
149889494|NCT02115269|540725204|FG000|Overall Study|Moved to another city|7|||
149889495|NCT02115269|540725204|FG000|Overall Study|Withdrawal by Subject|2|||
149889496|NCT02115269|540725204|FG000|Overall Study|Didn't take study drug|2|||
149889497|NCT03511105|540725205|FG000|Overall Study|Adverse Event|1|||
149889498|NCT03511105|540725206|FG001|Overall Study|Adverse Event|0|||
150175752|NCT00516321|541779898|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
150175753|NCT00516321|541779896|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
150175754|NCT00516321|541779897|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
150175755|NCT00516321|541779898|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
150175756|NCT00516321|541779896|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
150175757|NCT00516321|541779897|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
150175758|NCT00516321|541779898|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
150175759|NCT00516321|541779896|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
150175760|NCT00516321|541779897|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
150175761|NCT00516321|541779898|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
150175762|NCT00714714|541779904|FG000|Overall Study|Adverse Event|1|||
150175763|NCT01185561|541779907|FG000|Overall Study|Lost to Follow-up|0|||
150175764|NCT01185561|541779908|FG001|Overall Study|Lost to Follow-up|4|||
150175765|NCT01185561|541779907|FG000|Overall Study|Withdrawal by Subject|2|||
150175766|NCT01185561|541779908|FG001|Overall Study|Withdrawal by Subject|8|||
150175767|NCT01078116|541779909|FG000|Overall Study|Lost to Follow-up|17|||
150175768|NCT01078116|541779909|FG000|Overall Study|Adverse Event|5|||
150175769|NCT01078116|541779909|FG000|Overall Study|Withdrawal by Subject|8|||
150175770|NCT01078116|541779909|FG000|Overall Study|Lack of effectiveness|15|||
150175771|NCT01078116|541779909|FG000|Overall Study|Case report form not completed|3|||
150175772|NCT02252042|541779914|FG000|Overall Study|Adverse Event|9|||
150175773|NCT02252042|541779915|FG001|Overall Study|Adverse Event|6|||
150175774|NCT02252042|541779914|FG000|Overall Study|Death|209|||
150175775|NCT02252042|541779915|FG001|Overall Study|Death|217|||
150175776|NCT02252042|541779914|FG000|Overall Study|Physician Decision|0|||
150175777|NCT02252042|541779915|FG001|Overall Study|Physician Decision|2|||
150175778|NCT02252042|541779914|FG000|Overall Study|Transferred to Extension Study|7|||
150175779|NCT02252042|541779915|FG001|Overall Study|Transferred to Extension Study|1|||
150175780|NCT02252042|541779914|FG000|Overall Study|Did Not Continue on Extension Study|7|||
150175781|NCT02252042|541779915|FG001|Overall Study|Did Not Continue on Extension Study|2|||
150175782|NCT02252042|541779914|FG000|Overall Study|Withdrawal by Subject|15|||
150175783|NCT02252042|541779915|FG001|Overall Study|Withdrawal by Subject|20|||
150175784|NCT00979992|541779916|FG000|Overall Study|Ineligible - inadequate pathology|1|||
150175785|NCT00979992|541779916|FG000|Overall Study|Ineligible - wrong cell type|2|||
150175786|NCT00979992|541779916|FG000|Overall Study|Refused - Never Treated|2|||
150175787|NCT04532528|541779917|FG000|Overall Study|Adverse Event|12|||
150175788|NCT04532528|541779918|FG001|Overall Study|Adverse Event|17|||
150175789|NCT04532528|541779917|FG000|Overall Study|Withdrawal of consent|16|||
150175790|NCT04532528|541779918|FG001|Overall Study|Withdrawal of consent|17|||
150175791|NCT04532528|541779917|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
150175792|NCT04532528|541779918|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
150175793|NCT04532528|541779917|FG000|Overall Study|Lost to Follow-up|69|||
150175794|NCT04532528|541779918|FG001|Overall Study|Lost to Follow-up|68|||
150175795|NCT04532528|541779917|FG000|Overall Study|Administrative problems|12|||
150175796|NCT04532528|541779918|FG001|Overall Study|Administrative problems|14|||
150175797|NCT04532528|541779917|FG000|Overall Study|Death|3|||
149889499|NCT03511105|540725205|FG000|Overall Study|Withdrew consent|1|||
149889500|NCT03511105|540725206|FG001|Overall Study|Withdrew consent|0|||
149889501|NCT02810457|540725207|FG000|Overall Study|Randomised but no treatment received|2|||
150175798|NCT04532528|541779918|FG001|Overall Study|Death|3|||
150175799|NCT04532528|541779917|FG000|Overall Study|Other|38|||
150175800|NCT04532528|541779918|FG001|Overall Study|Other|46|||
150175801|NCT03691428|541779921|FG000|Overall Study|Withdrawal by Subject|6|||
150175802|NCT03691428|541779922|FG001|Overall Study|Withdrawal by Subject|8|||
149889502|NCT02810457|540725208|FG001|Overall Study|Randomised but no treatment received|1|||
149889503|NCT02810457|540725207|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
150175803|NCT01460290|541779923|FG000|Overall Study|Adverse Event|3|||
150175804|NCT01460290|541779923|FG000|Overall Study|Elevated liver function|1|||
150175805|NCT02527148|541779924|FG000|Overall Study|Did not receive study intervention|1|||
149967587|NCT00725985|541017925|FG000|OLMP (Up to 96 Weeks)|Death|0|||
149889504|NCT02810457|540725208|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
149889505|NCT02810457|540725207|FG000|Overall Study|Adverse Event|37|||
149889506|NCT02810457|540725208|FG001|Overall Study|Adverse Event|43|||
149889507|NCT02810457|540725207|FG000|Overall Study|Patient decision|31|||
149889508|NCT02810457|540725208|FG001|Overall Study|Patient decision|35|||
149889509|NCT02810457|540725207|FG000|Overall Study|Patient lost to follow-up|2|||
149889510|NCT02810457|540725208|FG001|Overall Study|Patient lost to follow-up|2|||
149889511|NCT02810457|540725207|FG000|Overall Study|Death|39|||
149889512|NCT02810457|540725208|FG001|Overall Study|Death|28|||
149889513|NCT02810457|540725207|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
149889514|NCT02810457|540725208|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
149889515|NCT02810457|540725207|FG000|Overall Study|Clinical progression|15|||
149889516|NCT02810457|540725208|FG001|Overall Study|Clinical progression|16|||
149889517|NCT02810457|540725207|FG000|Overall Study|Investigator decision|3|||
149889518|NCT02810457|540725208|FG001|Overall Study|Investigator decision|2|||
149889519|NCT02810457|540725207|FG000|Overall Study|Patient ineligibility|3|||
149889520|NCT02810457|540725208|FG001|Overall Study|Patient ineligibility|0|||
149889521|NCT02810457|540725207|FG000|Overall Study|Miscalculated PD|1|||
149889522|NCT02810457|540725208|FG001|Overall Study|Miscalculated PD|0|||
149889523|NCT02810457|540725207|FG000|Overall Study|Physician Decision|0|||
149889524|NCT02810457|540725208|FG001|Overall Study|Physician Decision|1|||
149889525|NCT01402570|540725209|FG000|Overall Study|Adverse Event|1|||
149889526|NCT03642262|540725212|FG000|Period 1|Withdrawal by Subject|1|||
149889527|NCT03642262|540725213|FG001|Period 1|Withdrawal by Subject|1|||
149889528|NCT03642262|540725212|FG000|Period 1|Adverse Event|0|||
149889529|NCT03642262|540725213|FG001|Period 1|Adverse Event|1|||
149889530|NCT01557504|540725214|FG000|Overall Study|Physician Decision|1|||
149889531|NCT01557504|540725215|FG001|Overall Study|Physician Decision|0|||
149889532|NCT02750618|540725218|FG000|Overall Study|Withdrawal by Subject|1|||
149889533|NCT02572570|540725221|FG000|Overall Study|Study Terminated|27|||
149889534|NCT02019472|540725222|FG000|Overall Study|Adverse Event|14|||
149889535|NCT02019472|540725223|FG001|Overall Study|Adverse Event|23|||
149889536|NCT02019472|540725224|FG002|Overall Study|Adverse Event|17|||
149889537|NCT02019472|540725222|FG000|Overall Study|Death|0|||
149889538|NCT02019472|540725223|FG001|Overall Study|Death|1|||
149889539|NCT02019472|540725224|FG002|Overall Study|Death|1|||
149889540|NCT02019472|540725222|FG000|Overall Study|Lack of Efficacy|7|||
149889541|NCT02019472|540725223|FG001|Overall Study|Lack of Efficacy|4|||
149889542|NCT02019472|540725224|FG002|Overall Study|Lack of Efficacy|4|||
149889543|NCT02019472|540725222|FG000|Overall Study|Lost to Follow-up|0|||
149889544|NCT02019472|540725223|FG001|Overall Study|Lost to Follow-up|2|||
149889545|NCT02019472|540725224|FG002|Overall Study|Lost to Follow-up|1|||
149889546|NCT02019472|540725222|FG000|Overall Study|Physician Decision|1|||
149889547|NCT02019472|540725223|FG001|Overall Study|Physician Decision|2|||
149889548|NCT02019472|540725224|FG002|Overall Study|Physician Decision|0|||
149889549|NCT02019472|540725222|FG000|Overall Study|Pregnancy|1|||
149889550|NCT02019472|540725223|FG001|Overall Study|Pregnancy|2|||
149889551|NCT02019472|540725224|FG002|Overall Study|Pregnancy|2|||
149889552|NCT02019472|540725222|FG000|Overall Study|Withdrawal by Subject|11|||
149889553|NCT02019472|540725223|FG001|Overall Study|Withdrawal by Subject|10|||
149889554|NCT02019472|540725224|FG002|Overall Study|Withdrawal by Subject|11|||
149967588|NCT00725985|541017926|FG001|OLMP (Up to 96 Weeks)|Death|0|||
149967589|NCT00725985|541017927|FG002|OLMP (Up to 96 Weeks)|Death|0|||
149967590|NCT00725985|541017928|FG003|OLMP (Up to 96 Weeks)|Death|0|||
149967591|NCT00725985|541017929|FG004|OLMP (Up to 96 Weeks)|Death|1|||
149889555|NCT02019472|540725222|FG000|Overall Study|Other|3|||
149889556|NCT02019472|540725223|FG001|Overall Study|Other|8|||
149889557|NCT02019472|540725224|FG002|Overall Study|Other|6|||
149889558|NCT00513695|540725225|FG000|Overall Study|Discontinued therapy|2|||
149889559|NCT00513695|540725225|FG000|Overall Study|Progression prior to surgery|3|||
149889560|NCT02157935|540725226|FG000|Overall Study|Withdrawal by Subject|25|||
149889561|NCT02157935|540725227|FG001|Overall Study|Withdrawal by Subject|39|||
149889562|NCT02157935|540725226|FG000|Overall Study|Screen failure|1|||
149889563|NCT02157935|540725227|FG001|Overall Study|Screen failure|2|||
149889564|NCT02157935|540725226|FG000|Overall Study|Protocol Violation|1|||
149889565|NCT02157935|540725227|FG001|Overall Study|Protocol Violation|0|||
149889566|NCT02157935|540725226|FG000|Overall Study|Progressive disease|0|||
149889567|NCT02157935|540725227|FG001|Overall Study|Progressive disease|2|||
149889568|NCT02157935|540725226|FG000|Overall Study|Other|5|||
149889569|NCT02157935|540725227|FG001|Overall Study|Other|12|||
149889570|NCT02157935|540725226|FG000|Overall Study|Lack of Efficacy|0|||
149889571|NCT02157935|540725227|FG001|Overall Study|Lack of Efficacy|1|||
149889572|NCT02157935|540725226|FG000|Overall Study|Death|4|||
149889573|NCT02157935|540725227|FG001|Overall Study|Death|4|||
149889574|NCT02157935|540725226|FG000|Overall Study|Adverse Event|3|||
149889575|NCT02157935|540725227|FG001|Overall Study|Adverse Event|5|||
149889576|NCT01417156|540725228|FG000|Overall Study|Adverse Event|12|||
149889577|NCT01417156|540725228|FG000|Overall Study|Protocol Violation|2|||
149889578|NCT01103180|540725232|FG000|Overall Study|Withdrawal by Subject|8|||
149889579|NCT01103180|540725233|FG001|Overall Study|Withdrawal by Subject|13|||
149889580|NCT01103180|540725232|FG000|Overall Study|Lost to Follow-up|13|||
149889581|NCT01103180|540725233|FG001|Overall Study|Lost to Follow-up|7|||
149889582|NCT01103180|540725232|FG000|Overall Study|Physician Decision|1|||
149889583|NCT01103180|540725233|FG001|Overall Study|Physician Decision|0|||
149889584|NCT01103180|540725232|FG000|Overall Study|Protocol Violation|0|||
149889585|NCT01103180|540725233|FG001|Overall Study|Protocol Violation|1|||
149889586|NCT00742209|540725237|FG000|Overall Study|Adverse Event|11|||
149889587|NCT00742209|540725238|FG001|Overall Study|Adverse Event|4|||
149889588|NCT00742209|540725239|FG002|Overall Study|Adverse Event|17|||
149889589|NCT00742209|540725240|FG003|Overall Study|Adverse Event|16|||
149889590|NCT00742209|540725241|FG004|Overall Study|Adverse Event|13|||
149889591|NCT00742209|540725237|FG000|Overall Study|Participant Withdrew Consent|8|||
149889592|NCT00742209|540725238|FG001|Overall Study|Participant Withdrew Consent|4|||
149889593|NCT00742209|540725239|FG002|Overall Study|Participant Withdrew Consent|14|||
149889594|NCT00742209|540725240|FG003|Overall Study|Participant Withdrew Consent|7|||
149889595|NCT00742209|540725241|FG004|Overall Study|Participant Withdrew Consent|4|||
149889596|NCT00742209|540725237|FG000|Overall Study|Protocol Violation|6|||
149889597|NCT00742209|540725238|FG001|Overall Study|Protocol Violation|5|||
149889598|NCT00742209|540725239|FG002|Overall Study|Protocol Violation|4|||
149889599|NCT00742209|540725240|FG003|Overall Study|Protocol Violation|5|||
149889600|NCT00742209|540725241|FG004|Overall Study|Protocol Violation|3|||
149889601|NCT00742209|540725237|FG000|Overall Study|Lost to Follow-up|3|||
149889602|NCT00742209|540725238|FG001|Overall Study|Lost to Follow-up|4|||
149889603|NCT00742209|540725239|FG002|Overall Study|Lost to Follow-up|5|||
149889604|NCT00742209|540725240|FG003|Overall Study|Lost to Follow-up|5|||
149889605|NCT00742209|540725241|FG004|Overall Study|Lost to Follow-up|3|||
149889606|NCT00742209|540725237|FG000|Overall Study|Lack of Efficacy|6|||
149889607|NCT00742209|540725238|FG001|Overall Study|Lack of Efficacy|1|||
149889608|NCT00742209|540725239|FG002|Overall Study|Lack of Efficacy|1|||
149889609|NCT00742209|540725240|FG003|Overall Study|Lack of Efficacy|3|||
149889610|NCT00742209|540725241|FG004|Overall Study|Lack of Efficacy|1|||
149889611|NCT00742209|540725237|FG000|Overall Study|Investigator Discretion|0|||
149889612|NCT00742209|540725238|FG001|Overall Study|Investigator Discretion|0|||
149889613|NCT00742209|540725239|FG002|Overall Study|Investigator Discretion|5|||
149889614|NCT00742209|540725240|FG003|Overall Study|Investigator Discretion|1|||
149889615|NCT00742209|540725241|FG004|Overall Study|Investigator Discretion|1|||
149889616|NCT02440464|540725244|FG000|Overall Study|Withdrawal by Subject|3|||
149889617|NCT02440464|540725245|FG001|Overall Study|Withdrawal by Subject|2|||
149889618|NCT02058069|540725248|FG000|Overall Study|Exclusion due to implant size|5|||
149889619|NCT02058069|540725248|FG000|Overall Study|Withdrawal by Subject|6|||
149889620|NCT02222922|540725249|FG000|Overall Study|Death|0|||
149889621|NCT02222922|540725250|FG001|Overall Study|Death|0|||
149889622|NCT02222922|540725251|FG002|Overall Study|Death|0|||
149889623|NCT02222922|540725252|FG003|Overall Study|Death|0|||
149889624|NCT02222922|540725253|FG004|Overall Study|Death|13|||
149889625|NCT02222922|540725254|FG005|Overall Study|Death|0|||
149889626|NCT02222922|540725255|FG006|Overall Study|Death|0|||
149889627|NCT02222922|540725256|FG007|Overall Study|Death|0|||
149889628|NCT02222922|540725257|FG008|Overall Study|Death|2|||
149889629|NCT02222922|540725249|FG000|Overall Study|Lost to Follow-up|0|||
149889630|NCT02222922|540725250|FG001|Overall Study|Lost to Follow-up|0|||
149889631|NCT02222922|540725251|FG002|Overall Study|Lost to Follow-up|1|||
149889632|NCT02222922|540725252|FG003|Overall Study|Lost to Follow-up|0|||
149889633|NCT02222922|540725253|FG004|Overall Study|Lost to Follow-up|9|||
149889634|NCT02222922|540725254|FG005|Overall Study|Lost to Follow-up|1|||
150175806|NCT02527148|541779925|FG001|Overall Study|Did not receive study intervention|0|||
150175807|NCT01140048|541779926|FG000|Overall Study|Physician Decision|1|||
150175808|NCT01140048|541779926|FG000|Overall Study|Withdrawal by Subject|13|||
150175809|NCT01140048|541779926|FG000|Overall Study|Lost to Follow-up|31|||
150175810|NCT02448446|541779929|FG000|Overall Study|Withdrawal by Subject|1|||
150175811|NCT02448446|541779930|FG001|Overall Study|Withdrawal by Subject|0|||
150175812|NCT01254188|541779931|FG000|Overall Study|Disease Progression|6|||
150175813|NCT01254188|541779931|FG000|Overall Study|Protocol Violation|6|||
150175814|NCT01254188|541779931|FG000|Overall Study|Pregnancy|2|||
150175815|NCT01254188|541779931|FG000|Overall Study|Death|4|||
150175816|NCT01254188|541779931|FG000|Overall Study|Lost to Follow-up|5|||
150175817|NCT01254188|541779931|FG000|Overall Study|Withdrawal by Subject|7|||
150175818|NCT01254188|541779931|FG000|Overall Study|Adverse Event|43|||
150175819|NCT01254188|541779931|FG000|Overall Study|per investigator discretion|20|||
150175820|NCT02957136|541779933|FG000|Overall Study|Withdrawal by Subject|2|||
150175821|NCT02957136|541779934|FG001|Overall Study|Withdrawal by Subject|1|||
150175822|NCT04975308|541779935|FG000|Overall Study|Withdrawal by Subject|6|||
149889635|NCT02222922|540725255|FG006|Overall Study|Lost to Follow-up|0|||
149889636|NCT02222922|540725256|FG007|Overall Study|Lost to Follow-up|0|||
149889637|NCT02222922|540725257|FG008|Overall Study|Lost to Follow-up|0|||
149889638|NCT02222922|540725249|FG000|Overall Study|Other|0|||
149889639|NCT02222922|540725250|FG001|Overall Study|Other|0|||
149889640|NCT02222922|540725251|FG002|Overall Study|Other|0|||
149889641|NCT02222922|540725252|FG003|Overall Study|Other|2|||
149889642|NCT02222922|540725253|FG004|Overall Study|Other|10|||
149889643|NCT02222922|540725254|FG005|Overall Study|Other|2|||
149889644|NCT02222922|540725255|FG006|Overall Study|Other|2|||
149889645|NCT02222922|540725256|FG007|Overall Study|Other|4|||
149889646|NCT02222922|540725257|FG008|Overall Study|Other|1|||
149889647|NCT02222922|540725249|FG000|Overall Study|Participant refused further follow-up|1|||
149889648|NCT02222922|540725250|FG001|Overall Study|Participant refused further follow-up|0|||
149889649|NCT02222922|540725251|FG002|Overall Study|Participant refused further follow-up|0|||
149889650|NCT02222922|540725252|FG003|Overall Study|Participant refused further follow-up|1|||
149889651|NCT02222922|540725253|FG004|Overall Study|Participant refused further follow-up|6|||
149889652|NCT02222922|540725254|FG005|Overall Study|Participant refused further follow-up|0|||
149889653|NCT02222922|540725255|FG006|Overall Study|Participant refused further follow-up|0|||
149889654|NCT02222922|540725256|FG007|Overall Study|Participant refused further follow-up|0|||
149889655|NCT02222922|540725257|FG008|Overall Study|Participant refused further follow-up|3|||
149889656|NCT02002221|540725264|FG000|Overall Study|Adverse Event|2|||
149889657|NCT02002221|540725265|FG001|Overall Study|Adverse Event|1|||
149889658|NCT02002221|540725264|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149889659|NCT02002221|540725265|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149889660|NCT02002221|540725264|FG000|Overall Study|Patient withdrew consent|0|||
149889661|NCT02002221|540725265|FG001|Overall Study|Patient withdrew consent|1|||
149889662|NCT00882518|540725266|FG000|Overall Study|Adverse Event|9|||
149889663|NCT00882518|540725267|FG001|Overall Study|Adverse Event|18|||
149889664|NCT00882518|540725266|FG000|Overall Study|Withdrawal by Subject|9|||
149889665|NCT00882518|540725267|FG001|Overall Study|Withdrawal by Subject|13|||
149889666|NCT00882518|540725266|FG000|Overall Study|Lack of Efficacy|12|||
149889667|NCT00882518|540725267|FG001|Overall Study|Lack of Efficacy|9|||
149889668|NCT00882518|540725266|FG000|Overall Study|Severe non-compliance to protocol|3|||
149889669|NCT00882518|540725267|FG001|Overall Study|Severe non-compliance to protocol|1|||
149889670|NCT00882518|540725266|FG000|Overall Study|Incorrect enrolment|4|||
149889671|NCT00882518|540725267|FG001|Overall Study|Incorrect enrolment|2|||
149889672|NCT00882518|540725266|FG000|Overall Study|Central lab closure for National day|1|||
149889673|NCT00882518|540725267|FG001|Overall Study|Central lab closure for National day|0|||
149889674|NCT00882518|540725266|FG000|Overall Study|Allocating random number by mistake|0|||
149889675|NCT00882518|540725267|FG001|Overall Study|Allocating random number by mistake|1|||
150175823|NCT04975308|541779936|FG001|Overall Study|Withdrawal by Subject|16|||
150175824|NCT04975308|541779937|FG002|Overall Study|Withdrawal by Subject|6|||
150175825|NCT04975308|541779935|FG000|Overall Study|Physician Decision|0|||
150175826|NCT04975308|541779936|FG001|Overall Study|Physician Decision|3|||
150175827|NCT04975308|541779937|FG002|Overall Study|Physician Decision|1|||
150175828|NCT04975308|541779935|FG000|Overall Study|Adverse Event|10|||
150175829|NCT04975308|541779936|FG001|Overall Study|Adverse Event|1|||
149889676|NCT03238651|540725268|FG000|Overall Study|Other|0|||
149889677|NCT03238651|540725269|FG001|Overall Study|Other|0|||
149889678|NCT03238651|540725270|FG002|Overall Study|Other|0|||
149889679|NCT03238651|540725271|FG003|Overall Study|Other|0|||
150044910|NCT02023697|541304239|FG002|Treatment Period|Clinical progression|28|||
150044911|NCT02023697|541304237|FG000|Treatment Period|Withdrawal by Subject|4|||
150044912|NCT02023697|541304238|FG001|Treatment Period|Withdrawal by Subject|5|||
150044913|NCT02023697|541304239|FG002|Treatment Period|Withdrawal by Subject|13|||
150044914|NCT02023697|541304237|FG000|Treatment Period|Safety outcome reached|0|||
150044915|NCT02023697|541304238|FG001|Treatment Period|Safety outcome reached|1|||
150044916|NCT02023697|541304239|FG002|Treatment Period|Safety outcome reached|0|||
150044917|NCT02023697|541304237|FG000|Treatment Period|Physician Decision|0|||
150044918|NCT02023697|541304238|FG001|Treatment Period|Physician Decision|0|||
150044919|NCT02023697|541304239|FG002|Treatment Period|Physician Decision|1|||
150044920|NCT02023697|541304237|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
150044921|NCT02023697|541304238|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
150044922|NCT02023697|541304239|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
150044923|NCT02023697|541304237|FG000|Active Follow-up Period|Lost to Follow-up|1|||
150044924|NCT02023697|541304238|FG001|Active Follow-up Period|Lost to Follow-up|1|||
150044925|NCT02023697|541304239|FG002|Active Follow-up Period|Lost to Follow-up|1|||
150044926|NCT02023697|541304237|FG000|Active Follow-up Period|Deterioration of general condition|1|||
150044927|NCT02023697|541304238|FG001|Active Follow-up Period|Deterioration of general condition|1|||
150044928|NCT02023697|541304239|FG002|Active Follow-up Period|Deterioration of general condition|1|||
150044929|NCT02023697|541304237|FG000|Active Follow-up Period|Other unspecified|2|||
150044930|NCT02023697|541304238|FG001|Active Follow-up Period|Other unspecified|0|||
149889680|NCT03238651|540725272|FG004|Overall Study|Other|1|||
149889681|NCT03238651|540725268|FG000|Overall Study|Progressive Disease|2|||
149889682|NCT03238651|540725269|FG001|Overall Study|Progressive Disease|2|||
149889683|NCT03238651|540725270|FG002|Overall Study|Progressive Disease|2|||
149889684|NCT03238651|540725271|FG003|Overall Study|Progressive Disease|2|||
149889685|NCT03238651|540725272|FG004|Overall Study|Progressive Disease|0|||
149889686|NCT03238651|540725268|FG000|Overall Study|Withdrawal by Subject|0|||
149889687|NCT03238651|540725269|FG001|Overall Study|Withdrawal by Subject|1|||
149889688|NCT03238651|540725270|FG002|Overall Study|Withdrawal by Subject|0|||
149889689|NCT03238651|540725271|FG003|Overall Study|Withdrawal by Subject|1|||
149889690|NCT03238651|540725272|FG004|Overall Study|Withdrawal by Subject|0|||
149889691|NCT03238651|540725268|FG000|Overall Study|Adverse Event|1|||
149889692|NCT03238651|540725269|FG001|Overall Study|Adverse Event|3|||
149889693|NCT03238651|540725270|FG002|Overall Study|Adverse Event|2|||
149889694|NCT03238651|540725271|FG003|Overall Study|Adverse Event|0|||
149889695|NCT03238651|540725272|FG004|Overall Study|Adverse Event|0|||
149889696|NCT03743051|540725273|FG000|Overall Study|Adverse Event|5|||
149889697|NCT03743051|540725274|FG001|Overall Study|Adverse Event|9|||
149889698|NCT03743051|540725273|FG000|Overall Study|Death|27|||
149889699|NCT03743051|540725274|FG001|Overall Study|Death|26|||
149889700|NCT03743051|540725273|FG000|Overall Study|Lost to Follow-up|4|||
149889701|NCT03743051|540725274|FG001|Overall Study|Lost to Follow-up|8|||
149889702|NCT03743051|540725273|FG000|Overall Study|Withdrawal by Subject|32|||
149889703|NCT03743051|540725274|FG001|Overall Study|Withdrawal by Subject|19|||
149889704|NCT03743051|540725273|FG000|Overall Study|Physician Decision|10|||
149889705|NCT03743051|540725274|FG001|Overall Study|Physician Decision|15|||
149889706|NCT03743051|540725273|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
149889707|NCT03743051|540725274|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
149889708|NCT00840749|540725277|FG000|Overall Study|Death|1|||
149889709|NCT00840749|540725278|FG001|Overall Study|Death|2|||
149889710|NCT00840749|540725277|FG000|Overall Study|not treated on study arm|11|||
149889711|NCT00840749|540725278|FG001|Overall Study|not treated on study arm|11|||
149889712|NCT00840749|540725277|FG000|Overall Study|study closed|19|||
149889713|NCT00840749|540725278|FG001|Overall Study|study closed|14|||
149889714|NCT01113892|540725283|FG000|Overall Study|Lost to Follow-up|2|||
149889715|NCT01113892|540725284|FG001|Overall Study|Lost to Follow-up|2|||
149889716|NCT01113892|540725283|FG000|Overall Study|Withdrawal by Subject|1|||
149889717|NCT01113892|540725284|FG001|Overall Study|Withdrawal by Subject|1|||
149889718|NCT01113892|540725283|FG000|Overall Study|Death|2|||
149889719|NCT01113892|540725284|FG001|Overall Study|Death|4|||
149889720|NCT01113892|540725283|FG000|Overall Study|Graft no longer evaluable|9|||
149889721|NCT01113892|540725284|FG001|Overall Study|Graft no longer evaluable|9|||
149889722|NCT04886596|540725285|FG000|Overall Study|Adverse Event|442|||
149889723|NCT04886596|540725286|FG001|Overall Study|Adverse Event|441|||
149889724|NCT04886596|540725285|FG000|Overall Study|Lost to Follow-up|448|||
150044931|NCT02023697|541304239|FG002|Active Follow-up Period|Other unspecified|1|||
150044932|NCT02023697|541304237|FG000|Active Follow-up Period|Clinical progression|0|||
150044933|NCT02023697|541304238|FG001|Active Follow-up Period|Clinical progression|2|||
150044934|NCT02023697|541304239|FG002|Active Follow-up Period|Clinical progression|1|||
150044935|NCT02023697|541304237|FG000|Active Follow-up Period|Radiological progression|0|||
150044936|NCT02023697|541304238|FG001|Active Follow-up Period|Radiological progression|0|||
150044937|NCT02023697|541304239|FG002|Active Follow-up Period|Radiological progression|1|||
150044938|NCT02023697|541304237|FG000|Active Follow-up Period|Death|83|||
150044939|NCT02023697|541304238|FG001|Active Follow-up Period|Death|82|||
150044940|NCT02023697|541304239|FG002|Active Follow-up Period|Death|87|||
150044941|NCT02023697|541304237|FG000|Long-term Follow-up Period|Death|9|||
150044942|NCT02023697|541304238|FG001|Long-term Follow-up Period|Death|6|||
150044943|NCT02023697|541304239|FG002|Long-term Follow-up Period|Death|4|||
150044944|NCT02023697|541304237|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
150044945|NCT02023697|541304238|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
150044946|NCT02023697|541304239|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
150044947|NCT02023697|541304237|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
150044948|NCT02023697|541304238|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
150044949|NCT02023697|541304239|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
150044950|NCT02023697|541304237|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
150044951|NCT02023697|541304238|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
150044952|NCT02023697|541304239|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
150044953|NCT02023697|541304237|FG000|Long-term Follow-up Period|Technical problems|0|||
150044954|NCT02023697|541304238|FG001|Long-term Follow-up Period|Technical problems|0|||
150044955|NCT02023697|541304239|FG002|Long-term Follow-up Period|Technical problems|1|||
150044956|NCT02023697|541304237|FG000|Long-term Follow-up Period|Other unspecified|6|||
150044957|NCT02023697|541304238|FG001|Long-term Follow-up Period|Other unspecified|3|||
150044958|NCT02023697|541304239|FG002|Long-term Follow-up Period|Other unspecified|5|||
150044959|NCT01354314|541304242|FG000|Overall Study|Lost to Follow-up|1|||
150044960|NCT01354314|541304243|FG001|Overall Study|Lost to Follow-up|0|||
150044961|NCT01354314|541304244|FG002|Overall Study|Lost to Follow-up|1|||
150044962|NCT01354314|541304245|FG003|Overall Study|Lost to Follow-up|1|||
150044963|NCT01354314|541304242|FG000|Overall Study|Withdrawal by Subject|0|||
150044964|NCT01354314|541304243|FG001|Overall Study|Withdrawal by Subject|0|||
150044965|NCT01354314|541304244|FG002|Overall Study|Withdrawal by Subject|1|||
150044966|NCT01354314|541304245|FG003|Overall Study|Withdrawal by Subject|0|||
150044967|NCT01354314|541304242|FG000|Overall Study|Adverse Event|0|||
150044968|NCT01354314|541304243|FG001|Overall Study|Adverse Event|0|||
150044969|NCT01354314|541304244|FG002|Overall Study|Adverse Event|0|||
150044970|NCT01354314|541304245|FG003|Overall Study|Adverse Event|1|||
150044971|NCT01354314|541304242|FG000|Overall Study|Protocol Violation|1|||
150044972|NCT01354314|541304243|FG001|Overall Study|Protocol Violation|1|||
150044973|NCT01354314|541304244|FG002|Overall Study|Protocol Violation|0|||
150044974|NCT01354314|541304245|FG003|Overall Study|Protocol Violation|0|||
149889725|NCT04886596|540725286|FG001|Overall Study|Lost to Follow-up|465|||
149889726|NCT04886596|540725285|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
150044975|NCT01354314|541304242|FG000|Overall Study|Less than 90% Adherence|4|||
150044976|NCT01354314|541304243|FG001|Overall Study|Less than 90% Adherence|2|||
150044977|NCT01354314|541304244|FG002|Overall Study|Less than 90% Adherence|6|||
150044978|NCT01354314|541304245|FG003|Overall Study|Less than 90% Adherence|4|||
150044979|NCT00478023|541304246|FG000|Overall Study|Adverse Event|11|||
150044980|NCT00478023|541304247|FG001|Overall Study|Adverse Event|7|||
150044981|NCT00478023|541304248|FG002|Overall Study|Adverse Event|8|||
150044982|NCT00478023|541304249|FG003|Overall Study|Adverse Event|14|||
150044983|NCT00478023|541304250|FG004|Overall Study|Adverse Event|6|||
149889727|NCT04886596|540725286|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
149889728|NCT04886596|540725285|FG000|Overall Study|Migrated/moved from the study area|201|||
149889729|NCT04886596|540725286|FG001|Overall Study|Migrated/moved from the study area|184|||
149889730|NCT04886596|540725285|FG000|Overall Study|Other|298|||
149889731|NCT04886596|540725286|FG001|Overall Study|Other|326|||
149889732|NCT02766335|540725287|FG000|Initial Registration|Adverse Event|6|||
149889733|NCT02766335|540725288|FG001|Initial Registration|Adverse Event|3|||
149889734|NCT02766335|540725289|FG002|Initial Registration|Adverse Event|0|||
149889735|NCT02766335|540725287|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
149889736|NCT02766335|540725288|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
149889737|NCT02766335|540725289|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
149889738|NCT02766335|540725287|FG000|Initial Registration|Progression/relapse|49|||
149889739|NCT02766335|540725288|FG001|Initial Registration|Progression/relapse|15|||
149889740|NCT02766335|540725289|FG002|Initial Registration|Progression/relapse|0|||
149889741|NCT02766335|540725287|FG000|Initial Registration|Death|1|||
149889742|NCT02766335|540725288|FG001|Initial Registration|Death|3|||
149889743|NCT02766335|540725289|FG002|Initial Registration|Death|0|||
149889744|NCT02766335|540725287|FG000|Initial Registration|not protocol specified|1|||
149889745|NCT02766335|540725288|FG001|Initial Registration|not protocol specified|9|||
149889746|NCT02766335|540725289|FG002|Initial Registration|not protocol specified|0|||
149889747|NCT02766335|540725287|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
149889748|NCT02766335|540725288|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
149889749|NCT02766335|540725289|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
149889750|NCT02766335|540725287|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
149889751|NCT02766335|540725288|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
149889752|NCT02766335|540725289|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
149889753|NCT03645863|540725290|FG000|Overall Study|Withdrawal by Subject|1|||
149889754|NCT03645863|540725291|FG001|Overall Study|Withdrawal by Subject|0|||
149889755|NCT03645863|540725292|FG002|Overall Study|Withdrawal by Subject|0|||
149889756|NCT02756611|540725293|FG000|Overall Study|Death|70|||
149889757|NCT02756611|540725293|FG000|Overall Study|Withdrawal by Subject|2|||
149889758|NCT02756611|540725293|FG000|Overall Study|Lost to Follow-up|3|||
149889759|NCT02756611|540725293|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
149889760|NCT02756611|540725293|FG000|Overall Study|Other|10|||
149889761|NCT00476190|540725294|FG000|Overall Study|Ineligible|1|||
149889762|NCT00476190|540725295|FG001|Overall Study|Ineligible|1|||
149889763|NCT00476190|540725294|FG000|Overall Study|Induction Death|2|||
149889764|NCT00476190|540725295|FG001|Overall Study|Induction Death|0|||
149889765|NCT00476190|540725294|FG000|Overall Study|Induction Failure|2|||
149889766|NCT00476190|540725295|FG001|Overall Study|Induction Failure|4|||
149889767|NCT00476190|540725294|FG000|Overall Study|Lost to Follow-up|1|||
149889768|NCT00476190|540725295|FG001|Overall Study|Lost to Follow-up|0|||
149889769|NCT00476190|540725294|FG000|Overall Study|Relapse/Progression|5|||
149889770|NCT00476190|540725295|FG001|Overall Study|Relapse/Progression|2|||
149889771|NCT00476190|540725294|FG000|Overall Study|Remission Death|0|||
149889772|NCT00476190|540725295|FG001|Overall Study|Remission Death|1|||
149889773|NCT00476190|540725294|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
149889774|NCT00476190|540725295|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
149889775|NCT00476190|540725294|FG000|Overall Study|Withdrawal by Subject|6|||
149889776|NCT00476190|540725295|FG001|Overall Study|Withdrawal by Subject|2|||
149889777|NCT00476190|540725294|FG000|Overall Study|Other|9|||
149889778|NCT00476190|540725295|FG001|Overall Study|Other|10|||
149889779|NCT02860546|540725296|FG000|Overall Study|Clinical Progression|6|||
149889780|NCT02860546|540725296|FG000|Overall Study|Radiological Progression|12|||
149889781|NCT02586155|540725298|FG000|Overall Study|Adverse Event|2|||
149889782|NCT02586155|540725299|FG001|Overall Study|Adverse Event|3|||
149889783|NCT02586155|540725298|FG000|Overall Study|Withdrawal by Subject|31|||
149889784|NCT02586155|540725299|FG001|Overall Study|Withdrawal by Subject|24|||
149889785|NCT02586155|540725298|FG000|Overall Study|Lost to Follow-up|7|||
149889786|NCT02586155|540725299|FG001|Overall Study|Lost to Follow-up|13|||
149889787|NCT02586155|540725298|FG000|Overall Study|Death|61|||
149889788|NCT02586155|540725299|FG001|Overall Study|Death|72|||
149967592|NCT00725985|541017930|FG005|OLMP (Up to 96 Weeks)|Death|0|||
149889789|NCT02586155|540725298|FG000|Overall Study|Other reasons|26|||
149889790|NCT02586155|540725299|FG001|Overall Study|Other reasons|15|||
150175830|NCT04975308|541779937|FG002|Overall Study|Adverse Event|12|||
149889791|NCT02072980|540725300|FG000|Period 2, Second Wear|Adverse Event|0|||
149889792|NCT02072980|540725301|FG001|Period 2, Second Wear|Adverse Event|1|||
149889793|NCT03367819|540725304|FG000|Overall Study|Adverse Event|4|||
149889794|NCT03367819|540725305|FG001|Overall Study|Adverse Event|4|||
150044984|NCT00478023|541304246|FG000|Overall Study|Death|1|||
149889795|NCT03367819|540725304|FG000|Overall Study|Progressive Disease|15|||
149889796|NCT03367819|540725305|FG001|Overall Study|Progressive Disease|13|||
149889797|NCT03367819|540725304|FG000|Overall Study|Withdrawal by Subject|1|||
149889798|NCT03367819|540725305|FG001|Overall Study|Withdrawal by Subject|0|||
149889799|NCT03367819|540725304|FG000|Overall Study|Other|4|||
149889800|NCT03367819|540725305|FG001|Overall Study|Other|2|||
149889801|NCT00550459|540725306|FG000|Overall Study|Adverse Event|0|||
149889802|NCT00550459|540725307|FG001|Overall Study|Adverse Event|2|||
149889803|NCT00550459|540725306|FG000|Overall Study|Withdrawal by Subject|1|||
149889804|NCT00550459|540725307|FG001|Overall Study|Withdrawal by Subject|1|||
149889805|NCT02404805|540725308|FG000|Overall Study|Withdrawal by Subject|1|||
149889806|NCT02404805|540725309|FG001|Overall Study|Withdrawal by Subject|0|||
149889807|NCT02404805|540725310|FG002|Overall Study|Withdrawal by Subject|0|||
149889808|NCT02404805|540725311|FG003|Overall Study|Withdrawal by Subject|0|||
149889809|NCT02404805|540725312|FG004|Overall Study|Withdrawal by Subject|0|||
149889810|NCT02404805|540725313|FG005|Overall Study|Withdrawal by Subject|0|||
149889811|NCT01173523|540727176|FG000|Overall Study|Clinical Progression|1|||
149889812|NCT01173523|540727177|FG001|Overall Study|Clinical Progression|1|||
149889813|NCT01173523|540727176|FG000|Overall Study|Progressive Disease|10|||
149889814|NCT01173523|540727177|FG001|Overall Study|Progressive Disease|8|||
149889815|NCT01173523|540727176|FG000|Overall Study|Other|2|||
149889816|NCT01173523|540727177|FG001|Overall Study|Other|3|||
149889817|NCT02302833|540727182|FG000|Overall Study|Lost to Follow-up|3|||
149889818|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
149889819|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
149889820|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
149889821|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
149889822|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
149889823|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
149889824|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
149889825|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
149889826|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
149889827|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
149967593|NCT00725985|541017931|FG006|OLMP (Up to 96 Weeks)|Death|0|||
149967594|NCT00725985|541017932|FG007|OLMP (Up to 96 Weeks)|Death|0|||
149889828|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
149967595|NCT00725985|541017933|FG008|OLMP (Up to 96 Weeks)|Death|0|||
149967596|NCT00725985|541017934|FG009|OLMP (Up to 96 Weeks)|Death|0|||
149967597|NCT00725985|541017935|FG010|OLMP (Up to 96 Weeks)|Death|0|||
149967598|NCT00725985|541017936|FG011|OLMP (Up to 96 Weeks)|Death|0|||
149967599|NCT00725985|541017925|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967600|NCT00725985|541017926|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967601|NCT00725985|541017927|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967602|NCT00725985|541017928|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
149967603|NCT00725985|541017929|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967604|NCT00725985|541017930|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967605|NCT00725985|541017931|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967606|NCT00725985|541017932|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967607|NCT00725985|541017933|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967608|NCT00725985|541017934|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967609|NCT00725985|541017935|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967610|NCT00725985|541017936|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
149967611|NCT00725985|541017925|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967612|NCT00725985|541017926|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967613|NCT00725985|541017927|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967614|NCT00725985|541017928|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967615|NCT00725985|541017929|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967616|NCT00725985|541017930|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
149967617|NCT00725985|541017931|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967618|NCT00725985|541017932|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967619|NCT00725985|541017933|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967620|NCT00725985|541017934|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967621|NCT00725985|541017935|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967622|NCT00725985|541017936|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
149967623|NCT00725985|541017925|FG000|OLMP (Up to 96 Weeks)|Other|0|||
149967624|NCT00725985|541017926|FG001|OLMP (Up to 96 Weeks)|Other|0|||
149967625|NCT00725985|541017927|FG002|OLMP (Up to 96 Weeks)|Other|0|||
149967626|NCT00725985|541017928|FG003|OLMP (Up to 96 Weeks)|Other|15|||
149889829|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
149889830|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
149967627|NCT00725985|541017929|FG004|OLMP (Up to 96 Weeks)|Other|20|||
149967628|NCT00725985|541017930|FG005|OLMP (Up to 96 Weeks)|Other|44|||
149967629|NCT00725985|541017931|FG006|OLMP (Up to 96 Weeks)|Other|0|||
149889831|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
149889832|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
149889833|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
149889834|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
149889835|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
149889836|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
149889837|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
149889838|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
149889839|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
149889840|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
149889841|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
149889842|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
149889843|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
149889844|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
149889845|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
149889846|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
149889847|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
149889848|NCT04429503|540727183|FG000|Main Study (Up to Wk 96)|Death|9|||
149889849|NCT04429503|540727184|FG001|Main Study (Up to Wk 96)|Death|18|||
149889850|NCT04429503|540727185|FG002|Main Study (Up to Wk 96)|Death|5|||
149889851|NCT04429503|540727186|FG003|Main Study (Up to Wk 96)|Death|0|||
149889852|NCT04429503|540727187|FG004|Main Study (Up to Wk 96)|Death|0|||
149889853|NCT04429503|540727188|FG005|Main Study (Up to Wk 96)|Death|0|||
149889854|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
149889855|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
149889856|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
149889857|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
149889858|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
149889859|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
149889860|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
149889861|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
149889862|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
149889863|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
149889864|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
149889865|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
149889866|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
149889867|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
149889868|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
149889869|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
149889870|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
149889871|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
149889872|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
149889873|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
149889874|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
149889875|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
149889876|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
149889877|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
149889878|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
149889879|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
149889880|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
149889881|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
149889882|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
149889883|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
149889884|NCT04429503|540727183|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
149889885|NCT04429503|540727184|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
149889886|NCT04429503|540727185|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
149889887|NCT04429503|540727186|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
149889888|NCT04429503|540727187|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
149889889|NCT04429503|540727188|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
149889890|NCT05516108|540727189|FG000|Overall Study|Time Commitment|3|||
149889891|NCT05516108|540727190|FG001|Overall Study|Time Commitment|1|||
149889892|NCT05516108|540727189|FG000|Overall Study|Reason Unknown|2|||
149967630|NCT00725985|541017932|FG007|OLMP (Up to 96 Weeks)|Other|0|||
149967631|NCT00725985|541017933|FG008|OLMP (Up to 96 Weeks)|Other|0|||
149967632|NCT00725985|541017934|FG009|OLMP (Up to 96 Weeks)|Other|0|||
149967633|NCT00725985|541017935|FG010|OLMP (Up to 96 Weeks)|Other|0|||
150175831|NCT04975308|541779935|FG000|Overall Study|On study treatment (Ongoing)|65|||
149889893|NCT05516108|540727190|FG001|Overall Study|Reason Unknown|4|||
149889894|NCT02717507|540727191|FG000|Overall Study|Lost to Follow-up|5|||
149889895|NCT02717507|540727192|FG001|Overall Study|Lost to Follow-up|8|||
149889896|NCT02717507|540727191|FG000|Overall Study|Pregnancy|1|||
149889897|NCT02717507|540727192|FG001|Overall Study|Pregnancy|1|||
149889898|NCT02717507|540727191|FG000|Overall Study|Protocol Violation|2|||
149889899|NCT02717507|540727192|FG001|Overall Study|Protocol Violation|2|||
149889900|NCT02717507|540727191|FG000|Overall Study|Withdrawal by Subject|20|||
149889901|NCT02717507|540727192|FG001|Overall Study|Withdrawal by Subject|20|||
149889902|NCT02717507|540727191|FG000|Overall Study|Relapse|1|||
149889903|NCT02717507|540727192|FG001|Overall Study|Relapse|1|||
149889904|NCT02717507|540727191|FG000|Overall Study|Cardiac Event|2|||
149889905|NCT02717507|540727192|FG001|Overall Study|Cardiac Event|6|||
149889906|NCT05017246|540727193|FG000|Overall Study|Withdrawal by Subject|5|||
149889907|NCT05017246|540727194|FG001|Overall Study|Withdrawal by Subject|3|||
149889908|NCT05017246|540727193|FG000|Overall Study|Determined to be ineligible|0|||
149889909|NCT05017246|540727194|FG001|Overall Study|Determined to be ineligible|1|||
149889910|NCT05017246|540727193|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
149889911|NCT05017246|540727194|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
149889912|NCT05017246|540727193|FG000|Overall Study|Technical failure|1|||
149889913|NCT05017246|540727194|FG001|Overall Study|Technical failure|3|||
149889914|NCT00709995|540727195|FG000|Overall Study|Adverse Event|4|||
149967634|NCT00725985|541017936|FG011|OLMP (Up to 96 Weeks)|Other|0|||
149967635|NCT00725985|541017925|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149889915|NCT00709995|540727196|FG001|Overall Study|Adverse Event|2|||
149967636|NCT00725985|541017926|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967637|NCT00725985|541017927|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967638|NCT00725985|541017928|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967639|NCT00725985|541017929|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149889916|NCT00709995|540727195|FG000|Overall Study|Withdrawal by Subject|1|||
149889917|NCT00709995|540727196|FG001|Overall Study|Withdrawal by Subject|3|||
149889918|NCT02003209|540727204|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
150044985|NCT00478023|541304247|FG001|Overall Study|Death|0|||
150044986|NCT00478023|541304248|FG002|Overall Study|Death|0|||
150044987|NCT00478023|541304249|FG003|Overall Study|Death|0|||
150044988|NCT00478023|541304250|FG004|Overall Study|Death|0|||
149889919|NCT02003209|540727205|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
150044989|NCT00478023|541304246|FG000|Overall Study|Lack of Efficacy|11|||
149889920|NCT00638508|540727206|FG000|Overall Study|Physician Decision|5|||
149889921|NCT00638508|540727207|FG001|Overall Study|Physician Decision|2|||
149889922|NCT00485264|540727208|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
149889923|NCT00485264|540727209|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
149889924|NCT00485264|540727210|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
149889925|NCT00485264|540727211|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
149889926|NCT00485264|540727212|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
149889927|NCT00485264|540727213|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
149889928|NCT00485264|540727208|FG000|Overall Study|Death|1|||
149889929|NCT00485264|540727209|FG001|Overall Study|Death|0|||
149889930|NCT00485264|540727210|FG002|Overall Study|Death|0|||
149889931|NCT00485264|540727211|FG003|Overall Study|Death|0|||
149889932|NCT00485264|540727212|FG004|Overall Study|Death|1|||
149889933|NCT00485264|540727213|FG005|Overall Study|Death|0|||
149889934|NCT00485264|540727208|FG000|Overall Study|Adverse Event|1|||
149889935|NCT00485264|540727209|FG001|Overall Study|Adverse Event|0|||
149889936|NCT00485264|540727210|FG002|Overall Study|Adverse Event|2|||
149889937|NCT00485264|540727211|FG003|Overall Study|Adverse Event|3|||
149889938|NCT00485264|540727212|FG004|Overall Study|Adverse Event|1|||
149889939|NCT00485264|540727213|FG005|Overall Study|Adverse Event|3|||
149889940|NCT00485264|540727208|FG000|Overall Study|Pregnancy|4|||
149889941|NCT00485264|540727209|FG001|Overall Study|Pregnancy|0|||
149889942|NCT00485264|540727210|FG002|Overall Study|Pregnancy|0|||
149889943|NCT00485264|540727211|FG003|Overall Study|Pregnancy|0|||
149889944|NCT00485264|540727212|FG004|Overall Study|Pregnancy|0|||
149889945|NCT00485264|540727213|FG005|Overall Study|Pregnancy|0|||
149889946|NCT00485264|540727208|FG000|Overall Study|Disallowed Medication|0|||
149889947|NCT00485264|540727209|FG001|Overall Study|Disallowed Medication|0|||
149889948|NCT00485264|540727210|FG002|Overall Study|Disallowed Medication|0|||
149889949|NCT00485264|540727211|FG003|Overall Study|Disallowed Medication|0|||
149889950|NCT00485264|540727212|FG004|Overall Study|Disallowed Medication|0|||
149889951|NCT00485264|540727213|FG005|Overall Study|Disallowed Medication|1|||
150044990|NCT00478023|541304247|FG001|Overall Study|Lack of Efficacy|10|||
150044991|NCT00478023|541304248|FG002|Overall Study|Lack of Efficacy|4|||
150044992|NCT00478023|541304249|FG003|Overall Study|Lack of Efficacy|5|||
150044993|NCT00478023|541304250|FG004|Overall Study|Lack of Efficacy|41|||
150044994|NCT00478023|541304246|FG000|Overall Study|Lost to Follow-up|3|||
150044995|NCT00478023|541304247|FG001|Overall Study|Lost to Follow-up|1|||
150044996|NCT00478023|541304248|FG002|Overall Study|Lost to Follow-up|1|||
150044997|NCT00478023|541304249|FG003|Overall Study|Lost to Follow-up|1|||
150044998|NCT00478023|541304250|FG004|Overall Study|Lost to Follow-up|0|||
150044999|NCT00478023|541304246|FG000|Overall Study|Withdrawal by Subject|2|||
150045000|NCT00478023|541304247|FG001|Overall Study|Withdrawal by Subject|3|||
150045001|NCT00478023|541304248|FG002|Overall Study|Withdrawal by Subject|2|||
150045002|NCT00478023|541304249|FG003|Overall Study|Withdrawal by Subject|4|||
150045003|NCT00478023|541304250|FG004|Overall Study|Withdrawal by Subject|5|||
150045004|NCT00478023|541304246|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
150045005|NCT00478023|541304247|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
150045006|NCT00478023|541304248|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
150045007|NCT00478023|541304249|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
150045008|NCT00478023|541304250|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
150045009|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
150045010|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
149889952|NCT00485264|540727208|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
150045011|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
150045012|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
150045013|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045014|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045015|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045016|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
149889953|NCT00485264|540727209|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
150045017|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
150045018|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
149889954|NCT00485264|540727210|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
149889955|NCT00485264|540727211|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
149889956|NCT00485264|540727212|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
149889957|NCT00485264|540727213|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
149889958|NCT00485264|540727208|FG000|Overall Study|Lack of Efficacy|0|||
149889959|NCT00485264|540727209|FG001|Overall Study|Lack of Efficacy|1|||
149889960|NCT00485264|540727210|FG002|Overall Study|Lack of Efficacy|0|||
149889961|NCT00485264|540727211|FG003|Overall Study|Lack of Efficacy|0|||
149889962|NCT00485264|540727212|FG004|Overall Study|Lack of Efficacy|0|||
149889963|NCT00485264|540727213|FG005|Overall Study|Lack of Efficacy|0|||
149889964|NCT00485264|540727208|FG000|Overall Study|Guardian Consent Withdrawn|1|||
149889965|NCT00485264|540727209|FG001|Overall Study|Guardian Consent Withdrawn|0|||
149889966|NCT00485264|540727210|FG002|Overall Study|Guardian Consent Withdrawn|0|||
149889967|NCT00485264|540727211|FG003|Overall Study|Guardian Consent Withdrawn|0|||
149889968|NCT00485264|540727212|FG004|Overall Study|Guardian Consent Withdrawn|1|||
149889969|NCT00485264|540727213|FG005|Overall Study|Guardian Consent Withdrawn|0|||
149889970|NCT00485264|540727208|FG000|Overall Study|Physician Decision|0|||
149889971|NCT00485264|540727209|FG001|Overall Study|Physician Decision|2|||
149889972|NCT00485264|540727210|FG002|Overall Study|Physician Decision|0|||
149889973|NCT00485264|540727211|FG003|Overall Study|Physician Decision|0|||
149889974|NCT00485264|540727212|FG004|Overall Study|Physician Decision|0|||
149889975|NCT00485264|540727213|FG005|Overall Study|Physician Decision|0|||
149889976|NCT00485264|540727208|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
149889977|NCT00485264|540727209|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
149889978|NCT00485264|540727210|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
149889979|NCT00485264|540727211|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
149889980|NCT00485264|540727212|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
149889981|NCT00485264|540727213|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
149889982|NCT00485264|540727208|FG000|Overall Study|Not Able to Attend Clinic|5|||
149889983|NCT00485264|540727209|FG001|Overall Study|Not Able to Attend Clinic|0|||
149889984|NCT00485264|540727210|FG002|Overall Study|Not Able to Attend Clinic|0|||
149889985|NCT00485264|540727211|FG003|Overall Study|Not Able to Attend Clinic|1|||
149889986|NCT00485264|540727212|FG004|Overall Study|Not Able to Attend Clinic|1|||
149889987|NCT00485264|540727213|FG005|Overall Study|Not Able to Attend Clinic|2|||
149889988|NCT00485264|540727208|FG000|Overall Study|Non-Compliant|17|||
149889989|NCT00485264|540727209|FG001|Overall Study|Non-Compliant|2|||
149889990|NCT00485264|540727210|FG002|Overall Study|Non-Compliant|1|||
149889991|NCT00485264|540727211|FG003|Overall Study|Non-Compliant|0|||
149889992|NCT00485264|540727212|FG004|Overall Study|Non-Compliant|1|||
149889993|NCT00485264|540727213|FG005|Overall Study|Non-Compliant|0|||
149889994|NCT00485264|540727208|FG000|Overall Study|Lost to Follow-up|2|||
149889995|NCT00485264|540727209|FG001|Overall Study|Lost to Follow-up|1|||
149889996|NCT00485264|540727210|FG002|Overall Study|Lost to Follow-up|1|||
149889997|NCT00485264|540727211|FG003|Overall Study|Lost to Follow-up|0|||
149889998|NCT00485264|540727212|FG004|Overall Study|Lost to Follow-up|0|||
149889999|NCT00485264|540727213|FG005|Overall Study|Lost to Follow-up|1|||
149890000|NCT00485264|540727208|FG000|Overall Study|Other Reason|3|||
149890001|NCT00485264|540727209|FG001|Overall Study|Other Reason|0|||
149890002|NCT00485264|540727210|FG002|Overall Study|Other Reason|0|||
149890003|NCT00485264|540727211|FG003|Overall Study|Other Reason|0|||
149890004|NCT00485264|540727212|FG004|Overall Study|Other Reason|0|||
149890005|NCT00485264|540727213|FG005|Overall Study|Other Reason|0|||
149890006|NCT03500198|540727214|FG000|Overall Study|Lost to Follow-up|0|||
149890007|NCT03500198|540727215|FG001|Overall Study|Lost to Follow-up|1|||
149890008|NCT01514461|540727216|FG000|Overall Study|Adverse Event|2|||
149890009|NCT01514461|540727217|FG001|Overall Study|Adverse Event|1|||
149890010|NCT01514461|540727218|FG002|Overall Study|Adverse Event|3|||
149890011|NCT01514461|540727216|FG000|Overall Study|Physician Decision|1|||
149890012|NCT01514461|540727217|FG001|Overall Study|Physician Decision|1|||
149890013|NCT01514461|540727218|FG002|Overall Study|Physician Decision|0|||
149890014|NCT01514461|540727216|FG000|Overall Study|Patient/guardian decision|1|||
149890015|NCT01514461|540727217|FG001|Overall Study|Patient/guardian decision|1|||
149890016|NCT01514461|540727218|FG002|Overall Study|Patient/guardian decision|1|||
149890017|NCT01514461|540727216|FG000|Overall Study|Death|1|||
149890018|NCT01514461|540727217|FG001|Overall Study|Death|0|||
149890019|NCT01514461|540727218|FG002|Overall Study|Death|0|||
149890020|NCT03499067|540727219|FG000|First Intervention|Physician Decision|2|||
149890021|NCT03499067|540727220|FG001|First Intervention|Physician Decision|1|||
149890022|NCT03499067|540727219|FG000|First Intervention|Withdrawal by Subject|3|||
149890023|NCT03499067|540727220|FG001|First Intervention|Withdrawal by Subject|6|||
149890024|NCT00595621|540727226|FG000|Open Label Run in|Adverse Event|1|||
149890025|NCT00595621|540727227|FG001|Open Label Run in|Adverse Event|0|||
149890026|NCT00595621|540727226|FG000|Open Label Run in|Physician Decision|1|||
149890027|NCT00595621|540727227|FG001|Open Label Run in|Physician Decision|0|||
149890028|NCT00595621|540727226|FG000|Open Label Run in|Withdrawal by Subject|1|||
149890029|NCT00595621|540727227|FG001|Open Label Run in|Withdrawal by Subject|0|||
149890030|NCT00595621|540727226|FG000|Randomization and Study|Adverse Event|2|||
149890031|NCT00595621|540727227|FG001|Randomization and Study|Adverse Event|0|||
149967640|NCT00725985|541017930|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149890032|NCT00595621|540727226|FG000|Randomization and Study|Withdrawal by Subject|0|||
149890033|NCT00595621|540727227|FG001|Randomization and Study|Withdrawal by Subject|1|||
149890034|NCT00324987|540727228|FG000|Overall Study|Adverse Event|2|||
149890035|NCT00324987|540727229|FG001|Overall Study|Adverse Event|1|||
149890036|NCT00324987|540727228|FG000|Overall Study|Withdrawal by Subject|1|||
149890037|NCT00324987|540727229|FG001|Overall Study|Withdrawal by Subject|1|||
149890038|NCT00324987|540727228|FG000|Overall Study|Progression|1|||
149890039|NCT00324987|540727229|FG001|Overall Study|Progression|1|||
149890040|NCT00324987|540727228|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
149890041|NCT00324987|540727229|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
149890042|NCT00897715|540727233|FG000|Overall Study|Lost to Follow-up|0|||
149890043|NCT00897715|540727234|FG001|Overall Study|Lost to Follow-up|1|||
149890044|NCT00897715|540727233|FG000|Overall Study|Physician Decision|1|||
149890045|NCT00897715|540727234|FG001|Overall Study|Physician Decision|0|||
149890046|NCT00897715|540727233|FG000|Overall Study|increased risk of infection|1|||
149890047|NCT00897715|540727234|FG001|Overall Study|increased risk of infection|0|||
149890048|NCT00513240|540727236|FG000|Overall Study|Did not have intended surgery|3|||
149890049|NCT00513240|540727237|FG001|Overall Study|Did not have intended surgery|0|||
149890050|NCT00513240|540727236|FG000|Overall Study|Death|3|||
149890051|NCT00513240|540727237|FG001|Overall Study|Death|3|||
149890052|NCT00513240|540727236|FG000|Overall Study|Withdrawal by Subject|7|||
149890053|NCT00513240|540727237|FG001|Overall Study|Withdrawal by Subject|4|||
149890054|NCT02714218|540727238|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149890055|NCT02714218|540727239|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149890056|NCT02714218|540727240|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149890057|NCT02714218|540727238|FG000|Pre-Treatment Period|Other reasons|0|||
149890058|NCT02714218|540727239|FG001|Pre-Treatment Period|Other reasons|1|||
149890059|NCT02714218|540727240|FG002|Pre-Treatment Period|Other reasons|0|||
149890060|NCT02714218|540727238|FG000|Treatment Period|Disease Progression|55|||
149890061|NCT02714218|540727239|FG001|Treatment Period|Disease Progression|52|||
149890062|NCT02714218|540727240|FG002|Treatment Period|Disease Progression|14|||
149890063|NCT02714218|540727238|FG000|Treatment Period|Study drug toxicity|46|||
149890064|NCT02714218|540727239|FG001|Treatment Period|Study drug toxicity|70|||
149890065|NCT02714218|540727240|FG002|Treatment Period|Study drug toxicity|6|||
149890066|NCT02714218|540727238|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
149890067|NCT02714218|540727239|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
149890068|NCT02714218|540727240|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
149890069|NCT02714218|540727238|FG000|Treatment Period|Request to discontinue treatment|1|||
149890070|NCT02714218|540727239|FG001|Treatment Period|Request to discontinue treatment|4|||
149890071|NCT02714218|540727240|FG002|Treatment Period|Request to discontinue treatment|1|||
149890072|NCT02714218|540727238|FG000|Treatment Period|Participant withdrew consent|2|||
149890073|NCT02714218|540727239|FG001|Treatment Period|Participant withdrew consent|2|||
149890074|NCT02714218|540727240|FG002|Treatment Period|Participant withdrew consent|0|||
149890075|NCT02714218|540727238|FG000|Treatment Period|Maximum clinical benefit|4|||
149890076|NCT02714218|540727239|FG001|Treatment Period|Maximum clinical benefit|2|||
149890077|NCT02714218|540727240|FG002|Treatment Period|Maximum clinical benefit|0|||
149890078|NCT02714218|540727238|FG000|Treatment Period|Administrative reason by sponsor|2|||
149890079|NCT02714218|540727239|FG001|Treatment Period|Administrative reason by sponsor|1|||
149890080|NCT02714218|540727240|FG002|Treatment Period|Administrative reason by sponsor|0|||
149890081|NCT02714218|540727238|FG000|Treatment Period|Other reasons|6|||
149890082|NCT02714218|540727239|FG001|Treatment Period|Other reasons|6|||
149890083|NCT02714218|540727240|FG002|Treatment Period|Other reasons|0|||
149890084|NCT02714218|540727238|FG000|Treatment Period|Completed treatment as per protocol|36|||
149890085|NCT02714218|540727239|FG001|Treatment Period|Completed treatment as per protocol|27|||
149890086|NCT02714218|540727240|FG002|Treatment Period|Completed treatment as per protocol|3|||
149890087|NCT02714218|540727238|FG000|Treatment Period|Not reported|9|||
149890088|NCT02714218|540727239|FG001|Treatment Period|Not reported|6|||
149890089|NCT02714218|540727240|FG002|Treatment Period|Not reported|0|||
149890090|NCT01930162|540727243|FG000|Overall Study|Abnormal test procedure result(s)|4|||
149890091|NCT01930162|540727243|FG000|Overall Study|Death|1|||
149890092|NCT02550561|540727244|FG000|Overall Study|Lost to Follow-up|5|||
149890093|NCT02550561|540727244|FG000|Overall Study|Withdrawal by Subject|1|||
149890094|NCT01960413|540727248|FG000|Overall Study|Withdrawal by Subject|1|||
149890095|NCT01960413|540727249|FG001|Overall Study|Withdrawal by Subject|1|||
149890096|NCT01960413|540727248|FG000|Overall Study|Physician Decision|1|||
149890097|NCT01960413|540727249|FG001|Overall Study|Physician Decision|0|||
149890098|NCT01960413|540727248|FG000|Overall Study|Lost to Follow-up|2|||
149890099|NCT01960413|540727249|FG001|Overall Study|Lost to Follow-up|0|||
149967641|NCT00725985|541017931|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967642|NCT00725985|541017932|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
149890100|NCT00791778|540727250|FG000|Double-blind Treatment|Adverse Event|49|||
149890101|NCT00791778|540727251|FG001|Double-blind Treatment|Adverse Event|9|||
149890102|NCT00791778|540727250|FG000|Double-blind Treatment|Physician Decision|6|||
149890103|NCT00791778|540727251|FG001|Double-blind Treatment|Physician Decision|26|||
149890104|NCT00791778|540727250|FG000|Double-blind Treatment|Protocol Violation|0|||
149890105|NCT00791778|540727251|FG001|Double-blind Treatment|Protocol Violation|4|||
149890106|NCT00791778|540727250|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
149890107|NCT00791778|540727251|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
149890108|NCT00791778|540727250|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
149890109|NCT00791778|540727251|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
149890110|NCT00791778|540727250|FG000|Follow-up|Withdrawal by Subject|3|||
149890111|NCT00791778|540727251|FG001|Follow-up|Withdrawal by Subject|0|||
149890112|NCT00791778|540727250|FG000|Follow-up|Lost to Follow-up|2|||
149890113|NCT00791778|540727251|FG001|Follow-up|Lost to Follow-up|1|||
149890114|NCT00931411|540727254|FG000|First Intervention - 42 Days|Adverse Event|2|||
149890115|NCT00931411|540727255|FG001|First Intervention - 42 Days|Adverse Event|3|||
149890116|NCT00931411|540727254|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
149890117|NCT00931411|540727255|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
149890118|NCT00931411|540727254|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
149890119|NCT00931411|540727255|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
149890120|NCT01949662|540727256|FG000|Overall Study|Death|9|||
149890121|NCT01949662|540727257|FG001|Overall Study|Death|7|||
149890122|NCT01949662|540727256|FG000|Overall Study|Discharged before an agitation event|8|||
149890123|NCT01949662|540727257|FG001|Overall Study|Discharged before an agitation event|3|||
149890124|NCT01949662|540727256|FG000|Overall Study|Dropped out|1|||
149890125|NCT01949662|540727257|FG001|Overall Study|Dropped out|3|||
149890126|NCT01949662|540727256|FG000|Overall Study|Ineligible|0|||
149890127|NCT01949662|540727257|FG001|Overall Study|Ineligible|1|||
149890128|NCT02291237|540727258|FG000|Overall Study|Study Terminated by Sponsor|72|||
149890129|NCT02291237|540727259|FG001|Overall Study|Study Terminated by Sponsor|67|||
149890130|NCT02291237|540727258|FG000|Overall Study|Adverse Event|1|||
149890131|NCT02291237|540727259|FG001|Overall Study|Adverse Event|3|||
149890132|NCT02291237|540727258|FG000|Overall Study|Investigator's Discretion|0|||
149890133|NCT02291237|540727259|FG001|Overall Study|Investigator's Discretion|3|||
149890134|NCT02291237|540727258|FG000|Overall Study|Withdrew Consent|11|||
149890135|NCT02291237|540727259|FG001|Overall Study|Withdrew Consent|11|||
149890136|NCT02291237|540727258|FG000|Overall Study|Lost to Follow-up|0|||
149890137|NCT02291237|540727259|FG001|Overall Study|Lost to Follow-up|2|||
149890138|NCT02291237|540727258|FG000|Overall Study|Subject Required Prohibited Medication|2|||
149890139|NCT02291237|540727259|FG001|Overall Study|Subject Required Prohibited Medication|0|||
149890140|NCT01478373|540727261|FG000|Treatment Phase|Protocol Violation|1|||
149890141|NCT01478373|540727261|FG000|Survival Phase|Adverse Event|8|||
149890142|NCT01478373|540727261|FG000|Survival Phase|Protocol Violation|1|||
149890143|NCT01478373|540727261|FG000|Survival Phase|crossover to another study|2|||
149890144|NCT01478373|540727261|FG000|Survival Phase|Progressive Disease|27|||
149890145|NCT01408043|540727264|FG000|Overall Study|unable to collect cells|1|||
149890146|NCT02552121|540727267|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
149890147|NCT02552121|540727268|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149967643|NCT00725985|541017933|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967644|NCT00725985|541017934|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967645|NCT00725985|541017935|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967646|NCT00725985|541017936|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
149967647|NCT00725985|541017925|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149890148|NCT02552121|540727269|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890149|NCT02552121|540727270|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890150|NCT02552121|540727271|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890151|NCT02552121|540727272|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890152|NCT02552121|540727273|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890153|NCT02552121|540727274|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
149890154|NCT02552121|540727267|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
149890155|NCT02552121|540727268|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890156|NCT02552121|540727269|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890157|NCT02552121|540727270|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890158|NCT02552121|540727271|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890159|NCT02552121|540727272|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890160|NCT02552121|540727273|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890161|NCT02552121|540727274|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
149890162|NCT02552121|540727267|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890163|NCT02552121|540727268|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
149890164|NCT02552121|540727269|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890165|NCT02552121|540727270|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890166|NCT02552121|540727271|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890167|NCT02552121|540727272|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890168|NCT02552121|540727273|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890169|NCT02552121|540727274|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
149890170|NCT02552121|540727267|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890171|NCT02552121|540727268|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
149890172|NCT02552121|540727269|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890173|NCT02552121|540727270|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890174|NCT02552121|540727271|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890175|NCT02552121|540727272|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890176|NCT02552121|540727273|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890177|NCT02552121|540727274|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
149890178|NCT02552121|540727267|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890179|NCT02552121|540727268|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
149890180|NCT02552121|540727269|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890181|NCT02552121|540727270|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890182|NCT02552121|540727271|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890183|NCT02552121|540727272|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890184|NCT02552121|540727273|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
149890185|NCT02552121|540727274|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
150175832|NCT04975308|541779936|FG001|Overall Study|On study treatment (Ongoing)|43|||
149890186|NCT02552121|540727267|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890187|NCT02552121|540727268|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
150045019|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
149890188|NCT02552121|540727269|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890189|NCT02552121|540727270|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890190|NCT02552121|540727271|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890191|NCT02552121|540727272|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890192|NCT02552121|540727273|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890193|NCT02552121|540727274|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
149890194|NCT02552121|540727267|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
149890195|NCT02552121|540727268|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
149890196|NCT02552121|540727269|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
149890197|NCT02552121|540727270|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
149890198|NCT02552121|540727271|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
149890199|NCT02552121|540727272|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
149890200|NCT02552121|540727273|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
149890201|NCT02552121|540727274|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
149890202|NCT02552121|540727267|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
149890203|NCT02552121|540727268|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
149890204|NCT02552121|540727269|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
149890205|NCT02552121|540727270|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
149890206|NCT02552121|540727271|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
149890207|NCT02552121|540727272|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
149890208|NCT02552121|540727273|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
149890209|NCT02552121|540727274|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
149890210|NCT02552121|540727267|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
149890211|NCT02552121|540727268|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
149890212|NCT02552121|540727269|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
149890213|NCT02552121|540727270|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
149890214|NCT02552121|540727271|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
149890215|NCT02552121|540727272|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
149890216|NCT02552121|540727273|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
149890217|NCT02552121|540727274|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
149890218|NCT02552121|540727267|FG000|Part 2: Cohort Expansion|Death|0|||
149890219|NCT02552121|540727268|FG001|Part 2: Cohort Expansion|Death|0|||
149890220|NCT02552121|540727269|FG002|Part 2: Cohort Expansion|Death|1|||
149890221|NCT02552121|540727270|FG003|Part 2: Cohort Expansion|Death|0|||
149890222|NCT02552121|540727271|FG004|Part 2: Cohort Expansion|Death|0|||
149890223|NCT02552121|540727272|FG005|Part 2: Cohort Expansion|Death|0|||
149890224|NCT02552121|540727273|FG006|Part 2: Cohort Expansion|Death|0|||
149890225|NCT02552121|540727274|FG007|Part 2: Cohort Expansion|Death|0|||
149890226|NCT01522456|540727275|FG000|Overall Study|Adverse Event|2|||
149890227|NCT01522456|540727275|FG000|Overall Study|Lost to Follow-up|2|||
149890228|NCT01522456|540727275|FG000|Overall Study|Withdrawal by Subject|2|||
149890229|NCT01522456|540727275|FG000|Overall Study|Pregnancy|1|||
149890230|NCT01522456|540727275|FG000|Overall Study|Tolerability Assessment|1|||
149890231|NCT04052620|540727276|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
149967648|NCT00725985|541017926|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967649|NCT00725985|541017927|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967650|NCT00725985|541017928|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967651|NCT00725985|541017929|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967652|NCT00725985|541017930|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967653|NCT00725985|541017931|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967654|NCT00725985|541017932|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967655|NCT00725985|541017933|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
149967656|NCT00725985|541017934|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967657|NCT00725985|541017935|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967658|NCT00725985|541017936|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
149967659|NCT00725985|541017925|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967660|NCT00725985|541017926|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967661|NCT00725985|541017927|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967662|NCT00725985|541017928|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967663|NCT00725985|541017929|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
150045020|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
150045021|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
149890232|NCT04052620|540727277|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
149890233|NCT04052620|540727276|FG000|Overall Study|Withdrawal by Subject|1|||
149890234|NCT04052620|540727277|FG001|Overall Study|Withdrawal by Subject|0|||
149890235|NCT04052620|540727276|FG000|Overall Study|Lost to Follow-up|1|||
149890236|NCT04052620|540727277|FG001|Overall Study|Lost to Follow-up|1|||
149890237|NCT04052620|540727276|FG000|Overall Study|Adverse Event|1|||
149890238|NCT04052620|540727277|FG001|Overall Study|Adverse Event|0|||
149967664|NCT00725985|541017930|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967665|NCT00725985|541017931|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
150175833|NCT04975308|541779937|FG002|Overall Study|On study treatment (Ongoing)|75|||
149890239|NCT04052620|540727276|FG000|Overall Study|Subject did not meet study Criteria|0|||
149890240|NCT04052620|540727277|FG001|Overall Study|Subject did not meet study Criteria|1|||
149890241|NCT04052620|540727276|FG000|Overall Study|Screened failure, randomized by mistake|0|||
149890242|NCT04052620|540727277|FG001|Overall Study|Screened failure, randomized by mistake|1|||
149890243|NCT04052620|540727276|FG000|Overall Study|Personal reasons|2|||
149890244|NCT04052620|540727277|FG001|Overall Study|Personal reasons|4|||
149890245|NCT04052620|540727276|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
149890246|NCT04052620|540727277|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
149890247|NCT02201784|540727279|FG000|Overall Study|Failure to achieve adequate block|2|||
149890248|NCT02201784|540727280|FG001|Overall Study|Failure to achieve adequate block|0|||
149890249|NCT00193050|540727281|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
149890250|NCT00193050|540727281|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
149890251|NCT00193050|540727281|FG000|Neoadjuvant Treatment|Physician Decision|2|||
149890252|NCT00193050|540727281|FG000|Neoadjuvant Treatment|Adverse Event|2|||
149890253|NCT00193050|540727281|FG000|Adjuvant|Physician Decision|5|||
149890254|NCT00193050|540727281|FG000|Adjuvant|Intercurrent Hospitalization|3|||
149890255|NCT00193050|540727281|FG000|Adjuvant|Lack of Efficacy|2|||
149890256|NCT02431364|540727282|FG000|Overall Study|Adverse Event|0|||
149890257|NCT02431364|540727283|FG001|Overall Study|Adverse Event|1|||
149890258|NCT02431364|540727284|FG002|Overall Study|Adverse Event|0|||
149890259|NCT02431364|540727285|FG003|Overall Study|Adverse Event|0|||
149890260|NCT02431364|540727286|FG004|Overall Study|Adverse Event|0|||
149890261|NCT02431364|540727282|FG000|Overall Study|Randomized but never treated|0|||
149890262|NCT02431364|540727283|FG001|Overall Study|Randomized but never treated|0|||
149890263|NCT02431364|540727284|FG002|Overall Study|Randomized but never treated|0|||
149890264|NCT02431364|540727285|FG003|Overall Study|Randomized but never treated|1|||
149890265|NCT02431364|540727286|FG004|Overall Study|Randomized but never treated|0|||
149890266|NCT00061932|540727287|FG000|Overall Study|Withdrawal by Subject|13|||
149890267|NCT00061932|540727288|FG001|Overall Study|Withdrawal by Subject|4|||
149890268|NCT00916383|540727289|FG000|Overall Study|Adverse Event|1|||
149890269|NCT00916383|540727289|FG000|Overall Study|Death|1|||
149890270|NCT00916383|540727289|FG000|Overall Study|Protocol Violation|1|||
149890271|NCT02899962|540727290|FG000|Open-label Phase|Adverse Event|2|||
149890272|NCT02899962|540727291|FG001|Open-label Phase|Adverse Event|0|||
149890273|NCT02899962|540727292|FG002|Open-label Phase|Adverse Event|0|||
149890274|NCT02899962|540727290|FG000|Open-label Phase|Lost to Follow-up|9|||
149890275|NCT02899962|540727291|FG001|Open-label Phase|Lost to Follow-up|0|||
149890276|NCT02899962|540727292|FG002|Open-label Phase|Lost to Follow-up|0|||
149890277|NCT02899962|540727290|FG000|Open-label Phase|Other reasons|9|||
149890278|NCT02899962|540727291|FG001|Open-label Phase|Other reasons|0|||
149890279|NCT02899962|540727292|FG002|Open-label Phase|Other reasons|0|||
149890280|NCT02899962|540727290|FG000|Open-label Phase|Withdrawal by Subject|7|||
149890281|NCT02899962|540727291|FG001|Open-label Phase|Withdrawal by Subject|0|||
149890282|NCT02899962|540727292|FG002|Open-label Phase|Withdrawal by Subject|0|||
149890283|NCT02899962|540727290|FG000|Maintenance Phase|Adverse Event|0|||
149890284|NCT02899962|540727291|FG001|Maintenance Phase|Adverse Event|2|||
149890285|NCT02899962|540727292|FG002|Maintenance Phase|Adverse Event|1|||
149890286|NCT02899962|540727290|FG000|Maintenance Phase|Death|0|||
149890287|NCT02899962|540727291|FG001|Maintenance Phase|Death|0|||
149890288|NCT02899962|540727292|FG002|Maintenance Phase|Death|1|||
149890289|NCT02899962|540727290|FG000|Maintenance Phase|Lack of Efficacy|0|||
149890290|NCT02899962|540727291|FG001|Maintenance Phase|Lack of Efficacy|20|||
149890291|NCT02899962|540727292|FG002|Maintenance Phase|Lack of Efficacy|16|||
149890292|NCT02899962|540727290|FG000|Maintenance Phase|Lost to Follow-up|0|||
149890293|NCT02899962|540727291|FG001|Maintenance Phase|Lost to Follow-up|12|||
149890294|NCT02899962|540727292|FG002|Maintenance Phase|Lost to Follow-up|14|||
149890295|NCT02899962|540727290|FG000|Maintenance Phase|Other reasons|0|||
149890296|NCT02899962|540727291|FG001|Maintenance Phase|Other reasons|9|||
149890297|NCT02899962|540727292|FG002|Maintenance Phase|Other reasons|13|||
149890298|NCT02899962|540727290|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
149890299|NCT02899962|540727291|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
149890300|NCT02899962|540727292|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
149890301|NCT02899962|540727290|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
149890302|NCT02899962|540727291|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
150175834|NCT04975308|541779935|FG000|Overall Study|Protocol Deviation|4|||
149890303|NCT02899962|540727292|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
149890304|NCT02899962|540727290|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149890305|NCT02899962|540727291|FG001|Maintenance Phase|Withdrawal by Subject|30|||
149890306|NCT02899962|540727292|FG002|Maintenance Phase|Withdrawal by Subject|36|||
149967666|NCT00725985|541017932|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
149967667|NCT00725985|541017933|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
149967668|NCT00725985|541017934|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967669|NCT00725985|541017935|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967670|NCT00725985|541017936|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
149967671|NCT00725985|541017925|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967672|NCT00725985|541017926|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967673|NCT00725985|541017927|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967674|NCT00725985|541017928|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967675|NCT00725985|541017929|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967676|NCT00725985|541017930|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967677|NCT00725985|541017931|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967678|NCT00725985|541017932|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967679|NCT00725985|541017933|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
149967680|NCT00725985|541017934|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
149967681|NCT00725985|541017935|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
149967682|NCT00725985|541017936|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
149967683|NCT02546323|541017937|FG000|Overall Study|Withdrawal by Subject|36|||
149967684|NCT02546323|541017938|FG001|Overall Study|Withdrawal by Subject|33|||
149967685|NCT02546323|541017937|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
149967686|NCT02546323|541017938|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
149967687|NCT02546323|541017937|FG000|Overall Study|Adverse Event|17|||
149967688|NCT02546323|541017938|FG001|Overall Study|Adverse Event|11|||
149967689|NCT02546323|541017937|FG000|Overall Study|Patient Specific Reasons|1|||
149967690|NCT02546323|541017938|FG001|Overall Study|Patient Specific Reasons|2|||
149967691|NCT02546323|541017937|FG000|Overall Study|Lost to Follow-up|2|||
149967692|NCT02546323|541017938|FG001|Overall Study|Lost to Follow-up|3|||
149967693|NCT02546323|541017937|FG000|Overall Study|Non-compliance with Study Drug|2|||
149967694|NCT02546323|541017938|FG001|Overall Study|Non-compliance with Study Drug|2|||
149967695|NCT02546323|541017937|FG000|Overall Study|Met Withdrawal Criteria|2|||
149967696|NCT02546323|541017938|FG001|Overall Study|Met Withdrawal Criteria|14|||
149967697|NCT04476784|541017939|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
149967698|NCT04476784|541017940|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
149967699|NCT00478257|541017941|FG000|Overall Study|Withdrawal by Subject|8|||
149967700|NCT00478257|541017942|FG001|Overall Study|Withdrawal by Subject|3|||
149967701|NCT06582732|541017943|FG000|Initial Study Period|Adverse Event|0|||
149967702|NCT06582732|541017944|FG001|Initial Study Period|Adverse Event|0|||
149967703|NCT06582732|541017945|FG002|Initial Study Period|Adverse Event|0|||
149967704|NCT06582732|541017946|FG003|Initial Study Period|Adverse Event|2|||
149967705|NCT06582732|541017947|FG004|Initial Study Period|Adverse Event|0|||
149967706|NCT06582732|541017948|FG005|Initial Study Period|Adverse Event|0|||
149967707|NCT06582732|541017949|FG006|Initial Study Period|Adverse Event|0|||
149967708|NCT06582732|541017943|FG000|Initial Study Period|Death|1|||
149967709|NCT06582732|541017944|FG001|Initial Study Period|Death|0|||
149967710|NCT06582732|541017945|FG002|Initial Study Period|Death|0|||
149967711|NCT06582732|541017946|FG003|Initial Study Period|Death|0|||
149967712|NCT06582732|541017947|FG004|Initial Study Period|Death|1|||
149967713|NCT06582732|541017948|FG005|Initial Study Period|Death|0|||
149967714|NCT06582732|541017949|FG006|Initial Study Period|Death|0|||
149967715|NCT06582732|541017943|FG000|Initial Study Period|Lost to Follow-up|0|||
149967716|NCT06582732|541017944|FG001|Initial Study Period|Lost to Follow-up|0|||
149967717|NCT06582732|541017945|FG002|Initial Study Period|Lost to Follow-up|2|||
149967718|NCT06582732|541017946|FG003|Initial Study Period|Lost to Follow-up|0|||
149967719|NCT06582732|541017947|FG004|Initial Study Period|Lost to Follow-up|0|||
149967720|NCT06582732|541017948|FG005|Initial Study Period|Lost to Follow-up|0|||
149967721|NCT06582732|541017949|FG006|Initial Study Period|Lost to Follow-up|0|||
149967722|NCT06582732|541017943|FG000|Initial Study Period|Withdrawal by Subject|0|||
149967723|NCT06582732|541017944|FG001|Initial Study Period|Withdrawal by Subject|1|||
150045022|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
150045023|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
150045024|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
149967724|NCT06582732|541017945|FG002|Initial Study Period|Withdrawal by Subject|0|||
149967725|NCT06582732|541017946|FG003|Initial Study Period|Withdrawal by Subject|1|||
149967726|NCT06582732|541017947|FG004|Initial Study Period|Withdrawal by Subject|3|||
149967727|NCT06582732|541017948|FG005|Initial Study Period|Withdrawal by Subject|1|||
149967728|NCT06582732|541017949|FG006|Initial Study Period|Withdrawal by Subject|2|||
149967729|NCT06582732|541017943|FG000|Initial Study Period|Moved Away|0|||
149967730|NCT06582732|541017944|FG001|Initial Study Period|Moved Away|0|||
149967731|NCT06582732|541017945|FG002|Initial Study Period|Moved Away|0|||
149967732|NCT06582732|541017946|FG003|Initial Study Period|Moved Away|0|||
149967733|NCT06582732|541017947|FG004|Initial Study Period|Moved Away|1|||
149967734|NCT06582732|541017948|FG005|Initial Study Period|Moved Away|0|||
149967735|NCT06582732|541017949|FG006|Initial Study Period|Moved Away|0|||
149967736|NCT04770285|541017950|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
149890307|NCT00258960|540727293|FG000|Overall Study|Death|2|||
149890308|NCT00258960|540727293|FG000|Overall Study|Disease Progression|7|||
149890309|NCT00258960|540727293|FG000|Overall Study|Adverse Event|4|||
149890310|NCT00258960|540727293|FG000|Overall Study|Physician Decision|1|||
149890311|NCT00258960|540727293|FG000|Overall Study|Withdrawal by Subject|1|||
149890312|NCT00258960|540727293|FG000|Overall Study|Mistake|2|||
149890313|NCT00473590|540727294|FG000|Overall Study|Adverse Event|3|||
149890314|NCT00473590|540727295|FG001|Overall Study|Adverse Event|3|||
149890315|NCT00473590|540727294|FG000|Overall Study|Death|4|||
149890316|NCT00473590|540727295|FG001|Overall Study|Death|2|||
149967737|NCT04770285|541017951|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
149890317|NCT00473590|540727294|FG000|Overall Study|Progression not resulting in death|24|||
149890318|NCT00473590|540727295|FG001|Overall Study|Progression not resulting in death|20|||
149890319|NCT00473590|540727294|FG000|Overall Study|Non-protocol-specified therapy|7|||
149890320|NCT00473590|540727295|FG001|Overall Study|Non-protocol-specified therapy|5|||
149890321|NCT00473590|540727294|FG000|Overall Study|Physician Decision|2|||
149890322|NCT00473590|540727295|FG001|Overall Study|Physician Decision|4|||
149890323|NCT00473590|540727294|FG000|Overall Study|Withdrawal by Subject|5|||
149890324|NCT00473590|540727295|FG001|Overall Study|Withdrawal by Subject|3|||
149890325|NCT00473590|540727294|FG000|Overall Study|Other|0|||
149967738|NCT04770285|541017950|FG000|Overall Study|Lack of Efficacy|0|||
149967739|NCT04770285|541017951|FG001|Overall Study|Lack of Efficacy|1|||
149890326|NCT00473590|540727295|FG001|Overall Study|Other|1|||
149890327|NCT01245283|540727298|FG000|Overall Study|Lost to Follow-up|14|||
149890328|NCT01245283|540727299|FG001|Overall Study|Lost to Follow-up|11|||
149890329|NCT01245283|540727300|FG002|Overall Study|Lost to Follow-up|11|||
149890330|NCT01610492|540727309|FG000|Overall Study|Adverse Event|1|||
149890331|NCT01610492|540727309|FG000|Overall Study|Lack of Efficacy|3|||
149967740|NCT04770285|541017950|FG000|Overall Study|Lost to Follow-up|11|||
149967741|NCT04770285|541017951|FG001|Overall Study|Lost to Follow-up|8|||
149890332|NCT01610492|540727309|FG000|Overall Study|Other: Reached stopping criteria|1|||
149890333|NCT01610492|540727309|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
149890334|NCT01757275|540727311|FG000|Overall Study|Lost to Follow-up|1|||
149890335|NCT01757275|540727312|FG001|Overall Study|Lost to Follow-up|2|||
149890336|NCT01757275|540727311|FG000|Overall Study|Adverse Event|3|||
149890337|NCT01757275|540727312|FG001|Overall Study|Adverse Event|3|||
149890338|NCT01757275|540727311|FG000|Overall Study|Withdrawal by Subject|2|||
149890339|NCT01757275|540727312|FG001|Overall Study|Withdrawal by Subject|4|||
149890340|NCT01757275|540727311|FG000|Overall Study|Not treated|3|||
149890341|NCT01757275|540727312|FG001|Overall Study|Not treated|4|||
149890342|NCT03093259|540727313|FG000|Overall Study|Adverse Event|1|||
149890343|NCT03093259|540727314|FG001|Overall Study|Adverse Event|0|||
149890344|NCT03093259|540727313|FG000|Overall Study|Withdrawal by Subject|1|||
149890345|NCT03093259|540727314|FG001|Overall Study|Withdrawal by Subject|0|||
149890346|NCT01821807|540727315|FG000|Overall Study|Lost to Follow-up|3|||
149890347|NCT01821807|540727316|FG001|Overall Study|Lost to Follow-up|1|||
149890348|NCT01401452|540727318|FG000|Overall Study|Adverse reaction|9|||
150045025|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
149890349|NCT01401452|540727318|FG000|Overall Study|Lost to Follow-up|12|||
149890350|NCT01401452|540727318|FG000|Overall Study|Lack of Efficacy|30|||
149890351|NCT01401452|540727318|FG000|Overall Study|Participant developed breast cancer|1|||
149890352|NCT01401452|540727318|FG000|Overall Study|Tx stopped due to financial reasons|1|||
149890353|NCT01401452|540727318|FG000|Overall Study|Tx stopped by psychiatrist|1|||
149890354|NCT01401452|540727318|FG000|Overall Study|No more visits within the 36 wk followup|4|||
149890355|NCT01401452|540727318|FG000|Overall Study|Subject did not come to follow up visits|2|||
149890356|NCT01401452|540727318|FG000|Overall Study|Subject didn't return for routine visits|1|||
149890357|NCT01401452|540727318|FG000|Overall Study|Subject moved to another city|1|||
149890358|NCT01401452|540727318|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
149890359|NCT01401452|540727318|FG000|Overall Study|Psoriatic arthritis|1|||
149890360|NCT01401452|540727318|FG000|Overall Study|Participant stopped Tx|2|||
149890361|NCT01401452|540727318|FG000|Overall Study|Discontinuation for personal reasons|1|||
149890362|NCT01401452|540727318|FG000|Overall Study|Treatment failure|1|||
149890363|NCT01401452|540727318|FG000|Overall Study|Unsatisfactory output|1|||
149890364|NCT01401452|540727318|FG000|Overall Study|Subject withdrew because of Tx success|1|||
149890365|NCT01401452|540727318|FG000|Overall Study|Subject chose to discontinue treatment|1|||
149890366|NCT01401452|540727318|FG000|Overall Study|Participant withdrew consent|1|||
149890367|NCT00584454|540727319|FG000|Overall Study|Adverse Event|1|||
149890368|NCT00584454|540727319|FG000|Overall Study|Relocation|1|||
149890369|NCT00584454|540727319|FG000|Overall Study|Clinical Hold|2|||
149890370|NCT01459783|540727321|FG000|Baseline to 6 Months|Death|1|||
149890371|NCT01459783|540727322|FG001|Baseline to 6 Months|Death|0|||
149890372|NCT01459783|540727321|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
149890373|NCT01459783|540727322|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
149890374|NCT01459783|540727321|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
149890375|NCT01459783|540727322|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
149890376|NCT01459783|540727321|FG000|6 Months to 12 Months|Death|0|||
149890377|NCT01459783|540727322|FG001|6 Months to 12 Months|Death|1|||
149890378|NCT01459783|540727321|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
149890379|NCT01459783|540727322|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
149890380|NCT01459783|540727321|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
149890381|NCT01459783|540727322|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
149890382|NCT01459783|540727321|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
149890383|NCT01459783|540727322|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
149890384|NCT02601014|540727323|FG000|Overall Study|Adverse Event|3|||
149890385|NCT02601014|540727324|FG001|Overall Study|Adverse Event|3|||
149890386|NCT02601014|540727323|FG000|Overall Study|Death|3|||
149890387|NCT02601014|540727324|FG001|Overall Study|Death|1|||
149890388|NCT02601014|540727323|FG000|Overall Study|Disease progression|4|||
149890389|NCT02601014|540727324|FG001|Overall Study|Disease progression|8|||
149890390|NCT00445146|540727328|FG000|Overall Study|Withdrew Consent|29|||
149890391|NCT00445146|540727328|FG000|Overall Study|Lack of Efficacy|28|||
149890392|NCT00445146|540727328|FG000|Overall Study|Investigator's Discretion|22|||
149890393|NCT00445146|540727328|FG000|Overall Study|Adverse Event|13|||
149890394|NCT00445146|540727328|FG000|Overall Study|Lost to Follow-up|13|||
149890395|NCT00445146|540727328|FG000|Overall Study|Death|9|||
149890396|NCT00445146|540727328|FG000|Overall Study|Protocol Violation|4|||
149890397|NCT00445146|540727328|FG000|Overall Study|Pregnancy|1|||
149890398|NCT06389487|540727330|FG000|Overall Study|Lost to Follow-up|9|||
149890399|NCT06389487|540727331|FG001|Overall Study|Lost to Follow-up|5|||
149890400|NCT06389487|540727332|FG002|Overall Study|Lost to Follow-up|13|||
149890401|NCT06389487|540727330|FG000|Overall Study|Protocol Violation|0|||
149890402|NCT06389487|540727331|FG001|Overall Study|Protocol Violation|0|||
149890403|NCT06389487|540727332|FG002|Overall Study|Protocol Violation|2|||
149890404|NCT06389487|540727330|FG000|Overall Study|Withdrawal by Subject|2|||
149890405|NCT06389487|540727331|FG001|Overall Study|Withdrawal by Subject|2|||
149890406|NCT06389487|540727332|FG002|Overall Study|Withdrawal by Subject|1|||
149890407|NCT06389487|540727330|FG000|Overall Study|Other|1|||
149890408|NCT06389487|540727331|FG001|Overall Study|Other|0|||
149890409|NCT06389487|540727332|FG002|Overall Study|Other|1|||
149890410|NCT00858273|540727333|FG000|Overall Study|Protocol Violation|3|||
149890411|NCT00858273|540727334|FG001|Overall Study|Protocol Violation|5|||
149890412|NCT03192488|540729344|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
149890413|NCT03192488|540729345|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
149890414|NCT03192488|540729346|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
149890415|NCT03192488|540729347|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
149890416|NCT03192488|540729348|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
149890417|NCT03192488|540729349|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
149890418|NCT03192488|540729344|FG000|Third Intervention (d1)|Adverse Event|0|||
149890419|NCT03192488|540729345|FG001|Third Intervention (d1)|Adverse Event|0|||
149890420|NCT03192488|540729346|FG002|Third Intervention (d1)|Adverse Event|0|||
149890421|NCT03192488|540729347|FG003|Third Intervention (d1)|Adverse Event|0|||
149890422|NCT03192488|540729348|FG004|Third Intervention (d1)|Adverse Event|1|||
149890423|NCT03192488|540729349|FG005|Third Intervention (d1)|Adverse Event|0|||
149890424|NCT02392481|540729351|FG000|Overall Study|Adverse Event|0|||
149890425|NCT02392481|540729352|FG001|Overall Study|Adverse Event|0|||
149890426|NCT02392481|540729353|FG002|Overall Study|Adverse Event|1|||
149890427|NCT02392481|540729354|FG003|Overall Study|Adverse Event|2|||
149890428|NCT02392481|540729351|FG000|Overall Study|Withdrawal by Subject|0|||
149890429|NCT02392481|540729352|FG001|Overall Study|Withdrawal by Subject|0|||
149890430|NCT02392481|540729353|FG002|Overall Study|Withdrawal by Subject|1|||
149890431|NCT02392481|540729354|FG003|Overall Study|Withdrawal by Subject|0|||
149890432|NCT03565900|540729356|FG000|Overall Study|Disposition Unknown|4|||
149890433|NCT03565900|540729357|FG001|Overall Study|Disposition Unknown|1|||
149890434|NCT03565900|540729356|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
149890435|NCT03565900|540729357|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
149890436|NCT03565900|540729356|FG000|Overall Study|Withdrawal by Subject|4|||
149890437|NCT03565900|540729357|FG001|Overall Study|Withdrawal by Subject|5|||
149890438|NCT03565900|540729356|FG000|Overall Study|Randomized By Mistake|0|||
149890439|NCT03565900|540729357|FG001|Overall Study|Randomized By Mistake|2|||
149890440|NCT03565900|540729356|FG000|Overall Study|Physician Decision|7|||
149890441|NCT03565900|540729357|FG001|Overall Study|Physician Decision|11|||
149890442|NCT03565900|540729356|FG000|Overall Study|Death|9|||
149890443|NCT03565900|540729357|FG001|Overall Study|Death|7|||
149890444|NCT01254643|540729358|FG000|Overall Study|Withdrawal by Subject|1|||
149890445|NCT03359850|540729361|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
149890446|NCT03359850|540729362|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
149890447|NCT03359850|540729361|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
149890448|NCT03359850|540729362|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
149890449|NCT03359850|540729361|FG000|Extension Phase (Up to 28 Months)|Death|2|||
149890450|NCT03359850|540729362|FG001|Extension Phase (Up to 28 Months)|Death|4|||
149890451|NCT03359850|540729361|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
149890452|NCT03359850|540729362|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
149890453|NCT03359850|540729361|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
149890454|NCT03359850|540729362|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
149890455|NCT03817125|540729377|FG000|Overall Study|Adverse Event|1|||
149890456|NCT03817125|540729378|FG001|Overall Study|Adverse Event|0|||
149890457|NCT03817125|540729377|FG000|Overall Study|Physician Decision|0|||
149890458|NCT03817125|540729378|FG001|Overall Study|Physician Decision|1|||
149890459|NCT03817125|540729377|FG000|Overall Study|Lack of Efficacy|1|||
149890460|NCT03817125|540729378|FG001|Overall Study|Lack of Efficacy|5|||
149890461|NCT00942084|540729379|FG000|Overall Study|Death|2|||
149890462|NCT01998919|540729380|FG000|Overall Study|Death|2|||
149890463|NCT01998919|540729381|FG001|Overall Study|Death|2|||
149890464|NCT01998919|540729380|FG000|Overall Study|Adverse Event|0|||
149890465|NCT01998919|540729381|FG001|Overall Study|Adverse Event|5|||
149967742|NCT04770285|541017950|FG000|Overall Study|Protocol Deviation|6|||
149967743|NCT04770285|541017951|FG001|Overall Study|Protocol Deviation|6|||
149967744|NCT04770285|541017950|FG000|Overall Study|Technical Problem|0|||
149967745|NCT04770285|541017951|FG001|Overall Study|Technical Problem|1|||
149967746|NCT04770285|541017950|FG000|Overall Study|Withdrawal by Subject|9|||
149967747|NCT04770285|541017951|FG001|Overall Study|Withdrawal by Subject|8|||
149967748|NCT04770285|541017950|FG000|Overall Study|Reason Not Specified|0|||
149967749|NCT04770285|541017951|FG001|Overall Study|Reason Not Specified|1|||
149967750|NCT05030766|541017952|FG000|Phase 1 Participants|Lost to Follow-up|12|||
149967751|NCT05030766|541017953|FG001|Phase 1 Participants|Lost to Follow-up|22|||
149967752|NCT05030766|541017954|FG002|Phase 1 Participants|Lost to Follow-up|0|||
149967753|NCT05030766|541017955|FG003|Phase 1 Participants|Lost to Follow-up|0|||
149967754|NCT05030766|541017952|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
149967755|NCT05030766|541017953|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
149890466|NCT01998919|540729380|FG000|Overall Study|Disease progression|31|||
149890467|NCT01998919|540729381|FG001|Overall Study|Disease progression|22|||
149890468|NCT01998919|540729380|FG000|Overall Study|Withdrawal by Subject|2|||
149890469|NCT01998919|540729381|FG001|Overall Study|Withdrawal by Subject|4|||
149890470|NCT01998919|540729380|FG000|Overall Study|Lost to Follow-up|2|||
149890471|NCT01998919|540729381|FG001|Overall Study|Lost to Follow-up|0|||
149890472|NCT01998919|540729380|FG000|Overall Study|Other|5|||
149890473|NCT01998919|540729381|FG001|Overall Study|Other|2|||
149890474|NCT02383017|540729382|FG000|Overall Study|Injury Sustained Outside Study|1|||
149890475|NCT02383017|540729383|FG001|Overall Study|Injury Sustained Outside Study|0|||
149890476|NCT02383017|540729382|FG000|Overall Study|Compliance|3|||
149890477|NCT02383017|540729383|FG001|Overall Study|Compliance|2|||
149890478|NCT02383017|540729382|FG000|Overall Study|Found to be Hypogonadal|1|||
149890479|NCT02383017|540729383|FG001|Overall Study|Found to be Hypogonadal|0|||
149890480|NCT01037218|540729386|FG000|Overall Study|Adverse Event|4|||
149890481|NCT01037218|540729387|FG001|Overall Study|Adverse Event|2|||
150045026|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
150045027|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
150045028|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
150045029|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
150045030|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
150045031|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
150045032|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
149890482|NCT01037218|540729388|FG002|Overall Study|Adverse Event|2|||
149890483|NCT01037218|540729389|FG003|Overall Study|Adverse Event|1|||
149890484|NCT01037218|540729386|FG000|Overall Study|Lack of Efficacy|0|||
149890485|NCT01037218|540729387|FG001|Overall Study|Lack of Efficacy|2|||
149890486|NCT01037218|540729388|FG002|Overall Study|Lack of Efficacy|1|||
149890487|NCT01037218|540729389|FG003|Overall Study|Lack of Efficacy|5|||
149890488|NCT01037218|540729386|FG000|Overall Study|Lost to Follow-up|3|||
149890489|NCT01037218|540729387|FG001|Overall Study|Lost to Follow-up|5|||
149890490|NCT01037218|540729388|FG002|Overall Study|Lost to Follow-up|4|||
149890491|NCT01037218|540729389|FG003|Overall Study|Lost to Follow-up|2|||
149890492|NCT01037218|540729386|FG000|Overall Study|Withdrawal by Subject|6|||
149890493|NCT01037218|540729387|FG001|Overall Study|Withdrawal by Subject|7|||
149890494|NCT01037218|540729388|FG002|Overall Study|Withdrawal by Subject|7|||
149890495|NCT01037218|540729389|FG003|Overall Study|Withdrawal by Subject|4|||
150045033|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
150045034|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
150045035|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
149890496|NCT01037218|540729386|FG000|Overall Study|Partner Withdrew Consent|0|||
149890497|NCT01037218|540729387|FG001|Overall Study|Partner Withdrew Consent|3|||
149890498|NCT01037218|540729388|FG002|Overall Study|Partner Withdrew Consent|2|||
149890499|NCT01037218|540729389|FG003|Overall Study|Partner Withdrew Consent|1|||
149890500|NCT01037218|540729386|FG000|Overall Study|Protocol Violation|0|||
149890501|NCT01037218|540729387|FG001|Overall Study|Protocol Violation|0|||
149890502|NCT01037218|540729388|FG002|Overall Study|Protocol Violation|2|||
149890503|NCT01037218|540729389|FG003|Overall Study|Protocol Violation|2|||
149890504|NCT01037218|540729386|FG000|Overall Study|Various|3|||
149890505|NCT01037218|540729387|FG001|Overall Study|Various|2|||
149890506|NCT01037218|540729388|FG002|Overall Study|Various|3|||
149967756|NCT05030766|541017954|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
149967757|NCT05030766|541017955|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
149967758|NCT05030766|541017952|FG000|Phase 2 Participants|Lost to Follow-up|0|||
149967759|NCT05030766|541017953|FG001|Phase 2 Participants|Lost to Follow-up|0|||
149967760|NCT05030766|541017954|FG002|Phase 2 Participants|Lost to Follow-up|6|||
149967761|NCT05030766|541017955|FG003|Phase 2 Participants|Lost to Follow-up|2|||
150045036|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
150045037|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
150045038|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
150045039|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
149890507|NCT01037218|540729389|FG003|Overall Study|Various|1|||
149890508|NCT01068860|540729390|FG000|Overall Study|Withdrawal by Subject|0|||
149890509|NCT01068860|540729391|FG001|Overall Study|Withdrawal by Subject|0|||
149890510|NCT01068860|540729392|FG002|Overall Study|Withdrawal by Subject|0|||
149890511|NCT01068860|540729393|FG003|Overall Study|Withdrawal by Subject|0|||
149890512|NCT01068860|540729394|FG004|Overall Study|Withdrawal by Subject|0|||
149890513|NCT01068860|540729395|FG005|Overall Study|Withdrawal by Subject|2|||
149890514|NCT01068860|540729396|FG006|Overall Study|Withdrawal by Subject|0|||
149890515|NCT01068860|540729397|FG007|Overall Study|Withdrawal by Subject|0|||
149890516|NCT01068860|540729398|FG008|Overall Study|Withdrawal by Subject|0|||
149890517|NCT01068860|540729399|FG009|Overall Study|Withdrawal by Subject|3|||
149890518|NCT01068860|540729390|FG000|Overall Study|Administrative problems; misrandomized|0|||
149890519|NCT01068860|540729391|FG001|Overall Study|Administrative problems; misrandomized|0|||
149890520|NCT01068860|540729392|FG002|Overall Study|Administrative problems; misrandomized|0|||
149890521|NCT01068860|540729393|FG003|Overall Study|Administrative problems; misrandomized|1|||
149890522|NCT01068860|540729394|FG004|Overall Study|Administrative problems; misrandomized|0|||
149890523|NCT01068860|540729395|FG005|Overall Study|Administrative problems; misrandomized|0|||
149890524|NCT01068860|540729396|FG006|Overall Study|Administrative problems; misrandomized|0|||
149890525|NCT01068860|540729397|FG007|Overall Study|Administrative problems; misrandomized|0|||
149890526|NCT01068860|540729398|FG008|Overall Study|Administrative problems; misrandomized|0|||
149890527|NCT01068860|540729399|FG009|Overall Study|Administrative problems; misrandomized|1|||
149890528|NCT01068860|540729390|FG000|Overall Study|Lost to Follow-up|0|||
149890529|NCT01068860|540729391|FG001|Overall Study|Lost to Follow-up|1|||
149890530|NCT01068860|540729392|FG002|Overall Study|Lost to Follow-up|0|||
149890531|NCT01068860|540729393|FG003|Overall Study|Lost to Follow-up|0|||
149890532|NCT01068860|540729394|FG004|Overall Study|Lost to Follow-up|0|||
149890533|NCT01068860|540729395|FG005|Overall Study|Lost to Follow-up|0|||
149890534|NCT01068860|540729396|FG006|Overall Study|Lost to Follow-up|0|||
149890535|NCT01068860|540729397|FG007|Overall Study|Lost to Follow-up|0|||
149890536|NCT01068860|540729398|FG008|Overall Study|Lost to Follow-up|0|||
149890537|NCT01068860|540729399|FG009|Overall Study|Lost to Follow-up|0|||
149890538|NCT02568072|540729400|FG000|Overall Study|Unavailable for appointment|23|||
149890539|NCT02568072|540729400|FG000|Overall Study|Unable to contact|3|||
149890540|NCT02568072|540729400|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
150045040|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
150045041|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
150045042|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
150045043|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
150175835|NCT04975308|541779936|FG001|Overall Study|Protocol Deviation|3|||
149890541|NCT02568072|540729400|FG000|Overall Study|Withdrawal by Subject|1|||
149890542|NCT02568072|540729400|FG000|Overall Study|Sustained injury, marathon not run|24|||
149890543|NCT00927589|540729401|FG000|Overall Study|Death|1|||
149890544|NCT00927589|540729401|FG000|Overall Study|Physician Decision|1|||
149890545|NCT00927589|540729401|FG000|Overall Study|Withdrawal by Subject|3|||
149890546|NCT00927589|540729401|FG000|Overall Study|Adverse Event|2|||
149890547|NCT00927589|540729401|FG000|Overall Study|Disease Progression|8|||
149890548|NCT00927589|540729401|FG000|Overall Study|Non-compliance|1|||
149890549|NCT01199939|540729405|FG000|Overall Study|Adverse Event|4|||
149890550|NCT01199939|540729405|FG000|Overall Study|Protocol Violation|3|||
149890551|NCT01199939|540729405|FG000|Overall Study|Lost to Follow-up|2|||
149890552|NCT01199939|540729405|FG000|Overall Study|Reached a virologic endpoint|4|||
149890553|NCT03875508|540729408|FG000|Overall Study|Adverse Event|1|||
149890554|NCT03875508|540729408|FG000|Overall Study|Lost to Follow-up|8|||
149890555|NCT03875508|540729408|FG000|Overall Study|Lack of Efficacy|1|||
149890556|NCT03875508|540729408|FG000|Overall Study|Other, not specified|2|||
149967762|NCT03895372|541017956|FG000|Investigational Treatment Period|Adverse Event|1|||
149967763|NCT03895372|541017957|FG001|Investigational Treatment Period|Adverse Event|0|||
149890557|NCT02137252|540729409|FG000|Overall Study|trial terminated early|2|||
149890558|NCT02137252|540729410|FG001|Overall Study|trial terminated early|1|||
149890559|NCT00063934|540729412|FG000|Overall Study|Ineligible|1|||
149890560|NCT02285361|540729416|FG000|Overall Study|Protocol Violation|43|||
149890561|NCT02285361|540729416|FG000|Overall Study|Lost to Follow-up|5|||
149890562|NCT02285361|540729416|FG000|Overall Study|Not taken GIOTRIF|2|||
149890563|NCT02285361|540729416|FG000|Overall Study|Consented prior to the contract date|1|||
149890564|NCT01283464|540729417|FG000|Overall Study|Lost to Follow-up|0|||
149890565|NCT01283464|540729418|FG001|Overall Study|Lost to Follow-up|1|||
149890566|NCT01283464|540729417|FG000|Overall Study|Withdrawal by Subject|1|||
150045044|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
149890567|NCT01283464|540729418|FG001|Overall Study|Withdrawal by Subject|0|||
149890568|NCT01283464|540729417|FG000|Overall Study|Physician Decision|1|||
149890569|NCT01283464|540729418|FG001|Overall Study|Physician Decision|0|||
149890570|NCT03051100|540729419|FG000|Overall Study|Withdrawal by Subject|1|||
149890571|NCT03051100|540729420|FG001|Overall Study|Withdrawal by Subject|0|||
149890572|NCT01778855|540729421|FG000|Overall Study|Death|0|||
149890573|NCT01778855|540729422|FG001|Overall Study|Death|1|||
149890574|NCT02059135|540729423|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
149890575|NCT02059135|540729424|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
149890576|NCT02059135|540729423|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
149890577|NCT02059135|540729424|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
149890578|NCT02059135|540729423|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
149890579|NCT02059135|540729424|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
149890580|NCT02059135|540729423|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
149890581|NCT02059135|540729424|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
149890582|NCT02059135|540729423|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
149890583|NCT02059135|540729424|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
149890584|NCT02059135|540729423|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
149890585|NCT02059135|540729424|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
149890586|NCT02059135|540729423|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
149890587|NCT02059135|540729424|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
149890588|NCT02059135|540729423|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
149890589|NCT02059135|540729424|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
149890590|NCT05317312|540729427|FG000|Overall Study|Withdrawal by Subject|0|||
149890591|NCT05317312|540729428|FG001|Overall Study|Withdrawal by Subject|1|||
149890592|NCT05317312|540729429|FG002|Overall Study|Withdrawal by Subject|0|||
149890593|NCT05317312|540729430|FG003|Overall Study|Withdrawal by Subject|0|||
149890594|NCT05317312|540729427|FG000|Overall Study|Lost to Follow-up|0|||
149890595|NCT05317312|540729428|FG001|Overall Study|Lost to Follow-up|0|||
149890596|NCT05317312|540729429|FG002|Overall Study|Lost to Follow-up|0|||
149890597|NCT05317312|540729430|FG003|Overall Study|Lost to Follow-up|1|||
149890598|NCT05317312|540729427|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
149890599|NCT05317312|540729428|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
149890600|NCT05317312|540729429|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
149890601|NCT05317312|540729430|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
149890602|NCT01422213|540729431|FG000|Overall Study|Adverse Event|8|||
149890603|NCT01422213|540729432|FG001|Overall Study|Adverse Event|7|||
149890604|NCT01422213|540729433|FG002|Overall Study|Adverse Event|11|||
149890605|NCT01422213|540729431|FG000|Overall Study|Lack of Efficacy|10|||
149890606|NCT01422213|540729432|FG001|Overall Study|Lack of Efficacy|2|||
149890607|NCT01422213|540729433|FG002|Overall Study|Lack of Efficacy|2|||
149890608|NCT01422213|540729431|FG000|Overall Study|Non-compliance with study drug|0|||
149890609|NCT01422213|540729432|FG001|Overall Study|Non-compliance with study drug|1|||
149890610|NCT01422213|540729433|FG002|Overall Study|Non-compliance with study drug|0|||
149890611|NCT01422213|540729431|FG000|Overall Study|Protocol Violation|0|||
149890612|NCT01422213|540729432|FG001|Overall Study|Protocol Violation|2|||
149890613|NCT01422213|540729433|FG002|Overall Study|Protocol Violation|4|||
149890614|NCT01422213|540729431|FG000|Overall Study|Withdrawal of Consent|7|||
150045045|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
149890615|NCT01422213|540729432|FG001|Overall Study|Withdrawal of Consent|3|||
149890616|NCT01422213|540729433|FG002|Overall Study|Withdrawal of Consent|5|||
149890617|NCT01422213|540729431|FG000|Overall Study|Lost to Follow-up|3|||
149890618|NCT01422213|540729432|FG001|Overall Study|Lost to Follow-up|3|||
149890619|NCT01422213|540729433|FG002|Overall Study|Lost to Follow-up|5|||
149890620|NCT01422213|540729431|FG000|Overall Study|Administrative or Other Reason(s)|5|||
149890621|NCT01422213|540729432|FG001|Overall Study|Administrative or Other Reason(s)|4|||
149890622|NCT01422213|540729433|FG002|Overall Study|Administrative or Other Reason(s)|2|||
149890623|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
149890624|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
149890625|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
149890626|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
149890627|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
149890628|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
149890629|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
149890630|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
149890631|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
149890632|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
149890633|NCT03762265|540729434|FG000|BT Period: Weeks 1 to 37|Other|0|||
149890634|NCT03762265|540729435|FG001|BT Period: Weeks 1 to 37|Other|1|||
149890635|NCT03762265|540729434|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
149890636|NCT03762265|540729435|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
149890637|NCT03762265|540729434|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
149890638|NCT03762265|540729435|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
149890639|NCT03762265|540729434|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
149890640|NCT03762265|540729435|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
149890641|NCT03762265|540729434|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
149890642|NCT03762265|540729435|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
149890643|NCT03762265|540729434|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
149890644|NCT03762265|540729435|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
149890645|NCT03762265|540729434|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
149890646|NCT03762265|540729435|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
149890647|NCT03762265|540729434|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
149890648|NCT03762265|540729435|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
149890649|NCT03762265|540729434|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
150045046|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
149890650|NCT03762265|540729435|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
149890651|NCT03762265|540729434|FG000|LTE Period: Weeks 61 to 109|Other|1|||
149890652|NCT03762265|540729435|FG001|LTE Period: Weeks 61 to 109|Other|0|||
149890653|NCT02857816|540729438|FG000|Overall Study|Screen Failure|33|||
149890654|NCT02857816|540729438|FG000|Overall Study|Withdrawal by Subject|4|||
149890655|NCT02857816|540729438|FG000|Overall Study|Lost to Follow-up|1|||
149890656|NCT02289729|540729439|FG000|Overall Study|Lack of Efficacy|3|||
150045047|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045048|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045049|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045050|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045051|NCT05019521|541304254|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
150045052|NCT05019521|541304255|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045053|NCT05019521|541304256|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
150045054|NCT05019521|541304257|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
150045055|NCT05019521|541304258|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045056|NCT05019521|541304259|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045057|NCT05019521|541304260|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045058|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
150045059|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
150045060|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
150045061|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045062|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045063|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
150045064|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
150045065|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
150045066|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
150045067|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
150045068|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
150045069|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
150045070|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
150045071|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
150045072|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
150045073|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
149890657|NCT02289729|540729439|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
149890658|NCT02289729|540729439|FG000|Overall Study|Withdrawal by Subject|1|||
149890659|NCT02289729|540729439|FG000|Overall Study|Death|1|||
150045074|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
150045075|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
150045076|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
150045077|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
150045078|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
150045079|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
150045080|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
150045081|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
150045082|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
150045083|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
150045084|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
150045085|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
150045086|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
150045087|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
150045088|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
150045089|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
150045090|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
150045091|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
150045092|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
150045093|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045094|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045095|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045096|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045097|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045098|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
150045099|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
150045100|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
150045101|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
150045102|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
150045103|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045104|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045105|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
150045106|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
150045107|NCT05019521|541304254|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
150045108|NCT05019521|541304255|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
150045109|NCT05019521|541304256|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
150045110|NCT05019521|541304257|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
150045111|NCT05019521|541304258|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
150045112|NCT05019521|541304259|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
150045113|NCT05019521|541304260|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
150045114|NCT00885534|541304261|FG000|Overall Study|Patient deemed ineligible|1|||
150045115|NCT01273519|541304262|FG000|Overall Study|Adverse Event|3|||
150045116|NCT01273519|541304263|FG001|Overall Study|Adverse Event|0|||
150045117|NCT01273519|541304264|FG002|Overall Study|Adverse Event|0|||
150045118|NCT01273519|541304262|FG000|Overall Study|Lost to Follow-up|2|||
150045119|NCT01273519|541304263|FG001|Overall Study|Lost to Follow-up|1|||
150045120|NCT01273519|541304264|FG002|Overall Study|Lost to Follow-up|3|||
150045121|NCT01273519|541304262|FG000|Overall Study|Lack of Efficacy|8|||
150045122|NCT01273519|541304263|FG001|Overall Study|Lack of Efficacy|3|||
150045123|NCT01273519|541304264|FG002|Overall Study|Lack of Efficacy|4|||
150045124|NCT01273519|541304262|FG000|Overall Study|Other|6|||
150045125|NCT01273519|541304263|FG001|Overall Study|Other|1|||
150045126|NCT01273519|541304264|FG002|Overall Study|Other|1|||
150045127|NCT04292899|541304265|FG000|Overall Study|Death|21|||
150045128|NCT04292899|541304266|FG001|Overall Study|Death|28|||
150045129|NCT04292899|541304267|FG002|Overall Study|Death|188|||
150045130|NCT04292899|541304268|FG003|Overall Study|Death|371|||
150045131|NCT04292899|541304265|FG000|Overall Study|Lost to Follow-up|8|||
150045132|NCT04292899|541304266|FG001|Overall Study|Lost to Follow-up|4|||
150045133|NCT04292899|541304267|FG002|Overall Study|Lost to Follow-up|22|||
150045134|NCT04292899|541304268|FG003|Overall Study|Lost to Follow-up|235|||
150045135|NCT04292899|541304265|FG000|Overall Study|Withdrew consent|1|||
150045136|NCT04292899|541304266|FG001|Overall Study|Withdrew consent|0|||
150045137|NCT04292899|541304267|FG002|Overall Study|Withdrew consent|11|||
150175836|NCT04975308|541779937|FG002|Overall Study|Protocol Deviation|2|||
149890660|NCT00470470|540729440|FG000|Overall Study|Adverse Event|2|||
149890661|NCT00470470|540729440|FG000|Overall Study|Death|2|||
149890662|NCT00470470|540729440|FG000|Overall Study|Not treated|1|||
149890663|NCT01149863|540729441|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
149890664|NCT03326193|540729442|FG000|Overall Study|Sponsor decision|35|||
149890665|NCT01964976|540729445|FG000|Overall Study|Protocol Violation|31|||
149890666|NCT01168427|540729446|FG000|Overall Study|Patient exited prior to implant|1|||
149890667|NCT00397514|540729447|FG000|Overall Study|Withdrawal by Subject|1|||
149890668|NCT00397514|540729447|FG000|Overall Study|Pacing wire malfunction|1|||
149890669|NCT00397514|540729447|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
149890670|NCT00397514|540729447|FG000|Overall Study|early extubation|2|||
149890671|NCT00397514|540729447|FG000|Overall Study|poor echocardiographic windows|1|||
149890672|NCT01256879|540729448|FG000|Overall Study|Withdrawal by Subject|1|||
149890673|NCT00640315|540729449|FG000|Overall Study|Withdrawal by Subject|0|||
149890674|NCT00640315|540729450|FG001|Overall Study|Withdrawal by Subject|1|||
149890675|NCT00725920|540729452|FG000|Overall Study|Lack of Efficacy|3|||
149890676|NCT00725920|540729453|FG001|Overall Study|Lack of Efficacy|6|||
149890677|NCT02623725|540729454|FG000|Overall Study|Non compliance with protocol|9|||
149890678|NCT02623725|540729455|FG001|Overall Study|Non compliance with protocol|3|||
149890679|NCT02623725|540729454|FG000|Overall Study|Serious adverse event|0|||
149890680|NCT02623725|540729455|FG001|Overall Study|Serious adverse event|2|||
149890681|NCT02623725|540729454|FG000|Overall Study|Withdrawal by Subject|7|||
149890682|NCT02623725|540729455|FG001|Overall Study|Withdrawal by Subject|1|||
149890683|NCT03918629|540729456|FG000|Overall Study|Adverse Event|19|||
149890684|NCT03918629|540729457|FG001|Overall Study|Adverse Event|20|||
149890685|NCT03918629|540729456|FG000|Overall Study|Death|14|||
149890686|NCT03918629|540729457|FG001|Overall Study|Death|7|||
149890687|NCT03918629|540729456|FG000|Overall Study|Lost to Follow-up|36|||
149890688|NCT03918629|540729457|FG001|Overall Study|Lost to Follow-up|28|||
149890689|NCT03918629|540729456|FG000|Overall Study|Physician Decision|1|||
149890690|NCT03918629|540729457|FG001|Overall Study|Physician Decision|0|||
149890691|NCT03918629|540729456|FG000|Overall Study|Protocol Violation|7|||
149890692|NCT03918629|540729457|FG001|Overall Study|Protocol Violation|4|||
149890693|NCT03918629|540729456|FG000|Overall Study|Withdrawal by Subject|47|||
149890694|NCT03918629|540729457|FG001|Overall Study|Withdrawal by Subject|47|||
149890695|NCT03918629|540729456|FG000|Overall Study|Other|7|||
149890696|NCT03918629|540729457|FG001|Overall Study|Other|11|||
149890697|NCT03918629|540729456|FG000|Overall Study|Randomized but not vaccinated|2|||
149890698|NCT03918629|540729457|FG001|Overall Study|Randomized but not vaccinated|1|||
149890699|NCT02456740|540729458|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
149890700|NCT02456740|540729459|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
149890701|NCT02456740|540729460|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
149890702|NCT02456740|540729461|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890703|NCT02456740|540729462|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890704|NCT02456740|540729463|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890705|NCT02456740|540729464|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890706|NCT02456740|540729465|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890707|NCT02456740|540729466|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
149890708|NCT02456740|540729458|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
149890709|NCT02456740|540729459|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
149890710|NCT02456740|540729460|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
149890711|NCT02456740|540729461|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890712|NCT02456740|540729462|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890713|NCT02456740|540729463|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890714|NCT02456740|540729464|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890715|NCT02456740|540729465|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890716|NCT02456740|540729466|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
149890717|NCT02456740|540729458|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
149890718|NCT02456740|540729459|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
149890719|NCT02456740|540729460|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
149890720|NCT02456740|540729461|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149890721|NCT02456740|540729462|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149890722|NCT02456740|540729463|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149890723|NCT02456740|540729464|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149890724|NCT02456740|540729465|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149890725|NCT02456740|540729466|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
149967764|NCT03895372|541017958|FG002|Investigational Treatment Period|Adverse Event|0|||
149967765|NCT03895372|541017959|FG003|Investigational Treatment Period|Adverse Event|0|||
149890726|NCT02456740|540729458|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890727|NCT02456740|540729459|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890728|NCT02456740|540729460|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890729|NCT02456740|540729461|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
149890730|NCT02456740|540729462|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
149890731|NCT02456740|540729463|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890732|NCT02456740|540729464|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890733|NCT02456740|540729465|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
149890734|NCT02456740|540729466|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
149890735|NCT02456740|540729458|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149890736|NCT02456740|540729459|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149890737|NCT02456740|540729460|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149890738|NCT02456740|540729461|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
149890739|NCT02456740|540729462|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
149890740|NCT02456740|540729463|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
149890741|NCT02456740|540729464|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
149890742|NCT02456740|540729465|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
149890743|NCT02456740|540729466|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
149890744|NCT02456740|540729458|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890745|NCT02456740|540729459|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890746|NCT02456740|540729460|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890747|NCT02456740|540729461|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890748|NCT02456740|540729462|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890749|NCT02456740|540729463|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890750|NCT02456740|540729464|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890751|NCT02456740|540729465|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
149890752|NCT02456740|540729466|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
149890753|NCT02456740|540729458|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149890754|NCT02456740|540729459|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149890755|NCT02456740|540729460|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149890756|NCT02456740|540729461|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
149890757|NCT02456740|540729462|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
149890758|NCT02456740|540729463|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
149890759|NCT02456740|540729464|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
149890760|NCT02456740|540729465|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
149967766|NCT03895372|541017960|FG004|Investigational Treatment Period|Adverse Event|0|||
149967767|NCT03895372|541017961|FG005|Investigational Treatment Period|Adverse Event|0|||
149890761|NCT02456740|540729466|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
149890762|NCT01891864|540729470|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
149890763|NCT01891864|540729471|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
149890764|NCT01891864|540729472|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
149890765|NCT01891864|540729473|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
149890766|NCT01891864|540729474|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
149890767|NCT01891864|540729475|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
149890768|NCT01891864|540729470|FG000|Treatment Period 1|Physician Decision|0|||
149890769|NCT01891864|540729471|FG001|Treatment Period 1|Physician Decision|1|||
149890770|NCT01891864|540729472|FG002|Treatment Period 1|Physician Decision|0|||
149890771|NCT01891864|540729473|FG003|Treatment Period 1|Physician Decision|0|||
149890772|NCT01891864|540729474|FG004|Treatment Period 1|Physician Decision|0|||
149890773|NCT01891864|540729475|FG005|Treatment Period 1|Physician Decision|0|||
149890774|NCT01891864|540729470|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
149890775|NCT01891864|540729471|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
149890776|NCT01891864|540729472|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
149890777|NCT01891864|540729473|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
149890778|NCT01891864|540729474|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
149890779|NCT01891864|540729475|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
149890780|NCT01891864|540729470|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
149890781|NCT01891864|540729471|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
149890782|NCT01891864|540729472|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
149890783|NCT01891864|540729473|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
149890784|NCT01891864|540729474|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
149890785|NCT01891864|540729475|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
149890786|NCT01891864|540729470|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149890787|NCT01891864|540729471|FG001|Treatment Period 1|Withdrawal by Subject|5|||
149890788|NCT01891864|540729472|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149890789|NCT01891864|540729473|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149890790|NCT01891864|540729474|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149890791|NCT01891864|540729475|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149890792|NCT01891864|540729470|FG000|Treatment Period 1|Lost to Follow-up|1|||
149890793|NCT01891864|540729471|FG001|Treatment Period 1|Lost to Follow-up|0|||
149890794|NCT01891864|540729472|FG002|Treatment Period 1|Lost to Follow-up|0|||
149890795|NCT01891864|540729473|FG003|Treatment Period 1|Lost to Follow-up|0|||
149890796|NCT01891864|540729474|FG004|Treatment Period 1|Lost to Follow-up|0|||
149890797|NCT01891864|540729475|FG005|Treatment Period 1|Lost to Follow-up|0|||
149890798|NCT01891864|540729470|FG000|Treatment Period 2|Protocol Violation|0|||
149890799|NCT01891864|540729471|FG001|Treatment Period 2|Protocol Violation|0|||
149890800|NCT01891864|540729472|FG002|Treatment Period 2|Protocol Violation|0|||
149890801|NCT01891864|540729473|FG003|Treatment Period 2|Protocol Violation|1|||
149890802|NCT01891864|540729474|FG004|Treatment Period 2|Protocol Violation|0|||
149890803|NCT01891864|540729475|FG005|Treatment Period 2|Protocol Violation|0|||
149890804|NCT01891864|540729470|FG000|Treatment Period 2|Physician Decision|0|||
149890805|NCT01891864|540729471|FG001|Treatment Period 2|Physician Decision|0|||
149890806|NCT01891864|540729472|FG002|Treatment Period 2|Physician Decision|1|||
149890807|NCT01891864|540729473|FG003|Treatment Period 2|Physician Decision|0|||
149890808|NCT01891864|540729474|FG004|Treatment Period 2|Physician Decision|0|||
149890809|NCT01891864|540729475|FG005|Treatment Period 2|Physician Decision|0|||
149890810|NCT01891864|540729470|FG000|Treatment Period 2|Site Termination|0|||
149890811|NCT01891864|540729471|FG001|Treatment Period 2|Site Termination|0|||
149890812|NCT01891864|540729472|FG002|Treatment Period 2|Site Termination|1|||
149890813|NCT01891864|540729473|FG003|Treatment Period 2|Site Termination|2|||
149890814|NCT01891864|540729474|FG004|Treatment Period 2|Site Termination|0|||
149890815|NCT01891864|540729475|FG005|Treatment Period 2|Site Termination|0|||
149890816|NCT01891864|540729470|FG000|Treatment Period 2|Lack of Efficacy|0|||
149890817|NCT01891864|540729471|FG001|Treatment Period 2|Lack of Efficacy|0|||
149890818|NCT01891864|540729472|FG002|Treatment Period 2|Lack of Efficacy|1|||
149890819|NCT01891864|540729473|FG003|Treatment Period 2|Lack of Efficacy|0|||
149890820|NCT01891864|540729474|FG004|Treatment Period 2|Lack of Efficacy|1|||
149890821|NCT01891864|540729475|FG005|Treatment Period 2|Lack of Efficacy|0|||
149890822|NCT01891864|540729470|FG000|Treatment Period 2|Adverse Event|0|||
149890823|NCT01891864|540729471|FG001|Treatment Period 2|Adverse Event|0|||
149890824|NCT01891864|540729472|FG002|Treatment Period 2|Adverse Event|1|||
149890825|NCT01891864|540729473|FG003|Treatment Period 2|Adverse Event|2|||
149890826|NCT01891864|540729474|FG004|Treatment Period 2|Adverse Event|0|||
149890827|NCT01891864|540729475|FG005|Treatment Period 2|Adverse Event|4|||
149967768|NCT03895372|541017962|FG006|Investigational Treatment Period|Adverse Event|4|||
149890828|NCT01891864|540729470|FG000|Treatment Period 2|Termination of Site|0|||
149890829|NCT01891864|540729471|FG001|Treatment Period 2|Termination of Site|0|||
149967769|NCT03895372|541017963|FG007|Investigational Treatment Period|Adverse Event|3|||
149890830|NCT01891864|540729472|FG002|Treatment Period 2|Termination of Site|0|||
149890831|NCT01891864|540729473|FG003|Treatment Period 2|Termination of Site|0|||
149890832|NCT01891864|540729474|FG004|Treatment Period 2|Termination of Site|2|||
149890833|NCT01891864|540729475|FG005|Treatment Period 2|Termination of Site|0|||
149890834|NCT01891864|540729470|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149890835|NCT01891864|540729471|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149890836|NCT01891864|540729472|FG002|Treatment Period 2|Withdrawal by Subject|3|||
149890837|NCT01891864|540729473|FG003|Treatment Period 2|Withdrawal by Subject|4|||
149890838|NCT01891864|540729474|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149890839|NCT01891864|540729475|FG005|Treatment Period 2|Withdrawal by Subject|1|||
149890840|NCT01891864|540729470|FG000|Extension Period|Lack of Efficacy|0|||
149890841|NCT01891864|540729471|FG001|Extension Period|Lack of Efficacy|0|||
149890842|NCT01891864|540729472|FG002|Extension Period|Lack of Efficacy|0|||
149890843|NCT01891864|540729473|FG003|Extension Period|Lack of Efficacy|1|||
149890844|NCT01891864|540729474|FG004|Extension Period|Lack of Efficacy|1|||
149890845|NCT01891864|540729475|FG005|Extension Period|Lack of Efficacy|0|||
149890846|NCT01891864|540729470|FG000|Extension Period|Pregnancy|0|||
149890847|NCT01891864|540729471|FG001|Extension Period|Pregnancy|0|||
150175837|NCT00442117|541779938|FG000|Overall Study|Adverse Event|3|||
149890848|NCT01891864|540729472|FG002|Extension Period|Pregnancy|1|||
149890849|NCT01891864|540729473|FG003|Extension Period|Pregnancy|0|||
149890850|NCT01891864|540729474|FG004|Extension Period|Pregnancy|0|||
149890851|NCT01891864|540729475|FG005|Extension Period|Pregnancy|0|||
149890852|NCT01891864|540729470|FG000|Extension Period|Adverse Event|0|||
149890853|NCT01891864|540729471|FG001|Extension Period|Adverse Event|0|||
149890854|NCT01891864|540729472|FG002|Extension Period|Adverse Event|4|||
149890855|NCT01891864|540729473|FG003|Extension Period|Adverse Event|2|||
149890856|NCT01891864|540729474|FG004|Extension Period|Adverse Event|2|||
149890857|NCT01891864|540729475|FG005|Extension Period|Adverse Event|0|||
149890858|NCT01891864|540729470|FG000|Extension Period|Withdrawal by Subject|0|||
149890859|NCT01891864|540729471|FG001|Extension Period|Withdrawal by Subject|0|||
149890860|NCT01891864|540729472|FG002|Extension Period|Withdrawal by Subject|1|||
149890861|NCT01891864|540729473|FG003|Extension Period|Withdrawal by Subject|2|||
149890862|NCT01891864|540729474|FG004|Extension Period|Withdrawal by Subject|4|||
149890863|NCT01891864|540729475|FG005|Extension Period|Withdrawal by Subject|0|||
149890864|NCT01891864|540729470|FG000|Extension Period|Lost to Follow-up|0|||
149890865|NCT01891864|540729471|FG001|Extension Period|Lost to Follow-up|0|||
149890866|NCT01891864|540729472|FG002|Extension Period|Lost to Follow-up|2|||
149890867|NCT01891864|540729473|FG003|Extension Period|Lost to Follow-up|0|||
149890868|NCT01891864|540729474|FG004|Extension Period|Lost to Follow-up|0|||
149890869|NCT01891864|540729475|FG005|Extension Period|Lost to Follow-up|0|||
149890870|NCT04720105|540729476|FG000|Overall Study|Lack of Efficacy|1|||
149890871|NCT04720105|540729476|FG000|Overall Study|Lost to Follow-up|1|||
149890872|NCT04720105|540729476|FG000|Overall Study|Withdrawal by Subject|3|||
149890873|NCT02892331|540729477|FG000|Overall Study|Withdrawal by Subject|0|||
149967770|NCT03895372|541017956|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
149967771|NCT03895372|541017957|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
149967772|NCT03895372|541017958|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
149967773|NCT03895372|541017959|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
150045138|NCT04292899|541304268|FG003|Overall Study|Withdrew consent|32|||
150045139|NCT04292899|541304265|FG000|Overall Study|Adverse Event|2|||
150045140|NCT04292899|541304266|FG001|Overall Study|Adverse Event|1|||
150045141|NCT04292899|541304267|FG002|Overall Study|Adverse Event|2|||
150045142|NCT04292899|541304268|FG003|Overall Study|Adverse Event|2|||
150045143|NCT04292899|541304265|FG000|Overall Study|Investigator's Discretion|0|||
150045144|NCT04292899|541304266|FG001|Overall Study|Investigator's Discretion|0|||
150045145|NCT04292899|541304267|FG002|Overall Study|Investigator's Discretion|0|||
150045146|NCT04292899|541304268|FG003|Overall Study|Investigator's Discretion|3|||
150045147|NCT04292899|541304265|FG000|Overall Study|Non-compliance With Study Drug|0|||
150045148|NCT04292899|541304266|FG001|Overall Study|Non-compliance With Study Drug|0|||
150045149|NCT04292899|541304267|FG002|Overall Study|Non-compliance With Study Drug|0|||
150045150|NCT04292899|541304268|FG003|Overall Study|Non-compliance With Study Drug|1|||
150045151|NCT04292899|541304265|FG000|Overall Study|Protocol Violation|0|||
150045152|NCT04292899|541304266|FG001|Overall Study|Protocol Violation|0|||
150045153|NCT04292899|541304267|FG002|Overall Study|Protocol Violation|0|||
150045154|NCT04292899|541304268|FG003|Overall Study|Protocol Violation|1|||
150045155|NCT04672655|541304272|FG000|Overall Study|Lost to Follow-up|12|||
150045156|NCT04672655|541304273|FG001|Overall Study|Lost to Follow-up|17|||
150045157|NCT04672655|541304272|FG000|Overall Study|Withdrawal by Subject|1|||
149890874|NCT02892331|540729478|FG001|Overall Study|Withdrawal by Subject|1|||
149967774|NCT03895372|541017960|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
149967775|NCT03895372|541017961|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
149967776|NCT03895372|541017962|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
149967777|NCT03895372|541017963|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
149967778|NCT03895372|541017956|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
149967779|NCT03895372|541017957|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
149967780|NCT03895372|541017958|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
149967781|NCT03895372|541017959|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
149890875|NCT02892331|540729479|FG002|Overall Study|Withdrawal by Subject|1|||
149890876|NCT02892331|540729477|FG000|Overall Study|Sick family member|0|||
149967782|NCT03895372|541017960|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
149967783|NCT03895372|541017961|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
149967784|NCT03895372|541017962|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
149967785|NCT03895372|541017963|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
150045158|NCT04672655|541304273|FG001|Overall Study|Withdrawal by Subject|0|||
150045159|NCT04672655|541304272|FG000|Overall Study|Withdrawal by Study|1|||
150045160|NCT04672655|541304273|FG001|Overall Study|Withdrawal by Study|0|||
150045161|NCT03892967|541304274|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
149890877|NCT02892331|540729478|FG001|Overall Study|Sick family member|0|||
149890878|NCT02892331|540729479|FG002|Overall Study|Sick family member|1|||
149890879|NCT02892331|540729477|FG000|Overall Study|Corona virus pandemic|1|||
149890880|NCT02892331|540729478|FG001|Overall Study|Corona virus pandemic|0|||
149890881|NCT02892331|540729479|FG002|Overall Study|Corona virus pandemic|1|||
149890882|NCT02892331|540729477|FG000|Overall Study|Lost to Follow-up|1|||
149890883|NCT02892331|540729478|FG001|Overall Study|Lost to Follow-up|0|||
149890884|NCT02892331|540729479|FG002|Overall Study|Lost to Follow-up|1|||
149890885|NCT02892331|540729477|FG000|Overall Study|Blood pressure was too elevated|0|||
149967786|NCT03895372|541017956|FG000|Investigational Treatment Period|Other|0|||
149967787|NCT03895372|541017957|FG001|Investigational Treatment Period|Other|0|||
149967788|NCT03895372|541017958|FG002|Investigational Treatment Period|Other|0|||
149967789|NCT03895372|541017959|FG003|Investigational Treatment Period|Other|0|||
149967790|NCT03895372|541017960|FG004|Investigational Treatment Period|Other|0|||
149967791|NCT03895372|541017961|FG005|Investigational Treatment Period|Other|1|||
149967792|NCT03895372|541017962|FG006|Investigational Treatment Period|Other|0|||
149967793|NCT03895372|541017963|FG007|Investigational Treatment Period|Other|2|||
149967794|NCT03895372|541017956|FG000|Investigational Treatment Period|Protocol Violation|0|||
149967795|NCT03895372|541017957|FG001|Investigational Treatment Period|Protocol Violation|0|||
149967796|NCT03895372|541017958|FG002|Investigational Treatment Period|Protocol Violation|0|||
149967797|NCT03895372|541017959|FG003|Investigational Treatment Period|Protocol Violation|1|||
149967798|NCT03895372|541017960|FG004|Investigational Treatment Period|Protocol Violation|0|||
149967799|NCT03895372|541017961|FG005|Investigational Treatment Period|Protocol Violation|0|||
149967800|NCT03895372|541017962|FG006|Investigational Treatment Period|Protocol Violation|0|||
149967801|NCT03895372|541017963|FG007|Investigational Treatment Period|Protocol Violation|0|||
149967802|NCT03895372|541017956|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
149967803|NCT03895372|541017957|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
149967804|NCT03895372|541017958|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
149967805|NCT03895372|541017959|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
149967806|NCT03895372|541017960|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
149967807|NCT03895372|541017961|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
149967808|NCT03895372|541017962|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
149967809|NCT03895372|541017963|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
149967810|NCT03895372|541017956|FG000|Extension Treatment Period|Adverse Event|0|||
149967811|NCT03895372|541017957|FG001|Extension Treatment Period|Adverse Event|1|||
149967812|NCT03895372|541017958|FG002|Extension Treatment Period|Adverse Event|0|||
149967813|NCT03895372|541017959|FG003|Extension Treatment Period|Adverse Event|1|||
149967814|NCT03895372|541017960|FG004|Extension Treatment Period|Adverse Event|0|||
149967815|NCT03895372|541017961|FG005|Extension Treatment Period|Adverse Event|0|||
149967816|NCT03895372|541017962|FG006|Extension Treatment Period|Adverse Event|3|||
149967817|NCT03895372|541017963|FG007|Extension Treatment Period|Adverse Event|3|||
149967818|NCT03895372|541017956|FG000|Extension Treatment Period|Other|1|||
149967819|NCT03895372|541017957|FG001|Extension Treatment Period|Other|3|||
149967820|NCT03895372|541017958|FG002|Extension Treatment Period|Other|0|||
149967821|NCT03895372|541017959|FG003|Extension Treatment Period|Other|0|||
149967822|NCT03895372|541017960|FG004|Extension Treatment Period|Other|1|||
149967823|NCT03895372|541017961|FG005|Extension Treatment Period|Other|0|||
149967824|NCT03895372|541017962|FG006|Extension Treatment Period|Other|0|||
149967825|NCT03895372|541017963|FG007|Extension Treatment Period|Other|2|||
149967826|NCT03895372|541017956|FG000|Extension Treatment Period|Pregnancy|0|||
149967827|NCT03895372|541017957|FG001|Extension Treatment Period|Pregnancy|0|||
149967828|NCT03895372|541017958|FG002|Extension Treatment Period|Pregnancy|0|||
149967829|NCT03895372|541017959|FG003|Extension Treatment Period|Pregnancy|0|||
149967830|NCT03895372|541017960|FG004|Extension Treatment Period|Pregnancy|1|||
149967831|NCT03895372|541017961|FG005|Extension Treatment Period|Pregnancy|0|||
149967832|NCT03895372|541017962|FG006|Extension Treatment Period|Pregnancy|0|||
149967833|NCT03895372|541017963|FG007|Extension Treatment Period|Pregnancy|0|||
149967834|NCT03895372|541017956|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
149967835|NCT03895372|541017957|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
150045162|NCT03892967|541304275|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
150045163|NCT03892967|541304276|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
149890886|NCT02892331|540729478|FG001|Overall Study|Blood pressure was too elevated|1|||
149890887|NCT02892331|540729479|FG002|Overall Study|Blood pressure was too elevated|0|||
149967836|NCT03895372|541017958|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
149967837|NCT03895372|541017959|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
149967838|NCT03895372|541017960|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
149967839|NCT03895372|541017961|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
149967840|NCT03895372|541017962|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
149967841|NCT03895372|541017963|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
149967842|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
149890888|NCT02892331|540729477|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
149890889|NCT02892331|540729478|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
149890890|NCT02892331|540729479|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
149890891|NCT02286713|540729483|FG000|One Week Follow-Up|Death|1|||
149890892|NCT02286713|540729484|FG001|One Week Follow-Up|Death|0|||
149890893|NCT02286713|540729483|FG000|One Week Follow-Up|Lost to Follow-up|17|||
150045164|NCT03892967|541304277|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
150045165|NCT03892967|541304278|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
150045166|NCT03892967|541304274|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
150045167|NCT03892967|541304275|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
150045168|NCT03892967|541304276|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
150175838|NCT00442117|541779939|FG001|Overall Study|Adverse Event|2|||
149890894|NCT02286713|540729484|FG001|One Week Follow-Up|Lost to Follow-up|21|||
149890895|NCT02286713|540729483|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
149890896|NCT02286713|540729484|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
149890897|NCT02286713|540729483|FG000|Three Month Follow-Up|Death|1|||
149890898|NCT02286713|540729484|FG001|Three Month Follow-Up|Death|1|||
149890899|NCT02286713|540729483|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
149890900|NCT02286713|540729484|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
149890901|NCT02286713|540729483|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
149890902|NCT02286713|540729484|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
149890903|NCT02286713|540729483|FG000|Six Month Follow-Up|Death|2|||
149890904|NCT02286713|540729484|FG001|Six Month Follow-Up|Death|0|||
149890905|NCT02286713|540729483|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
149890906|NCT02286713|540729484|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
149890907|NCT02654054|540729485|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
149890908|NCT02654054|540729486|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
149890909|NCT02654054|540729487|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
149890910|NCT02654054|540729485|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
149890911|NCT02654054|540729486|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149890912|NCT02654054|540729487|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
149890913|NCT02654054|540729485|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
149890914|NCT02654054|540729486|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
149890915|NCT02654054|540729487|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
149890916|NCT02654054|540729485|FG000|Post-Treatment Follow-Up Period|Other|1|||
149890917|NCT02654054|540729486|FG001|Post-Treatment Follow-Up Period|Other|0|||
149890918|NCT02654054|540729487|FG002|Post-Treatment Follow-Up Period|Other|4|||
149890919|NCT02654054|540729485|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
149890920|NCT02654054|540729486|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
149890921|NCT02654054|540729487|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
149890922|NCT06018129|540729492|FG000|Overall Study|Death|1|||
149890923|NCT06018129|540729493|FG001|Overall Study|Death|1|||
149890924|NCT06018129|540729494|FG002|Overall Study|Death|2|||
149890925|NCT06018129|540729492|FG000|Overall Study|Sponsor Decision|2|||
149890926|NCT06018129|540729493|FG001|Overall Study|Sponsor Decision|2|||
149890927|NCT06018129|540729494|FG002|Overall Study|Sponsor Decision|1|||
149890928|NCT03832686|540729495|FG000|Overall Study|Lost to Follow-up|6|||
149890929|NCT03832686|540729496|FG001|Overall Study|Lost to Follow-up|9|||
149890930|NCT03832686|540729495|FG000|Overall Study|Discontinued Intervention|5|||
149890931|NCT03832686|540729496|FG001|Overall Study|Discontinued Intervention|4|||
149890932|NCT03323398|540729497|FG000|Overall Study|Other than Specified|0|||
149890933|NCT03323398|540729498|FG001|Overall Study|Other than Specified|1|||
149890934|NCT03323398|540729499|FG002|Overall Study|Other than Specified|2|||
149890935|NCT03323398|540729500|FG003|Overall Study|Other than Specified|0|||
149890936|NCT03323398|540729501|FG004|Overall Study|Other than Specified|0|||
149890937|NCT03323398|540729502|FG005|Overall Study|Other than Specified|0|||
149890938|NCT03323398|540729503|FG006|Overall Study|Other than Specified|1|||
149890939|NCT03323398|540729504|FG007|Overall Study|Other than Specified|0|||
149890940|NCT03323398|540729505|FG008|Overall Study|Other than Specified|2|||
149890941|NCT03323398|540729497|FG000|Overall Study|Lost to Follow-up|1|||
149890942|NCT03323398|540729498|FG001|Overall Study|Lost to Follow-up|2|||
149890943|NCT03323398|540729499|FG002|Overall Study|Lost to Follow-up|1|||
149890944|NCT03323398|540729500|FG003|Overall Study|Lost to Follow-up|0|||
149890945|NCT03323398|540729501|FG004|Overall Study|Lost to Follow-up|0|||
149890946|NCT03323398|540729502|FG005|Overall Study|Lost to Follow-up|0|||
149890947|NCT03323398|540729503|FG006|Overall Study|Lost to Follow-up|0|||
149890948|NCT03323398|540729504|FG007|Overall Study|Lost to Follow-up|0|||
149890949|NCT03323398|540729505|FG008|Overall Study|Lost to Follow-up|0|||
149890950|NCT03323398|540729497|FG000|Overall Study|Death|4|||
149890951|NCT03323398|540729498|FG001|Overall Study|Death|6|||
149890952|NCT03323398|540729499|FG002|Overall Study|Death|2|||
149890953|NCT03323398|540729500|FG003|Overall Study|Death|2|||
149890954|NCT03323398|540729501|FG004|Overall Study|Death|1|||
149890955|NCT03323398|540729502|FG005|Overall Study|Death|2|||
149890956|NCT03323398|540729503|FG006|Overall Study|Death|0|||
149890957|NCT03323398|540729504|FG007|Overall Study|Death|0|||
149890958|NCT03323398|540729505|FG008|Overall Study|Death|6|||
149890959|NCT03323398|540729497|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
149890960|NCT03323398|540729498|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
149890961|NCT03323398|540729499|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
149890962|NCT03323398|540729500|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
149890963|NCT03323398|540729501|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
149890964|NCT03323398|540729502|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
149890965|NCT03323398|540729503|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
149890966|NCT03323398|540729504|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
149890967|NCT03323398|540729505|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
149890968|NCT03323398|540729497|FG000|Overall Study|Withdrawal by Subject|2|||
149890969|NCT03323398|540729498|FG001|Overall Study|Withdrawal by Subject|1|||
149890970|NCT03323398|540729499|FG002|Overall Study|Withdrawal by Subject|3|||
149890971|NCT03323398|540729500|FG003|Overall Study|Withdrawal by Subject|0|||
149890972|NCT03323398|540729501|FG004|Overall Study|Withdrawal by Subject|0|||
149890973|NCT03323398|540729502|FG005|Overall Study|Withdrawal by Subject|1|||
149890974|NCT03323398|540729503|FG006|Overall Study|Withdrawal by Subject|0|||
149890975|NCT03323398|540729504|FG007|Overall Study|Withdrawal by Subject|0|||
149967843|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967844|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967845|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967846|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967847|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967848|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
149967849|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
149967850|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
149967851|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
149967852|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
149967853|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
149967854|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
149967855|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
149967856|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
149967857|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
149967858|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
149967859|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
149967860|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
149967861|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
149967862|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
149967863|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
149890976|NCT03323398|540729505|FG008|Overall Study|Withdrawal by Subject|0|||
149890977|NCT03323398|540729497|FG000|Overall Study|Participant was Put on Hospice|0|||
149967864|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
149967865|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
149890978|NCT03323398|540729498|FG001|Overall Study|Participant was Put on Hospice|0|||
149967866|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
149890979|NCT03323398|540729499|FG002|Overall Study|Participant was Put on Hospice|0|||
149890980|NCT03323398|540729500|FG003|Overall Study|Participant was Put on Hospice|0|||
149890981|NCT03323398|540729501|FG004|Overall Study|Participant was Put on Hospice|0|||
149967867|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
149967868|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
149890982|NCT03323398|540729502|FG005|Overall Study|Participant was Put on Hospice|0|||
149890983|NCT03323398|540729503|FG006|Overall Study|Participant was Put on Hospice|1|||
149890984|NCT03323398|540729504|FG007|Overall Study|Participant was Put on Hospice|0|||
149890985|NCT03323398|540729505|FG008|Overall Study|Participant was Put on Hospice|0|||
149890986|NCT03323398|540729497|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
149890987|NCT03323398|540729498|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
149890988|NCT03323398|540729499|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
149890989|NCT03323398|540729500|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
149890990|NCT03323398|540729501|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
149890991|NCT03323398|540729502|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
149890992|NCT03323398|540729503|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
149890993|NCT03323398|540729504|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
149890994|NCT03323398|540729505|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
149890995|NCT02235454|540729506|FG000|Overall Study|Withdrawal by Subject|2|||
149890996|NCT03641469|540729507|FG000|Overall Study|Ineligible|2|||
149890997|NCT03641469|540729507|FG000|Overall Study|Withdrawal by Subject|5|||
149890998|NCT03641469|540729507|FG000|Overall Study|Physician Decision|1|||
149890999|NCT03641469|540729507|FG000|Overall Study|Protocol Violation|1|||
149891000|NCT03641469|540729507|FG000|Overall Study|Lost to Follow-up|2|||
149891001|NCT05479435|540729508|FG000|Overall Study|Withdrawal by Subject|1|||
149891002|NCT05479435|540729509|FG001|Overall Study|Withdrawal by Subject|0|||
149891003|NCT05479435|540729510|FG002|Overall Study|Withdrawal by Subject|0|||
149891004|NCT05479435|540729508|FG000|Overall Study|Covid 19|0|||
149891005|NCT05479435|540729509|FG001|Overall Study|Covid 19|0|||
149891006|NCT05479435|540729510|FG002|Overall Study|Covid 19|2|||
149891007|NCT00955617|540729513|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
149891008|NCT00955617|540729514|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
149891009|NCT00955617|540729513|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
149891010|NCT00955617|540729514|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
149891011|NCT00955617|540729513|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
149891012|NCT00955617|540729514|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
149891013|NCT00955617|540729513|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
149891014|NCT00955617|540729514|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
149891015|NCT00982657|540729515|FG000|Overall Study|Death|1|||
149891016|NCT00982657|540729516|FG001|Overall Study|Death|0|||
149891017|NCT00982657|540729517|FG002|Overall Study|Death|1|||
149891018|NCT00982657|540729518|FG003|Overall Study|Death|1|||
149891019|NCT00982657|540729515|FG000|Overall Study|Withdrawal by Subject|0|||
149891020|NCT00982657|540729516|FG001|Overall Study|Withdrawal by Subject|0|||
149891021|NCT00982657|540729517|FG002|Overall Study|Withdrawal by Subject|1|||
149891022|NCT00982657|540729518|FG003|Overall Study|Withdrawal by Subject|3|||
149891023|NCT00982657|540729515|FG000|Overall Study|Other|0|||
149891024|NCT00982657|540729516|FG001|Overall Study|Other|0|||
149891025|NCT00982657|540729517|FG002|Overall Study|Other|0|||
149891026|NCT00982657|540729518|FG003|Overall Study|Other|4|||
149891027|NCT00982657|540729515|FG000|Overall Study|On going at date of cut-off|0|||
149891028|NCT00982657|540729516|FG001|Overall Study|On going at date of cut-off|0|||
149891029|NCT00982657|540729517|FG002|Overall Study|On going at date of cut-off|0|||
149891030|NCT00982657|540729518|FG003|Overall Study|On going at date of cut-off|1|||
149891031|NCT04199104|540731396|FG000|Overall Study|Death|148|||
149891032|NCT04199104|540731397|FG001|Overall Study|Death|134|||
149891033|NCT04199104|540731396|FG000|Overall Study|Lost to Follow-up|1|||
149891034|NCT04199104|540731397|FG001|Overall Study|Lost to Follow-up|1|||
149967869|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
149967870|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
149891035|NCT04199104|540731396|FG000|Overall Study|Withdrawal by Subject|4|||
149891036|NCT04199104|540731397|FG001|Overall Study|Withdrawal by Subject|4|||
149891037|NCT04199104|540731396|FG000|Overall Study|Participants Ongoing|103|||
149967871|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
149891038|NCT04199104|540731397|FG001|Overall Study|Participants Ongoing|116|||
150175839|NCT00442117|541779938|FG000|Overall Study|Lack of Efficacy|2|||
149891039|NCT04563754|540731402|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
149891040|NCT04563754|540731403|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
149891041|NCT04563754|540731404|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
149891042|NCT04563754|540731402|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
149891043|NCT04563754|540731403|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
149891044|NCT04563754|540731404|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
149891045|NCT04563754|540731402|FG000|Follow up|Lost to Follow-up|61|||
149891046|NCT04563754|540731403|FG001|Follow up|Lost to Follow-up|23|||
149891047|NCT04563754|540731404|FG002|Follow up|Lost to Follow-up|5|||
149891048|NCT04563754|540731402|FG000|Follow up|Death|0|||
149891049|NCT04563754|540731403|FG001|Follow up|Death|2|||
149891050|NCT04563754|540731404|FG002|Follow up|Death|0|||
149891051|NCT04563754|540731402|FG000|Follow up|Ongoing|0|||
149891052|NCT04563754|540731403|FG001|Follow up|Ongoing|28|||
149891053|NCT04563754|540731404|FG002|Follow up|Ongoing|0|||
149891054|NCT04023396|540731405|FG000|Overall Study|Adverse Event|16|||
149891055|NCT04023396|540731405|FG000|Overall Study|Death|1|||
149891056|NCT04023396|540731405|FG000|Overall Study|Lost to Follow-up|1|||
149891057|NCT04023396|540731405|FG000|Overall Study|Withdrawal by Subject|14|||
149891058|NCT04023396|540731405|FG000|Overall Study|Pregnancy|4|||
149891059|NCT04023396|540731405|FG000|Overall Study|Lack of Efficacy|3|||
149891060|NCT04023396|540731405|FG000|Overall Study|Physician Decision|4|||
149891061|NCT04023396|540731405|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
149891062|NCT02325973|540731410|FG000|Overall Study|Death|5|||
149891063|NCT02325973|540731410|FG000|Overall Study|Withdrawal by subject or investigator|16|||
149891064|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
149891065|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
149891066|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
149891067|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
149891068|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
149891069|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
149891070|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
149891071|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
149891072|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
149891073|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
149891074|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
149891075|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
149891076|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
149891077|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
149891078|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
149891079|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
149891080|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
149891081|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
149891082|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
149891083|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
149891084|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
149891085|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
149891086|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
149891087|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
149891088|NCT02513160|540731411|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
149891089|NCT02513160|540731412|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
149891090|NCT02513160|540731413|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
149891091|NCT02513160|540731414|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
149891092|NCT02513160|540731411|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
149891093|NCT02513160|540731412|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
149891094|NCT02513160|540731413|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
149891095|NCT02513160|540731414|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
149891096|NCT02513160|540731411|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
150045169|NCT03892967|541304277|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
150045170|NCT03892967|541304278|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
150045171|NCT03892967|541304274|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
150051996|NCT00717236|541332848|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
149891097|NCT02513160|540731412|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
149891098|NCT02513160|540731413|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
149891099|NCT02513160|540731414|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
149891100|NCT02513160|540731411|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
149891101|NCT02513160|540731412|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
149891102|NCT02513160|540731413|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
149891103|NCT02513160|540731414|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
149891104|NCT02513160|540731411|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
149891105|NCT02513160|540731412|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
149891106|NCT02513160|540731413|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
149891107|NCT02513160|540731414|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
149891108|NCT02513160|540731411|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
149891109|NCT02513160|540731412|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
149891110|NCT02513160|540731413|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
149891111|NCT02513160|540731414|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
149891112|NCT04796909|540731419|FG000|Overall Study|Withdrawal by Subject|1|||
149891113|NCT04796909|540731420|FG001|Overall Study|Withdrawal by Subject|1|||
149891114|NCT03428958|540731421|FG000|Overall Study|Adverse Event|0|||
149891115|NCT03428958|540731422|FG001|Overall Study|Adverse Event|0|||
149891116|NCT03428958|540731423|FG002|Overall Study|Adverse Event|0|||
149891117|NCT03428958|540731424|FG003|Overall Study|Adverse Event|1|||
149891118|NCT03428958|540731425|FG004|Overall Study|Adverse Event|0|||
149891119|NCT03428958|540731426|FG005|Overall Study|Adverse Event|2|||
149891120|NCT03428958|540731427|FG006|Overall Study|Adverse Event|1|||
149891121|NCT03428958|540731428|FG007|Overall Study|Adverse Event|0|||
149891122|NCT03428958|540731429|FG008|Overall Study|Adverse Event|0|||
149891123|NCT03428958|540731430|FG009|Overall Study|Adverse Event|0|||
149891124|NCT03428958|540731431|FG010|Overall Study|Adverse Event|0|||
149891125|NCT03428958|540731432|FG011|Overall Study|Adverse Event|0|||
149891126|NCT03428958|540731433|FG012|Overall Study|Adverse Event|0|||
149891127|NCT03428958|540731434|FG013|Overall Study|Adverse Event|0|||
149891128|NCT03428958|540731435|FG014|Overall Study|Adverse Event|0|||
149891129|NCT03428958|540731436|FG015|Overall Study|Adverse Event|0|||
149891130|NCT03428958|540731437|FG016|Overall Study|Adverse Event|0|||
149891131|NCT03428958|540731421|FG000|Overall Study|Clinical Progression|2|||
149891132|NCT03428958|540731422|FG001|Overall Study|Clinical Progression|3|||
149891133|NCT03428958|540731423|FG002|Overall Study|Clinical Progression|2|||
149891134|NCT03428958|540731424|FG003|Overall Study|Clinical Progression|1|||
149891135|NCT03428958|540731425|FG004|Overall Study|Clinical Progression|0|||
149891136|NCT03428958|540731426|FG005|Overall Study|Clinical Progression|2|||
149891137|NCT03428958|540731427|FG006|Overall Study|Clinical Progression|0|||
149891138|NCT03428958|540731428|FG007|Overall Study|Clinical Progression|0|||
149891139|NCT03428958|540731429|FG008|Overall Study|Clinical Progression|0|||
149891140|NCT03428958|540731430|FG009|Overall Study|Clinical Progression|0|||
149891141|NCT03428958|540731431|FG010|Overall Study|Clinical Progression|0|||
149891142|NCT03428958|540731432|FG011|Overall Study|Clinical Progression|0|||
149891143|NCT03428958|540731433|FG012|Overall Study|Clinical Progression|0|||
149891144|NCT03428958|540731434|FG013|Overall Study|Clinical Progression|0|||
149891145|NCT03428958|540731435|FG014|Overall Study|Clinical Progression|0|||
149891146|NCT03428958|540731436|FG015|Overall Study|Clinical Progression|0|||
149891147|NCT03428958|540731437|FG016|Overall Study|Clinical Progression|0|||
149891148|NCT03428958|540731421|FG000|Overall Study|Progression per RECIST|6|||
149891149|NCT03428958|540731422|FG001|Overall Study|Progression per RECIST|6|||
149891150|NCT03428958|540731423|FG002|Overall Study|Progression per RECIST|7|||
149891151|NCT03428958|540731424|FG003|Overall Study|Progression per RECIST|4|||
149891152|NCT03428958|540731425|FG004|Overall Study|Progression per RECIST|0|||
149891153|NCT03428958|540731426|FG005|Overall Study|Progression per RECIST|7|||
149891154|NCT03428958|540731427|FG006|Overall Study|Progression per RECIST|8|||
149891155|NCT03428958|540731428|FG007|Overall Study|Progression per RECIST|0|||
149891156|NCT03428958|540731429|FG008|Overall Study|Progression per RECIST|0|||
149891157|NCT03428958|540731430|FG009|Overall Study|Progression per RECIST|0|||
149891158|NCT03428958|540731431|FG010|Overall Study|Progression per RECIST|0|||
149891159|NCT03428958|540731432|FG011|Overall Study|Progression per RECIST|0|||
149967872|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
149967873|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
149967874|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
149967875|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
149967876|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
149967877|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
149967878|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
149967879|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
149967880|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
149967881|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
149967882|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
149967883|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
149967884|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
149967885|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149891160|NCT03428958|540731433|FG012|Overall Study|Progression per RECIST|1|||
149891161|NCT03428958|540731434|FG013|Overall Study|Progression per RECIST|0|||
149891162|NCT03428958|540731435|FG014|Overall Study|Progression per RECIST|0|||
149891163|NCT03428958|540731436|FG015|Overall Study|Progression per RECIST|0|||
149891164|NCT03428958|540731437|FG016|Overall Study|Progression per RECIST|0|||
149891165|NCT03428958|540731421|FG000|Overall Study|Death|2|||
149891166|NCT03428958|540731422|FG001|Overall Study|Death|2|||
149891167|NCT03428958|540731423|FG002|Overall Study|Death|0|||
149891168|NCT03428958|540731424|FG003|Overall Study|Death|0|||
149891169|NCT03428958|540731425|FG004|Overall Study|Death|0|||
149891170|NCT03428958|540731426|FG005|Overall Study|Death|7|||
149891171|NCT03428958|540731427|FG006|Overall Study|Death|9|||
149891172|NCT03428958|540731428|FG007|Overall Study|Death|6|||
149891173|NCT03428958|540731429|FG008|Overall Study|Death|0|||
149891174|NCT03428958|540731430|FG009|Overall Study|Death|0|||
149891175|NCT03428958|540731431|FG010|Overall Study|Death|3|||
149891176|NCT03428958|540731432|FG011|Overall Study|Death|0|||
149891177|NCT03428958|540731433|FG012|Overall Study|Death|4|||
149891178|NCT03428958|540731434|FG013|Overall Study|Death|0|||
149891179|NCT03428958|540731435|FG014|Overall Study|Death|0|||
149891180|NCT03428958|540731436|FG015|Overall Study|Death|0|||
149891181|NCT03428958|540731437|FG016|Overall Study|Death|0|||
149891182|NCT03428958|540731421|FG000|Overall Study|Lost to Follow-up|0|||
149891183|NCT03428958|540731422|FG001|Overall Study|Lost to Follow-up|0|||
149891184|NCT03428958|540731423|FG002|Overall Study|Lost to Follow-up|0|||
149891185|NCT03428958|540731424|FG003|Overall Study|Lost to Follow-up|0|||
149891186|NCT03428958|540731425|FG004|Overall Study|Lost to Follow-up|0|||
149891187|NCT03428958|540731426|FG005|Overall Study|Lost to Follow-up|1|||
149891188|NCT03428958|540731427|FG006|Overall Study|Lost to Follow-up|1|||
149891189|NCT03428958|540731428|FG007|Overall Study|Lost to Follow-up|0|||
149891190|NCT03428958|540731429|FG008|Overall Study|Lost to Follow-up|0|||
149891191|NCT03428958|540731430|FG009|Overall Study|Lost to Follow-up|0|||
149891192|NCT03428958|540731431|FG010|Overall Study|Lost to Follow-up|0|||
149891193|NCT03428958|540731432|FG011|Overall Study|Lost to Follow-up|0|||
149891194|NCT03428958|540731433|FG012|Overall Study|Lost to Follow-up|0|||
149891195|NCT03428958|540731434|FG013|Overall Study|Lost to Follow-up|0|||
149891196|NCT03428958|540731435|FG014|Overall Study|Lost to Follow-up|0|||
149891197|NCT03428958|540731436|FG015|Overall Study|Lost to Follow-up|0|||
149891198|NCT03428958|540731437|FG016|Overall Study|Lost to Follow-up|0|||
149891199|NCT03428958|540731421|FG000|Overall Study|Physician/Sponsor Decision|1|||
149891200|NCT03428958|540731422|FG001|Overall Study|Physician/Sponsor Decision|0|||
149891201|NCT03428958|540731423|FG002|Overall Study|Physician/Sponsor Decision|1|||
149891202|NCT03428958|540731424|FG003|Overall Study|Physician/Sponsor Decision|0|||
149891203|NCT03428958|540731425|FG004|Overall Study|Physician/Sponsor Decision|0|||
149891204|NCT03428958|540731426|FG005|Overall Study|Physician/Sponsor Decision|2|||
149891205|NCT03428958|540731427|FG006|Overall Study|Physician/Sponsor Decision|2|||
149891206|NCT03428958|540731428|FG007|Overall Study|Physician/Sponsor Decision|2|||
149891207|NCT03428958|540731429|FG008|Overall Study|Physician/Sponsor Decision|0|||
149891208|NCT03428958|540731430|FG009|Overall Study|Physician/Sponsor Decision|0|||
149891209|NCT03428958|540731431|FG010|Overall Study|Physician/Sponsor Decision|2|||
149891210|NCT03428958|540731432|FG011|Overall Study|Physician/Sponsor Decision|0|||
149891211|NCT03428958|540731433|FG012|Overall Study|Physician/Sponsor Decision|4|||
149891212|NCT03428958|540731434|FG013|Overall Study|Physician/Sponsor Decision|0|||
149891213|NCT03428958|540731435|FG014|Overall Study|Physician/Sponsor Decision|0|||
149891214|NCT03428958|540731436|FG015|Overall Study|Physician/Sponsor Decision|0|||
149891215|NCT03428958|540731437|FG016|Overall Study|Physician/Sponsor Decision|0|||
149891216|NCT03428958|540731421|FG000|Overall Study|Withdrawal by Subject|0|||
149891217|NCT03428958|540731422|FG001|Overall Study|Withdrawal by Subject|0|||
149891218|NCT03428958|540731423|FG002|Overall Study|Withdrawal by Subject|2|||
149891219|NCT03428958|540731424|FG003|Overall Study|Withdrawal by Subject|0|||
149891220|NCT03428958|540731425|FG004|Overall Study|Withdrawal by Subject|0|||
149891221|NCT03428958|540731426|FG005|Overall Study|Withdrawal by Subject|2|||
149891222|NCT03428958|540731427|FG006|Overall Study|Withdrawal by Subject|4|||
149891223|NCT03428958|540731428|FG007|Overall Study|Withdrawal by Subject|1|||
149891224|NCT03428958|540731429|FG008|Overall Study|Withdrawal by Subject|0|||
149891225|NCT03428958|540731430|FG009|Overall Study|Withdrawal by Subject|0|||
149891226|NCT03428958|540731431|FG010|Overall Study|Withdrawal by Subject|0|||
149891227|NCT03428958|540731432|FG011|Overall Study|Withdrawal by Subject|0|||
149891228|NCT03428958|540731433|FG012|Overall Study|Withdrawal by Subject|0|||
149891229|NCT03428958|540731434|FG013|Overall Study|Withdrawal by Subject|0|||
149891230|NCT03428958|540731435|FG014|Overall Study|Withdrawal by Subject|0|||
149891231|NCT03428958|540731436|FG015|Overall Study|Withdrawal by Subject|0|||
149891232|NCT03428958|540731437|FG016|Overall Study|Withdrawal by Subject|0|||
149891233|NCT03874117|540731438|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
149891234|NCT03874117|540731439|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
149891235|NCT03874117|540731438|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
149891236|NCT03874117|540731439|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
150175840|NCT00442117|541779939|FG001|Overall Study|Lack of Efficacy|6|||
149891237|NCT03874117|540731438|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149891238|NCT03874117|540731439|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149891239|NCT03874117|540731438|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
149891240|NCT03874117|540731439|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
149891241|NCT03874117|540731438|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
149891242|NCT03874117|540731439|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
149891243|NCT03985800|540731440|FG000|Overall Study|Death|1|||
149891244|NCT03985800|540731441|FG001|Overall Study|Death|2|||
149891245|NCT03985800|540731440|FG000|Overall Study|Withdrawal by Subject|3|||
149891246|NCT03985800|540731441|FG001|Overall Study|Withdrawal by Subject|6|||
149967886|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149891247|NCT03985800|540731440|FG000|Overall Study|Protocol Violation|2|||
149891248|NCT03985800|540731441|FG001|Overall Study|Protocol Violation|0|||
149891249|NCT05012098|540731442|FG000|Overall Study|Disease progression|5|||
149891250|NCT05012098|540731443|FG001|Overall Study|Disease progression|2|||
149891251|NCT05012098|540731442|FG000|Overall Study|Adverse Event|1|||
149891252|NCT05012098|540731443|FG001|Overall Study|Adverse Event|0|||
149891253|NCT05012098|540731442|FG000|Overall Study|Withdrawal by Subject|1|||
149891254|NCT05012098|540731443|FG001|Overall Study|Withdrawal by Subject|0|||
149891255|NCT05012098|540731442|FG000|Overall Study|Discontinuation per protocol|1|||
149891256|NCT05012098|540731443|FG001|Overall Study|Discontinuation per protocol|0|||
149891257|NCT05258773|540731444|FG000|Overall Study|Screen Failure|1|||
149891258|NCT05258773|540731445|FG001|Overall Study|Screen Failure|1|||
149891259|NCT05258773|540731444|FG000|Overall Study|Adverse Event|1|||
149891260|NCT05258773|540731445|FG001|Overall Study|Adverse Event|0|||
149891261|NCT05258773|540731444|FG000|Overall Study|Withdrawal by Subject|0|||
149891262|NCT05258773|540731445|FG001|Overall Study|Withdrawal by Subject|1|||
149891263|NCT04815083|540731446|FG000|Overall Study|Physician Decision|1|||
149891264|NCT04815083|540731446|FG000|Overall Study|Study pause|2|||
149891265|NCT04815083|540731446|FG000|Overall Study|Screening failure|4|||
149891266|NCT06025721|540731447|FG000|Overall Study|Physician Decision|1|||
149891267|NCT06025721|540731447|FG000|Overall Study|Protocol Violation|1|||
149891268|NCT06025721|540731447|FG000|Overall Study|Incarceration|1|||
149891269|NCT05364931|540731452|FG000|Overall Study|Adverse Event|0|||
149891270|NCT05364931|540731453|FG001|Overall Study|Adverse Event|2|||
149891271|NCT05364931|540731454|FG002|Overall Study|Adverse Event|1|||
149891272|NCT05364931|540731455|FG003|Overall Study|Adverse Event|0|||
149891273|NCT05364931|540731452|FG000|Overall Study|Lost to Follow-up|1|||
149891274|NCT05364931|540731453|FG001|Overall Study|Lost to Follow-up|0|||
149891275|NCT05364931|540731454|FG002|Overall Study|Lost to Follow-up|0|||
149891276|NCT05364931|540731455|FG003|Overall Study|Lost to Follow-up|0|||
149891277|NCT05364931|540731452|FG000|Overall Study|Withdrawal by Subject|1|||
149891278|NCT05364931|540731453|FG001|Overall Study|Withdrawal by Subject|1|||
149891279|NCT05364931|540731454|FG002|Overall Study|Withdrawal by Subject|3|||
149891280|NCT05364931|540731455|FG003|Overall Study|Withdrawal by Subject|2|||
149891281|NCT05364931|540731452|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
149967887|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149967888|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149967889|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149967890|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
149967891|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967892|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
149967893|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967894|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967895|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967896|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967897|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
149967898|NCT01362790|541017966|FG000|Pilot Phase & Phase 2|Death on study|0|||
149967899|NCT01362790|541017967|FG001|Pilot Phase & Phase 2|Death on study|0|||
149967900|NCT01362790|541017968|FG002|Pilot Phase & Phase 2|Death on study|0|||
149967901|NCT01362790|541017969|FG003|Pilot Phase & Phase 2|Death on study|1|||
149967902|NCT01362790|541017970|FG004|Pilot Phase & Phase 2|Death on study|0|||
149967903|NCT01362790|541017971|FG005|Pilot Phase & Phase 2|Death on study|0|||
149967904|NCT01362790|541017972|FG006|Pilot Phase & Phase 2|Death on study|0|||
149967905|NCT01362790|541017966|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
149967906|NCT01362790|541017967|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
149967907|NCT01362790|541017968|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
149967908|NCT01362790|541017969|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
149967909|NCT01362790|541017970|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
149967910|NCT01362790|541017971|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
149967911|NCT01362790|541017972|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
149891282|NCT05364931|540731453|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
149891283|NCT05364931|540731454|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
149891284|NCT05364931|540731455|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
149967912|NCT01362790|541017966|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149891285|NCT05364931|540731452|FG000|Overall Study|Discontinued|1|||
149891286|NCT05364931|540731453|FG001|Overall Study|Discontinued|0|||
149891287|NCT05364931|540731454|FG002|Overall Study|Discontinued|0|||
149891288|NCT05364931|540731455|FG003|Overall Study|Discontinued|0|||
149891289|NCT02243605|540731456|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
149891290|NCT02243605|540731457|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
149891291|NCT02243605|540731456|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
149891292|NCT02243605|540731457|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
149891293|NCT02243605|540731456|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
149891294|NCT02243605|540731457|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
149891295|NCT02243605|540731456|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
149891296|NCT02243605|540731457|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
149891297|NCT02243605|540731456|FG000|Stage 2 - Final Analysis Population|Progression|0|||
149891298|NCT02243605|540731457|FG001|Stage 2 - Final Analysis Population|Progression|1|||
149891299|NCT00075816|540731458|FG000|Overall Study|Did not undergo transplantation|14|||
149891300|NCT00075816|540731459|FG001|Overall Study|Did not undergo transplantation|11|||
149891301|NCT04173507|540731460|FG000|Overall Study|On Treatment|3|||
149891302|NCT04173507|540731460|FG000|Overall Study|Adverse Event|3|||
149891303|NCT04173507|540731460|FG000|Overall Study|Progression/Relapse|34|||
149891304|NCT04173507|540731460|FG000|Overall Study|Death|2|||
149891305|NCT01823328|540731461|FG000|Overall Study|Withdrawal by Subject|8|||
149891306|NCT01823328|540731462|FG001|Overall Study|Withdrawal by Subject|6|||
149891307|NCT02832687|540731463|FG000|Overall Study|Adverse Event|0|||
149891308|NCT02832687|540731464|FG001|Overall Study|Adverse Event|2|||
149891309|NCT04231825|540731465|FG000|Overall Study|Protocol Violation|3|||
149891310|NCT04231825|540731466|FG001|Overall Study|Protocol Violation|3|||
149891311|NCT04231825|540731465|FG000|Overall Study|Lost to Follow-up|0|||
149891312|NCT04231825|540731466|FG001|Overall Study|Lost to Follow-up|1|||
149891313|NCT01662635|540731467|FG000|Overall Study|scarce samples for evaluation|30|||
149891314|NCT03588910|540731470|FG000|Overall Study|Withdrawal by Subject|1|||
149891315|NCT03588910|540731471|FG001|Overall Study|Withdrawal by Subject|0|||
149891316|NCT03588910|540731470|FG000|Overall Study|Allergy|2|||
149891317|NCT03588910|540731471|FG001|Overall Study|Allergy|0|||
149891318|NCT03588910|540731470|FG000|Overall Study|Protocol Violation|0|||
149891319|NCT03588910|540731471|FG001|Overall Study|Protocol Violation|3|||
149891320|NCT03588910|540731470|FG000|Overall Study|Did not complete Day 1 Survey|5|||
149891321|NCT03588910|540731471|FG001|Overall Study|Did not complete Day 1 Survey|10|||
149891322|NCT03588910|540731470|FG000|Overall Study|Did not complete Day 7 Survey|5|||
149967913|NCT01362790|541017967|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149967914|NCT01362790|541017968|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149967915|NCT01362790|541017969|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149967916|NCT01362790|541017970|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
149967917|NCT01362790|541017971|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149967918|NCT01362790|541017972|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
149967919|NCT01362790|541017966|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
150045172|NCT03892967|541304275|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
150175841|NCT00442117|541779938|FG000|Overall Study|Lost to Follow-up|1|||
149891323|NCT03588910|540731471|FG001|Overall Study|Did not complete Day 7 Survey|2|||
149891324|NCT02547428|540731472|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
149891325|NCT02547428|540731473|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
149891326|NCT02547428|540731472|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
150175842|NCT00442117|541779939|FG001|Overall Study|Lost to Follow-up|2|||
150175843|NCT00442117|541779938|FG000|Overall Study|Withdrawal by Subject|2|||
150175844|NCT00442117|541779939|FG001|Overall Study|Withdrawal by Subject|2|||
149891327|NCT02547428|540731473|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
149891328|NCT02547428|540731472|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
150175845|NCT00442117|541779938|FG000|Overall Study|Major Deviation|25|||
149891329|NCT02547428|540731473|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
149891330|NCT02547428|540731472|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
149891331|NCT02547428|540731473|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
149891332|NCT02547428|540731472|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
149891333|NCT02547428|540731473|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
149891334|NCT02547428|540731472|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
149891335|NCT02547428|540731473|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
149891336|NCT02547428|540731472|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
149891337|NCT02547428|540731473|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
149891338|NCT02547428|540731472|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
149891339|NCT02547428|540731473|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
149891340|NCT01892501|540731474|FG000|Overall Study|Protocol Violation|2|||
149891341|NCT01892501|540731474|FG000|Overall Study|Puncture not carried out|9|||
149891342|NCT01892501|540731474|FG000|Overall Study|Radiological monitoring not carried out|5|||
150175846|NCT00442117|541779939|FG001|Overall Study|Major Deviation|20|||
150175847|NCT00442117|541779938|FG000|Overall Study|Non compliance with protocol|3|||
150175848|NCT00442117|541779939|FG001|Overall Study|Non compliance with protocol|5|||
150175849|NCT00442117|541779938|FG000|Overall Study|Met Withdrawal Criteria|2|||
150175850|NCT00442117|541779939|FG001|Overall Study|Met Withdrawal Criteria|1|||
150175851|NCT00841035|541779945|FG000|Phase 1 Overall Study|Physician Decision|13|||
150175852|NCT00433199|541779950|FG000|Double-Blind Period|Adverse Event|0|||
150175853|NCT00433199|541779951|FG001|Double-Blind Period|Adverse Event|25|||
150175854|NCT00433199|541779950|FG000|Double-Blind Period|Lack of Efficacy|0|||
150175855|NCT00433199|541779951|FG001|Double-Blind Period|Lack of Efficacy|2|||
150175856|NCT00433199|541779950|FG000|Double-Blind Period|Lost to Follow-up|2|||
150175857|NCT00433199|541779951|FG001|Double-Blind Period|Lost to Follow-up|5|||
149891343|NCT01892501|540731474|FG000|Overall Study|Non-contributory histological result|12|||
149891344|NCT03664232|540731479|FG000|Overall Study|Withdrawal by Subject|0|||
149891345|NCT03664232|540731480|FG001|Overall Study|Withdrawal by Subject|1|||
149891346|NCT03664232|540731481|FG002|Overall Study|Withdrawal by Subject|0|||
149891347|NCT03664232|540731482|FG003|Overall Study|Withdrawal by Subject|1|||
149891348|NCT03664232|540731479|FG000|Overall Study|Adverse Event|0|||
149891349|NCT03664232|540731480|FG001|Overall Study|Adverse Event|0|||
149891350|NCT03664232|540731481|FG002|Overall Study|Adverse Event|1|||
149891351|NCT03664232|540731482|FG003|Overall Study|Adverse Event|0|||
149891352|NCT03664232|540731479|FG000|Overall Study|Other-Non-compliance with study drug|0|||
149891353|NCT03664232|540731480|FG001|Overall Study|Other-Non-compliance with study drug|1|||
149891354|NCT03664232|540731481|FG002|Overall Study|Other-Non-compliance with study drug|0|||
149891355|NCT03664232|540731482|FG003|Overall Study|Other-Non-compliance with study drug|2|||
149891356|NCT03664232|540731479|FG000|Overall Study|Other-Unspecified|0|||
149891357|NCT03664232|540731480|FG001|Overall Study|Other-Unspecified|3|||
149891358|NCT03664232|540731481|FG002|Overall Study|Other-Unspecified|0|||
149891359|NCT03664232|540731482|FG003|Overall Study|Other-Unspecified|1|||
149891360|NCT03664232|540731479|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
149891361|NCT03664232|540731480|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
149891362|NCT03664232|540731481|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
149891363|NCT03664232|540731482|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
149891364|NCT01439802|540731483|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
149891365|NCT01439802|540731483|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
149891366|NCT00370552|540731484|FG000|Overall Study|Adverse Event|2|||
149891367|NCT00370552|540731485|FG001|Overall Study|Adverse Event|2|||
149891368|NCT00370552|540731486|FG002|Overall Study|Adverse Event|2|||
149891369|NCT00370552|540731484|FG000|Overall Study|Disease progression|23|||
149891370|NCT00370552|540731485|FG001|Overall Study|Disease progression|23|||
149891371|NCT00370552|540731486|FG002|Overall Study|Disease progression|15|||
149891372|NCT00370552|540731484|FG000|Overall Study|Maximum clinical benefit|3|||
150175858|NCT00433199|541779950|FG000|Double-Blind Period|Withdrawal by Subject|8|||
149891373|NCT00370552|540731485|FG001|Overall Study|Maximum clinical benefit|5|||
149891374|NCT00370552|540731486|FG002|Overall Study|Maximum clinical benefit|5|||
149891375|NCT00370552|540731484|FG000|Overall Study|Poor or noncompliance|0|||
149891376|NCT00370552|540731485|FG001|Overall Study|Poor or noncompliance|0|||
149891377|NCT00370552|540731486|FG002|Overall Study|Poor or noncompliance|1|||
149891378|NCT00370552|540731484|FG000|Overall Study|Study drug toxicity|11|||
149891379|NCT00370552|540731485|FG001|Overall Study|Study drug toxicity|8|||
149891380|NCT00370552|540731486|FG002|Overall Study|Study drug toxicity|6|||
149891381|NCT00370552|540731484|FG000|Overall Study|Withdrawal by Subject|2|||
149891382|NCT00370552|540731485|FG001|Overall Study|Withdrawal by Subject|0|||
149891383|NCT00370552|540731486|FG002|Overall Study|Withdrawal by Subject|1|||
149891384|NCT00370552|540731484|FG000|Overall Study|Still on treatment|1|||
149891385|NCT00370552|540731485|FG001|Overall Study|Still on treatment|3|||
150175859|NCT00433199|541779951|FG001|Double-Blind Period|Withdrawal by Subject|19|||
150175860|NCT00433199|541779950|FG000|Double-Blind Period|Protocol Violation|1|||
150175861|NCT00433199|541779951|FG001|Double-Blind Period|Protocol Violation|10|||
150175862|NCT00433199|541779950|FG000|Double-Blind Period|Administrative|1|||
149891386|NCT00370552|540731486|FG002|Overall Study|Still on treatment|2|||
149891387|NCT00370552|540731484|FG000|Overall Study|Never treated|1|||
149891388|NCT00370552|540731485|FG001|Overall Study|Never treated|0|||
149891389|NCT00370552|540731486|FG002|Overall Study|Never treated|0|||
149891390|NCT00370552|540731484|FG000|Overall Study|Physician Decision|1|||
149891391|NCT00370552|540731485|FG001|Overall Study|Physician Decision|1|||
149891392|NCT00370552|540731486|FG002|Overall Study|Physician Decision|0|||
149891393|NCT00370552|540731484|FG000|Overall Study|Investigator decision|2|||
149891394|NCT00370552|540731485|FG001|Overall Study|Investigator decision|1|||
149891395|NCT00370552|540731486|FG002|Overall Study|Investigator decision|0|||
149891396|NCT00370552|540731484|FG000|Overall Study|High risk of allergic reaction|0|||
149891397|NCT00370552|540731485|FG001|Overall Study|High risk of allergic reaction|1|||
149891398|NCT00370552|540731486|FG002|Overall Study|High risk of allergic reaction|0|||
149891399|NCT00370552|540731484|FG000|Overall Study|Planned radiation for palliation|0|||
149891400|NCT00370552|540731485|FG001|Overall Study|Planned radiation for palliation|1|||
149891401|NCT00370552|540731486|FG002|Overall Study|Planned radiation for palliation|0|||
149891402|NCT00654095|540731487|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
149891403|NCT00654095|540731487|FG000|Overall Study|Elevated triglyceride level (2)|1|||
149891404|NCT00654095|540731487|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
149891405|NCT00654095|540731487|FG000|Overall Study|Adverse Event|11|||
149891406|NCT00654095|540731487|FG000|Overall Study|Withdrawal by Subject|5|||
149891407|NCT00654095|540731487|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
149891408|NCT00654095|540731487|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
149891409|NCT00654095|540731487|FG000|Overall Study|Did not meet inclusion criteria|1|||
149891410|NCT02502149|540731488|FG000|Intermediate|Discontinued prematurely|1|||
149891411|NCT02502149|540731489|FG001|Intermediate|Discontinued prematurely|0|||
149891412|NCT02502149|540731490|FG002|Intermediate|Discontinued prematurely|0|||
149891413|NCT02502149|540731491|FG003|Intermediate|Discontinued prematurely|0|||
149891414|NCT02502149|540731492|FG004|Intermediate|Discontinued prematurely|0|||
149891415|NCT02548832|540731493|FG000|Overall Study|Lost to Follow-up|2|||
149891416|NCT02548832|540731494|FG001|Overall Study|Lost to Follow-up|2|||
149891417|NCT02548832|540731495|FG002|Overall Study|Lost to Follow-up|2|||
149967920|NCT01362790|541017967|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
149967921|NCT01362790|541017968|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
149967922|NCT01362790|541017969|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
149967923|NCT01362790|541017970|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
149967924|NCT01362790|541017971|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
149967925|NCT01362790|541017972|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
149967926|NCT00635050|541017978|FG000|Overall Study|Withdrawal by Subject|1|||
149967927|NCT00437073|541017979|FG000|Overall Study|Sponsor Terminated Study|1|||
149967928|NCT00437073|541017980|FG001|Overall Study|Sponsor Terminated Study|0|||
149967929|NCT00437073|541017979|FG000|Overall Study|Physician Decision|0|||
149967930|NCT00437073|541017980|FG001|Overall Study|Physician Decision|1|||
149967931|NCT03485157|541017981|FG000|Double Blind Phase|Lost to Follow-up|4|||
149967932|NCT03485157|541017982|FG001|Double Blind Phase|Lost to Follow-up|4|||
149967933|NCT03485157|541017981|FG000|Double Blind Phase|Adverse Event|2|||
149967934|NCT03485157|541017982|FG001|Double Blind Phase|Adverse Event|1|||
149967935|NCT03485157|541017981|FG000|Double Blind Phase|Withdrawal by Subject|6|||
149967936|NCT03485157|541017982|FG001|Double Blind Phase|Withdrawal by Subject|9|||
149967937|NCT03485157|541017981|FG000|Double Blind Phase|Removal by PI|3|||
149967938|NCT03485157|541017982|FG001|Double Blind Phase|Removal by PI|7|||
149967939|NCT03485157|541017981|FG000|Open Label Phase|Lost to Follow-up|1|||
149967940|NCT03485157|541017982|FG001|Open Label Phase|Lost to Follow-up|2|||
149967941|NCT03485157|541017981|FG000|Open Label Phase|Adverse Event|0|||
149967942|NCT03485157|541017982|FG001|Open Label Phase|Adverse Event|1|||
150175863|NCT00433199|541779951|FG001|Double-Blind Period|Administrative|5|||
150175864|NCT00433199|541779950|FG000|Open-Label Period|Adverse Event|0|||
149891418|NCT02968576|540731496|FG000|Overall Study|Pregnancy|0|||
149891419|NCT02968576|540731497|FG001|Overall Study|Pregnancy|1|||
149891420|NCT01062425|540731508|FG000|Overall Study|Protocol Violation|3|||
149891421|NCT01062425|540731509|FG001|Overall Study|Protocol Violation|6|||
149891422|NCT05263908|540731510|FG000|Overall Study|No informed consent for publication of study results|397|||
149967943|NCT03485157|541017981|FG000|Open Label Phase|Withdrawal by Subject|1|||
149967944|NCT03485157|541017982|FG001|Open Label Phase|Withdrawal by Subject|2|||
149967945|NCT03485157|541017981|FG000|Open Label Phase|Removal by PI|2|||
149967946|NCT03485157|541017982|FG001|Open Label Phase|Removal by PI|0|||
149967947|NCT01849276|541017983|FG000|Followed for Survival for 5 Years|Death|1|||
149967948|NCT01849276|541017983|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
149891423|NCT05263908|540731510|FG000|Overall Study|CRF not collected|1|||
149891424|NCT01651117|540731513|FG000|Overall Study|Death|2|||
150175865|NCT00433199|541779951|FG001|Open-Label Period|Adverse Event|19|||
149891425|NCT01651117|540731514|FG001|Overall Study|Death|3|||
149891426|NCT01651117|540731515|FG002|Overall Study|Death|2|||
149967949|NCT00539500|541017984|FG000|Overall Study|Disease Progression|1|||
149967950|NCT00539500|541017984|FG000|Overall Study|Lost to Follow-up|2|||
149967951|NCT02657343|541017985|FG000|Overall Study|Death|0|||
149967952|NCT02657343|541017986|FG001|Overall Study|Death|2|||
149967953|NCT02657343|541017987|FG002|Overall Study|Death|0|||
149967954|NCT02657343|541017988|FG003|Overall Study|Death|0|||
149967955|NCT02657343|541017989|FG004|Overall Study|Death|0|||
149967956|NCT02657343|541017990|FG005|Overall Study|Death|0|||
149967957|NCT02657343|541017985|FG000|Overall Study|Patient went to hospice|1|||
149967958|NCT02657343|541017986|FG001|Overall Study|Patient went to hospice|0|||
149967959|NCT02657343|541017987|FG002|Overall Study|Patient went to hospice|0|||
149967960|NCT02657343|541017988|FG003|Overall Study|Patient went to hospice|0|||
149967961|NCT02657343|541017989|FG004|Overall Study|Patient went to hospice|0|||
149967962|NCT02657343|541017990|FG005|Overall Study|Patient went to hospice|0|||
149967963|NCT02657343|541017985|FG000|Overall Study|Withdrawal by Subject|0|||
149967964|NCT02657343|541017986|FG001|Overall Study|Withdrawal by Subject|0|||
149967965|NCT02657343|541017987|FG002|Overall Study|Withdrawal by Subject|0|||
149967966|NCT02657343|541017988|FG003|Overall Study|Withdrawal by Subject|0|||
149967967|NCT02657343|541017989|FG004|Overall Study|Withdrawal by Subject|1|||
149967968|NCT02657343|541017990|FG005|Overall Study|Withdrawal by Subject|0|||
149967969|NCT02011542|541017991|FG000|Overall Study|Physician Decision|1|||
149967970|NCT02904096|541017992|FG000|Overall Study|Adverse Event|1|||
149967971|NCT02904096|541017993|FG001|Overall Study|Adverse Event|0|||
149967972|NCT02904096|541017992|FG000|Overall Study|Withdrawal by Subject|4|||
149967973|NCT02904096|541017993|FG001|Overall Study|Withdrawal by Subject|3|||
149967974|NCT02904096|541017992|FG000|Overall Study|Lost to Follow-up|10|||
149967975|NCT02904096|541017993|FG001|Overall Study|Lost to Follow-up|17|||
149967976|NCT02904096|541017992|FG000|Overall Study|Non-compliant|3|||
149967977|NCT02904096|541017993|FG001|Overall Study|Non-compliant|1|||
149967978|NCT02904096|541017992|FG000|Overall Study|Sponsor instructed|1|||
149967979|NCT02904096|541017993|FG001|Overall Study|Sponsor instructed|0|||
149967980|NCT00663260|541017995|FG000|Overall Study|Lack of Efficacy|2|||
149967981|NCT00663260|541017996|FG001|Overall Study|Lack of Efficacy|0|||
149967982|NCT00663260|541017997|FG002|Overall Study|Lack of Efficacy|0|||
149967983|NCT00663260|541017995|FG000|Overall Study|Adverse Event|12|||
149967984|NCT00663260|541017996|FG001|Overall Study|Adverse Event|7|||
149967985|NCT00663260|541017997|FG002|Overall Study|Adverse Event|6|||
149967986|NCT00663260|541017995|FG000|Overall Study|Withdrawal by Subject|3|||
149967987|NCT00663260|541017996|FG001|Overall Study|Withdrawal by Subject|1|||
149967988|NCT00663260|541017997|FG002|Overall Study|Withdrawal by Subject|6|||
149967989|NCT00663260|541017995|FG000|Overall Study|Death|1|||
149967990|NCT00663260|541017996|FG001|Overall Study|Death|0|||
149967991|NCT00663260|541017997|FG002|Overall Study|Death|1|||
149967992|NCT00663260|541017995|FG000|Overall Study|Lost to Follow-up|0|||
149967993|NCT00663260|541017996|FG001|Overall Study|Lost to Follow-up|1|||
149967994|NCT00663260|541017997|FG002|Overall Study|Lost to Follow-up|0|||
149967995|NCT00663260|541017995|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
149967996|NCT00663260|541017996|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
149967997|NCT00663260|541017997|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
149967998|NCT01979185|541018001|FG000|Period 2|Other|0|||
149967999|NCT01979185|541018002|FG001|Period 2|Other|1|||
149968000|NCT00980798|541018003|FG000|Overall Study|Adverse Event|7|||
149968001|NCT00980798|541018004|FG001|Overall Study|Adverse Event|36|||
149968002|NCT00980798|541018003|FG000|Overall Study|Lack of Efficacy|16|||
149968003|NCT00980798|541018004|FG001|Overall Study|Lack of Efficacy|5|||
149968004|NCT00980798|541018003|FG000|Overall Study|Lost to Follow-up|0|||
149968005|NCT00980798|541018004|FG001|Overall Study|Lost to Follow-up|1|||
149968006|NCT00980798|541018003|FG000|Overall Study|Physician Decision|2|||
149968007|NCT00980798|541018004|FG001|Overall Study|Physician Decision|1|||
149968008|NCT00980798|541018003|FG000|Overall Study|Withdrawal by Subject|8|||
149968009|NCT00980798|541018004|FG001|Overall Study|Withdrawal by Subject|11|||
149968010|NCT00980798|541018003|FG000|Overall Study|Other|0|||
149968011|NCT00980798|541018004|FG001|Overall Study|Other|1|||
149968012|NCT02607722|541018005|FG000|Overall Study|No data reliability|1|||
149968013|NCT02607722|541018005|FG000|Overall Study|no patient visit|18|||
149968014|NCT02607722|541018005|FG000|Overall Study|missing info in CRF|13|||
149968015|NCT02607722|541018005|FG000|Overall Study|Withdrawal by Subject|616|||
149968016|NCT02607722|541018005|FG000|Overall Study|Lost to Follow-up|312|||
149968017|NCT02607722|541018005|FG000|Overall Study|Improved|22|||
149968018|NCT02607722|541018005|FG000|Overall Study|Lack of Efficacy|316|||
149968019|NCT02607722|541018005|FG000|Overall Study|Adverse Event|2553|||
149968020|NCT02607722|541018005|FG000|Overall Study|Not treated|1|||
149968021|NCT02607722|541018005|FG000|Overall Study|No CRF collected|138|||
149968022|NCT02607722|541018005|FG000|Overall Study|without CRF|4225|||
149891427|NCT01651117|540731516|FG003|Overall Study|Death|2|||
149891428|NCT02088177|540731519|FG000|Overall Study|Lost to Follow-up|3|||
149891429|NCT01641640|540731521|FG000|Overall Study|Enrolled but not treated|1|||
149891430|NCT01641640|540731521|FG000|Overall Study|Efficacy failure|29|||
149891431|NCT01641640|540731521|FG000|Overall Study|Lost to Follow-up|3|||
149891432|NCT01641640|540731521|FG000|Overall Study|Withdrawal by Subject|2|||
149891433|NCT01641640|540731521|FG000|Overall Study|Adverse Event|1|||
149891434|NCT01234350|540731523|FG000|Overall Study|Adverse Event|277|||
149891435|NCT01234350|540731524|FG001|Overall Study|Adverse Event|92|||
149891436|NCT01234350|540731523|FG000|Overall Study|Withdrawal by Subject|61|||
149891437|NCT01234350|540731524|FG001|Overall Study|Withdrawal by Subject|36|||
149891438|NCT01234350|540731523|FG000|Overall Study|Lost to Follow-up|115|||
149891439|NCT01234350|540731524|FG001|Overall Study|Lost to Follow-up|47|||
149891440|NCT01234350|540731523|FG000|Overall Study|Covers a diverse set of reasons|234|||
149891441|NCT01234350|540731524|FG001|Overall Study|Covers a diverse set of reasons|92|||
149891442|NCT00289848|540731525|FG000|Overall Study|Adverse Event|6|||
149891443|NCT00289848|540731526|FG001|Overall Study|Adverse Event|4|||
149891444|NCT00289848|540731525|FG000|Overall Study|Death|1|||
149891445|NCT00289848|540731526|FG001|Overall Study|Death|0|||
149891446|NCT00289848|540731525|FG000|Overall Study|Lack of Efficacy|20|||
149891447|NCT00289848|540731526|FG001|Overall Study|Lack of Efficacy|24|||
149891448|NCT00289848|540731525|FG000|Overall Study|Lost to Follow-up|3|||
149891449|NCT00289848|540731526|FG001|Overall Study|Lost to Follow-up|1|||
149891450|NCT00289848|540731525|FG000|Overall Study|Protocol Violation|5|||
149891451|NCT00289848|540731526|FG001|Overall Study|Protocol Violation|2|||
149891452|NCT00289848|540731525|FG000|Overall Study|Withdrawal by Subject|5|||
149891453|NCT00289848|540731526|FG001|Overall Study|Withdrawal by Subject|11|||
149891454|NCT00289848|540731525|FG000|Overall Study|Patient Moved|6|||
149891455|NCT00289848|540731526|FG001|Overall Study|Patient Moved|2|||
149891456|NCT00289848|540731525|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
149891457|NCT00289848|540731526|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
149891458|NCT02792517|540731534|FG000|Overall Study|Withdrawal by Subject|10|||
149891459|NCT02792517|540731534|FG000|Overall Study|Decision by Sponsor|7|||
149891460|NCT02792517|540731534|FG000|Overall Study|Lost to Follow-up|3|||
149891461|NCT01894919|540731535|FG000|Overall Study|Withdrawal by Subject|1|||
149891462|NCT01894919|540731536|FG001|Overall Study|Withdrawal by Subject|0|||
149891463|NCT01894919|540731537|FG002|Overall Study|Withdrawal by Subject|0|||
149891464|NCT01894919|540731538|FG003|Overall Study|Withdrawal by Subject|0|||
149891465|NCT01894919|540731539|FG004|Overall Study|Withdrawal by Subject|1|||
149891466|NCT01894919|540731540|FG005|Overall Study|Withdrawal by Subject|0|||
149891467|NCT01894919|540731541|FG006|Overall Study|Withdrawal by Subject|0|||
149891468|NCT01894919|540731542|FG007|Overall Study|Withdrawal by Subject|0|||
149891469|NCT01894919|540731543|FG008|Overall Study|Withdrawal by Subject|0|||
149891470|NCT01894919|540731544|FG009|Overall Study|Withdrawal by Subject|1|||
149891471|NCT01894919|540731545|FG010|Overall Study|Withdrawal by Subject|1|||
149891472|NCT01894919|540731546|FG011|Overall Study|Withdrawal by Subject|0|||
149891473|NCT01894919|540731547|FG012|Overall Study|Withdrawal by Subject|0|||
149891474|NCT01894919|540731535|FG000|Overall Study|Adverse Event|0|||
149891475|NCT01894919|540731536|FG001|Overall Study|Adverse Event|0|||
149891476|NCT01894919|540731537|FG002|Overall Study|Adverse Event|0|||
149891477|NCT01894919|540731538|FG003|Overall Study|Adverse Event|0|||
149891478|NCT01894919|540731539|FG004|Overall Study|Adverse Event|0|||
149891479|NCT01894919|540731540|FG005|Overall Study|Adverse Event|0|||
149891480|NCT01894919|540731541|FG006|Overall Study|Adverse Event|0|||
149891481|NCT01894919|540731542|FG007|Overall Study|Adverse Event|0|||
149891482|NCT01894919|540731543|FG008|Overall Study|Adverse Event|0|||
149891483|NCT01894919|540731544|FG009|Overall Study|Adverse Event|0|||
149891484|NCT01894919|540731545|FG010|Overall Study|Adverse Event|1|||
149891485|NCT01894919|540731546|FG011|Overall Study|Adverse Event|0|||
149891486|NCT01894919|540731547|FG012|Overall Study|Adverse Event|0|||
149891487|NCT01894919|540731535|FG000|Overall Study|Other-Unspecified|1|||
149891488|NCT01894919|540731536|FG001|Overall Study|Other-Unspecified|0|||
149891489|NCT01894919|540731537|FG002|Overall Study|Other-Unspecified|0|||
149891490|NCT01894919|540731538|FG003|Overall Study|Other-Unspecified|0|||
149891491|NCT01894919|540731539|FG004|Overall Study|Other-Unspecified|0|||
149891492|NCT01894919|540731540|FG005|Overall Study|Other-Unspecified|0|||
149891493|NCT01894919|540731541|FG006|Overall Study|Other-Unspecified|0|||
149891494|NCT01894919|540731542|FG007|Overall Study|Other-Unspecified|0|||
149891495|NCT01894919|540731543|FG008|Overall Study|Other-Unspecified|0|||
149891496|NCT01894919|540731544|FG009|Overall Study|Other-Unspecified|0|||
149891497|NCT01894919|540731545|FG010|Overall Study|Other-Unspecified|0|||
149891498|NCT01894919|540731546|FG011|Overall Study|Other-Unspecified|0|||
149891499|NCT01894919|540731547|FG012|Overall Study|Other-Unspecified|0|||
149891500|NCT01894919|540731535|FG000|Overall Study|Lost to Follow-up|0|||
149891501|NCT01894919|540731536|FG001|Overall Study|Lost to Follow-up|0|||
149891502|NCT01894919|540731537|FG002|Overall Study|Lost to Follow-up|0|||
150045173|NCT03892967|541304276|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
150045174|NCT03892967|541304277|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
149891503|NCT01894919|540731538|FG003|Overall Study|Lost to Follow-up|0|||
149891504|NCT01894919|540731539|FG004|Overall Study|Lost to Follow-up|2|||
149891505|NCT01894919|540731540|FG005|Overall Study|Lost to Follow-up|0|||
149891506|NCT01894919|540731541|FG006|Overall Study|Lost to Follow-up|0|||
150045175|NCT03892967|541304278|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
149891507|NCT01894919|540731542|FG007|Overall Study|Lost to Follow-up|0|||
149891508|NCT01894919|540731543|FG008|Overall Study|Lost to Follow-up|0|||
149891509|NCT01894919|540731544|FG009|Overall Study|Lost to Follow-up|0|||
149891510|NCT01894919|540731545|FG010|Overall Study|Lost to Follow-up|0|||
149891511|NCT01894919|540731546|FG011|Overall Study|Lost to Follow-up|0|||
149891512|NCT01894919|540731547|FG012|Overall Study|Lost to Follow-up|0|||
149891513|NCT01433471|540731548|FG000|Overall Study|Withdrawal by Subject|0|||
149891514|NCT01433471|540731549|FG001|Overall Study|Withdrawal by Subject|1|||
149891515|NCT03711188|540731552|FG000|Overall Study|Disease progression|11|||
149891516|NCT03711188|540731552|FG000|Overall Study|Adverse Event|1|||
149891517|NCT04341363|540731553|FG000|Overall Study|Adverse Event|1|||
149891518|NCT04341363|540731553|FG000|Overall Study|Withdrawal by Subject|1|||
149891519|NCT02570308|540731554|FG000|Overall Study|Death|1|||
149891520|NCT02570308|540731555|FG001|Overall Study|Death|5|||
149891521|NCT02570308|540731556|FG002|Overall Study|Death|4|||
149891522|NCT02570308|540731557|FG003|Overall Study|Death|4|||
149891523|NCT02570308|540731558|FG004|Overall Study|Death|69|||
149891524|NCT02570308|540731554|FG000|Overall Study|Lost to Follow-up|0|||
149891525|NCT02570308|540731555|FG001|Overall Study|Lost to Follow-up|0|||
149891526|NCT02570308|540731556|FG002|Overall Study|Lost to Follow-up|0|||
149891527|NCT02570308|540731557|FG003|Overall Study|Lost to Follow-up|0|||
149891528|NCT02570308|540731558|FG004|Overall Study|Lost to Follow-up|2|||
149891529|NCT02570308|540731554|FG000|Overall Study|Withdrawal by Subject|0|||
149891530|NCT02570308|540731555|FG001|Overall Study|Withdrawal by Subject|0|||
149891531|NCT02570308|540731556|FG002|Overall Study|Withdrawal by Subject|0|||
149891532|NCT02570308|540731557|FG003|Overall Study|Withdrawal by Subject|0|||
149891533|NCT02570308|540731558|FG004|Overall Study|Withdrawal by Subject|1|||
149891534|NCT02570308|540731554|FG000|Overall Study|Other|0|||
149891535|NCT02570308|540731555|FG001|Overall Study|Other|0|||
149891536|NCT02570308|540731556|FG002|Overall Study|Other|0|||
149891537|NCT02570308|540731557|FG003|Overall Study|Other|0|||
149891538|NCT02570308|540731558|FG004|Overall Study|Other|2|||
149891539|NCT02069015|540731559|FG000|Overall Study|Lost to Follow-up|39|||
149891540|NCT02069015|540731560|FG001|Overall Study|Lost to Follow-up|32|||
149891541|NCT02069015|540731559|FG000|Overall Study|Withdrawal by Subject|1|||
149891542|NCT02069015|540731560|FG001|Overall Study|Withdrawal by Subject|1|||
149891543|NCT03335475|540731563|FG000|Overall Study|Did not wear accelerometer|4|||
149891544|NCT03335475|540731564|FG001|Overall Study|Did not wear accelerometer|0|||
149891545|NCT03335475|540731563|FG000|Overall Study|Withdrawal by Subject|0|||
149891546|NCT03335475|540731564|FG001|Overall Study|Withdrawal by Subject|1|||
149891547|NCT02411656|540731565|FG000|Overall Study|Adverse Event|4|||
149891548|NCT02411656|540731565|FG000|Overall Study|Clinical Progression|33|||
149891549|NCT05921903|540731566|FG000|Overall Study|Unsolicited non-SAE|0|||
149891550|NCT05921903|540731567|FG001|Overall Study|Unsolicited non-SAE|1|||
149891551|NCT05921903|540731568|FG002|Overall Study|Unsolicited non-SAE|0|||
149891552|NCT05921903|540731566|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
149891553|NCT05921903|540731567|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
149891554|NCT05921903|540731568|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
149891555|NCT05921903|540731566|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
149891556|NCT05921903|540731567|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
149891557|NCT05921903|540731568|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
149891558|NCT03305848|540731569|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
149891559|NCT03305848|540731569|FG000|Overall Study|Physician Decision|2|||
149891560|NCT00789854|540731570|FG000|Overall Study|Adverse Event|28|||
149891561|NCT00789854|540731571|FG001|Overall Study|Adverse Event|23|||
149891562|NCT00789854|540731572|FG002|Overall Study|Adverse Event|18|||
149891563|NCT00789854|540731570|FG000|Overall Study|Lost to Follow-up|1|||
149891564|NCT00789854|540731571|FG001|Overall Study|Lost to Follow-up|1|||
149891565|NCT00789854|540731572|FG002|Overall Study|Lost to Follow-up|4|||
149891566|NCT00789854|540731570|FG000|Overall Study|Withdrawal by Subject|9|||
149891567|NCT00789854|540731571|FG001|Overall Study|Withdrawal by Subject|6|||
149891568|NCT00789854|540731572|FG002|Overall Study|Withdrawal by Subject|17|||
149891569|NCT00789854|540731570|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149891570|NCT00789854|540731571|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
149891571|NCT00789854|540731572|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
149891572|NCT00789854|540731570|FG000|Overall Study|Severe non-compliance to the protocol|3|||
149891573|NCT00789854|540731571|FG001|Overall Study|Severe non-compliance to the protocol|0|||
149891574|NCT00789854|540731572|FG002|Overall Study|Severe non-compliance to the protocol|0|||
149891575|NCT00789854|540731570|FG000|Overall Study|Safety reasons|0|||
149891576|NCT00789854|540731571|FG001|Overall Study|Safety reasons|0|||
149891577|NCT00789854|540731572|FG002|Overall Study|Safety reasons|2|||
149891578|NCT00789854|540731570|FG000|Overall Study|Other|6|||
149891579|NCT00789854|540731571|FG001|Overall Study|Other|0|||
149891580|NCT00789854|540731572|FG002|Overall Study|Other|5|||
149891581|NCT00923013|540731573|FG000|Overall Study|Refused further treatment|0|||
149891582|NCT00923013|540731574|FG001|Overall Study|Refused further treatment|1|||
149891583|NCT00923013|540731575|FG002|Overall Study|Refused further treatment|2|||
149891584|NCT00923013|540731576|FG003|Overall Study|Refused further treatment|0|||
149891585|NCT00923013|540731577|FG004|Overall Study|Refused further treatment|0|||
149891586|NCT00923013|540731578|FG005|Overall Study|Refused further treatment|0|||
149891587|NCT00923013|540731573|FG000|Overall Study|Switched to alternative treatment|0|||
149891588|NCT00923013|540731574|FG001|Overall Study|Switched to alternative treatment|1|||
149891589|NCT00923013|540731575|FG002|Overall Study|Switched to alternative treatment|0|||
149891590|NCT00923013|540731576|FG003|Overall Study|Switched to alternative treatment|0|||
149891591|NCT00923013|540731577|FG004|Overall Study|Switched to alternative treatment|0|||
149891592|NCT00923013|540731578|FG005|Overall Study|Switched to alternative treatment|0|||
149891593|NCT00923013|540731573|FG000|Overall Study|Death on study|2|||
149891594|NCT00923013|540731574|FG001|Overall Study|Death on study|2|||
149891595|NCT00923013|540731575|FG002|Overall Study|Death on study|0|||
149891596|NCT00923013|540731576|FG003|Overall Study|Death on study|1|||
149891597|NCT00923013|540731577|FG004|Overall Study|Death on study|0|||
149891598|NCT00923013|540731578|FG005|Overall Study|Death on study|0|||
149891599|NCT05366010|540731581|FG000|Overall Study|Withdrawal by Subject|1|||
149891600|NCT05366010|540731581|FG000|Overall Study|Protocol Violation|1|||
149891601|NCT05366010|540731581|FG000|Overall Study|Lost to Follow-up|2|||
149891602|NCT05366010|540731581|FG000|Overall Study|Screen Failure|2|||
149891603|NCT02224157|540731582|FG000|Overall Study|Severe non-compliance to protocol|2|||
149891604|NCT02224157|540731583|FG001|Overall Study|Severe non-compliance to protocol|2|||
149891605|NCT02224157|540731582|FG000|Overall Study|Other|13|||
149891606|NCT02224157|540731583|FG001|Overall Study|Other|10|||
149891607|NCT02224157|540731582|FG000|Overall Study|Subject decision|58|||
149891608|NCT02224157|540731583|FG001|Overall Study|Subject decision|50|||
149891609|NCT02224157|540731582|FG000|Overall Study|Prematurely closed site|4|||
149891610|NCT02224157|540731583|FG001|Overall Study|Prematurely closed site|2|||
149891611|NCT02224157|540731582|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
149891612|NCT02224157|540731583|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
149891613|NCT02224157|540731582|FG000|Overall Study|Lost to Follow-up|27|||
149891614|NCT02224157|540731583|FG001|Overall Study|Lost to Follow-up|35|||
149891615|NCT02224157|540731582|FG000|Overall Study|Death|1|||
149891616|NCT02224157|540731583|FG001|Overall Study|Death|1|||
149891617|NCT02224157|540731582|FG000|Overall Study|Adverse Event|1|||
149891618|NCT02224157|540731583|FG001|Overall Study|Adverse Event|3|||
149891619|NCT05906628|540731584|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
149891620|NCT05906628|540731585|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
149891621|NCT05906628|540731584|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
149891622|NCT05906628|540731585|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
149891623|NCT05906628|540731584|FG000|16-Week DBVC Period|Protocol Violation|4|||
149891624|NCT05906628|540731585|FG001|16-Week DBVC Period|Protocol Violation|2|||
149891625|NCT05906628|540731584|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
149891626|NCT05906628|540731585|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
149891627|NCT05906628|540731584|FG000|16-Week OLE Period|Death|1|||
149891628|NCT05906628|540731585|FG001|16-Week OLE Period|Death|0|||
149891629|NCT05906628|540731584|FG000|16-Week OLE Period|Lost to Follow-up|1|||
149891630|NCT05906628|540731585|FG001|16-Week OLE Period|Lost to Follow-up|1|||
149891631|NCT05906628|540731584|FG000|16-Week OLE Period|Protocol Violation|0|||
149891632|NCT05906628|540731585|FG001|16-Week OLE Period|Protocol Violation|1|||
149891633|NCT05906628|540731584|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
149891634|NCT05906628|540731585|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
149891635|NCT01108718|540731586|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
149891636|NCT01108718|540731587|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
149891637|NCT01060072|540731590|FG000|Overall Study|Adverse Event|1|||
149891638|NCT01060072|540731591|FG001|Overall Study|Adverse Event|1|||
149891639|NCT01060072|540731590|FG000|Overall Study|Physician Decision|0|||
149891640|NCT01060072|540731591|FG001|Overall Study|Physician Decision|2|||
149968023|NCT02607722|541018005|FG000|Overall Study|Physician Decision|367|||
149891641|NCT01060072|540731590|FG000|Overall Study|Protocol Violation|0|||
149968024|NCT04347538|541018006|FG000|Overall Study|Lost to Follow-up|4|||
149891642|NCT01060072|540731591|FG001|Overall Study|Protocol Violation|1|||
149891643|NCT01060072|540731590|FG000|Overall Study|Acute cholecystitis|1|||
149891644|NCT01060072|540731591|FG001|Overall Study|Acute cholecystitis|0|||
149891645|NCT01060072|540731590|FG000|Overall Study|Excluded Medications|0|||
149891646|NCT01060072|540731591|FG001|Overall Study|Excluded Medications|1|||
149891647|NCT00837148|540731592|FG000|Overall Study|Adverse Event|1|||
149968025|NCT04347538|541018007|FG001|Overall Study|Lost to Follow-up|5|||
149891648|NCT00837148|540731592|FG000|Overall Study|Death|1|||
149891649|NCT02301169|540731595|FG000|Overall Study|Adverse Event|1|||
149891650|NCT02301169|540731596|FG001|Overall Study|Adverse Event|0|||
149891651|NCT04075825|540733298|FG000|Overall Study|Withdrawal by Subject|6|||
149891652|NCT04075825|540733299|FG001|Overall Study|Withdrawal by Subject|8|||
149891653|NCT04075825|540733298|FG000|Overall Study|Physician Decision|3|||
149891654|NCT04075825|540733299|FG001|Overall Study|Physician Decision|1|||
149891655|NCT04075825|540733298|FG000|Overall Study|Lost to Follow-up|5|||
149891656|NCT04075825|540733299|FG001|Overall Study|Lost to Follow-up|1|||
149891657|NCT04075825|540733298|FG000|Overall Study|Participation in New Clinical Trial|1|||
149891658|NCT04075825|540733299|FG001|Overall Study|Participation in New Clinical Trial|1|||
149891659|NCT04075825|540733298|FG000|Overall Study|Reason Not Specified|2|||
149891660|NCT04075825|540733299|FG001|Overall Study|Reason Not Specified|2|||
149891661|NCT02861586|540733303|FG000|Overall Study|Withdrawal by Subject|1|||
149891662|NCT02861586|540733304|FG001|Overall Study|Withdrawal by Subject|2|||
149891663|NCT02861586|540733305|FG002|Overall Study|Withdrawal by Subject|0|||
149891664|NCT02861586|540733306|FG003|Overall Study|Withdrawal by Subject|0|||
149891665|NCT02861586|540733307|FG004|Overall Study|Withdrawal by Subject|0|||
149891666|NCT02861586|540733308|FG005|Overall Study|Withdrawal by Subject|1|||
149891667|NCT02861586|540733309|FG006|Overall Study|Withdrawal by Subject|1|||
149891668|NCT02861586|540733310|FG007|Overall Study|Withdrawal by Subject|0|||
149891669|NCT02861586|540733303|FG000|Overall Study|Lost to Follow-up|3|||
149891670|NCT02861586|540733304|FG001|Overall Study|Lost to Follow-up|1|||
149891671|NCT02861586|540733305|FG002|Overall Study|Lost to Follow-up|1|||
149891672|NCT02861586|540733306|FG003|Overall Study|Lost to Follow-up|0|||
149891673|NCT02861586|540733307|FG004|Overall Study|Lost to Follow-up|0|||
149891674|NCT02861586|540733308|FG005|Overall Study|Lost to Follow-up|3|||
149891675|NCT02861586|540733309|FG006|Overall Study|Lost to Follow-up|0|||
149891676|NCT02861586|540733310|FG007|Overall Study|Lost to Follow-up|0|||
149891677|NCT02861586|540733303|FG000|Overall Study|Adverse Event|0|||
149891678|NCT02861586|540733304|FG001|Overall Study|Adverse Event|0|||
149891679|NCT02861586|540733305|FG002|Overall Study|Adverse Event|0|||
149891680|NCT02861586|540733306|FG003|Overall Study|Adverse Event|0|||
149891681|NCT02861586|540733307|FG004|Overall Study|Adverse Event|0|||
149891682|NCT02861586|540733308|FG005|Overall Study|Adverse Event|1|||
149891683|NCT02861586|540733309|FG006|Overall Study|Adverse Event|0|||
149891684|NCT02861586|540733310|FG007|Overall Study|Adverse Event|0|||
149891685|NCT04581824|540733311|FG000|Overall Study|Lost to Follow-up|1|||
149891686|NCT04581824|540733312|FG001|Overall Study|Lost to Follow-up|0|||
149891687|NCT04581824|540733311|FG000|Overall Study|Withdrawal by Subject|2|||
149891688|NCT04581824|540733312|FG001|Overall Study|Withdrawal by Subject|7|||
149891689|NCT04581824|540733311|FG000|Overall Study|Study terminated by sponsor|37|||
149891690|NCT04581824|540733312|FG001|Overall Study|Study terminated by sponsor|23|||
149891691|NCT03879135|540733313|FG000|Overall Study|Physician Decision|0|||
149891692|NCT03879135|540733314|FG001|Overall Study|Physician Decision|0|||
149891693|NCT03879135|540733315|FG002|Overall Study|Physician Decision|0|||
149891694|NCT03879135|540733316|FG003|Overall Study|Physician Decision|1|||
149891695|NCT03879135|540733317|FG004|Overall Study|Physician Decision|0|||
149891696|NCT03879135|540733318|FG005|Overall Study|Physician Decision|0|||
149891697|NCT03879135|540733313|FG000|Overall Study|Withdrawal by Subject|0|||
149891698|NCT03879135|540733314|FG001|Overall Study|Withdrawal by Subject|0|||
149891699|NCT03879135|540733315|FG002|Overall Study|Withdrawal by Subject|0|||
149891700|NCT03879135|540733316|FG003|Overall Study|Withdrawal by Subject|0|||
149891701|NCT03879135|540733317|FG004|Overall Study|Withdrawal by Subject|0|||
149891702|NCT03879135|540733318|FG005|Overall Study|Withdrawal by Subject|1|||
149891703|NCT03879135|540733313|FG000|Overall Study|Site Closed by Sponsor|0|||
149891704|NCT03879135|540733314|FG001|Overall Study|Site Closed by Sponsor|0|||
149891705|NCT03879135|540733315|FG002|Overall Study|Site Closed by Sponsor|0|||
149891706|NCT03879135|540733316|FG003|Overall Study|Site Closed by Sponsor|1|||
149891707|NCT03879135|540733317|FG004|Overall Study|Site Closed by Sponsor|1|||
149891708|NCT03879135|540733318|FG005|Overall Study|Site Closed by Sponsor|0|||
149891709|NCT00210210|540733321|FG000|Overall Study|Withdrawal by Subject|3|||
149891710|NCT00210210|540733322|FG001|Overall Study|Withdrawal by Subject|2|||
149891711|NCT00210210|540733321|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
149891712|NCT00210210|540733322|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
149891713|NCT02445248|540733323|FG000|Overall Study|Death|45|||
149891714|NCT02445248|540733324|FG001|Overall Study|Death|12|||
149891715|NCT02445248|540733323|FG000|Overall Study|Progressive disease|13|||
149891716|NCT02445248|540733324|FG001|Overall Study|Progressive disease|1|||
149891717|NCT02445248|540733323|FG000|Overall Study|Subject decision|8|||
149891718|NCT02445248|540733324|FG001|Overall Study|Subject decision|0|||
149891719|NCT02445248|540733323|FG000|Overall Study|Physician Decision|5|||
149891720|NCT02445248|540733324|FG001|Overall Study|Physician Decision|0|||
149891721|NCT02445248|540733323|FG000|Overall Study|Adverse Event|1|||
149891722|NCT02445248|540733324|FG001|Overall Study|Adverse Event|0|||
149891723|NCT02445248|540733323|FG000|Overall Study|Lost to Follow-up|1|||
149891724|NCT02445248|540733324|FG001|Overall Study|Lost to Follow-up|0|||
149891725|NCT01217112|540733325|FG000|Overall Study|Adverse Event|0|||
149891726|NCT01217112|540733326|FG001|Overall Study|Adverse Event|2|||
149891727|NCT01217112|540733327|FG002|Overall Study|Adverse Event|0|||
149891728|NCT01217112|540733328|FG003|Overall Study|Adverse Event|2|||
149891729|NCT01217112|540733329|FG004|Overall Study|Adverse Event|0|||
149891730|NCT01217112|540733325|FG000|Overall Study|Withdrawal by Subject|0|||
149891731|NCT01217112|540733326|FG001|Overall Study|Withdrawal by Subject|0|||
149891732|NCT01217112|540733327|FG002|Overall Study|Withdrawal by Subject|1|||
149891733|NCT01217112|540733328|FG003|Overall Study|Withdrawal by Subject|0|||
149891734|NCT01217112|540733329|FG004|Overall Study|Withdrawal by Subject|0|||
149891735|NCT01217112|540733325|FG000|Overall Study|Physician Decision|0|||
149891736|NCT01217112|540733326|FG001|Overall Study|Physician Decision|0|||
149891737|NCT01217112|540733327|FG002|Overall Study|Physician Decision|0|||
149891738|NCT01217112|540733328|FG003|Overall Study|Physician Decision|0|||
149891739|NCT01217112|540733329|FG004|Overall Study|Physician Decision|1|||
149891740|NCT02596971|540733330|FG000|Overall Study|Death|5|||
149891741|NCT02596971|540733331|FG001|Overall Study|Death|1|||
149891742|NCT02596971|540733332|FG002|Overall Study|Death|5|||
149891743|NCT02596971|540733330|FG000|Overall Study|Withdrawal by Subject|5|||
149891744|NCT02596971|540733331|FG001|Overall Study|Withdrawal by Subject|1|||
149891745|NCT02596971|540733332|FG002|Overall Study|Withdrawal by Subject|4|||
149891746|NCT01401361|540733335|FG000|Overall Study|Withdrawal by Subject|16|||
149891747|NCT01401361|540733335|FG000|Overall Study|Lack of Efficacy|6|||
149891748|NCT01401361|540733335|FG000|Overall Study|Physician Decision|1|||
149891749|NCT01401361|540733335|FG000|Overall Study|Lost to Follow-up|3|||
149891750|NCT01401361|540733335|FG000|Overall Study|Subject/family decision post procedure|2|||
149891751|NCT00595920|540733336|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
149891752|NCT00351468|540733337|FG000|Overall Study|Adverse Event|42|||
149891753|NCT00351468|540733337|FG000|Overall Study|Withdrawal by Subject|39|||
149891754|NCT00351468|540733337|FG000|Overall Study|Various -follow up w clinical team|39|||
149891755|NCT00351468|540733337|FG000|Overall Study|Lack of Efficacy|32|||
149891756|NCT00351468|540733337|FG000|Overall Study|Non-compliance|8|||
149891757|NCT00351468|540733337|FG000|Overall Study|Lost to Follow-up|4|||
149891758|NCT00351468|540733337|FG000|Overall Study|Protocol Violation|3|||
149891759|NCT00611923|540733338|FG000|Overall Study|Withdrawal by Subject|2|||
149891760|NCT00611923|540733339|FG001|Overall Study|Withdrawal by Subject|2|||
149891761|NCT04565145|540733340|FG000|Overall Study|Withdrawal by Subject|1|||
149891762|NCT04565145|540733341|FG001|Overall Study|Withdrawal by Subject|1|||
149891763|NCT03096314|540733342|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
149891764|NCT03096314|540733343|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
149891765|NCT00471822|540733344|FG000|Overall Study|Protocol Violation|2|||
149891766|NCT03318861|540733345|FG000|Overall Study|Death|2|||
149891767|NCT03318861|540733346|FG001|Overall Study|Death|3|||
149891768|NCT03318861|540733347|FG002|Overall Study|Death|3|||
149891769|NCT03318861|540733348|FG003|Overall Study|Death|2|||
149891770|NCT03318861|540733349|FG004|Overall Study|Death|2|||
149891771|NCT03318861|540733345|FG000|Overall Study|Enrolled But Never Treated|0|||
149891772|NCT03318861|540733346|FG001|Overall Study|Enrolled But Never Treated|1|||
149891773|NCT03318861|540733347|FG002|Overall Study|Enrolled But Never Treated|0|||
149891774|NCT03318861|540733348|FG003|Overall Study|Enrolled But Never Treated|1|||
149891775|NCT03318861|540733349|FG004|Overall Study|Enrolled But Never Treated|1|||
149891776|NCT03318861|540733345|FG000|Overall Study|Informed Consent Withdraw|0|||
149891777|NCT03318861|540733346|FG001|Overall Study|Informed Consent Withdraw|0|||
149891778|NCT03318861|540733347|FG002|Overall Study|Informed Consent Withdraw|0|||
149891779|NCT03318861|540733348|FG003|Overall Study|Informed Consent Withdraw|1|||
149891780|NCT03318861|540733349|FG004|Overall Study|Informed Consent Withdraw|0|||
149891781|NCT03318861|540733345|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
149891782|NCT03318861|540733346|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
149891783|NCT03318861|540733347|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
149891784|NCT03318861|540733348|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
149891785|NCT03318861|540733349|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
149891786|NCT00917852|540733350|FG000|Overall Study|Death|6|||
149891787|NCT00471081|540733351|FG000|Active Phase|Protocol Violation|1|||
149891788|NCT00471081|540733352|FG001|Active Phase|Protocol Violation|1|||
149891789|NCT00471081|540733351|FG000|Active Phase|Withdrawal by Subject|0|||
149891790|NCT00471081|540733352|FG001|Active Phase|Withdrawal by Subject|3|||
149891791|NCT00471081|540733351|FG000|Active Phase|Lost to Follow-up|0|||
149891792|NCT00471081|540733352|FG001|Active Phase|Lost to Follow-up|1|||
149891793|NCT00471081|540733351|FG000|Active Phase|Lost health plan/insurance|1|||
149891794|NCT00471081|540733352|FG001|Active Phase|Lost health plan/insurance|8|||
149891795|NCT00471081|540733351|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
149891796|NCT00471081|540733352|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
149891797|NCT00471081|540733351|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
149891798|NCT00471081|540733352|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
149891799|NCT00471081|540733351|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
149891800|NCT00471081|540733352|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
149891801|NCT05486091|540733353|FG000|Overall Study|Withdrawal by Subject|1|||
149891802|NCT05486091|540733353|FG000|Overall Study|Lost to Follow-up|2|||
149891803|NCT03428152|540733356|FG000|Overall Study|Physician Decision|4|||
149891804|NCT03428152|540733357|FG001|Overall Study|Physician Decision|2|||
149891805|NCT03428152|540733356|FG000|Overall Study|Protocol Violation|3|||
149891806|NCT03428152|540733357|FG001|Overall Study|Protocol Violation|5|||
149891807|NCT03428152|540733356|FG000|Overall Study|Lack of Efficacy|0|||
149891808|NCT03428152|540733357|FG001|Overall Study|Lack of Efficacy|4|||
149891809|NCT00395629|540733358|FG000|Core Study|Adverse Event|0|||
149891810|NCT00395629|540733359|FG001|Core Study|Adverse Event|3|||
149891811|NCT00395629|540733360|FG002|Core Study|Adverse Event|4|||
149891812|NCT00395629|540733358|FG000|Core Study|Abnormal laboratory value(s)|0|||
149891813|NCT00395629|540733359|FG001|Core Study|Abnormal laboratory value(s)|0|||
149891814|NCT00395629|540733360|FG002|Core Study|Abnormal laboratory value(s)|1|||
149891815|NCT00395629|540733358|FG000|Core Study|Protocol Violation|1|||
149891816|NCT00395629|540733359|FG001|Core Study|Protocol Violation|0|||
149891817|NCT00395629|540733360|FG002|Core Study|Protocol Violation|0|||
149891818|NCT00395629|540733358|FG000|Core Study|Withdrawal by Subject|0|||
149891819|NCT00395629|540733359|FG001|Core Study|Withdrawal by Subject|1|||
149891820|NCT00395629|540733360|FG002|Core Study|Withdrawal by Subject|1|||
149891821|NCT00395629|540733358|FG000|Core Study|Lost to Follow-up|0|||
149891822|NCT00395629|540733359|FG001|Core Study|Lost to Follow-up|0|||
149891823|NCT00395629|540733360|FG002|Core Study|Lost to Follow-up|1|||
149891824|NCT00395629|540733358|FG000|Extension Study|Adverse Event|0|||
149891825|NCT00395629|540733359|FG001|Extension Study|Adverse Event|0|||
149891826|NCT00395629|540733360|FG002|Extension Study|Adverse Event|2|||
149891827|NCT00395629|540733358|FG000|Extension Study|Administrative problems|0|||
149891828|NCT00395629|540733359|FG001|Extension Study|Administrative problems|0|||
149891829|NCT00395629|540733360|FG002|Extension Study|Administrative problems|1|||
149891830|NCT01686373|540733361|FG000|Overall Study|Lost to Follow-up|3|||
149891831|NCT01686373|540733362|FG001|Overall Study|Lost to Follow-up|0|||
149891832|NCT01686373|540733361|FG000|Overall Study|Withdrawal by Subject|0|||
149891833|NCT01686373|540733362|FG001|Overall Study|Withdrawal by Subject|1|||
149891834|NCT01686373|540733361|FG000|Overall Study|Adverse Event|0|||
149891835|NCT01686373|540733362|FG001|Overall Study|Adverse Event|1|||
149891836|NCT03776357|540733369|FG000|Overall Study|Lost to Follow-up|3|||
149968026|NCT04347538|541018008|FG002|Overall Study|Lost to Follow-up|7|||
149891837|NCT06481709|540733370|FG000|Overall Study|Withdrawal by Subject|0|||
149891838|NCT06481709|540733371|FG001|Overall Study|Withdrawal by Subject|0|||
149891839|NCT06481709|540733372|FG002|Overall Study|Withdrawal by Subject|2|||
149891840|NCT06481709|540733373|FG003|Overall Study|Withdrawal by Subject|0|||
149891841|NCT01320293|540733377|FG000|Overall Study|Lack of Efficacy|1|||
149891842|NCT01320293|540733377|FG000|Overall Study|Adverse Event|1|||
149891843|NCT01532934|540733378|FG000|Overall Study|Lost to Follow-up|11|||
149891844|NCT01532934|540733379|FG001|Overall Study|Lost to Follow-up|11|||
149891845|NCT01532934|540733378|FG000|Overall Study|In controlled environment|3|||
149891846|NCT01532934|540733379|FG001|Overall Study|In controlled environment|2|||
149891847|NCT01147068|540733380|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
149891848|NCT01147068|540733381|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
149891849|NCT01147068|540733382|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
149891850|NCT01147068|540733383|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
149891851|NCT01147068|540733384|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
149968027|NCT02135133|541018009|FG000|Overall Study|Adverse Event|10|||
149968028|NCT02135133|541018009|FG000|Overall Study|regulatory mandate|5|||
149968029|NCT02259231|541018010|FG000|Overall Study|Adverse Event|1|||
149968030|NCT02259231|541018011|FG001|Overall Study|Adverse Event|1|||
149968031|NCT02259231|541018012|FG002|Overall Study|Adverse Event|2|||
149968032|NCT02259231|541018013|FG003|Overall Study|Adverse Event|0|||
149968033|NCT02259231|541018014|FG004|Overall Study|Adverse Event|0|||
149891852|NCT01147068|540733385|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
149891853|NCT01147068|540733386|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
149891854|NCT01147068|540733380|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
149891855|NCT01147068|540733381|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
149891856|NCT01147068|540733382|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
149891857|NCT01147068|540733383|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
149891858|NCT01147068|540733384|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
149891859|NCT01147068|540733385|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
149968034|NCT02259231|541018015|FG005|Overall Study|Adverse Event|0|||
149968035|NCT02259231|541018016|FG006|Overall Study|Adverse Event|0|||
149968036|NCT02259231|541018010|FG000|Overall Study|Progressive Disease|4|||
149968037|NCT02259231|541018011|FG001|Overall Study|Progressive Disease|5|||
149968038|NCT02259231|541018012|FG002|Overall Study|Progressive Disease|4|||
149968039|NCT02259231|541018013|FG003|Overall Study|Progressive Disease|5|||
149968040|NCT02259231|541018014|FG004|Overall Study|Progressive Disease|4|||
149968041|NCT02259231|541018015|FG005|Overall Study|Progressive Disease|5|||
149968042|NCT02259231|541018016|FG006|Overall Study|Progressive Disease|4|||
149968043|NCT02259231|541018010|FG000|Overall Study|Sponsor termination of study|1|||
150175866|NCT00433199|541779950|FG000|Open-Label Period|Lack of Efficacy|0|||
150175867|NCT00433199|541779951|FG001|Open-Label Period|Lack of Efficacy|2|||
150175868|NCT00433199|541779950|FG000|Open-Label Period|Lost to Follow-up|0|||
150175869|NCT00433199|541779951|FG001|Open-Label Period|Lost to Follow-up|3|||
149891860|NCT01147068|540733386|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
149891861|NCT01147068|540733380|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
149891862|NCT01147068|540733381|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
149891863|NCT01147068|540733382|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
149891864|NCT01147068|540733383|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
149891865|NCT01147068|540733384|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
149891866|NCT01147068|540733385|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
149891867|NCT01147068|540733386|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
149891868|NCT01147068|540733380|FG000|Subjects That Received 2nd Dose|Other|0|||
149891869|NCT01147068|540733381|FG001|Subjects That Received 2nd Dose|Other|3|||
149891870|NCT01147068|540733382|FG002|Subjects That Received 2nd Dose|Other|3|||
149891871|NCT01147068|540733383|FG003|Subjects That Received 2nd Dose|Other|0|||
149891872|NCT01147068|540733384|FG004|Subjects That Received 2nd Dose|Other|1|||
149891873|NCT01147068|540733385|FG005|Subjects That Received 2nd Dose|Other|0|||
149891874|NCT01147068|540733386|FG006|Subjects That Received 2nd Dose|Other|0|||
149891875|NCT01147068|540733380|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
149891876|NCT01147068|540733381|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
149891877|NCT01147068|540733382|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
149891878|NCT01147068|540733383|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
149891879|NCT01147068|540733384|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
149891880|NCT01147068|540733385|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
149891881|NCT01147068|540733386|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
149891882|NCT01147068|540733380|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891883|NCT01147068|540733381|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891884|NCT01147068|540733382|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891885|NCT01147068|540733383|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
149891886|NCT01147068|540733384|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891887|NCT01147068|540733385|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891888|NCT01147068|540733386|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
149891889|NCT01147068|540733380|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
149968044|NCT02259231|541018011|FG001|Overall Study|Sponsor termination of study|0|||
149968045|NCT02259231|541018012|FG002|Overall Study|Sponsor termination of study|0|||
149968046|NCT02259231|541018013|FG003|Overall Study|Sponsor termination of study|1|||
149968047|NCT02259231|541018014|FG004|Overall Study|Sponsor termination of study|2|||
149968048|NCT02259231|541018015|FG005|Overall Study|Sponsor termination of study|1|||
150175870|NCT00433199|541779950|FG000|Open-Label Period|Withdrawal by Subject|0|||
150175871|NCT00433199|541779951|FG001|Open-Label Period|Withdrawal by Subject|7|||
149891890|NCT01147068|540733381|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
149891891|NCT01147068|540733382|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
149891892|NCT01147068|540733383|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
149891893|NCT01147068|540733384|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
149891894|NCT01147068|540733385|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
149891895|NCT01147068|540733386|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
149891896|NCT03181633|540733389|FG000|Overall Study|Withdrawal by Subject|1|||
149891897|NCT03181633|540733389|FG000|Overall Study|Missing follow-up visit|1|||
149968049|NCT02259231|541018016|FG006|Overall Study|Sponsor termination of study|1|||
149968050|NCT03238196|541018017|FG000|Overall Study|Adverse Event|3|||
149968051|NCT03238196|541018018|FG001|Overall Study|Adverse Event|0|||
149968052|NCT03238196|541018019|FG002|Overall Study|Adverse Event|2|||
149968053|NCT03238196|541018020|FG003|Overall Study|Adverse Event|2|||
149968054|NCT03238196|541018017|FG000|Overall Study|Withdrawal by Subject|4|||
149891898|NCT01597778|540733394|FG000|Overall Study|Death|7|||
149891899|NCT01597778|540733395|FG001|Overall Study|Death|10|||
149891900|NCT01597778|540733394|FG000|Overall Study|Withdrawal by Subject|3|||
149891901|NCT01597778|540733395|FG001|Overall Study|Withdrawal by Subject|4|||
149891902|NCT01597778|540733394|FG000|Overall Study|Adverse Event|1|||
149891903|NCT01597778|540733395|FG001|Overall Study|Adverse Event|1|||
149891904|NCT01597778|540733394|FG000|Overall Study|Protocol Violation|1|||
149968055|NCT03238196|541018018|FG001|Overall Study|Withdrawal by Subject|1|||
149891905|NCT01597778|540733395|FG001|Overall Study|Protocol Violation|11|||
149891906|NCT01597778|540733394|FG000|Overall Study|Transplanted off protocol|2|||
149891907|NCT01597778|540733395|FG001|Overall Study|Transplanted off protocol|3|||
149968056|NCT03238196|541018019|FG002|Overall Study|Withdrawal by Subject|1|||
149968057|NCT03238196|541018020|FG003|Overall Study|Withdrawal by Subject|0|||
149968058|NCT03238196|541018017|FG000|Overall Study|Disease progression|14|||
149968059|NCT03238196|541018018|FG001|Overall Study|Disease progression|2|||
149968060|NCT03238196|541018019|FG002|Overall Study|Disease progression|3|||
149968061|NCT03238196|541018020|FG003|Overall Study|Disease progression|2|||
149968062|NCT03238196|541018017|FG000|Overall Study|Still on treatment|1|||
149968063|NCT03238196|541018018|FG001|Overall Study|Still on treatment|0|||
149968064|NCT03238196|541018019|FG002|Overall Study|Still on treatment|0|||
149968065|NCT03238196|541018020|FG003|Overall Study|Still on treatment|0|||
149968066|NCT04562090|541018021|FG000|Overall Study|Withdrawal by Subject|3|||
149968067|NCT04562090|541018022|FG001|Overall Study|Withdrawal by Subject|4|||
149968068|NCT04562090|541018021|FG000|Overall Study|Protocol Violation|2|||
149968069|NCT04562090|541018022|FG001|Overall Study|Protocol Violation|0|||
149968070|NCT04562090|541018021|FG000|Overall Study|Lack of Efficacy|0|||
149968071|NCT04562090|541018022|FG001|Overall Study|Lack of Efficacy|1|||
149968072|NCT04562090|541018021|FG000|Overall Study|Adverse Event|1|||
149968073|NCT04562090|541018022|FG001|Overall Study|Adverse Event|4|||
149968074|NCT04562090|541018021|FG000|Overall Study|Miscellaneous|0|||
149968075|NCT04562090|541018022|FG001|Overall Study|Miscellaneous|3|||
149968076|NCT00847730|541018023|FG000|Overall Study|Multiple interruptions in therapy|8|||
149968077|NCT04938427|541018026|FG000|Overall Study|Adverse Event|5|||
149968078|NCT04938427|541018027|FG001|Overall Study|Adverse Event|19|||
149968079|NCT04938427|541018026|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149968080|NCT04938427|541018027|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149968081|NCT04938427|541018026|FG000|Overall Study|Withdrawal by Subject|1|||
149968082|NCT04938427|541018027|FG001|Overall Study|Withdrawal by Subject|0|||
149968083|NCT04938427|541018026|FG000|Overall Study|Reason Not Specified|2|||
149968084|NCT04938427|541018027|FG001|Overall Study|Reason Not Specified|1|||
149968085|NCT02402647|541018028|FG000|Overall Study|Lost to Follow-up|13|||
149968086|NCT02402647|541018029|FG001|Overall Study|Lost to Follow-up|7|||
149968087|NCT02402647|541018028|FG000|Overall Study|Protocol Violation|1|||
149968088|NCT02402647|541018029|FG001|Overall Study|Protocol Violation|1|||
149968089|NCT02402647|541018028|FG000|Overall Study|scheduled and timed out|2|||
149968090|NCT02402647|541018029|FG001|Overall Study|scheduled and timed out|1|||
149968091|NCT02402647|541018028|FG000|Overall Study|medical illness|2|||
149968092|NCT02402647|541018029|FG001|Overall Study|medical illness|4|||
149968093|NCT02402647|541018028|FG000|Overall Study|Moved|2|||
149968094|NCT02402647|541018029|FG001|Overall Study|Moved|0|||
149968095|NCT02402647|541018028|FG000|Overall Study|loved one illness|1|||
149968096|NCT02402647|541018029|FG001|Overall Study|loved one illness|0|||
149968097|NCT02402647|541018028|FG000|Overall Study|deceased preexisting condition|2|||
149968098|NCT02402647|541018029|FG001|Overall Study|deceased preexisting condition|0|||
149968099|NCT02402647|541018028|FG000|Overall Study|Other|2|||
149968100|NCT02402647|541018029|FG001|Overall Study|Other|1|||
149968101|NCT04727151|541018036|FG000|Overall Study|Death|0|||
149968102|NCT04727151|541018037|FG001|Overall Study|Death|0|||
149968103|NCT04727151|541018038|FG002|Overall Study|Death|0|||
149968104|NCT04727151|541018039|FG003|Overall Study|Death|0|||
149968105|NCT04727151|541018040|FG004|Overall Study|Death|3|||
149968106|NCT04727151|541018036|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
149968107|NCT04727151|541018037|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
149891908|NCT00699998|540733402|FG000|Overall Study|Withdrawal by Subject|194|||
149891909|NCT00699998|540733403|FG001|Overall Study|Withdrawal by Subject|83|||
149891910|NCT00699998|540733404|FG002|Overall Study|Withdrawal by Subject|202|||
149891911|NCT00699998|540733405|FG003|Overall Study|Withdrawal by Subject|80|||
149891912|NCT00699998|540733402|FG000|Overall Study|Physician Decision|3|||
149891913|NCT00699998|540733403|FG001|Overall Study|Physician Decision|2|||
149891914|NCT00699998|540733404|FG002|Overall Study|Physician Decision|1|||
149891915|NCT00699998|540733405|FG003|Overall Study|Physician Decision|1|||
149891916|NCT00699998|540733402|FG000|Overall Study|Lost to Follow-up|2|||
149891917|NCT00699998|540733403|FG001|Overall Study|Lost to Follow-up|1|||
149891918|NCT00699998|540733404|FG002|Overall Study|Lost to Follow-up|3|||
149891919|NCT00699998|540733405|FG003|Overall Study|Lost to Follow-up|1|||
149891920|NCT01406574|540733406|FG000|Overall Study|Adverse Event|0|||
149891921|NCT01406574|540733407|FG001|Overall Study|Adverse Event|0|||
149891922|NCT01406574|540733408|FG002|Overall Study|Adverse Event|1|||
149891923|NCT01406574|540733409|FG003|Overall Study|Adverse Event|3|||
149891924|NCT01406574|540733406|FG000|Overall Study|Physician Decision|0|||
149891925|NCT01406574|540733407|FG001|Overall Study|Physician Decision|0|||
149891926|NCT01406574|540733408|FG002|Overall Study|Physician Decision|0|||
149891927|NCT01406574|540733409|FG003|Overall Study|Physician Decision|1|||
149891928|NCT01406574|540733406|FG000|Overall Study|Withdrawal by Subject|0|||
149891929|NCT01406574|540733407|FG001|Overall Study|Withdrawal by Subject|1|||
149891930|NCT01406574|540733408|FG002|Overall Study|Withdrawal by Subject|0|||
149891931|NCT01406574|540733409|FG003|Overall Study|Withdrawal by Subject|0|||
149891932|NCT01406574|540733406|FG000|Overall Study|Definite progression of primary disease|1|||
149891933|NCT01406574|540733407|FG001|Overall Study|Definite progression of primary disease|0|||
149891934|NCT01406574|540733408|FG002|Overall Study|Definite progression of primary disease|0|||
149891935|NCT01406574|540733409|FG003|Overall Study|Definite progression of primary disease|0|||
149891936|NCT00946920|540733416|FG000|Overall Study|Withdrawal by Subject|28|||
149891937|NCT00946920|540733417|FG001|Overall Study|Withdrawal by Subject|15|||
149891938|NCT00946920|540733416|FG000|Overall Study|Lost to Follow-up|2|||
149891939|NCT00946920|540733417|FG001|Overall Study|Lost to Follow-up|2|||
149891940|NCT00946920|540733416|FG000|Overall Study|Physician Decision|5|||
149891941|NCT00946920|540733417|FG001|Overall Study|Physician Decision|2|||
149891942|NCT00946920|540733416|FG000|Overall Study|Adverse Event|41|||
149891943|NCT00946920|540733417|FG001|Overall Study|Adverse Event|14|||
149891944|NCT00946920|540733416|FG000|Overall Study|Protocol Violation|16|||
149891945|NCT00946920|540733417|FG001|Overall Study|Protocol Violation|8|||
149891946|NCT00946920|540733416|FG000|Overall Study|Miscellaneous reasons|18|||
149891947|NCT00946920|540733417|FG001|Overall Study|Miscellaneous reasons|3|||
149891948|NCT04616612|540733418|FG000|Overall Study|Lost to Follow-up|6|||
149891949|NCT04616612|540733419|FG001|Overall Study|Lost to Follow-up|3|||
149891950|NCT04740918|540733420|FG000|Overall Study|Study Terminated by Sponsor|41|||
149891951|NCT04740918|540733421|FG001|Overall Study|Study Terminated by Sponsor|32|||
149891952|NCT04740918|540733420|FG000|Overall Study|Death|3|||
149891953|NCT04740918|540733421|FG001|Overall Study|Death|6|||
149891954|NCT04740918|540733420|FG000|Overall Study|Withdrawal by Subject|5|||
149891955|NCT04740918|540733421|FG001|Overall Study|Withdrawal by Subject|4|||
149891956|NCT04740918|540733420|FG000|Overall Study|Lost to Follow-up|1|||
149891957|NCT04740918|540733421|FG001|Overall Study|Lost to Follow-up|3|||
149891958|NCT04740918|540733420|FG000|Overall Study|Progressive disease|0|||
149891959|NCT04740918|540733421|FG001|Overall Study|Progressive disease|1|||
149891960|NCT03759392|540733423|FG000|Overall Study|Adverse Event|12|||
149891961|NCT03759392|540733424|FG001|Overall Study|Adverse Event|4|||
150175872|NCT00433199|541779950|FG000|Open-Label Period|Protocol Violation|0|||
150175873|NCT00433199|541779951|FG001|Open-Label Period|Protocol Violation|2|||
150175874|NCT00433199|541779950|FG000|Open-Label Period|Administrative|0|||
149891962|NCT03759392|540733423|FG000|Overall Study|Death|2|||
149891963|NCT03759392|540733424|FG001|Overall Study|Death|1|||
149891964|NCT03759392|540733423|FG000|Overall Study|Withdrawal by Subject|2|||
149891965|NCT03759392|540733424|FG001|Overall Study|Withdrawal by Subject|0|||
149891966|NCT03759392|540733423|FG000|Overall Study|Protocol Violation|2|||
149891967|NCT03759392|540733424|FG001|Overall Study|Protocol Violation|0|||
149891968|NCT03759392|540733423|FG000|Overall Study|Physician Decision|0|||
149891969|NCT03759392|540733424|FG001|Overall Study|Physician Decision|1|||
149891970|NCT03759392|540733423|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
149891971|NCT03759392|540733424|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
149891972|NCT03759392|540733423|FG000|Overall Study|No longer able to take medicines|1|||
149891973|NCT03759392|540733424|FG001|Overall Study|No longer able to take medicines|0|||
150175875|NCT00433199|541779951|FG001|Open-Label Period|Administrative|1|||
149968108|NCT04727151|541018038|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
149968109|NCT04727151|541018039|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
149968110|NCT04727151|541018040|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
149891974|NCT03759392|540733423|FG000|Overall Study|Stopped taking study drug|1|||
149891975|NCT03759392|540733424|FG001|Overall Study|Stopped taking study drug|0|||
149891976|NCT04314037|540733428|FG000|Treatment Period 2|Adverse Event|1|||
149891977|NCT04314037|540733429|FG001|Treatment Period 2|Adverse Event|0|||
149891978|NCT04314037|540733428|FG000|Treatment Period 3|Protocol Violation|1|||
149891979|NCT04314037|540733429|FG001|Treatment Period 3|Protocol Violation|0|||
149891980|NCT04314037|540733428|FG000|Treatment Period 3|Adverse Event|0|||
149891981|NCT04314037|540733429|FG001|Treatment Period 3|Adverse Event|1|||
149891982|NCT00273182|540733431|FG000|Overall Study|Death|450|||
149891983|NCT00273182|540733431|FG000|Overall Study|Lost to Follow-up|88|||
149891984|NCT00273182|540733431|FG000|Overall Study|Withdrawal by Subject|257|||
149968111|NCT02457793|541018044|FG000|Overall Study|Reason not specified|0|||
149968112|NCT02457793|541018045|FG001|Overall Study|Reason not specified|0|||
150175876|NCT00357097|541779952|FG000|Overall Study|Did not meet inclusion criteria|5|||
149891985|NCT00273182|540733431|FG000|Overall Study|Device/System Explant|154|||
149968113|NCT02457793|541018046|FG002|Overall Study|Reason not specified|0|||
149968114|NCT02457793|541018047|FG003|Overall Study|Reason not specified|1|||
149968115|NCT02457793|541018048|FG004|Overall Study|Reason not specified|1|||
149968116|NCT02457793|541018049|FG005|Overall Study|Reason not specified|1|||
149968117|NCT02457793|541018044|FG000|Overall Study|Withdrawal by Subject|0|||
149968118|NCT02457793|541018045|FG001|Overall Study|Withdrawal by Subject|4|||
149968119|NCT02457793|541018046|FG002|Overall Study|Withdrawal by Subject|2|||
149968120|NCT02457793|541018047|FG003|Overall Study|Withdrawal by Subject|2|||
149968121|NCT02457793|541018048|FG004|Overall Study|Withdrawal by Subject|2|||
149968122|NCT02457793|541018049|FG005|Overall Study|Withdrawal by Subject|2|||
149968123|NCT02457793|541018044|FG000|Overall Study|Adverse Event|0|||
149968124|NCT02457793|541018045|FG001|Overall Study|Adverse Event|0|||
149968125|NCT02457793|541018046|FG002|Overall Study|Adverse Event|0|||
149968126|NCT02457793|541018047|FG003|Overall Study|Adverse Event|1|||
149968127|NCT02457793|541018048|FG004|Overall Study|Adverse Event|0|||
149968128|NCT02457793|541018049|FG005|Overall Study|Adverse Event|0|||
149968129|NCT02457793|541018044|FG000|Overall Study|Physician Decision|1|||
149968130|NCT02457793|541018045|FG001|Overall Study|Physician Decision|0|||
149968131|NCT02457793|541018046|FG002|Overall Study|Physician Decision|1|||
149968132|NCT02457793|541018047|FG003|Overall Study|Physician Decision|1|||
149891986|NCT00273182|540733431|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
149891987|NCT00856492|540733432|FG000|Overall Study|Ineligible or withdrew consent|1|||
149891988|NCT00856492|540733433|FG001|Overall Study|Ineligible or withdrew consent|1|||
149891989|NCT00856492|540733434|FG002|Overall Study|Ineligible or withdrew consent|2|||
149891990|NCT01609790|540733435|FG000|Overall Study|Protocol Violation|1|||
149891991|NCT01609790|540733436|FG001|Overall Study|Protocol Violation|7|||
149891992|NCT01609790|540733437|FG002|Overall Study|Protocol Violation|8|||
149891993|NCT04162847|540734549|FG000|Overall Study|Withdrawal by Subject|7|||
149891994|NCT04162847|540734550|FG001|Overall Study|Withdrawal by Subject|1|||
149891995|NCT02764762|540734553|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
149891996|NCT02764762|540734553|FG000|Overall Study|Lost to Follow-up|4|||
149891997|NCT02764762|540734553|FG000|Overall Study|Voluntary Withdrawal|8|||
149891998|NCT02764762|540734553|FG000|Overall Study|Site Termination|1|||
149891999|NCT02764762|540734553|FG000|Overall Study|Lack of Efficacy|16|||
149892000|NCT02764762|540734553|FG000|Overall Study|Reason not Specified|1|||
149892001|NCT03534687|540734555|FG000|Overall Study|Lost to Follow-up|7|||
149892002|NCT03534687|540734556|FG001|Overall Study|Lost to Follow-up|2|||
149892003|NCT01836471|540734557|FG000|Overall Study|Pregnancy|1|||
149892004|NCT01836471|540734558|FG001|Overall Study|Pregnancy|0|||
149892005|NCT01836471|540734559|FG002|Overall Study|Pregnancy|0|||
149892006|NCT01836471|540734560|FG003|Overall Study|Pregnancy|0|||
149892007|NCT01836471|540734561|FG004|Overall Study|Pregnancy|0|||
149892008|NCT01836471|540734557|FG000|Overall Study|Withdrawal by Subject|3|||
149892009|NCT01836471|540734558|FG001|Overall Study|Withdrawal by Subject|4|||
149968133|NCT02457793|541018048|FG004|Overall Study|Physician Decision|1|||
149968134|NCT02457793|541018049|FG005|Overall Study|Physician Decision|3|||
149968135|NCT03814044|541018054|FG000|Overall Study|Protocol deviation|1|||
149968136|NCT02757768|541018055|FG000|Overall Study|Randomized Never Received Study Drug|3|||
150175877|NCT00357097|541779953|FG001|Overall Study|Did not meet inclusion criteria|3|||
149892010|NCT01836471|540734559|FG002|Overall Study|Withdrawal by Subject|1|||
149892011|NCT01836471|540734560|FG003|Overall Study|Withdrawal by Subject|0|||
149892012|NCT01836471|540734561|FG004|Overall Study|Withdrawal by Subject|2|||
149968137|NCT02757768|541018056|FG001|Overall Study|Randomized Never Received Study Drug|4|||
149968138|NCT02757768|541018055|FG000|Overall Study|Adverse Event|5|||
149892013|NCT01836471|540734557|FG000|Overall Study|Physician Decision|0|||
149892014|NCT01836471|540734558|FG001|Overall Study|Physician Decision|1|||
149968139|NCT02757768|541018056|FG001|Overall Study|Adverse Event|3|||
149968140|NCT02757768|541018055|FG000|Overall Study|Lack of Efficacy|2|||
149892015|NCT01836471|540734559|FG002|Overall Study|Physician Decision|0|||
149892016|NCT01836471|540734560|FG003|Overall Study|Physician Decision|0|||
149892017|NCT01836471|540734561|FG004|Overall Study|Physician Decision|0|||
149892018|NCT01836471|540734557|FG000|Overall Study|Lost to Follow-up|0|||
149892019|NCT01836471|540734558|FG001|Overall Study|Lost to Follow-up|0|||
149892020|NCT01836471|540734559|FG002|Overall Study|Lost to Follow-up|0|||
149892021|NCT01836471|540734560|FG003|Overall Study|Lost to Follow-up|1|||
149892022|NCT01836471|540734561|FG004|Overall Study|Lost to Follow-up|1|||
149892023|NCT01836471|540734557|FG000|Overall Study|Adverse Event|6|||
149892024|NCT01836471|540734558|FG001|Overall Study|Adverse Event|3|||
149892025|NCT01836471|540734559|FG002|Overall Study|Adverse Event|1|||
149892026|NCT01836471|540734560|FG003|Overall Study|Adverse Event|1|||
149892027|NCT01836471|540734561|FG004|Overall Study|Adverse Event|2|||
149892028|NCT01836471|540734557|FG000|Overall Study|Non compliance with tx|1|||
149892029|NCT01836471|540734558|FG001|Overall Study|Non compliance with tx|1|||
149892030|NCT01836471|540734559|FG002|Overall Study|Non compliance with tx|0|||
149892031|NCT01836471|540734560|FG003|Overall Study|Non compliance with tx|0|||
149892032|NCT01836471|540734561|FG004|Overall Study|Non compliance with tx|0|||
149892033|NCT00314340|540734562|FG000|Overall Study|lost interest|1|||
149892034|NCT05506046|540734564|FG000|Overall Study|Lost to Follow-up|89|||
149892035|NCT05506046|540734565|FG001|Overall Study|Lost to Follow-up|101|||
149892036|NCT05506046|540734566|FG002|Overall Study|Lost to Follow-up|102|||
149892037|NCT05506046|540734567|FG003|Overall Study|Lost to Follow-up|99|||
149892038|NCT00191477|540734568|FG000|Overall Study|Tumor Recurrence|49|||
149892039|NCT00191477|540734569|FG001|Overall Study|Tumor Recurrence|48|||
149892040|NCT00191477|540734568|FG000|Overall Study|Death, Study Disease|1|||
149892041|NCT00191477|540734569|FG001|Overall Study|Death, Study Disease|1|||
149892042|NCT00191477|540734568|FG000|Overall Study|Death, Other Cause|3|||
149892043|NCT00191477|540734569|FG001|Overall Study|Death, Other Cause|6|||
149892044|NCT00191477|540734568|FG000|Overall Study|Lost to Follow-up|23|||
149892045|NCT00191477|540734569|FG001|Overall Study|Lost to Follow-up|21|||
149892046|NCT00191477|540734568|FG000|Overall Study|Protocol Violation|1|||
149892047|NCT00191477|540734569|FG001|Overall Study|Protocol Violation|1|||
149892048|NCT00191477|540734568|FG000|Overall Study|Treatment Change|2|||
149892049|NCT00191477|540734569|FG001|Overall Study|Treatment Change|0|||
149892050|NCT00191477|540734568|FG000|Overall Study|Withdrawal by Subject|2|||
149892051|NCT00191477|540734569|FG001|Overall Study|Withdrawal by Subject|0|||
149892052|NCT00191477|540734568|FG000|Overall Study|Other|2|||
149892053|NCT00191477|540734569|FG001|Overall Study|Other|0|||
149892054|NCT00191477|540734568|FG000|Overall Study|Not Eligible|41|||
149892055|NCT00191477|540734569|FG001|Overall Study|Not Eligible|38|||
149892056|NCT00191477|540734568|FG000|Overall Study|Pathological Specimen Lost|1|||
149892057|NCT00191477|540734569|FG001|Overall Study|Pathological Specimen Lost|0|||
149892058|NCT00191477|540734568|FG000|Overall Study|Discontinued Prior to Instillation|13|||
149892059|NCT00191477|540734569|FG001|Overall Study|Discontinued Prior to Instillation|14|||
149892060|NCT01286467|540734578|FG000|Overall Study|Death|1|||
149892061|NCT01286467|540734579|FG001|Overall Study|Death|1|||
149892062|NCT01286467|540734580|FG002|Overall Study|Death|1|||
149892063|NCT01286467|540734581|FG003|Overall Study|Death|0|||
149892064|NCT01286467|540734578|FG000|Overall Study|Lost to Follow-up|0|||
149892065|NCT01286467|540734579|FG001|Overall Study|Lost to Follow-up|0|||
149892066|NCT01286467|540734580|FG002|Overall Study|Lost to Follow-up|0|||
149892067|NCT01286467|540734581|FG003|Overall Study|Lost to Follow-up|1|||
149892068|NCT01286467|540734578|FG000|Overall Study|Withdrawal by Subject|0|||
149892069|NCT01286467|540734579|FG001|Overall Study|Withdrawal by Subject|0|||
149892070|NCT01286467|540734580|FG002|Overall Study|Withdrawal by Subject|1|||
149892071|NCT01286467|540734581|FG003|Overall Study|Withdrawal by Subject|0|||
149892072|NCT01286467|540734578|FG000|Overall Study|Physician Decision|0|||
149892073|NCT01286467|540734579|FG001|Overall Study|Physician Decision|0|||
149892074|NCT01286467|540734580|FG002|Overall Study|Physician Decision|0|||
149892075|NCT01286467|540734581|FG003|Overall Study|Physician Decision|1|||
149892076|NCT01286467|540734578|FG000|Overall Study|Disease progression|3|||
149892077|NCT01286467|540734579|FG001|Overall Study|Disease progression|2|||
149892078|NCT01286467|540734580|FG002|Overall Study|Disease progression|2|||
149892079|NCT01286467|540734581|FG003|Overall Study|Disease progression|3|||
149892080|NCT01286467|540734578|FG000|Overall Study|Adverse Event|0|||
149892081|NCT01286467|540734579|FG001|Overall Study|Adverse Event|1|||
149892082|NCT01286467|540734580|FG002|Overall Study|Adverse Event|2|||
149892083|NCT01286467|540734581|FG003|Overall Study|Adverse Event|3|||
149892084|NCT01286467|540734578|FG000|Overall Study|Study drug stop longer than 14 days|0|||
149892085|NCT01286467|540734579|FG001|Overall Study|Study drug stop longer than 14 days|0|||
149892086|NCT01286467|540734580|FG002|Overall Study|Study drug stop longer than 14 days|1|||
149892087|NCT01286467|540734581|FG003|Overall Study|Study drug stop longer than 14 days|0|||
149892088|NCT01058642|540734582|FG000|Treatment Period 1|Adverse Event|0|||
149892089|NCT01058642|540734583|FG001|Treatment Period 1|Adverse Event|1|||
149892090|NCT01058642|540734584|FG002|Treatment Period 1|Adverse Event|1|||
149892091|NCT01058642|540734585|FG003|Treatment Period 1|Adverse Event|0|||
149892092|NCT01058642|540734582|FG000|Treatment Period 1|Physician Decision|0|||
149892093|NCT01058642|540734583|FG001|Treatment Period 1|Physician Decision|0|||
149892094|NCT01058642|540734584|FG002|Treatment Period 1|Physician Decision|1|||
149892095|NCT01058642|540734585|FG003|Treatment Period 1|Physician Decision|0|||
149892096|NCT01058642|540734582|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149892097|NCT01058642|540734583|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149892098|NCT01058642|540734584|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149892099|NCT01058642|540734585|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149892100|NCT01058642|540734582|FG000|Treatment Period 1|Lack of Efficacy|0|||
149892101|NCT01058642|540734583|FG001|Treatment Period 1|Lack of Efficacy|0|||
149892102|NCT01058642|540734584|FG002|Treatment Period 1|Lack of Efficacy|0|||
149892103|NCT01058642|540734585|FG003|Treatment Period 1|Lack of Efficacy|1|||
149892104|NCT01058642|540734582|FG000|Treatment Period 1|Protocol Violation|0|||
149892105|NCT01058642|540734583|FG001|Treatment Period 1|Protocol Violation|0|||
149892106|NCT01058642|540734584|FG002|Treatment Period 1|Protocol Violation|0|||
149892107|NCT01058642|540734585|FG003|Treatment Period 1|Protocol Violation|1|||
149892108|NCT01058642|540734582|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
149892109|NCT01058642|540734583|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
149892110|NCT01058642|540734584|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
149892111|NCT01058642|540734585|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
149892112|NCT03751098|540734591|FG000|Overall Study|Withdrawal by Subject|0|||
149892113|NCT03751098|540734592|FG001|Overall Study|Withdrawal by Subject|1|||
149892114|NCT01306305|540734602|FG000|Overall Study|Lost to Follow-up|1|||
149892115|NCT01306305|540734603|FG001|Overall Study|Lost to Follow-up|0|||
149892116|NCT01306305|540734602|FG000|Overall Study|Withdrew consent|1|||
149892117|NCT01306305|540734603|FG001|Overall Study|Withdrew consent|0|||
149892118|NCT04030299|540734604|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
149892119|NCT04030299|540734604|FG000|Overall Study|Withdrawal by Subject|3|||
149892120|NCT02964247|540734606|FG000|Overall Study|Lost to Follow-up|2|||
149892121|NCT02964247|540734607|FG001|Overall Study|Lost to Follow-up|0|||
149892122|NCT02964247|540734606|FG000|Overall Study|Withdrawal by Subject|1|||
149892123|NCT02964247|540734607|FG001|Overall Study|Withdrawal by Subject|2|||
149892124|NCT01288079|540734608|FG000|Overall Study|Withdrawal by Subject|2|||
149892125|NCT01288079|540734609|FG001|Overall Study|Withdrawal by Subject|4|||
149892126|NCT01288079|540734610|FG002|Overall Study|Withdrawal by Subject|1|||
149892127|NCT01288079|540734611|FG003|Overall Study|Withdrawal by Subject|0|||
149892128|NCT01288079|540734608|FG000|Overall Study|Adverse Event|2|||
149892129|NCT01288079|540734609|FG001|Overall Study|Adverse Event|1|||
149892130|NCT01288079|540734610|FG002|Overall Study|Adverse Event|2|||
149892131|NCT01288079|540734611|FG003|Overall Study|Adverse Event|3|||
149892132|NCT01288079|540734608|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
149892133|NCT01288079|540734609|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
149892134|NCT01288079|540734610|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
149892135|NCT01288079|540734611|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
149892136|NCT01288079|540734608|FG000|Overall Study|Condition under Investigation Worsened|0|||
149892137|NCT01288079|540734609|FG001|Overall Study|Condition under Investigation Worsened|0|||
149892138|NCT01288079|540734610|FG002|Overall Study|Condition under Investigation Worsened|0|||
149892139|NCT01288079|540734611|FG003|Overall Study|Condition under Investigation Worsened|1|||
149892140|NCT01288079|540734608|FG000|Overall Study|Lack of Efficacy|2|||
149892141|NCT01288079|540734609|FG001|Overall Study|Lack of Efficacy|2|||
149892142|NCT01288079|540734610|FG002|Overall Study|Lack of Efficacy|0|||
149892143|NCT01288079|540734611|FG003|Overall Study|Lack of Efficacy|2|||
149892144|NCT01288079|540734608|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
149892145|NCT01288079|540734609|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
149892146|NCT01288079|540734610|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
149892147|NCT01288079|540734611|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
149892148|NCT01288079|540734608|FG000|Overall Study|Lost to Follow-up|1|||
149892149|NCT01288079|540734609|FG001|Overall Study|Lost to Follow-up|1|||
149892150|NCT01288079|540734610|FG002|Overall Study|Lost to Follow-up|1|||
149892151|NCT01288079|540734611|FG003|Overall Study|Lost to Follow-up|0|||
149892152|NCT01288079|540734608|FG000|Overall Study|Other or Study Termination|11|||
149892153|NCT01288079|540734609|FG001|Overall Study|Other or Study Termination|15|||
149892154|NCT01288079|540734610|FG002|Overall Study|Other or Study Termination|14|||
149892155|NCT01288079|540734611|FG003|Overall Study|Other or Study Termination|8|||
149892156|NCT01530464|540734612|FG000|Washout (24h)|Withdrawal by Subject|1|||
149892157|NCT01530464|540734613|FG001|Washout (24h)|Withdrawal by Subject|0|||
149892158|NCT01530464|540734612|FG000|Washout (24h)|Withdrawal by Subject|0|||
149892159|NCT01530464|540734613|FG001|Washout (24h)|Withdrawal by Subject|1|||
149892160|NCT01709500|540734614|FG000|Overall Study|Randomized but not treated|0|||
149892161|NCT01709500|540734615|FG001|Overall Study|Randomized but not treated|1|||
149892162|NCT01709500|540734614|FG000|Overall Study|Adverse Event|5|||
149892163|NCT01709500|540734615|FG001|Overall Study|Adverse Event|1|||
149892164|NCT01709500|540734614|FG000|Overall Study|Poor compliance to protocol|2|||
149892165|NCT01709500|540734615|FG001|Overall Study|Poor compliance to protocol|1|||
149892166|NCT01709500|540734614|FG000|Overall Study|Other|3|||
149892167|NCT01709500|540734615|FG001|Overall Study|Other|1|||
149892168|NCT01709500|540734614|FG000|Overall Study|Related to IMP administration|1|||
149892169|NCT01709500|540734615|FG001|Overall Study|Related to IMP administration|0|||
149892170|NCT01709500|540734614|FG000|Overall Study|Treatment ongoing|156|||
149892171|NCT01709500|540734615|FG001|Overall Study|Treatment ongoing|78|||
149892172|NCT03539302|540734622|FG000|Overall Study|Spontaneous cardio version|0|||
149892173|NCT03539302|540734623|FG001|Overall Study|Spontaneous cardio version|0|||
149892174|NCT03539302|540734624|FG002|Overall Study|Spontaneous cardio version|0|||
149892175|NCT03539302|540734625|FG003|Overall Study|Spontaneous cardio version|0|||
149892176|NCT03539302|540734626|FG004|Overall Study|Spontaneous cardio version|0|||
149892177|NCT03539302|540734627|FG005|Overall Study|Spontaneous cardio version|1|||
149892178|NCT03539302|540734628|FG006|Overall Study|Spontaneous cardio version|1|||
149892179|NCT02107131|540734633|FG000|Overall Study|Lost to Follow-up|4|||
149892180|NCT02107131|540734634|FG001|Overall Study|Lost to Follow-up|4|||
149892181|NCT02107131|540734633|FG000|Overall Study|Physician Decision|1|||
149892182|NCT02107131|540734634|FG001|Overall Study|Physician Decision|0|||
149892183|NCT02107131|540734633|FG000|Overall Study|Withdrawal by Subject|2|||
149892184|NCT02107131|540734634|FG001|Overall Study|Withdrawal by Subject|0|||
149892185|NCT02107131|540734633|FG000|Overall Study|mental instability|1|||
149892186|NCT02107131|540734634|FG001|Overall Study|mental instability|0|||
149892187|NCT02107131|540734633|FG000|Overall Study|Death|0|||
149892188|NCT02107131|540734634|FG001|Overall Study|Death|1|||
149892189|NCT02107131|540734633|FG000|Overall Study|Protocol Violation|0|||
149892190|NCT02107131|540734634|FG001|Overall Study|Protocol Violation|4|||
149892191|NCT00420420|540734639|FG000|Overall Study|Adverse Event|5|||
149892192|NCT00420420|540734640|FG001|Overall Study|Adverse Event|3|||
149892193|NCT00420420|540734639|FG000|Overall Study|Protocol Violation|1|||
150175878|NCT00357097|541779952|FG000|Overall Study|Adverse Event|34|||
149892194|NCT00420420|540734640|FG001|Overall Study|Protocol Violation|1|||
149892195|NCT00420420|540734639|FG000|Overall Study|Withdrawal by Subject|1|||
149892196|NCT00420420|540734640|FG001|Overall Study|Withdrawal by Subject|0|||
149892197|NCT00420420|540734639|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
149892198|NCT00420420|540734640|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
149892199|NCT02362360|540734646|FG000|Period 1|Lack of Efficacy|1|||
149892200|NCT02362360|540734647|FG001|Period 1|Lack of Efficacy|0|||
149892201|NCT02362360|540734646|FG000|Period 1|Withdrawal by Subject|2|||
149892202|NCT02362360|540734647|FG001|Period 1|Withdrawal by Subject|1|||
149968141|NCT02757768|541018056|FG001|Overall Study|Lack of Efficacy|1|||
149968142|NCT02757768|541018055|FG000|Overall Study|Lost to Follow-up|1|||
150175879|NCT00357097|541779953|FG001|Overall Study|Adverse Event|6|||
150175880|NCT00357097|541779952|FG000|Overall Study|Withdrawal by Subject|8|||
149892203|NCT02208362|540734648|FG000|Overall Study|Participant did not complete treatment|0|||
149892204|NCT02208362|540734649|FG001|Overall Study|Participant did not complete treatment|1|||
149968143|NCT02757768|541018056|FG001|Overall Study|Lost to Follow-up|0|||
149968144|NCT02757768|541018055|FG000|Overall Study|Protocol Deviation|2|||
149968145|NCT02757768|541018056|FG001|Overall Study|Protocol Deviation|9|||
149968146|NCT02757768|541018055|FG000|Overall Study|Withdrawal by Subject|16|||
149968147|NCT02757768|541018056|FG001|Overall Study|Withdrawal by Subject|9|||
149968148|NCT02757768|541018055|FG000|Overall Study|Miscellaneous|4|||
149968149|NCT02757768|541018056|FG001|Overall Study|Miscellaneous|2|||
149968150|NCT00835367|541018068|FG000|Washout|Adverse Event|2|||
149968151|NCT00835367|541018069|FG001|Washout|Adverse Event|0|||
149968152|NCT00835367|541018068|FG000|Washout|Withdrawal by Subject|1|||
149968153|NCT00835367|541018069|FG001|Washout|Withdrawal by Subject|0|||
149968154|NCT00835367|541018068|FG000|Second Intervention|Adverse Event|1|||
149968155|NCT00835367|541018069|FG001|Second Intervention|Adverse Event|1|||
149968156|NCT05929326|541018070|FG000|Overall Study|unqualified sample|2|||
149968157|NCT05929326|541018071|FG001|Overall Study|unqualified sample|3|||
149968158|NCT05929326|541018072|FG002|Overall Study|unqualified sample|7|||
149968159|NCT04890509|541018073|FG000|Overall Study|Death|4|||
149968160|NCT04890509|541018074|FG001|Overall Study|Death|4|||
149968161|NCT02495883|541018083|FG000|Overall Study|Excessive head motion|1|||
149968162|NCT02495883|541018084|FG001|Overall Study|Excessive head motion|0|||
149892205|NCT02208362|540734650|FG002|Overall Study|Participant did not complete treatment|0|||
149892206|NCT02208362|540734651|FG003|Overall Study|Participant did not complete treatment|0|||
149892207|NCT02208362|540734652|FG004|Overall Study|Participant did not complete treatment|0|||
149892208|NCT02208362|540734653|FG005|Overall Study|Participant did not complete treatment|0|||
149892209|NCT02208362|540734654|FG006|Overall Study|Participant did not complete treatment|1|||
149892210|NCT02208362|540734655|FG007|Overall Study|Participant did not complete treatment|1|||
149892211|NCT02208362|540734656|FG008|Overall Study|Participant did not complete treatment|2|||
149892212|NCT02208362|540734657|FG009|Overall Study|Participant did not complete treatment|0|||
149892213|NCT02208362|540734658|FG010|Overall Study|Participant did not complete treatment|1|||
149892214|NCT02208362|540734659|FG011|Overall Study|Participant did not complete treatment|0|||
149892215|NCT02208362|540734648|FG000|Overall Study|Participant received disallowed treatment|0|||
149892216|NCT02208362|540734649|FG001|Overall Study|Participant received disallowed treatment|0|||
149892217|NCT02208362|540734650|FG002|Overall Study|Participant received disallowed treatment|0|||
149892218|NCT02208362|540734651|FG003|Overall Study|Participant received disallowed treatment|0|||
149892219|NCT02208362|540734652|FG004|Overall Study|Participant received disallowed treatment|0|||
149892220|NCT02208362|540734653|FG005|Overall Study|Participant received disallowed treatment|0|||
149892221|NCT02208362|540734654|FG006|Overall Study|Participant received disallowed treatment|0|||
149892222|NCT02208362|540734655|FG007|Overall Study|Participant received disallowed treatment|0|||
149892223|NCT02208362|540734656|FG008|Overall Study|Participant received disallowed treatment|1|||
149892224|NCT02208362|540734657|FG009|Overall Study|Participant received disallowed treatment|0|||
149968163|NCT03557502|541018085|FG000|Protocol 2|Withdrawal by Subject|1|||
149968164|NCT03557502|541018086|FG001|Protocol 2|Withdrawal by Subject|1|||
149968165|NCT03557502|541018085|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
149968166|NCT03557502|541018086|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
149968167|NCT02520154|541018093|FG000|Overall Study|Death|1|||
149968168|NCT02520154|541018093|FG000|Overall Study|Withdrawal by Subject|2|||
149968169|NCT02520154|541018093|FG000|Overall Study|Physician Decision|2|||
149968170|NCT00791648|541019753|FG000|Overall Study|Physician Decision|0|||
149968171|NCT00791648|541019754|FG001|Overall Study|Physician Decision|1|||
149968172|NCT00791648|541019753|FG000|Overall Study|Withdrawal by Subject|0|||
149968173|NCT00791648|541019754|FG001|Overall Study|Withdrawal by Subject|1|||
149968174|NCT04976777|541019755|FG000|Overall Study|COVID-19 Infection|1|||
149968175|NCT04976777|541019756|FG001|Overall Study|COVID-19 Infection|0|||
149968176|NCT03977155|541019757|FG000|Overall Study|Adverse Event|3|||
149968177|NCT03977155|541019758|FG001|Overall Study|Adverse Event|0|||
149968178|NCT03977155|541019759|FG002|Overall Study|Adverse Event|0|||
149968179|NCT03977155|541019757|FG000|Overall Study|Lost to Follow-up|0|||
149968180|NCT03977155|541019758|FG001|Overall Study|Lost to Follow-up|1|||
149968181|NCT03977155|541019759|FG002|Overall Study|Lost to Follow-up|0|||
149968182|NCT03977155|541019757|FG000|Overall Study|Withdrawal by Subject|1|||
149968183|NCT03977155|541019758|FG001|Overall Study|Withdrawal by Subject|1|||
150175881|NCT00357097|541779953|FG001|Overall Study|Withdrawal by Subject|7|||
150175882|NCT00357097|541779952|FG000|Overall Study|Non-compliance|1|||
150175883|NCT00357097|541779953|FG001|Overall Study|Non-compliance|2|||
149892225|NCT02208362|540734658|FG010|Overall Study|Participant received disallowed treatment|0|||
149968184|NCT03977155|541019759|FG002|Overall Study|Withdrawal by Subject|2|||
149968185|NCT03977155|541019757|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
150175884|NCT00357097|541779952|FG000|Overall Study|Lack of Efficacy|2|||
149892226|NCT02208362|540734659|FG011|Overall Study|Participant received disallowed treatment|0|||
149892227|NCT00868530|540734663|FG000|Overall Study|Adverse Event|3|||
149892228|NCT00868530|540734663|FG000|Overall Study|Lost to Follow-up|1|||
149892229|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Adverse Event|7|||
149892230|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
149892231|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Non-compliance|3|||
149892232|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Other|17|||
149892233|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Physician Decision|2|||
149892234|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Pregnancy|1|||
149892235|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
149892236|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
149892237|NCT05207865|540736646|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
149892238|NCT05207865|540736646|FG000|Follow-up Phase|Lost to Follow-up|1|||
149892239|NCT05207865|540736646|FG000|Follow-up Phase|Non-compliance|1|||
149892240|NCT05207865|540736646|FG000|Follow-up Phase|Not reported|2|||
149892241|NCT05207865|540736646|FG000|Follow-up Phase|Not collected|11|||
149892242|NCT02546986|540736649|FG000|Treatment Period|Progressive Disease|20|||
149892243|NCT02546986|540736650|FG001|Treatment Period|Progressive Disease|22|||
149892244|NCT02546986|540736649|FG000|Treatment Period|Adverse Event|14|||
149892245|NCT02546986|540736650|FG001|Treatment Period|Adverse Event|6|||
149892246|NCT02546986|540736649|FG000|Treatment Period|Symptomatic Deterioration|4|||
149892247|NCT02546986|540736650|FG001|Treatment Period|Symptomatic Deterioration|3|||
149892248|NCT02546986|540736649|FG000|Treatment Period|Death|3|||
149892249|NCT02546986|540736650|FG001|Treatment Period|Death|4|||
149892250|NCT02546986|540736649|FG000|Treatment Period|Physician Decision|1|||
149892251|NCT02546986|540736650|FG001|Treatment Period|Physician Decision|2|||
149892252|NCT02546986|540736649|FG000|Treatment Period|Protocol Violation|1|||
149892253|NCT02546986|540736650|FG001|Treatment Period|Protocol Violation|0|||
149892254|NCT02546986|540736649|FG000|Treatment Period|Withdrawal by Subject|1|||
149892255|NCT02546986|540736650|FG001|Treatment Period|Withdrawal by Subject|1|||
149892256|NCT02546986|540736649|FG000|Treatment Period|Non-compliance with Study Drug|0|||
149892257|NCT02546986|540736650|FG001|Treatment Period|Non-compliance with Study Drug|1|||
149892258|NCT02546986|540736649|FG000|Treatment Period|Study Terminated by Sponsor|0|||
149892259|NCT02546986|540736650|FG001|Treatment Period|Study Terminated by Sponsor|1|||
149892260|NCT02546986|540736649|FG000|Treatment Period|Miscellaneous|7|||
149892261|NCT02546986|540736650|FG001|Treatment Period|Miscellaneous|9|||
149892262|NCT02546986|540736649|FG000|Survival Follow-Up Phase|Missing Status|3|||
149892263|NCT02546986|540736650|FG001|Survival Follow-Up Phase|Missing Status|5|||
149892264|NCT02546986|540736649|FG000|Survival Follow-Up Phase|Death|18|||
149892265|NCT02546986|540736650|FG001|Survival Follow-Up Phase|Death|12|||
149892266|NCT02546986|540736649|FG000|Survival Follow-Up Phase|Alive|13|||
149892267|NCT02546986|540736650|FG001|Survival Follow-Up Phase|Alive|16|||
149892268|NCT02546986|540736649|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
149892269|NCT02546986|540736650|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
149892270|NCT00739882|540736651|FG000|Double-blind Period|Adverse Event|1|||
149892271|NCT00739882|540736652|FG001|Double-blind Period|Adverse Event|2|||
149892272|NCT00739882|540736651|FG000|Double-blind Period|Protocol Violation|1|||
149892273|NCT00739882|540736652|FG001|Double-blind Period|Protocol Violation|0|||
149892274|NCT00739882|540736651|FG000|Double-blind Period|Lack of Efficacy|1|||
149892275|NCT00739882|540736652|FG001|Double-blind Period|Lack of Efficacy|1|||
149892276|NCT00739882|540736651|FG000|Double-blind Period|Other|16|||
149892277|NCT00739882|540736652|FG001|Double-blind Period|Other|8|||
149892278|NCT00739882|540736651|FG000|Open-label Period|Adverse Event|1|||
149892279|NCT00739882|540736652|FG001|Open-label Period|Adverse Event|0|||
149892280|NCT00739882|540736651|FG000|Open-label Period|Other|9|||
149892281|NCT00739882|540736652|FG001|Open-label Period|Other|5|||
149892282|NCT04021914|540736653|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
149892283|NCT02844543|540736654|FG000|Overall Study|Withdrawal by Subject|4|||
149892284|NCT02844543|540736654|FG000|Overall Study|Did not meet eligibility criteria|1|||
149892285|NCT00955409|540736655|FG000|Overall Study|Lack of Efficacy|1|||
149892286|NCT00955409|540736656|FG001|Overall Study|Lack of Efficacy|0|||
149892287|NCT00955409|540736657|FG002|Overall Study|Lack of Efficacy|0|||
149892288|NCT00955409|540736658|FG003|Overall Study|Lack of Efficacy|0|||
149892289|NCT00955409|540736659|FG004|Overall Study|Lack of Efficacy|0|||
149892290|NCT00955409|540736660|FG005|Overall Study|Lack of Efficacy|0|||
149892291|NCT00955409|540736661|FG006|Overall Study|Lack of Efficacy|0|||
149892292|NCT00955409|540736662|FG007|Overall Study|Lack of Efficacy|0|||
149892293|NCT00955409|540736663|FG008|Overall Study|Lack of Efficacy|0|||
149892294|NCT00955409|540736664|FG009|Overall Study|Lack of Efficacy|0|||
149892295|NCT00955409|540736655|FG000|Overall Study|Withdrawal by Subject|1|||
149892296|NCT00955409|540736656|FG001|Overall Study|Withdrawal by Subject|0|||
149892297|NCT00955409|540736657|FG002|Overall Study|Withdrawal by Subject|5|||
149892298|NCT00955409|540736658|FG003|Overall Study|Withdrawal by Subject|2|||
149892299|NCT00955409|540736659|FG004|Overall Study|Withdrawal by Subject|0|||
149892300|NCT00955409|540736660|FG005|Overall Study|Withdrawal by Subject|0|||
149892301|NCT00955409|540736661|FG006|Overall Study|Withdrawal by Subject|2|||
150175885|NCT00357097|541779953|FG001|Overall Study|Lack of Efficacy|8|||
149892302|NCT00955409|540736662|FG007|Overall Study|Withdrawal by Subject|0|||
149892303|NCT00955409|540736663|FG008|Overall Study|Withdrawal by Subject|1|||
149892304|NCT00955409|540736664|FG009|Overall Study|Withdrawal by Subject|0|||
149892305|NCT00955409|540736655|FG000|Overall Study|Caregiver Request|2|||
149892306|NCT00955409|540736656|FG001|Overall Study|Caregiver Request|0|||
149892307|NCT00955409|540736657|FG002|Overall Study|Caregiver Request|6|||
149892308|NCT00955409|540736658|FG003|Overall Study|Caregiver Request|5|||
149892309|NCT00955409|540736659|FG004|Overall Study|Caregiver Request|0|||
149892310|NCT00955409|540736660|FG005|Overall Study|Caregiver Request|2|||
149892311|NCT00955409|540736661|FG006|Overall Study|Caregiver Request|3|||
149892312|NCT00955409|540736662|FG007|Overall Study|Caregiver Request|1|||
149892313|NCT00955409|540736663|FG008|Overall Study|Caregiver Request|3|||
149892314|NCT00955409|540736664|FG009|Overall Study|Caregiver Request|0|||
149892315|NCT00955409|540736655|FG000|Overall Study|Investigator Request|0|||
149892316|NCT00955409|540736656|FG001|Overall Study|Investigator Request|0|||
149892317|NCT00955409|540736657|FG002|Overall Study|Investigator Request|1|||
149892318|NCT00955409|540736658|FG003|Overall Study|Investigator Request|0|||
149892319|NCT00955409|540736659|FG004|Overall Study|Investigator Request|0|||
149892320|NCT00955409|540736660|FG005|Overall Study|Investigator Request|0|||
149892321|NCT00955409|540736661|FG006|Overall Study|Investigator Request|0|||
149892322|NCT00955409|540736662|FG007|Overall Study|Investigator Request|0|||
149892323|NCT00955409|540736663|FG008|Overall Study|Investigator Request|0|||
149892324|NCT00955409|540736664|FG009|Overall Study|Investigator Request|0|||
149892325|NCT00955409|540736655|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
149892326|NCT00955409|540736656|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
149892327|NCT00955409|540736657|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
149892328|NCT00955409|540736658|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
149892329|NCT00955409|540736659|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
149892330|NCT00955409|540736660|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
149892331|NCT00955409|540736661|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
149892332|NCT00955409|540736662|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
149892333|NCT00955409|540736663|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
149892334|NCT00955409|540736664|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
149892335|NCT00955409|540736655|FG000|Overall Study|Lost to Follow-up|0|||
149892336|NCT00955409|540736656|FG001|Overall Study|Lost to Follow-up|0|||
149892337|NCT00955409|540736657|FG002|Overall Study|Lost to Follow-up|1|||
149892338|NCT00955409|540736658|FG003|Overall Study|Lost to Follow-up|0|||
149892339|NCT00955409|540736659|FG004|Overall Study|Lost to Follow-up|0|||
149892340|NCT00955409|540736660|FG005|Overall Study|Lost to Follow-up|0|||
149892341|NCT00955409|540736661|FG006|Overall Study|Lost to Follow-up|1|||
149892342|NCT00955409|540736662|FG007|Overall Study|Lost to Follow-up|0|||
149892343|NCT00955409|540736663|FG008|Overall Study|Lost to Follow-up|0|||
149892344|NCT00955409|540736664|FG009|Overall Study|Lost to Follow-up|0|||
149892345|NCT00955409|540736655|FG000|Overall Study|Failed to Return|2|||
149892346|NCT00955409|540736656|FG001|Overall Study|Failed to Return|0|||
149892347|NCT00955409|540736657|FG002|Overall Study|Failed to Return|0|||
149892348|NCT00955409|540736658|FG003|Overall Study|Failed to Return|0|||
149892349|NCT00955409|540736659|FG004|Overall Study|Failed to Return|0|||
149892350|NCT00955409|540736660|FG005|Overall Study|Failed to Return|0|||
149892351|NCT00955409|540736661|FG006|Overall Study|Failed to Return|0|||
149892352|NCT00955409|540736662|FG007|Overall Study|Failed to Return|2|||
149892353|NCT00955409|540736663|FG008|Overall Study|Failed to Return|0|||
149892354|NCT00955409|540736664|FG009|Overall Study|Failed to Return|0|||
149892355|NCT00955409|540736655|FG000|Overall Study|Adverse Event (AE)|2|||
149892356|NCT00955409|540736656|FG001|Overall Study|Adverse Event (AE)|0|||
149892357|NCT00955409|540736657|FG002|Overall Study|Adverse Event (AE)|0|||
149892358|NCT00955409|540736658|FG003|Overall Study|Adverse Event (AE)|0|||
149892359|NCT00955409|540736659|FG004|Overall Study|Adverse Event (AE)|0|||
149892360|NCT00955409|540736660|FG005|Overall Study|Adverse Event (AE)|1|||
149892361|NCT00955409|540736661|FG006|Overall Study|Adverse Event (AE)|2|||
149892362|NCT00955409|540736662|FG007|Overall Study|Adverse Event (AE)|0|||
149892363|NCT00955409|540736663|FG008|Overall Study|Adverse Event (AE)|2|||
149892364|NCT00955409|540736664|FG009|Overall Study|Adverse Event (AE)|0|||
149892365|NCT00955409|540736655|FG000|Overall Study|Reason not Specified|2|||
149892366|NCT00955409|540736656|FG001|Overall Study|Reason not Specified|1|||
149892367|NCT00955409|540736657|FG002|Overall Study|Reason not Specified|13|||
150175886|NCT00357097|541779952|FG000|Overall Study|Met Exclusion Criteria|3|||
149892368|NCT00955409|540736658|FG003|Overall Study|Reason not Specified|1|||
149892369|NCT00955409|540736659|FG004|Overall Study|Reason not Specified|2|||
149892370|NCT00955409|540736660|FG005|Overall Study|Reason not Specified|0|||
149892371|NCT00955409|540736661|FG006|Overall Study|Reason not Specified|16|||
149892372|NCT00955409|540736662|FG007|Overall Study|Reason not Specified|0|||
149892373|NCT00955409|540736663|FG008|Overall Study|Reason not Specified|8|||
149892374|NCT00955409|540736664|FG009|Overall Study|Reason not Specified|1|||
149892375|NCT00803790|540736665|FG000|Period 1|Adverse Event|0|||
149892376|NCT00803790|540736666|FG001|Period 1|Adverse Event|1|||
149892377|NCT00803790|540736667|FG002|Period 1|Adverse Event|0|||
149892378|NCT00803790|540736668|FG003|Period 1|Adverse Event|0|||
149892379|NCT00803790|540736665|FG000|Period 1|Lost to Follow-up|1|||
149892380|NCT00803790|540736666|FG001|Period 1|Lost to Follow-up|2|||
149892381|NCT00803790|540736667|FG002|Period 1|Lost to Follow-up|0|||
149892382|NCT00803790|540736668|FG003|Period 1|Lost to Follow-up|0|||
149892383|NCT00803790|540736665|FG000|Period 1|Withdrawal by Subject|8|||
149892384|NCT00803790|540736666|FG001|Period 1|Withdrawal by Subject|6|||
149892385|NCT00803790|540736667|FG002|Period 1|Withdrawal by Subject|0|||
149892386|NCT00803790|540736668|FG003|Period 1|Withdrawal by Subject|0|||
149892387|NCT00803790|540736665|FG000|Period 1|positive drug screen or personal reasons|0|||
149892388|NCT00803790|540736666|FG001|Period 1|positive drug screen or personal reasons|3|||
149892389|NCT00803790|540736667|FG002|Period 1|positive drug screen or personal reasons|0|||
149892390|NCT00803790|540736668|FG003|Period 1|positive drug screen or personal reasons|4|||
149892391|NCT00803790|540736665|FG000|Period 1|Protocol Violation|0|||
149892392|NCT00803790|540736666|FG001|Period 1|Protocol Violation|0|||
149892393|NCT00803790|540736667|FG002|Period 1|Protocol Violation|1|||
149892394|NCT00803790|540736668|FG003|Period 1|Protocol Violation|0|||
149892395|NCT00803790|540736665|FG000|Period 2|Adverse Event|0|||
149892396|NCT00803790|540736666|FG001|Period 2|Adverse Event|0|||
149892397|NCT00803790|540736667|FG002|Period 2|Adverse Event|1|||
149892398|NCT00803790|540736668|FG003|Period 2|Adverse Event|1|||
149892399|NCT00803790|540736665|FG000|Period 2|Withdrawal by Subject|1|||
149892400|NCT00803790|540736666|FG001|Period 2|Withdrawal by Subject|0|||
149892401|NCT00803790|540736667|FG002|Period 2|Withdrawal by Subject|0|||
149892402|NCT00803790|540736668|FG003|Period 2|Withdrawal by Subject|0|||
149892403|NCT00803790|540736665|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
149892404|NCT00803790|540736666|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
149892405|NCT00803790|540736667|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
149892406|NCT00803790|540736668|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
149892407|NCT04710576|540736669|FG000|Overall Study|Participants still in the study|73|||
149892408|NCT04710576|540736670|FG001|Overall Study|Participants still in the study|70|||
149892409|NCT04710576|540736671|FG002|Overall Study|Participants still in the study|60|||
149892410|NCT04710576|540736669|FG000|Overall Study|Death|2|||
149892411|NCT04710576|540736670|FG001|Overall Study|Death|7|||
149892412|NCT04710576|540736671|FG002|Overall Study|Death|12|||
149892413|NCT04710576|540736669|FG000|Overall Study|Withdrawal by Subject|4|||
149892414|NCT04710576|540736670|FG001|Overall Study|Withdrawal by Subject|3|||
149892415|NCT04710576|540736671|FG002|Overall Study|Withdrawal by Subject|7|||
149892416|NCT04710576|540736669|FG000|Overall Study|Sponsor decision|1|||
149892417|NCT04710576|540736670|FG001|Overall Study|Sponsor decision|0|||
149892418|NCT04710576|540736671|FG002|Overall Study|Sponsor decision|0|||
149892419|NCT05573464|540736672|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
149892420|NCT05573464|540736673|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
149892421|NCT05573464|540736672|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
149892422|NCT05573464|540736673|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
149892423|NCT05573464|540736672|FG000|12-week Treatment Period|Protocol Violation|3|||
149892424|NCT05573464|540736673|FG001|12-week Treatment Period|Protocol Violation|1|||
149892425|NCT05573464|540736672|FG000|12-week Treatment Period|Physician Decision|1|||
149968186|NCT03977155|541019758|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
149968187|NCT03977155|541019759|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
149968188|NCT00936936|541019760|FG000|Overall Study|Adverse Event|7|||
149968189|NCT00936936|541019761|FG001|Overall Study|Adverse Event|1|||
149968190|NCT00936936|541019760|FG000|Overall Study|Disease Progression|2|||
149968191|NCT00936936|541019761|FG001|Overall Study|Disease Progression|2|||
149968192|NCT00936936|541019760|FG000|Overall Study|Unrelated|3|||
149968193|NCT00936936|541019761|FG001|Overall Study|Unrelated|1|||
149968194|NCT02278003|541019762|FG000|Overall Study|Withdrawal by Subject|11|||
149968195|NCT02278003|541019763|FG001|Overall Study|Withdrawal by Subject|0|||
149968196|NCT02278003|541019762|FG000|Overall Study|Not Treated|1|||
150175887|NCT00357097|541779953|FG001|Overall Study|Met Exclusion Criteria|1|||
149892426|NCT05573464|540736673|FG001|12-week Treatment Period|Physician Decision|2|||
149968197|NCT02278003|541019763|FG001|Overall Study|Not Treated|0|||
149968198|NCT02278003|541019762|FG000|Overall Study|Recognition task improperly completed|7|||
149892427|NCT05573464|540736672|FG000|12-week Treatment Period|Lost to Follow-up|2|||
149892428|NCT05573464|540736673|FG001|12-week Treatment Period|Lost to Follow-up|0|||
149892429|NCT05573464|540736672|FG000|12-week Treatment Period|Adverse Event|20|||
150175888|NCT00357097|541779952|FG000|Overall Study|Other|1|||
149892430|NCT05573464|540736673|FG001|12-week Treatment Period|Adverse Event|9|||
149892431|NCT05573464|540736672|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
149892432|NCT05573464|540736673|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
149892433|NCT05573464|540736672|FG000|12-week Treatment Period|Randomised, not treated|0|||
149892434|NCT05573464|540736673|FG001|12-week Treatment Period|Randomised, not treated|1|||
149892435|NCT05573464|540736672|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
149892436|NCT05573464|540736673|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
149892437|NCT05573464|540736672|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
149892438|NCT05573464|540736673|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
149892439|NCT05573464|540736672|FG000|52-week Treatment Period|Protocol Violation|1|||
149892440|NCT05573464|540736673|FG001|52-week Treatment Period|Protocol Violation|1|||
149892441|NCT05573464|540736672|FG000|52-week Treatment Period|Physician Decision|2|||
149892442|NCT05573464|540736673|FG001|52-week Treatment Period|Physician Decision|2|||
149892443|NCT05573464|540736672|FG000|52-week Treatment Period|Lost to Follow-up|1|||
149892444|NCT05573464|540736673|FG001|52-week Treatment Period|Lost to Follow-up|1|||
149892445|NCT05573464|540736672|FG000|52-week Treatment Period|Adverse Event|11|||
149892446|NCT05573464|540736673|FG001|52-week Treatment Period|Adverse Event|8|||
149892447|NCT05573464|540736672|FG000|52-week Treatment Period|Death|1|||
149892448|NCT05573464|540736673|FG001|52-week Treatment Period|Death|1|||
149892449|NCT01415518|540736674|FG000|Overall Study|Withdrawal by Subject|2|||
149892450|NCT01415518|540736675|FG001|Overall Study|Withdrawal by Subject|12|||
149892451|NCT01415518|540736674|FG000|Overall Study|Protocol Violation|6|||
149892452|NCT01415518|540736675|FG001|Overall Study|Protocol Violation|8|||
149892453|NCT01415518|540736674|FG000|Overall Study|Lost to Follow-up|3|||
149892454|NCT01415518|540736675|FG001|Overall Study|Lost to Follow-up|5|||
149892455|NCT01415518|540736674|FG000|Overall Study|Adverse Event|3|||
149892456|NCT01415518|540736675|FG001|Overall Study|Adverse Event|4|||
149892457|NCT01415518|540736674|FG000|Overall Study|Death|1|||
149892458|NCT01415518|540736675|FG001|Overall Study|Death|1|||
149892459|NCT01415518|540736674|FG000|Overall Study|Condition under Investigation Worsened|1|||
149892460|NCT01415518|540736675|FG001|Overall Study|Condition under Investigation Worsened|1|||
149892461|NCT02068508|540736679|FG000|Overall Study|Case report forms uncollected|27|||
149892462|NCT02068508|540736679|FG000|Overall Study|Patient did not visit the study site|1|||
149892463|NCT02068508|540736679|FG000|Overall Study|Protocol Violation|4|||
149892464|NCT00813150|540736680|FG000|Treatment Period|Adverse Event|16|||
149892465|NCT00813150|540736681|FG001|Treatment Period|Adverse Event|15|||
149892466|NCT00813150|540736680|FG000|Treatment Period|Death|2|||
149892467|NCT00813150|540736681|FG001|Treatment Period|Death|0|||
149892468|NCT00813150|540736680|FG000|Treatment Period|Progressive disease|1|||
149892469|NCT00813150|540736681|FG001|Treatment Period|Progressive disease|0|||
149892470|NCT00813150|540736680|FG000|Treatment Period|Complete response|0|||
149892471|NCT00813150|540736681|FG001|Treatment Period|Complete response|1|||
149892472|NCT00813150|540736680|FG000|Treatment Period|Stable disease|1|||
149892473|NCT00813150|540736681|FG001|Treatment Period|Stable disease|2|||
149968199|NCT02278003|541019763|FG001|Overall Study|Recognition task improperly completed|0|||
149968200|NCT00442702|541019766|FG000|Titration Period|Adverse Event|2|||
149968201|NCT00442702|541019767|FG001|Titration Period|Adverse Event|0|||
149968202|NCT00442702|541019766|FG000|Titration Period|Death|3|||
149968203|NCT00442702|541019767|FG001|Titration Period|Death|2|||
149968204|NCT00442702|541019766|FG000|Titration Period|Insufficient Therapeutic Response|1|||
149968205|NCT00442702|541019767|FG001|Titration Period|Insufficient Therapeutic Response|0|||
149968206|NCT00442702|541019766|FG000|Titration Period|Refused Treatment|4|||
149968207|NCT00442702|541019767|FG001|Titration Period|Refused Treatment|1|||
149968208|NCT00442702|541019766|FG000|Titration Period|Failure to return|1|||
149968209|NCT00442702|541019767|FG001|Titration Period|Failure to return|0|||
149968210|NCT00442702|541019766|FG000|Titration Period|Hospitalized in another hospital|1|||
149968211|NCT00442702|541019767|FG001|Titration Period|Hospitalized in another hospital|0|||
149968212|NCT00442702|541019766|FG000|Evaluation Period|Adverse Event|1|||
149968213|NCT00442702|541019767|FG001|Evaluation Period|Adverse Event|0|||
149968214|NCT00442702|541019766|FG000|Evaluation Period|Death|1|||
149968215|NCT00442702|541019767|FG001|Evaluation Period|Death|1|||
149968216|NCT00442702|541019766|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
149968217|NCT00442702|541019767|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
149968218|NCT00442702|541019766|FG000|Evaluation Period|Refused treatment|1|||
149968219|NCT00442702|541019767|FG001|Evaluation Period|Refused treatment|1|||
149968220|NCT00442702|541019766|FG000|Evaluation Period|Renal transplant|0|||
149968221|NCT00442702|541019767|FG001|Evaluation Period|Renal transplant|1|||
149968222|NCT00442702|541019766|FG000|Evaluation Period|Failure to return|1|||
149892474|NCT00813150|540736680|FG000|Treatment Period|Protocol Violation|3|||
149892475|NCT00813150|540736681|FG001|Treatment Period|Protocol Violation|4|||
149892476|NCT00813150|540736680|FG000|Treatment Period|Withdrawal by Subject|5|||
149892477|NCT00813150|540736681|FG001|Treatment Period|Withdrawal by Subject|3|||
149968223|NCT00442702|541019767|FG001|Evaluation Period|Failure to return|0|||
149968224|NCT00442702|541019766|FG000|Evaluation Period|Site closure|0|||
149968225|NCT00442702|541019767|FG001|Evaluation Period|Site closure|1|||
149892478|NCT00813150|540736680|FG000|Treatment Period|Non compliance|0|||
149892479|NCT00813150|540736681|FG001|Treatment Period|Non compliance|1|||
149892480|NCT00813150|540736680|FG000|Treatment Period|Reason not specified|3|||
149892481|NCT00813150|540736681|FG001|Treatment Period|Reason not specified|4|||
149892482|NCT00813150|540736680|FG000|Treatment Period|Data not available|1|||
149892483|NCT00813150|540736681|FG001|Treatment Period|Data not available|2|||
149892484|NCT00813150|540736680|FG000|Long Term Follow-up|Death|0|||
149892485|NCT00813150|540736681|FG001|Long Term Follow-up|Death|4|||
149892486|NCT00813150|540736680|FG000|Long Term Follow-up|Other|0|||
149892487|NCT00813150|540736681|FG001|Long Term Follow-up|Other|3|||
149892488|NCT00813150|540736680|FG000|Long Term Follow-up|Lost to Follow-up|2|||
149892489|NCT00813150|540736681|FG001|Long Term Follow-up|Lost to Follow-up|0|||
149892490|NCT00813150|540736680|FG000|Long Term Follow-up|Progression/Relapse|22|||
149892491|NCT00813150|540736681|FG001|Long Term Follow-up|Progression/Relapse|24|||
149892492|NCT05423093|540736689|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
149892493|NCT05423093|540736689|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
149892494|NCT05423093|540736689|FG000|Attended Intervention Session|Lost to Follow-up|3|||
149892495|NCT05423093|540736689|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
149892496|NCT05423093|540736689|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
149892497|NCT03593525|540736690|FG000|Overall Study|Withdrawal by Subject|1|||
149892498|NCT03593525|540736691|FG001|Overall Study|Withdrawal by Subject|0|||
149892499|NCT03593525|540736690|FG000|Overall Study|Lost to Follow-up|7|||
149892500|NCT03593525|540736691|FG001|Overall Study|Lost to Follow-up|5|||
149892501|NCT02393950|540736709|FG000|Overall Study|Adverse Event|1|||
149892502|NCT02393950|540736710|FG001|Overall Study|Adverse Event|0|||
149892503|NCT02393950|540736709|FG000|Overall Study|Withdrawal by Subject|0|||
149892504|NCT02393950|540736710|FG001|Overall Study|Withdrawal by Subject|1|||
149892505|NCT04335123|540736711|FG000|Overall Study|Withdrawal by Subject|2|||
149892506|NCT04335123|540736712|FG001|Overall Study|Withdrawal by Subject|0|||
149892507|NCT04335123|540736711|FG000|Overall Study|Physician Decision|2|||
149892508|NCT04335123|540736712|FG001|Overall Study|Physician Decision|0|||
149892509|NCT00957801|540736713|FG000|Overall Study|Withdrawal by Subject|0|||
149892510|NCT00957801|540736714|FG001|Overall Study|Withdrawal by Subject|0|||
149892511|NCT00957801|540736715|FG002|Overall Study|Withdrawal by Subject|0|||
149892512|NCT00957801|540736716|FG003|Overall Study|Withdrawal by Subject|1|||
149892513|NCT02626026|540736720|FG000|Overall Study|Randomized but Never Treated|0|||
149892514|NCT02626026|540736721|FG001|Overall Study|Randomized but Never Treated|0|||
149892515|NCT02626026|540736722|FG002|Overall Study|Randomized but Never Treated|0|||
149892516|NCT02626026|540736723|FG003|Overall Study|Randomized but Never Treated|0|||
149892517|NCT02626026|540736724|FG004|Overall Study|Randomized but Never Treated|1|||
149892518|NCT02626026|540736725|FG005|Overall Study|Randomized but Never Treated|0|||
149892519|NCT01592786|540736726|FG000|Overall Study|Adverse Event|60|||
149892520|NCT01592786|540736726|FG000|Overall Study|Lack of Efficacy|19|||
149892521|NCT01592786|540736726|FG000|Overall Study|Protocol Violation|14|||
149892522|NCT01592786|540736726|FG000|Overall Study|Withdrawal by Subject|23|||
149892523|NCT01592786|540736726|FG000|Overall Study|Lost to Follow-up|19|||
149892524|NCT01592786|540736726|FG000|Overall Study|Other|3|||
149892525|NCT01909934|540736727|FG000|Overall Study|Withdrawal by Subject|3|||
149892526|NCT01909934|540736727|FG000|Overall Study|Lost to Follow-up|1|||
149892527|NCT01909934|540736727|FG000|Overall Study|Death|25|||
149892528|NCT01909934|540736727|FG000|Overall Study|Withdrawal of Informed Consent|1|||
149892529|NCT01909934|540736727|FG000|Overall Study|Reason Not Specified|1|||
149892530|NCT03810092|540736728|FG000|Overall Study|no ground support|17|||
149892531|NCT03810092|540736728|FG000|Overall Study|ADL not done at J0|16|||
149892532|NCT03810092|540736728|FG000|Overall Study|No hemoglobin measure at J5|27|||
149892533|NCT04578535|540736730|FG000|Overall Study|Lost to Follow-up|1|||
149892534|NCT04578535|540736731|FG001|Overall Study|Lost to Follow-up|0|||
149892535|NCT04578535|540736732|FG002|Overall Study|Lost to Follow-up|0|||
149892536|NCT04578535|540736733|FG003|Overall Study|Lost to Follow-up|1|||
149892537|NCT04578535|540736734|FG004|Overall Study|Lost to Follow-up|0|||
149892538|NCT04578535|540736735|FG005|Overall Study|Lost to Follow-up|2|||
149892539|NCT04578535|540736730|FG000|Overall Study|Pregnancy|1|||
149892540|NCT04578535|540736731|FG001|Overall Study|Pregnancy|0|||
149892541|NCT04578535|540736732|FG002|Overall Study|Pregnancy|0|||
149892542|NCT04578535|540736733|FG003|Overall Study|Pregnancy|0|||
149892543|NCT04578535|540736734|FG004|Overall Study|Pregnancy|0|||
149892544|NCT04578535|540736735|FG005|Overall Study|Pregnancy|0|||
149892545|NCT04578535|540736730|FG000|Overall Study|Withdrawal by Subject|0|||
149892546|NCT04578535|540736731|FG001|Overall Study|Withdrawal by Subject|0|||
149892547|NCT04578535|540736732|FG002|Overall Study|Withdrawal by Subject|0|||
149892548|NCT04578535|540736733|FG003|Overall Study|Withdrawal by Subject|1|||
149892549|NCT04578535|540736734|FG004|Overall Study|Withdrawal by Subject|1|||
149892550|NCT04578535|540736735|FG005|Overall Study|Withdrawal by Subject|5|||
149892551|NCT04578535|540736730|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
149892552|NCT04578535|540736731|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
149892553|NCT04578535|540736732|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
149892554|NCT04578535|540736733|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
149892555|NCT04578535|540736734|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
149892556|NCT04578535|540736735|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
149892557|NCT00235755|540736736|FG000|4-Week Titration Phase|Adverse Event|6|||
149892558|NCT00235755|540736737|FG001|4-Week Titration Phase|Adverse Event|14|||
149892559|NCT00235755|540736738|FG002|4-Week Titration Phase|Adverse Event|20|||
149892560|NCT00235755|540736736|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
149892561|NCT00235755|540736737|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
149892562|NCT00235755|540736738|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
149892563|NCT00235755|540736736|FG000|4-Week Titration Phase|Protocol Violation|2|||
149892564|NCT00235755|540736737|FG001|4-Week Titration Phase|Protocol Violation|2|||
149968226|NCT04123704|541019779|FG000|Overall Study|Disease progression|2|||
149968227|NCT03440385|541019780|FG000|Overall Study|Other Reason|4|||
149968228|NCT03440385|541019781|FG001|Overall Study|Other Reason|1|||
149968229|NCT03440385|541019780|FG000|Overall Study|Site Closed|1|||
149968230|NCT03440385|541019781|FG001|Overall Study|Site Closed|0|||
149968231|NCT03440385|541019780|FG000|Overall Study|Lost to Follow-up|2|||
149968232|NCT03440385|541019781|FG001|Overall Study|Lost to Follow-up|0|||
149968233|NCT03440385|541019780|FG000|Overall Study|Withdrawal by Subject|12|||
149968234|NCT03440385|541019781|FG001|Overall Study|Withdrawal by Subject|6|||
149968235|NCT03440385|541019780|FG000|Overall Study|Lack of Efficacy|9|||
149968236|NCT03440385|541019781|FG001|Overall Study|Lack of Efficacy|2|||
149968237|NCT03440385|541019780|FG000|Overall Study|Adverse Event|15|||
149968238|NCT03440385|541019781|FG001|Overall Study|Adverse Event|11|||
149968239|NCT03552029|541019783|FG000|Overall Study|Death|3|||
149968240|NCT03552029|541019784|FG001|Overall Study|Death|0|||
149968241|NCT03552029|541019783|FG000|Overall Study|Adverse Event|1|||
149968242|NCT03552029|541019784|FG001|Overall Study|Adverse Event|0|||
149968243|NCT03552029|541019783|FG000|Overall Study|Lack of Efficacy|0|||
149968244|NCT03552029|541019784|FG001|Overall Study|Lack of Efficacy|2|||
149968245|NCT03552029|541019783|FG000|Overall Study|Physician Decision|0|||
149968246|NCT03552029|541019784|FG001|Overall Study|Physician Decision|1|||
149968247|NCT03552029|541019783|FG000|Overall Study|Study terminated by Sponsor|0|||
149968248|NCT03552029|541019784|FG001|Overall Study|Study terminated by Sponsor|1|||
149968249|NCT03552029|541019783|FG000|Overall Study|Other|0|||
149968250|NCT03552029|541019784|FG001|Overall Study|Other|2|||
149968251|NCT00730327|541019788|FG000|Overall Study|Lost to Follow-up|14|||
149968252|NCT00730327|541019789|FG001|Overall Study|Lost to Follow-up|16|||
149968253|NCT00730327|541019788|FG000|Overall Study|Adverse Event|8|||
149968254|NCT00730327|541019789|FG001|Overall Study|Adverse Event|1|||
149968255|NCT00730327|541019788|FG000|Overall Study|Withdrawal by Subject|3|||
149968256|NCT00730327|541019789|FG001|Overall Study|Withdrawal by Subject|13|||
149968257|NCT00730327|541019788|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
149968258|NCT00730327|541019789|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
149968259|NCT03122184|541019791|FG000|Overall Study|Lost to Follow-up|4|||
149968260|NCT03122184|541019792|FG001|Overall Study|Lost to Follow-up|6|||
149968261|NCT03122184|541019791|FG000|Overall Study|Withdrawal by Subject|3|||
149968262|NCT03122184|541019792|FG001|Overall Study|Withdrawal by Subject|0|||
149968263|NCT03122184|541019791|FG000|Overall Study|Terminated due to cognitive problem|1|||
149892565|NCT00235755|540736738|FG002|4-Week Titration Phase|Protocol Violation|1|||
149892566|NCT00235755|540736736|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
149892567|NCT00235755|540736737|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
149892568|NCT00235755|540736738|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
149892569|NCT00235755|540736736|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
149892570|NCT00235755|540736737|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
149892571|NCT00235755|540736738|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
149892572|NCT00235755|540736736|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
149892573|NCT00235755|540736737|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
149892574|NCT00235755|540736738|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
149892575|NCT00235755|540736736|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
149892576|NCT00235755|540736737|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
149892577|NCT00235755|540736738|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
149892578|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Adverse Event|8|||
149892579|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Adverse Event|12|||
149892580|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Adverse Event|26|||
149892581|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
149892582|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
149892583|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
149892584|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
149892585|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
149892586|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
149892587|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
149892588|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
149892589|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
149892590|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
149892591|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
149892592|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
149892593|NCT00235755|540736736|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
149892594|NCT00235755|540736737|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
149892595|NCT00235755|540736738|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
149892596|NCT03839628|540736739|FG000|Overall Study|Withdrawal by Subject|1|||
149892597|NCT05691712|540736741|FG000|Overall Study|Adverse Event|0|||
149892598|NCT05691712|540736742|FG001|Overall Study|Adverse Event|1|||
149968264|NCT03122184|541019792|FG001|Overall Study|Terminated due to cognitive problem|0|||
149968265|NCT00633126|541019793|FG000|Overall Study|Did not receive full dose|1|||
149968266|NCT00567502|541019803|FG000|Overall Study|Lost to Follow-up|91|||
149892599|NCT05691712|540736743|FG002|Overall Study|Adverse Event|2|||
149968267|NCT00567502|541019804|FG001|Overall Study|Lost to Follow-up|14|||
149968268|NCT00567502|541019805|FG002|Overall Study|Lost to Follow-up|351|||
149968269|NCT00567502|541019806|FG003|Overall Study|Lost to Follow-up|2|||
149968270|NCT00567502|541019803|FG000|Overall Study|Death|65|||
149968271|NCT00567502|541019804|FG001|Overall Study|Death|16|||
149968272|NCT00567502|541019805|FG002|Overall Study|Death|360|||
149968273|NCT00567502|541019806|FG003|Overall Study|Death|5|||
149968274|NCT00567502|541019803|FG000|Overall Study|Other|64|||
149968275|NCT00567502|541019804|FG001|Overall Study|Other|2|||
149968276|NCT00567502|541019805|FG002|Overall Study|Other|134|||
149968277|NCT00567502|541019806|FG003|Overall Study|Other|6|||
149968278|NCT00567502|541019803|FG000|Overall Study|Participant request|12|||
149968279|NCT00567502|541019804|FG001|Overall Study|Participant request|1|||
149968280|NCT00567502|541019805|FG002|Overall Study|Participant request|33|||
149968281|NCT00567502|541019806|FG003|Overall Study|Participant request|1|||
149968282|NCT00567502|541019803|FG000|Overall Study|Sponsor request|9|||
149968283|NCT00567502|541019804|FG001|Overall Study|Sponsor request|0|||
149968284|NCT00567502|541019805|FG002|Overall Study|Sponsor request|30|||
149968285|NCT00567502|541019806|FG003|Overall Study|Sponsor request|1|||
149968286|NCT00567502|541019803|FG000|Overall Study|Never Initiated Treatment|0|||
149892600|NCT05691712|540736744|FG003|Overall Study|Adverse Event|1|||
149892601|NCT05691712|540736741|FG000|Overall Study|Withdrawal by Subject|2|||
149892602|NCT05691712|540736742|FG001|Overall Study|Withdrawal by Subject|3|||
149892603|NCT05691712|540736743|FG002|Overall Study|Withdrawal by Subject|3|||
149968287|NCT00567502|541019804|FG001|Overall Study|Never Initiated Treatment|0|||
149968288|NCT00567502|541019805|FG002|Overall Study|Never Initiated Treatment|0|||
149968289|NCT00567502|541019806|FG003|Overall Study|Never Initiated Treatment|72|||
149968290|NCT01497197|541019809|FG000|Overall Study|Lost to Follow-up|1|||
149968291|NCT01497197|541019810|FG001|Overall Study|Lost to Follow-up|0|||
149968292|NCT01497197|541019809|FG000|Overall Study|Protocol Violation|0|||
149968293|NCT01497197|541019810|FG001|Overall Study|Protocol Violation|2|||
149968294|NCT01497197|541019809|FG000|Overall Study|Withdrawal by Subject|2|||
149968295|NCT01497197|541019810|FG001|Overall Study|Withdrawal by Subject|1|||
149892604|NCT05691712|540736744|FG003|Overall Study|Withdrawal by Subject|1|||
149892605|NCT05691712|540736741|FG000|Overall Study|Death|1|||
149892606|NCT05691712|540736742|FG001|Overall Study|Death|0|||
149892607|NCT05691712|540736743|FG002|Overall Study|Death|0|||
149892608|NCT05691712|540736744|FG003|Overall Study|Death|0|||
149892609|NCT05691712|540736741|FG000|Overall Study|Pregnancy|0|||
149892610|NCT05691712|540736742|FG001|Overall Study|Pregnancy|1|||
149892611|NCT05691712|540736743|FG002|Overall Study|Pregnancy|0|||
149892612|NCT05691712|540736744|FG003|Overall Study|Pregnancy|0|||
149892613|NCT05691712|540736741|FG000|Overall Study|Assigned Treatment by Mistake|1|||
149892614|NCT05691712|540736742|FG001|Overall Study|Assigned Treatment by Mistake|0|||
149892615|NCT05691712|540736743|FG002|Overall Study|Assigned Treatment by Mistake|0|||
149892616|NCT05691712|540736744|FG003|Overall Study|Assigned Treatment by Mistake|1|||
149892617|NCT05303194|540736745|FG000|Overall Study|Lost to Follow-up|1|||
149892618|NCT05303194|540736746|FG001|Overall Study|Lost to Follow-up|1|||
149892619|NCT05303194|540736745|FG000|Overall Study|Withdrawal by Subject|0|||
149892620|NCT05303194|540736746|FG001|Overall Study|Withdrawal by Subject|1|||
149892621|NCT04837196|540736756|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
149892622|NCT04837196|540736757|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
149892623|NCT04837196|540736758|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
149892624|NCT04837196|540736759|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
149892625|NCT04837196|540736760|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
149892626|NCT04837196|540736756|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
149892627|NCT04837196|540736757|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
149892628|NCT04837196|540736758|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
149892629|NCT04837196|540736759|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
149892630|NCT04837196|540736760|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
149892631|NCT04837196|540736756|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
149892632|NCT04837196|540736757|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
149892633|NCT04837196|540736758|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
149892634|NCT04837196|540736759|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
149892635|NCT04837196|540736760|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
149892636|NCT04837196|540736756|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
149892637|NCT04837196|540736757|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
149892638|NCT04837196|540736758|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
149892639|NCT04837196|540736759|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
149892640|NCT04837196|540736760|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
149892641|NCT04837196|540736756|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
149892642|NCT04837196|540736757|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
149892643|NCT04837196|540736758|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
149892644|NCT04837196|540736759|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
149892645|NCT04837196|540736760|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
149892646|NCT01289678|540736761|FG000|Overall Study|Physician Decision|6|||
149892647|NCT05271175|540736762|FG000|One Week Follow up|Lost to Follow-up|10|||
149892648|NCT05271175|540736763|FG001|One Week Follow up|Lost to Follow-up|7|||
149892649|NCT05271175|540736764|FG002|One Week Follow up|Lost to Follow-up|5|||
149892650|NCT05271175|540736762|FG000|One Month Follow up|Lost to Follow-up|12|||
149892651|NCT05271175|540736763|FG001|One Month Follow up|Lost to Follow-up|7|||
149892652|NCT05271175|540736764|FG002|One Month Follow up|Lost to Follow-up|9|||
149892653|NCT05271175|540736762|FG000|Six Months Follow up|Lost to Follow-up|8|||
149892654|NCT05271175|540736763|FG001|Six Months Follow up|Lost to Follow-up|2|||
149892655|NCT05271175|540736764|FG002|Six Months Follow up|Lost to Follow-up|2|||
149892656|NCT00226499|540736765|FG000|Overall Study|Adverse Event|10|||
149892657|NCT00226499|540736766|FG001|Overall Study|Adverse Event|6|||
149892658|NCT00226499|540736767|FG002|Overall Study|Adverse Event|3|||
149892659|NCT00226499|540736765|FG000|Overall Study|Others|1064|||
149892660|NCT00226499|540736766|FG001|Overall Study|Others|1066|||
149892661|NCT00226499|540736767|FG002|Overall Study|Others|356|||
149892662|NCT00991887|540736768|FG000|Overall Study|Lost to Follow-up|2|||
149892663|NCT00991887|540736769|FG001|Overall Study|Lost to Follow-up|1|||
149892664|NCT02387840|540736770|FG000|Overall Study|Death|0|||
149892665|NCT02387840|540736771|FG001|Overall Study|Death|0|||
149892666|NCT02387840|540736772|FG002|Overall Study|Death|0|||
149892667|NCT02387840|540736773|FG003|Overall Study|Death|0|||
149892668|NCT02387840|540736774|FG004|Overall Study|Death|0|||
149892669|NCT02387840|540736775|FG005|Overall Study|Death|1|||
149892670|NCT03170544|540736776|FG000|Part 1|Lost to Follow-up|1|||
149892671|NCT03170544|540736777|FG001|Part 1|Lost to Follow-up|0|||
149892672|NCT03170544|540736778|FG002|Part 1|Lost to Follow-up|0|||
149892673|NCT03170544|540736779|FG003|Part 1|Lost to Follow-up|0|||
149892674|NCT03170544|540736780|FG004|Part 1|Lost to Follow-up|0|||
149892675|NCT03170544|540736781|FG005|Part 1|Lost to Follow-up|0|||
149892676|NCT03170544|540736782|FG006|Part 1|Lost to Follow-up|0|||
149892677|NCT03170544|540736783|FG007|Part 1|Lost to Follow-up|0|||
149892678|NCT03170544|540736784|FG008|Part 1|Lost to Follow-up|0|||
149892679|NCT03170544|540736785|FG009|Part 1|Lost to Follow-up|0|||
149892680|NCT03170544|540736786|FG010|Part 1|Lost to Follow-up|0|||
149892681|NCT03170544|540736787|FG011|Part 1|Lost to Follow-up|0|||
149892682|NCT03170544|540736776|FG000|Part 1|Not treated|0|||
149892683|NCT03170544|540736777|FG001|Part 1|Not treated|0|||
149892684|NCT03170544|540736778|FG002|Part 1|Not treated|0|||
149892685|NCT03170544|540736779|FG003|Part 1|Not treated|1|||
149892686|NCT03170544|540736780|FG004|Part 1|Not treated|0|||
149892687|NCT03170544|540736781|FG005|Part 1|Not treated|0|||
149892688|NCT03170544|540736782|FG006|Part 1|Not treated|0|||
149892689|NCT03170544|540736783|FG007|Part 1|Not treated|0|||
149892690|NCT03170544|540736784|FG008|Part 1|Not treated|0|||
149892691|NCT03170544|540736785|FG009|Part 1|Not treated|0|||
149892692|NCT03170544|540736786|FG010|Part 1|Not treated|0|||
149892693|NCT03170544|540736787|FG011|Part 1|Not treated|0|||
149892694|NCT04564092|540736788|FG000|Overall Study|Withdrawal by Subject|1|||
149892695|NCT02859337|540736789|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
149892696|NCT02859337|540736790|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
149892697|NCT02859337|540736791|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
149892698|NCT02859337|540736789|FG000|Overall Study|Withdrawal by Subject|3|||
149892699|NCT02859337|540736790|FG001|Overall Study|Withdrawal by Subject|1|||
149892700|NCT02859337|540736791|FG002|Overall Study|Withdrawal by Subject|0|||
149892701|NCT02859337|540736789|FG000|Overall Study|Lost to Follow-up|1|||
149892702|NCT02859337|540736790|FG001|Overall Study|Lost to Follow-up|0|||
149892703|NCT02859337|540736791|FG002|Overall Study|Lost to Follow-up|0|||
149892704|NCT01546025|540736792|FG000|Overall Study|Lost to Follow-up|0|||
149892705|NCT01546025|540736793|FG001|Overall Study|Lost to Follow-up|1|||
149892706|NCT02729025|540736797|FG000|Overall Study|Sponsor Decision|0|||
149892707|NCT02729025|540736798|FG001|Overall Study|Sponsor Decision|1|||
149892708|NCT03349060|540738353|FG000|Overall Study|Adverse Event|9|||
149892709|NCT03349060|540738354|FG001|Overall Study|Adverse Event|9|||
149892710|NCT03349060|540738355|FG002|Overall Study|Adverse Event|7|||
149892711|NCT03349060|540738353|FG000|Overall Study|Lack of Efficacy|1|||
149892712|NCT03349060|540738354|FG001|Overall Study|Lack of Efficacy|0|||
149892713|NCT03349060|540738355|FG002|Overall Study|Lack of Efficacy|2|||
149892714|NCT03349060|540738353|FG000|Overall Study|Lost to Follow-up|2|||
149892715|NCT03349060|540738354|FG001|Overall Study|Lost to Follow-up|1|||
149892716|NCT03349060|540738355|FG002|Overall Study|Lost to Follow-up|1|||
149892717|NCT03349060|540738353|FG000|Overall Study|Protocol Violation|2|||
149892718|NCT03349060|540738354|FG001|Overall Study|Protocol Violation|2|||
149892719|NCT03349060|540738355|FG002|Overall Study|Protocol Violation|1|||
149892720|NCT03349060|540738353|FG000|Overall Study|Withdrawal by Subject|5|||
149892721|NCT03349060|540738354|FG001|Overall Study|Withdrawal by Subject|3|||
149892722|NCT03349060|540738355|FG002|Overall Study|Withdrawal by Subject|4|||
149892723|NCT03349060|540738353|FG000|Overall Study|Medication error,no linked adverse event|0|||
149892724|NCT03349060|540738354|FG001|Overall Study|Medication error,no linked adverse event|0|||
149892725|NCT03349060|540738355|FG002|Overall Study|Medication error,no linked adverse event|1|||
149892726|NCT03349060|540738353|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
149892727|NCT03349060|540738354|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
149892728|NCT03349060|540738355|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
149892729|NCT03349060|540738353|FG000|Overall Study|Other|2|||
149892730|NCT03349060|540738354|FG001|Overall Study|Other|1|||
149892731|NCT03349060|540738355|FG002|Overall Study|Other|0|||
149892732|NCT00485732|540738356|FG000|Overall Study|Protocol Violation|1|||
149892733|NCT00485732|540738357|FG001|Overall Study|Protocol Violation|3|||
149892734|NCT00485732|540738356|FG000|Overall Study|Withdrawal by Subject|5|||
149892735|NCT00485732|540738357|FG001|Overall Study|Withdrawal by Subject|4|||
149892736|NCT00485732|540738356|FG000|Overall Study|Lost to Follow-up|2|||
149892737|NCT00485732|540738357|FG001|Overall Study|Lost to Follow-up|2|||
149892738|NCT05734157|540738358|FG000|Overall Study|Death|3|||
149892739|NCT05734157|540738358|FG000|Overall Study|Withdrawal by Subject|2|||
149892740|NCT05734157|540738358|FG000|Overall Study|Lost to Follow-up|1|||
149892741|NCT05734157|540738358|FG000|Overall Study|Telephone call|3|||
149892742|NCT04846569|540738359|FG000|Overall Study|Withdrawal by Subject|3|||
149892743|NCT04846569|540738360|FG001|Overall Study|Withdrawal by Subject|1|||
149892744|NCT02512302|540738361|FG000|Period 1|Adverse Event|0|||
149968296|NCT01497197|541019809|FG000|Overall Study|Excessive/lack of response to treatment|1|||
149968297|NCT01497197|541019810|FG001|Overall Study|Excessive/lack of response to treatment|0|||
149892745|NCT02512302|540738362|FG001|Period 1|Adverse Event|1|||
149892746|NCT02512302|540738363|FG002|Period 1|Adverse Event|0|||
149892747|NCT02512302|540738364|FG003|Period 1|Adverse Event|0|||
149892748|NCT02512302|540738365|FG004|Period 1|Adverse Event|0|||
149892749|NCT02512302|540738366|FG005|Period 1|Adverse Event|0|||
149892750|NCT02512302|540738367|FG006|Period 1|Adverse Event|0|||
149892751|NCT02512302|540738368|FG007|Period 1|Adverse Event|0|||
149892752|NCT02512302|540738369|FG008|Period 1|Adverse Event|0|||
149892753|NCT02512302|540738370|FG009|Period 1|Adverse Event|0|||
149968298|NCT01497197|541019809|FG000|Overall Study|Risk of OHSS|1|||
149968299|NCT01497197|541019810|FG001|Overall Study|Risk of OHSS|0|||
149968300|NCT01497197|541019809|FG000|Overall Study|No oocytes retrieved|3|||
149968301|NCT01497197|541019810|FG001|Overall Study|No oocytes retrieved|2|||
149968302|NCT01497197|541019809|FG000|Overall Study|No fertilisation|6|||
149968303|NCT01497197|541019810|FG001|Overall Study|No fertilisation|5|||
149968304|NCT01497197|541019809|FG000|Overall Study|Intention to freeze all embryos|0|||
149968305|NCT01497197|541019810|FG001|Overall Study|Intention to freeze all embryos|1|||
149968306|NCT01497197|541019809|FG000|Overall Study|All embryos discarded|0|||
149968307|NCT01497197|541019810|FG001|Overall Study|All embryos discarded|3|||
149892754|NCT02512302|540738361|FG000|Period 2|Adverse Event|0|||
149968308|NCT01497197|541019809|FG000|Overall Study|Other|3|||
149968309|NCT01497197|541019810|FG001|Overall Study|Other|1|||
149968310|NCT00565747|541019818|FG000|Overall Study|No embryo transfer|67|||
149968311|NCT00565747|541019819|FG001|Overall Study|No embryo transfer|73|||
149968312|NCT04734210|541019822|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
149968313|NCT04734210|541019823|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
149968314|NCT04734210|541019824|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
149968315|NCT04734210|541019822|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
149968316|NCT04734210|541019823|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
149968317|NCT04734210|541019824|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
149968318|NCT04734210|541019822|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
149968319|NCT04734210|541019823|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
149968320|NCT04734210|541019824|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
149968321|NCT04734210|541019822|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
149968322|NCT04734210|541019823|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
149892755|NCT02512302|540738362|FG001|Period 2|Adverse Event|0|||
149892756|NCT02512302|540738363|FG002|Period 2|Adverse Event|0|||
149892757|NCT02512302|540738364|FG003|Period 2|Adverse Event|0|||
149892758|NCT02512302|540738365|FG004|Period 2|Adverse Event|0|||
149892759|NCT02512302|540738366|FG005|Period 2|Adverse Event|0|||
149892760|NCT02512302|540738367|FG006|Period 2|Adverse Event|0|||
149892761|NCT02512302|540738368|FG007|Period 2|Adverse Event|0|||
149892762|NCT02512302|540738369|FG008|Period 2|Adverse Event|0|||
149892763|NCT02512302|540738370|FG009|Period 2|Adverse Event|1|||
149968323|NCT04734210|541019824|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
149968324|NCT02684461|541019825|FG000|Overall Study|Adverse Event|1|||
149968325|NCT02684461|541019826|FG001|Overall Study|Adverse Event|0|||
149968326|NCT02684461|541019827|FG002|Overall Study|Adverse Event|0|||
149968327|NCT02684461|541019825|FG000|Overall Study|Lack of Efficacy|1|||
149968328|NCT02684461|541019826|FG001|Overall Study|Lack of Efficacy|2|||
149968329|NCT02684461|541019827|FG002|Overall Study|Lack of Efficacy|0|||
149968330|NCT02390076|541019828|FG000|Overall Study|Lost to Follow-up|2|||
149968331|NCT02390076|541019829|FG001|Overall Study|Lost to Follow-up|1|||
149968332|NCT02390076|541019830|FG002|Overall Study|Lost to Follow-up|4|||
149968333|NCT04507204|541019831|FG000|Overall Study|Adverse Event|8|||
149968334|NCT04507204|541019832|FG001|Overall Study|Adverse Event|13|||
149968335|NCT04507204|541019831|FG000|Overall Study|Death|0|||
149968336|NCT04507204|541019832|FG001|Overall Study|Death|1|||
149968337|NCT04507204|541019831|FG000|Overall Study|Lost to Follow-up|15|||
149968338|NCT04507204|541019832|FG001|Overall Study|Lost to Follow-up|14|||
149968339|NCT04507204|541019831|FG000|Overall Study|Poor Compliance with Protocol|2|||
149968340|NCT04507204|541019832|FG001|Overall Study|Poor Compliance with Protocol|4|||
149968341|NCT04507204|541019831|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
149968342|NCT04507204|541019832|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
149968343|NCT04507204|541019831|FG000|Overall Study|Withdrawal of Patient Consent|21|||
149968344|NCT04507204|541019832|FG001|Overall Study|Withdrawal of Patient Consent|13|||
149968345|NCT03580044|541019833|FG000|Overall Study|Death|2|||
149968346|NCT03580044|541019834|FG001|Overall Study|Death|1|||
149968347|NCT03580044|541019833|FG000|Overall Study|Withdrawal by Subject|1|||
149968348|NCT03580044|541019834|FG001|Overall Study|Withdrawal by Subject|1|||
149968349|NCT01206517|541019835|FG000|Overall Study|Withdrawal by Subject|0|||
149968350|NCT01206517|541019836|FG001|Overall Study|Withdrawal by Subject|0|||
149968351|NCT01206517|541019837|FG002|Overall Study|Withdrawal by Subject|2|||
149968352|NCT01206517|541019838|FG003|Overall Study|Withdrawal by Subject|0|||
149892764|NCT02512302|540738361|FG000|Period 3|Lost to Follow-up|0|||
149892765|NCT02512302|540738362|FG001|Period 3|Lost to Follow-up|0|||
149892766|NCT02512302|540738363|FG002|Period 3|Lost to Follow-up|1|||
149892767|NCT02512302|540738364|FG003|Period 3|Lost to Follow-up|0|||
149892768|NCT02512302|540738365|FG004|Period 3|Lost to Follow-up|0|||
149892769|NCT02512302|540738366|FG005|Period 3|Lost to Follow-up|0|||
149892770|NCT02512302|540738367|FG006|Period 3|Lost to Follow-up|0|||
149892771|NCT02512302|540738368|FG007|Period 3|Lost to Follow-up|0|||
149892772|NCT02512302|540738369|FG008|Period 3|Lost to Follow-up|0|||
149892773|NCT02512302|540738370|FG009|Period 3|Lost to Follow-up|0|||
149892774|NCT02512302|540738361|FG000|Period 4|Adverse Event|0|||
149892775|NCT02512302|540738362|FG001|Period 4|Adverse Event|0|||
149892776|NCT02512302|540738363|FG002|Period 4|Adverse Event|0|||
149892777|NCT02512302|540738364|FG003|Period 4|Adverse Event|0|||
149892778|NCT02512302|540738365|FG004|Period 4|Adverse Event|0|||
149892779|NCT02512302|540738366|FG005|Period 4|Adverse Event|0|||
149892780|NCT02512302|540738367|FG006|Period 4|Adverse Event|1|||
149892781|NCT02512302|540738368|FG007|Period 4|Adverse Event|0|||
149892782|NCT02512302|540738369|FG008|Period 4|Adverse Event|0|||
149892783|NCT02512302|540738370|FG009|Period 4|Adverse Event|0|||
149892784|NCT04570670|540738371|FG000|Overall Study|Withdrawal by Subject|1|||
149892785|NCT04570670|540738372|FG001|Overall Study|Withdrawal by Subject|0|||
149892786|NCT02844933|540738373|FG000|Overall Study|Discontinued due to premature termination of study|3|||
149892787|NCT02844933|540738374|FG001|Overall Study|Discontinued due to premature termination of study|2|||
149892788|NCT01479465|540738375|FG000|Overall Study|Disease Progression|9|||
149892789|NCT01479465|540738376|FG001|Overall Study|Disease Progression|61|||
149892790|NCT01479465|540738377|FG002|Overall Study|Disease Progression|65|||
149892791|NCT01479465|540738378|FG003|Overall Study|Disease Progression|70|||
149892792|NCT01479465|540738375|FG000|Overall Study|Study Discontinued by Sponsor|0|||
149892793|NCT01479465|540738376|FG001|Overall Study|Study Discontinued by Sponsor|7|||
149892794|NCT01479465|540738377|FG002|Overall Study|Study Discontinued by Sponsor|5|||
149892795|NCT01479465|540738378|FG003|Overall Study|Study Discontinued by Sponsor|3|||
149892796|NCT01479465|540738375|FG000|Overall Study|Adverse Event|0|||
149892797|NCT01479465|540738376|FG001|Overall Study|Adverse Event|3|||
149892798|NCT01479465|540738377|FG002|Overall Study|Adverse Event|6|||
149892799|NCT01479465|540738378|FG003|Overall Study|Adverse Event|4|||
149892800|NCT01479465|540738375|FG000|Overall Study|Investigator Discretion|1|||
149892801|NCT01479465|540738376|FG001|Overall Study|Investigator Discretion|4|||
149892802|NCT01479465|540738377|FG002|Overall Study|Investigator Discretion|2|||
149892803|NCT01479465|540738378|FG003|Overall Study|Investigator Discretion|4|||
149892804|NCT01479465|540738375|FG000|Overall Study|Subject Request|1|||
149892805|NCT01479465|540738376|FG001|Overall Study|Subject Request|3|||
149892806|NCT01479465|540738377|FG002|Overall Study|Subject Request|4|||
149892807|NCT01479465|540738378|FG003|Overall Study|Subject Request|2|||
149892808|NCT01479465|540738375|FG000|Overall Study|Subject Withdrew Consent|0|||
149892809|NCT01479465|540738376|FG001|Overall Study|Subject Withdrew Consent|5|||
149892810|NCT01479465|540738377|FG002|Overall Study|Subject Withdrew Consent|2|||
149892811|NCT01479465|540738378|FG003|Overall Study|Subject Withdrew Consent|1|||
149892812|NCT01479465|540738375|FG000|Overall Study|Protocol Violation|0|||
149892813|NCT01479465|540738376|FG001|Overall Study|Protocol Violation|1|||
149892814|NCT01479465|540738377|FG002|Overall Study|Protocol Violation|1|||
149892815|NCT01479465|540738378|FG003|Overall Study|Protocol Violation|0|||
149892816|NCT01479465|540738375|FG000|Overall Study|Death|0|||
149892817|NCT01479465|540738376|FG001|Overall Study|Death|0|||
149892818|NCT01479465|540738377|FG002|Overall Study|Death|0|||
149892819|NCT01479465|540738378|FG003|Overall Study|Death|1|||
149892820|NCT01479465|540738375|FG000|Overall Study|Lost to Follow-up|0|||
149892821|NCT01479465|540738376|FG001|Overall Study|Lost to Follow-up|0|||
149892822|NCT01479465|540738377|FG002|Overall Study|Lost to Follow-up|1|||
149892823|NCT01479465|540738378|FG003|Overall Study|Lost to Follow-up|0|||
149892824|NCT04067050|540738379|FG000|One Month|Lost to Follow-up|4|||
149892825|NCT04067050|540738380|FG001|One Month|Lost to Follow-up|0|||
149892826|NCT04067050|540738379|FG000|Two Month|Lost to Follow-up|1|||
149892827|NCT04067050|540738380|FG001|Two Month|Lost to Follow-up|0|||
149892828|NCT04067050|540738379|FG000|Two Month|Adverse Event|1|||
149892829|NCT04067050|540738380|FG001|Two Month|Adverse Event|0|||
149892830|NCT00460603|540738387|FG000|Phase 1|Death|1|||
149892831|NCT00460603|540738388|FG001|Phase 1|Death|0|||
149892832|NCT00460603|540738389|FG002|Phase 1|Death|0|||
149892833|NCT00460603|540738390|FG003|Phase 1|Death|2|||
149892834|NCT00460603|540738391|FG004|Phase 1|Death|0|||
149892835|NCT00460603|540738392|FG005|Phase 1|Death|0|||
149892836|NCT00460603|540738393|FG006|Phase 1|Death|0|||
149892837|NCT00460603|540738394|FG007|Phase 1|Death|0|||
149892838|NCT00460603|540738395|FG008|Phase 1|Death|1|||
149892839|NCT00460603|540738396|FG009|Phase 1|Death|0|||
149892840|NCT00460603|540738397|FG010|Phase 1|Death|0|||
149892841|NCT00460603|540738398|FG011|Phase 1|Death|0|||
149892842|NCT00460603|540738387|FG000|Phase 1|Adverse Event|3|||
149892843|NCT00460603|540738388|FG001|Phase 1|Adverse Event|1|||
149892844|NCT00460603|540738389|FG002|Phase 1|Adverse Event|1|||
149892845|NCT00460603|540738390|FG003|Phase 1|Adverse Event|2|||
149892846|NCT00460603|540738391|FG004|Phase 1|Adverse Event|0|||
149892847|NCT00460603|540738392|FG005|Phase 1|Adverse Event|0|||
149892848|NCT00460603|540738393|FG006|Phase 1|Adverse Event|3|||
149892849|NCT00460603|540738394|FG007|Phase 1|Adverse Event|0|||
149892850|NCT00460603|540738395|FG008|Phase 1|Adverse Event|4|||
149892851|NCT00460603|540738396|FG009|Phase 1|Adverse Event|0|||
149892852|NCT00460603|540738397|FG010|Phase 1|Adverse Event|0|||
149892853|NCT00460603|540738398|FG011|Phase 1|Adverse Event|0|||
149892854|NCT00460603|540738387|FG000|Phase 1|Lack of Efficacy|1|||
149892855|NCT00460603|540738388|FG001|Phase 1|Lack of Efficacy|0|||
149892856|NCT00460603|540738389|FG002|Phase 1|Lack of Efficacy|1|||
149892857|NCT00460603|540738390|FG003|Phase 1|Lack of Efficacy|2|||
149892858|NCT00460603|540738391|FG004|Phase 1|Lack of Efficacy|2|||
149892859|NCT00460603|540738392|FG005|Phase 1|Lack of Efficacy|2|||
149892860|NCT00460603|540738393|FG006|Phase 1|Lack of Efficacy|2|||
149892861|NCT00460603|540738394|FG007|Phase 1|Lack of Efficacy|2|||
149892862|NCT00460603|540738395|FG008|Phase 1|Lack of Efficacy|11|||
149892863|NCT00460603|540738396|FG009|Phase 1|Lack of Efficacy|0|||
149892864|NCT00460603|540738397|FG010|Phase 1|Lack of Efficacy|0|||
149892865|NCT00460603|540738398|FG011|Phase 1|Lack of Efficacy|0|||
149892866|NCT00460603|540738387|FG000|Phase 1|Withdrawal by Subject|1|||
149892867|NCT00460603|540738388|FG001|Phase 1|Withdrawal by Subject|2|||
149892868|NCT00460603|540738389|FG002|Phase 1|Withdrawal by Subject|1|||
149892869|NCT00460603|540738390|FG003|Phase 1|Withdrawal by Subject|1|||
149892870|NCT00460603|540738391|FG004|Phase 1|Withdrawal by Subject|3|||
149892871|NCT00460603|540738392|FG005|Phase 1|Withdrawal by Subject|0|||
149892872|NCT00460603|540738393|FG006|Phase 1|Withdrawal by Subject|1|||
149892873|NCT00460603|540738394|FG007|Phase 1|Withdrawal by Subject|0|||
149892874|NCT00460603|540738395|FG008|Phase 1|Withdrawal by Subject|2|||
149892875|NCT00460603|540738396|FG009|Phase 1|Withdrawal by Subject|0|||
149892876|NCT00460603|540738397|FG010|Phase 1|Withdrawal by Subject|0|||
149892877|NCT00460603|540738398|FG011|Phase 1|Withdrawal by Subject|0|||
149892878|NCT00460603|540738387|FG000|Phase 1|Other|0|||
149892879|NCT00460603|540738388|FG001|Phase 1|Other|3|||
149892880|NCT00460603|540738389|FG002|Phase 1|Other|1|||
149892881|NCT00460603|540738390|FG003|Phase 1|Other|1|||
149892882|NCT00460603|540738391|FG004|Phase 1|Other|1|||
149892883|NCT00460603|540738392|FG005|Phase 1|Other|2|||
149892884|NCT00460603|540738393|FG006|Phase 1|Other|0|||
149892885|NCT00460603|540738394|FG007|Phase 1|Other|1|||
149892886|NCT00460603|540738395|FG008|Phase 1|Other|0|||
149892887|NCT00460603|540738396|FG009|Phase 1|Other|0|||
149892888|NCT00460603|540738397|FG010|Phase 1|Other|0|||
149892889|NCT00460603|540738398|FG011|Phase 1|Other|0|||
149892890|NCT00460603|540738387|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892891|NCT00460603|540738388|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892892|NCT00460603|540738389|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892893|NCT00460603|540738390|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892894|NCT00460603|540738391|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892895|NCT00460603|540738392|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892896|NCT00460603|540738393|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892897|NCT00460603|540738394|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892898|NCT00460603|540738395|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892899|NCT00460603|540738396|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
149892900|NCT00460603|540738397|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892901|NCT00460603|540738398|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
149892902|NCT00460603|540738387|FG000|Phase 2|Adverse Event|0|||
149892903|NCT00460603|540738388|FG001|Phase 2|Adverse Event|0|||
149892904|NCT00460603|540738389|FG002|Phase 2|Adverse Event|0|||
149892905|NCT00460603|540738390|FG003|Phase 2|Adverse Event|0|||
149892906|NCT00460603|540738391|FG004|Phase 2|Adverse Event|0|||
149892907|NCT00460603|540738392|FG005|Phase 2|Adverse Event|0|||
149892908|NCT00460603|540738393|FG006|Phase 2|Adverse Event|0|||
149892909|NCT00460603|540738394|FG007|Phase 2|Adverse Event|0|||
149892910|NCT00460603|540738395|FG008|Phase 2|Adverse Event|0|||
149892911|NCT00460603|540738396|FG009|Phase 2|Adverse Event|12|||
149892912|NCT00460603|540738397|FG010|Phase 2|Adverse Event|9|||
149892913|NCT00460603|540738398|FG011|Phase 2|Adverse Event|10|||
149892914|NCT00460603|540738387|FG000|Phase 2|Death|0|||
149892915|NCT00460603|540738388|FG001|Phase 2|Death|0|||
149892916|NCT00460603|540738389|FG002|Phase 2|Death|0|||
149892917|NCT00460603|540738390|FG003|Phase 2|Death|0|||
149968353|NCT01206517|541019839|FG004|Overall Study|Withdrawal by Subject|1|||
149968354|NCT01206517|541019840|FG005|Overall Study|Withdrawal by Subject|0|||
149968355|NCT03633058|541019851|FG000|Overall Study|Adverse Event|0|||
149892918|NCT00460603|540738391|FG004|Phase 2|Death|0|||
149892919|NCT00460603|540738392|FG005|Phase 2|Death|0|||
149892920|NCT00460603|540738393|FG006|Phase 2|Death|0|||
149892921|NCT00460603|540738394|FG007|Phase 2|Death|0|||
149892922|NCT00460603|540738395|FG008|Phase 2|Death|0|||
149892923|NCT00460603|540738396|FG009|Phase 2|Death|4|||
149892924|NCT00460603|540738397|FG010|Phase 2|Death|2|||
149892925|NCT00460603|540738398|FG011|Phase 2|Death|2|||
149892926|NCT00460603|540738387|FG000|Phase 2|Protocol Violation|0|||
149892927|NCT00460603|540738388|FG001|Phase 2|Protocol Violation|0|||
149892928|NCT00460603|540738389|FG002|Phase 2|Protocol Violation|0|||
149892929|NCT00460603|540738390|FG003|Phase 2|Protocol Violation|0|||
149892930|NCT00460603|540738391|FG004|Phase 2|Protocol Violation|0|||
149892931|NCT00460603|540738392|FG005|Phase 2|Protocol Violation|0|||
149892932|NCT00460603|540738393|FG006|Phase 2|Protocol Violation|0|||
149892933|NCT00460603|540738394|FG007|Phase 2|Protocol Violation|0|||
149892934|NCT00460603|540738395|FG008|Phase 2|Protocol Violation|0|||
149892935|NCT00460603|540738396|FG009|Phase 2|Protocol Violation|1|||
149892936|NCT00460603|540738397|FG010|Phase 2|Protocol Violation|1|||
149892937|NCT00460603|540738398|FG011|Phase 2|Protocol Violation|0|||
149892938|NCT00460603|540738387|FG000|Phase 2|Lost to Follow-up|0|||
149892939|NCT00460603|540738388|FG001|Phase 2|Lost to Follow-up|0|||
149892940|NCT00460603|540738389|FG002|Phase 2|Lost to Follow-up|0|||
149892941|NCT00460603|540738390|FG003|Phase 2|Lost to Follow-up|0|||
149892942|NCT00460603|540738391|FG004|Phase 2|Lost to Follow-up|0|||
149892943|NCT00460603|540738392|FG005|Phase 2|Lost to Follow-up|0|||
149892944|NCT00460603|540738393|FG006|Phase 2|Lost to Follow-up|0|||
149892945|NCT00460603|540738394|FG007|Phase 2|Lost to Follow-up|0|||
149892946|NCT00460603|540738395|FG008|Phase 2|Lost to Follow-up|0|||
149892947|NCT00460603|540738396|FG009|Phase 2|Lost to Follow-up|1|||
149892948|NCT00460603|540738397|FG010|Phase 2|Lost to Follow-up|0|||
149892949|NCT00460603|540738398|FG011|Phase 2|Lost to Follow-up|0|||
149892950|NCT00460603|540738387|FG000|Phase 2|Other|0|||
149892951|NCT00460603|540738388|FG001|Phase 2|Other|0|||
149892952|NCT00460603|540738389|FG002|Phase 2|Other|0|||
149892953|NCT00460603|540738390|FG003|Phase 2|Other|0|||
149892954|NCT00460603|540738391|FG004|Phase 2|Other|0|||
149892955|NCT00460603|540738392|FG005|Phase 2|Other|0|||
149892956|NCT00460603|540738393|FG006|Phase 2|Other|0|||
149892957|NCT00460603|540738394|FG007|Phase 2|Other|0|||
149892958|NCT00460603|540738395|FG008|Phase 2|Other|0|||
149892959|NCT00460603|540738396|FG009|Phase 2|Other|6|||
149892960|NCT00460603|540738397|FG010|Phase 2|Other|16|||
149892961|NCT00460603|540738398|FG011|Phase 2|Other|7|||
149892962|NCT00460603|540738387|FG000|Phase 2|Objective Progression or Relapse|0|||
149892963|NCT00460603|540738388|FG001|Phase 2|Objective Progression or Relapse|0|||
149892964|NCT00460603|540738389|FG002|Phase 2|Objective Progression or Relapse|0|||
149892965|NCT00460603|540738390|FG003|Phase 2|Objective Progression or Relapse|0|||
149892966|NCT00460603|540738391|FG004|Phase 2|Objective Progression or Relapse|0|||
149892967|NCT00460603|540738392|FG005|Phase 2|Objective Progression or Relapse|0|||
149892968|NCT00460603|540738393|FG006|Phase 2|Objective Progression or Relapse|0|||
149892969|NCT00460603|540738394|FG007|Phase 2|Objective Progression or Relapse|0|||
149892970|NCT00460603|540738395|FG008|Phase 2|Objective Progression or Relapse|0|||
149892971|NCT00460603|540738396|FG009|Phase 2|Objective Progression or Relapse|9|||
149892972|NCT00460603|540738397|FG010|Phase 2|Objective Progression or Relapse|10|||
149892973|NCT00460603|540738398|FG011|Phase 2|Objective Progression or Relapse|17|||
149892974|NCT00460603|540738387|FG000|Phase 2|Global Deterioration of Health Status|0|||
149892975|NCT00460603|540738388|FG001|Phase 2|Global Deterioration of Health Status|0|||
149892976|NCT00460603|540738389|FG002|Phase 2|Global Deterioration of Health Status|0|||
149892977|NCT00460603|540738390|FG003|Phase 2|Global Deterioration of Health Status|0|||
149892978|NCT00460603|540738391|FG004|Phase 2|Global Deterioration of Health Status|0|||
149892979|NCT00460603|540738392|FG005|Phase 2|Global Deterioration of Health Status|0|||
149892980|NCT00460603|540738393|FG006|Phase 2|Global Deterioration of Health Status|0|||
149892981|NCT00460603|540738394|FG007|Phase 2|Global Deterioration of Health Status|0|||
149892982|NCT00460603|540738395|FG008|Phase 2|Global Deterioration of Health Status|0|||
149892983|NCT00460603|540738396|FG009|Phase 2|Global Deterioration of Health Status|0|||
149892984|NCT00460603|540738397|FG010|Phase 2|Global Deterioration of Health Status|1|||
149892985|NCT00460603|540738398|FG011|Phase 2|Global Deterioration of Health Status|0|||
149892986|NCT00460603|540738387|FG000|Phase 2|Withdrawal by Subject|0|||
149892987|NCT00460603|540738388|FG001|Phase 2|Withdrawal by Subject|0|||
149892988|NCT00460603|540738389|FG002|Phase 2|Withdrawal by Subject|0|||
149892989|NCT00460603|540738390|FG003|Phase 2|Withdrawal by Subject|0|||
149892990|NCT00460603|540738391|FG004|Phase 2|Withdrawal by Subject|0|||
149892991|NCT00460603|540738392|FG005|Phase 2|Withdrawal by Subject|0|||
149892992|NCT00460603|540738393|FG006|Phase 2|Withdrawal by Subject|0|||
149892993|NCT00460603|540738394|FG007|Phase 2|Withdrawal by Subject|0|||
149892994|NCT00460603|540738395|FG008|Phase 2|Withdrawal by Subject|0|||
149892995|NCT00460603|540738396|FG009|Phase 2|Withdrawal by Subject|5|||
149892996|NCT00460603|540738397|FG010|Phase 2|Withdrawal by Subject|4|||
149892997|NCT00460603|540738398|FG011|Phase 2|Withdrawal by Subject|5|||
149892998|NCT00460603|540738387|FG000|Phase 2|Randomized, but not treated|0|||
149892999|NCT00460603|540738388|FG001|Phase 2|Randomized, but not treated|0|||
149893000|NCT00460603|540738389|FG002|Phase 2|Randomized, but not treated|0|||
149893001|NCT00460603|540738390|FG003|Phase 2|Randomized, but not treated|0|||
149893002|NCT00460603|540738391|FG004|Phase 2|Randomized, but not treated|0|||
149968356|NCT03633058|541019852|FG001|Overall Study|Adverse Event|0|||
149968357|NCT03633058|541019853|FG002|Overall Study|Adverse Event|1|||
149968358|NCT03633058|541019854|FG003|Overall Study|Adverse Event|0|||
149968359|NCT03312543|541019857|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
149968360|NCT03312543|541019858|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
149968361|NCT03312543|541019857|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
149893003|NCT00460603|540738392|FG005|Phase 2|Randomized, but not treated|0|||
149893004|NCT00460603|540738393|FG006|Phase 2|Randomized, but not treated|0|||
149893005|NCT00460603|540738394|FG007|Phase 2|Randomized, but not treated|0|||
149893006|NCT00460603|540738395|FG008|Phase 2|Randomized, but not treated|0|||
149893007|NCT00460603|540738396|FG009|Phase 2|Randomized, but not treated|3|||
149893008|NCT00460603|540738397|FG010|Phase 2|Randomized, but not treated|0|||
149893009|NCT00460603|540738398|FG011|Phase 2|Randomized, but not treated|0|||
149893010|NCT03003962|540738399|FG000|Overall Study|Withdrawal by Subject|5|||
149893011|NCT03003962|540738400|FG001|Overall Study|Withdrawal by Subject|17|||
149893012|NCT03003962|540738399|FG000|Overall Study|Death|274|||
149893013|NCT03003962|540738400|FG001|Overall Study|Death|277|||
149968362|NCT03312543|541019858|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
149968363|NCT03312543|541019857|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
149968364|NCT03312543|541019858|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
149968365|NCT03312543|541019857|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
149968366|NCT03312543|541019858|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
149968367|NCT03312543|541019857|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
149968368|NCT03312543|541019858|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
149968369|NCT03312543|541019857|FG000|Regression (Week 12 to Week 24)|Death|0|||
149968370|NCT03312543|541019858|FG001|Regression (Week 12 to Week 24)|Death|1|||
149968371|NCT04507269|541019859|FG000|Overall Study|Withdrawal by Subject|1|||
149968372|NCT04507269|541019860|FG001|Overall Study|Withdrawal by Subject|1|||
149968373|NCT04507269|541019861|FG002|Overall Study|Withdrawal by Subject|0|||
149968374|NCT04507269|541019862|FG003|Overall Study|Withdrawal by Subject|0|||
149968375|NCT04507269|541019863|FG004|Overall Study|Withdrawal by Subject|0|||
149968376|NCT04507269|541019864|FG005|Overall Study|Withdrawal by Subject|0|||
149968377|NCT04507269|541019859|FG000|Overall Study|Lost to Follow-up|0|||
149968378|NCT04507269|541019860|FG001|Overall Study|Lost to Follow-up|0|||
149968379|NCT04507269|541019861|FG002|Overall Study|Lost to Follow-up|0|||
149968380|NCT04507269|541019862|FG003|Overall Study|Lost to Follow-up|0|||
149968381|NCT04507269|541019863|FG004|Overall Study|Lost to Follow-up|1|||
149968382|NCT04507269|541019864|FG005|Overall Study|Lost to Follow-up|0|||
149968383|NCT05852340|541019865|FG000|Period 5|Not completing the meal|0|||
149968384|NCT05852340|541019866|FG001|Period 5|Not completing the meal|1|||
149968385|NCT05852340|541019867|FG002|Period 5|Not completing the meal|0|||
149968386|NCT05852340|541019868|FG003|Period 5|Not completing the meal|0|||
149968387|NCT05852340|541019865|FG000|Period 5|Adverse Event|0|||
149968388|NCT05852340|541019866|FG001|Period 5|Adverse Event|0|||
149968389|NCT05852340|541019867|FG002|Period 5|Adverse Event|0|||
149968390|NCT05852340|541019868|FG003|Period 5|Adverse Event|1|||
149968391|NCT01722669|541019871|FG000|Overall Study|Withdrawal by Subject|0|||
149968392|NCT01722669|541019872|FG001|Overall Study|Withdrawal by Subject|0|||
149968393|NCT01722669|541019873|FG002|Overall Study|Withdrawal by Subject|0|||
149968394|NCT01722669|541019874|FG003|Overall Study|Withdrawal by Subject|0|||
149968395|NCT01722669|541019875|FG004|Overall Study|Withdrawal by Subject|0|||
149968396|NCT01722669|541019876|FG005|Overall Study|Withdrawal by Subject|2|||
149968397|NCT02496000|541019881|FG000|Overall Study|Withdrawal by Subject|1|||
149968398|NCT02496000|541019882|FG001|Overall Study|Withdrawal by Subject|2|||
149968399|NCT02496000|541019883|FG002|Overall Study|Withdrawal by Subject|0|||
149968400|NCT02496000|541019881|FG000|Overall Study|Lost to Follow-up|1|||
149968401|NCT02496000|541019882|FG001|Overall Study|Lost to Follow-up|0|||
149968402|NCT02496000|541019883|FG002|Overall Study|Lost to Follow-up|1|||
150045176|NCT03892967|541304274|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
150045177|NCT03892967|541304275|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
150045178|NCT03892967|541304276|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
150045179|NCT03892967|541304277|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
150045180|NCT03892967|541304278|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
150045181|NCT03892967|541304274|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
150045182|NCT03892967|541304275|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
150045183|NCT03892967|541304276|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
150045184|NCT03892967|541304277|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
150175889|NCT00357097|541779953|FG001|Overall Study|Other|1|||
150175890|NCT00357097|541779952|FG000|Overall Study|Increase of RLS Symptoms|0|||
150175891|NCT00357097|541779953|FG001|Overall Study|Increase of RLS Symptoms|1|||
149893014|NCT03003962|540738399|FG000|Overall Study|Participants ongoing at DCO|55|||
149968403|NCT02496000|541019881|FG000|Overall Study|Protocol Violation|0|||
149968404|NCT02496000|541019882|FG001|Overall Study|Protocol Violation|0|||
149968405|NCT02496000|541019883|FG002|Overall Study|Protocol Violation|1|||
149968406|NCT02496000|541019881|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
149968407|NCT02496000|541019882|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
149968408|NCT02496000|541019883|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
149968409|NCT02496000|541019881|FG000|Overall Study|undetermined|0|||
149893015|NCT03003962|540738400|FG001|Overall Study|Participants ongoing at DCO|40|||
149893016|NCT03871543|540738401|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
149893017|NCT03871543|540738401|FG000|Period 1|Investigator Error|1|||
149893018|NCT03871543|540738401|FG000|Period 1|Protocol Violation|2|||
149893019|NCT03871543|540738401|FG000|Period 1|COVID-19 Related|1|||
149893020|NCT03871543|540738401|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
149893021|NCT03871543|540738401|FG000|Period 1|Withdrawal by Subject|10|||
149893022|NCT03871543|540738401|FG000|Period 2|Adverse Event|1|||
149893023|NCT03871543|540738401|FG000|Period 2|Withdrawal by Subject|1|||
149893024|NCT01082328|540738404|FG000|Overall Study|Adverse Event|1|||
149893025|NCT00031590|540738405|FG000|Overall Study|Adverse Event|1|||
149893026|NCT00031590|540738405|FG000|Overall Study|Withdrawal by parents|2|||
149893027|NCT01568892|540738406|FG000|Open-label Phase|Adverse Event|2|||
149893028|NCT01568892|540738407|FG001|Open-label Phase|Adverse Event|0|||
149893029|NCT01568892|540738406|FG000|Open-label Phase|Lack of Efficacy|4|||
149893030|NCT01568892|540738407|FG001|Open-label Phase|Lack of Efficacy|2|||
149893031|NCT01568892|540738406|FG000|Open-label Phase|Lost to Follow-up|0|||
149893032|NCT01568892|540738407|FG001|Open-label Phase|Lost to Follow-up|1|||
149893033|NCT02755103|540738417|FG000|Overall Study|Lost to Follow-up|17|||
149893034|NCT02755103|540738418|FG001|Overall Study|Lost to Follow-up|15|||
149893035|NCT02755103|540738417|FG000|Overall Study|Death|0|||
149893036|NCT02755103|540738418|FG001|Overall Study|Death|1|||
149893037|NCT02755103|540738417|FG000|Overall Study|Physician Decision|0|||
149893038|NCT02755103|540738418|FG001|Overall Study|Physician Decision|1|||
149893039|NCT02755103|540738417|FG000|Overall Study|Pregnancy|0|||
149893040|NCT02755103|540738418|FG001|Overall Study|Pregnancy|1|||
149893041|NCT02755103|540738417|FG000|Overall Study|Withdrawal by Subject|3|||
149893042|NCT02755103|540738418|FG001|Overall Study|Withdrawal by Subject|0|||
149893043|NCT04177095|540738419|FG000|Overall Study|Withdrawal by Subject|3|||
149893044|NCT04177095|540738419|FG000|Overall Study|Screen Failure|3|||
149893045|NCT04177095|540738419|FG000|Overall Study|Problems with the Trugraf assay|1|||
149893046|NCT00777296|540738420|FG000|Overall Study|Adverse Event|0|||
149893047|NCT00777296|540738421|FG001|Overall Study|Adverse Event|1|||
149893048|NCT00777296|540738422|FG002|Overall Study|Adverse Event|0|||
149893049|NCT00777296|540738423|FG003|Overall Study|Adverse Event|1|||
149893050|NCT00777296|540738420|FG000|Overall Study|Withdrawal by Subject|1|||
149893051|NCT00777296|540738421|FG001|Overall Study|Withdrawal by Subject|0|||
149893052|NCT00777296|540738422|FG002|Overall Study|Withdrawal by Subject|0|||
149893053|NCT00777296|540738423|FG003|Overall Study|Withdrawal by Subject|0|||
149893054|NCT00777296|540738420|FG000|Overall Study|CRF form not completed|0|||
149893055|NCT00777296|540738421|FG001|Overall Study|CRF form not completed|0|||
149893056|NCT00777296|540738422|FG002|Overall Study|CRF form not completed|2|||
149893057|NCT00777296|540738423|FG003|Overall Study|CRF form not completed|0|||
149893058|NCT00658723|540738424|FG000|Overall Study|Lost to Follow-up|0|||
149893059|NCT00658723|540738425|FG001|Overall Study|Lost to Follow-up|2|||
149893060|NCT00658723|540738426|FG002|Overall Study|Lost to Follow-up|2|||
149893061|NCT00658723|540738424|FG000|Overall Study|Death|2|||
149893062|NCT00658723|540738425|FG001|Overall Study|Death|1|||
149893063|NCT00658723|540738426|FG002|Overall Study|Death|4|||
149893064|NCT00658723|540738424|FG000|Overall Study|Scheduling Issue|1|||
149893065|NCT00658723|540738425|FG001|Overall Study|Scheduling Issue|1|||
149893066|NCT00658723|540738426|FG002|Overall Study|Scheduling Issue|0|||
149893067|NCT00658723|540738424|FG000|Overall Study|Withdrawal by Subject|1|||
149893068|NCT00658723|540738425|FG001|Overall Study|Withdrawal by Subject|0|||
149893069|NCT00658723|540738426|FG002|Overall Study|Withdrawal by Subject|1|||
149893070|NCT03876743|540738427|FG000|Overall Study|Lost to Follow-up|6|||
149893071|NCT03876743|540738428|FG001|Overall Study|Lost to Follow-up|4|||
149893072|NCT03876743|540738429|FG002|Overall Study|Lost to Follow-up|4|||
149893073|NCT03876743|540738430|FG003|Overall Study|Lost to Follow-up|7|||
149893074|NCT03889418|540738431|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
149893075|NCT03889418|540738432|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893076|NCT03889418|540738433|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893077|NCT03889418|540738434|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893078|NCT03889418|540738435|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893079|NCT03889418|540738436|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893080|NCT03889418|540738437|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893081|NCT03889418|540738438|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893082|NCT03889418|540738439|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893083|NCT03889418|540738440|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
149893084|NCT03889418|540738431|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893085|NCT03889418|540738432|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
149893086|NCT03889418|540738433|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
149893087|NCT03889418|540738434|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893088|NCT03889418|540738435|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893089|NCT03889418|540738436|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893090|NCT03889418|540738437|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149968410|NCT02496000|541019882|FG001|Overall Study|undetermined|1|||
149893091|NCT03889418|540738438|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893092|NCT03889418|540738439|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893093|NCT03889418|540738440|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
149893094|NCT03889418|540738431|FG000|October-December 2019 (Month 7-9)|Death|0|||
149893095|NCT03889418|540738432|FG001|October-December 2019 (Month 7-9)|Death|0|||
149893096|NCT03889418|540738433|FG002|October-December 2019 (Month 7-9)|Death|0|||
149893097|NCT03889418|540738434|FG003|October-December 2019 (Month 7-9)|Death|0|||
149893098|NCT03889418|540738435|FG004|October-December 2019 (Month 7-9)|Death|0|||
149893099|NCT03889418|540738436|FG005|October-December 2019 (Month 7-9)|Death|0|||
149893100|NCT03889418|540738437|FG006|October-December 2019 (Month 7-9)|Death|0|||
149893101|NCT03889418|540738438|FG007|October-December 2019 (Month 7-9)|Death|0|||
149893102|NCT03889418|540738439|FG008|October-December 2019 (Month 7-9)|Death|1|||
149893103|NCT03889418|540738440|FG009|October-December 2019 (Month 7-9)|Death|0|||
149893104|NCT03889418|540738431|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
150045185|NCT03892967|541304278|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
149893105|NCT03889418|540738432|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893106|NCT03889418|540738433|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893107|NCT03889418|540738434|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
149893108|NCT03889418|540738435|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893109|NCT03889418|540738436|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893110|NCT03889418|540738437|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893111|NCT03889418|540738438|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
149893112|NCT03889418|540738439|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893113|NCT03889418|540738440|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
149893114|NCT03889418|540738431|FG000|April - June 2020 (Month 13-15)|Death|0|||
149893115|NCT03889418|540738432|FG001|April - June 2020 (Month 13-15)|Death|1|||
149893116|NCT03889418|540738433|FG002|April - June 2020 (Month 13-15)|Death|0|||
149893117|NCT03889418|540738434|FG003|April - June 2020 (Month 13-15)|Death|0|||
149893118|NCT03889418|540738435|FG004|April - June 2020 (Month 13-15)|Death|0|||
149893119|NCT03889418|540738436|FG005|April - June 2020 (Month 13-15)|Death|0|||
149893120|NCT03889418|540738437|FG006|April - June 2020 (Month 13-15)|Death|0|||
149893121|NCT03889418|540738438|FG007|April - June 2020 (Month 13-15)|Death|0|||
149893122|NCT03889418|540738439|FG008|April - June 2020 (Month 13-15)|Death|0|||
149893123|NCT03889418|540738440|FG009|April - June 2020 (Month 13-15)|Death|0|||
149893124|NCT03889418|540738431|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893125|NCT03889418|540738432|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893126|NCT03889418|540738433|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893127|NCT03889418|540738434|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
149893128|NCT03889418|540738435|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893129|NCT03889418|540738436|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893130|NCT03889418|540738437|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893131|NCT03889418|540738438|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
150045186|NCT03892967|541304274|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
150045187|NCT03892967|541304275|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
150045188|NCT03892967|541304276|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
150045189|NCT03892967|541304277|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
150045190|NCT03892967|541304278|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
150045191|NCT03387085|541304279|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
150045192|NCT01077050|541305498|FG000|Overall Study|Subjects signed ICF could not be located|1|||
150045193|NCT01077050|541305498|FG000|Overall Study|Screen failure|8|||
150045194|NCT01006291|541305502|FG000|Overall Study|Adverse Event|2|||
150045195|NCT01006291|541305503|FG001|Overall Study|Adverse Event|1|||
150045196|NCT01006291|541305504|FG002|Overall Study|Adverse Event|2|||
150045197|NCT01006291|541305502|FG000|Overall Study|Lack of Efficacy|2|||
150045198|NCT01006291|541305503|FG001|Overall Study|Lack of Efficacy|2|||
150045199|NCT01006291|541305504|FG002|Overall Study|Lack of Efficacy|1|||
150045200|NCT01006291|541305502|FG000|Overall Study|Protocol Violation|3|||
149893132|NCT03889418|540738439|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893133|NCT03889418|540738440|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
149893134|NCT03889418|540738431|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
149893135|NCT03889418|540738432|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
149893136|NCT03889418|540738433|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
149893137|NCT03889418|540738434|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
149893138|NCT03889418|540738435|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
149893139|NCT03889418|540738436|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
149893140|NCT03889418|540738437|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
150045201|NCT01006291|541305503|FG001|Overall Study|Protocol Violation|3|||
149893141|NCT03889418|540738438|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
149893142|NCT03889418|540738439|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
149893143|NCT03889418|540738440|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
149893144|NCT03889418|540738431|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
149893145|NCT03889418|540738432|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
149893146|NCT03889418|540738433|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
149893147|NCT03889418|540738434|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
149893148|NCT03889418|540738435|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
149893149|NCT03889418|540738436|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
149893150|NCT03889418|540738437|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
149893151|NCT03889418|540738438|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
149893152|NCT03889418|540738439|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
149893153|NCT03889418|540738440|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
149893154|NCT00092118|540738441|FG000|Overall Study|Adverse Event|35|||
149893155|NCT00092118|540738442|FG001|Overall Study|Adverse Event|32|||
149893156|NCT00092118|540738441|FG000|Overall Study|Lack of Efficacy|12|||
149893157|NCT00092118|540738442|FG001|Overall Study|Lack of Efficacy|14|||
149893158|NCT00092118|540738441|FG000|Overall Study|Lost to Follow-up|4|||
149893159|NCT00092118|540738442|FG001|Overall Study|Lost to Follow-up|3|||
149893160|NCT00092118|540738441|FG000|Overall Study|Protocol Violation|23|||
149893161|NCT00092118|540738442|FG001|Overall Study|Protocol Violation|25|||
149893162|NCT00092118|540738441|FG000|Overall Study|Withdrawal by Subject|4|||
149893163|NCT00092118|540738442|FG001|Overall Study|Withdrawal by Subject|10|||
149893164|NCT00092118|540738441|FG000|Overall Study|Other|6|||
149893165|NCT00092118|540738442|FG001|Overall Study|Other|5|||
149893166|NCT01139125|540738444|FG000|Overall Study|Withdrawal by Subject|1|||
149893167|NCT00380874|540738445|FG000|Overall Study|Adverse Event|7|||
149893168|NCT00380874|540738446|FG001|Overall Study|Adverse Event|7|||
149893169|NCT00380874|540738445|FG000|Overall Study|Death|1|||
149893170|NCT00380874|540738446|FG001|Overall Study|Death|0|||
149893171|NCT00380874|540738445|FG000|Overall Study|Withdrawal by Subject|2|||
149893172|NCT00380874|540738446|FG001|Overall Study|Withdrawal by Subject|1|||
149893173|NCT00380874|540738445|FG000|Overall Study|Not related to study drug|3|||
149893174|NCT00380874|540738446|FG001|Overall Study|Not related to study drug|2|||
149893175|NCT03380429|540738447|FG000|Overall Study|Physician Decision|0|||
149893176|NCT03380429|540738448|FG001|Overall Study|Physician Decision|1|||
149893177|NCT03380429|540738449|FG002|Overall Study|Physician Decision|0|||
149893178|NCT03380429|540738450|FG003|Overall Study|Physician Decision|1|||
149893179|NCT03380429|540738451|FG004|Overall Study|Physician Decision|1|||
149893180|NCT03380429|540738447|FG000|Overall Study|Withdrawal by Subject|3|||
149893181|NCT03380429|540738448|FG001|Overall Study|Withdrawal by Subject|3|||
149893182|NCT03380429|540738449|FG002|Overall Study|Withdrawal by Subject|5|||
149893183|NCT03380429|540738450|FG003|Overall Study|Withdrawal by Subject|2|||
149893184|NCT03380429|540738451|FG004|Overall Study|Withdrawal by Subject|1|||
149893185|NCT03380429|540738447|FG000|Overall Study|Lost to Follow-up|0|||
149893186|NCT03380429|540738448|FG001|Overall Study|Lost to Follow-up|2|||
149893187|NCT03380429|540738449|FG002|Overall Study|Lost to Follow-up|4|||
149893188|NCT03380429|540738450|FG003|Overall Study|Lost to Follow-up|3|||
149893189|NCT03380429|540738451|FG004|Overall Study|Lost to Follow-up|1|||
149893190|NCT03380429|540738447|FG000|Overall Study|Protocol Violation|1|||
149893191|NCT03380429|540738448|FG001|Overall Study|Protocol Violation|0|||
149893192|NCT03380429|540738449|FG002|Overall Study|Protocol Violation|1|||
149893193|NCT03380429|540738450|FG003|Overall Study|Protocol Violation|0|||
149893194|NCT03380429|540738451|FG004|Overall Study|Protocol Violation|1|||
149893195|NCT03380429|540738447|FG000|Overall Study|Lack of Efficacy|0|||
149893196|NCT03380429|540738448|FG001|Overall Study|Lack of Efficacy|0|||
149893197|NCT03380429|540738449|FG002|Overall Study|Lack of Efficacy|0|||
149893198|NCT03380429|540738450|FG003|Overall Study|Lack of Efficacy|2|||
149893199|NCT03380429|540738451|FG004|Overall Study|Lack of Efficacy|1|||
149893200|NCT03380429|540738447|FG000|Overall Study|Adverse Event|1|||
149893201|NCT03380429|540738448|FG001|Overall Study|Adverse Event|1|||
149893202|NCT03380429|540738449|FG002|Overall Study|Adverse Event|1|||
149893203|NCT03380429|540738450|FG003|Overall Study|Adverse Event|2|||
149893204|NCT03380429|540738451|FG004|Overall Study|Adverse Event|0|||
149968411|NCT02496000|541019883|FG002|Overall Study|undetermined|0|||
149968412|NCT02255656|541019884|FG000|Overall Study|Adverse Event|11|||
149968413|NCT02255656|541019884|FG000|Overall Study|Poor compliance to protocol|3|||
149893205|NCT01707290|540738458|FG000|Overall Study|Adverse event (AE)|1|||
149893206|NCT01707290|540738459|FG001|Overall Study|Adverse event (AE)|0|||
149893207|NCT01707290|540738458|FG000|Overall Study|Physician Decision|1|||
149893208|NCT01707290|540738459|FG001|Overall Study|Physician Decision|0|||
149893209|NCT01707290|540738458|FG000|Overall Study|Lost to Follow-up|3|||
149893210|NCT01707290|540738459|FG001|Overall Study|Lost to Follow-up|0|||
149893211|NCT01707290|540738458|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
149893212|NCT01707290|540738459|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
149893213|NCT01707290|540738458|FG000|Overall Study|Commercial drug available|60|||
149893214|NCT01707290|540738459|FG001|Overall Study|Commercial drug available|1|||
149893215|NCT01707290|540738458|FG000|Overall Study|Other unspecified|17|||
149893216|NCT01707290|540738459|FG001|Overall Study|Other unspecified|0|||
149893217|NCT01198470|540738460|FG000|Overall Study|Adverse Event|2|||
149893218|NCT02949973|540738461|FG000|Overall Study|Physician Decision|1|||
149968414|NCT02255656|541019884|FG000|Overall Study|Lost to Follow-up|30|||
150175892|NCT00658996|541779954|FG000|First Intervention|Positive slit lamp finding|1|||
149893219|NCT01139775|540738462|FG000|Overall Study|Adverse Event|0|||
149893220|NCT01139775|540738463|FG001|Overall Study|Adverse Event|6|||
149893221|NCT01139775|540738464|FG002|Overall Study|Adverse Event|2|||
149893222|NCT01139775|540738462|FG000|Overall Study|Protocol Violation|0|||
149893223|NCT01139775|540738463|FG001|Overall Study|Protocol Violation|5|||
149893224|NCT01139775|540738464|FG002|Overall Study|Protocol Violation|0|||
149893225|NCT01139775|540738462|FG000|Overall Study|Withdrawal by Subject|1|||
149893226|NCT01139775|540738463|FG001|Overall Study|Withdrawal by Subject|0|||
149893227|NCT01139775|540738464|FG002|Overall Study|Withdrawal by Subject|2|||
149893228|NCT01139775|540738462|FG000|Overall Study|Physician Decision|0|||
149893229|NCT01139775|540738463|FG001|Overall Study|Physician Decision|2|||
149893230|NCT01139775|540738464|FG002|Overall Study|Physician Decision|2|||
149893231|NCT00586703|540738465|FG000|Overall Study|Death|12|||
149893232|NCT04760626|540738468|FG000|Overall Study|Withdrawal by Subject|24|||
149893233|NCT04760626|540738469|FG001|Overall Study|Withdrawal by Subject|20|||
149893234|NCT04760626|540738468|FG000|Overall Study|Lost to Follow-up|14|||
149893235|NCT04760626|540738469|FG001|Overall Study|Lost to Follow-up|19|||
149893236|NCT04760626|540738468|FG000|Overall Study|Physician Decision|3|||
149893237|NCT04760626|540738469|FG001|Overall Study|Physician Decision|5|||
149893238|NCT04760626|540738468|FG000|Overall Study|Death|3|||
149893239|NCT04760626|540738469|FG001|Overall Study|Death|6|||
149893240|NCT04760626|540738468|FG000|Overall Study|Site closure|1|||
149893241|NCT04760626|540738469|FG001|Overall Study|Site closure|0|||
149893242|NCT00806403|540738472|FG000|Overall Study|Death|4|||
149893243|NCT00806403|540738473|FG001|Overall Study|Death|3|||
149893244|NCT01882985|540738474|FG000|Overall Study|Lost to Follow-up|1|||
149893245|NCT01882985|540738474|FG000|Overall Study|Withdrawal by Subject|1|||
149893246|NCT00765102|540738475|FG000|Overall Study|Progressive disease|18|||
149893247|NCT00765102|540738475|FG000|Overall Study|Adverse Event|6|||
149893248|NCT00765102|540738475|FG000|Overall Study|Physician Decision|4|||
149893249|NCT00765102|540738475|FG000|Overall Study|Withdrawal by Subject|2|||
149893250|NCT00765102|540738475|FG000|Overall Study|Protocol Violation|1|||
149893251|NCT03193853|540738482|FG000|Overall Study|Death|6|||
149893252|NCT04129125|540738483|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
149893253|NCT04129125|540738483|FG000|Overall Study|Study device was not used|3|||
149893254|NCT01787292|540738486|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
149893255|NCT01787292|540738487|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
149893256|NCT01787292|540738486|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
149893257|NCT01787292|540738487|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
149968415|NCT02255656|541019884|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
149968416|NCT02255656|541019884|FG000|Overall Study|Other|126|||
149968417|NCT01877278|541019885|FG000|Overall Study|Lost to Follow-up|3|||
149893258|NCT01827111|540738488|FG000|Overall Study|Disease Progression|1|||
149893259|NCT02962648|540738489|FG000|Overall Study|Withdrawal by Subject|3|||
149893260|NCT02962648|540738489|FG000|Overall Study|Lost to Follow-up|3|||
149893261|NCT02962648|540738489|FG000|Overall Study|Physician Decision|1|||
149893262|NCT02962648|540738489|FG000|Overall Study|Subject had problems with transportation|2|||
149968418|NCT01877278|541019886|FG001|Overall Study|Lost to Follow-up|3|||
149893263|NCT03267212|540738490|FG000|First Intervention|Lost to Follow-up|0|||
149893264|NCT03267212|540738491|FG001|First Intervention|Lost to Follow-up|2|||
149893265|NCT03267212|540738490|FG000|First Intervention|Withdrawal by Subject|1|||
149893266|NCT03267212|540738491|FG001|First Intervention|Withdrawal by Subject|1|||
149893267|NCT03267212|540738490|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
149893268|NCT03267212|540738491|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
149893269|NCT04383327|540738494|FG000|Overall Study|Lost to Follow-up|112|||
149893270|NCT04383327|540738495|FG001|Overall Study|Lost to Follow-up|14|||
149893271|NCT04383327|540738496|FG002|Overall Study|Lost to Follow-up|78|||
149893272|NCT04383327|540738497|FG003|Overall Study|Lost to Follow-up|13|||
149893273|NCT04383327|540738498|FG004|Overall Study|Lost to Follow-up|110|||
149893274|NCT04383327|540738499|FG005|Overall Study|Lost to Follow-up|13|||
149893275|NCT04383327|540738500|FG006|Overall Study|Lost to Follow-up|74|||
149893276|NCT04383327|540738501|FG007|Overall Study|Lost to Follow-up|13|||
149893277|NCT04383327|540738502|FG008|Overall Study|Lost to Follow-up|78|||
149893278|NCT04383327|540738503|FG009|Overall Study|Lost to Follow-up|10|||
149893279|NCT04383327|540738504|FG010|Overall Study|Lost to Follow-up|160|||
149893280|NCT04383327|540738505|FG011|Overall Study|Lost to Follow-up|13|||
149893281|NCT04146012|540738506|FG000|Overall Study|Study Terminated|30|||
149893282|NCT04146012|540738507|FG001|Overall Study|Study Terminated|15|||
149893283|NCT02342678|540739547|FG000|Overall Study|Lost to Follow-up|0|||
149893284|NCT02342678|540739548|FG001|Overall Study|Lost to Follow-up|1|||
149893285|NCT02342678|540739547|FG000|Overall Study|Too busy to complete study|0|||
149893286|NCT02342678|540739548|FG001|Overall Study|Too busy to complete study|2|||
149893287|NCT02342678|540739547|FG000|Overall Study|Family illness/emergency|0|||
149893288|NCT02342678|540739548|FG001|Overall Study|Family illness/emergency|1|||
149893289|NCT02342678|540739547|FG000|Overall Study|Illness/medical reason|1|||
149893290|NCT02342678|540739548|FG001|Overall Study|Illness/medical reason|1|||
149893291|NCT00350207|540739549|FG000|Overall Study|Adverse Event|5|||
149893292|NCT00350207|540739550|FG001|Overall Study|Adverse Event|2|||
149893293|NCT00350207|540739551|FG002|Overall Study|Adverse Event|2|||
149893294|NCT00350207|540739549|FG000|Overall Study|Lack of Efficacy|1|||
149893295|NCT00350207|540739550|FG001|Overall Study|Lack of Efficacy|0|||
149893296|NCT00350207|540739551|FG002|Overall Study|Lack of Efficacy|2|||
149893297|NCT00350207|540739549|FG000|Overall Study|Lost to Follow-up|1|||
149893298|NCT00350207|540739550|FG001|Overall Study|Lost to Follow-up|0|||
149893299|NCT00350207|540739551|FG002|Overall Study|Lost to Follow-up|1|||
149893300|NCT00350207|540739549|FG000|Overall Study|Withdrawal by Subject|0|||
149893301|NCT00350207|540739550|FG001|Overall Study|Withdrawal by Subject|1|||
149893302|NCT00350207|540739551|FG002|Overall Study|Withdrawal by Subject|1|||
149893303|NCT00350207|540739549|FG000|Overall Study|Other|1|||
149893304|NCT00350207|540739550|FG001|Overall Study|Other|3|||
149893305|NCT00350207|540739551|FG002|Overall Study|Other|1|||
149893306|NCT03214224|540739552|FG000|Overall Study|Protocol Violation|1|||
149893307|NCT03214224|540739552|FG000|Overall Study|Withdrawal by Subject|2|||
149893308|NCT03214224|540739552|FG000|Overall Study|Practice controls or therapists|6|||
149893309|NCT03802825|540739553|FG000|Overall Study|Lost to follow-up for intervention|12|||
149893310|NCT03802825|540739554|FG001|Overall Study|Lost to follow-up for intervention|3|||
150175893|NCT00658996|541779955|FG001|First Intervention|Positive slit lamp finding|0|||
149893311|NCT03802825|540739553|FG000|Overall Study|Received only 1 component of intervention|0|||
149893312|NCT03802825|540739554|FG001|Overall Study|Received only 1 component of intervention|13|||
149893313|NCT01051960|540739561|FG000|Overall Study|Adverse Event|1|||
149893314|NCT00360282|540739562|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
149893315|NCT00360282|540739563|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
149893316|NCT00360282|540739564|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
149893317|NCT00360282|540739565|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
149893318|NCT00360282|540739562|FG000|Second Intervention|Adverse Event|0|||
149893319|NCT00360282|540739563|FG001|Second Intervention|Adverse Event|1|||
149893320|NCT00360282|540739564|FG002|Second Intervention|Adverse Event|0|||
149893321|NCT00360282|540739565|FG003|Second Intervention|Adverse Event|0|||
150175894|NCT00658996|541779954|FG000|First Intervention|Lack of lenses|0|||
149893322|NCT04537078|540739568|FG000|Overall Study|Protocol Violation|3|||
149893323|NCT04537078|540739569|FG001|Overall Study|Protocol Violation|2|||
149893324|NCT04537078|540739568|FG000|Overall Study|Lost to Follow-up|1|||
149893325|NCT04537078|540739569|FG001|Overall Study|Lost to Follow-up|0|||
149893326|NCT04537078|540739568|FG000|Overall Study|Withdrawal by Subject|0|||
149893327|NCT04537078|540739569|FG001|Overall Study|Withdrawal by Subject|1|||
149893328|NCT01293695|540739573|FG000|Overall Study|Withdrawal by Subject|7|||
149893329|NCT01293695|540739574|FG001|Overall Study|Withdrawal by Subject|1|||
149893330|NCT01293695|540739573|FG000|Overall Study|Lost to Follow-up|8|||
149893331|NCT01293695|540739574|FG001|Overall Study|Lost to Follow-up|6|||
149893332|NCT02375971|540739579|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
149893333|NCT02375971|540739580|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
149893334|NCT02375971|540739581|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
149893335|NCT02375971|540739579|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
149893336|NCT02375971|540739580|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
149893337|NCT02375971|540739581|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
150175895|NCT00658996|541779955|FG001|First Intervention|Lack of lenses|1|||
149968419|NCT03510715|541019887|FG000|Overall Study|Adverse Event|1|||
149968420|NCT03510715|541019888|FG001|Overall Study|Adverse Event|0|||
149968421|NCT05318287|541019893|FG000|Overall Study|Lost to Follow-up|8|||
149968422|NCT04144517|541019896|FG000|Overall Study|Physician Decision|0|||
149968423|NCT04144517|541019897|FG001|Overall Study|Physician Decision|1|||
149968424|NCT04144517|541019896|FG000|Overall Study|Other|2|||
149968425|NCT04144517|541019897|FG001|Overall Study|Other|2|||
149968426|NCT04144517|541019896|FG000|Overall Study|Death|6|||
149968427|NCT04144517|541019897|FG001|Overall Study|Death|3|||
149968428|NCT03164356|541019898|FG000|Overall Study|Lost to Follow-up|1|||
149968429|NCT03164356|541019899|FG001|Overall Study|Lost to Follow-up|1|||
149968430|NCT03164356|541019900|FG002|Overall Study|Lost to Follow-up|2|||
149968431|NCT03164356|541019901|FG003|Overall Study|Lost to Follow-up|1|||
149968432|NCT03164356|541019898|FG000|Overall Study|Physician Decision|0|||
149968433|NCT03164356|541019899|FG001|Overall Study|Physician Decision|0|||
149968434|NCT03164356|541019900|FG002|Overall Study|Physician Decision|3|||
149968435|NCT03164356|541019901|FG003|Overall Study|Physician Decision|0|||
149968436|NCT03164356|541019898|FG000|Overall Study|Protocol Violation|2|||
149968437|NCT03164356|541019899|FG001|Overall Study|Protocol Violation|1|||
149968438|NCT03164356|541019900|FG002|Overall Study|Protocol Violation|0|||
149968439|NCT03164356|541019901|FG003|Overall Study|Protocol Violation|0|||
149968440|NCT03164356|541019898|FG000|Overall Study|Withdrawal by Subject|1|||
149968441|NCT03164356|541019899|FG001|Overall Study|Withdrawal by Subject|0|||
149968442|NCT03164356|541019900|FG002|Overall Study|Withdrawal by Subject|0|||
149968443|NCT03164356|541019901|FG003|Overall Study|Withdrawal by Subject|0|||
149968444|NCT03164356|541019898|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
149968445|NCT03164356|541019899|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
149968446|NCT03164356|541019900|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
149968447|NCT03164356|541019901|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
149968448|NCT03164356|541019898|FG000|Overall Study|Subject Incarcerated|0|||
149968449|NCT03164356|541019899|FG001|Overall Study|Subject Incarcerated|1|||
149968450|NCT03164356|541019900|FG002|Overall Study|Subject Incarcerated|0|||
149968451|NCT03164356|541019901|FG003|Overall Study|Subject Incarcerated|0|||
149968452|NCT03164356|541019898|FG000|Overall Study|Prosthetist unable to participate|0|||
149968453|NCT03164356|541019899|FG001|Overall Study|Prosthetist unable to participate|2|||
149968454|NCT03164356|541019900|FG002|Overall Study|Prosthetist unable to participate|1|||
149968455|NCT03164356|541019901|FG003|Overall Study|Prosthetist unable to participate|0|||
149968456|NCT01358734|541021946|FG000|Overall Study|Adverse Event|4|||
149968457|NCT01358734|541021947|FG001|Overall Study|Adverse Event|7|||
149968458|NCT01358734|541021948|FG002|Overall Study|Adverse Event|3|||
149968459|NCT01358734|541021946|FG000|Overall Study|Lack of Efficacy|0|||
149968460|NCT01358734|541021947|FG001|Overall Study|Lack of Efficacy|1|||
149968461|NCT01358734|541021948|FG002|Overall Study|Lack of Efficacy|3|||
149968462|NCT01358734|541021946|FG000|Overall Study|Withdrawal by Subject|1|||
149968463|NCT01358734|541021947|FG001|Overall Study|Withdrawal by Subject|6|||
149968464|NCT01358734|541021948|FG002|Overall Study|Withdrawal by Subject|3|||
149968465|NCT01358734|541021946|FG000|Overall Study|Death|3|||
149968466|NCT01358734|541021947|FG001|Overall Study|Death|7|||
149968467|NCT01358734|541021948|FG002|Overall Study|Death|2|||
149968468|NCT01358734|541021946|FG000|Overall Study|Progressive Disease|5|||
149968469|NCT01358734|541021947|FG001|Overall Study|Progressive Disease|13|||
149968470|NCT01358734|541021948|FG002|Overall Study|Progressive Disease|16|||
149968471|NCT01358734|541021946|FG000|Overall Study|Non-compliance with study drug|0|||
149968472|NCT01358734|541021947|FG001|Overall Study|Non-compliance with study drug|0|||
149968473|NCT01358734|541021948|FG002|Overall Study|Non-compliance with study drug|1|||
149968474|NCT01358734|541021946|FG000|Overall Study|Other|2|||
149968475|NCT01358734|541021947|FG001|Overall Study|Other|5|||
149968476|NCT01358734|541021948|FG002|Overall Study|Other|4|||
149968477|NCT01358734|541021946|FG000|Overall Study|Protocol Violation|0|||
149968478|NCT01358734|541021947|FG001|Overall Study|Protocol Violation|0|||
149968479|NCT01358734|541021948|FG002|Overall Study|Protocol Violation|2|||
149968480|NCT01822925|541021949|FG000|Overall Study|Adverse Event|1|||
149968481|NCT01822925|541021950|FG001|Overall Study|Adverse Event|1|||
149968482|NCT01822925|541021951|FG002|Overall Study|Adverse Event|1|||
149968483|NCT01822925|541021952|FG003|Overall Study|Adverse Event|1|||
149968484|NCT01822925|541021949|FG000|Overall Study|Lost to Follow-up|0|||
149968485|NCT01822925|541021950|FG001|Overall Study|Lost to Follow-up|1|||
149968486|NCT01822925|541021951|FG002|Overall Study|Lost to Follow-up|0|||
149968487|NCT01822925|541021952|FG003|Overall Study|Lost to Follow-up|0|||
149968488|NCT01822925|541021949|FG000|Overall Study|Protocol Violation|1|||
149968489|NCT01822925|541021950|FG001|Overall Study|Protocol Violation|0|||
149968490|NCT01822925|541021951|FG002|Overall Study|Protocol Violation|0|||
149968491|NCT01822925|541021952|FG003|Overall Study|Protocol Violation|1|||
149968492|NCT01822925|541021949|FG000|Overall Study|Withdrawal by Subject|2|||
149968493|NCT01822925|541021950|FG001|Overall Study|Withdrawal by Subject|0|||
149968494|NCT01822925|541021951|FG002|Overall Study|Withdrawal by Subject|2|||
149968495|NCT01822925|541021952|FG003|Overall Study|Withdrawal by Subject|2|||
149968496|NCT01822925|541021949|FG000|Overall Study|Taking prohibited medication|2|||
149893338|NCT02375971|540739579|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
149893339|NCT02375971|540739580|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
149893340|NCT02375971|540739581|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
149893341|NCT02375971|540739579|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
149893342|NCT02375971|540739580|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
149893343|NCT02375971|540739581|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
149893344|NCT02375971|540739579|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
149893345|NCT02375971|540739580|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
149893346|NCT02375971|540739581|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
149893347|NCT02375971|540739579|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
149893348|NCT02375971|540739580|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
149893349|NCT02375971|540739581|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
149893350|NCT02375971|540739579|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
149893351|NCT02375971|540739580|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
149893352|NCT02375971|540739581|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
149893353|NCT02375971|540739579|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
149893354|NCT02375971|540739580|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
149893355|NCT02375971|540739581|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
149893356|NCT02314026|540739586|FG000|Overall Study|Protocol Violation|28|||
149893357|NCT02723344|540739590|FG000|Overall Study|Lost to Follow-up|0|||
149893358|NCT02723344|540739591|FG001|Overall Study|Lost to Follow-up|4|||
149893359|NCT02524847|540739593|FG000|Overall Study|Adverse Event|4|||
149893360|NCT02524847|540739593|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
149893361|NCT02524847|540739593|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
149893362|NCT02524847|540739593|FG000|Overall Study|Death|1|||
149893363|NCT02524847|540739593|FG000|Overall Study|Reason not Specified|1|||
149893364|NCT01326845|540739594|FG000|Overall Study|Administrative Problems|5|||
149893365|NCT01326845|540739595|FG001|Overall Study|Administrative Problems|2|||
149893366|NCT01326845|540739594|FG000|Overall Study|Adverse Event|1|||
149893367|NCT01326845|540739595|FG001|Overall Study|Adverse Event|0|||
149893368|NCT01326845|540739594|FG000|Overall Study|Misisng|1|||
149893369|NCT01326845|540739595|FG001|Overall Study|Misisng|3|||
149893370|NCT04352101|540739596|FG000|Overall Study|Physician Decision|2|||
149893371|NCT04352101|540739597|FG001|Overall Study|Physician Decision|1|||
149893372|NCT00908544|540739604|FG000|Overall Study|Withdrawal by Subject|2|||
149893373|NCT00908544|540739605|FG001|Overall Study|Withdrawal by Subject|4|||
149893374|NCT00908544|540739604|FG000|Overall Study|Lack of Efficacy|0|||
149893375|NCT00908544|540739605|FG001|Overall Study|Lack of Efficacy|1|||
149893376|NCT00908544|540739604|FG000|Overall Study|Pregnancy|1|||
149893377|NCT00908544|540739605|FG001|Overall Study|Pregnancy|0|||
149893378|NCT00908544|540739604|FG000|Overall Study|Relocation abroad|1|||
149893379|NCT00908544|540739605|FG001|Overall Study|Relocation abroad|1|||
149893380|NCT00908544|540739604|FG000|Overall Study|Unable to visit sutdy center|1|||
149893381|NCT00908544|540739605|FG001|Overall Study|Unable to visit sutdy center|0|||
149893382|NCT01213966|540739606|FG000|Overall Study|Protocol Violation|1|||
149893383|NCT01213966|540739607|FG001|Overall Study|Protocol Violation|0|||
149893384|NCT01213966|540739608|FG002|Overall Study|Protocol Violation|3|||
149893385|NCT01213966|540739609|FG003|Overall Study|Protocol Violation|1|||
149893386|NCT00740636|540739614|FG000|Overall Study|Adverse Event|0|||
149893387|NCT00740636|540739615|FG001|Overall Study|Adverse Event|2|||
149893388|NCT00740636|540739614|FG000|Overall Study|Patient Ineligible|0|||
149893389|NCT00740636|540739615|FG001|Overall Study|Patient Ineligible|1|||
149893390|NCT00740636|540739614|FG000|Overall Study|Patient Not Treated|0|||
149893391|NCT00740636|540739615|FG001|Overall Study|Patient Not Treated|1|||
149893392|NCT00740636|540739614|FG000|Overall Study|Progressive Disease|1|||
149893393|NCT00740636|540739615|FG001|Overall Study|Progressive Disease|0|||
149893394|NCT00740636|540739614|FG000|Overall Study|Death|1|||
149893395|NCT00740636|540739615|FG001|Overall Study|Death|0|||
149893396|NCT02174627|540739620|FG000|Overall Study|Missing|0|||
149893397|NCT02174627|540739621|FG001|Overall Study|Missing|1|||
149893398|NCT02174627|540739620|FG000|Overall Study|Incorrect enrolment before randomization|0|||
149893399|NCT02174627|540739621|FG001|Overall Study|Incorrect enrolment before randomization|1|||
149893400|NCT02174627|540739620|FG000|Overall Study|Participant decision|84|||
149893401|NCT02174627|540739621|FG001|Overall Study|Participant decision|128|||
149968497|NCT01822925|541021950|FG001|Overall Study|Taking prohibited medication|0|||
149893402|NCT00682786|540739624|FG000|Overall Study|Withdrawal by Subject|2|||
149893403|NCT00682786|540739625|FG001|Overall Study|Withdrawal by Subject|2|||
149893404|NCT00682786|540739624|FG000|Overall Study|Did not receive irinotecan|0|||
149893405|NCT00682786|540739625|FG001|Overall Study|Did not receive irinotecan|1|||
149893406|NCT04762160|540739628|FG000|Overall Study|Study terminated early due to business reasons|5|||
149893407|NCT01831635|540739630|FG000|Overall Study|Withdrawal by Subject|0|||
149893408|NCT01831635|540739631|FG001|Overall Study|Withdrawal by Subject|2|||
149893409|NCT01831635|540739632|FG002|Overall Study|Withdrawal by Subject|0|||
149893410|NCT05142722|540741431|FG000|Overall Study|Lost to Follow-up|16|||
149893411|NCT05142722|540741432|FG001|Overall Study|Lost to Follow-up|38|||
149893412|NCT05142722|540741431|FG000|Overall Study|Withdrawal by Subject|20|||
149893413|NCT05142722|540741432|FG001|Overall Study|Withdrawal by Subject|27|||
149893414|NCT05142722|540741431|FG000|Overall Study|Death|11|||
149893415|NCT05142722|540741432|FG001|Overall Study|Death|17|||
149893416|NCT05142722|540741431|FG000|Overall Study|Physician Decision|0|||
149893417|NCT05142722|540741432|FG001|Overall Study|Physician Decision|1|||
149893418|NCT05142722|540741431|FG000|Overall Study|Participant Moved Away|0|||
149893419|NCT05142722|540741432|FG001|Overall Study|Participant Moved Away|2|||
149893420|NCT05142722|540741431|FG000|Overall Study|Adverse Event|2|||
149893421|NCT05142722|540741432|FG001|Overall Study|Adverse Event|1|||
149893422|NCT02141438|540741433|FG000|Overall Study|Death|1308|||
149893423|NCT02141438|540741433|FG000|Overall Study|Lost to Follow-up|84|||
149893424|NCT02141438|540741433|FG000|Overall Study|Withdrawal by Subject|52|||
149893425|NCT02141438|540741433|FG000|Overall Study|Physician Decision|1|||
149893426|NCT02141438|540741433|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
149893427|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
149893428|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
149893429|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
149893430|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
149893431|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
149893432|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
149893433|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
149893434|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
149893435|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893436|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893437|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
149893438|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893439|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893440|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
149893441|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893442|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
149893443|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
149893444|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
149893445|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
149893446|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
149893447|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
149893448|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
149893449|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
149893450|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
149893451|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
150045202|NCT01006291|541305504|FG002|Overall Study|Protocol Violation|3|||
150045203|NCT01006291|541305502|FG000|Overall Study|Withdrawal criteria|5|||
150045204|NCT01006291|541305503|FG001|Overall Study|Withdrawal criteria|4|||
150045205|NCT01006291|541305504|FG002|Overall Study|Withdrawal criteria|4|||
150045206|NCT01006291|541305502|FG000|Overall Study|Other|14|||
150045207|NCT01006291|541305503|FG001|Overall Study|Other|14|||
150045208|NCT01006291|541305504|FG002|Overall Study|Other|17|||
150045209|NCT00479687|541305509|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
150175896|NCT00658996|541779954|FG000|Crossover Period|Physician Decision|1|||
149893452|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
149893453|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
149893454|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
149893455|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
149893456|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
149893457|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
150045210|NCT00479687|541305510|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
150175897|NCT00658996|541779955|FG001|Crossover Period|Physician Decision|0|||
150175898|NCT00658996|541779954|FG000|Crossover Period|Ineligible|1|||
149893458|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
149893459|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893460|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893461|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
149893462|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893463|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893464|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893465|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
149893466|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893467|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
149893468|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
149893469|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
149893470|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
149893471|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
149893472|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
149893473|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
149893474|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
149893475|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
149893476|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
149893477|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893478|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893479|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893480|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893481|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893482|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
149893483|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893484|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
149893485|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893486|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893487|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893488|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893489|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893490|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
149893491|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893492|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893493|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893494|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893495|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
149893496|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893497|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893498|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
149893499|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893500|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893501|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893502|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893503|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893504|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
149893505|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149968498|NCT01822925|541021951|FG002|Overall Study|Taking prohibited medication|0|||
149968499|NCT01822925|541021952|FG003|Overall Study|Taking prohibited medication|1|||
149968500|NCT03243084|541021956|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
149968501|NCT03243084|541021957|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
149968502|NCT02095106|541021966|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
149968503|NCT02095106|541021967|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
149893506|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
149893507|NCT03896503|540741434|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893508|NCT03896503|540741435|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893509|NCT03896503|540741436|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893510|NCT03896503|540741437|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893511|NCT03896503|540741438|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893512|NCT03896503|540741439|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
149893513|NCT03896503|540741440|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
149893514|NCT03896503|540741441|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
149893515|NCT00437021|540741442|FG000|Overall Study|Adverse Event|0|||
149893516|NCT00437021|540741443|FG001|Overall Study|Adverse Event|0|||
149893517|NCT00437021|540741444|FG002|Overall Study|Adverse Event|0|||
149893518|NCT00437021|540741445|FG003|Overall Study|Adverse Event|0|||
149893519|NCT00437021|540741446|FG004|Overall Study|Adverse Event|0|||
149893520|NCT00437021|540741447|FG005|Overall Study|Adverse Event|0|||
149893521|NCT00437021|540741448|FG006|Overall Study|Adverse Event|1|||
149893522|NCT00437021|540741449|FG007|Overall Study|Adverse Event|0|||
149893523|NCT00437021|540741450|FG008|Overall Study|Adverse Event|0|||
149893524|NCT00437021|540741451|FG009|Overall Study|Adverse Event|0|||
149893525|NCT00437021|540741452|FG010|Overall Study|Adverse Event|0|||
149893526|NCT00437021|540741453|FG011|Overall Study|Adverse Event|0|||
149893527|NCT00437021|540741442|FG000|Overall Study|Lost to Follow-up|0|||
149893528|NCT00437021|540741443|FG001|Overall Study|Lost to Follow-up|3|||
149893529|NCT00437021|540741444|FG002|Overall Study|Lost to Follow-up|0|||
149893530|NCT00437021|540741445|FG003|Overall Study|Lost to Follow-up|0|||
149893531|NCT00437021|540741446|FG004|Overall Study|Lost to Follow-up|0|||
149893532|NCT00437021|540741447|FG005|Overall Study|Lost to Follow-up|2|||
149893533|NCT00437021|540741448|FG006|Overall Study|Lost to Follow-up|0|||
149893534|NCT00437021|540741449|FG007|Overall Study|Lost to Follow-up|1|||
149893535|NCT00437021|540741450|FG008|Overall Study|Lost to Follow-up|0|||
149893536|NCT00437021|540741451|FG009|Overall Study|Lost to Follow-up|0|||
149893537|NCT00437021|540741452|FG010|Overall Study|Lost to Follow-up|0|||
149893538|NCT00437021|540741453|FG011|Overall Study|Lost to Follow-up|0|||
149893539|NCT00437021|540741442|FG000|Overall Study|Withdrawal by Subject|2|||
149893540|NCT00437021|540741443|FG001|Overall Study|Withdrawal by Subject|1|||
149893541|NCT00437021|540741444|FG002|Overall Study|Withdrawal by Subject|0|||
149893542|NCT00437021|540741445|FG003|Overall Study|Withdrawal by Subject|0|||
149893543|NCT00437021|540741446|FG004|Overall Study|Withdrawal by Subject|0|||
149893544|NCT00437021|540741447|FG005|Overall Study|Withdrawal by Subject|0|||
149893545|NCT00437021|540741448|FG006|Overall Study|Withdrawal by Subject|0|||
149893546|NCT00437021|540741449|FG007|Overall Study|Withdrawal by Subject|0|||
149893547|NCT00437021|540741450|FG008|Overall Study|Withdrawal by Subject|0|||
149893548|NCT00437021|540741451|FG009|Overall Study|Withdrawal by Subject|0|||
149893549|NCT00437021|540741452|FG010|Overall Study|Withdrawal by Subject|0|||
149893550|NCT00437021|540741453|FG011|Overall Study|Withdrawal by Subject|0|||
149893551|NCT01880554|540741454|FG000|Overall Study|Protocol Violation|14|||
149893552|NCT01880554|540741454|FG000|Overall Study|Simon's design requirements|2|||
149893553|NCT05161481|540741455|FG000|Overall Study|Withdrawal of consent|0|||
149893554|NCT05161481|540741456|FG001|Overall Study|Withdrawal of consent|1|||
149893555|NCT05161481|540741457|FG002|Overall Study|Withdrawal of consent|1|||
149893556|NCT05161481|540741455|FG000|Overall Study|Study terminated by sponsor|3|||
149893557|NCT05161481|540741456|FG001|Overall Study|Study terminated by sponsor|3|||
149893558|NCT05161481|540741457|FG002|Overall Study|Study terminated by sponsor|2|||
149893559|NCT05161481|540741455|FG000|Overall Study|Adverse Event|3|||
149893560|NCT05161481|540741456|FG001|Overall Study|Adverse Event|0|||
149893561|NCT05161481|540741457|FG002|Overall Study|Adverse Event|6|||
149893562|NCT05161481|540741455|FG000|Overall Study|Randomised in error and was not treated|1|||
149893563|NCT05161481|540741456|FG001|Overall Study|Randomised in error and was not treated|0|||
149893564|NCT05161481|540741457|FG002|Overall Study|Randomised in error and was not treated|0|||
149893565|NCT05161481|540741455|FG000|Overall Study|Subject decision|0|||
149893566|NCT05161481|540741456|FG001|Overall Study|Subject decision|0|||
149893567|NCT05161481|540741457|FG002|Overall Study|Subject decision|1|||
149893568|NCT04632927|540741460|FG000|Overall Study|Adverse Event|0|||
149893569|NCT04632927|540741461|FG001|Overall Study|Adverse Event|1|||
149893570|NCT04632927|540741460|FG000|Overall Study|Lack of Efficacy|0|||
149893571|NCT04632927|540741461|FG001|Overall Study|Lack of Efficacy|4|||
149893572|NCT04632927|540741460|FG000|Overall Study|Loss of efficacy|0|||
149893573|NCT04632927|540741461|FG001|Overall Study|Loss of efficacy|1|||
149893574|NCT04632927|540741460|FG000|Overall Study|Non-compliance with study drug|0|||
149968504|NCT00553254|541021970|FG000|Overall Study|Death|3|||
149968505|NCT00553254|541021971|FG001|Overall Study|Death|6|||
149893575|NCT04632927|540741461|FG001|Overall Study|Non-compliance with study drug|1|||
149893576|NCT04632927|540741460|FG000|Overall Study|Physician Decision|0|||
149893577|NCT04632927|540741461|FG001|Overall Study|Physician Decision|1|||
149893578|NCT04632927|540741460|FG000|Overall Study|Subject decision|0|||
149893579|NCT04632927|540741461|FG001|Overall Study|Subject decision|1|||
149893580|NCT04632927|540741460|FG000|Overall Study|Withdrawal by Subject|0|||
149893581|NCT04632927|540741461|FG001|Overall Study|Withdrawal by Subject|1|||
149893582|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
149893583|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
149893584|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
149893585|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
149893586|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
149893587|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
149893588|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
149893589|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
149893590|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
149893591|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
149893592|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
149893593|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
149893594|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
149893595|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
149893596|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
149893597|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
149893598|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
149893599|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
149893600|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
149893601|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
149893602|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
149893603|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
149893604|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
149893605|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
149893606|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
149893607|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
149893608|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
149893609|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
149893610|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
149893611|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
149893612|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
149893613|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
149893614|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
149893615|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
149893616|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
149893617|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
149893618|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
149893619|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
149893620|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
149893621|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
149893622|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
149893623|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
149893624|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
149893625|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
149893626|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
149893627|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
149893628|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
149893629|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
149893630|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
149893631|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
149893632|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
149893633|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
149893634|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Site closed|0|||
149893635|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Site closed|0|||
149893636|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Site closed|1|||
149893637|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Site closed|0|||
149893638|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
149893639|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
149893640|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
149893641|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
149893642|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
149893643|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
149893644|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
149893645|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
149893646|NCT00838903|540741462|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
149893647|NCT00838903|540741463|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
149893648|NCT00838903|540741464|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
149893649|NCT00838903|540741465|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
149893650|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
149893651|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
149893652|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
149893653|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
149893654|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
149893655|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
149893656|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
149893657|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
149893658|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
149893659|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
149893660|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
149893661|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
149893662|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
149893663|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
149893664|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
149893665|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
149893666|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
149893667|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
149893668|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
149893669|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
149893670|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
149893671|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
149893672|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
149893673|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
149893674|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
149893675|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
149893676|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
149893677|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
149893678|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
149893679|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
149893680|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
149893681|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
149893682|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
149893683|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
149893684|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
149893685|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
149893686|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
149893687|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
149893688|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
149893689|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
149893690|NCT00838903|540741462|FG000|Follow-up Period (8 Weeks)|Missing|1|||
149893691|NCT00838903|540741463|FG001|Follow-up Period (8 Weeks)|Missing|2|||
149893692|NCT00838903|540741464|FG002|Follow-up Period (8 Weeks)|Missing|1|||
149893693|NCT00838903|540741465|FG003|Follow-up Period (8 Weeks)|Missing|1|||
149893694|NCT04225715|540741466|FG000|Overall Study|Reason not Specified|1|||
149893695|NCT04225715|540741467|FG001|Overall Study|Reason not Specified|0|||
149893696|NCT04225715|540741468|FG002|Overall Study|Reason not Specified|0|||
149893697|NCT04225715|540741469|FG003|Overall Study|Reason not Specified|0|||
149893698|NCT04225715|540741470|FG004|Overall Study|Reason not Specified|0|||
149893699|NCT04225715|540741471|FG005|Overall Study|Reason not Specified|0|||
149893700|NCT04225715|540741472|FG006|Overall Study|Reason not Specified|0|||
149893701|NCT04225715|540741473|FG007|Overall Study|Reason not Specified|0|||
149893702|NCT04225715|540741474|FG008|Overall Study|Reason not Specified|0|||
150045211|NCT00479687|541305511|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
150045212|NCT00479687|541305509|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
150045213|NCT00479687|541305510|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
149893703|NCT04225715|540741466|FG000|Overall Study|Protocol Violation|1|||
149893704|NCT04225715|540741467|FG001|Overall Study|Protocol Violation|0|||
149893705|NCT04225715|540741468|FG002|Overall Study|Protocol Violation|0|||
149893706|NCT04225715|540741469|FG003|Overall Study|Protocol Violation|0|||
149893707|NCT04225715|540741470|FG004|Overall Study|Protocol Violation|0|||
149893708|NCT04225715|540741471|FG005|Overall Study|Protocol Violation|9|||
150175899|NCT00658996|541779955|FG001|Crossover Period|Ineligible|1|||
149893709|NCT04225715|540741472|FG006|Overall Study|Protocol Violation|0|||
149893710|NCT04225715|540741473|FG007|Overall Study|Protocol Violation|0|||
149968506|NCT00553254|541021972|FG002|Overall Study|Death|25|||
149968507|NCT00553254|541021970|FG000|Overall Study|Lost to Follow-up|0|||
149968508|NCT00553254|541021971|FG001|Overall Study|Lost to Follow-up|0|||
149968509|NCT00553254|541021972|FG002|Overall Study|Lost to Follow-up|2|||
149968510|NCT00553254|541021970|FG000|Overall Study|Withdrawal by Subject|2|||
149968511|NCT00553254|541021971|FG001|Overall Study|Withdrawal by Subject|0|||
149968512|NCT00553254|541021972|FG002|Overall Study|Withdrawal by Subject|2|||
149968513|NCT00553254|541021970|FG000|Overall Study|Study terminated by Sponsor|0|||
149968514|NCT00553254|541021971|FG001|Overall Study|Study terminated by Sponsor|0|||
149968515|NCT00553254|541021972|FG002|Overall Study|Study terminated by Sponsor|1|||
149968516|NCT00553254|541021970|FG000|Overall Study|Other|1|||
149968517|NCT00553254|541021971|FG001|Overall Study|Other|0|||
149968518|NCT00553254|541021972|FG002|Overall Study|Other|13|||
149968519|NCT02314923|541021975|FG000|Overall Study|Death|0|||
149968520|NCT02314923|541021976|FG001|Overall Study|Death|0|||
149968521|NCT02314923|541021977|FG002|Overall Study|Death|0|||
149968522|NCT02314923|541021978|FG003|Overall Study|Death|1|||
149968523|NCT02314923|541021979|FG004|Overall Study|Death|0|||
149968524|NCT02314923|541021980|FG005|Overall Study|Death|0|||
149968525|NCT02314923|541021981|FG006|Overall Study|Death|0|||
149968526|NCT02314923|541021982|FG007|Overall Study|Death|0|||
149968527|NCT02314923|541021983|FG008|Overall Study|Death|0|||
149968528|NCT02314923|541021984|FG009|Overall Study|Death|0|||
149968529|NCT02314923|541021975|FG000|Overall Study|Lost to Follow-up|2|||
149968530|NCT02314923|541021976|FG001|Overall Study|Lost to Follow-up|3|||
149968531|NCT02314923|541021977|FG002|Overall Study|Lost to Follow-up|1|||
149968532|NCT02314923|541021978|FG003|Overall Study|Lost to Follow-up|0|||
149968533|NCT02314923|541021979|FG004|Overall Study|Lost to Follow-up|0|||
149968534|NCT02314923|541021980|FG005|Overall Study|Lost to Follow-up|0|||
149968535|NCT02314923|541021981|FG006|Overall Study|Lost to Follow-up|3|||
149968536|NCT02314923|541021982|FG007|Overall Study|Lost to Follow-up|4|||
149968537|NCT02314923|541021983|FG008|Overall Study|Lost to Follow-up|2|||
149968538|NCT02314923|541021984|FG009|Overall Study|Lost to Follow-up|0|||
149968539|NCT02314923|541021975|FG000|Overall Study|Withdrawal by Subject|0|||
149968540|NCT02314923|541021976|FG001|Overall Study|Withdrawal by Subject|0|||
149968541|NCT02314923|541021977|FG002|Overall Study|Withdrawal by Subject|1|||
149968542|NCT02314923|541021978|FG003|Overall Study|Withdrawal by Subject|0|||
149968543|NCT02314923|541021979|FG004|Overall Study|Withdrawal by Subject|1|||
149968544|NCT02314923|541021980|FG005|Overall Study|Withdrawal by Subject|0|||
149968545|NCT02314923|541021981|FG006|Overall Study|Withdrawal by Subject|1|||
149968546|NCT02314923|541021982|FG007|Overall Study|Withdrawal by Subject|0|||
149968547|NCT02314923|541021983|FG008|Overall Study|Withdrawal by Subject|0|||
149968548|NCT02314923|541021984|FG009|Overall Study|Withdrawal by Subject|0|||
149968549|NCT02314923|541021975|FG000|Overall Study|Physician Decision|0|||
150175900|NCT00658996|541779954|FG000|Second Intervention|Developed a stye on upper lid|1|||
150175901|NCT00658996|541779955|FG001|Second Intervention|Developed a stye on upper lid|0|||
150175902|NCT00658996|541779954|FG000|Second Intervention|Positive slit lamp finding|0|||
150175903|NCT00658996|541779955|FG001|Second Intervention|Positive slit lamp finding|1|||
150175904|NCT02994654|541779956|FG000|Overall Study|Lost to Follow-up|1|||
150175905|NCT03603717|541779961|FG000|Overall Study|Lost to Follow-up|20|||
150175906|NCT03603717|541779962|FG001|Overall Study|Lost to Follow-up|20|||
150175907|NCT03603717|541779961|FG000|Overall Study|Withdrawal by Subject|16|||
150175908|NCT03603717|541779962|FG001|Overall Study|Withdrawal by Subject|10|||
150175909|NCT00732381|541779963|FG000|Overall Study|Adverse Event|1|||
150175910|NCT00732381|541779964|FG001|Overall Study|Adverse Event|0|||
150175911|NCT00732381|541779963|FG000|Overall Study|Treatment Failure|1|||
150175912|NCT00732381|541779964|FG001|Overall Study|Treatment Failure|1|||
150175913|NCT00457691|541779965|FG000|Overall Study|Adverse Event|4|||
150175914|NCT00457691|541779966|FG001|Overall Study|Adverse Event|1|||
150175915|NCT00457691|541779965|FG000|Overall Study|Death|163|||
150175916|NCT00457691|541779966|FG001|Overall Study|Death|148|||
150175917|NCT00457691|541779965|FG000|Overall Study|Protocol Violation|1|||
150175918|NCT00457691|541779966|FG001|Overall Study|Protocol Violation|3|||
150175919|NCT00457691|541779965|FG000|Overall Study|Lost to Follow-up|23|||
150175920|NCT00457691|541779966|FG001|Overall Study|Lost to Follow-up|14|||
149893711|NCT04225715|540741474|FG008|Overall Study|Protocol Violation|0|||
149893712|NCT04225715|540741466|FG000|Overall Study|Withdrawal by Subject|4|||
149893713|NCT04225715|540741467|FG001|Overall Study|Withdrawal by Subject|1|||
149893714|NCT04225715|540741468|FG002|Overall Study|Withdrawal by Subject|1|||
149893715|NCT04225715|540741469|FG003|Overall Study|Withdrawal by Subject|0|||
149893716|NCT04225715|540741470|FG004|Overall Study|Withdrawal by Subject|3|||
149893717|NCT04225715|540741471|FG005|Overall Study|Withdrawal by Subject|1|||
149893718|NCT04225715|540741472|FG006|Overall Study|Withdrawal by Subject|1|||
149893719|NCT04225715|540741473|FG007|Overall Study|Withdrawal by Subject|1|||
149893720|NCT04225715|540741474|FG008|Overall Study|Withdrawal by Subject|0|||
149893721|NCT04225715|540741466|FG000|Overall Study|Adverse Event|0|||
149893722|NCT04225715|540741467|FG001|Overall Study|Adverse Event|0|||
149893723|NCT04225715|540741468|FG002|Overall Study|Adverse Event|0|||
149893724|NCT04225715|540741469|FG003|Overall Study|Adverse Event|0|||
149893725|NCT04225715|540741470|FG004|Overall Study|Adverse Event|0|||
149893726|NCT04225715|540741471|FG005|Overall Study|Adverse Event|0|||
149893727|NCT04225715|540741472|FG006|Overall Study|Adverse Event|0|||
149893728|NCT04225715|540741473|FG007|Overall Study|Adverse Event|0|||
149893729|NCT04225715|540741474|FG008|Overall Study|Adverse Event|1|||
149893730|NCT04225715|540741466|FG000|Overall Study|Arm Terminated By Sponsor|0|||
149893731|NCT04225715|540741467|FG001|Overall Study|Arm Terminated By Sponsor|0|||
149893732|NCT04225715|540741468|FG002|Overall Study|Arm Terminated By Sponsor|0|||
149893733|NCT04225715|540741469|FG003|Overall Study|Arm Terminated By Sponsor|0|||
149893734|NCT04225715|540741470|FG004|Overall Study|Arm Terminated By Sponsor|0|||
149893735|NCT04225715|540741471|FG005|Overall Study|Arm Terminated By Sponsor|0|||
149893736|NCT04225715|540741472|FG006|Overall Study|Arm Terminated By Sponsor|0|||
149893737|NCT04225715|540741473|FG007|Overall Study|Arm Terminated By Sponsor|17|||
149893738|NCT04225715|540741474|FG008|Overall Study|Arm Terminated By Sponsor|18|||
149893739|NCT00683618|540741477|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
149893740|NCT00683618|540741478|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
149893741|NCT00683618|540741479|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
149893742|NCT00683618|540741477|FG000|Randomised Treatment Period|Protocol Violation|0|||
149893743|NCT00683618|540741478|FG001|Randomised Treatment Period|Protocol Violation|1|||
149893744|NCT00683618|540741479|FG002|Randomised Treatment Period|Protocol Violation|0|||
149893745|NCT00683618|540741477|FG000|Randomised Treatment Period|Adverse Event|2|||
149893746|NCT00683618|540741478|FG001|Randomised Treatment Period|Adverse Event|0|||
149893747|NCT00683618|540741479|FG002|Randomised Treatment Period|Adverse Event|2|||
150175921|NCT00457691|541779965|FG000|Overall Study|Study terminated by Sponsor|1|||
150175922|NCT00457691|541779966|FG001|Overall Study|Study terminated by Sponsor|1|||
150175923|NCT00457691|541779965|FG000|Overall Study|Subject refused (reason other than AE)|14|||
150175924|NCT00457691|541779966|FG001|Overall Study|Subject refused (reason other than AE)|19|||
150175925|NCT00457691|541779965|FG000|Overall Study|Disease progression, study terminated|180|||
150175926|NCT00457691|541779966|FG001|Overall Study|Disease progression, study terminated|196|||
150175927|NCT03073941|541781861|FG000|Overall Study|Received non-study device intraoperatively|0|||
149893748|NCT00683618|540741477|FG000|Randomised Treatment Period|Reason not provided|0|||
149893749|NCT00683618|540741478|FG001|Randomised Treatment Period|Reason not provided|0|||
149893750|NCT00683618|540741479|FG002|Randomised Treatment Period|Reason not provided|2|||
149893751|NCT00683618|540741477|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
149893752|NCT00683618|540741478|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
149893753|NCT00683618|540741479|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
149893754|NCT00683618|540741477|FG000|Extension Treatment Period|Adverse Event|1|||
149893755|NCT00683618|540741478|FG001|Extension Treatment Period|Adverse Event|0|||
149893756|NCT00683618|540741479|FG002|Extension Treatment Period|Adverse Event|0|||
149893757|NCT00683618|540741477|FG000|Extension Treatment Period|Protocol Violation|1|||
149893758|NCT00683618|540741478|FG001|Extension Treatment Period|Protocol Violation|0|||
149893759|NCT00683618|540741479|FG002|Extension Treatment Period|Protocol Violation|0|||
149893760|NCT01002989|540741480|FG000|Overall Study|exclusion criteria, no consent|5|||
149893761|NCT01611935|540741485|FG000|Overall Study|Family Declined Participation|1|||
149893762|NCT01611935|540741486|FG001|Overall Study|Family Declined Participation|0|||
149893763|NCT05177484|540741493|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
149893764|NCT05177484|540741494|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
149893765|NCT05177484|540741493|FG000|Overall Study|Inadvertently withdrawn|3|||
149893766|NCT05177484|540741494|FG001|Overall Study|Inadvertently withdrawn|1|||
150045214|NCT00479687|541305511|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
150045215|NCT00479687|541305509|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
150045216|NCT00479687|541305510|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
150045217|NCT00479687|541305511|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
149893767|NCT05177484|540741493|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
149893768|NCT05177484|540741494|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
149893769|NCT02549859|540741495|FG000|Long-term 60 Hz DBS|Study Closed|1|||
149893770|NCT00729612|540741496|FG000|Overall Study|Non evaluable for response|10|||
149893771|NCT04878432|540741499|FG000|Overall Study|Adverse Event|1|||
149893772|NCT04878432|540741499|FG000|Overall Study|Death|2|||
149893773|NCT04878432|540741499|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149893774|NCT04878432|540741499|FG000|Overall Study|Withdrawal by Subject|6|||
149893775|NCT04878432|540741499|FG000|Overall Study|Progressive Disease|7|||
149893776|NCT04878432|540741499|FG000|Overall Study|New Therapy for Study Indication|7|||
149893777|NCT04878432|540741499|FG000|Overall Study|Physician Decision|11|||
149893778|NCT03971071|540741500|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
149893779|NCT03971071|540741501|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
149893780|NCT03971071|540741502|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
149893781|NCT03971071|540741503|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
150045218|NCT00479687|541305509|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
150045219|NCT00479687|541305510|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
150045220|NCT00479687|541305511|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
150045221|NCT00479687|541305509|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
150045222|NCT00479687|541305510|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
150045223|NCT00479687|541305511|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
150045224|NCT00479687|541305509|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
150045225|NCT00479687|541305510|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
150045226|NCT00479687|541305511|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
150045227|NCT00479687|541305509|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
150045228|NCT00479687|541305510|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
150045229|NCT00479687|541305511|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
150045230|NCT00479687|541305509|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
150045231|NCT00479687|541305510|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
150045232|NCT00479687|541305511|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
149893782|NCT03971071|540741504|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
149893783|NCT03971071|540741500|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
149893784|NCT03971071|540741501|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
149893785|NCT03971071|540741502|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
149893786|NCT03971071|540741503|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149893787|NCT03971071|540741504|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149893788|NCT03971071|540741500|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
149893789|NCT03971071|540741501|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
149893790|NCT03971071|540741502|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
149893791|NCT03971071|540741503|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
149893792|NCT03971071|540741504|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
149893793|NCT03971071|540741500|FG000|Open-label Treatment Period|Sponsor decision|0|||
149893794|NCT03971071|540741501|FG001|Open-label Treatment Period|Sponsor decision|0|||
149893795|NCT03971071|540741502|FG002|Open-label Treatment Period|Sponsor decision|0|||
149893796|NCT03971071|540741503|FG003|Open-label Treatment Period|Sponsor decision|0|||
149893797|NCT03971071|540741504|FG004|Open-label Treatment Period|Sponsor decision|1|||
149893798|NCT03971071|540741500|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
149893799|NCT03971071|540741501|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
149893800|NCT03971071|540741502|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
150045233|NCT00479687|541305509|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
150045234|NCT00479687|541305510|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
150045235|NCT00479687|541305511|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
150045236|NCT02565784|541305512|FG000|First Treatment|Adverse Event|1|||
150045237|NCT02565784|541305512|FG000|First Treatment|Withdrawal by Subject|1|||
150045238|NCT02565784|541305512|FG000|Second Treatment|Withdrawal by Subject|2|||
149893801|NCT03971071|540741503|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
149893802|NCT03971071|540741504|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
149893803|NCT03971071|540741500|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
149893804|NCT03971071|540741501|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
149893805|NCT03971071|540741502|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
149893806|NCT03971071|540741503|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
149893807|NCT03971071|540741504|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
149893808|NCT03922321|540741505|FG000|Overall Study|Participant Moved|1|||
149893809|NCT03922321|540741505|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
150045239|NCT03180840|541305513|FG000|Overall Study|Withdrawal by Subject|1|||
150175928|NCT03073941|541781862|FG001|Overall Study|Received non-study device intraoperatively|2|||
149893810|NCT00495391|540741506|FG000|Overall Study|Lack of Efficacy|34|||
149893811|NCT00495391|540741507|FG001|Overall Study|Lack of Efficacy|18|||
149893812|NCT00495391|540741506|FG000|Overall Study|Withdrawal by Subject|2|||
149893813|NCT00495391|540741507|FG001|Overall Study|Withdrawal by Subject|3|||
149893814|NCT02712320|540741508|FG000|Overall Study|Lost to Follow-up|1|||
149893815|NCT02712320|540741508|FG000|Overall Study|Withdrawal by Subject|1|||
149893816|NCT02712320|540741508|FG000|Overall Study|Transferred to another facility|1|||
149893817|NCT02712320|540741508|FG000|Overall Study|Treating with the prohibited medications|2|||
149893818|NCT01620138|540741509|FG000|Overall Study|Withdrawal by Subject|3|||
149893819|NCT01620138|540741510|FG001|Overall Study|Withdrawal by Subject|0|||
149893820|NCT01620138|540741509|FG000|Overall Study|Lack of Efficacy|1|||
149893821|NCT01620138|540741510|FG001|Overall Study|Lack of Efficacy|0|||
149893822|NCT01620138|540741509|FG000|Overall Study|Adverse Event|2|||
149893823|NCT01620138|540741510|FG001|Overall Study|Adverse Event|0|||
149893824|NCT00444535|540741511|FG000|Overall Study|Withdrawal by Subject|5|||
149893825|NCT00444535|540741511|FG000|Overall Study|Physician Decision|5|||
149893826|NCT00444535|540741511|FG000|Overall Study|progressive disease|1|||
149893827|NCT00444535|540741511|FG000|Overall Study|Adverse Event|2|||
149893828|NCT01697748|540741516|FG000|Overall Study|ineligible skin incision|1|||
149893829|NCT01697748|540741517|FG001|Overall Study|ineligible skin incision|2|||
149893830|NCT01697748|540741516|FG000|Overall Study|ineligible uterine incision|4|||
149893831|NCT01697748|540741517|FG001|Overall Study|ineligible uterine incision|1|||
149893832|NCT01697748|540741516|FG000|Overall Study|Lost to Follow-up|53|||
149893833|NCT01697748|540741517|FG001|Overall Study|Lost to Follow-up|65|||
149893834|NCT01704495|540741519|FG000|Subjects Randomized|Other Reason|3|||
149893835|NCT01704495|540741520|FG001|Subjects Randomized|Other Reason|2|||
149893836|NCT01704495|540741521|FG002|Subjects Randomized|Other Reason|3|||
149893837|NCT01704495|540741522|FG003|Subjects Randomized|Other Reason|2|||
149893838|NCT01704495|540741519|FG000|Subjects Randomized|Discontinuation criteria met|4|||
149893839|NCT01704495|540741520|FG001|Subjects Randomized|Discontinuation criteria met|2|||
150045240|NCT01675544|541305520|FG000|Overall Study|Withdrawal by Subject|2|||
150045241|NCT03126344|541305531|FG000|Overall Study|Lost to Follow-up|0|||
150045242|NCT03126344|541305532|FG001|Overall Study|Lost to Follow-up|0|||
150045243|NCT03126344|541305533|FG002|Overall Study|Lost to Follow-up|5|||
150045244|NCT01715857|541305534|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
150045245|NCT01027273|541305536|FG000|Overall Study|Lost to Follow-up|57|||
150045246|NCT01027273|541305537|FG001|Overall Study|Lost to Follow-up|31|||
150045247|NCT01027273|541305536|FG000|Overall Study|Death|2|||
150045248|NCT01027273|541305537|FG001|Overall Study|Death|2|||
150045249|NCT02563067|541305539|FG000|Overall Study|Subject/guardian decision|14|||
150045250|NCT02563067|541305540|FG001|Overall Study|Subject/guardian decision|20|||
150045251|NCT02563067|541305541|FG002|Overall Study|Subject/guardian decision|16|||
150045252|NCT02563067|541305539|FG000|Overall Study|Physician Decision|0|||
150045253|NCT02563067|541305540|FG001|Overall Study|Physician Decision|1|||
150045254|NCT02563067|541305541|FG002|Overall Study|Physician Decision|3|||
150045255|NCT02563067|541305539|FG000|Overall Study|Lost to Follow-up|1|||
149893840|NCT01704495|540741521|FG002|Subjects Randomized|Discontinuation criteria met|2|||
149893841|NCT01704495|540741522|FG003|Subjects Randomized|Discontinuation criteria met|0|||
149893842|NCT01704495|540741519|FG000|Subjects Randomized|Adverse Event|8|||
149893843|NCT01704495|540741520|FG001|Subjects Randomized|Adverse Event|2|||
149893844|NCT01704495|540741521|FG002|Subjects Randomized|Adverse Event|0|||
149893845|NCT01704495|540741522|FG003|Subjects Randomized|Adverse Event|7|||
150045256|NCT02563067|541305540|FG001|Overall Study|Lost to Follow-up|2|||
150045257|NCT02563067|541305541|FG002|Overall Study|Lost to Follow-up|0|||
150045258|NCT02563067|541305539|FG000|Overall Study|Technical problems|0|||
150045259|NCT02563067|541305540|FG001|Overall Study|Technical problems|1|||
150045260|NCT02563067|541305541|FG002|Overall Study|Technical problems|0|||
150045261|NCT02563067|541305539|FG000|Overall Study|Lack of Efficacy|1|||
150175929|NCT03073941|541781861|FG000|Overall Study|Death|1|||
149893846|NCT01704495|540741519|FG000|Subjects Randomized|Withdrawal by Subject|5|||
149893847|NCT01704495|540741520|FG001|Subjects Randomized|Withdrawal by Subject|5|||
150045262|NCT02563067|541305540|FG001|Overall Study|Lack of Efficacy|0|||
150045263|NCT02563067|541305541|FG002|Overall Study|Lack of Efficacy|0|||
150045264|NCT02563067|541305539|FG000|Overall Study|Death|0|||
150045265|NCT02563067|541305540|FG001|Overall Study|Death|1|||
150045266|NCT02563067|541305541|FG002|Overall Study|Death|1|||
150045267|NCT02563067|541305539|FG000|Overall Study|Adverse Event|2|||
150045268|NCT02563067|541305540|FG001|Overall Study|Adverse Event|1|||
150045269|NCT02563067|541305541|FG002|Overall Study|Adverse Event|0|||
150045270|NCT02563067|541305539|FG000|Overall Study|Death post Treatment/safety period|1|||
150045271|NCT02563067|541305540|FG001|Overall Study|Death post Treatment/safety period|0|||
149893848|NCT01704495|540741521|FG002|Subjects Randomized|Withdrawal by Subject|5|||
149893849|NCT01704495|540741522|FG003|Subjects Randomized|Withdrawal by Subject|5|||
149893850|NCT01704495|540741519|FG000|Subjects Randomized|Protocol Violation|1|||
149893851|NCT01704495|540741520|FG001|Subjects Randomized|Protocol Violation|1|||
149893852|NCT01704495|540741521|FG002|Subjects Randomized|Protocol Violation|2|||
149893853|NCT01704495|540741522|FG003|Subjects Randomized|Protocol Violation|0|||
150045272|NCT02563067|541305541|FG002|Overall Study|Death post Treatment/safety period|0|||
150045273|NCT01039519|541305551|FG000|Treatment|Progressive disease|20|||
150045274|NCT01039519|541305551|FG000|Treatment|Treatment failure|2|||
149893854|NCT01704495|540741519|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
149893855|NCT01704495|540741520|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
149893856|NCT01704495|540741521|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
149893857|NCT01704495|540741522|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
149893858|NCT01704495|540741519|FG000|Optional Safety Extension|Adverse Event|0|||
149893859|NCT01704495|540741520|FG001|Optional Safety Extension|Adverse Event|4|||
149893860|NCT01704495|540741521|FG002|Optional Safety Extension|Adverse Event|0|||
149893861|NCT01704495|540741522|FG003|Optional Safety Extension|Adverse Event|1|||
149893862|NCT01704495|540741519|FG000|Optional Safety Extension|Other reason|27|||
149893863|NCT01704495|540741520|FG001|Optional Safety Extension|Other reason|29|||
149893864|NCT01704495|540741521|FG002|Optional Safety Extension|Other reason|30|||
149893865|NCT01704495|540741522|FG003|Optional Safety Extension|Other reason|28|||
149893866|NCT01704495|540741519|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
149893867|NCT01704495|540741520|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
149893868|NCT01704495|540741521|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
149893869|NCT01704495|540741522|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
149893870|NCT00832455|540741523|FG000|Overall Study|Adverse Event|13|||
149893871|NCT00832455|540741523|FG000|Overall Study|Lost to Follow-up|26|||
149893872|NCT00832455|540741523|FG000|Overall Study|Protocol Violation|4|||
149893873|NCT00832455|540741523|FG000|Overall Study|Withdrawal by Subject|17|||
149893874|NCT00832455|540741523|FG000|Overall Study|Screening Failure|2|||
149893875|NCT00832455|540741523|FG000|Overall Study|Stopped Medication|4|||
149893876|NCT00832455|540741523|FG000|Overall Study|Parent misunderstood study|1|||
149893877|NCT00832455|540741523|FG000|Overall Study|Parent dissatisfied|1|||
149893878|NCT00832455|540741523|FG000|Overall Study|No improvement|3|||
149893879|NCT00832455|540741523|FG000|Overall Study|Patient moved|1|||
149893880|NCT02172664|540741532|FG000|Overall Study|Lost to Follow-up|4|||
149893881|NCT02172664|540741533|FG001|Overall Study|Lost to Follow-up|4|||
149893882|NCT02172664|540741532|FG000|Overall Study|Death|1|||
149893883|NCT02172664|540741533|FG001|Overall Study|Death|1|||
149893884|NCT02172664|540741532|FG000|Overall Study|Moved out of area|1|||
149893885|NCT02172664|540741533|FG001|Overall Study|Moved out of area|1|||
149893886|NCT02946463|540741534|FG000|Primary Evaluation Period|Physician Decision|0|||
149893887|NCT02946463|540741535|FG001|Primary Evaluation Period|Physician Decision|1|||
149893888|NCT02946463|540741536|FG002|Primary Evaluation Period|Physician Decision|0|||
149893889|NCT02946463|540741537|FG003|Primary Evaluation Period|Physician Decision|0|||
149893890|NCT02946463|540741534|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
149893891|NCT02946463|540741535|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
149893892|NCT02946463|540741536|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
149893893|NCT02946463|540741537|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
149893894|NCT02946463|540741534|FG000|Extension Period|Death|4|||
149893895|NCT02946463|540741535|FG001|Extension Period|Death|4|||
149893896|NCT02946463|540741536|FG002|Extension Period|Death|0|||
149893897|NCT02946463|540741537|FG003|Extension Period|Death|0|||
149893898|NCT02946463|540741534|FG000|Extension Period|Withdrawal by Subject|4|||
149893899|NCT02946463|540741535|FG001|Extension Period|Withdrawal by Subject|3|||
149893900|NCT02946463|540741536|FG002|Extension Period|Withdrawal by Subject|0|||
149893901|NCT02946463|540741537|FG003|Extension Period|Withdrawal by Subject|0|||
149893902|NCT02946463|540741534|FG000|Extension Period|Other than specified|2|||
149893903|NCT02946463|540741535|FG001|Extension Period|Other than specified|3|||
149893904|NCT02946463|540741536|FG002|Extension Period|Other than specified|2|||
149893905|NCT02946463|540741537|FG003|Extension Period|Other than specified|0|||
149893906|NCT02946463|540741534|FG000|Extension Period|Physician Decision|1|||
149893907|NCT02946463|540741535|FG001|Extension Period|Physician Decision|4|||
150045275|NCT01039519|541305551|FG000|Treatment|Adverse Event|3|||
149893908|NCT02946463|540741536|FG002|Extension Period|Physician Decision|0|||
149893909|NCT02946463|540741537|FG003|Extension Period|Physician Decision|0|||
149893910|NCT02946463|540741534|FG000|Extension Period|Pregnancy|3|||
149893911|NCT02946463|540741535|FG001|Extension Period|Pregnancy|1|||
149893912|NCT02946463|540741536|FG002|Extension Period|Pregnancy|0|||
149893913|NCT02946463|540741537|FG003|Extension Period|Pregnancy|0|||
149893914|NCT02946463|540741534|FG000|Extension Period|Adverse Event|1|||
150045276|NCT01039519|541305551|FG000|Treatment|Physician Decision|2|||
150045277|NCT01039519|541305551|FG000|Survival Follow-up|Death|23|||
149893915|NCT02946463|540741535|FG001|Extension Period|Adverse Event|2|||
149893916|NCT02946463|540741536|FG002|Extension Period|Adverse Event|0|||
149893917|NCT02946463|540741537|FG003|Extension Period|Adverse Event|0|||
149893918|NCT02946463|540741534|FG000|Extension Period|Lost to Follow-up|1|||
149893919|NCT02946463|540741535|FG001|Extension Period|Lost to Follow-up|0|||
149893920|NCT02946463|540741536|FG002|Extension Period|Lost to Follow-up|0|||
149893921|NCT02946463|540741537|FG003|Extension Period|Lost to Follow-up|0|||
149893922|NCT05581641|540741538|FG000|Overall Study|Withdrawal by Subject|0|||
149893923|NCT05581641|540741539|FG001|Overall Study|Withdrawal by Subject|1|||
149893924|NCT05581641|540741540|FG002|Overall Study|Withdrawal by Subject|3|||
149968550|NCT02314923|541021976|FG001|Overall Study|Physician Decision|1|||
150175930|NCT03073941|541781862|FG001|Overall Study|Death|0|||
150175931|NCT03073941|541781861|FG000|Overall Study|Withdrawal by Subject|1|||
150175932|NCT03073941|541781862|FG001|Overall Study|Withdrawal by Subject|3|||
150175933|NCT03073941|541781861|FG000|Overall Study|Lost to Follow-up|5|||
150175934|NCT03073941|541781862|FG001|Overall Study|Lost to Follow-up|4|||
150175935|NCT03073941|541781861|FG000|Overall Study|Adverse Event|4|||
150175936|NCT03073941|541781862|FG001|Overall Study|Adverse Event|2|||
150175937|NCT03073941|541781861|FG000|Overall Study|Met an exclusion criterion|0|||
150175938|NCT03073941|541781862|FG001|Overall Study|Met an exclusion criterion|1|||
150175939|NCT01149369|541781863|FG000|Overall Study|Adverse Event|6|||
150175940|NCT01149369|541781864|FG001|Overall Study|Adverse Event|3|||
150175941|NCT02616900|541781865|FG000|Overall Study|Lack of Efficacy|7|||
150175942|NCT02616900|541781865|FG000|Overall Study|Lost to Follow-up|2|||
150175943|NCT02616900|541781865|FG000|Overall Study|Protocol Violation|5|||
150175944|NCT02616900|541781865|FG000|Overall Study|Withdrawal by Subject|3|||
150175945|NCT02616900|541781865|FG000|Overall Study|Incomplete data|6|||
150175946|NCT02242487|541781866|FG000|Overall Study|Adverse Event|13|||
150175947|NCT02242487|541781867|FG001|Overall Study|Adverse Event|15|||
150175948|NCT02242487|541781866|FG000|Overall Study|Lack of Efficacy|4|||
150175949|NCT02242487|541781867|FG001|Overall Study|Lack of Efficacy|6|||
150175950|NCT02242487|541781866|FG000|Overall Study|Protocol Violation|2|||
150175951|NCT02242487|541781867|FG001|Overall Study|Protocol Violation|0|||
150175952|NCT02242487|541781866|FG000|Overall Study|Lost to Follow-up|2|||
150175953|NCT02242487|541781867|FG001|Overall Study|Lost to Follow-up|1|||
150175954|NCT02242487|541781866|FG000|Overall Study|Other - Miscellaneous|4|||
150175955|NCT02242487|541781867|FG001|Overall Study|Other - Miscellaneous|6|||
150175956|NCT02242487|541781866|FG000|Overall Study|Withdrawal by Subject|37|||
150175957|NCT02242487|541781867|FG001|Overall Study|Withdrawal by Subject|19|||
149893925|NCT05581641|540741541|FG003|Overall Study|Withdrawal by Subject|1|||
149893926|NCT05581641|540741538|FG000|Overall Study|Lost to Follow-up|0|||
149893927|NCT05581641|540741539|FG001|Overall Study|Lost to Follow-up|1|||
149893928|NCT05581641|540741540|FG002|Overall Study|Lost to Follow-up|0|||
149893929|NCT05581641|540741541|FG003|Overall Study|Lost to Follow-up|1|||
149893930|NCT05581641|540741538|FG000|Overall Study|Protocol Violation|1|||
149893931|NCT05581641|540741539|FG001|Overall Study|Protocol Violation|0|||
149893932|NCT05581641|540741540|FG002|Overall Study|Protocol Violation|0|||
149893933|NCT05581641|540741541|FG003|Overall Study|Protocol Violation|0|||
149893934|NCT05581641|540741538|FG000|Overall Study|Other|1|||
149893935|NCT05581641|540741539|FG001|Overall Study|Other|0|||
149893936|NCT05581641|540741540|FG002|Overall Study|Other|2|||
149893937|NCT05581641|540741541|FG003|Overall Study|Other|1|||
149893938|NCT01924689|540741542|FG000|Overall Study|Death|0|||
149893939|NCT01924689|540741543|FG001|Overall Study|Death|1|||
149893940|NCT01924689|540741544|FG002|Overall Study|Death|0|||
149893941|NCT01924689|540741545|FG003|Overall Study|Death|1|||
149893942|NCT01924689|540741546|FG004|Overall Study|Death|0|||
149893943|NCT01924689|540741547|FG005|Overall Study|Death|0|||
149893944|NCT01924689|540741542|FG000|Overall Study|Disease progression|0|||
149893945|NCT01924689|540741543|FG001|Overall Study|Disease progression|0|||
149893946|NCT01924689|540741544|FG002|Overall Study|Disease progression|2|||
149893947|NCT01924689|540741545|FG003|Overall Study|Disease progression|0|||
149893948|NCT01924689|540741546|FG004|Overall Study|Disease progression|3|||
149893949|NCT01924689|540741547|FG005|Overall Study|Disease progression|2|||
149893950|NCT01924689|540741542|FG000|Overall Study|New therapy or study|3|||
149893951|NCT01924689|540741543|FG001|Overall Study|New therapy or study|2|||
149893952|NCT01924689|540741544|FG002|Overall Study|New therapy or study|1|||
149893953|NCT01924689|540741545|FG003|Overall Study|New therapy or study|4|||
149893954|NCT01924689|540741546|FG004|Overall Study|New therapy or study|2|||
149893955|NCT01924689|540741547|FG005|Overall Study|New therapy or study|0|||
149893956|NCT01924689|540741542|FG000|Overall Study|Withdrawal of consent|0|||
149893957|NCT01924689|540741543|FG001|Overall Study|Withdrawal of consent|0|||
149893958|NCT01924689|540741544|FG002|Overall Study|Withdrawal of consent|1|||
149893959|NCT01924689|540741545|FG003|Overall Study|Withdrawal of consent|1|||
149893960|NCT01924689|540741546|FG004|Overall Study|Withdrawal of consent|0|||
149893961|NCT01924689|540741547|FG005|Overall Study|Withdrawal of consent|0|||
149893962|NCT01924689|540741542|FG000|Overall Study|Other|0|||
149893963|NCT01924689|540741543|FG001|Overall Study|Other|0|||
149893964|NCT01924689|540741544|FG002|Overall Study|Other|0|||
149893965|NCT01924689|540741545|FG003|Overall Study|Other|0|||
149893966|NCT01924689|540741546|FG004|Overall Study|Other|1|||
149893967|NCT01924689|540741547|FG005|Overall Study|Other|0|||
149893968|NCT00468819|540741548|FG000|Overall Study|Withdrawal by Subject|4|||
149893969|NCT00468819|540741549|FG001|Overall Study|Withdrawal by Subject|0|||
149893970|NCT00468819|540741550|FG002|Overall Study|Withdrawal by Subject|1|||
149893971|NCT00468819|540741548|FG000|Overall Study|Lost to Follow-up|0|||
149893972|NCT00468819|540741549|FG001|Overall Study|Lost to Follow-up|0|||
149893973|NCT00468819|540741550|FG002|Overall Study|Lost to Follow-up|1|||
149893974|NCT00468819|540741548|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
149893975|NCT00468819|540741549|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
149893976|NCT00468819|540741550|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
149893977|NCT02492867|540741551|FG000|Overall Study|Alternate therapy|1|||
149893978|NCT02492867|540741551|FG000|Overall Study|Withdrawal by Subject|2|||
149893979|NCT02492867|540741551|FG000|Overall Study|Disease progression after treatment started|1|||
149893980|NCT02492867|540741551|FG000|Overall Study|Death|1|||
149893981|NCT03296527|540741554|FG000|Overall Study|Adverse Event|15|||
149893982|NCT03296527|540741555|FG001|Overall Study|Adverse Event|33|||
149893983|NCT03296527|540741554|FG000|Overall Study|Protocol Deviation|4|||
149893984|NCT03296527|540741555|FG001|Overall Study|Protocol Deviation|0|||
149893985|NCT03296527|540741554|FG000|Overall Study|Participant withdrew consent|3|||
149893986|NCT03296527|540741555|FG001|Overall Study|Participant withdrew consent|1|||
149893987|NCT03296527|540741554|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
149893988|NCT03296527|540741555|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
149893989|NCT03296527|540741554|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
149893990|NCT03296527|540741555|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
149893991|NCT03296527|540741554|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
149893992|NCT03296527|540741555|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
149893993|NCT03296527|540741554|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
149893994|NCT03296527|540741555|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
149893995|NCT03296527|540741554|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
149893996|NCT03296527|540741555|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
149893997|NCT01597973|540741556|FG000|Overall Study|Found ineligible before study medication started|4|||
149893998|NCT01597973|540741557|FG001|Overall Study|Found ineligible before study medication started|2|||
149893999|NCT01597973|540741556|FG000|Overall Study|Eligible pathogen not confirmed|14|||
149894000|NCT01597973|540741557|FG001|Overall Study|Eligible pathogen not confirmed|15|||
149894001|NCT01597973|540741556|FG000|Overall Study|LAR not authorized to consent|0|||
149894002|NCT01597973|540741557|FG001|Overall Study|LAR not authorized to consent|1|||
149894003|NCT01597973|540741556|FG000|Overall Study|Ineligible due to early seizures|1|||
149894004|NCT01597973|540741557|FG001|Overall Study|Ineligible due to early seizures|0|||
149894005|NCT01597973|540741556|FG000|Overall Study|Ineligible due to non-target infection|1|||
149894006|NCT01597973|540741557|FG001|Overall Study|Ineligible due to non-target infection|1|||
149894007|NCT00122382|540741560|FG000|Double-Blind Study|Adverse Event|9|||
149894008|NCT00122382|540741561|FG001|Double-Blind Study|Adverse Event|11|||
149894009|NCT00122382|540741562|FG002|Double-Blind Study|Adverse Event|0|||
149894010|NCT00122382|540741560|FG000|Double-Blind Study|Death|2|||
149894011|NCT00122382|540741561|FG001|Double-Blind Study|Death|2|||
149968551|NCT02314923|541021977|FG002|Overall Study|Physician Decision|0|||
149968552|NCT02314923|541021978|FG003|Overall Study|Physician Decision|0|||
149968553|NCT02314923|541021979|FG004|Overall Study|Physician Decision|0|||
149968554|NCT02314923|541021980|FG005|Overall Study|Physician Decision|0|||
149968555|NCT02314923|541021981|FG006|Overall Study|Physician Decision|0|||
149968556|NCT02314923|541021982|FG007|Overall Study|Physician Decision|0|||
149968557|NCT02314923|541021983|FG008|Overall Study|Physician Decision|0|||
149894012|NCT00122382|540741562|FG002|Double-Blind Study|Death|0|||
149894013|NCT00122382|540741560|FG000|Double-Blind Study|Lack of Efficacy|0|||
149894014|NCT00122382|540741561|FG001|Double-Blind Study|Lack of Efficacy|8|||
149894015|NCT00122382|540741562|FG002|Double-Blind Study|Lack of Efficacy|0|||
149894016|NCT00122382|540741560|FG000|Double-Blind Study|Lost to Follow-up|2|||
149894017|NCT00122382|540741561|FG001|Double-Blind Study|Lost to Follow-up|1|||
149968558|NCT02314923|541021984|FG009|Overall Study|Physician Decision|0|||
149894018|NCT00122382|540741562|FG002|Double-Blind Study|Lost to Follow-up|0|||
149894019|NCT00122382|540741560|FG000|Double-Blind Study|Pregnancy|2|||
149894020|NCT00122382|540741561|FG001|Double-Blind Study|Pregnancy|0|||
149894021|NCT00122382|540741562|FG002|Double-Blind Study|Pregnancy|0|||
149894022|NCT00122382|540741560|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
149894023|NCT00122382|540741561|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
149894024|NCT00122382|540741562|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
149894025|NCT00122382|540741560|FG000|Double-Blind Study|Withdrawal of Consent|7|||
149894026|NCT00122382|540741561|FG001|Double-Blind Study|Withdrawal of Consent|3|||
149894027|NCT00122382|540741562|FG002|Double-Blind Study|Withdrawal of Consent|0|||
149894028|NCT00122382|540741560|FG000|Double-Blind Study|Protocol Violation|1|||
149894029|NCT00122382|540741561|FG001|Double-Blind Study|Protocol Violation|0|||
149894030|NCT00122382|540741562|FG002|Double-Blind Study|Protocol Violation|0|||
149894031|NCT00122382|540741560|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
149894032|NCT00122382|540741561|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
149894033|NCT00122382|540741562|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
149894034|NCT00122382|540741560|FG000|Double-Blind Study|Randomized but not treated|0|||
149968559|NCT02314923|541021975|FG000|Overall Study|Participant unavailable|0|||
149968560|NCT02314923|541021976|FG001|Overall Study|Participant unavailable|0|||
149968561|NCT02314923|541021977|FG002|Overall Study|Participant unavailable|0|||
149968562|NCT02314923|541021978|FG003|Overall Study|Participant unavailable|0|||
149968563|NCT02314923|541021979|FG004|Overall Study|Participant unavailable|0|||
149968564|NCT02314923|541021980|FG005|Overall Study|Participant unavailable|1|||
149968565|NCT02314923|541021981|FG006|Overall Study|Participant unavailable|0|||
149968566|NCT02314923|541021982|FG007|Overall Study|Participant unavailable|0|||
149968567|NCT02314923|541021983|FG008|Overall Study|Participant unavailable|0|||
149968568|NCT02314923|541021984|FG009|Overall Study|Participant unavailable|0|||
149968569|NCT02314923|541021975|FG000|Overall Study|Screen failure|0|||
150175958|NCT03644849|541781868|FG000|Overall Study|Lost to Follow-up|1|||
150175959|NCT03644849|541781869|FG001|Overall Study|Lost to Follow-up|3|||
150175960|NCT00508924|541781870|FG000|Overall Study|Protocol Violation|0|||
150175961|NCT00508924|541781871|FG001|Overall Study|Protocol Violation|0|||
149968570|NCT02314923|541021976|FG001|Overall Study|Screen failure|0|||
149968571|NCT02314923|541021977|FG002|Overall Study|Screen failure|0|||
149968572|NCT02314923|541021978|FG003|Overall Study|Screen failure|0|||
149968573|NCT02314923|541021979|FG004|Overall Study|Screen failure|0|||
149968574|NCT02314923|541021980|FG005|Overall Study|Screen failure|0|||
150045278|NCT01039519|541305551|FG000|Survival Follow-up|Sponsor decision|4|||
150045279|NCT00808080|541305554|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
150045280|NCT01330108|541305555|FG000|Overall Study|Withdrawal by Subject|4|||
150045281|NCT00423917|541305556|FG000|Overall Study|Cancel|2|||
150045282|NCT00423917|541305556|FG000|Overall Study|Ineligible|1|||
150045283|NCT03052400|541305557|FG000|Overall Study|Lost to Follow-up|1|||
150045284|NCT03052400|541305558|FG001|Overall Study|Lost to Follow-up|0|||
150045285|NCT03052400|541305557|FG000|Overall Study|Withdrawal by Subject|0|||
150045286|NCT03052400|541305558|FG001|Overall Study|Withdrawal by Subject|1|||
150045287|NCT00485134|541305562|FG000|Overall Study|Lost to Follow-up|1|||
150045288|NCT00485134|541305563|FG001|Overall Study|Lost to Follow-up|0|||
150045289|NCT00485134|541305564|FG002|Overall Study|Lost to Follow-up|0|||
150045290|NCT00485134|541305565|FG003|Overall Study|Lost to Follow-up|0|||
150045291|NCT00485134|541305566|FG004|Overall Study|Lost to Follow-up|0|||
150045292|NCT00485134|541305567|FG005|Overall Study|Lost to Follow-up|0|||
150045293|NCT00485134|541305568|FG006|Overall Study|Lost to Follow-up|0|||
150045294|NCT00485134|541305569|FG007|Overall Study|Lost to Follow-up|0|||
150045295|NCT00485134|541305562|FG000|Overall Study|Withdrawal by Subject|0|||
149968575|NCT02314923|541021981|FG006|Overall Study|Screen failure|1|||
149968576|NCT02314923|541021982|FG007|Overall Study|Screen failure|0|||
149968577|NCT02314923|541021983|FG008|Overall Study|Screen failure|0|||
149968578|NCT02314923|541021984|FG009|Overall Study|Screen failure|0|||
150045296|NCT00485134|541305563|FG001|Overall Study|Withdrawal by Subject|1|||
150045297|NCT00485134|541305564|FG002|Overall Study|Withdrawal by Subject|0|||
150045298|NCT00485134|541305565|FG003|Overall Study|Withdrawal by Subject|0|||
150045299|NCT00485134|541305566|FG004|Overall Study|Withdrawal by Subject|0|||
149894035|NCT00122382|540741561|FG001|Double-Blind Study|Randomized but not treated|2|||
149894036|NCT00122382|540741562|FG002|Double-Blind Study|Randomized but not treated|0|||
149894037|NCT00122382|540741560|FG000|Open-Label Study|Adverse Event|0|||
149894038|NCT00122382|540741561|FG001|Open-Label Study|Adverse Event|0|||
149894039|NCT00122382|540741562|FG002|Open-Label Study|Adverse Event|11|||
149894040|NCT00122382|540741560|FG000|Open-Label Study|Death|0|||
149894041|NCT00122382|540741561|FG001|Open-Label Study|Death|0|||
149894042|NCT00122382|540741562|FG002|Open-Label Study|Death|2|||
149894043|NCT00122382|540741560|FG000|Open-Label Study|Lack of Efficacy|0|||
149894044|NCT00122382|540741561|FG001|Open-Label Study|Lack of Efficacy|0|||
149894045|NCT00122382|540741562|FG002|Open-Label Study|Lack of Efficacy|3|||
149894046|NCT00122382|540741560|FG000|Open-Label Study|Lost to Follow-up|0|||
149894047|NCT00122382|540741561|FG001|Open-Label Study|Lost to Follow-up|0|||
149894048|NCT00122382|540741562|FG002|Open-Label Study|Lost to Follow-up|3|||
149894049|NCT00122382|540741560|FG000|Open-Label Study|Pregnancy|0|||
149894050|NCT00122382|540741561|FG001|Open-Label Study|Pregnancy|0|||
149894051|NCT00122382|540741562|FG002|Open-Label Study|Pregnancy|2|||
149894052|NCT00122382|540741560|FG000|Open-Label Study|Poor/Non-Compliance|0|||
149894053|NCT00122382|540741561|FG001|Open-Label Study|Poor/Non-Compliance|0|||
149894054|NCT00122382|540741562|FG002|Open-Label Study|Poor/Non-Compliance|1|||
149894055|NCT00122382|540741560|FG000|Open-Label Study|Withdrawal of Consent|0|||
149894056|NCT00122382|540741561|FG001|Open-Label Study|Withdrawal of Consent|0|||
149894057|NCT00122382|540741562|FG002|Open-Label Study|Withdrawal of Consent|4|||
149894058|NCT00359424|540741565|FG000|Overall Study|Death|99|||
149894059|NCT00359424|540741566|FG001|Overall Study|Death|58|||
149894060|NCT00359424|540741565|FG000|Overall Study|Lost to Follow-up|19|||
149894061|NCT00359424|540741566|FG001|Overall Study|Lost to Follow-up|7|||
149894062|NCT00359424|540741565|FG000|Overall Study|Withdrawal by Subject|10|||
149894063|NCT00359424|540741566|FG001|Overall Study|Withdrawal by Subject|2|||
149894064|NCT00359424|540741565|FG000|Overall Study|follow up not conducted|2|||
149894065|NCT00359424|540741566|FG001|Overall Study|follow up not conducted|0|||
149894066|NCT02462603|540741567|FG000|Overall Study|Investigator Decision|1|||
149894067|NCT02462603|540741567|FG000|Overall Study|Non-Compliance|1|||
149894068|NCT02462603|540741567|FG000|Overall Study|Withdrawal by Subject|2|||
149894069|NCT01591096|540741568|FG000|Overall Study|Adverse Event|1|||
149894070|NCT00848718|540741571|FG000|Overall Study|Adverse Event|2|||
149894071|NCT00848718|540741572|FG001|Overall Study|Adverse Event|2|||
149894072|NCT00848718|540741573|FG002|Overall Study|Adverse Event|1|||
149894073|NCT00848718|540741574|FG003|Overall Study|Adverse Event|1|||
149894074|NCT00848718|540741575|FG004|Overall Study|Adverse Event|1|||
149894075|NCT00848718|540741576|FG005|Overall Study|Adverse Event|0|||
149894076|NCT00848718|540741577|FG006|Overall Study|Adverse Event|0|||
149894077|NCT00848718|540741578|FG007|Overall Study|Adverse Event|1|||
149894078|NCT00848718|540741579|FG008|Overall Study|Adverse Event|1|||
149894079|NCT00848718|540741580|FG009|Overall Study|Adverse Event|0|||
149894080|NCT00848718|540741581|FG010|Overall Study|Adverse Event|0|||
149894081|NCT00848718|540741582|FG011|Overall Study|Adverse Event|0|||
149894082|NCT00848718|540741583|FG012|Overall Study|Adverse Event|2|||
149894083|NCT00848718|540741571|FG000|Overall Study|Lack of Efficacy|0|||
149894084|NCT00848718|540741572|FG001|Overall Study|Lack of Efficacy|0|||
149894085|NCT00848718|540741573|FG002|Overall Study|Lack of Efficacy|1|||
149894086|NCT00848718|540741574|FG003|Overall Study|Lack of Efficacy|0|||
149894087|NCT00848718|540741575|FG004|Overall Study|Lack of Efficacy|0|||
149894088|NCT00848718|540741576|FG005|Overall Study|Lack of Efficacy|0|||
149894089|NCT00848718|540741577|FG006|Overall Study|Lack of Efficacy|1|||
149894090|NCT00848718|540741578|FG007|Overall Study|Lack of Efficacy|0|||
149894091|NCT00848718|540741579|FG008|Overall Study|Lack of Efficacy|0|||
149894092|NCT00848718|540741580|FG009|Overall Study|Lack of Efficacy|0|||
149894093|NCT00848718|540741581|FG010|Overall Study|Lack of Efficacy|0|||
149894094|NCT00848718|540741582|FG011|Overall Study|Lack of Efficacy|0|||
149894095|NCT00848718|540741583|FG012|Overall Study|Lack of Efficacy|0|||
149894096|NCT00848718|540741571|FG000|Overall Study|Physician Decision|0|||
149894097|NCT00848718|540741572|FG001|Overall Study|Physician Decision|1|||
149894098|NCT00848718|540741573|FG002|Overall Study|Physician Decision|0|||
149894099|NCT00848718|540741574|FG003|Overall Study|Physician Decision|0|||
149894100|NCT00848718|540741575|FG004|Overall Study|Physician Decision|1|||
149894101|NCT00848718|540741576|FG005|Overall Study|Physician Decision|1|||
149894102|NCT00848718|540741577|FG006|Overall Study|Physician Decision|0|||
149894103|NCT00848718|540741578|FG007|Overall Study|Physician Decision|0|||
149894104|NCT00848718|540741579|FG008|Overall Study|Physician Decision|1|||
149894105|NCT00848718|540741580|FG009|Overall Study|Physician Decision|2|||
149894106|NCT00848718|540741581|FG010|Overall Study|Physician Decision|0|||
149968579|NCT02314923|541021975|FG000|Overall Study|Participant relocation|1|||
149894107|NCT00848718|540741582|FG011|Overall Study|Physician Decision|0|||
149894108|NCT00848718|540741583|FG012|Overall Study|Physician Decision|1|||
149894109|NCT00848718|540741571|FG000|Overall Study|Progressive disease before treatment|1|||
149894110|NCT00848718|540741572|FG001|Overall Study|Progressive disease before treatment|5|||
149894111|NCT00848718|540741573|FG002|Overall Study|Progressive disease before treatment|1|||
149894112|NCT00848718|540741574|FG003|Overall Study|Progressive disease before treatment|3|||
149894113|NCT00848718|540741575|FG004|Overall Study|Progressive disease before treatment|4|||
149894114|NCT00848718|540741576|FG005|Overall Study|Progressive disease before treatment|4|||
149894115|NCT00848718|540741577|FG006|Overall Study|Progressive disease before treatment|2|||
149894116|NCT00848718|540741578|FG007|Overall Study|Progressive disease before treatment|1|||
149894117|NCT00848718|540741579|FG008|Overall Study|Progressive disease before treatment|2|||
149894118|NCT00848718|540741580|FG009|Overall Study|Progressive disease before treatment|7|||
149894119|NCT00848718|540741581|FG010|Overall Study|Progressive disease before treatment|3|||
149894120|NCT00848718|540741582|FG011|Overall Study|Progressive disease before treatment|6|||
149894121|NCT00848718|540741583|FG012|Overall Study|Progressive disease before treatment|2|||
149894122|NCT00848718|540741571|FG000|Overall Study|Protocol Violation|0|||
149894123|NCT00848718|540741572|FG001|Overall Study|Protocol Violation|1|||
149894124|NCT00848718|540741573|FG002|Overall Study|Protocol Violation|0|||
149894125|NCT00848718|540741574|FG003|Overall Study|Protocol Violation|0|||
149894126|NCT00848718|540741575|FG004|Overall Study|Protocol Violation|0|||
149894127|NCT00848718|540741576|FG005|Overall Study|Protocol Violation|0|||
149894128|NCT00848718|540741577|FG006|Overall Study|Protocol Violation|0|||
149894129|NCT00848718|540741578|FG007|Overall Study|Protocol Violation|1|||
149894130|NCT00848718|540741579|FG008|Overall Study|Protocol Violation|0|||
149894131|NCT00848718|540741580|FG009|Overall Study|Protocol Violation|0|||
149894132|NCT00848718|540741581|FG010|Overall Study|Protocol Violation|0|||
149894133|NCT00848718|540741582|FG011|Overall Study|Protocol Violation|0|||
149894134|NCT00848718|540741583|FG012|Overall Study|Protocol Violation|1|||
149894135|NCT00848718|540741571|FG000|Overall Study|Withdrawal by Subject|1|||
149894136|NCT00848718|540741572|FG001|Overall Study|Withdrawal by Subject|0|||
149894137|NCT00848718|540741573|FG002|Overall Study|Withdrawal by Subject|0|||
149894138|NCT00848718|540741574|FG003|Overall Study|Withdrawal by Subject|1|||
149894139|NCT00848718|540741575|FG004|Overall Study|Withdrawal by Subject|0|||
149894140|NCT00848718|540741576|FG005|Overall Study|Withdrawal by Subject|0|||
149894141|NCT00848718|540741577|FG006|Overall Study|Withdrawal by Subject|0|||
149894142|NCT00848718|540741578|FG007|Overall Study|Withdrawal by Subject|0|||
149894143|NCT00848718|540741579|FG008|Overall Study|Withdrawal by Subject|0|||
149894144|NCT00848718|540741580|FG009|Overall Study|Withdrawal by Subject|0|||
149894145|NCT00848718|540741581|FG010|Overall Study|Withdrawal by Subject|1|||
149894146|NCT00848718|540741582|FG011|Overall Study|Withdrawal by Subject|0|||
149894147|NCT00848718|540741583|FG012|Overall Study|Withdrawal by Subject|0|||
149894148|NCT00848718|540741571|FG000|Overall Study|Progressive disease during treatment|3|||
149894149|NCT00848718|540741572|FG001|Overall Study|Progressive disease during treatment|0|||
149894150|NCT00848718|540741573|FG002|Overall Study|Progressive disease during treatment|3|||
149894151|NCT00848718|540741574|FG003|Overall Study|Progressive disease during treatment|0|||
149894152|NCT00848718|540741575|FG004|Overall Study|Progressive disease during treatment|0|||
149894153|NCT00848718|540741576|FG005|Overall Study|Progressive disease during treatment|0|||
149894154|NCT00848718|540741577|FG006|Overall Study|Progressive disease during treatment|0|||
149894155|NCT00848718|540741578|FG007|Overall Study|Progressive disease during treatment|2|||
149894156|NCT00848718|540741579|FG008|Overall Study|Progressive disease during treatment|0|||
149894157|NCT00848718|540741580|FG009|Overall Study|Progressive disease during treatment|0|||
149894158|NCT00848718|540741581|FG010|Overall Study|Progressive disease during treatment|0|||
149894159|NCT00848718|540741582|FG011|Overall Study|Progressive disease during treatment|0|||
149894160|NCT00848718|540741583|FG012|Overall Study|Progressive disease during treatment|2|||
149894161|NCT02389829|540741584|FG000|Overall Study|Lost to Follow-up|0|||
149894162|NCT02389829|540741585|FG001|Overall Study|Lost to Follow-up|1|||
149894163|NCT00571727|540741586|FG000|Overall Study|Did not enter in this study|1|||
149894164|NCT00571727|540741586|FG000|Overall Study|Non-compliance|4|||
149894165|NCT00571727|540741586|FG000|Overall Study|Lost to Follow-up|30|||
149894166|NCT00571727|540741586|FG000|Overall Study|Poor growth|1|||
149894167|NCT00571727|540741586|FG000|Overall Study|Parent/patient decision|2|||
149894168|NCT00571727|540741586|FG000|Overall Study|Participant transferred to commercial drug|14|||
149894169|NCT00571727|540741586|FG000|Overall Study|Unable to provide study drug|6|||
149894170|NCT00571727|540741586|FG000|Overall Study|On-treatment at end of study|8|||
149894171|NCT03817190|540741587|FG000|Overall Study|Early Termination|13|||
149894172|NCT03817190|540741588|FG001|Overall Study|Early Termination|20|||
149894173|NCT03817190|540741587|FG000|Overall Study|Adverse Event|10|||
149894174|NCT03817190|540741588|FG001|Overall Study|Adverse Event|17|||
149894175|NCT03817190|540741587|FG000|Overall Study|Withdrawal by Subject|12|||
149894176|NCT03817190|540741588|FG001|Overall Study|Withdrawal by Subject|8|||
149894177|NCT03817190|540741587|FG000|Overall Study|Lost to Follow-up|11|||
149894178|NCT03817190|540741588|FG001|Overall Study|Lost to Follow-up|7|||
149894179|NCT03817190|540741587|FG000|Overall Study|Lack of Efficacy|7|||
149894180|NCT03817190|540741588|FG001|Overall Study|Lack of Efficacy|5|||
149894181|NCT03817190|540741587|FG000|Overall Study|Investigator Decision|5|||
149894182|NCT03817190|540741588|FG001|Overall Study|Investigator Decision|1|||
149894183|NCT03817190|540741587|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
149894184|NCT03817190|540741588|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
149894185|NCT03817190|540741587|FG000|Overall Study|Lack of Contact|1|||
149894186|NCT03817190|540741588|FG001|Overall Study|Lack of Contact|0|||
150175962|NCT00508924|541781872|FG002|Overall Study|Protocol Violation|1|||
150175963|NCT00508924|541781873|FG003|Overall Study|Protocol Violation|1|||
150175964|NCT02755805|541781874|FG000|Overall Study|Lost to Follow-up|1|||
150175965|NCT02755805|541781875|FG001|Overall Study|Lost to Follow-up|2|||
150175966|NCT02755805|541781874|FG000|Overall Study|Refused assessments|1|||
150175967|NCT02755805|541781875|FG001|Overall Study|Refused assessments|0|||
150175968|NCT02755805|541781874|FG000|Overall Study|Withdrawal by Subject|0|||
150175969|NCT02755805|541781875|FG001|Overall Study|Withdrawal by Subject|2|||
150175970|NCT02593149|541781876|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
150175971|NCT02593149|541781877|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
150175972|NCT02593149|541781876|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
150175973|NCT02593149|541781877|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
150175974|NCT01636687|541781878|FG000|Induction Period|Withdrawal by Subject|1|||
150175975|NCT01636687|541781879|FG001|Induction Period|Withdrawal by Subject|0|||
150175976|NCT01636687|541781880|FG002|Induction Period|Withdrawal by Subject|0|||
150175977|NCT01636687|541781881|FG003|Induction Period|Withdrawal by Subject|0|||
150175978|NCT01636687|541781882|FG004|Induction Period|Withdrawal by Subject|0|||
149894187|NCT03817190|540741587|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
149894188|NCT03817190|540741588|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
150175979|NCT01636687|541781878|FG000|Induction Period|Adverse Event|1|||
150175980|NCT01636687|541781879|FG001|Induction Period|Adverse Event|0|||
150175981|NCT01636687|541781880|FG002|Induction Period|Adverse Event|0|||
150175982|NCT01636687|541781881|FG003|Induction Period|Adverse Event|0|||
149894189|NCT05086744|540743351|FG000|Part A|Adverse Event|0|||
149894190|NCT05086744|540743352|FG001|Part A|Adverse Event|1|||
149894191|NCT05086744|540743351|FG000|Part A|Lack of Efficacy|3|||
149894192|NCT05086744|540743352|FG001|Part A|Lack of Efficacy|0|||
149894193|NCT05086744|540743351|FG000|Part A|Protocol deviation|1|||
149894194|NCT05086744|540743352|FG001|Part A|Protocol deviation|0|||
149894195|NCT05086744|540743351|FG000|Part A|Subject decision|1|||
149894196|NCT05086744|540743352|FG001|Part A|Subject decision|0|||
149894197|NCT05086744|540743351|FG000|Part B|Adverse Event|0|||
149894198|NCT05086744|540743352|FG001|Part B|Adverse Event|1|||
149894199|NCT05086744|540743351|FG000|Part B|Lack of Efficacy|0|||
149894200|NCT05086744|540743352|FG001|Part B|Lack of Efficacy|1|||
149894201|NCT05086744|540743351|FG000|Part B|Study terminated by sponsor|1|||
149894202|NCT05086744|540743352|FG001|Part B|Study terminated by sponsor|6|||
149894203|NCT03055338|540743355|FG000|Overall Study|Lost to Follow-up|9|||
149894204|NCT03055338|540743356|FG001|Overall Study|Lost to Follow-up|2|||
149894205|NCT03055338|540743357|FG002|Overall Study|Lost to Follow-up|3|||
149894206|NCT03055338|540743355|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
149894207|NCT03055338|540743356|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
149894208|NCT03055338|540743357|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
149894209|NCT03055338|540743355|FG000|Overall Study|Physician Decision|0|||
149894210|NCT03055338|540743356|FG001|Overall Study|Physician Decision|0|||
149894211|NCT03055338|540743357|FG002|Overall Study|Physician Decision|2|||
149894212|NCT03055338|540743355|FG000|Overall Study|Withdrawal by Subject|9|||
149894213|NCT03055338|540743356|FG001|Overall Study|Withdrawal by Subject|8|||
149894214|NCT03055338|540743357|FG002|Overall Study|Withdrawal by Subject|7|||
149894215|NCT01894841|540743363|FG000|Overall Study|Withdrawal by Subject|9|||
149894216|NCT01894841|540743364|FG001|Overall Study|Withdrawal by Subject|4|||
149894217|NCT01894841|540743363|FG000|Overall Study|Withdrawn by investigator|2|||
149894218|NCT01894841|540743364|FG001|Overall Study|Withdrawn by investigator|2|||
149894219|NCT01894841|540743363|FG000|Overall Study|Lost to Follow-up|7|||
149894220|NCT01894841|540743364|FG001|Overall Study|Lost to Follow-up|3|||
149894221|NCT00529087|540743365|FG000|Overall Study|Adverse Event|10|||
149894222|NCT00529087|540743366|FG001|Overall Study|Adverse Event|13|||
149894223|NCT00529087|540743367|FG002|Overall Study|Adverse Event|4|||
149894224|NCT00529087|540743365|FG000|Overall Study|Lost to Follow-up|6|||
149894225|NCT00529087|540743366|FG001|Overall Study|Lost to Follow-up|4|||
149894226|NCT00529087|540743367|FG002|Overall Study|Lost to Follow-up|1|||
149894227|NCT00529087|540743365|FG000|Overall Study|Protocol Violation|8|||
149894228|NCT00529087|540743366|FG001|Overall Study|Protocol Violation|7|||
149894229|NCT00529087|540743367|FG002|Overall Study|Protocol Violation|6|||
149894230|NCT00529087|540743365|FG000|Overall Study|Withdrawal by Subject|3|||
149894231|NCT00529087|540743366|FG001|Overall Study|Withdrawal by Subject|3|||
149894232|NCT00529087|540743367|FG002|Overall Study|Withdrawal by Subject|3|||
149894233|NCT00529087|540743365|FG000|Overall Study|Protocol deviation|1|||
149894234|NCT00529087|540743366|FG001|Overall Study|Protocol deviation|1|||
149894235|NCT00529087|540743367|FG002|Overall Study|Protocol deviation|2|||
149894236|NCT02954601|540743368|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
149894237|NCT02954601|540743369|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
149894238|NCT02954601|540743370|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
149894239|NCT02954601|540743371|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
149894240|NCT00318474|540743372|FG000|Overall Study|Adverse Event|1|||
149894241|NCT00318474|540743373|FG001|Overall Study|Adverse Event|1|||
149894242|NCT00318474|540743372|FG000|Overall Study|Lost to Follow-up|0|||
149894243|NCT00318474|540743373|FG001|Overall Study|Lost to Follow-up|1|||
149894244|NCT00318474|540743372|FG000|Overall Study|Pregnancy|0|||
149894245|NCT00318474|540743373|FG001|Overall Study|Pregnancy|2|||
149894246|NCT00318474|540743372|FG000|Overall Study|Protocol Violation|1|||
149894247|NCT00318474|540743373|FG001|Overall Study|Protocol Violation|0|||
149894248|NCT00318474|540743372|FG000|Overall Study|Withdrawal by Subject|3|||
149894249|NCT00318474|540743373|FG001|Overall Study|Withdrawal by Subject|2|||
149894250|NCT00318474|540743372|FG000|Overall Study|Fall in GFR|3|||
149894251|NCT00318474|540743373|FG001|Overall Study|Fall in GFR|3|||
149894252|NCT00318474|540743372|FG000|Overall Study|Post-therapy hyperflycemia|0|||
149894253|NCT00318474|540743373|FG001|Overall Study|Post-therapy hyperflycemia|1|||
149894254|NCT00318474|540743372|FG000|Overall Study|Trial terminated|10|||
149894255|NCT00318474|540743373|FG001|Overall Study|Trial terminated|7|||
149894256|NCT01735916|540743374|FG000|Overall Study|Subject not eligible to be randomized|11|||
149894257|NCT01735916|540743375|FG001|Overall Study|Subject not eligible to be randomized|0|||
149894258|NCT01735916|540743376|FG002|Overall Study|Subject not eligible to be randomized|0|||
149894259|NCT01735916|540743374|FG000|Overall Study|Early termination of study by sponsor|4|||
149894260|NCT01735916|540743375|FG001|Overall Study|Early termination of study by sponsor|19|||
149894261|NCT01735916|540743376|FG002|Overall Study|Early termination of study by sponsor|7|||
149894262|NCT01735916|540743374|FG000|Overall Study|Withdrawal by Subject|3|||
149894263|NCT01735916|540743375|FG001|Overall Study|Withdrawal by Subject|0|||
149894264|NCT01735916|540743376|FG002|Overall Study|Withdrawal by Subject|0|||
149894265|NCT02955355|540743382|FG000|Overall Study|Adverse Event|4|||
149894266|NCT02955355|540743382|FG000|Overall Study|Death|1|||
149894267|NCT02955355|540743382|FG000|Overall Study|Physician Decision|21|||
149894268|NCT02955355|540743382|FG000|Overall Study|Site Terminated by Sponsor|35|||
149894269|NCT02955355|540743382|FG000|Overall Study|Withdrawal by Subject|19|||
149894270|NCT02955355|540743382|FG000|Overall Study|Reason Not Specified|5|||
149894271|NCT04227197|540743383|FG000|Randomization|Protocol Violation|1|||
149894272|NCT04227197|540743384|FG001|Randomization|Protocol Violation|0|||
149894273|NCT04227197|540743383|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
149894274|NCT04227197|540743384|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
149894275|NCT04227197|540743383|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
149894276|NCT04227197|540743384|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
149894277|NCT04227197|540743383|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
149894278|NCT04227197|540743384|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
149894279|NCT04227197|540743383|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
149894280|NCT04227197|540743384|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
149894281|NCT04227197|540743383|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
149894282|NCT04227197|540743384|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
149894283|NCT04227197|540743383|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
149894284|NCT04227197|540743384|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
149894285|NCT01379768|540743387|FG000|Overall Study|Adverse Event|1|||
149894286|NCT01379768|540743388|FG001|Overall Study|Adverse Event|1|||
149894287|NCT01379768|540743389|FG002|Overall Study|Adverse Event|0|||
149894288|NCT01379768|540743387|FG000|Overall Study|Lost to Follow-up|2|||
149894289|NCT01379768|540743388|FG001|Overall Study|Lost to Follow-up|0|||
149894290|NCT01379768|540743389|FG002|Overall Study|Lost to Follow-up|0|||
149894291|NCT01209949|540743392|FG000|Overall Study|Lost to Follow-up|3|||
149894292|NCT00708552|540743397|FG000|Overall Study|Adverse Event|10|||
149894293|NCT00708552|540743398|FG001|Overall Study|Adverse Event|3|||
149894294|NCT00708552|540743399|FG002|Overall Study|Adverse Event|4|||
149894295|NCT00708552|540743400|FG003|Overall Study|Adverse Event|6|||
149894296|NCT00708552|540743397|FG000|Overall Study|Lack of Efficacy|0|||
149894297|NCT00708552|540743398|FG001|Overall Study|Lack of Efficacy|4|||
149894298|NCT00708552|540743399|FG002|Overall Study|Lack of Efficacy|1|||
149894299|NCT00708552|540743400|FG003|Overall Study|Lack of Efficacy|0|||
149894300|NCT00708552|540743397|FG000|Overall Study|Protocol Violation|0|||
149894301|NCT00708552|540743398|FG001|Overall Study|Protocol Violation|0|||
149894302|NCT00708552|540743399|FG002|Overall Study|Protocol Violation|2|||
149894303|NCT00708552|540743400|FG003|Overall Study|Protocol Violation|4|||
149894304|NCT00708552|540743397|FG000|Overall Study|Lost to Follow-up|4|||
149894305|NCT00708552|540743398|FG001|Overall Study|Lost to Follow-up|2|||
149894306|NCT00708552|540743399|FG002|Overall Study|Lost to Follow-up|0|||
149894307|NCT00708552|540743400|FG003|Overall Study|Lost to Follow-up|1|||
149894308|NCT00708552|540743397|FG000|Overall Study|Physician Decision|1|||
149894309|NCT00708552|540743398|FG001|Overall Study|Physician Decision|2|||
149894310|NCT00708552|540743399|FG002|Overall Study|Physician Decision|0|||
149894311|NCT00708552|540743400|FG003|Overall Study|Physician Decision|0|||
149894312|NCT00708552|540743397|FG000|Overall Study|Withdrawal by Subject|12|||
149894313|NCT00708552|540743398|FG001|Overall Study|Withdrawal by Subject|7|||
149894314|NCT00708552|540743399|FG002|Overall Study|Withdrawal by Subject|8|||
149894315|NCT00708552|540743400|FG003|Overall Study|Withdrawal by Subject|10|||
149968580|NCT02314923|541021976|FG001|Overall Study|Participant relocation|0|||
149894316|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
149894317|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
149894318|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
149894319|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
149894320|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
149894321|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894322|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894323|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894324|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894325|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894326|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894327|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894328|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894329|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894330|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
149894331|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
149894332|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
149894333|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
149894334|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
149894335|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
149894336|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894337|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894338|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894339|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894340|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894341|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894342|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894343|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894344|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894345|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
149894346|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
149894347|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
149894348|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
149894349|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
149894350|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
149894351|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894352|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894353|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894354|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894355|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894356|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894357|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894358|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894359|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894360|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
149894361|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
149894362|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
149894363|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
150175983|NCT01636687|541781882|FG004|Induction Period|Adverse Event|1|||
150045300|NCT00485134|541305567|FG005|Overall Study|Withdrawal by Subject|0|||
150045301|NCT00485134|541305568|FG006|Overall Study|Withdrawal by Subject|0|||
150045302|NCT00485134|541305569|FG007|Overall Study|Withdrawal by Subject|0|||
150045303|NCT00485134|541305562|FG000|Overall Study|Change in health status|0|||
150045304|NCT00485134|541305563|FG001|Overall Study|Change in health status|1|||
150045305|NCT00485134|541305564|FG002|Overall Study|Change in health status|2|||
150045306|NCT00485134|541305565|FG003|Overall Study|Change in health status|1|||
150045307|NCT00485134|541305566|FG004|Overall Study|Change in health status|0|||
150045308|NCT00485134|541305567|FG005|Overall Study|Change in health status|1|||
150045309|NCT00485134|541305568|FG006|Overall Study|Change in health status|0|||
150045310|NCT00485134|541305569|FG007|Overall Study|Change in health status|0|||
150045311|NCT00485134|541305562|FG000|Overall Study|Withdrew for adverse event|0|||
150045312|NCT00485134|541305563|FG001|Overall Study|Withdrew for adverse event|0|||
150045313|NCT00485134|541305564|FG002|Overall Study|Withdrew for adverse event|1|||
150045314|NCT00485134|541305565|FG003|Overall Study|Withdrew for adverse event|0|||
150045315|NCT00485134|541305566|FG004|Overall Study|Withdrew for adverse event|0|||
150045316|NCT00485134|541305567|FG005|Overall Study|Withdrew for adverse event|0|||
150045317|NCT00485134|541305568|FG006|Overall Study|Withdrew for adverse event|0|||
150045318|NCT00485134|541305569|FG007|Overall Study|Withdrew for adverse event|0|||
150045319|NCT00485134|541305562|FG000|Overall Study|Positive drug test|0|||
150045320|NCT00485134|541305563|FG001|Overall Study|Positive drug test|0|||
150045321|NCT00485134|541305564|FG002|Overall Study|Positive drug test|0|||
150045322|NCT00485134|541305565|FG003|Overall Study|Positive drug test|0|||
150045323|NCT00485134|541305566|FG004|Overall Study|Positive drug test|2|||
150045324|NCT00485134|541305567|FG005|Overall Study|Positive drug test|1|||
150045325|NCT00485134|541305568|FG006|Overall Study|Positive drug test|0|||
150045326|NCT00485134|541305569|FG007|Overall Study|Positive drug test|0|||
150045327|NCT00485134|541305562|FG000|Overall Study|Non-compliance|0|||
150175984|NCT01636687|541781878|FG000|Induction Period|Lack of Efficacy|0|||
150175985|NCT01636687|541781879|FG001|Induction Period|Lack of Efficacy|0|||
150045328|NCT00485134|541305563|FG001|Overall Study|Non-compliance|0|||
150045329|NCT00485134|541305564|FG002|Overall Study|Non-compliance|0|||
150045330|NCT00485134|541305565|FG003|Overall Study|Non-compliance|0|||
150045331|NCT00485134|541305566|FG004|Overall Study|Non-compliance|1|||
149894364|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
149894365|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
149894366|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894367|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894368|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894369|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894370|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894371|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894372|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894373|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894374|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894375|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
149894376|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
149894377|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894378|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
149894379|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
149894380|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
149894381|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894382|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894383|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894384|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894385|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894386|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894387|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894388|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894389|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894390|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
149894391|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894392|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894393|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894394|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
149894395|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894396|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894397|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894398|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894399|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894400|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894401|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894402|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894403|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894404|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894405|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
149894406|NCT03334435|540743402|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894407|NCT03334435|540743403|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
149894408|NCT03334435|540743404|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
149894409|NCT03334435|540743405|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
149894410|NCT03334435|540743406|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
149894411|NCT03334435|540743407|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894412|NCT03334435|540743408|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894413|NCT03334435|540743409|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894414|NCT03334435|540743410|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894415|NCT03334435|540743411|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894416|NCT03334435|540743412|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894417|NCT03334435|540743413|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894418|NCT03334435|540743414|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894419|NCT03334435|540743415|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894420|NCT03334435|540743416|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
149894421|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
149894422|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
149894423|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
149894424|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
149894425|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
149894426|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
149894427|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
149968581|NCT02314923|541021977|FG002|Overall Study|Participant relocation|0|||
149894428|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
149894429|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
149894430|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
149894431|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
149894432|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
149894433|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
149894434|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
149894435|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
149894436|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
149894437|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
149894438|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
149894439|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
150175986|NCT01636687|541781880|FG002|Induction Period|Lack of Efficacy|0|||
150175987|NCT01636687|541781881|FG003|Induction Period|Lack of Efficacy|0|||
150175988|NCT01636687|541781882|FG004|Induction Period|Lack of Efficacy|1|||
150175989|NCT01636687|541781878|FG000|Induction Period|Physician Decision|1|||
150175990|NCT01636687|541781879|FG001|Induction Period|Physician Decision|0|||
150175991|NCT01636687|541781880|FG002|Induction Period|Physician Decision|0|||
150175992|NCT01636687|541781881|FG003|Induction Period|Physician Decision|0|||
150175993|NCT01636687|541781882|FG004|Induction Period|Physician Decision|0|||
150175994|NCT01636687|541781878|FG000|Maintenance Period|Withdrawal by Subject|2|||
150175995|NCT01636687|541781879|FG001|Maintenance Period|Withdrawal by Subject|0|||
150175996|NCT01636687|541781880|FG002|Maintenance Period|Withdrawal by Subject|2|||
150175997|NCT01636687|541781881|FG003|Maintenance Period|Withdrawal by Subject|0|||
150175998|NCT01636687|541781882|FG004|Maintenance Period|Withdrawal by Subject|0|||
150175999|NCT01636687|541781878|FG000|Maintenance Period|Adverse Event|1|||
150176000|NCT01636687|541781879|FG001|Maintenance Period|Adverse Event|0|||
150176001|NCT01636687|541781880|FG002|Maintenance Period|Adverse Event|0|||
150176002|NCT01636687|541781881|FG003|Maintenance Period|Adverse Event|0|||
150176003|NCT01636687|541781882|FG004|Maintenance Period|Adverse Event|0|||
150176004|NCT01636687|541781878|FG000|Maintenance Period|Lack of Efficacy|4|||
150176005|NCT01636687|541781879|FG001|Maintenance Period|Lack of Efficacy|1|||
150176006|NCT01636687|541781880|FG002|Maintenance Period|Lack of Efficacy|0|||
150176007|NCT01636687|541781881|FG003|Maintenance Period|Lack of Efficacy|0|||
150176008|NCT01636687|541781882|FG004|Maintenance Period|Lack of Efficacy|0|||
150176009|NCT01636687|541781878|FG000|Maintenance Period|Lost to Follow-up|1|||
150176010|NCT01636687|541781879|FG001|Maintenance Period|Lost to Follow-up|1|||
150176011|NCT01636687|541781880|FG002|Maintenance Period|Lost to Follow-up|0|||
150176012|NCT01636687|541781881|FG003|Maintenance Period|Lost to Follow-up|0|||
150176013|NCT01636687|541781882|FG004|Maintenance Period|Lost to Follow-up|1|||
150176014|NCT01636687|541781878|FG000|Maintenance Period|Physician Decision|0|||
150176015|NCT01636687|541781879|FG001|Maintenance Period|Physician Decision|0|||
150176016|NCT01636687|541781880|FG002|Maintenance Period|Physician Decision|0|||
150176017|NCT01636687|541781881|FG003|Maintenance Period|Physician Decision|0|||
150176018|NCT01636687|541781882|FG004|Maintenance Period|Physician Decision|1|||
150176019|NCT01636687|541781878|FG000|Extension Period|technical problems|0|||
150176020|NCT01636687|541781879|FG001|Extension Period|technical problems|1|||
149894440|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
149894441|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
149894442|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
149894443|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
149894444|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
149894445|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
149894446|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
149894447|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
149894448|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
150176021|NCT01636687|541781880|FG002|Extension Period|technical problems|2|||
150176022|NCT01636687|541781881|FG003|Extension Period|technical problems|1|||
150176023|NCT01636687|541781882|FG004|Extension Period|technical problems|0|||
150176024|NCT01636687|541781878|FG000|Extension Period|Adverse Event|4|||
150176025|NCT01636687|541781879|FG001|Extension Period|Adverse Event|3|||
150176026|NCT01636687|541781880|FG002|Extension Period|Adverse Event|2|||
150176027|NCT01636687|541781881|FG003|Extension Period|Adverse Event|1|||
150176028|NCT01636687|541781882|FG004|Extension Period|Adverse Event|0|||
150176029|NCT01636687|541781878|FG000|Extension Period|Lack of Efficacy|7|||
150176030|NCT01636687|541781879|FG001|Extension Period|Lack of Efficacy|0|||
149894449|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
149894450|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
149894451|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894452|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894453|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894454|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894455|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894456|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
149894457|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
149894458|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
149894459|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
149894460|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
149894461|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
149894462|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
149894463|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
149894464|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
149894465|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
149894466|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
149894467|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
149894468|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
149894469|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
149894470|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
149894471|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
149894472|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
149894473|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
149894474|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
149894475|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
149894476|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
149894477|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
149894478|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
149894479|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
149894480|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
149894481|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894482|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894483|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894484|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894485|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894486|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894487|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
149894488|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
149894489|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
149894490|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
149894491|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
149894492|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
149894493|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
149894494|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
149894495|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
149894496|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894497|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894498|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894499|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894500|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894501|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894502|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894503|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894504|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894505|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894506|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894507|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
149894508|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894509|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
149894510|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
149894511|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894512|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894513|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894514|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894515|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894516|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
149894517|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894518|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
150176031|NCT01636687|541781880|FG002|Extension Period|Lack of Efficacy|2|||
150176032|NCT01636687|541781881|FG003|Extension Period|Lack of Efficacy|1|||
150176033|NCT01636687|541781882|FG004|Extension Period|Lack of Efficacy|0|||
149894519|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894520|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894521|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894522|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894523|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894524|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
149894525|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
149894526|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894527|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894528|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894529|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894530|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894531|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894532|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894533|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894534|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894535|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
149894536|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894537|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
149894538|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894539|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894540|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
149894541|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894542|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894543|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894544|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894545|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894546|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
149894547|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
149894548|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894549|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149968582|NCT02314923|541021978|FG003|Overall Study|Participant relocation|0|||
149968583|NCT02314923|541021979|FG004|Overall Study|Participant relocation|0|||
149968584|NCT02314923|541021980|FG005|Overall Study|Participant relocation|0|||
149968585|NCT02314923|541021981|FG006|Overall Study|Participant relocation|0|||
149968586|NCT02314923|541021982|FG007|Overall Study|Participant relocation|1|||
149968587|NCT02314923|541021983|FG008|Overall Study|Participant relocation|0|||
149968588|NCT02314923|541021984|FG009|Overall Study|Participant relocation|0|||
149968589|NCT01055028|541021989|FG000|Screening|Screen Failure|1|||
149968590|NCT01055028|541021990|FG001|Screening|Screen Failure|1|||
149968591|NCT01055028|541021989|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
149968592|NCT01055028|541021990|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
149968593|NCT01055028|541021989|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
149968594|NCT01055028|541021990|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
149968595|NCT01055028|541021989|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
149968596|NCT01055028|541021990|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
149968597|NCT01381679|541021991|FG000|Overall Study|Adverse Event|3|||
149968598|NCT01381679|541021991|FG000|Overall Study|Lost to Follow-up|885|||
149968599|NCT04023487|541021992|FG000|Overall Study|Lost to Follow-up|5|||
149968600|NCT04023487|541021993|FG001|Overall Study|Lost to Follow-up|4|||
149968601|NCT04023487|541021992|FG000|Overall Study|Pregnancy|1|||
149968602|NCT04023487|541021993|FG001|Overall Study|Pregnancy|2|||
149968603|NCT04023487|541021992|FG000|Overall Study|Withdrawal by Subject|4|||
149968604|NCT04023487|541021993|FG001|Overall Study|Withdrawal by Subject|5|||
149968605|NCT04023487|541021992|FG000|Overall Study|Partially completed testing|8|||
149968606|NCT04023487|541021993|FG001|Overall Study|Partially completed testing|4|||
149968607|NCT03898180|541021994|FG000|Overall Study|Death|178|||
149894550|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894551|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
149894552|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
149894553|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
149894554|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
150176034|NCT01636687|541781878|FG000|Extension Period|Lost to Follow-up|1|||
150176035|NCT01636687|541781879|FG001|Extension Period|Lost to Follow-up|0|||
150176036|NCT01636687|541781880|FG002|Extension Period|Lost to Follow-up|1|||
150176037|NCT01636687|541781881|FG003|Extension Period|Lost to Follow-up|0|||
150176038|NCT01636687|541781882|FG004|Extension Period|Lost to Follow-up|0|||
150176039|NCT01636687|541781878|FG000|Extension Period|Physician Decision|1|||
150176040|NCT01636687|541781879|FG001|Extension Period|Physician Decision|0|||
150176041|NCT01636687|541781880|FG002|Extension Period|Physician Decision|0|||
150176042|NCT01636687|541781881|FG003|Extension Period|Physician Decision|1|||
150176043|NCT01636687|541781882|FG004|Extension Period|Physician Decision|0|||
150176044|NCT01636687|541781878|FG000|Extension Period|study terminated by sponsor|33|||
150176045|NCT01636687|541781879|FG001|Extension Period|study terminated by sponsor|50|||
150176046|NCT01636687|541781880|FG002|Extension Period|study terminated by sponsor|17|||
150176047|NCT01636687|541781881|FG003|Extension Period|study terminated by sponsor|23|||
150176048|NCT01636687|541781882|FG004|Extension Period|study terminated by sponsor|0|||
150176049|NCT01636687|541781878|FG000|Extension Period|Withdrawal by Subject|1|||
150176050|NCT01636687|541781879|FG001|Extension Period|Withdrawal by Subject|0|||
150176051|NCT01636687|541781880|FG002|Extension Period|Withdrawal by Subject|1|||
150176052|NCT01636687|541781881|FG003|Extension Period|Withdrawal by Subject|1|||
149894555|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
149894556|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
150176053|NCT01636687|541781882|FG004|Extension Period|Withdrawal by Subject|0|||
150176054|NCT01636687|541781878|FG000|Follow-up Period|Withdrawal by Subject|1|||
150176055|NCT01636687|541781879|FG001|Follow-up Period|Withdrawal by Subject|0|||
150176056|NCT01636687|541781880|FG002|Follow-up Period|Withdrawal by Subject|0|||
150176057|NCT01636687|541781881|FG003|Follow-up Period|Withdrawal by Subject|0|||
150176058|NCT01636687|541781882|FG004|Follow-up Period|Withdrawal by Subject|1|||
150176059|NCT00980330|541781887|FG000|Overall Study|Adverse Event|0|||
150176060|NCT00980330|541781888|FG001|Overall Study|Adverse Event|0|||
150176061|NCT00980330|541781889|FG002|Overall Study|Adverse Event|0|||
150176062|NCT00980330|541781890|FG003|Overall Study|Adverse Event|1|||
150176063|NCT00980330|541781891|FG004|Overall Study|Adverse Event|0|||
150176064|NCT00980330|541781892|FG005|Overall Study|Adverse Event|0|||
150176065|NCT00980330|541781893|FG006|Overall Study|Adverse Event|0|||
150176066|NCT00980330|541781887|FG000|Overall Study|Lost to Follow-up|1|||
150176067|NCT00980330|541781888|FG001|Overall Study|Lost to Follow-up|1|||
150176068|NCT00980330|541781889|FG002|Overall Study|Lost to Follow-up|4|||
150176069|NCT00980330|541781890|FG003|Overall Study|Lost to Follow-up|2|||
150176070|NCT00980330|541781891|FG004|Overall Study|Lost to Follow-up|1|||
150176071|NCT00980330|541781892|FG005|Overall Study|Lost to Follow-up|1|||
150176072|NCT00980330|541781893|FG006|Overall Study|Lost to Follow-up|2|||
150176073|NCT00980330|541781887|FG000|Overall Study|Withdrawal by Subject|2|||
150176074|NCT00980330|541781888|FG001|Overall Study|Withdrawal by Subject|4|||
150176075|NCT00980330|541781889|FG002|Overall Study|Withdrawal by Subject|4|||
150176076|NCT00980330|541781890|FG003|Overall Study|Withdrawal by Subject|1|||
150176077|NCT00980330|541781891|FG004|Overall Study|Withdrawal by Subject|3|||
150176078|NCT00980330|541781892|FG005|Overall Study|Withdrawal by Subject|2|||
150176079|NCT00980330|541781893|FG006|Overall Study|Withdrawal by Subject|5|||
150176080|NCT00980330|541781887|FG000|Overall Study|(not specified)|2|||
150176081|NCT00980330|541781888|FG001|Overall Study|(not specified)|0|||
150176082|NCT00980330|541781889|FG002|Overall Study|(not specified)|0|||
150176083|NCT00980330|541781890|FG003|Overall Study|(not specified)|1|||
150176084|NCT00980330|541781891|FG004|Overall Study|(not specified)|1|||
150176085|NCT00980330|541781892|FG005|Overall Study|(not specified)|1|||
149894557|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894558|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894559|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
150176086|NCT00980330|541781893|FG006|Overall Study|(not specified)|0|||
150176087|NCT01039688|541781894|FG000|Overall Study|Adverse Event|38|||
150176088|NCT01039688|541781895|FG001|Overall Study|Adverse Event|39|||
150176089|NCT01039688|541781896|FG002|Overall Study|Adverse Event|24|||
150176090|NCT01039688|541781894|FG000|Overall Study|Lack of Efficacy|20|||
150176091|NCT01039688|541781895|FG001|Overall Study|Lack of Efficacy|11|||
150176092|NCT01039688|541781896|FG002|Overall Study|Lack of Efficacy|26|||
150176093|NCT01039688|541781894|FG000|Overall Study|Lost to Follow-up|11|||
150176094|NCT01039688|541781895|FG001|Overall Study|Lost to Follow-up|9|||
150176095|NCT01039688|541781896|FG002|Overall Study|Lost to Follow-up|5|||
149894560|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894561|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
149894562|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894563|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894564|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894565|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894566|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
149894567|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894568|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894569|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
149894570|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
149894571|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894572|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894573|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894574|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894575|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894576|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894577|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894578|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
149894579|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
149894580|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894581|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
149894582|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
149894583|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
149894584|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894585|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
149894586|NCT03334435|540743402|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894587|NCT03334435|540743403|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894588|NCT03334435|540743404|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894589|NCT03334435|540743405|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894590|NCT03334435|540743406|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894591|NCT03334435|540743407|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894592|NCT03334435|540743408|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894593|NCT03334435|540743409|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894594|NCT03334435|540743410|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894595|NCT03334435|540743411|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894596|NCT03334435|540743412|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894597|NCT03334435|540743413|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
149894598|NCT03334435|540743414|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
149894599|NCT03334435|540743415|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
149894600|NCT03334435|540743416|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
149894601|NCT02075203|540743421|FG000|Overall Study|Withdrawal by Subject|1|||
149894602|NCT02075203|540743422|FG001|Overall Study|Withdrawal by Subject|0|||
149894603|NCT02075203|540743423|FG002|Overall Study|Withdrawal by Subject|1|||
149894604|NCT02075203|540743421|FG000|Overall Study|Adverse Event|1|||
149894605|NCT02075203|540743422|FG001|Overall Study|Adverse Event|0|||
149894606|NCT02075203|540743423|FG002|Overall Study|Adverse Event|0|||
149968608|NCT03898180|541021995|FG001|Overall Study|Death|173|||
149968609|NCT03898180|541021994|FG000|Overall Study|Physician Decision|1|||
149968610|NCT03898180|541021995|FG001|Overall Study|Physician Decision|0|||
149968611|NCT03898180|541021994|FG000|Overall Study|Sponsor Decision|3|||
149968612|NCT03898180|541021995|FG001|Overall Study|Sponsor Decision|0|||
149968613|NCT03898180|541021994|FG000|Overall Study|Lost to Follow-up|1|||
149968614|NCT03898180|541021995|FG001|Overall Study|Lost to Follow-up|0|||
149968615|NCT03898180|541021994|FG000|Overall Study|Withdrawal by Subject|5|||
149968616|NCT03898180|541021995|FG001|Overall Study|Withdrawal by Subject|4|||
149968617|NCT02507934|541021996|FG000|Overall Study|Lost to Follow-up|2|||
149968618|NCT02507934|541021997|FG001|Overall Study|Lost to Follow-up|0|||
149968619|NCT02507934|541021996|FG000|Overall Study|Withdrawal by Subject|2|||
149968620|NCT02507934|541021997|FG001|Overall Study|Withdrawal by Subject|0|||
149968621|NCT03766399|541021999|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968622|NCT03766399|541022000|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968623|NCT03766399|541022001|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968624|NCT03766399|541022002|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968625|NCT03766399|541022003|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968626|NCT03766399|541022004|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968627|NCT03766399|541022005|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968628|NCT03766399|541022006|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968629|NCT03766399|541022007|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968630|NCT03766399|541022008|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968631|NCT03766399|541022009|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968632|NCT03766399|541022010|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968633|NCT03766399|541022011|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968634|NCT03766399|541022012|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
149968635|NCT03766399|541022013|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968636|NCT03766399|541022014|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968637|NCT03766399|541022015|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968638|NCT03766399|541022016|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
149968639|NCT00645658|541022017|FG000|Overall Study|Withdrawal by Subject|1|||
149968640|NCT00645658|541022018|FG001|Overall Study|Withdrawal by Subject|0|||
149968641|NCT00645658|541022017|FG000|Overall Study|Did not complete all assesments|0|||
149894607|NCT02075203|540743421|FG000|Overall Study|participant refused to use contraception|1|||
149894608|NCT02075203|540743422|FG001|Overall Study|participant refused to use contraception|0|||
149894609|NCT02075203|540743423|FG002|Overall Study|participant refused to use contraception|0|||
149894610|NCT00568451|540743432|FG000|Overall Study|Disease Progression|0|||
149894611|NCT00568451|540743433|FG001|Overall Study|Disease Progression|0|||
149894612|NCT00568451|540743434|FG002|Overall Study|Disease Progression|2|||
149894613|NCT00568451|540743435|FG003|Overall Study|Disease Progression|7|||
149894614|NCT05344560|540743436|FG000|Period 1|Subject out of visit window|1|||
149894615|NCT05344560|540743437|FG001|Period 1|Subject out of visit window|1|||
149894616|NCT05344560|540743436|FG000|Period 2|Covid-19 Related|1|||
149894617|NCT05344560|540743437|FG001|Period 2|Covid-19 Related|0|||
149894618|NCT05344560|540743436|FG000|Period 2|Adverse Event|1|||
149894619|NCT05344560|540743437|FG001|Period 2|Adverse Event|0|||
149894620|NCT05344560|540743436|FG000|Period 2|Subject out of visit window|1|||
149894621|NCT05344560|540743437|FG001|Period 2|Subject out of visit window|1|||
149894622|NCT05344560|540743436|FG000|Period 3|Subject out of visit window|1|||
149894623|NCT05344560|540743437|FG001|Period 3|Subject out of visit window|0|||
149894624|NCT02996968|540743438|FG000|Overall Study|Withdrawal by Subject|1|||
149894625|NCT02996968|540743439|FG001|Overall Study|Withdrawal by Subject|0|||
149894626|NCT03922308|540743440|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
149894627|NCT03922308|540743441|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
149894628|NCT03922308|540743442|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
149894629|NCT03922308|540743440|FG000|Overall Study|Lost to Follow-up|1|||
149894630|NCT03922308|540743441|FG001|Overall Study|Lost to Follow-up|0|||
149894631|NCT03922308|540743442|FG002|Overall Study|Lost to Follow-up|0|||
149894632|NCT03922308|540743440|FG000|Overall Study|Reason not Specified|0|||
149968642|NCT00645658|541022018|FG001|Overall Study|Did not complete all assesments|2|||
149968643|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
149968644|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
149968645|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
149968646|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
149968647|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
149968648|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
149968649|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
149968650|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
149894633|NCT03922308|540743441|FG001|Overall Study|Reason not Specified|2|||
149894634|NCT03922308|540743442|FG002|Overall Study|Reason not Specified|1|||
149894635|NCT05005507|540743443|FG000|Overall Study|Premature termination of study|1|||
149894636|NCT03313180|540743444|FG000|Overall Study|Adverse Event|120|||
149894637|NCT03313180|540743444|FG000|Overall Study|Lost to Follow-up|3|||
149894638|NCT03313180|540743444|FG000|Overall Study|Withdrawal by Subject|39|||
149894639|NCT03313180|540743444|FG000|Overall Study|Other than listed above|15|||
149894640|NCT03313180|540743444|FG000|Overall Study|Covid-19 related|2|||
149894641|NCT01256450|540743445|FG000|Open-label Titration|Adverse Event|39|||
149894642|NCT01256450|540743446|FG001|Open-label Titration|Adverse Event|0|||
149894643|NCT01256450|540743447|FG002|Open-label Titration|Adverse Event|0|||
149894644|NCT01256450|540743445|FG000|Open-label Titration|Lost to Follow-up|7|||
149894645|NCT01256450|540743446|FG001|Open-label Titration|Lost to Follow-up|0|||
149894646|NCT01256450|540743447|FG002|Open-label Titration|Lost to Follow-up|0|||
149894647|NCT01256450|540743445|FG000|Open-label Titration|Lack of analgesic effect|30|||
149894648|NCT01256450|540743446|FG001|Open-label Titration|Lack of analgesic effect|0|||
149894649|NCT01256450|540743447|FG002|Open-label Titration|Lack of analgesic effect|0|||
149894650|NCT01256450|540743445|FG000|Open-label Titration|Non-compliance|9|||
149894651|NCT01256450|540743446|FG001|Open-label Titration|Non-compliance|0|||
149894652|NCT01256450|540743447|FG002|Open-label Titration|Non-compliance|0|||
149894653|NCT01256450|540743445|FG000|Open-label Titration|Screen failure|1|||
149894654|NCT01256450|540743446|FG001|Open-label Titration|Screen failure|0|||
149894655|NCT01256450|540743447|FG002|Open-label Titration|Screen failure|0|||
149894656|NCT01256450|540743445|FG000|Open-label Titration|Other|13|||
149894657|NCT01256450|540743446|FG001|Open-label Titration|Other|0|||
149894658|NCT01256450|540743447|FG002|Open-label Titration|Other|0|||
149894659|NCT01256450|540743445|FG000|Double-blind Treatment|Adverse Event|0|||
149894660|NCT01256450|540743446|FG001|Double-blind Treatment|Adverse Event|8|||
149894661|NCT01256450|540743447|FG002|Double-blind Treatment|Adverse Event|6|||
149894662|NCT01256450|540743445|FG000|Double-blind Treatment|Lost to Follow-up|0|||
149894663|NCT01256450|540743446|FG001|Double-blind Treatment|Lost to Follow-up|1|||
149894664|NCT01256450|540743447|FG002|Double-blind Treatment|Lost to Follow-up|7|||
149894665|NCT01256450|540743445|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
149894666|NCT01256450|540743446|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
149894667|NCT01256450|540743447|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
149968651|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
149968652|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
149968653|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
149968654|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
149968655|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
149968656|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
149968657|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
149968658|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
149968659|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
149968660|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
149968661|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
149894668|NCT01256450|540743445|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
149894669|NCT01256450|540743446|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
149894670|NCT01256450|540743447|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
149894671|NCT01256450|540743445|FG000|Double-blind Treatment|Non-compliance|0|||
149894672|NCT01256450|540743446|FG001|Double-blind Treatment|Non-compliance|5|||
149894673|NCT01256450|540743447|FG002|Double-blind Treatment|Non-compliance|4|||
149894674|NCT01256450|540743445|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
149894675|NCT01256450|540743446|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
149894676|NCT01256450|540743447|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
149894677|NCT01256450|540743445|FG000|Double-blind Treatment|Other|0|||
149894678|NCT01256450|540743446|FG001|Double-blind Treatment|Other|9|||
149894679|NCT01256450|540743447|FG002|Double-blind Treatment|Other|12|||
149894680|NCT03866512|540743448|FG000|Overall Study|Lost to Follow-up|1|||
149894681|NCT03866512|540743449|FG001|Overall Study|Lost to Follow-up|2|||
149894682|NCT03866512|540743450|FG002|Overall Study|Lost to Follow-up|1|||
149894683|NCT03866512|540743448|FG000|Overall Study|Cannulation issues|0|||
149894684|NCT03866512|540743449|FG001|Overall Study|Cannulation issues|1|||
149894685|NCT03866512|540743450|FG002|Overall Study|Cannulation issues|2|||
149894686|NCT02556775|540743461|FG000|Overall Study|Withdrawal by Subject|1|||
149894687|NCT02556775|540743462|FG001|Overall Study|Withdrawal by Subject|0|||
149894688|NCT02556775|540743463|FG002|Overall Study|Withdrawal by Subject|1|||
149894689|NCT02556775|540743464|FG003|Overall Study|Withdrawal by Subject|0|||
149894690|NCT02556775|540743461|FG000|Overall Study|Lost to Follow-up|1|||
149894691|NCT02556775|540743462|FG001|Overall Study|Lost to Follow-up|0|||
149894692|NCT02556775|540743463|FG002|Overall Study|Lost to Follow-up|0|||
149894693|NCT02556775|540743464|FG003|Overall Study|Lost to Follow-up|0|||
149894694|NCT01346059|540743465|FG000|Overall Study|Withdrawal by Subject|1|||
149894695|NCT01346059|540743466|FG001|Overall Study|Withdrawal by Subject|0|||
149894696|NCT02211209|540743467|FG000|Overall Study|Investigator judgment|0|||
149894697|NCT02211209|540743468|FG001|Overall Study|Investigator judgment|1|||
149894698|NCT02211209|540743467|FG000|Overall Study|Voluntary withdrawal|1|||
149894699|NCT02211209|540743468|FG001|Overall Study|Voluntary withdrawal|4|||
149894700|NCT02211209|540743467|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
149894701|NCT02211209|540743468|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
149894702|NCT02211209|540743467|FG000|Overall Study|Reason Not Specified|1|||
149894703|NCT02211209|540743468|FG001|Overall Study|Reason Not Specified|0|||
149894704|NCT02792062|540743471|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
149894705|NCT02792062|540743472|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
149894706|NCT02792062|540743473|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
149894707|NCT02792062|540743474|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
149894708|NCT02792062|540743475|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
149894709|NCT02792062|540743476|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
149894710|NCT02025725|540743479|FG000|Overall Study|Adverse Event|5|||
149894711|NCT02025725|540743480|FG001|Overall Study|Adverse Event|0|||
149894712|NCT02025725|540743479|FG000|Overall Study|Lost to Follow-up|2|||
149894713|NCT02025725|540743480|FG001|Overall Study|Lost to Follow-up|0|||
149894714|NCT02025725|540743479|FG000|Overall Study|Protocol Violation|1|||
149894715|NCT02025725|540743480|FG001|Overall Study|Protocol Violation|1|||
149894716|NCT02025725|540743479|FG000|Overall Study|Withdrawal by Subject|3|||
149894717|NCT02025725|540743480|FG001|Overall Study|Withdrawal by Subject|2|||
149894718|NCT02025725|540743479|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
149894719|NCT02025725|540743480|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
149894720|NCT01464424|540743481|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
149894721|NCT01464424|540743482|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
149894722|NCT00739661|540743483|FG000|Overall Study|Adverse Event|2|||
149894723|NCT00739661|540743484|FG001|Overall Study|Adverse Event|0|||
149894724|NCT00739661|540743483|FG000|Overall Study|Physician decision to withdraw patient|1|||
149894725|NCT00739661|540743484|FG001|Overall Study|Physician decision to withdraw patient|0|||
149894726|NCT00739661|540743483|FG000|Overall Study|Patient decision to withdraw|9|||
149894727|NCT00739661|540743484|FG001|Overall Study|Patient decision to withdraw|4|||
149894728|NCT00739661|540743483|FG000|Overall Study|Disease progression, radiographic|33|||
149894729|NCT00739661|540743484|FG001|Overall Study|Disease progression, radiographic|37|||
149894730|NCT00739661|540743483|FG000|Overall Study|Reason for discontinuation not available|1|||
149894731|NCT00739661|540743484|FG001|Overall Study|Reason for discontinuation not available|1|||
149894732|NCT01808066|540743485|FG000|Overall Study|Withdrawal by Subject|15|||
149894733|NCT00745901|540743486|FG000|Overall Study|Adverse Event|3|||
149894734|NCT00745901|540743487|FG001|Overall Study|Adverse Event|4|||
149894735|NCT00745901|540743486|FG000|Overall Study|Protocol Violation|0|||
149894736|NCT00745901|540743487|FG001|Overall Study|Protocol Violation|1|||
149894737|NCT00745901|540743486|FG000|Overall Study|Withdrawal by Subject|1|||
149894738|NCT00745901|540743487|FG001|Overall Study|Withdrawal by Subject|0|||
149894739|NCT00745901|540743486|FG000|Overall Study|Lost to Follow-up|7|||
149894740|NCT00745901|540743487|FG001|Overall Study|Lost to Follow-up|4|||
149894741|NCT00745901|540743486|FG000|Overall Study|Pregnancy|2|||
149894742|NCT00745901|540743487|FG001|Overall Study|Pregnancy|4|||
149894743|NCT00745901|540743486|FG000|Overall Study|Lack of compliance|2|||
149894744|NCT00745901|540743487|FG001|Overall Study|Lack of compliance|2|||
149894745|NCT00745901|540743486|FG000|Overall Study|Patient's next menses did not start with|1|||
149894746|NCT00745901|540743487|FG001|Overall Study|Patient's next menses did not start with|0|||
149894747|NCT00745901|540743486|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
149894748|NCT00745901|540743487|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
149894749|NCT00745901|540743486|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
149894750|NCT00745901|540743487|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
149894751|NCT00745901|540743486|FG000|Overall Study|Patient didn't take any study medication|7|||
149894752|NCT00745901|540743487|FG001|Overall Study|Patient didn't take any study medication|3|||
149894753|NCT03591874|540743490|FG000|Overall Study|Adverse Event|4|||
149894754|NCT03591874|540743491|FG001|Overall Study|Adverse Event|0|||
149894755|NCT03591874|540743490|FG000|Overall Study|Withdrawal by Subject|2|||
149894756|NCT03591874|540743491|FG001|Overall Study|Withdrawal by Subject|1|||
149894757|NCT03591874|540743490|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
149894758|NCT03591874|540743491|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
149894759|NCT03591874|540743490|FG000|Overall Study|On Study at Time of Study Termination|12|||
149894760|NCT03591874|540743491|FG001|Overall Study|On Study at Time of Study Termination|6|||
149894761|NCT02166333|540743493|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
149894762|NCT02166333|540743494|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
149894763|NCT02166333|540743495|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
149894764|NCT02166333|540743496|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
149894765|NCT02166333|540743497|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
149894766|NCT02166333|540743498|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
149894767|NCT02166333|540743493|FG000|Stage 1|Death|4|||
149894768|NCT02166333|540743494|FG001|Stage 1|Death|0|||
149894769|NCT02166333|540743495|FG002|Stage 1|Death|2|||
149894770|NCT02166333|540743496|FG003|Stage 1|Death|0|||
149894771|NCT02166333|540743497|FG004|Stage 1|Death|3|||
149894772|NCT02166333|540743498|FG005|Stage 1|Death|2|||
149894773|NCT02166333|540743493|FG000|Stage 1|Lost to Follow-up|12|||
149894774|NCT02166333|540743494|FG001|Stage 1|Lost to Follow-up|0|||
149894775|NCT02166333|540743495|FG002|Stage 1|Lost to Follow-up|6|||
149894776|NCT02166333|540743496|FG003|Stage 1|Lost to Follow-up|0|||
149894777|NCT02166333|540743497|FG004|Stage 1|Lost to Follow-up|3|||
149894778|NCT02166333|540743498|FG005|Stage 1|Lost to Follow-up|3|||
149894779|NCT02166333|540743493|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
149894780|NCT02166333|540743494|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
149894781|NCT02166333|540743495|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
149894782|NCT02166333|540743496|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
149894783|NCT02166333|540743497|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
149894784|NCT02166333|540743498|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
149894785|NCT02166333|540743493|FG000|Stage 2|Death|4|||
149894786|NCT02166333|540743494|FG001|Stage 2|Death|2|||
149894787|NCT02166333|540743495|FG002|Stage 2|Death|1|||
149975756|NCT00457392|541049414|FG000|Overall Study|Objective Progression or Relapse|229|||
149894788|NCT02166333|540743496|FG003|Stage 2|Death|0|||
149894789|NCT02166333|540743497|FG004|Stage 2|Death|0|||
149894790|NCT02166333|540743498|FG005|Stage 2|Death|1|||
149894791|NCT02166333|540743493|FG000|Stage 2|Lost to Follow-up|23|||
149894792|NCT02166333|540743494|FG001|Stage 2|Lost to Follow-up|4|||
149894793|NCT02166333|540743495|FG002|Stage 2|Lost to Follow-up|11|||
149894794|NCT02166333|540743496|FG003|Stage 2|Lost to Follow-up|9|||
149894795|NCT02166333|540743497|FG004|Stage 2|Lost to Follow-up|3|||
149894796|NCT02166333|540743498|FG005|Stage 2|Lost to Follow-up|6|||
149894797|NCT00503698|540743499|FG000|Overall Study|Protocol Violation|5|||
149894798|NCT00503698|540743500|FG001|Overall Study|Protocol Violation|6|||
149894799|NCT00503698|540743499|FG000|Overall Study|Adverse Event|52|||
149894800|NCT00503698|540743500|FG001|Overall Study|Adverse Event|41|||
149894801|NCT00503698|540743499|FG000|Overall Study|Death|1|||
149894802|NCT00503698|540743500|FG001|Overall Study|Death|0|||
149894803|NCT00503698|540743499|FG000|Overall Study|Lack of Efficacy|3|||
149894804|NCT00503698|540743500|FG001|Overall Study|Lack of Efficacy|4|||
149894805|NCT00503698|540743499|FG000|Overall Study|Trial terminated|216|||
149894806|NCT00503698|540743500|FG001|Overall Study|Trial terminated|253|||
149894807|NCT00503698|540743499|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
149894808|NCT00503698|540743500|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
149894809|NCT00503698|540743499|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
149894810|NCT00503698|540743500|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
149894811|NCT00503698|540743499|FG000|Overall Study|Any condition in exclusion criteria|4|||
149894812|NCT00503698|540743500|FG001|Overall Study|Any condition in exclusion criteria|6|||
149894813|NCT00503698|540743499|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
149894814|NCT00503698|540743500|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
149894815|NCT00503698|540743499|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
149894816|NCT00503698|540743500|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
149894817|NCT00503698|540743499|FG000|Overall Study|Critically ill|2|||
149894818|NCT00503698|540743500|FG001|Overall Study|Critically ill|0|||
149894819|NCT00503698|540743499|FG000|Overall Study|Unclassified|48|||
149894820|NCT00503698|540743500|FG001|Overall Study|Unclassified|32|||
149894821|NCT00503698|540743499|FG000|Overall Study|Not exposed to trial drug|11|||
149894822|NCT00503698|540743500|FG001|Overall Study|Not exposed to trial drug|6|||
149894823|NCT02269098|540743501|FG000|Overall Study|Lost to Follow-up|14|||
149894824|NCT02269098|540743502|FG001|Overall Study|Lost to Follow-up|9|||
149894825|NCT03644342|540743504|FG000|Overall Study|Adverse Event|2|||
149894826|NCT03644342|540743505|FG001|Overall Study|Adverse Event|0|||
149894827|NCT03644342|540743504|FG000|Overall Study|Protocol Violation|0|||
149894828|NCT03644342|540743505|FG001|Overall Study|Protocol Violation|1|||
149894829|NCT05514873|540743514|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
149894830|NCT05514873|540743514|FG000|Main Treatment Period|Adverse Event|2|||
149894831|NCT05514873|540743514|FG000|Extension Treatment Period|Lost to Follow-up|3|||
149894832|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
149894833|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
149894834|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
149894835|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
149894836|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
149894837|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
149894838|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
149894839|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
149894840|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
149894841|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
149894842|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
149894843|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
149894844|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
149894845|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
149894846|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
149894847|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
149894848|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
149894849|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
149894850|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
149894851|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
149894852|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
149894853|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
149894854|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
149894855|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
149894856|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
149894857|NCT03525678|540743517|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
149894858|NCT03525678|540743518|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
149894859|NCT03525678|540743519|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
150176096|NCT01039688|541781894|FG000|Overall Study|Other|13|||
150176097|NCT01039688|541781895|FG001|Overall Study|Other|25|||
150176098|NCT01039688|541781896|FG002|Overall Study|Other|12|||
150176099|NCT01039688|541781894|FG000|Overall Study|Withdrawal by Subject|23|||
150176100|NCT01039688|541781895|FG001|Overall Study|Withdrawal by Subject|27|||
150176101|NCT01039688|541781896|FG002|Overall Study|Withdrawal by Subject|13|||
150176102|NCT01039688|541781894|FG000|Overall Study|Death|2|||
150176103|NCT01039688|541781895|FG001|Overall Study|Death|0|||
150176104|NCT01039688|541781896|FG002|Overall Study|Death|0|||
150176105|NCT03520413|541781900|FG000|Overall Study|Lost to Follow-up|1|||
149894860|NCT03525678|540743520|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
149894861|NCT03525678|540743521|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
149894862|NCT01102257|540745204|FG000|Overall Study|Adverse Event|1|||
149894863|NCT01102257|540745205|FG001|Overall Study|Adverse Event|0|||
149894864|NCT01102257|540745204|FG000|Overall Study|Adverse Event|1|||
149894865|NCT01102257|540745205|FG001|Overall Study|Adverse Event|0|||
149894866|NCT04066244|540745206|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
149894867|NCT04066244|540745207|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
149894868|NCT04066244|540745208|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
149894869|NCT04066244|540745209|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
149894870|NCT04066244|540745210|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
149894871|NCT04066244|540745211|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
149894872|NCT04066244|540745206|FG000|Part 2 (Cohort 5)|Death|0|||
149894873|NCT04066244|540745207|FG001|Part 2 (Cohort 5)|Death|0|||
149894874|NCT04066244|540745208|FG002|Part 2 (Cohort 5)|Death|0|||
149894875|NCT04066244|540745209|FG003|Part 2 (Cohort 5)|Death|0|||
149894876|NCT04066244|540745210|FG004|Part 2 (Cohort 5)|Death|0|||
149894877|NCT04066244|540745211|FG005|Part 2 (Cohort 5)|Death|2|||
149894878|NCT04066244|540745206|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
149894879|NCT04066244|540745207|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
149894880|NCT04066244|540745208|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
149894881|NCT04066244|540745209|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
149894882|NCT04066244|540745210|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
149894883|NCT04066244|540745211|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
149894884|NCT04066244|540745206|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
149894885|NCT04066244|540745207|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
149894886|NCT04066244|540745208|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
149894887|NCT04066244|540745209|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
149894888|NCT04066244|540745210|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
149894889|NCT04066244|540745211|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
149894890|NCT03752970|540745212|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
149894891|NCT03752970|540745213|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
150176106|NCT03520413|541781901|FG001|Overall Study|Lost to Follow-up|1|||
150176107|NCT03520413|541781900|FG000|Overall Study|Withdrawal by Subject|1|||
150176108|NCT03520413|541781901|FG001|Overall Study|Withdrawal by Subject|2|||
150176109|NCT03520413|541781900|FG000|Overall Study|Death|0|||
149894892|NCT03752970|540745214|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
149894893|NCT03752970|540745212|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
149894894|NCT03752970|540745213|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
149894895|NCT03752970|540745214|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
149894896|NCT03752970|540745212|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
149894897|NCT03752970|540745213|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
149894898|NCT03752970|540745214|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
149894899|NCT03752970|540745212|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
149894900|NCT03752970|540745213|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
149894901|NCT03752970|540745214|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
149894902|NCT03752970|540745212|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
149894903|NCT03752970|540745213|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
149894904|NCT03752970|540745214|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
149894905|NCT03976362|540745215|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
149894906|NCT03976362|540745216|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
149894907|NCT03976362|540745217|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
149894908|NCT03976362|540745215|FG000|Induction Phase|Death|62|||
149894909|NCT03976362|540745216|FG001|Induction Phase|Death|0|||
149894910|NCT03976362|540745217|FG002|Induction Phase|Death|0|||
149894911|NCT03976362|540745215|FG000|Maintenance Phase|Participants Ongoing|0|||
149894912|NCT03976362|540745216|FG001|Maintenance Phase|Participants Ongoing|106|||
149894913|NCT03976362|540745217|FG002|Maintenance Phase|Participants Ongoing|103|||
149894914|NCT03976362|540745215|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149894915|NCT03976362|540745216|FG001|Maintenance Phase|Withdrawal by Subject|4|||
149894916|NCT03976362|540745217|FG002|Maintenance Phase|Withdrawal by Subject|4|||
149894917|NCT03976362|540745215|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
149894918|NCT03976362|540745216|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
149894919|NCT03976362|540745217|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
149894920|NCT03976362|540745215|FG000|Maintenance Phase|Death|0|||
149894921|NCT03976362|540745216|FG001|Maintenance Phase|Death|186|||
149894922|NCT03976362|540745217|FG002|Maintenance Phase|Death|187|||
149894923|NCT04767282|540745218|FG000|Overall Study|Refused or did not begin surveys|6|||
149894924|NCT04767282|540745219|FG001|Overall Study|Refused or did not begin surveys|2|||
149894925|NCT04767282|540745220|FG002|Overall Study|Refused or did not begin surveys|2|||
149894926|NCT04767282|540745218|FG000|Overall Study|Duplicate household previously enrolled|2|||
149894927|NCT04767282|540745219|FG001|Overall Study|Duplicate household previously enrolled|0|||
149894928|NCT04767282|540745220|FG002|Overall Study|Duplicate household previously enrolled|8|||
149894929|NCT04767282|540745218|FG000|Overall Study|Unable to confirm legal guardian|0|||
149894930|NCT04767282|540745219|FG001|Overall Study|Unable to confirm legal guardian|2|||
149894931|NCT04767282|540745220|FG002|Overall Study|Unable to confirm legal guardian|8|||
149894932|NCT04767282|540745218|FG000|Overall Study|Withdrawal by Subject|0|||
149894933|NCT04767282|540745219|FG001|Overall Study|Withdrawal by Subject|0|||
149894934|NCT04767282|540745220|FG002|Overall Study|Withdrawal by Subject|6|||
149894935|NCT04767282|540745218|FG000|Overall Study|Survey comprehension challenges|4|||
149894936|NCT04767282|540745219|FG001|Overall Study|Survey comprehension challenges|0|||
149894937|NCT04767282|540745220|FG002|Overall Study|Survey comprehension challenges|0|||
149894938|NCT01467713|540745222|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
149894939|NCT01467713|540745223|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
149894940|NCT01467713|540745224|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
149894941|NCT01467713|540745225|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
149894942|NCT01467713|540745222|FG000|Overall Study|Major Protocol Deviation|2|||
149894943|NCT01467713|540745223|FG001|Overall Study|Major Protocol Deviation|4|||
149894944|NCT01467713|540745224|FG002|Overall Study|Major Protocol Deviation|4|||
149894945|NCT01467713|540745225|FG003|Overall Study|Major Protocol Deviation|1|||
149894946|NCT01467713|540745222|FG000|Overall Study|Lost to Follow-up|9|||
149894947|NCT01467713|540745223|FG001|Overall Study|Lost to Follow-up|12|||
149894948|NCT01467713|540745224|FG002|Overall Study|Lost to Follow-up|6|||
149894949|NCT01467713|540745225|FG003|Overall Study|Lost to Follow-up|9|||
149894950|NCT01467713|540745222|FG000|Overall Study|Voluntary Withdrawal|18|||
149894951|NCT01467713|540745223|FG001|Overall Study|Voluntary Withdrawal|14|||
149894952|NCT01467713|540745224|FG002|Overall Study|Voluntary Withdrawal|21|||
149894953|NCT01467713|540745225|FG003|Overall Study|Voluntary Withdrawal|20|||
149894954|NCT01467713|540745222|FG000|Overall Study|Study Termination|23|||
149894955|NCT01467713|540745223|FG001|Overall Study|Study Termination|33|||
149894956|NCT01467713|540745224|FG002|Overall Study|Study Termination|28|||
149894957|NCT01467713|540745225|FG003|Overall Study|Study Termination|29|||
149894958|NCT01467713|540745222|FG000|Overall Study|Pregnancy|0|||
149894959|NCT01467713|540745223|FG001|Overall Study|Pregnancy|1|||
149894960|NCT01467713|540745224|FG002|Overall Study|Pregnancy|1|||
149894961|NCT01467713|540745225|FG003|Overall Study|Pregnancy|3|||
149894962|NCT01467713|540745222|FG000|Overall Study|Relapse|35|||
149894963|NCT01467713|540745223|FG001|Overall Study|Relapse|25|||
149894964|NCT01467713|540745224|FG002|Overall Study|Relapse|28|||
149894965|NCT01467713|540745225|FG003|Overall Study|Relapse|35|||
149894966|NCT01467713|540745222|FG000|Overall Study|Reason not Specified|6|||
149894967|NCT01467713|540745223|FG001|Overall Study|Reason not Specified|11|||
149894968|NCT01467713|540745224|FG002|Overall Study|Reason not Specified|8|||
149894969|NCT01467713|540745225|FG003|Overall Study|Reason not Specified|7|||
149894970|NCT01120184|540745230|FG000|Overall Study|Adverse Event|0|||
149894971|NCT01120184|540745231|FG001|Overall Study|Adverse Event|1|||
149894972|NCT01120184|540745232|FG002|Overall Study|Adverse Event|0|||
149894973|NCT01120184|540745230|FG000|Overall Study|Lost to Follow-up|13|||
149894974|NCT01120184|540745231|FG001|Overall Study|Lost to Follow-up|13|||
149894975|NCT01120184|540745232|FG002|Overall Study|Lost to Follow-up|11|||
149894976|NCT01120184|540745230|FG000|Overall Study|Physician Decision|9|||
149894977|NCT01120184|540745231|FG001|Overall Study|Physician Decision|1|||
149894978|NCT01120184|540745232|FG002|Overall Study|Physician Decision|3|||
149894979|NCT01120184|540745230|FG000|Overall Study|Reason not Specified|8|||
149894980|NCT01120184|540745231|FG001|Overall Study|Reason not Specified|3|||
149894981|NCT01120184|540745232|FG002|Overall Study|Reason not Specified|12|||
149894982|NCT01120184|540745230|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
149894983|NCT01120184|540745231|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
149894984|NCT01120184|540745232|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
149894985|NCT01120184|540745230|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
149894986|NCT01120184|540745231|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
149894987|NCT01120184|540745232|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
149894988|NCT01120184|540745230|FG000|Overall Study|Death|170|||
149894989|NCT01120184|540745231|FG001|Overall Study|Death|176|||
149894990|NCT01120184|540745232|FG002|Overall Study|Death|169|||
149894991|NCT02525783|540745233|FG000|Overall Study|Lost to Follow-up|10|||
149894992|NCT00824772|540745234|FG000|Overall Study|Withdrawal by Subject|8|||
149894993|NCT00536939|540745235|FG000|Overall Study|Withdrawal by Subject|1|||
149894994|NCT00536939|540745236|FG001|Overall Study|Withdrawal by Subject|0|||
149894995|NCT00536939|540745235|FG000|Overall Study|Other Complicating Disease|1|||
150045332|NCT00485134|541305567|FG005|Overall Study|Non-compliance|2|||
150045333|NCT00485134|541305568|FG006|Overall Study|Non-compliance|2|||
150045334|NCT00485134|541305569|FG007|Overall Study|Non-compliance|0|||
150045335|NCT00485134|541305562|FG000|Overall Study|Unable to comply with study schedule|0|||
150045336|NCT00485134|541305563|FG001|Overall Study|Unable to comply with study schedule|0|||
150045337|NCT00485134|541305564|FG002|Overall Study|Unable to comply with study schedule|0|||
150045338|NCT00485134|541305565|FG003|Overall Study|Unable to comply with study schedule|0|||
150045339|NCT00485134|541305566|FG004|Overall Study|Unable to comply with study schedule|0|||
150045340|NCT00485134|541305567|FG005|Overall Study|Unable to comply with study schedule|0|||
150045341|NCT00485134|541305568|FG006|Overall Study|Unable to comply with study schedule|0|||
150045342|NCT00485134|541305569|FG007|Overall Study|Unable to comply with study schedule|1|||
150045343|NCT00485134|541305562|FG000|Overall Study|Pregnancy|0|||
150045344|NCT00485134|541305563|FG001|Overall Study|Pregnancy|0|||
150045345|NCT00485134|541305564|FG002|Overall Study|Pregnancy|0|||
150045346|NCT00485134|541305565|FG003|Overall Study|Pregnancy|0|||
150045347|NCT00485134|541305566|FG004|Overall Study|Pregnancy|0|||
149894996|NCT00536939|540745236|FG001|Overall Study|Other Complicating Disease|0|||
149894997|NCT01100086|540745239|FG000|Period 1|Withdrawal by Subject|1|||
149894998|NCT01100086|540745240|FG001|Period 1|Withdrawal by Subject|0|||
149894999|NCT05266053|540745256|FG000|Overall Study|Withdrawal by Subject|8|||
149895000|NCT05266053|540745257|FG001|Overall Study|Withdrawal by Subject|4|||
149895001|NCT03817853|540745258|FG000|Induction Phase|Adverse Event|5|||
149895002|NCT03817853|540745259|FG001|Induction Phase|Adverse Event|0|||
149895003|NCT03817853|540745260|FG002|Induction Phase|Adverse Event|0|||
149895004|NCT03817853|540745258|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
149895005|NCT03817853|540745259|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
150045348|NCT00485134|541305567|FG005|Overall Study|Pregnancy|0|||
150045349|NCT00485134|541305568|FG006|Overall Study|Pregnancy|1|||
150045350|NCT00485134|541305569|FG007|Overall Study|Pregnancy|0|||
150045351|NCT00970684|541305570|FG000|Overall Study|Lack of Efficacy|5|||
150045352|NCT00970684|541305570|FG000|Overall Study|Adverse Event|4|||
149895006|NCT03817853|540745260|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
149895007|NCT03817853|540745258|FG000|Induction Phase|Physician Decision|2|||
149895008|NCT03817853|540745259|FG001|Induction Phase|Physician Decision|0|||
149895009|NCT03817853|540745260|FG002|Induction Phase|Physician Decision|0|||
149895010|NCT03817853|540745258|FG000|Induction Phase|Progressive Disease|6|||
149895011|NCT03817853|540745259|FG001|Induction Phase|Progressive Disease|0|||
149895012|NCT03817853|540745260|FG002|Induction Phase|Progressive Disease|0|||
149895013|NCT03817853|540745258|FG000|Induction Phase|Withdrawal by Subject|4|||
149895014|NCT03817853|540745259|FG001|Induction Phase|Withdrawal by Subject|0|||
149895015|NCT03817853|540745260|FG002|Induction Phase|Withdrawal by Subject|0|||
149895016|NCT03817853|540745258|FG000|Maintenance Phase|Adverse Event|0|||
149895017|NCT03817853|540745259|FG001|Maintenance Phase|Adverse Event|8|||
149895018|NCT03817853|540745260|FG002|Maintenance Phase|Adverse Event|0|||
149895019|NCT03817853|540745258|FG000|Maintenance Phase|Death|0|||
149895020|NCT03817853|540745259|FG001|Maintenance Phase|Death|5|||
149895021|NCT03817853|540745260|FG002|Maintenance Phase|Death|0|||
149895022|NCT03817853|540745258|FG000|Maintenance Phase|Progressive Disease|0|||
149895023|NCT03817853|540745259|FG001|Maintenance Phase|Progressive Disease|7|||
149895024|NCT03817853|540745260|FG002|Maintenance Phase|Progressive Disease|0|||
149895025|NCT03817853|540745258|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149895026|NCT03817853|540745259|FG001|Maintenance Phase|Withdrawal by Subject|2|||
149895027|NCT03817853|540745260|FG002|Maintenance Phase|Withdrawal by Subject|0|||
149895028|NCT03817853|540745258|FG000|Maintenance Phase|Physician Decision|0|||
149895029|NCT03817853|540745259|FG001|Maintenance Phase|Physician Decision|1|||
149895030|NCT03817853|540745260|FG002|Maintenance Phase|Physician Decision|0|||
149895031|NCT03817853|540745258|FG000|Maintenance Phase|Various reasons|0|||
149895032|NCT03817853|540745259|FG001|Maintenance Phase|Various reasons|4|||
149895033|NCT03817853|540745260|FG002|Maintenance Phase|Various reasons|0|||
149895034|NCT03817853|540745258|FG000|Maintenance Phase|Protocol Deviation|0|||
149895035|NCT03817853|540745259|FG001|Maintenance Phase|Protocol Deviation|1|||
149895036|NCT03817853|540745260|FG002|Maintenance Phase|Protocol Deviation|0|||
149895037|NCT03817853|540745258|FG000|Follow-up Phase|Adverse Event|0|||
149895038|NCT03817853|540745259|FG001|Follow-up Phase|Adverse Event|0|||
149895039|NCT03817853|540745260|FG002|Follow-up Phase|Adverse Event|2|||
149895040|NCT03817853|540745258|FG000|Follow-up Phase|Death|0|||
149895041|NCT03817853|540745259|FG001|Follow-up Phase|Death|0|||
149895042|NCT03817853|540745260|FG002|Follow-up Phase|Death|1|||
149895043|NCT03817853|540745258|FG000|Follow-up Phase|Progressive Disease|0|||
149895044|NCT03817853|540745259|FG001|Follow-up Phase|Progressive Disease|0|||
149895045|NCT03817853|540745260|FG002|Follow-up Phase|Progressive Disease|3|||
149895046|NCT03817853|540745258|FG000|Follow-up Phase|Withdrawal by Subject|0|||
149895047|NCT03817853|540745259|FG001|Follow-up Phase|Withdrawal by Subject|0|||
149895048|NCT03817853|540745260|FG002|Follow-up Phase|Withdrawal by Subject|1|||
149895049|NCT00391768|540745261|FG000|Overall Study|Withdrawal by Subject|0|||
149895050|NCT00391768|540745262|FG001|Overall Study|Withdrawal by Subject|0|||
149895051|NCT00391768|540745263|FG002|Overall Study|Withdrawal by Subject|1|||
149895052|NCT00391768|540745264|FG003|Overall Study|Withdrawal by Subject|0|||
149895053|NCT00391768|540745265|FG004|Overall Study|Withdrawal by Subject|0|||
149895054|NCT00391768|540745266|FG005|Overall Study|Withdrawal by Subject|1|||
149895055|NCT00391768|540745267|FG006|Overall Study|Withdrawal by Subject|1|||
149895056|NCT00391768|540745261|FG000|Overall Study|Lost to Follow-up|0|||
149895057|NCT00391768|540745262|FG001|Overall Study|Lost to Follow-up|0|||
149895058|NCT00391768|540745263|FG002|Overall Study|Lost to Follow-up|0|||
149895059|NCT00391768|540745264|FG003|Overall Study|Lost to Follow-up|1|||
149895060|NCT00391768|540745265|FG004|Overall Study|Lost to Follow-up|2|||
149895061|NCT00391768|540745266|FG005|Overall Study|Lost to Follow-up|2|||
149895062|NCT00391768|540745267|FG006|Overall Study|Lost to Follow-up|3|||
149895063|NCT00891020|540745269|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
149895064|NCT00891020|540745270|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
149895065|NCT00891020|540745271|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
149895066|NCT00891020|540745269|FG000|24 Week Treatment Period|Death|0|||
149895067|NCT00891020|540745270|FG001|24 Week Treatment Period|Death|2|||
149895068|NCT00891020|540745271|FG002|24 Week Treatment Period|Death|0|||
149895069|NCT00891020|540745269|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
149895070|NCT00891020|540745270|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
149895071|NCT00891020|540745271|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
149895072|NCT00891020|540745269|FG000|24 Week Treatment Period|Failure to return|4|||
149895073|NCT00891020|540745270|FG001|24 Week Treatment Period|Failure to return|5|||
149895074|NCT00891020|540745271|FG002|24 Week Treatment Period|Failure to return|5|||
149895075|NCT00891020|540745269|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
149895076|NCT00891020|540745270|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
149895077|NCT00891020|540745271|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
149895078|NCT00891020|540745269|FG000|24 Week Treatment Period|Other protocol violation|1|||
149895079|NCT00891020|540745270|FG001|24 Week Treatment Period|Other protocol violation|1|||
149895080|NCT00891020|540745271|FG002|24 Week Treatment Period|Other protocol violation|2|||
149895081|NCT00891020|540745269|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
149895082|NCT00891020|540745270|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
149895083|NCT00891020|540745271|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
149895084|NCT00891020|540745269|FG000|24 Week Treatment Period|Withdrew consent|6|||
149895085|NCT00891020|540745270|FG001|24 Week Treatment Period|Withdrew consent|3|||
149895086|NCT00891020|540745271|FG002|24 Week Treatment Period|Withdrew consent|15|||
149895087|NCT00891020|540745269|FG000|24 Week Treatment Period|Administrative/Other|5|||
149895088|NCT00891020|540745270|FG001|24 Week Treatment Period|Administrative/Other|6|||
149895089|NCT00891020|540745271|FG002|24 Week Treatment Period|Administrative/Other|1|||
149895090|NCT00891020|540745269|FG000|Long-term Extension Period|Adverse Event|1|||
149895091|NCT00891020|540745270|FG001|Long-term Extension Period|Adverse Event|11|||
149895092|NCT00891020|540745271|FG002|Long-term Extension Period|Adverse Event|10|||
149895093|NCT00891020|540745269|FG000|Long-term Extension Period|Death|0|||
149895094|NCT00891020|540745270|FG001|Long-term Extension Period|Death|0|||
149895095|NCT00891020|540745271|FG002|Long-term Extension Period|Death|1|||
149895096|NCT00891020|540745269|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
149895097|NCT00891020|540745270|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
149895098|NCT00891020|540745271|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
149895099|NCT00891020|540745269|FG000|Long-term Extension Period|Protocol Violation|0|||
149895100|NCT00891020|540745270|FG001|Long-term Extension Period|Protocol Violation|1|||
149895101|NCT00891020|540745271|FG002|Long-term Extension Period|Protocol Violation|1|||
149895102|NCT00891020|540745269|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
149895103|NCT00891020|540745270|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
149895104|NCT00891020|540745271|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
149895105|NCT00891020|540745269|FG000|Long-term Extension Period|Failure to return|0|||
149895106|NCT00891020|540745270|FG001|Long-term Extension Period|Failure to return|2|||
149895107|NCT00891020|540745271|FG002|Long-term Extension Period|Failure to return|3|||
149895108|NCT00891020|540745269|FG000|Long-term Extension Period|Administrative|1|||
149895109|NCT00891020|540745270|FG001|Long-term Extension Period|Administrative|2|||
149895110|NCT00891020|540745271|FG002|Long-term Extension Period|Administrative|2|||
149895111|NCT00320710|540745272|FG000|Overall Study|Disease progression|24|||
149895112|NCT00320710|540745273|FG001|Overall Study|Disease progression|19|||
149895113|NCT00320710|540745274|FG002|Overall Study|Disease progression|2|||
149895114|NCT00320710|540745272|FG000|Overall Study|Death|10|||
149895115|NCT00320710|540745273|FG001|Overall Study|Death|7|||
149895116|NCT00320710|540745274|FG002|Overall Study|Death|1|||
149895117|NCT00320710|540745272|FG000|Overall Study|Administrative problems|1|||
149895118|NCT00320710|540745273|FG001|Overall Study|Administrative problems|2|||
149895119|NCT00320710|540745274|FG002|Overall Study|Administrative problems|0|||
149895120|NCT00320710|540745272|FG000|Overall Study|Withdrawal by Subject|20|||
149895121|NCT00320710|540745273|FG001|Overall Study|Withdrawal by Subject|26|||
149895122|NCT00320710|540745274|FG002|Overall Study|Withdrawal by Subject|1|||
149895123|NCT00320710|540745272|FG000|Overall Study|Protocol Violation|6|||
149895124|NCT00320710|540745273|FG001|Overall Study|Protocol Violation|5|||
149895125|NCT00320710|540745274|FG002|Overall Study|Protocol Violation|0|||
149895126|NCT00320710|540745272|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149895127|NCT00320710|540745273|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149895128|NCT00320710|540745274|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149895129|NCT00320710|540745272|FG000|Overall Study|Abnormal laboratory value(s)|12|||
149895130|NCT00320710|540745273|FG001|Overall Study|Abnormal laboratory value(s)|3|||
149895131|NCT00320710|540745274|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149895132|NCT00320710|540745272|FG000|Overall Study|Adverse Event|18|||
149895133|NCT00320710|540745273|FG001|Overall Study|Adverse Event|14|||
149895134|NCT00320710|540745274|FG002|Overall Study|Adverse Event|1|||
149895135|NCT00320710|540745272|FG000|Overall Study|Lost to Follow-up|1|||
149895136|NCT00320710|540745273|FG001|Overall Study|Lost to Follow-up|0|||
149895137|NCT00320710|540745274|FG002|Overall Study|Lost to Follow-up|0|||
149895138|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
149895139|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895140|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895141|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895142|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
149895143|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
149895144|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
149895145|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
149895146|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
149895147|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
149895148|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
149895149|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
149895150|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
149895151|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895152|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895153|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895154|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
149895155|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895156|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895157|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895158|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
149895159|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895160|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895161|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895162|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
149895163|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
149895164|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
149895165|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
149895166|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
149895167|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
149895168|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
149895169|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
149895170|NCT00506415|540745276|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
149895171|NCT00506415|540745277|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895172|NCT00506415|540745278|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895173|NCT00506415|540745279|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895174|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
149895175|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
149895176|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
149895177|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
149895178|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
149895179|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
149895180|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
149895181|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
149895182|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
149895183|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
149895184|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
149895185|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
149895186|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
149895187|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
149895188|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
149895189|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
149895190|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
149895191|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
149895192|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
149895193|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
149895194|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
149895195|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
149895196|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
149968662|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
149968663|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
149968664|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
149968665|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
149968666|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
149968667|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
149968668|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
149968669|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
149968670|NCT03093415|541022021|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
149968671|NCT03093415|541022022|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
149968672|NCT03093415|541022023|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
149968673|NCT03093415|541022021|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
149968674|NCT03093415|541022022|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
149968675|NCT03093415|541022023|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
149968676|NCT01559935|541022028|FG000|Car Phase|Toxicity|4|||
149968677|NCT01559935|541022028|FG000|Car Phase|Death|1|||
149968678|NCT01559935|541022028|FG000|Car Phase|Lack of Efficacy|2|||
149968679|NCT01559935|541022028|FG000|Car Phase|Lost to Follow-up|1|||
149895197|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
149895198|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
149895199|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
149895200|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
149895201|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
149895202|NCT00506415|540745276|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
149895203|NCT00506415|540745277|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
149895204|NCT00506415|540745278|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
149895205|NCT00506415|540745279|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
149895206|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
149895207|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
149895208|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
149895209|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
149895210|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895211|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895212|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
149895213|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
149895214|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895215|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895216|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
149895217|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
149895218|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895219|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895220|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
149895221|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
149895222|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895223|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895224|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
149895225|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
149895226|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895227|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895228|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
149895229|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
149895230|NCT00506415|540745276|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
149895231|NCT00506415|540745277|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
149895232|NCT00506415|540745278|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
149895233|NCT00506415|540745279|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
149895234|NCT04578457|540745280|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
149895235|NCT04578457|540745280|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
149895236|NCT04578457|540745280|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
149895237|NCT04578457|540745280|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
149895238|NCT00997373|540745281|FG000|Overall Study|Withdrawal by Subject|5|||
149895239|NCT00997373|540745282|FG001|Overall Study|Withdrawal by Subject|0|||
149895240|NCT00997373|540745281|FG000|Overall Study|wrong tumor type|4|||
149895241|NCT00997373|540745282|FG001|Overall Study|wrong tumor type|0|||
149895242|NCT00997373|540745281|FG000|Overall Study|could not have hysterectomy|6|||
149895243|NCT00997373|540745282|FG001|Overall Study|could not have hysterectomy|0|||
149895244|NCT02841995|540745283|FG000|Overall Study|Disease progression|5|||
149895245|NCT02841995|540745284|FG001|Overall Study|Disease progression|11|||
149895246|NCT02841995|540745285|FG002|Overall Study|Disease progression|8|||
149895247|NCT02841995|540745283|FG000|Overall Study|Withdrawal by Subject|2|||
149895248|NCT02841995|540745284|FG001|Overall Study|Withdrawal by Subject|4|||
149895249|NCT02841995|540745285|FG002|Overall Study|Withdrawal by Subject|4|||
149895250|NCT02841995|540745283|FG000|Overall Study|Adverse Event|2|||
149895251|NCT02841995|540745284|FG001|Overall Study|Adverse Event|0|||
149895252|NCT02841995|540745285|FG002|Overall Study|Adverse Event|1|||
149895253|NCT02841995|540745283|FG000|Overall Study|Investigator decision|2|||
149895254|NCT02841995|540745284|FG001|Overall Study|Investigator decision|0|||
149895255|NCT02841995|540745285|FG002|Overall Study|Investigator decision|1|||
149895256|NCT02841995|540745283|FG000|Overall Study|Death|0|||
149895257|NCT02841995|540745284|FG001|Overall Study|Death|0|||
149895258|NCT02841995|540745285|FG002|Overall Study|Death|2|||
149895259|NCT02841995|540745283|FG000|Overall Study|Noncompliance to protocol|1|||
149895260|NCT02841995|540745284|FG001|Overall Study|Noncompliance to protocol|0|||
149895261|NCT02841995|540745285|FG002|Overall Study|Noncompliance to protocol|0|||
149895262|NCT02841995|540745283|FG000|Overall Study|Sponsor decision|1|||
149895263|NCT02841995|540745284|FG001|Overall Study|Sponsor decision|0|||
149895264|NCT02841995|540745285|FG002|Overall Study|Sponsor decision|0|||
149895265|NCT02841995|540745283|FG000|Overall Study|Other|4|||
149895266|NCT02841995|540745284|FG001|Overall Study|Other|1|||
149895267|NCT02841995|540745285|FG002|Overall Study|Other|5|||
149895268|NCT03809663|540745292|FG000|Overall Study|Decision by sponsor|24|||
149895269|NCT03809663|540745293|FG001|Overall Study|Decision by sponsor|18|||
149895270|NCT03809663|540745294|FG002|Overall Study|Decision by sponsor|20|||
149895271|NCT03809663|540745295|FG003|Overall Study|Decision by sponsor|20|||
149895272|NCT03809663|540745296|FG004|Overall Study|Decision by sponsor|0|||
149895273|NCT03809663|540745297|FG005|Overall Study|Decision by sponsor|0|||
149895274|NCT03809663|540745292|FG000|Overall Study|Withdrawal by Subject|26|||
149895275|NCT03809663|540745293|FG001|Overall Study|Withdrawal by Subject|22|||
149895276|NCT03809663|540745294|FG002|Overall Study|Withdrawal by Subject|27|||
149895277|NCT03809663|540745295|FG003|Overall Study|Withdrawal by Subject|26|||
149895278|NCT03809663|540745296|FG004|Overall Study|Withdrawal by Subject|0|||
149895279|NCT03809663|540745297|FG005|Overall Study|Withdrawal by Subject|0|||
149895280|NCT03809663|540745292|FG000|Overall Study|Lost to Follow-up|1|||
149895281|NCT03809663|540745293|FG001|Overall Study|Lost to Follow-up|4|||
149895282|NCT03809663|540745294|FG002|Overall Study|Lost to Follow-up|1|||
149895283|NCT03809663|540745295|FG003|Overall Study|Lost to Follow-up|1|||
149895284|NCT03809663|540745296|FG004|Overall Study|Lost to Follow-up|0|||
149895285|NCT03809663|540745297|FG005|Overall Study|Lost to Follow-up|0|||
149895286|NCT03376789|540745299|FG000|Overall Study|Withdrawal by Subject|3|||
149895287|NCT03376789|540745300|FG001|Overall Study|Withdrawal by Subject|5|||
149895288|NCT03376789|540745299|FG000|Overall Study|Protocol Violation|0|||
149895289|NCT03376789|540745300|FG001|Overall Study|Protocol Violation|1|||
149895290|NCT03376789|540745299|FG000|Overall Study|Adverse Event|0|||
149895291|NCT03376789|540745300|FG001|Overall Study|Adverse Event|1|||
149895292|NCT03376789|540745299|FG000|Overall Study|Lost to Follow-up|1|||
149895293|NCT03376789|540745300|FG001|Overall Study|Lost to Follow-up|1|||
149895294|NCT03376789|540745299|FG000|Overall Study|Per sponsor due to noncompliance|1|||
149895295|NCT03376789|540745300|FG001|Overall Study|Per sponsor due to noncompliance|0|||
149895296|NCT03376789|540745299|FG000|Overall Study|Subject off study medication|0|||
149895297|NCT03376789|540745300|FG001|Overall Study|Subject off study medication|1|||
149895298|NCT01703260|540745301|FG000|Overall Study|Adverse Event|1|||
149895299|NCT01703260|540745302|FG001|Overall Study|Adverse Event|2|||
149895300|NCT01703260|540745303|FG002|Overall Study|Adverse Event|2|||
149895301|NCT01703260|540745301|FG000|Overall Study|Lost to Follow-up|1|||
149895302|NCT01703260|540745302|FG001|Overall Study|Lost to Follow-up|0|||
149895303|NCT01703260|540745303|FG002|Overall Study|Lost to Follow-up|0|||
149895304|NCT01703260|540745301|FG000|Overall Study|Withdrawal by Subject|0|||
149895305|NCT01703260|540745302|FG001|Overall Study|Withdrawal by Subject|0|||
149895306|NCT01703260|540745303|FG002|Overall Study|Withdrawal by Subject|1|||
149895307|NCT01703260|540745301|FG000|Overall Study|Study Termination|1|||
149895308|NCT01703260|540745302|FG001|Overall Study|Study Termination|2|||
149895309|NCT01703260|540745303|FG002|Overall Study|Study Termination|0|||
149895310|NCT02275819|540745307|FG000|Overall Study|Adverse Event|0|||
149895311|NCT02275819|540745308|FG001|Overall Study|Adverse Event|1|||
149895312|NCT02198664|540745312|FG000|Overall Study|Adverse Event|2|||
149895313|NCT02198664|540745313|FG001|Overall Study|Adverse Event|0|||
149895314|NCT02198664|540745312|FG000|Overall Study|Withdrawal by Subject|11|||
149895315|NCT02198664|540745313|FG001|Overall Study|Withdrawal by Subject|8|||
149895316|NCT02198664|540745312|FG000|Overall Study|Failure to tolerate|2|||
149895317|NCT02198664|540745313|FG001|Overall Study|Failure to tolerate|0|||
149895318|NCT02198664|540745312|FG000|Overall Study|Not stated|1|||
149895319|NCT02198664|540745313|FG001|Overall Study|Not stated|0|||
150045353|NCT00970684|541305570|FG000|Overall Study|Withdrawal by Subject|1|||
150045354|NCT04294680|541305571|FG000|Overall Study|Withdrawal by Subject|2|||
149895320|NCT02632409|540745314|FG000|Randomized|AE unrelated to study Drug|0|||
149895321|NCT02632409|540745315|FG001|Randomized|AE unrelated to study Drug|1|||
149895322|NCT02632409|540745314|FG000|Randomized|Participant withdrew consent|2|||
149895323|NCT02632409|540745315|FG001|Randomized|Participant withdrew consent|1|||
149895324|NCT02632409|540745314|FG000|Randomized|No Longer meets study criteria|5|||
149895325|NCT02632409|540745315|FG001|Randomized|No Longer meets study criteria|0|||
149895326|NCT02632409|540745314|FG000|Randomized|other reasons|1|||
149895327|NCT02632409|540745315|FG001|Randomized|other reasons|0|||
149895328|NCT02632409|540745314|FG000|Treatment Period|Ongoing Treatment|20|||
149895329|NCT02632409|540745315|FG001|Treatment Period|Ongoing Treatment|21|||
149895330|NCT02632409|540745314|FG000|Treatment Period|Disease Recurrence|147|||
150045355|NCT04294680|541305572|FG001|Overall Study|Withdrawal by Subject|1|||
149895331|NCT02632409|540745315|FG001|Treatment Period|Disease Recurrence|90|||
149895332|NCT02632409|540745314|FG000|Treatment Period|Study Drug Toxicity|8|||
149895333|NCT02632409|540745315|FG001|Treatment Period|Study Drug Toxicity|49|||
149895334|NCT02632409|540745314|FG000|Treatment Period|Death|1|||
149895335|NCT02632409|540745315|FG001|Treatment Period|Death|0|||
149895336|NCT02632409|540745314|FG000|Treatment Period|AE unrelated to study drug|15|||
149895337|NCT02632409|540745315|FG001|Treatment Period|AE unrelated to study drug|16|||
149895338|NCT02632409|540745314|FG000|Treatment Period|Request to discontinue treatment|4|||
149895339|NCT02632409|540745315|FG001|Treatment Period|Request to discontinue treatment|19|||
150045356|NCT04294680|541305571|FG000|Overall Study|Follow-up visits completed outside of window|1|||
149895340|NCT02632409|540745314|FG000|Treatment Period|Participant withdrew consent|7|||
149895341|NCT02632409|540745315|FG001|Treatment Period|Participant withdrew consent|5|||
149895342|NCT02632409|540745314|FG000|Treatment Period|Lost to Follow-up|0|||
149895343|NCT02632409|540745315|FG001|Treatment Period|Lost to Follow-up|1|||
149895344|NCT02632409|540745314|FG000|Treatment Period|Maximum clinical benefit|1|||
149895345|NCT02632409|540745315|FG001|Treatment Period|Maximum clinical benefit|0|||
149895346|NCT02632409|540745314|FG000|Treatment Period|No longer meets study criteria|3|||
149895347|NCT02632409|540745315|FG001|Treatment Period|No longer meets study criteria|0|||
149895348|NCT02632409|540745314|FG000|Treatment Period|Administrative Reason by sponsor|0|||
149895349|NCT02632409|540745315|FG001|Treatment Period|Administrative Reason by sponsor|1|||
149895350|NCT02632409|540745314|FG000|Treatment Period|Other Reasons|10|||
149895351|NCT02632409|540745315|FG001|Treatment Period|Other Reasons|6|||
149895352|NCT05600283|540745316|FG000|Overall Study|Withdrawal by Subject|3|||
149895353|NCT05600283|540745317|FG001|Overall Study|Withdrawal by Subject|8|||
149895354|NCT05600283|540745316|FG000|Overall Study|invalid individual swab|1|||
149895355|NCT05600283|540745317|FG001|Overall Study|invalid individual swab|0|||
149895356|NCT05600283|540745316|FG000|Overall Study|missing clinician collection|3|||
149895357|NCT05600283|540745317|FG001|Overall Study|missing clinician collection|0|||
149895358|NCT05600283|540745316|FG000|Overall Study|screening failure|0|||
149895359|NCT05600283|540745317|FG001|Overall Study|screening failure|2|||
149895360|NCT01000155|540745318|FG000|Overall Study|Withdrawal by Subject|1|||
149895361|NCT01000155|540745318|FG000|Overall Study|Adverse Event|1|||
149895362|NCT00720213|540745321|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
149895363|NCT00720213|540745322|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
149895364|NCT00720213|540745323|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
149895365|NCT01420068|540745329|FG000|Overall Study|Administrative problems|1|||
149895366|NCT01420068|540745330|FG001|Overall Study|Administrative problems|3|||
149895367|NCT01420068|540745329|FG000|Overall Study|Withdrawal by Subject|1|||
149895368|NCT01420068|540745330|FG001|Overall Study|Withdrawal by Subject|2|||
149895369|NCT01252095|540745331|FG000|Overall Study|Disease progression|1|||
149895370|NCT01252095|540745332|FG001|Overall Study|Disease progression|0|||
149895371|NCT00365794|540745333|FG000|Overall Study|Withdrawal by Subject|2|||
149895372|NCT02554682|540745334|FG000|Overall Study|Lost to Follow-up|11|||
149895373|NCT02554682|540745335|FG001|Overall Study|Lost to Follow-up|9|||
149895374|NCT02554682|540745336|FG002|Overall Study|Lost to Follow-up|4|||
149895375|NCT02554682|540745337|FG003|Overall Study|Lost to Follow-up|3|||
149895376|NCT02554682|540745338|FG004|Overall Study|Lost to Follow-up|2|||
149895377|NCT02554682|540745339|FG005|Overall Study|Lost to Follow-up|1|||
149895378|NCT02554682|540745340|FG006|Overall Study|Lost to Follow-up|6|||
149895379|NCT02554682|540745341|FG007|Overall Study|Lost to Follow-up|6|||
149895380|NCT02554682|540745342|FG008|Overall Study|Lost to Follow-up|2|||
149895381|NCT02554682|540745343|FG009|Overall Study|Lost to Follow-up|2|||
149895382|NCT02554682|540745334|FG000|Overall Study|Withdrawal by Subject|2|||
149895383|NCT02554682|540745335|FG001|Overall Study|Withdrawal by Subject|1|||
149895384|NCT02554682|540745336|FG002|Overall Study|Withdrawal by Subject|0|||
149895385|NCT02554682|540745337|FG003|Overall Study|Withdrawal by Subject|0|||
149895386|NCT02554682|540745338|FG004|Overall Study|Withdrawal by Subject|0|||
149895387|NCT02554682|540745339|FG005|Overall Study|Withdrawal by Subject|0|||
149895388|NCT02554682|540745340|FG006|Overall Study|Withdrawal by Subject|0|||
149895389|NCT02554682|540745341|FG007|Overall Study|Withdrawal by Subject|0|||
149895390|NCT02554682|540745342|FG008|Overall Study|Withdrawal by Subject|0|||
149895391|NCT02554682|540745343|FG009|Overall Study|Withdrawal by Subject|0|||
149895392|NCT02554682|540745334|FG000|Overall Study|Physician Decision|2|||
149895393|NCT02554682|540745335|FG001|Overall Study|Physician Decision|2|||
149895394|NCT02554682|540745336|FG002|Overall Study|Physician Decision|0|||
149895395|NCT02554682|540745337|FG003|Overall Study|Physician Decision|0|||
149895396|NCT02554682|540745338|FG004|Overall Study|Physician Decision|0|||
149895397|NCT02554682|540745339|FG005|Overall Study|Physician Decision|0|||
149895398|NCT02554682|540745340|FG006|Overall Study|Physician Decision|0|||
149895399|NCT02554682|540745341|FG007|Overall Study|Physician Decision|0|||
149895400|NCT02554682|540745342|FG008|Overall Study|Physician Decision|0|||
149895401|NCT02554682|540745343|FG009|Overall Study|Physician Decision|0|||
149895402|NCT00884117|540745344|FG000|Overall Study|Adverse Event|2|||
149895403|NCT00884117|540745344|FG000|Overall Study|Withdrawal by Subject|89|||
149895404|NCT00884117|540745344|FG000|Overall Study|Death|3|||
149895405|NCT00884117|540745344|FG000|Overall Study|Lost to Follow-up|143|||
149895406|NCT00884117|540745344|FG000|Overall Study|Other|12|||
149895407|NCT01383174|540745347|FG000|3 Month Assessment|Death|0|||
149895408|NCT01383174|540745348|FG001|3 Month Assessment|Death|1|||
149895409|NCT01383174|540745347|FG000|3 Month Assessment|Lost to Follow-up|2|||
149895410|NCT01383174|540745348|FG001|3 Month Assessment|Lost to Follow-up|0|||
149895411|NCT01383174|540745347|FG000|3 Month Assessment|Refused to complete|4|||
149895412|NCT01383174|540745348|FG001|3 Month Assessment|Refused to complete|0|||
149895413|NCT01383174|540745347|FG000|6 Month Assessment|Lost to Follow-up|1|||
149895414|NCT01383174|540745348|FG001|6 Month Assessment|Lost to Follow-up|1|||
149895415|NCT01383174|540745347|FG000|6 Month Assessment|Refused to complete|4|||
149895416|NCT01383174|540745348|FG001|6 Month Assessment|Refused to complete|0|||
149895417|NCT01153815|540745351|FG000|Overall Study|Adverse Event|3|||
149895418|NCT01153815|540745352|FG001|Overall Study|Adverse Event|1|||
149895419|NCT01153815|540745351|FG000|Overall Study|Withdrawal by Subject|6|||
149895420|NCT01153815|540745352|FG001|Overall Study|Withdrawal by Subject|4|||
149895421|NCT01786993|540745353|FG000|Overall Study|Death|6|||
149895422|NCT01786993|540745354|FG001|Overall Study|Death|7|||
149895423|NCT01786993|540745353|FG000|Overall Study|Withdrawal by Subject|3|||
149895424|NCT01786993|540745354|FG001|Overall Study|Withdrawal by Subject|2|||
149895425|NCT01786993|540745353|FG000|Overall Study|Lost to Follow-up|0|||
149895426|NCT01786993|540745354|FG001|Overall Study|Lost to Follow-up|1|||
149895427|NCT01786993|540745353|FG000|Overall Study|Subject Non-Compliance|1|||
149895428|NCT01786993|540745354|FG001|Overall Study|Subject Non-Compliance|0|||
149895429|NCT01786993|540745353|FG000|Overall Study|System Explant|1|||
149895430|NCT01786993|540745354|FG001|Overall Study|System Explant|0|||
149895431|NCT01786993|540745353|FG000|Overall Study|Hospice Admission|1|||
149895432|NCT01786993|540745354|FG001|Overall Study|Hospice Admission|0|||
149895433|NCT00450437|540745355|FG000|Overall Study|Withdrawal by Subject|10|||
149895434|NCT00450437|540745356|FG001|Overall Study|Withdrawal by Subject|2|||
149895435|NCT00450437|540745357|FG002|Overall Study|Withdrawal by Subject|0|||
149895436|NCT00450437|540745358|FG003|Overall Study|Withdrawal by Subject|1|||
149895437|NCT00450437|540745355|FG000|Overall Study|Lost to Follow-up|31|||
149895438|NCT00450437|540745356|FG001|Overall Study|Lost to Follow-up|12|||
149895439|NCT00450437|540745357|FG002|Overall Study|Lost to Follow-up|19|||
149895440|NCT00450437|540745358|FG003|Overall Study|Lost to Follow-up|9|||
149895441|NCT00450437|540745355|FG000|Overall Study|Protocol Violation|0|||
149895442|NCT00450437|540745356|FG001|Overall Study|Protocol Violation|1|||
149895443|NCT00450437|540745357|FG002|Overall Study|Protocol Violation|0|||
149895444|NCT00450437|540745358|FG003|Overall Study|Protocol Violation|1|||
149895445|NCT00450437|540745355|FG000|Overall Study|Inappropriate enrollment|4|||
149895446|NCT00450437|540745356|FG001|Overall Study|Inappropriate enrollment|1|||
149895447|NCT00450437|540745357|FG002|Overall Study|Inappropriate enrollment|3|||
149895448|NCT00450437|540745358|FG003|Overall Study|Inappropriate enrollment|0|||
149895449|NCT00450437|540745355|FG000|Overall Study|Administrative reason|0|||
149895450|NCT00450437|540745356|FG001|Overall Study|Administrative reason|0|||
149895451|NCT00450437|540745357|FG002|Overall Study|Administrative reason|1|||
149895452|NCT00450437|540745358|FG003|Overall Study|Administrative reason|0|||
149895453|NCT00450437|540745355|FG000|Overall Study|Unable to Classify|1|||
149895454|NCT00450437|540745356|FG001|Overall Study|Unable to Classify|0|||
149895455|NCT00450437|540745357|FG002|Overall Study|Unable to Classify|1|||
149895456|NCT00450437|540745358|FG003|Overall Study|Unable to Classify|0|||
149895457|NCT01890122|540745359|FG000|Overall Study|Adverse Event|1|||
149895458|NCT01890122|540745360|FG001|Overall Study|Adverse Event|1|||
149895459|NCT01890122|540745361|FG002|Overall Study|Adverse Event|1|||
149895460|NCT01890122|540745362|FG003|Overall Study|Adverse Event|2|||
149895461|NCT01890122|540745359|FG000|Overall Study|Major Protocol Deviation|3|||
149895462|NCT01890122|540745360|FG001|Overall Study|Major Protocol Deviation|1|||
149895463|NCT01890122|540745361|FG002|Overall Study|Major Protocol Deviation|0|||
149895464|NCT01890122|540745362|FG003|Overall Study|Major Protocol Deviation|1|||
149895465|NCT01890122|540745359|FG000|Overall Study|Lost to Follow-up|0|||
149895466|NCT01890122|540745360|FG001|Overall Study|Lost to Follow-up|1|||
149895467|NCT01890122|540745361|FG002|Overall Study|Lost to Follow-up|2|||
149895468|NCT01890122|540745362|FG003|Overall Study|Lost to Follow-up|2|||
149895469|NCT01890122|540745359|FG000|Overall Study|Voluntary Withdrawal|8|||
149895470|NCT01890122|540745360|FG001|Overall Study|Voluntary Withdrawal|8|||
149895471|NCT01890122|540745361|FG002|Overall Study|Voluntary Withdrawal|2|||
149895472|NCT01890122|540745362|FG003|Overall Study|Voluntary Withdrawal|11|||
149895473|NCT01890122|540745359|FG000|Overall Study|Lack of Efficacy|14|||
149895474|NCT01890122|540745360|FG001|Overall Study|Lack of Efficacy|24|||
149895475|NCT01890122|540745361|FG002|Overall Study|Lack of Efficacy|7|||
149895476|NCT01890122|540745362|FG003|Overall Study|Lack of Efficacy|41|||
149895477|NCT01890122|540745359|FG000|Overall Study|Reason not Specified|0|||
149895478|NCT01890122|540745360|FG001|Overall Study|Reason not Specified|1|||
149895479|NCT01890122|540745361|FG002|Overall Study|Reason not Specified|1|||
149895480|NCT01890122|540745362|FG003|Overall Study|Reason not Specified|2|||
149895481|NCT01890122|540745359|FG000|Overall Study|Randomized but not Treated|1|||
149895482|NCT01890122|540745360|FG001|Overall Study|Randomized but not Treated|1|||
149895483|NCT01890122|540745361|FG002|Overall Study|Randomized but not Treated|0|||
149895484|NCT01890122|540745362|FG003|Overall Study|Randomized but not Treated|0|||
149895485|NCT01565889|540745363|FG000|Part A|Withdrawal by Subject|1|||
149895486|NCT01565889|540745364|FG001|Part A|Withdrawal by Subject|0|||
149895487|NCT01565889|540745365|FG002|Part A|Withdrawal by Subject|0|||
149895488|NCT01565889|540745366|FG003|Part A|Withdrawal by Subject|0|||
149895489|NCT01565889|540745367|FG004|Part A|Withdrawal by Subject|0|||
149895490|NCT01565889|540745368|FG005|Part A|Withdrawal by Subject|0|||
149895491|NCT01565889|540745363|FG000|Part B|Withdrawal by Subject|0|||
149895492|NCT01565889|540745364|FG001|Part B|Withdrawal by Subject|0|||
149895493|NCT01565889|540745365|FG002|Part B|Withdrawal by Subject|0|||
149895494|NCT01565889|540745366|FG003|Part B|Withdrawal by Subject|0|||
149895495|NCT01565889|540745367|FG004|Part B|Withdrawal by Subject|0|||
149895496|NCT01565889|540745368|FG005|Part B|Withdrawal by Subject|1|||
149895497|NCT01565889|540745363|FG000|Part B|Lack of Efficacy|0|||
149895498|NCT01565889|540745364|FG001|Part B|Lack of Efficacy|0|||
149895499|NCT01565889|540745365|FG002|Part B|Lack of Efficacy|0|||
149895500|NCT01565889|540745366|FG003|Part B|Lack of Efficacy|0|||
149895501|NCT01565889|540745367|FG004|Part B|Lack of Efficacy|0|||
149895502|NCT01565889|540745368|FG005|Part B|Lack of Efficacy|2|||
149895503|NCT01565889|540745363|FG000|Part B|Lost to Follow-up|0|||
149895504|NCT01565889|540745364|FG001|Part B|Lost to Follow-up|0|||
149895505|NCT01565889|540745365|FG002|Part B|Lost to Follow-up|0|||
149895506|NCT01565889|540745366|FG003|Part B|Lost to Follow-up|0|||
149895507|NCT01565889|540745367|FG004|Part B|Lost to Follow-up|0|||
149895508|NCT01565889|540745368|FG005|Part B|Lost to Follow-up|1|||
149895509|NCT00071110|540745371|FG000|Overall Study|Protocol Violation|0|||
149895510|NCT00071110|540745372|FG001|Overall Study|Protocol Violation|4|||
149895511|NCT01445730|540745377|FG000|Overall Study|Adverse Event|1|||
149895512|NCT01445730|540745377|FG000|Overall Study|For the advice of a dentist|1|||
149895513|NCT01445730|540745377|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
149895514|NCT01167140|540745380|FG000|Overall Study|Withdrawal by Subject|1|||
149895515|NCT03805412|540745381|FG000|Overall Study|Lost to Follow-up|0|||
149895516|NCT03805412|540745382|FG001|Overall Study|Lost to Follow-up|1|||
149895517|NCT00030901|540745383|FG000|Initial Registration|Ineligible|167|||
149895518|NCT00030901|540745384|FG001|Initial Registration|Ineligible|0|||
149895519|NCT00030901|540745385|FG002|Initial Registration|Ineligible|0|||
149895520|NCT00030901|540745383|FG000|Randomization|Adverse Event|0|||
149895521|NCT00030901|540745384|FG001|Randomization|Adverse Event|11|||
149895522|NCT00030901|540745385|FG002|Randomization|Adverse Event|7|||
149895523|NCT00030901|540745383|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
149895524|NCT00030901|540745384|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
149895525|NCT00030901|540745385|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
149895526|NCT00030901|540745383|FG000|Randomization|Progression/Relapse|0|||
149895527|NCT00030901|540745384|FG001|Randomization|Progression/Relapse|22|||
149895528|NCT00030901|540745385|FG002|Randomization|Progression/Relapse|21|||
149895529|NCT00030901|540745383|FG000|Randomization|Death|0|||
149895530|NCT00030901|540745384|FG001|Randomization|Death|1|||
149895531|NCT00030901|540745385|FG002|Randomization|Death|3|||
149895532|NCT00030901|540745383|FG000|Randomization|Other|0|||
149895533|NCT00030901|540745384|FG001|Randomization|Other|36|||
149895534|NCT00030901|540745385|FG002|Randomization|Other|33|||
149895535|NCT00030901|540745383|FG000|Randomization|Ineligible|0|||
149895536|NCT00030901|540745384|FG001|Randomization|Ineligible|15|||
149895537|NCT00030901|540745385|FG002|Randomization|Ineligible|14|||
149895538|NCT02576847|540745386|FG000|Overall Study|Adverse Event|27|||
149895539|NCT02576847|540745386|FG000|Overall Study|Lost to Follow-up|22|||
149895540|NCT02576847|540745386|FG000|Overall Study|Physician Decision|1|||
149895541|NCT02576847|540745386|FG000|Overall Study|Pregnancy|1|||
149895542|NCT02576847|540745386|FG000|Overall Study|Protocol Violation|3|||
149895543|NCT02576847|540745386|FG000|Overall Study|Withdrawal by Subject|78|||
149895544|NCT02576847|540745386|FG000|Overall Study|Other|5|||
149895545|NCT01806051|540745387|FG000|Overall Study|Withdrawal by Subject|6|||
149895546|NCT05966584|540745394|FG000|Overall Study|Lost to Follow-up|1|||
149895547|NCT04955691|540747413|FG000|Period 2|Discontinued intervention|1|||
149895548|NCT04955691|540747414|FG001|Period 2|Discontinued intervention|2|||
149895549|NCT05795153|540747415|FG000|Overall Study|Adverse Event|2|||
149895550|NCT05795153|540747415|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149895551|NCT05795153|540747415|FG000|Overall Study|Lost to Follow-up|1|||
149895552|NCT05795153|540747415|FG000|Overall Study|Subject decision|2|||
149895553|NCT03760744|540747416|FG000|Overall Study|Lost to Follow-up|3|||
149895554|NCT03760744|540747417|FG001|Overall Study|Lost to Follow-up|0|||
149895555|NCT03668119|540747418|FG000|Pre-treatment|Disease Progression|1|||
149895556|NCT03668119|540747419|FG001|Pre-treatment|Disease Progression|0|||
149895557|NCT03668119|540747418|FG000|Treatment|Disease Progression|76|||
149895558|NCT03668119|540747419|FG001|Treatment|Disease Progression|57|||
149895559|NCT03668119|540747418|FG000|Treatment|Study drug toxicity|19|||
149895560|NCT03668119|540747419|FG001|Treatment|Study drug toxicity|1|||
149895561|NCT03668119|540747418|FG000|Treatment|Death|3|||
149895562|NCT03668119|540747419|FG001|Treatment|Death|0|||
149895563|NCT03668119|540747418|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
149895564|NCT03668119|540747419|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
149895565|NCT03668119|540747418|FG000|Treatment|Withdrawal by Subject|1|||
149895566|NCT03668119|540747419|FG001|Treatment|Withdrawal by Subject|1|||
149895567|NCT03668119|540747418|FG000|Treatment|Participant request to discontinue study treatment|3|||
149895568|NCT03668119|540747419|FG001|Treatment|Participant request to discontinue study treatment|1|||
149895569|NCT03668119|540747418|FG000|Treatment|Maximum Clinical Benefit|0|||
149895570|NCT03668119|540747419|FG001|Treatment|Maximum Clinical Benefit|1|||
149895571|NCT03668119|540747418|FG000|Treatment|Participants completed treatment|27|||
149895572|NCT03668119|540747419|FG001|Treatment|Participants completed treatment|11|||
149895573|NCT03668119|540747418|FG000|Treatment|Other reasons|2|||
149895574|NCT03668119|540747419|FG001|Treatment|Other reasons|1|||
149895575|NCT03769168|540747420|FG000|Overall Study|Adverse Event|0|||
149895576|NCT03769168|540747421|FG001|Overall Study|Adverse Event|1|||
149895577|NCT03769168|540747420|FG000|Overall Study|Lack of Efficacy|2|||
149895578|NCT03769168|540747421|FG001|Overall Study|Lack of Efficacy|4|||
149895579|NCT03769168|540747420|FG000|Overall Study|Post study access to treatment|3|||
149895580|NCT03769168|540747421|FG001|Overall Study|Post study access to treatment|11|||
149895581|NCT03769168|540747420|FG000|Overall Study|Physician Decision|1|||
149895582|NCT03769168|540747421|FG001|Overall Study|Physician Decision|4|||
149895583|NCT03769168|540747420|FG000|Overall Study|Subject Decision|2|||
149895584|NCT03769168|540747421|FG001|Overall Study|Subject Decision|4|||
149895585|NCT03769168|540747420|FG000|Overall Study|Guardian decision|1|||
149895586|NCT03769168|540747421|FG001|Overall Study|Guardian decision|0|||
149895587|NCT05336227|540747422|FG000|Overall Study|Adverse Event|1|||
149895588|NCT05336227|540747423|FG001|Overall Study|Adverse Event|0|||
149895589|NCT05336227|540747422|FG000|Overall Study|Lost to Follow-up|2|||
149895590|NCT05336227|540747423|FG001|Overall Study|Lost to Follow-up|0|||
149895591|NCT05336227|540747422|FG000|Overall Study|Withdrawal by Subject|1|||
149895592|NCT05336227|540747423|FG001|Overall Study|Withdrawal by Subject|0|||
149895593|NCT04050462|540747424|FG000|Overall Study|Withdrawal by Subject|1|||
149895594|NCT04050462|540747425|FG001|Overall Study|Withdrawal by Subject|0|||
149895595|NCT04050462|540747426|FG002|Overall Study|Withdrawal by Subject|0|||
149895596|NCT05151744|540747429|FG000|Overall Study|Adverse Event|6|||
149895597|NCT05151744|540747430|FG001|Overall Study|Adverse Event|2|||
149895598|NCT05151744|540747429|FG000|Overall Study|Death|1|||
149895599|NCT05151744|540747430|FG001|Overall Study|Death|2|||
149895600|NCT05151744|540747429|FG000|Overall Study|Lack of Efficacy|1|||
149895601|NCT05151744|540747430|FG001|Overall Study|Lack of Efficacy|1|||
149895602|NCT05151744|540747429|FG000|Overall Study|Lost to Follow-up|2|||
149895603|NCT05151744|540747430|FG001|Overall Study|Lost to Follow-up|2|||
149895604|NCT05151744|540747429|FG000|Overall Study|Need for Rescue Treatment|0|||
149895605|NCT05151744|540747430|FG001|Overall Study|Need for Rescue Treatment|1|||
149895606|NCT05151744|540747429|FG000|Overall Study|Non-compliance with Study Drug|0|||
149895607|NCT05151744|540747430|FG001|Overall Study|Non-compliance with Study Drug|1|||
149895608|NCT05151744|540747429|FG000|Overall Study|Reason not Specified|10|||
150045357|NCT04294680|541305572|FG001|Overall Study|Follow-up visits completed outside of window|0|||
150045358|NCT00475306|541305573|FG000|Overall Study|Protocol Violation|1|||
150045359|NCT00475306|541305574|FG001|Overall Study|Protocol Violation|1|||
150045360|NCT00475306|541305575|FG002|Overall Study|Protocol Violation|0|||
150045361|NCT00475306|541305576|FG003|Overall Study|Protocol Violation|1|||
150045362|NCT03656562|541305579|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
150045363|NCT03656562|541305580|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
150045364|NCT03656562|541305581|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
150045365|NCT03656562|541305582|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
150045366|NCT03656562|541305579|FG000|Overall Study|Physician Decision|1|||
150045367|NCT03656562|541305580|FG001|Overall Study|Physician Decision|2|||
149895609|NCT05151744|540747430|FG001|Overall Study|Reason not Specified|0|||
149895610|NCT05151744|540747429|FG000|Overall Study|Physician Decision|2|||
149895611|NCT05151744|540747430|FG001|Overall Study|Physician Decision|1|||
149895612|NCT05151744|540747429|FG000|Overall Study|Protocol Violation|1|||
149895613|NCT05151744|540747430|FG001|Overall Study|Protocol Violation|0|||
149895614|NCT05151744|540747429|FG000|Overall Study|Withdrawal by Subject|6|||
149895615|NCT05151744|540747430|FG001|Overall Study|Withdrawal by Subject|3|||
149895616|NCT05228470|540747431|FG000|Overall Study|Death|6|||
149895617|NCT05228470|540747432|FG001|Overall Study|Death|11|||
149895618|NCT05228470|540747431|FG000|Overall Study|Withdrawal by Subject|1|||
149895619|NCT05228470|540747432|FG001|Overall Study|Withdrawal by Subject|8|||
149895620|NCT05228470|540747431|FG000|Overall Study|Ongoing|1|||
150045368|NCT03656562|541305581|FG002|Overall Study|Physician Decision|0|||
150045369|NCT03656562|541305582|FG003|Overall Study|Physician Decision|0|||
150045370|NCT03656562|541305579|FG000|Overall Study|Subject Decision|3|||
149895621|NCT05228470|540747432|FG001|Overall Study|Ongoing|11|||
149895622|NCT04053868|540747433|FG000|Overall Study|Withdrawal by Subject|1|||
149895623|NCT04053868|540747434|FG001|Overall Study|Withdrawal by Subject|0|||
149895624|NCT05731700|540747435|FG000|Overall Study|Death|1|||
149895625|NCT05400655|540747438|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
149895626|NCT05400655|540747439|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
149895627|NCT05400655|540747440|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
149895628|NCT05400655|540747441|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
149895629|NCT05400655|540747442|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
149895630|NCT05400655|540747443|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
149895631|NCT05400655|540747444|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
149895632|NCT05400655|540747445|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
149895633|NCT05400655|540747446|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
149895634|NCT05400655|540747447|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
149895635|NCT05400655|540747448|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
149895636|NCT05400655|540747449|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
149895637|NCT05400655|540747450|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
149895638|NCT05400655|540747451|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
149895639|NCT05400655|540747452|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
149895640|NCT05400655|540747453|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
149895641|NCT05400655|540747454|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
149895642|NCT05400655|540747455|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
149895643|NCT05400655|540747456|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
149895644|NCT05400655|540747457|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
149895645|NCT05400655|540747458|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
149895646|NCT05400655|540747459|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
149895647|NCT05400655|540747438|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895648|NCT05400655|540747439|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895649|NCT05400655|540747440|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895650|NCT05400655|540747441|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895651|NCT05400655|540747442|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895652|NCT05400655|540747443|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895653|NCT05400655|540747444|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895654|NCT05400655|540747445|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895655|NCT05400655|540747446|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895656|NCT05400655|540747447|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895657|NCT05400655|540747448|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895658|NCT05400655|540747449|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895659|NCT05400655|540747450|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
149895660|NCT05400655|540747451|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895661|NCT05400655|540747452|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895662|NCT05400655|540747453|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895663|NCT05400655|540747454|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
149895664|NCT05400655|540747455|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895665|NCT05400655|540747456|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
149895666|NCT05400655|540747457|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
149895667|NCT05400655|540747458|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895668|NCT05400655|540747459|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
149895669|NCT05400655|540747438|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895670|NCT05400655|540747439|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895671|NCT05400655|540747440|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895672|NCT05400655|540747441|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895673|NCT05400655|540747442|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895674|NCT05400655|540747443|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895675|NCT05400655|540747444|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895676|NCT05400655|540747445|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895677|NCT05400655|540747446|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895678|NCT05400655|540747447|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895679|NCT05400655|540747448|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895680|NCT05400655|540747449|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895681|NCT05400655|540747450|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895682|NCT05400655|540747451|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
149895683|NCT05400655|540747452|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895684|NCT05400655|540747453|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895685|NCT05400655|540747454|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
149895686|NCT05400655|540747455|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895687|NCT05400655|540747456|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
149895688|NCT05400655|540747457|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895689|NCT05400655|540747458|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895690|NCT05400655|540747459|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
149895691|NCT05400655|540747438|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895692|NCT05400655|540747439|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895693|NCT05400655|540747440|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895694|NCT05400655|540747441|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
150176110|NCT03520413|541781901|FG001|Overall Study|Death|1|||
150176111|NCT03520413|541781900|FG000|Overall Study|Physician Decision|3|||
150176112|NCT03520413|541781901|FG001|Overall Study|Physician Decision|3|||
150176113|NCT03520413|541781900|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
149895695|NCT05400655|540747442|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895696|NCT05400655|540747443|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895697|NCT05400655|540747444|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895698|NCT05400655|540747445|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895699|NCT05400655|540747446|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895700|NCT05400655|540747447|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895701|NCT05400655|540747448|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895702|NCT05400655|540747449|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895703|NCT05400655|540747450|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895704|NCT05400655|540747451|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895705|NCT05400655|540747452|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895706|NCT05400655|540747453|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895707|NCT05400655|540747454|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
149895708|NCT05400655|540747455|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
149895709|NCT05400655|540747456|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
149895710|NCT05400655|540747457|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
149895711|NCT05400655|540747458|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
149895712|NCT05400655|540747459|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
149968680|NCT01559935|541022028|FG000|Car Phase|Physician Decision|1|||
149968681|NCT01559935|541022028|FG000|Car Phase|Withdrawal by Subject|2|||
149968682|NCT01559935|541022028|FG000|Car Phase|Per protocol|1|||
149968683|NCT01559935|541022028|FG000|Car Phase|Insurance|1|||
150176114|NCT03520413|541781901|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
149895713|NCT05400655|540747438|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895714|NCT05400655|540747439|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895715|NCT05400655|540747440|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149968684|NCT01559935|541022028|FG000|Car Phase|non-compliance|1|||
150176115|NCT00346151|541781902|FG000|Overall Study|Withdrawal by Subject|3|||
149895716|NCT05400655|540747441|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895717|NCT05400655|540747442|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895718|NCT05400655|540747443|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895719|NCT05400655|540747444|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895720|NCT05400655|540747445|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895721|NCT05400655|540747446|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895722|NCT05400655|540747447|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895723|NCT05400655|540747448|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895724|NCT05400655|540747449|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895725|NCT05400655|540747450|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895726|NCT05400655|540747451|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895727|NCT05400655|540747452|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895728|NCT05400655|540747453|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895729|NCT05400655|540747454|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895730|NCT05400655|540747455|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
149895731|NCT05400655|540747456|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
149895732|NCT05400655|540747457|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895733|NCT05400655|540747458|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895734|NCT05400655|540747459|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
149895735|NCT05400655|540747438|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895736|NCT05400655|540747439|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895737|NCT05400655|540747440|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895738|NCT05400655|540747441|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895739|NCT05400655|540747442|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895740|NCT05400655|540747443|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895741|NCT05400655|540747444|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895742|NCT05400655|540747445|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895743|NCT05400655|540747446|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895744|NCT05400655|540747447|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895745|NCT05400655|540747448|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895746|NCT05400655|540747449|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895747|NCT05400655|540747450|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895748|NCT05400655|540747451|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895749|NCT05400655|540747452|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895750|NCT05400655|540747453|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895751|NCT05400655|540747454|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
149895752|NCT05400655|540747455|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
149895753|NCT05400655|540747456|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
149895754|NCT05400655|540747457|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
149895755|NCT05400655|540747458|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
149895756|NCT05400655|540747459|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
149895757|NCT01068678|540747468|FG000|Overall Study|Lack of Efficacy|3|||
149895758|NCT01068678|540747469|FG001|Overall Study|Lack of Efficacy|2|||
149895759|NCT01068678|540747468|FG000|Overall Study|Protocol Violation|5|||
149895760|NCT01068678|540747469|FG001|Overall Study|Protocol Violation|1|||
149895761|NCT01068678|540747468|FG000|Overall Study|Withdrawal criteria|12|||
149895762|NCT01068678|540747469|FG001|Overall Study|Withdrawal criteria|6|||
149895763|NCT01068678|540747468|FG000|Overall Study|Unclassified|18|||
149895764|NCT01068678|540747469|FG001|Overall Study|Unclassified|15|||
149895765|NCT03058705|540747472|FG000|Overall Study|Withdrawal by Subject|2|||
149895766|NCT03058705|540747472|FG000|Overall Study|Physician Decision|2|||
149895767|NCT02088554|540747484|FG000|Overall Study|Exited before procedure|130|||
149895768|NCT02088554|540747484|FG000|Overall Study|Attempted but not implanted|31|||
149895769|NCT02088554|540747484|FG000|Overall Study|Implant not attempted|19|||
149895770|NCT02088554|540747484|FG000|Overall Study|Pending next visit|532|||
149895771|NCT02088554|540747484|FG000|Overall Study|Death|170|||
149895772|NCT02088554|540747484|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
149895773|NCT02088554|540747484|FG000|Overall Study|Lost to Follow-up|23|||
149895774|NCT02088554|540747484|FG000|Overall Study|Explanted|32|||
149895775|NCT02088554|540747484|FG000|Overall Study|Any other reason not covered by previous categories|11|||
149895776|NCT05468164|540747485|FG000|Treatment Period 4|Adverse Event|0|||
149895777|NCT05468164|540747486|FG001|Treatment Period 4|Adverse Event|0|||
149895778|NCT05468164|540747487|FG002|Treatment Period 4|Adverse Event|0|||
149895779|NCT05468164|540747488|FG003|Treatment Period 4|Adverse Event|1|||
149895780|NCT03827291|540747489|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
149895781|NCT03827291|540747490|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
149895782|NCT04795466|540747491|FG000|Overall Study|Adverse Event|3|||
149895783|NCT04795466|540747492|FG001|Overall Study|Adverse Event|1|||
149895784|NCT04795466|540747491|FG000|Overall Study|Physician Decision|1|||
149895785|NCT04795466|540747492|FG001|Overall Study|Physician Decision|0|||
149895786|NCT04795466|540747491|FG000|Overall Study|Withdrawal by Subject|2|||
149895787|NCT04795466|540747492|FG001|Overall Study|Withdrawal by Subject|1|||
149895788|NCT04652726|540747493|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
149895789|NCT04652726|540747494|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
149895790|NCT04652726|540747495|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
149895791|NCT04652726|540747493|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
149968685|NCT01559935|541022028|FG000|BiRD Phase|Toxicity|1|||
149968686|NCT01559935|541022028|FG000|BiRD Phase|Lack of Efficacy|1|||
149968687|NCT01559935|541022028|FG000|BiRD Phase|Withdrawal by Subject|2|||
149968688|NCT01559935|541022028|FG000|Maintenance Phase|Remains on study|28|||
149895792|NCT04652726|540747494|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
149895793|NCT04652726|540747495|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
149968689|NCT01559935|541022028|FG000|Maintenance Phase|Toxicity|1|||
149895794|NCT00866281|540747510|FG000|Overall Study|Adverse Event|1|||
149895795|NCT00866281|540747511|FG001|Overall Study|Adverse Event|0|||
149895796|NCT00866281|540747510|FG000|Overall Study|Withdrawal by participants|3|||
149895797|NCT00866281|540747511|FG001|Overall Study|Withdrawal by participants|0|||
149895798|NCT00866281|540747510|FG000|Overall Study|Disease progression|3|||
149895799|NCT00866281|540747511|FG001|Overall Study|Disease progression|11|||
149895800|NCT00866281|540747510|FG000|Overall Study|New cancer therapy|0|||
149968690|NCT01559935|541022028|FG000|Maintenance Phase|Lack of Efficacy|18|||
150176116|NCT04054635|541781905|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
150176117|NCT04054635|541781906|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
150176118|NCT04054635|541781907|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
150176119|NCT04054635|541781905|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
150176120|NCT04054635|541781906|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
150176121|NCT04054635|541781907|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
150176122|NCT03737240|541781908|FG000|Overall Study|Lost to Follow-up|16|||
150176123|NCT03737240|541781909|FG001|Overall Study|Lost to Follow-up|15|||
150176124|NCT00891930|541781910|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
150176125|NCT00891930|541781910|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
150176126|NCT00891930|541781910|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
150176127|NCT00891930|541781910|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
150176128|NCT00891930|541781910|FG000|Part 2 Panitumumab + AMG479|Death|30|||
150176129|NCT02202499|541781916|FG000|Overall Study|Cancer diagnosis|0|||
150176130|NCT02202499|541781917|FG001|Overall Study|Cancer diagnosis|0|||
150176131|NCT02202499|541781918|FG002|Overall Study|Cancer diagnosis|1|||
150176132|NCT02202499|541781916|FG000|Overall Study|Moved from area|0|||
150176133|NCT02202499|541781917|FG001|Overall Study|Moved from area|0|||
150176134|NCT02202499|541781918|FG002|Overall Study|Moved from area|1|||
150176135|NCT02202499|541781916|FG000|Overall Study|Declined before randomization|1|||
150176136|NCT02202499|541781917|FG001|Overall Study|Declined before randomization|0|||
150176137|NCT02202499|541781918|FG002|Overall Study|Declined before randomization|0|||
150176138|NCT02202499|541781916|FG000|Overall Study|Auto accident|1|||
150176139|NCT02202499|541781917|FG001|Overall Study|Auto accident|0|||
150176140|NCT02202499|541781918|FG002|Overall Study|Auto accident|0|||
149895801|NCT00866281|540747511|FG001|Overall Study|New cancer therapy|4|||
149895802|NCT02275546|540747512|FG000|Treatment Period 2|Withdrawal by Subject|2|||
149895803|NCT02275546|540747513|FG001|Treatment Period 2|Withdrawal by Subject|1|||
150176141|NCT00535145|541781922|FG000|Phase I|Adverse Event|3|||
150176142|NCT00535145|541781922|FG000|Phase I|Lost to Follow-up|7|||
150176143|NCT00535145|541781922|FG000|Phase I|Withdrawal by Subject|6|||
150176144|NCT00535145|541781922|FG000|Phase I|(eligibility)|8|||
149895804|NCT02275546|540747512|FG000|Treatment Period 2|Protocol Violation|0|||
149895805|NCT02275546|540747513|FG001|Treatment Period 2|Protocol Violation|1|||
149895806|NCT02612623|540747519|FG000|Overall Study|Withdrawal by Subject|0|||
149895807|NCT02612623|540747520|FG001|Overall Study|Withdrawal by Subject|1|||
149895808|NCT02612623|540747521|FG002|Overall Study|Withdrawal by Subject|0|||
149895809|NCT02612623|540747522|FG003|Overall Study|Withdrawal by Subject|0|||
149895810|NCT02612623|540747519|FG000|Overall Study|Adverse Event|1|||
149895811|NCT02612623|540747520|FG001|Overall Study|Adverse Event|0|||
149895812|NCT02612623|540747521|FG002|Overall Study|Adverse Event|1|||
149895813|NCT02612623|540747522|FG003|Overall Study|Adverse Event|0|||
149895814|NCT00570141|540747527|FG000|Overall Study|Adverse Event|1|||
149895815|NCT00570141|540747527|FG000|Overall Study|Missed visits|1|||
149895816|NCT00570141|540747527|FG000|Overall Study|Lost to Follow-up|1|||
149895817|NCT02309411|540747530|FG000|Overall Study|Physician Decision|1|||
149895818|NCT02309411|540747531|FG001|Overall Study|Physician Decision|0|||
149895819|NCT02309411|540747532|FG002|Overall Study|Physician Decision|0|||
149895820|NCT02309411|540747530|FG000|Overall Study|Withdrawal by Subject|1|||
149895821|NCT02309411|540747531|FG001|Overall Study|Withdrawal by Subject|1|||
149895822|NCT02309411|540747532|FG002|Overall Study|Withdrawal by Subject|0|||
149895823|NCT02883062|540747539|FG000|Overall Study|Withdrawal by Subject|6|||
149895824|NCT02883062|540747540|FG001|Overall Study|Withdrawal by Subject|0|||
149895825|NCT04426006|540747541|FG000|Inclusion|Protocol Violation|1|||
149895826|NCT04426006|540747541|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
149895827|NCT04426006|540747541|FG000|Inclusion|Blood sample at inclusion not done|1|||
149895828|NCT04426006|540747541|FG000|3 Months|Lost to Follow-up|17|||
150045371|NCT03656562|541305580|FG001|Overall Study|Subject Decision|5|||
150176145|NCT00535145|541781922|FG000|Phase I|(protocol violation)|1|||
150176146|NCT00535145|541781922|FG000|Phase I|(PI decision)|1|||
150176147|NCT00535145|541781922|FG000|Phase I|(diagnosis)|3|||
150176148|NCT00535145|541781922|FG000|Phase II|Adverse Event|2|||
150176149|NCT00535145|541781922|FG000|Phase II|Lack of Efficacy|1|||
150176150|NCT00535145|541781922|FG000|Phase II|Lost to Follow-up|5|||
150176151|NCT00535145|541781922|FG000|Phase II|Withdrawal by Subject|5|||
150176152|NCT00535145|541781922|FG000|Phase II|Subject non-compliance|2|||
150176153|NCT00439569|541781928|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
149895829|NCT04426006|540747541|FG000|12 Months|Lost to Follow-up|38|||
149895830|NCT01262872|540747542|FG000|Step 2|Death|0|||
149895831|NCT01262872|540747543|FG001|Step 2|Death|0|||
149895832|NCT01262872|540747544|FG002|Step 2|Death|0|||
149895833|NCT01262872|540747545|FG003|Step 2|Death|1|||
149895834|NCT01262872|540747546|FG004|Step 2|Death|0|||
149895835|NCT01262872|540747547|FG005|Step 2|Death|2|||
149895836|NCT01262872|540747548|FG006|Step 2|Death|2|||
149895837|NCT01262872|540747549|FG007|Step 2|Death|1|||
149895838|NCT01262872|540747542|FG000|Step 2|Protocol Violation|0|||
149895839|NCT01262872|540747543|FG001|Step 2|Protocol Violation|0|||
150176154|NCT00439569|541781928|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
150176155|NCT00439569|541781928|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
150176156|NCT02214160|541781929|FG000|Overall Study|Withdrawal by Subject|1|||
150176157|NCT02214160|541781930|FG001|Overall Study|Withdrawal by Subject|0|||
150176158|NCT02214160|541781931|FG002|Overall Study|Withdrawal by Subject|6|||
149895840|NCT01262872|540747544|FG002|Step 2|Protocol Violation|1|||
149895841|NCT01262872|540747545|FG003|Step 2|Protocol Violation|0|||
149895842|NCT01262872|540747546|FG004|Step 2|Protocol Violation|0|||
149895843|NCT01262872|540747547|FG005|Step 2|Protocol Violation|0|||
149895844|NCT01262872|540747548|FG006|Step 2|Protocol Violation|3|||
149895845|NCT01262872|540747549|FG007|Step 2|Protocol Violation|1|||
149895846|NCT01262872|540747542|FG000|Step 2|Withdrawal by Subject|0|||
149895847|NCT01262872|540747543|FG001|Step 2|Withdrawal by Subject|0|||
149895848|NCT01262872|540747544|FG002|Step 2|Withdrawal by Subject|4|||
149895849|NCT01262872|540747545|FG003|Step 2|Withdrawal by Subject|6|||
149895850|NCT01262872|540747546|FG004|Step 2|Withdrawal by Subject|3|||
149895851|NCT01262872|540747547|FG005|Step 2|Withdrawal by Subject|1|||
149895852|NCT01262872|540747548|FG006|Step 2|Withdrawal by Subject|2|||
149895853|NCT01262872|540747549|FG007|Step 2|Withdrawal by Subject|1|||
149895854|NCT01262872|540747542|FG000|Step 2|Migrated/moved from study area|0|||
149895855|NCT01262872|540747543|FG001|Step 2|Migrated/moved from study area|0|||
149895856|NCT01262872|540747544|FG002|Step 2|Migrated/moved from study area|4|||
149895857|NCT01262872|540747545|FG003|Step 2|Migrated/moved from study area|3|||
149895858|NCT01262872|540747546|FG004|Step 2|Migrated/moved from study area|2|||
149895859|NCT01262872|540747547|FG005|Step 2|Migrated/moved from study area|6|||
149895860|NCT01262872|540747548|FG006|Step 2|Migrated/moved from study area|2|||
149895861|NCT01262872|540747549|FG007|Step 2|Migrated/moved from study area|3|||
149895862|NCT01753310|540747550|FG000|Overall Study|Entered into open label extension study|25|||
149895863|NCT01753310|540747551|FG001|Overall Study|Entered into open label extension study|22|||
149895864|NCT01753310|540747550|FG000|Overall Study|Adverse Event|1|||
149895865|NCT01753310|540747551|FG001|Overall Study|Adverse Event|0|||
149895866|NCT01753310|540747550|FG000|Overall Study|Lost to Follow-up|2|||
149895867|NCT01753310|540747551|FG001|Overall Study|Lost to Follow-up|0|||
149895868|NCT01753310|540747550|FG000|Overall Study|Subject decision|2|||
149895869|NCT01753310|540747551|FG001|Overall Study|Subject decision|2|||
149895870|NCT01753310|540747550|FG000|Overall Study|Sponsor decision|1|||
149895871|NCT01753310|540747551|FG001|Overall Study|Sponsor decision|0|||
149895872|NCT01753310|540747550|FG000|Overall Study|Withdrawal by Subject|1|||
149895873|NCT01753310|540747551|FG001|Overall Study|Withdrawal by Subject|0|||
149895874|NCT00952068|540747553|FG000|Overall Study|Adverse Event|3|||
149895875|NCT00952068|540747553|FG000|Overall Study|Withdrawal by Subject|4|||
149895876|NCT02022202|540747554|FG000|Overall Study|Withdrawal by Subject|2|||
149895877|NCT02022202|540747554|FG000|Overall Study|Disease Progression|3|||
149895878|NCT02022202|540747554|FG000|Overall Study|Desire go to immediately to surgery|3|||
149895879|NCT04390763|540747556|FG000|Safety run-in Part|Adverse Event|4|||
149895880|NCT04390763|540747557|FG001|Safety run-in Part|Adverse Event|0|||
149895881|NCT04390763|540747558|FG002|Safety run-in Part|Adverse Event|0|||
149895882|NCT04390763|540747559|FG003|Safety run-in Part|Adverse Event|0|||
149895883|NCT04390763|540747556|FG000|Safety run-in Part|Physician Decision|1|||
149895884|NCT04390763|540747557|FG001|Safety run-in Part|Physician Decision|0|||
149895885|NCT04390763|540747558|FG002|Safety run-in Part|Physician Decision|0|||
149895886|NCT04390763|540747559|FG003|Safety run-in Part|Physician Decision|0|||
149895887|NCT04390763|540747556|FG000|Safety run-in Part|Progressive Disease|6|||
149895888|NCT04390763|540747557|FG001|Safety run-in Part|Progressive Disease|0|||
149895889|NCT04390763|540747558|FG002|Safety run-in Part|Progressive Disease|0|||
149895890|NCT04390763|540747559|FG003|Safety run-in Part|Progressive Disease|0|||
149895891|NCT04390763|540747556|FG000|Randomized Part|Adverse Event|0|||
149895892|NCT04390763|540747557|FG001|Randomized Part|Adverse Event|11|||
149895893|NCT04390763|540747558|FG002|Randomized Part|Adverse Event|5|||
149895894|NCT04390763|540747559|FG003|Randomized Part|Adverse Event|5|||
149895895|NCT04390763|540747556|FG000|Randomized Part|Death|0|||
149895896|NCT04390763|540747557|FG001|Randomized Part|Death|3|||
149895897|NCT04390763|540747558|FG002|Randomized Part|Death|4|||
149895898|NCT04390763|540747559|FG003|Randomized Part|Death|2|||
149895899|NCT04390763|540747556|FG000|Randomized Part|Physician Decision|0|||
149895900|NCT04390763|540747557|FG001|Randomized Part|Physician Decision|2|||
150176159|NCT02214160|541781929|FG000|Overall Study|Death|2|||
149895901|NCT04390763|540747558|FG002|Randomized Part|Physician Decision|2|||
149895902|NCT04390763|540747559|FG003|Randomized Part|Physician Decision|9|||
149895903|NCT04390763|540747556|FG000|Randomized Part|Progressive Disease|0|||
149895904|NCT04390763|540747557|FG001|Randomized Part|Progressive Disease|24|||
149895905|NCT04390763|540747558|FG002|Randomized Part|Progressive Disease|31|||
149895906|NCT04390763|540747559|FG003|Randomized Part|Progressive Disease|23|||
149895907|NCT04390763|540747556|FG000|Randomized Part|Study terminated by sponsor|0|||
149895908|NCT04390763|540747557|FG001|Randomized Part|Study terminated by sponsor|1|||
149895909|NCT04390763|540747558|FG002|Randomized Part|Study terminated by sponsor|0|||
149895910|NCT04390763|540747559|FG003|Randomized Part|Study terminated by sponsor|0|||
149895911|NCT04390763|540747556|FG000|Randomized Part|Participant Decision|0|||
149895912|NCT04390763|540747557|FG001|Randomized Part|Participant Decision|5|||
149895913|NCT04390763|540747558|FG002|Randomized Part|Participant Decision|7|||
149895914|NCT04390763|540747559|FG003|Randomized Part|Participant Decision|6|||
149895915|NCT04390763|540747556|FG000|Randomized Part|Not treated|0|||
149895916|NCT04390763|540747557|FG001|Randomized Part|Not treated|4|||
149895917|NCT04390763|540747558|FG002|Randomized Part|Not treated|2|||
149895918|NCT04390763|540747559|FG003|Randomized Part|Not treated|7|||
149895919|NCT01956773|540747564|FG000|Overall Study|Lost to Follow-up|628|||
149895920|NCT01956773|540747565|FG001|Overall Study|Lost to Follow-up|1|||
149895921|NCT02040805|540747567|FG000|Overall Study|Lost to Follow-up|14|||
149895922|NCT02040805|540747568|FG001|Overall Study|Lost to Follow-up|9|||
149895923|NCT02040805|540747567|FG000|Overall Study|Withdrawal by Subject|28|||
149895924|NCT02040805|540747568|FG001|Overall Study|Withdrawal by Subject|41|||
149895925|NCT04495829|540747569|FG000|Overall Study|Lost to Follow-up|2|||
149895926|NCT04495829|540747569|FG000|Overall Study|Inclusion criterion not met|3|||
149895927|NCT02259010|540747572|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
149895928|NCT03194542|540747573|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
149895929|NCT03194542|540747574|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
149895930|NCT03194542|540747575|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
149895931|NCT03194542|540747576|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
149895932|NCT03194542|540747573|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
149895933|NCT03194542|540747574|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
149895934|NCT03194542|540747575|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
149895935|NCT03194542|540747576|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
149895936|NCT03194542|540747573|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
149895937|NCT03194542|540747574|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
149895938|NCT03194542|540747575|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
149895939|NCT03194542|540747576|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
149895940|NCT03194542|540747573|FG000|Overall Study|Loss of Response|4|||
149895941|NCT03194542|540747574|FG001|Overall Study|Loss of Response|2|||
149895942|NCT03194542|540747575|FG002|Overall Study|Loss of Response|3|||
149895943|NCT03194542|540747576|FG003|Overall Study|Loss of Response|4|||
149895944|NCT03194542|540747573|FG000|Overall Study|Physician Decision|0|||
149895945|NCT03194542|540747574|FG001|Overall Study|Physician Decision|1|||
149895946|NCT03194542|540747575|FG002|Overall Study|Physician Decision|0|||
149895947|NCT03194542|540747576|FG003|Overall Study|Physician Decision|0|||
149895948|NCT03194542|540747573|FG000|Overall Study|Lack of Efficacy|2|||
149895949|NCT03194542|540747574|FG001|Overall Study|Lack of Efficacy|2|||
149895950|NCT03194542|540747575|FG002|Overall Study|Lack of Efficacy|2|||
149895951|NCT03194542|540747576|FG003|Overall Study|Lack of Efficacy|6|||
149895952|NCT03194542|540747573|FG000|Overall Study|Withdrawal by Subject|2|||
149895953|NCT03194542|540747574|FG001|Overall Study|Withdrawal by Subject|1|||
150176160|NCT02214160|541781930|FG001|Overall Study|Death|2|||
149895954|NCT03194542|540747575|FG002|Overall Study|Withdrawal by Subject|5|||
149895955|NCT03194542|540747576|FG003|Overall Study|Withdrawal by Subject|4|||
149895956|NCT03194542|540747573|FG000|Overall Study|Progressive Disease|1|||
149895957|NCT03194542|540747574|FG001|Overall Study|Progressive Disease|0|||
149895958|NCT03194542|540747575|FG002|Overall Study|Progressive Disease|1|||
149895959|NCT03194542|540747576|FG003|Overall Study|Progressive Disease|1|||
149895960|NCT03194542|540747573|FG000|Overall Study|Adverse Event|1|||
149895961|NCT03194542|540747574|FG001|Overall Study|Adverse Event|2|||
149895962|NCT03194542|540747575|FG002|Overall Study|Adverse Event|0|||
149895963|NCT03194542|540747576|FG003|Overall Study|Adverse Event|5|||
149895964|NCT03194542|540747573|FG000|Overall Study|Death|1|||
149895965|NCT03194542|540747574|FG001|Overall Study|Death|2|||
149895966|NCT03194542|540747575|FG002|Overall Study|Death|0|||
149895967|NCT03194542|540747576|FG003|Overall Study|Death|5|||
149895968|NCT03194542|540747573|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
149895969|NCT03194542|540747574|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
149895970|NCT03194542|540747575|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
149895971|NCT03194542|540747576|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
149895972|NCT03655405|540747579|FG000|Overall Study|Death after initial data collection|4|||
150045372|NCT03656562|541305581|FG002|Overall Study|Subject Decision|0|||
149895973|NCT03655405|540747580|FG001|Overall Study|Death after initial data collection|2|||
149895974|NCT03655405|540747579|FG000|Overall Study|Died before initial data collection|1|||
149895975|NCT03655405|540747580|FG001|Overall Study|Died before initial data collection|2|||
149895976|NCT03655405|540747579|FG000|Overall Study|Protocol Violation|0|||
149895977|NCT03655405|540747580|FG001|Overall Study|Protocol Violation|1|||
149895978|NCT00975611|540749188|FG000|Overall Study|Screen Fail|16|||
149895979|NCT00975611|540749188|FG000|Overall Study|Physician Decision|1|||
149895980|NCT03123120|540749189|FG000|Overall Study|Lost to Follow-up|0|||
149895981|NCT03123120|540749190|FG001|Overall Study|Lost to Follow-up|1|||
149895982|NCT03123120|540749189|FG000|Overall Study|Withdrawal by Subject|0|||
149895983|NCT03123120|540749190|FG001|Overall Study|Withdrawal by Subject|1|||
149895984|NCT02632175|540749191|FG000|Overall Study|Withdrawal by Subject|6|||
149895985|NCT02632175|540749191|FG000|Overall Study|Lost to Follow-up|1|||
149895986|NCT02632175|540749191|FG000|Overall Study|Lack of Efficacy|18|||
149895987|NCT02632175|540749191|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
149895988|NCT02632175|540749191|FG000|Overall Study|Subject noncompliance|3|||
149895989|NCT02632175|540749191|FG000|Overall Study|other|2|||
149895990|NCT03207815|540749192|FG000|Overall Study|Protocol Violation|3|||
149895991|NCT03207815|540749193|FG001|Overall Study|Protocol Violation|1|||
149895992|NCT03207815|540749192|FG000|Overall Study|Adverse Event|1|||
149895993|NCT03207815|540749193|FG001|Overall Study|Adverse Event|2|||
149895994|NCT03207815|540749192|FG000|Overall Study|Lost to Follow-up|1|||
149895995|NCT03207815|540749193|FG001|Overall Study|Lost to Follow-up|2|||
149895996|NCT03207815|540749192|FG000|Overall Study|Investigator's Discretion|1|||
149895997|NCT03207815|540749193|FG001|Overall Study|Investigator's Discretion|1|||
149895998|NCT03207815|540749192|FG000|Overall Study|Lack of Efficacy|0|||
149895999|NCT03207815|540749193|FG001|Overall Study|Lack of Efficacy|1|||
149896000|NCT03207815|540749192|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
149896001|NCT03207815|540749193|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
149896002|NCT03207815|540749192|FG000|Overall Study|Withdrew Consent|1|||
149896003|NCT03207815|540749193|FG001|Overall Study|Withdrew Consent|0|||
149896004|NCT01671007|540749194|FG000|Overall Study|Other reasons than listed|166|||
149896005|NCT01671007|540749195|FG001|Overall Study|Other reasons than listed|373|||
149896006|NCT01671007|540749196|FG002|Overall Study|Other reasons than listed|197|||
149896007|NCT01671007|540749197|FG003|Overall Study|Other reasons than listed|228|||
149896008|NCT01671007|540749198|FG004|Overall Study|Other reasons than listed|14|||
149896009|NCT01671007|540749199|FG005|Overall Study|Other reasons than listed|71|||
149896010|NCT01671007|540749200|FG006|Overall Study|Other reasons than listed|17|||
149896011|NCT01671007|540749201|FG007|Overall Study|Other reasons than listed|66|||
149896012|NCT01671007|540749202|FG008|Overall Study|Other reasons than listed|0|||
149896013|NCT01671007|540749194|FG000|Overall Study|Withdrawal by Subject|36|||
149896014|NCT01671007|540749195|FG001|Overall Study|Withdrawal by Subject|59|||
149896015|NCT01671007|540749196|FG002|Overall Study|Withdrawal by Subject|53|||
149896016|NCT01671007|540749197|FG003|Overall Study|Withdrawal by Subject|58|||
149896017|NCT01671007|540749198|FG004|Overall Study|Withdrawal by Subject|4|||
149896018|NCT01671007|540749199|FG005|Overall Study|Withdrawal by Subject|15|||
149896019|NCT01671007|540749200|FG006|Overall Study|Withdrawal by Subject|1|||
149896020|NCT01671007|540749201|FG007|Overall Study|Withdrawal by Subject|19|||
149896021|NCT01671007|540749202|FG008|Overall Study|Withdrawal by Subject|0|||
149896022|NCT01671007|540749194|FG000|Overall Study|Lost to Follow-up|93|||
149896023|NCT01671007|540749195|FG001|Overall Study|Lost to Follow-up|142|||
149896024|NCT01671007|540749196|FG002|Overall Study|Lost to Follow-up|91|||
149896025|NCT01671007|540749197|FG003|Overall Study|Lost to Follow-up|63|||
149896026|NCT01671007|540749198|FG004|Overall Study|Lost to Follow-up|7|||
149896027|NCT01671007|540749199|FG005|Overall Study|Lost to Follow-up|20|||
149896028|NCT01671007|540749200|FG006|Overall Study|Lost to Follow-up|2|||
149896029|NCT01671007|540749201|FG007|Overall Study|Lost to Follow-up|28|||
149896030|NCT01671007|540749202|FG008|Overall Study|Lost to Follow-up|0|||
149896031|NCT01671007|540749194|FG000|Overall Study|No end of study case report form|3|||
149896032|NCT01671007|540749195|FG001|Overall Study|No end of study case report form|1|||
149896033|NCT01671007|540749196|FG002|Overall Study|No end of study case report form|0|||
149896034|NCT01671007|540749197|FG003|Overall Study|No end of study case report form|2|||
149896035|NCT01671007|540749198|FG004|Overall Study|No end of study case report form|0|||
150045373|NCT03656562|541305582|FG003|Overall Study|Subject Decision|2|||
149896036|NCT01671007|540749199|FG005|Overall Study|No end of study case report form|0|||
149896037|NCT01671007|540749200|FG006|Overall Study|No end of study case report form|0|||
149896038|NCT01671007|540749201|FG007|Overall Study|No end of study case report form|0|||
149896039|NCT01671007|540749202|FG008|Overall Study|No end of study case report form|0|||
149896040|NCT01671007|540749194|FG000|Overall Study|Not eligible|23|||
149896041|NCT01671007|540749195|FG001|Overall Study|Not eligible|76|||
149896042|NCT01671007|540749196|FG002|Overall Study|Not eligible|25|||
149896043|NCT01671007|540749197|FG003|Overall Study|Not eligible|17|||
149896044|NCT01671007|540749198|FG004|Overall Study|Not eligible|0|||
149896045|NCT01671007|540749199|FG005|Overall Study|Not eligible|6|||
149896046|NCT01671007|540749200|FG006|Overall Study|Not eligible|1|||
149896047|NCT01671007|540749201|FG007|Overall Study|Not eligible|19|||
149896048|NCT01671007|540749202|FG008|Overall Study|Not eligible|0|||
150176161|NCT02214160|541781931|FG002|Overall Study|Death|1|||
150176162|NCT02214160|541781929|FG000|Overall Study|Subject Non-Compliance|0|||
150176163|NCT02214160|541781930|FG001|Overall Study|Subject Non-Compliance|3|||
150176164|NCT02214160|541781931|FG002|Overall Study|Subject Non-Compliance|1|||
150176165|NCT02214160|541781929|FG000|Overall Study|Adverse Event|0|||
150176166|NCT02214160|541781930|FG001|Overall Study|Adverse Event|1|||
150176167|NCT02214160|541781931|FG002|Overall Study|Adverse Event|1|||
150176168|NCT02214160|541781929|FG000|Overall Study|Sponsor Decision|0|||
150176169|NCT02214160|541781930|FG001|Overall Study|Sponsor Decision|2|||
150176170|NCT02214160|541781931|FG002|Overall Study|Sponsor Decision|0|||
150176171|NCT02214160|541781929|FG000|Overall Study|Protocol Violation|1|||
150176172|NCT02214160|541781930|FG001|Overall Study|Protocol Violation|0|||
150176173|NCT02214160|541781931|FG002|Overall Study|Protocol Violation|0|||
150176174|NCT02214160|541781929|FG000|Overall Study|Physician Decision|0|||
150176175|NCT02214160|541781930|FG001|Overall Study|Physician Decision|0|||
150176176|NCT02214160|541781931|FG002|Overall Study|Physician Decision|1|||
149896049|NCT03877068|540749203|FG000|Overall Study|Physician Decision|9|||
149896050|NCT03877068|540749204|FG001|Overall Study|Physician Decision|3|||
149896051|NCT00449865|540749205|FG000|Overall Study|Withdrawal by Subject|110|||
149896052|NCT00449865|540749206|FG001|Overall Study|Withdrawal by Subject|110|||
149896053|NCT00449865|540749205|FG000|Overall Study|Lost to Follow-up|36|||
149896054|NCT00449865|540749206|FG001|Overall Study|Lost to Follow-up|37|||
149896055|NCT00449865|540749205|FG000|Overall Study|Physician Decision|13|||
149896056|NCT00449865|540749206|FG001|Overall Study|Physician Decision|12|||
149896057|NCT00449865|540749205|FG000|Overall Study|Death|31|||
149896058|NCT00449865|540749206|FG001|Overall Study|Death|40|||
149896059|NCT00449865|540749205|FG000|Overall Study|Protocol Violation|8|||
149896060|NCT00449865|540749206|FG001|Overall Study|Protocol Violation|7|||
149896061|NCT00449865|540749205|FG000|Overall Study|Study was stopped|324|||
149896062|NCT00449865|540749206|FG001|Overall Study|Study was stopped|328|||
149896063|NCT00406367|540749207|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
149896064|NCT00406367|540749208|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
149896065|NCT00406367|540749207|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
149896066|NCT00406367|540749208|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
149896067|NCT00406367|540749207|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
149896068|NCT00406367|540749208|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
149896069|NCT00406367|540749207|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
149896070|NCT00406367|540749208|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
149896071|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
149896072|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
149896073|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
149896074|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
149896075|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
149896076|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
149896077|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
149896078|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
149896079|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
149896080|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
149896081|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
149896082|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
149896083|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
149896084|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
149896085|NCT00406367|540749207|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
149896086|NCT00406367|540749208|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
149896087|NCT00171210|540749209|FG000|Overall Study|Adverse Event|16|||
149896088|NCT00171210|540749210|FG001|Overall Study|Adverse Event|27|||
149896089|NCT00171210|540749209|FG000|Overall Study|Abnormal laboratory value(s)|6|||
149896090|NCT00171210|540749210|FG001|Overall Study|Abnormal laboratory value(s)|3|||
149896091|NCT00171210|540749209|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149896092|NCT00171210|540749210|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149896093|NCT00171210|540749209|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
149896094|NCT00171210|540749210|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
149896095|NCT00171210|540749209|FG000|Overall Study|Protocol Violation|0|||
149896096|NCT00171210|540749210|FG001|Overall Study|Protocol Violation|2|||
150176177|NCT02423798|541781932|FG000|Overall Study|Withdrawal by Subject|3|||
150176178|NCT01430611|541781939|FG000|Overall Study|Adverse Event|0|||
150176179|NCT01430611|541781940|FG001|Overall Study|Adverse Event|1|||
150176180|NCT01430611|541781939|FG000|Overall Study|Protocol Violation|1|||
150176181|NCT01430611|541781940|FG001|Overall Study|Protocol Violation|0|||
149896097|NCT00171210|540749209|FG000|Overall Study|Withdrawal by Subject|32|||
149896098|NCT00171210|540749210|FG001|Overall Study|Withdrawal by Subject|30|||
149896099|NCT00171210|540749209|FG000|Overall Study|Lost to Follow-up|1|||
149896100|NCT00171210|540749210|FG001|Overall Study|Lost to Follow-up|0|||
149896101|NCT00171210|540749209|FG000|Overall Study|Administrative problems|1|||
149896102|NCT00171210|540749210|FG001|Overall Study|Administrative problems|1|||
149896103|NCT00171210|540749209|FG000|Overall Study|Death|2|||
149896104|NCT00171210|540749210|FG001|Overall Study|Death|3|||
149896105|NCT00171210|540749209|FG000|Overall Study|Stopped at end of core|0|||
149896106|NCT00171210|540749210|FG001|Overall Study|Stopped at end of core|32|||
149896107|NCT00171210|540749209|FG000|Overall Study|Stopped at end of extension 1|0|||
149896108|NCT00171210|540749210|FG001|Overall Study|Stopped at end of extension 1|1|||
149896109|NCT03187301|540749213|FG000|Titration Period|Adverse Event|0|||
149896110|NCT03187301|540749214|FG001|Titration Period|Adverse Event|0|||
149896111|NCT03187301|540749215|FG002|Titration Period|Adverse Event|0|||
149896112|NCT03187301|540749216|FG003|Titration Period|Adverse Event|0|||
149896113|NCT03187301|540749217|FG004|Titration Period|Adverse Event|0|||
149896114|NCT03187301|540749218|FG005|Titration Period|Adverse Event|0|||
149896115|NCT03187301|540749219|FG006|Titration Period|Adverse Event|5|||
149896116|NCT03187301|540749213|FG000|Titration Period|Withdrawal by Subject|0|||
149896117|NCT03187301|540749214|FG001|Titration Period|Withdrawal by Subject|0|||
149896118|NCT03187301|540749215|FG002|Titration Period|Withdrawal by Subject|0|||
149896119|NCT03187301|540749216|FG003|Titration Period|Withdrawal by Subject|0|||
149896120|NCT03187301|540749217|FG004|Titration Period|Withdrawal by Subject|0|||
150045374|NCT00905645|541305583|FG000|Overall Study|Death (not device related)|10|||
150045375|NCT00905645|541305584|FG001|Overall Study|Death (not device related)|4|||
149896121|NCT03187301|540749218|FG005|Titration Period|Withdrawal by Subject|0|||
150045376|NCT00905645|541305585|FG002|Overall Study|Death (not device related)|15|||
150045377|NCT00905645|541305586|FG003|Overall Study|Death (not device related)|8|||
150045378|NCT00905645|541305583|FG000|Overall Study|Explantation of study device(s)|78|||
150045379|NCT00905645|541305584|FG001|Overall Study|Explantation of study device(s)|47|||
150045380|NCT00905645|541305585|FG002|Overall Study|Explantation of study device(s)|28|||
150045381|NCT00905645|541305586|FG003|Overall Study|Explantation of study device(s)|21|||
150045382|NCT00905645|541305583|FG000|Overall Study|Subject Request|41|||
150045383|NCT00905645|541305584|FG001|Overall Study|Subject Request|17|||
150045384|NCT00905645|541305585|FG002|Overall Study|Subject Request|13|||
150045385|NCT00905645|541305586|FG003|Overall Study|Subject Request|11|||
150045386|NCT00905645|541305583|FG000|Overall Study|Lost to Follow-up|299|||
150045387|NCT00905645|541305584|FG001|Overall Study|Lost to Follow-up|103|||
150045388|NCT00905645|541305585|FG002|Overall Study|Lost to Follow-up|51|||
150045389|NCT00905645|541305586|FG003|Overall Study|Lost to Follow-up|12|||
150045390|NCT00578292|541305587|FG000|Overall Study|Death|1|||
150045391|NCT00578292|541305587|FG000|Overall Study|Graft failure|2|||
150045392|NCT01485172|541305588|FG000|Overall Study|Adverse Event|2|||
150045393|NCT01485172|541305589|FG001|Overall Study|Adverse Event|1|||
150045394|NCT01485172|541305590|FG002|Overall Study|Adverse Event|2|||
150045395|NCT01485172|541305591|FG003|Overall Study|Adverse Event|2|||
150045396|NCT01485172|541305592|FG004|Overall Study|Adverse Event|1|||
150045397|NCT01485172|541305593|FG005|Overall Study|Adverse Event|2|||
150045398|NCT01485172|541305588|FG000|Overall Study|Lack of Efficacy|2|||
149896122|NCT03187301|540749219|FG006|Titration Period|Withdrawal by Subject|1|||
149896123|NCT03187301|540749213|FG000|Titration Period|Exclusion Criteria Met|0|||
149896124|NCT03187301|540749214|FG001|Titration Period|Exclusion Criteria Met|0|||
150045399|NCT01485172|541305589|FG001|Overall Study|Lack of Efficacy|0|||
150045400|NCT01485172|541305590|FG002|Overall Study|Lack of Efficacy|0|||
150045401|NCT01485172|541305591|FG003|Overall Study|Lack of Efficacy|0|||
150045402|NCT01485172|541305592|FG004|Overall Study|Lack of Efficacy|0|||
150045403|NCT01485172|541305593|FG005|Overall Study|Lack of Efficacy|0|||
149896125|NCT03187301|540749215|FG002|Titration Period|Exclusion Criteria Met|0|||
149896126|NCT03187301|540749216|FG003|Titration Period|Exclusion Criteria Met|0|||
149896127|NCT03187301|540749217|FG004|Titration Period|Exclusion Criteria Met|0|||
149896128|NCT03187301|540749218|FG005|Titration Period|Exclusion Criteria Met|0|||
149896129|NCT03187301|540749219|FG006|Titration Period|Exclusion Criteria Met|1|||
149896130|NCT03187301|540749213|FG000|Pre-Intervention|Withdrawal by Subject|1|||
149896131|NCT03187301|540749214|FG001|Pre-Intervention|Withdrawal by Subject|0|||
149896132|NCT03187301|540749215|FG002|Pre-Intervention|Withdrawal by Subject|0|||
149896133|NCT03187301|540749216|FG003|Pre-Intervention|Withdrawal by Subject|0|||
149896134|NCT03187301|540749217|FG004|Pre-Intervention|Withdrawal by Subject|0|||
149896135|NCT03187301|540749218|FG005|Pre-Intervention|Withdrawal by Subject|0|||
149896136|NCT03187301|540749219|FG006|Pre-Intervention|Withdrawal by Subject|0|||
149896137|NCT01812109|540749223|FG000|Overall Study|research personnel delay|16|||
149896138|NCT01812109|540749223|FG000|Overall Study|NIRS Unattainable|17|||
149896139|NCT01966120|540749226|FG000|Overall Study|Withdrawal by Subject|0|||
149896140|NCT01966120|540749227|FG001|Overall Study|Withdrawal by Subject|5|||
149896141|NCT01966120|540749226|FG000|Overall Study|Lost to Follow-up|1|||
149896142|NCT01966120|540749227|FG001|Overall Study|Lost to Follow-up|1|||
149896143|NCT00461630|540749228|FG000|Overall Study|Death|798|||
149896144|NCT00461630|540749229|FG001|Overall Study|Death|732|||
149896145|NCT00461630|540749228|FG000|Overall Study|Lost to Follow-up|108|||
149896146|NCT00461630|540749229|FG001|Overall Study|Lost to Follow-up|95|||
149896147|NCT00442897|540749233|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
149896148|NCT00442897|540749234|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
149896149|NCT00442897|540749233|FG000|Base Study (12 Week Follow-up)|Death|0|||
149896150|NCT00442897|540749234|FG001|Base Study (12 Week Follow-up)|Death|1|||
149896151|NCT00442897|540749233|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
149896152|NCT00442897|540749234|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
149896153|NCT00442897|540749233|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
149896154|NCT00442897|540749234|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
149968691|NCT01559935|541022028|FG000|Maintenance Phase|Withdrawal by Subject|5|||
149968692|NCT01559935|541022028|FG000|Maintenance Phase|Non-compliance|2|||
149968693|NCT01472185|541022029|FG000|Overall Study|Randomized but Not Treated|0|||
149968694|NCT01472185|541022030|FG001|Overall Study|Randomized but Not Treated|1|||
149968695|NCT01472185|541022029|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
149968696|NCT01472185|541022030|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
149968697|NCT01472185|541022029|FG000|Overall Study|Hyperglycemia|5|||
149968698|NCT01472185|541022030|FG001|Overall Study|Hyperglycemia|2|||
149968699|NCT01472185|541022029|FG000|Overall Study|Investigator's Discretion|3|||
149968700|NCT01472185|541022030|FG001|Overall Study|Investigator's Discretion|1|||
149896155|NCT00442897|540749233|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
149896156|NCT00442897|540749234|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
149896157|NCT00442897|540749233|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
149896158|NCT00442897|540749234|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
149896159|NCT00442897|540749233|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
149896160|NCT00442897|540749234|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
149896161|NCT00442897|540749233|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
149896162|NCT00442897|540749234|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
149896163|NCT04498182|540749235|FG000|Overall Study|Adverse Event|2|||
149896164|NCT04498182|540749236|FG001|Overall Study|Adverse Event|3|||
149896165|NCT04498182|540749237|FG002|Overall Study|Adverse Event|2|||
149896166|NCT04498182|540749235|FG000|Overall Study|Withdrawal of Consent|3|||
149896167|NCT04498182|540749236|FG001|Overall Study|Withdrawal of Consent|4|||
149896168|NCT04498182|540749237|FG002|Overall Study|Withdrawal of Consent|3|||
149896169|NCT04498182|540749235|FG000|Overall Study|Non-Compliant|1|||
149896170|NCT04498182|540749236|FG001|Overall Study|Non-Compliant|0|||
149896171|NCT04498182|540749237|FG002|Overall Study|Non-Compliant|1|||
149896172|NCT04498182|540749235|FG000|Overall Study|Lost to Follow-up|0|||
149896173|NCT04498182|540749236|FG001|Overall Study|Lost to Follow-up|0|||
149896174|NCT04498182|540749237|FG002|Overall Study|Lost to Follow-up|1|||
149896175|NCT04498182|540749235|FG000|Overall Study|Investigator Decision|0|||
149896176|NCT04498182|540749236|FG001|Overall Study|Investigator Decision|0|||
149896177|NCT04498182|540749237|FG002|Overall Study|Investigator Decision|1|||
149896178|NCT04498182|540749235|FG000|Overall Study|Protocol Violation|1|||
149896179|NCT04498182|540749236|FG001|Overall Study|Protocol Violation|0|||
149896180|NCT04498182|540749237|FG002|Overall Study|Protocol Violation|2|||
149896181|NCT02182843|540749238|FG000|Overall Study|Withdrawal by Subject|7|||
149896182|NCT02182843|540749238|FG000|Overall Study|Lost to Follow-up|2|||
149896183|NCT02182843|540749238|FG000|Overall Study|Adverse Event|1|||
149896184|NCT02588612|540749251|FG000|Overall Study|Physician Decision|1|||
149896185|NCT02588612|540749251|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
149896186|NCT02588612|540749251|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
149896187|NCT02588612|540749251|FG000|Overall Study|Death prior to T-cell infusion|1|||
149896188|NCT00630825|540749261|FG000|Overall Study|Adverse Event|4|||
149896189|NCT00630825|540749262|FG001|Overall Study|Adverse Event|4|||
149896190|NCT00630825|540749263|FG002|Overall Study|Adverse Event|3|||
149896191|NCT00630825|540749264|FG003|Overall Study|Adverse Event|1|||
149896192|NCT00630825|540749261|FG000|Overall Study|Entry Criteria Not Met|1|||
149896193|NCT00630825|540749262|FG001|Overall Study|Entry Criteria Not Met|0|||
149896194|NCT00630825|540749263|FG002|Overall Study|Entry Criteria Not Met|2|||
149896195|NCT00630825|540749264|FG003|Overall Study|Entry Criteria Not Met|1|||
149896196|NCT00630825|540749261|FG000|Overall Study|Lost to Follow-up|1|||
149896197|NCT00630825|540749262|FG001|Overall Study|Lost to Follow-up|1|||
149896198|NCT00630825|540749263|FG002|Overall Study|Lost to Follow-up|1|||
149896199|NCT00630825|540749264|FG003|Overall Study|Lost to Follow-up|1|||
149896200|NCT00630825|540749261|FG000|Overall Study|Physician Decision|1|||
149896201|NCT00630825|540749262|FG001|Overall Study|Physician Decision|0|||
149896202|NCT00630825|540749263|FG002|Overall Study|Physician Decision|0|||
149896203|NCT00630825|540749264|FG003|Overall Study|Physician Decision|0|||
149896204|NCT00630825|540749261|FG000|Overall Study|Withdrawal by Subject|2|||
149896205|NCT00630825|540749262|FG001|Overall Study|Withdrawal by Subject|2|||
149896206|NCT00630825|540749263|FG002|Overall Study|Withdrawal by Subject|2|||
149896207|NCT00630825|540749264|FG003|Overall Study|Withdrawal by Subject|3|||
149896208|NCT02042014|540749265|FG000|Overall Study|Adverse Event|1|||
149896209|NCT02042014|540749265|FG000|Overall Study|Physician Decision|7|||
149896210|NCT03123393|540749269|FG000|Overall Study|Study Terminated by Sponsor|6|||
149896211|NCT03123393|540749270|FG001|Overall Study|Study Terminated by Sponsor|9|||
149896212|NCT03123393|540749269|FG000|Overall Study|Withdrawal by Subject|2|||
149896213|NCT03123393|540749270|FG001|Overall Study|Withdrawal by Subject|1|||
149896214|NCT03123393|540749269|FG000|Overall Study|Reason not Specified|13|||
149896215|NCT03123393|540749270|FG001|Overall Study|Reason not Specified|13|||
149896216|NCT00558701|540749272|FG000|Overall Study|Protocol Deviations|1|||
149896217|NCT00558701|540749273|FG001|Overall Study|Protocol Deviations|4|||
149896218|NCT00427648|540749274|FG000|Overall Study|Protocol Violation|1|||
149896219|NCT00427648|540749275|FG001|Overall Study|Protocol Violation|2|||
149896220|NCT00427648|540749274|FG000|Overall Study|Adverse Event|0|||
149896221|NCT00427648|540749275|FG001|Overall Study|Adverse Event|1|||
149896222|NCT02230904|540749276|FG000|Overall Study|Safety follow up could not take place|0|||
149896223|NCT02230904|540749277|FG001|Overall Study|Safety follow up could not take place|1|||
149896224|NCT01464333|540749279|FG000|Overall Study|Adverse Event|34|||
149896225|NCT01464333|540749279|FG000|Overall Study|Lack of Efficacy|72|||
149896226|NCT01464333|540749279|FG000|Overall Study|Withdrawal by Subject|11|||
149896227|NCT01464333|540749279|FG000|Overall Study|Other|4|||
149896228|NCT01464333|540749279|FG000|Overall Study|No Hospital Visit|42|||
149896229|NCT05047211|540749282|FG000|Overall Study|Lost to Follow-up|8|||
149896230|NCT05047211|540749283|FG001|Overall Study|Lost to Follow-up|5|||
149896231|NCT02187198|540749284|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
149896232|NCT02187198|540749285|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
149896233|NCT02187198|540749284|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
149896234|NCT02187198|540749285|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
149896235|NCT00561392|540749286|FG000|Overall Study|Adverse Event|38|||
149896236|NCT00561392|540749286|FG000|Overall Study|Lack of Efficacy|2|||
149896237|NCT00561392|540749286|FG000|Overall Study|Protocol Violation|1|||
149896238|NCT00561392|540749286|FG000|Overall Study|Withdrawal by Subject|8|||
149896239|NCT00561392|540749286|FG000|Overall Study|Administrative problems|4|||
149896240|NCT03321968|540749287|FG000|Overall Study|Withdrawal by Subject|1|||
149896241|NCT03321968|540749288|FG001|Overall Study|Withdrawal by Subject|2|||
149896242|NCT03321968|540749289|FG002|Overall Study|Withdrawal by Subject|1|||
149896243|NCT03321968|540749287|FG000|Overall Study|Lost to Follow-up|2|||
149896244|NCT03321968|540749288|FG001|Overall Study|Lost to Follow-up|0|||
149896245|NCT03321968|540749289|FG002|Overall Study|Lost to Follow-up|1|||
149896246|NCT03321968|540749287|FG000|Overall Study|Other than specified|0|||
149896247|NCT03321968|540749288|FG001|Overall Study|Other than specified|0|||
149896248|NCT03321968|540749289|FG002|Overall Study|Other than specified|1|||
149896249|NCT03822468|540749290|FG000|Treatment Period|Progressive disease|98|||
149896250|NCT03822468|540749291|FG001|Treatment Period|Progressive disease|94|||
149896251|NCT03822468|540749290|FG000|Treatment Period|Adverse Event|21|||
149896252|NCT03822468|540749291|FG001|Treatment Period|Adverse Event|24|||
149896253|NCT03822468|540749290|FG000|Treatment Period|Withdrawal by Subject|9|||
149896254|NCT03822468|540749291|FG001|Treatment Period|Withdrawal by Subject|5|||
149896255|NCT03822468|540749290|FG000|Treatment Period|Physician Decision|9|||
149896256|NCT03822468|540749291|FG001|Treatment Period|Physician Decision|7|||
149896257|NCT03822468|540749290|FG000|Treatment Period|Protocol Violation|2|||
149896258|NCT03822468|540749291|FG001|Treatment Period|Protocol Violation|1|||
149896259|NCT03822468|540749290|FG000|Treatment Period|Death|2|||
149896260|NCT03822468|540749291|FG001|Treatment Period|Death|3|||
149896261|NCT03822468|540749290|FG000|Treatment Period|Lost to Follow-up|1|||
149896262|NCT03822468|540749291|FG001|Treatment Period|Lost to Follow-up|1|||
149896263|NCT03822468|540749290|FG000|Treatment Period|Sponsor decision|46|||
149896264|NCT03822468|540749291|FG001|Treatment Period|Sponsor decision|53|||
149896265|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
149896266|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
149896267|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
149896268|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
149896269|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Death|1|||
149896270|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Death|0|||
149896271|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149896272|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
149896273|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
149896274|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
149896275|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
149896276|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
149896277|NCT03822468|540749290|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
149896278|NCT03822468|540749291|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
149896279|NCT02155283|540749292|FG000|Overall Study|Lost to Follow-up|3|||
149896280|NCT02155283|540749292|FG000|Overall Study|Withdrawal by Subject|1|||
149896281|NCT02155283|540749292|FG000|Overall Study|Protocol Violation|3|||
149896282|NCT01741688|540749294|FG000|Overall Study|Lack of insurance coverage|2|||
149896283|NCT01741688|540749294|FG000|Overall Study|Withdrawal by Subject|1|||
149896284|NCT00463047|540749298|FG000|Titration Period 1|Adverse Event|10|||
149896285|NCT00463047|540749299|FG001|Titration Period 1|Adverse Event|8|||
149896286|NCT00463047|540749298|FG000|Titration Period 1|Lack of Efficacy|10|||
149896287|NCT00463047|540749299|FG001|Titration Period 1|Lack of Efficacy|4|||
149896288|NCT00463047|540749298|FG000|Titration Period 1|Lost to Follow-up|2|||
149896289|NCT00463047|540749299|FG001|Titration Period 1|Lost to Follow-up|0|||
149896290|NCT00463047|540749298|FG000|Titration Period 1|Non-compliance with study medication|3|||
149896291|NCT00463047|540749299|FG001|Titration Period 1|Non-compliance with study medication|5|||
149896292|NCT00463047|540749298|FG000|Titration Period 1|Protocol Violation|5|||
149896293|NCT00463047|540749299|FG001|Titration Period 1|Protocol Violation|5|||
149968701|NCT01472185|541022029|FG000|Overall Study|Lost to Follow-up|4|||
149896294|NCT00463047|540749298|FG000|Titration Period 1|Withdrawal by Subject|3|||
149896295|NCT00463047|540749299|FG001|Titration Period 1|Withdrawal by Subject|5|||
149896296|NCT00463047|540749298|FG000|Titration Period 1|Non-compliance procedures|4|||
149896297|NCT00463047|540749299|FG001|Titration Period 1|Non-compliance procedures|10|||
149896298|NCT00463047|540749298|FG000|Titration Period 1|Other|0|||
149896299|NCT00463047|540749299|FG001|Titration Period 1|Other|2|||
149896300|NCT00463047|540749298|FG000|Titration Period 2|Adverse Event|9|||
149896301|NCT00463047|540749299|FG001|Titration Period 2|Adverse Event|9|||
149896302|NCT00463047|540749298|FG000|Titration Period 2|Lack of Efficacy|6|||
149896303|NCT00463047|540749299|FG001|Titration Period 2|Lack of Efficacy|4|||
149896304|NCT00463047|540749298|FG000|Titration Period 2|Withdrawal by Subject|1|||
149896305|NCT00463047|540749299|FG001|Titration Period 2|Withdrawal by Subject|0|||
149896306|NCT00463047|540749298|FG000|Titration Period 2|Protocol Violation|2|||
149896307|NCT00463047|540749299|FG001|Titration Period 2|Protocol Violation|3|||
149896308|NCT00463047|540749298|FG000|Titration Period 2|Lost to Follow-up|1|||
149896309|NCT00463047|540749299|FG001|Titration Period 2|Lost to Follow-up|2|||
149896310|NCT00463047|540749298|FG000|Titration Period 2|Non-compliance study medication|4|||
149896311|NCT00463047|540749299|FG001|Titration Period 2|Non-compliance study medication|2|||
149896312|NCT00463047|540749298|FG000|Titration Period 2|Non-compliance procedures|4|||
149896313|NCT00463047|540749299|FG001|Titration Period 2|Non-compliance procedures|1|||
149896314|NCT00463047|540749298|FG000|Titration Period 2|Other|3|||
149896315|NCT00463047|540749299|FG001|Titration Period 2|Other|2|||
149896316|NCT00463047|540749298|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
149896317|NCT00463047|540749299|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
149896318|NCT00463047|540749298|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
149896319|NCT00463047|540749299|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
149896320|NCT00463047|540749298|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
149896321|NCT00463047|540749299|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
149896322|NCT00463047|540749298|FG000|Double-Blind Treatment Period 1|Other|1|||
149896323|NCT00463047|540749299|FG001|Double-Blind Treatment Period 1|Other|0|||
149896324|NCT00463047|540749298|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
149896325|NCT00463047|540749299|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
149896326|NCT00463047|540749298|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
149896327|NCT00463047|540749299|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
149896328|NCT00463047|540749298|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
149896329|NCT00463047|540749299|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
149896330|NCT02712554|540749305|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
149896331|NCT02712554|540749306|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
149896332|NCT02712554|540749305|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
149896333|NCT02712554|540749306|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
149896334|NCT02712554|540749305|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
149896335|NCT02712554|540749306|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
149896336|NCT02712554|540749305|FG000|Part B: Qualification Phase|Adverse Event|0|||
149896337|NCT02712554|540749306|FG001|Part B: Qualification Phase|Adverse Event|1|||
149896338|NCT02712554|540749305|FG000|Part B: Treatment Phase|Adverse Event|0|||
149896339|NCT02712554|540749306|FG001|Part B: Treatment Phase|Adverse Event|1|||
149896340|NCT02712554|540749305|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
149896341|NCT02712554|540749306|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
149896342|NCT02712554|540749305|FG000|Part B: Treatment Phase|Other|0|||
149896343|NCT02712554|540749306|FG001|Part B: Treatment Phase|Other|1|||
149896344|NCT02503540|540749308|FG000|Overall Study|Death|2|||
149896345|NCT02503540|540749308|FG000|Overall Study|Withdrawal by Subject|1|||
149896346|NCT01662492|540749309|FG000|Overall Study|Other miscellaneous reasons.|1|||
149896347|NCT01662492|540749310|FG001|Overall Study|Other miscellaneous reasons.|0|||
149896348|NCT01662492|540749311|FG002|Overall Study|Other miscellaneous reasons.|1|||
149896349|NCT01662492|540749309|FG000|Overall Study|Withdrawal by Subject|0|||
149896350|NCT01662492|540749310|FG001|Overall Study|Withdrawal by Subject|0|||
149896351|NCT01662492|540749311|FG002|Overall Study|Withdrawal by Subject|1|||
149896352|NCT01662492|540749309|FG000|Overall Study|Protocol Violation|1|||
149896353|NCT01662492|540749310|FG001|Overall Study|Protocol Violation|0|||
149896354|NCT01662492|540749311|FG002|Overall Study|Protocol Violation|0|||
149896355|NCT01662492|540749309|FG000|Overall Study|Lost to Follow-up|0|||
149896356|NCT01662492|540749310|FG001|Overall Study|Lost to Follow-up|0|||
149896357|NCT01662492|540749311|FG002|Overall Study|Lost to Follow-up|2|||
149896358|NCT01662492|540749309|FG000|Overall Study|Lack of Efficacy|1|||
149896359|NCT01662492|540749310|FG001|Overall Study|Lack of Efficacy|1|||
149896360|NCT01662492|540749311|FG002|Overall Study|Lack of Efficacy|2|||
149896361|NCT01991743|540749315|FG000|Overall Study|external cephalic version not performed|0|||
149896362|NCT01991743|540749316|FG001|Overall Study|external cephalic version not performed|0|||
149896363|NCT01991743|540749317|FG002|Overall Study|external cephalic version not performed|1|||
149896364|NCT01991743|540749318|FG003|Overall Study|external cephalic version not performed|0|||
149896365|NCT03830333|540749319|FG000|Overall Study|Death|0|||
149896366|NCT03830333|540749320|FG001|Overall Study|Death|1|||
149896367|NCT03830333|540749319|FG000|Overall Study|Withdrawal by Subject|5|||
149896368|NCT03830333|540749320|FG001|Overall Study|Withdrawal by Subject|1|||
149896369|NCT03830333|540749319|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
149896370|NCT03830333|540749320|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
149896371|NCT01129557|540749321|FG000|Overall Study|Adverse Event|1|||
149896372|NCT01129557|540749322|FG001|Overall Study|Adverse Event|2|||
149896373|NCT01129557|540749323|FG002|Overall Study|Adverse Event|2|||
149896374|NCT01129557|540749321|FG000|Overall Study|Novartis terminated study early|3|||
149896375|NCT01129557|540749322|FG001|Overall Study|Novartis terminated study early|3|||
149896376|NCT01129557|540749323|FG002|Overall Study|Novartis terminated study early|2|||
149896377|NCT01486446|540749324|FG000|Overall Study|Adverse Event|1|||
149896378|NCT01486446|540749325|FG001|Overall Study|Adverse Event|0|||
149896379|NCT04390113|540749326|FG000|Overall Study|Not Treated|0|||
149896380|NCT04390113|540749327|FG001|Overall Study|Not Treated|1|||
149896381|NCT04390113|540749326|FG000|Overall Study|Adverse Event|1|||
149896382|NCT04390113|540749327|FG001|Overall Study|Adverse Event|0|||
149896383|NCT04390113|540749326|FG000|Overall Study|Death|2|||
149896384|NCT04390113|540749327|FG001|Overall Study|Death|1|||
149896385|NCT04390113|540749326|FG000|Overall Study|Physician Decision|1|||
149896386|NCT04390113|540749327|FG001|Overall Study|Physician Decision|3|||
149896387|NCT04390113|540749326|FG000|Overall Study|Study Terminated by Sponsor|5|||
149896388|NCT04390113|540749327|FG001|Overall Study|Study Terminated by Sponsor|3|||
149896389|NCT04390113|540749326|FG000|Overall Study|Withdrawal by Subject|10|||
149896390|NCT04390113|540749327|FG001|Overall Study|Withdrawal by Subject|5|||
149896391|NCT04390113|540749326|FG000|Overall Study|Other|1|||
149896392|NCT04390113|540749327|FG001|Overall Study|Other|0|||
149896393|NCT04390113|540749326|FG000|Overall Study|Missing|0|||
149896394|NCT04390113|540749327|FG001|Overall Study|Missing|1|||
149896395|NCT01611883|540749328|FG000|Overall Study|Adverse Event|1|||
149896396|NCT01611883|540749329|FG001|Overall Study|Adverse Event|1|||
149896397|NCT03379727|540749330|FG000|Overall Study|Lack of Efficacy|73|||
149896398|NCT03379727|540749330|FG000|Overall Study|Adverse Event|32|||
149896399|NCT03379727|540749330|FG000|Overall Study|Death|18|||
149896400|NCT03379727|540749330|FG000|Overall Study|Patient/guardian decision|17|||
149896401|NCT03379727|540749330|FG000|Overall Study|Physician Decision|104|||
149896402|NCT03379727|540749330|FG000|Overall Study|Protocol Violation|4|||
149896403|NCT03379727|540749330|FG000|Overall Study|Lost to Follow-up|1|||
149896404|NCT02418182|540749335|FG000|Overall Study|Unable to re-consent|18|||
149896405|NCT02418182|540749336|FG001|Overall Study|Unable to re-consent|15|||
149896406|NCT02418182|540749335|FG000|Overall Study|Lost to Follow-up|0|||
149896407|NCT02418182|540749336|FG001|Overall Study|Lost to Follow-up|2|||
149896408|NCT02747108|540749337|FG000|Overall Study|Death|2|||
149896409|NCT02747108|540749338|FG001|Overall Study|Death|2|||
149896410|NCT02747108|540749337|FG000|Overall Study|Withdrawal by Subject|1|||
149896411|NCT02747108|540749338|FG001|Overall Study|Withdrawal by Subject|0|||
149896412|NCT02747108|540749337|FG000|Overall Study|Protocol Violation|2|||
149896413|NCT02747108|540749338|FG001|Overall Study|Protocol Violation|0|||
149896414|NCT00570687|540751119|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896415|NCT00570687|540751120|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896416|NCT00570687|540751121|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896417|NCT00570687|540751122|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896418|NCT00570687|540751123|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
149896419|NCT00570687|540751124|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
149896420|NCT00570687|540751125|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
149896421|NCT00570687|540751126|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
149896422|NCT00570687|540751127|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
149896423|NCT00570687|540751128|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
149896424|NCT00570687|540751119|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896425|NCT00570687|540751120|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149968702|NCT01472185|541022030|FG001|Overall Study|Lost to Follow-up|1|||
149968703|NCT01472185|541022029|FG000|Overall Study|Protocol Violation|5|||
149968704|NCT01472185|541022030|FG001|Overall Study|Protocol Violation|1|||
149968705|NCT01472185|541022029|FG000|Overall Study|Subject Noncompliance|8|||
149968706|NCT01472185|541022030|FG001|Overall Study|Subject Noncompliance|15|||
149968707|NCT01472185|541022029|FG000|Overall Study|Subject Withdrew Consent|6|||
149968708|NCT01472185|541022030|FG001|Overall Study|Subject Withdrew Consent|3|||
150045404|NCT01485172|541305588|FG000|Overall Study|Protocol Violation|0|||
150045405|NCT01485172|541305589|FG001|Overall Study|Protocol Violation|0|||
150045406|NCT01485172|541305590|FG002|Overall Study|Protocol Violation|4|||
149896426|NCT00570687|540751121|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896427|NCT00570687|540751122|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896428|NCT00570687|540751123|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896429|NCT00570687|540751124|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896430|NCT00570687|540751125|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896431|NCT00570687|540751126|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149968709|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
150045407|NCT01485172|541305591|FG003|Overall Study|Protocol Violation|5|||
149896432|NCT00570687|540751127|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
149896433|NCT00570687|540751128|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896434|NCT00570687|540751119|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896435|NCT00570687|540751120|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896436|NCT00570687|540751121|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896437|NCT00570687|540751122|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896438|NCT00570687|540751123|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896439|NCT00570687|540751124|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896440|NCT00570687|540751125|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
149896441|NCT00570687|540751126|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896442|NCT00570687|540751127|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896443|NCT00570687|540751128|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
149896444|NCT03771898|540751129|FG000|Overall Study|Adverse Event|1|||
149896445|NCT03771898|540751130|FG001|Overall Study|Adverse Event|0|||
149896446|NCT03771898|540751131|FG002|Overall Study|Adverse Event|0|||
149896447|NCT03771898|540751132|FG003|Overall Study|Adverse Event|0|||
149896448|NCT03771898|540751133|FG004|Overall Study|Adverse Event|0|||
149896449|NCT03771898|540751129|FG000|Overall Study|Lost to Follow-up|1|||
149896450|NCT03771898|540751130|FG001|Overall Study|Lost to Follow-up|1|||
149896451|NCT03771898|540751131|FG002|Overall Study|Lost to Follow-up|1|||
149896452|NCT03771898|540751132|FG003|Overall Study|Lost to Follow-up|0|||
149896453|NCT03771898|540751133|FG004|Overall Study|Lost to Follow-up|0|||
149968710|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
149968711|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968712|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
149968713|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
149968714|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
149968715|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
149968716|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968717|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968718|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968719|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968720|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968721|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968722|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968723|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
149968724|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
150045408|NCT01485172|541305592|FG004|Overall Study|Protocol Violation|1|||
149896454|NCT03771898|540751129|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149896455|NCT03771898|540751130|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149896456|NCT03771898|540751131|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149896457|NCT03771898|540751132|FG003|Overall Study|Withdrawal by parent/guardian|0|||
149896458|NCT03771898|540751133|FG004|Overall Study|Withdrawal by parent/guardian|0|||
149896459|NCT03771898|540751129|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
149896460|NCT03771898|540751130|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
149896461|NCT03771898|540751131|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
149896462|NCT03771898|540751132|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
149896463|NCT03771898|540751133|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
149896464|NCT05343000|540751134|FG000|Overall Study|Physician Decision|2|||
149896465|NCT03135548|540751135|FG000|Overall Study|Lost to Follow-up|3|||
149896466|NCT03135548|540751136|FG001|Overall Study|Lost to Follow-up|0|||
149896467|NCT03135548|540751137|FG002|Overall Study|Lost to Follow-up|0|||
149896468|NCT03135548|540751135|FG000|Overall Study|Withdrawal by Subject|2|||
149896469|NCT03135548|540751136|FG001|Overall Study|Withdrawal by Subject|2|||
149896470|NCT03135548|540751137|FG002|Overall Study|Withdrawal by Subject|1|||
149896471|NCT03135548|540751135|FG000|Overall Study|Other than listed|0|||
149896472|NCT03135548|540751136|FG001|Overall Study|Other than listed|2|||
149896473|NCT03135548|540751137|FG002|Overall Study|Other than listed|2|||
149896474|NCT04623216|540751138|FG000|Overall Study|Death|5|||
149896475|NCT04623216|540751139|FG001|Overall Study|Death|2|||
149896476|NCT04623216|540751140|FG002|Overall Study|Death|0|||
149896477|NCT04623216|540751141|FG003|Overall Study|Death|0|||
149896478|NCT04623216|540751138|FG000|Overall Study|Terminated by Sponsor|3|||
149896479|NCT04623216|540751139|FG001|Overall Study|Terminated by Sponsor|2|||
149896480|NCT04623216|540751140|FG002|Overall Study|Terminated by Sponsor|2|||
149896481|NCT04623216|540751141|FG003|Overall Study|Terminated by Sponsor|0|||
149896482|NCT04623216|540751138|FG000|Overall Study|Physician Decision|1|||
149896483|NCT04623216|540751139|FG001|Overall Study|Physician Decision|0|||
149896484|NCT04623216|540751140|FG002|Overall Study|Physician Decision|0|||
149896485|NCT04623216|540751141|FG003|Overall Study|Physician Decision|0|||
149896486|NCT03521154|540751144|FG000|Overall Study|Ongoing study at data cut-off|111|||
149896487|NCT03521154|540751145|FG001|Overall Study|Ongoing study at data cut-off|52|||
149896488|NCT05386680|540751146|FG000|Overall Study|Guardian decision|2|||
149896489|NCT05271370|540751147|FG000|Overall Study|Study early termination|8|||
149896490|NCT05271370|540751148|FG001|Overall Study|Study early termination|16|||
149896491|NCT05271370|540751149|FG002|Overall Study|Study early termination|29|||
149896492|NCT04168112|540751152|FG000|Overall Study|Lost to Follow-up|1|||
149896493|NCT04168112|540751153|FG001|Overall Study|Lost to Follow-up|0|||
149896494|NCT04168112|540751152|FG000|Overall Study|Withdrawal by Subject|1|||
149896495|NCT04168112|540751153|FG001|Overall Study|Withdrawal by Subject|0|||
149896496|NCT02283268|540751159|FG000|Overall Study|Withdrawal by Subject|1|||
149896497|NCT00333983|540751160|FG000|Overall Study|Lost to Follow-up|2|||
149896498|NCT00333983|540751161|FG001|Overall Study|Lost to Follow-up|1|||
149896499|NCT00333983|540751162|FG002|Overall Study|Lost to Follow-up|0|||
149896500|NCT00333983|540751160|FG000|Overall Study|Adverse Event|1|||
149896501|NCT00333983|540751161|FG001|Overall Study|Adverse Event|1|||
149896502|NCT00333983|540751162|FG002|Overall Study|Adverse Event|1|||
149896503|NCT00333983|540751160|FG000|Overall Study|Withdrawal by Subject|0|||
149896504|NCT00333983|540751161|FG001|Overall Study|Withdrawal by Subject|3|||
149896505|NCT00333983|540751162|FG002|Overall Study|Withdrawal by Subject|1|||
149896506|NCT01780038|540751165|FG000|Overall Study|Lost to Follow-up|4|||
149896507|NCT01780038|540751166|FG001|Overall Study|Lost to Follow-up|1|||
149896508|NCT03270657|540751167|FG000|Overall Study|Withdrawal by Subject|1|||
149896509|NCT00455403|540751168|FG000|Overall Study|Lost to Follow-up|2|||
149896510|NCT00455403|540751169|FG001|Overall Study|Lost to Follow-up|1|||
149896511|NCT00455403|540751168|FG000|Overall Study|Withdrawal by Subject|1|||
149896512|NCT00455403|540751169|FG001|Overall Study|Withdrawal by Subject|3|||
149896513|NCT00455403|540751168|FG000|Overall Study|Protocol Violation|0|||
149896514|NCT00455403|540751169|FG001|Overall Study|Protocol Violation|2|||
149896515|NCT04509076|540751170|FG000|Overall Study|Withdrawal by Subject|1|||
149896516|NCT04509076|540751171|FG001|Overall Study|Withdrawal by Subject|2|||
149896517|NCT04509076|540751170|FG000|Overall Study|Lost to Follow-up|1|||
149896518|NCT04509076|540751171|FG001|Overall Study|Lost to Follow-up|2|||
149896519|NCT01343043|540751174|FG000|Overall Study|Disease progression before treatment|1|||
149896520|NCT01343043|540751175|FG001|Overall Study|Disease progression before treatment|0|||
149896521|NCT01343043|540751176|FG002|Overall Study|Disease progression before treatment|0|||
149896522|NCT01343043|540751177|FG003|Overall Study|Disease progression before treatment|0|||
149896523|NCT01343043|540751174|FG000|Overall Study|Withdrawal by Subject|1|||
149896524|NCT01343043|540751175|FG001|Overall Study|Withdrawal by Subject|0|||
149896525|NCT01343043|540751176|FG002|Overall Study|Withdrawal by Subject|0|||
149896526|NCT01343043|540751177|FG003|Overall Study|Withdrawal by Subject|0|||
149896527|NCT01343043|540751174|FG000|Overall Study|Death|1|||
149896528|NCT01343043|540751175|FG001|Overall Study|Death|1|||
149896529|NCT01343043|540751176|FG002|Overall Study|Death|0|||
149896530|NCT01343043|540751177|FG003|Overall Study|Death|1|||
149896531|NCT00925704|540751178|FG000|First Intervention|Withdrew consent|0|||
149896532|NCT00925704|540751179|FG001|First Intervention|Withdrew consent|0|||
149896533|NCT00925704|540751180|FG002|First Intervention|Withdrew consent|0|||
149896534|NCT00925704|540751181|FG003|First Intervention|Withdrew consent|1|||
149896535|NCT00925704|540751182|FG004|First Intervention|Withdrew consent|1|||
149896536|NCT00925704|540751183|FG005|First Intervention|Withdrew consent|0|||
149896537|NCT00925704|540751178|FG000|Second Intervention|Withdrawal by Subject|1|||
149896538|NCT00925704|540751179|FG001|Second Intervention|Withdrawal by Subject|0|||
149896539|NCT00925704|540751180|FG002|Second Intervention|Withdrawal by Subject|0|||
149896540|NCT00925704|540751181|FG003|Second Intervention|Withdrawal by Subject|0|||
149896541|NCT00925704|540751182|FG004|Second Intervention|Withdrawal by Subject|1|||
149968725|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
149968726|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
149968727|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
149968728|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
149968729|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
149968730|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
149968731|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
149968732|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
149968733|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
149968734|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
149968735|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
149968736|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
149968737|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
149968738|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
149968739|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
149968740|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
149968741|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
149968742|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
149968743|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968744|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968745|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968746|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968747|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
150176182|NCT01430611|541781939|FG000|Overall Study|Lost to Follow-up|1|||
150176183|NCT01430611|541781940|FG001|Overall Study|Lost to Follow-up|0|||
150176184|NCT01430611|541781939|FG000|Overall Study|Withdrawal by Subject|15|||
150176185|NCT01430611|541781940|FG001|Overall Study|Withdrawal by Subject|14|||
150176186|NCT02204982|541781941|FG000|Overall Study|Patient ineligible-medical monitor|1|||
150176187|NCT02204982|541781942|FG001|Overall Study|Patient ineligible-medical monitor|0|||
149896542|NCT00925704|540751183|FG005|Second Intervention|Withdrawal by Subject|0|||
149896543|NCT00925704|540751178|FG000|Third Intervention|Withdrew consent|0|||
149896544|NCT00925704|540751179|FG001|Third Intervention|Withdrew consent|0|||
149896545|NCT00925704|540751180|FG002|Third Intervention|Withdrew consent|0|||
149896546|NCT00925704|540751181|FG003|Third Intervention|Withdrew consent|0|||
149896547|NCT00925704|540751182|FG004|Third Intervention|Withdrew consent|0|||
149896548|NCT00925704|540751183|FG005|Third Intervention|Withdrew consent|1|||
149896549|NCT00502242|540751189|FG000|Overall Study|Lack of Efficacy|1|||
149896550|NCT00502242|540751190|FG001|Overall Study|Lack of Efficacy|11|||
149896551|NCT00502242|540751189|FG000|Overall Study|Adverse Event|31|||
149896552|NCT00502242|540751190|FG001|Overall Study|Adverse Event|20|||
149896553|NCT00502242|540751189|FG000|Overall Study|Physician Decision|2|||
149896554|NCT00502242|540751190|FG001|Overall Study|Physician Decision|3|||
149896555|NCT00502242|540751189|FG000|Overall Study|Other - Unspecified|8|||
149896556|NCT00502242|540751190|FG001|Overall Study|Other - Unspecified|14|||
149896557|NCT00502242|540751189|FG000|Overall Study|Protocol Violation|3|||
149896558|NCT00502242|540751190|FG001|Overall Study|Protocol Violation|1|||
149896559|NCT00502242|540751189|FG000|Overall Study|Withdrawal by Subject|6|||
149896560|NCT00502242|540751190|FG001|Overall Study|Withdrawal by Subject|7|||
149896561|NCT03252535|540751191|FG000|Overall Study|Withdrawal by Subject|1|||
149896562|NCT03252535|540751192|FG001|Overall Study|Withdrawal by Subject|0|||
149896563|NCT03252535|540751193|FG002|Overall Study|Withdrawal by Subject|0|||
149896564|NCT03252535|540751191|FG000|Overall Study|Physician Decision|0|||
149896565|NCT03252535|540751192|FG001|Overall Study|Physician Decision|1|||
149896566|NCT03252535|540751193|FG002|Overall Study|Physician Decision|0|||
149896567|NCT03252535|540751191|FG000|Overall Study|Met discontinuation criteria|0|||
149896568|NCT03252535|540751192|FG001|Overall Study|Met discontinuation criteria|1|||
149896569|NCT03252535|540751193|FG002|Overall Study|Met discontinuation criteria|0|||
149896570|NCT04548193|540751195|FG000|Overall Study|Lost to Follow-up|0|||
149896571|NCT04548193|540751196|FG001|Overall Study|Lost to Follow-up|1|||
149896572|NCT04548193|540751195|FG000|Overall Study|Death|0|||
150176188|NCT02204982|541781941|FG000|Overall Study|Withdrawal by Subject|1|||
149896573|NCT04548193|540751196|FG001|Overall Study|Death|1|||
149896574|NCT04548193|540751195|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
149896575|NCT04548193|540751196|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
149896576|NCT04548193|540751195|FG000|Overall Study|Withdrawal by Subject|2|||
149896577|NCT04548193|540751196|FG001|Overall Study|Withdrawal by Subject|2|||
149896578|NCT01681212|540751206|FG000|Overall Study|No longer met study criteria|5|||
150176189|NCT02204982|541781942|FG001|Overall Study|Withdrawal by Subject|0|||
149896579|NCT01681212|540751206|FG000|Overall Study|Administrative reason by sponsor|1|||
149896580|NCT01532518|540751208|FG000|Overall Study|Withdrawal by Subject|0|||
149896581|NCT01532518|540751209|FG001|Overall Study|Withdrawal by Subject|0|||
149896582|NCT01532518|540751210|FG002|Overall Study|Withdrawal by Subject|1|||
149896583|NCT01575834|540751211|FG000|Overall Study|Withdrawal by Subject|352|||
149896584|NCT01575834|540751212|FG001|Overall Study|Withdrawal by Subject|390|||
149896585|NCT01575834|540751211|FG000|Overall Study|Death|81|||
149896586|NCT01575834|540751212|FG001|Overall Study|Death|74|||
149896587|NCT01575834|540751211|FG000|Overall Study|Other|70|||
149896588|NCT01575834|540751212|FG001|Overall Study|Other|70|||
149896589|NCT01575834|540751211|FG000|Overall Study|Adverse Event|63|||
149896590|NCT01575834|540751212|FG001|Overall Study|Adverse Event|61|||
150176190|NCT02204982|541781941|FG000|Overall Study|Adverse Event|1|||
149896591|NCT01575834|540751211|FG000|Overall Study|Lost to Follow-up|55|||
149896592|NCT01575834|540751212|FG001|Overall Study|Lost to Follow-up|68|||
150176191|NCT02204982|541781942|FG001|Overall Study|Adverse Event|0|||
149896593|NCT01575834|540751211|FG000|Overall Study|Noncompliance|52|||
149896594|NCT01575834|540751212|FG001|Overall Study|Noncompliance|27|||
149896595|NCT01575834|540751211|FG000|Overall Study|Administrative decision|15|||
149896596|NCT01575834|540751212|FG001|Overall Study|Administrative decision|33|||
149896597|NCT01575834|540751211|FG000|Overall Study|Ineligibility Determined|5|||
150045409|NCT01485172|541305593|FG005|Overall Study|Protocol Violation|0|||
150045410|NCT01485172|541305588|FG000|Overall Study|Protocol defined stopping criteria|1|||
150045411|NCT01485172|541305589|FG001|Overall Study|Protocol defined stopping criteria|0|||
150045412|NCT01485172|541305590|FG002|Overall Study|Protocol defined stopping criteria|0|||
149896598|NCT01575834|540751212|FG001|Overall Study|Ineligibility Determined|8|||
149896599|NCT01575834|540751211|FG000|Overall Study|Protocol Deviation|4|||
149896600|NCT01575834|540751212|FG001|Overall Study|Protocol Deviation|3|||
149896601|NCT01575834|540751211|FG000|Overall Study|Requirement for Alternative Therapy|2|||
149896602|NCT01575834|540751212|FG001|Overall Study|Requirement for Alternative Therapy|4|||
149896603|NCT02282813|540751216|FG000|Overall Study|Withdrawal by Subject|4|||
149896604|NCT02282813|540751217|FG001|Overall Study|Withdrawal by Subject|5|||
149896605|NCT02282813|540751218|FG002|Overall Study|Withdrawal by Subject|0|||
149896606|NCT02282813|540751216|FG000|Overall Study|Adverse Event|3|||
149896607|NCT02282813|540751217|FG001|Overall Study|Adverse Event|10|||
150176192|NCT02204982|541781941|FG000|Overall Study|Adverse Event and Investigator decision|1|||
150176193|NCT02204982|541781942|FG001|Overall Study|Adverse Event and Investigator decision|0|||
150176194|NCT02204982|541781941|FG000|Overall Study|Physician Decision|0|||
150176195|NCT02204982|541781942|FG001|Overall Study|Physician Decision|2|||
150176196|NCT02204982|541781941|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
150176197|NCT02204982|541781942|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
150176198|NCT02204982|541781941|FG000|Overall Study|Termination of Study bySponsor|0|||
150176199|NCT02204982|541781942|FG001|Overall Study|Termination of Study bySponsor|1|||
150176200|NCT00457743|541781946|FG000|Overall Study|Adverse Event|0|||
150176201|NCT00457743|541781947|FG001|Overall Study|Adverse Event|4|||
150176202|NCT00457743|541781948|FG002|Overall Study|Adverse Event|0|||
150176203|NCT00457743|541781946|FG000|Overall Study|Lack of Efficacy|3|||
150176204|NCT00457743|541781947|FG001|Overall Study|Lack of Efficacy|23|||
150176205|NCT00457743|541781948|FG002|Overall Study|Lack of Efficacy|3|||
150176206|NCT01837966|541781949|FG000|Overall Study|Withdrawal by Subject|2|||
150176207|NCT01837966|541781950|FG001|Overall Study|Withdrawal by Subject|1|||
150176208|NCT00159783|541781955|FG000|Overall Study|Adverse Event|5|||
150176209|NCT00159783|541781956|FG001|Overall Study|Adverse Event|7|||
150176210|NCT00159783|541781957|FG002|Overall Study|Adverse Event|9|||
150176211|NCT00159783|541781955|FG000|Overall Study|Lack of Efficacy|1|||
150176212|NCT00159783|541781956|FG001|Overall Study|Lack of Efficacy|2|||
150176213|NCT00159783|541781957|FG002|Overall Study|Lack of Efficacy|3|||
150176214|NCT00159783|541781955|FG000|Overall Study|Withdrawal by Subject|7|||
150176215|NCT00159783|541781956|FG001|Overall Study|Withdrawal by Subject|11|||
150176216|NCT00159783|541781957|FG002|Overall Study|Withdrawal by Subject|12|||
150176217|NCT00159783|541781955|FG000|Overall Study|Lost to Follow-up|6|||
150176218|NCT00159783|541781956|FG001|Overall Study|Lost to Follow-up|5|||
149896608|NCT02282813|540751218|FG002|Overall Study|Adverse Event|1|||
149896609|NCT02282813|540751216|FG000|Overall Study|Subject non-compliance|1|||
149896610|NCT02282813|540751217|FG001|Overall Study|Subject non-compliance|4|||
149896611|NCT02282813|540751218|FG002|Overall Study|Subject non-compliance|0|||
149896612|NCT02282813|540751216|FG000|Overall Study|Physician Decision|0|||
149896613|NCT02282813|540751217|FG001|Overall Study|Physician Decision|3|||
149896614|NCT02282813|540751218|FG002|Overall Study|Physician Decision|1|||
150176219|NCT00159783|541781957|FG002|Overall Study|Lost to Follow-up|11|||
150176220|NCT00159783|541781955|FG000|Overall Study|Other|0|||
150176221|NCT00159783|541781956|FG001|Overall Study|Other|2|||
150176222|NCT00159783|541781957|FG002|Overall Study|Other|4|||
150176223|NCT02928224|541781958|FG000|Overall Study|Lost to Follow-up|1|||
150176224|NCT02928224|541781959|FG001|Overall Study|Lost to Follow-up|1|||
150176225|NCT02928224|541781960|FG002|Overall Study|Lost to Follow-up|3|||
150176226|NCT02928224|541781961|FG003|Overall Study|Lost to Follow-up|0|||
149896615|NCT02282813|540751216|FG000|Overall Study|Lost to Follow-up|2|||
149896616|NCT02282813|540751217|FG001|Overall Study|Lost to Follow-up|0|||
149896617|NCT02282813|540751218|FG002|Overall Study|Lost to Follow-up|1|||
149896618|NCT02282813|540751216|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
149896619|NCT02282813|540751217|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
149896620|NCT02282813|540751218|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
149896621|NCT02282813|540751216|FG000|Overall Study|Lack of Efficacy|1|||
149896622|NCT02282813|540751217|FG001|Overall Study|Lack of Efficacy|0|||
149896623|NCT02282813|540751218|FG002|Overall Study|Lack of Efficacy|0|||
149896624|NCT02282813|540751216|FG000|Overall Study|Administrative reasons|0|||
149896625|NCT02282813|540751217|FG001|Overall Study|Administrative reasons|1|||
149896626|NCT02282813|540751218|FG002|Overall Study|Administrative reasons|0|||
149896627|NCT02220764|540751220|FG000|Overall Study|Lost to Follow-up|3|||
149896628|NCT02220764|540751221|FG001|Overall Study|Lost to Follow-up|1|||
149896629|NCT02220764|540751220|FG000|Overall Study|Death|1|||
149896630|NCT02220764|540751221|FG001|Overall Study|Death|0|||
149896631|NCT05000164|540751222|FG000|Overall Study|Adverse Event|1|||
149896632|NCT05000164|540751222|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
149896633|NCT05000164|540751222|FG000|Overall Study|Lens Discomfort|3|||
149896634|NCT05000164|540751222|FG000|Overall Study|Withdrew Consent during Study|2|||
149896635|NCT05000164|540751222|FG000|Overall Study|Subject Withdrawn by PI|2|||
149896636|NCT05000164|540751222|FG000|Overall Study|Other Fractured Test Article|1|||
149896637|NCT02861807|540751223|FG000|Overall Study|Lost to Follow-up|7|||
149896638|NCT02861807|540751224|FG001|Overall Study|Lost to Follow-up|6|||
149896639|NCT02861807|540751223|FG000|Overall Study|Withdrawal by Subject|5|||
149896640|NCT02861807|540751224|FG001|Overall Study|Withdrawal by Subject|8|||
149896641|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
149896642|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
149896643|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
149896644|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
149896645|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
149896646|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
149896647|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
149896648|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
149896649|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
149896650|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
149896651|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
149896652|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
149896653|NCT03493854|540751225|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
149896654|NCT03493854|540751226|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
149896655|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
149896656|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
149896657|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
149896658|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
149896659|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
149896660|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
149896661|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
149896662|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
149896663|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
149896664|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
149896665|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
149896666|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
150045413|NCT01485172|541305591|FG003|Overall Study|Protocol defined stopping criteria|0|||
150045414|NCT01485172|541305592|FG004|Overall Study|Protocol defined stopping criteria|1|||
150045415|NCT01485172|541305593|FG005|Overall Study|Protocol defined stopping criteria|0|||
150045416|NCT01485172|541305588|FG000|Overall Study|Lost to Follow-up|0|||
150045417|NCT01485172|541305589|FG001|Overall Study|Lost to Follow-up|0|||
150045418|NCT01485172|541305590|FG002|Overall Study|Lost to Follow-up|1|||
150045419|NCT01485172|541305591|FG003|Overall Study|Lost to Follow-up|0|||
150045420|NCT01485172|541305592|FG004|Overall Study|Lost to Follow-up|0|||
150045421|NCT01485172|541305593|FG005|Overall Study|Lost to Follow-up|1|||
149896667|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
149896668|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
149896669|NCT03493854|540751225|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
150045422|NCT01485172|541305588|FG000|Overall Study|Physician Decision|0|||
149896670|NCT03493854|540751226|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
149896671|NCT03493854|540751225|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
149896672|NCT03493854|540751226|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
150045423|NCT01485172|541305589|FG001|Overall Study|Physician Decision|0|||
150176227|NCT02928224|541781958|FG000|Overall Study|Death|30|||
150176228|NCT02928224|541781959|FG001|Overall Study|Death|209|||
150045424|NCT01485172|541305590|FG002|Overall Study|Physician Decision|0|||
149896673|NCT03493854|540751225|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
149896674|NCT03493854|540751226|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
149896675|NCT03493854|540751225|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
149896676|NCT03493854|540751226|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
149896677|NCT00410813|540751229|FG000|Overall Study|Adverse Event|6|||
149896678|NCT00410813|540751230|FG001|Overall Study|Adverse Event|11|||
149896679|NCT00410813|540751229|FG000|Overall Study|Progression|32|||
149896680|NCT00410813|540751230|FG001|Overall Study|Progression|21|||
149896681|NCT00410813|540751229|FG000|Overall Study|Not protocol specified|3|||
149896682|NCT00410813|540751230|FG001|Overall Study|Not protocol specified|4|||
149896683|NCT00410813|540751229|FG000|Overall Study|Ineligible|2|||
149896684|NCT00410813|540751230|FG001|Overall Study|Ineligible|4|||
149896685|NCT00410813|540751229|FG000|Overall Study|Death|0|||
149896686|NCT00410813|540751230|FG001|Overall Study|Death|2|||
149896687|NCT00529308|540751231|FG000|Overall Study|Withdrawal by Subject|1|||
149896688|NCT00529308|540751232|FG001|Overall Study|Withdrawal by Subject|1|||
149896689|NCT04278417|540751233|FG000|Overall Study|Withdrawal by Subject|20|||
149896690|NCT04278417|540751234|FG001|Overall Study|Withdrawal by Subject|20|||
149896691|NCT04278417|540751233|FG000|Overall Study|Progressive disease|0|||
149896692|NCT04278417|540751234|FG001|Overall Study|Progressive disease|2|||
149896693|NCT04278417|540751233|FG000|Overall Study|Physician Decision|4|||
149896694|NCT04278417|540751234|FG001|Overall Study|Physician Decision|6|||
149896695|NCT04278417|540751233|FG000|Overall Study|Lost to Follow-up|11|||
149896696|NCT04278417|540751234|FG001|Overall Study|Lost to Follow-up|13|||
149896697|NCT04278417|540751233|FG000|Overall Study|Death|8|||
149896698|NCT04278417|540751234|FG001|Overall Study|Death|9|||
149896699|NCT04278417|540751233|FG000|Overall Study|Adverse Event|3|||
150045425|NCT01485172|541305591|FG003|Overall Study|Physician Decision|0|||
150045426|NCT01485172|541305592|FG004|Overall Study|Physician Decision|1|||
150045427|NCT01485172|541305593|FG005|Overall Study|Physician Decision|0|||
149896700|NCT04278417|540751234|FG001|Overall Study|Adverse Event|5|||
149896701|NCT06509438|540751235|FG000|Overall Study|Adverse Event|1|||
149896702|NCT06509438|540751235|FG000|Overall Study|Lost to Follow-up|3|||
149896703|NCT03331796|540751236|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
149896704|NCT03331796|540751237|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
149896705|NCT03331796|540751238|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
149896706|NCT03331796|540751236|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
149896707|NCT03331796|540751237|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
149896708|NCT03331796|540751238|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
149896709|NCT03331796|540751236|FG000|Extended Follow-up|Adverse Event|1|||
149896710|NCT03331796|540751237|FG001|Extended Follow-up|Adverse Event|0|||
149896711|NCT03331796|540751238|FG002|Extended Follow-up|Adverse Event|1|||
149896712|NCT03331796|540751236|FG000|Extended Follow-up|Lost to Follow-up|0|||
149896713|NCT03331796|540751237|FG001|Extended Follow-up|Lost to Follow-up|0|||
149896714|NCT03331796|540751238|FG002|Extended Follow-up|Lost to Follow-up|1|||
149896715|NCT03331796|540751236|FG000|Extended Follow-up|Withdrawal by Subject|1|||
149896716|NCT03331796|540751237|FG001|Extended Follow-up|Withdrawal by Subject|0|||
149896717|NCT03331796|540751238|FG002|Extended Follow-up|Withdrawal by Subject|0|||
149896718|NCT03331796|540751236|FG000|Extended Follow-up|Termination of Funding|0|||
149896719|NCT03331796|540751237|FG001|Extended Follow-up|Termination of Funding|1|||
149896720|NCT03331796|540751238|FG002|Extended Follow-up|Termination of Funding|0|||
149896721|NCT04526288|540751247|FG000|Overall Study|Disease Progression|1|||
149896722|NCT04526288|540751248|FG001|Overall Study|Disease Progression|0|||
149896723|NCT04830969|540751249|FG000|Overall Study|Withdrawal by Subject|6|||
149896724|NCT04830969|540751250|FG001|Overall Study|Withdrawal by Subject|2|||
149896725|NCT04830969|540751249|FG000|Overall Study|Protocol Violation|3|||
149896726|NCT04830969|540751250|FG001|Overall Study|Protocol Violation|9|||
149896727|NCT04830969|540751249|FG000|Overall Study|Lost to Follow-up|4|||
149896728|NCT04830969|540751250|FG001|Overall Study|Lost to Follow-up|4|||
150045428|NCT01485172|541305588|FG000|Overall Study|Withdrawal by Subject|2|||
150045429|NCT01485172|541305589|FG001|Overall Study|Withdrawal by Subject|0|||
150045430|NCT01485172|541305590|FG002|Overall Study|Withdrawal by Subject|0|||
150045431|NCT01485172|541305591|FG003|Overall Study|Withdrawal by Subject|1|||
149896729|NCT01580670|540751251|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
149896730|NCT01580670|540751251|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
149896731|NCT00996125|540751252|FG000|Overall Study|Adverse Event|0|||
149896732|NCT00996125|540751253|FG001|Overall Study|Adverse Event|2|||
149896733|NCT00996125|540751252|FG000|Overall Study|Lost to Follow-up|1|||
150045432|NCT01485172|541305592|FG004|Overall Study|Withdrawal by Subject|1|||
149896734|NCT00996125|540751253|FG001|Overall Study|Lost to Follow-up|6|||
149896735|NCT00996125|540751252|FG000|Overall Study|Withdrawal by Subject|4|||
149896736|NCT00996125|540751253|FG001|Overall Study|Withdrawal by Subject|3|||
149896737|NCT02169271|540751256|FG000|Overall Study|Protocol Violation|1|||
149896738|NCT02169271|540751257|FG001|Overall Study|Protocol Violation|2|||
149896739|NCT04926831|540751258|FG000|Overall Study|Withdrawal by Subject|2|||
150045433|NCT01485172|541305593|FG005|Overall Study|Withdrawal by Subject|1|||
150045434|NCT01587014|541305594|FG000|Overall Study|Death|2|||
149896740|NCT04926831|540751258|FG000|Overall Study|Adverse Event|2|||
149896741|NCT04025879|540751259|FG000|Randomization|Participant withdrew consent|0|||
149896742|NCT04025879|540751260|FG001|Randomization|Participant withdrew consent|1|||
149896743|NCT04025879|540751259|FG000|Randomization|Participant no longer met study criteria|1|||
149896744|NCT04025879|540751260|FG001|Randomization|Participant no longer met study criteria|1|||
149896745|NCT04025879|540751259|FG000|Treatment|Ongoing treatment|10|||
149896746|NCT04025879|540751260|FG001|Treatment|Ongoing treatment|8|||
149896747|NCT04025879|540751259|FG000|Treatment|Disease progression/recurrence|36|||
149896748|NCT04025879|540751260|FG001|Treatment|Disease progression/recurrence|72|||
149896749|NCT04025879|540751259|FG000|Treatment|Study drug toxicity|36|||
149896750|NCT04025879|540751260|FG001|Treatment|Study drug toxicity|13|||
149896751|NCT04025879|540751259|FG000|Treatment|Death|2|||
149896752|NCT04025879|540751260|FG001|Treatment|Death|0|||
149896753|NCT04025879|540751259|FG000|Treatment|Adverse event unrelated to study drug|21|||
149896754|NCT04025879|540751260|FG001|Treatment|Adverse event unrelated to study drug|14|||
149896755|NCT04025879|540751259|FG000|Treatment|Participant request to discontinue study treatment|16|||
149896756|NCT04025879|540751260|FG001|Treatment|Participant request to discontinue study treatment|8|||
149896757|NCT04025879|540751259|FG000|Treatment|Participant withdrew consent|1|||
149896758|NCT04025879|540751260|FG001|Treatment|Participant withdrew consent|3|||
149896759|NCT04025879|540751259|FG000|Treatment|Participant no longer meets study criteria|3|||
149896760|NCT04025879|540751260|FG001|Treatment|Participant no longer meets study criteria|2|||
149896761|NCT04025879|540751259|FG000|Treatment|Lost to Follow-up|1|||
149896762|NCT04025879|540751260|FG001|Treatment|Lost to Follow-up|0|||
149896763|NCT04025879|540751259|FG000|Treatment|Other reasons|15|||
149896764|NCT04025879|540751260|FG001|Treatment|Other reasons|17|||
149896765|NCT04025879|540751259|FG000|Treatment|Administrative reason by sponsor|0|||
149896766|NCT04025879|540751260|FG001|Treatment|Administrative reason by sponsor|1|||
149896767|NCT04025879|540751259|FG000|Treatment|Not reported|2|||
149896768|NCT04025879|540751260|FG001|Treatment|Not reported|0|||
149896769|NCT03482635|540751261|FG000|Overall Study|Lack of Efficacy|0|||
149896770|NCT03482635|540751262|FG001|Overall Study|Lack of Efficacy|0|||
149896771|NCT03482635|540751263|FG002|Overall Study|Lack of Efficacy|1|||
149896772|NCT03482635|540751264|FG003|Overall Study|Lack of Efficacy|3|||
149896773|NCT03482635|540751261|FG000|Overall Study|Adverse Event|2|||
149896774|NCT03482635|540751262|FG001|Overall Study|Adverse Event|2|||
149896775|NCT03482635|540751263|FG002|Overall Study|Adverse Event|0|||
149896776|NCT03482635|540751264|FG003|Overall Study|Adverse Event|3|||
149896777|NCT03482635|540751261|FG000|Overall Study|Withdrawal by Subject|2|||
149896778|NCT03482635|540751262|FG001|Overall Study|Withdrawal by Subject|1|||
149896779|NCT03482635|540751263|FG002|Overall Study|Withdrawal by Subject|0|||
149896780|NCT03482635|540751264|FG003|Overall Study|Withdrawal by Subject|1|||
149896781|NCT03482635|540751261|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
149896782|NCT03482635|540751262|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
149896783|NCT03482635|540751263|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
149896784|NCT03482635|540751264|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
149896785|NCT03482635|540751261|FG000|Overall Study|Not treated|0|||
149896786|NCT03482635|540751262|FG001|Overall Study|Not treated|0|||
149896787|NCT03482635|540751263|FG002|Overall Study|Not treated|0|||
149896788|NCT03482635|540751264|FG003|Overall Study|Not treated|1|||
149896789|NCT00979654|540751273|FG000|Overall Study|Lost to Follow-up|1|||
149896790|NCT00979654|540751273|FG000|Overall Study|Withdrawal by Subject|22|||
149896791|NCT00979654|540751273|FG000|Overall Study|Death|1|||
149896792|NCT00979654|540751273|FG000|Overall Study|Lack of Efficacy|6|||
149896793|NCT00979654|540751273|FG000|Overall Study|Adverse Event|1|||
149896794|NCT00979654|540751273|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
149896795|NCT00979654|540751273|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
149896796|NCT00979654|540751273|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
149896797|NCT00979654|540751273|FG000|Overall Study|Serious Adverse Event|1|||
149896798|NCT00979654|540751273|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
149896799|NCT00722137|540751274|FG000|Overall Study|Overt Disease Progression|5|||
149896800|NCT00722137|540751275|FG001|Overall Study|Overt Disease Progression|4|||
149896801|NCT00722137|540751274|FG000|Overall Study|Adverse Event|17|||
149968748|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968749|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968750|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968751|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968752|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968753|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968754|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968755|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968756|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
149968757|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
149968758|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149968759|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
149968760|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
150045435|NCT04995419|541305600|FG000|Overall Study|Withdrawal by Subject|3|||
150045436|NCT04995419|541305600|FG000|Overall Study|Progressive Disease|19|||
150045437|NCT04995419|541305600|FG000|Overall Study|Adverse Event|2|||
150045438|NCT04995419|541305600|FG000|Overall Study|Ongoing|16|||
150045439|NCT00838513|541305601|FG000|Screening Period|Screen Failure|3|||
150045440|NCT00838513|541305601|FG000|Extension Treatment Period|Death|1|||
150045441|NCT00838513|541305601|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
150045442|NCT00139477|541305605|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
150045443|NCT00139477|541305606|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
150045444|NCT00139477|541305605|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
150045445|NCT00139477|541305606|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
150045446|NCT00139477|541305605|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
150045447|NCT00139477|541305606|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
150045448|NCT00139477|541305605|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
150045449|NCT00139477|541305606|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
150045450|NCT00139477|541305605|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
150045451|NCT00139477|541305606|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
150045452|NCT00139477|541305605|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
150045453|NCT00139477|541305606|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
150045454|NCT00139477|541305605|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
150045455|NCT00139477|541305606|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
149968761|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
149968762|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
149968763|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
149968764|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149896802|NCT00722137|540751275|FG001|Overall Study|Adverse Event|21|||
149896803|NCT00722137|540751274|FG000|Overall Study|Death|12|||
149896804|NCT00722137|540751275|FG001|Overall Study|Death|7|||
149896805|NCT00722137|540751274|FG000|Overall Study|Withdrawal by Subject|6|||
149896806|NCT00722137|540751275|FG001|Overall Study|Withdrawal by Subject|9|||
149896807|NCT00722137|540751274|FG000|Overall Study|Other Reason Unknown|3|||
149896808|NCT00722137|540751275|FG001|Overall Study|Other Reason Unknown|4|||
149896809|NCT00722137|540751274|FG000|Overall Study|Randomized But Not Treated|2|||
149896810|NCT00722137|540751275|FG001|Overall Study|Randomized But Not Treated|3|||
149896811|NCT01367886|540751278|FG000|Overall Study|Lost to Follow-up|4|||
149896812|NCT01367886|540751278|FG000|Overall Study|Lack of Efficacy|2|||
149896813|NCT01367886|540751278|FG000|Overall Study|Death|1|||
149896814|NCT00985504|540751279|FG000|Acute Treatment Period|Adverse Event|3|||
149896815|NCT00985504|540751280|FG001|Acute Treatment Period|Adverse Event|4|||
149896816|NCT00985504|540751279|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
149896817|NCT00985504|540751280|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
149896818|NCT00985504|540751279|FG000|Acute Treatment Period|Protocol Violation|2|||
149896819|NCT00985504|540751280|FG001|Acute Treatment Period|Protocol Violation|0|||
149896820|NCT00985504|540751279|FG000|Acute Treatment Period|Sponsor Decision|0|||
149896821|NCT00985504|540751280|FG001|Acute Treatment Period|Sponsor Decision|1|||
150045456|NCT00441064|541305609|FG000|Overall Study|Adverse Event|1|||
150045457|NCT00441064|541305610|FG001|Overall Study|Adverse Event|0|||
149896822|NCT00985504|540751279|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
149896823|NCT00985504|540751280|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
149896824|NCT00985504|540751279|FG000|Optimization Period|Adverse Event|7|||
149896825|NCT00985504|540751280|FG001|Optimization Period|Adverse Event|9|||
149896826|NCT00985504|540751279|FG000|Optimization Period|Death|0|||
149896827|NCT00985504|540751280|FG001|Optimization Period|Death|1|||
149896828|NCT00985504|540751279|FG000|Optimization Period|Lack of Efficacy|5|||
149896829|NCT00985504|540751280|FG001|Optimization Period|Lack of Efficacy|3|||
149896830|NCT00985504|540751279|FG000|Optimization Period|Lost to Follow-up|0|||
149896831|NCT00985504|540751280|FG001|Optimization Period|Lost to Follow-up|1|||
149896832|NCT00985504|540751279|FG000|Optimization Period|Physician Decision|1|||
149896833|NCT00985504|540751280|FG001|Optimization Period|Physician Decision|0|||
149896834|NCT00985504|540751279|FG000|Optimization Period|Protocol Violation|3|||
149896835|NCT00985504|540751280|FG001|Optimization Period|Protocol Violation|1|||
149896836|NCT00985504|540751279|FG000|Optimization Period|Withdrawal by Subject|10|||
149896837|NCT00985504|540751280|FG001|Optimization Period|Withdrawal by Subject|8|||
149896838|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
149896839|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
149896840|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
149896841|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
149896842|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
149896843|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
149896844|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
149896845|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
149896846|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
149896847|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
149896848|NCT03711786|540751285|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
149896849|NCT03711786|540751286|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
149896850|NCT00734994|540751292|FG000|Overall Study|Withdrawal by Subject|1|||
149896851|NCT01622673|540751293|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149896852|NCT01622673|540751294|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149896853|NCT01622673|540751295|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149896854|NCT01622673|540751296|FG003|Treatment Period 1|Withdrawal by Subject|1|||
149968765|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149896855|NCT01622673|540751297|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149896856|NCT01622673|540751298|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149896857|NCT01622673|540751293|FG000|Treatment Period 1|Protocol Violation|0|||
149896858|NCT01622673|540751294|FG001|Treatment Period 1|Protocol Violation|1|||
149896859|NCT01622673|540751295|FG002|Treatment Period 1|Protocol Violation|0|||
149896860|NCT01622673|540751296|FG003|Treatment Period 1|Protocol Violation|0|||
149896861|NCT01622673|540751297|FG004|Treatment Period 1|Protocol Violation|0|||
149896862|NCT01622673|540751298|FG005|Treatment Period 1|Protocol Violation|0|||
149896863|NCT01622673|540751293|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149896864|NCT01622673|540751294|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149896865|NCT01622673|540751295|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149896866|NCT01622673|540751296|FG003|Treatment Period 2|Withdrawal by Subject|1|||
149896867|NCT01622673|540751297|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149968766|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149968767|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149896868|NCT01622673|540751298|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149896869|NCT01622673|540751293|FG000|Treatment Period 3|Protocol Violation|0|||
149896870|NCT01622673|540751294|FG001|Treatment Period 3|Protocol Violation|1|||
149896871|NCT01622673|540751295|FG002|Treatment Period 3|Protocol Violation|0|||
149896872|NCT01622673|540751296|FG003|Treatment Period 3|Protocol Violation|0|||
149896873|NCT01622673|540751297|FG004|Treatment Period 3|Protocol Violation|0|||
149896874|NCT01622673|540751298|FG005|Treatment Period 3|Protocol Violation|0|||
149896875|NCT04010240|540753309|FG000|Overall Study|IHC not performed|2299|||
149896876|NCT01682226|540753310|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
149896877|NCT01682226|540753310|FG000|Overall Study|Participants did not receive treatment|2|||
149896878|NCT01682226|540753310|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
149896879|NCT03263936|540753311|FG000|Overall Study|Adverse Event|0|||
149896880|NCT03263936|540753312|FG001|Overall Study|Adverse Event|1|||
149896881|NCT03263936|540753313|FG002|Overall Study|Adverse Event|0|||
149896882|NCT03263936|540753311|FG000|Overall Study|Death|0|||
149896883|NCT03263936|540753312|FG001|Overall Study|Death|1|||
149896884|NCT03263936|540753313|FG002|Overall Study|Death|0|||
149896885|NCT03048747|540753324|FG000|Overall Study|Adverse Event|2|||
149896886|NCT03048747|540753324|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
149896887|NCT03048747|540753324|FG000|Overall Study|Physician Decision|1|||
149896888|NCT00298272|540753325|FG000|Double-blind Phase|Adverse Event|2|||
150176229|NCT02928224|541781960|FG002|Overall Study|Death|193|||
150176230|NCT02928224|541781961|FG003|Overall Study|Death|198|||
150176231|NCT02928224|541781958|FG000|Overall Study|Withdrawal by Subject|0|||
150176232|NCT02928224|541781959|FG001|Overall Study|Withdrawal by Subject|3|||
150176233|NCT02928224|541781960|FG002|Overall Study|Withdrawal by Subject|7|||
149896889|NCT00298272|540753326|FG001|Double-blind Phase|Adverse Event|0|||
149896890|NCT00298272|540753325|FG000|Double-blind Phase|Failure to Return|2|||
149896891|NCT00298272|540753326|FG001|Double-blind Phase|Failure to Return|0|||
149896892|NCT00298272|540753325|FG000|Double-blind Phase|Protocol Violation|2|||
149896893|NCT00298272|540753326|FG001|Double-blind Phase|Protocol Violation|0|||
149896894|NCT00298272|540753325|FG000|Double-blind Phase|Withdrawal by Subject|2|||
149896895|NCT00298272|540753326|FG001|Double-blind Phase|Withdrawal by Subject|0|||
149896896|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Adverse Event|1|||
149896897|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Adverse Event|2|||
149896898|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
150176234|NCT02928224|541781961|FG003|Overall Study|Withdrawal by Subject|20|||
150176235|NCT02928224|541781958|FG000|Overall Study|Study participation terminated by sponsor|3|||
150176236|NCT02928224|541781959|FG001|Overall Study|Study participation terminated by sponsor|8|||
149896899|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
149896900|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Failure to Return|1|||
149896901|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Failure to Return|0|||
149896902|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
149896903|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
149896904|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
149896905|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
149896906|NCT00298272|540753325|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
149896907|NCT00298272|540753326|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
149896908|NCT00298272|540753325|FG000|Safety Follow-up Phase|Failure to Return|1|||
149896909|NCT00298272|540753326|FG001|Safety Follow-up Phase|Failure to Return|1|||
149896910|NCT00298272|540753325|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
149896911|NCT00298272|540753326|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
149896912|NCT00298272|540753325|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
149896913|NCT00298272|540753326|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
149896914|NCT00915018|540753327|FG000|Overall Study|Death|75|||
149896915|NCT00915018|540753328|FG001|Overall Study|Death|70|||
149896916|NCT00915018|540753327|FG000|Overall Study|Lost to Follow-up|10|||
149896917|NCT00915018|540753328|FG001|Overall Study|Lost to Follow-up|5|||
149896918|NCT00915018|540753327|FG000|Overall Study|Withdrawal by Subject|38|||
149896919|NCT00915018|540753328|FG001|Overall Study|Withdrawal by Subject|27|||
149896920|NCT00915018|540753327|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
149896921|NCT00915018|540753328|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
149896922|NCT00457002|540753329|FG000|Overall Study|Death|40|||
149896923|NCT00457002|540753330|FG001|Overall Study|Death|47|||
149896924|NCT00457002|540753329|FG000|Overall Study|Adverse Event|284|||
149896925|NCT00457002|540753330|FG001|Overall Study|Adverse Event|260|||
149896926|NCT00457002|540753329|FG000|Overall Study|Withdrawal by Subject|299|||
149896927|NCT00457002|540753330|FG001|Overall Study|Withdrawal by Subject|271|||
149896928|NCT00457002|540753329|FG000|Overall Study|Lost to Follow-up|72|||
149896929|NCT00457002|540753330|FG001|Overall Study|Lost to Follow-up|71|||
149896930|NCT00457002|540753329|FG000|Overall Study|Poor/Non-compliance|46|||
149896931|NCT00457002|540753330|FG001|Overall Study|Poor/Non-compliance|33|||
149896932|NCT00457002|540753329|FG000|Overall Study|No longer met criteria|41|||
149896933|NCT00457002|540753330|FG001|Overall Study|No longer met criteria|37|||
149896934|NCT00457002|540753329|FG000|Overall Study|Administrative reason by Sponsor|1|||
149896935|NCT00457002|540753330|FG001|Overall Study|Administrative reason by Sponsor|0|||
149896936|NCT00457002|540753329|FG000|Overall Study|non-specified|29|||
149896937|NCT00457002|540753330|FG001|Overall Study|non-specified|38|||
149896938|NCT00457002|540753329|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
149896939|NCT00457002|540753330|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
149896940|NCT00454246|540753331|FG000|Overall Study|Adverse Event|2|||
149896941|NCT00454246|540753332|FG001|Overall Study|Adverse Event|2|||
149896942|NCT00454246|540753333|FG002|Overall Study|Adverse Event|0|||
149896943|NCT00454246|540753331|FG000|Overall Study|Violation of selection criteria at entry|6|||
149896944|NCT00454246|540753332|FG001|Overall Study|Violation of selection criteria at entry|0|||
149896945|NCT00454246|540753333|FG002|Overall Study|Violation of selection criteria at entry|0|||
149896946|NCT00454246|540753331|FG000|Overall Study|Protocol Violation|1|||
149896947|NCT00454246|540753332|FG001|Overall Study|Protocol Violation|0|||
149896948|NCT00454246|540753333|FG002|Overall Study|Protocol Violation|0|||
149896949|NCT00454246|540753331|FG000|Overall Study|Refused Treatment|1|||
149896950|NCT00454246|540753332|FG001|Overall Study|Refused Treatment|1|||
149968768|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149896951|NCT00454246|540753333|FG002|Overall Study|Refused Treatment|0|||
149896952|NCT00454246|540753331|FG000|Overall Study|Failure to return|1|||
149896953|NCT00454246|540753332|FG001|Overall Study|Failure to return|0|||
149896954|NCT00454246|540753333|FG002|Overall Study|Failure to return|0|||
149896955|NCT00454246|540753331|FG000|Overall Study|Early termination of study|62|||
149896956|NCT00454246|540753332|FG001|Overall Study|Early termination of study|26|||
150045458|NCT00441064|541305609|FG000|Overall Study|Abnormal laboratory values|0|||
150045459|NCT00441064|541305610|FG001|Overall Study|Abnormal laboratory values|2|||
150045460|NCT00441064|541305609|FG000|Overall Study|Abnormal test procedure results|0|||
149896957|NCT00454246|540753333|FG002|Overall Study|Early termination of study|9|||
149896958|NCT00833105|540753334|FG000|Overall Study|Withdrawal by Subject|1|||
149896959|NCT00833105|540753334|FG000|Overall Study|Adverse Event|2|||
149896960|NCT02898597|540753335|FG000|Overall Study|Protocol Violation|4|||
149896961|NCT02898597|540753336|FG001|Overall Study|Protocol Violation|2|||
149896962|NCT02898597|540753335|FG000|Overall Study|Lost to Follow-up|0|||
149896963|NCT02898597|540753336|FG001|Overall Study|Lost to Follow-up|9|||
149896964|NCT02898597|540753335|FG000|Overall Study|Death|0|||
149896965|NCT02898597|540753336|FG001|Overall Study|Death|1|||
149896966|NCT03656068|540753337|FG000|Overall Study|Withdrawal by Subject|4|||
149896967|NCT03656068|540753337|FG000|Overall Study|Adverse Event|1|||
149896968|NCT05326529|540753338|FG000|Overall Study|Lack of Efficacy|0|||
149896969|NCT05326529|540753339|FG001|Overall Study|Lack of Efficacy|1|||
149896970|NCT05326529|540753340|FG002|Overall Study|Lack of Efficacy|0|||
149896971|NCT05326529|540753338|FG000|Overall Study|Physician Decision|0|||
149896972|NCT05326529|540753339|FG001|Overall Study|Physician Decision|0|||
149896973|NCT05326529|540753340|FG002|Overall Study|Physician Decision|2|||
149896974|NCT00154284|540753341|FG000|Overall Study|Adverse Event|6|||
149896975|NCT00154284|540753342|FG001|Overall Study|Adverse Event|9|||
149896976|NCT00154284|540753341|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149896977|NCT00154284|540753342|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149896978|NCT00154284|540753341|FG000|Overall Study|Lack of Efficacy|1|||
149896979|NCT00154284|540753342|FG001|Overall Study|Lack of Efficacy|2|||
149896980|NCT00154284|540753341|FG000|Overall Study|Protocol Violation|0|||
149896981|NCT00154284|540753342|FG001|Overall Study|Protocol Violation|1|||
149896982|NCT00326716|540753343|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
149896983|NCT00326716|540753344|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
149896984|NCT00326716|540753345|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
149896985|NCT00326716|540753346|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
149896986|NCT00684411|540753347|FG000|Overall Study|New Primary Cancer|1|||
149896987|NCT00684411|540753347|FG000|Overall Study|Disease Progression|10|||
149896988|NCT00684411|540753347|FG000|Overall Study|Adverse Event|1|||
149896989|NCT05253573|540753348|FG000|Overall Study|Death|1|||
149896990|NCT05253573|540753349|FG001|Overall Study|Death|0|||
149896991|NCT01344824|540753350|FG000|Overall Study|Adverse Event|15|||
149896992|NCT01344824|540753350|FG000|Overall Study|Withdrawal by Subject|6|||
149896993|NCT01344824|540753350|FG000|Overall Study|Other complicating disease|1|||
149896994|NCT01344824|540753350|FG000|Overall Study|Progression|15|||
149896995|NCT02126579|540753359|FG000|Overall Study|disease progression|0|||
149896996|NCT02126579|540753360|FG001|Overall Study|disease progression|0|||
149896997|NCT02126579|540753361|FG002|Overall Study|disease progression|0|||
149896998|NCT02126579|540753362|FG003|Overall Study|disease progression|1|||
149896999|NCT02126579|540753363|FG004|Overall Study|disease progression|0|||
149897000|NCT02126579|540753364|FG005|Overall Study|disease progression|0|||
149897001|NCT02126579|540753365|FG006|Overall Study|disease progression|1|||
149897002|NCT01085630|540753366|FG000|Overall Study|Insufficient data|1|||
149897003|NCT01085630|540753367|FG001|Overall Study|Insufficient data|0|||
149897004|NCT01085630|540753366|FG000|Overall Study|Ineligible|3|||
149897005|NCT01085630|540753367|FG001|Overall Study|Ineligible|0|||
149897006|NCT02366637|540753373|FG000|First Intervention Period|Adverse Event|0|||
149897007|NCT02366637|540753374|FG001|First Intervention Period|Adverse Event|1|||
149897008|NCT02366637|540753373|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
149897009|NCT02366637|540753374|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
149897010|NCT02366637|540753373|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
149897011|NCT02366637|540753374|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
149897012|NCT02609607|540753375|FG000|Overall Study|Lost to Follow-up|0|||
149897013|NCT02609607|540753376|FG001|Overall Study|Lost to Follow-up|1|||
149897014|NCT03168711|540753379|FG000|Overall Study|Adverse Event|2|||
149897015|NCT03168711|540753380|FG001|Overall Study|Adverse Event|0|||
149897016|NCT03168711|540753379|FG000|Overall Study|Withdrawal by Subject|0|||
149897017|NCT03168711|540753380|FG001|Overall Study|Withdrawal by Subject|1|||
149897018|NCT03168711|540753379|FG000|Overall Study|Death|0|||
149897019|NCT03168711|540753380|FG001|Overall Study|Death|1|||
149897020|NCT00651261|540753381|FG000|Overall Study|Adverse Event|32|||
149897021|NCT00651261|540753382|FG001|Overall Study|Adverse Event|22|||
149897022|NCT00651261|540753381|FG000|Overall Study|Death|18|||
149897023|NCT00651261|540753382|FG001|Overall Study|Death|18|||
149897024|NCT00651261|540753381|FG000|Overall Study|Withdrawal by Subject|22|||
149897025|NCT00651261|540753382|FG001|Overall Study|Withdrawal by Subject|40|||
149897026|NCT00651261|540753381|FG000|Overall Study|Induction failure|24|||
149897027|NCT00651261|540753382|FG001|Overall Study|Induction failure|35|||
149897028|NCT00651261|540753381|FG000|Overall Study|Disease progression|58|||
149897029|NCT00651261|540753382|FG001|Overall Study|Disease progression|58|||
149897030|NCT00651261|540753381|FG000|Overall Study|Alternative therapy|109|||
149897031|NCT00651261|540753382|FG001|Overall Study|Alternative therapy|107|||
149897032|NCT00651261|540753381|FG000|Overall Study|Other disease or participant decisions|23|||
149897033|NCT00651261|540753382|FG001|Overall Study|Other disease or participant decisions|23|||
149897034|NCT00651261|540753381|FG000|Overall Study|Never treated|5|||
149897035|NCT00651261|540753382|FG001|Overall Study|Never treated|3|||
149897036|NCT01609010|540753383|FG000|Overall Study|Stable disease (SD)|22|||
149897037|NCT01609010|540753384|FG001|Overall Study|Stable disease (SD)|16|||
150045461|NCT00441064|541305610|FG001|Overall Study|Abnormal test procedure results|1|||
150045462|NCT00441064|541305609|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149897038|NCT01609010|540753383|FG000|Overall Study|Progressive disease (PD)|8|||
149897039|NCT01609010|540753384|FG001|Overall Study|Progressive disease (PD)|10|||
149897040|NCT01609010|540753383|FG000|Overall Study|Adverse Event|3|||
149897041|NCT01609010|540753384|FG001|Overall Study|Adverse Event|6|||
149897042|NCT01609010|540753383|FG000|Overall Study|Withdrawal by Subject|2|||
149897043|NCT01609010|540753384|FG001|Overall Study|Withdrawal by Subject|2|||
149897044|NCT01609010|540753383|FG000|Overall Study|Other|2|||
149897045|NCT01609010|540753384|FG001|Overall Study|Other|0|||
149897046|NCT01609010|540753383|FG000|Overall Study|Other malignancy|1|||
149897047|NCT01609010|540753384|FG001|Overall Study|Other malignancy|0|||
149897048|NCT01609010|540753383|FG000|Overall Study|Pathology review|2|||
149897049|NCT01609010|540753384|FG001|Overall Study|Pathology review|1|||
149968769|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150045463|NCT00441064|541305610|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149897050|NCT01609010|540753383|FG000|Overall Study|Protocol Violation|1|||
149897051|NCT01609010|540753384|FG001|Overall Study|Protocol Violation|1|||
149897052|NCT01609010|540753383|FG000|Overall Study|New cancer|1|||
150176237|NCT02928224|541781960|FG002|Overall Study|Study participation terminated by sponsor|12|||
149897053|NCT01609010|540753384|FG001|Overall Study|New cancer|0|||
149897054|NCT01609010|540753383|FG000|Overall Study|Lost to Follow-up|1|||
149897055|NCT01609010|540753384|FG001|Overall Study|Lost to Follow-up|1|||
149897056|NCT02770170|540753388|FG000|Overall Study|Withdrawal by Subject|0|||
149897057|NCT02770170|540753389|FG001|Overall Study|Withdrawal by Subject|0|||
149897058|NCT02770170|540753390|FG002|Overall Study|Withdrawal by Subject|0|||
149897059|NCT02770170|540753391|FG003|Overall Study|Withdrawal by Subject|2|||
149897060|NCT02770170|540753388|FG000|Overall Study|due to pregnancy|1|||
149897061|NCT02770170|540753389|FG001|Overall Study|due to pregnancy|0|||
149897062|NCT02770170|540753390|FG002|Overall Study|due to pregnancy|0|||
149897063|NCT02770170|540753391|FG003|Overall Study|due to pregnancy|0|||
149897064|NCT02770170|540753388|FG000|Overall Study|Lack of Efficacy|2|||
149897065|NCT02770170|540753389|FG001|Overall Study|Lack of Efficacy|0|||
149897066|NCT02770170|540753390|FG002|Overall Study|Lack of Efficacy|0|||
149897067|NCT02770170|540753391|FG003|Overall Study|Lack of Efficacy|1|||
149897068|NCT02770170|540753388|FG000|Overall Study|Adverse Event|4|||
149897069|NCT02770170|540753389|FG001|Overall Study|Adverse Event|3|||
149897070|NCT02770170|540753390|FG002|Overall Study|Adverse Event|5|||
149897071|NCT02770170|540753391|FG003|Overall Study|Adverse Event|3|||
149897072|NCT02770170|540753388|FG000|Overall Study|due to disease worsening|0|||
149897073|NCT02770170|540753389|FG001|Overall Study|due to disease worsening|0|||
149897074|NCT02770170|540753390|FG002|Overall Study|due to disease worsening|0|||
149968770|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149897075|NCT02770170|540753391|FG003|Overall Study|due to disease worsening|1|||
149897076|NCT03351608|540753392|FG000|Overall Study|Lost to Follow-up|0|||
149897077|NCT03351608|540753393|FG001|Overall Study|Lost to Follow-up|1|||
149897078|NCT03351608|540753394|FG002|Overall Study|Lost to Follow-up|1|||
149897079|NCT03351608|540753395|FG003|Overall Study|Lost to Follow-up|1|||
149897080|NCT03351608|540753396|FG004|Overall Study|Lost to Follow-up|1|||
149897081|NCT03351608|540753392|FG000|Overall Study|Physician Decision|1|||
149897082|NCT03351608|540753393|FG001|Overall Study|Physician Decision|0|||
149897083|NCT03351608|540753394|FG002|Overall Study|Physician Decision|0|||
149897084|NCT03351608|540753395|FG003|Overall Study|Physician Decision|2|||
149897085|NCT03351608|540753396|FG004|Overall Study|Physician Decision|1|||
149897086|NCT03351608|540753392|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
149897087|NCT03351608|540753393|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
149897088|NCT03351608|540753394|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
149897089|NCT03351608|540753395|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
149897090|NCT03351608|540753396|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
149897091|NCT03351608|540753392|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149897092|NCT03351608|540753393|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149897093|NCT03351608|540753394|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149897094|NCT03351608|540753395|FG003|Overall Study|Withdrawal by parent/guardian|1|||
149897095|NCT03351608|540753396|FG004|Overall Study|Withdrawal by parent/guardian|0|||
149897096|NCT03351608|540753392|FG000|Overall Study|Other|0|||
149897097|NCT03351608|540753393|FG001|Overall Study|Other|1|||
149897098|NCT03351608|540753394|FG002|Overall Study|Other|1|||
149897099|NCT03351608|540753395|FG003|Overall Study|Other|3|||
149897100|NCT03351608|540753396|FG004|Overall Study|Other|0|||
149897101|NCT01346696|540753401|FG000|Overall Study|Death|1|||
149897102|NCT04630002|540753402|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
149897103|NCT04630002|540753403|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
149897104|NCT04630002|540753404|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
149897105|NCT04630002|540753402|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
149897106|NCT04630002|540753403|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
149897107|NCT04630002|540753404|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
149897108|NCT04630002|540753402|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
149897109|NCT04630002|540753403|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
149897110|NCT04630002|540753404|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
149897111|NCT04630002|540753402|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
149897112|NCT04630002|540753403|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
149897113|NCT04630002|540753404|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
149897114|NCT04630002|540753402|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
149897115|NCT04630002|540753403|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
149897116|NCT04630002|540753404|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
149897117|NCT04630002|540753402|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
149897118|NCT04630002|540753403|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
149897119|NCT04630002|540753404|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
149897120|NCT04630002|540753402|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
149897121|NCT04630002|540753403|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
149897122|NCT04630002|540753404|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
149897123|NCT04630002|540753402|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
149897124|NCT04630002|540753403|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
149897125|NCT04630002|540753404|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
149897126|NCT03448419|540753405|FG000|Overall Study|Adverse Event|10|||
149897127|NCT03448419|540753406|FG001|Overall Study|Adverse Event|9|||
149897128|NCT03448419|540753405|FG000|Overall Study|Lost to Follow-up|0|||
149897129|NCT03448419|540753406|FG001|Overall Study|Lost to Follow-up|2|||
149897130|NCT03448419|540753405|FG000|Overall Study|Withdrawal by Subject|3|||
149897131|NCT03448419|540753406|FG001|Overall Study|Withdrawal by Subject|1|||
149897132|NCT03448419|540753405|FG000|Overall Study|Not treated|0|||
149897133|NCT03448419|540753406|FG001|Overall Study|Not treated|1|||
149897134|NCT03448419|540753405|FG000|Overall Study|Patient did not attend all visits|0|||
149897135|NCT03448419|540753406|FG001|Overall Study|Patient did not attend all visits|2|||
149897136|NCT03448419|540753405|FG000|Overall Study|Withdrawn by Sponsor|0|||
149897137|NCT03448419|540753406|FG001|Overall Study|Withdrawn by Sponsor|1|||
149897138|NCT03020992|540753408|FG000|Overall Study|Adverse Event|5|||
149897139|NCT03020992|540753408|FG000|Overall Study|Withdrawal by Subject|1|||
149897140|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
149897141|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
149897142|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
149897143|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
149897144|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Pregnancy|0|||
149897145|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Pregnancy|1|||
149897146|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
149897147|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
149897148|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
149897149|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
149897150|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
149897151|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
149897152|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Other|3|||
149897153|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Other|0|||
149897154|NCT01006122|540753409|FG000|First Double-blind Intervention Period|Adverse Event|0|||
149897155|NCT01006122|540753410|FG001|First Double-blind Intervention Period|Adverse Event|4|||
149897156|NCT01006122|540753409|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
149897157|NCT01006122|540753410|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
149897158|NCT01006122|540753409|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
149897159|NCT01006122|540753410|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
149897160|NCT01006122|540753409|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
149897161|NCT01006122|540753410|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
149897162|NCT01006122|540753409|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
149897163|NCT01006122|540753410|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
149897164|NCT01006122|540753409|FG000|Second Double-blind Intervention Period|Death|0|||
149897165|NCT01006122|540753410|FG001|Second Double-blind Intervention Period|Death|1|||
149897166|NCT00488644|540753426|FG000|Overall Study|Not Eligible|1|||
149897167|NCT00488644|540753426|FG000|Overall Study|Not Evaluable|1|||
150176238|NCT02928224|541781961|FG003|Overall Study|Study participation terminated by sponsor|3|||
149897168|NCT03859427|540753428|FG000|Overall Study|Withdrawal by Subject|4|||
149897169|NCT03859427|540753429|FG001|Overall Study|Withdrawal by Subject|7|||
149897170|NCT03859427|540753428|FG000|Overall Study|Decision by sponsor|0|||
149897171|NCT03859427|540753429|FG001|Overall Study|Decision by sponsor|3|||
149968771|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149968772|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149897172|NCT03859427|540753428|FG000|Overall Study|Lost to Follow-up|3|||
149897173|NCT03859427|540753429|FG001|Overall Study|Lost to Follow-up|2|||
149897174|NCT03859427|540753428|FG000|Overall Study|Death|22|||
149897175|NCT03859427|540753429|FG001|Overall Study|Death|25|||
149897176|NCT01804946|540753432|FG000|Overall Study|Protocol Violation|1|||
149897177|NCT01804946|540753433|FG001|Overall Study|Protocol Violation|0|||
150045464|NCT00441064|541305609|FG000|Overall Study|Protocol Deviation|3|||
150045465|NCT00441064|541305610|FG001|Overall Study|Protocol Deviation|2|||
150045466|NCT00441064|541305609|FG000|Overall Study|Patient withdrew consent|5|||
150045467|NCT00441064|541305610|FG001|Overall Study|Patient withdrew consent|2|||
150045468|NCT00953056|541305611|FG000|Overall Study|Withdrew Consent|0|||
150045469|NCT00953056|541305612|FG001|Overall Study|Withdrew Consent|0|||
150045470|NCT00953056|541305613|FG002|Overall Study|Withdrew Consent|0|||
150045471|NCT00953056|541305614|FG003|Overall Study|Withdrew Consent|0|||
150045472|NCT00953056|541305615|FG004|Overall Study|Withdrew Consent|2|||
150045473|NCT00953056|541305616|FG005|Overall Study|Withdrew Consent|3|||
150045474|NCT00953056|541305611|FG000|Overall Study|Serious Adverse Event|0|||
150045475|NCT00953056|541305612|FG001|Overall Study|Serious Adverse Event|0|||
149897178|NCT01804946|540753432|FG000|Overall Study|Adverse Event|0|||
149897179|NCT01804946|540753433|FG001|Overall Study|Adverse Event|1|||
149897180|NCT01804946|540753432|FG000|Overall Study|Insufficient data available|0|||
150045476|NCT00953056|541305613|FG002|Overall Study|Serious Adverse Event|0|||
149897181|NCT01804946|540753433|FG001|Overall Study|Insufficient data available|1|||
150045477|NCT00953056|541305614|FG003|Overall Study|Serious Adverse Event|0|||
150045478|NCT00953056|541305615|FG004|Overall Study|Serious Adverse Event|0|||
150045479|NCT00953056|541305616|FG005|Overall Study|Serious Adverse Event|1|||
150045480|NCT03962504|541305617|FG000|Overall Study|Other|11|||
149897182|NCT01804946|540753432|FG000|Overall Study|Do not meet inclusion criteria|1|||
149897183|NCT01804946|540753433|FG001|Overall Study|Do not meet inclusion criteria|2|||
149897184|NCT00669669|540753434|FG000|Overall Study|To late to start treatment|1|||
149897185|NCT01205776|540753438|FG000|Overall Study|Lost to Follow-up|53|||
149897186|NCT01205776|540753439|FG001|Overall Study|Lost to Follow-up|61|||
149897187|NCT01205776|540753438|FG000|Overall Study|Withdrawal by Subject|11|||
149897188|NCT01205776|540753439|FG001|Overall Study|Withdrawal by Subject|34|||
149897189|NCT04031846|540753442|FG000|Overall Study|Lost to Follow-up|4|||
149897190|NCT04031846|540753443|FG001|Overall Study|Lost to Follow-up|4|||
149897191|NCT04031846|540753442|FG000|Overall Study|Physician Decision|0|||
149897192|NCT04031846|540753443|FG001|Overall Study|Physician Decision|1|||
149897193|NCT04031846|540753442|FG000|Overall Study|Protocol Violation|1|||
149897194|NCT04031846|540753443|FG001|Overall Study|Protocol Violation|1|||
149897195|NCT04031846|540753442|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
149897196|NCT04031846|540753443|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
149897197|NCT02431676|540753444|FG000|Overall Study|no lab obtained|0|||
149897198|NCT02431676|540753445|FG001|Overall Study|no lab obtained|1|||
149897199|NCT02431676|540753446|FG002|Overall Study|no lab obtained|2|||
149897200|NCT03103152|540753447|FG000|Overall Study|Physician Decision|5|||
149897201|NCT03103152|540753448|FG001|Overall Study|Physician Decision|2|||
149897202|NCT03103152|540753449|FG002|Overall Study|Physician Decision|6|||
149897203|NCT03103152|540753450|FG003|Overall Study|Physician Decision|3|||
149897204|NCT03103152|540753451|FG004|Overall Study|Physician Decision|3|||
149897205|NCT03103152|540753452|FG005|Overall Study|Physician Decision|1|||
149897206|NCT03103152|540753447|FG000|Overall Study|Protocol Violation|2|||
149897207|NCT03103152|540753448|FG001|Overall Study|Protocol Violation|2|||
149897208|NCT03103152|540753449|FG002|Overall Study|Protocol Violation|1|||
149897209|NCT03103152|540753450|FG003|Overall Study|Protocol Violation|2|||
149897210|NCT03103152|540753451|FG004|Overall Study|Protocol Violation|1|||
149897211|NCT03103152|540753452|FG005|Overall Study|Protocol Violation|1|||
149897212|NCT03103152|540753447|FG000|Overall Study|Inter-current illness|0|||
149897213|NCT03103152|540753448|FG001|Overall Study|Inter-current illness|0|||
149897214|NCT03103152|540753449|FG002|Overall Study|Inter-current illness|1|||
149897215|NCT03103152|540753450|FG003|Overall Study|Inter-current illness|0|||
149897216|NCT03103152|540753451|FG004|Overall Study|Inter-current illness|0|||
149897217|NCT03103152|540753452|FG005|Overall Study|Inter-current illness|0|||
149897218|NCT03103152|540753447|FG000|Overall Study|Death|0|||
149897219|NCT03103152|540753448|FG001|Overall Study|Death|1|||
149897220|NCT03103152|540753449|FG002|Overall Study|Death|0|||
149897221|NCT03103152|540753450|FG003|Overall Study|Death|0|||
149897222|NCT03103152|540753451|FG004|Overall Study|Death|0|||
149897223|NCT03103152|540753452|FG005|Overall Study|Death|0|||
149968773|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149897224|NCT03103152|540753447|FG000|Overall Study|Adverse Event|0|||
149897225|NCT03103152|540753448|FG001|Overall Study|Adverse Event|0|||
149897226|NCT03103152|540753449|FG002|Overall Study|Adverse Event|1|||
149897227|NCT03103152|540753450|FG003|Overall Study|Adverse Event|0|||
149897228|NCT03103152|540753451|FG004|Overall Study|Adverse Event|0|||
149897229|NCT03103152|540753452|FG005|Overall Study|Adverse Event|1|||
149897230|NCT03103152|540753447|FG000|Overall Study|Withdrawal by Subject|1|||
149897231|NCT03103152|540753448|FG001|Overall Study|Withdrawal by Subject|0|||
149897232|NCT03103152|540753449|FG002|Overall Study|Withdrawal by Subject|1|||
149897233|NCT03103152|540753450|FG003|Overall Study|Withdrawal by Subject|1|||
149897234|NCT03103152|540753451|FG004|Overall Study|Withdrawal by Subject|1|||
149897235|NCT03103152|540753452|FG005|Overall Study|Withdrawal by Subject|1|||
149897236|NCT03103152|540753447|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
149897237|NCT03103152|540753448|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
149897238|NCT03103152|540753449|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
149897239|NCT03103152|540753450|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
149897240|NCT03103152|540753451|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
149897241|NCT03103152|540753452|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
149897242|NCT03103152|540753447|FG000|Overall Study|Unacceptable side effects|0|||
149897243|NCT03103152|540753448|FG001|Overall Study|Unacceptable side effects|0|||
149897244|NCT03103152|540753449|FG002|Overall Study|Unacceptable side effects|0|||
149897245|NCT03103152|540753450|FG003|Overall Study|Unacceptable side effects|0|||
149897246|NCT03103152|540753451|FG004|Overall Study|Unacceptable side effects|0|||
149897247|NCT03103152|540753452|FG005|Overall Study|Unacceptable side effects|1|||
149897248|NCT03103152|540753447|FG000|Overall Study|Lost to Follow-up|0|||
149897249|NCT03103152|540753448|FG001|Overall Study|Lost to Follow-up|1|||
149897250|NCT03103152|540753449|FG002|Overall Study|Lost to Follow-up|0|||
149897251|NCT03103152|540753450|FG003|Overall Study|Lost to Follow-up|1|||
149897252|NCT03103152|540753451|FG004|Overall Study|Lost to Follow-up|0|||
149897253|NCT03103152|540753452|FG005|Overall Study|Lost to Follow-up|1|||
149897254|NCT03103152|540753447|FG000|Overall Study|Testicular pain|0|||
149897255|NCT03103152|540753448|FG001|Overall Study|Testicular pain|0|||
149897256|NCT03103152|540753449|FG002|Overall Study|Testicular pain|0|||
149897257|NCT03103152|540753450|FG003|Overall Study|Testicular pain|1|||
149897258|NCT03103152|540753451|FG004|Overall Study|Testicular pain|0|||
149897259|NCT03103152|540753452|FG005|Overall Study|Testicular pain|0|||
149897260|NCT03474965|540753453|FG000|Overall Study|Pregnancy|1|||
149897261|NCT03474965|540753454|FG001|Overall Study|Pregnancy|0|||
149897262|NCT03474965|540753455|FG002|Overall Study|Pregnancy|0|||
149897263|NCT03474965|540753456|FG003|Overall Study|Pregnancy|0|||
149897264|NCT03474965|540753453|FG000|Overall Study|Lost to Follow-up|0|||
149897265|NCT03474965|540753454|FG001|Overall Study|Lost to Follow-up|0|||
149897266|NCT03474965|540753455|FG002|Overall Study|Lost to Follow-up|1|||
149897267|NCT03474965|540753456|FG003|Overall Study|Lost to Follow-up|0|||
149897268|NCT03474965|540753453|FG000|Overall Study|Death|1|||
149897269|NCT03474965|540753454|FG001|Overall Study|Death|0|||
149897270|NCT03474965|540753455|FG002|Overall Study|Death|0|||
149897271|NCT03474965|540753456|FG003|Overall Study|Death|0|||
149897272|NCT03474965|540753453|FG000|Overall Study|Adverse Event|1|||
149897273|NCT03474965|540753454|FG001|Overall Study|Adverse Event|0|||
149897274|NCT03474965|540753455|FG002|Overall Study|Adverse Event|0|||
149897275|NCT03474965|540753456|FG003|Overall Study|Adverse Event|1|||
149897276|NCT03474965|540753453|FG000|Overall Study|Physician Decision|3|||
149897277|NCT03474965|540753454|FG001|Overall Study|Physician Decision|1|||
149897278|NCT03474965|540753455|FG002|Overall Study|Physician Decision|2|||
149897279|NCT03474965|540753456|FG003|Overall Study|Physician Decision|0|||
149897280|NCT03474965|540753453|FG000|Overall Study|Participant Decision|7|||
149897281|NCT03474965|540753454|FG001|Overall Study|Participant Decision|0|||
149897282|NCT03474965|540753455|FG002|Overall Study|Participant Decision|1|||
149897283|NCT03474965|540753456|FG003|Overall Study|Participant Decision|0|||
149897284|NCT03474965|540753453|FG000|Overall Study|Guardian Decision|4|||
149897285|NCT03474965|540753454|FG001|Overall Study|Guardian Decision|2|||
149897286|NCT03474965|540753455|FG002|Overall Study|Guardian Decision|7|||
149968774|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968775|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149897287|NCT03474965|540753456|FG003|Overall Study|Guardian Decision|2|||
149897288|NCT03100903|540754883|FG000|Overall Study|Withdrawal by Subject|0|||
149897289|NCT03100903|540754884|FG001|Overall Study|Withdrawal by Subject|0|||
149897290|NCT03100903|540754885|FG002|Overall Study|Withdrawal by Subject|1|||
149897291|NCT04659993|540754886|FG000|Overall Study|Withdrawal by Subject|2|||
149897292|NCT04659993|540754886|FG000|Overall Study|Lost to Follow-up|2|||
149897293|NCT03782792|540754887|FG000|Overall Study|Patient left the country|0|||
149897294|NCT03782792|540754888|FG001|Overall Study|Patient left the country|1|||
149897295|NCT03782792|540754887|FG000|Overall Study|Withdrawal by Subject|1|||
149897296|NCT03782792|540754888|FG001|Overall Study|Withdrawal by Subject|2|||
149897297|NCT01295671|540754891|FG000|Overall Study|Lost to Follow-up|4|||
149897298|NCT01295671|540754892|FG001|Overall Study|Lost to Follow-up|6|||
149897299|NCT01295671|540754893|FG002|Overall Study|Lost to Follow-up|3|||
149897300|NCT01295671|540754891|FG000|Overall Study|Withdrawal by Subject|3|||
149897301|NCT01295671|540754892|FG001|Overall Study|Withdrawal by Subject|1|||
149897302|NCT01295671|540754893|FG002|Overall Study|Withdrawal by Subject|0|||
149897303|NCT01436370|540754894|FG000|Overall Study|Lost to Follow-up|0|||
149897304|NCT01436370|540754895|FG001|Overall Study|Lost to Follow-up|0|||
149897305|NCT01436370|540754896|FG002|Overall Study|Lost to Follow-up|0|||
149897306|NCT01436370|540754897|FG003|Overall Study|Lost to Follow-up|0|||
149897307|NCT01436370|540754898|FG004|Overall Study|Lost to Follow-up|1|||
149897308|NCT01436370|540754899|FG005|Overall Study|Lost to Follow-up|0|||
149897309|NCT01436370|540754900|FG006|Overall Study|Lost to Follow-up|0|||
149897310|NCT01436370|540754901|FG007|Overall Study|Lost to Follow-up|0|||
149897311|NCT02395848|540754902|FG000|Overall Study|Lost to Follow-up|2|||
149897312|NCT01754129|540754903|FG000|Overall Study|Death|13|||
150176239|NCT02928224|541781958|FG000|Overall Study|Other|3|||
150176240|NCT02928224|541781959|FG001|Overall Study|Other|3|||
150176241|NCT02928224|541781960|FG002|Overall Study|Other|5|||
150176242|NCT02928224|541781961|FG003|Overall Study|Other|0|||
149897313|NCT01754129|540754903|FG000|Overall Study|Duodopa discontinuation|9|||
150176243|NCT02538107|541781962|FG000|Overall Study|Did not receive any Mircera dose|11|||
150176244|NCT02538107|541781962|FG000|Overall Study|Missing|5|||
150176245|NCT02538107|541781962|FG000|Overall Study|Necessity of dialysis|20|||
150176246|NCT02538107|541781962|FG000|Overall Study|Administration of other ESA|11|||
150176247|NCT02538107|541781962|FG000|Overall Study|No further treatment necessary|18|||
150176248|NCT02538107|541781962|FG000|Overall Study|Withdrawal by Subject|17|||
150176249|NCT02538107|541781962|FG000|Overall Study|Death|4|||
150176250|NCT02538107|541781962|FG000|Overall Study|Administrative reason|5|||
150176251|NCT02538107|541781962|FG000|Overall Study|Adverse Event|4|||
150176252|NCT02538107|541781962|FG000|Overall Study|Surgery|1|||
150176253|NCT02538107|541781962|FG000|Overall Study|Other|7|||
150176254|NCT02538107|541781962|FG000|Overall Study|Not recorded|7|||
150176255|NCT01236560|541781963|FG000|Overall Study|Adverse Event|0|||
150176256|NCT01236560|541781964|FG001|Overall Study|Adverse Event|2|||
150176257|NCT01236560|541781965|FG002|Overall Study|Adverse Event|1|||
150176258|NCT01236560|541781966|FG003|Overall Study|Adverse Event|3|||
150176259|NCT01236560|541781967|FG004|Overall Study|Adverse Event|0|||
150176260|NCT01236560|541781968|FG005|Overall Study|Adverse Event|0|||
150176261|NCT01236560|541781963|FG000|Overall Study|Death|0|||
150176262|NCT01236560|541781964|FG001|Overall Study|Death|1|||
150176263|NCT01236560|541781965|FG002|Overall Study|Death|0|||
150176264|NCT01236560|541781966|FG003|Overall Study|Death|1|||
150176265|NCT01236560|541781967|FG004|Overall Study|Death|0|||
150176266|NCT01236560|541781968|FG005|Overall Study|Death|0|||
150176267|NCT01236560|541781963|FG000|Overall Study|Lost to Follow-up|0|||
150176268|NCT01236560|541781964|FG001|Overall Study|Lost to Follow-up|1|||
150176269|NCT01236560|541781965|FG002|Overall Study|Lost to Follow-up|1|||
150176270|NCT01236560|541781966|FG003|Overall Study|Lost to Follow-up|0|||
150176271|NCT01236560|541781967|FG004|Overall Study|Lost to Follow-up|0|||
150176272|NCT01236560|541781968|FG005|Overall Study|Lost to Follow-up|0|||
150176273|NCT01236560|541781963|FG000|Overall Study|Physician Decision|0|||
150176274|NCT01236560|541781964|FG001|Overall Study|Physician Decision|1|||
150176275|NCT01236560|541781965|FG002|Overall Study|Physician Decision|8|||
150176276|NCT01236560|541781966|FG003|Overall Study|Physician Decision|0|||
150176277|NCT01236560|541781967|FG004|Overall Study|Physician Decision|0|||
150176278|NCT01236560|541781968|FG005|Overall Study|Physician Decision|0|||
150176279|NCT01236560|541781963|FG000|Overall Study|Withdrawal by Subject|0|||
150176280|NCT01236560|541781964|FG001|Overall Study|Withdrawal by Subject|0|||
150176281|NCT01236560|541781965|FG002|Overall Study|Withdrawal by Subject|1|||
150176282|NCT01236560|541781966|FG003|Overall Study|Withdrawal by Subject|2|||
150176283|NCT01236560|541781967|FG004|Overall Study|Withdrawal by Subject|0|||
150176284|NCT01236560|541781968|FG005|Overall Study|Withdrawal by Subject|0|||
150176285|NCT01236560|541781963|FG000|Overall Study|Progressive disease|5|||
150176286|NCT01236560|541781964|FG001|Overall Study|Progressive disease|19|||
150176287|NCT01236560|541781965|FG002|Overall Study|Progressive disease|9|||
149897314|NCT01754129|540754903|FG000|Overall Study|Lost to Follow-up|7|||
150176288|NCT01236560|541781966|FG003|Overall Study|Progressive disease|16|||
150176289|NCT01236560|541781967|FG004|Overall Study|Progressive disease|0|||
150176290|NCT01236560|541781968|FG005|Overall Study|Progressive disease|0|||
150176291|NCT00919763|541781969|FG000|Overall Study|Adverse Event|7|||
149897315|NCT01754129|540754903|FG000|Overall Study|Withdrew consent|1|||
149897316|NCT01754129|540754903|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
149897317|NCT02276560|540754904|FG000|Overall Study|Adverse Event|1|||
149897318|NCT02276560|540754905|FG001|Overall Study|Adverse Event|0|||
149897319|NCT02276560|540754906|FG002|Overall Study|Adverse Event|0|||
149897320|NCT03691207|540754913|FG000|Overall Study|Death|41|||
150045481|NCT03962504|541305618|FG001|Overall Study|Other|32|||
150045482|NCT01388335|541305619|FG000|Period 1|Progressive Disease|1|||
149897321|NCT03691207|540754914|FG001|Overall Study|Death|26|||
149897322|NCT03691207|540754913|FG000|Overall Study|Lost to Follow-up|1|||
149897323|NCT03691207|540754914|FG001|Overall Study|Lost to Follow-up|1|||
149897324|NCT03691207|540754913|FG000|Overall Study|Withdrawal by Subject|2|||
149897325|NCT03691207|540754914|FG001|Overall Study|Withdrawal by Subject|8|||
149897326|NCT03691207|540754913|FG000|Overall Study|Sponsor decision|1|||
149897327|NCT03691207|540754914|FG001|Overall Study|Sponsor decision|7|||
149897328|NCT01134107|540754915|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
149897329|NCT01134107|540754916|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
149897330|NCT01134107|540754915|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
149897331|NCT01134107|540754916|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
149897332|NCT01134107|540754915|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
149897333|NCT01134107|540754916|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
149897334|NCT01134107|540754915|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
149897335|NCT01134107|540754916|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
149897336|NCT01134107|540754915|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
149897337|NCT01134107|540754916|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
149897338|NCT01134107|540754915|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
149897339|NCT01134107|540754916|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
149897340|NCT01134107|540754915|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
149897341|NCT01134107|540754916|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
149897342|NCT00687271|540754917|FG000|Overall Study|Adverse Event|1|||
149897343|NCT00687271|540754918|FG001|Overall Study|Adverse Event|3|||
149897344|NCT00687271|540754919|FG002|Overall Study|Adverse Event|1|||
149897345|NCT00687271|540754920|FG003|Overall Study|Adverse Event|0|||
149897346|NCT00687271|540754917|FG000|Overall Study|Lost to Follow-up|0|||
149897347|NCT00687271|540754918|FG001|Overall Study|Lost to Follow-up|1|||
149897348|NCT00687271|540754919|FG002|Overall Study|Lost to Follow-up|0|||
149897349|NCT00687271|540754920|FG003|Overall Study|Lost to Follow-up|0|||
149897350|NCT00687271|540754917|FG000|Overall Study|Protocol Violation|2|||
149897351|NCT00687271|540754918|FG001|Overall Study|Protocol Violation|1|||
149897352|NCT00687271|540754919|FG002|Overall Study|Protocol Violation|1|||
149897353|NCT00687271|540754920|FG003|Overall Study|Protocol Violation|0|||
149897354|NCT00687271|540754917|FG000|Overall Study|Withdrawal by Subject|0|||
149897355|NCT00687271|540754918|FG001|Overall Study|Withdrawal by Subject|1|||
149897356|NCT00687271|540754919|FG002|Overall Study|Withdrawal by Subject|3|||
149897357|NCT00687271|540754920|FG003|Overall Study|Withdrawal by Subject|0|||
149897358|NCT02027545|540754923|FG000|Overall Study|Failed to sign HIPAA|0|||
149897359|NCT02027545|540754924|FG001|Overall Study|Failed to sign HIPAA|2|||
149897360|NCT02027545|540754923|FG000|Overall Study|Failed to attend study visit|2|||
149897361|NCT02027545|540754924|FG001|Overall Study|Failed to attend study visit|0|||
149897362|NCT02027545|540754923|FG000|Overall Study|Protocol Violation|1|||
149897363|NCT02027545|540754924|FG001|Overall Study|Protocol Violation|0|||
149897364|NCT04541589|540754929|FG000|Treatment Period|Adverse Event|8|||
149897365|NCT04541589|540754930|FG001|Treatment Period|Adverse Event|2|||
149897366|NCT04541589|540754929|FG000|Treatment Period|Physician Decision|3|||
149897367|NCT04541589|540754930|FG001|Treatment Period|Physician Decision|1|||
149897368|NCT04541589|540754929|FG000|Treatment Period|Subject decision|7|||
149897369|NCT04541589|540754930|FG001|Treatment Period|Subject decision|4|||
149897370|NCT04541589|540754929|FG000|Treatment Period|Withdrawal by Subject|1|||
149897371|NCT04541589|540754930|FG001|Treatment Period|Withdrawal by Subject|0|||
149897372|NCT04541589|540754929|FG000|Safety Follow-up Period|Adverse Event|2|||
149897373|NCT04541589|540754930|FG001|Safety Follow-up Period|Adverse Event|1|||
149897374|NCT04541589|540754929|FG000|Safety Follow-up Period|Physician Decision|1|||
149897375|NCT04541589|540754930|FG001|Safety Follow-up Period|Physician Decision|0|||
149897376|NCT04541589|540754929|FG000|Safety Follow-up Period|Subject decision|5|||
149897377|NCT04541589|540754930|FG001|Safety Follow-up Period|Subject decision|3|||
149897378|NCT04541589|540754929|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
149897379|NCT04541589|540754930|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
149897380|NCT03581123|540754933|FG000|2-month Follow-up|Withdrawal by Subject|5|||
149897381|NCT03581123|540754934|FG001|2-month Follow-up|Withdrawal by Subject|4|||
149897382|NCT03581123|540754935|FG002|2-month Follow-up|Withdrawal by Subject|6|||
149897383|NCT03581123|540754936|FG003|2-month Follow-up|Withdrawal by Subject|4|||
149897384|NCT03581123|540754933|FG000|2-month Follow-up|Lost to Follow-up|8|||
149897385|NCT03581123|540754934|FG001|2-month Follow-up|Lost to Follow-up|1|||
149897386|NCT03581123|540754935|FG002|2-month Follow-up|Lost to Follow-up|2|||
149897387|NCT03581123|540754936|FG003|2-month Follow-up|Lost to Follow-up|2|||
149897388|NCT03581123|540754933|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
149897389|NCT03581123|540754934|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
149897390|NCT03581123|540754935|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
149897391|NCT03581123|540754936|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
149897392|NCT03581123|540754933|FG000|6-Month Follow-up|Lost to Follow-up|3|||
149897393|NCT03581123|540754934|FG001|6-Month Follow-up|Lost to Follow-up|3|||
149897394|NCT03581123|540754935|FG002|6-Month Follow-up|Lost to Follow-up|1|||
149897395|NCT03581123|540754936|FG003|6-Month Follow-up|Lost to Follow-up|1|||
149897396|NCT03581123|540754933|FG000|12-Month Follow-up|Lost to Follow-up|4|||
149897397|NCT03581123|540754934|FG001|12-Month Follow-up|Lost to Follow-up|3|||
150045483|NCT01388335|541305619|FG000|Period 2|Progressive Disease|2|||
150045484|NCT01388335|541305619|FG000|Period 2|Sponsor Decision|1|||
150045485|NCT01388335|541305619|FG000|Safety Extension|Progressive Disease|7|||
149897398|NCT03581123|540754935|FG002|12-Month Follow-up|Lost to Follow-up|4|||
149897399|NCT03581123|540754936|FG003|12-Month Follow-up|Lost to Follow-up|5|||
149897400|NCT00162981|540754937|FG000|Overall Study|Adverse Event|2|||
149897401|NCT00162981|540754938|FG001|Overall Study|Adverse Event|5|||
149897402|NCT00162981|540754937|FG000|Overall Study|Withdrawal by Subject|1|||
149897403|NCT00162981|540754938|FG001|Overall Study|Withdrawal by Subject|1|||
149897404|NCT00162981|540754937|FG000|Overall Study|Physician Decision|1|||
149897405|NCT00162981|540754938|FG001|Overall Study|Physician Decision|0|||
149897406|NCT04195685|540754939|FG000|Overall Study|Withdrawal by Subject|6|||
149897407|NCT04195685|540754940|FG001|Overall Study|Withdrawal by Subject|2|||
149897408|NCT04195685|540754939|FG000|Overall Study|Lost to Follow-up|1|||
149897409|NCT04195685|540754940|FG001|Overall Study|Lost to Follow-up|4|||
149897410|NCT02877004|540754947|FG000|Overall Study|Pregnancy|0|||
149897411|NCT02877004|540754948|FG001|Overall Study|Pregnancy|0|||
149897412|NCT02877004|540754949|FG002|Overall Study|Pregnancy|1|||
149897413|NCT02044302|540754951|FG000|Overall Study|study terminated|2|||
149897414|NCT02044302|540754952|FG001|Overall Study|study terminated|0|||
149897415|NCT03150719|540754953|FG000|Overall Study|Adverse Event|0|||
149897416|NCT03150719|540754954|FG001|Overall Study|Adverse Event|1|||
149897417|NCT03150719|540754953|FG000|Overall Study|Death|0|||
149897418|NCT03150719|540754954|FG001|Overall Study|Death|1|||
149897419|NCT03150719|540754953|FG000|Overall Study|Other|1|||
149897420|NCT03150719|540754954|FG001|Overall Study|Other|0|||
149897421|NCT01051791|540754957|FG000|Overall Study|Failed screening|3|||
149897422|NCT01051791|540754957|FG000|Overall Study|Withdrawal by Subject|1|||
149897423|NCT00288626|540754964|FG000|Overall Study|Death|3|||
149897424|NCT00288626|540754964|FG000|Overall Study|Withdrawal by Subject|4|||
149897425|NCT01372618|540754965|FG000|Overall Study|PI Died. Study Terminated|9|||
149897426|NCT04610346|540754967|FG000|Overall Study|Withdrawal by Subject|1|||
149897427|NCT04610346|540754968|FG001|Overall Study|Withdrawal by Subject|1|||
150045486|NCT00067002|541305623|FG000|Overall Study|Early Death|1|||
150045487|NCT00067002|541305624|FG001|Overall Study|Early Death|2|||
149897428|NCT04610346|540754967|FG000|Overall Study|did not complete shelter onboarding|2|||
149897429|NCT04610346|540754968|FG001|Overall Study|did not complete shelter onboarding|1|||
149897430|NCT01081769|540754969|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
149897431|NCT01081769|540754970|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
149897432|NCT01081769|540754969|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
149897433|NCT01081769|540754970|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
149897434|NCT01081769|540754969|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
149897435|NCT01081769|540754970|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
149897436|NCT01081769|540754969|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
149897437|NCT01081769|540754970|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
149897438|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Adverse Event|14|||
149897439|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Adverse Event|11|||
149897440|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Death|1|||
149897441|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Death|1|||
149897442|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
149897443|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
149897444|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
149897445|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
149897446|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Pregnancy|1|||
149897447|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Pregnancy|0|||
149897448|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
149897449|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
149897450|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
149897451|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
149897452|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Other|0|||
149897453|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Other|1|||
149897454|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Ineligibility|3|||
149897455|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Ineligibility|4|||
149897456|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
149897457|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
149897458|NCT01081769|540754969|FG000|CORE Intent-To-Treat|Patient Moved|2|||
149897459|NCT01081769|540754970|FG001|CORE Intent-To-Treat|Patient Moved|2|||
149897460|NCT03309943|540754971|FG000|Overall Study|Withdrawal by Subject|0|||
149897461|NCT03309943|540754972|FG001|Overall Study|Withdrawal by Subject|1|||
149897462|NCT03309943|540754971|FG000|Overall Study|Inappropriate behavior towards staff|0|||
149897463|NCT03309943|540754972|FG001|Overall Study|Inappropriate behavior towards staff|1|||
149897464|NCT02019264|540754980|FG000|Overall Study|Not treated|6|||
149897465|NCT02019264|540754981|FG001|Overall Study|Not treated|4|||
149897466|NCT02019264|540754980|FG000|Overall Study|Lost to Follow-up|50|||
149897467|NCT02019264|540754981|FG001|Overall Study|Lost to Follow-up|47|||
149897468|NCT02019264|540754980|FG000|Overall Study|Withdrawal by Subject|142|||
149897469|NCT02019264|540754981|FG001|Overall Study|Withdrawal by Subject|117|||
149897470|NCT02019264|540754980|FG000|Overall Study|Administrative reason|36|||
149897471|NCT02019264|540754981|FG001|Overall Study|Administrative reason|28|||
149897472|NCT02019264|540754980|FG000|Overall Study|Missing|14|||
149897473|NCT02019264|540754981|FG001|Overall Study|Missing|11|||
149897474|NCT00628212|540754982|FG000|Overall Study|Adverse Event|2|||
149897475|NCT00628212|540754983|FG001|Overall Study|Adverse Event|0|||
149897476|NCT00628212|540754984|FG002|Overall Study|Adverse Event|1|||
149897477|NCT00628212|540754985|FG003|Overall Study|Adverse Event|2|||
149897478|NCT00628212|540754982|FG000|Overall Study|Physician Decision|1|||
149897479|NCT00628212|540754983|FG001|Overall Study|Physician Decision|1|||
149897480|NCT00628212|540754984|FG002|Overall Study|Physician Decision|2|||
149897481|NCT00628212|540754985|FG003|Overall Study|Physician Decision|3|||
149897482|NCT02914613|540754986|FG000|Overall Study|Withdrawal by Subject|1|||
149897483|NCT02914613|540754987|FG001|Overall Study|Withdrawal by Subject|2|||
149897484|NCT02914613|540754986|FG000|Overall Study|Adverse Event|1|||
149897485|NCT02914613|540754987|FG001|Overall Study|Adverse Event|0|||
149897486|NCT00546377|540754988|FG000|Overall Study|Deemed ineligible|1|||
149897487|NCT00546377|540754988|FG000|Overall Study|Adverse Event|6|||
149897488|NCT01684423|540754992|FG000|Overall Study|Withdrawal by Subject|0|||
149897489|NCT01684423|540754993|FG001|Overall Study|Withdrawal by Subject|0|||
149897490|NCT01684423|540754994|FG002|Overall Study|Withdrawal by Subject|1|||
149897491|NCT01684423|540754995|FG003|Overall Study|Withdrawal by Subject|0|||
149897492|NCT01684423|540754996|FG004|Overall Study|Withdrawal by Subject|0|||
149897493|NCT03850496|540755000|FG000|Overall Study|Withdrawal by Subject|1|||
149897494|NCT03850496|540755001|FG001|Overall Study|Withdrawal by Subject|0|||
149897495|NCT03850496|540755002|FG002|Overall Study|Withdrawal by Subject|0|||
149897496|NCT03850496|540755000|FG000|Overall Study|Lost to Follow-up|0|||
149897497|NCT03850496|540755001|FG001|Overall Study|Lost to Follow-up|1|||
149897498|NCT03850496|540755002|FG002|Overall Study|Lost to Follow-up|4|||
149897499|NCT00869999|540755009|FG000|Overall Study|Withdrawal by Subject|1|||
149897500|NCT00869999|540755009|FG000|Overall Study|removed prior to starting therapy|1|||
149897501|NCT05343364|540755020|FG000|Overall Study|Miscellaneous|0|||
149897502|NCT05343364|540755021|FG001|Overall Study|Miscellaneous|1|||
149897503|NCT01753570|540755022|FG000|Overall Study|Adverse Event|1|||
149897504|NCT01753570|540755023|FG001|Overall Study|Adverse Event|0|||
149897505|NCT01753570|540755024|FG002|Overall Study|Adverse Event|1|||
149897506|NCT01753570|540755022|FG000|Overall Study|Physician Decision|0|||
149897507|NCT01753570|540755023|FG001|Overall Study|Physician Decision|1|||
149897508|NCT01753570|540755024|FG002|Overall Study|Physician Decision|0|||
149897509|NCT01753570|540755022|FG000|Overall Study|Withdrawal by Subject|1|||
149897510|NCT01753570|540755023|FG001|Overall Study|Withdrawal by Subject|4|||
149897511|NCT01753570|540755024|FG002|Overall Study|Withdrawal by Subject|0|||
149897512|NCT01422889|540755025|FG000|Overall Study|No Data Entered for Study Stent|9|||
149897513|NCT04331067|540755026|FG000|Overall Study|Adverse Event|1|||
149897514|NCT04331067|540755027|FG001|Overall Study|Adverse Event|3|||
149897515|NCT04331067|540755028|FG002|Overall Study|Adverse Event|1|||
149897516|NCT04331067|540755026|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
149897517|NCT04331067|540755027|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
149897518|NCT04331067|540755028|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
149897519|NCT02062450|540755029|FG000|Overall Study|No follow-up visit|124|||
149897520|NCT02203721|540755032|FG000|Overall Study|Lost to Follow-up|1|||
149897521|NCT02203721|540755033|FG001|Overall Study|Lost to Follow-up|0|||
149897522|NCT02203721|540755032|FG000|Overall Study|Death|0|||
149897523|NCT02203721|540755033|FG001|Overall Study|Death|2|||
150045488|NCT00067002|541305623|FG000|Overall Study|Delayed|1|||
150045489|NCT00067002|541305624|FG001|Overall Study|Delayed|1|||
150045490|NCT00067002|541305623|FG000|Overall Study|Graft Failure|5|||
150045491|NCT00067002|541305624|FG001|Overall Study|Graft Failure|6|||
150045492|NCT01032889|541305630|FG000|Overall Study|Adverse Event|2|||
150045493|NCT01032889|541305631|FG001|Overall Study|Adverse Event|2|||
150045494|NCT01032889|541305632|FG002|Overall Study|Adverse Event|0|||
150045495|NCT01032889|541305630|FG000|Overall Study|Withdrawal of Consent|1|||
150045496|NCT01032889|541305631|FG001|Overall Study|Withdrawal of Consent|2|||
150045497|NCT01032889|541305632|FG002|Overall Study|Withdrawal of Consent|1|||
150045498|NCT01032889|541305630|FG000|Overall Study|Patient Request|0|||
150045499|NCT01032889|541305631|FG001|Overall Study|Patient Request|1|||
150045500|NCT01032889|541305632|FG002|Overall Study|Patient Request|0|||
150045501|NCT01032889|541305630|FG000|Overall Study|Lost to Follow-up|1|||
150045502|NCT01032889|541305631|FG001|Overall Study|Lost to Follow-up|1|||
150045503|NCT01032889|541305632|FG002|Overall Study|Lost to Follow-up|0|||
150045504|NCT01032889|541305630|FG000|Overall Study|Lack of Submental Fat|2|||
150045505|NCT01032889|541305631|FG001|Overall Study|Lack of Submental Fat|8|||
150045506|NCT01032889|541305632|FG002|Overall Study|Lack of Submental Fat|1|||
150045507|NCT01032889|541305630|FG000|Overall Study|Miscellaneous Reasons|2|||
150045508|NCT01032889|541305631|FG001|Overall Study|Miscellaneous Reasons|1|||
150045509|NCT01032889|541305632|FG002|Overall Study|Miscellaneous Reasons|1|||
150045510|NCT03532451|541305639|FG000|Overall Study|Withdrawal by Subject|0|||
149897524|NCT02203721|540755032|FG000|Overall Study|Illness|0|||
150045511|NCT03532451|541305640|FG001|Overall Study|Withdrawal by Subject|1|||
150045512|NCT03532451|541305639|FG000|Overall Study|Did not undergo surgery|1|||
150045513|NCT03532451|541305640|FG001|Overall Study|Did not undergo surgery|1|||
150045514|NCT02527421|541305641|FG000|Overall Study|Withdrawal by Subject|1|||
150045515|NCT02527421|541305642|FG001|Overall Study|Withdrawal by Subject|0|||
150045516|NCT02541604|541305643|FG000|Overall Study|Death|6|||
149897525|NCT02203721|540755033|FG001|Overall Study|Illness|1|||
149897526|NCT00314327|540755035|FG000|Overall Study|Withdrawal by Subject|1|||
149897527|NCT05678959|540756982|FG000|Overall Study|Study Terminated by Sponsor|76|||
149897528|NCT05678959|540756983|FG001|Overall Study|Study Terminated by Sponsor|76|||
149897529|NCT05678959|540756982|FG000|Overall Study|Physician Decision|2|||
149897530|NCT05678959|540756983|FG001|Overall Study|Physician Decision|3|||
149897531|NCT05678959|540756982|FG000|Overall Study|Adverse Event|1|||
149897532|NCT05678959|540756983|FG001|Overall Study|Adverse Event|1|||
149897533|NCT05678959|540756982|FG000|Overall Study|Guardian Decision|1|||
149897534|NCT05678959|540756983|FG001|Overall Study|Guardian Decision|0|||
149897535|NCT05678959|540756982|FG000|Overall Study|Protocol Deviation|0|||
149897536|NCT05678959|540756983|FG001|Overall Study|Protocol Deviation|1|||
149975757|NCT00457392|541049415|FG001|Overall Study|Objective Progression or Relapse|296|||
149897537|NCT05678959|540756982|FG000|Overall Study|Subject Decision|1|||
149897538|NCT05678959|540756983|FG001|Overall Study|Subject Decision|0|||
149897539|NCT05678959|540756982|FG000|Overall Study|Technical Problem|0|||
149897540|NCT05678959|540756983|FG001|Overall Study|Technical Problem|1|||
149897541|NCT00617890|540756986|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
149897542|NCT00617890|540756987|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
149897543|NCT00617890|540756988|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
149897544|NCT00617890|540756989|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
149897545|NCT00617890|540756986|FG000|Overall Study|Lack of Efficacy|23|||
149897546|NCT00617890|540756987|FG001|Overall Study|Lack of Efficacy|26|||
149897547|NCT00617890|540756988|FG002|Overall Study|Lack of Efficacy|30|||
149897548|NCT00617890|540756989|FG003|Overall Study|Lack of Efficacy|97|||
149897549|NCT00617890|540756986|FG000|Overall Study|Lost to Follow-up|0|||
149897550|NCT00617890|540756987|FG001|Overall Study|Lost to Follow-up|0|||
149897551|NCT00617890|540756988|FG002|Overall Study|Lost to Follow-up|1|||
149897552|NCT00617890|540756989|FG003|Overall Study|Lost to Follow-up|2|||
149897553|NCT00617890|540756986|FG000|Overall Study|Withdrawal by Subject|4|||
149897554|NCT00617890|540756987|FG001|Overall Study|Withdrawal by Subject|1|||
149897555|NCT00617890|540756988|FG002|Overall Study|Withdrawal by Subject|0|||
149897556|NCT00617890|540756989|FG003|Overall Study|Withdrawal by Subject|2|||
149897557|NCT00617890|540756986|FG000|Overall Study|Protocol Violation|2|||
149897558|NCT00617890|540756987|FG001|Overall Study|Protocol Violation|1|||
149897559|NCT00617890|540756988|FG002|Overall Study|Protocol Violation|0|||
149897560|NCT00617890|540756989|FG003|Overall Study|Protocol Violation|0|||
149897561|NCT00617890|540756986|FG000|Overall Study|Adverse Event|1|||
149897562|NCT00617890|540756987|FG001|Overall Study|Adverse Event|0|||
149897563|NCT00617890|540756988|FG002|Overall Study|Adverse Event|3|||
149897564|NCT00617890|540756989|FG003|Overall Study|Adverse Event|8|||
149897565|NCT00617890|540756986|FG000|Overall Study|Not treated|1|||
149897566|NCT00617890|540756987|FG001|Overall Study|Not treated|0|||
149897567|NCT00617890|540756988|FG002|Overall Study|Not treated|1|||
149897568|NCT00617890|540756989|FG003|Overall Study|Not treated|1|||
149897569|NCT03503370|540756990|FG000|Overall Study|Death|3|||
149897570|NCT03503370|540756991|FG001|Overall Study|Death|1|||
149897571|NCT04545489|540756992|FG000|Overall Study|Withdrawal by Subject|12|||
149897572|NCT04545489|540756993|FG001|Overall Study|Withdrawal by Subject|4|||
149897573|NCT04545489|540756992|FG000|Overall Study|Lost to Follow-up|17|||
149897574|NCT04545489|540756993|FG001|Overall Study|Lost to Follow-up|18|||
149897575|NCT04545489|540756992|FG000|Overall Study|12month BP not collected|4|||
149897576|NCT04545489|540756993|FG001|Overall Study|12month BP not collected|4|||
149897577|NCT02727478|540756994|FG000|Overall Study|Withdrawal by Subject|8|||
149897578|NCT02727478|540756995|FG001|Overall Study|Withdrawal by Subject|10|||
149897579|NCT02633293|540756996|FG000|Overall Study|Death|56|||
149897580|NCT02633293|540756996|FG000|Overall Study|Progressive Disease|12|||
149897581|NCT02633293|540756996|FG000|Overall Study|Adverse Event|29|||
149897582|NCT02633293|540756996|FG000|Overall Study|Withdrawal by Subject|41|||
149897583|NCT02633293|540756996|FG000|Overall Study|Protocol Violation|1|||
149897584|NCT02633293|540756996|FG000|Overall Study|Lost to Follow-up|1|||
149897585|NCT02633293|540756996|FG000|Overall Study|Study Terminated by Sponsor|24|||
149897586|NCT02633293|540756996|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
149897587|NCT02633293|540756996|FG000|Overall Study|Lung Transplant|5|||
149897588|NCT02633293|540756996|FG000|Overall Study|Lack of Efficacy|2|||
149897589|NCT02633293|540756996|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
149897590|NCT01017874|540756997|FG000|Overall Study|Withdrawal by Subject|23|||
149897591|NCT01017874|540756998|FG001|Overall Study|Withdrawal by Subject|20|||
149897592|NCT01017874|540756997|FG000|Overall Study|Sponsor decision|3|||
149897593|NCT01017874|540756998|FG001|Overall Study|Sponsor decision|1|||
149897594|NCT01017874|540756997|FG000|Overall Study|Lost to Follow-up|3|||
149897595|NCT01017874|540756998|FG001|Overall Study|Lost to Follow-up|2|||
149897596|NCT01017874|540756997|FG000|Overall Study|Physician Decision|1|||
149897597|NCT01017874|540756998|FG001|Overall Study|Physician Decision|3|||
149897598|NCT00808210|540757002|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
149897599|NCT00808210|540757003|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
149897600|NCT00808210|540757002|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
149897601|NCT00808210|540757003|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
149897602|NCT00808210|540757002|FG000|Double-Blind TX Period|Adverse Event|0|||
150045517|NCT02541604|541305644|FG001|Overall Study|Death|5|||
150045518|NCT02541604|541305645|FG002|Overall Study|Death|7|||
150045519|NCT02541604|541305646|FG003|Overall Study|Death|2|||
150045520|NCT02541604|541305647|FG004|Overall Study|Death|9|||
150045521|NCT02541604|541305648|FG005|Overall Study|Death|8|||
150045522|NCT02541604|541305649|FG006|Overall Study|Death|9|||
149897603|NCT00808210|540757003|FG001|Double-Blind TX Period|Adverse Event|1|||
149897604|NCT00808210|540757002|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
150045523|NCT02541604|541305650|FG007|Overall Study|Death|9|||
150045524|NCT02541604|541305651|FG008|Overall Study|Death|3|||
149897605|NCT00808210|540757003|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
149897606|NCT00808210|540757002|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
150045525|NCT02541604|541305652|FG009|Overall Study|Death|4|||
150045526|NCT02541604|541305653|FG010|Overall Study|Death|2|||
149897607|NCT00808210|540757003|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
149897608|NCT00808210|540757002|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
149897609|NCT00808210|540757003|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
149897610|NCT00778817|540757005|FG000|Overall Study|Adverse Event|2|||
149897611|NCT00778817|540757005|FG000|Overall Study|Withdrawal by Subject|2|||
149897612|NCT02356588|540757006|FG000|Overall Study|Lack of Efficacy|4|||
149897613|NCT02356588|540757007|FG001|Overall Study|Lack of Efficacy|10|||
149897614|NCT02356588|540757006|FG000|Overall Study|Adverse Event|0|||
149897615|NCT02356588|540757007|FG001|Overall Study|Adverse Event|2|||
149897616|NCT02356588|540757006|FG000|Overall Study|Withdrawal by Subject|1|||
149897617|NCT02356588|540757007|FG001|Overall Study|Withdrawal by Subject|0|||
149897618|NCT02356588|540757006|FG000|Overall Study|Protocol Violation|0|||
149897619|NCT02356588|540757007|FG001|Overall Study|Protocol Violation|1|||
149897620|NCT01418378|540757008|FG000|Overall Study|Death|1|||
149897621|NCT01418378|540757009|FG001|Overall Study|Death|2|||
149897622|NCT01418378|540757008|FG000|Overall Study|Physician Decision|0|||
149897623|NCT01418378|540757009|FG001|Overall Study|Physician Decision|1|||
149897624|NCT01418378|540757008|FG000|Overall Study|ligament imbalance|0|||
149897625|NCT01418378|540757009|FG001|Overall Study|ligament imbalance|1|||
149897626|NCT01418378|540757008|FG000|Overall Study|developed chronic myopathy|0|||
149897627|NCT01418378|540757009|FG001|Overall Study|developed chronic myopathy|1|||
149897628|NCT01790984|540757010|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
149897629|NCT01790984|540757011|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
149897630|NCT01790984|540757012|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
149897631|NCT01790984|540757013|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
149897632|NCT00558467|540757018|FG000|Overall Study|Adverse Event|1|||
149897633|NCT00558467|540757019|FG001|Overall Study|Adverse Event|2|||
149897634|NCT00558467|540757018|FG000|Overall Study|Lack of Efficacy|0|||
149897635|NCT00558467|540757019|FG001|Overall Study|Lack of Efficacy|1|||
149897636|NCT00558467|540757018|FG000|Overall Study|Patient moving out of state|0|||
149897637|NCT00558467|540757019|FG001|Overall Study|Patient moving out of state|1|||
149897638|NCT00507455|540757020|FG000|Overall Study|Adverse Event|3|||
149897639|NCT00507455|540757021|FG001|Overall Study|Adverse Event|3|||
149897640|NCT00507455|540757022|FG002|Overall Study|Adverse Event|6|||
149897641|NCT00507455|540757020|FG000|Overall Study|Withdrawal by Subject|2|||
149975758|NCT00457392|541049414|FG000|Overall Study|Death|106|||
149897642|NCT00507455|540757021|FG001|Overall Study|Withdrawal by Subject|1|||
149897643|NCT00507455|540757022|FG002|Overall Study|Withdrawal by Subject|2|||
149897644|NCT00507455|540757020|FG000|Overall Study|Protocol Violation|4|||
149897645|NCT00507455|540757021|FG001|Overall Study|Protocol Violation|1|||
149897646|NCT00507455|540757022|FG002|Overall Study|Protocol Violation|1|||
149897647|NCT00507455|540757020|FG000|Overall Study|Lost to Follow-up|2|||
150045527|NCT02541604|541305654|FG011|Overall Study|Death|3|||
150045528|NCT02541604|541305643|FG000|Overall Study|Lost to Follow-up|2|||
150045529|NCT02541604|541305644|FG001|Overall Study|Lost to Follow-up|0|||
150045530|NCT02541604|541305645|FG002|Overall Study|Lost to Follow-up|1|||
150176292|NCT00919763|541781970|FG001|Overall Study|Adverse Event|1|||
150176293|NCT00919763|541781969|FG000|Overall Study|Lost to Follow-up|1|||
150176294|NCT00919763|541781970|FG001|Overall Study|Lost to Follow-up|0|||
150176295|NCT00919763|541781969|FG000|Overall Study|Protocol Violation|1|||
150176296|NCT00919763|541781970|FG001|Overall Study|Protocol Violation|1|||
150176297|NCT00919763|541781969|FG000|Overall Study|Withdrawal by Subject|3|||
149897648|NCT00507455|540757021|FG001|Overall Study|Lost to Follow-up|0|||
149897649|NCT00507455|540757022|FG002|Overall Study|Lost to Follow-up|2|||
149897650|NCT00507455|540757020|FG000|Overall Study|Lack of Efficacy|0|||
149897651|NCT00507455|540757021|FG001|Overall Study|Lack of Efficacy|1|||
149897652|NCT00507455|540757022|FG002|Overall Study|Lack of Efficacy|0|||
149897653|NCT00507455|540757020|FG000|Overall Study|Other - miscellaneous reason|1|||
149897654|NCT00507455|540757021|FG001|Overall Study|Other - miscellaneous reason|0|||
149897655|NCT00507455|540757022|FG002|Overall Study|Other - miscellaneous reason|1|||
149897656|NCT00931255|540757023|FG000|Overall Study|Follow up biopsy not done|2|||
149897657|NCT00931255|540757024|FG001|Overall Study|Follow up biopsy not done|3|||
149897658|NCT01372995|540757025|FG000|Overall Study|Spouse withdrew participant from study|0|||
149897659|NCT01372995|540757026|FG001|Overall Study|Spouse withdrew participant from study|1|||
149897660|NCT01372995|540757027|FG002|Overall Study|Spouse withdrew participant from study|0|||
149897661|NCT01372995|540757025|FG000|Overall Study|Physician Decision|0|||
149897662|NCT01372995|540757026|FG001|Overall Study|Physician Decision|0|||
149897663|NCT01372995|540757027|FG002|Overall Study|Physician Decision|1|||
149897664|NCT01297517|540757037|FG000|Overall Study|Adverse Event|21|||
149897665|NCT01297517|540757038|FG001|Overall Study|Adverse Event|7|||
149897666|NCT01297517|540757039|FG002|Overall Study|Adverse Event|16|||
149897667|NCT01297517|540757037|FG000|Overall Study|Lost to Follow-up|1|||
149897668|NCT01297517|540757038|FG001|Overall Study|Lost to Follow-up|0|||
149897669|NCT01297517|540757039|FG002|Overall Study|Lost to Follow-up|1|||
149897670|NCT01297517|540757037|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
149897671|NCT01297517|540757038|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
149897672|NCT01297517|540757039|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
149897673|NCT01297517|540757037|FG000|Overall Study|Noncompliance|1|||
149975759|NCT00457392|541049415|FG001|Overall Study|Death|106|||
149897674|NCT01297517|540757038|FG001|Overall Study|Noncompliance|0|||
149897675|NCT01297517|540757039|FG002|Overall Study|Noncompliance|0|||
149897676|NCT01297517|540757037|FG000|Overall Study|Protocol Violation|1|||
149897677|NCT01297517|540757038|FG001|Overall Study|Protocol Violation|1|||
149897678|NCT01297517|540757039|FG002|Overall Study|Protocol Violation|1|||
149897679|NCT01297517|540757037|FG000|Overall Study|Inadequate Control of IOP|1|||
149975760|NCT00457392|541049414|FG000|Overall Study|Adverse Event|84|||
149975761|NCT00457392|541049415|FG001|Overall Study|Adverse Event|41|||
149975762|NCT00457392|541049414|FG000|Overall Study|Global Deterioration of Health Status|22|||
149975763|NCT00457392|541049415|FG001|Overall Study|Global Deterioration of Health Status|8|||
149975764|NCT00457392|541049414|FG000|Overall Study|Withdrawal by Subject|14|||
149975765|NCT00457392|541049415|FG001|Overall Study|Withdrawal by Subject|8|||
149975766|NCT00457392|541049414|FG000|Overall Study|Lost to Follow-up|6|||
149975767|NCT00457392|541049415|FG001|Overall Study|Lost to Follow-up|7|||
149975768|NCT00457392|541049414|FG000|Overall Study|Protocol Violation|4|||
149975769|NCT00457392|541049415|FG001|Overall Study|Protocol Violation|3|||
149975770|NCT00457392|541049414|FG000|Overall Study|Other|7|||
149975771|NCT00457392|541049415|FG001|Overall Study|Other|4|||
149975772|NCT00457392|541049414|FG000|Overall Study|Study Terminated by Sponsor|1|||
149975773|NCT00457392|541049415|FG001|Overall Study|Study Terminated by Sponsor|4|||
149975774|NCT00457392|541049414|FG000|Overall Study|Randomized, Not Treated|7|||
149975775|NCT00457392|541049415|FG001|Overall Study|Randomized, Not Treated|3|||
149897680|NCT01297517|540757038|FG001|Overall Study|Inadequate Control of IOP|1|||
149897681|NCT01297517|540757039|FG002|Overall Study|Inadequate Control of IOP|2|||
149897682|NCT01609296|540757040|FG000|Overall Study|Death|253|||
149897683|NCT01609296|540757040|FG000|Overall Study|Withdrawal by Subject|151|||
149897684|NCT01609296|540757040|FG000|Overall Study|Lost to Follow-up|21|||
149897685|NCT01609296|540757040|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
149897686|NCT01609296|540757040|FG000|Overall Study|missed visit but known to be alive|28|||
149897687|NCT00386360|540757041|FG000|Overall Study|Adverse Event|4|||
149897688|NCT00386360|540757042|FG001|Overall Study|Adverse Event|2|||
149897689|NCT00386360|540757041|FG000|Overall Study|Physician Decision|2|||
149897690|NCT00386360|540757042|FG001|Overall Study|Physician Decision|2|||
150045531|NCT02541604|541305646|FG003|Overall Study|Lost to Follow-up|0|||
150045532|NCT02541604|541305647|FG004|Overall Study|Lost to Follow-up|0|||
150045533|NCT02541604|541305648|FG005|Overall Study|Lost to Follow-up|1|||
150045534|NCT02541604|541305649|FG006|Overall Study|Lost to Follow-up|1|||
150045535|NCT02541604|541305650|FG007|Overall Study|Lost to Follow-up|0|||
150045536|NCT02541604|541305651|FG008|Overall Study|Lost to Follow-up|0|||
150045537|NCT02541604|541305652|FG009|Overall Study|Lost to Follow-up|0|||
150045538|NCT02541604|541305653|FG010|Overall Study|Lost to Follow-up|0|||
150045539|NCT02541604|541305654|FG011|Overall Study|Lost to Follow-up|0|||
150045540|NCT02541604|541305643|FG000|Overall Study|Withdrawal by Subject|2|||
150045541|NCT02541604|541305644|FG001|Overall Study|Withdrawal by Subject|0|||
150045542|NCT02541604|541305645|FG002|Overall Study|Withdrawal by Subject|1|||
150045543|NCT02541604|541305646|FG003|Overall Study|Withdrawal by Subject|0|||
150045544|NCT02541604|541305647|FG004|Overall Study|Withdrawal by Subject|1|||
150045545|NCT02541604|541305648|FG005|Overall Study|Withdrawal by Subject|1|||
150045546|NCT02541604|541305649|FG006|Overall Study|Withdrawal by Subject|0|||
150045547|NCT02541604|541305650|FG007|Overall Study|Withdrawal by Subject|0|||
149897691|NCT00386360|540757041|FG000|Overall Study|Lost to Follow-up|0|||
149897692|NCT00386360|540757042|FG001|Overall Study|Lost to Follow-up|2|||
149897693|NCT00386360|540757041|FG000|Overall Study|Protocol Violation|0|||
149897694|NCT00386360|540757042|FG001|Overall Study|Protocol Violation|3|||
149897695|NCT00386360|540757041|FG000|Overall Study|Withdrawal by Subject|3|||
150045548|NCT02541604|541305651|FG008|Overall Study|Withdrawal by Subject|1|||
149897696|NCT00386360|540757042|FG001|Overall Study|Withdrawal by Subject|6|||
149897697|NCT00386360|540757041|FG000|Overall Study|Did not take any study medication|0|||
149897698|NCT00386360|540757042|FG001|Overall Study|Did not take any study medication|2|||
149897699|NCT00789373|540757048|FG000|Induction|Adverse Event|64|||
149897700|NCT00789373|540757049|FG001|Induction|Adverse Event|0|||
149897701|NCT00789373|540757050|FG002|Induction|Adverse Event|0|||
149897702|NCT00789373|540757048|FG000|Induction|Death Due to study disease|24|||
149897703|NCT00789373|540757049|FG001|Induction|Death Due to study disease|0|||
149897704|NCT00789373|540757050|FG002|Induction|Death Due to study disease|0|||
149897705|NCT00789373|540757048|FG000|Induction|Death due to adverse event|19|||
149897706|NCT00789373|540757049|FG001|Induction|Death due to adverse event|0|||
149897707|NCT00789373|540757050|FG002|Induction|Death due to adverse event|0|||
150045549|NCT02541604|541305652|FG009|Overall Study|Withdrawal by Subject|0|||
149897708|NCT00789373|540757048|FG000|Induction|Death due to toxicity|11|||
149897709|NCT00789373|540757049|FG001|Induction|Death due to toxicity|0|||
149897710|NCT00789373|540757050|FG002|Induction|Death due to toxicity|0|||
149897711|NCT00789373|540757048|FG000|Induction|Death due to procedure|1|||
149968776|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
149968777|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968778|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968779|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
149968780|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968781|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968782|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968783|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968784|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968785|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968786|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968787|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968788|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
149968789|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968790|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968791|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
149968792|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968793|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968794|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968795|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
150045550|NCT02541604|541305653|FG010|Overall Study|Withdrawal by Subject|0|||
150045551|NCT02541604|541305654|FG011|Overall Study|Withdrawal by Subject|0|||
150045552|NCT02541604|541305643|FG000|Overall Study|Study Terminated by Sponsor|1|||
150045553|NCT02541604|541305644|FG001|Overall Study|Study Terminated by Sponsor|4|||
150045554|NCT02541604|541305645|FG002|Overall Study|Study Terminated by Sponsor|2|||
150045555|NCT02541604|541305646|FG003|Overall Study|Study Terminated by Sponsor|1|||
150045556|NCT02541604|541305647|FG004|Overall Study|Study Terminated by Sponsor|0|||
150045557|NCT02541604|541305648|FG005|Overall Study|Study Terminated by Sponsor|0|||
150045558|NCT02541604|541305649|FG006|Overall Study|Study Terminated by Sponsor|0|||
150045559|NCT02541604|541305650|FG007|Overall Study|Study Terminated by Sponsor|0|||
150045560|NCT02541604|541305651|FG008|Overall Study|Study Terminated by Sponsor|0|||
150045561|NCT02541604|541305652|FG009|Overall Study|Study Terminated by Sponsor|0|||
150045562|NCT02541604|541305653|FG010|Overall Study|Study Terminated by Sponsor|0|||
150045563|NCT02541604|541305654|FG011|Overall Study|Study Terminated by Sponsor|0|||
150045564|NCT02541604|541305643|FG000|Overall Study|Medical condition may jeopardize safety|0|||
150045565|NCT02541604|541305644|FG001|Overall Study|Medical condition may jeopardize safety|0|||
150045566|NCT02541604|541305645|FG002|Overall Study|Medical condition may jeopardize safety|0|||
150045567|NCT02541604|541305646|FG003|Overall Study|Medical condition may jeopardize safety|0|||
150045568|NCT02541604|541305647|FG004|Overall Study|Medical condition may jeopardize safety|0|||
150045569|NCT02541604|541305648|FG005|Overall Study|Medical condition may jeopardize safety|0|||
150045570|NCT02541604|541305649|FG006|Overall Study|Medical condition may jeopardize safety|0|||
150045571|NCT02541604|541305650|FG007|Overall Study|Medical condition may jeopardize safety|1|||
149897712|NCT00789373|540757049|FG001|Induction|Death due to procedure|0|||
149897713|NCT00789373|540757050|FG002|Induction|Death due to procedure|0|||
149897714|NCT00789373|540757048|FG000|Induction|Investigator decision|7|||
149897715|NCT00789373|540757049|FG001|Induction|Investigator decision|0|||
149897716|NCT00789373|540757050|FG002|Induction|Investigator decision|0|||
149897717|NCT00789373|540757048|FG000|Induction|Protocol entry criteria not met|9|||
150176298|NCT00919763|541781970|FG001|Overall Study|Withdrawal by Subject|1|||
149897718|NCT00789373|540757049|FG001|Induction|Protocol entry criteria not met|0|||
149897719|NCT00789373|540757050|FG002|Induction|Protocol entry criteria not met|0|||
149897720|NCT00789373|540757048|FG000|Induction|Lost to Follow-up|6|||
149897721|NCT00789373|540757049|FG001|Induction|Lost to Follow-up|0|||
149897722|NCT00789373|540757050|FG002|Induction|Lost to Follow-up|0|||
149897723|NCT00789373|540757048|FG000|Induction|Protocol Violation|1|||
149897724|NCT00789373|540757049|FG001|Induction|Protocol Violation|0|||
149897725|NCT00789373|540757050|FG002|Induction|Protocol Violation|0|||
149897726|NCT00789373|540757048|FG000|Induction|Progressive Disease|220|||
149897727|NCT00789373|540757049|FG001|Induction|Progressive Disease|0|||
149897728|NCT00789373|540757050|FG002|Induction|Progressive Disease|0|||
149897729|NCT00789373|540757048|FG000|Induction|Withdrawal by Subject|37|||
149897730|NCT00789373|540757049|FG001|Induction|Withdrawal by Subject|0|||
149897731|NCT00789373|540757050|FG002|Induction|Withdrawal by Subject|0|||
149897732|NCT00789373|540757048|FG000|Maintenance|Adverse Event|0|||
149897733|NCT00789373|540757049|FG001|Maintenance|Adverse Event|65|||
150176299|NCT00919763|541781969|FG000|Overall Study|Non-compliance|0|||
149897734|NCT00789373|540757050|FG002|Maintenance|Adverse Event|12|||
149968796|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149897735|NCT00789373|540757048|FG000|Maintenance|Death due to study disease|0|||
149897736|NCT00789373|540757049|FG001|Maintenance|Death due to study disease|3|||
149897737|NCT00789373|540757050|FG002|Maintenance|Death due to study disease|1|||
149897738|NCT00789373|540757048|FG000|Maintenance|Death due to adverse event|0|||
150176300|NCT00919763|541781970|FG001|Overall Study|Non-compliance|1|||
150176301|NCT02471755|541781972|FG000|Overall Study|Withdrawal by Subject|1|||
150176302|NCT02471755|541781973|FG001|Overall Study|Withdrawal by Subject|0|||
150176303|NCT02471755|541781972|FG000|Overall Study|Lost to Follow-up|0|||
149897739|NCT00789373|540757049|FG001|Maintenance|Death due to adverse event|4|||
149897740|NCT00789373|540757050|FG002|Maintenance|Death due to adverse event|1|||
149897741|NCT00789373|540757048|FG000|Maintenance|Death due to toxicity|0|||
149897742|NCT00789373|540757049|FG001|Maintenance|Death due to toxicity|1|||
149897743|NCT00789373|540757050|FG002|Maintenance|Death due to toxicity|2|||
149897744|NCT00789373|540757048|FG000|Maintenance|Investigator Decision|0|||
149897745|NCT00789373|540757049|FG001|Maintenance|Investigator Decision|4|||
149897746|NCT00789373|540757050|FG002|Maintenance|Investigator Decision|2|||
149897747|NCT00789373|540757048|FG000|Maintenance|Protocol entry criteria not met|0|||
149897748|NCT00789373|540757049|FG001|Maintenance|Protocol entry criteria not met|2|||
149897749|NCT00789373|540757050|FG002|Maintenance|Protocol entry criteria not met|0|||
149897750|NCT00789373|540757048|FG000|Maintenance|Lost to Follow-up|0|||
149897751|NCT00789373|540757049|FG001|Maintenance|Lost to Follow-up|2|||
149897752|NCT00789373|540757050|FG002|Maintenance|Lost to Follow-up|0|||
149897753|NCT00789373|540757048|FG000|Maintenance|Progressive Disease|0|||
149897754|NCT00789373|540757049|FG001|Maintenance|Progressive Disease|253|||
149897755|NCT00789373|540757050|FG002|Maintenance|Progressive Disease|152|||
149897756|NCT00789373|540757048|FG000|Maintenance|Withdrawal by Subject|0|||
149968797|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968798|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968799|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968800|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968801|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968802|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968803|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968804|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
149968805|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
149968806|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
149968807|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
149968808|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968809|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968810|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149897757|NCT00789373|540757049|FG001|Maintenance|Withdrawal by Subject|21|||
149897758|NCT00789373|540757050|FG002|Maintenance|Withdrawal by Subject|8|||
149897759|NCT00789373|540757048|FG000|Maintenance|Sponsor Decision|0|||
149897760|NCT00789373|540757049|FG001|Maintenance|Sponsor Decision|0|||
149897761|NCT00789373|540757050|FG002|Maintenance|Sponsor Decision|2|||
149897762|NCT00789373|540757048|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
149897763|NCT00789373|540757049|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
150176304|NCT02471755|541781973|FG001|Overall Study|Lost to Follow-up|1|||
149897764|NCT00789373|540757050|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
149897765|NCT03363776|540757055|FG000|Overall Study|Progressive disease|2|||
149897766|NCT03363776|540757056|FG001|Overall Study|Progressive disease|3|||
149897767|NCT03363776|540757057|FG002|Overall Study|Progressive disease|1|||
149897768|NCT03363776|540757055|FG000|Overall Study|Study drug toxicity|0|||
149897769|NCT03363776|540757056|FG001|Overall Study|Study drug toxicity|0|||
149897770|NCT03363776|540757057|FG002|Overall Study|Study drug toxicity|1|||
149897771|NCT03363776|540757055|FG000|Overall Study|Death|1|||
149897772|NCT03363776|540757056|FG001|Overall Study|Death|0|||
149897773|NCT03363776|540757057|FG002|Overall Study|Death|0|||
149897774|NCT04157348|540757058|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
149897775|NCT04157348|540757059|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
149897776|NCT04157348|540757058|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
149897777|NCT04157348|540757059|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
149897778|NCT04157348|540757058|FG000|Double-blind Treatment Period|Adverse Event|0|||
149897779|NCT04157348|540757059|FG001|Double-blind Treatment Period|Adverse Event|1|||
149897780|NCT04157348|540757058|FG000|Open-label Extension Period|Adverse Event|1|||
149897781|NCT04157348|540757059|FG001|Open-label Extension Period|Adverse Event|1|||
149897782|NCT04157348|540757058|FG000|Open-label Extension Period|Death|0|||
149897783|NCT04157348|540757059|FG001|Open-label Extension Period|Death|1|||
149897784|NCT04157348|540757058|FG000|Open-label Extension Period|Lack of Efficacy|2|||
149897785|NCT04157348|540757059|FG001|Open-label Extension Period|Lack of Efficacy|2|||
149897786|NCT04157348|540757058|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
149897787|NCT04157348|540757059|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
149897788|NCT04157348|540757058|FG000|Open-label Extension Period|Ongoing|60|||
149897789|NCT04157348|540757059|FG001|Open-label Extension Period|Ongoing|57|||
149897790|NCT04157348|540757058|FG000|Open-label Extension Period|other reasons|1|||
149897791|NCT04157348|540757059|FG001|Open-label Extension Period|other reasons|1|||
149968811|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968812|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149897792|NCT02527434|540757060|FG000|Overall Study|Lost to Follow-up|2|||
149897793|NCT02527434|540757061|FG001|Overall Study|Lost to Follow-up|2|||
149897794|NCT02527434|540757062|FG002|Overall Study|Lost to Follow-up|0|||
149897795|NCT02527434|540757060|FG000|Overall Study|Death|19|||
149897796|NCT02527434|540757061|FG001|Overall Study|Death|6|||
149897797|NCT02527434|540757062|FG002|Overall Study|Death|17|||
149897798|NCT02527434|540757060|FG000|Overall Study|Withdrawal by Subject|5|||
149897799|NCT02527434|540757061|FG001|Overall Study|Withdrawal by Subject|3|||
149897800|NCT02527434|540757062|FG002|Overall Study|Withdrawal by Subject|3|||
149897801|NCT02527434|540757060|FG000|Overall Study|Reason Not Specified|1|||
149897802|NCT02527434|540757061|FG001|Overall Study|Reason Not Specified|0|||
149897803|NCT02527434|540757062|FG002|Overall Study|Reason Not Specified|0|||
149897804|NCT02527434|540757060|FG000|Overall Study|Site closure|1|||
149897805|NCT02527434|540757061|FG001|Overall Study|Site closure|0|||
149897806|NCT02527434|540757062|FG002|Overall Study|Site closure|0|||
149897807|NCT00568061|540757063|FG000|Overall Study|Inclusion / exclusion criteria|5|||
149897808|NCT00568061|540757064|FG001|Overall Study|Inclusion / exclusion criteria|1|||
149897809|NCT00568061|540757063|FG000|Overall Study|Adverse Event|0|||
149897810|NCT00568061|540757064|FG001|Overall Study|Adverse Event|1|||
149897811|NCT05027451|540757065|FG000|Overall Study|Lost to Follow-up|1|||
149897812|NCT05027451|540757066|FG001|Overall Study|Lost to Follow-up|1|||
149897813|NCT02693002|540757068|FG000|Overall Study|Withdrawal by Subject|1|||
149897814|NCT02693002|540757069|FG001|Overall Study|Withdrawal by Subject|0|||
149897815|NCT01791894|540757072|FG000|Overall Study|Adverse Event|1|||
149897816|NCT02268916|540757073|FG000|Overall Study|Lost to Follow-up|1|||
149897817|NCT02268916|540757074|FG001|Overall Study|Lost to Follow-up|1|||
149897818|NCT02268916|540757073|FG000|Overall Study|Withdrawal by Subject|6|||
149897819|NCT02268916|540757074|FG001|Overall Study|Withdrawal by Subject|5|||
149897820|NCT02268916|540757073|FG000|Overall Study|Participant did not have diabetes|1|||
149897821|NCT02268916|540757074|FG001|Overall Study|Participant did not have diabetes|0|||
149897822|NCT02268916|540757073|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
149897823|NCT02268916|540757074|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
149897824|NCT00594165|540757075|FG000|Overall Study|Major protocol violation|1|||
149897825|NCT00594165|540757075|FG000|Overall Study|Lack of Efficacy|12|||
149897826|NCT00594165|540757075|FG000|Overall Study|Adverse Event|52|||
149897827|NCT00594165|540757075|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
149897828|NCT00594165|540757075|FG000|Overall Study|Subject withdrew consent|27|||
149897829|NCT00594165|540757075|FG000|Overall Study|Study ended per sponsor|102|||
149897830|NCT00594165|540757075|FG000|Overall Study|Lost to Follow-up|4|||
149897831|NCT00594165|540757075|FG000|Overall Study|Other: PI discretion|5|||
149897832|NCT00594165|540757075|FG000|Overall Study|Other: Subject moving|3|||
150045572|NCT02541604|541305651|FG008|Overall Study|Medical condition may jeopardize safety|0|||
149897833|NCT00594165|540757075|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
149897834|NCT00594165|540757075|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
149897835|NCT00594165|540757075|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
149897836|NCT00594165|540757075|FG000|Overall Study|Other: Site terminated participation|2|||
149897837|NCT04495751|540757077|FG000|Overall Study|Withdrawal by Subject|1|||
149897838|NCT04495751|540757078|FG001|Overall Study|Withdrawal by Subject|0|||
149897839|NCT04495751|540757077|FG000|Overall Study|Lost to Follow-up|1|||
149897840|NCT04495751|540757078|FG001|Overall Study|Lost to Follow-up|0|||
149897841|NCT03289754|540757079|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
149897842|NCT04873934|540757080|FG000|Overall Study|Adverse Event|0|||
149897843|NCT04873934|540757081|FG001|Overall Study|Adverse Event|1|||
149897844|NCT04873934|540757080|FG000|Overall Study|Death|0|||
149897845|NCT04873934|540757081|FG001|Overall Study|Death|2|||
149897846|NCT04873934|540757080|FG000|Overall Study|Lost to Follow-up|13|||
149897847|NCT04873934|540757081|FG001|Overall Study|Lost to Follow-up|9|||
149897848|NCT04873934|540757080|FG000|Overall Study|Physician Decision|1|||
149897849|NCT04873934|540757081|FG001|Overall Study|Physician Decision|1|||
149897850|NCT04873934|540757080|FG000|Overall Study|Protocol deviation|2|||
149897851|NCT04873934|540757081|FG001|Overall Study|Protocol deviation|1|||
149897852|NCT04873934|540757080|FG000|Overall Study|Subject decision|1|||
149897853|NCT04873934|540757081|FG001|Overall Study|Subject decision|8|||
149897854|NCT04873934|540757080|FG000|Overall Study|Withdrew consent|0|||
149897855|NCT04873934|540757081|FG001|Overall Study|Withdrew consent|4|||
149897856|NCT04873934|540757080|FG000|Overall Study|Missing|1|||
150045573|NCT02541604|541305652|FG009|Overall Study|Medical condition may jeopardize safety|0|||
150045574|NCT02541604|541305653|FG010|Overall Study|Medical condition may jeopardize safety|0|||
150045575|NCT02541604|541305654|FG011|Overall Study|Medical condition may jeopardize safety|0|||
150045576|NCT02840461|541305660|FG000|Overall Study|Adverse Event|1|||
150045577|NCT02840461|541305661|FG001|Overall Study|Adverse Event|5|||
150045578|NCT02840461|541305662|FG002|Overall Study|Adverse Event|3|||
150045579|NCT02840461|541305660|FG000|Overall Study|Lost to Follow-up|10|||
149897857|NCT04873934|540757081|FG001|Overall Study|Missing|0|||
149897858|NCT00708461|540757082|FG000|Overall Study|Lost to Follow-up|18|||
149897859|NCT00708461|540757083|FG001|Overall Study|Lost to Follow-up|11|||
149897860|NCT00708461|540757082|FG000|Overall Study|Withdrawal by Subject|8|||
149897861|NCT00708461|540757083|FG001|Overall Study|Withdrawal by Subject|9|||
149897862|NCT00708461|540757082|FG000|Overall Study|left workforce|115|||
149897863|NCT00708461|540757083|FG001|Overall Study|left workforce|180|||
149897864|NCT03584854|540757089|FG000|Overall Study|Primary outcome not measured|1|||
149897865|NCT03584854|540757090|FG001|Overall Study|Primary outcome not measured|2|||
149897866|NCT02907177|540757091|FG000|Overall Study|Death|0|||
149897867|NCT02907177|540757092|FG001|Overall Study|Death|1|||
149897868|NCT02907177|540757091|FG000|Overall Study|Physician Decision|3|||
149897869|NCT02907177|540757092|FG001|Overall Study|Physician Decision|3|||
149897870|NCT02907177|540757091|FG000|Overall Study|Withdrawal by Subject|15|||
149897871|NCT02907177|540757092|FG001|Overall Study|Withdrawal by Subject|7|||
149897872|NCT02907177|540757091|FG000|Overall Study|Sponsor's Decision|50|||
149897873|NCT02907177|540757092|FG001|Overall Study|Sponsor's Decision|57|||
149897874|NCT02670525|540757093|FG000|Overall Study|Death|94|||
149897875|NCT02670525|540757094|FG001|Overall Study|Death|14|||
149897876|NCT02670525|540757093|FG000|Overall Study|Lost to Follow-up|4|||
149897877|NCT02670525|540757094|FG001|Overall Study|Lost to Follow-up|1|||
149897878|NCT02670525|540757093|FG000|Overall Study|Subject withdrew consent|1|||
149897879|NCT02670525|540757094|FG001|Overall Study|Subject withdrew consent|0|||
149897880|NCT02670525|540757093|FG000|Overall Study|Unknown, data entry delayed|123|||
149897881|NCT02670525|540757094|FG001|Overall Study|Unknown, data entry delayed|78|||
149897882|NCT01796392|540757095|FG000|Overall Study|Withdrawal by Subject|2|||
149897883|NCT01796392|540757096|FG001|Overall Study|Withdrawal by Subject|0|||
149897884|NCT01796392|540757095|FG000|Overall Study|Death|5|||
149897885|NCT01796392|540757096|FG001|Overall Study|Death|1|||
149897886|NCT01796392|540757095|FG000|Overall Study|Excluded for medical reasons|1|||
149897887|NCT01796392|540757096|FG001|Overall Study|Excluded for medical reasons|2|||
149897888|NCT01796392|540757095|FG000|Overall Study|Lost to Follow-up|1|||
149897889|NCT01796392|540757096|FG001|Overall Study|Lost to Follow-up|0|||
149897890|NCT02505217|540757097|FG000|Overall Study|Withdrawal by Subject|1|||
149897891|NCT02505217|540757098|FG001|Overall Study|Withdrawal by Subject|2|||
149897892|NCT04639219|540757099|FG000|Overall Study|Withdrawal by Subject|8|||
149897893|NCT04639219|540757099|FG000|Overall Study|Lost to Follow-up|6|||
149897894|NCT04639219|540757099|FG000|Overall Study|Death|55|||
149897895|NCT04681066|540757100|FG000|Overall Study|Lost to Follow-up|3|||
149897896|NCT04681066|540757101|FG001|Overall Study|Lost to Follow-up|1|||
149897897|NCT04681066|540757102|FG002|Overall Study|Lost to Follow-up|2|||
149897898|NCT04681066|540757103|FG003|Overall Study|Lost to Follow-up|1|||
149897899|NCT04681066|540757100|FG000|Overall Study|Withdrawal by Subject|2|||
149897900|NCT04681066|540757101|FG001|Overall Study|Withdrawal by Subject|1|||
149897901|NCT04681066|540757102|FG002|Overall Study|Withdrawal by Subject|0|||
149897902|NCT04681066|540757103|FG003|Overall Study|Withdrawal by Subject|3|||
149897903|NCT04681066|540757100|FG000|Overall Study|Death|0|||
149897904|NCT04681066|540757101|FG001|Overall Study|Death|1|||
149897905|NCT04681066|540757102|FG002|Overall Study|Death|0|||
149897906|NCT04681066|540757103|FG003|Overall Study|Death|0|||
149897907|NCT00153179|540757107|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
149897908|NCT00153179|540757108|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
149897909|NCT00153179|540757109|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
149897910|NCT00153179|540757110|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
149897911|NCT00564850|540757117|FG000|Overall Study|Protocol Violation|2|||
149897912|NCT02640664|540757118|FG000|Epoch 1|Withdrawal of informed consent|1|||
149897913|NCT02640664|540757119|FG001|Epoch 1|Withdrawal of informed consent|0|||
149897914|NCT02640664|540757120|FG002|Epoch 1|Withdrawal of informed consent|0|||
149897915|NCT02640664|540757118|FG000|Epoch 1|Death|0|||
149897916|NCT02640664|540757119|FG001|Epoch 1|Death|0|||
149897917|NCT02640664|540757120|FG002|Epoch 1|Death|1|||
149897918|NCT02640664|540757118|FG000|Epoch 2|Withdrawal of informed consent|3|||
149897919|NCT02640664|540757119|FG001|Epoch 2|Withdrawal of informed consent|4|||
149897920|NCT02640664|540757120|FG002|Epoch 2|Withdrawal of informed consent|2|||
149897921|NCT02640664|540757118|FG000|Epoch 2|Subject/guardian decision|0|||
149897922|NCT02640664|540757119|FG001|Epoch 2|Subject/guardian decision|2|||
149897923|NCT02640664|540757120|FG002|Epoch 2|Subject/guardian decision|2|||
149897924|NCT02640664|540757118|FG000|Epoch 2|Lost to Follow-up|3|||
149897925|NCT02640664|540757119|FG001|Epoch 2|Lost to Follow-up|4|||
149897926|NCT02640664|540757120|FG002|Epoch 2|Lost to Follow-up|1|||
149897927|NCT02640664|540757118|FG000|Epoch 2|Death|0|||
149897928|NCT02640664|540757119|FG001|Epoch 2|Death|0|||
149897929|NCT02640664|540757120|FG002|Epoch 2|Death|1|||
149897930|NCT01205269|540757121|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
149897931|NCT01205269|540757122|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
149897932|NCT01205269|540757123|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
149897933|NCT01205269|540757124|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
149897934|NCT01205269|540757125|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
149897935|NCT01205269|540757126|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
149897936|NCT01408303|540757127|FG000|Overall Study|Adverse Event|3|||
149897937|NCT01408303|540757128|FG001|Overall Study|Adverse Event|7|||
149897938|NCT01408303|540757129|FG002|Overall Study|Adverse Event|2|||
149897939|NCT01408303|540757127|FG000|Overall Study|Lost to Follow-up|0|||
149897940|NCT01408303|540757128|FG001|Overall Study|Lost to Follow-up|1|||
149897941|NCT01408303|540757129|FG002|Overall Study|Lost to Follow-up|2|||
149897942|NCT01408303|540757127|FG000|Overall Study|Withdrawal by Subject|2|||
149897943|NCT01408303|540757128|FG001|Overall Study|Withdrawal by Subject|3|||
149897944|NCT01408303|540757129|FG002|Overall Study|Withdrawal by Subject|1|||
149897945|NCT01408303|540757127|FG000|Overall Study|Protocol Violation|0|||
149897946|NCT01408303|540757128|FG001|Overall Study|Protocol Violation|1|||
149897947|NCT01408303|540757129|FG002|Overall Study|Protocol Violation|0|||
149897948|NCT01408303|540757127|FG000|Overall Study|Noncompliance|1|||
149897949|NCT01408303|540757128|FG001|Overall Study|Noncompliance|0|||
149897950|NCT01408303|540757129|FG002|Overall Study|Noncompliance|1|||
149897951|NCT00987337|540757130|FG000|Overall Study|Adverse Event|10|||
149897952|NCT00987337|540757131|FG001|Overall Study|Adverse Event|9|||
149897953|NCT00987337|540757132|FG002|Overall Study|Adverse Event|8|||
149897954|NCT00987337|540757130|FG000|Overall Study|Insufficient Virologic Response|10|||
149897955|NCT00987337|540757131|FG001|Overall Study|Insufficient Virologic Response|7|||
149897956|NCT00987337|540757132|FG002|Overall Study|Insufficient Virologic Response|12|||
149897957|NCT00987337|540757130|FG000|Overall Study|Virologic Breakthrough|2|||
149897958|NCT00987337|540757131|FG001|Overall Study|Virologic Breakthrough|2|||
149897959|NCT00987337|540757132|FG002|Overall Study|Virologic Breakthrough|8|||
149897960|NCT00987337|540757130|FG000|Overall Study|Lost to Follow-up|10|||
149897961|NCT00987337|540757131|FG001|Overall Study|Lost to Follow-up|6|||
149897962|NCT00987337|540757132|FG002|Overall Study|Lost to Follow-up|2|||
149897963|NCT00987337|540757130|FG000|Overall Study|Withdrawal by Subject|6|||
149897964|NCT00987337|540757131|FG001|Overall Study|Withdrawal by Subject|9|||
149897965|NCT00987337|540757132|FG002|Overall Study|Withdrawal by Subject|9|||
149897966|NCT00987337|540757130|FG000|Overall Study|Other|0|||
149897967|NCT00987337|540757131|FG001|Overall Study|Other|2|||
149897968|NCT00987337|540757132|FG002|Overall Study|Other|5|||
149897969|NCT00987337|540757130|FG000|Overall Study|Protocol Violation|1|||
149897970|NCT00987337|540757131|FG001|Overall Study|Protocol Violation|0|||
149897971|NCT00987337|540757132|FG002|Overall Study|Protocol Violation|2|||
149897972|NCT00987337|540757130|FG000|Overall Study|Participant Relapsed|18|||
149897973|NCT00987337|540757131|FG001|Overall Study|Participant Relapsed|20|||
149897974|NCT00987337|540757132|FG002|Overall Study|Participant Relapsed|5|||
149897975|NCT02134015|540757134|FG000|Overall Study|Protocol Violation|0|||
149897976|NCT02134015|540757135|FG001|Overall Study|Protocol Violation|1|||
149897977|NCT02134015|540757134|FG000|Overall Study|Death|2|||
149897978|NCT02134015|540757135|FG001|Overall Study|Death|1|||
149897979|NCT02134015|540757134|FG000|Overall Study|Reason not provided|1|||
149897980|NCT02134015|540757135|FG001|Overall Study|Reason not provided|2|||
149897981|NCT02134015|540757134|FG000|Overall Study|Clinical progression|14|||
149897982|NCT02134015|540757135|FG001|Overall Study|Clinical progression|7|||
149897983|NCT02134015|540757134|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
149897984|NCT02134015|540757135|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
149897985|NCT02134015|540757134|FG000|Overall Study|Study terminated by sponsor|2|||
149897986|NCT02134015|540757135|FG001|Overall Study|Study terminated by sponsor|3|||
149897987|NCT02134015|540757134|FG000|Overall Study|Adverse Event|9|||
149897988|NCT02134015|540757135|FG001|Overall Study|Adverse Event|10|||
149897989|NCT02134015|540757134|FG000|Overall Study|Withdrawal by Subject|3|||
149897990|NCT02134015|540757135|FG001|Overall Study|Withdrawal by Subject|7|||
149897991|NCT02186873|540759288|FG000|Overall Study|Adverse Event|1|||
149897992|NCT02186873|540759289|FG001|Overall Study|Adverse Event|3|||
149897993|NCT02186873|540759288|FG000|Overall Study|Lack of Efficacy|0|||
149897994|NCT02186873|540759289|FG001|Overall Study|Lack of Efficacy|1|||
149897995|NCT02186873|540759288|FG000|Overall Study|Lost to Follow-up|1|||
149897996|NCT02186873|540759289|FG001|Overall Study|Lost to Follow-up|2|||
149897997|NCT02186873|540759288|FG000|Overall Study|Withdrawal by Subject|7|||
149897998|NCT02186873|540759289|FG001|Overall Study|Withdrawal by Subject|2|||
149897999|NCT03694002|540759290|FG000|Overall Study|Progression|4|||
150176305|NCT04740164|541781974|FG000|Overall Study|Lack of Efficacy|4|||
150176306|NCT04740164|541781975|FG001|Overall Study|Lack of Efficacy|0|||
149898000|NCT03694002|540759291|FG001|Overall Study|Progression|2|||
149898001|NCT03694002|540759290|FG000|Overall Study|Adverse Event|2|||
149898002|NCT03694002|540759291|FG001|Overall Study|Adverse Event|0|||
149898003|NCT03694002|540759290|FG000|Overall Study|Other not protocol specified|1|||
149898004|NCT03694002|540759291|FG001|Overall Study|Other not protocol specified|0|||
149898005|NCT03694002|540759290|FG000|Overall Study|Ineligible|0|||
149898006|NCT03694002|540759291|FG001|Overall Study|Ineligible|1|||
149898007|NCT03694002|540759290|FG000|Overall Study|Withdrew consent before starting treatment|0|||
149898008|NCT03694002|540759291|FG001|Overall Study|Withdrew consent before starting treatment|3|||
149898009|NCT06360588|540759292|FG000|Overall Study|Adverse Event|3|||
149898010|NCT06360588|540759292|FG000|Overall Study|Death|2|||
149898011|NCT06360588|540759292|FG000|Overall Study|Disease Progression|14|||
149898012|NCT06360588|540759292|FG000|Overall Study|Withdrawal by Subject|1|||
149898013|NCT06360588|540759292|FG000|Overall Study|Lack of Efficacy|1|||
149898014|NCT06360588|540759292|FG000|Overall Study|Ineligible|1|||
149898015|NCT01481766|540759294|FG000|4 months|Lost to Follow-up|3|||
149898016|NCT01481766|540759295|FG001|4 months|Lost to Follow-up|2|||
149898017|NCT01481766|540759296|FG002|4 months|Lost to Follow-up|1|||
149898018|NCT01481766|540759297|FG003|4 months|Lost to Follow-up|5|||
149898019|NCT01481766|540759294|FG000|12 months|Lost to Follow-up|7|||
149898020|NCT01481766|540759295|FG001|12 months|Lost to Follow-up|8|||
149898021|NCT01481766|540759296|FG002|12 months|Lost to Follow-up|5|||
149898022|NCT01481766|540759297|FG003|12 months|Lost to Follow-up|3|||
149898023|NCT00347958|540759298|FG000|Overall Study|Adverse Event|1|||
149898024|NCT00347958|540759298|FG000|Overall Study|Protocol Violation|2|||
149898025|NCT00347958|540759298|FG000|Overall Study|Withdrawal by Subject|1|||
149898026|NCT00754234|540759299|FG000|Overall Study|Withdrawal by Subject|3|||
149898027|NCT03868930|540759300|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
149898028|NCT03868930|540759301|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
149898029|NCT03868930|540759300|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
149898030|NCT03868930|540759301|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
149898031|NCT03868930|540759300|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
149898032|NCT03868930|540759301|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
149898033|NCT03868930|540759300|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
149898034|NCT03868930|540759301|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
149898035|NCT03868930|540759300|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
149898036|NCT03868930|540759301|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
149898037|NCT04432831|540759302|FG000|Overall Study|Withdrawal by Subject|24|||
149898038|NCT04432831|540759303|FG001|Overall Study|Withdrawal by Subject|28|||
149898039|NCT04432831|540759304|FG002|Overall Study|Withdrawal by Subject|21|||
149898040|NCT04432831|540759302|FG000|Overall Study|Death|23|||
149898041|NCT04432831|540759303|FG001|Overall Study|Death|23|||
149898042|NCT04432831|540759304|FG002|Overall Study|Death|17|||
149898043|NCT04432831|540759302|FG000|Overall Study|Lost to Follow-up|15|||
149898044|NCT04432831|540759303|FG001|Overall Study|Lost to Follow-up|15|||
149898045|NCT04432831|540759304|FG002|Overall Study|Lost to Follow-up|12|||
149898046|NCT04432831|540759302|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
149898047|NCT04432831|540759303|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
149898048|NCT04432831|540759304|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
149898049|NCT04432831|540759302|FG000|Overall Study|Reason Not Specified|7|||
149898050|NCT04432831|540759303|FG001|Overall Study|Reason Not Specified|11|||
149898051|NCT04432831|540759304|FG002|Overall Study|Reason Not Specified|9|||
149898052|NCT04432831|540759302|FG000|Overall Study|Adverse Event|7|||
149898053|NCT04432831|540759303|FG001|Overall Study|Adverse Event|7|||
149898054|NCT04432831|540759304|FG002|Overall Study|Adverse Event|7|||
149898055|NCT04432831|540759302|FG000|Overall Study|Physician Decision|1|||
149898056|NCT04432831|540759303|FG001|Overall Study|Physician Decision|3|||
149898057|NCT04432831|540759304|FG002|Overall Study|Physician Decision|6|||
149898058|NCT04432831|540759302|FG000|Overall Study|Protocol Violation|1|||
149898059|NCT04432831|540759303|FG001|Overall Study|Protocol Violation|0|||
149898060|NCT04432831|540759304|FG002|Overall Study|Protocol Violation|2|||
149898061|NCT04432831|540759302|FG000|Overall Study|Pregnancy|0|||
149898062|NCT04432831|540759303|FG001|Overall Study|Pregnancy|1|||
149898063|NCT04432831|540759304|FG002|Overall Study|Pregnancy|0|||
149898064|NCT04432831|540759302|FG000|Overall Study|Lack of Efficacy|0|||
149898065|NCT04432831|540759303|FG001|Overall Study|Lack of Efficacy|0|||
149898066|NCT04432831|540759304|FG002|Overall Study|Lack of Efficacy|2|||
149898067|NCT02151851|540759311|FG000|Overall Study|Lack of Efficacy|67|||
149898068|NCT02151851|540759312|FG001|Overall Study|Lack of Efficacy|94|||
149898069|NCT02151851|540759311|FG000|Overall Study|Protocol Violation|0|||
149898070|NCT02151851|540759312|FG001|Overall Study|Protocol Violation|1|||
149898071|NCT02151851|540759311|FG000|Overall Study|Withdrawal by Subject|2|||
149898072|NCT02151851|540759312|FG001|Overall Study|Withdrawal by Subject|5|||
149898073|NCT02151851|540759311|FG000|Overall Study|Medical impairment|1|||
149898074|NCT02151851|540759312|FG001|Overall Study|Medical impairment|0|||
149898075|NCT02151851|540759311|FG000|Overall Study|Low compliance to study visits|0|||
149898076|NCT02151851|540759312|FG001|Overall Study|Low compliance to study visits|1|||
150045580|NCT02840461|541305661|FG001|Overall Study|Lost to Follow-up|7|||
149898077|NCT02151851|540759311|FG000|Overall Study|Subject entered into study in error|0|||
149898078|NCT02151851|540759312|FG001|Overall Study|Subject entered into study in error|1|||
149898079|NCT02151851|540759311|FG000|Overall Study|Adverse Event|6|||
149898080|NCT02151851|540759312|FG001|Overall Study|Adverse Event|28|||
149898081|NCT02159053|540759313|FG000|Overall Study|Death|2|||
149898082|NCT02159053|540759314|FG001|Overall Study|Death|0|||
149898083|NCT02159053|540759315|FG002|Overall Study|Death|1|||
149898084|NCT02159053|540759313|FG000|Overall Study|Physician Decision|0|||
149898085|NCT02159053|540759314|FG001|Overall Study|Physician Decision|1|||
149898086|NCT02159053|540759315|FG002|Overall Study|Physician Decision|1|||
149898087|NCT02159053|540759313|FG000|Overall Study|Lack of Efficacy|3|||
149898088|NCT02159053|540759314|FG001|Overall Study|Lack of Efficacy|4|||
149898089|NCT02159053|540759315|FG002|Overall Study|Lack of Efficacy|7|||
149898090|NCT02159053|540759313|FG000|Overall Study|Adverse Event|7|||
149898091|NCT02159053|540759314|FG001|Overall Study|Adverse Event|6|||
149898092|NCT02159053|540759315|FG002|Overall Study|Adverse Event|5|||
149898093|NCT02159053|540759313|FG000|Overall Study|Participants/guardian decision|8|||
149898094|NCT02159053|540759314|FG001|Overall Study|Participants/guardian decision|10|||
149898095|NCT02159053|540759315|FG002|Overall Study|Participants/guardian decision|6|||
149898096|NCT01540487|540759316|FG000|Overall Study|Protocol Violation|1|||
149898097|NCT01540487|540759317|FG001|Overall Study|Protocol Violation|0|||
149898098|NCT03483961|540759318|FG000|Overall Study|Lost to Follow-up|7|||
149898099|NCT03483961|540759319|FG001|Overall Study|Lost to Follow-up|6|||
149898100|NCT03483961|540759320|FG002|Overall Study|Lost to Follow-up|6|||
149898101|NCT03483961|540759321|FG003|Overall Study|Lost to Follow-up|6|||
149898102|NCT03483961|540759322|FG004|Overall Study|Lost to Follow-up|6|||
149898103|NCT03483961|540759323|FG005|Overall Study|Lost to Follow-up|4|||
149898104|NCT03483961|540759324|FG006|Overall Study|Lost to Follow-up|4|||
149898105|NCT03483961|540759325|FG007|Overall Study|Lost to Follow-up|11|||
149898106|NCT03483961|540759326|FG008|Overall Study|Lost to Follow-up|1|||
149898107|NCT03483961|540759327|FG009|Overall Study|Lost to Follow-up|0|||
149898108|NCT03483961|540759318|FG000|Overall Study|Withdrawal by Subject|3|||
149898109|NCT03483961|540759319|FG001|Overall Study|Withdrawal by Subject|4|||
149898110|NCT03483961|540759320|FG002|Overall Study|Withdrawal by Subject|5|||
149898111|NCT03483961|540759321|FG003|Overall Study|Withdrawal by Subject|3|||
149898112|NCT03483961|540759322|FG004|Overall Study|Withdrawal by Subject|4|||
149898113|NCT03483961|540759323|FG005|Overall Study|Withdrawal by Subject|2|||
149898114|NCT03483961|540759324|FG006|Overall Study|Withdrawal by Subject|1|||
149898115|NCT03483961|540759325|FG007|Overall Study|Withdrawal by Subject|2|||
149898116|NCT03483961|540759326|FG008|Overall Study|Withdrawal by Subject|1|||
149898117|NCT03483961|540759327|FG009|Overall Study|Withdrawal by Subject|0|||
149898118|NCT03483961|540759318|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
149898119|NCT03483961|540759319|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898120|NCT03483961|540759320|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898121|NCT03483961|540759321|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898122|NCT03483961|540759322|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898123|NCT03483961|540759323|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898124|NCT03483961|540759324|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898125|NCT03483961|540759325|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898126|NCT03483961|540759326|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898127|NCT03483961|540759327|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
149898128|NCT03483961|540759318|FG000|Overall Study|Adverse Event|0|||
149898129|NCT03483961|540759319|FG001|Overall Study|Adverse Event|0|||
149898130|NCT03483961|540759320|FG002|Overall Study|Adverse Event|1|||
149898131|NCT03483961|540759321|FG003|Overall Study|Adverse Event|0|||
149898132|NCT03483961|540759322|FG004|Overall Study|Adverse Event|0|||
149898133|NCT03483961|540759323|FG005|Overall Study|Adverse Event|0|||
149898134|NCT03483961|540759324|FG006|Overall Study|Adverse Event|0|||
149898135|NCT03483961|540759325|FG007|Overall Study|Adverse Event|0|||
149898136|NCT03483961|540759326|FG008|Overall Study|Adverse Event|0|||
149898137|NCT03483961|540759327|FG009|Overall Study|Adverse Event|0|||
149898138|NCT02640950|540759328|FG000|Overall Study|Adverse Event|1|||
149898139|NCT02640950|540759328|FG000|Overall Study|Withdrawal by Subject|1|||
149898140|NCT00652626|540759329|FG000|Initial Treatment Phase|Adverse Event|0|||
149898141|NCT00652626|540759330|FG001|Initial Treatment Phase|Adverse Event|0|||
149898142|NCT00652626|540759331|FG002|Initial Treatment Phase|Adverse Event|0|||
149898143|NCT00652626|540759332|FG003|Initial Treatment Phase|Adverse Event|0|||
149898144|NCT00652626|540759333|FG004|Initial Treatment Phase|Adverse Event|1|||
149898145|NCT00652626|540759334|FG005|Initial Treatment Phase|Adverse Event|0|||
149898146|NCT00652626|540759335|FG006|Initial Treatment Phase|Adverse Event|0|||
149898147|NCT00652626|540759329|FG000|Initial Treatment Phase|Protocol Violation|0|||
150176307|NCT04740164|541781974|FG000|Overall Study|Physician Decision|3|||
150176308|NCT04740164|541781975|FG001|Overall Study|Physician Decision|3|||
150176309|NCT05323734|541781979|FG000|Overall Study|Adverse Event|5|||
149898148|NCT00652626|540759330|FG001|Initial Treatment Phase|Protocol Violation|0|||
149898149|NCT00652626|540759331|FG002|Initial Treatment Phase|Protocol Violation|0|||
149898150|NCT00652626|540759332|FG003|Initial Treatment Phase|Protocol Violation|1|||
149898151|NCT00652626|540759333|FG004|Initial Treatment Phase|Protocol Violation|0|||
149898152|NCT00652626|540759334|FG005|Initial Treatment Phase|Protocol Violation|0|||
149898153|NCT00652626|540759335|FG006|Initial Treatment Phase|Protocol Violation|0|||
149898154|NCT00652626|540759329|FG000|Initial Treatment Phase|Physician Decision|0|||
149898155|NCT00652626|540759330|FG001|Initial Treatment Phase|Physician Decision|0|||
149898156|NCT00652626|540759331|FG002|Initial Treatment Phase|Physician Decision|0|||
149898157|NCT00652626|540759332|FG003|Initial Treatment Phase|Physician Decision|0|||
149898158|NCT00652626|540759333|FG004|Initial Treatment Phase|Physician Decision|1|||
149898159|NCT00652626|540759334|FG005|Initial Treatment Phase|Physician Decision|0|||
149898160|NCT00652626|540759335|FG006|Initial Treatment Phase|Physician Decision|0|||
149898161|NCT00652626|540759329|FG000|Initial Treatment Phase|Sponsor Request|0|||
149898162|NCT00652626|540759330|FG001|Initial Treatment Phase|Sponsor Request|0|||
149898163|NCT00652626|540759331|FG002|Initial Treatment Phase|Sponsor Request|1|||
149898164|NCT00652626|540759332|FG003|Initial Treatment Phase|Sponsor Request|0|||
149898165|NCT00652626|540759333|FG004|Initial Treatment Phase|Sponsor Request|0|||
149898166|NCT00652626|540759334|FG005|Initial Treatment Phase|Sponsor Request|0|||
149898167|NCT00652626|540759335|FG006|Initial Treatment Phase|Sponsor Request|0|||
149898168|NCT00652626|540759329|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
149898169|NCT00652626|540759330|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
149898170|NCT00652626|540759331|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
149898171|NCT00652626|540759332|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
149898172|NCT00652626|540759333|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
149898173|NCT00652626|540759334|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
149898174|NCT00652626|540759335|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
149898175|NCT00652626|540759329|FG000|Extension Phase|Withdrawal by Subject|0|||
149898176|NCT00652626|540759330|FG001|Extension Phase|Withdrawal by Subject|0|||
149898177|NCT00652626|540759331|FG002|Extension Phase|Withdrawal by Subject|0|||
149898178|NCT00652626|540759332|FG003|Extension Phase|Withdrawal by Subject|0|||
149898179|NCT00652626|540759333|FG004|Extension Phase|Withdrawal by Subject|0|||
149898180|NCT00652626|540759334|FG005|Extension Phase|Withdrawal by Subject|2|||
149898181|NCT00652626|540759335|FG006|Extension Phase|Withdrawal by Subject|0|||
149898182|NCT00652626|540759329|FG000|Extension Phase|Adverse Event|0|||
149898183|NCT00652626|540759330|FG001|Extension Phase|Adverse Event|0|||
149898184|NCT00652626|540759331|FG002|Extension Phase|Adverse Event|0|||
149898185|NCT00652626|540759332|FG003|Extension Phase|Adverse Event|0|||
149898186|NCT00652626|540759333|FG004|Extension Phase|Adverse Event|0|||
149898187|NCT00652626|540759334|FG005|Extension Phase|Adverse Event|2|||
149898188|NCT00652626|540759335|FG006|Extension Phase|Adverse Event|1|||
149898189|NCT00652626|540759329|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
150176310|NCT05323734|541781980|FG001|Overall Study|Adverse Event|2|||
150176311|NCT05323734|541781979|FG000|Overall Study|Physician Decision|1|||
150176312|NCT05323734|541781980|FG001|Overall Study|Physician Decision|0|||
150176313|NCT05323734|541781979|FG000|Overall Study|Lack of Efficacy|1|||
150176314|NCT05323734|541781980|FG001|Overall Study|Lack of Efficacy|2|||
150176315|NCT05323734|541781979|FG000|Overall Study|Withdrawal by Subject|2|||
150176316|NCT05323734|541781980|FG001|Overall Study|Withdrawal by Subject|0|||
150176317|NCT05323734|541781979|FG000|Overall Study|Participant Withdrawn Due|0|||
150176318|NCT05323734|541781980|FG001|Overall Study|Participant Withdrawn Due|1|||
150176319|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
149898190|NCT00652626|540759330|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
150176320|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
150176321|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
150176322|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898191|NCT00652626|540759331|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
149898192|NCT00652626|540759332|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
149898193|NCT00652626|540759333|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
150176323|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898194|NCT00652626|540759334|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
149898195|NCT00652626|540759335|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
149898196|NCT00652626|540759329|FG000|Extension Phase|Physician Decision|0|||
149898197|NCT00652626|540759330|FG001|Extension Phase|Physician Decision|0|||
149898198|NCT00652626|540759331|FG002|Extension Phase|Physician Decision|0|||
150176324|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898199|NCT00652626|540759332|FG003|Extension Phase|Physician Decision|0|||
149898200|NCT00652626|540759333|FG004|Extension Phase|Physician Decision|0|||
149898201|NCT00652626|540759334|FG005|Extension Phase|Physician Decision|1|||
149898202|NCT00652626|540759335|FG006|Extension Phase|Physician Decision|1|||
149898203|NCT00652626|540759329|FG000|Extension Phase|Death|0|||
149898204|NCT00652626|540759330|FG001|Extension Phase|Death|0|||
149898205|NCT00652626|540759331|FG002|Extension Phase|Death|0|||
149898206|NCT00652626|540759332|FG003|Extension Phase|Death|0|||
149898207|NCT00652626|540759333|FG004|Extension Phase|Death|0|||
149898208|NCT00652626|540759334|FG005|Extension Phase|Death|1|||
149898209|NCT00652626|540759335|FG006|Extension Phase|Death|1|||
149898210|NCT04003636|540759336|FG000|Overall Study|Death|409|||
149898211|NCT04003636|540759337|FG001|Overall Study|Death|443|||
149898212|NCT04003636|540759336|FG000|Overall Study|Lost to Follow-up|0|||
149898213|NCT04003636|540759337|FG001|Overall Study|Lost to Follow-up|1|||
149898214|NCT04003636|540759336|FG000|Overall Study|Withdrawal by Subject|5|||
149898215|NCT04003636|540759337|FG001|Overall Study|Withdrawal by Subject|2|||
149898216|NCT04003636|540759336|FG000|Overall Study|Participant On-going|119|||
149898217|NCT04003636|540759337|FG001|Overall Study|Participant On-going|90|||
149898218|NCT01623310|540759340|FG000|Overall Study|Adverse Event|21|||
149898219|NCT01623310|540759340|FG000|Overall Study|Lost to Follow-up|18|||
149898220|NCT01623310|540759340|FG000|Overall Study|Lack of Efficacy|6|||
149898221|NCT01623310|540759340|FG000|Overall Study|Protocol Violation|6|||
149898222|NCT01623310|540759340|FG000|Overall Study|Withdrawal by Subject|25|||
149898223|NCT01623310|540759340|FG000|Overall Study|Became potentially child-bearing|1|||
149898224|NCT01623310|540759340|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
149898225|NCT01623310|540759340|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
149898226|NCT00356603|540759341|FG000|Overall Study|Other|6|||
149898227|NCT00356603|540759342|FG001|Overall Study|Other|3|||
149898228|NCT00734162|540759344|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
149898229|NCT00734162|540759345|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
149898230|NCT00734162|540759346|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
149898231|NCT00734162|540759347|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
149898232|NCT00734162|540759344|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
149898233|NCT00734162|540759345|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
149898234|NCT00734162|540759346|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
149898235|NCT00734162|540759347|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
149898236|NCT00734162|540759344|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
149898237|NCT00734162|540759345|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
149898238|NCT00734162|540759346|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
149898239|NCT00734162|540759347|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
149898240|NCT00734162|540759344|FG000|Open-Label Phase|Withdrew Consent|1|||
149898241|NCT00734162|540759345|FG001|Open-Label Phase|Withdrew Consent|0|||
149898242|NCT00734162|540759346|FG002|Open-Label Phase|Withdrew Consent|1|||
149898243|NCT00734162|540759347|FG003|Open-Label Phase|Withdrew Consent|1|||
149898244|NCT00734162|540759344|FG000|Open-Label Phase|Lost to Follow-up|1|||
149898245|NCT00734162|540759345|FG001|Open-Label Phase|Lost to Follow-up|2|||
149898246|NCT00734162|540759346|FG002|Open-Label Phase|Lost to Follow-up|0|||
149898247|NCT00734162|540759347|FG003|Open-Label Phase|Lost to Follow-up|1|||
149898248|NCT00734162|540759344|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
149898249|NCT00734162|540759345|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
149898250|NCT00734162|540759346|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
149898251|NCT00734162|540759347|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
149898252|NCT00566020|540759348|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
149898253|NCT00566020|540759349|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
149898254|NCT00566020|540759348|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
149898255|NCT00566020|540759349|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
149898256|NCT00566020|540759348|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
149898257|NCT00566020|540759349|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
149898258|NCT00566020|540759348|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
149898259|NCT00566020|540759349|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
149898260|NCT00566020|540759348|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
149898261|NCT00566020|540759349|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
149898262|NCT00566020|540759348|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
149898263|NCT00566020|540759349|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
149898264|NCT01964222|540759350|FG000|Overall Study|Lost to Follow-up|7|||
149898265|NCT01964222|540759351|FG001|Overall Study|Lost to Follow-up|5|||
149898266|NCT01964222|540759350|FG000|Overall Study|Withdrawal by Subject|6|||
149898267|NCT01964222|540759351|FG001|Overall Study|Withdrawal by Subject|6|||
149898268|NCT01964222|540759350|FG000|Overall Study|Screening Failure|2|||
149898269|NCT01964222|540759351|FG001|Overall Study|Screening Failure|0|||
149898270|NCT01019694|540759356|FG000|Overall Study|Adverse Event|12|||
149898271|NCT01019694|540759357|FG001|Overall Study|Adverse Event|16|||
149898272|NCT01019694|540759358|FG002|Overall Study|Adverse Event|19|||
149898273|NCT01019694|540759356|FG000|Overall Study|Protocol Violation|2|||
149898274|NCT01019694|540759357|FG001|Overall Study|Protocol Violation|6|||
149898275|NCT01019694|540759358|FG002|Overall Study|Protocol Violation|4|||
149898276|NCT01019694|540759356|FG000|Overall Study|Lost to Follow-up|5|||
149898277|NCT01019694|540759357|FG001|Overall Study|Lost to Follow-up|3|||
149898278|NCT01019694|540759358|FG002|Overall Study|Lost to Follow-up|3|||
149898279|NCT01019694|540759356|FG000|Overall Study|Withdrawal by Subject|4|||
149898280|NCT01019694|540759357|FG001|Overall Study|Withdrawal by Subject|6|||
149898281|NCT01019694|540759358|FG002|Overall Study|Withdrawal by Subject|12|||
149898282|NCT01019694|540759356|FG000|Overall Study|Not treated|0|||
149898283|NCT01019694|540759357|FG001|Overall Study|Not treated|2|||
149898284|NCT01019694|540759358|FG002|Overall Study|Not treated|3|||
149898285|NCT01019694|540759356|FG000|Overall Study|Other reason (not specified)|1|||
149898286|NCT01019694|540759357|FG001|Overall Study|Other reason (not specified)|5|||
149898287|NCT01019694|540759358|FG002|Overall Study|Other reason (not specified)|6|||
149898288|NCT00026494|540759363|FG000|Overall Study|Withdrawal by Subject|1|||
149898289|NCT00026494|540759364|FG001|Overall Study|Withdrawal by Subject|0|||
149898290|NCT00026494|540759365|FG002|Overall Study|Withdrawal by Subject|1|||
149898291|NCT00026494|540759366|FG003|Overall Study|Withdrawal by Subject|0|||
149898292|NCT00026494|540759363|FG000|Overall Study|Patient non-compliance|1|||
149898293|NCT00026494|540759364|FG001|Overall Study|Patient non-compliance|0|||
149898294|NCT00026494|540759365|FG002|Overall Study|Patient non-compliance|0|||
149898295|NCT00026494|540759366|FG003|Overall Study|Patient non-compliance|0|||
149898296|NCT00026494|540759363|FG000|Overall Study|Patient not treated|0|||
149898297|NCT00026494|540759364|FG001|Overall Study|Patient not treated|0|||
149898298|NCT00026494|540759365|FG002|Overall Study|Patient not treated|2|||
149898299|NCT00026494|540759366|FG003|Overall Study|Patient not treated|0|||
149898300|NCT00026494|540759363|FG000|Overall Study|Clinical progression|0|||
149898301|NCT00026494|540759364|FG001|Overall Study|Clinical progression|0|||
149898302|NCT00026494|540759365|FG002|Overall Study|Clinical progression|3|||
149898303|NCT00026494|540759366|FG003|Overall Study|Clinical progression|0|||
149898304|NCT00441129|540759367|FG000|Overall Study|Withdrawal by Subject|6|||
149898305|NCT00441129|540759368|FG001|Overall Study|Withdrawal by Subject|14|||
149898306|NCT01455597|540759369|FG000|Overall Study|Adverse Event|7|||
149898307|NCT01455597|540759370|FG001|Overall Study|Adverse Event|0|||
149898308|NCT01455597|540759371|FG002|Overall Study|Adverse Event|5|||
149898309|NCT01455597|540759372|FG003|Overall Study|Adverse Event|1|||
149898310|NCT01455597|540759369|FG000|Overall Study|Lack of Efficacy|0|||
149898311|NCT01455597|540759370|FG001|Overall Study|Lack of Efficacy|1|||
149898312|NCT01455597|540759371|FG002|Overall Study|Lack of Efficacy|2|||
149898313|NCT01455597|540759372|FG003|Overall Study|Lack of Efficacy|0|||
149898314|NCT01455597|540759369|FG000|Overall Study|Lost to Follow-up|3|||
149898315|NCT01455597|540759370|FG001|Overall Study|Lost to Follow-up|0|||
149898316|NCT01455597|540759371|FG002|Overall Study|Lost to Follow-up|2|||
149898317|NCT01455597|540759372|FG003|Overall Study|Lost to Follow-up|1|||
149898318|NCT01455597|540759369|FG000|Overall Study|Withdrew Consent|6|||
149898319|NCT01455597|540759370|FG001|Overall Study|Withdrew Consent|5|||
149898320|NCT01455597|540759371|FG002|Overall Study|Withdrew Consent|8|||
149898321|NCT01455597|540759372|FG003|Overall Study|Withdrew Consent|5|||
149898322|NCT01455597|540759369|FG000|Overall Study|Reason not Specified|1|||
149898323|NCT01455597|540759370|FG001|Overall Study|Reason not Specified|2|||
149898324|NCT01455597|540759371|FG002|Overall Study|Reason not Specified|3|||
149898325|NCT01455597|540759372|FG003|Overall Study|Reason not Specified|3|||
149898326|NCT01737710|540759373|FG000|Overall Study|Lost to Follow-up|0|||
149898327|NCT01737710|540759374|FG001|Overall Study|Lost to Follow-up|2|||
150176325|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898328|NCT01737710|540759375|FG002|Overall Study|Lost to Follow-up|2|||
149898329|NCT01737710|540759376|FG003|Overall Study|Lost to Follow-up|0|||
150176326|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898330|NCT01737710|540759377|FG004|Overall Study|Lost to Follow-up|0|||
149898331|NCT01737710|540759373|FG000|Overall Study|Withdrawal by Subject|1|||
149898332|NCT01737710|540759374|FG001|Overall Study|Withdrawal by Subject|1|||
149898333|NCT01737710|540759375|FG002|Overall Study|Withdrawal by Subject|1|||
149898334|NCT01737710|540759376|FG003|Overall Study|Withdrawal by Subject|0|||
149898335|NCT01737710|540759377|FG004|Overall Study|Withdrawal by Subject|0|||
149898336|NCT01737710|540759373|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
149898337|NCT01737710|540759374|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
149898338|NCT01737710|540759375|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
149898339|NCT01737710|540759376|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
149898340|NCT01737710|540759377|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
149898341|NCT00656292|540759378|FG000|Overall Study|Withdrawal by Subject|2|||
149898342|NCT00656292|540759379|FG001|Overall Study|Withdrawal by Subject|3|||
149898343|NCT00656292|540759378|FG000|Overall Study|Screen failure|1|||
149898344|NCT00656292|540759379|FG001|Overall Study|Screen failure|2|||
149898345|NCT03674112|540759380|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
149898346|NCT03674112|540759381|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
149898347|NCT03674112|540759380|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
149898348|NCT03674112|540759381|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
149898349|NCT03674112|540759380|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
149898350|NCT03674112|540759381|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
149898351|NCT03674112|540759380|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
149898352|NCT03674112|540759381|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
149898353|NCT03674112|540759380|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
149898354|NCT03674112|540759381|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
149898355|NCT03674112|540759380|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
149898356|NCT03674112|540759381|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
149898357|NCT03674112|540759380|FG000|Follow-Up Period (≥3 Years)|Death|2|||
149898358|NCT03674112|540759381|FG001|Follow-Up Period (≥3 Years)|Death|0|||
149898359|NCT03674112|540759380|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
149898360|NCT03674112|540759381|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
149898361|NCT00812981|540759387|FG000|Overall Study|Other|0|||
149898362|NCT00812981|540759388|FG001|Overall Study|Other|1|||
149898363|NCT04666259|540759393|FG000|Treatment Phase|Physician Decision|9|||
149898364|NCT04666259|540759394|FG001|Treatment Phase|Physician Decision|3|||
149898365|NCT04666259|540759395|FG002|Treatment Phase|Physician Decision|3|||
149898366|NCT04666259|540759393|FG000|Treatment Phase|Adverse Event|3|||
149898367|NCT04666259|540759394|FG001|Treatment Phase|Adverse Event|1|||
149898368|NCT04666259|540759395|FG002|Treatment Phase|Adverse Event|0|||
149898369|NCT04666259|540759393|FG000|Treatment Phase|Subject decision|1|||
149898370|NCT04666259|540759394|FG001|Treatment Phase|Subject decision|2|||
149898371|NCT04666259|540759395|FG002|Treatment Phase|Subject decision|0|||
149898372|NCT04666259|540759393|FG000|Treatment Phase|Progressive disease|0|||
149898373|NCT04666259|540759394|FG001|Treatment Phase|Progressive disease|1|||
149898374|NCT04666259|540759395|FG002|Treatment Phase|Progressive disease|0|||
149898375|NCT04666259|540759393|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
149898376|NCT04666259|540759394|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
149898377|NCT04666259|540759395|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
149898378|NCT04666259|540759393|FG000|Safety Follow-up Phase|Physician Decision|2|||
149898379|NCT04666259|540759394|FG001|Safety Follow-up Phase|Physician Decision|0|||
149898380|NCT04666259|540759395|FG002|Safety Follow-up Phase|Physician Decision|0|||
149898381|NCT04666259|540759393|FG000|Safety Follow-up Phase|Subject decision|1|||
149898382|NCT04666259|540759394|FG001|Safety Follow-up Phase|Subject decision|0|||
149898383|NCT04666259|540759395|FG002|Safety Follow-up Phase|Subject decision|0|||
149898384|NCT04666259|540759393|FG000|Safety Follow-up Phase|Death|0|||
149898385|NCT04666259|540759394|FG001|Safety Follow-up Phase|Death|1|||
149898386|NCT04666259|540759395|FG002|Safety Follow-up Phase|Death|0|||
149898387|NCT04178122|540759396|FG000|Overall Study|Withdrawal by Subject|1|||
149898388|NCT04178122|540759397|FG001|Overall Study|Withdrawal by Subject|1|||
149898389|NCT04178122|540759396|FG000|Overall Study|Death|2|||
149898390|NCT04178122|540759397|FG001|Overall Study|Death|0|||
149898391|NCT04178122|540759396|FG000|Overall Study|Did not complete testing|3|||
149898392|NCT04178122|540759397|FG001|Overall Study|Did not complete testing|13|||
149898393|NCT02677922|540759398|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
149898394|NCT02677922|540759399|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
149898395|NCT02677922|540759400|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
149898396|NCT02677922|540759401|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
149898397|NCT02677922|540759402|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
149898398|NCT02677922|540759403|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
149898399|NCT02677922|540759398|FG000|Treatment Period|Adverse Event|0|||
149898400|NCT02677922|540759399|FG001|Treatment Period|Adverse Event|0|||
149898401|NCT02677922|540759400|FG002|Treatment Period|Adverse Event|1|||
149898402|NCT02677922|540759401|FG003|Treatment Period|Adverse Event|3|||
149898403|NCT02677922|540759402|FG004|Treatment Period|Adverse Event|5|||
149898404|NCT02677922|540759403|FG005|Treatment Period|Adverse Event|2|||
149898405|NCT02677922|540759398|FG000|Treatment Period|Progressive Disease|1|||
149898406|NCT02677922|540759399|FG001|Treatment Period|Progressive Disease|1|||
149898407|NCT02677922|540759400|FG002|Treatment Period|Progressive Disease|0|||
149898408|NCT02677922|540759401|FG003|Treatment Period|Progressive Disease|0|||
149898409|NCT02677922|540759402|FG004|Treatment Period|Progressive Disease|8|||
149898410|NCT02677922|540759403|FG005|Treatment Period|Progressive Disease|7|||
149898411|NCT02677922|540759398|FG000|Treatment Period|Lack of Efficacy|0|||
149898412|NCT02677922|540759399|FG001|Treatment Period|Lack of Efficacy|0|||
149898413|NCT02677922|540759400|FG002|Treatment Period|Lack of Efficacy|0|||
149898414|NCT02677922|540759401|FG003|Treatment Period|Lack of Efficacy|1|||
149898415|NCT02677922|540759402|FG004|Treatment Period|Lack of Efficacy|1|||
149898416|NCT02677922|540759403|FG005|Treatment Period|Lack of Efficacy|6|||
149898417|NCT02677922|540759398|FG000|Treatment Period|Withdrawal by Subject|0|||
149898418|NCT02677922|540759399|FG001|Treatment Period|Withdrawal by Subject|0|||
149898419|NCT02677922|540759400|FG002|Treatment Period|Withdrawal by Subject|1|||
149898420|NCT02677922|540759401|FG003|Treatment Period|Withdrawal by Subject|3|||
149898421|NCT02677922|540759402|FG004|Treatment Period|Withdrawal by Subject|5|||
149898422|NCT02677922|540759403|FG005|Treatment Period|Withdrawal by Subject|5|||
149898423|NCT02677922|540759398|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
149898424|NCT02677922|540759399|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
149898425|NCT02677922|540759400|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
149898426|NCT02677922|540759401|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
149898427|NCT02677922|540759402|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
149898428|NCT02677922|540759403|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
149898429|NCT02677922|540759398|FG000|Treatment Period|Disease Relapse|0|||
149898430|NCT02677922|540759399|FG001|Treatment Period|Disease Relapse|0|||
149898431|NCT02677922|540759400|FG002|Treatment Period|Disease Relapse|0|||
149898432|NCT02677922|540759401|FG003|Treatment Period|Disease Relapse|3|||
149898433|NCT02677922|540759402|FG004|Treatment Period|Disease Relapse|6|||
149898434|NCT02677922|540759403|FG005|Treatment Period|Disease Relapse|1|||
149898435|NCT02677922|540759398|FG000|Treatment Period|Allogeneic HSCT|1|||
149898436|NCT02677922|540759399|FG001|Treatment Period|Allogeneic HSCT|0|||
149898437|NCT02677922|540759400|FG002|Treatment Period|Allogeneic HSCT|0|||
149898438|NCT02677922|540759401|FG003|Treatment Period|Allogeneic HSCT|1|||
149898439|NCT02677922|540759402|FG004|Treatment Period|Allogeneic HSCT|4|||
149898440|NCT02677922|540759403|FG005|Treatment Period|Allogeneic HSCT|1|||
149898441|NCT02677922|540759398|FG000|Treatment Period|Other Reasons|0|||
149898442|NCT02677922|540759399|FG001|Treatment Period|Other Reasons|0|||
149898443|NCT02677922|540759400|FG002|Treatment Period|Other Reasons|0|||
149898444|NCT02677922|540759401|FG003|Treatment Period|Other Reasons|1|||
149898445|NCT02677922|540759402|FG004|Treatment Period|Other Reasons|3|||
149898446|NCT02677922|540759403|FG005|Treatment Period|Other Reasons|5|||
149898447|NCT02677922|540759398|FG000|Treatment Period|Death|0|||
149898448|NCT02677922|540759399|FG001|Treatment Period|Death|0|||
149898449|NCT02677922|540759400|FG002|Treatment Period|Death|0|||
149898450|NCT02677922|540759401|FG003|Treatment Period|Death|0|||
149898451|NCT02677922|540759402|FG004|Treatment Period|Death|12|||
149898452|NCT02677922|540759403|FG005|Treatment Period|Death|1|||
150045581|NCT02840461|541305662|FG002|Overall Study|Lost to Follow-up|6|||
150045582|NCT02840461|541305660|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
150045583|NCT02840461|541305661|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
150045584|NCT02840461|541305662|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
149898453|NCT02677922|540759398|FG000|Treatment Period|Non-compliance with Study Drug|0|||
149898454|NCT02677922|540759399|FG001|Treatment Period|Non-compliance with Study Drug|0|||
149898455|NCT02677922|540759400|FG002|Treatment Period|Non-compliance with Study Drug|0|||
149898456|NCT02677922|540759401|FG003|Treatment Period|Non-compliance with Study Drug|0|||
149898457|NCT02677922|540759402|FG004|Treatment Period|Non-compliance with Study Drug|1|||
149898458|NCT02677922|540759403|FG005|Treatment Period|Non-compliance with Study Drug|0|||
149898459|NCT02677922|540759398|FG000|Treatment Period|Physician Decision|0|||
149898460|NCT02677922|540759399|FG001|Treatment Period|Physician Decision|0|||
149898461|NCT02677922|540759400|FG002|Treatment Period|Physician Decision|0|||
149898462|NCT02677922|540759401|FG003|Treatment Period|Physician Decision|0|||
149898463|NCT02677922|540759402|FG004|Treatment Period|Physician Decision|0|||
149898464|NCT02677922|540759403|FG005|Treatment Period|Physician Decision|1|||
149898465|NCT02677922|540759398|FG000|Treatment Period|Symptomatic Deterioration|0|||
149898466|NCT02677922|540759399|FG001|Treatment Period|Symptomatic Deterioration|0|||
149898467|NCT02677922|540759400|FG002|Treatment Period|Symptomatic Deterioration|0|||
149898468|NCT02677922|540759401|FG003|Treatment Period|Symptomatic Deterioration|0|||
149898469|NCT02677922|540759402|FG004|Treatment Period|Symptomatic Deterioration|1|||
149898470|NCT02677922|540759403|FG005|Treatment Period|Symptomatic Deterioration|0|||
150045585|NCT02840461|541305660|FG000|Overall Study|Protocol Violation|2|||
149898471|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
149898472|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
149898473|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
149898474|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
149898475|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
149898476|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
149898477|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
149898478|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
149898479|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
149898480|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
149898481|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
149898482|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
149898483|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
149898484|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
149898485|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898486|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898487|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898488|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898489|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
149898490|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
149898491|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898492|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898493|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898494|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898495|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
149898496|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
149898497|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
149898498|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
149898499|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
149898500|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
149898501|NCT02105987|540759405|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
149898502|NCT02105987|540759406|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
149898503|NCT02105987|540759407|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
149898504|NCT02105987|540759408|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
149898505|NCT02105987|540759409|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
149898506|NCT02105987|540759410|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
149898507|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
149898508|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
149898509|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
149898510|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
149898511|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
149898512|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
149898513|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
149898514|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
149898515|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
149898516|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
149898517|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
149898518|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
149898519|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898520|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
150045586|NCT02840461|541305661|FG001|Overall Study|Protocol Violation|3|||
150045587|NCT02840461|541305662|FG002|Overall Study|Protocol Violation|1|||
150045588|NCT02840461|541305660|FG000|Overall Study|Withdrawal by Subject|10|||
150045589|NCT02840461|541305661|FG001|Overall Study|Withdrawal by Subject|6|||
150045590|NCT02840461|541305662|FG002|Overall Study|Withdrawal by Subject|2|||
150045591|NCT02840461|541305660|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
150045592|NCT02840461|541305661|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
150045593|NCT02840461|541305662|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
150045594|NCT01287741|541305663|FG000|Overall Study|Withdrawal by Subject|35|||
150045595|NCT01287741|541305664|FG001|Overall Study|Withdrawal by Subject|38|||
150045596|NCT01287741|541305663|FG000|Overall Study|Protocol Violation|2|||
150045597|NCT01287741|541305664|FG001|Overall Study|Protocol Violation|0|||
150045598|NCT01287741|541305663|FG000|Overall Study|Physician Decision|15|||
150045599|NCT01287741|541305664|FG001|Overall Study|Physician Decision|23|||
150045600|NCT01287741|541305663|FG000|Overall Study|Non-compliance|8|||
150045601|NCT01287741|541305664|FG001|Overall Study|Non-compliance|6|||
150045602|NCT01287741|541305663|FG000|Overall Study|Lost to Follow-up|10|||
150045603|NCT01287741|541305664|FG001|Overall Study|Lost to Follow-up|8|||
150045604|NCT01287741|541305663|FG000|Overall Study|Death|32|||
150045605|NCT01287741|541305664|FG001|Overall Study|Death|44|||
150045606|NCT01287741|541305663|FG000|Overall Study|Adverse Event|4|||
150045607|NCT01287741|541305664|FG001|Overall Study|Adverse Event|6|||
150045608|NCT01287741|541305663|FG000|Overall Study|Study terminated by Sponsor|307|||
150045609|NCT01287741|541305664|FG001|Overall Study|Study terminated by Sponsor|315|||
149898521|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
150045610|NCT01287741|541305663|FG000|Overall Study|Progressive disease|190|||
150045611|NCT01287741|541305664|FG001|Overall Study|Progressive disease|166|||
150045612|NCT01287741|541305663|FG000|Overall Study|Reason not specified|23|||
150045613|NCT01287741|541305664|FG001|Overall Study|Reason not specified|9|||
150045614|NCT04434937|541305667|FG000|Overall Study|Death|4|||
149898522|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
149898523|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898524|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
149898525|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898526|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898527|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
149898528|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
149898529|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898530|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
149898531|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
149898532|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
149898533|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
149898534|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
149898535|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
149898536|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
149898537|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
149898538|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
149898539|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
149898540|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
149898541|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
149898542|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
149898543|NCT02105987|540759405|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
149898544|NCT02105987|540759406|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
149898545|NCT02105987|540759407|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
149898546|NCT02105987|540759408|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
149898547|NCT02105987|540759409|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
149898548|NCT02105987|540759410|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
149898549|NCT02105987|540759405|FG000|Continuation Phase|Protocol Violation|0|||
149898550|NCT02105987|540759406|FG001|Continuation Phase|Protocol Violation|0|||
149898551|NCT02105987|540759407|FG002|Continuation Phase|Protocol Violation|0|||
149898552|NCT02105987|540759408|FG003|Continuation Phase|Protocol Violation|0|||
149898553|NCT02105987|540759409|FG004|Continuation Phase|Protocol Violation|1|||
149898554|NCT02105987|540759410|FG005|Continuation Phase|Protocol Violation|0|||
149898555|NCT03926117|540759417|FG000|Overall Study|Unclassified|1|||
149898556|NCT03926117|540759418|FG001|Overall Study|Unclassified|4|||
149898557|NCT03926117|540759419|FG002|Overall Study|Unclassified|1|||
149898558|NCT03926117|540759420|FG003|Overall Study|Unclassified|4|||
149898559|NCT03926117|540759417|FG000|Overall Study|Withdrawal by Subject|3|||
149898560|NCT03926117|540759418|FG001|Overall Study|Withdrawal by Subject|0|||
149898561|NCT03926117|540759419|FG002|Overall Study|Withdrawal by Subject|1|||
149898562|NCT03926117|540759420|FG003|Overall Study|Withdrawal by Subject|1|||
149898563|NCT03926117|540759417|FG000|Overall Study|Lost to Follow-up|0|||
149898564|NCT03926117|540759418|FG001|Overall Study|Lost to Follow-up|2|||
149898565|NCT03926117|540759419|FG002|Overall Study|Lost to Follow-up|1|||
149898566|NCT03926117|540759420|FG003|Overall Study|Lost to Follow-up|0|||
149898567|NCT03926117|540759417|FG000|Overall Study|Adverse Event|1|||
149898568|NCT03926117|540759418|FG001|Overall Study|Adverse Event|2|||
149898569|NCT03926117|540759419|FG002|Overall Study|Adverse Event|3|||
149898570|NCT03926117|540759420|FG003|Overall Study|Adverse Event|1|||
149898571|NCT03926117|540759417|FG000|Overall Study|Randomized but not treated|1|||
149898572|NCT03926117|540759418|FG001|Overall Study|Randomized but not treated|1|||
149898573|NCT03926117|540759419|FG002|Overall Study|Randomized but not treated|0|||
149898574|NCT03926117|540759420|FG003|Overall Study|Randomized but not treated|1|||
149898575|NCT02684097|540759427|FG000|Overall Study|Lack of Efficacy|13|||
149898576|NCT02684097|540759428|FG001|Overall Study|Lack of Efficacy|6|||
149898577|NCT00462709|540759429|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
149898578|NCT00462709|540759429|FG000|Overall Study|Lost to Follow-up|10|||
149898579|NCT00462709|540759429|FG000|Overall Study|Withdrawal by Subject|8|||
149898580|NCT00462709|540759429|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
149898581|NCT00462709|540759429|FG000|Overall Study|Death|2|||
149898582|NCT00462709|540759429|FG000|Overall Study|Logistical reasons|2|||
149898583|NCT00462709|540759429|FG000|Overall Study|Physician Decision|1|||
149898584|NCT00462709|540759429|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
149898585|NCT02748356|540759430|FG000|Overall Study|Withdrawal by Subject|1|||
149898586|NCT01732458|540759431|FG000|Overall Study|Lost to Follow-up|0|||
149898587|NCT01732458|540759432|FG001|Overall Study|Lost to Follow-up|2|||
149898588|NCT01732458|540759433|FG002|Overall Study|Lost to Follow-up|0|||
149898589|NCT01732458|540759434|FG003|Overall Study|Lost to Follow-up|0|||
149898590|NCT01732458|540759431|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149898591|NCT01732458|540759432|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149898592|NCT01732458|540759433|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149898593|NCT01732458|540759434|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149898594|NCT01732458|540759431|FG000|Overall Study|Physician Decision|1|||
149898595|NCT01732458|540759432|FG001|Overall Study|Physician Decision|2|||
149898596|NCT01732458|540759433|FG002|Overall Study|Physician Decision|2|||
149898597|NCT01732458|540759434|FG003|Overall Study|Physician Decision|0|||
149898598|NCT01732458|540759431|FG000|Overall Study|Protocol Violation|2|||
149898599|NCT01732458|540759432|FG001|Overall Study|Protocol Violation|0|||
149898600|NCT01732458|540759433|FG002|Overall Study|Protocol Violation|0|||
149898601|NCT01732458|540759434|FG003|Overall Study|Protocol Violation|2|||
149898602|NCT01732458|540759431|FG000|Overall Study|Screen Failure|0|||
149898603|NCT01732458|540759432|FG001|Overall Study|Screen Failure|1|||
149898604|NCT01732458|540759433|FG002|Overall Study|Screen Failure|0|||
149898605|NCT01732458|540759434|FG003|Overall Study|Screen Failure|0|||
149898606|NCT05107492|540759435|FG000|Overall Study|Lost to Follow-up|1|||
149898607|NCT05107492|540759436|FG001|Overall Study|Lost to Follow-up|0|||
149898608|NCT05236764|540759437|FG000|Overall Study|In follow up (ongoing)|1|||
149898609|NCT05236764|540759437|FG000|Overall Study|Taken off study - secondary graft failure|1|||
149898610|NCT05236764|540759437|FG000|Overall Study|Death|1|||
149898611|NCT05870371|540759438|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
149898612|NCT05870371|540759439|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
149898613|NCT02589639|540759441|FG000|Overall Study|Lost to Follow-up|1|||
149898614|NCT02589639|540759442|FG001|Overall Study|Lost to Follow-up|0|||
150045615|NCT04434937|541305667|FG000|Overall Study|Withdrawal by Subject|1|||
150045616|NCT04434937|541305667|FG000|Overall Study|Transitioned to Rollover Study|19|||
150045617|NCT04434937|541305667|FG000|Overall Study|Progressive Disease|18|||
150045618|NCT01865552|541307915|FG000|Period 1|Adverse Event|1|||
150045619|NCT01865552|541307916|FG001|Period 1|Adverse Event|0|||
150045620|NCT01865552|541307917|FG002|Period 1|Adverse Event|0|||
150045621|NCT01865552|541307918|FG003|Period 1|Adverse Event|1|||
150045622|NCT01865552|541307919|FG004|Period 1|Adverse Event|1|||
150045623|NCT01865552|541307920|FG005|Period 1|Adverse Event|1|||
150045624|NCT01865552|541307915|FG000|Period 1|Pathological lab|0|||
150045625|NCT01865552|541307916|FG001|Period 1|Pathological lab|0|||
150045626|NCT01865552|541307917|FG002|Period 1|Pathological lab|0|||
150045627|NCT01865552|541307918|FG003|Period 1|Pathological lab|0|||
150045628|NCT01865552|541307919|FG004|Period 1|Pathological lab|1|||
150045629|NCT01865552|541307920|FG005|Period 1|Pathological lab|0|||
150045630|NCT01865552|541307915|FG000|Period 1|Other|0|||
150045631|NCT01865552|541307916|FG001|Period 1|Other|0|||
150045632|NCT01865552|541307917|FG002|Period 1|Other|0|||
150045633|NCT01865552|541307918|FG003|Period 1|Other|0|||
150045634|NCT01865552|541307919|FG004|Period 1|Other|1|||
150045635|NCT01865552|541307920|FG005|Period 1|Other|0|||
150045636|NCT03079102|541307923|FG000|Overall Study|Physician Decision|0|||
150045637|NCT03079102|541307924|FG001|Overall Study|Physician Decision|1|||
150045638|NCT02923921|541307925|FG000|Overall Study|Sponsor Decision|39|||
150045639|NCT02923921|541307926|FG001|Overall Study|Sponsor Decision|38|||
150045640|NCT02923921|541307925|FG000|Overall Study|Lost to Follow-up|1|||
150045641|NCT02923921|541307926|FG001|Overall Study|Lost to Follow-up|0|||
150045642|NCT02923921|541307925|FG000|Overall Study|Withdrawal by Subject|6|||
150045643|NCT02923921|541307926|FG001|Overall Study|Withdrawal by Subject|13|||
150045644|NCT02923921|541307925|FG000|Overall Study|Unknown, Not Collected|7|||
150045645|NCT02923921|541307926|FG001|Overall Study|Unknown, Not Collected|6|||
150045646|NCT03083873|541307927|FG000|Overall Study|Death|6|||
150045647|NCT03083873|541307928|FG001|Overall Study|Death|15|||
149898615|NCT02589639|540759443|FG002|Overall Study|Lost to Follow-up|0|||
149898616|NCT02589639|540759441|FG000|Overall Study|Protocol Violation|1|||
149898617|NCT02589639|540759442|FG001|Overall Study|Protocol Violation|0|||
149898618|NCT02589639|540759443|FG002|Overall Study|Protocol Violation|0|||
149898619|NCT02589639|540759441|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
149898620|NCT02589639|540759442|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
149898621|NCT02589639|540759443|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
150045648|NCT03083873|541307929|FG002|Overall Study|Death|13|||
150045649|NCT03083873|541307930|FG003|Overall Study|Death|9|||
150045650|NCT03083873|541307931|FG004|Overall Study|Death|0|||
150045651|NCT03083873|541307927|FG000|Overall Study|Sponsor Terminated Study|0|||
150045652|NCT03083873|541307928|FG001|Overall Study|Sponsor Terminated Study|1|||
150045653|NCT03083873|541307929|FG002|Overall Study|Sponsor Terminated Study|2|||
150045654|NCT03083873|541307930|FG003|Overall Study|Sponsor Terminated Study|3|||
150045655|NCT03083873|541307931|FG004|Overall Study|Sponsor Terminated Study|0|||
150045656|NCT03083873|541307927|FG000|Overall Study|Lost to Follow-up|0|||
150045657|NCT03083873|541307928|FG001|Overall Study|Lost to Follow-up|1|||
149898622|NCT02589639|540759441|FG000|Overall Study|Adverse Event|4|||
149898623|NCT02589639|540759442|FG001|Overall Study|Adverse Event|5|||
149898624|NCT02589639|540759443|FG002|Overall Study|Adverse Event|3|||
149898625|NCT02589639|540759441|FG000|Overall Study|Other reason than specified above|1|||
149898626|NCT02589639|540759442|FG001|Overall Study|Other reason than specified above|2|||
149898627|NCT02589639|540759443|FG002|Overall Study|Other reason than specified above|1|||
149898628|NCT02589639|540759441|FG000|Overall Study|Not Treated|0|||
149898629|NCT02589639|540759442|FG001|Overall Study|Not Treated|3|||
149898630|NCT02589639|540759443|FG002|Overall Study|Not Treated|0|||
149898631|NCT00347009|540759444|FG000|Overall Study|Death|1|||
149898632|NCT00347009|540759444|FG000|Overall Study|Adverse Event|6|||
149898633|NCT00347009|540759444|FG000|Overall Study|Withdrawal by Subject|3|||
149898634|NCT00347009|540759444|FG000|Overall Study|Physician Decision|5|||
149898635|NCT00347009|540759444|FG000|Overall Study|Lost to Follow-up|4|||
149898636|NCT00347009|540759444|FG000|Overall Study|Protocol Violation|2|||
149898637|NCT00347009|540759444|FG000|Overall Study|Adverse Laboratory Experience|1|||
149898638|NCT00347009|540759444|FG000|Overall Study|Insufficient Viral Suppression|3|||
149898639|NCT00347009|540759444|FG000|Overall Study|Increased ALT/HBV DNA|1|||
149898640|NCT00347009|540759444|FG000|Overall Study|Serious Adverse Event|1|||
149898641|NCT02522884|540759445|FG000|Overall Study|Withdrawal by Subject|6|||
149898642|NCT02522884|540759445|FG000|Overall Study|Death|3|||
149898643|NCT02522884|540759445|FG000|Overall Study|Missed 12-month Follow-up|9|||
149898644|NCT03867201|540759451|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
149898645|NCT03867201|540759452|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
149898646|NCT03867201|540759451|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
149898647|NCT03867201|540759452|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
149898648|NCT03867201|540759451|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
149898649|NCT03867201|540759452|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
149898650|NCT03867201|540759451|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
149898651|NCT03867201|540759452|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
149898652|NCT03867201|540759451|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
149898653|NCT03867201|540759452|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
149898654|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Adverse Event|5|||
149898655|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Adverse Event|11|||
149898656|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
149898657|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
149898658|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Physician Decision|6|||
149898659|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Physician Decision|3|||
149898660|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Pregnancy|2|||
149898661|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Pregnancy|2|||
149898662|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
149898663|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
149898664|NCT03867201|540759451|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
149898665|NCT03867201|540759452|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
149898666|NCT03867201|540759451|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
149898667|NCT03867201|540759452|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
149898668|NCT03867201|540759451|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
149898669|NCT03867201|540759452|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
149898670|NCT05763875|540759453|FG000|Overall Study|Subject decision|5|||
149898671|NCT05763875|540759454|FG001|Overall Study|Subject decision|2|||
149898672|NCT05763875|540759455|FG002|Overall Study|Subject decision|1|||
149898673|NCT05763875|540759453|FG000|Overall Study|Lost to Follow-up|4|||
149898674|NCT05763875|540759454|FG001|Overall Study|Lost to Follow-up|1|||
149898675|NCT05763875|540759455|FG002|Overall Study|Lost to Follow-up|2|||
149898676|NCT05763875|540759453|FG000|Overall Study|Adverse Event|1|||
149898677|NCT05763875|540759454|FG001|Overall Study|Adverse Event|0|||
149898678|NCT05763875|540759455|FG002|Overall Study|Adverse Event|0|||
149898679|NCT01262287|540760901|FG000|Overall Study|Lost to Follow-up|2|||
149898680|NCT01262287|540760902|FG001|Overall Study|Lost to Follow-up|1|||
149898681|NCT00596687|540760903|FG000|Overall Study|< 24 hours of insulin treatment|8|||
149898682|NCT00596687|540760904|FG001|Overall Study|< 24 hours of insulin treatment|6|||
149898683|NCT00596687|540760903|FG000|Overall Study|continuous insulin infusion during TPN|2|||
150176327|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149898684|NCT00596687|540760904|FG001|Overall Study|continuous insulin infusion during TPN|1|||
149898685|NCT00596687|540760903|FG000|Overall Study|Withdrawal by Subject|3|||
149898686|NCT00596687|540760904|FG001|Overall Study|Withdrawal by Subject|1|||
149898687|NCT00596687|540760903|FG000|Overall Study|cancelled surgery|1|||
149898688|NCT00596687|540760904|FG001|Overall Study|cancelled surgery|1|||
149898689|NCT00932373|540760905|FG000|Overall Study|Progressive disease|3|||
149898690|NCT00932373|540760906|FG001|Overall Study|Progressive disease|1|||
149898691|NCT00932373|540760907|FG002|Overall Study|Progressive disease|0|||
149898692|NCT00932373|540760908|FG003|Overall Study|Progressive disease|0|||
149898693|NCT00932373|540760909|FG004|Overall Study|Progressive disease|10|||
149898694|NCT00932373|540760910|FG005|Overall Study|Progressive disease|1|||
150045658|NCT03083873|541307929|FG002|Overall Study|Lost to Follow-up|1|||
150045659|NCT03083873|541307930|FG003|Overall Study|Lost to Follow-up|0|||
150045660|NCT03083873|541307931|FG004|Overall Study|Lost to Follow-up|0|||
150045661|NCT03083873|541307927|FG000|Overall Study|Withdrawal by Subject|2|||
150045662|NCT03083873|541307928|FG001|Overall Study|Withdrawal by Subject|0|||
149898695|NCT00932373|540760911|FG006|Overall Study|Progressive disease|0|||
149898696|NCT00932373|540760912|FG007|Overall Study|Progressive disease|2|||
149898697|NCT00932373|540760913|FG008|Overall Study|Progressive disease|1|||
149898698|NCT00932373|540760914|FG009|Overall Study|Progressive disease|9|||
149898699|NCT00932373|540760915|FG010|Overall Study|Progressive disease|2|||
149898700|NCT00932373|540760905|FG000|Overall Study|Adverse Event|0|||
149898701|NCT00932373|540760906|FG001|Overall Study|Adverse Event|0|||
149898702|NCT00932373|540760907|FG002|Overall Study|Adverse Event|0|||
149898703|NCT00932373|540760908|FG003|Overall Study|Adverse Event|0|||
149898704|NCT00932373|540760909|FG004|Overall Study|Adverse Event|2|||
149898705|NCT00932373|540760910|FG005|Overall Study|Adverse Event|1|||
149898706|NCT00932373|540760911|FG006|Overall Study|Adverse Event|0|||
149898707|NCT00932373|540760912|FG007|Overall Study|Adverse Event|1|||
149898708|NCT00932373|540760913|FG008|Overall Study|Adverse Event|0|||
149898709|NCT00932373|540760914|FG009|Overall Study|Adverse Event|2|||
149898710|NCT00932373|540760915|FG010|Overall Study|Adverse Event|1|||
149898711|NCT00932373|540760905|FG000|Overall Study|Physician Decision|0|||
149898712|NCT00932373|540760906|FG001|Overall Study|Physician Decision|0|||
149898713|NCT00932373|540760907|FG002|Overall Study|Physician Decision|1|||
149898714|NCT00932373|540760908|FG003|Overall Study|Physician Decision|0|||
149898715|NCT00932373|540760909|FG004|Overall Study|Physician Decision|2|||
149898716|NCT00932373|540760910|FG005|Overall Study|Physician Decision|0|||
149898717|NCT00932373|540760911|FG006|Overall Study|Physician Decision|0|||
149898718|NCT00932373|540760912|FG007|Overall Study|Physician Decision|0|||
149898719|NCT00932373|540760913|FG008|Overall Study|Physician Decision|0|||
149898720|NCT00932373|540760914|FG009|Overall Study|Physician Decision|1|||
149898721|NCT00932373|540760915|FG010|Overall Study|Physician Decision|0|||
150045663|NCT03083873|541307929|FG002|Overall Study|Withdrawal by Subject|0|||
150176328|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
150176329|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
150176330|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
150176331|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
150176332|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
150176333|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
150176334|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
150176335|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
150176336|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
150176337|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
150176338|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
150176339|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
150176340|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
150176341|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
150176342|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
150176343|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
150176344|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176345|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176346|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176347|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176348|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176349|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176350|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176351|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176352|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176353|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176354|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
150176355|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176356|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149898722|NCT00932373|540760905|FG000|Overall Study|Dose limiting toxicity|0|||
149898723|NCT00932373|540760906|FG001|Overall Study|Dose limiting toxicity|0|||
149898724|NCT00932373|540760907|FG002|Overall Study|Dose limiting toxicity|0|||
149898725|NCT00932373|540760908|FG003|Overall Study|Dose limiting toxicity|0|||
149898726|NCT00932373|540760909|FG004|Overall Study|Dose limiting toxicity|0|||
149898727|NCT00932373|540760910|FG005|Overall Study|Dose limiting toxicity|1|||
149898728|NCT00932373|540760911|FG006|Overall Study|Dose limiting toxicity|0|||
149898729|NCT00932373|540760912|FG007|Overall Study|Dose limiting toxicity|0|||
149898730|NCT00932373|540760913|FG008|Overall Study|Dose limiting toxicity|0|||
149898731|NCT00932373|540760914|FG009|Overall Study|Dose limiting toxicity|0|||
149898732|NCT00932373|540760915|FG010|Overall Study|Dose limiting toxicity|0|||
149898733|NCT00932373|540760905|FG000|Overall Study|Withdrawal by Subject|0|||
149898734|NCT00932373|540760906|FG001|Overall Study|Withdrawal by Subject|0|||
149898735|NCT00932373|540760907|FG002|Overall Study|Withdrawal by Subject|0|||
149898736|NCT00932373|540760908|FG003|Overall Study|Withdrawal by Subject|0|||
149898737|NCT00932373|540760909|FG004|Overall Study|Withdrawal by Subject|0|||
149898738|NCT00932373|540760910|FG005|Overall Study|Withdrawal by Subject|0|||
149898739|NCT00932373|540760911|FG006|Overall Study|Withdrawal by Subject|0|||
149898740|NCT00932373|540760912|FG007|Overall Study|Withdrawal by Subject|0|||
149898741|NCT00932373|540760913|FG008|Overall Study|Withdrawal by Subject|1|||
149898742|NCT00932373|540760914|FG009|Overall Study|Withdrawal by Subject|0|||
149898743|NCT00932373|540760915|FG010|Overall Study|Withdrawal by Subject|0|||
149898744|NCT00932373|540760905|FG000|Overall Study|Clinical progression|0|||
149898745|NCT00932373|540760906|FG001|Overall Study|Clinical progression|0|||
149898746|NCT00932373|540760907|FG002|Overall Study|Clinical progression|0|||
149898747|NCT00932373|540760908|FG003|Overall Study|Clinical progression|0|||
149898748|NCT00932373|540760909|FG004|Overall Study|Clinical progression|0|||
149898749|NCT00932373|540760910|FG005|Overall Study|Clinical progression|0|||
149898750|NCT00932373|540760911|FG006|Overall Study|Clinical progression|1|||
149898751|NCT00932373|540760912|FG007|Overall Study|Clinical progression|0|||
149898752|NCT00932373|540760913|FG008|Overall Study|Clinical progression|0|||
149898753|NCT00932373|540760914|FG009|Overall Study|Clinical progression|0|||
149898754|NCT00932373|540760915|FG010|Overall Study|Clinical progression|0|||
149898755|NCT00932373|540760905|FG000|Overall Study|Lack of Efficacy|0|||
149898756|NCT00932373|540760906|FG001|Overall Study|Lack of Efficacy|0|||
149898757|NCT00932373|540760907|FG002|Overall Study|Lack of Efficacy|0|||
149898758|NCT00932373|540760908|FG003|Overall Study|Lack of Efficacy|0|||
149898759|NCT00932373|540760909|FG004|Overall Study|Lack of Efficacy|0|||
149898760|NCT00932373|540760910|FG005|Overall Study|Lack of Efficacy|0|||
149898761|NCT00932373|540760911|FG006|Overall Study|Lack of Efficacy|0|||
149898762|NCT00932373|540760912|FG007|Overall Study|Lack of Efficacy|0|||
149898763|NCT00932373|540760913|FG008|Overall Study|Lack of Efficacy|0|||
149898764|NCT00932373|540760914|FG009|Overall Study|Lack of Efficacy|1|||
149898765|NCT00932373|540760915|FG010|Overall Study|Lack of Efficacy|0|||
149898766|NCT06098339|540760916|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
149898767|NCT06098339|540760917|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
149898768|NCT06098339|540760916|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
149898769|NCT06098339|540760917|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
149898770|NCT04134767|540760920|FG000|Overall Study|Death|0|||
149898771|NCT04134767|540760921|FG001|Overall Study|Death|1|||
149898772|NCT04134767|540760920|FG000|Overall Study|Removed for harassing staff|0|||
149898773|NCT04134767|540760921|FG001|Overall Study|Removed for harassing staff|1|||
149898774|NCT04134767|540760920|FG000|Overall Study|Lost to Follow-up|44|||
149898775|NCT04134767|540760921|FG001|Overall Study|Lost to Follow-up|40|||
149898776|NCT02058537|540760922|FG000|Overall Study|Withdrawal by Subject|1|||
149898777|NCT02582242|540760923|FG000|Overall Study|Adverse Event|4|||
149898778|NCT02582242|540760924|FG001|Overall Study|Adverse Event|3|||
149898779|NCT02582242|540760923|FG000|Overall Study|Protocol Violation|3|||
149898780|NCT02582242|540760924|FG001|Overall Study|Protocol Violation|1|||
149898781|NCT02582242|540760923|FG000|Overall Study|Lost to Follow-up|0|||
149898782|NCT02582242|540760924|FG001|Overall Study|Lost to Follow-up|1|||
149898783|NCT02582242|540760923|FG000|Overall Study|Withdrawal by Subject|11|||
149898784|NCT02582242|540760924|FG001|Overall Study|Withdrawal by Subject|11|||
149898785|NCT02582242|540760923|FG000|Overall Study|Unclassified|2|||
149898786|NCT02582242|540760924|FG001|Overall Study|Unclassified|1|||
149898787|NCT00300885|540760925|FG000|Treatment|Adverse Event|134|||
149898788|NCT00300885|540760926|FG001|Treatment|Adverse Event|82|||
149898789|NCT00300885|540760925|FG000|Treatment|Death|20|||
149898790|NCT00300885|540760926|FG001|Treatment|Death|7|||
149898791|NCT00300885|540760925|FG000|Treatment|Lack of Efficacy|1|||
149898792|NCT00300885|540760926|FG001|Treatment|Lack of Efficacy|1|||
149898793|NCT00300885|540760925|FG000|Treatment|Lost to Follow-up|3|||
149898794|NCT00300885|540760926|FG001|Treatment|Lost to Follow-up|2|||
149898795|NCT00300885|540760925|FG000|Treatment|Physician Decision|4|||
150045664|NCT03083873|541307930|FG003|Overall Study|Withdrawal by Subject|0|||
150045665|NCT03083873|541307931|FG004|Overall Study|Withdrawal by Subject|0|||
150045666|NCT03083873|541307927|FG000|Overall Study|Did Not Receive TIL|2|||
150045667|NCT03083873|541307928|FG001|Overall Study|Did Not Receive TIL|5|||
150045668|NCT03083873|541307929|FG002|Overall Study|Did Not Receive TIL|3|||
150045669|NCT03083873|541307930|FG003|Overall Study|Did Not Receive TIL|1|||
150045670|NCT03083873|541307931|FG004|Overall Study|Did Not Receive TIL|0|||
150045671|NCT00295880|541307932|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
150045672|NCT00295880|541307932|FG000|Overall Study|Unit randomization did not occur|1|||
150045673|NCT01474239|541307933|FG000|Overall Study|Disease Progression|37|||
149898796|NCT00300885|540760926|FG001|Treatment|Physician Decision|5|||
149898797|NCT00300885|540760925|FG000|Treatment|Protocol Violation|11|||
149898798|NCT00300885|540760926|FG001|Treatment|Protocol Violation|11|||
149898799|NCT00300885|540760925|FG000|Treatment|Withdrawal by Subject|26|||
149898800|NCT00300885|540760926|FG001|Treatment|Withdrawal by Subject|23|||
149898801|NCT00300885|540760925|FG000|Treatment|Disease progression|171|||
149898802|NCT00300885|540760926|FG001|Treatment|Disease progression|238|||
150045674|NCT01474239|541307934|FG001|Overall Study|Disease Progression|25|||
150045675|NCT01474239|541307933|FG000|Overall Study|Adverse Event|12|||
149898803|NCT00300885|540760925|FG000|Treatment|Random code broken (subject died)|0|||
149898804|NCT00300885|540760926|FG001|Treatment|Random code broken (subject died)|1|||
149898805|NCT00300885|540760925|FG000|Treatment|Non-compliant with study medication|3|||
149898806|NCT00300885|540760926|FG001|Treatment|Non-compliant with study medication|4|||
149898807|NCT00300885|540760925|FG000|Follow-up|Death|141|||
149898808|NCT00300885|540760926|FG001|Follow-up|Death|163|||
149898809|NCT00300885|540760925|FG000|Follow-up|Lost to Follow-up|11|||
149898810|NCT00300885|540760926|FG001|Follow-up|Lost to Follow-up|7|||
149898811|NCT00300885|540760925|FG000|Follow-up|Withdrawal by Subject|26|||
149898812|NCT00300885|540760926|FG001|Follow-up|Withdrawal by Subject|25|||
149898813|NCT00638404|540760927|FG000|Overall Study|Physician Decision|8|||
149898814|NCT00638404|540760928|FG001|Overall Study|Physician Decision|0|||
149898815|NCT02492984|540760932|FG000|Overall Study|Adverse Event|1|||
149898816|NCT02492984|540760933|FG001|Overall Study|Adverse Event|0|||
149898817|NCT02492984|540760932|FG000|Overall Study|Protocol Violation|1|||
149898818|NCT02492984|540760933|FG001|Overall Study|Protocol Violation|0|||
149898819|NCT02492984|540760932|FG000|Overall Study|Withdrawal by Subject|1|||
149898820|NCT02492984|540760933|FG001|Overall Study|Withdrawal by Subject|0|||
149898821|NCT02101736|540760934|FG000|Overall Study|Protocol Violation|3|||
149898822|NCT02101736|540760935|FG001|Overall Study|Protocol Violation|0|||
149898823|NCT02101736|540760934|FG000|Overall Study|Withdrawal by Subject|1|||
149898824|NCT02101736|540760935|FG001|Overall Study|Withdrawal by Subject|1|||
149898825|NCT02282631|540760936|FG000|Overall Study|Lost to Follow-up|2|||
149898826|NCT02282631|540760937|FG001|Overall Study|Lost to Follow-up|0|||
149898827|NCT00459290|540760938|FG000|Overall Study|Adverse Event|3|||
149898828|NCT00459290|540760938|FG000|Overall Study|Ineligible|2|||
149898829|NCT02453334|540760939|FG000|Overall Study|Death|15|||
149898830|NCT02453334|540760940|FG001|Overall Study|Death|13|||
149898831|NCT02453334|540760939|FG000|Overall Study|Adverse Event|2|||
149898832|NCT02453334|540760940|FG001|Overall Study|Adverse Event|1|||
149898833|NCT02453334|540760939|FG000|Overall Study|Lost to Follow-up|5|||
149898834|NCT02453334|540760940|FG001|Overall Study|Lost to Follow-up|9|||
149898835|NCT02453334|540760939|FG000|Overall Study|Physician Decision|1|||
149898836|NCT02453334|540760940|FG001|Overall Study|Physician Decision|0|||
149898837|NCT02453334|540760939|FG000|Overall Study|Withdrawal by Subject|17|||
149898838|NCT02453334|540760940|FG001|Overall Study|Withdrawal by Subject|13|||
149898839|NCT02453334|540760939|FG000|Overall Study|Other reason|1|||
149898840|NCT02453334|540760940|FG001|Overall Study|Other reason|4|||
149898841|NCT05483686|540760944|FG000|Overall Study|Lost to Follow-up|5|||
149898842|NCT05483686|540760945|FG001|Overall Study|Lost to Follow-up|7|||
149898843|NCT05780983|540760946|FG000|Overall Study|Withdrawal by Subject|1|||
149898844|NCT01954056|540760952|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
149898845|NCT01954056|540760953|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
149898846|NCT00105079|540760956|FG000|Overall Study|Adverse Event|5|||
149898847|NCT00105079|540760957|FG001|Overall Study|Adverse Event|12|||
149898848|NCT00105079|540760956|FG000|Overall Study|Death|3|||
149898849|NCT00105079|540760957|FG001|Overall Study|Death|1|||
149898850|NCT00105079|540760956|FG000|Overall Study|Lost to Follow-up|12|||
149898851|NCT00105079|540760957|FG001|Overall Study|Lost to Follow-up|12|||
149898852|NCT00105079|540760956|FG000|Overall Study|Lack of Efficacy|9|||
149898853|NCT00105079|540760957|FG001|Overall Study|Lack of Efficacy|3|||
149898854|NCT00105079|540760956|FG000|Overall Study|Refused treatment|6|||
149898855|NCT00105079|540760957|FG001|Overall Study|Refused treatment|4|||
149898856|NCT00105079|540760956|FG000|Overall Study|Violation of selection criteria at entry|0|||
149898857|NCT00105079|540760957|FG001|Overall Study|Violation of selection criteria at entry|2|||
149898858|NCT00105079|540760956|FG000|Overall Study|Protocol Violation|1|||
149898859|NCT00105079|540760957|FG001|Overall Study|Protocol Violation|0|||
149898860|NCT00105079|540760956|FG000|Overall Study|Other|3|||
149898861|NCT00105079|540760957|FG001|Overall Study|Other|1|||
149898862|NCT01464593|540760958|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
149898863|NCT04747886|540760963|FG000|Overall Study|Withdrawal by Subject|1|||
149898864|NCT04747886|540760964|FG001|Overall Study|Withdrawal by Subject|4|||
149898865|NCT03777436|540760965|FG000|Placebo-controlled Phase|Adverse Event|8|||
149898866|NCT03777436|540760966|FG001|Placebo-controlled Phase|Adverse Event|10|||
149898867|NCT03777436|540760967|FG002|Placebo-controlled Phase|Adverse Event|0|||
149898868|NCT03777436|540760965|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
149898869|NCT03777436|540760966|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
149898870|NCT03777436|540760967|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
149898871|NCT03777436|540760965|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
149898872|NCT03777436|540760966|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
149898873|NCT03777436|540760967|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
149898874|NCT03777436|540760965|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
149898875|NCT03777436|540760966|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
149898876|NCT03777436|540760967|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
149898877|NCT03777436|540760965|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
149898878|NCT03777436|540760966|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
149898879|NCT03777436|540760967|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
149898880|NCT03777436|540760965|FG000|Placebo-controlled Phase|Physician Decision|0|||
149898881|NCT03777436|540760966|FG001|Placebo-controlled Phase|Physician Decision|1|||
149898882|NCT03777436|540760967|FG002|Placebo-controlled Phase|Physician Decision|0|||
149898883|NCT03777436|540760965|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
149898884|NCT03777436|540760966|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
149898885|NCT03777436|540760967|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
149898886|NCT03777436|540760965|FG000|Apremilast Extension Phase|Adverse Event|0|||
149898887|NCT03777436|540760966|FG001|Apremilast Extension Phase|Adverse Event|0|||
149898888|NCT03777436|540760967|FG002|Apremilast Extension Phase|Adverse Event|6|||
149898889|NCT03777436|540760965|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
149898890|NCT03777436|540760966|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
149898891|NCT03777436|540760967|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
149898892|NCT03777436|540760965|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
149898893|NCT03777436|540760966|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
149898894|NCT03777436|540760967|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
149898895|NCT03777436|540760965|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
149898896|NCT03777436|540760966|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
149898897|NCT03777436|540760967|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
149898898|NCT03777436|540760965|FG000|Apremilast Extension Phase|Miscellaneous|0|||
149898899|NCT03777436|540760966|FG001|Apremilast Extension Phase|Miscellaneous|0|||
149898900|NCT03777436|540760967|FG002|Apremilast Extension Phase|Miscellaneous|1|||
149898901|NCT00685399|540760968|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149898902|NCT00685399|540760969|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149898903|NCT00685399|540760970|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149898904|NCT00685399|540760971|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149898905|NCT00685399|540760972|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149898906|NCT00685399|540760973|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149898907|NCT00685399|540760974|FG006|Treatment Period 1|Withdrawal by Subject|0|||
149898908|NCT00685399|540760975|FG007|Treatment Period 1|Withdrawal by Subject|0|||
149898909|NCT00685399|540760968|FG000|Treatment Period 1|Protocol Violation|1|||
149898910|NCT00685399|540760969|FG001|Treatment Period 1|Protocol Violation|0|||
149898911|NCT00685399|540760970|FG002|Treatment Period 1|Protocol Violation|0|||
149898912|NCT00685399|540760971|FG003|Treatment Period 1|Protocol Violation|0|||
149898913|NCT00685399|540760972|FG004|Treatment Period 1|Protocol Violation|0|||
149968813|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968814|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968815|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968816|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968817|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968818|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149898914|NCT00685399|540760973|FG005|Treatment Period 1|Protocol Violation|0|||
149898915|NCT00685399|540760974|FG006|Treatment Period 1|Protocol Violation|0|||
149898916|NCT00685399|540760975|FG007|Treatment Period 1|Protocol Violation|0|||
149898917|NCT00685399|540760968|FG000|Treatment Period 1|Administrative|2|||
149898918|NCT00685399|540760969|FG001|Treatment Period 1|Administrative|0|||
149898919|NCT00685399|540760970|FG002|Treatment Period 1|Administrative|0|||
149898920|NCT00685399|540760971|FG003|Treatment Period 1|Administrative|0|||
149898921|NCT00685399|540760972|FG004|Treatment Period 1|Administrative|0|||
149898922|NCT00685399|540760973|FG005|Treatment Period 1|Administrative|0|||
149898923|NCT00685399|540760974|FG006|Treatment Period 1|Administrative|0|||
149898924|NCT00685399|540760975|FG007|Treatment Period 1|Administrative|0|||
149898925|NCT00685399|540760968|FG000|Treatment Period 1|Lack of Efficacy|1|||
149898926|NCT00685399|540760969|FG001|Treatment Period 1|Lack of Efficacy|0|||
149898927|NCT00685399|540760970|FG002|Treatment Period 1|Lack of Efficacy|0|||
149898928|NCT00685399|540760971|FG003|Treatment Period 1|Lack of Efficacy|0|||
149898929|NCT00685399|540760972|FG004|Treatment Period 1|Lack of Efficacy|0|||
149898930|NCT00685399|540760973|FG005|Treatment Period 1|Lack of Efficacy|0|||
149898931|NCT00685399|540760974|FG006|Treatment Period 1|Lack of Efficacy|0|||
149898932|NCT00685399|540760975|FG007|Treatment Period 1|Lack of Efficacy|0|||
149898933|NCT00685399|540760968|FG000|Treatment Period 2|Administrative Problems|0|||
149898934|NCT00685399|540760969|FG001|Treatment Period 2|Administrative Problems|2|||
149898935|NCT00685399|540760970|FG002|Treatment Period 2|Administrative Problems|1|||
149898936|NCT00685399|540760971|FG003|Treatment Period 2|Administrative Problems|0|||
149898937|NCT00685399|540760972|FG004|Treatment Period 2|Administrative Problems|0|||
149898938|NCT00685399|540760973|FG005|Treatment Period 2|Administrative Problems|0|||
149898939|NCT00685399|540760974|FG006|Treatment Period 2|Administrative Problems|0|||
149898940|NCT00685399|540760975|FG007|Treatment Period 2|Administrative Problems|0|||
149898941|NCT00685399|540760968|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149898942|NCT00685399|540760969|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149898943|NCT00685399|540760970|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149898944|NCT00685399|540760971|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149898945|NCT00685399|540760972|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149898946|NCT00685399|540760973|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149898947|NCT00685399|540760974|FG006|Treatment Period 2|Withdrawal by Subject|0|||
149898948|NCT00685399|540760975|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149898949|NCT00685399|540760968|FG000|Treatment Period 2|Adverse Event|0|||
149898950|NCT00685399|540760969|FG001|Treatment Period 2|Adverse Event|0|||
149898951|NCT00685399|540760970|FG002|Treatment Period 2|Adverse Event|0|||
149898952|NCT00685399|540760971|FG003|Treatment Period 2|Adverse Event|0|||
149898953|NCT00685399|540760972|FG004|Treatment Period 2|Adverse Event|0|||
149898954|NCT00685399|540760973|FG005|Treatment Period 2|Adverse Event|1|||
149898955|NCT00685399|540760974|FG006|Treatment Period 2|Adverse Event|0|||
149898956|NCT00685399|540760975|FG007|Treatment Period 2|Adverse Event|0|||
149898957|NCT00685399|540760968|FG000|Treatment Period 2|Lack of Efficacy|0|||
149898958|NCT00685399|540760969|FG001|Treatment Period 2|Lack of Efficacy|10|||
149898959|NCT00685399|540760970|FG002|Treatment Period 2|Lack of Efficacy|2|||
150045676|NCT01474239|541307934|FG001|Overall Study|Adverse Event|3|||
150045677|NCT01474239|541307933|FG000|Overall Study|Withdrawal by Subject|1|||
150045678|NCT01474239|541307934|FG001|Overall Study|Withdrawal by Subject|2|||
150045679|NCT01474239|541307933|FG000|Overall Study|Death|1|||
150045680|NCT01474239|541307934|FG001|Overall Study|Death|1|||
150045681|NCT01474239|541307933|FG000|Overall Study|Clinical Disease Progression|7|||
150045682|NCT01474239|541307934|FG001|Overall Study|Clinical Disease Progression|1|||
150045683|NCT01474239|541307933|FG000|Overall Study|Withdrawal for Economic Reason|1|||
150045684|NCT01474239|541307934|FG001|Overall Study|Withdrawal for Economic Reason|0|||
150045685|NCT00854113|541307938|FG000|Overall Study|Adverse Event|0|||
150045686|NCT00854113|541307939|FG001|Overall Study|Adverse Event|0|||
150045687|NCT00854113|541307940|FG002|Overall Study|Adverse Event|0|||
150045688|NCT00854113|541307941|FG003|Overall Study|Adverse Event|0|||
149898960|NCT00685399|540760971|FG003|Treatment Period 2|Lack of Efficacy|0|||
149898961|NCT00685399|540760972|FG004|Treatment Period 2|Lack of Efficacy|0|||
149898962|NCT00685399|540760973|FG005|Treatment Period 2|Lack of Efficacy|1|||
149898963|NCT00685399|540760974|FG006|Treatment Period 2|Lack of Efficacy|0|||
149898964|NCT00685399|540760975|FG007|Treatment Period 2|Lack of Efficacy|0|||
149898965|NCT00685399|540760968|FG000|Extension|Administrative Issues|0|||
149898966|NCT00685399|540760969|FG001|Extension|Administrative Issues|0|||
149898967|NCT00685399|540760970|FG002|Extension|Administrative Issues|0|||
149898968|NCT00685399|540760971|FG003|Extension|Administrative Issues|1|||
149898969|NCT00685399|540760972|FG004|Extension|Administrative Issues|0|||
150045689|NCT00854113|541307942|FG004|Overall Study|Adverse Event|0|||
149898970|NCT00685399|540760973|FG005|Extension|Administrative Issues|0|||
149898971|NCT00685399|540760974|FG006|Extension|Administrative Issues|0|||
149898972|NCT00685399|540760975|FG007|Extension|Administrative Issues|0|||
149898973|NCT00685399|540760968|FG000|Extension|Withdrawal by Subject|0|||
149898974|NCT00685399|540760969|FG001|Extension|Withdrawal by Subject|0|||
149898975|NCT00685399|540760970|FG002|Extension|Withdrawal by Subject|0|||
149898976|NCT00685399|540760971|FG003|Extension|Withdrawal by Subject|1|||
149898977|NCT00685399|540760972|FG004|Extension|Withdrawal by Subject|0|||
149898978|NCT00685399|540760973|FG005|Extension|Withdrawal by Subject|0|||
149898979|NCT00685399|540760974|FG006|Extension|Withdrawal by Subject|0|||
149898980|NCT00685399|540760975|FG007|Extension|Withdrawal by Subject|0|||
149898981|NCT00685399|540760968|FG000|Extension|Protocol Violation|0|||
149898982|NCT00685399|540760969|FG001|Extension|Protocol Violation|0|||
149898983|NCT00685399|540760970|FG002|Extension|Protocol Violation|0|||
149898984|NCT00685399|540760971|FG003|Extension|Protocol Violation|1|||
149898985|NCT00685399|540760972|FG004|Extension|Protocol Violation|0|||
149898986|NCT00685399|540760973|FG005|Extension|Protocol Violation|0|||
149898987|NCT00685399|540760974|FG006|Extension|Protocol Violation|0|||
149898988|NCT00685399|540760975|FG007|Extension|Protocol Violation|0|||
149898989|NCT00685399|540760968|FG000|Extension|Lack of Efficacy|0|||
149898990|NCT00685399|540760969|FG001|Extension|Lack of Efficacy|0|||
149898991|NCT00685399|540760970|FG002|Extension|Lack of Efficacy|0|||
149898992|NCT00685399|540760971|FG003|Extension|Lack of Efficacy|2|||
149898993|NCT00685399|540760972|FG004|Extension|Lack of Efficacy|0|||
149898994|NCT00685399|540760973|FG005|Extension|Lack of Efficacy|0|||
149898995|NCT00685399|540760974|FG006|Extension|Lack of Efficacy|0|||
149898996|NCT00685399|540760975|FG007|Extension|Lack of Efficacy|0|||
149898997|NCT00685399|540760968|FG000|Extension|Adverse Event|0|||
149898998|NCT00685399|540760969|FG001|Extension|Adverse Event|0|||
149898999|NCT00685399|540760970|FG002|Extension|Adverse Event|0|||
149899000|NCT00685399|540760971|FG003|Extension|Adverse Event|2|||
149899001|NCT00685399|540760972|FG004|Extension|Adverse Event|0|||
149899002|NCT00685399|540760973|FG005|Extension|Adverse Event|0|||
149899003|NCT00685399|540760974|FG006|Extension|Adverse Event|0|||
149899004|NCT00685399|540760975|FG007|Extension|Adverse Event|0|||
149899005|NCT01106911|540760977|FG000|Overall Study|Physician Decision|2|||
149899006|NCT01106911|540760977|FG000|Overall Study|deemed ineligible after screening|3|||
149899007|NCT02199795|540760981|FG000|Overall Study|no longer met inclusion criteria|1|||
149899008|NCT02199795|540760982|FG001|Overall Study|no longer met inclusion criteria|0|||
149899009|NCT02199795|540760981|FG000|Overall Study|withdrew due to shoulder pain|1|||
149899010|NCT02199795|540760982|FG001|Overall Study|withdrew due to shoulder pain|0|||
149899011|NCT00984542|540760989|FG000|Overall Study|disease progression|19|||
149899012|NCT00984542|540760989|FG000|Overall Study|toxicity|7|||
149899013|NCT00984542|540760989|FG000|Overall Study|Death|7|||
149899014|NCT00984542|540760989|FG000|Overall Study|complicating disease|3|||
149899015|NCT00984542|540760989|FG000|Overall Study|Withdrawal by Subject|3|||
149899016|NCT00984542|540760989|FG000|Overall Study|clinical deterioration|2|||
149899017|NCT00425750|540760990|FG000|Overall Study|Death|1|||
149899018|NCT00425750|540760990|FG000|Overall Study|Withdrawal by Subject|3|||
149899019|NCT00425750|540760990|FG000|Overall Study|Adverse Event|3|||
149899020|NCT00425750|540760990|FG000|Overall Study|Progression of disease|18|||
149899021|NCT02064816|540760991|FG000|Overall Study|Adverse Event|3|||
149899022|NCT02064816|540760992|FG001|Overall Study|Adverse Event|2|||
149899023|NCT02064816|540760991|FG000|Overall Study|Withdrawal by Subject|2|||
149899024|NCT02064816|540760992|FG001|Overall Study|Withdrawal by Subject|1|||
150045690|NCT00854113|541307943|FG005|Overall Study|Adverse Event|0|||
150045691|NCT00854113|541307944|FG006|Overall Study|Adverse Event|0|||
150045692|NCT00854113|541307945|FG007|Overall Study|Adverse Event|2|||
150045693|NCT00854113|541307946|FG008|Overall Study|Adverse Event|0|||
150045694|NCT00854113|541307947|FG009|Overall Study|Adverse Event|0|||
150045695|NCT00854113|541307948|FG010|Overall Study|Adverse Event|0|||
150045696|NCT00854113|541307938|FG000|Overall Study|Withdrawal by Subject|0|||
150045697|NCT00854113|541307939|FG001|Overall Study|Withdrawal by Subject|0|||
150045698|NCT00854113|541307940|FG002|Overall Study|Withdrawal by Subject|0|||
150045699|NCT00854113|541307941|FG003|Overall Study|Withdrawal by Subject|0|||
150045700|NCT00854113|541307942|FG004|Overall Study|Withdrawal by Subject|0|||
149899025|NCT02064816|540760991|FG000|Overall Study|Lost to Follow-up|2|||
149899026|NCT02064816|540760992|FG001|Overall Study|Lost to Follow-up|1|||
149899027|NCT02064816|540760991|FG000|Overall Study|Therapeutic failure|0|||
149899028|NCT02064816|540760992|FG001|Overall Study|Therapeutic failure|1|||
149899029|NCT02064816|540760991|FG000|Overall Study|Other|1|||
149899030|NCT02064816|540760992|FG001|Overall Study|Other|3|||
149899031|NCT04468347|540760993|FG000|Overall Study|Withdrawal by Subject|0|||
149899032|NCT04468347|540760994|FG001|Overall Study|Withdrawal by Subject|1|||
149899033|NCT04468347|540760995|FG002|Overall Study|Withdrawal by Subject|3|||
149899034|NCT04468347|540760996|FG003|Overall Study|Withdrawal by Subject|3|||
150045701|NCT00854113|541307943|FG005|Overall Study|Withdrawal by Subject|0|||
150045702|NCT00854113|541307944|FG006|Overall Study|Withdrawal by Subject|0|||
149899035|NCT04468347|540760993|FG000|Overall Study|Lost to Follow-up|0|||
149899036|NCT04468347|540760994|FG001|Overall Study|Lost to Follow-up|0|||
149899037|NCT04468347|540760995|FG002|Overall Study|Lost to Follow-up|1|||
149899038|NCT04468347|540760996|FG003|Overall Study|Lost to Follow-up|1|||
149899039|NCT04468347|540760993|FG000|Overall Study|Physician Decision|1|||
149899040|NCT04468347|540760994|FG001|Overall Study|Physician Decision|0|||
149899041|NCT04468347|540760995|FG002|Overall Study|Physician Decision|2|||
149899042|NCT04468347|540760996|FG003|Overall Study|Physician Decision|0|||
149899043|NCT04468347|540760993|FG000|Overall Study|Protocol Violation|1|||
149899044|NCT04468347|540760994|FG001|Overall Study|Protocol Violation|0|||
149899045|NCT04468347|540760995|FG002|Overall Study|Protocol Violation|0|||
149899046|NCT04468347|540760996|FG003|Overall Study|Protocol Violation|0|||
149899047|NCT04339062|540760997|FG000|Overall Study|Death|0|||
149899048|NCT04339062|540760998|FG001|Overall Study|Death|1|||
149899049|NCT03218826|540760999|FG000|Overall Study|Non-compliance with protocol|1|||
149899050|NCT03218826|540761000|FG001|Overall Study|Non-compliance with protocol|0|||
149899051|NCT03218826|540761001|FG002|Overall Study|Non-compliance with protocol|2|||
149899052|NCT03218826|540761002|FG003|Overall Study|Non-compliance with protocol|1|||
149899053|NCT03218826|540761003|FG004|Overall Study|Non-compliance with protocol|1|||
149899054|NCT01197534|540761004|FG000|Overall Study|Not reported|16|||
149899055|NCT01197534|540761005|FG001|Overall Study|Not reported|10|||
149899056|NCT01197534|540761006|FG002|Overall Study|Not reported|16|||
149899057|NCT01197534|540761004|FG000|Overall Study|Enrolment in long term extension|57|||
149899058|NCT01197534|540761005|FG001|Overall Study|Enrolment in long term extension|66|||
149899059|NCT01197534|540761006|FG002|Overall Study|Enrolment in long term extension|119|||
149899060|NCT01197534|540761004|FG000|Overall Study|Severe non-compliance to protocol|3|||
149899061|NCT01197534|540761005|FG001|Overall Study|Severe non-compliance to protocol|4|||
149899062|NCT01197534|540761006|FG002|Overall Study|Severe non-compliance to protocol|1|||
149899063|NCT01197534|540761004|FG000|Overall Study|Lack of therapeutic response|9|||
149899064|NCT01197534|540761005|FG001|Overall Study|Lack of therapeutic response|4|||
149899065|NCT01197534|540761006|FG002|Overall Study|Lack of therapeutic response|9|||
149899066|NCT01197534|540761004|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
149899067|NCT01197534|540761005|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
149899068|NCT01197534|540761006|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
149899069|NCT01197534|540761004|FG000|Overall Study|Lost to Follow-up|1|||
149899070|NCT01197534|540761005|FG001|Overall Study|Lost to Follow-up|4|||
149899071|NCT01197534|540761006|FG002|Overall Study|Lost to Follow-up|2|||
149899072|NCT01197534|540761004|FG000|Overall Study|Adverse Event|35|||
149899073|NCT01197534|540761005|FG001|Overall Study|Adverse Event|36|||
149899074|NCT01197534|540761006|FG002|Overall Study|Adverse Event|24|||
150045703|NCT00854113|541307945|FG007|Overall Study|Withdrawal by Subject|1|||
150045704|NCT00854113|541307946|FG008|Overall Study|Withdrawal by Subject|1|||
150045705|NCT00854113|541307947|FG009|Overall Study|Withdrawal by Subject|0|||
150045706|NCT00854113|541307948|FG010|Overall Study|Withdrawal by Subject|0|||
150045707|NCT00796419|541307950|FG000|Overall Study|Death|0|||
150045708|NCT00796419|541307951|FG001|Overall Study|Death|1|||
150045709|NCT00539864|541307952|FG000|Overall Study|Lost to Follow-up|0|||
150045710|NCT00539864|541307953|FG001|Overall Study|Lost to Follow-up|1|||
150045711|NCT00539864|541307952|FG000|Overall Study|Withdrawal by Subject|1|||
150045712|NCT00539864|541307953|FG001|Overall Study|Withdrawal by Subject|1|||
150045713|NCT01250145|541307954|FG000|Overall Study|Adverse Event|2|||
150045714|NCT01250145|541307955|FG001|Overall Study|Adverse Event|1|||
150045715|NCT01250145|541307954|FG000|Overall Study|Withdrawal by Subject|0|||
150045716|NCT01250145|541307955|FG001|Overall Study|Withdrawal by Subject|4|||
150045717|NCT02840799|541307958|FG000|Phase 1|Physician Decision|1|||
150045718|NCT02840799|541307959|FG001|Phase 1|Physician Decision|3|||
150045719|NCT02840799|541307958|FG000|Phase 1|Withdrawal by Subject|4|||
150045720|NCT02840799|541307959|FG001|Phase 1|Withdrawal by Subject|0|||
149899075|NCT00703157|540761012|FG000|Overall Study|Lost to Follow-up|0|||
149899076|NCT00703157|540761013|FG001|Overall Study|Lost to Follow-up|1|||
149899077|NCT00703157|540761012|FG000|Overall Study|source data permanently lost/ other|4|||
149899078|NCT00703157|540761013|FG001|Overall Study|source data permanently lost/ other|1|||
150045721|NCT02840799|541307958|FG000|Phase 2 (Crossover)|Adverse Event|0|||
149899079|NCT02968173|540761016|FG000|Overall Study|Withdrawal by Subject|1|||
149899080|NCT04586244|540761017|FG000|Overall Study|Lost to Follow-up|1|||
150045722|NCT02840799|541307959|FG001|Phase 2 (Crossover)|Adverse Event|1|||
150045723|NCT02840799|541307958|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
150045724|NCT02840799|541307959|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
150045725|NCT02687191|541307963|FG000|Overall Study|Death|0|||
149899081|NCT04586244|540761018|FG001|Overall Study|Lost to Follow-up|0|||
149899082|NCT04586244|540761019|FG002|Overall Study|Lost to Follow-up|0|||
149899083|NCT04586244|540761020|FG003|Overall Study|Lost to Follow-up|1|||
149899084|NCT04586244|540761021|FG004|Overall Study|Lost to Follow-up|0|||
149899085|NCT04586244|540761017|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
149899086|NCT04586244|540761018|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
149899087|NCT04586244|540761019|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
149899088|NCT04586244|540761020|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
149899089|NCT04586244|540761021|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
149899090|NCT03517540|540761024|FG000|Overall Study|Protocol Violation|2|||
149899091|NCT03517540|540761025|FG001|Overall Study|Protocol Violation|0|||
149899092|NCT03517540|540761026|FG002|Overall Study|Protocol Violation|0|||
149899093|NCT03517540|540761027|FG003|Overall Study|Protocol Violation|1|||
149899094|NCT03517540|540761024|FG000|Overall Study|Adverse Event|9|||
149899095|NCT03517540|540761025|FG001|Overall Study|Adverse Event|3|||
149899096|NCT03517540|540761026|FG002|Overall Study|Adverse Event|8|||
149899097|NCT03517540|540761027|FG003|Overall Study|Adverse Event|1|||
149899098|NCT03517540|540761024|FG000|Overall Study|Withdrawal by Subject|3|||
149899099|NCT03517540|540761025|FG001|Overall Study|Withdrawal by Subject|4|||
149899100|NCT03517540|540761026|FG002|Overall Study|Withdrawal by Subject|1|||
149899101|NCT03517540|540761027|FG003|Overall Study|Withdrawal by Subject|3|||
149899102|NCT00615550|540761028|FG000|Overall Study|Lost to Follow-up|6|||
149899103|NCT00615550|540761029|FG001|Overall Study|Lost to Follow-up|1|||
149899104|NCT01207687|540761030|FG000|Overall Study|Adverse Event|1|||
149899105|NCT01207687|540761030|FG000|Overall Study|Withdrawal by Subject|1|||
149899106|NCT01801865|540761031|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
149899107|NCT01801865|540761031|FG000|Overall Study|Physician Decision|7|||
149899108|NCT01500382|540761034|FG000|Washout Period|Study site went out of business|0|||
149899109|NCT01500382|540761035|FG001|Washout Period|Study site went out of business|0|||
149899110|NCT01500382|540761036|FG002|Washout Period|Study site went out of business|1|||
149899111|NCT01500382|540761037|FG003|Washout Period|Study site went out of business|0|||
149899112|NCT01777282|540761038|FG000|Overall Study|Persistent Hyperglycemia|0|||
149899113|NCT01777282|540761039|FG001|Overall Study|Persistent Hyperglycemia|0|||
149899114|NCT01777282|540761040|FG002|Overall Study|Persistent Hyperglycemia|1|||
149899115|NCT01777282|540761041|FG003|Overall Study|Persistent Hyperglycemia|0|||
149899116|NCT01777282|540761042|FG004|Overall Study|Persistent Hyperglycemia|0|||
149899117|NCT01777282|540761038|FG000|Overall Study|New Antidiabetic Medication|0|||
149899118|NCT01777282|540761039|FG001|Overall Study|New Antidiabetic Medication|0|||
149899119|NCT01777282|540761040|FG002|Overall Study|New Antidiabetic Medication|1|||
149899120|NCT01777282|540761041|FG003|Overall Study|New Antidiabetic Medication|0|||
149899121|NCT01777282|540761042|FG004|Overall Study|New Antidiabetic Medication|0|||
149899122|NCT01777282|540761038|FG000|Overall Study|Adverse Event|4|||
149899123|NCT01777282|540761039|FG001|Overall Study|Adverse Event|4|||
150045726|NCT02687191|541307964|FG001|Overall Study|Death|1|||
150045727|NCT02687191|541307965|FG002|Overall Study|Death|1|||
150045728|NCT02687191|541307966|FG003|Overall Study|Death|0|||
150045729|NCT02687191|541307967|FG004|Overall Study|Death|1|||
150045730|NCT02687191|541307968|FG005|Overall Study|Death|1|||
150045731|NCT02687191|541307963|FG000|Overall Study|Withdrawal by Subject|0|||
150045732|NCT02687191|541307964|FG001|Overall Study|Withdrawal by Subject|0|||
150045733|NCT02687191|541307965|FG002|Overall Study|Withdrawal by Subject|0|||
149899124|NCT01777282|540761040|FG002|Overall Study|Adverse Event|2|||
149899125|NCT01777282|540761041|FG003|Overall Study|Adverse Event|1|||
149899126|NCT01777282|540761042|FG004|Overall Study|Adverse Event|3|||
149899127|NCT01777282|540761038|FG000|Overall Study|Withdrawal by Subject|4|||
149899128|NCT01777282|540761039|FG001|Overall Study|Withdrawal by Subject|0|||
149899129|NCT01777282|540761040|FG002|Overall Study|Withdrawal by Subject|0|||
149899130|NCT01777282|540761041|FG003|Overall Study|Withdrawal by Subject|1|||
149899131|NCT01777282|540761042|FG004|Overall Study|Withdrawal by Subject|2|||
150045734|NCT02687191|541307966|FG003|Overall Study|Withdrawal by Subject|1|||
150045735|NCT02687191|541307967|FG004|Overall Study|Withdrawal by Subject|0|||
149899132|NCT01777282|540761038|FG000|Overall Study|Protocol Violation|2|||
149899133|NCT01777282|540761039|FG001|Overall Study|Protocol Violation|0|||
149899134|NCT01777282|540761040|FG002|Overall Study|Protocol Violation|1|||
149899135|NCT01777282|540761041|FG003|Overall Study|Protocol Violation|0|||
149899136|NCT01777282|540761042|FG004|Overall Study|Protocol Violation|2|||
149899137|NCT01777282|540761038|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
149899138|NCT01777282|540761039|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
149899139|NCT01777282|540761040|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
149899140|NCT01777282|540761041|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
149899141|NCT01777282|540761042|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
149899142|NCT04015518|540761043|FG000|Overall Study|Adverse Event|6|||
149899143|NCT04015518|540761044|FG001|Overall Study|Adverse Event|1|||
149899144|NCT04015518|540761045|FG002|Overall Study|Adverse Event|1|||
149899145|NCT04015518|540761046|FG003|Overall Study|Adverse Event|3|||
149899146|NCT04015518|540761047|FG004|Overall Study|Adverse Event|3|||
149899147|NCT04015518|540761043|FG000|Overall Study|Lack of Efficacy|1|||
149899148|NCT04015518|540761044|FG001|Overall Study|Lack of Efficacy|0|||
149899149|NCT04015518|540761045|FG002|Overall Study|Lack of Efficacy|1|||
149899150|NCT04015518|540761046|FG003|Overall Study|Lack of Efficacy|0|||
149899151|NCT04015518|540761047|FG004|Overall Study|Lack of Efficacy|4|||
149899152|NCT04015518|540761043|FG000|Overall Study|Lost to Follow-up|0|||
149899153|NCT04015518|540761044|FG001|Overall Study|Lost to Follow-up|0|||
149899154|NCT04015518|540761045|FG002|Overall Study|Lost to Follow-up|0|||
149899155|NCT04015518|540761046|FG003|Overall Study|Lost to Follow-up|0|||
149899156|NCT04015518|540761047|FG004|Overall Study|Lost to Follow-up|1|||
149899157|NCT04015518|540761043|FG000|Overall Study|Withdrawal by Subject|0|||
149899158|NCT04015518|540761044|FG001|Overall Study|Withdrawal by Subject|1|||
149899159|NCT04015518|540761045|FG002|Overall Study|Withdrawal by Subject|0|||
149899160|NCT04015518|540761046|FG003|Overall Study|Withdrawal by Subject|1|||
149899161|NCT04015518|540761047|FG004|Overall Study|Withdrawal by Subject|1|||
149899162|NCT04015518|540761043|FG000|Overall Study|Patient did not come for consecutive visits|0|||
149899163|NCT04015518|540761044|FG001|Overall Study|Patient did not come for consecutive visits|1|||
149899164|NCT04015518|540761045|FG002|Overall Study|Patient did not come for consecutive visits|0|||
149899165|NCT04015518|540761046|FG003|Overall Study|Patient did not come for consecutive visits|0|||
149899166|NCT04015518|540761047|FG004|Overall Study|Patient did not come for consecutive visits|0|||
149899167|NCT04015518|540761043|FG000|Overall Study|not willing to travel due to Covid-19|0|||
149899168|NCT04015518|540761044|FG001|Overall Study|not willing to travel due to Covid-19|0|||
149899169|NCT04015518|540761045|FG002|Overall Study|not willing to travel due to Covid-19|1|||
149899170|NCT04015518|540761046|FG003|Overall Study|not willing to travel due to Covid-19|0|||
149899171|NCT04015518|540761047|FG004|Overall Study|not willing to travel due to Covid-19|0|||
149899172|NCT04015518|540761043|FG000|Overall Study|Patient wants to discontinue treatment|0|||
149899173|NCT04015518|540761044|FG001|Overall Study|Patient wants to discontinue treatment|0|||
149899174|NCT04015518|540761045|FG002|Overall Study|Patient wants to discontinue treatment|0|||
149899175|NCT04015518|540761046|FG003|Overall Study|Patient wants to discontinue treatment|1|||
149899176|NCT04015518|540761047|FG004|Overall Study|Patient wants to discontinue treatment|0|||
149899177|NCT04015518|540761043|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
149899178|NCT04015518|540761044|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
149899179|NCT04015518|540761045|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
149899180|NCT04015518|540761046|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
149899181|NCT04015518|540761047|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
149899182|NCT04015518|540761043|FG000|Overall Study|Pregnancy|0|||
149899183|NCT04015518|540761044|FG001|Overall Study|Pregnancy|0|||
149899184|NCT04015518|540761045|FG002|Overall Study|Pregnancy|0|||
149899185|NCT04015518|540761046|FG003|Overall Study|Pregnancy|0|||
149899186|NCT04015518|540761047|FG004|Overall Study|Pregnancy|1|||
149899187|NCT04015518|540761043|FG000|Overall Study|Personal reasons|1|||
149899188|NCT04015518|540761044|FG001|Overall Study|Personal reasons|0|||
149899189|NCT04015518|540761045|FG002|Overall Study|Personal reasons|0|||
149899190|NCT04015518|540761046|FG003|Overall Study|Personal reasons|0|||
149899191|NCT04015518|540761047|FG004|Overall Study|Personal reasons|1|||
149899192|NCT04015518|540761043|FG000|Overall Study|Withdrew consent|1|||
149899193|NCT04015518|540761044|FG001|Overall Study|Withdrew consent|0|||
149899194|NCT04015518|540761045|FG002|Overall Study|Withdrew consent|0|||
149899195|NCT04015518|540761046|FG003|Overall Study|Withdrew consent|0|||
149899196|NCT04015518|540761047|FG004|Overall Study|Withdrew consent|0|||
149899197|NCT04015518|540761043|FG000|Overall Study|Prostate carcinoma|1|||
149899198|NCT04015518|540761044|FG001|Overall Study|Prostate carcinoma|0|||
149899199|NCT04015518|540761045|FG002|Overall Study|Prostate carcinoma|0|||
149899200|NCT04015518|540761046|FG003|Overall Study|Prostate carcinoma|0|||
149899201|NCT04015518|540761047|FG004|Overall Study|Prostate carcinoma|0|||
149899202|NCT04015518|540761043|FG000|Overall Study|Could not keep appointments due to work|1|||
149899203|NCT04015518|540761044|FG001|Overall Study|Could not keep appointments due to work|0|||
150176357|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
149899204|NCT04015518|540761045|FG002|Overall Study|Could not keep appointments due to work|0|||
149899205|NCT04015518|540761046|FG003|Overall Study|Could not keep appointments due to work|0|||
149899206|NCT04015518|540761047|FG004|Overall Study|Could not keep appointments due to work|0|||
149899207|NCT00550745|540761048|FG000|Overall Study|Death|20|||
150045736|NCT02687191|541307968|FG005|Overall Study|Withdrawal by Subject|0|||
149899208|NCT00550745|540761049|FG001|Overall Study|Death|16|||
149899209|NCT00550745|540761048|FG000|Overall Study|Lost to Follow-up|45|||
149899210|NCT00550745|540761049|FG001|Overall Study|Lost to Follow-up|30|||
149899211|NCT00550745|540761048|FG000|Overall Study|Physician Decision|0|||
149899212|NCT00550745|540761049|FG001|Overall Study|Physician Decision|2|||
149899213|NCT00550745|540761048|FG000|Overall Study|Protocol Violation|4|||
149899214|NCT00550745|540761049|FG001|Overall Study|Protocol Violation|2|||
149899215|NCT00550745|540761048|FG000|Overall Study|Withdrawal by Subject|17|||
149899216|NCT00550745|540761049|FG001|Overall Study|Withdrawal by Subject|10|||
149899217|NCT00550745|540761048|FG000|Overall Study|Screen failure|1|||
149899218|NCT00550745|540761049|FG001|Overall Study|Screen failure|0|||
149899219|NCT00764660|540761050|FG000|Overall Study|Adverse Event|6|||
149899220|NCT00764660|540761051|FG001|Overall Study|Adverse Event|3|||
149899221|NCT00764660|540761050|FG000|Overall Study|Lost to Follow-up|3|||
149899222|NCT00764660|540761051|FG001|Overall Study|Lost to Follow-up|4|||
149899223|NCT00764660|540761050|FG000|Overall Study|Withdrawal by Subject|7|||
149899224|NCT00764660|540761051|FG001|Overall Study|Withdrawal by Subject|3|||
149899225|NCT00764660|540761050|FG000|Overall Study|Noncompliance With Protocol|5|||
149899226|NCT00764660|540761051|FG001|Overall Study|Noncompliance With Protocol|1|||
149899227|NCT00764660|540761050|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
149899228|NCT00764660|540761051|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
149899229|NCT03831113|540762784|FG000|Overall Study|Withdrawal by Subject|0|||
149899230|NCT03831113|540762785|FG001|Overall Study|Withdrawal by Subject|2|||
149899231|NCT03831113|540762784|FG000|Overall Study|Protocol Violation|0|||
149899232|NCT03831113|540762785|FG001|Overall Study|Protocol Violation|9|||
149899233|NCT02498444|540762789|FG000|Overall Study|Withdrawal by Subject|3|||
149899234|NCT02498444|540762790|FG001|Overall Study|Withdrawal by Subject|0|||
149899235|NCT02498444|540762789|FG000|Overall Study|Physician Decision|1|||
149899236|NCT02498444|540762790|FG001|Overall Study|Physician Decision|0|||
149899237|NCT03656692|540762791|FG000|Overall Study|Worsening of disease activity|2|||
149899238|NCT03656692|540762791|FG000|Overall Study|Physician Decision|1|||
149899239|NCT01841762|540762792|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
149899240|NCT01841762|540762792|FG000|Treatment Period|Adverse Event|16|||
149899241|NCT01841762|540762792|FG000|Treatment Period|Death|1|||
149899242|NCT01841762|540762792|FG000|Treatment Period|Withdrawal by Subject|7|||
149899243|NCT01841762|540762792|FG000|Treatment Period|Lost to Follow-up|1|||
149899244|NCT01841762|540762792|FG000|Treatment Period|Physician Decision|2|||
149899245|NCT01841762|540762792|FG000|Treatment Period|Other, including non-compliance|5|||
149899246|NCT01841762|540762792|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
149899247|NCT01841762|540762792|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
149899248|NCT01841762|540762792|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
149899249|NCT01841762|540762792|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
149899250|NCT03981900|540762793|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
149899251|NCT03981900|540762793|FG000|Overall Study|Adverse Event|5|||
149899252|NCT03981900|540762793|FG000|Overall Study|Protocol Violation|1|||
149899253|NCT03981900|540762793|FG000|Overall Study|Withdrawal by Subject|7|||
149899254|NCT03981900|540762793|FG000|Overall Study|Lost to Follow-up|46|||
149899255|NCT03981900|540762793|FG000|Overall Study|Decision of the researcher|3|||
149899256|NCT03981900|540762793|FG000|Overall Study|Death|3|||
149899257|NCT03981900|540762793|FG000|Overall Study|Other|5|||
149899258|NCT02693106|540762795|FG000|Overall Study|No time|3|||
149899259|NCT06152224|540762804|FG000|Overall Study|Withdrawal by Subject|1|||
149899260|NCT06152224|540762805|FG001|Overall Study|Withdrawal by Subject|0|||
149899261|NCT06152224|540762804|FG000|Overall Study|Lost to Follow-up|0|||
149899262|NCT06152224|540762805|FG001|Overall Study|Lost to Follow-up|1|||
149899263|NCT06152224|540762804|FG000|Overall Study|On Follow Up|18|||
149899264|NCT06152224|540762805|FG001|Overall Study|On Follow Up|18|||
149899265|NCT06028438|540762808|FG000|Overall Study|Adverse Event|3|||
149899266|NCT06028438|540762809|FG001|Overall Study|Adverse Event|9|||
149899267|NCT06028438|540762808|FG000|Overall Study|Lack of Efficacy|1|||
149899268|NCT06028438|540762809|FG001|Overall Study|Lack of Efficacy|1|||
149899269|NCT06028438|540762808|FG000|Overall Study|Lost to Follow-up|1|||
149899270|NCT06028438|540762809|FG001|Overall Study|Lost to Follow-up|0|||
149899271|NCT06028438|540762808|FG000|Overall Study|Withdrawal by Subject|1|||
149899272|NCT06028438|540762809|FG001|Overall Study|Withdrawal by Subject|0|||
149899273|NCT06028438|540762808|FG000|Overall Study|Other|3|||
149899274|NCT06028438|540762809|FG001|Overall Study|Other|3|||
149899275|NCT05625802|540762810|FG000|Overall Study|Lost to Follow-up|1|||
149899276|NCT05625802|540762811|FG001|Overall Study|Lost to Follow-up|0|||
149899277|NCT02509507|540762812|FG000|Overall Study|Death|21|||
149899278|NCT02509507|540762813|FG001|Overall Study|Death|3|||
149899279|NCT02509507|540762814|FG002|Overall Study|Death|22|||
149899280|NCT02509507|540762815|FG003|Overall Study|Death|14|||
149899281|NCT02509507|540762816|FG004|Overall Study|Death|8|||
149899282|NCT02509507|540762817|FG005|Overall Study|Death|12|||
149899283|NCT02509507|540762818|FG006|Overall Study|Death|5|||
149899284|NCT02509507|540762819|FG007|Overall Study|Death|4|||
149899285|NCT02509507|540762820|FG008|Overall Study|Death|8|||
149899286|NCT02509507|540762812|FG000|Overall Study|Lost to Follow-up|0|||
149899287|NCT02509507|540762813|FG001|Overall Study|Lost to Follow-up|1|||
149899288|NCT02509507|540762814|FG002|Overall Study|Lost to Follow-up|0|||
149899289|NCT02509507|540762815|FG003|Overall Study|Lost to Follow-up|0|||
149899290|NCT02509507|540762816|FG004|Overall Study|Lost to Follow-up|0|||
149899291|NCT02509507|540762817|FG005|Overall Study|Lost to Follow-up|2|||
149899292|NCT02509507|540762818|FG006|Overall Study|Lost to Follow-up|0|||
149899293|NCT02509507|540762819|FG007|Overall Study|Lost to Follow-up|0|||
149899294|NCT02509507|540762820|FG008|Overall Study|Lost to Follow-up|0|||
149899295|NCT02509507|540762812|FG000|Overall Study|Withdrawal by Subject|2|||
149899296|NCT02509507|540762813|FG001|Overall Study|Withdrawal by Subject|0|||
149899297|NCT02509507|540762814|FG002|Overall Study|Withdrawal by Subject|1|||
149899298|NCT02509507|540762815|FG003|Overall Study|Withdrawal by Subject|4|||
149899299|NCT02509507|540762816|FG004|Overall Study|Withdrawal by Subject|1|||
149899300|NCT02509507|540762817|FG005|Overall Study|Withdrawal by Subject|3|||
149899301|NCT02509507|540762818|FG006|Overall Study|Withdrawal by Subject|4|||
149899302|NCT02509507|540762819|FG007|Overall Study|Withdrawal by Subject|0|||
149899303|NCT02509507|540762820|FG008|Overall Study|Withdrawal by Subject|1|||
149899304|NCT04090060|540762824|FG000|Overall Study|Lost to Follow-up|76|||
149899305|NCT04090060|540762825|FG001|Overall Study|Lost to Follow-up|77|||
149899306|NCT03337113|540762832|FG000|Overall Study|Adverse Event|1|||
149899307|NCT03337113|540762833|FG001|Overall Study|Adverse Event|1|||
149899308|NCT03337113|540762834|FG002|Overall Study|Adverse Event|0|||
149899309|NCT03337113|540762835|FG003|Overall Study|Adverse Event|1|||
149899310|NCT03337113|540762832|FG000|Overall Study|Physician Decision|0|||
149899311|NCT03337113|540762833|FG001|Overall Study|Physician Decision|2|||
149899312|NCT03337113|540762834|FG002|Overall Study|Physician Decision|0|||
149899313|NCT03337113|540762835|FG003|Overall Study|Physician Decision|1|||
149899314|NCT03337113|540762832|FG000|Overall Study|Withdrawal by Subject|0|||
149899315|NCT03337113|540762833|FG001|Overall Study|Withdrawal by Subject|0|||
149899316|NCT03337113|540762834|FG002|Overall Study|Withdrawal by Subject|1|||
149899317|NCT03337113|540762835|FG003|Overall Study|Withdrawal by Subject|0|||
149899318|NCT02176655|540762838|FG000|Overall Study|Subjects did not treat|6|||
149899319|NCT06110494|540762839|FG000|Overall Study|Protocol Violation|2|||
149899320|NCT06110494|540762840|FG001|Overall Study|Protocol Violation|0|||
149899321|NCT06110494|540762841|FG002|Overall Study|Protocol Violation|1|||
149899322|NCT06110494|540762839|FG000|Overall Study|Dixon's test for outlier analysis|1|||
149899323|NCT06110494|540762840|FG001|Overall Study|Dixon's test for outlier analysis|1|||
149899324|NCT06110494|540762841|FG002|Overall Study|Dixon's test for outlier analysis|0|||
149899325|NCT02490371|540762853|FG000|Overall Study|Lost to Follow-up|1|||
149899326|NCT02490371|540762854|FG001|Overall Study|Lost to Follow-up|1|||
149899327|NCT01718535|540762857|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
149899328|NCT01718535|540762858|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
149899329|NCT01718535|540762859|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
149899330|NCT01718535|540762860|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
149899331|NCT01718535|540762861|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
149899332|NCT01718535|540762862|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
149899333|NCT01718535|540762863|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
149899334|NCT01718535|540762864|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
149899335|NCT01718535|540762865|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
149899336|NCT01718535|540762866|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
149899337|NCT01163851|540762869|FG000|Overall Study|Site Closure|0|||
149899338|NCT01163851|540762870|FG001|Overall Study|Site Closure|1|||
149899339|NCT01163851|540762869|FG000|Overall Study|Enrolled but not treated|1|||
149899340|NCT01163851|540762870|FG001|Overall Study|Enrolled but not treated|0|||
149899341|NCT02476578|540762871|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
149899342|NCT02476578|540762872|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
149899343|NCT02476578|540762871|FG000|Overall Study|Lost to Follow-up|6|||
149899344|NCT02476578|540762872|FG001|Overall Study|Lost to Follow-up|13|||
149899345|NCT01073605|540762873|FG000|Overall Study|Ongoing at Cutoff Date|1|||
149899346|NCT01073605|540762874|FG001|Overall Study|Ongoing at Cutoff Date|1|||
149899347|NCT01073605|540762875|FG002|Overall Study|Ongoing at Cutoff Date|0|||
149899348|NCT01073605|540762873|FG000|Overall Study|Adverse Event|2|||
149899349|NCT01073605|540762874|FG001|Overall Study|Adverse Event|1|||
149899350|NCT01073605|540762875|FG002|Overall Study|Adverse Event|0|||
149899351|NCT01073605|540762873|FG000|Overall Study|Lost to Follow-up|3|||
149899352|NCT01073605|540762874|FG001|Overall Study|Lost to Follow-up|4|||
149899353|NCT01073605|540762875|FG002|Overall Study|Lost to Follow-up|9|||
149899354|NCT01073605|540762873|FG000|Overall Study|Other|25|||
149899355|NCT01073605|540762874|FG001|Overall Study|Other|21|||
149899356|NCT01073605|540762875|FG002|Overall Study|Other|29|||
149899357|NCT01073605|540762873|FG000|Overall Study|Withdrawal by Subject|31|||
149899358|NCT01073605|540762874|FG001|Overall Study|Withdrawal by Subject|39|||
149899359|NCT01073605|540762875|FG002|Overall Study|Withdrawal by Subject|22|||
149899360|NCT01073605|540762873|FG000|Overall Study|Randomized But Not Treated|0|||
149899361|NCT01073605|540762874|FG001|Overall Study|Randomized But Not Treated|1|||
149899362|NCT01073605|540762875|FG002|Overall Study|Randomized But Not Treated|1|||
149899363|NCT04938180|540762876|FG000|Overall Study|Adverse Event|1|||
149899364|NCT03018080|540762877|FG000|Overall Study|Death|12|||
149899365|NCT03018080|540762878|FG001|Overall Study|Death|19|||
149899366|NCT03491462|540762879|FG000|Overall Study|Lost to Follow-up|2|||
149899367|NCT03491462|540762880|FG001|Overall Study|Lost to Follow-up|0|||
149899368|NCT03491462|540762879|FG000|Overall Study|Adverse Event|11|||
149899369|NCT03491462|540762880|FG001|Overall Study|Adverse Event|1|||
149899370|NCT03491462|540762879|FG000|Overall Study|Physician Decision|3|||
149899371|NCT03491462|540762880|FG001|Overall Study|Physician Decision|0|||
149899372|NCT03491462|540762879|FG000|Overall Study|Withdrawal by Subject|22|||
149899373|NCT03491462|540762880|FG001|Overall Study|Withdrawal by Subject|15|||
149899374|NCT00423332|540762881|FG000|Overall Study|Adverse Event|6|||
149899375|NCT00423332|540762882|FG001|Overall Study|Adverse Event|2|||
149899376|NCT00423332|540762881|FG000|Overall Study|Withdrawal by Subject|1|||
149899377|NCT00423332|540762882|FG001|Overall Study|Withdrawal by Subject|0|||
149899378|NCT00423332|540762881|FG000|Overall Study|Condition under investigation worsened|1|||
149899379|NCT00423332|540762882|FG001|Overall Study|Condition under investigation worsened|1|||
149899380|NCT00423332|540762881|FG000|Overall Study|Progressive at Week 6|0|||
149899381|NCT00423332|540762882|FG001|Overall Study|Progressive at Week 6|1|||
149899382|NCT00423332|540762881|FG000|Overall Study|Unblinded before 12 weeks|1|||
149899383|NCT00423332|540762882|FG001|Overall Study|Unblinded before 12 weeks|3|||
149899384|NCT02035202|540762892|FG000|Overall Study|Lost to Follow-up|8|||
149899385|NCT02035202|540762893|FG001|Overall Study|Lost to Follow-up|16|||
149899386|NCT02035202|540762894|FG002|Overall Study|Lost to Follow-up|2|||
149899387|NCT00644917|540762895|FG000|Overall Study|Withdrawal by Subject|2|||
149899388|NCT00758485|540762896|FG000|Overall Study|Lost to Follow-up|0|||
149899389|NCT00758485|540762897|FG001|Overall Study|Lost to Follow-up|1|||
149899390|NCT00758485|540762896|FG000|Overall Study|Not Treated|1|||
149899391|NCT00758485|540762897|FG001|Overall Study|Not Treated|2|||
149899392|NCT00921557|540762898|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
149899393|NCT00921557|540762899|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
149899394|NCT00921557|540762900|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
149899395|NCT00921557|540762898|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
149899396|NCT00921557|540762899|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
149899397|NCT00921557|540762900|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
149899398|NCT00921557|540762898|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
149899399|NCT00921557|540762899|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
149899400|NCT00921557|540762900|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
149899401|NCT00921557|540762898|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
149899402|NCT00921557|540762899|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
149899403|NCT00921557|540762900|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
149899404|NCT00921557|540762898|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
149899405|NCT00921557|540762899|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
149899406|NCT00921557|540762900|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
149899407|NCT03259425|540762910|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
149899408|NCT02097238|540762920|FG000|Overall Study|Death|1|||
149899409|NCT02097238|540762920|FG000|Overall Study|Physician Decision|1|||
149899410|NCT02097238|540762920|FG000|Overall Study|Progressive Disease|17|||
149899411|NCT01282372|540762921|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
149899412|NCT01282372|540762921|FG000|Overall Study|Lost to Follow-up|23|||
149899413|NCT01282372|540762921|FG000|Overall Study|Withdrawal by Subject|11|||
149899414|NCT01282372|540762921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
149899415|NCT01282372|540762921|FG000|Overall Study|Death|1|||
149899416|NCT01282372|540762921|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
149899417|NCT01282372|540762921|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
149899418|NCT01282372|540762921|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
149899419|NCT01282372|540762921|FG000|Overall Study|Adverse Event|12|||
149899420|NCT02097745|540762925|FG000|Overall Study|Adverse Event|25|||
149899421|NCT02097745|540762925|FG000|Overall Study|Death|16|||
149899422|NCT02097745|540762925|FG000|Overall Study|Failure to Return|14|||
149899423|NCT02097745|540762925|FG000|Overall Study|Administrative/Other|27|||
149899424|NCT02097745|540762925|FG000|Overall Study|Reason Not Specified|96|||
149899425|NCT03515811|540762930|FG000|Overall Study|Lost to Follow-up|2|||
149899426|NCT03515811|540762931|FG001|Overall Study|Lost to Follow-up|1|||
149899427|NCT03515811|540762930|FG000|Overall Study|Protocol Violation|1|||
149899428|NCT03515811|540762931|FG001|Overall Study|Protocol Violation|1|||
149899429|NCT03515811|540762930|FG000|Overall Study|Death|1|||
149899430|NCT03515811|540762931|FG001|Overall Study|Death|1|||
149899431|NCT03515811|540762930|FG000|Overall Study|Withdrawal by Subject|0|||
149899432|NCT03515811|540762931|FG001|Overall Study|Withdrawal by Subject|2|||
149899433|NCT03515811|540762930|FG000|Overall Study|Technical Problems|1|||
149899434|NCT03515811|540762931|FG001|Overall Study|Technical Problems|0|||
149899435|NCT03515811|540762930|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
149899436|NCT03515811|540762931|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
149899437|NCT03515811|540762930|FG000|Overall Study|COVID-19|0|||
149899438|NCT03515811|540762931|FG001|Overall Study|COVID-19|1|||
149899439|NCT00237458|540762932|FG000|Overall Study|Lack of Efficacy|1|||
149899440|NCT00237458|540762932|FG000|Overall Study|Adverse Event|1|||
149899441|NCT00237458|540762932|FG000|Overall Study|Withdrawal by Subject|1|||
149899442|NCT01276756|540762935|FG000|Overall Study|Lost to Follow-up|2|||
149899443|NCT01276756|540762936|FG001|Overall Study|Lost to Follow-up|0|||
149899444|NCT01276756|540762935|FG000|Overall Study|Adverse Event|3|||
149899445|NCT01276756|540762936|FG001|Overall Study|Adverse Event|2|||
149899446|NCT05868577|540762939|FG000|Overall Study|Lost to Follow-up|5|||
149899447|NCT05868577|540762940|FG001|Overall Study|Lost to Follow-up|5|||
149899448|NCT02630251|540762941|FG000|Overall Study|Physician Decision|0|||
149899449|NCT02630251|540762942|FG001|Overall Study|Physician Decision|0|||
149899450|NCT02630251|540762943|FG002|Overall Study|Physician Decision|1|||
149899451|NCT02630251|540762944|FG003|Overall Study|Physician Decision|0|||
149899452|NCT03564119|540762945|FG000|Overall Study|Adverse Event|4|||
149899453|NCT03564119|540762946|FG001|Overall Study|Adverse Event|0|||
149899454|NCT03564119|540762945|FG000|Overall Study|Lost to Follow-up|1|||
149899455|NCT03564119|540762946|FG001|Overall Study|Lost to Follow-up|4|||
149899456|NCT03564119|540762945|FG000|Overall Study|Protocol Violation|1|||
149899457|NCT03564119|540762946|FG001|Overall Study|Protocol Violation|0|||
149899458|NCT03564119|540762945|FG000|Overall Study|Withdrawal by Subject|9|||
149899459|NCT03564119|540762946|FG001|Overall Study|Withdrawal by Subject|4|||
149899460|NCT03564119|540762945|FG000|Overall Study|Other Than Specified|0|||
150045737|NCT00943072|541307969|FG000|Overall Study|Adverse Event|0|||
150045738|NCT00943072|541307970|FG001|Overall Study|Adverse Event|3|||
150045739|NCT00943072|541307969|FG000|Overall Study|Death|0|||
150045740|NCT00943072|541307970|FG001|Overall Study|Death|2|||
149899461|NCT03564119|540762946|FG001|Overall Study|Other Than Specified|1|||
149899462|NCT00634036|540762947|FG000|Overall Study|Lost to Follow-up|1|||
149899463|NCT00634036|540762948|FG001|Overall Study|Lost to Follow-up|1|||
149899464|NCT00634036|540762947|FG000|Overall Study|Withdrawal by Subject|1|||
149899465|NCT00634036|540762948|FG001|Overall Study|Withdrawal by Subject|1|||
149899466|NCT03896022|540762949|FG000|Overall Study|Withdrawal by Subject|1|||
149899467|NCT03896022|540762950|FG001|Overall Study|Withdrawal by Subject|0|||
149899468|NCT03896022|540762951|FG002|Overall Study|Withdrawal by Subject|0|||
150045741|NCT00943072|541307969|FG000|Overall Study|Withdrawal by Subject|3|||
149899469|NCT03896022|540762949|FG000|Overall Study|Did not have procedure|3|||
149899470|NCT03896022|540762950|FG001|Overall Study|Did not have procedure|0|||
149899471|NCT03896022|540762951|FG002|Overall Study|Did not have procedure|0|||
149899472|NCT01131455|540762956|FG000|Overall Study|Death of PI|6|||
149899473|NCT01131455|540762957|FG001|Overall Study|Death of PI|4|||
149899474|NCT01131455|540762958|FG002|Overall Study|Death of PI|0|||
149899475|NCT01760655|540764436|FG000|Overall Study|Death|18|||
149899476|NCT01760655|540764436|FG000|Overall Study|Physician Decision|1|||
149899477|NCT03056638|540764449|FG000|Overall Study|Death|1|||
149899478|NCT03056638|540764450|FG001|Overall Study|Death|0|||
149899479|NCT02530125|540764451|FG000|Completed Treatment|Early termination of study|1|||
149899480|NCT02530125|540764451|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
149899481|NCT00468481|540764452|FG000|Overall Study|Adverse Event|13|||
149899482|NCT00468481|540764453|FG001|Overall Study|Adverse Event|3|||
149899483|NCT00468481|540764452|FG000|Overall Study|Lost to Follow-up|25|||
149899484|NCT00468481|540764453|FG001|Overall Study|Lost to Follow-up|8|||
149899485|NCT00468481|540764452|FG000|Overall Study|Pregnancy|2|||
149899486|NCT00468481|540764453|FG001|Overall Study|Pregnancy|0|||
149899487|NCT00468481|540764452|FG000|Overall Study|Protocol Violation|18|||
149899488|NCT00468481|540764453|FG001|Overall Study|Protocol Violation|8|||
149899489|NCT00468481|540764452|FG000|Overall Study|Withdrawal by Subject|12|||
149899490|NCT00468481|540764453|FG001|Overall Study|Withdrawal by Subject|3|||
149899491|NCT00468481|540764452|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
149899492|NCT00468481|540764453|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
149899493|NCT00468481|540764452|FG000|Overall Study|Prohibited Medication|1|||
149899494|NCT00468481|540764453|FG001|Overall Study|Prohibited Medication|1|||
149899495|NCT00468481|540764452|FG000|Overall Study|Egg Donor|1|||
149899496|NCT00468481|540764453|FG001|Overall Study|Egg Donor|0|||
149899497|NCT00468481|540764452|FG000|Overall Study|Moved out of area|4|||
149899498|NCT00468481|540764453|FG001|Overall Study|Moved out of area|1|||
149899499|NCT00468481|540764452|FG000|Overall Study|Non-Compliance|5|||
149899500|NCT00468481|540764453|FG001|Overall Study|Non-Compliance|0|||
149899501|NCT00468481|540764452|FG000|Overall Study|Other|6|||
149899502|NCT00468481|540764453|FG001|Overall Study|Other|0|||
149899503|NCT01568034|540764455|FG000|Overall Study|Withdrawal by Subject|1|||
149899504|NCT01568034|540764456|FG001|Overall Study|Withdrawal by Subject|0|||
149899505|NCT01568034|540764457|FG002|Overall Study|Withdrawal by Subject|0|||
149899506|NCT01568034|540764458|FG003|Overall Study|Withdrawal by Subject|0|||
149899507|NCT00728468|540764459|FG000|Overall Study|Enrolled but not treated|1|||
149968819|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968820|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149968821|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
149968822|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
149899508|NCT00728468|540764459|FG000|Overall Study|Death|1|||
149968823|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
149968824|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
149899509|NCT00728468|540764459|FG000|Overall Study|Protocol Violation|4|||
149899510|NCT00728468|540764459|FG000|Overall Study|Objective progression or relapse|9|||
149899511|NCT00728468|540764459|FG000|Overall Study|Study terminated by sponsor|1|||
149899512|NCT01637922|540764460|FG000|Overall Study|Adverse Event|0|||
149899513|NCT01637922|540764461|FG001|Overall Study|Adverse Event|1|||
149899514|NCT01637922|540764460|FG000|Overall Study|Protocol Violation|0|||
149899515|NCT01637922|540764461|FG001|Overall Study|Protocol Violation|1|||
149899516|NCT01637922|540764460|FG000|Overall Study|Withdrawal by Subject|0|||
149899517|NCT01637922|540764461|FG001|Overall Study|Withdrawal by Subject|3|||
149899518|NCT01637922|540764460|FG000|Overall Study|Lost to Follow-up|2|||
149899519|NCT01637922|540764461|FG001|Overall Study|Lost to Follow-up|0|||
149899520|NCT01515865|540764462|FG000|Part A (Open-label)|Other|3|||
149899521|NCT01515865|540764463|FG001|Part A (Open-label)|Other|0|||
149899522|NCT01515865|540764464|FG002|Part A (Open-label)|Other|0|||
149899523|NCT01515865|540764462|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
149899524|NCT01515865|540764463|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
149899525|NCT01515865|540764464|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
149899526|NCT01515865|540764462|FG000|Part B (Open-label)|Other|1|||
149899527|NCT01515865|540764463|FG001|Part B (Open-label)|Other|0|||
149899528|NCT01515865|540764464|FG002|Part B (Open-label)|Other|0|||
149899529|NCT02510664|540764469|FG000|Overall Study|Transferred Care|9|||
149899530|NCT02510664|540764470|FG001|Overall Study|Transferred Care|9|||
149899531|NCT02510664|540764471|FG002|Overall Study|Transferred Care|0|||
149899532|NCT02510664|540764469|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
149899533|NCT02510664|540764470|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
149899534|NCT02510664|540764471|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
149899535|NCT02510664|540764469|FG000|Overall Study|Time Constraints|1|||
149899536|NCT02510664|540764470|FG001|Overall Study|Time Constraints|1|||
149899537|NCT02510664|540764471|FG002|Overall Study|Time Constraints|0|||
149899538|NCT00740792|540764478|FG000|Overall Study|Adverse Event|3|||
149899539|NCT00740792|540764479|FG001|Overall Study|Adverse Event|1|||
149899540|NCT00740792|540764480|FG002|Overall Study|Adverse Event|1|||
149899541|NCT00740792|540764481|FG003|Overall Study|Adverse Event|3|||
149899542|NCT00740792|540764478|FG000|Overall Study|Lack of Efficacy|1|||
149899543|NCT00740792|540764479|FG001|Overall Study|Lack of Efficacy|1|||
149899544|NCT00740792|540764480|FG002|Overall Study|Lack of Efficacy|0|||
149899545|NCT00740792|540764481|FG003|Overall Study|Lack of Efficacy|3|||
149899546|NCT00740792|540764478|FG000|Overall Study|Lost to Follow-up|2|||
149899547|NCT00740792|540764479|FG001|Overall Study|Lost to Follow-up|1|||
149899548|NCT00740792|540764480|FG002|Overall Study|Lost to Follow-up|0|||
149899549|NCT00740792|540764481|FG003|Overall Study|Lost to Follow-up|0|||
149899550|NCT00740792|540764478|FG000|Overall Study|Protocol Violation|0|||
149899551|NCT00740792|540764479|FG001|Overall Study|Protocol Violation|1|||
149899552|NCT00740792|540764480|FG002|Overall Study|Protocol Violation|0|||
149899553|NCT00740792|540764481|FG003|Overall Study|Protocol Violation|2|||
149899554|NCT00740792|540764478|FG000|Overall Study|Withdrawal by Subject|1|||
149899555|NCT00740792|540764479|FG001|Overall Study|Withdrawal by Subject|1|||
149899556|NCT00740792|540764480|FG002|Overall Study|Withdrawal by Subject|0|||
149899557|NCT00740792|540764481|FG003|Overall Study|Withdrawal by Subject|0|||
149899558|NCT00740792|540764478|FG000|Overall Study|administrative|3|||
149899559|NCT00740792|540764479|FG001|Overall Study|administrative|3|||
149899560|NCT00740792|540764480|FG002|Overall Study|administrative|8|||
149899561|NCT00740792|540764481|FG003|Overall Study|administrative|2|||
149899562|NCT03412734|540764490|FG000|Overall Study|Incorrect labeling of samples|2|||
149899563|NCT03412734|540764491|FG001|Overall Study|Incorrect labeling of samples|0|||
149899564|NCT03412734|540764490|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
149899565|NCT03412734|540764491|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
149899566|NCT00179660|540764492|FG000|Overall Study|Adverse Event|7|||
149899567|NCT00179660|540764492|FG000|Overall Study|Lack of therapeutic effect|28|||
149899568|NCT00179660|540764492|FG000|Overall Study|Withdrawal by Subject|2|||
149899569|NCT00179660|540764492|FG000|Overall Study|Lost to Follow-up|1|||
149899570|NCT00179660|540764492|FG000|Overall Study|Death|3|||
149899571|NCT00179660|540764492|FG000|Overall Study|Other - Unspecified|9|||
149899572|NCT04478695|540764495|FG000|Overall Study|Death|1|||
149899573|NCT04478695|540764496|FG001|Overall Study|Death|0|||
149899574|NCT00402688|540764497|FG000|Overall Study|Adverse Event|12|||
149899575|NCT00402688|540764498|FG001|Overall Study|Adverse Event|9|||
149899576|NCT00402688|540764499|FG002|Overall Study|Adverse Event|3|||
149899577|NCT00402688|540764497|FG000|Overall Study|Withdrawal by Subject|3|||
149899578|NCT00402688|540764498|FG001|Overall Study|Withdrawal by Subject|1|||
149899579|NCT00402688|540764499|FG002|Overall Study|Withdrawal by Subject|1|||
149899580|NCT00402688|540764497|FG000|Overall Study|Physician Decision|0|||
149899581|NCT00402688|540764498|FG001|Overall Study|Physician Decision|0|||
149899582|NCT00402688|540764499|FG002|Overall Study|Physician Decision|1|||
149899583|NCT00402688|540764497|FG000|Overall Study|Lack of Efficacy|4|||
149899584|NCT00402688|540764498|FG001|Overall Study|Lack of Efficacy|4|||
149899585|NCT00402688|540764499|FG002|Overall Study|Lack of Efficacy|5|||
149899586|NCT00402688|540764497|FG000|Overall Study|Protocol Violation|1|||
149899587|NCT00402688|540764498|FG001|Overall Study|Protocol Violation|1|||
149899588|NCT00402688|540764499|FG002|Overall Study|Protocol Violation|1|||
149899589|NCT00402688|540764497|FG000|Overall Study|Lost to Follow-up|1|||
149899590|NCT00402688|540764498|FG001|Overall Study|Lost to Follow-up|0|||
149899591|NCT00402688|540764499|FG002|Overall Study|Lost to Follow-up|2|||
149899592|NCT00402688|540764497|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
149899593|NCT00402688|540764498|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
149899594|NCT00402688|540764499|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
149899595|NCT00402688|540764497|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
149899596|NCT00402688|540764498|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
149899597|NCT00402688|540764499|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
149899598|NCT00402688|540764497|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
150176358|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176359|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176360|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176361|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176362|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176363|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176364|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149899599|NCT00402688|540764498|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
149899600|NCT00402688|540764499|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
149899601|NCT00927862|540764500|FG000|Overall Study|Missing data needed for endpt analyses|27|||
149899602|NCT00927862|540764501|FG001|Overall Study|Missing data needed for endpt analyses|45|||
149899603|NCT01814696|540764508|FG000|Overall Study|Withdrawal by Subject|1|||
149899604|NCT01814696|540764509|FG001|Overall Study|Withdrawal by Subject|0|||
149899605|NCT01814696|540764508|FG000|Overall Study|Randomized to wrong group|1|||
149899606|NCT01814696|540764509|FG001|Overall Study|Randomized to wrong group|0|||
149899607|NCT00713258|540764510|FG000|Overall Study|Adverse Event|2|||
149899608|NCT00713258|540764511|FG001|Overall Study|Adverse Event|4|||
149899609|NCT00713258|540764510|FG000|Overall Study|Non-Compliance|2|||
149899610|NCT00713258|540764511|FG001|Overall Study|Non-Compliance|1|||
149899611|NCT00713258|540764510|FG000|Overall Study|Other|1|||
149899612|NCT00713258|540764511|FG001|Overall Study|Other|1|||
149899613|NCT01322490|540764512|FG000|Treatment Period|Adverse Event|12|||
149899614|NCT01322490|540764513|FG001|Treatment Period|Adverse Event|18|||
149899615|NCT01322490|540764514|FG002|Treatment Period|Adverse Event|15|||
149899616|NCT01322490|540764512|FG000|Treatment Period|Death|5|||
149899617|NCT01322490|540764513|FG001|Treatment Period|Death|7|||
149899618|NCT01322490|540764514|FG002|Treatment Period|Death|3|||
149899619|NCT01322490|540764512|FG000|Treatment Period|Lack of Efficacy|89|||
149899620|NCT01322490|540764513|FG001|Treatment Period|Lack of Efficacy|100|||
149899621|NCT01322490|540764514|FG002|Treatment Period|Lack of Efficacy|112|||
149899622|NCT01322490|540764512|FG000|Treatment Period|Physician Decision|0|||
149899623|NCT01322490|540764513|FG001|Treatment Period|Physician Decision|2|||
149899624|NCT01322490|540764514|FG002|Treatment Period|Physician Decision|1|||
150045742|NCT00943072|541307970|FG001|Overall Study|Withdrawal by Subject|1|||
149899625|NCT01322490|540764512|FG000|Treatment Period|Protocol Violation|7|||
149899626|NCT01322490|540764513|FG001|Treatment Period|Protocol Violation|5|||
149899627|NCT01322490|540764514|FG002|Treatment Period|Protocol Violation|4|||
149899628|NCT01322490|540764512|FG000|Treatment Period|Withdrawal by Subject|14|||
149899629|NCT01322490|540764513|FG001|Treatment Period|Withdrawal by Subject|16|||
150045743|NCT00943072|541307969|FG000|Overall Study|Protocol Violation|0|||
150045744|NCT00943072|541307970|FG001|Overall Study|Protocol Violation|1|||
150045745|NCT00943072|541307969|FG000|Overall Study|Lost to Follow-up|1|||
150045746|NCT00943072|541307970|FG001|Overall Study|Lost to Follow-up|2|||
149899630|NCT01322490|540764514|FG002|Treatment Period|Withdrawal by Subject|11|||
150045747|NCT00943072|541307969|FG000|Overall Study|Lack of Efficacy|0|||
150045748|NCT00943072|541307970|FG001|Overall Study|Lack of Efficacy|4|||
150045749|NCT00943072|541307969|FG000|Overall Study|Other|1|||
150045750|NCT00943072|541307970|FG001|Overall Study|Other|1|||
150176365|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149899631|NCT01322490|540764512|FG000|Treatment Period|Non-compliance with study drug|0|||
149899632|NCT01322490|540764513|FG001|Treatment Period|Non-compliance with study drug|0|||
149899633|NCT01322490|540764514|FG002|Treatment Period|Non-compliance with study drug|1|||
149899634|NCT01322490|540764512|FG000|Treatment Period|Other per report|2|||
149899635|NCT01322490|540764513|FG001|Treatment Period|Other per report|2|||
149899636|NCT01322490|540764514|FG002|Treatment Period|Other per report|1|||
150045751|NCT01349049|541307971|FG000|Overall Study|Disease progression|3|||
150045752|NCT01349049|541307972|FG001|Overall Study|Disease progression|5|||
149899637|NCT01322490|540764512|FG000|Treatment Period|Randomized but Not Treated|3|||
149899638|NCT01322490|540764513|FG001|Treatment Period|Randomized but Not Treated|3|||
149899639|NCT01322490|540764514|FG002|Treatment Period|Randomized but Not Treated|5|||
149899640|NCT01322490|540764512|FG000|Long Term Follow-up Period|Death|235|||
149899641|NCT01322490|540764513|FG001|Long Term Follow-up Period|Death|239|||
149899642|NCT01322490|540764514|FG002|Long Term Follow-up Period|Death|236|||
149899643|NCT01322490|540764512|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
149899644|NCT01322490|540764513|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
149899645|NCT01322490|540764514|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
149899646|NCT01322490|540764512|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
149899647|NCT01322490|540764513|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
149899648|NCT01322490|540764514|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
149899649|NCT01322490|540764512|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
149899650|NCT01322490|540764513|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
149899651|NCT01322490|540764514|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
149899652|NCT01322490|540764512|FG000|Long Term Follow-up Period|Other per report|3|||
149899653|NCT01322490|540764513|FG001|Long Term Follow-up Period|Other per report|2|||
149899654|NCT01322490|540764514|FG002|Long Term Follow-up Period|Other per report|2|||
149899655|NCT01322490|540764512|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
149899656|NCT01322490|540764513|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
150045753|NCT01349049|541307973|FG002|Overall Study|Disease progression|3|||
149899657|NCT01322490|540764514|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
149899658|NCT01431716|540764515|FG000|Overall Study|Withdrawal of consent|1|||
150045754|NCT01349049|541307974|FG003|Overall Study|Disease progression|2|||
150045755|NCT01349049|541307975|FG004|Overall Study|Disease progression|2|||
150045756|NCT01349049|541307976|FG005|Overall Study|Disease progression|2|||
150045757|NCT01349049|541307977|FG006|Overall Study|Disease progression|3|||
150045758|NCT01349049|541307978|FG007|Overall Study|Disease progression|2|||
150045759|NCT01349049|541307979|FG008|Overall Study|Disease progression|33|||
150045760|NCT01349049|541307971|FG000|Overall Study|Adverse Event|0|||
150045761|NCT01349049|541307972|FG001|Overall Study|Adverse Event|1|||
150045762|NCT01349049|541307973|FG002|Overall Study|Adverse Event|0|||
150045763|NCT01349049|541307974|FG003|Overall Study|Adverse Event|0|||
150045764|NCT01349049|541307975|FG004|Overall Study|Adverse Event|0|||
150045765|NCT01349049|541307976|FG005|Overall Study|Adverse Event|3|||
150045766|NCT01349049|541307977|FG006|Overall Study|Adverse Event|1|||
150045767|NCT01349049|541307978|FG007|Overall Study|Adverse Event|0|||
150045768|NCT01349049|541307979|FG008|Overall Study|Adverse Event|4|||
150045769|NCT01349049|541307971|FG000|Overall Study|Physician Decision|0|||
150045770|NCT01349049|541307972|FG001|Overall Study|Physician Decision|1|||
150045771|NCT01349049|541307973|FG002|Overall Study|Physician Decision|0|||
150045772|NCT01349049|541307974|FG003|Overall Study|Physician Decision|0|||
150045773|NCT01349049|541307975|FG004|Overall Study|Physician Decision|0|||
150045774|NCT01349049|541307976|FG005|Overall Study|Physician Decision|0|||
150045775|NCT01349049|541307977|FG006|Overall Study|Physician Decision|0|||
150045776|NCT01349049|541307978|FG007|Overall Study|Physician Decision|0|||
150045777|NCT01349049|541307979|FG008|Overall Study|Physician Decision|2|||
150045778|NCT01349049|541307971|FG000|Overall Study|Protocol Violation|0|||
150045779|NCT01349049|541307972|FG001|Overall Study|Protocol Violation|0|||
150045780|NCT01349049|541307973|FG002|Overall Study|Protocol Violation|0|||
150045781|NCT01349049|541307974|FG003|Overall Study|Protocol Violation|0|||
150045782|NCT01349049|541307975|FG004|Overall Study|Protocol Violation|0|||
150045783|NCT01349049|541307976|FG005|Overall Study|Protocol Violation|0|||
150045784|NCT01349049|541307977|FG006|Overall Study|Protocol Violation|0|||
150045785|NCT01349049|541307978|FG007|Overall Study|Protocol Violation|0|||
150045786|NCT01349049|541307979|FG008|Overall Study|Protocol Violation|1|||
149899659|NCT00708214|540764520|FG000|Overall Study|Other Adverse Event|3|||
149899660|NCT00708214|540764521|FG001|Overall Study|Other Adverse Event|6|||
149899661|NCT00708214|540764522|FG002|Overall Study|Other Adverse Event|2|||
149899662|NCT00708214|540764520|FG000|Overall Study|Other|0|||
149899663|NCT00708214|540764521|FG001|Overall Study|Other|1|||
150045787|NCT01349049|541307971|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
150045788|NCT01349049|541307972|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
150045789|NCT01349049|541307973|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
150176366|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
150176367|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
149899664|NCT00708214|540764522|FG002|Overall Study|Other|1|||
149899665|NCT00708214|540764520|FG000|Overall Study|Progressive Disease|4|||
149899666|NCT00708214|540764521|FG001|Overall Study|Progressive Disease|6|||
150045790|NCT01349049|541307974|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
150045791|NCT01349049|541307975|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
150045792|NCT01349049|541307976|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
150045793|NCT01349049|541307977|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
150045794|NCT01349049|541307978|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
150045795|NCT01349049|541307979|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
150045796|NCT01349049|541307971|FG000|Overall Study|Other|0|||
150176368|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
150176369|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
150176370|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
150176371|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176372|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176373|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176374|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176375|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176376|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176377|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149899667|NCT00708214|540764522|FG002|Overall Study|Progressive Disease|5|||
150176378|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
150176379|NCT05061693|541781981|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
150176380|NCT05061693|541781982|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
150176381|NCT05061693|541781983|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
150176382|NCT05061693|541781984|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
150176383|NCT05061693|541781985|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149899668|NCT05310071|540764539|FG000|Overall Study|Death|0|||
149899669|NCT05310071|540764540|FG001|Overall Study|Death|3|||
149899670|NCT05310071|540764539|FG000|Overall Study|Adverse Event|4|||
149899671|NCT05310071|540764540|FG001|Overall Study|Adverse Event|31|||
149899672|NCT05310071|540764539|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
149899673|NCT05310071|540764540|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
149899674|NCT05310071|540764539|FG000|Overall Study|Protocol Deviation|2|||
149899675|NCT05310071|540764540|FG001|Overall Study|Protocol Deviation|0|||
149899676|NCT05310071|540764539|FG000|Overall Study|Randomized by Mistake|0|||
149899677|NCT05310071|540764540|FG001|Overall Study|Randomized by Mistake|1|||
149899678|NCT05310071|540764539|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
149899679|NCT05310071|540764540|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
149899680|NCT05310071|540764539|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
149899681|NCT05310071|540764540|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
149899682|NCT05310071|540764539|FG000|Overall Study|Site Terminated by Sponsor|0|||
149899683|NCT05310071|540764540|FG001|Overall Study|Site Terminated by Sponsor|2|||
149899684|NCT05310071|540764539|FG000|Overall Study|Study Terminated by Sponsor|282|||
149899685|NCT05310071|540764540|FG001|Overall Study|Study Terminated by Sponsor|559|||
149899686|NCT05310071|540764539|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
149899687|NCT05310071|540764540|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
149899688|NCT05310071|540764539|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
149899689|NCT05310071|540764540|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
149899690|NCT05310071|540764539|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
149899691|NCT05310071|540764540|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
149899692|NCT05310071|540764539|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
149899693|NCT05310071|540764540|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
149899694|NCT05310071|540764539|FG000|Overall Study|Withdrawal by Participant - Other|25|||
149899695|NCT05310071|540764540|FG001|Overall Study|Withdrawal by Participant - Other|30|||
149899696|NCT05310071|540764539|FG000|Overall Study|Lost to Follow-up|2|||
149899697|NCT05310071|540764540|FG001|Overall Study|Lost to Follow-up|4|||
149899698|NCT05310071|540764539|FG000|Overall Study|Reason Not Specified|1|||
149899699|NCT05310071|540764540|FG001|Overall Study|Reason Not Specified|3|||
149899700|NCT02418949|540764541|FG000|Overall Study|Withdrawal by Subject|1|||
149899701|NCT02418949|540764542|FG001|Overall Study|Withdrawal by Subject|0|||
149899702|NCT02418949|540764543|FG002|Overall Study|Withdrawal by Subject|1|||
149899703|NCT02418949|540764544|FG003|Overall Study|Withdrawal by Subject|1|||
149899704|NCT02418949|540764541|FG000|Overall Study|Lost to Follow-up|1|||
149899705|NCT02418949|540764542|FG001|Overall Study|Lost to Follow-up|0|||
149899706|NCT02418949|540764543|FG002|Overall Study|Lost to Follow-up|1|||
149899707|NCT02418949|540764544|FG003|Overall Study|Lost to Follow-up|0|||
150045797|NCT01349049|541307972|FG001|Overall Study|Other|0|||
150045798|NCT01349049|541307973|FG002|Overall Study|Other|0|||
149899708|NCT02418949|540764541|FG000|Overall Study|Physician Decision|1|||
149899709|NCT02418949|540764542|FG001|Overall Study|Physician Decision|1|||
149899710|NCT02418949|540764543|FG002|Overall Study|Physician Decision|1|||
150176384|NCT05061693|541781986|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176385|NCT05061693|541781987|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176386|NCT05061693|541781988|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176387|NCT05061693|541781989|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176388|NCT05061693|541781990|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176389|NCT05061693|541781991|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176390|NCT05061693|541781992|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
150176391|NCT05061693|541781981|FG000|24-week Extension Period|Adverse Event|0|||
150176392|NCT05061693|541781982|FG001|24-week Extension Period|Adverse Event|0|||
150176393|NCT05061693|541781983|FG002|24-week Extension Period|Adverse Event|0|||
150176394|NCT05061693|541781984|FG003|24-week Extension Period|Adverse Event|0|||
150176395|NCT05061693|541781985|FG004|24-week Extension Period|Adverse Event|0|||
150176396|NCT05061693|541781986|FG005|24-week Extension Period|Adverse Event|0|||
150176397|NCT05061693|541781987|FG006|24-week Extension Period|Adverse Event|0|||
150176398|NCT05061693|541781988|FG007|24-week Extension Period|Adverse Event|2|||
150176399|NCT05061693|541781989|FG008|24-week Extension Period|Adverse Event|2|||
150176400|NCT05061693|541781990|FG009|24-week Extension Period|Adverse Event|0|||
150176401|NCT05061693|541781991|FG010|24-week Extension Period|Adverse Event|1|||
150176402|NCT05061693|541781992|FG011|24-week Extension Period|Adverse Event|3|||
150176403|NCT05061693|541781981|FG000|24-week Extension Period|Lack of Efficacy|0|||
150176404|NCT05061693|541781982|FG001|24-week Extension Period|Lack of Efficacy|0|||
150176405|NCT05061693|541781983|FG002|24-week Extension Period|Lack of Efficacy|0|||
150176406|NCT05061693|541781984|FG003|24-week Extension Period|Lack of Efficacy|0|||
150176407|NCT05061693|541781985|FG004|24-week Extension Period|Lack of Efficacy|0|||
150176408|NCT05061693|541781986|FG005|24-week Extension Period|Lack of Efficacy|0|||
150176409|NCT05061693|541781987|FG006|24-week Extension Period|Lack of Efficacy|0|||
150176410|NCT05061693|541781988|FG007|24-week Extension Period|Lack of Efficacy|0|||
149899711|NCT02418949|540764544|FG003|Overall Study|Physician Decision|0|||
149899712|NCT02343939|540764545|FG000|Overall Study|Death|0|||
149899713|NCT02343939|540764546|FG001|Overall Study|Death|15|||
149899714|NCT02343939|540764547|FG002|Overall Study|Death|4|||
149899715|NCT02343939|540764548|FG003|Overall Study|Death|2|||
149899716|NCT02343939|540764549|FG004|Overall Study|Death|5|||
149899717|NCT02343939|540764550|FG005|Overall Study|Death|11|||
149899718|NCT02343939|540764551|FG006|Overall Study|Death|8|||
149899719|NCT02343939|540764552|FG007|Overall Study|Death|22|||
149899720|NCT02343939|540764553|FG008|Overall Study|Death|1|||
149899721|NCT02343939|540764545|FG000|Overall Study|Study terminated by sponsor|0|||
149899722|NCT02343939|540764546|FG001|Overall Study|Study terminated by sponsor|27|||
149899723|NCT02343939|540764547|FG002|Overall Study|Study terminated by sponsor|0|||
149899724|NCT02343939|540764548|FG003|Overall Study|Study terminated by sponsor|1|||
149899725|NCT02343939|540764549|FG004|Overall Study|Study terminated by sponsor|1|||
149899726|NCT02343939|540764550|FG005|Overall Study|Study terminated by sponsor|5|||
149899727|NCT02343939|540764551|FG006|Overall Study|Study terminated by sponsor|3|||
149899728|NCT02343939|540764552|FG007|Overall Study|Study terminated by sponsor|4|||
149899729|NCT02343939|540764553|FG008|Overall Study|Study terminated by sponsor|0|||
149899730|NCT02343939|540764545|FG000|Overall Study|Withdrew consent|3|||
149899731|NCT02343939|540764546|FG001|Overall Study|Withdrew consent|6|||
149899732|NCT02343939|540764547|FG002|Overall Study|Withdrew consent|1|||
149899733|NCT02343939|540764548|FG003|Overall Study|Withdrew consent|2|||
149899734|NCT02343939|540764549|FG004|Overall Study|Withdrew consent|2|||
149899735|NCT02343939|540764550|FG005|Overall Study|Withdrew consent|0|||
149899736|NCT02343939|540764551|FG006|Overall Study|Withdrew consent|0|||
149899737|NCT02343939|540764552|FG007|Overall Study|Withdrew consent|8|||
149899738|NCT02343939|540764553|FG008|Overall Study|Withdrew consent|6|||
149899739|NCT02343939|540764545|FG000|Overall Study|Treatment failure|0|||
149899740|NCT02343939|540764546|FG001|Overall Study|Treatment failure|0|||
149899741|NCT02343939|540764547|FG002|Overall Study|Treatment failure|0|||
149899742|NCT02343939|540764548|FG003|Overall Study|Treatment failure|0|||
149899743|NCT02343939|540764549|FG004|Overall Study|Treatment failure|0|||
149899744|NCT02343939|540764550|FG005|Overall Study|Treatment failure|0|||
149899745|NCT02343939|540764551|FG006|Overall Study|Treatment failure|2|||
150176411|NCT05061693|541781989|FG008|24-week Extension Period|Lack of Efficacy|0|||
150176412|NCT05061693|541781990|FG009|24-week Extension Period|Lack of Efficacy|0|||
150176413|NCT05061693|541781991|FG010|24-week Extension Period|Lack of Efficacy|2|||
150176414|NCT05061693|541781992|FG011|24-week Extension Period|Lack of Efficacy|0|||
149899746|NCT02343939|540764552|FG007|Overall Study|Treatment failure|1|||
149899747|NCT02343939|540764553|FG008|Overall Study|Treatment failure|0|||
149899748|NCT02343939|540764545|FG000|Overall Study|Investigator's discretion|0|||
149899749|NCT02343939|540764546|FG001|Overall Study|Investigator's discretion|0|||
149899750|NCT02343939|540764547|FG002|Overall Study|Investigator's discretion|0|||
149899751|NCT02343939|540764548|FG003|Overall Study|Investigator's discretion|1|||
149899752|NCT02343939|540764549|FG004|Overall Study|Investigator's discretion|0|||
149899753|NCT02343939|540764550|FG005|Overall Study|Investigator's discretion|0|||
150176415|NCT05061693|541781981|FG000|24-week Extension Period|Lost to Follow-up|0|||
150176416|NCT05061693|541781982|FG001|24-week Extension Period|Lost to Follow-up|0|||
149899754|NCT02343939|540764551|FG006|Overall Study|Investigator's discretion|1|||
149899755|NCT02343939|540764552|FG007|Overall Study|Investigator's discretion|0|||
149899756|NCT02343939|540764553|FG008|Overall Study|Investigator's discretion|0|||
149899757|NCT02343939|540764545|FG000|Overall Study|Adverse Event|0|||
149899758|NCT02343939|540764546|FG001|Overall Study|Adverse Event|0|||
149899759|NCT02343939|540764547|FG002|Overall Study|Adverse Event|0|||
149899760|NCT02343939|540764548|FG003|Overall Study|Adverse Event|0|||
149899761|NCT02343939|540764549|FG004|Overall Study|Adverse Event|0|||
149899762|NCT02343939|540764550|FG005|Overall Study|Adverse Event|1|||
149899763|NCT02343939|540764551|FG006|Overall Study|Adverse Event|0|||
149899764|NCT02343939|540764552|FG007|Overall Study|Adverse Event|0|||
149899765|NCT02343939|540764553|FG008|Overall Study|Adverse Event|0|||
149899766|NCT02343939|540764545|FG000|Overall Study|Never Treated With ENTO|0|||
149899767|NCT02343939|540764546|FG001|Overall Study|Never Treated With ENTO|0|||
149899768|NCT02343939|540764547|FG002|Overall Study|Never Treated With ENTO|0|||
149899769|NCT02343939|540764548|FG003|Overall Study|Never Treated With ENTO|0|||
149899770|NCT02343939|540764549|FG004|Overall Study|Never Treated With ENTO|0|||
150045799|NCT01349049|541307974|FG003|Overall Study|Other|0|||
150045800|NCT01349049|541307975|FG004|Overall Study|Other|0|||
149899771|NCT02343939|540764550|FG005|Overall Study|Never Treated With ENTO|0|||
149899772|NCT02343939|540764551|FG006|Overall Study|Never Treated With ENTO|1|||
149899773|NCT02343939|540764552|FG007|Overall Study|Never Treated With ENTO|2|||
149899774|NCT02343939|540764553|FG008|Overall Study|Never Treated With ENTO|0|||
149899775|NCT00460811|540764554|FG000|Overall Study|Adverse Event|4|||
149899776|NCT00460811|540764555|FG001|Overall Study|Adverse Event|6|||
149899777|NCT00460811|540764556|FG002|Overall Study|Adverse Event|3|||
149899778|NCT00460811|540764557|FG003|Overall Study|Adverse Event|10|||
149899779|NCT00460811|540764558|FG004|Overall Study|Adverse Event|2|||
149899780|NCT00460811|540764554|FG000|Overall Study|Noncompliance|1|||
149899781|NCT00460811|540764555|FG001|Overall Study|Noncompliance|0|||
149899782|NCT00460811|540764556|FG002|Overall Study|Noncompliance|0|||
149899783|NCT00460811|540764557|FG003|Overall Study|Noncompliance|2|||
149899784|NCT00460811|540764558|FG004|Overall Study|Noncompliance|1|||
149899785|NCT00460811|540764554|FG000|Overall Study|Withdrawal by Subject|7|||
149899786|NCT00460811|540764555|FG001|Overall Study|Withdrawal by Subject|7|||
149899787|NCT00460811|540764556|FG002|Overall Study|Withdrawal by Subject|6|||
149899788|NCT00460811|540764557|FG003|Overall Study|Withdrawal by Subject|3|||
149899789|NCT00460811|540764558|FG004|Overall Study|Withdrawal by Subject|11|||
149899790|NCT00460811|540764554|FG000|Overall Study|Physician Decision|1|||
149899791|NCT00460811|540764555|FG001|Overall Study|Physician Decision|0|||
149899792|NCT00460811|540764556|FG002|Overall Study|Physician Decision|0|||
149899793|NCT00460811|540764557|FG003|Overall Study|Physician Decision|0|||
149899794|NCT00460811|540764558|FG004|Overall Study|Physician Decision|0|||
149899795|NCT00460811|540764554|FG000|Overall Study|Lost to Follow-up|3|||
149899796|NCT00460811|540764555|FG001|Overall Study|Lost to Follow-up|2|||
149899797|NCT00460811|540764556|FG002|Overall Study|Lost to Follow-up|5|||
149899798|NCT00460811|540764557|FG003|Overall Study|Lost to Follow-up|3|||
149899799|NCT00460811|540764558|FG004|Overall Study|Lost to Follow-up|6|||
149899800|NCT02099110|540764565|FG000|Overall Study|Protocol Violation|2|||
150045801|NCT01349049|541307976|FG005|Overall Study|Other|1|||
150045802|NCT01349049|541307977|FG006|Overall Study|Other|0|||
150045803|NCT01349049|541307978|FG007|Overall Study|Other|0|||
149899801|NCT02099110|540764566|FG001|Overall Study|Protocol Violation|1|||
149899802|NCT02099110|540764567|FG002|Overall Study|Protocol Violation|0|||
149899803|NCT02099110|540764568|FG003|Overall Study|Protocol Violation|3|||
149899804|NCT02099110|540764569|FG004|Overall Study|Protocol Violation|1|||
149899805|NCT02099110|540764565|FG000|Overall Study|Participant moved|1|||
149899806|NCT02099110|540764566|FG001|Overall Study|Participant moved|1|||
149899807|NCT02099110|540764567|FG002|Overall Study|Participant moved|1|||
149899808|NCT02099110|540764568|FG003|Overall Study|Participant moved|0|||
150045804|NCT01349049|541307979|FG008|Overall Study|Other|4|||
149899809|NCT02099110|540764569|FG004|Overall Study|Participant moved|2|||
150045805|NCT01349049|541307971|FG000|Overall Study|Death|0|||
149899810|NCT02099110|540764565|FG000|Overall Study|Withdrawal by Subject|7|||
149899811|NCT02099110|540764566|FG001|Overall Study|Withdrawal by Subject|11|||
149899812|NCT02099110|540764567|FG002|Overall Study|Withdrawal by Subject|13|||
149899813|NCT02099110|540764568|FG003|Overall Study|Withdrawal by Subject|9|||
149899814|NCT02099110|540764569|FG004|Overall Study|Withdrawal by Subject|13|||
149899815|NCT02099110|540764565|FG000|Overall Study|Adverse Event|3|||
149899816|NCT02099110|540764566|FG001|Overall Study|Adverse Event|5|||
149899817|NCT02099110|540764567|FG002|Overall Study|Adverse Event|2|||
149899818|NCT02099110|540764568|FG003|Overall Study|Adverse Event|3|||
149899819|NCT02099110|540764569|FG004|Overall Study|Adverse Event|2|||
149899820|NCT02099110|540764565|FG000|Overall Study|Lost to Follow-up|6|||
149899821|NCT02099110|540764566|FG001|Overall Study|Lost to Follow-up|12|||
149899822|NCT02099110|540764567|FG002|Overall Study|Lost to Follow-up|11|||
149899823|NCT02099110|540764568|FG003|Overall Study|Lost to Follow-up|5|||
149899824|NCT02099110|540764569|FG004|Overall Study|Lost to Follow-up|6|||
149899825|NCT02099110|540764565|FG000|Overall Study|Death|0|||
149899826|NCT02099110|540764566|FG001|Overall Study|Death|1|||
149899827|NCT02099110|540764567|FG002|Overall Study|Death|0|||
149899828|NCT02099110|540764568|FG003|Overall Study|Death|0|||
149899829|NCT02099110|540764569|FG004|Overall Study|Death|0|||
149899830|NCT02099110|540764565|FG000|Overall Study|Screen failure|0|||
149899831|NCT02099110|540764566|FG001|Overall Study|Screen failure|0|||
149899832|NCT02099110|540764567|FG002|Overall Study|Screen failure|0|||
149899833|NCT02099110|540764568|FG003|Overall Study|Screen failure|0|||
149899834|NCT02099110|540764569|FG004|Overall Study|Screen failure|1|||
149899835|NCT02099110|540764565|FG000|Overall Study|Non-compliance with study drug|2|||
149899836|NCT02099110|540764566|FG001|Overall Study|Non-compliance with study drug|0|||
149899837|NCT02099110|540764567|FG002|Overall Study|Non-compliance with study drug|0|||
149899838|NCT02099110|540764568|FG003|Overall Study|Non-compliance with study drug|0|||
149899839|NCT02099110|540764569|FG004|Overall Study|Non-compliance with study drug|1|||
149899840|NCT02099110|540764565|FG000|Overall Study|Physician Decision|3|||
149899841|NCT02099110|540764566|FG001|Overall Study|Physician Decision|0|||
150045806|NCT01349049|541307972|FG001|Overall Study|Death|0|||
150045807|NCT01349049|541307973|FG002|Overall Study|Death|0|||
150045808|NCT01349049|541307974|FG003|Overall Study|Death|0|||
150045809|NCT01349049|541307975|FG004|Overall Study|Death|0|||
150045810|NCT01349049|541307976|FG005|Overall Study|Death|0|||
150045811|NCT01349049|541307977|FG006|Overall Study|Death|0|||
150045812|NCT01349049|541307978|FG007|Overall Study|Death|1|||
150045813|NCT01349049|541307979|FG008|Overall Study|Death|5|||
150045814|NCT01349049|541307971|FG000|Overall Study|Non-compliance|0|||
150045815|NCT01349049|541307972|FG001|Overall Study|Non-compliance|0|||
150045816|NCT01349049|541307973|FG002|Overall Study|Non-compliance|0|||
150045817|NCT01349049|541307974|FG003|Overall Study|Non-compliance|1|||
150045818|NCT01349049|541307975|FG004|Overall Study|Non-compliance|0|||
150045819|NCT01349049|541307976|FG005|Overall Study|Non-compliance|0|||
150045820|NCT01349049|541307977|FG006|Overall Study|Non-compliance|0|||
150045821|NCT01349049|541307978|FG007|Overall Study|Non-compliance|0|||
150045822|NCT01349049|541307979|FG008|Overall Study|Non-compliance|0|||
150045823|NCT01349049|541307971|FG000|Overall Study|Withdrawal by Subject|0|||
150045824|NCT01349049|541307972|FG001|Overall Study|Withdrawal by Subject|0|||
150045825|NCT01349049|541307973|FG002|Overall Study|Withdrawal by Subject|0|||
150045826|NCT01349049|541307974|FG003|Overall Study|Withdrawal by Subject|0|||
150045827|NCT01349049|541307975|FG004|Overall Study|Withdrawal by Subject|0|||
150045828|NCT01349049|541307976|FG005|Overall Study|Withdrawal by Subject|0|||
150045829|NCT01349049|541307977|FG006|Overall Study|Withdrawal by Subject|0|||
150045830|NCT01349049|541307978|FG007|Overall Study|Withdrawal by Subject|0|||
150045831|NCT01349049|541307979|FG008|Overall Study|Withdrawal by Subject|6|||
150045832|NCT00552188|541307982|FG000|Overall Study|Adverse Event|0|||
150045833|NCT00552188|541307983|FG001|Overall Study|Adverse Event|2|||
150045834|NCT00552188|541307982|FG000|Overall Study|Lost to Follow-up|2|||
150045835|NCT00552188|541307983|FG001|Overall Study|Lost to Follow-up|1|||
150045836|NCT00552188|541307982|FG000|Overall Study|Withdrawal of consent|0|||
150045837|NCT00552188|541307983|FG001|Overall Study|Withdrawal of consent|1|||
150045838|NCT00552188|541307982|FG000|Overall Study|Subject returned to home country|0|||
150045839|NCT00552188|541307983|FG001|Overall Study|Subject returned to home country|1|||
150045840|NCT03887702|541307984|FG000|Overall Study|Study terminated|0|||
150045841|NCT03887702|541307985|FG001|Overall Study|Study terminated|0|||
150045842|NCT03887702|541307986|FG002|Overall Study|Study terminated|2|||
150045843|NCT03887702|541307987|FG003|Overall Study|Study terminated|2|||
150045844|NCT01193257|541307990|FG000|Overall Study|Death|202|||
150045845|NCT01193257|541307991|FG001|Overall Study|Death|391|||
149899842|NCT02099110|540764567|FG002|Overall Study|Physician Decision|1|||
149899843|NCT02099110|540764568|FG003|Overall Study|Physician Decision|2|||
149899844|NCT02099110|540764569|FG004|Overall Study|Physician Decision|1|||
149899845|NCT01757184|540764574|FG000|Double-blind Period|Adverse Event|1|||
149899846|NCT01757184|540764575|FG001|Double-blind Period|Adverse Event|0|||
149899847|NCT01757184|540764576|FG002|Double-blind Period|Adverse Event|0|||
150045846|NCT01193257|541307990|FG000|Overall Study|Study termination by sponsor|0|||
150045847|NCT01193257|541307991|FG001|Overall Study|Study termination by sponsor|3|||
149801795|NCT04338685|540402441|FG003|Overall Study|Study terminated by Sponsor|4|||
149801796|NCT04338685|540402442|FG004|Overall Study|Study terminated by Sponsor|0|||
150045848|NCT01193257|541307990|FG000|Overall Study|Withdrawal by Subject|26|||
150045849|NCT01193257|541307991|FG001|Overall Study|Withdrawal by Subject|86|||
150045850|NCT01193257|541307990|FG000|Overall Study|Lost to Follow-up|2|||
150045851|NCT01193257|541307991|FG001|Overall Study|Lost to Follow-up|3|||
150045852|NCT01193257|541307990|FG000|Overall Study|Unblinded due to futility|135|||
150045853|NCT01193257|541307991|FG001|Overall Study|Unblinded due to futility|251|||
150045854|NCT02881567|541307992|FG000|Overall Study|Adverse Event|1|||
150045855|NCT02881567|541307992|FG000|Overall Study|Lost to Follow-up|3|||
150045856|NCT02881567|541307992|FG000|Overall Study|Consent withdrawn|1|||
149899848|NCT01757184|540764577|FG003|Double-blind Period|Adverse Event|0|||
149899849|NCT01757184|540764574|FG000|Open-label Period|Lost to Follow-up|0|||
149899850|NCT01757184|540764575|FG001|Open-label Period|Lost to Follow-up|0|||
149899851|NCT01757184|540764576|FG002|Open-label Period|Lost to Follow-up|2|||
149899852|NCT01757184|540764577|FG003|Open-label Period|Lost to Follow-up|0|||
149899853|NCT01757184|540764574|FG000|Open-label Period|Withdrawal by Subject|0|||
149899854|NCT01757184|540764575|FG001|Open-label Period|Withdrawal by Subject|0|||
149899855|NCT01757184|540764576|FG002|Open-label Period|Withdrawal by Subject|1|||
149899856|NCT01757184|540764577|FG003|Open-label Period|Withdrawal by Subject|1|||
149899857|NCT01757184|540764574|FG000|Open-label Period|Discontinued by Sponsor|0|||
149899858|NCT01757184|540764575|FG001|Open-label Period|Discontinued by Sponsor|0|||
149899859|NCT01757184|540764576|FG002|Open-label Period|Discontinued by Sponsor|1|||
149899860|NCT01757184|540764577|FG003|Open-label Period|Discontinued by Sponsor|2|||
149899861|NCT02977572|540764578|FG000|Overall Study|Exclusion criterion|2|||
149899862|NCT02977572|540764579|FG001|Overall Study|Exclusion criterion|2|||
149899863|NCT01537042|540764580|FG000|Overall Study|Adverse Event|0|||
149899864|NCT01537042|540764581|FG001|Overall Study|Adverse Event|2|||
149899865|NCT01537042|540764580|FG000|Overall Study|Lack of Efficacy|0|||
149899866|NCT01537042|540764581|FG001|Overall Study|Lack of Efficacy|1|||
149899867|NCT01537042|540764580|FG000|Overall Study|Protocol Violation|0|||
149899868|NCT01537042|540764581|FG001|Overall Study|Protocol Violation|1|||
150045857|NCT02881567|541307992|FG000|Overall Study|Investigator decision|1|||
150176417|NCT05061693|541781983|FG002|24-week Extension Period|Lost to Follow-up|0|||
150176418|NCT05061693|541781984|FG003|24-week Extension Period|Lost to Follow-up|0|||
150176419|NCT05061693|541781985|FG004|24-week Extension Period|Lost to Follow-up|0|||
149899869|NCT01537042|540764580|FG000|Overall Study|Other|0|||
149899870|NCT01537042|540764581|FG001|Overall Study|Other|1|||
149899871|NCT02741076|540764582|FG000|Overall Study|Adverse Event|0|||
149899872|NCT02741076|540764583|FG001|Overall Study|Adverse Event|1|||
149899873|NCT02741076|540764584|FG002|Overall Study|Adverse Event|1|||
149899874|NCT02741076|540764585|FG003|Overall Study|Adverse Event|0|||
150045858|NCT02881567|541307992|FG000|Overall Study|Study terminated by sponsor|9|||
150045859|NCT02881567|541307992|FG000|Overall Study|Reason not Specified|3|||
150045860|NCT02405442|541307993|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
149899875|NCT02741076|540764582|FG000|Overall Study|Lack of Efficacy|1|||
149899876|NCT02741076|540764583|FG001|Overall Study|Lack of Efficacy|0|||
149899877|NCT02741076|540764584|FG002|Overall Study|Lack of Efficacy|0|||
149899878|NCT02741076|540764585|FG003|Overall Study|Lack of Efficacy|0|||
149899879|NCT02741076|540764582|FG000|Overall Study|Withdrawal by Subject|0|||
149899880|NCT02741076|540764583|FG001|Overall Study|Withdrawal by Subject|1|||
149899881|NCT02741076|540764584|FG002|Overall Study|Withdrawal by Subject|0|||
149899882|NCT02741076|540764585|FG003|Overall Study|Withdrawal by Subject|0|||
149899883|NCT02741076|540764582|FG000|Overall Study|Sponsor Request|2|||
149899884|NCT02741076|540764583|FG001|Overall Study|Sponsor Request|3|||
149899885|NCT02741076|540764584|FG002|Overall Study|Sponsor Request|0|||
149899886|NCT02741076|540764585|FG003|Overall Study|Sponsor Request|1|||
149899887|NCT02741076|540764582|FG000|Overall Study|No additional information available|0|||
149899888|NCT02741076|540764583|FG001|Overall Study|No additional information available|0|||
149899889|NCT02741076|540764584|FG002|Overall Study|No additional information available|1|||
149899890|NCT02741076|540764585|FG003|Overall Study|No additional information available|1|||
149899891|NCT01779440|540764587|FG000|Overall Study|Withdrawal by Subject|3|||
149899892|NCT01779440|540764588|FG001|Overall Study|Withdrawal by Subject|5|||
149899893|NCT00315458|540764591|FG000|Overall Study|Administrative|0|||
149899894|NCT00315458|540764592|FG001|Overall Study|Administrative|3|||
149899895|NCT00315458|540764593|FG002|Overall Study|Administrative|8|||
149899896|NCT00315458|540764594|FG003|Overall Study|Administrative|21|||
149899897|NCT00315458|540764591|FG000|Overall Study|Adverse Event|2|||
149899898|NCT00315458|540764592|FG001|Overall Study|Adverse Event|4|||
149899899|NCT00315458|540764593|FG002|Overall Study|Adverse Event|23|||
149899900|NCT00315458|540764594|FG003|Overall Study|Adverse Event|3|||
149899901|NCT00315458|540764591|FG000|Overall Study|Lost to Follow-up|1|||
149899902|NCT00315458|540764592|FG001|Overall Study|Lost to Follow-up|2|||
149899903|NCT00315458|540764593|FG002|Overall Study|Lost to Follow-up|0|||
149899904|NCT00315458|540764594|FG003|Overall Study|Lost to Follow-up|2|||
149899905|NCT00315458|540764591|FG000|Overall Study|Withdrawal by Subject|0|||
149899906|NCT00315458|540764592|FG001|Overall Study|Withdrawal by Subject|3|||
149899907|NCT00315458|540764593|FG002|Overall Study|Withdrawal by Subject|0|||
149899908|NCT00315458|540764594|FG003|Overall Study|Withdrawal by Subject|2|||
149899909|NCT00315458|540764591|FG000|Overall Study|Lack of Efficacy|0|||
149899910|NCT00315458|540764592|FG001|Overall Study|Lack of Efficacy|0|||
149899911|NCT00315458|540764593|FG002|Overall Study|Lack of Efficacy|20|||
149899912|NCT00315458|540764594|FG003|Overall Study|Lack of Efficacy|1|||
149899913|NCT00315458|540764591|FG000|Overall Study|Did not qualify|0|||
150045861|NCT02405442|541307994|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
150045862|NCT02405442|541307995|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
150045863|NCT02405442|541307996|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
150045864|NCT02405442|541307993|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
150045865|NCT02405442|541307994|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
150045866|NCT02405442|541307995|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
150045867|NCT02405442|541307996|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
150045868|NCT02405442|541307993|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
150045869|NCT02405442|541307994|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
150045870|NCT02405442|541307995|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
150045871|NCT02405442|541307996|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
150045872|NCT02405442|541307993|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
150045873|NCT02405442|541307994|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
150045874|NCT02405442|541307995|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
150045875|NCT02405442|541307996|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
150045876|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
150045877|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
150045878|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
150045879|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
150045880|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
150045881|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
150045882|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
149899914|NCT00315458|540764592|FG001|Overall Study|Did not qualify|0|||
149899915|NCT00315458|540764593|FG002|Overall Study|Did not qualify|1|||
149899916|NCT00315458|540764594|FG003|Overall Study|Did not qualify|0|||
149899917|NCT00523848|540764595|FG000|Overall Study|Adverse Event|11|||
149899918|NCT00523848|540764595|FG000|Overall Study|Withdrawal by Subject|2|||
149899919|NCT00523848|540764595|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
149899920|NCT00523848|540764595|FG000|Overall Study|Disease Progression|5|||
149899921|NCT00523848|540764595|FG000|Overall Study|Other, unspecified|4|||
149899922|NCT00086619|540764596|FG000|Overall Study|Withdrawal by Subject|6|||
149899923|NCT00086619|540764597|FG001|Overall Study|Withdrawal by Subject|6|||
149899924|NCT00086619|540764596|FG000|Overall Study|Adverse Event|8|||
149899925|NCT00086619|540764597|FG001|Overall Study|Adverse Event|10|||
149899926|NCT00086619|540764596|FG000|Overall Study|Protocol Violation|1|||
149899927|NCT00086619|540764597|FG001|Overall Study|Protocol Violation|1|||
149899928|NCT00489918|540764598|FG000|Overall Study|Withdrawal by Subject|2|||
149899929|NCT00489918|540764599|FG001|Overall Study|Withdrawal by Subject|1|||
149899930|NCT00489918|540764600|FG002|Overall Study|Withdrawal by Subject|1|||
149899931|NCT00489918|540764601|FG003|Overall Study|Withdrawal by Subject|0|||
149899932|NCT00489918|540764602|FG004|Overall Study|Withdrawal by Subject|1|||
149899933|NCT00489918|540764598|FG000|Overall Study|Adverse Event|0|||
149899934|NCT00489918|540764599|FG001|Overall Study|Adverse Event|1|||
150176420|NCT05061693|541781986|FG005|24-week Extension Period|Lost to Follow-up|0|||
150176421|NCT05061693|541781987|FG006|24-week Extension Period|Lost to Follow-up|1|||
150176422|NCT05061693|541781988|FG007|24-week Extension Period|Lost to Follow-up|0|||
150176423|NCT05061693|541781989|FG008|24-week Extension Period|Lost to Follow-up|1|||
150176424|NCT05061693|541781990|FG009|24-week Extension Period|Lost to Follow-up|1|||
150176425|NCT05061693|541781991|FG010|24-week Extension Period|Lost to Follow-up|0|||
150176426|NCT05061693|541781992|FG011|24-week Extension Period|Lost to Follow-up|0|||
150176427|NCT05061693|541781981|FG000|24-week Extension Period|Withdrawal by Subject|0|||
150176428|NCT05061693|541781982|FG001|24-week Extension Period|Withdrawal by Subject|0|||
150176429|NCT05061693|541781983|FG002|24-week Extension Period|Withdrawal by Subject|0|||
150176430|NCT05061693|541781984|FG003|24-week Extension Period|Withdrawal by Subject|0|||
149899935|NCT00489918|540764600|FG002|Overall Study|Adverse Event|1|||
149899936|NCT00489918|540764601|FG003|Overall Study|Adverse Event|0|||
149899937|NCT00489918|540764602|FG004|Overall Study|Adverse Event|0|||
149899938|NCT00489918|540764598|FG000|Overall Study|Lost to Follow-up|0|||
149899939|NCT00489918|540764599|FG001|Overall Study|Lost to Follow-up|0|||
149899940|NCT00489918|540764600|FG002|Overall Study|Lost to Follow-up|1|||
149899941|NCT00489918|540764601|FG003|Overall Study|Lost to Follow-up|1|||
149899942|NCT00489918|540764602|FG004|Overall Study|Lost to Follow-up|0|||
149899943|NCT00489918|540764598|FG000|Overall Study|Physician Decision|0|||
149899944|NCT00489918|540764599|FG001|Overall Study|Physician Decision|0|||
149899945|NCT00489918|540764600|FG002|Overall Study|Physician Decision|1|||
149899946|NCT00489918|540764601|FG003|Overall Study|Physician Decision|0|||
149899947|NCT00489918|540764602|FG004|Overall Study|Physician Decision|0|||
149899948|NCT02748213|540764603|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
149899949|NCT02748213|540764604|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
149899950|NCT02748213|540764603|FG000|Overall Study|Abnormal Laboratory Test|1|||
150176431|NCT05061693|541781985|FG004|24-week Extension Period|Withdrawal by Subject|0|||
150176432|NCT05061693|541781986|FG005|24-week Extension Period|Withdrawal by Subject|0|||
150176433|NCT05061693|541781987|FG006|24-week Extension Period|Withdrawal by Subject|0|||
150176434|NCT05061693|541781988|FG007|24-week Extension Period|Withdrawal by Subject|0|||
150176435|NCT05061693|541781989|FG008|24-week Extension Period|Withdrawal by Subject|1|||
150176436|NCT05061693|541781990|FG009|24-week Extension Period|Withdrawal by Subject|2|||
150176437|NCT05061693|541781991|FG010|24-week Extension Period|Withdrawal by Subject|2|||
150176438|NCT05061693|541781992|FG011|24-week Extension Period|Withdrawal by Subject|1|||
150176439|NCT05061693|541781981|FG000|24-week Extension Period|Sponsor Decision|0|||
149899951|NCT02748213|540764604|FG001|Overall Study|Abnormal Laboratory Test|0|||
150176440|NCT05061693|541781982|FG001|24-week Extension Period|Sponsor Decision|0|||
150176441|NCT05061693|541781983|FG002|24-week Extension Period|Sponsor Decision|0|||
150176442|NCT05061693|541781984|FG003|24-week Extension Period|Sponsor Decision|0|||
150176443|NCT05061693|541781985|FG004|24-week Extension Period|Sponsor Decision|0|||
150176444|NCT05061693|541781986|FG005|24-week Extension Period|Sponsor Decision|0|||
150176445|NCT05061693|541781987|FG006|24-week Extension Period|Sponsor Decision|0|||
149899952|NCT02748213|540764603|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
149899953|NCT02748213|540764604|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
149899954|NCT02748213|540764603|FG000|Overall Study|Death|5|||
149899955|NCT02748213|540764604|FG001|Overall Study|Death|3|||
149899956|NCT02748213|540764603|FG000|Overall Study|Insufficient Therapeutic Response|56|||
149899957|NCT02748213|540764604|FG001|Overall Study|Insufficient Therapeutic Response|57|||
150045883|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
150176446|NCT05061693|541781988|FG007|24-week Extension Period|Sponsor Decision|1|||
149899958|NCT02748213|540764603|FG000|Overall Study|Violation of Selection Criteria|2|||
149899959|NCT02748213|540764604|FG001|Overall Study|Violation of Selection Criteria|0|||
149899960|NCT02748213|540764603|FG000|Overall Study|Protocol Violation|6|||
149899961|NCT02748213|540764604|FG001|Overall Study|Protocol Violation|4|||
149899962|NCT02748213|540764603|FG000|Overall Study|Refused Treatment*|6|||
149899963|NCT02748213|540764604|FG001|Overall Study|Refused Treatment*|6|||
149899964|NCT02748213|540764603|FG000|Overall Study|Failure to Return|1|||
149899965|NCT02748213|540764604|FG001|Overall Study|Failure to Return|0|||
149899966|NCT02748213|540764603|FG000|Overall Study|Other|30|||
149899967|NCT02748213|540764604|FG001|Overall Study|Other|29|||
149899968|NCT01209520|540764606|FG000|Overall Study|Withdrawal by Subject|3|||
149899969|NCT00961350|540764607|FG000|Overall Study|Adverse Event|18|||
149899970|NCT00961350|540764608|FG001|Overall Study|Adverse Event|33|||
149899971|NCT00961350|540764607|FG000|Overall Study|Withdrawal by Subject|10|||
149899972|NCT00961350|540764608|FG001|Overall Study|Withdrawal by Subject|10|||
149899973|NCT00961350|540764607|FG000|Overall Study|Lost to Follow-up|3|||
149899974|NCT00961350|540764608|FG001|Overall Study|Lost to Follow-up|3|||
149899975|NCT00961350|540764607|FG000|Overall Study|Misc|16|||
149899976|NCT00961350|540764608|FG001|Overall Study|Misc|21|||
149899977|NCT06868654|540764610|FG000|Overall Study|Death|4|||
149899978|NCT06868654|540764611|FG001|Overall Study|Death|14|||
149899979|NCT06868654|540764610|FG000|Overall Study|Lost to Follow-up|0|||
149899980|NCT06868654|540764611|FG001|Overall Study|Lost to Follow-up|1|||
149899981|NCT06868654|540764610|FG000|Overall Study|Withdrawal by Subject|5|||
149899982|NCT06868654|540764611|FG001|Overall Study|Withdrawal by Subject|3|||
149899983|NCT06868654|540764610|FG000|Overall Study|Physician Decision|0|||
149899984|NCT06868654|540764611|FG001|Overall Study|Physician Decision|1|||
149899985|NCT06868654|540764610|FG000|Overall Study|Ongoing|23|||
149899986|NCT06868654|540764611|FG001|Overall Study|Ongoing|21|||
149899987|NCT01270464|540766219|FG000|Overall Study|Protocol Violation|4|||
149899988|NCT01270464|540766220|FG001|Overall Study|Protocol Violation|3|||
149899989|NCT01270464|540766221|FG002|Overall Study|Protocol Violation|2|||
149899990|NCT01270464|540766219|FG000|Overall Study|Lack of Efficacy|2|||
149899991|NCT01270464|540766220|FG001|Overall Study|Lack of Efficacy|3|||
149899992|NCT01270464|540766221|FG002|Overall Study|Lack of Efficacy|1|||
149899993|NCT01270464|540766219|FG000|Overall Study|Adverse Event|9|||
149899994|NCT01270464|540766220|FG001|Overall Study|Adverse Event|1|||
149899995|NCT01270464|540766221|FG002|Overall Study|Adverse Event|7|||
149899996|NCT01270464|540766219|FG000|Overall Study|Withdrawal by Subject|2|||
149899997|NCT01270464|540766220|FG001|Overall Study|Withdrawal by Subject|1|||
149899998|NCT01270464|540766221|FG002|Overall Study|Withdrawal by Subject|4|||
149899999|NCT01270464|540766219|FG000|Overall Study|Lost to Follow-up|2|||
149900000|NCT01270464|540766220|FG001|Overall Study|Lost to Follow-up|3|||
150045884|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
150045885|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
150045886|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
150045887|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
150045888|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
150045889|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
150045890|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
150045891|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
150045892|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
150045893|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
150045894|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
150045895|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
150045896|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
150045897|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
150045898|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
149900001|NCT01270464|540766221|FG002|Overall Study|Lost to Follow-up|1|||
150045899|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
149900002|NCT01270464|540766219|FG000|Overall Study|Other|1|||
149900003|NCT01270464|540766220|FG001|Overall Study|Other|1|||
149900004|NCT01270464|540766221|FG002|Overall Study|Other|3|||
149900005|NCT02448537|540766222|FG000|Overall Study|Withdrawal by Subject|1|||
149900006|NCT02448537|540766223|FG001|Overall Study|Withdrawal by Subject|1|||
149900007|NCT02448537|540766224|FG002|Overall Study|Withdrawal by Subject|1|||
149900008|NCT04725812|540766225|FG000|Overall Study|Withdrawal by Subject|1|||
149900009|NCT02801617|540766227|FG000|Overall Study|Protocol Violation|2|||
149900010|NCT02801617|540766228|FG001|Overall Study|Protocol Violation|6|||
150176447|NCT05061693|541781989|FG008|24-week Extension Period|Sponsor Decision|0|||
150176448|NCT05061693|541781990|FG009|24-week Extension Period|Sponsor Decision|0|||
150176449|NCT05061693|541781991|FG010|24-week Extension Period|Sponsor Decision|0|||
150176450|NCT05061693|541781992|FG011|24-week Extension Period|Sponsor Decision|0|||
150176451|NCT05061693|541781981|FG000|24-week Extension Period|Site Closure|0|||
150176452|NCT05061693|541781982|FG001|24-week Extension Period|Site Closure|0|||
150176453|NCT05061693|541781983|FG002|24-week Extension Period|Site Closure|0|||
150176454|NCT05061693|541781984|FG003|24-week Extension Period|Site Closure|0|||
150176455|NCT05061693|541781985|FG004|24-week Extension Period|Site Closure|0|||
150176456|NCT05061693|541781986|FG005|24-week Extension Period|Site Closure|0|||
149900011|NCT01164579|540766229|FG000|Overall Study|Lack of Efficacy|0|||
149900012|NCT01164579|540766230|FG001|Overall Study|Lack of Efficacy|0|||
149900013|NCT01164579|540766231|FG002|Overall Study|Lack of Efficacy|6|||
149900014|NCT01164579|540766229|FG000|Overall Study|Lost to Follow-up|1|||
149900015|NCT01164579|540766230|FG001|Overall Study|Lost to Follow-up|1|||
150045900|NCT02405442|541307993|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
150045901|NCT02405442|541307994|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
150045902|NCT02405442|541307995|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
150045903|NCT02405442|541307996|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
150045904|NCT02405442|541307993|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
150045905|NCT02405442|541307994|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
150045906|NCT02405442|541307995|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
150045907|NCT02405442|541307996|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
149900016|NCT01164579|540766231|FG002|Overall Study|Lost to Follow-up|0|||
149900017|NCT01164579|540766229|FG000|Overall Study|Withdrawal by Subject|2|||
149900018|NCT01164579|540766230|FG001|Overall Study|Withdrawal by Subject|5|||
149900019|NCT01164579|540766231|FG002|Overall Study|Withdrawal by Subject|3|||
149900020|NCT01164579|540766229|FG000|Overall Study|Protocol Violation|0|||
149900021|NCT01164579|540766230|FG001|Overall Study|Protocol Violation|1|||
149900022|NCT01164579|540766231|FG002|Overall Study|Protocol Violation|2|||
149900023|NCT01164579|540766229|FG000|Overall Study|Adverse Event|4|||
149900024|NCT01164579|540766230|FG001|Overall Study|Adverse Event|2|||
149900025|NCT01164579|540766231|FG002|Overall Study|Adverse Event|5|||
149900026|NCT01164579|540766229|FG000|Overall Study|Reason not specified|1|||
149900027|NCT01164579|540766230|FG001|Overall Study|Reason not specified|0|||
149900028|NCT01164579|540766231|FG002|Overall Study|Reason not specified|0|||
149900029|NCT02875613|540766237|FG000|Overall Study|Withdrawal by Subject|1|||
149900030|NCT02875613|540766237|FG000|Overall Study|Screen Failure|1|||
149900031|NCT02347774|540766238|FG000|Study Participation|Lost to Follow-up|3|||
149900032|NCT02347774|540766239|FG001|Study Participation|Lost to Follow-up|6|||
149900033|NCT02347774|540766240|FG002|Study Participation|Lost to Follow-up|2|||
149900034|NCT02347774|540766238|FG000|Study Participation|Withdrawal by Subject|8|||
149900035|NCT02347774|540766239|FG001|Study Participation|Withdrawal by Subject|9|||
149900036|NCT02347774|540766240|FG002|Study Participation|Withdrawal by Subject|15|||
149900037|NCT02347774|540766238|FG000|Study Participation|Adverse Event|1|||
149900038|NCT02347774|540766239|FG001|Study Participation|Adverse Event|4|||
149900039|NCT02347774|540766240|FG002|Study Participation|Adverse Event|6|||
150045908|NCT02405442|541307993|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
150045909|NCT02405442|541307994|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
150045910|NCT02405442|541307995|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
150045911|NCT02405442|541307996|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
150045912|NCT02405442|541307993|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
150045913|NCT02405442|541307994|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
150045914|NCT02405442|541307995|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
150045915|NCT02405442|541307996|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
150045916|NCT00373113|541307997|FG000|Overall Study|Death|1|||
150045917|NCT00373113|541307998|FG001|Overall Study|Death|7|||
150045918|NCT00373113|541307997|FG000|Overall Study|Adverse Event|38|||
150045919|NCT00373113|541307998|FG001|Overall Study|Adverse Event|24|||
150045920|NCT00373113|541307997|FG000|Overall Study|Study terminated by sponsor|9|||
150045921|NCT00373113|541307998|FG001|Overall Study|Study terminated by sponsor|1|||
150045922|NCT00373113|541307997|FG000|Overall Study|Global deterioration of health status|10|||
150045923|NCT00373113|541307998|FG001|Overall Study|Global deterioration of health status|7|||
150045924|NCT00373113|541307997|FG000|Overall Study|Lost to Follow-up|1|||
150045925|NCT00373113|541307998|FG001|Overall Study|Lost to Follow-up|3|||
150045926|NCT00373113|541307997|FG000|Overall Study|Objective progression or relapse|150|||
150045927|NCT00373113|541307998|FG001|Overall Study|Objective progression or relapse|169|||
150045928|NCT00373113|541307997|FG000|Overall Study|Other|14|||
149900040|NCT02347774|540766238|FG000|Study Participation|withdrew consent|1|||
149900041|NCT02347774|540766239|FG001|Study Participation|withdrew consent|1|||
149900042|NCT02347774|540766240|FG002|Study Participation|withdrew consent|1|||
149900043|NCT02347774|540766238|FG000|Study Participation|Met Prolonged QT criteria|1|||
149900044|NCT02347774|540766239|FG001|Study Participation|Met Prolonged QT criteria|0|||
150045929|NCT00373113|541307998|FG001|Overall Study|Other|17|||
150045930|NCT00373113|541307997|FG000|Overall Study|Protocol Violation|5|||
149900045|NCT02347774|540766240|FG002|Study Participation|Met Prolonged QT criteria|0|||
149900046|NCT02347774|540766238|FG000|Study Participation|non-compliance with study drug|0|||
149900047|NCT02347774|540766239|FG001|Study Participation|non-compliance with study drug|1|||
149900048|NCT02347774|540766240|FG002|Study Participation|non-compliance with study drug|0|||
149900049|NCT02347774|540766238|FG000|Study Participation|incarceration|1|||
149900050|NCT02347774|540766239|FG001|Study Participation|incarceration|0|||
149900051|NCT02347774|540766240|FG002|Study Participation|incarceration|0|||
149900052|NCT02347774|540766238|FG000|Study Participation|randomized in error|0|||
149900053|NCT02347774|540766239|FG001|Study Participation|randomized in error|0|||
149900054|NCT02347774|540766240|FG002|Study Participation|randomized in error|1|||
149900055|NCT02347774|540766238|FG000|On Study Treatment|Adverse Event|9|||
149900056|NCT02347774|540766239|FG001|On Study Treatment|Adverse Event|15|||
149900057|NCT02347774|540766240|FG002|On Study Treatment|Adverse Event|19|||
149900058|NCT02347774|540766238|FG000|On Study Treatment|Lack of Efficacy|3|||
149900059|NCT02347774|540766239|FG001|On Study Treatment|Lack of Efficacy|0|||
149900060|NCT02347774|540766240|FG002|On Study Treatment|Lack of Efficacy|2|||
149900061|NCT02347774|540766238|FG000|On Study Treatment|non-complicance with study medication|0|||
149900062|NCT02347774|540766239|FG001|On Study Treatment|non-complicance with study medication|2|||
149900063|NCT02347774|540766240|FG002|On Study Treatment|non-complicance with study medication|0|||
149900064|NCT02347774|540766238|FG000|On Study Treatment|Protocol Violation|0|||
149900065|NCT02347774|540766239|FG001|On Study Treatment|Protocol Violation|0|||
149900066|NCT02347774|540766240|FG002|On Study Treatment|Protocol Violation|1|||
149900067|NCT02347774|540766238|FG000|On Study Treatment|withdrew consent|9|||
149900068|NCT02347774|540766239|FG001|On Study Treatment|withdrew consent|8|||
149900069|NCT02347774|540766240|FG002|On Study Treatment|withdrew consent|12|||
149900070|NCT02347774|540766238|FG000|On Study Treatment|Lost to Follow-up|2|||
149900071|NCT02347774|540766239|FG001|On Study Treatment|Lost to Follow-up|6|||
149900072|NCT02347774|540766240|FG002|On Study Treatment|Lost to Follow-up|1|||
149900073|NCT02347774|540766238|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
149900074|NCT02347774|540766239|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
149900075|NCT02347774|540766240|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
149900076|NCT02347774|540766238|FG000|On Study Treatment|ranomized in error|0|||
149900077|NCT02347774|540766239|FG001|On Study Treatment|ranomized in error|0|||
149900078|NCT02347774|540766240|FG002|On Study Treatment|ranomized in error|1|||
149900079|NCT00820248|540766242|FG000|Overall Study|No treated|4|||
149900080|NCT00820248|540766243|FG001|Overall Study|No treated|1|||
149900081|NCT01562782|540766244|FG000|Overall Study|Withdrawal by Subject|3|||
149900082|NCT01562782|540766245|FG001|Overall Study|Withdrawal by Subject|3|||
149900083|NCT01562782|540766244|FG000|Overall Study|screen failure|1|||
149900084|NCT01562782|540766245|FG001|Overall Study|screen failure|2|||
149900085|NCT01091662|540766246|FG000|Overall Study|Adverse Event|1|||
149900086|NCT01091662|540766247|FG001|Overall Study|Adverse Event|9|||
149900087|NCT01091662|540766246|FG000|Overall Study|Physician Decision|1|||
149900088|NCT01091662|540766247|FG001|Overall Study|Physician Decision|1|||
149900089|NCT01091662|540766246|FG000|Overall Study|Withdrawal by Subject|7|||
149900090|NCT01091662|540766247|FG001|Overall Study|Withdrawal by Subject|6|||
149900091|NCT01091662|540766246|FG000|Overall Study|met exit criteria|7|||
149900092|NCT01091662|540766247|FG001|Overall Study|met exit criteria|13|||
149900093|NCT01091662|540766246|FG000|Overall Study|met exclusion criteria|1|||
149900094|NCT01091662|540766247|FG001|Overall Study|met exclusion criteria|0|||
149900095|NCT01091662|540766246|FG000|Overall Study|Lost to Follow-up|0|||
149900096|NCT01091662|540766247|FG001|Overall Study|Lost to Follow-up|1|||
149900097|NCT01091662|540766246|FG000|Overall Study|Pregnancy|0|||
149900098|NCT01091662|540766247|FG001|Overall Study|Pregnancy|1|||
149900099|NCT01091662|540766246|FG000|Overall Study|Protocol Violation|0|||
149900100|NCT01091662|540766247|FG001|Overall Study|Protocol Violation|2|||
149900101|NCT01091662|540766246|FG000|Overall Study|unable to swallow capsule|0|||
149900102|NCT01091662|540766247|FG001|Overall Study|unable to swallow capsule|1|||
149900103|NCT02308540|540766248|FG000|Overall Study|Lost to Follow-up|0|||
149900104|NCT02308540|540766249|FG001|Overall Study|Lost to Follow-up|0|||
149900105|NCT02308540|540766250|FG002|Overall Study|Lost to Follow-up|0|||
149968825|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
149968826|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
149900106|NCT02308540|540766251|FG003|Overall Study|Lost to Follow-up|0|||
149900107|NCT02308540|540766252|FG004|Overall Study|Lost to Follow-up|0|||
149900108|NCT02308540|540766253|FG005|Overall Study|Lost to Follow-up|1|||
149900109|NCT04109391|540766254|FG000|Overall Study|Adverse Event|2|||
149900110|NCT04109391|540766255|FG001|Overall Study|Adverse Event|2|||
149900111|NCT04109391|540766256|FG002|Overall Study|Adverse Event|0|||
149900112|NCT04109391|540766254|FG000|Overall Study|Withdrawal by Subject|2|||
149900113|NCT04109391|540766255|FG001|Overall Study|Withdrawal by Subject|0|||
149900114|NCT04109391|540766256|FG002|Overall Study|Withdrawal by Subject|0|||
149900115|NCT04109391|540766254|FG000|Overall Study|Pregnancy|1|||
149900116|NCT04109391|540766255|FG001|Overall Study|Pregnancy|0|||
149900117|NCT04109391|540766256|FG002|Overall Study|Pregnancy|0|||
149900118|NCT04109391|540766254|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
149968827|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
149900119|NCT04109391|540766255|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
149900120|NCT04109391|540766256|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
149900121|NCT04109391|540766254|FG000|Overall Study|Lost to Follow-up|0|||
149900122|NCT04109391|540766255|FG001|Overall Study|Lost to Follow-up|0|||
149900123|NCT04109391|540766256|FG002|Overall Study|Lost to Follow-up|1|||
149900124|NCT04109391|540766254|FG000|Overall Study|Lack of Efficacy|2|||
149900125|NCT04109391|540766255|FG001|Overall Study|Lack of Efficacy|2|||
149900126|NCT04109391|540766256|FG002|Overall Study|Lack of Efficacy|3|||
149900127|NCT02993250|540766264|FG000|Overall Study|Lost to Follow-up|0|||
149900128|NCT02993250|540766265|FG001|Overall Study|Lost to Follow-up|1|||
149900129|NCT00356148|540766267|FG000|Overall Study|Reoperation within 30 days|2|||
149900130|NCT00356148|540766268|FG001|Overall Study|Reoperation within 30 days|1|||
149900131|NCT02484456|540766269|FG000|Washout Period|Withdrawal by Subject|0|||
149900132|NCT02484456|540766270|FG001|Washout Period|Withdrawal by Subject|1|||
149900133|NCT02484456|540766269|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
149900134|NCT02484456|540766270|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
149900135|NCT02484456|540766269|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
149900136|NCT02484456|540766270|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
149900137|NCT02484456|540766269|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
149900138|NCT02484456|540766270|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
149900139|NCT03852264|540766272|FG000|Third Research Visit|Lost to Follow-up|1|||
149900140|NCT03852264|540766273|FG001|Third Research Visit|Lost to Follow-up|0|||
149900141|NCT02737930|540766277|FG000|Overall Study|Withdrawal by Subject|0|||
149900142|NCT02737930|540766278|FG001|Overall Study|Withdrawal by Subject|1|||
149900143|NCT04481789|540766281|FG000|Period 1|Withdrawal by Subject|1|||
149900144|NCT04481789|540766282|FG001|Period 1|Withdrawal by Subject|0|||
149900145|NCT04481789|540766283|FG002|Period 1|Withdrawal by Subject|0|||
149900146|NCT04481789|540766284|FG003|Period 1|Withdrawal by Subject|0|||
149900147|NCT04481789|540766285|FG004|Period 1|Withdrawal by Subject|0|||
149900148|NCT04481789|540766286|FG005|Period 1|Withdrawal by Subject|0|||
149900149|NCT03124407|540766291|FG000|Overall Study|Lost to Follow-up|1|||
149900150|NCT03124407|540766292|FG001|Overall Study|Lost to Follow-up|0|||
149900151|NCT03124407|540766293|FG002|Overall Study|Lost to Follow-up|0|||
149900152|NCT03124407|540766294|FG003|Overall Study|Lost to Follow-up|0|||
149900153|NCT03124407|540766291|FG000|Overall Study|Adverse Event|0|||
149900154|NCT03124407|540766292|FG001|Overall Study|Adverse Event|0|||
149900155|NCT03124407|540766293|FG002|Overall Study|Adverse Event|1|||
149968828|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
149968829|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
149968830|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
149968831|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
149968832|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
149968833|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
149968834|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
149968835|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
149968836|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
149968837|NCT02958865|541022032|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968838|NCT02958865|541022033|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968839|NCT02958865|541022034|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968840|NCT02958865|541022035|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968841|NCT02958865|541022036|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
149968842|NCT02958865|541022037|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968843|NCT02958865|541022038|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968844|NCT02958865|541022039|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968845|NCT02958865|541022040|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968846|NCT02958865|541022041|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968847|NCT02958865|541022042|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968848|NCT02958865|541022043|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968849|NCT02958865|541022044|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968850|NCT02958865|541022045|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968851|NCT02958865|541022046|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968852|NCT02958865|541022047|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149968853|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968854|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968855|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968856|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149900156|NCT03124407|540766294|FG003|Overall Study|Adverse Event|0|||
149900157|NCT05708976|540766297|FG000|Overall Study|Withdrawal by Subject|0|||
149900158|NCT05708976|540766298|FG001|Overall Study|Withdrawal by Subject|1|||
149900159|NCT02929589|540766332|FG000|Overall Study|Withdrawal by Subject|1|||
149900160|NCT02929589|540766333|FG001|Overall Study|Withdrawal by Subject|0|||
149968857|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149900161|NCT02929589|540766334|FG002|Overall Study|Withdrawal by Subject|0|||
149900162|NCT02929589|540766335|FG003|Overall Study|Withdrawal by Subject|0|||
149900163|NCT02929589|540766332|FG000|Overall Study|Physician Decision|2|||
149900164|NCT02929589|540766333|FG001|Overall Study|Physician Decision|0|||
149900165|NCT02929589|540766334|FG002|Overall Study|Physician Decision|0|||
149900166|NCT02929589|540766335|FG003|Overall Study|Physician Decision|0|||
149900167|NCT02091089|540766337|FG000|Overall Study|Lost to Follow-up|2|||
149900168|NCT01303172|540766344|FG000|Overall Study|Physician Decision|9|||
149900169|NCT01303172|540766345|FG001|Overall Study|Physician Decision|6|||
149900170|NCT01303172|540766344|FG000|Overall Study|Adverse Event|5|||
149900171|NCT01303172|540766345|FG001|Overall Study|Adverse Event|2|||
149900172|NCT01303172|540766344|FG000|Overall Study|Withdrawal by Subject|4|||
149900173|NCT01303172|540766345|FG001|Overall Study|Withdrawal by Subject|2|||
149900174|NCT01303172|540766344|FG000|Overall Study|Death|20|||
149900175|NCT01303172|540766345|FG001|Overall Study|Death|7|||
149900176|NCT01303172|540766344|FG000|Overall Study|Lack of Efficacy|25|||
149900177|NCT01303172|540766345|FG001|Overall Study|Lack of Efficacy|17|||
149900178|NCT02821754|540766346|FG000|Overall Study|Procedure not required prior to amendment change|13|||
149900179|NCT02821754|540766347|FG001|Overall Study|Procedure not required prior to amendment change|11|||
149900180|NCT02821754|540766348|FG002|Overall Study|Procedure not required prior to amendment change|0|||
149900181|NCT02821754|540766346|FG000|Overall Study|Participant's Clinical status|2|||
149900182|NCT02821754|540766347|FG001|Overall Study|Participant's Clinical status|0|||
149900183|NCT02821754|540766348|FG002|Overall Study|Participant's Clinical status|0|||
149900184|NCT02821754|540766346|FG000|Overall Study|Participant removed for noncompliance|1|||
149900185|NCT02821754|540766347|FG001|Overall Study|Participant removed for noncompliance|0|||
149900186|NCT02821754|540766348|FG002|Overall Study|Participant removed for noncompliance|0|||
149900187|NCT02821754|540766346|FG000|Overall Study|Drug not available.|0|||
149900188|NCT02821754|540766347|FG001|Overall Study|Drug not available.|0|||
149900189|NCT02821754|540766348|FG002|Overall Study|Drug not available.|1|||
149900190|NCT02821754|540766346|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
149900191|NCT02821754|540766347|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
150176457|NCT05061693|541781987|FG006|24-week Extension Period|Site Closure|0|||
149900192|NCT02821754|540766348|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
149900193|NCT00994461|540766351|FG000|Overall Study|Adverse Event|2|||
149900194|NCT00994461|540766352|FG001|Overall Study|Adverse Event|1|||
149900195|NCT00994461|540766353|FG002|Overall Study|Adverse Event|0|||
149900196|NCT00766636|540766354|FG000|Overall Study|Withdrawal by Subject|1|||
149900197|NCT00766636|540766355|FG001|Overall Study|Withdrawal by Subject|1|||
149900198|NCT00766636|540766354|FG000|Overall Study|Incomplete Treatment|0|||
149900199|NCT00766636|540766355|FG001|Overall Study|Incomplete Treatment|1|||
149900200|NCT00766636|540766354|FG000|Overall Study|Adverse Event|1|||
149900201|NCT00766636|540766355|FG001|Overall Study|Adverse Event|0|||
149900202|NCT00766636|540766354|FG000|Overall Study|Disease Progression|1|||
149900203|NCT00766636|540766355|FG001|Overall Study|Disease Progression|0|||
149900204|NCT00591565|540766368|FG000|Overall Study|lost follow up, withdrawn|5|||
149900205|NCT00454363|540766369|FG000|Overall Study|Adverse Event|1|||
149900206|NCT00454363|540766370|FG001|Overall Study|Adverse Event|2|||
149900207|NCT00454363|540766369|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
149900208|NCT00454363|540766370|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
149900209|NCT01863667|540766372|FG000|Overall Study|Adverse Event|1|||
149900210|NCT01863667|540766373|FG001|Overall Study|Adverse Event|0|||
149900211|NCT01863667|540766372|FG000|Overall Study|Study terminated by Sponsor|30|||
149900212|NCT01863667|540766373|FG001|Overall Study|Study terminated by Sponsor|30|||
149900213|NCT01863667|540766372|FG000|Overall Study|Withdrawal by Subject|2|||
149900214|NCT01863667|540766373|FG001|Overall Study|Withdrawal by Subject|2|||
149900215|NCT03627546|540766376|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
149900216|NCT03627546|540766377|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
149900217|NCT03627546|540766378|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
149900218|NCT03627546|540766376|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
149900219|NCT03627546|540766377|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
149900220|NCT03627546|540766378|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
149900221|NCT02837731|540766384|FG000|Allocation|Admitted to General Floor|3|||
149900222|NCT02837731|540766385|FG001|Allocation|Admitted to General Floor|4|||
149900223|NCT02837731|540766384|FG000|Allocation|Immediate surgery/withdrew|2|||
149900224|NCT02837731|540766385|FG001|Allocation|Immediate surgery/withdrew|0|||
149900225|NCT02837731|540766384|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
149968858|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968859|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968860|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
149968861|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
149968862|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
149968863|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
149968864|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
149968865|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
149968866|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
149968867|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
149968868|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
149968869|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968870|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968871|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968872|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968873|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968874|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968875|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968876|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149900226|NCT02837731|540766385|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
149900227|NCT02837731|540766384|FG000|Allocation|Withdrawal by Subject|2|||
149900228|NCT02837731|540766385|FG001|Allocation|Withdrawal by Subject|0|||
149900229|NCT02837731|540766384|FG000|Allocation|Device not available|1|||
149900230|NCT02837731|540766385|FG001|Allocation|Device not available|0|||
149900231|NCT02837731|540766384|FG000|Allocation|Protocol not implemented|7|||
149900232|NCT02837731|540766385|FG001|Allocation|Protocol not implemented|0|||
149900233|NCT02837731|540766384|FG000|Allocation|Moribund/Do not resuscitate|2|||
149900234|NCT02837731|540766385|FG001|Allocation|Moribund/Do not resuscitate|0|||
149900235|NCT02837731|540766384|FG000|Allocation|Did not meet sepsis criteria|1|||
149900236|NCT02837731|540766385|FG001|Allocation|Did not meet sepsis criteria|2|||
149900237|NCT02837731|540766384|FG000|Allocation|Known aortic abnormalities|0|||
149900238|NCT02837731|540766385|FG001|Allocation|Known aortic abnormalities|1|||
149900239|NCT02965573|540766386|FG000|Overall Study|Lack of Efficacy|1|||
149900240|NCT02965573|540766387|FG001|Overall Study|Lack of Efficacy|0|||
149900241|NCT02644668|540766390|FG000|Overall Study|Adverse Event|2|||
149900242|NCT02644668|540766391|FG001|Overall Study|Adverse Event|0|||
149900243|NCT02644668|540766392|FG002|Overall Study|Adverse Event|1|||
149900244|NCT02644668|540766390|FG000|Overall Study|Protocol Violation|0|||
149900245|NCT02644668|540766391|FG001|Overall Study|Protocol Violation|0|||
149900246|NCT02644668|540766392|FG002|Overall Study|Protocol Violation|1|||
149900247|NCT02644668|540766390|FG000|Overall Study|Withdrawal by Subject|0|||
149900248|NCT02644668|540766391|FG001|Overall Study|Withdrawal by Subject|0|||
149900249|NCT02644668|540766392|FG002|Overall Study|Withdrawal by Subject|1|||
149900250|NCT03291431|540766393|FG000|Overall Study|Protocol Violation|2|||
149900251|NCT03291431|540766394|FG001|Overall Study|Protocol Violation|1|||
149900252|NCT03291431|540766393|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
149900253|NCT03291431|540766394|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
149900254|NCT03291431|540766393|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
149900255|NCT03291431|540766394|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
149900256|NCT03850483|540766399|FG000|Treatment for Stage 1|Adverse Event|1|||
149900257|NCT03850483|540766400|FG001|Treatment for Stage 1|Adverse Event|1|||
149900258|NCT03850483|540766401|FG002|Treatment for Stage 1|Adverse Event|3|||
149900259|NCT03850483|540766402|FG003|Treatment for Stage 1|Adverse Event|0|||
149900260|NCT03850483|540766403|FG004|Treatment for Stage 1|Adverse Event|2|||
149900261|NCT03850483|540766404|FG005|Treatment for Stage 1|Adverse Event|0|||
149900262|NCT03850483|540766405|FG006|Treatment for Stage 1|Adverse Event|2|||
149900263|NCT03850483|540766406|FG007|Treatment for Stage 1|Adverse Event|2|||
149900264|NCT03850483|540766407|FG008|Treatment for Stage 1|Adverse Event|0|||
149900265|NCT03850483|540766408|FG009|Treatment for Stage 1|Adverse Event|0|||
149900266|NCT03850483|540766399|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
149900267|NCT03850483|540766400|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
149900268|NCT03850483|540766401|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
149900269|NCT03850483|540766402|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
149900270|NCT03850483|540766403|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
149900271|NCT03850483|540766404|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
149900272|NCT03850483|540766405|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
149900273|NCT03850483|540766406|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
149900274|NCT03850483|540766407|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
149900275|NCT03850483|540766408|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
149900276|NCT03850483|540766399|FG000|Treatment for Stage 1|Protocol Violation|1|||
149900277|NCT03850483|540766400|FG001|Treatment for Stage 1|Protocol Violation|0|||
149900278|NCT03850483|540766401|FG002|Treatment for Stage 1|Protocol Violation|0|||
149900279|NCT03850483|540766402|FG003|Treatment for Stage 1|Protocol Violation|0|||
149900280|NCT03850483|540766403|FG004|Treatment for Stage 1|Protocol Violation|0|||
149900281|NCT03850483|540766404|FG005|Treatment for Stage 1|Protocol Violation|0|||
149900282|NCT03850483|540766405|FG006|Treatment for Stage 1|Protocol Violation|1|||
149900283|NCT03850483|540766406|FG007|Treatment for Stage 1|Protocol Violation|0|||
149900284|NCT03850483|540766407|FG008|Treatment for Stage 1|Protocol Violation|0|||
149900285|NCT03850483|540766408|FG009|Treatment for Stage 1|Protocol Violation|0|||
149900286|NCT03850483|540766399|FG000|Treatment for Stage 1|Physician Decision|0|||
149900287|NCT03850483|540766400|FG001|Treatment for Stage 1|Physician Decision|0|||
149900288|NCT03850483|540766401|FG002|Treatment for Stage 1|Physician Decision|0|||
149900289|NCT03850483|540766402|FG003|Treatment for Stage 1|Physician Decision|0|||
149900290|NCT03850483|540766403|FG004|Treatment for Stage 1|Physician Decision|0|||
149900291|NCT03850483|540766404|FG005|Treatment for Stage 1|Physician Decision|1|||
149900292|NCT03850483|540766405|FG006|Treatment for Stage 1|Physician Decision|0|||
149900293|NCT03850483|540766406|FG007|Treatment for Stage 1|Physician Decision|0|||
149900294|NCT03850483|540766407|FG008|Treatment for Stage 1|Physician Decision|0|||
149900295|NCT03850483|540766408|FG009|Treatment for Stage 1|Physician Decision|0|||
149900296|NCT03850483|540766399|FG000|Treatment for Stage 1|Other|0|||
149900297|NCT03850483|540766400|FG001|Treatment for Stage 1|Other|0|||
149900298|NCT03850483|540766401|FG002|Treatment for Stage 1|Other|0|||
149900299|NCT03850483|540766402|FG003|Treatment for Stage 1|Other|0|||
149900300|NCT03850483|540766403|FG004|Treatment for Stage 1|Other|2|||
149900301|NCT03850483|540766404|FG005|Treatment for Stage 1|Other|1|||
149900302|NCT03850483|540766405|FG006|Treatment for Stage 1|Other|0|||
149900303|NCT03850483|540766406|FG007|Treatment for Stage 1|Other|0|||
149900304|NCT03850483|540766407|FG008|Treatment for Stage 1|Other|0|||
149900305|NCT03850483|540766408|FG009|Treatment for Stage 1|Other|0|||
149900306|NCT03850483|540766399|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900307|NCT03850483|540766400|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900308|NCT03850483|540766401|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
149900309|NCT03850483|540766402|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900310|NCT03850483|540766403|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900311|NCT03850483|540766404|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900312|NCT03850483|540766405|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900313|NCT03850483|540766406|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900314|NCT03850483|540766407|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900315|NCT03850483|540766408|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
149900316|NCT03850483|540766399|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900317|NCT03850483|540766400|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900318|NCT03850483|540766401|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900319|NCT03850483|540766402|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900320|NCT03850483|540766403|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900321|NCT03850483|540766404|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
149900322|NCT03850483|540766405|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900323|NCT03850483|540766406|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900324|NCT03850483|540766407|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900325|NCT03850483|540766408|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
149900326|NCT03850483|540766399|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
149900327|NCT03850483|540766400|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
149900328|NCT03850483|540766401|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
149900329|NCT03850483|540766402|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
149900330|NCT03850483|540766403|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
149900331|NCT03850483|540766404|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
149900332|NCT03850483|540766405|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
149900333|NCT03850483|540766406|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
149900334|NCT03850483|540766407|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
149900335|NCT03850483|540766408|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
149900336|NCT03850483|540766399|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
149900337|NCT03850483|540766400|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
149900338|NCT03850483|540766401|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
149900339|NCT03850483|540766402|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
149900340|NCT03850483|540766403|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
149900341|NCT03850483|540766404|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
149900342|NCT03850483|540766405|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
149900343|NCT03850483|540766406|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
149900344|NCT03850483|540766407|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
149900345|NCT03850483|540766408|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
149900346|NCT03850483|540766399|FG000|Treatment for Stage 1|Death|0|||
149900347|NCT03850483|540766400|FG001|Treatment for Stage 1|Death|0|||
149900348|NCT03850483|540766401|FG002|Treatment for Stage 1|Death|0|||
149900349|NCT03850483|540766402|FG003|Treatment for Stage 1|Death|0|||
149900350|NCT03850483|540766403|FG004|Treatment for Stage 1|Death|0|||
149900351|NCT03850483|540766404|FG005|Treatment for Stage 1|Death|1|||
149900352|NCT03850483|540766405|FG006|Treatment for Stage 1|Death|0|||
149900353|NCT03850483|540766406|FG007|Treatment for Stage 1|Death|0|||
149900354|NCT03850483|540766407|FG008|Treatment for Stage 1|Death|0|||
149900355|NCT03850483|540766408|FG009|Treatment for Stage 1|Death|0|||
149900356|NCT03850483|540766399|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
149900357|NCT03850483|540766400|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
149900358|NCT03850483|540766401|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
149900359|NCT03850483|540766402|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
149900360|NCT03850483|540766403|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
149900361|NCT03850483|540766404|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
149900362|NCT03850483|540766405|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
149900363|NCT03850483|540766406|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
149900364|NCT03850483|540766407|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
149900365|NCT03850483|540766408|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
149900366|NCT03850483|540766399|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
149900367|NCT03850483|540766400|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
149900368|NCT03850483|540766401|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
149900369|NCT03850483|540766402|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
149900370|NCT03850483|540766403|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
149900371|NCT03850483|540766404|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
149900372|NCT03850483|540766405|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
149900373|NCT03850483|540766406|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
149900374|NCT03850483|540766407|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
149900375|NCT03850483|540766408|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
149900376|NCT03850483|540766399|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900377|NCT03850483|540766400|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
150045931|NCT00373113|541307998|FG001|Overall Study|Protocol Violation|1|||
149900378|NCT03850483|540766401|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900379|NCT03850483|540766402|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900380|NCT03850483|540766403|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900381|NCT03850483|540766404|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900382|NCT03850483|540766405|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
149900383|NCT03850483|540766406|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
149900384|NCT03850483|540766407|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900385|NCT03850483|540766408|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
149900386|NCT03850483|540766399|FG000|Follow-up for Stage 1|Physician Decision|0|||
149900387|NCT03850483|540766400|FG001|Follow-up for Stage 1|Physician Decision|0|||
149900388|NCT03850483|540766401|FG002|Follow-up for Stage 1|Physician Decision|0|||
149900389|NCT03850483|540766402|FG003|Follow-up for Stage 1|Physician Decision|0|||
149900390|NCT03850483|540766403|FG004|Follow-up for Stage 1|Physician Decision|1|||
149900391|NCT03850483|540766404|FG005|Follow-up for Stage 1|Physician Decision|0|||
149900392|NCT03850483|540766405|FG006|Follow-up for Stage 1|Physician Decision|1|||
149900393|NCT03850483|540766406|FG007|Follow-up for Stage 1|Physician Decision|0|||
149900394|NCT03850483|540766407|FG008|Follow-up for Stage 1|Physician Decision|0|||
149900395|NCT03850483|540766408|FG009|Follow-up for Stage 1|Physician Decision|0|||
149900396|NCT03850483|540766399|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
149900397|NCT03850483|540766400|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
149900398|NCT03850483|540766401|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
149900399|NCT03850483|540766402|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
149900400|NCT03850483|540766403|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
149900401|NCT03850483|540766404|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
149900402|NCT03850483|540766405|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
149900403|NCT03850483|540766406|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
149900404|NCT03850483|540766407|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
149900405|NCT03850483|540766408|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
149900406|NCT03850483|540766399|FG000|Follow-up for Stage 1|Adverse Event|0|||
149900407|NCT03850483|540766400|FG001|Follow-up for Stage 1|Adverse Event|0|||
149900408|NCT03850483|540766401|FG002|Follow-up for Stage 1|Adverse Event|1|||
149900409|NCT03850483|540766402|FG003|Follow-up for Stage 1|Adverse Event|0|||
149900410|NCT03850483|540766403|FG004|Follow-up for Stage 1|Adverse Event|0|||
149900411|NCT03850483|540766404|FG005|Follow-up for Stage 1|Adverse Event|1|||
149900412|NCT03850483|540766405|FG006|Follow-up for Stage 1|Adverse Event|0|||
149900413|NCT03850483|540766406|FG007|Follow-up for Stage 1|Adverse Event|0|||
149900414|NCT03850483|540766407|FG008|Follow-up for Stage 1|Adverse Event|0|||
149900415|NCT03850483|540766408|FG009|Follow-up for Stage 1|Adverse Event|0|||
149900416|NCT03850483|540766399|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900417|NCT03850483|540766400|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
149900418|NCT03850483|540766401|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900419|NCT03850483|540766402|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900420|NCT03850483|540766403|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
149900421|NCT03850483|540766404|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
149900422|NCT03850483|540766405|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900423|NCT03850483|540766406|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
150176458|NCT05061693|541781988|FG007|24-week Extension Period|Site Closure|0|||
150176459|NCT05061693|541781989|FG008|24-week Extension Period|Site Closure|1|||
150176460|NCT05061693|541781990|FG009|24-week Extension Period|Site Closure|0|||
150176461|NCT05061693|541781991|FG010|24-week Extension Period|Site Closure|0|||
150176462|NCT05061693|541781992|FG011|24-week Extension Period|Site Closure|1|||
150176463|NCT04009577|541781993|FG000|Core Study|Adverse Event|1|||
150176464|NCT04009577|541781994|FG001|Core Study|Adverse Event|0|||
150176465|NCT04009577|541781995|FG002|Core Study|Adverse Event|2|||
150176466|NCT04009577|541781996|FG003|Core Study|Adverse Event|4|||
150176467|NCT04009577|541781993|FG000|Core Study|Withdrawal by Subject|0|||
150176468|NCT04009577|541781994|FG001|Core Study|Withdrawal by Subject|0|||
149900424|NCT03850483|540766407|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900425|NCT03850483|540766408|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
149900426|NCT03850483|540766399|FG000|Follow-up for Stage 1|Other|0|||
149900427|NCT03850483|540766400|FG001|Follow-up for Stage 1|Other|2|||
149900428|NCT03850483|540766401|FG002|Follow-up for Stage 1|Other|0|||
149900429|NCT03850483|540766402|FG003|Follow-up for Stage 1|Other|2|||
149900430|NCT03850483|540766403|FG004|Follow-up for Stage 1|Other|0|||
149900431|NCT03850483|540766404|FG005|Follow-up for Stage 1|Other|1|||
149900432|NCT03850483|540766405|FG006|Follow-up for Stage 1|Other|0|||
149900433|NCT03850483|540766406|FG007|Follow-up for Stage 1|Other|0|||
149900434|NCT03850483|540766407|FG008|Follow-up for Stage 1|Other|0|||
149900435|NCT03850483|540766408|FG009|Follow-up for Stage 1|Other|0|||
149900436|NCT03850483|540766399|FG000|Treatment for Stage 2|Adverse Event|0|||
149900437|NCT03850483|540766400|FG001|Treatment for Stage 2|Adverse Event|0|||
149900438|NCT03850483|540766401|FG002|Treatment for Stage 2|Adverse Event|0|||
149900439|NCT03850483|540766402|FG003|Treatment for Stage 2|Adverse Event|0|||
149900440|NCT03850483|540766403|FG004|Treatment for Stage 2|Adverse Event|0|||
149900441|NCT03850483|540766404|FG005|Treatment for Stage 2|Adverse Event|0|||
149900442|NCT03850483|540766405|FG006|Treatment for Stage 2|Adverse Event|0|||
149900443|NCT03850483|540766406|FG007|Treatment for Stage 2|Adverse Event|0|||
149900444|NCT03850483|540766407|FG008|Treatment for Stage 2|Adverse Event|0|||
149900445|NCT03850483|540766408|FG009|Treatment for Stage 2|Adverse Event|1|||
149900446|NCT03850483|540766399|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
149900447|NCT03850483|540766400|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
149900448|NCT03850483|540766401|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
149900449|NCT03850483|540766402|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
149900450|NCT03850483|540766403|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
150176469|NCT04009577|541781995|FG002|Core Study|Withdrawal by Subject|2|||
150176470|NCT04009577|541781996|FG003|Core Study|Withdrawal by Subject|0|||
149900451|NCT03850483|540766404|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
149900452|NCT03850483|540766405|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
149900453|NCT03850483|540766406|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
149900454|NCT03850483|540766407|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
149968877|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
150176471|NCT04009577|541781993|FG000|Core Study|Other|0|||
150176472|NCT04009577|541781994|FG001|Core Study|Other|0|||
150176473|NCT04009577|541781995|FG002|Core Study|Other|0|||
150176474|NCT04009577|541781996|FG003|Core Study|Other|1|||
150176475|NCT04009577|541781993|FG000|Extension Phase|Adverse Event|0|||
149900455|NCT03850483|540766408|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
149900456|NCT03850483|540766399|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
149900457|NCT03850483|540766400|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
149900458|NCT03850483|540766401|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
149900459|NCT03850483|540766402|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
149900460|NCT03850483|540766403|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
149900461|NCT03850483|540766404|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
149900462|NCT03850483|540766405|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
149900463|NCT03850483|540766406|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
149900464|NCT03850483|540766407|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
149900465|NCT03850483|540766408|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
149900466|NCT03850483|540766399|FG000|Treatment for Stage 2|Physician Decision|0|||
149900467|NCT03850483|540766400|FG001|Treatment for Stage 2|Physician Decision|0|||
149900468|NCT03850483|540766401|FG002|Treatment for Stage 2|Physician Decision|0|||
149900469|NCT03850483|540766402|FG003|Treatment for Stage 2|Physician Decision|0|||
149900470|NCT03850483|540766403|FG004|Treatment for Stage 2|Physician Decision|0|||
149900471|NCT03850483|540766404|FG005|Treatment for Stage 2|Physician Decision|0|||
149900472|NCT03850483|540766405|FG006|Treatment for Stage 2|Physician Decision|0|||
149900473|NCT03850483|540766406|FG007|Treatment for Stage 2|Physician Decision|0|||
149900474|NCT03850483|540766407|FG008|Treatment for Stage 2|Physician Decision|0|||
149900475|NCT03850483|540766408|FG009|Treatment for Stage 2|Physician Decision|1|||
149900476|NCT03850483|540766399|FG000|Treatment for Stage 2|Protocol Violation|0|||
149900477|NCT03850483|540766400|FG001|Treatment for Stage 2|Protocol Violation|0|||
149900478|NCT03850483|540766401|FG002|Treatment for Stage 2|Protocol Violation|0|||
149900479|NCT03850483|540766402|FG003|Treatment for Stage 2|Protocol Violation|0|||
149900480|NCT03850483|540766403|FG004|Treatment for Stage 2|Protocol Violation|0|||
149900481|NCT03850483|540766404|FG005|Treatment for Stage 2|Protocol Violation|0|||
149900482|NCT03850483|540766405|FG006|Treatment for Stage 2|Protocol Violation|0|||
149900483|NCT03850483|540766406|FG007|Treatment for Stage 2|Protocol Violation|0|||
149900484|NCT03850483|540766407|FG008|Treatment for Stage 2|Protocol Violation|1|||
149900485|NCT03850483|540766408|FG009|Treatment for Stage 2|Protocol Violation|0|||
149900486|NCT03850483|540766399|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
149900487|NCT03850483|540766400|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
149900488|NCT03850483|540766401|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
149900489|NCT03850483|540766402|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
149900490|NCT03850483|540766403|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
149900491|NCT03850483|540766404|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
149900492|NCT03850483|540766405|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
149900493|NCT03850483|540766406|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
149900494|NCT03850483|540766407|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
149900495|NCT03850483|540766408|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
149900496|NCT03850483|540766399|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900497|NCT03850483|540766400|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900498|NCT03850483|540766401|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900499|NCT03850483|540766402|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900500|NCT03850483|540766403|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900501|NCT03850483|540766404|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900502|NCT03850483|540766405|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900503|NCT03850483|540766406|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900504|NCT03850483|540766407|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
149900505|NCT03850483|540766408|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
149900506|NCT03850483|540766399|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
149900507|NCT03850483|540766400|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
149900508|NCT03850483|540766401|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
149968878|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
149968879|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968880|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
149900509|NCT03850483|540766402|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
149900510|NCT03850483|540766403|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
149900511|NCT03850483|540766404|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
149900512|NCT03850483|540766405|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
149900513|NCT03850483|540766406|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
149900514|NCT03850483|540766407|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
149900515|NCT03850483|540766408|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
149900516|NCT03850483|540766399|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
149900517|NCT03850483|540766400|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
149900518|NCT03850483|540766401|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
149900519|NCT03850483|540766402|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
149900520|NCT03850483|540766403|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
149900521|NCT03850483|540766404|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
149900522|NCT03850483|540766405|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
149900523|NCT03850483|540766406|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
149900524|NCT03850483|540766407|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
149900525|NCT03850483|540766408|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
149900526|NCT03850483|540766399|FG000|Follow-up For Stage 2|Other|0|||
149900527|NCT03850483|540766400|FG001|Follow-up For Stage 2|Other|0|||
149900528|NCT03850483|540766401|FG002|Follow-up For Stage 2|Other|0|||
149900529|NCT03850483|540766402|FG003|Follow-up For Stage 2|Other|0|||
149900530|NCT03850483|540766403|FG004|Follow-up For Stage 2|Other|0|||
149900531|NCT03850483|540766404|FG005|Follow-up For Stage 2|Other|0|||
149900532|NCT03850483|540766405|FG006|Follow-up For Stage 2|Other|0|||
149900533|NCT03850483|540766406|FG007|Follow-up For Stage 2|Other|0|||
149900534|NCT03850483|540766407|FG008|Follow-up For Stage 2|Other|0|||
149900535|NCT03850483|540766408|FG009|Follow-up For Stage 2|Other|1|||
149900536|NCT01190410|540768188|FG000|Overall Study|Adverse Event|0|||
149900537|NCT01190410|540768189|FG001|Overall Study|Adverse Event|3|||
149900538|NCT01190410|540768188|FG000|Overall Study|Lack of Efficacy|0|||
149900539|NCT01190410|540768189|FG001|Overall Study|Lack of Efficacy|2|||
149900540|NCT01190410|540768188|FG000|Overall Study|Withdrawal by Subject|0|||
149900541|NCT01190410|540768189|FG001|Overall Study|Withdrawal by Subject|2|||
149900542|NCT01190410|540768188|FG000|Overall Study|Administrative decision|1|||
149900543|NCT01190410|540768189|FG001|Overall Study|Administrative decision|0|||
149900544|NCT01190410|540768188|FG000|Overall Study|PI discretion|0|||
149900545|NCT01190410|540768189|FG001|Overall Study|PI discretion|2|||
149900546|NCT01108341|540768194|FG000|Overall Study|Death|2|||
149900547|NCT01108341|540768194|FG000|Overall Study|Withdrawal by Subject|1|||
149900548|NCT01108341|540768194|FG000|Overall Study|Lost to Follow-up|1|||
149900549|NCT01108341|540768194|FG000|Overall Study|Other|1|||
149900550|NCT05656534|540768195|FG000|Overall Study|Withdrawal by Subject|1|||
149900551|NCT05656534|540768196|FG001|Overall Study|Withdrawal by Subject|1|||
149900552|NCT05656534|540768197|FG002|Overall Study|Withdrawal by Subject|0|||
149968881|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968882|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
149900553|NCT05656534|540768198|FG003|Overall Study|Withdrawal by Subject|0|||
149968883|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
149968884|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
149968885|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968886|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968887|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968888|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968889|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968890|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968891|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968892|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968893|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968894|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
149968895|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968896|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968897|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968898|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968899|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
149968900|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
149968901|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968902|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968903|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968904|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968905|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968906|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968907|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968908|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968909|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968910|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968911|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
149968912|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
149968913|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
149968914|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
149968915|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
149968916|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
149968917|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
149968918|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
149968919|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
149900554|NCT05656534|540768195|FG000|Overall Study|Physician Decision|1|||
149900555|NCT05656534|540768196|FG001|Overall Study|Physician Decision|1|||
149900556|NCT05656534|540768197|FG002|Overall Study|Physician Decision|0|||
149900557|NCT05656534|540768198|FG003|Overall Study|Physician Decision|0|||
149900558|NCT00839800|540768200|FG000|Overall Study|Adverse Event|8|||
149900559|NCT00839800|540768201|FG001|Overall Study|Adverse Event|12|||
149900560|NCT00839800|540768200|FG000|Overall Study|Lost to Follow-up|31|||
149900561|NCT00839800|540768201|FG001|Overall Study|Lost to Follow-up|26|||
149900562|NCT00839800|540768200|FG000|Overall Study|Withdrawal by Subject|28|||
149900563|NCT00839800|540768201|FG001|Overall Study|Withdrawal by Subject|34|||
149900564|NCT00839800|540768200|FG000|Overall Study|Incorrect Enrolment|3|||
149900565|NCT00839800|540768201|FG001|Overall Study|Incorrect Enrolment|3|||
149900566|NCT00839800|540768200|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
149900567|NCT00839800|540768201|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
149900568|NCT00839800|540768200|FG000|Overall Study|Safety Reasons|2|||
149900569|NCT00839800|540768201|FG001|Overall Study|Safety Reasons|1|||
149900570|NCT00839800|540768200|FG000|Overall Study|Other|8|||
149900571|NCT00839800|540768201|FG001|Overall Study|Other|14|||
149900572|NCT00839800|540768200|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
149900573|NCT00839800|540768201|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
149900574|NCT00302328|540768202|FG000|Overall Study|Physician Decision|0|||
149900575|NCT00302328|540768203|FG001|Overall Study|Physician Decision|1|||
149900576|NCT00302328|540768204|FG002|Overall Study|Physician Decision|0|||
149900577|NCT01288937|540768205|FG000|Overall Study|Adverse Event|1|||
149900578|NCT01288937|540768206|FG001|Overall Study|Adverse Event|0|||
149900579|NCT00912743|540768211|FG000|Overall Study|Adverse Event|3|||
149900580|NCT00912743|540768212|FG001|Overall Study|Adverse Event|1|||
149900581|NCT00912743|540768211|FG000|Overall Study|Lack of Efficacy|9|||
149900582|NCT00912743|540768212|FG001|Overall Study|Lack of Efficacy|18|||
149900583|NCT00912743|540768211|FG000|Overall Study|Toxicity|0|||
149900584|NCT00912743|540768212|FG001|Overall Study|Toxicity|1|||
149900585|NCT00912743|540768211|FG000|Overall Study|End of treatment form was not collected|1|||
149900586|NCT00912743|540768212|FG001|Overall Study|End of treatment form was not collected|0|||
149900587|NCT01136356|540768213|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
149900588|NCT01136356|540768214|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
149900589|NCT01136356|540768213|FG000|First 18-day Withdrawal|Physician Decision|1|||
149900590|NCT01136356|540768214|FG001|First 18-day Withdrawal|Physician Decision|0|||
149900591|NCT01136356|540768213|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
149900592|NCT01136356|540768214|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
149900593|NCT04112043|540768215|FG000|Overall Study|Withdrawal by Subject|1|||
149900594|NCT04112043|540768216|FG001|Overall Study|Withdrawal by Subject|1|||
149900595|NCT04112043|540768217|FG002|Overall Study|Withdrawal by Subject|1|||
149900596|NCT04112043|540768215|FG000|Overall Study|Taking NR supplement|1|||
149900597|NCT04112043|540768216|FG001|Overall Study|Taking NR supplement|0|||
149900598|NCT04112043|540768217|FG002|Overall Study|Taking NR supplement|0|||
149900599|NCT04112043|540768215|FG000|Overall Study|Adverse Event|0|||
149900600|NCT04112043|540768216|FG001|Overall Study|Adverse Event|1|||
149900601|NCT04112043|540768217|FG002|Overall Study|Adverse Event|0|||
149900602|NCT04157296|540768218|FG000|Overall Study|Withdrawal by Subject|0|||
150045932|NCT00373113|541307997|FG000|Overall Study|Withdrawal by Subject|10|||
150045933|NCT00373113|541307998|FG001|Overall Study|Withdrawal by Subject|15|||
150045934|NCT02078960|541307999|FG000|Treatment Period|Other|0|||
150045935|NCT02078960|541308000|FG001|Treatment Period|Other|0|||
150045936|NCT02078960|541308001|FG002|Treatment Period|Other|1|||
150045937|NCT02078960|541307999|FG000|Treatment Period|Lack of Efficacy|0|||
150045938|NCT02078960|541308000|FG001|Treatment Period|Lack of Efficacy|1|||
150045939|NCT02078960|541308001|FG002|Treatment Period|Lack of Efficacy|0|||
150045940|NCT02078960|541307999|FG000|Treatment Period|Disease progression - accelerated phase|0|||
150045941|NCT02078960|541308000|FG001|Treatment Period|Disease progression - accelerated phase|1|||
150045942|NCT02078960|541308001|FG002|Treatment Period|Disease progression - accelerated phase|0|||
150045943|NCT02078960|541307999|FG000|Treatment Period|Disease progression - blast phase|1|||
150045944|NCT02078960|541308000|FG001|Treatment Period|Disease progression - blast phase|0|||
149900603|NCT04157296|540768219|FG001|Overall Study|Withdrawal by Subject|1|||
149900604|NCT04157296|540768218|FG000|Overall Study|Did not obtain second fMRI.|0|||
149900605|NCT04157296|540768219|FG001|Overall Study|Did not obtain second fMRI.|1|||
149900606|NCT04157296|540768218|FG000|Overall Study|MRI failed/no second fMRI|0|||
150045945|NCT02078960|541308001|FG002|Treatment Period|Disease progression - blast phase|0|||
150045946|NCT02078960|541307999|FG000|Treatment Period|Withdrawal by Subject|0|||
150045947|NCT02078960|541308000|FG001|Treatment Period|Withdrawal by Subject|1|||
150045948|NCT02078960|541308001|FG002|Treatment Period|Withdrawal by Subject|1|||
150045949|NCT02078960|541307999|FG000|Treatment Period|Adverse Event|1|||
150176476|NCT04009577|541781994|FG001|Extension Phase|Adverse Event|0|||
150176477|NCT04009577|541781995|FG002|Extension Phase|Adverse Event|0|||
149900607|NCT04157296|540768219|FG001|Overall Study|MRI failed/no second fMRI|1|||
149900608|NCT02237196|540768220|FG000|Overall Study|Adverse Event|0|||
149900609|NCT02237196|540768221|FG001|Overall Study|Adverse Event|1|||
149900610|NCT02237196|540768222|FG002|Overall Study|Adverse Event|1|||
149900611|NCT02237196|540768223|FG003|Overall Study|Adverse Event|0|||
149900612|NCT02237196|540768220|FG000|Overall Study|Lost to Follow-up|4|||
149900613|NCT02237196|540768221|FG001|Overall Study|Lost to Follow-up|2|||
149900614|NCT02237196|540768222|FG002|Overall Study|Lost to Follow-up|4|||
149900615|NCT02237196|540768223|FG003|Overall Study|Lost to Follow-up|6|||
149900616|NCT02237196|540768220|FG000|Overall Study|Physician Decision|2|||
149900617|NCT02237196|540768221|FG001|Overall Study|Physician Decision|0|||
149900618|NCT02237196|540768222|FG002|Overall Study|Physician Decision|0|||
149900619|NCT02237196|540768223|FG003|Overall Study|Physician Decision|1|||
149900620|NCT02237196|540768220|FG000|Overall Study|Pregnancy|0|||
149900621|NCT02237196|540768221|FG001|Overall Study|Pregnancy|0|||
149900622|NCT02237196|540768222|FG002|Overall Study|Pregnancy|1|||
149900623|NCT02237196|540768223|FG003|Overall Study|Pregnancy|1|||
149900624|NCT02237196|540768220|FG000|Overall Study|Withdrawal by Subject|1|||
149900625|NCT02237196|540768221|FG001|Overall Study|Withdrawal by Subject|1|||
149900626|NCT02237196|540768222|FG002|Overall Study|Withdrawal by Subject|4|||
149900627|NCT02237196|540768223|FG003|Overall Study|Withdrawal by Subject|1|||
149900628|NCT02237196|540768220|FG000|Overall Study|Site Error|1|||
149900629|NCT02237196|540768221|FG001|Overall Study|Site Error|2|||
149900630|NCT02237196|540768222|FG002|Overall Study|Site Error|0|||
149900631|NCT02237196|540768223|FG003|Overall Study|Site Error|2|||
149900632|NCT01750697|540768224|FG000|Overall Study|Transferred Back to Local Hospital|1|||
149900633|NCT01750697|540768224|FG000|Overall Study|Physician and Family Decision|1|||
149900634|NCT01750697|540768224|FG000|Overall Study|Transferred to Adult Services|5|||
149900635|NCT01750697|540768224|FG000|Overall Study|Physician Decision|1|||
149900636|NCT01750697|540768224|FG000|Overall Study|Withdrawal by Subject|1|||
149900637|NCT01057810|540768225|FG000|Overall Study|Disease progression|156|||
149900638|NCT01057810|540768226|FG001|Overall Study|Disease progression|197|||
149900639|NCT01057810|540768225|FG000|Overall Study|Study drug toxicity|5|||
149900640|NCT01057810|540768226|FG001|Overall Study|Study drug toxicity|114|||
149900641|NCT01057810|540768225|FG000|Overall Study|Adverse event unrelated to study drug|13|||
149900642|NCT01057810|540768226|FG001|Overall Study|Adverse event unrelated to study drug|29|||
149900643|NCT01057810|540768225|FG000|Overall Study|Withdrawal by Subject|10|||
150045950|NCT02078960|541308000|FG001|Treatment Period|Adverse Event|0|||
150045951|NCT02078960|541308001|FG002|Treatment Period|Adverse Event|0|||
150045952|NCT02078960|541307999|FG000|Treatment Period|Death|0|||
150045953|NCT02078960|541308000|FG001|Treatment Period|Death|0|||
150045954|NCT02078960|541308001|FG002|Treatment Period|Death|1|||
150045955|NCT02078960|541307999|FG000|Follow-up Period|Death|2|||
150045956|NCT02078960|541308000|FG001|Follow-up Period|Death|0|||
150045957|NCT02078960|541308001|FG002|Follow-up Period|Death|0|||
150045958|NCT02078960|541307999|FG000|Follow-up Period|Lost to Follow-up|0|||
150045959|NCT02078960|541308000|FG001|Follow-up Period|Lost to Follow-up|1|||
150045960|NCT02078960|541308001|FG002|Follow-up Period|Lost to Follow-up|0|||
150045961|NCT03275350|541308002|FG000|Overall Study|Lost to Follow-up|4|||
150045962|NCT03275350|541308003|FG001|Overall Study|Lost to Follow-up|6|||
150045963|NCT03275350|541308002|FG000|Overall Study|Death|2|||
150045964|NCT03275350|541308003|FG001|Overall Study|Death|1|||
150045965|NCT03275350|541308002|FG000|Overall Study|Physician Decision|1|||
150045966|NCT03275350|541308003|FG001|Overall Study|Physician Decision|0|||
150045967|NCT03275350|541308002|FG000|Overall Study|Incarcerated|1|||
150045968|NCT03275350|541308003|FG001|Overall Study|Incarcerated|1|||
150045969|NCT04661579|541308006|FG000|Overall Study|Lost to Follow-up|19|||
150045970|NCT04661579|541308007|FG001|Overall Study|Lost to Follow-up|10|||
150045971|NCT04661579|541308008|FG002|Overall Study|Lost to Follow-up|2|||
150045972|NCT04661579|541308009|FG003|Overall Study|Lost to Follow-up|7|||
150045973|NCT04661579|541308010|FG004|Overall Study|Lost to Follow-up|11|||
150045974|NCT04661579|541308006|FG000|Overall Study|Physician Decision|2|||
149900644|NCT01057810|540768226|FG001|Overall Study|Withdrawal by Subject|25|||
149900645|NCT01057810|540768225|FG000|Overall Study|Death|2|||
149900646|NCT01057810|540768226|FG001|Overall Study|Death|12|||
149900647|NCT01057810|540768225|FG000|Overall Study|Maximum clinical benefit|5|||
149900648|NCT01057810|540768226|FG001|Overall Study|Maximum clinical benefit|5|||
149900649|NCT01057810|540768225|FG000|Overall Study|Poor/non-compliance|0|||
149900650|NCT01057810|540768226|FG001|Overall Study|Poor/non-compliance|1|||
149900651|NCT01057810|540768225|FG000|Overall Study|No longer met study criteria|0|||
149900652|NCT01057810|540768226|FG001|Overall Study|No longer met study criteria|1|||
149900653|NCT01057810|540768225|FG000|Overall Study|Other|7|||
149900654|NCT01057810|540768226|FG001|Overall Study|Other|14|||
149900655|NCT02088905|540768227|FG000|Overall Study|Withdrawal by Subject|5|||
150045975|NCT04661579|541308007|FG001|Overall Study|Physician Decision|0|||
150045976|NCT04661579|541308008|FG002|Overall Study|Physician Decision|0|||
150045977|NCT04661579|541308009|FG003|Overall Study|Physician Decision|1|||
150045978|NCT04661579|541308010|FG004|Overall Study|Physician Decision|0|||
150045979|NCT04661579|541308006|FG000|Overall Study|Withdrawal by Subject|1|||
150045980|NCT04661579|541308007|FG001|Overall Study|Withdrawal by Subject|4|||
150045981|NCT04661579|541308008|FG002|Overall Study|Withdrawal by Subject|0|||
150045982|NCT04661579|541308009|FG003|Overall Study|Withdrawal by Subject|2|||
150045983|NCT04661579|541308010|FG004|Overall Study|Withdrawal by Subject|0|||
150045984|NCT04661579|541308006|FG000|Overall Study|Death|1|||
150045985|NCT04661579|541308007|FG001|Overall Study|Death|0|||
150176478|NCT04009577|541781996|FG003|Extension Phase|Adverse Event|1|||
150176479|NCT04009577|541781993|FG000|Extension Phase|Inadequate therapeutic effect|0|||
150176480|NCT04009577|541781994|FG001|Extension Phase|Inadequate therapeutic effect|0|||
150176481|NCT04009577|541781995|FG002|Extension Phase|Inadequate therapeutic effect|1|||
150176482|NCT04009577|541781996|FG003|Extension Phase|Inadequate therapeutic effect|0|||
150176483|NCT04009577|541781993|FG000|Extension Phase|Withdrawal by Subject|0|||
150176484|NCT04009577|541781994|FG001|Extension Phase|Withdrawal by Subject|0|||
150176485|NCT04009577|541781995|FG002|Extension Phase|Withdrawal by Subject|1|||
150176486|NCT04009577|541781996|FG003|Extension Phase|Withdrawal by Subject|0|||
150176487|NCT04009577|541781993|FG000|Extension Phase|Not Treated|0|||
150176488|NCT04009577|541781994|FG001|Extension Phase|Not Treated|0|||
150176489|NCT04009577|541781995|FG002|Extension Phase|Not Treated|2|||
150176490|NCT04009577|541781996|FG003|Extension Phase|Not Treated|0|||
149968920|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
150176491|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
150176492|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
150176493|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
150176494|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
150176495|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
150176496|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
149900656|NCT02088905|540768228|FG001|Overall Study|Withdrawal by Subject|1|||
149900657|NCT00267969|540768229|FG000|Controlled Period|Adverse Event|6|||
149900658|NCT00267969|540768230|FG001|Controlled Period|Adverse Event|0|||
149900659|NCT00267969|540768231|FG002|Controlled Period|Adverse Event|2|||
149900660|NCT00267969|540768232|FG003|Controlled Period|Adverse Event|0|||
149900661|NCT00267969|540768233|FG004|Controlled Period|Adverse Event|0|||
149900662|NCT00267969|540768234|FG005|Controlled Period|Adverse Event|0|||
149900663|NCT00267969|540768235|FG006|Controlled Period|Adverse Event|0|||
149900664|NCT00267969|540768229|FG000|Controlled Period|Lack of Efficacy|3|||
149968921|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
149968922|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
149968923|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
149968924|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
149968925|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
149968926|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
149968927|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
149968928|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
149968929|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
149968930|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
149968931|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
149968932|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
149900665|NCT00267969|540768230|FG001|Controlled Period|Lack of Efficacy|0|||
149968933|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968934|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149900666|NCT00267969|540768231|FG002|Controlled Period|Lack of Efficacy|1|||
149900667|NCT00267969|540768232|FG003|Controlled Period|Lack of Efficacy|0|||
149900668|NCT00267969|540768233|FG004|Controlled Period|Lack of Efficacy|0|||
149900669|NCT00267969|540768234|FG005|Controlled Period|Lack of Efficacy|0|||
149900670|NCT00267969|540768235|FG006|Controlled Period|Lack of Efficacy|0|||
149900671|NCT00267969|540768229|FG000|Controlled Period|Lost to Follow-up|1|||
149900672|NCT00267969|540768230|FG001|Controlled Period|Lost to Follow-up|0|||
149900673|NCT00267969|540768231|FG002|Controlled Period|Lost to Follow-up|1|||
149900674|NCT00267969|540768232|FG003|Controlled Period|Lost to Follow-up|0|||
149900675|NCT00267969|540768233|FG004|Controlled Period|Lost to Follow-up|0|||
149900676|NCT00267969|540768234|FG005|Controlled Period|Lost to Follow-up|0|||
149900677|NCT00267969|540768235|FG006|Controlled Period|Lost to Follow-up|0|||
149900678|NCT00267969|540768229|FG000|Controlled Period|Randomized but not treated|0|||
149900679|NCT00267969|540768230|FG001|Controlled Period|Randomized but not treated|0|||
149900680|NCT00267969|540768231|FG002|Controlled Period|Randomized but not treated|1|||
149900681|NCT00267969|540768232|FG003|Controlled Period|Randomized but not treated|0|||
149900682|NCT00267969|540768233|FG004|Controlled Period|Randomized but not treated|0|||
149900683|NCT00267969|540768234|FG005|Controlled Period|Randomized but not treated|0|||
149900684|NCT00267969|540768235|FG006|Controlled Period|Randomized but not treated|0|||
149900685|NCT00267969|540768229|FG000|Controlled Period|Other|2|||
149900686|NCT00267969|540768230|FG001|Controlled Period|Other|1|||
149900687|NCT00267969|540768231|FG002|Controlled Period|Other|6|||
149900688|NCT00267969|540768232|FG003|Controlled Period|Other|0|||
149900689|NCT00267969|540768233|FG004|Controlled Period|Other|0|||
149900690|NCT00267969|540768234|FG005|Controlled Period|Other|0|||
149900691|NCT00267969|540768235|FG006|Controlled Period|Other|0|||
149900692|NCT00267969|540768229|FG000|After Controlled Period|Adverse Event|0|||
149900693|NCT00267969|540768230|FG001|After Controlled Period|Adverse Event|0|||
149900694|NCT00267969|540768231|FG002|After Controlled Period|Adverse Event|0|||
149900695|NCT00267969|540768232|FG003|After Controlled Period|Adverse Event|7|||
149900696|NCT00267969|540768233|FG004|After Controlled Period|Adverse Event|8|||
149900697|NCT00267969|540768234|FG005|After Controlled Period|Adverse Event|23|||
149900698|NCT00267969|540768235|FG006|After Controlled Period|Adverse Event|21|||
149900699|NCT00267969|540768229|FG000|After Controlled Period|Death|0|||
149900700|NCT00267969|540768230|FG001|After Controlled Period|Death|0|||
149900701|NCT00267969|540768231|FG002|After Controlled Period|Death|0|||
149900702|NCT00267969|540768232|FG003|After Controlled Period|Death|1|||
149900703|NCT00267969|540768233|FG004|After Controlled Period|Death|2|||
149900704|NCT00267969|540768234|FG005|After Controlled Period|Death|0|||
149900705|NCT00267969|540768235|FG006|After Controlled Period|Death|1|||
149900706|NCT00267969|540768229|FG000|After Controlled Period|Lack of Efficacy|0|||
149900707|NCT00267969|540768230|FG001|After Controlled Period|Lack of Efficacy|0|||
149900708|NCT00267969|540768231|FG002|After Controlled Period|Lack of Efficacy|0|||
149900709|NCT00267969|540768232|FG003|After Controlled Period|Lack of Efficacy|10|||
149900710|NCT00267969|540768233|FG004|After Controlled Period|Lack of Efficacy|6|||
149900711|NCT00267969|540768234|FG005|After Controlled Period|Lack of Efficacy|28|||
149900712|NCT00267969|540768235|FG006|After Controlled Period|Lack of Efficacy|15|||
149900713|NCT00267969|540768229|FG000|After Controlled Period|Lost to Follow-up|0|||
149900714|NCT00267969|540768230|FG001|After Controlled Period|Lost to Follow-up|0|||
149900715|NCT00267969|540768231|FG002|After Controlled Period|Lost to Follow-up|0|||
149900716|NCT00267969|540768232|FG003|After Controlled Period|Lost to Follow-up|5|||
149900717|NCT00267969|540768233|FG004|After Controlled Period|Lost to Follow-up|8|||
149900718|NCT00267969|540768234|FG005|After Controlled Period|Lost to Follow-up|9|||
149900719|NCT00267969|540768235|FG006|After Controlled Period|Lost to Follow-up|10|||
149900720|NCT00267969|540768229|FG000|After Controlled Period|Other|0|||
149900721|NCT00267969|540768230|FG001|After Controlled Period|Other|0|||
149900722|NCT00267969|540768231|FG002|After Controlled Period|Other|0|||
149900723|NCT00267969|540768232|FG003|After Controlled Period|Other|13|||
149900724|NCT00267969|540768233|FG004|After Controlled Period|Other|11|||
149900725|NCT00267969|540768234|FG005|After Controlled Period|Other|22|||
149968935|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968936|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968937|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968938|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968939|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968940|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968941|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968942|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968943|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968944|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
150045986|NCT04661579|541308008|FG002|Overall Study|Death|0|||
150045987|NCT04661579|541308009|FG003|Overall Study|Death|0|||
149900726|NCT00267969|540768235|FG006|After Controlled Period|Other|25|||
149900727|NCT00862823|540768236|FG000|First Intervention|Withdrawal by Subject|1|||
149900728|NCT00862823|540768237|FG001|First Intervention|Withdrawal by Subject|1|||
149900729|NCT00619892|540768242|FG000|Overall Study|Adverse Event|3|||
150045988|NCT04661579|541308010|FG004|Overall Study|Death|0|||
149900730|NCT00619892|540768243|FG001|Overall Study|Adverse Event|0|||
149900731|NCT00619892|540768242|FG000|Overall Study|Lost to Follow-up|0|||
149900732|NCT00619892|540768243|FG001|Overall Study|Lost to Follow-up|1|||
149900733|NCT00619892|540768242|FG000|Overall Study|Intercurrent illness|0|||
149900734|NCT00619892|540768243|FG001|Overall Study|Intercurrent illness|1|||
149900735|NCT00857896|540768248|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
149900736|NCT02049814|540768249|FG000|Overall Study|Reason not Specified|4|||
150045989|NCT04661579|541308006|FG000|Overall Study|Other|1|||
150045990|NCT04661579|541308007|FG001|Overall Study|Other|2|||
149900737|NCT02049814|540768250|FG001|Overall Study|Reason not Specified|3|||
149900738|NCT02049814|540768249|FG000|Overall Study|Pregnancy|1|||
149900739|NCT02049814|540768250|FG001|Overall Study|Pregnancy|0|||
149900740|NCT02049814|540768249|FG000|Overall Study|Lost to Follow-up|2|||
149900741|NCT02049814|540768250|FG001|Overall Study|Lost to Follow-up|3|||
149900742|NCT02049814|540768249|FG000|Overall Study|Serious Protocol Violation|5|||
149900743|NCT02049814|540768250|FG001|Overall Study|Serious Protocol Violation|7|||
149900744|NCT02049814|540768249|FG000|Overall Study|Study Termination|0|||
149900745|NCT02049814|540768250|FG001|Overall Study|Study Termination|1|||
149900746|NCT02049814|540768249|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
149900747|NCT02049814|540768250|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
149900748|NCT02049814|540768249|FG000|Overall Study|Voluntary withdrawal|9|||
149900749|NCT02049814|540768250|FG001|Overall Study|Voluntary withdrawal|8|||
149900750|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
149900751|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
149900752|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
149900753|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
149900754|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
149900755|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
149900756|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
149900757|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
149900758|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
149900759|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
149900760|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
149900761|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
149900762|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
149900763|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
149900764|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
149900765|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
149900766|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
149900767|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
149900768|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
149900769|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
149900770|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
149900771|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
149900772|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
149968945|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968946|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
149968947|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968948|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
149968949|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968950|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968951|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968952|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
150045991|NCT04661579|541308008|FG002|Overall Study|Other|1|||
150045992|NCT04661579|541308009|FG003|Overall Study|Other|1|||
150045993|NCT04661579|541308010|FG004|Overall Study|Other|1|||
150045994|NCT04661579|541308006|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
150045995|NCT04661579|541308007|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
150045996|NCT04661579|541308008|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
150045997|NCT04661579|541308009|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
150045998|NCT04661579|541308010|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
150045999|NCT01396447|541308011|FG000|Overall Study|Did Not Receive Treatment|3|||
150046000|NCT01396447|541308012|FG001|Overall Study|Did Not Receive Treatment|2|||
150046001|NCT01396447|541308013|FG002|Overall Study|Did Not Receive Treatment|1|||
150176497|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
149900773|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
149900774|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
149900775|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
149900776|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
149968953|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
150046002|NCT01396447|541308014|FG003|Overall Study|Did Not Receive Treatment|0|||
150046003|NCT01396447|541308011|FG000|Overall Study|Adverse Event|15|||
150046004|NCT01396447|541308012|FG001|Overall Study|Adverse Event|12|||
149900777|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
149900778|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
149900779|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
149900780|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
149900781|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
149900782|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
149900783|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
149900784|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
149900785|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
149900786|NCT02016105|540768258|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
149900787|NCT02016105|540768259|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
149900788|NCT02016105|540768260|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
149900789|NCT02016105|540768261|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
149900790|NCT02016105|540768262|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
149900791|NCT02016105|540768263|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
149900792|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
149900793|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
149900794|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
149900795|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
149900796|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
149900797|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
149968954|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968955|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968956|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968957|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968958|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968959|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968960|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968961|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968962|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
149968963|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968964|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
149968965|NCT02958865|541022032|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968966|NCT02958865|541022033|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968967|NCT02958865|541022034|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968968|NCT02958865|541022035|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968969|NCT02958865|541022036|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968970|NCT02958865|541022037|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968971|NCT02958865|541022038|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968972|NCT02958865|541022039|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968973|NCT02958865|541022040|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968974|NCT02958865|541022041|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
149968975|NCT02958865|541022042|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968976|NCT02958865|541022043|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968977|NCT02958865|541022044|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968978|NCT02958865|541022045|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968979|NCT02958865|541022046|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968980|NCT02958865|541022047|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
149968981|NCT02661815|541022048|FG000|Overall Study|Withdrawal by Subject|1|||
149968982|NCT02661815|541022049|FG001|Overall Study|Withdrawal by Subject|0|||
149968983|NCT02661815|541022050|FG002|Overall Study|Withdrawal by Subject|0|||
149968984|NCT02661815|541022051|FG003|Overall Study|Withdrawal by Subject|0|||
149968985|NCT01767987|541022052|FG000|Overall Study|Physician Decision|4|||
149968986|NCT01767987|541022053|FG001|Overall Study|Physician Decision|1|||
149968987|NCT03232567|541022054|FG000|Overall Study|Withdrawal by Subject|0|||
149968988|NCT03232567|541022055|FG001|Overall Study|Withdrawal by Subject|1|||
149968989|NCT03232567|541022056|FG002|Overall Study|Withdrawal by Subject|0|||
149968990|NCT03232567|541022057|FG003|Overall Study|Withdrawal by Subject|0|||
149968991|NCT01153516|541022058|FG000|Overall Study|Both subjects refused surgery|2|||
149968992|NCT01153516|541022059|FG001|Overall Study|Both subjects refused surgery|0|||
149968993|NCT05837481|541022060|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
149968994|NCT05837481|541022061|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
149968995|NCT04581395|541022062|FG000|Overall Study|Protocol Violation|4|||
149968996|NCT04581395|541022063|FG001|Overall Study|Protocol Violation|3|||
149968997|NCT04581395|541022064|FG002|Overall Study|Protocol Violation|2|||
149968998|NCT04581395|541022062|FG000|Overall Study|Physician Decision|0|||
149968999|NCT04581395|541022063|FG001|Overall Study|Physician Decision|1|||
149969000|NCT04581395|541022064|FG002|Overall Study|Physician Decision|0|||
149969001|NCT00815633|541022071|FG000|Overall Study|study terminated|1|||
149969002|NCT00654355|541022076|FG000|Overall Study|Lost to Follow-up|2|||
149969003|NCT00654355|541022077|FG001|Overall Study|Lost to Follow-up|2|||
149969004|NCT01605097|541022080|FG000|Overall Study|Protocol Violation|1|||
149969005|NCT02284893|541022083|FG000|26 Week (Short Term)|Adverse Event|1|||
149969006|NCT02284893|541022084|FG001|26 Week (Short Term)|Adverse Event|9|||
149969007|NCT02284893|541022083|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
149969008|NCT02284893|541022084|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
149969009|NCT02284893|541022083|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
149969010|NCT02284893|541022084|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
149969011|NCT02284893|541022083|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
149969012|NCT02284893|541022084|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
149969013|NCT02284893|541022083|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
149969014|NCT02284893|541022084|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
149969015|NCT02284893|541022083|FG000|26 Week (Short Term)|Other|1|||
149969016|NCT02284893|541022084|FG001|26 Week (Short Term)|Other|1|||
149969017|NCT02284893|541022083|FG000|52 Week (Long Term)|Adverse Event|3|||
149969018|NCT02284893|541022084|FG001|52 Week (Long Term)|Adverse Event|1|||
149969019|NCT02284893|541022083|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
149969020|NCT02284893|541022084|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
149900798|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
149900799|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
149900800|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
149900801|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
149900802|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
149900803|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
149900804|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
149900805|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
149900806|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
149900807|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
149900808|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
149900809|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
149900810|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Death|0|||
149900811|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Death|0|||
149900812|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Death|0|||
149900813|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Death|0|||
149900814|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Death|0|||
149900815|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Death|1|||
149900816|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
149900817|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
149900818|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
149900819|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
149900820|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
149900821|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
149900822|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
149900823|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
149900824|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
149900825|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
149900826|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
149900827|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
149900828|NCT02016105|540768258|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
149900829|NCT02016105|540768259|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
149900830|NCT02016105|540768260|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
149900831|NCT02016105|540768261|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
149900832|NCT02016105|540768262|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
149900833|NCT02016105|540768263|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
149900834|NCT02016105|540768258|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
149900835|NCT02016105|540768259|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
149900836|NCT02016105|540768260|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
149900837|NCT02016105|540768261|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
149900838|NCT02016105|540768262|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
149900839|NCT02016105|540768263|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
149900840|NCT02016105|540768258|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
149900841|NCT02016105|540768259|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
150046005|NCT01396447|541308013|FG002|Overall Study|Adverse Event|12|||
150046006|NCT01396447|541308014|FG003|Overall Study|Adverse Event|17|||
149900842|NCT02016105|540768260|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
149900843|NCT02016105|540768261|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
149900844|NCT02016105|540768262|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
149900845|NCT02016105|540768263|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
149900846|NCT02016105|540768258|FG000|EXTENSION PERIOD|Adverse Event|0|||
149900847|NCT02016105|540768259|FG001|EXTENSION PERIOD|Adverse Event|0|||
149900848|NCT02016105|540768260|FG002|EXTENSION PERIOD|Adverse Event|2|||
149900849|NCT02016105|540768261|FG003|EXTENSION PERIOD|Adverse Event|0|||
149900850|NCT02016105|540768262|FG004|EXTENSION PERIOD|Adverse Event|1|||
149900851|NCT02016105|540768263|FG005|EXTENSION PERIOD|Adverse Event|0|||
149900852|NCT02016105|540768258|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
149900853|NCT02016105|540768259|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
149900854|NCT02016105|540768260|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
149900855|NCT02016105|540768261|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
149900856|NCT02016105|540768262|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
149900857|NCT02016105|540768263|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
149900858|NCT02016105|540768258|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
149900859|NCT02016105|540768259|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
149900860|NCT02016105|540768260|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
149900861|NCT02016105|540768261|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
149900862|NCT02016105|540768262|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
149900863|NCT02016105|540768263|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
149969021|NCT02284893|541022083|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
149969022|NCT02284893|541022084|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
149969023|NCT02284893|541022083|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
149969024|NCT02284893|541022084|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
149969025|NCT02284893|541022083|FG000|52 Week (Long Term)|Non-Compliance|2|||
149900864|NCT02016105|540768258|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
149900865|NCT02016105|540768259|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
149900866|NCT02016105|540768260|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
149969026|NCT02284893|541022084|FG001|52 Week (Long Term)|Non-Compliance|3|||
149969027|NCT03078868|541022087|FG000|Overall Study|Physician Decision|3|||
149900867|NCT02016105|540768261|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
149900868|NCT02016105|540768262|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
149900869|NCT02016105|540768263|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
149900870|NCT00090493|540768264|FG000|Overall Study|Physician Decision|2|||
149900871|NCT01908829|540768268|FG000|Overall Study|Adverse Event|13|||
149900872|NCT01908829|540768269|FG001|Overall Study|Adverse Event|11|||
149900873|NCT01908829|540768270|FG002|Overall Study|Adverse Event|13|||
149900874|NCT01908829|540768268|FG000|Overall Study|Lost to Follow-up|4|||
149900875|NCT01908829|540768269|FG001|Overall Study|Lost to Follow-up|2|||
149900876|NCT01908829|540768270|FG002|Overall Study|Lost to Follow-up|1|||
149900877|NCT01908829|540768268|FG000|Overall Study|Randomized no double-blind drug received|1|||
149900878|NCT01908829|540768269|FG001|Overall Study|Randomized no double-blind drug received|0|||
149900879|NCT01908829|540768270|FG002|Overall Study|Randomized no double-blind drug received|1|||
149900880|NCT01908829|540768268|FG000|Overall Study|Discontinued (no EoT page)|2|||
149900881|NCT01908829|540768269|FG001|Overall Study|Discontinued (no EoT page)|0|||
149900882|NCT01908829|540768270|FG002|Overall Study|Discontinued (no EoT page)|0|||
149900883|NCT01908829|540768268|FG000|Overall Study|Miscellaneous|0|||
149900884|NCT01908829|540768269|FG001|Overall Study|Miscellaneous|2|||
149900885|NCT01908829|540768270|FG002|Overall Study|Miscellaneous|0|||
149900886|NCT01908829|540768268|FG000|Overall Study|Protocol Violation|2|||
149900887|NCT01908829|540768269|FG001|Overall Study|Protocol Violation|2|||
149900888|NCT01908829|540768270|FG002|Overall Study|Protocol Violation|0|||
149900889|NCT01908829|540768268|FG000|Overall Study|Lack of Efficacy|1|||
149900890|NCT01908829|540768269|FG001|Overall Study|Lack of Efficacy|3|||
149900891|NCT01908829|540768270|FG002|Overall Study|Lack of Efficacy|2|||
149900892|NCT01908829|540768268|FG000|Overall Study|Withdrawal by Subject|26|||
149900893|NCT01908829|540768269|FG001|Overall Study|Withdrawal by Subject|29|||
149900894|NCT01908829|540768270|FG002|Overall Study|Withdrawal by Subject|22|||
149900895|NCT02865499|540768271|FG000|Baseline|Adverse Event|1|||
149900896|NCT02865499|540768271|FG000|Baseline|Withdrawal by Subject|1|||
149900897|NCT02792192|540768272|FG000|Overall Study|Death|1|||
149900898|NCT02792192|540768273|FG001|Overall Study|Death|0|||
149900899|NCT02792192|540768274|FG002|Overall Study|Death|0|||
149900900|NCT02792192|540768275|FG003|Overall Study|Death|0|||
149900901|NCT02792192|540768272|FG000|Overall Study|Informed Consent Withdrawn|4|||
149900902|NCT02792192|540768273|FG001|Overall Study|Informed Consent Withdrawn|0|||
149900903|NCT02792192|540768274|FG002|Overall Study|Informed Consent Withdrawn|0|||
149900904|NCT02792192|540768275|FG003|Overall Study|Informed Consent Withdrawn|0|||
149900905|NCT02792192|540768272|FG000|Overall Study|Physician Decision|1|||
149900906|NCT02792192|540768273|FG001|Overall Study|Physician Decision|0|||
149900907|NCT02792192|540768274|FG002|Overall Study|Physician Decision|0|||
149900908|NCT02792192|540768275|FG003|Overall Study|Physician Decision|0|||
149900909|NCT02792192|540768272|FG000|Overall Study|Progressive Disease|0|||
149900910|NCT02792192|540768273|FG001|Overall Study|Progressive Disease|1|||
149900911|NCT02792192|540768274|FG002|Overall Study|Progressive Disease|0|||
149900912|NCT02792192|540768275|FG003|Overall Study|Progressive Disease|0|||
149900913|NCT02792192|540768272|FG000|Overall Study|Study Terminated By Sponsor|6|||
149900914|NCT02792192|540768273|FG001|Overall Study|Study Terminated By Sponsor|10|||
149900915|NCT02792192|540768274|FG002|Overall Study|Study Terminated By Sponsor|0|||
149900916|NCT02792192|540768275|FG003|Overall Study|Study Terminated By Sponsor|0|||
149969028|NCT01983111|541022088|FG000|Overall Study|Withdrawal by Subject|8|||
149969029|NCT01983111|541022089|FG001|Overall Study|Withdrawal by Subject|6|||
149969030|NCT01983111|541022088|FG000|Overall Study|Adverse Event|4|||
149969031|NCT01983111|541022089|FG001|Overall Study|Adverse Event|0|||
149969032|NCT01983111|541022088|FG000|Overall Study|Protocol Violation|0|||
149969033|NCT01983111|541022089|FG001|Overall Study|Protocol Violation|1|||
149969034|NCT03038620|541022090|FG000|Overall Study|Lost to Follow-up|18|||
149969035|NCT03038620|541022091|FG001|Overall Study|Lost to Follow-up|23|||
149969036|NCT03038620|541022090|FG000|Overall Study|Withdrawal by Subject|0|||
149969037|NCT03038620|541022091|FG001|Overall Study|Withdrawal by Subject|15|||
149969038|NCT03038620|541022090|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
149969039|NCT03038620|541022091|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
149969040|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Adverse Event|3|||
149969041|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Adverse Event|0|||
149969042|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Adverse Event|0|||
149969043|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
149969044|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
149969045|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
149969046|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
149969047|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
149969048|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
149969049|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
149969050|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
149969051|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
149969052|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
149969053|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
149969054|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
149969055|NCT04380142|541022095|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
149969056|NCT04380142|541022096|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
149969057|NCT04380142|541022097|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
149969058|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149969059|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149969060|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Adverse Event|14|||
149969061|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
149969062|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
149969063|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
149969064|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
149969065|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
149969066|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
149969067|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
149969068|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
149969069|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
149969070|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
149969071|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
149900917|NCT02320058|540768276|FG000|Overall Study|Death|25|||
149969072|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
149969073|NCT04380142|541022095|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
149969074|NCT04380142|541022096|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
149900918|NCT02320058|540768277|FG001|Overall Study|Death|10|||
149969075|NCT04380142|541022097|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
149969076|NCT00105066|541022098|FG000|Overall Study|Adverse Event|2|||
149969077|NCT00105066|541022099|FG001|Overall Study|Adverse Event|5|||
149969078|NCT05205616|541022104|FG000|Overall Study|Lost to Follow-up|4|||
149969079|NCT05205616|541022105|FG001|Overall Study|Lost to Follow-up|4|||
149969080|NCT04875533|541022106|FG000|Overall Study|Adverse Event|6|||
149969081|NCT04875533|541022107|FG001|Overall Study|Adverse Event|4|||
149900919|NCT02320058|540768276|FG000|Overall Study|Lost to Follow-up|4|||
149900920|NCT02320058|540768277|FG001|Overall Study|Lost to Follow-up|0|||
149900921|NCT02320058|540768276|FG000|Overall Study|Other reasons|4|||
149900922|NCT02320058|540768277|FG001|Overall Study|Other reasons|1|||
149900923|NCT02320058|540768276|FG000|Overall Study|Withdrawal by Subject|8|||
149900924|NCT02320058|540768277|FG001|Overall Study|Withdrawal by Subject|2|||
149900925|NCT02320058|540768276|FG000|Overall Study|Not reported|1|||
149900926|NCT02320058|540768277|FG001|Overall Study|Not reported|0|||
149900927|NCT01339923|540768278|FG000|Overall Study|Adverse Event|1|||
149900928|NCT01339923|540768279|FG001|Overall Study|Adverse Event|1|||
149900929|NCT01339923|540768280|FG002|Overall Study|Adverse Event|1|||
149900930|NCT01339923|540768281|FG003|Overall Study|Adverse Event|0|||
149900931|NCT01339923|540768282|FG004|Overall Study|Adverse Event|0|||
149900932|NCT01339923|540768283|FG005|Overall Study|Adverse Event|0|||
149900933|NCT01339923|540768284|FG006|Overall Study|Adverse Event|1|||
149900934|NCT01339923|540768278|FG000|Overall Study|Inappropriate Enrollment|1|||
149900935|NCT01339923|540768279|FG001|Overall Study|Inappropriate Enrollment|0|||
149900936|NCT01339923|540768280|FG002|Overall Study|Inappropriate Enrollment|0|||
149900937|NCT01339923|540768281|FG003|Overall Study|Inappropriate Enrollment|0|||
149900938|NCT01339923|540768282|FG004|Overall Study|Inappropriate Enrollment|0|||
149900939|NCT01339923|540768283|FG005|Overall Study|Inappropriate Enrollment|1|||
149900940|NCT01339923|540768284|FG006|Overall Study|Inappropriate Enrollment|0|||
149900941|NCT01339923|540768278|FG000|Overall Study|Lost to Follow-up|4|||
149900942|NCT01339923|540768279|FG001|Overall Study|Lost to Follow-up|4|||
149900943|NCT01339923|540768280|FG002|Overall Study|Lost to Follow-up|0|||
149900944|NCT01339923|540768281|FG003|Overall Study|Lost to Follow-up|3|||
149900945|NCT01339923|540768282|FG004|Overall Study|Lost to Follow-up|1|||
149900946|NCT01339923|540768283|FG005|Overall Study|Lost to Follow-up|1|||
149900947|NCT01339923|540768284|FG006|Overall Study|Lost to Follow-up|5|||
149900948|NCT01339923|540768278|FG000|Overall Study|Protocol Violation|0|||
149900949|NCT01339923|540768279|FG001|Overall Study|Protocol Violation|0|||
149900950|NCT01339923|540768280|FG002|Overall Study|Protocol Violation|0|||
149900951|NCT01339923|540768281|FG003|Overall Study|Protocol Violation|0|||
149900952|NCT01339923|540768282|FG004|Overall Study|Protocol Violation|0|||
149900953|NCT01339923|540768283|FG005|Overall Study|Protocol Violation|3|||
149900954|NCT01339923|540768284|FG006|Overall Study|Protocol Violation|1|||
149900955|NCT01339923|540768278|FG000|Overall Study|Unable to Classify|1|||
149900956|NCT01339923|540768279|FG001|Overall Study|Unable to Classify|0|||
149900957|NCT01339923|540768280|FG002|Overall Study|Unable to Classify|1|||
149900958|NCT01339923|540768281|FG003|Overall Study|Unable to Classify|0|||
149900959|NCT01339923|540768282|FG004|Overall Study|Unable to Classify|0|||
149900960|NCT01339923|540768283|FG005|Overall Study|Unable to Classify|1|||
149900961|NCT01339923|540768284|FG006|Overall Study|Unable to Classify|5|||
149900962|NCT01339923|540768278|FG000|Overall Study|Withdrawal by Subject|7|||
149900963|NCT01339923|540768279|FG001|Overall Study|Withdrawal by Subject|11|||
149900964|NCT01339923|540768280|FG002|Overall Study|Withdrawal by Subject|6|||
149900965|NCT01339923|540768281|FG003|Overall Study|Withdrawal by Subject|1|||
149900966|NCT01339923|540768282|FG004|Overall Study|Withdrawal by Subject|4|||
149900967|NCT01339923|540768283|FG005|Overall Study|Withdrawal by Subject|3|||
149900968|NCT01339923|540768284|FG006|Overall Study|Withdrawal by Subject|2|||
149900969|NCT01430403|540768285|FG000|Overall Study|Lost to Follow-up|5|||
149900970|NCT01430403|540768286|FG001|Overall Study|Lost to Follow-up|5|||
149900971|NCT01430403|540768287|FG002|Overall Study|Lost to Follow-up|3|||
149900972|NCT01430403|540768285|FG000|Overall Study|Physician Decision|1|||
149900973|NCT01430403|540768286|FG001|Overall Study|Physician Decision|0|||
149900974|NCT01430403|540768287|FG002|Overall Study|Physician Decision|0|||
149900975|NCT01430403|540768285|FG000|Overall Study|Protocol Violation|2|||
149900976|NCT01430403|540768286|FG001|Overall Study|Protocol Violation|3|||
149900977|NCT01430403|540768287|FG002|Overall Study|Protocol Violation|2|||
149900978|NCT01430403|540768285|FG000|Overall Study|Withdrawal by Subject|9|||
149900979|NCT01430403|540768286|FG001|Overall Study|Withdrawal by Subject|1|||
149900980|NCT01430403|540768287|FG002|Overall Study|Withdrawal by Subject|3|||
149900981|NCT00183885|540768292|FG000|Overall Study|Adverse Event|11|||
149900982|NCT00183885|540768292|FG000|Overall Study|Death|1|||
149900983|NCT00183885|540768292|FG000|Overall Study|Lost to Follow-up|3|||
149900984|NCT00183885|540768292|FG000|Overall Study|Physician Decision|6|||
149900985|NCT00183885|540768292|FG000|Overall Study|Withdrawal by Subject|5|||
149900986|NCT00183885|540768292|FG000|Overall Study|Switched to alternative treatment|8|||
149900987|NCT00183885|540768292|FG000|Overall Study|Treatment delayed too long|4|||
149900988|NCT00183885|540768292|FG000|Overall Study|Developed second malignancy|1|||
149900989|NCT00014495|540768293|FG000|Overall Study|Death|0|||
149900990|NCT00014495|540768294|FG001|Overall Study|Death|0|||
149900991|NCT00014495|540768295|FG002|Overall Study|Death|1|||
149900992|NCT00014495|540768296|FG003|Overall Study|Death|0|||
149900993|NCT00014495|540768293|FG000|Overall Study|Clinical deterioration|0|||
149900994|NCT00014495|540768294|FG001|Overall Study|Clinical deterioration|0|||
149900995|NCT00014495|540768295|FG002|Overall Study|Clinical deterioration|0|||
149900996|NCT00014495|540768296|FG003|Overall Study|Clinical deterioration|1|||
149900997|NCT00396656|540768299|FG000|First Treatment Period|Withdrawal by Subject|0|||
149900998|NCT00396656|540768300|FG001|First Treatment Period|Withdrawal by Subject|2|||
149900999|NCT00396656|540768299|FG000|Second Treatment Period|Adverse Event|0|||
149901000|NCT00396656|540768300|FG001|Second Treatment Period|Adverse Event|1|||
149901001|NCT00554515|540768303|FG000|Overall Study|Withdrawal by Subject|3|||
149901002|NCT00554515|540768303|FG000|Overall Study|Disease progression|52|||
149901003|NCT00554515|540768303|FG000|Overall Study|Physician Decision|18|||
149901004|NCT00554515|540768303|FG000|Overall Study|Withdrawal by Subject|11|||
149901005|NCT00554515|540768303|FG000|Overall Study|Adverse Event|9|||
149901006|NCT00554515|540768303|FG000|Overall Study|Death|2|||
149901007|NCT00554515|540768303|FG000|Overall Study|Achieved Stable Disease|7|||
149901008|NCT00554515|540768303|FG000|Overall Study|Other|1|||
149901009|NCT00554515|540768303|FG000|Overall Study|Misc|15|||
149901010|NCT02477332|540768304|FG000|Overall Study|Adverse Event|0|||
149901011|NCT02477332|540768305|FG001|Overall Study|Adverse Event|1|||
149901012|NCT02477332|540768306|FG002|Overall Study|Adverse Event|1|||
149901013|NCT02477332|540768307|FG003|Overall Study|Adverse Event|2|||
150176498|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
149901014|NCT02477332|540768308|FG004|Overall Study|Adverse Event|1|||
149901015|NCT02477332|540768309|FG005|Overall Study|Adverse Event|2|||
149901016|NCT02477332|540768304|FG000|Overall Study|Lack of Efficacy|1|||
149901017|NCT02477332|540768305|FG001|Overall Study|Lack of Efficacy|2|||
149901018|NCT02477332|540768306|FG002|Overall Study|Lack of Efficacy|1|||
149901019|NCT02477332|540768307|FG003|Overall Study|Lack of Efficacy|2|||
149901020|NCT02477332|540768308|FG004|Overall Study|Lack of Efficacy|1|||
149901021|NCT02477332|540768309|FG005|Overall Study|Lack of Efficacy|1|||
149901022|NCT02477332|540768304|FG000|Overall Study|Non-compliance with study treatment|0|||
149901023|NCT02477332|540768305|FG001|Overall Study|Non-compliance with study treatment|1|||
149901024|NCT02477332|540768306|FG002|Overall Study|Non-compliance with study treatment|2|||
149901025|NCT02477332|540768307|FG003|Overall Study|Non-compliance with study treatment|0|||
149901026|NCT02477332|540768308|FG004|Overall Study|Non-compliance with study treatment|0|||
149901027|NCT02477332|540768309|FG005|Overall Study|Non-compliance with study treatment|0|||
149901028|NCT02477332|540768304|FG000|Overall Study|Pregnancy|0|||
149901029|NCT02477332|540768305|FG001|Overall Study|Pregnancy|0|||
149901030|NCT02477332|540768306|FG002|Overall Study|Pregnancy|0|||
149901031|NCT02477332|540768307|FG003|Overall Study|Pregnancy|1|||
149901032|NCT02477332|540768308|FG004|Overall Study|Pregnancy|0|||
149901033|NCT02477332|540768309|FG005|Overall Study|Pregnancy|0|||
149901034|NCT02477332|540768304|FG000|Overall Study|Protocol Violation|2|||
149901035|NCT02477332|540768305|FG001|Overall Study|Protocol Violation|0|||
149901036|NCT02477332|540768306|FG002|Overall Study|Protocol Violation|3|||
149901037|NCT02477332|540768307|FG003|Overall Study|Protocol Violation|3|||
149901038|NCT02477332|540768308|FG004|Overall Study|Protocol Violation|1|||
149901039|NCT02477332|540768309|FG005|Overall Study|Protocol Violation|1|||
149901040|NCT02477332|540768304|FG000|Overall Study|Technical problems|0|||
149901041|NCT02477332|540768305|FG001|Overall Study|Technical problems|0|||
150176499|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
149901042|NCT02477332|540768306|FG002|Overall Study|Technical problems|1|||
149901043|NCT02477332|540768307|FG003|Overall Study|Technical problems|0|||
149901044|NCT02477332|540768308|FG004|Overall Study|Technical problems|0|||
149901045|NCT02477332|540768309|FG005|Overall Study|Technical problems|0|||
149901046|NCT02477332|540768304|FG000|Overall Study|Lost to Follow-up|0|||
149901047|NCT02477332|540768305|FG001|Overall Study|Lost to Follow-up|0|||
149901048|NCT02477332|540768306|FG002|Overall Study|Lost to Follow-up|2|||
149901049|NCT02477332|540768307|FG003|Overall Study|Lost to Follow-up|0|||
150046007|NCT01396447|541308011|FG000|Overall Study|Insufficient Therapeutic Response|5|||
150046008|NCT01396447|541308012|FG001|Overall Study|Insufficient Therapeutic Response|5|||
150046009|NCT01396447|541308013|FG002|Overall Study|Insufficient Therapeutic Response|2|||
150046010|NCT01396447|541308014|FG003|Overall Study|Insufficient Therapeutic Response|4|||
150046011|NCT01396447|541308011|FG000|Overall Study|Protocol Violation|5|||
150046012|NCT01396447|541308012|FG001|Overall Study|Protocol Violation|2|||
150046013|NCT01396447|541308013|FG002|Overall Study|Protocol Violation|3|||
150046014|NCT01396447|541308014|FG003|Overall Study|Protocol Violation|7|||
150046015|NCT01396447|541308011|FG000|Overall Study|Withdrawal of Consent|11|||
150046016|NCT01396447|541308012|FG001|Overall Study|Withdrawal of Consent|9|||
150046017|NCT01396447|541308013|FG002|Overall Study|Withdrawal of Consent|4|||
150176500|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
150176501|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
149901050|NCT02477332|540768308|FG004|Overall Study|Lost to Follow-up|0|||
149901051|NCT02477332|540768309|FG005|Overall Study|Lost to Follow-up|0|||
149901052|NCT02477332|540768304|FG000|Overall Study|Physician Decision|0|||
149901053|NCT02477332|540768305|FG001|Overall Study|Physician Decision|0|||
149901054|NCT02477332|540768306|FG002|Overall Study|Physician Decision|1|||
150046018|NCT01396447|541308014|FG003|Overall Study|Withdrawal of Consent|15|||
150176502|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
150046019|NCT01396447|541308011|FG000|Overall Study|Lost to Follow-up|4|||
149901055|NCT02477332|540768307|FG003|Overall Study|Physician Decision|3|||
149901056|NCT02477332|540768308|FG004|Overall Study|Physician Decision|0|||
149901057|NCT02477332|540768309|FG005|Overall Study|Physician Decision|1|||
149901058|NCT02477332|540768304|FG000|Overall Study|Withdrawal by Subject|0|||
149901059|NCT02477332|540768305|FG001|Overall Study|Withdrawal by Subject|3|||
149901060|NCT02477332|540768306|FG002|Overall Study|Withdrawal by Subject|1|||
149901061|NCT02477332|540768307|FG003|Overall Study|Withdrawal by Subject|2|||
149901062|NCT02477332|540768308|FG004|Overall Study|Withdrawal by Subject|1|||
149901063|NCT02477332|540768309|FG005|Overall Study|Withdrawal by Subject|0|||
149901064|NCT02593097|540768314|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
149901065|NCT02593097|540768315|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
149901066|NCT02593097|540768314|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149901067|NCT02593097|540768315|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
149901068|NCT02593097|540768314|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
149901069|NCT02593097|540768315|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
149901070|NCT02593097|540768314|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
149901071|NCT02593097|540768315|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
149901072|NCT02593097|540768314|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
149901073|NCT02593097|540768315|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
149901074|NCT03759587|540768316|FG000|Overall Study|Adverse Event|5|||
149901075|NCT03759587|540768316|FG000|Overall Study|Progressive Disease|10|||
149901076|NCT03759587|540768316|FG000|Overall Study|Site Terminated by Sponsor|3|||
149901077|NCT03759587|540768316|FG000|Overall Study|Withdrawal by Subject|1|||
149901078|NCT00665431|540768318|FG000|Overall Study|Adverse Event|16|||
149901079|NCT00665431|540768319|FG001|Overall Study|Adverse Event|22|||
149901080|NCT00665431|540768320|FG002|Overall Study|Adverse Event|6|||
149901081|NCT00665431|540768318|FG000|Overall Study|Withdrawal by Subject|17|||
149901082|NCT00665431|540768319|FG001|Overall Study|Withdrawal by Subject|25|||
149901083|NCT00665431|540768320|FG002|Overall Study|Withdrawal by Subject|15|||
149901084|NCT00665431|540768318|FG000|Overall Study|Lost to Follow-up|3|||
149901085|NCT00665431|540768319|FG001|Overall Study|Lost to Follow-up|3|||
149901086|NCT00665431|540768320|FG002|Overall Study|Lost to Follow-up|1|||
149901087|NCT00665431|540768318|FG000|Overall Study|Other|4|||
149901088|NCT00665431|540768319|FG001|Overall Study|Other|7|||
149901089|NCT00665431|540768320|FG002|Overall Study|Other|2|||
149901090|NCT01578239|540768321|FG000|Treatment Period|Progressive Disease|19|||
149901091|NCT01578239|540768322|FG001|Treatment Period|Progressive Disease|64|||
149901092|NCT01578239|540768321|FG000|Treatment Period|Physician Decision|17|||
149901093|NCT01578239|540768322|FG001|Treatment Period|Physician Decision|17|||
149901094|NCT01578239|540768321|FG000|Treatment Period|Adverse Event|13|||
149901095|NCT01578239|540768322|FG001|Treatment Period|Adverse Event|10|||
149901096|NCT01578239|540768321|FG000|Treatment Period|Non-compliance|2|||
149901097|NCT01578239|540768322|FG001|Treatment Period|Non-compliance|0|||
149901098|NCT01578239|540768321|FG000|Treatment Period|Withdrawal by Subject|10|||
149901099|NCT01578239|540768322|FG001|Treatment Period|Withdrawal by Subject|9|||
149901100|NCT01578239|540768321|FG000|Treatment Period|Other|6|||
149901101|NCT01578239|540768322|FG001|Treatment Period|Other|1|||
149901102|NCT01578239|540768321|FG000|Long-term Follow-Up Period|Death|69|||
149901103|NCT01578239|540768322|FG001|Long-term Follow-Up Period|Death|64|||
149901104|NCT01578239|540768321|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
149901105|NCT01578239|540768322|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
149901106|NCT01578239|540768321|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
149901107|NCT01578239|540768322|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
149901108|NCT01578239|540768321|FG000|Long-term Follow-Up Period|Other|2|||
149901109|NCT01578239|540768322|FG001|Long-term Follow-Up Period|Other|2|||
149901110|NCT01119859|540768323|FG000|Overall Study|Adverse Event|9|||
149901111|NCT01119859|540768324|FG001|Overall Study|Adverse Event|10|||
149901112|NCT01119859|540768323|FG000|Overall Study|Death|2|||
149901113|NCT01119859|540768324|FG001|Overall Study|Death|0|||
149901114|NCT01119859|540768323|FG000|Overall Study|Insufficient therapeutic response|7|||
149901115|NCT01119859|540768324|FG001|Overall Study|Insufficient therapeutic response|14|||
149901116|NCT01119859|540768323|FG000|Overall Study|Refused treatment|3|||
149901117|NCT01119859|540768324|FG001|Overall Study|Refused treatment|6|||
149901118|NCT01119859|540768323|FG000|Overall Study|Failure to return|3|||
149901119|NCT01119859|540768324|FG001|Overall Study|Failure to return|0|||
149901120|NCT01134939|540768325|FG000|Overall Study|Adverse Event|9|||
149901121|NCT01134939|540768326|FG001|Overall Study|Adverse Event|3|||
149901122|NCT01134939|540768327|FG002|Overall Study|Adverse Event|4|||
149901123|NCT01134939|540768328|FG003|Overall Study|Adverse Event|5|||
149901124|NCT01134939|540768329|FG004|Overall Study|Adverse Event|5|||
149901125|NCT01134939|540768330|FG005|Overall Study|Adverse Event|5|||
149901126|NCT01134939|540768331|FG006|Overall Study|Adverse Event|1|||
149901127|NCT01134939|540768332|FG007|Overall Study|Adverse Event|0|||
149901128|NCT01134939|540768325|FG000|Overall Study|Lack of Efficacy|2|||
149901129|NCT01134939|540768326|FG001|Overall Study|Lack of Efficacy|5|||
149901130|NCT01134939|540768327|FG002|Overall Study|Lack of Efficacy|1|||
149901131|NCT01134939|540768328|FG003|Overall Study|Lack of Efficacy|0|||
149901132|NCT01134939|540768329|FG004|Overall Study|Lack of Efficacy|3|||
149901133|NCT01134939|540768330|FG005|Overall Study|Lack of Efficacy|0|||
149901134|NCT01134939|540768331|FG006|Overall Study|Lack of Efficacy|1|||
149901135|NCT01134939|540768332|FG007|Overall Study|Lack of Efficacy|0|||
149901136|NCT01134939|540768325|FG000|Overall Study|Lost to Follow-up|2|||
149901137|NCT01134939|540768326|FG001|Overall Study|Lost to Follow-up|3|||
149901138|NCT01134939|540768327|FG002|Overall Study|Lost to Follow-up|0|||
149901139|NCT01134939|540768328|FG003|Overall Study|Lost to Follow-up|1|||
149901140|NCT01134939|540768329|FG004|Overall Study|Lost to Follow-up|2|||
149901141|NCT01134939|540768330|FG005|Overall Study|Lost to Follow-up|1|||
149901142|NCT01134939|540768331|FG006|Overall Study|Lost to Follow-up|0|||
149901143|NCT01134939|540768332|FG007|Overall Study|Lost to Follow-up|0|||
149901144|NCT01134939|540768325|FG000|Overall Study|Death|0|||
149901145|NCT01134939|540768326|FG001|Overall Study|Death|1|||
149901146|NCT01134939|540768327|FG002|Overall Study|Death|0|||
149901147|NCT01134939|540768328|FG003|Overall Study|Death|0|||
149901148|NCT01134939|540768329|FG004|Overall Study|Death|0|||
149901149|NCT01134939|540768330|FG005|Overall Study|Death|0|||
149901150|NCT01134939|540768331|FG006|Overall Study|Death|0|||
149901151|NCT01134939|540768332|FG007|Overall Study|Death|0|||
149901152|NCT01134939|540768325|FG000|Overall Study|Termination page not available|4|||
149901153|NCT01134939|540768326|FG001|Overall Study|Termination page not available|6|||
149901154|NCT01134939|540768327|FG002|Overall Study|Termination page not available|5|||
149901155|NCT01134939|540768328|FG003|Overall Study|Termination page not available|8|||
149901156|NCT01134939|540768329|FG004|Overall Study|Termination page not available|0|||
149901157|NCT01134939|540768330|FG005|Overall Study|Termination page not available|3|||
149969082|NCT04875533|541022106|FG000|Overall Study|Protocol Violation|4|||
149969083|NCT04875533|541022107|FG001|Overall Study|Protocol Violation|0|||
149969084|NCT04875533|541022106|FG000|Overall Study|Withdrawal by Subject|8|||
149969085|NCT04875533|541022107|FG001|Overall Study|Withdrawal by Subject|5|||
149969086|NCT04875533|541022106|FG000|Overall Study|No longer meets eligibility criteria|1|||
149969087|NCT04875533|541022107|FG001|Overall Study|No longer meets eligibility criteria|0|||
149969088|NCT04875533|541022106|FG000|Overall Study|Other|0|||
149969089|NCT04875533|541022107|FG001|Overall Study|Other|2|||
149969090|NCT00982280|541022112|FG000|Observation Period|Not eligible to be dosed|19|||
149969091|NCT00982280|541022112|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
149969092|NCT00982280|541022112|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
149969093|NCT00982280|541022112|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
149969094|NCT00982280|541022112|FG000|Maintenance Period|Adverse Event|1|||
149969095|NCT01506726|541022113|FG000|Overall Study|Adverse Event|1|||
149969096|NCT01506726|541022114|FG001|Overall Study|Adverse Event|2|||
149969097|NCT02231580|541022115|FG000|Overall Study|Adverse Event|5|||
149969098|NCT02231580|541022116|FG001|Overall Study|Adverse Event|0|||
149969099|NCT03781570|541022117|FG000|Overall Study|Technical Issues (equipment failure)|31|||
149969100|NCT03781570|541022117|FG000|Overall Study|Withdrawal by Subject|7|||
149969101|NCT03781570|541022117|FG000|Overall Study|Physical Constraints|11|||
149969102|NCT01107496|541022118|FG000|Overall Study|Adverse Event|1|||
149969103|NCT01107496|541022119|FG001|Overall Study|Adverse Event|0|||
149969104|NCT01107496|541022118|FG000|Overall Study|Lack of Efficacy|1|||
149969105|NCT01107496|541022119|FG001|Overall Study|Lack of Efficacy|0|||
149969106|NCT01107496|541022118|FG000|Overall Study|Protocol Violation|0|||
149969107|NCT01107496|541022119|FG001|Overall Study|Protocol Violation|1|||
149901158|NCT01134939|540768331|FG006|Overall Study|Termination page not available|7|||
149901159|NCT01134939|540768332|FG007|Overall Study|Termination page not available|0|||
149901160|NCT00757042|540768340|FG000|Overall Study|Lost to Follow-up|0|||
149969108|NCT01107496|541022118|FG000|Overall Study|Lost to Follow-up|0|||
149969109|NCT01107496|541022119|FG001|Overall Study|Lost to Follow-up|1|||
149901161|NCT00757042|540768341|FG001|Overall Study|Lost to Follow-up|0|||
149901162|NCT00757042|540768342|FG002|Overall Study|Lost to Follow-up|0|||
149901163|NCT00757042|540768343|FG003|Overall Study|Lost to Follow-up|0|||
149901164|NCT00757042|540768344|FG004|Overall Study|Lost to Follow-up|0|||
149901165|NCT00757042|540768345|FG005|Overall Study|Lost to Follow-up|0|||
149969110|NCT01346592|541022120|FG000|Overall Study|Lost to Follow-up|62|||
149969111|NCT01346592|541022121|FG001|Overall Study|Lost to Follow-up|29|||
149969112|NCT01346592|541022122|FG002|Overall Study|Lost to Follow-up|29|||
149901166|NCT00757042|540768346|FG006|Overall Study|Lost to Follow-up|0|||
149901167|NCT00757042|540768347|FG007|Overall Study|Lost to Follow-up|0|||
149901168|NCT00757042|540768348|FG008|Overall Study|Lost to Follow-up|1|||
149901169|NCT00757042|540768349|FG009|Overall Study|Lost to Follow-up|0|||
149901170|NCT00757042|540768350|FG010|Overall Study|Lost to Follow-up|0|||
149901171|NCT00757042|540768340|FG000|Overall Study|Ineligibility Determined|0|||
149901172|NCT00757042|540768341|FG001|Overall Study|Ineligibility Determined|0|||
150046020|NCT01396447|541308012|FG001|Overall Study|Lost to Follow-up|8|||
150046021|NCT01396447|541308013|FG002|Overall Study|Lost to Follow-up|7|||
150046022|NCT01396447|541308014|FG003|Overall Study|Lost to Follow-up|9|||
150046023|NCT01396447|541308011|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150046024|NCT01396447|541308012|FG001|Overall Study|Other Miscellaneous Reasons|2|||
150046025|NCT01396447|541308013|FG002|Overall Study|Other Miscellaneous Reasons|1|||
150046026|NCT01396447|541308014|FG003|Overall Study|Other Miscellaneous Reasons|0|||
150046027|NCT01402102|541308016|FG000|Overall Study|Protocol Violation|1|||
150046028|NCT01402102|541308017|FG001|Overall Study|Protocol Violation|0|||
150046029|NCT01402102|541308016|FG000|Overall Study|Insufficiency of compliance|1|||
150046030|NCT01402102|541308017|FG001|Overall Study|Insufficiency of compliance|1|||
150046031|NCT01402102|541308016|FG000|Overall Study|Withdrawal by Subject|0|||
150046032|NCT01402102|541308017|FG001|Overall Study|Withdrawal by Subject|2|||
150046033|NCT01386970|541308018|FG000|Overall Study|Withdrawal by Subject|0|||
150046034|NCT01386970|541308019|FG001|Overall Study|Withdrawal by Subject|1|||
150046035|NCT01386970|541308018|FG000|Overall Study|Adverse Event|4|||
150046036|NCT01386970|541308019|FG001|Overall Study|Adverse Event|1|||
150046037|NCT04881942|541308021|FG000|Overall Study|Adverse Event|0|||
150046038|NCT04881942|541308022|FG001|Overall Study|Adverse Event|0|||
150046039|NCT04881942|541308023|FG002|Overall Study|Adverse Event|0|||
150046040|NCT04881942|541308024|FG003|Overall Study|Adverse Event|0|||
150046041|NCT04881942|541308025|FG004|Overall Study|Adverse Event|1|||
150046042|NCT04881942|541308021|FG000|Overall Study|Alternates|0|||
150046043|NCT04881942|541308022|FG001|Overall Study|Alternates|0|||
150046044|NCT04881942|541308023|FG002|Overall Study|Alternates|0|||
150046045|NCT04881942|541308024|FG003|Overall Study|Alternates|0|||
150046046|NCT04881942|541308025|FG004|Overall Study|Alternates|2|||
150046047|NCT02948088|541308026|FG000|Overall Study|Lost to Follow-up|8|||
150046048|NCT02948088|541308026|FG000|Overall Study|Death|1|||
150046049|NCT02948088|541308026|FG000|Overall Study|Withdrawal by Subject|4|||
150046050|NCT02948088|541308026|FG000|Overall Study|Other|2|||
150046051|NCT00975780|541308027|FG000|Follow Up|Death|88|||
150046052|NCT00975780|541308028|FG001|Follow Up|Death|122|||
150046053|NCT00975780|541308027|FG000|Follow Up|Facility Withdrawal|7|||
150046054|NCT00975780|541308028|FG001|Follow Up|Facility Withdrawal|23|||
150046055|NCT00975780|541308027|FG000|Follow Up|Discharged from Facility|7|||
150046056|NCT00975780|541308028|FG001|Follow Up|Discharged from Facility|12|||
150046057|NCT01077076|541308031|FG000|First Intervention|Withdrawal by Subject|1|||
150046058|NCT01077076|541308032|FG001|First Intervention|Withdrawal by Subject|0|||
150046059|NCT01077076|541308033|FG002|First Intervention|Withdrawal by Subject|0|||
150046060|NCT01077076|541308034|FG003|First Intervention|Withdrawal by Subject|0|||
150046061|NCT01077076|541308035|FG004|First Intervention|Withdrawal by Subject|0|||
150046062|NCT01077076|541308036|FG005|First Intervention|Withdrawal by Subject|0|||
150046063|NCT01077076|541308031|FG000|Third Intervention|Death in the participant's family|0|||
150046064|NCT01077076|541308032|FG001|Third Intervention|Death in the participant's family|0|||
150046065|NCT01077076|541308033|FG002|Third Intervention|Death in the participant's family|0|||
150046066|NCT01077076|541308034|FG003|Third Intervention|Death in the participant's family|0|||
150046067|NCT01077076|541308035|FG004|Third Intervention|Death in the participant's family|0|||
150046068|NCT01077076|541308036|FG005|Third Intervention|Death in the participant's family|1|||
149901173|NCT00757042|540768342|FG002|Overall Study|Ineligibility Determined|0|||
149901174|NCT00757042|540768343|FG003|Overall Study|Ineligibility Determined|0|||
149901175|NCT00757042|540768344|FG004|Overall Study|Ineligibility Determined|0|||
149901176|NCT00757042|540768345|FG005|Overall Study|Ineligibility Determined|0|||
149901177|NCT00757042|540768346|FG006|Overall Study|Ineligibility Determined|0|||
149901178|NCT00757042|540768347|FG007|Overall Study|Ineligibility Determined|0|||
149901179|NCT00757042|540768348|FG008|Overall Study|Ineligibility Determined|0|||
149901180|NCT00757042|540768349|FG009|Overall Study|Ineligibility Determined|0|||
149901181|NCT00757042|540768350|FG010|Overall Study|Ineligibility Determined|1|||
149901182|NCT00757042|540768340|FG000|Overall Study|Withdrawal by Subject|0|||
150046069|NCT01976741|541308039|FG000|Overall Study|Withdrawal by Subject|1|||
150046070|NCT01976741|541308040|FG001|Overall Study|Withdrawal by Subject|0|||
150046071|NCT01976741|541308041|FG002|Overall Study|Withdrawal by Subject|1|||
149901183|NCT00757042|540768341|FG001|Overall Study|Withdrawal by Subject|0|||
149901184|NCT00757042|540768342|FG002|Overall Study|Withdrawal by Subject|0|||
149901185|NCT00757042|540768343|FG003|Overall Study|Withdrawal by Subject|0|||
150046072|NCT01976741|541308042|FG003|Overall Study|Withdrawal by Subject|1|||
150046073|NCT01976741|541308043|FG004|Overall Study|Withdrawal by Subject|0|||
150046074|NCT01976741|541308044|FG005|Overall Study|Withdrawal by Subject|0|||
150046075|NCT01976741|541308045|FG006|Overall Study|Withdrawal by Subject|1|||
150046076|NCT01976741|541308046|FG007|Overall Study|Withdrawal by Subject|4|||
150046077|NCT01976741|541308047|FG008|Overall Study|Withdrawal by Subject|0|||
150046078|NCT01976741|541308048|FG009|Overall Study|Withdrawal by Subject|0|||
150046079|NCT01976741|541308039|FG000|Overall Study|Adverse Event|0|||
150046080|NCT01976741|541308040|FG001|Overall Study|Adverse Event|0|||
150046081|NCT01976741|541308041|FG002|Overall Study|Adverse Event|2|||
150046082|NCT01976741|541308042|FG003|Overall Study|Adverse Event|0|||
150046083|NCT01976741|541308043|FG004|Overall Study|Adverse Event|0|||
150046084|NCT01976741|541308044|FG005|Overall Study|Adverse Event|0|||
150046085|NCT01976741|541308045|FG006|Overall Study|Adverse Event|3|||
150046086|NCT01976741|541308046|FG007|Overall Study|Adverse Event|8|||
150046087|NCT01976741|541308047|FG008|Overall Study|Adverse Event|1|||
150046088|NCT01976741|541308048|FG009|Overall Study|Adverse Event|4|||
150046089|NCT01415882|541308049|FG000|Overall Study|Ineligible|1|||
150046090|NCT01415882|541308050|FG001|Overall Study|Ineligible|0|||
150046091|NCT01415882|541308051|FG002|Overall Study|Ineligible|0|||
150046092|NCT01415882|541308052|FG003|Overall Study|Ineligible|3|||
150046093|NCT01415882|541308053|FG004|Overall Study|Ineligible|0|||
150046094|NCT01415882|541308049|FG000|Overall Study|Withdrawal by Subject|0|||
150046095|NCT01415882|541308050|FG001|Overall Study|Withdrawal by Subject|1|||
150046096|NCT01415882|541308051|FG002|Overall Study|Withdrawal by Subject|0|||
150046097|NCT01415882|541308052|FG003|Overall Study|Withdrawal by Subject|1|||
150046098|NCT01415882|541308053|FG004|Overall Study|Withdrawal by Subject|0|||
150046099|NCT00670306|541308054|FG000|Overall Study|Adverse Event|8|||
150046100|NCT00670306|541308054|FG000|Overall Study|Lack of Efficacy|10|||
150046101|NCT00670306|541308054|FG000|Overall Study|Withdrawal by Subject|9|||
150046102|NCT00670306|541308054|FG000|Overall Study|Physician Decision|1|||
150046103|NCT00670306|541308054|FG000|Overall Study|Lost to Follow-up|8|||
150046104|NCT00670306|541308054|FG000|Overall Study|incl/excl criterias did not meet|19|||
150046105|NCT01301027|541308055|FG000|Overall Study|Physician Decision|2|||
150046106|NCT01301027|541308056|FG001|Overall Study|Physician Decision|0|||
150046107|NCT01301027|541308055|FG000|Overall Study|Withdrawal by Subject|2|||
150046108|NCT01301027|541308056|FG001|Overall Study|Withdrawal by Subject|3|||
150046109|NCT01301027|541308055|FG000|Overall Study|Adverse Event|0|||
150046110|NCT01301027|541308056|FG001|Overall Study|Adverse Event|2|||
150046111|NCT01301027|541308055|FG000|Overall Study|Fracture|1|||
150046112|NCT01301027|541308056|FG001|Overall Study|Fracture|3|||
150046113|NCT01301027|541308055|FG000|Overall Study|Transplant|0|||
150046114|NCT01301027|541308056|FG001|Overall Study|Transplant|2|||
150046115|NCT01301027|541308055|FG000|Overall Study|Volume Overload|3|||
150046116|NCT01301027|541308056|FG001|Overall Study|Volume Overload|0|||
150046117|NCT00845897|541308057|FG000|Overall Study|Lost to Follow-up|1|||
150046118|NCT00845897|541308058|FG001|Overall Study|Lost to Follow-up|1|||
150046119|NCT00845897|541308059|FG002|Overall Study|Lost to Follow-up|0|||
150046120|NCT00845897|541308057|FG000|Overall Study|Withdrawal by Subject|0|||
150046121|NCT00845897|541308058|FG001|Overall Study|Withdrawal by Subject|3|||
150046122|NCT00845897|541308059|FG002|Overall Study|Withdrawal by Subject|2|||
150046123|NCT00845897|541308057|FG000|Overall Study|Ulcer did not heal|1|||
150046124|NCT00845897|541308058|FG001|Overall Study|Ulcer did not heal|0|||
150046125|NCT00845897|541308059|FG002|Overall Study|Ulcer did not heal|1|||
150046126|NCT00845897|541308057|FG000|Overall Study|Too ill to participate|0|||
150046127|NCT00845897|541308058|FG001|Overall Study|Too ill to participate|1|||
149901186|NCT00757042|540768344|FG004|Overall Study|Withdrawal by Subject|0|||
150046128|NCT00845897|541308059|FG002|Overall Study|Too ill to participate|0|||
150046129|NCT02722499|541308060|FG000|Overall Study|Lost to Follow-up|2|||
150046130|NCT02722499|541308061|FG001|Overall Study|Lost to Follow-up|0|||
150046131|NCT02722499|541308062|FG002|Overall Study|Lost to Follow-up|1|||
150046132|NCT03566485|541308072|FG000|Overall Study|Disease progression|5|||
150046133|NCT03566485|541308073|FG001|Overall Study|Disease progression|4|||
150046134|NCT03566485|541308072|FG000|Overall Study|Clinical progression|0|||
150046135|NCT03566485|541308073|FG001|Overall Study|Clinical progression|1|||
150046136|NCT03566485|541308072|FG000|Overall Study|Toxicity|0|||
150046137|NCT03566485|541308073|FG001|Overall Study|Toxicity|2|||
150046138|NCT00369265|541308074|FG000|Overall Study|Study terminated|4|||
149901187|NCT00757042|540768345|FG005|Overall Study|Withdrawal by Subject|0|||
150046139|NCT00369265|541308075|FG001|Overall Study|Study terminated|7|||
150046140|NCT01192191|541308076|FG000|Overall Study|Adverse Event|7|||
150046141|NCT01192191|541308077|FG001|Overall Study|Adverse Event|12|||
150046142|NCT01192191|541308076|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
150046143|NCT01192191|541308077|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
150046144|NCT01192191|541308076|FG000|Overall Study|Lost to Follow-up|0|||
150046145|NCT01192191|541308077|FG001|Overall Study|Lost to Follow-up|1|||
150046146|NCT01192191|541308076|FG000|Overall Study|Withdrawal by Subject|1|||
150046147|NCT01192191|541308077|FG001|Overall Study|Withdrawal by Subject|6|||
150046148|NCT01047553|541308078|FG000|Overall Study|Adverse Event|10|||
150046149|NCT01047553|541308079|FG001|Overall Study|Adverse Event|5|||
150046150|NCT01047553|541308078|FG000|Overall Study|Withdrawal by Subject|4|||
149901188|NCT00757042|540768346|FG006|Overall Study|Withdrawal by Subject|0|||
149901189|NCT00757042|540768347|FG007|Overall Study|Withdrawal by Subject|0|||
149901190|NCT00757042|540768348|FG008|Overall Study|Withdrawal by Subject|0|||
149901191|NCT00757042|540768349|FG009|Overall Study|Withdrawal by Subject|1|||
149901192|NCT00757042|540768350|FG010|Overall Study|Withdrawal by Subject|0|||
149901193|NCT03300505|540769804|FG000|Overall Study|Death|0|||
149901194|NCT03300505|540769805|FG001|Overall Study|Death|1|||
149901195|NCT03300505|540769806|FG002|Overall Study|Death|0|||
149901196|NCT03300505|540769804|FG000|Overall Study|Withdrawal by Subject|0|||
149901197|NCT03300505|540769805|FG001|Overall Study|Withdrawal by Subject|1|||
149901198|NCT03300505|540769806|FG002|Overall Study|Withdrawal by Subject|1|||
149901199|NCT03300505|540769804|FG000|Overall Study|Sponsor Termination|0|||
149901200|NCT03300505|540769805|FG001|Overall Study|Sponsor Termination|1|||
149901201|NCT03300505|540769806|FG002|Overall Study|Sponsor Termination|0|||
149901202|NCT03300505|540769804|FG000|Overall Study|Adverse Event|0|||
149901203|NCT03300505|540769805|FG001|Overall Study|Adverse Event|0|||
149901204|NCT03300505|540769806|FG002|Overall Study|Adverse Event|2|||
149901205|NCT05119595|540769807|FG000|Overall Study|Death|1|||
149901206|NCT05119595|540769807|FG000|Overall Study|Lost to Follow-up|7|||
149901207|NCT03508726|540769808|FG000|Overall Study|Withdrawal by Subject|0|||
149901208|NCT03508726|540769809|FG001|Overall Study|Withdrawal by Subject|1|||
149901209|NCT00178685|540769814|FG000|Overall Study|Death|3|||
149901210|NCT00178685|540769815|FG001|Overall Study|Death|3|||
149901211|NCT00178685|540769816|FG002|Overall Study|Death|6|||
149901212|NCT00178685|540769814|FG000|Overall Study|Lost to Follow-up|100|||
149901213|NCT00178685|540769815|FG001|Overall Study|Lost to Follow-up|187|||
149901214|NCT00178685|540769816|FG002|Overall Study|Lost to Follow-up|183|||
149901215|NCT00178685|540769814|FG000|Overall Study|Withdrawal by Subject|8|||
149901216|NCT00178685|540769815|FG001|Overall Study|Withdrawal by Subject|14|||
149901217|NCT00178685|540769816|FG002|Overall Study|Withdrawal by Subject|7|||
149901218|NCT00887315|540769819|FG000|Overall Study|Study termination|7|||
149901219|NCT00887315|540769820|FG001|Overall Study|Study termination|4|||
149901220|NCT00384839|540769827|FG000|Overall Study|Adverse Event|4|||
149901221|NCT00384839|540769827|FG000|Overall Study|Investigator Request|1|||
149901222|NCT00384839|540769827|FG000|Overall Study|Patient Request|1|||
149901223|NCT00384839|540769827|FG000|Overall Study|Ineligible|2|||
149901224|NCT00443079|540769830|FG000|Overall Study|Lost to Follow-up|0|||
149901225|NCT00443079|540769831|FG001|Overall Study|Lost to Follow-up|1|||
149901226|NCT02649439|540769832|FG000|Overall Study|Switched to alternative treatment|6|||
149901227|NCT02649439|540769833|FG001|Overall Study|Switched to alternative treatment|4|||
149901228|NCT02649439|540769832|FG000|Overall Study|Patient decision|1|||
149901229|NCT02649439|540769833|FG001|Overall Study|Patient decision|0|||
149901230|NCT02649439|540769832|FG000|Overall Study|Patient going out of country|1|||
149901231|NCT02649439|540769833|FG001|Overall Study|Patient going out of country|0|||
149901232|NCT02649439|540769832|FG000|Overall Study|To start finasteride|1|||
149901233|NCT02649439|540769833|FG001|Overall Study|To start finasteride|0|||
149901234|NCT02649439|540769832|FG000|Overall Study|Physician Decision|1|||
149901235|NCT02649439|540769833|FG001|Overall Study|Physician Decision|0|||
149901236|NCT02649439|540769832|FG000|Overall Study|Disease progression on study|12|||
149901237|NCT02649439|540769833|FG001|Overall Study|Disease progression on study|13|||
149901238|NCT02649439|540769832|FG000|Overall Study|Refused further treatment|1|||
149969113|NCT01346592|541022120|FG000|Overall Study|Protocol Violation|2|||
149969114|NCT01346592|541022121|FG001|Overall Study|Protocol Violation|1|||
149969115|NCT01346592|541022122|FG002|Overall Study|Protocol Violation|0|||
149969116|NCT01346592|541022120|FG000|Overall Study|Death|1|||
149969117|NCT01346592|541022121|FG001|Overall Study|Death|3|||
149901239|NCT02649439|540769833|FG001|Overall Study|Refused further treatment|0|||
149901240|NCT02649439|540769832|FG000|Overall Study|Refused further follow up|2|||
149901241|NCT02649439|540769833|FG001|Overall Study|Refused further follow up|7|||
149969118|NCT01346592|541022122|FG002|Overall Study|Death|4|||
149969119|NCT01346592|541022120|FG000|Overall Study|Adverse Event|0|||
149901242|NCT02649439|540769832|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
149901243|NCT02649439|540769833|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
149901244|NCT02649439|540769832|FG000|Overall Study|No treatment, per protocol|1|||
149901245|NCT02649439|540769833|FG001|Overall Study|No treatment, per protocol|0|||
149901246|NCT02649439|540769832|FG000|Overall Study|PSA DT makes ineligible|0|||
149901247|NCT02649439|540769833|FG001|Overall Study|PSA DT makes ineligible|1|||
149901248|NCT02649439|540769832|FG000|Overall Study|Rising PSA No Mets|0|||
149901249|NCT02649439|540769833|FG001|Overall Study|Rising PSA No Mets|1|||
149901250|NCT02649439|540769832|FG000|Overall Study|Rising PSA|0|||
149901251|NCT02649439|540769833|FG001|Overall Study|Rising PSA|1|||
149901252|NCT02649439|540769832|FG000|Overall Study|Signed follow up protocol|0|||
149901253|NCT02649439|540769833|FG001|Overall Study|Signed follow up protocol|1|||
149901254|NCT02714595|540769834|FG000|Overall Study|Lost to Follow-up|1|||
149901255|NCT02714595|540769835|FG001|Overall Study|Lost to Follow-up|0|||
149901256|NCT02714595|540769834|FG000|Overall Study|Withdrawal by Subject|1|||
149901257|NCT02714595|540769835|FG001|Overall Study|Withdrawal by Subject|2|||
149969120|NCT01346592|541022121|FG001|Overall Study|Adverse Event|1|||
149969121|NCT01346592|541022122|FG002|Overall Study|Adverse Event|0|||
149969122|NCT01346592|541022120|FG000|Overall Study|Withdrawal by Subject|77|||
149969123|NCT01346592|541022121|FG001|Overall Study|Withdrawal by Subject|51|||
149969124|NCT01346592|541022122|FG002|Overall Study|Withdrawal by Subject|38|||
149969125|NCT01346592|541022120|FG000|Overall Study|Inappropriate enrollment|3|||
149969126|NCT01346592|541022121|FG001|Overall Study|Inappropriate enrollment|1|||
149969127|NCT01346592|541022122|FG002|Overall Study|Inappropriate enrollment|1|||
149969128|NCT01346592|541022120|FG000|Overall Study|Administrative reason|1|||
149969129|NCT01346592|541022121|FG001|Overall Study|Administrative reason|0|||
149969130|NCT01346592|541022122|FG002|Overall Study|Administrative reason|0|||
149969131|NCT01346592|541022120|FG000|Overall Study|Unable to Classify|7|||
149969132|NCT01346592|541022121|FG001|Overall Study|Unable to Classify|3|||
149969133|NCT01346592|541022122|FG002|Overall Study|Unable to Classify|6|||
149969134|NCT05185453|541022123|FG000|Overall Study|Lost to Follow-up|13|||
149969135|NCT05185453|541022124|FG001|Overall Study|Lost to Follow-up|3|||
149969136|NCT04569084|541022125|FG000|Overall Study|Adverse Event|10|||
149969137|NCT04569084|541022126|FG001|Overall Study|Adverse Event|14|||
149969138|NCT04569084|541022125|FG000|Overall Study|Death|2|||
149969139|NCT04569084|541022126|FG001|Overall Study|Death|3|||
149969140|NCT04569084|541022125|FG000|Overall Study|Lost to Follow-up|1|||
149969141|NCT04569084|541022126|FG001|Overall Study|Lost to Follow-up|1|||
149969142|NCT04569084|541022125|FG000|Overall Study|Physician Decision|3|||
149969143|NCT04569084|541022126|FG001|Overall Study|Physician Decision|3|||
149969144|NCT04569084|541022125|FG000|Overall Study|Protocol Violation|2|||
149901258|NCT02714595|540769834|FG000|Overall Study|Lack of Efficacy|0|||
149901259|NCT02714595|540769835|FG001|Overall Study|Lack of Efficacy|1|||
149901260|NCT02714595|540769834|FG000|Overall Study|Death|30|||
149901261|NCT02714595|540769835|FG001|Overall Study|Death|9|||
149901262|NCT02714595|540769834|FG000|Overall Study|Other-Miscellaneous|0|||
149901263|NCT02714595|540769835|FG001|Overall Study|Other-Miscellaneous|1|||
149901264|NCT02257489|540769836|FG000|Overall Study|Withdrawal by Subject|0|||
149901265|NCT02257489|540769837|FG001|Overall Study|Withdrawal by Subject|0|||
149901266|NCT02257489|540769838|FG002|Overall Study|Withdrawal by Subject|0|||
149901267|NCT02257489|540769839|FG003|Overall Study|Withdrawal by Subject|1|||
149901268|NCT02257489|540769840|FG004|Overall Study|Withdrawal by Subject|0|||
149901269|NCT02257489|540769841|FG005|Overall Study|Withdrawal by Subject|0|||
149901270|NCT02257489|540769842|FG006|Overall Study|Withdrawal by Subject|0|||
149901271|NCT02257489|540769843|FG007|Overall Study|Withdrawal by Subject|0|||
149901272|NCT02257489|540769844|FG008|Overall Study|Withdrawal by Subject|0|||
149901273|NCT04606394|540769845|FG000|Overall Study|Withdrawal by Subject|3|||
149901274|NCT04606394|540769845|FG000|Overall Study|Exclusion criteria screen failure|12|||
150046151|NCT01047553|541308079|FG001|Overall Study|Withdrawal by Subject|2|||
150046152|NCT01047553|541308078|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
150046153|NCT01047553|541308079|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
150046154|NCT01047553|541308078|FG000|Overall Study|Lost to Follow-up|1|||
150046155|NCT01047553|541308079|FG001|Overall Study|Lost to Follow-up|0|||
149901275|NCT01896128|540769846|FG000|Overall Study|Withdrawal by Subject|3|||
149901276|NCT01896128|540769847|FG001|Overall Study|Withdrawal by Subject|3|||
150046156|NCT01047553|541308078|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
150046157|NCT01047553|541308079|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
150046158|NCT01047553|541308078|FG000|Overall Study|PI's decision|0|||
149901277|NCT00954941|540769848|FG000|Overall Study|Received treatment at home|1|||
149901278|NCT00954941|540769849|FG001|Overall Study|Received treatment at home|0|||
149901279|NCT00954941|540769848|FG000|Overall Study|Withdrawal by Subject|1|||
149901280|NCT00954941|540769849|FG001|Overall Study|Withdrawal by Subject|0|||
149901281|NCT00954941|540769848|FG000|Overall Study|Insurance Denial|2|||
149901282|NCT00954941|540769849|FG001|Overall Study|Insurance Denial|2|||
149901283|NCT00954941|540769848|FG000|Overall Study|Physician Decision|2|||
149901284|NCT00954941|540769849|FG001|Overall Study|Physician Decision|2|||
149901285|NCT00954941|540769848|FG000|Overall Study|Ineligible|2|||
149901286|NCT00954941|540769849|FG001|Overall Study|Ineligible|2|||
149901287|NCT00954941|540769848|FG000|Overall Study|Adverse Event|0|||
149901288|NCT00954941|540769849|FG001|Overall Study|Adverse Event|1|||
149901289|NCT01996254|540769853|FG000|Overall Study|Change in Eligibility|0|||
149901290|NCT01996254|540769854|FG001|Overall Study|Change in Eligibility|2|||
149901291|NCT01996254|540769855|FG002|Overall Study|Change in Eligibility|0|||
149901292|NCT01996254|540769853|FG000|Overall Study|Withdrawal by Subject|0|||
149901293|NCT01996254|540769854|FG001|Overall Study|Withdrawal by Subject|3|||
149901294|NCT01996254|540769855|FG002|Overall Study|Withdrawal by Subject|4|||
149901295|NCT01996254|540769853|FG000|Overall Study|Lost to Follow-up|1|||
149901296|NCT01996254|540769854|FG001|Overall Study|Lost to Follow-up|0|||
149901297|NCT01996254|540769855|FG002|Overall Study|Lost to Follow-up|4|||
149901298|NCT03423173|540769856|FG000|Overall Study|Randomized but not vaccinated|1|||
149901299|NCT03423173|540769857|FG001|Overall Study|Randomized but not vaccinated|0|||
149901300|NCT03423173|540769858|FG002|Overall Study|Randomized but not vaccinated|2|||
149901301|NCT03423173|540769859|FG003|Overall Study|Randomized but not vaccinated|1|||
149901302|NCT03423173|540769856|FG000|Overall Study|Adverse Event|1|||
149901303|NCT03423173|540769857|FG001|Overall Study|Adverse Event|1|||
149901304|NCT03423173|540769858|FG002|Overall Study|Adverse Event|1|||
149901305|NCT03423173|540769859|FG003|Overall Study|Adverse Event|1|||
149901306|NCT03423173|540769856|FG000|Overall Study|Lost to Follow-up|10|||
149901307|NCT03423173|540769857|FG001|Overall Study|Lost to Follow-up|19|||
149901308|NCT03423173|540769858|FG002|Overall Study|Lost to Follow-up|17|||
149901309|NCT03423173|540769859|FG003|Overall Study|Lost to Follow-up|22|||
149901310|NCT03423173|540769856|FG000|Overall Study|Withdrawal of consent|4|||
149901311|NCT03423173|540769857|FG001|Overall Study|Withdrawal of consent|10|||
149901312|NCT03423173|540769858|FG002|Overall Study|Withdrawal of consent|4|||
149901313|NCT03423173|540769859|FG003|Overall Study|Withdrawal of consent|5|||
149901314|NCT03423173|540769856|FG000|Overall Study|Death|1|||
149901315|NCT03423173|540769857|FG001|Overall Study|Death|0|||
149901316|NCT03423173|540769858|FG002|Overall Study|Death|0|||
149901317|NCT03423173|540769859|FG003|Overall Study|Death|0|||
149901318|NCT03423173|540769856|FG000|Overall Study|Reason not Specified|2|||
149901319|NCT03423173|540769857|FG001|Overall Study|Reason not Specified|5|||
149901320|NCT03423173|540769858|FG002|Overall Study|Reason not Specified|3|||
149901321|NCT03423173|540769859|FG003|Overall Study|Reason not Specified|1|||
149901322|NCT01053663|540769860|FG000|Overall Study|Death|2|||
149901323|NCT01053663|540769860|FG000|Overall Study|Lost to Follow-up|1|||
149901324|NCT01053663|540769860|FG000|Overall Study|Poor IV Access|1|||
149901325|NCT01053663|540769860|FG000|Overall Study|Transferred to Another Hospital|1|||
149901326|NCT01053663|540769860|FG000|Overall Study|Negative Influenza Diagnosis|1|||
149901327|NCT03533114|540769861|FG000|Overall|Adverse Event|16|||
149901328|NCT03533114|540769862|FG001|Overall|Adverse Event|11|||
149901329|NCT03533114|540769861|FG000|Overall|Consent Withdrawal by Participant|7|||
149901330|NCT03533114|540769862|FG001|Overall|Consent Withdrawal by Participant|6|||
149901331|NCT03533114|540769861|FG000|Overall|Lack of Efficacy|5|||
149901332|NCT03533114|540769862|FG001|Overall|Lack of Efficacy|3|||
149901333|NCT03533114|540769861|FG000|Overall|Lost to Follow-up|1|||
149901334|NCT03533114|540769862|FG001|Overall|Lost to Follow-up|1|||
149901335|NCT03533114|540769861|FG000|Overall|Physician Decision|0|||
149901336|NCT03533114|540769862|FG001|Overall|Physician Decision|2|||
149901337|NCT03533114|540769861|FG000|Overall|Protocol deviation|1|||
149901338|NCT03533114|540769862|FG001|Overall|Protocol deviation|1|||
149901339|NCT03533114|540769861|FG000|Overall|Failure to meet randomization criteria|1|||
149901340|NCT03533114|540769862|FG001|Overall|Failure to meet randomization criteria|2|||
149901341|NCT03533114|540769861|FG000|Overall|Non-Compliance with study drug|0|||
149901342|NCT03533114|540769862|FG001|Overall|Non-Compliance with study drug|1|||
149901343|NCT03533114|540769861|FG000|Overall|Other|0|||
149901344|NCT03533114|540769862|FG001|Overall|Other|1|||
149901345|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Adverse Event|11|||
149901346|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Adverse Event|8|||
149901347|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
149901348|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
149901349|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
149901350|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
149901351|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
149901352|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
149901353|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
149901354|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
149901355|NCT03533114|540769861|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
149901356|NCT03533114|540769862|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
149901357|NCT03533114|540769861|FG000|Stable Dose|Adverse Event|0|||
149901358|NCT03533114|540769862|FG001|Stable Dose|Adverse Event|2|||
149901359|NCT03533114|540769861|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
149901360|NCT03533114|540769862|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
149901361|NCT03533114|540769861|FG000|Stable Dose|Lack of Efficacy|1|||
149901362|NCT03533114|540769862|FG001|Stable Dose|Lack of Efficacy|0|||
149901363|NCT03533114|540769861|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
149901364|NCT03533114|540769862|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
149901365|NCT03533114|540769861|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
149901366|NCT03533114|540769862|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
149901367|NCT03533114|540769861|FG000|Open-Label Safety Extension|Adverse Event|3|||
149901368|NCT03533114|540769862|FG001|Open-Label Safety Extension|Adverse Event|0|||
149901369|NCT03533114|540769861|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
149901370|NCT03533114|540769862|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
149901371|NCT03533114|540769861|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
149901372|NCT03533114|540769862|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
149901373|NCT03533114|540769861|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
149901374|NCT03533114|540769862|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
149901375|NCT03533114|540769861|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
149901376|NCT03533114|540769862|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
149901377|NCT02411396|540769866|FG000|Overall Study|Lost to Follow-up|31|||
149901378|NCT02411396|540769866|FG000|Overall Study|Death|10|||
149901379|NCT02071706|540769873|FG000|Overall Study|Adverse Event|1|||
149901380|NCT02071706|540769873|FG000|Overall Study|Withdrawal by Subject|2|||
149901381|NCT02247440|540769876|FG000|Overall Study|Withdrawal by Subject|1|||
149901382|NCT02247440|540769876|FG000|Overall Study|Lack of Efficacy|3|||
149901383|NCT00661609|540769877|FG000|Overall Study|Adverse Event|4|||
149901384|NCT00661609|540769877|FG000|Overall Study|Death|20|||
149901385|NCT00661609|540769877|FG000|Overall Study|Withdrawal by Subject|2|||
149901386|NCT00661609|540769877|FG000|Overall Study|PI Decision|1|||
149901387|NCT00661609|540769877|FG000|Overall Study|Survival follow up stage discontinued|11|||
149901388|NCT00661609|540769877|FG000|Overall Study|Disease progression|3|||
149901389|NCT00637000|540769878|FG000|Overall Study|Withdrawal by Subject|4|||
149901390|NCT00637000|540769879|FG001|Overall Study|Withdrawal by Subject|3|||
149901391|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
149901392|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
150046159|NCT01047553|541308079|FG001|Overall Study|PI's decision|1|||
149901393|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
149901394|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
149901395|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
149901396|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
149901397|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
149969145|NCT04569084|541022126|FG001|Overall Study|Protocol Violation|1|||
149969146|NCT04569084|541022125|FG000|Overall Study|Withdrawal by Subject|20|||
149969147|NCT04569084|541022126|FG001|Overall Study|Withdrawal by Subject|21|||
149969148|NCT04569084|541022125|FG000|Overall Study|Study terminated by sponsor|26|||
149969149|NCT04569084|541022126|FG001|Overall Study|Study terminated by sponsor|23|||
149969150|NCT04569084|541022125|FG000|Overall Study|Other|3|||
149969151|NCT04569084|541022126|FG001|Overall Study|Other|5|||
149969152|NCT00964678|541022127|FG000|Overall Study|Physician Decision|4|||
149969153|NCT03359395|541022128|FG000|First Intervention A / B|Withdrawal by Subject|1|||
149969154|NCT03359395|541022129|FG001|First Intervention A / B|Withdrawal by Subject|0|||
149969155|NCT03359395|541022128|FG000|First Intervention A / B|Lost to Follow-up|2|||
149969156|NCT03359395|541022129|FG001|First Intervention A / B|Lost to Follow-up|3|||
149901398|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
149901399|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
149901400|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
149901401|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
149901402|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
149901403|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
149901404|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
149901405|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
149901406|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
149901407|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
149901408|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
149901409|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
149901410|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
149901411|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
149901412|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
149901413|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
149901414|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
149901415|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
149901416|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
149901417|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
149901418|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
149901419|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
149901420|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
149901421|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
149901422|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
149901423|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
149901424|NCT00839527|540769880|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
149901425|NCT00839527|540769881|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
149901426|NCT00839527|540769882|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
149901427|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
149901428|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
149901429|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
149901430|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
149901431|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
149901432|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
149901433|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
149901434|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
149901435|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
149901436|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
149901437|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
149901438|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
149901439|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
149901440|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
149901441|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
149901442|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
149901443|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
149901444|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
149901445|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
149901446|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
149969157|NCT03359395|541022128|FG000|Second Intervention B/A|Exclusion criteria|0|||
149969158|NCT03359395|541022129|FG001|Second Intervention B/A|Exclusion criteria|1|||
149969159|NCT03359395|541022128|FG000|Second Intervention B/A|Lost to Follow-up|3|||
149969160|NCT03359395|541022129|FG001|Second Intervention B/A|Lost to Follow-up|2|||
149969161|NCT06022107|541022134|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
149901447|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
149901448|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
149901449|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
149969162|NCT06022107|541022134|FG000|Overall Study|Dropped out of study for higher level of care|1|||
149969163|NCT06022107|541022134|FG000|Overall Study|Lost to Follow-up|2|||
150046160|NCT02817464|541308081|FG000|Overall Study|Lost to Follow-up|1|||
150046161|NCT02817464|541308082|FG001|Overall Study|Lost to Follow-up|0|||
150046162|NCT02817464|541308081|FG000|Overall Study|Discontinued early due to personal decision|1|||
149969164|NCT05943990|541022138|FG000|Overall Study|Study Terminated by Sponsor|0|||
149969165|NCT05943990|541022139|FG001|Overall Study|Study Terminated by Sponsor|0|||
149969166|NCT05943990|541022140|FG002|Overall Study|Study Terminated by Sponsor|1|||
149969167|NCT02333799|541023631|FG000|Treatment Period|Withdrawal by Subject|1|||
149969168|NCT02333799|541023631|FG000|Treatment Period|Death|6|||
149969169|NCT02333799|541023631|FG000|6 Month Follow Up Period|Physician Decision|1|||
149969170|NCT02333799|541023631|FG000|6 Month Follow Up Period|Death|1|||
149969171|NCT02333799|541023631|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
149969172|NCT02333799|541023631|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
149969173|NCT05484895|541023632|FG000|Overall Study|Lost to Follow-up|63|||
149969174|NCT05484895|541023633|FG001|Overall Study|Lost to Follow-up|64|||
149969175|NCT02552225|541023637|FG000|Overall Study|Withdrawal by Subject|1|||
149969176|NCT02552225|541023638|FG001|Overall Study|Withdrawal by Subject|0|||
149969177|NCT01168596|541023639|FG000|Overall Study|Withdrawal by Subject|3|||
149969178|NCT01168596|541023640|FG001|Overall Study|Withdrawal by Subject|1|||
149969179|NCT00876447|541023641|FG000|Overall Study|Other miscellaneous reasons|3|||
149969180|NCT00876447|541023642|FG001|Overall Study|Other miscellaneous reasons|8|||
149969181|NCT00876447|541023641|FG000|Overall Study|Site closure|19|||
149969182|NCT00876447|541023642|FG001|Overall Study|Site closure|14|||
150046163|NCT02817464|541308082|FG001|Overall Study|Discontinued early due to personal decision|1|||
150046164|NCT00828204|541308083|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
150046165|NCT00828204|541308084|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
150046166|NCT00828204|541308083|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
150046167|NCT00828204|541308084|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
150046168|NCT00828204|541308083|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
150046169|NCT00828204|541308084|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
150046170|NCT00828204|541308083|FG000|Main Study: After Study Restart|Adverse Event|0|||
149901450|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
149901451|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
149901452|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
149901453|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
149901454|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
149901455|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
149901456|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
149901457|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
149901458|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
149901459|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
149901460|NCT00839527|540769880|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
149901461|NCT00839527|540769881|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
149901462|NCT00839527|540769882|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
149901463|NCT01855243|540769883|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
149901464|NCT01855243|540769884|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
149901465|NCT01855243|540769885|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
149901466|NCT01860040|540769888|FG000|Overall Study|Withdrawal by Subject|1|||
149901467|NCT01860040|540769889|FG001|Overall Study|Withdrawal by Subject|0|||
149901468|NCT01931995|540769890|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
149901469|NCT01931995|540769891|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
149901470|NCT01931995|540769890|FG000|First Intervention (1 Day)|Physician Decision|1|||
149901471|NCT01931995|540769891|FG001|First Intervention (1 Day)|Physician Decision|1|||
149901472|NCT01931995|540769890|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
149901473|NCT01931995|540769891|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
149901474|NCT02477826|540769910|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
149901475|NCT02477826|540769911|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
149901476|NCT02477826|540769912|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
149969183|NCT00876447|541023641|FG000|Overall Study|Protocol Violation|9|||
149969184|NCT00876447|541023642|FG001|Overall Study|Protocol Violation|3|||
149969185|NCT00876447|541023641|FG000|Overall Study|Personal reasons|30|||
150046171|NCT00828204|541308084|FG001|Main Study: After Study Restart|Adverse Event|2|||
149969186|NCT00876447|541023642|FG001|Overall Study|Personal reasons|28|||
149969187|NCT00876447|541023641|FG000|Overall Study|Lost to Follow-up|6|||
150046172|NCT00828204|541308083|FG000|Main Study: After Study Restart|Noncompliance|0|||
149969188|NCT00876447|541023642|FG001|Overall Study|Lost to Follow-up|15|||
149969189|NCT00876447|541023641|FG000|Overall Study|Pregnancy|4|||
149969190|NCT00876447|541023642|FG001|Overall Study|Pregnancy|2|||
149969191|NCT00876447|541023641|FG000|Overall Study|Lack of Efficacy|5|||
149969192|NCT00876447|541023642|FG001|Overall Study|Lack of Efficacy|3|||
149969193|NCT00876447|541023641|FG000|Overall Study|Adverse Event|4|||
150046173|NCT00828204|541308084|FG001|Main Study: After Study Restart|Noncompliance|1|||
149901477|NCT02477826|540769913|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
149901478|NCT02477826|540769914|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
149901479|NCT02477826|540769915|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
149901480|NCT02477826|540769916|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
149901481|NCT02477826|540769917|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
149901482|NCT02477826|540769918|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
149901483|NCT02477826|540769919|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
149901484|NCT02477826|540769910|FG000|Pre-Treatment|Other reasons|4|||
149901485|NCT02477826|540769911|FG001|Pre-Treatment|Other reasons|1|||
149901486|NCT02477826|540769912|FG002|Pre-Treatment|Other reasons|4|||
149901487|NCT02477826|540769913|FG003|Pre-Treatment|Other reasons|1|||
149901488|NCT02477826|540769914|FG004|Pre-Treatment|Other reasons|4|||
149901489|NCT02477826|540769915|FG005|Pre-Treatment|Other reasons|2|||
149901490|NCT02477826|540769916|FG006|Pre-Treatment|Other reasons|0|||
149901491|NCT02477826|540769917|FG007|Pre-Treatment|Other reasons|0|||
149901492|NCT02477826|540769918|FG008|Pre-Treatment|Other reasons|0|||
149901493|NCT02477826|540769919|FG009|Pre-Treatment|Other reasons|0|||
149901494|NCT02477826|540769910|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
149901495|NCT02477826|540769911|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
149901496|NCT02477826|540769912|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
149901497|NCT02477826|540769913|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
149901498|NCT02477826|540769914|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
149901499|NCT02477826|540769915|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
149901500|NCT02477826|540769916|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
149901501|NCT02477826|540769917|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
149901502|NCT02477826|540769918|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
149901503|NCT02477826|540769919|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
149901504|NCT02477826|540769910|FG000|Pre-Treatment|Subject withdrew consent|0|||
149901505|NCT02477826|540769911|FG001|Pre-Treatment|Subject withdrew consent|0|||
149901506|NCT02477826|540769912|FG002|Pre-Treatment|Subject withdrew consent|3|||
149901507|NCT02477826|540769913|FG003|Pre-Treatment|Subject withdrew consent|0|||
149901508|NCT02477826|540769914|FG004|Pre-Treatment|Subject withdrew consent|0|||
149901509|NCT02477826|540769915|FG005|Pre-Treatment|Subject withdrew consent|1|||
149901510|NCT02477826|540769916|FG006|Pre-Treatment|Subject withdrew consent|0|||
149901511|NCT02477826|540769917|FG007|Pre-Treatment|Subject withdrew consent|1|||
149901512|NCT02477826|540769918|FG008|Pre-Treatment|Subject withdrew consent|0|||
149901513|NCT02477826|540769919|FG009|Pre-Treatment|Subject withdrew consent|3|||
149901514|NCT02477826|540769910|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901515|NCT02477826|540769911|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
149901516|NCT02477826|540769912|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901517|NCT02477826|540769913|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901518|NCT02477826|540769914|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901519|NCT02477826|540769915|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901520|NCT02477826|540769916|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901521|NCT02477826|540769917|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901522|NCT02477826|540769918|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
149901523|NCT02477826|540769919|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
149901524|NCT02477826|540769910|FG000|Pre-Treatment|Death|0|||
149901525|NCT02477826|540769911|FG001|Pre-Treatment|Death|0|||
149901526|NCT02477826|540769912|FG002|Pre-Treatment|Death|0|||
149901527|NCT02477826|540769913|FG003|Pre-Treatment|Death|0|||
149901528|NCT02477826|540769914|FG004|Pre-Treatment|Death|0|||
149901529|NCT02477826|540769915|FG005|Pre-Treatment|Death|0|||
149901530|NCT02477826|540769916|FG006|Pre-Treatment|Death|1|||
149901531|NCT02477826|540769917|FG007|Pre-Treatment|Death|0|||
149901532|NCT02477826|540769918|FG008|Pre-Treatment|Death|0|||
149901533|NCT02477826|540769919|FG009|Pre-Treatment|Death|0|||
149901534|NCT02477826|540769910|FG000|Treatment Period|Not reported|8|||
149901535|NCT02477826|540769911|FG001|Treatment Period|Not reported|6|||
149901536|NCT02477826|540769912|FG002|Treatment Period|Not reported|4|||
149901537|NCT02477826|540769913|FG003|Treatment Period|Not reported|4|||
149901538|NCT02477826|540769914|FG004|Treatment Period|Not reported|2|||
149901539|NCT02477826|540769915|FG005|Treatment Period|Not reported|1|||
149901540|NCT02477826|540769916|FG006|Treatment Period|Not reported|14|||
149969194|NCT00876447|541023642|FG001|Overall Study|Adverse Event|8|||
149901541|NCT02477826|540769917|FG007|Treatment Period|Not reported|8|||
149901542|NCT02477826|540769918|FG008|Treatment Period|Not reported|5|||
149901543|NCT02477826|540769919|FG009|Treatment Period|Not reported|2|||
149901544|NCT02477826|540769910|FG000|Treatment Period|Other reasons|5|||
149901545|NCT02477826|540769911|FG001|Treatment Period|Other reasons|6|||
149901546|NCT02477826|540769912|FG002|Treatment Period|Other reasons|12|||
149901547|NCT02477826|540769913|FG003|Treatment Period|Other reasons|7|||
149901548|NCT02477826|540769914|FG004|Treatment Period|Other reasons|5|||
149901549|NCT02477826|540769915|FG005|Treatment Period|Other reasons|1|||
149901550|NCT02477826|540769916|FG006|Treatment Period|Other reasons|8|||
149901551|NCT02477826|540769917|FG007|Treatment Period|Other reasons|8|||
149901552|NCT02477826|540769918|FG008|Treatment Period|Other reasons|21|||
149901553|NCT02477826|540769919|FG009|Treatment Period|Other reasons|1|||
149901554|NCT02477826|540769910|FG000|Treatment Period|Administrative reason by sponsor|0|||
149901555|NCT02477826|540769911|FG001|Treatment Period|Administrative reason by sponsor|3|||
149901556|NCT02477826|540769912|FG002|Treatment Period|Administrative reason by sponsor|0|||
149901557|NCT02477826|540769913|FG003|Treatment Period|Administrative reason by sponsor|0|||
149901558|NCT02477826|540769914|FG004|Treatment Period|Administrative reason by sponsor|0|||
149901559|NCT02477826|540769915|FG005|Treatment Period|Administrative reason by sponsor|0|||
149901560|NCT02477826|540769916|FG006|Treatment Period|Administrative reason by sponsor|0|||
149901561|NCT02477826|540769917|FG007|Treatment Period|Administrative reason by sponsor|0|||
149901562|NCT02477826|540769918|FG008|Treatment Period|Administrative reason by sponsor|0|||
149901563|NCT02477826|540769919|FG009|Treatment Period|Administrative reason by sponsor|0|||
149901564|NCT02477826|540769910|FG000|Treatment Period|Participant meet no longer study criteria|1|||
149901565|NCT02477826|540769911|FG001|Treatment Period|Participant meet no longer study criteria|1|||
149901566|NCT02477826|540769912|FG002|Treatment Period|Participant meet no longer study criteria|0|||
149901567|NCT02477826|540769913|FG003|Treatment Period|Participant meet no longer study criteria|0|||
149901568|NCT02477826|540769914|FG004|Treatment Period|Participant meet no longer study criteria|1|||
149901569|NCT02477826|540769915|FG005|Treatment Period|Participant meet no longer study criteria|1|||
149901570|NCT02477826|540769916|FG006|Treatment Period|Participant meet no longer study criteria|0|||
149901571|NCT02477826|540769917|FG007|Treatment Period|Participant meet no longer study criteria|1|||
149901572|NCT02477826|540769918|FG008|Treatment Period|Participant meet no longer study criteria|0|||
149901573|NCT02477826|540769919|FG009|Treatment Period|Participant meet no longer study criteria|0|||
149901574|NCT02477826|540769910|FG000|Treatment Period|Poor/Non Compliance|1|||
149901575|NCT02477826|540769911|FG001|Treatment Period|Poor/Non Compliance|0|||
149901576|NCT02477826|540769912|FG002|Treatment Period|Poor/Non Compliance|2|||
149901577|NCT02477826|540769913|FG003|Treatment Period|Poor/Non Compliance|0|||
149901578|NCT02477826|540769914|FG004|Treatment Period|Poor/Non Compliance|0|||
149901579|NCT02477826|540769915|FG005|Treatment Period|Poor/Non Compliance|1|||
149901580|NCT02477826|540769916|FG006|Treatment Period|Poor/Non Compliance|1|||
149901581|NCT02477826|540769917|FG007|Treatment Period|Poor/Non Compliance|0|||
149901582|NCT02477826|540769918|FG008|Treatment Period|Poor/Non Compliance|0|||
149901583|NCT02477826|540769919|FG009|Treatment Period|Poor/Non Compliance|1|||
149901584|NCT02477826|540769910|FG000|Treatment Period|Maximum Clinical Benefit|3|||
149901585|NCT02477826|540769911|FG001|Treatment Period|Maximum Clinical Benefit|3|||
149901586|NCT02477826|540769912|FG002|Treatment Period|Maximum Clinical Benefit|1|||
149901587|NCT02477826|540769913|FG003|Treatment Period|Maximum Clinical Benefit|1|||
149901588|NCT02477826|540769914|FG004|Treatment Period|Maximum Clinical Benefit|3|||
149901589|NCT02477826|540769915|FG005|Treatment Period|Maximum Clinical Benefit|0|||
149901590|NCT02477826|540769916|FG006|Treatment Period|Maximum Clinical Benefit|3|||
149901591|NCT02477826|540769917|FG007|Treatment Period|Maximum Clinical Benefit|2|||
149901592|NCT02477826|540769918|FG008|Treatment Period|Maximum Clinical Benefit|2|||
149901593|NCT02477826|540769919|FG009|Treatment Period|Maximum Clinical Benefit|2|||
149901594|NCT02477826|540769910|FG000|Treatment Period|Lost to Follow-up|0|||
149901595|NCT02477826|540769911|FG001|Treatment Period|Lost to Follow-up|0|||
149901596|NCT02477826|540769912|FG002|Treatment Period|Lost to Follow-up|1|||
149901597|NCT02477826|540769913|FG003|Treatment Period|Lost to Follow-up|1|||
149901598|NCT02477826|540769914|FG004|Treatment Period|Lost to Follow-up|0|||
149901599|NCT02477826|540769915|FG005|Treatment Period|Lost to Follow-up|0|||
149901600|NCT02477826|540769916|FG006|Treatment Period|Lost to Follow-up|2|||
149901601|NCT02477826|540769917|FG007|Treatment Period|Lost to Follow-up|2|||
149901602|NCT02477826|540769918|FG008|Treatment Period|Lost to Follow-up|0|||
149901603|NCT02477826|540769919|FG009|Treatment Period|Lost to Follow-up|0|||
149901604|NCT02477826|540769910|FG000|Treatment Period|Participant withdrew Consent|5|||
149901605|NCT02477826|540769911|FG001|Treatment Period|Participant withdrew Consent|5|||
149901606|NCT02477826|540769912|FG002|Treatment Period|Participant withdrew Consent|3|||
149901607|NCT02477826|540769913|FG003|Treatment Period|Participant withdrew Consent|3|||
149901608|NCT02477826|540769914|FG004|Treatment Period|Participant withdrew Consent|1|||
149901609|NCT02477826|540769915|FG005|Treatment Period|Participant withdrew Consent|3|||
149901610|NCT02477826|540769916|FG006|Treatment Period|Participant withdrew Consent|3|||
149901611|NCT02477826|540769917|FG007|Treatment Period|Participant withdrew Consent|3|||
149901612|NCT02477826|540769918|FG008|Treatment Period|Participant withdrew Consent|2|||
150046174|NCT00828204|541308083|FG000|Extension Study|Lost to Follow-up|0|||
149969195|NCT02297516|541023645|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
149969196|NCT02297516|541023646|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
149969197|NCT02297516|541023645|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
149969198|NCT02297516|541023646|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
149969199|NCT02297516|541023645|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
149969200|NCT02297516|541023646|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
149969201|NCT00710593|541023647|FG000|Overall Study|Incarceration|1|||
149969202|NCT00710593|541023648|FG001|Overall Study|Incarceration|0|||
149969203|NCT00710593|541023647|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
149969204|NCT00710593|541023648|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
149969205|NCT00710593|541023647|FG000|Overall Study|Lost to Follow-up|3|||
149969206|NCT00710593|541023648|FG001|Overall Study|Lost to Follow-up|1|||
149969207|NCT00710593|541023647|FG000|Overall Study|Moved out of area|1|||
149969208|NCT00710593|541023648|FG001|Overall Study|Moved out of area|0|||
149969209|NCT00710593|541023647|FG000|Overall Study|Failure to adhere or complete study eval|1|||
149969210|NCT00710593|541023648|FG001|Overall Study|Failure to adhere or complete study eval|1|||
149969211|NCT00710593|541023647|FG000|Overall Study|Protocol Violation|1|||
149969212|NCT00710593|541023648|FG001|Overall Study|Protocol Violation|1|||
149969213|NCT00710593|541023647|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
149969214|NCT00710593|541023648|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
149969215|NCT04490278|541023649|FG000|Overall Study|Lost to Follow-up|6|||
149969216|NCT00366457|541023655|FG000|Overall Study|never began study therapy|2|||
149969217|NCT00189423|541023656|FG000|Overall Study|Death|746|||
149969218|NCT00189423|541023657|FG001|Overall Study|Death|747|||
149969219|NCT00189423|541023656|FG000|Overall Study|Withdrawal by Subject|9|||
149969220|NCT00189423|541023657|FG001|Overall Study|Withdrawal by Subject|9|||
149969221|NCT00189423|541023656|FG000|Overall Study|Lost to Follow-up|10|||
149969222|NCT00189423|541023657|FG001|Overall Study|Lost to Follow-up|10|||
149969223|NCT00183248|541023665|FG000|Overall Study|Lost to Follow-up|0|||
149969224|NCT00183248|541023666|FG001|Overall Study|Lost to Follow-up|1|||
149969225|NCT00183248|541023665|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
149969226|NCT00183248|541023666|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
149969227|NCT03493958|541023669|FG000|Overall Study|Withdrawal by Subject|6|||
149969228|NCT03493958|541023669|FG000|Overall Study|Lost to Follow-up|7|||
149969229|NCT03493958|541023669|FG000|Overall Study|Did not complete all required study procedures|2|||
149969230|NCT01029535|541023670|FG000|Overall Study|Lost to Follow-up|24|||
149969231|NCT01029535|541023670|FG000|Overall Study|Protocol Violation|2|||
149969232|NCT01029535|541023670|FG000|Overall Study|Participant Withdrew Consent|2|||
149969233|NCT01029535|541023670|FG000|Overall Study|Adverse Event|1|||
149969234|NCT01029535|541023670|FG000|Overall Study|Use of Another Treatment|1|||
149969235|NCT01029535|541023670|FG000|Overall Study|Death|1|||
149969236|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149969237|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
149969238|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149969239|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149969240|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
149969241|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
149969242|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
149969243|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
149969244|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
149969245|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
149969246|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
149969247|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
149969248|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149969249|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149969250|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149969251|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149969252|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
149969253|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
149969254|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
149969255|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
149969256|NCT02836249|541023671|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
149969257|NCT02836249|541023672|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
149969258|NCT02836249|541023673|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
149969259|NCT02836249|541023674|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
149969260|NCT02836249|541023671|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
149969261|NCT02836249|541023672|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
149969262|NCT02836249|541023673|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
149969263|NCT02836249|541023674|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
150046175|NCT00828204|541308084|FG001|Extension Study|Lost to Follow-up|1|||
150176503|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
150176504|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
149901613|NCT02477826|540769919|FG009|Treatment Period|Participant withdrew Consent|3|||
149901614|NCT02477826|540769910|FG000|Treatment Period|Participant request to discontinue treatment|5|||
149901615|NCT02477826|540769911|FG001|Treatment Period|Participant request to discontinue treatment|3|||
149901616|NCT02477826|540769912|FG002|Treatment Period|Participant request to discontinue treatment|15|||
149901617|NCT02477826|540769913|FG003|Treatment Period|Participant request to discontinue treatment|5|||
149901618|NCT02477826|540769914|FG004|Treatment Period|Participant request to discontinue treatment|3|||
149901619|NCT02477826|540769915|FG005|Treatment Period|Participant request to discontinue treatment|6|||
149901620|NCT02477826|540769916|FG006|Treatment Period|Participant request to discontinue treatment|13|||
149901621|NCT02477826|540769917|FG007|Treatment Period|Participant request to discontinue treatment|15|||
149901622|NCT02477826|540769918|FG008|Treatment Period|Participant request to discontinue treatment|4|||
149901623|NCT02477826|540769919|FG009|Treatment Period|Participant request to discontinue treatment|18|||
149901624|NCT02477826|540769910|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
149901625|NCT02477826|540769911|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
149901626|NCT02477826|540769912|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
149901627|NCT02477826|540769913|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
149901628|NCT02477826|540769914|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
149901629|NCT02477826|540769915|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
149901630|NCT02477826|540769916|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
149901631|NCT02477826|540769917|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
149901632|NCT02477826|540769918|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
149901633|NCT02477826|540769919|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
149901634|NCT02477826|540769910|FG000|Treatment Period|Death|4|||
149901635|NCT02477826|540769911|FG001|Treatment Period|Death|7|||
149901636|NCT02477826|540769912|FG002|Treatment Period|Death|0|||
149901637|NCT02477826|540769913|FG003|Treatment Period|Death|0|||
149901638|NCT02477826|540769914|FG004|Treatment Period|Death|1|||
149901639|NCT02477826|540769915|FG005|Treatment Period|Death|2|||
149901640|NCT02477826|540769916|FG006|Treatment Period|Death|6|||
149901641|NCT02477826|540769917|FG007|Treatment Period|Death|5|||
149901642|NCT02477826|540769918|FG008|Treatment Period|Death|9|||
149901643|NCT02477826|540769919|FG009|Treatment Period|Death|0|||
149901644|NCT02477826|540769910|FG000|Treatment Period|Study Drug Toxicity|79|||
149901645|NCT02477826|540769911|FG001|Treatment Period|Study Drug Toxicity|51|||
149901646|NCT02477826|540769912|FG002|Treatment Period|Study Drug Toxicity|31|||
149901647|NCT02477826|540769913|FG003|Treatment Period|Study Drug Toxicity|39|||
149901648|NCT02477826|540769914|FG004|Treatment Period|Study Drug Toxicity|12|||
149901649|NCT02477826|540769915|FG005|Treatment Period|Study Drug Toxicity|25|||
149901650|NCT02477826|540769916|FG006|Treatment Period|Study Drug Toxicity|52|||
149901651|NCT02477826|540769917|FG007|Treatment Period|Study Drug Toxicity|30|||
149901652|NCT02477826|540769918|FG008|Treatment Period|Study Drug Toxicity|20|||
149901653|NCT02477826|540769919|FG009|Treatment Period|Study Drug Toxicity|9|||
149901654|NCT02477826|540769910|FG000|Treatment Period|Disease progression|212|||
149901655|NCT02477826|540769911|FG001|Treatment Period|Disease progression|240|||
149901656|NCT02477826|540769912|FG002|Treatment Period|Disease progression|202|||
149901657|NCT02477826|540769913|FG003|Treatment Period|Disease progression|93|||
149901658|NCT02477826|540769914|FG004|Treatment Period|Disease progression|113|||
149901659|NCT02477826|540769915|FG005|Treatment Period|Disease progression|96|||
149901660|NCT02477826|540769916|FG006|Treatment Period|Disease progression|208|||
149901661|NCT02477826|540769917|FG007|Treatment Period|Disease progression|195|||
149901662|NCT02477826|540769918|FG008|Treatment Period|Disease progression|59|||
149901663|NCT02477826|540769919|FG009|Treatment Period|Disease progression|46|||
149901664|NCT02477826|540769910|FG000|Treatment Period|Pregnancy|0|||
149901665|NCT02477826|540769911|FG001|Treatment Period|Pregnancy|0|||
149901666|NCT02477826|540769912|FG002|Treatment Period|Pregnancy|0|||
149901667|NCT02477826|540769913|FG003|Treatment Period|Pregnancy|0|||
149901668|NCT02477826|540769914|FG004|Treatment Period|Pregnancy|0|||
149901669|NCT02477826|540769915|FG005|Treatment Period|Pregnancy|0|||
149901670|NCT02477826|540769916|FG006|Treatment Period|Pregnancy|0|||
149901671|NCT02477826|540769917|FG007|Treatment Period|Pregnancy|0|||
149901672|NCT02477826|540769918|FG008|Treatment Period|Pregnancy|0|||
149901673|NCT02477826|540769919|FG009|Treatment Period|Pregnancy|1|||
149901674|NCT02477826|540769910|FG000|Treatment Period|Other|0|||
149901675|NCT02477826|540769911|FG001|Treatment Period|Other|0|||
149901676|NCT02477826|540769912|FG002|Treatment Period|Other|0|||
149901677|NCT02477826|540769913|FG003|Treatment Period|Other|0|||
149901678|NCT02477826|540769914|FG004|Treatment Period|Other|0|||
149901679|NCT02477826|540769915|FG005|Treatment Period|Other|0|||
149901680|NCT02477826|540769916|FG006|Treatment Period|Other|0|||
149901681|NCT02477826|540769917|FG007|Treatment Period|Other|0|||
149901682|NCT02477826|540769918|FG008|Treatment Period|Other|0|||
149901683|NCT02477826|540769919|FG009|Treatment Period|Other|1|||
149901684|NCT00828568|540769920|FG000|Randomized|Withdrawal by Subject|1|||
149901685|NCT00828568|540769921|FG001|Randomized|Withdrawal by Subject|0|||
149901686|NCT00828568|540769922|FG002|Randomized|Withdrawal by Subject|2|||
149901687|NCT00828568|540769920|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
149901688|NCT00828568|540769921|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
149901689|NCT00828568|540769922|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
149901690|NCT00828568|540769920|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
149901691|NCT00828568|540769921|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
149901692|NCT00828568|540769922|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
149901693|NCT00828568|540769920|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
149901694|NCT00828568|540769921|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
149901695|NCT00828568|540769922|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
149901696|NCT00828568|540769920|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
149901697|NCT00828568|540769921|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
149901698|NCT00828568|540769922|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
149901699|NCT00403481|540769923|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
149901700|NCT00403481|540769923|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
149901701|NCT00403481|540769923|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
149901702|NCT00403481|540769923|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
149901703|NCT00403481|540769923|FG000|Olm 40 mg|Adverse Event|2|||
149901704|NCT00403481|540769923|FG000|Olm 40 mg|Protocol Violation|1|||
149901705|NCT00403481|540769923|FG000|Olm 40 mg|Withdrawal by Subject|1|||
149901706|NCT00403481|540769923|FG000|Olm 40 mg|Other|1|||
149901707|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
149901708|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
149901709|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
149901710|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
149901711|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
149901712|NCT00403481|540769923|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
149901713|NCT04657198|540769929|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
149901714|NCT04657198|540769930|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
149901715|NCT04657198|540769931|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
149901716|NCT02549287|540769932|FG000|Overall Study|Lost to Follow-up|65|||
149901717|NCT02549287|540769933|FG001|Overall Study|Lost to Follow-up|26|||
149901718|NCT02549287|540769932|FG000|Overall Study|Withdrawal by Subject|15|||
149901719|NCT02549287|540769933|FG001|Overall Study|Withdrawal by Subject|6|||
149901720|NCT03793842|540769934|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
149901721|NCT03793842|540769935|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
149901722|NCT03793842|540769934|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
149901723|NCT03793842|540769935|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
149901724|NCT00427921|540769939|FG000|Overall Study|Adverse Event|26|||
149901725|NCT00427921|540769939|FG000|Overall Study|Withdrawal by Subject|4|||
149901726|NCT00427921|540769939|FG000|Overall Study|Lost to Follow-up|2|||
149901727|NCT00427921|540769939|FG000|Overall Study|Other reason not specified|10|||
149901728|NCT00427921|540769939|FG000|Overall Study|Adverse Event + Hospitalization|1|||
149901729|NCT00427921|540769939|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
149901730|NCT00427921|540769939|FG000|Overall Study|Adverse Event + No Response|1|||
149901731|NCT00427921|540769939|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
149901732|NCT00427921|540769939|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
149901733|NCT00427921|540769939|FG000|Overall Study|Adverse Event + Lost Response|1|||
149901734|NCT00427921|540769939|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
149901735|NCT00427921|540769939|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
149901736|NCT00520533|540769940|FG000|Overall Study|Death|1|||
149901737|NCT00520533|540769940|FG000|Overall Study|Suspension of the study for safety reasons|1|||
149969264|NCT02836249|541023671|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
149969265|NCT02836249|541023672|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
149969266|NCT02836249|541023673|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
149969267|NCT02836249|541023674|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
149969268|NCT02836249|541023671|FG000|Open-Label TAF Treatment Phase|Death|0|||
149969269|NCT02836249|541023672|FG001|Open-Label TAF Treatment Phase|Death|0|||
149969270|NCT02836249|541023673|FG002|Open-Label TAF Treatment Phase|Death|1|||
149969271|NCT02836249|541023674|FG003|Open-Label TAF Treatment Phase|Death|0|||
149969272|NCT02836249|541023671|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
149969273|NCT02836249|541023672|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
150046176|NCT00828204|541308083|FG000|Extension Study|Physician Decision|0|||
150176505|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
149901738|NCT00520533|540769940|FG000|Overall Study|Withdrawal by Subject|1|||
149901739|NCT00520533|540769940|FG000|Overall Study|Physician Decision|1|||
149901740|NCT00900159|540769941|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
149969274|NCT02836249|541023673|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
149969275|NCT02836249|541023674|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
150176506|NCT00958633|541782000|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
150176507|NCT00958633|541782001|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
149901741|NCT00900159|540769942|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
149901742|NCT01166438|540769943|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
149901743|NCT01166438|540769944|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
149901744|NCT01166438|540769943|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
149901745|NCT01166438|540769944|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
149901746|NCT01166438|540769943|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
149901747|NCT01166438|540769944|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
149901748|NCT01166438|540769943|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
149901749|NCT01166438|540769944|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
149901750|NCT01166438|540769943|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
149901751|NCT01166438|540769944|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
149901752|NCT01166438|540769943|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
149901753|NCT01166438|540769944|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
149901754|NCT01075256|540769945|FG000|Overall Study|Withdrawal by Subject|1|||
149901755|NCT01075256|540769946|FG001|Overall Study|Withdrawal by Subject|0|||
149901756|NCT01075256|540769947|FG002|Overall Study|Withdrawal by Subject|0|||
149901757|NCT03502070|540769948|FG000|Overall Study|Withdrawal by Subject|1|||
149901758|NCT03502070|540769948|FG000|Overall Study|Screen Failure|1|||
149901759|NCT02654977|540769963|FG000|Overall Study|Death|1|||
149901760|NCT02654977|540769963|FG000|Overall Study|Lost to Follow-up|1|||
149901761|NCT02654977|540769963|FG000|Overall Study|Adverse Event|1|||
149901762|NCT02654977|540769963|FG000|Overall Study|Withdrawal by Subject|1|||
149901763|NCT02654977|540769963|FG000|Overall Study|Lack of Efficacy|3|||
149901764|NCT01266291|540769964|FG000|Overall Study|Adverse Event|1|||
149901765|NCT03232931|540771098|FG000|Overall Study|Physician Decision|1|||
149901766|NCT03232931|540771099|FG001|Overall Study|Physician Decision|1|||
149901767|NCT03232931|540771098|FG000|Overall Study|Withdrawal by Subject|6|||
149901768|NCT03232931|540771099|FG001|Overall Study|Withdrawal by Subject|0|||
149901769|NCT03232931|540771098|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
149901770|NCT03232931|540771099|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
149901771|NCT03232931|540771098|FG000|Overall Study|Parent did not record voice|1|||
149901772|NCT03232931|540771099|FG001|Overall Study|Parent did not record voice|2|||
149901773|NCT03232931|540771098|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
149901774|NCT03232931|540771099|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
149901775|NCT04925557|540771100|FG000|Overall Study|Study closed|5|||
149901776|NCT04925557|540771101|FG001|Overall Study|Study closed|3|||
149901777|NCT05488470|540771102|FG000|Overall Study|Physician Decision|2|||
149901778|NCT05488470|540771102|FG000|Overall Study|Withdrawal by Subject|1|||
149901779|NCT05488470|540771102|FG000|Overall Study|Death|1|||
149901780|NCT00068393|540771107|FG000|Overall Study|Adverse Event|2|||
149901781|NCT00068393|540771107|FG000|Overall Study|Death|3|||
149901782|NCT00068393|540771107|FG000|Overall Study|Withdrawal by Subject|3|||
149901783|NCT00068393|540771107|FG000|Overall Study|Alternative treatment|1|||
149901784|NCT00068393|540771107|FG000|Overall Study|Quality of life worsening|1|||
149901785|NCT01399047|540771108|FG000|Overall Study|Withdrawal by Subject|0|||
149901786|NCT01399047|540771109|FG001|Overall Study|Withdrawal by Subject|1|||
149901787|NCT03652636|540771117|FG000|Overall Study|Withdrawal by Subject|7|||
149901788|NCT01806961|540771122|FG000|Overall Study|sponsor decision|16|||
149901789|NCT00679029|540771125|FG000|Overall Study|Adverse Event|3|||
149901790|NCT00679029|540771125|FG000|Overall Study|Withdrawal by Subject|1|||
149901791|NCT00679029|540771125|FG000|Overall Study|Lost to Follow-up|1|||
149901792|NCT01283334|540771131|FG000|Overall Study|Withdrawal by Subject|1|||
149901793|NCT01283334|540771131|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
149901794|NCT01283334|540771131|FG000|Overall Study|Adverse Event|4|||
149901795|NCT01283334|540771131|FG000|Overall Study|Physician Decision|1|||
149901796|NCT03467217|540771132|FG000|Overall Study|Trial stopped early|5|||
149901797|NCT03467217|540771133|FG001|Overall Study|Trial stopped early|2|||
149901798|NCT03467217|540771132|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
149901799|NCT03467217|540771133|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
149901800|NCT03467217|540771132|FG000|Overall Study|Lost to Follow-up|0|||
149901801|NCT03467217|540771133|FG001|Overall Study|Lost to Follow-up|2|||
149901802|NCT00769067|540771134|FG000|Overall Study|Death|89|||
149901803|NCT00769067|540771135|FG001|Overall Study|Death|86|||
149901804|NCT00769067|540771134|FG000|Overall Study|Lost to Follow-up|3|||
149901805|NCT00769067|540771135|FG001|Overall Study|Lost to Follow-up|1|||
149901806|NCT00769067|540771134|FG000|Overall Study|Study terminated by sponsor|1|||
149901807|NCT00769067|540771135|FG001|Overall Study|Study terminated by sponsor|3|||
149901808|NCT00769067|540771134|FG000|Overall Study|Other|1|||
149901809|NCT00769067|540771135|FG001|Overall Study|Other|3|||
149901810|NCT00769067|540771134|FG000|Overall Study|Withdrawal by Subject|0|||
149901811|NCT00769067|540771135|FG001|Overall Study|Withdrawal by Subject|1|||
149901812|NCT04981470|540771138|FG000|Overall Study|Device failure in all 4 patients|4|||
149901813|NCT04402138|540771139|FG000|Overall Study|Progressive Disease|2|||
149901814|NCT04402138|540771139|FG000|Overall Study|Adverse Event|1|||
149901815|NCT00784238|540771140|FG000|Overall Study|Adverse Event|14|||
149901816|NCT00784238|540771140|FG000|Overall Study|Death|2|||
149901817|NCT00784238|540771140|FG000|Overall Study|Lack of Efficacy|33|||
149901818|NCT00784238|540771140|FG000|Overall Study|Lost to Follow-up|29|||
149901819|NCT00784238|540771140|FG000|Overall Study|Pregnancy|1|||
149901820|NCT00784238|540771140|FG000|Overall Study|Withdrawal by Subject|26|||
149901821|NCT00784238|540771140|FG000|Overall Study|Other|14|||
149901822|NCT04390503|540771141|FG000|Overall Study|Physician Decision|2|||
149901823|NCT04390503|540771142|FG001|Overall Study|Physician Decision|1|||
149901824|NCT04390503|540771141|FG000|Overall Study|Adverse Event|1|||
149901825|NCT04390503|540771142|FG001|Overall Study|Adverse Event|0|||
149901826|NCT03806933|540771143|FG000|Main Period|Physician Decision|0|||
149901827|NCT03806933|540771144|FG001|Main Period|Physician Decision|0|||
149901828|NCT03806933|540771145|FG002|Main Period|Physician Decision|0|||
149901829|NCT03806933|540771146|FG003|Main Period|Physician Decision|1|||
149901830|NCT03806933|540771143|FG000|Main Period|Pregnancy|0|||
149901831|NCT03806933|540771144|FG001|Main Period|Pregnancy|0|||
149901832|NCT03806933|540771145|FG002|Main Period|Pregnancy|1|||
149901833|NCT03806933|540771146|FG003|Main Period|Pregnancy|0|||
149901834|NCT03806933|540771143|FG000|Main Period|Withdrawal by Subject|2|||
149901835|NCT03806933|540771144|FG001|Main Period|Withdrawal by Subject|1|||
149901836|NCT03806933|540771145|FG002|Main Period|Withdrawal by Subject|1|||
149901837|NCT03806933|540771146|FG003|Main Period|Withdrawal by Subject|2|||
149901838|NCT03806933|540771143|FG000|Main Period|Lost to Follow-up|2|||
149901839|NCT03806933|540771144|FG001|Main Period|Lost to Follow-up|2|||
149901840|NCT03806933|540771145|FG002|Main Period|Lost to Follow-up|0|||
149901841|NCT03806933|540771146|FG003|Main Period|Lost to Follow-up|0|||
149901842|NCT03806933|540771143|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
149901843|NCT03806933|540771144|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
149901844|NCT03806933|540771145|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
149901845|NCT03806933|540771146|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
149901846|NCT00078767|540771147|FG000|Overall Study|Withdrawal by Subject|1|||
149901847|NCT00078767|540771148|FG001|Overall Study|Withdrawal by Subject|1|||
149901848|NCT01068730|540771149|FG000|Period 3|Personal reason|1|||
149901849|NCT01068730|540771150|FG001|Period 3|Personal reason|0|||
149901850|NCT01068730|540771151|FG002|Period 3|Personal reason|0|||
149901851|NCT01068730|540771152|FG003|Period 3|Personal reason|0|||
149901852|NCT01068730|540771149|FG000|Period 4|Family emergency|0|||
149901853|NCT01068730|540771150|FG001|Period 4|Family emergency|1|||
149901854|NCT01068730|540771151|FG002|Period 4|Family emergency|0|||
149901855|NCT01068730|540771152|FG003|Period 4|Family emergency|0|||
149901856|NCT03233529|540771155|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
149901857|NCT03233529|540771155|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
149901858|NCT03260244|540771156|FG000|Overall Study|Death|19|||
149901859|NCT03260244|540771156|FG000|Overall Study|Lost to Follow-up|60|||
149901860|NCT03260244|540771156|FG000|Overall Study|Withdrawal by Subject|48|||
149901861|NCT03260244|540771156|FG000|Overall Study|Procedure Not Performed|21|||
149901862|NCT03260244|540771156|FG000|Overall Study|Enrollment Criteria Not Met|31|||
149901863|NCT03260244|540771156|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
149901864|NCT03260244|540771156|FG000|Overall Study|Subject Noncompliance|6|||
149901865|NCT03260244|540771156|FG000|Overall Study|No inducible Arrhythmia|2|||
149901866|NCT03260244|540771156|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
149969276|NCT02836249|541023671|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
149901867|NCT03260244|540771156|FG000|Overall Study|Screen Failure|2|||
149901868|NCT03260244|540771156|FG000|Overall Study|Treated Off Label|69|||
149901869|NCT03260244|540771156|FG000|Overall Study|No Radiofrequency Ablation|14|||
149901870|NCT01177293|540771160|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
149901871|NCT01177293|540771161|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
149901872|NCT00594100|540771168|FG000|Procedure|Technical Failure|9|||
149901873|NCT00594100|540771168|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
149901874|NCT00594100|540771168|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
149901875|NCT00594100|540771168|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
149901876|NCT00956592|540771169|FG000|Overall Study|Protocol Violation|1|||
149901877|NCT00956592|540771170|FG001|Overall Study|Protocol Violation|3|||
149901878|NCT03528369|540771173|FG000|Overall Study|Withdrawal by Subject|2|||
149901879|NCT03528369|540771174|FG001|Overall Study|Withdrawal by Subject|0|||
149901880|NCT03528369|540771175|FG002|Overall Study|Withdrawal by Subject|0|||
149901881|NCT03528369|540771173|FG000|Overall Study|Lost to Follow-up|1|||
149901882|NCT03528369|540771174|FG001|Overall Study|Lost to Follow-up|0|||
149901883|NCT03528369|540771175|FG002|Overall Study|Lost to Follow-up|0|||
149901884|NCT03528369|540771173|FG000|Overall Study|Adverse Event|0|||
149901885|NCT03528369|540771174|FG001|Overall Study|Adverse Event|1|||
149901886|NCT03528369|540771175|FG002|Overall Study|Adverse Event|0|||
149901887|NCT04075682|540771177|FG000|Overall Study|Lost to Follow-up|5|||
149901888|NCT04075682|540771178|FG001|Overall Study|Lost to Follow-up|5|||
149901889|NCT04075682|540771179|FG002|Overall Study|Lost to Follow-up|2|||
149901890|NCT04075682|540771180|FG003|Overall Study|Lost to Follow-up|2|||
149901891|NCT04075682|540771177|FG000|Overall Study|Withdrawal by Subject|1|||
149901892|NCT04075682|540771178|FG001|Overall Study|Withdrawal by Subject|0|||
149901893|NCT04075682|540771179|FG002|Overall Study|Withdrawal by Subject|1|||
149901894|NCT04075682|540771180|FG003|Overall Study|Withdrawal by Subject|0|||
149901895|NCT04075682|540771177|FG000|Overall Study|Protocol Violation|0|||
149901896|NCT04075682|540771178|FG001|Overall Study|Protocol Violation|1|||
149901897|NCT04075682|540771179|FG002|Overall Study|Protocol Violation|1|||
149901898|NCT04075682|540771180|FG003|Overall Study|Protocol Violation|0|||
149901899|NCT04075682|540771177|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
149901900|NCT04075682|540771178|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
149901901|NCT04075682|540771179|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
149901902|NCT04075682|540771180|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
149901903|NCT04075682|540771177|FG000|Overall Study|Lost study phone the first day of study participation|0|||
149901904|NCT04075682|540771178|FG001|Overall Study|Lost study phone the first day of study participation|1|||
149901905|NCT04075682|540771179|FG002|Overall Study|Lost study phone the first day of study participation|0|||
149901906|NCT04075682|540771180|FG003|Overall Study|Lost study phone the first day of study participation|0|||
149901907|NCT02285166|540771183|FG000|Overall Study|Case Report Forms Uncollected|564|||
149901908|NCT02285166|540771183|FG000|Overall Study|Protocol Deviation|402|||
149901909|NCT01421225|540771184|FG000|Overall Study|Withdrawal by Subject|0|||
149901910|NCT01421225|540771185|FG001|Overall Study|Withdrawal by Subject|1|||
149901911|NCT01862250|540771188|FG000|Overall Study|Adverse Event|4|||
150046177|NCT00828204|541308084|FG001|Extension Study|Physician Decision|2|||
150046178|NCT01615029|541308088|FG000|Overall Study|Adverse Event|0|||
150046179|NCT01615029|541308089|FG001|Overall Study|Adverse Event|0|||
150046180|NCT01615029|541308090|FG002|Overall Study|Adverse Event|0|||
150046181|NCT01615029|541308091|FG003|Overall Study|Adverse Event|0|||
150046182|NCT01615029|541308092|FG004|Overall Study|Adverse Event|1|||
150046183|NCT01615029|541308088|FG000|Overall Study|Death|0|||
150046184|NCT01615029|541308089|FG001|Overall Study|Death|0|||
150046185|NCT01615029|541308090|FG002|Overall Study|Death|0|||
150046186|NCT01615029|541308091|FG003|Overall Study|Death|0|||
150046187|NCT01615029|541308092|FG004|Overall Study|Death|1|||
150046188|NCT01615029|541308088|FG000|Overall Study|Lost to Follow-up|0|||
150046189|NCT01615029|541308089|FG001|Overall Study|Lost to Follow-up|0|||
150046190|NCT01615029|541308090|FG002|Overall Study|Lost to Follow-up|0|||
150046191|NCT01615029|541308091|FG003|Overall Study|Lost to Follow-up|0|||
149901912|NCT01028014|540771189|FG000|Overall Study|Lost to Follow-up|1|||
149901913|NCT01028014|540771190|FG001|Overall Study|Lost to Follow-up|2|||
149901914|NCT01028014|540771191|FG002|Overall Study|Lost to Follow-up|0|||
149901915|NCT01028014|540771192|FG003|Overall Study|Lost to Follow-up|1|||
149901916|NCT01028014|540771193|FG004|Overall Study|Lost to Follow-up|1|||
149901917|NCT01028014|540771194|FG005|Overall Study|Lost to Follow-up|2|||
149901918|NCT04087720|540771195|FG000|Overall Study|Withdrawal by Subject|2|||
150046192|NCT01615029|541308092|FG004|Overall Study|Lost to Follow-up|1|||
150046193|NCT01615029|541308088|FG000|Overall Study|Progressive disease|2|||
150046194|NCT01615029|541308089|FG001|Overall Study|Progressive disease|1|||
149901919|NCT04087720|540771195|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
149901920|NCT01218087|540771196|FG000|Overall Study|Death|2|||
150046195|NCT01615029|541308090|FG002|Overall Study|Progressive disease|1|||
150046196|NCT01615029|541308091|FG003|Overall Study|Progressive disease|1|||
150046197|NCT01615029|541308092|FG004|Overall Study|Progressive disease|5|||
150046198|NCT01615029|541308088|FG000|Overall Study|Physician Decision|0|||
150046199|NCT01615029|541308089|FG001|Overall Study|Physician Decision|0|||
150046200|NCT01615029|541308090|FG002|Overall Study|Physician Decision|0|||
150046201|NCT01615029|541308091|FG003|Overall Study|Physician Decision|0|||
149901921|NCT01218087|540771197|FG001|Overall Study|Death|1|||
149901922|NCT01218087|540771196|FG000|Overall Study|Withdrawal by Subject|5|||
149901923|NCT01218087|540771197|FG001|Overall Study|Withdrawal by Subject|0|||
149901924|NCT01218087|540771196|FG000|Overall Study|Transferred|8|||
149901925|NCT01218087|540771197|FG001|Overall Study|Transferred|5|||
149901926|NCT03340454|540771198|FG000|Overall Study|Lost to Follow-up|0|||
149901927|NCT03340454|540771199|FG001|Overall Study|Lost to Follow-up|4|||
149901928|NCT01464164|540771200|FG000|Overall Study|Screen failure|0|||
149901929|NCT01464164|540771201|FG001|Overall Study|Screen failure|1|||
149901930|NCT01464164|540771202|FG002|Overall Study|Screen failure|2|||
149901931|NCT01464164|540771203|FG003|Overall Study|Screen failure|0|||
149901932|NCT01464164|540771204|FG004|Overall Study|Screen failure|0|||
149901933|NCT01464164|540771205|FG005|Overall Study|Screen failure|0|||
149901934|NCT01464164|540771206|FG006|Overall Study|Screen failure|0|||
149901935|NCT01464164|540771200|FG000|Overall Study|Physician Decision|0|||
149901936|NCT01464164|540771201|FG001|Overall Study|Physician Decision|1|||
149901937|NCT01464164|540771202|FG002|Overall Study|Physician Decision|0|||
149901938|NCT01464164|540771203|FG003|Overall Study|Physician Decision|0|||
149901939|NCT01464164|540771204|FG004|Overall Study|Physician Decision|0|||
149901940|NCT01464164|540771205|FG005|Overall Study|Physician Decision|0|||
149901941|NCT01464164|540771206|FG006|Overall Study|Physician Decision|2|||
149901942|NCT02568189|540771207|FG000|Overall Study|Protocol Violation|0|||
149901943|NCT02568189|540771208|FG001|Overall Study|Protocol Violation|0|||
149901944|NCT02568189|540771209|FG002|Overall Study|Protocol Violation|19|||
149901945|NCT02568189|540771210|FG003|Overall Study|Protocol Violation|18|||
149901946|NCT02347813|540771213|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
149901947|NCT02347813|540771214|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
149901948|NCT02347813|540771213|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
149901949|NCT02347813|540771214|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
149901950|NCT03817229|540771215|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
149901951|NCT03817229|540771216|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
149901952|NCT03817229|540771217|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
149901953|NCT03817229|540771218|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
149901954|NCT03817229|540771215|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
149901955|NCT03817229|540771216|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
149901956|NCT03817229|540771217|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
149901957|NCT03817229|540771218|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
149901958|NCT03817229|540771215|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
149901959|NCT03817229|540771216|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
149901960|NCT03817229|540771217|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
149901961|NCT03817229|540771218|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
149901962|NCT03817229|540771215|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
149901963|NCT03817229|540771216|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
149901964|NCT03817229|540771217|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
149901965|NCT03817229|540771218|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
149901966|NCT03817229|540771215|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
149901967|NCT03817229|540771216|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
149901968|NCT03817229|540771217|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
149901969|NCT03817229|540771218|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
149901970|NCT03817229|540771215|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
149901971|NCT03817229|540771216|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
149901972|NCT03817229|540771217|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
149901973|NCT03817229|540771218|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
149901974|NCT03817229|540771215|FG000|Post-Intervention|Withdrawal by Subject|6|||
149901975|NCT03817229|540771216|FG001|Post-Intervention|Withdrawal by Subject|0|||
149901976|NCT03817229|540771217|FG002|Post-Intervention|Withdrawal by Subject|2|||
149901977|NCT03817229|540771218|FG003|Post-Intervention|Withdrawal by Subject|2|||
149969277|NCT02836249|541023672|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
149969278|NCT02836249|541023673|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
149969279|NCT02836249|541023674|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
149901978|NCT03817229|540771215|FG000|Post-Intervention|Withdrawal by Study Team|3|||
149901979|NCT03817229|540771216|FG001|Post-Intervention|Withdrawal by Study Team|1|||
149901980|NCT03817229|540771217|FG002|Post-Intervention|Withdrawal by Study Team|1|||
149901981|NCT03817229|540771218|FG003|Post-Intervention|Withdrawal by Study Team|4|||
149901982|NCT03817229|540771215|FG000|Post-Intervention|Weaned from medication|3|||
149901983|NCT03817229|540771216|FG001|Post-Intervention|Weaned from medication|0|||
149901984|NCT03817229|540771217|FG002|Post-Intervention|Weaned from medication|2|||
149901985|NCT03817229|540771218|FG003|Post-Intervention|Weaned from medication|1|||
149901986|NCT03817229|540771215|FG000|Post-Intervention|Transferred care to another institution|1|||
149901987|NCT03817229|540771216|FG001|Post-Intervention|Transferred care to another institution|0|||
149969280|NCT03605693|541023675|FG000|Overall Study|Lost to Follow-up|4|||
149969281|NCT03605693|541023676|FG001|Overall Study|Lost to Follow-up|0|||
149969282|NCT03605693|541023675|FG000|Overall Study|Physician Decision|1|||
149901988|NCT03817229|540771217|FG002|Post-Intervention|Transferred care to another institution|0|||
149901989|NCT03817229|540771218|FG003|Post-Intervention|Transferred care to another institution|0|||
149901990|NCT03817229|540771215|FG000|Post-Intervention|Change in parental guardianship|0|||
149901991|NCT03817229|540771216|FG001|Post-Intervention|Change in parental guardianship|0|||
149901992|NCT03817229|540771217|FG002|Post-Intervention|Change in parental guardianship|1|||
149901993|NCT03817229|540771218|FG003|Post-Intervention|Change in parental guardianship|0|||
149901994|NCT03817229|540771215|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
149901995|NCT03817229|540771216|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
149901996|NCT03817229|540771217|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
149901997|NCT03817229|540771218|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
149901998|NCT03817229|540771215|FG000|Follow-up 1|Withdrawal by Subject|1|||
149901999|NCT03817229|540771216|FG001|Follow-up 1|Withdrawal by Subject|2|||
149902000|NCT03817229|540771217|FG002|Follow-up 1|Withdrawal by Subject|0|||
149902001|NCT03817229|540771218|FG003|Follow-up 1|Withdrawal by Subject|0|||
149902002|NCT03817229|540771215|FG000|Follow-up 1|Withdrawal by Study Team|3|||
149902003|NCT03817229|540771216|FG001|Follow-up 1|Withdrawal by Study Team|1|||
149969283|NCT03605693|541023676|FG001|Overall Study|Physician Decision|0|||
149969284|NCT04752566|541023677|FG000|Overall Study|Protocol Violation|0|||
149969285|NCT04752566|541023678|FG001|Overall Study|Protocol Violation|1|||
149969286|NCT04752566|541023677|FG000|Overall Study|Death|1|||
149969287|NCT04752566|541023678|FG001|Overall Study|Death|0|||
149969288|NCT04752566|541023677|FG000|Overall Study|Adverse Event|1|||
149969289|NCT04752566|541023678|FG001|Overall Study|Adverse Event|0|||
149969290|NCT04752566|541023677|FG000|Overall Study|Withdrawal by Subject|2|||
149969291|NCT04752566|541023678|FG001|Overall Study|Withdrawal by Subject|0|||
149969292|NCT04752566|541023677|FG000|Overall Study|Physician Decision|1|||
149969293|NCT04752566|541023678|FG001|Overall Study|Physician Decision|1|||
149969294|NCT03331354|541023679|FG000|Overall Study|Withdrawal by Subject|1|||
149969295|NCT03331354|541023680|FG001|Overall Study|Withdrawal by Subject|3|||
149969296|NCT03331354|541023679|FG000|Overall Study|Lost to Follow-up|3|||
149969297|NCT03331354|541023680|FG001|Overall Study|Lost to Follow-up|3|||
149969298|NCT03331354|541023679|FG000|Overall Study|Found employment before initiated active intervention|0|||
149969299|NCT03331354|541023680|FG001|Overall Study|Found employment before initiated active intervention|4|||
149969300|NCT01646827|541023683|FG000|Overall Study|Lost to Follow-up|0|||
149969301|NCT01646827|541023684|FG001|Overall Study|Lost to Follow-up|3|||
149969302|NCT01646827|541023683|FG000|Overall Study|Physician Decision|1|||
149969303|NCT01646827|541023684|FG001|Overall Study|Physician Decision|2|||
149969304|NCT01646827|541023683|FG000|Overall Study|Withdrawal by Subject|1|||
149969305|NCT01646827|541023684|FG001|Overall Study|Withdrawal by Subject|0|||
149969306|NCT05134649|541023685|FG000|Overall Study|Lost to Follow-up|12|||
149969307|NCT05134649|541023685|FG000|Overall Study|Withdrawal by Subject|14|||
149969308|NCT05134649|541023685|FG000|Overall Study|Pregnancy|1|||
149969309|NCT05134649|541023685|FG000|Overall Study|Other, not specified|3|||
149969310|NCT00928668|541023688|FG000|Overall Study|Adverse Event|1|||
149969311|NCT00928668|541023689|FG001|Overall Study|Adverse Event|0|||
149969312|NCT00928668|541023690|FG002|Overall Study|Adverse Event|0|||
149902004|NCT03817229|540771217|FG002|Follow-up 1|Withdrawal by Study Team|0|||
149969313|NCT00928668|541023691|FG003|Overall Study|Adverse Event|0|||
149902005|NCT03817229|540771218|FG003|Follow-up 1|Withdrawal by Study Team|0|||
149902006|NCT03817229|540771215|FG000|Follow-up 1|Wean from medication|3|||
149902007|NCT03817229|540771216|FG001|Follow-up 1|Wean from medication|4|||
149902008|NCT03817229|540771217|FG002|Follow-up 1|Wean from medication|0|||
149902009|NCT03817229|540771218|FG003|Follow-up 1|Wean from medication|1|||
149902010|NCT03817229|540771215|FG000|Follow-up 1|Transferred care to another hospital|1|||
149902011|NCT03817229|540771216|FG001|Follow-up 1|Transferred care to another hospital|0|||
149902012|NCT03817229|540771217|FG002|Follow-up 1|Transferred care to another hospital|0|||
149902013|NCT03817229|540771218|FG003|Follow-up 1|Transferred care to another hospital|0|||
149902014|NCT03817229|540771215|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
149902015|NCT03817229|540771216|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
149902016|NCT03817229|540771217|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
149902017|NCT03817229|540771218|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
149902018|NCT03817229|540771215|FG000|Follow-up 2|Withdrawal by Subject|2|||
149902019|NCT03817229|540771216|FG001|Follow-up 2|Withdrawal by Subject|0|||
149902020|NCT03817229|540771217|FG002|Follow-up 2|Withdrawal by Subject|1|||
149902021|NCT03817229|540771218|FG003|Follow-up 2|Withdrawal by Subject|1|||
149902022|NCT03817229|540771215|FG000|Follow-up 2|Withdrawal by Study Team|2|||
149902023|NCT03817229|540771216|FG001|Follow-up 2|Withdrawal by Study Team|0|||
149902024|NCT03817229|540771217|FG002|Follow-up 2|Withdrawal by Study Team|1|||
149902025|NCT03817229|540771218|FG003|Follow-up 2|Withdrawal by Study Team|0|||
149902026|NCT03817229|540771215|FG000|Follow-up 2|Wean from medication|1|||
149902027|NCT03817229|540771216|FG001|Follow-up 2|Wean from medication|0|||
149902028|NCT03817229|540771217|FG002|Follow-up 2|Wean from medication|0|||
149902029|NCT03817229|540771218|FG003|Follow-up 2|Wean from medication|0|||
149902030|NCT03817229|540771215|FG000|Follow-up 2|Transferred care|0|||
149902031|NCT03817229|540771216|FG001|Follow-up 2|Transferred care|0|||
149902032|NCT03817229|540771217|FG002|Follow-up 2|Transferred care|1|||
149902033|NCT03817229|540771218|FG003|Follow-up 2|Transferred care|0|||
149902034|NCT01186692|540771219|FG000|Overall Study|Not Catheterized|11|||
150046202|NCT01615029|541308092|FG004|Overall Study|Physician Decision|1|||
150046203|NCT01615029|541308088|FG000|Overall Study|Ongoing|1|||
149902035|NCT01186692|540771219|FG000|Overall Study|Futher testing contraindicated implant|19|||
149902036|NCT01186692|540771219|FG000|Overall Study|Adverse Event|2|||
149902037|NCT03319732|540771220|FG000|Overall Study|Adverse Event|40|||
149902038|NCT03319732|540771220|FG000|Overall Study|Withdrawal by Subject|50|||
150046204|NCT01615029|541308089|FG001|Overall Study|Ongoing|2|||
149902039|NCT03319732|540771220|FG000|Overall Study|MS relapse|10|||
149902040|NCT03319732|540771220|FG000|Overall Study|reason not specified|5|||
149902041|NCT01736397|540772706|FG000|Overall Study|Lack of Efficacy|1|||
149902042|NCT01736397|540772707|FG001|Overall Study|Lack of Efficacy|11|||
149902043|NCT01736397|540772706|FG000|Overall Study|Withdrawal by Subject|6|||
149902044|NCT01736397|540772707|FG001|Overall Study|Withdrawal by Subject|5|||
149902045|NCT01736397|540772706|FG000|Overall Study|Lost to Follow-up|0|||
149902046|NCT01736397|540772707|FG001|Overall Study|Lost to Follow-up|1|||
149902047|NCT01736397|540772706|FG000|Overall Study|Adverse Event|6|||
149902048|NCT01736397|540772707|FG001|Overall Study|Adverse Event|3|||
149902049|NCT01736397|540772706|FG000|Overall Study|Not stated|1|||
149902050|NCT01736397|540772707|FG001|Overall Study|Not stated|4|||
149902051|NCT05088603|540772708|FG000|Overall Study|Protocol Violation|6|||
149902052|NCT05088603|540772709|FG001|Overall Study|Protocol Violation|1|||
149902053|NCT01868438|540772712|FG000|First Intervention|Withdrawal by Subject|5|||
149902054|NCT01868438|540772713|FG001|First Intervention|Withdrawal by Subject|1|||
149902055|NCT01868438|540772712|FG000|First Intervention|Lost to Follow-up|2|||
149902056|NCT01868438|540772713|FG001|First Intervention|Lost to Follow-up|3|||
149902057|NCT01868438|540772712|FG000|First Intervention|Meeting the non-redosing criteria|0|||
149902058|NCT01868438|540772713|FG001|First Intervention|Meeting the non-redosing criteria|1|||
149902059|NCT01868438|540772712|FG000|Second Intervention|Adverse Event|3|||
149902060|NCT01868438|540772713|FG001|Second Intervention|Adverse Event|3|||
149902061|NCT03555565|540772714|FG000|Overall Study|Case Report Forms Uncollected|2|||
149902062|NCT03555565|540772714|FG000|Overall Study|Protocol Deviation|13|||
149902063|NCT00379080|540772717|FG000|Overall Study|Withdrawal by Subject|0|||
149902064|NCT00379080|540772718|FG001|Overall Study|Withdrawal by Subject|4|||
149902065|NCT00379080|540772719|FG002|Overall Study|Withdrawal by Subject|0|||
149902066|NCT01222520|540772720|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
149902067|NCT01222520|540772721|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
149902068|NCT01222520|540772720|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
149902069|NCT01222520|540772721|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
149902070|NCT01222520|540772720|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
149902071|NCT01222520|540772721|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
149902072|NCT01222520|540772720|FG000|Double-blind Period|Adverse Event|0|||
149902073|NCT01222520|540772721|FG001|Double-blind Period|Adverse Event|1|||
149902074|NCT01222520|540772720|FG000|Double-blind Period|Lack of Efficacy|0|||
149902075|NCT01222520|540772721|FG001|Double-blind Period|Lack of Efficacy|1|||
149902076|NCT01222520|540772720|FG000|Double-blind Period|Study medication stolen|1|||
149902077|NCT01222520|540772721|FG001|Double-blind Period|Study medication stolen|0|||
149902078|NCT00955955|540772724|FG000|Overall Study|Lost to Follow-up|2|||
149902079|NCT00955955|540772725|FG001|Overall Study|Lost to Follow-up|0|||
149902080|NCT00955955|540772726|FG002|Overall Study|Lost to Follow-up|0|||
149902081|NCT03348930|540772727|FG000|Washout (1 Week)|Lost to Follow-up|1|||
149902082|NCT03348930|540772728|FG001|Washout (1 Week)|Lost to Follow-up|1|||
149902083|NCT02920008|540772729|FG000|Overall Study|Death|117|||
149902084|NCT02920008|540772730|FG001|Overall Study|Death|127|||
149902085|NCT02920008|540772729|FG000|Overall Study|Withdrawal by Subject|3|||
149902086|NCT02920008|540772730|FG001|Overall Study|Withdrawal by Subject|6|||
149902087|NCT02920008|540772729|FG000|Overall Study|Lost to Follow-up|0|||
149902088|NCT02920008|540772730|FG001|Overall Study|Lost to Follow-up|1|||
149902089|NCT04590586|540772731|FG000|Overall Study|Death|7|||
149902090|NCT04590586|540772732|FG001|Overall Study|Death|1|||
149902091|NCT04590586|540772733|FG002|Overall Study|Death|37|||
149902092|NCT04590586|540772734|FG003|Overall Study|Death|34|||
149902093|NCT04590586|540772735|FG004|Overall Study|Death|19|||
149902094|NCT04590586|540772736|FG005|Overall Study|Death|3|||
149902095|NCT04590586|540772731|FG000|Overall Study|Lost to Follow-up|3|||
149902096|NCT04590586|540772732|FG001|Overall Study|Lost to Follow-up|0|||
149902097|NCT04590586|540772733|FG002|Overall Study|Lost to Follow-up|11|||
149902098|NCT04590586|540772734|FG003|Overall Study|Lost to Follow-up|11|||
149969314|NCT00928668|541023692|FG004|Overall Study|Adverse Event|0|||
149902099|NCT04590586|540772735|FG004|Overall Study|Lost to Follow-up|6|||
149969315|NCT00928668|541023688|FG000|Overall Study|Protocol Violation|0|||
149969316|NCT00928668|541023689|FG001|Overall Study|Protocol Violation|0|||
149902100|NCT04590586|540772736|FG005|Overall Study|Lost to Follow-up|0|||
149902101|NCT04590586|540772731|FG000|Overall Study|Withdrawal by Subject|0|||
149902102|NCT04590586|540772732|FG001|Overall Study|Withdrawal by Subject|0|||
149902103|NCT04590586|540772733|FG002|Overall Study|Withdrawal by Subject|6|||
149902104|NCT04590586|540772734|FG003|Overall Study|Withdrawal by Subject|0|||
149969317|NCT00928668|541023690|FG002|Overall Study|Protocol Violation|0|||
149902105|NCT04590586|540772735|FG004|Overall Study|Withdrawal by Subject|3|||
149969318|NCT00928668|541023691|FG003|Overall Study|Protocol Violation|0|||
149902106|NCT04590586|540772736|FG005|Overall Study|Withdrawal by Subject|0|||
149902107|NCT04590586|540772731|FG000|Overall Study|Other|3|||
149902108|NCT04590586|540772732|FG001|Overall Study|Other|0|||
149902109|NCT04590586|540772733|FG002|Overall Study|Other|1|||
149902110|NCT04590586|540772734|FG003|Overall Study|Other|1|||
149902111|NCT04590586|540772735|FG004|Overall Study|Other|2|||
149902112|NCT04590586|540772736|FG005|Overall Study|Other|1|||
149902113|NCT02751450|540772739|FG000|Overall Study|Adverse Event|1|||
149902114|NCT02751450|540772740|FG001|Overall Study|Adverse Event|0|||
149902115|NCT01598090|540772741|FG000|Treatment Period|Poor/non-compliance|0|||
149902116|NCT01598090|540772742|FG001|Treatment Period|Poor/non-compliance|2|||
149902117|NCT01598090|540772743|FG002|Treatment Period|Poor/non-compliance|0|||
149902118|NCT01598090|540772741|FG000|Treatment Period|No longer meet study criteria|0|||
149902119|NCT01598090|540772742|FG001|Treatment Period|No longer meet study criteria|1|||
149902120|NCT01598090|540772743|FG002|Treatment Period|No longer meet study criteria|0|||
149902121|NCT01598090|540772741|FG000|Treatment Period|Lack of Efficacy|5|||
149902122|NCT01598090|540772742|FG001|Treatment Period|Lack of Efficacy|14|||
149902123|NCT01598090|540772743|FG002|Treatment Period|Lack of Efficacy|6|||
149902124|NCT01598090|540772741|FG000|Treatment Period|Adverse Event|2|||
149902125|NCT01598090|540772742|FG001|Treatment Period|Adverse Event|33|||
149902126|NCT01598090|540772743|FG002|Treatment Period|Adverse Event|17|||
149902127|NCT01598090|540772741|FG000|Treatment Period|Other reasons|0|||
149902128|NCT01598090|540772742|FG001|Treatment Period|Other reasons|4|||
149902129|NCT01598090|540772743|FG002|Treatment Period|Other reasons|1|||
149902130|NCT01598090|540772741|FG000|Treatment Period|Withdrawal by Subject|3|||
149902131|NCT01598090|540772742|FG001|Treatment Period|Withdrawal by Subject|13|||
149902132|NCT01598090|540772743|FG002|Treatment Period|Withdrawal by Subject|10|||
149902133|NCT01598090|540772741|FG000|Treatment Period|Lost to Follow-up|1|||
149902134|NCT01598090|540772742|FG001|Treatment Period|Lost to Follow-up|5|||
149902135|NCT01598090|540772743|FG002|Treatment Period|Lost to Follow-up|1|||
149902136|NCT01598090|540772741|FG000|Follow-up Period|Death|0|||
149902137|NCT01598090|540772742|FG001|Follow-up Period|Death|1|||
149902138|NCT01598090|540772743|FG002|Follow-up Period|Death|0|||
149902139|NCT01598090|540772741|FG000|Follow-up Period|No longer required per protocol|1|||
149902140|NCT01598090|540772742|FG001|Follow-up Period|No longer required per protocol|3|||
149902141|NCT01598090|540772743|FG002|Follow-up Period|No longer required per protocol|2|||
149902142|NCT01598090|540772741|FG000|Follow-up Period|Not reported|0|||
149902143|NCT01598090|540772742|FG001|Follow-up Period|Not reported|10|||
149902144|NCT01598090|540772743|FG002|Follow-up Period|Not reported|4|||
149902145|NCT01598090|540772741|FG000|Follow-up Period|Withdrawal by Subject|0|||
149902146|NCT01598090|540772742|FG001|Follow-up Period|Withdrawal by Subject|3|||
149902147|NCT01598090|540772743|FG002|Follow-up Period|Withdrawal by Subject|2|||
149902148|NCT01598090|540772741|FG000|Follow-up Period|Other reasons|2|||
149902149|NCT01598090|540772742|FG001|Follow-up Period|Other reasons|8|||
149902150|NCT01598090|540772743|FG002|Follow-up Period|Other reasons|8|||
149902151|NCT01598090|540772741|FG000|Follow-up Period|Lost to Follow-up|2|||
149902152|NCT01598090|540772742|FG001|Follow-up Period|Lost to Follow-up|10|||
149902153|NCT01598090|540772743|FG002|Follow-up Period|Lost to Follow-up|12|||
149902154|NCT02587598|540772744|FG000|Overall Study|Death|4|||
149902155|NCT02587598|540772745|FG001|Overall Study|Death|8|||
149902156|NCT02587598|540772746|FG002|Overall Study|Death|4|||
149902157|NCT02587598|540772747|FG003|Overall Study|Death|16|||
149902158|NCT02587598|540772748|FG004|Overall Study|Death|9|||
149902159|NCT02587598|540772749|FG005|Overall Study|Death|4|||
149902160|NCT02587598|540772750|FG006|Overall Study|Death|6|||
149902161|NCT02587598|540772751|FG007|Overall Study|Death|7|||
149902162|NCT02587598|540772752|FG008|Overall Study|Death|9|||
149902163|NCT02587598|540772753|FG009|Overall Study|Death|1|||
149902164|NCT02587598|540772754|FG010|Overall Study|Death|3|||
149902165|NCT02587598|540772744|FG000|Overall Study|Study Terminated by the Sponsor|0|||
150176508|NCT00958633|541782002|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
150176509|NCT00958633|541782000|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
150176510|NCT00958633|541782001|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
149902166|NCT02587598|540772745|FG001|Overall Study|Study Terminated by the Sponsor|1|||
149902167|NCT02587598|540772746|FG002|Overall Study|Study Terminated by the Sponsor|0|||
149902168|NCT02587598|540772747|FG003|Overall Study|Study Terminated by the Sponsor|3|||
149902169|NCT02587598|540772748|FG004|Overall Study|Study Terminated by the Sponsor|0|||
149902170|NCT02587598|540772749|FG005|Overall Study|Study Terminated by the Sponsor|1|||
149902171|NCT02587598|540772750|FG006|Overall Study|Study Terminated by the Sponsor|0|||
149902172|NCT02587598|540772751|FG007|Overall Study|Study Terminated by the Sponsor|0|||
149902173|NCT02587598|540772752|FG008|Overall Study|Study Terminated by the Sponsor|0|||
149902174|NCT02587598|540772753|FG009|Overall Study|Study Terminated by the Sponsor|1|||
149902175|NCT02587598|540772754|FG010|Overall Study|Study Terminated by the Sponsor|6|||
149902176|NCT02587598|540772744|FG000|Overall Study|Reason for study withdrawal not specified|0|||
149902177|NCT02587598|540772745|FG001|Overall Study|Reason for study withdrawal not specified|1|||
149902178|NCT02587598|540772746|FG002|Overall Study|Reason for study withdrawal not specified|0|||
149902179|NCT02587598|540772747|FG003|Overall Study|Reason for study withdrawal not specified|0|||
149902180|NCT02587598|540772748|FG004|Overall Study|Reason for study withdrawal not specified|0|||
149902181|NCT02587598|540772749|FG005|Overall Study|Reason for study withdrawal not specified|0|||
149902182|NCT02587598|540772750|FG006|Overall Study|Reason for study withdrawal not specified|0|||
149902183|NCT02587598|540772751|FG007|Overall Study|Reason for study withdrawal not specified|0|||
149902184|NCT02587598|540772752|FG008|Overall Study|Reason for study withdrawal not specified|0|||
149902185|NCT02587598|540772753|FG009|Overall Study|Reason for study withdrawal not specified|0|||
149902186|NCT02587598|540772754|FG010|Overall Study|Reason for study withdrawal not specified|0|||
149902187|NCT02587598|540772744|FG000|Overall Study|Withdrawal by Subject|0|||
149902188|NCT02587598|540772745|FG001|Overall Study|Withdrawal by Subject|1|||
149902189|NCT02587598|540772746|FG002|Overall Study|Withdrawal by Subject|0|||
149902190|NCT02587598|540772747|FG003|Overall Study|Withdrawal by Subject|2|||
149902191|NCT02587598|540772748|FG004|Overall Study|Withdrawal by Subject|3|||
149902192|NCT02587598|540772749|FG005|Overall Study|Withdrawal by Subject|1|||
149902193|NCT02587598|540772750|FG006|Overall Study|Withdrawal by Subject|0|||
149902194|NCT02587598|540772751|FG007|Overall Study|Withdrawal by Subject|0|||
149902195|NCT02587598|540772752|FG008|Overall Study|Withdrawal by Subject|0|||
149902196|NCT02587598|540772753|FG009|Overall Study|Withdrawal by Subject|1|||
149902197|NCT02587598|540772754|FG010|Overall Study|Withdrawal by Subject|2|||
149902198|NCT02587598|540772744|FG000|Overall Study|Physician Decision|0|||
149902199|NCT02587598|540772745|FG001|Overall Study|Physician Decision|0|||
149902200|NCT02587598|540772746|FG002|Overall Study|Physician Decision|0|||
149902201|NCT02587598|540772747|FG003|Overall Study|Physician Decision|0|||
149902202|NCT02587598|540772748|FG004|Overall Study|Physician Decision|0|||
149902203|NCT02587598|540772749|FG005|Overall Study|Physician Decision|0|||
149902204|NCT02587598|540772750|FG006|Overall Study|Physician Decision|0|||
149902205|NCT02587598|540772751|FG007|Overall Study|Physician Decision|0|||
149902206|NCT02587598|540772752|FG008|Overall Study|Physician Decision|0|||
149902207|NCT02587598|540772753|FG009|Overall Study|Physician Decision|0|||
149902208|NCT02587598|540772754|FG010|Overall Study|Physician Decision|3|||
149902209|NCT00791661|540772757|FG000|7 Day Wash-out|Adverse Event|0|||
149902210|NCT00791661|540772758|FG001|7 Day Wash-out|Adverse Event|0|||
149902211|NCT00791661|540772759|FG002|7 Day Wash-out|Adverse Event|1|||
149902212|NCT00791661|540772757|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
149902213|NCT00791661|540772758|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
149902214|NCT00791661|540772759|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
149902215|NCT03605862|540772760|FG000|Overall Study|Withdrawal by Subject|12|||
149902216|NCT03605862|540772761|FG001|Overall Study|Withdrawal by Subject|9|||
149902217|NCT03605862|540772760|FG000|Overall Study|Adverse Event|2|||
149902218|NCT03605862|540772761|FG001|Overall Study|Adverse Event|1|||
149902219|NCT03605862|540772760|FG000|Overall Study|Physician Decision|3|||
149902220|NCT03605862|540772761|FG001|Overall Study|Physician Decision|1|||
149902221|NCT03605862|540772760|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
149902222|NCT03605862|540772761|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
149902223|NCT00679289|540772762|FG000|Overall Study|Progressive disease|4|||
149902224|NCT00679289|540772763|FG001|Overall Study|Progressive disease|5|||
149902225|NCT00679289|540772764|FG002|Overall Study|Progressive disease|18|||
149902226|NCT00679289|540772762|FG000|Overall Study|Withdrawal by Subject|0|||
149902227|NCT00679289|540772763|FG001|Overall Study|Withdrawal by Subject|1|||
149902228|NCT00679289|540772764|FG002|Overall Study|Withdrawal by Subject|1|||
149902229|NCT00679289|540772762|FG000|Overall Study|Adverse Event|0|||
149902230|NCT00679289|540772763|FG001|Overall Study|Adverse Event|0|||
149902231|NCT00679289|540772764|FG002|Overall Study|Adverse Event|3|||
149902232|NCT00679289|540772762|FG000|Overall Study|Physician Decision|1|||
149902233|NCT00679289|540772763|FG001|Overall Study|Physician Decision|0|||
149902234|NCT00679289|540772764|FG002|Overall Study|Physician Decision|1|||
149902235|NCT00937040|540772765|FG000|Overall Study|Adverse Event|5|||
149902236|NCT00937040|540772766|FG001|Overall Study|Adverse Event|8|||
149902237|NCT00937040|540772765|FG000|Overall Study|Lost to Follow-up|12|||
149902238|NCT00937040|540772766|FG001|Overall Study|Lost to Follow-up|12|||
149902239|NCT00937040|540772765|FG000|Overall Study|Protocol Violation|3|||
149902240|NCT00937040|540772766|FG001|Overall Study|Protocol Violation|0|||
149902241|NCT00937040|540772765|FG000|Overall Study|Withdrawal by Subject|13|||
149969319|NCT00928668|541023692|FG004|Overall Study|Protocol Violation|1|||
149969320|NCT00928668|541023688|FG000|Overall Study|Withdrawal by Subject|0|||
149969321|NCT00928668|541023689|FG001|Overall Study|Withdrawal by Subject|1|||
149969322|NCT00928668|541023690|FG002|Overall Study|Withdrawal by Subject|1|||
149969323|NCT00928668|541023691|FG003|Overall Study|Withdrawal by Subject|0|||
149902242|NCT00937040|540772766|FG001|Overall Study|Withdrawal by Subject|7|||
149902243|NCT00937040|540772765|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
149902244|NCT00937040|540772766|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
149902245|NCT00937040|540772765|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
149902246|NCT00937040|540772766|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
149969324|NCT00928668|541023692|FG004|Overall Study|Withdrawal by Subject|0|||
149969325|NCT00928668|541023688|FG000|Overall Study|Other reasons not listed above|0|||
149969326|NCT00928668|541023689|FG001|Overall Study|Other reasons not listed above|0|||
149969327|NCT00928668|541023690|FG002|Overall Study|Other reasons not listed above|0|||
149902247|NCT02858583|540772769|FG000|Overall Study|Declined consent|1|||
149902248|NCT02858583|540772770|FG001|Overall Study|Declined consent|1|||
149902249|NCT03170362|540772771|FG000|Overall Study|Death|2|||
149902250|NCT03170362|540772772|FG001|Overall Study|Death|2|||
149902251|NCT03170362|540772771|FG000|Overall Study|Withdrawal by Subject|23|||
149902252|NCT03170362|540772772|FG001|Overall Study|Withdrawal by Subject|22|||
149902253|NCT03170362|540772771|FG000|Overall Study|Lost to Follow-up|187|||
149902254|NCT03170362|540772772|FG001|Overall Study|Lost to Follow-up|167|||
149902255|NCT01972438|540772773|FG000|Baseline-Month 3 Crossover Period|Death|1|||
149902256|NCT01972438|540772774|FG001|Baseline-Month 3 Crossover Period|Death|0|||
149902257|NCT01972438|540772773|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
149902258|NCT01972438|540772774|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
149902259|NCT01972438|540772773|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
149902260|NCT01972438|540772774|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
149902261|NCT01972438|540772773|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
149902262|NCT01972438|540772774|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
149902263|NCT01972438|540772773|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
149902264|NCT01972438|540772774|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
149902265|NCT01972438|540772773|FG000|Months 6-12 Study Period|Death|1|||
149902266|NCT01972438|540772774|FG001|Months 6-12 Study Period|Death|0|||
149902267|NCT01972438|540772773|FG000|Months 6-12 Study Period|Early Study Closure|2|||
149902268|NCT01972438|540772774|FG001|Months 6-12 Study Period|Early Study Closure|2|||
149902269|NCT01972438|540772773|FG000|Post Month 12 Study Period|Early Study Closure|3|||
149902270|NCT01972438|540772774|FG001|Post Month 12 Study Period|Early Study Closure|4|||
149902271|NCT01052480|540772780|FG000|Overall Study|Lost to Follow-up|3|||
149902272|NCT01052480|540772781|FG001|Overall Study|Lost to Follow-up|3|||
149902273|NCT01052480|540772780|FG000|Overall Study|Protocol Violation|1|||
149902274|NCT01052480|540772781|FG001|Overall Study|Protocol Violation|0|||
149902275|NCT01052480|540772780|FG000|Overall Study|Withdrawal by Subject|3|||
149902276|NCT01052480|540772781|FG001|Overall Study|Withdrawal by Subject|7|||
149902277|NCT01052480|540772780|FG000|Overall Study|Physician Decision|0|||
149902278|NCT01052480|540772781|FG001|Overall Study|Physician Decision|2|||
149902279|NCT01052480|540772780|FG000|Overall Study|Death|1|||
149902280|NCT01052480|540772781|FG001|Overall Study|Death|5|||
149902281|NCT02157376|540772782|FG000|Overall Study|Death|10|||
149902282|NCT02157376|540772783|FG001|Overall Study|Death|4|||
149902283|NCT02157376|540772782|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149902284|NCT02157376|540772783|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149902285|NCT02157376|540772782|FG000|Overall Study|Withdrawal by Subject|3|||
149902286|NCT02157376|540772783|FG001|Overall Study|Withdrawal by Subject|8|||
149902287|NCT02157376|540772782|FG000|Overall Study|Not treated|8|||
149902288|NCT02157376|540772783|FG001|Overall Study|Not treated|3|||
149902289|NCT02157376|540772782|FG000|Overall Study|Investigator's misjudgement|1|||
149902290|NCT02157376|540772783|FG001|Overall Study|Investigator's misjudgement|2|||
149902291|NCT00529373|540772784|FG000|Base Study|Adverse Event|525|||
149902292|NCT00529373|540772785|FG001|Base Study|Adverse Event|470|||
149902293|NCT00529373|540772784|FG000|Base Study|Lack of Efficacy|16|||
149902294|NCT00529373|540772785|FG001|Base Study|Lack of Efficacy|75|||
149902295|NCT00529373|540772784|FG000|Base Study|Lost to Follow-up|221|||
149902296|NCT00529373|540772785|FG001|Base Study|Lost to Follow-up|208|||
149902297|NCT00529373|540772784|FG000|Base Study|Other Protocol Specified Criteria|19|||
149902298|NCT00529373|540772785|FG001|Base Study|Other Protocol Specified Criteria|20|||
149902299|NCT00529373|540772784|FG000|Base Study|Physician Decision|60|||
149902300|NCT00529373|540772785|FG001|Base Study|Physician Decision|52|||
149902301|NCT00529373|540772784|FG000|Base Study|Protocol Violation|48|||
149902302|NCT00529373|540772785|FG001|Base Study|Protocol Violation|38|||
149902303|NCT00529373|540772784|FG000|Base Study|Withdrawal by Subject|1062|||
149902304|NCT00529373|540772785|FG001|Base Study|Withdrawal by Subject|967|||
149902305|NCT00529373|540772784|FG000|Base Study|Did not continue into Extension|1795|||
149902306|NCT00529373|540772785|FG001|Base Study|Did not continue into Extension|2238|||
149902307|NCT00529373|540772784|FG000|First Extension Study|Adverse Event|162|||
149902308|NCT00529373|540772785|FG001|First Extension Study|Adverse Event|142|||
149902309|NCT00529373|540772784|FG000|First Extension Study|Lack of Efficacy|65|||
149902310|NCT00529373|540772785|FG001|First Extension Study|Lack of Efficacy|427|||
149902311|NCT00529373|540772784|FG000|First Extension Study|Lost to Follow-up|41|||
149902312|NCT00529373|540772785|FG001|First Extension Study|Lost to Follow-up|37|||
149902313|NCT00529373|540772784|FG000|First Extension Study|Other|27|||
149902314|NCT00529373|540772785|FG001|First Extension Study|Other|47|||
149902315|NCT00529373|540772784|FG000|First Extension Study|Physician Decision|50|||
149902316|NCT00529373|540772785|FG001|First Extension Study|Physician Decision|45|||
149902317|NCT00529373|540772784|FG000|First Extension Study|Protocol Violation|16|||
149902318|NCT00529373|540772785|FG001|First Extension Study|Protocol Violation|13|||
149902319|NCT00529373|540772784|FG000|First Extension Study|Withdrawal by Subject|296|||
149902320|NCT00529373|540772785|FG001|First Extension Study|Withdrawal by Subject|287|||
149902321|NCT00529373|540772784|FG000|First Extension Study|Disposition record non-existing|0|||
149902322|NCT00529373|540772785|FG001|First Extension Study|Disposition record non-existing|1|||
149902323|NCT00529373|540772784|FG000|First Extension Study|Discontinued after 5 years completion|208|||
149902324|NCT00529373|540772785|FG001|First Extension Study|Discontinued after 5 years completion|346|||
149902325|NCT00529373|540772784|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
149902326|NCT00529373|540772785|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
149902327|NCT00529373|540772784|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
149902328|NCT00529373|540772785|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
149902329|NCT00529373|540772784|FG000|Second Extension Study|Adverse Event|101|||
149902330|NCT00529373|540772785|FG001|Second Extension Study|Adverse Event|51|||
149902331|NCT00529373|540772784|FG000|Second Extension Study|Lack of Efficacy|7|||
149902332|NCT00529373|540772785|FG001|Second Extension Study|Lack of Efficacy|15|||
149902333|NCT00529373|540772784|FG000|Second Extension Study|Lost to Follow-up|18|||
149902334|NCT00529373|540772785|FG001|Second Extension Study|Lost to Follow-up|12|||
149902335|NCT00529373|540772784|FG000|Second Extension Study|Other|7|||
149902336|NCT00529373|540772785|FG001|Second Extension Study|Other|12|||
149902337|NCT00529373|540772784|FG000|Second Extension Study|Physician Decision|63|||
149902338|NCT00529373|540772785|FG001|Second Extension Study|Physician Decision|26|||
149902339|NCT00529373|540772784|FG000|Second Extension Study|Protocol Violation|2|||
149902340|NCT00529373|540772785|FG001|Second Extension Study|Protocol Violation|1|||
149902341|NCT00529373|540772784|FG000|Second Extension Study|Withdrawal by Subject|97|||
149902342|NCT00529373|540772785|FG001|Second Extension Study|Withdrawal by Subject|75|||
149902343|NCT00529373|540772784|FG000|Second Extension Study|Status Missing|5|||
149902344|NCT00529373|540772785|FG001|Second Extension Study|Status Missing|5|||
149902345|NCT01074268|540772792|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
149902346|NCT01074268|540772793|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
149902347|NCT01074268|540772792|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
149902348|NCT01074268|540772793|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
149902349|NCT01074268|540772792|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
149902350|NCT01074268|540772793|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
149902351|NCT01074268|540772792|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
149902352|NCT01074268|540772793|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
149902353|NCT01074268|540772792|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
149902354|NCT01074268|540772793|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
149902355|NCT01074268|540772792|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
149902356|NCT01074268|540772793|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
149902357|NCT01074268|540772792|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
149902358|NCT01074268|540772793|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
149902359|NCT01074268|540772792|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
149902360|NCT01074268|540772793|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
149902361|NCT01074268|540772792|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
149902362|NCT01074268|540772793|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
149902363|NCT00603473|540772794|FG000|Overall Study|Adverse Event|4|||
149902364|NCT00603473|540772794|FG000|Overall Study|Lack of Efficacy|4|||
149902365|NCT00603473|540772794|FG000|Overall Study|Protocol Violation|1|||
149902366|NCT04200651|540772795|FG000|Overall Study|Moved to another country during follow-up|2|||
149902367|NCT04200651|540772796|FG001|Overall Study|Moved to another country during follow-up|2|||
149902368|NCT04200651|540772795|FG000|Overall Study|Lost to Follow-up|1|||
149902369|NCT04200651|540772796|FG001|Overall Study|Lost to Follow-up|3|||
149902370|NCT00733421|540772800|FG000|Overall Study|Withdrawal by Subject|1|||
149902371|NCT00733421|540772801|FG001|Overall Study|Withdrawal by Subject|1|||
149902372|NCT02547220|540772802|FG000|Overall Study|Withdrawal by Subject|1|||
149902373|NCT02547220|540772803|FG001|Overall Study|Withdrawal by Subject|0|||
149902374|NCT02547220|540772802|FG000|Overall Study|Study terminated by sponsor|18|||
149902375|NCT02547220|540772803|FG001|Overall Study|Study terminated by sponsor|20|||
149902376|NCT04185220|540772804|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
149902377|NCT04185220|540772805|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
149902378|NCT04185220|540772804|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
149902379|NCT04185220|540772805|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
149902380|NCT02887183|540772810|FG000|Overall Study|Adverse Event|44|||
149902381|NCT02887183|540772810|FG000|Overall Study|Death|30|||
149902382|NCT02887183|540772810|FG000|Overall Study|Pregnancy|1|||
149902383|NCT02887183|540772810|FG000|Overall Study|Protocol Violation|6|||
149902384|NCT02887183|540772810|FG000|Overall Study|Technical Problems|2|||
149902385|NCT02887183|540772810|FG000|Overall Study|Lost to Follow-up|13|||
149902386|NCT02887183|540772810|FG000|Overall Study|Physician Decision|10|||
149902387|NCT02887183|540772810|FG000|Overall Study|Withdrawal by Subject|35|||
149902388|NCT01031680|540772811|FG000|Overall Study|Adverse Event|8|||
149902389|NCT01031680|540772812|FG001|Overall Study|Adverse Event|3|||
149902390|NCT01031680|540772811|FG000|Overall Study|Lost to Follow-up|2|||
149902391|NCT01031680|540772812|FG001|Overall Study|Lost to Follow-up|10|||
149902392|NCT01031680|540772811|FG000|Overall Study|Withdrawal by Subject|12|||
149902393|NCT01031680|540772812|FG001|Overall Study|Withdrawal by Subject|16|||
149902394|NCT01031680|540772811|FG000|Overall Study|Death|2|||
149902395|NCT01031680|540772812|FG001|Overall Study|Death|1|||
149902396|NCT01031680|540772811|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
149902397|NCT01031680|540772812|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
149902398|NCT01031680|540772811|FG000|Overall Study|Poor/Non-compliance|5|||
149902399|NCT01031680|540772812|FG001|Overall Study|Poor/Non-compliance|6|||
149902400|NCT01031680|540772811|FG000|Overall Study|Safety|1|||
149902401|NCT01031680|540772812|FG001|Overall Study|Safety|0|||
149902402|NCT01031680|540772811|FG000|Overall Study|Incorrect Enrolment|1|||
149902403|NCT01031680|540772812|FG001|Overall Study|Incorrect Enrolment|2|||
149902404|NCT01031680|540772811|FG000|Overall Study|Administrative Reason by Sponsor|0|||
149902405|NCT01031680|540772812|FG001|Overall Study|Administrative Reason by Sponsor|1|||
149902406|NCT01031680|540772811|FG000|Overall Study|Various|0|||
149902407|NCT01031680|540772812|FG001|Overall Study|Various|2|||
149902408|NCT01029782|540772815|FG000|Overall Study|Lost to Follow-up|2|||
149902409|NCT01029782|540772816|FG001|Overall Study|Lost to Follow-up|2|||
149902410|NCT01029782|540772815|FG000|Overall Study|Diagnosis changed|1|||
149902411|NCT01029782|540772816|FG001|Overall Study|Diagnosis changed|1|||
149902412|NCT01029782|540772815|FG000|Overall Study|Adverse Event|0|||
149902413|NCT01029782|540772816|FG001|Overall Study|Adverse Event|1|||
149902414|NCT01029782|540772815|FG000|Overall Study|Physician Decision|0|||
149902415|NCT01029782|540772816|FG001|Overall Study|Physician Decision|1|||
149902416|NCT01029782|540772815|FG000|Overall Study|Protocol Violation|0|||
149902417|NCT01029782|540772816|FG001|Overall Study|Protocol Violation|2|||
149902418|NCT01029782|540772815|FG000|Overall Study|Withdrawal by Subject|0|||
149902419|NCT01029782|540772816|FG001|Overall Study|Withdrawal by Subject|1|||
149902420|NCT02195869|540772821|FG000|Overall Study|cGVHD Progression|5|||
149902421|NCT02195869|540772821|FG000|Overall Study|Malignancy Progression/relapse|2|||
149902422|NCT02195869|540772821|FG000|Overall Study|Adverse Event|15|||
149902423|NCT02195869|540772821|FG000|Overall Study|Withdrawal by Subject|7|||
149902424|NCT02195869|540772821|FG000|Overall Study|Physician Decision|4|||
149902425|NCT02195869|540772821|FG000|Overall Study|Study Terminated by Sponsor|7|||
149902426|NCT02195869|540772821|FG000|Overall Study|Noncompliance with study drug|2|||
149902427|NCT00789698|540772822|FG000|Overall Study|Lack of Efficacy|10|||
149902428|NCT00789698|540772823|FG001|Overall Study|Lack of Efficacy|4|||
149902429|NCT00789698|540772824|FG002|Overall Study|Lack of Efficacy|5|||
149902430|NCT00789698|540772825|FG003|Overall Study|Lack of Efficacy|18|||
149902431|NCT00789698|540772822|FG000|Overall Study|Adverse Event|5|||
149902432|NCT00789698|540772823|FG001|Overall Study|Adverse Event|5|||
149902433|NCT00789698|540772824|FG002|Overall Study|Adverse Event|3|||
149902434|NCT00789698|540772825|FG003|Overall Study|Adverse Event|4|||
149902435|NCT00789698|540772822|FG000|Overall Study|Lost to Follow-up|5|||
149902436|NCT00789698|540772823|FG001|Overall Study|Lost to Follow-up|5|||
149902437|NCT00789698|540772824|FG002|Overall Study|Lost to Follow-up|2|||
149902438|NCT00789698|540772825|FG003|Overall Study|Lost to Follow-up|9|||
149902439|NCT00789698|540772822|FG000|Overall Study|Protocol Violation|6|||
149902440|NCT00789698|540772823|FG001|Overall Study|Protocol Violation|1|||
149902441|NCT00789698|540772824|FG002|Overall Study|Protocol Violation|2|||
149902442|NCT00789698|540772825|FG003|Overall Study|Protocol Violation|1|||
149902443|NCT00789698|540772822|FG000|Overall Study|Withdrawal by Subject|14|||
149902444|NCT00789698|540772823|FG001|Overall Study|Withdrawal by Subject|15|||
149902445|NCT00789698|540772824|FG002|Overall Study|Withdrawal by Subject|12|||
149902446|NCT00789698|540772825|FG003|Overall Study|Withdrawal by Subject|19|||
149902447|NCT00789698|540772822|FG000|Overall Study|Administrative|0|||
149902448|NCT00789698|540772823|FG001|Overall Study|Administrative|3|||
149902449|NCT00789698|540772824|FG002|Overall Study|Administrative|3|||
149902450|NCT00789698|540772825|FG003|Overall Study|Administrative|1|||
150046205|NCT01615029|541308090|FG002|Overall Study|Ongoing|3|||
149902451|NCT00767455|540772826|FG000|Overall Study|Investigator error|19|||
149902452|NCT01921101|540772827|FG000|Overall Study|Death|16|||
149902453|NCT01921101|540772828|FG001|Overall Study|Death|6|||
149902454|NCT01870973|540772829|FG000|Overall Study|Lost to Follow-up|10|||
149902455|NCT01870973|540772830|FG001|Overall Study|Lost to Follow-up|3|||
149902456|NCT02729051|540772834|FG000|Overall Study|Adverse Event|21|||
149902457|NCT02729051|540772835|FG001|Overall Study|Adverse Event|11|||
149902458|NCT02729051|540772834|FG000|Overall Study|Lack of Efficacy|1|||
149902459|NCT02729051|540772835|FG001|Overall Study|Lack of Efficacy|1|||
149902460|NCT02729051|540772834|FG000|Overall Study|Lost to Follow-up|1|||
149902461|NCT02729051|540772835|FG001|Overall Study|Lost to Follow-up|2|||
149902462|NCT02729051|540772834|FG000|Overall Study|Physician Decision|1|||
149902463|NCT02729051|540772835|FG001|Overall Study|Physician Decision|1|||
149902464|NCT02729051|540772834|FG000|Overall Study|Withdrawal by Subject|6|||
149902465|NCT02729051|540772835|FG001|Overall Study|Withdrawal by Subject|17|||
149902466|NCT02702388|540772836|FG000|Overall Study|Disease Progression|18|||
149902467|NCT02702388|540772837|FG001|Overall Study|Disease Progression|25|||
149902468|NCT02702388|540772836|FG000|Overall Study|Withdrawal by Subject|9|||
149902469|NCT02702388|540772837|FG001|Overall Study|Withdrawal by Subject|7|||
149902470|NCT02702388|540772836|FG000|Overall Study|Adverse Event|11|||
149902471|NCT02702388|540772837|FG001|Overall Study|Adverse Event|15|||
149902472|NCT02702388|540772836|FG000|Overall Study|Other|2|||
149902473|NCT02702388|540772837|FG001|Overall Study|Other|4|||
149902474|NCT00160706|540774275|FG000|Overall Study|Adverse Event|53|||
149902475|NCT00160706|540774275|FG000|Overall Study|Adverse Event and Other Reason|105|||
149902476|NCT00160706|540774275|FG000|Overall Study|Protocol Violation|3|||
149902477|NCT00160706|540774275|FG000|Overall Study|Withdrawal by Subject|41|||
149902478|NCT00160706|540774275|FG000|Overall Study|Withdrawal by Subject and Other|12|||
149902479|NCT00160706|540774275|FG000|Overall Study|Physician Decision|10|||
149902480|NCT00160706|540774275|FG000|Overall Study|Physician Decision and Other|3|||
149902481|NCT00160706|540774275|FG000|Overall Study|Lost to Follow-up|4|||
149902482|NCT00160706|540774275|FG000|Overall Study|Lost to Follow-up and Other|1|||
149902483|NCT00160706|540774275|FG000|Overall Study|Lack of Efficacy|42|||
149902484|NCT00160706|540774275|FG000|Overall Study|Lack of Efficacy and Other|1|||
149902485|NCT00160706|540774275|FG000|Overall Study|Other Reason|11|||
149902486|NCT02162719|540774276|FG000|Overall Study|Death|41|||
149902487|NCT02162719|540774277|FG001|Overall Study|Death|46|||
149902488|NCT02162719|540774276|FG000|Overall Study|Lost to Follow-up|1|||
149902489|NCT02162719|540774277|FG001|Overall Study|Lost to Follow-up|3|||
149902490|NCT02162719|540774276|FG000|Overall Study|Disease Progression|2|||
149902491|NCT02162719|540774277|FG001|Overall Study|Disease Progression|1|||
149902492|NCT02162719|540774276|FG000|Overall Study|Withdrawal by Subject|8|||
149902493|NCT02162719|540774277|FG001|Overall Study|Withdrawal by Subject|2|||
149902494|NCT02162719|540774276|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
149902495|NCT02162719|540774277|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
149902496|NCT00076752|540774283|FG000|Overall Study|Death|2|||
149902497|NCT00076752|540774283|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
149902498|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
149902499|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
149902500|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
149902501|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
149902502|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
149902503|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
149902504|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
149902505|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
149902506|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Death|0|||
149902507|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Death|1|||
149902508|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
149902509|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
149902510|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
149902511|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
149902512|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
149902513|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
149902514|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
149902515|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
149902516|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
149902517|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
149902518|NCT00394836|540774284|FG000|Teatment or Follow-up Phase|Non compliance|0|||
149902519|NCT00394836|540774285|FG001|Teatment or Follow-up Phase|Non compliance|1|||
149902520|NCT00394836|540774284|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
149902521|NCT00394836|540774285|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
149902522|NCT00394836|540774284|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
149902523|NCT00394836|540774285|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
149902524|NCT00394836|540774284|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
149902525|NCT00394836|540774285|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
149902526|NCT00394836|540774284|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
149902527|NCT00394836|540774285|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
149902528|NCT00748189|540774286|FG000|Overall Study|Death|99|||
149902529|NCT00748189|540774287|FG001|Overall Study|Death|84|||
149902530|NCT00748189|540774286|FG000|Overall Study|Withdrawal by Subject|23|||
149902531|NCT00748189|540774287|FG001|Overall Study|Withdrawal by Subject|29|||
149902532|NCT00748189|540774286|FG000|Overall Study|Physician Decision|16|||
149902533|NCT00748189|540774287|FG001|Overall Study|Physician Decision|5|||
149902534|NCT00748189|540774286|FG000|Overall Study|Lost to Follow-up|8|||
149902535|NCT00748189|540774287|FG001|Overall Study|Lost to Follow-up|15|||
150046206|NCT01615029|541308091|FG003|Overall Study|Ongoing|2|||
150046207|NCT01615029|541308092|FG004|Overall Study|Ongoing|23|||
150046208|NCT05064358|541308093|FG000|Overall Study|Death|23|||
150046209|NCT05064358|541308094|FG001|Overall Study|Death|23|||
150046210|NCT05064358|541308095|FG002|Overall Study|Death|25|||
150046211|NCT05064358|541308096|FG003|Overall Study|Death|21|||
150046212|NCT05064358|541308097|FG004|Overall Study|Death|5|||
150046213|NCT05064358|541308093|FG000|Overall Study|Lost to Follow-up|1|||
150046214|NCT05064358|541308094|FG001|Overall Study|Lost to Follow-up|2|||
149902536|NCT00748189|540774286|FG000|Overall Study|Study terminated by Sponsor|70|||
149902537|NCT00748189|540774287|FG001|Overall Study|Study terminated by Sponsor|79|||
149902538|NCT04696055|540774293|FG000|Overall Study|Adverse Event|10|||
149902539|NCT04696055|540774294|FG001|Overall Study|Adverse Event|2|||
149902540|NCT04696055|540774293|FG000|Overall Study|Death|4|||
149902541|NCT04696055|540774294|FG001|Overall Study|Death|0|||
149902542|NCT04696055|540774293|FG000|Overall Study|Other|7|||
149902543|NCT04696055|540774294|FG001|Overall Study|Other|2|||
149902544|NCT04696055|540774293|FG000|Overall Study|Physician Decision|3|||
149902545|NCT04696055|540774294|FG001|Overall Study|Physician Decision|0|||
149902546|NCT04696055|540774293|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
149902547|NCT04696055|540774294|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
149902548|NCT04696055|540774293|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
149902549|NCT04696055|540774294|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
149902550|NCT04696055|540774293|FG000|Overall Study|Subject Decision|1|||
149902551|NCT04696055|540774294|FG001|Overall Study|Subject Decision|2|||
149902552|NCT03969901|540774295|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149902553|NCT03969901|540774296|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149902554|NCT03969901|540774297|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149902555|NCT03969901|540774298|FG003|Overall Study|Withdrawal by parent/guardian|0|||
149902556|NCT03969901|540774299|FG004|Overall Study|Withdrawal by parent/guardian|1|||
149902557|NCT03969901|540774300|FG005|Overall Study|Withdrawal by parent/guardian|0|||
149902558|NCT03969901|540774301|FG006|Overall Study|Withdrawal by parent/guardian|0|||
149902559|NCT03969901|540774302|FG007|Overall Study|Withdrawal by parent/guardian|1|||
149902560|NCT03969901|540774303|FG008|Overall Study|Withdrawal by parent/guardian|1|||
149902561|NCT03969901|540774304|FG009|Overall Study|Withdrawal by parent/guardian|0|||
149902562|NCT04411810|540774305|FG000|Overall Study|Screen failure|1|||
149902563|NCT04411810|540774305|FG000|Overall Study|Withdrawal by Subject|1|||
149902564|NCT01920958|540774306|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
149902565|NCT00610155|540774307|FG000|Period 1|Withdrawal by Subject|0|||
149902566|NCT00610155|540774308|FG001|Period 1|Withdrawal by Subject|0|||
149902567|NCT00610155|540774309|FG002|Period 1|Withdrawal by Subject|1|||
149902568|NCT00610155|540774310|FG003|Period 1|Withdrawal by Subject|0|||
149902569|NCT00610155|540774311|FG004|Period 1|Withdrawal by Subject|0|||
149902570|NCT00610155|540774312|FG005|Period 1|Withdrawal by Subject|0|||
149969328|NCT00928668|541023691|FG003|Overall Study|Other reasons not listed above|1|||
149969329|NCT00928668|541023692|FG004|Overall Study|Other reasons not listed above|0|||
149969330|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
149969331|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
149969332|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
149969333|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
149902571|NCT00610155|540774307|FG000|Period 3|Adverse Event|1|||
149902572|NCT00610155|540774308|FG001|Period 3|Adverse Event|0|||
149902573|NCT00610155|540774309|FG002|Period 3|Adverse Event|0|||
149902574|NCT00610155|540774310|FG003|Period 3|Adverse Event|0|||
149902575|NCT00610155|540774311|FG004|Period 3|Adverse Event|0|||
149902576|NCT00610155|540774312|FG005|Period 3|Adverse Event|0|||
149902577|NCT01560234|540774313|FG000|Overall Study|Lost to Follow-up|3|||
149902578|NCT01560234|540774314|FG001|Overall Study|Lost to Follow-up|0|||
149902579|NCT01560234|540774315|FG002|Overall Study|Lost to Follow-up|1|||
149969334|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
149969335|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
149969336|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
150046215|NCT05064358|541308095|FG002|Overall Study|Lost to Follow-up|0|||
149902580|NCT01560234|540774316|FG003|Overall Study|Lost to Follow-up|0|||
149902581|NCT01560234|540774317|FG004|Overall Study|Lost to Follow-up|0|||
149902582|NCT01560234|540774318|FG005|Overall Study|Lost to Follow-up|2|||
149902583|NCT01560234|540774319|FG006|Overall Study|Lost to Follow-up|0|||
149902584|NCT01560234|540774320|FG007|Overall Study|Lost to Follow-up|2|||
149902585|NCT02028767|540774323|FG000|Treatment Period 2|Non compliant with protocol|1|||
149902586|NCT02028767|540774324|FG001|Treatment Period 2|Non compliant with protocol|0|||
149902587|NCT02028767|540774323|FG000|Treatment Period 2|Reason other than those specified above|1|||
149902588|NCT02028767|540774324|FG001|Treatment Period 2|Reason other than those specified above|0|||
149902589|NCT01284348|540774325|FG000|Overall Study|Death|1|||
149902590|NCT01284348|540774326|FG001|Overall Study|Death|1|||
149902591|NCT01284348|540774325|FG000|Overall Study|Withdrew consent|0|||
149902592|NCT01284348|540774326|FG001|Overall Study|Withdrew consent|1|||
149902593|NCT01284348|540774325|FG000|Overall Study|Status not recorded|9|||
149902594|NCT01284348|540774326|FG001|Overall Study|Status not recorded|10|||
149902595|NCT03192306|540774331|FG000|Overall Study|Did not treat cold sore during study|149|||
149902596|NCT03192306|540774332|FG001|Overall Study|Did not treat cold sore during study|143|||
149902597|NCT03192306|540774331|FG000|Overall Study|Withdrawal by Subject|1|||
149902598|NCT03192306|540774332|FG001|Overall Study|Withdrawal by Subject|1|||
149902599|NCT03192306|540774331|FG000|Overall Study|Lost to Follow-up|1|||
149902600|NCT03192306|540774332|FG001|Overall Study|Lost to Follow-up|0|||
149902601|NCT03192306|540774331|FG000|Overall Study|Protocol Violation|1|||
149902602|NCT03192306|540774332|FG001|Overall Study|Protocol Violation|1|||
149902603|NCT00083759|540774337|FG000|Overall Study|Adverse Event|5|||
149902604|NCT00083759|540774338|FG001|Overall Study|Adverse Event|3|||
149902605|NCT00083759|540774337|FG000|Overall Study|Lost to Follow-up|1|||
149902606|NCT00083759|540774338|FG001|Overall Study|Lost to Follow-up|0|||
149902607|NCT00083759|540774337|FG000|Overall Study|Death|1|||
149902608|NCT00083759|540774338|FG001|Overall Study|Death|1|||
149902609|NCT00083759|540774337|FG000|Overall Study|Inadequate Therapeutic Response|32|||
149902610|NCT00083759|540774338|FG001|Overall Study|Inadequate Therapeutic Response|35|||
149902611|NCT00083759|540774337|FG000|Overall Study|Subject Withdrew Consent|2|||
149902612|NCT00083759|540774338|FG001|Overall Study|Subject Withdrew Consent|2|||
149902613|NCT00083759|540774337|FG000|Overall Study|Non-Compliance|1|||
149902614|NCT00083759|540774338|FG001|Overall Study|Non-Compliance|0|||
149902615|NCT00083759|540774337|FG000|Overall Study|Sponsor's Discretion|28|||
149902616|NCT00083759|540774338|FG001|Overall Study|Sponsor's Discretion|29|||
149902617|NCT00083759|540774337|FG000|Overall Study|Other|14|||
149902618|NCT00083759|540774338|FG001|Overall Study|Other|13|||
149902619|NCT03645395|540774339|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
149902620|NCT03645395|540774340|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
149902621|NCT03645395|540774341|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
149902622|NCT03645395|540774342|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
149902623|NCT03645395|540774339|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
149902624|NCT03645395|540774340|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
149902625|NCT03645395|540774341|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
149902626|NCT03645395|540774342|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
149902627|NCT03645395|540774339|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
149902628|NCT03645395|540774340|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
149902629|NCT03645395|540774341|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
149902630|NCT03645395|540774342|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
149902631|NCT03645395|540774339|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
149902632|NCT03645395|540774340|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
149902633|NCT03645395|540774341|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
149902634|NCT03645395|540774342|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
149902635|NCT00892151|540774343|FG000|Overall Study|Protocol Violation|1|||
149902636|NCT01089608|540774344|FG000|Overall Study|Adverse Event|0|||
149902637|NCT01089608|540774345|FG001|Overall Study|Adverse Event|4|||
149902638|NCT01089608|540774344|FG000|Overall Study|Lost to Follow-up|0|||
149902639|NCT01089608|540774345|FG001|Overall Study|Lost to Follow-up|2|||
149902640|NCT03575793|540774348|FG000|Overall Study|Withdrawal by Subject|0|||
149902641|NCT03575793|540774349|FG001|Overall Study|Withdrawal by Subject|1|||
149902642|NCT03575793|540774348|FG000|Overall Study|Never Treated|0|||
149902643|NCT03575793|540774349|FG001|Overall Study|Never Treated|2|||
149902644|NCT01250873|540774350|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
149902645|NCT01250873|540774350|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
149902646|NCT01940887|540774351|FG000|Year 1|Protocol Violation|0|||
149902647|NCT01940887|540774352|FG001|Year 1|Protocol Violation|1|||
149902648|NCT01940887|540774351|FG000|Year 1|Physician Decision|7|||
149902649|NCT01940887|540774352|FG001|Year 1|Physician Decision|3|||
149902650|NCT01940887|540774351|FG000|Year 1|Death|5|||
149902651|NCT01940887|540774352|FG001|Year 1|Death|3|||
149902652|NCT01940887|540774351|FG000|Year 1|Adverse Event|7|||
149902653|NCT01940887|540774352|FG001|Year 1|Adverse Event|6|||
149902654|NCT01940887|540774351|FG000|Year 1|Withdrawal by Subject|18|||
149902655|NCT01940887|540774352|FG001|Year 1|Withdrawal by Subject|9|||
149902656|NCT01940887|540774351|FG000|Year 1|Lost to Follow-up|2|||
149902657|NCT01940887|540774352|FG001|Year 1|Lost to Follow-up|1|||
149902658|NCT01940887|540774351|FG000|Year 2|Physician Decision|8|||
149902659|NCT01940887|540774352|FG001|Year 2|Physician Decision|1|||
149902660|NCT01940887|540774351|FG000|Year 2|Death|0|||
149902661|NCT01940887|540774352|FG001|Year 2|Death|2|||
149902662|NCT01940887|540774351|FG000|Year 2|Sponsor Decision, early termination|192|||
149902663|NCT01940887|540774352|FG001|Year 2|Sponsor Decision, early termination|203|||
149902664|NCT01940887|540774351|FG000|Year 2|Adverse Event|8|||
149902665|NCT01940887|540774352|FG001|Year 2|Adverse Event|2|||
149902666|NCT01940887|540774351|FG000|Year 2|Withdrawal by Subject|8|||
149902667|NCT01940887|540774352|FG001|Year 2|Withdrawal by Subject|8|||
149902668|NCT01940887|540774351|FG000|Year 2|Lost to Follow-up|1|||
149902669|NCT01940887|540774352|FG001|Year 2|Lost to Follow-up|6|||
149902670|NCT01062113|540774354|FG000|Overall Study|Adverse Event|1|||
149902671|NCT01062113|540774355|FG001|Overall Study|Adverse Event|0|||
149902672|NCT01062113|540774356|FG002|Overall Study|Adverse Event|0|||
149902673|NCT01062113|540774354|FG000|Overall Study|Lack of Efficacy|38|||
149902674|NCT01062113|540774355|FG001|Overall Study|Lack of Efficacy|22|||
149902675|NCT01062113|540774356|FG002|Overall Study|Lack of Efficacy|31|||
149902676|NCT01062113|540774354|FG000|Overall Study|Withdrawal by Subject|1|||
149902677|NCT01062113|540774355|FG001|Overall Study|Withdrawal by Subject|0|||
149902678|NCT01062113|540774356|FG002|Overall Study|Withdrawal by Subject|0|||
149902679|NCT02429778|540774357|FG000|Overall Study|Lost to Follow-up|2|||
149902680|NCT02429778|540774358|FG001|Overall Study|Lost to Follow-up|0|||
149902681|NCT02429778|540774357|FG000|Overall Study|Withdrawal by Subject|5|||
149902682|NCT02429778|540774358|FG001|Overall Study|Withdrawal by Subject|0|||
149902683|NCT03521115|540774359|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
149902684|NCT03521115|540774360|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
149902685|NCT03521115|540774359|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
149902686|NCT03521115|540774360|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
149902687|NCT02475265|540774364|FG000|Overall Study|Physician Decision|1|||
149902688|NCT02475265|540774364|FG000|Overall Study|Withdrawal by Subject|2|||
149902689|NCT03063086|540774370|FG000|Overall Study|technical problems|1|||
149902690|NCT03063086|540774371|FG001|Overall Study|technical problems|0|||
149902691|NCT03063086|540774372|FG002|Overall Study|technical problems|0|||
149902692|NCT03063086|540774373|FG003|Overall Study|technical problems|0|||
149969337|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
149902693|NCT03063086|540774374|FG004|Overall Study|technical problems|0|||
149902694|NCT03063086|540774375|FG005|Overall Study|technical problems|0|||
149902695|NCT03063086|540774370|FG000|Overall Study|Adverse Event|1|||
149902696|NCT03063086|540774371|FG001|Overall Study|Adverse Event|1|||
149902697|NCT03063086|540774372|FG002|Overall Study|Adverse Event|1|||
149902698|NCT03063086|540774373|FG003|Overall Study|Adverse Event|1|||
149902699|NCT03063086|540774374|FG004|Overall Study|Adverse Event|0|||
149902700|NCT03063086|540774375|FG005|Overall Study|Adverse Event|0|||
149902701|NCT03063086|540774370|FG000|Overall Study|subject/guardian decision|1|||
149902702|NCT03063086|540774371|FG001|Overall Study|subject/guardian decision|0|||
149902703|NCT03063086|540774372|FG002|Overall Study|subject/guardian decision|0|||
149902704|NCT03063086|540774373|FG003|Overall Study|subject/guardian decision|0|||
149902705|NCT03063086|540774374|FG004|Overall Study|subject/guardian decision|0|||
149902706|NCT03063086|540774375|FG005|Overall Study|subject/guardian decision|0|||
149902707|NCT03063086|540774370|FG000|Overall Study|Non-compliance with study treatment|0|||
149902708|NCT03063086|540774371|FG001|Overall Study|Non-compliance with study treatment|0|||
149902709|NCT03063086|540774372|FG002|Overall Study|Non-compliance with study treatment|0|||
149902710|NCT03063086|540774373|FG003|Overall Study|Non-compliance with study treatment|1|||
149902711|NCT03063086|540774374|FG004|Overall Study|Non-compliance with study treatment|0|||
149902712|NCT03063086|540774375|FG005|Overall Study|Non-compliance with study treatment|1|||
149902713|NCT03063086|540774370|FG000|Overall Study|Physician Decision|0|||
149902714|NCT03063086|540774371|FG001|Overall Study|Physician Decision|0|||
149902715|NCT03063086|540774372|FG002|Overall Study|Physician Decision|0|||
149902716|NCT03063086|540774373|FG003|Overall Study|Physician Decision|1|||
149902717|NCT03063086|540774374|FG004|Overall Study|Physician Decision|0|||
149902718|NCT03063086|540774375|FG005|Overall Study|Physician Decision|0|||
149902719|NCT01893281|540774376|FG000|Overall Study|Adverse Event|1|||
149902720|NCT01893281|540774376|FG000|Overall Study|Protocol Violation|1|||
149902721|NCT01893281|540774376|FG000|Overall Study|Withdrawal by Subject|1|||
149902722|NCT05481125|540774379|FG000|Overall Study|Adverse Event|1|||
149902723|NCT05481125|540774380|FG001|Overall Study|Adverse Event|0|||
149902724|NCT05481125|540774379|FG000|Overall Study|Lost to Follow-up|0|||
149902725|NCT05481125|540774380|FG001|Overall Study|Lost to Follow-up|1|||
149902726|NCT05481125|540774379|FG000|Overall Study|Withdrawal by Subject|0|||
149902727|NCT05481125|540774380|FG001|Overall Study|Withdrawal by Subject|1|||
149902728|NCT01769508|540774381|FG000|Overall Study|Death|3|||
149902729|NCT01769508|540774381|FG000|Overall Study|Withdrawal by Subject|1|||
149902730|NCT01769508|540774381|FG000|Overall Study|Adverse Event|1|||
149902731|NCT01769508|540774381|FG000|Overall Study|Lost to Follow-up|1|||
149902732|NCT01290679|540774385|FG000|Overall Study|Adverse Event|2|||
149902733|NCT01290679|540774386|FG001|Overall Study|Adverse Event|0|||
149902734|NCT01290679|540774385|FG000|Overall Study|Lost to Follow-up|8|||
149902735|NCT01290679|540774386|FG001|Overall Study|Lost to Follow-up|10|||
149902736|NCT01290679|540774385|FG000|Overall Study|Protocol Violation|0|||
149902737|NCT01290679|540774386|FG001|Overall Study|Protocol Violation|1|||
149902738|NCT01290679|540774385|FG000|Overall Study|Withdrawal by Subject|6|||
149902739|NCT01290679|540774386|FG001|Overall Study|Withdrawal by Subject|5|||
149902740|NCT01290679|540774385|FG000|Overall Study|Subject Entered Another Trial|0|||
149902741|NCT01290679|540774386|FG001|Overall Study|Subject Entered Another Trial|5|||
149902742|NCT00562302|540774387|FG000|Overall Study|Lost to Follow-up|3|||
149902743|NCT00562302|540774388|FG001|Overall Study|Lost to Follow-up|3|||
149902744|NCT00562302|540774387|FG000|Overall Study|Adverse Event|0|||
149902745|NCT00562302|540774388|FG001|Overall Study|Adverse Event|6|||
149902746|NCT00562302|540774387|FG000|Overall Study|Non-compliance|1|||
149902747|NCT00562302|540774388|FG001|Overall Study|Non-compliance|2|||
149902748|NCT00562302|540774387|FG000|Overall Study|Withdrawal by Subject|7|||
149902749|NCT00562302|540774388|FG001|Overall Study|Withdrawal by Subject|8|||
149902750|NCT00562302|540774387|FG000|Overall Study|Death|1|||
149902751|NCT00562302|540774388|FG001|Overall Study|Death|2|||
149902752|NCT00562302|540774387|FG000|Overall Study|Lung resection prior to study completion|7|||
149902753|NCT00562302|540774388|FG001|Overall Study|Lung resection prior to study completion|7|||
149902754|NCT00562302|540774387|FG000|Overall Study|Not stated|1|||
149969338|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
149969339|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
149969340|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
150177974|NCT02824029|541790320|FG000|Overall Study|Inadequate response to therapy|2|||
149902755|NCT00562302|540774388|FG001|Overall Study|Not stated|4|||
149902756|NCT03615144|540774389|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
149902757|NCT03615144|540774390|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
149902758|NCT01704651|540774391|FG000|Overall Study|Pre-op withdrawal by subject|1|||
149902759|NCT01704651|540774392|FG001|Overall Study|Pre-op withdrawal by subject|1|||
149902760|NCT01704651|540774391|FG000|Overall Study|Pre-op change in treatment plan|1|||
149902761|NCT01704651|540774392|FG001|Overall Study|Pre-op change in treatment plan|4|||
149902762|NCT01704651|540774391|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
149902763|NCT01704651|540774392|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
149902764|NCT01704651|540774391|FG000|Overall Study|Post-op did not have laparotomy|2|||
149902765|NCT01704651|540774392|FG001|Overall Study|Post-op did not have laparotomy|1|||
149902766|NCT00634803|540774395|FG000|Overall Study|Lost to Follow-up|6|||
149902767|NCT00634803|540774396|FG001|Overall Study|Lost to Follow-up|7|||
149902768|NCT00634803|540774397|FG002|Overall Study|Lost to Follow-up|7|||
149902769|NCT00675428|540774400|FG000|Overall Study|Disease Progression|2|||
149902770|NCT00675428|540774401|FG001|Overall Study|Disease Progression|2|||
149902771|NCT00675428|540774400|FG000|Overall Study|No Disease Response After Cycle 6|0|||
149902772|NCT00675428|540774401|FG001|Overall Study|No Disease Response After Cycle 6|1|||
149902773|NCT00675428|540774400|FG000|Overall Study|Physician Decision|1|||
149902774|NCT00675428|540774401|FG001|Overall Study|Physician Decision|0|||
149902775|NCT01377922|540774402|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
149902776|NCT01377922|540774403|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
149902777|NCT04615403|540774405|FG000|Overall Study|Death|1|||
149902778|NCT00596817|540774413|FG000|Open-label Period|Adverse Event|0|||
149902779|NCT00596817|540774414|FG001|Open-label Period|Adverse Event|49|||
149902780|NCT00596817|540774413|FG000|Open-label Period|Lack of Efficacy|0|||
149902781|NCT00596817|540774414|FG001|Open-label Period|Lack of Efficacy|33|||
149902782|NCT00596817|540774413|FG000|Open-label Period|Other Reasons|0|||
149902783|NCT00596817|540774414|FG001|Open-label Period|Other Reasons|65|||
149902784|NCT00596817|540774413|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
149902785|NCT00596817|540774414|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
149902786|NCT00596817|540774413|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
149902787|NCT00596817|540774414|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
149902788|NCT00596817|540774413|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
149902789|NCT00596817|540774414|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
149902790|NCT00596817|540774413|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
149902791|NCT00596817|540774414|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
149902792|NCT00596817|540774413|FG000|Double-blind Period|Adverse Event|5|||
149902793|NCT00596817|540774414|FG001|Double-blind Period|Adverse Event|16|||
149902794|NCT00596817|540774413|FG000|Double-blind Period|Lack of Efficacy|52|||
149902795|NCT00596817|540774414|FG001|Double-blind Period|Lack of Efficacy|28|||
149902796|NCT00596817|540774413|FG000|Double-blind Period|Non-compliance With Study Product|3|||
149902797|NCT00596817|540774414|FG001|Double-blind Period|Non-compliance With Study Product|4|||
149902798|NCT00596817|540774413|FG000|Double-blind Period|Protocol Violation|11|||
149902799|NCT00596817|540774414|FG001|Double-blind Period|Protocol Violation|8|||
149902800|NCT00596817|540774413|FG000|Double-blind Period|Withdrawal of Consent|7|||
149902801|NCT00596817|540774414|FG001|Double-blind Period|Withdrawal of Consent|3|||
149902802|NCT00596817|540774413|FG000|Double-blind Period|Lost to Follow-up|0|||
149902803|NCT00596817|540774414|FG001|Double-blind Period|Lost to Follow-up|2|||
149902804|NCT00596817|540774413|FG000|Double-blind Period|Other Reasons|10|||
149902805|NCT00596817|540774414|FG001|Double-blind Period|Other Reasons|18|||
149902806|NCT03225105|540774421|FG000|Overall Study|Withdrawal by Subject|1|||
149902807|NCT03225105|540774422|FG001|Overall Study|Withdrawal by Subject|0|||
149902808|NCT03225105|540774423|FG002|Overall Study|Withdrawal by Subject|0|||
149902809|NCT03225105|540774424|FG003|Overall Study|Withdrawal by Subject|0|||
149902810|NCT03225105|540774421|FG000|Overall Study|Death|0|||
149902811|NCT03225105|540774422|FG001|Overall Study|Death|4|||
149902812|NCT03225105|540774423|FG002|Overall Study|Death|2|||
149902813|NCT03225105|540774424|FG003|Overall Study|Death|0|||
149902814|NCT03225105|540774421|FG000|Overall Study|Study termination per Sponsor Decision|2|||
149902815|NCT03225105|540774422|FG001|Overall Study|Study termination per Sponsor Decision|0|||
149902816|NCT03225105|540774423|FG002|Overall Study|Study termination per Sponsor Decision|3|||
149902817|NCT03225105|540774424|FG003|Overall Study|Study termination per Sponsor Decision|3|||
149902818|NCT03214380|540776023|FG000|Lead-in|Adverse Event|3|||
149902819|NCT03214380|540776024|FG001|Lead-in|Adverse Event|0|||
149902820|NCT03214380|540776025|FG002|Lead-in|Adverse Event|0|||
149902821|NCT03214380|540776026|FG003|Lead-in|Adverse Event|1|||
149902822|NCT03214380|540776027|FG004|Lead-in|Adverse Event|0|||
149902823|NCT03214380|540776028|FG005|Lead-in|Adverse Event|0|||
149902824|NCT03214380|540776023|FG000|Lead-in|Lost to Follow-up|4|||
149902825|NCT03214380|540776024|FG001|Lead-in|Lost to Follow-up|0|||
149902826|NCT03214380|540776025|FG002|Lead-in|Lost to Follow-up|0|||
149902827|NCT03214380|540776026|FG003|Lead-in|Lost to Follow-up|1|||
149902828|NCT03214380|540776027|FG004|Lead-in|Lost to Follow-up|0|||
149902829|NCT03214380|540776028|FG005|Lead-in|Lost to Follow-up|0|||
149902830|NCT03214380|540776023|FG000|Lead-in|Eligibility Criteria|3|||
149902831|NCT03214380|540776024|FG001|Lead-in|Eligibility Criteria|0|||
149902832|NCT03214380|540776025|FG002|Lead-in|Eligibility Criteria|0|||
149902833|NCT03214380|540776026|FG003|Lead-in|Eligibility Criteria|0|||
149969341|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
149969342|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
149969343|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
149969344|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
149969345|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
149969346|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
149902834|NCT03214380|540776027|FG004|Lead-in|Eligibility Criteria|0|||
150046216|NCT05064358|541308096|FG003|Overall Study|Lost to Follow-up|2|||
150046217|NCT05064358|541308097|FG004|Overall Study|Lost to Follow-up|0|||
150046218|NCT05064358|541308093|FG000|Overall Study|Physician Decision|1|||
150046219|NCT05064358|541308094|FG001|Overall Study|Physician Decision|1|||
150046220|NCT05064358|541308095|FG002|Overall Study|Physician Decision|2|||
150046221|NCT05064358|541308096|FG003|Overall Study|Physician Decision|0|||
150046222|NCT05064358|541308097|FG004|Overall Study|Physician Decision|0|||
149902835|NCT03214380|540776028|FG005|Lead-in|Eligibility Criteria|0|||
149902836|NCT03214380|540776023|FG000|Lead-in|Physician Decision|6|||
149902837|NCT03214380|540776024|FG001|Lead-in|Physician Decision|0|||
149902838|NCT03214380|540776025|FG002|Lead-in|Physician Decision|0|||
149902839|NCT03214380|540776026|FG003|Lead-in|Physician Decision|0|||
149902840|NCT03214380|540776027|FG004|Lead-in|Physician Decision|0|||
149902841|NCT03214380|540776028|FG005|Lead-in|Physician Decision|0|||
149902842|NCT03214380|540776023|FG000|Lead-in|Protocol Deviation|7|||
149902843|NCT03214380|540776024|FG001|Lead-in|Protocol Deviation|0|||
149902844|NCT03214380|540776025|FG002|Lead-in|Protocol Deviation|0|||
149902845|NCT03214380|540776026|FG003|Lead-in|Protocol Deviation|3|||
149902846|NCT03214380|540776027|FG004|Lead-in|Protocol Deviation|0|||
149902847|NCT03214380|540776028|FG005|Lead-in|Protocol Deviation|0|||
149902848|NCT03214380|540776023|FG000|Lead-in|Withdrawal by Subject|41|||
149902849|NCT03214380|540776024|FG001|Lead-in|Withdrawal by Subject|0|||
149902850|NCT03214380|540776025|FG002|Lead-in|Withdrawal by Subject|0|||
149902851|NCT03214380|540776026|FG003|Lead-in|Withdrawal by Subject|14|||
149902852|NCT03214380|540776027|FG004|Lead-in|Withdrawal by Subject|0|||
149902853|NCT03214380|540776028|FG005|Lead-in|Withdrawal by Subject|0|||
149902854|NCT03214380|540776023|FG000|Lead-in|Family Emergency|1|||
149902855|NCT03214380|540776024|FG001|Lead-in|Family Emergency|0|||
149902856|NCT03214380|540776025|FG002|Lead-in|Family Emergency|0|||
149902857|NCT03214380|540776026|FG003|Lead-in|Family Emergency|0|||
149902858|NCT03214380|540776027|FG004|Lead-in|Family Emergency|0|||
149902859|NCT03214380|540776028|FG005|Lead-in|Family Emergency|0|||
149902860|NCT03214380|540776023|FG000|Lead-in|Natural Disaster|9|||
149902861|NCT03214380|540776024|FG001|Lead-in|Natural Disaster|0|||
149902862|NCT03214380|540776025|FG002|Lead-in|Natural Disaster|0|||
149902863|NCT03214380|540776026|FG003|Lead-in|Natural Disaster|0|||
149902864|NCT03214380|540776027|FG004|Lead-in|Natural Disaster|0|||
149902865|NCT03214380|540776028|FG005|Lead-in|Natural Disaster|0|||
149902866|NCT03214380|540776023|FG000|Lead-in|Non Compliance|1|||
149902867|NCT03214380|540776024|FG001|Lead-in|Non Compliance|0|||
149902868|NCT03214380|540776025|FG002|Lead-in|Non Compliance|0|||
149902869|NCT03214380|540776026|FG003|Lead-in|Non Compliance|0|||
149902870|NCT03214380|540776027|FG004|Lead-in|Non Compliance|0|||
149902871|NCT03214380|540776028|FG005|Lead-in|Non Compliance|0|||
149902872|NCT03214380|540776023|FG000|Lead-in|Participant Schedule|2|||
149902873|NCT03214380|540776024|FG001|Lead-in|Participant Schedule|0|||
149902874|NCT03214380|540776025|FG002|Lead-in|Participant Schedule|0|||
149902875|NCT03214380|540776026|FG003|Lead-in|Participant Schedule|0|||
149902876|NCT03214380|540776027|FG004|Lead-in|Participant Schedule|0|||
149902877|NCT03214380|540776028|FG005|Lead-in|Participant Schedule|0|||
149902878|NCT03214380|540776023|FG000|Treatment Period|Adverse Event|0|||
149902879|NCT03214380|540776024|FG001|Treatment Period|Adverse Event|1|||
149902880|NCT03214380|540776025|FG002|Treatment Period|Adverse Event|1|||
149902881|NCT03214380|540776026|FG003|Treatment Period|Adverse Event|0|||
149902882|NCT03214380|540776027|FG004|Treatment Period|Adverse Event|1|||
149902883|NCT03214380|540776028|FG005|Treatment Period|Adverse Event|0|||
149902884|NCT03214380|540776023|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
149902885|NCT03214380|540776024|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
149902886|NCT03214380|540776025|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
149902887|NCT03214380|540776026|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
149902888|NCT03214380|540776027|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
150046223|NCT05064358|541308093|FG000|Overall Study|Withdrawal by Subject|4|||
150046224|NCT05064358|541308094|FG001|Overall Study|Withdrawal by Subject|5|||
149902889|NCT03214380|540776028|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
149902890|NCT03214380|540776023|FG000|Treatment Period|Withdrawal by Subject|0|||
149902891|NCT03214380|540776024|FG001|Treatment Period|Withdrawal by Subject|10|||
149902892|NCT03214380|540776025|FG002|Treatment Period|Withdrawal by Subject|8|||
149902893|NCT03214380|540776026|FG003|Treatment Period|Withdrawal by Subject|0|||
149902894|NCT03214380|540776027|FG004|Treatment Period|Withdrawal by Subject|7|||
150046225|NCT05064358|541308095|FG002|Overall Study|Withdrawal by Subject|3|||
150046226|NCT05064358|541308096|FG003|Overall Study|Withdrawal by Subject|6|||
150046227|NCT05064358|541308097|FG004|Overall Study|Withdrawal by Subject|3|||
150046228|NCT05064358|541308093|FG000|Overall Study|Ongoing at the time of analysis|1|||
149902895|NCT03214380|540776028|FG005|Treatment Period|Withdrawal by Subject|11|||
149902896|NCT03214380|540776023|FG000|Treatment Period|Death|0|||
149902897|NCT03214380|540776024|FG001|Treatment Period|Death|1|||
149902898|NCT03214380|540776025|FG002|Treatment Period|Death|2|||
149902899|NCT03214380|540776026|FG003|Treatment Period|Death|0|||
150046229|NCT05064358|541308094|FG001|Overall Study|Ongoing at the time of analysis|2|||
150046230|NCT05064358|541308095|FG002|Overall Study|Ongoing at the time of analysis|2|||
149902900|NCT03214380|540776027|FG004|Treatment Period|Death|0|||
149902901|NCT03214380|540776028|FG005|Treatment Period|Death|0|||
149902902|NCT03214380|540776023|FG000|Treatment Period|Lost to Follow-up|0|||
149902903|NCT03214380|540776024|FG001|Treatment Period|Lost to Follow-up|6|||
149902904|NCT03214380|540776025|FG002|Treatment Period|Lost to Follow-up|3|||
149902905|NCT03214380|540776026|FG003|Treatment Period|Lost to Follow-up|0|||
149902906|NCT03214380|540776027|FG004|Treatment Period|Lost to Follow-up|0|||
149902907|NCT03214380|540776028|FG005|Treatment Period|Lost to Follow-up|0|||
149902908|NCT03214380|540776023|FG000|Treatment Period|Participant schedule|0|||
149902909|NCT03214380|540776024|FG001|Treatment Period|Participant schedule|0|||
149902910|NCT03214380|540776025|FG002|Treatment Period|Participant schedule|1|||
149902911|NCT03214380|540776026|FG003|Treatment Period|Participant schedule|0|||
149902912|NCT03214380|540776027|FG004|Treatment Period|Participant schedule|0|||
149902913|NCT03214380|540776028|FG005|Treatment Period|Participant schedule|0|||
149902914|NCT03214380|540776023|FG000|Treatment Period|Treatment Interruption|0|||
149902915|NCT03214380|540776024|FG001|Treatment Period|Treatment Interruption|0|||
149902916|NCT03214380|540776025|FG002|Treatment Period|Treatment Interruption|1|||
149902917|NCT03214380|540776026|FG003|Treatment Period|Treatment Interruption|0|||
149902918|NCT03214380|540776027|FG004|Treatment Period|Treatment Interruption|0|||
149902919|NCT03214380|540776028|FG005|Treatment Period|Treatment Interruption|0|||
149902920|NCT01905553|540776032|FG000|Period 2|Adverse Event|1|||
149902921|NCT01905553|540776033|FG001|Period 2|Adverse Event|0|||
149902922|NCT03692325|540776037|FG000|Overall Study|Adverse Event|2|||
149902923|NCT03692325|540776037|FG000|Overall Study|Progression/Recurrence|2|||
149902924|NCT02817516|540776038|FG000|Overall Study|Other|0|||
149902925|NCT02817516|540776039|FG001|Overall Study|Other|0|||
149902926|NCT02817516|540776040|FG002|Overall Study|Other|1|||
149902927|NCT02817516|540776041|FG003|Overall Study|Other|0|||
149902928|NCT00664859|540776042|FG000|Overall Study|Adverse Event|2|||
149902929|NCT00664859|540776043|FG001|Overall Study|Adverse Event|1|||
149902930|NCT00664859|540776044|FG002|Overall Study|Adverse Event|3|||
149902931|NCT00664859|540776042|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
149902932|NCT00664859|540776043|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
149902933|NCT00664859|540776044|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
149902934|NCT00664859|540776042|FG000|Overall Study|Noncompliance with protocol|1|||
149902935|NCT00664859|540776043|FG001|Overall Study|Noncompliance with protocol|0|||
149902936|NCT00664859|540776044|FG002|Overall Study|Noncompliance with protocol|4|||
149902937|NCT00664859|540776042|FG000|Overall Study|Laboratory abnormality|2|||
149902938|NCT00664859|540776043|FG001|Overall Study|Laboratory abnormality|1|||
149902939|NCT00664859|540776044|FG002|Overall Study|Laboratory abnormality|4|||
149902940|NCT00664859|540776042|FG000|Overall Study|Withdrawal by Subject|4|||
149902941|NCT00664859|540776043|FG001|Overall Study|Withdrawal by Subject|1|||
149902942|NCT00664859|540776044|FG002|Overall Study|Withdrawal by Subject|3|||
149902943|NCT00664859|540776042|FG000|Overall Study|Lost to Follow-up|2|||
149902944|NCT00664859|540776043|FG001|Overall Study|Lost to Follow-up|2|||
149902945|NCT00664859|540776044|FG002|Overall Study|Lost to Follow-up|1|||
149902946|NCT00664859|540776042|FG000|Overall Study|Other|0|||
149902947|NCT00664859|540776043|FG001|Overall Study|Other|1|||
149902948|NCT00664859|540776044|FG002|Overall Study|Other|2|||
149902949|NCT04481191|540776045|FG000|Overall Study|Withdrawn by parent/guardian|15|||
149902950|NCT04481191|540776046|FG001|Overall Study|Withdrawn by parent/guardian|10|||
149902951|NCT00546117|540776047|FG000|Overall Study|Withdrawal by Subject|3|||
149902952|NCT00546117|540776048|FG001|Overall Study|Withdrawal by Subject|0|||
149902953|NCT00546117|540776047|FG000|Overall Study|Inability to schedule follow-up visit|1|||
149902954|NCT00546117|540776048|FG001|Overall Study|Inability to schedule follow-up visit|0|||
149902955|NCT00348595|540776051|FG000|Overall Study|Adverse Event|5|||
149902956|NCT00348595|540776052|FG001|Overall Study|Adverse Event|8|||
149902957|NCT02589626|540776058|FG000|Overall Study|Other than the reason specified|1|||
149902958|NCT02589626|540776059|FG001|Overall Study|Other than the reason specified|0|||
149902959|NCT02589626|540776058|FG000|Overall Study|Withdrawal by Subject|1|||
149902960|NCT02589626|540776059|FG001|Overall Study|Withdrawal by Subject|1|||
149902961|NCT02589626|540776058|FG000|Overall Study|Adverse Event|1|||
149902962|NCT02589626|540776059|FG001|Overall Study|Adverse Event|1|||
149902963|NCT02564900|540776060|FG000|Dose Escalation|Progressive disease per RECIST|2|||
149902964|NCT02564900|540776061|FG001|Dose Escalation|Progressive disease per RECIST|3|||
149902965|NCT02564900|540776062|FG002|Dose Escalation|Progressive disease per RECIST|3|||
149902966|NCT02564900|540776063|FG003|Dose Escalation|Progressive disease per RECIST|3|||
149902967|NCT02564900|540776064|FG004|Dose Escalation|Progressive disease per RECIST|3|||
149902968|NCT02564900|540776065|FG005|Dose Escalation|Progressive disease per RECIST|1|||
149902969|NCT02564900|540776066|FG006|Dose Escalation|Progressive disease per RECIST|0|||
149902970|NCT02564900|540776067|FG007|Dose Escalation|Progressive disease per RECIST|0|||
149902971|NCT02564900|540776068|FG008|Dose Escalation|Progressive disease per RECIST|0|||
149902972|NCT02564900|540776069|FG009|Dose Escalation|Progressive disease per RECIST|0|||
149902973|NCT02564900|540776070|FG010|Dose Escalation|Progressive disease per RECIST|0|||
149902974|NCT02564900|540776071|FG011|Dose Escalation|Progressive disease per RECIST|0|||
149902975|NCT02564900|540776072|FG012|Dose Escalation|Progressive disease per RECIST|0|||
149902976|NCT02564900|540776073|FG013|Dose Escalation|Progressive disease per RECIST|0|||
149902977|NCT02564900|540776074|FG014|Dose Escalation|Progressive disease per RECIST|0|||
149902978|NCT02564900|540776060|FG000|Dose Escalation|Ongoing|1|||
149902979|NCT02564900|540776061|FG001|Dose Escalation|Ongoing|0|||
149902980|NCT02564900|540776062|FG002|Dose Escalation|Ongoing|0|||
149902981|NCT02564900|540776063|FG003|Dose Escalation|Ongoing|2|||
149902982|NCT02564900|540776064|FG004|Dose Escalation|Ongoing|2|||
149902983|NCT02564900|540776065|FG005|Dose Escalation|Ongoing|2|||
149902984|NCT02564900|540776066|FG006|Dose Escalation|Ongoing|0|||
149902985|NCT02564900|540776067|FG007|Dose Escalation|Ongoing|0|||
149902986|NCT02564900|540776068|FG008|Dose Escalation|Ongoing|0|||
149902987|NCT02564900|540776069|FG009|Dose Escalation|Ongoing|0|||
149902988|NCT02564900|540776070|FG010|Dose Escalation|Ongoing|0|||
149902989|NCT02564900|540776071|FG011|Dose Escalation|Ongoing|0|||
149902990|NCT02564900|540776072|FG012|Dose Escalation|Ongoing|0|||
149902991|NCT02564900|540776073|FG013|Dose Escalation|Ongoing|0|||
149902992|NCT02564900|540776074|FG014|Dose Escalation|Ongoing|0|||
149902993|NCT02564900|540776060|FG000|Dose Escalation|Adverse Event|0|||
149902994|NCT02564900|540776061|FG001|Dose Escalation|Adverse Event|0|||
149902995|NCT02564900|540776062|FG002|Dose Escalation|Adverse Event|0|||
149902996|NCT02564900|540776063|FG003|Dose Escalation|Adverse Event|1|||
149902997|NCT02564900|540776064|FG004|Dose Escalation|Adverse Event|1|||
149902998|NCT02564900|540776065|FG005|Dose Escalation|Adverse Event|3|||
149902999|NCT02564900|540776066|FG006|Dose Escalation|Adverse Event|0|||
149903000|NCT02564900|540776067|FG007|Dose Escalation|Adverse Event|0|||
149903001|NCT02564900|540776068|FG008|Dose Escalation|Adverse Event|0|||
149903002|NCT02564900|540776069|FG009|Dose Escalation|Adverse Event|0|||
149903003|NCT02564900|540776070|FG010|Dose Escalation|Adverse Event|0|||
149903004|NCT02564900|540776071|FG011|Dose Escalation|Adverse Event|0|||
149903005|NCT02564900|540776072|FG012|Dose Escalation|Adverse Event|0|||
149903006|NCT02564900|540776073|FG013|Dose Escalation|Adverse Event|0|||
149903007|NCT02564900|540776074|FG014|Dose Escalation|Adverse Event|0|||
149903008|NCT02564900|540776060|FG000|Dose Expansion|Progressive disease per RECIST|0|||
149903009|NCT02564900|540776061|FG001|Dose Expansion|Progressive disease per RECIST|0|||
149903010|NCT02564900|540776062|FG002|Dose Expansion|Progressive disease per RECIST|0|||
149903011|NCT02564900|540776063|FG003|Dose Expansion|Progressive disease per RECIST|0|||
149903012|NCT02564900|540776064|FG004|Dose Expansion|Progressive disease per RECIST|0|||
149903013|NCT02564900|540776065|FG005|Dose Expansion|Progressive disease per RECIST|0|||
149903014|NCT02564900|540776066|FG006|Dose Expansion|Progressive disease per RECIST|19|||
149903015|NCT02564900|540776067|FG007|Dose Expansion|Progressive disease per RECIST|17|||
149903016|NCT02564900|540776068|FG008|Dose Expansion|Progressive disease per RECIST|8|||
149969347|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
149969348|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
149969349|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
149969350|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
149969351|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
149969352|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
149969353|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
150046231|NCT05064358|541308096|FG003|Overall Study|Ongoing at the time of analysis|2|||
149903017|NCT02564900|540776069|FG009|Dose Expansion|Progressive disease per RECIST|16|||
149903018|NCT02564900|540776070|FG010|Dose Expansion|Progressive disease per RECIST|13|||
149903019|NCT02564900|540776071|FG011|Dose Expansion|Progressive disease per RECIST|19|||
149903020|NCT02564900|540776072|FG012|Dose Expansion|Progressive disease per RECIST|10|||
149903021|NCT02564900|540776073|FG013|Dose Expansion|Progressive disease per RECIST|13|||
149903022|NCT02564900|540776074|FG014|Dose Expansion|Progressive disease per RECIST|11|||
149903023|NCT02564900|540776060|FG000|Dose Expansion|Clinical progression|0|||
149903024|NCT02564900|540776061|FG001|Dose Expansion|Clinical progression|0|||
149903025|NCT02564900|540776062|FG002|Dose Expansion|Clinical progression|0|||
149903026|NCT02564900|540776063|FG003|Dose Expansion|Clinical progression|0|||
149903027|NCT02564900|540776064|FG004|Dose Expansion|Clinical progression|0|||
149903028|NCT02564900|540776065|FG005|Dose Expansion|Clinical progression|0|||
149903029|NCT02564900|540776066|FG006|Dose Expansion|Clinical progression|5|||
149903030|NCT02564900|540776067|FG007|Dose Expansion|Clinical progression|12|||
149903031|NCT02564900|540776068|FG008|Dose Expansion|Clinical progression|0|||
149903032|NCT02564900|540776069|FG009|Dose Expansion|Clinical progression|3|||
149903033|NCT02564900|540776070|FG010|Dose Expansion|Clinical progression|2|||
149903034|NCT02564900|540776071|FG011|Dose Expansion|Clinical progression|0|||
149903035|NCT02564900|540776072|FG012|Dose Expansion|Clinical progression|1|||
149903036|NCT02564900|540776073|FG013|Dose Expansion|Clinical progression|3|||
149903037|NCT02564900|540776074|FG014|Dose Expansion|Clinical progression|1|||
149903038|NCT02564900|540776060|FG000|Dose Expansion|Adverse Event|0|||
149903039|NCT02564900|540776061|FG001|Dose Expansion|Adverse Event|0|||
149903040|NCT02564900|540776062|FG002|Dose Expansion|Adverse Event|0|||
149903041|NCT02564900|540776063|FG003|Dose Expansion|Adverse Event|0|||
149903042|NCT02564900|540776064|FG004|Dose Expansion|Adverse Event|0|||
149903043|NCT02564900|540776065|FG005|Dose Expansion|Adverse Event|0|||
149903044|NCT02564900|540776066|FG006|Dose Expansion|Adverse Event|9|||
149903045|NCT02564900|540776067|FG007|Dose Expansion|Adverse Event|22|||
149903046|NCT02564900|540776068|FG008|Dose Expansion|Adverse Event|0|||
149903047|NCT02564900|540776069|FG009|Dose Expansion|Adverse Event|11|||
149903048|NCT02564900|540776070|FG010|Dose Expansion|Adverse Event|0|||
149903049|NCT02564900|540776071|FG011|Dose Expansion|Adverse Event|5|||
149903050|NCT02564900|540776072|FG012|Dose Expansion|Adverse Event|2|||
149903051|NCT02564900|540776073|FG013|Dose Expansion|Adverse Event|2|||
149903052|NCT02564900|540776074|FG014|Dose Expansion|Adverse Event|1|||
149903053|NCT02564900|540776060|FG000|Dose Expansion|Ongoing|0|||
149903054|NCT02564900|540776061|FG001|Dose Expansion|Ongoing|0|||
149903055|NCT02564900|540776062|FG002|Dose Expansion|Ongoing|0|||
149903056|NCT02564900|540776063|FG003|Dose Expansion|Ongoing|0|||
149903057|NCT02564900|540776064|FG004|Dose Expansion|Ongoing|0|||
149903058|NCT02564900|540776065|FG005|Dose Expansion|Ongoing|0|||
149903059|NCT02564900|540776066|FG006|Dose Expansion|Ongoing|9|||
149903060|NCT02564900|540776067|FG007|Dose Expansion|Ongoing|10|||
149903061|NCT02564900|540776068|FG008|Dose Expansion|Ongoing|11|||
149903062|NCT02564900|540776069|FG009|Dose Expansion|Ongoing|3|||
149903063|NCT02564900|540776070|FG010|Dose Expansion|Ongoing|0|||
149903064|NCT02564900|540776071|FG011|Dose Expansion|Ongoing|0|||
149903065|NCT02564900|540776072|FG012|Dose Expansion|Ongoing|4|||
149903066|NCT02564900|540776073|FG013|Dose Expansion|Ongoing|0|||
149903067|NCT02564900|540776074|FG014|Dose Expansion|Ongoing|6|||
149903068|NCT02564900|540776060|FG000|Dose Expansion|Death|0|||
149903069|NCT02564900|540776061|FG001|Dose Expansion|Death|0|||
149903070|NCT02564900|540776062|FG002|Dose Expansion|Death|0|||
149903071|NCT02564900|540776063|FG003|Dose Expansion|Death|0|||
149903072|NCT02564900|540776064|FG004|Dose Expansion|Death|0|||
149903073|NCT02564900|540776065|FG005|Dose Expansion|Death|0|||
149903074|NCT02564900|540776066|FG006|Dose Expansion|Death|1|||
149903075|NCT02564900|540776067|FG007|Dose Expansion|Death|0|||
149903076|NCT02564900|540776068|FG008|Dose Expansion|Death|0|||
149903077|NCT02564900|540776069|FG009|Dose Expansion|Death|0|||
149903078|NCT02564900|540776070|FG010|Dose Expansion|Death|1|||
149903079|NCT02564900|540776071|FG011|Dose Expansion|Death|0|||
149903080|NCT02564900|540776072|FG012|Dose Expansion|Death|1|||
150046232|NCT05064358|541308097|FG004|Overall Study|Ongoing at the time of analysis|2|||
150046233|NCT04421027|541308098|FG000|Treatment Period|Adverse Event|5|||
150046234|NCT04421027|541308099|FG001|Treatment Period|Adverse Event|3|||
150046235|NCT04421027|541308100|FG002|Treatment Period|Adverse Event|0|||
150046236|NCT04421027|541308101|FG003|Treatment Period|Adverse Event|0|||
150046237|NCT04421027|541308098|FG000|Treatment Period|Death|98|||
149903081|NCT02564900|540776073|FG013|Dose Expansion|Death|1|||
149903082|NCT02564900|540776074|FG014|Dose Expansion|Death|0|||
149903083|NCT02564900|540776060|FG000|Dose Expansion|Withdrawal by Subject|0|||
150046238|NCT04421027|541308099|FG001|Treatment Period|Death|61|||
150046239|NCT04421027|541308100|FG002|Treatment Period|Death|0|||
150046240|NCT04421027|541308101|FG003|Treatment Period|Death|0|||
149903084|NCT02564900|540776061|FG001|Dose Expansion|Withdrawal by Subject|0|||
149903085|NCT02564900|540776062|FG002|Dose Expansion|Withdrawal by Subject|0|||
149903086|NCT02564900|540776063|FG003|Dose Expansion|Withdrawal by Subject|0|||
149903087|NCT02564900|540776064|FG004|Dose Expansion|Withdrawal by Subject|0|||
149903088|NCT02564900|540776065|FG005|Dose Expansion|Withdrawal by Subject|0|||
150046241|NCT04421027|541308098|FG000|Treatment Period|Lost to Follow-up|22|||
149903089|NCT02564900|540776066|FG006|Dose Expansion|Withdrawal by Subject|4|||
149903090|NCT02564900|540776067|FG007|Dose Expansion|Withdrawal by Subject|0|||
149903091|NCT02564900|540776068|FG008|Dose Expansion|Withdrawal by Subject|0|||
149903092|NCT02564900|540776069|FG009|Dose Expansion|Withdrawal by Subject|0|||
149903093|NCT02564900|540776070|FG010|Dose Expansion|Withdrawal by Subject|1|||
150046242|NCT04421027|541308099|FG001|Treatment Period|Lost to Follow-up|20|||
149903094|NCT02564900|540776071|FG011|Dose Expansion|Withdrawal by Subject|0|||
149903095|NCT02564900|540776072|FG012|Dose Expansion|Withdrawal by Subject|0|||
149903096|NCT02564900|540776073|FG013|Dose Expansion|Withdrawal by Subject|1|||
149903097|NCT02564900|540776074|FG014|Dose Expansion|Withdrawal by Subject|1|||
149903098|NCT02564900|540776060|FG000|Dose Expansion|Other|0|||
149903099|NCT02564900|540776061|FG001|Dose Expansion|Other|0|||
149903100|NCT02564900|540776062|FG002|Dose Expansion|Other|0|||
149903101|NCT02564900|540776063|FG003|Dose Expansion|Other|0|||
149903102|NCT02564900|540776064|FG004|Dose Expansion|Other|0|||
149903103|NCT02564900|540776065|FG005|Dose Expansion|Other|0|||
149903104|NCT02564900|540776066|FG006|Dose Expansion|Other|1|||
149903105|NCT02564900|540776067|FG007|Dose Expansion|Other|0|||
149903106|NCT02564900|540776068|FG008|Dose Expansion|Other|1|||
149903107|NCT02564900|540776069|FG009|Dose Expansion|Other|0|||
149903108|NCT02564900|540776070|FG010|Dose Expansion|Other|0|||
149903109|NCT02564900|540776071|FG011|Dose Expansion|Other|0|||
149903110|NCT02564900|540776072|FG012|Dose Expansion|Other|0|||
149903111|NCT02564900|540776073|FG013|Dose Expansion|Other|0|||
149903112|NCT02564900|540776074|FG014|Dose Expansion|Other|1|||
149903113|NCT02564900|540776060|FG000|Dose Expansion|Did not receive treatment|0|||
149903114|NCT02564900|540776061|FG001|Dose Expansion|Did not receive treatment|0|||
149903115|NCT02564900|540776062|FG002|Dose Expansion|Did not receive treatment|0|||
149903116|NCT02564900|540776063|FG003|Dose Expansion|Did not receive treatment|0|||
149903117|NCT02564900|540776064|FG004|Dose Expansion|Did not receive treatment|0|||
149903118|NCT02564900|540776065|FG005|Dose Expansion|Did not receive treatment|0|||
149903119|NCT02564900|540776066|FG006|Dose Expansion|Did not receive treatment|1|||
149903120|NCT02564900|540776067|FG007|Dose Expansion|Did not receive treatment|1|||
149903121|NCT02564900|540776068|FG008|Dose Expansion|Did not receive treatment|0|||
149903122|NCT02564900|540776069|FG009|Dose Expansion|Did not receive treatment|0|||
149903123|NCT02564900|540776070|FG010|Dose Expansion|Did not receive treatment|0|||
149903124|NCT02564900|540776071|FG011|Dose Expansion|Did not receive treatment|0|||
149903125|NCT02564900|540776072|FG012|Dose Expansion|Did not receive treatment|0|||
149903126|NCT02564900|540776073|FG013|Dose Expansion|Did not receive treatment|0|||
149903127|NCT02564900|540776074|FG014|Dose Expansion|Did not receive treatment|1|||
149903128|NCT04292912|540776076|FG000|Overall Study|Physician Decision|1|||
149903129|NCT04292912|540776076|FG000|Overall Study|Protocol Violation|6|||
149903130|NCT00280397|540776077|FG000|Overall Study|Adverse Event|1|||
149903131|NCT05338502|540776085|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
149903132|NCT05338502|540776086|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
149903133|NCT05338502|540776087|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
149903134|NCT05338502|540776085|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
149903135|NCT05338502|540776086|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
149903136|NCT05338502|540776087|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
149903137|NCT02278939|540776088|FG000|Overall Study|lack of time|1|||
149903138|NCT02278939|540776089|FG001|Overall Study|lack of time|0|||
149903139|NCT02278939|540776088|FG000|Overall Study|Lost to Follow-up|1|||
149903140|NCT02278939|540776089|FG001|Overall Study|Lost to Follow-up|1|||
149903141|NCT02278939|540776088|FG000|Overall Study|death in family|1|||
149903142|NCT02278939|540776089|FG001|Overall Study|death in family|0|||
149903143|NCT02278939|540776088|FG000|Overall Study|family emergency unable to commit|2|||
149903144|NCT02278939|540776089|FG001|Overall Study|family emergency unable to commit|0|||
149903145|NCT02423343|540776092|FG000|Overall Study|Withdrawal by Subject|0|||
149903146|NCT02423343|540776093|FG001|Overall Study|Withdrawal by Subject|1|||
149903147|NCT02423343|540776094|FG002|Overall Study|Withdrawal by Subject|0|||
149903148|NCT02423343|540776095|FG003|Overall Study|Withdrawal by Subject|0|||
149903149|NCT02423343|540776096|FG004|Overall Study|Withdrawal by Subject|0|||
149903150|NCT02423343|540776097|FG005|Overall Study|Withdrawal by Subject|0|||
149903151|NCT02423343|540776092|FG000|Overall Study|Progressive Disease|0|||
149903152|NCT02423343|540776093|FG001|Overall Study|Progressive Disease|0|||
149903153|NCT02423343|540776094|FG002|Overall Study|Progressive Disease|0|||
149903154|NCT02423343|540776095|FG003|Overall Study|Progressive Disease|0|||
149903155|NCT02423343|540776096|FG004|Overall Study|Progressive Disease|2|||
149903156|NCT02423343|540776097|FG005|Overall Study|Progressive Disease|0|||
149903157|NCT02423343|540776092|FG000|Overall Study|Adverse Event|0|||
149903158|NCT02423343|540776093|FG001|Overall Study|Adverse Event|0|||
149903159|NCT02423343|540776094|FG002|Overall Study|Adverse Event|0|||
149903160|NCT02423343|540776095|FG003|Overall Study|Adverse Event|0|||
149903161|NCT02423343|540776096|FG004|Overall Study|Adverse Event|2|||
149903162|NCT02423343|540776097|FG005|Overall Study|Adverse Event|0|||
149903163|NCT02423343|540776092|FG000|Overall Study|Death|0|||
149903164|NCT02423343|540776093|FG001|Overall Study|Death|0|||
150046243|NCT04421027|541308100|FG002|Treatment Period|Lost to Follow-up|0|||
149903165|NCT02423343|540776094|FG002|Overall Study|Death|0|||
149903166|NCT02423343|540776095|FG003|Overall Study|Death|0|||
149903167|NCT02423343|540776096|FG004|Overall Study|Death|1|||
149903168|NCT02423343|540776097|FG005|Overall Study|Death|0|||
149903169|NCT01127451|540776103|FG000|Overall Study|Other|2|||
149903170|NCT01127451|540776104|FG001|Overall Study|Other|1|||
149903171|NCT01127451|540776103|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
149903172|NCT01127451|540776104|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
149903173|NCT01127451|540776103|FG000|Overall Study|Death|22|||
149903174|NCT01127451|540776104|FG001|Overall Study|Death|17|||
149903175|NCT01127451|540776103|FG000|Overall Study|Lost to Follow-up|3|||
149903176|NCT01127451|540776104|FG001|Overall Study|Lost to Follow-up|0|||
149903177|NCT01127451|540776103|FG000|Overall Study|Administrative Reason by Sponsor|2|||
149903178|NCT01127451|540776104|FG001|Overall Study|Administrative Reason by Sponsor|2|||
149903179|NCT02111577|540776105|FG000|Overall Study|Protocol Violation|2|||
149903180|NCT02111577|540776106|FG001|Overall Study|Protocol Violation|0|||
149903181|NCT02111577|540776105|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
149903182|NCT02111577|540776106|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
149903183|NCT02111577|540776105|FG000|Overall Study|Failure to produce study treatment|6|||
149903184|NCT02111577|540776106|FG001|Overall Study|Failure to produce study treatment|0|||
149903185|NCT02111577|540776105|FG000|Overall Study|Death|518|||
149903186|NCT02111577|540776106|FG001|Overall Study|Death|254|||
149903187|NCT02111577|540776105|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
149903188|NCT02111577|540776106|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
149903189|NCT02111577|540776105|FG000|Overall Study|Adverse Event|1|||
149903190|NCT02111577|540776106|FG001|Overall Study|Adverse Event|1|||
149903191|NCT02111577|540776105|FG000|Overall Study|Withdrawal by Subject|51|||
149903192|NCT02111577|540776106|FG001|Overall Study|Withdrawal by Subject|23|||
149903193|NCT02111577|540776105|FG000|Overall Study|Disease progression|0|||
149903194|NCT02111577|540776106|FG001|Overall Study|Disease progression|1|||
149903195|NCT02111577|540776105|FG000|Overall Study|Lost to Follow-up|19|||
149903196|NCT02111577|540776106|FG001|Overall Study|Lost to Follow-up|10|||
149903197|NCT01014988|540776107|FG000|Overall Study|Adverse Event|20|||
149903198|NCT01014988|540776108|FG001|Overall Study|Adverse Event|0|||
149903199|NCT01014988|540776109|FG002|Overall Study|Adverse Event|1|||
149903200|NCT01014988|540776110|FG003|Overall Study|Adverse Event|0|||
149903201|NCT01014988|540776111|FG004|Overall Study|Adverse Event|1|||
149903202|NCT01014988|540776112|FG005|Overall Study|Adverse Event|3|||
149903203|NCT01014988|540776107|FG000|Overall Study|Lost to Follow-up|1|||
149903204|NCT01014988|540776108|FG001|Overall Study|Lost to Follow-up|0|||
149903205|NCT01014988|540776109|FG002|Overall Study|Lost to Follow-up|1|||
149903206|NCT01014988|540776110|FG003|Overall Study|Lost to Follow-up|0|||
149903207|NCT01014988|540776111|FG004|Overall Study|Lost to Follow-up|0|||
149903208|NCT01014988|540776112|FG005|Overall Study|Lost to Follow-up|0|||
149903209|NCT01014988|540776107|FG000|Overall Study|Physician Decision|1|||
149903210|NCT01014988|540776108|FG001|Overall Study|Physician Decision|0|||
149903211|NCT01014988|540776109|FG002|Overall Study|Physician Decision|0|||
149903212|NCT01014988|540776110|FG003|Overall Study|Physician Decision|0|||
149903213|NCT01014988|540776111|FG004|Overall Study|Physician Decision|0|||
149903214|NCT01014988|540776112|FG005|Overall Study|Physician Decision|0|||
149903215|NCT01014988|540776107|FG000|Overall Study|Withdrawal by Subject|1|||
149903216|NCT01014988|540776108|FG001|Overall Study|Withdrawal by Subject|0|||
149903217|NCT01014988|540776109|FG002|Overall Study|Withdrawal by Subject|0|||
149903218|NCT01014988|540776110|FG003|Overall Study|Withdrawal by Subject|0|||
149903219|NCT01014988|540776111|FG004|Overall Study|Withdrawal by Subject|0|||
149903220|NCT01014988|540776112|FG005|Overall Study|Withdrawal by Subject|0|||
149903221|NCT00729157|540776113|FG000|Overall Study|Withdrawal by Subject|1|||
149903222|NCT01683266|540776114|FG000|Overall Study|Adverse Event|5|||
149903223|NCT01683266|540776115|FG001|Overall Study|Adverse Event|4|||
149903224|NCT01683266|540776114|FG000|Overall Study|Lack of Efficacy|5|||
149903225|NCT01683266|540776115|FG001|Overall Study|Lack of Efficacy|2|||
149903226|NCT01683266|540776114|FG000|Overall Study|Protocol Violation|13|||
149903227|NCT01683266|540776115|FG001|Overall Study|Protocol Violation|6|||
149903228|NCT01683266|540776114|FG000|Overall Study|Personal Reason|17|||
149903229|NCT01683266|540776115|FG001|Overall Study|Personal Reason|25|||
149903230|NCT01683266|540776114|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
149903231|NCT01683266|540776115|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
149903232|NCT01683266|540776114|FG000|Overall Study|Lost to Follow-up|5|||
149903233|NCT01683266|540776115|FG001|Overall Study|Lost to Follow-up|0|||
149903234|NCT01683266|540776114|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
149903235|NCT01683266|540776115|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
149903236|NCT01683266|540776114|FG000|Overall Study|Nonserious Hypoglycemia|0|||
149903237|NCT01683266|540776115|FG001|Overall Study|Nonserious Hypoglycemia|3|||
149903238|NCT01683266|540776114|FG000|Overall Study|Perceived Lack of Efficacy|1|||
149903239|NCT01683266|540776115|FG001|Overall Study|Perceived Lack of Efficacy|1|||
149903240|NCT01683266|540776114|FG000|Overall Study|Possibly Hypoglycemia|1|||
149903241|NCT01683266|540776115|FG001|Overall Study|Possibly Hypoglycemia|0|||
149903242|NCT01683266|540776114|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
149903243|NCT01683266|540776115|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
149903244|NCT00886743|540776116|FG000|Overall Study|Adverse Event|3|||
149903245|NCT00886743|540776116|FG000|Overall Study|Other|1|||
149903246|NCT00626821|540776117|FG000|Overall Study|Adverse Event|44|||
149903247|NCT00626821|540776117|FG000|Overall Study|Protocol Violation|33|||
149903248|NCT00626821|540776117|FG000|Overall Study|Withdrawal by Subject|10|||
149903249|NCT00626821|540776117|FG000|Overall Study|Physician Decision|9|||
149903250|NCT00626821|540776117|FG000|Overall Study|Product dysfunction|21|||
149903251|NCT00626821|540776117|FG000|Overall Study|other/unknown reason|104|||
149903252|NCT03655470|540776125|FG000|Overall Study|Lost to Follow-up|6|||
149903253|NCT03655470|540776126|FG001|Overall Study|Lost to Follow-up|7|||
149903254|NCT02244463|540776127|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
149903255|NCT02244463|540776128|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
149903256|NCT02244463|540776129|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
149903257|NCT02244463|540776130|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
149903258|NCT02244463|540776131|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
149903259|NCT02244463|540776132|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
149903260|NCT02244463|540776127|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
149903261|NCT02244463|540776128|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
149903262|NCT02244463|540776129|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
149903263|NCT02244463|540776130|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
149903264|NCT02244463|540776131|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
149903265|NCT02244463|540776132|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
149903266|NCT02244463|540776127|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
149903267|NCT02244463|540776128|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
149903268|NCT02244463|540776129|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
149903269|NCT02244463|540776130|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
150046244|NCT04421027|541308101|FG003|Treatment Period|Lost to Follow-up|0|||
149903270|NCT02244463|540776131|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
149903271|NCT02244463|540776132|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
149903272|NCT02244463|540776127|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
149903273|NCT02244463|540776128|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
149903274|NCT02244463|540776129|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
149903275|NCT02244463|540776130|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
149903276|NCT02244463|540776131|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
149903277|NCT02244463|540776132|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
149903278|NCT02244463|540776127|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
149903279|NCT02244463|540776128|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
149903280|NCT02244463|540776129|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
149903281|NCT02244463|540776130|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
149903282|NCT02244463|540776131|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
149903283|NCT02244463|540776132|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
149903284|NCT02244463|540776127|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
149903285|NCT02244463|540776128|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
149903286|NCT02244463|540776129|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
149903287|NCT02244463|540776130|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
149903288|NCT02244463|540776131|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
149903289|NCT02244463|540776132|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
149903290|NCT02244463|540776127|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
149903291|NCT02244463|540776128|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
149903292|NCT02244463|540776129|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
149903293|NCT02244463|540776130|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
149903294|NCT02244463|540776131|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
149903295|NCT02244463|540776132|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
149903296|NCT02244463|540776127|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
149903297|NCT02244463|540776128|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
149903298|NCT02244463|540776129|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
149903299|NCT02244463|540776130|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
149903300|NCT02244463|540776131|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
149903301|NCT02244463|540776132|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
149903302|NCT02244463|540776127|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
149903303|NCT02244463|540776128|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
149903304|NCT02244463|540776129|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
149903305|NCT02244463|540776130|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
149903306|NCT02244463|540776131|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
149903307|NCT02244463|540776132|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
149903308|NCT02244463|540776127|FG000|Period 5: Phase II|Disease Progression|0|||
149903309|NCT02244463|540776128|FG001|Period 5: Phase II|Disease Progression|0|||
149903310|NCT02244463|540776129|FG002|Period 5: Phase II|Disease Progression|0|||
149903311|NCT02244463|540776130|FG003|Period 5: Phase II|Disease Progression|0|||
149903312|NCT02244463|540776131|FG004|Period 5: Phase II|Disease Progression|10|||
149903313|NCT02244463|540776132|FG005|Period 5: Phase II|Disease Progression|11|||
149903314|NCT02244463|540776127|FG000|Period 5: Phase II|Physician Decision|0|||
149903315|NCT02244463|540776128|FG001|Period 5: Phase II|Physician Decision|0|||
149903316|NCT02244463|540776129|FG002|Period 5: Phase II|Physician Decision|0|||
149903317|NCT02244463|540776130|FG003|Period 5: Phase II|Physician Decision|0|||
149903318|NCT02244463|540776131|FG004|Period 5: Phase II|Physician Decision|3|||
149903319|NCT02244463|540776132|FG005|Period 5: Phase II|Physician Decision|2|||
149903320|NCT02244463|540776127|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
149903321|NCT02244463|540776128|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
149903322|NCT02244463|540776129|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
149903323|NCT02244463|540776130|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
149903324|NCT02244463|540776131|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
149903325|NCT02244463|540776132|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
149903326|NCT02244463|540776127|FG000|Period 5: Phase II|Intercurrent Illness|0|||
149903327|NCT02244463|540776128|FG001|Period 5: Phase II|Intercurrent Illness|0|||
149903328|NCT02244463|540776129|FG002|Period 5: Phase II|Intercurrent Illness|0|||
149903329|NCT02244463|540776130|FG003|Period 5: Phase II|Intercurrent Illness|0|||
149903330|NCT02244463|540776131|FG004|Period 5: Phase II|Intercurrent Illness|2|||
149903331|NCT02244463|540776132|FG005|Period 5: Phase II|Intercurrent Illness|0|||
149903332|NCT02244463|540776127|FG000|Period 5: Phase II|Adverse Event|0|||
149903333|NCT02244463|540776128|FG001|Period 5: Phase II|Adverse Event|0|||
149903334|NCT02244463|540776129|FG002|Period 5: Phase II|Adverse Event|0|||
149903335|NCT02244463|540776130|FG003|Period 5: Phase II|Adverse Event|0|||
149903336|NCT02244463|540776131|FG004|Period 5: Phase II|Adverse Event|0|||
149903337|NCT02244463|540776132|FG005|Period 5: Phase II|Adverse Event|2|||
149903338|NCT02244463|540776127|FG000|Period 5: Phase II|Still On treatment|0|||
149903339|NCT02244463|540776128|FG001|Period 5: Phase II|Still On treatment|0|||
149903340|NCT02244463|540776129|FG002|Period 5: Phase II|Still On treatment|0|||
149903341|NCT02244463|540776130|FG003|Period 5: Phase II|Still On treatment|0|||
149903342|NCT02244463|540776131|FG004|Period 5: Phase II|Still On treatment|0|||
149903343|NCT02244463|540776132|FG005|Period 5: Phase II|Still On treatment|3|||
149903344|NCT03702010|540776135|FG000|Follow-up (30days)|Lack of Efficacy|2|||
149903345|NCT03702010|540776136|FG001|Follow-up (30days)|Lack of Efficacy|2|||
149903346|NCT02295020|540776143|FG000|Overall Study|Adverse Event|0|||
149903347|NCT02295020|540776144|FG001|Overall Study|Adverse Event|1|||
149903348|NCT02295020|540776143|FG000|Overall Study|Withdrawal by Subject|3|||
149903349|NCT02295020|540776144|FG001|Overall Study|Withdrawal by Subject|2|||
149903350|NCT04791319|540776145|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
149903351|NCT04791319|540776146|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
149903352|NCT04791319|540776147|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
149903353|NCT04791319|540776148|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
149903354|NCT04791319|540776149|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903355|NCT04791319|540776150|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903356|NCT04791319|540776151|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903357|NCT04791319|540776152|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903358|NCT04791319|540776153|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903359|NCT04791319|540776154|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903360|NCT04791319|540776155|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
149903361|NCT04791319|540776145|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
149903362|NCT04791319|540776146|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903363|NCT04791319|540776147|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
149903364|NCT04791319|540776148|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
149903365|NCT04791319|540776149|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903366|NCT04791319|540776150|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903367|NCT04791319|540776151|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903368|NCT04791319|540776152|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903369|NCT04791319|540776153|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903370|NCT04791319|540776154|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903371|NCT04791319|540776155|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
149903372|NCT04791319|540776145|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
149903373|NCT04791319|540776146|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
149903374|NCT04791319|540776147|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
149903375|NCT04791319|540776148|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
149903376|NCT04791319|540776149|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903377|NCT04791319|540776150|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903378|NCT04791319|540776151|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903379|NCT04791319|540776152|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903380|NCT04791319|540776153|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903381|NCT04791319|540776154|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903382|NCT04791319|540776155|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
149903383|NCT04791319|540776145|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
149903384|NCT04791319|540776146|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
149903385|NCT04791319|540776147|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
149903386|NCT04791319|540776148|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
149903387|NCT04791319|540776149|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903388|NCT04791319|540776150|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903389|NCT04791319|540776151|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903390|NCT04791319|540776152|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903391|NCT04791319|540776153|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903392|NCT04791319|540776154|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903393|NCT04791319|540776155|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
149903394|NCT04791319|540776145|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903395|NCT04791319|540776146|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
150046245|NCT04421027|541308098|FG000|Treatment Period|Other-Unknown|15|||
150046246|NCT04421027|541308099|FG001|Treatment Period|Other-Unknown|9|||
150046247|NCT04421027|541308100|FG002|Treatment Period|Other-Unknown|0|||
149903396|NCT04791319|540776147|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903397|NCT04791319|540776148|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
149903398|NCT04791319|540776149|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903399|NCT04791319|540776150|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903400|NCT04791319|540776151|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903401|NCT04791319|540776152|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903402|NCT04791319|540776153|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903403|NCT04791319|540776154|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903404|NCT04791319|540776155|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
149903405|NCT04791319|540776145|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903406|NCT04791319|540776146|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903407|NCT04791319|540776147|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903408|NCT04791319|540776148|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903409|NCT04791319|540776149|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
149903410|NCT04791319|540776150|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
149903411|NCT04791319|540776151|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
149903412|NCT04791319|540776152|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903413|NCT04791319|540776153|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903414|NCT04791319|540776154|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
149903415|NCT04791319|540776155|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
149903416|NCT04791319|540776145|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903417|NCT04791319|540776146|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903418|NCT04791319|540776147|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903419|NCT04791319|540776148|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903420|NCT04791319|540776149|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903421|NCT04791319|540776150|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903422|NCT04791319|540776151|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903423|NCT04791319|540776152|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903424|NCT04791319|540776153|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903425|NCT04791319|540776154|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
149903426|NCT04791319|540776155|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
149903427|NCT04791319|540776145|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
149903428|NCT04791319|540776146|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
150046248|NCT04421027|541308101|FG003|Treatment Period|Other-Unknown|0|||
150176511|NCT00958633|541782002|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
150176512|NCT00305695|541782005|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
149903429|NCT04791319|540776147|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
149903430|NCT04791319|540776148|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
149903431|NCT04791319|540776149|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
149903432|NCT04791319|540776150|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
149903433|NCT04791319|540776151|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
149903434|NCT04791319|540776152|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
149903435|NCT04791319|540776153|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
149903436|NCT04791319|540776154|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
149903437|NCT04791319|540776155|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
149903438|NCT04791319|540776145|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
149903439|NCT04791319|540776146|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
149903440|NCT04791319|540776147|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
149903441|NCT04791319|540776148|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
149903442|NCT04791319|540776149|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
149903443|NCT04791319|540776150|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
149903444|NCT04791319|540776151|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
149903445|NCT04791319|540776152|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
149903446|NCT04791319|540776153|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
149903447|NCT04791319|540776154|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
149903448|NCT04791319|540776155|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
149903449|NCT00355147|540776162|FG000|Overall Study|Lost to Follow-up|10|||
149903450|NCT00355147|540776163|FG001|Overall Study|Lost to Follow-up|8|||
149903451|NCT00355147|540776162|FG000|Overall Study|Withdrawal by Subject|8|||
149903452|NCT00355147|540776163|FG001|Overall Study|Withdrawal by Subject|12|||
149903453|NCT00765336|540776170|FG000|Overall Study|Protocol Violation|4|||
149903454|NCT00765336|540776171|FG001|Overall Study|Protocol Violation|2|||
149903455|NCT00765336|540776170|FG000|Overall Study|Withdrawal by Subject|6|||
149903456|NCT00765336|540776171|FG001|Overall Study|Withdrawal by Subject|4|||
149903457|NCT00765336|540776170|FG000|Overall Study|Lost to Follow-up|7|||
149903458|NCT00765336|540776171|FG001|Overall Study|Lost to Follow-up|9|||
149903459|NCT00765336|540776170|FG000|Overall Study|Adverse Event|2|||
149903460|NCT00765336|540776171|FG001|Overall Study|Adverse Event|1|||
149903461|NCT01323387|540776183|FG000|Overall Study|Withdrawal by Subject|41|||
149903462|NCT01323387|540776183|FG000|Overall Study|Radiographic Data Unavailable|1|||
149903463|NCT01323387|540776183|FG000|Overall Study|Revision|14|||
149903464|NCT01323387|540776183|FG000|Overall Study|Protocol Violation|12|||
149903465|NCT01323387|540776183|FG000|Overall Study|Randomized but Never Treated|16|||
149903466|NCT00697463|540776186|FG000|Overall Study|Withdrawal by Subject|1|||
149903467|NCT03307252|540776187|FG000|Part 2, Period 1|Treatment not received|0|||
149903468|NCT03307252|540776188|FG001|Part 2, Period 1|Treatment not received|0|||
149903469|NCT03307252|540776189|FG002|Part 2, Period 1|Treatment not received|0|||
149903470|NCT03307252|540776190|FG003|Part 2, Period 1|Treatment not received|0|||
149903471|NCT03307252|540776191|FG004|Part 2, Period 1|Treatment not received|0|||
149903472|NCT03307252|540776192|FG005|Part 2, Period 1|Treatment not received|1|||
149903473|NCT03307252|540776193|FG006|Part 2, Period 1|Treatment not received|0|||
149903474|NCT03307252|540776194|FG007|Part 2, Period 1|Treatment not received|0|||
149903475|NCT03307252|540776195|FG008|Part 2, Period 1|Treatment not received|0|||
149903476|NCT03307252|540776196|FG009|Part 2, Period 1|Treatment not received|0|||
149903477|NCT03307252|540776197|FG010|Part 2, Period 1|Treatment not received|0|||
149903478|NCT03307252|540776187|FG000|Part 2, Period 3|Other than listed|0|||
149903479|NCT03307252|540776188|FG001|Part 2, Period 3|Other than listed|0|||
149903480|NCT03307252|540776189|FG002|Part 2, Period 3|Other than listed|0|||
149903481|NCT03307252|540776190|FG003|Part 2, Period 3|Other than listed|0|||
149903482|NCT03307252|540776191|FG004|Part 2, Period 3|Other than listed|1|||
149903483|NCT03307252|540776192|FG005|Part 2, Period 3|Other than listed|0|||
149903484|NCT03307252|540776193|FG006|Part 2, Period 3|Other than listed|0|||
149903485|NCT03307252|540776194|FG007|Part 2, Period 3|Other than listed|0|||
149903486|NCT03307252|540776195|FG008|Part 2, Period 3|Other than listed|0|||
149903487|NCT03307252|540776196|FG009|Part 2, Period 3|Other than listed|0|||
149903488|NCT03307252|540776197|FG010|Part 2, Period 3|Other than listed|0|||
149903489|NCT03307252|540776187|FG000|Part 2, Period 4|Other than listed|0|||
149903490|NCT03307252|540776188|FG001|Part 2, Period 4|Other than listed|0|||
149903491|NCT03307252|540776189|FG002|Part 2, Period 4|Other than listed|0|||
149903492|NCT03307252|540776190|FG003|Part 2, Period 4|Other than listed|0|||
149903493|NCT03307252|540776191|FG004|Part 2, Period 4|Other than listed|0|||
149903494|NCT03307252|540776192|FG005|Part 2, Period 4|Other than listed|0|||
149903495|NCT03307252|540776193|FG006|Part 2, Period 4|Other than listed|1|||
149903496|NCT03307252|540776194|FG007|Part 2, Period 4|Other than listed|0|||
149903497|NCT03307252|540776195|FG008|Part 2, Period 4|Other than listed|0|||
149903498|NCT03307252|540776196|FG009|Part 2, Period 4|Other than listed|0|||
149903499|NCT03307252|540776197|FG010|Part 2, Period 4|Other than listed|0|||
149903500|NCT03307252|540776187|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903501|NCT03307252|540776188|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903502|NCT03307252|540776189|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903503|NCT03307252|540776190|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903504|NCT03307252|540776191|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903505|NCT03307252|540776192|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903506|NCT03307252|540776193|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903507|NCT03307252|540776194|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903508|NCT03307252|540776195|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903509|NCT03307252|540776196|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
149903510|NCT03307252|540776197|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
149903511|NCT03482453|540776198|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903512|NCT03482453|540776199|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903513|NCT03482453|540776200|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903514|NCT03482453|540776201|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903515|NCT03482453|540776202|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903516|NCT03482453|540776203|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903517|NCT03482453|540776204|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903518|NCT03482453|540776205|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903519|NCT03482453|540776206|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903520|NCT03482453|540776207|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903521|NCT03482453|540776208|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
149903522|NCT03482453|540776209|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
149903523|NCT01554527|540776210|FG000|Overall Study|Withdrawal by Subject|1|||
149903524|NCT01554527|540776211|FG001|Overall Study|Withdrawal by Subject|0|||
149969354|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
149969355|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
149969356|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
149903525|NCT01554527|540776212|FG002|Overall Study|Withdrawal by Subject|3|||
149903526|NCT01554527|540776210|FG000|Overall Study|Lost to Follow-up|0|||
149903527|NCT01554527|540776211|FG001|Overall Study|Lost to Follow-up|0|||
149903528|NCT01554527|540776212|FG002|Overall Study|Lost to Follow-up|4|||
149903529|NCT01554527|540776210|FG000|Overall Study|Physician Decision|0|||
149903530|NCT01554527|540776211|FG001|Overall Study|Physician Decision|0|||
149903531|NCT01554527|540776212|FG002|Overall Study|Physician Decision|1|||
149903532|NCT00199797|540777781|FG000|Overall Study|Progressive Disease|1|||
149903533|NCT00199797|540777781|FG000|Overall Study|Adverse Event|1|||
149903534|NCT00199797|540777781|FG000|Overall Study|Physician Decision|1|||
149903535|NCT00504725|540777786|FG000|Overall Study|Protocol Violation|1|||
149903536|NCT00504725|540777787|FG001|Overall Study|Protocol Violation|0|||
149903537|NCT01435018|540777788|FG000|Overall Study|Death|37|||
149903538|NCT01435018|540777789|FG001|Overall Study|Death|18|||
149903539|NCT01435018|540777790|FG002|Overall Study|Death|25|||
149903540|NCT01435018|540777788|FG000|Overall Study|Site is closing|4|||
149903541|NCT01435018|540777789|FG001|Overall Study|Site is closing|9|||
149903542|NCT01435018|540777790|FG002|Overall Study|Site is closing|7|||
149903543|NCT01435018|540777788|FG000|Overall Study|Withdrew consent|0|||
149903544|NCT01435018|540777789|FG001|Overall Study|Withdrew consent|3|||
149903545|NCT01435018|540777790|FG002|Overall Study|Withdrew consent|1|||
149903546|NCT01435018|540777788|FG000|Overall Study|Not willing to adhere to requirements|0|||
149903547|NCT01435018|540777789|FG001|Overall Study|Not willing to adhere to requirements|2|||
149903548|NCT01435018|540777790|FG002|Overall Study|Not willing to adhere to requirements|3|||
149903549|NCT01435018|540777788|FG000|Overall Study|Not able to get to clinic|2|||
149903550|NCT01435018|540777789|FG001|Overall Study|Not able to get to clinic|0|||
149903551|NCT01435018|540777790|FG002|Overall Study|Not able to get to clinic|2|||
149903552|NCT01435018|540777788|FG000|Overall Study|Severe debilitation, unable to continue|0|||
149903553|NCT01435018|540777789|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149903554|NCT01435018|540777790|FG002|Overall Study|Severe debilitation, unable to continue|1|||
149903555|NCT01435018|540777788|FG000|Overall Study|Unable to contact participant/parent|1|||
149903556|NCT01435018|540777789|FG001|Overall Study|Unable to contact participant/parent|1|||
149903557|NCT01435018|540777790|FG002|Overall Study|Unable to contact participant/parent|1|||
149903558|NCT01435018|540777788|FG000|Overall Study|Enrollment Violation|0|||
149903559|NCT01435018|540777789|FG001|Overall Study|Enrollment Violation|1|||
149903560|NCT01435018|540777790|FG002|Overall Study|Enrollment Violation|0|||
149903561|NCT01435018|540777788|FG000|Overall Study|Never started chemotherapy|3|||
149903562|NCT01435018|540777789|FG001|Overall Study|Never started chemotherapy|0|||
149903563|NCT01435018|540777790|FG002|Overall Study|Never started chemotherapy|1|||
149903564|NCT00378508|540777791|FG000|Overall Study|Withdrawal by Subject|1|||
149903565|NCT00378508|540777792|FG001|Overall Study|Withdrawal by Subject|3|||
149903566|NCT00378508|540777791|FG000|Overall Study|Lost to Follow-up|1|||
149903567|NCT00378508|540777792|FG001|Overall Study|Lost to Follow-up|0|||
149903568|NCT00972816|540777793|FG000|Overall Study|Adverse Event|0|||
149903569|NCT00972816|540777794|FG001|Overall Study|Adverse Event|0|||
149903570|NCT00972816|540777795|FG002|Overall Study|Adverse Event|1|||
149903571|NCT00972816|540777796|FG003|Overall Study|Adverse Event|0|||
149903572|NCT00972816|540777797|FG004|Overall Study|Adverse Event|0|||
149903573|NCT00972816|540777798|FG005|Overall Study|Adverse Event|0|||
149903574|NCT00972816|540777799|FG006|Overall Study|Adverse Event|0|||
149903575|NCT00972816|540777800|FG007|Overall Study|Adverse Event|0|||
149903576|NCT00972816|540777793|FG000|Overall Study|Withdrawal by Subject|4|||
149903577|NCT00972816|540777794|FG001|Overall Study|Withdrawal by Subject|2|||
149903578|NCT00972816|540777795|FG002|Overall Study|Withdrawal by Subject|1|||
149903579|NCT00972816|540777796|FG003|Overall Study|Withdrawal by Subject|3|||
149903580|NCT00972816|540777797|FG004|Overall Study|Withdrawal by Subject|0|||
149903581|NCT00972816|540777798|FG005|Overall Study|Withdrawal by Subject|1|||
149903582|NCT00972816|540777799|FG006|Overall Study|Withdrawal by Subject|1|||
149903583|NCT00972816|540777800|FG007|Overall Study|Withdrawal by Subject|2|||
149903584|NCT00972816|540777793|FG000|Overall Study|Lost to Follow-up|11|||
149903585|NCT00972816|540777794|FG001|Overall Study|Lost to Follow-up|9|||
149903586|NCT00972816|540777795|FG002|Overall Study|Lost to Follow-up|7|||
149903587|NCT00972816|540777796|FG003|Overall Study|Lost to Follow-up|5|||
149903588|NCT00972816|540777797|FG004|Overall Study|Lost to Follow-up|11|||
149903589|NCT00972816|540777798|FG005|Overall Study|Lost to Follow-up|10|||
149903590|NCT00972816|540777799|FG006|Overall Study|Lost to Follow-up|7|||
149903591|NCT00972816|540777800|FG007|Overall Study|Lost to Follow-up|7|||
149903592|NCT00972816|540777793|FG000|Overall Study|Inappropriate enrolment|0|||
149903593|NCT00972816|540777794|FG001|Overall Study|Inappropriate enrolment|0|||
149903594|NCT00972816|540777795|FG002|Overall Study|Inappropriate enrolment|0|||
149903595|NCT00972816|540777796|FG003|Overall Study|Inappropriate enrolment|0|||
149903596|NCT00972816|540777797|FG004|Overall Study|Inappropriate enrolment|0|||
149903597|NCT00972816|540777798|FG005|Overall Study|Inappropriate enrolment|0|||
149903598|NCT00972816|540777799|FG006|Overall Study|Inappropriate enrolment|2|||
149903599|NCT00972816|540777800|FG007|Overall Study|Inappropriate enrolment|0|||
149903600|NCT00972816|540777793|FG000|Overall Study|Unable to classify|2|||
149903601|NCT00972816|540777794|FG001|Overall Study|Unable to classify|0|||
149903602|NCT00972816|540777795|FG002|Overall Study|Unable to classify|0|||
149903603|NCT00972816|540777796|FG003|Overall Study|Unable to classify|0|||
149903604|NCT00972816|540777797|FG004|Overall Study|Unable to classify|1|||
149903605|NCT00972816|540777798|FG005|Overall Study|Unable to classify|0|||
149903606|NCT00972816|540777799|FG006|Overall Study|Unable to classify|0|||
149903607|NCT00972816|540777800|FG007|Overall Study|Unable to classify|0|||
149903608|NCT00593684|540777803|FG000|Overall Study|Death|2|||
149903609|NCT00593684|540777804|FG001|Overall Study|Death|1|||
149903610|NCT03625466|540777805|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
149903611|NCT03625466|540777806|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
149903612|NCT03625466|540777807|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
149903613|NCT03625466|540777805|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
149903614|NCT03625466|540777806|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
149903615|NCT03625466|540777807|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
149903616|NCT03625466|540777805|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
149903617|NCT03625466|540777806|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
149903618|NCT03625466|540777807|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
149903619|NCT00809471|540777810|FG000|Overall Study|Protocol non-compliance|15|||
149903620|NCT00809471|540777811|FG001|Overall Study|Protocol non-compliance|15|||
149903621|NCT00809471|540777812|FG002|Overall Study|Protocol non-compliance|6|||
149903622|NCT00809471|540777810|FG000|Overall Study|Lost to Follow-up|4|||
149903623|NCT00809471|540777811|FG001|Overall Study|Lost to Follow-up|2|||
149903624|NCT00809471|540777812|FG002|Overall Study|Lost to Follow-up|9|||
149903625|NCT00809471|540777810|FG000|Overall Study|Adverse Event|0|||
149903626|NCT00809471|540777811|FG001|Overall Study|Adverse Event|2|||
149903627|NCT00809471|540777812|FG002|Overall Study|Adverse Event|2|||
149903628|NCT00809471|540777810|FG000|Overall Study|Requirement for restricted medication|1|||
149903629|NCT00809471|540777811|FG001|Overall Study|Requirement for restricted medication|1|||
149903630|NCT00809471|540777812|FG002|Overall Study|Requirement for restricted medication|0|||
149903631|NCT00831311|540777813|FG000|Overall Study|Definitive Contraindication|3|||
149903632|NCT00831311|540777814|FG001|Overall Study|Definitive Contraindication|3|||
149903633|NCT00831311|540777813|FG000|Overall Study|Lost to Follow-up|3|||
149903634|NCT00831311|540777814|FG001|Overall Study|Lost to Follow-up|0|||
149903635|NCT00831311|540777813|FG000|Overall Study|Physician Decision|0|||
149903636|NCT00831311|540777814|FG001|Overall Study|Physician Decision|1|||
149903637|NCT00831311|540777813|FG000|Overall Study|Withdrawal by Subject|6|||
149903638|NCT00831311|540777814|FG001|Overall Study|Withdrawal by Subject|4|||
149903639|NCT03557931|540777823|FG000|Overall Study|Adverse Event|4|||
149903640|NCT03557931|540777824|FG001|Overall Study|Adverse Event|6|||
149903641|NCT03557931|540777825|FG002|Overall Study|Adverse Event|1|||
149903642|NCT03557931|540777823|FG000|Overall Study|Lost to Follow-up|4|||
149903643|NCT03557931|540777824|FG001|Overall Study|Lost to Follow-up|4|||
149903644|NCT03557931|540777825|FG002|Overall Study|Lost to Follow-up|1|||
149903645|NCT03557931|540777823|FG000|Overall Study|Protocol Violation|1|||
149903646|NCT03557931|540777824|FG001|Overall Study|Protocol Violation|4|||
149903647|NCT03557931|540777825|FG002|Overall Study|Protocol Violation|1|||
149903648|NCT03557931|540777823|FG000|Overall Study|Withdrawal by Subject|14|||
149903649|NCT03557931|540777824|FG001|Overall Study|Withdrawal by Subject|0|||
149903650|NCT03557931|540777825|FG002|Overall Study|Withdrawal by Subject|7|||
149903651|NCT03557931|540777823|FG000|Overall Study|Miscellaneous|8|||
149903652|NCT03557931|540777824|FG001|Overall Study|Miscellaneous|5|||
149903653|NCT03557931|540777825|FG002|Overall Study|Miscellaneous|3|||
149903654|NCT00364923|540777827|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
149903655|NCT00364923|540777827|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
149903656|NCT03474731|540777834|FG000|Overall Study|Withdrawal by Subject|36|||
149903657|NCT03474731|540777835|FG001|Overall Study|Withdrawal by Subject|29|||
149903658|NCT03474731|540777836|FG002|Overall Study|Withdrawal by Subject|11|||
149903659|NCT03474731|540777837|FG003|Overall Study|Withdrawal by Subject|27|||
149903660|NCT03474731|540777834|FG000|Overall Study|COVID|0|||
149903661|NCT03474731|540777835|FG001|Overall Study|COVID|23|||
149903662|NCT03474731|540777836|FG002|Overall Study|COVID|0|||
149903663|NCT03474731|540777837|FG003|Overall Study|COVID|0|||
149903664|NCT03474731|540777834|FG000|Overall Study|Participant moved from area|1|||
149903665|NCT03474731|540777835|FG001|Overall Study|Participant moved from area|0|||
149903666|NCT03474731|540777836|FG002|Overall Study|Participant moved from area|0|||
149903667|NCT03474731|540777837|FG003|Overall Study|Participant moved from area|0|||
149903668|NCT03474731|540777834|FG000|Overall Study|Lost to Follow-up|11|||
149903669|NCT03474731|540777835|FG001|Overall Study|Lost to Follow-up|3|||
149903670|NCT03474731|540777836|FG002|Overall Study|Lost to Follow-up|18|||
149903671|NCT03474731|540777837|FG003|Overall Study|Lost to Follow-up|17|||
149903672|NCT03474731|540777834|FG000|Overall Study|Death|0|||
149903673|NCT03474731|540777835|FG001|Overall Study|Death|1|||
149903674|NCT03474731|540777836|FG002|Overall Study|Death|0|||
149903675|NCT03474731|540777837|FG003|Overall Study|Death|0|||
149903676|NCT03474731|540777834|FG000|Overall Study|Participant Removed|0|||
149903677|NCT03474731|540777835|FG001|Overall Study|Participant Removed|0|||
149903678|NCT03474731|540777836|FG002|Overall Study|Participant Removed|0|||
149903679|NCT03474731|540777837|FG003|Overall Study|Participant Removed|1|||
149903680|NCT01355575|540777841|FG000|Overall Study|Withdrawal by Subject|2|||
149903681|NCT02887248|540777842|FG000|Overall Study|Withdrawal by Subject|1|||
149903682|NCT02887248|540777842|FG000|Overall Study|Adverse Event|1|||
149903683|NCT02887248|540777842|FG000|Overall Study|Progressive Disease|1|||
149903684|NCT02438826|540777845|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
149903685|NCT02438826|540777846|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
149903686|NCT02438826|540777847|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
149903687|NCT02438826|540777848|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149903688|NCT02438826|540777845|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
149903689|NCT02438826|540777846|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149903690|NCT02438826|540777847|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149903691|NCT02438826|540777848|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149903692|NCT02438826|540777845|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
149903693|NCT02438826|540777846|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
149903694|NCT02438826|540777847|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149903695|NCT02438826|540777848|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149903696|NCT02438826|540777845|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
149903697|NCT02438826|540777846|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
149903698|NCT02438826|540777847|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
149903699|NCT02438826|540777848|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
149903700|NCT02438826|540777845|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
149903701|NCT02438826|540777846|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
149903702|NCT02438826|540777847|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
149903703|NCT02438826|540777848|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
149903704|NCT02438826|540777845|FG000|Open-Label Treatment Phase|Adverse Event|11|||
149903705|NCT02438826|540777846|FG001|Open-Label Treatment Phase|Adverse Event|6|||
149903706|NCT02438826|540777847|FG002|Open-Label Treatment Phase|Adverse Event|0|||
149903707|NCT02438826|540777848|FG003|Open-Label Treatment Phase|Adverse Event|0|||
149903708|NCT02438826|540777845|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
149903709|NCT02438826|540777846|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
149903710|NCT02438826|540777847|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
149903711|NCT02438826|540777848|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
149903712|NCT02438826|540777845|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
149903713|NCT02438826|540777846|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
149903714|NCT02438826|540777847|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
149903715|NCT02438826|540777848|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
149903716|NCT02438826|540777845|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
149903717|NCT02438826|540777846|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
149903718|NCT02438826|540777847|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
149903719|NCT02438826|540777848|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
149903720|NCT02438826|540777845|FG000|Post-Treatment Phase|Adverse Event|3|||
149903721|NCT02438826|540777846|FG001|Post-Treatment Phase|Adverse Event|0|||
149903722|NCT02438826|540777847|FG002|Post-Treatment Phase|Adverse Event|0|||
149903723|NCT02438826|540777848|FG003|Post-Treatment Phase|Adverse Event|0|||
149903724|NCT02438826|540777845|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
149903725|NCT02438826|540777846|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
149903726|NCT02438826|540777847|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
149903727|NCT02438826|540777848|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
149903728|NCT02438826|540777845|FG000|Post-Treatment Phase|Physician Decision|1|||
149903729|NCT02438826|540777846|FG001|Post-Treatment Phase|Physician Decision|0|||
150046249|NCT04421027|541308098|FG000|Treatment Period|Physician Decision|1|||
150046250|NCT04421027|541308099|FG001|Treatment Period|Physician Decision|1|||
150046251|NCT04421027|541308100|FG002|Treatment Period|Physician Decision|0|||
150046252|NCT04421027|541308101|FG003|Treatment Period|Physician Decision|0|||
150046253|NCT04421027|541308098|FG000|Treatment Period|Withdrawal by Subject|7|||
150046254|NCT04421027|541308099|FG001|Treatment Period|Withdrawal by Subject|12|||
150046255|NCT04421027|541308100|FG002|Treatment Period|Withdrawal by Subject|0|||
150046256|NCT04421027|541308101|FG003|Treatment Period|Withdrawal by Subject|0|||
149903730|NCT02438826|540777847|FG002|Post-Treatment Phase|Physician Decision|0|||
149903731|NCT02438826|540777848|FG003|Post-Treatment Phase|Physician Decision|0|||
149903732|NCT02438826|540777845|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
149903733|NCT02438826|540777846|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
150046257|NCT04421027|541308098|FG000|Treatment Period|Randomized Not Dosed|9|||
150046258|NCT04421027|541308099|FG001|Treatment Period|Randomized Not Dosed|14|||
150046259|NCT04421027|541308100|FG002|Treatment Period|Randomized Not Dosed|0|||
150046260|NCT04421027|541308101|FG003|Treatment Period|Randomized Not Dosed|0|||
149903734|NCT02438826|540777847|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
149903735|NCT02438826|540777848|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
149903736|NCT00478777|540777854|FG000|Overall Study|Adverse Event|29|||
149903737|NCT00478777|540777854|FG000|Overall Study|Lack of Efficacy|23|||
149903738|NCT00478777|540777854|FG000|Overall Study|Withdrawal by Subject|4|||
149903739|NCT00478777|540777854|FG000|Overall Study|Death|3|||
149903740|NCT00478777|540777854|FG000|Overall Study|Protocol Violation|3|||
149903741|NCT00478777|540777854|FG000|Overall Study|Lost to Follow-up|3|||
149903742|NCT00478777|540777854|FG000|Overall Study|Physician Decision|1|||
149903743|NCT00478777|540777854|FG000|Overall Study|Intolerance of therapy|1|||
149903744|NCT00478777|540777854|FG000|Overall Study|Lack of compliance|1|||
150046261|NCT04421027|541308098|FG000|Follow-Up Period|Adverse Event|0|||
149903745|NCT00478777|540777854|FG000|Overall Study|Lymphocytes infusion|1|||
149903746|NCT00478777|540777854|FG000|Overall Study|End of therapy|2|||
149903747|NCT00478777|540777854|FG000|Overall Study|Not treated with lenalidomide|6|||
149903748|NCT04105218|540777860|FG000|Overall Study|Withdrawal by Subject|3|||
149903749|NCT04105218|540777861|FG001|Overall Study|Withdrawal by Subject|2|||
149903750|NCT04105218|540777860|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
149903751|NCT04105218|540777861|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
149903752|NCT04105218|540777860|FG000|Overall Study|Failed screening tests|2|||
149903753|NCT04105218|540777861|FG001|Overall Study|Failed screening tests|1|||
149903754|NCT00552396|540777865|FG000|Overall Study|protocol withdrawal criteria|3|||
149903755|NCT00552396|540777866|FG001|Overall Study|protocol withdrawal criteria|3|||
149903756|NCT00552396|540777867|FG002|Overall Study|protocol withdrawal criteria|3|||
149903757|NCT00552396|540777868|FG003|Overall Study|protocol withdrawal criteria|6|||
149903758|NCT00552396|540777869|FG004|Overall Study|protocol withdrawal criteria|3|||
149903759|NCT00552396|540777870|FG005|Overall Study|protocol withdrawal criteria|3|||
150046262|NCT04421027|541308099|FG001|Follow-Up Period|Adverse Event|0|||
150046263|NCT04421027|541308100|FG002|Follow-Up Period|Adverse Event|0|||
150046264|NCT04421027|541308101|FG003|Follow-Up Period|Adverse Event|3|||
150046265|NCT04421027|541308098|FG000|Follow-Up Period|Death|0|||
149903760|NCT00552396|540777871|FG006|Overall Study|protocol withdrawal criteria|9|||
149903761|NCT02553499|540777872|FG000|Overall Study|Adverse Event|0|||
149903762|NCT02553499|540777873|FG001|Overall Study|Adverse Event|0|||
149903763|NCT02553499|540777874|FG002|Overall Study|Adverse Event|0|||
149903764|NCT02553499|540777875|FG003|Overall Study|Adverse Event|0|||
149903765|NCT02553499|540777876|FG004|Overall Study|Adverse Event|0|||
149903766|NCT02553499|540777877|FG005|Overall Study|Adverse Event|0|||
149903767|NCT02553499|540777878|FG006|Overall Study|Adverse Event|1|||
149903768|NCT02553499|540777879|FG007|Overall Study|Adverse Event|1|||
149903769|NCT02553499|540777880|FG008|Overall Study|Adverse Event|0|||
149903770|NCT02553499|540777881|FG009|Overall Study|Adverse Event|0|||
149903771|NCT02553499|540777882|FG010|Overall Study|Adverse Event|0|||
149903772|NCT02553499|540777883|FG011|Overall Study|Adverse Event|0|||
149903773|NCT02553499|540777884|FG012|Overall Study|Adverse Event|0|||
149903774|NCT02553499|540777885|FG013|Overall Study|Adverse Event|1|||
150046266|NCT04421027|541308099|FG001|Follow-Up Period|Death|0|||
150046267|NCT04421027|541308100|FG002|Follow-Up Period|Death|16|||
150046268|NCT04421027|541308101|FG003|Follow-Up Period|Death|17|||
150046269|NCT04421027|541308098|FG000|Follow-Up Period|Lost to Follow-up|0|||
150046270|NCT04421027|541308099|FG001|Follow-Up Period|Lost to Follow-up|0|||
150046271|NCT04421027|541308100|FG002|Follow-Up Period|Lost to Follow-up|7|||
149903775|NCT02553499|540777872|FG000|Overall Study|Death|0|||
150046272|NCT04421027|541308101|FG003|Follow-Up Period|Lost to Follow-up|7|||
150046273|NCT04421027|541308098|FG000|Follow-Up Period|Protocol Deviation|0|||
150046274|NCT04421027|541308099|FG001|Follow-Up Period|Protocol Deviation|0|||
149903776|NCT02553499|540777873|FG001|Overall Study|Death|1|||
149903777|NCT02553499|540777874|FG002|Overall Study|Death|1|||
149903778|NCT02553499|540777875|FG003|Overall Study|Death|0|||
149903779|NCT02553499|540777876|FG004|Overall Study|Death|1|||
149903780|NCT02553499|540777877|FG005|Overall Study|Death|2|||
149903781|NCT02553499|540777878|FG006|Overall Study|Death|0|||
149903782|NCT02553499|540777879|FG007|Overall Study|Death|0|||
149903783|NCT02553499|540777880|FG008|Overall Study|Death|0|||
149903784|NCT02553499|540777881|FG009|Overall Study|Death|0|||
149903785|NCT02553499|540777882|FG010|Overall Study|Death|1|||
149903786|NCT02553499|540777883|FG011|Overall Study|Death|0|||
149903787|NCT02553499|540777884|FG012|Overall Study|Death|0|||
149903788|NCT02553499|540777885|FG013|Overall Study|Death|0|||
149903789|NCT02553499|540777872|FG000|Overall Study|Lost to Follow-up|0|||
149903790|NCT02553499|540777873|FG001|Overall Study|Lost to Follow-up|0|||
149903791|NCT02553499|540777874|FG002|Overall Study|Lost to Follow-up|0|||
149903792|NCT02553499|540777875|FG003|Overall Study|Lost to Follow-up|0|||
149903793|NCT02553499|540777876|FG004|Overall Study|Lost to Follow-up|0|||
149903794|NCT02553499|540777877|FG005|Overall Study|Lost to Follow-up|0|||
149903795|NCT02553499|540777878|FG006|Overall Study|Lost to Follow-up|1|||
149903796|NCT02553499|540777879|FG007|Overall Study|Lost to Follow-up|0|||
149903797|NCT02553499|540777880|FG008|Overall Study|Lost to Follow-up|0|||
149903798|NCT02553499|540777881|FG009|Overall Study|Lost to Follow-up|0|||
149903799|NCT02553499|540777882|FG010|Overall Study|Lost to Follow-up|0|||
149903800|NCT02553499|540777883|FG011|Overall Study|Lost to Follow-up|0|||
149903801|NCT02553499|540777884|FG012|Overall Study|Lost to Follow-up|0|||
149903802|NCT02553499|540777885|FG013|Overall Study|Lost to Follow-up|0|||
149903803|NCT02553499|540777872|FG000|Overall Study|Physician Decision|0|||
149903804|NCT02553499|540777873|FG001|Overall Study|Physician Decision|1|||
149903805|NCT02553499|540777874|FG002|Overall Study|Physician Decision|1|||
149903806|NCT02553499|540777875|FG003|Overall Study|Physician Decision|0|||
149969357|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
149969358|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
149969359|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
149903807|NCT02553499|540777876|FG004|Overall Study|Physician Decision|1|||
149969360|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
149903808|NCT02553499|540777877|FG005|Overall Study|Physician Decision|0|||
149903809|NCT02553499|540777878|FG006|Overall Study|Physician Decision|0|||
149903810|NCT02553499|540777879|FG007|Overall Study|Physician Decision|1|||
149903811|NCT02553499|540777880|FG008|Overall Study|Physician Decision|1|||
149903812|NCT02553499|540777881|FG009|Overall Study|Physician Decision|2|||
149903813|NCT02553499|540777882|FG010|Overall Study|Physician Decision|1|||
149903814|NCT02553499|540777883|FG011|Overall Study|Physician Decision|3|||
149903815|NCT02553499|540777884|FG012|Overall Study|Physician Decision|1|||
149903816|NCT02553499|540777885|FG013|Overall Study|Physician Decision|0|||
149903817|NCT02553499|540777872|FG000|Overall Study|Progressive Disease|0|||
149903818|NCT02553499|540777873|FG001|Overall Study|Progressive Disease|0|||
149903819|NCT02553499|540777874|FG002|Overall Study|Progressive Disease|0|||
149903820|NCT02553499|540777875|FG003|Overall Study|Progressive Disease|2|||
149903821|NCT02553499|540777876|FG004|Overall Study|Progressive Disease|1|||
149903822|NCT02553499|540777877|FG005|Overall Study|Progressive Disease|1|||
149903823|NCT02553499|540777878|FG006|Overall Study|Progressive Disease|1|||
149903824|NCT02553499|540777879|FG007|Overall Study|Progressive Disease|0|||
149903825|NCT02553499|540777880|FG008|Overall Study|Progressive Disease|0|||
149903826|NCT02553499|540777881|FG009|Overall Study|Progressive Disease|1|||
149903827|NCT02553499|540777882|FG010|Overall Study|Progressive Disease|0|||
149903828|NCT02553499|540777883|FG011|Overall Study|Progressive Disease|0|||
149903829|NCT02553499|540777884|FG012|Overall Study|Progressive Disease|2|||
149903830|NCT02553499|540777885|FG013|Overall Study|Progressive Disease|1|||
149903831|NCT02553499|540777872|FG000|Overall Study|Study Terminated by Sponsor|0|||
149903832|NCT02553499|540777873|FG001|Overall Study|Study Terminated by Sponsor|0|||
150176513|NCT00305695|541782006|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
150176514|NCT00305695|541782005|FG000|Overall Study|Did not have baseline scan|1|||
150176515|NCT00305695|541782006|FG001|Overall Study|Did not have baseline scan|1|||
150176516|NCT00794118|541782009|FG000|Overall Study|Lost to Follow-up|16|||
150176517|NCT00794118|541782009|FG000|Overall Study|Withdrawal by Subject|9|||
150176518|NCT00794118|541782009|FG000|Overall Study|Changed hospital center|2|||
150176519|NCT04305405|541782010|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150176520|NCT04305405|541782011|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150176521|NCT00206375|541782013|FG000|Overall Study|Lost to Follow-up|1|||
149903833|NCT02553499|540777874|FG002|Overall Study|Study Terminated by Sponsor|0|||
149903834|NCT02553499|540777875|FG003|Overall Study|Study Terminated by Sponsor|0|||
149903835|NCT02553499|540777876|FG004|Overall Study|Study Terminated by Sponsor|0|||
149903836|NCT02553499|540777877|FG005|Overall Study|Study Terminated by Sponsor|0|||
149903837|NCT02553499|540777878|FG006|Overall Study|Study Terminated by Sponsor|0|||
149903838|NCT02553499|540777879|FG007|Overall Study|Study Terminated by Sponsor|0|||
149903839|NCT02553499|540777880|FG008|Overall Study|Study Terminated by Sponsor|1|||
149903840|NCT02553499|540777881|FG009|Overall Study|Study Terminated by Sponsor|0|||
149903841|NCT02553499|540777882|FG010|Overall Study|Study Terminated by Sponsor|0|||
149903842|NCT02553499|540777883|FG011|Overall Study|Study Terminated by Sponsor|0|||
149903843|NCT02553499|540777884|FG012|Overall Study|Study Terminated by Sponsor|0|||
149903844|NCT02553499|540777885|FG013|Overall Study|Study Terminated by Sponsor|0|||
149903845|NCT02553499|540777872|FG000|Overall Study|Withdrawal by Subject|2|||
149903846|NCT02553499|540777873|FG001|Overall Study|Withdrawal by Subject|0|||
149903847|NCT02553499|540777874|FG002|Overall Study|Withdrawal by Subject|0|||
149903848|NCT02553499|540777875|FG003|Overall Study|Withdrawal by Subject|0|||
149903849|NCT02553499|540777876|FG004|Overall Study|Withdrawal by Subject|0|||
149903850|NCT02553499|540777877|FG005|Overall Study|Withdrawal by Subject|0|||
149903851|NCT02553499|540777878|FG006|Overall Study|Withdrawal by Subject|0|||
149903852|NCT02553499|540777879|FG007|Overall Study|Withdrawal by Subject|1|||
149903853|NCT02553499|540777880|FG008|Overall Study|Withdrawal by Subject|1|||
149903854|NCT02553499|540777881|FG009|Overall Study|Withdrawal by Subject|0|||
149903855|NCT02553499|540777882|FG010|Overall Study|Withdrawal by Subject|1|||
149903856|NCT02553499|540777883|FG011|Overall Study|Withdrawal by Subject|0|||
149903857|NCT02553499|540777884|FG012|Overall Study|Withdrawal by Subject|0|||
149903858|NCT02553499|540777885|FG013|Overall Study|Withdrawal by Subject|0|||
149903859|NCT01582178|540777886|FG000|Overall Study|Physician Decision|6|||
149969361|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
149969362|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
149969363|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
149969364|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
149969365|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
149969366|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
150176522|NCT00206375|541782014|FG001|Overall Study|Lost to Follow-up|0|||
149903860|NCT01582178|540777887|FG001|Overall Study|Physician Decision|5|||
149903861|NCT01726270|540777888|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
149903862|NCT01726270|540777888|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
149903863|NCT01726270|540777888|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
149903864|NCT01726270|540777888|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
149903865|NCT01726270|540777888|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
149903866|NCT01726270|540777888|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
150176523|NCT00206375|541782015|FG002|Overall Study|Lost to Follow-up|0|||
149903867|NCT00582608|540777890|FG000|Overall Study|Not Treated|7|||
149903868|NCT00582608|540777890|FG000|Overall Study|Patient Ineligible|1|||
149903869|NCT00582608|540777890|FG000|Overall Study|Lack of accrual|4|||
149903870|NCT00570063|540777891|FG000|Overall Study|Adverse Event|4|||
149903871|NCT00570063|540777892|FG001|Overall Study|Adverse Event|1|||
149903872|NCT00570063|540777891|FG000|Overall Study|Lack of Efficacy|0|||
149903873|NCT00570063|540777892|FG001|Overall Study|Lack of Efficacy|1|||
149903874|NCT00570063|540777891|FG000|Overall Study|Withdrawal by Subject|4|||
149903875|NCT00570063|540777892|FG001|Overall Study|Withdrawal by Subject|3|||
149903876|NCT00570063|540777891|FG000|Overall Study|Sponsor's Decision|7|||
149903877|NCT00570063|540777892|FG001|Overall Study|Sponsor's Decision|3|||
149903878|NCT00550043|540777896|FG000|Overall Study|Adverse Event|0|||
149903879|NCT00550043|540777897|FG001|Overall Study|Adverse Event|0|||
149903880|NCT00550043|540777898|FG002|Overall Study|Adverse Event|0|||
149903881|NCT00550043|540777899|FG003|Overall Study|Adverse Event|1|||
149903882|NCT00550043|540777900|FG004|Overall Study|Adverse Event|1|||
149903883|NCT00550043|540777896|FG000|Overall Study|Subject Withdrew Consent|0|||
149903884|NCT00550043|540777897|FG001|Overall Study|Subject Withdrew Consent|2|||
149903885|NCT00550043|540777898|FG002|Overall Study|Subject Withdrew Consent|1|||
149903886|NCT00550043|540777899|FG003|Overall Study|Subject Withdrew Consent|0|||
149903887|NCT00550043|540777900|FG004|Overall Study|Subject Withdrew Consent|0|||
149903888|NCT00550043|540777896|FG000|Overall Study|Other Reasons- Unspecified|0|||
149903889|NCT00550043|540777897|FG001|Overall Study|Other Reasons- Unspecified|1|||
149903890|NCT00550043|540777898|FG002|Overall Study|Other Reasons- Unspecified|0|||
149903891|NCT00550043|540777899|FG003|Overall Study|Other Reasons- Unspecified|1|||
149903892|NCT00550043|540777900|FG004|Overall Study|Other Reasons- Unspecified|0|||
149903893|NCT03478644|540777901|FG000|Phase 2|Withdrawal by Subject|2|||
149903894|NCT03478644|540777902|FG001|Phase 2|Withdrawal by Subject|1|||
149903895|NCT03478644|540777901|FG000|Phase 2|Lost to Follow-up|1|||
149903896|NCT03478644|540777902|FG001|Phase 2|Lost to Follow-up|0|||
149903897|NCT04152837|540777907|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
149903898|NCT04152837|540777907|FG000|Maintenance Period|Adverse Event|1|||
149903899|NCT04152837|540777907|FG000|Maintenance Period|Withdrawal by Subject|1|||
149903900|NCT04152837|540777907|FG000|Maintenance Period|Sponsor Termination of Study|2|||
149903901|NCT00586820|540777908|FG000|Overall Study|Unsuccessful PCI|1|||
149903902|NCT00586820|540777909|FG001|Overall Study|Unsuccessful PCI|0|||
149903903|NCT02073929|540777910|FG000|Overall Study|Lost to Follow-up|2|||
149903904|NCT02073929|540777911|FG001|Overall Study|Lost to Follow-up|1|||
149903905|NCT02073929|540777910|FG000|Overall Study|Adverse Event|2|||
149903906|NCT02073929|540777911|FG001|Overall Study|Adverse Event|1|||
149969367|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
149969368|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
149969369|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
149969370|NCT04392154|541023693|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
149969371|NCT04392154|541023694|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
149969372|NCT04392154|541023695|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
149969373|NCT04392154|541023696|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
149969374|NCT04392154|541023693|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
149969375|NCT04392154|541023694|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
149969376|NCT04392154|541023695|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
149969377|NCT04392154|541023696|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
149969378|NCT04392154|541023693|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
149969379|NCT04392154|541023694|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
149969380|NCT04392154|541023695|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
149969381|NCT04392154|541023696|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
149969382|NCT04392154|541023693|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
149969383|NCT04392154|541023694|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
149903907|NCT02073929|540777910|FG000|Overall Study|Withdrawal by Subject|0|||
149903908|NCT02073929|540777911|FG001|Overall Study|Withdrawal by Subject|1|||
149903909|NCT01483027|540777912|FG000|Overall Study|Administrative Reasons|2|||
149903910|NCT01483027|540777913|FG001|Overall Study|Administrative Reasons|1|||
149903911|NCT01483027|540777912|FG000|Overall Study|Withdrawal by Subject|21|||
149903912|NCT01483027|540777913|FG001|Overall Study|Withdrawal by Subject|32|||
149903913|NCT01483027|540777912|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
149903914|NCT01483027|540777913|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
149903915|NCT01483027|540777912|FG000|Overall Study|Lost to Follow-up|1|||
149903916|NCT01483027|540777913|FG001|Overall Study|Lost to Follow-up|1|||
149903917|NCT01483027|540777912|FG000|Overall Study|Adverse Event|0|||
149903918|NCT01483027|540777913|FG001|Overall Study|Adverse Event|1|||
149903919|NCT01483027|540777912|FG000|Overall Study|Withdrawal by Subject|0|||
150046275|NCT04421027|541308100|FG002|Follow-Up Period|Protocol Deviation|1|||
150046276|NCT04421027|541308101|FG003|Follow-Up Period|Protocol Deviation|0|||
150046277|NCT04421027|541308098|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
150046278|NCT04421027|541308099|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
149903920|NCT01483027|540777913|FG001|Overall Study|Withdrawal by Subject|1|||
149903921|NCT00101166|540777918|FG000|Overall Study|progressive disease|10|||
149903922|NCT00686829|540777919|FG000|Overall Study|Adverse Event|5|||
149903923|NCT00686829|540777919|FG000|Overall Study|Lack of Efficacy|6|||
149903924|NCT00686829|540777919|FG000|Overall Study|Lost to Follow-up|4|||
149903925|NCT00686829|540777919|FG000|Overall Study|Withdrawal by Subject|14|||
149903926|NCT00686829|540777919|FG000|Overall Study|Protocol Violation|3|||
149903927|NCT00686829|540777919|FG000|Overall Study|Sponsor discontinued VCV|47|||
149903928|NCT01827267|540777920|FG000|Overall Study|Did not receive study drug|1|||
149903929|NCT01827267|540777921|FG001|Overall Study|Did not receive study drug|1|||
149903930|NCT01827267|540777920|FG000|Overall Study|Physician Decision|1|||
149903931|NCT01827267|540777921|FG001|Overall Study|Physician Decision|0|||
149903932|NCT01827267|540777920|FG000|Overall Study|Disease Progression|1|||
149903933|NCT01827267|540777921|FG001|Overall Study|Disease Progression|1|||
149903934|NCT01827267|540777920|FG000|Overall Study|Sponsor Discontinued Study|2|||
149903935|NCT01827267|540777921|FG001|Overall Study|Sponsor Discontinued Study|8|||
149903936|NCT01827267|540777920|FG000|Overall Study|Still on study|0|||
149903937|NCT01827267|540777921|FG001|Overall Study|Still on study|2|||
149903938|NCT01314872|540777924|FG000|Treatment Period 1|Protocol Violation|2|||
149903939|NCT01314872|540777925|FG001|Treatment Period 1|Protocol Violation|1|||
149903940|NCT01314872|540777926|FG002|Treatment Period 1|Protocol Violation|1|||
149903941|NCT01314872|540777927|FG003|Treatment Period 1|Protocol Violation|0|||
149903942|NCT01314872|540777928|FG004|Treatment Period 1|Protocol Violation|1|||
149903943|NCT01314872|540777929|FG005|Treatment Period 1|Protocol Violation|0|||
149903944|NCT01314872|540777930|FG006|Treatment Period 1|Protocol Violation|0|||
149903945|NCT01314872|540777931|FG007|Treatment Period 1|Protocol Violation|0|||
149903946|NCT01314872|540777932|FG008|Treatment Period 1|Protocol Violation|0|||
149903947|NCT01314872|540777933|FG009|Treatment Period 1|Protocol Violation|1|||
149903948|NCT01314872|540777934|FG010|Treatment Period 1|Protocol Violation|1|||
149903949|NCT01314872|540777935|FG011|Treatment Period 1|Protocol Violation|0|||
149903950|NCT01314872|540777936|FG012|Treatment Period 1|Protocol Violation|0|||
149903951|NCT01314872|540777937|FG013|Treatment Period 1|Protocol Violation|0|||
149903952|NCT01314872|540777938|FG014|Treatment Period 1|Protocol Violation|0|||
149903953|NCT01314872|540777924|FG000|Treatment Period 1|Physician Decision|0|||
149903954|NCT01314872|540777925|FG001|Treatment Period 1|Physician Decision|1|||
149903955|NCT01314872|540777926|FG002|Treatment Period 1|Physician Decision|0|||
149903956|NCT01314872|540777927|FG003|Treatment Period 1|Physician Decision|1|||
149903957|NCT01314872|540777928|FG004|Treatment Period 1|Physician Decision|0|||
149903958|NCT01314872|540777929|FG005|Treatment Period 1|Physician Decision|0|||
149903959|NCT01314872|540777930|FG006|Treatment Period 1|Physician Decision|0|||
149903960|NCT01314872|540777931|FG007|Treatment Period 1|Physician Decision|0|||
149903961|NCT01314872|540777932|FG008|Treatment Period 1|Physician Decision|0|||
149903962|NCT01314872|540777933|FG009|Treatment Period 1|Physician Decision|1|||
149903963|NCT01314872|540777934|FG010|Treatment Period 1|Physician Decision|0|||
149903964|NCT01314872|540777935|FG011|Treatment Period 1|Physician Decision|0|||
149903965|NCT01314872|540777936|FG012|Treatment Period 1|Physician Decision|0|||
149903966|NCT01314872|540777937|FG013|Treatment Period 1|Physician Decision|0|||
149903967|NCT01314872|540777938|FG014|Treatment Period 1|Physician Decision|0|||
149903968|NCT01314872|540777924|FG000|Treatment Period 1|Lack of Efficacy|1|||
149903969|NCT01314872|540777925|FG001|Treatment Period 1|Lack of Efficacy|0|||
149903970|NCT01314872|540777926|FG002|Treatment Period 1|Lack of Efficacy|0|||
149903971|NCT01314872|540777927|FG003|Treatment Period 1|Lack of Efficacy|0|||
149903972|NCT01314872|540777928|FG004|Treatment Period 1|Lack of Efficacy|0|||
149903973|NCT01314872|540777929|FG005|Treatment Period 1|Lack of Efficacy|1|||
149903974|NCT01314872|540777930|FG006|Treatment Period 1|Lack of Efficacy|0|||
149903975|NCT01314872|540777931|FG007|Treatment Period 1|Lack of Efficacy|2|||
149903976|NCT01314872|540777932|FG008|Treatment Period 1|Lack of Efficacy|0|||
149903977|NCT01314872|540777933|FG009|Treatment Period 1|Lack of Efficacy|0|||
149903978|NCT01314872|540777934|FG010|Treatment Period 1|Lack of Efficacy|0|||
149903979|NCT01314872|540777935|FG011|Treatment Period 1|Lack of Efficacy|0|||
149903980|NCT01314872|540777936|FG012|Treatment Period 1|Lack of Efficacy|0|||
149903981|NCT01314872|540777937|FG013|Treatment Period 1|Lack of Efficacy|0|||
149903982|NCT01314872|540777938|FG014|Treatment Period 1|Lack of Efficacy|0|||
149903983|NCT01314872|540777924|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
149903984|NCT01314872|540777925|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
149903985|NCT01314872|540777926|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
149903986|NCT01314872|540777927|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
149903987|NCT01314872|540777928|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
149903988|NCT01314872|540777929|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
149903989|NCT01314872|540777930|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
150176524|NCT00206375|541782013|FG000|Overall Study|Withdrawal by Subject|2|||
149969384|NCT04392154|541023695|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
149969385|NCT04392154|541023696|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
149969386|NCT02038647|541023697|FG000|Overall Study|Progressive Disease|50|||
149969387|NCT02038647|541023698|FG001|Overall Study|Progressive Disease|59|||
149969388|NCT02038647|541023697|FG000|Overall Study|Adverse Event|18|||
149969389|NCT02038647|541023698|FG001|Overall Study|Adverse Event|10|||
149969390|NCT02038647|541023697|FG000|Overall Study|Symptomatic Deterioration|7|||
149969391|NCT02038647|541023698|FG001|Overall Study|Symptomatic Deterioration|7|||
149969392|NCT02038647|541023697|FG000|Overall Study|Withdrawal by Subject|5|||
149969393|NCT02038647|541023698|FG001|Overall Study|Withdrawal by Subject|2|||
149969394|NCT02038647|541023697|FG000|Overall Study|Not Reported|0|||
149969395|NCT02038647|541023698|FG001|Overall Study|Not Reported|1|||
149969396|NCT02038647|541023697|FG000|Overall Study|Ongoing at Datacut|9|||
149969397|NCT02038647|541023698|FG001|Overall Study|Ongoing at Datacut|10|||
149969398|NCT02757430|541023699|FG000|Overall Study|Physician Decision|6|||
149969399|NCT02757430|541023699|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
149969400|NCT02757430|541023699|FG000|Overall Study|No informed consent|1|||
149969401|NCT02757430|541023699|FG000|Overall Study|No procedure performed|2|||
149969402|NCT02106832|541023708|FG000|Overall Study|Adverse Event|1|||
149969403|NCT02106832|541023709|FG001|Overall Study|Adverse Event|2|||
149969404|NCT02106832|541023710|FG002|Overall Study|Adverse Event|3|||
149969405|NCT02106832|541023711|FG003|Overall Study|Adverse Event|0|||
149969406|NCT02106832|541023708|FG000|Overall Study|Death|4|||
149969407|NCT02106832|541023709|FG001|Overall Study|Death|4|||
149969408|NCT02106832|541023710|FG002|Overall Study|Death|1|||
149969409|NCT02106832|541023711|FG003|Overall Study|Death|4|||
149969410|NCT02106832|541023708|FG000|Overall Study|Deterioration of general conditions|0|||
149969411|NCT02106832|541023709|FG001|Overall Study|Deterioration of general conditions|0|||
149969412|NCT02106832|541023710|FG002|Overall Study|Deterioration of general conditions|1|||
149969413|NCT02106832|541023711|FG003|Overall Study|Deterioration of general conditions|0|||
149969414|NCT02106832|541023708|FG000|Overall Study|Lost to Follow-up|0|||
149969415|NCT02106832|541023709|FG001|Overall Study|Lost to Follow-up|1|||
149969416|NCT02106832|541023710|FG002|Overall Study|Lost to Follow-up|1|||
149969417|NCT02106832|541023711|FG003|Overall Study|Lost to Follow-up|3|||
149969418|NCT02106832|541023708|FG000|Overall Study|Physician Decision|1|||
149969419|NCT02106832|541023709|FG001|Overall Study|Physician Decision|0|||
149969420|NCT02106832|541023710|FG002|Overall Study|Physician Decision|0|||
149969421|NCT02106832|541023711|FG003|Overall Study|Physician Decision|0|||
149969422|NCT02106832|541023708|FG000|Overall Study|Protocol Violation|0|||
149969423|NCT02106832|541023709|FG001|Overall Study|Protocol Violation|0|||
150176525|NCT00206375|541782014|FG001|Overall Study|Withdrawal by Subject|1|||
149969424|NCT02106832|541023710|FG002|Overall Study|Protocol Violation|0|||
149969425|NCT02106832|541023711|FG003|Overall Study|Protocol Violation|1|||
149969426|NCT02106832|541023708|FG000|Overall Study|Withdrawal by Subject|17|||
149969427|NCT02106832|541023709|FG001|Overall Study|Withdrawal by Subject|17|||
150176526|NCT00206375|541782015|FG002|Overall Study|Withdrawal by Subject|3|||
150176527|NCT00206375|541782013|FG000|Overall Study|Study terminated due to lack of funds|0|||
150176528|NCT00206375|541782014|FG001|Overall Study|Study terminated due to lack of funds|1|||
149903990|NCT01314872|540777931|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
149903991|NCT01314872|540777932|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
149903992|NCT01314872|540777933|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
149903993|NCT01314872|540777934|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
149903994|NCT01314872|540777935|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
149903995|NCT01314872|540777936|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
149903996|NCT01314872|540777937|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
149903997|NCT01314872|540777938|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
149903998|NCT01314872|540777924|FG000|Treatment Period 1|Withdrawal by Subject|3|||
149903999|NCT01314872|540777925|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149904000|NCT01314872|540777926|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149904001|NCT01314872|540777927|FG003|Treatment Period 1|Withdrawal by Subject|2|||
149904002|NCT01314872|540777928|FG004|Treatment Period 1|Withdrawal by Subject|3|||
149904003|NCT01314872|540777929|FG005|Treatment Period 1|Withdrawal by Subject|1|||
149904004|NCT01314872|540777930|FG006|Treatment Period 1|Withdrawal by Subject|3|||
149904005|NCT01314872|540777931|FG007|Treatment Period 1|Withdrawal by Subject|2|||
149904006|NCT01314872|540777932|FG008|Treatment Period 1|Withdrawal by Subject|2|||
149904007|NCT01314872|540777933|FG009|Treatment Period 1|Withdrawal by Subject|2|||
149904008|NCT01314872|540777934|FG010|Treatment Period 1|Withdrawal by Subject|1|||
149904009|NCT01314872|540777935|FG011|Treatment Period 1|Withdrawal by Subject|0|||
149904010|NCT01314872|540777936|FG012|Treatment Period 1|Withdrawal by Subject|0|||
149904011|NCT01314872|540777937|FG013|Treatment Period 1|Withdrawal by Subject|0|||
149904012|NCT01314872|540777938|FG014|Treatment Period 1|Withdrawal by Subject|0|||
149904013|NCT01314872|540777924|FG000|Treatment Period 1|Lost to Follow-up|0|||
149904014|NCT01314872|540777925|FG001|Treatment Period 1|Lost to Follow-up|1|||
149904015|NCT01314872|540777926|FG002|Treatment Period 1|Lost to Follow-up|2|||
149904016|NCT01314872|540777927|FG003|Treatment Period 1|Lost to Follow-up|2|||
149904017|NCT01314872|540777928|FG004|Treatment Period 1|Lost to Follow-up|1|||
149969428|NCT02106832|541023710|FG002|Overall Study|Withdrawal by Subject|10|||
149969429|NCT02106832|541023711|FG003|Overall Study|Withdrawal by Subject|7|||
149969430|NCT02106832|541023708|FG000|Overall Study|Technical problems|0|||
149969431|NCT02106832|541023709|FG001|Overall Study|Technical problems|1|||
149969432|NCT02106832|541023710|FG002|Overall Study|Technical problems|0|||
149969433|NCT02106832|541023711|FG003|Overall Study|Technical problems|0|||
149969434|NCT00265122|541023728|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
149969435|NCT00265122|541023729|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
149969436|NCT00265122|541023730|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
149969437|NCT00265122|541023731|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
149969438|NCT00265122|541023732|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
149969439|NCT00265122|541023733|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
149969440|NCT00265122|541023728|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
149969441|NCT00265122|541023729|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
149969442|NCT00265122|541023730|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
149969443|NCT00265122|541023731|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
149969444|NCT00265122|541023732|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
149969445|NCT00265122|541023733|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
149969446|NCT00265122|541023728|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
150176529|NCT00206375|541782015|FG002|Overall Study|Study terminated due to lack of funds|1|||
149904018|NCT01314872|540777929|FG005|Treatment Period 1|Lost to Follow-up|1|||
149904019|NCT01314872|540777930|FG006|Treatment Period 1|Lost to Follow-up|1|||
149904020|NCT01314872|540777931|FG007|Treatment Period 1|Lost to Follow-up|1|||
149969447|NCT00265122|541023729|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
150046279|NCT04421027|541308100|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
150046280|NCT04421027|541308101|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
150046281|NCT04421027|541308098|FG000|Follow-Up Period|Left message, participant did not call back|0|||
150046282|NCT04421027|541308099|FG001|Follow-Up Period|Left message, participant did not call back|0|||
150046283|NCT04421027|541308100|FG002|Follow-Up Period|Left message, participant did not call back|0|||
150046284|NCT04421027|541308101|FG003|Follow-Up Period|Left message, participant did not call back|1|||
150046285|NCT04421027|541308098|FG000|Follow-Up Period|Participant died|0|||
150046286|NCT04421027|541308099|FG001|Follow-Up Period|Participant died|0|||
150046287|NCT04421027|541308100|FG002|Follow-Up Period|Participant died|0|||
150046288|NCT04421027|541308101|FG003|Follow-Up Period|Participant died|1|||
150046289|NCT04421027|541308098|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
150046290|NCT04421027|541308099|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
150046291|NCT04421027|541308100|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
150046292|NCT04421027|541308101|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
150046293|NCT00481091|541309574|FG000|Overall Study|Withdrawal by Subject|0|||
149904021|NCT01314872|540777932|FG008|Treatment Period 1|Lost to Follow-up|1|||
149904022|NCT01314872|540777933|FG009|Treatment Period 1|Lost to Follow-up|0|||
149904023|NCT01314872|540777934|FG010|Treatment Period 1|Lost to Follow-up|0|||
149904024|NCT01314872|540777935|FG011|Treatment Period 1|Lost to Follow-up|0|||
149904025|NCT01314872|540777936|FG012|Treatment Period 1|Lost to Follow-up|0|||
149904026|NCT01314872|540777937|FG013|Treatment Period 1|Lost to Follow-up|0|||
149904027|NCT01314872|540777938|FG014|Treatment Period 1|Lost to Follow-up|0|||
149904028|NCT01314872|540777924|FG000|Period 2|Protocol Violation|0|||
149904029|NCT01314872|540777925|FG001|Period 2|Protocol Violation|0|||
149904030|NCT01314872|540777926|FG002|Period 2|Protocol Violation|0|||
149904031|NCT01314872|540777927|FG003|Period 2|Protocol Violation|0|||
149904032|NCT01314872|540777928|FG004|Period 2|Protocol Violation|0|||
149904033|NCT01314872|540777929|FG005|Period 2|Protocol Violation|0|||
149904034|NCT01314872|540777930|FG006|Period 2|Protocol Violation|0|||
149904035|NCT01314872|540777931|FG007|Period 2|Protocol Violation|0|||
149904036|NCT01314872|540777932|FG008|Period 2|Protocol Violation|0|||
149904037|NCT01314872|540777933|FG009|Period 2|Protocol Violation|0|||
149904038|NCT01314872|540777934|FG010|Period 2|Protocol Violation|0|||
149904039|NCT01314872|540777935|FG011|Period 2|Protocol Violation|3|||
149904040|NCT01314872|540777936|FG012|Period 2|Protocol Violation|3|||
149904041|NCT01314872|540777937|FG013|Period 2|Protocol Violation|2|||
149904042|NCT01314872|540777938|FG014|Period 2|Protocol Violation|0|||
149904043|NCT01314872|540777924|FG000|Period 2|Non-compliance with study drug|0|||
150046294|NCT00481091|541309575|FG001|Overall Study|Withdrawal by Subject|1|||
150046295|NCT00481091|541309576|FG002|Overall Study|Withdrawal by Subject|1|||
150046296|NCT00481091|541309577|FG003|Overall Study|Withdrawal by Subject|0|||
150046297|NCT00481091|541309578|FG004|Overall Study|Withdrawal by Subject|0|||
150046298|NCT00481091|541309579|FG005|Overall Study|Withdrawal by Subject|0|||
150046299|NCT00481091|541309580|FG006|Overall Study|Withdrawal by Subject|0|||
150046300|NCT00481091|541309581|FG007|Overall Study|Withdrawal by Subject|0|||
150046301|NCT00481091|541309582|FG008|Overall Study|Withdrawal by Subject|1|||
150046302|NCT00481091|541309583|FG009|Overall Study|Withdrawal by Subject|6|||
150046303|NCT00481091|541309574|FG000|Overall Study|Other, Not Specified|0|||
150046304|NCT00481091|541309575|FG001|Overall Study|Other, Not Specified|1|||
150046305|NCT00481091|541309576|FG002|Overall Study|Other, Not Specified|1|||
150046306|NCT00481091|541309577|FG003|Overall Study|Other, Not Specified|0|||
150046307|NCT00481091|541309578|FG004|Overall Study|Other, Not Specified|0|||
150046308|NCT00481091|541309579|FG005|Overall Study|Other, Not Specified|1|||
150046309|NCT00481091|541309580|FG006|Overall Study|Other, Not Specified|0|||
150046310|NCT00481091|541309581|FG007|Overall Study|Other, Not Specified|0|||
150046311|NCT00481091|541309582|FG008|Overall Study|Other, Not Specified|0|||
150046312|NCT00481091|541309583|FG009|Overall Study|Other, Not Specified|4|||
150046313|NCT00481091|541309574|FG000|Overall Study|Adverse Event|1|||
150046314|NCT00481091|541309575|FG001|Overall Study|Adverse Event|2|||
150046315|NCT00481091|541309576|FG002|Overall Study|Adverse Event|0|||
150046316|NCT00481091|541309577|FG003|Overall Study|Adverse Event|1|||
150046317|NCT00481091|541309578|FG004|Overall Study|Adverse Event|1|||
150046318|NCT00481091|541309579|FG005|Overall Study|Adverse Event|1|||
150046319|NCT00481091|541309580|FG006|Overall Study|Adverse Event|2|||
149904044|NCT01314872|540777925|FG001|Period 2|Non-compliance with study drug|0|||
149904045|NCT01314872|540777926|FG002|Period 2|Non-compliance with study drug|0|||
149904046|NCT01314872|540777927|FG003|Period 2|Non-compliance with study drug|0|||
149904047|NCT01314872|540777928|FG004|Period 2|Non-compliance with study drug|0|||
150046320|NCT00481091|541309581|FG007|Overall Study|Adverse Event|1|||
150046321|NCT00481091|541309582|FG008|Overall Study|Adverse Event|1|||
150046322|NCT00481091|541309583|FG009|Overall Study|Adverse Event|6|||
149904048|NCT01314872|540777929|FG005|Period 2|Non-compliance with study drug|0|||
149904049|NCT01314872|540777930|FG006|Period 2|Non-compliance with study drug|0|||
149904050|NCT01314872|540777931|FG007|Period 2|Non-compliance with study drug|0|||
149904051|NCT01314872|540777932|FG008|Period 2|Non-compliance with study drug|0|||
149904052|NCT01314872|540777933|FG009|Period 2|Non-compliance with study drug|0|||
149904053|NCT01314872|540777934|FG010|Period 2|Non-compliance with study drug|0|||
149904054|NCT01314872|540777935|FG011|Period 2|Non-compliance with study drug|3|||
149904055|NCT01314872|540777936|FG012|Period 2|Non-compliance with study drug|3|||
149904056|NCT01314872|540777937|FG013|Period 2|Non-compliance with study drug|1|||
149904057|NCT01314872|540777938|FG014|Period 2|Non-compliance with study drug|2|||
149904058|NCT01314872|540777924|FG000|Period 2|Lack of Efficacy|0|||
149904059|NCT01314872|540777925|FG001|Period 2|Lack of Efficacy|0|||
149904060|NCT01314872|540777926|FG002|Period 2|Lack of Efficacy|0|||
149904061|NCT01314872|540777927|FG003|Period 2|Lack of Efficacy|0|||
149904062|NCT01314872|540777928|FG004|Period 2|Lack of Efficacy|0|||
149904063|NCT01314872|540777929|FG005|Period 2|Lack of Efficacy|0|||
149904064|NCT01314872|540777930|FG006|Period 2|Lack of Efficacy|0|||
149904065|NCT01314872|540777931|FG007|Period 2|Lack of Efficacy|0|||
149904066|NCT01314872|540777932|FG008|Period 2|Lack of Efficacy|0|||
149904067|NCT01314872|540777933|FG009|Period 2|Lack of Efficacy|0|||
149904068|NCT01314872|540777934|FG010|Period 2|Lack of Efficacy|0|||
149904069|NCT01314872|540777935|FG011|Period 2|Lack of Efficacy|7|||
149904070|NCT01314872|540777936|FG012|Period 2|Lack of Efficacy|12|||
149904071|NCT01314872|540777937|FG013|Period 2|Lack of Efficacy|9|||
149904072|NCT01314872|540777938|FG014|Period 2|Lack of Efficacy|2|||
149904073|NCT01314872|540777924|FG000|Period 2|Pregnancy|0|||
149904074|NCT01314872|540777925|FG001|Period 2|Pregnancy|0|||
149904075|NCT01314872|540777926|FG002|Period 2|Pregnancy|0|||
149904076|NCT01314872|540777927|FG003|Period 2|Pregnancy|0|||
149904077|NCT01314872|540777928|FG004|Period 2|Pregnancy|0|||
149904078|NCT01314872|540777929|FG005|Period 2|Pregnancy|0|||
149904079|NCT01314872|540777930|FG006|Period 2|Pregnancy|0|||
149904080|NCT01314872|540777931|FG007|Period 2|Pregnancy|0|||
149904081|NCT01314872|540777932|FG008|Period 2|Pregnancy|0|||
149904082|NCT01314872|540777933|FG009|Period 2|Pregnancy|0|||
149904083|NCT01314872|540777934|FG010|Period 2|Pregnancy|0|||
149904084|NCT01314872|540777935|FG011|Period 2|Pregnancy|0|||
149904085|NCT01314872|540777936|FG012|Period 2|Pregnancy|0|||
149904086|NCT01314872|540777937|FG013|Period 2|Pregnancy|0|||
149904087|NCT01314872|540777938|FG014|Period 2|Pregnancy|1|||
149904088|NCT01314872|540777924|FG000|Period 2|Study terminated by Sponsor|0|||
149904089|NCT01314872|540777925|FG001|Period 2|Study terminated by Sponsor|0|||
149904090|NCT01314872|540777926|FG002|Period 2|Study terminated by Sponsor|0|||
149904091|NCT01314872|540777927|FG003|Period 2|Study terminated by Sponsor|0|||
149904092|NCT01314872|540777928|FG004|Period 2|Study terminated by Sponsor|0|||
149969448|NCT00265122|541023730|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
149969449|NCT00265122|541023731|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
149969450|NCT00265122|541023732|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
149969451|NCT00265122|541023733|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
149969452|NCT00265122|541023728|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
149969453|NCT00265122|541023729|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
149969454|NCT00265122|541023730|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
149969455|NCT00265122|541023731|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
149969456|NCT00265122|541023732|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
149969457|NCT00265122|541023733|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
149969458|NCT00265122|541023728|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
149969459|NCT00265122|541023729|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
149969460|NCT00265122|541023730|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
149969461|NCT00265122|541023731|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
149969462|NCT00265122|541023732|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
149969463|NCT00265122|541023733|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
149969464|NCT00265122|541023728|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
149969465|NCT00265122|541023729|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
149969466|NCT00265122|541023730|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
149969467|NCT00265122|541023731|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
149969468|NCT00265122|541023732|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
150176530|NCT01353963|541782016|FG000|Overall Study|Adverse Event|2|||
149904093|NCT01314872|540777929|FG005|Period 2|Study terminated by Sponsor|0|||
149969469|NCT00265122|541023733|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
149969470|NCT04716894|541023734|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
149969471|NCT04716894|541023734|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
149904094|NCT01314872|540777930|FG006|Period 2|Study terminated by Sponsor|0|||
149904095|NCT01314872|540777931|FG007|Period 2|Study terminated by Sponsor|0|||
149904096|NCT01314872|540777932|FG008|Period 2|Study terminated by Sponsor|0|||
149904097|NCT01314872|540777933|FG009|Period 2|Study terminated by Sponsor|0|||
149904098|NCT01314872|540777934|FG010|Period 2|Study terminated by Sponsor|0|||
149904099|NCT01314872|540777935|FG011|Period 2|Study terminated by Sponsor|2|||
149904100|NCT01314872|540777936|FG012|Period 2|Study terminated by Sponsor|2|||
149904101|NCT01314872|540777937|FG013|Period 2|Study terminated by Sponsor|3|||
149904102|NCT01314872|540777938|FG014|Period 2|Study terminated by Sponsor|0|||
149904103|NCT01314872|540777924|FG000|Period 2|Adverse event, non-fatal|0|||
149904104|NCT01314872|540777925|FG001|Period 2|Adverse event, non-fatal|0|||
149904105|NCT01314872|540777926|FG002|Period 2|Adverse event, non-fatal|0|||
149904106|NCT01314872|540777927|FG003|Period 2|Adverse event, non-fatal|0|||
149904107|NCT01314872|540777928|FG004|Period 2|Adverse event, non-fatal|0|||
149904108|NCT01314872|540777929|FG005|Period 2|Adverse event, non-fatal|0|||
149904109|NCT01314872|540777930|FG006|Period 2|Adverse event, non-fatal|0|||
149904110|NCT01314872|540777931|FG007|Period 2|Adverse event, non-fatal|0|||
149904111|NCT01314872|540777932|FG008|Period 2|Adverse event, non-fatal|0|||
149904112|NCT01314872|540777933|FG009|Period 2|Adverse event, non-fatal|0|||
149904113|NCT01314872|540777934|FG010|Period 2|Adverse event, non-fatal|0|||
149904114|NCT01314872|540777935|FG011|Period 2|Adverse event, non-fatal|13|||
149904115|NCT01314872|540777936|FG012|Period 2|Adverse event, non-fatal|16|||
149904116|NCT01314872|540777937|FG013|Period 2|Adverse event, non-fatal|24|||
149904117|NCT01314872|540777938|FG014|Period 2|Adverse event, non-fatal|9|||
149904118|NCT01314872|540777924|FG000|Period 2|Withdrawal by Subject|0|||
149904119|NCT01314872|540777925|FG001|Period 2|Withdrawal by Subject|0|||
149904120|NCT01314872|540777926|FG002|Period 2|Withdrawal by Subject|0|||
149904121|NCT01314872|540777927|FG003|Period 2|Withdrawal by Subject|0|||
149904122|NCT01314872|540777928|FG004|Period 2|Withdrawal by Subject|0|||
149904123|NCT01314872|540777929|FG005|Period 2|Withdrawal by Subject|0|||
149904124|NCT01314872|540777930|FG006|Period 2|Withdrawal by Subject|0|||
149904125|NCT01314872|540777931|FG007|Period 2|Withdrawal by Subject|0|||
149904126|NCT01314872|540777932|FG008|Period 2|Withdrawal by Subject|0|||
149904127|NCT01314872|540777933|FG009|Period 2|Withdrawal by Subject|0|||
149904128|NCT01314872|540777934|FG010|Period 2|Withdrawal by Subject|0|||
149904129|NCT01314872|540777935|FG011|Period 2|Withdrawal by Subject|14|||
149904130|NCT01314872|540777936|FG012|Period 2|Withdrawal by Subject|17|||
149904131|NCT01314872|540777937|FG013|Period 2|Withdrawal by Subject|12|||
149904132|NCT01314872|540777938|FG014|Period 2|Withdrawal by Subject|4|||
149904133|NCT01314872|540777924|FG000|Period 2|Lost to Follow-up|0|||
149904134|NCT01314872|540777925|FG001|Period 2|Lost to Follow-up|0|||
149904135|NCT01314872|540777926|FG002|Period 2|Lost to Follow-up|0|||
149904136|NCT01314872|540777927|FG003|Period 2|Lost to Follow-up|0|||
149904137|NCT01314872|540777928|FG004|Period 2|Lost to Follow-up|0|||
149904138|NCT01314872|540777929|FG005|Period 2|Lost to Follow-up|0|||
149904139|NCT01314872|540777930|FG006|Period 2|Lost to Follow-up|0|||
149904140|NCT01314872|540777931|FG007|Period 2|Lost to Follow-up|0|||
149904141|NCT01314872|540777932|FG008|Period 2|Lost to Follow-up|0|||
149904142|NCT01314872|540777933|FG009|Period 2|Lost to Follow-up|0|||
149904143|NCT01314872|540777934|FG010|Period 2|Lost to Follow-up|0|||
149904144|NCT01314872|540777935|FG011|Period 2|Lost to Follow-up|6|||
149904145|NCT01314872|540777936|FG012|Period 2|Lost to Follow-up|7|||
149904146|NCT01314872|540777937|FG013|Period 2|Lost to Follow-up|2|||
149904147|NCT01314872|540777938|FG014|Period 2|Lost to Follow-up|6|||
149904148|NCT03937908|540779623|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
149904149|NCT03937908|540779624|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
149904150|NCT03205761|540779625|FG000|Overall Study|Withdrawal by Subject|1|||
149904151|NCT03205761|540779625|FG000|Overall Study|Progressive Disease|10|||
149904152|NCT00636194|540779626|FG000|Overall Study|Study related symptoms and complaints|1|||
149904153|NCT00636194|540779627|FG001|Overall Study|Study related symptoms and complaints|0|||
149904154|NCT00636194|540779626|FG000|Overall Study|Protocol Violation|2|||
149904155|NCT00636194|540779627|FG001|Overall Study|Protocol Violation|0|||
149904156|NCT02163226|540779629|FG000|Overall Study|Death|2|||
149904157|NCT02163226|540779630|FG001|Overall Study|Death|1|||
149904158|NCT02163226|540779629|FG000|Overall Study|Withdrawal by Subject|5|||
149904159|NCT02163226|540779630|FG001|Overall Study|Withdrawal by Subject|2|||
149904160|NCT02163226|540779629|FG000|Overall Study|Returned home, local radiotherapy|3|||
149904161|NCT02163226|540779630|FG001|Overall Study|Returned home, local radiotherapy|0|||
149904162|NCT02163226|540779629|FG000|Overall Study|Repeat imaging showed no disease|2|||
149904163|NCT02163226|540779630|FG001|Overall Study|Repeat imaging showed no disease|0|||
149904164|NCT02163226|540779629|FG000|Overall Study|Incomplete radiotherapy|3|||
149904165|NCT02163226|540779630|FG001|Overall Study|Incomplete radiotherapy|0|||
149904166|NCT02163226|540779629|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
149904167|NCT02163226|540779630|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
149904168|NCT02163226|540779629|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
150176531|NCT01420549|541782017|FG000|Overall Study|Adverse Event|1|||
149904169|NCT02163226|540779630|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
149904170|NCT02163226|540779629|FG000|Overall Study|ineligible|0|||
149904171|NCT02163226|540779630|FG001|Overall Study|ineligible|3|||
149904172|NCT01300338|540779641|FG000|Overall Study|Lost to Follow-up|5|||
149904173|NCT01300338|540779642|FG001|Overall Study|Lost to Follow-up|0|||
149904174|NCT00401544|540779652|FG000|Overall Study|Adverse Event|5|||
149904175|NCT00401544|540779653|FG001|Overall Study|Adverse Event|1|||
149904176|NCT00401544|540779654|FG002|Overall Study|Adverse Event|1|||
149904177|NCT00401544|540779655|FG003|Overall Study|Adverse Event|1|||
149904178|NCT00401544|540779652|FG000|Overall Study|Death|3|||
149904179|NCT00401544|540779653|FG001|Overall Study|Death|6|||
150046323|NCT00481091|541309574|FG000|Overall Study|Progressive disease clinical|0|||
150046324|NCT00481091|541309575|FG001|Overall Study|Progressive disease clinical|0|||
150046325|NCT00481091|541309576|FG002|Overall Study|Progressive disease clinical|0|||
150046326|NCT00481091|541309577|FG003|Overall Study|Progressive disease clinical|0|||
150046327|NCT00481091|541309578|FG004|Overall Study|Progressive disease clinical|0|||
150046328|NCT00481091|541309579|FG005|Overall Study|Progressive disease clinical|0|||
150046329|NCT00481091|541309580|FG006|Overall Study|Progressive disease clinical|0|||
150046330|NCT00481091|541309581|FG007|Overall Study|Progressive disease clinical|0|||
150046331|NCT00481091|541309582|FG008|Overall Study|Progressive disease clinical|1|||
150046332|NCT00481091|541309583|FG009|Overall Study|Progressive disease clinical|7|||
150046333|NCT00481091|541309574|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
150046334|NCT00481091|541309575|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
150046335|NCT00481091|541309576|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046336|NCT00481091|541309577|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046337|NCT00481091|541309578|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046338|NCT00481091|541309579|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
150046339|NCT00481091|541309580|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046340|NCT00481091|541309581|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046341|NCT00481091|541309582|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046342|NCT00481091|541309583|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
150046343|NCT00481091|541309574|FG000|Overall Study|Progressive disease other|1|||
149904180|NCT00401544|540779654|FG002|Overall Study|Death|2|||
149904181|NCT00401544|540779655|FG003|Overall Study|Death|5|||
149904182|NCT00401544|540779652|FG000|Overall Study|Lost to Follow-up|2|||
149904183|NCT00401544|540779653|FG001|Overall Study|Lost to Follow-up|0|||
149904184|NCT00401544|540779654|FG002|Overall Study|Lost to Follow-up|1|||
149904185|NCT00401544|540779655|FG003|Overall Study|Lost to Follow-up|1|||
149904186|NCT00401544|540779652|FG000|Overall Study|Withdrawal by Subject|7|||
149904187|NCT00401544|540779653|FG001|Overall Study|Withdrawal by Subject|6|||
149904188|NCT00401544|540779654|FG002|Overall Study|Withdrawal by Subject|6|||
149904189|NCT00401544|540779655|FG003|Overall Study|Withdrawal by Subject|5|||
149904190|NCT00401544|540779652|FG000|Overall Study|Physician Decision|1|||
149904191|NCT00401544|540779653|FG001|Overall Study|Physician Decision|3|||
149904192|NCT00401544|540779654|FG002|Overall Study|Physician Decision|0|||
149904193|NCT00401544|540779655|FG003|Overall Study|Physician Decision|0|||
150176532|NCT01420549|541782018|FG001|Overall Study|Adverse Event|1|||
150176533|NCT01420549|541782017|FG000|Overall Study|Lost to Follow-up|2|||
150176534|NCT01420549|541782018|FG001|Overall Study|Lost to Follow-up|2|||
150176535|NCT01420549|541782017|FG000|Overall Study|Protocol Violation|0|||
150176536|NCT01420549|541782018|FG001|Overall Study|Protocol Violation|1|||
150176537|NCT01420549|541782017|FG000|Overall Study|Non-adherence to medication|4|||
150176538|NCT01420549|541782018|FG001|Overall Study|Non-adherence to medication|1|||
150176539|NCT04250883|541783315|FG000|Overall Study|Lost to Follow-up|1|||
150176540|NCT04250883|541783316|FG001|Overall Study|Lost to Follow-up|0|||
150176541|NCT02763319|541783317|FG000|Overall Study|Adverse Event|12|||
149904194|NCT00401544|540779652|FG000|Overall Study|Ineligibility determined|0|||
149904195|NCT00401544|540779653|FG001|Overall Study|Ineligibility determined|1|||
149904196|NCT00401544|540779654|FG002|Overall Study|Ineligibility determined|0|||
149904197|NCT00401544|540779655|FG003|Overall Study|Ineligibility determined|2|||
149904198|NCT00401544|540779652|FG000|Overall Study|Disease progression|0|||
149904199|NCT00401544|540779653|FG001|Overall Study|Disease progression|1|||
149904200|NCT00401544|540779654|FG002|Overall Study|Disease progression|0|||
149904201|NCT00401544|540779655|FG003|Overall Study|Disease progression|0|||
149904202|NCT00401544|540779652|FG000|Overall Study|Other|0|||
149904203|NCT00401544|540779653|FG001|Overall Study|Other|0|||
149904204|NCT00401544|540779654|FG002|Overall Study|Other|2|||
149904205|NCT00401544|540779655|FG003|Overall Study|Other|2|||
149904206|NCT02780713|540779656|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
149904207|NCT02780713|540779657|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
149904208|NCT02780713|540779658|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
149904209|NCT02780713|540779659|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
149904210|NCT02780713|540779660|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
149904211|NCT01931475|540779663|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
149904212|NCT01931475|540779664|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
149904213|NCT01931475|540779663|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
149969472|NCT01467466|541023747|FG000|Overall Study|Withdrawal by Subject|15|||
149969473|NCT01467466|541023748|FG001|Overall Study|Withdrawal by Subject|18|||
149969474|NCT01467466|541023749|FG002|Overall Study|Withdrawal by Subject|13|||
149969475|NCT01467466|541023750|FG003|Overall Study|Withdrawal by Subject|11|||
149969476|NCT01467466|541023747|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
149969477|NCT01467466|541023748|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
149969478|NCT01467466|541023749|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
149969479|NCT01467466|541023750|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
149969480|NCT01467466|541023747|FG000|Overall Study|Procedure Cancelled|46|||
149969481|NCT01467466|541023748|FG001|Overall Study|Procedure Cancelled|45|||
149969482|NCT01467466|541023749|FG002|Overall Study|Procedure Cancelled|25|||
149969483|NCT01467466|541023750|FG003|Overall Study|Procedure Cancelled|29|||
149969484|NCT01467466|541023747|FG000|Overall Study|No Endpoint Blood Draw|38|||
149969485|NCT01467466|541023748|FG001|Overall Study|No Endpoint Blood Draw|32|||
149969486|NCT01467466|541023749|FG002|Overall Study|No Endpoint Blood Draw|51|||
149969487|NCT01467466|541023750|FG003|Overall Study|No Endpoint Blood Draw|43|||
149969488|NCT03261505|541023755|FG000|Overall Study|Withdrawal by Subject|2|||
149969489|NCT03261505|541023756|FG001|Overall Study|Withdrawal by Subject|3|||
149969490|NCT03261505|541023757|FG002|Overall Study|Withdrawal by Subject|4|||
149969491|NCT03261505|541023758|FG003|Overall Study|Withdrawal by Subject|3|||
149969492|NCT03261505|541023755|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
149969493|NCT03261505|541023756|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
149969494|NCT03261505|541023757|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
149969495|NCT03261505|541023758|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
149969496|NCT03261505|541023755|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
149969497|NCT03261505|541023756|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
149969498|NCT03261505|541023757|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
149969499|NCT03261505|541023758|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
149969500|NCT03261505|541023755|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
149969501|NCT03261505|541023756|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
149969502|NCT03261505|541023757|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
149969503|NCT03261505|541023758|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
149969504|NCT04724837|541023768|FG000|Overall Study|Other|4|||
149969505|NCT04724837|541023769|FG001|Overall Study|Other|16|||
149969506|NCT04724837|541023770|FG002|Overall Study|Other|0|||
149969507|NCT04724837|541023768|FG000|Overall Study|Withdrawal by Subject|2|||
150176542|NCT02763319|541783318|FG001|Overall Study|Adverse Event|3|||
150176543|NCT02763319|541783317|FG000|Overall Study|Death|123|||
149969508|NCT04724837|541023769|FG001|Overall Study|Withdrawal by Subject|9|||
149969509|NCT04724837|541023770|FG002|Overall Study|Withdrawal by Subject|9|||
150176544|NCT02763319|541783318|FG001|Overall Study|Death|123|||
150176545|NCT02763319|541783317|FG000|Overall Study|Lost to Follow-up|6|||
150176546|NCT02763319|541783318|FG001|Overall Study|Lost to Follow-up|7|||
150046344|NCT00481091|541309575|FG001|Overall Study|Progressive disease other|1|||
150046345|NCT00481091|541309576|FG002|Overall Study|Progressive disease other|0|||
150046346|NCT00481091|541309577|FG003|Overall Study|Progressive disease other|1|||
150046347|NCT00481091|541309578|FG004|Overall Study|Progressive disease other|1|||
150046348|NCT00481091|541309579|FG005|Overall Study|Progressive disease other|1|||
150046349|NCT00481091|541309580|FG006|Overall Study|Progressive disease other|0|||
150046350|NCT00481091|541309581|FG007|Overall Study|Progressive disease other|2|||
150046351|NCT00481091|541309582|FG008|Overall Study|Progressive disease other|0|||
150046352|NCT00481091|541309583|FG009|Overall Study|Progressive disease other|0|||
150046353|NCT00481091|541309574|FG000|Overall Study|No reason given|0|||
150046354|NCT00481091|541309575|FG001|Overall Study|No reason given|0|||
150046355|NCT00481091|541309576|FG002|Overall Study|No reason given|1|||
150046356|NCT00481091|541309577|FG003|Overall Study|No reason given|1|||
150046357|NCT00481091|541309578|FG004|Overall Study|No reason given|1|||
150046358|NCT00481091|541309579|FG005|Overall Study|No reason given|0|||
150046359|NCT00481091|541309580|FG006|Overall Study|No reason given|1|||
150046360|NCT00481091|541309581|FG007|Overall Study|No reason given|1|||
150046361|NCT00481091|541309582|FG008|Overall Study|No reason given|1|||
150046362|NCT00481091|541309583|FG009|Overall Study|No reason given|4|||
150046363|NCT00975689|541309586|FG000|Overall Study|Adverse Event|0|||
150046364|NCT00975689|541309587|FG001|Overall Study|Adverse Event|3|||
150046365|NCT00975689|541309586|FG000|Overall Study|Withdrawal by Subject|1|||
150046366|NCT00975689|541309587|FG001|Overall Study|Withdrawal by Subject|0|||
150046367|NCT00975689|541309586|FG000|Overall Study|Physician Decision|1|||
150046368|NCT00975689|541309587|FG001|Overall Study|Physician Decision|0|||
150046369|NCT02423902|541309588|FG000|Overall Study|Disease progression|1|||
150046370|NCT02423902|541309589|FG001|Overall Study|Disease progression|4|||
150046371|NCT04329806|541309590|FG000|Overall Study|Physician Decision|3|||
150046372|NCT04329806|541309591|FG001|Overall Study|Physician Decision|4|||
150046373|NCT04838626|541309592|FG000|Overall Study|Adverse Event|2|||
150046374|NCT04838626|541309592|FG000|Overall Study|Physician Decision|6|||
150046375|NCT04838626|541309592|FG000|Overall Study|Protocol Violation|3|||
150046376|NCT04838626|541309592|FG000|Overall Study|Withdrawal by Subject|9|||
150046377|NCT04838626|541309592|FG000|Overall Study|Technical Problems|2|||
150046378|NCT02867384|541309593|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
150046379|NCT02867384|541309594|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
150046380|NCT02867384|541309595|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
150046381|NCT02867384|541309593|FG000|Overall Study|Progression/ Relapse|15|||
150046382|NCT02867384|541309594|FG001|Overall Study|Progression/ Relapse|19|||
150046383|NCT02867384|541309595|FG002|Overall Study|Progression/ Relapse|0|||
150046384|NCT02867384|541309593|FG000|Overall Study|Adverse Event|13|||
150046385|NCT02867384|541309594|FG001|Overall Study|Adverse Event|1|||
150046386|NCT02867384|541309595|FG002|Overall Study|Adverse Event|0|||
150046387|NCT02867384|541309593|FG000|Overall Study|Withdrawal by Subject|6|||
150046388|NCT02867384|541309594|FG001|Overall Study|Withdrawal by Subject|5|||
150046389|NCT02867384|541309595|FG002|Overall Study|Withdrawal by Subject|0|||
150046390|NCT02867384|541309593|FG000|Overall Study|Physician Decision|1|||
150046391|NCT02867384|541309594|FG001|Overall Study|Physician Decision|2|||
150046392|NCT02867384|541309595|FG002|Overall Study|Physician Decision|0|||
150046393|NCT02867384|541309593|FG000|Overall Study|Patient compliance|1|||
150046394|NCT02867384|541309594|FG001|Overall Study|Patient compliance|0|||
150046395|NCT02867384|541309595|FG002|Overall Study|Patient compliance|0|||
150046396|NCT02867384|541309593|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
150046397|NCT02867384|541309594|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
150046398|NCT02867384|541309595|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
150046399|NCT02867384|541309593|FG000|Overall Study|Never start treatment|3|||
150046400|NCT02867384|541309594|FG001|Overall Study|Never start treatment|0|||
150046401|NCT02867384|541309595|FG002|Overall Study|Never start treatment|0|||
150046402|NCT03901469|541309596|FG000|Overall Study|Radiographic Progression|4|||
150046403|NCT03901469|541309597|FG001|Overall Study|Radiographic Progression|6|||
150046404|NCT03901469|541309598|FG002|Overall Study|Radiographic Progression|3|||
150046405|NCT03901469|541309599|FG003|Overall Study|Radiographic Progression|30|||
149904214|NCT01931475|540779664|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
149904215|NCT01931475|540779663|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
149904216|NCT01931475|540779664|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
149904217|NCT01931475|540779663|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
149904218|NCT01931475|540779664|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
149904219|NCT01931475|540779663|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
149904220|NCT01931475|540779664|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
149904221|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
149904222|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
149904223|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
149904224|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
149904225|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
149904226|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
149904227|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
149904228|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
149904229|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
149904230|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
149904231|NCT01931475|540779663|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
149904232|NCT01931475|540779664|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
149904233|NCT03991299|540779665|FG000|Overall Study|Study closed, sponsor decision|3|||
149904234|NCT03991299|540779665|FG000|Overall Study|Withdrawal by Subject|1|||
149904235|NCT04304235|540779666|FG000|Overall Study|incomplete triage data|0|||
149904236|NCT04304235|540779667|FG001|Overall Study|incomplete triage data|69|||
149904237|NCT04304235|540779668|FG002|Overall Study|incomplete triage data|0|||
149904238|NCT04304235|540779669|FG003|Overall Study|incomplete triage data|0|||
149904239|NCT04304235|540779670|FG004|Overall Study|incomplete triage data|289|||
149904240|NCT04304235|540779671|FG005|Overall Study|incomplete triage data|123|||
149904241|NCT04304235|540779672|FG006|Overall Study|incomplete triage data|65|||
149904242|NCT04429555|540779674|FG000|Overall Study|Death|0|||
149904243|NCT04429555|540779675|FG001|Overall Study|Death|2|||
149904244|NCT04429555|540779674|FG000|Overall Study|Other|2|||
149904245|NCT04429555|540779675|FG001|Overall Study|Other|0|||
149904246|NCT00930774|540779676|FG000|Overall Study|Withdrawal by Subject|1|||
149904247|NCT00930774|540779677|FG001|Overall Study|Withdrawal by Subject|9|||
149904248|NCT00930774|540779678|FG002|Overall Study|Withdrawal by Subject|2|||
149904249|NCT00930774|540779679|FG003|Overall Study|Withdrawal by Subject|0|||
149904250|NCT03200704|540779680|FG000|Overall Study|Withdrawal by Subject|1|||
149904251|NCT00425061|540779681|FG000|Overall Study|Adverse Event|1|||
149904252|NCT00425061|540779682|FG001|Overall Study|Adverse Event|0|||
149904253|NCT00425061|540779683|FG002|Overall Study|Adverse Event|0|||
149904254|NCT00425061|540779684|FG003|Overall Study|Adverse Event|2|||
149904255|NCT00425061|540779685|FG004|Overall Study|Adverse Event|2|||
149904256|NCT00425061|540779686|FG005|Overall Study|Adverse Event|0|||
149904257|NCT00425061|540779687|FG006|Overall Study|Adverse Event|0|||
149904258|NCT00425061|540779681|FG000|Overall Study|Lost to Follow-up|0|||
149904259|NCT00425061|540779682|FG001|Overall Study|Lost to Follow-up|1|||
149904260|NCT00425061|540779683|FG002|Overall Study|Lost to Follow-up|0|||
149904261|NCT00425061|540779684|FG003|Overall Study|Lost to Follow-up|0|||
149904262|NCT00425061|540779685|FG004|Overall Study|Lost to Follow-up|0|||
149904263|NCT00425061|540779686|FG005|Overall Study|Lost to Follow-up|0|||
149904264|NCT00425061|540779687|FG006|Overall Study|Lost to Follow-up|0|||
149904265|NCT00425061|540779681|FG000|Overall Study|Protocol Violation|1|||
149904266|NCT00425061|540779682|FG001|Overall Study|Protocol Violation|0|||
149904267|NCT00425061|540779683|FG002|Overall Study|Protocol Violation|0|||
149904268|NCT00425061|540779684|FG003|Overall Study|Protocol Violation|0|||
149904269|NCT00425061|540779685|FG004|Overall Study|Protocol Violation|0|||
149904270|NCT00425061|540779686|FG005|Overall Study|Protocol Violation|0|||
149904271|NCT00425061|540779687|FG006|Overall Study|Protocol Violation|0|||
149904272|NCT00425061|540779681|FG000|Overall Study|Withdrawal by Subject|0|||
149904273|NCT00425061|540779682|FG001|Overall Study|Withdrawal by Subject|1|||
149904274|NCT00425061|540779683|FG002|Overall Study|Withdrawal by Subject|0|||
149904275|NCT00425061|540779684|FG003|Overall Study|Withdrawal by Subject|0|||
149904276|NCT00425061|540779685|FG004|Overall Study|Withdrawal by Subject|1|||
149904277|NCT00425061|540779686|FG005|Overall Study|Withdrawal by Subject|0|||
149969510|NCT04724837|541023768|FG000|Overall Study|Adverse Event|2|||
149969511|NCT04724837|541023769|FG001|Overall Study|Adverse Event|7|||
149904278|NCT00425061|540779687|FG006|Overall Study|Withdrawal by Subject|3|||
149904279|NCT00425061|540779681|FG000|Overall Study|Sponsor's request|0|||
149904280|NCT00425061|540779682|FG001|Overall Study|Sponsor's request|0|||
149969512|NCT04724837|541023770|FG002|Overall Study|Adverse Event|4|||
149904281|NCT00425061|540779683|FG002|Overall Study|Sponsor's request|0|||
149904282|NCT00425061|540779684|FG003|Overall Study|Sponsor's request|0|||
149969513|NCT04724837|541023768|FG000|Overall Study|Lost to Follow-up|0|||
149904283|NCT00425061|540779685|FG004|Overall Study|Sponsor's request|19|||
149904284|NCT00425061|540779686|FG005|Overall Study|Sponsor's request|4|||
149904285|NCT00425061|540779687|FG006|Overall Study|Sponsor's request|15|||
149904286|NCT00425061|540779681|FG000|Overall Study|Physician Decision|0|||
149904287|NCT00425061|540779682|FG001|Overall Study|Physician Decision|0|||
149904288|NCT00425061|540779683|FG002|Overall Study|Physician Decision|0|||
149904289|NCT00425061|540779684|FG003|Overall Study|Physician Decision|0|||
149904290|NCT00425061|540779685|FG004|Overall Study|Physician Decision|1|||
149969514|NCT04724837|541023769|FG001|Overall Study|Lost to Follow-up|1|||
149969515|NCT04724837|541023770|FG002|Overall Study|Lost to Follow-up|3|||
149969516|NCT04724837|541023768|FG000|Overall Study|Physician Decision|1|||
149969517|NCT04724837|541023769|FG001|Overall Study|Physician Decision|2|||
149969518|NCT04724837|541023770|FG002|Overall Study|Physician Decision|0|||
149969519|NCT04724837|541023768|FG000|Overall Study|Death|0|||
149969520|NCT04724837|541023769|FG001|Overall Study|Death|0|||
149969521|NCT04724837|541023770|FG002|Overall Study|Death|1|||
149969522|NCT04724837|541023768|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
149969523|NCT04724837|541023769|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
149969524|NCT04724837|541023770|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
149969525|NCT04724837|541023768|FG000|Overall Study|Study Terminated by Sponsor|0|||
149969526|NCT04724837|541023769|FG001|Overall Study|Study Terminated by Sponsor|1|||
149969527|NCT04724837|541023770|FG002|Overall Study|Study Terminated by Sponsor|0|||
149969528|NCT04079738|541023771|FG000|Study Treatment|Death|1|||
149969529|NCT04079738|541023772|FG001|Study Treatment|Death|0|||
149969530|NCT04079738|541023773|FG002|Study Treatment|Death|0|||
149969531|NCT04079738|541023774|FG003|Study Treatment|Death|0|||
149969532|NCT04079738|541023771|FG000|Study Treatment|Adverse Event|2|||
149969533|NCT04079738|541023772|FG001|Study Treatment|Adverse Event|0|||
149969534|NCT04079738|541023773|FG002|Study Treatment|Adverse Event|0|||
149969535|NCT04079738|541023774|FG003|Study Treatment|Adverse Event|0|||
149969536|NCT04079738|541023771|FG000|Study Treatment|withdrawal before treatment|1|||
149969537|NCT04079738|541023772|FG001|Study Treatment|withdrawal before treatment|0|||
149969538|NCT04079738|541023773|FG002|Study Treatment|withdrawal before treatment|0|||
149969539|NCT04079738|541023774|FG003|Study Treatment|withdrawal before treatment|0|||
149969540|NCT04079738|541023771|FG000|Study Treatment|symptomatic deterioration|2|||
149969541|NCT04079738|541023772|FG001|Study Treatment|symptomatic deterioration|0|||
150046406|NCT03901469|541309600|FG004|Overall Study|Radiographic Progression|7|||
150046407|NCT03901469|541309601|FG005|Overall Study|Radiographic Progression|2|||
150046408|NCT03901469|541309602|FG006|Overall Study|Radiographic Progression|11|||
150046409|NCT03901469|541309596|FG000|Overall Study|Clinical Progression|0|||
150046410|NCT03901469|541309597|FG001|Overall Study|Clinical Progression|2|||
150046411|NCT03901469|541309598|FG002|Overall Study|Clinical Progression|0|||
150046412|NCT03901469|541309599|FG003|Overall Study|Clinical Progression|7|||
150046413|NCT03901469|541309600|FG004|Overall Study|Clinical Progression|6|||
150046414|NCT03901469|541309601|FG005|Overall Study|Clinical Progression|0|||
150046415|NCT03901469|541309602|FG006|Overall Study|Clinical Progression|2|||
150046416|NCT03901469|541309596|FG000|Overall Study|Adverse Event|1|||
150046417|NCT03901469|541309597|FG001|Overall Study|Adverse Event|0|||
150046418|NCT03901469|541309598|FG002|Overall Study|Adverse Event|0|||
150046419|NCT03901469|541309599|FG003|Overall Study|Adverse Event|0|||
150046420|NCT03901469|541309600|FG004|Overall Study|Adverse Event|0|||
150046421|NCT03901469|541309601|FG005|Overall Study|Adverse Event|0|||
150046422|NCT03901469|541309602|FG006|Overall Study|Adverse Event|9|||
150046423|NCT03901469|541309596|FG000|Overall Study|Physician Decision|0|||
150046424|NCT03901469|541309597|FG001|Overall Study|Physician Decision|0|||
150046425|NCT03901469|541309598|FG002|Overall Study|Physician Decision|0|||
150046426|NCT03901469|541309599|FG003|Overall Study|Physician Decision|1|||
150046427|NCT03901469|541309600|FG004|Overall Study|Physician Decision|0|||
150046428|NCT03901469|541309601|FG005|Overall Study|Physician Decision|0|||
150046429|NCT03901469|541309602|FG006|Overall Study|Physician Decision|0|||
150046430|NCT03901469|541309596|FG000|Overall Study|Withdrawal by Subject|0|||
150046431|NCT03901469|541309597|FG001|Overall Study|Withdrawal by Subject|0|||
150046432|NCT03901469|541309598|FG002|Overall Study|Withdrawal by Subject|0|||
150046433|NCT03901469|541309599|FG003|Overall Study|Withdrawal by Subject|0|||
150046434|NCT03901469|541309600|FG004|Overall Study|Withdrawal by Subject|2|||
150046435|NCT03901469|541309601|FG005|Overall Study|Withdrawal by Subject|0|||
150046436|NCT03901469|541309602|FG006|Overall Study|Withdrawal by Subject|8|||
150046437|NCT03901469|541309596|FG000|Overall Study|Death|0|||
150176547|NCT02763319|541783317|FG000|Overall Study|Noncompliance with Study Drug|2|||
149904291|NCT00425061|540779686|FG005|Overall Study|Physician Decision|0|||
149904292|NCT00425061|540779687|FG006|Overall Study|Physician Decision|0|||
149904293|NCT00425061|540779681|FG000|Overall Study|Other|0|||
149904294|NCT00425061|540779682|FG001|Overall Study|Other|0|||
149969542|NCT04079738|541023773|FG002|Study Treatment|symptomatic deterioration|0|||
149969543|NCT04079738|541023774|FG003|Study Treatment|symptomatic deterioration|0|||
149969544|NCT04079738|541023771|FG000|Study Treatment|Disease Progression|1|||
150046438|NCT03901469|541309597|FG001|Overall Study|Death|0|||
149904295|NCT00425061|540779683|FG002|Overall Study|Other|0|||
149904296|NCT00425061|540779684|FG003|Overall Study|Other|0|||
149904297|NCT00425061|540779685|FG004|Overall Study|Other|3|||
149904298|NCT00425061|540779686|FG005|Overall Study|Other|0|||
149904299|NCT00425061|540779687|FG006|Overall Study|Other|1|||
149904300|NCT03436693|540779688|FG000|Overall Study|Adverse Event|22|||
149904301|NCT03436693|540779689|FG001|Overall Study|Adverse Event|10|||
149904302|NCT03436693|540779688|FG000|Overall Study|Physician Decision|3|||
149904303|NCT03436693|540779689|FG001|Overall Study|Physician Decision|3|||
149904304|NCT03436693|540779688|FG000|Overall Study|Withdrawal by Subject|4|||
149904305|NCT03436693|540779689|FG001|Overall Study|Withdrawal by Subject|13|||
149904306|NCT03436693|540779688|FG000|Overall Study|Progressive Disease|1|||
149904307|NCT03436693|540779689|FG001|Overall Study|Progressive Disease|1|||
149904308|NCT01680861|540779690|FG000|Early Post-transplant Period|Protocol Violation|1|||
149904309|NCT01680861|540779691|FG001|Early Post-transplant Period|Protocol Violation|1|||
149904310|NCT00654875|540779692|FG000|Overall Study|Adverse Event|5|||
149904311|NCT00654875|540779693|FG001|Overall Study|Adverse Event|5|||
149904312|NCT00654875|540779692|FG000|Overall Study|Withdrawal by Subject|4|||
149904313|NCT00654875|540779693|FG001|Overall Study|Withdrawal by Subject|4|||
149904314|NCT00654875|540779692|FG000|Overall Study|Protocol Violation|3|||
149904315|NCT00654875|540779693|FG001|Overall Study|Protocol Violation|3|||
149904316|NCT00654875|540779692|FG000|Overall Study|Lack of Efficacy|2|||
149904317|NCT00654875|540779693|FG001|Overall Study|Lack of Efficacy|2|||
149904318|NCT00654875|540779692|FG000|Overall Study|Lost to Follow-up|1|||
149904319|NCT00654875|540779693|FG001|Overall Study|Lost to Follow-up|3|||
149904320|NCT00654875|540779692|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
149904321|NCT00654875|540779693|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
149904322|NCT00654875|540779692|FG000|Overall Study|Administrative Problems|1|||
149904323|NCT00654875|540779693|FG001|Overall Study|Administrative Problems|0|||
149904324|NCT01011465|540779694|FG000|Overall Study|Withdrawal by Subject|2|||
149904325|NCT01011465|540779695|FG001|Overall Study|Withdrawal by Subject|1|||
149904326|NCT01011465|540779696|FG002|Overall Study|Withdrawal by Subject|0|||
149904327|NCT01011465|540779697|FG003|Overall Study|Withdrawal by Subject|0|||
149904328|NCT01011465|540779698|FG004|Overall Study|Withdrawal by Subject|1|||
149904329|NCT01011465|540779699|FG005|Overall Study|Withdrawal by Subject|0|||
149904330|NCT01011465|540779700|FG006|Overall Study|Withdrawal by Subject|1|||
149904331|NCT01011465|540779701|FG007|Overall Study|Withdrawal by Subject|0|||
149904332|NCT02042950|540779704|FG000|Overall Study|Progressive Disease|4|||
149904333|NCT00723008|540779705|FG000|Enrollment|Lost to Follow-up|1|||
149904334|NCT00723008|540779706|FG001|Enrollment|Lost to Follow-up|0|||
149904335|NCT00723008|540779705|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
149904336|NCT00723008|540779706|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
149904337|NCT00723008|540779705|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
149904338|NCT00723008|540779706|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
149904339|NCT00723008|540779705|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
149969545|NCT04079738|541023772|FG001|Study Treatment|Disease Progression|0|||
149969546|NCT04079738|541023773|FG002|Study Treatment|Disease Progression|0|||
149969547|NCT04079738|541023774|FG003|Study Treatment|Disease Progression|0|||
149969548|NCT04079738|541023771|FG000|Study Treatment|withdrawal after treatment|1|||
149969549|NCT04079738|541023772|FG001|Study Treatment|withdrawal after treatment|0|||
149969550|NCT04079738|541023773|FG002|Study Treatment|withdrawal after treatment|0|||
149969551|NCT04079738|541023774|FG003|Study Treatment|withdrawal after treatment|0|||
149969552|NCT04079738|541023771|FG000|Follow up|Withdrawal by Subject|3|||
149969553|NCT04079738|541023772|FG001|Follow up|Withdrawal by Subject|0|||
149969554|NCT04079738|541023773|FG002|Follow up|Withdrawal by Subject|0|||
149969555|NCT04079738|541023774|FG003|Follow up|Withdrawal by Subject|0|||
149969556|NCT04079738|541023771|FG000|Follow up|Death|5|||
149969557|NCT04079738|541023772|FG001|Follow up|Death|0|||
149969558|NCT04079738|541023773|FG002|Follow up|Death|0|||
149969559|NCT04079738|541023774|FG003|Follow up|Death|0|||
149969560|NCT00071032|541023775|FG000|Overall Study|Lost to Follow-up|1|||
149969561|NCT00071032|541023776|FG001|Overall Study|Lost to Follow-up|1|||
149969562|NCT00071032|541023775|FG000|Overall Study|Withdrawal by Subject|8|||
149969563|NCT00071032|541023776|FG001|Overall Study|Withdrawal by Subject|6|||
149969564|NCT00071032|541023775|FG000|Overall Study|Missing Primary Outcome|0|||
149969565|NCT00071032|541023776|FG001|Overall Study|Missing Primary Outcome|1|||
149904340|NCT00723008|540779706|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
149904341|NCT00723008|540779705|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
149904342|NCT00723008|540779706|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
149904343|NCT00723008|540779705|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
149904344|NCT00723008|540779706|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
149904345|NCT02217410|540779710|FG000|Overall Study|Graft Loss|0|||
149904346|NCT02217410|540779711|FG001|Overall Study|Graft Loss|0|||
149904347|NCT02217410|540779712|FG002|Overall Study|Graft Loss|2|||
149969566|NCT01889251|541023777|FG000|Overall Study|Adverse Event|1|||
149969567|NCT01889251|541023778|FG001|Overall Study|Adverse Event|0|||
149969568|NCT05852470|541023780|FG000|Overall Study|Withdrawal by Subject|0|||
149969569|NCT05852470|541023781|FG001|Overall Study|Withdrawal by Subject|1|||
149969570|NCT06071104|541023782|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
150046439|NCT03901469|541309598|FG002|Overall Study|Death|0|||
150046440|NCT03901469|541309599|FG003|Overall Study|Death|3|||
150046441|NCT03901469|541309600|FG004|Overall Study|Death|5|||
150046442|NCT03901469|541309601|FG005|Overall Study|Death|0|||
150046443|NCT03901469|541309602|FG006|Overall Study|Death|1|||
150046444|NCT03901469|541309596|FG000|Overall Study|Termination of study by sponsor|0|||
150046445|NCT03901469|541309597|FG001|Overall Study|Termination of study by sponsor|0|||
150046446|NCT03901469|541309598|FG002|Overall Study|Termination of study by sponsor|0|||
150046447|NCT03901469|541309599|FG003|Overall Study|Termination of study by sponsor|0|||
150046448|NCT03901469|541309600|FG004|Overall Study|Termination of study by sponsor|1|||
150046449|NCT03901469|541309601|FG005|Overall Study|Termination of study by sponsor|1|||
150046450|NCT03901469|541309602|FG006|Overall Study|Termination of study by sponsor|0|||
150046451|NCT03901469|541309596|FG000|Overall Study|Not Reported|1|||
150046452|NCT03901469|541309597|FG001|Overall Study|Not Reported|0|||
150046453|NCT03901469|541309598|FG002|Overall Study|Not Reported|0|||
150046454|NCT03901469|541309599|FG003|Overall Study|Not Reported|1|||
150046455|NCT03901469|541309600|FG004|Overall Study|Not Reported|0|||
150046456|NCT03901469|541309601|FG005|Overall Study|Not Reported|0|||
150046457|NCT03901469|541309602|FG006|Overall Study|Not Reported|1|||
150046458|NCT01349959|541309603|FG000|Overall Study|Adverse Event|7|||
150046459|NCT02675634|541309604|FG000|Test Period 1|Adverse Event|0|||
150046460|NCT02675634|541309605|FG001|Test Period 1|Adverse Event|1|||
150046461|NCT02675634|541309606|FG002|Test Period 1|Adverse Event|0|||
150176548|NCT02763319|541783318|FG001|Overall Study|Noncompliance with Study Drug|0|||
149904348|NCT02217410|540779710|FG000|Overall Study|Withdrawal by Subject|0|||
149904349|NCT02217410|540779711|FG001|Overall Study|Withdrawal by Subject|0|||
149904350|NCT02217410|540779712|FG002|Overall Study|Withdrawal by Subject|2|||
149904351|NCT02217410|540779710|FG000|Overall Study|Lost to Follow-up|0|||
149904352|NCT02217410|540779711|FG001|Overall Study|Lost to Follow-up|0|||
149904353|NCT02217410|540779712|FG002|Overall Study|Lost to Follow-up|1|||
149904354|NCT02217410|540779710|FG000|Overall Study|Lack of Efficacy|0|||
149904355|NCT02217410|540779711|FG001|Overall Study|Lack of Efficacy|1|||
149904356|NCT02217410|540779712|FG002|Overall Study|Lack of Efficacy|0|||
149904357|NCT02217410|540779710|FG000|Overall Study|Physician Decision|1|||
149904358|NCT02217410|540779711|FG001|Overall Study|Physician Decision|3|||
149904359|NCT02217410|540779712|FG002|Overall Study|Physician Decision|0|||
149904360|NCT00090220|540779715|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
149904361|NCT00090220|540779716|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
150176549|NCT02763319|541783317|FG000|Overall Study|"Captured as Other in Database"|29|||
150176550|NCT02763319|541783318|FG001|Overall Study|"Captured as Other in Database"|34|||
150176551|NCT02763319|541783317|FG000|Overall Study|Physician Decision|1|||
150176552|NCT02763319|541783318|FG001|Overall Study|Physician Decision|7|||
150176553|NCT02763319|541783317|FG000|Overall Study|Progressive Disease|24|||
150176554|NCT02763319|541783318|FG001|Overall Study|Progressive Disease|27|||
150176555|NCT02763319|541783317|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
150176556|NCT02763319|541783318|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
150176557|NCT02763319|541783317|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
150176558|NCT02763319|541783318|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
150176559|NCT02763319|541783317|FG000|Overall Study|Withdrawal by Subject|26|||
150176560|NCT02763319|541783318|FG001|Overall Study|Withdrawal by Subject|25|||
150176561|NCT02499159|541783320|FG000|Randomization|Protocol Violation|1|||
150176562|NCT02499159|541783321|FG001|Randomization|Protocol Violation|1|||
150176563|NCT02499159|541783320|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
150176564|NCT02499159|541783321|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
150176565|NCT02499159|541783320|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
150176566|NCT02499159|541783321|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
150176567|NCT02499159|541783320|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
150046462|NCT02675634|541309607|FG003|Test Period 1|Adverse Event|1|||
150046463|NCT02675634|541309608|FG004|Test Period 1|Adverse Event|0|||
150046464|NCT02675634|541309609|FG005|Test Period 1|Adverse Event|0|||
149904362|NCT00090220|540779717|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149904363|NCT00090220|540779718|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149904364|NCT00090220|540779719|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
150046465|NCT02675634|541309604|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
150046466|NCT02675634|541309605|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
150046467|NCT02675634|541309606|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
150046468|NCT02675634|541309607|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
150046469|NCT02675634|541309608|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
150046470|NCT02675634|541309609|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
150046471|NCT02675634|541309604|FG000|Test Period 2|Lack of Efficacy|1|||
150046472|NCT02675634|541309605|FG001|Test Period 2|Lack of Efficacy|0|||
150046473|NCT02675634|541309606|FG002|Test Period 2|Lack of Efficacy|0|||
150046474|NCT02675634|541309607|FG003|Test Period 2|Lack of Efficacy|0|||
150046475|NCT02675634|541309608|FG004|Test Period 2|Lack of Efficacy|0|||
150046476|NCT02675634|541309609|FG005|Test Period 2|Lack of Efficacy|0|||
150046477|NCT02675634|541309604|FG000|Test Period 2|Adverse Event|0|||
150046478|NCT02675634|541309605|FG001|Test Period 2|Adverse Event|0|||
150046479|NCT02675634|541309606|FG002|Test Period 2|Adverse Event|0|||
150046480|NCT02675634|541309607|FG003|Test Period 2|Adverse Event|0|||
150046481|NCT02675634|541309608|FG004|Test Period 2|Adverse Event|0|||
150046482|NCT02675634|541309609|FG005|Test Period 2|Adverse Event|1|||
150046483|NCT01652534|541309610|FG000|Overall Study|Lack of Efficacy|1|||
150046484|NCT01652534|541309611|FG001|Overall Study|Lack of Efficacy|0|||
150046485|NCT03710083|541309612|FG000|Overall Study|Withdrawal by Subject|2|||
150046486|NCT03710083|541309612|FG000|Overall Study|Unsuccessful Procedure|1|||
150046487|NCT01727024|541309613|FG000|Period 1|Lost to Follow-up|1|||
150046488|NCT01727024|541309614|FG001|Period 1|Lost to Follow-up|1|||
150046489|NCT01727024|541309613|FG000|Period 1|Withdrawal by Subject|2|||
150046490|NCT01727024|541309614|FG001|Period 1|Withdrawal by Subject|3|||
150046491|NCT00467753|541309617|FG000|Overall Study|Lost to Follow-up|1|||
150046492|NCT00467753|541309618|FG001|Overall Study|Lost to Follow-up|2|||
150046493|NCT00467753|541309617|FG000|Overall Study|Adverse Event|2|||
150046494|NCT00467753|541309618|FG001|Overall Study|Adverse Event|0|||
150046495|NCT00948441|541309623|FG000|Overall Study|no longer meet inclusion criteria|1|||
150046496|NCT00948441|541309624|FG001|Overall Study|no longer meet inclusion criteria|4|||
150046497|NCT00104520|541309626|FG000|Overall Study|Unrelated adverse event|34|||
150046498|NCT00104520|541309627|FG001|Overall Study|Unrelated adverse event|47|||
150046499|NCT00104520|541309626|FG000|Overall Study|Study drug intolerance|0|||
150046500|NCT00104520|541309627|FG001|Overall Study|Study drug intolerance|1|||
150046501|NCT00104520|541309626|FG000|Overall Study|Related adverse event|13|||
150046502|NCT00104520|541309627|FG001|Overall Study|Related adverse event|15|||
150046503|NCT00104520|541309626|FG000|Overall Study|Lost to Follow-up|1|||
150046504|NCT00104520|541309627|FG001|Overall Study|Lost to Follow-up|0|||
150046505|NCT00104520|541309626|FG000|Overall Study|Noncompliance|0|||
150046506|NCT00104520|541309627|FG001|Overall Study|Noncompliance|2|||
150046507|NCT00104520|541309626|FG000|Overall Study|Personal/administrative|1|||
150046508|NCT00104520|541309627|FG001|Overall Study|Personal/administrative|1|||
150046509|NCT00104520|541309626|FG000|Overall Study|Other|1|||
150046510|NCT00104520|541309627|FG001|Overall Study|Other|5|||
150046511|NCT01026324|541309628|FG000|Follow up/Survival|Withdrawal by Subject|1|||
150046512|NCT01026324|541309629|FG001|Follow up/Survival|Withdrawal by Subject|0|||
150046513|NCT01026324|541309630|FG002|Follow up/Survival|Withdrawal by Subject|0|||
150046514|NCT02442804|541309631|FG000|Overall Study|Withdrawal by Subject|0|||
150046515|NCT02442804|541309632|FG001|Overall Study|Withdrawal by Subject|1|||
150046516|NCT02442804|541309631|FG000|Overall Study|Adverse Event|1|||
149904365|NCT00090220|540779720|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149904366|NCT00090220|540779715|FG000|Base Study Vaccination Period|Adverse Event|6|||
149904367|NCT00090220|540779716|FG001|Base Study Vaccination Period|Adverse Event|1|||
149904368|NCT00090220|540779717|FG002|Base Study Vaccination Period|Adverse Event|0|||
149904369|NCT00090220|540779718|FG003|Base Study Vaccination Period|Adverse Event|0|||
149904370|NCT00090220|540779719|FG004|Base Study Vaccination Period|Adverse Event|0|||
149904371|NCT00090220|540779720|FG005|Base Study Vaccination Period|Adverse Event|0|||
149904372|NCT00090220|540779715|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
150046517|NCT02442804|541309632|FG001|Overall Study|Adverse Event|0|||
150046518|NCT02624986|541309636|FG000|Overall Study|Death|0|||
150046519|NCT02624986|541309637|FG001|Overall Study|Death|1|||
150046520|NCT02624986|541309638|FG002|Overall Study|Death|2|||
150046521|NCT02624986|541309639|FG003|Overall Study|Death|2|||
150046522|NCT02624986|541309640|FG004|Overall Study|Death|2|||
150046523|NCT02624986|541309641|FG005|Overall Study|Death|0|||
150046524|NCT02624986|541309642|FG006|Overall Study|Death|0|||
150046525|NCT02624986|541309643|FG007|Overall Study|Death|1|||
150046526|NCT02624986|541309636|FG000|Overall Study|Study Terminated by Sponsor|1|||
150046527|NCT02624986|541309637|FG001|Overall Study|Study Terminated by Sponsor|1|||
150046528|NCT02624986|541309638|FG002|Overall Study|Study Terminated by Sponsor|0|||
150046529|NCT02624986|541309639|FG003|Overall Study|Study Terminated by Sponsor|1|||
150046530|NCT02624986|541309640|FG004|Overall Study|Study Terminated by Sponsor|2|||
150046531|NCT02624986|541309641|FG005|Overall Study|Study Terminated by Sponsor|2|||
150046532|NCT02624986|541309642|FG006|Overall Study|Study Terminated by Sponsor|4|||
149904373|NCT00090220|540779716|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
149904374|NCT00090220|540779717|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
149904375|NCT00090220|540779718|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
149904376|NCT00090220|540779719|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
149904377|NCT00090220|540779720|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
149904378|NCT00090220|540779715|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
149904379|NCT00090220|540779716|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
149904380|NCT00090220|540779717|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
149904381|NCT00090220|540779718|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
149904382|NCT00090220|540779719|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
149904383|NCT00090220|540779720|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
149904384|NCT00090220|540779715|FG000|Base Study Vaccination Period|Patient Moved|6|||
149969571|NCT01903863|541023785|FG000|Overall Study|Physician Decision|2|||
149969572|NCT01903863|541023786|FG001|Overall Study|Physician Decision|0|||
149969573|NCT01344226|541023791|FG000|Overall Study|Protocol Violation|2|||
149969574|NCT01344226|541023791|FG000|Overall Study|Withdrawal by Subject|3|||
149969575|NCT01344226|541023791|FG000|Overall Study|Lack of Efficacy|3|||
149969576|NCT02420717|541023797|FG000|Overall Study|Did not receive all study medication|2|||
149969577|NCT02420717|541023798|FG001|Overall Study|Did not receive all study medication|0|||
149969578|NCT02420717|541023799|FG002|Overall Study|Did not receive all study medication|0|||
149969579|NCT04116489|541023800|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
149969580|NCT04116489|541023800|FG000|Overall Study|Withdrawal by Subject|1|||
149969581|NCT03734536|541023801|FG000|Overall Study|Withdrew Consent|1|||
149969582|NCT03734536|541023802|FG001|Overall Study|Withdrew Consent|5|||
149969583|NCT03734536|541023801|FG000|Overall Study|Lost to Follow-up|10|||
149969584|NCT03734536|541023802|FG001|Overall Study|Lost to Follow-up|7|||
149969585|NCT02538614|541025203|FG000|Overall Study|Progressive Disease|2|||
149969586|NCT02829996|541025204|FG000|Overall Study|Withdrawal by Subject|1|||
149969587|NCT02829996|541025205|FG001|Overall Study|Withdrawal by Subject|0|||
149969588|NCT02829996|541025206|FG002|Overall Study|Withdrawal by Subject|0|||
149969589|NCT02829996|541025207|FG003|Overall Study|Withdrawal by Subject|0|||
149969590|NCT02829996|541025208|FG004|Overall Study|Withdrawal by Subject|0|||
149969591|NCT01517984|541025223|FG000|Overall Study|Lost to Follow-up|0|||
149969592|NCT01517984|541025224|FG001|Overall Study|Lost to Follow-up|1|||
149969593|NCT01517984|541025225|FG002|Overall Study|Lost to Follow-up|0|||
149904385|NCT00090220|540779716|FG001|Base Study Vaccination Period|Patient Moved|2|||
149904386|NCT00090220|540779717|FG002|Base Study Vaccination Period|Patient Moved|0|||
149904387|NCT00090220|540779718|FG003|Base Study Vaccination Period|Patient Moved|0|||
149904388|NCT00090220|540779719|FG004|Base Study Vaccination Period|Patient Moved|0|||
149904389|NCT00090220|540779720|FG005|Base Study Vaccination Period|Patient Moved|0|||
149904390|NCT00090220|540779715|FG000|Base Study Vaccination Period|Other|4|||
149904391|NCT00090220|540779716|FG001|Base Study Vaccination Period|Other|4|||
149904392|NCT00090220|540779717|FG002|Base Study Vaccination Period|Other|0|||
149904393|NCT00090220|540779718|FG003|Base Study Vaccination Period|Other|0|||
149904394|NCT00090220|540779719|FG004|Base Study Vaccination Period|Other|0|||
149904395|NCT00090220|540779720|FG005|Base Study Vaccination Period|Other|0|||
149904396|NCT00090220|540779715|FG000|Base Study Follow-up Period|Adverse Event|6|||
149904397|NCT00090220|540779716|FG001|Base Study Follow-up Period|Adverse Event|1|||
149969594|NCT01517984|541025226|FG003|Overall Study|Lost to Follow-up|0|||
149904398|NCT00090220|540779717|FG002|Base Study Follow-up Period|Adverse Event|0|||
149904399|NCT00090220|540779718|FG003|Base Study Follow-up Period|Adverse Event|0|||
149904400|NCT00090220|540779719|FG004|Base Study Follow-up Period|Adverse Event|0|||
149904401|NCT00090220|540779720|FG005|Base Study Follow-up Period|Adverse Event|0|||
149904402|NCT00090220|540779715|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
149904403|NCT00090220|540779716|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
149904404|NCT00090220|540779717|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
149904405|NCT00090220|540779718|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
149904406|NCT00090220|540779719|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
149904407|NCT00090220|540779720|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
149904408|NCT00090220|540779715|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
149904409|NCT00090220|540779716|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
149904410|NCT00090220|540779717|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
149904411|NCT00090220|540779718|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
149904412|NCT00090220|540779719|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
149904413|NCT00090220|540779720|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
149904414|NCT00090220|540779715|FG000|Base Study Follow-up Period|Patient Moved|20|||
149904415|NCT00090220|540779716|FG001|Base Study Follow-up Period|Patient Moved|28|||
149904416|NCT00090220|540779717|FG002|Base Study Follow-up Period|Patient Moved|0|||
149904417|NCT00090220|540779718|FG003|Base Study Follow-up Period|Patient Moved|0|||
149904418|NCT00090220|540779719|FG004|Base Study Follow-up Period|Patient Moved|0|||
149904419|NCT00090220|540779720|FG005|Base Study Follow-up Period|Patient Moved|0|||
149904420|NCT00090220|540779715|FG000|Base Study Follow-up Period|Other|19|||
149904421|NCT00090220|540779716|FG001|Base Study Follow-up Period|Other|21|||
149904422|NCT00090220|540779717|FG002|Base Study Follow-up Period|Other|0|||
149904423|NCT00090220|540779718|FG003|Base Study Follow-up Period|Other|0|||
149904424|NCT00090220|540779719|FG004|Base Study Follow-up Period|Other|0|||
149904425|NCT00090220|540779720|FG005|Base Study Follow-up Period|Other|0|||
149904426|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Adverse Event|0|||
149904427|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Adverse Event|0|||
149904428|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Adverse Event|4|||
149904429|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Adverse Event|0|||
149904430|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Adverse Event|0|||
149904431|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Adverse Event|0|||
149904432|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
149904433|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
149969595|NCT01517984|541025223|FG000|Overall Study|Withdrawal by Subject|1|||
149969596|NCT01517984|541025224|FG001|Overall Study|Withdrawal by Subject|8|||
149969597|NCT01517984|541025225|FG002|Overall Study|Withdrawal by Subject|4|||
149969598|NCT01517984|541025226|FG003|Overall Study|Withdrawal by Subject|1|||
149969599|NCT01517984|541025223|FG000|Overall Study|Screen Failure|4|||
149969600|NCT01517984|541025224|FG001|Overall Study|Screen Failure|0|||
149969601|NCT01517984|541025225|FG002|Overall Study|Screen Failure|0|||
149969602|NCT01517984|541025226|FG003|Overall Study|Screen Failure|0|||
149969603|NCT01517984|541025223|FG000|Overall Study|Ineligible for randomization|0|||
149969604|NCT01517984|541025224|FG001|Overall Study|Ineligible for randomization|14|||
149969605|NCT01517984|541025225|FG002|Overall Study|Ineligible for randomization|0|||
149969606|NCT01517984|541025226|FG003|Overall Study|Ineligible for randomization|0|||
149969607|NCT04903288|541025227|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
149969608|NCT04903288|541025227|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
149969609|NCT04903288|541025227|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
149969610|NCT04903288|541025227|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
149969611|NCT00573768|541025228|FG000|Overall Study|Adverse Event|1|||
149969612|NCT00573768|541025229|FG001|Overall Study|Adverse Event|1|||
149969613|NCT00573768|541025230|FG002|Overall Study|Adverse Event|2|||
149969614|NCT00573768|541025228|FG000|Overall Study|Protocol Violation|1|||
149969615|NCT00573768|541025229|FG001|Overall Study|Protocol Violation|0|||
150046533|NCT02624986|541309643|FG007|Overall Study|Study Terminated by Sponsor|3|||
150046534|NCT02624986|541309636|FG000|Overall Study|Progressive Disease|0|||
150046535|NCT02624986|541309637|FG001|Overall Study|Progressive Disease|1|||
150046536|NCT02624986|541309638|FG002|Overall Study|Progressive Disease|0|||
150046537|NCT02624986|541309639|FG003|Overall Study|Progressive Disease|0|||
150046538|NCT02624986|541309640|FG004|Overall Study|Progressive Disease|0|||
150046539|NCT02624986|541309641|FG005|Overall Study|Progressive Disease|0|||
150046540|NCT02624986|541309642|FG006|Overall Study|Progressive Disease|0|||
150046541|NCT02624986|541309643|FG007|Overall Study|Progressive Disease|0|||
150046542|NCT02624986|541309636|FG000|Overall Study|Protocol Violation|1|||
150046543|NCT02624986|541309637|FG001|Overall Study|Protocol Violation|0|||
150046544|NCT02624986|541309638|FG002|Overall Study|Protocol Violation|0|||
150046545|NCT02624986|541309639|FG003|Overall Study|Protocol Violation|0|||
150046546|NCT02624986|541309640|FG004|Overall Study|Protocol Violation|0|||
150046547|NCT02624986|541309641|FG005|Overall Study|Protocol Violation|0|||
150046548|NCT02624986|541309642|FG006|Overall Study|Protocol Violation|0|||
150046549|NCT02624986|541309643|FG007|Overall Study|Protocol Violation|0|||
150046550|NCT02624986|541309636|FG000|Overall Study|Withdrawal by Subject|0|||
150046551|NCT02624986|541309637|FG001|Overall Study|Withdrawal by Subject|0|||
150046552|NCT02624986|541309638|FG002|Overall Study|Withdrawal by Subject|0|||
150046553|NCT02624986|541309639|FG003|Overall Study|Withdrawal by Subject|0|||
150046554|NCT02624986|541309640|FG004|Overall Study|Withdrawal by Subject|0|||
150046555|NCT02624986|541309641|FG005|Overall Study|Withdrawal by Subject|0|||
150046556|NCT02624986|541309642|FG006|Overall Study|Withdrawal by Subject|0|||
150046557|NCT02624986|541309643|FG007|Overall Study|Withdrawal by Subject|1|||
150046558|NCT02116205|541309644|FG000|Overall Study|Withdrawal by Subject|2|||
150046559|NCT02116205|541309645|FG001|Overall Study|Withdrawal by Subject|4|||
150046560|NCT02116205|541309646|FG002|Overall Study|Withdrawal by Subject|1|||
150046561|NCT02116205|541309647|FG003|Overall Study|Withdrawal by Subject|3|||
150046562|NCT02116205|541309644|FG000|Overall Study|Lost to Follow-up|0|||
150046563|NCT02116205|541309645|FG001|Overall Study|Lost to Follow-up|2|||
150046564|NCT02116205|541309646|FG002|Overall Study|Lost to Follow-up|1|||
150046565|NCT02116205|541309647|FG003|Overall Study|Lost to Follow-up|2|||
150046566|NCT02116205|541309644|FG000|Overall Study|Physician Decision|0|||
150046567|NCT02116205|541309645|FG001|Overall Study|Physician Decision|1|||
150046568|NCT02116205|541309646|FG002|Overall Study|Physician Decision|1|||
150046569|NCT02116205|541309647|FG003|Overall Study|Physician Decision|1|||
150046570|NCT02116205|541309644|FG000|Overall Study|Exclusion criteria|0|||
150046571|NCT02116205|541309645|FG001|Overall Study|Exclusion criteria|0|||
150046572|NCT02116205|541309646|FG002|Overall Study|Exclusion criteria|1|||
150046573|NCT02116205|541309647|FG003|Overall Study|Exclusion criteria|0|||
150046574|NCT04200352|541309653|FG000|Overall Study|Death|1|||
150046575|NCT04200352|541309653|FG000|Overall Study|Adverse Event|6|||
150046576|NCT04200352|541309653|FG000|Overall Study|Withdrawal by parent/guardian|6|||
150046577|NCT04200352|541309653|FG000|Overall Study|Lack of Efficacy|1|||
150046578|NCT04200352|541309653|FG000|Overall Study|Other than specified|6|||
150046579|NCT00993148|541309654|FG000|Overall Study|Lost to Follow-up|2|||
150046580|NCT00993148|541309654|FG000|Overall Study|never initiated treatment|1|||
150046581|NCT00806819|541309655|FG000|Overall Study|progressive disease (modified RECIST )|217|||
150046582|NCT00806819|541309656|FG001|Overall Study|progressive disease (modified RECIST )|216|||
150046583|NCT00806819|541309655|FG000|Overall Study|Worsening or AE of underlying disease|18|||
150046584|NCT00806819|541309656|FG001|Overall Study|Worsening or AE of underlying disease|25|||
150046585|NCT00806819|541309655|FG000|Overall Study|Other AE|38|||
150046586|NCT00806819|541309656|FG001|Overall Study|Other AE|40|||
150046587|NCT00806819|541309655|FG000|Overall Study|Protocol Violation|9|||
150046588|NCT00806819|541309656|FG001|Overall Study|Protocol Violation|4|||
150046589|NCT00806819|541309655|FG000|Overall Study|Lost to Follow-up|1|||
150046590|NCT00806819|541309656|FG001|Overall Study|Lost to Follow-up|0|||
150046591|NCT00806819|541309655|FG000|Overall Study|Withdrawal by Subject|32|||
150046592|NCT00806819|541309656|FG001|Overall Study|Withdrawal by Subject|29|||
150046593|NCT00806819|541309655|FG000|Overall Study|Not treated|6|||
150046594|NCT00806819|541309656|FG001|Overall Study|Not treated|3|||
150046595|NCT00806819|541309655|FG000|Overall Study|Reasons other than stated above|25|||
150046596|NCT00806819|541309656|FG001|Overall Study|Reasons other than stated above|41|||
150046597|NCT01737502|541309659|FG000|Phase I|Disease progression|2|||
150046598|NCT01737502|541309660|FG001|Phase I|Disease progression|3|||
150046599|NCT01737502|541309659|FG000|Phase I|Complicating disease|1|||
150046600|NCT01737502|541309660|FG001|Phase I|Complicating disease|0|||
150046601|NCT01737502|541309659|FG000|Phase II|Adverse Event|0|||
150046602|NCT01737502|541309660|FG001|Phase II|Adverse Event|3|||
150046603|NCT01737502|541309659|FG000|Phase II|Disease progression|0|||
150046604|NCT01737502|541309660|FG001|Phase II|Disease progression|18|||
150046605|NCT01737502|541309659|FG000|Phase II|Death|0|||
150046606|NCT01737502|541309660|FG001|Phase II|Death|1|||
150046607|NCT01737502|541309659|FG000|Phase II|Transition to hospice care|0|||
150046608|NCT01737502|541309660|FG001|Phase II|Transition to hospice care|1|||
150046609|NCT01326104|541309661|FG000|Overall Study|progressed prior to vaccine|0|||
150046610|NCT01326104|541309662|FG001|Overall Study|progressed prior to vaccine|2|||
150046611|NCT01326104|541309661|FG000|Overall Study|unable to make vaccine|0|||
150046612|NCT01326104|541309662|FG001|Overall Study|unable to make vaccine|2|||
150046613|NCT04073225|541309663|FG000|Overall Study|Lost to Follow-up|4|||
150046614|NCT04073225|541309664|FG001|Overall Study|Lost to Follow-up|3|||
150046615|NCT00124306|541309674|FG000|Overall Study|Adverse Event|7|||
150046616|NCT00124306|541309675|FG001|Overall Study|Adverse Event|2|||
149904434|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
149904435|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
149904436|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
149904437|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
149904438|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Moved|0|||
150046617|NCT00124306|541309674|FG000|Overall Study|Lost to Follow-up|10|||
150046618|NCT00124306|541309675|FG001|Overall Study|Lost to Follow-up|6|||
150046619|NCT00124306|541309674|FG000|Overall Study|Lack of Efficacy|3|||
150046620|NCT00124306|541309675|FG001|Overall Study|Lack of Efficacy|6|||
150046621|NCT00124306|541309674|FG000|Overall Study|Personal constraints|0|||
150046622|NCT00124306|541309675|FG001|Overall Study|Personal constraints|2|||
150046623|NCT00124306|541309674|FG000|Overall Study|Use of unacceptable medication|1|||
150046624|NCT00124306|541309675|FG001|Overall Study|Use of unacceptable medication|0|||
150046625|NCT00124306|541309674|FG000|Overall Study|Abnormal lab result|0|||
150046626|NCT00124306|541309675|FG001|Overall Study|Abnormal lab result|1|||
150046627|NCT00124306|541309674|FG000|Overall Study|Other|2|||
150046628|NCT00124306|541309675|FG001|Overall Study|Other|0|||
150046629|NCT00560352|541309677|FG000|Overall Study|Adverse event unrelated to study drug|2|||
150046630|NCT00560352|541309678|FG001|Overall Study|Adverse event unrelated to study drug|1|||
150046631|NCT00560352|541309679|FG002|Overall Study|Adverse event unrelated to study drug|1|||
150046632|NCT00560352|541309677|FG000|Overall Study|Study drug toxicity|3|||
150046633|NCT00560352|541309678|FG001|Overall Study|Study drug toxicity|0|||
150046634|NCT00560352|541309679|FG002|Overall Study|Study drug toxicity|1|||
150046635|NCT00560352|541309677|FG000|Overall Study|Disease progression|0|||
150046636|NCT00560352|541309678|FG001|Overall Study|Disease progression|1|||
150046637|NCT00560352|541309679|FG002|Overall Study|Disease progression|1|||
150046638|NCT00560352|541309677|FG000|Overall Study|Withdrawal by Subject|1|||
150046639|NCT00560352|541309678|FG001|Overall Study|Withdrawal by Subject|1|||
150046640|NCT00560352|541309679|FG002|Overall Study|Withdrawal by Subject|1|||
150046641|NCT00560352|541309677|FG000|Overall Study|Maximum clinical benefit|1|||
150046642|NCT00560352|541309678|FG001|Overall Study|Maximum clinical benefit|0|||
150046643|NCT00560352|541309679|FG002|Overall Study|Maximum clinical benefit|0|||
150046644|NCT05767749|541309683|FG000|Overall Study|Withdrawal by Subject|0|||
150046645|NCT05767749|541309684|FG001|Overall Study|Withdrawal by Subject|0|||
150046646|NCT05767749|541309685|FG002|Overall Study|Withdrawal by Subject|2|||
150046647|NCT05767749|541309686|FG003|Overall Study|Withdrawal by Subject|2|||
150046648|NCT05767749|541309687|FG004|Overall Study|Withdrawal by Subject|2|||
150046649|NCT05767749|541309688|FG005|Overall Study|Withdrawal by Subject|2|||
150046650|NCT00114517|541309689|FG000|Overall Study|Adverse Event|6|||
150046651|NCT00114517|541309690|FG001|Overall Study|Adverse Event|1|||
150046652|NCT00114517|541309691|FG002|Overall Study|Adverse Event|6|||
150046653|NCT00114517|541309692|FG003|Overall Study|Adverse Event|3|||
150046654|NCT00114517|541309689|FG000|Overall Study|Lost to Follow-up|2|||
150046655|NCT00114517|541309690|FG001|Overall Study|Lost to Follow-up|2|||
150046656|NCT00114517|541309691|FG002|Overall Study|Lost to Follow-up|2|||
150046657|NCT00114517|541309692|FG003|Overall Study|Lost to Follow-up|1|||
150046658|NCT00114517|541309689|FG000|Overall Study|Too busy|3|||
150046659|NCT00114517|541309690|FG001|Overall Study|Too busy|1|||
150046660|NCT00114517|541309691|FG002|Overall Study|Too busy|1|||
150046661|NCT00114517|541309692|FG003|Overall Study|Too busy|2|||
150046662|NCT00114517|541309689|FG000|Overall Study|Moved from area|0|||
150046663|NCT00114517|541309690|FG001|Overall Study|Moved from area|3|||
149904439|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Moved|0|||
150046664|NCT00114517|541309691|FG002|Overall Study|Moved from area|2|||
150046665|NCT00114517|541309692|FG003|Overall Study|Moved from area|1|||
150046666|NCT00114517|541309689|FG000|Overall Study|Did not want estradiol|1|||
150046667|NCT00114517|541309690|FG001|Overall Study|Did not want estradiol|1|||
150046668|NCT00114517|541309691|FG002|Overall Study|Did not want estradiol|0|||
150046669|NCT00114517|541309692|FG003|Overall Study|Did not want estradiol|0|||
150046670|NCT00114517|541309689|FG000|Overall Study|Armed-services duty|0|||
150046671|NCT00114517|541309690|FG001|Overall Study|Armed-services duty|1|||
150046672|NCT00114517|541309691|FG002|Overall Study|Armed-services duty|0|||
150046673|NCT00114517|541309692|FG003|Overall Study|Armed-services duty|1|||
150046674|NCT00114517|541309689|FG000|Overall Study|Competing family issue|0|||
150046675|NCT00114517|541309690|FG001|Overall Study|Competing family issue|1|||
150046676|NCT00114517|541309691|FG002|Overall Study|Competing family issue|0|||
150046677|NCT00114517|541309692|FG003|Overall Study|Competing family issue|1|||
150046678|NCT00114517|541309689|FG000|Overall Study|Physician Decision|0|||
150046679|NCT00114517|541309690|FG001|Overall Study|Physician Decision|1|||
150046680|NCT00114517|541309691|FG002|Overall Study|Physician Decision|0|||
150046681|NCT00114517|541309692|FG003|Overall Study|Physician Decision|0|||
150046682|NCT00114517|541309689|FG000|Overall Study|Lost interest|0|||
150046683|NCT00114517|541309690|FG001|Overall Study|Lost interest|0|||
150046684|NCT00114517|541309691|FG002|Overall Study|Lost interest|1|||
150046685|NCT00114517|541309692|FG003|Overall Study|Lost interest|0|||
150046686|NCT00114517|541309689|FG000|Overall Study|Weight increase|0|||
150046687|NCT00114517|541309690|FG001|Overall Study|Weight increase|0|||
150046688|NCT00114517|541309691|FG002|Overall Study|Weight increase|1|||
150046689|NCT00114517|541309692|FG003|Overall Study|Weight increase|0|||
150046690|NCT00114517|541309689|FG000|Overall Study|Concern about blood clots|0|||
150046691|NCT00114517|541309690|FG001|Overall Study|Concern about blood clots|0|||
150046692|NCT00114517|541309691|FG002|Overall Study|Concern about blood clots|1|||
150046693|NCT00114517|541309692|FG003|Overall Study|Concern about blood clots|0|||
150046694|NCT00114517|541309689|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
150046695|NCT00114517|541309690|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
150046696|NCT00114517|541309691|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
150046697|NCT00114517|541309692|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
150046698|NCT03568461|541309696|FG000|Overall Study|Death|7|||
150046699|NCT03568461|541309696|FG000|Overall Study|Physician Decision|5|||
150046700|NCT03568461|541309696|FG000|Overall Study|Subject decision|5|||
150046701|NCT03568461|541309696|FG000|Overall Study|Lost to Follow-up|1|||
150046702|NCT04695977|541309697|FG000|Overall Study|Sponsor Decision|9|||
150046703|NCT04695977|541309698|FG001|Overall Study|Sponsor Decision|4|||
150046704|NCT04695977|541309697|FG000|Overall Study|Death|2|||
150046705|NCT04695977|541309698|FG001|Overall Study|Death|5|||
150046706|NCT04681352|541310953|FG000|Overall Study|Lost to Follow-up|2|||
150046707|NCT04681352|541310953|FG000|Overall Study|Withdrawal by Subject|22|||
150046708|NCT03860818|541310954|FG000|Overall Study|Death|144|||
150046709|NCT03860818|541310955|FG001|Overall Study|Death|195|||
150046710|NCT03860818|541310954|FG000|Overall Study|Graft Loss|32|||
150046711|NCT03860818|541310955|FG001|Overall Study|Graft Loss|45|||
150046712|NCT00792571|541310956|FG000|Overall Study|Death|1|||
150046713|NCT00792571|541310956|FG000|Overall Study|Adverse Event|4|||
150046714|NCT00792571|541310956|FG000|Overall Study|Withdrawal by Subject|1|||
150046715|NCT00792571|541310956|FG000|Overall Study|Other|4|||
150046716|NCT02600819|541310957|FG000|GEN Phase|Adverse Event|2|||
150046717|NCT02600819|541310958|FG001|GEN Phase|Adverse Event|0|||
150046718|NCT02600819|541310957|FG000|GEN Phase|Death|2|||
150046719|NCT02600819|541310958|FG001|GEN Phase|Death|0|||
150046720|NCT02600819|541310957|FG000|GEN Phase|Investigator's Discretion|4|||
150046721|NCT02600819|541310958|FG001|GEN Phase|Investigator's Discretion|0|||
150046722|NCT02600819|541310957|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
150046723|NCT02600819|541310958|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
150046724|NCT02600819|541310957|FG000|GEN Phase|Withdrew Consent|5|||
150046725|NCT02600819|541310958|FG001|GEN Phase|Withdrew Consent|0|||
150046726|NCT02600819|541310957|FG000|GEN Phase|Lost to Follow-up|2|||
150046727|NCT02600819|541310958|FG001|GEN Phase|Lost to Follow-up|0|||
150046728|NCT00505778|541310959|FG000|Overall Study|Adverse Event|2|||
150046729|NCT00505778|541310960|FG001|Overall Study|Adverse Event|7|||
150046730|NCT00505778|541310959|FG000|Overall Study|Physician Decision|8|||
150046731|NCT00505778|541310960|FG001|Overall Study|Physician Decision|14|||
150046732|NCT00505778|541310959|FG000|Overall Study|Lost to Follow-up|17|||
150046733|NCT00505778|541310960|FG001|Overall Study|Lost to Follow-up|23|||
149904440|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Moved|2|||
149904441|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Moved|1|||
149904442|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Moved|0|||
149904443|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Moved|0|||
149904444|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
149904445|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
149904446|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
149904447|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
150046734|NCT00505778|541310959|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
150046735|NCT00505778|541310960|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
150046736|NCT00505778|541310959|FG000|Overall Study|Protocol Violation|7|||
150046737|NCT00505778|541310960|FG001|Overall Study|Protocol Violation|9|||
150046738|NCT00505778|541310959|FG000|Overall Study|Withdrawal by Subject|29|||
150046739|NCT00505778|541310960|FG001|Overall Study|Withdrawal by Subject|14|||
150046740|NCT00505778|541310959|FG000|Overall Study|Relapse|65|||
150046741|NCT00505778|541310960|FG001|Overall Study|Relapse|65|||
150046742|NCT00505778|541310959|FG000|Overall Study|Took No Study Drug|2|||
150046743|NCT00505778|541310960|FG001|Overall Study|Took No Study Drug|2|||
150046744|NCT03790696|541310962|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
150046745|NCT03790696|541310963|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
150046746|NCT00811018|541310969|FG000|Overall Study|Additional Chronic Treatment|31|||
149904448|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
149904449|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
149904450|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
149904451|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
149904452|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
149904453|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
149904454|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
149904455|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
149904456|NCT00090220|540779715|FG000|Extension 1 (EXT1)|Other reason|0|||
149904457|NCT00090220|540779716|FG001|Extension 1 (EXT1)|Other reason|0|||
149904458|NCT00090220|540779717|FG002|Extension 1 (EXT1)|Other reason|2|||
149904459|NCT00090220|540779718|FG003|Extension 1 (EXT1)|Other reason|0|||
149904460|NCT00090220|540779719|FG004|Extension 1 (EXT1)|Other reason|0|||
149904461|NCT00090220|540779720|FG005|Extension 1 (EXT1)|Other reason|0|||
149969616|NCT00573768|541025230|FG002|Overall Study|Protocol Violation|1|||
149969617|NCT00573768|541025228|FG000|Overall Study|Withdrawal by Subject|0|||
149969618|NCT00573768|541025229|FG001|Overall Study|Withdrawal by Subject|1|||
149969619|NCT00573768|541025230|FG002|Overall Study|Withdrawal by Subject|0|||
149969620|NCT00573768|541025228|FG000|Overall Study|Lost to Follow-up|0|||
149969621|NCT00573768|541025229|FG001|Overall Study|Lost to Follow-up|0|||
149969622|NCT00573768|541025230|FG002|Overall Study|Lost to Follow-up|1|||
149969623|NCT04617860|541025238|FG000|Overall Study|Adverse Event|0|||
149969624|NCT04617860|541025239|FG001|Overall Study|Adverse Event|2|||
149969625|NCT04617860|541025240|FG002|Overall Study|Adverse Event|2|||
149969626|NCT04617860|541025238|FG000|Overall Study|Withdrawal by Subject|0|||
149969627|NCT04617860|541025239|FG001|Overall Study|Withdrawal by Subject|0|||
149969628|NCT04617860|541025240|FG002|Overall Study|Withdrawal by Subject|2|||
149969629|NCT04617860|541025238|FG000|Overall Study|Physician Decision|0|||
149969630|NCT04617860|541025239|FG001|Overall Study|Physician Decision|1|||
149969631|NCT04617860|541025240|FG002|Overall Study|Physician Decision|0|||
149969632|NCT04617860|541025238|FG000|Overall Study|Sponsor Decision|0|||
149969633|NCT04617860|541025239|FG001|Overall Study|Sponsor Decision|3|||
149969634|NCT04617860|541025240|FG002|Overall Study|Sponsor Decision|1|||
149969635|NCT04617860|541025238|FG000|Overall Study|Termination of Study by Sponsor|8|||
149969636|NCT04617860|541025239|FG001|Overall Study|Termination of Study by Sponsor|4|||
149969637|NCT04617860|541025240|FG002|Overall Study|Termination of Study by Sponsor|13|||
149969638|NCT00806585|541025241|FG000|Overall Study|Study terminated by Sponsor|0|||
149969639|NCT00806585|541025242|FG001|Overall Study|Study terminated by Sponsor|0|||
149969640|NCT00806585|541025243|FG002|Overall Study|Study terminated by Sponsor|1|||
149969641|NCT00806585|541025244|FG003|Overall Study|Study terminated by Sponsor|2|||
149969642|NCT00806585|541025245|FG004|Overall Study|Study terminated by Sponsor|0|||
149969643|NCT00806585|541025241|FG000|Overall Study|Protocol Violation|3|||
149969644|NCT00806585|541025242|FG001|Overall Study|Protocol Violation|1|||
149969645|NCT00806585|541025243|FG002|Overall Study|Protocol Violation|2|||
149969646|NCT00806585|541025244|FG003|Overall Study|Protocol Violation|0|||
149969647|NCT00806585|541025245|FG004|Overall Study|Protocol Violation|0|||
149969648|NCT00806585|541025241|FG000|Overall Study|Physician Decision|0|||
149969649|NCT00806585|541025242|FG001|Overall Study|Physician Decision|2|||
149969650|NCT00806585|541025243|FG002|Overall Study|Physician Decision|3|||
149969651|NCT00806585|541025244|FG003|Overall Study|Physician Decision|0|||
149969652|NCT00806585|541025245|FG004|Overall Study|Physician Decision|1|||
149969653|NCT00806585|541025241|FG000|Overall Study|Lost to Follow-up|2|||
149969654|NCT00806585|541025242|FG001|Overall Study|Lost to Follow-up|1|||
149969655|NCT00806585|541025243|FG002|Overall Study|Lost to Follow-up|2|||
149969656|NCT00806585|541025244|FG003|Overall Study|Lost to Follow-up|2|||
149969657|NCT00806585|541025245|FG004|Overall Study|Lost to Follow-up|5|||
149969658|NCT00806585|541025241|FG000|Overall Study|Lack of Efficacy|1|||
149969659|NCT00806585|541025242|FG001|Overall Study|Lack of Efficacy|0|||
149969660|NCT00806585|541025243|FG002|Overall Study|Lack of Efficacy|0|||
149969661|NCT00806585|541025244|FG003|Overall Study|Lack of Efficacy|0|||
149969662|NCT00806585|541025245|FG004|Overall Study|Lack of Efficacy|0|||
149969663|NCT00806585|541025241|FG000|Overall Study|Adverse Event|1|||
149969664|NCT00806585|541025242|FG001|Overall Study|Adverse Event|5|||
149969665|NCT00806585|541025243|FG002|Overall Study|Adverse Event|3|||
149969666|NCT00806585|541025244|FG003|Overall Study|Adverse Event|4|||
149969667|NCT00806585|541025245|FG004|Overall Study|Adverse Event|2|||
149969668|NCT00806585|541025241|FG000|Overall Study|Withdrawal by Subject|10|||
149969669|NCT00806585|541025242|FG001|Overall Study|Withdrawal by Subject|8|||
149969670|NCT00806585|541025243|FG002|Overall Study|Withdrawal by Subject|9|||
149969671|NCT00806585|541025244|FG003|Overall Study|Withdrawal by Subject|3|||
149969672|NCT00806585|541025245|FG004|Overall Study|Withdrawal by Subject|11|||
149969673|NCT00806585|541025241|FG000|Overall Study|Completion status unknown|15|||
149904462|NCT00090220|540779715|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149904463|NCT00090220|540779716|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149969674|NCT00806585|541025242|FG001|Overall Study|Completion status unknown|14|||
149969675|NCT00806585|541025243|FG002|Overall Study|Completion status unknown|12|||
149969676|NCT00806585|541025244|FG003|Overall Study|Completion status unknown|4|||
149969677|NCT00806585|541025245|FG004|Overall Study|Completion status unknown|12|||
150046747|NCT00811018|541310969|FG000|Overall Study|Adverse Event|79|||
150046748|NCT00811018|541310969|FG000|Overall Study|Death|147|||
150046749|NCT00811018|541310969|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
150046750|NCT00811018|541310969|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
150046751|NCT00811018|541310969|FG000|Overall Study|Investigator Decision|57|||
150046752|NCT00811018|541310969|FG000|Overall Study|Lost to Follow-up|19|||
150046753|NCT00811018|541310969|FG000|Overall Study|Pregnancy|6|||
150046754|NCT00811018|541310969|FG000|Overall Study|Sponsor Decision|450|||
150046755|NCT00811018|541310969|FG000|Overall Study|Withdrawal by Subject|70|||
150046756|NCT00811018|541310969|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
150046757|NCT00811018|541310969|FG000|Overall Study|Other|26|||
150046758|NCT02722304|541310973|FG000|Overall Study|Study Terminated by Sponsor|1|||
150046759|NCT02722304|541310974|FG001|Overall Study|Study Terminated by Sponsor|0|||
150046760|NCT02722304|541310975|FG002|Overall Study|Study Terminated by Sponsor|2|||
150046761|NCT02722304|541310976|FG003|Overall Study|Study Terminated by Sponsor|1|||
150046762|NCT02722304|541310977|FG004|Overall Study|Study Terminated by Sponsor|1|||
150046763|NCT02722304|541310973|FG000|Overall Study|Other|0|||
150046764|NCT02722304|541310974|FG001|Overall Study|Other|0|||
150046765|NCT02722304|541310975|FG002|Overall Study|Other|0|||
150046766|NCT02722304|541310976|FG003|Overall Study|Other|1|||
150046767|NCT02722304|541310977|FG004|Overall Study|Other|1|||
150046768|NCT00934362|541310978|FG000|Overall Study|Adverse Event|1|||
150046769|NCT00934362|541310979|FG001|Overall Study|Adverse Event|0|||
150046770|NCT01092117|541310982|FG000|Index Procedure to 1 Month|Death|1|||
150046771|NCT01092117|541310982|FG000|1 Month|Death|1|||
150046772|NCT01092117|541310982|FG000|1 Month|Withdrawal by Subject|1|||
150046773|NCT01092117|541310982|FG000|1 Month|Lost to Follow-up|1|||
150046774|NCT01092117|541310982|FG000|6 Months|Death|2|||
150046775|NCT01092117|541310982|FG000|6 Months|Withdrawal by Subject|3|||
150046776|NCT01092117|541310982|FG000|12 Month|Death|11|||
150046777|NCT01092117|541310982|FG000|12 Month|Withdrawal by Subject|2|||
150046778|NCT01092117|541310982|FG000|12 Month|Lost to Follow-up|1|||
150046779|NCT01092117|541310982|FG000|Year 2|Death|5|||
150046780|NCT01092117|541310982|FG000|Year 2|Withdrawal by Subject|4|||
150046781|NCT01092117|541310982|FG000|Year 2|Lost to Follow-up|1|||
150046782|NCT01092117|541310982|FG000|Year 3|Death|7|||
150046783|NCT01092117|541310982|FG000|Year 3|Withdrawal by Subject|9|||
150046784|NCT01092117|541310982|FG000|Year 3|Lost to Follow-up|3|||
150046785|NCT01092117|541310982|FG000|Year 4|Death|8|||
150046786|NCT01092117|541310982|FG000|Year 4|Withdrawal by Subject|4|||
150046787|NCT01092117|541310982|FG000|Year 4|Lost to Follow-up|4|||
150046788|NCT04380519|541310983|FG000|Overall Study|Withdrawal by Subject|4|||
150046789|NCT04380519|541310984|FG001|Overall Study|Withdrawal by Subject|0|||
150046790|NCT04380519|541310985|FG002|Overall Study|Withdrawal by Subject|1|||
150046791|NCT04380519|541310983|FG000|Overall Study|Death|14|||
150046792|NCT04380519|541310984|FG001|Overall Study|Death|9|||
150046793|NCT04380519|541310985|FG002|Overall Study|Death|6|||
150046794|NCT04380519|541310983|FG000|Overall Study|Adverse Event|0|||
150046795|NCT04380519|541310984|FG001|Overall Study|Adverse Event|1|||
150046796|NCT04380519|541310985|FG002|Overall Study|Adverse Event|0|||
150046797|NCT04380519|541310983|FG000|Overall Study|relatives' decision|0|||
150046798|NCT04380519|541310984|FG001|Overall Study|relatives' decision|1|||
150046799|NCT04380519|541310985|FG002|Overall Study|relatives' decision|0|||
150046800|NCT02147561|541310990|FG000|Overall Study|Lost to Follow-up|3|||
150046801|NCT02147561|541310990|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
150046802|NCT05300763|541310991|FG000|Overall Study|Adverse Event|0|||
150046803|NCT05300763|541310992|FG001|Overall Study|Adverse Event|1|||
150046804|NCT05300763|541310991|FG000|Overall Study|Major Protocol Deviation|1|||
150046805|NCT05300763|541310992|FG001|Overall Study|Major Protocol Deviation|0|||
150046806|NCT05300763|541310991|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
150046807|NCT05300763|541310992|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
150046808|NCT01598506|541310994|FG000|Overall Study|Withdrawal by Subject|2|||
150046809|NCT02100696|541310995|FG000|Induction Phase|Adverse Event|0|||
150046810|NCT02100696|541310996|FG001|Induction Phase|Adverse Event|0|||
150046811|NCT02100696|541310997|FG002|Induction Phase|Adverse Event|1|||
150046812|NCT02100696|541310998|FG003|Induction Phase|Adverse Event|0|||
150046813|NCT02100696|541310999|FG004|Induction Phase|Adverse Event|0|||
150046814|NCT02100696|541311000|FG005|Induction Phase|Adverse Event|0|||
150046815|NCT02100696|541310995|FG000|Induction Phase|Lost to Follow-up|1|||
150046816|NCT02100696|541310996|FG001|Induction Phase|Lost to Follow-up|0|||
150046817|NCT02100696|541310997|FG002|Induction Phase|Lost to Follow-up|1|||
150046818|NCT02100696|541310998|FG003|Induction Phase|Lost to Follow-up|0|||
150176568|NCT02499159|541783321|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
150046819|NCT02100696|541310999|FG004|Induction Phase|Lost to Follow-up|0|||
150046820|NCT02100696|541311000|FG005|Induction Phase|Lost to Follow-up|0|||
150046821|NCT02100696|541310995|FG000|Induction Phase|Protocol Violation|0|||
150046822|NCT02100696|541310996|FG001|Induction Phase|Protocol Violation|1|||
150046823|NCT02100696|541310997|FG002|Induction Phase|Protocol Violation|1|||
150046824|NCT02100696|541310998|FG003|Induction Phase|Protocol Violation|0|||
150046825|NCT02100696|541310999|FG004|Induction Phase|Protocol Violation|0|||
149969678|NCT01968980|541025248|FG000|Overall Study|Death|0|||
149969679|NCT01968980|541025249|FG001|Overall Study|Death|1|||
149969680|NCT01968980|541025248|FG000|Overall Study|Adverse Event|1|||
149969681|NCT01968980|541025249|FG001|Overall Study|Adverse Event|3|||
149969682|NCT01968980|541025248|FG000|Overall Study|Does not meet entry criteria|1|||
149969683|NCT01968980|541025249|FG001|Overall Study|Does not meet entry criteria|3|||
149904464|NCT00090220|540779717|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149904465|NCT00090220|540779718|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149904466|NCT00090220|540779719|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
149904467|NCT00090220|540779720|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
149904468|NCT00090220|540779715|FG000|Long-term Follow-up (EXT2)|Death|0|||
149904469|NCT00090220|540779716|FG001|Long-term Follow-up (EXT2)|Death|0|||
149904470|NCT00090220|540779717|FG002|Long-term Follow-up (EXT2)|Death|0|||
149904471|NCT00090220|540779718|FG003|Long-term Follow-up (EXT2)|Death|0|||
149904472|NCT00090220|540779719|FG004|Long-term Follow-up (EXT2)|Death|1|||
149904473|NCT00090220|540779720|FG005|Long-term Follow-up (EXT2)|Death|1|||
149904474|NCT00090220|540779715|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149904475|NCT00090220|540779716|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149904476|NCT00090220|540779717|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149904477|NCT00090220|540779718|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149904478|NCT00090220|540779719|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
149904479|NCT00090220|540779720|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
149904480|NCT00090220|540779715|FG000|Long-term Follow-up (EXT2)|Other|0|||
149904481|NCT00090220|540779716|FG001|Long-term Follow-up (EXT2)|Other|0|||
149904482|NCT00090220|540779717|FG002|Long-term Follow-up (EXT2)|Other|0|||
149904483|NCT00090220|540779718|FG003|Long-term Follow-up (EXT2)|Other|0|||
149904484|NCT00090220|540779719|FG004|Long-term Follow-up (EXT2)|Other|1|||
149904485|NCT00090220|540779720|FG005|Long-term Follow-up (EXT2)|Other|0|||
149904486|NCT01471340|540779721|FG000|Overall Study|Death|5|||
149904487|NCT01471340|540779722|FG001|Overall Study|Death|4|||
149904488|NCT01471340|540779721|FG000|Overall Study|Lost to Follow-up|0|||
149904489|NCT01471340|540779722|FG001|Overall Study|Lost to Follow-up|1|||
149904490|NCT01471340|540779721|FG000|Overall Study|Investigational site closure|0|||
149904491|NCT01471340|540779722|FG001|Overall Study|Investigational site closure|1|||
149904492|NCT01471340|540779721|FG000|Overall Study|Invalid informed consent|1|||
149904493|NCT01471340|540779722|FG001|Overall Study|Invalid informed consent|0|||
149904494|NCT03499899|540779723|FG000|Overall Study|Adverse Event|2|||
149904495|NCT03499899|540779724|FG001|Overall Study|Adverse Event|3|||
149904496|NCT03499899|540779725|FG002|Overall Study|Adverse Event|3|||
149904497|NCT03499899|540779723|FG000|Overall Study|Death|0|||
149904498|NCT03499899|540779724|FG001|Overall Study|Death|0|||
149904499|NCT03499899|540779725|FG002|Overall Study|Death|1|||
149904500|NCT03499899|540779723|FG000|Overall Study|Physician Decision|3|||
149904501|NCT03499899|540779724|FG001|Overall Study|Physician Decision|6|||
149904502|NCT03499899|540779725|FG002|Overall Study|Physician Decision|6|||
149904503|NCT03499899|540779723|FG000|Overall Study|Progressive disease|15|||
149904504|NCT03499899|540779724|FG001|Overall Study|Progressive disease|23|||
149904505|NCT03499899|540779725|FG002|Overall Study|Progressive disease|23|||
149904506|NCT03499899|540779723|FG000|Overall Study|Patient decision|0|||
149904507|NCT03499899|540779724|FG001|Overall Study|Patient decision|1|||
149904508|NCT03499899|540779725|FG002|Overall Study|Patient decision|1|||
149904509|NCT03499899|540779723|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
149904510|NCT03499899|540779724|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
149904511|NCT03499899|540779725|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
149904512|NCT01981954|540779730|FG000|Titration Period|Protocol Deviation|1|||
149904513|NCT01981954|540779730|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
149904514|NCT01609543|540779740|FG000|Overall Study|Disease Progression|28|||
149904515|NCT01609543|540779740|FG000|Overall Study|Adverse Event|5|||
149904516|NCT01609543|540779740|FG000|Overall Study|Withdrawal by Subject|1|||
149904517|NCT01609543|540779740|FG000|Overall Study|Protocol Violation|1|||
149904518|NCT01609543|540779740|FG000|Overall Study|Death|7|||
149904519|NCT02218736|540779741|FG000|Overall Study|Withdrawal by Subject|10|||
149969684|NCT01968980|541025248|FG000|Overall Study|Withdrawal by Subject|13|||
149969685|NCT01968980|541025249|FG001|Overall Study|Withdrawal by Subject|5|||
149969686|NCT01968980|541025248|FG000|Overall Study|Other unspecified|1|||
149969687|NCT01968980|541025249|FG001|Overall Study|Other unspecified|2|||
149969688|NCT03773484|541025261|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
149904520|NCT02218736|540779742|FG001|Overall Study|Withdrawal by Subject|9|||
149904521|NCT02218736|540779741|FG000|Overall Study|Protocol Violation|2|||
149904522|NCT02218736|540779742|FG001|Overall Study|Protocol Violation|0|||
149904523|NCT01254318|540779747|FG000|Overall Study|Lost to Follow-up|5|||
149904524|NCT01254318|540779747|FG000|Overall Study|Death|47|||
149904525|NCT01137110|540779754|FG000|Overall Study|Protocol Violation|1|||
149904526|NCT01137110|540779755|FG001|Overall Study|Protocol Violation|0|||
149904527|NCT02394340|540779760|FG000|Overall Study|Failed drug screen test|1|||
149904528|NCT02394340|540779760|FG000|Overall Study|Adverse Event|1|||
149904529|NCT01732640|540779766|FG000|Overall Study|Adverse Event|0|||
149904530|NCT01732640|540779767|FG001|Overall Study|Adverse Event|1|||
149904531|NCT01732640|540779766|FG000|Overall Study|Death|0|||
149904532|NCT01732640|540779767|FG001|Overall Study|Death|1|||
149904533|NCT03070002|540779770|FG000|Follow up for 2 Years|Death|1|||
149904534|NCT00712543|540779773|FG000|Day 8-14|Lost to Follow-up|0|||
149904535|NCT00712543|540779774|FG001|Day 8-14|Lost to Follow-up|2|||
149904536|NCT02981082|540779785|FG000|Overall Study|Withdrawal by Subject|2|||
149904537|NCT02981082|540779786|FG001|Overall Study|Withdrawal by Subject|0|||
149904538|NCT02981082|540779785|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
149904539|NCT02981082|540779786|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
149904540|NCT02981082|540779785|FG000|Overall Study|Adverse Event|0|||
149904541|NCT02981082|540779786|FG001|Overall Study|Adverse Event|1|||
149904542|NCT04250350|540783523|FG000|Overall Study|Withdrawal by Subject|13|||
149904543|NCT04250350|540783523|FG000|Overall Study|Lost to Follow-up|8|||
149904544|NCT04250350|540783523|FG000|Overall Study|Adverse Event|5|||
149904545|NCT04250350|540783523|FG000|Overall Study|Lack of Efficacy|4|||
149904546|NCT04250350|540783523|FG000|Overall Study|Physician Decision|1|||
149904547|NCT04250350|540783523|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
149904548|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
149904549|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
149904550|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
149904551|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
149904552|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Death|0|||
149904553|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Death|0|||
149904554|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Death|1|||
149904555|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Death|0|||
149904556|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
149904557|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
149904558|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
149904559|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
149904560|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
149904561|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
149969689|NCT03620981|541025262|FG000|Overall Study|Adverse Event|14|||
149969690|NCT03620981|541025263|FG001|Overall Study|Adverse Event|38|||
149969691|NCT03620981|541025264|FG002|Overall Study|Adverse Event|25|||
149969692|NCT03620981|541025262|FG000|Overall Study|Lack of Efficacy|2|||
149969693|NCT03620981|541025263|FG001|Overall Study|Lack of Efficacy|1|||
149969694|NCT03620981|541025264|FG002|Overall Study|Lack of Efficacy|1|||
149969695|NCT03620981|541025262|FG000|Overall Study|Physician Decision|7|||
149969696|NCT03620981|541025263|FG001|Overall Study|Physician Decision|4|||
149969697|NCT03620981|541025264|FG002|Overall Study|Physician Decision|4|||
149969698|NCT03620981|541025262|FG000|Overall Study|Protocol Violation|1|||
149969699|NCT03620981|541025263|FG001|Overall Study|Protocol Violation|2|||
149969700|NCT03620981|541025264|FG002|Overall Study|Protocol Violation|1|||
149969701|NCT03620981|541025262|FG000|Overall Study|Withdrawal by Legal Representative|2|||
149969702|NCT03620981|541025263|FG001|Overall Study|Withdrawal by Legal Representative|1|||
149969703|NCT03620981|541025264|FG002|Overall Study|Withdrawal by Legal Representative|1|||
149969704|NCT03620981|541025262|FG000|Overall Study|Withdrawal by Care Giver|2|||
149969705|NCT03620981|541025263|FG001|Overall Study|Withdrawal by Care Giver|0|||
149969706|NCT03620981|541025264|FG002|Overall Study|Withdrawal by Care Giver|1|||
149969707|NCT03620981|541025262|FG000|Overall Study|Non-compliance with Study Drug|1|||
149969708|NCT03620981|541025263|FG001|Overall Study|Non-compliance with Study Drug|1|||
149969709|NCT03620981|541025264|FG002|Overall Study|Non-compliance with Study Drug|0|||
149969710|NCT05552859|541025265|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
149969711|NCT05552859|541025266|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
149969712|NCT01380080|541025267|FG000|Overall Study|Death|36|||
149969713|NCT01380080|541025268|FG001|Overall Study|Death|44|||
149969714|NCT01380080|541025267|FG000|Overall Study|Site is closing|28|||
149969715|NCT01380080|541025268|FG001|Overall Study|Site is closing|31|||
149969716|NCT01380080|541025267|FG000|Overall Study|Not able to get to clinic|7|||
149969717|NCT01380080|541025268|FG001|Overall Study|Not able to get to clinic|1|||
149969718|NCT01380080|541025267|FG000|Overall Study|Not willing to adhere to requirements|6|||
149969719|NCT01380080|541025268|FG001|Overall Study|Not willing to adhere to requirements|2|||
149969720|NCT01380080|541025267|FG000|Overall Study|Withdrawal by Subject|5|||
149969721|NCT01380080|541025268|FG001|Overall Study|Withdrawal by Subject|2|||
149969722|NCT01380080|541025267|FG000|Overall Study|Lost to Follow-up|3|||
149969723|NCT01380080|541025268|FG001|Overall Study|Lost to Follow-up|3|||
149969724|NCT04251533|541025269|FG000|Overall Study|Progressive disease|33|||
149969725|NCT04251533|541025270|FG001|Overall Study|Progressive disease|29|||
149969726|NCT04251533|541025271|FG002|Overall Study|Progressive disease|22|||
149969727|NCT04251533|541025269|FG000|Overall Study|Death|5|||
149969728|NCT04251533|541025270|FG001|Overall Study|Death|1|||
149969729|NCT04251533|541025271|FG002|Overall Study|Death|3|||
149969730|NCT04251533|541025269|FG000|Overall Study|Physician Decision|3|||
149969731|NCT04251533|541025270|FG001|Overall Study|Physician Decision|2|||
150046826|NCT02100696|541311000|FG005|Induction Phase|Protocol Violation|0|||
150046827|NCT02100696|541310995|FG000|Induction Phase|Withdrawal by Subject|8|||
150046828|NCT02100696|541310996|FG001|Induction Phase|Withdrawal by Subject|2|||
150046829|NCT02100696|541310997|FG002|Induction Phase|Withdrawal by Subject|13|||
150046830|NCT02100696|541310998|FG003|Induction Phase|Withdrawal by Subject|0|||
150046831|NCT02100696|541310999|FG004|Induction Phase|Withdrawal by Subject|0|||
150046832|NCT02100696|541311000|FG005|Induction Phase|Withdrawal by Subject|0|||
150046833|NCT02100696|541310995|FG000|Induction Phase|Physician Decision|1|||
150046834|NCT02100696|541310996|FG001|Induction Phase|Physician Decision|0|||
150046835|NCT02100696|541310997|FG002|Induction Phase|Physician Decision|2|||
150046836|NCT02100696|541310998|FG003|Induction Phase|Physician Decision|0|||
150046837|NCT02100696|541310999|FG004|Induction Phase|Physician Decision|0|||
150046838|NCT02100696|541311000|FG005|Induction Phase|Physician Decision|0|||
150046839|NCT02100696|541310995|FG000|Induction Phase|Multiple Reasons|5|||
150046840|NCT02100696|541310996|FG001|Induction Phase|Multiple Reasons|2|||
150046841|NCT02100696|541310997|FG002|Induction Phase|Multiple Reasons|8|||
150046842|NCT02100696|541310998|FG003|Induction Phase|Multiple Reasons|0|||
150046843|NCT02100696|541310999|FG004|Induction Phase|Multiple Reasons|0|||
150046844|NCT02100696|541311000|FG005|Induction Phase|Multiple Reasons|0|||
150046845|NCT02100696|541310995|FG000|Maintenance Phase|Adverse Event|0|||
150046846|NCT02100696|541310996|FG001|Maintenance Phase|Adverse Event|0|||
150046847|NCT02100696|541310997|FG002|Maintenance Phase|Adverse Event|0|||
150046848|NCT02100696|541310998|FG003|Maintenance Phase|Adverse Event|0|||
150046849|NCT02100696|541310999|FG004|Maintenance Phase|Adverse Event|0|||
150046850|NCT02100696|541311000|FG005|Maintenance Phase|Adverse Event|2|||
150046851|NCT02100696|541310995|FG000|Maintenance Phase|Lost to Follow-up|0|||
150046852|NCT02100696|541310996|FG001|Maintenance Phase|Lost to Follow-up|0|||
150046853|NCT02100696|541310997|FG002|Maintenance Phase|Lost to Follow-up|0|||
150046854|NCT02100696|541310998|FG003|Maintenance Phase|Lost to Follow-up|0|||
150046855|NCT02100696|541310999|FG004|Maintenance Phase|Lost to Follow-up|1|||
150046856|NCT02100696|541311000|FG005|Maintenance Phase|Lost to Follow-up|0|||
150046857|NCT02100696|541310995|FG000|Maintenance Phase|Protocol Violation|0|||
150046858|NCT02100696|541310996|FG001|Maintenance Phase|Protocol Violation|0|||
150046859|NCT02100696|541310997|FG002|Maintenance Phase|Protocol Violation|0|||
150046860|NCT02100696|541310998|FG003|Maintenance Phase|Protocol Violation|0|||
150046861|NCT02100696|541310999|FG004|Maintenance Phase|Protocol Violation|1|||
150046862|NCT02100696|541311000|FG005|Maintenance Phase|Protocol Violation|0|||
150046863|NCT02100696|541310995|FG000|Maintenance Phase|Withdrawal by Subject|0|||
150046864|NCT02100696|541310996|FG001|Maintenance Phase|Withdrawal by Subject|0|||
150046865|NCT02100696|541310997|FG002|Maintenance Phase|Withdrawal by Subject|0|||
150046866|NCT02100696|541310998|FG003|Maintenance Phase|Withdrawal by Subject|1|||
150046867|NCT02100696|541310999|FG004|Maintenance Phase|Withdrawal by Subject|4|||
149904562|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
149904563|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
149904564|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
149904565|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
149904566|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
149904567|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
149904568|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
149904569|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
149904570|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
149904571|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
149904572|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
149904573|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
149904574|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
149904575|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
149904576|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
149904577|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
149904578|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
149904579|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
149904580|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149904581|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
149904582|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
150046868|NCT02100696|541311000|FG005|Maintenance Phase|Withdrawal by Subject|2|||
150046869|NCT02100696|541310995|FG000|Maintenance Phase|Physician Decision|0|||
150046870|NCT02100696|541310996|FG001|Maintenance Phase|Physician Decision|0|||
150046871|NCT02100696|541310997|FG002|Maintenance Phase|Physician Decision|0|||
150046872|NCT02100696|541310998|FG003|Maintenance Phase|Physician Decision|0|||
150046873|NCT02100696|541310999|FG004|Maintenance Phase|Physician Decision|1|||
150046874|NCT02100696|541311000|FG005|Maintenance Phase|Physician Decision|0|||
150046875|NCT02100696|541310995|FG000|Maintenance Phase|Multiple Reasons|0|||
150046876|NCT02100696|541310996|FG001|Maintenance Phase|Multiple Reasons|0|||
150046877|NCT02100696|541310997|FG002|Maintenance Phase|Multiple Reasons|0|||
150046878|NCT02100696|541310998|FG003|Maintenance Phase|Multiple Reasons|0|||
150046879|NCT02100696|541310999|FG004|Maintenance Phase|Multiple Reasons|2|||
150046880|NCT02100696|541311000|FG005|Maintenance Phase|Multiple Reasons|1|||
150046881|NCT05626322|541311001|FG000|Overall Study|Death|2|||
150046882|NCT05626322|541311002|FG001|Overall Study|Death|0|||
150046883|NCT05626322|541311003|FG002|Overall Study|Death|0|||
150046884|NCT05626322|541311001|FG000|Overall Study|Physician Decision|1|||
150046885|NCT05626322|541311002|FG001|Overall Study|Physician Decision|0|||
150046886|NCT05626322|541311003|FG002|Overall Study|Physician Decision|0|||
150046887|NCT05626322|541311001|FG000|Overall Study|Progressive Disease|0|||
150046888|NCT05626322|541311002|FG001|Overall Study|Progressive Disease|1|||
150046889|NCT05626322|541311003|FG002|Overall Study|Progressive Disease|1|||
150046890|NCT05626322|541311001|FG000|Overall Study|Study terminated by sponsor|0|||
150046891|NCT05626322|541311002|FG001|Overall Study|Study terminated by sponsor|1|||
150046892|NCT05626322|541311003|FG002|Overall Study|Study terminated by sponsor|0|||
150046893|NCT00048074|541311007|FG000|Overall Study|Adverse Event|46|||
150046894|NCT00048074|541311008|FG001|Overall Study|Adverse Event|41|||
150046895|NCT00048074|541311009|FG002|Overall Study|Adverse Event|53|||
150046896|NCT00048074|541311007|FG000|Overall Study|Death|3|||
150046897|NCT00048074|541311008|FG001|Overall Study|Death|3|||
150046898|NCT00048074|541311009|FG002|Overall Study|Death|2|||
150046899|NCT00048074|541311007|FG000|Overall Study|Lost to Follow-up|2|||
150046900|NCT00048074|541311008|FG001|Overall Study|Lost to Follow-up|6|||
150046901|NCT00048074|541311009|FG002|Overall Study|Lost to Follow-up|6|||
150046902|NCT00048074|541311007|FG000|Overall Study|Withdrawal by Subject|28|||
150046903|NCT00048074|541311008|FG001|Overall Study|Withdrawal by Subject|30|||
150046904|NCT00048074|541311009|FG002|Overall Study|Withdrawal by Subject|35|||
150046905|NCT00048074|541311007|FG000|Overall Study|Protocol Violation|1|||
150046906|NCT00048074|541311008|FG001|Overall Study|Protocol Violation|3|||
150046907|NCT00048074|541311009|FG002|Overall Study|Protocol Violation|0|||
150046908|NCT00048074|541311007|FG000|Overall Study|Study participation was terminated|0|||
150046909|NCT00048074|541311008|FG001|Overall Study|Study participation was terminated|1|||
150046910|NCT00048074|541311009|FG002|Overall Study|Study participation was terminated|0|||
150046911|NCT00048074|541311007|FG000|Overall Study|Husband ill|0|||
150046912|NCT00048074|541311008|FG001|Overall Study|Husband ill|1|||
150046913|NCT00048074|541311009|FG002|Overall Study|Husband ill|0|||
150046914|NCT00048074|541311007|FG000|Overall Study|Poor compliance|0|||
150046915|NCT00048074|541311008|FG001|Overall Study|Poor compliance|1|||
150046916|NCT00048074|541311009|FG002|Overall Study|Poor compliance|0|||
150046917|NCT00048074|541311007|FG000|Overall Study|Out of station|0|||
150046918|NCT00048074|541311008|FG001|Overall Study|Out of station|1|||
150046919|NCT00048074|541311009|FG002|Overall Study|Out of station|1|||
150046920|NCT00048074|541311007|FG000|Overall Study|Social reasons|1|||
150046921|NCT00048074|541311008|FG001|Overall Study|Social reasons|0|||
150046922|NCT00048074|541311009|FG002|Overall Study|Social reasons|0|||
150046923|NCT02873377|541311010|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
150046924|NCT02873377|541311011|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
150046925|NCT02873377|541311010|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
150046926|NCT02873377|541311011|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
150046927|NCT01583296|541311014|FG000|Overall Study|Withdrawal by Subject|11|||
150046928|NCT01583296|541311015|FG001|Overall Study|Withdrawal by Subject|10|||
150046929|NCT01063283|541311016|FG000|Cycle 1|Adverse Event|2|||
150046930|NCT01063283|541311017|FG001|Cycle 1|Adverse Event|0|||
150046931|NCT01063283|541311018|FG002|Cycle 1|Adverse Event|0|||
150046932|NCT01063283|541311016|FG000|Cycle 1|Technical failure in data collection|1|||
150046933|NCT01063283|541311017|FG001|Cycle 1|Technical failure in data collection|0|||
150046934|NCT01063283|541311018|FG002|Cycle 1|Technical failure in data collection|0|||
150046935|NCT02504216|541311021|FG000|Overall Study|Lost to Follow-up|3|||
150046936|NCT02504216|541311022|FG001|Overall Study|Lost to Follow-up|3|||
150046937|NCT02504216|541311021|FG000|Overall Study|Withdrawal by Subject|8|||
150046938|NCT02504216|541311022|FG001|Overall Study|Withdrawal by Subject|12|||
150046939|NCT00223080|541311023|FG000|Overall Study|Withdrawal by Subject|253|||
150046940|NCT00223080|541311024|FG001|Overall Study|Withdrawal by Subject|232|||
150046941|NCT00223080|541311023|FG000|Overall Study|Required contraindicated med|0|||
150046942|NCT00223080|541311024|FG001|Overall Study|Required contraindicated med|1|||
150046943|NCT00223080|541311023|FG000|Overall Study|Non-compliant|7|||
150046944|NCT00223080|541311024|FG001|Overall Study|Non-compliant|7|||
150046945|NCT00223080|541311023|FG000|Overall Study|Moved from study area|37|||
150046946|NCT00223080|541311024|FG001|Overall Study|Moved from study area|47|||
150046947|NCT00223080|541311023|FG000|Overall Study|Lost to Follow-up|259|||
150046948|NCT00223080|541311024|FG001|Overall Study|Lost to Follow-up|284|||
150046949|NCT00223080|541311023|FG000|Overall Study|Death|85|||
150046950|NCT00223080|541311024|FG001|Overall Study|Death|74|||
150046951|NCT00223080|541311023|FG000|Overall Study|Other|14|||
150046952|NCT00223080|541311024|FG001|Overall Study|Other|11|||
149904583|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149904584|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
149904585|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
149904586|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
149904587|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
149904588|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
149904589|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
149904590|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
149904591|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
149904592|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Other|8|||
149904593|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Other|14|||
149904594|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Other|8|||
149904595|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Other|23|||
149904596|NCT01106677|540783524|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
149904597|NCT01106677|540783525|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
149904598|NCT01106677|540783526|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
149904599|NCT01106677|540783527|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
149904600|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
149904601|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
149904602|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
149904603|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
149904604|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Death|0|||
149904605|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Death|0|||
149904606|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Death|0|||
149904607|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Death|1|||
149904608|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
149904609|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
149904610|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
149904611|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
149904612|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
149904613|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
149904614|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
149904615|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
149904616|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
149904617|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
149904618|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
149904619|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
149904620|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149904621|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149904622|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149904623|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149904624|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149904625|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
149904626|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
149904627|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149904628|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
149904629|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
149904630|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
149904631|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
149904632|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149904633|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149904634|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
149904635|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
149904636|NCT01106677|540783524|FG000|Extension Period: Week 26 to Week 52|Other|6|||
149904637|NCT01106677|540783525|FG001|Extension Period: Week 26 to Week 52|Other|5|||
149904638|NCT01106677|540783526|FG002|Extension Period: Week 26 to Week 52|Other|8|||
149904639|NCT01106677|540783527|FG003|Extension Period: Week 26 to Week 52|Other|5|||
150046953|NCT00223080|541311023|FG000|Overall Study|Reason not provided|141|||
150046954|NCT00223080|541311024|FG001|Overall Study|Reason not provided|140|||
150046955|NCT00223080|541311023|FG000|Overall Study|Adverse Event|0|||
150046956|NCT00223080|541311024|FG001|Overall Study|Adverse Event|1|||
150046957|NCT02598583|541311025|FG000|Extension Period|Withdrawal by Subject|1|||
150046958|NCT02598583|541311026|FG001|Extension Period|Withdrawal by Subject|0|||
150046959|NCT03237286|541311027|FG000|Overall Study|Withdrawal by Subject|1|||
150046960|NCT03237286|541311028|FG001|Overall Study|Withdrawal by Subject|0|||
150046961|NCT03237286|541311029|FG002|Overall Study|Withdrawal by Subject|2|||
150046962|NCT03237286|541311027|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
150046963|NCT03237286|541311028|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
150046964|NCT03237286|541311029|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
150046965|NCT02792829|541311037|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046966|NCT02792829|541311038|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
150046967|NCT02792829|541311039|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046968|NCT02792829|541311040|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046969|NCT02792829|541311041|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046970|NCT02792829|541311042|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046971|NCT02792829|541311043|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046972|NCT02792829|541311044|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
150046973|NCT02792829|541311037|FG000|Treatment Period 2|Adverse Event|0|||
150046974|NCT02792829|541311038|FG001|Treatment Period 2|Adverse Event|0|||
150046975|NCT02792829|541311039|FG002|Treatment Period 2|Adverse Event|0|||
150046976|NCT02792829|541311040|FG003|Treatment Period 2|Adverse Event|0|||
150046977|NCT02792829|541311041|FG004|Treatment Period 2|Adverse Event|1|||
150046978|NCT02792829|541311042|FG005|Treatment Period 2|Adverse Event|0|||
150046979|NCT02792829|541311043|FG006|Treatment Period 2|Adverse Event|1|||
150046980|NCT02792829|541311044|FG007|Treatment Period 2|Adverse Event|1|||
150046981|NCT02792829|541311037|FG000|Treatment Period 2|Use of proscribed medications|0|||
150046982|NCT02792829|541311038|FG001|Treatment Period 2|Use of proscribed medications|0|||
150046983|NCT02792829|541311039|FG002|Treatment Period 2|Use of proscribed medications|0|||
150046984|NCT02792829|541311040|FG003|Treatment Period 2|Use of proscribed medications|0|||
150046985|NCT02792829|541311041|FG004|Treatment Period 2|Use of proscribed medications|0|||
150046986|NCT02792829|541311042|FG005|Treatment Period 2|Use of proscribed medications|0|||
150046987|NCT02792829|541311043|FG006|Treatment Period 2|Use of proscribed medications|0|||
150046988|NCT02792829|541311044|FG007|Treatment Period 2|Use of proscribed medications|1|||
150046989|NCT01262820|541311047|FG000|Overall Study|Adverse Event|5|||
150046990|NCT01262820|541311047|FG000|Overall Study|Lack of Efficacy|9|||
150046991|NCT01262820|541311047|FG000|Overall Study|Drug held for 21+ days|1|||
150046992|NCT01010867|541311049|FG000|Overall Study|< 50% adherence to probiotic|1|||
150046993|NCT02302339|541311050|FG000|Overall Study|Lost to Follow-up|1|||
150046994|NCT02302339|541311051|FG001|Overall Study|Lost to Follow-up|0|||
150046995|NCT02302339|541311052|FG002|Overall Study|Lost to Follow-up|0|||
150046996|NCT02302339|541311053|FG003|Overall Study|Lost to Follow-up|0|||
150046997|NCT02302339|541311050|FG000|Overall Study|Withdrawal by Subject|0|||
150046998|NCT02302339|541311051|FG001|Overall Study|Withdrawal by Subject|2|||
150046999|NCT02302339|541311052|FG002|Overall Study|Withdrawal by Subject|1|||
150047000|NCT02302339|541311053|FG003|Overall Study|Withdrawal by Subject|0|||
150047001|NCT02752165|541311057|FG000|Overall Study|Withdrawal by Subject|6|||
150047002|NCT02752165|541311058|FG001|Overall Study|Withdrawal by Subject|6|||
150047003|NCT02752165|541311057|FG000|Overall Study|Protocol Violation|6|||
150047004|NCT02752165|541311058|FG001|Overall Study|Protocol Violation|5|||
150047005|NCT02752165|541311057|FG000|Overall Study|Lost to Follow-up|33|||
150047006|NCT02752165|541311058|FG001|Overall Study|Lost to Follow-up|38|||
150047007|NCT01704599|541311061|FG000|Overall Study|Adverse Event|1|||
150047008|NCT00912197|541311064|FG000|Overall Study|Withdrawal by Subject|3|||
150047009|NCT00912197|541311065|FG001|Overall Study|Withdrawal by Subject|3|||
150047010|NCT00494676|541311073|FG000|Allocation|Withdrawal by Subject|2|||
150047011|NCT00494676|541311074|FG001|Allocation|Withdrawal by Subject|4|||
150047012|NCT00494676|541311073|FG000|First Intervention|Withdrawal by Subject|1|||
150047013|NCT00494676|541311074|FG001|First Intervention|Withdrawal by Subject|3|||
150047014|NCT00494676|541311073|FG000|Second Intervention|Withdrawal by Subject|1|||
150047015|NCT00494676|541311074|FG001|Second Intervention|Withdrawal by Subject|1|||
150047016|NCT01256294|541312751|FG000|Overall Study|Adverse Event|1|||
150047017|NCT01256294|541312752|FG001|Overall Study|Adverse Event|0|||
150047018|NCT01256294|541312751|FG000|Overall Study|Withdrawal by Subject|1|||
150047019|NCT01256294|541312752|FG001|Overall Study|Withdrawal by Subject|1|||
150047020|NCT01256294|541312751|FG000|Overall Study|Protocol deviation|2|||
150047021|NCT01256294|541312752|FG001|Overall Study|Protocol deviation|1|||
150047022|NCT01643772|541312753|FG000|Overall Study|Protocol Violation|0|||
149904640|NCT03875092|540783528|FG000|Overall Study|Adverse Event|2|||
150047023|NCT01643772|541312754|FG001|Overall Study|Protocol Violation|0|||
149904641|NCT03875092|540783529|FG001|Overall Study|Adverse Event|5|||
149904642|NCT03875092|540783528|FG000|Overall Study|Death|44|||
149969732|NCT04251533|541025271|FG002|Overall Study|Physician Decision|4|||
149969733|NCT04251533|541025269|FG000|Overall Study|Participant decision|1|||
149969734|NCT04251533|541025270|FG001|Overall Study|Participant decision|3|||
149969735|NCT04251533|541025271|FG002|Overall Study|Participant decision|1|||
149969736|NCT04251533|541025269|FG000|Overall Study|Adverse Event|2|||
149969737|NCT04251533|541025270|FG001|Overall Study|Adverse Event|1|||
149969738|NCT04251533|541025271|FG002|Overall Study|Adverse Event|1|||
149969739|NCT00210132|541025276|FG000|Overall Study|Protocol Violation|1|||
149969740|NCT00210132|541025277|FG001|Overall Study|Protocol Violation|4|||
149969741|NCT02711202|541025278|FG000|Overall Study|Adverse Event|3|||
149969742|NCT02711202|541025279|FG001|Overall Study|Adverse Event|0|||
149969743|NCT02711202|541025278|FG000|Overall Study|graft loss|1|||
149969744|NCT02711202|541025279|FG001|Overall Study|graft loss|0|||
149969745|NCT00432965|541025280|FG000|Overall Study|Lost to Follow-up|22|||
149969746|NCT00432965|541025281|FG001|Overall Study|Lost to Follow-up|19|||
149969747|NCT00432965|541025280|FG000|Overall Study|Withdrawal by Subject|13|||
149969748|NCT00432965|541025281|FG001|Overall Study|Withdrawal by Subject|13|||
149969749|NCT00432965|541025280|FG000|Overall Study|Physician Decision|14|||
149969750|NCT00432965|541025281|FG001|Overall Study|Physician Decision|13|||
149969751|NCT00432965|541025280|FG000|Overall Study|Lack of Efficacy|8|||
149969752|NCT00432965|541025281|FG001|Overall Study|Lack of Efficacy|13|||
149969753|NCT00432965|541025280|FG000|Overall Study|Non-compliance|7|||
149969754|NCT00432965|541025281|FG001|Overall Study|Non-compliance|0|||
149969755|NCT00432965|541025280|FG000|Overall Study|Adverse Event|22|||
149969756|NCT00432965|541025281|FG001|Overall Study|Adverse Event|19|||
149969757|NCT00432965|541025280|FG000|Overall Study|Death|3|||
149969758|NCT00432965|541025281|FG001|Overall Study|Death|4|||
149969759|NCT00432965|541025280|FG000|Overall Study|Exclusionary Methods|1|||
149969760|NCT00432965|541025281|FG001|Overall Study|Exclusionary Methods|2|||
149969761|NCT00432965|541025280|FG000|Overall Study|Incomplete Data|4|||
149969762|NCT00432965|541025281|FG001|Overall Study|Incomplete Data|3|||
149969763|NCT03909971|541025283|FG000|Overall Study|Participant transition to rollover study|26|||
149969764|NCT03909971|541025284|FG001|Overall Study|Participant transition to rollover study|9|||
149969765|NCT03909971|541025283|FG000|Overall Study|Global Deterioration of Health Status|2|||
149969766|NCT03909971|541025284|FG001|Overall Study|Global Deterioration of Health Status|2|||
149969767|NCT03909971|541025283|FG000|Overall Study|Progressive Disease|28|||
149969768|NCT03909971|541025284|FG001|Overall Study|Progressive Disease|21|||
149969769|NCT03909971|541025283|FG000|Overall Study|Death|6|||
149969770|NCT03909971|541025284|FG001|Overall Study|Death|6|||
149969771|NCT03909971|541025283|FG000|Overall Study|Adverse Event|1|||
149969772|NCT03909971|541025284|FG001|Overall Study|Adverse Event|2|||
149969773|NCT03909971|541025283|FG000|Overall Study|Withdrawal by Subject|2|||
149969774|NCT03909971|541025284|FG001|Overall Study|Withdrawal by Subject|1|||
149969775|NCT03909971|541025283|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
149969776|NCT03909971|541025284|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
149969777|NCT03909971|541025283|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
149969778|NCT03909971|541025284|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
149969779|NCT05177354|541025285|FG000|Implant to 30-day Visit|Physician Decision|1|||
149969780|NCT05177354|541025285|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
149969781|NCT05177354|541025285|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
149969782|NCT05177354|541025285|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
149969783|NCT06028464|541025289|FG000|Washout|Positive drug test.|1|||
149969784|NCT03636022|541025290|FG000|Overall Study|Withdrawal by Subject|1|||
149969785|NCT03636022|541025291|FG001|Overall Study|Withdrawal by Subject|3|||
149969786|NCT03448393|541025295|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969787|NCT03448393|541025296|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969788|NCT03448393|541025297|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
149969789|NCT03448393|541025298|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969790|NCT03448393|541025299|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969791|NCT03448393|541025300|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969792|NCT03448393|541025301|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969793|NCT03448393|541025302|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
149969794|NCT03448393|541025303|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
149969795|NCT03448393|541025295|FG000|Dose Expansion|Not treated - screen failure|0|||
149969796|NCT03448393|541025296|FG001|Dose Expansion|Not treated - screen failure|0|||
149969797|NCT03448393|541025297|FG002|Dose Expansion|Not treated - screen failure|0|||
149969798|NCT03448393|541025298|FG003|Dose Expansion|Not treated - screen failure|0|||
149969799|NCT03448393|541025299|FG004|Dose Expansion|Not treated - screen failure|0|||
149969800|NCT03448393|541025300|FG005|Dose Expansion|Not treated - screen failure|0|||
150176569|NCT02499159|541783320|FG000|30-Day Follow-Up Phone Call|Other|1|||
149904643|NCT03875092|540783529|FG001|Overall Study|Death|51|||
149904644|NCT03875092|540783528|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
149904645|NCT03875092|540783529|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
149904646|NCT04114357|540783530|FG000|Baseline-Randomization|Adverse Event|2|||
149904647|NCT04114357|540783531|FG001|Baseline-Randomization|Adverse Event|1|||
149904648|NCT04114357|540783530|FG000|Baseline-Randomization|Lost to Follow-up|1|||
149904649|NCT04114357|540783531|FG001|Baseline-Randomization|Lost to Follow-up|1|||
149904650|NCT04114357|540783530|FG000|Cross-over|Adverse Event|0|||
149904651|NCT04114357|540783531|FG001|Cross-over|Adverse Event|1|||
149904652|NCT03693612|540783532|FG000|Overall Study|Lost to Follow-up|0|||
149969801|NCT03448393|541025301|FG006|Dose Expansion|Not treated - screen failure|0|||
149969802|NCT03448393|541025302|FG007|Dose Expansion|Not treated - screen failure|0|||
149969803|NCT03448393|541025303|FG008|Dose Expansion|Not treated - screen failure|7|||
149969804|NCT01587196|541025304|FG000|Overall Study|Lost to Follow-up|50|||
149969805|NCT01587196|541025304|FG000|Overall Study|Withdrawal by Subject|4|||
149969806|NCT00642759|541025305|FG000|Overall Study|Protocol Violation|1|||
149969807|NCT03612570|541025312|FG000|Overall Study|Lost to Follow-up|1|||
149969808|NCT03537508|541025317|FG000|Overall Study|Adverse Event|2|||
149969809|NCT03537508|541025318|FG001|Overall Study|Adverse Event|1|||
149969810|NCT03537508|541025317|FG000|Overall Study|Protocol Violation|65|||
149969811|NCT03537508|541025318|FG001|Overall Study|Protocol Violation|48|||
149969812|NCT03537508|541025317|FG000|Overall Study|Lost to Follow-up|86|||
149969813|NCT03537508|541025318|FG001|Overall Study|Lost to Follow-up|60|||
149969814|NCT03537508|541025317|FG000|Overall Study|Withdrawal by parent/guardian|263|||
149969815|NCT03537508|541025318|FG001|Overall Study|Withdrawal by parent/guardian|149|||
149969816|NCT01972659|541025331|FG000|Overall Study|Protocol Violation|2|||
149969817|NCT01972659|541025332|FG001|Overall Study|Protocol Violation|2|||
149969818|NCT01972659|541025331|FG000|Overall Study|problems realted to acceleromyograph|2|||
149969819|NCT01972659|541025332|FG001|Overall Study|problems realted to acceleromyograph|1|||
149969820|NCT05715827|541025343|FG000|Overall Study|Physician Decision|0|||
149969821|NCT05715827|541025344|FG001|Overall Study|Physician Decision|1|||
149969822|NCT05715827|541025343|FG000|Overall Study|console communication error|0|||
149969823|NCT05715827|541025344|FG001|Overall Study|console communication error|1|||
149969824|NCT03274466|541025345|FG000|Overall Study|Withdrawal by Subject|7|||
149969825|NCT03274466|541025346|FG001|Overall Study|Withdrawal by Subject|3|||
149969826|NCT03274466|541025345|FG000|Overall Study|Protocol Specified Withdrawal|5|||
149969827|NCT03274466|541025346|FG001|Overall Study|Protocol Specified Withdrawal|11|||
149969828|NCT03274466|541025345|FG000|Overall Study|Lost to Follow-up|5|||
149969829|NCT03274466|541025346|FG001|Overall Study|Lost to Follow-up|7|||
149969830|NCT03274466|541025345|FG000|Overall Study|Subject Non-compliance|0|||
149969831|NCT03274466|541025346|FG001|Overall Study|Subject Non-compliance|1|||
149969832|NCT03274466|541025345|FG000|Overall Study|Adverse Event|3|||
149969833|NCT03274466|541025346|FG001|Overall Study|Adverse Event|3|||
149969834|NCT03274466|541025345|FG000|Overall Study|Physician Decision|0|||
149969835|NCT03274466|541025346|FG001|Overall Study|Physician Decision|1|||
149969836|NCT03274466|541025345|FG000|Overall Study|Protocol Violation|3|||
149969837|NCT03274466|541025346|FG001|Overall Study|Protocol Violation|3|||
149969838|NCT05847686|541028253|FG000|Overall Study|Withdrawal by Subject|3|||
149969839|NCT03716830|541028254|FG000|Overall Study|Withdrawal by Subject|2|||
149969840|NCT03716830|541028255|FG001|Overall Study|Withdrawal by Subject|2|||
149969841|NCT03716830|541028256|FG002|Overall Study|Withdrawal by Subject|6|||
149969842|NCT03716830|541028257|FG003|Overall Study|Withdrawal by Subject|5|||
149969843|NCT03716830|541028254|FG000|Overall Study|Adverse Event|1|||
149969844|NCT03716830|541028255|FG001|Overall Study|Adverse Event|2|||
149969845|NCT03716830|541028256|FG002|Overall Study|Adverse Event|0|||
149969846|NCT03716830|541028257|FG003|Overall Study|Adverse Event|1|||
149969847|NCT03716830|541028254|FG000|Overall Study|Lost to Follow-up|1|||
149969848|NCT03716830|541028255|FG001|Overall Study|Lost to Follow-up|1|||
149969849|NCT03716830|541028256|FG002|Overall Study|Lost to Follow-up|0|||
149969850|NCT03716830|541028257|FG003|Overall Study|Lost to Follow-up|0|||
149969851|NCT05489328|541028258|FG000|Overall Study|Lost to Follow-up|0|||
149969852|NCT05489328|541028259|FG001|Overall Study|Lost to Follow-up|0|||
149969853|NCT05489328|541028260|FG002|Overall Study|Lost to Follow-up|1|||
149969854|NCT05489328|541028261|FG003|Overall Study|Lost to Follow-up|0|||
149969855|NCT05489328|541028262|FG004|Overall Study|Lost to Follow-up|2|||
149969856|NCT05489328|541028263|FG005|Overall Study|Lost to Follow-up|0|||
149969857|NCT05489328|541028264|FG006|Overall Study|Lost to Follow-up|0|||
149969858|NCT05489328|541028265|FG007|Overall Study|Lost to Follow-up|1|||
149969859|NCT05489328|541028266|FG008|Overall Study|Lost to Follow-up|0|||
149969860|NCT05489328|541028258|FG000|Overall Study|Withdrawal by Subject|0|||
149969861|NCT05489328|541028259|FG001|Overall Study|Withdrawal by Subject|0|||
149969862|NCT05489328|541028260|FG002|Overall Study|Withdrawal by Subject|0|||
149969863|NCT05489328|541028261|FG003|Overall Study|Withdrawal by Subject|0|||
149969864|NCT05489328|541028262|FG004|Overall Study|Withdrawal by Subject|0|||
150176570|NCT02499159|541783321|FG001|30-Day Follow-Up Phone Call|Other|0|||
149904653|NCT03693612|540783533|FG001|Overall Study|Lost to Follow-up|0|||
149904654|NCT03693612|540783534|FG002|Overall Study|Lost to Follow-up|0|||
150176571|NCT02564744|541783325|FG000|Overall Study|Investigator decision|0|||
150176572|NCT02564744|541783326|FG001|Overall Study|Investigator decision|0|||
150176573|NCT02564744|541783327|FG002|Overall Study|Investigator decision|0|||
150176574|NCT02564744|541783328|FG003|Overall Study|Investigator decision|0|||
150176575|NCT02564744|541783329|FG004|Overall Study|Investigator decision|1|||
150176576|NCT02564744|541783325|FG000|Overall Study|Death|10|||
150176577|NCT02564744|541783326|FG001|Overall Study|Death|5|||
150176578|NCT02564744|541783327|FG002|Overall Study|Death|4|||
150176579|NCT02564744|541783328|FG003|Overall Study|Death|16|||
149969865|NCT05489328|541028263|FG005|Overall Study|Withdrawal by Subject|0|||
149969866|NCT05489328|541028264|FG006|Overall Study|Withdrawal by Subject|1|||
149969867|NCT05489328|541028265|FG007|Overall Study|Withdrawal by Subject|1|||
149969868|NCT05489328|541028266|FG008|Overall Study|Withdrawal by Subject|0|||
150176580|NCT02564744|541783329|FG004|Overall Study|Death|16|||
150176581|NCT02564744|541783325|FG000|Overall Study|End of study Page Missing|0|||
150176582|NCT02564744|541783326|FG001|Overall Study|End of study Page Missing|0|||
150176583|NCT02564744|541783327|FG002|Overall Study|End of study Page Missing|3|||
150176584|NCT02564744|541783328|FG003|Overall Study|End of study Page Missing|3|||
149969869|NCT05489328|541028258|FG000|Overall Study|Other|0|||
149969870|NCT05489328|541028259|FG001|Overall Study|Other|0|||
149969871|NCT05489328|541028260|FG002|Overall Study|Other|0|||
149969872|NCT05489328|541028261|FG003|Overall Study|Other|0|||
149969873|NCT05489328|541028262|FG004|Overall Study|Other|0|||
149969874|NCT05489328|541028263|FG005|Overall Study|Other|0|||
149969875|NCT05489328|541028264|FG006|Overall Study|Other|0|||
149969876|NCT05489328|541028265|FG007|Overall Study|Other|1|||
149969877|NCT05489328|541028266|FG008|Overall Study|Other|1|||
149969878|NCT03021486|541028267|FG000|Overall Study|Withdrawal by Subject|1|||
149969879|NCT03021486|541028268|FG001|Overall Study|Withdrawal by Subject|1|||
149969880|NCT03021486|541028269|FG002|Overall Study|Withdrawal by Subject|3|||
150047024|NCT01643772|541312755|FG002|Overall Study|Protocol Violation|0|||
150047025|NCT01643772|541312756|FG003|Overall Study|Protocol Violation|1|||
150047026|NCT01643772|541312753|FG000|Overall Study|Adverse Event|0|||
150047027|NCT01643772|541312754|FG001|Overall Study|Adverse Event|0|||
150047028|NCT01643772|541312755|FG002|Overall Study|Adverse Event|0|||
150047029|NCT01643772|541312756|FG003|Overall Study|Adverse Event|1|||
150047030|NCT00724711|541312757|FG000|Overall Study|Adverse Event|7|||
150047031|NCT00724711|541312758|FG001|Overall Study|Adverse Event|3|||
150047032|NCT00724711|541312757|FG000|Overall Study|Pregnancy|0|||
150047033|NCT00724711|541312758|FG001|Overall Study|Pregnancy|1|||
150047034|NCT00724711|541312757|FG000|Overall Study|Lack of Efficacy|0|||
150047035|NCT00724711|541312758|FG001|Overall Study|Lack of Efficacy|1|||
150047036|NCT00724711|541312757|FG000|Overall Study|Physician Decision|0|||
150047037|NCT00724711|541312758|FG001|Overall Study|Physician Decision|3|||
150047038|NCT00724711|541312757|FG000|Overall Study|Withdrawal by Subject|5|||
150047039|NCT00724711|541312758|FG001|Overall Study|Withdrawal by Subject|4|||
150047040|NCT00724711|541312757|FG000|Overall Study|Lost to Follow-up|4|||
150047041|NCT00724711|541312758|FG001|Overall Study|Lost to Follow-up|5|||
150047042|NCT00724711|541312757|FG000|Overall Study|Protocol Violation|1|||
150047043|NCT00724711|541312758|FG001|Overall Study|Protocol Violation|0|||
150047044|NCT01139008|541312759|FG000|Overall Study|Withdrawal by Subject|5|||
150047045|NCT01139008|541312759|FG000|Overall Study|Non-compliant, lost product|1|||
150047046|NCT01088048|541312761|FG000|Overall Study|Adverse Event|7|||
150047047|NCT01088048|541312762|FG001|Overall Study|Adverse Event|9|||
150047048|NCT01088048|541312763|FG002|Overall Study|Adverse Event|7|||
150047049|NCT01088048|541312764|FG003|Overall Study|Adverse Event|5|||
150047050|NCT01088048|541312765|FG004|Overall Study|Adverse Event|6|||
150047051|NCT01088048|541312766|FG005|Overall Study|Adverse Event|3|||
150047052|NCT01088048|541312767|FG006|Overall Study|Adverse Event|3|||
150047053|NCT01088048|541312768|FG007|Overall Study|Adverse Event|0|||
150047054|NCT01088048|541312769|FG008|Overall Study|Adverse Event|2|||
150176585|NCT02564744|541783329|FG004|Overall Study|End of study Page Missing|0|||
149969881|NCT03021486|541028267|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
149969882|NCT03021486|541028268|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
149969883|NCT03021486|541028269|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
150047055|NCT01088048|541312770|FG009|Overall Study|Adverse Event|2|||
150047056|NCT01088048|541312761|FG000|Overall Study|Withdrew Consent|1|||
150047057|NCT01088048|541312762|FG001|Overall Study|Withdrew Consent|1|||
150047058|NCT01088048|541312763|FG002|Overall Study|Withdrew Consent|1|||
150176586|NCT02564744|541783325|FG000|Overall Study|Subject Withdrew Consent|1|||
150176587|NCT02564744|541783326|FG001|Overall Study|Subject Withdrew Consent|1|||
150176588|NCT02564744|541783327|FG002|Overall Study|Subject Withdrew Consent|1|||
150047059|NCT01088048|541312764|FG003|Overall Study|Withdrew Consent|1|||
150047060|NCT01088048|541312765|FG004|Overall Study|Withdrew Consent|2|||
150047061|NCT01088048|541312766|FG005|Overall Study|Withdrew Consent|1|||
150047062|NCT01088048|541312767|FG006|Overall Study|Withdrew Consent|0|||
150047063|NCT01088048|541312768|FG007|Overall Study|Withdrew Consent|2|||
150047064|NCT01088048|541312769|FG008|Overall Study|Withdrew Consent|2|||
150047065|NCT01088048|541312770|FG009|Overall Study|Withdrew Consent|1|||
150047066|NCT01088048|541312761|FG000|Overall Study|Concomitant Medication Prohibited|1|||
150047067|NCT01088048|541312762|FG001|Overall Study|Concomitant Medication Prohibited|0|||
150047068|NCT01088048|541312763|FG002|Overall Study|Concomitant Medication Prohibited|0|||
150047069|NCT01088048|541312764|FG003|Overall Study|Concomitant Medication Prohibited|0|||
150047070|NCT01088048|541312765|FG004|Overall Study|Concomitant Medication Prohibited|0|||
150047071|NCT01088048|541312766|FG005|Overall Study|Concomitant Medication Prohibited|0|||
150047072|NCT01088048|541312767|FG006|Overall Study|Concomitant Medication Prohibited|0|||
150047073|NCT01088048|541312768|FG007|Overall Study|Concomitant Medication Prohibited|0|||
150047074|NCT01088048|541312769|FG008|Overall Study|Concomitant Medication Prohibited|0|||
150047075|NCT01088048|541312770|FG009|Overall Study|Concomitant Medication Prohibited|0|||
150047076|NCT01088048|541312761|FG000|Overall Study|Investigator Request|2|||
150047077|NCT01088048|541312762|FG001|Overall Study|Investigator Request|2|||
150047078|NCT01088048|541312763|FG002|Overall Study|Investigator Request|0|||
150047079|NCT01088048|541312764|FG003|Overall Study|Investigator Request|0|||
150047080|NCT01088048|541312765|FG004|Overall Study|Investigator Request|3|||
150047081|NCT01088048|541312766|FG005|Overall Study|Investigator Request|1|||
150047082|NCT01088048|541312767|FG006|Overall Study|Investigator Request|1|||
150047083|NCT01088048|541312768|FG007|Overall Study|Investigator Request|0|||
150047084|NCT01088048|541312769|FG008|Overall Study|Investigator Request|0|||
150047085|NCT01088048|541312770|FG009|Overall Study|Investigator Request|0|||
150047086|NCT01088048|541312761|FG000|Overall Study|Patient Non-compliance|0|||
150047087|NCT01088048|541312762|FG001|Overall Study|Patient Non-compliance|1|||
150047088|NCT01088048|541312763|FG002|Overall Study|Patient Non-compliance|0|||
150047089|NCT01088048|541312764|FG003|Overall Study|Patient Non-compliance|0|||
150047090|NCT01088048|541312765|FG004|Overall Study|Patient Non-compliance|0|||
150047091|NCT01088048|541312766|FG005|Overall Study|Patient Non-compliance|0|||
150047092|NCT01088048|541312767|FG006|Overall Study|Patient Non-compliance|0|||
150047093|NCT01088048|541312768|FG007|Overall Study|Patient Non-compliance|0|||
150047094|NCT01088048|541312769|FG008|Overall Study|Patient Non-compliance|0|||
150047095|NCT01088048|541312770|FG009|Overall Study|Patient Non-compliance|0|||
150047096|NCT01088048|541312761|FG000|Overall Study|Disease Progression|7|||
150047097|NCT01088048|541312762|FG001|Overall Study|Disease Progression|4|||
150047098|NCT01088048|541312763|FG002|Overall Study|Disease Progression|3|||
150047099|NCT01088048|541312764|FG003|Overall Study|Disease Progression|5|||
150047100|NCT01088048|541312765|FG004|Overall Study|Disease Progression|3|||
150047101|NCT01088048|541312766|FG005|Overall Study|Disease Progression|3|||
150047102|NCT01088048|541312767|FG006|Overall Study|Disease Progression|2|||
150047103|NCT01088048|541312768|FG007|Overall Study|Disease Progression|1|||
150047104|NCT01088048|541312769|FG008|Overall Study|Disease Progression|0|||
150047105|NCT01088048|541312770|FG009|Overall Study|Disease Progression|0|||
150047106|NCT01088048|541312761|FG000|Overall Study|Death|1|||
150047107|NCT01088048|541312762|FG001|Overall Study|Death|5|||
150047108|NCT01088048|541312763|FG002|Overall Study|Death|3|||
150047109|NCT01088048|541312764|FG003|Overall Study|Death|3|||
150047110|NCT01088048|541312765|FG004|Overall Study|Death|1|||
150047111|NCT01088048|541312766|FG005|Overall Study|Death|3|||
150047112|NCT01088048|541312767|FG006|Overall Study|Death|0|||
150047113|NCT01088048|541312768|FG007|Overall Study|Death|0|||
150047114|NCT01088048|541312769|FG008|Overall Study|Death|3|||
150047115|NCT01088048|541312770|FG009|Overall Study|Death|1|||
150047116|NCT01088048|541312761|FG000|Overall Study|Other|3|||
150047117|NCT01088048|541312762|FG001|Overall Study|Other|5|||
150047118|NCT01088048|541312763|FG002|Overall Study|Other|0|||
150047119|NCT01088048|541312764|FG003|Overall Study|Other|0|||
150047120|NCT01088048|541312765|FG004|Overall Study|Other|2|||
150047121|NCT01088048|541312766|FG005|Overall Study|Other|0|||
150047122|NCT01088048|541312767|FG006|Overall Study|Other|0|||
150047123|NCT01088048|541312768|FG007|Overall Study|Other|2|||
150047124|NCT01088048|541312769|FG008|Overall Study|Other|0|||
150047125|NCT01088048|541312770|FG009|Overall Study|Other|0|||
150047126|NCT01621802|541312771|FG000|Overall Study|Protocol Violation|0|||
150047127|NCT01621802|541312772|FG001|Overall Study|Protocol Violation|0|||
150047128|NCT01621802|541312773|FG002|Overall Study|Protocol Violation|0|||
150047129|NCT01621802|541312774|FG003|Overall Study|Protocol Violation|0|||
150047130|NCT01621802|541312775|FG004|Overall Study|Protocol Violation|0|||
150047131|NCT01621802|541312776|FG005|Overall Study|Protocol Violation|1|||
150047132|NCT01621802|541312771|FG000|Overall Study|Withdrawal by Subject|8|||
150047133|NCT01621802|541312772|FG001|Overall Study|Withdrawal by Subject|4|||
150047134|NCT01621802|541312773|FG002|Overall Study|Withdrawal by Subject|4|||
150047135|NCT01621802|541312774|FG003|Overall Study|Withdrawal by Subject|2|||
150047136|NCT01621802|541312775|FG004|Overall Study|Withdrawal by Subject|2|||
150047137|NCT01621802|541312776|FG005|Overall Study|Withdrawal by Subject|0|||
150047138|NCT01621802|541312771|FG000|Overall Study|Migrated/moved from study area|0|||
150047139|NCT01621802|541312772|FG001|Overall Study|Migrated/moved from study area|0|||
150047140|NCT01621802|541312773|FG002|Overall Study|Migrated/moved from study area|2|||
150047141|NCT01621802|541312774|FG003|Overall Study|Migrated/moved from study area|0|||
150047142|NCT01621802|541312775|FG004|Overall Study|Migrated/moved from study area|1|||
150047143|NCT01621802|541312776|FG005|Overall Study|Migrated/moved from study area|0|||
150047144|NCT01621802|541312771|FG000|Overall Study|Others|3|||
150047145|NCT01621802|541312772|FG001|Overall Study|Others|3|||
150047146|NCT01621802|541312773|FG002|Overall Study|Others|3|||
150047147|NCT01621802|541312774|FG003|Overall Study|Others|2|||
150047148|NCT01621802|541312775|FG004|Overall Study|Others|1|||
150047149|NCT01621802|541312776|FG005|Overall Study|Others|0|||
150047150|NCT01621802|541312771|FG000|Overall Study|Lost to Follow-up|36|||
150047151|NCT01621802|541312772|FG001|Overall Study|Lost to Follow-up|16|||
150047152|NCT01621802|541312773|FG002|Overall Study|Lost to Follow-up|24|||
150047153|NCT01621802|541312774|FG003|Overall Study|Lost to Follow-up|7|||
150047154|NCT01621802|541312775|FG004|Overall Study|Lost to Follow-up|31|||
150047155|NCT01621802|541312776|FG005|Overall Study|Lost to Follow-up|11|||
150047156|NCT01149148|541312777|FG000|Overall Study|Lost to Follow-up|1|||
150047157|NCT01149148|541312778|FG001|Overall Study|Lost to Follow-up|2|||
150047158|NCT01149148|541312777|FG000|Overall Study|Death|1|||
150047159|NCT01149148|541312778|FG001|Overall Study|Death|0|||
150047160|NCT03436082|541312779|FG000|Overall Study|Did not undergo procedure|1|||
150047161|NCT03436082|541312780|FG001|Overall Study|Did not undergo procedure|0|||
150047162|NCT00950859|541312781|FG000|Overall Study|Adverse Event|3|||
150047163|NCT00950859|541312782|FG001|Overall Study|Adverse Event|3|||
150047164|NCT00950859|541312781|FG000|Overall Study|Insufficient Viral Load Response|12|||
150047165|NCT00950859|541312782|FG001|Overall Study|Insufficient Viral Load Response|3|||
150047166|NCT00950859|541312781|FG000|Overall Study|Protocol Violation|1|||
150047167|NCT00950859|541312782|FG001|Overall Study|Protocol Violation|1|||
150047168|NCT00950859|541312781|FG000|Overall Study|Lost to Follow-up|0|||
150047169|NCT00950859|541312782|FG001|Overall Study|Lost to Follow-up|3|||
150047170|NCT04896086|541312783|FG000|Overall Study|Lost to Follow-up|0|||
150047171|NCT04896086|541312784|FG001|Overall Study|Lost to Follow-up|2|||
150047172|NCT04896086|541312785|FG002|Overall Study|Lost to Follow-up|1|||
150047173|NCT04896086|541312786|FG003|Overall Study|Lost to Follow-up|0|||
150047174|NCT04896086|541312787|FG004|Overall Study|Lost to Follow-up|0|||
150047175|NCT04896086|541312783|FG000|Overall Study|Physician Decision|0|||
150047176|NCT04896086|541312784|FG001|Overall Study|Physician Decision|1|||
150047177|NCT04896086|541312785|FG002|Overall Study|Physician Decision|0|||
150047178|NCT04896086|541312786|FG003|Overall Study|Physician Decision|0|||
150047179|NCT04896086|541312787|FG004|Overall Study|Physician Decision|0|||
150047180|NCT04896086|541312783|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
150047181|NCT04896086|541312784|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
150176589|NCT02564744|541783328|FG003|Overall Study|Subject Withdrew Consent|0|||
150176590|NCT02564744|541783329|FG004|Overall Study|Subject Withdrew Consent|2|||
150176591|NCT02564744|541783325|FG000|Overall Study|Lost to Follow-up|0|||
150047182|NCT04896086|541312785|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
150047183|NCT04896086|541312786|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
150047184|NCT04896086|541312787|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
150047185|NCT04896086|541312783|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
150047186|NCT04896086|541312784|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
150047187|NCT04896086|541312785|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
150047188|NCT04896086|541312786|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
150047189|NCT04896086|541312787|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
150047190|NCT02249832|541312790|FG000|Overall Study|Withdrawal by Subject|3|||
150047191|NCT02249832|541312790|FG000|Overall Study|Lost to Follow-up|10|||
150047192|NCT00545272|541312794|FG000|Overall Study|Protocol deviation|0|||
150047193|NCT00545272|541312795|FG001|Overall Study|Protocol deviation|1|||
150176592|NCT02564744|541783326|FG001|Overall Study|Lost to Follow-up|1|||
149904655|NCT03693612|540783535|FG003|Overall Study|Lost to Follow-up|0|||
149904656|NCT03693612|540783536|FG004|Overall Study|Lost to Follow-up|1|||
149904657|NCT03693612|540783537|FG005|Overall Study|Lost to Follow-up|0|||
149904658|NCT03693612|540783538|FG006|Overall Study|Lost to Follow-up|0|||
149904659|NCT03693612|540783532|FG000|Overall Study|Withdrawal by Subject|0|||
149904660|NCT03693612|540783533|FG001|Overall Study|Withdrawal by Subject|0|||
149904661|NCT03693612|540783534|FG002|Overall Study|Withdrawal by Subject|1|||
149904662|NCT03693612|540783535|FG003|Overall Study|Withdrawal by Subject|0|||
149904663|NCT03693612|540783536|FG004|Overall Study|Withdrawal by Subject|2|||
149904664|NCT03693612|540783537|FG005|Overall Study|Withdrawal by Subject|0|||
149904665|NCT03693612|540783538|FG006|Overall Study|Withdrawal by Subject|0|||
149904666|NCT03693612|540783532|FG000|Overall Study|Study Terminated by Sponsor|0|||
149904667|NCT03693612|540783533|FG001|Overall Study|Study Terminated by Sponsor|1|||
149904668|NCT03693612|540783534|FG002|Overall Study|Study Terminated by Sponsor|0|||
149904669|NCT03693612|540783535|FG003|Overall Study|Study Terminated by Sponsor|0|||
149904670|NCT03693612|540783536|FG004|Overall Study|Study Terminated by Sponsor|3|||
149904671|NCT03693612|540783537|FG005|Overall Study|Study Terminated by Sponsor|0|||
149904672|NCT03693612|540783538|FG006|Overall Study|Study Terminated by Sponsor|0|||
149904673|NCT05318092|540783539|FG000|Overall Study|Lost to Follow-up|3|||
149904674|NCT05318092|540783539|FG000|Overall Study|Withdrawal by Subject|1|||
149904675|NCT01669174|540783546|FG000|Overall Study|Subject withdrew consent|2|||
149904676|NCT01669174|540783547|FG001|Overall Study|Subject withdrew consent|2|||
149904677|NCT01669174|540783546|FG000|Overall Study|Lost to Follow-up|1|||
149904678|NCT01669174|540783547|FG001|Overall Study|Lost to Follow-up|0|||
149904679|NCT01669174|540783546|FG000|Overall Study|Adverse Event|2|||
149904680|NCT01669174|540783547|FG001|Overall Study|Adverse Event|2|||
149904681|NCT01669174|540783546|FG000|Overall Study|Administrative problems|1|||
150047194|NCT00545272|541312796|FG002|Overall Study|Protocol deviation|0|||
149904682|NCT01669174|540783547|FG001|Overall Study|Administrative problems|2|||
149904683|NCT01953601|540783548|FG000|Part 1 (Base Study)|Adverse Event|24|||
149904684|NCT01953601|540783549|FG001|Part 1 (Base Study)|Adverse Event|37|||
149904685|NCT01953601|540783550|FG002|Part 1 (Base Study)|Adverse Event|15|||
149904686|NCT01953601|540783548|FG000|Part 1 (Base Study)|Death|2|||
149904687|NCT01953601|540783549|FG001|Part 1 (Base Study)|Death|0|||
149904688|NCT01953601|540783550|FG002|Part 1 (Base Study)|Death|3|||
149904689|NCT01953601|540783548|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
149904690|NCT01953601|540783549|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
149904691|NCT01953601|540783550|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
149904692|NCT01953601|540783548|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
149904693|NCT01953601|540783549|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
149904694|NCT01953601|540783550|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
149904695|NCT01953601|540783548|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
149904696|NCT01953601|540783549|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
149904697|NCT01953601|540783550|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
149904698|NCT01953601|540783548|FG000|Part 1 (Base Study)|Physician Decision|3|||
149904699|NCT01953601|540783549|FG001|Part 1 (Base Study)|Physician Decision|7|||
149904700|NCT01953601|540783550|FG002|Part 1 (Base Study)|Physician Decision|4|||
149904701|NCT01953601|540783548|FG000|Part 1 (Base Study)|Screen failure|1|||
149904702|NCT01953601|540783549|FG001|Part 1 (Base Study)|Screen failure|0|||
149904703|NCT01953601|540783550|FG002|Part 1 (Base Study)|Screen failure|1|||
149904704|NCT01953601|540783548|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
149904705|NCT01953601|540783549|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
149904706|NCT01953601|540783550|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
149904707|NCT01953601|540783548|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
149904708|NCT01953601|540783549|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
149904709|NCT01953601|540783550|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
149904710|NCT01953601|540783548|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
149904711|NCT01953601|540783549|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
149904712|NCT01953601|540783550|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
149904713|NCT01953601|540783548|FG000|Part 1 (Base Study)|Subject moved|2|||
149904714|NCT01953601|540783549|FG001|Part 1 (Base Study)|Subject moved|2|||
149904715|NCT01953601|540783550|FG002|Part 1 (Base Study)|Subject moved|1|||
149904716|NCT01953601|540783548|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
149904717|NCT01953601|540783549|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
149904718|NCT01953601|540783550|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
149904719|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Adverse Event|1|||
149904720|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Adverse Event|1|||
149904721|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Adverse Event|10|||
149904722|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Death|0|||
149904723|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Death|3|||
149904724|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Death|0|||
149904725|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
150047195|NCT00545272|541312797|FG003|Overall Study|Protocol deviation|1|||
149904726|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
149904727|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
150047196|NCT00545272|541312798|FG004|Overall Study|Protocol deviation|0|||
150047197|NCT00545272|541312799|FG005|Overall Study|Protocol deviation|1|||
150047198|NCT00545272|541312794|FG000|Overall Study|Adverse Event|0|||
150047199|NCT00545272|541312795|FG001|Overall Study|Adverse Event|0|||
150047200|NCT00545272|541312796|FG002|Overall Study|Adverse Event|1|||
150047201|NCT00545272|541312797|FG003|Overall Study|Adverse Event|0|||
150047202|NCT00545272|541312798|FG004|Overall Study|Adverse Event|0|||
150047203|NCT00545272|541312799|FG005|Overall Study|Adverse Event|1|||
150047204|NCT00545272|541312794|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150047205|NCT00545272|541312795|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150047206|NCT00545272|541312796|FG002|Overall Study|Abnormal laboratory value(s)|0|||
150047207|NCT00545272|541312797|FG003|Overall Study|Abnormal laboratory value(s)|0|||
150047208|NCT00545272|541312798|FG004|Overall Study|Abnormal laboratory value(s)|0|||
150047209|NCT00545272|541312799|FG005|Overall Study|Abnormal laboratory value(s)|1|||
150047210|NCT00545272|541312794|FG000|Overall Study|Abnormal test procedure result(s)|0|||
150047211|NCT00545272|541312795|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150047212|NCT00545272|541312796|FG002|Overall Study|Abnormal test procedure result(s)|0|||
150047213|NCT00545272|541312797|FG003|Overall Study|Abnormal test procedure result(s)|0|||
150047214|NCT00545272|541312798|FG004|Overall Study|Abnormal test procedure result(s)|1|||
150047215|NCT00545272|541312799|FG005|Overall Study|Abnormal test procedure result(s)|0|||
150047216|NCT00545272|541312794|FG000|Overall Study|Lost to Follow-up|0|||
150047217|NCT00545272|541312795|FG001|Overall Study|Lost to Follow-up|0|||
150047218|NCT00545272|541312796|FG002|Overall Study|Lost to Follow-up|0|||
150047219|NCT00545272|541312797|FG003|Overall Study|Lost to Follow-up|0|||
150047220|NCT00545272|541312798|FG004|Overall Study|Lost to Follow-up|1|||
150047221|NCT00545272|541312799|FG005|Overall Study|Lost to Follow-up|0|||
149904728|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
149904729|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
149904730|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
149904731|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Physician Decision|2|||
149904732|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Physician Decision|0|||
149904733|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Physician Decision|2|||
149904734|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
149904735|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
149904736|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
149904737|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
149904738|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
149904739|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
149904740|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
149904741|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
149904742|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
149904743|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Subject moved|0|||
149904744|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Subject moved|0|||
149904745|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Subject moved|1|||
149904746|NCT01953601|540783548|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
150047222|NCT00724867|541312800|FG000|Overall Study|Adverse Event|25|||
150047223|NCT00724867|541312800|FG000|Overall Study|Lack of Efficacy|14|||
150047224|NCT00724867|541312800|FG000|Overall Study|Lost to Follow-up|12|||
150047225|NCT00724867|541312800|FG000|Overall Study|Non-compliance with study drug|6|||
150047226|NCT00724867|541312800|FG000|Overall Study|Physician Decision|17|||
150047227|NCT00724867|541312800|FG000|Overall Study|Protocol Violation|1|||
150047228|NCT00724867|541312800|FG000|Overall Study|Withdrawal by Subject|31|||
149904747|NCT01953601|540783549|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
149904748|NCT01953601|540783550|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
150047229|NCT00724867|541312800|FG000|Overall Study|Sponsor decision to end study|14|||
150047230|NCT00724867|541312800|FG000|Overall Study|Subject incarcerated|1|||
150047231|NCT00724867|541312800|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
150047232|NCT00724867|541312800|FG000|Overall Study|Subject moved out of state|1|||
150047233|NCT00724867|541312800|FG000|Overall Study|Elected to exit due to site closure|2|||
150047234|NCT01175083|541312801|FG000|Primary Epoch|Withdrawal by Subject|0|||
149904749|NCT04310397|540783557|FG000|Overall Study|Lack of Efficacy|3|||
149904750|NCT04310397|540783557|FG000|Overall Study|Withdrawal by Subject|1|||
149904751|NCT00723255|540783560|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
149904752|NCT00723255|540783560|FG000|Overall Study|Ineligible: Second primary|1|||
150047235|NCT01175083|541312802|FG001|Primary Epoch|Withdrawal by Subject|0|||
150047236|NCT01175083|541312803|FG002|Primary Epoch|Withdrawal by Subject|0|||
150047237|NCT01175083|541312804|FG003|Primary Epoch|Withdrawal by Subject|0|||
150047238|NCT01175083|541312805|FG004|Primary Epoch|Withdrawal by Subject|0|||
150047239|NCT01175083|541312806|FG005|Primary Epoch|Withdrawal by Subject|2|||
150047240|NCT01175083|541312801|FG000|Primary Epoch|Lost to Follow-up|0|||
150047241|NCT01175083|541312802|FG001|Primary Epoch|Lost to Follow-up|0|||
150047242|NCT01175083|541312803|FG002|Primary Epoch|Lost to Follow-up|0|||
149904753|NCT00723255|540783560|FG000|Overall Study|Ineligible: Wrong Primary|2|||
150047243|NCT01175083|541312804|FG003|Primary Epoch|Lost to Follow-up|0|||
150047244|NCT01175083|541312805|FG004|Primary Epoch|Lost to Follow-up|0|||
150047245|NCT01175083|541312806|FG005|Primary Epoch|Lost to Follow-up|1|||
150047246|NCT01175083|541312801|FG000|Booster Epoch|Death|0|||
150047247|NCT01175083|541312802|FG001|Booster Epoch|Death|0|||
150047248|NCT01175083|541312803|FG002|Booster Epoch|Death|1|||
150047249|NCT01175083|541312804|FG003|Booster Epoch|Death|0|||
150047250|NCT01175083|541312805|FG004|Booster Epoch|Death|0|||
150047251|NCT01175083|541312806|FG005|Booster Epoch|Death|0|||
150047252|NCT01175083|541312801|FG000|Booster Epoch|Withdrawal by Subject|0|||
150047253|NCT01175083|541312802|FG001|Booster Epoch|Withdrawal by Subject|0|||
150047254|NCT01175083|541312803|FG002|Booster Epoch|Withdrawal by Subject|0|||
150047255|NCT01175083|541312804|FG003|Booster Epoch|Withdrawal by Subject|1|||
150047256|NCT01175083|541312805|FG004|Booster Epoch|Withdrawal by Subject|0|||
150047257|NCT01175083|541312806|FG005|Booster Epoch|Withdrawal by Subject|0|||
150047258|NCT04027608|541312807|FG000|Overall Study|Withdrawal by Subject|13|||
150047259|NCT04027608|541312808|FG001|Overall Study|Withdrawal by Subject|2|||
150047260|NCT04027608|541312807|FG000|Overall Study|Protocol Violation|2|||
150047261|NCT04027608|541312808|FG001|Overall Study|Protocol Violation|1|||
150047262|NCT04027608|541312807|FG000|Overall Study|Physician Decision|1|||
150047263|NCT04027608|541312808|FG001|Overall Study|Physician Decision|0|||
150047264|NCT04027608|541312807|FG000|Overall Study|Lost to Follow-up|20|||
150047265|NCT04027608|541312808|FG001|Overall Study|Lost to Follow-up|4|||
150047266|NCT04335136|541312813|FG000|Overall Study|Death|8|||
150047267|NCT04335136|541312814|FG001|Overall Study|Death|4|||
150047268|NCT04335136|541312813|FG000|Overall Study|Lost to Follow-up|2|||
149904754|NCT00614523|540783561|FG000|Overall Study|Adverse Event|4|||
150047269|NCT04335136|541312814|FG001|Overall Study|Lost to Follow-up|0|||
150047270|NCT04335136|541312813|FG000|Overall Study|Protocol Violation|1|||
150047271|NCT04335136|541312814|FG001|Overall Study|Protocol Violation|0|||
150047272|NCT04335136|541312813|FG000|Overall Study|Withdrawal by Subject|1|||
150047273|NCT04335136|541312814|FG001|Overall Study|Withdrawal by Subject|1|||
150047274|NCT04335136|541312813|FG000|Overall Study|Health-threatening condition|0|||
150047275|NCT04335136|541312814|FG001|Overall Study|Health-threatening condition|1|||
150047276|NCT04335136|541312813|FG000|Overall Study|Adverse Event|0|||
150047277|NCT04335136|541312814|FG001|Overall Study|Adverse Event|1|||
150047278|NCT04335136|541312813|FG000|Overall Study|Erroneously randomized|2|||
150047279|NCT04335136|541312814|FG001|Overall Study|Erroneously randomized|0|||
150047280|NCT00771953|541312815|FG000|Overall Study|Adverse Event|5|||
150047281|NCT00771953|541312816|FG001|Overall Study|Adverse Event|3|||
150047282|NCT00771953|541312815|FG000|Overall Study|Death|2|||
150047283|NCT00771953|541312816|FG001|Overall Study|Death|2|||
150047284|NCT00771953|541312815|FG000|Overall Study|Progression before active Tx|1|||
150047285|NCT00771953|541312816|FG001|Overall Study|Progression before active Tx|2|||
150047286|NCT00771953|541312815|FG000|Overall Study|Sponsor decision|1|||
150047287|NCT00771953|541312816|FG001|Overall Study|Sponsor decision|0|||
150047288|NCT00771953|541312815|FG000|Overall Study|Other complicating disease|1|||
150047289|NCT00771953|541312816|FG001|Overall Study|Other complicating disease|0|||
150047290|NCT00771953|541312815|FG000|Overall Study|Withdrawal by Subject|0|||
150047291|NCT00771953|541312816|FG001|Overall Study|Withdrawal by Subject|3|||
150047292|NCT00947193|541312819|FG000|Overall Study|Lost to Follow-up|1|||
150047293|NCT00947193|541312820|FG001|Overall Study|Lost to Follow-up|0|||
150047294|NCT00947193|541312819|FG000|Overall Study|Withdrawal by Subject|1|||
150047295|NCT00947193|541312820|FG001|Overall Study|Withdrawal by Subject|0|||
150047296|NCT00947193|541312819|FG000|Overall Study|Factor VIII >1%|1|||
150047297|NCT00947193|541312820|FG001|Overall Study|Factor VIII >1%|0|||
150047298|NCT04364984|541312821|FG000|Overall Study|Death|2|||
150047299|NCT04364984|541312822|FG001|Overall Study|Death|2|||
150047300|NCT04364984|541312823|FG002|Overall Study|Death|0|||
150047301|NCT01941186|541312824|FG000|Follow-up|Lost to Follow-up|1|||
150047302|NCT01941186|541312825|FG001|Follow-up|Lost to Follow-up|0|||
150047303|NCT02105961|541312826|FG000|Overall Study|Adverse Event|18|||
150047304|NCT02105961|541312827|FG001|Overall Study|Adverse Event|7|||
150047305|NCT02105961|541312828|FG002|Overall Study|Adverse Event|13|||
150047306|NCT02105961|541312826|FG000|Overall Study|Lack of Efficacy|3|||
150047307|NCT02105961|541312827|FG001|Overall Study|Lack of Efficacy|0|||
150047308|NCT02105961|541312828|FG002|Overall Study|Lack of Efficacy|3|||
150047309|NCT02105961|541312826|FG000|Overall Study|Lost to Follow-up|2|||
150047310|NCT02105961|541312827|FG001|Overall Study|Lost to Follow-up|0|||
150047311|NCT02105961|541312828|FG002|Overall Study|Lost to Follow-up|1|||
150047312|NCT02105961|541312826|FG000|Overall Study|Physician Decision|3|||
150047313|NCT02105961|541312827|FG001|Overall Study|Physician Decision|3|||
150047314|NCT02105961|541312828|FG002|Overall Study|Physician Decision|2|||
150047315|NCT02105961|541312826|FG000|Overall Study|Withdrawal by Subject|15|||
150047316|NCT02105961|541312827|FG001|Overall Study|Withdrawal by Subject|7|||
150047317|NCT02105961|541312828|FG002|Overall Study|Withdrawal by Subject|11|||
150047318|NCT03860259|541312829|FG000|Overall Study|Lost to Follow-up|5|||
150047319|NCT03860259|541312830|FG001|Overall Study|Lost to Follow-up|5|||
150047320|NCT03860259|541312829|FG000|Overall Study|Protocol Violation|1|||
149904755|NCT00614523|540783562|FG001|Overall Study|Adverse Event|20|||
149904756|NCT00614523|540783561|FG000|Overall Study|Death|5|||
149904757|NCT00614523|540783562|FG001|Overall Study|Death|8|||
149904758|NCT00614523|540783561|FG000|Overall Study|Lack of Efficacy|9|||
149904759|NCT00614523|540783562|FG001|Overall Study|Lack of Efficacy|11|||
149904760|NCT00614523|540783561|FG000|Overall Study|Lost to Follow-up|0|||
149904761|NCT00614523|540783562|FG001|Overall Study|Lost to Follow-up|1|||
149904762|NCT00614523|540783561|FG000|Overall Study|Protocol Violation|3|||
149904763|NCT00614523|540783562|FG001|Overall Study|Protocol Violation|2|||
149904764|NCT00614523|540783561|FG000|Overall Study|Withdrawal by Subject|12|||
149904765|NCT00614523|540783562|FG001|Overall Study|Withdrawal by Subject|22|||
149904766|NCT00614523|540783561|FG000|Overall Study|Other|6|||
149904767|NCT00614523|540783562|FG001|Overall Study|Other|11|||
149904768|NCT00614523|540783561|FG000|Overall Study|Ineligibility Determined|1|||
149904769|NCT00614523|540783562|FG001|Overall Study|Ineligibility Determined|2|||
149904770|NCT00614523|540783561|FG000|Overall Study|Disease Progression|0|||
149904771|NCT00614523|540783562|FG001|Overall Study|Disease Progression|8|||
149904772|NCT00614523|540783561|FG000|Overall Study|Administrative Decision|23|||
149904773|NCT00614523|540783562|FG001|Overall Study|Administrative Decision|46|||
149904774|NCT03962790|540783563|FG000|Period 1|Adverse Event|0|||
149904775|NCT03962790|540783564|FG001|Period 1|Adverse Event|1|||
149904776|NCT03962790|540783563|FG000|Period 1|Failed to meet all eligibility criteria|1|||
149904777|NCT03962790|540783564|FG001|Period 1|Failed to meet all eligibility criteria|1|||
149904778|NCT03962790|540783563|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
149904779|NCT03962790|540783564|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
149904780|NCT03962790|540783563|FG000|Period 1|Withdrawal by Subject|1|||
149904781|NCT03962790|540783564|FG001|Period 1|Withdrawal by Subject|0|||
149904782|NCT03854370|540783574|FG000|Overall Study|samples not collected|1|||
149904783|NCT03854370|540783575|FG001|Overall Study|samples not collected|1|||
149904784|NCT03854370|540783576|FG002|Overall Study|samples not collected|1|||
149904785|NCT03854370|540783577|FG003|Overall Study|samples not collected|1|||
149904786|NCT00452673|540783578|FG000|Dose Escalation Period|Disease Progression|6|||
149904787|NCT00452673|540783579|FG001|Dose Escalation Period|Disease Progression|6|||
149904788|NCT00452673|540783580|FG002|Dose Escalation Period|Disease Progression|2|||
149904789|NCT00452673|540783581|FG003|Dose Escalation Period|Disease Progression|6|||
149904790|NCT00452673|540783582|FG004|Dose Escalation Period|Disease Progression|0|||
149904791|NCT00452673|540783578|FG000|Dose Escalation Period|study drug toxicity|1|||
149904792|NCT00452673|540783579|FG001|Dose Escalation Period|study drug toxicity|3|||
149904793|NCT00452673|540783580|FG002|Dose Escalation Period|study drug toxicity|3|||
149904794|NCT00452673|540783581|FG003|Dose Escalation Period|study drug toxicity|1|||
149904795|NCT00452673|540783582|FG004|Dose Escalation Period|study drug toxicity|0|||
149904796|NCT00452673|540783578|FG000|Dose Escalation Period|Other|0|||
149904797|NCT00452673|540783579|FG001|Dose Escalation Period|Other|0|||
149904798|NCT00452673|540783580|FG002|Dose Escalation Period|Other|1|||
149904799|NCT00452673|540783581|FG003|Dose Escalation Period|Other|0|||
149904800|NCT00452673|540783582|FG004|Dose Escalation Period|Other|0|||
149904801|NCT00452673|540783578|FG000|Dose Escalation Period|Adverse Event|0|||
149904802|NCT00452673|540783579|FG001|Dose Escalation Period|Adverse Event|0|||
149904803|NCT00452673|540783580|FG002|Dose Escalation Period|Adverse Event|0|||
149904804|NCT00452673|540783581|FG003|Dose Escalation Period|Adverse Event|1|||
149904805|NCT00452673|540783582|FG004|Dose Escalation Period|Adverse Event|0|||
149904806|NCT00452673|540783578|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
149904807|NCT00452673|540783579|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
149904808|NCT00452673|540783580|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
149904809|NCT00452673|540783581|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
149904810|NCT00452673|540783582|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
149904811|NCT00452673|540783578|FG000|Dose Expansion Period|Disease Progression|0|||
149904812|NCT00452673|540783579|FG001|Dose Expansion Period|Disease Progression|0|||
149904813|NCT00452673|540783580|FG002|Dose Expansion Period|Disease Progression|0|||
149904814|NCT00452673|540783581|FG003|Dose Expansion Period|Disease Progression|0|||
149904815|NCT00452673|540783582|FG004|Dose Expansion Period|Disease Progression|19|||
149904816|NCT00452673|540783578|FG000|Dose Expansion Period|Other|0|||
149904817|NCT00452673|540783579|FG001|Dose Expansion Period|Other|0|||
149904818|NCT00452673|540783580|FG002|Dose Expansion Period|Other|0|||
149969884|NCT04795531|541028270|FG000|Overall Study|Withdrawal by Subject|4|||
149969885|NCT04795531|541028271|FG001|Overall Study|Withdrawal by Subject|4|||
149969886|NCT04795531|541028270|FG000|Overall Study|Lost to Follow-up|0|||
149969887|NCT04795531|541028271|FG001|Overall Study|Lost to Follow-up|1|||
149969888|NCT04795531|541028270|FG000|Overall Study|Physician Decision|0|||
149904819|NCT00452673|540783581|FG003|Dose Expansion Period|Other|0|||
149904820|NCT00452673|540783582|FG004|Dose Expansion Period|Other|2|||
149904821|NCT02656290|540783583|FG000|Overall Study|Lost to Follow-up|1|||
149904822|NCT02656290|540783583|FG000|Overall Study|Reintervention|3|||
149904823|NCT01608087|540783586|FG000|Overall Study|Lost to Follow-up|0|||
149904824|NCT01608087|540783587|FG001|Overall Study|Lost to Follow-up|1|||
149904825|NCT01608087|540783588|FG002|Overall Study|Lost to Follow-up|0|||
149969889|NCT04795531|541028271|FG001|Overall Study|Physician Decision|2|||
150047321|NCT03860259|541312830|FG001|Overall Study|Protocol Violation|0|||
150047322|NCT02283762|541312831|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
150047323|NCT02283762|541312832|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
150047324|NCT02283762|541312831|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
150047325|NCT02283762|541312832|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
150047326|NCT02283762|541312831|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
150047327|NCT02283762|541312832|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
150047328|NCT02283762|541312831|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
150047329|NCT02283762|541312832|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
150047330|NCT02283762|541312831|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
149904826|NCT01608087|540783586|FG000|Overall Study|Other Reason|0|||
149904827|NCT01608087|540783587|FG001|Overall Study|Other Reason|1|||
149904828|NCT01608087|540783588|FG002|Overall Study|Other Reason|0|||
149904829|NCT02461524|540783596|FG000|Overall Study|Death|16|||
149904830|NCT02461524|540783596|FG000|Overall Study|Withdrawal by Subject|4|||
150047331|NCT02283762|541312832|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
150047332|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
150047333|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
149904831|NCT02461524|540783596|FG000|Overall Study|Device Explanted|5|||
149904832|NCT02461524|540783596|FG000|Overall Study|Missed Visit|6|||
149904833|NCT01943851|540783600|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904834|NCT01943851|540783601|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904835|NCT01943851|540783602|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904836|NCT01943851|540783603|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
149904837|NCT01943851|540783604|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904838|NCT01943851|540783605|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904839|NCT01943851|540783606|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
149904840|NCT01943851|540783607|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
149904841|NCT01943851|540783608|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
149904842|NCT01943851|540783609|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904843|NCT01943851|540783610|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904844|NCT01943851|540783611|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904845|NCT01943851|540783612|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904846|NCT01943851|540783613|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904847|NCT01943851|540783614|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149969890|NCT04795531|541028270|FG000|Overall Study|Death|2|||
149969891|NCT04795531|541028271|FG001|Overall Study|Death|1|||
149969892|NCT04887831|541028272|FG000|Overall Study|Death|26|||
150047334|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
150047335|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
150047336|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
150047337|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
150047338|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
150047339|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
150047340|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
150047341|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
150047342|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
150047343|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
150047344|NCT02283762|541312831|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
150047345|NCT02283762|541312832|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
150047346|NCT02367833|541312833|FG000|Overall Study|Withdrawal by Subject|1|||
150047347|NCT02367833|541312834|FG001|Overall Study|Withdrawal by Subject|1|||
150047348|NCT02367833|541312835|FG002|Overall Study|Withdrawal by Subject|0|||
150047349|NCT00889720|541312838|FG000|Overall Study|Withdrawal by Subject|4|||
150047350|NCT00889720|541312838|FG000|Overall Study|Other|4|||
150176593|NCT02564744|541783327|FG002|Overall Study|Lost to Follow-up|0|||
149969893|NCT04887831|541028273|FG001|Overall Study|Death|26|||
149969894|NCT04887831|541028272|FG000|Overall Study|Lost to Follow-up|0|||
149969895|NCT04887831|541028273|FG001|Overall Study|Lost to Follow-up|1|||
149969896|NCT04887831|541028272|FG000|Overall Study|Withdrawal by Subject|2|||
149969897|NCT04887831|541028273|FG001|Overall Study|Withdrawal by Subject|1|||
149969898|NCT04887831|541028272|FG000|Overall Study|Study Terminated by Sponsor|18|||
149904848|NCT01943851|540783615|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904849|NCT01943851|540783616|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149969899|NCT04887831|541028273|FG001|Overall Study|Study Terminated by Sponsor|17|||
149969900|NCT04887831|541028272|FG000|Overall Study|Other|1|||
149969901|NCT04887831|541028273|FG001|Overall Study|Other|0|||
149969902|NCT01323192|541028274|FG000|Overall Study|Adverse Event|6|||
149969903|NCT01323192|541028275|FG001|Overall Study|Adverse Event|1|||
150047351|NCT00775593|541312839|FG000|Overall Study|Unmet eligibility criteria|6|||
150047352|NCT00775593|541312839|FG000|Overall Study|Death|1|||
150047353|NCT02067676|541312840|FG000|Overall Study|Withdrawal by Subject|1|||
150047354|NCT02067676|541312841|FG001|Overall Study|Withdrawal by Subject|0|||
150047355|NCT02067676|541312842|FG002|Overall Study|Withdrawal by Subject|0|||
149904850|NCT01943851|540783617|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
149904851|NCT01943851|540783600|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904852|NCT01943851|540783601|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904853|NCT01943851|540783602|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904854|NCT01943851|540783603|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904855|NCT01943851|540783604|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
149904856|NCT01943851|540783605|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904857|NCT01943851|540783606|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904858|NCT01943851|540783607|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
149904859|NCT01943851|540783608|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904860|NCT01943851|540783609|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904861|NCT01943851|540783610|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904862|NCT01943851|540783611|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904863|NCT01943851|540783612|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904864|NCT01943851|540783613|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904865|NCT01943851|540783614|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904866|NCT01943851|540783615|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904867|NCT01943851|540783616|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904868|NCT01943851|540783617|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
149904869|NCT01943851|540783600|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904870|NCT01943851|540783601|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904871|NCT01943851|540783602|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904872|NCT01943851|540783603|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904873|NCT01943851|540783604|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904874|NCT01943851|540783605|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904875|NCT01943851|540783606|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904876|NCT01943851|540783607|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904877|NCT01943851|540783608|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904878|NCT01943851|540783609|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904879|NCT01943851|540783610|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904880|NCT01943851|540783611|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904881|NCT01943851|540783612|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904882|NCT01943851|540783613|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
149904883|NCT01943851|540783614|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904884|NCT01943851|540783615|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904885|NCT01943851|540783616|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904886|NCT01943851|540783617|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
149904887|NCT01943851|540783600|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904888|NCT01943851|540783601|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904889|NCT01943851|540783602|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904890|NCT01943851|540783603|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904891|NCT01943851|540783604|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904892|NCT01943851|540783605|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904893|NCT01943851|540783606|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904894|NCT01943851|540783607|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904895|NCT01943851|540783608|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904896|NCT01943851|540783609|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904897|NCT01943851|540783610|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904898|NCT01943851|540783611|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904899|NCT01943851|540783612|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904900|NCT01943851|540783613|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904901|NCT01943851|540783614|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904902|NCT01943851|540783615|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
149904903|NCT01943851|540783616|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904904|NCT01943851|540783617|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
149904905|NCT01943851|540783600|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904906|NCT01943851|540783601|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904907|NCT01943851|540783602|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904908|NCT01943851|540783603|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904909|NCT01943851|540783604|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904910|NCT01943851|540783605|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904911|NCT01943851|540783606|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904912|NCT01943851|540783607|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904913|NCT01943851|540783608|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904914|NCT01943851|540783609|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149969904|NCT01323192|541028274|FG000|Overall Study|Withdrawal by Subject|3|||
149904915|NCT01943851|540783610|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904916|NCT01943851|540783611|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149969905|NCT01323192|541028275|FG001|Overall Study|Withdrawal by Subject|1|||
150176594|NCT02564744|541783328|FG003|Overall Study|Lost to Follow-up|0|||
149904917|NCT01943851|540783612|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904918|NCT01943851|540783613|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904919|NCT01943851|540783614|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
149904920|NCT01943851|540783615|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
149904921|NCT01943851|540783616|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
149904922|NCT01943851|540783617|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
149904923|NCT00381238|540783624|FG000|Overall Study|Adverse Event|3|||
149904924|NCT00381238|540783624|FG000|Overall Study|Protocol Violation|1|||
149904925|NCT00381238|540783624|FG000|Overall Study|Withdrawal by Subject|4|||
149904926|NCT00381238|540783624|FG000|Overall Study|Lack of Efficacy|2|||
149904927|NCT00381238|540783624|FG000|Overall Study|Withdrew by physician|1|||
149904928|NCT00381238|540783624|FG000|Overall Study|Disease progression|1|||
149904929|NCT00843037|540783625|FG000|Overall Study|Lost to Follow-up|1|||
149904930|NCT04984278|540783626|FG000|Period 1|Withdrawal by Subject|1|||
149904931|NCT04984278|540783627|FG001|Period 1|Withdrawal by Subject|0|||
149904932|NCT04984278|540783626|FG000|Period 1|Other|0|||
149904933|NCT04984278|540783627|FG001|Period 1|Other|1|||
149904934|NCT04984278|540783626|FG000|Period 2|Adverse Event|1|||
149969906|NCT01323192|541028274|FG000|Overall Study|Noncompliance with study medication|0|||
149969907|NCT01323192|541028275|FG001|Overall Study|Noncompliance with study medication|3|||
149969908|NCT01323192|541028274|FG000|Overall Study|Nonmedical reasons|0|||
149969909|NCT01323192|541028275|FG001|Overall Study|Nonmedical reasons|1|||
149969910|NCT03396445|541028276|FG000|Treatment Period|Death|2|||
149969911|NCT03396445|541028277|FG001|Treatment Period|Death|2|||
149969912|NCT03396445|541028278|FG002|Treatment Period|Death|1|||
149969913|NCT03396445|541028279|FG003|Treatment Period|Death|1|||
149969914|NCT03396445|541028280|FG004|Treatment Period|Death|3|||
149969915|NCT03396445|541028281|FG005|Treatment Period|Death|2|||
149969916|NCT03396445|541028282|FG006|Treatment Period|Death|5|||
149969917|NCT03396445|541028283|FG007|Treatment Period|Death|3|||
149969918|NCT03396445|541028284|FG008|Treatment Period|Death|3|||
149969919|NCT03396445|541028285|FG009|Treatment Period|Death|3|||
149969920|NCT03396445|541028286|FG010|Treatment Period|Death|7|||
149969921|NCT03396445|541028287|FG011|Treatment Period|Death|12|||
149969922|NCT03396445|541028288|FG012|Treatment Period|Death|28|||
149969923|NCT03396445|541028289|FG013|Treatment Period|Death|14|||
149969924|NCT03396445|541028290|FG014|Treatment Period|Death|10|||
149969925|NCT03396445|541028291|FG015|Treatment Period|Death|8|||
149969926|NCT03396445|541028292|FG016|Treatment Period|Death|18|||
149969927|NCT03396445|541028293|FG017|Treatment Period|Death|0|||
149969928|NCT03396445|541028294|FG018|Treatment Period|Death|0|||
149969929|NCT03396445|541028295|FG019|Treatment Period|Death|0|||
149969930|NCT03396445|541028296|FG020|Treatment Period|Death|0|||
149969931|NCT03396445|541028297|FG021|Treatment Period|Death|0|||
149969932|NCT03396445|541028298|FG022|Treatment Period|Death|0|||
149969933|NCT03396445|541028299|FG023|Treatment Period|Death|0|||
149969934|NCT03396445|541028300|FG024|Treatment Period|Death|0|||
149969935|NCT03396445|541028301|FG025|Treatment Period|Death|0|||
149969936|NCT03396445|541028276|FG000|Treatment Period|Lost to Follow-up|0|||
149969937|NCT03396445|541028277|FG001|Treatment Period|Lost to Follow-up|0|||
149969938|NCT03396445|541028278|FG002|Treatment Period|Lost to Follow-up|0|||
149969939|NCT03396445|541028279|FG003|Treatment Period|Lost to Follow-up|0|||
149969940|NCT03396445|541028280|FG004|Treatment Period|Lost to Follow-up|0|||
149969941|NCT03396445|541028281|FG005|Treatment Period|Lost to Follow-up|0|||
149969942|NCT03396445|541028282|FG006|Treatment Period|Lost to Follow-up|0|||
149969943|NCT03396445|541028283|FG007|Treatment Period|Lost to Follow-up|0|||
149969944|NCT03396445|541028284|FG008|Treatment Period|Lost to Follow-up|0|||
149969945|NCT03396445|541028285|FG009|Treatment Period|Lost to Follow-up|0|||
149969946|NCT03396445|541028286|FG010|Treatment Period|Lost to Follow-up|0|||
149904935|NCT04984278|540783627|FG001|Period 2|Adverse Event|0|||
149904936|NCT04984278|540783626|FG000|Period 2|Other|0|||
149904937|NCT04984278|540783627|FG001|Period 2|Other|1|||
149969947|NCT03396445|541028287|FG011|Treatment Period|Lost to Follow-up|0|||
149969948|NCT03396445|541028288|FG012|Treatment Period|Lost to Follow-up|1|||
149969949|NCT03396445|541028289|FG013|Treatment Period|Lost to Follow-up|0|||
149904938|NCT03535194|540783628|FG000|Induction Period|Adverse Event|2|||
149969950|NCT03396445|541028290|FG014|Treatment Period|Lost to Follow-up|1|||
150047356|NCT02067676|541312843|FG003|Overall Study|Withdrawal by Subject|0|||
149904939|NCT03535194|540783629|FG001|Induction Period|Adverse Event|2|||
149904940|NCT03535194|540783630|FG002|Induction Period|Adverse Event|1|||
149904941|NCT03535194|540783631|FG003|Induction Period|Adverse Event|3|||
149904942|NCT03535194|540783632|FG004|Induction Period|Adverse Event|0|||
149904943|NCT03535194|540783628|FG000|Induction Period|Death|0|||
149904944|NCT03535194|540783629|FG001|Induction Period|Death|1|||
149904945|NCT03535194|540783630|FG002|Induction Period|Death|0|||
149969951|NCT03396445|541028291|FG015|Treatment Period|Lost to Follow-up|0|||
149969952|NCT03396445|541028292|FG016|Treatment Period|Lost to Follow-up|0|||
149969953|NCT03396445|541028293|FG017|Treatment Period|Lost to Follow-up|0|||
149969954|NCT03396445|541028294|FG018|Treatment Period|Lost to Follow-up|0|||
149969955|NCT03396445|541028295|FG019|Treatment Period|Lost to Follow-up|0|||
149969956|NCT03396445|541028296|FG020|Treatment Period|Lost to Follow-up|0|||
149904946|NCT03535194|540783631|FG003|Induction Period|Death|0|||
149904947|NCT03535194|540783632|FG004|Induction Period|Death|0|||
149904948|NCT03535194|540783628|FG000|Induction Period|Lack of Efficacy|1|||
149904949|NCT03535194|540783629|FG001|Induction Period|Lack of Efficacy|3|||
149904950|NCT03535194|540783630|FG002|Induction Period|Lack of Efficacy|2|||
149904951|NCT03535194|540783631|FG003|Induction Period|Lack of Efficacy|2|||
149904952|NCT03535194|540783632|FG004|Induction Period|Lack of Efficacy|0|||
149904953|NCT03535194|540783628|FG000|Induction Period|Lost to Follow-up|3|||
149904954|NCT03535194|540783629|FG001|Induction Period|Lost to Follow-up|5|||
149904955|NCT03535194|540783630|FG002|Induction Period|Lost to Follow-up|2|||
149904956|NCT03535194|540783631|FG003|Induction Period|Lost to Follow-up|3|||
149904957|NCT03535194|540783632|FG004|Induction Period|Lost to Follow-up|0|||
149904958|NCT03535194|540783628|FG000|Induction Period|Physician Decision|1|||
149904959|NCT03535194|540783629|FG001|Induction Period|Physician Decision|1|||
149904960|NCT03535194|540783630|FG002|Induction Period|Physician Decision|0|||
149904961|NCT03535194|540783631|FG003|Induction Period|Physician Decision|0|||
149904962|NCT03535194|540783632|FG004|Induction Period|Physician Decision|0|||
149904963|NCT03535194|540783628|FG000|Induction Period|Protocol Violation|1|||
149904964|NCT03535194|540783629|FG001|Induction Period|Protocol Violation|0|||
149969957|NCT03396445|541028297|FG021|Treatment Period|Lost to Follow-up|0|||
149969958|NCT03396445|541028298|FG022|Treatment Period|Lost to Follow-up|0|||
149969959|NCT03396445|541028299|FG023|Treatment Period|Lost to Follow-up|0|||
149969960|NCT03396445|541028300|FG024|Treatment Period|Lost to Follow-up|0|||
149969961|NCT03396445|541028301|FG025|Treatment Period|Lost to Follow-up|0|||
149969962|NCT03396445|541028276|FG000|Treatment Period|Physician Decision|0|||
149969963|NCT03396445|541028277|FG001|Treatment Period|Physician Decision|0|||
149969964|NCT03396445|541028278|FG002|Treatment Period|Physician Decision|0|||
149969965|NCT03396445|541028279|FG003|Treatment Period|Physician Decision|0|||
149969966|NCT03396445|541028280|FG004|Treatment Period|Physician Decision|1|||
149969967|NCT03396445|541028281|FG005|Treatment Period|Physician Decision|0|||
149969968|NCT03396445|541028282|FG006|Treatment Period|Physician Decision|0|||
149969969|NCT03396445|541028283|FG007|Treatment Period|Physician Decision|0|||
149969970|NCT03396445|541028284|FG008|Treatment Period|Physician Decision|0|||
149969971|NCT03396445|541028285|FG009|Treatment Period|Physician Decision|1|||
149969972|NCT03396445|541028286|FG010|Treatment Period|Physician Decision|0|||
149969973|NCT03396445|541028287|FG011|Treatment Period|Physician Decision|0|||
149969974|NCT03396445|541028288|FG012|Treatment Period|Physician Decision|0|||
149969975|NCT03396445|541028289|FG013|Treatment Period|Physician Decision|0|||
149969976|NCT03396445|541028290|FG014|Treatment Period|Physician Decision|0|||
149969977|NCT03396445|541028291|FG015|Treatment Period|Physician Decision|0|||
149969978|NCT03396445|541028292|FG016|Treatment Period|Physician Decision|0|||
149969979|NCT03396445|541028293|FG017|Treatment Period|Physician Decision|0|||
149969980|NCT03396445|541028294|FG018|Treatment Period|Physician Decision|0|||
149969981|NCT03396445|541028295|FG019|Treatment Period|Physician Decision|0|||
149969982|NCT03396445|541028296|FG020|Treatment Period|Physician Decision|0|||
149969983|NCT03396445|541028297|FG021|Treatment Period|Physician Decision|0|||
149969984|NCT03396445|541028298|FG022|Treatment Period|Physician Decision|0|||
149969985|NCT03396445|541028299|FG023|Treatment Period|Physician Decision|0|||
149969986|NCT03396445|541028300|FG024|Treatment Period|Physician Decision|0|||
149969987|NCT03396445|541028301|FG025|Treatment Period|Physician Decision|0|||
149969988|NCT03396445|541028276|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969989|NCT03396445|541028277|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969990|NCT03396445|541028278|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969991|NCT03396445|541028279|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969992|NCT03396445|541028280|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969993|NCT03396445|541028281|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969994|NCT03396445|541028282|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969995|NCT03396445|541028283|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969996|NCT03396445|541028284|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969997|NCT03396445|541028285|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969998|NCT03396445|541028286|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149969999|NCT03396445|541028287|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970000|NCT03396445|541028288|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
149970001|NCT03396445|541028289|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970002|NCT03396445|541028290|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
149970003|NCT03396445|541028291|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970004|NCT03396445|541028292|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970005|NCT03396445|541028293|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149904965|NCT03535194|540783630|FG002|Induction Period|Protocol Violation|0|||
149904966|NCT03535194|540783631|FG003|Induction Period|Protocol Violation|1|||
149904967|NCT03535194|540783632|FG004|Induction Period|Protocol Violation|0|||
149904968|NCT03535194|540783628|FG000|Induction Period|Screen Failure|0|||
150047357|NCT02067676|541312844|FG004|Overall Study|Withdrawal by Subject|0|||
150047358|NCT02067676|541312845|FG005|Overall Study|Withdrawal by Subject|0|||
150047359|NCT00996333|541312846|FG000|Overall Study|Screen failure|1|||
150047360|NCT00996333|541312846|FG000|Overall Study|Withdrawal by Subject|1|||
150047361|NCT00996333|541312846|FG000|Overall Study|Death|4|||
150047362|NCT00996333|541312846|FG000|Overall Study|Adverse Event|1|||
150047363|NCT00996333|541312846|FG000|Overall Study|Physician Decision|1|||
150047364|NCT00996333|541312846|FG000|Overall Study|Other|5|||
150047365|NCT01327482|541312847|FG000|Overall Study|Adverse Event|1|||
150047366|NCT00476229|541312848|FG000|Overall Study|Progressive shortness of breath|1|||
150047367|NCT02164461|541312849|FG000|Overall Study|Adverse Event|0|||
150047368|NCT02164461|541312850|FG001|Overall Study|Adverse Event|0|||
150047369|NCT02164461|541312851|FG002|Overall Study|Adverse Event|1|||
150047370|NCT02164461|541312849|FG000|Overall Study|Disease Progression|1|||
150047371|NCT02164461|541312850|FG001|Overall Study|Disease Progression|3|||
150047372|NCT02164461|541312851|FG002|Overall Study|Disease Progression|4|||
150047373|NCT02164461|541312849|FG000|Overall Study|Withdrawal by Subject|0|||
150047374|NCT02164461|541312850|FG001|Overall Study|Withdrawal by Subject|3|||
150176595|NCT02564744|541783329|FG004|Overall Study|Lost to Follow-up|1|||
149904969|NCT03535194|540783629|FG001|Induction Period|Screen Failure|1|||
149904970|NCT03535194|540783630|FG002|Induction Period|Screen Failure|0|||
149904971|NCT03535194|540783631|FG003|Induction Period|Screen Failure|0|||
149904972|NCT03535194|540783632|FG004|Induction Period|Screen Failure|0|||
149904973|NCT03535194|540783628|FG000|Induction Period|Withdrawal by Subject|3|||
149904974|NCT03535194|540783629|FG001|Induction Period|Withdrawal by Subject|4|||
149904975|NCT03535194|540783630|FG002|Induction Period|Withdrawal by Subject|3|||
149904976|NCT03535194|540783631|FG003|Induction Period|Withdrawal by Subject|2|||
149904977|NCT03535194|540783632|FG004|Induction Period|Withdrawal by Subject|0|||
149904978|NCT03535194|540783628|FG000|Maintenance Period|Adverse Event|6|||
149904979|NCT03535194|540783629|FG001|Maintenance Period|Adverse Event|5|||
149904980|NCT03535194|540783630|FG002|Maintenance Period|Adverse Event|1|||
149904981|NCT03535194|540783631|FG003|Maintenance Period|Adverse Event|11|||
149904982|NCT03535194|540783632|FG004|Maintenance Period|Adverse Event|4|||
149904983|NCT03535194|540783628|FG000|Maintenance Period|Lack of Efficacy|3|||
149904984|NCT03535194|540783629|FG001|Maintenance Period|Lack of Efficacy|2|||
149904985|NCT03535194|540783630|FG002|Maintenance Period|Lack of Efficacy|5|||
149904986|NCT03535194|540783631|FG003|Maintenance Period|Lack of Efficacy|9|||
149904987|NCT03535194|540783632|FG004|Maintenance Period|Lack of Efficacy|0|||
149904988|NCT03535194|540783628|FG000|Maintenance Period|Lost to Follow-up|4|||
149904989|NCT03535194|540783629|FG001|Maintenance Period|Lost to Follow-up|2|||
149904990|NCT03535194|540783630|FG002|Maintenance Period|Lost to Follow-up|1|||
149904991|NCT03535194|540783631|FG003|Maintenance Period|Lost to Follow-up|5|||
149904992|NCT03535194|540783632|FG004|Maintenance Period|Lost to Follow-up|2|||
149904993|NCT03535194|540783628|FG000|Maintenance Period|Other|1|||
149904994|NCT03535194|540783629|FG001|Maintenance Period|Other|2|||
149904995|NCT03535194|540783630|FG002|Maintenance Period|Other|0|||
149904996|NCT03535194|540783631|FG003|Maintenance Period|Other|0|||
149904997|NCT03535194|540783632|FG004|Maintenance Period|Other|0|||
149904998|NCT03535194|540783628|FG000|Maintenance Period|Physician Decision|1|||
149904999|NCT03535194|540783629|FG001|Maintenance Period|Physician Decision|2|||
149905000|NCT03535194|540783630|FG002|Maintenance Period|Physician Decision|0|||
149905001|NCT03535194|540783631|FG003|Maintenance Period|Physician Decision|2|||
149905002|NCT03535194|540783632|FG004|Maintenance Period|Physician Decision|0|||
149905003|NCT03535194|540783628|FG000|Maintenance Period|Pregnancy|0|||
149905004|NCT03535194|540783629|FG001|Maintenance Period|Pregnancy|0|||
149905005|NCT03535194|540783630|FG002|Maintenance Period|Pregnancy|0|||
149905006|NCT03535194|540783631|FG003|Maintenance Period|Pregnancy|2|||
149905007|NCT03535194|540783632|FG004|Maintenance Period|Pregnancy|0|||
149905008|NCT03535194|540783628|FG000|Maintenance Period|Protocol Violation|0|||
149905009|NCT03535194|540783629|FG001|Maintenance Period|Protocol Violation|1|||
149905010|NCT03535194|540783630|FG002|Maintenance Period|Protocol Violation|0|||
149905011|NCT03535194|540783631|FG003|Maintenance Period|Protocol Violation|0|||
149905012|NCT03535194|540783632|FG004|Maintenance Period|Protocol Violation|0|||
149905013|NCT03535194|540783628|FG000|Maintenance Period|Withdrawal by Subject|7|||
149905014|NCT03535194|540783629|FG001|Maintenance Period|Withdrawal by Subject|2|||
150047375|NCT02164461|541312851|FG002|Overall Study|Withdrawal by Subject|0|||
150176596|NCT02564744|541783325|FG000|Overall Study|Reason not specified|1|||
150176597|NCT02564744|541783326|FG001|Overall Study|Reason not specified|0|||
150047376|NCT03865381|541312856|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
150176598|NCT02564744|541783327|FG002|Overall Study|Reason not specified|0|||
149905015|NCT03535194|540783630|FG002|Maintenance Period|Withdrawal by Subject|1|||
149905016|NCT03535194|540783631|FG003|Maintenance Period|Withdrawal by Subject|8|||
149905017|NCT03535194|540783632|FG004|Maintenance Period|Withdrawal by Subject|0|||
149905018|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Adverse Event|4|||
150047377|NCT03865381|541312856|FG000|Overall Study|Withdrawal by Subject|2|||
150047378|NCT04999852|541312857|FG000|Overall Study|Withdrawal by Subject|11|||
150047379|NCT04999852|541312858|FG001|Overall Study|Withdrawal by Subject|1|||
150176599|NCT02564744|541783328|FG003|Overall Study|Reason not specified|0|||
149905019|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Adverse Event|5|||
149905020|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Adverse Event|1|||
149905021|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Adverse Event|8|||
149905022|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Adverse Event|0|||
150176600|NCT02564744|541783329|FG004|Overall Study|Reason not specified|0|||
150176601|NCT01177670|541783334|FG000|Overall Study|Study Terminated|115|||
149905023|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
149905024|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
149905025|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
149905026|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
149905027|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
149905028|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
149905029|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
149905030|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
149905031|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
149905032|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
149970006|NCT03396445|541028294|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970007|NCT03396445|541028295|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970008|NCT03396445|541028296|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970009|NCT03396445|541028297|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970010|NCT03396445|541028298|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970011|NCT03396445|541028299|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970012|NCT03396445|541028300|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970013|NCT03396445|541028301|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149970014|NCT03396445|541028276|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
149970015|NCT03396445|541028277|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
149970016|NCT03396445|541028278|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
149970017|NCT03396445|541028279|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
149970018|NCT03396445|541028280|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
149970019|NCT03396445|541028281|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970020|NCT03396445|541028282|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
149970021|NCT03396445|541028283|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970022|NCT03396445|541028284|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970023|NCT03396445|541028285|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970024|NCT03396445|541028286|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970025|NCT03396445|541028287|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970026|NCT03396445|541028288|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970027|NCT03396445|541028289|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970028|NCT03396445|541028290|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970029|NCT03396445|541028291|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970030|NCT03396445|541028292|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970031|NCT03396445|541028293|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970032|NCT03396445|541028294|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970033|NCT03396445|541028295|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970034|NCT03396445|541028296|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970035|NCT03396445|541028297|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970036|NCT03396445|541028298|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970037|NCT03396445|541028299|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970038|NCT03396445|541028300|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970039|NCT03396445|541028301|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
149970040|NCT03396445|541028276|FG000|Treatment Period|Withdrawal by Subject|0|||
149970041|NCT03396445|541028277|FG001|Treatment Period|Withdrawal by Subject|0|||
149970042|NCT03396445|541028278|FG002|Treatment Period|Withdrawal by Subject|0|||
149970043|NCT03396445|541028279|FG003|Treatment Period|Withdrawal by Subject|0|||
150047380|NCT04999852|541312857|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
150047381|NCT04999852|541312858|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
149970044|NCT03396445|541028280|FG004|Treatment Period|Withdrawal by Subject|0|||
149970045|NCT03396445|541028281|FG005|Treatment Period|Withdrawal by Subject|0|||
149970046|NCT03396445|541028282|FG006|Treatment Period|Withdrawal by Subject|0|||
149970047|NCT03396445|541028283|FG007|Treatment Period|Withdrawal by Subject|0|||
149970048|NCT03396445|541028284|FG008|Treatment Period|Withdrawal by Subject|0|||
149970049|NCT03396445|541028285|FG009|Treatment Period|Withdrawal by Subject|0|||
149970050|NCT03396445|541028286|FG010|Treatment Period|Withdrawal by Subject|0|||
149970051|NCT03396445|541028287|FG011|Treatment Period|Withdrawal by Subject|0|||
149970052|NCT03396445|541028288|FG012|Treatment Period|Withdrawal by Subject|0|||
149970053|NCT03396445|541028289|FG013|Treatment Period|Withdrawal by Subject|0|||
149970054|NCT03396445|541028290|FG014|Treatment Period|Withdrawal by Subject|1|||
149970055|NCT03396445|541028291|FG015|Treatment Period|Withdrawal by Subject|0|||
149970056|NCT03396445|541028292|FG016|Treatment Period|Withdrawal by Subject|1|||
149970057|NCT03396445|541028293|FG017|Treatment Period|Withdrawal by Subject|0|||
149970058|NCT03396445|541028294|FG018|Treatment Period|Withdrawal by Subject|0|||
149970059|NCT03396445|541028295|FG019|Treatment Period|Withdrawal by Subject|0|||
149970060|NCT03396445|541028296|FG020|Treatment Period|Withdrawal by Subject|0|||
149970061|NCT03396445|541028297|FG021|Treatment Period|Withdrawal by Subject|0|||
149970062|NCT03396445|541028298|FG022|Treatment Period|Withdrawal by Subject|0|||
149970063|NCT03396445|541028299|FG023|Treatment Period|Withdrawal by Subject|0|||
149970064|NCT03396445|541028300|FG024|Treatment Period|Withdrawal by Subject|0|||
149970065|NCT03396445|541028301|FG025|Treatment Period|Withdrawal by Subject|0|||
149970066|NCT03396445|541028276|FG000|Switch-over Period|Death|0|||
149970067|NCT03396445|541028277|FG001|Switch-over Period|Death|0|||
149970068|NCT03396445|541028278|FG002|Switch-over Period|Death|0|||
149970069|NCT03396445|541028279|FG003|Switch-over Period|Death|0|||
149970070|NCT03396445|541028280|FG004|Switch-over Period|Death|0|||
149970071|NCT03396445|541028281|FG005|Switch-over Period|Death|0|||
149970072|NCT03396445|541028282|FG006|Switch-over Period|Death|0|||
149970073|NCT03396445|541028283|FG007|Switch-over Period|Death|0|||
149970074|NCT03396445|541028284|FG008|Switch-over Period|Death|0|||
149970075|NCT03396445|541028285|FG009|Switch-over Period|Death|0|||
149970076|NCT03396445|541028286|FG010|Switch-over Period|Death|0|||
149970077|NCT03396445|541028287|FG011|Switch-over Period|Death|0|||
149970078|NCT03396445|541028288|FG012|Switch-over Period|Death|0|||
149970079|NCT03396445|541028289|FG013|Switch-over Period|Death|0|||
149970080|NCT03396445|541028290|FG014|Switch-over Period|Death|0|||
149970081|NCT03396445|541028291|FG015|Switch-over Period|Death|0|||
149970082|NCT03396445|541028292|FG016|Switch-over Period|Death|0|||
149970083|NCT03396445|541028293|FG017|Switch-over Period|Death|0|||
149970084|NCT03396445|541028294|FG018|Switch-over Period|Death|1|||
149970085|NCT03396445|541028295|FG019|Switch-over Period|Death|2|||
149970086|NCT03396445|541028296|FG020|Switch-over Period|Death|2|||
149970087|NCT03396445|541028297|FG021|Switch-over Period|Death|1|||
149970088|NCT03396445|541028298|FG022|Switch-over Period|Death|2|||
149970089|NCT03396445|541028299|FG023|Switch-over Period|Death|0|||
149970090|NCT03396445|541028300|FG024|Switch-over Period|Death|1|||
149970091|NCT03396445|541028301|FG025|Switch-over Period|Death|6|||
149970092|NCT03396445|541028276|FG000|Switch-over Period|Lost to Follow-up|0|||
149970093|NCT03396445|541028277|FG001|Switch-over Period|Lost to Follow-up|0|||
149970094|NCT03396445|541028278|FG002|Switch-over Period|Lost to Follow-up|0|||
149970095|NCT03396445|541028279|FG003|Switch-over Period|Lost to Follow-up|0|||
149970096|NCT03396445|541028280|FG004|Switch-over Period|Lost to Follow-up|0|||
149970097|NCT03396445|541028281|FG005|Switch-over Period|Lost to Follow-up|0|||
149970098|NCT03396445|541028282|FG006|Switch-over Period|Lost to Follow-up|0|||
149970099|NCT03396445|541028283|FG007|Switch-over Period|Lost to Follow-up|0|||
149970100|NCT03396445|541028284|FG008|Switch-over Period|Lost to Follow-up|0|||
149970101|NCT03396445|541028285|FG009|Switch-over Period|Lost to Follow-up|0|||
149970102|NCT03396445|541028286|FG010|Switch-over Period|Lost to Follow-up|0|||
149970103|NCT03396445|541028287|FG011|Switch-over Period|Lost to Follow-up|0|||
149970104|NCT03396445|541028288|FG012|Switch-over Period|Lost to Follow-up|0|||
149970105|NCT03396445|541028289|FG013|Switch-over Period|Lost to Follow-up|0|||
149970106|NCT03396445|541028290|FG014|Switch-over Period|Lost to Follow-up|0|||
149970107|NCT03396445|541028291|FG015|Switch-over Period|Lost to Follow-up|0|||
150047382|NCT03776812|541312859|FG000|Overall Study|Death|53|||
150176602|NCT01177670|541783334|FG000|Overall Study|Physician Decision|50|||
149970108|NCT03396445|541028292|FG016|Switch-over Period|Lost to Follow-up|0|||
149970109|NCT03396445|541028293|FG017|Switch-over Period|Lost to Follow-up|0|||
149970110|NCT03396445|541028294|FG018|Switch-over Period|Lost to Follow-up|0|||
149970111|NCT03396445|541028295|FG019|Switch-over Period|Lost to Follow-up|0|||
149970112|NCT03396445|541028296|FG020|Switch-over Period|Lost to Follow-up|0|||
149970113|NCT03396445|541028297|FG021|Switch-over Period|Lost to Follow-up|0|||
149970114|NCT03396445|541028298|FG022|Switch-over Period|Lost to Follow-up|0|||
149970115|NCT03396445|541028299|FG023|Switch-over Period|Lost to Follow-up|1|||
149970116|NCT03396445|541028300|FG024|Switch-over Period|Lost to Follow-up|0|||
149970117|NCT03396445|541028301|FG025|Switch-over Period|Lost to Follow-up|0|||
149970118|NCT04622592|541028302|FG000|Overall Study|Death|0|||
149970119|NCT04622592|541028303|FG001|Overall Study|Death|0|||
149970120|NCT04622592|541028304|FG002|Overall Study|Death|1|||
150047383|NCT03776812|541312860|FG001|Overall Study|Death|49|||
149905033|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Other|1|||
149905034|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Other|0|||
149905035|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Other|0|||
149905036|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Other|5|||
149905037|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Other|0|||
149905038|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Physician Decision|0|||
149905039|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Physician Decision|2|||
149905040|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Physician Decision|1|||
149905041|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Physician Decision|1|||
149905042|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Physician Decision|0|||
149905043|NCT03535194|540783628|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
149905044|NCT03535194|540783629|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
149905045|NCT03535194|540783630|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
149905046|NCT03535194|540783631|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
149905047|NCT03535194|540783632|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
149905048|NCT01289639|540783635|FG000|Overall Study|Lost to Follow-up|1|||
149905049|NCT01289639|540783636|FG001|Overall Study|Lost to Follow-up|0|||
149905050|NCT01289639|540783637|FG002|Overall Study|Lost to Follow-up|0|||
149905051|NCT04967885|540783640|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
149905052|NCT04967885|540783641|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
149905053|NCT04967885|540783640|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
149905054|NCT04967885|540783641|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
149905055|NCT04967885|540783640|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
149905056|NCT04967885|540783641|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
149905057|NCT04967885|540783640|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
149905058|NCT04967885|540783641|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
149905059|NCT04967885|540783640|FG000|EMI-II Intervention|Lost to Follow-up|14|||
149905060|NCT04967885|540783641|FG001|EMI-II Intervention|Lost to Follow-up|10|||
149905061|NCT05835011|540783642|FG000|Overall Study|Study Terminated by the Sponsor|1|||
149905062|NCT05835011|540783642|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
149905063|NCT00941863|540783645|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
149905064|NCT00941863|540783646|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
149905065|NCT00941863|540783647|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
149905066|NCT00941863|540783648|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
149905067|NCT00941863|540783649|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
149905068|NCT00941863|540783645|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
149905069|NCT00941863|540783646|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
149905070|NCT00941863|540783647|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
149905071|NCT00941863|540783648|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
149905072|NCT00941863|540783649|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
149905073|NCT00941863|540783645|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
149905074|NCT00941863|540783646|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
149905075|NCT00941863|540783647|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
149905076|NCT00941863|540783648|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
149905077|NCT00941863|540783649|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
149905078|NCT00941863|540783645|FG000|Until Primary Completion Date (PCD)|Death|0|||
149905079|NCT00941863|540783646|FG001|Until Primary Completion Date (PCD)|Death|0|||
149905080|NCT00941863|540783647|FG002|Until Primary Completion Date (PCD)|Death|1|||
149905081|NCT00941863|540783648|FG003|Until Primary Completion Date (PCD)|Death|2|||
149905082|NCT00941863|540783649|FG004|Until Primary Completion Date (PCD)|Death|7|||
149905083|NCT00941863|540783645|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
149905084|NCT00941863|540783646|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
149905085|NCT00941863|540783647|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
149905086|NCT00941863|540783648|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
149905087|NCT00941863|540783649|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
149905088|NCT00941863|540783645|FG000|Continued After PCD|Withdrawal by Subject|0|||
149905089|NCT00941863|540783646|FG001|Continued After PCD|Withdrawal by Subject|0|||
149905090|NCT00941863|540783647|FG002|Continued After PCD|Withdrawal by Subject|0|||
149905091|NCT00941863|540783648|FG003|Continued After PCD|Withdrawal by Subject|0|||
149905092|NCT00941863|540783649|FG004|Continued After PCD|Withdrawal by Subject|1|||
149905093|NCT00941863|540783645|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
149905094|NCT00941863|540783646|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
149905095|NCT00941863|540783647|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
149905096|NCT00941863|540783648|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
149905097|NCT00941863|540783649|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
149970121|NCT04622592|541028305|FG003|Overall Study|Death|0|||
149970122|NCT04622592|541028306|FG004|Overall Study|Death|0|||
149970123|NCT04622592|541028307|FG005|Overall Study|Death|0|||
149970124|NCT04622592|541028308|FG006|Overall Study|Death|0|||
149970125|NCT04622592|541028309|FG007|Overall Study|Death|1|||
149970126|NCT04622592|541028302|FG000|Overall Study|Lost to Follow-up|0|||
150047384|NCT03776812|541312861|FG002|Overall Study|Death|56|||
150047385|NCT03776812|541312859|FG000|Overall Study|Withdrawal by Subject|1|||
150047386|NCT03776812|541312860|FG001|Overall Study|Withdrawal by Subject|7|||
150047387|NCT03776812|541312861|FG002|Overall Study|Withdrawal by Subject|2|||
150047388|NCT03776812|541312859|FG000|Overall Study|Lost to Follow-up|1|||
150047389|NCT03776812|541312860|FG001|Overall Study|Lost to Follow-up|1|||
150047390|NCT03776812|541312861|FG002|Overall Study|Lost to Follow-up|0|||
150047391|NCT03776812|541312859|FG000|Overall Study|Did not enter long-term follow-up|3|||
150047392|NCT03776812|541312860|FG001|Overall Study|Did not enter long-term follow-up|3|||
150047393|NCT03776812|541312861|FG002|Overall Study|Did not enter long-term follow-up|2|||
150047394|NCT04758637|541312864|FG000|Overall Study|Lost to Follow-up|0|||
150047395|NCT04758637|541312865|FG001|Overall Study|Lost to Follow-up|1|||
150047396|NCT04758637|541312866|FG002|Overall Study|Lost to Follow-up|0|||
150047397|NCT04758637|541312867|FG003|Overall Study|Lost to Follow-up|0|||
150047398|NCT03350672|541312870|FG000|Overall Study|Withdrawal by Subject|7|||
150047399|NCT03350672|541312871|FG001|Overall Study|Withdrawal by Subject|0|||
150047400|NCT03350672|541312872|FG002|Overall Study|Withdrawal by Subject|0|||
150047401|NCT00452361|541312873|FG000|Overall Study|Adverse Event|8|||
150047402|NCT00452361|541312874|FG001|Overall Study|Adverse Event|0|||
150047403|NCT00452361|541312873|FG000|Overall Study|Withdrawal by Subject|0|||
150047404|NCT00452361|541312874|FG001|Overall Study|Withdrawal by Subject|1|||
150047405|NCT00452361|541312873|FG000|Overall Study|Premature termination|13|||
150047406|NCT00452361|541312874|FG001|Overall Study|Premature termination|9|||
150047407|NCT01668589|541312877|FG000|Overall Study|Lost to Follow-up|29|||
150047408|NCT01668589|541312878|FG001|Overall Study|Lost to Follow-up|37|||
150176603|NCT01177670|541783334|FG000|Overall Study|Withdrawal by Subject|4|||
150176604|NCT02918279|541783343|FG000|Overall Study|Lost to Follow-up|3|||
150176605|NCT02918279|541783344|FG001|Overall Study|Lost to Follow-up|6|||
150176606|NCT02918279|541783343|FG000|Overall Study|Withdrawal by Subject|5|||
150176607|NCT02918279|541783344|FG001|Overall Study|Withdrawal by Subject|15|||
150176608|NCT02918279|541783343|FG000|Overall Study|Withdrawal by parent/guardian|2|||
150176609|NCT02918279|541783344|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150176610|NCT02918279|541783343|FG000|Overall Study|Other|3|||
150176611|NCT02918279|541783344|FG001|Overall Study|Other|1|||
150176612|NCT00309907|541783345|FG000|Overall Study|Death|4|||
150176613|NCT00309907|541783345|FG000|Overall Study|Physician Decision|1|||
150176614|NCT00309907|541783345|FG000|Overall Study|Ineligible|11|||
150176615|NCT00309907|541783345|FG000|Overall Study|Major infectious event|4|||
150176616|NCT00869258|541783346|FG000|Overall Study|Physician Decision|1|||
150176617|NCT00636207|541783347|FG000|Overall Study|Adverse Event|1|||
150176618|NCT00636207|541783348|FG001|Overall Study|Adverse Event|0|||
150176619|NCT00636207|541783349|FG002|Overall Study|Adverse Event|0|||
150176620|NCT00636207|541783350|FG003|Overall Study|Adverse Event|0|||
150176621|NCT00636207|541783351|FG004|Overall Study|Adverse Event|0|||
150176622|NCT00636207|541783352|FG005|Overall Study|Adverse Event|0|||
150176623|NCT00636207|541783353|FG006|Overall Study|Adverse Event|0|||
150176624|NCT00636207|541783347|FG000|Overall Study|Withdrawal by Subject|0|||
150176625|NCT00636207|541783348|FG001|Overall Study|Withdrawal by Subject|1|||
150176626|NCT00636207|541783349|FG002|Overall Study|Withdrawal by Subject|0|||
150176627|NCT00636207|541783350|FG003|Overall Study|Withdrawal by Subject|0|||
150176628|NCT00636207|541783351|FG004|Overall Study|Withdrawal by Subject|1|||
150176629|NCT00636207|541783352|FG005|Overall Study|Withdrawal by Subject|0|||
150176630|NCT00636207|541783353|FG006|Overall Study|Withdrawal by Subject|0|||
150176631|NCT02888080|541783354|FG000|Overall Study|Subject / Guardian decision|1|||
150176632|NCT02888080|541783355|FG001|Overall Study|Subject / Guardian decision|3|||
150176633|NCT02888080|541783354|FG000|Overall Study|New Therapy for study indication|1|||
150176634|NCT02888080|541783355|FG001|Overall Study|New Therapy for study indication|0|||
149905098|NCT01867710|540783655|FG000|Overall Study|Death|25|||
150047409|NCT01668589|541312879|FG002|Overall Study|Lost to Follow-up|15|||
150047410|NCT01668589|541312880|FG003|Overall Study|Lost to Follow-up|5|||
150047411|NCT01668589|541312877|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
150047412|NCT01668589|541312878|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
150047413|NCT01668589|541312879|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
150176635|NCT02888080|541783354|FG000|Overall Study|Lack of Efficacy|0|||
150176636|NCT02888080|541783355|FG001|Overall Study|Lack of Efficacy|1|||
150176637|NCT02888080|541783354|FG000|Overall Study|Adverse Event|0|||
150176638|NCT02888080|541783355|FG001|Overall Study|Adverse Event|1|||
150047414|NCT01668589|541312880|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
150047415|NCT01668589|541312877|FG000|Overall Study|Death|12|||
150047416|NCT01668589|541312878|FG001|Overall Study|Death|3|||
150047417|NCT01668589|541312879|FG002|Overall Study|Death|2|||
150047418|NCT01668589|541312880|FG003|Overall Study|Death|11|||
150047419|NCT01668589|541312877|FG000|Overall Study|Other|44|||
150047420|NCT01668589|541312878|FG001|Overall Study|Other|10|||
150176639|NCT01641198|541783356|FG000|After 12 Months of Function|Lost to Follow-up|3|||
150176640|NCT01641198|541783357|FG001|After 12 Months of Function|Lost to Follow-up|2|||
150176641|NCT01641198|541783358|FG002|After 12 Months of Function|Lost to Follow-up|2|||
150176642|NCT01641198|541783356|FG000|After 12 Months of Function|Protocol Violation|1|||
150047421|NCT01668589|541312879|FG002|Overall Study|Other|7|||
150047422|NCT01668589|541312880|FG003|Overall Study|Other|15|||
150047423|NCT01120964|541312881|FG000|Overall Study|Did not receive full treatment|1|||
150047424|NCT01120964|541312882|FG001|Overall Study|Did not receive full treatment|0|||
150047425|NCT04198714|541312883|FG000|Overall Study|Physician Decision|0|||
149970127|NCT04622592|541028303|FG001|Overall Study|Lost to Follow-up|0|||
149970128|NCT04622592|541028304|FG002|Overall Study|Lost to Follow-up|0|||
149970129|NCT04622592|541028305|FG003|Overall Study|Lost to Follow-up|3|||
149970130|NCT04622592|541028306|FG004|Overall Study|Lost to Follow-up|1|||
149970131|NCT04622592|541028307|FG005|Overall Study|Lost to Follow-up|0|||
149970132|NCT04622592|541028308|FG006|Overall Study|Lost to Follow-up|2|||
149970133|NCT04622592|541028309|FG007|Overall Study|Lost to Follow-up|2|||
149970134|NCT04622592|541028302|FG000|Overall Study|Physician Decision|0|||
149970135|NCT04622592|541028303|FG001|Overall Study|Physician Decision|0|||
149970136|NCT04622592|541028304|FG002|Overall Study|Physician Decision|0|||
149970137|NCT04622592|541028305|FG003|Overall Study|Physician Decision|0|||
149970138|NCT04622592|541028306|FG004|Overall Study|Physician Decision|1|||
149970139|NCT04622592|541028307|FG005|Overall Study|Physician Decision|0|||
149970140|NCT04622592|541028308|FG006|Overall Study|Physician Decision|0|||
149970141|NCT04622592|541028309|FG007|Overall Study|Physician Decision|0|||
149970142|NCT04622592|541028302|FG000|Overall Study|Withdrawal by Subject|1|||
149970143|NCT04622592|541028303|FG001|Overall Study|Withdrawal by Subject|0|||
149970144|NCT04622592|541028304|FG002|Overall Study|Withdrawal by Subject|2|||
149970145|NCT04622592|541028305|FG003|Overall Study|Withdrawal by Subject|0|||
149970146|NCT04622592|541028306|FG004|Overall Study|Withdrawal by Subject|0|||
149970147|NCT04622592|541028307|FG005|Overall Study|Withdrawal by Subject|0|||
149970148|NCT04622592|541028308|FG006|Overall Study|Withdrawal by Subject|1|||
149970149|NCT04622592|541028309|FG007|Overall Study|Withdrawal by Subject|4|||
149970150|NCT04622592|541028302|FG000|Overall Study|Other than specified above|0|||
149970151|NCT04622592|541028303|FG001|Overall Study|Other than specified above|0|||
149970152|NCT04622592|541028304|FG002|Overall Study|Other than specified above|1|||
149970153|NCT04622592|541028305|FG003|Overall Study|Other than specified above|0|||
149970154|NCT04622592|541028306|FG004|Overall Study|Other than specified above|0|||
149970155|NCT04622592|541028307|FG005|Overall Study|Other than specified above|0|||
149970156|NCT04622592|541028308|FG006|Overall Study|Other than specified above|0|||
149970157|NCT04622592|541028309|FG007|Overall Study|Other than specified above|0|||
149970158|NCT01664624|541028310|FG000|Overall Study|Adverse Event|0|||
149970159|NCT01664624|541028311|FG001|Overall Study|Adverse Event|1|||
149970160|NCT01664624|541028312|FG002|Overall Study|Adverse Event|0|||
149970161|NCT01664624|541028313|FG003|Overall Study|Adverse Event|0|||
149970162|NCT00904371|541028317|FG000|Overall Study|Adverse Event|2|||
149970163|NCT00904371|541028317|FG000|Overall Study|Lost to Follow-up|4|||
149970164|NCT00904371|541028317|FG000|Overall Study|Discontinued at target blood pressure|2|||
149970165|NCT00904371|541028317|FG000|Overall Study|Continued with Tritace|1|||
149970166|NCT02300233|541028322|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
149970167|NCT02300233|541028323|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
149970168|NCT02300233|541028324|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
149970169|NCT02300233|541028322|FG000|Overall Study|Withdrawal by Subject|1|||
149970170|NCT02300233|541028323|FG001|Overall Study|Withdrawal by Subject|0|||
149970171|NCT02300233|541028324|FG002|Overall Study|Withdrawal by Subject|3|||
149970172|NCT02300233|541028322|FG000|Overall Study|Investigator Judgement|0|||
149970173|NCT02300233|541028323|FG001|Overall Study|Investigator Judgement|0|||
149970174|NCT02300233|541028324|FG002|Overall Study|Investigator Judgement|1|||
149970175|NCT02300233|541028322|FG000|Overall Study|Reason Not Specified|0|||
149970176|NCT02300233|541028323|FG001|Overall Study|Reason Not Specified|0|||
149970177|NCT02300233|541028324|FG002|Overall Study|Reason Not Specified|5|||
149970178|NCT00833690|541028325|FG000|Overall Study|Withdrawal by Subject|1|||
149970179|NCT00833690|541028326|FG001|Overall Study|Withdrawal by Subject|0|||
149970180|NCT00833690|541028327|FG002|Overall Study|Withdrawal by Subject|0|||
149970181|NCT00833690|541028325|FG000|Overall Study|Discontinued study drug|3|||
149970182|NCT00833690|541028326|FG001|Overall Study|Discontinued study drug|2|||
149970183|NCT00833690|541028327|FG002|Overall Study|Discontinued study drug|0|||
149970184|NCT04462471|541028337|FG000|Overall Study|Adverse Event|0|||
149970185|NCT04462471|541028338|FG001|Overall Study|Adverse Event|1|||
150047426|NCT04198714|541312884|FG001|Overall Study|Physician Decision|1|||
150047427|NCT04238819|541312885|FG000|Overall Study|Ongoing Treatment|0|||
149970186|NCT04462471|541028339|FG002|Overall Study|Adverse Event|0|||
149970187|NCT04462471|541028340|FG003|Overall Study|Adverse Event|0|||
149970188|NCT04462471|541028337|FG000|Overall Study|Disease progression|1|||
149970189|NCT04462471|541028338|FG001|Overall Study|Disease progression|0|||
150047428|NCT04238819|541312886|FG001|Overall Study|Ongoing Treatment|0|||
150047429|NCT04238819|541312887|FG002|Overall Study|Ongoing Treatment|0|||
149970190|NCT04462471|541028339|FG002|Overall Study|Disease progression|0|||
149970191|NCT04462471|541028340|FG003|Overall Study|Disease progression|0|||
149970192|NCT05805150|541028341|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
149970193|NCT05805150|541028342|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
150047430|NCT04238819|541312888|FG003|Overall Study|Ongoing Treatment|0|||
150047431|NCT04238819|541312889|FG004|Overall Study|Ongoing Treatment|1|||
150047432|NCT04238819|541312890|FG005|Overall Study|Ongoing Treatment|4|||
150047433|NCT04238819|541312891|FG006|Overall Study|Ongoing Treatment|0|||
150047434|NCT04238819|541312885|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
150047435|NCT04238819|541312886|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
150047436|NCT04238819|541312887|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
150047437|NCT04238819|541312888|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
150047438|NCT04238819|541312889|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
150047439|NCT04238819|541312890|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
150047440|NCT04238819|541312891|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
150047441|NCT02529553|541312892|FG000|Overall Study|Progressive Disease|1|||
150047442|NCT02529553|541312893|FG001|Overall Study|Progressive Disease|0|||
150047443|NCT02529553|541312894|FG002|Overall Study|Progressive Disease|1|||
150047444|NCT02529553|541312895|FG003|Overall Study|Progressive Disease|3|||
150047445|NCT02529553|541312896|FG004|Overall Study|Progressive Disease|2|||
150047446|NCT02529553|541312897|FG005|Overall Study|Progressive Disease|3|||
150047447|NCT02529553|541312898|FG006|Overall Study|Progressive Disease|3|||
150047448|NCT02529553|541312899|FG007|Overall Study|Progressive Disease|5|||
150047449|NCT02529553|541312900|FG008|Overall Study|Progressive Disease|3|||
150047450|NCT02529553|541312892|FG000|Overall Study|Physician Decision|0|||
150047451|NCT02529553|541312893|FG001|Overall Study|Physician Decision|1|||
150047452|NCT02529553|541312894|FG002|Overall Study|Physician Decision|0|||
150047453|NCT02529553|541312895|FG003|Overall Study|Physician Decision|0|||
150047454|NCT02529553|541312896|FG004|Overall Study|Physician Decision|1|||
150047455|NCT02529553|541312897|FG005|Overall Study|Physician Decision|0|||
150047456|NCT02529553|541312898|FG006|Overall Study|Physician Decision|0|||
150047457|NCT02529553|541312899|FG007|Overall Study|Physician Decision|0|||
150047458|NCT02529553|541312900|FG008|Overall Study|Physician Decision|0|||
150047459|NCT02529553|541312892|FG000|Overall Study|Withdrawal by Subject|0|||
150047460|NCT02529553|541312893|FG001|Overall Study|Withdrawal by Subject|0|||
150047461|NCT02529553|541312894|FG002|Overall Study|Withdrawal by Subject|0|||
150047462|NCT02529553|541312895|FG003|Overall Study|Withdrawal by Subject|0|||
150047463|NCT02529553|541312896|FG004|Overall Study|Withdrawal by Subject|0|||
150047464|NCT02529553|541312897|FG005|Overall Study|Withdrawal by Subject|1|||
150047465|NCT02529553|541312898|FG006|Overall Study|Withdrawal by Subject|0|||
150047466|NCT02529553|541312899|FG007|Overall Study|Withdrawal by Subject|1|||
150047467|NCT02529553|541312900|FG008|Overall Study|Withdrawal by Subject|0|||
150047468|NCT04549545|541314514|FG000|Initial Period|Withdrawal by Subject|4|||
150047469|NCT04549545|541314515|FG001|Initial Period|Withdrawal by Subject|0|||
150047470|NCT04549545|541314514|FG000|Initial Period|Additional ENT Procedure|3|||
150047471|NCT04549545|541314515|FG001|Initial Period|Additional ENT Procedure|0|||
150047472|NCT04549545|541314514|FG000|Initial Period|Lost to Follow-up|3|||
150047473|NCT04549545|541314515|FG001|Initial Period|Lost to Follow-up|1|||
150047474|NCT04549545|541314514|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
150047475|NCT04549545|541314515|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
150047476|NCT04549545|541314514|FG000|Crossover Period|Additional ENT Procedure|0|||
150047477|NCT04549545|541314515|FG001|Crossover Period|Additional ENT Procedure|6|||
150047478|NCT04549545|541314514|FG000|Crossover Period|Lost to Follow-up|0|||
150047479|NCT04549545|541314515|FG001|Crossover Period|Lost to Follow-up|1|||
150047480|NCT04549545|541314514|FG000|Crossover Period|Withdrawal by Subject|0|||
150047481|NCT04549545|541314515|FG001|Crossover Period|Withdrawal by Subject|4|||
149905099|NCT01867710|540783656|FG001|Overall Study|Death|15|||
149905100|NCT01867710|540783657|FG002|Overall Study|Death|27|||
149905101|NCT01867710|540783658|FG003|Overall Study|Death|20|||
149905102|NCT01867710|540783655|FG000|Overall Study|Lost to Follow-up|3|||
149905103|NCT01867710|540783656|FG001|Overall Study|Lost to Follow-up|4|||
149905104|NCT01867710|540783657|FG002|Overall Study|Lost to Follow-up|3|||
149905105|NCT01867710|540783658|FG003|Overall Study|Lost to Follow-up|2|||
149905106|NCT01867710|540783655|FG000|Overall Study|Withdrawal of consent|2|||
149905107|NCT01867710|540783656|FG001|Overall Study|Withdrawal of consent|5|||
149905108|NCT01867710|540783657|FG002|Overall Study|Withdrawal of consent|1|||
149905109|NCT01867710|540783658|FG003|Overall Study|Withdrawal of consent|2|||
149905110|NCT01867710|540783655|FG000|Overall Study|Study Terminated by Sponsor|9|||
149905111|NCT01867710|540783656|FG001|Overall Study|Study Terminated by Sponsor|13|||
149905112|NCT01867710|540783657|FG002|Overall Study|Study Terminated by Sponsor|8|||
149905113|NCT01867710|540783658|FG003|Overall Study|Study Terminated by Sponsor|16|||
149905114|NCT01867710|540783655|FG000|Overall Study|Biochemical progression|0|||
149905115|NCT01867710|540783656|FG001|Overall Study|Biochemical progression|1|||
149905116|NCT01867710|540783657|FG002|Overall Study|Biochemical progression|0|||
150047482|NCT01395524|541314520|FG000|Overall Study|Non-compliance with study schedule|1|||
150047483|NCT01395524|541314521|FG001|Overall Study|Non-compliance with study schedule|0|||
149905117|NCT01867710|540783658|FG003|Overall Study|Biochemical progression|0|||
149905118|NCT01867710|540783655|FG000|Overall Study|Clinical progression|0|||
150047484|NCT01395524|541314522|FG002|Overall Study|Non-compliance with study schedule|1|||
149905119|NCT01867710|540783656|FG001|Overall Study|Clinical progression|0|||
149905120|NCT01867710|540783657|FG002|Overall Study|Clinical progression|1|||
149905121|NCT01867710|540783658|FG003|Overall Study|Clinical progression|0|||
149905122|NCT01867710|540783655|FG000|Overall Study|Disease progression|1|||
150047485|NCT01395524|541314520|FG000|Overall Study|Lost to Follow-up|3|||
149905123|NCT01867710|540783656|FG001|Overall Study|Disease progression|0|||
149905124|NCT01867710|540783657|FG002|Overall Study|Disease progression|0|||
149905125|NCT01867710|540783658|FG003|Overall Study|Disease progression|0|||
149905126|NCT01867710|540783655|FG000|Overall Study|Patient decision|0|||
149905127|NCT01867710|540783656|FG001|Overall Study|Patient decision|0|||
149905128|NCT01867710|540783657|FG002|Overall Study|Patient decision|0|||
149905129|NCT01867710|540783658|FG003|Overall Study|Patient decision|1|||
149905130|NCT01867710|540783655|FG000|Overall Study|Patient to follow subsequent treatment|0|||
149905131|NCT01867710|540783656|FG001|Overall Study|Patient to follow subsequent treatment|1|||
149905132|NCT01867710|540783657|FG002|Overall Study|Patient to follow subsequent treatment|0|||
149905133|NCT01867710|540783658|FG003|Overall Study|Patient to follow subsequent treatment|0|||
149905134|NCT01867710|540783655|FG000|Overall Study|Progressive disease|1|||
149905135|NCT01867710|540783656|FG001|Overall Study|Progressive disease|0|||
150047486|NCT01395524|541314521|FG001|Overall Study|Lost to Follow-up|1|||
150047487|NCT01395524|541314522|FG002|Overall Study|Lost to Follow-up|1|||
150047488|NCT01395524|541314520|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
150047489|NCT01395524|541314521|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
150047490|NCT01395524|541314522|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
150047491|NCT01395524|541314520|FG000|Overall Study|Severe noncompliance with protocol|1|||
150047492|NCT01395524|541314521|FG001|Overall Study|Severe noncompliance with protocol|0|||
150047493|NCT01395524|541314522|FG002|Overall Study|Severe noncompliance with protocol|0|||
150047494|NCT01395524|541314520|FG000|Overall Study|Adverse Event|4|||
150047495|NCT01395524|541314521|FG001|Overall Study|Adverse Event|4|||
150047496|NCT01395524|541314522|FG002|Overall Study|Adverse Event|3|||
150047497|NCT01395524|541314520|FG000|Overall Study|Death|1|||
150047498|NCT01395524|541314521|FG001|Overall Study|Death|0|||
150047499|NCT01395524|541314522|FG002|Overall Study|Death|0|||
150047500|NCT01395524|541314520|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
150047501|NCT01395524|541314521|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
150047502|NCT01395524|541314522|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
150047503|NCT01395524|541314520|FG000|Overall Study|Withdrawal by Subject|4|||
150047504|NCT01395524|541314521|FG001|Overall Study|Withdrawal by Subject|8|||
150047505|NCT01395524|541314522|FG002|Overall Study|Withdrawal by Subject|8|||
150047506|NCT01395524|541314520|FG000|Overall Study|Did not receive treatment|1|||
150047507|NCT01395524|541314521|FG001|Overall Study|Did not receive treatment|1|||
150047508|NCT01395524|541314522|FG002|Overall Study|Did not receive treatment|3|||
150047509|NCT01395524|541314520|FG000|Overall Study|Subject had spinal surgery|0|||
150047510|NCT01395524|541314521|FG001|Overall Study|Subject had spinal surgery|0|||
150047511|NCT01395524|541314522|FG002|Overall Study|Subject had spinal surgery|1|||
150047512|NCT01657461|541314523|FG000|Overall Study|Death|9|||
150047513|NCT01657461|541314524|FG001|Overall Study|Death|12|||
150047514|NCT01657461|541314523|FG000|Overall Study|Lost to Follow-up|0|||
150047515|NCT01657461|541314524|FG001|Overall Study|Lost to Follow-up|3|||
150047516|NCT01657461|541314523|FG000|Overall Study|Physician Decision|0|||
150047517|NCT01657461|541314524|FG001|Overall Study|Physician Decision|2|||
150047518|NCT01657461|541314523|FG000|Overall Study|Withdrawal by Subject|1|||
150047519|NCT01657461|541314524|FG001|Overall Study|Withdrawal by Subject|3|||
150047520|NCT01868542|541314525|FG000|Overall Study|Protocol Violation|0|||
150047521|NCT01868542|541314526|FG001|Overall Study|Protocol Violation|1|||
150047522|NCT01868542|541314525|FG000|Overall Study|Unclassified|0|||
150047523|NCT01868542|541314526|FG001|Overall Study|Unclassified|1|||
150047524|NCT00130247|541314527|FG000|Overall Study|Pregnancy|1|||
150047525|NCT00130247|541314528|FG001|Overall Study|Pregnancy|0|||
150047526|NCT00130247|541314527|FG000|Overall Study|Post-randomization exclusion|1|||
149905136|NCT01867710|540783657|FG002|Overall Study|Progressive disease|0|||
149905137|NCT01867710|540783658|FG003|Overall Study|Progressive disease|0|||
150047527|NCT00130247|541314528|FG001|Overall Study|Post-randomization exclusion|2|||
150047528|NCT00130247|541314527|FG000|Overall Study|Not compliant with DOT|0|||
150047529|NCT00130247|541314528|FG001|Overall Study|Not compliant with DOT|2|||
150047530|NCT00843284|541314533|FG000|Overall Study|Adverse Event|39|||
150047531|NCT00843284|541314533|FG000|Overall Study|Lack of Efficacy|5|||
150047532|NCT00843284|541314533|FG000|Overall Study|Lost to Follow-up|11|||
150047533|NCT00843284|541314533|FG000|Overall Study|Other|10|||
150047534|NCT00843284|541314533|FG000|Overall Study|Withdrawal by Subject|4|||
150047535|NCT00843284|541314533|FG000|Overall Study|Death|3|||
150047536|NCT02175199|541314540|FG000|Overall Study|Withdrawal by Subject|1|||
149905138|NCT01867710|540783655|FG000|Overall Study|Protocol Violation|0|||
149905139|NCT01867710|540783656|FG001|Overall Study|Protocol Violation|0|||
149905140|NCT01867710|540783657|FG002|Overall Study|Protocol Violation|0|||
149905141|NCT01867710|540783658|FG003|Overall Study|Protocol Violation|1|||
150047537|NCT02175199|541314541|FG001|Overall Study|Withdrawal by Subject|5|||
150047538|NCT02175199|541314540|FG000|Overall Study|Randomized in Error|1|||
150047539|NCT02175199|541314541|FG001|Overall Study|Randomized in Error|0|||
149905142|NCT01867710|540783655|FG000|Overall Study|PSA-progression|0|||
149905143|NCT01867710|540783656|FG001|Overall Study|PSA-progression|1|||
149905144|NCT01867710|540783657|FG002|Overall Study|PSA-progression|0|||
149905145|NCT01867710|540783658|FG003|Overall Study|PSA-progression|0|||
149905146|NCT01867710|540783655|FG000|Overall Study|Study medication no longer effective|0|||
149905147|NCT01867710|540783656|FG001|Overall Study|Study medication no longer effective|1|||
149905148|NCT01867710|540783657|FG002|Overall Study|Study medication no longer effective|0|||
149905149|NCT01867710|540783658|FG003|Overall Study|Study medication no longer effective|0|||
149905150|NCT00526669|540783659|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
149905151|NCT00526669|540783660|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
149905152|NCT00526669|540783659|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
149905153|NCT00526669|540783660|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
149905154|NCT00526669|540783659|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
149905155|NCT00526669|540783660|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
149905156|NCT00526669|540783659|FG000|Combined Treatment Phase|Death|0|||
149905157|NCT00526669|540783660|FG001|Combined Treatment Phase|Death|2|||
149905158|NCT02828124|540783661|FG000|Overall Study|Disease Progression|1|||
149905159|NCT02828124|540783662|FG001|Overall Study|Disease Progression|2|||
149905160|NCT02828124|540783663|FG002|Overall Study|Disease Progression|1|||
149905161|NCT02828124|540783664|FG003|Overall Study|Disease Progression|4|||
149905162|NCT02828124|540783661|FG000|Overall Study|AE Unrelated to Study Drug|0|||
149905163|NCT02828124|540783662|FG001|Overall Study|AE Unrelated to Study Drug|0|||
149905164|NCT02828124|540783663|FG002|Overall Study|AE Unrelated to Study Drug|0|||
149905165|NCT02828124|540783664|FG003|Overall Study|AE Unrelated to Study Drug|1|||
149905166|NCT02828124|540783661|FG000|Overall Study|Subject Withdrew Consent|0|||
149905167|NCT02828124|540783662|FG001|Overall Study|Subject Withdrew Consent|0|||
149905168|NCT02828124|540783663|FG002|Overall Study|Subject Withdrew Consent|0|||
149905169|NCT02828124|540783664|FG003|Overall Study|Subject Withdrew Consent|1|||
149905170|NCT00747474|540783666|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905171|NCT00747474|540783667|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905172|NCT00747474|540783668|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905173|NCT00747474|540783669|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905174|NCT00747474|540783670|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905175|NCT00747474|540783671|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905176|NCT00747474|540783672|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905177|NCT00747474|540783673|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
149905178|NCT00747474|540783674|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905179|NCT00747474|540783675|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905180|NCT00747474|540783676|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905181|NCT00747474|540783677|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
149905182|NCT02829723|540783678|FG000|Overall Study|Adverse Event|0|||
149905183|NCT02829723|540783679|FG001|Overall Study|Adverse Event|0|||
149905184|NCT02829723|540783680|FG002|Overall Study|Adverse Event|1|||
149905185|NCT02829723|540783681|FG003|Overall Study|Adverse Event|1|||
149905186|NCT02829723|540783682|FG004|Overall Study|Adverse Event|0|||
149905187|NCT02829723|540783683|FG005|Overall Study|Adverse Event|0|||
149905188|NCT02829723|540783684|FG006|Overall Study|Adverse Event|0|||
149905189|NCT02829723|540783685|FG007|Overall Study|Adverse Event|1|||
150047540|NCT02175199|541314540|FG000|Overall Study|Sponsor Decision|1|||
150047541|NCT02175199|541314541|FG001|Overall Study|Sponsor Decision|0|||
150047542|NCT00122980|541314542|FG000|Overall Study|Death|0|||
150047543|NCT00122980|541314543|FG001|Overall Study|Death|1|||
150047544|NCT00122980|541314542|FG000|Overall Study|Physician Decision|2|||
150047545|NCT00122980|541314543|FG001|Overall Study|Physician Decision|0|||
150047546|NCT00122980|541314542|FG000|Overall Study|Protocol Violation|5|||
150047547|NCT00122980|541314543|FG001|Overall Study|Protocol Violation|1|||
150047548|NCT00122980|541314542|FG000|Overall Study|Withdrawal by Subject|2|||
150047549|NCT00122980|541314543|FG001|Overall Study|Withdrawal by Subject|3|||
150047550|NCT00122980|541314542|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
150047551|NCT00122980|541314543|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
150047552|NCT00122980|541314542|FG000|Overall Study|Study termination|27|||
150047553|NCT00122980|541314543|FG001|Overall Study|Study termination|35|||
150047554|NCT01124864|541314546|FG000|Overall Study|Follow up phase competed as per protocol|18|||
150047555|NCT01124864|541314547|FG001|Overall Study|Follow up phase competed as per protocol|22|||
150047556|NCT01124864|541314548|FG002|Overall Study|Follow up phase competed as per protocol|24|||
150047557|NCT01124864|541314549|FG003|Overall Study|Follow up phase competed as per protocol|18|||
150047558|NCT01124864|541314550|FG004|Overall Study|Follow up phase competed as per protocol|26|||
150047559|NCT01124864|541314551|FG005|Overall Study|Follow up phase competed as per protocol|2|||
150047560|NCT01124864|541314546|FG000|Overall Study|Death|6|||
150047561|NCT01124864|541314547|FG001|Overall Study|Death|9|||
150047562|NCT01124864|541314548|FG002|Overall Study|Death|6|||
150047563|NCT01124864|541314549|FG003|Overall Study|Death|2|||
150047564|NCT01124864|541314550|FG004|Overall Study|Death|1|||
150047565|NCT01124864|541314551|FG005|Overall Study|Death|0|||
150047566|NCT01124864|541314546|FG000|Overall Study|Withdrawal by Subject|2|||
150047567|NCT01124864|541314547|FG001|Overall Study|Withdrawal by Subject|3|||
150047568|NCT01124864|541314548|FG002|Overall Study|Withdrawal by Subject|4|||
150047569|NCT01124864|541314549|FG003|Overall Study|Withdrawal by Subject|0|||
150047570|NCT01124864|541314550|FG004|Overall Study|Withdrawal by Subject|2|||
150047571|NCT01124864|541314551|FG005|Overall Study|Withdrawal by Subject|1|||
150047572|NCT01124864|541314546|FG000|Overall Study|Lost to Follow-up|1|||
150047573|NCT01124864|541314547|FG001|Overall Study|Lost to Follow-up|1|||
150047574|NCT01124864|541314548|FG002|Overall Study|Lost to Follow-up|0|||
150047575|NCT01124864|541314549|FG003|Overall Study|Lost to Follow-up|1|||
150047576|NCT01124864|541314550|FG004|Overall Study|Lost to Follow-up|0|||
150047577|NCT01124864|541314551|FG005|Overall Study|Lost to Follow-up|0|||
150047578|NCT01124864|541314546|FG000|Overall Study|Protocol Violation|1|||
150047579|NCT01124864|541314547|FG001|Overall Study|Protocol Violation|0|||
150047580|NCT01124864|541314548|FG002|Overall Study|Protocol Violation|0|||
150047581|NCT01124864|541314549|FG003|Overall Study|Protocol Violation|0|||
150047582|NCT01124864|541314550|FG004|Overall Study|Protocol Violation|1|||
150047583|NCT01124864|541314551|FG005|Overall Study|Protocol Violation|0|||
150047584|NCT01243242|541314552|FG000|Overall Study|Adverse Event|1|||
150047585|NCT01243242|541314553|FG001|Overall Study|Adverse Event|1|||
150047586|NCT01243242|541314552|FG000|Overall Study|Withdrawal by Subject|1|||
150047587|NCT01243242|541314553|FG001|Overall Study|Withdrawal by Subject|1|||
150047588|NCT01243242|541314552|FG000|Overall Study|Physician Decision|0|||
150047589|NCT01243242|541314553|FG001|Overall Study|Physician Decision|1|||
150047590|NCT01243242|541314552|FG000|Overall Study|sponsor decision|0|||
150047591|NCT01243242|541314553|FG001|Overall Study|sponsor decision|1|||
150047592|NCT01243242|541314552|FG000|Overall Study|non compliance|1|||
150047593|NCT01243242|541314553|FG001|Overall Study|non compliance|0|||
150047594|NCT03983317|541314558|FG000|Overall Study|Physician Decision|5|||
150047595|NCT01761162|541314559|FG000|Overall Study|Withdrawal by Subject|3|||
149905190|NCT02829723|540783686|FG008|Overall Study|Adverse Event|0|||
149905191|NCT02829723|540783687|FG009|Overall Study|Adverse Event|0|||
149905192|NCT02829723|540783688|FG010|Overall Study|Adverse Event|0|||
149905193|NCT02829723|540783689|FG011|Overall Study|Adverse Event|0|||
149905194|NCT02829723|540783690|FG012|Overall Study|Adverse Event|0|||
149905195|NCT02829723|540783691|FG013|Overall Study|Adverse Event|0|||
150047596|NCT00436345|541314560|FG000|Overall Study|ICU resident beyond follow-up period|3|||
150047597|NCT00436345|541314561|FG001|Overall Study|ICU resident beyond follow-up period|0|||
150047598|NCT01296672|541314562|FG000|Overall Study|Lost to Follow-up|73|||
150047599|NCT01296672|541314563|FG001|Overall Study|Lost to Follow-up|18|||
150047600|NCT01716052|541314564|FG000|Overall Study|Withdrawal of funding|1|||
150047601|NCT01716052|541314565|FG001|Overall Study|Withdrawal of funding|1|||
150047602|NCT04248491|541314566|FG000|Overall Study|Lost to Follow-up|1|||
150047603|NCT04248491|541314567|FG001|Overall Study|Lost to Follow-up|0|||
150047604|NCT01311024|541314570|FG000|Overall Study|Protocol Violation|35|||
150047605|NCT01311024|541314571|FG001|Overall Study|Protocol Violation|22|||
150047606|NCT01652469|541314575|FG000|Overall Study|Withdrawal by Subject|1|||
150047607|NCT01652469|541314576|FG001|Overall Study|Withdrawal by Subject|4|||
150047608|NCT01652469|541314575|FG000|Overall Study|Lost to Follow-up|0|||
150047609|NCT01652469|541314576|FG001|Overall Study|Lost to Follow-up|2|||
149905196|NCT02829723|540783692|FG014|Overall Study|Adverse Event|1|||
150047610|NCT01305577|541314577|FG000|Overall Study|Adverse Event|2|||
149905197|NCT02829723|540783693|FG015|Overall Study|Adverse Event|1|||
149905198|NCT02829723|540783694|FG016|Overall Study|Adverse Event|1|||
149905199|NCT02829723|540783695|FG017|Overall Study|Adverse Event|2|||
149905200|NCT02829723|540783696|FG018|Overall Study|Adverse Event|1|||
149905201|NCT02829723|540783697|FG019|Overall Study|Adverse Event|1|||
149905202|NCT02829723|540783698|FG020|Overall Study|Adverse Event|3|||
149905203|NCT02829723|540783699|FG021|Overall Study|Adverse Event|0|||
149905204|NCT02829723|540783700|FG022|Overall Study|Adverse Event|0|||
149905205|NCT02829723|540783701|FG023|Overall Study|Adverse Event|1|||
149905206|NCT02829723|540783702|FG024|Overall Study|Adverse Event|1|||
149905207|NCT02829723|540783703|FG025|Overall Study|Adverse Event|3|||
149905208|NCT02829723|540783704|FG026|Overall Study|Adverse Event|5|||
149905209|NCT02829723|540783678|FG000|Overall Study|Death|1|||
149905210|NCT02829723|540783679|FG001|Overall Study|Death|0|||
149905211|NCT02829723|540783680|FG002|Overall Study|Death|1|||
149905212|NCT02829723|540783681|FG003|Overall Study|Death|1|||
149905213|NCT02829723|540783682|FG004|Overall Study|Death|0|||
149905214|NCT02829723|540783683|FG005|Overall Study|Death|0|||
149905215|NCT02829723|540783684|FG006|Overall Study|Death|2|||
149905216|NCT02829723|540783685|FG007|Overall Study|Death|0|||
149905217|NCT02829723|540783686|FG008|Overall Study|Death|1|||
149905218|NCT02829723|540783687|FG009|Overall Study|Death|0|||
149905219|NCT02829723|540783688|FG010|Overall Study|Death|0|||
149905220|NCT02829723|540783689|FG011|Overall Study|Death|0|||
149905221|NCT02829723|540783690|FG012|Overall Study|Death|2|||
149905222|NCT02829723|540783691|FG013|Overall Study|Death|1|||
149905223|NCT02829723|540783692|FG014|Overall Study|Death|0|||
149905224|NCT02829723|540783693|FG015|Overall Study|Death|0|||
149905225|NCT02829723|540783694|FG016|Overall Study|Death|0|||
149905226|NCT02829723|540783695|FG017|Overall Study|Death|0|||
149905227|NCT02829723|540783696|FG018|Overall Study|Death|0|||
149905228|NCT02829723|540783697|FG019|Overall Study|Death|0|||
149905229|NCT02829723|540783698|FG020|Overall Study|Death|0|||
149905230|NCT02829723|540783699|FG021|Overall Study|Death|2|||
149905231|NCT02829723|540783700|FG022|Overall Study|Death|0|||
149905232|NCT02829723|540783701|FG023|Overall Study|Death|0|||
149905233|NCT02829723|540783702|FG024|Overall Study|Death|0|||
149905234|NCT02829723|540783703|FG025|Overall Study|Death|1|||
149905235|NCT02829723|540783704|FG026|Overall Study|Death|2|||
149905236|NCT02829723|540783678|FG000|Overall Study|Physician Decision|0|||
149905237|NCT02829723|540783679|FG001|Overall Study|Physician Decision|0|||
149970194|NCT00855335|541028343|FG000|Overall Study|Lost to Follow-up|0|||
149970195|NCT00855335|541028344|FG001|Overall Study|Lost to Follow-up|0|||
149970196|NCT00855335|541028345|FG002|Overall Study|Lost to Follow-up|3|||
149970197|NCT00855335|541028346|FG003|Overall Study|Lost to Follow-up|1|||
149970198|NCT00855335|541028347|FG004|Overall Study|Lost to Follow-up|0|||
149970199|NCT00855335|541028343|FG000|Overall Study|Withdrawal by Subject|0|||
149970200|NCT00855335|541028344|FG001|Overall Study|Withdrawal by Subject|0|||
149970201|NCT00855335|541028345|FG002|Overall Study|Withdrawal by Subject|0|||
149970202|NCT00855335|541028346|FG003|Overall Study|Withdrawal by Subject|1|||
149970203|NCT00855335|541028347|FG004|Overall Study|Withdrawal by Subject|0|||
149970204|NCT00855335|541028343|FG000|Overall Study|Adverse Event|2|||
149970205|NCT00855335|541028344|FG001|Overall Study|Adverse Event|0|||
149970206|NCT00855335|541028345|FG002|Overall Study|Adverse Event|0|||
149970207|NCT00855335|541028346|FG003|Overall Study|Adverse Event|0|||
149970208|NCT00855335|541028347|FG004|Overall Study|Adverse Event|0|||
149970209|NCT00855335|541028343|FG000|Overall Study|Physician Decision|1|||
149970210|NCT00855335|541028344|FG001|Overall Study|Physician Decision|1|||
149970211|NCT00855335|541028345|FG002|Overall Study|Physician Decision|0|||
149970212|NCT00855335|541028346|FG003|Overall Study|Physician Decision|0|||
149905238|NCT02829723|540783680|FG002|Overall Study|Physician Decision|0|||
149970213|NCT00855335|541028347|FG004|Overall Study|Physician Decision|0|||
149905239|NCT02829723|540783681|FG003|Overall Study|Physician Decision|0|||
149905240|NCT02829723|540783682|FG004|Overall Study|Physician Decision|0|||
149905241|NCT02829723|540783683|FG005|Overall Study|Physician Decision|0|||
149905242|NCT02829723|540783684|FG006|Overall Study|Physician Decision|0|||
149905243|NCT02829723|540783685|FG007|Overall Study|Physician Decision|0|||
149905244|NCT02829723|540783686|FG008|Overall Study|Physician Decision|0|||
149905245|NCT02829723|540783687|FG009|Overall Study|Physician Decision|1|||
149905246|NCT02829723|540783688|FG010|Overall Study|Physician Decision|1|||
149905247|NCT02829723|540783689|FG011|Overall Study|Physician Decision|0|||
149905248|NCT02829723|540783690|FG012|Overall Study|Physician Decision|0|||
149905249|NCT02829723|540783691|FG013|Overall Study|Physician Decision|1|||
149905250|NCT02829723|540783692|FG014|Overall Study|Physician Decision|0|||
149905251|NCT02829723|540783693|FG015|Overall Study|Physician Decision|0|||
149905252|NCT02829723|540783694|FG016|Overall Study|Physician Decision|2|||
149905253|NCT02829723|540783695|FG017|Overall Study|Physician Decision|0|||
149905254|NCT02829723|540783696|FG018|Overall Study|Physician Decision|0|||
149905255|NCT02829723|540783697|FG019|Overall Study|Physician Decision|0|||
149905256|NCT02829723|540783698|FG020|Overall Study|Physician Decision|0|||
149905257|NCT02829723|540783699|FG021|Overall Study|Physician Decision|0|||
149905258|NCT02829723|540783700|FG022|Overall Study|Physician Decision|1|||
149905259|NCT02829723|540783701|FG023|Overall Study|Physician Decision|1|||
149905260|NCT02829723|540783702|FG024|Overall Study|Physician Decision|1|||
149905261|NCT02829723|540783703|FG025|Overall Study|Physician Decision|1|||
149905262|NCT02829723|540783704|FG026|Overall Study|Physician Decision|3|||
149905263|NCT02829723|540783678|FG000|Overall Study|Progressive disease|4|||
149905264|NCT02829723|540783679|FG001|Overall Study|Progressive disease|6|||
149905265|NCT02829723|540783680|FG002|Overall Study|Progressive disease|3|||
149905266|NCT02829723|540783681|FG003|Overall Study|Progressive disease|3|||
149905267|NCT02829723|540783682|FG004|Overall Study|Progressive disease|3|||
149905268|NCT02829723|540783683|FG005|Overall Study|Progressive disease|5|||
149905269|NCT02829723|540783684|FG006|Overall Study|Progressive disease|4|||
149905270|NCT02829723|540783685|FG007|Overall Study|Progressive disease|6|||
149905271|NCT02829723|540783686|FG008|Overall Study|Progressive disease|8|||
149905272|NCT02829723|540783687|FG009|Overall Study|Progressive disease|4|||
149905273|NCT02829723|540783688|FG010|Overall Study|Progressive disease|9|||
149905274|NCT02829723|540783689|FG011|Overall Study|Progressive disease|0|||
149905275|NCT02829723|540783690|FG012|Overall Study|Progressive disease|3|||
149905276|NCT02829723|540783691|FG013|Overall Study|Progressive disease|4|||
149905277|NCT02829723|540783692|FG014|Overall Study|Progressive disease|2|||
149905278|NCT02829723|540783693|FG015|Overall Study|Progressive disease|4|||
149905279|NCT02829723|540783694|FG016|Overall Study|Progressive disease|5|||
149905280|NCT02829723|540783695|FG017|Overall Study|Progressive disease|3|||
149905281|NCT02829723|540783696|FG018|Overall Study|Progressive disease|4|||
149905282|NCT02829723|540783697|FG019|Overall Study|Progressive disease|4|||
149905283|NCT02829723|540783698|FG020|Overall Study|Progressive disease|7|||
149905284|NCT02829723|540783699|FG021|Overall Study|Progressive disease|6|||
149905285|NCT02829723|540783700|FG022|Overall Study|Progressive disease|3|||
149905286|NCT02829723|540783701|FG023|Overall Study|Progressive disease|3|||
149905287|NCT02829723|540783702|FG024|Overall Study|Progressive disease|3|||
149905288|NCT02829723|540783703|FG025|Overall Study|Progressive disease|16|||
149905289|NCT02829723|540783704|FG026|Overall Study|Progressive disease|10|||
149905290|NCT02829723|540783678|FG000|Overall Study|Subject/guardian decision|0|||
149905291|NCT02829723|540783679|FG001|Overall Study|Subject/guardian decision|1|||
149905292|NCT02829723|540783680|FG002|Overall Study|Subject/guardian decision|0|||
149905293|NCT02829723|540783681|FG003|Overall Study|Subject/guardian decision|1|||
149905294|NCT02829723|540783682|FG004|Overall Study|Subject/guardian decision|0|||
149905295|NCT02829723|540783683|FG005|Overall Study|Subject/guardian decision|0|||
149905296|NCT02829723|540783684|FG006|Overall Study|Subject/guardian decision|0|||
149905297|NCT02829723|540783685|FG007|Overall Study|Subject/guardian decision|1|||
149905298|NCT02829723|540783686|FG008|Overall Study|Subject/guardian decision|0|||
149905299|NCT02829723|540783687|FG009|Overall Study|Subject/guardian decision|0|||
149905300|NCT02829723|540783688|FG010|Overall Study|Subject/guardian decision|0|||
149970214|NCT00855335|541028343|FG000|Overall Study|Other|2|||
149905301|NCT02829723|540783689|FG011|Overall Study|Subject/guardian decision|0|||
149905302|NCT02829723|540783690|FG012|Overall Study|Subject/guardian decision|0|||
149905303|NCT02829723|540783691|FG013|Overall Study|Subject/guardian decision|0|||
149905304|NCT02829723|540783692|FG014|Overall Study|Subject/guardian decision|1|||
149905305|NCT02829723|540783693|FG015|Overall Study|Subject/guardian decision|0|||
149905306|NCT02829723|540783694|FG016|Overall Study|Subject/guardian decision|1|||
149905307|NCT02829723|540783695|FG017|Overall Study|Subject/guardian decision|0|||
149905308|NCT02829723|540783696|FG018|Overall Study|Subject/guardian decision|1|||
149905309|NCT02829723|540783697|FG019|Overall Study|Subject/guardian decision|0|||
149905310|NCT02829723|540783698|FG020|Overall Study|Subject/guardian decision|1|||
149905311|NCT02829723|540783699|FG021|Overall Study|Subject/guardian decision|0|||
149905312|NCT02829723|540783700|FG022|Overall Study|Subject/guardian decision|0|||
149905313|NCT02829723|540783701|FG023|Overall Study|Subject/guardian decision|1|||
149905314|NCT02829723|540783702|FG024|Overall Study|Subject/guardian decision|0|||
149905315|NCT02829723|540783703|FG025|Overall Study|Subject/guardian decision|1|||
149905316|NCT02829723|540783704|FG026|Overall Study|Subject/guardian decision|1|||
149905317|NCT02829723|540783678|FG000|Overall Study|Study terminated by sponsor|0|||
149905318|NCT02829723|540783679|FG001|Overall Study|Study terminated by sponsor|0|||
149905319|NCT02829723|540783680|FG002|Overall Study|Study terminated by sponsor|0|||
149905320|NCT02829723|540783681|FG003|Overall Study|Study terminated by sponsor|0|||
149905321|NCT02829723|540783682|FG004|Overall Study|Study terminated by sponsor|0|||
149905322|NCT02829723|540783683|FG005|Overall Study|Study terminated by sponsor|0|||
149905323|NCT02829723|540783684|FG006|Overall Study|Study terminated by sponsor|0|||
149905324|NCT02829723|540783685|FG007|Overall Study|Study terminated by sponsor|0|||
149905325|NCT02829723|540783686|FG008|Overall Study|Study terminated by sponsor|0|||
149905326|NCT02829723|540783687|FG009|Overall Study|Study terminated by sponsor|0|||
149905327|NCT02829723|540783688|FG010|Overall Study|Study terminated by sponsor|0|||
149905328|NCT02829723|540783689|FG011|Overall Study|Study terminated by sponsor|0|||
149905329|NCT02829723|540783690|FG012|Overall Study|Study terminated by sponsor|0|||
149905330|NCT02829723|540783691|FG013|Overall Study|Study terminated by sponsor|0|||
149905331|NCT02829723|540783692|FG014|Overall Study|Study terminated by sponsor|0|||
149905332|NCT02829723|540783693|FG015|Overall Study|Study terminated by sponsor|0|||
149905333|NCT02829723|540783694|FG016|Overall Study|Study terminated by sponsor|0|||
149905334|NCT02829723|540783695|FG017|Overall Study|Study terminated by sponsor|0|||
149905335|NCT02829723|540783696|FG018|Overall Study|Study terminated by sponsor|0|||
149905336|NCT02829723|540783697|FG019|Overall Study|Study terminated by sponsor|0|||
149905337|NCT02829723|540783698|FG020|Overall Study|Study terminated by sponsor|0|||
149905338|NCT02829723|540783699|FG021|Overall Study|Study terminated by sponsor|1|||
149905339|NCT02829723|540783700|FG022|Overall Study|Study terminated by sponsor|0|||
149905340|NCT02829723|540783701|FG023|Overall Study|Study terminated by sponsor|0|||
149905341|NCT02829723|540783702|FG024|Overall Study|Study terminated by sponsor|0|||
149905342|NCT02829723|540783703|FG025|Overall Study|Study terminated by sponsor|0|||
149905343|NCT02829723|540783704|FG026|Overall Study|Study terminated by sponsor|0|||
149905344|NCT03514485|540783706|FG000|Overall Study|Lost to Follow-up|5|||
149905345|NCT03514485|540783707|FG001|Overall Study|Lost to Follow-up|3|||
149905346|NCT03514485|540783708|FG002|Overall Study|Lost to Follow-up|2|||
149905347|NCT03514485|540783709|FG003|Overall Study|Lost to Follow-up|0|||
149905348|NCT03514485|540783710|FG004|Overall Study|Lost to Follow-up|1|||
149905349|NCT03514485|540783711|FG005|Overall Study|Lost to Follow-up|4|||
149905350|NCT03514485|540783706|FG000|Overall Study|Withdrawal by Subject|0|||
149905351|NCT03514485|540783707|FG001|Overall Study|Withdrawal by Subject|1|||
149905352|NCT03514485|540783708|FG002|Overall Study|Withdrawal by Subject|3|||
149905353|NCT03514485|540783709|FG003|Overall Study|Withdrawal by Subject|1|||
149905354|NCT03514485|540783710|FG004|Overall Study|Withdrawal by Subject|2|||
149905355|NCT03514485|540783711|FG005|Overall Study|Withdrawal by Subject|1|||
149905356|NCT03075891|540783713|FG000|Overall Study|Withdrawal by Subject|3|||
149905357|NCT03075891|540783714|FG001|Overall Study|Withdrawal by Subject|6|||
149905358|NCT03075891|540783713|FG000|Overall Study|Lost to Follow-up|1|||
149905359|NCT03075891|540783714|FG001|Overall Study|Lost to Follow-up|0|||
149905360|NCT03075891|540783713|FG000|Overall Study|Pregnancy|3|||
149905361|NCT03075891|540783714|FG001|Overall Study|Pregnancy|1|||
149905362|NCT03075891|540783713|FG000|Overall Study|visits not performed (no time)|1|||
149905363|NCT03075891|540783714|FG001|Overall Study|visits not performed (no time)|0|||
149905364|NCT03075891|540783713|FG000|Overall Study|Drug abuse relapse issue|0|||
149905365|NCT03075891|540783714|FG001|Overall Study|Drug abuse relapse issue|1|||
149905366|NCT03075891|540783713|FG000|Overall Study|Participant requiring study withdrawal|0|||
149970215|NCT00855335|541028344|FG001|Overall Study|Other|1|||
149905367|NCT03075891|540783714|FG001|Overall Study|Participant requiring study withdrawal|1|||
149905368|NCT03075891|540783713|FG000|Overall Study|Adverse event, non-fatal|1|||
149905369|NCT03075891|540783714|FG001|Overall Study|Adverse event, non-fatal|4|||
149905370|NCT02004886|540783715|FG000|Overall Study|Adverse Event|0|||
149905371|NCT02004886|540783716|FG001|Overall Study|Adverse Event|1|||
149905372|NCT02004886|540783717|FG002|Overall Study|Adverse Event|0|||
150176643|NCT01641198|541783357|FG001|After 12 Months of Function|Protocol Violation|0|||
150176644|NCT01641198|541783358|FG002|After 12 Months of Function|Protocol Violation|0|||
150176645|NCT01641198|541783356|FG000|After 12 Months of Function|Adverse Event|0|||
149905373|NCT02004886|540783718|FG003|Overall Study|Adverse Event|0|||
149905374|NCT02004886|540783715|FG000|Overall Study|Unable to attend future visits|1|||
149905375|NCT02004886|540783716|FG001|Overall Study|Unable to attend future visits|0|||
149905376|NCT02004886|540783717|FG002|Overall Study|Unable to attend future visits|0|||
149905377|NCT02004886|540783718|FG003|Overall Study|Unable to attend future visits|0|||
149905378|NCT00638443|540783719|FG000|First Intervention|Adverse Event|2|||
149905379|NCT00638443|540783720|FG001|First Intervention|Adverse Event|1|||
149905380|NCT00282113|540783722|FG000|Overall Study|Removed at parents request|1|||
149905381|NCT00282113|540783723|FG001|Overall Study|Removed at parents request|0|||
149905382|NCT00282113|540783724|FG002|Overall Study|Removed at parents request|0|||
149905383|NCT02387957|540783725|FG000|Overall Study|The study was discontinued|21|||
149905384|NCT02387957|540783726|FG001|Overall Study|The study was discontinued|21|||
149905385|NCT02387957|540783727|FG002|Overall Study|The study was discontinued|20|||
149905386|NCT02294396|540783728|FG000|Overall Study|Adverse Event|26|||
149905387|NCT02294396|540783729|FG001|Overall Study|Adverse Event|25|||
149905388|NCT02294396|540783730|FG002|Overall Study|Adverse Event|21|||
149905389|NCT02294396|540783731|FG003|Overall Study|Adverse Event|24|||
149905390|NCT02294396|540783728|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
149905391|NCT02294396|540783729|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
149905392|NCT02294396|540783730|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
149905393|NCT02294396|540783731|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
149905394|NCT02294396|540783728|FG000|Overall Study|Withdrawal by Subject|8|||
149905395|NCT02294396|540783729|FG001|Overall Study|Withdrawal by Subject|6|||
149905396|NCT02294396|540783730|FG002|Overall Study|Withdrawal by Subject|6|||
149905397|NCT02294396|540783731|FG003|Overall Study|Withdrawal by Subject|8|||
149905398|NCT02294396|540783728|FG000|Overall Study|Lost to Follow-up|0|||
149905399|NCT02294396|540783729|FG001|Overall Study|Lost to Follow-up|0|||
149905400|NCT02294396|540783730|FG002|Overall Study|Lost to Follow-up|1|||
149905401|NCT02294396|540783731|FG003|Overall Study|Lost to Follow-up|1|||
149905402|NCT02294396|540783728|FG000|Overall Study|Protocol Deviation|3|||
149905403|NCT02294396|540783729|FG001|Overall Study|Protocol Deviation|2|||
149905404|NCT02294396|540783730|FG002|Overall Study|Protocol Deviation|2|||
149905405|NCT02294396|540783731|FG003|Overall Study|Protocol Deviation|1|||
149905406|NCT02294396|540783728|FG000|Overall Study|Miscellaneous|2|||
149905407|NCT02294396|540783729|FG001|Overall Study|Miscellaneous|0|||
149905408|NCT02294396|540783730|FG002|Overall Study|Miscellaneous|5|||
149905409|NCT02294396|540783731|FG003|Overall Study|Miscellaneous|2|||
149905410|NCT02949843|540783732|FG000|Overall Study|Withdrawal by Subject|0|||
149905411|NCT02949843|540783733|FG001|Overall Study|Withdrawal by Subject|1|||
149905412|NCT02949843|540783734|FG002|Overall Study|Withdrawal by Subject|1|||
149905413|NCT02120833|540783735|FG000|Overall Study|Adverse Event|1|||
149905414|NCT02120833|540783736|FG001|Overall Study|Adverse Event|0|||
149905415|NCT02120833|540783735|FG000|Overall Study|Withdrawal by Subject|2|||
149905416|NCT02120833|540783736|FG001|Overall Study|Withdrawal by Subject|0|||
149905417|NCT02120833|540783735|FG000|Overall Study|Lost to Follow-up|1|||
149905418|NCT02120833|540783736|FG001|Overall Study|Lost to Follow-up|1|||
149905419|NCT04463251|540783737|FG000|Overall Study|Death|1|||
149905420|NCT04463251|540783738|FG001|Overall Study|Death|0|||
149905421|NCT04463251|540783739|FG002|Overall Study|Death|1|||
150176646|NCT01641198|541783357|FG001|After 12 Months of Function|Adverse Event|1|||
150176647|NCT01641198|541783358|FG002|After 12 Months of Function|Adverse Event|0|||
149905422|NCT04463251|540783737|FG000|Overall Study|Adverse Event|0|||
149905423|NCT04463251|540783738|FG001|Overall Study|Adverse Event|1|||
149905424|NCT04463251|540783739|FG002|Overall Study|Adverse Event|0|||
149905425|NCT04463251|540783737|FG000|Overall Study|Lost to Follow-up|0|||
149905426|NCT04463251|540783738|FG001|Overall Study|Lost to Follow-up|1|||
149905427|NCT04463251|540783739|FG002|Overall Study|Lost to Follow-up|0|||
149905428|NCT04463251|540783737|FG000|Overall Study|Withdrawal by Subject|0|||
149905429|NCT04463251|540783738|FG001|Overall Study|Withdrawal by Subject|2|||
149905430|NCT04463251|540783739|FG002|Overall Study|Withdrawal by Subject|2|||
149905431|NCT04520997|540783740|FG000|Overall Study|Lost to Follow-up|1|||
149905432|NCT04520997|540783741|FG001|Overall Study|Lost to Follow-up|1|||
149905433|NCT04520997|540783740|FG000|Overall Study|Withdrawal by Subject|1|||
149905434|NCT04520997|540783741|FG001|Overall Study|Withdrawal by Subject|0|||
149905435|NCT04520997|540783740|FG000|Overall Study|Not Treated|0|||
149905436|NCT04520997|540783741|FG001|Overall Study|Not Treated|1|||
149905437|NCT03689374|540783744|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
149905438|NCT03689374|540783745|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
149905439|NCT03689374|540783746|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
149905440|NCT03689374|540783744|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
149905441|NCT03689374|540783745|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
149905442|NCT03689374|540783746|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
149905443|NCT03689374|540783744|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
149905444|NCT03689374|540783745|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
149905445|NCT03689374|540783746|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
149905446|NCT03689374|540783744|FG000|Treatment Period (Week 0 to 52)|Death|0|||
149905447|NCT03689374|540783745|FG001|Treatment Period (Week 0 to 52)|Death|11|||
149905448|NCT03689374|540783746|FG002|Treatment Period (Week 0 to 52)|Death|1|||
149905449|NCT05367973|540783747|FG000|Overall Study|Adverse Event|0|||
149905450|NCT05367973|540783748|FG001|Overall Study|Adverse Event|2|||
149905451|NCT03634033|540785687|FG000|Overall Study|Did not have a post-assessment|384|||
149905452|NCT03634033|540785688|FG001|Overall Study|Did not have a post-assessment|291|||
149905453|NCT03634033|540785689|FG002|Overall Study|Did not have a post-assessment|114|||
149905454|NCT03634033|540785690|FG003|Overall Study|Did not have a post-assessment|161|||
149905455|NCT03634033|540785691|FG004|Overall Study|Did not have a post-assessment|5|||
149905456|NCT03634033|540785692|FG005|Overall Study|Did not have a post-assessment|0|||
149905457|NCT03634033|540785693|FG006|Overall Study|Did not have a post-assessment|0|||
149905458|NCT03634033|540785687|FG000|Overall Study|Death|0|||
149905459|NCT03634033|540785688|FG001|Overall Study|Death|0|||
149905460|NCT03634033|540785689|FG002|Overall Study|Death|0|||
149905461|NCT03634033|540785690|FG003|Overall Study|Death|0|||
149905462|NCT03634033|540785691|FG004|Overall Study|Death|0|||
149970216|NCT00855335|541028345|FG002|Overall Study|Other|2|||
149970217|NCT00855335|541028346|FG003|Overall Study|Other|5|||
149970218|NCT00855335|541028347|FG004|Overall Study|Other|1|||
149970219|NCT02526290|541028352|FG000|Overall Study|Adverse Event|3|||
149970220|NCT02526290|541028352|FG000|Overall Study|Withdrawal by Subject|4|||
149970221|NCT02526290|541028352|FG000|Overall Study|Physician Decision|1|||
149970222|NCT02082977|541028355|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
149970223|NCT02082977|541028356|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
149970224|NCT02082977|541028357|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
149970225|NCT02082977|541028358|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
149970226|NCT02082977|541028359|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
149970227|NCT02082977|541028360|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
149970228|NCT02082977|541028361|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
149970229|NCT02082977|541028362|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
149970230|NCT02082977|541028363|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
149970231|NCT02082977|541028364|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
149970232|NCT02082977|541028355|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970233|NCT02082977|541028356|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970234|NCT02082977|541028357|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970235|NCT02082977|541028358|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970236|NCT02082977|541028359|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970237|NCT02082977|541028360|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970238|NCT02082977|541028361|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970239|NCT02082977|541028362|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
149970240|NCT02082977|541028363|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970241|NCT02082977|541028364|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
149970242|NCT02082977|541028355|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970243|NCT02082977|541028356|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149905463|NCT03634033|540785692|FG005|Overall Study|Death|7|||
149905464|NCT03634033|540785693|FG006|Overall Study|Death|7|||
149905465|NCT03634033|540785687|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
149905466|NCT03634033|540785688|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
149905467|NCT03634033|540785689|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
149905468|NCT03634033|540785690|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
149905469|NCT03634033|540785691|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
149905470|NCT03634033|540785692|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
149905471|NCT03634033|540785693|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
149905472|NCT03634033|540785687|FG000|Overall Study|Lost to Follow-up|0|||
149905473|NCT03634033|540785688|FG001|Overall Study|Lost to Follow-up|0|||
149905474|NCT03634033|540785689|FG002|Overall Study|Lost to Follow-up|0|||
149905475|NCT03634033|540785690|FG003|Overall Study|Lost to Follow-up|0|||
149905476|NCT03634033|540785691|FG004|Overall Study|Lost to Follow-up|0|||
149905477|NCT03634033|540785692|FG005|Overall Study|Lost to Follow-up|1|||
149905478|NCT03634033|540785693|FG006|Overall Study|Lost to Follow-up|2|||
149905479|NCT03634033|540785687|FG000|Overall Study|Withdrawal by Subject|0|||
149905480|NCT03634033|540785688|FG001|Overall Study|Withdrawal by Subject|0|||
149905481|NCT03634033|540785689|FG002|Overall Study|Withdrawal by Subject|0|||
149905482|NCT03634033|540785690|FG003|Overall Study|Withdrawal by Subject|0|||
149905483|NCT03634033|540785691|FG004|Overall Study|Withdrawal by Subject|0|||
149905484|NCT03634033|540785692|FG005|Overall Study|Withdrawal by Subject|0|||
149905485|NCT03634033|540785693|FG006|Overall Study|Withdrawal by Subject|1|||
149905486|NCT06366087|540785694|FG000|Overall Study|Withdrawal by Subject|0|||
149905487|NCT06366087|540785695|FG001|Overall Study|Withdrawal by Subject|1|||
149905488|NCT01397786|540785698|FG000|Phase A|Lost to Follow-up|0|||
149905489|NCT01397786|540785699|FG001|Phase A|Lost to Follow-up|0|||
149905490|NCT01397786|540785700|FG002|Phase A|Lost to Follow-up|6|||
149905491|NCT01397786|540785698|FG000|Phase A|Adverse Event|0|||
149905492|NCT01397786|540785699|FG001|Phase A|Adverse Event|0|||
149905493|NCT01397786|540785700|FG002|Phase A|Adverse Event|8|||
149905494|NCT01397786|540785698|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
149905495|NCT01397786|540785699|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
149905496|NCT01397786|540785700|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
149905497|NCT01397786|540785698|FG000|Phase A|Physician Decision|0|||
149905498|NCT01397786|540785699|FG001|Phase A|Physician Decision|0|||
149905499|NCT01397786|540785700|FG002|Phase A|Physician Decision|1|||
149905500|NCT01397786|540785698|FG000|Phase A|Withdrawal by Subject|0|||
149905501|NCT01397786|540785699|FG001|Phase A|Withdrawal by Subject|0|||
149905502|NCT01397786|540785700|FG002|Phase A|Withdrawal by Subject|5|||
149905503|NCT01397786|540785698|FG000|Phase A|Lack of Efficacy|0|||
149905504|NCT01397786|540785699|FG001|Phase A|Lack of Efficacy|0|||
149905505|NCT01397786|540785700|FG002|Phase A|Lack of Efficacy|1|||
149905506|NCT01397786|540785698|FG000|Phase B|Lost to Follow-up|22|||
149905507|NCT01397786|540785699|FG001|Phase B|Lost to Follow-up|12|||
149905508|NCT01397786|540785700|FG002|Phase B|Lost to Follow-up|22|||
149905509|NCT01397786|540785698|FG000|Phase B|Adverse Event|109|||
149905510|NCT01397786|540785699|FG001|Phase B|Adverse Event|23|||
149905511|NCT01397786|540785700|FG002|Phase B|Adverse Event|27|||
149905512|NCT01397786|540785698|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
149905513|NCT01397786|540785699|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
149905514|NCT01397786|540785700|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
149905515|NCT01397786|540785698|FG000|Phase B|Physician Decision|9|||
149905516|NCT01397786|540785699|FG001|Phase B|Physician Decision|1|||
149905517|NCT01397786|540785700|FG002|Phase B|Physician Decision|3|||
149905518|NCT01397786|540785698|FG000|Phase B|Withdrawal by Subject|102|||
149905519|NCT01397786|540785699|FG001|Phase B|Withdrawal by Subject|45|||
149905520|NCT01397786|540785700|FG002|Phase B|Withdrawal by Subject|30|||
149905521|NCT01397786|540785698|FG000|Phase B|Protocol Deviation|1|||
149905522|NCT01397786|540785699|FG001|Phase B|Protocol Deviation|2|||
149905523|NCT01397786|540785700|FG002|Phase B|Protocol Deviation|4|||
149905524|NCT01397786|540785698|FG000|Phase B|Lack of Efficacy|22|||
149905525|NCT01397786|540785699|FG001|Phase B|Lack of Efficacy|7|||
149905526|NCT01397786|540785700|FG002|Phase B|Lack of Efficacy|14|||
149905527|NCT00860249|540785704|FG000|Overall Study|trial was terminated prior to completion|21|||
149905528|NCT00860249|540785705|FG001|Overall Study|trial was terminated prior to completion|18|||
149905529|NCT00860249|540785706|FG002|Overall Study|trial was terminated prior to completion|21|||
149905530|NCT00519428|540785707|FG000|Overall Study|Adverse Event|5|||
149905531|NCT00519428|540785708|FG001|Overall Study|Adverse Event|2|||
149905532|NCT00519428|540785709|FG002|Overall Study|Adverse Event|10|||
149905533|NCT00519428|540785707|FG000|Overall Study|Lost to Follow-up|7|||
149905534|NCT00519428|540785708|FG001|Overall Study|Lost to Follow-up|7|||
149970244|NCT02082977|541028357|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970245|NCT02082977|541028358|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970246|NCT02082977|541028359|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149905535|NCT00519428|540785709|FG002|Overall Study|Lost to Follow-up|6|||
149970247|NCT02082977|541028360|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
149970248|NCT02082977|541028361|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149905536|NCT00519428|540785707|FG000|Overall Study|Withdrawal by Subject|8|||
149905537|NCT00519428|540785708|FG001|Overall Study|Withdrawal by Subject|3|||
149905538|NCT00519428|540785709|FG002|Overall Study|Withdrawal by Subject|7|||
149905539|NCT00519428|540785707|FG000|Overall Study|unstated|1|||
149905540|NCT00519428|540785708|FG001|Overall Study|unstated|3|||
149905541|NCT00519428|540785709|FG002|Overall Study|unstated|2|||
150047611|NCT01305577|541314578|FG001|Overall Study|Adverse Event|2|||
150047612|NCT01305577|541314579|FG002|Overall Study|Adverse Event|1|||
150047613|NCT01305577|541314577|FG000|Overall Study|Withdrawal by Subject|7|||
150047614|NCT01305577|541314578|FG001|Overall Study|Withdrawal by Subject|5|||
149905542|NCT02836236|540785713|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
149905543|NCT02836236|540785714|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
149905544|NCT02836236|540785715|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
149905545|NCT02836236|540785716|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
149905546|NCT02836236|540785713|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
149905547|NCT02836236|540785714|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
149905548|NCT02836236|540785715|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
149905549|NCT02836236|540785716|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
149905550|NCT02836236|540785713|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149905551|NCT02836236|540785714|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
149905552|NCT02836236|540785715|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
149905553|NCT02836236|540785716|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149905554|NCT02836236|540785713|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
149905555|NCT02836236|540785714|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149905556|NCT02836236|540785715|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149905557|NCT02836236|540785716|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
149905558|NCT02836236|540785713|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
149905559|NCT02836236|540785714|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
149905560|NCT02836236|540785715|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
149905561|NCT02836236|540785716|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
149905562|NCT02836236|540785713|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
149905563|NCT02836236|540785714|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
149905564|NCT02836236|540785715|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
149905565|NCT02836236|540785716|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
149970249|NCT02082977|541028362|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970250|NCT02082977|541028363|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970251|NCT02082977|541028364|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
149970252|NCT02082977|541028355|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
149970253|NCT02082977|541028356|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
149970254|NCT02082977|541028357|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
149970255|NCT02082977|541028358|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
149970256|NCT02082977|541028359|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
149970257|NCT02082977|541028360|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
149970258|NCT02082977|541028361|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
149970259|NCT02082977|541028362|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
149970260|NCT02082977|541028363|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
149970261|NCT02082977|541028364|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
149970262|NCT02082977|541028355|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970263|NCT02082977|541028356|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970264|NCT02082977|541028357|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970265|NCT02082977|541028358|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970266|NCT02082977|541028359|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970267|NCT02082977|541028360|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970268|NCT02082977|541028361|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970269|NCT02082977|541028362|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
149970270|NCT02082977|541028363|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970271|NCT02082977|541028364|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
149970272|NCT00049543|541028365|FG000|Overall Study|still on treatment|2|||
149970273|NCT00049543|541028366|FG001|Overall Study|still on treatment|9|||
149970274|NCT04138056|541028371|FG000|Primary Study|Lost to Follow-up|3|||
149970275|NCT04138056|541028372|FG001|Primary Study|Lost to Follow-up|4|||
149970276|NCT04138056|541028373|FG002|Primary Study|Lost to Follow-up|1|||
149970277|NCT04138056|541028374|FG003|Primary Study|Lost to Follow-up|1|||
149970278|NCT04138056|541028375|FG004|Primary Study|Lost to Follow-up|4|||
149970279|NCT04138056|541028371|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
149970280|NCT04138056|541028372|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
149970281|NCT04138056|541028373|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
150047615|NCT01305577|541314579|FG002|Overall Study|Withdrawal by Subject|6|||
149905566|NCT02836236|540785713|FG000|Open-Label TAF Treatment Phase|Death|0|||
149970282|NCT04138056|541028374|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
149970283|NCT04138056|541028375|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
149970284|NCT04138056|541028371|FG000|Extension Study|Lost to Follow-up|1|||
149970285|NCT04138056|541028372|FG001|Extension Study|Lost to Follow-up|2|||
150047616|NCT01305577|541314577|FG000|Overall Study|Lost to Follow-up|4|||
150047617|NCT01305577|541314578|FG001|Overall Study|Lost to Follow-up|3|||
150047618|NCT01305577|541314579|FG002|Overall Study|Lost to Follow-up|2|||
150047619|NCT01305577|541314577|FG000|Overall Study|Protocol Deviation|0|||
150047620|NCT01305577|541314578|FG001|Overall Study|Protocol Deviation|1|||
150047621|NCT01305577|541314579|FG002|Overall Study|Protocol Deviation|1|||
150047622|NCT00796978|541314580|FG000|Overall Study|Cardiac adverse event|5|||
150047623|NCT00796978|541314580|FG000|Overall Study|Adverse Event|4|||
150047624|NCT00796978|541314580|FG000|Overall Study|Withdrawal by Subject|3|||
150047625|NCT02834793|541314581|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
150047626|NCT02834793|541314582|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
150047627|NCT02834793|541314583|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
150047628|NCT02834793|541314584|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
150047629|NCT02834793|541314581|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
150047630|NCT02834793|541314582|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
150047631|NCT02834793|541314583|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
150047632|NCT02834793|541314584|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
150047633|NCT02834793|541314581|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
150047634|NCT02834793|541314582|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
150047635|NCT02834793|541314583|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
150047636|NCT02834793|541314584|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
150047637|NCT02834793|541314581|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
150047638|NCT02834793|541314582|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
150047639|NCT02834793|541314583|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
150047640|NCT02834793|541314584|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
150047641|NCT02834793|541314581|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
150047642|NCT02834793|541314582|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
150047643|NCT02834793|541314583|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
150047644|NCT02834793|541314584|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
150047645|NCT02834793|541314581|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
150047646|NCT02834793|541314582|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
150047647|NCT02834793|541314583|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
150047648|NCT02834793|541314584|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
150047649|NCT02834793|541314581|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
150047650|NCT02834793|541314582|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
150047651|NCT02834793|541314583|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
150047652|NCT02834793|541314584|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
150047653|NCT02834793|541314581|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
150047654|NCT02834793|541314582|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
150047655|NCT02834793|541314583|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
150047656|NCT02834793|541314584|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
150047657|NCT02834793|541314581|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
150047658|NCT02834793|541314582|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
150047659|NCT02834793|541314583|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
149905567|NCT02836236|540785714|FG001|Open-Label TAF Treatment Phase|Death|0|||
150047660|NCT02834793|541314584|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
150047661|NCT02834793|541314581|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
150047662|NCT02834793|541314582|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
149905568|NCT02836236|540785715|FG002|Open-Label TAF Treatment Phase|Death|1|||
149905569|NCT02836236|540785716|FG003|Open-Label TAF Treatment Phase|Death|1|||
149905570|NCT02836236|540785713|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
149905571|NCT02836236|540785714|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
149905572|NCT02836236|540785715|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
149905573|NCT02836236|540785716|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
149905574|NCT02703272|540785723|FG000|Overall Study|Death|4|||
149905575|NCT02703272|540785724|FG001|Overall Study|Death|9|||
149905576|NCT02703272|540785725|FG002|Overall Study|Death|19|||
149905577|NCT02703272|540785726|FG003|Overall Study|Death|10|||
149905578|NCT02703272|540785723|FG000|Overall Study|Withdrawal by Subject|0|||
150047663|NCT02834793|541314583|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
150047664|NCT02834793|541314584|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
150047665|NCT02834793|541314581|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
150047666|NCT02834793|541314582|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
149905579|NCT02703272|540785724|FG001|Overall Study|Withdrawal by Subject|0|||
149905580|NCT02703272|540785725|FG002|Overall Study|Withdrawal by Subject|4|||
149905581|NCT02703272|540785726|FG003|Overall Study|Withdrawal by Subject|2|||
150047667|NCT02834793|541314583|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
150047668|NCT02834793|541314584|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
149905582|NCT02703272|540785723|FG000|Overall Study|Study Terminated by Sponsor|6|||
149905583|NCT02703272|540785724|FG001|Overall Study|Study Terminated by Sponsor|1|||
149905584|NCT02703272|540785725|FG002|Overall Study|Study Terminated by Sponsor|12|||
149905585|NCT02703272|540785726|FG003|Overall Study|Study Terminated by Sponsor|4|||
149905586|NCT02703272|540785723|FG000|Overall Study|Other|1|||
149905587|NCT02703272|540785724|FG001|Overall Study|Other|0|||
149905588|NCT02703272|540785725|FG002|Overall Study|Other|0|||
149905589|NCT02703272|540785726|FG003|Overall Study|Other|0|||
149905590|NCT04470544|540785727|FG000|Overall Study|Withdrawal by Subject|4|||
149905591|NCT04470544|540785728|FG001|Overall Study|Withdrawal by Subject|6|||
149905592|NCT04720911|540785733|FG000|Overall Study|Withdrawal by Subject|0|||
149905593|NCT04720911|540785734|FG001|Overall Study|Withdrawal by Subject|1|||
149905594|NCT04720911|540785735|FG002|Overall Study|Withdrawal by Subject|0|||
149905595|NCT03315286|540785742|FG000|Overall Study|Lost to Follow-up|0|||
149905596|NCT03315286|540785743|FG001|Overall Study|Lost to Follow-up|3|||
149905597|NCT03315286|540785742|FG000|Overall Study|Withdrawal by Subject|1|||
149905598|NCT03315286|540785743|FG001|Overall Study|Withdrawal by Subject|0|||
149905599|NCT03315286|540785742|FG000|Overall Study|Protocol Violation|0|||
149905600|NCT03315286|540785743|FG001|Overall Study|Protocol Violation|1|||
149905601|NCT02989649|540785744|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
149905602|NCT02989649|540785744|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
149905603|NCT02989649|540785744|FG000|Overall Study|Lost For Observation During Study|3|||
149905604|NCT02989649|540785744|FG000|Overall Study|Reason Not Specified|13|||
149905605|NCT00256854|540785745|FG000|Overall Study|Withdrawal by Subject|2|||
149905606|NCT00256854|540785746|FG001|Overall Study|Withdrawal by Subject|3|||
149905607|NCT00256854|540785747|FG002|Overall Study|Withdrawal by Subject|0|||
149905608|NCT00256854|540785748|FG003|Overall Study|Withdrawal by Subject|0|||
149905609|NCT00256854|540785749|FG004|Overall Study|Withdrawal by Subject|0|||
149970286|NCT04138056|541028373|FG002|Extension Study|Lost to Follow-up|1|||
149970287|NCT04138056|541028374|FG003|Extension Study|Lost to Follow-up|0|||
149970288|NCT04138056|541028375|FG004|Extension Study|Lost to Follow-up|1|||
149970289|NCT02706392|541028380|FG000|Overall Study|Death|1|||
149970290|NCT02706392|541028381|FG001|Overall Study|Death|0|||
149970291|NCT02706392|541028382|FG002|Overall Study|Death|2|||
149970292|NCT02706392|541028383|FG003|Overall Study|Death|2|||
149970293|NCT02706392|541028384|FG004|Overall Study|Death|5|||
149970294|NCT02706392|541028385|FG005|Overall Study|Death|2|||
149970295|NCT00619866|541028388|FG000|Weeks 1 - 12|Adverse Event|0|||
149970296|NCT00619866|541028389|FG001|Weeks 1 - 12|Adverse Event|1|||
149970297|NCT00619866|541028390|FG002|Weeks 1 - 12|Adverse Event|2|||
149970298|NCT00619866|541028391|FG003|Weeks 1 - 12|Adverse Event|0|||
149970299|NCT00619866|541028392|FG004|Weeks 1 - 12|Adverse Event|0|||
149970300|NCT00619866|541028388|FG000|Weeks 1 - 12|Non-compliance|0|||
149970301|NCT00619866|541028389|FG001|Weeks 1 - 12|Non-compliance|0|||
149970302|NCT00619866|541028390|FG002|Weeks 1 - 12|Non-compliance|1|||
149970303|NCT00619866|541028391|FG003|Weeks 1 - 12|Non-compliance|0|||
149970304|NCT00619866|541028392|FG004|Weeks 1 - 12|Non-compliance|0|||
149970305|NCT00619866|541028388|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
149970306|NCT00619866|541028389|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
149970307|NCT00619866|541028390|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
149970308|NCT00619866|541028391|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
149970309|NCT00619866|541028392|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
149970310|NCT00619866|541028388|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
149970311|NCT00619866|541028389|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
149970312|NCT00619866|541028390|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
149970313|NCT00619866|541028391|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
149905610|NCT00256854|540785750|FG005|Overall Study|Withdrawal by Subject|0|||
149905611|NCT00256854|540785745|FG000|Overall Study|Lack of Efficacy|1|||
149905612|NCT00256854|540785746|FG001|Overall Study|Lack of Efficacy|0|||
149905613|NCT00256854|540785747|FG002|Overall Study|Lack of Efficacy|0|||
149905614|NCT00256854|540785748|FG003|Overall Study|Lack of Efficacy|0|||
149905615|NCT00256854|540785749|FG004|Overall Study|Lack of Efficacy|0|||
149905616|NCT00256854|540785750|FG005|Overall Study|Lack of Efficacy|0|||
149905617|NCT00256854|540785745|FG000|Overall Study|Protocol Violation|0|||
149970314|NCT00619866|541028392|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
149970315|NCT00619866|541028388|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
149970316|NCT00619866|541028389|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
149970317|NCT00619866|541028390|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
149970318|NCT00619866|541028391|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
149970319|NCT00619866|541028392|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
149970320|NCT00619866|541028388|FG000|Weeks 1 - 12|Sponsor Decision|0|||
149970321|NCT00619866|541028389|FG001|Weeks 1 - 12|Sponsor Decision|1|||
149970322|NCT00619866|541028390|FG002|Weeks 1 - 12|Sponsor Decision|0|||
149970323|NCT00619866|541028391|FG003|Weeks 1 - 12|Sponsor Decision|0|||
149970324|NCT00619866|541028392|FG004|Weeks 1 - 12|Sponsor Decision|0|||
149970325|NCT00619866|541028388|FG000|Weeks 13 - 24|Adverse Event|0|||
149970326|NCT00619866|541028389|FG001|Weeks 13 - 24|Adverse Event|0|||
149970327|NCT00619866|541028390|FG002|Weeks 13 - 24|Adverse Event|2|||
149970328|NCT00619866|541028391|FG003|Weeks 13 - 24|Adverse Event|1|||
149905618|NCT00256854|540785746|FG001|Overall Study|Protocol Violation|1|||
149905619|NCT00256854|540785747|FG002|Overall Study|Protocol Violation|1|||
149905620|NCT00256854|540785748|FG003|Overall Study|Protocol Violation|1|||
149905621|NCT00256854|540785749|FG004|Overall Study|Protocol Violation|0|||
149905622|NCT00256854|540785750|FG005|Overall Study|Protocol Violation|0|||
149905623|NCT00256854|540785745|FG000|Overall Study|Adverse Event|0|||
149905624|NCT00256854|540785746|FG001|Overall Study|Adverse Event|0|||
149905625|NCT00256854|540785747|FG002|Overall Study|Adverse Event|2|||
149905626|NCT00256854|540785748|FG003|Overall Study|Adverse Event|2|||
149905627|NCT00256854|540785749|FG004|Overall Study|Adverse Event|0|||
149905628|NCT00256854|540785750|FG005|Overall Study|Adverse Event|1|||
149905629|NCT00256854|540785745|FG000|Overall Study|Not compliant with the study drug|0|||
149905630|NCT00256854|540785746|FG001|Overall Study|Not compliant with the study drug|0|||
149905631|NCT00256854|540785747|FG002|Overall Study|Not compliant with the study drug|0|||
149905632|NCT00256854|540785748|FG003|Overall Study|Not compliant with the study drug|0|||
149905633|NCT00256854|540785749|FG004|Overall Study|Not compliant with the study drug|1|||
149905634|NCT00256854|540785750|FG005|Overall Study|Not compliant with the study drug|0|||
149905635|NCT02353442|540785751|FG000|Overall Study|Withdrawal by Subject|3|||
149905636|NCT02353442|540785752|FG001|Overall Study|Withdrawal by Subject|4|||
149905637|NCT03990571|540785753|FG000|Overall Study|Withdrawal by Subject|1|||
149905638|NCT03990571|540785753|FG000|Overall Study|Insurance Issues|3|||
149905639|NCT03990571|540785753|FG000|Overall Study|Covid Restrictions|2|||
149905640|NCT02980341|540785754|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
149905641|NCT02980341|540785755|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
149905642|NCT02980341|540785756|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
149905643|NCT02980341|540785757|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
149905644|NCT02980341|540785758|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
149905645|NCT02980341|540785759|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
149970329|NCT00619866|541028392|FG004|Weeks 13 - 24|Adverse Event|0|||
149970330|NCT00619866|541028388|FG000|Weeks 13 - 24|Protocol Deviation|0|||
149970331|NCT00619866|541028389|FG001|Weeks 13 - 24|Protocol Deviation|0|||
149970332|NCT00619866|541028390|FG002|Weeks 13 - 24|Protocol Deviation|0|||
149970333|NCT00619866|541028391|FG003|Weeks 13 - 24|Protocol Deviation|1|||
149970334|NCT00619866|541028392|FG004|Weeks 13 - 24|Protocol Deviation|0|||
149970335|NCT00619866|541028388|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
149970336|NCT00619866|541028389|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
149970337|NCT00619866|541028390|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
149970338|NCT00619866|541028391|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
149970339|NCT00619866|541028392|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
149970340|NCT00619866|541028388|FG000|Weeks 13 - 24|Non-compliance|0|||
149970341|NCT00619866|541028389|FG001|Weeks 13 - 24|Non-compliance|1|||
149970342|NCT00619866|541028390|FG002|Weeks 13 - 24|Non-compliance|1|||
149970343|NCT00619866|541028391|FG003|Weeks 13 - 24|Non-compliance|0|||
149970344|NCT00619866|541028392|FG004|Weeks 13 - 24|Non-compliance|0|||
149970345|NCT00619866|541028388|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
149970346|NCT00619866|541028389|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
149970347|NCT00619866|541028390|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
149970348|NCT00619866|541028391|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
149970349|NCT00619866|541028392|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
149970350|NCT01276106|541028401|FG000|Overall Study|Adverse Event|3|||
149970351|NCT01276106|541028402|FG001|Overall Study|Adverse Event|3|||
149970352|NCT01276106|541028403|FG002|Overall Study|Adverse Event|11|||
149970353|NCT01276106|541028404|FG003|Overall Study|Adverse Event|3|||
149970354|NCT01276106|541028401|FG000|Overall Study|Withdrawal by Subject|6|||
149970355|NCT01276106|541028402|FG001|Overall Study|Withdrawal by Subject|3|||
149970356|NCT01276106|541028403|FG002|Overall Study|Withdrawal by Subject|1|||
149970357|NCT01276106|541028404|FG003|Overall Study|Withdrawal by Subject|6|||
149970358|NCT01276106|541028401|FG000|Overall Study|Lack of Efficacy|0|||
149970359|NCT01276106|541028402|FG001|Overall Study|Lack of Efficacy|1|||
149970360|NCT01276106|541028403|FG002|Overall Study|Lack of Efficacy|0|||
149970361|NCT01276106|541028404|FG003|Overall Study|Lack of Efficacy|1|||
149970362|NCT01276106|541028401|FG000|Overall Study|Lost to Follow-up|2|||
149970363|NCT01276106|541028402|FG001|Overall Study|Lost to Follow-up|1|||
149970364|NCT01276106|541028403|FG002|Overall Study|Lost to Follow-up|1|||
149970365|NCT01276106|541028404|FG003|Overall Study|Lost to Follow-up|0|||
150047669|NCT02834793|541314581|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
149905646|NCT02980341|540785760|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
149970366|NCT01276106|541028401|FG000|Overall Study|Physician Decision|0|||
149970367|NCT01276106|541028402|FG001|Overall Study|Physician Decision|0|||
149905647|NCT02980341|540785761|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
149905648|NCT02980341|540785762|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
149905649|NCT02980341|540785763|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
149970368|NCT01276106|541028403|FG002|Overall Study|Physician Decision|1|||
149970369|NCT01276106|541028404|FG003|Overall Study|Physician Decision|1|||
149970370|NCT01276106|541028401|FG000|Overall Study|Protocol Violation|1|||
149970371|NCT01276106|541028402|FG001|Overall Study|Protocol Violation|1|||
149970372|NCT01276106|541028403|FG002|Overall Study|Protocol Violation|0|||
149905650|NCT02980341|540785764|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
150047670|NCT02834793|541314582|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
150047671|NCT02834793|541314583|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
149905651|NCT02980341|540785754|FG000|Dose Escalation|Clinical progression|0|||
149905652|NCT02980341|540785755|FG001|Dose Escalation|Clinical progression|0|||
149905653|NCT02980341|540785756|FG002|Dose Escalation|Clinical progression|2|||
149905654|NCT02980341|540785757|FG003|Dose Escalation|Clinical progression|1|||
149905655|NCT02980341|540785758|FG004|Dose Escalation|Clinical progression|0|||
149905656|NCT02980341|540785759|FG005|Dose Escalation|Clinical progression|0|||
149905657|NCT02980341|540785760|FG006|Dose Escalation|Clinical progression|0|||
149905658|NCT02980341|540785761|FG007|Dose Escalation|Clinical progression|0|||
149905659|NCT02980341|540785762|FG008|Dose Escalation|Clinical progression|0|||
149905660|NCT02980341|540785763|FG009|Dose Escalation|Clinical progression|0|||
149905661|NCT02980341|540785764|FG010|Dose Escalation|Clinical progression|0|||
149905662|NCT02980341|540785754|FG000|Dose Escalation|Adverse Event|0|||
149905663|NCT02980341|540785755|FG001|Dose Escalation|Adverse Event|0|||
149905664|NCT02980341|540785756|FG002|Dose Escalation|Adverse Event|1|||
149905665|NCT02980341|540785757|FG003|Dose Escalation|Adverse Event|2|||
149905666|NCT02980341|540785758|FG004|Dose Escalation|Adverse Event|2|||
149905667|NCT02980341|540785759|FG005|Dose Escalation|Adverse Event|0|||
149905668|NCT02980341|540785760|FG006|Dose Escalation|Adverse Event|0|||
149905669|NCT02980341|540785761|FG007|Dose Escalation|Adverse Event|0|||
149905670|NCT02980341|540785762|FG008|Dose Escalation|Adverse Event|0|||
149905671|NCT02980341|540785763|FG009|Dose Escalation|Adverse Event|0|||
149905672|NCT02980341|540785764|FG010|Dose Escalation|Adverse Event|0|||
149905673|NCT02980341|540785754|FG000|Dose Escalation|Withdrawal by Subject|0|||
149905674|NCT02980341|540785755|FG001|Dose Escalation|Withdrawal by Subject|0|||
149905675|NCT02980341|540785756|FG002|Dose Escalation|Withdrawal by Subject|1|||
149905676|NCT02980341|540785757|FG003|Dose Escalation|Withdrawal by Subject|0|||
149905677|NCT02980341|540785758|FG004|Dose Escalation|Withdrawal by Subject|0|||
149905678|NCT02980341|540785759|FG005|Dose Escalation|Withdrawal by Subject|0|||
149905679|NCT02980341|540785760|FG006|Dose Escalation|Withdrawal by Subject|0|||
149905680|NCT02980341|540785761|FG007|Dose Escalation|Withdrawal by Subject|0|||
149905681|NCT02980341|540785762|FG008|Dose Escalation|Withdrawal by Subject|0|||
149905682|NCT02980341|540785763|FG009|Dose Escalation|Withdrawal by Subject|0|||
149905683|NCT02980341|540785764|FG010|Dose Escalation|Withdrawal by Subject|0|||
149905684|NCT02980341|540785754|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905685|NCT02980341|540785755|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905686|NCT02980341|540785756|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905687|NCT02980341|540785757|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
149905688|NCT02980341|540785758|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905689|NCT02980341|540785759|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905690|NCT02980341|540785760|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905691|NCT02980341|540785761|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905692|NCT02980341|540785762|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905693|NCT02980341|540785763|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905694|NCT02980341|540785764|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
149905695|NCT02980341|540785754|FG000|Dose Escalation|Due to investigator's decision|0|||
149905696|NCT02980341|540785755|FG001|Dose Escalation|Due to investigator's decision|0|||
149905697|NCT02980341|540785756|FG002|Dose Escalation|Due to investigator's decision|0|||
149970373|NCT01276106|541028404|FG003|Overall Study|Protocol Violation|2|||
149970374|NCT01276106|541028401|FG000|Overall Study|Insufficient therapeutic effects|0|||
149970375|NCT01276106|541028402|FG001|Overall Study|Insufficient therapeutic effects|0|||
149970376|NCT01276106|541028403|FG002|Overall Study|Insufficient therapeutic effects|2|||
149970377|NCT01276106|541028404|FG003|Overall Study|Insufficient therapeutic effects|0|||
149970378|NCT01242514|541028407|FG000|Overall Study|e.g., project closure|1042|||
149970379|NCT01242514|541028408|FG001|Overall Study|e.g., project closure|305|||
149970380|NCT01242514|541028409|FG002|Overall Study|e.g., project closure|171|||
149970381|NCT01242514|541028407|FG000|Overall Study|Subject decision|33|||
149970382|NCT01242514|541028408|FG001|Overall Study|Subject decision|8|||
149970383|NCT01242514|541028409|FG002|Overall Study|Subject decision|2|||
149970384|NCT01242514|541028407|FG000|Overall Study|Severe non-compliance to protocol|5|||
150047672|NCT02834793|541314584|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
149970385|NCT01242514|541028408|FG001|Overall Study|Severe non-compliance to protocol|2|||
149970386|NCT01242514|541028409|FG002|Overall Study|Severe non-compliance to protocol|1|||
149905698|NCT02980341|540785757|FG003|Dose Escalation|Due to investigator's decision|0|||
149905699|NCT02980341|540785758|FG004|Dose Escalation|Due to investigator's decision|1|||
149905700|NCT02980341|540785759|FG005|Dose Escalation|Due to investigator's decision|0|||
149970387|NCT01242514|541028407|FG000|Overall Study|Lack of therapeutic response|99|||
149905701|NCT02980341|540785760|FG006|Dose Escalation|Due to investigator's decision|0|||
149905702|NCT02980341|540785761|FG007|Dose Escalation|Due to investigator's decision|0|||
149905703|NCT02980341|540785762|FG008|Dose Escalation|Due to investigator's decision|0|||
150047673|NCT02834793|541314581|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
150047674|NCT02834793|541314582|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
150047675|NCT02834793|541314583|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
150047676|NCT02834793|541314584|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
150047677|NCT02834793|541314581|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
150047678|NCT02834793|541314582|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
150047679|NCT02834793|541314583|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
150047680|NCT02834793|541314584|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
150047681|NCT02834793|541314581|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
150047682|NCT02834793|541314582|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
150047683|NCT02834793|541314583|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
150047684|NCT02834793|541314584|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
150047685|NCT02364336|541314585|FG000|Overall Study|Adverse Event|0|||
150047686|NCT02364336|541314586|FG001|Overall Study|Adverse Event|1|||
150047687|NCT01731938|541314587|FG000|Preliminary Part I|Withdrawal by Subject|2|||
150047688|NCT01731938|541314588|FG001|Preliminary Part I|Withdrawal by Subject|2|||
150047689|NCT01731938|541314587|FG000|Preliminary Part I|Physician Decision|1|||
150047690|NCT01731938|541314588|FG001|Preliminary Part I|Physician Decision|0|||
150047691|NCT01731938|541314587|FG000|Preliminary Part I|Lost to Follow-up|0|||
150047692|NCT01731938|541314588|FG001|Preliminary Part I|Lost to Follow-up|3|||
150047693|NCT01731938|541314587|FG000|Preliminary Part I|Missed Week 6 visit|0|||
150047694|NCT01731938|541314588|FG001|Preliminary Part I|Missed Week 6 visit|3|||
150047695|NCT01731938|541314587|FG000|Primary Part II|Withdrawal by Subject|5|||
150047696|NCT01731938|541314588|FG001|Primary Part II|Withdrawal by Subject|4|||
150047697|NCT01731938|541314587|FG000|Primary Part II|Lost to Follow-up|4|||
150047698|NCT01731938|541314588|FG001|Primary Part II|Lost to Follow-up|5|||
150047699|NCT01731938|541314587|FG000|Primary Part II|Death|2|||
150047700|NCT01731938|541314588|FG001|Primary Part II|Death|1|||
150047701|NCT01731938|541314587|FG000|Primary Part II|Missed Week 6 visit|2|||
150047702|NCT01731938|541314588|FG001|Primary Part II|Missed Week 6 visit|3|||
150047703|NCT01049009|541314589|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
150047704|NCT01049009|541314590|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
150047705|NCT01049009|541314589|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150047706|NCT01049009|541314590|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
150047707|NCT01049009|541314589|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
150047708|NCT01049009|541314590|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
150047709|NCT01049009|541314589|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
150047710|NCT01049009|541314590|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
150047711|NCT03179202|541314591|FG000|Overall Study|Screen Failure|67|||
150047712|NCT03179202|541314591|FG000|Overall Study|Subject Lost to Follow Up|12|||
150047713|NCT03179202|541314591|FG000|Overall Study|Withdrawal by Subject|7|||
150047714|NCT03179202|541314591|FG000|Overall Study|Adverse Event|3|||
150047715|NCT03179202|541314591|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
150047716|NCT03179202|541314591|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
150047717|NCT00859638|541314592|FG000|Overall Study|Lost to Follow-up|6|||
150047718|NCT00859638|541314593|FG001|Overall Study|Lost to Follow-up|1|||
150047719|NCT00859638|541314592|FG000|Overall Study|Withdrawal by Subject|3|||
150047720|NCT00859638|541314593|FG001|Overall Study|Withdrawal by Subject|2|||
150047721|NCT00859638|541314592|FG000|Overall Study|Ill health|1|||
150047722|NCT00859638|541314593|FG001|Overall Study|Ill health|1|||
150047723|NCT02969408|541314595|FG000|Overall Study|Adverse Event|2|||
150047724|NCT02969408|541314595|FG000|Overall Study|Withdrawal by Subject|8|||
150047725|NCT02969408|541314595|FG000|Overall Study|Lost to Follow-up|4|||
150047726|NCT02969408|541314595|FG000|Overall Study|Protocol Violation|1|||
150047727|NCT02969408|541314595|FG000|Overall Study|Other than specified|1|||
150047728|NCT04643158|541314599|FG000|Overall Study|Study terminated by sponsor|0|||
150047729|NCT04643158|541314600|FG001|Overall Study|Study terminated by sponsor|0|||
150047730|NCT04643158|541314601|FG002|Overall Study|Study terminated by sponsor|1|||
150047731|NCT04643158|541314602|FG003|Overall Study|Study terminated by sponsor|0|||
150047732|NCT04643158|541314603|FG004|Overall Study|Study terminated by sponsor|0|||
150047733|NCT04643158|541314604|FG005|Overall Study|Study terminated by sponsor|1|||
150047734|NCT04643158|541314605|FG006|Overall Study|Study terminated by sponsor|0|||
150047735|NCT04643158|541314599|FG000|Overall Study|Global/country situation|0|||
150047736|NCT04643158|541314600|FG001|Overall Study|Global/country situation|0|||
150047737|NCT04643158|541314601|FG002|Overall Study|Global/country situation|1|||
150047738|NCT04643158|541314602|FG003|Overall Study|Global/country situation|0|||
150047739|NCT04643158|541314603|FG004|Overall Study|Global/country situation|0|||
150047740|NCT04643158|541314604|FG005|Overall Study|Global/country situation|0|||
149905704|NCT02980341|540785763|FG009|Dose Escalation|Due to investigator's decision|0|||
149905705|NCT02980341|540785764|FG010|Dose Escalation|Due to investigator's decision|0|||
149905706|NCT02980341|540785754|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905707|NCT02980341|540785755|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905708|NCT02980341|540785756|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905709|NCT02980341|540785757|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905710|NCT02980341|540785758|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905711|NCT02980341|540785759|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
149905712|NCT02980341|540785760|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
149905713|NCT02980341|540785761|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905714|NCT02980341|540785762|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905715|NCT02980341|540785763|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905716|NCT02980341|540785764|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
149905717|NCT02980341|540785754|FG000|Dose Finding|Adverse Event|0|||
149905718|NCT02980341|540785755|FG001|Dose Finding|Adverse Event|0|||
149905719|NCT02980341|540785756|FG002|Dose Finding|Adverse Event|0|||
149905720|NCT02980341|540785757|FG003|Dose Finding|Adverse Event|0|||
149905721|NCT02980341|540785758|FG004|Dose Finding|Adverse Event|0|||
149905722|NCT02980341|540785759|FG005|Dose Finding|Adverse Event|3|||
149905723|NCT02980341|540785760|FG006|Dose Finding|Adverse Event|0|||
149905724|NCT02980341|540785761|FG007|Dose Finding|Adverse Event|0|||
149905725|NCT02980341|540785762|FG008|Dose Finding|Adverse Event|0|||
149905726|NCT02980341|540785763|FG009|Dose Finding|Adverse Event|0|||
149905727|NCT02980341|540785764|FG010|Dose Finding|Adverse Event|0|||
149905728|NCT02980341|540785754|FG000|Dose Finding|Withdrawal by Subject|0|||
149905729|NCT02980341|540785755|FG001|Dose Finding|Withdrawal by Subject|0|||
149905730|NCT02980341|540785756|FG002|Dose Finding|Withdrawal by Subject|0|||
149905731|NCT02980341|540785757|FG003|Dose Finding|Withdrawal by Subject|0|||
149905732|NCT02980341|540785758|FG004|Dose Finding|Withdrawal by Subject|0|||
149905733|NCT02980341|540785759|FG005|Dose Finding|Withdrawal by Subject|1|||
149905734|NCT02980341|540785760|FG006|Dose Finding|Withdrawal by Subject|1|||
149905735|NCT02980341|540785761|FG007|Dose Finding|Withdrawal by Subject|0|||
149905736|NCT02980341|540785762|FG008|Dose Finding|Withdrawal by Subject|0|||
149905737|NCT02980341|540785763|FG009|Dose Finding|Withdrawal by Subject|0|||
149905738|NCT02980341|540785764|FG010|Dose Finding|Withdrawal by Subject|0|||
149905739|NCT02980341|540785754|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905740|NCT02980341|540785755|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905741|NCT02980341|540785756|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905742|NCT02980341|540785757|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905743|NCT02980341|540785758|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905744|NCT02980341|540785759|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905745|NCT02980341|540785760|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
149905746|NCT02980341|540785761|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
149905747|NCT02980341|540785762|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
149905748|NCT02980341|540785763|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
149905749|NCT02980341|540785764|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
149905750|NCT02980341|540785754|FG000|Dose Expansion|Clinical progression|0|||
149905751|NCT02980341|540785755|FG001|Dose Expansion|Clinical progression|0|||
149905752|NCT02980341|540785756|FG002|Dose Expansion|Clinical progression|0|||
149905753|NCT02980341|540785757|FG003|Dose Expansion|Clinical progression|0|||
149905754|NCT02980341|540785758|FG004|Dose Expansion|Clinical progression|0|||
149905755|NCT02980341|540785759|FG005|Dose Expansion|Clinical progression|0|||
149970388|NCT01242514|541028408|FG001|Overall Study|Lack of therapeutic response|16|||
149905756|NCT02980341|540785760|FG006|Dose Expansion|Clinical progression|0|||
149905757|NCT02980341|540785761|FG007|Dose Expansion|Clinical progression|4|||
149905758|NCT02980341|540785762|FG008|Dose Expansion|Clinical progression|3|||
149905759|NCT02980341|540785763|FG009|Dose Expansion|Clinical progression|1|||
149905760|NCT02980341|540785764|FG010|Dose Expansion|Clinical progression|4|||
149905761|NCT02980341|540785754|FG000|Dose Expansion|Adverse Event|0|||
149905762|NCT02980341|540785755|FG001|Dose Expansion|Adverse Event|0|||
149905763|NCT02980341|540785756|FG002|Dose Expansion|Adverse Event|0|||
149905764|NCT02980341|540785757|FG003|Dose Expansion|Adverse Event|0|||
149905765|NCT02980341|540785758|FG004|Dose Expansion|Adverse Event|0|||
149905766|NCT02980341|540785759|FG005|Dose Expansion|Adverse Event|0|||
149905767|NCT02980341|540785760|FG006|Dose Expansion|Adverse Event|0|||
149905768|NCT02980341|540785761|FG007|Dose Expansion|Adverse Event|3|||
149970389|NCT01242514|541028409|FG002|Overall Study|Lack of therapeutic response|10|||
149970390|NCT01242514|541028407|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
149970391|NCT01242514|541028408|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
149905769|NCT02980341|540785762|FG008|Dose Expansion|Adverse Event|0|||
149905770|NCT02980341|540785763|FG009|Dose Expansion|Adverse Event|1|||
149905771|NCT02980341|540785764|FG010|Dose Expansion|Adverse Event|3|||
149905772|NCT02980341|540785754|FG000|Dose Expansion|Death|0|||
149905773|NCT02980341|540785755|FG001|Dose Expansion|Death|0|||
149905774|NCT02980341|540785756|FG002|Dose Expansion|Death|0|||
149905775|NCT02980341|540785757|FG003|Dose Expansion|Death|0|||
149905776|NCT02980341|540785758|FG004|Dose Expansion|Death|0|||
149905777|NCT02980341|540785759|FG005|Dose Expansion|Death|0|||
149905778|NCT02980341|540785760|FG006|Dose Expansion|Death|0|||
149905779|NCT02980341|540785761|FG007|Dose Expansion|Death|0|||
149905780|NCT02980341|540785762|FG008|Dose Expansion|Death|2|||
149905781|NCT02980341|540785763|FG009|Dose Expansion|Death|1|||
149905782|NCT02980341|540785764|FG010|Dose Expansion|Death|0|||
149905783|NCT02980341|540785754|FG000|Dose Expansion|Withdrawal by Subject|0|||
149905784|NCT02980341|540785755|FG001|Dose Expansion|Withdrawal by Subject|0|||
149905785|NCT02980341|540785756|FG002|Dose Expansion|Withdrawal by Subject|0|||
149905786|NCT02980341|540785757|FG003|Dose Expansion|Withdrawal by Subject|0|||
149905787|NCT02980341|540785758|FG004|Dose Expansion|Withdrawal by Subject|0|||
149905788|NCT02980341|540785759|FG005|Dose Expansion|Withdrawal by Subject|0|||
149905789|NCT02980341|540785760|FG006|Dose Expansion|Withdrawal by Subject|0|||
149905790|NCT02980341|540785761|FG007|Dose Expansion|Withdrawal by Subject|2|||
149905791|NCT02980341|540785762|FG008|Dose Expansion|Withdrawal by Subject|0|||
149905792|NCT02980341|540785763|FG009|Dose Expansion|Withdrawal by Subject|1|||
149905793|NCT02980341|540785764|FG010|Dose Expansion|Withdrawal by Subject|0|||
149905794|NCT02980341|540785754|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905795|NCT02980341|540785755|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905796|NCT02980341|540785756|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905797|NCT02980341|540785757|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905798|NCT02980341|540785758|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149970392|NCT01242514|541028409|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
149970393|NCT01242514|541028407|FG000|Overall Study|Lost to Follow-up|14|||
149970394|NCT01242514|541028408|FG001|Overall Study|Lost to Follow-up|5|||
149970395|NCT01242514|541028409|FG002|Overall Study|Lost to Follow-up|4|||
149970396|NCT01242514|541028407|FG000|Overall Study|Adverse Event|129|||
149970397|NCT01242514|541028408|FG001|Overall Study|Adverse Event|18|||
149970398|NCT01242514|541028409|FG002|Overall Study|Adverse Event|19|||
149970399|NCT00862940|541028411|FG000|Overall Study|Adverse Event|15|||
149970400|NCT00862940|541028412|FG001|Overall Study|Adverse Event|12|||
149970401|NCT00862940|541028411|FG000|Overall Study|Lack of Efficacy|1|||
149970402|NCT00862940|541028412|FG001|Overall Study|Lack of Efficacy|3|||
149970403|NCT00862940|541028411|FG000|Overall Study|Protocol Violation|2|||
149970404|NCT00862940|541028412|FG001|Overall Study|Protocol Violation|5|||
149970405|NCT00862940|541028411|FG000|Overall Study|Withdrawal by Subject|4|||
149970406|NCT00862940|541028412|FG001|Overall Study|Withdrawal by Subject|6|||
149970407|NCT00862940|541028411|FG000|Overall Study|Non-compliance|4|||
149970408|NCT00862940|541028412|FG001|Overall Study|Non-compliance|0|||
149970409|NCT00862940|541028411|FG000|Overall Study|Lost to Follow-up|0|||
149970410|NCT00862940|541028412|FG001|Overall Study|Lost to Follow-up|1|||
149970411|NCT00862940|541028411|FG000|Overall Study|Administrative or other reason(s)|4|||
149970412|NCT00862940|541028412|FG001|Overall Study|Administrative or other reason(s)|3|||
149970413|NCT00787150|541028413|FG000|Overall Study|Adverse Event|4|||
149970414|NCT00787150|541028414|FG001|Overall Study|Adverse Event|4|||
149970415|NCT00787150|541028415|FG002|Overall Study|Adverse Event|4|||
149970416|NCT00787150|541028413|FG000|Overall Study|Physician Decision|1|||
149970417|NCT00787150|541028414|FG001|Overall Study|Physician Decision|2|||
149970418|NCT00787150|541028415|FG002|Overall Study|Physician Decision|1|||
149970419|NCT00787150|541028413|FG000|Overall Study|Withdrawal by Subject|2|||
149970420|NCT00787150|541028414|FG001|Overall Study|Withdrawal by Subject|1|||
149970421|NCT00787150|541028415|FG002|Overall Study|Withdrawal by Subject|0|||
149970422|NCT00787150|541028413|FG000|Overall Study|Dosing incorrect study durg|2|||
149970423|NCT00787150|541028414|FG001|Overall Study|Dosing incorrect study durg|0|||
149970424|NCT00787150|541028415|FG002|Overall Study|Dosing incorrect study durg|0|||
149970425|NCT00879398|541028416|FG000|Overall Study|Visit Stop|399|||
149970426|NCT00879398|541028416|FG000|Overall Study|Lack of Efficacy|64|||
149970427|NCT00879398|541028416|FG000|Overall Study|Adverse Event|41|||
149970428|NCT00879398|541028416|FG000|Overall Study|Other Reasons|171|||
149970429|NCT05901636|541028433|FG000|Overall Study|Lost to Follow-up|0|||
149970430|NCT05901636|541028434|FG001|Overall Study|Lost to Follow-up|1|||
149970431|NCT05901636|541028435|FG002|Overall Study|Lost to Follow-up|0|||
149970432|NCT05901636|541028436|FG003|Overall Study|Lost to Follow-up|1|||
149970433|NCT05901636|541028437|FG004|Overall Study|Lost to Follow-up|1|||
149970434|NCT05901636|541028438|FG005|Overall Study|Lost to Follow-up|3|||
149970435|NCT05901636|541028439|FG006|Overall Study|Lost to Follow-up|1|||
149970436|NCT05901636|541028433|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
149970437|NCT05901636|541028434|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
149970438|NCT05901636|541028435|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
149970439|NCT05901636|541028436|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
149970440|NCT05901636|541028437|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
149970441|NCT05901636|541028438|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
149905799|NCT02980341|540785759|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905800|NCT02980341|540785760|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905801|NCT02980341|540785761|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
149905802|NCT02980341|540785762|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905803|NCT02980341|540785763|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905804|NCT02980341|540785764|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
149905805|NCT02980341|540785754|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905806|NCT02980341|540785755|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905807|NCT02980341|540785756|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905808|NCT02980341|540785757|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905809|NCT02980341|540785758|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905810|NCT02980341|540785759|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905811|NCT02980341|540785760|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905812|NCT02980341|540785761|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905813|NCT02980341|540785762|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
149905814|NCT02980341|540785763|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905815|NCT02980341|540785764|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
149905816|NCT02980341|540785754|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905817|NCT02980341|540785755|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905818|NCT02980341|540785756|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905819|NCT02980341|540785757|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905820|NCT02980341|540785758|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905821|NCT02980341|540785759|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905822|NCT02980341|540785760|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905823|NCT02980341|540785761|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905824|NCT02980341|540785762|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
149905825|NCT02980341|540785763|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905826|NCT02980341|540785764|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
149905827|NCT02980341|540785754|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905828|NCT02980341|540785755|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905829|NCT02980341|540785756|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905830|NCT02980341|540785757|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905831|NCT02980341|540785758|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905832|NCT02980341|540785759|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905833|NCT02980341|540785760|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905834|NCT02980341|540785761|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905835|NCT02980341|540785762|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905836|NCT02980341|540785763|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
149905837|NCT02980341|540785764|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
149905838|NCT02892422|540785770|FG000|Overall Study|Enrolled not treated|4|||
149905839|NCT02892422|540785770|FG000|Overall Study|Adverse Event|38|||
149905840|NCT02892422|540785770|FG000|Overall Study|Lack of Efficacy|32|||
149905841|NCT02892422|540785770|FG000|Overall Study|Non-compliance with study drug|11|||
149905842|NCT02892422|540785770|FG000|Overall Study|Protocol Violation|4|||
149905843|NCT02892422|540785770|FG000|Overall Study|Withdrawal by Subject|56|||
149905844|NCT02892422|540785770|FG000|Overall Study|Lost to Follow-up|5|||
149905845|NCT02892422|540785770|FG000|Overall Study|sponsor information 16159A results|21|||
149905846|NCT02892422|540785770|FG000|Overall Study|withdrawal of consent|13|||
149905847|NCT02892422|540785770|FG000|Overall Study|exclusion criteria met|3|||
149905848|NCT02892422|540785770|FG000|Overall Study|moving elsewhere|4|||
149905849|NCT02892422|540785770|FG000|Overall Study|non-compliance|10|||
149905850|NCT02892422|540785770|FG000|Overall Study|patient legally incapable|1|||
149905851|NCT02892422|540785770|FG000|Overall Study|patient decision|7|||
149905852|NCT02892422|540785770|FG000|Overall Study|Investigator decision|1|||
149905853|NCT03089697|540785771|FG000|Overall Study|Adverse Event|1|||
149905854|NCT03089697|540785772|FG001|Overall Study|Adverse Event|2|||
149905855|NCT03089697|540785771|FG000|Overall Study|Withdrawal by Subject|1|||
149905856|NCT03089697|540785772|FG001|Overall Study|Withdrawal by Subject|0|||
149905857|NCT00373958|540785784|FG000|Infant Series|Withdrawal by Subject|13|||
149905858|NCT00373958|540785785|FG001|Infant Series|Withdrawal by Subject|15|||
149905859|NCT00373958|540785784|FG000|Infant Series|Failed to return|8|||
149905860|NCT00373958|540785785|FG001|Infant Series|Failed to return|13|||
149905861|NCT00373958|540785784|FG000|Infant Series|Lost to Follow-up|6|||
149905862|NCT00373958|540785785|FG001|Infant Series|Lost to Follow-up|5|||
149905863|NCT00373958|540785784|FG000|Infant Series|Protocol Violation|3|||
149905864|NCT00373958|540785785|FG001|Infant Series|Protocol Violation|7|||
149905865|NCT00373958|540785784|FG000|Infant Series|Lost Kaiser coverage|4|||
149905866|NCT00373958|540785785|FG001|Infant Series|Lost Kaiser coverage|0|||
149905867|NCT00373958|540785784|FG000|Infant Series|Child relocated|1|||
149905868|NCT00373958|540785785|FG001|Infant Series|Child relocated|0|||
149905869|NCT00373958|540785784|FG000|Infant Series|Consent was not received|1|||
149905870|NCT00373958|540785785|FG001|Infant Series|Consent was not received|0|||
149905871|NCT00373958|540785784|FG000|Infant Series|Adverse Event|3|||
149905872|NCT00373958|540785785|FG001|Infant Series|Adverse Event|1|||
149905873|NCT00373958|540785784|FG000|Infant Series|Physician Decision|1|||
149905874|NCT00373958|540785785|FG001|Infant Series|Physician Decision|1|||
149905875|NCT00373958|540785784|FG000|Toddler Dose|Lost to Follow-up|5|||
149905876|NCT00373958|540785785|FG001|Toddler Dose|Lost to Follow-up|8|||
149905877|NCT00373958|540785784|FG000|Toddler Dose|Withdrawal by Subject|2|||
149905878|NCT00373958|540785785|FG001|Toddler Dose|Withdrawal by Subject|2|||
149905879|NCT00373958|540785784|FG000|Toddler Dose|Failed to return|1|||
149905880|NCT00373958|540785785|FG001|Toddler Dose|Failed to return|2|||
149905881|NCT00373958|540785784|FG000|Toddler Dose|Protocol Violation|0|||
149905882|NCT00373958|540785785|FG001|Toddler Dose|Protocol Violation|1|||
149905883|NCT00373958|540785784|FG000|Toddler Dose|Withdrawn after infant series|22|||
149905884|NCT00373958|540785785|FG001|Toddler Dose|Withdrawn after infant series|25|||
149905885|NCT00492648|540785788|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
149905886|NCT00492648|540785789|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
149905887|NCT03613649|540785790|FG000|Second Treatment|Lost to Follow-up|0|||
149905888|NCT03613649|540785791|FG001|Second Treatment|Lost to Follow-up|0|||
149905889|NCT03613649|540785792|FG002|Second Treatment|Lost to Follow-up|1|||
149905890|NCT03613649|540785793|FG003|Second Treatment|Lost to Follow-up|0|||
149905891|NCT03613649|540785794|FG004|Second Treatment|Lost to Follow-up|0|||
149905892|NCT03613649|540785795|FG005|Second Treatment|Lost to Follow-up|0|||
149905893|NCT03613649|540785796|FG006|Second Treatment|Lost to Follow-up|0|||
149905894|NCT03613649|540785797|FG007|Second Treatment|Lost to Follow-up|0|||
149905895|NCT03613649|540785798|FG008|Second Treatment|Lost to Follow-up|0|||
149905896|NCT03613649|540785799|FG009|Second Treatment|Lost to Follow-up|0|||
149905897|NCT03613649|540785800|FG010|Second Treatment|Lost to Follow-up|0|||
149905898|NCT03613649|540785801|FG011|Second Treatment|Lost to Follow-up|0|||
149905899|NCT03613649|540785790|FG000|Second Treatment|Withdrawal by Subject|0|||
149905900|NCT03613649|540785791|FG001|Second Treatment|Withdrawal by Subject|0|||
149905901|NCT03613649|540785792|FG002|Second Treatment|Withdrawal by Subject|0|||
149905902|NCT03613649|540785793|FG003|Second Treatment|Withdrawal by Subject|0|||
149905903|NCT03613649|540785794|FG004|Second Treatment|Withdrawal by Subject|1|||
149905904|NCT03613649|540785795|FG005|Second Treatment|Withdrawal by Subject|0|||
149905905|NCT03613649|540785796|FG006|Second Treatment|Withdrawal by Subject|0|||
149905906|NCT03613649|540785797|FG007|Second Treatment|Withdrawal by Subject|0|||
149905907|NCT03613649|540785798|FG008|Second Treatment|Withdrawal by Subject|0|||
149905908|NCT03613649|540785799|FG009|Second Treatment|Withdrawal by Subject|0|||
149905909|NCT03613649|540785800|FG010|Second Treatment|Withdrawal by Subject|0|||
149905910|NCT03613649|540785801|FG011|Second Treatment|Withdrawal by Subject|0|||
149905911|NCT03613649|540785790|FG000|Third Treatment|Lost to Follow-up|0|||
149905912|NCT03613649|540785791|FG001|Third Treatment|Lost to Follow-up|0|||
149905913|NCT03613649|540785792|FG002|Third Treatment|Lost to Follow-up|0|||
149905914|NCT03613649|540785793|FG003|Third Treatment|Lost to Follow-up|0|||
149905915|NCT03613649|540785794|FG004|Third Treatment|Lost to Follow-up|1|||
149905916|NCT03613649|540785795|FG005|Third Treatment|Lost to Follow-up|0|||
149905917|NCT03613649|540785796|FG006|Third Treatment|Lost to Follow-up|0|||
149905918|NCT03613649|540785797|FG007|Third Treatment|Lost to Follow-up|0|||
149905919|NCT03613649|540785798|FG008|Third Treatment|Lost to Follow-up|0|||
149905920|NCT03613649|540785799|FG009|Third Treatment|Lost to Follow-up|0|||
150176648|NCT01641198|541783356|FG000|After 24 Months of Function|Lost to Follow-up|4|||
150176649|NCT01641198|541783357|FG001|After 24 Months of Function|Lost to Follow-up|9|||
150176650|NCT01641198|541783358|FG002|After 24 Months of Function|Lost to Follow-up|6|||
149905921|NCT03613649|540785800|FG010|Third Treatment|Lost to Follow-up|0|||
150176651|NCT01641198|541783356|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
150176652|NCT01641198|541783357|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
150176653|NCT01641198|541783358|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
149905922|NCT03613649|540785801|FG011|Third Treatment|Lost to Follow-up|1|||
149905923|NCT03613649|540785790|FG000|Third Treatment|Protocol Violation|0|||
149905924|NCT03613649|540785791|FG001|Third Treatment|Protocol Violation|0|||
149905925|NCT03613649|540785792|FG002|Third Treatment|Protocol Violation|0|||
149905926|NCT03613649|540785793|FG003|Third Treatment|Protocol Violation|0|||
149905927|NCT03613649|540785794|FG004|Third Treatment|Protocol Violation|0|||
149905928|NCT03613649|540785795|FG005|Third Treatment|Protocol Violation|0|||
149905929|NCT03613649|540785796|FG006|Third Treatment|Protocol Violation|1|||
149905930|NCT03613649|540785797|FG007|Third Treatment|Protocol Violation|0|||
149905931|NCT03613649|540785798|FG008|Third Treatment|Protocol Violation|0|||
149905932|NCT03613649|540785799|FG009|Third Treatment|Protocol Violation|0|||
149905933|NCT03613649|540785800|FG010|Third Treatment|Protocol Violation|0|||
149905934|NCT03613649|540785801|FG011|Third Treatment|Protocol Violation|1|||
149905935|NCT03613649|540785790|FG000|Fourth Treatment|Protocol Violation|1|||
149905936|NCT03613649|540785791|FG001|Fourth Treatment|Protocol Violation|0|||
149905937|NCT03613649|540785792|FG002|Fourth Treatment|Protocol Violation|0|||
149905938|NCT03613649|540785793|FG003|Fourth Treatment|Protocol Violation|0|||
149905939|NCT03613649|540785794|FG004|Fourth Treatment|Protocol Violation|1|||
149905940|NCT03613649|540785795|FG005|Fourth Treatment|Protocol Violation|0|||
149905941|NCT03613649|540785796|FG006|Fourth Treatment|Protocol Violation|0|||
149905942|NCT03613649|540785797|FG007|Fourth Treatment|Protocol Violation|0|||
149905943|NCT03613649|540785798|FG008|Fourth Treatment|Protocol Violation|0|||
149905944|NCT03613649|540785799|FG009|Fourth Treatment|Protocol Violation|0|||
149905945|NCT03613649|540785800|FG010|Fourth Treatment|Protocol Violation|0|||
149905946|NCT03613649|540785801|FG011|Fourth Treatment|Protocol Violation|0|||
149905947|NCT03613649|540785790|FG000|Fourth Treatment|Physician Decision|0|||
149905948|NCT03613649|540785791|FG001|Fourth Treatment|Physician Decision|0|||
149905949|NCT03613649|540785792|FG002|Fourth Treatment|Physician Decision|0|||
149905950|NCT03613649|540785793|FG003|Fourth Treatment|Physician Decision|0|||
149905951|NCT03613649|540785794|FG004|Fourth Treatment|Physician Decision|0|||
149905952|NCT03613649|540785795|FG005|Fourth Treatment|Physician Decision|0|||
149905953|NCT03613649|540785796|FG006|Fourth Treatment|Physician Decision|1|||
149905954|NCT03613649|540785797|FG007|Fourth Treatment|Physician Decision|0|||
149905955|NCT03613649|540785798|FG008|Fourth Treatment|Physician Decision|0|||
149905956|NCT03613649|540785799|FG009|Fourth Treatment|Physician Decision|0|||
149905957|NCT03613649|540785800|FG010|Fourth Treatment|Physician Decision|0|||
149905958|NCT03613649|540785801|FG011|Fourth Treatment|Physician Decision|0|||
149905959|NCT03429244|540785804|FG000|Overall Study|Withdrawal by Subject|2|||
149905960|NCT03429244|540785805|FG001|Overall Study|Withdrawal by Subject|1|||
149905961|NCT03429244|540785806|FG002|Overall Study|Withdrawal by Subject|1|||
149905962|NCT01500187|540785808|FG000|Overall Study|Lost to Follow-up|6|||
149905963|NCT01500187|540785809|FG001|Overall Study|Lost to Follow-up|0|||
149905964|NCT00750139|540785810|FG000|Overall Study|Adverse Event|1|||
149905965|NCT00750139|540785811|FG001|Overall Study|Adverse Event|2|||
149905966|NCT00750139|540785812|FG002|Overall Study|Adverse Event|0|||
149905967|NCT00750139|540785813|FG003|Overall Study|Adverse Event|1|||
149905968|NCT00750139|540785810|FG000|Overall Study|Lost to Follow-up|17|||
149905969|NCT00750139|540785811|FG001|Overall Study|Lost to Follow-up|12|||
149905970|NCT00750139|540785812|FG002|Overall Study|Lost to Follow-up|15|||
149905971|NCT00750139|540785813|FG003|Overall Study|Lost to Follow-up|6|||
149905972|NCT00750139|540785810|FG000|Overall Study|Withdrawal by Subject|3|||
149905973|NCT00750139|540785811|FG001|Overall Study|Withdrawal by Subject|2|||
149905974|NCT00750139|540785812|FG002|Overall Study|Withdrawal by Subject|6|||
149905975|NCT00750139|540785813|FG003|Overall Study|Withdrawal by Subject|2|||
149905976|NCT00750139|540785810|FG000|Overall Study|Physician Decision|1|||
149905977|NCT00750139|540785811|FG001|Overall Study|Physician Decision|1|||
149905978|NCT00750139|540785812|FG002|Overall Study|Physician Decision|0|||
149905979|NCT00750139|540785813|FG003|Overall Study|Physician Decision|0|||
149905980|NCT00750139|540785810|FG000|Overall Study|Non-compliance|1|||
149905981|NCT00750139|540785811|FG001|Overall Study|Non-compliance|0|||
149905982|NCT00750139|540785812|FG002|Overall Study|Non-compliance|1|||
149905983|NCT00750139|540785813|FG003|Overall Study|Non-compliance|3|||
149905984|NCT00750139|540785810|FG000|Overall Study|Termination by sponsor|4|||
149905985|NCT00750139|540785811|FG001|Overall Study|Termination by sponsor|0|||
149905986|NCT00750139|540785812|FG002|Overall Study|Termination by sponsor|0|||
149905987|NCT00750139|540785813|FG003|Overall Study|Termination by sponsor|1|||
149905988|NCT00750139|540785810|FG000|Overall Study|Non-specific|62|||
149905989|NCT00750139|540785811|FG001|Overall Study|Non-specific|42|||
149905990|NCT00750139|540785812|FG002|Overall Study|Non-specific|79|||
149905991|NCT00750139|540785813|FG003|Overall Study|Non-specific|33|||
149905992|NCT00595517|540785814|FG000|Overall Study|Adverse Event|6|||
149905993|NCT00595517|540785814|FG000|Overall Study|Withdrawal by Subject|4|||
149905994|NCT00595517|540785814|FG000|Overall Study|Protocol Violation|2|||
149905995|NCT00595517|540785814|FG000|Overall Study|Recurrence of ulcer|5|||
149905996|NCT00595517|540785814|FG000|Overall Study|usage of prohibited treatment|1|||
149905997|NCT00595517|540785814|FG000|Overall Study|No intention to attend regularly|1|||
149905998|NCT00658775|540785815|FG000|Overall Study|Adverse Event|4|||
149905999|NCT00658775|540785816|FG001|Overall Study|Adverse Event|6|||
149906000|NCT00658775|540785815|FG000|Overall Study|Lost to Follow-up|17|||
149906001|NCT00658775|540785816|FG001|Overall Study|Lost to Follow-up|18|||
149906002|NCT00658775|540785815|FG000|Overall Study|Withdrawal by Subject|6|||
149906003|NCT00658775|540785816|FG001|Overall Study|Withdrawal by Subject|4|||
149906004|NCT00658775|540785815|FG000|Overall Study|Withdrawal of consent|8|||
149906005|NCT00658775|540785816|FG001|Overall Study|Withdrawal of consent|7|||
149906006|NCT00658775|540785815|FG000|Overall Study|Other|7|||
149906007|NCT00658775|540785816|FG001|Overall Study|Other|8|||
149906008|NCT01435460|540785830|FG000|Overall Study|Adverse Event|2|||
149906009|NCT01435460|540785831|FG001|Overall Study|Adverse Event|1|||
149906010|NCT01435460|540785830|FG000|Overall Study|Lost to Follow-up|6|||
149906011|NCT01435460|540785831|FG001|Overall Study|Lost to Follow-up|1|||
149906012|NCT01435460|540785830|FG000|Overall Study|Withdrawal by Subject|1|||
149906013|NCT01435460|540785831|FG001|Overall Study|Withdrawal by Subject|3|||
149906014|NCT01435460|540785830|FG000|Overall Study|Protocol Violation|0|||
149906015|NCT01435460|540785831|FG001|Overall Study|Protocol Violation|1|||
149906016|NCT01435460|540785830|FG000|Overall Study|Did not meet eligibility criteria|2|||
149906017|NCT01435460|540785831|FG001|Overall Study|Did not meet eligibility criteria|0|||
149906018|NCT01706939|540785832|FG000|Pre Randomization|Screen Failure|1|||
149906019|NCT01706939|540785833|FG001|Pre Randomization|Screen Failure|0|||
149906020|NCT01706939|540785834|FG002|Pre Randomization|Screen Failure|0|||
149906021|NCT01706939|540785832|FG000|Pre Randomization|Ineligible for Randomization|1|||
149906022|NCT01706939|540785833|FG001|Pre Randomization|Ineligible for Randomization|0|||
149906023|NCT01706939|540785834|FG002|Pre Randomization|Ineligible for Randomization|0|||
149906024|NCT01706939|540785832|FG000|Pre Randomization|Withdrawal by Subject|1|||
149906025|NCT01706939|540785833|FG001|Pre Randomization|Withdrawal by Subject|0|||
149906026|NCT01706939|540785834|FG002|Pre Randomization|Withdrawal by Subject|0|||
149906027|NCT01706939|540785832|FG000|Randomization|Insufficient QoL survey compliance|0|||
149906028|NCT01706939|540785833|FG001|Randomization|Insufficient QoL survey compliance|1|||
149906029|NCT01706939|540785834|FG002|Randomization|Insufficient QoL survey compliance|1|||
149906030|NCT01706939|540785832|FG000|Randomization|Progression of disease|0|||
149906031|NCT01706939|540785833|FG001|Randomization|Progression of disease|2|||
149906032|NCT01706939|540785834|FG002|Randomization|Progression of disease|1|||
149906033|NCT01046903|540785835|FG000|Overall Study|Lost to Follow-up|16|||
149906034|NCT01046903|540785835|FG000|Overall Study|Adverse Event|4|||
149906035|NCT01046903|540785835|FG000|Overall Study|Withdrawal by Subject|3|||
149906036|NCT01046903|540785835|FG000|Overall Study|Other|5|||
149906037|NCT01343277|540785836|FG000|Overall Study|Other|3|||
149906038|NCT01343277|540785837|FG001|Overall Study|Other|3|||
149906039|NCT01343277|540785836|FG000|Overall Study|Withdrawal by Subject|18|||
149906040|NCT01343277|540785837|FG001|Overall Study|Withdrawal by Subject|13|||
149906041|NCT01343277|540785836|FG000|Overall Study|Physician Decision|1|||
149906042|NCT01343277|540785837|FG001|Overall Study|Physician Decision|2|||
149906043|NCT01343277|540785836|FG000|Overall Study|Death|10|||
149906044|NCT01343277|540785837|FG001|Overall Study|Death|1|||
149906045|NCT01343277|540785836|FG000|Overall Study|Adverse Event|67|||
149906046|NCT01343277|540785837|FG001|Overall Study|Adverse Event|13|||
149906047|NCT01343277|540785836|FG000|Overall Study|Disease progression|270|||
149906048|NCT01343277|540785837|FG001|Overall Study|Disease progression|138|||
149906049|NCT01343277|540785836|FG000|Overall Study|Randomized not treated|6|||
149906050|NCT01343277|540785837|FG001|Overall Study|Randomized not treated|21|||
149906051|NCT01343277|540785836|FG000|Overall Study|Treatment ongoing|8|||
149906052|NCT01343277|540785837|FG001|Overall Study|Treatment ongoing|2|||
149906053|NCT01343277|540785836|FG000|Overall Study|Subsequent anticancer therapy|1|||
149906054|NCT01343277|540785837|FG001|Overall Study|Subsequent anticancer therapy|0|||
149906055|NCT01894100|540785838|FG000|Overall Study|Lost to Follow-up|0|||
149906056|NCT01894100|540785839|FG001|Overall Study|Lost to Follow-up|1|||
149906057|NCT01894100|540785838|FG000|Overall Study|Withdrawal by Subject|3|||
149906058|NCT01894100|540785839|FG001|Overall Study|Withdrawal by Subject|0|||
149906059|NCT00135512|540785840|FG000|Overall Study|Adverse Event|56|||
149906060|NCT00135512|540785840|FG000|Overall Study|Lack of Efficacy|25|||
149906061|NCT00135512|540785840|FG000|Overall Study|Other|42|||
149906062|NCT01094301|540785841|FG000|Trial Stage|Withdrawal by Subject|1|||
149906063|NCT01094301|540785841|FG000|Implant Stage|Adverse Event|1|||
149906064|NCT01094301|540785841|FG000|Implant Stage|Protocol Violation|1|||
149906065|NCT01094301|540785841|FG000|Implant Stage|Withdrawal by Subject|2|||
149906066|NCT01094301|540785841|FG000|Implant Stage|No return of pain|4|||
149906067|NCT04013672|540785843|FG000|Overall Study|Withdrawal by Subject|3|||
149906068|NCT04013672|540785844|FG001|Overall Study|Withdrawal by Subject|0|||
149906069|NCT04013672|540785843|FG000|Overall Study|Death|1|||
149906070|NCT04013672|540785844|FG001|Overall Study|Death|0|||
149906071|NCT04013672|540785843|FG000|Overall Study|Physician Decision|5|||
149906072|NCT04013672|540785844|FG001|Overall Study|Physician Decision|0|||
149906073|NCT00430573|540785845|FG000|Overall Study|Withdrawal by Subject|5|||
149906074|NCT05020665|540785848|FG000|Overall Study|Study terminated by Sponsor|5|||
149906075|NCT05020665|540785849|FG001|Overall Study|Study terminated by Sponsor|4|||
149906076|NCT05020665|540785848|FG000|Overall Study|Death|2|||
149906077|NCT05020665|540785849|FG001|Overall Study|Death|1|||
149906078|NCT05020665|540785848|FG000|Overall Study|Physician Decision|0|||
150047741|NCT04643158|541314605|FG006|Overall Study|Global/country situation|0|||
149906079|NCT05020665|540785849|FG001|Overall Study|Physician Decision|1|||
149906080|NCT05020665|540785848|FG000|Overall Study|Withdrawal by Subject|0|||
149906081|NCT05020665|540785849|FG001|Overall Study|Withdrawal by Subject|1|||
149906082|NCT05020665|540785848|FG000|Overall Study|Reason not specified|1|||
149906083|NCT05020665|540785849|FG001|Overall Study|Reason not specified|0|||
149906084|NCT01868022|540785850|FG000|Overall Study|Withdrawal by Subject|0|||
149906085|NCT01868022|540785851|FG001|Overall Study|Withdrawal by Subject|0|||
149906086|NCT01868022|540785852|FG002|Overall Study|Withdrawal by Subject|1|||
149906087|NCT01868022|540785853|FG003|Overall Study|Withdrawal by Subject|1|||
149906088|NCT01868022|540785854|FG004|Overall Study|Withdrawal by Subject|0|||
149906089|NCT01868022|540785855|FG005|Overall Study|Withdrawal by Subject|0|||
149906090|NCT01868022|540785856|FG006|Overall Study|Withdrawal by Subject|0|||
149906091|NCT01868022|540785857|FG007|Overall Study|Withdrawal by Subject|1|||
149906092|NCT01868022|540785858|FG008|Overall Study|Withdrawal by Subject|0|||
149906093|NCT01868022|540785850|FG000|Overall Study|Adverse Event|0|||
149906094|NCT01868022|540785851|FG001|Overall Study|Adverse Event|0|||
149906095|NCT01868022|540785852|FG002|Overall Study|Adverse Event|0|||
149906096|NCT01868022|540785853|FG003|Overall Study|Adverse Event|0|||
149906097|NCT01868022|540785854|FG004|Overall Study|Adverse Event|2|||
149906098|NCT01868022|540785855|FG005|Overall Study|Adverse Event|0|||
149906099|NCT01868022|540785856|FG006|Overall Study|Adverse Event|0|||
149906100|NCT01868022|540785857|FG007|Overall Study|Adverse Event|2|||
149906101|NCT01868022|540785858|FG008|Overall Study|Adverse Event|2|||
149906102|NCT01868022|540785850|FG000|Overall Study|Physician Decision|0|||
149906103|NCT01868022|540785851|FG001|Overall Study|Physician Decision|0|||
149906104|NCT01868022|540785852|FG002|Overall Study|Physician Decision|0|||
149906105|NCT01868022|540785853|FG003|Overall Study|Physician Decision|0|||
149906106|NCT01868022|540785854|FG004|Overall Study|Physician Decision|0|||
149906107|NCT01868022|540785855|FG005|Overall Study|Physician Decision|1|||
149906108|NCT01868022|540785856|FG006|Overall Study|Physician Decision|0|||
149906109|NCT01868022|540785857|FG007|Overall Study|Physician Decision|2|||
149906110|NCT01868022|540785858|FG008|Overall Study|Physician Decision|0|||
149906111|NCT01868022|540785850|FG000|Overall Study|Study closed/terminated|0|||
149906112|NCT01868022|540785851|FG001|Overall Study|Study closed/terminated|0|||
149906113|NCT01868022|540785852|FG002|Overall Study|Study closed/terminated|0|||
149906114|NCT01868022|540785853|FG003|Overall Study|Study closed/terminated|0|||
149906115|NCT01868022|540785854|FG004|Overall Study|Study closed/terminated|0|||
149906116|NCT01868022|540785855|FG005|Overall Study|Study closed/terminated|0|||
149906117|NCT01868022|540785856|FG006|Overall Study|Study closed/terminated|0|||
149906118|NCT01868022|540785857|FG007|Overall Study|Study closed/terminated|1|||
149906119|NCT01868022|540785858|FG008|Overall Study|Study closed/terminated|0|||
149906120|NCT01868022|540785850|FG000|Overall Study|Ongoing|0|||
149906121|NCT01868022|540785851|FG001|Overall Study|Ongoing|0|||
149906122|NCT01868022|540785852|FG002|Overall Study|Ongoing|0|||
149906123|NCT01868022|540785853|FG003|Overall Study|Ongoing|0|||
149906124|NCT01868022|540785854|FG004|Overall Study|Ongoing|0|||
149970442|NCT05901636|541028439|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
149970443|NCT05901636|541028433|FG000|Overall Study|Withdrawal by Subject|1|||
149970444|NCT05901636|541028434|FG001|Overall Study|Withdrawal by Subject|1|||
149906125|NCT01868022|540785855|FG005|Overall Study|Ongoing|0|||
149906126|NCT01868022|540785856|FG006|Overall Study|Ongoing|0|||
149906127|NCT01868022|540785857|FG007|Overall Study|Ongoing|3|||
149906128|NCT01868022|540785858|FG008|Overall Study|Ongoing|0|||
149906129|NCT02504827|540785862|FG000|Overall Study|Could not produce sputum|1|||
149906130|NCT03386994|540785863|FG000|Overall Study|Lung transplant|1|||
149906131|NCT03386994|540785863|FG000|Overall Study|Adverse Event|14|||
149906132|NCT03386994|540785863|FG000|Overall Study|Lost to Follow-up|4|||
149906133|NCT03386994|540785863|FG000|Overall Study|Withdrawal by Subject|3|||
149906134|NCT03386994|540785863|FG000|Overall Study|Death|16|||
149906135|NCT04740827|540785870|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
149970445|NCT05901636|541028435|FG002|Overall Study|Withdrawal by Subject|0|||
149970446|NCT05901636|541028436|FG003|Overall Study|Withdrawal by Subject|0|||
149906136|NCT04740827|540785871|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
149906137|NCT04740827|540785870|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
149906138|NCT04740827|540785871|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
149906139|NCT04740827|540785870|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
149906140|NCT04740827|540785871|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
149906141|NCT04740827|540785870|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
149906142|NCT04740827|540785871|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
149906143|NCT04740827|540785870|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
149906144|NCT04740827|540785871|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
149906145|NCT04740827|540785870|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
149906146|NCT04740827|540785871|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
149906147|NCT02147158|540785872|FG000|Treatment Course 1|Adverse Event|1|||
149906148|NCT02147158|540785873|FG001|Treatment Course 1|Adverse Event|4|||
149906149|NCT02147158|540785874|FG002|Treatment Course 1|Adverse Event|3|||
149906150|NCT02147158|540785875|FG003|Treatment Course 1|Adverse Event|4|||
149906151|NCT02147158|540785876|FG004|Treatment Course 1|Adverse Event|1|||
149906152|NCT02147158|540785877|FG005|Treatment Course 1|Adverse Event|2|||
149906153|NCT02147158|540785872|FG000|Treatment Course 1|Lost to Follow-up|2|||
149906154|NCT02147158|540785873|FG001|Treatment Course 1|Lost to Follow-up|4|||
149906155|NCT02147158|540785874|FG002|Treatment Course 1|Lost to Follow-up|3|||
149906156|NCT02147158|540785875|FG003|Treatment Course 1|Lost to Follow-up|3|||
149906157|NCT02147158|540785876|FG004|Treatment Course 1|Lost to Follow-up|2|||
149906158|NCT02147158|540785877|FG005|Treatment Course 1|Lost to Follow-up|4|||
149906159|NCT02147158|540785872|FG000|Treatment Course 1|Protocol Violation|0|||
149906160|NCT02147158|540785873|FG001|Treatment Course 1|Protocol Violation|0|||
149906161|NCT02147158|540785874|FG002|Treatment Course 1|Protocol Violation|1|||
149906162|NCT02147158|540785875|FG003|Treatment Course 1|Protocol Violation|1|||
149906163|NCT02147158|540785876|FG004|Treatment Course 1|Protocol Violation|0|||
149906164|NCT02147158|540785877|FG005|Treatment Course 1|Protocol Violation|0|||
149906165|NCT02147158|540785872|FG000|Treatment Course 1|Withdrawal of Consent|1|||
149906166|NCT02147158|540785873|FG001|Treatment Course 1|Withdrawal of Consent|1|||
149906167|NCT02147158|540785874|FG002|Treatment Course 1|Withdrawal of Consent|1|||
149906168|NCT02147158|540785875|FG003|Treatment Course 1|Withdrawal of Consent|5|||
149906169|NCT02147158|540785876|FG004|Treatment Course 1|Withdrawal of Consent|3|||
149906170|NCT02147158|540785877|FG005|Treatment Course 1|Withdrawal of Consent|2|||
149906171|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Adverse Event|1|||
149906172|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Adverse Event|0|||
149906173|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Adverse Event|0|||
149906174|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Adverse Event|1|||
149906175|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Adverse Event|0|||
149906176|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Adverse Event|0|||
149906177|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
149906178|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
149906179|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
149906180|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
149906181|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
149906182|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
149906183|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
149906184|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
149906185|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
149906186|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
149906187|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
149906188|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
149906189|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
149970447|NCT05901636|541028437|FG004|Overall Study|Withdrawal by Subject|1|||
149970448|NCT05901636|541028438|FG005|Overall Study|Withdrawal by Subject|1|||
149970449|NCT05901636|541028439|FG006|Overall Study|Withdrawal by Subject|0|||
149970450|NCT05901636|541028433|FG000|Overall Study|Other|0|||
149970451|NCT05901636|541028434|FG001|Overall Study|Other|0|||
149970452|NCT05901636|541028435|FG002|Overall Study|Other|1|||
149970453|NCT05901636|541028436|FG003|Overall Study|Other|1|||
149970454|NCT05901636|541028437|FG004|Overall Study|Other|0|||
149970455|NCT05901636|541028438|FG005|Overall Study|Other|0|||
149970456|NCT05901636|541028439|FG006|Overall Study|Other|0|||
149906190|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
149906191|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
149906192|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
149906193|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
149906194|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
149970457|NCT02303821|541028440|FG000|Overall Study|Withdrawal by Subject|0|||
149970458|NCT02303821|541028441|FG001|Overall Study|Withdrawal by Subject|0|||
149906195|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
149906196|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
149906197|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
149906198|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
149906199|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
149906200|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
149906201|NCT02147158|540785872|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
149906202|NCT02147158|540785873|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
149906203|NCT02147158|540785874|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
149906204|NCT02147158|540785875|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
149906205|NCT02147158|540785876|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
149906206|NCT02147158|540785877|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
149906207|NCT02147158|540785872|FG000|Treatment Course 2|Adverse Event|0|||
149906208|NCT02147158|540785873|FG001|Treatment Course 2|Adverse Event|4|||
149906209|NCT02147158|540785874|FG002|Treatment Course 2|Adverse Event|2|||
149906210|NCT02147158|540785875|FG003|Treatment Course 2|Adverse Event|1|||
149906211|NCT02147158|540785876|FG004|Treatment Course 2|Adverse Event|0|||
149906212|NCT02147158|540785877|FG005|Treatment Course 2|Adverse Event|1|||
149906213|NCT02147158|540785872|FG000|Treatment Course 2|Withdrawal of Consent|0|||
149906214|NCT02147158|540785873|FG001|Treatment Course 2|Withdrawal of Consent|1|||
149906215|NCT02147158|540785874|FG002|Treatment Course 2|Withdrawal of Consent|2|||
149906216|NCT02147158|540785875|FG003|Treatment Course 2|Withdrawal of Consent|3|||
149906217|NCT02147158|540785876|FG004|Treatment Course 2|Withdrawal of Consent|0|||
149906218|NCT02147158|540785877|FG005|Treatment Course 2|Withdrawal of Consent|0|||
149906219|NCT02147158|540785872|FG000|Treatment Course 2|Lost to Follow-up|1|||
149906220|NCT02147158|540785873|FG001|Treatment Course 2|Lost to Follow-up|0|||
149906221|NCT02147158|540785874|FG002|Treatment Course 2|Lost to Follow-up|1|||
149906222|NCT02147158|540785875|FG003|Treatment Course 2|Lost to Follow-up|1|||
149906223|NCT02147158|540785876|FG004|Treatment Course 2|Lost to Follow-up|0|||
149906224|NCT02147158|540785877|FG005|Treatment Course 2|Lost to Follow-up|1|||
149906225|NCT02147158|540785872|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
149906226|NCT02147158|540785873|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
149906227|NCT02147158|540785874|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
149906228|NCT02147158|540785875|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
149906229|NCT02147158|540785876|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
149906230|NCT02147158|540785877|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
149906231|NCT02147158|540785872|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
149906232|NCT02147158|540785873|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
149906233|NCT02147158|540785874|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
149906234|NCT02147158|540785875|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
149906235|NCT02147158|540785876|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
149906236|NCT02147158|540785877|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
149906237|NCT02147158|540785872|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
149906238|NCT02147158|540785873|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
149906239|NCT02147158|540785874|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
149906240|NCT02147158|540785875|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
149970459|NCT02303821|541028442|FG002|Overall Study|Withdrawal by Subject|0|||
149970460|NCT02303821|541028443|FG003|Overall Study|Withdrawal by Subject|0|||
149970461|NCT02303821|541028444|FG004|Overall Study|Withdrawal by Subject|0|||
149970462|NCT02303821|541028445|FG005|Overall Study|Withdrawal by Subject|0|||
149970463|NCT02303821|541028446|FG006|Overall Study|Withdrawal by Subject|0|||
149970464|NCT02303821|541028447|FG007|Overall Study|Withdrawal by Subject|2|||
149970465|NCT02303821|541028440|FG000|Overall Study|Death|0|||
149970466|NCT02303821|541028441|FG001|Overall Study|Death|2|||
149970467|NCT02303821|541028442|FG002|Overall Study|Death|0|||
149970468|NCT02303821|541028443|FG003|Overall Study|Death|0|||
149970469|NCT02303821|541028444|FG004|Overall Study|Death|0|||
149970470|NCT02303821|541028445|FG005|Overall Study|Death|3|||
149970471|NCT02303821|541028446|FG006|Overall Study|Death|41|||
149970472|NCT02303821|541028447|FG007|Overall Study|Death|29|||
149970473|NCT02303821|541028440|FG000|Overall Study|Lost to Follow-up|0|||
149970474|NCT02303821|541028441|FG001|Overall Study|Lost to Follow-up|0|||
149970475|NCT02303821|541028442|FG002|Overall Study|Lost to Follow-up|0|||
149970476|NCT02303821|541028443|FG003|Overall Study|Lost to Follow-up|0|||
149970477|NCT02303821|541028444|FG004|Overall Study|Lost to Follow-up|0|||
150176654|NCT01641198|541783356|FG000|At 15-20 Years of Function|Death|1|||
149906241|NCT02147158|540785876|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
149906242|NCT02147158|540785877|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
149906243|NCT02147158|540785872|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
149906244|NCT02147158|540785873|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
149906245|NCT02147158|540785874|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
149970478|NCT02303821|541028445|FG005|Overall Study|Lost to Follow-up|0|||
149970479|NCT02303821|541028446|FG006|Overall Study|Lost to Follow-up|1|||
149970480|NCT02303821|541028447|FG007|Overall Study|Lost to Follow-up|0|||
150176655|NCT01641198|541783357|FG001|At 15-20 Years of Function|Death|0|||
149970481|NCT02303821|541028440|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970482|NCT02303821|541028441|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970483|NCT02303821|541028442|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970484|NCT02303821|541028443|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970485|NCT02303821|541028444|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970486|NCT02303821|541028445|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970487|NCT02303821|541028446|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
149970488|NCT02303821|541028447|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
149970489|NCT02303821|541028440|FG000|Overall Study|Decision by sponsor|0|||
149970490|NCT02303821|541028441|FG001|Overall Study|Decision by sponsor|0|||
149970491|NCT02303821|541028442|FG002|Overall Study|Decision by sponsor|0|||
149970492|NCT02303821|541028443|FG003|Overall Study|Decision by sponsor|0|||
149970493|NCT02303821|541028444|FG004|Overall Study|Decision by sponsor|0|||
149970494|NCT02303821|541028445|FG005|Overall Study|Decision by sponsor|1|||
149970495|NCT02303821|541028446|FG006|Overall Study|Decision by sponsor|0|||
149970496|NCT02303821|541028447|FG007|Overall Study|Decision by sponsor|0|||
149970497|NCT02303821|541028440|FG000|Overall Study|Protocol-specified criteria|0|||
149970498|NCT02303821|541028441|FG001|Overall Study|Protocol-specified criteria|1|||
149970499|NCT02303821|541028442|FG002|Overall Study|Protocol-specified criteria|0|||
149970500|NCT02303821|541028443|FG003|Overall Study|Protocol-specified criteria|0|||
149970501|NCT02303821|541028444|FG004|Overall Study|Protocol-specified criteria|0|||
149970502|NCT02303821|541028445|FG005|Overall Study|Protocol-specified criteria|1|||
149970503|NCT02303821|541028446|FG006|Overall Study|Protocol-specified criteria|0|||
149970504|NCT02303821|541028447|FG007|Overall Study|Protocol-specified criteria|0|||
149970505|NCT02302222|541028448|FG000|Overall Study|Physician Decision|0|||
149970506|NCT02302222|541028449|FG001|Overall Study|Physician Decision|4|||
149970507|NCT02302222|541028448|FG000|Overall Study|Lost to Follow-up|1|||
149970508|NCT02302222|541028449|FG001|Overall Study|Lost to Follow-up|0|||
149970509|NCT02302222|541028448|FG000|Overall Study|Treatment discontinued before day 5|0|||
149970510|NCT02302222|541028449|FG001|Overall Study|Treatment discontinued before day 5|1|||
149970511|NCT02302222|541028448|FG000|Overall Study|Withdrawn prior to any treatment|0|||
149970512|NCT02302222|541028449|FG001|Overall Study|Withdrawn prior to any treatment|1|||
149970513|NCT03193801|541028450|FG000|Overall Study|Physician Decision|2|||
149970514|NCT03193801|541028450|FG000|Overall Study|Withdrawal by Subject|1|||
149970515|NCT03138564|541028451|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
149970516|NCT03138564|541028452|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
149970517|NCT03138564|541028451|FG000|Overall Study|Lost to Follow-up|16|||
149970518|NCT03138564|541028452|FG001|Overall Study|Lost to Follow-up|2|||
149970519|NCT03138564|541028451|FG000|Overall Study|Withdrawal by Subject|48|||
149970520|NCT03138564|541028452|FG001|Overall Study|Withdrawal by Subject|4|||
149970521|NCT03138564|541028451|FG000|Overall Study|No longer met eligibility criteria|2|||
149970522|NCT03138564|541028452|FG001|Overall Study|No longer met eligibility criteria|0|||
150047742|NCT04643158|541314599|FG000|Overall Study|Withdrawal by Subject|0|||
150047743|NCT04643158|541314600|FG001|Overall Study|Withdrawal by Subject|0|||
150047744|NCT04643158|541314601|FG002|Overall Study|Withdrawal by Subject|0|||
149906246|NCT02147158|540785875|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
149906247|NCT02147158|540785876|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
149906248|NCT02147158|540785877|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
149906249|NCT02147158|540785872|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
149906250|NCT02147158|540785873|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
149906251|NCT02147158|540785874|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
149906252|NCT02147158|540785875|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
149906253|NCT02147158|540785876|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
149906254|NCT02147158|540785877|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
149906255|NCT00940823|540785878|FG000|Overall Study|Death|8|||
149906256|NCT00940823|540785879|FG001|Overall Study|Death|12|||
149906257|NCT00940823|540785878|FG000|Overall Study|Lost to Follow-up|27|||
149906258|NCT00940823|540785879|FG001|Overall Study|Lost to Follow-up|20|||
149906259|NCT01082211|540785880|FG000|Overall Study|Protocol Violation|4|||
149906260|NCT01082211|540785880|FG000|Overall Study|No protocol treatment received|3|||
149906261|NCT04999163|540785881|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
149970523|NCT03138564|541028451|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
150176656|NCT01641198|541783358|FG002|At 15-20 Years of Function|Death|1|||
149906262|NCT04999163|540785882|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
149970524|NCT03138564|541028452|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
149970525|NCT03138564|541028451|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
149970526|NCT03138564|541028452|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
150047745|NCT04643158|541314602|FG003|Overall Study|Withdrawal by Subject|0|||
149906263|NCT04999163|540785881|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
149906264|NCT04999163|540785882|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
150047746|NCT04643158|541314603|FG004|Overall Study|Withdrawal by Subject|0|||
149906265|NCT04999163|540785881|FG000|Overall Study|Withdrawal by Subject|1|||
149906266|NCT04999163|540785882|FG001|Overall Study|Withdrawal by Subject|0|||
149906267|NCT01275755|540787480|FG000|Double-blind Treatment Period|Adverse Event|0|||
149906268|NCT01275755|540787481|FG001|Double-blind Treatment Period|Adverse Event|2|||
149906269|NCT01275755|540787480|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
149906270|NCT01275755|540787481|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
149906271|NCT01275755|540787480|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149906272|NCT01275755|540787481|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
149906273|NCT01275755|540787480|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
149906274|NCT01275755|540787481|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
149906275|NCT00174967|540787484|FG000|Overall Study|Adverse Event|1|||
149906276|NCT00174967|540787485|FG001|Overall Study|Adverse Event|2|||
149906277|NCT00174967|540787486|FG002|Overall Study|Adverse Event|2|||
149906278|NCT00174967|540787487|FG003|Overall Study|Adverse Event|1|||
149906279|NCT00174967|540787484|FG000|Overall Study|Gout Flare|0|||
149906280|NCT00174967|540787485|FG001|Overall Study|Gout Flare|0|||
149906281|NCT00174967|540787486|FG002|Overall Study|Gout Flare|0|||
150047747|NCT04643158|541314604|FG005|Overall Study|Withdrawal by Subject|1|||
150047748|NCT04643158|541314605|FG006|Overall Study|Withdrawal by Subject|0|||
149906282|NCT00174967|540787487|FG003|Overall Study|Gout Flare|1|||
149906283|NCT00174967|540787484|FG000|Overall Study|Other|0|||
149906284|NCT00174967|540787485|FG001|Overall Study|Other|1|||
149906285|NCT00174967|540787486|FG002|Overall Study|Other|0|||
149906286|NCT00174967|540787487|FG003|Overall Study|Other|0|||
149906287|NCT04420585|540787488|FG000|Overall Study|Adverse Event|1|||
149906288|NCT04420585|540787488|FG000|Overall Study|Never initiated medication|2|||
149906289|NCT00477750|540787489|FG000|Overall Study|Currently Receiving Treatment|11|||
149906290|NCT03558152|540787490|FG000|Overall Study|Adverse Event|0|||
149906291|NCT03558152|540787491|FG001|Overall Study|Adverse Event|0|||
149906292|NCT03558152|540787492|FG002|Overall Study|Adverse Event|1|||
149906293|NCT03558152|540787493|FG003|Overall Study|Adverse Event|1|||
149906294|NCT03558152|540787494|FG004|Overall Study|Adverse Event|2|||
149906295|NCT03558152|540787495|FG005|Overall Study|Adverse Event|1|||
149906296|NCT03558152|540787496|FG006|Overall Study|Adverse Event|1|||
149906297|NCT03558152|540787497|FG007|Overall Study|Adverse Event|0|||
149906298|NCT03558152|540787490|FG000|Overall Study|Death|0|||
149906299|NCT03558152|540787491|FG001|Overall Study|Death|0|||
149906300|NCT03558152|540787492|FG002|Overall Study|Death|0|||
149906301|NCT03558152|540787493|FG003|Overall Study|Death|0|||
149906302|NCT03558152|540787494|FG004|Overall Study|Death|1|||
149906303|NCT03558152|540787495|FG005|Overall Study|Death|0|||
149906304|NCT03558152|540787496|FG006|Overall Study|Death|0|||
149906305|NCT03558152|540787497|FG007|Overall Study|Death|0|||
149906306|NCT03558152|540787490|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
149906307|NCT03558152|540787491|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906308|NCT03558152|540787492|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906309|NCT03558152|540787493|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906310|NCT03558152|540787494|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906311|NCT03558152|540787495|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906312|NCT03558152|540787496|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906313|NCT03558152|540787497|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
149906314|NCT03558152|540787490|FG000|Overall Study|Miscalculation in mmcs|0|||
149906315|NCT03558152|540787491|FG001|Overall Study|Miscalculation in mmcs|0|||
149906316|NCT03558152|540787492|FG002|Overall Study|Miscalculation in mmcs|0|||
149906317|NCT03558152|540787493|FG003|Overall Study|Miscalculation in mmcs|0|||
149906318|NCT03558152|540787494|FG004|Overall Study|Miscalculation in mmcs|0|||
149906319|NCT03558152|540787495|FG005|Overall Study|Miscalculation in mmcs|0|||
149906320|NCT03558152|540787496|FG006|Overall Study|Miscalculation in mmcs|1|||
149906321|NCT03558152|540787497|FG007|Overall Study|Miscalculation in mmcs|0|||
149906322|NCT03558152|540787490|FG000|Overall Study|Mistake in calculation|0|||
149906323|NCT03558152|540787491|FG001|Overall Study|Mistake in calculation|0|||
149906324|NCT03558152|540787492|FG002|Overall Study|Mistake in calculation|0|||
149906325|NCT03558152|540787493|FG003|Overall Study|Mistake in calculation|1|||
150047749|NCT01092546|541314606|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
150047750|NCT00622440|541314619|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
150047751|NCT00622440|541314620|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
149906326|NCT03558152|540787494|FG004|Overall Study|Mistake in calculation|0|||
149906327|NCT03558152|540787495|FG005|Overall Study|Mistake in calculation|0|||
149906328|NCT03558152|540787496|FG006|Overall Study|Mistake in calculation|0|||
149906329|NCT03558152|540787497|FG007|Overall Study|Mistake in calculation|0|||
149906330|NCT03558152|540787490|FG000|Overall Study|Mistake in evaluation of disease status|0|||
149906331|NCT03558152|540787491|FG001|Overall Study|Mistake in evaluation of disease status|0|||
149906332|NCT03558152|540787492|FG002|Overall Study|Mistake in evaluation of disease status|0|||
150047752|NCT00622440|541314619|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
150047753|NCT00622440|541314620|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
149906333|NCT03558152|540787493|FG003|Overall Study|Mistake in evaluation of disease status|0|||
149906334|NCT03558152|540787494|FG004|Overall Study|Mistake in evaluation of disease status|0|||
149906335|NCT03558152|540787495|FG005|Overall Study|Mistake in evaluation of disease status|0|||
149906336|NCT03558152|540787496|FG006|Overall Study|Mistake in evaluation of disease status|0|||
149906337|NCT03558152|540787497|FG007|Overall Study|Mistake in evaluation of disease status|1|||
149906338|NCT03558152|540787490|FG000|Overall Study|Physician Decision|0|||
149906339|NCT03558152|540787491|FG001|Overall Study|Physician Decision|0|||
149906340|NCT03558152|540787492|FG002|Overall Study|Physician Decision|0|||
149906341|NCT03558152|540787493|FG003|Overall Study|Physician Decision|0|||
149906342|NCT03558152|540787494|FG004|Overall Study|Physician Decision|0|||
149906343|NCT03558152|540787495|FG005|Overall Study|Physician Decision|0|||
149906344|NCT03558152|540787496|FG006|Overall Study|Physician Decision|1|||
149906345|NCT03558152|540787497|FG007|Overall Study|Physician Decision|0|||
149906346|NCT03558152|540787490|FG000|Overall Study|Withdrawal by Subject|2|||
149906347|NCT03558152|540787491|FG001|Overall Study|Withdrawal by Subject|3|||
149906348|NCT03558152|540787492|FG002|Overall Study|Withdrawal by Subject|2|||
149906349|NCT03558152|540787493|FG003|Overall Study|Withdrawal by Subject|1|||
149906350|NCT03558152|540787494|FG004|Overall Study|Withdrawal by Subject|1|||
149906351|NCT03558152|540787495|FG005|Overall Study|Withdrawal by Subject|1|||
149906352|NCT03558152|540787496|FG006|Overall Study|Withdrawal by Subject|3|||
149906353|NCT03558152|540787497|FG007|Overall Study|Withdrawal by Subject|2|||
149906354|NCT03558152|540787490|FG000|Overall Study|Lack of Efficacy|11|||
149906355|NCT03558152|540787491|FG001|Overall Study|Lack of Efficacy|11|||
149906356|NCT03558152|540787492|FG002|Overall Study|Lack of Efficacy|10|||
149906357|NCT03558152|540787493|FG003|Overall Study|Lack of Efficacy|11|||
149906358|NCT03558152|540787494|FG004|Overall Study|Lack of Efficacy|14|||
149906359|NCT03558152|540787495|FG005|Overall Study|Lack of Efficacy|12|||
149906360|NCT03558152|540787496|FG006|Overall Study|Lack of Efficacy|14|||
149906361|NCT03558152|540787497|FG007|Overall Study|Lack of Efficacy|13|||
149906362|NCT03558152|540787490|FG000|Overall Study|Protocol Violation|1|||
149906363|NCT03558152|540787491|FG001|Overall Study|Protocol Violation|1|||
149906364|NCT03558152|540787492|FG002|Overall Study|Protocol Violation|0|||
149906365|NCT03558152|540787493|FG003|Overall Study|Protocol Violation|1|||
149906366|NCT03558152|540787494|FG004|Overall Study|Protocol Violation|1|||
149906367|NCT03558152|540787495|FG005|Overall Study|Protocol Violation|0|||
149906368|NCT03558152|540787496|FG006|Overall Study|Protocol Violation|2|||
149906369|NCT03558152|540787497|FG007|Overall Study|Protocol Violation|0|||
149906370|NCT00601172|540787498|FG000|Overall Study|Adverse Event|43|||
149906371|NCT00601172|540787499|FG001|Overall Study|Adverse Event|32|||
149906372|NCT00601172|540787498|FG000|Overall Study|Lack of Efficacy|11|||
149906373|NCT00601172|540787499|FG001|Overall Study|Lack of Efficacy|12|||
149906374|NCT00601172|540787498|FG000|Overall Study|Protocol Violation|2|||
149906375|NCT00601172|540787499|FG001|Overall Study|Protocol Violation|5|||
149906376|NCT00601172|540787498|FG000|Overall Study|Lost to Follow-up|4|||
149906377|NCT00601172|540787499|FG001|Overall Study|Lost to Follow-up|3|||
149906378|NCT00601172|540787498|FG000|Overall Study|Physician Decision|27|||
149906379|NCT00601172|540787499|FG001|Overall Study|Physician Decision|28|||
149906380|NCT00601172|540787498|FG000|Overall Study|Withdrawal by Subject|35|||
149906381|NCT00601172|540787499|FG001|Overall Study|Withdrawal by Subject|27|||
149906382|NCT00601172|540787498|FG000|Overall Study|Did not meet continuation criteria|19|||
150047754|NCT00622440|541314619|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
150047755|NCT00622440|541314620|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
150047756|NCT00622440|541314619|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
150047757|NCT00622440|541314620|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
149906383|NCT00601172|540787499|FG001|Overall Study|Did not meet continuation criteria|20|||
149906384|NCT04434469|540787503|FG000|Overall Study|Death|2|||
149906385|NCT04434469|540787504|FG001|Overall Study|Death|3|||
149906386|NCT04434469|540787505|FG002|Overall Study|Death|2|||
149906387|NCT04434469|540787506|FG003|Overall Study|Death|2|||
149906388|NCT04434469|540787507|FG004|Overall Study|Death|2|||
149906389|NCT04434469|540787508|FG005|Overall Study|Death|0|||
149906390|NCT04434469|540787503|FG000|Overall Study|Lost to Follow-up|0|||
149906391|NCT04434469|540787504|FG001|Overall Study|Lost to Follow-up|0|||
149906392|NCT04434469|540787505|FG002|Overall Study|Lost to Follow-up|0|||
149906393|NCT04434469|540787506|FG003|Overall Study|Lost to Follow-up|1|||
149906394|NCT04434469|540787507|FG004|Overall Study|Lost to Follow-up|1|||
149906395|NCT04434469|540787508|FG005|Overall Study|Lost to Follow-up|0|||
149906396|NCT04434469|540787503|FG000|Overall Study|Study terminated by sponsor|1|||
149906397|NCT04434469|540787504|FG001|Overall Study|Study terminated by sponsor|1|||
149906398|NCT04434469|540787505|FG002|Overall Study|Study terminated by sponsor|1|||
149906399|NCT04434469|540787506|FG003|Overall Study|Study terminated by sponsor|2|||
149906400|NCT04434469|540787507|FG004|Overall Study|Study terminated by sponsor|3|||
149906401|NCT04434469|540787508|FG005|Overall Study|Study terminated by sponsor|3|||
149906402|NCT04434469|540787503|FG000|Overall Study|Withdrawal by Subject|0|||
149906403|NCT04434469|540787504|FG001|Overall Study|Withdrawal by Subject|0|||
149906404|NCT04434469|540787505|FG002|Overall Study|Withdrawal by Subject|1|||
149906405|NCT04434469|540787506|FG003|Overall Study|Withdrawal by Subject|0|||
149906406|NCT04434469|540787507|FG004|Overall Study|Withdrawal by Subject|0|||
149906407|NCT04434469|540787508|FG005|Overall Study|Withdrawal by Subject|0|||
149906408|NCT01936181|540787515|FG000|Randomised, Double-blind|Adverse Event|27|||
149906409|NCT01936181|540787516|FG001|Randomised, Double-blind|Adverse Event|21|||
149906410|NCT01936181|540787517|FG002|Randomised, Double-blind|Adverse Event|0|||
149906411|NCT01936181|540787518|FG003|Randomised, Double-blind|Adverse Event|0|||
149906412|NCT01936181|540787515|FG000|Randomised, Double-blind|Protocol Violation|1|||
149906413|NCT01936181|540787516|FG001|Randomised, Double-blind|Protocol Violation|5|||
149906414|NCT01936181|540787517|FG002|Randomised, Double-blind|Protocol Violation|0|||
149906415|NCT01936181|540787518|FG003|Randomised, Double-blind|Protocol Violation|0|||
149906416|NCT01936181|540787515|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
149906417|NCT01936181|540787516|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
149906418|NCT01936181|540787517|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
149906419|NCT01936181|540787518|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
149906420|NCT01936181|540787515|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
149906421|NCT01936181|540787516|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
149906422|NCT01936181|540787517|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
149906423|NCT01936181|540787518|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
149906424|NCT01936181|540787515|FG000|Randomised, Double-blind|Pregnancy|0|||
149906425|NCT01936181|540787516|FG001|Randomised, Double-blind|Pregnancy|1|||
149906426|NCT01936181|540787517|FG002|Randomised, Double-blind|Pregnancy|0|||
149906427|NCT01936181|540787518|FG003|Randomised, Double-blind|Pregnancy|0|||
149906428|NCT01936181|540787515|FG000|Randomised, Double-blind|Physician Decision|4|||
149906429|NCT01936181|540787516|FG001|Randomised, Double-blind|Physician Decision|4|||
149906430|NCT01936181|540787517|FG002|Randomised, Double-blind|Physician Decision|0|||
149906431|NCT01936181|540787518|FG003|Randomised, Double-blind|Physician Decision|0|||
149906432|NCT01936181|540787515|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
149906433|NCT01936181|540787516|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
149906434|NCT01936181|540787517|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
149906435|NCT01936181|540787518|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
149906436|NCT01936181|540787515|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
149906437|NCT01936181|540787516|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
149906438|NCT01936181|540787517|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
149906439|NCT01936181|540787518|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
149906440|NCT01936181|540787515|FG000|Transition-extension|Adverse Event|3|||
149906441|NCT01936181|540787516|FG001|Transition-extension|Adverse Event|0|||
149906442|NCT01936181|540787517|FG002|Transition-extension|Adverse Event|3|||
149906443|NCT01936181|540787518|FG003|Transition-extension|Adverse Event|1|||
149906444|NCT01936181|540787515|FG000|Transition-extension|Lost to Follow-up|3|||
149906445|NCT01936181|540787516|FG001|Transition-extension|Lost to Follow-up|0|||
149906446|NCT01936181|540787517|FG002|Transition-extension|Lost to Follow-up|1|||
149906447|NCT01936181|540787518|FG003|Transition-extension|Lost to Follow-up|2|||
149906448|NCT01936181|540787515|FG000|Transition-extension|Physician Decision|2|||
149906449|NCT01936181|540787516|FG001|Transition-extension|Physician Decision|0|||
149906450|NCT01936181|540787517|FG002|Transition-extension|Physician Decision|0|||
149906451|NCT01936181|540787518|FG003|Transition-extension|Physician Decision|1|||
149906452|NCT01936181|540787515|FG000|Transition-extension|Withdrawal by Subject|7|||
149906453|NCT01936181|540787516|FG001|Transition-extension|Withdrawal by Subject|0|||
149906454|NCT01936181|540787517|FG002|Transition-extension|Withdrawal by Subject|2|||
149906455|NCT01936181|540787518|FG003|Transition-extension|Withdrawal by Subject|1|||
149906456|NCT00900757|540787519|FG000|Overall Study|screen failure|19|||
149906457|NCT00712881|540787524|FG000|Overall Study|Adverse Event|3|||
149906458|NCT00712881|540787525|FG001|Overall Study|Adverse Event|3|||
149906459|NCT00712881|540787524|FG000|Overall Study|Withdrawal by Subject|1|||
149906460|NCT00712881|540787525|FG001|Overall Study|Withdrawal by Subject|1|||
149906461|NCT00712881|540787524|FG000|Overall Study|Disease Progression|2|||
149906462|NCT00712881|540787525|FG001|Overall Study|Disease Progression|1|||
149906463|NCT00712881|540787524|FG000|Overall Study|Lost to Follow-up|1|||
149906464|NCT00712881|540787525|FG001|Overall Study|Lost to Follow-up|1|||
149906465|NCT00712881|540787524|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
149906466|NCT00712881|540787525|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
149906467|NCT00712881|540787524|FG000|Overall Study|Protocol Violation|1|||
149906468|NCT00712881|540787525|FG001|Overall Study|Protocol Violation|1|||
149906469|NCT00712881|540787524|FG000|Overall Study|Randomized but not treated|1|||
149906470|NCT00712881|540787525|FG001|Overall Study|Randomized but not treated|0|||
149906471|NCT02222545|540787527|FG000|Overall Study|Adverse Event|1|||
149906472|NCT02222545|540787528|FG001|Overall Study|Adverse Event|0|||
149906473|NCT02222545|540787529|FG002|Overall Study|Adverse Event|2|||
149906474|NCT02222545|540787527|FG000|Overall Study|Death|0|||
149906475|NCT02222545|540787528|FG001|Overall Study|Death|0|||
149906476|NCT02222545|540787529|FG002|Overall Study|Death|9|||
149906477|NCT02222545|540787527|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
149906478|NCT02222545|540787528|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
149906479|NCT02222545|540787529|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
149906480|NCT02222545|540787527|FG000|Overall Study|Withdrawal by Subject|0|||
149906481|NCT02222545|540787528|FG001|Overall Study|Withdrawal by Subject|0|||
149906482|NCT02222545|540787529|FG002|Overall Study|Withdrawal by Subject|3|||
149906483|NCT02222545|540787527|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
149906484|NCT02222545|540787528|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
149906485|NCT02222545|540787529|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
149906486|NCT02651155|540787530|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149906487|NCT02651155|540787531|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
149906488|NCT02651155|540787530|FG000|Overall Study|Voluntary Withdrawal|5|||
149906489|NCT02651155|540787531|FG001|Overall Study|Voluntary Withdrawal|0|||
149906490|NCT00537316|540787532|FG000|Part 1|Adverse Event|7|||
149906491|NCT00537316|540787533|FG001|Part 1|Adverse Event|11|||
149906492|NCT00537316|540787534|FG002|Part 1|Adverse Event|8|||
149906493|NCT00537316|540787535|FG003|Part 1|Adverse Event|0|||
149906494|NCT00537316|540787536|FG004|Part 1|Adverse Event|0|||
149906495|NCT00537316|540787537|FG005|Part 1|Adverse Event|0|||
149906496|NCT00537316|540787538|FG006|Part 1|Adverse Event|0|||
149906497|NCT00537316|540787532|FG000|Part 1|Protocol defined clinical event|1|||
149906498|NCT00537316|540787533|FG001|Part 1|Protocol defined clinical event|0|||
149906499|NCT00537316|540787534|FG002|Part 1|Protocol defined clinical event|0|||
149906500|NCT00537316|540787535|FG003|Part 1|Protocol defined clinical event|0|||
149906501|NCT00537316|540787536|FG004|Part 1|Protocol defined clinical event|0|||
149906502|NCT00537316|540787537|FG005|Part 1|Protocol defined clinical event|0|||
149906503|NCT00537316|540787538|FG006|Part 1|Protocol defined clinical event|0|||
149906504|NCT00537316|540787532|FG000|Part 1|Lost to Follow-up|1|||
149906505|NCT00537316|540787533|FG001|Part 1|Lost to Follow-up|0|||
149906506|NCT00537316|540787534|FG002|Part 1|Lost to Follow-up|0|||
149906507|NCT00537316|540787535|FG003|Part 1|Lost to Follow-up|0|||
149906508|NCT00537316|540787536|FG004|Part 1|Lost to Follow-up|0|||
149906509|NCT00537316|540787537|FG005|Part 1|Lost to Follow-up|0|||
149906510|NCT00537316|540787538|FG006|Part 1|Lost to Follow-up|0|||
149906511|NCT00537316|540787532|FG000|Part 1|Withdrawal by Subject|3|||
149906512|NCT00537316|540787533|FG001|Part 1|Withdrawal by Subject|8|||
149906513|NCT00537316|540787534|FG002|Part 1|Withdrawal by Subject|4|||
149906514|NCT00537316|540787535|FG003|Part 1|Withdrawal by Subject|0|||
149906515|NCT00537316|540787536|FG004|Part 1|Withdrawal by Subject|0|||
149906516|NCT00537316|540787537|FG005|Part 1|Withdrawal by Subject|0|||
149906517|NCT00537316|540787538|FG006|Part 1|Withdrawal by Subject|0|||
149906518|NCT00537316|540787532|FG000|Part 1|Protocol Violation|1|||
149906519|NCT00537316|540787533|FG001|Part 1|Protocol Violation|5|||
149906520|NCT00537316|540787534|FG002|Part 1|Protocol Violation|1|||
149906521|NCT00537316|540787535|FG003|Part 1|Protocol Violation|0|||
149906522|NCT00537316|540787536|FG004|Part 1|Protocol Violation|0|||
149906523|NCT00537316|540787537|FG005|Part 1|Protocol Violation|0|||
149906524|NCT00537316|540787538|FG006|Part 1|Protocol Violation|0|||
149906525|NCT00537316|540787532|FG000|Part 1|Did not meet protocol eligibility|1|||
149906526|NCT00537316|540787533|FG001|Part 1|Did not meet protocol eligibility|3|||
149906527|NCT00537316|540787534|FG002|Part 1|Did not meet protocol eligibility|2|||
149906528|NCT00537316|540787535|FG003|Part 1|Did not meet protocol eligibility|0|||
149906529|NCT00537316|540787536|FG004|Part 1|Did not meet protocol eligibility|0|||
149906530|NCT00537316|540787537|FG005|Part 1|Did not meet protocol eligibility|0|||
149906531|NCT00537316|540787538|FG006|Part 1|Did not meet protocol eligibility|0|||
149906532|NCT00537316|540787532|FG000|Part 1|Administrative|0|||
149906533|NCT00537316|540787533|FG001|Part 1|Administrative|0|||
149906534|NCT00537316|540787534|FG002|Part 1|Administrative|2|||
149906535|NCT00537316|540787535|FG003|Part 1|Administrative|0|||
149906536|NCT00537316|540787536|FG004|Part 1|Administrative|0|||
149906537|NCT00537316|540787537|FG005|Part 1|Administrative|0|||
149906538|NCT00537316|540787538|FG006|Part 1|Administrative|0|||
149906539|NCT00537316|540787532|FG000|Part 2|Never entered follow-up|0|||
149906540|NCT00537316|540787533|FG001|Part 2|Never entered follow-up|0|||
149906541|NCT00537316|540787534|FG002|Part 2|Never entered follow-up|0|||
149906542|NCT00537316|540787535|FG003|Part 2|Never entered follow-up|0|||
149906543|NCT00537316|540787536|FG004|Part 2|Never entered follow-up|0|||
149906544|NCT00537316|540787537|FG005|Part 2|Never entered follow-up|0|||
149906545|NCT00537316|540787538|FG006|Part 2|Never entered follow-up|1|||
149906546|NCT00537316|540787532|FG000|Part 2|Adverse Event|4|||
149906547|NCT00537316|540787533|FG001|Part 2|Adverse Event|0|||
149906548|NCT00537316|540787534|FG002|Part 2|Adverse Event|2|||
149906549|NCT00537316|540787535|FG003|Part 2|Adverse Event|0|||
149906550|NCT00537316|540787536|FG004|Part 2|Adverse Event|0|||
149906551|NCT00537316|540787537|FG005|Part 2|Adverse Event|0|||
149906552|NCT00537316|540787538|FG006|Part 2|Adverse Event|0|||
149906553|NCT00537316|540787532|FG000|Part 2|Lost to Follow-up|1|||
149906554|NCT00537316|540787533|FG001|Part 2|Lost to Follow-up|0|||
149906555|NCT00537316|540787534|FG002|Part 2|Lost to Follow-up|2|||
149906556|NCT00537316|540787535|FG003|Part 2|Lost to Follow-up|0|||
149906557|NCT00537316|540787536|FG004|Part 2|Lost to Follow-up|0|||
149906558|NCT00537316|540787537|FG005|Part 2|Lost to Follow-up|0|||
149906559|NCT00537316|540787538|FG006|Part 2|Lost to Follow-up|0|||
149906560|NCT00537316|540787532|FG000|Part 2|Withdrawal by Subject|5|||
149906561|NCT00537316|540787533|FG001|Part 2|Withdrawal by Subject|1|||
149906562|NCT00537316|540787534|FG002|Part 2|Withdrawal by Subject|4|||
149906563|NCT00537316|540787535|FG003|Part 2|Withdrawal by Subject|0|||
149906564|NCT00537316|540787536|FG004|Part 2|Withdrawal by Subject|0|||
149906565|NCT00537316|540787537|FG005|Part 2|Withdrawal by Subject|0|||
149906566|NCT00537316|540787538|FG006|Part 2|Withdrawal by Subject|0|||
149906567|NCT00537316|540787532|FG000|Part 2|Administrative|16|||
149906568|NCT00537316|540787533|FG001|Part 2|Administrative|8|||
149906569|NCT00537316|540787534|FG002|Part 2|Administrative|24|||
149906570|NCT00537316|540787535|FG003|Part 2|Administrative|3|||
149906571|NCT00537316|540787536|FG004|Part 2|Administrative|1|||
149906572|NCT00537316|540787537|FG005|Part 2|Administrative|4|||
149906573|NCT00537316|540787538|FG006|Part 2|Administrative|1|||
149906574|NCT04533412|540787539|FG000|Overall Study|Withdrawal by Subject|1|||
149906575|NCT04533412|540787540|FG001|Overall Study|Withdrawal by Subject|1|||
149906576|NCT04533412|540787539|FG000|Overall Study|Lost to Follow-up|1|||
149906577|NCT04533412|540787540|FG001|Overall Study|Lost to Follow-up|4|||
149906578|NCT05113979|540787541|FG000|Overall Study|Death|2|||
149906579|NCT05113979|540787541|FG000|Overall Study|Lost to Follow-up|1|||
149906580|NCT02048826|540787542|FG000|Overall Study|Withdrawal by Subject|1|||
149906581|NCT02048826|540787543|FG001|Overall Study|Withdrawal by Subject|0|||
149906582|NCT03452488|540787545|FG000|Overall Study|Adverse Event|4|||
149906583|NCT03452488|540787546|FG001|Overall Study|Adverse Event|6|||
149906584|NCT03452488|540787547|FG002|Overall Study|Adverse Event|1|||
149906585|NCT03452488|540787545|FG000|Overall Study|Death|0|||
149906586|NCT03452488|540787546|FG001|Overall Study|Death|0|||
149906587|NCT03452488|540787547|FG002|Overall Study|Death|1|||
149906588|NCT03452488|540787545|FG000|Overall Study|Lost to Follow-up|1|||
149906589|NCT03452488|540787546|FG001|Overall Study|Lost to Follow-up|2|||
149906590|NCT03452488|540787547|FG002|Overall Study|Lost to Follow-up|0|||
149906591|NCT03452488|540787545|FG000|Overall Study|PI Decision|1|||
149906592|NCT03452488|540787546|FG001|Overall Study|PI Decision|0|||
149906593|NCT03452488|540787547|FG002|Overall Study|PI Decision|0|||
149906594|NCT03452488|540787545|FG000|Overall Study|Withdrew consent|4|||
149906595|NCT03452488|540787546|FG001|Overall Study|Withdrew consent|2|||
149906596|NCT03452488|540787547|FG002|Overall Study|Withdrew consent|2|||
149906597|NCT03452488|540787545|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
149906598|NCT03452488|540787546|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
149906599|NCT03452488|540787547|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
149906600|NCT03452488|540787545|FG000|Overall Study|Other|0|||
149906601|NCT03452488|540787546|FG001|Overall Study|Other|2|||
149906602|NCT03452488|540787547|FG002|Overall Study|Other|2|||
149906603|NCT04016779|540787548|FG000|Overall Study|Adverse Event|9|||
149906604|NCT04016779|540787549|FG001|Overall Study|Adverse Event|17|||
149906605|NCT04016779|540787548|FG000|Overall Study|Lack of Efficacy|4|||
149906606|NCT04016779|540787549|FG001|Overall Study|Lack of Efficacy|1|||
149906607|NCT04016779|540787548|FG000|Overall Study|Lost to Follow-up|5|||
149970527|NCT03138564|541028451|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
149970528|NCT03138564|541028452|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
149970529|NCT03138564|541028451|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
149970530|NCT03138564|541028452|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
149906608|NCT04016779|540787549|FG001|Overall Study|Lost to Follow-up|14|||
149906609|NCT04016779|540787548|FG000|Overall Study|Physician Decision|1|||
149906610|NCT04016779|540787549|FG001|Overall Study|Physician Decision|3|||
149970531|NCT00643279|541028454|FG000|Overall Study|Death|13|||
149970532|NCT00643279|541028455|FG001|Overall Study|Death|11|||
149970533|NCT00643279|541028454|FG000|Overall Study|Withdrawal by Subject|3|||
149970534|NCT00643279|541028455|FG001|Overall Study|Withdrawal by Subject|0|||
149970535|NCT00643279|541028454|FG000|Overall Study|Lost to Follow-up|0|||
149970536|NCT00643279|541028455|FG001|Overall Study|Lost to Follow-up|1|||
149906611|NCT04016779|540787548|FG000|Overall Study|Withdrawal by Subject|6|||
149906612|NCT04016779|540787549|FG001|Overall Study|Withdrawal by Subject|8|||
149906613|NCT04016779|540787548|FG000|Overall Study|Non-compliance with Study Drug|2|||
149906614|NCT04016779|540787549|FG001|Overall Study|Non-compliance with Study Drug|3|||
149906615|NCT04016779|540787548|FG000|Overall Study|Other, Multiple categories|17|||
149906616|NCT04016779|540787549|FG001|Overall Study|Other, Multiple categories|17|||
149970537|NCT00643279|541028454|FG000|Overall Study|Physician Decision|0|||
149970538|NCT00643279|541028455|FG001|Overall Study|Physician Decision|1|||
150176657|NCT00666276|541783361|FG000|Overall Study|Protocol Violation|34|||
149906617|NCT00330343|540787550|FG000|Overall Study|Lost to Follow-up|5|||
149906618|NCT00281632|540787551|FG000|Overall Study|Adverse Event|7|||
149906619|NCT00281632|540787551|FG000|Overall Study|Withdrawal by Subject|2|||
149906620|NCT00281632|540787551|FG000|Overall Study|Disease Progression|22|||
149906621|NCT00281632|540787551|FG000|Overall Study|Death|1|||
149906622|NCT00281632|540787551|FG000|Overall Study|Physician Decision|1|||
149906623|NCT00281632|540787551|FG000|Overall Study|Ongoing|3|||
149906624|NCT06586788|540787552|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
149906625|NCT02691936|540787553|FG000|Overall Study|Withdrawal by Subject|2|||
149906626|NCT02691936|540787554|FG001|Overall Study|Withdrawal by Subject|5|||
149906627|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
149906628|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
149906629|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
149906630|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
149906631|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
149906632|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
149906633|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
149906634|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
149906635|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
149906636|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
149906637|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Death|1|||
149906638|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Death|0|||
149906639|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
149906640|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
149906641|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
149906642|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
149906643|NCT01876784|540787555|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
149906644|NCT01876784|540787556|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
149906645|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
149906646|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
149906647|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Adverse Event|2|||
149906648|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Adverse Event|6|||
149906649|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
149906650|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
149906651|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Progressive disease|4|||
149906652|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Progressive disease|35|||
149906653|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
149906654|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
149906655|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
149906656|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
149906657|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Death|0|||
149906658|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Death|1|||
149906659|NCT01876784|540787555|FG000|Open-label Period (31 Months)|Other than specified above|9|||
149906660|NCT01876784|540787556|FG001|Open-label Period (31 Months)|Other than specified above|18|||
149906661|NCT01878084|540787557|FG000|Overall Study|Physician Decision|2|||
149906662|NCT00749684|540787558|FG000|Overall Study|Death|1|||
149906663|NCT00749684|540787558|FG000|Overall Study|Adverse Event|27|||
149906664|NCT00749684|540787558|FG000|Overall Study|Participant's Wish|10|||
149906665|NCT00749684|540787558|FG000|Overall Study|Not Documented|1|||
149906666|NCT00749684|540787558|FG000|Overall Study|Progressive Desease|31|||
149906667|NCT00749684|540787558|FG000|Overall Study|Therapy according to protocol + AE|2|||
149906668|NCT00749684|540787558|FG000|Overall Study|AE+discontinuation on participants wish|1|||
149906669|NCT00749684|540787558|FG000|Overall Study|Missing|9|||
149906670|NCT03696108|540787559|FG000|Overall Study|Physician Decision|1|||
149906671|NCT03696108|540787560|FG001|Overall Study|Physician Decision|0|||
149906672|NCT03696108|540787559|FG000|Overall Study|Withdrawal by Subject|3|||
149906673|NCT03696108|540787560|FG001|Overall Study|Withdrawal by Subject|6|||
149906674|NCT05239494|540787562|FG000|Overall Study|Lost to Follow-up|1|||
149906675|NCT04603482|540787568|FG000|Overall Study|Lost to Follow-up|15|||
149906676|NCT04603482|540787569|FG001|Overall Study|Lost to Follow-up|15|||
149906677|NCT04603482|540787570|FG002|Overall Study|Lost to Follow-up|15|||
149906678|NCT00732758|540787571|FG000|Overall Study|Lost to Follow-up|8|||
149906679|NCT00732758|540787572|FG001|Overall Study|Lost to Follow-up|16|||
149906680|NCT03382834|540787573|FG000|Step 1|Lost to Follow-up|0|||
149906681|NCT03382834|540787574|FG001|Step 1|Lost to Follow-up|1|||
149906682|NCT03382834|540787573|FG000|Step 2|Death|1|||
149906683|NCT03382834|540787574|FG001|Step 2|Death|0|||
149906684|NCT03382834|540787573|FG000|Step 2|Lost to Follow-up|2|||
149906685|NCT03382834|540787574|FG001|Step 2|Lost to Follow-up|2|||
149906686|NCT03382834|540787573|FG000|Step 2|Site Terminated by Sponsor|1|||
149906687|NCT03382834|540787574|FG001|Step 2|Site Terminated by Sponsor|0|||
149906688|NCT02693171|540787575|FG000|Overall Study|Adverse Event|1|||
149906689|NCT02693171|540787575|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
149906690|NCT01167881|540787576|FG000|Overall Study|Adverse Event|47|||
149906691|NCT01167881|540787577|FG001|Overall Study|Adverse Event|51|||
149970539|NCT04846868|541028456|FG000|Overall Study|Adverse Event|12|||
149970540|NCT04846868|541028457|FG001|Overall Study|Adverse Event|11|||
149970541|NCT04846868|541028456|FG000|Overall Study|Protocol deviation|6|||
149970542|NCT04846868|541028457|FG001|Overall Study|Protocol deviation|2|||
149970543|NCT04846868|541028456|FG000|Overall Study|Perceived lack of efficacy|3|||
149970544|NCT04846868|541028457|FG001|Overall Study|Perceived lack of efficacy|2|||
149970545|NCT04846868|541028456|FG000|Overall Study|Change of residence|2|||
149970546|NCT04846868|541028457|FG001|Overall Study|Change of residence|3|||
149906692|NCT01167881|540787576|FG000|Overall Study|Lack of Efficacy|4|||
149906693|NCT01167881|540787577|FG001|Overall Study|Lack of Efficacy|7|||
149906694|NCT01167881|540787576|FG000|Overall Study|Non compliant with protocol|9|||
149906695|NCT01167881|540787577|FG001|Overall Study|Non compliant with protocol|18|||
149906696|NCT01167881|540787576|FG000|Overall Study|Lost to Follow-up|19|||
149906697|NCT01167881|540787577|FG001|Overall Study|Lost to Follow-up|20|||
149906698|NCT01167881|540787576|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
149906699|NCT01167881|540787577|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
149906700|NCT01167881|540787576|FG000|Overall Study|Not treated|4|||
149906701|NCT01167881|540787577|FG001|Overall Study|Not treated|0|||
149906702|NCT01167881|540787576|FG000|Overall Study|Other not defined above|31|||
149970547|NCT04846868|541028456|FG000|Overall Study|Burden of study procedures|1|||
149906703|NCT01167881|540787577|FG001|Overall Study|Other not defined above|55|||
149906704|NCT01992653|540787578|FG000|Overall Study|Death|0|||
149906705|NCT01992653|540787579|FG001|Overall Study|Death|0|||
149906706|NCT01992653|540787580|FG002|Overall Study|Death|1|||
149906707|NCT01992653|540787581|FG003|Overall Study|Death|0|||
149906708|NCT01992653|540787582|FG004|Overall Study|Death|1|||
149906709|NCT01992653|540787583|FG005|Overall Study|Death|0|||
149906710|NCT01992653|540787584|FG006|Overall Study|Death|4|||
149906711|NCT01992653|540787585|FG007|Overall Study|Death|2|||
149906712|NCT01992653|540787578|FG000|Overall Study|Lost to Follow-up|0|||
149906713|NCT01992653|540787579|FG001|Overall Study|Lost to Follow-up|0|||
149906714|NCT01992653|540787580|FG002|Overall Study|Lost to Follow-up|0|||
149906715|NCT01992653|540787581|FG003|Overall Study|Lost to Follow-up|0|||
149970548|NCT04846868|541028457|FG001|Overall Study|Burden of study procedures|1|||
149970549|NCT04846868|541028456|FG000|Overall Study|No reason available|2|||
149970550|NCT04846868|541028457|FG001|Overall Study|No reason available|5|||
149970551|NCT04846868|541028456|FG000|Overall Study|Other reason listed|20|||
149970552|NCT04846868|541028457|FG001|Overall Study|Other reason listed|10|||
149970553|NCT04846868|541028456|FG000|Overall Study|Not treated|0|||
149970554|NCT04846868|541028457|FG001|Overall Study|Not treated|1|||
149970555|NCT04116853|541028458|FG000|Overall Study|Adverse Event|1|||
149970556|NCT04116853|541028459|FG001|Overall Study|Adverse Event|3|||
150176658|NCT02594735|541783362|FG000|Overall Study|Adverse Event|1|||
150176659|NCT03844269|541783366|FG000|Overall Study|Withdrawal pre-intervention|1|||
150176660|NCT03844269|541783366|FG000|Overall Study|Did not complete the intervention|2|||
149906716|NCT01992653|540787582|FG004|Overall Study|Lost to Follow-up|0|||
149906717|NCT01992653|540787583|FG005|Overall Study|Lost to Follow-up|0|||
149906718|NCT01992653|540787584|FG006|Overall Study|Lost to Follow-up|0|||
149906719|NCT01992653|540787585|FG007|Overall Study|Lost to Follow-up|1|||
149906720|NCT01992653|540787578|FG000|Overall Study|Study Completed|0|||
149906721|NCT01992653|540787579|FG001|Overall Study|Study Completed|0|||
149906722|NCT01992653|540787580|FG002|Overall Study|Study Completed|0|||
149906723|NCT01992653|540787581|FG003|Overall Study|Study Completed|0|||
149906724|NCT01992653|540787582|FG004|Overall Study|Study Completed|0|||
149906725|NCT01992653|540787583|FG005|Overall Study|Study Completed|0|||
149906726|NCT01992653|540787584|FG006|Overall Study|Study Completed|0|||
149970557|NCT04116853|541028458|FG000|Overall Study|Lost to Follow-up|2|||
149970558|NCT04116853|541028459|FG001|Overall Study|Lost to Follow-up|0|||
149970559|NCT04116853|541028458|FG000|Overall Study|Incarceration|0|||
149970560|NCT04116853|541028459|FG001|Overall Study|Incarceration|1|||
150047758|NCT04154189|541314623|FG000|Overall Study|Withdrawal by Subject|4|||
150176661|NCT00665444|541783367|FG000|Overall Study|Physician Decision|1|||
149906727|NCT01992653|540787585|FG007|Overall Study|Study Completed|1|||
149906728|NCT01992653|540787578|FG000|Overall Study|Disease Progression|0|||
149906729|NCT01992653|540787579|FG001|Overall Study|Disease Progression|0|||
149906730|NCT01992653|540787580|FG002|Overall Study|Disease Progression|0|||
149906731|NCT01992653|540787581|FG003|Overall Study|Disease Progression|0|||
149906732|NCT01992653|540787582|FG004|Overall Study|Disease Progression|0|||
149906733|NCT01992653|540787583|FG005|Overall Study|Disease Progression|0|||
149906734|NCT01992653|540787584|FG006|Overall Study|Disease Progression|4|||
149906735|NCT01992653|540787585|FG007|Overall Study|Disease Progression|0|||
149906736|NCT00977314|540787586|FG000|Overall Study|Withdrawal by Subject|1|||
149906737|NCT00977314|540787587|FG001|Overall Study|Withdrawal by Subject|0|||
149970561|NCT04116853|541028458|FG000|Overall Study|Pregnancy|1|||
149970562|NCT04116853|541028459|FG001|Overall Study|Pregnancy|1|||
149970563|NCT04116853|541028458|FG000|Overall Study|Began Other Weight Loss program|4|||
149906738|NCT00977314|540787586|FG000|Overall Study|Physician Decision|1|||
149906739|NCT00977314|540787587|FG001|Overall Study|Physician Decision|0|||
149906740|NCT02107859|540787588|FG000|Overall Study|Withdrawal by Subject|14|||
149906741|NCT02107859|540787588|FG000|Overall Study|Adverse Event|3|||
149906742|NCT02107859|540787588|FG000|Overall Study|Study closure|41|||
149906743|NCT02107859|540787588|FG000|Overall Study|Other than specified|3|||
149906744|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
149906745|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
149906746|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
149906747|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
149906748|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
149906749|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
149906750|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
149906751|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
149906752|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
149906753|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
149906754|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
149906755|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
149906756|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
149906757|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
149906758|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
149906759|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
149906760|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
149906761|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
149906762|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
149906763|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
149906764|NCT00556933|540787598|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
149906765|NCT00556933|540787599|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
149906766|NCT00556933|540787600|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
149906767|NCT00556933|540787601|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
149906768|NCT00556933|540787598|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
149906769|NCT00556933|540787599|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
149906770|NCT00556933|540787600|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
149906771|NCT00556933|540787601|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
149906772|NCT00556933|540787598|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
149906773|NCT00556933|540787599|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
149906774|NCT00556933|540787600|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
149906775|NCT00556933|540787601|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
149906776|NCT00556933|540787598|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
150176662|NCT00665444|541783367|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
150176663|NCT00101010|541783368|FG000|Overall Study|Physician Decision|1|||
150176664|NCT01075217|541783369|FG000|Overall Study|Adverse Event|1|||
150176665|NCT01075217|541783370|FG001|Overall Study|Adverse Event|1|||
150176666|NCT01075217|541783369|FG000|Overall Study|Physician Decision|1|||
150176667|NCT01075217|541783370|FG001|Overall Study|Physician Decision|0|||
150176668|NCT01369498|541783375|FG000|Overall Study|Lack of Efficacy|9|||
150176669|NCT01369498|541783376|FG001|Overall Study|Lack of Efficacy|9|||
150176670|NCT01369498|541783377|FG002|Overall Study|Lack of Efficacy|1|||
150176671|NCT01369498|541783378|FG003|Overall Study|Lack of Efficacy|3|||
150176672|NCT01369498|541783375|FG000|Overall Study|Adverse Event|1|||
150176673|NCT01369498|541783376|FG001|Overall Study|Adverse Event|2|||
150176674|NCT01369498|541783377|FG002|Overall Study|Adverse Event|0|||
150176675|NCT01369498|541783378|FG003|Overall Study|Adverse Event|1|||
150176676|NCT01369498|541783375|FG000|Overall Study|Withdrawal of Consent|0|||
150176677|NCT01369498|541783376|FG001|Overall Study|Withdrawal of Consent|1|||
149906777|NCT00556933|540787599|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
150176678|NCT01369498|541783377|FG002|Overall Study|Withdrawal of Consent|1|||
150176679|NCT01369498|541783378|FG003|Overall Study|Withdrawal of Consent|1|||
149906778|NCT00556933|540787600|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
149906779|NCT00556933|540787601|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
149906780|NCT00556933|540787598|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
149906781|NCT00556933|540787599|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
149906782|NCT00556933|540787600|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
149906783|NCT00556933|540787601|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
149906784|NCT00556933|540787598|FG000|CNI Withdrawal vs. Minimization|Death|0|||
149906785|NCT00556933|540787599|FG001|CNI Withdrawal vs. Minimization|Death|0|||
149906786|NCT00556933|540787600|FG002|CNI Withdrawal vs. Minimization|Death|0|||
149906787|NCT00556933|540787601|FG003|CNI Withdrawal vs. Minimization|Death|1|||
149906788|NCT03887442|540787602|FG000|Overall Study|Adverse Event|1|||
149906789|NCT03887442|540787603|FG001|Overall Study|Adverse Event|0|||
149906790|NCT00022698|540787606|FG000|Overall Study|Adverse Event|5|||
149906791|NCT00022698|540787607|FG001|Overall Study|Adverse Event|9|||
149906792|NCT00022698|540787606|FG000|Overall Study|Death|0|||
149906793|NCT00022698|540787607|FG001|Overall Study|Death|2|||
149906794|NCT00022698|540787606|FG000|Overall Study|Failure to return|0|||
149906795|NCT00022698|540787607|FG001|Overall Study|Failure to return|1|||
149906796|NCT00022698|540787606|FG000|Overall Study|Refused treatment|0|||
149906797|NCT00022698|540787607|FG001|Overall Study|Refused treatment|2|||
149906798|NCT00022698|540787606|FG000|Overall Study|Insufficient therapeutic response|2|||
149906799|NCT00022698|540787607|FG001|Overall Study|Insufficient therapeutic response|14|||
149906800|NCT00022698|540787606|FG000|Overall Study|Administrative /other|1|||
149906801|NCT00022698|540787607|FG001|Overall Study|Administrative /other|7|||
149906802|NCT01628198|540787609|FG000|Overall Study|Lost to Follow-up|7|||
149906803|NCT01628198|540787609|FG000|Overall Study|Withdrawal by Subject|10|||
149906804|NCT01628198|540787609|FG000|Overall Study|Screen failure|1|||
149970564|NCT04116853|541028459|FG001|Overall Study|Began Other Weight Loss program|8|||
149970565|NCT04116853|541028458|FG000|Overall Study|Began Anti-Obesity Medication|3|||
149970566|NCT04116853|541028459|FG001|Overall Study|Began Anti-Obesity Medication|3|||
149970567|NCT04116853|541028458|FG000|Overall Study|Protocol Violation|0|||
149970568|NCT04116853|541028459|FG001|Overall Study|Protocol Violation|1|||
149970569|NCT05212168|541028460|FG000|Overall Study|Lost to Follow-up|0|||
149970570|NCT05212168|541028461|FG001|Overall Study|Lost to Follow-up|3|||
149970571|NCT05212168|541028460|FG000|Overall Study|Study terminated by sponsor|30|||
149970572|NCT05212168|541028461|FG001|Overall Study|Study terminated by sponsor|27|||
149970573|NCT05212168|541028460|FG000|Overall Study|Other|4|||
149970574|NCT05212168|541028461|FG001|Overall Study|Other|7|||
149970575|NCT02276040|541030042|FG000|Overall Study|Physician Decision|15|||
149970576|NCT02835690|541030043|FG000|Overall Study|Death|12|||
149970577|NCT02835690|541030044|FG001|Overall Study|Death|11|||
149970578|NCT02835690|541030045|FG002|Overall Study|Death|13|||
149970579|NCT02835690|541030043|FG000|Overall Study|Transferred to Extension Study|2|||
149970580|NCT02835690|541030044|FG001|Overall Study|Transferred to Extension Study|2|||
149970581|NCT02835690|541030045|FG002|Overall Study|Transferred to Extension Study|1|||
149970582|NCT02835690|541030043|FG000|Overall Study|Did Not Continue on Extension Study|0|||
149970583|NCT02835690|541030044|FG001|Overall Study|Did Not Continue on Extension Study|0|||
149970584|NCT02835690|541030045|FG002|Overall Study|Did Not Continue on Extension Study|1|||
149970585|NCT02835690|541030043|FG000|Overall Study|Not Treated|0|||
149970586|NCT02835690|541030044|FG001|Overall Study|Not Treated|2|||
149970587|NCT02835690|541030045|FG002|Overall Study|Not Treated|0|||
149970588|NCT03674281|541030046|FG000|Overall Study|screen failure|2|||
149970589|NCT03674281|541030047|FG001|Overall Study|screen failure|0|||
149970590|NCT03674281|541030048|FG002|Overall Study|screen failure|0|||
149970591|NCT03674281|541030046|FG000|Overall Study|Withdrawal by Subject|1|||
149970592|NCT03674281|541030047|FG001|Overall Study|Withdrawal by Subject|3|||
149970593|NCT03674281|541030048|FG002|Overall Study|Withdrawal by Subject|3|||
149970594|NCT00582907|541030049|FG000|1st Course|Withdrawal by Subject|1|||
149970595|NCT00582907|541030050|FG001|1st Course|Withdrawal by Subject|0|||
149970596|NCT00582907|541030051|FG002|1st Course|Withdrawal by Subject|0|||
149970597|NCT00582907|541030052|FG003|1st Course|Withdrawal by Subject|0|||
149970598|NCT00582907|541030049|FG000|1st Course|Lost to Follow-up|0|||
149970599|NCT00582907|541030050|FG001|1st Course|Lost to Follow-up|0|||
149970600|NCT00582907|541030051|FG002|1st Course|Lost to Follow-up|0|||
149970601|NCT00582907|541030052|FG003|1st Course|Lost to Follow-up|1|||
149970602|NCT00582907|541030049|FG000|2nd Course|Lack of Efficacy|1|||
149906805|NCT01743560|540787610|FG000|Overall Study|Disease progression|26|||
149906806|NCT01743560|540787610|FG000|Overall Study|Adverse Event|8|||
149906807|NCT01743560|540787610|FG000|Overall Study|Death|3|||
149906808|NCT01743560|540787610|FG000|Overall Study|Withdrawal by Subject|2|||
149906809|NCT01743560|540787610|FG000|Overall Study|Protocol Violation|1|||
149970603|NCT00582907|541030050|FG001|2nd Course|Lack of Efficacy|0|||
149970604|NCT00582907|541030051|FG002|2nd Course|Lack of Efficacy|0|||
149970605|NCT00582907|541030052|FG003|2nd Course|Lack of Efficacy|0|||
149906810|NCT01743560|540787610|FG000|Overall Study|>1 dose of study drug|3|||
149906811|NCT03425396|540787611|FG000|Overall Study|Lost to Follow-up|2|||
149906812|NCT03425396|540787612|FG001|Overall Study|Lost to Follow-up|5|||
149906813|NCT03425396|540787613|FG002|Overall Study|Lost to Follow-up|2|||
149906814|NCT03425396|540787614|FG003|Overall Study|Lost to Follow-up|0|||
149906815|NCT03425396|540787615|FG004|Overall Study|Lost to Follow-up|0|||
150176680|NCT01369498|541783375|FG000|Overall Study|Death|0|||
150176681|NCT01369498|541783376|FG001|Overall Study|Death|0|||
150176682|NCT01369498|541783377|FG002|Overall Study|Death|1|||
149906816|NCT03425396|540787611|FG000|Overall Study|Withdrawal by Subject|0|||
149906817|NCT03425396|540787612|FG001|Overall Study|Withdrawal by Subject|1|||
149906818|NCT03425396|540787613|FG002|Overall Study|Withdrawal by Subject|0|||
149906819|NCT03425396|540787614|FG003|Overall Study|Withdrawal by Subject|1|||
149906820|NCT03425396|540787615|FG004|Overall Study|Withdrawal by Subject|0|||
149906821|NCT03425396|540787611|FG000|Overall Study|Other|0|||
149906822|NCT03425396|540787612|FG001|Overall Study|Other|1|||
149906823|NCT03425396|540787613|FG002|Overall Study|Other|1|||
149970606|NCT01441960|541030055|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
149970607|NCT01441960|541030056|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
149970608|NCT01441960|541030055|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
149970609|NCT01441960|541030056|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
149970610|NCT01441960|541030055|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
149970611|NCT01441960|541030056|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
149970612|NCT03309202|541030059|FG000|Overall Study|Lost to Follow-up|1|||
149970613|NCT03309202|541030060|FG001|Overall Study|Lost to Follow-up|0|||
149970614|NCT03309202|541030061|FG002|Overall Study|Lost to Follow-up|0|||
149970615|NCT03309202|541030062|FG003|Overall Study|Lost to Follow-up|0|||
149970616|NCT00415636|541030063|FG000|Overall Study|Symptomatic deterioration|1|||
149970617|NCT00415636|541030064|FG001|Overall Study|Symptomatic deterioration|0|||
149970618|NCT00415636|541030065|FG002|Overall Study|Symptomatic deterioration|1|||
149970619|NCT00415636|541030066|FG003|Overall Study|Symptomatic deterioration|2|||
149970620|NCT00415636|541030067|FG004|Overall Study|Symptomatic deterioration|0|||
149970621|NCT00415636|541030068|FG005|Overall Study|Symptomatic deterioration|1|||
149970622|NCT00415636|541030063|FG000|Overall Study|Adverse Event|0|||
149970623|NCT00415636|541030064|FG001|Overall Study|Adverse Event|0|||
149970624|NCT00415636|541030065|FG002|Overall Study|Adverse Event|0|||
149970625|NCT00415636|541030066|FG003|Overall Study|Adverse Event|1|||
150176683|NCT01369498|541783378|FG003|Overall Study|Death|0|||
149906824|NCT03425396|540787614|FG003|Overall Study|Other|0|||
149906825|NCT03425396|540787615|FG004|Overall Study|Other|1|||
149906826|NCT03033602|540787616|FG000|Overall Study|Withdrawal by Subject|11|||
149906827|NCT03033602|540787617|FG001|Overall Study|Withdrawal by Subject|21|||
149906828|NCT03033602|540787616|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
149906829|NCT03033602|540787617|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
149906830|NCT01441765|540787618|FG000|Overall Study|Death|1|||
149906831|NCT01441765|540787619|FG001|Overall Study|Death|0|||
149906832|NCT00784550|540789598|FG000|Overall Study|Adverse Event|12|||
149906833|NCT00784550|540789599|FG001|Overall Study|Adverse Event|10|||
149906834|NCT00784550|540789598|FG000|Overall Study|Lack of Efficacy|0|||
149906835|NCT00784550|540789599|FG001|Overall Study|Lack of Efficacy|1|||
149906836|NCT00784550|540789598|FG000|Overall Study|Protocol Violation|10|||
149906837|NCT00784550|540789599|FG001|Overall Study|Protocol Violation|10|||
149906838|NCT00784550|540789598|FG000|Overall Study|Lost to Follow-up|8|||
149906839|NCT00784550|540789599|FG001|Overall Study|Lost to Follow-up|5|||
149906840|NCT00784550|540789598|FG000|Overall Study|Physician Decision|2|||
149906841|NCT00784550|540789599|FG001|Overall Study|Physician Decision|3|||
149906842|NCT00784550|540789598|FG000|Overall Study|Withdrawal by Subject|4|||
149906843|NCT00784550|540789599|FG001|Overall Study|Withdrawal by Subject|13|||
149906844|NCT00743288|540789600|FG000|Overall Study|Adverse Event|1|||
149906845|NCT00743288|540789601|FG001|Overall Study|Adverse Event|1|||
149906846|NCT00743288|540789602|FG002|Overall Study|Adverse Event|2|||
149906847|NCT00743288|540789603|FG003|Overall Study|Adverse Event|2|||
149906848|NCT00743288|540789604|FG004|Overall Study|Adverse Event|1|||
149906849|NCT00743288|540789605|FG005|Overall Study|Adverse Event|1|||
149906850|NCT00743288|540789606|FG006|Overall Study|Adverse Event|2|||
149906851|NCT00743288|540789600|FG000|Overall Study|Withdrawal by Subject|0|||
149906852|NCT00743288|540789601|FG001|Overall Study|Withdrawal by Subject|0|||
149906853|NCT00743288|540789602|FG002|Overall Study|Withdrawal by Subject|1|||
149906854|NCT00743288|540789603|FG003|Overall Study|Withdrawal by Subject|0|||
149906855|NCT00743288|540789604|FG004|Overall Study|Withdrawal by Subject|0|||
149906856|NCT00743288|540789605|FG005|Overall Study|Withdrawal by Subject|1|||
149906857|NCT00743288|540789606|FG006|Overall Study|Withdrawal by Subject|1|||
149906858|NCT00743288|540789600|FG000|Overall Study|Progressive disease (PD)|2|||
149906859|NCT00743288|540789601|FG001|Overall Study|Progressive disease (PD)|0|||
149906860|NCT00743288|540789602|FG002|Overall Study|Progressive disease (PD)|1|||
149906861|NCT00743288|540789603|FG003|Overall Study|Progressive disease (PD)|4|||
149906862|NCT00743288|540789604|FG004|Overall Study|Progressive disease (PD)|5|||
149906863|NCT00743288|540789605|FG005|Overall Study|Progressive disease (PD)|3|||
149906864|NCT00743288|540789606|FG006|Overall Study|Progressive disease (PD)|6|||
149906865|NCT00743288|540789600|FG000|Overall Study|Worsening of condition (Not PD)|0|||
149906866|NCT00743288|540789601|FG001|Overall Study|Worsening of condition (Not PD)|2|||
149906867|NCT00743288|540789602|FG002|Overall Study|Worsening of condition (Not PD)|1|||
149906868|NCT00743288|540789603|FG003|Overall Study|Worsening of condition (Not PD)|1|||
149906869|NCT00743288|540789604|FG004|Overall Study|Worsening of condition (Not PD)|0|||
149906870|NCT00743288|540789605|FG005|Overall Study|Worsening of condition (Not PD)|0|||
149906871|NCT00743288|540789606|FG006|Overall Study|Worsening of condition (Not PD)|0|||
149906872|NCT00688701|540789607|FG000|Overall Study|Adverse Event|1|||
149906873|NCT00688701|540789608|FG001|Overall Study|Adverse Event|0|||
149906874|NCT00688701|540789609|FG002|Overall Study|Adverse Event|5|||
149906875|NCT00688701|540789610|FG003|Overall Study|Adverse Event|3|||
149906876|NCT00688701|540789607|FG000|Overall Study|Lack of Efficacy|0|||
149906877|NCT00688701|540789608|FG001|Overall Study|Lack of Efficacy|1|||
149906878|NCT00688701|540789609|FG002|Overall Study|Lack of Efficacy|0|||
149906879|NCT00688701|540789610|FG003|Overall Study|Lack of Efficacy|0|||
149906880|NCT00688701|540789607|FG000|Overall Study|Withdrawal by Subject|3|||
149906881|NCT00688701|540789608|FG001|Overall Study|Withdrawal by Subject|3|||
149906882|NCT00688701|540789609|FG002|Overall Study|Withdrawal by Subject|4|||
149906883|NCT00688701|540789610|FG003|Overall Study|Withdrawal by Subject|8|||
149970626|NCT00415636|541030067|FG004|Overall Study|Adverse Event|1|||
149970627|NCT00415636|541030068|FG005|Overall Study|Adverse Event|0|||
149970628|NCT00415636|541030063|FG000|Overall Study|Withdrawal by Subject|0|||
149970629|NCT00415636|541030064|FG001|Overall Study|Withdrawal by Subject|0|||
149906884|NCT00688701|540789607|FG000|Overall Study|Poor compliance to protocol|0|||
149906885|NCT00688701|540789608|FG001|Overall Study|Poor compliance to protocol|1|||
149906886|NCT00688701|540789609|FG002|Overall Study|Poor compliance to protocol|1|||
149906887|NCT00688701|540789610|FG003|Overall Study|Poor compliance to protocol|0|||
149906888|NCT01346189|540789616|FG000|Overall Study|Withdrawal by Subject|7|||
149906889|NCT01346189|540789617|FG001|Overall Study|Withdrawal by Subject|5|||
149906890|NCT01346189|540789618|FG002|Overall Study|Withdrawal by Subject|3|||
149906891|NCT01346189|540789619|FG003|Overall Study|Withdrawal by Subject|5|||
149906892|NCT01346189|540789616|FG000|Overall Study|Physician Decision|4|||
149906893|NCT01346189|540789617|FG001|Overall Study|Physician Decision|0|||
149906894|NCT01346189|540789618|FG002|Overall Study|Physician Decision|0|||
149906895|NCT01346189|540789619|FG003|Overall Study|Physician Decision|0|||
149906896|NCT01346189|540789616|FG000|Overall Study|Moved|3|||
149906897|NCT01346189|540789617|FG001|Overall Study|Moved|0|||
149906898|NCT01346189|540789618|FG002|Overall Study|Moved|4|||
149906899|NCT01346189|540789619|FG003|Overall Study|Moved|0|||
149906900|NCT01346189|540789616|FG000|Overall Study|Other|2|||
149906901|NCT01346189|540789617|FG001|Overall Study|Other|4|||
149906902|NCT01346189|540789618|FG002|Overall Study|Other|7|||
149906903|NCT01346189|540789619|FG003|Overall Study|Other|3|||
149906904|NCT01346189|540789616|FG000|Overall Study|Death|0|||
149906905|NCT01346189|540789617|FG001|Overall Study|Death|3|||
149906906|NCT01346189|540789618|FG002|Overall Study|Death|0|||
149906907|NCT01346189|540789619|FG003|Overall Study|Death|0|||
149906908|NCT01346189|540789616|FG000|Overall Study|Non-health system primary care physician|0|||
149906909|NCT01346189|540789617|FG001|Overall Study|Non-health system primary care physician|5|||
149906910|NCT01346189|540789618|FG002|Overall Study|Non-health system primary care physician|0|||
149970630|NCT00415636|541030065|FG002|Overall Study|Withdrawal by Subject|0|||
149970631|NCT00415636|541030066|FG003|Overall Study|Withdrawal by Subject|0|||
149970632|NCT00415636|541030067|FG004|Overall Study|Withdrawal by Subject|1|||
149970633|NCT00415636|541030068|FG005|Overall Study|Withdrawal by Subject|0|||
149970634|NCT00415636|541030063|FG000|Overall Study|Disease progression|0|||
149970635|NCT00415636|541030064|FG001|Overall Study|Disease progression|0|||
149970636|NCT00415636|541030065|FG002|Overall Study|Disease progression|0|||
149970637|NCT00415636|541030066|FG003|Overall Study|Disease progression|3|||
149970638|NCT00415636|541030067|FG004|Overall Study|Disease progression|0|||
149970639|NCT00415636|541030068|FG005|Overall Study|Disease progression|1|||
149970640|NCT01263119|541030069|FG000|Period 1|Protocol Violation|2|||
149970641|NCT01263119|541030069|FG000|Period 2|Adverse Event|2|||
149970642|NCT02138825|541030070|FG000|Main Study Treatment|Adverse Event|11|||
149970643|NCT02138825|541030071|FG001|Main Study Treatment|Adverse Event|3|||
149970644|NCT02138825|541030070|FG000|Main Study Treatment|Death|1|||
149970645|NCT02138825|541030071|FG001|Main Study Treatment|Death|2|||
149970646|NCT02138825|541030070|FG000|Main Study Treatment|Protocol Violation|2|||
149970647|NCT02138825|541030071|FG001|Main Study Treatment|Protocol Violation|2|||
149970648|NCT02138825|541030070|FG000|Main Study Treatment|Sponsor decision|12|||
149970649|NCT02138825|541030071|FG001|Main Study Treatment|Sponsor decision|18|||
149970650|NCT02138825|541030070|FG000|Main Study Treatment|Study terminated by sponsor|10|||
149970651|NCT02138825|541030071|FG001|Main Study Treatment|Study terminated by sponsor|9|||
149970652|NCT02138825|541030070|FG000|Main Study Treatment|Withdrawal by Subject|3|||
149970653|NCT02138825|541030071|FG001|Main Study Treatment|Withdrawal by Subject|1|||
149970654|NCT02138825|541030070|FG000|Main Study Treatment|Medical decision|1|||
149970655|NCT02138825|541030071|FG001|Main Study Treatment|Medical decision|0|||
149970656|NCT02138825|541030070|FG000|Long-term Extension|Study termination by sponsor|32|||
149970657|NCT02138825|541030071|FG001|Long-term Extension|Study termination by sponsor|38|||
149970658|NCT02138825|541030070|FG000|Safety Follow-up|Adverse Event|4|||
149970659|NCT02138825|541030071|FG001|Safety Follow-up|Adverse Event|3|||
149970660|NCT02138825|541030070|FG000|Safety Follow-up|Death|11|||
149970661|NCT02138825|541030071|FG001|Safety Follow-up|Death|5|||
149970662|NCT02138825|541030070|FG000|Safety Follow-up|Withdrawal by Subject|5|||
149970663|NCT02138825|541030071|FG001|Safety Follow-up|Withdrawal by Subject|3|||
149970664|NCT02138825|541030070|FG000|Safety Follow-up|clinic worsening|1|||
149970665|NCT02138825|541030071|FG001|Safety Follow-up|clinic worsening|0|||
149970666|NCT02138825|541030070|FG000|Safety Follow-up|withdrawal by PI|1|||
149970667|NCT02138825|541030071|FG001|Safety Follow-up|withdrawal by PI|0|||
149906911|NCT01346189|540789619|FG003|Overall Study|Non-health system primary care physician|0|||
149906912|NCT01346189|540789616|FG000|Overall Study|Travel|0|||
149970668|NCT02138825|541030070|FG000|Safety Follow-up|logistical difficulties|0|||
149970669|NCT02138825|541030071|FG001|Safety Follow-up|logistical difficulties|1|||
149970670|NCT02138825|541030070|FG000|Safety Follow-up|progressive disease|0|||
149970671|NCT02138825|541030071|FG001|Safety Follow-up|progressive disease|2|||
149970672|NCT02138825|541030070|FG000|Safety Follow-up|too unwell to attend the visit|0|||
149970673|NCT02138825|541030071|FG001|Safety Follow-up|too unwell to attend the visit|1|||
149906913|NCT01346189|540789617|FG001|Overall Study|Travel|0|||
149906914|NCT01346189|540789618|FG002|Overall Study|Travel|0|||
149970674|NCT02138825|541030070|FG000|Safety Follow-up|treatment unblinded|0|||
149970675|NCT02138825|541030071|FG001|Safety Follow-up|treatment unblinded|1|||
149970676|NCT02138825|541030070|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
149970677|NCT02138825|541030071|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
149906915|NCT01346189|540789619|FG003|Overall Study|Travel|3|||
149906916|NCT03320850|540789622|FG000|Overall Study|Lost to Follow-up|0|||
149906917|NCT03320850|540789623|FG001|Overall Study|Lost to Follow-up|0|||
149906918|NCT03320850|540789624|FG002|Overall Study|Lost to Follow-up|0|||
149906919|NCT03320850|540789625|FG003|Overall Study|Lost to Follow-up|0|||
149906920|NCT03320850|540789626|FG004|Overall Study|Lost to Follow-up|1|||
149906921|NCT03320850|540789627|FG005|Overall Study|Lost to Follow-up|2|||
149906922|NCT03320850|540789628|FG006|Overall Study|Lost to Follow-up|2|||
149906923|NCT03320850|540789629|FG007|Overall Study|Lost to Follow-up|0|||
149906924|NCT03320850|540789630|FG008|Overall Study|Lost to Follow-up|6|||
149906925|NCT03320850|540789631|FG009|Overall Study|Lost to Follow-up|4|||
149906926|NCT03320850|540789622|FG000|Overall Study|Withdrawal by Subject|0|||
150047759|NCT04154189|541314624|FG001|Overall Study|Withdrawal by Subject|6|||
150047760|NCT04154189|541314623|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
150047761|NCT04154189|541314624|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
150047762|NCT04154189|541314623|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
150047763|NCT04154189|541314624|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
150047764|NCT04154189|541314623|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
150047765|NCT04154189|541314624|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
150047766|NCT04154189|541314623|FG000|Overall Study|Death|25|||
150047767|NCT04154189|541314624|FG001|Overall Study|Death|25|||
150047768|NCT02280408|541314625|FG000|Overall Study|Lost to Follow-up|0|||
150047769|NCT02280408|541314626|FG001|Overall Study|Lost to Follow-up|2|||
150047770|NCT02280408|541314627|FG002|Overall Study|Lost to Follow-up|0|||
150047771|NCT02280408|541314628|FG003|Overall Study|Lost to Follow-up|0|||
150047772|NCT01068600|541314629|FG000|Overall Study|Withdrawal by Subject|5|||
150047773|NCT01068600|541314630|FG001|Overall Study|Withdrawal by Subject|6|||
150047774|NCT01068600|541314629|FG000|Overall Study|Adverse Event|3|||
150047775|NCT01068600|541314630|FG001|Overall Study|Adverse Event|3|||
150047776|NCT01068600|541314629|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150047777|NCT01068600|541314630|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150047778|NCT01068600|541314629|FG000|Overall Study|Lost to Follow-up|1|||
150047779|NCT01068600|541314630|FG001|Overall Study|Lost to Follow-up|2|||
150047780|NCT01068600|541314629|FG000|Overall Study|Protocol deviation|1|||
150047781|NCT01068600|541314630|FG001|Overall Study|Protocol deviation|1|||
150047782|NCT01068600|541314629|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150047783|NCT01068600|541314630|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
150047784|NCT01068600|541314629|FG000|Overall Study|Administrative problems|0|||
150047785|NCT01068600|541314630|FG001|Overall Study|Administrative problems|1|||
150047786|NCT02474069|541314631|FG000|Selection Phase (SP)|Adverse Event|8|||
150047787|NCT02474069|541314632|FG001|Selection Phase (SP)|Adverse Event|0|||
150047788|NCT02474069|541314633|FG002|Selection Phase (SP)|Adverse Event|0|||
150047789|NCT02474069|541314631|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
150047790|NCT02474069|541314632|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
150047791|NCT02474069|541314633|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
150047792|NCT02474069|541314631|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
150047793|NCT02474069|541314632|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
150047794|NCT02474069|541314633|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
150047795|NCT02474069|541314631|FG000|Selection Phase (SP)|Physician Decision|1|||
150047796|NCT02474069|541314632|FG001|Selection Phase (SP)|Physician Decision|0|||
150047797|NCT02474069|541314633|FG002|Selection Phase (SP)|Physician Decision|0|||
150047798|NCT02474069|541314631|FG000|Selection Phase (SP)|Protocol Violation|1|||
150047799|NCT02474069|541314632|FG001|Selection Phase (SP)|Protocol Violation|0|||
150047800|NCT02474069|541314633|FG002|Selection Phase (SP)|Protocol Violation|0|||
150047801|NCT02474069|541314631|FG000|Selection Phase (SP)|No longer requires treatment|1|||
150047802|NCT02474069|541314632|FG001|Selection Phase (SP)|No longer requires treatment|0|||
150047803|NCT02474069|541314633|FG002|Selection Phase (SP)|No longer requires treatment|0|||
150047804|NCT02474069|541314631|FG000|Selection Phase (SP)|Technical Problem|1|||
150047805|NCT02474069|541314632|FG001|Selection Phase (SP)|Technical Problem|0|||
150047806|NCT02474069|541314633|FG002|Selection Phase (SP)|Technical Problem|0|||
150047807|NCT02474069|541314631|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
150047808|NCT02474069|541314632|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
150047809|NCT02474069|541314633|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
150047810|NCT02474069|541314631|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
150047811|NCT02474069|541314632|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
150047812|NCT02474069|541314633|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
150047813|NCT02474069|541314631|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
150047814|NCT02474069|541314632|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
150047815|NCT02474069|541314633|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
150047816|NCT02474069|541314631|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
150047817|NCT02474069|541314632|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
150047818|NCT02474069|541314633|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
150047819|NCT02474069|541314631|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
150047820|NCT02474069|541314632|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
150047821|NCT02474069|541314633|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
150047822|NCT02474069|541314631|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
150176684|NCT01369498|541783375|FG000|Overall Study|Investigator's Discretion|1|||
150047823|NCT02474069|541314632|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
150047824|NCT02474069|541314633|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
150047825|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
150047826|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
150047827|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
150047828|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
150176685|NCT01369498|541783376|FG001|Overall Study|Investigator's Discretion|0|||
149906927|NCT03320850|540789623|FG001|Overall Study|Withdrawal by Subject|0|||
149906928|NCT03320850|540789624|FG002|Overall Study|Withdrawal by Subject|0|||
149906929|NCT03320850|540789625|FG003|Overall Study|Withdrawal by Subject|0|||
149906930|NCT03320850|540789626|FG004|Overall Study|Withdrawal by Subject|1|||
149906931|NCT03320850|540789627|FG005|Overall Study|Withdrawal by Subject|2|||
149906932|NCT03320850|540789628|FG006|Overall Study|Withdrawal by Subject|4|||
149906933|NCT03320850|540789629|FG007|Overall Study|Withdrawal by Subject|5|||
149906934|NCT03320850|540789630|FG008|Overall Study|Withdrawal by Subject|2|||
149906935|NCT03320850|540789631|FG009|Overall Study|Withdrawal by Subject|1|||
149906936|NCT03320850|540789622|FG000|Overall Study|Lack of Efficacy|0|||
149906937|NCT03320850|540789623|FG001|Overall Study|Lack of Efficacy|0|||
149906938|NCT03320850|540789624|FG002|Overall Study|Lack of Efficacy|0|||
149906939|NCT03320850|540789625|FG003|Overall Study|Lack of Efficacy|1|||
150047829|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
150047830|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
150047831|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
150047832|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
150047833|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
150047834|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
150047835|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
150047836|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
150047837|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
150047838|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
150047839|NCT04173494|541314634|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
150047840|NCT04173494|541314635|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
150047841|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
150047842|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
150047843|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
150047844|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
150047845|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
150047846|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
150047847|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
150047848|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
150047849|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
150047850|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
150047851|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
150047852|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
150047853|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
150047854|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
150047855|NCT04173494|541314634|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
150047856|NCT04173494|541314635|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
150047857|NCT01623050|541314636|FG000|Overall Study|Lost to Follow-up|9|||
150047858|NCT01191762|541314637|FG000|Overall Study|Adverse Event|1|||
150047859|NCT01191762|541314638|FG001|Overall Study|Adverse Event|0|||
150047860|NCT01519869|541314641|FG000|Overall Study|Lost to Follow-up|1|||
150047861|NCT03023813|541314642|FG000|Overall Study|Lost to Follow-up|1|||
150047862|NCT03023813|541314643|FG001|Overall Study|Lost to Follow-up|2|||
150047863|NCT03023813|541314644|FG002|Overall Study|Lost to Follow-up|0|||
150047864|NCT00393861|541314645|FG000|Overall Study|Adverse Event|2|||
150047865|NCT00393861|541314645|FG000|Overall Study|Disease Progression|24|||
150047866|NCT00202878|541314650|FG000|Overall Study|Death|964|||
150047867|NCT00202878|541314651|FG001|Overall Study|Death|968|||
150047868|NCT00202878|541314650|FG000|Overall Study|Only Vital Status Known|357|||
150047869|NCT00202878|541314651|FG001|Overall Study|Only Vital Status Known|356|||
150047870|NCT00202878|541314650|FG000|Overall Study|Lost to Follow-up|44|||
150047871|NCT00202878|541314651|FG001|Overall Study|Lost to Follow-up|49|||
150047872|NCT00202878|541314650|FG000|Overall Study|Site Closure|39|||
150047873|NCT00202878|541314651|FG001|Overall Study|Site Closure|36|||
150047874|NCT00202878|541314650|FG000|Overall Study|Withdrawal by Subject|795|||
150047875|NCT00202878|541314651|FG001|Overall Study|Withdrawal by Subject|808|||
150047876|NCT02123472|541314652|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
150047877|NCT02123472|541314653|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
150047878|NCT01474018|541314654|FG000|Overall Study|Lost to Follow-up|0|||
150047879|NCT01474018|541314655|FG001|Overall Study|Lost to Follow-up|1|||
150047880|NCT01474018|541314654|FG000|Overall Study|Withdrawal by Subject|0|||
150047881|NCT01474018|541314655|FG001|Overall Study|Withdrawal by Subject|2|||
150047882|NCT02433080|541314657|FG000|Overall Study|Lost to Follow-up|1|||
150047883|NCT02433080|541314658|FG001|Overall Study|Lost to Follow-up|2|||
150047884|NCT02433080|541314657|FG000|Overall Study|Withdrawal by Subject|0|||
150047885|NCT02433080|541314658|FG001|Overall Study|Withdrawal by Subject|2|||
150047886|NCT03801031|541314660|FG000|Overall Study|Lost to Follow-up|1|||
150047887|NCT03801031|541314661|FG001|Overall Study|Lost to Follow-up|0|||
150047888|NCT03801031|541314660|FG000|Overall Study|Unable to comply|1|||
150047889|NCT03801031|541314661|FG001|Overall Study|Unable to comply|0|||
150047890|NCT03801031|541314660|FG000|Overall Study|Withdrawal by Subject|0|||
150047891|NCT03801031|541314661|FG001|Overall Study|Withdrawal by Subject|1|||
150047892|NCT00486291|541314665|FG000|Overall Study|Adverse Event|3|||
150047893|NCT00486291|541314666|FG001|Overall Study|Adverse Event|4|||
150047894|NCT00486291|541314665|FG000|Overall Study|Lost to Follow-up|3|||
150047895|NCT00486291|541314666|FG001|Overall Study|Lost to Follow-up|7|||
150047896|NCT00486291|541314665|FG000|Overall Study|protocol non-compliance|10|||
150047897|NCT00486291|541314666|FG001|Overall Study|protocol non-compliance|15|||
150047898|NCT00486291|541314665|FG000|Overall Study|requirement for restricted medication|0|||
150047899|NCT00486291|541314666|FG001|Overall Study|requirement for restricted medication|3|||
150047900|NCT00126490|541314672|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
149906940|NCT03320850|540789626|FG004|Overall Study|Lack of Efficacy|0|||
149906941|NCT03320850|540789627|FG005|Overall Study|Lack of Efficacy|1|||
149906942|NCT03320850|540789628|FG006|Overall Study|Lack of Efficacy|0|||
149906943|NCT03320850|540789629|FG007|Overall Study|Lack of Efficacy|2|||
149906944|NCT03320850|540789630|FG008|Overall Study|Lack of Efficacy|0|||
149906945|NCT03320850|540789631|FG009|Overall Study|Lack of Efficacy|3|||
150047901|NCT03462511|541314676|FG000|Overall Study|Withdrawal by Subject|2|||
149906946|NCT03320850|540789622|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
150047902|NCT03462511|541314677|FG001|Overall Study|Withdrawal by Subject|3|||
150047903|NCT02925416|541314678|FG000|Overall Study|Adverse Event|2|||
150047904|NCT02925416|541314679|FG001|Overall Study|Adverse Event|0|||
150047905|NCT00200356|541314680|FG000|Overall Study|Lack of Efficacy|3|||
150047906|NCT00200356|541314681|FG001|Overall Study|Lack of Efficacy|3|||
150047907|NCT00200356|541314680|FG000|Overall Study|Protocol Violation|4|||
150047908|NCT00200356|541314681|FG001|Overall Study|Protocol Violation|4|||
150047909|NCT00200356|541314680|FG000|Overall Study|Nontreatment|1|||
150047910|NCT00200356|541314681|FG001|Overall Study|Nontreatment|0|||
150047911|NCT02355184|541314684|FG000|Overall Study|Lost to Follow-up|2|||
150047912|NCT02355184|541314684|FG000|Overall Study|Study Terminated|10|||
150047913|NCT02160899|541316748|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
150047914|NCT02160899|541316749|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
150047915|NCT02160899|541316750|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
150047916|NCT02160899|541316751|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
150047917|NCT02160899|541316752|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
150047918|NCT02160899|541316753|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
150047919|NCT04129151|541316754|FG000|Overall Study|Adverse Event|1|||
150047920|NCT04129151|541316754|FG000|Overall Study|Disease Progression|7|||
150047921|NCT04129151|541316754|FG000|Overall Study|Study closure|1|||
150047922|NCT01463007|541316758|FG000|Overall Study|Physician Decision|1|||
150047923|NCT02314637|541316761|FG000|Overall Study|Adverse Event|4|||
150047924|NCT02314637|541316762|FG001|Overall Study|Adverse Event|8|||
150047925|NCT02314637|541316761|FG000|Overall Study|Lack of Efficacy|1|||
150047926|NCT02314637|541316762|FG001|Overall Study|Lack of Efficacy|0|||
150047927|NCT02314637|541316761|FG000|Overall Study|Physician Decision|5|||
150047928|NCT02314637|541316762|FG001|Overall Study|Physician Decision|2|||
150047929|NCT02314637|541316761|FG000|Overall Study|Withdrawal by Subject|5|||
150047930|NCT02314637|541316762|FG001|Overall Study|Withdrawal by Subject|4|||
150047931|NCT02314637|541316761|FG000|Overall Study|Other Reason|1|||
150047932|NCT02314637|541316762|FG001|Overall Study|Other Reason|0|||
150047933|NCT02934503|541316763|FG000|Overall Study|progression of disease|3|||
150047934|NCT02934503|541316763|FG000|Overall Study|Withdrawal by Subject|1|||
150047935|NCT03110770|541316764|FG000|Overall Study|Death|1|||
150047936|NCT03110770|541316765|FG001|Overall Study|Death|0|||
150047937|NCT03110770|541316766|FG002|Overall Study|Death|0|||
150047938|NCT03110770|541316767|FG003|Overall Study|Death|1|||
150047939|NCT03110770|541316768|FG004|Overall Study|Death|0|||
150047940|NCT03110770|541316764|FG000|Overall Study|Enrolled but did not receive product|0|||
150047941|NCT03110770|541316765|FG001|Overall Study|Enrolled but did not receive product|0|||
150047942|NCT03110770|541316766|FG002|Overall Study|Enrolled but did not receive product|0|||
150047943|NCT03110770|541316767|FG003|Overall Study|Enrolled but did not receive product|8|||
150047944|NCT03110770|541316768|FG004|Overall Study|Enrolled but did not receive product|7|||
150047945|NCT03110770|541316764|FG000|Overall Study|Lost to Follow-up|0|||
150047946|NCT03110770|541316765|FG001|Overall Study|Lost to Follow-up|0|||
150047947|NCT03110770|541316766|FG002|Overall Study|Lost to Follow-up|0|||
149906947|NCT03320850|540789623|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
150047948|NCT03110770|541316767|FG003|Overall Study|Lost to Follow-up|53|||
150047949|NCT03110770|541316768|FG004|Overall Study|Lost to Follow-up|45|||
150047950|NCT03110770|541316764|FG000|Overall Study|Investigator Decision|0|||
150047951|NCT03110770|541316765|FG001|Overall Study|Investigator Decision|0|||
149906948|NCT03320850|540789624|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
149906949|NCT03320850|540789625|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
149906950|NCT03320850|540789626|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
149906951|NCT03320850|540789627|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
149906952|NCT03320850|540789628|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
149906953|NCT03320850|540789629|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
149906954|NCT03320850|540789630|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
149906955|NCT03320850|540789631|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
149906956|NCT03320850|540789622|FG000|Overall Study|Adverse Event|0|||
149906957|NCT03320850|540789623|FG001|Overall Study|Adverse Event|0|||
149906958|NCT03320850|540789624|FG002|Overall Study|Adverse Event|0|||
149906959|NCT03320850|540789625|FG003|Overall Study|Adverse Event|0|||
149970678|NCT02090764|541030074|FG000|Overall Study|Adverse Event|1|||
149970679|NCT02090764|541030075|FG001|Overall Study|Adverse Event|3|||
149970680|NCT02090764|541030074|FG000|Overall Study|Lack of Efficacy|0|||
149970681|NCT02090764|541030075|FG001|Overall Study|Lack of Efficacy|13|||
149970682|NCT02090764|541030074|FG000|Overall Study|Withdrawal by Subject|2|||
149970683|NCT02090764|541030075|FG001|Overall Study|Withdrawal by Subject|1|||
149970684|NCT02090764|541030074|FG000|Overall Study|Intercurrent illness and other|1|||
149970685|NCT02090764|541030075|FG001|Overall Study|Intercurrent illness and other|1|||
149970686|NCT02090764|541030074|FG000|Overall Study|Lost to Follow-up|2|||
149970687|NCT02090764|541030075|FG001|Overall Study|Lost to Follow-up|2|||
149970688|NCT00673920|541030078|FG000|Baseline up to Week 48|Withdrew consent|1|||
149970689|NCT00673920|541030079|FG001|Baseline up to Week 48|Withdrew consent|0|||
149970690|NCT00673920|541030080|FG002|Baseline up to Week 48|Withdrew consent|2|||
149970691|NCT00673920|541030081|FG003|Baseline up to Week 48|Withdrew consent|0|||
149970692|NCT00673920|541030082|FG004|Baseline up to Week 48|Withdrew consent|0|||
149970693|NCT00673920|541030083|FG005|Baseline up to Week 48|Withdrew consent|0|||
149970694|NCT00673920|541030084|FG006|Baseline up to Week 48|Withdrew consent|0|||
149970695|NCT00673920|541030085|FG007|Baseline up to Week 48|Withdrew consent|0|||
149970696|NCT00673920|541030078|FG000|Baseline up to Week 48|Refused treatment|1|||
149970697|NCT00673920|541030079|FG001|Baseline up to Week 48|Refused treatment|0|||
149970698|NCT00673920|541030080|FG002|Baseline up to Week 48|Refused treatment|0|||
149970699|NCT00673920|541030081|FG003|Baseline up to Week 48|Refused treatment|0|||
149970700|NCT00673920|541030082|FG004|Baseline up to Week 48|Refused treatment|0|||
149970701|NCT00673920|541030083|FG005|Baseline up to Week 48|Refused treatment|0|||
149970702|NCT00673920|541030084|FG006|Baseline up to Week 48|Refused treatment|0|||
149970703|NCT00673920|541030085|FG007|Baseline up to Week 48|Refused treatment|0|||
149970704|NCT00673920|541030078|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
149970705|NCT00673920|541030079|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
149970706|NCT00673920|541030080|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
149970707|NCT00673920|541030081|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
149970708|NCT00673920|541030082|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
149970709|NCT00673920|541030083|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
150176686|NCT01369498|541783377|FG002|Overall Study|Investigator's Discretion|1|||
150047952|NCT03110770|541316766|FG002|Overall Study|Investigator Decision|0|||
150047953|NCT03110770|541316767|FG003|Overall Study|Investigator Decision|5|||
150047954|NCT03110770|541316768|FG004|Overall Study|Investigator Decision|3|||
150047955|NCT03110770|541316764|FG000|Overall Study|Withdrawal by Subject|0|||
150047956|NCT03110770|541316765|FG001|Overall Study|Withdrawal by Subject|0|||
150047957|NCT03110770|541316766|FG002|Overall Study|Withdrawal by Subject|0|||
150047958|NCT03110770|541316767|FG003|Overall Study|Withdrawal by Subject|24|||
150047959|NCT03110770|541316768|FG004|Overall Study|Withdrawal by Subject|24|||
150047960|NCT03110770|541316764|FG000|Overall Study|Moved from area|5|||
150047961|NCT03110770|541316765|FG001|Overall Study|Moved from area|0|||
150047962|NCT03110770|541316766|FG002|Overall Study|Moved from area|2|||
150047963|NCT03110770|541316767|FG003|Overall Study|Moved from area|42|||
150047964|NCT03110770|541316768|FG004|Overall Study|Moved from area|43|||
150047965|NCT03110770|541316764|FG000|Overall Study|Illness/Injury unrelated to product|0|||
150047966|NCT03110770|541316765|FG001|Overall Study|Illness/Injury unrelated to product|0|||
150047967|NCT03110770|541316766|FG002|Overall Study|Illness/Injury unrelated to product|0|||
150047968|NCT03110770|541316767|FG003|Overall Study|Illness/Injury unrelated to product|0|||
150047969|NCT03110770|541316768|FG004|Overall Study|Illness/Injury unrelated to product|1|||
150047970|NCT01667419|541316769|FG000|Overall Study|Reason Not Specified|1|||
150047971|NCT01667419|541316770|FG001|Overall Study|Reason Not Specified|0|||
150047972|NCT01667419|541316771|FG002|Overall Study|Reason Not Specified|0|||
150047973|NCT01667419|541316772|FG003|Overall Study|Reason Not Specified|0|||
150047974|NCT01667419|541316769|FG000|Overall Study|Withdrawal by Subject|16|||
150047975|NCT01667419|541316770|FG001|Overall Study|Withdrawal by Subject|8|||
150047976|NCT01667419|541316771|FG002|Overall Study|Withdrawal by Subject|9|||
150047977|NCT01667419|541316772|FG003|Overall Study|Withdrawal by Subject|8|||
150047978|NCT01667419|541316769|FG000|Overall Study|Non-compliance|0|||
150047979|NCT01667419|541316770|FG001|Overall Study|Non-compliance|0|||
150047980|NCT01667419|541316771|FG002|Overall Study|Non-compliance|0|||
150047981|NCT01667419|541316772|FG003|Overall Study|Non-compliance|1|||
150047982|NCT01667419|541316769|FG000|Overall Study|Protocol Violation|1|||
150047983|NCT01667419|541316770|FG001|Overall Study|Protocol Violation|0|||
150047984|NCT01667419|541316771|FG002|Overall Study|Protocol Violation|0|||
150047985|NCT01667419|541316772|FG003|Overall Study|Protocol Violation|0|||
150047986|NCT01667419|541316769|FG000|Overall Study|Lost to Follow-up|7|||
150047987|NCT01667419|541316770|FG001|Overall Study|Lost to Follow-up|6|||
150047988|NCT01667419|541316771|FG002|Overall Study|Lost to Follow-up|2|||
150047989|NCT01667419|541316772|FG003|Overall Study|Lost to Follow-up|4|||
150047990|NCT01667419|541316769|FG000|Overall Study|Death|18|||
150047991|NCT01667419|541316770|FG001|Overall Study|Death|33|||
150047992|NCT01667419|541316771|FG002|Overall Study|Death|25|||
150047993|NCT01667419|541316772|FG003|Overall Study|Death|26|||
150047994|NCT00856518|541316773|FG000|Overall Study|Lost to Follow-up|4|||
150047995|NCT00856518|541316774|FG001|Overall Study|Lost to Follow-up|2|||
150047996|NCT02082340|541316775|FG000|Overall Study|Lost to Follow-up|1|||
150047997|NCT02082340|541316776|FG001|Overall Study|Lost to Follow-up|1|||
150047998|NCT04195893|541316779|FG000|Second Intervention|Withdrawal by Subject|1|||
150047999|NCT04195893|541316780|FG001|Second Intervention|Withdrawal by Subject|0|||
150048000|NCT00035932|541316787|FG000|Overall Study|Adverse Event|10|||
150048001|NCT00035932|541316788|FG001|Overall Study|Adverse Event|9|||
150048002|NCT00035932|541316789|FG002|Overall Study|Adverse Event|9|||
150048003|NCT00035932|541316787|FG000|Overall Study|Death|0|||
150048004|NCT00035932|541316788|FG001|Overall Study|Death|0|||
150048005|NCT00035932|541316789|FG002|Overall Study|Death|1|||
150048006|NCT00035932|541316787|FG000|Overall Study|Disease Progression / Relapse|1|||
150048007|NCT00035932|541316788|FG001|Overall Study|Disease Progression / Relapse|1|||
150176687|NCT01369498|541783378|FG003|Overall Study|Investigator's Discretion|3|||
150048008|NCT00035932|541316789|FG002|Overall Study|Disease Progression / Relapse|0|||
150048009|NCT00035932|541316787|FG000|Overall Study|Lost to Follow-up|4|||
150048010|NCT00035932|541316788|FG001|Overall Study|Lost to Follow-up|4|||
150048011|NCT00035932|541316789|FG002|Overall Study|Lost to Follow-up|3|||
150048012|NCT00035932|541316787|FG000|Overall Study|Noncompliance|6|||
150048013|NCT00035932|541316788|FG001|Overall Study|Noncompliance|7|||
150048014|NCT00035932|541316789|FG002|Overall Study|Noncompliance|6|||
150048015|NCT00035932|541316787|FG000|Overall Study|Protocol Violation While on Study|0|||
150048016|NCT00035932|541316788|FG001|Overall Study|Protocol Violation While on Study|1|||
150048017|NCT00035932|541316789|FG002|Overall Study|Protocol Violation While on Study|2|||
150048018|NCT00035932|541316787|FG000|Overall Study|Withdrawal by Subject|1|||
150048019|NCT00035932|541316788|FG001|Overall Study|Withdrawal by Subject|5|||
150048020|NCT00035932|541316789|FG002|Overall Study|Withdrawal by Subject|0|||
150048021|NCT00035932|541316787|FG000|Overall Study|Study Termination by Sponsor|1|||
150048022|NCT00035932|541316788|FG001|Overall Study|Study Termination by Sponsor|0|||
150048023|NCT00035932|541316789|FG002|Overall Study|Study Termination by Sponsor|0|||
150048024|NCT00035932|541316787|FG000|Overall Study|Lack of Efficacy|33|||
150048025|NCT00035932|541316788|FG001|Overall Study|Lack of Efficacy|33|||
150048026|NCT00035932|541316789|FG002|Overall Study|Lack of Efficacy|28|||
150048027|NCT04413617|541316793|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
150048028|NCT04413617|541316794|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
150048029|NCT04413617|541316795|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
150048030|NCT04413617|541316796|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
150048031|NCT04413617|541316797|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
150048032|NCT04413617|541316793|FG000|Overall Study|Protocol Violation|0|||
150048033|NCT04413617|541316794|FG001|Overall Study|Protocol Violation|1|||
150048034|NCT04413617|541316795|FG002|Overall Study|Protocol Violation|0|||
150048035|NCT04413617|541316796|FG003|Overall Study|Protocol Violation|0|||
150048036|NCT04413617|541316797|FG004|Overall Study|Protocol Violation|1|||
150048037|NCT04413617|541316793|FG000|Overall Study|Lack of Efficacy|2|||
150048038|NCT04413617|541316794|FG001|Overall Study|Lack of Efficacy|0|||
150048039|NCT04413617|541316795|FG002|Overall Study|Lack of Efficacy|2|||
150048040|NCT04413617|541316796|FG003|Overall Study|Lack of Efficacy|1|||
150048041|NCT04413617|541316797|FG004|Overall Study|Lack of Efficacy|0|||
150048042|NCT04413617|541316793|FG000|Overall Study|Withdrawal by Subject|3|||
150048043|NCT04413617|541316794|FG001|Overall Study|Withdrawal by Subject|4|||
150048044|NCT04413617|541316795|FG002|Overall Study|Withdrawal by Subject|2|||
150048045|NCT04413617|541316796|FG003|Overall Study|Withdrawal by Subject|5|||
150048046|NCT04413617|541316797|FG004|Overall Study|Withdrawal by Subject|3|||
150048047|NCT04413617|541316793|FG000|Overall Study|Death|1|||
150048048|NCT04413617|541316794|FG001|Overall Study|Death|0|||
150048049|NCT04413617|541316795|FG002|Overall Study|Death|0|||
150048050|NCT04413617|541316796|FG003|Overall Study|Death|0|||
149906960|NCT03320850|540789626|FG004|Overall Study|Adverse Event|0|||
149906961|NCT03320850|540789627|FG005|Overall Study|Adverse Event|2|||
149906962|NCT03320850|540789628|FG006|Overall Study|Adverse Event|1|||
149906963|NCT03320850|540789629|FG007|Overall Study|Adverse Event|0|||
149906964|NCT03320850|540789630|FG008|Overall Study|Adverse Event|2|||
149906965|NCT03320850|540789631|FG009|Overall Study|Adverse Event|0|||
149906966|NCT03320850|540789622|FG000|Overall Study|Reason Not Specified|0|||
150048051|NCT04413617|541316797|FG004|Overall Study|Death|0|||
150048052|NCT04413617|541316793|FG000|Overall Study|Adverse Event|1|||
150048053|NCT04413617|541316794|FG001|Overall Study|Adverse Event|0|||
150048054|NCT04413617|541316795|FG002|Overall Study|Adverse Event|0|||
149906967|NCT03320850|540789623|FG001|Overall Study|Reason Not Specified|0|||
149906968|NCT03320850|540789624|FG002|Overall Study|Reason Not Specified|0|||
150048055|NCT04413617|541316796|FG003|Overall Study|Adverse Event|1|||
150048056|NCT04413617|541316797|FG004|Overall Study|Adverse Event|1|||
150048057|NCT04413617|541316793|FG000|Overall Study|COVID-19|0|||
150048058|NCT04413617|541316794|FG001|Overall Study|COVID-19|1|||
149906969|NCT03320850|540789625|FG003|Overall Study|Reason Not Specified|0|||
149906970|NCT03320850|540789626|FG004|Overall Study|Reason Not Specified|0|||
149906971|NCT03320850|540789627|FG005|Overall Study|Reason Not Specified|1|||
149906972|NCT03320850|540789628|FG006|Overall Study|Reason Not Specified|0|||
149906973|NCT03320850|540789629|FG007|Overall Study|Reason Not Specified|0|||
149906974|NCT03320850|540789630|FG008|Overall Study|Reason Not Specified|0|||
149906975|NCT03320850|540789631|FG009|Overall Study|Reason Not Specified|1|||
149906976|NCT03781583|540789633|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
149906977|NCT03781583|540789634|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
149906978|NCT03781583|540789635|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
149906979|NCT03781583|540789636|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
149906980|NCT03781583|540789633|FG000|Overall Study|Technology did not work for that person in that environment|1|||
149906981|NCT03781583|540789634|FG001|Overall Study|Technology did not work for that person in that environment|0|||
149906982|NCT03781583|540789635|FG002|Overall Study|Technology did not work for that person in that environment|0|||
149906983|NCT03781583|540789636|FG003|Overall Study|Technology did not work for that person in that environment|0|||
149906984|NCT03781583|540789633|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
149906985|NCT03781583|540789634|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
149906986|NCT03781583|540789635|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
150048059|NCT04413617|541316795|FG002|Overall Study|COVID-19|0|||
149906987|NCT03781583|540789636|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
149906988|NCT03781583|540789633|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
149970710|NCT00673920|541030084|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
149970711|NCT00673920|541030085|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
149970712|NCT00673920|541030078|FG000|Baseline up to Week 48|Protocol Violation|0|||
149970713|NCT00673920|541030079|FG001|Baseline up to Week 48|Protocol Violation|0|||
149970714|NCT00673920|541030080|FG002|Baseline up to Week 48|Protocol Violation|1|||
149970715|NCT00673920|541030081|FG003|Baseline up to Week 48|Protocol Violation|0|||
149970716|NCT00673920|541030082|FG004|Baseline up to Week 48|Protocol Violation|0|||
149970717|NCT00673920|541030083|FG005|Baseline up to Week 48|Protocol Violation|0|||
149970718|NCT00673920|541030084|FG006|Baseline up to Week 48|Protocol Violation|0|||
149970719|NCT00673920|541030085|FG007|Baseline up to Week 48|Protocol Violation|0|||
149970720|NCT00673920|541030078|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970721|NCT00673920|541030079|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970722|NCT00673920|541030080|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
149970723|NCT00673920|541030081|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970724|NCT00673920|541030082|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970725|NCT00673920|541030083|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970726|NCT00673920|541030084|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970727|NCT00673920|541030085|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
149970728|NCT00673920|541030078|FG000|Baseline up to Week 48|Administrative/Other|0|||
149970729|NCT00673920|541030079|FG001|Baseline up to Week 48|Administrative/Other|1|||
149970730|NCT00673920|541030080|FG002|Baseline up to Week 48|Administrative/Other|2|||
149970731|NCT00673920|541030081|FG003|Baseline up to Week 48|Administrative/Other|0|||
149970732|NCT00673920|541030082|FG004|Baseline up to Week 48|Administrative/Other|0|||
149970733|NCT00673920|541030083|FG005|Baseline up to Week 48|Administrative/Other|0|||
149970734|NCT00673920|541030084|FG006|Baseline up to Week 48|Administrative/Other|0|||
149970735|NCT00673920|541030085|FG007|Baseline up to Week 48|Administrative/Other|0|||
149970736|NCT00673920|541030078|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970737|NCT00673920|541030079|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
149970738|NCT00673920|541030080|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
149970739|NCT00673920|541030081|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970740|NCT00673920|541030082|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970741|NCT00673920|541030083|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970742|NCT00673920|541030084|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970743|NCT00673920|541030085|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
149970744|NCT00673920|541030078|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970745|NCT00673920|541030079|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970746|NCT00673920|541030080|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970747|NCT00673920|541030081|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970748|NCT00673920|541030082|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970749|NCT00673920|541030083|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970750|NCT00673920|541030084|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
149970751|NCT00673920|541030085|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
149970752|NCT00673920|541030078|FG000|Week 24 to Week 48|Failure to return|0|||
149970753|NCT00673920|541030079|FG001|Week 24 to Week 48|Failure to return|0|||
149970754|NCT00673920|541030080|FG002|Week 24 to Week 48|Failure to return|0|||
149970755|NCT00673920|541030081|FG003|Week 24 to Week 48|Failure to return|0|||
149970756|NCT00673920|541030082|FG004|Week 24 to Week 48|Failure to return|0|||
149970757|NCT00673920|541030083|FG005|Week 24 to Week 48|Failure to return|1|||
149970758|NCT00673920|541030084|FG006|Week 24 to Week 48|Failure to return|0|||
149970759|NCT00673920|541030085|FG007|Week 24 to Week 48|Failure to return|0|||
149970760|NCT00673920|541030078|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970761|NCT00673920|541030079|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970762|NCT00673920|541030080|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970763|NCT00673920|541030081|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970764|NCT00673920|541030082|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970765|NCT00673920|541030083|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
149970766|NCT00673920|541030084|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970767|NCT00673920|541030085|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
149970768|NCT00673920|541030078|FG000|Week 24 to Week 48|Death|0|||
149970769|NCT00673920|541030079|FG001|Week 24 to Week 48|Death|0|||
149970770|NCT00673920|541030080|FG002|Week 24 to Week 48|Death|0|||
149970771|NCT00673920|541030081|FG003|Week 24 to Week 48|Death|0|||
149970772|NCT00673920|541030082|FG004|Week 24 to Week 48|Death|0|||
149970773|NCT00673920|541030083|FG005|Week 24 to Week 48|Death|1|||
149970774|NCT00673920|541030084|FG006|Week 24 to Week 48|Death|0|||
149970775|NCT00673920|541030085|FG007|Week 24 to Week 48|Death|0|||
149970776|NCT00673920|541030078|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
149970777|NCT00673920|541030079|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
149970778|NCT00673920|541030080|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
149970779|NCT00673920|541030081|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
150048060|NCT04413617|541316796|FG003|Overall Study|COVID-19|0|||
150048061|NCT04413617|541316797|FG004|Overall Study|COVID-19|0|||
150048062|NCT02511106|541316800|FG000|Overall Study|Lost to Follow-up|6|||
150048063|NCT02511106|541316801|FG001|Overall Study|Lost to Follow-up|4|||
150048064|NCT02511106|541316800|FG000|Overall Study|Withdrawal by Subject|24|||
150048065|NCT02511106|541316801|FG001|Overall Study|Withdrawal by Subject|21|||
150048066|NCT02511106|541316800|FG000|Overall Study|Death|42|||
150048067|NCT02511106|541316801|FG001|Overall Study|Death|82|||
150048068|NCT02511106|541316800|FG000|Overall Study|Ongoing study at data cut-off|3|||
150048069|NCT02511106|541316801|FG001|Overall Study|Ongoing study at data cut-off|2|||
150048070|NCT02511106|541316800|FG000|Overall Study|Without specified reason|3|||
150048071|NCT02511106|541316801|FG001|Overall Study|Without specified reason|0|||
150048072|NCT01015638|541316802|FG000|Overall Study|Withdrawal by Subject|1|||
150048073|NCT01015638|541316803|FG001|Overall Study|Withdrawal by Subject|0|||
150048074|NCT00984620|541316804|FG000|Overall Study|Adverse Event|5|||
150048075|NCT00984620|541316805|FG001|Overall Study|Adverse Event|5|||
150048076|NCT00984620|541316804|FG000|Overall Study|Lost to Follow-up|1|||
150048077|NCT00984620|541316805|FG001|Overall Study|Lost to Follow-up|1|||
150048078|NCT00984620|541316804|FG000|Overall Study|Withdrawal by Subject|0|||
150048079|NCT00984620|541316805|FG001|Overall Study|Withdrawal by Subject|2|||
150048080|NCT00984620|541316804|FG000|Overall Study|reason other than listed above|0|||
150048081|NCT00984620|541316805|FG001|Overall Study|reason other than listed above|4|||
150048082|NCT01703754|541316811|FG000|Overall Study|Clinically significant disease progression|2|||
150048083|NCT01703754|541316812|FG001|Overall Study|Clinically significant disease progression|2|||
150048084|NCT01703754|541316813|FG002|Overall Study|Clinically significant disease progression|1|||
150048085|NCT01703754|541316811|FG000|Overall Study|Adverse Event|1|||
150048086|NCT01703754|541316812|FG001|Overall Study|Adverse Event|1|||
150048087|NCT01703754|541316813|FG002|Overall Study|Adverse Event|0|||
150048088|NCT01703754|541316811|FG000|Overall Study|Withdrawal by Subject|2|||
150048089|NCT01703754|541316812|FG001|Overall Study|Withdrawal by Subject|0|||
150048090|NCT01703754|541316813|FG002|Overall Study|Withdrawal by Subject|0|||
150048091|NCT01459497|541316817|FG000|Overall Study|Inability to meet trial constraints.|1|||
150048092|NCT01459497|541316818|FG001|Overall Study|Inability to meet trial constraints.|0|||
150048093|NCT01459497|541316817|FG000|Overall Study|Physician Decision|1|||
150048094|NCT01459497|541316818|FG001|Overall Study|Physician Decision|1|||
150048095|NCT01459497|541316817|FG000|Overall Study|Hospitalization.|0|||
150048096|NCT01459497|541316818|FG001|Overall Study|Hospitalization.|3|||
150048097|NCT01459497|541316817|FG000|Overall Study|Disease progression.|0|||
150048098|NCT01459497|541316818|FG001|Overall Study|Disease progression.|1|||
150048099|NCT03530124|541316819|FG000|Overall Study|Withdrawal by Subject|0|||
150048100|NCT03530124|541316820|FG001|Overall Study|Withdrawal by Subject|1|||
150048101|NCT03530124|541316819|FG000|Overall Study|Protocol Violation|1|||
150048102|NCT03530124|541316820|FG001|Overall Study|Protocol Violation|0|||
150048103|NCT03530124|541316819|FG000|Overall Study|Discharged prior to study completion|1|||
150048104|NCT03530124|541316820|FG001|Overall Study|Discharged prior to study completion|0|||
150048105|NCT03179319|541316821|FG000|Overall Study|Lost to Follow-up|6|||
150048106|NCT03179319|541316822|FG001|Overall Study|Lost to Follow-up|0|||
150048107|NCT01120717|541316823|FG000|Overall Study|Withdrawal by Subject|11|||
150048108|NCT01120717|541316824|FG001|Overall Study|Withdrawal by Subject|6|||
150048109|NCT01120717|541316823|FG000|Overall Study|Adverse Event|10|||
150048110|NCT01120717|541316824|FG001|Overall Study|Adverse Event|6|||
150048111|NCT01120717|541316823|FG000|Overall Study|Protocol Deviation|2|||
150048112|NCT01120717|541316824|FG001|Overall Study|Protocol Deviation|5|||
150048113|NCT01120717|541316823|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
150048114|NCT01120717|541316824|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
150048115|NCT01120717|541316823|FG000|Overall Study|Lost to Follow-up|2|||
150048116|NCT01120717|541316824|FG001|Overall Study|Lost to Follow-up|3|||
150048117|NCT01120717|541316823|FG000|Overall Study|Death|3|||
150048118|NCT01120717|541316824|FG001|Overall Study|Death|1|||
150048119|NCT01120717|541316823|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
150048120|NCT01120717|541316824|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
150048121|NCT00947882|541316829|FG000|Overall Study|Adverse Event|0|||
150048122|NCT00947882|541316830|FG001|Overall Study|Adverse Event|1|||
150048123|NCT00947882|541316831|FG002|Overall Study|Adverse Event|4|||
150048124|NCT00947882|541316832|FG003|Overall Study|Adverse Event|4|||
150048125|NCT00947882|541316829|FG000|Overall Study|Withdrawal by Subject|2|||
150048126|NCT00947882|541316830|FG001|Overall Study|Withdrawal by Subject|0|||
150048127|NCT00947882|541316831|FG002|Overall Study|Withdrawal by Subject|8|||
150048128|NCT00947882|541316832|FG003|Overall Study|Withdrawal by Subject|2|||
150048129|NCT00947882|541316829|FG000|Overall Study|Protocol Violation|0|||
150048130|NCT00947882|541316830|FG001|Overall Study|Protocol Violation|0|||
150048131|NCT00947882|541316831|FG002|Overall Study|Protocol Violation|1|||
150048132|NCT00947882|541316832|FG003|Overall Study|Protocol Violation|0|||
150048133|NCT00947882|541316829|FG000|Overall Study|Lost to Follow-up|0|||
150048134|NCT00947882|541316830|FG001|Overall Study|Lost to Follow-up|2|||
150048135|NCT00947882|541316831|FG002|Overall Study|Lost to Follow-up|1|||
150048136|NCT00947882|541316832|FG003|Overall Study|Lost to Follow-up|0|||
150048137|NCT00947882|541316829|FG000|Overall Study|Other/Unknown|10|||
150048138|NCT00947882|541316830|FG001|Overall Study|Other/Unknown|13|||
150048139|NCT00947882|541316831|FG002|Overall Study|Other/Unknown|3|||
150048140|NCT00947882|541316832|FG003|Overall Study|Other/Unknown|6|||
149970780|NCT00673920|541030082|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
149970781|NCT00673920|541030083|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
149970782|NCT00673920|541030084|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
149970783|NCT00673920|541030085|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
149970784|NCT03746015|541030090|FG000|Overall Study|Withdrawal of Consent|1|||
149970785|NCT03746015|541030091|FG001|Overall Study|Withdrawal of Consent|0|||
149970786|NCT03746015|541030092|FG002|Overall Study|Withdrawal of Consent|0|||
149970787|NCT04562116|541030093|FG000|Overall Study|Lost to Follow-up|1|||
149970788|NCT04562116|541030093|FG000|Overall Study|Withdrawal by Subject|3|||
149970789|NCT03502200|541030103|FG000|Overall Study|Adverse Event|1|||
149970790|NCT03502200|541030104|FG001|Overall Study|Adverse Event|0|||
149970791|NCT03502200|541030103|FG000|Overall Study|Lost to Follow-up|36|||
149970792|NCT03502200|541030104|FG001|Overall Study|Lost to Follow-up|38|||
149970793|NCT03502200|541030103|FG000|Overall Study|Study Team Decision|1|||
149970794|NCT03502200|541030104|FG001|Overall Study|Study Team Decision|1|||
149970795|NCT03502200|541030103|FG000|Overall Study|Withdrawal by Subject|5|||
149970796|NCT03502200|541030104|FG001|Overall Study|Withdrawal by Subject|7|||
149970797|NCT03502200|541030103|FG000|Overall Study|Death|0|||
149970798|NCT03502200|541030104|FG001|Overall Study|Death|2|||
149970799|NCT03097289|541030105|FG000|Overall Study|Adverse Event|1|||
149970800|NCT03097289|541030105|FG000|Overall Study|Equipment failure|2|||
149970801|NCT03097289|541030105|FG000|Overall Study|Collected platelet product unusable|3|||
149970802|NCT01121757|541030108|FG000|First Drug|Death|1|||
149970803|NCT01121757|541030109|FG001|First Drug|Death|0|||
149970804|NCT01121757|541030108|FG000|First Drug|Disease Progression|0|||
149970805|NCT01121757|541030109|FG001|First Drug|Disease Progression|2|||
149970806|NCT01121757|541030108|FG000|Combination|Physician Decision|0|||
149970807|NCT01121757|541030109|FG001|Combination|Physician Decision|1|||
149970808|NCT01121757|541030108|FG000|Combination|Disease Progression|2|||
149970809|NCT01121757|541030109|FG001|Combination|Disease Progression|0|||
149970810|NCT03213509|541030111|FG000|Overall Study|Did not consent for verbal autopsy|4|||
149970811|NCT03213509|541030112|FG001|Overall Study|Did not consent for verbal autopsy|5|||
149970812|NCT02297412|541030113|FG000|Overall Study|Canceled|1|||
149970813|NCT02297412|541030114|FG001|Overall Study|Canceled|1|||
149970814|NCT03330847|541030123|FG000|Overall Study|Patients ongoing study|62|||
149970815|NCT03330847|541030124|FG001|Overall Study|Patients ongoing study|65|||
149970816|NCT03330847|541030125|FG002|Overall Study|Patients ongoing study|15|||
149970817|NCT05211596|541030128|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
149970818|NCT05211596|541030128|FG000|Baseline to 6 Months|Death|1|||
149970819|NCT05211596|541030128|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
149970820|NCT05211596|541030128|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
149970821|NCT02769481|541030129|FG000|Overall Study|Protocol Violation|1|||
149970822|NCT02769481|541030130|FG001|Overall Study|Protocol Violation|0|||
149970823|NCT02769481|541030129|FG000|Overall Study|Adverse Event|3|||
149970824|NCT02769481|541030130|FG001|Overall Study|Adverse Event|6|||
149970825|NCT02769481|541030129|FG000|Overall Study|Entry Criteria Not Met|1|||
149970826|NCT02769481|541030130|FG001|Overall Study|Entry Criteria Not Met|2|||
149970827|NCT02769481|541030129|FG000|Overall Study|Withdrawal by Subject|14|||
149970828|NCT02769481|541030130|FG001|Overall Study|Withdrawal by Subject|16|||
149970829|NCT02769481|541030129|FG000|Overall Study|Lost to Follow-up|9|||
149970830|NCT02769481|541030130|FG001|Overall Study|Lost to Follow-up|9|||
149970831|NCT02769481|541030129|FG000|Overall Study|Physician Decision|0|||
149970832|NCT02769481|541030130|FG001|Overall Study|Physician Decision|1|||
149970833|NCT02769481|541030129|FG000|Overall Study|Terminated by Sponsor|1|||
149970834|NCT02769481|541030130|FG001|Overall Study|Terminated by Sponsor|0|||
149970835|NCT02769481|541030129|FG000|Overall Study|Death|0|||
149970836|NCT02769481|541030130|FG001|Overall Study|Death|1|||
149970837|NCT02769481|541030129|FG000|Overall Study|Undefined|4|||
149970838|NCT02769481|541030130|FG001|Overall Study|Undefined|1|||
149970839|NCT06272383|541030131|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
149970840|NCT06272383|541030132|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
149970841|NCT04398706|541030133|FG000|Overall Study|Adverse Event|0|||
149970842|NCT04398706|541030134|FG001|Overall Study|Adverse Event|0|||
149970843|NCT04398706|541030135|FG002|Overall Study|Adverse Event|0|||
149970844|NCT04398706|541030136|FG003|Overall Study|Adverse Event|0|||
149970845|NCT04398706|541030137|FG004|Overall Study|Adverse Event|0|||
149970846|NCT04398706|541030138|FG005|Overall Study|Adverse Event|1|||
149970847|NCT04398706|541030139|FG006|Overall Study|Adverse Event|1|||
150048141|NCT00947882|541316829|FG000|Overall Study|Trial Terminated by Sponsor|62|||
149970848|NCT04398706|541030140|FG007|Overall Study|Adverse Event|0|||
149970849|NCT04398706|541030133|FG000|Overall Study|Lost to Follow-up|0|||
149970850|NCT04398706|541030134|FG001|Overall Study|Lost to Follow-up|1|||
149970851|NCT04398706|541030135|FG002|Overall Study|Lost to Follow-up|2|||
149970852|NCT04398706|541030136|FG003|Overall Study|Lost to Follow-up|1|||
149970853|NCT04398706|541030137|FG004|Overall Study|Lost to Follow-up|6|||
149970854|NCT04398706|541030138|FG005|Overall Study|Lost to Follow-up|3|||
149970855|NCT04398706|541030139|FG006|Overall Study|Lost to Follow-up|8|||
149970856|NCT04398706|541030140|FG007|Overall Study|Lost to Follow-up|2|||
150048142|NCT00947882|541316830|FG001|Overall Study|Trial Terminated by Sponsor|61|||
150048143|NCT00947882|541316831|FG002|Overall Study|Trial Terminated by Sponsor|62|||
150048144|NCT00947882|541316832|FG003|Overall Study|Trial Terminated by Sponsor|70|||
150048145|NCT05188053|541316833|FG000|Overall Study|Lost to Follow-up|23|||
150048146|NCT05188053|541316834|FG001|Overall Study|Lost to Follow-up|30|||
150048147|NCT05188053|541316833|FG000|Overall Study|Protocol Violation|16|||
150048148|NCT05188053|541316834|FG001|Overall Study|Protocol Violation|16|||
150048149|NCT05188053|541316833|FG000|Overall Study|Physician Decision|3|||
150048150|NCT05188053|541316834|FG001|Overall Study|Physician Decision|0|||
150048151|NCT05188053|541316833|FG000|Overall Study|Withdrawal by Subject|0|||
150048152|NCT05188053|541316834|FG001|Overall Study|Withdrawal by Subject|1|||
150048153|NCT02379637|541316838|FG000|Overall Study|Protocol Violation|0|||
150048154|NCT02379637|541316839|FG001|Overall Study|Protocol Violation|1|||
150048155|NCT02379637|541316838|FG000|Overall Study|Adverse Event|1|||
150048156|NCT02379637|541316839|FG001|Overall Study|Adverse Event|0|||
150048157|NCT02379637|541316838|FG000|Overall Study|Withdrawal by Subject|1|||
150048158|NCT02379637|541316839|FG001|Overall Study|Withdrawal by Subject|0|||
150048159|NCT01561313|541316846|FG000|Overall Study|Withdrawal by Subject|1|||
150048160|NCT01561313|541316847|FG001|Overall Study|Withdrawal by Subject|0|||
150048161|NCT01561313|541316846|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
150048162|NCT01561313|541316847|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
150048163|NCT04535453|541316848|FG000|Overall Study|Death|0|||
150048164|NCT04535453|541316849|FG001|Overall Study|Death|1|||
150048165|NCT04535453|541316850|FG002|Overall Study|Death|0|||
150048166|NCT04535453|541316851|FG003|Overall Study|Death|0|||
150048167|NCT04535453|541316852|FG004|Overall Study|Death|0|||
150048168|NCT04535453|541316853|FG005|Overall Study|Death|0|||
150048169|NCT04535453|541316854|FG006|Overall Study|Death|0|||
150048170|NCT04535453|541316855|FG007|Overall Study|Death|0|||
150048171|NCT04535453|541316856|FG008|Overall Study|Death|0|||
150048172|NCT04535453|541316857|FG009|Overall Study|Death|0|||
150048173|NCT04535453|541316858|FG010|Overall Study|Death|0|||
150048174|NCT04535453|541316859|FG011|Overall Study|Death|0|||
150048175|NCT04535453|541316848|FG000|Overall Study|Lost to Follow-up|1|||
150048176|NCT04535453|541316849|FG001|Overall Study|Lost to Follow-up|1|||
150048177|NCT04535453|541316850|FG002|Overall Study|Lost to Follow-up|1|||
150048178|NCT04535453|541316851|FG003|Overall Study|Lost to Follow-up|0|||
150176688|NCT01369498|541783375|FG000|Overall Study|Unknown Reason|1|||
150176689|NCT01369498|541783376|FG001|Overall Study|Unknown Reason|0|||
150048179|NCT04535453|541316852|FG004|Overall Study|Lost to Follow-up|3|||
150048180|NCT04535453|541316853|FG005|Overall Study|Lost to Follow-up|1|||
150048181|NCT04535453|541316854|FG006|Overall Study|Lost to Follow-up|0|||
150048182|NCT04535453|541316855|FG007|Overall Study|Lost to Follow-up|0|||
150048183|NCT04535453|541316856|FG008|Overall Study|Lost to Follow-up|1|||
150176690|NCT01369498|541783377|FG002|Overall Study|Unknown Reason|11|||
150176691|NCT01369498|541783378|FG003|Overall Study|Unknown Reason|6|||
150048184|NCT04535453|541316857|FG009|Overall Study|Lost to Follow-up|1|||
150048185|NCT04535453|541316858|FG010|Overall Study|Lost to Follow-up|0|||
150048186|NCT04535453|541316859|FG011|Overall Study|Lost to Follow-up|0|||
150176692|NCT01369498|541783375|FG000|Overall Study|Disease Progression|0|||
150176693|NCT01369498|541783376|FG001|Overall Study|Disease Progression|0|||
150048187|NCT04535453|541316848|FG000|Overall Study|Physician Decision|0|||
149970857|NCT04398706|541030133|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149970858|NCT04398706|541030134|FG001|Overall Study|Withdrawal by parent/guardian|2|||
150048188|NCT04535453|541316849|FG001|Overall Study|Physician Decision|0|||
150048189|NCT04535453|541316850|FG002|Overall Study|Physician Decision|0|||
150048190|NCT04535453|541316851|FG003|Overall Study|Physician Decision|1|||
150048191|NCT04535453|541316852|FG004|Overall Study|Physician Decision|0|||
150048192|NCT04535453|541316853|FG005|Overall Study|Physician Decision|0|||
150048193|NCT04535453|541316854|FG006|Overall Study|Physician Decision|0|||
150048194|NCT04535453|541316855|FG007|Overall Study|Physician Decision|0|||
150048195|NCT04535453|541316856|FG008|Overall Study|Physician Decision|0|||
150048196|NCT04535453|541316857|FG009|Overall Study|Physician Decision|0|||
150048197|NCT04535453|541316858|FG010|Overall Study|Physician Decision|0|||
150048198|NCT04535453|541316859|FG011|Overall Study|Physician Decision|0|||
150048199|NCT04535453|541316848|FG000|Overall Study|Withdrawal by Subject|3|||
150048200|NCT04535453|541316849|FG001|Overall Study|Withdrawal by Subject|6|||
150048201|NCT04535453|541316850|FG002|Overall Study|Withdrawal by Subject|3|||
150048202|NCT04535453|541316851|FG003|Overall Study|Withdrawal by Subject|3|||
150048203|NCT04535453|541316852|FG004|Overall Study|Withdrawal by Subject|2|||
150048204|NCT04535453|541316853|FG005|Overall Study|Withdrawal by Subject|1|||
150048205|NCT04535453|541316854|FG006|Overall Study|Withdrawal by Subject|1|||
150048206|NCT04535453|541316855|FG007|Overall Study|Withdrawal by Subject|1|||
150048207|NCT04535453|541316856|FG008|Overall Study|Withdrawal by Subject|1|||
150048208|NCT04535453|541316857|FG009|Overall Study|Withdrawal by Subject|1|||
150048209|NCT04535453|541316858|FG010|Overall Study|Withdrawal by Subject|0|||
150048210|NCT04535453|541316859|FG011|Overall Study|Withdrawal by Subject|1|||
150048211|NCT04535453|541316848|FG000|Overall Study|Other|0|||
150048212|NCT04535453|541316849|FG001|Overall Study|Other|0|||
150048213|NCT04535453|541316850|FG002|Overall Study|Other|1|||
150048214|NCT04535453|541316851|FG003|Overall Study|Other|0|||
150048215|NCT04535453|541316852|FG004|Overall Study|Other|1|||
150048216|NCT04535453|541316853|FG005|Overall Study|Other|0|||
150048217|NCT04535453|541316854|FG006|Overall Study|Other|1|||
150048218|NCT04535453|541316855|FG007|Overall Study|Other|1|||
150048219|NCT04535453|541316856|FG008|Overall Study|Other|1|||
150048220|NCT04535453|541316857|FG009|Overall Study|Other|0|||
150048221|NCT04535453|541316858|FG010|Overall Study|Other|0|||
150048222|NCT04535453|541316859|FG011|Overall Study|Other|0|||
150048223|NCT02695420|541316860|FG000|Overall Study|Death|0|||
150048224|NCT02695420|541316861|FG001|Overall Study|Death|1|||
150048225|NCT02695420|541316862|FG002|Overall Study|Death|0|||
150048226|NCT02695420|541316863|FG003|Overall Study|Death|0|||
150048227|NCT02929407|541316866|FG000|Overall Study|Adverse Event|1|||
150048228|NCT01742286|541316867|FG000|Escalation Phase|Administrative problems|1|||
150048229|NCT01742286|541316868|FG001|Escalation Phase|Administrative problems|1|||
150048230|NCT01742286|541316869|FG002|Escalation Phase|Administrative problems|0|||
150048231|NCT01742286|541316870|FG003|Escalation Phase|Administrative problems|0|||
150048232|NCT01742286|541316871|FG004|Escalation Phase|Administrative problems|0|||
150048233|NCT01742286|541316872|FG005|Escalation Phase|Administrative problems|0|||
150048234|NCT01742286|541316873|FG006|Escalation Phase|Administrative problems|2|||
150048235|NCT01742286|541316867|FG000|Escalation Phase|Adverse Event|0|||
150048236|NCT01742286|541316868|FG001|Escalation Phase|Adverse Event|1|||
150048237|NCT01742286|541316869|FG002|Escalation Phase|Adverse Event|2|||
150048238|NCT01742286|541316870|FG003|Escalation Phase|Adverse Event|0|||
150048239|NCT01742286|541316871|FG004|Escalation Phase|Adverse Event|0|||
150048240|NCT01742286|541316872|FG005|Escalation Phase|Adverse Event|1|||
150048241|NCT01742286|541316873|FG006|Escalation Phase|Adverse Event|0|||
150048242|NCT01742286|541316867|FG000|Escalation Phase|Disease progression|3|||
150048243|NCT01742286|541316868|FG001|Escalation Phase|Disease progression|7|||
150048244|NCT01742286|541316869|FG002|Escalation Phase|Disease progression|4|||
150048245|NCT01742286|541316870|FG003|Escalation Phase|Disease progression|1|||
150048246|NCT01742286|541316871|FG004|Escalation Phase|Disease progression|4|||
150048247|NCT01742286|541316872|FG005|Escalation Phase|Disease progression|3|||
150048248|NCT01742286|541316873|FG006|Escalation Phase|Disease progression|2|||
150048249|NCT01742286|541316867|FG000|Escalation Phase|Death|0|||
150048250|NCT01742286|541316868|FG001|Escalation Phase|Death|0|||
150048251|NCT01742286|541316869|FG002|Escalation Phase|Death|0|||
150048252|NCT01742286|541316870|FG003|Escalation Phase|Death|0|||
150048253|NCT01742286|541316871|FG004|Escalation Phase|Death|0|||
150048254|NCT01742286|541316872|FG005|Escalation Phase|Death|1|||
150048255|NCT01742286|541316873|FG006|Escalation Phase|Death|0|||
150048256|NCT01742286|541316867|FG000|Escalation Phase|Physician Decision|0|||
150048257|NCT01742286|541316868|FG001|Escalation Phase|Physician Decision|3|||
150048258|NCT01742286|541316869|FG002|Escalation Phase|Physician Decision|0|||
150048259|NCT01742286|541316870|FG003|Escalation Phase|Physician Decision|1|||
150048260|NCT01742286|541316871|FG004|Escalation Phase|Physician Decision|0|||
150048261|NCT01742286|541316872|FG005|Escalation Phase|Physician Decision|0|||
150048262|NCT01742286|541316873|FG006|Escalation Phase|Physician Decision|2|||
150048263|NCT01742286|541316867|FG000|Escalation Phase|Subject/guardian decision|1|||
150048264|NCT01742286|541316868|FG001|Escalation Phase|Subject/guardian decision|0|||
150048265|NCT01742286|541316869|FG002|Escalation Phase|Subject/guardian decision|0|||
150048266|NCT01742286|541316870|FG003|Escalation Phase|Subject/guardian decision|0|||
150048267|NCT01742286|541316871|FG004|Escalation Phase|Subject/guardian decision|0|||
150048268|NCT01742286|541316872|FG005|Escalation Phase|Subject/guardian decision|0|||
150048269|NCT01742286|541316873|FG006|Escalation Phase|Subject/guardian decision|0|||
150048270|NCT01742286|541316867|FG000|Expansion Phase|Administrative problems|0|||
150048271|NCT01742286|541316868|FG001|Expansion Phase|Administrative problems|0|||
150048272|NCT01742286|541316869|FG002|Expansion Phase|Administrative problems|0|||
150048273|NCT01742286|541316870|FG003|Expansion Phase|Administrative problems|0|||
150048274|NCT01742286|541316871|FG004|Expansion Phase|Administrative problems|0|||
150048275|NCT01742286|541316872|FG005|Expansion Phase|Administrative problems|0|||
150048276|NCT01742286|541316873|FG006|Expansion Phase|Administrative problems|5|||
150048277|NCT01742286|541316867|FG000|Expansion Phase|Physician Decision|0|||
150048278|NCT01742286|541316868|FG001|Expansion Phase|Physician Decision|0|||
150048279|NCT01742286|541316869|FG002|Expansion Phase|Physician Decision|4|||
150048280|NCT01742286|541316870|FG003|Expansion Phase|Physician Decision|0|||
150048281|NCT01742286|541316871|FG004|Expansion Phase|Physician Decision|0|||
150048282|NCT01742286|541316872|FG005|Expansion Phase|Physician Decision|0|||
150048283|NCT01742286|541316873|FG006|Expansion Phase|Physician Decision|9|||
150048284|NCT01742286|541316867|FG000|Expansion Phase|Adverse Event|0|||
150048285|NCT01742286|541316868|FG001|Expansion Phase|Adverse Event|0|||
150048286|NCT01742286|541316869|FG002|Expansion Phase|Adverse Event|0|||
150048287|NCT01742286|541316870|FG003|Expansion Phase|Adverse Event|0|||
150048288|NCT01742286|541316871|FG004|Expansion Phase|Adverse Event|0|||
150048289|NCT01742286|541316872|FG005|Expansion Phase|Adverse Event|0|||
150048290|NCT01742286|541316873|FG006|Expansion Phase|Adverse Event|6|||
150048291|NCT01742286|541316867|FG000|Expansion Phase|Disease progression|0|||
150048292|NCT01742286|541316868|FG001|Expansion Phase|Disease progression|0|||
150048293|NCT01742286|541316869|FG002|Expansion Phase|Disease progression|3|||
150048294|NCT01742286|541316870|FG003|Expansion Phase|Disease progression|0|||
150048295|NCT01742286|541316871|FG004|Expansion Phase|Disease progression|0|||
149906989|NCT03781583|540789634|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
149906990|NCT03781583|540789635|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
149906991|NCT03781583|540789636|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
149906992|NCT01938430|540789637|FG000|Overall Study|Randomized but Not Treated|0|||
149906993|NCT01938430|540789638|FG001|Overall Study|Randomized but Not Treated|0|||
149906994|NCT01938430|540789639|FG002|Overall Study|Randomized but Not Treated|0|||
150048296|NCT01742286|541316872|FG005|Expansion Phase|Disease progression|0|||
150048297|NCT01742286|541316873|FG006|Expansion Phase|Disease progression|15|||
150048298|NCT01742286|541316867|FG000|Expansion Phase|Withdrawal by Subject|0|||
150048299|NCT01742286|541316868|FG001|Expansion Phase|Withdrawal by Subject|0|||
150048300|NCT01742286|541316869|FG002|Expansion Phase|Withdrawal by Subject|0|||
150048301|NCT01742286|541316870|FG003|Expansion Phase|Withdrawal by Subject|0|||
150048302|NCT01742286|541316871|FG004|Expansion Phase|Withdrawal by Subject|0|||
150176694|NCT01369498|541783377|FG002|Overall Study|Disease Progression|0|||
149970859|NCT04398706|541030135|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149970860|NCT04398706|541030136|FG003|Overall Study|Withdrawal by parent/guardian|2|||
149970861|NCT04398706|541030137|FG004|Overall Study|Withdrawal by parent/guardian|19|||
149970862|NCT04398706|541030138|FG005|Overall Study|Withdrawal by parent/guardian|23|||
149970863|NCT04398706|541030139|FG006|Overall Study|Withdrawal by parent/guardian|13|||
149970864|NCT04398706|541030140|FG007|Overall Study|Withdrawal by parent/guardian|11|||
149970865|NCT04398706|541030133|FG000|Overall Study|Protocol deviation|0|||
149970866|NCT04398706|541030134|FG001|Overall Study|Protocol deviation|1|||
149970867|NCT04398706|541030135|FG002|Overall Study|Protocol deviation|0|||
149970868|NCT04398706|541030136|FG003|Overall Study|Protocol deviation|0|||
149970869|NCT04398706|541030137|FG004|Overall Study|Protocol deviation|6|||
149970870|NCT04398706|541030138|FG005|Overall Study|Protocol deviation|4|||
149970871|NCT04398706|541030139|FG006|Overall Study|Protocol deviation|6|||
149970872|NCT04398706|541030140|FG007|Overall Study|Protocol deviation|3|||
149970873|NCT00618787|541030142|FG000|Overall Study|Adverse Event|0|||
149970874|NCT00618787|541030143|FG001|Overall Study|Adverse Event|1|||
149970875|NCT00618787|541030142|FG000|Overall Study|Withdrawal by Subject|2|||
149970876|NCT00618787|541030143|FG001|Overall Study|Withdrawal by Subject|1|||
149970877|NCT00618787|541030142|FG000|Overall Study|Lost to Follow-up|1|||
149970878|NCT00618787|541030143|FG001|Overall Study|Lost to Follow-up|0|||
149970879|NCT01107886|541030144|FG000|Overall Study|Lost to Follow-up|15|||
149970880|NCT01107886|541030145|FG001|Overall Study|Lost to Follow-up|13|||
149970881|NCT01107886|541030144|FG000|Overall Study|Withdrawal by Subject|180|||
149970882|NCT01107886|541030145|FG001|Overall Study|Withdrawal by Subject|196|||
149970883|NCT01107886|541030144|FG000|Overall Study|Administrative withdrawal of consent|7|||
149970884|NCT01107886|541030145|FG001|Overall Study|Administrative withdrawal of consent|5|||
149970885|NCT01346176|541030146|FG000|Recruited|Protocol Violation|1|||
149970886|NCT01346176|541030147|FG001|Recruited|Protocol Violation|0|||
149970887|NCT01346176|541030148|FG002|Recruited|Protocol Violation|0|||
149970888|NCT01346176|541030146|FG000|Completed Advance Directive|Death|3|||
149970889|NCT01346176|541030147|FG001|Completed Advance Directive|Death|2|||
149970890|NCT01346176|541030148|FG002|Completed Advance Directive|Death|2|||
149970891|NCT01346176|541030146|FG000|Completed Advance Directive|Became Ineligible|3|||
149970892|NCT01346176|541030147|FG001|Completed Advance Directive|Became Ineligible|0|||
149970893|NCT01346176|541030148|FG002|Completed Advance Directive|Became Ineligible|1|||
149970894|NCT01346176|541030146|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
149970895|NCT01346176|541030147|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
149970896|NCT01346176|541030148|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
149970897|NCT01346176|541030146|FG000|Completed Satisfaction Survey|Death|3|||
149970898|NCT01346176|541030147|FG001|Completed Satisfaction Survey|Death|0|||
149970899|NCT01346176|541030148|FG002|Completed Satisfaction Survey|Death|2|||
149970900|NCT01346176|541030146|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
149970901|NCT01346176|541030147|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
149970902|NCT01346176|541030148|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
149970903|NCT01994876|541030149|FG000|Test Period 1|Withdrawal by Subject|0|||
149970904|NCT01994876|541030150|FG001|Test Period 1|Withdrawal by Subject|1|||
149970905|NCT01994876|541030149|FG000|Test Period 1|Adverse Event|0|||
149970906|NCT01994876|541030150|FG001|Test Period 1|Adverse Event|1|||
149970907|NCT01994876|541030149|FG000|Test Period 2|Adverse Event|1|||
149970908|NCT01994876|541030150|FG001|Test Period 2|Adverse Event|0|||
149970909|NCT01994876|541030149|FG000|Test Period 2|Protocol Violation|0|||
149970910|NCT01994876|541030150|FG001|Test Period 2|Protocol Violation|1|||
149970911|NCT05819398|541030151|FG000|Overall Study|Withdrawal by Subject|11|||
149970912|NCT05819398|541030152|FG001|Overall Study|Withdrawal by Subject|7|||
149970913|NCT05819398|541030153|FG002|Overall Study|Withdrawal by Subject|6|||
150048303|NCT01742286|541316872|FG005|Expansion Phase|Withdrawal by Subject|0|||
149906995|NCT01938430|540789640|FG003|Overall Study|Randomized but Not Treated|0|||
149906996|NCT01938430|540789641|FG004|Overall Study|Randomized but Not Treated|0|||
149906997|NCT01938430|540789642|FG005|Overall Study|Randomized but Not Treated|0|||
149906998|NCT01938430|540789643|FG006|Overall Study|Randomized but Not Treated|0|||
149906999|NCT01938430|540789644|FG007|Overall Study|Randomized but Not Treated|0|||
149907000|NCT01938430|540789645|FG008|Overall Study|Randomized but Not Treated|0|||
149907001|NCT01938430|540789646|FG009|Overall Study|Randomized but Not Treated|0|||
149907002|NCT01938430|540789647|FG010|Overall Study|Randomized but Not Treated|1|||
149907003|NCT01938430|540789648|FG011|Overall Study|Randomized but Not Treated|0|||
149907004|NCT01938430|540789649|FG012|Overall Study|Randomized but Not Treated|0|||
149907005|NCT01938430|540789650|FG013|Overall Study|Randomized but Not Treated|1|||
149907006|NCT01938430|540789637|FG000|Overall Study|Adverse Event|0|||
149907007|NCT01938430|540789638|FG001|Overall Study|Adverse Event|0|||
149907008|NCT01938430|540789639|FG002|Overall Study|Adverse Event|0|||
149907009|NCT01938430|540789640|FG003|Overall Study|Adverse Event|0|||
149907010|NCT01938430|540789641|FG004|Overall Study|Adverse Event|0|||
149907011|NCT01938430|540789642|FG005|Overall Study|Adverse Event|0|||
149907012|NCT01938430|540789643|FG006|Overall Study|Adverse Event|1|||
149907013|NCT01938430|540789644|FG007|Overall Study|Adverse Event|0|||
149907014|NCT01938430|540789645|FG008|Overall Study|Adverse Event|0|||
149970914|NCT05819398|541030154|FG003|Overall Study|Withdrawal by Subject|6|||
149970915|NCT05819398|541030151|FG000|Overall Study|Lost to Follow-up|0|||
149970916|NCT05819398|541030152|FG001|Overall Study|Lost to Follow-up|2|||
149970917|NCT05819398|541030153|FG002|Overall Study|Lost to Follow-up|0|||
149970918|NCT05819398|541030154|FG003|Overall Study|Lost to Follow-up|1|||
149970919|NCT05819398|541030151|FG000|Overall Study|Adverse Event|1|||
149970920|NCT05819398|541030152|FG001|Overall Study|Adverse Event|3|||
149970921|NCT05819398|541030153|FG002|Overall Study|Adverse Event|4|||
149970922|NCT05819398|541030154|FG003|Overall Study|Adverse Event|5|||
149970923|NCT05819398|541030151|FG000|Overall Study|Other than listed|0|||
149970924|NCT05819398|541030152|FG001|Overall Study|Other than listed|2|||
149970925|NCT05819398|541030153|FG002|Overall Study|Other than listed|2|||
149970926|NCT05819398|541030154|FG003|Overall Study|Other than listed|0|||
149970927|NCT05819398|541030151|FG000|Overall Study|Lack of Efficacy|0|||
149970928|NCT05819398|541030152|FG001|Overall Study|Lack of Efficacy|1|||
149970929|NCT05819398|541030153|FG002|Overall Study|Lack of Efficacy|0|||
149907015|NCT01938430|540789646|FG009|Overall Study|Adverse Event|0|||
149907016|NCT01938430|540789647|FG010|Overall Study|Adverse Event|0|||
149907017|NCT01938430|540789648|FG011|Overall Study|Adverse Event|0|||
149907018|NCT01938430|540789649|FG012|Overall Study|Adverse Event|0|||
149907019|NCT01938430|540789650|FG013|Overall Study|Adverse Event|0|||
149907020|NCT01938430|540789637|FG000|Overall Study|Death|1|||
149907021|NCT01938430|540789638|FG001|Overall Study|Death|2|||
149907022|NCT01938430|540789639|FG002|Overall Study|Death|2|||
149907023|NCT01938430|540789640|FG003|Overall Study|Death|1|||
149907024|NCT01938430|540789641|FG004|Overall Study|Death|0|||
149907025|NCT01938430|540789642|FG005|Overall Study|Death|0|||
149907026|NCT01938430|540789643|FG006|Overall Study|Death|1|||
149907027|NCT01938430|540789644|FG007|Overall Study|Death|1|||
149907028|NCT01938430|540789645|FG008|Overall Study|Death|2|||
149907029|NCT01938430|540789646|FG009|Overall Study|Death|3|||
149907030|NCT01938430|540789647|FG010|Overall Study|Death|0|||
149970930|NCT05819398|541030154|FG003|Overall Study|Lack of Efficacy|0|||
149970931|NCT05819398|541030151|FG000|Overall Study|Study terminated by sponsor|20|||
149970932|NCT05819398|541030152|FG001|Overall Study|Study terminated by sponsor|18|||
149970933|NCT05819398|541030153|FG002|Overall Study|Study terminated by sponsor|20|||
149970934|NCT05819398|541030154|FG003|Overall Study|Study terminated by sponsor|22|||
149970935|NCT04522973|541030155|FG000|Overall Study|Lost to Follow-up|4|||
149970936|NCT04522973|541030155|FG000|Overall Study|Could not adhere to study schedule|1|||
149970937|NCT01649869|541030161|FG000|Overall Study|Family member illness|1|||
149970938|NCT01649869|541030162|FG001|Overall Study|Family member illness|0|||
149970939|NCT01649869|541030161|FG000|Overall Study|Required treatment outside protocol|1|||
149970940|NCT01649869|541030162|FG001|Overall Study|Required treatment outside protocol|0|||
149970941|NCT01649869|541030161|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
149970942|NCT01649869|541030162|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
149970943|NCT02776735|541030163|FG000|Overall Study|Adverse Event|0|||
149907031|NCT01938430|540789648|FG011|Overall Study|Death|0|||
149907032|NCT01938430|540789649|FG012|Overall Study|Death|0|||
149907033|NCT01938430|540789650|FG013|Overall Study|Death|0|||
149907034|NCT01938430|540789637|FG000|Overall Study|Investigator's Discretion|0|||
149907035|NCT01938430|540789638|FG001|Overall Study|Investigator's Discretion|0|||
149907036|NCT01938430|540789639|FG002|Overall Study|Investigator's Discretion|1|||
149907037|NCT01938430|540789640|FG003|Overall Study|Investigator's Discretion|0|||
149907038|NCT01938430|540789641|FG004|Overall Study|Investigator's Discretion|0|||
149907039|NCT01938430|540789642|FG005|Overall Study|Investigator's Discretion|0|||
149907040|NCT01938430|540789643|FG006|Overall Study|Investigator's Discretion|0|||
149907041|NCT01938430|540789644|FG007|Overall Study|Investigator's Discretion|0|||
149907042|NCT01938430|540789645|FG008|Overall Study|Investigator's Discretion|0|||
149907043|NCT01938430|540789646|FG009|Overall Study|Investigator's Discretion|0|||
149907044|NCT01938430|540789647|FG010|Overall Study|Investigator's Discretion|0|||
149907045|NCT01938430|540789648|FG011|Overall Study|Investigator's Discretion|0|||
149907046|NCT01938430|540789649|FG012|Overall Study|Investigator's Discretion|0|||
149907047|NCT01938430|540789650|FG013|Overall Study|Investigator's Discretion|0|||
149907048|NCT01938430|540789637|FG000|Overall Study|Lack of Efficacy|3|||
149907049|NCT01938430|540789638|FG001|Overall Study|Lack of Efficacy|1|||
149907050|NCT01938430|540789639|FG002|Overall Study|Lack of Efficacy|1|||
149907051|NCT01938430|540789640|FG003|Overall Study|Lack of Efficacy|1|||
149907052|NCT01938430|540789641|FG004|Overall Study|Lack of Efficacy|0|||
149907053|NCT01938430|540789642|FG005|Overall Study|Lack of Efficacy|0|||
149907054|NCT01938430|540789643|FG006|Overall Study|Lack of Efficacy|0|||
149907055|NCT01938430|540789644|FG007|Overall Study|Lack of Efficacy|0|||
149907056|NCT01938430|540789645|FG008|Overall Study|Lack of Efficacy|1|||
149907057|NCT01938430|540789646|FG009|Overall Study|Lack of Efficacy|0|||
149907058|NCT01938430|540789647|FG010|Overall Study|Lack of Efficacy|2|||
149970944|NCT02776735|541030164|FG001|Overall Study|Adverse Event|0|||
149970945|NCT02776735|541030165|FG002|Overall Study|Adverse Event|0|||
149970946|NCT02776735|541030166|FG003|Overall Study|Adverse Event|1|||
149970947|NCT02776735|541030167|FG004|Overall Study|Adverse Event|0|||
149907059|NCT01938430|540789648|FG011|Overall Study|Lack of Efficacy|1|||
149907060|NCT01938430|540789649|FG012|Overall Study|Lack of Efficacy|0|||
149907061|NCT01938430|540789650|FG013|Overall Study|Lack of Efficacy|0|||
149907062|NCT01938430|540789637|FG000|Overall Study|Lost to Follow-up|0|||
149907063|NCT01938430|540789638|FG001|Overall Study|Lost to Follow-up|0|||
149970948|NCT02776735|541030168|FG005|Overall Study|Adverse Event|1|||
150048304|NCT01742286|541316873|FG006|Expansion Phase|Withdrawal by Subject|1|||
149907064|NCT01938430|540789639|FG002|Overall Study|Lost to Follow-up|1|||
149907065|NCT01938430|540789640|FG003|Overall Study|Lost to Follow-up|0|||
149907066|NCT01938430|540789641|FG004|Overall Study|Lost to Follow-up|0|||
149907067|NCT01938430|540789642|FG005|Overall Study|Lost to Follow-up|1|||
149970949|NCT02776735|541030163|FG000|Overall Study|Lost to Follow-up|0|||
149970950|NCT02776735|541030164|FG001|Overall Study|Lost to Follow-up|0|||
149970951|NCT02776735|541030165|FG002|Overall Study|Lost to Follow-up|0|||
149907068|NCT01938430|540789643|FG006|Overall Study|Lost to Follow-up|0|||
149907069|NCT01938430|540789644|FG007|Overall Study|Lost to Follow-up|0|||
149907070|NCT01938430|540789645|FG008|Overall Study|Lost to Follow-up|0|||
149907071|NCT01938430|540789646|FG009|Overall Study|Lost to Follow-up|0|||
149907072|NCT01938430|540789647|FG010|Overall Study|Lost to Follow-up|0|||
149907073|NCT01938430|540789648|FG011|Overall Study|Lost to Follow-up|0|||
149907074|NCT01938430|540789649|FG012|Overall Study|Lost to Follow-up|0|||
149907075|NCT01938430|540789650|FG013|Overall Study|Lost to Follow-up|0|||
149907076|NCT01938430|540789637|FG000|Overall Study|Withdrew Consent|0|||
149907077|NCT01938430|540789638|FG001|Overall Study|Withdrew Consent|0|||
149907078|NCT01938430|540789639|FG002|Overall Study|Withdrew Consent|0|||
149907079|NCT01938430|540789640|FG003|Overall Study|Withdrew Consent|0|||
149907080|NCT01938430|540789641|FG004|Overall Study|Withdrew Consent|0|||
149907081|NCT01938430|540789642|FG005|Overall Study|Withdrew Consent|0|||
149907082|NCT01938430|540789643|FG006|Overall Study|Withdrew Consent|0|||
149907083|NCT01938430|540789644|FG007|Overall Study|Withdrew Consent|0|||
149907084|NCT01938430|540789645|FG008|Overall Study|Withdrew Consent|1|||
149907085|NCT01938430|540789646|FG009|Overall Study|Withdrew Consent|0|||
149907086|NCT01938430|540789647|FG010|Overall Study|Withdrew Consent|0|||
149907087|NCT01938430|540789648|FG011|Overall Study|Withdrew Consent|0|||
149907088|NCT01938430|540789649|FG012|Overall Study|Withdrew Consent|0|||
149907089|NCT01938430|540789650|FG013|Overall Study|Withdrew Consent|0|||
149907090|NCT00976820|540789651|FG000|Overall Study|Lost to Follow-up|5|||
149907091|NCT00976820|540789652|FG001|Overall Study|Lost to Follow-up|16|||
149907092|NCT00976820|540789653|FG002|Overall Study|Lost to Follow-up|2|||
149907093|NCT00976820|540789654|FG003|Overall Study|Lost to Follow-up|3|||
149907094|NCT00976820|540789651|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
149907095|NCT00976820|540789652|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
149907096|NCT00976820|540789653|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
149907097|NCT00976820|540789654|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
149907098|NCT00976820|540789651|FG000|Overall Study|Withdrawal by Subject|2|||
149907099|NCT00976820|540789652|FG001|Overall Study|Withdrawal by Subject|4|||
149907100|NCT00976820|540789653|FG002|Overall Study|Withdrawal by Subject|1|||
149907101|NCT00976820|540789654|FG003|Overall Study|Withdrawal by Subject|4|||
149907102|NCT00968981|540789655|FG000|Overall Study|Adverse Event|2|||
149907103|NCT00968981|540789656|FG001|Overall Study|Adverse Event|0|||
149907104|NCT00968981|540789657|FG002|Overall Study|Adverse Event|0|||
149907105|NCT00968981|540789655|FG000|Overall Study|Disease Progression|14|||
149907106|NCT00968981|540789656|FG001|Overall Study|Disease Progression|16|||
149907107|NCT00968981|540789657|FG002|Overall Study|Disease Progression|13|||
149907108|NCT00968981|540789655|FG000|Overall Study|Lost to Follow-up|0|||
149907109|NCT00968981|540789656|FG001|Overall Study|Lost to Follow-up|0|||
149907110|NCT00968981|540789657|FG002|Overall Study|Lost to Follow-up|1|||
149907111|NCT00968981|540789655|FG000|Overall Study|Physician Decision|5|||
149907112|NCT00968981|540789656|FG001|Overall Study|Physician Decision|3|||
149907113|NCT00968981|540789657|FG002|Overall Study|Physician Decision|5|||
149907114|NCT00968981|540789655|FG000|Overall Study|Withdrawal by Subject|1|||
149907115|NCT00968981|540789656|FG001|Overall Study|Withdrawal by Subject|3|||
149907116|NCT00968981|540789657|FG002|Overall Study|Withdrawal by Subject|3|||
149907117|NCT01489254|540789660|FG000|Double-blind Part|Adverse Event|7|||
149907118|NCT01489254|540789661|FG001|Double-blind Part|Adverse Event|2|||
149907119|NCT01489254|540789662|FG002|Double-blind Part|Adverse Event|2|||
149907120|NCT01489254|540789663|FG003|Double-blind Part|Adverse Event|0|||
149907121|NCT01489254|540789660|FG000|Double-blind Part|Pregnancy|1|||
149907122|NCT01489254|540789661|FG001|Double-blind Part|Pregnancy|3|||
149907123|NCT01489254|540789662|FG002|Double-blind Part|Pregnancy|0|||
149907124|NCT01489254|540789663|FG003|Double-blind Part|Pregnancy|0|||
149907125|NCT01489254|540789660|FG000|Double-blind Part|Withdrawal by Subject|12|||
149907126|NCT01489254|540789661|FG001|Double-blind Part|Withdrawal by Subject|20|||
149907127|NCT01489254|540789662|FG002|Double-blind Part|Withdrawal by Subject|1|||
149907128|NCT01489254|540789663|FG003|Double-blind Part|Withdrawal by Subject|0|||
149907129|NCT01489254|540789660|FG000|Double-blind Part|Lost to Follow-up|1|||
149907130|NCT01489254|540789661|FG001|Double-blind Part|Lost to Follow-up|2|||
149907131|NCT01489254|540789662|FG002|Double-blind Part|Lost to Follow-up|0|||
149907132|NCT01489254|540789663|FG003|Double-blind Part|Lost to Follow-up|0|||
149907133|NCT01489254|540789660|FG000|Double-blind Part|Other reasons for not completing study|4|||
149907134|NCT01489254|540789661|FG001|Double-blind Part|Other reasons for not completing study|6|||
149907135|NCT01489254|540789662|FG002|Double-blind Part|Other reasons for not completing study|0|||
149907136|NCT01489254|540789663|FG003|Double-blind Part|Other reasons for not completing study|0|||
149907137|NCT01489254|540789660|FG000|Open-label Extension Part|Adverse Event|0|||
149907138|NCT01489254|540789661|FG001|Open-label Extension Part|Adverse Event|0|||
149907139|NCT01489254|540789662|FG002|Open-label Extension Part|Adverse Event|0|||
149907140|NCT01489254|540789663|FG003|Open-label Extension Part|Adverse Event|10|||
149907141|NCT01489254|540789660|FG000|Open-label Extension Part|Pregnancy|0|||
149907142|NCT01489254|540789661|FG001|Open-label Extension Part|Pregnancy|0|||
149907143|NCT01489254|540789662|FG002|Open-label Extension Part|Pregnancy|0|||
149907144|NCT01489254|540789663|FG003|Open-label Extension Part|Pregnancy|3|||
149970952|NCT02776735|541030166|FG003|Overall Study|Lost to Follow-up|1|||
149970953|NCT02776735|541030167|FG004|Overall Study|Lost to Follow-up|0|||
149970954|NCT02776735|541030168|FG005|Overall Study|Lost to Follow-up|0|||
149970955|NCT02776735|541030163|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149970956|NCT02776735|541030164|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149970957|NCT02776735|541030165|FG002|Overall Study|Withdrawal by parent/guardian|2|||
149907145|NCT01489254|540789660|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
149907146|NCT01489254|540789661|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
149970958|NCT02776735|541030166|FG003|Overall Study|Withdrawal by parent/guardian|2|||
149970959|NCT02776735|541030167|FG004|Overall Study|Withdrawal by parent/guardian|0|||
149970960|NCT02776735|541030168|FG005|Overall Study|Withdrawal by parent/guardian|0|||
149970961|NCT02776735|541030163|FG000|Overall Study|Withdrawal by Subject|1|||
149970962|NCT02776735|541030164|FG001|Overall Study|Withdrawal by Subject|0|||
149907147|NCT01489254|540789662|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
149907148|NCT01489254|540789663|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
149907149|NCT01489254|540789660|FG000|Open-label Extension Part|Protocol Violation|0|||
149907150|NCT01489254|540789661|FG001|Open-label Extension Part|Protocol Violation|0|||
149907151|NCT01489254|540789662|FG002|Open-label Extension Part|Protocol Violation|0|||
149907152|NCT01489254|540789663|FG003|Open-label Extension Part|Protocol Violation|1|||
149907153|NCT01489254|540789660|FG000|Open-label Extension Part|Lost to Follow-up|0|||
149907154|NCT01489254|540789661|FG001|Open-label Extension Part|Lost to Follow-up|0|||
149907155|NCT01489254|540789662|FG002|Open-label Extension Part|Lost to Follow-up|0|||
149907156|NCT01489254|540789663|FG003|Open-label Extension Part|Lost to Follow-up|9|||
149907157|NCT01489254|540789660|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
149907158|NCT01489254|540789661|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
149907159|NCT01489254|540789662|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
149907160|NCT01489254|540789663|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
149907161|NCT01194531|540789668|FG000|Overall Study|Withdrawal by Subject|1|||
149907162|NCT01194531|540789669|FG001|Overall Study|Withdrawal by Subject|0|||
149907163|NCT01194531|540789668|FG000|Overall Study|Protocol Violation|4|||
149907164|NCT01194531|540789669|FG001|Overall Study|Protocol Violation|1|||
149907165|NCT01194531|540789668|FG000|Overall Study|Physician Decision|0|||
149907166|NCT01194531|540789669|FG001|Overall Study|Physician Decision|2|||
149907167|NCT03891862|540789670|FG000|Open-label Period|Adverse Event|2|||
149907168|NCT03891862|540789671|FG001|Open-label Period|Adverse Event|0|||
149907169|NCT03891862|540789672|FG002|Open-label Period|Adverse Event|0|||
149907170|NCT03891862|540789670|FG000|Open-label Period|Protocol Violation|5|||
149907171|NCT03891862|540789671|FG001|Open-label Period|Protocol Violation|0|||
149907172|NCT03891862|540789672|FG002|Open-label Period|Protocol Violation|0|||
149907173|NCT03891862|540789670|FG000|Open-label Period|Withdrawal by Subject|6|||
149907174|NCT03891862|540789671|FG001|Open-label Period|Withdrawal by Subject|0|||
149907175|NCT03891862|540789672|FG002|Open-label Period|Withdrawal by Subject|0|||
149907176|NCT03891862|540789670|FG000|Open-label Period|Death|1|||
149907177|NCT03891862|540789671|FG001|Open-label Period|Death|0|||
149907178|NCT03891862|540789672|FG002|Open-label Period|Death|0|||
149907179|NCT03891862|540789670|FG000|Open-label Period|Lost to Follow-up|2|||
149907180|NCT03891862|540789671|FG001|Open-label Period|Lost to Follow-up|0|||
149907181|NCT03891862|540789672|FG002|Open-label Period|Lost to Follow-up|0|||
149907182|NCT03891862|540789670|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
149907183|NCT03891862|540789671|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
149907184|NCT03891862|540789672|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
149907185|NCT03891862|540789670|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
149907186|NCT03891862|540789671|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
149907187|NCT03891862|540789672|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
149907188|NCT03891862|540789670|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
149907189|NCT03891862|540789671|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
149907190|NCT03891862|540789672|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
149907191|NCT03891862|540789670|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
149907192|NCT03891862|540789671|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
149907193|NCT03891862|540789672|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
149907194|NCT02822573|540789673|FG000|Overall Study|Lost to Follow-up|5|||
149907195|NCT02822573|540789674|FG001|Overall Study|Lost to Follow-up|3|||
149907196|NCT02822573|540789673|FG000|Overall Study|Physician Decision|1|||
149907197|NCT02822573|540789674|FG001|Overall Study|Physician Decision|1|||
149907198|NCT02822573|540789673|FG000|Overall Study|Withdrawal by Subject|9|||
149907199|NCT02822573|540789674|FG001|Overall Study|Withdrawal by Subject|5|||
149907200|NCT02822573|540789673|FG000|Overall Study|Protocol Violation|6|||
149907201|NCT02822573|540789674|FG001|Overall Study|Protocol Violation|4|||
149907202|NCT02822573|540789673|FG000|Overall Study|Too sick or ill|2|||
149907203|NCT02822573|540789674|FG001|Overall Study|Too sick or ill|1|||
149907204|NCT02822573|540789673|FG000|Overall Study|Disease Progression|1|||
149907205|NCT02822573|540789674|FG001|Overall Study|Disease Progression|1|||
149907206|NCT02822573|540789673|FG000|Overall Study|No reason given|6|||
149907207|NCT02822573|540789674|FG001|Overall Study|No reason given|4|||
149907208|NCT01053962|540789675|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
149970963|NCT02776735|541030165|FG002|Overall Study|Withdrawal by Subject|0|||
149970964|NCT02776735|541030166|FG003|Overall Study|Withdrawal by Subject|0|||
149970965|NCT02776735|541030167|FG004|Overall Study|Withdrawal by Subject|0|||
149970966|NCT02776735|541030168|FG005|Overall Study|Withdrawal by Subject|1|||
149970967|NCT02776735|541030163|FG000|Overall Study|Other|0|||
149970968|NCT02776735|541030164|FG001|Overall Study|Other|0|||
149970969|NCT02776735|541030165|FG002|Overall Study|Other|3|||
149970970|NCT02776735|541030166|FG003|Overall Study|Other|0|||
149970971|NCT02776735|541030167|FG004|Overall Study|Other|0|||
149970972|NCT02776735|541030168|FG005|Overall Study|Other|0|||
149970973|NCT05201807|541031716|FG000|Overall Study|Adverse Event|1|||
149970974|NCT05201807|541031716|FG000|Overall Study|COVID-19 Related|1|||
149970975|NCT01209767|541031720|FG000|Overall Study|Withdrawal by Subject|1|||
149970976|NCT01209767|541031720|FG000|Overall Study|Lost to Follow-up|3|||
149970977|NCT01702298|541031721|FG000|Overall Study|Withdrawal by Subject|1|||
149970978|NCT00560508|541031724|FG000|12 Week Double-blind Period|Adverse Event|3|||
149970979|NCT00560508|541031725|FG001|12 Week Double-blind Period|Adverse Event|2|||
149970980|NCT00560508|541031724|FG000|12 Week Double-blind Period|Protocol Violation|1|||
149970981|NCT00560508|541031725|FG001|12 Week Double-blind Period|Protocol Violation|0|||
149970982|NCT00560508|541031724|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
149970983|NCT00560508|541031725|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
149970984|NCT00560508|541031724|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
149970985|NCT00560508|541031725|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
149970986|NCT00560508|541031724|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
149970987|NCT00560508|541031725|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
149970988|NCT00560508|541031724|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
149970989|NCT00560508|541031725|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
149970990|NCT00560508|541031724|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
149970991|NCT00560508|541031725|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
149970992|NCT02367456|541031728|FG000|Overall Study|Death|8|||
149970993|NCT02367456|541031729|FG001|Overall Study|Death|24|||
150048305|NCT04530136|541316874|FG000|Overall Study|Lost to Follow-up|2|||
149907209|NCT01053962|540789676|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
149907210|NCT01053962|540789677|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
149970994|NCT02367456|541031730|FG002|Overall Study|Death|17|||
149970995|NCT02367456|541031728|FG000|Overall Study|Lost to Follow-up|1|||
149970996|NCT02367456|541031729|FG001|Overall Study|Lost to Follow-up|3|||
150048306|NCT04530136|541316875|FG001|Overall Study|Lost to Follow-up|3|||
150048307|NCT04530136|541316874|FG000|Overall Study|Withdrawal by Subject|1|||
150048308|NCT04530136|541316875|FG001|Overall Study|Withdrawal by Subject|0|||
150048309|NCT04530136|541316874|FG000|Overall Study|Death|0|||
150048310|NCT04530136|541316875|FG001|Overall Study|Death|1|||
150048311|NCT02878798|541316876|FG000|Overall Study|Withdrawal by Subject|5|||
150048312|NCT02878798|541316877|FG001|Overall Study|Withdrawal by Subject|4|||
150048313|NCT02878798|541316876|FG000|Overall Study|Lost to Follow-up|2|||
150048314|NCT02878798|541316877|FG001|Overall Study|Lost to Follow-up|2|||
150048315|NCT02878798|541316876|FG000|Overall Study|Protocol Violation|0|||
150048316|NCT02878798|541316877|FG001|Overall Study|Protocol Violation|1|||
150048317|NCT01309282|541316878|FG000|Overall Study|Lost to Follow-up|1|||
150048318|NCT02087423|541316879|FG000|Overall Study|Withdrawal by Subject|20|||
150048319|NCT02087423|541316880|FG001|Overall Study|Withdrawal by Subject|20|||
150048320|NCT02087423|541316881|FG002|Overall Study|Withdrawal by Subject|3|||
150048321|NCT02087423|541316879|FG000|Overall Study|Death|68|||
150048322|NCT02087423|541316880|FG001|Overall Study|Death|207|||
150048323|NCT02087423|541316881|FG002|Overall Study|Death|40|||
150048324|NCT02087423|541316879|FG000|Overall Study|Lost to Follow-up|0|||
150048325|NCT02087423|541316880|FG001|Overall Study|Lost to Follow-up|2|||
150048326|NCT02087423|541316881|FG002|Overall Study|Lost to Follow-up|0|||
150048327|NCT02087423|541316879|FG000|Overall Study|Terminated from study at final DCO|23|||
150048328|NCT02087423|541316880|FG001|Overall Study|Terminated from study at final DCO|36|||
150048329|NCT02087423|541316881|FG002|Overall Study|Terminated from study at final DCO|25|||
150048330|NCT01387542|541316882|FG000|Overall Study|Adverse Event|3|||
150048331|NCT01387542|541316882|FG000|Overall Study|Withdrawal by Subject|1|||
150048332|NCT01387542|541316882|FG000|Overall Study|Changed diagnosis|1|||
150048333|NCT01387542|541316882|FG000|Overall Study|Insufficient response|1|||
150048334|NCT01387542|541316882|FG000|Overall Study|Non-compliant|1|||
150048335|NCT01387542|541316882|FG000|Overall Study|Lost to Follow-up|1|||
150048336|NCT02762370|541316885|FG000|Overall Study|Protocol Violation|1|||
150048337|NCT02762370|541316886|FG001|Overall Study|Protocol Violation|0|||
150048338|NCT02954172|541316888|FG000|Overall Study|Protocol Violation|3|||
150048339|NCT02954172|541316889|FG001|Overall Study|Protocol Violation|0|||
150048340|NCT02954172|541316888|FG000|Overall Study|allergic reaction|2|||
150048341|NCT02954172|541316889|FG001|Overall Study|allergic reaction|1|||
150048342|NCT02954172|541316888|FG000|Overall Study|non-measurable lesions at baseline|1|||
150048343|NCT02954172|541316889|FG001|Overall Study|non-measurable lesions at baseline|2|||
150048344|NCT01519167|541316890|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
150048345|NCT01519167|541316891|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
150048346|NCT01519167|541316890|FG000|Overall Study|Adverse Event|0|||
150048347|NCT01519167|541316891|FG001|Overall Study|Adverse Event|1|||
150048348|NCT01519167|541316890|FG000|Overall Study|Lack of Efficacy|0|||
150048349|NCT01519167|541316891|FG001|Overall Study|Lack of Efficacy|1|||
150048350|NCT01519167|541316890|FG000|Overall Study|Medical condition changes&deep sedation|0|||
150048351|NCT01519167|541316891|FG001|Overall Study|Medical condition changes&deep sedation|2|||
150048352|NCT01519167|541316890|FG000|Overall Study|Physician Decision|0|||
150048353|NCT01519167|541316891|FG001|Overall Study|Physician Decision|1|||
150048354|NCT00233064|541316894|FG000|Overall Study|Lost to Follow-up|7|||
150048355|NCT00233064|541316895|FG001|Overall Study|Lost to Follow-up|7|||
150048356|NCT00233064|541316894|FG000|Overall Study|Withdrawal by Subject|5|||
150048357|NCT00233064|541316895|FG001|Overall Study|Withdrawal by Subject|3|||
150048358|NCT00233064|541316894|FG000|Overall Study|Death|0|||
150048359|NCT00233064|541316895|FG001|Overall Study|Death|1|||
150048360|NCT00233064|541316894|FG000|Overall Study|Relocation|0|||
150048361|NCT00233064|541316895|FG001|Overall Study|Relocation|1|||
150048362|NCT00233064|541316894|FG000|Overall Study|Protocol Violation|1|||
150048363|NCT00233064|541316895|FG001|Overall Study|Protocol Violation|0|||
150048364|NCT00233064|541316894|FG000|Overall Study|Moved to Dom. Republic|1|||
150048365|NCT00233064|541316895|FG001|Overall Study|Moved to Dom. Republic|0|||
150048366|NCT04393454|541316896|FG000|Overall Study|Death|1|||
150048367|NCT04393454|541316896|FG000|Overall Study|Lost to Follow-up|1|||
150048368|NCT03304249|541316898|FG000|Overall Study|Lost to Follow-up|8|||
150048369|NCT03304249|541316899|FG001|Overall Study|Lost to Follow-up|10|||
150048370|NCT03304249|541316898|FG000|Overall Study|Withdrawal by Subject|12|||
150048371|NCT03304249|541316899|FG001|Overall Study|Withdrawal by Subject|2|||
150048372|NCT03304249|541316898|FG000|Overall Study|Moved Out of District|4|||
150048373|NCT03304249|541316899|FG001|Overall Study|Moved Out of District|2|||
150048374|NCT04976192|541316900|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048375|NCT04976192|541316901|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
150048376|NCT04976192|541316902|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048377|NCT04976192|541316903|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048378|NCT04976192|541316904|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048379|NCT04976192|541316905|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048380|NCT04976192|541316906|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048381|NCT04976192|541316907|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048382|NCT04976192|541316908|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048383|NCT04976192|541316909|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
150048384|NCT04976192|541316900|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
150048385|NCT04976192|541316901|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
150048386|NCT04976192|541316902|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
150048387|NCT04976192|541316903|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
149907211|NCT01053962|540789678|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
149907212|NCT01053962|540789679|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
149907213|NCT01053962|540789675|FG000|Pretreatment Period|Venipuncture Failure|0|||
149970997|NCT02367456|541031730|FG002|Overall Study|Lost to Follow-up|1|||
149970998|NCT02367456|541031728|FG000|Overall Study|Other reason|3|||
149970999|NCT02367456|541031729|FG001|Overall Study|Other reason|3|||
149971000|NCT02367456|541031730|FG002|Overall Study|Other reason|9|||
149971001|NCT02367456|541031728|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
149971002|NCT02367456|541031729|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
149971003|NCT02367456|541031730|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
149971004|NCT02862574|541031731|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149971005|NCT02862574|541031732|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149971006|NCT02862574|541031733|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149971007|NCT02862574|541031731|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
149971008|NCT02862574|541031732|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
149971009|NCT02862574|541031733|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
149971010|NCT02862574|541031731|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
149971011|NCT02862574|541031732|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
149971012|NCT02862574|541031733|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
149971013|NCT02410772|541031739|FG000|Overall Study|Death|3|||
149971014|NCT02410772|541031740|FG001|Overall Study|Death|4|||
149971015|NCT02410772|541031741|FG002|Overall Study|Death|8|||
149971016|NCT02410772|541031739|FG000|Overall Study|Lost to Follow-up|31|||
149971017|NCT02410772|541031740|FG001|Overall Study|Lost to Follow-up|23|||
149971018|NCT02410772|541031741|FG002|Overall Study|Lost to Follow-up|22|||
149971019|NCT02410772|541031739|FG000|Overall Study|Pregnancy|8|||
149971020|NCT02410772|541031740|FG001|Overall Study|Pregnancy|4|||
149971021|NCT02410772|541031741|FG002|Overall Study|Pregnancy|5|||
149971022|NCT02410772|541031739|FG000|Overall Study|Protocol Violation|8|||
149971023|NCT02410772|541031740|FG001|Overall Study|Protocol Violation|8|||
149971024|NCT02410772|541031741|FG002|Overall Study|Protocol Violation|4|||
149971025|NCT02410772|541031739|FG000|Overall Study|Baseline Drug Resistance|49|||
149971026|NCT02410772|541031740|FG001|Overall Study|Baseline Drug Resistance|40|||
149971027|NCT02410772|541031741|FG002|Overall Study|Baseline Drug Resistance|51|||
149971028|NCT02410772|541031739|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
149971029|NCT02410772|541031740|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
149971030|NCT02410772|541031741|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
149971031|NCT02410772|541031739|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
149971032|NCT02410772|541031740|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
149971033|NCT02410772|541031741|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
149971034|NCT04573972|541031742|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
149971035|NCT04573972|541031743|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
149971036|NCT05067335|541031746|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
149971037|NCT05067335|541031747|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
150176695|NCT01369498|541783378|FG003|Overall Study|Disease Progression|1|||
149971038|NCT05067335|541031748|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
149971039|NCT05067335|541031749|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
149971040|NCT05067335|541031746|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
149971041|NCT05067335|541031747|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
149971042|NCT05067335|541031748|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
149971043|NCT05067335|541031749|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
149971044|NCT05067335|541031746|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
149971045|NCT05067335|541031747|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
149971046|NCT05067335|541031748|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
149971047|NCT05067335|541031749|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
149971048|NCT05067335|541031746|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
149971049|NCT05067335|541031747|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
149971050|NCT05067335|541031748|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
149971051|NCT05067335|541031749|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
149971052|NCT05067335|541031746|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
149971053|NCT05067335|541031747|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
149971054|NCT05067335|541031748|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
149971055|NCT05067335|541031749|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
149971056|NCT05067335|541031746|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
149971057|NCT05067335|541031747|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
149971058|NCT05067335|541031748|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
149971059|NCT05067335|541031749|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
149971060|NCT05067335|541031746|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
149971061|NCT05067335|541031747|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
149971062|NCT05067335|541031748|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
149971063|NCT05067335|541031749|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
149971064|NCT05067335|541031746|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
149971065|NCT05067335|541031747|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
149971066|NCT05067335|541031748|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
149971067|NCT05067335|541031749|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
149971068|NCT05067335|541031746|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
149971069|NCT05067335|541031747|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
149971070|NCT05067335|541031748|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
149971071|NCT05067335|541031749|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
149971072|NCT05067335|541031746|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
149971073|NCT05067335|541031747|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
149971074|NCT05067335|541031748|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
149971075|NCT05067335|541031749|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
149971076|NCT02724839|541031750|FG000|Overall Study|Withdrawal by Subject|1|||
149971077|NCT02724839|541031751|FG001|Overall Study|Withdrawal by Subject|1|||
149971078|NCT02724839|541031752|FG002|Overall Study|Withdrawal by Subject|0|||
149971079|NCT02724839|541031750|FG000|Overall Study|Lost to Follow-up|0|||
149971080|NCT02724839|541031751|FG001|Overall Study|Lost to Follow-up|3|||
149971081|NCT02724839|541031752|FG002|Overall Study|Lost to Follow-up|2|||
149971082|NCT02724839|541031750|FG000|Overall Study|Physician Decision|0|||
149971083|NCT02724839|541031751|FG001|Overall Study|Physician Decision|0|||
149971084|NCT02724839|541031752|FG002|Overall Study|Physician Decision|3|||
149971085|NCT01645176|541031753|FG000|Overall Study|Lack of Efficacy|4|||
149971086|NCT01645176|541031753|FG000|Overall Study|did not complete final MRI|1|||
149971087|NCT00949533|541031754|FG000|Overall Study|Lost to Follow-up|0|||
149971088|NCT00949533|541031755|FG001|Overall Study|Lost to Follow-up|1|||
149971089|NCT01493089|541031756|FG000|Overall Study|Protocol Violation|2|||
149971090|NCT01493089|541031757|FG001|Overall Study|Protocol Violation|2|||
149971091|NCT01493089|541031756|FG000|Overall Study|Withdrawal by Subject|1|||
149971092|NCT01493089|541031757|FG001|Overall Study|Withdrawal by Subject|0|||
149971093|NCT01493089|541031756|FG000|Overall Study|Physician Decision|0|||
149971094|NCT01493089|541031757|FG001|Overall Study|Physician Decision|1|||
149971095|NCT02164864|541031760|FG000|Overall Study|Trial disease worsening|7|||
149971096|NCT02164864|541031761|FG001|Overall Study|Trial disease worsening|5|||
149971097|NCT02164864|541031762|FG002|Overall Study|Trial disease worsening|1|||
149971098|NCT02164864|541031760|FG000|Overall Study|Other pre-existing disease worsening|6|||
149971099|NCT02164864|541031761|FG001|Overall Study|Other pre-existing disease worsening|4|||
149971100|NCT02164864|541031762|FG002|Overall Study|Other pre-existing disease worsening|9|||
149971101|NCT02164864|541031760|FG000|Overall Study|Other Adverse Event (AE)|52|||
149907214|NCT01053962|540789676|FG001|Pretreatment Period|Venipuncture Failure|0|||
149907215|NCT01053962|540789677|FG002|Pretreatment Period|Venipuncture Failure|1|||
149907216|NCT01053962|540789678|FG003|Pretreatment Period|Venipuncture Failure|0|||
149907217|NCT01053962|540789679|FG004|Pretreatment Period|Venipuncture Failure|0|||
149907218|NCT01053962|540789675|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
149907219|NCT01053962|540789676|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
149907220|NCT01053962|540789677|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
149907221|NCT01053962|540789678|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
149907222|NCT01053962|540789679|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
149907223|NCT01053962|540789675|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
149907224|NCT01053962|540789676|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
149907225|NCT01053962|540789677|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
149907226|NCT01053962|540789678|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
149907227|NCT01053962|540789679|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
149907228|NCT01053962|540789675|FG000|Treatment Period|Lack of Efficacy|0|||
149907229|NCT01053962|540789676|FG001|Treatment Period|Lack of Efficacy|0|||
149907230|NCT01053962|540789677|FG002|Treatment Period|Lack of Efficacy|0|||
149907231|NCT01053962|540789678|FG003|Treatment Period|Lack of Efficacy|0|||
149907232|NCT01053962|540789679|FG004|Treatment Period|Lack of Efficacy|1|||
149907233|NCT01053962|540789675|FG000|Treatment Period|Adverse Event|0|||
149907234|NCT01053962|540789676|FG001|Treatment Period|Adverse Event|0|||
149907235|NCT01053962|540789677|FG002|Treatment Period|Adverse Event|0|||
149907236|NCT01053962|540789678|FG003|Treatment Period|Adverse Event|0|||
149907237|NCT01053962|540789679|FG004|Treatment Period|Adverse Event|1|||
149907238|NCT01053962|540789675|FG000|Treatment Period|Withdrawal by Subject|0|||
149907239|NCT01053962|540789676|FG001|Treatment Period|Withdrawal by Subject|0|||
149907240|NCT01053962|540789677|FG002|Treatment Period|Withdrawal by Subject|0|||
149907241|NCT01053962|540789678|FG003|Treatment Period|Withdrawal by Subject|0|||
149907242|NCT01053962|540789679|FG004|Treatment Period|Withdrawal by Subject|1|||
149907243|NCT01053962|540789675|FG000|Treatment Period|Noncompliance with protocol|1|||
149907244|NCT01053962|540789676|FG001|Treatment Period|Noncompliance with protocol|0|||
149907245|NCT01053962|540789677|FG002|Treatment Period|Noncompliance with protocol|0|||
149907246|NCT01053962|540789678|FG003|Treatment Period|Noncompliance with protocol|0|||
149907247|NCT01053962|540789679|FG004|Treatment Period|Noncompliance with protocol|0|||
149907248|NCT04143594|540789680|FG000|Overall Study|Withdrew consent|3|||
149907249|NCT04143594|540789681|FG001|Overall Study|Withdrew consent|10|||
149907250|NCT04143594|540789682|FG002|Overall Study|Withdrew consent|3|||
149907251|NCT04143594|540789683|FG003|Overall Study|Withdrew consent|1|||
149907252|NCT04143594|540789680|FG000|Overall Study|Lost to Follow-up|3|||
149907253|NCT04143594|540789681|FG001|Overall Study|Lost to Follow-up|5|||
149907254|NCT04143594|540789682|FG002|Overall Study|Lost to Follow-up|11|||
149907255|NCT04143594|540789683|FG003|Overall Study|Lost to Follow-up|0|||
149907256|NCT04143594|540789680|FG000|Overall Study|Investigator's discretion|2|||
149907257|NCT04143594|540789681|FG001|Overall Study|Investigator's discretion|2|||
149907258|NCT04143594|540789682|FG002|Overall Study|Investigator's discretion|0|||
149907259|NCT04143594|540789683|FG003|Overall Study|Investigator's discretion|0|||
149907260|NCT04143594|540789680|FG000|Overall Study|Randomized but never treated|0|||
149907261|NCT04143594|540789681|FG001|Overall Study|Randomized but never treated|0|||
149907262|NCT04143594|540789682|FG002|Overall Study|Randomized but never treated|0|||
150048388|NCT04976192|541316904|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149907263|NCT04143594|540789683|FG003|Overall Study|Randomized but never treated|1|||
150048389|NCT04976192|541316905|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048390|NCT04976192|541316906|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048391|NCT04976192|541316907|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048392|NCT04976192|541316908|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048393|NCT04976192|541316909|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048394|NCT04976192|541316900|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
150048395|NCT04976192|541316901|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048396|NCT04976192|541316902|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
150048397|NCT04976192|541316903|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048398|NCT04976192|541316904|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
149907264|NCT04143594|540789680|FG000|Overall Study|Death|1|||
149907265|NCT04143594|540789681|FG001|Overall Study|Death|0|||
149907266|NCT04143594|540789682|FG002|Overall Study|Death|1|||
149907267|NCT04143594|540789683|FG003|Overall Study|Death|0|||
149907268|NCT04143594|540789680|FG000|Overall Study|Adverse Event|1|||
149907269|NCT04143594|540789681|FG001|Overall Study|Adverse Event|0|||
149907270|NCT04143594|540789682|FG002|Overall Study|Adverse Event|0|||
149907271|NCT04143594|540789683|FG003|Overall Study|Adverse Event|0|||
149907272|NCT04143594|540789680|FG000|Overall Study|Pregnancy|0|||
149907273|NCT04143594|540789681|FG001|Overall Study|Pregnancy|0|||
149907274|NCT04143594|540789682|FG002|Overall Study|Pregnancy|1|||
149907275|NCT04143594|540789683|FG003|Overall Study|Pregnancy|0|||
149907276|NCT04143594|540789680|FG000|Overall Study|Lack of Efficacy|1|||
149971102|NCT02164864|541031761|FG001|Overall Study|Other Adverse Event (AE)|32|||
149971103|NCT02164864|541031762|FG002|Overall Study|Other Adverse Event (AE)|49|||
150176696|NCT01968226|541783383|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
150176697|NCT00566527|541783384|FG000|Overall Study|Reason not provided|3|||
150176698|NCT00566527|541783385|FG001|Overall Study|Reason not provided|11|||
149907277|NCT04143594|540789681|FG001|Overall Study|Lack of Efficacy|1|||
149907278|NCT04143594|540789682|FG002|Overall Study|Lack of Efficacy|0|||
149907279|NCT04143594|540789683|FG003|Overall Study|Lack of Efficacy|0|||
149907280|NCT00308087|540789684|FG000|Overall Study|Progressive Disease|19|||
149907281|NCT00308087|540789685|FG001|Overall Study|Progressive Disease|21|||
149907282|NCT00308087|540789684|FG000|Overall Study|Study Closure|11|||
149907283|NCT00308087|540789685|FG001|Overall Study|Study Closure|12|||
149907284|NCT00308087|540789684|FG000|Overall Study|Withdrawal by Subject|2|||
149907285|NCT00308087|540789685|FG001|Overall Study|Withdrawal by Subject|1|||
149907286|NCT00308087|540789684|FG000|Overall Study|Other|4|||
149907287|NCT00308087|540789685|FG001|Overall Study|Other|3|||
150176699|NCT00566527|541783386|FG002|Overall Study|Reason not provided|10|||
150176700|NCT00566527|541783384|FG000|Overall Study|Adverse Event|2|||
150176701|NCT00566527|541783385|FG001|Overall Study|Adverse Event|0|||
150176702|NCT00566527|541783386|FG002|Overall Study|Adverse Event|1|||
150176703|NCT00566527|541783384|FG000|Overall Study|Physician Decision|3|||
150176704|NCT00566527|541783385|FG001|Overall Study|Physician Decision|8|||
150176705|NCT00566527|541783386|FG002|Overall Study|Physician Decision|20|||
150176706|NCT00566527|541783384|FG000|Overall Study|Lost to Follow-up|3|||
150176707|NCT00566527|541783385|FG001|Overall Study|Lost to Follow-up|4|||
150176708|NCT00566527|541783386|FG002|Overall Study|Lost to Follow-up|4|||
150176709|NCT00566527|541783384|FG000|Overall Study|Withdrawal by Subject|6|||
150176710|NCT00566527|541783385|FG001|Overall Study|Withdrawal by Subject|43|||
150176711|NCT00566527|541783386|FG002|Overall Study|Withdrawal by Subject|43|||
150176712|NCT01943916|541783387|FG000|Overall Study|Technically invalid images|10|||
150176713|NCT01943916|541783387|FG000|Overall Study|Enrollment Failure|23|||
150176714|NCT01943916|541783387|FG000|Overall Study|Pilot Phase exclusion|100|||
150176715|NCT01943916|541783387|FG000|Overall Study|Quality Assurance Reader Fail|130|||
150176716|NCT01943916|541783387|FG000|Overall Study|Technical Failure|39|||
150176717|NCT01943916|541783387|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
150176718|NCT01943916|541783387|FG000|Overall Study|No Truth Panel Review|38|||
150176719|NCT01943916|541783387|FG000|Overall Study|Protocol Deviation|1|||
150176720|NCT01576484|541783388|FG000|Overall Study|Adverse Event|1|||
150176721|NCT01576484|541783389|FG001|Overall Study|Adverse Event|1|||
150176722|NCT01576484|541783388|FG000|Overall Study|Protocol Violation|0|||
150176723|NCT01576484|541783389|FG001|Overall Study|Protocol Violation|2|||
150176724|NCT01576484|541783388|FG000|Overall Study|Sponsor Decision|2|||
150176725|NCT01576484|541783389|FG001|Overall Study|Sponsor Decision|8|||
150176726|NCT01576484|541783388|FG000|Overall Study|Withdrawal by Subject|0|||
150176727|NCT01576484|541783389|FG001|Overall Study|Withdrawal by Subject|3|||
150176728|NCT01576484|541783388|FG000|Overall Study|Other|2|||
150176729|NCT01576484|541783389|FG001|Overall Study|Other|5|||
150176730|NCT03823911|541783393|FG000|Overall Study|Lost to Follow-up|1|||
150176731|NCT03823911|541783394|FG001|Overall Study|Lost to Follow-up|5|||
150176732|NCT03823911|541783395|FG002|Overall Study|Lost to Follow-up|2|||
150176733|NCT03823911|541783393|FG000|Overall Study|Did not meet eligibility criteria|13|||
150048399|NCT04976192|541316905|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048400|NCT04976192|541316906|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048401|NCT04976192|541316907|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150176734|NCT03823911|541783394|FG001|Overall Study|Did not meet eligibility criteria|7|||
150176735|NCT03823911|541783395|FG002|Overall Study|Did not meet eligibility criteria|4|||
150176736|NCT03823911|541783393|FG000|Overall Study|Death|0|||
149907288|NCT01044290|540789686|FG000|Follow-up 1|Death|3|||
149907289|NCT01044290|540789687|FG001|Follow-up 1|Death|3|||
149907290|NCT01044290|540789688|FG002|Follow-up 1|Death|1|||
149907291|NCT01044290|540789686|FG000|Follow-up 1|Withdrawal by Subject|2|||
149971104|NCT02164864|541031760|FG000|Overall Study|Protocol Violation|2|||
149971105|NCT02164864|541031761|FG001|Overall Study|Protocol Violation|4|||
149971106|NCT02164864|541031762|FG002|Overall Study|Protocol Violation|1|||
149971107|NCT02164864|541031760|FG000|Overall Study|Lost to Follow-up|4|||
149971108|NCT02164864|541031761|FG001|Overall Study|Lost to Follow-up|3|||
149971109|NCT02164864|541031762|FG002|Overall Study|Lost to Follow-up|2|||
149971110|NCT02164864|541031760|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
149971111|NCT02164864|541031761|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
149971112|NCT02164864|541031762|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
150176737|NCT03823911|541783394|FG001|Overall Study|Death|1|||
150176738|NCT03823911|541783395|FG002|Overall Study|Death|0|||
149971113|NCT02164864|541031760|FG000|Overall Study|Other than stated|3|||
149971114|NCT02164864|541031761|FG001|Overall Study|Other than stated|4|||
149971115|NCT02164864|541031762|FG002|Overall Study|Other than stated|14|||
149907292|NCT01044290|540789687|FG001|Follow-up 1|Withdrawal by Subject|2|||
149907293|NCT01044290|540789688|FG002|Follow-up 1|Withdrawal by Subject|0|||
149907294|NCT01044290|540789686|FG000|Follow-Up 2|Death|0|||
149907295|NCT01044290|540789687|FG001|Follow-Up 2|Death|1|||
149907296|NCT01044290|540789688|FG002|Follow-Up 2|Death|1|||
149907297|NCT01044290|540789686|FG000|Follow-Up 2|Withdrawal by Subject|0|||
149907298|NCT01044290|540789687|FG001|Follow-Up 2|Withdrawal by Subject|1|||
149907299|NCT01044290|540789688|FG002|Follow-Up 2|Withdrawal by Subject|1|||
149907300|NCT04323306|540789689|FG000|Overall Study|Physician Decision|1|||
149907301|NCT04323306|540789690|FG001|Overall Study|Physician Decision|0|||
149907302|NCT04323306|540789691|FG002|Overall Study|Physician Decision|0|||
149907303|NCT04323306|540789692|FG003|Overall Study|Physician Decision|0|||
149907304|NCT04323306|540789693|FG004|Overall Study|Physician Decision|0|||
149907305|NCT04323306|540789694|FG005|Overall Study|Physician Decision|0|||
149907306|NCT04323306|540789695|FG006|Overall Study|Physician Decision|0|||
149907307|NCT04323306|540789696|FG007|Overall Study|Physician Decision|0|||
149907308|NCT04323306|540789697|FG008|Overall Study|Physician Decision|0|||
149907309|NCT04323306|540789689|FG000|Overall Study|Withdrawal by Subject|0|||
149907310|NCT04323306|540789690|FG001|Overall Study|Withdrawal by Subject|0|||
149907311|NCT04323306|540789691|FG002|Overall Study|Withdrawal by Subject|0|||
149907312|NCT04323306|540789692|FG003|Overall Study|Withdrawal by Subject|0|||
149907313|NCT04323306|540789693|FG004|Overall Study|Withdrawal by Subject|0|||
149907314|NCT04323306|540789694|FG005|Overall Study|Withdrawal by Subject|1|||
149907315|NCT04323306|540789695|FG006|Overall Study|Withdrawal by Subject|3|||
149907316|NCT04323306|540789696|FG007|Overall Study|Withdrawal by Subject|0|||
149907317|NCT04323306|540789697|FG008|Overall Study|Withdrawal by Subject|1|||
149907318|NCT01646021|540789700|FG000|Overall Study|Death|77|||
149907319|NCT01646021|540789701|FG001|Overall Study|Death|83|||
149907320|NCT01646021|540789700|FG000|Overall Study|Study Terminated by Sponsor|50|||
149907321|NCT01646021|540789701|FG001|Overall Study|Study Terminated by Sponsor|41|||
149907322|NCT01646021|540789700|FG000|Overall Study|Lost to Follow-up|2|||
149907323|NCT01646021|540789701|FG001|Overall Study|Lost to Follow-up|2|||
149907324|NCT01646021|540789700|FG000|Overall Study|Withdrawal by Subject|10|||
149907325|NCT01646021|540789701|FG001|Overall Study|Withdrawal by Subject|15|||
149907326|NCT01967706|540789704|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
149907327|NCT01967706|540789705|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
149907328|NCT01967706|540789706|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
149907329|NCT01967706|540789707|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
149907330|NCT00725608|540789708|FG000|Overall Study|Lost to Follow-up|60|||
149907331|NCT00725608|540789708|FG000|Overall Study|Adverse Event|14|||
149907332|NCT00725608|540789708|FG000|Overall Study|Individual reasons|86|||
149907333|NCT00725608|540789708|FG000|Overall Study|Other|7|||
149907334|NCT03047720|540789712|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
149971116|NCT01870869|541031763|FG000|Overall Study|Implanted with nonstudy device|1|||
149971117|NCT01870869|541031764|FG001|Overall Study|Implanted with nonstudy device|3|||
149971118|NCT01870869|541031765|FG002|Overall Study|Implanted with nonstudy device|14|||
149971119|NCT01870869|541031766|FG003|Overall Study|Implanted with nonstudy device|4|||
149971120|NCT01870869|541031763|FG000|Overall Study|Death|0|||
149971121|NCT01870869|541031764|FG001|Overall Study|Death|0|||
149971122|NCT01870869|541031765|FG002|Overall Study|Death|7|||
149971123|NCT01870869|541031766|FG003|Overall Study|Death|1|||
149971124|NCT01870869|541031763|FG000|Overall Study|Subject choice|6|||
149971125|NCT01870869|541031764|FG001|Overall Study|Subject choice|2|||
149971126|NCT01870869|541031765|FG002|Overall Study|Subject choice|22|||
149971127|NCT01870869|541031766|FG003|Overall Study|Subject choice|8|||
149971128|NCT01870869|541031763|FG000|Overall Study|Lost to Follow-up|10|||
149971129|NCT01870869|541031764|FG001|Overall Study|Lost to Follow-up|2|||
149971130|NCT01870869|541031765|FG002|Overall Study|Lost to Follow-up|25|||
149971131|NCT01870869|541031766|FG003|Overall Study|Lost to Follow-up|3|||
149971132|NCT01870869|541031763|FG000|Overall Study|Reason not Specified|1|||
149971133|NCT01870869|541031764|FG001|Overall Study|Reason not Specified|2|||
149971134|NCT01870869|541031765|FG002|Overall Study|Reason not Specified|20|||
149971135|NCT01870869|541031766|FG003|Overall Study|Reason not Specified|4|||
149971136|NCT01870869|541031763|FG000|Overall Study|Not evaluable|10|||
149971137|NCT01870869|541031764|FG001|Overall Study|Not evaluable|5|||
149971138|NCT01870869|541031765|FG002|Overall Study|Not evaluable|42|||
149971139|NCT01870869|541031766|FG003|Overall Study|Not evaluable|10|||
149971140|NCT00557193|541031767|FG000|Induction|Adverse Event|2|||
150176739|NCT00094575|541783401|FG000|Overall Study|Death|146|||
150176740|NCT00094575|541783402|FG001|Overall Study|Death|146|||
150176741|NCT00837616|541783405|FG000|Overall Study|Withdrawal by Subject|0|||
149907335|NCT03047720|540789713|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
149907336|NCT00614120|540789714|FG000|Overall Study|Adverse Event|9|||
149907337|NCT00614120|540789715|FG001|Overall Study|Adverse Event|22|||
149907338|NCT00614120|540789716|FG002|Overall Study|Adverse Event|30|||
149907339|NCT00614120|540789717|FG003|Overall Study|Adverse Event|3|||
150176742|NCT00837616|541783406|FG001|Overall Study|Withdrawal by Subject|1|||
149907340|NCT00614120|540789714|FG000|Overall Study|Lack of Efficacy|3|||
149907341|NCT00614120|540789715|FG001|Overall Study|Lack of Efficacy|3|||
149907342|NCT00614120|540789716|FG002|Overall Study|Lack of Efficacy|2|||
149907343|NCT00614120|540789717|FG003|Overall Study|Lack of Efficacy|2|||
149907344|NCT00614120|540789714|FG000|Overall Study|Protocol Violation|2|||
149907345|NCT00614120|540789715|FG001|Overall Study|Protocol Violation|5|||
149907346|NCT00614120|540789716|FG002|Overall Study|Protocol Violation|3|||
149907347|NCT00614120|540789717|FG003|Overall Study|Protocol Violation|1|||
149907348|NCT00614120|540789714|FG000|Overall Study|Withdrawal criteria|1|||
149907349|NCT00614120|540789715|FG001|Overall Study|Withdrawal criteria|0|||
149907350|NCT00614120|540789716|FG002|Overall Study|Withdrawal criteria|0|||
149907351|NCT00614120|540789717|FG003|Overall Study|Withdrawal criteria|0|||
149907352|NCT00614120|540789714|FG000|Overall Study|Withdrawal by Subject|9|||
149907353|NCT00614120|540789715|FG001|Overall Study|Withdrawal by Subject|10|||
149907354|NCT00614120|540789716|FG002|Overall Study|Withdrawal by Subject|16|||
149907355|NCT00614120|540789717|FG003|Overall Study|Withdrawal by Subject|3|||
149907356|NCT00614120|540789714|FG000|Overall Study|Did not meet trial criteria|0|||
149907357|NCT00614120|540789715|FG001|Overall Study|Did not meet trial criteria|1|||
149907358|NCT00614120|540789716|FG002|Overall Study|Did not meet trial criteria|1|||
149907359|NCT00614120|540789717|FG003|Overall Study|Did not meet trial criteria|1|||
149907360|NCT00614120|540789714|FG000|Overall Study|hCG positive (not pregnant)|0|||
149907361|NCT00614120|540789715|FG001|Overall Study|hCG positive (not pregnant)|0|||
149907362|NCT00614120|540789716|FG002|Overall Study|hCG positive (not pregnant)|1|||
149907363|NCT00614120|540789717|FG003|Overall Study|hCG positive (not pregnant)|0|||
149907364|NCT00614120|540789714|FG000|Overall Study|Hypoglycaemia|0|||
149907365|NCT00614120|540789715|FG001|Overall Study|Hypoglycaemia|0|||
149907366|NCT00614120|540789716|FG002|Overall Study|Hypoglycaemia|0|||
149907367|NCT00614120|540789717|FG003|Overall Study|Hypoglycaemia|1|||
149907368|NCT00614120|540789714|FG000|Overall Study|Lack of trial product|3|||
150048402|NCT04976192|541316908|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048403|NCT04976192|541316909|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
150048404|NCT04976192|541316900|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048405|NCT04976192|541316901|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048406|NCT04976192|541316902|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048407|NCT04976192|541316903|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150048408|NCT04976192|541316904|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
150048409|NCT04976192|541316905|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
149907369|NCT00614120|540789715|FG001|Overall Study|Lack of trial product|3|||
149907370|NCT00614120|540789716|FG002|Overall Study|Lack of trial product|2|||
150048410|NCT04976192|541316906|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
150048411|NCT04976192|541316907|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
150048412|NCT04976192|541316908|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
149907371|NCT00614120|540789717|FG003|Overall Study|Lack of trial product|0|||
149907372|NCT00614120|540789714|FG000|Overall Study|Late syphilis, latent|1|||
149907373|NCT00614120|540789715|FG001|Overall Study|Late syphilis, latent|0|||
149907374|NCT00614120|540789716|FG002|Overall Study|Late syphilis, latent|0|||
149907375|NCT00614120|540789717|FG003|Overall Study|Late syphilis, latent|0|||
149907376|NCT00614120|540789714|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
149907377|NCT00614120|540789715|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
149907378|NCT00614120|540789716|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
149907379|NCT00614120|540789717|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
149907380|NCT00614120|540789714|FG000|Overall Study|Lost to Follow-up|1|||
150048413|NCT04976192|541316909|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
150048414|NCT04976192|541316900|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048415|NCT04976192|541316901|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048416|NCT04976192|541316902|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048417|NCT04976192|541316903|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048418|NCT04976192|541316904|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
150048419|NCT04976192|541316905|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048420|NCT04976192|541316906|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048421|NCT04976192|541316907|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048422|NCT04976192|541316908|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048423|NCT04976192|541316909|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
150048424|NCT04976192|541316900|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048425|NCT04976192|541316901|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048426|NCT04976192|541316902|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048427|NCT04976192|541316903|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048428|NCT04976192|541316904|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048429|NCT04976192|541316905|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
150048430|NCT04976192|541316906|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048431|NCT04976192|541316907|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048432|NCT04976192|541316908|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048433|NCT04976192|541316909|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150048434|NCT02621151|541316910|FG000|Overall Study|Not eligible for trial|6|||
150048435|NCT00924027|541316911|FG000|Overall Study|Lost to Further Follow-Up|4|||
150048436|NCT00924027|541316912|FG001|Overall Study|Lost to Further Follow-Up|0|||
150048437|NCT00924027|541316913|FG002|Overall Study|Lost to Further Follow-Up|0|||
150048438|NCT00924027|541316914|FG003|Overall Study|Lost to Further Follow-Up|0|||
150048439|NCT00924027|541316911|FG000|Overall Study|Physician Decision|1|||
150048440|NCT00924027|541316912|FG001|Overall Study|Physician Decision|0|||
150048441|NCT00924027|541316913|FG002|Overall Study|Physician Decision|0|||
150048442|NCT00924027|541316914|FG003|Overall Study|Physician Decision|1|||
150048443|NCT00924027|541316911|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
150048444|NCT00924027|541316912|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
150048445|NCT00924027|541316913|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
150048446|NCT00924027|541316914|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
150048447|NCT00924027|541316911|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
150048448|NCT00924027|541316912|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
150048449|NCT00924027|541316913|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
150048450|NCT00924027|541316914|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
150048451|NCT00924027|541316911|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
150048452|NCT00924027|541316912|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
150048453|NCT00924027|541316913|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
150048454|NCT00924027|541316914|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
150048455|NCT04236141|541319310|FG000|Overall Study|Death|18|||
150048456|NCT04236141|541319311|FG001|Overall Study|Death|10|||
150048457|NCT04236141|541319310|FG000|Overall Study|Withdrawal by Participant|1|||
150048458|NCT04236141|541319311|FG001|Overall Study|Withdrawal by Participant|0|||
150048459|NCT04236141|541319310|FG000|Overall Study|Reason not Specified|1|||
150048460|NCT04236141|541319311|FG001|Overall Study|Reason not Specified|0|||
150048461|NCT04236141|541319310|FG000|Overall Study|Study terminated by Sponsor|8|||
150048462|NCT04236141|541319311|FG001|Overall Study|Study terminated by Sponsor|4|||
150048463|NCT01925131|541319312|FG000|Overall Study|Death|0|||
150048464|NCT01925131|541319313|FG001|Overall Study|Death|0|||
150048465|NCT01925131|541319314|FG002|Overall Study|Death|1|||
150048466|NCT01925131|541319315|FG003|Overall Study|Death|0|||
150048467|NCT01925131|541319316|FG004|Overall Study|Death|0|||
150048468|NCT01925131|541319317|FG005|Overall Study|Death|0|||
149907381|NCT00614120|540789715|FG001|Overall Study|Lost to Follow-up|2|||
150048469|NCT01925131|541319312|FG000|Overall Study|Progression/Relapse|1|||
150048470|NCT01925131|541319313|FG001|Overall Study|Progression/Relapse|1|||
149907382|NCT00614120|540789716|FG002|Overall Study|Lost to Follow-up|3|||
150048471|NCT01925131|541319314|FG002|Overall Study|Progression/Relapse|4|||
150048472|NCT01925131|541319315|FG003|Overall Study|Progression/Relapse|0|||
150048473|NCT01925131|541319316|FG004|Overall Study|Progression/Relapse|0|||
150048474|NCT01925131|541319317|FG005|Overall Study|Progression/Relapse|1|||
149907383|NCT00614120|540789717|FG003|Overall Study|Lost to Follow-up|4|||
149907384|NCT00179673|540789719|FG000|Overall Study|Adverse Event|7|||
149907385|NCT00179673|540789719|FG000|Overall Study|Lack of Efficacy|15|||
149907386|NCT00179673|540789719|FG000|Overall Study|Withdrawal by Subject|3|||
149907387|NCT00179673|540789719|FG000|Overall Study|Death|4|||
149907388|NCT00179673|540789719|FG000|Overall Study|Other Observations and options|14|||
149907389|NCT00319592|540789721|FG000|Overall Study|Protocol Violation|1|||
149907390|NCT00319592|540789722|FG001|Overall Study|Protocol Violation|0|||
149907391|NCT00319592|540789721|FG000|Overall Study|Physician Decision|0|||
149907392|NCT00319592|540789722|FG001|Overall Study|Physician Decision|1|||
149907393|NCT01820572|540789729|FG000|Randomization|Not Treated|2|||
149971141|NCT00557193|541031768|FG001|Induction|Adverse Event|0|||
149971142|NCT00557193|541031769|FG002|Induction|Adverse Event|0|||
149971143|NCT00557193|541031770|FG003|Induction|Adverse Event|0|||
149971144|NCT00557193|541031771|FG004|Induction|Adverse Event|0|||
149971145|NCT00557193|541031772|FG005|Induction|Adverse Event|0|||
149971146|NCT00557193|541031767|FG000|Induction|Death|6|||
149971147|NCT00557193|541031768|FG001|Induction|Death|0|||
149971148|NCT00557193|541031769|FG002|Induction|Death|0|||
149971149|NCT00557193|541031770|FG003|Induction|Death|0|||
149971150|NCT00557193|541031771|FG004|Induction|Death|0|||
149971151|NCT00557193|541031772|FG005|Induction|Death|0|||
149971152|NCT00557193|541031767|FG000|Induction|Physician Decision|3|||
149971153|NCT00557193|541031768|FG001|Induction|Physician Decision|0|||
149971154|NCT00557193|541031769|FG002|Induction|Physician Decision|0|||
149971155|NCT00557193|541031770|FG003|Induction|Physician Decision|0|||
149971156|NCT00557193|541031771|FG004|Induction|Physician Decision|0|||
149971157|NCT00557193|541031772|FG005|Induction|Physician Decision|0|||
149971158|NCT00557193|541031767|FG000|Induction|Withdrawal by Subject|1|||
149971159|NCT00557193|541031768|FG001|Induction|Withdrawal by Subject|0|||
149971160|NCT00557193|541031769|FG002|Induction|Withdrawal by Subject|0|||
149971161|NCT00557193|541031770|FG003|Induction|Withdrawal by Subject|0|||
149971162|NCT00557193|541031771|FG004|Induction|Withdrawal by Subject|0|||
149971163|NCT00557193|541031772|FG005|Induction|Withdrawal by Subject|0|||
149971164|NCT00557193|541031767|FG000|Induction|Refusal of Further Protocol Therapy|2|||
149971165|NCT00557193|541031768|FG001|Induction|Refusal of Further Protocol Therapy|0|||
149971166|NCT00557193|541031769|FG002|Induction|Refusal of Further Protocol Therapy|0|||
149971167|NCT00557193|541031770|FG003|Induction|Refusal of Further Protocol Therapy|0|||
149971168|NCT00557193|541031771|FG004|Induction|Refusal of Further Protocol Therapy|0|||
149971169|NCT00557193|541031772|FG005|Induction|Refusal of Further Protocol Therapy|0|||
149971170|NCT00557193|541031767|FG000|Induction|Ineligible|8|||
149971171|NCT00557193|541031768|FG001|Induction|Ineligible|0|||
149971172|NCT00557193|541031769|FG002|Induction|Ineligible|0|||
149971173|NCT00557193|541031770|FG003|Induction|Ineligible|0|||
149971174|NCT00557193|541031771|FG004|Induction|Ineligible|0|||
149971175|NCT00557193|541031772|FG005|Induction|Ineligible|0|||
149971176|NCT00557193|541031767|FG000|Induction|Inevaluable for post Induction|2|||
149971177|NCT00557193|541031768|FG001|Induction|Inevaluable for post Induction|0|||
149971178|NCT00557193|541031769|FG002|Induction|Inevaluable for post Induction|0|||
149971179|NCT00557193|541031770|FG003|Induction|Inevaluable for post Induction|0|||
149971180|NCT00557193|541031771|FG004|Induction|Inevaluable for post Induction|0|||
149971181|NCT00557193|541031772|FG005|Induction|Inevaluable for post Induction|0|||
149971182|NCT00557193|541031767|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
149971183|NCT00557193|541031768|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
149971184|NCT00557193|541031769|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
149971185|NCT00557193|541031770|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
149971186|NCT00557193|541031771|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
149971187|NCT00557193|541031772|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
149971188|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149971189|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
149971190|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
149971191|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
149971192|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149971193|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
149971194|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
149971195|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
149971196|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
149971197|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
149971198|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
149971199|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
149971200|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
149971201|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
149971202|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
149907394|NCT01820572|540789730|FG001|Randomization|Not Treated|1|||
149907395|NCT01820572|540789729|FG000|Treatment Period|Adverse Event|12|||
149907396|NCT01820572|540789730|FG001|Treatment Period|Adverse Event|7|||
150176743|NCT02674750|541783408|FG000|Overall Study|Death|4|||
150176744|NCT02674750|541783409|FG001|Overall Study|Death|5|||
150176745|NCT02674750|541783410|FG002|Overall Study|Death|8|||
150176746|NCT02674750|541783408|FG000|Overall Study|Lost to Follow-up|0|||
150176747|NCT02674750|541783409|FG001|Overall Study|Lost to Follow-up|8|||
149907397|NCT01820572|540789729|FG000|Treatment Period|Death|3|||
149907398|NCT01820572|540789730|FG001|Treatment Period|Death|3|||
150048475|NCT01925131|541319312|FG000|Overall Study|Patient Refusal|1|||
150048476|NCT01925131|541319313|FG001|Overall Study|Patient Refusal|0|||
150048477|NCT01925131|541319314|FG002|Overall Study|Patient Refusal|0|||
150048478|NCT01925131|541319315|FG003|Overall Study|Patient Refusal|0|||
150048479|NCT01925131|541319316|FG004|Overall Study|Patient Refusal|0|||
150048480|NCT01925131|541319317|FG005|Overall Study|Patient Refusal|0|||
150048481|NCT01925131|541319312|FG000|Overall Study|Adverse Event|0|||
150048482|NCT01925131|541319313|FG001|Overall Study|Adverse Event|0|||
150048483|NCT01925131|541319314|FG002|Overall Study|Adverse Event|2|||
150048484|NCT01925131|541319315|FG003|Overall Study|Adverse Event|0|||
150048485|NCT01925131|541319316|FG004|Overall Study|Adverse Event|1|||
150048486|NCT01925131|541319317|FG005|Overall Study|Adverse Event|3|||
150048487|NCT01925131|541319312|FG000|Overall Study|Other - Not Protocol Specified|3|||
150048488|NCT01925131|541319313|FG001|Overall Study|Other - Not Protocol Specified|1|||
150048489|NCT01925131|541319314|FG002|Overall Study|Other - Not Protocol Specified|2|||
150048490|NCT01925131|541319315|FG003|Overall Study|Other - Not Protocol Specified|5|||
150048491|NCT01925131|541319316|FG004|Overall Study|Other - Not Protocol Specified|10|||
150048492|NCT01925131|541319317|FG005|Overall Study|Other - Not Protocol Specified|6|||
150048493|NCT01217307|541319321|FG000|Overall Study|Withdrawal by Subject|0|||
150048494|NCT01217307|541319322|FG001|Overall Study|Withdrawal by Subject|1|||
150048495|NCT01888432|541319327|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
150048496|NCT01888432|541319328|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
150048497|NCT01888432|541319327|FG000|12-month Analysis (FAS)|Physician Decision|1|||
150048498|NCT01888432|541319328|FG001|12-month Analysis (FAS)|Physician Decision|1|||
150048499|NCT01888432|541319327|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
150048500|NCT01888432|541319328|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
150048501|NCT01888432|541319327|FG000|12-month Analysis (FAS)|Death|4|||
150048502|NCT01888432|541319328|FG001|12-month Analysis (FAS)|Death|3|||
150048503|NCT01888432|541319327|FG000|24-month Analysis (FAS)|Graft loss|0|||
150048504|NCT01888432|541319328|FG001|24-month Analysis (FAS)|Graft loss|1|||
150048505|NCT01888432|541319327|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
150048506|NCT01888432|541319328|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
150048507|NCT01888432|541319327|FG000|24-month Analysis (FAS)|Physician Decision|2|||
150048508|NCT01888432|541319328|FG001|24-month Analysis (FAS)|Physician Decision|4|||
150048509|NCT01888432|541319327|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
150048510|NCT01888432|541319328|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
150048511|NCT01888432|541319327|FG000|24-month Analysis (FAS)|Death|8|||
150048512|NCT01888432|541319328|FG001|24-month Analysis (FAS)|Death|4|||
150048513|NCT01888432|541319327|FG000|36-month Analysis (Extension)|Death|1|||
150048514|NCT01888432|541319328|FG001|36-month Analysis (Extension)|Death|0|||
150048515|NCT03844945|541319331|FG000|Overall Study|Adverse Event|1|||
150048516|NCT03844945|541319332|FG001|Overall Study|Adverse Event|1|||
150048517|NCT03844945|541319333|FG002|Overall Study|Adverse Event|4|||
150048518|NCT03844945|541319334|FG003|Overall Study|Adverse Event|0|||
150048519|NCT03844945|541319331|FG000|Overall Study|Withdrawal by Subject|0|||
150048520|NCT03844945|541319332|FG001|Overall Study|Withdrawal by Subject|0|||
150048521|NCT03844945|541319333|FG002|Overall Study|Withdrawal by Subject|1|||
150048522|NCT03844945|541319334|FG003|Overall Study|Withdrawal by Subject|0|||
150048523|NCT03844945|541319331|FG000|Overall Study|Lack of Efficacy|0|||
150048524|NCT03844945|541319332|FG001|Overall Study|Lack of Efficacy|0|||
150048525|NCT03844945|541319333|FG002|Overall Study|Lack of Efficacy|0|||
150048526|NCT03844945|541319334|FG003|Overall Study|Lack of Efficacy|1|||
150048527|NCT01696929|541319335|FG000|Overall Study|Physician Decision|1|||
150048528|NCT01954927|541319342|FG000|Overall Study|Withdrawal by Subject|3|||
150048529|NCT01954927|541319343|FG001|Overall Study|Withdrawal by Subject|1|||
150048530|NCT02156271|541319344|FG000|Overall Study|Physician Decision|4|||
150048531|NCT02156271|541319345|FG001|Overall Study|Physician Decision|3|||
150048532|NCT00375609|541319348|FG000|Overall Study|Did not receive treatment|1|||
150048533|NCT00375609|541319349|FG001|Overall Study|Did not receive treatment|0|||
150048534|NCT00375609|541319350|FG002|Overall Study|Did not receive treatment|0|||
150048535|NCT00375609|541319348|FG000|Overall Study|Adverse Event|0|||
150048536|NCT00375609|541319349|FG001|Overall Study|Adverse Event|3|||
150048537|NCT00375609|541319350|FG002|Overall Study|Adverse Event|0|||
150048538|NCT00375609|541319348|FG000|Overall Study|Lost to Follow-up|1|||
150048539|NCT00375609|541319349|FG001|Overall Study|Lost to Follow-up|0|||
150048540|NCT00375609|541319350|FG002|Overall Study|Lost to Follow-up|0|||
150048541|NCT00375609|541319348|FG000|Overall Study|Physician Decision|0|||
150048542|NCT00375609|541319349|FG001|Overall Study|Physician Decision|0|||
150176748|NCT02674750|541783410|FG002|Overall Study|Lost to Follow-up|0|||
150176749|NCT02674750|541783408|FG000|Overall Study|Lack of Efficacy|1|||
149907399|NCT01820572|540789729|FG000|Treatment Period|Lack of Efficacy|1|||
149907400|NCT01820572|540789730|FG001|Treatment Period|Lack of Efficacy|0|||
149907401|NCT01820572|540789729|FG000|Treatment Period|poor/non compliance|0|||
149907402|NCT01820572|540789730|FG001|Treatment Period|poor/non compliance|3|||
149907403|NCT01820572|540789729|FG000|Treatment Period|request to discontinue|6|||
149907404|NCT01820572|540789730|FG001|Treatment Period|request to discontinue|11|||
149907405|NCT01820572|540789729|FG000|Treatment Period|No longer meets study criteria|3|||
149907406|NCT01820572|540789730|FG001|Treatment Period|No longer meets study criteria|10|||
149907407|NCT01820572|540789729|FG000|Treatment Period|withdrew consent|1|||
149907408|NCT01820572|540789730|FG001|Treatment Period|withdrew consent|2|||
149907409|NCT04439214|540789736|FG000|Overall Study|Adverse Event|13|||
149907410|NCT04439214|540789736|FG000|Overall Study|Disease progression|16|||
149907411|NCT04439214|540789736|FG000|Overall Study|Death|1|||
149907412|NCT04439214|540789736|FG000|Overall Study|Withdrawal by Subject|2|||
149907413|NCT04439214|540789736|FG000|Overall Study|Declining health|1|||
149907414|NCT04439214|540789736|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
149907415|NCT04439214|540789736|FG000|Overall Study|Ineligible|5|||
149907416|NCT02235077|540789737|FG000|Overall Study|Death|5|||
149907417|NCT02235077|540789738|FG001|Overall Study|Death|7|||
149907418|NCT02235077|540789737|FG000|Overall Study|Lost to Follow-up|5|||
149907419|NCT02235077|540789738|FG001|Overall Study|Lost to Follow-up|6|||
149907420|NCT02235077|540789737|FG000|Overall Study|Withdrawal by Subject|8|||
149907421|NCT02235077|540789738|FG001|Overall Study|Withdrawal by Subject|5|||
149907422|NCT02235077|540789737|FG000|Overall Study|Physician Decision|0|||
149907423|NCT02235077|540789738|FG001|Overall Study|Physician Decision|1|||
149907424|NCT03852628|540789739|FG000|Overall Study|Lost to Follow-up|7|||
149907425|NCT03852628|540789740|FG001|Overall Study|Lost to Follow-up|6|||
149907426|NCT03852628|540789739|FG000|Overall Study|Lack of Efficacy|6|||
149907427|NCT03852628|540789740|FG001|Overall Study|Lack of Efficacy|6|||
149907428|NCT02964208|540789741|FG000|Overall Study|Death|103|||
149907429|NCT02964208|540789741|FG000|Overall Study|Withdrawal by Subject|6|||
149907430|NCT02964208|540789741|FG000|Overall Study|Lost to Follow-up|6|||
149907431|NCT02964208|540789741|FG000|Overall Study|Unsuccessful Procedure|5|||
149971203|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
149971204|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
149971205|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
149971206|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
149907432|NCT02964208|540789741|FG000|Overall Study|Device Explant|1|||
149907433|NCT02964208|540789741|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
149907434|NCT00877487|540789744|FG000|Open-label Treatment Phase|Adverse Event|1|||
149907435|NCT00877487|540789745|FG001|Open-label Treatment Phase|Adverse Event|0|||
149907436|NCT00877487|540789744|FG000|Open-label Treatment Phase|Protocol Violation|3|||
150048543|NCT00375609|541319350|FG002|Overall Study|Physician Decision|1|||
149907437|NCT00877487|540789745|FG001|Open-label Treatment Phase|Protocol Violation|0|||
149971207|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
149971208|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
149971209|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
149971210|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
149971211|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
149971212|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
149971213|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
149971214|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
149971215|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
149971216|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
149971217|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
149971218|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
149971219|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
149971220|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
149971221|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
149971222|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
149971223|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
149971224|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
149971225|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
149971226|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
149971227|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
149971228|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
149971229|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
149971230|NCT00557193|541031767|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
149971231|NCT00557193|541031768|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
149971232|NCT00557193|541031769|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
149971233|NCT00557193|541031770|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
149971234|NCT00557193|541031771|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
149971235|NCT00557193|541031772|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
149971236|NCT00652834|541031773|FG000|Overall Study|Withdrawal by Subject|3|||
149971237|NCT00652834|541031773|FG000|Overall Study|Lost to Follow-up|2|||
149971238|NCT01948427|541031774|FG000|Overall Study|Serious Adverse Event|3|||
149971239|NCT01948427|541031775|FG001|Overall Study|Serious Adverse Event|0|||
149971240|NCT01948427|541031776|FG002|Overall Study|Serious Adverse Event|0|||
149971241|NCT01948427|541031777|FG003|Overall Study|Serious Adverse Event|0|||
149971242|NCT01948427|541031778|FG004|Overall Study|Serious Adverse Event|1|||
149971243|NCT01948427|541031774|FG000|Overall Study|Investigator Request|0|||
149971244|NCT01948427|541031775|FG001|Overall Study|Investigator Request|8|||
149971245|NCT01948427|541031776|FG002|Overall Study|Investigator Request|0|||
149971246|NCT01948427|541031777|FG003|Overall Study|Investigator Request|0|||
149971247|NCT01948427|541031778|FG004|Overall Study|Investigator Request|6|||
149971248|NCT01948427|541031774|FG000|Overall Study|Lost to Follow-up|1|||
149971249|NCT01948427|541031775|FG001|Overall Study|Lost to Follow-up|0|||
149971250|NCT01948427|541031776|FG002|Overall Study|Lost to Follow-up|0|||
149971251|NCT01948427|541031777|FG003|Overall Study|Lost to Follow-up|0|||
149971252|NCT01948427|541031778|FG004|Overall Study|Lost to Follow-up|4|||
149971253|NCT01948427|541031774|FG000|Overall Study|Withdrawal by Subject|2|||
149971254|NCT01948427|541031775|FG001|Overall Study|Withdrawal by Subject|0|||
149971255|NCT01948427|541031776|FG002|Overall Study|Withdrawal by Subject|0|||
149971256|NCT01948427|541031777|FG003|Overall Study|Withdrawal by Subject|0|||
149971257|NCT01948427|541031778|FG004|Overall Study|Withdrawal by Subject|1|||
149971258|NCT01948427|541031774|FG000|Overall Study|Other, Not Specified|1|||
149971259|NCT01948427|541031775|FG001|Overall Study|Other, Not Specified|9|||
149971260|NCT01948427|541031776|FG002|Overall Study|Other, Not Specified|0|||
149971261|NCT01948427|541031777|FG003|Overall Study|Other, Not Specified|0|||
149971262|NCT01948427|541031778|FG004|Overall Study|Other, Not Specified|2|||
149971263|NCT00402987|541031779|FG000|Overall Study|Lack of Efficacy|0|||
149971264|NCT00402987|541031780|FG001|Overall Study|Lack of Efficacy|0|||
149971265|NCT00402987|541031781|FG002|Overall Study|Lack of Efficacy|1|||
149971266|NCT00402987|541031782|FG003|Overall Study|Lack of Efficacy|0|||
149971267|NCT01668004|541031783|FG000|Overall Study|Adverse Event|7|||
149971268|NCT01668004|541031783|FG000|Overall Study|Withdrawal by Subject|2|||
149971269|NCT01668004|541031783|FG000|Overall Study|Lost to Follow-up|5|||
149971270|NCT01668004|541031783|FG000|Overall Study|Lack of Efficacy|9|||
149971271|NCT01668004|541031783|FG000|Overall Study|Non-compliance with treatment|2|||
149971272|NCT00419744|541031784|FG000|Overall Study|Adverse Event|39|||
149971273|NCT00419744|541031785|FG001|Overall Study|Adverse Event|40|||
149971274|NCT00419744|541031786|FG002|Overall Study|Adverse Event|50|||
149971275|NCT00419744|541031784|FG000|Overall Study|Withdrawal by Subject|45|||
149971276|NCT00419744|541031785|FG001|Overall Study|Withdrawal by Subject|49|||
149971277|NCT00419744|541031786|FG002|Overall Study|Withdrawal by Subject|52|||
149971278|NCT00419744|541031784|FG000|Overall Study|Lost to Follow-up|8|||
149971279|NCT00419744|541031785|FG001|Overall Study|Lost to Follow-up|10|||
149971280|NCT00419744|541031786|FG002|Overall Study|Lost to Follow-up|6|||
149971281|NCT00419744|541031784|FG000|Overall Study|Protocol Violation|4|||
149971282|NCT00419744|541031785|FG001|Overall Study|Protocol Violation|7|||
149971283|NCT00419744|541031786|FG002|Overall Study|Protocol Violation|8|||
149971284|NCT00419744|541031784|FG000|Overall Study|Randomized in error|9|||
149971285|NCT00419744|541031785|FG001|Overall Study|Randomized in error|6|||
149971286|NCT00419744|541031786|FG002|Overall Study|Randomized in error|7|||
149971287|NCT00419744|541031784|FG000|Overall Study|Moving out of state|2|||
149971288|NCT00419744|541031785|FG001|Overall Study|Moving out of state|0|||
149971289|NCT00419744|541031786|FG002|Overall Study|Moving out of state|1|||
149971290|NCT00419744|541031784|FG000|Overall Study|Physician Decision|10|||
149971291|NCT00419744|541031785|FG001|Overall Study|Physician Decision|5|||
149971292|NCT00419744|541031786|FG002|Overall Study|Physician Decision|6|||
149971293|NCT00419744|541031784|FG000|Overall Study|Spirometry mouthpiece issues|0|||
149971294|NCT00419744|541031785|FG001|Overall Study|Spirometry mouthpiece issues|1|||
149971295|NCT00419744|541031786|FG002|Overall Study|Spirometry mouthpiece issues|2|||
149971296|NCT00419744|541031784|FG000|Overall Study|Incorrect medication kit dispensed|0|||
149971297|NCT00419744|541031785|FG001|Overall Study|Incorrect medication kit dispensed|0|||
149971298|NCT00419744|541031786|FG002|Overall Study|Incorrect medication kit dispensed|1|||
149971299|NCT02448381|541031794|FG000|Overall Study|Adverse Event|2|||
149971300|NCT02448381|541031795|FG001|Overall Study|Adverse Event|0|||
149971301|NCT02448381|541031794|FG000|Overall Study|Lost to Follow-up|16|||
149971302|NCT02448381|541031795|FG001|Overall Study|Lost to Follow-up|9|||
149971303|NCT02448381|541031794|FG000|Overall Study|Physician Decision|1|||
149971304|NCT02448381|541031795|FG001|Overall Study|Physician Decision|1|||
149971305|NCT02448381|541031794|FG000|Overall Study|Pregnancy|1|||
149971306|NCT02448381|541031795|FG001|Overall Study|Pregnancy|0|||
149971307|NCT02448381|541031794|FG000|Overall Study|Withdrawal by Subject|13|||
149971308|NCT02448381|541031795|FG001|Overall Study|Withdrawal by Subject|9|||
149971309|NCT02448381|541031794|FG000|Overall Study|Noncompliance with Study Procedures|2|||
149971310|NCT02448381|541031795|FG001|Overall Study|Noncompliance with Study Procedures|0|||
149971311|NCT01500317|541031798|FG000|Overall Study|Withdrawal by Subject|3|||
149971312|NCT01500317|541031799|FG001|Overall Study|Withdrawal by Subject|2|||
149971313|NCT01500317|541031800|FG002|Overall Study|Withdrawal by Subject|0|||
149971314|NCT00976456|541031801|FG000|Overall Study|Adverse Event|17|||
149971315|NCT00976456|541031802|FG001|Overall Study|Adverse Event|22|||
150048544|NCT00375609|541319348|FG000|Overall Study|Withdrawal by Subject|1|||
150048545|NCT00375609|541319349|FG001|Overall Study|Withdrawal by Subject|4|||
150048546|NCT00375609|541319350|FG002|Overall Study|Withdrawal by Subject|0|||
150048547|NCT00375609|541319348|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
150048548|NCT00375609|541319349|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
150048549|NCT00375609|541319350|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
150048550|NCT01368562|541319351|FG000|Overall Study|Adverse Event|1|||
150048551|NCT01368562|541319351|FG000|Overall Study|Disease progression|1|||
150048552|NCT01368562|541319351|FG000|Overall Study|Lost to Follow-up|1|||
150048553|NCT01368562|541319351|FG000|Overall Study|Death|6|||
150048554|NCT01368562|541319351|FG000|Overall Study|Unresponsive to treatment|5|||
150048555|NCT01368562|541319351|FG000|Overall Study|Other|3|||
150048556|NCT01368562|541319351|FG000|Overall Study|Other than specified|2|||
150048557|NCT00727441|541319353|FG000|Overall Study|Disease Progression|11|||
150048558|NCT00727441|541319354|FG001|Overall Study|Disease Progression|14|||
150048559|NCT00727441|541319355|FG002|Overall Study|Disease Progression|17|||
150048560|NCT00727441|541319353|FG000|Overall Study|Eligibility|7|||
150048561|NCT00727441|541319354|FG001|Overall Study|Eligibility|5|||
150048562|NCT00727441|541319355|FG002|Overall Study|Eligibility|7|||
150048563|NCT00727441|541319353|FG000|Overall Study|Death|0|||
150048564|NCT00727441|541319354|FG001|Overall Study|Death|1|||
150048565|NCT00727441|541319355|FG002|Overall Study|Death|1|||
150048566|NCT00727441|541319353|FG000|Overall Study|Physician Decision|0|||
150048567|NCT00727441|541319354|FG001|Overall Study|Physician Decision|1|||
150048568|NCT00727441|541319355|FG002|Overall Study|Physician Decision|0|||
150048569|NCT00727441|541319353|FG000|Overall Study|Withdrawal by Subject|0|||
150048570|NCT00727441|541319354|FG001|Overall Study|Withdrawal by Subject|1|||
150048571|NCT00727441|541319355|FG002|Overall Study|Withdrawal by Subject|0|||
150048572|NCT01239992|541319356|FG000|Overall Study|Withdrawal by Subject|2|||
150048573|NCT00535288|541319357|FG000|Overall Study|Adverse Event|20|||
150048574|NCT00535288|541319358|FG001|Overall Study|Adverse Event|19|||
150048575|NCT00535288|541319359|FG002|Overall Study|Adverse Event|25|||
150048576|NCT00535288|541319360|FG003|Overall Study|Adverse Event|20|||
150048577|NCT00535288|541319361|FG004|Overall Study|Adverse Event|30|||
150048578|NCT00535288|541319357|FG000|Overall Study|Lost to Follow-up|0|||
150048579|NCT00535288|541319358|FG001|Overall Study|Lost to Follow-up|3|||
150048580|NCT00535288|541319359|FG002|Overall Study|Lost to Follow-up|0|||
150048581|NCT00535288|541319360|FG003|Overall Study|Lost to Follow-up|0|||
150048582|NCT00535288|541319361|FG004|Overall Study|Lost to Follow-up|0|||
150048583|NCT00535288|541319357|FG000|Overall Study|Lack of Efficacy|26|||
150048584|NCT00535288|541319358|FG001|Overall Study|Lack of Efficacy|3|||
150048585|NCT00535288|541319359|FG002|Overall Study|Lack of Efficacy|4|||
150048586|NCT00535288|541319360|FG003|Overall Study|Lack of Efficacy|4|||
150048587|NCT00535288|541319361|FG004|Overall Study|Lack of Efficacy|7|||
150048588|NCT00535288|541319357|FG000|Overall Study|Unwilling to cooperate|6|||
150048589|NCT00535288|541319358|FG001|Overall Study|Unwilling to cooperate|6|||
150048590|NCT00535288|541319359|FG002|Overall Study|Unwilling to cooperate|3|||
150048591|NCT00535288|541319360|FG003|Overall Study|Unwilling to cooperate|3|||
150048592|NCT00535288|541319361|FG004|Overall Study|Unwilling to cooperate|4|||
150048593|NCT00535288|541319357|FG000|Overall Study|Other|2|||
150048594|NCT00535288|541319358|FG001|Overall Study|Other|1|||
150048595|NCT00535288|541319359|FG002|Overall Study|Other|1|||
150048596|NCT00535288|541319360|FG003|Overall Study|Other|2|||
150048597|NCT00535288|541319361|FG004|Overall Study|Other|1|||
150048598|NCT02810444|541319362|FG000|Overall Study|Screen Failures|14|||
150048599|NCT02810444|541319362|FG000|Overall Study|Withdrawal by Subject|4|||
150048600|NCT02810444|541319362|FG000|Overall Study|Adverse Event|3|||
150048601|NCT00745849|541319363|FG000|First Intervention|Withdrawal by Subject|0|||
150048602|NCT00745849|541319364|FG001|First Intervention|Withdrawal by Subject|1|||
150048603|NCT00745849|541319363|FG000|First Intervention|Lost to Follow-up|1|||
150048604|NCT00745849|541319364|FG001|First Intervention|Lost to Follow-up|1|||
150048605|NCT00745849|541319363|FG000|Second Intervention|Lost to Follow-up|2|||
150048606|NCT00745849|541319364|FG001|Second Intervention|Lost to Follow-up|1|||
150048607|NCT01754727|541319367|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
150048608|NCT02785770|541319368|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
150048609|NCT02785770|541319369|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
150048610|NCT02785770|541319370|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
150048611|NCT02785770|541319371|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
150048612|NCT02785770|541319368|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
150048613|NCT02785770|541319369|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
150048614|NCT02785770|541319370|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
150048615|NCT02785770|541319371|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
150176750|NCT02674750|541783409|FG001|Overall Study|Lack of Efficacy|17|||
149907438|NCT00877487|540789744|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
150048616|NCT02785770|541319368|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
150048617|NCT02785770|541319369|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
150048618|NCT02785770|541319370|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
149971316|NCT00976456|541031801|FG000|Overall Study|Death|7|||
149971317|NCT00976456|541031802|FG001|Overall Study|Death|9|||
149971318|NCT00976456|541031801|FG000|Overall Study|Lack of Efficacy|5|||
149971319|NCT00976456|541031802|FG001|Overall Study|Lack of Efficacy|2|||
149971320|NCT00976456|541031801|FG000|Overall Study|Withdrawal by Subject|3|||
149971321|NCT00976456|541031802|FG001|Overall Study|Withdrawal by Subject|1|||
149971322|NCT00976456|541031801|FG000|Overall Study|screening failure, unknown|11|||
149971323|NCT00976456|541031802|FG001|Overall Study|screening failure, unknown|4|||
149971324|NCT00335829|541031803|FG000|Overall Study|Withdrawal by Subject|1|||
149971325|NCT00335829|541031803|FG000|Overall Study|Lost to Follow-up|1|||
149971326|NCT00335829|541031803|FG000|Overall Study|Adverse Event|1|||
149971327|NCT00583219|541031804|FG000|Phase 2|Withdrawal by Subject|1|||
149971328|NCT02037529|541031805|FG000|Overall Study|Withdrawal by Subject|1|||
149971329|NCT02037529|541031806|FG001|Overall Study|Withdrawal by Subject|3|||
149971330|NCT02037529|541031805|FG000|Overall Study|Adverse Event|0|||
149971331|NCT02037529|541031806|FG001|Overall Study|Adverse Event|1|||
149971332|NCT02131766|541031807|FG000|Overall Study|Withdrawal by Subject|4|||
149971333|NCT00754572|541031808|FG000|Overall Study|Adverse Event|19|||
149971334|NCT00754572|541031808|FG000|Overall Study|Other|39|||
149971335|NCT00754572|541031808|FG000|Overall Study|Protocol Violation|3|||
149971336|NCT00754572|541031808|FG000|Overall Study|Withdrawal by Subject|3|||
149971337|NCT00754572|541031808|FG000|Overall Study|Lack of Efficacy|2|||
149971338|NCT00754572|541031808|FG000|Overall Study|Death|1|||
149971339|NCT00754572|541031808|FG000|Overall Study|Administrative Reason|3|||
149971340|NCT00754572|541031808|FG000|Overall Study|Lost to Follow-up|1|||
149971341|NCT00718315|541031809|FG000|Overall Study|Adverse Event|1|||
149971342|NCT00718315|541031810|FG001|Overall Study|Adverse Event|2|||
149971343|NCT00718315|541031811|FG002|Overall Study|Adverse Event|3|||
149971344|NCT00718315|541031809|FG000|Overall Study|Death|6|||
149971345|NCT00718315|541031810|FG001|Overall Study|Death|6|||
149971346|NCT00718315|541031811|FG002|Overall Study|Death|5|||
149971347|NCT00718315|541031809|FG000|Overall Study|Lost to Follow-up|2|||
149971348|NCT00718315|541031810|FG001|Overall Study|Lost to Follow-up|3|||
150176751|NCT02674750|541783410|FG002|Overall Study|Lack of Efficacy|3|||
150176752|NCT02674750|541783408|FG000|Overall Study|Withdrawal by Subject|0|||
149971349|NCT00718315|541031811|FG002|Overall Study|Lost to Follow-up|4|||
149971350|NCT00718315|541031809|FG000|Overall Study|Protocol Violation|5|||
149971351|NCT00718315|541031810|FG001|Overall Study|Protocol Violation|5|||
149971352|NCT00718315|541031811|FG002|Overall Study|Protocol Violation|3|||
149971353|NCT00718315|541031809|FG000|Overall Study|Erlotinib dose decreased|4|||
149971354|NCT00718315|541031810|FG001|Overall Study|Erlotinib dose decreased|3|||
149971355|NCT00718315|541031811|FG002|Overall Study|Erlotinib dose decreased|1|||
149971356|NCT00718315|541031809|FG000|Overall Study|Use of Minocyclin|1|||
149971357|NCT00718315|541031810|FG001|Overall Study|Use of Minocyclin|1|||
150048619|NCT02785770|541319371|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
150048620|NCT04838977|541319375|FG000|Overall Study|Lost to Follow-up|2|||
150048621|NCT04838977|541319376|FG001|Overall Study|Lost to Follow-up|3|||
150048622|NCT04838977|541319375|FG000|Overall Study|Withdrawal by Subject|1|||
150048623|NCT04838977|541319376|FG001|Overall Study|Withdrawal by Subject|1|||
150048624|NCT02597478|541319390|FG000|Overall Study|Withdrawal by Subject|2|||
150048625|NCT02597478|541319391|FG001|Overall Study|Withdrawal by Subject|0|||
150048626|NCT02597478|541319390|FG000|Overall Study|Change of opioid dose|1|||
150048627|NCT02597478|541319391|FG001|Overall Study|Change of opioid dose|0|||
150048628|NCT02597478|541319390|FG000|Overall Study|Insufficient exertional dyspnea|0|||
150048629|NCT02597478|541319391|FG001|Overall Study|Insufficient exertional dyspnea|1|||
150048630|NCT01256190|541319393|FG000|Overall Study|Lost to Follow-up|2|||
150048631|NCT01256190|541319394|FG001|Overall Study|Lost to Follow-up|0|||
150048632|NCT04931888|541319395|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
150048633|NCT04931888|541319396|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
150048634|NCT04931888|541319397|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
150048635|NCT04931888|541319398|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
150048636|NCT02350478|541319399|FG000|Overall Study|Lost to Follow-up|5|||
150048637|NCT02350478|541319400|FG001|Overall Study|Lost to Follow-up|1|||
150048638|NCT02779556|541319401|FG000|Baseline|Partial baseline interview completed|1|||
150048639|NCT02779556|541319402|FG001|Baseline|Partial baseline interview completed|0|||
150048640|NCT02779556|541319401|FG000|3 Months|Lost to Follow-up|40|||
150048641|NCT02779556|541319402|FG001|3 Months|Lost to Follow-up|29|||
150048642|NCT02779556|541319401|FG000|3 Months|Missed 3 month clinic visit|27|||
150048643|NCT02779556|541319402|FG001|3 Months|Missed 3 month clinic visit|19|||
150048644|NCT02779556|541319401|FG000|6 Month|Lost to Follow-up|33|||
150048645|NCT02779556|541319402|FG001|6 Month|Lost to Follow-up|39|||
150048646|NCT02779556|541319401|FG000|6 Month HbA1c|No value collected during window|69|||
150048647|NCT02779556|541319402|FG001|6 Month HbA1c|No value collected during window|50|||
150048648|NCT02779556|541319401|FG000|12 Month HbA1c|No value collected during window|138|||
150048649|NCT02779556|541319402|FG001|12 Month HbA1c|No value collected during window|102|||
150048650|NCT02644109|541319410|FG000|Overall Study|Adverse Event|0|||
150048651|NCT02644109|541319411|FG001|Overall Study|Adverse Event|4|||
150048652|NCT00918736|541319412|FG000|Overall Study|Withdrawal by Subject|4|||
150048653|NCT01942733|541319413|FG000|Overall Study|Lost to Follow-up|1|||
150048654|NCT01942733|541319413|FG000|Overall Study|Non-compliance with IMP|1|||
150048655|NCT01942733|541319413|FG000|Overall Study|Administrative|1|||
150048656|NCT02625909|541319414|FG000|Overall Study|Death|2|||
150048657|NCT02625909|541319415|FG001|Overall Study|Death|0|||
150048658|NCT02625909|541319414|FG000|Overall Study|Lost to Follow-up|3|||
150048659|NCT02625909|541319415|FG001|Overall Study|Lost to Follow-up|5|||
150048660|NCT02625909|541319414|FG000|Overall Study|Lack of Efficacy|9|||
150048661|NCT02625909|541319415|FG001|Overall Study|Lack of Efficacy|2|||
150048662|NCT02625909|541319414|FG000|Overall Study|Reinfection|3|||
150048663|NCT02625909|541319415|FG001|Overall Study|Reinfection|2|||
150048664|NCT04080167|541319419|FG000|Overall Study|Lost to Follow-up-Patients|7|||
150048665|NCT04080167|541319420|FG001|Overall Study|Lost to Follow-up-Patients|14|||
150048666|NCT04080167|541319421|FG002|Overall Study|Lost to Follow-up-Patients|0|||
150048667|NCT04080167|541319419|FG000|Overall Study|Lost to Follow-up-Providers|2|||
150048668|NCT04080167|541319420|FG001|Overall Study|Lost to Follow-up-Providers|2|||
150048669|NCT04080167|541319421|FG002|Overall Study|Lost to Follow-up-Providers|0|||
150048670|NCT04080167|541319419|FG000|Overall Study|Withdrawal by Subject|1|||
150048671|NCT04080167|541319420|FG001|Overall Study|Withdrawal by Subject|2|||
150048672|NCT04080167|541319421|FG002|Overall Study|Withdrawal by Subject|0|||
150048673|NCT04080167|541319419|FG000|Overall Study|Withdrawal by Provider|0|||
150048674|NCT04080167|541319420|FG001|Overall Study|Withdrawal by Provider|0|||
150048675|NCT04080167|541319421|FG002|Overall Study|Withdrawal by Provider|4|||
150048676|NCT04080167|541319419|FG000|Overall Study|Death-Patient|2|||
150048677|NCT04080167|541319420|FG001|Overall Study|Death-Patient|1|||
150048678|NCT04080167|541319421|FG002|Overall Study|Death-Patient|0|||
150048679|NCT04080167|541319419|FG000|Overall Study|Hydroxyurea New Starts|0|||
150048680|NCT04080167|541319420|FG001|Overall Study|Hydroxyurea New Starts|0|||
150048681|NCT04080167|541319421|FG002|Overall Study|Hydroxyurea New Starts|1|||
150048682|NCT04080167|541319419|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
150048683|NCT04080167|541319420|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
150048684|NCT04080167|541319421|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
150048685|NCT02167139|541319422|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
150048686|NCT02167139|541319423|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
150048687|NCT02167139|541319424|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
150048688|NCT02167139|541319425|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
150048689|NCT02167139|541319422|FG000|Randomised, Double-blind|Adverse Event|2|||
150048690|NCT02167139|541319423|FG001|Randomised, Double-blind|Adverse Event|9|||
150048691|NCT02167139|541319424|FG002|Randomised, Double-blind|Adverse Event|0|||
150048692|NCT02167139|541319425|FG003|Randomised, Double-blind|Adverse Event|0|||
150048693|NCT02167139|541319422|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
150048694|NCT02167139|541319423|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
150048695|NCT02167139|541319424|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
150048696|NCT02167139|541319425|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
150048697|NCT02167139|541319422|FG000|Randomised, Double-blind|Other|3|||
150048698|NCT02167139|541319423|FG001|Randomised, Double-blind|Other|0|||
150048699|NCT02167139|541319424|FG002|Randomised, Double-blind|Other|0|||
150048700|NCT02167139|541319425|FG003|Randomised, Double-blind|Other|0|||
150048701|NCT02167139|541319422|FG000|Transition-extension|Adverse Event|2|||
150048702|NCT02167139|541319423|FG001|Transition-extension|Adverse Event|0|||
150048703|NCT02167139|541319424|FG002|Transition-extension|Adverse Event|2|||
150048704|NCT02167139|541319425|FG003|Transition-extension|Adverse Event|3|||
150048705|NCT02167139|541319422|FG000|Transition-extension|Withdrawal by Subject|2|||
150048706|NCT02167139|541319423|FG001|Transition-extension|Withdrawal by Subject|0|||
150048707|NCT02167139|541319424|FG002|Transition-extension|Withdrawal by Subject|4|||
150048708|NCT02167139|541319425|FG003|Transition-extension|Withdrawal by Subject|1|||
150048709|NCT02167139|541319422|FG000|Transition-extension|Lack of Efficacy|0|||
150048710|NCT02167139|541319423|FG001|Transition-extension|Lack of Efficacy|0|||
150048711|NCT02167139|541319424|FG002|Transition-extension|Lack of Efficacy|1|||
150048712|NCT02167139|541319425|FG003|Transition-extension|Lack of Efficacy|1|||
150048713|NCT02167139|541319422|FG000|Transition-extension|Other|1|||
150048714|NCT02167139|541319423|FG001|Transition-extension|Other|0|||
150048715|NCT02167139|541319424|FG002|Transition-extension|Other|1|||
150048716|NCT02167139|541319425|FG003|Transition-extension|Other|0|||
150048717|NCT02167139|541319422|FG000|Transition-extension|Lost to Follow-up|1|||
150048718|NCT02167139|541319423|FG001|Transition-extension|Lost to Follow-up|0|||
150048719|NCT02167139|541319424|FG002|Transition-extension|Lost to Follow-up|0|||
150048720|NCT02167139|541319425|FG003|Transition-extension|Lost to Follow-up|0|||
149907439|NCT00877487|540789745|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
149907440|NCT00877487|540789744|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
149907441|NCT00877487|540789745|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
149907442|NCT00877487|540789744|FG000|Open-label Treatment Phase|Out of country for business|1|||
149907443|NCT00877487|540789745|FG001|Open-label Treatment Phase|Out of country for business|0|||
149907444|NCT00877487|540789744|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
149907445|NCT00877487|540789745|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
149907446|NCT00877487|540789744|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
149907447|NCT00877487|540789745|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
149907448|NCT00877487|540789744|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
149907449|NCT00877487|540789745|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
149907450|NCT00877487|540789744|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
149907451|NCT00877487|540789745|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
149907452|NCT01516008|540789746|FG000|Overall Study|Adverse Event|0|||
149907453|NCT01516008|540789747|FG001|Overall Study|Adverse Event|2|||
149907454|NCT01516008|540789748|FG002|Overall Study|Adverse Event|7|||
149907455|NCT01516008|540789746|FG000|Overall Study|Lack of Efficacy|44|||
149907456|NCT01516008|540789747|FG001|Overall Study|Lack of Efficacy|14|||
149907457|NCT01516008|540789748|FG002|Overall Study|Lack of Efficacy|10|||
149907458|NCT01516008|540789746|FG000|Overall Study|Protocol Violation|1|||
149907459|NCT01516008|540789747|FG001|Overall Study|Protocol Violation|0|||
149907460|NCT01516008|540789748|FG002|Overall Study|Protocol Violation|0|||
149907461|NCT01516008|540789746|FG000|Overall Study|Reason not specified|0|||
149907462|NCT01516008|540789747|FG001|Overall Study|Reason not specified|0|||
149907463|NCT01516008|540789748|FG002|Overall Study|Reason not specified|1|||
149971358|NCT00718315|541031811|FG002|Overall Study|Use of Minocyclin|1|||
149971359|NCT00718315|541031809|FG000|Overall Study|Disease progression|0|||
149971360|NCT00718315|541031810|FG001|Overall Study|Disease progression|1|||
149971361|NCT00718315|541031811|FG002|Overall Study|Disease progression|1|||
149971362|NCT00718315|541031809|FG000|Overall Study|Other|0|||
149971363|NCT00718315|541031810|FG001|Overall Study|Other|0|||
149971364|NCT00718315|541031811|FG002|Overall Study|Other|1|||
149971365|NCT00718315|541031809|FG000|Overall Study|Use of ATB and Corticoids|0|||
149971366|NCT00718315|541031810|FG001|Overall Study|Use of ATB and Corticoids|1|||
149971367|NCT00718315|541031811|FG002|Overall Study|Use of ATB and Corticoids|2|||
149971368|NCT02303262|541031822|FG000|Overall Study|Withdrawal by Subject|2|||
149971369|NCT01728246|541031825|FG000|Overall Study|Participant needed rescue medication|1|||
149971370|NCT01728246|541031826|FG001|Overall Study|Participant needed rescue medication|5|||
149971371|NCT01728246|541031825|FG000|Overall Study|Protocol Violation|1|||
149971372|NCT01728246|541031826|FG001|Overall Study|Protocol Violation|0|||
149971373|NCT01728246|541031825|FG000|Overall Study|Withdrawal by Subject|2|||
149971374|NCT01728246|541031826|FG001|Overall Study|Withdrawal by Subject|3|||
149971375|NCT01728246|541031825|FG000|Overall Study|Lost to Follow-up|23|||
149971376|NCT01728246|541031826|FG001|Overall Study|Lost to Follow-up|22|||
149971377|NCT01728246|541031825|FG000|Overall Study|Lack of Efficacy|1|||
149907464|NCT01217476|540789751|FG000|Overall Study|Adverse Event|6|||
149907465|NCT01217476|540789752|FG001|Overall Study|Adverse Event|1|||
149907466|NCT01217476|540789751|FG000|Overall Study|Physician Decision|0|||
149907467|NCT01217476|540789752|FG001|Overall Study|Physician Decision|1|||
149907468|NCT01217476|540789751|FG000|Overall Study|Withdrawal by Subject|3|||
149907469|NCT01217476|540789752|FG001|Overall Study|Withdrawal by Subject|3|||
149907470|NCT01217476|540789751|FG000|Overall Study|Surgery on the Target Limb|0|||
149907471|NCT01217476|540789752|FG001|Overall Study|Surgery on the Target Limb|2|||
149907472|NCT01217476|540789751|FG000|Overall Study|Protocol Deviation|1|||
149907473|NCT01217476|540789752|FG001|Overall Study|Protocol Deviation|0|||
149907474|NCT01217476|540789751|FG000|Overall Study|Other|2|||
149907475|NCT01217476|540789752|FG001|Overall Study|Other|0|||
149907476|NCT00813813|540789755|FG000|Overall Study|Withdrawal by Subject|1|||
149907477|NCT00813813|540789756|FG001|Overall Study|Withdrawal by Subject|1|||
149907478|NCT00813813|540789755|FG000|Overall Study|Lost to Follow-up|2|||
149907479|NCT00813813|540789756|FG001|Overall Study|Lost to Follow-up|7|||
149907480|NCT00813813|540789755|FG000|Overall Study|Other|0|||
149907481|NCT00813813|540789756|FG001|Overall Study|Other|1|||
149907482|NCT00986921|540789757|FG000|Overall Study|Physician Decision|1|||
149907483|NCT00986921|540789758|FG001|Overall Study|Physician Decision|0|||
149971378|NCT01728246|541031826|FG001|Overall Study|Lack of Efficacy|1|||
149971379|NCT01728246|541031825|FG000|Overall Study|Adverse Event|8|||
149971380|NCT01728246|541031826|FG001|Overall Study|Adverse Event|5|||
149971381|NCT01143402|541031827|FG000|Overall Study|Rapid clinical decline|1|||
149971382|NCT01143402|541031828|FG001|Overall Study|Rapid clinical decline|1|||
149907484|NCT01758731|540789759|FG000|Overall Study|Physician Decision|1|||
149907485|NCT04445714|540789760|FG000|Overall Study|Discontinuation of the study|14|||
149907486|NCT04445714|540789760|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
149907487|NCT04445714|540789760|FG000|Overall Study|Withdrawal of Informed Consent|8|||
149907488|NCT02805660|540789761|FG000|Overall Study|Death|5|||
149907489|NCT02805660|540789762|FG001|Overall Study|Death|2|||
149907490|NCT02805660|540789763|FG002|Overall Study|Death|9|||
149907491|NCT02805660|540789764|FG003|Overall Study|Death|5|||
149907492|NCT02805660|540789765|FG004|Overall Study|Death|0|||
149907493|NCT02805660|540789766|FG005|Overall Study|Death|14|||
149907494|NCT02805660|540789767|FG006|Overall Study|Death|12|||
149907495|NCT02805660|540789761|FG000|Overall Study|Lost to Follow-up|0|||
149907496|NCT02805660|540789762|FG001|Overall Study|Lost to Follow-up|1|||
149907497|NCT02805660|540789763|FG002|Overall Study|Lost to Follow-up|1|||
149907498|NCT02805660|540789764|FG003|Overall Study|Lost to Follow-up|2|||
149907499|NCT02805660|540789765|FG004|Overall Study|Lost to Follow-up|0|||
149907500|NCT02805660|540789766|FG005|Overall Study|Lost to Follow-up|0|||
149907501|NCT02805660|540789767|FG006|Overall Study|Lost to Follow-up|0|||
149907502|NCT02805660|540789761|FG000|Overall Study|Withdrawal by Subject|0|||
149907503|NCT02805660|540789762|FG001|Overall Study|Withdrawal by Subject|0|||
149907504|NCT02805660|540789763|FG002|Overall Study|Withdrawal by Subject|0|||
149907505|NCT02805660|540789764|FG003|Overall Study|Withdrawal by Subject|3|||
149907506|NCT02805660|540789765|FG004|Overall Study|Withdrawal by Subject|1|||
149907507|NCT02805660|540789766|FG005|Overall Study|Withdrawal by Subject|0|||
149907508|NCT02805660|540789767|FG006|Overall Study|Withdrawal by Subject|2|||
149907509|NCT02805660|540789761|FG000|Overall Study|Study terminated by Sponsor|0|||
149907510|NCT02805660|540789762|FG001|Overall Study|Study terminated by Sponsor|0|||
149907511|NCT02805660|540789763|FG002|Overall Study|Study terminated by Sponsor|1|||
149907512|NCT02805660|540789764|FG003|Overall Study|Study terminated by Sponsor|4|||
149907513|NCT02805660|540789765|FG004|Overall Study|Study terminated by Sponsor|2|||
149907514|NCT02805660|540789766|FG005|Overall Study|Study terminated by Sponsor|3|||
149907515|NCT02805660|540789767|FG006|Overall Study|Study terminated by Sponsor|1|||
150048721|NCT01297491|541319426|FG000|Overall Study|Adverse Event|11|||
150048722|NCT01297491|541319427|FG001|Overall Study|Adverse Event|6|||
150048723|NCT01297491|541319426|FG000|Overall Study|Physician Decision|3|||
150048724|NCT01297491|541319427|FG001|Overall Study|Physician Decision|2|||
149907516|NCT02805660|540789761|FG000|Overall Study|Miscellaneous|0|||
150048725|NCT01297491|541319426|FG000|Overall Study|Progressive disease|11|||
149907517|NCT02805660|540789762|FG001|Overall Study|Miscellaneous|1|||
149907518|NCT02805660|540789763|FG002|Overall Study|Miscellaneous|0|||
150048726|NCT01297491|541319427|FG001|Overall Study|Progressive disease|20|||
149907519|NCT02805660|540789764|FG003|Overall Study|Miscellaneous|4|||
149907520|NCT02805660|540789765|FG004|Overall Study|Miscellaneous|0|||
149907521|NCT02805660|540789766|FG005|Overall Study|Miscellaneous|6|||
149907522|NCT02805660|540789767|FG006|Overall Study|Miscellaneous|4|||
149907523|NCT02572076|540789769|FG000|Overall Study|Protocol Violation|1|||
149907524|NCT01684943|540789774|FG000|Overall Study|Inadequate Venous Access|3|||
149907525|NCT01684943|540789775|FG001|Overall Study|Inadequate Venous Access|0|||
149907526|NCT01684943|540789776|FG002|Overall Study|Inadequate Venous Access|0|||
149907527|NCT01684943|540789774|FG000|Overall Study|Principal Investigator Determination|1|||
149907528|NCT01684943|540789775|FG001|Overall Study|Principal Investigator Determination|0|||
149907529|NCT01684943|540789776|FG002|Overall Study|Principal Investigator Determination|0|||
149907530|NCT01684943|540789774|FG000|Overall Study|Excluded from Analysis|1|||
149907531|NCT01684943|540789775|FG001|Overall Study|Excluded from Analysis|1|||
149907532|NCT01684943|540789776|FG002|Overall Study|Excluded from Analysis|1|||
149907533|NCT01684943|540789774|FG000|Overall Study|Lost to Follow-up|3|||
149907534|NCT01684943|540789775|FG001|Overall Study|Lost to Follow-up|0|||
149907535|NCT01684943|540789776|FG002|Overall Study|Lost to Follow-up|0|||
149907536|NCT01684943|540789774|FG000|Overall Study|Planning Pregnancy|1|||
149907537|NCT01684943|540789775|FG001|Overall Study|Planning Pregnancy|0|||
149907538|NCT01684943|540789776|FG002|Overall Study|Planning Pregnancy|0|||
149907539|NCT01672710|540789780|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
149907540|NCT01672710|540789781|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
149907541|NCT01672710|540789780|FG000|3 Month Follow up|Lost to Follow-up|2|||
149907542|NCT01672710|540789781|FG001|3 Month Follow up|Lost to Follow-up|3|||
149907543|NCT01672710|540789780|FG000|3 Month Follow up|follow up due after termination date|4|||
149907544|NCT01672710|540789781|FG001|3 Month Follow up|follow up due after termination date|1|||
149907545|NCT02122887|540789782|FG000|Overall Study|Withdrawal by Subject|20|||
149907546|NCT02122887|540789783|FG001|Overall Study|Withdrawal by Subject|2|||
149907547|NCT03725761|540789784|FG000|Overall Study|still on study|1|||
149907548|NCT03055494|540791784|FG000|Overall Study|Lost to Follow-up|6|||
149907549|NCT03055494|540791785|FG001|Overall Study|Lost to Follow-up|0|||
149907550|NCT03055494|540791784|FG000|Overall Study|Physician Decision|2|||
149907551|NCT03055494|540791785|FG001|Overall Study|Physician Decision|0|||
149907552|NCT03055494|540791784|FG000|Overall Study|Withdrawal by Subject|1|||
149907553|NCT03055494|540791785|FG001|Overall Study|Withdrawal by Subject|0|||
149907554|NCT03055494|540791784|FG000|Overall Study|Adverse Event|0|||
149907555|NCT03055494|540791785|FG001|Overall Study|Adverse Event|1|||
149907556|NCT03055494|540791784|FG000|Overall Study|Non-compliance with study treatment|1|||
149907557|NCT03055494|540791785|FG001|Overall Study|Non-compliance with study treatment|0|||
149907558|NCT05903924|540791790|FG000|Overall Study|Lost to Follow-up|1|||
149907559|NCT05903924|540791791|FG001|Overall Study|Lost to Follow-up|0|||
149907560|NCT05903924|540791792|FG002|Overall Study|Lost to Follow-up|0|||
149907561|NCT04166591|540791793|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
149907562|NCT04166591|540791794|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
149907563|NCT04166591|540791795|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149907564|NCT04166591|540791796|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149907565|NCT04166591|540791793|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
149907566|NCT04166591|540791794|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
149907567|NCT04166591|540791795|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149907568|NCT04166591|540791796|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149907569|NCT01424514|540791803|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
149907570|NCT01424514|540791804|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
149907571|NCT01424514|540791803|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
149907572|NCT01424514|540791804|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
149907573|NCT01286168|540791805|FG000|Overall Study|Withdrawal by Subject|1|||
149907574|NCT01286168|540791805|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
149907575|NCT02487771|540791808|FG000|Overall Study|Lost to Follow-up|2|||
149907576|NCT02487771|540791809|FG001|Overall Study|Lost to Follow-up|3|||
149907577|NCT02487771|540791808|FG000|Overall Study|Moved out of area|5|||
149907578|NCT02487771|540791809|FG001|Overall Study|Moved out of area|6|||
149907579|NCT02487771|540791808|FG000|Overall Study|Withdrawal by Subject|3|||
149907580|NCT02487771|540791809|FG001|Overall Study|Withdrawal by Subject|5|||
149907581|NCT02002533|540791810|FG000|Overall Study|Withdrawal by Subject|6|||
149907582|NCT02002533|540791811|FG001|Overall Study|Withdrawal by Subject|13|||
149907583|NCT02002533|540791810|FG000|Overall Study|Protocol Violation|0|||
149907584|NCT02002533|540791811|FG001|Overall Study|Protocol Violation|1|||
149907585|NCT02002533|540791810|FG000|Overall Study|Adverse Event|0|||
149907586|NCT02002533|540791811|FG001|Overall Study|Adverse Event|3|||
149907587|NCT02002533|540791810|FG000|Overall Study|Lost to Follow-up|0|||
149907588|NCT02002533|540791811|FG001|Overall Study|Lost to Follow-up|1|||
149907589|NCT04598451|540791812|FG000|Overall Study|Adverse Event|3|||
149907590|NCT04598451|540791813|FG001|Overall Study|Adverse Event|2|||
149907591|NCT04598451|540791812|FG000|Overall Study|Withdrawal by Subject|3|||
149907592|NCT04598451|540791813|FG001|Overall Study|Withdrawal by Subject|7|||
149907593|NCT04598451|540791812|FG000|Overall Study|Lost to Follow-up|2|||
149907594|NCT04598451|540791813|FG001|Overall Study|Lost to Follow-up|0|||
149907595|NCT04598451|540791812|FG000|Overall Study|Physician Decision|4|||
149907596|NCT04598451|540791813|FG001|Overall Study|Physician Decision|1|||
149907597|NCT04598451|540791812|FG000|Overall Study|Requires Prohibited Medication|1|||
149907598|NCT04598451|540791813|FG001|Overall Study|Requires Prohibited Medication|0|||
149907599|NCT04598451|540791812|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
149907600|NCT04598451|540791813|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
149907601|NCT01871402|540791823|FG000|Overall Study|Lost to Follow-up|1|||
149907602|NCT01871402|540791824|FG001|Overall Study|Lost to Follow-up|0|||
149907603|NCT01871402|540791823|FG000|Overall Study|Withdrawal by Subject|0|||
149907604|NCT01871402|540791824|FG001|Overall Study|Withdrawal by Subject|2|||
149907605|NCT01871402|540791823|FG000|Overall Study|Non-compliance|0|||
149907606|NCT01871402|540791824|FG001|Overall Study|Non-compliance|1|||
149907607|NCT04594941|540791825|FG000|Overall Study|Other|0|||
149907608|NCT04594941|540791826|FG001|Overall Study|Other|3|||
149907609|NCT04594941|540791827|FG002|Overall Study|Other|1|||
149907610|NCT04594941|540791828|FG003|Overall Study|Other|0|||
149907611|NCT00231114|540791829|FG000|Randomized|Withdrawal by Subject|6|||
149907612|NCT00231114|540791830|FG001|Randomized|Withdrawal by Subject|3|||
149907613|NCT00231114|540791829|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
149907614|NCT00231114|540791830|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
149907615|NCT00231114|540791829|FG000|Post-Treatment Period|Lost to Follow-up|6|||
149907616|NCT00231114|540791830|FG001|Post-Treatment Period|Lost to Follow-up|1|||
149907617|NCT00231114|540791829|FG000|Post-Treatment Period|Physician Decision|1|||
149907618|NCT00231114|540791830|FG001|Post-Treatment Period|Physician Decision|0|||
149907619|NCT00231114|540791829|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
149907620|NCT00231114|540791830|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
149907621|NCT02031640|540791831|FG000|Screening Period|Adverse Event|1|||
149907622|NCT02031640|540791832|FG001|Screening Period|Adverse Event|0|||
149907623|NCT02031640|540791833|FG002|Screening Period|Adverse Event|0|||
149907624|NCT02031640|540791834|FG003|Screening Period|Adverse Event|0|||
149907625|NCT02031640|540791835|FG004|Screening Period|Adverse Event|0|||
149907626|NCT02031640|540791836|FG005|Screening Period|Adverse Event|0|||
149907627|NCT02031640|540791831|FG000|Screening Period|Withdrawal by Subject|29|||
149907628|NCT02031640|540791832|FG001|Screening Period|Withdrawal by Subject|0|||
149907629|NCT02031640|540791833|FG002|Screening Period|Withdrawal by Subject|0|||
149907630|NCT02031640|540791834|FG003|Screening Period|Withdrawal by Subject|0|||
149907631|NCT02031640|540791835|FG004|Screening Period|Withdrawal by Subject|0|||
149907632|NCT02031640|540791836|FG005|Screening Period|Withdrawal by Subject|0|||
149907633|NCT02031640|540791831|FG000|Screening Period|Inclusion criteria not met|312|||
149907634|NCT02031640|540791832|FG001|Screening Period|Inclusion criteria not met|0|||
149907635|NCT02031640|540791833|FG002|Screening Period|Inclusion criteria not met|0|||
149907636|NCT02031640|540791834|FG003|Screening Period|Inclusion criteria not met|0|||
149907637|NCT02031640|540791835|FG004|Screening Period|Inclusion criteria not met|0|||
149907638|NCT02031640|540791836|FG005|Screening Period|Inclusion criteria not met|0|||
149907639|NCT02031640|540791831|FG000|Screening Period|Exclusion criteria met|30|||
149907640|NCT02031640|540791832|FG001|Screening Period|Exclusion criteria met|0|||
149907641|NCT02031640|540791833|FG002|Screening Period|Exclusion criteria met|0|||
149907642|NCT02031640|540791834|FG003|Screening Period|Exclusion criteria met|0|||
149907643|NCT02031640|540791835|FG004|Screening Period|Exclusion criteria met|0|||
149907644|NCT02031640|540791836|FG005|Screening Period|Exclusion criteria met|0|||
149907645|NCT02031640|540791831|FG000|Screening Period|Lost to Follow-up|14|||
149907646|NCT02031640|540791832|FG001|Screening Period|Lost to Follow-up|0|||
149907647|NCT02031640|540791833|FG002|Screening Period|Lost to Follow-up|0|||
149907648|NCT02031640|540791834|FG003|Screening Period|Lost to Follow-up|0|||
149907649|NCT02031640|540791835|FG004|Screening Period|Lost to Follow-up|0|||
149907650|NCT02031640|540791836|FG005|Screening Period|Lost to Follow-up|0|||
149907651|NCT02031640|540791831|FG000|Screening Period|Enrollment closed|26|||
149907652|NCT02031640|540791832|FG001|Screening Period|Enrollment closed|0|||
149907653|NCT02031640|540791833|FG002|Screening Period|Enrollment closed|0|||
149907654|NCT02031640|540791834|FG003|Screening Period|Enrollment closed|0|||
149907655|NCT02031640|540791835|FG004|Screening Period|Enrollment closed|0|||
149907656|NCT02031640|540791836|FG005|Screening Period|Enrollment closed|0|||
149907657|NCT02031640|540791831|FG000|Run-In Period|Adverse Event|4|||
149907658|NCT02031640|540791832|FG001|Run-In Period|Adverse Event|0|||
149907659|NCT02031640|540791833|FG002|Run-In Period|Adverse Event|0|||
149907660|NCT02031640|540791834|FG003|Run-In Period|Adverse Event|0|||
149907661|NCT02031640|540791835|FG004|Run-In Period|Adverse Event|0|||
149907662|NCT02031640|540791836|FG005|Run-In Period|Adverse Event|0|||
149907663|NCT02031640|540791831|FG000|Run-In Period|Withdrawal by Subject|17|||
149907664|NCT02031640|540791832|FG001|Run-In Period|Withdrawal by Subject|0|||
149907665|NCT02031640|540791833|FG002|Run-In Period|Withdrawal by Subject|0|||
149907666|NCT02031640|540791834|FG003|Run-In Period|Withdrawal by Subject|0|||
149907667|NCT02031640|540791835|FG004|Run-In Period|Withdrawal by Subject|0|||
149907668|NCT02031640|540791836|FG005|Run-In Period|Withdrawal by Subject|0|||
149907669|NCT02031640|540791831|FG000|Run-In Period|Inclusion criteria not met|38|||
149907670|NCT02031640|540791832|FG001|Run-In Period|Inclusion criteria not met|0|||
149907671|NCT02031640|540791833|FG002|Run-In Period|Inclusion criteria not met|0|||
149907672|NCT02031640|540791834|FG003|Run-In Period|Inclusion criteria not met|0|||
149907673|NCT02031640|540791835|FG004|Run-In Period|Inclusion criteria not met|0|||
149907674|NCT02031640|540791836|FG005|Run-In Period|Inclusion criteria not met|0|||
149907675|NCT02031640|540791831|FG000|Run-In Period|Exclusion criteria met|8|||
149907676|NCT02031640|540791832|FG001|Run-In Period|Exclusion criteria met|0|||
149907677|NCT02031640|540791833|FG002|Run-In Period|Exclusion criteria met|0|||
149907678|NCT02031640|540791834|FG003|Run-In Period|Exclusion criteria met|0|||
149907679|NCT02031640|540791835|FG004|Run-In Period|Exclusion criteria met|0|||
149907680|NCT02031640|540791836|FG005|Run-In Period|Exclusion criteria met|0|||
149907681|NCT02031640|540791831|FG000|Run-In Period|Randomization criteria not met|85|||
149907682|NCT02031640|540791832|FG001|Run-In Period|Randomization criteria not met|0|||
149907683|NCT02031640|540791833|FG002|Run-In Period|Randomization criteria not met|0|||
149907684|NCT02031640|540791834|FG003|Run-In Period|Randomization criteria not met|0|||
149907685|NCT02031640|540791835|FG004|Run-In Period|Randomization criteria not met|0|||
149907686|NCT02031640|540791836|FG005|Run-In Period|Randomization criteria not met|0|||
149907687|NCT02031640|540791831|FG000|Run-In Period|Various administrative reasons|17|||
149907688|NCT02031640|540791832|FG001|Run-In Period|Various administrative reasons|0|||
149907689|NCT02031640|540791833|FG002|Run-In Period|Various administrative reasons|0|||
149907690|NCT02031640|540791834|FG003|Run-In Period|Various administrative reasons|0|||
149907691|NCT02031640|540791835|FG004|Run-In Period|Various administrative reasons|0|||
149907692|NCT02031640|540791836|FG005|Run-In Period|Various administrative reasons|0|||
149907693|NCT02031640|540791831|FG000|Double-blind Treatment Period|Protocol deviation|0|||
149907694|NCT02031640|540791832|FG001|Double-blind Treatment Period|Protocol deviation|2|||
149907695|NCT02031640|540791833|FG002|Double-blind Treatment Period|Protocol deviation|0|||
149907696|NCT02031640|540791834|FG003|Double-blind Treatment Period|Protocol deviation|1|||
149907697|NCT02031640|540791835|FG004|Double-blind Treatment Period|Protocol deviation|3|||
149907698|NCT02031640|540791836|FG005|Double-blind Treatment Period|Protocol deviation|1|||
149907699|NCT02031640|540791831|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
149907700|NCT02031640|540791832|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
149907701|NCT02031640|540791833|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
149907702|NCT02031640|540791834|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
149907703|NCT02031640|540791835|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
149907704|NCT02031640|540791836|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
149907705|NCT02031640|540791831|FG000|Double-blind Treatment Period|Non-compliance|0|||
149907706|NCT02031640|540791832|FG001|Double-blind Treatment Period|Non-compliance|1|||
149907707|NCT02031640|540791833|FG002|Double-blind Treatment Period|Non-compliance|0|||
149907708|NCT02031640|540791834|FG003|Double-blind Treatment Period|Non-compliance|1|||
149907709|NCT02031640|540791835|FG004|Double-blind Treatment Period|Non-compliance|1|||
149907710|NCT02031640|540791836|FG005|Double-blind Treatment Period|Non-compliance|0|||
149907711|NCT02031640|540791831|FG000|Double-blind Treatment Period|Adverse Event|0|||
149907712|NCT02031640|540791832|FG001|Double-blind Treatment Period|Adverse Event|0|||
149907713|NCT02031640|540791833|FG002|Double-blind Treatment Period|Adverse Event|0|||
149907714|NCT02031640|540791834|FG003|Double-blind Treatment Period|Adverse Event|2|||
149907715|NCT02031640|540791835|FG004|Double-blind Treatment Period|Adverse Event|0|||
149907716|NCT02031640|540791836|FG005|Double-blind Treatment Period|Adverse Event|0|||
149907717|NCT02031640|540791831|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
149907718|NCT02031640|540791832|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149907719|NCT02031640|540791833|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
149907720|NCT02031640|540791834|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
149907721|NCT02031640|540791835|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
149907722|NCT02031640|540791836|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
149907723|NCT02031640|540791831|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149907724|NCT02031640|540791832|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
149907725|NCT02031640|540791833|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
149907726|NCT02031640|540791834|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
149907727|NCT02031640|540791835|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
149907728|NCT02031640|540791836|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
149907729|NCT02005692|540791837|FG000|Overall Study|Protocol Violation|1|||
149907730|NCT02005692|540791837|FG000|Overall Study|Withdrawal by Subject|1|||
149907731|NCT02005692|540791837|FG000|Overall Study|Discharged earlier than anticipated|5|||
149907732|NCT01194999|540791838|FG000|Overall Study|Lost to Follow-up|17|||
149907733|NCT02091375|540791844|FG000|Overall Study|Adverse Event|8|||
149907734|NCT02091375|540791845|FG001|Overall Study|Adverse Event|1|||
149907735|NCT02091375|540791844|FG000|Overall Study|Lost to Follow-up|0|||
149907736|NCT02091375|540791845|FG001|Overall Study|Lost to Follow-up|1|||
149907737|NCT02091375|540791844|FG000|Overall Study|Withdrawal by Subject|0|||
149907738|NCT02091375|540791845|FG001|Overall Study|Withdrawal by Subject|1|||
149907739|NCT02091375|540791844|FG000|Overall Study|Withdrawn by the investigator|1|||
149907740|NCT02091375|540791845|FG001|Overall Study|Withdrawn by the investigator|0|||
149907741|NCT02682823|540791846|FG000|Overall Study|Withdrawal by Subject|0|||
149907742|NCT02682823|540791847|FG001|Overall Study|Withdrawal by Subject|0|||
149907743|NCT02682823|540791848|FG002|Overall Study|Withdrawal by Subject|1|||
149907744|NCT02682823|540791849|FG003|Overall Study|Withdrawal by Subject|0|||
149907745|NCT02682823|540791850|FG004|Overall Study|Withdrawal by Subject|1|||
149907746|NCT02682823|540791846|FG000|Overall Study|Protocol Deviation|0|||
149907747|NCT02682823|540791847|FG001|Overall Study|Protocol Deviation|1|||
149907748|NCT02682823|540791848|FG002|Overall Study|Protocol Deviation|0|||
149907749|NCT02682823|540791849|FG003|Overall Study|Protocol Deviation|0|||
149907750|NCT02682823|540791850|FG004|Overall Study|Protocol Deviation|0|||
149907751|NCT02682823|540791846|FG000|Overall Study|Adverse Event|0|||
149907752|NCT02682823|540791847|FG001|Overall Study|Adverse Event|0|||
149907753|NCT02682823|540791848|FG002|Overall Study|Adverse Event|0|||
149907754|NCT02682823|540791849|FG003|Overall Study|Adverse Event|1|||
149907755|NCT02682823|540791850|FG004|Overall Study|Adverse Event|0|||
149907756|NCT05896527|540791851|FG000|Overall Study|Withdrawal by Subject|11|||
149907757|NCT05896527|540791852|FG001|Overall Study|Withdrawal by Subject|10|||
149907758|NCT05896527|540791853|FG002|Overall Study|Withdrawal by Subject|4|||
149907759|NCT05896527|540791854|FG003|Overall Study|Withdrawal by Subject|3|||
149907760|NCT05896527|540791855|FG004|Overall Study|Withdrawal by Subject|2|||
149907761|NCT05896527|540791851|FG000|Overall Study|Lost to Follow-up|0|||
149907762|NCT05896527|540791852|FG001|Overall Study|Lost to Follow-up|2|||
149907763|NCT05896527|540791853|FG002|Overall Study|Lost to Follow-up|2|||
149907764|NCT05896527|540791854|FG003|Overall Study|Lost to Follow-up|2|||
149907765|NCT05896527|540791855|FG004|Overall Study|Lost to Follow-up|1|||
149907766|NCT05896527|540791851|FG000|Overall Study|Significant protocol noncompliance|0|||
149907767|NCT05896527|540791852|FG001|Overall Study|Significant protocol noncompliance|1|||
149907768|NCT05896527|540791853|FG002|Overall Study|Significant protocol noncompliance|0|||
149907769|NCT05896527|540791854|FG003|Overall Study|Significant protocol noncompliance|0|||
149907770|NCT05896527|540791855|FG004|Overall Study|Significant protocol noncompliance|0|||
149907771|NCT05896527|540791851|FG000|Overall Study|Eligibility criteria not met|1|||
149907772|NCT05896527|540791852|FG001|Overall Study|Eligibility criteria not met|0|||
149907773|NCT05896527|540791853|FG002|Overall Study|Eligibility criteria not met|0|||
149907774|NCT05896527|540791854|FG003|Overall Study|Eligibility criteria not met|0|||
149907775|NCT05896527|540791855|FG004|Overall Study|Eligibility criteria not met|0|||
149907776|NCT05896527|540791851|FG000|Overall Study|Sponsor's decision|0|||
149907777|NCT05896527|540791852|FG001|Overall Study|Sponsor's decision|0|||
149907778|NCT05896527|540791853|FG002|Overall Study|Sponsor's decision|0|||
149907779|NCT05896527|540791854|FG003|Overall Study|Sponsor's decision|1|||
149907780|NCT05896527|540791855|FG004|Overall Study|Sponsor's decision|0|||
149907781|NCT05896527|540791851|FG000|Overall Study|Investigator's decision|0|||
149907782|NCT05896527|540791852|FG001|Overall Study|Investigator's decision|1|||
149907783|NCT05896527|540791853|FG002|Overall Study|Investigator's decision|0|||
149907784|NCT05896527|540791854|FG003|Overall Study|Investigator's decision|0|||
149907785|NCT05896527|540791855|FG004|Overall Study|Investigator's decision|0|||
149907786|NCT05896527|540791851|FG000|Overall Study|Pregnancy of his partner|0|||
149907787|NCT05896527|540791852|FG001|Overall Study|Pregnancy of his partner|0|||
149907788|NCT05896527|540791853|FG002|Overall Study|Pregnancy of his partner|0|||
149907789|NCT05896527|540791854|FG003|Overall Study|Pregnancy of his partner|1|||
149907790|NCT05896527|540791855|FG004|Overall Study|Pregnancy of his partner|0|||
149907791|NCT03085238|540791856|FG000|Overall Study|Adverse Event|2|||
149907792|NCT03085238|540791856|FG000|Overall Study|Death|2|||
149907793|NCT01279070|540791857|FG000|Overall Study|Withdrawal by Subject|2|||
149907794|NCT01279070|540791858|FG001|Overall Study|Withdrawal by Subject|3|||
149907795|NCT01279070|540791857|FG000|Overall Study|Acute exacerbation|3|||
149907796|NCT01279070|540791858|FG001|Overall Study|Acute exacerbation|1|||
149907797|NCT03261674|540791859|FG000|Overall Study|Lost to Follow-up|6|||
149907798|NCT03261674|540791860|FG001|Overall Study|Lost to Follow-up|7|||
149907799|NCT03261674|540791859|FG000|Overall Study|Protocol Violation|1|||
149907800|NCT03261674|540791860|FG001|Overall Study|Protocol Violation|4|||
149907801|NCT03261674|540791859|FG000|Overall Study|Withdrawal by Subject|1|||
149907802|NCT03261674|540791860|FG001|Overall Study|Withdrawal by Subject|4|||
149907803|NCT03261674|540791859|FG000|Overall Study|Physician Decision|1|||
149907804|NCT03261674|540791860|FG001|Overall Study|Physician Decision|0|||
149907805|NCT00623935|540791863|FG000|Overall Study|Death|1|||
149907806|NCT00623935|540791863|FG000|Overall Study|Patient Declined Transplant|1|||
149907807|NCT00782184|540791864|FG000|Overall Study|Adverse Event|1|||
149907808|NCT00782184|540791865|FG001|Overall Study|Adverse Event|2|||
149907809|NCT00782184|540791864|FG000|Overall Study|Protocol Violation|0|||
149907810|NCT00782184|540791865|FG001|Overall Study|Protocol Violation|1|||
149907811|NCT00782184|540791864|FG000|Overall Study|Withdrawal by Subject|3|||
149907812|NCT00782184|540791865|FG001|Overall Study|Withdrawal by Subject|2|||
149907813|NCT01154088|540791869|FG000|Overall Study|Lost to Follow-up|4|||
149907814|NCT01154088|540791870|FG001|Overall Study|Lost to Follow-up|6|||
149907815|NCT01154088|540791871|FG002|Overall Study|Lost to Follow-up|7|||
149907816|NCT05129137|540791874|FG000|Second Period|Adverse Event|1|||
149907817|NCT05129137|540791875|FG001|Second Period|Adverse Event|0|||
149907818|NCT05129137|540791876|FG002|Second Period|Adverse Event|0|||
149907819|NCT05129137|540791877|FG003|Second Period|Adverse Event|0|||
149907820|NCT05129137|540791874|FG000|Second Period|Protocol Violation|0|||
149907821|NCT05129137|540791875|FG001|Second Period|Protocol Violation|0|||
149907822|NCT05129137|540791876|FG002|Second Period|Protocol Violation|0|||
149907823|NCT05129137|540791877|FG003|Second Period|Protocol Violation|1|||
149907824|NCT05129137|540791874|FG000|Third Period|Protocol Violation|0|||
149907825|NCT05129137|540791875|FG001|Third Period|Protocol Violation|0|||
149907826|NCT05129137|540791876|FG002|Third Period|Protocol Violation|0|||
149907827|NCT05129137|540791877|FG003|Third Period|Protocol Violation|1|||
149907828|NCT05129137|540791874|FG000|Forth Period|Protocol Violation|0|||
149907829|NCT05129137|540791875|FG001|Forth Period|Protocol Violation|1|||
149907830|NCT05129137|540791876|FG002|Forth Period|Protocol Violation|0|||
149907831|NCT05129137|540791877|FG003|Forth Period|Protocol Violation|0|||
149907832|NCT05129137|540791874|FG000|Forth Period|Withdrawal by Subject|0|||
149907833|NCT05129137|540791875|FG001|Forth Period|Withdrawal by Subject|0|||
149907834|NCT05129137|540791876|FG002|Forth Period|Withdrawal by Subject|1|||
149907835|NCT05129137|540791877|FG003|Forth Period|Withdrawal by Subject|0|||
149907836|NCT01084668|540791878|FG000|Overall Study|Lack of Efficacy|5|||
149907837|NCT01084668|540791878|FG000|Overall Study|Withdrawal by Subject|2|||
149907838|NCT01084668|540791878|FG000|Overall Study|Pregnancy|1|||
149907839|NCT01084668|540791878|FG000|Overall Study|Non-compliance|1|||
149907840|NCT01869699|540791880|FG000|Overall Study|Withdrawal by Subject|1|||
149907841|NCT01869699|540791881|FG001|Overall Study|Withdrawal by Subject|0|||
149907842|NCT01475851|540791884|FG000|Overall Study|Protocol defined stopping criteria|1|||
149907843|NCT01475851|540791885|FG001|Overall Study|Protocol defined stopping criteria|0|||
149907844|NCT02447497|540791888|FG000|Overall Study|Did not meet treatment day baseline.|6|||
149907845|NCT02447497|540791889|FG001|Overall Study|Did not meet treatment day baseline.|5|||
149907846|NCT02447497|540791890|FG002|Overall Study|Did not meet treatment day baseline.|2|||
149907847|NCT02447497|540791891|FG003|Overall Study|Did not meet treatment day baseline.|2|||
149907848|NCT02447497|540791888|FG000|Overall Study|Dressing was compromised|0|||
149907849|NCT02447497|540791889|FG001|Overall Study|Dressing was compromised|1|||
149907850|NCT02447497|540791890|FG002|Overall Study|Dressing was compromised|0|||
149907851|NCT02447497|540791891|FG003|Overall Study|Dressing was compromised|0|||
149907852|NCT01552915|540791892|FG000|Overall Study|Adverse Event|3|||
149907853|NCT01552915|540791893|FG001|Overall Study|Adverse Event|14|||
149907854|NCT01552915|540791894|FG002|Overall Study|Adverse Event|3|||
149907855|NCT01552915|540791892|FG000|Overall Study|Lost to Follow-up|4|||
149907856|NCT01552915|540791893|FG001|Overall Study|Lost to Follow-up|6|||
149907857|NCT01552915|540791894|FG002|Overall Study|Lost to Follow-up|5|||
149907858|NCT01552915|540791892|FG000|Overall Study|Withdrawal by Subject|6|||
149907859|NCT01552915|540791893|FG001|Overall Study|Withdrawal by Subject|4|||
149907860|NCT01552915|540791894|FG002|Overall Study|Withdrawal by Subject|5|||
149907861|NCT01552915|540791892|FG000|Overall Study|Protocol Violation|0|||
149971383|NCT01143402|541031829|FG002|Overall Study|Rapid clinical decline|0|||
149907862|NCT01552915|540791893|FG001|Overall Study|Protocol Violation|4|||
149907863|NCT01552915|540791894|FG002|Overall Study|Protocol Violation|4|||
149907864|NCT01552915|540791892|FG000|Overall Study|Lack of Efficacy|8|||
149907865|NCT01552915|540791893|FG001|Overall Study|Lack of Efficacy|1|||
149907866|NCT01552915|540791894|FG002|Overall Study|Lack of Efficacy|4|||
149907867|NCT01552915|540791892|FG000|Overall Study|Other|2|||
149907868|NCT01552915|540791893|FG001|Overall Study|Other|0|||
149971384|NCT01143402|541031827|FG000|Overall Study|Not Treated|0|||
149907869|NCT01552915|540791894|FG002|Overall Study|Other|6|||
149907870|NCT04240457|540791898|FG000|Overall Study|Lost to Follow-up|5|||
149907871|NCT04240457|540791899|FG001|Overall Study|Lost to Follow-up|1|||
149907872|NCT02858180|540791900|FG000|Overall Study|Lost to Follow-up|0|||
149907873|NCT02858180|540791901|FG001|Overall Study|Lost to Follow-up|2|||
149907874|NCT00844480|540791902|FG000|Overall Study|Withdrawal by Subject|2|||
149907875|NCT00844480|540791903|FG001|Overall Study|Withdrawal by Subject|3|||
149907876|NCT00979420|540791904|FG000|Overall Study|Adverse Event|1|||
149907877|NCT00979420|540791905|FG001|Overall Study|Adverse Event|0|||
149971385|NCT01143402|541031828|FG001|Overall Study|Not Treated|0|||
149907878|NCT00979420|540791906|FG002|Overall Study|Adverse Event|0|||
149907879|NCT00979420|540791907|FG003|Overall Study|Adverse Event|0|||
149907880|NCT00979420|540791904|FG000|Overall Study|Lack of Efficacy|3|||
149971386|NCT01143402|541031829|FG002|Overall Study|Not Treated|1|||
149971387|NCT01959932|541031833|FG000|Overall Study|Withdrawal by Subject|1|||
149971388|NCT01959932|541031834|FG001|Overall Study|Withdrawal by Subject|0|||
149907881|NCT00979420|540791905|FG001|Overall Study|Lack of Efficacy|0|||
149907882|NCT00979420|540791906|FG002|Overall Study|Lack of Efficacy|1|||
149971389|NCT01959932|541031835|FG002|Overall Study|Withdrawal by Subject|0|||
149907883|NCT00979420|540791907|FG003|Overall Study|Lack of Efficacy|1|||
149907884|NCT00979420|540791904|FG000|Overall Study|Other reasons not related to Viramune|3|||
149907885|NCT00979420|540791905|FG001|Overall Study|Other reasons not related to Viramune|0|||
149907886|NCT00979420|540791906|FG002|Overall Study|Other reasons not related to Viramune|0|||
149907887|NCT00979420|540791907|FG003|Overall Study|Other reasons not related to Viramune|1|||
149907888|NCT01054196|540791909|FG000|Overall Study|Physician Decision|0|||
149907889|NCT01054196|540791910|FG001|Overall Study|Physician Decision|0|||
149907890|NCT01054196|540791911|FG002|Overall Study|Physician Decision|0|||
149907891|NCT01054196|540791912|FG003|Overall Study|Physician Decision|1|||
149907892|NCT01054196|540791913|FG004|Overall Study|Physician Decision|0|||
149907893|NCT01054196|540791914|FG005|Overall Study|Physician Decision|0|||
149907894|NCT01054196|540791915|FG006|Overall Study|Physician Decision|1|||
149907895|NCT01295827|540791916|FG000|Overall Study|Adverse Event|1|||
149907896|NCT01295827|540791917|FG001|Overall Study|Adverse Event|2|||
149907897|NCT01295827|540791918|FG002|Overall Study|Adverse Event|2|||
149907898|NCT01295827|540791919|FG003|Overall Study|Adverse Event|1|||
149907899|NCT01295827|540791920|FG004|Overall Study|Adverse Event|1|||
149907900|NCT01295827|540791921|FG005|Overall Study|Adverse Event|4|||
149907901|NCT01295827|540791922|FG006|Overall Study|Adverse Event|15|||
149907902|NCT01295827|540791923|FG007|Overall Study|Adverse Event|49|||
149907903|NCT01295827|540791924|FG008|Overall Study|Adverse Event|22|||
149907904|NCT01295827|540791925|FG009|Overall Study|Adverse Event|7|||
149907905|NCT01295827|540791926|FG010|Overall Study|Adverse Event|50|||
149907906|NCT01295827|540791927|FG011|Overall Study|Adverse Event|21|||
149907907|NCT01295827|540791928|FG012|Overall Study|Adverse Event|0|||
149907908|NCT01295827|540791929|FG013|Overall Study|Adverse Event|0|||
149907909|NCT01295827|540791930|FG014|Overall Study|Adverse Event|0|||
149907910|NCT01295827|540791916|FG000|Overall Study|Lost to Follow-up|0|||
149907911|NCT01295827|540791917|FG001|Overall Study|Lost to Follow-up|0|||
149907912|NCT01295827|540791918|FG002|Overall Study|Lost to Follow-up|3|||
149907913|NCT01295827|540791919|FG003|Overall Study|Lost to Follow-up|0|||
149907914|NCT01295827|540791920|FG004|Overall Study|Lost to Follow-up|1|||
149907915|NCT01295827|540791921|FG005|Overall Study|Lost to Follow-up|0|||
149907916|NCT01295827|540791922|FG006|Overall Study|Lost to Follow-up|4|||
149907917|NCT01295827|540791923|FG007|Overall Study|Lost to Follow-up|8|||
149907918|NCT01295827|540791924|FG008|Overall Study|Lost to Follow-up|7|||
149907919|NCT01295827|540791925|FG009|Overall Study|Lost to Follow-up|4|||
149907920|NCT01295827|540791926|FG010|Overall Study|Lost to Follow-up|7|||
149907921|NCT01295827|540791927|FG011|Overall Study|Lost to Follow-up|3|||
149907922|NCT01295827|540791928|FG012|Overall Study|Lost to Follow-up|0|||
149907923|NCT01295827|540791929|FG013|Overall Study|Lost to Follow-up|0|||
149907924|NCT01295827|540791930|FG014|Overall Study|Lost to Follow-up|0|||
149907925|NCT01295827|540791916|FG000|Overall Study|Not Reported|0|||
149907926|NCT01295827|540791917|FG001|Overall Study|Not Reported|0|||
149907927|NCT01295827|540791918|FG002|Overall Study|Not Reported|0|||
149971390|NCT00397540|541031836|FG000|Overall Study|short follow-up duration < 12 months|1|||
149971391|NCT00397540|541031837|FG001|Overall Study|short follow-up duration < 12 months|0|||
149971392|NCT01656161|541031838|FG000|Overall Study|Death|3|||
149971393|NCT01656161|541031838|FG000|Overall Study|Adverse Event|2|||
149971394|NCT01656161|541031838|FG000|Overall Study|Protocol Violation|1|||
149971395|NCT01656161|541031838|FG000|Overall Study|Withdrawal by Subject|1|||
149907928|NCT01295827|540791919|FG003|Overall Study|Not Reported|1|||
149907929|NCT01295827|540791920|FG004|Overall Study|Not Reported|0|||
149907930|NCT01295827|540791921|FG005|Overall Study|Not Reported|0|||
149907931|NCT01295827|540791922|FG006|Overall Study|Not Reported|24|||
149907932|NCT01295827|540791923|FG007|Overall Study|Not Reported|58|||
149907933|NCT01295827|540791924|FG008|Overall Study|Not Reported|41|||
149907934|NCT01295827|540791925|FG009|Overall Study|Not Reported|2|||
149907935|NCT01295827|540791926|FG010|Overall Study|Not Reported|23|||
149971396|NCT00776230|541031841|FG000|Overall Study|Lost to Follow-up|2|||
149907936|NCT01295827|540791927|FG011|Overall Study|Not Reported|13|||
149907937|NCT01295827|540791928|FG012|Overall Study|Not Reported|0|||
149907938|NCT01295827|540791929|FG013|Overall Study|Not Reported|0|||
149907939|NCT01295827|540791930|FG014|Overall Study|Not Reported|0|||
149907940|NCT01295827|540791916|FG000|Overall Study|Progressive Disease|2|||
149907941|NCT01295827|540791917|FG001|Overall Study|Progressive Disease|1|||
149907942|NCT01295827|540791918|FG002|Overall Study|Progressive Disease|5|||
149907943|NCT01295827|540791919|FG003|Overall Study|Progressive Disease|2|||
149907944|NCT01295827|540791920|FG004|Overall Study|Progressive Disease|0|||
149907945|NCT01295827|540791921|FG005|Overall Study|Progressive Disease|1|||
149907946|NCT01295827|540791922|FG006|Overall Study|Progressive Disease|87|||
149971397|NCT00776230|541031842|FG001|Overall Study|Lost to Follow-up|1|||
149907947|NCT01295827|540791923|FG007|Overall Study|Progressive Disease|144|||
149907948|NCT01295827|540791924|FG008|Overall Study|Progressive Disease|85|||
149907949|NCT01295827|540791925|FG009|Overall Study|Progressive Disease|40|||
149907950|NCT01295827|540791926|FG010|Overall Study|Progressive Disease|175|||
149907951|NCT01295827|540791927|FG011|Overall Study|Progressive Disease|136|||
149907952|NCT01295827|540791928|FG012|Overall Study|Progressive Disease|0|||
149907953|NCT01295827|540791929|FG013|Overall Study|Progressive Disease|0|||
149907954|NCT01295827|540791930|FG014|Overall Study|Progressive Disease|0|||
149907955|NCT01295827|540791916|FG000|Overall Study|Screen Failure|0|||
149907956|NCT01295827|540791917|FG001|Overall Study|Screen Failure|0|||
149907957|NCT01295827|540791918|FG002|Overall Study|Screen Failure|0|||
149907958|NCT01295827|540791919|FG003|Overall Study|Screen Failure|0|||
149907959|NCT01295827|540791920|FG004|Overall Study|Screen Failure|0|||
149907960|NCT01295827|540791921|FG005|Overall Study|Screen Failure|0|||
149907961|NCT01295827|540791922|FG006|Overall Study|Screen Failure|2|||
149907962|NCT01295827|540791923|FG007|Overall Study|Screen Failure|2|||
149907963|NCT01295827|540791924|FG008|Overall Study|Screen Failure|2|||
149907964|NCT01295827|540791925|FG009|Overall Study|Screen Failure|0|||
149907965|NCT01295827|540791926|FG010|Overall Study|Screen Failure|1|||
149907966|NCT01295827|540791927|FG011|Overall Study|Screen Failure|0|||
149907967|NCT01295827|540791928|FG012|Overall Study|Screen Failure|0|||
149907968|NCT01295827|540791929|FG013|Overall Study|Screen Failure|0|||
149907969|NCT01295827|540791930|FG014|Overall Study|Screen Failure|0|||
149907970|NCT01295827|540791916|FG000|Overall Study|Withdrawal by Subject|1|||
149907971|NCT01295827|540791917|FG001|Overall Study|Withdrawal by Subject|0|||
149907972|NCT01295827|540791918|FG002|Overall Study|Withdrawal by Subject|2|||
149907973|NCT01295827|540791919|FG003|Overall Study|Withdrawal by Subject|0|||
149907974|NCT01295827|540791920|FG004|Overall Study|Withdrawal by Subject|0|||
149907975|NCT01295827|540791921|FG005|Overall Study|Withdrawal by Subject|1|||
149907976|NCT01295827|540791922|FG006|Overall Study|Withdrawal by Subject|13|||
149907977|NCT01295827|540791923|FG007|Overall Study|Withdrawal by Subject|35|||
149907978|NCT01295827|540791924|FG008|Overall Study|Withdrawal by Subject|11|||
149907979|NCT01295827|540791925|FG009|Overall Study|Withdrawal by Subject|2|||
149907980|NCT01295827|540791926|FG010|Overall Study|Withdrawal by Subject|18|||
149907981|NCT01295827|540791927|FG011|Overall Study|Withdrawal by Subject|13|||
149907982|NCT01295827|540791928|FG012|Overall Study|Withdrawal by Subject|0|||
149907983|NCT01295827|540791929|FG013|Overall Study|Withdrawal by Subject|0|||
149907984|NCT01295827|540791930|FG014|Overall Study|Withdrawal by Subject|0|||
149907985|NCT01295827|540791916|FG000|Overall Study|Other|0|||
149907986|NCT01295827|540791917|FG001|Overall Study|Other|0|||
149907987|NCT01295827|540791918|FG002|Overall Study|Other|0|||
149907988|NCT01295827|540791919|FG003|Overall Study|Other|0|||
149907989|NCT01295827|540791920|FG004|Overall Study|Other|0|||
149907990|NCT01295827|540791921|FG005|Overall Study|Other|0|||
149907991|NCT01295827|540791922|FG006|Overall Study|Other|1|||
149907992|NCT01295827|540791923|FG007|Overall Study|Other|1|||
149907993|NCT01295827|540791924|FG008|Overall Study|Other|1|||
149907994|NCT01295827|540791925|FG009|Overall Study|Other|0|||
149907995|NCT01295827|540791926|FG010|Overall Study|Other|2|||
149907996|NCT01295827|540791927|FG011|Overall Study|Other|0|||
149907997|NCT01295827|540791928|FG012|Overall Study|Other|0|||
149907998|NCT01295827|540791929|FG013|Overall Study|Other|0|||
149907999|NCT01295827|540791930|FG014|Overall Study|Other|0|||
149908000|NCT01668173|540791931|FG000|Overall Study|Adverse Event|3|||
149908001|NCT01668173|540791931|FG000|Overall Study|Trial suspension|4|||
149908002|NCT02778074|540791938|FG000|Overall Study|Lost to Follow-up|7|||
149908003|NCT02778074|540791939|FG001|Overall Study|Lost to Follow-up|10|||
149908004|NCT02396420|540791942|FG000|Overall Study|Death|1|||
149908005|NCT01273623|540791945|FG000|Overall Study|did not meet IVUS criteria|29|||
149908006|NCT01493284|540791948|FG000|Overall Study|Death|29|||
149908007|NCT01493284|540791948|FG000|Overall Study|Withdrawal by Subject|32|||
149908008|NCT03489707|540791949|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
149908009|NCT03489707|540791950|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
149908010|NCT03489707|540791949|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
149908011|NCT03489707|540791950|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
149908012|NCT00325156|540791951|FG000|Overall Study|Protocol Violation|8|||
149908013|NCT00325156|540791951|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
149908014|NCT00325156|540791951|FG000|Overall Study|Migrated/moved from study area|12|||
149908015|NCT00325156|540791951|FG000|Overall Study|Adverse event, non-fatal|3|||
149908016|NCT00325156|540791951|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
149908017|NCT00325156|540791951|FG000|Overall Study|Other|1|||
149908018|NCT00325156|540791951|FG000|Overall Study|Withdrawal by Subject|31|||
149908019|NCT04064411|540791952|FG000|Overall Study|Adverse Event|29|||
149908020|NCT04064411|540791953|FG001|Overall Study|Adverse Event|19|||
149908021|NCT04064411|540791952|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
149908022|NCT04064411|540791953|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
149908023|NCT04064411|540791952|FG000|Overall Study|Protocol Deviation|0|||
149908024|NCT04064411|540791953|FG001|Overall Study|Protocol Deviation|2|||
149908025|NCT04064411|540791952|FG000|Overall Study|Withdrawal by Subject|25|||
149908026|NCT04064411|540791953|FG001|Overall Study|Withdrawal by Subject|29|||
149908027|NCT04064411|540791952|FG000|Overall Study|Lost to Follow-up|5|||
149908028|NCT04064411|540791953|FG001|Overall Study|Lost to Follow-up|2|||
149908029|NCT04064411|540791952|FG000|Overall Study|Other than Specified|4|||
149908030|NCT04064411|540791953|FG001|Overall Study|Other than Specified|1|||
149908031|NCT04064411|540791952|FG000|Overall Study|Death|1|||
149908032|NCT04064411|540791953|FG001|Overall Study|Death|0|||
149908033|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
149908034|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
149908035|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
149908036|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
149908037|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
149908038|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
149908039|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
149908040|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
149908041|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
149908042|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
149908043|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
149908044|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
149908045|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
149908046|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
149908047|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
149908048|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
149908049|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149908050|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149908051|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149908052|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149908053|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149908054|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149908055|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
149908056|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149971398|NCT00776230|541031843|FG002|Overall Study|Lost to Follow-up|5|||
149971399|NCT00776230|541031841|FG000|Overall Study|Not vaccinated at Day 0|1|||
149971400|NCT00776230|541031842|FG001|Overall Study|Not vaccinated at Day 0|0|||
149971401|NCT00776230|541031843|FG002|Overall Study|Not vaccinated at Day 0|0|||
149971402|NCT00776230|541031841|FG000|Overall Study|Withdrawal by Subject|0|||
149971403|NCT00776230|541031842|FG001|Overall Study|Withdrawal by Subject|1|||
149971404|NCT00776230|541031843|FG002|Overall Study|Withdrawal by Subject|0|||
149971405|NCT00776230|541031841|FG000|Overall Study|Subject missed Visit 4|0|||
149971406|NCT00776230|541031842|FG001|Overall Study|Subject missed Visit 4|1|||
149971407|NCT00776230|541031843|FG002|Overall Study|Subject missed Visit 4|0|||
149971408|NCT01215851|541031844|FG000|Treatment Period|Adverse Event|1|||
149971409|NCT01215851|541031845|FG001|Treatment Period|Adverse Event|1|||
149971410|NCT01215851|541031846|FG002|Treatment Period|Adverse Event|1|||
149971411|NCT01215851|541031847|FG003|Treatment Period|Adverse Event|3|||
149971412|NCT01215851|541031848|FG004|Treatment Period|Adverse Event|0|||
149971413|NCT01215851|541031849|FG005|Treatment Period|Adverse Event|1|||
149971414|NCT01215851|541031844|FG000|Follow up Period|Lost to Follow-up|0|||
149971415|NCT01215851|541031845|FG001|Follow up Period|Lost to Follow-up|0|||
149971416|NCT01215851|541031846|FG002|Follow up Period|Lost to Follow-up|0|||
149971417|NCT01215851|541031847|FG003|Follow up Period|Lost to Follow-up|0|||
149971418|NCT01215851|541031848|FG004|Follow up Period|Lost to Follow-up|0|||
149971419|NCT01215851|541031849|FG005|Follow up Period|Lost to Follow-up|1|||
149971420|NCT03510273|541031850|FG000|Overall Study|Withdrawal by Subject|2|||
149971421|NCT03510273|541031850|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
149971422|NCT03510273|541031850|FG000|Overall Study|Moved away from study area|4|||
149971423|NCT02589938|541031853|FG000|Overall Study|Withdrawal by Subject|11|||
149971424|NCT02589938|541031854|FG001|Overall Study|Withdrawal by Subject|5|||
149971425|NCT02589938|541031855|FG002|Overall Study|Withdrawal by Subject|6|||
149971426|NCT02589938|541031853|FG000|Overall Study|Lost to Follow-up|3|||
149908057|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149971427|NCT02589938|541031854|FG001|Overall Study|Lost to Follow-up|3|||
149971428|NCT02589938|541031855|FG002|Overall Study|Lost to Follow-up|3|||
149971429|NCT02589938|541031853|FG000|Overall Study|Death|1|||
149971430|NCT02589938|541031854|FG001|Overall Study|Death|0|||
149971431|NCT02589938|541031855|FG002|Overall Study|Death|1|||
149971432|NCT02589938|541031853|FG000|Overall Study|Protocol Violation|6|||
149971433|NCT02589938|541031854|FG001|Overall Study|Protocol Violation|2|||
149971434|NCT02589938|541031855|FG002|Overall Study|Protocol Violation|3|||
149971435|NCT02589938|541031853|FG000|Overall Study|Physician Decision|1|||
149908058|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149908059|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149908060|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
149908061|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
149908062|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149908063|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
149908064|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149908065|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149908066|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149908067|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149908068|NCT03395184|540791954|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
149908069|NCT03395184|540791955|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
149908070|NCT03395184|540791956|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
149908071|NCT03395184|540791957|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
149908072|NCT03395184|540791958|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
149908073|NCT03395184|540791959|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
150048727|NCT01297491|541319426|FG000|Overall Study|Patient/Guardian decision|3|||
150048728|NCT01297491|541319427|FG001|Overall Study|Patient/Guardian decision|4|||
150048729|NCT01297491|541319426|FG000|Overall Study|Death|2|||
150048730|NCT01297491|541319427|FG001|Overall Study|Death|1|||
150048731|NCT00312195|541319430|FG000|Overall Study|Adverse Event|4|||
150048732|NCT00312195|541319431|FG001|Overall Study|Adverse Event|6|||
150048733|NCT00312195|541319430|FG000|Overall Study|Lost to Follow-up|1|||
150048734|NCT00312195|541319431|FG001|Overall Study|Lost to Follow-up|0|||
150048735|NCT00312195|541319430|FG000|Overall Study|Protocol Violation|1|||
150048736|NCT00312195|541319431|FG001|Overall Study|Protocol Violation|0|||
150048737|NCT00324961|541319432|FG000|Overall Study|Adverse Event|5|||
150048738|NCT00324961|541319432|FG000|Overall Study|Consent Withdrawn|11|||
150048739|NCT00324961|541319432|FG000|Overall Study|Lost to Follow-up|22|||
150048740|NCT00324961|541319432|FG000|Overall Study|Protocol Violation|3|||
150048741|NCT00324961|541319432|FG000|Overall Study|Other|2|||
150048742|NCT00344487|541319433|FG000|Overall Study|immunologic failure|1|||
150048743|NCT02791763|541319437|FG000|Overall Study|Protocol Violation|0|||
150048744|NCT02791763|541319438|FG001|Overall Study|Protocol Violation|0|||
150048745|NCT02791763|541319439|FG002|Overall Study|Protocol Violation|1|||
150048746|NCT02791763|541319437|FG000|Overall Study|Withdrawal by Subject|5|||
150048747|NCT02791763|541319438|FG001|Overall Study|Withdrawal by Subject|1|||
150048748|NCT02791763|541319439|FG002|Overall Study|Withdrawal by Subject|0|||
150048749|NCT02791763|541319437|FG000|Overall Study|Physician Decision|0|||
150048750|NCT02791763|541319438|FG001|Overall Study|Physician Decision|1|||
150048751|NCT02791763|541319439|FG002|Overall Study|Physician Decision|0|||
150048752|NCT02791763|541319437|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
150048753|NCT02791763|541319438|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
150048754|NCT02791763|541319439|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
150048755|NCT02791763|541319437|FG000|Overall Study|Cancer event|1|||
150048756|NCT02791763|541319438|FG001|Overall Study|Cancer event|3|||
150048757|NCT02791763|541319439|FG002|Overall Study|Cancer event|0|||
150048758|NCT02791763|541319437|FG000|Overall Study|Participant had renal transplant|3|||
150048759|NCT02791763|541319438|FG001|Overall Study|Participant had renal transplant|0|||
150048760|NCT02791763|541319439|FG002|Overall Study|Participant had renal transplant|0|||
150048761|NCT02791763|541319437|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
150048762|NCT02791763|541319438|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
150048763|NCT02791763|541319439|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
150048764|NCT02791763|541319437|FG000|Overall Study|Adverse Event|12|||
150048765|NCT02791763|541319438|FG001|Overall Study|Adverse Event|13|||
150048766|NCT02791763|541319439|FG002|Overall Study|Adverse Event|7|||
150048767|NCT01456897|541319442|FG000|Overall Study|Adverse Event|19|||
150048768|NCT01456897|541319443|FG001|Overall Study|Adverse Event|22|||
150048769|NCT01456897|541319442|FG000|Overall Study|Protocol Violation|3|||
150048770|NCT01456897|541319443|FG001|Overall Study|Protocol Violation|4|||
150048771|NCT01456897|541319442|FG000|Overall Study|Physician Decision|5|||
150048772|NCT01456897|541319443|FG001|Overall Study|Physician Decision|3|||
150176753|NCT02674750|541783409|FG001|Overall Study|Withdrawal by Subject|7|||
150176754|NCT02674750|541783410|FG002|Overall Study|Withdrawal by Subject|1|||
150048773|NCT01456897|541319442|FG000|Overall Study|Withdrawal by Subject|44|||
150048774|NCT01456897|541319443|FG001|Overall Study|Withdrawal by Subject|17|||
150048775|NCT01456897|541319442|FG000|Overall Study|Lack of Efficacy|4|||
150048776|NCT01456897|541319443|FG001|Overall Study|Lack of Efficacy|11|||
150048777|NCT01396070|541319445|FG000|Overall Study|Withdrawal by Subject|2|||
150048778|NCT01396070|541319445|FG000|Overall Study|Death|2|||
150048779|NCT01396070|541319445|FG000|Overall Study|Adverse Event|8|||
150048780|NCT01396070|541319445|FG000|Overall Study|Physician Decision|3|||
150048781|NCT01396070|541319445|FG000|Overall Study|Lack of Efficacy|4|||
150048782|NCT04254913|541319446|FG000|Overall Study|Adverse Event|1|||
150048783|NCT01396057|541319447|FG000|Overall Study|Adverse Event|2|||
149908074|NCT03395184|540791960|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
149908075|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
149908076|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
149908077|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
149908078|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
149908079|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
149908080|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
149908081|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
149908082|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
149908083|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
149908084|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
149908085|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
149908086|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
149908087|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
149908088|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
149908089|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908090|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908091|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908092|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908093|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
149908094|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908095|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
149908096|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
149908097|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
149908098|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
149908099|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
149908100|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
149908101|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
149908102|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
149908103|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
149908104|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
149908105|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
149908106|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
149908107|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
149908108|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
149908109|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
149908110|NCT03395184|540791954|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
149908111|NCT03395184|540791955|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
149908112|NCT03395184|540791956|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
149908113|NCT03395184|540791957|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
149908114|NCT03395184|540791958|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
149908115|NCT03395184|540791959|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
149908116|NCT03395184|540791960|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
149908117|NCT03053063|540791961|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
149908118|NCT03053063|540791962|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
149908119|NCT03053063|540791963|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
149908120|NCT03053063|540791964|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
149908121|NCT03053063|540791961|FG000|Randomized Phase|Withdrew consent|8|||
149908122|NCT03053063|540791962|FG001|Randomized Phase|Withdrew consent|11|||
149908123|NCT03053063|540791963|FG002|Randomized Phase|Withdrew consent|5|||
149908124|NCT03053063|540791964|FG003|Randomized Phase|Withdrew consent|0|||
149908125|NCT03053063|540791961|FG000|Randomized Phase|Investigator's Discretion|8|||
149971436|NCT02589938|541031854|FG001|Overall Study|Physician Decision|0|||
149971437|NCT02589938|541031855|FG002|Overall Study|Physician Decision|0|||
149971438|NCT02589938|541031853|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
150048784|NCT01396057|541319448|FG001|Overall Study|Adverse Event|6|||
149908126|NCT03053063|540791962|FG001|Randomized Phase|Investigator's Discretion|6|||
149908127|NCT03053063|540791963|FG002|Randomized Phase|Investigator's Discretion|2|||
149908128|NCT03053063|540791964|FG003|Randomized Phase|Investigator's Discretion|0|||
149908129|NCT03053063|540791961|FG000|Randomized Phase|Lost to Follow-up|3|||
149971439|NCT02589938|541031854|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
149908130|NCT03053063|540791962|FG001|Randomized Phase|Lost to Follow-up|5|||
149908131|NCT03053063|540791963|FG002|Randomized Phase|Lost to Follow-up|1|||
149908132|NCT03053063|540791964|FG003|Randomized Phase|Lost to Follow-up|0|||
149908133|NCT03053063|540791961|FG000|Randomized Phase|Adverse Event|0|||
149908134|NCT03053063|540791962|FG001|Randomized Phase|Adverse Event|1|||
149908135|NCT03053063|540791963|FG002|Randomized Phase|Adverse Event|0|||
149908136|NCT03053063|540791964|FG003|Randomized Phase|Adverse Event|0|||
149908137|NCT03053063|540791961|FG000|Randomized Phase|Randomized but Never Treated|1|||
149908138|NCT03053063|540791962|FG001|Randomized Phase|Randomized but Never Treated|3|||
149908139|NCT03053063|540791963|FG002|Randomized Phase|Randomized but Never Treated|2|||
149908140|NCT03053063|540791964|FG003|Randomized Phase|Randomized but Never Treated|0|||
149908141|NCT03053063|540791961|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
149908142|NCT03053063|540791962|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
149908143|NCT03053063|540791963|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
149908144|NCT03053063|540791964|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
149908145|NCT03053063|540791961|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
149908146|NCT03053063|540791962|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
149908147|NCT03053063|540791963|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
149908148|NCT03053063|540791964|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
149908149|NCT03053063|540791961|FG000|Open-Label Phase|Death|0|||
149908150|NCT03053063|540791962|FG001|Open-Label Phase|Death|0|||
149908151|NCT03053063|540791963|FG002|Open-Label Phase|Death|0|||
149908152|NCT03053063|540791964|FG003|Open-Label Phase|Death|2|||
149908153|NCT03053063|540791961|FG000|Open-Label Phase|Investigator's discretion|0|||
149908154|NCT03053063|540791962|FG001|Open-Label Phase|Investigator's discretion|0|||
149908155|NCT03053063|540791963|FG002|Open-Label Phase|Investigator's discretion|0|||
149908156|NCT03053063|540791964|FG003|Open-Label Phase|Investigator's discretion|2|||
149908157|NCT03963232|540791969|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149908158|NCT03963232|540791970|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
149908159|NCT03963232|540791969|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
149908160|NCT03963232|540791970|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
149908161|NCT03963232|540791969|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
149908162|NCT03963232|540791970|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
149908163|NCT03963232|540791969|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
149908164|NCT03963232|540791970|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
149908165|NCT03963232|540791969|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
149908166|NCT03963232|540791970|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
149908167|NCT03963232|540791969|FG000|Open-Label Treatment Phase|Adverse Event|1|||
149908168|NCT03963232|540791970|FG001|Open-Label Treatment Phase|Adverse Event|2|||
149908169|NCT03963232|540791969|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
149908170|NCT03963232|540791970|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
149908171|NCT03963232|540791969|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
149908172|NCT03963232|540791970|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
149908173|NCT03963232|540791969|FG000|Open-Label Treatment Phase|Pregnancy|1|||
149908174|NCT03963232|540791970|FG001|Open-Label Treatment Phase|Pregnancy|0|||
149908175|NCT03963232|540791969|FG000|Follow-up Phase|Withdrawal by Subject|7|||
149908176|NCT03963232|540791970|FG001|Follow-up Phase|Withdrawal by Subject|5|||
149908177|NCT03963232|540791969|FG000|Follow-up Phase|Protocol Violation|0|||
149908178|NCT03963232|540791970|FG001|Follow-up Phase|Protocol Violation|2|||
149908179|NCT03963232|540791969|FG000|Follow-up Phase|Adverse Event|0|||
149908180|NCT03963232|540791970|FG001|Follow-up Phase|Adverse Event|1|||
149908181|NCT03963232|540791969|FG000|Follow-up Phase|Lost to Follow-up|0|||
149908182|NCT03963232|540791970|FG001|Follow-up Phase|Lost to Follow-up|1|||
149908183|NCT00356135|540791971|FG000|Overall Study|Protocol Violation|1|||
149908184|NCT00356135|540791972|FG001|Overall Study|Protocol Violation|0|||
149908185|NCT00356135|540791973|FG002|Overall Study|Protocol Violation|0|||
149908186|NCT00356135|540791971|FG000|Overall Study|Adverse Event|1|||
149908187|NCT00356135|540791972|FG001|Overall Study|Adverse Event|0|||
149908188|NCT00356135|540791973|FG002|Overall Study|Adverse Event|0|||
149908189|NCT00356135|540791971|FG000|Overall Study|Lost to Follow-up|0|||
149908190|NCT00356135|540791972|FG001|Overall Study|Lost to Follow-up|0|||
149908191|NCT00356135|540791973|FG002|Overall Study|Lost to Follow-up|1|||
149908192|NCT00356135|540791971|FG000|Overall Study|Physician Decision|1|||
150176755|NCT02674750|541783408|FG000|Overall Study|Other|0|||
149908193|NCT00356135|540791972|FG001|Overall Study|Physician Decision|1|||
150176756|NCT02674750|541783409|FG001|Overall Study|Other|8|||
149908194|NCT00356135|540791973|FG002|Overall Study|Physician Decision|1|||
149908195|NCT00356135|540791971|FG000|Overall Study|Subject non-compliance|1|||
149908196|NCT00356135|540791972|FG001|Overall Study|Subject non-compliance|1|||
149908197|NCT00356135|540791973|FG002|Overall Study|Subject non-compliance|3|||
149908198|NCT03617770|540791974|FG000|Overall Study|Lost to Follow-up|1|||
149908199|NCT03617770|540791975|FG001|Overall Study|Lost to Follow-up|0|||
149908200|NCT03512210|540791976|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
149908201|NCT03512210|540791976|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
149908202|NCT03512210|540791976|FG000|Step 2:Post-MINMON|Death|2|||
149908203|NCT03512210|540791976|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
149908204|NCT03512210|540791976|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
149908205|NCT05033262|540791984|FG000|Overall Study|Lost to Follow-up|1|||
149908206|NCT05033262|540791985|FG001|Overall Study|Lost to Follow-up|0|||
149908207|NCT05033262|540791986|FG002|Overall Study|Lost to Follow-up|0|||
149908208|NCT05033262|540791987|FG003|Overall Study|Lost to Follow-up|1|||
149908209|NCT05270395|540791988|FG000|Overall Study|Lost to Follow-up|2|||
149908210|NCT05270395|540791989|FG001|Overall Study|Lost to Follow-up|2|||
149908211|NCT05270395|540791988|FG000|Overall Study|Death|1|||
149908212|NCT05270395|540791989|FG001|Overall Study|Death|2|||
149908213|NCT05270395|540791988|FG000|Overall Study|Study Team Withdrew|1|||
149908214|NCT05270395|540791989|FG001|Overall Study|Study Team Withdrew|0|||
149908215|NCT03960021|540793703|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
149908216|NCT03030989|540793704|FG000|Overall Study|Fever|2|||
149908217|NCT03030989|540793705|FG001|Overall Study|Fever|2|||
149908218|NCT03030989|540793704|FG000|Overall Study|Rash|2|||
149908219|NCT03030989|540793705|FG001|Overall Study|Rash|1|||
149908220|NCT03030989|540793704|FG000|Overall Study|Fatigue/Overwhelmed|1|||
149908221|NCT03030989|540793705|FG001|Overall Study|Fatigue/Overwhelmed|5|||
149908222|NCT03030989|540793704|FG000|Overall Study|Positive Blood Cultures|2|||
149908223|NCT03030989|540793705|FG001|Overall Study|Positive Blood Cultures|1|||
149908224|NCT03030989|540793704|FG000|Overall Study|Line Removed|0|||
149908225|NCT03030989|540793705|FG001|Overall Study|Line Removed|2|||
149908226|NCT03030989|540793704|FG000|Overall Study|No longer interested|5|||
149908227|NCT03030989|540793705|FG001|Overall Study|No longer interested|3|||
149908228|NCT02730377|540793706|FG000|Overall Study|Other|5|||
149908229|NCT02730377|540793707|FG001|Overall Study|Other|4|||
149908230|NCT02730377|540793706|FG000|Overall Study|Death|1|||
149908231|NCT02730377|540793707|FG001|Overall Study|Death|8|||
149908232|NCT02730377|540793706|FG000|Overall Study|Inadequate glycaemic control|368|||
149908233|NCT02730377|540793707|FG001|Overall Study|Inadequate glycaemic control|473|||
149908234|NCT02730377|540793706|FG000|Overall Study|Adverse Event|79|||
149908235|NCT02730377|540793707|FG001|Overall Study|Adverse Event|41|||
149908236|NCT02730377|540793706|FG000|Overall Study|Protocol Violation|23|||
149908237|NCT02730377|540793707|FG001|Overall Study|Protocol Violation|30|||
149908238|NCT02730377|540793706|FG000|Overall Study|Lack of Efficacy|4|||
149908239|NCT02730377|540793707|FG001|Overall Study|Lack of Efficacy|13|||
149908240|NCT02730377|540793706|FG000|Overall Study|Pregnancy|0|||
149908241|NCT02730377|540793707|FG001|Overall Study|Pregnancy|1|||
149908242|NCT02730377|540793706|FG000|Overall Study|Withdrawal by Subject|45|||
149908243|NCT02730377|540793707|FG001|Overall Study|Withdrawal by Subject|42|||
149908244|NCT02730377|540793706|FG000|Overall Study|Lost to Follow-up|25|||
149908245|NCT02730377|540793707|FG001|Overall Study|Lost to Follow-up|21|||
149908246|NCT02706886|540793708|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
149908247|NCT02706886|540793709|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
149908248|NCT02706886|540793710|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
149908249|NCT02706886|540793711|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
149908250|NCT02706886|540793712|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
149908251|NCT02706886|540793713|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
149908252|NCT02706886|540793714|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
149908253|NCT02706886|540793715|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
150048785|NCT01396057|541319447|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150048786|NCT01396057|541319448|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
150048787|NCT01396057|541319447|FG000|Overall Study|Protocol deviation|4|||
150048788|NCT01396057|541319448|FG001|Overall Study|Protocol deviation|4|||
149908254|NCT02706886|540793716|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
149908255|NCT03917472|540793717|FG000|Overall Study|Physician Decision|4|||
149908256|NCT03917472|540793718|FG001|Overall Study|Physician Decision|0|||
149908257|NCT03917472|540793717|FG000|Overall Study|Adverse Event|3|||
149908258|NCT03917472|540793718|FG001|Overall Study|Adverse Event|1|||
149908259|NCT03917472|540793717|FG000|Overall Study|Death|7|||
149908260|NCT03917472|540793718|FG001|Overall Study|Death|5|||
149908261|NCT03917472|540793717|FG000|Overall Study|Withdrawal by Subject|11|||
150048789|NCT01396057|541319447|FG000|Overall Study|Consent withdrawn|3|||
150048790|NCT01396057|541319448|FG001|Overall Study|Consent withdrawn|2|||
150176757|NCT02674750|541783410|FG002|Overall Study|Other|0|||
149908262|NCT03917472|540793718|FG001|Overall Study|Withdrawal by Subject|4|||
149908263|NCT03917472|540793717|FG000|Overall Study|Lost to Follow-up|10|||
149908264|NCT03917472|540793718|FG001|Overall Study|Lost to Follow-up|5|||
149908265|NCT01154296|540793719|FG000|Randomization and Intervention|Decided to decline|1|||
149908266|NCT01154296|540793720|FG001|Randomization and Intervention|Decided to decline|1|||
149908267|NCT01154296|540793719|FG000|Randomization and Intervention|Declined by staff|1|||
150048791|NCT01761240|541319449|FG000|Overall Study|Progressive disease:radiology assessment|3|||
150048792|NCT01761240|541319450|FG001|Overall Study|Progressive disease:radiology assessment|3|||
149908268|NCT01154296|540793720|FG001|Randomization and Intervention|Declined by staff|0|||
149908269|NCT01154296|540793719|FG000|Randomization and Intervention|Did not return|1|||
149908270|NCT01154296|540793720|FG001|Randomization and Intervention|Did not return|0|||
149908271|NCT01154296|540793719|FG000|Randomization and Intervention|Left before test|0|||
149908272|NCT01154296|540793720|FG001|Randomization and Intervention|Left before test|1|||
149908273|NCT01154296|540793719|FG000|Randomization and Intervention|Left clinic early|2|||
149908274|NCT01154296|540793720|FG001|Randomization and Intervention|Left clinic early|0|||
149908275|NCT01154296|540793719|FG000|6-month Follow-up|Lost contact|269|||
149908276|NCT01154296|540793720|FG001|6-month Follow-up|Lost contact|275|||
149908277|NCT01154296|540793719|FG000|6-month Follow-up|Incarcerated|37|||
149908278|NCT01154296|540793720|FG001|6-month Follow-up|Incarcerated|32|||
149908279|NCT01154296|540793719|FG000|6-month Follow-up|Withdrew consent|14|||
149908280|NCT01154296|540793720|FG001|6-month Follow-up|Withdrew consent|15|||
149908281|NCT01154296|540793719|FG000|6-month Follow-up|Death|3|||
149908282|NCT01154296|540793720|FG001|6-month Follow-up|Death|2|||
149908283|NCT01154296|540793719|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
149908284|NCT01154296|540793720|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
149908285|NCT02759055|540793721|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
149908286|NCT02759055|540793722|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
149908287|NCT02203851|540793723|FG000|Overall Study|Lost to Follow-up|4|||
149908288|NCT02203851|540793723|FG000|Overall Study|Withdrawal by Subject|6|||
149908289|NCT02203851|540793723|FG000|Overall Study|Other|1|||
149908290|NCT04934189|540793724|FG000|Overall Study|Lost to Follow-up|4|||
149908291|NCT04934189|540793724|FG000|Overall Study|Withdrawal by Subject|17|||
149908292|NCT00970632|540793730|FG000|Overall Study|Adverse Event|2|||
149908293|NCT00970632|540793731|FG001|Overall Study|Adverse Event|2|||
149908294|NCT00970632|540793732|FG002|Overall Study|Adverse Event|1|||
149908295|NCT00970632|540793730|FG000|Overall Study|Lack of Efficacy|3|||
149908296|NCT00970632|540793731|FG001|Overall Study|Lack of Efficacy|0|||
149908297|NCT00970632|540793732|FG002|Overall Study|Lack of Efficacy|0|||
149908298|NCT00970632|540793730|FG000|Overall Study|Lost to Follow-up|3|||
149908299|NCT00970632|540793731|FG001|Overall Study|Lost to Follow-up|0|||
149908300|NCT00970632|540793732|FG002|Overall Study|Lost to Follow-up|2|||
149908301|NCT00970632|540793730|FG000|Overall Study|Protocol Violation|8|||
149908302|NCT00970632|540793731|FG001|Overall Study|Protocol Violation|5|||
149971440|NCT02589938|541031855|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
149971441|NCT00485173|541031856|FG000|Overall Study|Death|4|||
149971442|NCT00485173|541031857|FG001|Overall Study|Death|3|||
149971443|NCT00485173|541031856|FG000|Overall Study|Lost to Follow-up|32|||
149971444|NCT00485173|541031857|FG001|Overall Study|Lost to Follow-up|61|||
149971445|NCT04237584|541031858|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
149971446|NCT04237584|541031859|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
149971447|NCT04237584|541031860|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
149971448|NCT04237584|541031861|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
149971449|NCT04237584|541031858|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
149971450|NCT04237584|541031859|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
149971451|NCT04237584|541031860|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
149971452|NCT04237584|541031861|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
149971453|NCT04237584|541031858|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
149971454|NCT04237584|541031859|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
149971455|NCT04237584|541031860|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
149971456|NCT04237584|541031861|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
150048793|NCT01761240|541319451|FG002|Overall Study|Progressive disease:radiology assessment|0|||
149908303|NCT00970632|540793732|FG002|Overall Study|Protocol Violation|8|||
149908304|NCT00970632|540793730|FG000|Overall Study|Withdrawal by Subject|7|||
149908305|NCT00970632|540793731|FG001|Overall Study|Withdrawal by Subject|6|||
149908306|NCT00970632|540793732|FG002|Overall Study|Withdrawal by Subject|4|||
149908307|NCT00970632|540793730|FG000|Overall Study|Entry criteria not met|0|||
149908308|NCT00970632|540793731|FG001|Overall Study|Entry criteria not met|2|||
149908309|NCT00970632|540793732|FG002|Overall Study|Entry criteria not met|2|||
149908310|NCT00970632|540793730|FG000|Overall Study|Sponsor decision|1|||
149971457|NCT04237584|541031858|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
149971458|NCT04237584|541031859|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
149908311|NCT00970632|540793731|FG001|Overall Study|Sponsor decision|0|||
149908312|NCT00970632|540793732|FG002|Overall Study|Sponsor decision|1|||
149908313|NCT02653170|540793733|FG000|Overall Study|Withdrawal by Subject|3|||
149908314|NCT02653170|540793734|FG001|Overall Study|Withdrawal by Subject|8|||
149908315|NCT02653170|540793735|FG002|Overall Study|Withdrawal by Subject|3|||
149908316|NCT02653170|540793733|FG000|Overall Study|withdrawn by study team|2|||
149908317|NCT02653170|540793734|FG001|Overall Study|withdrawn by study team|4|||
149908318|NCT02653170|540793735|FG002|Overall Study|withdrawn by study team|5|||
149971459|NCT04237584|541031860|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
149971460|NCT04237584|541031861|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
149971461|NCT04237584|541031858|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
149971462|NCT04237584|541031859|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
149971463|NCT04237584|541031860|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
149971464|NCT04237584|541031861|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
149971465|NCT02581930|541031866|FG000|Overall Study|Withdrawal by Subject|1|||
149971466|NCT02581930|541031866|FG000|Overall Study|patient declined further treatment|1|||
149971467|NCT01400412|541031867|FG000|Overall Study|Lost to Follow-up|4|||
150176758|NCT01685606|541783413|FG000|Overall Study|Withdrawal by Subject|1|||
149908319|NCT02653170|540793733|FG000|Overall Study|Lost to Follow-up|12|||
149908320|NCT02653170|540793734|FG001|Overall Study|Lost to Follow-up|4|||
149908321|NCT02653170|540793735|FG002|Overall Study|Lost to Follow-up|10|||
150048794|NCT01761240|541319452|FG003|Overall Study|Progressive disease:radiology assessment|0|||
150048795|NCT01761240|541319453|FG004|Overall Study|Progressive disease:radiology assessment|0|||
149908322|NCT02086448|540793736|FG000|Overall Study|Withdrawal by Subject|1|||
149908323|NCT02086448|540793737|FG001|Overall Study|Withdrawal by Subject|0|||
149908324|NCT02086448|540793738|FG002|Overall Study|Withdrawal by Subject|0|||
149908325|NCT02086448|540793739|FG003|Overall Study|Withdrawal by Subject|2|||
149908326|NCT01895270|540793750|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
149908327|NCT01895270|540793751|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
149908328|NCT01895270|540793750|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
149908329|NCT01895270|540793751|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
149908330|NCT01895270|540793750|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
149908331|NCT01895270|540793751|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
149908332|NCT01895270|540793750|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
149908333|NCT01895270|540793751|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
149908334|NCT01895270|540793750|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
149908335|NCT01895270|540793751|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
149908336|NCT01895270|540793750|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
149908337|NCT01895270|540793751|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
149908338|NCT01895270|540793750|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
149908339|NCT01895270|540793751|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
149908340|NCT05139303|540793752|FG000|Overall Study|Lost to Follow-up|3|||
149908341|NCT05139303|540793753|FG001|Overall Study|Lost to Follow-up|0|||
149908342|NCT05139303|540793752|FG000|Overall Study|Adverse Event|1|||
149908343|NCT05139303|540793753|FG001|Overall Study|Adverse Event|0|||
149908344|NCT03875482|540793754|FG000|Overall Study|Adverse Event|0|||
149908345|NCT03875482|540793755|FG001|Overall Study|Adverse Event|1|||
149908346|NCT03875482|540793754|FG000|Overall Study|Withdrew consent|5|||
149908347|NCT03875482|540793755|FG001|Overall Study|Withdrew consent|6|||
149908348|NCT03875482|540793754|FG000|Overall Study|Lost to Follow-up|8|||
149908349|NCT03875482|540793755|FG001|Overall Study|Lost to Follow-up|2|||
149908350|NCT03875482|540793754|FG000|Overall Study|Lack of Efficacy|0|||
149908351|NCT03875482|540793755|FG001|Overall Study|Lack of Efficacy|11|||
149908352|NCT00507819|540793757|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
149908353|NCT00507819|540793758|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
149908354|NCT02738879|540793771|FG000|Overall Study|Adverse Event|1|||
149908355|NCT02738879|540793772|FG001|Overall Study|Adverse Event|1|||
149908356|NCT02738879|540793771|FG000|Overall Study|Death|0|||
149908357|NCT02738879|540793772|FG001|Overall Study|Death|2|||
149908358|NCT02738879|540793771|FG000|Overall Study|Lost to Follow-up|1|||
149908359|NCT02738879|540793772|FG001|Overall Study|Lost to Follow-up|5|||
149908360|NCT02738879|540793771|FG000|Overall Study|Protocol Violation|1|||
149908361|NCT02738879|540793772|FG001|Overall Study|Protocol Violation|3|||
149908362|NCT02738879|540793771|FG000|Overall Study|Physician Decision|3|||
149908363|NCT02738879|540793772|FG001|Overall Study|Physician Decision|4|||
149908364|NCT02738879|540793771|FG000|Overall Study|Pregnancy|0|||
149908365|NCT02738879|540793772|FG001|Overall Study|Pregnancy|1|||
149908366|NCT02738879|540793771|FG000|Overall Study|Screen Failure|1|||
149908367|NCT02738879|540793772|FG001|Overall Study|Screen Failure|2|||
149908368|NCT02738879|540793771|FG000|Overall Study|Site Discontinued Study Participation|1|||
149908369|NCT02738879|540793772|FG001|Overall Study|Site Discontinued Study Participation|0|||
149908370|NCT02738879|540793771|FG000|Overall Study|Withdrawal by Subject|5|||
149908371|NCT02738879|540793772|FG001|Overall Study|Withdrawal by Subject|7|||
149908372|NCT00890084|540793773|FG000|Overall Study|Adverse Event|16|||
149908373|NCT00890084|540793773|FG000|Overall Study|Lost to Follow-up|126|||
149908374|NCT01438294|540793774|FG000|Overall Study|Lost to Follow-up|3|||
149908375|NCT01438294|540793775|FG001|Overall Study|Lost to Follow-up|7|||
149908376|NCT01075646|540793776|FG000|Overall Study|Lost to Follow-up|4|||
149908377|NCT01075646|540793777|FG001|Overall Study|Lost to Follow-up|3|||
149908378|NCT01075646|540793778|FG002|Overall Study|Lost to Follow-up|1|||
149908379|NCT01075646|540793779|FG003|Overall Study|Lost to Follow-up|2|||
149908380|NCT01730534|540793783|FG000|Overall Study|Withdrawal by Subject|97|||
149908381|NCT01730534|540793784|FG001|Overall Study|Withdrawal by Subject|127|||
149908382|NCT01730534|540793783|FG000|Overall Study|Lost to Follow-up|12|||
149908383|NCT01730534|540793784|FG001|Overall Study|Lost to Follow-up|18|||
149908384|NCT01676896|540793785|FG000|Overall Study|Withdrawal by Subject|12|||
149908385|NCT01676896|540793786|FG001|Overall Study|Withdrawal by Subject|7|||
149908386|NCT01676896|540793787|FG002|Overall Study|Withdrawal by Subject|19|||
149908387|NCT01647516|540793788|FG000|Induction Period (IP)|Physician Decision|2|||
149908388|NCT01647516|540793789|FG001|Induction Period (IP)|Physician Decision|0|||
149908389|NCT01647516|540793790|FG002|Induction Period (IP)|Physician Decision|0|||
149908390|NCT01647516|540793791|FG003|Induction Period (IP)|Physician Decision|0|||
149908391|NCT01647516|540793792|FG004|Induction Period (IP)|Physician Decision|0|||
150048796|NCT01761240|541319449|FG000|Overall Study|Progressive disease:clinical assessment|0|||
150048797|NCT01761240|541319450|FG001|Overall Study|Progressive disease:clinical assessment|0|||
150048798|NCT01761240|541319451|FG002|Overall Study|Progressive disease:clinical assessment|3|||
150048799|NCT01761240|541319452|FG003|Overall Study|Progressive disease:clinical assessment|1|||
150048800|NCT01761240|541319453|FG004|Overall Study|Progressive disease:clinical assessment|0|||
150048801|NCT01761240|541319449|FG000|Overall Study|Withdrawal by Subject|0|||
150048802|NCT01761240|541319450|FG001|Overall Study|Withdrawal by Subject|0|||
150048803|NCT01761240|541319451|FG002|Overall Study|Withdrawal by Subject|0|||
150048804|NCT01761240|541319452|FG003|Overall Study|Withdrawal by Subject|3|||
150048805|NCT01761240|541319453|FG004|Overall Study|Withdrawal by Subject|1|||
150048806|NCT01761240|541319449|FG000|Overall Study|Adverse Event|0|||
150048807|NCT01761240|541319450|FG001|Overall Study|Adverse Event|0|||
150048808|NCT01761240|541319451|FG002|Overall Study|Adverse Event|0|||
150048809|NCT01761240|541319452|FG003|Overall Study|Adverse Event|1|||
150048810|NCT01761240|541319453|FG004|Overall Study|Adverse Event|6|||
150048811|NCT01761240|541319449|FG000|Overall Study|Death|0|||
150048812|NCT01761240|541319450|FG001|Overall Study|Death|1|||
150048813|NCT01761240|541319451|FG002|Overall Study|Death|1|||
150048814|NCT01761240|541319452|FG003|Overall Study|Death|2|||
150048815|NCT01761240|541319453|FG004|Overall Study|Death|1|||
150048816|NCT01761240|541319449|FG000|Overall Study|Non-compliance|0|||
150048817|NCT01761240|541319450|FG001|Overall Study|Non-compliance|0|||
150048818|NCT01761240|541319451|FG002|Overall Study|Non-compliance|1|||
150048819|NCT01761240|541319452|FG003|Overall Study|Non-compliance|0|||
150048820|NCT01761240|541319453|FG004|Overall Study|Non-compliance|0|||
150048821|NCT01233232|541319454|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
150048822|NCT01233232|541319455|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
150048823|NCT01233232|541319456|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
150048824|NCT01708902|541319462|FG000|Overall Study|Adverse Event|3|||
150048825|NCT01708902|541319463|FG001|Overall Study|Adverse Event|4|||
150048826|NCT01708902|541319464|FG002|Overall Study|Adverse Event|9|||
150048827|NCT01708902|541319465|FG003|Overall Study|Adverse Event|2|||
150048828|NCT01708902|541319466|FG004|Overall Study|Adverse Event|7|||
150048829|NCT01708902|541319467|FG005|Overall Study|Adverse Event|3|||
149908392|NCT01647516|540793793|FG005|Induction Period (IP)|Physician Decision|0|||
149908393|NCT01647516|540793788|FG000|Induction Period (IP)|Adverse Event|1|||
149908394|NCT01647516|540793789|FG001|Induction Period (IP)|Adverse Event|2|||
149908395|NCT01647516|540793790|FG002|Induction Period (IP)|Adverse Event|0|||
149908396|NCT01647516|540793791|FG003|Induction Period (IP)|Adverse Event|0|||
149908397|NCT01647516|540793792|FG004|Induction Period (IP)|Adverse Event|0|||
149908398|NCT01647516|540793793|FG005|Induction Period (IP)|Adverse Event|0|||
149908399|NCT01647516|540793788|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
149908400|NCT01647516|540793789|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
149908401|NCT01647516|540793790|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
149908402|NCT01647516|540793791|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
149908403|NCT01647516|540793792|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
149908404|NCT01647516|540793793|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
149908405|NCT01647516|540793788|FG000|Induction Period (IP)|Participant Choice|0|||
149908406|NCT01647516|540793789|FG001|Induction Period (IP)|Participant Choice|0|||
149908407|NCT01647516|540793790|FG002|Induction Period (IP)|Participant Choice|1|||
149908408|NCT01647516|540793791|FG003|Induction Period (IP)|Participant Choice|0|||
149908409|NCT01647516|540793792|FG004|Induction Period (IP)|Participant Choice|0|||
149908410|NCT01647516|540793793|FG005|Induction Period (IP)|Participant Choice|0|||
150048830|NCT01708902|541319468|FG006|Overall Study|Adverse Event|5|||
150048831|NCT01708902|541319462|FG000|Overall Study|Lack of Efficacy|3|||
150048832|NCT01708902|541319463|FG001|Overall Study|Lack of Efficacy|1|||
150048833|NCT01708902|541319464|FG002|Overall Study|Lack of Efficacy|0|||
150048834|NCT01708902|541319465|FG003|Overall Study|Lack of Efficacy|0|||
150048835|NCT01708902|541319466|FG004|Overall Study|Lack of Efficacy|0|||
150048836|NCT01708902|541319467|FG005|Overall Study|Lack of Efficacy|1|||
150048837|NCT01708902|541319468|FG006|Overall Study|Lack of Efficacy|0|||
150048838|NCT01708902|541319462|FG000|Overall Study|Non compliance with protocol|0|||
150048839|NCT01708902|541319463|FG001|Overall Study|Non compliance with protocol|2|||
150048840|NCT01708902|541319464|FG002|Overall Study|Non compliance with protocol|1|||
150048841|NCT01708902|541319465|FG003|Overall Study|Non compliance with protocol|3|||
149908411|NCT01647516|540793788|FG000|Induction Period (IP)|Lack of Efficacy|1|||
149908412|NCT01647516|540793789|FG001|Induction Period (IP)|Lack of Efficacy|0|||
149908413|NCT01647516|540793790|FG002|Induction Period (IP)|Lack of Efficacy|0|||
149908414|NCT01647516|540793791|FG003|Induction Period (IP)|Lack of Efficacy|0|||
149908415|NCT01647516|540793792|FG004|Induction Period (IP)|Lack of Efficacy|0|||
150048842|NCT01708902|541319466|FG004|Overall Study|Non compliance with protocol|0|||
150048843|NCT01708902|541319467|FG005|Overall Study|Non compliance with protocol|0|||
150048844|NCT01708902|541319468|FG006|Overall Study|Non compliance with protocol|0|||
150048845|NCT01708902|541319462|FG000|Overall Study|Lost to Follow-up|2|||
150048846|NCT01708902|541319463|FG001|Overall Study|Lost to Follow-up|1|||
150048847|NCT01708902|541319464|FG002|Overall Study|Lost to Follow-up|2|||
149908416|NCT01647516|540793793|FG005|Induction Period (IP)|Lack of Efficacy|0|||
149908417|NCT01647516|540793788|FG000|Induction Period (IP)|No study drug received|1|||
149908418|NCT01647516|540793789|FG001|Induction Period (IP)|No study drug received|1|||
149908419|NCT01647516|540793790|FG002|Induction Period (IP)|No study drug received|0|||
149908420|NCT01647516|540793791|FG003|Induction Period (IP)|No study drug received|0|||
149908421|NCT01647516|540793792|FG004|Induction Period (IP)|No study drug received|0|||
149908422|NCT01647516|540793793|FG005|Induction Period (IP)|No study drug received|0|||
149908423|NCT01647516|540793788|FG000|Maintenance Period (MP)|Adverse Event|2|||
149908424|NCT01647516|540793789|FG001|Maintenance Period (MP)|Adverse Event|1|||
149908425|NCT01647516|540793790|FG002|Maintenance Period (MP)|Adverse Event|0|||
149908426|NCT01647516|540793791|FG003|Maintenance Period (MP)|Adverse Event|0|||
149908427|NCT01647516|540793792|FG004|Maintenance Period (MP)|Adverse Event|0|||
149908428|NCT01647516|540793793|FG005|Maintenance Period (MP)|Adverse Event|0|||
149908429|NCT01647516|540793788|FG000|Maintenance Period (MP)|Non-compliance|1|||
149908430|NCT01647516|540793789|FG001|Maintenance Period (MP)|Non-compliance|0|||
149908431|NCT01647516|540793790|FG002|Maintenance Period (MP)|Non-compliance|0|||
149908432|NCT01647516|540793791|FG003|Maintenance Period (MP)|Non-compliance|0|||
149908433|NCT01647516|540793792|FG004|Maintenance Period (MP)|Non-compliance|0|||
149908434|NCT01647516|540793793|FG005|Maintenance Period (MP)|Non-compliance|0|||
149908435|NCT01647516|540793788|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
149908436|NCT01647516|540793789|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
149908437|NCT01647516|540793790|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
149908438|NCT01647516|540793791|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
149908439|NCT01647516|540793792|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
149908440|NCT01647516|540793793|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
149908441|NCT01647516|540793788|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
149908442|NCT01647516|540793789|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
149908443|NCT01647516|540793790|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
149908444|NCT01647516|540793791|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
149908445|NCT01647516|540793792|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
149908446|NCT01647516|540793793|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
149908447|NCT01647516|540793788|FG000|Open-Label Period|Adverse Event|0|||
149908448|NCT01647516|540793789|FG001|Open-Label Period|Adverse Event|0|||
149908449|NCT01647516|540793790|FG002|Open-Label Period|Adverse Event|0|||
149908450|NCT01647516|540793791|FG003|Open-Label Period|Adverse Event|5|||
149908451|NCT01647516|540793792|FG004|Open-Label Period|Adverse Event|6|||
149908452|NCT01647516|540793793|FG005|Open-Label Period|Adverse Event|3|||
149908453|NCT01647516|540793788|FG000|Open-Label Period|Pregnancy|0|||
149908454|NCT01647516|540793789|FG001|Open-Label Period|Pregnancy|0|||
149908455|NCT01647516|540793790|FG002|Open-Label Period|Pregnancy|0|||
149908456|NCT01647516|540793791|FG003|Open-Label Period|Pregnancy|0|||
149908457|NCT01647516|540793792|FG004|Open-Label Period|Pregnancy|0|||
149908458|NCT01647516|540793793|FG005|Open-Label Period|Pregnancy|1|||
149908459|NCT01647516|540793788|FG000|Open-Label Period|Non-compliance|0|||
149908460|NCT01647516|540793789|FG001|Open-Label Period|Non-compliance|0|||
149908461|NCT01647516|540793790|FG002|Open-Label Period|Non-compliance|0|||
149908462|NCT01647516|540793791|FG003|Open-Label Period|Non-compliance|1|||
149908463|NCT01647516|540793792|FG004|Open-Label Period|Non-compliance|0|||
149908464|NCT01647516|540793793|FG005|Open-Label Period|Non-compliance|1|||
149908465|NCT01647516|540793788|FG000|Open-Label Period|Physician Decision|0|||
149908466|NCT01647516|540793789|FG001|Open-Label Period|Physician Decision|0|||
149908467|NCT01647516|540793790|FG002|Open-Label Period|Physician Decision|0|||
149908468|NCT01647516|540793791|FG003|Open-Label Period|Physician Decision|1|||
149908469|NCT01647516|540793792|FG004|Open-Label Period|Physician Decision|1|||
149908470|NCT01647516|540793793|FG005|Open-Label Period|Physician Decision|0|||
149908471|NCT01647516|540793788|FG000|Open-Label Period|Withdrawal by Subject|0|||
149908472|NCT01647516|540793789|FG001|Open-Label Period|Withdrawal by Subject|0|||
149908473|NCT01647516|540793790|FG002|Open-Label Period|Withdrawal by Subject|0|||
149908474|NCT01647516|540793791|FG003|Open-Label Period|Withdrawal by Subject|9|||
149908475|NCT01647516|540793792|FG004|Open-Label Period|Withdrawal by Subject|11|||
149908476|NCT01647516|540793793|FG005|Open-Label Period|Withdrawal by Subject|6|||
149908477|NCT01647516|540793788|FG000|Open-Label Period|Lost to Follow-up|0|||
149908478|NCT01647516|540793789|FG001|Open-Label Period|Lost to Follow-up|0|||
149908479|NCT01647516|540793790|FG002|Open-Label Period|Lost to Follow-up|0|||
149908480|NCT01647516|540793791|FG003|Open-Label Period|Lost to Follow-up|1|||
149908481|NCT01647516|540793792|FG004|Open-Label Period|Lost to Follow-up|0|||
149908482|NCT01647516|540793793|FG005|Open-Label Period|Lost to Follow-up|1|||
149908483|NCT01647516|540793788|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
149908484|NCT01647516|540793789|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
149971468|NCT01400412|541031868|FG001|Overall Study|Lost to Follow-up|7|||
149971469|NCT01400412|541031867|FG000|Overall Study|Withdrawal by Subject|3|||
149971470|NCT01400412|541031868|FG001|Overall Study|Withdrawal by Subject|4|||
149971471|NCT01400412|541031867|FG000|Overall Study|Unable to complete|3|||
149971472|NCT01400412|541031868|FG001|Overall Study|Unable to complete|3|||
149971473|NCT01400412|541031867|FG000|Overall Study|Never started study treatment|0|||
150176759|NCT01787760|541783414|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
150176760|NCT01787760|541783415|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
149908485|NCT01647516|540793790|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
149908486|NCT01647516|540793791|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
149908487|NCT01647516|540793792|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
149908488|NCT01647516|540793793|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
149908489|NCT01647516|540793788|FG000|Open-Label Period|Lack of Efficacy|0|||
149908490|NCT01647516|540793789|FG001|Open-Label Period|Lack of Efficacy|0|||
149908491|NCT01647516|540793790|FG002|Open-Label Period|Lack of Efficacy|0|||
149908492|NCT01647516|540793791|FG003|Open-Label Period|Lack of Efficacy|7|||
149908493|NCT01647516|540793792|FG004|Open-Label Period|Lack of Efficacy|9|||
149908494|NCT01647516|540793793|FG005|Open-Label Period|Lack of Efficacy|10|||
149908495|NCT01647516|540793788|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
149908496|NCT01647516|540793789|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
149908497|NCT01647516|540793790|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
149908498|NCT01647516|540793791|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
149908499|NCT01647516|540793792|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
149908500|NCT01647516|540793793|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
149908501|NCT01647516|540793788|FG000|Open-Label Period|No completion / discontinuation visit|0|||
149908502|NCT01647516|540793789|FG001|Open-Label Period|No completion / discontinuation visit|0|||
149908503|NCT01647516|540793790|FG002|Open-Label Period|No completion / discontinuation visit|0|||
149908504|NCT01647516|540793791|FG003|Open-Label Period|No completion / discontinuation visit|0|||
149908505|NCT01647516|540793792|FG004|Open-Label Period|No completion / discontinuation visit|2|||
149908506|NCT01647516|540793793|FG005|Open-Label Period|No completion / discontinuation visit|1|||
149908507|NCT01613222|540793796|FG000|Overall Study|Physician Decision|1|||
149908508|NCT01613222|540793796|FG000|Overall Study|Unable to place arterial line|1|||
149908509|NCT01613222|540793796|FG000|Overall Study|Reused disposable sensors|10|||
149908510|NCT01895608|540793797|FG000|Overall Study|change in health status|0|||
149908511|NCT01895608|540793798|FG001|Overall Study|change in health status|1|||
149908512|NCT01895608|540793799|FG002|Overall Study|change in health status|1|||
149908513|NCT01895608|540793800|FG003|Overall Study|change in health status|0|||
149908514|NCT01895608|540793797|FG000|Overall Study|Withdrawal by Subject|0|||
149908515|NCT01895608|540793798|FG001|Overall Study|Withdrawal by Subject|0|||
149908516|NCT01895608|540793799|FG002|Overall Study|Withdrawal by Subject|2|||
149908517|NCT01895608|540793800|FG003|Overall Study|Withdrawal by Subject|0|||
149908518|NCT03505593|540793801|FG000|Overall Study|Withdrawal by Subject|1|||
149908519|NCT03505593|540793801|FG000|Overall Study|Died before procedure|1|||
149908520|NCT03505593|540793801|FG000|Overall Study|Anatomical abnormality|1|||
149908521|NCT03505593|540793801|FG000|Overall Study|Unable to pass through esophagus|1|||
149908522|NCT03505593|540793801|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
149908523|NCT02855359|540793805|FG000|Overall Study|Death|2|||
149908524|NCT02855359|540793806|FG001|Overall Study|Death|2|||
149908525|NCT02855359|540793807|FG002|Overall Study|Death|0|||
149908526|NCT02855359|540793808|FG003|Overall Study|Death|0|||
149908527|NCT02855359|540793805|FG000|Overall Study|Study Termination by Sponsor|9|||
149908528|NCT02855359|540793806|FG001|Overall Study|Study Termination by Sponsor|11|||
149908529|NCT02855359|540793807|FG002|Overall Study|Study Termination by Sponsor|0|||
149908530|NCT02855359|540793808|FG003|Overall Study|Study Termination by Sponsor|0|||
149908531|NCT03155178|540793809|FG000|Overall Study|Did not meet treatment day baseline|7|||
149908532|NCT03155178|540793810|FG001|Overall Study|Did not meet treatment day baseline|7|||
149908533|NCT03155178|540793811|FG002|Overall Study|Did not meet treatment day baseline|7|||
149908534|NCT03155178|540793812|FG003|Overall Study|Did not meet treatment day baseline|7|||
149908535|NCT01023256|540793813|FG000|Overall Study|Protocol Violation|2|||
149908536|NCT01023256|540793814|FG001|Overall Study|Protocol Violation|3|||
149908537|NCT01023256|540793815|FG002|Overall Study|Protocol Violation|0|||
149908538|NCT01023256|540793816|FG003|Overall Study|Protocol Violation|0|||
149908539|NCT01023256|540793813|FG000|Overall Study|Randomized but not treated|1|||
149908540|NCT01023256|540793814|FG001|Overall Study|Randomized but not treated|0|||
149908541|NCT01023256|540793815|FG002|Overall Study|Randomized but not treated|1|||
149908542|NCT01023256|540793816|FG003|Overall Study|Randomized but not treated|0|||
149908543|NCT01023256|540793813|FG000|Overall Study|Other|1|||
149908544|NCT01023256|540793814|FG001|Overall Study|Other|0|||
149908545|NCT01023256|540793815|FG002|Overall Study|Other|0|||
149908546|NCT01023256|540793816|FG003|Overall Study|Other|2|||
149908547|NCT01023256|540793813|FG000|Overall Study|Adverse Event|0|||
149908548|NCT01023256|540793814|FG001|Overall Study|Adverse Event|0|||
149908549|NCT01023256|540793815|FG002|Overall Study|Adverse Event|0|||
149908550|NCT01023256|540793816|FG003|Overall Study|Adverse Event|1|||
149908551|NCT01023256|540793813|FG000|Overall Study|Withdrawal by Subject|0|||
149908552|NCT01023256|540793814|FG001|Overall Study|Withdrawal by Subject|0|||
149908553|NCT01023256|540793815|FG002|Overall Study|Withdrawal by Subject|0|||
150048848|NCT01708902|541319465|FG003|Overall Study|Lost to Follow-up|2|||
150048849|NCT01708902|541319466|FG004|Overall Study|Lost to Follow-up|0|||
150048850|NCT01708902|541319467|FG005|Overall Study|Lost to Follow-up|0|||
150048851|NCT01708902|541319468|FG006|Overall Study|Lost to Follow-up|1|||
150048852|NCT01708902|541319462|FG000|Overall Study|Refused to continue trial medication|8|||
150048853|NCT01708902|541319463|FG001|Overall Study|Refused to continue trial medication|0|||
149908554|NCT01023256|540793816|FG003|Overall Study|Withdrawal by Subject|2|||
149908555|NCT02833844|540793817|FG000|Double-Blind Period|Withdrawal by Subject|2|||
149908556|NCT02833844|540793818|FG001|Double-Blind Period|Withdrawal by Subject|3|||
149908557|NCT02833844|540793817|FG000|Double-Blind Period|Protocol Violation|0|||
149908558|NCT02833844|540793818|FG001|Double-Blind Period|Protocol Violation|4|||
149908559|NCT02833844|540793817|FG000|Open-Label Period|Death|0|||
149908560|NCT02833844|540793818|FG001|Open-Label Period|Death|2|||
149908561|NCT02833844|540793817|FG000|Open-Label Period|Lost to Follow-up|1|||
149908562|NCT02833844|540793818|FG001|Open-Label Period|Lost to Follow-up|0|||
149908563|NCT02833844|540793817|FG000|Open-Label Period|Withdrawal by Subject|1|||
149908564|NCT02833844|540793818|FG001|Open-Label Period|Withdrawal by Subject|0|||
149908565|NCT04712019|540793819|FG000|Overall Study|Withdrawal by Subject|2|||
149908566|NCT04712019|540793820|FG001|Overall Study|Withdrawal by Subject|2|||
149908567|NCT04712019|540793819|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
149908568|NCT04712019|540793820|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
149908569|NCT02541669|540793828|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
149908570|NCT02541669|540793829|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
149908571|NCT02541669|540793830|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
149908572|NCT02541669|540793831|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
149908573|NCT02541669|540793832|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
149908574|NCT04739722|540793833|FG000|Overall Study|Lost to Follow-up|5301|||
149908575|NCT04739722|540793833|FG000|Overall Study|Withdrawal by Subject|42|||
149908576|NCT04739722|540793833|FG000|Overall Study|Non Average-risk|1157|||
149908577|NCT03729570|540793834|FG000|Overall Study|Lost to Follow-up|16|||
149908578|NCT03729570|540793835|FG001|Overall Study|Lost to Follow-up|20|||
149908579|NCT03729570|540793834|FG000|Overall Study|Seroconversion|5|||
149908580|NCT03729570|540793835|FG001|Overall Study|Seroconversion|0|||
149908581|NCT03729570|540793834|FG000|Overall Study|Moved out of the city|1|||
149908582|NCT03729570|540793835|FG001|Overall Study|Moved out of the city|0|||
149908583|NCT03729570|540793834|FG000|Overall Study|Time Conflict|1|||
149908584|NCT03729570|540793835|FG001|Overall Study|Time Conflict|0|||
149908585|NCT03729570|540793834|FG000|Overall Study|Time Commitment|2|||
149908586|NCT03729570|540793835|FG001|Overall Study|Time Commitment|0|||
149908587|NCT03729570|540793834|FG000|Overall Study|Bad Experience|0|||
149908588|NCT03729570|540793835|FG001|Overall Study|Bad Experience|1|||
149908589|NCT03729570|540793834|FG000|Overall Study|No reason provided|2|||
149908590|NCT03729570|540793835|FG001|Overall Study|No reason provided|1|||
149908591|NCT03729570|540793834|FG000|Overall Study|Family Conflict|0|||
149908592|NCT03729570|540793835|FG001|Overall Study|Family Conflict|1|||
149908593|NCT03729570|540793834|FG000|Overall Study|Did not want to continue taking medications|0|||
149908594|NCT03729570|540793835|FG001|Overall Study|Did not want to continue taking medications|1|||
149908595|NCT03729570|540793834|FG000|Overall Study|Found another PrEP provider|1|||
149908596|NCT03729570|540793835|FG001|Overall Study|Found another PrEP provider|0|||
149908597|NCT03729570|540793834|FG000|Overall Study|Did not enjoy being in the control group|0|||
149908598|NCT03729570|540793835|FG001|Overall Study|Did not enjoy being in the control group|1|||
149908599|NCT00631410|540793836|FG000|Overall Study|Adverse Event|1|||
149908600|NCT00631410|540793837|FG001|Overall Study|Adverse Event|3|||
149908601|NCT00631410|540793836|FG000|Overall Study|Objective Progression or Relapse|4|||
149908602|NCT00631410|540793837|FG001|Overall Study|Objective Progression or Relapse|3|||
149908603|NCT00631410|540793836|FG000|Overall Study|Surgery|1|||
149908604|NCT00631410|540793837|FG001|Overall Study|Surgery|0|||
149908605|NCT03419598|540793839|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
149908606|NCT01322035|540793840|FG000|Overall Study|Lost to Follow-up|8|||
149908607|NCT01322035|540793841|FG001|Overall Study|Lost to Follow-up|3|||
149908608|NCT04569968|540793842|FG000|Overall Study|Lost to Follow-up|2|||
149908609|NCT04569968|540793843|FG001|Overall Study|Lost to Follow-up|5|||
149908610|NCT04569968|540793842|FG000|Overall Study|Story of head and/or neck surgery|2|||
150048854|NCT01708902|541319464|FG002|Overall Study|Refused to continue trial medication|4|||
149908611|NCT04569968|540793843|FG001|Overall Study|Story of head and/or neck surgery|2|||
149908612|NCT04569968|540793842|FG000|Overall Study|Time of stroke onset|8|||
149908613|NCT04569968|540793843|FG001|Overall Study|Time of stroke onset|7|||
150048855|NCT01708902|541319465|FG003|Overall Study|Refused to continue trial medication|2|||
150048856|NCT01708902|541319466|FG004|Overall Study|Refused to continue trial medication|8|||
149908614|NCT04569968|540793842|FG000|Overall Study|Type of strokr|12|||
149908615|NCT04569968|540793843|FG001|Overall Study|Type of strokr|8|||
150048857|NCT01708902|541319467|FG005|Overall Study|Refused to continue trial medication|1|||
150048858|NCT01708902|541319468|FG006|Overall Study|Refused to continue trial medication|1|||
150048859|NCT01708902|541319462|FG000|Overall Study|Other Reason|1|||
150048860|NCT01708902|541319463|FG001|Overall Study|Other Reason|0|||
150048861|NCT01708902|541319464|FG002|Overall Study|Other Reason|1|||
150048862|NCT01708902|541319465|FG003|Overall Study|Other Reason|1|||
150048863|NCT01708902|541319466|FG004|Overall Study|Other Reason|1|||
150048864|NCT01708902|541319467|FG005|Overall Study|Other Reason|2|||
150048865|NCT01708902|541319468|FG006|Overall Study|Other Reason|0|||
150048866|NCT02633020|541319470|FG000|Overall Study|Adverse Event|1|||
150048867|NCT02633020|541319471|FG001|Overall Study|Adverse Event|0|||
150048868|NCT00934440|541319472|FG000|Overall Study|Lost to Follow-up|1|||
150048869|NCT05661851|541319473|FG000|Overall Study|Protocol Violation|1|||
150048870|NCT05661851|541319474|FG001|Overall Study|Protocol Violation|1|||
150048871|NCT05661851|541319473|FG000|Overall Study|Covid-19 Related|3|||
150048872|NCT05661851|541319474|FG001|Overall Study|Covid-19 Related|4|||
150048873|NCT05661851|541319473|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
150048874|NCT05661851|541319474|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
150048875|NCT05661851|541319473|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
150048876|NCT05661851|541319474|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
150048877|NCT00530816|541319475|FG000|Overall Study|Progressive Disease|16|||
150048878|NCT00530816|541319476|FG001|Overall Study|Progressive Disease|24|||
150048879|NCT00530816|541319477|FG002|Overall Study|Progressive Disease|24|||
150048880|NCT00530816|541319475|FG000|Overall Study|Adverse Event|6|||
150048881|NCT00530816|541319476|FG001|Overall Study|Adverse Event|13|||
150048882|NCT00530816|541319477|FG002|Overall Study|Adverse Event|7|||
150176761|NCT01787760|541783416|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
150048883|NCT00530816|541319475|FG000|Overall Study|Other|3|||
150048884|NCT00530816|541319476|FG001|Overall Study|Other|3|||
150176762|NCT01787760|541783414|FG000|Overall Study|Decompensated on left exotropia|0|||
150048885|NCT00530816|541319477|FG002|Overall Study|Other|4|||
150048886|NCT00530816|541319475|FG000|Overall Study|Withdrawal by Subject|1|||
150048887|NCT00530816|541319476|FG001|Overall Study|Withdrawal by Subject|2|||
150048888|NCT00530816|541319477|FG002|Overall Study|Withdrawal by Subject|6|||
150048889|NCT02152956|541319478|FG000|Overall Study|Adverse Event|0|||
150048890|NCT02152956|541319479|FG001|Overall Study|Adverse Event|0|||
150048891|NCT02152956|541319480|FG002|Overall Study|Adverse Event|0|||
150048892|NCT02152956|541319481|FG003|Overall Study|Adverse Event|0|||
150048893|NCT02152956|541319482|FG004|Overall Study|Adverse Event|0|||
150048894|NCT02152956|541319483|FG005|Overall Study|Adverse Event|0|||
150048895|NCT02152956|541319484|FG006|Overall Study|Adverse Event|0|||
150048896|NCT02152956|541319485|FG007|Overall Study|Adverse Event|0|||
150048897|NCT02152956|541319486|FG008|Overall Study|Adverse Event|0|||
150048898|NCT02152956|541319487|FG009|Overall Study|Adverse Event|0|||
150048899|NCT02152956|541319488|FG010|Overall Study|Adverse Event|0|||
150048900|NCT02152956|541319489|FG011|Overall Study|Adverse Event|4|||
150048901|NCT02152956|541319490|FG012|Overall Study|Adverse Event|0|||
150048902|NCT02152956|541319478|FG000|Overall Study|Death|0|||
150048903|NCT02152956|541319479|FG001|Overall Study|Death|3|||
150048904|NCT02152956|541319480|FG002|Overall Study|Death|3|||
150048905|NCT02152956|541319481|FG003|Overall Study|Death|4|||
150048906|NCT02152956|541319482|FG004|Overall Study|Death|1|||
150048907|NCT02152956|541319483|FG005|Overall Study|Death|2|||
150048908|NCT02152956|541319484|FG006|Overall Study|Death|6|||
150048909|NCT02152956|541319485|FG007|Overall Study|Death|6|||
150048910|NCT02152956|541319486|FG008|Overall Study|Death|4|||
150048911|NCT02152956|541319487|FG009|Overall Study|Death|5|||
150048912|NCT02152956|541319488|FG010|Overall Study|Death|3|||
150048913|NCT02152956|541319489|FG011|Overall Study|Death|143|||
150048914|NCT02152956|541319490|FG012|Overall Study|Death|12|||
150048915|NCT02152956|541319478|FG000|Overall Study|Lost to Follow-up|0|||
150048916|NCT02152956|541319479|FG001|Overall Study|Lost to Follow-up|1|||
150048917|NCT02152956|541319480|FG002|Overall Study|Lost to Follow-up|0|||
150048918|NCT02152956|541319481|FG003|Overall Study|Lost to Follow-up|0|||
150048919|NCT02152956|541319482|FG004|Overall Study|Lost to Follow-up|0|||
150048920|NCT02152956|541319483|FG005|Overall Study|Lost to Follow-up|0|||
150048921|NCT02152956|541319484|FG006|Overall Study|Lost to Follow-up|0|||
150048922|NCT02152956|541319485|FG007|Overall Study|Lost to Follow-up|0|||
150048923|NCT02152956|541319486|FG008|Overall Study|Lost to Follow-up|0|||
150048924|NCT02152956|541319487|FG009|Overall Study|Lost to Follow-up|0|||
150048925|NCT02152956|541319488|FG010|Overall Study|Lost to Follow-up|0|||
150048926|NCT02152956|541319489|FG011|Overall Study|Lost to Follow-up|3|||
150048927|NCT02152956|541319490|FG012|Overall Study|Lost to Follow-up|0|||
150048928|NCT02152956|541319478|FG000|Overall Study|Withdrawal by Subject|1|||
150048929|NCT02152956|541319479|FG001|Overall Study|Withdrawal by Subject|0|||
150048930|NCT02152956|541319480|FG002|Overall Study|Withdrawal by Subject|1|||
150048931|NCT02152956|541319481|FG003|Overall Study|Withdrawal by Subject|0|||
150048932|NCT02152956|541319482|FG004|Overall Study|Withdrawal by Subject|2|||
150048933|NCT02152956|541319483|FG005|Overall Study|Withdrawal by Subject|2|||
150048934|NCT02152956|541319484|FG006|Overall Study|Withdrawal by Subject|0|||
150048935|NCT02152956|541319485|FG007|Overall Study|Withdrawal by Subject|0|||
150048936|NCT02152956|541319486|FG008|Overall Study|Withdrawal by Subject|1|||
150048937|NCT02152956|541319487|FG009|Overall Study|Withdrawal by Subject|0|||
150048938|NCT02152956|541319488|FG010|Overall Study|Withdrawal by Subject|0|||
149908616|NCT04569968|540793842|FG000|Overall Study|Cooperation|8|||
149908617|NCT04569968|540793843|FG001|Overall Study|Cooperation|8|||
149908618|NCT04569968|540793842|FG000|Overall Study|Age interval|17|||
149908619|NCT04569968|540793843|FG001|Overall Study|Age interval|6|||
149908620|NCT04569968|540793842|FG000|Overall Study|Denial of participation to the study|0|||
149908621|NCT04569968|540793843|FG001|Overall Study|Denial of participation to the study|3|||
149908622|NCT04569968|540793842|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
149908623|NCT04569968|540793843|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
150048939|NCT02152956|541319489|FG011|Overall Study|Withdrawal by Subject|4|||
150048940|NCT02152956|541319490|FG012|Overall Study|Withdrawal by Subject|0|||
150048941|NCT02152956|541319478|FG000|Overall Study|Physician Decision|0|||
150048942|NCT02152956|541319479|FG001|Overall Study|Physician Decision|0|||
150048943|NCT02152956|541319480|FG002|Overall Study|Physician Decision|0|||
150048944|NCT02152956|541319481|FG003|Overall Study|Physician Decision|0|||
150048945|NCT02152956|541319482|FG004|Overall Study|Physician Decision|0|||
150048946|NCT02152956|541319483|FG005|Overall Study|Physician Decision|0|||
150048947|NCT02152956|541319484|FG006|Overall Study|Physician Decision|0|||
150048948|NCT02152956|541319485|FG007|Overall Study|Physician Decision|0|||
150048949|NCT02152956|541319486|FG008|Overall Study|Physician Decision|0|||
150048950|NCT02152956|541319487|FG009|Overall Study|Physician Decision|0|||
150048951|NCT02152956|541319488|FG010|Overall Study|Physician Decision|0|||
150048952|NCT02152956|541319489|FG011|Overall Study|Physician Decision|1|||
150048953|NCT02152956|541319490|FG012|Overall Study|Physician Decision|0|||
150048954|NCT02152956|541319478|FG000|Overall Study|Study terminated by sponsor|0|||
150048955|NCT02152956|541319479|FG001|Overall Study|Study terminated by sponsor|0|||
150048956|NCT02152956|541319480|FG002|Overall Study|Study terminated by sponsor|0|||
150048957|NCT02152956|541319481|FG003|Overall Study|Study terminated by sponsor|0|||
150048958|NCT02152956|541319482|FG004|Overall Study|Study terminated by sponsor|0|||
149908624|NCT04569968|540793842|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
149908625|NCT04569968|540793843|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
149908626|NCT04569968|540793842|FG000|Overall Study|Quarantine|1|||
150176763|NCT01787760|541783415|FG001|Overall Study|Decompensated on left exotropia|0|||
150176764|NCT01787760|541783416|FG002|Overall Study|Decompensated on left exotropia|1|||
149908627|NCT04569968|540793843|FG001|Overall Study|Quarantine|0|||
150048959|NCT02152956|541319483|FG005|Overall Study|Study terminated by sponsor|0|||
150048960|NCT02152956|541319484|FG006|Overall Study|Study terminated by sponsor|0|||
150048961|NCT02152956|541319485|FG007|Overall Study|Study terminated by sponsor|0|||
150048962|NCT02152956|541319486|FG008|Overall Study|Study terminated by sponsor|0|||
150048963|NCT02152956|541319487|FG009|Overall Study|Study terminated by sponsor|0|||
150048964|NCT02152956|541319488|FG010|Overall Study|Study terminated by sponsor|0|||
150048965|NCT02152956|541319489|FG011|Overall Study|Study terminated by sponsor|29|||
150048966|NCT02152956|541319490|FG012|Overall Study|Study terminated by sponsor|0|||
150048967|NCT02152956|541319478|FG000|Overall Study|progressive disease|0|||
150048968|NCT02152956|541319479|FG001|Overall Study|progressive disease|0|||
150048969|NCT02152956|541319480|FG002|Overall Study|progressive disease|0|||
150048970|NCT02152956|541319481|FG003|Overall Study|progressive disease|0|||
150048971|NCT02152956|541319482|FG004|Overall Study|progressive disease|0|||
150048972|NCT02152956|541319483|FG005|Overall Study|progressive disease|0|||
150048973|NCT02152956|541319484|FG006|Overall Study|progressive disease|0|||
150048974|NCT02152956|541319485|FG007|Overall Study|progressive disease|0|||
150048975|NCT02152956|541319486|FG008|Overall Study|progressive disease|1|||
150048976|NCT02152956|541319487|FG009|Overall Study|progressive disease|0|||
150048977|NCT02152956|541319488|FG010|Overall Study|progressive disease|0|||
150048978|NCT02152956|541319489|FG011|Overall Study|progressive disease|1|||
150048979|NCT02152956|541319490|FG012|Overall Study|progressive disease|0|||
150048980|NCT01014910|541319491|FG000|Overall Study|Withdrawal by Subject|0|||
149908628|NCT04569968|540793842|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
149908629|NCT04569968|540793843|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
149908630|NCT04569968|540793842|FG000|Overall Study|Repetitive stroke|8|||
149908631|NCT04569968|540793843|FG001|Overall Study|Repetitive stroke|0|||
149908632|NCT04569968|540793842|FG000|Overall Study|Insufficient mastication|1|||
149908633|NCT04569968|540793843|FG001|Overall Study|Insufficient mastication|0|||
149908634|NCT04569968|540793842|FG000|Overall Study|Infection|1|||
149908635|NCT04569968|540793843|FG001|Overall Study|Infection|0|||
149908636|NCT00727844|540793844|FG000|Initial Randomization|Physician Decision|2|||
149908637|NCT00727844|540793845|FG001|Initial Randomization|Physician Decision|0|||
149908638|NCT00727844|540793846|FG002|Initial Randomization|Physician Decision|0|||
149908639|NCT00727844|540793847|FG003|Initial Randomization|Physician Decision|0|||
149908640|NCT00985959|540793855|FG000|Overall Study|Adverse Event|0|||
149908641|NCT00985959|540793856|FG001|Overall Study|Adverse Event|0|||
149908642|NCT00985959|540793857|FG002|Overall Study|Adverse Event|19|||
149908643|NCT00985959|540793855|FG000|Overall Study|Withdrawal by Subject|0|||
149908644|NCT00985959|540793856|FG001|Overall Study|Withdrawal by Subject|0|||
149908645|NCT00985959|540793857|FG002|Overall Study|Withdrawal by Subject|8|||
149908646|NCT00985959|540793855|FG000|Overall Study|Progressive disease|1|||
149908647|NCT00985959|540793856|FG001|Overall Study|Progressive disease|2|||
149908648|NCT00985959|540793857|FG002|Overall Study|Progressive disease|8|||
149971474|NCT01400412|541031868|FG001|Overall Study|Never started study treatment|3|||
149971475|NCT01083602|541033648|FG000|Overall Study|Adverse Event|11|||
149971476|NCT01083602|541033648|FG000|Overall Study|New Cancer Therapy|2|||
149971477|NCT01083602|541033648|FG000|Overall Study|Death|1|||
149971478|NCT01083602|541033648|FG000|Overall Study|Withdrawal by Subject|5|||
149971479|NCT01083602|541033648|FG000|Overall Study|Lack of Efficacy|36|||
149971480|NCT01657370|541033649|FG000|Overall Study|Withdrawal by Subject|0|||
149971481|NCT01657370|541033650|FG001|Overall Study|Withdrawal by Subject|0|||
149971482|NCT01657370|541033651|FG002|Overall Study|Withdrawal by Subject|1|||
149971483|NCT01657370|541033652|FG003|Overall Study|Withdrawal by Subject|0|||
149971484|NCT01657370|541033653|FG004|Overall Study|Withdrawal by Subject|0|||
149971485|NCT01657370|541033654|FG005|Overall Study|Withdrawal by Subject|1|||
149971486|NCT01657370|541033649|FG000|Overall Study|Physician Decision|2|||
150048981|NCT01014910|541319492|FG001|Overall Study|Withdrawal by Subject|2|||
150048982|NCT02445794|541319493|FG000|Overall Study|Adverse Event|0|||
150048983|NCT02445794|541319494|FG001|Overall Study|Adverse Event|0|||
150048984|NCT02445794|541319495|FG002|Overall Study|Adverse Event|2|||
150176765|NCT01787760|541783414|FG000|Overall Study|Dryness|0|||
150176766|NCT01787760|541783415|FG001|Overall Study|Dryness|1|||
149908649|NCT00985959|540793855|FG000|Overall Study|Unrecovered toxicity|0|||
149908650|NCT00985959|540793856|FG001|Overall Study|Unrecovered toxicity|0|||
149908651|NCT00985959|540793857|FG002|Overall Study|Unrecovered toxicity|7|||
149971487|NCT01657370|541033650|FG001|Overall Study|Physician Decision|3|||
149971488|NCT01657370|541033651|FG002|Overall Study|Physician Decision|1|||
149971489|NCT01657370|541033652|FG003|Overall Study|Physician Decision|2|||
149971490|NCT01657370|541033653|FG004|Overall Study|Physician Decision|5|||
149971491|NCT01657370|541033654|FG005|Overall Study|Physician Decision|0|||
150048985|NCT02445794|541319496|FG003|Overall Study|Adverse Event|0|||
150176767|NCT01787760|541783416|FG002|Overall Study|Dryness|0|||
149971492|NCT01657370|541033649|FG000|Overall Study|Lack of Qualifying Event|1|||
149971493|NCT01657370|541033650|FG001|Overall Study|Lack of Qualifying Event|0|||
149971494|NCT01657370|541033651|FG002|Overall Study|Lack of Qualifying Event|3|||
149971495|NCT01657370|541033652|FG003|Overall Study|Lack of Qualifying Event|2|||
149971496|NCT01657370|541033653|FG004|Overall Study|Lack of Qualifying Event|1|||
149971497|NCT01657370|541033654|FG005|Overall Study|Lack of Qualifying Event|2|||
149971498|NCT01657370|541033649|FG000|Overall Study|Adverse Event|0|||
149971499|NCT01657370|541033650|FG001|Overall Study|Adverse Event|0|||
149971500|NCT01657370|541033651|FG002|Overall Study|Adverse Event|0|||
149971501|NCT01657370|541033652|FG003|Overall Study|Adverse Event|0|||
149971502|NCT01657370|541033653|FG004|Overall Study|Adverse Event|1|||
149971503|NCT01657370|541033654|FG005|Overall Study|Adverse Event|0|||
149971504|NCT01657370|541033649|FG000|Overall Study|Protocol Violation|1|||
149971505|NCT01657370|541033650|FG001|Overall Study|Protocol Violation|1|||
149971506|NCT01657370|541033651|FG002|Overall Study|Protocol Violation|1|||
150048986|NCT01136785|541319497|FG000|Overall Study|Protocol Violation|2|||
150048987|NCT01136785|541319498|FG001|Overall Study|Protocol Violation|1|||
150048988|NCT01388985|541319499|FG000|Overall Study|Death|0|||
150048989|NCT01388985|541319500|FG001|Overall Study|Death|1|||
150048990|NCT01388985|541319499|FG000|Overall Study|Lost to Follow-up|30|||
150048991|NCT01388985|541319500|FG001|Overall Study|Lost to Follow-up|30|||
150048992|NCT01388985|541319499|FG000|Overall Study|Withdrawal by Subject|13|||
150048993|NCT01388985|541319500|FG001|Overall Study|Withdrawal by Subject|4|||
150048994|NCT01388985|541319499|FG000|Overall Study|Subject unavailable|1|||
150048995|NCT01388985|541319500|FG001|Overall Study|Subject unavailable|1|||
150048996|NCT01388985|541319499|FG000|Overall Study|Other (no reason)|0|||
150048997|NCT01388985|541319500|FG001|Overall Study|Other (no reason)|1|||
150048998|NCT01388985|541319499|FG000|Overall Study|Error of nurse|5|||
150048999|NCT01388985|541319500|FG001|Overall Study|Error of nurse|1|||
150049000|NCT01794338|541321701|FG000|Overall Study|Death|2|||
150049001|NCT01794338|541321702|FG001|Overall Study|Death|0|||
150049002|NCT01794338|541321701|FG000|Overall Study|Lost to Follow-up|6|||
150049003|NCT01794338|541321702|FG001|Overall Study|Lost to Follow-up|9|||
150049004|NCT04473235|541321703|FG000|Overall Study|Lost to Follow-up|6|||
150049005|NCT04473235|541321704|FG001|Overall Study|Lost to Follow-up|5|||
150049006|NCT04473235|541321703|FG000|Overall Study|Declined continuation|2|||
150049007|NCT04473235|541321704|FG001|Overall Study|Declined continuation|0|||
150049008|NCT04473235|541321703|FG000|Overall Study|Physician Decision|1|||
150049009|NCT04473235|541321704|FG001|Overall Study|Physician Decision|1|||
150049010|NCT04473235|541321703|FG000|Overall Study|Protocol Violation|10|||
150049011|NCT04473235|541321704|FG001|Overall Study|Protocol Violation|6|||
150049012|NCT01754402|541321705|FG000|Overall Study|Death|0|||
150049013|NCT01754402|541321706|FG001|Overall Study|Death|0|||
150049014|NCT01754402|541321707|FG002|Overall Study|Death|1|||
150049015|NCT01754402|541321705|FG000|Overall Study|Adverse Event|2|||
150049016|NCT01754402|541321706|FG001|Overall Study|Adverse Event|2|||
150049017|NCT01754402|541321707|FG002|Overall Study|Adverse Event|1|||
150049018|NCT01754402|541321705|FG000|Overall Study|Withdrawal by Subject|0|||
150049019|NCT01754402|541321706|FG001|Overall Study|Withdrawal by Subject|0|||
149971507|NCT01657370|541033652|FG003|Overall Study|Protocol Violation|1|||
150049020|NCT01754402|541321707|FG002|Overall Study|Withdrawal by Subject|1|||
150049021|NCT01754402|541321705|FG000|Overall Study|Lack of Efficacy|0|||
150049022|NCT01754402|541321706|FG001|Overall Study|Lack of Efficacy|0|||
150049023|NCT01754402|541321707|FG002|Overall Study|Lack of Efficacy|1|||
150049024|NCT01282463|541321708|FG000|Overall Study|Lost to Follow-up|1|||
150049025|NCT01282463|541321709|FG001|Overall Study|Lost to Follow-up|0|||
150049026|NCT01282463|541321710|FG002|Overall Study|Lost to Follow-up|0|||
150049027|NCT01282463|541321708|FG000|Overall Study|Withdrawal by Subject|6|||
150049028|NCT01282463|541321709|FG001|Overall Study|Withdrawal by Subject|2|||
150049029|NCT01282463|541321710|FG002|Overall Study|Withdrawal by Subject|3|||
150049030|NCT01282463|541321708|FG000|Overall Study|"Never Treated Death"|0|||
150049031|NCT01282463|541321709|FG001|Overall Study|"Never Treated Death"|1|||
150049032|NCT01282463|541321710|FG002|Overall Study|"Never Treated Death"|0|||
150049033|NCT01282463|541321708|FG000|Overall Study|"Never Treated PD"|0|||
150049034|NCT01282463|541321709|FG001|Overall Study|"Never Treated PD"|1|||
150049035|NCT01282463|541321710|FG002|Overall Study|"Never Treated PD"|0|||
150049036|NCT01282463|541321708|FG000|Overall Study|Protocol Violation|0|||
150049037|NCT01282463|541321709|FG001|Overall Study|Protocol Violation|0|||
150049038|NCT01282463|541321710|FG002|Overall Study|Protocol Violation|1|||
150049039|NCT01282463|541321708|FG000|Overall Study|Physician Decision|1|||
150049040|NCT01282463|541321709|FG001|Overall Study|Physician Decision|0|||
150049041|NCT01282463|541321710|FG002|Overall Study|Physician Decision|0|||
149971508|NCT01657370|541033653|FG004|Overall Study|Protocol Violation|0|||
149971509|NCT01657370|541033654|FG005|Overall Study|Protocol Violation|0|||
149971510|NCT01657370|541033649|FG000|Overall Study|Lost to Follow-up|2|||
149971511|NCT01657370|541033650|FG001|Overall Study|Lost to Follow-up|0|||
149971512|NCT01657370|541033651|FG002|Overall Study|Lost to Follow-up|1|||
149971513|NCT01657370|541033652|FG003|Overall Study|Lost to Follow-up|0|||
150049042|NCT00798759|541321711|FG000|Overall Study|Adverse Event|3|||
150049043|NCT00798759|541321712|FG001|Overall Study|Adverse Event|3|||
150049044|NCT00798759|541321711|FG000|Overall Study|Lost to Follow-up|1|||
150049045|NCT00798759|541321712|FG001|Overall Study|Lost to Follow-up|1|||
150049046|NCT00798759|541321711|FG000|Overall Study|Protocol Violation|4|||
150049047|NCT00798759|541321712|FG001|Overall Study|Protocol Violation|8|||
150049048|NCT00798759|541321711|FG000|Overall Study|Other|0|||
150049049|NCT00798759|541321712|FG001|Overall Study|Other|1|||
149971514|NCT01657370|541033653|FG004|Overall Study|Lost to Follow-up|0|||
150049050|NCT03320824|541321713|FG000|Overall Study|Withdrawal by Subject|8|||
150049051|NCT03320824|541321714|FG001|Overall Study|Withdrawal by Subject|1|||
150049052|NCT03320824|541321713|FG000|Overall Study|Lost to Follow-up|10|||
150049053|NCT03320824|541321714|FG001|Overall Study|Lost to Follow-up|1|||
150049054|NCT03320824|541321713|FG000|Overall Study|moved out of state|0|||
150049055|NCT03320824|541321714|FG001|Overall Study|moved out of state|1|||
150049056|NCT03320824|541321713|FG000|Overall Study|could not complete final visit|0|||
150049057|NCT03320824|541321714|FG001|Overall Study|could not complete final visit|1|||
150049058|NCT00955305|541321715|FG000|Overall Study|Disease progression|39|||
150049059|NCT00955305|541321716|FG001|Overall Study|Disease progression|41|||
150049060|NCT00955305|541321715|FG000|Overall Study|Adverse Event|22|||
150049061|NCT00955305|541321716|FG001|Overall Study|Adverse Event|22|||
150049062|NCT00955305|541321715|FG000|Overall Study|Death|2|||
150049063|NCT00955305|541321716|FG001|Overall Study|Death|1|||
150049064|NCT00955305|541321715|FG000|Overall Study|Withdrawal by Subject|5|||
150049065|NCT00955305|541321716|FG001|Overall Study|Withdrawal by Subject|4|||
150049066|NCT00955305|541321715|FG000|Overall Study|Alternative therapy|4|||
150049067|NCT00955305|541321716|FG001|Overall Study|Alternative therapy|0|||
150049068|NCT00955305|541321715|FG000|Overall Study|Other complicating disease|2|||
150049069|NCT00955305|541321716|FG001|Overall Study|Other complicating disease|4|||
149971515|NCT01657370|541033654|FG005|Overall Study|Lost to Follow-up|1|||
149971516|NCT04043286|541033655|FG000|Overall Study|Withdrawal by Subject|2|||
149971517|NCT04043286|541033656|FG001|Overall Study|Withdrawal by Subject|2|||
149971518|NCT03698279|541033657|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149971519|NCT03698279|541033658|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149971520|NCT03698279|541033659|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149971521|NCT03698279|541033660|FG003|Overall Study|Withdrawal by parent/guardian|1|||
149971522|NCT03698279|541033661|FG004|Overall Study|Withdrawal by parent/guardian|0|||
149971523|NCT03698279|541033662|FG005|Overall Study|Withdrawal by parent/guardian|0|||
149971524|NCT03698279|541033657|FG000|Overall Study|Protocol deviation|1|||
149971525|NCT03698279|541033658|FG001|Overall Study|Protocol deviation|0|||
149971526|NCT03698279|541033659|FG002|Overall Study|Protocol deviation|1|||
149971527|NCT03698279|541033660|FG003|Overall Study|Protocol deviation|0|||
149971528|NCT03698279|541033661|FG004|Overall Study|Protocol deviation|0|||
149971529|NCT03698279|541033662|FG005|Overall Study|Protocol deviation|0|||
149971530|NCT03698279|541033657|FG000|Overall Study|Withdrawal by Subject|0|||
149971531|NCT03698279|541033658|FG001|Overall Study|Withdrawal by Subject|0|||
149971532|NCT03698279|541033659|FG002|Overall Study|Withdrawal by Subject|1|||
149971533|NCT03698279|541033660|FG003|Overall Study|Withdrawal by Subject|0|||
149971534|NCT03698279|541033661|FG004|Overall Study|Withdrawal by Subject|0|||
149971535|NCT03698279|541033662|FG005|Overall Study|Withdrawal by Subject|0|||
149971536|NCT03698279|541033657|FG000|Overall Study|Lost to Follow-up|3|||
149971537|NCT03698279|541033658|FG001|Overall Study|Lost to Follow-up|1|||
149971538|NCT03698279|541033659|FG002|Overall Study|Lost to Follow-up|4|||
149971539|NCT03698279|541033660|FG003|Overall Study|Lost to Follow-up|5|||
149971540|NCT03698279|541033661|FG004|Overall Study|Lost to Follow-up|0|||
149971541|NCT03698279|541033662|FG005|Overall Study|Lost to Follow-up|0|||
149971542|NCT01198587|541033668|FG000|Overall Study|Lost to Follow-up|8|||
149971543|NCT01198587|541033669|FG001|Overall Study|Lost to Follow-up|0|||
149971544|NCT01198587|541033670|FG002|Overall Study|Lost to Follow-up|9|||
149971545|NCT01198587|541033671|FG003|Overall Study|Lost to Follow-up|0|||
149971546|NCT02234362|541033672|FG000|Overall Study|Not eligible after first screening visit|17|||
149971547|NCT02234362|541033672|FG000|Overall Study|Lost to Follow-up|6|||
149971548|NCT02234362|541033672|FG000|Overall Study|Withdrawal by Subject|3|||
149971549|NCT01959529|541033673|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
150049070|NCT00955305|541321715|FG000|Overall Study|Physician Decision|1|||
150049071|NCT00955305|541321716|FG001|Overall Study|Physician Decision|0|||
150049072|NCT00955305|541321715|FG000|Overall Study|Continued presence of residual disease|0|||
150049073|NCT00955305|541321716|FG001|Overall Study|Continued presence of residual disease|1|||
150049074|NCT00955305|541321715|FG000|Overall Study|Functional decline|2|||
149971550|NCT01959529|541033674|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
149971551|NCT01959529|541033673|FG000|Overall Study|Lost to Follow-up|4|||
149971552|NCT01959529|541033674|FG001|Overall Study|Lost to Follow-up|1|||
150049075|NCT00955305|541321716|FG001|Overall Study|Functional decline|0|||
150049076|NCT00955305|541321715|FG000|Overall Study|Maximum response achieved|0|||
149971553|NCT01959529|541033673|FG000|Overall Study|Other|70|||
149971554|NCT01959529|541033674|FG001|Overall Study|Other|68|||
149971555|NCT01959529|541033673|FG000|Overall Study|Hypoglycaemia|1|||
149971556|NCT01959529|541033674|FG001|Overall Study|Hypoglycaemia|1|||
149971557|NCT01959529|541033673|FG000|Overall Study|Lack of glycaemic control|1|||
149971558|NCT01959529|541033674|FG001|Overall Study|Lack of glycaemic control|1|||
149908652|NCT00985959|540793855|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
150049077|NCT00955305|541321716|FG001|Overall Study|Maximum response achieved|1|||
150049078|NCT00955305|541321715|FG000|Overall Study|Lost to Follow-up|0|||
150049079|NCT00955305|541321716|FG001|Overall Study|Lost to Follow-up|1|||
150049080|NCT00955305|541321715|FG000|Overall Study|No off-treatment reason submitted|1|||
150049081|NCT00955305|541321716|FG001|Overall Study|No off-treatment reason submitted|0|||
150049082|NCT00955305|541321715|FG000|Overall Study|Never started protocol treatment|5|||
150049083|NCT00955305|541321716|FG001|Overall Study|Never started protocol treatment|5|||
150049084|NCT00955305|541321715|FG000|Overall Study|Ineligible|5|||
150049085|NCT00955305|541321716|FG001|Overall Study|Ineligible|7|||
150049086|NCT00109590|541321717|FG000|Overall Study|Lost to Follow-up|1|||
150049087|NCT00109590|541321718|FG001|Overall Study|Lost to Follow-up|0|||
150049088|NCT00109590|541321719|FG002|Overall Study|Lost to Follow-up|1|||
150049089|NCT00109590|541321717|FG000|Overall Study|Never Started Treatment|1|||
150049090|NCT00109590|541321718|FG001|Overall Study|Never Started Treatment|2|||
150049091|NCT00109590|541321719|FG002|Overall Study|Never Started Treatment|3|||
150049092|NCT02123251|541321720|FG000|Overall Study|Death|1|||
150049093|NCT02123251|541321721|FG001|Overall Study|Death|1|||
150049094|NCT02123251|541321720|FG000|Overall Study|Withdrawal by Subject|0|||
150049095|NCT02123251|541321721|FG001|Overall Study|Withdrawal by Subject|3|||
150049096|NCT02123251|541321720|FG000|Overall Study|Lost Medicaid eligibility|29|||
150049097|NCT02123251|541321721|FG001|Overall Study|Lost Medicaid eligibility|22|||
150049098|NCT02123251|541321720|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
150049099|NCT02123251|541321721|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
150049100|NCT01221285|541321722|FG000|Overall Study|Withdrawal by Subject|1|||
150049101|NCT03387111|541321723|FG000|Overall Study|Progressive Disease|3|||
150049102|NCT03387111|541321723|FG000|Overall Study|Other|1|||
150049103|NCT01945710|541321727|FG000|Overall Study|Progressive Disease|5|||
150049104|NCT01945710|541321728|FG001|Overall Study|Progressive Disease|4|||
150049105|NCT01945710|541321729|FG002|Overall Study|Progressive Disease|3|||
150049106|NCT01945710|541321730|FG003|Overall Study|Progressive Disease|2|||
150049107|NCT01945710|541321731|FG004|Overall Study|Progressive Disease|7|||
150049108|NCT01945710|541321732|FG005|Overall Study|Progressive Disease|3|||
150049109|NCT01945710|541321733|FG006|Overall Study|Progressive Disease|19|||
150049110|NCT01945710|541321727|FG000|Overall Study|Adverse Event|0|||
150049111|NCT01945710|541321728|FG001|Overall Study|Adverse Event|1|||
150049112|NCT01945710|541321729|FG002|Overall Study|Adverse Event|0|||
150049113|NCT01945710|541321730|FG003|Overall Study|Adverse Event|0|||
150049114|NCT01945710|541321731|FG004|Overall Study|Adverse Event|0|||
150049115|NCT01945710|541321732|FG005|Overall Study|Adverse Event|0|||
150049116|NCT01945710|541321733|FG006|Overall Study|Adverse Event|0|||
150049117|NCT01945710|541321727|FG000|Overall Study|Other|2|||
150049118|NCT01945710|541321728|FG001|Overall Study|Other|0|||
150049119|NCT01945710|541321729|FG002|Overall Study|Other|3|||
150049120|NCT01945710|541321730|FG003|Overall Study|Other|1|||
150049121|NCT01945710|541321731|FG004|Overall Study|Other|1|||
150049122|NCT01945710|541321732|FG005|Overall Study|Other|0|||
150049123|NCT01945710|541321733|FG006|Overall Study|Other|4|||
150049124|NCT01945710|541321727|FG000|Overall Study|Withdrawal by Subject|0|||
150049125|NCT01945710|541321728|FG001|Overall Study|Withdrawal by Subject|1|||
150049126|NCT01945710|541321729|FG002|Overall Study|Withdrawal by Subject|1|||
150049127|NCT01945710|541321730|FG003|Overall Study|Withdrawal by Subject|0|||
150049128|NCT01945710|541321731|FG004|Overall Study|Withdrawal by Subject|1|||
150049129|NCT01945710|541321732|FG005|Overall Study|Withdrawal by Subject|0|||
150049130|NCT01945710|541321733|FG006|Overall Study|Withdrawal by Subject|0|||
150049131|NCT02730195|541321734|FG000|Overall Study|Withdrawal by Subject|1|||
150049132|NCT02338882|541321735|FG000|Overall Study|Death|1|||
150049133|NCT02338882|541321736|FG001|Overall Study|Death|0|||
150049134|NCT02338882|541321735|FG000|Overall Study|Lost to Follow-up|6|||
150049135|NCT02338882|541321736|FG001|Overall Study|Lost to Follow-up|3|||
150049136|NCT01904773|541321739|FG000|Screen|Screen failure|3|||
150049137|NCT01904773|541321740|FG001|Screen|Screen failure|0|||
150049138|NCT01904773|541321741|FG002|Screen|Screen failure|0|||
150049139|NCT01904773|541321742|FG003|Screen|Screen failure|0|||
150049140|NCT01904773|541321743|FG004|Screen|Screen failure|0|||
150049141|NCT01904773|541321744|FG005|Screen|Screen failure|0|||
149908653|NCT00985959|540793856|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
150049142|NCT01904773|541321745|FG006|Screen|Screen failure|0|||
150049143|NCT01904773|541321746|FG007|Screen|Screen failure|0|||
150049144|NCT01904773|541321747|FG008|Screen|Screen failure|0|||
150049145|NCT01904773|541321739|FG000|Screen|Withdrawal by Subject|1|||
150049146|NCT01904773|541321740|FG001|Screen|Withdrawal by Subject|0|||
150049147|NCT01904773|541321741|FG002|Screen|Withdrawal by Subject|0|||
149908654|NCT00985959|540793857|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
149908655|NCT00985959|540793855|FG000|Overall Study|Complete response observed over 2 cycles|0|||
150049148|NCT01904773|541321742|FG003|Screen|Withdrawal by Subject|0|||
150049149|NCT01904773|541321743|FG004|Screen|Withdrawal by Subject|0|||
150049150|NCT01904773|541321744|FG005|Screen|Withdrawal by Subject|0|||
150049151|NCT01904773|541321745|FG006|Screen|Withdrawal by Subject|0|||
149908656|NCT00985959|540793856|FG001|Overall Study|Complete response observed over 2 cycles|1|||
149908657|NCT00985959|540793857|FG002|Overall Study|Complete response observed over 2 cycles|4|||
149908658|NCT00985959|540793855|FG000|Overall Study|Other|0|||
149908659|NCT00985959|540793856|FG001|Overall Study|Other|0|||
149908660|NCT00985959|540793857|FG002|Overall Study|Other|11|||
149908661|NCT00471718|540793859|FG000|Overall Study|Adverse Event|3|||
149908662|NCT00471718|540793859|FG000|Overall Study|other complicating disease|1|||
149908663|NCT00471718|540793859|FG000|Overall Study|disease progression|22|||
149908664|NCT00471718|540793859|FG000|Overall Study|Withdrawal by Subject|1|||
149908665|NCT00746564|540793868|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
149908666|NCT02640677|540793871|FG000|Overall Study|Lost to Follow-up|1|||
149908667|NCT02640677|540793871|FG000|Overall Study|Withdrawal by Subject|1|||
149908668|NCT00957268|540793873|FG000|Overall Study|Voluntary Withdrawal|0|||
149908669|NCT00957268|540793874|FG001|Overall Study|Voluntary Withdrawal|0|||
149908670|NCT00957268|540793875|FG002|Overall Study|Voluntary Withdrawal|1|||
149908671|NCT00957268|540793876|FG003|Overall Study|Voluntary Withdrawal|0|||
149908672|NCT00957268|540793877|FG004|Overall Study|Voluntary Withdrawal|0|||
149908673|NCT01817582|540793880|FG000|Overall Study|Withdrawal by Subject|0|||
149908674|NCT01817582|540793881|FG001|Overall Study|Withdrawal by Subject|1|||
149908675|NCT01817582|540793882|FG002|Overall Study|Withdrawal by Subject|0|||
149908676|NCT01817582|540793880|FG000|Overall Study|Participant revealed masked treatment|1|||
149908677|NCT01817582|540793881|FG001|Overall Study|Participant revealed masked treatment|0|||
149908678|NCT01817582|540793882|FG002|Overall Study|Participant revealed masked treatment|0|||
149908679|NCT01817582|540793880|FG000|Overall Study|Randomized but exclusion criteria met|1|||
149908680|NCT01817582|540793881|FG001|Overall Study|Randomized but exclusion criteria met|0|||
149908681|NCT01817582|540793882|FG002|Overall Study|Randomized but exclusion criteria met|0|||
149908682|NCT03197467|540796183|FG000|Overall Study|Withdrawal by Subject|1|||
149908683|NCT04338269|540796188|FG000|Overall Study|Death|86|||
149908684|NCT04338269|540796189|FG001|Overall Study|Death|89|||
149908685|NCT04338269|540796188|FG000|Overall Study|Lost to Follow-up|1|||
149908686|NCT04338269|540796189|FG001|Overall Study|Lost to Follow-up|2|||
149908687|NCT04338269|540796188|FG000|Overall Study|Physician Decision|1|||
149908688|NCT04338269|540796189|FG001|Overall Study|Physician Decision|0|||
149908689|NCT04338269|540796188|FG000|Overall Study|Withdrawal by Subject|14|||
149908690|NCT04338269|540796189|FG001|Overall Study|Withdrawal by Subject|11|||
149908691|NCT03339726|540796190|FG000|Overall Study|Withdrawal by Subject|1|||
149908692|NCT03339726|540796191|FG001|Overall Study|Withdrawal by Subject|0|||
149908693|NCT03339726|540796192|FG002|Overall Study|Withdrawal by Subject|0|||
149908694|NCT03339726|540796190|FG000|Overall Study|Lost to Follow-up|0|||
149908695|NCT03339726|540796191|FG001|Overall Study|Lost to Follow-up|1|||
149908696|NCT03339726|540796192|FG002|Overall Study|Lost to Follow-up|0|||
149908697|NCT01482065|540796209|FG000|Overall Study|Withdrawal by Subject|0|||
149908698|NCT01482065|540796210|FG001|Overall Study|Withdrawal by Subject|1|||
149908699|NCT01942486|540796211|FG000|Overall Study|Lost to Follow-up|27|||
149908700|NCT03728426|540796212|FG000|Overall Study|Death|3|||
149908701|NCT02424630|540796213|FG000|Overall Study|No rotator cuff tear|1|||
149908702|NCT02424630|540796214|FG001|Overall Study|No rotator cuff tear|2|||
149908703|NCT02424630|540796213|FG000|Overall Study|Open procedure|0|||
149908704|NCT02424630|540796214|FG001|Overall Study|Open procedure|1|||
149908705|NCT02637895|540796215|FG000|Overall Study|Lost to Follow-up|4|||
149908706|NCT02637895|540796216|FG001|Overall Study|Lost to Follow-up|0|||
149908707|NCT02637895|540796215|FG000|Overall Study|Protocol Violation|0|||
149908708|NCT02637895|540796216|FG001|Overall Study|Protocol Violation|1|||
149908709|NCT02637895|540796215|FG000|Overall Study|Lack of Efficacy|1|||
149908710|NCT02637895|540796216|FG001|Overall Study|Lack of Efficacy|0|||
149908711|NCT02637895|540796215|FG000|Overall Study|Withdrawal by Subject|1|||
149908712|NCT02637895|540796216|FG001|Overall Study|Withdrawal by Subject|1|||
149908713|NCT02637895|540796215|FG000|Overall Study|Abnormal baseline lab|0|||
149908714|NCT02637895|540796216|FG001|Overall Study|Abnormal baseline lab|1|||
149908715|NCT01741792|540796217|FG000|Overall Study|Death|6|||
149908716|NCT01741792|540796218|FG001|Overall Study|Death|1|||
149908717|NCT01741792|540796219|FG002|Overall Study|Death|12|||
149908718|NCT00761280|540796220|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
149908719|NCT00761280|540796221|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
149908720|NCT00761280|540796220|FG000|Randomization to First Dose|Sponsor decision|1|||
149908721|NCT00761280|540796221|FG001|Randomization to First Dose|Sponsor decision|0|||
150049152|NCT01904773|541321746|FG007|Screen|Withdrawal by Subject|0|||
150049153|NCT01904773|541321747|FG008|Screen|Withdrawal by Subject|0|||
150049154|NCT01904773|541321739|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
150049155|NCT01904773|541321740|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049156|NCT01904773|541321741|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049157|NCT01904773|541321742|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049158|NCT01904773|541321743|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049159|NCT01904773|541321744|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049160|NCT01904773|541321745|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049161|NCT01904773|541321746|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049162|NCT01904773|541321747|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
150049163|NCT01904773|541321739|FG000|First Intervention|Adverse Event|0|||
150049164|NCT01904773|541321740|FG001|First Intervention|Adverse Event|0|||
150049165|NCT01904773|541321741|FG002|First Intervention|Adverse Event|0|||
150049166|NCT01904773|541321742|FG003|First Intervention|Adverse Event|0|||
149908722|NCT00761280|540796220|FG000|Randomization to First Dose|Other|1|||
149908723|NCT00761280|540796221|FG001|Randomization to First Dose|Other|0|||
149908724|NCT00761280|540796220|FG000|First Dose to End of Study|End of trial|5|||
149908725|NCT00761280|540796221|FG001|First Dose to End of Study|End of trial|5|||
149908726|NCT00761280|540796220|FG000|First Dose to End of Study|Progressive disease|5|||
149908727|NCT00761280|540796221|FG001|First Dose to End of Study|Progressive disease|3|||
149908728|NCT00761280|540796220|FG000|First Dose to End of Study|Sponsor decision|1|||
149908729|NCT00761280|540796221|FG001|First Dose to End of Study|Sponsor decision|2|||
149908730|NCT00761280|540796220|FG000|First Dose to End of Study|Death|1|||
149908731|NCT00761280|540796221|FG001|First Dose to End of Study|Death|0|||
149908732|NCT00761280|540796220|FG000|First Dose to End of Study|Lost to Follow-up|0|||
149908733|NCT00761280|540796221|FG001|First Dose to End of Study|Lost to Follow-up|1|||
149908734|NCT02045862|540796226|FG000|Overall Study|Death|0|||
149908735|NCT02045862|540796227|FG001|Overall Study|Death|0|||
149908736|NCT02045862|540796228|FG002|Overall Study|Death|1|||
149908737|NCT02045862|540796226|FG000|Overall Study|Miscellaneous|5|||
149908738|NCT02045862|540796227|FG001|Overall Study|Miscellaneous|0|||
149908739|NCT02045862|540796228|FG002|Overall Study|Miscellaneous|8|||
149908740|NCT02045862|540796226|FG000|Overall Study|Withdrawal by Patient|18|||
149908741|NCT02045862|540796227|FG001|Overall Study|Withdrawal by Patient|27|||
149908742|NCT02045862|540796228|FG002|Overall Study|Withdrawal by Patient|57|||
149908743|NCT02045862|540796226|FG000|Overall Study|Protocol Violation|0|||
149908744|NCT02045862|540796227|FG001|Overall Study|Protocol Violation|0|||
149908745|NCT02045862|540796228|FG002|Overall Study|Protocol Violation|6|||
149908746|NCT02045862|540796226|FG000|Overall Study|Lack of Efficacy|8|||
149971559|NCT00560417|541033682|FG000|Overall Study|Adverse Event|3|||
149971560|NCT00560417|541033683|FG001|Overall Study|Adverse Event|2|||
149971561|NCT00560417|541033682|FG000|Overall Study|Entry Criteria Not Met|1|||
149971562|NCT00560417|541033683|FG001|Overall Study|Entry Criteria Not Met|0|||
149971563|NCT00560417|541033682|FG000|Overall Study|Lost to Follow-up|0|||
149971564|NCT00560417|541033683|FG001|Overall Study|Lost to Follow-up|1|||
149971565|NCT00560417|541033682|FG000|Overall Study|Physician Decision|2|||
149971566|NCT00560417|541033683|FG001|Overall Study|Physician Decision|6|||
149971567|NCT00560417|541033682|FG000|Overall Study|Protocol Violation|6|||
149971568|NCT00560417|541033683|FG001|Overall Study|Protocol Violation|5|||
149971569|NCT00560417|541033682|FG000|Overall Study|Sponsor Decision|2|||
149971570|NCT00560417|541033683|FG001|Overall Study|Sponsor Decision|0|||
149971571|NCT00560417|541033682|FG000|Overall Study|Withdrawal by Subject|3|||
149971572|NCT00560417|541033683|FG001|Overall Study|Withdrawal by Subject|3|||
149971573|NCT02569853|541033684|FG000|Overall Study|Adverse Event|2|||
150049167|NCT01904773|541321743|FG004|First Intervention|Adverse Event|0|||
150049168|NCT01904773|541321744|FG005|First Intervention|Adverse Event|0|||
150049169|NCT01904773|541321745|FG006|First Intervention|Adverse Event|1|||
149908747|NCT02045862|540796227|FG001|Overall Study|Lack of Efficacy|4|||
149908748|NCT02045862|540796228|FG002|Overall Study|Lack of Efficacy|13|||
149908749|NCT02045862|540796226|FG000|Overall Study|Randomized but not Received Study Drug|0|||
149908750|NCT02045862|540796227|FG001|Overall Study|Randomized but not Received Study Drug|2|||
149908751|NCT02045862|540796228|FG002|Overall Study|Randomized but not Received Study Drug|8|||
149908752|NCT02045862|540796226|FG000|Overall Study|Adverse Event|7|||
149908753|NCT02045862|540796227|FG001|Overall Study|Adverse Event|5|||
149908754|NCT02045862|540796228|FG002|Overall Study|Adverse Event|27|||
149908755|NCT02045862|540796226|FG000|Overall Study|Lost to Follow-up|1|||
149971574|NCT02569853|541033685|FG001|Overall Study|Adverse Event|0|||
149971575|NCT02569853|541033684|FG000|Overall Study|Withdrawal by Subject|3|||
149971576|NCT02569853|541033685|FG001|Overall Study|Withdrawal by Subject|2|||
149971577|NCT02569853|541033684|FG000|Overall Study|Lost to Follow-up|3|||
149971578|NCT02569853|541033685|FG001|Overall Study|Lost to Follow-up|3|||
149971579|NCT02569853|541033684|FG000|Overall Study|Protocol Violation|1|||
149971580|NCT02569853|541033685|FG001|Overall Study|Protocol Violation|1|||
150049170|NCT01904773|541321746|FG007|First Intervention|Adverse Event|0|||
149908756|NCT02045862|540796227|FG001|Overall Study|Lost to Follow-up|2|||
149908757|NCT02045862|540796228|FG002|Overall Study|Lost to Follow-up|6|||
149908758|NCT04507256|540796231|FG000|Overall Study|Withdrawal by Subject|1|||
149908759|NCT04507256|540796232|FG001|Overall Study|Withdrawal by Subject|0|||
149908760|NCT04507256|540796233|FG002|Overall Study|Withdrawal by Subject|0|||
149908761|NCT04507256|540796234|FG003|Overall Study|Withdrawal by Subject|1|||
149908762|NCT04507256|540796235|FG004|Overall Study|Withdrawal by Subject|0|||
149908763|NCT04507256|540796236|FG005|Overall Study|Withdrawal by Subject|0|||
149908764|NCT02256982|540796239|FG000|Overall Study|Disease Progression|0|||
149908765|NCT02256982|540796240|FG001|Overall Study|Disease Progression|1|||
149908766|NCT03614078|540796241|FG000|Overall Study|Withdrawal by Subject|2|||
149908767|NCT03614078|540796242|FG001|Overall Study|Withdrawal by Subject|2|||
149908768|NCT03614078|540796243|FG002|Overall Study|Withdrawal by Subject|3|||
149908769|NCT03614078|540796241|FG000|Overall Study|Participant Did Not Return for Visit|0|||
149908770|NCT03614078|540796242|FG001|Overall Study|Participant Did Not Return for Visit|1|||
149908771|NCT03614078|540796243|FG002|Overall Study|Participant Did Not Return for Visit|0|||
149908772|NCT03614078|540796241|FG000|Overall Study|High Neutrophils|0|||
149908773|NCT03614078|540796242|FG001|Overall Study|High Neutrophils|0|||
149908774|NCT03614078|540796243|FG002|Overall Study|High Neutrophils|2|||
149908775|NCT03614078|540796241|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
149908776|NCT03614078|540796242|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
149908777|NCT03614078|540796243|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
149908778|NCT03614078|540796241|FG000|Overall Study|Exacerbation of Psoriasis|0|||
149908779|NCT03614078|540796242|FG001|Overall Study|Exacerbation of Psoriasis|1|||
149908780|NCT03614078|540796243|FG002|Overall Study|Exacerbation of Psoriasis|0|||
149908781|NCT03614078|540796241|FG000|Overall Study|Adverse Event|0|||
149908782|NCT03614078|540796242|FG001|Overall Study|Adverse Event|2|||
149908783|NCT03614078|540796243|FG002|Overall Study|Adverse Event|0|||
149908784|NCT03614078|540796241|FG000|Overall Study|Dizziness and Rash|0|||
149908785|NCT03614078|540796242|FG001|Overall Study|Dizziness and Rash|1|||
149908786|NCT03614078|540796243|FG002|Overall Study|Dizziness and Rash|0|||
149908787|NCT04964544|540796246|FG000|Overall Study|Screen failure or other uncategorised|10|||
149908788|NCT04964544|540796246|FG000|Overall Study|Physician Decision|4|||
149908789|NCT04964544|540796246|FG000|Overall Study|Lost to Follow-up|9|||
149908790|NCT04964544|540796246|FG000|Overall Study|Withdrawal by Subject|18|||
149908791|NCT04964544|540796246|FG000|Overall Study|Death|1|||
149908792|NCT02777970|540796252|FG000|Overall Study|Lost to Follow-up|0|||
149908793|NCT02777970|540796253|FG001|Overall Study|Lost to Follow-up|1|||
149908794|NCT02777970|540796254|FG002|Overall Study|Lost to Follow-up|0|||
149908795|NCT02777970|540796252|FG000|Overall Study|Protocol Violation|1|||
149908796|NCT02777970|540796253|FG001|Overall Study|Protocol Violation|0|||
149908797|NCT02777970|540796254|FG002|Overall Study|Protocol Violation|0|||
149908798|NCT02347891|540796258|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
149908799|NCT02347891|540796259|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
149908800|NCT02347891|540796258|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
149908801|NCT02347891|540796259|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
149908802|NCT00834639|540796260|FG000|Second Intervention|Physician Decision|0|||
149908803|NCT00834639|540796261|FG001|Second Intervention|Physician Decision|2|||
149908804|NCT01968707|540796262|FG000|Overall Study|Did not meet treatment day baseline|49|||
149908805|NCT01968707|540796263|FG001|Overall Study|Did not meet treatment day baseline|12|||
149908806|NCT01968707|540796264|FG002|Overall Study|Did not meet treatment day baseline|41|||
149908807|NCT01968707|540796265|FG003|Overall Study|Did not meet treatment day baseline|44|||
149908808|NCT01968707|540796266|FG004|Overall Study|Did not meet treatment day baseline|36|||
149908809|NCT01968707|540796267|FG005|Overall Study|Did not meet treatment day baseline|11|||
149908810|NCT01968707|540796268|FG006|Overall Study|Did not meet treatment day baseline|34|||
149908811|NCT01968707|540796269|FG007|Overall Study|Did not meet treatment day baseline|35|||
149908812|NCT01104246|540796270|FG000|Overall Study|Withdrawal by Subject|1|||
149908813|NCT01104246|540796270|FG000|Overall Study|did not meet inclusion criteria|4|||
149908814|NCT01083186|540796271|FG000|Overall Study|Lost to Follow-up|48|||
149908815|NCT01083186|540796271|FG000|Overall Study|Consent Withdrawal|7|||
150049171|NCT01904773|541321747|FG008|First Intervention|Adverse Event|0|||
150049172|NCT01904773|541321739|FG000|Placebo Washout First Intervention|Condition worsened|0|||
150049173|NCT01904773|541321740|FG001|Placebo Washout First Intervention|Condition worsened|1|||
150049174|NCT01904773|541321741|FG002|Placebo Washout First Intervention|Condition worsened|0|||
149908816|NCT01083186|540796271|FG000|Overall Study|Death|3|||
149908817|NCT01083186|540796271|FG000|Overall Study|Adverse Event|3|||
149908818|NCT01083186|540796271|FG000|Overall Study|Lack of Efficacy|2|||
149908819|NCT01083186|540796271|FG000|Overall Study|Hemodialysis Initiation|28|||
149908820|NCT01083186|540796271|FG000|Overall Study|Administrative Reasons|2|||
149908821|NCT01083186|540796271|FG000|Overall Study|Non-compliance to Study Treatment|1|||
149908822|NCT01867294|540796281|FG000|Overall Study|Withdrawal by Subject|1|||
149908823|NCT01867294|540796282|FG001|Overall Study|Withdrawal by Subject|1|||
149908824|NCT01867294|540796283|FG002|Overall Study|Withdrawal by Subject|0|||
149908825|NCT01867294|540796284|FG003|Overall Study|Withdrawal by Subject|0|||
150049175|NCT01904773|541321742|FG003|Placebo Washout First Intervention|Condition worsened|0|||
150049176|NCT01904773|541321743|FG004|Placebo Washout First Intervention|Condition worsened|0|||
149908826|NCT00278148|540796285|FG000|Phase II - Expansion Phase|Disease progression|0|||
149908827|NCT00278148|540796286|FG001|Phase II - Expansion Phase|Disease progression|0|||
149908828|NCT00278148|540796287|FG002|Phase II - Expansion Phase|Disease progression|4|||
149908829|NCT00278148|540796285|FG000|Phase II - Expansion Phase|Adverse Event|0|||
149908830|NCT00278148|540796286|FG001|Phase II - Expansion Phase|Adverse Event|0|||
149908831|NCT00278148|540796287|FG002|Phase II - Expansion Phase|Adverse Event|2|||
149908832|NCT02083185|540796288|FG000|Overall Study|Lost to Follow-up|0|||
149908833|NCT02083185|540796289|FG001|Overall Study|Lost to Follow-up|3|||
149908834|NCT02083185|540796290|FG002|Overall Study|Lost to Follow-up|0|||
149908835|NCT02083185|540796288|FG000|Overall Study|Withdrawal by Subject|9|||
149908836|NCT02083185|540796289|FG001|Overall Study|Withdrawal by Subject|15|||
149908837|NCT02083185|540796290|FG002|Overall Study|Withdrawal by Subject|1|||
149908838|NCT02083185|540796288|FG000|Overall Study|Death|2|||
149908839|NCT02083185|540796289|FG001|Overall Study|Death|2|||
149908840|NCT02083185|540796290|FG002|Overall Study|Death|1|||
149908841|NCT02083185|540796288|FG000|Overall Study|Reason not Specified|9|||
149908842|NCT02083185|540796289|FG001|Overall Study|Reason not Specified|6|||
149908843|NCT02083185|540796290|FG002|Overall Study|Reason not Specified|5|||
149908844|NCT02083185|540796288|FG000|Overall Study|Study Terminated by Sponsor|0|||
149908845|NCT02083185|540796289|FG001|Overall Study|Study Terminated by Sponsor|1|||
149908846|NCT02083185|540796290|FG002|Overall Study|Study Terminated by Sponsor|0|||
149908847|NCT02083185|540796288|FG000|Overall Study|Did not Receive Study Drug|0|||
149908848|NCT02083185|540796289|FG001|Overall Study|Did not Receive Study Drug|2|||
149908849|NCT02083185|540796290|FG002|Overall Study|Did not Receive Study Drug|0|||
149908850|NCT00380081|540796291|FG000|Overall Study|Withdrawal by Subject|0|||
149908851|NCT00380081|540796292|FG001|Overall Study|Withdrawal by Subject|0|||
149908852|NCT00380081|540796293|FG002|Overall Study|Withdrawal by Subject|0|||
149908853|NCT00380081|540796294|FG003|Overall Study|Withdrawal by Subject|0|||
149971581|NCT02569853|541033684|FG000|Overall Study|Did not experience migraine attack|10|||
149971582|NCT02569853|541033685|FG001|Overall Study|Did not experience migraine attack|7|||
149971583|NCT02569853|541033684|FG000|Overall Study|Physician Decision|1|||
149971584|NCT02569853|541033685|FG001|Overall Study|Physician Decision|1|||
149971585|NCT00261833|541033686|FG000|Overall Study|Death|1|||
149971586|NCT00261833|541033687|FG001|Overall Study|Death|3|||
149971587|NCT00261833|541033686|FG000|Overall Study|Adverse Event|1|||
149971588|NCT00261833|541033687|FG001|Overall Study|Adverse Event|4|||
149971589|NCT00261833|541033686|FG000|Overall Study|Withdrawal by Subject|5|||
149971590|NCT00261833|541033687|FG001|Overall Study|Withdrawal by Subject|7|||
149971591|NCT00261833|541033686|FG000|Overall Study|Protocol Violation|0|||
149971592|NCT00261833|541033687|FG001|Overall Study|Protocol Violation|1|||
149971593|NCT00261833|541033686|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
149971594|NCT00261833|541033687|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
149971595|NCT00261833|541033686|FG000|Overall Study|Lung transplantation|1|||
149971596|NCT00261833|541033687|FG001|Overall Study|Lung transplantation|1|||
149971597|NCT00261833|541033686|FG000|Overall Study|Missing reason|1|||
149971598|NCT00261833|541033687|FG001|Overall Study|Missing reason|0|||
149971599|NCT00261833|541033686|FG000|Overall Study|Not interested in being participant|0|||
149971600|NCT00261833|541033687|FG001|Overall Study|Not interested in being participant|1|||
149971601|NCT00622726|541033688|FG000|March, 2008 to August, 2010|Death|5|||
149971602|NCT00622726|541033689|FG001|March, 2008 to August, 2010|Death|2|||
149971603|NCT00622726|541033688|FG000|August, 2010 to April, 2013|Death|1|||
149971604|NCT00622726|541033689|FG001|August, 2010 to April, 2013|Death|5|||
149971605|NCT02434081|541033692|FG000|Overall Study|Death (never started treatment)|2|||
149971606|NCT02434081|541033692|FG000|Overall Study|Death|2|||
149971607|NCT02434081|541033692|FG000|Overall Study|Progression|20|||
149971608|NCT02434081|541033692|FG000|Overall Study|Adverse Event|20|||
149908854|NCT00380081|540796295|FG004|Overall Study|Withdrawal by Subject|1|||
149908855|NCT00380081|540796296|FG005|Overall Study|Withdrawal by Subject|0|||
149908856|NCT00380081|540796291|FG000|Overall Study|Family Emergency|0|||
149908857|NCT00380081|540796292|FG001|Overall Study|Family Emergency|0|||
149908858|NCT00380081|540796293|FG002|Overall Study|Family Emergency|0|||
149908859|NCT00380081|540796294|FG003|Overall Study|Family Emergency|0|||
149908860|NCT00380081|540796295|FG004|Overall Study|Family Emergency|0|||
149971609|NCT02434081|541033692|FG000|Overall Study|Physician Decision|2|||
149971610|NCT02434081|541033692|FG000|Overall Study|Withdrawal by Subject|1|||
149971611|NCT02434081|541033692|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
149971612|NCT00854360|541033695|FG000|Overall Study|Adverse Event|0|||
149971613|NCT00854360|541033696|FG001|Overall Study|Adverse Event|1|||
149971614|NCT00854360|541033697|FG002|Overall Study|Adverse Event|2|||
149971615|NCT00854360|541033698|FG003|Overall Study|Adverse Event|6|||
149971616|NCT00854360|541033695|FG000|Overall Study|Withdrawal by Subject|0|||
149971617|NCT00854360|541033696|FG001|Overall Study|Withdrawal by Subject|0|||
149971618|NCT00854360|541033697|FG002|Overall Study|Withdrawal by Subject|0|||
149971619|NCT00854360|541033698|FG003|Overall Study|Withdrawal by Subject|1|||
149971620|NCT00854360|541033695|FG000|Overall Study|Pregnancy|0|||
149971621|NCT00854360|541033696|FG001|Overall Study|Pregnancy|1|||
149908861|NCT00380081|540796296|FG005|Overall Study|Family Emergency|1|||
149908862|NCT02017912|540796297|FG000|Overall Study|Withdrawal by Subject|2|||
149908863|NCT02017912|540796298|FG001|Overall Study|Withdrawal by Subject|1|||
149908864|NCT02017912|540796297|FG000|Overall Study|miscellaneous|1|||
149908865|NCT02017912|540796298|FG001|Overall Study|miscellaneous|1|||
149908866|NCT01446237|540796299|FG000|Overall Study|Adverse Event|1|||
149908867|NCT01446237|540796299|FG000|Overall Study|Lost to Follow-up|2|||
149908868|NCT01446237|540796299|FG000|Overall Study|Withdrawal by Subject|7|||
149908869|NCT01931956|540796300|FG000|Overall Study|Death|42|||
149908870|NCT01931956|540796301|FG001|Overall Study|Death|7|||
149908871|NCT01931956|540796302|FG002|Overall Study|Death|379|||
149908872|NCT01931956|540796303|FG003|Overall Study|Death|96|||
149908873|NCT01931956|540796300|FG000|Overall Study|Withdrawal by Subject|5|||
149908874|NCT01931956|540796301|FG001|Overall Study|Withdrawal by Subject|0|||
149908875|NCT01931956|540796302|FG002|Overall Study|Withdrawal by Subject|70|||
149908876|NCT01931956|540796303|FG003|Overall Study|Withdrawal by Subject|30|||
149908877|NCT01931956|540796300|FG000|Overall Study|Lost to Follow-up|2|||
149908878|NCT01931956|540796301|FG001|Overall Study|Lost to Follow-up|0|||
149908879|NCT01931956|540796302|FG002|Overall Study|Lost to Follow-up|11|||
149908880|NCT01931956|540796303|FG003|Overall Study|Lost to Follow-up|7|||
149908881|NCT01931956|540796300|FG000|Overall Study|Expected|2|||
149908882|NCT01931956|540796301|FG001|Overall Study|Expected|0|||
149908883|NCT01931956|540796302|FG002|Overall Study|Expected|6|||
149908884|NCT01931956|540796303|FG003|Overall Study|Expected|0|||
149908885|NCT01931956|540796300|FG000|Overall Study|Not due|0|||
149908886|NCT01931956|540796301|FG001|Overall Study|Not due|0|||
149908887|NCT01931956|540796302|FG002|Overall Study|Not due|21|||
149908888|NCT01931956|540796303|FG003|Overall Study|Not due|0|||
149908889|NCT02847494|540796304|FG000|Overall Study|Lost to Follow-up|8|||
149908890|NCT02847494|540796305|FG001|Overall Study|Lost to Follow-up|5|||
149908891|NCT02294175|540796306|FG000|Overall Study|Withdrawal by Subject|1|||
149908892|NCT02294175|540796307|FG001|Overall Study|Withdrawal by Subject|2|||
149908893|NCT02294175|540796306|FG000|Overall Study|pt taking excluded medication|3|||
149908894|NCT02294175|540796307|FG001|Overall Study|pt taking excluded medication|1|||
149908895|NCT02294175|540796306|FG000|Overall Study|Protocol Violation|1|||
149908896|NCT02294175|540796307|FG001|Overall Study|Protocol Violation|0|||
149908897|NCT02294175|540796306|FG000|Overall Study|Lost to Follow-up|0|||
149908898|NCT02294175|540796307|FG001|Overall Study|Lost to Follow-up|1|||
149908899|NCT02294175|540796306|FG000|Overall Study|wound healed|0|||
149908900|NCT02294175|540796307|FG001|Overall Study|wound healed|2|||
149908901|NCT02548351|540796310|FG000|Overall Study|Withdrawal by Subject|149|||
149908902|NCT02548351|540796311|FG001|Overall Study|Withdrawal by Subject|154|||
149908903|NCT02548351|540796312|FG002|Overall Study|Withdrawal by Subject|152|||
149908904|NCT02548351|540796310|FG000|Overall Study|Death|11|||
149908905|NCT02548351|540796311|FG001|Overall Study|Death|15|||
149908906|NCT02548351|540796312|FG002|Overall Study|Death|12|||
149908907|NCT02548351|540796310|FG000|Overall Study|Adverse Event|22|||
149908908|NCT02548351|540796311|FG001|Overall Study|Adverse Event|56|||
149908909|NCT02548351|540796312|FG002|Overall Study|Adverse Event|36|||
149908910|NCT02548351|540796310|FG000|Overall Study|Study Terminated by Sponsor|549|||
149908911|NCT02548351|540796311|FG001|Overall Study|Study Terminated by Sponsor|509|||
149908912|NCT02548351|540796312|FG002|Overall Study|Study Terminated by Sponsor|528|||
149908913|NCT02548351|540796310|FG000|Overall Study|Site Closure|14|||
149908914|NCT02548351|540796311|FG001|Overall Study|Site Closure|5|||
149908915|NCT02548351|540796312|FG002|Overall Study|Site Closure|7|||
149908916|NCT02548351|540796310|FG000|Overall Study|Non-compliance with Study Drug|4|||
149908917|NCT02548351|540796311|FG001|Overall Study|Non-compliance with Study Drug|2|||
149908918|NCT02548351|540796312|FG002|Overall Study|Non-compliance with Study Drug|0|||
149908919|NCT02548351|540796310|FG000|Overall Study|Protocol Violation|2|||
149908920|NCT02548351|540796311|FG001|Overall Study|Protocol Violation|1|||
149908921|NCT02548351|540796312|FG002|Overall Study|Protocol Violation|2|||
149908922|NCT02548351|540796310|FG000|Overall Study|Physician Decision|11|||
149908923|NCT02548351|540796311|FG001|Overall Study|Physician Decision|18|||
149908924|NCT02548351|540796312|FG002|Overall Study|Physician Decision|11|||
149908925|NCT02548351|540796310|FG000|Overall Study|Lost to Follow-up|43|||
149908926|NCT02548351|540796311|FG001|Overall Study|Lost to Follow-up|50|||
149908927|NCT02548351|540796312|FG002|Overall Study|Lost to Follow-up|57|||
149908928|NCT02548351|540796310|FG000|Overall Study|Other|19|||
149908929|NCT02548351|540796311|FG001|Overall Study|Other|16|||
149908930|NCT02548351|540796312|FG002|Overall Study|Other|20|||
149908931|NCT02548351|540796310|FG000|Overall Study|Missing|1|||
149908932|NCT02548351|540796311|FG001|Overall Study|Missing|1|||
149908933|NCT02548351|540796312|FG002|Overall Study|Missing|0|||
149908934|NCT01901653|540796313|FG000|Overall Study|Death|2|||
149908935|NCT01901653|540796314|FG001|Overall Study|Death|1|||
149908936|NCT01901653|540796315|FG002|Overall Study|Death|8|||
149908937|NCT01901653|540796316|FG003|Overall Study|Death|3|||
149908938|NCT01901653|540796317|FG004|Overall Study|Death|2|||
149908939|NCT01901653|540796318|FG005|Overall Study|Death|2|||
149908940|NCT01901653|540796319|FG006|Overall Study|Death|6|||
149908941|NCT01901653|540796320|FG007|Overall Study|Death|9|||
149908942|NCT01901653|540796321|FG008|Overall Study|Death|1|||
149908943|NCT01901653|540796322|FG009|Overall Study|Death|16|||
149908944|NCT01901653|540796323|FG010|Overall Study|Death|2|||
149908945|NCT01901653|540796324|FG011|Overall Study|Death|15|||
149908946|NCT01901653|540796325|FG012|Overall Study|Death|4|||
149908947|NCT01901653|540796313|FG000|Overall Study|Lost to Follow-up|1|||
149908948|NCT01901653|540796314|FG001|Overall Study|Lost to Follow-up|0|||
149908949|NCT01901653|540796315|FG002|Overall Study|Lost to Follow-up|2|||
149908950|NCT01901653|540796316|FG003|Overall Study|Lost to Follow-up|0|||
149908951|NCT01901653|540796317|FG004|Overall Study|Lost to Follow-up|0|||
149908952|NCT01901653|540796318|FG005|Overall Study|Lost to Follow-up|1|||
149908953|NCT01901653|540796319|FG006|Overall Study|Lost to Follow-up|0|||
149908954|NCT01901653|540796320|FG007|Overall Study|Lost to Follow-up|1|||
149908955|NCT01901653|540796321|FG008|Overall Study|Lost to Follow-up|0|||
149908956|NCT01901653|540796322|FG009|Overall Study|Lost to Follow-up|0|||
149908957|NCT01901653|540796323|FG010|Overall Study|Lost to Follow-up|0|||
149908958|NCT01901653|540796324|FG011|Overall Study|Lost to Follow-up|0|||
149908959|NCT01901653|540796325|FG012|Overall Study|Lost to Follow-up|0|||
149908960|NCT01901653|540796313|FG000|Overall Study|Withdrawal by Subject|0|||
149908961|NCT01901653|540796314|FG001|Overall Study|Withdrawal by Subject|0|||
149908962|NCT01901653|540796315|FG002|Overall Study|Withdrawal by Subject|0|||
149908963|NCT01901653|540796316|FG003|Overall Study|Withdrawal by Subject|0|||
149908964|NCT01901653|540796317|FG004|Overall Study|Withdrawal by Subject|0|||
149908965|NCT01901653|540796318|FG005|Overall Study|Withdrawal by Subject|0|||
149908966|NCT01901653|540796319|FG006|Overall Study|Withdrawal by Subject|1|||
149908967|NCT01901653|540796320|FG007|Overall Study|Withdrawal by Subject|0|||
149908968|NCT01901653|540796321|FG008|Overall Study|Withdrawal by Subject|0|||
149908969|NCT01901653|540796322|FG009|Overall Study|Withdrawal by Subject|0|||
149908970|NCT01901653|540796323|FG010|Overall Study|Withdrawal by Subject|0|||
149908971|NCT01901653|540796324|FG011|Overall Study|Withdrawal by Subject|0|||
149908972|NCT01901653|540796325|FG012|Overall Study|Withdrawal by Subject|0|||
149908973|NCT01901653|540796313|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
149908974|NCT01901653|540796314|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
149908975|NCT01901653|540796315|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
149908976|NCT01901653|540796316|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
149908977|NCT01901653|540796317|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
149908978|NCT01901653|540796318|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
149908979|NCT01901653|540796319|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
149908980|NCT01901653|540796320|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
149908981|NCT01901653|540796321|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
149908982|NCT01901653|540796322|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
149908983|NCT01901653|540796323|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
149908984|NCT01901653|540796324|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
149908985|NCT01901653|540796325|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
149908986|NCT01744184|540796326|FG000|Overall Study|Adverse Event|1|||
149908987|NCT01744184|540796327|FG001|Overall Study|Adverse Event|0|||
149908988|NCT01744184|540796326|FG000|Overall Study|Withdrawal by Subject|0|||
149908989|NCT01744184|540796327|FG001|Overall Study|Withdrawal by Subject|1|||
149908990|NCT00072280|540796331|FG000|Treatment|Found ineligible|1|||
149908991|NCT00072280|540796332|FG001|Treatment|Found ineligible|2|||
149908992|NCT00072280|540796331|FG000|Follow-up|Early termination of study|2|||
149908993|NCT00072280|540796332|FG001|Follow-up|Early termination of study|2|||
149908994|NCT03226769|540796333|FG000|Overall Study|Withdrawal by Subject|0|||
149908995|NCT03226769|540796334|FG001|Overall Study|Withdrawal by Subject|1|||
149908996|NCT04553471|540796341|FG000|Overall Study|Did not start treatment on protocol|3|||
149908997|NCT04553471|540796341|FG000|Overall Study|Death|1|||
149908998|NCT01340027|540796343|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
149908999|NCT01340027|540796344|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
149909000|NCT01340027|540796345|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
149909001|NCT01340027|540796346|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
149909002|NCT01340027|540796347|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
149909003|NCT01340027|540796348|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
149909004|NCT01340027|540796349|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
149909005|NCT01340027|540796350|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
149909006|NCT01340027|540796351|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
149909007|NCT01340027|540796352|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
149971622|NCT00854360|541033697|FG002|Overall Study|Pregnancy|0|||
149971623|NCT00854360|541033698|FG003|Overall Study|Pregnancy|0|||
149971624|NCT00854360|541033695|FG000|Overall Study|Lack of Efficacy|2|||
149971625|NCT00854360|541033696|FG001|Overall Study|Lack of Efficacy|1|||
149971626|NCT00854360|541033697|FG002|Overall Study|Lack of Efficacy|0|||
149971627|NCT00854360|541033698|FG003|Overall Study|Lack of Efficacy|0|||
149909008|NCT01340027|540796353|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
149971628|NCT00854360|541033695|FG000|Overall Study|Other|0|||
149971629|NCT00854360|541033696|FG001|Overall Study|Other|0|||
149971630|NCT00854360|541033697|FG002|Overall Study|Other|0|||
149909009|NCT01340027|540796354|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
149909010|NCT01340027|540796343|FG000|Overall Study|Adverse Event|0|||
149909011|NCT01340027|540796344|FG001|Overall Study|Adverse Event|1|||
149909012|NCT01340027|540796345|FG002|Overall Study|Adverse Event|2|||
149909013|NCT01340027|540796346|FG003|Overall Study|Adverse Event|0|||
149909014|NCT01340027|540796347|FG004|Overall Study|Adverse Event|1|||
149909015|NCT01340027|540796348|FG005|Overall Study|Adverse Event|2|||
149909016|NCT01340027|540796349|FG006|Overall Study|Adverse Event|2|||
149909017|NCT01340027|540796350|FG007|Overall Study|Adverse Event|1|||
149909018|NCT01340027|540796351|FG008|Overall Study|Adverse Event|4|||
149909019|NCT01340027|540796352|FG009|Overall Study|Adverse Event|1|||
149909020|NCT01340027|540796353|FG010|Overall Study|Adverse Event|1|||
149909021|NCT01340027|540796354|FG011|Overall Study|Adverse Event|3|||
149909022|NCT01340027|540796343|FG000|Overall Study|Lack of Efficacy|0|||
149909023|NCT01340027|540796344|FG001|Overall Study|Lack of Efficacy|0|||
149909024|NCT01340027|540796345|FG002|Overall Study|Lack of Efficacy|0|||
149909025|NCT01340027|540796346|FG003|Overall Study|Lack of Efficacy|0|||
149909026|NCT01340027|540796347|FG004|Overall Study|Lack of Efficacy|0|||
149909027|NCT01340027|540796348|FG005|Overall Study|Lack of Efficacy|0|||
149909028|NCT01340027|540796349|FG006|Overall Study|Lack of Efficacy|1|||
149909029|NCT01340027|540796350|FG007|Overall Study|Lack of Efficacy|1|||
149909030|NCT01340027|540796351|FG008|Overall Study|Lack of Efficacy|1|||
149909031|NCT01340027|540796352|FG009|Overall Study|Lack of Efficacy|0|||
149909032|NCT01340027|540796353|FG010|Overall Study|Lack of Efficacy|0|||
149909033|NCT01340027|540796354|FG011|Overall Study|Lack of Efficacy|0|||
149909034|NCT01340027|540796343|FG000|Overall Study|Lost to Follow-up|0|||
149909035|NCT01340027|540796344|FG001|Overall Study|Lost to Follow-up|1|||
149909036|NCT01340027|540796345|FG002|Overall Study|Lost to Follow-up|0|||
149909037|NCT01340027|540796346|FG003|Overall Study|Lost to Follow-up|0|||
149909038|NCT01340027|540796347|FG004|Overall Study|Lost to Follow-up|0|||
149909039|NCT01340027|540796348|FG005|Overall Study|Lost to Follow-up|0|||
149909040|NCT01340027|540796349|FG006|Overall Study|Lost to Follow-up|1|||
149909041|NCT01340027|540796350|FG007|Overall Study|Lost to Follow-up|0|||
149909042|NCT01340027|540796351|FG008|Overall Study|Lost to Follow-up|0|||
149909043|NCT01340027|540796352|FG009|Overall Study|Lost to Follow-up|1|||
149909044|NCT01340027|540796353|FG010|Overall Study|Lost to Follow-up|0|||
149909045|NCT01340027|540796354|FG011|Overall Study|Lost to Follow-up|0|||
149909046|NCT01340027|540796343|FG000|Overall Study|Protocol Violation|1|||
149909047|NCT01340027|540796344|FG001|Overall Study|Protocol Violation|2|||
149909048|NCT01340027|540796345|FG002|Overall Study|Protocol Violation|0|||
149909049|NCT01340027|540796346|FG003|Overall Study|Protocol Violation|0|||
149909050|NCT01340027|540796347|FG004|Overall Study|Protocol Violation|6|||
149909051|NCT01340027|540796348|FG005|Overall Study|Protocol Violation|0|||
149909052|NCT01340027|540796349|FG006|Overall Study|Protocol Violation|0|||
149909053|NCT01340027|540796350|FG007|Overall Study|Protocol Violation|1|||
149909054|NCT01340027|540796351|FG008|Overall Study|Protocol Violation|2|||
149909055|NCT01340027|540796352|FG009|Overall Study|Protocol Violation|2|||
149909056|NCT01340027|540796353|FG010|Overall Study|Protocol Violation|0|||
149909057|NCT01340027|540796354|FG011|Overall Study|Protocol Violation|0|||
149909058|NCT01340027|540796343|FG000|Overall Study|Withdrawal by Subject|4|||
149909059|NCT01340027|540796344|FG001|Overall Study|Withdrawal by Subject|3|||
149909060|NCT01340027|540796345|FG002|Overall Study|Withdrawal by Subject|1|||
149909061|NCT01340027|540796346|FG003|Overall Study|Withdrawal by Subject|3|||
149909062|NCT01340027|540796347|FG004|Overall Study|Withdrawal by Subject|3|||
149909063|NCT01340027|540796348|FG005|Overall Study|Withdrawal by Subject|2|||
149909064|NCT01340027|540796349|FG006|Overall Study|Withdrawal by Subject|3|||
149909065|NCT01340027|540796350|FG007|Overall Study|Withdrawal by Subject|4|||
149909066|NCT01340027|540796351|FG008|Overall Study|Withdrawal by Subject|1|||
149909067|NCT01340027|540796352|FG009|Overall Study|Withdrawal by Subject|2|||
149971631|NCT00854360|541033698|FG003|Overall Study|Other|3|||
149971632|NCT02271880|541033700|FG000|Overall Study|Premature discontinuation of study|3|||
149971633|NCT02271880|541033701|FG001|Overall Study|Premature discontinuation of study|4|||
149971634|NCT00474903|541033702|FG000|Overall Study|Protocol Violation|1|||
149971635|NCT00474903|541033703|FG001|Overall Study|Protocol Violation|5|||
149971636|NCT00474903|541033704|FG002|Overall Study|Protocol Violation|2|||
149971637|NCT00399529|541033705|FG000|Overall Study|Off Study Prior to Treatment|2|||
149971638|NCT02735200|541033706|FG000|Overall Study|Lost to Follow-up|0|||
149971639|NCT02735200|541033707|FG001|Overall Study|Lost to Follow-up|5|||
149971640|NCT02735200|541033706|FG000|Overall Study|Withdrawal by Subject|8|||
149971641|NCT02735200|541033707|FG001|Overall Study|Withdrawal by Subject|0|||
149971642|NCT00744861|541033710|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
149909068|NCT01340027|540796353|FG010|Overall Study|Withdrawal by Subject|0|||
149909069|NCT01340027|540796354|FG011|Overall Study|Withdrawal by Subject|1|||
149909070|NCT01340027|540796343|FG000|Overall Study|Miscellaneous|0|||
149909071|NCT01340027|540796344|FG001|Overall Study|Miscellaneous|0|||
149909072|NCT01340027|540796345|FG002|Overall Study|Miscellaneous|0|||
149909073|NCT01340027|540796346|FG003|Overall Study|Miscellaneous|1|||
149909074|NCT01340027|540796347|FG004|Overall Study|Miscellaneous|0|||
149909075|NCT01340027|540796348|FG005|Overall Study|Miscellaneous|0|||
149909076|NCT01340027|540796349|FG006|Overall Study|Miscellaneous|0|||
149909077|NCT01340027|540796350|FG007|Overall Study|Miscellaneous|0|||
149909078|NCT01340027|540796351|FG008|Overall Study|Miscellaneous|0|||
149909079|NCT01340027|540796352|FG009|Overall Study|Miscellaneous|0|||
149909080|NCT01340027|540796353|FG010|Overall Study|Miscellaneous|1|||
149909081|NCT01340027|540796354|FG011|Overall Study|Miscellaneous|0|||
149909082|NCT02496091|540796355|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149909083|NCT02272842|540796356|FG000|Overall Study|Lost to Follow-up|8|||
149909084|NCT02272842|540796357|FG001|Overall Study|Lost to Follow-up|8|||
149909085|NCT02272842|540796356|FG000|Overall Study|Withdrawal by Subject|8|||
149909086|NCT02272842|540796357|FG001|Overall Study|Withdrawal by Subject|2|||
149909087|NCT02017717|540797974|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909088|NCT02017717|540797975|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909089|NCT02017717|540797976|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909090|NCT02017717|540797977|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909091|NCT02017717|540797978|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909092|NCT02017717|540797979|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909093|NCT02017717|540797980|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909094|NCT02017717|540797981|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
149909095|NCT02017717|540797982|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
149909096|NCT02017717|540797974|FG000|Before Treatment Period|Participant request to stop therapy|0|||
149909097|NCT02017717|540797975|FG001|Before Treatment Period|Participant request to stop therapy|0|||
149909098|NCT02017717|540797976|FG002|Before Treatment Period|Participant request to stop therapy|0|||
149909099|NCT02017717|540797977|FG003|Before Treatment Period|Participant request to stop therapy|0|||
149909100|NCT02017717|540797978|FG004|Before Treatment Period|Participant request to stop therapy|0|||
149909101|NCT02017717|540797979|FG005|Before Treatment Period|Participant request to stop therapy|0|||
149909102|NCT02017717|540797980|FG006|Before Treatment Period|Participant request to stop therapy|0|||
149909103|NCT02017717|540797981|FG007|Before Treatment Period|Participant request to stop therapy|0|||
149909104|NCT02017717|540797982|FG008|Before Treatment Period|Participant request to stop therapy|5|||
149909105|NCT02017717|540797974|FG000|Before Treatment Period|Participant withdrew consent|0|||
149909106|NCT02017717|540797975|FG001|Before Treatment Period|Participant withdrew consent|0|||
149909107|NCT02017717|540797976|FG002|Before Treatment Period|Participant withdrew consent|0|||
149909108|NCT02017717|540797977|FG003|Before Treatment Period|Participant withdrew consent|0|||
149909109|NCT02017717|540797978|FG004|Before Treatment Period|Participant withdrew consent|0|||
149909110|NCT02017717|540797979|FG005|Before Treatment Period|Participant withdrew consent|0|||
149909111|NCT02017717|540797980|FG006|Before Treatment Period|Participant withdrew consent|2|||
149909112|NCT02017717|540797981|FG007|Before Treatment Period|Participant withdrew consent|0|||
149909113|NCT02017717|540797982|FG008|Before Treatment Period|Participant withdrew consent|11|||
149909114|NCT02017717|540797974|FG000|Before Treatment Period|Lost to Follow-up|0|||
149909115|NCT02017717|540797975|FG001|Before Treatment Period|Lost to Follow-up|0|||
149909116|NCT02017717|540797976|FG002|Before Treatment Period|Lost to Follow-up|0|||
149909117|NCT02017717|540797977|FG003|Before Treatment Period|Lost to Follow-up|0|||
149909118|NCT02017717|540797978|FG004|Before Treatment Period|Lost to Follow-up|0|||
149909119|NCT02017717|540797979|FG005|Before Treatment Period|Lost to Follow-up|0|||
149909120|NCT02017717|540797980|FG006|Before Treatment Period|Lost to Follow-up|0|||
149909121|NCT02017717|540797981|FG007|Before Treatment Period|Lost to Follow-up|0|||
149909122|NCT02017717|540797982|FG008|Before Treatment Period|Lost to Follow-up|1|||
149909123|NCT02017717|540797974|FG000|Before Treatment Period|Participant no longer met criteria|0|||
149909124|NCT02017717|540797975|FG001|Before Treatment Period|Participant no longer met criteria|0|||
149909125|NCT02017717|540797976|FG002|Before Treatment Period|Participant no longer met criteria|0|||
149909126|NCT02017717|540797977|FG003|Before Treatment Period|Participant no longer met criteria|0|||
149909127|NCT02017717|540797978|FG004|Before Treatment Period|Participant no longer met criteria|0|||
149909128|NCT02017717|540797979|FG005|Before Treatment Period|Participant no longer met criteria|1|||
149909129|NCT02017717|540797980|FG006|Before Treatment Period|Participant no longer met criteria|0|||
149909130|NCT02017717|540797981|FG007|Before Treatment Period|Participant no longer met criteria|1|||
149909131|NCT02017717|540797982|FG008|Before Treatment Period|Participant no longer met criteria|2|||
149909132|NCT02017717|540797974|FG000|Before Treatment Period|other reason|0|||
149909133|NCT02017717|540797975|FG001|Before Treatment Period|other reason|0|||
149909134|NCT02017717|540797976|FG002|Before Treatment Period|other reason|0|||
149909135|NCT02017717|540797977|FG003|Before Treatment Period|other reason|0|||
149909136|NCT02017717|540797978|FG004|Before Treatment Period|other reason|0|||
149909137|NCT02017717|540797979|FG005|Before Treatment Period|other reason|0|||
149909138|NCT02017717|540797980|FG006|Before Treatment Period|other reason|0|||
149909139|NCT02017717|540797981|FG007|Before Treatment Period|other reason|0|||
149909140|NCT02017717|540797982|FG008|Before Treatment Period|other reason|1|||
149909141|NCT02017717|540797974|FG000|Treatment Period|Disease progression|7|||
149909142|NCT02017717|540797975|FG001|Treatment Period|Disease progression|9|||
149909143|NCT02017717|540797976|FG002|Treatment Period|Disease progression|12|||
149909144|NCT02017717|540797977|FG003|Treatment Period|Disease progression|20|||
149909145|NCT02017717|540797978|FG004|Treatment Period|Disease progression|26|||
149909146|NCT02017717|540797979|FG005|Treatment Period|Disease progression|16|||
149909147|NCT02017717|540797980|FG006|Treatment Period|Disease progression|22|||
149909148|NCT02017717|540797981|FG007|Treatment Period|Disease progression|165|||
149909149|NCT02017717|540797982|FG008|Treatment Period|Disease progression|135|||
149909150|NCT02017717|540797974|FG000|Treatment Period|Study drug toxicity|3|||
149909151|NCT02017717|540797975|FG001|Treatment Period|Study drug toxicity|0|||
149909152|NCT02017717|540797976|FG002|Treatment Period|Study drug toxicity|1|||
149909153|NCT02017717|540797977|FG003|Treatment Period|Study drug toxicity|4|||
149909154|NCT02017717|540797978|FG004|Treatment Period|Study drug toxicity|4|||
149909155|NCT02017717|540797979|FG005|Treatment Period|Study drug toxicity|5|||
149909156|NCT02017717|540797980|FG006|Treatment Period|Study drug toxicity|3|||
149909157|NCT02017717|540797981|FG007|Treatment Period|Study drug toxicity|7|||
149909158|NCT02017717|540797982|FG008|Treatment Period|Study drug toxicity|11|||
149909159|NCT02017717|540797974|FG000|Treatment Period|Death|0|||
149909160|NCT02017717|540797975|FG001|Treatment Period|Death|0|||
149909161|NCT02017717|540797976|FG002|Treatment Period|Death|1|||
149909162|NCT02017717|540797977|FG003|Treatment Period|Death|0|||
149909163|NCT02017717|540797978|FG004|Treatment Period|Death|0|||
149909164|NCT02017717|540797979|FG005|Treatment Period|Death|2|||
149909165|NCT02017717|540797980|FG006|Treatment Period|Death|0|||
149909166|NCT02017717|540797981|FG007|Treatment Period|Death|0|||
149909167|NCT02017717|540797982|FG008|Treatment Period|Death|0|||
149909168|NCT02017717|540797974|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
149909169|NCT02017717|540797975|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
149909170|NCT02017717|540797976|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
149909171|NCT02017717|540797977|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
149909172|NCT02017717|540797978|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
149909173|NCT02017717|540797979|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
149909174|NCT02017717|540797980|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
149909175|NCT02017717|540797981|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
149909176|NCT02017717|540797982|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
149909177|NCT02017717|540797974|FG000|Treatment Period|Participant request to stop therapy|0|||
149909178|NCT02017717|540797975|FG001|Treatment Period|Participant request to stop therapy|0|||
149909179|NCT02017717|540797976|FG002|Treatment Period|Participant request to stop therapy|3|||
149909180|NCT02017717|540797977|FG003|Treatment Period|Participant request to stop therapy|6|||
149909181|NCT02017717|540797978|FG004|Treatment Period|Participant request to stop therapy|0|||
149909182|NCT02017717|540797979|FG005|Treatment Period|Participant request to stop therapy|2|||
149909183|NCT02017717|540797980|FG006|Treatment Period|Participant request to stop therapy|1|||
149909184|NCT02017717|540797981|FG007|Treatment Period|Participant request to stop therapy|4|||
149909185|NCT02017717|540797982|FG008|Treatment Period|Participant request to stop therapy|7|||
149909186|NCT02017717|540797974|FG000|Treatment Period|Participant withdrew consent|0|||
149909187|NCT02017717|540797975|FG001|Treatment Period|Participant withdrew consent|0|||
149909188|NCT02017717|540797976|FG002|Treatment Period|Participant withdrew consent|1|||
149909189|NCT02017717|540797977|FG003|Treatment Period|Participant withdrew consent|0|||
149909190|NCT02017717|540797978|FG004|Treatment Period|Participant withdrew consent|0|||
149909191|NCT02017717|540797979|FG005|Treatment Period|Participant withdrew consent|2|||
149909192|NCT02017717|540797980|FG006|Treatment Period|Participant withdrew consent|0|||
149909193|NCT02017717|540797981|FG007|Treatment Period|Participant withdrew consent|1|||
149909194|NCT02017717|540797982|FG008|Treatment Period|Participant withdrew consent|4|||
149909195|NCT02017717|540797974|FG000|Treatment Period|Participant no longer met criteria|0|||
149909196|NCT02017717|540797975|FG001|Treatment Period|Participant no longer met criteria|0|||
149909197|NCT02017717|540797976|FG002|Treatment Period|Participant no longer met criteria|0|||
149909198|NCT02017717|540797977|FG003|Treatment Period|Participant no longer met criteria|0|||
149909199|NCT02017717|540797978|FG004|Treatment Period|Participant no longer met criteria|0|||
149909200|NCT02017717|540797979|FG005|Treatment Period|Participant no longer met criteria|0|||
149909201|NCT02017717|540797980|FG006|Treatment Period|Participant no longer met criteria|0|||
150049177|NCT01904773|541321744|FG005|Placebo Washout First Intervention|Condition worsened|0|||
150049178|NCT01904773|541321745|FG006|Placebo Washout First Intervention|Condition worsened|0|||
150049179|NCT01904773|541321746|FG007|Placebo Washout First Intervention|Condition worsened|0|||
149909202|NCT02017717|540797981|FG007|Treatment Period|Participant no longer met criteria|0|||
149909203|NCT02017717|540797982|FG008|Treatment Period|Participant no longer met criteria|1|||
149909204|NCT02017717|540797974|FG000|Treatment Period|Other reasons|0|||
149909205|NCT02017717|540797975|FG001|Treatment Period|Other reasons|0|||
149909206|NCT02017717|540797976|FG002|Treatment Period|Other reasons|0|||
150049180|NCT01904773|541321747|FG008|Placebo Washout First Intervention|Condition worsened|0|||
149909207|NCT02017717|540797977|FG003|Treatment Period|Other reasons|1|||
149909208|NCT02017717|540797978|FG004|Treatment Period|Other reasons|0|||
149909209|NCT02017717|540797979|FG005|Treatment Period|Other reasons|1|||
149909210|NCT02017717|540797980|FG006|Treatment Period|Other reasons|1|||
149909211|NCT02017717|540797981|FG007|Treatment Period|Other reasons|1|||
149909212|NCT02017717|540797982|FG008|Treatment Period|Other reasons|1|||
149909213|NCT02017717|540797974|FG000|Treatment Period|Maximum clinical benefit|0|||
149909214|NCT02017717|540797975|FG001|Treatment Period|Maximum clinical benefit|0|||
149909215|NCT02017717|540797976|FG002|Treatment Period|Maximum clinical benefit|0|||
149909216|NCT02017717|540797977|FG003|Treatment Period|Maximum clinical benefit|0|||
149909217|NCT02017717|540797978|FG004|Treatment Period|Maximum clinical benefit|0|||
149909218|NCT02017717|540797979|FG005|Treatment Period|Maximum clinical benefit|0|||
149909219|NCT02017717|540797980|FG006|Treatment Period|Maximum clinical benefit|0|||
149909220|NCT02017717|540797981|FG007|Treatment Period|Maximum clinical benefit|0|||
149909221|NCT02017717|540797982|FG008|Treatment Period|Maximum clinical benefit|1|||
149909222|NCT02017717|540797974|FG000|Treatment Period|Not reported|0|||
149909223|NCT02017717|540797975|FG001|Treatment Period|Not reported|1|||
149909224|NCT02017717|540797976|FG002|Treatment Period|Not reported|0|||
149909225|NCT02017717|540797977|FG003|Treatment Period|Not reported|0|||
149909226|NCT02017717|540797978|FG004|Treatment Period|Not reported|0|||
149909227|NCT02017717|540797979|FG005|Treatment Period|Not reported|0|||
149909228|NCT02017717|540797980|FG006|Treatment Period|Not reported|0|||
149909229|NCT02017717|540797981|FG007|Treatment Period|Not reported|0|||
149909230|NCT02017717|540797982|FG008|Treatment Period|Not reported|0|||
149909231|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
149909232|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
149909233|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
149909234|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
149909235|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
149909236|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
149909237|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
149909238|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
149909239|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
149909240|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
149909241|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
149909242|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
149909243|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
149909244|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
149909245|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
149909246|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
149909247|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
149909248|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
149909249|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
149909250|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
149909251|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
149909252|NCT04488419|540797983|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
149909253|NCT04488419|540797984|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
149909254|NCT04488419|540797985|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
149909255|NCT04488419|540797983|FG000|Primary Analysis Population|Adverse Event|6|||
149909256|NCT04488419|540797984|FG001|Primary Analysis Population|Adverse Event|9|||
149909257|NCT04488419|540797985|FG002|Primary Analysis Population|Adverse Event|0|||
149909258|NCT04488419|540797983|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
149971643|NCT00744861|541033711|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
149971644|NCT00744861|541033712|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
149971645|NCT00744861|541033713|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
149971646|NCT00744861|541033710|FG000|Feasibility Stage 1|Pregnancy|0|||
149971647|NCT00744861|541033711|FG001|Feasibility Stage 1|Pregnancy|1|||
149971648|NCT00744861|541033712|FG002|Feasibility Stage 1|Pregnancy|0|||
149971649|NCT00744861|541033713|FG003|Feasibility Stage 1|Pregnancy|0|||
149909259|NCT04488419|540797984|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
149909260|NCT04488419|540797985|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
149909261|NCT04488419|540797983|FG000|Primary Analysis Population|Protocol Violation|1|||
149909262|NCT04488419|540797984|FG001|Primary Analysis Population|Protocol Violation|1|||
149909263|NCT04488419|540797985|FG002|Primary Analysis Population|Protocol Violation|0|||
149909264|NCT04488419|540797983|FG000|Primary Analysis Population|Undetermined|7|||
149909265|NCT04488419|540797984|FG001|Primary Analysis Population|Undetermined|3|||
149909266|NCT04488419|540797985|FG002|Primary Analysis Population|Undetermined|0|||
149909267|NCT04488419|540797983|FG000|Primary Analysis Population|>1 Reason|2|||
149971650|NCT00744861|541033710|FG000|Pivotal Stage 2|Adverse Event|0|||
149909268|NCT04488419|540797984|FG001|Primary Analysis Population|>1 Reason|4|||
149909269|NCT04488419|540797985|FG002|Primary Analysis Population|>1 Reason|0|||
149909270|NCT04161079|540797986|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
149909271|NCT02515994|540797987|FG000|Overall Study|Protocol Violation|3|||
149909272|NCT02515994|540797988|FG001|Overall Study|Protocol Violation|5|||
149971651|NCT00744861|541033711|FG001|Pivotal Stage 2|Adverse Event|0|||
149971652|NCT00744861|541033712|FG002|Pivotal Stage 2|Adverse Event|6|||
149909273|NCT02515994|540797987|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
149909274|NCT02515994|540797988|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
149909275|NCT02515994|540797987|FG000|Overall Study|Adverse Event|3|||
149909276|NCT02515994|540797988|FG001|Overall Study|Adverse Event|1|||
149909277|NCT02515994|540797987|FG000|Overall Study|Withdrawal by Subject|2|||
149909278|NCT02515994|540797988|FG001|Overall Study|Withdrawal by Subject|0|||
149909279|NCT04045132|540797991|FG000|Overall Study|Lost to Follow-up|3|||
149909280|NCT04045132|540797992|FG001|Overall Study|Lost to Follow-up|6|||
149909281|NCT01899742|540797999|FG000|Overall Study|Adverse Event|5|||
149909282|NCT01899742|540798000|FG001|Overall Study|Adverse Event|4|||
149909283|NCT01899742|540797999|FG000|Overall Study|Lack of Efficacy|1|||
149909284|NCT01899742|540798000|FG001|Overall Study|Lack of Efficacy|5|||
149909285|NCT01899742|540797999|FG000|Overall Study|Protocol Violation|2|||
149909286|NCT01899742|540798000|FG001|Overall Study|Protocol Violation|2|||
149909287|NCT01899742|540797999|FG000|Overall Study|Withdrawal by Subject|9|||
149909288|NCT01899742|540798000|FG001|Overall Study|Withdrawal by Subject|5|||
149909289|NCT02662764|540798001|FG000|Overall Study|Adverse Event|6|||
149909290|NCT02662764|540798001|FG000|Overall Study|Lack of Efficacy|8|||
149909291|NCT02662764|540798001|FG000|Overall Study|Protocol Violation|1|||
149909292|NCT02662764|540798001|FG000|Overall Study|Withdrawal by Subject|5|||
149909293|NCT02662764|540798001|FG000|Overall Study|Device failure|4|||
149909294|NCT02662764|540798001|FG000|Overall Study|Patient changed treatment|1|||
149909295|NCT02662764|540798001|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
149909296|NCT00089778|540798008|FG000|Overall Study|Protocol Violation|0|||
149909297|NCT00089778|540798009|FG001|Overall Study|Protocol Violation|0|||
149909298|NCT00089778|540798010|FG002|Overall Study|Protocol Violation|1|||
149909299|NCT00177307|540798011|FG000|Overall Study|Withdrawal by Subject|1|||
149909300|NCT02677038|540798013|FG000|Overall Study|Physician Decision|1|||
149909301|NCT02677038|540798013|FG000|Overall Study|Withdrawal by Subject|1|||
149909302|NCT03640481|540798022|FG000|Overall Study|Death|14|||
149909303|NCT03640481|540798023|FG001|Overall Study|Death|14|||
149909304|NCT03640481|540798024|FG002|Overall Study|Death|0|||
149909305|NCT03640481|540798025|FG003|Overall Study|Death|0|||
149909306|NCT03640481|540798022|FG000|Overall Study|Lost to Follow-up|2|||
149909307|NCT03640481|540798023|FG001|Overall Study|Lost to Follow-up|0|||
149909308|NCT03640481|540798024|FG002|Overall Study|Lost to Follow-up|0|||
149909309|NCT03640481|540798025|FG003|Overall Study|Lost to Follow-up|0|||
149909310|NCT03640481|540798022|FG000|Overall Study|Site terminated by sponsor|1|||
149909311|NCT03640481|540798023|FG001|Overall Study|Site terminated by sponsor|3|||
149909312|NCT03640481|540798024|FG002|Overall Study|Site terminated by sponsor|0|||
149909313|NCT03640481|540798025|FG003|Overall Study|Site terminated by sponsor|0|||
149909314|NCT03640481|540798022|FG000|Overall Study|Study terminated by sponsor|29|||
149909315|NCT03640481|540798023|FG001|Overall Study|Study terminated by sponsor|42|||
149909316|NCT03640481|540798024|FG002|Overall Study|Study terminated by sponsor|1|||
149909317|NCT03640481|540798025|FG003|Overall Study|Study terminated by sponsor|0|||
149909318|NCT03640481|540798022|FG000|Overall Study|Withdrawal by Subject|5|||
149909319|NCT03640481|540798023|FG001|Overall Study|Withdrawal by Subject|4|||
149909320|NCT03640481|540798024|FG002|Overall Study|Withdrawal by Subject|0|||
149909321|NCT03640481|540798025|FG003|Overall Study|Withdrawal by Subject|1|||
149909322|NCT03640481|540798022|FG000|Overall Study|Other|26|||
149909323|NCT03640481|540798023|FG001|Overall Study|Other|12|||
149909324|NCT03640481|540798024|FG002|Overall Study|Other|1|||
149909325|NCT03640481|540798025|FG003|Overall Study|Other|0|||
149909326|NCT03640481|540798022|FG000|Overall Study|Randomized, but not treated|1|||
149909327|NCT03640481|540798023|FG001|Overall Study|Randomized, but not treated|3|||
149909328|NCT03640481|540798024|FG002|Overall Study|Randomized, but not treated|0|||
149909329|NCT03640481|540798025|FG003|Overall Study|Randomized, but not treated|0|||
149909330|NCT00535847|540798026|FG000|Overall Study|Adverse Event|5|||
149909331|NCT00535847|540798027|FG001|Overall Study|Adverse Event|3|||
149909332|NCT00535847|540798028|FG002|Overall Study|Adverse Event|2|||
149909333|NCT00535847|540798026|FG000|Overall Study|Non compliance|1|||
149909334|NCT00535847|540798027|FG001|Overall Study|Non compliance|1|||
149909335|NCT00535847|540798028|FG002|Overall Study|Non compliance|0|||
149909336|NCT00535847|540798026|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
149909337|NCT00535847|540798027|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
149909338|NCT00535847|540798028|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
149909339|NCT05007041|540798029|FG000|Overall Study|Missing Diary Entries|0|||
149909340|NCT05007041|540798030|FG001|Overall Study|Missing Diary Entries|1|||
149971653|NCT00744861|541033713|FG003|Pivotal Stage 2|Adverse Event|11|||
149971654|NCT00744861|541033710|FG000|Pivotal Stage 2|Death|0|||
149971655|NCT00744861|541033711|FG001|Pivotal Stage 2|Death|0|||
149971656|NCT00744861|541033712|FG002|Pivotal Stage 2|Death|0|||
149971657|NCT00744861|541033713|FG003|Pivotal Stage 2|Death|1|||
149971658|NCT00744861|541033710|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
149971659|NCT00744861|541033711|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
149971660|NCT00744861|541033712|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
149971661|NCT00744861|541033713|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
149909341|NCT01546168|540798033|FG000|Overall Study|Lost to Follow-up|1|||
149909342|NCT01546168|540798034|FG001|Overall Study|Lost to Follow-up|0|||
149909343|NCT01546168|540798033|FG000|Overall Study|Withdrawal by Subject|1|||
149909344|NCT01546168|540798034|FG001|Overall Study|Withdrawal by Subject|0|||
149909345|NCT01546168|540798033|FG000|Overall Study|ineligible after signing consent|2|||
149909346|NCT01546168|540798034|FG001|Overall Study|ineligible after signing consent|0|||
149909347|NCT02850016|540798035|FG000|Overall Study|Withdrawal by Subject|1|||
149909348|NCT02850016|540798036|FG001|Overall Study|Withdrawal by Subject|2|||
149909349|NCT00423189|540798039|FG000|Overall Study|Death|0|||
149909350|NCT00423189|540798040|FG001|Overall Study|Death|1|||
149909351|NCT00423189|540798041|FG002|Overall Study|Death|0|||
149909352|NCT00070018|540798046|FG000|Overall Study|Adverse Event|2|||
149971662|NCT00744861|541033710|FG000|Pivotal Stage 2|Physician Decision|0|||
149971663|NCT00744861|541033711|FG001|Pivotal Stage 2|Physician Decision|0|||
149971664|NCT00744861|541033712|FG002|Pivotal Stage 2|Physician Decision|3|||
149971665|NCT00744861|541033713|FG003|Pivotal Stage 2|Physician Decision|1|||
149971666|NCT00744861|541033710|FG000|Pivotal Stage 2|Protocol Violation|0|||
149971667|NCT00744861|541033711|FG001|Pivotal Stage 2|Protocol Violation|0|||
149971668|NCT00744861|541033712|FG002|Pivotal Stage 2|Protocol Violation|0|||
149971669|NCT00744861|541033713|FG003|Pivotal Stage 2|Protocol Violation|1|||
149971670|NCT00744861|541033710|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
149971671|NCT00744861|541033711|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
150049181|NCT01904773|541321739|FG000|Fifth Intervention|Adverse Event|0|||
149909353|NCT00070018|540798046|FG000|Overall Study|Lack of Efficacy|1|||
149909354|NCT00070018|540798046|FG000|Overall Study|Withdrawal by Subject|1|||
149909355|NCT00574249|540798056|FG000|Overall Study|Adverse Event|6|||
149909356|NCT00574249|540798057|FG001|Overall Study|Adverse Event|18|||
149909357|NCT00574249|540798056|FG000|Overall Study|Lack of Efficacy|5|||
149909358|NCT00574249|540798057|FG001|Overall Study|Lack of Efficacy|3|||
149909359|NCT00574249|540798056|FG000|Overall Study|Lost to Follow-up|4|||
149909360|NCT00574249|540798057|FG001|Overall Study|Lost to Follow-up|3|||
149909361|NCT00574249|540798056|FG000|Overall Study|Protocol Violation|5|||
149909362|NCT00574249|540798057|FG001|Overall Study|Protocol Violation|2|||
149909363|NCT00574249|540798056|FG000|Overall Study|History of carcinoma|1|||
149909364|NCT00574249|540798057|FG001|Overall Study|History of carcinoma|0|||
149909365|NCT00574249|540798056|FG000|Overall Study|Withdrawal by Subject|3|||
149909366|NCT00574249|540798057|FG001|Overall Study|Withdrawal by Subject|0|||
149909367|NCT00574249|540798056|FG000|Overall Study|Physician Decision|1|||
149909368|NCT00574249|540798057|FG001|Overall Study|Physician Decision|0|||
149909369|NCT00574249|540798056|FG000|Overall Study|Pregnancy|1|||
149909370|NCT00574249|540798057|FG001|Overall Study|Pregnancy|0|||
149909371|NCT00574249|540798056|FG000|Overall Study|Excluded by company|0|||
149909372|NCT00574249|540798057|FG001|Overall Study|Excluded by company|1|||
149909373|NCT00574249|540798056|FG000|Overall Study|PPD test taken twice|0|||
149909374|NCT00574249|540798057|FG001|Overall Study|PPD test taken twice|1|||
149909375|NCT03197870|540798059|FG000|Overall Study|Adverse Event|9|||
149909376|NCT03197870|540798060|FG001|Overall Study|Adverse Event|4|||
149909377|NCT03197870|540798061|FG002|Overall Study|Adverse Event|6|||
149909378|NCT03197870|540798059|FG000|Overall Study|Withdrawal by Subject|2|||
149909379|NCT03197870|540798060|FG001|Overall Study|Withdrawal by Subject|3|||
149909380|NCT03197870|540798061|FG002|Overall Study|Withdrawal by Subject|0|||
149909381|NCT03197870|540798059|FG000|Overall Study|Lost to Follow-up|2|||
149909382|NCT03197870|540798060|FG001|Overall Study|Lost to Follow-up|2|||
149909383|NCT03197870|540798061|FG002|Overall Study|Lost to Follow-up|0|||
149909384|NCT03197870|540798059|FG000|Overall Study|data not available|1|||
149909385|NCT03197870|540798060|FG001|Overall Study|data not available|1|||
149909386|NCT03197870|540798061|FG002|Overall Study|data not available|0|||
149909387|NCT01618019|540798062|FG000|Overall Study|Withdrawal by Subject|14|||
149909388|NCT01618019|540798063|FG001|Overall Study|Withdrawal by Subject|14|||
149909389|NCT01542034|540798064|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
149909390|NCT01542034|540798065|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
149909391|NCT01542034|540798064|FG000|Overall Study|Administrative decision|0|||
149909392|NCT01542034|540798065|FG001|Overall Study|Administrative decision|3|||
149909393|NCT01542034|540798064|FG000|Overall Study|Subject Noncompliance|1|||
149909394|NCT01542034|540798065|FG001|Overall Study|Subject Noncompliance|0|||
149909395|NCT01542034|540798064|FG000|Overall Study|Adverse Event|2|||
149909396|NCT01542034|540798065|FG001|Overall Study|Adverse Event|2|||
149909397|NCT01542034|540798064|FG000|Overall Study|Lost to Follow-up|7|||
149909398|NCT01542034|540798065|FG001|Overall Study|Lost to Follow-up|6|||
149909399|NCT01508130|540798069|FG000|Overall Study|Adverse Event|81|||
149909400|NCT01508130|540798070|FG001|Overall Study|Adverse Event|28|||
149909401|NCT01508130|540798069|FG000|Overall Study|Death|3|||
149909402|NCT01508130|540798070|FG001|Overall Study|Death|1|||
149909403|NCT01508130|540798069|FG000|Overall Study|Protocol Violation|2|||
149909404|NCT01508130|540798070|FG001|Overall Study|Protocol Violation|0|||
149909405|NCT01508130|540798069|FG000|Overall Study|Lost to Follow-up|25|||
149909406|NCT01508130|540798070|FG001|Overall Study|Lost to Follow-up|2|||
149909407|NCT01508130|540798069|FG000|Overall Study|Withdrawal by Subject|3|||
149909408|NCT01508130|540798070|FG001|Overall Study|Withdrawal by Subject|3|||
149909409|NCT01508130|540798069|FG000|Overall Study|Subject's substantial non-compliance|25|||
149909410|NCT01508130|540798070|FG001|Overall Study|Subject's substantial non-compliance|9|||
149909411|NCT01508130|540798069|FG000|Overall Study|Insufficient therapeutic response|74|||
149909412|NCT01508130|540798070|FG001|Overall Study|Insufficient therapeutic response|23|||
149909413|NCT01508130|540798069|FG000|Overall Study|Administrative|14|||
149909414|NCT01508130|540798070|FG001|Overall Study|Administrative|3|||
149909415|NCT01680159|540798071|FG000|Screening Period|Not meet criteria for dose-up period|7|||
149909416|NCT01680159|540798071|FG000|Increased Dose Period|Adverse Event|6|||
149909417|NCT01680159|540798071|FG000|Increased Dose Period|Withdrawal by Subject|2|||
149909418|NCT02783729|540798075|FG000|Overall Study|Lack of Efficacy|1|||
149909419|NCT02783729|540798076|FG001|Overall Study|Lack of Efficacy|0|||
149909420|NCT02783729|540798077|FG002|Overall Study|Lack of Efficacy|0|||
149909421|NCT02783729|540798078|FG003|Overall Study|Lack of Efficacy|0|||
149909422|NCT02783729|540798075|FG000|Overall Study|Adverse Event|2|||
149909423|NCT02783729|540798076|FG001|Overall Study|Adverse Event|6|||
149909424|NCT02783729|540798077|FG002|Overall Study|Adverse Event|2|||
149909425|NCT02783729|540798078|FG003|Overall Study|Adverse Event|3|||
149909426|NCT02783729|540798075|FG000|Overall Study|Other|1|||
149909427|NCT02783729|540798076|FG001|Overall Study|Other|6|||
149909428|NCT02783729|540798077|FG002|Overall Study|Other|2|||
149909429|NCT02783729|540798078|FG003|Overall Study|Other|3|||
149909430|NCT02783729|540798075|FG000|Overall Study|Withdrawal by Subject|2|||
149909431|NCT02783729|540798076|FG001|Overall Study|Withdrawal by Subject|3|||
149909432|NCT02783729|540798077|FG002|Overall Study|Withdrawal by Subject|1|||
149909433|NCT02783729|540798078|FG003|Overall Study|Withdrawal by Subject|2|||
149909434|NCT02783729|540798075|FG000|Overall Study|Participant's choice|2|||
149909435|NCT02783729|540798076|FG001|Overall Study|Participant's choice|1|||
149909436|NCT02783729|540798077|FG002|Overall Study|Participant's choice|2|||
149909437|NCT02783729|540798078|FG003|Overall Study|Participant's choice|1|||
149909438|NCT02783729|540798075|FG000|Overall Study|Lost to Follow-up|2|||
149909439|NCT02783729|540798076|FG001|Overall Study|Lost to Follow-up|1|||
149909440|NCT02783729|540798077|FG002|Overall Study|Lost to Follow-up|1|||
149909441|NCT02783729|540798078|FG003|Overall Study|Lost to Follow-up|0|||
149909442|NCT02288091|540798081|FG000|Overall Study|Lost to Follow-up|1|||
149909443|NCT02288091|540798081|FG000|Overall Study|Screen fail|7|||
149909444|NCT04021121|540798082|FG000|Overall Study|Death|3|||
149909445|NCT04021121|540798083|FG001|Overall Study|Death|3|||
149909446|NCT04021121|540798084|FG002|Overall Study|Death|5|||
149909447|NCT04021121|540798085|FG003|Overall Study|Death|4|||
149909448|NCT00978250|540798091|FG000|Overall Study|Late determination of ineligibility|0|||
149909449|NCT00978250|540798092|FG001|Overall Study|Late determination of ineligibility|1|||
149909450|NCT00978250|540798093|FG002|Overall Study|Late determination of ineligibility|0|||
149909451|NCT00978250|540798094|FG003|Overall Study|Late determination of ineligibility|1|||
149909452|NCT03843632|540798097|FG000|Overall Study|Withdrawal by Subject|1|||
149909453|NCT03843632|540798098|FG001|Overall Study|Withdrawal by Subject|0|||
149909454|NCT03843632|540798099|FG002|Overall Study|Withdrawal by Subject|0|||
149909455|NCT03843632|540798100|FG003|Overall Study|Withdrawal by Subject|0|||
149909456|NCT03403751|540798101|FG000|Overall Study|Death|5|||
149909457|NCT03403751|540798102|FG001|Overall Study|Death|6|||
149909458|NCT03403751|540798101|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
149909459|NCT03403751|540798102|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
149909460|NCT05036668|540798103|FG000|Overall Study|lost to follow Up|0|||
149909461|NCT05036668|540798104|FG001|Overall Study|lost to follow Up|0|||
149909462|NCT05036668|540798105|FG002|Overall Study|lost to follow Up|1|||
149909463|NCT00387010|540798109|FG000|Dose Titration Period|Adverse Event|12|||
149909464|NCT00387010|540798109|FG000|Dose Titration Period|Lack of Efficacy|5|||
149909465|NCT00387010|540798109|FG000|Dose Titration Period|Withdrawal by Subject|3|||
149909466|NCT00387010|540798109|FG000|Dose Titration Period|Protocol Violation|1|||
149909467|NCT00387010|540798109|FG000|Dose Titration Period|Lost to Follow-up|2|||
149909468|NCT00387010|540798109|FG000|Dose Titration Period|Noncompliance with study medication|8|||
149909469|NCT00387010|540798109|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
149909470|NCT00387010|540798109|FG000|Treatment Period|Adverse Event|4|||
149909471|NCT00387010|540798109|FG000|Treatment Period|Withdrawal by Subject|1|||
149909472|NCT00387010|540798109|FG000|Treatment Period|Noncompliance with study medication|2|||
149909473|NCT00387010|540798109|FG000|Treatment Period|Noncompliance with study procedures|3|||
149909474|NCT00387010|540798109|FG000|Treatment Period|Participant reported study drug stolen|1|||
149909475|NCT00520481|540798115|FG000|Overall Study|Adverse Event|4|||
149909476|NCT00520481|540798116|FG001|Overall Study|Adverse Event|1|||
149909477|NCT00520481|540798115|FG000|Overall Study|Withdrawal by Subject|3|||
149909478|NCT00520481|540798116|FG001|Overall Study|Withdrawal by Subject|0|||
149909479|NCT00381043|540798121|FG000|Overall Study|Lost to Follow-up|8|||
149909480|NCT00381043|540798122|FG001|Overall Study|Lost to Follow-up|6|||
149909481|NCT00381043|540798121|FG000|Overall Study|Withdrawal by Subject|3|||
149909482|NCT00381043|540798122|FG001|Overall Study|Withdrawal by Subject|1|||
149909483|NCT00381043|540798121|FG000|Overall Study|wanted more care|0|||
149909484|NCT00381043|540798122|FG001|Overall Study|wanted more care|1|||
149909485|NCT00381043|540798121|FG000|Overall Study|incarcerated|1|||
149909486|NCT00381043|540798122|FG001|Overall Study|incarcerated|0|||
149909487|NCT02880865|540798123|FG000|Overall Study|Adverse Event|1|||
149909488|NCT02880865|540798124|FG001|Overall Study|Adverse Event|0|||
149971672|NCT00744861|541033712|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
149971673|NCT00744861|541033713|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
149971674|NCT00744861|541033710|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
149971675|NCT00744861|541033711|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
150049182|NCT01904773|541321740|FG001|Fifth Intervention|Adverse Event|0|||
149909489|NCT02880865|540798123|FG000|Overall Study|Withdrawal by Subject|0|||
149909490|NCT02880865|540798124|FG001|Overall Study|Withdrawal by Subject|2|||
150049183|NCT01904773|541321741|FG002|Fifth Intervention|Adverse Event|0|||
150049184|NCT01904773|541321742|FG003|Fifth Intervention|Adverse Event|0|||
150176768|NCT01787760|541783414|FG000|Overall Study|Relocation|1|||
150176769|NCT01787760|541783415|FG001|Overall Study|Relocation|1|||
149909491|NCT02880865|540798123|FG000|Overall Study|Physician Decision|0|||
149909492|NCT02880865|540798124|FG001|Overall Study|Physician Decision|1|||
149909493|NCT02841280|540798132|FG000|Overall Study|Adverse Event|2|||
149909494|NCT02841280|540798133|FG001|Overall Study|Adverse Event|1|||
149909495|NCT02841280|540798132|FG000|Overall Study|Death|1|||
149909496|NCT02841280|540798133|FG001|Overall Study|Death|0|||
149909497|NCT02841280|540798132|FG000|Overall Study|Lost to Follow-up|2|||
149909498|NCT02841280|540798133|FG001|Overall Study|Lost to Follow-up|2|||
149909499|NCT02841280|540798132|FG000|Overall Study|Withdrawal by Subject|7|||
149909500|NCT02841280|540798133|FG001|Overall Study|Withdrawal by Subject|3|||
149909501|NCT02841280|540798132|FG000|Overall Study|Stop Point: BP above threshold|2|||
149909502|NCT02841280|540798133|FG001|Overall Study|Stop Point: BP above threshold|0|||
149909503|NCT00833482|540798134|FG000|Days 11-20|Adverse Event|0|||
149909504|NCT00833482|540798135|FG001|Days 11-20|Adverse Event|2|||
149909505|NCT00833482|540798136|FG002|Days 11-20|Adverse Event|0|||
149909506|NCT00833482|540798137|FG003|Days 11-20|Adverse Event|0|||
149909507|NCT00833482|540798138|FG004|Days 11-20|Adverse Event|0|||
149909508|NCT00833482|540798139|FG005|Days 11-20|Adverse Event|0|||
149909509|NCT00833482|540798134|FG000|Days 11-20|Withdrawal by Subject|0|||
149909510|NCT00833482|540798135|FG001|Days 11-20|Withdrawal by Subject|1|||
149909511|NCT00833482|540798136|FG002|Days 11-20|Withdrawal by Subject|0|||
149909512|NCT00833482|540798137|FG003|Days 11-20|Withdrawal by Subject|0|||
149909513|NCT00833482|540798138|FG004|Days 11-20|Withdrawal by Subject|0|||
149909514|NCT00833482|540798139|FG005|Days 11-20|Withdrawal by Subject|0|||
149909515|NCT00833482|540798134|FG000|Days 21-30|Adverse Event|0|||
149909516|NCT00833482|540798135|FG001|Days 21-30|Adverse Event|0|||
149909517|NCT00833482|540798136|FG002|Days 21-30|Adverse Event|1|||
149909518|NCT00833482|540798137|FG003|Days 21-30|Adverse Event|0|||
149909519|NCT00833482|540798138|FG004|Days 21-30|Adverse Event|0|||
149909520|NCT00833482|540798139|FG005|Days 21-30|Adverse Event|0|||
149909521|NCT00833482|540798134|FG000|Days 21-30|Withdrawal by Subject|0|||
149909522|NCT00833482|540798135|FG001|Days 21-30|Withdrawal by Subject|0|||
149909523|NCT00833482|540798136|FG002|Days 21-30|Withdrawal by Subject|0|||
149909524|NCT00833482|540798137|FG003|Days 21-30|Withdrawal by Subject|0|||
149909525|NCT00833482|540798138|FG004|Days 21-30|Withdrawal by Subject|1|||
149909526|NCT00833482|540798139|FG005|Days 21-30|Withdrawal by Subject|0|||
149909527|NCT02600845|540798146|FG000|Overall Study|Reason Not Specified|3|||
149909528|NCT02600845|540798146|FG000|Overall Study|Non-compliance with Study Procedures|10|||
149909529|NCT02600845|540798146|FG000|Overall Study|Consent Withdrawal|5|||
149909530|NCT03666533|540799554|FG000|Overall Study|Lost to Follow-up|2|||
149909531|NCT03666533|540799555|FG001|Overall Study|Lost to Follow-up|2|||
149909532|NCT04240886|540799556|FG000|Treatment Phase|Death|4|||
149909533|NCT04240886|540799556|FG000|Treatment Phase|Discontinuation by Subject|1|||
149909534|NCT04240886|540799556|FG000|Treatment Phase|Adverse Event|5|||
149971676|NCT00744861|541033712|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
149971677|NCT00744861|541033713|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
149971678|NCT04856527|541033714|FG000|Overall Study|Unable to complete experimental task|2|||
149971679|NCT04856527|541033715|FG001|Overall Study|Unable to complete experimental task|0|||
149971680|NCT02493764|541033716|FG000|Overall Study|Adverse Event|2|||
149971681|NCT02493764|541033717|FG001|Overall Study|Adverse Event|2|||
149971682|NCT02493764|541033716|FG000|Overall Study|Death|44|||
149971683|NCT02493764|541033717|FG001|Overall Study|Death|58|||
149971684|NCT02493764|541033716|FG000|Overall Study|Lost to Follow-up|2|||
149971685|NCT02493764|541033717|FG001|Overall Study|Lost to Follow-up|1|||
149971686|NCT02493764|541033716|FG000|Overall Study|Protocol Violation|6|||
149971687|NCT02493764|541033717|FG001|Overall Study|Protocol Violation|7|||
149971688|NCT02493764|541033716|FG000|Overall Study|Physician Decision|1|||
149971689|NCT02493764|541033717|FG001|Overall Study|Physician Decision|1|||
149971690|NCT02493764|541033716|FG000|Overall Study|Participant moved|17|||
149971691|NCT02493764|541033717|FG001|Overall Study|Participant moved|5|||
149971692|NCT02493764|541033716|FG000|Overall Study|Withdrawal parent/guardian|0|||
149971693|NCT02493764|541033717|FG001|Overall Study|Withdrawal parent/guardian|1|||
149909535|NCT04240886|540799556|FG000|Follow-up Phase|Withdrawal by Subject|1|||
150049185|NCT01904773|541321743|FG004|Fifth Intervention|Adverse Event|0|||
149909536|NCT04240886|540799556|FG000|Follow-up Phase|Discontinuation by Subject|1|||
149909537|NCT04240886|540799556|FG000|Follow-up Phase|Death|2|||
149909538|NCT04743804|540799559|FG000|Overall Study|Other|1|||
149909539|NCT04743804|540799560|FG001|Overall Study|Other|0|||
149909540|NCT04743804|540799559|FG000|Overall Study|Withdrawal by Subject|0|||
149909541|NCT04743804|540799560|FG001|Overall Study|Withdrawal by Subject|1|||
149909542|NCT04743804|540799559|FG000|Overall Study|Study Terminated by Sponsor|1|||
149909543|NCT04743804|540799560|FG001|Overall Study|Study Terminated by Sponsor|4|||
149909544|NCT04743804|540799559|FG000|Overall Study|Physician Decision|0|||
149909545|NCT04743804|540799560|FG001|Overall Study|Physician Decision|1|||
149909546|NCT04743804|540799559|FG000|Overall Study|Death|3|||
149971694|NCT02493764|541033716|FG000|Overall Study|Withdrawal by Subject|11|||
150176770|NCT01787760|541783416|FG002|Overall Study|Relocation|0|||
149971695|NCT02493764|541033717|FG001|Overall Study|Withdrawal by Subject|7|||
149971696|NCT01561976|541033718|FG000|Period 1|Adverse Event|0|||
149971697|NCT01561976|541033719|FG001|Period 1|Adverse Event|0|||
149971698|NCT01561976|541033720|FG002|Period 1|Adverse Event|1|||
149971699|NCT01561976|541033721|FG003|Period 1|Adverse Event|0|||
149971700|NCT01561976|541033722|FG004|Period 1|Adverse Event|0|||
149971701|NCT01561976|541033723|FG005|Period 1|Adverse Event|0|||
149971702|NCT01561976|541033718|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
149971703|NCT01561976|541033719|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
149971704|NCT01561976|541033720|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
149971705|NCT01561976|541033721|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
149971706|NCT01561976|541033722|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
149971707|NCT01561976|541033723|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
149971708|NCT01561976|541033718|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149971709|NCT01561976|541033719|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149971710|NCT01561976|541033720|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149971711|NCT01561976|541033721|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149971712|NCT01561976|541033722|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149971713|NCT01561976|541033723|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149971714|NCT01561976|541033718|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
149971715|NCT01561976|541033719|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
149971716|NCT01561976|541033720|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
149971717|NCT01561976|541033721|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
149971718|NCT01561976|541033722|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
149971719|NCT01561976|541033723|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
149971720|NCT01463527|541033726|FG000|Overall Study|Protocol Violation|1|||
149971721|NCT01463527|541033727|FG001|Overall Study|Protocol Violation|1|||
150049186|NCT01904773|541321744|FG005|Fifth Intervention|Adverse Event|0|||
150049187|NCT01904773|541321745|FG006|Fifth Intervention|Adverse Event|0|||
150049188|NCT01904773|541321746|FG007|Fifth Intervention|Adverse Event|1|||
150049189|NCT01904773|541321747|FG008|Fifth Intervention|Adverse Event|0|||
150049190|NCT01904773|541321739|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049191|NCT01904773|541321740|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
150049192|NCT01904773|541321741|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049193|NCT01904773|541321742|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049194|NCT01904773|541321743|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049195|NCT01904773|541321744|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049196|NCT01904773|541321745|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049197|NCT01904773|541321746|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049198|NCT01904773|541321747|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
150049199|NCT04518995|541321748|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
150049200|NCT04518995|541321749|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
150049201|NCT04518995|541321750|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
150049202|NCT04518995|541321748|FG000|Overall Study|Lack of Efficacy|2|||
150049203|NCT04518995|541321749|FG001|Overall Study|Lack of Efficacy|1|||
150049204|NCT04518995|541321750|FG002|Overall Study|Lack of Efficacy|0|||
150049205|NCT04518995|541321748|FG000|Overall Study|Non-compliance With Study Drug|0|||
150049206|NCT04518995|541321749|FG001|Overall Study|Non-compliance With Study Drug|3|||
150049207|NCT04518995|541321750|FG002|Overall Study|Non-compliance With Study Drug|2|||
150049208|NCT04518995|541321748|FG000|Overall Study|Pregnancy|0|||
150049209|NCT04518995|541321749|FG001|Overall Study|Pregnancy|0|||
150049210|NCT04518995|541321750|FG002|Overall Study|Pregnancy|1|||
150049211|NCT04518995|541321748|FG000|Overall Study|Protocol Violation|2|||
150049212|NCT04518995|541321749|FG001|Overall Study|Protocol Violation|0|||
150049213|NCT04518995|541321750|FG002|Overall Study|Protocol Violation|1|||
150049214|NCT04518995|541321748|FG000|Overall Study|Reason not Specified|4|||
150049215|NCT04518995|541321749|FG001|Overall Study|Reason not Specified|11|||
150049216|NCT04518995|541321750|FG002|Overall Study|Reason not Specified|2|||
150049217|NCT04518995|541321748|FG000|Overall Study|Lost to Follow-up|1|||
150049218|NCT04518995|541321749|FG001|Overall Study|Lost to Follow-up|10|||
150049219|NCT04518995|541321750|FG002|Overall Study|Lost to Follow-up|6|||
150049220|NCT03390101|541321751|FG000|Weeks 0-12|Withdrawal by Subject|0|||
150049221|NCT03390101|541321752|FG001|Weeks 0-12|Withdrawal by Subject|1|||
150049222|NCT03390101|541321753|FG002|Weeks 0-12|Withdrawal by Subject|1|||
150049223|NCT03390101|541321751|FG000|Weeks 0-12|Lost to Follow-up|0|||
150049224|NCT03390101|541321752|FG001|Weeks 0-12|Lost to Follow-up|1|||
150049225|NCT03390101|541321753|FG002|Weeks 0-12|Lost to Follow-up|0|||
150049226|NCT03390101|541321751|FG000|Weeks 12-54|Withdrawal by Subject|0|||
150049227|NCT03390101|541321752|FG001|Weeks 12-54|Withdrawal by Subject|3|||
150049228|NCT03390101|541321753|FG002|Weeks 12-54|Withdrawal by Subject|1|||
149971722|NCT01463527|541033726|FG000|Overall Study|Crying >20% of sedation|5|||
149971723|NCT01463527|541033727|FG001|Overall Study|Crying >20% of sedation|6|||
149971724|NCT01493414|541033728|FG000|Overall Study|Adverse Event|405|||
149971725|NCT01493414|541033728|FG000|Overall Study|Disease progression|204|||
149909547|NCT04743804|540799560|FG001|Overall Study|Death|0|||
149909548|NCT01632150|540799561|FG000|Overall Study|Disease progression|27|||
149909549|NCT01632150|540799561|FG000|Overall Study|Study drug toxicity|1|||
150176771|NCT01787760|541783414|FG000|Overall Study|Lens discomfort|3|||
150176772|NCT01787760|541783415|FG001|Overall Study|Lens discomfort|0|||
150176773|NCT01787760|541783416|FG002|Overall Study|Lens discomfort|0|||
150176774|NCT01787760|541783414|FG000|Overall Study|Lens handling difficulty|1|||
150176775|NCT01787760|541783415|FG001|Overall Study|Lens handling difficulty|2|||
150176776|NCT01787760|541783416|FG002|Overall Study|Lens handling difficulty|0|||
150049229|NCT03390101|541321751|FG000|Weeks 12-54|Pregnancy|1|||
150049230|NCT03390101|541321752|FG001|Weeks 12-54|Pregnancy|0|||
150049231|NCT03390101|541321753|FG002|Weeks 12-54|Pregnancy|0|||
150049232|NCT03390101|541321751|FG000|Weeks 12-54|Adverse Event|2|||
149909550|NCT01632150|540799561|FG000|Overall Study|Unrelated adverse event|7|||
149909551|NCT01632150|540799561|FG000|Overall Study|Withdrawal by Subject|2|||
149909552|NCT01632150|540799561|FG000|Overall Study|Patient underwent autologous transplant|1|||
149909553|NCT01632150|540799561|FG000|Overall Study|Moved to compassionate program|2|||
149909554|NCT02143791|540799564|FG000|Enrolled|Withdrawal by Subject|4|||
149909555|NCT02143791|540799564|FG000|Trial Stimulation|Lack of Efficacy|21|||
149909556|NCT02143791|540799564|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
149909557|NCT02143791|540799564|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
149909558|NCT02143791|540799564|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
149909559|NCT02143791|540799564|FG000|Any Programming (3-6 Months)|Missing Data|1|||
149909560|NCT02143791|540799564|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
149909561|NCT03408444|540799569|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
149909562|NCT03408444|540799570|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
149909563|NCT03408444|540799571|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
149909564|NCT03408444|540799572|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
149909565|NCT03408444|540799569|FG000|Overall Study|Lens Discomfort|0|||
150049233|NCT03390101|541321752|FG001|Weeks 12-54|Adverse Event|1|||
150049234|NCT03390101|541321753|FG002|Weeks 12-54|Adverse Event|1|||
150049235|NCT01511055|541321754|FG000|Overall Study|Withdrawal by Subject|6|||
150049236|NCT00813943|541321756|FG000|Overall Study|Ongoing at cut-off date|5|||
150049237|NCT00813943|541321757|FG001|Overall Study|Ongoing at cut-off date|5|||
150049238|NCT00813943|541321758|FG002|Overall Study|Ongoing at cut-off date|3|||
150049239|NCT01235598|541321759|FG000|Overall Study|Adverse Event|0|||
150049240|NCT01235598|541321760|FG001|Overall Study|Adverse Event|3|||
150049241|NCT01235598|541321759|FG000|Overall Study|Lack of Efficacy|0|||
150049242|NCT01235598|541321760|FG001|Overall Study|Lack of Efficacy|1|||
150049243|NCT01235598|541321759|FG000|Overall Study|Withdrawal by Subject|1|||
150049244|NCT01235598|541321760|FG001|Overall Study|Withdrawal by Subject|0|||
150049245|NCT02151773|541321761|FG000|Overall Study|Protocol Deviation|64|||
150049246|NCT02551991|541321762|FG000|Overall Study|Death|5|||
150049247|NCT02551991|541321763|FG001|Overall Study|Death|7|||
150049248|NCT02551991|541321764|FG002|Overall Study|Death|8|||
150049249|NCT02551991|541321765|FG003|Overall Study|Death|7|||
150049250|NCT02551991|541321766|FG004|Overall Study|Death|17|||
150049251|NCT02551991|541321762|FG000|Overall Study|Withdrawal by Subject|1|||
149909566|NCT03408444|540799570|FG001|Overall Study|Lens Discomfort|1|||
149909567|NCT03408444|540799571|FG002|Overall Study|Lens Discomfort|0|||
150049252|NCT02551991|541321763|FG001|Overall Study|Withdrawal by Subject|0|||
150049253|NCT02551991|541321764|FG002|Overall Study|Withdrawal by Subject|0|||
150049254|NCT02551991|541321765|FG003|Overall Study|Withdrawal by Subject|0|||
150049255|NCT02551991|541321766|FG004|Overall Study|Withdrawal by Subject|2|||
150176777|NCT01787760|541783414|FG000|Overall Study|Protocol Violation|6|||
150176778|NCT01787760|541783415|FG001|Overall Study|Protocol Violation|0|||
149909568|NCT03408444|540799572|FG003|Overall Study|Lens Discomfort|0|||
149909569|NCT03408444|540799569|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
149909570|NCT03408444|540799570|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
149909571|NCT03408444|540799571|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
149909572|NCT03408444|540799572|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
149909573|NCT03408444|540799569|FG000|Overall Study|Withdrawal by Subject|0|||
149909574|NCT03408444|540799570|FG001|Overall Study|Withdrawal by Subject|2|||
149909575|NCT03408444|540799571|FG002|Overall Study|Withdrawal by Subject|3|||
149909576|NCT03408444|540799572|FG003|Overall Study|Withdrawal by Subject|0|||
149909577|NCT03408444|540799569|FG000|Overall Study|Lost to Follow-up|0|||
149909578|NCT03408444|540799570|FG001|Overall Study|Lost to Follow-up|0|||
149909579|NCT03408444|540799571|FG002|Overall Study|Lost to Follow-up|1|||
150049256|NCT02551991|541321762|FG000|Overall Study|Lost to Follow-up|0|||
150049257|NCT02551991|541321763|FG001|Overall Study|Lost to Follow-up|0|||
150049258|NCT02551991|541321764|FG002|Overall Study|Lost to Follow-up|1|||
150049259|NCT02551991|541321765|FG003|Overall Study|Lost to Follow-up|0|||
149909580|NCT03408444|540799572|FG003|Overall Study|Lost to Follow-up|0|||
149909581|NCT03408444|540799569|FG000|Overall Study|Adverse Event|0|||
149909582|NCT03408444|540799570|FG001|Overall Study|Adverse Event|0|||
150176779|NCT01787760|541783416|FG002|Overall Study|Protocol Violation|1|||
150176780|NCT01787760|541783414|FG000|Overall Study|Withdrawal by Subject|5|||
149909583|NCT03408444|540799571|FG002|Overall Study|Adverse Event|0|||
150049260|NCT02551991|541321766|FG004|Overall Study|Lost to Follow-up|0|||
150049261|NCT02551991|541321762|FG000|Overall Study|Sponsor Decision|1|||
149909584|NCT03408444|540799572|FG003|Overall Study|Adverse Event|1|||
149909585|NCT03408444|540799569|FG000|Overall Study|Lens Handling Difficulties|0|||
149909586|NCT03408444|540799570|FG001|Overall Study|Lens Handling Difficulties|0|||
150049262|NCT02551991|541321763|FG001|Overall Study|Sponsor Decision|0|||
150049263|NCT02551991|541321764|FG002|Overall Study|Sponsor Decision|1|||
150049264|NCT02551991|541321765|FG003|Overall Study|Sponsor Decision|0|||
150049265|NCT02551991|541321766|FG004|Overall Study|Sponsor Decision|5|||
150049266|NCT02551991|541321762|FG000|Overall Study|Other|0|||
149909587|NCT03408444|540799571|FG002|Overall Study|Lens Handling Difficulties|1|||
149909588|NCT03408444|540799572|FG003|Overall Study|Lens Handling Difficulties|0|||
149909589|NCT03408444|540799569|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
149909590|NCT03408444|540799570|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
149909591|NCT03408444|540799571|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
149909592|NCT03408444|540799572|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
149909593|NCT04984681|540799573|FG000|Overall Study|Lost to Follow-up|3|||
149909594|NCT04984681|540799574|FG001|Overall Study|Lost to Follow-up|1|||
149909595|NCT01214252|540799575|FG000|Overall Study|Not eligible per protocol|82|||
149909596|NCT04327661|540799576|FG000|Overall Study|Withdrawal by Subject|1|||
149909597|NCT04327661|540799577|FG001|Overall Study|Withdrawal by Subject|0|||
149909598|NCT04327661|540799578|FG002|Overall Study|Withdrawal by Subject|0|||
149909599|NCT03391232|540799580|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
149909600|NCT03391232|540799581|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
149909601|NCT03391232|540799580|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
149909602|NCT03391232|540799581|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
149909603|NCT00552032|540799582|FG000|Overall Study|Withdrawal by Subject|2|||
149909604|NCT00552032|540799583|FG001|Overall Study|Withdrawal by Subject|2|||
149909605|NCT00552032|540799582|FG000|Overall Study|Protocol Violation|7|||
149909606|NCT00552032|540799583|FG001|Overall Study|Protocol Violation|12|||
149909607|NCT00552032|540799582|FG000|Overall Study|Lost to Follow-up|8|||
149909608|NCT00552032|540799583|FG001|Overall Study|Lost to Follow-up|5|||
149909609|NCT02091960|540799584|FG000|Overall Study|Death|7|||
149909610|NCT02091960|540799584|FG000|Overall Study|Withdrawal by Subject|1|||
149909611|NCT02091960|540799584|FG000|Overall Study|Miscellaneous Reasons|37|||
149909612|NCT04777201|540799585|FG000|Main Study|Withdrawal by Subject|19|||
149909613|NCT04777201|540799586|FG001|Main Study|Withdrawal by Subject|27|||
149909614|NCT04777201|540799587|FG002|Main Study|Withdrawal by Subject|0|||
149909615|NCT04777201|540799585|FG000|Main Study|Death|13|||
149909616|NCT04777201|540799586|FG001|Main Study|Death|27|||
149909617|NCT04777201|540799587|FG002|Main Study|Death|0|||
149909618|NCT04777201|540799585|FG000|Main Study|Subject missed the safety follow-up visit|9|||
149909619|NCT04777201|540799586|FG001|Main Study|Subject missed the safety follow-up visit|10|||
150049267|NCT02551991|541321763|FG001|Overall Study|Other|0|||
150049268|NCT02551991|541321764|FG002|Overall Study|Other|0|||
150049269|NCT02551991|541321765|FG003|Overall Study|Other|0|||
150049270|NCT02551991|541321766|FG004|Overall Study|Other|1|||
149909620|NCT04777201|540799587|FG002|Main Study|Subject missed the safety follow-up visit|0|||
149909621|NCT04777201|540799585|FG000|Main Study|Physician Decision|8|||
149909622|NCT04777201|540799586|FG001|Main Study|Physician Decision|10|||
149909623|NCT04777201|540799587|FG002|Main Study|Physician Decision|0|||
149909624|NCT04777201|540799585|FG000|Main Study|Adverse Event|8|||
149909625|NCT04777201|540799586|FG001|Main Study|Adverse Event|8|||
149909626|NCT04777201|540799587|FG002|Main Study|Adverse Event|0|||
149909627|NCT04777201|540799585|FG000|Main Study|Lost to Follow-up|9|||
149909628|NCT04777201|540799586|FG001|Main Study|Lost to Follow-up|4|||
149909629|NCT04777201|540799587|FG002|Main Study|Lost to Follow-up|0|||
149909630|NCT04777201|540799585|FG000|Main Study|Reason not specified|3|||
149909631|NCT04777201|540799586|FG001|Main Study|Reason not specified|3|||
149909632|NCT04777201|540799587|FG002|Main Study|Reason not specified|0|||
149909633|NCT04777201|540799585|FG000|Main Study|Lack of Efficacy|1|||
149909634|NCT04777201|540799586|FG001|Main Study|Lack of Efficacy|1|||
149909635|NCT04777201|540799587|FG002|Main Study|Lack of Efficacy|0|||
149909636|NCT04777201|540799585|FG000|Main Study|Protocol Violation|1|||
149909637|NCT04777201|540799586|FG001|Main Study|Protocol Violation|0|||
149909638|NCT04777201|540799587|FG002|Main Study|Protocol Violation|0|||
149971726|NCT01493414|541033728|FG000|Overall Study|Death|101|||
149971727|NCT01493414|541033728|FG000|Overall Study|Physician Decision|93|||
149971728|NCT01493414|541033728|FG000|Overall Study|Withdrawal by Subject|79|||
149971729|NCT01493414|541033728|FG000|Overall Study|Protocol deviation|27|||
149971730|NCT01493414|541033728|FG000|Overall Study|Administrative problems|25|||
149971731|NCT01493414|541033728|FG000|Overall Study|Lost to Follow-up|16|||
149971732|NCT01977222|541033733|FG000|Overall Study|Withdrawal by Subject|1|||
149971733|NCT04165824|541033734|FG000|Overall Study|Adverse Event|23|||
149971734|NCT04165824|541033734|FG000|Overall Study|Physician Decision|1|||
149971735|NCT04165824|541033734|FG000|Overall Study|Withdrawal by Subject|17|||
149971736|NCT04165824|541033734|FG000|Overall Study|Other|5|||
149971737|NCT04403919|541033735|FG000|Overall Study|Lost to Follow-up|0|||
149971738|NCT04403919|541033736|FG001|Overall Study|Lost to Follow-up|0|||
149971739|NCT04403919|541033737|FG002|Overall Study|Lost to Follow-up|0|||
149971740|NCT04403919|541033738|FG003|Overall Study|Lost to Follow-up|1|||
149971741|NCT04846231|541033742|FG000|Overall Study|Lost to Follow-up|1|||
149971742|NCT04846231|541033743|FG001|Overall Study|Lost to Follow-up|0|||
149971743|NCT04846231|541033744|FG002|Overall Study|Lost to Follow-up|0|||
149971744|NCT04846231|541033745|FG003|Overall Study|Lost to Follow-up|0|||
149971745|NCT04846231|541033746|FG004|Overall Study|Lost to Follow-up|0|||
149971746|NCT04846231|541033747|FG005|Overall Study|Lost to Follow-up|0|||
149971747|NCT04846231|541033748|FG006|Overall Study|Lost to Follow-up|0|||
149971748|NCT04846231|541033749|FG007|Overall Study|Lost to Follow-up|1|||
149971749|NCT04846231|541033742|FG000|Overall Study|Withdrawal by Subject|0|||
149971750|NCT04846231|541033743|FG001|Overall Study|Withdrawal by Subject|1|||
149971751|NCT04846231|541033744|FG002|Overall Study|Withdrawal by Subject|2|||
149971752|NCT04846231|541033745|FG003|Overall Study|Withdrawal by Subject|1|||
149971753|NCT04846231|541033746|FG004|Overall Study|Withdrawal by Subject|0|||
149971754|NCT04846231|541033747|FG005|Overall Study|Withdrawal by Subject|0|||
149971755|NCT04846231|541033748|FG006|Overall Study|Withdrawal by Subject|0|||
149971756|NCT04846231|541033749|FG007|Overall Study|Withdrawal by Subject|0|||
149971757|NCT04846231|541033742|FG000|Overall Study|Protocol Violation|0|||
149971758|NCT04846231|541033743|FG001|Overall Study|Protocol Violation|1|||
149971759|NCT04846231|541033744|FG002|Overall Study|Protocol Violation|0|||
149971760|NCT04846231|541033745|FG003|Overall Study|Protocol Violation|0|||
149971761|NCT04846231|541033746|FG004|Overall Study|Protocol Violation|0|||
149971762|NCT04846231|541033747|FG005|Overall Study|Protocol Violation|0|||
149971763|NCT04846231|541033748|FG006|Overall Study|Protocol Violation|0|||
149971764|NCT04846231|541033749|FG007|Overall Study|Protocol Violation|0|||
149971765|NCT04846231|541033742|FG000|Overall Study|Adverse Event|0|||
149971766|NCT04846231|541033743|FG001|Overall Study|Adverse Event|0|||
149971767|NCT04846231|541033744|FG002|Overall Study|Adverse Event|0|||
149971768|NCT04846231|541033745|FG003|Overall Study|Adverse Event|0|||
149971769|NCT04846231|541033746|FG004|Overall Study|Adverse Event|0|||
149909639|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
149909640|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
149971770|NCT04846231|541033747|FG005|Overall Study|Adverse Event|0|||
149971771|NCT04846231|541033748|FG006|Overall Study|Adverse Event|1|||
149971772|NCT04846231|541033749|FG007|Overall Study|Adverse Event|1|||
149971773|NCT02980107|541033750|FG000|Overall Study|Withdrawal by Subject|51|||
149971774|NCT02980107|541033751|FG001|Overall Study|Withdrawal by Subject|62|||
149909641|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
149971775|NCT05448950|541033754|FG000|Overall Study|Death|2|||
149971776|NCT05448950|541033754|FG000|Overall Study|Withdrawal by Subject|1|||
149971777|NCT05448950|541033754|FG000|Overall Study|AVG abandoned|4|||
149971778|NCT00829244|541033759|FG000|Overall Study|Adverse Event|1|||
149971779|NCT00829244|541033760|FG001|Overall Study|Adverse Event|3|||
149971780|NCT00829244|541033759|FG000|Overall Study|Protocol Violation|1|||
149971781|NCT00829244|541033760|FG001|Overall Study|Protocol Violation|0|||
149909642|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
149909643|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
149909644|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
149909645|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
149909646|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
149909647|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
149909648|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
149909649|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
149909650|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
149909651|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
149909652|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
149909653|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
149909654|NCT04777201|540799585|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
149909655|NCT04777201|540799586|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
149909656|NCT04777201|540799587|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
149909657|NCT02691013|540799590|FG000|Overall Study|Withdrawal by Subject|3|||
149909658|NCT02691013|540799591|FG001|Overall Study|Withdrawal by Subject|0|||
149909659|NCT02111785|540799595|FG000|Overall Study|Death|0|||
149909660|NCT02111785|540799596|FG001|Overall Study|Death|1|||
149909661|NCT02111785|540799597|FG002|Overall Study|Death|0|||
149909662|NCT02111785|540799598|FG003|Overall Study|Death|0|||
149909663|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Adverse Event|6|||
149909664|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Adverse Event|14|||
149909665|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Death|3|||
149909666|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Death|1|||
149909667|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
149909668|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
149909669|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
149909670|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
149909671|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
149909672|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
149909673|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
149909674|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
149909675|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
149909676|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
149909677|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Physician Decision|2|||
149909678|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Physician Decision|4|||
149909679|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Pregnancy|2|||
149909680|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Pregnancy|1|||
149909681|NCT02275780|540799601|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
149909682|NCT02275780|540799602|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
149909683|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
149909684|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
149909685|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
149909686|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
149909687|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
149909688|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
149909689|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
149909690|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
149909691|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
149909692|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
149909693|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
149909694|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
149909695|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
149909696|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
149909697|NCT02275780|540799601|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
149909698|NCT02275780|540799602|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
149909699|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
149909700|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
149909701|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
149909702|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
149909703|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
149909704|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
149909705|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
149909706|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
149971782|NCT00829244|541033759|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
149971783|NCT00829244|541033760|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
149909707|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
149909708|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
149909709|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
149909710|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
149909711|NCT02275780|540799601|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
149909712|NCT02275780|540799602|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
149909713|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
149909714|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
149909715|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
149909716|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
149909717|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
149909718|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
149909719|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
149909720|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
149909721|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
149909722|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
149909723|NCT02275780|540799601|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
149909724|NCT02275780|540799602|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
149909725|NCT01054300|540799607|FG000|Period 1|Adverse Event|1|||
149909726|NCT01054300|540799608|FG001|Period 1|Adverse Event|0|||
149909727|NCT01054300|540799609|FG002|Period 1|Adverse Event|0|||
149909728|NCT01054300|540799610|FG003|Period 1|Adverse Event|0|||
149909729|NCT01054300|540799607|FG000|Period 2|Withdrawal by Subject|0|||
149909730|NCT01054300|540799608|FG001|Period 2|Withdrawal by Subject|0|||
149909731|NCT01054300|540799609|FG002|Period 2|Withdrawal by Subject|1|||
149909732|NCT01054300|540799610|FG003|Period 2|Withdrawal by Subject|0|||
149909733|NCT00738881|540799616|FG000|Overall Study|Withdrawal by Subject|0|||
149909734|NCT00738881|540799617|FG001|Overall Study|Withdrawal by Subject|2|||
149909735|NCT00759785|540799618|FG000|Overall Study|Participant sample not evaluable|11|||
149909736|NCT00759785|540799619|FG001|Overall Study|Participant sample not evaluable|2|||
149909737|NCT00759785|540799618|FG000|Overall Study|Participant sample lost|0|||
149909738|NCT00759785|540799619|FG001|Overall Study|Participant sample lost|1|||
149909739|NCT00759785|540799618|FG000|Overall Study|Protocol Violation|1|||
149909740|NCT00759785|540799619|FG001|Overall Study|Protocol Violation|0|||
149909741|NCT00759785|540799618|FG000|Overall Study|Physician Decision|0|||
149909742|NCT00759785|540799619|FG001|Overall Study|Physician Decision|1|||
149909743|NCT00759785|540799618|FG000|Overall Study|Withdrawal by Subject|0|||
149909744|NCT00759785|540799619|FG001|Overall Study|Withdrawal by Subject|1|||
149909745|NCT01282164|540799622|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
149909746|NCT01282164|540799623|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
149909747|NCT03671564|540799624|FG000|Overall Study|Progressive Disease|3|||
149909748|NCT03671564|540799625|FG001|Overall Study|Progressive Disease|5|||
149909749|NCT03671564|540799626|FG002|Overall Study|Progressive Disease|3|||
149909750|NCT03671564|540799624|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
149909751|NCT03671564|540799625|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
149909752|NCT03671564|540799626|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
149909753|NCT03671564|540799624|FG000|Overall Study|Withdrawal by Subject|1|||
149909754|NCT03671564|540799625|FG001|Overall Study|Withdrawal by Subject|1|||
149909755|NCT03671564|540799626|FG002|Overall Study|Withdrawal by Subject|0|||
149909756|NCT04521621|540799627|FG000|Overall Study|Death|17|||
149909757|NCT04521621|540799628|FG001|Overall Study|Death|8|||
149909758|NCT04521621|540799629|FG002|Overall Study|Death|8|||
149909759|NCT04521621|540799630|FG003|Overall Study|Death|5|||
149909760|NCT04521621|540799631|FG004|Overall Study|Death|2|||
149909761|NCT04521621|540799632|FG005|Overall Study|Death|7|||
149909762|NCT04521621|540799633|FG006|Overall Study|Death|0|||
149909763|NCT04521621|540799634|FG007|Overall Study|Death|0|||
149909764|NCT04521621|540799627|FG000|Overall Study|Study Terminated by Sponsor|4|||
149909765|NCT04521621|540799628|FG001|Overall Study|Study Terminated by Sponsor|6|||
149909766|NCT04521621|540799629|FG002|Overall Study|Study Terminated by Sponsor|8|||
149971784|NCT00829244|541033759|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
149971785|NCT00829244|541033760|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
149909767|NCT04521621|540799630|FG003|Overall Study|Study Terminated by Sponsor|0|||
149909768|NCT04521621|540799631|FG004|Overall Study|Study Terminated by Sponsor|1|||
149909769|NCT04521621|540799632|FG005|Overall Study|Study Terminated by Sponsor|7|||
149909770|NCT04521621|540799633|FG006|Overall Study|Study Terminated by Sponsor|0|||
149909771|NCT04521621|540799634|FG007|Overall Study|Study Terminated by Sponsor|0|||
150176781|NCT01787760|541783415|FG001|Overall Study|Withdrawal by Subject|1|||
149909772|NCT04521621|540799627|FG000|Overall Study|Withdrawal by Subject|0|||
149909773|NCT04521621|540799628|FG001|Overall Study|Withdrawal by Subject|0|||
149909774|NCT04521621|540799629|FG002|Overall Study|Withdrawal by Subject|1|||
149971786|NCT00829244|541033759|FG000|Overall Study|No fertilization|2|||
149971787|NCT00829244|541033760|FG001|Overall Study|No fertilization|2|||
150049271|NCT00395343|541321767|FG000|Overall Study|Adverse Event|13|||
150049272|NCT00395343|541321768|FG001|Overall Study|Adverse Event|5|||
150049273|NCT00395343|541321767|FG000|Overall Study|Lack of Efficacy|0|||
149909775|NCT04521621|540799630|FG003|Overall Study|Withdrawal by Subject|1|||
149909776|NCT04521621|540799631|FG004|Overall Study|Withdrawal by Subject|0|||
150049274|NCT00395343|541321768|FG001|Overall Study|Lack of Efficacy|1|||
150049275|NCT00395343|541321767|FG000|Overall Study|Lost to Follow-up|4|||
149909777|NCT04521621|540799632|FG005|Overall Study|Withdrawal by Subject|0|||
149909778|NCT04521621|540799633|FG006|Overall Study|Withdrawal by Subject|0|||
149909779|NCT04521621|540799634|FG007|Overall Study|Withdrawal by Subject|0|||
149909780|NCT04521621|540799627|FG000|Overall Study|Allocated in error without study intervention|1|||
149909781|NCT04521621|540799628|FG001|Overall Study|Allocated in error without study intervention|0|||
149909782|NCT04521621|540799629|FG002|Overall Study|Allocated in error without study intervention|0|||
149909783|NCT04521621|540799630|FG003|Overall Study|Allocated in error without study intervention|0|||
149909784|NCT04521621|540799631|FG004|Overall Study|Allocated in error without study intervention|0|||
149909785|NCT04521621|540799632|FG005|Overall Study|Allocated in error without study intervention|0|||
149909786|NCT04521621|540799633|FG006|Overall Study|Allocated in error without study intervention|0|||
149909787|NCT04521621|540799634|FG007|Overall Study|Allocated in error without study intervention|0|||
149909788|NCT05845567|540799639|FG000|Overall Study|Withdrawal by Subject|1|||
149909789|NCT03409107|540799640|FG000|Overall Study|Withdrawal by Subject|4|||
149909790|NCT03409107|540799641|FG001|Overall Study|Withdrawal by Subject|2|||
149909791|NCT03409107|540799640|FG000|Overall Study|Physician Decision|1|||
149909792|NCT03409107|540799641|FG001|Overall Study|Physician Decision|0|||
149909793|NCT03409107|540799640|FG000|Overall Study|Lost to Follow-up|7|||
149909794|NCT03409107|540799641|FG001|Overall Study|Lost to Follow-up|2|||
149909795|NCT03409107|540799640|FG000|Overall Study|Adverse Event|5|||
149909796|NCT03409107|540799641|FG001|Overall Study|Adverse Event|3|||
149909797|NCT00916344|540799642|FG000|Overall Study|Death|2|||
149909798|NCT00916344|540799642|FG000|Overall Study|ICD upgrade|1|||
150049276|NCT00395343|541321768|FG001|Overall Study|Lost to Follow-up|4|||
150049277|NCT00395343|541321767|FG000|Overall Study|Physician Decision|2|||
149909799|NCT00916344|540799642|FG000|Overall Study|Drop-out|5|||
150049278|NCT00395343|541321768|FG001|Overall Study|Physician Decision|4|||
149909800|NCT02062944|540799645|FG000|Overall Study|Lost to Follow-up|1|||
150049279|NCT00395343|541321767|FG000|Overall Study|Protocol Violation|6|||
149909801|NCT02062944|540799645|FG000|Overall Study|New hemotological disorder identified|1|||
150049280|NCT00395343|541321768|FG001|Overall Study|Protocol Violation|8|||
150049281|NCT00395343|541321767|FG000|Overall Study|Withdrawal by Subject|11|||
150049282|NCT00395343|541321768|FG001|Overall Study|Withdrawal by Subject|12|||
150049283|NCT00395343|541321767|FG000|Overall Study|Other|5|||
150049284|NCT00395343|541321768|FG001|Overall Study|Other|2|||
149909802|NCT02062944|540799645|FG000|Overall Study|Uncontrolled Hypertension|1|||
149909803|NCT02062944|540799645|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
149909804|NCT01740128|540799646|FG000|Overall Study|Pregnancy|0|||
149909805|NCT01740128|540799647|FG001|Overall Study|Pregnancy|1|||
149909806|NCT01740128|540799646|FG000|Overall Study|Protocol Violation|1|||
150049285|NCT00265148|541321769|FG000|Overall Study|Adverse Event|2|||
150049286|NCT00265148|541321770|FG001|Overall Study|Adverse Event|2|||
150049287|NCT00265148|541321769|FG000|Overall Study|Lack of Efficacy|0|||
150049288|NCT00265148|541321770|FG001|Overall Study|Lack of Efficacy|2|||
150049289|NCT00265148|541321769|FG000|Overall Study|Protocol Violation|3|||
150049290|NCT00265148|541321770|FG001|Overall Study|Protocol Violation|2|||
150049291|NCT00265148|541321769|FG000|Overall Study|Lost to Follow-up|0|||
150049292|NCT00265148|541321770|FG001|Overall Study|Lost to Follow-up|1|||
150049293|NCT00265148|541321769|FG000|Overall Study|Withdrawal by Subject|2|||
150049294|NCT00265148|541321770|FG001|Overall Study|Withdrawal by Subject|1|||
150049295|NCT00265148|541321769|FG000|Overall Study|Physician Decision|1|||
150049296|NCT00265148|541321770|FG001|Overall Study|Physician Decision|0|||
150049297|NCT00265148|541321769|FG000|Overall Study|Increasing frailty|0|||
150049298|NCT00265148|541321770|FG001|Overall Study|Increasing frailty|1|||
150049299|NCT00265148|541321769|FG000|Overall Study|Subject chose to change of the dose|1|||
150049300|NCT00265148|541321770|FG001|Overall Study|Subject chose to change of the dose|0|||
150049301|NCT00942994|541321776|FG000|Overall Study|Adverse Event|7|||
150049302|NCT00942994|541321777|FG001|Overall Study|Adverse Event|4|||
150049303|NCT00942994|541321776|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150049304|NCT00942994|541321777|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150049305|NCT00942994|541321776|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150049306|NCT00942994|541321777|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150049307|NCT00942994|541321776|FG000|Overall Study|Patient withdrew consent|5|||
150049308|NCT00942994|541321777|FG001|Overall Study|Patient withdrew consent|8|||
150049309|NCT00942994|541321776|FG000|Overall Study|Lost to Follow-up|1|||
150049310|NCT00942994|541321777|FG001|Overall Study|Lost to Follow-up|4|||
150049311|NCT00942994|541321776|FG000|Overall Study|Protocol deviation|1|||
150049312|NCT00942994|541321777|FG001|Overall Study|Protocol deviation|2|||
150049313|NCT03583385|541321778|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150049314|NCT03583385|541321779|FG001|Treatment Period 1|Withdrawal by Subject|1|||
150049315|NCT03583385|541321778|FG000|Treatment Period 2|Adverse Event|1|||
150049316|NCT03583385|541321779|FG001|Treatment Period 2|Adverse Event|0|||
150049317|NCT00095940|541321782|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
150049318|NCT00095940|541321783|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
150049319|NCT00095940|541321784|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
150049320|NCT00095940|541321785|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
150049321|NCT00095940|541321786|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
150049322|NCT00095940|541321787|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
150049323|NCT00095940|541321788|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
150049324|NCT00095940|541321789|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
150049325|NCT00095940|541321790|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
150049326|NCT00095940|541321782|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
149909807|NCT01740128|540799647|FG001|Overall Study|Protocol Violation|2|||
149909808|NCT01740128|540799646|FG000|Overall Study|Lost to Follow-up|2|||
149909809|NCT01740128|540799647|FG001|Overall Study|Lost to Follow-up|2|||
149909810|NCT01740128|540799646|FG000|Overall Study|Withdrawal by Subject|1|||
149909811|NCT01740128|540799647|FG001|Overall Study|Withdrawal by Subject|0|||
150049327|NCT00095940|541321783|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
150049328|NCT00095940|541321784|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
150049329|NCT00095940|541321785|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
150049330|NCT00095940|541321786|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
150049331|NCT00095940|541321787|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
150049332|NCT00095940|541321788|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
150049333|NCT00095940|541321789|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
150049334|NCT00095940|541321790|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
150049335|NCT00095940|541321782|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
149909812|NCT01740128|540799646|FG000|Overall Study|Insufficient protocol compliance|2|||
149909813|NCT01740128|540799647|FG001|Overall Study|Insufficient protocol compliance|2|||
150049336|NCT00095940|541321783|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
150049337|NCT00095940|541321784|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
150049338|NCT00095940|541321785|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
150049339|NCT00095940|541321786|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
149909814|NCT02658734|540799650|FG000|Overall Study|Adverse Event|2|||
149909815|NCT02658734|540799650|FG000|Overall Study|Death|4|||
149909816|NCT02658734|540799650|FG000|Overall Study|Lost to Follow-up|7|||
149909817|NCT02658734|540799650|FG000|Overall Study|Withdrawal of Consent|16|||
149909818|NCT02658734|540799650|FG000|Overall Study|Disease Progression|28|||
149909819|NCT02231879|540799651|FG000|Overall Study|Adverse Event|2|||
149909820|NCT02231879|540799652|FG001|Overall Study|Adverse Event|1|||
149909821|NCT02231879|540799651|FG000|Overall Study|Lack of Efficacy|0|||
149909822|NCT02231879|540799652|FG001|Overall Study|Lack of Efficacy|1|||
149909823|NCT00189306|540799653|FG000|Treatment Period|Withdrawal by Subject|2|||
149909824|NCT00189306|540799653|FG000|Treatment Period|Adverse Event|2|||
149909825|NCT00189306|540799653|FG000|Treatment Period|Protocol Violation|1|||
149909826|NCT00189306|540799653|FG000|Posttreatment Period|Death|1|||
149909827|NCT00189306|540799653|FG000|Posttreatment Period|Withdrawal by Subject|2|||
149909828|NCT00189306|540799653|FG000|Posttreatment Period|Noncompliance|1|||
149909829|NCT00189306|540799653|FG000|Posttreatment Period|Target lesion excised|1|||
149909830|NCT00189306|540799653|FG000|Posttreatment Period|Protocol Violation|1|||
149909831|NCT00189306|540799653|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
149909832|NCT00189306|540799653|FG000|Posttreatment Period|Local skin reaction/sign|1|||
149909833|NCT00189306|540799653|FG000|Long-Term Follow-up|Adverse Event|2|||
149909834|NCT00189306|540799653|FG000|Long-Term Follow-up|Death|4|||
149909835|NCT00189306|540799653|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
149909836|NCT00189306|540799653|FG000|Long-Term Follow-up|Intercurrent disease|2|||
149909837|NCT00189306|540799653|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
149909838|NCT00189306|540799653|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
149909839|NCT00459706|540799654|FG000|Overall Study|Adverse Event|19|||
149909840|NCT00459706|540799655|FG001|Overall Study|Adverse Event|13|||
149909841|NCT00459706|540799654|FG000|Overall Study|Withdrawal by Subject|1|||
149909842|NCT00459706|540799655|FG001|Overall Study|Withdrawal by Subject|6|||
149909843|NCT00459706|540799654|FG000|Overall Study|Physician Decision|2|||
149909844|NCT00459706|540799655|FG001|Overall Study|Physician Decision|0|||
149909845|NCT00459706|540799654|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
149909846|NCT00459706|540799655|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
149909847|NCT00459706|540799654|FG000|Overall Study|Protocol Violation|2|||
149909848|NCT00459706|540799655|FG001|Overall Study|Protocol Violation|1|||
149909849|NCT00459706|540799654|FG000|Overall Study|Failed to Return|1|||
149909850|NCT00459706|540799655|FG001|Overall Study|Failed to Return|0|||
149909851|NCT00459706|540799654|FG000|Overall Study|Other|0|||
149909852|NCT00459706|540799655|FG001|Overall Study|Other|1|||
149909853|NCT02939716|540799656|FG000|Overall Study|scanner failure|0|||
149909854|NCT02939716|540799657|FG001|Overall Study|scanner failure|0|||
149909855|NCT02939716|540799658|FG002|Overall Study|scanner failure|0|||
149909856|NCT02939716|540799659|FG003|Overall Study|scanner failure|1|||
149909857|NCT02939716|540799660|FG004|Overall Study|scanner failure|1|||
149909858|NCT02939716|540799661|FG005|Overall Study|scanner failure|1|||
149909859|NCT00976209|540799662|FG000|Treatment Period 1|Protocol Violation|1|||
149909860|NCT00976209|540799663|FG001|Treatment Period 1|Protocol Violation|0|||
149909861|NCT00976209|540799662|FG000|Treatment Period 1|Lost to Follow-up|2|||
149909862|NCT00976209|540799663|FG001|Treatment Period 1|Lost to Follow-up|0|||
149909863|NCT00976209|540799662|FG000|Treatment Period 1|Other|0|||
149909864|NCT00976209|540799663|FG001|Treatment Period 1|Other|1|||
149909865|NCT00976209|540799662|FG000|Wash-out Period|Adverse Event|1|||
149909866|NCT00976209|540799663|FG001|Wash-out Period|Adverse Event|2|||
149909867|NCT00976209|540799662|FG000|Wash-out Period|Lost to Follow-up|1|||
149909868|NCT00976209|540799663|FG001|Wash-out Period|Lost to Follow-up|0|||
150049340|NCT00095940|541321787|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
149909869|NCT00976209|540799662|FG000|Wash-out Period|Protocol Violation|1|||
149909870|NCT00976209|540799663|FG001|Wash-out Period|Protocol Violation|0|||
149909871|NCT00976209|540799662|FG000|Wash-out Period|Other|1|||
149909872|NCT00976209|540799663|FG001|Wash-out Period|Other|0|||
149909873|NCT00976209|540799662|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149909874|NCT00976209|540799663|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149909875|NCT00976209|540799662|FG000|Treatment Period 2|Lost to Follow-up|0|||
149909876|NCT00976209|540799663|FG001|Treatment Period 2|Lost to Follow-up|1|||
149909877|NCT01252563|540799664|FG000|Overall Study|Contract Deviation|41|||
149909878|NCT01252563|540799664|FG000|Overall Study|Centralized Registration Deviation|30|||
149909879|NCT01252563|540799664|FG000|Overall Study|Lost to Follow-up|161|||
149909880|NCT01252563|540799664|FG000|Overall Study|No visit after first day of treatment|194|||
149909881|NCT01252563|540799664|FG000|Overall Study|No drug administration|6|||
149909882|NCT02029989|540799669|FG000|Overall Study|Withdrawal by Subject|1|||
149909883|NCT02029989|540799670|FG001|Overall Study|Withdrawal by Subject|0|||
149909884|NCT02029989|540799669|FG000|Overall Study|Withdrawal: Fear of needles|1|||
149909885|NCT02029989|540799670|FG001|Overall Study|Withdrawal: Fear of needles|0|||
149909886|NCT02029989|540799669|FG000|Overall Study|Change of location|2|||
149909887|NCT02029989|540799670|FG001|Overall Study|Change of location|3|||
149909888|NCT02029989|540799669|FG000|Overall Study|Physician Decision|2|||
149909889|NCT02029989|540799670|FG001|Overall Study|Physician Decision|0|||
149909890|NCT02029989|540799669|FG000|Overall Study|Lost to Follow-up|9|||
149909891|NCT02029989|540799670|FG001|Overall Study|Lost to Follow-up|7|||
149909892|NCT02029989|540799669|FG000|Overall Study|Death|0|||
149909893|NCT02029989|540799670|FG001|Overall Study|Death|1|||
149909894|NCT02029989|540799669|FG000|Overall Study|Protocol Violation|1|||
149909895|NCT02029989|540799670|FG001|Overall Study|Protocol Violation|0|||
149909896|NCT03045276|540799674|FG000|Intervention Phase|Withdrawal by Subject|7|||
149909897|NCT03045276|540799675|FG001|Intervention Phase|Withdrawal by Subject|2|||
149909898|NCT03045276|540799676|FG002|Intervention Phase|Withdrawal by Subject|3|||
149909899|NCT03045276|540799677|FG003|Intervention Phase|Withdrawal by Subject|7|||
149909900|NCT03045276|540799674|FG000|Intervention Phase|Developed exclusionary criteria|3|||
149909901|NCT03045276|540799675|FG001|Intervention Phase|Developed exclusionary criteria|3|||
149909902|NCT03045276|540799676|FG002|Intervention Phase|Developed exclusionary criteria|0|||
149909903|NCT03045276|540799677|FG003|Intervention Phase|Developed exclusionary criteria|0|||
149909904|NCT03045276|540799674|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
149909905|NCT03045276|540799675|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
149909906|NCT03045276|540799676|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
149909907|NCT03045276|540799677|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
149909908|NCT03045276|540799674|FG000|Follow-Up Phase|Lost to Follow-up|0|||
149909909|NCT03045276|540799675|FG001|Follow-Up Phase|Lost to Follow-up|1|||
149909910|NCT03045276|540799676|FG002|Follow-Up Phase|Lost to Follow-up|0|||
149909911|NCT03045276|540799677|FG003|Follow-Up Phase|Lost to Follow-up|1|||
149909912|NCT03045276|540799674|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
149909913|NCT03045276|540799675|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
149909914|NCT03045276|540799676|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
149909915|NCT03045276|540799677|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
149909916|NCT05072106|540801948|FG000|Overall Study|Progressive disease|3|||
149909917|NCT05072106|540801949|FG001|Overall Study|Progressive disease|3|||
149909918|NCT05072106|540801948|FG000|Overall Study|Compassionate use|3|||
149909919|NCT05072106|540801949|FG001|Overall Study|Compassionate use|1|||
149909920|NCT05072106|540801948|FG000|Overall Study|Withdrawal by Subject|1|||
149909921|NCT05072106|540801949|FG001|Overall Study|Withdrawal by Subject|0|||
149909922|NCT01944670|540801952|FG000|Overall Study|Lost to Follow-up|2|||
149909923|NCT02879994|540801953|FG000|Overall Study|off treatment early|7|||
149909924|NCT02879994|540801953|FG000|Overall Study|Adverse Event|2|||
149909925|NCT02879994|540801953|FG000|Overall Study|Death|2|||
149909926|NCT04063657|540801955|FG000|Overall Study|Lost to Follow-up|1|||
149909927|NCT04063657|540801956|FG001|Overall Study|Lost to Follow-up|0|||
149909928|NCT01473394|540801957|FG000|Overall Study|Adverse Event|13|||
149909929|NCT01473394|540801958|FG001|Overall Study|Adverse Event|16|||
149909930|NCT01473394|540801957|FG000|Overall Study|Insufficient Therapeutic Response|4|||
149909931|NCT01473394|540801958|FG001|Overall Study|Insufficient Therapeutic Response|1|||
149909932|NCT01473394|540801957|FG000|Overall Study|Protocol Violation|7|||
149909933|NCT01473394|540801958|FG001|Overall Study|Protocol Violation|5|||
149909934|NCT01473394|540801957|FG000|Overall Study|Withdrew Consent|12|||
149909935|NCT01473394|540801958|FG001|Overall Study|Withdrew Consent|10|||
149909936|NCT01473394|540801957|FG000|Overall Study|Lost to Follow-up|9|||
149909937|NCT01473394|540801958|FG001|Overall Study|Lost to Follow-up|11|||
149909938|NCT01995175|540801964|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
149909939|NCT01995175|540801964|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
149909940|NCT01995175|540801964|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
149909941|NCT01995175|540801964|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
149909942|NCT01995175|540801964|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
149909943|NCT01995175|540801964|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
149909944|NCT01995175|540801964|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
149909945|NCT01995175|540801964|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
149909946|NCT01995175|540801964|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
149909947|NCT00984061|540801965|FG000|Clarithromycin Alone|Protocol Violation|1|||
149909948|NCT01185509|540801969|FG000|Overall Study|Progression/Relapse|9|||
149909949|NCT01185509|540801970|FG001|Overall Study|Progression/Relapse|15|||
149909950|NCT01185509|540801969|FG000|Overall Study|Physician Decision|2|||
149909951|NCT01185509|540801970|FG001|Overall Study|Physician Decision|2|||
149909952|NCT01185509|540801969|FG000|Overall Study|Withdrawal by Subject|0|||
149909953|NCT01185509|540801970|FG001|Overall Study|Withdrawal by Subject|1|||
149909954|NCT01185509|540801969|FG000|Overall Study|Death|0|||
149909955|NCT01185509|540801970|FG001|Overall Study|Death|1|||
149909956|NCT01185509|540801969|FG000|Overall Study|Intercurrent Illness|0|||
149909957|NCT01185509|540801970|FG001|Overall Study|Intercurrent Illness|1|||
149909958|NCT05178641|540801977|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
149909959|NCT05178641|540801978|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
149909960|NCT05178641|540801977|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
149909961|NCT05178641|540801978|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
149909962|NCT00108485|540801987|FG000|Overall Study|Withdrawal by Subject|3|||
149909963|NCT00108485|540801988|FG001|Overall Study|Withdrawal by Subject|0|||
149909964|NCT00108485|540801987|FG000|Overall Study|Lost to Follow-up|0|||
149909965|NCT00108485|540801988|FG001|Overall Study|Lost to Follow-up|2|||
150049341|NCT00095940|541321788|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
150049342|NCT00095940|541321789|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
149909966|NCT00655733|540801992|FG000|Overall Study|Lost to Follow-up|2|||
149909967|NCT00655733|540801993|FG001|Overall Study|Lost to Follow-up|2|||
149909968|NCT00655733|540801992|FG000|Overall Study|Adverse Event|2|||
149909969|NCT00655733|540801993|FG001|Overall Study|Adverse Event|2|||
149909970|NCT00655733|540801992|FG000|Overall Study|Withdrawal by Subject|3|||
149909971|NCT00655733|540801993|FG001|Overall Study|Withdrawal by Subject|3|||
149909972|NCT00655733|540801992|FG000|Overall Study|Physician Decision|0|||
149909973|NCT00655733|540801993|FG001|Overall Study|Physician Decision|1|||
149909974|NCT02035748|540801997|FG000|Overall Study|Adverse Event|5|||
149909975|NCT02035748|540801997|FG000|Overall Study|Death|3|||
149909976|NCT02035748|540801997|FG000|Overall Study|Lost to Follow-up|2|||
149909977|NCT02035748|540801997|FG000|Overall Study|Physician Decision|3|||
149909978|NCT02035748|540801997|FG000|Overall Study|Withdrawal by Subject|6|||
149909979|NCT02035748|540801997|FG000|Overall Study|Progressive Disease|1|||
149909980|NCT02122770|540801998|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
149909981|NCT02122770|540801999|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
149909982|NCT02122770|540802000|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
149909983|NCT02122770|540802001|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
149909984|NCT02122770|540802002|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
149909985|NCT02122770|540802003|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
149909986|NCT02122770|540801998|FG000|Part A: Drug-drug Interaction 2|Other|0|||
149909987|NCT02122770|540801999|FG001|Part A: Drug-drug Interaction 2|Other|0|||
149909988|NCT02122770|540802000|FG002|Part A: Drug-drug Interaction 2|Other|1|||
149909989|NCT02122770|540802001|FG003|Part A: Drug-drug Interaction 2|Other|0|||
149909990|NCT02122770|540802002|FG004|Part A: Drug-drug Interaction 2|Other|0|||
149909991|NCT02122770|540802003|FG005|Part A: Drug-drug Interaction 2|Other|0|||
149909992|NCT02122770|540801998|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
149909993|NCT02122770|540801999|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
149909994|NCT02122770|540802000|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
149909995|NCT02122770|540802001|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
149909996|NCT02122770|540802002|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
149909997|NCT02122770|540802003|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
149909998|NCT02122770|540801998|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
149909999|NCT02122770|540801999|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
149910000|NCT02122770|540802000|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
149910001|NCT02122770|540802001|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
149910002|NCT02122770|540802002|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
149910003|NCT02122770|540802003|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
149910004|NCT02122770|540801998|FG000|Part B: Standard of Care|Adverse Event|0|||
149910005|NCT02122770|540801999|FG001|Part B: Standard of Care|Adverse Event|0|||
149910006|NCT02122770|540802000|FG002|Part B: Standard of Care|Adverse Event|0|||
149910007|NCT02122770|540802001|FG003|Part B: Standard of Care|Adverse Event|0|||
149910008|NCT02122770|540802002|FG004|Part B: Standard of Care|Adverse Event|4|||
150049343|NCT00095940|541321790|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
150049344|NCT00387790|541321791|FG000|Overall Study|Adverse Event|5|||
150049345|NCT00387790|541321791|FG000|Overall Study|Lack of Efficacy|2|||
150049346|NCT00387790|541321791|FG000|Overall Study|Physician Decision|2|||
150049347|NCT00387790|541321791|FG000|Overall Study|Withdrawal by Subject|3|||
150049348|NCT00387790|541321791|FG000|Overall Study|Ineligible for study|2|||
150049349|NCT04491604|541321792|FG000|Overall Study|Withdrawal by Subject|3|||
150049350|NCT01874340|541321795|FG000|Overall Study|Study terminated by Sponsor|6|||
150049351|NCT01874340|541321796|FG001|Overall Study|Study terminated by Sponsor|8|||
150049352|NCT01874340|541321797|FG002|Overall Study|Study terminated by Sponsor|8|||
150049353|NCT01874340|541321798|FG003|Overall Study|Study terminated by Sponsor|4|||
150049354|NCT01874340|541321795|FG000|Overall Study|Withdrawal by Subject|0|||
149910009|NCT02122770|540802003|FG005|Part B: Standard of Care|Adverse Event|1|||
149910010|NCT02122770|540801998|FG000|Part B: Standard of Care|Other|0|||
149910011|NCT02122770|540801999|FG001|Part B: Standard of Care|Other|0|||
149910012|NCT02122770|540802000|FG002|Part B: Standard of Care|Other|0|||
149910013|NCT02122770|540802001|FG003|Part B: Standard of Care|Other|0|||
150176782|NCT01787760|541783416|FG002|Overall Study|Withdrawal by Subject|2|||
149910014|NCT02122770|540802002|FG004|Part B: Standard of Care|Other|0|||
149910015|NCT02122770|540802003|FG005|Part B: Standard of Care|Other|2|||
149910016|NCT02122770|540801998|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
149910017|NCT02122770|540801999|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
149910018|NCT02122770|540802000|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
149910019|NCT02122770|540802001|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
150176783|NCT01787760|541783414|FG000|Overall Study|Lost to Follow-up|1|||
150049355|NCT01874340|541321796|FG001|Overall Study|Withdrawal by Subject|0|||
150049356|NCT01874340|541321797|FG002|Overall Study|Withdrawal by Subject|0|||
149910020|NCT02122770|540802002|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
149910021|NCT02122770|540802003|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
149910022|NCT02122770|540801998|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
149910023|NCT02122770|540801999|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
149910024|NCT02122770|540802000|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
149910025|NCT02122770|540802001|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
149910026|NCT02122770|540802002|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
149910027|NCT02122770|540802003|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
149910028|NCT02122770|540801998|FG000|Part B: Standard of Care|Progressive Disease|0|||
149910029|NCT02122770|540801999|FG001|Part B: Standard of Care|Progressive Disease|0|||
149910030|NCT02122770|540802000|FG002|Part B: Standard of Care|Progressive Disease|0|||
149910031|NCT02122770|540802001|FG003|Part B: Standard of Care|Progressive Disease|0|||
149910032|NCT02122770|540802002|FG004|Part B: Standard of Care|Progressive Disease|10|||
149910033|NCT02122770|540802003|FG005|Part B: Standard of Care|Progressive Disease|8|||
149910034|NCT02474589|540802004|FG000|Overall Study|Adverse Event|6|||
149910035|NCT02474589|540802005|FG001|Overall Study|Adverse Event|2|||
149910036|NCT02474589|540802004|FG000|Overall Study|Lost to Follow-up|6|||
149910037|NCT02474589|540802005|FG001|Overall Study|Lost to Follow-up|1|||
149910038|NCT02474589|540802004|FG000|Overall Study|Protocol Violation|4|||
149910039|NCT02474589|540802005|FG001|Overall Study|Protocol Violation|1|||
149910040|NCT02474589|540802004|FG000|Overall Study|Withdrawal by Subject|4|||
149910041|NCT02474589|540802005|FG001|Overall Study|Withdrawal by Subject|0|||
149910042|NCT02474589|540802004|FG000|Overall Study|Inability to complete study procedures|5|||
149910043|NCT02474589|540802005|FG001|Overall Study|Inability to complete study procedures|1|||
149910044|NCT01041976|540802006|FG000|Overall Study|Withdrawal by Subject|3|||
149910045|NCT01041976|540802007|FG001|Overall Study|Withdrawal by Subject|0|||
149910046|NCT01041976|540802006|FG000|Overall Study|Incarceration|2|||
149910047|NCT01041976|540802007|FG001|Overall Study|Incarceration|0|||
149910048|NCT01041976|540802006|FG000|Overall Study|Death|0|||
149910049|NCT01041976|540802007|FG001|Overall Study|Death|4|||
149910050|NCT00705718|540802008|FG000|Overall Study|Death|6|||
149910051|NCT00705718|540802009|FG001|Overall Study|Death|6|||
149910052|NCT00705718|540802008|FG000|Overall Study|Not due for Visit|0|||
149910053|NCT00705718|540802009|FG001|Overall Study|Not due for Visit|12|||
149910054|NCT00705718|540802008|FG000|Overall Study|Follow up not done|1|||
149910055|NCT00705718|540802009|FG001|Overall Study|Follow up not done|4|||
149910056|NCT02954653|540802010|FG000|Overall Study|Death|3|||
149910057|NCT02954653|540802011|FG001|Overall Study|Death|1|||
149910058|NCT02954653|540802012|FG002|Overall Study|Death|0|||
149910059|NCT02954653|540802013|FG003|Overall Study|Death|0|||
149910060|NCT02954653|540802014|FG004|Overall Study|Death|0|||
149910061|NCT02954653|540802015|FG005|Overall Study|Death|0|||
149910062|NCT02954653|540802016|FG006|Overall Study|Death|0|||
149910063|NCT02954653|540802017|FG007|Overall Study|Death|0|||
150049357|NCT01874340|541321798|FG003|Overall Study|Withdrawal by Subject|1|||
150049358|NCT03539549|541321800|FG000|Overall Study|Adverse Event|12|||
150049359|NCT03539549|541321800|FG000|Overall Study|Lost to Follow-up|1|||
150049360|NCT03539549|541321800|FG000|Overall Study|Death|2|||
150049361|NCT03539549|541321800|FG000|Overall Study|Progressive Disease|1|||
150049362|NCT03539549|541321800|FG000|Overall Study|Reason not Specified|1|||
150049363|NCT02864862|541321805|FG000|Overall Study|Lost to Follow-up|1|||
149910064|NCT02954653|540802018|FG008|Overall Study|Death|0|||
149910065|NCT02954653|540802010|FG000|Overall Study|Randomized but did not receive treatment|1|||
149910066|NCT02954653|540802011|FG001|Overall Study|Randomized but did not receive treatment|0|||
149910067|NCT02954653|540802012|FG002|Overall Study|Randomized but did not receive treatment|0|||
149910068|NCT02954653|540802013|FG003|Overall Study|Randomized but did not receive treatment|0|||
149910069|NCT02954653|540802014|FG004|Overall Study|Randomized but did not receive treatment|0|||
149910070|NCT02954653|540802015|FG005|Overall Study|Randomized but did not receive treatment|0|||
149910071|NCT02954653|540802016|FG006|Overall Study|Randomized but did not receive treatment|0|||
149910072|NCT02954653|540802017|FG007|Overall Study|Randomized but did not receive treatment|0|||
149910073|NCT02954653|540802018|FG008|Overall Study|Randomized but did not receive treatment|0|||
149910074|NCT02954653|540802010|FG000|Overall Study|Started another anti-cancer therapy|0|||
149910075|NCT02954653|540802011|FG001|Overall Study|Started another anti-cancer therapy|1|||
149910076|NCT02954653|540802012|FG002|Overall Study|Started another anti-cancer therapy|0|||
149910077|NCT02954653|540802013|FG003|Overall Study|Started another anti-cancer therapy|0|||
149910078|NCT02954653|540802014|FG004|Overall Study|Started another anti-cancer therapy|0|||
149910079|NCT02954653|540802015|FG005|Overall Study|Started another anti-cancer therapy|0|||
149910080|NCT02954653|540802016|FG006|Overall Study|Started another anti-cancer therapy|0|||
149910081|NCT02954653|540802017|FG007|Overall Study|Started another anti-cancer therapy|0|||
149910082|NCT02954653|540802018|FG008|Overall Study|Started another anti-cancer therapy|0|||
150049364|NCT02864862|541321806|FG001|Overall Study|Lost to Follow-up|0|||
150049365|NCT02864862|541321807|FG002|Overall Study|Lost to Follow-up|1|||
150176784|NCT01787760|541783415|FG001|Overall Study|Lost to Follow-up|0|||
150176785|NCT01787760|541783416|FG002|Overall Study|Lost to Follow-up|1|||
149910083|NCT02954653|540802010|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
149910084|NCT02954653|540802011|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
149910085|NCT02954653|540802012|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
149910086|NCT02954653|540802013|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
149910087|NCT02954653|540802014|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
149910088|NCT02954653|540802015|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
149910089|NCT02954653|540802016|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
149910090|NCT02954653|540802017|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
149910091|NCT02954653|540802018|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
149910092|NCT03054064|540802019|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
149910093|NCT03054064|540802019|FG000|Overall Study|Investigator Decision|2|||
149910094|NCT03054064|540802019|FG000|Overall Study|Bladder Issue|1|||
149910095|NCT03054064|540802019|FG000|Overall Study|High Blood Pressure|1|||
149910096|NCT03054064|540802019|FG000|Overall Study|Change in Status|1|||
149910097|NCT01459718|540802023|FG000|Overall Study|Physician Decision|1|||
149910098|NCT01459718|540802023|FG000|Overall Study|Lost to Follow-up|1|||
149910099|NCT01459718|540802023|FG000|Overall Study|Adverse Event|1|||
149910100|NCT01258075|540802026|FG000|Overall Study|Adverse Event|8|||
149910101|NCT01258075|540802027|FG001|Overall Study|Adverse Event|3|||
149910102|NCT01258075|540802026|FG000|Overall Study|Lost to Follow-up|11|||
149910103|NCT01258075|540802027|FG001|Overall Study|Lost to Follow-up|6|||
149910104|NCT01258075|540802026|FG000|Overall Study|Withdrawal by Subject|10|||
149910105|NCT01258075|540802027|FG001|Overall Study|Withdrawal by Subject|7|||
149910106|NCT01258075|540802026|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
149910107|NCT01258075|540802027|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
149910108|NCT01258075|540802026|FG000|Overall Study|Other|12|||
149910109|NCT01258075|540802027|FG001|Overall Study|Other|5|||
149910110|NCT00785213|540802028|FG000|Quinine Sulfate Alone|Adverse Event|4|||
149910111|NCT00785213|540802028|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
149910112|NCT01500213|540802029|FG000|Overall Study|Adverse Event|35|||
149910113|NCT01500213|540802030|FG001|Overall Study|Adverse Event|35|||
149910114|NCT01500213|540802029|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
149910115|NCT01500213|540802030|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
149910116|NCT01500213|540802029|FG000|Overall Study|Withdrawal by Subject|28|||
149910117|NCT01500213|540802030|FG001|Overall Study|Withdrawal by Subject|37|||
149910118|NCT01500213|540802029|FG000|Overall Study|Death|7|||
149910119|NCT01500213|540802030|FG001|Overall Study|Death|3|||
149910120|NCT01500213|540802029|FG000|Overall Study|Disease Progression|13|||
149910121|NCT01500213|540802030|FG001|Overall Study|Disease Progression|21|||
149910122|NCT01500213|540802029|FG000|Overall Study|Protocol Violation|19|||
149910123|NCT01500213|540802030|FG001|Overall Study|Protocol Violation|19|||
149910124|NCT01500213|540802029|FG000|Overall Study|Physician Decision|12|||
149910125|NCT01500213|540802030|FG001|Overall Study|Physician Decision|10|||
149910126|NCT01500213|540802029|FG000|Overall Study|Lack of Efficacy|9|||
149910127|NCT01500213|540802030|FG001|Overall Study|Lack of Efficacy|7|||
149910128|NCT01500213|540802029|FG000|Overall Study|Lost to Follow-up|3|||
149910129|NCT01500213|540802030|FG001|Overall Study|Lost to Follow-up|6|||
149910130|NCT01500213|540802029|FG000|Overall Study|Other Reasons|7|||
149910131|NCT01500213|540802030|FG001|Overall Study|Other Reasons|5|||
149910132|NCT02386345|540802031|FG000|Overall Study|Not treated|14|||
149910133|NCT02386345|540802031|FG000|Overall Study|Lost to Follow-up|1|||
149910134|NCT02386345|540802031|FG000|Overall Study|Adverse Event|5|||
149910135|NCT02386345|540802031|FG000|Overall Study|Repeat Procedure|10|||
149910136|NCT02386345|540802031|FG000|Overall Study|Did not complete 12-month follow-up|72|||
149910137|NCT02612610|540802032|FG000|Overall Study|Withdrawal by Subject|1|||
149910138|NCT02612610|540802033|FG001|Overall Study|Withdrawal by Subject|1|||
149910139|NCT02612610|540802034|FG002|Overall Study|Withdrawal by Subject|0|||
149910140|NCT02612610|540802035|FG003|Overall Study|Withdrawal by Subject|2|||
149910141|NCT02612610|540802032|FG000|Overall Study|Adverse Event|2|||
149910142|NCT02612610|540802033|FG001|Overall Study|Adverse Event|2|||
149910143|NCT02612610|540802034|FG002|Overall Study|Adverse Event|3|||
149910144|NCT02612610|540802035|FG003|Overall Study|Adverse Event|10|||
149910145|NCT02612610|540802032|FG000|Overall Study|Lost to Follow-up|0|||
149910146|NCT02612610|540802033|FG001|Overall Study|Lost to Follow-up|1|||
149910147|NCT02612610|540802034|FG002|Overall Study|Lost to Follow-up|0|||
149910148|NCT02612610|540802035|FG003|Overall Study|Lost to Follow-up|0|||
149910149|NCT02612610|540802032|FG000|Overall Study|Protocol Violation|0|||
149910150|NCT02612610|540802033|FG001|Overall Study|Protocol Violation|1|||
149910151|NCT02612610|540802034|FG002|Overall Study|Protocol Violation|1|||
149910152|NCT02612610|540802035|FG003|Overall Study|Protocol Violation|0|||
149910153|NCT02612610|540802032|FG000|Overall Study|Lack of Efficacy|1|||
149910154|NCT02612610|540802033|FG001|Overall Study|Lack of Efficacy|2|||
149910155|NCT02612610|540802034|FG002|Overall Study|Lack of Efficacy|0|||
149910156|NCT02612610|540802035|FG003|Overall Study|Lack of Efficacy|1|||
150176786|NCT01787760|541783414|FG000|Overall Study|Stroke|1|||
150049366|NCT02864862|541321805|FG000|Overall Study|Protocol Violation|0|||
150049367|NCT02864862|541321806|FG001|Overall Study|Protocol Violation|0|||
150049368|NCT02864862|541321807|FG002|Overall Study|Protocol Violation|1|||
150049369|NCT04605991|541321808|FG000|Overall Study|Adverse Event|5|||
150049370|NCT04605991|541321808|FG000|Overall Study|Lack of Efficacy|1|||
150049371|NCT04605991|541321808|FG000|Overall Study|Lost to Follow-up|8|||
150049372|NCT04605991|541321808|FG000|Overall Study|Physician Decision|4|||
150049373|NCT04605991|541321808|FG000|Overall Study|Withdrawal by Subject|14|||
150049374|NCT04605991|541321808|FG000|Overall Study|Non-compliance with study|1|||
150049375|NCT01523275|541321812|FG000|Overall Study|Lost to Follow-up|1|||
150049376|NCT01523275|541321813|FG001|Overall Study|Lost to Follow-up|2|||
150049377|NCT01523275|541321812|FG000|Overall Study|Withdrawal by Subject|1|||
150049378|NCT01523275|541321813|FG001|Overall Study|Withdrawal by Subject|0|||
150049379|NCT03263702|541321814|FG000|Overall Study|Lost to Follow-up|2|||
150049380|NCT03263702|541321815|FG001|Overall Study|Lost to Follow-up|2|||
150049381|NCT03263702|541321814|FG000|Overall Study|Withdrawal by Subject|1|||
150049382|NCT03263702|541321815|FG001|Overall Study|Withdrawal by Subject|2|||
150049383|NCT03598114|541321816|FG000|Overall Study|Staff turnover/left the program|3|||
150049384|NCT03598114|541321817|FG001|Overall Study|Staff turnover/left the program|39|||
150049385|NCT02527200|541321818|FG000|Overall Study|Withdrawal by Subject|3|||
150049386|NCT02527200|541321819|FG001|Overall Study|Withdrawal by Subject|2|||
150049387|NCT02527200|541321820|FG002|Overall Study|Withdrawal by Subject|1|||
150049388|NCT02527200|541321821|FG003|Overall Study|Withdrawal by Subject|0|||
150049389|NCT02527200|541321818|FG000|Overall Study|Unclassified|0|||
150049390|NCT02527200|541321819|FG001|Overall Study|Unclassified|1|||
150049391|NCT02527200|541321820|FG002|Overall Study|Unclassified|0|||
150049392|NCT02527200|541321821|FG003|Overall Study|Unclassified|0|||
150049393|NCT02527200|541321818|FG000|Overall Study|Lost to Follow-up|0|||
150049394|NCT02527200|541321819|FG001|Overall Study|Lost to Follow-up|0|||
150049395|NCT02527200|541321820|FG002|Overall Study|Lost to Follow-up|1|||
150049396|NCT02527200|541321821|FG003|Overall Study|Lost to Follow-up|0|||
150049397|NCT00689117|541321822|FG000|Overall Study|Adverse Event|6|||
150049398|NCT00689117|541321823|FG001|Overall Study|Adverse Event|0|||
150049399|NCT00689117|541321824|FG002|Overall Study|Adverse Event|5|||
150049400|NCT00689117|541321825|FG003|Overall Study|Adverse Event|0|||
150176787|NCT01787760|541783415|FG001|Overall Study|Stroke|0|||
150176788|NCT01787760|541783416|FG002|Overall Study|Stroke|0|||
149910157|NCT02612610|540802032|FG000|Overall Study|Physician Decision|0|||
149910158|NCT02612610|540802033|FG001|Overall Study|Physician Decision|1|||
149910159|NCT02612610|540802034|FG002|Overall Study|Physician Decision|0|||
149910160|NCT02612610|540802035|FG003|Overall Study|Physician Decision|0|||
149910161|NCT02612610|540802032|FG000|Overall Study|Noncompliance|1|||
149910162|NCT02612610|540802033|FG001|Overall Study|Noncompliance|0|||
149910163|NCT02612610|540802034|FG002|Overall Study|Noncompliance|0|||
149910164|NCT02612610|540802035|FG003|Overall Study|Noncompliance|0|||
149910165|NCT02612610|540802032|FG000|Overall Study|Cough Improvement|0|||
149910166|NCT02612610|540802033|FG001|Overall Study|Cough Improvement|0|||
149910167|NCT02612610|540802034|FG002|Overall Study|Cough Improvement|1|||
149910168|NCT02612610|540802035|FG003|Overall Study|Cough Improvement|0|||
149910169|NCT01546571|540802037|FG000|Overall Study|Adverse Event|1|||
149910170|NCT01546571|540802038|FG001|Overall Study|Adverse Event|0|||
149910171|NCT01546571|540802039|FG002|Overall Study|Adverse Event|0|||
149910172|NCT01546571|540802040|FG003|Overall Study|Adverse Event|1|||
149910173|NCT01546571|540802041|FG004|Overall Study|Adverse Event|0|||
149910174|NCT01546571|540802037|FG000|Overall Study|assigned placebo in Part A|0|||
149910175|NCT01546571|540802038|FG001|Overall Study|assigned placebo in Part A|0|||
150049401|NCT00689117|541321822|FG000|Overall Study|Lost to Follow-up|26|||
150049402|NCT00689117|541321823|FG001|Overall Study|Lost to Follow-up|19|||
150049403|NCT00689117|541321824|FG002|Overall Study|Lost to Follow-up|17|||
150049404|NCT00689117|541321825|FG003|Overall Study|Lost to Follow-up|11|||
149910176|NCT01546571|540802039|FG002|Overall Study|assigned placebo in Part A|22|||
149910177|NCT01546571|540802040|FG003|Overall Study|assigned placebo in Part A|0|||
149910178|NCT01546571|540802041|FG004|Overall Study|assigned placebo in Part A|0|||
149910179|NCT01546571|540802037|FG000|Overall Study|Death|0|||
149910180|NCT01546571|540802038|FG001|Overall Study|Death|1|||
149910181|NCT01546571|540802039|FG002|Overall Study|Death|0|||
149910182|NCT01546571|540802040|FG003|Overall Study|Death|0|||
149910183|NCT01546571|540802041|FG004|Overall Study|Death|0|||
149910184|NCT01546571|540802037|FG000|Overall Study|Lost to Follow-up|0|||
149910185|NCT01546571|540802038|FG001|Overall Study|Lost to Follow-up|0|||
149910186|NCT01546571|540802039|FG002|Overall Study|Lost to Follow-up|2|||
149910187|NCT01546571|540802040|FG003|Overall Study|Lost to Follow-up|2|||
149910188|NCT01546571|540802041|FG004|Overall Study|Lost to Follow-up|3|||
149910189|NCT01546571|540802037|FG000|Overall Study|Pregnancy|0|||
149910190|NCT01546571|540802038|FG001|Overall Study|Pregnancy|0|||
149910191|NCT01546571|540802039|FG002|Overall Study|Pregnancy|0|||
149910192|NCT01546571|540802040|FG003|Overall Study|Pregnancy|1|||
149910193|NCT01546571|540802041|FG004|Overall Study|Pregnancy|0|||
149910194|NCT01546571|540802037|FG000|Overall Study|Disease Progression|20|||
149910195|NCT01546571|540802038|FG001|Overall Study|Disease Progression|18|||
149910196|NCT01546571|540802039|FG002|Overall Study|Disease Progression|15|||
149910197|NCT01546571|540802040|FG003|Overall Study|Disease Progression|73|||
149910198|NCT01546571|540802041|FG004|Overall Study|Disease Progression|37|||
149910199|NCT01546571|540802037|FG000|Overall Study|Withdrawal by Subject|1|||
149910200|NCT01546571|540802038|FG001|Overall Study|Withdrawal by Subject|2|||
149910201|NCT01546571|540802039|FG002|Overall Study|Withdrawal by Subject|4|||
149910202|NCT01546571|540802040|FG003|Overall Study|Withdrawal by Subject|9|||
149910203|NCT01546571|540802041|FG004|Overall Study|Withdrawal by Subject|2|||
149910204|NCT01546571|540802037|FG000|Overall Study|Intercurrent Illness|1|||
149910205|NCT01546571|540802038|FG001|Overall Study|Intercurrent Illness|2|||
150049405|NCT00689117|541321822|FG000|Overall Study|Lack of Efficacy|1|||
149910206|NCT01546571|540802039|FG002|Overall Study|Intercurrent Illness|0|||
149910207|NCT01546571|540802040|FG003|Overall Study|Intercurrent Illness|0|||
149910208|NCT01546571|540802041|FG004|Overall Study|Intercurrent Illness|0|||
149910209|NCT01546571|540802037|FG000|Overall Study|Other Cancers|0|||
149910210|NCT01546571|540802038|FG001|Overall Study|Other Cancers|0|||
149910211|NCT01546571|540802039|FG002|Overall Study|Other Cancers|0|||
149910212|NCT01546571|540802040|FG003|Overall Study|Other Cancers|3|||
149910213|NCT01546571|540802041|FG004|Overall Study|Other Cancers|1|||
149910214|NCT01546571|540802037|FG000|Overall Study|Other|0|||
149910215|NCT01546571|540802038|FG001|Overall Study|Other|0|||
149910216|NCT01546571|540802039|FG002|Overall Study|Other|3|||
149910217|NCT01546571|540802040|FG003|Overall Study|Other|0|||
149910218|NCT01546571|540802041|FG004|Overall Study|Other|0|||
149910219|NCT01866657|540802049|FG000|Overall Study|Surgery canceled|2|||
149910220|NCT01866657|540802050|FG001|Overall Study|Surgery canceled|0|||
149910221|NCT01880086|540802051|FG000|Overall Study|Lost to Follow-up|1|||
149910222|NCT01880086|540802052|FG001|Overall Study|Lost to Follow-up|1|||
149910223|NCT03973918|540802058|FG000|Overall Study|Adverse Event|0|||
149910224|NCT03973918|540802059|FG001|Overall Study|Adverse Event|0|||
149910225|NCT03973918|540802060|FG002|Overall Study|Adverse Event|0|||
149910226|NCT03973918|540802061|FG003|Overall Study|Adverse Event|1|||
149910227|NCT03973918|540802058|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
149910228|NCT03973918|540802059|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
149910229|NCT03973918|540802060|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
149910230|NCT03973918|540802061|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
149910231|NCT02951533|540802062|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
149910232|NCT02951533|540802063|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
149910233|NCT02951533|540802064|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
149910234|NCT02951533|540802062|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
149910235|NCT02951533|540802063|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
149910236|NCT02951533|540802064|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
149910237|NCT02951533|540802062|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
149910238|NCT02951533|540802063|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
149910239|NCT02951533|540802064|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
149910240|NCT02951533|540802062|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
149910241|NCT02951533|540802063|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
149910242|NCT02951533|540802064|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
149910243|NCT02951533|540802062|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
149910244|NCT02951533|540802063|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
149910245|NCT02951533|540802064|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
149910246|NCT02951533|540802062|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
149910247|NCT02951533|540802063|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
150049406|NCT00689117|541321823|FG001|Overall Study|Lack of Efficacy|2|||
150049407|NCT00689117|541321824|FG002|Overall Study|Lack of Efficacy|2|||
149910248|NCT02951533|540802064|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
149910249|NCT02951533|540802062|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
149910250|NCT02951533|540802063|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
149910251|NCT02951533|540802064|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
149910252|NCT02951533|540802062|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
150049408|NCT00689117|541321825|FG003|Overall Study|Lack of Efficacy|2|||
150049409|NCT00689117|541321822|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
150049410|NCT00689117|541321823|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
150049411|NCT00689117|541321824|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
150049412|NCT00689117|541321825|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
150049413|NCT00689117|541321822|FG000|Overall Study|Withdrawal by Subject|19|||
150049414|NCT00689117|541321823|FG001|Overall Study|Withdrawal by Subject|18|||
150049415|NCT00689117|541321824|FG002|Overall Study|Withdrawal by Subject|26|||
150049416|NCT00689117|541321825|FG003|Overall Study|Withdrawal by Subject|13|||
150049417|NCT00689117|541321822|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
150049418|NCT00689117|541321823|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
150049419|NCT00689117|541321824|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
150049420|NCT00689117|541321825|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
150049421|NCT00689117|541321822|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
150049422|NCT00689117|541321823|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
150049423|NCT00689117|541321824|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150049424|NCT00689117|541321825|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150049425|NCT00689117|541321822|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
150049426|NCT00689117|541321823|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
150049427|NCT00689117|541321824|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
150049428|NCT00689117|541321825|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
150049429|NCT00689117|541321822|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
150049430|NCT00689117|541321823|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
150049431|NCT00689117|541321824|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
150049432|NCT00689117|541321825|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
150049433|NCT00689117|541321822|FG000|Overall Study|Use of Prohibitive Medication|2|||
150049434|NCT00689117|541321823|FG001|Overall Study|Use of Prohibitive Medication|1|||
150049435|NCT00689117|541321824|FG002|Overall Study|Use of Prohibitive Medication|3|||
150049436|NCT00689117|541321825|FG003|Overall Study|Use of Prohibitive Medication|0|||
150049437|NCT00689117|541321822|FG000|Overall Study|Pregnancy|0|||
150049438|NCT00689117|541321823|FG001|Overall Study|Pregnancy|2|||
150049439|NCT00689117|541321824|FG002|Overall Study|Pregnancy|0|||
150049440|NCT00689117|541321825|FG003|Overall Study|Pregnancy|2|||
150049441|NCT00689117|541321822|FG000|Overall Study|Incarceration|2|||
150049442|NCT00689117|541321823|FG001|Overall Study|Incarceration|0|||
150049443|NCT00689117|541321824|FG002|Overall Study|Incarceration|0|||
150049444|NCT00689117|541321825|FG003|Overall Study|Incarceration|0|||
150049445|NCT00689117|541321822|FG000|Overall Study|Fear of Birth Defects|0|||
150049446|NCT00689117|541321823|FG001|Overall Study|Fear of Birth Defects|0|||
150049447|NCT00689117|541321824|FG002|Overall Study|Fear of Birth Defects|1|||
150049448|NCT00689117|541321825|FG003|Overall Study|Fear of Birth Defects|0|||
150049449|NCT00689117|541321822|FG000|Overall Study|Transportation|1|||
150049450|NCT00689117|541321823|FG001|Overall Study|Transportation|0|||
150049451|NCT00689117|541321824|FG002|Overall Study|Transportation|0|||
150049452|NCT00689117|541321825|FG003|Overall Study|Transportation|0|||
150049453|NCT00689117|541321822|FG000|Overall Study|Patient Withdrew from Study|0|||
150049454|NCT00689117|541321823|FG001|Overall Study|Patient Withdrew from Study|0|||
150049455|NCT00689117|541321824|FG002|Overall Study|Patient Withdrew from Study|0|||
150049456|NCT00689117|541321825|FG003|Overall Study|Patient Withdrew from Study|1|||
150049457|NCT00689117|541321822|FG000|Overall Study|Personal Reason|0|||
150049458|NCT00689117|541321823|FG001|Overall Study|Personal Reason|1|||
150049459|NCT00689117|541321824|FG002|Overall Study|Personal Reason|0|||
150049460|NCT00689117|541321825|FG003|Overall Study|Personal Reason|0|||
150049461|NCT00689117|541321822|FG000|Overall Study|Dispensing Error|0|||
150049462|NCT00689117|541321823|FG001|Overall Study|Dispensing Error|1|||
150049463|NCT00689117|541321824|FG002|Overall Study|Dispensing Error|0|||
150049464|NCT00689117|541321825|FG003|Overall Study|Dispensing Error|0|||
150049465|NCT01206322|541321826|FG000|Overall Study|Adverse Event|0|||
150049466|NCT01206322|541321827|FG001|Overall Study|Adverse Event|0|||
150049467|NCT01206322|541321828|FG002|Overall Study|Adverse Event|0|||
150049468|NCT01206322|541321829|FG003|Overall Study|Adverse Event|1|||
150049469|NCT00444678|541321830|FG000|Overall Study|Toxicity|11|||
150176789|NCT01787760|541783414|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
150049470|NCT00444678|541321830|FG000|Overall Study|Disease Progression|12|||
150049471|NCT00444678|541321830|FG000|Overall Study|Death|3|||
150049472|NCT00444678|541321830|FG000|Overall Study|Physician Decision|3|||
150049473|NCT00444678|541321830|FG000|Overall Study|Withdrawal by Subject|2|||
150049474|NCT05573386|541321835|FG000|Overall Study|Withdrawal by Subject|3|||
150049475|NCT05573386|541321836|FG001|Overall Study|Withdrawal by Subject|2|||
150049476|NCT03646123|541321837|FG000|Overall Study|Withdrawal by Subject|2|||
150049477|NCT03646123|541321838|FG001|Overall Study|Withdrawal by Subject|2|||
150049478|NCT03646123|541321839|FG002|Overall Study|Withdrawal by Subject|3|||
150049479|NCT03646123|541321837|FG000|Overall Study|Study termination by sponsor|0|||
150049480|NCT03646123|541321838|FG001|Overall Study|Study termination by sponsor|45|||
150176790|NCT01787760|541783415|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
150049481|NCT03646123|541321839|FG002|Overall Study|Study termination by sponsor|139|||
150049482|NCT03646123|541321837|FG000|Overall Study|Lost to Follow-up|4|||
150049483|NCT03646123|541321838|FG001|Overall Study|Lost to Follow-up|10|||
150049484|NCT03646123|541321839|FG002|Overall Study|Lost to Follow-up|10|||
150049485|NCT03646123|541321837|FG000|Overall Study|Death|2|||
150049486|NCT03646123|541321838|FG001|Overall Study|Death|1|||
150049487|NCT03646123|541321839|FG002|Overall Study|Death|1|||
150049488|NCT03646123|541321837|FG000|Overall Study|Other|2|||
150049489|NCT03646123|541321838|FG001|Overall Study|Other|0|||
150049490|NCT03646123|541321839|FG002|Overall Study|Other|2|||
150049491|NCT02657408|541321842|FG000|Overall Study|Adverse Event|3|||
150049492|NCT02657408|541321843|FG001|Overall Study|Adverse Event|7|||
150049493|NCT02447302|541321844|FG000|Overall Study|Physician Decision|1|||
150049494|NCT02447302|541321845|FG001|Overall Study|Physician Decision|0|||
150049495|NCT02447302|541321846|FG002|Overall Study|Physician Decision|0|||
150049496|NCT02447302|541321844|FG000|Overall Study|Adverse Event|4|||
150049497|NCT02447302|541321845|FG001|Overall Study|Adverse Event|3|||
150049498|NCT02447302|541321846|FG002|Overall Study|Adverse Event|0|||
150049499|NCT02447302|541321844|FG000|Overall Study|Withdrawal by Subject|0|||
150049500|NCT02447302|541321845|FG001|Overall Study|Withdrawal by Subject|1|||
150049501|NCT02447302|541321846|FG002|Overall Study|Withdrawal by Subject|5|||
150049502|NCT02447302|541321844|FG000|Overall Study|Sponsor Decision|0|||
150049503|NCT02447302|541321845|FG001|Overall Study|Sponsor Decision|0|||
150049504|NCT02447302|541321846|FG002|Overall Study|Sponsor Decision|1|||
150049505|NCT05334212|541321847|FG000|Overall Study|Study terminated prematurely|7|||
150049506|NCT00910299|541321848|FG000|Overall Study|Withdrawal by Subject|16|||
150049507|NCT00910299|541321849|FG001|Overall Study|Withdrawal by Subject|13|||
150049508|NCT00910299|541321848|FG000|Overall Study|Sponsor Decision|58|||
150049509|NCT00910299|541321849|FG001|Overall Study|Sponsor Decision|60|||
150049510|NCT00910299|541321848|FG000|Overall Study|Didn't receive any study drug|2|||
150049511|NCT00910299|541321849|FG001|Overall Study|Didn't receive any study drug|1|||
150049512|NCT01057589|541321855|FG000|Overall Study|Disease Progression|35|||
150049513|NCT01057589|541321855|FG000|Overall Study|Adverse Event|10|||
150049514|NCT01057589|541321855|FG000|Overall Study|Physician Decision|8|||
150049515|NCT01057589|541321855|FG000|Overall Study|Withdrawal by Subject|3|||
150049516|NCT01057589|541321855|FG000|Overall Study|Sponsor Decision|1|||
150049517|NCT01057589|541321855|FG000|Overall Study|Death|8|||
150049518|NCT01057589|541321855|FG000|Overall Study|Lost to Follow-up|1|||
150049519|NCT02281383|541321857|FG000|Overall Study|Progressive Disease|1|||
150049520|NCT02281383|541321857|FG000|Overall Study|Withdrawal by Subject|6|||
150049521|NCT02281383|541321857|FG000|Overall Study|Protocol Violation|2|||
150049522|NCT02281383|541321857|FG000|Overall Study|Death|1|||
150049523|NCT02281383|541321857|FG000|Overall Study|Adverse Event|2|||
150049524|NCT01215097|541321858|FG000|Overall Study|Adverse Event|1|||
150049525|NCT01215097|541321859|FG001|Overall Study|Adverse Event|3|||
150049526|NCT01215097|541321858|FG000|Overall Study|Protocol Violation|0|||
150049527|NCT01215097|541321859|FG001|Overall Study|Protocol Violation|2|||
150049528|NCT01215097|541321858|FG000|Overall Study|Lost to Follow-up|2|||
150049529|NCT01215097|541321859|FG001|Overall Study|Lost to Follow-up|0|||
150049530|NCT01215097|541321858|FG000|Overall Study|Withdrawal by Subject|6|||
150049531|NCT01215097|541321859|FG001|Overall Study|Withdrawal by Subject|3|||
150049532|NCT01215097|541321858|FG000|Overall Study|Lack of Efficacy|0|||
150049533|NCT01215097|541321859|FG001|Overall Study|Lack of Efficacy|3|||
150049534|NCT01215097|541321858|FG000|Overall Study|patient's refusal to come|2|||
150049535|NCT01215097|541321859|FG001|Overall Study|patient's refusal to come|2|||
150049536|NCT01215097|541321858|FG000|Overall Study|patient's private reason|1|||
150049537|NCT01215097|541321859|FG001|Overall Study|patient's private reason|1|||
150049538|NCT02252939|541321860|FG000|Overall Study|Lost to Follow-up|3|||
150049539|NCT01516034|541321861|FG000|Overall Study|Physician Decision|1|||
150049540|NCT01516034|541321861|FG000|Overall Study|Lack of Efficacy|7|||
150049541|NCT01033448|541321862|FG000|Overall Study|Withdrawal by Subject|4|||
150049542|NCT01033448|541321862|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
150049543|NCT01033448|541321862|FG000|Overall Study|Lost to Follow-up|3|||
150049544|NCT01033448|541321862|FG000|Overall Study|Withdrew due to other reasons|3|||
150049545|NCT01033448|541321862|FG000|Overall Study|Unknown disposition|1|||
150049546|NCT00870584|541321863|FG000|Overall Study|Adverse Event|3|||
150049547|NCT00870584|541321864|FG001|Overall Study|Adverse Event|3|||
150049548|NCT00870584|541321863|FG000|Overall Study|Withdrawal by Subject|6|||
150176791|NCT01787760|541783416|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
149910253|NCT02951533|540802063|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
150049549|NCT00870584|541321864|FG001|Overall Study|Withdrawal by Subject|7|||
150049550|NCT00870584|541321863|FG000|Overall Study|Lost to Follow-up|5|||
150049551|NCT00870584|541321864|FG001|Overall Study|Lost to Follow-up|1|||
150049552|NCT00870584|541321863|FG000|Overall Study|Protocol Deviation|2|||
150049553|NCT00870584|541321864|FG001|Overall Study|Protocol Deviation|2|||
150049554|NCT01497366|541321865|FG000|Overall Study|Virologic failure|2|||
150049555|NCT01497366|541321866|FG001|Overall Study|Virologic failure|50|||
150049556|NCT01497366|541321865|FG000|Overall Study|Lost to Follow-up|11|||
150049557|NCT01497366|541321866|FG001|Overall Study|Lost to Follow-up|10|||
150049558|NCT01497366|541321865|FG000|Overall Study|Withdrawal by Subject|6|||
150049559|NCT01497366|541321866|FG001|Overall Study|Withdrawal by Subject|6|||
150049560|NCT01497366|541321865|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
150049561|NCT01497366|541321866|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
150049562|NCT01497366|541321865|FG000|Overall Study|Other|5|||
150049563|NCT01497366|541321866|FG001|Overall Study|Other|0|||
150049564|NCT01497366|541321865|FG000|Overall Study|Death|1|||
150049565|NCT01497366|541321866|FG001|Overall Study|Death|1|||
150049566|NCT01497366|541321865|FG000|Overall Study|Randomized but not treated|7|||
150049567|NCT01497366|541321866|FG001|Overall Study|Randomized but not treated|21|||
150049568|NCT00472030|541321880|FG000|Overall Study|Physician Decision|1|||
150049569|NCT00472030|541321881|FG001|Overall Study|Physician Decision|0|||
150049570|NCT00829504|541321882|FG000|First Intervention|Adverse Event|1|||
150049571|NCT00829504|541321883|FG001|First Intervention|Adverse Event|0|||
150049572|NCT00829504|541321882|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
150049573|NCT00829504|541321883|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149910254|NCT02951533|540802064|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
149910255|NCT02951533|540802062|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
149910256|NCT02951533|540802063|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
149910257|NCT02951533|540802064|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
150049574|NCT00829504|541321882|FG000|Second Intervention|Physician Decision|1|||
150049575|NCT00829504|541321883|FG001|Second Intervention|Physician Decision|0|||
149910258|NCT02951533|540802062|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
149910259|NCT02951533|540802063|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
149910260|NCT02951533|540802064|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
149910261|NCT02951533|540802062|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
150049576|NCT04189224|541321884|FG000|Period 2|Adverse Event|0|||
150049577|NCT04189224|541321885|FG001|Period 2|Adverse Event|1|||
150049578|NCT03254459|541323943|FG000|Overall Study|Adverse Event|7|||
150049579|NCT03254459|541323944|FG001|Overall Study|Adverse Event|20|||
150049580|NCT03254459|541323943|FG000|Overall Study|Withdrawal by Subject Consent|3|||
150049581|NCT03254459|541323944|FG001|Overall Study|Withdrawal by Subject Consent|1|||
150049582|NCT03254459|541323943|FG000|Overall Study|Lost to Follow-up|0|||
150049583|NCT03254459|541323944|FG001|Overall Study|Lost to Follow-up|1|||
150049584|NCT03254459|541323943|FG000|Overall Study|Miscellaneous|0|||
150049585|NCT03254459|541323944|FG001|Overall Study|Miscellaneous|1|||
150049586|NCT01129583|541323947|FG000|Overall Study|Death|1|||
150049587|NCT01129583|541323948|FG001|Overall Study|Death|0|||
150049588|NCT01129583|541323947|FG000|Overall Study|Lost to Follow-up|1|||
150049589|NCT01129583|541323948|FG001|Overall Study|Lost to Follow-up|1|||
150049590|NCT01129583|541323947|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
150049591|NCT01129583|541323948|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
150049592|NCT00830869|541323954|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
150049593|NCT00830869|541323955|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
150049594|NCT00830869|541323956|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
150049595|NCT00830869|541323957|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
150049596|NCT00830869|541323958|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
150049597|NCT00830869|541323959|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
150049598|NCT00830869|541323960|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
150049599|NCT00830869|541323961|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
150049600|NCT00830869|541323962|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
150049601|NCT00830869|541323963|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
150049602|NCT00830869|541323964|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
150049603|NCT00830869|541323965|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
150049604|NCT00830869|541323954|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
150049605|NCT00830869|541323955|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
150049606|NCT00830869|541323956|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
150049607|NCT00830869|541323957|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
150049608|NCT00830869|541323958|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
150049609|NCT00830869|541323959|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
150049610|NCT00830869|541323960|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
150049611|NCT00830869|541323961|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
150049612|NCT00830869|541323962|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
150049613|NCT00830869|541323963|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
150049614|NCT00830869|541323964|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
150049615|NCT00830869|541323965|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
150049616|NCT00830869|541323954|FG000|Period 1: Part 1|Adverse Event|0|||
150049617|NCT00830869|541323955|FG001|Period 1: Part 1|Adverse Event|0|||
150049618|NCT00830869|541323956|FG002|Period 1: Part 1|Adverse Event|0|||
150049619|NCT00830869|541323957|FG003|Period 1: Part 1|Adverse Event|0|||
150049620|NCT00830869|541323958|FG004|Period 1: Part 1|Adverse Event|0|||
150049621|NCT00830869|541323959|FG005|Period 1: Part 1|Adverse Event|1|||
150049622|NCT00830869|541323960|FG006|Period 1: Part 1|Adverse Event|1|||
150049623|NCT00830869|541323961|FG007|Period 1: Part 1|Adverse Event|0|||
150049624|NCT00830869|541323962|FG008|Period 1: Part 1|Adverse Event|0|||
149910262|NCT02951533|540802063|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
149910263|NCT02951533|540802064|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
149910264|NCT02375555|540802076|FG000|Induction Period|Adverse Event|7|||
149910265|NCT02375555|540802076|FG000|Induction Period|Withdrawal by Subject|2|||
149910266|NCT02375555|540802076|FG000|Induction Period|Other|1|||
149910267|NCT02375555|540802076|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
149910268|NCT02375555|540802076|FG000|Maintenance Period|Adverse Event|2|||
149910269|NCT02375555|540802076|FG000|Maintenance Period|Withdrawal by Subject|4|||
149910270|NCT02375555|540802076|FG000|Maintenance Period|Death|1|||
149910271|NCT02375555|540802076|FG000|Maintenance Period|Disease Progression|5|||
149910272|NCT02375555|540802076|FG000|Maintenance Period|Patient Non-compliance|1|||
149910273|NCT02375555|540802076|FG000|Maintenance Period|Still on maintenance|16|||
149910274|NCT02091986|540802079|FG000|Overall Study|7 rand in error 1 patient decision|2|||
149910275|NCT02091986|540802080|FG001|Overall Study|7 rand in error 1 patient decision|3|||
149910276|NCT02091986|540802081|FG002|Overall Study|7 rand in error 1 patient decision|3|||
149910277|NCT02091986|540802079|FG000|Overall Study|Lost to Follow-up|1|||
149910278|NCT02091986|540802080|FG001|Overall Study|Lost to Follow-up|0|||
149910279|NCT02091986|540802081|FG002|Overall Study|Lost to Follow-up|0|||
149910280|NCT02091986|540802079|FG000|Overall Study|Withdrawal by Subject|4|||
149910281|NCT02091986|540802080|FG001|Overall Study|Withdrawal by Subject|8|||
149910282|NCT02091986|540802081|FG002|Overall Study|Withdrawal by Subject|3|||
149910283|NCT02091986|540802079|FG000|Overall Study|Adverse Event|0|||
149910284|NCT02091986|540802080|FG001|Overall Study|Adverse Event|0|||
149910285|NCT02091986|540802081|FG002|Overall Study|Adverse Event|2|||
149910286|NCT00125242|540802082|FG000|Overall Study|did not qualify|7|||
149910287|NCT00125242|540802083|FG001|Overall Study|did not qualify|2|||
149910288|NCT01664949|540802086|FG000|Overall Study|Adverse Event|11|||
149910289|NCT01664949|540802087|FG001|Overall Study|Adverse Event|12|||
149910290|NCT01664949|540802086|FG000|Overall Study|Lack of Efficacy|1|||
149910291|NCT01664949|540802087|FG001|Overall Study|Lack of Efficacy|1|||
149910292|NCT01664949|540802086|FG000|Overall Study|Lost to Follow-up|1|||
149910293|NCT01664949|540802087|FG001|Overall Study|Lost to Follow-up|2|||
149910294|NCT01664949|540802086|FG000|Overall Study|Personal Reasons|3|||
149910295|NCT01664949|540802087|FG001|Overall Study|Personal Reasons|4|||
149910296|NCT01664949|540802086|FG000|Overall Study|Protocol Violation|5|||
149910297|NCT01664949|540802087|FG001|Overall Study|Protocol Violation|5|||
149910298|NCT01664949|540802086|FG000|Overall Study|Other Miscellaneous Reasons|3|||
149910299|NCT01664949|540802087|FG001|Overall Study|Other Miscellaneous Reasons|1|||
149910300|NCT02727777|540802088|FG000|Overall Study|Screen Failure|2|||
149910301|NCT02727777|540802089|FG001|Overall Study|Screen Failure|0|||
149910302|NCT02727777|540802090|FG002|Overall Study|Screen Failure|0|||
149910303|NCT02727777|540802088|FG000|Overall Study|Progressive disease|2|||
149910304|NCT02727777|540802089|FG001|Overall Study|Progressive disease|0|||
149910305|NCT02727777|540802090|FG002|Overall Study|Progressive disease|0|||
149910306|NCT01738503|540802091|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
149910307|NCT01738503|540802092|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910308|NCT01738503|540802093|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910309|NCT01738503|540802094|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910310|NCT01738503|540802095|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910311|NCT01738503|540802096|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910312|NCT01738503|540802097|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
149910313|NCT01738503|540802091|FG000|Treatment Period|Adverse Event|0|||
149910314|NCT01738503|540802092|FG001|Treatment Period|Adverse Event|1|||
149910315|NCT01738503|540802093|FG002|Treatment Period|Adverse Event|0|||
149910316|NCT01738503|540802094|FG003|Treatment Period|Adverse Event|1|||
149910317|NCT01738503|540802095|FG004|Treatment Period|Adverse Event|2|||
149910318|NCT01738503|540802096|FG005|Treatment Period|Adverse Event|2|||
149910319|NCT01738503|540802097|FG006|Treatment Period|Adverse Event|2|||
149910320|NCT01738503|540802091|FG000|Treatment Period|Lost to Follow-up|0|||
149910321|NCT01738503|540802092|FG001|Treatment Period|Lost to Follow-up|0|||
149910322|NCT01738503|540802093|FG002|Treatment Period|Lost to Follow-up|3|||
149910323|NCT01738503|540802094|FG003|Treatment Period|Lost to Follow-up|4|||
149910324|NCT01738503|540802095|FG004|Treatment Period|Lost to Follow-up|1|||
149910325|NCT01738503|540802096|FG005|Treatment Period|Lost to Follow-up|1|||
149910326|NCT01738503|540802097|FG006|Treatment Period|Lost to Follow-up|5|||
149910327|NCT01738503|540802091|FG000|Treatment Period|Withdrawal by Subject|0|||
149910328|NCT01738503|540802092|FG001|Treatment Period|Withdrawal by Subject|1|||
149910329|NCT01738503|540802093|FG002|Treatment Period|Withdrawal by Subject|0|||
149910330|NCT01738503|540802094|FG003|Treatment Period|Withdrawal by Subject|1|||
149910331|NCT01738503|540802095|FG004|Treatment Period|Withdrawal by Subject|1|||
149910332|NCT01738503|540802096|FG005|Treatment Period|Withdrawal by Subject|1|||
149910333|NCT01738503|540802097|FG006|Treatment Period|Withdrawal by Subject|1|||
149910334|NCT01738503|540802091|FG000|Treatment Period|Protocol Violation|0|||
149910335|NCT01738503|540802092|FG001|Treatment Period|Protocol Violation|3|||
149910336|NCT01738503|540802093|FG002|Treatment Period|Protocol Violation|1|||
149910337|NCT01738503|540802094|FG003|Treatment Period|Protocol Violation|0|||
149910338|NCT01738503|540802095|FG004|Treatment Period|Protocol Violation|4|||
149910339|NCT01738503|540802096|FG005|Treatment Period|Protocol Violation|2|||
149910340|NCT01738503|540802097|FG006|Treatment Period|Protocol Violation|0|||
149910341|NCT01738503|540802091|FG000|Treatment Period|Other|0|||
149910342|NCT01738503|540802092|FG001|Treatment Period|Other|0|||
149910343|NCT01738503|540802093|FG002|Treatment Period|Other|1|||
149910344|NCT01738503|540802094|FG003|Treatment Period|Other|0|||
149910345|NCT01738503|540802095|FG004|Treatment Period|Other|0|||
149910346|NCT01738503|540802096|FG005|Treatment Period|Other|0|||
149910347|NCT01738503|540802097|FG006|Treatment Period|Other|0|||
149910348|NCT01738503|540802091|FG000|PET Imaging Sub-study|Adverse Event|0|||
149910349|NCT01738503|540802092|FG001|PET Imaging Sub-study|Adverse Event|0|||
149910350|NCT01738503|540802093|FG002|PET Imaging Sub-study|Adverse Event|0|||
149910351|NCT01738503|540802094|FG003|PET Imaging Sub-study|Adverse Event|0|||
149910352|NCT01738503|540802095|FG004|PET Imaging Sub-study|Adverse Event|0|||
149910353|NCT01738503|540802096|FG005|PET Imaging Sub-study|Adverse Event|1|||
149910354|NCT01738503|540802097|FG006|PET Imaging Sub-study|Adverse Event|0|||
149910355|NCT01738503|540802091|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
149910356|NCT01738503|540802092|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
149910357|NCT01738503|540802093|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
149910358|NCT01738503|540802094|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
149910359|NCT01738503|540802095|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
149910360|NCT01738503|540802096|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
149910361|NCT01738503|540802097|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
149910362|NCT04687072|540802098|FG000|Overall Study|Adverse Event|2|||
149910363|NCT04687072|540802099|FG001|Overall Study|Adverse Event|0|||
149910364|NCT04687072|540802098|FG000|Overall Study|Death|1|||
149910365|NCT04687072|540802099|FG001|Overall Study|Death|0|||
149910366|NCT04687072|540802098|FG000|Overall Study|Lack of Efficacy|2|||
149910367|NCT04687072|540802099|FG001|Overall Study|Lack of Efficacy|1|||
149910368|NCT04687072|540802098|FG000|Overall Study|Physician Decision|1|||
149910369|NCT04687072|540802099|FG001|Overall Study|Physician Decision|0|||
149910370|NCT04687072|540802098|FG000|Overall Study|Pregnancy|1|||
149910371|NCT04687072|540802099|FG001|Overall Study|Pregnancy|0|||
149910372|NCT04687072|540802098|FG000|Overall Study|Requires Prohibited Medication|2|||
149910373|NCT04687072|540802099|FG001|Overall Study|Requires Prohibited Medication|0|||
149910374|NCT04687072|540802098|FG000|Overall Study|Withdrawal of Consent|11|||
149910375|NCT04687072|540802099|FG001|Overall Study|Withdrawal of Consent|6|||
149910376|NCT04687072|540802098|FG000|Overall Study|Miscellaneous|4|||
149910377|NCT04687072|540802099|FG001|Overall Study|Miscellaneous|1|||
149910378|NCT03626363|540802102|FG000|Overall Study|Protocol Violation|4|||
149910379|NCT03626363|540802103|FG001|Overall Study|Protocol Violation|0|||
149910380|NCT03626363|540802102|FG000|Overall Study|Lost to Follow-up|5|||
149910381|NCT03626363|540802103|FG001|Overall Study|Lost to Follow-up|7|||
149910382|NCT01970475|540802106|FG000|Overall Study|Withdrawal by Subject|11|||
149910383|NCT01970475|540802107|FG001|Overall Study|Withdrawal by Subject|6|||
149910384|NCT01970475|540802106|FG000|Overall Study|Adverse Event|7|||
149910385|NCT01970475|540802107|FG001|Overall Study|Adverse Event|3|||
149910386|NCT01970475|540802106|FG000|Overall Study|Lost to Follow-up|2|||
149910387|NCT01970475|540802107|FG001|Overall Study|Lost to Follow-up|2|||
149910388|NCT01970475|540802106|FG000|Overall Study|Protocol Violation|1|||
149910389|NCT01970475|540802107|FG001|Overall Study|Protocol Violation|0|||
149910390|NCT00960986|540802108|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
149910391|NCT00960986|540802109|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
149910392|NCT00960986|540802110|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
149910393|NCT00960986|540802111|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
149910394|NCT00960986|540802108|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
149910395|NCT00960986|540802109|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
149910396|NCT00960986|540802110|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
149910397|NCT00960986|540802111|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
149910398|NCT00960986|540802108|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
149910399|NCT00960986|540802109|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
149910400|NCT00960986|540802110|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
149910401|NCT00960986|540802111|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
149910402|NCT00960986|540802108|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
149910403|NCT00960986|540802109|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
149910404|NCT00960986|540802110|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
149910405|NCT00960986|540802111|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
149910406|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
149910407|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
149910408|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
149910409|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
149910410|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Death|0|||
149910411|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Death|0|||
149910412|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Death|1|||
149910413|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Death|0|||
149910414|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
149910415|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
149910416|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
149910417|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
149910418|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
149910419|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
149910420|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
149910421|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
149910422|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
149910423|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
149910424|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
149910425|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
149910426|NCT00960986|540802108|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
149910427|NCT00960986|540802109|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
149910428|NCT00960986|540802110|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
150049625|NCT00830869|541323963|FG009|Period 1: Part 1|Adverse Event|0|||
150049626|NCT00830869|541323964|FG010|Period 1: Part 1|Adverse Event|0|||
150049627|NCT00830869|541323965|FG011|Period 1: Part 1|Adverse Event|0|||
150049628|NCT00830869|541323954|FG000|Period 1: Part 1|Progressive disease|1|||
150049629|NCT00830869|541323955|FG001|Period 1: Part 1|Progressive disease|0|||
149910429|NCT00960986|540802111|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
149910430|NCT01984892|540802112|FG000|Overall Study|Progressive disease|7|||
149910431|NCT04464720|540802113|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
149910432|NCT02234596|540802119|FG000|Overall Study|Participant not treated|2|||
149910433|NCT04852679|540802122|FG000|Main Intervention Period|Withdrawal by Subject|3|||
149971788|NCT00829244|541033759|FG000|Overall Study|All embryos discarded|0|||
150049630|NCT00830869|541323956|FG002|Period 1: Part 1|Progressive disease|1|||
149971789|NCT00829244|541033760|FG001|Overall Study|All embryos discarded|3|||
150049631|NCT00830869|541323957|FG003|Period 1: Part 1|Progressive disease|6|||
150049632|NCT00830869|541323958|FG004|Period 1: Part 1|Progressive disease|4|||
150049633|NCT00830869|541323959|FG005|Period 1: Part 1|Progressive disease|4|||
150049634|NCT00830869|541323960|FG006|Period 1: Part 1|Progressive disease|1|||
150049635|NCT00830869|541323961|FG007|Period 1: Part 1|Progressive disease|0|||
150049636|NCT00830869|541323962|FG008|Period 1: Part 1|Progressive disease|0|||
150049637|NCT00830869|541323963|FG009|Period 1: Part 1|Progressive disease|0|||
150049638|NCT00830869|541323964|FG010|Period 1: Part 1|Progressive disease|0|||
150049639|NCT00830869|541323965|FG011|Period 1: Part 1|Progressive disease|0|||
150049640|NCT00830869|541323954|FG000|Period 2: Part 2|Protocol Violation|0|||
150049641|NCT00830869|541323955|FG001|Period 2: Part 2|Protocol Violation|0|||
150049642|NCT00830869|541323956|FG002|Period 2: Part 2|Protocol Violation|0|||
150049643|NCT00830869|541323957|FG003|Period 2: Part 2|Protocol Violation|0|||
150049644|NCT00830869|541323958|FG004|Period 2: Part 2|Protocol Violation|0|||
150049645|NCT00830869|541323959|FG005|Period 2: Part 2|Protocol Violation|0|||
150049646|NCT00830869|541323960|FG006|Period 2: Part 2|Protocol Violation|0|||
150049647|NCT00830869|541323961|FG007|Period 2: Part 2|Protocol Violation|1|||
150049648|NCT00830869|541323962|FG008|Period 2: Part 2|Protocol Violation|0|||
150049649|NCT00830869|541323963|FG009|Period 2: Part 2|Protocol Violation|1|||
150049650|NCT00830869|541323964|FG010|Period 2: Part 2|Protocol Violation|0|||
150049651|NCT00830869|541323965|FG011|Period 2: Part 2|Protocol Violation|0|||
149910434|NCT04852679|540802122|FG000|Main Intervention Period|Adverse Event|1|||
149910435|NCT04852679|540802122|FG000|Main Intervention Period|Progressive Disease|16|||
149910436|NCT04852679|540802122|FG000|Main Intervention Period|Refused study visit|1|||
149971790|NCT00829244|541033759|FG000|Overall Study|No embryo cleavage|0|||
149971791|NCT00829244|541033760|FG001|Overall Study|No embryo cleavage|2|||
149971792|NCT04222673|541033761|FG000|Overall Study|Lost to Follow-up|5|||
149971793|NCT04583618|541033771|FG000|Overall Study|Adverse Event|0|||
149971794|NCT04583618|541033772|FG001|Overall Study|Adverse Event|0|||
149971795|NCT04583618|541033773|FG002|Overall Study|Adverse Event|1|||
149971796|NCT04583618|541033774|FG003|Overall Study|Adverse Event|0|||
149971797|NCT04583618|541033775|FG004|Overall Study|Adverse Event|0|||
149971798|NCT04583618|541033771|FG000|Overall Study|Protocol deviation|1|||
150049652|NCT00830869|541323954|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
150049653|NCT00830869|541323955|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
149910437|NCT04852679|540802122|FG000|Independent Injection Period|Missed study visit|1|||
149910438|NCT01294696|540802125|FG000|Overall Study|Screening failures|7|||
149971799|NCT04583618|541033772|FG001|Overall Study|Protocol deviation|1|||
149971800|NCT04583618|541033773|FG002|Overall Study|Protocol deviation|1|||
150049654|NCT00830869|541323956|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
150049655|NCT00830869|541323957|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
150049656|NCT00830869|541323958|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
149910439|NCT01294696|540802125|FG000|Overall Study|Protocol Violation|8|||
149910440|NCT01294696|540802125|FG000|Overall Study|Missing BPI Response|7|||
149910441|NCT01294696|540802125|FG000|Overall Study|Site closure|52|||
149910442|NCT00197002|540803840|FG000|Overall Study|Adverse Event|0|||
149910443|NCT00197002|540803841|FG001|Overall Study|Adverse Event|1|||
149910444|NCT00197002|540803842|FG002|Overall Study|Adverse Event|0|||
149910445|NCT00197002|540803840|FG000|Overall Study|Protocol Violation|1|||
149910446|NCT00197002|540803841|FG001|Overall Study|Protocol Violation|0|||
149910447|NCT00197002|540803842|FG002|Overall Study|Protocol Violation|2|||
149910448|NCT00197002|540803840|FG000|Overall Study|Withdrawal by Subject|9|||
149910449|NCT00197002|540803841|FG001|Overall Study|Withdrawal by Subject|5|||
149910450|NCT00197002|540803842|FG002|Overall Study|Withdrawal by Subject|7|||
149910451|NCT00197002|540803840|FG000|Overall Study|Migrated/moved from study area|3|||
149910452|NCT00197002|540803841|FG001|Overall Study|Migrated/moved from study area|5|||
149910453|NCT00197002|540803842|FG002|Overall Study|Migrated/moved from study area|1|||
149910454|NCT00197002|540803840|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
149910455|NCT00197002|540803841|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
149910456|NCT00197002|540803842|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
149910457|NCT00197002|540803840|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
149910458|NCT00197002|540803841|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
149910459|NCT00197002|540803842|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
149910460|NCT00197002|540803840|FG000|Overall Study|Others|3|||
149910461|NCT00197002|540803841|FG001|Overall Study|Others|1|||
149910462|NCT00197002|540803842|FG002|Overall Study|Others|1|||
149910463|NCT03569293|540803845|FG000|Overall Study|Adverse Event|4|||
149910464|NCT03569293|540803846|FG001|Overall Study|Adverse Event|1|||
149910465|NCT03569293|540803847|FG002|Overall Study|Adverse Event|5|||
150049657|NCT00830869|541323959|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
150049658|NCT00830869|541323960|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
149910466|NCT03569293|540803848|FG003|Overall Study|Adverse Event|1|||
149910467|NCT03569293|540803849|FG004|Overall Study|Adverse Event|0|||
149910468|NCT03569293|540803850|FG005|Overall Study|Adverse Event|0|||
149910469|NCT03569293|540803845|FG000|Overall Study|Withdrawal by Subject|16|||
149910470|NCT03569293|540803846|FG001|Overall Study|Withdrawal by Subject|2|||
149910471|NCT03569293|540803847|FG002|Overall Study|Withdrawal by Subject|4|||
149910472|NCT03569293|540803848|FG003|Overall Study|Withdrawal by Subject|1|||
149910473|NCT03569293|540803849|FG004|Overall Study|Withdrawal by Subject|0|||
149910474|NCT03569293|540803850|FG005|Overall Study|Withdrawal by Subject|0|||
149910475|NCT03569293|540803845|FG000|Overall Study|Lost to Follow-up|1|||
149910476|NCT03569293|540803846|FG001|Overall Study|Lost to Follow-up|3|||
149910477|NCT03569293|540803847|FG002|Overall Study|Lost to Follow-up|1|||
149910478|NCT03569293|540803848|FG003|Overall Study|Lost to Follow-up|1|||
149910479|NCT03569293|540803849|FG004|Overall Study|Lost to Follow-up|0|||
149910480|NCT03569293|540803850|FG005|Overall Study|Lost to Follow-up|0|||
149910481|NCT03569293|540803845|FG000|Overall Study|Other|8|||
149910482|NCT03569293|540803846|FG001|Overall Study|Other|2|||
149910483|NCT03569293|540803847|FG002|Overall Study|Other|1|||
149910484|NCT03569293|540803848|FG003|Overall Study|Other|1|||
149910485|NCT03569293|540803849|FG004|Overall Study|Other|0|||
149910486|NCT03569293|540803850|FG005|Overall Study|Other|0|||
149910487|NCT03569293|540803845|FG000|Overall Study|Ongoing at Time of Analysis|8|||
149910488|NCT03569293|540803846|FG001|Overall Study|Ongoing at Time of Analysis|1|||
149910489|NCT03569293|540803847|FG002|Overall Study|Ongoing at Time of Analysis|3|||
149910490|NCT03569293|540803848|FG003|Overall Study|Ongoing at Time of Analysis|0|||
149910491|NCT03569293|540803849|FG004|Overall Study|Ongoing at Time of Analysis|0|||
149910492|NCT03569293|540803850|FG005|Overall Study|Ongoing at Time of Analysis|0|||
149910493|NCT03839459|540803861|FG000|Overall Study|Withdrawal by Subject|2|||
149910494|NCT03839459|540803861|FG000|Overall Study|progression of disease|3|||
149910495|NCT01088243|540803863|FG000|Overall Study|Adverse Event|1|||
149910496|NCT01088243|540803864|FG001|Overall Study|Adverse Event|0|||
149910497|NCT02370667|540803867|FG000|Overall Study|Lost to Follow-up|0|||
149910498|NCT02370667|540803868|FG001|Overall Study|Lost to Follow-up|1|||
149910499|NCT02370667|540803869|FG002|Overall Study|Lost to Follow-up|0|||
149910500|NCT00478699|540803874|FG000|Overall Study|Inclusion Error|1|||
149910501|NCT00478699|540803875|FG001|Overall Study|Inclusion Error|7|||
149910502|NCT00478699|540803874|FG000|Overall Study|Not receive study treatment|6|||
149910503|NCT00478699|540803875|FG001|Overall Study|Not receive study treatment|30|||
149910504|NCT01043705|540803878|FG000|Overall Study|Death|28|||
150049659|NCT00830869|541323961|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
149910505|NCT01043705|540803879|FG001|Overall Study|Death|60|||
149910506|NCT01043705|540803880|FG002|Overall Study|Death|26|||
149910507|NCT01043705|540803878|FG000|Overall Study|Lost to Follow-up|27|||
149910508|NCT01043705|540803879|FG001|Overall Study|Lost to Follow-up|12|||
149910509|NCT01043705|540803880|FG002|Overall Study|Lost to Follow-up|0|||
149910510|NCT01043705|540803878|FG000|Overall Study|Multiple Reasons|4|||
149910511|NCT01043705|540803879|FG001|Overall Study|Multiple Reasons|7|||
150049660|NCT00830869|541323962|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
150049661|NCT00830869|541323963|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
150049662|NCT00830869|541323964|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
150049663|NCT00830869|541323965|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
150049664|NCT00830869|541323954|FG000|Period 2: Part 2|Adverse Event|0|||
150049665|NCT00830869|541323955|FG001|Period 2: Part 2|Adverse Event|0|||
150049666|NCT00830869|541323956|FG002|Period 2: Part 2|Adverse Event|0|||
150049667|NCT00830869|541323957|FG003|Period 2: Part 2|Adverse Event|0|||
150049668|NCT00830869|541323958|FG004|Period 2: Part 2|Adverse Event|0|||
150049669|NCT00830869|541323959|FG005|Period 2: Part 2|Adverse Event|0|||
150049670|NCT00830869|541323960|FG006|Period 2: Part 2|Adverse Event|0|||
150049671|NCT00830869|541323961|FG007|Period 2: Part 2|Adverse Event|4|||
150049672|NCT00830869|541323962|FG008|Period 2: Part 2|Adverse Event|3|||
150049673|NCT00830869|541323963|FG009|Period 2: Part 2|Adverse Event|2|||
150049674|NCT00830869|541323964|FG010|Period 2: Part 2|Adverse Event|2|||
150049675|NCT00830869|541323965|FG011|Period 2: Part 2|Adverse Event|0|||
150049676|NCT00830869|541323954|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
150049677|NCT00830869|541323955|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
150049678|NCT00830869|541323956|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
150049679|NCT00830869|541323957|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
150049680|NCT00830869|541323958|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
150049681|NCT00830869|541323959|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
150049682|NCT00830869|541323960|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
150049683|NCT00830869|541323961|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
150049684|NCT00830869|541323962|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
150049685|NCT00830869|541323963|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
150049686|NCT00830869|541323964|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
150049687|NCT00830869|541323965|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
150049688|NCT00830869|541323954|FG000|Period 2: Part 2|Progressive disease|0|||
150049689|NCT00830869|541323955|FG001|Period 2: Part 2|Progressive disease|0|||
150049690|NCT00830869|541323956|FG002|Period 2: Part 2|Progressive disease|0|||
150049691|NCT00830869|541323957|FG003|Period 2: Part 2|Progressive disease|0|||
150049692|NCT00830869|541323958|FG004|Period 2: Part 2|Progressive disease|0|||
150049693|NCT00830869|541323959|FG005|Period 2: Part 2|Progressive disease|0|||
150049694|NCT00830869|541323960|FG006|Period 2: Part 2|Progressive disease|0|||
150049695|NCT00830869|541323961|FG007|Period 2: Part 2|Progressive disease|14|||
150049696|NCT00830869|541323962|FG008|Period 2: Part 2|Progressive disease|11|||
150049697|NCT00830869|541323963|FG009|Period 2: Part 2|Progressive disease|12|||
150049698|NCT00830869|541323964|FG010|Period 2: Part 2|Progressive disease|8|||
150049699|NCT00830869|541323965|FG011|Period 2: Part 2|Progressive disease|15|||
150049700|NCT00830869|541323954|FG000|Period 2: Part 2|Other|0|||
150049701|NCT00830869|541323955|FG001|Period 2: Part 2|Other|0|||
150049702|NCT00830869|541323956|FG002|Period 2: Part 2|Other|0|||
150049703|NCT00830869|541323957|FG003|Period 2: Part 2|Other|0|||
150049704|NCT00830869|541323958|FG004|Period 2: Part 2|Other|0|||
150049705|NCT00830869|541323959|FG005|Period 2: Part 2|Other|0|||
150049706|NCT00830869|541323960|FG006|Period 2: Part 2|Other|0|||
150049707|NCT00830869|541323961|FG007|Period 2: Part 2|Other|0|||
150049708|NCT00830869|541323962|FG008|Period 2: Part 2|Other|0|||
150049709|NCT00830869|541323963|FG009|Period 2: Part 2|Other|1|||
150049710|NCT00830869|541323964|FG010|Period 2: Part 2|Other|0|||
150049711|NCT00830869|541323965|FG011|Period 2: Part 2|Other|0|||
150049712|NCT00281658|541323970|FG000|Randomized Phase|Adverse Event|0|||
150049713|NCT00281658|541323971|FG001|Randomized Phase|Adverse Event|2|||
150049714|NCT00281658|541323972|FG002|Randomized Phase|Adverse Event|0|||
150049715|NCT00281658|541323973|FG003|Randomized Phase|Adverse Event|0|||
150049716|NCT00281658|541323970|FG000|Randomized Phase|Lost to Follow-up|34|||
150049717|NCT00281658|541323971|FG001|Randomized Phase|Lost to Follow-up|27|||
150049718|NCT00281658|541323972|FG002|Randomized Phase|Lost to Follow-up|0|||
150049719|NCT00281658|541323973|FG003|Randomized Phase|Lost to Follow-up|0|||
150049720|NCT00281658|541323970|FG000|Randomized Phase|Withdrawal by Subject|8|||
150049721|NCT00281658|541323971|FG001|Randomized Phase|Withdrawal by Subject|7|||
150049722|NCT00281658|541323972|FG002|Randomized Phase|Withdrawal by Subject|0|||
150049723|NCT00281658|541323973|FG003|Randomized Phase|Withdrawal by Subject|0|||
150049724|NCT00281658|541323970|FG000|Randomized Phase|Study closed/terminated|1|||
150049725|NCT00281658|541323971|FG001|Randomized Phase|Study closed/terminated|1|||
150049726|NCT00281658|541323972|FG002|Randomized Phase|Study closed/terminated|0|||
150049727|NCT00281658|541323973|FG003|Randomized Phase|Study closed/terminated|0|||
150049728|NCT00281658|541323970|FG000|Randomized Phase|Disease progression|36|||
150049729|NCT00281658|541323971|FG001|Randomized Phase|Disease progression|27|||
150049730|NCT00281658|541323972|FG002|Randomized Phase|Disease progression|0|||
150049731|NCT00281658|541323973|FG003|Randomized Phase|Disease progression|0|||
150049732|NCT00281658|541323970|FG000|Randomized Phase|Physician Decision|1|||
150049733|NCT00281658|541323971|FG001|Randomized Phase|Physician Decision|1|||
150049734|NCT00281658|541323972|FG002|Randomized Phase|Physician Decision|0|||
150049735|NCT00281658|541323973|FG003|Randomized Phase|Physician Decision|0|||
150049736|NCT00281658|541323970|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
150049737|NCT00281658|541323971|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
150049738|NCT00281658|541323972|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
150049739|NCT00281658|541323973|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
150049740|NCT00281658|541323970|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
150049741|NCT00281658|541323971|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
150049742|NCT00281658|541323972|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
150049743|NCT00281658|541323973|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
150049744|NCT00281658|541323970|FG000|Randomized Phase|Treatment ongoing|1|||
150049745|NCT00281658|541323971|FG001|Randomized Phase|Treatment ongoing|0|||
150049746|NCT00281658|541323972|FG002|Randomized Phase|Treatment ongoing|0|||
150049747|NCT00281658|541323973|FG003|Randomized Phase|Treatment ongoing|0|||
150049748|NCT00281658|541323970|FG000|Open Label Phase|Adverse Event|0|||
150049749|NCT00281658|541323971|FG001|Open Label Phase|Adverse Event|0|||
150049750|NCT00281658|541323972|FG002|Open Label Phase|Adverse Event|1|||
150049751|NCT00281658|541323973|FG003|Open Label Phase|Adverse Event|0|||
150049752|NCT00281658|541323970|FG000|Open Label Phase|Lost to Follow-up|0|||
150049753|NCT00281658|541323971|FG001|Open Label Phase|Lost to Follow-up|0|||
150049754|NCT00281658|541323972|FG002|Open Label Phase|Lost to Follow-up|16|||
150049755|NCT00281658|541323973|FG003|Open Label Phase|Lost to Follow-up|2|||
150049756|NCT00281658|541323970|FG000|Open Label Phase|Withdrawal by Subject|0|||
150049757|NCT00281658|541323971|FG001|Open Label Phase|Withdrawal by Subject|0|||
150049758|NCT00281658|541323972|FG002|Open Label Phase|Withdrawal by Subject|3|||
150049759|NCT00281658|541323973|FG003|Open Label Phase|Withdrawal by Subject|2|||
150049760|NCT00281658|541323970|FG000|Open Label Phase|Disease progression|0|||
150049761|NCT00281658|541323971|FG001|Open Label Phase|Disease progression|0|||
150049762|NCT00281658|541323972|FG002|Open Label Phase|Disease progression|18|||
150049763|NCT00281658|541323973|FG003|Open Label Phase|Disease progression|0|||
150049764|NCT00281658|541323970|FG000|Open Label Phase|Physician Decision|0|||
150049765|NCT00281658|541323971|FG001|Open Label Phase|Physician Decision|0|||
150049766|NCT00281658|541323972|FG002|Open Label Phase|Physician Decision|1|||
150049767|NCT00281658|541323973|FG003|Open Label Phase|Physician Decision|0|||
150049768|NCT00281658|541323970|FG000|Open Label Phase|Relocation of patient|0|||
150049769|NCT00281658|541323971|FG001|Open Label Phase|Relocation of patient|0|||
150049770|NCT00281658|541323972|FG002|Open Label Phase|Relocation of patient|1|||
150049771|NCT00281658|541323973|FG003|Open Label Phase|Relocation of patient|0|||
150049772|NCT00281658|541323970|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
150049773|NCT00281658|541323971|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
150049774|NCT00281658|541323972|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
150049775|NCT00281658|541323973|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
150049776|NCT00669409|541323974|FG000|Part 2|Withdrawal by Subject|0|||
150049777|NCT00669409|541323975|FG001|Part 2|Withdrawal by Subject|0|||
150049778|NCT00669409|541323976|FG002|Part 2|Withdrawal by Subject|0|||
150049779|NCT00669409|541323977|FG003|Part 2|Withdrawal by Subject|0|||
150049780|NCT00669409|541323978|FG004|Part 2|Withdrawal by Subject|0|||
150049781|NCT00669409|541323979|FG005|Part 2|Withdrawal by Subject|0|||
150049782|NCT00669409|541323980|FG006|Part 2|Withdrawal by Subject|0|||
150049783|NCT00669409|541323981|FG007|Part 2|Withdrawal by Subject|0|||
150049784|NCT00669409|541323982|FG008|Part 2|Withdrawal by Subject|0|||
150049785|NCT00669409|541323983|FG009|Part 2|Withdrawal by Subject|1|||
150049786|NCT00669409|541323984|FG010|Part 2|Withdrawal by Subject|0|||
150049787|NCT04590248|541323985|FG000|Overall Study|Lost to Follow-up|1|||
150049788|NCT04590248|541323985|FG000|Overall Study|Withdrawal by Subject|16|||
150049789|NCT04590248|541323985|FG000|Overall Study|Other|2|||
150049790|NCT02052414|541323988|FG000|Overall Study|Adverse Event|12|||
150049791|NCT02052414|541323988|FG000|Overall Study|Lack of Efficacy|2|||
150049792|NCT02052414|541323988|FG000|Overall Study|Withdrawal by Subject|3|||
150049793|NCT05367492|541323994|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
150049794|NCT05367492|541323995|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
150049795|NCT05367492|541323996|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
150049796|NCT05367492|541323994|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
150049797|NCT05367492|541323995|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
150049798|NCT05367492|541323996|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
150049799|NCT05367492|541323994|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
150049800|NCT05367492|541323995|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
150049801|NCT05367492|541323996|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
150049802|NCT05367492|541323994|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
150049803|NCT05367492|541323995|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
150049804|NCT05367492|541323996|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
150049805|NCT01343693|541324005|FG000|Overall Study|Lost to Follow-up|9|||
150049806|NCT02891070|541324006|FG000|Overall Study|Adverse Event|1|||
150049807|NCT02891070|541324007|FG001|Overall Study|Adverse Event|0|||
150049808|NCT02891070|541324006|FG000|Overall Study|Physician Decision|0|||
150049809|NCT02891070|541324007|FG001|Overall Study|Physician Decision|1|||
150049810|NCT02891070|541324006|FG000|Overall Study|Lost to Follow-up|4|||
150049811|NCT02891070|541324007|FG001|Overall Study|Lost to Follow-up|4|||
150049812|NCT02891070|541324006|FG000|Overall Study|Other|1|||
150049813|NCT02891070|541324007|FG001|Overall Study|Other|0|||
150049814|NCT02891070|541324006|FG000|Overall Study|Protocol Violation|0|||
150049815|NCT02891070|541324007|FG001|Overall Study|Protocol Violation|1|||
150049816|NCT02891070|541324006|FG000|Overall Study|Withdrawal by Subject|1|||
150049817|NCT02891070|541324007|FG001|Overall Study|Withdrawal by Subject|2|||
150049818|NCT02891070|541324006|FG000|Overall Study|Death|3|||
150049819|NCT02891070|541324007|FG001|Overall Study|Death|0|||
150049820|NCT02704143|541324008|FG000|Overall Study|disease progression|10|||
150049821|NCT02888119|541324013|FG000|Overall Study|Lost to Follow-up|5|||
150049822|NCT02888119|541324014|FG001|Overall Study|Lost to Follow-up|4|||
150049823|NCT02888119|541324015|FG002|Overall Study|Lost to Follow-up|0|||
150049824|NCT01767142|541324016|FG000|Overall Study|Lost to Follow-up|3|||
150049825|NCT00926029|541324025|FG000|Overall Study|Lost to Follow-up|2|||
150049826|NCT00926029|541324026|FG001|Overall Study|Lost to Follow-up|1|||
150049827|NCT00926029|541324027|FG002|Overall Study|Lost to Follow-up|1|||
150049828|NCT02471612|541324028|FG000|Overall Study|Lost to Follow-up|2|||
150049829|NCT03206788|541324029|FG000|Overall Study|Withdrawal by Subject|0|||
150176792|NCT01787760|541783414|FG000|Overall Study|Unsatisfactory physiological response|2|||
150176793|NCT01787760|541783415|FG001|Overall Study|Unsatisfactory physiological response|4|||
150176794|NCT01787760|541783416|FG002|Overall Study|Unsatisfactory physiological response|0|||
150176795|NCT01787760|541783414|FG000|Overall Study|Unsatisfactory visual response|1|||
149910512|NCT01043705|540803880|FG002|Overall Study|Multiple Reasons|0|||
149910513|NCT01043705|540803878|FG000|Overall Study|Protocol Violation|2|||
149910514|NCT01043705|540803879|FG001|Overall Study|Protocol Violation|1|||
149910515|NCT01043705|540803880|FG002|Overall Study|Protocol Violation|0|||
149910516|NCT01043705|540803878|FG000|Overall Study|Withdrawal by Subject|8|||
149910517|NCT01043705|540803879|FG001|Overall Study|Withdrawal by Subject|6|||
149910518|NCT01043705|540803880|FG002|Overall Study|Withdrawal by Subject|0|||
149910519|NCT01043705|540803878|FG000|Overall Study|Site Closure|8|||
149910520|NCT01043705|540803879|FG001|Overall Study|Site Closure|0|||
149910521|NCT01043705|540803880|FG002|Overall Study|Site Closure|0|||
149910522|NCT01043705|540803878|FG000|Overall Study|Subsequent Procedure|9|||
149910523|NCT01043705|540803879|FG001|Overall Study|Subsequent Procedure|24|||
149910524|NCT01043705|540803880|FG002|Overall Study|Subsequent Procedure|29|||
149910525|NCT01043705|540803878|FG000|Overall Study|Adverse Event|0|||
149910526|NCT01043705|540803879|FG001|Overall Study|Adverse Event|2|||
149910527|NCT01043705|540803880|FG002|Overall Study|Adverse Event|0|||
149910528|NCT01043705|540803878|FG000|Overall Study|Screen Fail|21|||
149910529|NCT01043705|540803879|FG001|Overall Study|Screen Fail|0|||
149910530|NCT01043705|540803880|FG002|Overall Study|Screen Fail|0|||
149910531|NCT01043705|540803878|FG000|Overall Study|Other|0|||
149910532|NCT01043705|540803879|FG001|Overall Study|Other|19|||
149910533|NCT01043705|540803880|FG002|Overall Study|Other|25|||
149910534|NCT02003963|540803882|FG000|Overall Study|Lost to Follow-up|2|||
149910535|NCT02003963|540803883|FG001|Overall Study|Lost to Follow-up|1|||
149910536|NCT01801280|540803884|FG000|Period 1|Withdrawal by Subject|0|||
149910537|NCT01801280|540803885|FG001|Period 1|Withdrawal by Subject|1|||
149910538|NCT01801280|540803886|FG002|Period 1|Withdrawal by Subject|0|||
149910539|NCT01801280|540803887|FG003|Period 1|Withdrawal by Subject|0|||
149910540|NCT01801280|540803884|FG000|Period 2|Withdrawal by Subject|1|||
149910541|NCT01801280|540803885|FG001|Period 2|Withdrawal by Subject|0|||
149910542|NCT01801280|540803886|FG002|Period 2|Withdrawal by Subject|0|||
149910543|NCT01801280|540803887|FG003|Period 2|Withdrawal by Subject|0|||
150049830|NCT03206788|541324030|FG001|Overall Study|Withdrawal by Subject|1|||
150176796|NCT01787760|541783415|FG001|Overall Study|Unsatisfactory visual response|1|||
149910544|NCT01801280|540803884|FG000|Period 4|Protocol Violation|0|||
149910545|NCT01801280|540803885|FG001|Period 4|Protocol Violation|0|||
149910546|NCT01801280|540803886|FG002|Period 4|Protocol Violation|1|||
149910547|NCT01801280|540803887|FG003|Period 4|Protocol Violation|0|||
149910548|NCT00581542|540803888|FG000|Overall Study|they met an exclusion criteria|2|||
149910549|NCT00581542|540803889|FG001|Overall Study|they met an exclusion criteria|2|||
149910550|NCT00581542|540803888|FG000|Overall Study|Lost to Follow-up|9|||
149910551|NCT00581542|540803889|FG001|Overall Study|Lost to Follow-up|21|||
149910552|NCT00176644|540803890|FG000|Overall Study|Withdrawal by Subject|1|||
149910553|NCT05020366|540803891|FG000|Overall Study|Lost to Follow-up|2|||
149910554|NCT05020366|540803892|FG001|Overall Study|Lost to Follow-up|0|||
149910555|NCT05020366|540803891|FG000|Overall Study|Withdrawal by Subject|2|||
149910556|NCT05020366|540803892|FG001|Overall Study|Withdrawal by Subject|0|||
149910557|NCT05174949|540803900|FG000|Overall Study|Physician Decision|1|||
150049831|NCT03206788|541324029|FG000|Overall Study|Adverse Event|0|||
150049832|NCT03206788|541324030|FG001|Overall Study|Adverse Event|1|||
150049833|NCT03206788|541324029|FG000|Overall Study|Physician Decision|0|||
150049834|NCT03206788|541324030|FG001|Overall Study|Physician Decision|1|||
150049835|NCT00833417|541324031|FG000|Overall Study|Adverse Event|5|||
150049836|NCT00833417|541324032|FG001|Overall Study|Adverse Event|16|||
150049837|NCT00833417|541324031|FG000|Overall Study|Death|1|||
150049838|NCT00833417|541324032|FG001|Overall Study|Death|3|||
150049839|NCT00833417|541324031|FG000|Overall Study|Lost to Follow-up|1|||
150049840|NCT00833417|541324032|FG001|Overall Study|Lost to Follow-up|2|||
150049841|NCT00833417|541324031|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
150049842|NCT00833417|541324032|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
150049843|NCT00833417|541324031|FG000|Overall Study|Patient Decision to Withdraw|4|||
150049844|NCT00833417|541324032|FG001|Overall Study|Patient Decision to Withdraw|23|||
150049845|NCT00833417|541324031|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
150049846|NCT00833417|541324032|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
150049847|NCT00833417|541324031|FG000|Overall Study|Disease Progression|18|||
150049848|NCT00833417|541324032|FG001|Overall Study|Disease Progression|17|||
150049849|NCT00833417|541324031|FG000|Overall Study|Reason Not Specified|0|||
150049850|NCT00833417|541324032|FG001|Overall Study|Reason Not Specified|1|||
150049851|NCT03330002|541324033|FG000|Overall Study|Lost to Follow-up|15|||
150049852|NCT03330002|541324033|FG000|Overall Study|Death|7|||
150049853|NCT01625260|541324034|FG000|Overall Study|Adverse Event|3|||
149910558|NCT05174949|540803901|FG001|Overall Study|Physician Decision|2|||
149910559|NCT05174949|540803902|FG002|Overall Study|Physician Decision|0|||
149910560|NCT05174949|540803903|FG003|Overall Study|Physician Decision|1|||
149910561|NCT05174949|540803904|FG004|Overall Study|Physician Decision|0|||
149910562|NCT05174949|540803905|FG005|Overall Study|Physician Decision|0|||
149910563|NCT05174949|540803900|FG000|Overall Study|Withdrawal by Subject|0|||
149910564|NCT05174949|540803901|FG001|Overall Study|Withdrawal by Subject|1|||
149910565|NCT05174949|540803902|FG002|Overall Study|Withdrawal by Subject|0|||
149910566|NCT05174949|540803903|FG003|Overall Study|Withdrawal by Subject|0|||
149910567|NCT05174949|540803904|FG004|Overall Study|Withdrawal by Subject|0|||
149910568|NCT05174949|540803905|FG005|Overall Study|Withdrawal by Subject|0|||
149910569|NCT05174949|540803900|FG000|Overall Study|Lost to Follow-up|0|||
149910570|NCT05174949|540803901|FG001|Overall Study|Lost to Follow-up|0|||
149910571|NCT05174949|540803902|FG002|Overall Study|Lost to Follow-up|0|||
149910572|NCT05174949|540803903|FG003|Overall Study|Lost to Follow-up|1|||
149910573|NCT05174949|540803904|FG004|Overall Study|Lost to Follow-up|0|||
149910574|NCT05174949|540803905|FG005|Overall Study|Lost to Follow-up|0|||
149910575|NCT04351373|540803906|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
149910576|NCT01123941|540803911|FG000|Overall Study|Lost to Follow-up|2|||
149910577|NCT01123941|540803912|FG001|Overall Study|Lost to Follow-up|1|||
149910578|NCT04050124|540803915|FG000|Overall Study|Death|1|||
149910579|NCT04050124|540803916|FG001|Overall Study|Death|0|||
149910580|NCT04601103|540803919|FG000|Overall Study|Needed crown & cleaning|0|||
149910581|NCT04601103|540803920|FG001|Overall Study|Needed crown & cleaning|0|||
149910582|NCT04601103|540803921|FG002|Overall Study|Needed crown & cleaning|1|||
149910583|NCT04601103|540803919|FG000|Overall Study|study was terminated|18|||
149910584|NCT04601103|540803920|FG001|Overall Study|study was terminated|18|||
149910585|NCT04601103|540803921|FG002|Overall Study|study was terminated|16|||
149910586|NCT05083923|540803922|FG000|Overall Study|Adverse Event|2|||
149910587|NCT05083923|540803923|FG001|Overall Study|Adverse Event|0|||
149910588|NCT05083923|540803922|FG000|Overall Study|Lack of Efficacy|1|||
149910589|NCT05083923|540803923|FG001|Overall Study|Lack of Efficacy|3|||
149910590|NCT05083923|540803922|FG000|Overall Study|Withdrawal by Subject|2|||
149910591|NCT05083923|540803923|FG001|Overall Study|Withdrawal by Subject|6|||
149910592|NCT05083923|540803922|FG000|Overall Study|Reason Not Specified|0|||
149910593|NCT05083923|540803923|FG001|Overall Study|Reason Not Specified|1|||
149910594|NCT01537068|540803928|FG000|Overall Study|Lost to Follow-up|2|||
149910595|NCT01537068|540803929|FG001|Overall Study|Lost to Follow-up|1|||
149910596|NCT01537068|540803928|FG000|Overall Study|Adverse Event|0|||
149910597|NCT01537068|540803929|FG001|Overall Study|Adverse Event|1|||
149910598|NCT01537068|540803928|FG000|Overall Study|Withdrawal by Subject|1|||
149910599|NCT01537068|540803929|FG001|Overall Study|Withdrawal by Subject|1|||
149910600|NCT01537068|540803928|FG000|Overall Study|Lack of Efficacy|1|||
149910601|NCT01537068|540803929|FG001|Overall Study|Lack of Efficacy|0|||
149910602|NCT06011161|540803930|FG000|Overall Study|Withdrawal by Subject|2|||
149910603|NCT06011161|540803930|FG000|Overall Study|Lost to Follow-up|5|||
149910604|NCT04442269|540803931|FG000|Overall Study|Adverse Event|1|||
149910605|NCT04442269|540803932|FG001|Overall Study|Adverse Event|0|||
149910606|NCT04442269|540803931|FG000|Overall Study|Death|0|||
149910607|NCT04442269|540803932|FG001|Overall Study|Death|1|||
149910608|NCT04442269|540803931|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
149910609|NCT04442269|540803932|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
149910610|NCT04442269|540803931|FG000|Overall Study|Lost to Follow-up|1|||
149910611|NCT04442269|540803932|FG001|Overall Study|Lost to Follow-up|0|||
149910612|NCT04442269|540803931|FG000|Overall Study|Withdrawal by Subject|3|||
149910613|NCT04442269|540803932|FG001|Overall Study|Withdrawal by Subject|2|||
149910614|NCT04442269|540803931|FG000|Overall Study|Protocol Deviation|0|||
150049854|NCT01625260|541324035|FG001|Overall Study|Adverse Event|0|||
150049855|NCT01625260|541324034|FG000|Overall Study|Study Terminated by Investigator|2|||
150049856|NCT01625260|541324035|FG001|Overall Study|Study Terminated by Investigator|0|||
150049857|NCT01625260|541324034|FG000|Overall Study|Disease Progression|2|||
149910615|NCT04442269|540803932|FG001|Overall Study|Protocol Deviation|1|||
149910616|NCT04442269|540803931|FG000|Overall Study|Travel Limitations|1|||
149910617|NCT04442269|540803932|FG001|Overall Study|Travel Limitations|1|||
149910618|NCT03802565|540803933|FG000|Overall Study|Adverse Event|0|||
149910619|NCT03802565|540803934|FG001|Overall Study|Adverse Event|1|||
149910620|NCT03802565|540803935|FG002|Overall Study|Adverse Event|2|||
149910621|NCT03802565|540803936|FG003|Overall Study|Adverse Event|1|||
149910622|NCT03802565|540803937|FG004|Overall Study|Adverse Event|1|||
149910623|NCT03802565|540803933|FG000|Overall Study|Withdrawal by Subject|2|||
149910624|NCT03802565|540803934|FG001|Overall Study|Withdrawal by Subject|2|||
149910625|NCT03802565|540803935|FG002|Overall Study|Withdrawal by Subject|2|||
149910626|NCT03802565|540803936|FG003|Overall Study|Withdrawal by Subject|0|||
149910627|NCT03802565|540803937|FG004|Overall Study|Withdrawal by Subject|1|||
149910628|NCT03802565|540803933|FG000|Overall Study|Protocol Violation|2|||
149910629|NCT03802565|540803934|FG001|Overall Study|Protocol Violation|1|||
149910630|NCT03802565|540803935|FG002|Overall Study|Protocol Violation|4|||
149910631|NCT03802565|540803936|FG003|Overall Study|Protocol Violation|5|||
149910632|NCT03802565|540803937|FG004|Overall Study|Protocol Violation|1|||
149910633|NCT03802565|540803933|FG000|Overall Study|Lost to Follow-up|0|||
149910634|NCT03802565|540803934|FG001|Overall Study|Lost to Follow-up|0|||
149910635|NCT03802565|540803935|FG002|Overall Study|Lost to Follow-up|1|||
149910636|NCT03802565|540803936|FG003|Overall Study|Lost to Follow-up|0|||
149910637|NCT03802565|540803937|FG004|Overall Study|Lost to Follow-up|0|||
149910638|NCT03802565|540803933|FG000|Overall Study|Subjects Related to Each Other|1|||
149910639|NCT03802565|540803934|FG001|Overall Study|Subjects Related to Each Other|0|||
149910640|NCT03802565|540803935|FG002|Overall Study|Subjects Related to Each Other|0|||
149910641|NCT03802565|540803936|FG003|Overall Study|Subjects Related to Each Other|2|||
149910642|NCT03802565|540803937|FG004|Overall Study|Subjects Related to Each Other|1|||
149910643|NCT03802565|540803933|FG000|Overall Study|Elevated Enzymes|0|||
149910644|NCT03802565|540803934|FG001|Overall Study|Elevated Enzymes|0|||
149910645|NCT03802565|540803935|FG002|Overall Study|Elevated Enzymes|0|||
149910646|NCT03802565|540803936|FG003|Overall Study|Elevated Enzymes|0|||
149910647|NCT03802565|540803937|FG004|Overall Study|Elevated Enzymes|2|||
149910648|NCT00430352|540803941|FG000|Overall Study|Disease progression|58|||
149910649|NCT00430352|540803941|FG000|Overall Study|Withdrawal by Subject|11|||
149971801|NCT04583618|541033774|FG003|Overall Study|Protocol deviation|0|||
149971802|NCT04583618|541033775|FG004|Overall Study|Protocol deviation|0|||
149971803|NCT04583618|541033771|FG000|Overall Study|Withdrawal by Subject|2|||
149971804|NCT04583618|541033772|FG001|Overall Study|Withdrawal by Subject|1|||
149971805|NCT04583618|541033773|FG002|Overall Study|Withdrawal by Subject|3|||
149971806|NCT04583618|541033774|FG003|Overall Study|Withdrawal by Subject|1|||
149971807|NCT04583618|541033775|FG004|Overall Study|Withdrawal by Subject|1|||
149971808|NCT04583618|541033771|FG000|Overall Study|Lost to Follow-up|0|||
149971809|NCT04583618|541033772|FG001|Overall Study|Lost to Follow-up|1|||
149971810|NCT04583618|541033773|FG002|Overall Study|Lost to Follow-up|3|||
149971811|NCT04583618|541033774|FG003|Overall Study|Lost to Follow-up|1|||
149971812|NCT04583618|541033775|FG004|Overall Study|Lost to Follow-up|1|||
149971813|NCT00016354|541033778|FG000|Overall Study|Lack of Efficacy|0|||
149971814|NCT00016354|541033779|FG001|Overall Study|Lack of Efficacy|0|||
149971815|NCT00016354|541033780|FG002|Overall Study|Lack of Efficacy|0|||
149971816|NCT00016354|541033781|FG003|Overall Study|Lack of Efficacy|0|||
149971817|NCT00016354|541033782|FG004|Overall Study|Lack of Efficacy|0|||
149971818|NCT00016354|541033783|FG005|Overall Study|Lack of Efficacy|0|||
149971819|NCT00016354|541033784|FG006|Overall Study|Lack of Efficacy|0|||
149971820|NCT00016354|541033785|FG007|Overall Study|Lack of Efficacy|1|||
149971821|NCT03110562|541033786|FG000|Initial Treatment Period|Disease Progression|1|||
149971822|NCT03110562|541033787|FG001|Initial Treatment Period|Disease Progression|1|||
149971823|NCT03110562|541033788|FG002|Initial Treatment Period|Disease Progression|0|||
149971824|NCT03110562|541033789|FG003|Initial Treatment Period|Disease Progression|0|||
149971825|NCT03110562|541033786|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
149971826|NCT03110562|541033787|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
149971827|NCT03110562|541033788|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
149971828|NCT03110562|541033789|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
149971829|NCT03110562|541033786|FG000|Initial Treatment Period|Adverse Event|1|||
149971830|NCT03110562|541033787|FG001|Initial Treatment Period|Adverse Event|0|||
149971831|NCT03110562|541033788|FG002|Initial Treatment Period|Adverse Event|0|||
149971832|NCT03110562|541033789|FG003|Initial Treatment Period|Adverse Event|0|||
149971833|NCT03110562|541033786|FG000|Initial Treatment Period|Death|74|||
149971834|NCT03110562|541033787|FG001|Initial Treatment Period|Death|82|||
149971835|NCT03110562|541033788|FG002|Initial Treatment Period|Death|0|||
149971836|NCT03110562|541033789|FG003|Initial Treatment Period|Death|0|||
149910650|NCT00430352|540803941|FG000|Overall Study|Adverse Event|16|||
149910651|NCT00430352|540803941|FG000|Overall Study|Death|5|||
149910652|NCT00430352|540803941|FG000|Overall Study|Other|48|||
149910653|NCT03099694|540803942|FG000|Overall Study|Withdrawal by Subject|11|||
149910654|NCT03099694|540803943|FG001|Overall Study|Withdrawal by Subject|13|||
150049858|NCT01625260|541324035|FG001|Overall Study|Disease Progression|0|||
149910655|NCT03099694|540803942|FG000|Overall Study|Lost to Follow-up|9|||
149910656|NCT03099694|540803943|FG001|Overall Study|Lost to Follow-up|5|||
149910657|NCT04326439|540803944|FG000|Overall Study|Withdrawal by Subject|1|||
149910658|NCT04326439|540803945|FG001|Overall Study|Withdrawal by Subject|0|||
149910659|NCT04326439|540803944|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
149910660|NCT04326439|540803945|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
149910661|NCT04326439|540803944|FG000|Overall Study|Relapse after Induction 2|0|||
149910662|NCT04326439|540803945|FG001|Overall Study|Relapse after Induction 2|1|||
149910663|NCT04326439|540803944|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
149910664|NCT04326439|540803945|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
149910665|NCT02291601|540803948|FG000|Abdomen|Did not qualify|333|||
149910666|NCT02291601|540803949|FG001|Abdomen|Did not qualify|54|||
149910667|NCT02291601|540803950|FG002|Abdomen|Did not qualify|339|||
149910668|NCT02291601|540803948|FG000|Groin|Did not qualify|183|||
149910669|NCT02291601|540803949|FG001|Groin|Did not qualify|30|||
149910670|NCT02291601|540803950|FG002|Groin|Did not qualify|177|||
149910671|NCT01597375|540803958|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
149910672|NCT01597375|540803959|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
150049859|NCT01625260|541324034|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
150049860|NCT01625260|541324035|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
150049861|NCT03899805|541324036|FG000|Overall Study|Physician Decision|3|||
150049862|NCT03899805|541324037|FG001|Overall Study|Physician Decision|0|||
150049863|NCT03899805|541324038|FG002|Overall Study|Physician Decision|2|||
150049864|NCT03899805|541324036|FG000|Overall Study|Withdrawal by Subject|1|||
150049865|NCT03899805|541324037|FG001|Overall Study|Withdrawal by Subject|0|||
150049866|NCT03899805|541324038|FG002|Overall Study|Withdrawal by Subject|2|||
150049867|NCT03899805|541324036|FG000|Overall Study|Progressive Disease|10|||
150049868|NCT03899805|541324037|FG001|Overall Study|Progressive Disease|18|||
150049869|NCT03899805|541324038|FG002|Overall Study|Progressive Disease|12|||
150049870|NCT03899805|541324036|FG000|Overall Study|Adverse Event|3|||
150049871|NCT03899805|541324037|FG001|Overall Study|Adverse Event|1|||
149910673|NCT01597375|540803958|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
149910674|NCT01597375|540803959|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
149910675|NCT01597375|540803958|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
149910676|NCT01597375|540803959|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
149910677|NCT01597375|540803958|FG000|Washout (2 Weeks)|Adverse Event|1|||
149910678|NCT01597375|540803959|FG001|Washout (2 Weeks)|Adverse Event|0|||
149910679|NCT01597375|540803958|FG000|Second Intervention|Failed to react at both Aspirin|1|||
149910680|NCT01597375|540803959|FG001|Second Intervention|Failed to react at both Aspirin|1|||
149910681|NCT00347919|540803960|FG000|Overall Study|Lost to Follow-up|11|||
149910682|NCT00347919|540803961|FG001|Overall Study|Lost to Follow-up|13|||
149910683|NCT00347919|540803962|FG002|Overall Study|Lost to Follow-up|0|||
149910684|NCT00347919|540803960|FG000|Overall Study|Withdrawal by Subject|6|||
149910685|NCT00347919|540803961|FG001|Overall Study|Withdrawal by Subject|8|||
149910686|NCT00347919|540803962|FG002|Overall Study|Withdrawal by Subject|0|||
149971837|NCT03110562|541033786|FG000|Initial Treatment Period|Lost to Follow-up|13|||
149971838|NCT03110562|541033787|FG001|Initial Treatment Period|Lost to Follow-up|8|||
149971839|NCT03110562|541033788|FG002|Initial Treatment Period|Lost to Follow-up|0|||
149971840|NCT03110562|541033789|FG003|Initial Treatment Period|Lost to Follow-up|0|||
149971841|NCT03110562|541033786|FG000|Initial Treatment Period|Protocol Deviation|1|||
149971842|NCT03110562|541033787|FG001|Initial Treatment Period|Protocol Deviation|0|||
149971843|NCT03110562|541033788|FG002|Initial Treatment Period|Protocol Deviation|0|||
149971844|NCT03110562|541033789|FG003|Initial Treatment Period|Protocol Deviation|0|||
149971845|NCT03110562|541033786|FG000|Initial Treatment Period|Physician Decision|2|||
149971846|NCT03110562|541033787|FG001|Initial Treatment Period|Physician Decision|1|||
149971847|NCT03110562|541033788|FG002|Initial Treatment Period|Physician Decision|0|||
149971848|NCT03110562|541033789|FG003|Initial Treatment Period|Physician Decision|0|||
149971849|NCT03110562|541033786|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
149971850|NCT03110562|541033787|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
149971851|NCT03110562|541033788|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
149971852|NCT03110562|541033789|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
149971853|NCT03110562|541033786|FG000|Initial Treatment Period|Other|5|||
149971854|NCT03110562|541033787|FG001|Initial Treatment Period|Other|4|||
149971855|NCT03110562|541033788|FG002|Initial Treatment Period|Other|0|||
149971856|NCT03110562|541033789|FG003|Initial Treatment Period|Other|0|||
149971857|NCT03110562|541033786|FG000|Initial Treatment Period|Randomized but never treated|0|||
149971858|NCT03110562|541033787|FG001|Initial Treatment Period|Randomized but never treated|3|||
149971859|NCT03110562|541033788|FG002|Initial Treatment Period|Randomized but never treated|0|||
149971860|NCT03110562|541033789|FG003|Initial Treatment Period|Randomized but never treated|0|||
149971861|NCT03110562|541033786|FG000|Crossover Period|Disease Progression|0|||
149971862|NCT03110562|541033787|FG001|Crossover Period|Disease Progression|0|||
149971863|NCT03110562|541033788|FG002|Crossover Period|Disease Progression|1|||
149971864|NCT03110562|541033789|FG003|Crossover Period|Disease Progression|0|||
149971865|NCT03110562|541033786|FG000|Crossover Period|Withdrawal by Subject|0|||
149971866|NCT03110562|541033787|FG001|Crossover Period|Withdrawal by Subject|0|||
149971867|NCT03110562|541033788|FG002|Crossover Period|Withdrawal by Subject|8|||
149910687|NCT00347919|540803960|FG000|Overall Study|Physician Decision|1|||
149910688|NCT00347919|540803961|FG001|Overall Study|Physician Decision|1|||
149910689|NCT00347919|540803962|FG002|Overall Study|Physician Decision|0|||
149910690|NCT00347919|540803960|FG000|Overall Study|Sponsor terminated study|15|||
149910691|NCT00347919|540803961|FG001|Overall Study|Sponsor terminated study|10|||
149971868|NCT03110562|541033789|FG003|Crossover Period|Withdrawal by Subject|6|||
150049872|NCT03899805|541324038|FG002|Overall Study|Adverse Event|0|||
150049873|NCT03899805|541324036|FG000|Overall Study|Death|2|||
150049874|NCT03899805|541324037|FG001|Overall Study|Death|0|||
150049875|NCT03899805|541324038|FG002|Overall Study|Death|0|||
150049876|NCT03899805|541324036|FG000|Overall Study|Came off for surgery|0|||
150049877|NCT03899805|541324037|FG001|Overall Study|Came off for surgery|0|||
150049878|NCT03899805|541324038|FG002|Overall Study|Came off for surgery|1|||
150049879|NCT05246514|541324039|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
150049880|NCT05246514|541324039|FG000|Overall Study|Withdrawal by Subject|1|||
150049881|NCT05246514|541324039|FG000|Overall Study|Death|13|||
149910692|NCT00347919|540803962|FG002|Overall Study|Sponsor terminated study|16|||
149910693|NCT00347919|540803960|FG000|Overall Study|Death|35|||
149910694|NCT00347919|540803961|FG001|Overall Study|Death|42|||
149910695|NCT00347919|540803962|FG002|Overall Study|Death|19|||
149910696|NCT00347919|540803960|FG000|Overall Study|Par. Started Other Treatment|1|||
149910697|NCT00347919|540803961|FG001|Overall Study|Par. Started Other Treatment|1|||
149910698|NCT00347919|540803962|FG002|Overall Study|Par. Started Other Treatment|1|||
149910699|NCT00347919|540803960|FG000|Overall Study|Missing|2|||
149910700|NCT00347919|540803961|FG001|Overall Study|Missing|1|||
149910701|NCT00347919|540803962|FG002|Overall Study|Missing|2|||
149910702|NCT01190267|540803965|FG000|Overall Study|Adverse Event|10|||
149910703|NCT01190267|540803966|FG001|Overall Study|Adverse Event|0|||
149910704|NCT01190267|540803965|FG000|Overall Study|Treatment Failure|8|||
149910705|NCT01190267|540803966|FG001|Overall Study|Treatment Failure|2|||
149910706|NCT01190267|540803965|FG000|Overall Study|Lost to Follow-up|2|||
149910707|NCT01190267|540803966|FG001|Overall Study|Lost to Follow-up|0|||
149910708|NCT01190267|540803965|FG000|Overall Study|Withdrawal by Subject|13|||
149910709|NCT01190267|540803966|FG001|Overall Study|Withdrawal by Subject|1|||
149910710|NCT01190267|540803965|FG000|Overall Study|Protocol Violation|8|||
149910711|NCT01190267|540803966|FG001|Overall Study|Protocol Violation|1|||
149910712|NCT04017832|540803967|FG000|Overall Study|Withdrawal by Subject|13|||
149910713|NCT04017832|540803968|FG001|Overall Study|Withdrawal by Subject|12|||
149910714|NCT04017832|540803969|FG002|Overall Study|Withdrawal by Subject|21|||
149910715|NCT04017832|540803970|FG003|Overall Study|Withdrawal by Subject|7|||
149910716|NCT04017832|540803967|FG000|Overall Study|Lost to Follow-up|0|||
149910717|NCT04017832|540803968|FG001|Overall Study|Lost to Follow-up|3|||
149971869|NCT03110562|541033786|FG000|Crossover Period|Death|0|||
149971870|NCT03110562|541033787|FG001|Crossover Period|Death|0|||
149971871|NCT03110562|541033788|FG002|Crossover Period|Death|37|||
149971872|NCT03110562|541033789|FG003|Crossover Period|Death|3|||
149971873|NCT03110562|541033786|FG000|Crossover Period|Lost to Follow-up|0|||
149971874|NCT03110562|541033787|FG001|Crossover Period|Lost to Follow-up|0|||
149971875|NCT03110562|541033788|FG002|Crossover Period|Lost to Follow-up|0|||
149971876|NCT03110562|541033789|FG003|Crossover Period|Lost to Follow-up|1|||
149971877|NCT03110562|541033786|FG000|Crossover Period|Other|0|||
149971878|NCT03110562|541033787|FG001|Crossover Period|Other|0|||
149971879|NCT03110562|541033788|FG002|Crossover Period|Other|1|||
149971880|NCT03110562|541033789|FG003|Crossover Period|Other|1|||
149971881|NCT03110562|541033786|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
149971882|NCT03110562|541033787|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
149971883|NCT03110562|541033788|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
149971884|NCT03110562|541033789|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
149971885|NCT03189719|541033794|FG000|Overall Study|Death|325|||
149971886|NCT03189719|541033795|FG001|Overall Study|Death|361|||
149971887|NCT03189719|541033794|FG000|Overall Study|Physician Decision|1|||
149971888|NCT03189719|541033795|FG001|Overall Study|Physician Decision|0|||
149971889|NCT03189719|541033794|FG000|Overall Study|Sponsor Decision|40|||
150049882|NCT01802073|541324042|FG000|Overall Study|Lost to Follow-up|0|||
150049883|NCT01802073|541324043|FG001|Overall Study|Lost to Follow-up|1|||
150049884|NCT01802073|541324042|FG000|Overall Study|Non-compliant|4|||
150049885|NCT01802073|541324043|FG001|Overall Study|Non-compliant|2|||
150049886|NCT01802073|541324042|FG000|Overall Study|Withdrawal by Subject|1|||
150049887|NCT01802073|541324043|FG001|Overall Study|Withdrawal by Subject|1|||
150049888|NCT01802073|541324042|FG000|Overall Study|Physician Decision|0|||
150049889|NCT01802073|541324043|FG001|Overall Study|Physician Decision|7|||
150049890|NCT01776307|541324046|FG000|Overall Study|Not dosed|0|||
150049891|NCT01776307|541324047|FG001|Overall Study|Not dosed|0|||
150049892|NCT01776307|541324048|FG002|Overall Study|Not dosed|1|||
150049893|NCT02745145|541324051|FG000|Overall Study|Adverse Event|1|||
150049894|NCT02745145|541324052|FG001|Overall Study|Adverse Event|0|||
150049895|NCT02745145|541324053|FG002|Overall Study|Adverse Event|0|||
149910718|NCT04017832|540803969|FG002|Overall Study|Lost to Follow-up|3|||
150049896|NCT02745145|541324051|FG000|Overall Study|Death|0|||
149910719|NCT04017832|540803970|FG003|Overall Study|Lost to Follow-up|1|||
149910720|NCT04017832|540803967|FG000|Overall Study|Physician Decision|1|||
149910721|NCT04017832|540803968|FG001|Overall Study|Physician Decision|1|||
149971890|NCT03189719|541033795|FG001|Overall Study|Sponsor Decision|12|||
149971891|NCT03189719|541033794|FG000|Overall Study|Withdrawal by Subject|7|||
150049897|NCT02745145|541324052|FG001|Overall Study|Death|1|||
150049898|NCT02745145|541324053|FG002|Overall Study|Death|0|||
150049899|NCT02745145|541324051|FG000|Overall Study|Progressive disease|0|||
150049900|NCT02745145|541324052|FG001|Overall Study|Progressive disease|0|||
150049901|NCT02745145|541324053|FG002|Overall Study|Progressive disease|1|||
150049902|NCT02745145|541324051|FG000|Overall Study|Withdrew consent|1|||
150176797|NCT01787760|541783416|FG002|Overall Study|Unsatisfactory visual response|0|||
150176798|NCT01787760|541783414|FG000|Overall Study|Near vision blur|1|||
150176799|NCT01787760|541783415|FG001|Overall Study|Near vision blur|0|||
150049903|NCT02745145|541324052|FG001|Overall Study|Withdrew consent|1|||
150049904|NCT02745145|541324053|FG002|Overall Study|Withdrew consent|1|||
150049905|NCT02745145|541324051|FG000|Overall Study|Study Termination|8|||
149910722|NCT04017832|540803969|FG002|Overall Study|Physician Decision|1|||
149910723|NCT04017832|540803970|FG003|Overall Study|Physician Decision|1|||
149910724|NCT04017832|540803967|FG000|Overall Study|Death|2|||
149910725|NCT04017832|540803968|FG001|Overall Study|Death|2|||
149910726|NCT04017832|540803969|FG002|Overall Study|Death|1|||
149910727|NCT04017832|540803970|FG003|Overall Study|Death|0|||
149910728|NCT01419080|540803971|FG000|Overall Study|Withdrawal by Subject|75|||
149910729|NCT01419080|540803971|FG000|Overall Study|Death|30|||
149910730|NCT01419080|540803971|FG000|Overall Study|Lost to Follow-up|23|||
149910731|NCT01419080|540803971|FG000|Overall Study|Too Ill|3|||
149910732|NCT00794040|540803984|FG000|Overall Study|Withdrawal by Subject|3|||
149910733|NCT00794040|540803985|FG001|Overall Study|Withdrawal by Subject|4|||
149910734|NCT00794040|540803984|FG000|Overall Study|Physician Decision|0|||
149910735|NCT00794040|540803985|FG001|Overall Study|Physician Decision|1|||
149910736|NCT04696354|540803986|FG000|Overall Study|Study termination|6|||
149910737|NCT04696354|540803987|FG001|Overall Study|Study termination|6|||
149910738|NCT03005327|540803988|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
149910739|NCT03005327|540803989|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
149910740|NCT03005327|540803990|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
149910741|NCT03005327|540803991|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
149910742|NCT03005327|540803988|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149910743|NCT03005327|540803989|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149910744|NCT03005327|540803990|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149910745|NCT03005327|540803991|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149910746|NCT01263782|540803992|FG000|Overall Study|Death|0|||
149910747|NCT01263782|540803993|FG001|Overall Study|Death|0|||
149910748|NCT01263782|540803994|FG002|Overall Study|Death|1|||
149910749|NCT01263782|540803995|FG003|Overall Study|Death|0|||
149910750|NCT01263782|540803992|FG000|Overall Study|Progressive disease|0|||
149910751|NCT01263782|540803993|FG001|Overall Study|Progressive disease|0|||
149910752|NCT01263782|540803994|FG002|Overall Study|Progressive disease|0|||
149910753|NCT01263782|540803995|FG003|Overall Study|Progressive disease|1|||
149910754|NCT01263782|540803992|FG000|Overall Study|Too early|0|||
149910755|NCT01263782|540803993|FG001|Overall Study|Too early|0|||
149910756|NCT01263782|540803994|FG002|Overall Study|Too early|1|||
149910757|NCT01263782|540803995|FG003|Overall Study|Too early|0|||
149910758|NCT01263782|540803992|FG000|Overall Study|Inevaluable|0|||
149910759|NCT01263782|540803993|FG001|Overall Study|Inevaluable|0|||
149910760|NCT01263782|540803994|FG002|Overall Study|Inevaluable|1|||
149910761|NCT01263782|540803995|FG003|Overall Study|Inevaluable|0|||
149910762|NCT00915876|540803996|FG000|Overall Study|Adverse Event|0|||
149910763|NCT00915876|540803997|FG001|Overall Study|Adverse Event|1|||
149910764|NCT04545567|540804001|FG000|Overall Study|tested positive for SARS-co-V2|1|||
149910765|NCT04545567|540804002|FG001|Overall Study|tested positive for SARS-co-V2|1|||
149910766|NCT04545567|540804001|FG000|Overall Study|Withdrawal by Subject|0|||
149910767|NCT04545567|540804002|FG001|Overall Study|Withdrawal by Subject|1|||
149910768|NCT02419612|540804006|FG000|Short-term Treatment Period|Adverse Event|1|||
149910769|NCT02419612|540804007|FG001|Short-term Treatment Period|Adverse Event|1|||
150049906|NCT02745145|541324052|FG001|Overall Study|Study Termination|3|||
150049907|NCT02745145|541324053|FG002|Overall Study|Study Termination|7|||
150049908|NCT03083990|541324054|FG000|Overall Study|Adverse Event|1|||
150176800|NCT01787760|541783416|FG002|Overall Study|Near vision blur|0|||
149910770|NCT02419612|540804006|FG000|Short-term Treatment Period|Death|0|||
150049909|NCT03083990|541324055|FG001|Overall Study|Adverse Event|0|||
150049910|NCT01018810|541324056|FG000|Overall Study|Withdrawal by Subject|0|||
150049911|NCT01018810|541324057|FG001|Overall Study|Withdrawal by Subject|1|||
150049912|NCT01018810|541324058|FG002|Overall Study|Withdrawal by Subject|0|||
150049913|NCT01018810|541324059|FG003|Overall Study|Withdrawal by Subject|0|||
150176801|NCT03512756|541783417|FG000|Part 1|Death|23|||
149910771|NCT02419612|540804007|FG001|Short-term Treatment Period|Death|2|||
149910772|NCT02419612|540804006|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
149910773|NCT02419612|540804007|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
149910774|NCT02419612|540804006|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
149910775|NCT02419612|540804007|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
149910776|NCT02419612|540804006|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
149910777|NCT02419612|540804007|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
149910778|NCT02419612|540804006|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
149910779|NCT02419612|540804007|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
150049914|NCT01018810|541324060|FG004|Overall Study|Withdrawal by Subject|0|||
150049915|NCT01018810|541324056|FG000|Overall Study|Sponsor Decision|2|||
150049916|NCT01018810|541324057|FG001|Overall Study|Sponsor Decision|0|||
150049917|NCT01018810|541324058|FG002|Overall Study|Sponsor Decision|1|||
149910780|NCT02419612|540804006|FG000|Short-term Treatment Period|Worsening of liver function|0|||
149910781|NCT02419612|540804007|FG001|Short-term Treatment Period|Worsening of liver function|1|||
149910782|NCT02419612|540804006|FG000|Short-term Treatment Period|Subject moved out of state|0|||
149910783|NCT02419612|540804007|FG001|Short-term Treatment Period|Subject moved out of state|1|||
149910784|NCT02419612|540804006|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
149910785|NCT02419612|540804007|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
149910786|NCT02419612|540804006|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
149910787|NCT02419612|540804007|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
149910788|NCT02419612|540804006|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
149910789|NCT02419612|540804007|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
149910790|NCT02419612|540804006|FG000|Long-term Treatment Period|Death|0|||
149910791|NCT02419612|540804007|FG001|Long-term Treatment Period|Death|1|||
149910792|NCT02419612|540804006|FG000|Long-term Treatment Period|Adverse Event|0|||
149910793|NCT02419612|540804007|FG001|Long-term Treatment Period|Adverse Event|5|||
149910794|NCT02419612|540804006|FG000|Long-term Treatment Period|Other|4|||
149910795|NCT02419612|540804007|FG001|Long-term Treatment Period|Other|4|||
149910796|NCT02419612|540804006|FG000|Long-term Treatment Period|Subject Decision|2|||
149971892|NCT03189719|541033795|FG001|Overall Study|Withdrawal by Subject|3|||
149971893|NCT03012880|541033796|FG000|Overall Study|Withdrawal by Subject|1|||
149971894|NCT03012880|541033797|FG001|Overall Study|Withdrawal by Subject|0|||
149971895|NCT03012880|541033796|FG000|Overall Study|Ineligible|1|||
149971896|NCT03012880|541033797|FG001|Overall Study|Ineligible|0|||
149971897|NCT01355627|541033798|FG000|Overall Study|Request By the Patient to Discontinue|5|||
149971898|NCT01355627|541033799|FG001|Overall Study|Request By the Patient to Discontinue|7|||
149971899|NCT01355627|541033798|FG000|Overall Study|Lost to Follow-up|8|||
149971900|NCT01355627|541033799|FG001|Overall Study|Lost to Follow-up|7|||
149971901|NCT01355627|541033798|FG000|Overall Study|Fatal Adverse Event|19|||
149971902|NCT01355627|541033799|FG001|Overall Study|Fatal Adverse Event|23|||
149971903|NCT01355627|541033798|FG000|Overall Study|Other|1|||
149971904|NCT01355627|541033799|FG001|Overall Study|Other|1|||
149971905|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
150176802|NCT03512756|541783418|FG001|Part 1|Death|18|||
150176803|NCT03512756|541783419|FG002|Part 1|Death|0|||
150176804|NCT03512756|541783420|FG003|Part 1|Death|0|||
150176805|NCT03512756|541783417|FG000|Part 1|Lost to Follow-up|0|||
150176806|NCT03512756|541783418|FG001|Part 1|Lost to Follow-up|3|||
150176807|NCT03512756|541783419|FG002|Part 1|Lost to Follow-up|0|||
150176808|NCT03512756|541783420|FG003|Part 1|Lost to Follow-up|0|||
150176809|NCT03512756|541783417|FG000|Part 1|Physician Decision|0|||
150176810|NCT03512756|541783418|FG001|Part 1|Physician Decision|1|||
150176811|NCT03512756|541783419|FG002|Part 1|Physician Decision|0|||
150176812|NCT03512756|541783420|FG003|Part 1|Physician Decision|0|||
150176813|NCT03512756|541783417|FG000|Part 1|Withdrawal by Subject|2|||
150176814|NCT03512756|541783418|FG001|Part 1|Withdrawal by Subject|2|||
150176815|NCT03512756|541783419|FG002|Part 1|Withdrawal by Subject|0|||
150176816|NCT03512756|541783420|FG003|Part 1|Withdrawal by Subject|0|||
150176817|NCT03512756|541783417|FG000|Part 2|Death|0|||
150176818|NCT03512756|541783418|FG001|Part 2|Death|0|||
150176819|NCT03512756|541783419|FG002|Part 2|Death|32|||
150176820|NCT03512756|541783420|FG003|Part 2|Death|21|||
150176821|NCT03512756|541783417|FG000|Part 2|Lost to Follow-up|0|||
150176822|NCT03512756|541783418|FG001|Part 2|Lost to Follow-up|0|||
150176823|NCT03512756|541783419|FG002|Part 2|Lost to Follow-up|1|||
150176824|NCT03512756|541783420|FG003|Part 2|Lost to Follow-up|0|||
149910797|NCT02419612|540804007|FG001|Long-term Treatment Period|Subject Decision|4|||
149910798|NCT02419612|540804006|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
149910799|NCT02419612|540804007|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
149971906|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
149910800|NCT00533702|540804008|FG000|Overall Study|Withdrawal by Subject|3|||
149910801|NCT00533702|540804009|FG001|Overall Study|Withdrawal by Subject|1|||
149971907|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
150176825|NCT03512756|541783417|FG000|Part 2|Physician Decision|0|||
150176826|NCT03512756|541783418|FG001|Part 2|Physician Decision|0|||
150176827|NCT03512756|541783419|FG002|Part 2|Physician Decision|2|||
149910802|NCT00533702|540804008|FG000|Overall Study|Found ineligible after randomization|2|||
149910803|NCT00533702|540804009|FG001|Overall Study|Found ineligible after randomization|1|||
149971908|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
150176828|NCT03512756|541783420|FG003|Part 2|Physician Decision|4|||
150176829|NCT03512756|541783417|FG000|Part 2|Study Terminated by Sponsor|0|||
150176830|NCT03512756|541783418|FG001|Part 2|Study Terminated by Sponsor|0|||
150176831|NCT03512756|541783419|FG002|Part 2|Study Terminated by Sponsor|2|||
150176832|NCT03512756|541783420|FG003|Part 2|Study Terminated by Sponsor|6|||
150176833|NCT03512756|541783417|FG000|Part 2|Protocol Violation|0|||
150176834|NCT03512756|541783418|FG001|Part 2|Protocol Violation|0|||
150049918|NCT01018810|541324059|FG003|Overall Study|Sponsor Decision|1|||
150049919|NCT01018810|541324060|FG004|Overall Study|Sponsor Decision|1|||
149910804|NCT01095978|540804010|FG000|Overall Study|Did not take Klacid SR|2|||
149910805|NCT01095978|540804010|FG000|Overall Study|Adverse Event|1|||
149910806|NCT00965341|540804011|FG000|Overall Study|Withdrew consent|1|||
149910807|NCT00965341|540804012|FG001|Overall Study|Withdrew consent|5|||
149910808|NCT00965341|540804011|FG000|Overall Study|Lost to Follow-up|1|||
149910809|NCT00965341|540804012|FG001|Overall Study|Lost to Follow-up|0|||
149910810|NCT00965341|540804011|FG000|Overall Study|Transportation issues|4|||
149910811|NCT00965341|540804012|FG001|Overall Study|Transportation issues|3|||
149910812|NCT04413552|540804018|FG000|Overall Study|Adverse Event|0|||
149910813|NCT04413552|540804019|FG001|Overall Study|Adverse Event|0|||
149910814|NCT04413552|540804020|FG002|Overall Study|Adverse Event|0|||
149910815|NCT04413552|540804021|FG003|Overall Study|Adverse Event|0|||
149910816|NCT04413552|540804022|FG004|Overall Study|Adverse Event|0|||
149910817|NCT04413552|540804023|FG005|Overall Study|Adverse Event|0|||
149910818|NCT04413552|540804024|FG006|Overall Study|Adverse Event|1|||
149910819|NCT04413552|540804025|FG007|Overall Study|Adverse Event|0|||
149910820|NCT04413552|540804026|FG008|Overall Study|Adverse Event|0|||
149910821|NCT04413552|540804027|FG009|Overall Study|Adverse Event|0|||
150049920|NCT02424578|541324061|FG000|Overall Study|Withdrawal by Subject|0|||
150049921|NCT02424578|541324062|FG001|Overall Study|Withdrawal by Subject|1|||
150049922|NCT02872935|541324067|FG000|Overall Study|Other|0|||
150049923|NCT02872935|541324068|FG001|Overall Study|Other|1|||
150049924|NCT05343624|541324069|FG000|Overall Study|Chart review not completed|1|||
150049925|NCT00862082|541324070|FG000|Overall Study|Sponsor decision to terminate the study|5|||
150049926|NCT00862082|541324071|FG001|Overall Study|Sponsor decision to terminate the study|0|||
150049927|NCT00862082|541324070|FG000|Overall Study|Withdrawal by Subject|0|||
150049928|NCT00862082|541324071|FG001|Overall Study|Withdrawal by Subject|1|||
149910822|NCT01794793|540804030|FG000|Treatment Period|Withdrawal by Subject|24|||
150049929|NCT05405257|541324072|FG000|Overall Study|Withdrawal by Subject|1|||
150049930|NCT00916929|541324075|FG000|Overall Study|Lost to Follow-up|1|||
150049931|NCT00916929|541324076|FG001|Overall Study|Lost to Follow-up|3|||
150049932|NCT00916929|541324075|FG000|Overall Study|Death|5|||
150049933|NCT00916929|541324076|FG001|Overall Study|Death|10|||
150049934|NCT00916929|541324075|FG000|Overall Study|Withdrawal by Subject|1|||
150049935|NCT00916929|541324076|FG001|Overall Study|Withdrawal by Subject|5|||
150049936|NCT00916929|541324075|FG000|Overall Study|Left ventricular epicardial lead|1|||
150049937|NCT00916929|541324076|FG001|Overall Study|Left ventricular epicardial lead|2|||
150049938|NCT00916929|541324075|FG000|Overall Study|Transferred to hospice care|1|||
150049939|NCT00916929|541324076|FG001|Overall Study|Transferred to hospice care|1|||
149910823|NCT01794793|540804030|FG000|Treatment Period|Lack of Efficacy|22|||
150049940|NCT00916929|541324075|FG000|Overall Study|System explant|1|||
150049941|NCT00916929|541324076|FG001|Overall Study|System explant|0|||
150049942|NCT00916929|541324075|FG000|Overall Study|Moved to another state|0|||
150049943|NCT00916929|541324076|FG001|Overall Study|Moved to another state|1|||
150049944|NCT00916929|541324075|FG000|Overall Study|Device unable to process impedance data|0|||
150049945|NCT00916929|541324076|FG001|Overall Study|Device unable to process impedance data|7|||
149910824|NCT01794793|540804030|FG000|Treatment Period|Adverse Event|17|||
149910825|NCT01794793|540804030|FG000|Treatment Period|Physician Decision|14|||
150049946|NCT00782834|541324082|FG000|Treatment Phase|fibrous tumor not GIST|1|||
150049947|NCT02055118|541324083|FG000|Overall Study|Withdrawal by Subject|0|||
150049948|NCT02055118|541324084|FG001|Overall Study|Withdrawal by Subject|2|||
150049949|NCT02055118|541324085|FG002|Overall Study|Withdrawal by Subject|0|||
150049950|NCT02560025|541324092|FG000|Overall Study|Ineligible after consent/ registration|3|||
150049951|NCT02703337|541324093|FG000|Period One (Part A)|Withdrawal by Subject|0|||
150049952|NCT02703337|541324094|FG001|Period One (Part A)|Withdrawal by Subject|0|||
150049953|NCT02703337|541324095|FG002|Period One (Part A)|Withdrawal by Subject|0|||
150049954|NCT02703337|541324096|FG003|Period One (Part A)|Withdrawal by Subject|0|||
150049955|NCT02703337|541324097|FG004|Period One (Part A)|Withdrawal by Subject|1|||
150049956|NCT02703337|541324098|FG005|Period One (Part A)|Withdrawal by Subject|0|||
150049957|NCT02703337|541324099|FG006|Period One (Part A)|Withdrawal by Subject|0|||
149910826|NCT01794793|540804030|FG000|Treatment Period|Lost to Follow-up|7|||
150049958|NCT02703337|541324100|FG007|Period One (Part A)|Withdrawal by Subject|0|||
150049959|NCT02745080|541324107|FG000|Overall Study|Adverse Event|13|||
150049960|NCT02745080|541324108|FG001|Overall Study|Adverse Event|21|||
150049961|NCT02745080|541324107|FG000|Overall Study|Lack of Efficacy|11|||
150049962|NCT02745080|541324108|FG001|Overall Study|Lack of Efficacy|23|||
150049963|NCT02745080|541324107|FG000|Overall Study|Lost to Follow-up|3|||
150049964|NCT02745080|541324108|FG001|Overall Study|Lost to Follow-up|3|||
150049965|NCT02745080|541324107|FG000|Overall Study|Physician Decision|3|||
150049966|NCT02745080|541324108|FG001|Overall Study|Physician Decision|0|||
150049967|NCT02745080|541324107|FG000|Overall Study|Protocol Violation|3|||
149910827|NCT01794793|540804030|FG000|Treatment Period|Death|6|||
149910828|NCT01794793|540804030|FG000|Treatment Period|Protocol Violation|5|||
149910829|NCT01794793|540804030|FG000|Treatment Period|administrative problem|3|||
150049968|NCT02745080|541324108|FG001|Overall Study|Protocol Violation|1|||
149910830|NCT01794793|540804030|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
149910831|NCT01794793|540804030|FG000|Post-treatment Follow-up|Adverse Event|8|||
149910832|NCT01794793|540804030|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
149910833|NCT01794793|540804030|FG000|Post-treatment Follow-up|administrative problem|5|||
149910834|NCT01794793|540804030|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
149910835|NCT01794793|540804030|FG000|Post-treatment Follow-up|Protocol Violation|3|||
149910836|NCT02417961|540805627|FG000|Overall Study|Adverse Event|1|||
149910837|NCT02417961|540805627|FG000|Overall Study|Lost to Follow-up|1|||
149910838|NCT02417961|540805627|FG000|Overall Study|Withdrawal by Subject|2|||
149910839|NCT05079750|540805628|FG000|Overall Study|Lost to Follow-up|0|||
149910840|NCT05079750|540805629|FG001|Overall Study|Lost to Follow-up|0|||
149910841|NCT05079750|540805630|FG002|Overall Study|Lost to Follow-up|1|||
149910842|NCT05091346|540805631|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
149910843|NCT05091346|540805632|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
149910844|NCT05091346|540805633|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
149910845|NCT05091346|540805634|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
149910846|NCT05091346|540805635|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
149910847|NCT05091346|540805631|FG000|Overall Study|Death|6|||
149910848|NCT05091346|540805632|FG001|Overall Study|Death|5|||
149910849|NCT05091346|540805633|FG002|Overall Study|Death|8|||
149910850|NCT05091346|540805634|FG003|Overall Study|Death|16|||
149910851|NCT05091346|540805635|FG004|Overall Study|Death|26|||
149910852|NCT05091346|540805631|FG000|Overall Study|Lost to Follow-up|0|||
149910853|NCT05091346|540805632|FG001|Overall Study|Lost to Follow-up|0|||
149910854|NCT05091346|540805633|FG002|Overall Study|Lost to Follow-up|0|||
149910855|NCT05091346|540805634|FG003|Overall Study|Lost to Follow-up|1|||
149910856|NCT05091346|540805635|FG004|Overall Study|Lost to Follow-up|0|||
149910857|NCT05091346|540805631|FG000|Overall Study|Withdrawal by Subject|0|||
149910858|NCT05091346|540805632|FG001|Overall Study|Withdrawal by Subject|1|||
149910859|NCT05091346|540805633|FG002|Overall Study|Withdrawal by Subject|2|||
149910860|NCT05091346|540805634|FG003|Overall Study|Withdrawal by Subject|2|||
149910861|NCT05091346|540805635|FG004|Overall Study|Withdrawal by Subject|1|||
149910862|NCT03036098|540805636|FG000|Pre-Treatment|Other Reasons|1|||
149910863|NCT03036098|540805637|FG001|Pre-Treatment|Other Reasons|2|||
149910864|NCT03036098|540805638|FG002|Pre-Treatment|Other Reasons|0|||
149910865|NCT03036098|540805639|FG003|Pre-Treatment|Other Reasons|5|||
149910866|NCT03036098|540805636|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
149910867|NCT03036098|540805637|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
149910868|NCT03036098|540805638|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
149910869|NCT03036098|540805639|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
149910870|NCT03036098|540805636|FG000|Pre-Treatment|Withdrawal by Subject|1|||
149910871|NCT03036098|540805637|FG001|Pre-Treatment|Withdrawal by Subject|14|||
149910872|NCT03036098|540805638|FG002|Pre-Treatment|Withdrawal by Subject|0|||
149910873|NCT03036098|540805639|FG003|Pre-Treatment|Withdrawal by Subject|5|||
149910874|NCT03036098|540805636|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
149910875|NCT03036098|540805637|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
149910876|NCT03036098|540805638|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
149910877|NCT03036098|540805639|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
149910878|NCT03036098|540805636|FG000|Treatment|Disease Progression|130|||
149910879|NCT03036098|540805637|FG001|Treatment|Disease Progression|77|||
149910880|NCT03036098|540805638|FG002|Treatment|Disease Progression|168|||
149910881|NCT03036098|540805639|FG003|Treatment|Disease Progression|50|||
149971909|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
149971910|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
149971911|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
149971912|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
149971913|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
149971914|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
149971915|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
149971916|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
149971917|NCT04532749|541033800|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
149971918|NCT04532749|541033801|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
149971919|NCT04532749|541033800|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
149971920|NCT04532749|541033801|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
149971921|NCT04532749|541033800|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
149971922|NCT04532749|541033801|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
149971923|NCT04532749|541033800|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
149971924|NCT04532749|541033801|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
149971925|NCT04756531|541033802|FG000|Overall Study|Adverse Event|0|||
149971926|NCT04756531|541033803|FG001|Overall Study|Adverse Event|0|||
149971927|NCT04756531|541033804|FG002|Overall Study|Adverse Event|0|||
149971928|NCT04756531|541033805|FG003|Overall Study|Adverse Event|0|||
149971929|NCT04756531|541033806|FG004|Overall Study|Adverse Event|1|||
149910882|NCT03036098|540805636|FG000|Treatment|Study Drug Toxicity|95|||
149910883|NCT03036098|540805637|FG001|Treatment|Study Drug Toxicity|45|||
149910884|NCT03036098|540805638|FG002|Treatment|Study Drug Toxicity|26|||
150049969|NCT02745080|541324107|FG000|Overall Study|Withdrawal by Subject|22|||
150049970|NCT02745080|541324108|FG001|Overall Study|Withdrawal by Subject|41|||
149910885|NCT03036098|540805639|FG003|Treatment|Study Drug Toxicity|22|||
149910886|NCT03036098|540805636|FG000|Treatment|Death|9|||
149910887|NCT03036098|540805637|FG001|Treatment|Death|3|||
149910888|NCT03036098|540805638|FG002|Treatment|Death|1|||
149910889|NCT03036098|540805639|FG003|Treatment|Death|2|||
149910890|NCT03036098|540805636|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
149910891|NCT03036098|540805637|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
149910892|NCT03036098|540805638|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
149910893|NCT03036098|540805639|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
149910894|NCT03036098|540805636|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
149910895|NCT03036098|540805637|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
149910896|NCT03036098|540805638|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
149910897|NCT03036098|540805639|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
149910898|NCT03036098|540805636|FG000|Treatment|Withdrawal by Subject|2|||
149910899|NCT03036098|540805637|FG001|Treatment|Withdrawal by Subject|9|||
149910900|NCT03036098|540805638|FG002|Treatment|Withdrawal by Subject|2|||
150049971|NCT00282308|541324109|FG000|Treatment Period|Lost to Follow-up|1|||
150049972|NCT00282308|541324110|FG001|Treatment Period|Lost to Follow-up|0|||
150049973|NCT00282308|541324111|FG002|Treatment Period|Lost to Follow-up|0|||
150049974|NCT00282308|541324109|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
150049975|NCT00282308|541324110|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
150049976|NCT00282308|541324111|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
150049977|NCT00282308|541324109|FG000|Treatment Period|Adverse Event|0|||
150049978|NCT00282308|541324110|FG001|Treatment Period|Adverse Event|2|||
149910901|NCT03036098|540805639|FG003|Treatment|Withdrawal by Subject|4|||
149910902|NCT03036098|540805636|FG000|Treatment|Maximum Clinical Benefit|6|||
149910903|NCT03036098|540805637|FG001|Treatment|Maximum Clinical Benefit|1|||
149910904|NCT03036098|540805638|FG002|Treatment|Maximum Clinical Benefit|6|||
149910905|NCT03036098|540805639|FG003|Treatment|Maximum Clinical Benefit|10|||
149910906|NCT03036098|540805636|FG000|Treatment|Poor/Non Compliance|1|||
149910907|NCT03036098|540805637|FG001|Treatment|Poor/Non Compliance|2|||
149910908|NCT03036098|540805638|FG002|Treatment|Poor/Non Compliance|0|||
149910909|NCT03036098|540805639|FG003|Treatment|Poor/Non Compliance|1|||
149910910|NCT03036098|540805636|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
149910911|NCT03036098|540805637|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
149971930|NCT04756531|541033807|FG005|Overall Study|Adverse Event|0|||
149971931|NCT04756531|541033808|FG006|Overall Study|Adverse Event|0|||
149971932|NCT04756531|541033809|FG007|Overall Study|Adverse Event|0|||
149971933|NCT04756531|541033810|FG008|Overall Study|Adverse Event|0|||
149971934|NCT04756531|541033811|FG009|Overall Study|Adverse Event|0|||
149971935|NCT04756531|541033812|FG010|Overall Study|Adverse Event|0|||
149971936|NCT04756531|541033813|FG011|Overall Study|Adverse Event|0|||
149971937|NCT04756531|541033814|FG012|Overall Study|Adverse Event|0|||
149971938|NCT04756531|541033815|FG013|Overall Study|Adverse Event|0|||
149971939|NCT04756531|541033816|FG014|Overall Study|Adverse Event|0|||
149971940|NCT04756531|541033817|FG015|Overall Study|Adverse Event|0|||
149971941|NCT04756531|541033818|FG016|Overall Study|Adverse Event|0|||
149971942|NCT04756531|541033819|FG017|Overall Study|Adverse Event|0|||
149971943|NCT04756531|541033802|FG000|Overall Study|Withdrawal by Subject|0|||
149971944|NCT04756531|541033803|FG001|Overall Study|Withdrawal by Subject|0|||
149971945|NCT04756531|541033804|FG002|Overall Study|Withdrawal by Subject|0|||
149971946|NCT04756531|541033805|FG003|Overall Study|Withdrawal by Subject|0|||
149971947|NCT04756531|541033806|FG004|Overall Study|Withdrawal by Subject|0|||
149971948|NCT04756531|541033807|FG005|Overall Study|Withdrawal by Subject|0|||
149971949|NCT04756531|541033808|FG006|Overall Study|Withdrawal by Subject|1|||
149971950|NCT04756531|541033809|FG007|Overall Study|Withdrawal by Subject|0|||
149971951|NCT04756531|541033810|FG008|Overall Study|Withdrawal by Subject|0|||
149971952|NCT04756531|541033811|FG009|Overall Study|Withdrawal by Subject|0|||
149971953|NCT04756531|541033812|FG010|Overall Study|Withdrawal by Subject|0|||
149971954|NCT04756531|541033813|FG011|Overall Study|Withdrawal by Subject|0|||
149971955|NCT04756531|541033814|FG012|Overall Study|Withdrawal by Subject|0|||
149971956|NCT04756531|541033815|FG013|Overall Study|Withdrawal by Subject|0|||
149971957|NCT04756531|541033816|FG014|Overall Study|Withdrawal by Subject|0|||
149971958|NCT04756531|541033817|FG015|Overall Study|Withdrawal by Subject|0|||
149971959|NCT04756531|541033818|FG016|Overall Study|Withdrawal by Subject|0|||
149971960|NCT04756531|541033819|FG017|Overall Study|Withdrawal by Subject|0|||
149971961|NCT05239221|541033820|FG000|Overall Study|Adverse Event|0|||
149971962|NCT05239221|541033821|FG001|Overall Study|Adverse Event|0|||
149971963|NCT05239221|541033822|FG002|Overall Study|Adverse Event|0|||
150049979|NCT00282308|541324111|FG002|Treatment Period|Adverse Event|0|||
150049980|NCT00282308|541324109|FG000|Treatment Period|Not Treated with Study Drug|1|||
149910912|NCT03036098|540805638|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
149910913|NCT03036098|540805639|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
149910914|NCT03036098|540805636|FG000|Treatment|Administrative Reason by Sponsor|1|||
149910915|NCT03036098|540805637|FG001|Treatment|Administrative Reason by Sponsor|0|||
149910916|NCT03036098|540805638|FG002|Treatment|Administrative Reason by Sponsor|2|||
149910917|NCT03036098|540805639|FG003|Treatment|Administrative Reason by Sponsor|1|||
149910918|NCT03036098|540805636|FG000|Treatment|Other Reasons|31|||
149910919|NCT03036098|540805637|FG001|Treatment|Other Reasons|5|||
149910920|NCT03036098|540805638|FG002|Treatment|Other Reasons|21|||
149910921|NCT03036098|540805639|FG003|Treatment|Other Reasons|8|||
149910922|NCT03036098|540805636|FG000|Treatment|Ongoing Treatment|0|||
149910923|NCT03036098|540805637|FG001|Treatment|Ongoing Treatment|0|||
149910924|NCT03036098|540805638|FG002|Treatment|Ongoing Treatment|23|||
149910925|NCT03036098|540805639|FG003|Treatment|Ongoing Treatment|0|||
149910926|NCT01632904|540805640|FG000|Overall Study|Adverse Event|4|||
149910927|NCT01632904|540805641|FG001|Overall Study|Adverse Event|1|||
149910928|NCT01632904|540805640|FG000|Overall Study|Physician Decision|0|||
149910929|NCT01632904|540805641|FG001|Overall Study|Physician Decision|1|||
149910930|NCT01632904|540805640|FG000|Overall Study|Subject decision|3|||
149910931|NCT01632904|540805641|FG001|Overall Study|Subject decision|2|||
149910932|NCT01632904|540805640|FG000|Overall Study|Disease Progression|0|||
149910933|NCT01632904|540805641|FG001|Overall Study|Disease Progression|1|||
149910934|NCT01632904|540805640|FG000|Overall Study|Reason for discontinuation not available|0|||
149910935|NCT01632904|540805641|FG001|Overall Study|Reason for discontinuation not available|1|||
149910936|NCT04542499|540805646|FG000|Overall Study|Adverse Event|23|||
149910937|NCT04542499|540805647|FG001|Overall Study|Adverse Event|43|||
149910938|NCT04542499|540805646|FG000|Overall Study|Lack of Efficacy|5|||
149910939|NCT04542499|540805647|FG001|Overall Study|Lack of Efficacy|2|||
150049981|NCT00282308|541324110|FG001|Treatment Period|Not Treated with Study Drug|0|||
150049982|NCT00282308|541324111|FG002|Treatment Period|Not Treated with Study Drug|0|||
150176835|NCT03512756|541783419|FG002|Part 2|Protocol Violation|1|||
150176836|NCT03512756|541783420|FG003|Part 2|Protocol Violation|0|||
150176837|NCT03512756|541783417|FG000|Part 2|Withdrawal by Subject|0|||
150176838|NCT03512756|541783418|FG001|Part 2|Withdrawal by Subject|0|||
150176839|NCT03512756|541783419|FG002|Part 2|Withdrawal by Subject|3|||
150176840|NCT03512756|541783420|FG003|Part 2|Withdrawal by Subject|9|||
150176841|NCT01597258|541783421|FG000|Overall Study|No Drug Administration|1|||
150176842|NCT00933400|541783422|FG000|Overall Study|Withdrawal by Subject|21|||
150176843|NCT00933400|541783423|FG001|Overall Study|Withdrawal by Subject|1|||
150176844|NCT01764464|541783424|FG000|First Intervention|Withdrawal by Subject|1|||
150176845|NCT01764464|541783425|FG001|First Intervention|Withdrawal by Subject|0|||
150176846|NCT01764464|541783424|FG000|First Intervention|Lost to Follow-up|1|||
150176847|NCT01764464|541783425|FG001|First Intervention|Lost to Follow-up|0|||
150176848|NCT01764464|541783424|FG000|First Intervention|Adverse Event|0|||
150176849|NCT01764464|541783425|FG001|First Intervention|Adverse Event|2|||
150176850|NCT01764464|541783424|FG000|First Intervention|did not receive study drug|0|||
150176851|NCT01764464|541783425|FG001|First Intervention|did not receive study drug|1|||
150176852|NCT01764464|541783424|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
150176853|NCT01764464|541783425|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
150176854|NCT02079844|541783426|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
150176855|NCT02079844|541783427|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
150176856|NCT02079844|541783428|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
150176857|NCT02079844|541783426|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
150176858|NCT02079844|541783427|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
150176859|NCT02079844|541783428|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
150176860|NCT03936660|541784644|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
150049983|NCT00282308|541324109|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
150049984|NCT00282308|541324110|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
150049985|NCT00282308|541324111|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
150049986|NCT00282308|541324109|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
150049987|NCT00282308|541324110|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
150049988|NCT00282308|541324111|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
150049989|NCT00282308|541324109|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
150049990|NCT00282308|541324110|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
150049991|NCT00282308|541324111|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
150049992|NCT00282308|541324109|FG000|Safety Follow-up Period|Adverse Event|0|||
150049993|NCT00282308|541324110|FG001|Safety Follow-up Period|Adverse Event|0|||
150049994|NCT00282308|541324111|FG002|Safety Follow-up Period|Adverse Event|1|||
150049995|NCT00282308|541324109|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
150049996|NCT00282308|541324110|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
150049997|NCT00282308|541324111|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
150049998|NCT00282308|541324109|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
150049999|NCT00282308|541324110|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
150050000|NCT00282308|541324111|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
150050001|NCT00282308|541324109|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
150050002|NCT00282308|541324110|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
150050003|NCT00282308|541324111|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
150050004|NCT01001325|541324114|FG000|Overall Study|Lost to Follow-up|16|||
150050005|NCT01001325|541324115|FG001|Overall Study|Lost to Follow-up|10|||
150050006|NCT01001325|541324114|FG000|Overall Study|Protocol Violation|2|||
150050007|NCT01001325|541324115|FG001|Overall Study|Protocol Violation|0|||
150050008|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
150050009|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
150050010|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
150050011|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
150050012|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
150050013|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
150050014|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
150050015|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
150050016|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
150050017|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
150176861|NCT03936660|541784645|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
150050018|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
150176862|NCT00840177|541784648|FG000|Overall Study|Adverse Event|5|||
150176863|NCT00840177|541784649|FG001|Overall Study|Adverse Event|1|||
150050019|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
150050020|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
150176864|NCT00840177|541784650|FG002|Overall Study|Adverse Event|1|||
149910940|NCT04542499|540805646|FG000|Overall Study|Lost to Follow-up|3|||
149910941|NCT04542499|540805647|FG001|Overall Study|Lost to Follow-up|4|||
149910942|NCT04542499|540805646|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
149910943|NCT04542499|540805647|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
149910944|NCT04542499|540805646|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
149910945|NCT04542499|540805647|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
149910946|NCT04542499|540805646|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149910947|NCT04542499|540805647|FG001|Overall Study|Non-Compliance with Study Drug|2|||
149910948|NCT04542499|540805646|FG000|Overall Study|Physician Decision|0|||
149910949|NCT04542499|540805647|FG001|Overall Study|Physician Decision|1|||
149910950|NCT04542499|540805646|FG000|Overall Study|Site Terminated by Sponsor|3|||
149910951|NCT04542499|540805647|FG001|Overall Study|Site Terminated by Sponsor|5|||
149910952|NCT04542499|540805646|FG000|Overall Study|Withdrawal by Subject|12|||
149910953|NCT04542499|540805647|FG001|Overall Study|Withdrawal by Subject|33|||
149910954|NCT04542499|540805646|FG000|Overall Study|Other|2|||
149910955|NCT04542499|540805647|FG001|Overall Study|Other|2|||
149910956|NCT04035434|540805653|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910957|NCT04035434|540805654|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149910958|NCT04035434|540805655|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910959|NCT04035434|540805656|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
149910960|NCT04035434|540805657|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149910961|NCT04035434|540805658|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910962|NCT04035434|540805659|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910963|NCT04035434|540805660|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910964|NCT04035434|540805661|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149971964|NCT05239221|541033823|FG003|Overall Study|Adverse Event|0|||
149971965|NCT05239221|541033824|FG004|Overall Study|Adverse Event|0|||
149971966|NCT05239221|541033825|FG005|Overall Study|Adverse Event|0|||
149971967|NCT05239221|541033826|FG006|Overall Study|Adverse Event|1|||
149971968|NCT05239221|541033827|FG007|Overall Study|Adverse Event|0|||
149971969|NCT05239221|541033828|FG008|Overall Study|Adverse Event|0|||
149971970|NCT05239221|541033829|FG009|Overall Study|Adverse Event|0|||
149971971|NCT05239221|541033830|FG010|Overall Study|Adverse Event|1|||
149971972|NCT05239221|541033831|FG011|Overall Study|Adverse Event|1|||
149971973|NCT05239221|541033832|FG012|Overall Study|Adverse Event|0|||
149971974|NCT05239221|541033833|FG013|Overall Study|Adverse Event|0|||
149971975|NCT05239221|541033834|FG014|Overall Study|Adverse Event|0|||
149971976|NCT05239221|541033835|FG015|Overall Study|Adverse Event|0|||
149971977|NCT05239221|541033820|FG000|Overall Study|Withdrawal by Subject|0|||
149971978|NCT05239221|541033821|FG001|Overall Study|Withdrawal by Subject|0|||
149971979|NCT05239221|541033822|FG002|Overall Study|Withdrawal by Subject|0|||
149971980|NCT05239221|541033823|FG003|Overall Study|Withdrawal by Subject|0|||
149971981|NCT05239221|541033824|FG004|Overall Study|Withdrawal by Subject|0|||
149971982|NCT05239221|541033825|FG005|Overall Study|Withdrawal by Subject|0|||
149971983|NCT05239221|541033826|FG006|Overall Study|Withdrawal by Subject|0|||
149971984|NCT05239221|541033827|FG007|Overall Study|Withdrawal by Subject|0|||
149971985|NCT05239221|541033828|FG008|Overall Study|Withdrawal by Subject|0|||
149971986|NCT05239221|541033829|FG009|Overall Study|Withdrawal by Subject|0|||
149971987|NCT05239221|541033830|FG010|Overall Study|Withdrawal by Subject|1|||
149971988|NCT05239221|541033831|FG011|Overall Study|Withdrawal by Subject|0|||
149971989|NCT05239221|541033832|FG012|Overall Study|Withdrawal by Subject|0|||
149971990|NCT05239221|541033833|FG013|Overall Study|Withdrawal by Subject|0|||
149971991|NCT05239221|541033834|FG014|Overall Study|Withdrawal by Subject|0|||
149971992|NCT05239221|541033835|FG015|Overall Study|Withdrawal by Subject|1|||
149971993|NCT04696146|541035519|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
149971994|NCT04696146|541035520|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
149971995|NCT04696146|541035519|FG000|Overall Study|Off hours issue with product|1|||
149971996|NCT04696146|541035520|FG001|Overall Study|Off hours issue with product|0|||
149971997|NCT01334918|541035525|FG000|Overall Study|Did not receive study drug|6|||
149971998|NCT01334918|541035526|FG001|Overall Study|Did not receive study drug|0|||
149971999|NCT01334918|541035525|FG000|Overall Study|Adverse Event|2|||
149972000|NCT01334918|541035526|FG001|Overall Study|Adverse Event|0|||
149972001|NCT01334918|541035525|FG000|Overall Study|Withdrawal by Subject|0|||
149972002|NCT01334918|541035526|FG001|Overall Study|Withdrawal by Subject|1|||
149972003|NCT00529633|541035527|FG000|Overall Study|Withdrawal by Subject|1|||
149972004|NCT00529633|541035528|FG001|Overall Study|Withdrawal by Subject|1|||
149972005|NCT01576783|541035532|FG000|Overall Study|Change in Medical Care|1|||
149972006|NCT01576783|541035533|FG001|Overall Study|Change in Medical Care|0|||
149972007|NCT01576783|541035532|FG000|Overall Study|Lost to Follow-up|14|||
149972008|NCT01576783|541035533|FG001|Overall Study|Lost to Follow-up|16|||
149972009|NCT01576783|541035532|FG000|Overall Study|Withdrawal by Subject|5|||
149972010|NCT01576783|541035533|FG001|Overall Study|Withdrawal by Subject|1|||
149910965|NCT04035434|540805662|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910966|NCT04035434|540805663|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149910967|NCT04035434|540805664|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149910968|NCT04035434|540805665|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149910969|NCT04035434|540805653|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
149910970|NCT04035434|540805654|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
149910971|NCT04035434|540805655|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
149910972|NCT04035434|540805656|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
149910973|NCT04035434|540805657|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
149910974|NCT04035434|540805658|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
149910975|NCT04035434|540805659|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
149910976|NCT04035434|540805660|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
149910977|NCT04035434|540805661|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
149910978|NCT04035434|540805662|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
149910979|NCT04035434|540805663|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
149910980|NCT04035434|540805664|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
149910981|NCT04035434|540805665|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
149910982|NCT04035434|540805653|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149910983|NCT04035434|540805654|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
149910984|NCT04035434|540805655|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
149910985|NCT04035434|540805656|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149910986|NCT04035434|540805657|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
149910987|NCT04035434|540805658|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
149910988|NCT04035434|540805659|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149910989|NCT04035434|540805660|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149910990|NCT04035434|540805661|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
149910991|NCT04035434|540805662|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
149910992|NCT04035434|540805663|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149910993|NCT04035434|540805664|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
149910994|NCT04035434|540805665|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
149910995|NCT04035434|540805653|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149910996|NCT04035434|540805654|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149910997|NCT04035434|540805655|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149910998|NCT04035434|540805656|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
149910999|NCT04035434|540805657|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911000|NCT04035434|540805658|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911001|NCT04035434|540805659|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911002|NCT04035434|540805660|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911003|NCT04035434|540805661|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911004|NCT04035434|540805662|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911005|NCT04035434|540805663|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911006|NCT04035434|540805664|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911007|NCT04035434|540805665|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
149911008|NCT04035434|540805653|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911009|NCT04035434|540805654|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911010|NCT04035434|540805655|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911011|NCT04035434|540805656|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911012|NCT04035434|540805657|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911013|NCT04035434|540805658|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
149911014|NCT04035434|540805659|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
149911015|NCT04035434|540805660|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911016|NCT04035434|540805661|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911017|NCT04035434|540805662|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911018|NCT04035434|540805663|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911019|NCT04035434|540805664|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911020|NCT04035434|540805665|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
149911021|NCT04035434|540805653|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
150050021|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
150050022|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
150050023|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
150050024|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
150050025|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
150050026|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
150050027|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
150050028|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
150050029|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
150050030|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
150176865|NCT00840177|541784648|FG000|Overall Study|Refusal unrelated to adverse events|1|||
150050031|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
150050032|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
150050033|NCT01584440|541324118|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
150050034|NCT01584440|541324119|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
150050035|NCT01584440|541324120|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
150050036|NCT01584440|541324121|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
150050037|NCT01584440|541324122|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
150050038|NCT01584440|541324118|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
150176866|NCT00840177|541784649|FG001|Overall Study|Refusal unrelated to adverse events|0|||
150176867|NCT00840177|541784650|FG002|Overall Study|Refusal unrelated to adverse events|1|||
150176868|NCT00840177|541784648|FG000|Overall Study|Progression/relapse|2|||
150176869|NCT00840177|541784649|FG001|Overall Study|Progression/relapse|0|||
150176870|NCT00840177|541784650|FG002|Overall Study|Progression/relapse|0|||
150050039|NCT01584440|541324119|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
150050040|NCT01584440|541324120|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
150050041|NCT01584440|541324121|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
150050042|NCT01584440|541324122|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
150050043|NCT01584440|541324118|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
150050044|NCT01584440|541324119|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
150050045|NCT01584440|541324120|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
150050046|NCT01584440|541324121|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
150050047|NCT01584440|541324122|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
150050048|NCT01584440|541324118|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
150050049|NCT01584440|541324119|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
150176871|NCT00840177|541784648|FG000|Overall Study|Death|4|||
150176872|NCT00840177|541784649|FG001|Overall Study|Death|5|||
150176873|NCT00840177|541784650|FG002|Overall Study|Death|5|||
150176874|NCT00840177|541784648|FG000|Overall Study|not protocol specified|6|||
150176875|NCT00840177|541784649|FG001|Overall Study|not protocol specified|3|||
149911022|NCT04035434|540805654|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911023|NCT04035434|540805655|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
150050050|NCT01584440|541324120|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
150050051|NCT01584440|541324121|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
150050052|NCT01584440|541324122|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
150050053|NCT04237116|541324123|FG000|Overall Study|Adverse Event|0|||
150050054|NCT04237116|541324124|FG001|Overall Study|Adverse Event|1|||
150050055|NCT04237116|541324123|FG000|Overall Study|Study terminated by Sponsor|4|||
150050056|NCT04237116|541324124|FG001|Overall Study|Study terminated by Sponsor|1|||
150050057|NCT00899431|541324125|FG000|Overall Study|Physician Decision|1|||
150050058|NCT00899431|541324126|FG001|Overall Study|Physician Decision|0|||
150050059|NCT00899431|541324127|FG002|Overall Study|Physician Decision|0|||
150050060|NCT03212144|541324128|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
150050061|NCT03212144|541324129|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
150050062|NCT03212144|541324128|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
150050063|NCT03212144|541324129|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
150050064|NCT00661427|541324130|FG000|Overall Study|Adverse Event|5|||
150050065|NCT00661427|541324131|FG001|Overall Study|Adverse Event|5|||
150050066|NCT00661427|541324130|FG000|Overall Study|Patient not treated|0|||
150050067|NCT00661427|541324131|FG001|Overall Study|Patient not treated|2|||
150050068|NCT00599339|541324132|FG000|Overall Study|Adverse Event|79|||
150050069|NCT00599339|541324132|FG000|Overall Study|Withdrawal by Subject|137|||
150050070|NCT00599339|541324132|FG000|Overall Study|Other Reason|179|||
150050071|NCT00599339|541324132|FG000|Overall Study|Lost to Follow-up|221|||
150050072|NCT00599339|541324132|FG000|Overall Study|No valid data consent|36|||
149972011|NCT01897493|541035535|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
149972012|NCT02777086|541035539|FG000|Overall Study|Lost to Follow-up|96|||
149972013|NCT02777086|541035540|FG001|Overall Study|Lost to Follow-up|99|||
149972014|NCT01133665|541035541|FG000|Overall Study|Physician Decision|2|||
149972015|NCT01819272|541035542|FG000|Overall Study|Adverse Event|1|||
149972016|NCT01819272|541035543|FG001|Overall Study|Adverse Event|0|||
149972017|NCT01819272|541035544|FG002|Overall Study|Adverse Event|0|||
149972018|NCT01819272|541035545|FG003|Overall Study|Adverse Event|2|||
149972019|NCT01819272|541035546|FG004|Overall Study|Adverse Event|0|||
149972020|NCT01819272|541035547|FG005|Overall Study|Adverse Event|0|||
149972021|NCT01819272|541035542|FG000|Overall Study|Lost to Follow-up|3|||
149972022|NCT01819272|541035543|FG001|Overall Study|Lost to Follow-up|0|||
149972023|NCT01819272|541035544|FG002|Overall Study|Lost to Follow-up|1|||
149972024|NCT01819272|541035545|FG003|Overall Study|Lost to Follow-up|0|||
149972025|NCT01819272|541035546|FG004|Overall Study|Lost to Follow-up|0|||
149972026|NCT01819272|541035547|FG005|Overall Study|Lost to Follow-up|3|||
149972027|NCT01819272|541035542|FG000|Overall Study|Protocol Violation|0|||
149972028|NCT01819272|541035543|FG001|Overall Study|Protocol Violation|0|||
149972029|NCT01819272|541035544|FG002|Overall Study|Protocol Violation|0|||
149972030|NCT01819272|541035545|FG003|Overall Study|Protocol Violation|1|||
149972031|NCT01819272|541035546|FG004|Overall Study|Protocol Violation|2|||
149972032|NCT01819272|541035547|FG005|Overall Study|Protocol Violation|3|||
149972033|NCT01819272|541035542|FG000|Overall Study|Physician Decision|0|||
149972034|NCT01819272|541035543|FG001|Overall Study|Physician Decision|1|||
149972035|NCT01819272|541035544|FG002|Overall Study|Physician Decision|0|||
149972036|NCT01819272|541035545|FG003|Overall Study|Physician Decision|0|||
149972037|NCT01819272|541035546|FG004|Overall Study|Physician Decision|0|||
149972038|NCT01819272|541035547|FG005|Overall Study|Physician Decision|0|||
149972039|NCT01819272|541035542|FG000|Overall Study|Withdrawal of Consent|0|||
149972040|NCT01819272|541035543|FG001|Overall Study|Withdrawal of Consent|1|||
149972041|NCT01819272|541035544|FG002|Overall Study|Withdrawal of Consent|2|||
149972042|NCT01819272|541035545|FG003|Overall Study|Withdrawal of Consent|1|||
149911024|NCT04035434|540805656|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911025|NCT04035434|540805657|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911026|NCT04035434|540805658|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149911027|NCT04035434|540805659|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
149911028|NCT04035434|540805660|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911029|NCT04035434|540805661|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911030|NCT04035434|540805662|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911031|NCT04035434|540805663|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911032|NCT04035434|540805664|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911033|NCT04035434|540805665|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
149911034|NCT04035434|540805653|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911035|NCT04035434|540805654|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911036|NCT04035434|540805655|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911037|NCT04035434|540805656|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911038|NCT04035434|540805657|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911039|NCT04035434|540805658|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
149911040|NCT04035434|540805659|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
149911041|NCT04035434|540805660|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911042|NCT04035434|540805661|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911043|NCT04035434|540805662|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911044|NCT04035434|540805663|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911045|NCT04035434|540805664|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911046|NCT04035434|540805665|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
149911047|NCT04488497|540805666|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
149911048|NCT04488497|540805667|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
149911049|NCT04488497|540805666|FG000|Intervention|Physician Decision|2|||
149911050|NCT04488497|540805667|FG001|Intervention|Physician Decision|1|||
149911051|NCT04488497|540805666|FG000|Intervention|Withdrawal by Subject|5|||
149911052|NCT04488497|540805667|FG001|Intervention|Withdrawal by Subject|6|||
149911053|NCT04488497|540805666|FG000|Intervention|Lost to Follow-up|2|||
149911054|NCT04488497|540805667|FG001|Intervention|Lost to Follow-up|0|||
149911055|NCT04488497|540805666|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
149911056|NCT04488497|540805667|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
149911057|NCT04488497|540805666|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
149911058|NCT04488497|540805667|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
149911059|NCT01877551|540805679|FG000|Overall Study|Physician Decision|0|||
149911060|NCT01877551|540805680|FG001|Overall Study|Physician Decision|1|||
149911061|NCT00348790|540805681|FG000|Completed Treatment|Withdrawal by Subject|4|||
149911062|NCT00348790|540805681|FG000|Completed Treatment|Disease progression|14|||
149911063|NCT00348790|540805681|FG000|Completed Treatment|Adverse Event|4|||
149911064|NCT00348790|540805681|FG000|Completed Treatment|Required surgery|2|||
149911065|NCT00348790|540805681|FG000|Completed Treatment|Unable to travel to study site|1|||
149911066|NCT03602391|540805684|FG000|Overall Study|COVID-19|7|||
149911067|NCT03602391|540805685|FG001|Overall Study|COVID-19|6|||
149911068|NCT00878969|540805688|FG000|Overall Study|Physician Decision|5|||
149911069|NCT00878969|540805689|FG001|Overall Study|Physician Decision|3|||
149911070|NCT00878969|540805690|FG002|Overall Study|Physician Decision|2|||
149972043|NCT01819272|541035546|FG004|Overall Study|Withdrawal of Consent|0|||
149972044|NCT01819272|541035547|FG005|Overall Study|Withdrawal of Consent|1|||
149972045|NCT01819272|541035542|FG000|Overall Study|Loss of Glucose Control|2|||
149972046|NCT01819272|541035543|FG001|Overall Study|Loss of Glucose Control|1|||
149972047|NCT01819272|541035544|FG002|Overall Study|Loss of Glucose Control|0|||
149972048|NCT01819272|541035545|FG003|Overall Study|Loss of Glucose Control|1|||
149972049|NCT01819272|541035546|FG004|Overall Study|Loss of Glucose Control|2|||
149972050|NCT01819272|541035547|FG005|Overall Study|Loss of Glucose Control|0|||
149972051|NCT01732536|541035548|FG000|Overall Study|Withdrawal by Subject|1|||
149972052|NCT01732536|541035549|FG001|Overall Study|Withdrawal by Subject|1|||
149972053|NCT00805389|541035550|FG000|Overall Study|Adverse Event|0|||
149972054|NCT00805389|541035551|FG001|Overall Study|Adverse Event|0|||
149972055|NCT00805389|541035552|FG002|Overall Study|Adverse Event|1|||
149972056|NCT00805389|541035553|FG003|Overall Study|Adverse Event|2|||
149972057|NCT00805389|541035554|FG004|Overall Study|Adverse Event|0|||
149972058|NCT00805389|541035550|FG000|Overall Study|Lost to Follow-up|4|||
149972059|NCT00805389|541035551|FG001|Overall Study|Lost to Follow-up|3|||
149972060|NCT00805389|541035552|FG002|Overall Study|Lost to Follow-up|6|||
149972061|NCT00805389|541035553|FG003|Overall Study|Lost to Follow-up|10|||
149972062|NCT00805389|541035554|FG004|Overall Study|Lost to Follow-up|9|||
149972063|NCT00805389|541035550|FG000|Overall Study|Protocol Violation|0|||
149972064|NCT00805389|541035551|FG001|Overall Study|Protocol Violation|0|||
149911071|NCT00878969|540805688|FG000|Overall Study|Withdrawal by Subject|1|||
149911072|NCT00878969|540805689|FG001|Overall Study|Withdrawal by Subject|6|||
149911073|NCT00878969|540805690|FG002|Overall Study|Withdrawal by Subject|3|||
149911074|NCT00878969|540805688|FG000|Overall Study|kidney transplant|2|||
149911075|NCT00878969|540805689|FG001|Overall Study|kidney transplant|3|||
149911076|NCT00878969|540805690|FG002|Overall Study|kidney transplant|2|||
149911077|NCT00878969|540805688|FG000|Overall Study|Adverse Event|3|||
149911078|NCT00878969|540805689|FG001|Overall Study|Adverse Event|1|||
149911079|NCT00878969|540805690|FG002|Overall Study|Adverse Event|2|||
149911080|NCT00878969|540805688|FG000|Overall Study|Lost to Follow-up|2|||
149911081|NCT00878969|540805689|FG001|Overall Study|Lost to Follow-up|1|||
149911082|NCT00878969|540805690|FG002|Overall Study|Lost to Follow-up|0|||
149911083|NCT00878969|540805688|FG000|Overall Study|Protocol Violation|2|||
149911084|NCT00878969|540805689|FG001|Overall Study|Protocol Violation|0|||
149911085|NCT00878969|540805690|FG002|Overall Study|Protocol Violation|0|||
149911086|NCT00878969|540805688|FG000|Overall Study|Death|0|||
149911087|NCT00878969|540805689|FG001|Overall Study|Death|0|||
149911088|NCT00878969|540805690|FG002|Overall Study|Death|2|||
149911089|NCT00878969|540805688|FG000|Overall Study|Pregnancy|0|||
149911090|NCT00878969|540805689|FG001|Overall Study|Pregnancy|1|||
149911091|NCT00878969|540805690|FG002|Overall Study|Pregnancy|0|||
149911092|NCT04495816|540805706|FG000|Overall Study|Lost to Follow-up|10|||
149911093|NCT04495816|540805707|FG001|Overall Study|Lost to Follow-up|4|||
149911094|NCT04495816|540805706|FG000|Overall Study|Withdrawal by Subject|3|||
149911095|NCT04495816|540805707|FG001|Overall Study|Withdrawal by Subject|5|||
149911096|NCT06137703|540805708|FG000|Overall Study|Other|0|||
149911097|NCT06137703|540805709|FG001|Overall Study|Other|1|||
149911098|NCT06137703|540805710|FG002|Overall Study|Other|0|||
149911099|NCT06137703|540805711|FG003|Overall Study|Other|0|||
149911100|NCT06137703|540805708|FG000|Overall Study|Adverse Event|0|||
149911101|NCT06137703|540805709|FG001|Overall Study|Adverse Event|0|||
149911102|NCT06137703|540805710|FG002|Overall Study|Adverse Event|1|||
149911103|NCT06137703|540805711|FG003|Overall Study|Adverse Event|0|||
149911104|NCT04329091|540805714|FG000|Overall Study|Physician Decision|5|||
149911105|NCT00741091|540805715|FG000|Overall Study|Death|13|||
149911106|NCT00741091|540805715|FG000|Overall Study|Lost to Follow-up|16|||
149911107|NCT00741091|540805715|FG000|Overall Study|Withdrawal by Subject|6|||
149911108|NCT00741091|540805715|FG000|Overall Study|Missed Visit|22|||
149911109|NCT01801358|540805716|FG000|Overall Study|Adverse Event|0|||
149911110|NCT01801358|540805717|FG001|Overall Study|Adverse Event|2|||
149911111|NCT01801358|540805718|FG002|Overall Study|Adverse Event|1|||
149911112|NCT01801358|540805719|FG003|Overall Study|Adverse Event|0|||
149911113|NCT01801358|540805720|FG004|Overall Study|Adverse Event|0|||
149911114|NCT01801358|540805721|FG005|Overall Study|Adverse Event|1|||
149911115|NCT01801358|540805716|FG000|Overall Study|Physician Decision|0|||
149911116|NCT01801358|540805717|FG001|Overall Study|Physician Decision|0|||
149911117|NCT01801358|540805718|FG002|Overall Study|Physician Decision|1|||
149911118|NCT01801358|540805719|FG003|Overall Study|Physician Decision|0|||
149911119|NCT01801358|540805720|FG004|Overall Study|Physician Decision|0|||
149911120|NCT01801358|540805721|FG005|Overall Study|Physician Decision|0|||
149911121|NCT01801358|540805716|FG000|Overall Study|Progressive Disease|6|||
149911122|NCT01801358|540805717|FG001|Overall Study|Progressive Disease|4|||
149911123|NCT01801358|540805718|FG002|Overall Study|Progressive Disease|4|||
149911124|NCT01801358|540805719|FG003|Overall Study|Progressive Disease|5|||
149911125|NCT01801358|540805720|FG004|Overall Study|Progressive Disease|6|||
149911126|NCT01801358|540805721|FG005|Overall Study|Progressive Disease|5|||
149911127|NCT01801358|540805716|FG000|Overall Study|Withdrawal by Subject|0|||
149911128|NCT01801358|540805717|FG001|Overall Study|Withdrawal by Subject|0|||
149972065|NCT00805389|541035552|FG002|Overall Study|Protocol Violation|1|||
149972066|NCT00805389|541035553|FG003|Overall Study|Protocol Violation|0|||
149972067|NCT00805389|541035554|FG004|Overall Study|Protocol Violation|0|||
149972068|NCT00805389|541035550|FG000|Overall Study|Withdrawal by Subject|3|||
149972069|NCT00805389|541035551|FG001|Overall Study|Withdrawal by Subject|2|||
149972070|NCT00805389|541035552|FG002|Overall Study|Withdrawal by Subject|4|||
149972071|NCT00805389|541035553|FG003|Overall Study|Withdrawal by Subject|5|||
149911129|NCT01801358|540805718|FG002|Overall Study|Withdrawal by Subject|0|||
149972072|NCT00805389|541035554|FG004|Overall Study|Withdrawal by Subject|4|||
149972073|NCT05111145|541035557|FG000|Overall Study|Commercial drug is available for participant|76|||
149972074|NCT05111145|541035557|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
149911130|NCT01801358|540805719|FG003|Overall Study|Withdrawal by Subject|1|||
149911131|NCT01801358|540805720|FG004|Overall Study|Withdrawal by Subject|0|||
149911132|NCT01801358|540805721|FG005|Overall Study|Withdrawal by Subject|2|||
149911133|NCT03787303|540805722|FG000|Overall Study|Death|1|||
149911134|NCT03787303|540805722|FG000|Overall Study|Premature Termination of Study|1|||
149911135|NCT01527487|540805723|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
149911136|NCT01527487|540805724|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
149911137|NCT01527487|540805723|FG000|Overall Study|Disease Progression|4|||
149911138|NCT01527487|540805724|FG001|Overall Study|Disease Progression|1|||
149911139|NCT01527487|540805723|FG000|Overall Study|Adverse Event|1|||
149972075|NCT01276704|541035560|FG000|Overall Study|Lost to Follow-up|2|||
149911140|NCT01527487|540805724|FG001|Overall Study|Adverse Event|1|||
149911141|NCT01527487|540805723|FG000|Overall Study|Death|0|||
149911142|NCT01527487|540805724|FG001|Overall Study|Death|1|||
149911143|NCT01210495|540805727|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
149911144|NCT01210495|540805728|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
149911145|NCT01210495|540805729|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
149911146|NCT01210495|540805730|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
149911147|NCT01210495|540805727|FG000|Overall Study|Death|14|||
149911148|NCT01210495|540805728|FG001|Overall Study|Death|7|||
149911149|NCT01210495|540805729|FG002|Overall Study|Death|112|||
149911150|NCT01210495|540805730|FG003|Overall Study|Death|54|||
149911151|NCT01210495|540805727|FG000|Overall Study|Study Terminated by Sponsor|0|||
149911152|NCT01210495|540805728|FG001|Overall Study|Study Terminated by Sponsor|0|||
149911153|NCT01210495|540805729|FG002|Overall Study|Study Terminated by Sponsor|4|||
149911154|NCT01210495|540805730|FG003|Overall Study|Study Terminated by Sponsor|11|||
149911155|NCT01210495|540805727|FG000|Overall Study|Lost to Follow-up|0|||
149911156|NCT01210495|540805728|FG001|Overall Study|Lost to Follow-up|0|||
149911157|NCT01210495|540805729|FG002|Overall Study|Lost to Follow-up|1|||
149911158|NCT01210495|540805730|FG003|Overall Study|Lost to Follow-up|1|||
149911159|NCT01210495|540805727|FG000|Overall Study|Other unspecified|0|||
149911160|NCT01210495|540805728|FG001|Overall Study|Other unspecified|0|||
149911161|NCT01210495|540805729|FG002|Overall Study|Other unspecified|6|||
149911162|NCT01210495|540805730|FG003|Overall Study|Other unspecified|0|||
149911163|NCT01826370|540805733|FG000|Overall Study|Protocol Violation|6|||
149911164|NCT01826370|540805733|FG000|Overall Study|Lost to Follow-up|12|||
149911165|NCT01826370|540805733|FG000|Overall Study|Other reason not defined above|2|||
149911166|NCT00597506|540805740|FG000|Overall Study|Subject is being followed for survival|1|||
149911167|NCT03199612|540805743|FG000|Overall Study|Adverse Event|1|||
149911168|NCT03199612|540805744|FG001|Overall Study|Adverse Event|0|||
149911169|NCT00526331|540805747|FG000|Overall Study|Sponsor Termination|55|||
149911170|NCT01259375|540805748|FG000|Overall Study|Adverse Event|1|||
149911171|NCT00628095|540805749|FG000|Overall Study|Adverse Event|5|||
149911172|NCT00628095|540805750|FG001|Overall Study|Adverse Event|3|||
149911173|NCT00628095|540805749|FG000|Overall Study|Lack of Efficacy|0|||
149911174|NCT00628095|540805750|FG001|Overall Study|Lack of Efficacy|3|||
149911175|NCT00628095|540805749|FG000|Overall Study|Withdrawal by Subject|2|||
149911176|NCT00628095|540805750|FG001|Overall Study|Withdrawal by Subject|0|||
149911177|NCT00628095|540805749|FG000|Overall Study|Other|0|||
149911178|NCT00628095|540805750|FG001|Overall Study|Other|1|||
149911179|NCT02225366|540805762|FG000|Overall Study|Lack of Efficacy|1|||
149911180|NCT02225366|540805763|FG001|Overall Study|Lack of Efficacy|0|||
149911181|NCT02537431|540805767|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
149911182|NCT03003494|540805768|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
149911183|NCT01077739|540805772|FG000|Overall Study|Premature withdrawal|1|||
149911184|NCT01077739|540805773|FG001|Overall Study|Premature withdrawal|3|||
149911185|NCT01077739|540805772|FG000|Overall Study|Withdrawal by Subject|1|||
149911186|NCT01077739|540805773|FG001|Overall Study|Withdrawal by Subject|0|||
149911187|NCT01077739|540805772|FG000|Overall Study|Death|0|||
149911188|NCT01077739|540805773|FG001|Overall Study|Death|3|||
149911189|NCT01077739|540805772|FG000|Overall Study|Unacceptable toxicity|1|||
149911190|NCT01077739|540805773|FG001|Overall Study|Unacceptable toxicity|2|||
149911191|NCT01077739|540805772|FG000|Overall Study|Other|2|||
149911192|NCT01077739|540805773|FG001|Overall Study|Other|2|||
149911193|NCT00877071|540805774|FG000|Overall Study|disease progression|2|||
149911194|NCT05723328|540805775|FG000|Overall Study|Investigator's Decision|5|||
149911195|NCT05723328|540805776|FG001|Overall Study|Investigator's Decision|2|||
149911196|NCT03495154|540805778|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
149911197|NCT03495154|540805778|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
149911198|NCT03495154|540805778|FG000|Overall Study|Screen Failures During Surgery|6|||
149911199|NCT03495154|540805778|FG000|Overall Study|Death|2|||
149911200|NCT03495154|540805778|FG000|Overall Study|Lost to Follow-up|16|||
149911201|NCT03495154|540805778|FG000|Overall Study|Withdrawal by Subject|2|||
149911202|NCT03495154|540805778|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
149911203|NCT01390428|540807457|FG000|Overall Study|Elective Surgery|0|||
149911204|NCT01390428|540807458|FG001|Overall Study|Elective Surgery|0|||
149911205|NCT01390428|540807459|FG002|Overall Study|Elective Surgery|0|||
149911206|NCT01390428|540807460|FG003|Overall Study|Elective Surgery|0|||
149911207|NCT01390428|540807461|FG004|Overall Study|Elective Surgery|1|||
149972076|NCT01276704|541035561|FG001|Overall Study|Lost to Follow-up|3|||
149972077|NCT01276704|541035560|FG000|Overall Study|Non-compliant|2|||
149911208|NCT01390428|540807462|FG005|Overall Study|Elective Surgery|0|||
149911209|NCT01390428|540807457|FG000|Overall Study|Withdrawal by Subject|0|||
149911210|NCT01390428|540807458|FG001|Overall Study|Withdrawal by Subject|0|||
149911211|NCT01390428|540807459|FG002|Overall Study|Withdrawal by Subject|1|||
149911212|NCT01390428|540807460|FG003|Overall Study|Withdrawal by Subject|0|||
149911213|NCT01390428|540807461|FG004|Overall Study|Withdrawal by Subject|0|||
149911214|NCT01390428|540807462|FG005|Overall Study|Withdrawal by Subject|0|||
149911215|NCT05897827|540807465|FG000|Overall Study|Lost to Follow-up|33|||
150050073|NCT00599339|541324132|FG000|Overall Study|Study Termination Status Unknown|12|||
150050074|NCT05564052|541324133|FG000|Overall Study|Withdrawal by Subject|0|||
150050075|NCT05564052|541324134|FG001|Overall Study|Withdrawal by Subject|0|||
150050076|NCT05564052|541324135|FG002|Overall Study|Withdrawal by Subject|0|||
150050077|NCT05564052|541324136|FG003|Overall Study|Withdrawal by Subject|1|||
150050078|NCT01821560|541324137|FG000|Overall Study|Lost to Follow-up|5|||
150050079|NCT01821560|541324138|FG001|Overall Study|Lost to Follow-up|5|||
150050080|NCT01821560|541324137|FG000|Overall Study|Withdrawal by Subject|1|||
150050081|NCT01821560|541324138|FG001|Overall Study|Withdrawal by Subject|1|||
150050082|NCT01821560|541324137|FG000|Overall Study|Protocol Violation|0|||
150050083|NCT01821560|541324138|FG001|Overall Study|Protocol Violation|1|||
150050084|NCT01338298|541324139|FG000|Overall Study|Withdrawal by Subject|1|||
150050085|NCT01338298|541324140|FG001|Overall Study|Withdrawal by Subject|1|||
150050086|NCT01338298|541324139|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
150050087|NCT01338298|541324140|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
150050088|NCT01338298|541324139|FG000|Overall Study|Administrative error|0|||
150050089|NCT01338298|541324140|FG001|Overall Study|Administrative error|1|||
150050090|NCT01338298|541324139|FG000|Overall Study|Positive symptom worsening|1|||
150050091|NCT01338298|541324140|FG001|Overall Study|Positive symptom worsening|0|||
150050092|NCT01338298|541324139|FG000|Overall Study|Depressive symptoms and nausea|1|||
150050093|NCT01338298|541324140|FG001|Overall Study|Depressive symptoms and nausea|0|||
150050094|NCT01338298|541324139|FG000|Overall Study|Non-adherence|1|||
150050095|NCT01338298|541324140|FG001|Overall Study|Non-adherence|0|||
150050096|NCT00531427|541324141|FG000|Overall Study|Withdrawal by Subject|7|||
150050097|NCT00531427|541324142|FG001|Overall Study|Withdrawal by Subject|13|||
150050098|NCT00531427|541324141|FG000|Overall Study|Adverse Event|44|||
150050099|NCT00531427|541324142|FG001|Overall Study|Adverse Event|30|||
150050100|NCT00531427|541324141|FG000|Overall Study|Lost to Follow-up|4|||
150050101|NCT00531427|541324142|FG001|Overall Study|Lost to Follow-up|3|||
150050102|NCT00531427|541324141|FG000|Overall Study|Lack of Efficacy|14|||
150050103|NCT00531427|541324142|FG001|Overall Study|Lack of Efficacy|39|||
150050104|NCT00531427|541324141|FG000|Overall Study|Administrative|4|||
150050105|NCT00531427|541324142|FG001|Overall Study|Administrative|9|||
150050106|NCT02051933|541325880|FG000|Overall Study|Physician Decision|0|||
150050107|NCT02051933|541325881|FG001|Overall Study|Physician Decision|1|||
150050108|NCT00588861|541325885|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
150050109|NCT00588861|541325886|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
150050110|NCT00588861|541325885|FG000|6 Months|Patients did not return for follow-up|98|||
150050111|NCT00588861|541325886|FG001|6 Months|Patients did not return for follow-up|73|||
150050112|NCT00588861|541325885|FG000|1 Year|Patients did not return for follow-up|89|||
150050113|NCT00588861|541325886|FG001|1 Year|Patients did not return for follow-up|82|||
150050114|NCT00588861|541325885|FG000|2 Years|Patients did not return for follow-up|92|||
150050115|NCT00588861|541325886|FG001|2 Years|Patients did not return for follow-up|87|||
150050116|NCT00588861|541325885|FG000|4 Years|Patients did not return for follow-up|91|||
150050117|NCT00588861|541325886|FG001|4 Years|Patients did not return for follow-up|103|||
150050118|NCT00588861|541325885|FG000|6 Years|Patients did not return for follow-up|104|||
150050119|NCT00588861|541325886|FG001|6 Years|Patients did not return for follow-up|109|||
150050120|NCT00588861|541325885|FG000|8 Years|Patients did not return for follow-up|105|||
150050121|NCT00588861|541325886|FG001|8 Years|Patients did not return for follow-up|114|||
150050122|NCT00588861|541325885|FG000|10 Years|Incomplete due to study termination|107|||
150050123|NCT00588861|541325886|FG001|10 Years|Incomplete due to study termination|114|||
150050124|NCT02848729|541325894|FG000|Overall Study|Withdrawal by Subject|1|||
150050125|NCT02848729|541325895|FG001|Overall Study|Withdrawal by Subject|0|||
150050126|NCT02848729|541325894|FG000|Overall Study|Emesis|15|||
150050127|NCT02848729|541325895|FG001|Overall Study|Emesis|11|||
150050128|NCT02617485|541325899|FG000|Treatment and Observation Period|Adverse Event|9|||
150050129|NCT02617485|541325900|FG001|Treatment and Observation Period|Adverse Event|1|||
150176876|NCT00840177|541784650|FG002|Overall Study|not protocol specified|0|||
150050130|NCT02617485|541325899|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
150050131|NCT02617485|541325900|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
150050132|NCT02617485|541325899|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
150050133|NCT02617485|541325900|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
150050134|NCT02617485|541325899|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
150050135|NCT02617485|541325900|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
150176877|NCT00840177|541784648|FG000|Overall Study|Ineligible|0|||
150176878|NCT00840177|541784649|FG001|Overall Study|Ineligible|0|||
150176879|NCT00840177|541784650|FG002|Overall Study|Ineligible|3|||
150176880|NCT00840177|541784648|FG000|Overall Study|Did not start treatment|0|||
150176881|NCT00840177|541784649|FG001|Overall Study|Did not start treatment|0|||
150176882|NCT00840177|541784650|FG002|Overall Study|Did not start treatment|1|||
150176883|NCT02407249|541784651|FG000|Overall Study|Did not complete 12-month follow-up|13|||
150176884|NCT02407249|541784651|FG000|Overall Study|Not treated|13|||
150176885|NCT01622868|541784652|FG000|Overall Study|Protocol Violation|7|||
150176886|NCT01622868|541784653|FG001|Overall Study|Protocol Violation|0|||
150176887|NCT01318382|541784655|FG000|Overall Study|Physician Decision|2|||
150176888|NCT01318382|541784655|FG000|Overall Study|Device Malfunction|10|||
150176889|NCT01318382|541784655|FG000|Overall Study|Protocol Violation|1|||
150176890|NCT01599104|541784656|FG000|Overall Study|Withdrawal by Subject|1|||
150176891|NCT01599104|541784657|FG001|Overall Study|Withdrawal by Subject|1|||
150176892|NCT01599104|541784658|FG002|Overall Study|Withdrawal by Subject|2|||
150176893|NCT01599104|541784656|FG000|Overall Study|Technical Problems|1|||
150176894|NCT01599104|541784657|FG001|Overall Study|Technical Problems|0|||
150050136|NCT02617485|541325899|FG000|Treatment and Observation Period|Physician Decision|0|||
150050137|NCT02617485|541325900|FG001|Treatment and Observation Period|Physician Decision|1|||
150050138|NCT02617485|541325899|FG000|Follow-up Period|Adverse Event|1|||
150050139|NCT02617485|541325900|FG001|Follow-up Period|Adverse Event|0|||
150050140|NCT02617485|541325899|FG000|Follow-up Period|Withdrawal by Subject|1|||
150050141|NCT02617485|541325900|FG001|Follow-up Period|Withdrawal by Subject|0|||
150050142|NCT02617485|541325899|FG000|Follow-up Period|Disease progression|2|||
150050143|NCT02617485|541325900|FG001|Follow-up Period|Disease progression|1|||
150176895|NCT01599104|541784658|FG002|Overall Study|Technical Problems|0|||
150176896|NCT01599104|541784656|FG000|Overall Study|Physician Decision|3|||
150176897|NCT01599104|541784657|FG001|Overall Study|Physician Decision|2|||
149911216|NCT05897827|540807466|FG001|Overall Study|Lost to Follow-up|14|||
149911217|NCT05897827|540807465|FG000|Overall Study|Withdrawal by Subject|1|||
149911218|NCT05897827|540807466|FG001|Overall Study|Withdrawal by Subject|1|||
149911219|NCT05376241|540807467|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
149911220|NCT05376241|540807467|FG000|Overall Study|103 did not complete the survey|103|||
149911221|NCT05376241|540807467|FG000|Overall Study|17 failed 2 attention check questions|17|||
149911222|NCT02276053|540807470|FG000|Overall Study|Death|2|||
149911223|NCT02276053|540807470|FG000|Overall Study|Adverse Event|5|||
150176898|NCT01599104|541784658|FG002|Overall Study|Physician Decision|2|||
150176899|NCT01599104|541784656|FG000|Overall Study|Non-compliance with study treatment|0|||
150176900|NCT01599104|541784657|FG001|Overall Study|Non-compliance with study treatment|1|||
150176901|NCT01599104|541784658|FG002|Overall Study|Non-compliance with study treatment|0|||
150176902|NCT01599104|541784656|FG000|Overall Study|Lack of Efficacy|4|||
150176903|NCT01599104|541784657|FG001|Overall Study|Lack of Efficacy|4|||
150176904|NCT01599104|541784658|FG002|Overall Study|Lack of Efficacy|10|||
149911224|NCT02276053|540807470|FG000|Overall Study|Lack of Efficacy|2|||
150176905|NCT01599104|541784656|FG000|Overall Study|Adverse Event|7|||
150176906|NCT01599104|541784657|FG001|Overall Study|Adverse Event|6|||
150176907|NCT01599104|541784658|FG002|Overall Study|Adverse Event|12|||
150176908|NCT02271854|541784663|FG000|Overall Study|Withdrawal by Subject|2|||
150176909|NCT02271854|541784663|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
150176910|NCT02271854|541784663|FG000|Overall Study|Lost to Follow-up|1|||
150176911|NCT01308567|541784664|FG000|Overall Study|Lost to Follow-up|2|||
150176912|NCT01308567|541784665|FG001|Overall Study|Lost to Follow-up|4|||
150176913|NCT01308567|541784666|FG002|Overall Study|Lost to Follow-up|4|||
150176914|NCT00542789|541784667|FG000|Overall Study|Adverse Event|18|||
150176915|NCT00542789|541784668|FG001|Overall Study|Adverse Event|17|||
150176916|NCT00542789|541784667|FG000|Overall Study|Withdrawal by Subject|7|||
150176917|NCT00542789|541784668|FG001|Overall Study|Withdrawal by Subject|3|||
149972078|NCT01276704|541035561|FG001|Overall Study|Non-compliant|2|||
149972079|NCT01276704|541035560|FG000|Overall Study|Withdrawal by Subject|7|||
149972080|NCT01276704|541035561|FG001|Overall Study|Withdrawal by Subject|1|||
149972081|NCT01276704|541035560|FG000|Overall Study|Physician Decision|3|||
149972082|NCT01276704|541035561|FG001|Overall Study|Physician Decision|5|||
149972083|NCT01359956|541035562|FG000|Overall Study|Death|58|||
149972084|NCT01359956|541035563|FG001|Overall Study|Death|60|||
149972085|NCT01359956|541035564|FG002|Overall Study|Death|66|||
149972086|NCT01359956|541035565|FG003|Overall Study|Death|57|||
149972087|NCT01359956|541035562|FG000|Overall Study|Lost to Follow-up|3|||
149972088|NCT01359956|541035563|FG001|Overall Study|Lost to Follow-up|4|||
149972089|NCT01359956|541035564|FG002|Overall Study|Lost to Follow-up|1|||
149972090|NCT01359956|541035565|FG003|Overall Study|Lost to Follow-up|1|||
149972091|NCT03728933|541035566|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149972092|NCT03728933|541035567|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149972093|NCT03728933|541035568|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149972094|NCT03728933|541035566|FG000|Overall Study|Withdrawal by Subject|0|||
149972095|NCT03728933|541035567|FG001|Overall Study|Withdrawal by Subject|0|||
149972096|NCT03728933|541035568|FG002|Overall Study|Withdrawal by Subject|1|||
149972097|NCT03728933|541035566|FG000|Overall Study|Lost to Follow-up|0|||
149972098|NCT03728933|541035567|FG001|Overall Study|Lost to Follow-up|1|||
149972099|NCT03728933|541035568|FG002|Overall Study|Lost to Follow-up|0|||
149972100|NCT03728933|541035566|FG000|Overall Study|Adverse Event|1|||
149972101|NCT03728933|541035567|FG001|Overall Study|Adverse Event|0|||
149972102|NCT03728933|541035568|FG002|Overall Study|Adverse Event|0|||
149972103|NCT01784029|541035569|FG000|Overall Study|Lost to Follow-up|19|||
149972104|NCT01784029|541035570|FG001|Overall Study|Lost to Follow-up|20|||
149972105|NCT01784029|541035571|FG002|Overall Study|Lost to Follow-up|22|||
149972106|NCT00370292|541035572|FG000|Overall Study|Disease Progression|4|||
149972107|NCT00370292|541035572|FG000|Overall Study|Adverse Event|7|||
149972108|NCT00370292|541035572|FG000|Overall Study|Physician Decision|2|||
149972109|NCT00276419|541035575|FG000|First Intervention|Adverse Event|1|||
149972110|NCT00276419|541035576|FG001|First Intervention|Adverse Event|0|||
149972111|NCT00276419|541035575|FG000|First Intervention|Withdrawal by Subject|0|||
149972112|NCT00276419|541035576|FG001|First Intervention|Withdrawal by Subject|2|||
149972113|NCT00069641|541035577|FG000|Overall Study|Death|1|||
149972114|NCT00069641|541035578|FG001|Overall Study|Death|0|||
149972115|NCT00069641|541035579|FG002|Overall Study|Death|1|||
149972116|NCT03186638|541035580|FG000|Overall Study|Withdrawal by Subject|4|||
149972117|NCT03186638|541035581|FG001|Overall Study|Withdrawal by Subject|4|||
149972118|NCT03186638|541035580|FG000|Overall Study|Withdrawn due to medical problem|3|||
149972119|NCT03186638|541035581|FG001|Overall Study|Withdrawn due to medical problem|2|||
149972120|NCT03186638|541035580|FG000|Overall Study|Lost to Follow-up|1|||
149972121|NCT03186638|541035581|FG001|Overall Study|Lost to Follow-up|0|||
149972122|NCT02239926|541035582|FG000|Overall Study|Withdrawal by Subject|0|||
149972123|NCT02239926|541035583|FG001|Overall Study|Withdrawal by Subject|1|||
149972124|NCT02704208|541035584|FG000|Overall Study|Lost to Follow-up|42|||
149972125|NCT02704208|541035585|FG001|Overall Study|Lost to Follow-up|37|||
149972126|NCT03801525|541035586|FG000|Overall Study|Adverse Event|17|||
149972127|NCT03801525|541035587|FG001|Overall Study|Adverse Event|1|||
149972128|NCT03801525|541035588|FG002|Overall Study|Adverse Event|0|||
149972129|NCT03801525|541035586|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
149972130|NCT03801525|541035587|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
149972131|NCT03801525|541035588|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
149972132|NCT03801525|541035586|FG000|Overall Study|Death|29|||
149972133|NCT03801525|541035587|FG001|Overall Study|Death|1|||
150176918|NCT00542789|541784667|FG000|Overall Study|Protocol Violation|8|||
150176919|NCT00542789|541784668|FG001|Overall Study|Protocol Violation|1|||
149972134|NCT03801525|541035588|FG002|Overall Study|Death|4|||
149972135|NCT03801525|541035586|FG000|Overall Study|Disease Progression|6|||
149972136|NCT03801525|541035587|FG001|Overall Study|Disease Progression|0|||
149972137|NCT03801525|541035588|FG002|Overall Study|Disease Progression|1|||
149911225|NCT02276053|540807470|FG000|Overall Study|Withdrawal by Subject|1|||
149911226|NCT02276053|540807470|FG000|Overall Study|Patient does not meet selection criteria|3|||
149911227|NCT02276053|540807470|FG000|Overall Study|Patient needs to increase baseline AED|1|||
149911228|NCT02059434|540807474|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
149911229|NCT02059434|540807475|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
149911230|NCT02059434|540807476|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
149911231|NCT02059434|540807477|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
149911232|NCT02059434|540807478|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
149911233|NCT02059434|540807479|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
149911234|NCT02059434|540807480|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
149911235|NCT02059434|540807481|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
149911236|NCT02059434|540807482|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
149911237|NCT02059434|540807474|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
149911238|NCT02059434|540807475|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
149911239|NCT02059434|540807476|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
149911240|NCT02059434|540807477|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
149911241|NCT02059434|540807478|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
149911242|NCT02059434|540807479|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
149911243|NCT02059434|540807480|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
149911244|NCT02059434|540807481|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
149911245|NCT02059434|540807482|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
149911246|NCT02059434|540807474|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
149911247|NCT02059434|540807475|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
149911248|NCT02059434|540807476|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
149911249|NCT02059434|540807477|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
149911250|NCT02059434|540807478|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
149911251|NCT02059434|540807479|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
149911252|NCT02059434|540807480|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
149911253|NCT02059434|540807481|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
149911254|NCT02059434|540807482|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
149911255|NCT02059434|540807474|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
149911256|NCT02059434|540807475|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
149911257|NCT02059434|540807476|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
149911258|NCT02059434|540807477|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
149911259|NCT02059434|540807478|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
149911260|NCT02059434|540807479|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
149911261|NCT02059434|540807480|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
149911262|NCT02059434|540807481|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
149911263|NCT02059434|540807482|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
149911264|NCT02059434|540807474|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911265|NCT02059434|540807475|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911266|NCT02059434|540807476|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911267|NCT02059434|540807477|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911268|NCT02059434|540807478|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911269|NCT02059434|540807479|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911270|NCT02059434|540807480|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911271|NCT02059434|540807481|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
149911272|NCT02059434|540807482|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
149911273|NCT01004406|540807483|FG000|Overall Study|Withdrawal by Subject|2|||
149911274|NCT01004406|540807484|FG001|Overall Study|Withdrawal by Subject|0|||
149911275|NCT01004406|540807483|FG000|Overall Study|Lost to Follow-up|1|||
149911276|NCT01004406|540807484|FG001|Overall Study|Lost to Follow-up|0|||
149911277|NCT02928770|540807485|FG000|Overall Study|Withdrawal by Subject|2|||
149911278|NCT03201874|540807488|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
149911279|NCT03201874|540807489|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
149911280|NCT03201874|540807488|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
150176920|NCT00542789|541784667|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
150176921|NCT00542789|541784668|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
150176922|NCT01571596|541784669|FG000|Overall Study|Adverse Event|2|||
150176923|NCT01571596|541784670|FG001|Overall Study|Adverse Event|0|||
150176924|NCT01571596|541784671|FG002|Overall Study|Adverse Event|0|||
150176925|NCT01571596|541784669|FG000|Overall Study|Study Terminated by the Sponsor|0|||
150176926|NCT01571596|541784670|FG001|Overall Study|Study Terminated by the Sponsor|1|||
150176927|NCT01571596|541784671|FG002|Overall Study|Study Terminated by the Sponsor|1|||
150176928|NCT00585052|541784682|FG000|Overall Study|Withdrawal by Subject|1|||
150176929|NCT00774397|541784683|FG000|Overall Study|Adverse Event|1|||
149911281|NCT03201874|540807489|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
149911282|NCT02907593|540807490|FG000|Overall Study|Withdrawal by Subject|0|||
149911283|NCT02907593|540807491|FG001|Overall Study|Withdrawal by Subject|0|||
149911284|NCT02907593|540807492|FG002|Overall Study|Withdrawal by Subject|1|||
149911285|NCT02907593|540807493|FG003|Overall Study|Withdrawal by Subject|0|||
149911286|NCT01752634|540807497|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
149911287|NCT01752634|540807498|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
149911288|NCT01752634|540807499|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
149911289|NCT01752634|540807500|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
149911290|NCT01752634|540807501|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
149911291|NCT01752634|540807502|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
149911292|NCT01752634|540807497|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
149911293|NCT01752634|540807498|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
149911294|NCT01752634|540807499|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
149911295|NCT01752634|540807500|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
149911296|NCT01752634|540807501|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
149911297|NCT01752634|540807502|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
149911298|NCT01752634|540807497|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
149911299|NCT01752634|540807498|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
149911300|NCT01752634|540807499|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
149911301|NCT01752634|540807500|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
149911302|NCT01752634|540807501|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
149911303|NCT01752634|540807502|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
149911304|NCT01752634|540807497|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
149911305|NCT01752634|540807498|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
149911306|NCT01752634|540807499|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
149911307|NCT01752634|540807500|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
149911308|NCT01752634|540807501|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
149911309|NCT01752634|540807502|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
149911310|NCT01752634|540807497|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
149911311|NCT01752634|540807498|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
149911312|NCT01752634|540807499|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
149911313|NCT01752634|540807500|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
149911314|NCT01752634|540807501|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
149911315|NCT01752634|540807502|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
149911316|NCT01752634|540807497|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
149911317|NCT01752634|540807498|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
149911318|NCT01752634|540807499|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
149911319|NCT01752634|540807500|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
150176930|NCT00774397|541784684|FG001|Overall Study|Adverse Event|3|||
149911320|NCT01752634|540807501|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
149911321|NCT01752634|540807502|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
149911322|NCT01752634|540807497|FG000|Week 24 to Week 260|Physician Decision|1|||
149911323|NCT01752634|540807498|FG001|Week 24 to Week 260|Physician Decision|2|||
149911324|NCT01752634|540807499|FG002|Week 24 to Week 260|Physician Decision|4|||
149911325|NCT01752634|540807500|FG003|Week 24 to Week 260|Physician Decision|2|||
149911326|NCT01752634|540807501|FG004|Week 24 to Week 260|Physician Decision|1|||
149911327|NCT01752634|540807502|FG005|Week 24 to Week 260|Physician Decision|0|||
149911328|NCT01752634|540807497|FG000|Week 24 to Week 260|Death|0|||
149911329|NCT01752634|540807498|FG001|Week 24 to Week 260|Death|1|||
149911330|NCT01752634|540807499|FG002|Week 24 to Week 260|Death|0|||
149911331|NCT01752634|540807500|FG003|Week 24 to Week 260|Death|0|||
149911332|NCT01752634|540807501|FG004|Week 24 to Week 260|Death|0|||
149911333|NCT01752634|540807502|FG005|Week 24 to Week 260|Death|0|||
149911334|NCT01752634|540807497|FG000|Week 24 to Week 260|Pregnancy|0|||
149911335|NCT01752634|540807498|FG001|Week 24 to Week 260|Pregnancy|0|||
149911336|NCT01752634|540807499|FG002|Week 24 to Week 260|Pregnancy|1|||
149911337|NCT01752634|540807500|FG003|Week 24 to Week 260|Pregnancy|0|||
149911338|NCT01752634|540807501|FG004|Week 24 to Week 260|Pregnancy|0|||
149911339|NCT01752634|540807502|FG005|Week 24 to Week 260|Pregnancy|0|||
149911340|NCT01752634|540807497|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
149911341|NCT01752634|540807498|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
149911342|NCT01752634|540807499|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
149911343|NCT01752634|540807500|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
149911344|NCT01752634|540807501|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
149911345|NCT01752634|540807502|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
149911346|NCT01752634|540807497|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
149911347|NCT01752634|540807498|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
149911348|NCT01752634|540807499|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
149911349|NCT01752634|540807500|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
149911350|NCT01752634|540807501|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
149911351|NCT01752634|540807502|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
149911352|NCT01752634|540807497|FG000|Week 24 to Week 260|Adverse Event|4|||
149911353|NCT01752634|540807498|FG001|Week 24 to Week 260|Adverse Event|8|||
149911354|NCT01752634|540807499|FG002|Week 24 to Week 260|Adverse Event|8|||
149911355|NCT01752634|540807500|FG003|Week 24 to Week 260|Adverse Event|4|||
149911356|NCT01752634|540807501|FG004|Week 24 to Week 260|Adverse Event|2|||
149911357|NCT01752634|540807502|FG005|Week 24 to Week 260|Adverse Event|0|||
149911358|NCT05562934|540807506|FG000|Overall Study|Adverse Event|0|||
149911359|NCT05562934|540807507|FG001|Overall Study|Adverse Event|2|||
149911360|NCT05562934|540807508|FG002|Overall Study|Adverse Event|0|||
149911361|NCT05562934|540807509|FG003|Overall Study|Adverse Event|0|||
149911362|NCT05562934|540807510|FG004|Overall Study|Adverse Event|2|||
149911363|NCT05562934|540807506|FG000|Overall Study|Lost to Follow-up|0|||
149911364|NCT05562934|540807507|FG001|Overall Study|Lost to Follow-up|0|||
149911365|NCT05562934|540807508|FG002|Overall Study|Lost to Follow-up|0|||
150050144|NCT02617485|541325899|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
150050145|NCT02617485|541325900|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
150050146|NCT02617485|541325899|FG000|Follow-up Period|Patient needed radiotherapy|9|||
150050147|NCT02617485|541325900|FG001|Follow-up Period|Patient needed radiotherapy|5|||
150050148|NCT02617485|541325899|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
150050149|NCT02617485|541325900|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
150050150|NCT00220779|541325901|FG000|Overall Study|Adverse Event|1|||
150050151|NCT00220779|541325902|FG001|Overall Study|Adverse Event|0|||
150050152|NCT00220779|541325903|FG002|Overall Study|Adverse Event|0|||
150050153|NCT00220779|541325901|FG000|Overall Study|Withdrawal by Subject|1|||
150050154|NCT00220779|541325902|FG001|Overall Study|Withdrawal by Subject|4|||
150050155|NCT00220779|541325903|FG002|Overall Study|Withdrawal by Subject|1|||
150050156|NCT00220779|541325901|FG000|Overall Study|Non-compliance|1|||
150050157|NCT00220779|541325902|FG001|Overall Study|Non-compliance|0|||
150050158|NCT00220779|541325903|FG002|Overall Study|Non-compliance|0|||
150050159|NCT00220779|541325901|FG000|Overall Study|Too time consuming|1|||
150176931|NCT00774397|541784685|FG002|Overall Study|Adverse Event|16|||
150176932|NCT00774397|541784686|FG003|Overall Study|Adverse Event|8|||
150176933|NCT00774397|541784687|FG004|Overall Study|Adverse Event|8|||
150176934|NCT00774397|541784688|FG005|Overall Study|Adverse Event|3|||
149911366|NCT05562934|540807509|FG003|Overall Study|Lost to Follow-up|0|||
149911367|NCT05562934|540807510|FG004|Overall Study|Lost to Follow-up|1|||
149911368|NCT05562934|540807506|FG000|Overall Study|Protocol Violation|0|||
149911369|NCT05562934|540807507|FG001|Overall Study|Protocol Violation|0|||
149911370|NCT05562934|540807508|FG002|Overall Study|Protocol Violation|0|||
149911371|NCT05562934|540807509|FG003|Overall Study|Protocol Violation|1|||
149911372|NCT05562934|540807510|FG004|Overall Study|Protocol Violation|1|||
149911373|NCT05562934|540807506|FG000|Overall Study|Withdrawal by Subject|0|||
149911374|NCT05562934|540807507|FG001|Overall Study|Withdrawal by Subject|0|||
149911375|NCT05562934|540807508|FG002|Overall Study|Withdrawal by Subject|1|||
149911376|NCT05562934|540807509|FG003|Overall Study|Withdrawal by Subject|1|||
149911377|NCT05562934|540807510|FG004|Overall Study|Withdrawal by Subject|0|||
149911378|NCT05128773|540807521|FG000|Overall Study|Sponsor decision to terminate study|3|||
149911379|NCT04697056|540807522|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
149911380|NCT04697056|540807523|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
149911381|NCT04322539|540807524|FG000|Overall Study|Adverse Event|2|||
149911382|NCT04322539|540807525|FG001|Overall Study|Adverse Event|0|||
149911383|NCT04322539|540807524|FG000|Overall Study|Death|411|||
149911384|NCT04322539|540807525|FG001|Overall Study|Death|203|||
149911385|NCT04322539|540807524|FG000|Overall Study|Lost to Follow-up|3|||
149911386|NCT04322539|540807525|FG001|Overall Study|Lost to Follow-up|1|||
149911387|NCT04322539|540807524|FG000|Overall Study|Withdrawal of consent|14|||
149911388|NCT04322539|540807525|FG001|Overall Study|Withdrawal of consent|8|||
149911389|NCT04322539|540807524|FG000|Overall Study|Radiological Disease Progression|6|||
149911390|NCT04322539|540807525|FG001|Overall Study|Radiological Disease Progression|0|||
149911391|NCT04322539|540807524|FG000|Overall Study|Sponsor Decision|19|||
149911392|NCT04322539|540807525|FG001|Overall Study|Sponsor Decision|14|||
149911393|NCT04322539|540807524|FG000|Overall Study|Other|6|||
149911394|NCT04322539|540807525|FG001|Overall Study|Other|4|||
149911395|NCT03617861|540807526|FG000|Second Intervention (1 Day)|Adverse Event|0|||
149911396|NCT03617861|540807527|FG001|Second Intervention (1 Day)|Adverse Event|0|||
149911397|NCT03617861|540807528|FG002|Second Intervention (1 Day)|Adverse Event|1|||
149911398|NCT03617861|540807529|FG003|Second Intervention (1 Day)|Adverse Event|0|||
149911399|NCT01702532|540807530|FG000|Overall Study|Adverse Event|0|||
149911400|NCT01702532|540807531|FG001|Overall Study|Adverse Event|1|||
149911401|NCT00623597|540807532|FG000|Overall Study|Failed to return|1|||
149911402|NCT00623597|540807533|FG001|Overall Study|Failed to return|0|||
149911403|NCT01451164|540807534|FG000|Overall Study|Adverse Event|19|||
149911404|NCT01451164|540807535|FG001|Overall Study|Adverse Event|12|||
149911405|NCT01451164|540807536|FG002|Overall Study|Adverse Event|18|||
149911406|NCT01451164|540807537|FG003|Overall Study|Adverse Event|21|||
149911407|NCT01451164|540807534|FG000|Overall Study|Withdrawal Criteria|1|||
149911408|NCT01451164|540807535|FG001|Overall Study|Withdrawal Criteria|1|||
149911409|NCT01451164|540807536|FG002|Overall Study|Withdrawal Criteria|1|||
149911410|NCT01451164|540807537|FG003|Overall Study|Withdrawal Criteria|1|||
149911411|NCT01451164|540807534|FG000|Overall Study|Physician Decision|2|||
149911412|NCT01451164|540807535|FG001|Overall Study|Physician Decision|0|||
149911413|NCT01451164|540807536|FG002|Overall Study|Physician Decision|1|||
149911414|NCT01451164|540807537|FG003|Overall Study|Physician Decision|0|||
149911415|NCT01451164|540807534|FG000|Overall Study|Withdrawal by Subject|14|||
149911416|NCT01451164|540807535|FG001|Overall Study|Withdrawal by Subject|11|||
149911417|NCT01451164|540807536|FG002|Overall Study|Withdrawal by Subject|16|||
149911418|NCT01451164|540807537|FG003|Overall Study|Withdrawal by Subject|17|||
149911419|NCT01451164|540807534|FG000|Overall Study|Protocol Violation|0|||
149911420|NCT01451164|540807535|FG001|Overall Study|Protocol Violation|1|||
149911421|NCT01451164|540807536|FG002|Overall Study|Protocol Violation|0|||
149911422|NCT01451164|540807537|FG003|Overall Study|Protocol Violation|0|||
149911423|NCT01451164|540807534|FG000|Overall Study|Lack of Efficacy|7|||
149911424|NCT01451164|540807535|FG001|Overall Study|Lack of Efficacy|9|||
149911425|NCT01451164|540807536|FG002|Overall Study|Lack of Efficacy|9|||
149911426|NCT01451164|540807537|FG003|Overall Study|Lack of Efficacy|7|||
149911427|NCT01846221|540807542|FG000|Overall Study|Catheter Failure|2|||
149911428|NCT01846221|540807543|FG001|Overall Study|Catheter Failure|0|||
149911429|NCT01846221|540807542|FG000|Overall Study|Age Exclusion|1|||
149911430|NCT01846221|540807543|FG001|Overall Study|Age Exclusion|0|||
149911431|NCT02659514|540807544|FG000|Overall Study|Adverse Event|3|||
149911432|NCT02659514|540807545|FG001|Overall Study|Adverse Event|12|||
149911433|NCT02659514|540807544|FG000|Overall Study|Disease Progression|23|||
149911434|NCT02659514|540807545|FG001|Overall Study|Disease Progression|13|||
149911435|NCT02659514|540807544|FG000|Overall Study|Withdrawal by Subject|0|||
149911436|NCT02659514|540807545|FG001|Overall Study|Withdrawal by Subject|4|||
149911437|NCT02659514|540807544|FG000|Overall Study|Lost to Follow-up|0|||
149911438|NCT02659514|540807545|FG001|Overall Study|Lost to Follow-up|1|||
149911439|NCT02659514|540807544|FG000|Overall Study|Death|6|||
149911440|NCT02659514|540807545|FG001|Overall Study|Death|1|||
149911441|NCT02659514|540807544|FG000|Overall Study|Reason Unspecified|0|||
149911442|NCT02659514|540807545|FG001|Overall Study|Reason Unspecified|3|||
149911443|NCT04186806|540807548|FG000|Period 1: 7 Days|Adverse Event|1|||
149911444|NCT04186806|540807549|FG001|Period 1: 7 Days|Adverse Event|0|||
149911445|NCT03687372|540807550|FG000|Overall Study|Lost to Follow-up|12|||
149911446|NCT03687372|540807551|FG001|Overall Study|Lost to Follow-up|21|||
149911447|NCT03687372|540807550|FG000|Overall Study|Withdrawal by Subject|4|||
150050160|NCT00220779|541325902|FG001|Overall Study|Too time consuming|0|||
149911448|NCT03687372|540807551|FG001|Overall Study|Withdrawal by Subject|17|||
149911449|NCT03687372|540807550|FG000|Overall Study|Investigator Decision|1|||
149911450|NCT03687372|540807551|FG001|Overall Study|Investigator Decision|1|||
149911451|NCT03536949|540807554|FG000|Overall Study|Adverse Event|4|||
149911452|NCT03536949|540807555|FG001|Overall Study|Adverse Event|0|||
149911453|NCT03536949|540807554|FG000|Overall Study|Lost to Follow-up|2|||
149911454|NCT03536949|540807555|FG001|Overall Study|Lost to Follow-up|1|||
149911455|NCT03536949|540807554|FG000|Overall Study|Withdrawal by Subject|6|||
149911456|NCT03536949|540807555|FG001|Overall Study|Withdrawal by Subject|0|||
149911457|NCT03536949|540807554|FG000|Overall Study|Non-compliance|2|||
149911458|NCT03536949|540807555|FG001|Overall Study|Non-compliance|1|||
149911459|NCT01384019|540807561|FG000|Overall Study|Withdrawal by Subject|3|||
149911460|NCT01384019|540807562|FG001|Overall Study|Withdrawal by Subject|0|||
149911461|NCT01384019|540807561|FG000|Overall Study|Death|1|||
149911462|NCT01384019|540807562|FG001|Overall Study|Death|0|||
149911463|NCT01384019|540807561|FG000|Overall Study|MRI refusal|6|||
149911464|NCT01384019|540807562|FG001|Overall Study|MRI refusal|6|||
149911465|NCT00767039|540807565|FG000|Overall Study|Death|5|||
149911466|NCT00767039|540807566|FG001|Overall Study|Death|2|||
149911467|NCT03932331|540807567|FG000|Overall Study|Death|0|||
149911468|NCT03932331|540807568|FG001|Overall Study|Death|7|||
149911469|NCT03932331|540807569|FG002|Overall Study|Death|2|||
149911470|NCT03932331|540807567|FG000|Overall Study|Withdrawal by Subject|0|||
149911471|NCT03932331|540807568|FG001|Overall Study|Withdrawal by Subject|3|||
149911472|NCT03932331|540807569|FG002|Overall Study|Withdrawal by Subject|0|||
149911473|NCT03932331|540807567|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
149911474|NCT03932331|540807568|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
149911475|NCT03932331|540807569|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
149911476|NCT03932331|540807567|FG000|Overall Study|Progressive disease|3|||
149911477|NCT03932331|540807568|FG001|Overall Study|Progressive disease|0|||
149911478|NCT03932331|540807569|FG002|Overall Study|Progressive disease|0|||
149911479|NCT03932331|540807567|FG000|Overall Study|Lung infection|1|||
149911480|NCT03932331|540807568|FG001|Overall Study|Lung infection|0|||
149911481|NCT03932331|540807569|FG002|Overall Study|Lung infection|0|||
149911482|NCT03932331|540807567|FG000|Overall Study|Other|0|||
149911483|NCT03932331|540807568|FG001|Overall Study|Other|0|||
149911484|NCT03932331|540807569|FG002|Overall Study|Other|58|||
149911485|NCT03379753|540807570|FG000|Overall Study|Withdrawal by Subject|2|||
149911486|NCT03379753|540807571|FG001|Overall Study|Withdrawal by Subject|1|||
149911487|NCT03379753|540807570|FG000|Overall Study|not having correct procedure|1|||
149911488|NCT03379753|540807571|FG001|Overall Study|not having correct procedure|2|||
149911489|NCT03379753|540807570|FG000|Overall Study|No primary outcome|12|||
149911490|NCT03379753|540807571|FG001|Overall Study|No primary outcome|22|||
149911491|NCT01032239|540807572|FG000|Overall Study|Lost to Follow-up|3|||
149911492|NCT01032239|540807573|FG001|Overall Study|Lost to Follow-up|2|||
149911493|NCT01032239|540807572|FG000|Overall Study|Withdrawal by Subject|2|||
149911494|NCT01032239|540807573|FG001|Overall Study|Withdrawal by Subject|3|||
149911495|NCT01032239|540807572|FG000|Overall Study|Death|1|||
149911496|NCT01032239|540807573|FG001|Overall Study|Death|0|||
149911497|NCT01032239|540807572|FG000|Overall Study|Protocol Violation|1|||
149911498|NCT01032239|540807573|FG001|Overall Study|Protocol Violation|0|||
149911499|NCT04713592|540807576|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
149911500|NCT04713592|540807577|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
149911501|NCT04713592|540807578|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
149911502|NCT04713592|540807579|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
150050161|NCT00220779|541325903|FG002|Overall Study|Too time consuming|0|||
150050162|NCT00220779|541325901|FG000|Overall Study|Pregnancy|0|||
150050163|NCT00220779|541325902|FG001|Overall Study|Pregnancy|0|||
150050164|NCT00220779|541325903|FG002|Overall Study|Pregnancy|2|||
150050165|NCT00220779|541325901|FG000|Overall Study|Lack of Efficacy|3|||
150050166|NCT00220779|541325902|FG001|Overall Study|Lack of Efficacy|0|||
150050167|NCT00220779|541325903|FG002|Overall Study|Lack of Efficacy|1|||
150050168|NCT00791076|541325904|FG000|Overall Study|Study was terminated,PI left institution|8|||
150050169|NCT02248675|541325912|FG000|Overall Study|Lost to Follow-up|3|||
150050170|NCT02248675|541325913|FG001|Overall Study|Lost to Follow-up|1|||
150050171|NCT03745820|541325918|FG000|Overall Study|Adverse Event|0|||
149911503|NCT04713592|540807576|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
149911504|NCT04713592|540807577|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
149911505|NCT04713592|540807578|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
149911506|NCT04713592|540807579|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
149911507|NCT04713592|540807576|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
149911508|NCT04713592|540807577|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
149911509|NCT04713592|540807578|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
149911510|NCT04713592|540807579|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
149911511|NCT04713592|540807576|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149911512|NCT04713592|540807577|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149911513|NCT04713592|540807578|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
150050172|NCT03745820|541325919|FG001|Overall Study|Adverse Event|3|||
149911514|NCT04713592|540807579|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
149911515|NCT04713592|540807576|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
149911516|NCT04713592|540807577|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
149911517|NCT04713592|540807578|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
149911518|NCT04713592|540807579|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
149911519|NCT04713592|540807576|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149911520|NCT04713592|540807577|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
149911521|NCT04713592|540807578|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
149911522|NCT04713592|540807579|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
149911523|NCT04713592|540807576|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
149911524|NCT04713592|540807577|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
149911525|NCT04713592|540807578|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
149911526|NCT04713592|540807579|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
149911527|NCT03782298|540807580|FG000|Overall Study|Protocol Deviation|4|||
149911528|NCT01382225|540807583|FG000|Overall Study|Adverse Event|3|||
149911529|NCT01382225|540807584|FG001|Overall Study|Adverse Event|2|||
149911530|NCT01382225|540807583|FG000|Overall Study|Protocol Violation|2|||
149911531|NCT01382225|540807584|FG001|Overall Study|Protocol Violation|1|||
149911532|NCT01382225|540807583|FG000|Overall Study|Subject Withdrew Consent|5|||
149911533|NCT01382225|540807584|FG001|Overall Study|Subject Withdrew Consent|2|||
149911534|NCT01382225|540807583|FG000|Overall Study|Other|4|||
149911535|NCT01382225|540807584|FG001|Overall Study|Other|2|||
149911536|NCT01797081|540807585|FG000|Overall Study|Adverse Event|1|||
149911537|NCT01797081|540807586|FG001|Overall Study|Adverse Event|0|||
149911538|NCT01797081|540807587|FG002|Overall Study|Adverse Event|1|||
149911539|NCT01797081|540807588|FG003|Overall Study|Adverse Event|0|||
149911540|NCT01797081|540807585|FG000|Overall Study|Pregnancy|1|||
149911541|NCT01797081|540807586|FG001|Overall Study|Pregnancy|0|||
149911542|NCT01797081|540807587|FG002|Overall Study|Pregnancy|0|||
149911543|NCT01797081|540807588|FG003|Overall Study|Pregnancy|0|||
149911544|NCT01797081|540807585|FG000|Overall Study|Personal Reasons|12|||
149911545|NCT01797081|540807586|FG001|Overall Study|Personal Reasons|4|||
149911546|NCT01797081|540807587|FG002|Overall Study|Personal Reasons|4|||
149911547|NCT01797081|540807588|FG003|Overall Study|Personal Reasons|8|||
149911548|NCT01797081|540807585|FG000|Overall Study|Protocol Violation|0|||
149911549|NCT01797081|540807586|FG001|Overall Study|Protocol Violation|0|||
149911550|NCT01797081|540807587|FG002|Overall Study|Protocol Violation|0|||
149911551|NCT01797081|540807588|FG003|Overall Study|Protocol Violation|1|||
149911552|NCT01793688|540807599|FG000|Overall Study|Protocol Violation|2|||
149911553|NCT02484651|540807600|FG000|Overall Study|Patients' data files were corrupted.|1|||
149911554|NCT02484651|540807601|FG001|Overall Study|Patients' data files were corrupted.|1|||
149911555|NCT02484651|540807600|FG000|Overall Study|BIS monitoring failed.|1|||
149911556|NCT02484651|540807601|FG001|Overall Study|BIS monitoring failed.|1|||
149911557|NCT02484651|540807600|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
149911558|NCT02484651|540807601|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
149911559|NCT03649178|540807602|FG000|Overall Study|Adverse Event|1|||
149911560|NCT03649178|540807603|FG001|Overall Study|Adverse Event|2|||
149911561|NCT03649178|540807602|FG000|Overall Study|Withdrawal by Subject|0|||
149911562|NCT03649178|540807603|FG001|Overall Study|Withdrawal by Subject|2|||
149911563|NCT03649178|540807602|FG000|Overall Study|COVID regulation required halt in protocol|1|||
149911564|NCT03649178|540807603|FG001|Overall Study|COVID regulation required halt in protocol|0|||
149911565|NCT00954512|540807605|FG000|Overall Study|Withdrawal by Subject|0|||
149911566|NCT00954512|540807606|FG001|Overall Study|Withdrawal by Subject|0|||
149911567|NCT00954512|540807607|FG002|Overall Study|Withdrawal by Subject|0|||
149972138|NCT03801525|541035586|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
149972139|NCT03801525|541035587|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
149972140|NCT03801525|541035588|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
149972141|NCT03801525|541035586|FG000|Overall Study|Investigator Decision|18|||
149972142|NCT03801525|541035587|FG001|Overall Study|Investigator Decision|1|||
149972143|NCT03801525|541035588|FG002|Overall Study|Investigator Decision|0|||
149972144|NCT03801525|541035586|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
149972145|NCT03801525|541035587|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
149972146|NCT03801525|541035588|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
149972147|NCT03801525|541035586|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
149972148|NCT03801525|541035587|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
149911568|NCT00954512|540807608|FG003|Overall Study|Withdrawal by Subject|0|||
149911569|NCT00954512|540807609|FG004|Overall Study|Withdrawal by Subject|0|||
149911570|NCT00954512|540807610|FG005|Overall Study|Withdrawal by Subject|1|||
149911571|NCT00954512|540807605|FG000|Overall Study|Adverse Event|0|||
149911572|NCT00954512|540807606|FG001|Overall Study|Adverse Event|0|||
149911573|NCT00954512|540807607|FG002|Overall Study|Adverse Event|0|||
150050173|NCT03745820|541325920|FG002|Overall Study|Adverse Event|2|||
150050174|NCT03745820|541325918|FG000|Overall Study|Non-Compliance with Study Drug|4|||
150050175|NCT03745820|541325919|FG001|Overall Study|Non-Compliance with Study Drug|3|||
150050176|NCT03745820|541325920|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150050177|NCT03745820|541325918|FG000|Overall Study|Withdrawal by Subject|4|||
150050178|NCT03745820|541325919|FG001|Overall Study|Withdrawal by Subject|4|||
150050179|NCT03745820|541325920|FG002|Overall Study|Withdrawal by Subject|4|||
150050180|NCT03745820|541325918|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
149911574|NCT00954512|540807608|FG003|Overall Study|Adverse Event|0|||
149911575|NCT00954512|540807609|FG004|Overall Study|Adverse Event|1|||
149911576|NCT00954512|540807610|FG005|Overall Study|Adverse Event|2|||
149911577|NCT00954512|540807605|FG000|Overall Study|Physician Decision|0|||
149911578|NCT00954512|540807606|FG001|Overall Study|Physician Decision|1|||
149911579|NCT00954512|540807607|FG002|Overall Study|Physician Decision|0|||
149911580|NCT00954512|540807608|FG003|Overall Study|Physician Decision|1|||
149911581|NCT00954512|540807609|FG004|Overall Study|Physician Decision|0|||
149911582|NCT00954512|540807610|FG005|Overall Study|Physician Decision|0|||
149911583|NCT00954512|540807605|FG000|Overall Study|Symptomatic Deterioration|0|||
149911584|NCT00954512|540807606|FG001|Overall Study|Symptomatic Deterioration|1|||
150050181|NCT03745820|541325919|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
150050182|NCT03745820|541325920|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
150050183|NCT03745820|541325918|FG000|Overall Study|Lost to Follow-up|2|||
150050184|NCT03745820|541325919|FG001|Overall Study|Lost to Follow-up|0|||
150050185|NCT03745820|541325920|FG002|Overall Study|Lost to Follow-up|3|||
149911585|NCT00954512|540807607|FG002|Overall Study|Symptomatic Deterioration|0|||
149911586|NCT00954512|540807608|FG003|Overall Study|Symptomatic Deterioration|0|||
149911587|NCT00954512|540807609|FG004|Overall Study|Symptomatic Deterioration|2|||
149911588|NCT00954512|540807610|FG005|Overall Study|Symptomatic Deterioration|0|||
149911589|NCT00954512|540807605|FG000|Overall Study|Progression of Disease|2|||
149911590|NCT00954512|540807606|FG001|Overall Study|Progression of Disease|1|||
149911591|NCT00954512|540807607|FG002|Overall Study|Progression of Disease|0|||
149911592|NCT00954512|540807608|FG003|Overall Study|Progression of Disease|1|||
149911593|NCT00954512|540807609|FG004|Overall Study|Progression of Disease|1|||
149911594|NCT00954512|540807610|FG005|Overall Study|Progression of Disease|1|||
149911595|NCT05685732|540807611|FG000|Overall Study|Withdrawal by Subject|2|||
149911596|NCT05685732|540807612|FG001|Overall Study|Withdrawal by Subject|0|||
149911597|NCT05685732|540807613|FG002|Overall Study|Withdrawal by Subject|2|||
149911598|NCT05685732|540807614|FG003|Overall Study|Withdrawal by Subject|3|||
149911599|NCT05685732|540807611|FG000|Overall Study|Protocol Violation|1|||
149911600|NCT05685732|540807612|FG001|Overall Study|Protocol Violation|2|||
149911601|NCT05685732|540807613|FG002|Overall Study|Protocol Violation|4|||
149911602|NCT05685732|540807614|FG003|Overall Study|Protocol Violation|1|||
149911603|NCT05685732|540807611|FG000|Overall Study|Lost to Follow-up|5|||
149911604|NCT05685732|540807612|FG001|Overall Study|Lost to Follow-up|1|||
149911605|NCT05685732|540807613|FG002|Overall Study|Lost to Follow-up|3|||
149911606|NCT05685732|540807614|FG003|Overall Study|Lost to Follow-up|1|||
149911607|NCT05685732|540807611|FG000|Overall Study|Adverse Event|2|||
150050186|NCT03745820|541325918|FG000|Overall Study|Reason not Specified|2|||
150050187|NCT03745820|541325919|FG001|Overall Study|Reason not Specified|4|||
150050188|NCT03745820|541325920|FG002|Overall Study|Reason not Specified|1|||
150050189|NCT00507728|541325921|FG000|Randomization to Month 3|Lost to Follow-up|15|||
150050190|NCT00507728|541325922|FG001|Randomization to Month 3|Lost to Follow-up|14|||
150050191|NCT00507728|541325923|FG002|Randomization to Month 3|Lost to Follow-up|20|||
150050192|NCT00507728|541325921|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
150050193|NCT00507728|541325922|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
150050194|NCT00507728|541325923|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
150050195|NCT00966875|541325926|FG000|Part A|Adverse Event|2|||
150050196|NCT00966875|541325927|FG001|Part A|Adverse Event|1|||
150050197|NCT00966875|541325928|FG002|Part A|Adverse Event|0|||
150050198|NCT00966875|541325929|FG003|Part A|Adverse Event|1|||
149911608|NCT05685732|540807612|FG001|Overall Study|Adverse Event|1|||
149911609|NCT05685732|540807613|FG002|Overall Study|Adverse Event|0|||
149911610|NCT05685732|540807614|FG003|Overall Study|Adverse Event|0|||
150050199|NCT00966875|541325930|FG004|Part A|Adverse Event|0|||
150050200|NCT00966875|541325931|FG005|Part A|Adverse Event|1|||
150050201|NCT00966875|541325932|FG006|Part A|Adverse Event|0|||
149911611|NCT05685732|540807611|FG000|Overall Study|Physician Decision|1|||
149911612|NCT05685732|540807612|FG001|Overall Study|Physician Decision|0|||
149911613|NCT05685732|540807613|FG002|Overall Study|Physician Decision|0|||
149911614|NCT05685732|540807614|FG003|Overall Study|Physician Decision|0|||
149911615|NCT02640404|540807615|FG000|Overall Study|Protocol Violation|1|||
149911616|NCT02640404|540807616|FG001|Overall Study|Protocol Violation|0|||
149911617|NCT02640404|540807615|FG000|Overall Study|Withdrawal by Subject|1|||
149911618|NCT02640404|540807616|FG001|Overall Study|Withdrawal by Subject|0|||
149911619|NCT04908202|540807618|FG000|Pre-Treatment Period|OTHER REASONS|3|||
149911620|NCT04908202|540807619|FG001|Pre-Treatment Period|OTHER REASONS|1|||
149911621|NCT04908202|540807620|FG002|Pre-Treatment Period|OTHER REASONS|0|||
149911622|NCT04908202|540807621|FG003|Pre-Treatment Period|OTHER REASONS|0|||
149911623|NCT04908202|540807618|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
149911624|NCT04908202|540807619|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911625|NCT04908202|540807620|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911626|NCT04908202|540807621|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911627|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
149911628|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
149911629|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
149911630|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
149911631|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
149911632|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
149911633|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
149911634|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
149911635|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
149911636|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
149911637|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
149911638|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
149911639|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
149911640|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
149911641|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911642|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911643|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
149911644|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
149911645|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
149911646|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
149911647|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
149911648|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
149911649|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
149911650|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
149911651|NCT04908202|540807618|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
149911652|NCT04908202|540807619|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
149911653|NCT04908202|540807620|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
149911654|NCT04908202|540807621|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
149911655|NCT04908202|540807618|FG000|Active Treatment Period|OTHER REASONS|0|||
149911656|NCT04908202|540807619|FG001|Active Treatment Period|OTHER REASONS|0|||
149911657|NCT04908202|540807620|FG002|Active Treatment Period|OTHER REASONS|1|||
149911658|NCT04908202|540807621|FG003|Active Treatment Period|OTHER REASONS|3|||
149911659|NCT04908202|540807618|FG000|Active Treatment Period|Lack of Efficacy|0|||
149911660|NCT04908202|540807619|FG001|Active Treatment Period|Lack of Efficacy|0|||
149911661|NCT04908202|540807620|FG002|Active Treatment Period|Lack of Efficacy|4|||
149911662|NCT04908202|540807621|FG003|Active Treatment Period|Lack of Efficacy|5|||
149911663|NCT04908202|540807618|FG000|Active Treatment Period|Adverse Event|0|||
149911664|NCT04908202|540807619|FG001|Active Treatment Period|Adverse Event|0|||
149911665|NCT04908202|540807620|FG002|Active Treatment Period|Adverse Event|5|||
149911666|NCT04908202|540807621|FG003|Active Treatment Period|Adverse Event|8|||
149911667|NCT04908202|540807618|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
149911668|NCT04908202|540807619|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
149911669|NCT04908202|540807620|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
149911670|NCT04908202|540807621|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
149911671|NCT04908202|540807618|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911672|NCT04908202|540807619|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
149911673|NCT04908202|540807620|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
149911674|NCT04908202|540807621|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
149911675|NCT04908202|540807618|FG000|Active Treatment Period|Lost to Follow-up|0|||
149911676|NCT04908202|540807619|FG001|Active Treatment Period|Lost to Follow-up|0|||
149911677|NCT04908202|540807620|FG002|Active Treatment Period|Lost to Follow-up|2|||
149911678|NCT04908202|540807621|FG003|Active Treatment Period|Lost to Follow-up|2|||
149911679|NCT04908202|540807618|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
149972149|NCT03801525|541035588|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
149972150|NCT03801525|541035586|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
149972151|NCT03801525|541035587|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
149972152|NCT03801525|541035588|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
150050202|NCT00966875|541325933|FG007|Part A|Adverse Event|3|||
149911680|NCT04908202|540807619|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
149911681|NCT04908202|540807620|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
149911682|NCT04908202|540807621|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
149911683|NCT04908202|540807618|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
149911684|NCT04908202|540807619|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
149911685|NCT04908202|540807620|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
149911686|NCT04908202|540807621|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
149911687|NCT04908202|540807618|FG000|Active Treatment Period|ONGOING Treatment|0|||
149911688|NCT04908202|540807619|FG001|Active Treatment Period|ONGOING Treatment|0|||
149911689|NCT04908202|540807620|FG002|Active Treatment Period|ONGOING Treatment|117|||
149911690|NCT04908202|540807621|FG003|Active Treatment Period|ONGOING Treatment|114|||
149911691|NCT05397171|540807622|FG000|Overall Study|Death|2|||
149911692|NCT05397171|540807623|FG001|Overall Study|Death|3|||
149911693|NCT05397171|540807624|FG002|Overall Study|Death|3|||
149911694|NCT05397171|540807622|FG000|Overall Study|Study Terminated By Sponsor|1|||
149911695|NCT05397171|540807623|FG001|Overall Study|Study Terminated By Sponsor|2|||
149911696|NCT05397171|540807624|FG002|Overall Study|Study Terminated By Sponsor|3|||
150176935|NCT00774397|541784689|FG006|Overall Study|Adverse Event|16|||
149911697|NCT05397171|540807622|FG000|Overall Study|Withdrawal by Subject|0|||
149911698|NCT05397171|540807623|FG001|Overall Study|Withdrawal by Subject|1|||
149911699|NCT05397171|540807624|FG002|Overall Study|Withdrawal by Subject|1|||
149911700|NCT02100670|540807625|FG000|Overall Study|Adverse Event|10|||
149911701|NCT02100670|540807626|FG001|Overall Study|Adverse Event|3|||
149911702|NCT02100670|540807627|FG002|Overall Study|Adverse Event|3|||
149911703|NCT02100670|540807628|FG003|Overall Study|Adverse Event|0|||
149972153|NCT03801525|541035586|FG000|Overall Study|Withdrawal of Subject Consent|38|||
149972154|NCT03801525|541035587|FG001|Overall Study|Withdrawal of Subject Consent|2|||
149972155|NCT03801525|541035588|FG002|Overall Study|Withdrawal of Subject Consent|1|||
149972156|NCT03801525|541035586|FG000|Overall Study|Reason not Specified|4|||
149972157|NCT03801525|541035587|FG001|Overall Study|Reason not Specified|0|||
149972158|NCT03801525|541035588|FG002|Overall Study|Reason not Specified|4|||
149972159|NCT03545672|541035591|FG000|Overall Study|Uncertain diagnosis|2|||
149972160|NCT03545672|541035592|FG001|Overall Study|Uncertain diagnosis|1|||
149972161|NCT03545672|541035591|FG000|Overall Study|Protocol Violation|2|||
149972162|NCT03545672|541035592|FG001|Overall Study|Protocol Violation|2|||
149972163|NCT01628913|541035593|FG000|Overall Study|Adverse Event|12|||
149972164|NCT01628913|541035594|FG001|Overall Study|Adverse Event|5|||
149972165|NCT01628913|541035593|FG000|Overall Study|Disease Progression|11|||
149972166|NCT01628913|541035594|FG001|Overall Study|Disease Progression|14|||
149972167|NCT01628913|541035593|FG000|Overall Study|Protocol Violation|1|||
149972168|NCT01628913|541035594|FG001|Overall Study|Protocol Violation|0|||
149972169|NCT01628913|541035593|FG000|Overall Study|Death|1|||
149972170|NCT01628913|541035594|FG001|Overall Study|Death|0|||
149972171|NCT01628913|541035593|FG000|Overall Study|study terminated by Sponsor|4|||
149972172|NCT01628913|541035594|FG001|Overall Study|study terminated by Sponsor|9|||
149972173|NCT01628913|541035593|FG000|Overall Study|Withdrawal by Subject|1|||
149972174|NCT01628913|541035594|FG001|Overall Study|Withdrawal by Subject|0|||
149972175|NCT01628913|541035593|FG000|Overall Study|Physician Decision|1|||
149972176|NCT01628913|541035594|FG001|Overall Study|Physician Decision|3|||
149972177|NCT04388826|541035596|FG000|Overall Study|Lost to Follow-up|3|||
149972178|NCT04388826|541035597|FG001|Overall Study|Lost to Follow-up|2|||
149972179|NCT04388826|541035596|FG000|Overall Study|Adverse Event|1|||
149972180|NCT04388826|541035597|FG001|Overall Study|Adverse Event|0|||
149972181|NCT04047446|541035598|FG000|Overall Study|Physician Decision|1|||
149972182|NCT04047446|541035599|FG001|Overall Study|Physician Decision|0|||
149972183|NCT00329420|541035600|FG000|Re-induction Phase|Lack of Efficacy|0|||
149972184|NCT00329420|541035601|FG001|Re-induction Phase|Lack of Efficacy|1|||
149972185|NCT00329420|541035602|FG002|Re-induction Phase|Lack of Efficacy|0|||
149972186|NCT00329420|541035600|FG000|Re-induction Phase|Withdrawal of Consent|0|||
149972187|NCT00329420|541035601|FG001|Re-induction Phase|Withdrawal of Consent|0|||
149972188|NCT00329420|541035602|FG002|Re-induction Phase|Withdrawal of Consent|1|||
149972189|NCT00329420|541035600|FG000|Re-induction Phase|Did not respond to re-induction|6|||
149972190|NCT00329420|541035601|FG001|Re-induction Phase|Did not respond to re-induction|5|||
149972191|NCT00329420|541035602|FG002|Re-induction Phase|Did not respond to re-induction|7|||
149972192|NCT00329420|541035600|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
149972193|NCT00329420|541035601|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
149972194|NCT00329420|541035602|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
149972195|NCT00329420|541035600|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
149972196|NCT00329420|541035601|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
149972197|NCT00329420|541035602|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
149972198|NCT00329420|541035600|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
149972199|NCT00329420|541035601|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
149911704|NCT02100670|540807625|FG000|Overall Study|Lost to Follow-up|1|||
149911705|NCT02100670|540807626|FG001|Overall Study|Lost to Follow-up|0|||
149911706|NCT02100670|540807627|FG002|Overall Study|Lost to Follow-up|0|||
150050203|NCT00966875|541325934|FG008|Part A|Adverse Event|3|||
150050204|NCT00966875|541325926|FG000|Part A|Entry Criteria|0|||
150050205|NCT00966875|541325927|FG001|Part A|Entry Criteria|0|||
150050206|NCT00966875|541325928|FG002|Part A|Entry Criteria|0|||
149911707|NCT02100670|540807628|FG003|Overall Study|Lost to Follow-up|0|||
149911708|NCT02100670|540807625|FG000|Overall Study|Protocol Violation|0|||
149911709|NCT02100670|540807626|FG001|Overall Study|Protocol Violation|1|||
149911710|NCT02100670|540807627|FG002|Overall Study|Protocol Violation|0|||
149911711|NCT02100670|540807628|FG003|Overall Study|Protocol Violation|1|||
149911712|NCT02100670|540807625|FG000|Overall Study|Withdrawal of Consent|0|||
149911713|NCT02100670|540807626|FG001|Overall Study|Withdrawal of Consent|1|||
149911714|NCT02100670|540807627|FG002|Overall Study|Withdrawal of Consent|1|||
149911715|NCT02100670|540807628|FG003|Overall Study|Withdrawal of Consent|0|||
149911716|NCT02100670|540807625|FG000|Overall Study|No swelling no pain|1|||
149911717|NCT02100670|540807626|FG001|Overall Study|No swelling no pain|0|||
149911718|NCT02100670|540807627|FG002|Overall Study|No swelling no pain|0|||
149911719|NCT02100670|540807628|FG003|Overall Study|No swelling no pain|0|||
149911720|NCT02100670|540807625|FG000|Overall Study|Poor Efficacy|0|||
149911721|NCT02100670|540807626|FG001|Overall Study|Poor Efficacy|1|||
149911722|NCT02100670|540807627|FG002|Overall Study|Poor Efficacy|0|||
149911723|NCT02100670|540807628|FG003|Overall Study|Poor Efficacy|0|||
149911724|NCT02100670|540807625|FG000|Overall Study|Physician Decision|0|||
149911725|NCT02100670|540807626|FG001|Overall Study|Physician Decision|1|||
149911726|NCT02100670|540807627|FG002|Overall Study|Physician Decision|0|||
149911727|NCT02100670|540807628|FG003|Overall Study|Physician Decision|0|||
149911728|NCT02100670|540807625|FG000|Overall Study|Withdrawal by Subject|1|||
149911729|NCT02100670|540807626|FG001|Overall Study|Withdrawal by Subject|0|||
149911730|NCT02100670|540807627|FG002|Overall Study|Withdrawal by Subject|0|||
149911731|NCT02100670|540807628|FG003|Overall Study|Withdrawal by Subject|0|||
149911732|NCT04250714|540809312|FG000|Overall Study|Treatment - withdrawal by subject|14|||
149911733|NCT04250714|540809312|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
149911734|NCT04250714|540809312|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
149911735|NCT04250714|540809312|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
149911736|NCT04250714|540809312|FG000|Overall Study|Treatment - Death|1|||
149911737|NCT04250714|540809312|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
149911738|NCT04250714|540809312|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
149911739|NCT04250714|540809312|FG000|Overall Study|Attempt|2|||
149911740|NCT04250714|540809312|FG000|Overall Study|Intent|7|||
149911741|NCT01668966|540809313|FG000|Overall Study|Withdrawal by Subject|1|||
149911742|NCT01668966|540809313|FG000|Overall Study|Death|1|||
149911743|NCT01668966|540809313|FG000|Overall Study|Not treated|2|||
149911744|NCT04599933|540809314|FG000|Overall Study|Adverse Event|4|||
149911745|NCT04599933|540809315|FG001|Overall Study|Adverse Event|1|||
149911746|NCT04599933|540809314|FG000|Overall Study|Withdrawal by Subject|4|||
149911747|NCT04599933|540809315|FG001|Overall Study|Withdrawal by Subject|2|||
149911748|NCT04599933|540809314|FG000|Overall Study|Lost to Follow-up|0|||
149911749|NCT04599933|540809315|FG001|Overall Study|Lost to Follow-up|1|||
149911750|NCT04599933|540809314|FG000|Overall Study|Physician Decision|0|||
149911751|NCT04599933|540809315|FG001|Overall Study|Physician Decision|1|||
149911752|NCT04599933|540809314|FG000|Overall Study|Screen Failure|1|||
149911753|NCT04599933|540809315|FG001|Overall Study|Screen Failure|2|||
149911754|NCT00345878|540809322|FG000|Overall Study|Adverse Event|1|||
149911755|NCT00345878|540809323|FG001|Overall Study|Adverse Event|0|||
149911756|NCT00345878|540809322|FG000|Overall Study|Lost to Follow-up|2|||
149911757|NCT00345878|540809323|FG001|Overall Study|Lost to Follow-up|1|||
149911758|NCT00345878|540809322|FG000|Overall Study|Other|1|||
149911759|NCT00345878|540809323|FG001|Overall Study|Other|0|||
149911760|NCT06303167|540809326|FG000|Overall Study|Ineligible|1|||
150050207|NCT00966875|541325929|FG003|Part A|Entry Criteria|0|||
150176936|NCT00774397|541784683|FG000|Overall Study|Lack of Efficacy|11|||
149911761|NCT06303167|540809326|FG000|Overall Study|Never start protocol therapy|2|||
149911762|NCT06303167|540809326|FG000|Overall Study|Disease progression|16|||
149911763|NCT04076059|540809329|FG000|Double Blind Phase|Progressive disease|22|||
149911764|NCT04076059|540809330|FG001|Double Blind Phase|Progressive disease|26|||
149911765|NCT04076059|540809331|FG002|Double Blind Phase|Progressive disease|0|||
149911766|NCT04076059|540809329|FG000|Double Blind Phase|Withdrawal by Subject|4|||
149911767|NCT04076059|540809330|FG001|Double Blind Phase|Withdrawal by Subject|11|||
150176937|NCT00774397|541784684|FG001|Overall Study|Lack of Efficacy|4|||
149911768|NCT04076059|540809331|FG002|Double Blind Phase|Withdrawal by Subject|0|||
150050208|NCT00966875|541325930|FG004|Part A|Entry Criteria|0|||
150050209|NCT00966875|541325931|FG005|Part A|Entry Criteria|2|||
149911769|NCT04076059|540809329|FG000|Double Blind Phase|Death|1|||
149911770|NCT04076059|540809330|FG001|Double Blind Phase|Death|1|||
149911771|NCT04076059|540809331|FG002|Double Blind Phase|Death|0|||
149911772|NCT04076059|540809329|FG000|Double Blind Phase|Lost to Follow-up|1|||
149911773|NCT04076059|540809330|FG001|Double Blind Phase|Lost to Follow-up|0|||
149911774|NCT04076059|540809331|FG002|Double Blind Phase|Lost to Follow-up|0|||
150050210|NCT00966875|541325932|FG006|Part A|Entry Criteria|0|||
150176938|NCT00774397|541784685|FG002|Overall Study|Lack of Efficacy|5|||
150176939|NCT00774397|541784686|FG003|Overall Study|Lack of Efficacy|3|||
150176940|NCT00774397|541784687|FG004|Overall Study|Lack of Efficacy|27|||
150176941|NCT00774397|541784688|FG005|Overall Study|Lack of Efficacy|15|||
150176942|NCT00774397|541784689|FG006|Overall Study|Lack of Efficacy|9|||
150176943|NCT00774397|541784683|FG000|Overall Study|Protocol Violation|0|||
150176944|NCT00774397|541784684|FG001|Overall Study|Protocol Violation|1|||
150176945|NCT00774397|541784685|FG002|Overall Study|Protocol Violation|3|||
150176946|NCT00774397|541784686|FG003|Overall Study|Protocol Violation|1|||
150176947|NCT00774397|541784687|FG004|Overall Study|Protocol Violation|2|||
150176948|NCT00774397|541784688|FG005|Overall Study|Protocol Violation|1|||
150176949|NCT00774397|541784689|FG006|Overall Study|Protocol Violation|0|||
150176950|NCT00774397|541784683|FG000|Overall Study|Lost to Follow-up|0|||
150176951|NCT00774397|541784684|FG001|Overall Study|Lost to Follow-up|1|||
150176952|NCT00774397|541784685|FG002|Overall Study|Lost to Follow-up|1|||
150176953|NCT00774397|541784686|FG003|Overall Study|Lost to Follow-up|1|||
150176954|NCT00774397|541784687|FG004|Overall Study|Lost to Follow-up|0|||
150176955|NCT00774397|541784688|FG005|Overall Study|Lost to Follow-up|1|||
150176956|NCT00774397|541784689|FG006|Overall Study|Lost to Follow-up|0|||
150176957|NCT00774397|541784683|FG000|Overall Study|Refused to continue trial medication|1|||
150176958|NCT00774397|541784684|FG001|Overall Study|Refused to continue trial medication|3|||
150176959|NCT00774397|541784685|FG002|Overall Study|Refused to continue trial medication|2|||
150176960|NCT00774397|541784686|FG003|Overall Study|Refused to continue trial medication|2|||
150176961|NCT00774397|541784687|FG004|Overall Study|Refused to continue trial medication|6|||
150176962|NCT00774397|541784688|FG005|Overall Study|Refused to continue trial medication|2|||
150176963|NCT00774397|541784689|FG006|Overall Study|Refused to continue trial medication|3|||
150176964|NCT00774397|541784683|FG000|Overall Study|Not treated|0|||
150050211|NCT00966875|541325933|FG007|Part A|Entry Criteria|0|||
150050212|NCT00966875|541325934|FG008|Part A|Entry Criteria|0|||
150050213|NCT00966875|541325926|FG000|Part A|Lack of Efficacy|0|||
150050214|NCT00966875|541325927|FG001|Part A|Lack of Efficacy|1|||
150050215|NCT00966875|541325928|FG002|Part A|Lack of Efficacy|0|||
150050216|NCT00966875|541325929|FG003|Part A|Lack of Efficacy|0|||
150050217|NCT00966875|541325930|FG004|Part A|Lack of Efficacy|0|||
150050218|NCT00966875|541325931|FG005|Part A|Lack of Efficacy|0|||
150050219|NCT00966875|541325932|FG006|Part A|Lack of Efficacy|4|||
150050220|NCT00966875|541325933|FG007|Part A|Lack of Efficacy|0|||
150176965|NCT00774397|541784684|FG001|Overall Study|Not treated|0|||
150176966|NCT00774397|541784685|FG002|Overall Study|Not treated|0|||
150176967|NCT00774397|541784686|FG003|Overall Study|Not treated|0|||
150176968|NCT00774397|541784687|FG004|Overall Study|Not treated|1|||
150176969|NCT00774397|541784688|FG005|Overall Study|Not treated|0|||
150176970|NCT00774397|541784689|FG006|Overall Study|Not treated|1|||
150176971|NCT00774397|541784683|FG000|Overall Study|Other than those stated above|1|||
150176972|NCT00774397|541784684|FG001|Overall Study|Other than those stated above|1|||
150176973|NCT00774397|541784685|FG002|Overall Study|Other than those stated above|3|||
150176974|NCT00774397|541784686|FG003|Overall Study|Other than those stated above|2|||
150176975|NCT00774397|541784687|FG004|Overall Study|Other than those stated above|2|||
150176976|NCT00774397|541784688|FG005|Overall Study|Other than those stated above|0|||
150176977|NCT00774397|541784689|FG006|Overall Study|Other than those stated above|1|||
150176978|NCT00077675|541784690|FG000|Overall Study|Adverse Event|1|||
150176979|NCT00077675|541784691|FG001|Overall Study|Adverse Event|2|||
150176980|NCT00077675|541784690|FG000|Overall Study|Lost to Follow-up|6|||
150176981|NCT00077675|541784691|FG001|Overall Study|Lost to Follow-up|3|||
149911775|NCT04076059|540809329|FG000|Double Blind Phase|Adverse Event|5|||
149911776|NCT04076059|540809330|FG001|Double Blind Phase|Adverse Event|1|||
149911777|NCT04076059|540809331|FG002|Double Blind Phase|Adverse Event|0|||
149911778|NCT04076059|540809329|FG000|Double Blind Phase|Ongoing Participants|82|||
149911779|NCT04076059|540809330|FG001|Double Blind Phase|Ongoing Participants|18|||
150050221|NCT00966875|541325934|FG008|Part A|Lack of Efficacy|0|||
149911780|NCT04076059|540809331|FG002|Double Blind Phase|Ongoing Participants|0|||
150050222|NCT00966875|541325926|FG000|Part A|Lost to Follow-up|2|||
150050223|NCT00966875|541325927|FG001|Part A|Lost to Follow-up|0|||
150050224|NCT00966875|541325928|FG002|Part A|Lost to Follow-up|0|||
150176982|NCT00077675|541784690|FG000|Overall Study|Withdrawal by Subject|1|||
150176983|NCT00077675|541784691|FG001|Overall Study|Withdrawal by Subject|0|||
150176984|NCT00077675|541784690|FG000|Overall Study|Other|0|||
150176985|NCT00077675|541784691|FG001|Overall Study|Other|1|||
150176986|NCT00077675|541784690|FG000|Overall Study|Never received study treatment|3|||
150176987|NCT00077675|541784691|FG001|Overall Study|Never received study treatment|3|||
150176988|NCT04425863|541784692|FG000|Overall Study|Death|0|||
150176989|NCT04425863|541784693|FG001|Overall Study|Death|0|||
150050225|NCT00966875|541325929|FG003|Part A|Lost to Follow-up|0|||
150050226|NCT00966875|541325930|FG004|Part A|Lost to Follow-up|0|||
150050227|NCT00966875|541325931|FG005|Part A|Lost to Follow-up|1|||
150050228|NCT00966875|541325932|FG006|Part A|Lost to Follow-up|0|||
150176990|NCT04425863|541784694|FG002|Overall Study|Death|1|||
149911781|NCT04076059|540809329|FG000|Double Blind Phase|Miscellaneous|3|||
149911782|NCT04076059|540809330|FG001|Double Blind Phase|Miscellaneous|1|||
150050229|NCT00966875|541325933|FG007|Part A|Lost to Follow-up|0|||
149911783|NCT04076059|540809331|FG002|Double Blind Phase|Miscellaneous|0|||
149911784|NCT04076059|540809329|FG000|Double Blind Phase|Protocol Deviation|1|||
149911785|NCT04076059|540809330|FG001|Double Blind Phase|Protocol Deviation|1|||
149911786|NCT04076059|540809331|FG002|Double Blind Phase|Protocol Deviation|0|||
149911787|NCT04076059|540809329|FG000|Double Blind Phase|Did not take study drug|1|||
149911788|NCT04076059|540809330|FG001|Double Blind Phase|Did not take study drug|1|||
149911789|NCT04076059|540809331|FG002|Double Blind Phase|Did not take study drug|0|||
149911790|NCT04076059|540809329|FG000|Open Label Phase|Progressive disease|0|||
149911791|NCT04076059|540809330|FG001|Open Label Phase|Progressive disease|0|||
149911792|NCT04076059|540809331|FG002|Open Label Phase|Progressive disease|7|||
149911793|NCT04076059|540809329|FG000|Open Label Phase|Withdrawal by Subject|0|||
149911794|NCT04076059|540809330|FG001|Open Label Phase|Withdrawal by Subject|0|||
149911795|NCT04076059|540809331|FG002|Open Label Phase|Withdrawal by Subject|3|||
149911796|NCT04076059|540809329|FG000|Open Label Phase|Death|0|||
149911797|NCT04076059|540809330|FG001|Open Label Phase|Death|0|||
149911798|NCT04076059|540809331|FG002|Open Label Phase|Death|2|||
149911799|NCT04076059|540809329|FG000|Open Label Phase|Ongoing Participants|0|||
149911800|NCT04076059|540809330|FG001|Open Label Phase|Ongoing Participants|0|||
149911801|NCT04076059|540809331|FG002|Open Label Phase|Ongoing Participants|11|||
149911802|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Death|117|||
149911803|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Death|197|||
149911804|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
149911805|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
149911806|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
149911807|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
149911808|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
149911809|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
149911810|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
149911811|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
149911812|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
149911813|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
149911814|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
149911815|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
149911816|NCT02677896|540809332|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
149911817|NCT02677896|540809333|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
149911818|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
149911819|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
149911820|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
149911821|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
149911822|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
149911823|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
149911824|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
149911825|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
149911826|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
149911827|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
149911828|NCT02677896|540809332|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
149911829|NCT02677896|540809333|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
149911830|NCT03385304|540809343|FG000|Overall Study|Death|19|||
149911831|NCT03385304|540809344|FG001|Overall Study|Death|7|||
149911832|NCT03385304|540809343|FG000|Overall Study|Lost to Follow-up|17|||
149911833|NCT03385304|540809344|FG001|Overall Study|Lost to Follow-up|14|||
149911834|NCT03385304|540809343|FG000|Overall Study|Withdrawal by Subject|3|||
149911835|NCT03385304|540809344|FG001|Overall Study|Withdrawal by Subject|2|||
149911836|NCT03385304|540809343|FG000|Overall Study|Incarceration|2|||
149911837|NCT03385304|540809344|FG001|Overall Study|Incarceration|3|||
149911838|NCT01097421|540809345|FG000|Overall Study|Adverse Event|8|||
149911839|NCT01097421|540809345|FG000|Overall Study|Protocol Violation|2|||
149911840|NCT01097421|540809345|FG000|Overall Study|Lost to Follow-up|1|||
149911841|NCT01097421|540809345|FG000|Overall Study|Withdrawal by Subject|3|||
149911842|NCT01120249|540809348|FG000|Overall Study|No protocol treatment received|21|||
149911843|NCT01120249|540809349|FG001|Overall Study|No protocol treatment received|15|||
149911844|NCT01120249|540809348|FG000|Overall Study|Disease recurrence|107|||
149911845|NCT01120249|540809349|FG001|Overall Study|Disease recurrence|57|||
149911846|NCT01120249|540809348|FG000|Overall Study|Death|1|||
149911847|NCT01120249|540809349|FG001|Overall Study|Death|0|||
149911848|NCT01120249|540809348|FG000|Overall Study|Adverse Event|40|||
149911849|NCT01120249|540809349|FG001|Overall Study|Adverse Event|276|||
149911850|NCT01120249|540809348|FG000|Overall Study|Participant refusal|34|||
149911851|NCT01120249|540809349|FG001|Overall Study|Participant refusal|42|||
150050230|NCT00966875|541325934|FG008|Part A|Lost to Follow-up|0|||
150050231|NCT00966875|541325926|FG000|Part A|Parent/Caregiver Decision|0|||
150050232|NCT00966875|541325927|FG001|Part A|Parent/Caregiver Decision|0|||
149911852|NCT01120249|540809348|FG000|Overall Study|Other reasons, not protocol specified|29|||
149911853|NCT01120249|540809349|FG001|Overall Study|Other reasons, not protocol specified|22|||
149911854|NCT01701193|540809350|FG000|Overall Study|Withdrawal by Subject|2|||
149911855|NCT01701193|540809351|FG001|Overall Study|Withdrawal by Subject|2|||
149911856|NCT01701193|540809352|FG002|Overall Study|Withdrawal by Subject|1|||
149911857|NCT01701193|540809353|FG003|Overall Study|Withdrawal by Subject|2|||
149911858|NCT01701193|540809350|FG000|Overall Study|Adverse Event|1|||
149911859|NCT01701193|540809351|FG001|Overall Study|Adverse Event|0|||
149911860|NCT01701193|540809352|FG002|Overall Study|Adverse Event|0|||
149911861|NCT01701193|540809353|FG003|Overall Study|Adverse Event|0|||
149911862|NCT02720744|540809354|FG000|Overall Study|Protocol Violation|0|||
149911863|NCT02720744|540809355|FG001|Overall Study|Protocol Violation|2|||
149911864|NCT02720744|540809354|FG000|Overall Study|Pregnancy|2|||
149911865|NCT02720744|540809355|FG001|Overall Study|Pregnancy|0|||
149911866|NCT02720744|540809354|FG000|Overall Study|Lack of Efficacy|2|||
149911867|NCT02720744|540809355|FG001|Overall Study|Lack of Efficacy|8|||
149911868|NCT02720744|540809354|FG000|Overall Study|Adverse Event|21|||
149911869|NCT02720744|540809355|FG001|Overall Study|Adverse Event|3|||
149911870|NCT02720744|540809354|FG000|Overall Study|Withdrawal by Subject|11|||
149911871|NCT02720744|540809355|FG001|Overall Study|Withdrawal by Subject|11|||
149911872|NCT02720744|540809354|FG000|Overall Study|Lost to follow up|2|||
149911873|NCT02720744|540809355|FG001|Overall Study|Lost to follow up|0|||
149911874|NCT02720744|540809354|FG000|Overall Study|Non Compliance with Investigational Product|0|||
149911875|NCT02720744|540809355|FG001|Overall Study|Non Compliance with Investigational Product|1|||
149911876|NCT02720744|540809354|FG000|Overall Study|Excluded Concomitant Medication|0|||
149911877|NCT02720744|540809355|FG001|Overall Study|Excluded Concomitant Medication|1|||
149911878|NCT01482962|540809356|FG000|Overall Study|Progressive Disease|65|||
149911879|NCT01482962|540809357|FG001|Overall Study|Progressive Disease|53|||
149911880|NCT01482962|540809356|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
149911881|NCT01482962|540809357|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
149911882|NCT01482962|540809356|FG000|Overall Study|Adverse Event|18|||
149911883|NCT01482962|540809357|FG001|Overall Study|Adverse Event|22|||
149911884|NCT01482962|540809356|FG000|Overall Study|Withdrawal by Participant|8|||
149911885|NCT01482962|540809357|FG001|Overall Study|Withdrawal by Participant|13|||
149911886|NCT01482962|540809356|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
149911887|NCT01482962|540809357|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
149911888|NCT01482962|540809356|FG000|Overall Study|Other Reason|1|||
149911889|NCT01482962|540809357|FG001|Overall Study|Other Reason|5|||
149911890|NCT01482962|540809356|FG000|Overall Study|Study Terminated by Sponsor|5|||
149911891|NCT01482962|540809357|FG001|Overall Study|Study Terminated by Sponsor|2|||
149911892|NCT01482962|540809356|FG000|Overall Study|Did not Receive Study Drug|1|||
149911893|NCT01482962|540809357|FG001|Overall Study|Did not Receive Study Drug|6|||
150176991|NCT02601820|541784695|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
149911894|NCT02407457|540809358|FG000|1 Month|Death|3|||
149911895|NCT02407457|540809359|FG001|1 Month|Death|0|||
149911896|NCT02407457|540809358|FG000|1 Month|Lost to Follow-up|1|||
149911897|NCT02407457|540809359|FG001|1 Month|Lost to Follow-up|1|||
149911898|NCT02407457|540809358|FG000|1 Month|missed visit|2|||
149911899|NCT02407457|540809359|FG001|1 Month|missed visit|5|||
149911900|NCT02407457|540809358|FG000|6-Month|Death|2|||
149911901|NCT02407457|540809359|FG001|6-Month|Death|8|||
149911902|NCT02407457|540809358|FG000|6-Month|Lost to Follow-up|2|||
149911903|NCT02407457|540809359|FG001|6-Month|Lost to Follow-up|2|||
149911904|NCT02407457|540809358|FG000|6-Month|missed visit|16|||
149911905|NCT02407457|540809359|FG001|6-Month|missed visit|14|||
149911906|NCT02407457|540809358|FG000|6-Month|Open Repair|0|||
149911907|NCT02407457|540809359|FG001|6-Month|Open Repair|1|||
149911908|NCT02407457|540809358|FG000|1 Year|Death|6|||
149911909|NCT02407457|540809359|FG001|1 Year|Death|11|||
149911910|NCT02407457|540809358|FG000|1 Year|Lost to Follow-up|3|||
149911911|NCT02407457|540809359|FG001|1 Year|Lost to Follow-up|2|||
149911912|NCT02407457|540809358|FG000|1 Year|Missed Visit|24|||
149911913|NCT02407457|540809359|FG001|1 Year|Missed Visit|14|||
149911914|NCT02407457|540809358|FG000|1 Year|Open Repair|0|||
149911915|NCT02407457|540809359|FG001|1 Year|Open Repair|1|||
149911916|NCT02407457|540809358|FG000|2-year|Death|14|||
149911917|NCT02407457|540809359|FG001|2-year|Death|8|||
149911918|NCT02407457|540809358|FG000|2-year|Lost to Follow-up|7|||
149911919|NCT02407457|540809359|FG001|2-year|Lost to Follow-up|10|||
149911920|NCT02407457|540809358|FG000|2-year|Missed Visit|13|||
149911921|NCT02407457|540809359|FG001|2-year|Missed Visit|15|||
150176992|NCT02601820|541784695|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
149911922|NCT02407457|540809358|FG000|2-year|Open Repair|0|||
149911923|NCT02407457|540809359|FG001|2-year|Open Repair|2|||
149911924|NCT02407457|540809358|FG000|3-year|Death|11|||
149911925|NCT02407457|540809359|FG001|3-year|Death|10|||
149911926|NCT02407457|540809358|FG000|3-year|Lost to Follow-up|9|||
149911927|NCT02407457|540809359|FG001|3-year|Lost to Follow-up|10|||
149911928|NCT02407457|540809358|FG000|3-year|Missed Visit|19|||
149911929|NCT02407457|540809359|FG001|3-year|Missed Visit|16|||
149911930|NCT02407457|540809358|FG000|4-year|Death|18|||
149911931|NCT02407457|540809359|FG001|4-year|Death|10|||
150176993|NCT02601820|541784695|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
150176994|NCT02601820|541784695|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
150176995|NCT01599793|541784696|FG000|Overall Study|Adverse Event|2|||
150176996|NCT00277355|541784704|FG000|Overall Study|Withdrawal by Subject|3|||
150176997|NCT00277355|541784705|FG001|Overall Study|Withdrawal by Subject|3|||
150176998|NCT00277355|541784704|FG000|Overall Study|Lost to Follow-up|2|||
150176999|NCT00277355|541784705|FG001|Overall Study|Lost to Follow-up|2|||
150177000|NCT00277355|541784704|FG000|Overall Study|Adverse Event|5|||
150177001|NCT00277355|541784705|FG001|Overall Study|Adverse Event|0|||
150177002|NCT00277355|541784704|FG000|Overall Study|Death|3|||
150177003|NCT00277355|541784705|FG001|Overall Study|Death|0|||
150177004|NCT00277355|541784704|FG000|Overall Study|Physician Decision|1|||
150177005|NCT00277355|541784705|FG001|Overall Study|Physician Decision|0|||
150177006|NCT02675244|541784715|FG000|Overall Study|Death|9|||
150177007|NCT02675244|541784716|FG001|Overall Study|Death|6|||
150177008|NCT02675244|541784715|FG000|Overall Study|Withdrawal by Subject|3|||
150177009|NCT02675244|541784716|FG001|Overall Study|Withdrawal by Subject|6|||
150177010|NCT02675244|541784715|FG000|Overall Study|Lost to Follow-up|1|||
150177011|NCT02675244|541784716|FG001|Overall Study|Lost to Follow-up|1|||
150177012|NCT02675244|541784715|FG000|Overall Study|Ongoing at 2 Years|190|||
150177013|NCT02675244|541784716|FG001|Overall Study|Ongoing at 2 Years|185|||
150177014|NCT00391898|541784717|FG000|Overall Study|Adverse Event|3|||
150177015|NCT00391898|541784718|FG001|Overall Study|Adverse Event|0|||
150177016|NCT00391898|541784717|FG000|Overall Study|Other|8|||
150177017|NCT00391898|541784718|FG001|Overall Study|Other|10|||
150177018|NCT02512965|541784725|FG000|Overall Study|Withdrawal by Subject|0|||
150177019|NCT02512965|541784726|FG001|Overall Study|Withdrawal by Subject|4|||
150177020|NCT00835770|541784727|FG000|Overall Study|MS Relapse|17|||
150177021|NCT00835770|541784728|FG001|Overall Study|MS Relapse|23|||
150177022|NCT00835770|541784727|FG000|Overall Study|MS Progression|14|||
150177023|NCT00835770|541784728|FG001|Overall Study|MS Progression|9|||
150177024|NCT00835770|541784727|FG000|Overall Study|Adverse Event|113|||
150177025|NCT00835770|541784728|FG001|Overall Study|Adverse Event|124|||
150177026|NCT00835770|541784727|FG000|Overall Study|Lost to Follow-up|22|||
150177027|NCT00835770|541784728|FG001|Overall Study|Lost to Follow-up|19|||
150177028|NCT00835770|541784727|FG000|Overall Study|Consent Withdrawn|144|||
150177029|NCT00835770|541784728|FG001|Overall Study|Consent Withdrawn|156|||
150177030|NCT00835770|541784727|FG000|Overall Study|Investigator Decision|42|||
150177031|NCT00835770|541784728|FG001|Overall Study|Investigator Decision|42|||
150177032|NCT00835770|541784727|FG000|Overall Study|Participant Non-Compliance|11|||
150177033|NCT00835770|541784728|FG001|Overall Study|Participant Non-Compliance|9|||
150177034|NCT00835770|541784727|FG000|Overall Study|Death|4|||
150177035|NCT00835770|541784728|FG001|Overall Study|Death|6|||
150177036|NCT00835770|541784727|FG000|Overall Study|Other|115|||
150177037|NCT00835770|541784728|FG001|Overall Study|Other|104|||
150177038|NCT00835770|541784727|FG000|Overall Study|Other|2|||
150177039|NCT00835770|541784728|FG001|Overall Study|Other|1|||
150177040|NCT01185782|541784729|FG000|Overall Study|Adverse Event|0|||
150177041|NCT01185782|541784730|FG001|Overall Study|Adverse Event|1|||
150177042|NCT01185782|541784729|FG000|Overall Study|Protocol Violation|1|||
150177043|NCT01185782|541784730|FG001|Overall Study|Protocol Violation|0|||
150177044|NCT01185782|541784729|FG000|Overall Study|Poor Response to Treatment|3|||
150177045|NCT01185782|541784730|FG001|Overall Study|Poor Response to Treatment|1|||
150177046|NCT01185782|541784729|FG000|Overall Study|Other|2|||
150177047|NCT01185782|541784730|FG001|Overall Study|Other|5|||
150177048|NCT01185782|541784729|FG000|Overall Study|Randomized but not treated|0|||
150177049|NCT01185782|541784730|FG001|Overall Study|Randomized but not treated|4|||
150177050|NCT02507752|541784731|FG000|Overall Study|Adverse Event|1|||
150050233|NCT00966875|541325928|FG002|Part A|Parent/Caregiver Decision|0|||
150050234|NCT00966875|541325929|FG003|Part A|Parent/Caregiver Decision|1|||
150050235|NCT00966875|541325930|FG004|Part A|Parent/Caregiver Decision|0|||
150050236|NCT00966875|541325931|FG005|Part A|Parent/Caregiver Decision|0|||
150050237|NCT00966875|541325932|FG006|Part A|Parent/Caregiver Decision|0|||
150050238|NCT00966875|541325933|FG007|Part A|Parent/Caregiver Decision|0|||
150050239|NCT00966875|541325934|FG008|Part A|Parent/Caregiver Decision|0|||
150177051|NCT02507752|541784731|FG000|Overall Study|Protocol Violation|6|||
150177052|NCT02507752|541784731|FG000|Overall Study|Lost to Follow-up|7|||
150177053|NCT02507752|541784731|FG000|Overall Study|Infusion reaction at first infusion|1|||
150177054|NCT02507752|541784731|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
150177055|NCT02507752|541784731|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
150177056|NCT01444417|541784732|FG000|Overall Study|Ineligibility Determined|0|||
150177057|NCT01444417|541784733|FG001|Overall Study|Ineligibility Determined|1|||
150177058|NCT01444417|541784732|FG000|Overall Study|Withdrawal by Subject|2|||
150050240|NCT00966875|541325926|FG000|Part A|Physician Decision|0|||
150050241|NCT00966875|541325927|FG001|Part A|Physician Decision|0|||
150177059|NCT01444417|541784733|FG001|Overall Study|Withdrawal by Subject|0|||
150177060|NCT00736853|541784746|FG000|Open-Label Period|Physician Decision|2|||
150177061|NCT00736853|541784747|FG001|Open-Label Period|Physician Decision|0|||
150050242|NCT00966875|541325928|FG002|Part A|Physician Decision|0|||
150177062|NCT00736853|541784748|FG002|Open-Label Period|Physician Decision|0|||
149972200|NCT00329420|541035602|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
149972201|NCT03983421|541035604|FG000|Overall Study|Lost to Follow-up|1|||
149972202|NCT03386773|541035605|FG000|Overall Study|Lost to Follow-up|24|||
149972203|NCT03386773|541035606|FG001|Overall Study|Lost to Follow-up|33|||
149972204|NCT03386773|541035605|FG000|Overall Study|Withdrawal by Subject|3|||
149972205|NCT03386773|541035606|FG001|Overall Study|Withdrawal by Subject|2|||
149972206|NCT03639610|541035607|FG000|Overall Study|Adverse Event|7|||
149972207|NCT03639610|541035608|FG001|Overall Study|Adverse Event|1|||
149972208|NCT03639610|541035609|FG002|Overall Study|Adverse Event|0|||
149972209|NCT03639610|541035607|FG000|Overall Study|Physician Decision|3|||
149972210|NCT03639610|541035608|FG001|Overall Study|Physician Decision|1|||
149972211|NCT03639610|541035609|FG002|Overall Study|Physician Decision|0|||
149972212|NCT03639610|541035607|FG000|Overall Study|Disease progression|8|||
149972213|NCT03639610|541035608|FG001|Overall Study|Disease progression|5|||
149972214|NCT03639610|541035609|FG002|Overall Study|Disease progression|3|||
149972215|NCT03639610|541035607|FG000|Overall Study|Study terminated by sponsor|2|||
149972216|NCT03639610|541035608|FG001|Overall Study|Study terminated by sponsor|1|||
149972217|NCT03639610|541035609|FG002|Overall Study|Study terminated by sponsor|1|||
149972218|NCT03639610|541035607|FG000|Overall Study|Patient request to stop treatment|1|||
149972219|NCT03639610|541035608|FG001|Overall Study|Patient request to stop treatment|2|||
149972220|NCT03639610|541035609|FG002|Overall Study|Patient request to stop treatment|0|||
149972221|NCT00892008|541035610|FG000|Overall Study|Death|5|||
149972222|NCT00892008|541035610|FG000|Overall Study|Lack of Efficacy|3|||
149972223|NCT00892008|541035610|FG000|Overall Study|Lost to Follow-up|142|||
149972224|NCT00892008|541035610|FG000|Overall Study|Other|378|||
149972225|NCT00892008|541035610|FG000|Overall Study|Adverse Event|37|||
149972226|NCT05878067|541035614|FG000|Overall Study|Lost to Follow-up|2|||
149972227|NCT01170663|541035615|FG000|Overall Study|Lost to Follow-up|3|||
149972228|NCT01170663|541035616|FG001|Overall Study|Lost to Follow-up|9|||
149972229|NCT01170663|541035615|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
149972230|NCT01170663|541035616|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
149972231|NCT02006927|541035617|FG000|Overall Study|Adverse Event|2|||
149972232|NCT02006927|541035617|FG000|Overall Study|Withdrawal by Subject|1|||
149972233|NCT02746809|541035618|FG000|Enrollment|Inclusion Exclusion not met|9|||
149972234|NCT02746809|541035618|FG000|Enrollment|Withdrawal by Subject|1|||
149972235|NCT02746809|541035618|FG000|Enrollment|Expected Enrollment Met|2|||
149972236|NCT02746809|541035618|FG000|Procedure|Death|1|||
149972237|NCT02746809|541035618|FG000|1-Month|Death|5|||
149972238|NCT02746809|541035618|FG000|6-Month|Death|2|||
149972239|NCT02746809|541035618|FG000|6-Month|Withdrawal by Subject|1|||
149972240|NCT02746809|541035618|FG000|12-Month|Death|3|||
149972241|NCT02746809|541035618|FG000|12-Month|Withdrawal by Subject|2|||
149972242|NCT02746809|541035618|FG000|24-Month|Death|1|||
149972243|NCT02746809|541035618|FG000|24-Month|Withdrawal by Subject|1|||
149972244|NCT02746809|541035618|FG000|36-Month|Death|8|||
149972245|NCT02746809|541035618|FG000|36-Month|Withdrawal by Subject|1|||
149972246|NCT02746809|541035618|FG000|48-Month|Death|7|||
149972247|NCT02746809|541035618|FG000|48-Month|Withdrawal by Subject|1|||
149972248|NCT02746809|541035618|FG000|60-Month|Death|1|||
149972249|NCT02746809|541035618|FG000|60-Month|Lost to Follow-up|2|||
149972250|NCT00742625|541035622|FG000|Remission Induction|Progression|6|||
149972251|NCT00742625|541035622|FG000|Remission Induction|Failed induction|8|||
149972252|NCT00742625|541035622|FG000|Remission Induction|Adverse Event|3|||
149972253|NCT00742625|541035622|FG000|Remission Induction|Death|10|||
149972254|NCT00742625|541035622|FG000|Remission Induction|Refusal|5|||
149972255|NCT00742625|541035622|FG000|Remission Induction|Non protocol treatment|17|||
149972256|NCT00742625|541035622|FG000|Remission Induction|Other, not specified|5|||
149972257|NCT00742625|541035622|FG000|Consolidation|Progression|5|||
149972258|NCT00742625|541035622|FG000|Consolidation|Adverse Event|1|||
149972259|NCT00742625|541035622|FG000|Consolidation|Death|1|||
149972260|NCT00742625|541035622|FG000|Consolidation|Refused|1|||
149972261|NCT00742625|541035622|FG000|Consolidation|Non protocol therapy|13|||
149972262|NCT01164007|541035623|FG000|Overall Study|Adverse Event|5|||
149972263|NCT01164007|541035623|FG000|Overall Study|Progression of Disease|30|||
149972264|NCT01164007|541035623|FG000|Overall Study|Protocol Violation|1|||
149972265|NCT01164007|541035623|FG000|Overall Study|Withdrawal by Subject|1|||
149972266|NCT01164007|541035623|FG000|Overall Study|Medical Decision|3|||
149972267|NCT00894387|541035624|FG000|Overall Study|Adverse Event|44|||
149972268|NCT00894387|541035625|FG001|Overall Study|Adverse Event|45|||
149972269|NCT00894387|541035624|FG000|Overall Study|Abnormal Laboratory values|2|||
149972270|NCT00894387|541035625|FG001|Overall Study|Abnormal Laboratory values|2|||
149972271|NCT00894387|541035624|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149972272|NCT00894387|541035625|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149972273|NCT00894387|541035624|FG000|Overall Study|Lost to Follow-up|3|||
149972274|NCT00894387|541035625|FG001|Overall Study|Lost to Follow-up|5|||
149972275|NCT00894387|541035624|FG000|Overall Study|Administrative problems|2|||
149972276|NCT00894387|541035625|FG001|Overall Study|Administrative problems|2|||
149972277|NCT00894387|541035624|FG000|Overall Study|Death|77|||
149972278|NCT00894387|541035625|FG001|Overall Study|Death|76|||
149972279|NCT00894387|541035624|FG000|Overall Study|Protocol Deviation|4|||
149911932|NCT02407457|540809358|FG000|4-year|Lost to Follow-up|10|||
149911933|NCT02407457|540809359|FG001|4-year|Lost to Follow-up|12|||
149911934|NCT02407457|540809358|FG000|4-year|Missed Visit|18|||
149911935|NCT02407457|540809359|FG001|4-year|Missed Visit|16|||
149911936|NCT02407457|540809358|FG000|5-year|Death|10|||
149911937|NCT02407457|540809359|FG001|5-year|Death|3|||
149911938|NCT02407457|540809358|FG000|5-year|Lost to Follow-up|22|||
149911939|NCT02407457|540809359|FG001|5-year|Lost to Follow-up|13|||
149911940|NCT02407457|540809358|FG000|5-year|Missed Visit|9|||
149911941|NCT02407457|540809359|FG001|5-year|Missed Visit|1|||
149911942|NCT04416737|540809360|FG000|Week 1 (First Injection)|Physician Decision|0|||
149911943|NCT04416737|540809361|FG001|Week 1 (First Injection)|Physician Decision|1|||
149911944|NCT03332628|540809362|FG000|Overall Study|Physician Decision|2|||
149911945|NCT01472757|540809363|FG000|Overall Study|Withdrawal by Subject|1|||
149911946|NCT01472757|540809364|FG001|Overall Study|Withdrawal by Subject|2|||
149911947|NCT01472757|540809365|FG002|Overall Study|Withdrawal by Subject|2|||
149911948|NCT01472757|540809366|FG003|Overall Study|Withdrawal by Subject|0|||
149911949|NCT01472757|540809363|FG000|Overall Study|Asthma exacerbation|4|||
149911950|NCT01472757|540809364|FG001|Overall Study|Asthma exacerbation|1|||
149911951|NCT01472757|540809365|FG002|Overall Study|Asthma exacerbation|2|||
149911952|NCT01472757|540809366|FG003|Overall Study|Asthma exacerbation|1|||
149911953|NCT01472757|540809363|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
149911954|NCT01472757|540809364|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
149911955|NCT01472757|540809365|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
149911956|NCT01472757|540809366|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
149911957|NCT01472757|540809363|FG000|Overall Study|Protocol Violation|3|||
149911958|NCT01472757|540809364|FG001|Overall Study|Protocol Violation|2|||
149911959|NCT01472757|540809365|FG002|Overall Study|Protocol Violation|4|||
149911960|NCT01472757|540809366|FG003|Overall Study|Protocol Violation|4|||
149911961|NCT01472757|540809363|FG000|Overall Study|Other reasons|1|||
149911962|NCT01472757|540809364|FG001|Overall Study|Other reasons|0|||
149911963|NCT01472757|540809365|FG002|Overall Study|Other reasons|2|||
149911964|NCT01472757|540809366|FG003|Overall Study|Other reasons|2|||
149911965|NCT04489381|540809373|FG000|Overall Study|Lost to Follow-up|2|||
149911966|NCT04489381|540809374|FG001|Overall Study|Lost to Follow-up|3|||
149911967|NCT04489381|540809373|FG000|Overall Study|Withdrawal by Subject|1|||
149911968|NCT04489381|540809374|FG001|Overall Study|Withdrawal by Subject|0|||
149911969|NCT02505334|540809375|FG000|Main Treatment Period|Adverse Event|3|||
149911970|NCT02505334|540809376|FG001|Main Treatment Period|Adverse Event|3|||
149911971|NCT02505334|540809375|FG000|Main Treatment Period|Lack of Efficacy|7|||
149911972|NCT02505334|540809376|FG001|Main Treatment Period|Lack of Efficacy|17|||
149911973|NCT02505334|540809375|FG000|Main Treatment Period|Protocol Violation|0|||
149911974|NCT02505334|540809376|FG001|Main Treatment Period|Protocol Violation|1|||
149911975|NCT02505334|540809375|FG000|Main Treatment Period|Withdrawal by Subject|1|||
149911976|NCT02505334|540809376|FG001|Main Treatment Period|Withdrawal by Subject|8|||
149911977|NCT02505334|540809375|FG000|Main Treatment Period|Unclassified|4|||
149911978|NCT02505334|540809376|FG001|Main Treatment Period|Unclassified|10|||
149911979|NCT02505334|540809375|FG000|Extension Treatment Period|Adverse Event|5|||
149911980|NCT02505334|540809376|FG001|Extension Treatment Period|Adverse Event|0|||
149911981|NCT02505334|540809375|FG000|Extension Treatment Period|Lack of Efficacy|4|||
149911982|NCT02505334|540809376|FG001|Extension Treatment Period|Lack of Efficacy|0|||
149911983|NCT02505334|540809375|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
149911984|NCT02505334|540809376|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
149911985|NCT02505334|540809375|FG000|Extension Treatment Period|Unclassified|3|||
149911986|NCT02505334|540809376|FG001|Extension Treatment Period|Unclassified|0|||
149911987|NCT01549041|540809379|FG000|Overall Study|Lack of Efficacy|2|||
149911988|NCT01549041|540809380|FG001|Overall Study|Lack of Efficacy|4|||
149911989|NCT01549041|540809379|FG000|Overall Study|Adverse Event|0|||
149911990|NCT01549041|540809380|FG001|Overall Study|Adverse Event|4|||
149911991|NCT02543892|540809381|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
149911992|NCT02543892|540809382|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
149911993|NCT02543892|540809383|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
149911994|NCT02543892|540809384|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
149911995|NCT02543892|540809385|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
149911996|NCT02543892|540809386|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
149911997|NCT02543892|540809387|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
149911998|NCT02543892|540809388|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
149911999|NCT02543892|540809381|FG000|Received Vaccination 2|Physician Decision|0|||
149972280|NCT00894387|541035625|FG001|Overall Study|Protocol Deviation|0|||
149972281|NCT00894387|541035624|FG000|Overall Study|Patient's request|25|||
149972282|NCT00894387|541035625|FG001|Overall Study|Patient's request|30|||
149972283|NCT00894387|541035624|FG000|Overall Study|Other (Missing)|5|||
149972284|NCT00894387|541035625|FG001|Overall Study|Other (Missing)|3|||
149972285|NCT00894387|541035624|FG000|Overall Study|Mis-randomized|13|||
149912000|NCT02543892|540809382|FG001|Received Vaccination 2|Physician Decision|0|||
149912001|NCT02543892|540809383|FG002|Received Vaccination 2|Physician Decision|0|||
149912002|NCT02543892|540809384|FG003|Received Vaccination 2|Physician Decision|0|||
149912003|NCT02543892|540809385|FG004|Received Vaccination 2|Physician Decision|0|||
149912004|NCT02543892|540809386|FG005|Received Vaccination 2|Physician Decision|1|||
149912005|NCT02543892|540809387|FG006|Received Vaccination 2|Physician Decision|0|||
149912006|NCT02543892|540809388|FG007|Received Vaccination 2|Physician Decision|0|||
149912007|NCT02543892|540809381|FG000|Received Vaccination 2|Adverse Event|0|||
149912008|NCT02543892|540809382|FG001|Received Vaccination 2|Adverse Event|1|||
149912009|NCT02543892|540809383|FG002|Received Vaccination 2|Adverse Event|0|||
149912010|NCT02543892|540809384|FG003|Received Vaccination 2|Adverse Event|0|||
149912011|NCT02543892|540809385|FG004|Received Vaccination 2|Adverse Event|0|||
149912012|NCT02543892|540809386|FG005|Received Vaccination 2|Adverse Event|0|||
149912013|NCT02543892|540809387|FG006|Received Vaccination 2|Adverse Event|0|||
149912014|NCT02543892|540809388|FG007|Received Vaccination 2|Adverse Event|0|||
149912015|NCT02543892|540809381|FG000|Had Immunology Data|Withdrawal by Subject|0|||
149912016|NCT02543892|540809382|FG001|Had Immunology Data|Withdrawal by Subject|0|||
149912017|NCT02543892|540809383|FG002|Had Immunology Data|Withdrawal by Subject|0|||
149912018|NCT02543892|540809384|FG003|Had Immunology Data|Withdrawal by Subject|0|||
149912019|NCT02543892|540809385|FG004|Had Immunology Data|Withdrawal by Subject|0|||
149912020|NCT02543892|540809386|FG005|Had Immunology Data|Withdrawal by Subject|0|||
149912021|NCT02543892|540809387|FG006|Had Immunology Data|Withdrawal by Subject|1|||
149912022|NCT02543892|540809388|FG007|Had Immunology Data|Withdrawal by Subject|0|||
149912023|NCT00081731|540809389|FG000|Overall Study|scientific integrity issue|8|||
149912024|NCT00081731|540809390|FG001|Overall Study|scientific integrity issue|8|||
149912025|NCT00656851|540809394|FG000|Overall Study|Withdrawal by Subject|0|||
149912026|NCT00656851|540809395|FG001|Overall Study|Withdrawal by Subject|4|||
149912027|NCT00742508|540809397|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
149912028|NCT00742508|540809398|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
149912029|NCT00742508|540809397|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
149912030|NCT00742508|540809398|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
149912031|NCT00742508|540809397|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
149912032|NCT00742508|540809398|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
149912033|NCT00742508|540809397|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
149912034|NCT00742508|540809398|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
149912035|NCT00742508|540809397|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
149912036|NCT00742508|540809398|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
149912037|NCT02431806|540809399|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
149912038|NCT02431806|540809400|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
149912039|NCT02431806|540809401|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
149912040|NCT02431806|540809402|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
149912041|NCT02431806|540809399|FG000|Double-blind Treatment Period|Adverse Event|4|||
149912042|NCT02431806|540809400|FG001|Double-blind Treatment Period|Adverse Event|7|||
149912043|NCT02431806|540809401|FG002|Double-blind Treatment Period|Adverse Event|11|||
149912044|NCT02431806|540809402|FG003|Double-blind Treatment Period|Adverse Event|7|||
149912045|NCT02431806|540809399|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
149912046|NCT02431806|540809400|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
149912047|NCT02431806|540809401|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
149912048|NCT02431806|540809402|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
149912049|NCT02431806|540809399|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
149912050|NCT02431806|540809400|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
149912051|NCT02431806|540809401|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
149912052|NCT02431806|540809402|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
149912053|NCT02431806|540809399|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
149912054|NCT02431806|540809400|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
149912055|NCT02431806|540809401|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
149912056|NCT02431806|540809402|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
149912057|NCT02431806|540809399|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
149912058|NCT02431806|540809400|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
149912059|NCT02431806|540809401|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
149912060|NCT02431806|540809402|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
149912061|NCT02431806|540809399|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
149912062|NCT02431806|540809400|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
149912063|NCT02431806|540809401|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
149912064|NCT02431806|540809402|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
149912065|NCT05513703|540809403|FG000|Overall Study|Death|4|||
150050243|NCT00966875|541325929|FG003|Part A|Physician Decision|0|||
150050244|NCT00966875|541325930|FG004|Part A|Physician Decision|1|||
150050245|NCT00966875|541325931|FG005|Part A|Physician Decision|0|||
150050246|NCT00966875|541325932|FG006|Part A|Physician Decision|1|||
150050247|NCT00966875|541325933|FG007|Part A|Physician Decision|0|||
150050248|NCT00966875|541325934|FG008|Part A|Physician Decision|2|||
150050249|NCT00966875|541325926|FG000|Part A|Sponsor Decision|0|||
150050250|NCT00966875|541325927|FG001|Part A|Sponsor Decision|0|||
150177063|NCT00736853|541784746|FG000|Open-Label Period|Adverse Event|31|||
150177064|NCT00736853|541784747|FG001|Open-Label Period|Adverse Event|0|||
150177065|NCT00736853|541784748|FG002|Open-Label Period|Adverse Event|0|||
150177066|NCT00736853|541784746|FG000|Open-Label Period|Withdrawal by Subject|16|||
150177067|NCT00736853|541784747|FG001|Open-Label Period|Withdrawal by Subject|0|||
150177068|NCT00736853|541784748|FG002|Open-Label Period|Withdrawal by Subject|0|||
150177069|NCT00736853|541784746|FG000|Open-Label Period|Started but not treated|42|||
150177070|NCT00736853|541784747|FG001|Open-Label Period|Started but not treated|0|||
150177071|NCT00736853|541784748|FG002|Open-Label Period|Started but not treated|0|||
150177072|NCT00736853|541784746|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
150177073|NCT00736853|541784747|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
150177074|NCT00736853|541784748|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
150177075|NCT00736853|541784746|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
149912066|NCT05513703|540809403|FG000|Overall Study|Study terminated by sponsor|5|||
149912067|NCT03619902|540809405|FG000|Overall Study|Termination of Study by Investigator|1|||
149912068|NCT03619902|540809405|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
149912069|NCT04450407|540809406|FG000|Overall Study|Withdrawal by Subject|10|||
149912070|NCT04450407|540809407|FG001|Overall Study|Withdrawal by Subject|1|||
149912071|NCT04450407|540809408|FG002|Overall Study|Withdrawal by Subject|4|||
149912072|NCT04450407|540809406|FG000|Overall Study|Adverse Event|0|||
149912073|NCT04450407|540809407|FG001|Overall Study|Adverse Event|0|||
149912074|NCT04450407|540809408|FG002|Overall Study|Adverse Event|1|||
149912075|NCT04450407|540809406|FG000|Overall Study|Lost to Follow-up|1|||
149912076|NCT04450407|540809407|FG001|Overall Study|Lost to Follow-up|0|||
149912077|NCT04450407|540809408|FG002|Overall Study|Lost to Follow-up|0|||
149912078|NCT04450407|540809406|FG000|Overall Study|Physician Decision|0|||
149912079|NCT04450407|540809407|FG001|Overall Study|Physician Decision|0|||
149912080|NCT04450407|540809408|FG002|Overall Study|Physician Decision|1|||
149912081|NCT04450407|540809406|FG000|Overall Study|Pregnancy|1|||
149912082|NCT04450407|540809407|FG001|Overall Study|Pregnancy|0|||
149912083|NCT04450407|540809408|FG002|Overall Study|Pregnancy|0|||
149912084|NCT04450407|540809406|FG000|Overall Study|Protocol Violation|2|||
149912085|NCT04450407|540809407|FG001|Overall Study|Protocol Violation|0|||
149912086|NCT04450407|540809408|FG002|Overall Study|Protocol Violation|0|||
149912087|NCT04450407|540809406|FG000|Overall Study|Investigational site terminated by sponsor|3|||
149912088|NCT04450407|540809407|FG001|Overall Study|Investigational site terminated by sponsor|0|||
149912089|NCT04450407|540809408|FG002|Overall Study|Investigational site terminated by sponsor|2|||
149912090|NCT05238025|540809411|FG000|Overall Study|Adverse Event|2|||
149912091|NCT05238025|540809412|FG001|Overall Study|Adverse Event|2|||
149912092|NCT05238025|540809411|FG000|Overall Study|Lost to Follow-up|334|||
149912093|NCT05238025|540809412|FG001|Overall Study|Lost to Follow-up|339|||
149912094|NCT05238025|540809411|FG000|Overall Study|Withdrawal by Subject|203|||
149912095|NCT05238025|540809412|FG001|Overall Study|Withdrawal by Subject|222|||
149912096|NCT05238025|540809411|FG000|Overall Study|Physician Decision|20|||
149912097|NCT05238025|540809412|FG001|Overall Study|Physician Decision|8|||
149912098|NCT05238025|540809411|FG000|Overall Study|Protocol Violation|6|||
149912099|NCT05238025|540809412|FG001|Overall Study|Protocol Violation|2|||
149912100|NCT05238025|540809411|FG000|Overall Study|Death|38|||
149912101|NCT05238025|540809412|FG001|Overall Study|Death|32|||
149912102|NCT05238025|540809411|FG000|Overall Study|Study terminated by Sponsor|6358|||
149912103|NCT05238025|540809412|FG001|Overall Study|Study terminated by Sponsor|6358|||
149912104|NCT05238025|540809411|FG000|Overall Study|Other Reason|669|||
149912105|NCT05238025|540809412|FG001|Overall Study|Other Reason|690|||
149912106|NCT03814720|540809418|FG000|Overall Study|Lost to Follow-up|0|||
149912107|NCT03814720|540809419|FG001|Overall Study|Lost to Follow-up|1|||
149912108|NCT03814720|540809420|FG002|Overall Study|Lost to Follow-up|0|||
149912109|NCT03814720|540809421|FG003|Overall Study|Lost to Follow-up|0|||
149912110|NCT03814720|540809422|FG004|Overall Study|Lost to Follow-up|0|||
149912111|NCT00474045|540809429|FG000|Overall Study|Adverse Event|18|||
149912112|NCT00474045|540809430|FG001|Overall Study|Adverse Event|8|||
149912113|NCT00474045|540809429|FG000|Overall Study|Unclassified|1|||
150177076|NCT00736853|541784747|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
149912114|NCT00474045|540809430|FG001|Overall Study|Unclassified|3|||
149912115|NCT00474045|540809429|FG000|Overall Study|Lack of Efficacy|0|||
150177077|NCT00736853|541784748|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
150177078|NCT00736853|541784746|FG000|Double-Blind Period|Lack of Efficacy|0|||
150177079|NCT00736853|541784747|FG001|Double-Blind Period|Lack of Efficacy|19|||
149912116|NCT00474045|540809430|FG001|Overall Study|Lack of Efficacy|9|||
149912117|NCT00474045|540809429|FG000|Overall Study|Lost to Follow-up|1|||
149912118|NCT00474045|540809430|FG001|Overall Study|Lost to Follow-up|1|||
149912119|NCT00474045|540809429|FG000|Overall Study|Protocol Violation|10|||
149912120|NCT00474045|540809430|FG001|Overall Study|Protocol Violation|12|||
149912121|NCT00474045|540809429|FG000|Overall Study|Withdrawal by Subject|16|||
149912122|NCT00474045|540809430|FG001|Overall Study|Withdrawal by Subject|18|||
149912123|NCT00474045|540809429|FG000|Overall Study|Withdrawal criteria|60|||
149912124|NCT00474045|540809430|FG001|Overall Study|Withdrawal criteria|50|||
149912125|NCT02135107|540809431|FG000|Treatment Period|Withdrawal by Subject|11|||
149912126|NCT02135107|540809432|FG001|Treatment Period|Withdrawal by Subject|0|||
149912127|NCT02135107|540809433|FG002|Treatment Period|Withdrawal by Subject|0|||
149912128|NCT02135107|540809434|FG003|Treatment Period|Withdrawal by Subject|0|||
149912129|NCT02135107|540809431|FG000|Treatment Period|Adverse Event|5|||
149912130|NCT02135107|540809432|FG001|Treatment Period|Adverse Event|2|||
149912131|NCT02135107|540809433|FG002|Treatment Period|Adverse Event|0|||
149912132|NCT02135107|540809434|FG003|Treatment Period|Adverse Event|0|||
149912133|NCT02135107|540809431|FG000|Treatment Period|Pregnancy|1|||
149912134|NCT02135107|540809432|FG001|Treatment Period|Pregnancy|0|||
149912135|NCT02135107|540809433|FG002|Treatment Period|Pregnancy|0|||
149912136|NCT02135107|540809434|FG003|Treatment Period|Pregnancy|0|||
149912137|NCT02135107|540809431|FG000|Treatment Period|Other|115|||
149912138|NCT02135107|540809432|FG001|Treatment Period|Other|24|||
149912139|NCT02135107|540809433|FG002|Treatment Period|Other|0|||
149912140|NCT02135107|540809434|FG003|Treatment Period|Other|0|||
149912141|NCT02135107|540809431|FG000|Maintenance Therapy Period|Adverse Event|0|||
149912142|NCT02135107|540809432|FG001|Maintenance Therapy Period|Adverse Event|0|||
149912143|NCT02135107|540809433|FG002|Maintenance Therapy Period|Adverse Event|3|||
149912144|NCT02135107|540809434|FG003|Maintenance Therapy Period|Adverse Event|7|||
149912145|NCT02135107|540809431|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
149912146|NCT02135107|540809432|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
149912147|NCT02135107|540809433|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
149912148|NCT02135107|540809434|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
149912149|NCT02135107|540809431|FG000|Maintenance Therapy Period|Pregnancy|0|||
149912150|NCT02135107|540809432|FG001|Maintenance Therapy Period|Pregnancy|0|||
149912151|NCT02135107|540809433|FG002|Maintenance Therapy Period|Pregnancy|0|||
149912152|NCT02135107|540809434|FG003|Maintenance Therapy Period|Pregnancy|1|||
149912153|NCT02135107|540809431|FG000|Maintenance Therapy Period|Other|0|||
149912154|NCT02135107|540809432|FG001|Maintenance Therapy Period|Other|0|||
149912155|NCT02135107|540809433|FG002|Maintenance Therapy Period|Other|7|||
149912156|NCT02135107|540809434|FG003|Maintenance Therapy Period|Other|8|||
149912157|NCT02009397|540809435|FG000|Overall Study|Protocol Violation|6|||
149912158|NCT02009397|540809435|FG000|Overall Study|Death|8|||
149912159|NCT02009397|540809435|FG000|Overall Study|Lost to Follow-up|6|||
149912160|NCT02278120|540809440|FG000|Treatment Period|Progressive disease|234|||
149912161|NCT02278120|540809441|FG001|Treatment Period|Progressive disease|260|||
149912162|NCT02278120|540809440|FG000|Treatment Period|Subject/guardian decision|23|||
149912163|NCT02278120|540809441|FG001|Treatment Period|Subject/guardian decision|20|||
149912164|NCT02278120|540809440|FG000|Treatment Period|Adverse Event|16|||
149912165|NCT02278120|540809441|FG001|Treatment Period|Adverse Event|14|||
149912166|NCT02278120|540809440|FG000|Treatment Period|Physician Decision|14|||
149912167|NCT02278120|540809441|FG001|Treatment Period|Physician Decision|27|||
149912168|NCT02278120|540809440|FG000|Treatment Period|Death|3|||
149912169|NCT02278120|540809441|FG001|Treatment Period|Death|3|||
149912170|NCT02278120|540809440|FG000|Treatment Period|Lost to Follow-up|2|||
149912171|NCT02278120|540809441|FG001|Treatment Period|Lost to Follow-up|0|||
149912172|NCT02278120|540809440|FG000|Treatment Period|Protocol deviation|0|||
149912173|NCT02278120|540809441|FG001|Treatment Period|Protocol deviation|2|||
149912174|NCT02278120|540809440|FG000|Treatment Period|Study terminated as per protocol|43|||
149912175|NCT02278120|540809441|FG001|Treatment Period|Study terminated as per protocol|11|||
149912176|NCT02278120|540809440|FG000|Post-treatment Efficacy Follow-up|Death|0|||
149912177|NCT02278120|540809441|FG001|Post-treatment Efficacy Follow-up|Death|1|||
149912178|NCT02278120|540809440|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
149912179|NCT02278120|540809441|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
149912180|NCT02278120|540809440|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
149912181|NCT02278120|540809441|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
149912182|NCT02278120|540809440|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
150050251|NCT00966875|541325928|FG002|Part A|Sponsor Decision|1|||
150050252|NCT00966875|541325929|FG003|Part A|Sponsor Decision|0|||
150050253|NCT00966875|541325930|FG004|Part A|Sponsor Decision|1|||
149912183|NCT02278120|540809441|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
149912184|NCT02278120|540809440|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149912185|NCT02278120|540809441|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149912186|NCT03197324|540809445|FG000|Overall Study|Adverse Event|0|||
149912187|NCT03197324|540809446|FG001|Overall Study|Adverse Event|1|||
149912188|NCT00102531|540809447|FG000|Overall Study|Adverse Event|0|||
149912189|NCT00102531|540809448|FG001|Overall Study|Adverse Event|1|||
149912190|NCT00102531|540809447|FG000|Overall Study|Disease Progression|5|||
149912191|NCT00102531|540809448|FG001|Overall Study|Disease Progression|9|||
149912192|NCT00102531|540809447|FG000|Overall Study|Physician Decision|0|||
149912193|NCT00102531|540809448|FG001|Overall Study|Physician Decision|1|||
149912194|NCT00514904|540809452|FG000|Overall Study|Withdrawal by Subject|3|||
149912195|NCT00514904|540809453|FG001|Overall Study|Withdrawal by Subject|2|||
149912196|NCT00514904|540809452|FG000|Overall Study|Lost to Follow-up|21|||
149912197|NCT00514904|540809453|FG001|Overall Study|Lost to Follow-up|3|||
150050254|NCT00966875|541325931|FG005|Part A|Sponsor Decision|0|||
150050255|NCT00966875|541325932|FG006|Part A|Sponsor Decision|0|||
149912198|NCT03430895|540809454|FG000|Overall Study|Not Treated|2|||
149912199|NCT00084318|540809455|FG000|Overall Study|Withdrawal by Subject|5|||
149912200|NCT00084318|540809456|FG001|Overall Study|Withdrawal by Subject|2|||
149912201|NCT00084318|540809455|FG000|Overall Study|Protocol Violation|15|||
149912202|NCT00084318|540809456|FG001|Overall Study|Protocol Violation|11|||
149912203|NCT00084318|540809455|FG000|Overall Study|No protocol treatment|2|||
149912204|NCT00084318|540809456|FG001|Overall Study|No protocol treatment|0|||
149912205|NCT01317797|540809457|FG000|Overall Study|Other|0|||
149912206|NCT01317797|540809458|FG001|Overall Study|Other|1|||
149912207|NCT01317797|540809459|FG002|Overall Study|Other|0|||
149912208|NCT01317797|540809457|FG000|Overall Study|Withdrawal of Patient|0|||
149912209|NCT01317797|540809458|FG001|Overall Study|Withdrawal of Patient|0|||
150050256|NCT00966875|541325933|FG007|Part A|Sponsor Decision|2|||
150050257|NCT00966875|541325934|FG008|Part A|Sponsor Decision|1|||
150050258|NCT00966875|541325926|FG000|Part A|Withdrawal by Subject|2|||
150050259|NCT00966875|541325927|FG001|Part A|Withdrawal by Subject|2|||
150050260|NCT00966875|541325928|FG002|Part A|Withdrawal by Subject|1|||
150050261|NCT00966875|541325929|FG003|Part A|Withdrawal by Subject|1|||
150050262|NCT00966875|541325930|FG004|Part A|Withdrawal by Subject|3|||
150050263|NCT00966875|541325931|FG005|Part A|Withdrawal by Subject|0|||
150050264|NCT00966875|541325932|FG006|Part A|Withdrawal by Subject|5|||
150050265|NCT00966875|541325933|FG007|Part A|Withdrawal by Subject|1|||
150050266|NCT00966875|541325934|FG008|Part A|Withdrawal by Subject|1|||
150050267|NCT00966875|541325926|FG000|Part A|Protocol Violation|0|||
150050268|NCT00966875|541325927|FG001|Part A|Protocol Violation|0|||
150050269|NCT00966875|541325928|FG002|Part A|Protocol Violation|0|||
150050270|NCT00966875|541325929|FG003|Part A|Protocol Violation|0|||
150050271|NCT00966875|541325930|FG004|Part A|Protocol Violation|0|||
150050272|NCT00966875|541325931|FG005|Part A|Protocol Violation|0|||
150050273|NCT00966875|541325932|FG006|Part A|Protocol Violation|2|||
150050274|NCT00966875|541325933|FG007|Part A|Protocol Violation|1|||
150050275|NCT00966875|541325934|FG008|Part A|Protocol Violation|1|||
150050276|NCT00966875|541325926|FG000|Part B|Adverse Event|0|||
150050277|NCT00966875|541325927|FG001|Part B|Adverse Event|1|||
150050278|NCT00966875|541325928|FG002|Part B|Adverse Event|1|||
150050279|NCT00966875|541325929|FG003|Part B|Adverse Event|0|||
150050280|NCT00966875|541325930|FG004|Part B|Adverse Event|1|||
150050281|NCT00966875|541325931|FG005|Part B|Adverse Event|0|||
150050282|NCT00966875|541325932|FG006|Part B|Adverse Event|5|||
150050283|NCT00966875|541325933|FG007|Part B|Adverse Event|2|||
150050284|NCT00966875|541325934|FG008|Part B|Adverse Event|2|||
150050285|NCT00966875|541325926|FG000|Part B|Death|0|||
150050286|NCT00966875|541325927|FG001|Part B|Death|0|||
150050287|NCT00966875|541325928|FG002|Part B|Death|1|||
150050288|NCT00966875|541325929|FG003|Part B|Death|0|||
149912210|NCT01317797|540809459|FG002|Overall Study|Withdrawal of Patient|1|||
149912211|NCT04676412|540811124|FG000|Overall Study|Death|28|||
149912212|NCT04676412|540811125|FG001|Overall Study|Death|31|||
149912213|NCT04676412|540811124|FG000|Overall Study|Lost to Follow-up|1|||
150050289|NCT00966875|541325930|FG004|Part B|Death|0|||
150050290|NCT00966875|541325931|FG005|Part B|Death|0|||
150050291|NCT00966875|541325932|FG006|Part B|Death|0|||
150050292|NCT00966875|541325933|FG007|Part B|Death|1|||
150050293|NCT00966875|541325934|FG008|Part B|Death|0|||
150050294|NCT00966875|541325926|FG000|Part B|Lack of Efficacy|2|||
150050295|NCT00966875|541325927|FG001|Part B|Lack of Efficacy|1|||
150050296|NCT00966875|541325928|FG002|Part B|Lack of Efficacy|1|||
150050297|NCT00966875|541325929|FG003|Part B|Lack of Efficacy|1|||
150050298|NCT00966875|541325930|FG004|Part B|Lack of Efficacy|2|||
150050299|NCT00966875|541325931|FG005|Part B|Lack of Efficacy|3|||
150050300|NCT00966875|541325932|FG006|Part B|Lack of Efficacy|12|||
150050301|NCT00966875|541325933|FG007|Part B|Lack of Efficacy|9|||
150177080|NCT00736853|541784748|FG002|Double-Blind Period|Lack of Efficacy|42|||
149912214|NCT04676412|540811125|FG001|Overall Study|Lost to Follow-up|2|||
149912215|NCT04676412|540811124|FG000|Overall Study|Sponsor Decision|20|||
149912216|NCT04676412|540811125|FG001|Overall Study|Sponsor Decision|23|||
149912217|NCT04676412|540811124|FG000|Overall Study|Withdrawal by Subject|0|||
150050302|NCT00966875|541325934|FG008|Part B|Lack of Efficacy|6|||
150050303|NCT00966875|541325926|FG000|Part B|Lost to Follow-up|0|||
150050304|NCT00966875|541325927|FG001|Part B|Lost to Follow-up|0|||
150050305|NCT00966875|541325928|FG002|Part B|Lost to Follow-up|0|||
150050306|NCT00966875|541325929|FG003|Part B|Lost to Follow-up|1|||
150050307|NCT00966875|541325930|FG004|Part B|Lost to Follow-up|0|||
150050308|NCT00966875|541325931|FG005|Part B|Lost to Follow-up|0|||
150050309|NCT00966875|541325932|FG006|Part B|Lost to Follow-up|0|||
150050310|NCT00966875|541325933|FG007|Part B|Lost to Follow-up|0|||
150050311|NCT00966875|541325934|FG008|Part B|Lost to Follow-up|1|||
149912218|NCT04676412|540811125|FG001|Overall Study|Withdrawal by Subject|2|||
150050312|NCT00966875|541325926|FG000|Part B|Physician Decision|0|||
150050313|NCT00966875|541325927|FG001|Part B|Physician Decision|0|||
150050314|NCT00966875|541325928|FG002|Part B|Physician Decision|1|||
150050315|NCT00966875|541325929|FG003|Part B|Physician Decision|0|||
150050316|NCT00966875|541325930|FG004|Part B|Physician Decision|2|||
150050317|NCT00966875|541325931|FG005|Part B|Physician Decision|1|||
150050318|NCT00966875|541325932|FG006|Part B|Physician Decision|0|||
150050319|NCT00966875|541325933|FG007|Part B|Physician Decision|0|||
149912219|NCT05741346|540811126|FG000|Overall Study|Withdrawn due to termination of study|28|||
149912220|NCT05906836|540811138|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
149912221|NCT05906836|540811138|FG000|Overall Study|Lost to Follow-up|1|||
149912222|NCT04982575|540811139|FG000|Overall Study|Withdrawal by Subject|2|||
149912223|NCT04982575|540811140|FG001|Overall Study|Withdrawal by Subject|0|||
149912224|NCT04982575|540811141|FG002|Overall Study|Withdrawal by Subject|2|||
149912225|NCT01458951|540811150|FG000|Overall Study|Other|1|||
149912226|NCT01458951|540811151|FG001|Overall Study|Other|0|||
149912227|NCT01458951|540811152|FG002|Overall Study|Other|0|||
149912228|NCT01458951|540811150|FG000|Overall Study|Protocol Violation|5|||
149912229|NCT01458951|540811151|FG001|Overall Study|Protocol Violation|1|||
149912230|NCT01458951|540811152|FG002|Overall Study|Protocol Violation|0|||
149912231|NCT01458951|540811150|FG000|Overall Study|Withdrawal by Subject|2|||
149912232|NCT01458951|540811151|FG001|Overall Study|Withdrawal by Subject|0|||
149912233|NCT01458951|540811152|FG002|Overall Study|Withdrawal by Subject|2|||
149912234|NCT01458951|540811150|FG000|Overall Study|Adverse Event|7|||
149912235|NCT01458951|540811151|FG001|Overall Study|Adverse Event|0|||
149912236|NCT01458951|540811152|FG002|Overall Study|Adverse Event|2|||
149912237|NCT01458951|540811150|FG000|Overall Study|Insufficient Clinical Response|17|||
149912238|NCT01458951|540811151|FG001|Overall Study|Insufficient Clinical Response|0|||
149912239|NCT01458951|540811152|FG002|Overall Study|Insufficient Clinical Response|11|||
149912240|NCT04392167|540811163|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
149912241|NCT02963558|540811164|FG000|Overall Study|Withdrawn by investigator|1|||
149912242|NCT02963558|540811165|FG001|Overall Study|Withdrawn by investigator|0|||
149912243|NCT02963558|540811164|FG000|Overall Study|Withdrawal by Subject|0|||
149912244|NCT02963558|540811165|FG001|Overall Study|Withdrawal by Subject|1|||
149912245|NCT01573767|540811166|FG000|Overall Study|Adverse Event|0|||
149912246|NCT01573767|540811167|FG001|Overall Study|Adverse Event|1|||
149912247|NCT01573767|540811168|FG002|Overall Study|Adverse Event|0|||
149912248|NCT01573767|540811169|FG003|Overall Study|Adverse Event|1|||
149912249|NCT01573767|540811166|FG000|Overall Study|Lack of Efficacy|18|||
149912250|NCT01573767|540811167|FG001|Overall Study|Lack of Efficacy|15|||
149912251|NCT01573767|540811168|FG002|Overall Study|Lack of Efficacy|12|||
149912252|NCT01573767|540811169|FG003|Overall Study|Lack of Efficacy|17|||
149912253|NCT01573767|540811166|FG000|Overall Study|Protocol Violation|3|||
149912254|NCT01573767|540811167|FG001|Overall Study|Protocol Violation|1|||
149912255|NCT01573767|540811168|FG002|Overall Study|Protocol Violation|1|||
149912256|NCT01573767|540811169|FG003|Overall Study|Protocol Violation|3|||
149912257|NCT01573767|540811166|FG000|Overall Study|Lost to Follow-up|0|||
149912258|NCT01573767|540811167|FG001|Overall Study|Lost to Follow-up|1|||
149912259|NCT01573767|540811168|FG002|Overall Study|Lost to Follow-up|1|||
149912260|NCT01573767|540811169|FG003|Overall Study|Lost to Follow-up|1|||
149912261|NCT01573767|540811166|FG000|Overall Study|Physician Decision|1|||
149912262|NCT01573767|540811167|FG001|Overall Study|Physician Decision|2|||
149912263|NCT01573767|540811168|FG002|Overall Study|Physician Decision|0|||
149912264|NCT01573767|540811169|FG003|Overall Study|Physician Decision|2|||
149912265|NCT01573767|540811166|FG000|Overall Study|Withdrawal by Subject|0|||
149912266|NCT01573767|540811167|FG001|Overall Study|Withdrawal by Subject|1|||
149912267|NCT01573767|540811168|FG002|Overall Study|Withdrawal by Subject|0|||
149912268|NCT01573767|540811169|FG003|Overall Study|Withdrawal by Subject|0|||
149912269|NCT02339155|540811170|FG000|Overall Study|Adverse Event|0|||
149912270|NCT02339155|540811171|FG001|Overall Study|Adverse Event|6|||
150177081|NCT00736853|541784746|FG000|Double-Blind Period|Adverse Event|0|||
150177082|NCT00736853|541784747|FG001|Double-Blind Period|Adverse Event|3|||
149912271|NCT02339155|540811170|FG000|Overall Study|Death|1|||
149912272|NCT02339155|540811171|FG001|Overall Study|Death|1|||
149912273|NCT02339155|540811170|FG000|Overall Study|Lost to Follow-up|8|||
149912274|NCT02339155|540811171|FG001|Overall Study|Lost to Follow-up|9|||
149912275|NCT02339155|540811170|FG000|Overall Study|Physician Decision|2|||
149912276|NCT02339155|540811171|FG001|Overall Study|Physician Decision|1|||
149912277|NCT02339155|540811170|FG000|Overall Study|Withdrawal by Subject|4|||
149912278|NCT02339155|540811171|FG001|Overall Study|Withdrawal by Subject|4|||
149912279|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Adverse Event|0|||
149912280|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Adverse Event|1|||
149912281|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Adverse Event|0|||
150177083|NCT00736853|541784748|FG002|Double-Blind Period|Adverse Event|2|||
150177084|NCT00736853|541784746|FG000|Double-Blind Period|Withdrawal by Subject|0|||
149912282|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Adverse Event|0|||
149912283|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Adverse Event|0|||
149912284|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Adverse Event|0|||
149912285|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Death|0|||
149912286|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Death|0|||
149912287|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Death|1|||
149912288|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Death|0|||
149912289|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Death|0|||
149912290|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Death|0|||
149912291|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
149912292|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
149912293|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
149912294|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
149912295|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
149912296|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
149912297|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
149912298|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
149912299|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
149912300|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
149912301|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
149912302|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
149912303|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
150050320|NCT00966875|541325934|FG008|Part B|Physician Decision|2|||
150050321|NCT00966875|541325926|FG000|Part B|Sponsor Decision|1|||
150050322|NCT00966875|541325927|FG001|Part B|Sponsor Decision|0|||
150050323|NCT00966875|541325928|FG002|Part B|Sponsor Decision|0|||
150050324|NCT00966875|541325929|FG003|Part B|Sponsor Decision|0|||
150050325|NCT00966875|541325930|FG004|Part B|Sponsor Decision|0|||
150050326|NCT00966875|541325931|FG005|Part B|Sponsor Decision|1|||
150050327|NCT00966875|541325932|FG006|Part B|Sponsor Decision|0|||
150050328|NCT00966875|541325933|FG007|Part B|Sponsor Decision|2|||
150050329|NCT00966875|541325934|FG008|Part B|Sponsor Decision|1|||
150050330|NCT00966875|541325926|FG000|Part B|Withdrawal by Subject|2|||
150050331|NCT00966875|541325927|FG001|Part B|Withdrawal by Subject|1|||
150050332|NCT00966875|541325928|FG002|Part B|Withdrawal by Subject|2|||
150050333|NCT00966875|541325929|FG003|Part B|Withdrawal by Subject|1|||
150050334|NCT00966875|541325930|FG004|Part B|Withdrawal by Subject|2|||
150050335|NCT00966875|541325931|FG005|Part B|Withdrawal by Subject|1|||
150050336|NCT00966875|541325932|FG006|Part B|Withdrawal by Subject|4|||
150050337|NCT00966875|541325933|FG007|Part B|Withdrawal by Subject|5|||
150050338|NCT00966875|541325934|FG008|Part B|Withdrawal by Subject|5|||
150050339|NCT00966875|541325926|FG000|Part B|Entry Criteria|0|||
150050340|NCT00966875|541325927|FG001|Part B|Entry Criteria|0|||
150050341|NCT00966875|541325928|FG002|Part B|Entry Criteria|0|||
150050342|NCT00966875|541325929|FG003|Part B|Entry Criteria|0|||
150050343|NCT00966875|541325930|FG004|Part B|Entry Criteria|0|||
150050344|NCT00966875|541325931|FG005|Part B|Entry Criteria|0|||
150050345|NCT00966875|541325932|FG006|Part B|Entry Criteria|1|||
150050346|NCT00966875|541325933|FG007|Part B|Entry Criteria|0|||
150050347|NCT00966875|541325934|FG008|Part B|Entry Criteria|1|||
150050348|NCT01589653|541325937|FG000|Overall Study|Protocol Violation|3|||
150050349|NCT01589653|541325938|FG001|Overall Study|Protocol Violation|1|||
150050350|NCT01589653|541325937|FG000|Overall Study|Withdrawal criteria|4|||
150050351|NCT01589653|541325938|FG001|Overall Study|Withdrawal criteria|7|||
150050352|NCT01589653|541325937|FG000|Overall Study|Unclassified|0|||
150050353|NCT01589653|541325938|FG001|Overall Study|Unclassified|3|||
150050354|NCT01536067|541325939|FG000|Overall Study|Disease Progression|1|||
150050355|NCT02386189|541325942|FG000|Overall Study|Lost to Follow-up|2|||
150050356|NCT02386189|541325943|FG001|Overall Study|Lost to Follow-up|3|||
150050357|NCT02386189|541325942|FG000|Overall Study|Withdrawal by Subject|1|||
149912304|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
149912305|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
149912306|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
149912307|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
149912308|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
149972286|NCT00894387|541035625|FG001|Overall Study|Mis-randomized|9|||
149972287|NCT00894387|541035624|FG000|Overall Study|GCP non-compliance|0|||
149972288|NCT00894387|541035625|FG001|Overall Study|GCP non-compliance|2|||
149972289|NCT02519842|541035626|FG000|Base Study: Cycle 1|Screening Failure|1|||
149972290|NCT02519842|541035627|FG001|Base Study: Cycle 1|Screening Failure|1|||
149972291|NCT02519842|541035628|FG002|Base Study: Cycle 1|Screening Failure|0|||
149972292|NCT02519842|541035626|FG000|Base Study: Cycle 1|Adverse Event|1|||
149972293|NCT02519842|541035627|FG001|Base Study: Cycle 1|Adverse Event|0|||
149972294|NCT02519842|541035628|FG002|Base Study: Cycle 1|Adverse Event|0|||
149972295|NCT02519842|541035626|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
149972296|NCT02519842|541035627|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
149972297|NCT02519842|541035628|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
149972298|NCT02519842|541035626|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
149972299|NCT02519842|541035627|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
149972300|NCT02519842|541035628|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
149972301|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
149972302|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
149972303|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
149972304|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
149972305|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
149972306|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
149972307|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149912309|NCT03226678|540811176|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
150050358|NCT02386189|541325943|FG001|Overall Study|Withdrawal by Subject|0|||
150050359|NCT02386189|541325942|FG000|Overall Study|Death|1|||
150050360|NCT02386189|541325943|FG001|Overall Study|Death|0|||
150050361|NCT04657666|541325944|FG000|Period 1|Withdrawal of participant consent|2|||
150050362|NCT04657666|541325945|FG001|Period 1|Withdrawal of participant consent|1|||
150050363|NCT04657666|541325944|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
150050364|NCT04657666|541325945|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
150050365|NCT04657666|541325944|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
150050366|NCT04657666|541325945|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
150050367|NCT04657666|541325944|FG000|Period 2|Other|2|||
150050368|NCT04657666|541325945|FG001|Period 2|Other|0|||
150050369|NCT04657666|541325944|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
150050370|NCT04657666|541325945|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
150050371|NCT00606905|541325946|FG000|Overall Study|No Pregnancy|9|||
150050372|NCT00606905|541325947|FG001|Overall Study|No Pregnancy|6|||
150050373|NCT00606905|541325946|FG000|Overall Study|Non-Index Pregnancy|1|||
150050374|NCT00606905|541325947|FG001|Overall Study|Non-Index Pregnancy|4|||
150050375|NCT00606905|541325946|FG000|Overall Study|Withdrew|5|||
150050376|NCT00606905|541325947|FG001|Overall Study|Withdrew|5|||
150050377|NCT03120351|541325948|FG000|Overall Study|Physician Decision|1|||
150050378|NCT03120351|541325949|FG001|Overall Study|Physician Decision|1|||
150050379|NCT04250077|541325958|FG000|Overall Study|Withdrawal by Subject|0|||
150050380|NCT04250077|541325959|FG001|Overall Study|Withdrawal by Subject|1|||
150050381|NCT04250077|541325960|FG002|Overall Study|Withdrawal by Subject|0|||
150050382|NCT04250077|541325958|FG000|Overall Study|Lost to Follow-up|2|||
150050383|NCT04250077|541325959|FG001|Overall Study|Lost to Follow-up|3|||
150050384|NCT04250077|541325960|FG002|Overall Study|Lost to Follow-up|0|||
150050385|NCT01022398|541325961|FG000|Overall Study|Study terminated|2|||
150050386|NCT01022398|541325962|FG001|Overall Study|Study terminated|2|||
150050387|NCT03319745|541325964|FG000|Overall Study|Death|1|||
150050388|NCT03319745|541325964|FG000|Overall Study|Toxicity Precluding Surgery|1|||
150050389|NCT01317550|541325965|FG000|Overall Study|Withdrawal by Subject|1|||
150050390|NCT01317550|541325966|FG001|Overall Study|Withdrawal by Subject|0|||
150050391|NCT01317550|541325967|FG002|Overall Study|Withdrawal by Subject|0|||
150050392|NCT01317550|541325968|FG003|Overall Study|Withdrawal by Subject|0|||
150050393|NCT01317550|541325965|FG000|Overall Study|Lack of compliance study med|1|||
150050394|NCT01317550|541325966|FG001|Overall Study|Lack of compliance study med|0|||
150050395|NCT01317550|541325967|FG002|Overall Study|Lack of compliance study med|0|||
150050396|NCT01317550|541325968|FG003|Overall Study|Lack of compliance study med|0|||
150050397|NCT00870103|541325969|FG000|Overall Study|Physician Decision|2|||
150050398|NCT00870103|541325969|FG000|Overall Study|Lost to Follow-up|2|||
150050399|NCT03255629|541325970|FG000|Overall Study|Adverse Event|1|||
150050400|NCT03255629|541325971|FG001|Overall Study|Adverse Event|0|||
150050401|NCT03255629|541325970|FG000|Overall Study|did not experience hypoglycemia|2|||
150050402|NCT03255629|541325971|FG001|Overall Study|did not experience hypoglycemia|1|||
150050403|NCT04540198|541325972|FG000|Overall Study|Lost to Follow-up|25|||
150050404|NCT04540198|541325973|FG001|Overall Study|Lost to Follow-up|23|||
150050405|NCT04540198|541325972|FG000|Overall Study|Withdrawal by Subject|15|||
150050406|NCT04540198|541325973|FG001|Overall Study|Withdrawal by Subject|9|||
150050407|NCT04540198|541325972|FG000|Overall Study|Discontinued|1|||
150050408|NCT04540198|541325973|FG001|Overall Study|Discontinued|0|||
150050409|NCT04075734|541325974|FG000|Overall Study|Lost to Follow-up|1|||
150177085|NCT00736853|541784747|FG001|Double-Blind Period|Withdrawal by Subject|1|||
150050410|NCT04075734|541325975|FG001|Overall Study|Lost to Follow-up|1|||
150050411|NCT04075734|541325976|FG002|Overall Study|Lost to Follow-up|0|||
150050412|NCT04075734|541325974|FG000|Overall Study|Withdrawal by Subject|3|||
150050413|NCT04075734|541325975|FG001|Overall Study|Withdrawal by Subject|0|||
150050414|NCT04075734|541325976|FG002|Overall Study|Withdrawal by Subject|0|||
150050415|NCT01137604|541325977|FG000|Overall Study|Adverse Event|3|||
150050416|NCT01137604|541325978|FG001|Overall Study|Adverse Event|6|||
150050417|NCT01137604|541325979|FG002|Overall Study|Adverse Event|9|||
150050418|NCT01137604|541325980|FG003|Overall Study|Adverse Event|9|||
150050419|NCT01137604|541325977|FG000|Overall Study|Participant Choice|0|||
150050420|NCT01137604|541325978|FG001|Overall Study|Participant Choice|2|||
150050421|NCT01137604|541325979|FG002|Overall Study|Participant Choice|2|||
150050422|NCT01137604|541325980|FG003|Overall Study|Participant Choice|0|||
150050423|NCT01137604|541325977|FG000|Overall Study|Withdrawal of consent|0|||
150050424|NCT01137604|541325978|FG001|Overall Study|Withdrawal of consent|0|||
150050425|NCT01137604|541325979|FG002|Overall Study|Withdrawal of consent|0|||
150050426|NCT01137604|541325980|FG003|Overall Study|Withdrawal of consent|2|||
150050427|NCT01137604|541325977|FG000|Overall Study|Clinical progression/deterioration|1|||
150050428|NCT01137604|541325978|FG001|Overall Study|Clinical progression/deterioration|2|||
150050429|NCT01137604|541325979|FG002|Overall Study|Clinical progression/deterioration|2|||
150050430|NCT01137604|541325980|FG003|Overall Study|Clinical progression/deterioration|0|||
150050431|NCT01024309|541325986|FG000|Overall Study|Physician Decision|4|||
150050432|NCT01024309|541325987|FG001|Overall Study|Physician Decision|0|||
150050433|NCT01024309|541325986|FG000|Overall Study|Withdrawal by Subject|4|||
150050434|NCT01024309|541325987|FG001|Overall Study|Withdrawal by Subject|4|||
150050435|NCT00329797|541325988|FG000|Overall Study|Protocol Violation|1|||
150050436|NCT00329797|541325989|FG001|Overall Study|Protocol Violation|0|||
150050437|NCT00329797|541325988|FG000|Overall Study|Withdrawal by Subject|6|||
150050438|NCT00329797|541325989|FG001|Overall Study|Withdrawal by Subject|6|||
150050439|NCT00862641|541326001|FG000|Overall Study|Randomized, but drug not received|1|||
150050440|NCT00862641|541326002|FG001|Overall Study|Randomized, but drug not received|4|||
150050441|NCT00862641|541326003|FG002|Overall Study|Randomized, but drug not received|1|||
150050442|NCT00862641|541326004|FG003|Overall Study|Randomized, but drug not received|4|||
150050443|NCT03179605|541326005|FG000|Overall Study|Withdrawal by Subject|1|||
150050444|NCT00635999|541326006|FG000|Overall Study|Withdrawal by Subject|4|||
149912310|NCT03226678|540811177|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
149912311|NCT03226678|540811178|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
149912312|NCT03226678|540811179|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
149912313|NCT03226678|540811180|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
149912314|NCT03226678|540811181|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
149912315|NCT03226678|540811176|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
149912316|NCT03226678|540811177|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
149912317|NCT03226678|540811178|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
149912318|NCT03226678|540811179|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
149912319|NCT03226678|540811180|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
149912320|NCT03226678|540811181|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
149912321|NCT03226678|540811176|FG000|Part B (Long-Term Extension Phase)|Death|0|||
149912322|NCT03226678|540811177|FG001|Part B (Long-Term Extension Phase)|Death|0|||
149912323|NCT03226678|540811178|FG002|Part B (Long-Term Extension Phase)|Death|0|||
149912324|NCT03226678|540811179|FG003|Part B (Long-Term Extension Phase)|Death|0|||
149912325|NCT03226678|540811180|FG004|Part B (Long-Term Extension Phase)|Death|0|||
149912326|NCT03226678|540811181|FG005|Part B (Long-Term Extension Phase)|Death|1|||
150050445|NCT00635999|541326007|FG001|Overall Study|Withdrawal by Subject|2|||
150050446|NCT00635999|541326008|FG002|Overall Study|Withdrawal by Subject|1|||
150050447|NCT00711477|541326009|FG000|Overall Study|Adverse Event|3|||
150050448|NCT00711477|541326010|FG001|Overall Study|Adverse Event|1|||
149912327|NCT03226678|540811176|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
149912328|NCT03226678|540811177|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
150050449|NCT00711477|541326009|FG000|Overall Study|Lost to Follow-up|0|||
150050450|NCT00711477|541326010|FG001|Overall Study|Lost to Follow-up|1|||
150050451|NCT00711477|541326009|FG000|Overall Study|Noncompliance|0|||
150050452|NCT00711477|541326010|FG001|Overall Study|Noncompliance|1|||
150050453|NCT03037580|541326011|FG000|Overall Study|Withdrawal by Subject|3|||
149912329|NCT03226678|540811178|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
149912330|NCT03226678|540811179|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
149912331|NCT03226678|540811180|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
149912332|NCT03226678|540811181|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
149912333|NCT03226678|540811176|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
149912334|NCT03226678|540811177|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
149912335|NCT03226678|540811178|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
149912336|NCT03226678|540811179|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
149912337|NCT03226678|540811180|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
149912338|NCT03226678|540811181|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
149912339|NCT03226678|540811176|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
149912340|NCT03226678|540811177|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
149912341|NCT03226678|540811178|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
149912342|NCT03226678|540811179|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
149912343|NCT03226678|540811180|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
149912344|NCT03226678|540811181|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
149912345|NCT01371877|540811182|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
149912346|NCT01371877|540811183|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
149912347|NCT05932225|540811186|FG000|Overall Study|Lost to Follow-up|0|||
149912348|NCT05932225|540811187|FG001|Overall Study|Lost to Follow-up|1|||
149912349|NCT05932225|540811188|FG002|Overall Study|Lost to Follow-up|0|||
149912350|NCT05932225|540811186|FG000|Overall Study|Withdrawal by Subject|1|||
149912351|NCT05932225|540811187|FG001|Overall Study|Withdrawal by Subject|0|||
149912352|NCT05932225|540811188|FG002|Overall Study|Withdrawal by Subject|0|||
149912353|NCT05932225|540811186|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
149912354|NCT05932225|540811187|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
149912355|NCT05932225|540811188|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
149912356|NCT03427268|540811189|FG000|Overall Study|Progressive disease|25|||
149912357|NCT03427268|540811189|FG000|Overall Study|Never treated|2|||
149912358|NCT03427268|540811189|FG000|Overall Study|Compassionate use|1|||
149912359|NCT03427268|540811189|FG000|Overall Study|Withdrawal by Subject|1|||
149912360|NCT03427268|540811189|FG000|Overall Study|Adverse Event|3|||
149912361|NCT03117881|540811190|FG000|Baseline|Withdrawal by Subject|21|||
149912362|NCT03117881|540811191|FG001|Baseline|Withdrawal by Subject|10|||
149912363|NCT03117881|540811192|FG002|Baseline|Withdrawal by Subject|0|||
149912364|NCT03117881|540811190|FG000|Baseline|Lost to Follow-up|22|||
149912365|NCT03117881|540811191|FG001|Baseline|Lost to Follow-up|25|||
149912366|NCT03117881|540811192|FG002|Baseline|Lost to Follow-up|0|||
149912367|NCT03117881|540811190|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
149912368|NCT03117881|540811191|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
149912369|NCT03117881|540811192|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
149912370|NCT03117881|540811190|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
149912371|NCT03117881|540811191|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
149912372|NCT03117881|540811192|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
149912373|NCT03117881|540811190|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
149912374|NCT03117881|540811191|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
149912375|NCT03117881|540811192|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
149912376|NCT03117881|540811190|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
149912377|NCT03117881|540811191|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
149912378|NCT03117881|540811192|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
149912379|NCT03117881|540811190|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
149912380|NCT03117881|540811191|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
149912381|NCT03117881|540811192|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
149912382|NCT03117881|540811190|FG000|6-Month Follow-Up|Did not complete test|53|||
149912383|NCT03117881|540811191|FG001|6-Month Follow-Up|Did not complete test|25|||
149912384|NCT03117881|540811192|FG002|6-Month Follow-Up|Did not complete test|7|||
149912385|NCT03117881|540811190|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
149912386|NCT03117881|540811191|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
149912387|NCT03117881|540811192|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
149912388|NCT03117881|540811190|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
149912389|NCT03117881|540811191|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
149912390|NCT03117881|540811192|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
149912391|NCT03117881|540811190|FG000|12-Month Follow-Up|Did not complete test|40|||
149912392|NCT03117881|540811191|FG001|12-Month Follow-Up|Did not complete test|0|||
149912393|NCT03117881|540811192|FG002|12-Month Follow-Up|Did not complete test|0|||
149912394|NCT00308750|540811196|FG000|Overall Study|Adverse Event|9|||
149912395|NCT00308750|540811197|FG001|Overall Study|Adverse Event|9|||
149912396|NCT00308750|540811198|FG002|Overall Study|Adverse Event|13|||
149912397|NCT00308750|540811196|FG000|Overall Study|Withdrawal by Subject|6|||
149912398|NCT00308750|540811197|FG001|Overall Study|Withdrawal by Subject|2|||
150177086|NCT00736853|541784748|FG002|Double-Blind Period|Withdrawal by Subject|4|||
150177087|NCT00736853|541784746|FG000|Double-Blind Period|Ineligible to participate the study|0|||
150177088|NCT00736853|541784747|FG001|Double-Blind Period|Ineligible to participate the study|1|||
150177089|NCT00736853|541784748|FG002|Double-Blind Period|Ineligible to participate the study|0|||
150177090|NCT03473340|541784749|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
150177091|NCT03473340|541784750|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
150177092|NCT03473340|541784749|FG000|Overall Study|Withdrawal by Subject|1|||
150177093|NCT03473340|541784750|FG001|Overall Study|Withdrawal by Subject|0|||
150177094|NCT03473340|541784749|FG000|Overall Study|Lost to Follow-up|1|||
150177095|NCT03473340|541784750|FG001|Overall Study|Lost to Follow-up|2|||
150177096|NCT04623008|541786098|FG000|Baseline to T2|Withdrawal by Subject|4|||
150177097|NCT04623008|541786099|FG001|Baseline to T2|Withdrawal by Subject|2|||
150177098|NCT04623008|541786098|FG000|Baseline to T3|Withdrawal by Subject|4|||
150177099|NCT04623008|541786099|FG001|Baseline to T3|Withdrawal by Subject|2|||
150177100|NCT01875848|541786107|FG000|Overall Study|Withdrawal by Subject|2|||
150177101|NCT01875848|541786108|FG001|Overall Study|Withdrawal by Subject|0|||
150177102|NCT00434304|541786111|FG000|Overall Study|Adverse Event|14|||
150177103|NCT00434304|541786111|FG000|Overall Study|Lack of Efficacy|2|||
150177104|NCT00434304|541786111|FG000|Overall Study|Withdrawal by Subject|4|||
150177105|NCT05262738|541786112|FG000|Overall Study|Withdrawal by Subject|1|||
150177106|NCT05262738|541786113|FG001|Overall Study|Withdrawal by Subject|0|||
150177107|NCT02374463|541786116|FG000|Overall Study|Withdrawal by Subject|3|||
150177108|NCT02374463|541786117|FG001|Overall Study|Withdrawal by Subject|3|||
150177109|NCT01424397|541786119|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177110|NCT01424397|541786120|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
149912399|NCT00308750|540811198|FG002|Overall Study|Withdrawal by Subject|3|||
149912400|NCT00308750|540811196|FG000|Overall Study|Physician Decision|3|||
149912401|NCT00308750|540811197|FG001|Overall Study|Physician Decision|4|||
149912402|NCT00308750|540811198|FG002|Overall Study|Physician Decision|3|||
149912403|NCT00308750|540811196|FG000|Overall Study|Sponsor Decision|1|||
149912404|NCT00308750|540811197|FG001|Overall Study|Sponsor Decision|0|||
149912405|NCT00308750|540811198|FG002|Overall Study|Sponsor Decision|0|||
149912406|NCT00308750|540811196|FG000|Overall Study|Disease Progression|47|||
149912407|NCT00308750|540811197|FG001|Overall Study|Disease Progression|24|||
149912408|NCT00308750|540811198|FG002|Overall Study|Disease Progression|28|||
149912409|NCT00308750|540811196|FG000|Overall Study|Unrelated Complication|3|||
149912410|NCT00308750|540811197|FG001|Overall Study|Unrelated Complication|0|||
149912411|NCT00308750|540811198|FG002|Overall Study|Unrelated Complication|1|||
149912412|NCT00308750|540811196|FG000|Overall Study|Death|1|||
149912413|NCT00308750|540811197|FG001|Overall Study|Death|0|||
149912414|NCT00308750|540811198|FG002|Overall Study|Death|1|||
149912415|NCT00308750|540811196|FG000|Overall Study|Protocol Violation|1|||
149912416|NCT00308750|540811197|FG001|Overall Study|Protocol Violation|0|||
149912417|NCT00308750|540811198|FG002|Overall Study|Protocol Violation|0|||
149912418|NCT00308750|540811196|FG000|Overall Study|New Primary Disease Identified|1|||
149912419|NCT00308750|540811197|FG001|Overall Study|New Primary Disease Identified|1|||
149912420|NCT00308750|540811198|FG002|Overall Study|New Primary Disease Identified|0|||
149912421|NCT01358578|540811199|FG000|Induction Period|Adverse Event|2|||
149912422|NCT01358578|540811200|FG001|Induction Period|Adverse Event|4|||
149912423|NCT01358578|540811201|FG002|Induction Period|Adverse Event|2|||
149912424|NCT01358578|540811202|FG003|Induction Period|Adverse Event|6|||
149912425|NCT01358578|540811203|FG004|Induction Period|Adverse Event|0|||
149912426|NCT01358578|540811204|FG005|Induction Period|Adverse Event|0|||
149912427|NCT01358578|540811199|FG000|Induction Period|Lack of Efficacy|0|||
149912428|NCT01358578|540811200|FG001|Induction Period|Lack of Efficacy|0|||
149912429|NCT01358578|540811201|FG002|Induction Period|Lack of Efficacy|9|||
149912430|NCT01358578|540811202|FG003|Induction Period|Lack of Efficacy|1|||
149912431|NCT01358578|540811203|FG004|Induction Period|Lack of Efficacy|0|||
149912432|NCT01358578|540811204|FG005|Induction Period|Lack of Efficacy|0|||
149912433|NCT01358578|540811199|FG000|Induction Period|Lost to Follow-up|0|||
149912434|NCT01358578|540811200|FG001|Induction Period|Lost to Follow-up|0|||
149912435|NCT01358578|540811201|FG002|Induction Period|Lost to Follow-up|1|||
150177111|NCT01424397|541786121|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
149912436|NCT01358578|540811202|FG003|Induction Period|Lost to Follow-up|4|||
149912437|NCT01358578|540811203|FG004|Induction Period|Lost to Follow-up|0|||
149912438|NCT01358578|540811204|FG005|Induction Period|Lost to Follow-up|0|||
149912439|NCT01358578|540811199|FG000|Induction Period|Physician Decision|2|||
149972308|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
149912440|NCT01358578|540811200|FG001|Induction Period|Physician Decision|1|||
149912441|NCT01358578|540811201|FG002|Induction Period|Physician Decision|2|||
149912442|NCT01358578|540811202|FG003|Induction Period|Physician Decision|0|||
149912443|NCT01358578|540811203|FG004|Induction Period|Physician Decision|0|||
149912444|NCT01358578|540811204|FG005|Induction Period|Physician Decision|0|||
149912445|NCT01358578|540811199|FG000|Induction Period|Protocol Deviation|3|||
149912446|NCT01358578|540811200|FG001|Induction Period|Protocol Deviation|5|||
149912447|NCT01358578|540811201|FG002|Induction Period|Protocol Deviation|0|||
150050454|NCT03037580|541326012|FG001|Overall Study|Withdrawal by Subject|0|||
150050455|NCT03037580|541326011|FG000|Overall Study|Adverse Event|1|||
149912448|NCT01358578|540811202|FG003|Induction Period|Protocol Deviation|3|||
149912449|NCT01358578|540811203|FG004|Induction Period|Protocol Deviation|0|||
149912450|NCT01358578|540811204|FG005|Induction Period|Protocol Deviation|0|||
149912451|NCT01358578|540811199|FG000|Induction Period|technical problems|0|||
149912452|NCT01358578|540811200|FG001|Induction Period|technical problems|0|||
149912453|NCT01358578|540811201|FG002|Induction Period|technical problems|1|||
149912454|NCT01358578|540811202|FG003|Induction Period|technical problems|1|||
149912455|NCT01358578|540811203|FG004|Induction Period|technical problems|0|||
149912456|NCT01358578|540811204|FG005|Induction Period|technical problems|0|||
149912457|NCT01358578|540811199|FG000|Induction Period|Withdrawal by Subject|5|||
149912458|NCT01358578|540811200|FG001|Induction Period|Withdrawal by Subject|5|||
149912459|NCT01358578|540811201|FG002|Induction Period|Withdrawal by Subject|10|||
149912460|NCT01358578|540811202|FG003|Induction Period|Withdrawal by Subject|6|||
149912461|NCT01358578|540811203|FG004|Induction Period|Withdrawal by Subject|0|||
149912462|NCT01358578|540811204|FG005|Induction Period|Withdrawal by Subject|0|||
149912463|NCT01358578|540811199|FG000|Maintenance Period|Adverse Event|2|||
149912464|NCT01358578|540811200|FG001|Maintenance Period|Adverse Event|7|||
149912465|NCT01358578|540811201|FG002|Maintenance Period|Adverse Event|0|||
149912466|NCT01358578|540811202|FG003|Maintenance Period|Adverse Event|6|||
149912467|NCT01358578|540811203|FG004|Maintenance Period|Adverse Event|4|||
149912468|NCT01358578|540811204|FG005|Maintenance Period|Adverse Event|3|||
149912469|NCT01358578|540811199|FG000|Maintenance Period|Lack of Efficacy|10|||
149912470|NCT01358578|540811200|FG001|Maintenance Period|Lack of Efficacy|2|||
149912471|NCT01358578|540811201|FG002|Maintenance Period|Lack of Efficacy|0|||
149912472|NCT01358578|540811202|FG003|Maintenance Period|Lack of Efficacy|11|||
149912473|NCT01358578|540811203|FG004|Maintenance Period|Lack of Efficacy|3|||
149912474|NCT01358578|540811204|FG005|Maintenance Period|Lack of Efficacy|0|||
149912475|NCT01358578|540811199|FG000|Maintenance Period|Lost to Follow-up|4|||
149912476|NCT01358578|540811200|FG001|Maintenance Period|Lost to Follow-up|0|||
149912477|NCT01358578|540811201|FG002|Maintenance Period|Lost to Follow-up|0|||
149912478|NCT01358578|540811202|FG003|Maintenance Period|Lost to Follow-up|5|||
149912479|NCT01358578|540811203|FG004|Maintenance Period|Lost to Follow-up|1|||
149912480|NCT01358578|540811204|FG005|Maintenance Period|Lost to Follow-up|1|||
149912481|NCT01358578|540811199|FG000|Maintenance Period|Non-compliance with study treatment|3|||
149912482|NCT01358578|540811200|FG001|Maintenance Period|Non-compliance with study treatment|1|||
149912483|NCT01358578|540811201|FG002|Maintenance Period|Non-compliance with study treatment|0|||
149912484|NCT01358578|540811202|FG003|Maintenance Period|Non-compliance with study treatment|2|||
149912485|NCT01358578|540811203|FG004|Maintenance Period|Non-compliance with study treatment|1|||
149912486|NCT01358578|540811204|FG005|Maintenance Period|Non-compliance with study treatment|2|||
149912487|NCT01358578|540811199|FG000|Maintenance Period|Physician Decision|0|||
149912488|NCT01358578|540811200|FG001|Maintenance Period|Physician Decision|1|||
149912489|NCT01358578|540811201|FG002|Maintenance Period|Physician Decision|0|||
149912490|NCT01358578|540811202|FG003|Maintenance Period|Physician Decision|1|||
149912491|NCT01358578|540811203|FG004|Maintenance Period|Physician Decision|0|||
149912492|NCT01358578|540811204|FG005|Maintenance Period|Physician Decision|0|||
149912493|NCT01358578|540811199|FG000|Maintenance Period|Pregnancy|1|||
149912494|NCT01358578|540811200|FG001|Maintenance Period|Pregnancy|0|||
149912495|NCT01358578|540811201|FG002|Maintenance Period|Pregnancy|0|||
149912496|NCT01358578|540811202|FG003|Maintenance Period|Pregnancy|0|||
149912497|NCT01358578|540811203|FG004|Maintenance Period|Pregnancy|0|||
149972309|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
149972310|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
149972311|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
149972312|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
149972313|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Death|0|||
149972314|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Death|0|||
149972315|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Death|1|||
149972316|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
149972317|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
149972318|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
150050456|NCT03037580|541326012|FG001|Overall Study|Adverse Event|0|||
150050457|NCT03037580|541326011|FG000|Overall Study|Study Terminated by Sponsor|12|||
150050458|NCT03037580|541326012|FG001|Overall Study|Study Terminated by Sponsor|15|||
150050459|NCT03037580|541326011|FG000|Overall Study|Death|0|||
149912498|NCT01358578|540811204|FG005|Maintenance Period|Pregnancy|0|||
149912499|NCT01358578|540811199|FG000|Maintenance Period|Protocol deviation|7|||
149912500|NCT01358578|540811200|FG001|Maintenance Period|Protocol deviation|4|||
149912501|NCT01358578|540811201|FG002|Maintenance Period|Protocol deviation|0|||
149912502|NCT01358578|540811202|FG003|Maintenance Period|Protocol deviation|2|||
149912503|NCT01358578|540811203|FG004|Maintenance Period|Protocol deviation|2|||
149912504|NCT01358578|540811204|FG005|Maintenance Period|Protocol deviation|2|||
149912505|NCT01358578|540811199|FG000|Maintenance Period|Withdrawal by Subject|12|||
149912506|NCT01358578|540811200|FG001|Maintenance Period|Withdrawal by Subject|7|||
149912507|NCT01358578|540811201|FG002|Maintenance Period|Withdrawal by Subject|2|||
149912508|NCT01358578|540811202|FG003|Maintenance Period|Withdrawal by Subject|15|||
149912509|NCT01358578|540811203|FG004|Maintenance Period|Withdrawal by Subject|6|||
149912510|NCT01358578|540811204|FG005|Maintenance Period|Withdrawal by Subject|3|||
149912511|NCT01358578|540811199|FG000|Follow-up Period|Adverse Event|1|||
149912512|NCT01358578|540811200|FG001|Follow-up Period|Adverse Event|1|||
149912513|NCT01358578|540811201|FG002|Follow-up Period|Adverse Event|0|||
149912514|NCT01358578|540811202|FG003|Follow-up Period|Adverse Event|0|||
149912515|NCT01358578|540811203|FG004|Follow-up Period|Adverse Event|0|||
149912516|NCT01358578|540811204|FG005|Follow-up Period|Adverse Event|0|||
149912517|NCT01358578|540811199|FG000|Follow-up Period|Lack of Efficacy|3|||
149912518|NCT01358578|540811200|FG001|Follow-up Period|Lack of Efficacy|0|||
149912519|NCT01358578|540811201|FG002|Follow-up Period|Lack of Efficacy|4|||
149912520|NCT01358578|540811202|FG003|Follow-up Period|Lack of Efficacy|1|||
149912521|NCT01358578|540811203|FG004|Follow-up Period|Lack of Efficacy|0|||
149912522|NCT01358578|540811204|FG005|Follow-up Period|Lack of Efficacy|0|||
149912523|NCT01358578|540811199|FG000|Follow-up Period|Lost to Follow-up|0|||
149912524|NCT01358578|540811200|FG001|Follow-up Period|Lost to Follow-up|1|||
149912525|NCT01358578|540811201|FG002|Follow-up Period|Lost to Follow-up|0|||
149912526|NCT01358578|540811202|FG003|Follow-up Period|Lost to Follow-up|4|||
149912527|NCT01358578|540811203|FG004|Follow-up Period|Lost to Follow-up|0|||
149912528|NCT01358578|540811204|FG005|Follow-up Period|Lost to Follow-up|0|||
149912529|NCT01358578|540811199|FG000|Follow-up Period|non- compliance with study treatment|1|||
149912530|NCT01358578|540811200|FG001|Follow-up Period|non- compliance with study treatment|0|||
149912531|NCT01358578|540811201|FG002|Follow-up Period|non- compliance with study treatment|0|||
149912532|NCT01358578|540811202|FG003|Follow-up Period|non- compliance with study treatment|0|||
149912533|NCT01358578|540811203|FG004|Follow-up Period|non- compliance with study treatment|0|||
149912534|NCT01358578|540811204|FG005|Follow-up Period|non- compliance with study treatment|0|||
149912535|NCT01358578|540811199|FG000|Follow-up Period|Pregnancy|1|||
149912536|NCT01358578|540811200|FG001|Follow-up Period|Pregnancy|0|||
149912537|NCT01358578|540811201|FG002|Follow-up Period|Pregnancy|0|||
149912538|NCT01358578|540811202|FG003|Follow-up Period|Pregnancy|0|||
149912539|NCT01358578|540811203|FG004|Follow-up Period|Pregnancy|0|||
149912540|NCT01358578|540811204|FG005|Follow-up Period|Pregnancy|0|||
149912541|NCT01358578|540811199|FG000|Follow-up Period|Withdrawal by Subject|3|||
149912542|NCT01358578|540811200|FG001|Follow-up Period|Withdrawal by Subject|3|||
149972319|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
149972320|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
149972321|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
149972322|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
149972323|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
149972324|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
149972325|NCT02519842|541035626|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
149972326|NCT02519842|541035627|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
149972327|NCT02519842|541035628|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
149972328|NCT05643495|541035634|FG000|Overall Study|Adverse Event|0|||
149972329|NCT05643495|541035635|FG001|Overall Study|Adverse Event|1|||
149972330|NCT05643495|541035634|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
149972331|NCT05643495|541035635|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
149972332|NCT02661672|541035639|FG000|Overall Study|Lost to Follow-up|1|||
149972333|NCT02661672|541035639|FG000|Overall Study|Death|4|||
149972334|NCT00698828|541036865|FG000|Overall Study|Adverse Event|3|||
149972335|NCT00698828|541036866|FG001|Overall Study|Adverse Event|4|||
149972336|NCT00698828|541036867|FG002|Overall Study|Adverse Event|4|||
149972337|NCT00698828|541036865|FG000|Overall Study|Death|0|||
149972338|NCT00698828|541036866|FG001|Overall Study|Death|0|||
149972339|NCT00698828|541036867|FG002|Overall Study|Death|1|||
149972340|NCT00698828|541036865|FG000|Overall Study|Exacerbation of COPD|1|||
149972341|NCT00698828|541036866|FG001|Overall Study|Exacerbation of COPD|3|||
149912543|NCT01358578|540811201|FG002|Follow-up Period|Withdrawal by Subject|1|||
149912544|NCT01358578|540811202|FG003|Follow-up Period|Withdrawal by Subject|12|||
149972342|NCT00698828|541036867|FG002|Overall Study|Exacerbation of COPD|0|||
149972343|NCT00698828|541036865|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
149972344|NCT00698828|541036866|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
149972345|NCT00698828|541036867|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
149972346|NCT00698828|541036865|FG000|Overall Study|Investigator/Sponsor decision|1|||
149972347|NCT00698828|541036866|FG001|Overall Study|Investigator/Sponsor decision|0|||
149972348|NCT00698828|541036867|FG002|Overall Study|Investigator/Sponsor decision|2|||
149912545|NCT01358578|540811203|FG004|Follow-up Period|Withdrawal by Subject|0|||
149912546|NCT01358578|540811204|FG005|Follow-up Period|Withdrawal by Subject|0|||
149912547|NCT01358578|540811199|FG000|Follow-up Period|Physician Decision|1|||
149912548|NCT01358578|540811200|FG001|Follow-up Period|Physician Decision|1|||
149912549|NCT01358578|540811201|FG002|Follow-up Period|Physician Decision|0|||
149912550|NCT01358578|540811202|FG003|Follow-up Period|Physician Decision|2|||
149912551|NCT01358578|540811203|FG004|Follow-up Period|Physician Decision|0|||
149912552|NCT01358578|540811204|FG005|Follow-up Period|Physician Decision|0|||
149912553|NCT01643798|540811205|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
149912554|NCT01643798|540811206|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
149912555|NCT03605849|540811207|FG000|Overall Study|Adverse Event|20|||
149912556|NCT03605849|540811208|FG001|Overall Study|Adverse Event|21|||
149912557|NCT03605849|540811209|FG002|Overall Study|Adverse Event|29|||
150050460|NCT03037580|541326012|FG001|Overall Study|Death|1|||
149912558|NCT03605849|540811210|FG003|Overall Study|Adverse Event|11|||
149912559|NCT03605849|540811207|FG000|Overall Study|Lack of Efficacy|4|||
149912560|NCT03605849|540811208|FG001|Overall Study|Lack of Efficacy|7|||
149912561|NCT03605849|540811209|FG002|Overall Study|Lack of Efficacy|9|||
149912562|NCT03605849|540811210|FG003|Overall Study|Lack of Efficacy|2|||
149912563|NCT03605849|540811207|FG000|Overall Study|Lost to Follow-up|8|||
149912564|NCT03605849|540811208|FG001|Overall Study|Lost to Follow-up|8|||
149912565|NCT03605849|540811209|FG002|Overall Study|Lost to Follow-up|14|||
149912566|NCT03605849|540811210|FG003|Overall Study|Lost to Follow-up|11|||
149912567|NCT03605849|540811207|FG000|Overall Study|Non-compliance With IMP|6|||
149912568|NCT03605849|540811208|FG001|Overall Study|Non-compliance With IMP|5|||
149912569|NCT03605849|540811209|FG002|Overall Study|Non-compliance With IMP|2|||
149912570|NCT03605849|540811210|FG003|Overall Study|Non-compliance With IMP|1|||
149912571|NCT03605849|540811207|FG000|Overall Study|Protocol Deviation|1|||
149912572|NCT03605849|540811208|FG001|Overall Study|Protocol Deviation|2|||
149912573|NCT03605849|540811209|FG002|Overall Study|Protocol Deviation|1|||
149912574|NCT03605849|540811210|FG003|Overall Study|Protocol Deviation|3|||
149912575|NCT03605849|540811207|FG000|Overall Study|Withdrawal by Subject|33|||
149912576|NCT03605849|540811208|FG001|Overall Study|Withdrawal by Subject|28|||
149912577|NCT03605849|540811209|FG002|Overall Study|Withdrawal by Subject|30|||
149912578|NCT03605849|540811210|FG003|Overall Study|Withdrawal by Subject|28|||
149912579|NCT03605849|540811207|FG000|Overall Study|Site Terminated by Sponsor|0|||
149912580|NCT03605849|540811208|FG001|Overall Study|Site Terminated by Sponsor|0|||
149912581|NCT03605849|540811209|FG002|Overall Study|Site Terminated by Sponsor|0|||
149912582|NCT03605849|540811210|FG003|Overall Study|Site Terminated by Sponsor|1|||
149912583|NCT03605849|540811207|FG000|Overall Study|Physician Decision|2|||
149912584|NCT03605849|540811208|FG001|Overall Study|Physician Decision|1|||
149912585|NCT03605849|540811209|FG002|Overall Study|Physician Decision|2|||
149912586|NCT03605849|540811210|FG003|Overall Study|Physician Decision|1|||
149912587|NCT03605849|540811207|FG000|Overall Study|Enrolled, but not Treated|2|||
149912588|NCT03605849|540811208|FG001|Overall Study|Enrolled, but not Treated|2|||
149912589|NCT03605849|540811209|FG002|Overall Study|Enrolled, but not Treated|3|||
149912590|NCT03605849|540811210|FG003|Overall Study|Enrolled, but not Treated|2|||
149912591|NCT03605849|540811207|FG000|Overall Study|Other (COVID-19 Related)|0|||
149912592|NCT03605849|540811208|FG001|Overall Study|Other (COVID-19 Related)|1|||
149912593|NCT03605849|540811209|FG002|Overall Study|Other (COVID-19 Related)|1|||
149912594|NCT03605849|540811210|FG003|Overall Study|Other (COVID-19 Related)|0|||
149912595|NCT03605849|540811207|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
149912596|NCT03605849|540811208|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
149912597|NCT03605849|540811209|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
149912598|NCT03605849|540811210|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
149912599|NCT02304380|540811212|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
149912600|NCT02304380|540811213|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
149912601|NCT02304380|540811214|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
149912602|NCT02304380|540811215|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
149912603|NCT02304380|540811216|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
149912604|NCT02304380|540811217|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
149912605|NCT01027897|540811218|FG000|Overall Study|Protocol Violation|1|||
149912606|NCT01027897|540811218|FG000|Overall Study|Withdrawal by Subject|1|||
150050461|NCT03500224|541326013|FG000|Overall Study|Withdrawal by Subject|2|||
150050462|NCT01324401|541326014|FG000|Overall Study|Withdrawn before any treatment|0|||
150050463|NCT01324401|541326015|FG001|Overall Study|Withdrawn before any treatment|3|||
150050464|NCT01324401|541326014|FG000|Overall Study|Adverse Event|1|||
150050465|NCT01324401|541326015|FG001|Overall Study|Adverse Event|3|||
150050466|NCT00335764|541326016|FG000|Overall Study|wrong histology|1|||
150050467|NCT00335764|541326017|FG001|Overall Study|wrong histology|0|||
150050468|NCT00335764|541326018|FG002|Overall Study|wrong histology|0|||
150050469|NCT00335764|541326019|FG003|Overall Study|wrong histology|0|||
150050470|NCT00335764|541326020|FG004|Overall Study|wrong histology|1|||
149912607|NCT00328094|540811219|FG000|Overall Study|Physician Decision|3|||
149912608|NCT00328094|540811220|FG001|Overall Study|Physician Decision|3|||
149912609|NCT01911780|540811221|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
149912610|NCT01911780|540811222|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
149912611|NCT01911780|540811221|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
149912612|NCT01911780|540811222|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
150050471|NCT00499590|541326021|FG000|Overall Study|Study Terminated|112|||
149912613|NCT01911780|540811221|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
149912614|NCT01911780|540811222|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
149912615|NCT01911780|540811221|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
149912616|NCT01911780|540811222|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
149912617|NCT01911780|540811221|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
149912618|NCT01911780|540811222|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
149912619|NCT01911780|540811221|FG000|Extension Period (52 Weeks)|Personal reason|1|||
149912620|NCT01911780|540811222|FG001|Extension Period (52 Weeks)|Personal reason|1|||
149912621|NCT02045732|540811225|FG000|Overall Study|At the discretion of the investigator|1|||
149912622|NCT02045732|540811226|FG001|Overall Study|At the discretion of the investigator|1|||
149912623|NCT02667626|540811227|FG000|Overall Study|Withdrawal by Subject|0|||
149912624|NCT02667626|540811228|FG001|Overall Study|Withdrawal by Subject|1|||
149912625|NCT00473824|540811229|FG000|Overall Study|Virologic Breakthrough|1|||
149912626|NCT00473824|540811230|FG001|Overall Study|Virologic Breakthrough|0|||
149912627|NCT00473824|540811229|FG000|Overall Study|Adverse Event|1|||
149912628|NCT00473824|540811230|FG001|Overall Study|Adverse Event|0|||
149912629|NCT00473824|540811229|FG000|Overall Study|Death|1|||
149912630|NCT00473824|540811230|FG001|Overall Study|Death|0|||
149912631|NCT00473824|540811229|FG000|Overall Study|Lost to Follow-up|1|||
149912632|NCT00473824|540811230|FG001|Overall Study|Lost to Follow-up|0|||
149912633|NCT00473824|540811229|FG000|Overall Study|Withdrawal by physician|1|||
149912634|NCT00473824|540811230|FG001|Overall Study|Withdrawal by physician|0|||
149912635|NCT02560623|540811231|FG000|Overall Study|Unable to swallow sponge|0|||
149912636|NCT02560623|540811232|FG001|Overall Study|Unable to swallow sponge|1|||
149912637|NCT02560623|540811233|FG002|Overall Study|Unable to swallow sponge|0|||
149912638|NCT02560623|540811234|FG003|Overall Study|Unable to swallow sponge|0|||
149912639|NCT02560623|540811231|FG000|Overall Study|Intervention prior to sponge administration|0|||
149912640|NCT02560623|540811232|FG001|Overall Study|Intervention prior to sponge administration|1|||
149912641|NCT02560623|540811233|FG002|Overall Study|Intervention prior to sponge administration|0|||
149912642|NCT02560623|540811234|FG003|Overall Study|Intervention prior to sponge administration|0|||
149912643|NCT01349322|540811235|FG000|Overall Study|Protocol Violation|45|||
149912644|NCT01349322|540811236|FG001|Overall Study|Protocol Violation|47|||
149912645|NCT05014815|540811237|FG000|Overall Study|Death|63|||
149912646|NCT05014815|540811238|FG001|Overall Study|Death|70|||
149912647|NCT05014815|540811237|FG000|Overall Study|Withdrawal by Subject|10|||
149912648|NCT05014815|540811238|FG001|Overall Study|Withdrawal by Subject|10|||
149912649|NCT05014815|540811237|FG000|Overall Study|Lost to Follow-up|4|||
149912650|NCT05014815|540811238|FG001|Overall Study|Lost to Follow-up|2|||
149912651|NCT05014815|540811237|FG000|Overall Study|Physician Decision|2|||
149912652|NCT05014815|540811238|FG001|Overall Study|Physician Decision|4|||
149912653|NCT04247880|540811239|FG000|Overall Study|Lost to Follow-up|24|||
149912654|NCT04247880|540811240|FG001|Overall Study|Lost to Follow-up|17|||
149912655|NCT04247880|540811239|FG000|Overall Study|Withdrawal by Subject|3|||
149912656|NCT04247880|540811240|FG001|Overall Study|Withdrawal by Subject|0|||
149912657|NCT00250458|540811245|FG000|Overall Study|Lost to Follow-up|4|||
149912658|NCT00250458|540811246|FG001|Overall Study|Lost to Follow-up|2|||
149912659|NCT00250458|540811245|FG000|Overall Study|Protocol Violation|0|||
149912660|NCT00250458|540811246|FG001|Overall Study|Protocol Violation|1|||
149912661|NCT00250458|540811245|FG000|Overall Study|Withdrawal by Subject|4|||
149912662|NCT00250458|540811246|FG001|Overall Study|Withdrawal by Subject|2|||
149912663|NCT00250458|540811245|FG000|Overall Study|Lack of Migraine Attack|20|||
149912664|NCT00250458|540811246|FG001|Overall Study|Lack of Migraine Attack|9|||
149912665|NCT00250458|540811245|FG000|Overall Study|Qualifying migraine but did not treat|3|||
149912666|NCT00250458|540811246|FG001|Overall Study|Qualifying migraine but did not treat|3|||
149912667|NCT00250458|540811245|FG000|Overall Study|Other|1|||
149912668|NCT00250458|540811246|FG001|Overall Study|Other|0|||
149912669|NCT00480493|540811249|FG000|Overall Study|moved|2|||
149912670|NCT00480493|540811250|FG001|Overall Study|moved|7|||
149912671|NCT04027075|540811251|FG000|Overall Study|Lost to Follow-up|41|||
149912672|NCT04027075|540811252|FG001|Overall Study|Lost to Follow-up|22|||
149912673|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
149912674|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
149912675|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
149912676|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
149912677|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
149912678|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
149912679|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
149912680|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
149912681|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
149912682|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
149912683|NCT00455520|540811254|FG000|Open Label Tapentadol Extended Release|All other|33|||
149912684|NCT00455520|540811255|FG001|Open Label Tapentadol Extended Release|All other|0|||
149912685|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
150050472|NCT00499590|541326022|FG001|Overall Study|Study Terminated|112|||
150050473|NCT00499590|541326023|FG002|Overall Study|Study Terminated|112|||
150050474|NCT00499590|541326021|FG000|Overall Study|Not treated|1|||
150050475|NCT00499590|541326022|FG001|Overall Study|Not treated|0|||
150050476|NCT00499590|541326023|FG002|Overall Study|Not treated|1|||
150050477|NCT02873429|541326026|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
150050478|NCT02873429|541326027|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
150050479|NCT02873429|541326026|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
150050480|NCT02873429|541326027|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
150050481|NCT02873429|541326026|FG000|16 Weeks|Lost to Follow-up|3|||
150050482|NCT02873429|541326027|FG001|16 Weeks|Lost to Follow-up|0|||
150050483|NCT00612807|541326028|FG000|Overall Study|Withdrawal by Subject|2|||
150050484|NCT00612807|541326029|FG001|Overall Study|Withdrawal by Subject|0|||
150050485|NCT00744042|541326032|FG000|Overall Study|Withdrawal by Subject|1|||
150050486|NCT00853567|541326034|FG000|Overall Study|Study prematurely terminated|71|||
150050487|NCT02259088|541326035|FG000|Overall Study|Adverse Event|6|||
150050488|NCT02259088|541326036|FG001|Overall Study|Adverse Event|4|||
150050489|NCT02259088|541326035|FG000|Overall Study|Lost to Follow-up|2|||
150050490|NCT02259088|541326036|FG001|Overall Study|Lost to Follow-up|0|||
150050491|NCT02259088|541326035|FG000|Overall Study|Death|2|||
150050492|NCT02259088|541326036|FG001|Overall Study|Death|0|||
150050493|NCT02259088|541326035|FG000|Overall Study|Physician Decision|5|||
150050494|NCT02259088|541326036|FG001|Overall Study|Physician Decision|2|||
150050495|NCT02259088|541326035|FG000|Overall Study|Protocol deviation|5|||
150050496|NCT02259088|541326036|FG001|Overall Study|Protocol deviation|0|||
150050497|NCT02259088|541326035|FG000|Overall Study|Subject/guardian decision|8|||
150050498|NCT02259088|541326036|FG001|Overall Study|Subject/guardian decision|8|||
150050499|NCT01818752|541326038|FG000|Overall Study|Adverse Event|64|||
150050500|NCT01818752|541326039|FG001|Overall Study|Adverse Event|74|||
150050501|NCT01818752|541326038|FG000|Overall Study|Death|14|||
150050502|NCT01818752|541326039|FG001|Overall Study|Death|18|||
150050503|NCT01818752|541326038|FG000|Overall Study|Non-compliance|16|||
150050504|NCT01818752|541326039|FG001|Overall Study|Non-compliance|20|||
150050505|NCT01818752|541326038|FG000|Overall Study|Withdrawal by Subject|15|||
150050506|NCT01818752|541326039|FG001|Overall Study|Withdrawal by Subject|14|||
150050507|NCT01818752|541326038|FG000|Overall Study|Physician Decision|9|||
150050508|NCT01818752|541326039|FG001|Overall Study|Physician Decision|8|||
150050509|NCT01818752|541326038|FG000|Overall Study|Disease Progression|54|||
150050510|NCT01818752|541326039|FG001|Overall Study|Disease Progression|48|||
150050511|NCT01818752|541326038|FG000|Overall Study|Other|7|||
150050512|NCT01818752|541326039|FG001|Overall Study|Other|8|||
150050513|NCT01818752|541326038|FG000|Overall Study|Continuing Treatment|1|||
150050514|NCT01818752|541326039|FG001|Overall Study|Continuing Treatment|4|||
150050515|NCT01818752|541326038|FG000|Overall Study|Randomized but not Dosed|7|||
150050516|NCT01818752|541326039|FG001|Overall Study|Randomized but not Dosed|4|||
150050517|NCT04270370|541326040|FG000|Overall Study|Lost to Follow-up|1|||
150050518|NCT04270370|541326041|FG001|Overall Study|Lost to Follow-up|0|||
150050519|NCT04270370|541326042|FG002|Overall Study|Lost to Follow-up|0|||
150050520|NCT04270370|541326043|FG003|Overall Study|Lost to Follow-up|0|||
150050521|NCT04270370|541326044|FG004|Overall Study|Lost to Follow-up|0|||
150050522|NCT04270370|541326045|FG005|Overall Study|Lost to Follow-up|0|||
149912686|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
149912687|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
149912688|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
149912689|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
149912690|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
149912691|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
149912692|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
149912693|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
149912694|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
149912695|NCT00455520|540811254|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
149912696|NCT00455520|540811255|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
149912697|NCT01068626|540811260|FG000|Overall Study|Adverse Event|3|||
149912698|NCT01068626|540811261|FG001|Overall Study|Adverse Event|0|||
149912699|NCT01068626|540811260|FG000|Overall Study|Withdrawal by Subject|0|||
149912700|NCT01068626|540811261|FG001|Overall Study|Withdrawal by Subject|2|||
149912701|NCT01785849|540811262|FG000|Overall Study|Death|7|||
149912702|NCT01785849|540811263|FG001|Overall Study|Death|9|||
149912703|NCT01785849|540811262|FG000|Overall Study|Protocol Specified Criteria|29|||
149912704|NCT01785849|540811263|FG001|Overall Study|Protocol Specified Criteria|1|||
150050523|NCT04270370|541326046|FG006|Overall Study|Lost to Follow-up|0|||
150050524|NCT04270370|541326047|FG007|Overall Study|Lost to Follow-up|0|||
150050525|NCT04270370|541326048|FG008|Overall Study|Lost to Follow-up|1|||
150050526|NCT04270370|541326049|FG009|Overall Study|Lost to Follow-up|0|||
150050527|NCT04270370|541326050|FG010|Overall Study|Lost to Follow-up|0|||
150050528|NCT04270370|541326051|FG011|Overall Study|Lost to Follow-up|0|||
150050529|NCT01324141|541326052|FG000|Overall Study|Declined to participate before treatment started|1|||
150050530|NCT01324141|541326052|FG000|Overall Study|Disease progression on study|1|||
150050531|NCT02872285|541326053|FG000|Overall Study|Withdrawal by Subject|2|||
150050532|NCT02872285|541326054|FG001|Overall Study|Withdrawal by Subject|0|||
150050533|NCT02872285|541326053|FG000|Overall Study|Lost to Follow-up|2|||
150050534|NCT02872285|541326054|FG001|Overall Study|Lost to Follow-up|2|||
150050535|NCT02872285|541326053|FG000|Overall Study|Discontinued due to back surgery|1|||
150050536|NCT02872285|541326054|FG001|Overall Study|Discontinued due to back surgery|0|||
150050537|NCT06457204|541326055|FG000|Washout|Adverse Event|0|||
150050538|NCT06457204|541326056|FG001|Washout|Adverse Event|2|||
150050539|NCT01031836|541327559|FG000|Stage I|Adverse Event|1|||
150050540|NCT01031836|541327560|FG001|Stage I|Adverse Event|1|||
150050541|NCT01031836|541327561|FG002|Stage I|Adverse Event|0|||
150050542|NCT01031836|541327562|FG003|Stage I|Adverse Event|0|||
150050543|NCT01031836|541327563|FG004|Stage I|Adverse Event|0|||
150050544|NCT01031836|541327564|FG005|Stage I|Adverse Event|0|||
150050545|NCT01031836|541327559|FG000|Stage I|Other|0|||
150050546|NCT01031836|541327560|FG001|Stage I|Other|1|||
150050547|NCT01031836|541327561|FG002|Stage I|Other|0|||
150050548|NCT01031836|541327562|FG003|Stage I|Other|0|||
150050549|NCT01031836|541327563|FG004|Stage I|Other|0|||
150050550|NCT01031836|541327564|FG005|Stage I|Other|1|||
150050551|NCT01031836|541327559|FG000|Stage II|Adverse Event|0|||
150050552|NCT01031836|541327560|FG001|Stage II|Adverse Event|0|||
150050553|NCT01031836|541327561|FG002|Stage II|Adverse Event|2|||
150050554|NCT01031836|541327562|FG003|Stage II|Adverse Event|2|||
150050555|NCT01031836|541327563|FG004|Stage II|Adverse Event|1|||
150050556|NCT01031836|541327564|FG005|Stage II|Adverse Event|1|||
150050557|NCT01031836|541327559|FG000|Stage II|Other|2|||
150050558|NCT01031836|541327560|FG001|Stage II|Other|0|||
150050559|NCT01031836|541327561|FG002|Stage II|Other|0|||
150050560|NCT01031836|541327562|FG003|Stage II|Other|1|||
150050561|NCT01031836|541327563|FG004|Stage II|Other|1|||
150050562|NCT01031836|541327564|FG005|Stage II|Other|0|||
150050563|NCT00490529|541327565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
150050564|NCT00490529|541327565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
150050565|NCT00490529|541327565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
150050566|NCT00490529|541327565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
150050567|NCT00490529|541327565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
150050568|NCT00490529|541327565|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
150050569|NCT00617669|541327572|FG000|Overall Study|Withdrawal by Subject|71|||
150050570|NCT00617669|541327573|FG001|Overall Study|Withdrawal by Subject|77|||
150050571|NCT00617669|541327572|FG000|Overall Study|Lost to Follow-up|3|||
150050572|NCT00617669|541327573|FG001|Overall Study|Lost to Follow-up|2|||
150050573|NCT00617669|541327572|FG000|Overall Study|Adverse Event|87|||
150050574|NCT00617669|541327573|FG001|Overall Study|Adverse Event|76|||
150050575|NCT00617669|541327572|FG000|Overall Study|Protocol Violation|2|||
150050576|NCT00617669|541327573|FG001|Overall Study|Protocol Violation|3|||
150050577|NCT00617669|541327572|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
150050578|NCT00617669|541327573|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
150050579|NCT00617669|541327572|FG000|Overall Study|Patients randomized but not treated|2|||
150050580|NCT00617669|541327573|FG001|Overall Study|Patients randomized but not treated|3|||
150050581|NCT01410357|541327574|FG000|Overall Study|Death|2|||
150050582|NCT01410357|541327575|FG001|Overall Study|Death|1|||
150050583|NCT01410357|541327574|FG000|Overall Study|Withdrawal by Subject|1|||
150050584|NCT01410357|541327575|FG001|Overall Study|Withdrawal by Subject|2|||
150050585|NCT01410357|541327574|FG000|Overall Study|Lost to Follow-up|23|||
150050586|NCT01410357|541327575|FG001|Overall Study|Lost to Follow-up|21|||
150050587|NCT03467152|541327582|FG000|Overall Study|Adverse Event|4|||
150050588|NCT03467152|541327583|FG001|Overall Study|Adverse Event|5|||
150050589|NCT03467152|541327584|FG002|Overall Study|Adverse Event|0|||
150050590|NCT03467152|541327582|FG000|Overall Study|Subject Choice|1|||
150050591|NCT03467152|541327583|FG001|Overall Study|Subject Choice|3|||
150050592|NCT03467152|541327584|FG002|Overall Study|Subject Choice|0|||
150050593|NCT03467152|541327582|FG000|Overall Study|Lost to Follow-up|1|||
150050594|NCT03467152|541327583|FG001|Overall Study|Lost to Follow-up|0|||
150050595|NCT03467152|541327584|FG002|Overall Study|Lost to Follow-up|0|||
150050596|NCT03467152|541327582|FG000|Overall Study|Withdrawal by Subject|4|||
150177112|NCT01424397|541786122|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177113|NCT01424397|541786123|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
150050597|NCT03467152|541327583|FG001|Overall Study|Withdrawal by Subject|2|||
150050598|NCT03467152|541327584|FG002|Overall Study|Withdrawal by Subject|0|||
150050599|NCT03467152|541327582|FG000|Overall Study|Others|3|||
150050600|NCT03467152|541327583|FG001|Overall Study|Others|0|||
150050601|NCT03467152|541327584|FG002|Overall Study|Others|0|||
150050602|NCT03467152|541327582|FG000|Overall Study|Not treated|3|||
150050603|NCT03467152|541327583|FG001|Overall Study|Not treated|1|||
150050604|NCT03467152|541327584|FG002|Overall Study|Not treated|6|||
150050605|NCT00945906|541327585|FG000|Overall Study|Withdrawal by Subject|1|||
150050606|NCT00945906|541327585|FG000|Overall Study|Did not want to return for last visit|2|||
149912705|NCT01785849|540811262|FG000|Overall Study|Withdrawal by Subject|15|||
149912706|NCT01785849|540811263|FG001|Overall Study|Withdrawal by Subject|12|||
149912707|NCT01785849|540811262|FG000|Overall Study|Sponsor Decision|0|||
149912708|NCT01785849|540811263|FG001|Overall Study|Sponsor Decision|1|||
149912709|NCT01785849|540811262|FG000|Overall Study|Lost to Follow-up|10|||
149912710|NCT01785849|540811263|FG001|Overall Study|Lost to Follow-up|11|||
149912711|NCT00808639|540811266|FG000|Overall Study|Disease progression before surgery.|1|||
149912712|NCT02089334|540811269|FG000|Overall Study|Withdrawal by Subject|0|||
149912713|NCT02089334|540811270|FG001|Overall Study|Withdrawal by Subject|0|||
149912714|NCT02089334|540811271|FG002|Overall Study|Withdrawal by Subject|0|||
149912715|NCT02089334|540811272|FG003|Overall Study|Withdrawal by Subject|2|||
149912716|NCT02089334|540811269|FG000|Overall Study|Adverse Event|0|||
149912717|NCT02089334|540811270|FG001|Overall Study|Adverse Event|0|||
149912718|NCT02089334|540811271|FG002|Overall Study|Adverse Event|0|||
149912719|NCT02089334|540811272|FG003|Overall Study|Adverse Event|2|||
149912720|NCT02089334|540811269|FG000|Overall Study|Progressive disease|0|||
149912721|NCT02089334|540811270|FG001|Overall Study|Progressive disease|0|||
149912722|NCT02089334|540811271|FG002|Overall Study|Progressive disease|0|||
149912723|NCT02089334|540811272|FG003|Overall Study|Progressive disease|2|||
149912724|NCT02089334|540811269|FG000|Overall Study|Physician Decision|0|||
149912725|NCT02089334|540811270|FG001|Overall Study|Physician Decision|0|||
149912726|NCT02089334|540811271|FG002|Overall Study|Physician Decision|1|||
149912727|NCT02089334|540811272|FG003|Overall Study|Physician Decision|1|||
149912728|NCT00710684|540811275|FG000|Overall Study|Adverse Event|11|||
149912729|NCT00710684|540811276|FG001|Overall Study|Adverse Event|19|||
149912730|NCT00710684|540811277|FG002|Overall Study|Adverse Event|16|||
149912731|NCT00710684|540811275|FG000|Overall Study|Lack of Efficacy|4|||
149912732|NCT00710684|540811276|FG001|Overall Study|Lack of Efficacy|3|||
149912733|NCT00710684|540811277|FG002|Overall Study|Lack of Efficacy|5|||
149912734|NCT00710684|540811275|FG000|Overall Study|Protocol Violation|5|||
149912735|NCT00710684|540811276|FG001|Overall Study|Protocol Violation|5|||
149912736|NCT00710684|540811277|FG002|Overall Study|Protocol Violation|5|||
149912737|NCT00710684|540811275|FG000|Overall Study|Lost to Follow-up|4|||
149912738|NCT00710684|540811276|FG001|Overall Study|Lost to Follow-up|6|||
149912739|NCT00710684|540811277|FG002|Overall Study|Lost to Follow-up|7|||
149912740|NCT00710684|540811275|FG000|Overall Study|Physician Decision|0|||
149912741|NCT00710684|540811276|FG001|Overall Study|Physician Decision|2|||
149912742|NCT00710684|540811277|FG002|Overall Study|Physician Decision|4|||
149912743|NCT00710684|540811275|FG000|Overall Study|Withdrawal by Subject|24|||
149912744|NCT00710684|540811276|FG001|Overall Study|Withdrawal by Subject|18|||
149912745|NCT00710684|540811277|FG002|Overall Study|Withdrawal by Subject|11|||
149912746|NCT00710684|540811275|FG000|Overall Study|Missing|1|||
149912747|NCT00710684|540811276|FG001|Overall Study|Missing|0|||
149912748|NCT00710684|540811277|FG002|Overall Study|Missing|0|||
149912749|NCT00710684|540811275|FG000|Overall Study|Did not continue after week 24|25|||
149912750|NCT00710684|540811276|FG001|Overall Study|Did not continue after week 24|21|||
149912751|NCT00710684|540811277|FG002|Overall Study|Did not continue after week 24|16|||
149912752|NCT04778059|540811278|FG000|Overall Study|Death|2|||
149912753|NCT04778059|540811279|FG001|Overall Study|Death|2|||
149912754|NCT04778059|540811280|FG002|Overall Study|Death|1|||
149912755|NCT04778059|540811281|FG003|Overall Study|Death|1|||
149912756|NCT04778059|540811282|FG004|Overall Study|Death|1|||
149912757|NCT04778059|540811278|FG000|Overall Study|Lost to Follow-up|0|||
149912758|NCT04778059|540811279|FG001|Overall Study|Lost to Follow-up|0|||
149912759|NCT04778059|540811280|FG002|Overall Study|Lost to Follow-up|0|||
149912760|NCT04778059|540811281|FG003|Overall Study|Lost to Follow-up|0|||
149912761|NCT04778059|540811282|FG004|Overall Study|Lost to Follow-up|1|||
149912762|NCT04778059|540811278|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
149912763|NCT04778059|540811279|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
149912764|NCT04778059|540811280|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
149912765|NCT04778059|540811281|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
149912766|NCT04778059|540811282|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
149912767|NCT02832375|540811283|FG000|Overall Study|Lost to Follow-up|1|||
149912768|NCT02832375|540811284|FG001|Overall Study|Lost to Follow-up|0|||
149912769|NCT02832375|540811283|FG000|Overall Study|Withdrawal of Consent|1|||
149912770|NCT02832375|540811284|FG001|Overall Study|Withdrawal of Consent|0|||
149912771|NCT01645891|540811288|FG000|Overall Study|Adverse Event|6|||
149912772|NCT01645891|540811289|FG001|Overall Study|Adverse Event|10|||
149912773|NCT01645891|540811288|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
149912774|NCT01645891|540811289|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
149912775|NCT01645891|540811288|FG000|Overall Study|Withdrawal by Subject|3|||
149912776|NCT01645891|540811289|FG001|Overall Study|Withdrawal by Subject|3|||
149912777|NCT01645891|540811288|FG000|Overall Study|Protocol Violation|4|||
149912778|NCT01645891|540811289|FG001|Overall Study|Protocol Violation|0|||
149912779|NCT01645891|540811288|FG000|Overall Study|Lost to Follow-up|4|||
149912780|NCT01645891|540811289|FG001|Overall Study|Lost to Follow-up|1|||
149912781|NCT01645891|540811288|FG000|Overall Study|Death|0|||
149912782|NCT01645891|540811289|FG001|Overall Study|Death|2|||
149912783|NCT03026530|540811292|FG000|Overall Study|Lost to Follow-up|19|||
149912784|NCT03026530|540811293|FG001|Overall Study|Lost to Follow-up|24|||
149912785|NCT03026530|540811292|FG000|Overall Study|Protocol Violation|2|||
149912786|NCT03026530|540811293|FG001|Overall Study|Protocol Violation|5|||
149912787|NCT00138073|540811294|FG000|Overall Study|lack of resources|55|||
149912788|NCT03301740|540811295|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
149912789|NCT03301740|540811296|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
149912790|NCT03301740|540811295|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
149912791|NCT03301740|540811296|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
149912792|NCT01173055|540811300|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
149912793|NCT01173055|540811301|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
149912794|NCT01173055|540811300|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
149912795|NCT01173055|540811301|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
149912796|NCT04814368|540811302|FG000|Overall Study|Study Terminated by Sponsor|0|||
149912797|NCT04814368|540811303|FG001|Overall Study|Study Terminated by Sponsor|3|||
149912798|NCT04814368|540811304|FG002|Overall Study|Study Terminated by Sponsor|0|||
149912799|NCT04814368|540811305|FG003|Overall Study|Study Terminated by Sponsor|2|||
149912800|NCT04814368|540811302|FG000|Overall Study|Subject Decision|1|||
149912801|NCT04814368|540811303|FG001|Overall Study|Subject Decision|2|||
149912802|NCT04814368|540811304|FG002|Overall Study|Subject Decision|0|||
149912803|NCT04814368|540811305|FG003|Overall Study|Subject Decision|0|||
149912804|NCT04216589|540811307|FG000|Overall Study|Withdrawal by Subject|2|||
149912805|NCT04216589|540811307|FG000|Overall Study|Protocol Violation|1|||
149912806|NCT04216589|540811307|FG000|Overall Study|Incarceration|1|||
149912807|NCT03721835|540811308|FG000|Overall Study|Participant not able to return|1|||
149912808|NCT03721835|540811308|FG000|Overall Study|Lost to Follow-up|1|||
149912809|NCT03721835|540811308|FG000|Overall Study|Revision of the components of the study device|2|||
149912810|NCT03721835|540811308|FG000|Overall Study|Sponsor terminated study|6|||
149912811|NCT03721835|540811308|FG000|Overall Study|Death|1|||
149912812|NCT03721835|540811308|FG000|Overall Study|Sponsor decision|1|||
149912813|NCT01306045|540811313|FG000|Met General Eligibility Criteria|Screen failures|193|||
149912814|NCT01306045|540811314|FG001|Met General Eligibility Criteria|Screen failures|11|||
149912815|NCT01306045|540811315|FG002|Met General Eligibility Criteria|Screen failures|8|||
149912816|NCT02000882|540813010|FG000|Overall Study|Adverse Event|3|||
149912817|NCT02000882|540813010|FG000|Overall Study|Physician Decision|2|||
149912818|NCT02000882|540813010|FG000|Overall Study|Withdrawal by Subject|1|||
149912819|NCT04550832|540813011|FG000|Overall Study|Adverse Event|0|||
149912820|NCT04550832|540813012|FG001|Overall Study|Adverse Event|0|||
149912821|NCT04550832|540813013|FG002|Overall Study|Adverse Event|2|||
149912822|NCT04550832|540813014|FG003|Overall Study|Adverse Event|0|||
149912823|NCT04550832|540813015|FG004|Overall Study|Adverse Event|1|||
149912824|NCT04823130|540813016|FG000|Overall Study|Withdrawal by Subject|2|||
149912825|NCT04823130|540813017|FG001|Overall Study|Withdrawal by Subject|3|||
149912826|NCT04823130|540813016|FG000|Overall Study|Failure to meet inclusion criteria|6|||
149912827|NCT04823130|540813017|FG001|Overall Study|Failure to meet inclusion criteria|4|||
149912828|NCT04823130|540813016|FG000|Overall Study|Other-unspecified|1|||
149912829|NCT04823130|540813017|FG001|Overall Study|Other-unspecified|0|||
149912830|NCT03315455|540813019|FG000|Overall Study|Ongoing in the Study|13|||
149912831|NCT03315455|540813020|FG001|Overall Study|Ongoing in the Study|24|||
149912832|NCT03315455|540813021|FG002|Overall Study|Ongoing in the Study|17|||
149912833|NCT03315455|540813022|FG003|Overall Study|Ongoing in the Study|15|||
149912834|NCT03315455|540813019|FG000|Overall Study|Withdrawal by Subject|0|||
149912835|NCT03315455|540813020|FG001|Overall Study|Withdrawal by Subject|1|||
149972349|NCT00698828|541036865|FG000|Overall Study|Lost to Follow-up|1|||
149972350|NCT00698828|541036866|FG001|Overall Study|Lost to Follow-up|1|||
149972351|NCT00698828|541036867|FG002|Overall Study|Lost to Follow-up|0|||
149972352|NCT00698828|541036865|FG000|Overall Study|Withdrew consent|0|||
149972353|NCT00698828|541036866|FG001|Overall Study|Withdrew consent|7|||
149972354|NCT00698828|541036867|FG002|Overall Study|Withdrew consent|4|||
149972355|NCT00698828|541036865|FG000|Overall Study|Withdrew consent (not treated)|2|||
149972356|NCT00698828|541036866|FG001|Overall Study|Withdrew consent (not treated)|0|||
149972357|NCT00698828|541036867|FG002|Overall Study|Withdrew consent (not treated)|0|||
149972358|NCT02013609|541036868|FG000|Overall Study|Withdrawal by Subject|9|||
149972359|NCT02013609|541036868|FG000|Overall Study|Lost to Follow-up|3|||
149972360|NCT02013609|541036868|FG000|Overall Study|Adverse Event|3|||
149972361|NCT02013609|541036868|FG000|Overall Study|Met Withdrawal Criteria|3|||
149972362|NCT01816295|541036869|FG000|Double Blind Phase|Adverse Event|11|||
149972363|NCT01816295|541036870|FG001|Double Blind Phase|Adverse Event|8|||
149912836|NCT03315455|540813021|FG002|Overall Study|Withdrawal by Subject|0|||
149912837|NCT03315455|540813022|FG003|Overall Study|Withdrawal by Subject|0|||
149912838|NCT04439357|540813023|FG000|Overall Study|Disease Progression|4|||
149912839|NCT00985426|540813027|FG000|Overall Study|Adverse Event|0|||
149912840|NCT00985426|540813028|FG001|Overall Study|Adverse Event|1|||
149912841|NCT00985426|540813027|FG000|Overall Study|Subject Non-Compliance|3|||
149912842|NCT00985426|540813028|FG001|Overall Study|Subject Non-Compliance|3|||
149912843|NCT00985426|540813027|FG000|Overall Study|Withdrawal by Subject|12|||
149912844|NCT00985426|540813028|FG001|Overall Study|Withdrawal by Subject|16|||
149912845|NCT00985426|540813027|FG000|Overall Study|Lost to Follow-up|8|||
149912846|NCT00985426|540813028|FG001|Overall Study|Lost to Follow-up|10|||
149912847|NCT00985426|540813027|FG000|Overall Study|Death|7|||
149912848|NCT00985426|540813028|FG001|Overall Study|Death|3|||
149912849|NCT00985426|540813027|FG000|Overall Study|Protocol Violation|2|||
149912850|NCT00985426|540813028|FG001|Overall Study|Protocol Violation|0|||
149912851|NCT00985426|540813027|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
149912852|NCT00985426|540813028|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
149912853|NCT02052596|540813029|FG000|Active Phase|Adverse Event|3|||
149912854|NCT02052596|540813030|FG001|Active Phase|Adverse Event|2|||
149912855|NCT02052596|540813029|FG000|Active Phase|Lost to Follow-up|8|||
149912856|NCT02052596|540813030|FG001|Active Phase|Lost to Follow-up|11|||
149912857|NCT02052596|540813029|FG000|Active Phase|Protocol Violation|1|||
149912858|NCT02052596|540813030|FG001|Active Phase|Protocol Violation|2|||
149912859|NCT02052596|540813029|FG000|Active Phase|Withdrawal by Subject|3|||
149912860|NCT02052596|540813030|FG001|Active Phase|Withdrawal by Subject|4|||
149912861|NCT02052596|540813029|FG000|Active Phase|Enrolled in error|1|||
149912862|NCT02052596|540813030|FG001|Active Phase|Enrolled in error|0|||
149912863|NCT02052596|540813029|FG000|Active Phase|Lost due to Crohn's disease|0|||
149912864|NCT02052596|540813030|FG001|Active Phase|Lost due to Crohn's disease|1|||
149912865|NCT02052596|540813029|FG000|Safety Phase|Adverse Event|6|||
149912866|NCT02052596|540813030|FG001|Safety Phase|Adverse Event|3|||
149912867|NCT02052596|540813029|FG000|Safety Phase|Lost to Follow-up|11|||
149912868|NCT02052596|540813030|FG001|Safety Phase|Lost to Follow-up|18|||
149912869|NCT02052596|540813029|FG000|Safety Phase|Protocol Violation|1|||
149912870|NCT02052596|540813030|FG001|Safety Phase|Protocol Violation|2|||
149912871|NCT02052596|540813029|FG000|Safety Phase|Withdrawal by Subject|8|||
149912872|NCT02052596|540813030|FG001|Safety Phase|Withdrawal by Subject|11|||
149912873|NCT02052596|540813029|FG000|Safety Phase|Enrolled in error|1|||
149912874|NCT02052596|540813030|FG001|Safety Phase|Enrolled in error|0|||
149912875|NCT02052596|540813029|FG000|Safety Phase|Lost due to Crohn's disease|0|||
149912876|NCT02052596|540813030|FG001|Safety Phase|Lost due to Crohn's disease|1|||
149912877|NCT00558896|540813031|FG000|Overall Study|Adverse Event|1|||
149912878|NCT00558896|540813032|FG001|Overall Study|Adverse Event|1|||
149912879|NCT00558896|540813033|FG002|Overall Study|Adverse Event|1|||
149912880|NCT00558896|540813034|FG003|Overall Study|Adverse Event|3|||
149912881|NCT00558896|540813035|FG004|Overall Study|Adverse Event|4|||
149912882|NCT00558896|540813036|FG005|Overall Study|Adverse Event|10|||
149912883|NCT00558896|540813037|FG006|Overall Study|Adverse Event|3|||
149912884|NCT00558896|540813031|FG000|Overall Study|Death|3|||
149912885|NCT00558896|540813032|FG001|Overall Study|Death|0|||
149912886|NCT00558896|540813033|FG002|Overall Study|Death|2|||
149912887|NCT00558896|540813034|FG003|Overall Study|Death|3|||
149912888|NCT00558896|540813035|FG004|Overall Study|Death|2|||
149912889|NCT00558896|540813036|FG005|Overall Study|Death|2|||
149912890|NCT00558896|540813037|FG006|Overall Study|Death|6|||
149912891|NCT00558896|540813031|FG000|Overall Study|Withdrawal by Subject|2|||
149912892|NCT00558896|540813032|FG001|Overall Study|Withdrawal by Subject|1|||
149912893|NCT00558896|540813033|FG002|Overall Study|Withdrawal by Subject|1|||
149912894|NCT00558896|540813034|FG003|Overall Study|Withdrawal by Subject|1|||
149912895|NCT00558896|540813035|FG004|Overall Study|Withdrawal by Subject|1|||
149912896|NCT00558896|540813036|FG005|Overall Study|Withdrawal by Subject|5|||
149912897|NCT00558896|540813037|FG006|Overall Study|Withdrawal by Subject|5|||
149912898|NCT00558896|540813031|FG000|Overall Study|Alternative Treatment|2|||
149912899|NCT00558896|540813032|FG001|Overall Study|Alternative Treatment|2|||
149912900|NCT00558896|540813033|FG002|Overall Study|Alternative Treatment|0|||
149912901|NCT00558896|540813034|FG003|Overall Study|Alternative Treatment|2|||
149912902|NCT00558896|540813035|FG004|Overall Study|Alternative Treatment|6|||
149912903|NCT00558896|540813036|FG005|Overall Study|Alternative Treatment|7|||
149912904|NCT00558896|540813037|FG006|Overall Study|Alternative Treatment|1|||
149912905|NCT00558896|540813031|FG000|Overall Study|Physician discretion|3|||
149912906|NCT00558896|540813032|FG001|Overall Study|Physician discretion|2|||
149912907|NCT00558896|540813033|FG002|Overall Study|Physician discretion|1|||
149912908|NCT00558896|540813034|FG003|Overall Study|Physician discretion|2|||
149912909|NCT00558896|540813035|FG004|Overall Study|Physician discretion|1|||
149912910|NCT00558896|540813036|FG005|Overall Study|Physician discretion|3|||
149912911|NCT00558896|540813037|FG006|Overall Study|Physician discretion|3|||
149912912|NCT00558896|540813031|FG000|Overall Study|Continues on treatment|10|||
149912913|NCT00558896|540813032|FG001|Overall Study|Continues on treatment|1|||
149912914|NCT00558896|540813033|FG002|Overall Study|Continues on treatment|0|||
149912915|NCT00558896|540813034|FG003|Overall Study|Continues on treatment|1|||
149912916|NCT00558896|540813035|FG004|Overall Study|Continues on treatment|9|||
149972364|NCT01816295|541036869|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
149972365|NCT01816295|541036870|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
149912917|NCT00558896|540813036|FG005|Overall Study|Continues on treatment|25|||
149912918|NCT00558896|540813037|FG006|Overall Study|Continues on treatment|6|||
149912919|NCT00723190|540813043|FG000|Overall Study|Withdrawal by Subject|45|||
149912920|NCT00723190|540813043|FG000|Overall Study|Lost to Follow-up|37|||
149912921|NCT00723190|540813043|FG000|Overall Study|Adverse Event|18|||
149912922|NCT00723190|540813043|FG000|Overall Study|Lack of Efficacy|16|||
149912923|NCT00723190|540813043|FG000|Overall Study|Protocol Violation|15|||
149912924|NCT00723190|540813043|FG000|Overall Study|Other-Premature Discontinuation|9|||
149912925|NCT00723190|540813043|FG000|Overall Study|Other-Not included in safety population|2|||
149912926|NCT00454818|540813044|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
149912927|NCT00454818|540813045|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
149912928|NCT00454818|540813046|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
149912929|NCT00454818|540813047|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
149912930|NCT00454818|540813048|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
149912931|NCT00454818|540813044|FG000|Phase I: Open-label Dose-escalation|Death|0|||
149912932|NCT00454818|540813045|FG001|Phase I: Open-label Dose-escalation|Death|1|||
149912933|NCT00454818|540813046|FG002|Phase I: Open-label Dose-escalation|Death|0|||
149912934|NCT00454818|540813047|FG003|Phase I: Open-label Dose-escalation|Death|0|||
149912935|NCT00454818|540813048|FG004|Phase I: Open-label Dose-escalation|Death|0|||
149912936|NCT00454818|540813044|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
149912937|NCT00454818|540813045|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
149912938|NCT00454818|540813046|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
149912939|NCT00454818|540813047|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
149912940|NCT00454818|540813048|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
149912941|NCT00454818|540813044|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
149912942|NCT00454818|540813045|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
149912943|NCT00454818|540813046|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
149912944|NCT00454818|540813047|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
149912945|NCT00454818|540813048|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
149912946|NCT00454818|540813044|FG000|Phase 2: Randomized Double-blind|Death|0|||
149912947|NCT00454818|540813045|FG001|Phase 2: Randomized Double-blind|Death|1|||
149912948|NCT00454818|540813046|FG002|Phase 2: Randomized Double-blind|Death|0|||
149912949|NCT00454818|540813047|FG003|Phase 2: Randomized Double-blind|Death|0|||
149912950|NCT00454818|540813048|FG004|Phase 2: Randomized Double-blind|Death|1|||
149912951|NCT00454818|540813044|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
149912952|NCT00454818|540813045|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
149912953|NCT00454818|540813046|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
149912954|NCT00454818|540813047|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
149912955|NCT00454818|540813048|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
149912956|NCT00454818|540813044|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
149912957|NCT00454818|540813045|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
149912958|NCT00454818|540813046|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
149912959|NCT00454818|540813047|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
149912960|NCT00454818|540813048|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
149912961|NCT03181503|540813049|FG000|Overall Study|Adverse Event|2|||
149912962|NCT03181503|540813050|FG001|Overall Study|Adverse Event|2|||
149912963|NCT03181503|540813049|FG000|Overall Study|Protocol Violation|1|||
149912964|NCT03181503|540813050|FG001|Overall Study|Protocol Violation|0|||
149912965|NCT03181503|540813049|FG000|Overall Study|Withdrawal by Subject|3|||
149912966|NCT03181503|540813050|FG001|Overall Study|Withdrawal by Subject|0|||
149912967|NCT03181503|540813049|FG000|Overall Study|Lost to Follow-up|1|||
149912968|NCT03181503|540813050|FG001|Overall Study|Lost to Follow-up|1|||
149912969|NCT01892085|540813053|FG000|Overall Study|Death|4|||
149912970|NCT01892085|540813054|FG001|Overall Study|Death|1|||
149912971|NCT01892085|540813055|FG002|Overall Study|Death|3|||
149912972|NCT01892085|540813053|FG000|Overall Study|Withdrawal by Subject|2|||
149912973|NCT01892085|540813054|FG001|Overall Study|Withdrawal by Subject|0|||
149912974|NCT01892085|540813055|FG002|Overall Study|Withdrawal by Subject|2|||
149912975|NCT01629823|540813061|FG000|Trial Period|Missed visit|11|||
149912976|NCT01629823|540813062|FG001|Trial Period|Missed visit|9|||
149912977|NCT01629823|540813063|FG002|Trial Period|Missed visit|8|||
149912978|NCT01629823|540813061|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
149912979|NCT01629823|540813062|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
149912980|NCT01629823|540813063|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
149912981|NCT01629823|540813061|FG000|Trial Period|Pregnancy|1|||
149912982|NCT01629823|540813062|FG001|Trial Period|Pregnancy|0|||
149912983|NCT01629823|540813063|FG002|Trial Period|Pregnancy|0|||
149912984|NCT01629823|540813061|FG000|Trial Period|Adverse Event|0|||
149912985|NCT01629823|540813062|FG001|Trial Period|Adverse Event|1|||
149912986|NCT01629823|540813063|FG002|Trial Period|Adverse Event|0|||
149912987|NCT01629823|540813061|FG000|Trial Period|Out-of-window visit|0|||
149912988|NCT01629823|540813062|FG001|Trial Period|Out-of-window visit|2|||
149912989|NCT01629823|540813063|FG002|Trial Period|Out-of-window visit|0|||
149912990|NCT01629823|540813061|FG000|Trial Period|Failed to hold medication|0|||
150177114|NCT01424397|541786124|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177115|NCT01424397|541786125|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177116|NCT01424397|541786126|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177117|NCT01424397|541786127|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177118|NCT01424397|541786128|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177119|NCT01424397|541786129|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177120|NCT01424397|541786130|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
150177121|NCT02767765|541786131|FG000|Overall Study|Adverse Event|4|||
150177122|NCT02767765|541786131|FG000|Overall Study|Death|1|||
150050607|NCT00945906|541327585|FG000|Overall Study|Unable to return for last visit|2|||
150050608|NCT00945906|541327585|FG000|Overall Study|Moved to another country|2|||
150050609|NCT01086358|541327587|FG000|First Intervention|Lost to Follow-up|9|||
150050610|NCT01086358|541327588|FG001|First Intervention|Lost to Follow-up|4|||
150050611|NCT01086358|541327587|FG000|First Intervention|Withdrawal by Subject|0|||
150050612|NCT01086358|541327588|FG001|First Intervention|Withdrawal by Subject|1|||
150050613|NCT01086358|541327587|FG000|Second Intervention|Lost to Follow-up|4|||
150050614|NCT01086358|541327588|FG001|Second Intervention|Lost to Follow-up|4|||
150050615|NCT03317405|541327589|FG000|Overall Study|Withdrawal by Subject|1|||
150050616|NCT03317405|541327590|FG001|Overall Study|Withdrawal by Subject|0|||
150050617|NCT03317405|541327591|FG002|Overall Study|Withdrawal by Subject|0|||
150050618|NCT03317405|541327589|FG000|Overall Study|Physician Decision|0|||
149912991|NCT01629823|540813062|FG001|Trial Period|Failed to hold medication|0|||
149912992|NCT01629823|540813063|FG002|Trial Period|Failed to hold medication|1|||
149912993|NCT01629823|540813061|FG000|Washout Period|Safety|2|||
149912994|NCT01629823|540813062|FG001|Washout Period|Safety|5|||
149912995|NCT01629823|540813063|FG002|Washout Period|Safety|0|||
149912996|NCT01629823|540813061|FG000|Washout Period|Pregnancy|1|||
149912997|NCT01629823|540813062|FG001|Washout Period|Pregnancy|0|||
149912998|NCT01629823|540813063|FG002|Washout Period|Pregnancy|0|||
149912999|NCT01629823|540813061|FG000|Washout Period|Protocol Violation|0|||
149913000|NCT01629823|540813062|FG001|Washout Period|Protocol Violation|1|||
149913001|NCT01629823|540813063|FG002|Washout Period|Protocol Violation|0|||
149913002|NCT01199822|540813065|FG000|Overall Study|Investigator discontinued therapy|0|||
149913003|NCT01199822|540813066|FG001|Overall Study|Investigator discontinued therapy|1|||
149913004|NCT01199822|540813067|FG002|Overall Study|Investigator discontinued therapy|0|||
149913005|NCT00525902|540813068|FG000|Overall Study|Lack of Efficacy|1|||
149913006|NCT02258542|540813069|FG000|Overall Study|eg. not made to the visit|7|||
149913007|NCT02258542|540813070|FG001|Overall Study|eg. not made to the visit|4|||
149913008|NCT02258542|540813071|FG002|Overall Study|eg. not made to the visit|0|||
149913009|NCT02258542|540813072|FG003|Overall Study|eg. not made to the visit|1|||
149913010|NCT02258542|540813069|FG000|Overall Study|study specific discount. criteria|1|||
149913011|NCT02258542|540813070|FG001|Overall Study|study specific discount. criteria|1|||
149913012|NCT02258542|540813071|FG002|Overall Study|study specific discount. criteria|0|||
150050619|NCT03317405|541327590|FG001|Overall Study|Physician Decision|0|||
150050620|NCT03317405|541327591|FG002|Overall Study|Physician Decision|1|||
150050621|NCT03317405|541327589|FG000|Overall Study|Surgery Rescheduled|0|||
150050622|NCT03317405|541327590|FG001|Overall Study|Surgery Rescheduled|1|||
150050623|NCT03317405|541327591|FG002|Overall Study|Surgery Rescheduled|0|||
150050624|NCT00591318|541327594|FG000|Overall Study|Lack of Efficacy|2|||
150050625|NCT00591318|541327595|FG001|Overall Study|Lack of Efficacy|0|||
150050626|NCT00591318|541327594|FG000|Overall Study|Adverse Event|2|||
150177123|NCT02767765|541786131|FG000|Overall Study|Insufficient response|1|||
149913013|NCT02258542|540813072|FG003|Overall Study|study specific discount. criteria|0|||
149913014|NCT02258542|540813069|FG000|Overall Study|Withdrawal by Subject|20|||
149913015|NCT02258542|540813070|FG001|Overall Study|Withdrawal by Subject|20|||
149913016|NCT02258542|540813071|FG002|Overall Study|Withdrawal by Subject|7|||
149913017|NCT02258542|540813072|FG003|Overall Study|Withdrawal by Subject|1|||
149913018|NCT02258542|540813069|FG000|Overall Study|Lost to Follow-up|5|||
149913019|NCT02258542|540813070|FG001|Overall Study|Lost to Follow-up|12|||
149913020|NCT02258542|540813071|FG002|Overall Study|Lost to Follow-up|1|||
149913021|NCT02258542|540813072|FG003|Overall Study|Lost to Follow-up|2|||
149913022|NCT02258542|540813069|FG000|Overall Study|Death|5|||
149913023|NCT02258542|540813070|FG001|Overall Study|Death|4|||
149913024|NCT02258542|540813071|FG002|Overall Study|Death|0|||
149913025|NCT02258542|540813072|FG003|Overall Study|Death|1|||
149913026|NCT02258542|540813069|FG000|Overall Study|Adverse Event|3|||
149913027|NCT02258542|540813070|FG001|Overall Study|Adverse Event|4|||
149913028|NCT02258542|540813071|FG002|Overall Study|Adverse Event|0|||
149913029|NCT02258542|540813072|FG003|Overall Study|Adverse Event|0|||
149913030|NCT02258542|540813069|FG000|Overall Study|Protocol Violation|1|||
149913031|NCT02258542|540813070|FG001|Overall Study|Protocol Violation|2|||
150050627|NCT00591318|541327595|FG001|Overall Study|Adverse Event|0|||
150050628|NCT01743001|541327596|FG000|Overall Study|Physician Decision|1|||
149913032|NCT02258542|540813071|FG002|Overall Study|Protocol Violation|0|||
150050629|NCT01743001|541327597|FG001|Overall Study|Physician Decision|0|||
150050630|NCT01743001|541327596|FG000|Overall Study|Pregnancy|1|||
150050631|NCT01743001|541327597|FG001|Overall Study|Pregnancy|0|||
150050632|NCT01743001|541327596|FG000|Overall Study|Death|1|||
150177124|NCT02767765|541786131|FG000|Overall Study|Lost to Follow-up|2|||
150050633|NCT01743001|541327597|FG001|Overall Study|Death|0|||
150050634|NCT03052426|541327600|FG000|Overall Study|Withdrawal by Subject|0|||
150050635|NCT03052426|541327601|FG001|Overall Study|Withdrawal by Subject|1|||
150050636|NCT03052426|541327602|FG002|Overall Study|Withdrawal by Subject|0|||
150050637|NCT03052426|541327600|FG000|Overall Study|Lost to Follow-up|2|||
150050638|NCT03052426|541327601|FG001|Overall Study|Lost to Follow-up|0|||
150050639|NCT03052426|541327602|FG002|Overall Study|Lost to Follow-up|1|||
149913033|NCT02258542|540813072|FG003|Overall Study|Protocol Violation|0|||
149913034|NCT02258542|540813069|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149913035|NCT02258542|540813070|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
149913036|NCT02258542|540813071|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
149913037|NCT02258542|540813072|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
149913038|NCT02844907|540813073|FG000|With Dexamethasone|No IV access|1|||
149913039|NCT00550862|540813074|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
149913040|NCT00550862|540813075|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
149913041|NCT00550862|540813076|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
149913042|NCT00550862|540813077|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
149913043|NCT00550862|540813078|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
149913044|NCT00550862|540813074|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
149913045|NCT00550862|540813075|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
149913046|NCT00550862|540813076|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
149913047|NCT00550862|540813077|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
149913048|NCT00550862|540813078|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
149913049|NCT00550862|540813074|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
149913050|NCT00550862|540813075|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
149913051|NCT00550862|540813076|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
149913052|NCT00550862|540813077|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
149913053|NCT00550862|540813078|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
149913054|NCT00550862|540813074|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
149913055|NCT00550862|540813075|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
149913056|NCT00550862|540813076|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
149913057|NCT00550862|540813077|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
149913058|NCT00550862|540813078|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
149913059|NCT00550862|540813074|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
149913060|NCT00550862|540813075|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
149913061|NCT00550862|540813076|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
149913062|NCT00550862|540813077|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
149913063|NCT00550862|540813078|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
149913064|NCT00550862|540813074|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
149913065|NCT00550862|540813075|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
149913066|NCT00550862|540813076|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
149913067|NCT00550862|540813077|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
149913068|NCT00550862|540813078|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
149913069|NCT00550862|540813074|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
149913070|NCT00550862|540813075|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
149913071|NCT00550862|540813076|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
149913072|NCT00550862|540813077|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
149913073|NCT00550862|540813078|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
149913074|NCT00550862|540813074|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
149913075|NCT00550862|540813075|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
149913076|NCT00550862|540813076|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
150050640|NCT03679754|541327606|FG000|Overall Study|Investigator request|1|||
150050641|NCT00964171|541327607|FG000|Overall Study|Death|5|||
150050642|NCT00080899|541327608|FG000|Overall Study|Adverse Event|1|||
150050643|NCT02640508|541327610|FG000|Overall Study|Death|19|||
149913077|NCT00550862|540813077|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
149913078|NCT00550862|540813078|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
149913079|NCT00550862|540813074|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
150050644|NCT02640508|541327610|FG000|Overall Study|Withdrawal by Subject|8|||
150050645|NCT02640508|541327610|FG000|Overall Study|Physician Decision|1|||
150050646|NCT02640508|541327610|FG000|Overall Study|Lost to Follow-up|1|||
150050647|NCT00776919|541327611|FG000|Overall Study|Withdrawal by Subject|16|||
150050648|NCT00776919|541327612|FG001|Overall Study|Withdrawal by Subject|14|||
150050649|NCT00776919|541327613|FG002|Overall Study|Withdrawal by Subject|15|||
150050650|NCT00776919|541327614|FG003|Overall Study|Withdrawal by Subject|26|||
150050651|NCT00776919|541327611|FG000|Overall Study|Lost to Follow-up|8|||
150050652|NCT00776919|541327612|FG001|Overall Study|Lost to Follow-up|12|||
149913080|NCT00550862|540813075|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
149913081|NCT00550862|540813076|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
149913082|NCT00550862|540813077|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
149913083|NCT00550862|540813078|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
149913084|NCT00550862|540813074|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
149913085|NCT00550862|540813075|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
149913086|NCT00550862|540813076|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
149913087|NCT00550862|540813077|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
149913088|NCT00550862|540813078|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
149913089|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
149913090|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
149913091|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
149913092|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
149913093|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Death|1|||
149913094|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Death|1|||
149913095|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
149913096|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
149913097|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
149913098|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
149913099|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
149913100|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
149913101|NCT00033657|540813079|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
149913102|NCT00033657|540813080|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
149913103|NCT00033657|540813079|FG000|Surgical Resection|not complete resection|0|||
149913104|NCT00033657|540813080|FG001|Surgical Resection|not complete resection|3|||
149913105|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
149913106|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
149913107|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
149913108|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
149913109|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|Death|2|||
149913110|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|Death|1|||
149913111|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
149913112|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
149913113|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
149913114|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
149913115|NCT00033657|540813079|FG000|Adjuvant Chemotherapy|Other|0|||
149913116|NCT00033657|540813080|FG001|Adjuvant Chemotherapy|Other|2|||
149913117|NCT00986986|540813082|FG000|Overall Study|Lost to Follow-up|0|||
149913118|NCT00986986|540813083|FG001|Overall Study|Lost to Follow-up|1|||
149913119|NCT03235115|540813085|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
149913120|NCT03235115|540813086|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
149913121|NCT03235115|540813087|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
149913122|NCT03235115|540813088|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
149913123|NCT03235115|540813089|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
149913124|NCT03235115|540813090|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
149913125|NCT04631107|540813093|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
149913126|NCT04631107|540813093|FG000|Second Intervention (1 Night)|Adverse Event|1|||
149913127|NCT04631107|540813093|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
149913128|NCT04631107|540813093|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
149913129|NCT00096993|540813100|FG000|Overall Study|Death|1|||
149913130|NCT00096993|540813101|FG001|Overall Study|Death|0|||
149913131|NCT00096993|540813100|FG000|Overall Study|Disease progression|56|||
149913132|NCT00096993|540813101|FG001|Overall Study|Disease progression|53|||
149913133|NCT00096993|540813100|FG000|Overall Study|Adverse Event|2|||
149913134|NCT00096993|540813101|FG001|Overall Study|Adverse Event|8|||
149913135|NCT00096993|540813100|FG000|Overall Study|Subject's decision|3|||
149913136|NCT00096993|540813101|FG001|Overall Study|Subject's decision|1|||
149913137|NCT00096993|540813100|FG000|Overall Study|Physician Decision|2|||
149913138|NCT00096993|540813101|FG001|Overall Study|Physician Decision|1|||
149913139|NCT00096993|540813100|FG000|Overall Study|Non-compliance|0|||
149913140|NCT00096993|540813101|FG001|Overall Study|Non-compliance|1|||
149913141|NCT00096993|540813100|FG000|Overall Study|Other unspecified|1|||
150050653|NCT00776919|541327613|FG002|Overall Study|Lost to Follow-up|11|||
150050654|NCT00776919|541327614|FG003|Overall Study|Lost to Follow-up|8|||
150050655|NCT00776919|541327611|FG000|Overall Study|Adverse Event|1|||
150050656|NCT00776919|541327612|FG001|Overall Study|Adverse Event|0|||
149913142|NCT00096993|540813101|FG001|Overall Study|Other unspecified|1|||
150050657|NCT00776919|541327613|FG002|Overall Study|Adverse Event|2|||
149913143|NCT01440569|540813105|FG000|Main Study|Enrolled but not treated|1|||
149913144|NCT01440569|540813106|FG001|Main Study|Enrolled but not treated|0|||
149913145|NCT01440569|540813105|FG000|Main Study|Adverse Event|9|||
149913146|NCT01440569|540813106|FG001|Main Study|Adverse Event|0|||
149913147|NCT01440569|540813105|FG000|Main Study|Pregnancy|1|||
149913148|NCT01440569|540813106|FG001|Main Study|Pregnancy|0|||
149913149|NCT01440569|540813105|FG000|Main Study|Investigator's Discretion|1|||
149913150|NCT01440569|540813106|FG001|Main Study|Investigator's Discretion|1|||
149913151|NCT01440569|540813105|FG000|Main Study|Withdrew Consent|7|||
149913152|NCT01440569|540813106|FG001|Main Study|Withdrew Consent|1|||
149913153|NCT01440569|540813105|FG000|Main Study|Lost to Follow-up|13|||
149913154|NCT01440569|540813106|FG001|Main Study|Lost to Follow-up|2|||
149913155|NCT01440569|540813105|FG000|Main Study|Subject Non-Compliance|3|||
149913156|NCT01440569|540813106|FG001|Main Study|Subject Non-Compliance|0|||
149913157|NCT01440569|540813105|FG000|Main Study|Protocol Violation|1|||
149913158|NCT01440569|540813106|FG001|Main Study|Protocol Violation|0|||
149913159|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Adverse Event|3|||
149913160|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Adverse Event|0|||
149913161|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Pregnancy|1|||
149913162|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Pregnancy|0|||
149913163|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
149913164|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
149913165|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
149913166|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
149913167|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
149913168|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
149913169|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
149913170|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
149913171|NCT01440569|540813105|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
149913172|NCT01440569|540813106|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
149913173|NCT00435487|540813107|FG000|Overall Study|Death|3|||
149913174|NCT00435487|540813108|FG001|Overall Study|Death|4|||
149913175|NCT00435487|540813107|FG000|Overall Study|Adverse Event|0|||
149913176|NCT00435487|540813108|FG001|Overall Study|Adverse Event|3|||
149913177|NCT00435487|540813107|FG000|Overall Study|Lost to Follow-up|2|||
149913178|NCT00435487|540813108|FG001|Overall Study|Lost to Follow-up|2|||
149913179|NCT00435487|540813107|FG000|Overall Study|Other|5|||
149913180|NCT00435487|540813108|FG001|Overall Study|Other|2|||
149913181|NCT00435487|540813107|FG000|Overall Study|Withdrawal by Subject|2|||
149913182|NCT00435487|540813108|FG001|Overall Study|Withdrawal by Subject|1|||
149913183|NCT00435487|540813107|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
149913184|NCT00435487|540813108|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
149913185|NCT00435487|540813107|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
149913186|NCT00435487|540813108|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
149913187|NCT00835679|540813109|FG000|Overall Study|Withdrawal by Subject|1|||
149913188|NCT00835679|540813110|FG001|Overall Study|Withdrawal by Subject|0|||
149913189|NCT00835679|540813111|FG002|Overall Study|Withdrawal by Subject|0|||
149913190|NCT00835679|540813112|FG003|Overall Study|Withdrawal by Subject|0|||
149913191|NCT00955968|540813115|FG000|Overall Study|Death|2|||
149913192|NCT00955968|540813116|FG001|Overall Study|Death|4|||
149913193|NCT00955968|540813115|FG000|Overall Study|Withdrawal by Subject|35|||
149913194|NCT00955968|540813116|FG001|Overall Study|Withdrawal by Subject|31|||
149913195|NCT00955968|540813115|FG000|Overall Study|Lost to Follow-up|45|||
149913196|NCT00955968|540813116|FG001|Overall Study|Lost to Follow-up|39|||
149913197|NCT00955968|540813115|FG000|Overall Study|Site closed|55|||
149913198|NCT00955968|540813116|FG001|Overall Study|Site closed|52|||
149972366|NCT01816295|541036869|FG000|Double Blind Phase|Lost to Follow-up|3|||
149972367|NCT01816295|541036870|FG001|Double Blind Phase|Lost to Follow-up|5|||
149972368|NCT01816295|541036869|FG000|Double Blind Phase|Physician Decision|2|||
149972369|NCT01816295|541036870|FG001|Double Blind Phase|Physician Decision|2|||
149972370|NCT01816295|541036869|FG000|Double Blind Phase|Protocol Violation|17|||
149972371|NCT01816295|541036870|FG001|Double Blind Phase|Protocol Violation|11|||
149972372|NCT01816295|541036869|FG000|Double Blind Phase|Sponsor Decision|8|||
149972373|NCT01816295|541036870|FG001|Double Blind Phase|Sponsor Decision|8|||
149972374|NCT01816295|541036869|FG000|Double Blind Phase|Withdrawal by Subject|22|||
149972375|NCT01816295|541036870|FG001|Double Blind Phase|Withdrawal by Subject|20|||
150050658|NCT00776919|541327614|FG003|Overall Study|Adverse Event|2|||
150050659|NCT00776919|541327611|FG000|Overall Study|Protocol Violation|1|||
150050660|NCT00776919|541327612|FG001|Overall Study|Protocol Violation|2|||
150050661|NCT00776919|541327613|FG002|Overall Study|Protocol Violation|0|||
150177125|NCT02767765|541786131|FG000|Overall Study|Investigator decision|1|||
149913199|NCT05020899|540813117|FG000|8 Week Follow-up|Lost to Follow-up|3|||
149913200|NCT05020899|540813118|FG001|8 Week Follow-up|Lost to Follow-up|6|||
149913201|NCT05020899|540813117|FG000|12 Week Follow-up|Lost to Follow-up|1|||
149913202|NCT05020899|540813118|FG001|12 Week Follow-up|Lost to Follow-up|0|||
149913203|NCT05020899|540813117|FG000|12 Week Follow-up|Death|0|||
149913204|NCT05020899|540813118|FG001|12 Week Follow-up|Death|1|||
150050662|NCT00776919|541327614|FG003|Overall Study|Protocol Violation|1|||
149913205|NCT01940900|540813121|FG000|Overall Study|Physician Decision|4|||
149913206|NCT01940900|540813122|FG001|Overall Study|Physician Decision|0|||
149913207|NCT01940900|540813121|FG000|Overall Study|Adverse Event|10|||
149913208|NCT01940900|540813122|FG001|Overall Study|Adverse Event|15|||
149913209|NCT01940900|540813121|FG000|Overall Study|Withdrawal by Subject|11|||
149913210|NCT01940900|540813122|FG001|Overall Study|Withdrawal by Subject|15|||
149913211|NCT01940900|540813121|FG000|Overall Study|Lost to Follow-up|1|||
149913212|NCT01940900|540813122|FG001|Overall Study|Lost to Follow-up|0|||
149913213|NCT01940900|540813121|FG000|Overall Study|Sponsor Decision|1|||
149913214|NCT01940900|540813122|FG001|Overall Study|Sponsor Decision|0|||
149913215|NCT01940900|540813121|FG000|Overall Study|subject non-compliance|1|||
149913216|NCT01940900|540813122|FG001|Overall Study|subject non-compliance|1|||
149913217|NCT01940900|540813121|FG000|Overall Study|other|1|||
149913218|NCT01940900|540813122|FG001|Overall Study|other|0|||
149913219|NCT04972968|540813126|FG000|Overall Study|Adverse Event|3|||
149913220|NCT04972968|540813127|FG001|Overall Study|Adverse Event|1|||
149913221|NCT04972968|540813128|FG002|Overall Study|Adverse Event|1|||
149913222|NCT04972968|540813129|FG003|Overall Study|Adverse Event|7|||
149913223|NCT04972968|540813126|FG000|Overall Study|Lack of Efficacy|2|||
149913224|NCT04972968|540813127|FG001|Overall Study|Lack of Efficacy|1|||
149913225|NCT04972968|540813128|FG002|Overall Study|Lack of Efficacy|0|||
149913226|NCT04972968|540813129|FG003|Overall Study|Lack of Efficacy|0|||
149913227|NCT04972968|540813126|FG000|Overall Study|Withdrawal by Subject|7|||
149913228|NCT04972968|540813127|FG001|Overall Study|Withdrawal by Subject|4|||
149913229|NCT04972968|540813128|FG002|Overall Study|Withdrawal by Subject|3|||
149913230|NCT04972968|540813129|FG003|Overall Study|Withdrawal by Subject|2|||
149913231|NCT04972968|540813126|FG000|Overall Study|Study Terminated by Sponsor|25|||
149913232|NCT04972968|540813127|FG001|Overall Study|Study Terminated by Sponsor|28|||
149913233|NCT04972968|540813128|FG002|Overall Study|Study Terminated by Sponsor|32|||
149913234|NCT04972968|540813129|FG003|Overall Study|Study Terminated by Sponsor|27|||
149913235|NCT04972968|540813126|FG000|Overall Study|Other|1|||
149913236|NCT04972968|540813127|FG001|Overall Study|Other|0|||
149913237|NCT04972968|540813128|FG002|Overall Study|Other|1|||
149913238|NCT04972968|540813129|FG003|Overall Study|Other|1|||
149913239|NCT01698879|540813130|FG000|Overall Study|Withdrawal by Subject|1|||
149913240|NCT01698879|540813131|FG001|Overall Study|Withdrawal by Subject|0|||
149913241|NCT01698879|540813132|FG002|Overall Study|Withdrawal by Subject|0|||
149913242|NCT00191282|540813133|FG000|Overall Study|Adverse Event|5|||
149913243|NCT00191282|540813134|FG001|Overall Study|Adverse Event|6|||
149913244|NCT00191282|540813133|FG000|Overall Study|Death|51|||
149913245|NCT00191282|540813134|FG001|Overall Study|Death|51|||
149913246|NCT00191282|540813133|FG000|Overall Study|Lack of Efficacy|11|||
149913247|NCT00191282|540813134|FG001|Overall Study|Lack of Efficacy|6|||
149913248|NCT00191282|540813133|FG000|Overall Study|Noncompliance|14|||
149913249|NCT00191282|540813134|FG001|Overall Study|Noncompliance|17|||
149913250|NCT00191282|540813133|FG000|Overall Study|Patient moved|11|||
149913251|NCT00191282|540813134|FG001|Overall Study|Patient moved|14|||
149913252|NCT00191282|540813133|FG000|Overall Study|Withdrawal by Subject|59|||
149913253|NCT00191282|540813134|FG001|Overall Study|Withdrawal by Subject|44|||
149913254|NCT00191282|540813133|FG000|Overall Study|Physician Decision|18|||
149913255|NCT00191282|540813134|FG001|Overall Study|Physician Decision|15|||
149913256|NCT00191282|540813133|FG000|Overall Study|Protocol entry criteria not met|14|||
149913257|NCT00191282|540813134|FG001|Overall Study|Protocol entry criteria not met|9|||
149913258|NCT00191282|540813133|FG000|Overall Study|Protocol Violation|9|||
149913259|NCT00191282|540813134|FG001|Overall Study|Protocol Violation|12|||
149913260|NCT00191282|540813133|FG000|Overall Study|Severity of outcome|2|||
149913261|NCT00191282|540813134|FG001|Overall Study|Severity of outcome|5|||
149913262|NCT00191282|540813133|FG000|Overall Study|Sponsor's decision|2|||
149913263|NCT00191282|540813134|FG001|Overall Study|Sponsor's decision|2|||
149913264|NCT00191282|540813133|FG000|Overall Study|Lost to Follow-up|24|||
149913265|NCT00191282|540813134|FG001|Overall Study|Lost to Follow-up|31|||
149972376|NCT01816295|541036869|FG000|OLE Phase|Adverse Event|17|||
149972377|NCT01816295|541036870|FG001|OLE Phase|Adverse Event|15|||
149972378|NCT01816295|541036869|FG000|OLE Phase|Death|1|||
149972379|NCT01816295|541036870|FG001|OLE Phase|Death|0|||
149913266|NCT04756154|540813137|FG000|Overall Study|Did not meet treatment day baseline|30|||
149913267|NCT04756154|540813138|FG001|Overall Study|Did not meet treatment day baseline|28|||
149913268|NCT04756154|540813139|FG002|Overall Study|Did not meet treatment day baseline|7|||
149913269|NCT04756154|540813137|FG000|Overall Study|Did not return for final sample collection|1|||
149913270|NCT04756154|540813138|FG001|Overall Study|Did not return for final sample collection|1|||
149913271|NCT04756154|540813139|FG002|Overall Study|Did not return for final sample collection|0|||
149972380|NCT01816295|541036869|FG000|OLE Phase|Entry Criteria Not Met|3|||
149972381|NCT01816295|541036870|FG001|OLE Phase|Entry Criteria Not Met|5|||
149913272|NCT03589976|540813140|FG000|Overall Study|Death|5|||
149913273|NCT03589976|540813141|FG001|Overall Study|Death|1|||
149913274|NCT03589976|540813140|FG000|Overall Study|Adverse Event|5|||
149913275|NCT03589976|540813141|FG001|Overall Study|Adverse Event|1|||
149913276|NCT03589976|540813140|FG000|Overall Study|Withdrawal by Subject|4|||
149913277|NCT03589976|540813141|FG001|Overall Study|Withdrawal by Subject|1|||
149913278|NCT03589976|540813140|FG000|Overall Study|Lost to Follow-up|1|||
149913279|NCT03589976|540813141|FG001|Overall Study|Lost to Follow-up|0|||
149972382|NCT01816295|541036869|FG000|OLE Phase|Lost to Follow-up|5|||
149913280|NCT03589976|540813140|FG000|Overall Study|Other|4|||
149913281|NCT03589976|540813141|FG001|Overall Study|Other|3|||
149913282|NCT04253782|540813143|FG000|Overall Study|Death|2|||
149913283|NCT04253782|540813144|FG001|Overall Study|Death|0|||
149913284|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
149913285|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
149913286|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
149913287|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
149913288|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
149913289|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
149913290|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
149913291|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
149913292|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
149913293|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
149913294|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
149913295|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
149913296|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
149913297|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
149913298|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
149913299|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
149913300|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
149913301|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
149913302|NCT02294461|540813145|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
149913303|NCT02294461|540813146|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
149913304|NCT02294461|540813147|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
149913305|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
149913306|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
149913307|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
149913308|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
149913309|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
149913310|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
149913311|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
149913312|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
149913313|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
149913314|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
149913315|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
149913316|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
149913317|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
149913318|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
149913319|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
149913320|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
149913321|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
149913322|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
149913323|NCT02294461|540813145|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
149913324|NCT02294461|540813146|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
149913325|NCT02294461|540813147|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
149913326|NCT00908596|540814875|FG000|Overall Study|Other reasons|46|||
149913327|NCT00908596|540814876|FG001|Overall Study|Other reasons|6|||
149913328|NCT00908596|540814877|FG002|Overall Study|Other reasons|2|||
149913329|NCT00908596|540814878|FG003|Overall Study|Other reasons|0|||
149913330|NCT00908596|540814875|FG000|Overall Study|Lost to Follow-up|0|||
149913331|NCT00908596|540814876|FG001|Overall Study|Lost to Follow-up|1|||
149913332|NCT00908596|540814877|FG002|Overall Study|Lost to Follow-up|12|||
149913333|NCT00908596|540814878|FG003|Overall Study|Lost to Follow-up|4|||
149913334|NCT00908596|540814875|FG000|Overall Study|Death|0|||
149972383|NCT01816295|541036870|FG001|OLE Phase|Lost to Follow-up|5|||
149972384|NCT01816295|541036869|FG000|OLE Phase|Physician Decision|3|||
149972385|NCT01816295|541036870|FG001|OLE Phase|Physician Decision|1|||
149972386|NCT01816295|541036869|FG000|OLE Phase|Protocol Violation|4|||
149972387|NCT01816295|541036870|FG001|OLE Phase|Protocol Violation|4|||
149972388|NCT01816295|541036869|FG000|OLE Phase|Sponsor Decision|7|||
149913335|NCT00908596|540814876|FG001|Overall Study|Death|5|||
149913336|NCT00908596|540814877|FG002|Overall Study|Death|57|||
149913337|NCT00908596|540814878|FG003|Overall Study|Death|32|||
149913338|NCT00908596|540814875|FG000|Overall Study|Protocol Violation|1|||
149913339|NCT00908596|540814876|FG001|Overall Study|Protocol Violation|0|||
149913340|NCT00908596|540814877|FG002|Overall Study|Protocol Violation|0|||
149972389|NCT01816295|541036870|FG001|OLE Phase|Sponsor Decision|9|||
149972390|NCT01816295|541036869|FG000|OLE Phase|Withdrawal by Subject|10|||
149972391|NCT01816295|541036870|FG001|OLE Phase|Withdrawal by Subject|10|||
149913341|NCT00908596|540814878|FG003|Overall Study|Protocol Violation|0|||
149913342|NCT00908596|540814875|FG000|Overall Study|Withdrawal by Subject|0|||
149913343|NCT00908596|540814876|FG001|Overall Study|Withdrawal by Subject|1|||
149913344|NCT00908596|540814877|FG002|Overall Study|Withdrawal by Subject|3|||
149913345|NCT00908596|540814878|FG003|Overall Study|Withdrawal by Subject|1|||
149913346|NCT02949908|540814879|FG000|Overall Study|Study termination|2|||
149913347|NCT01143064|540814880|FG000|Overall Study|Death|109|||
149913348|NCT01143064|540814881|FG001|Overall Study|Death|91|||
149913349|NCT01143064|540814880|FG000|Overall Study|Adverse Event|0|||
149913350|NCT01143064|540814881|FG001|Overall Study|Adverse Event|1|||
149913351|NCT01143064|540814880|FG000|Overall Study|Withdrawal by Subject|7|||
149913352|NCT01143064|540814881|FG001|Overall Study|Withdrawal by Subject|5|||
149913353|NCT01143064|540814880|FG000|Overall Study|Lost to Follow-up|17|||
149913354|NCT01143064|540814881|FG001|Overall Study|Lost to Follow-up|14|||
149913355|NCT01143064|540814880|FG000|Overall Study|Physician Decision|0|||
149913356|NCT01143064|540814881|FG001|Overall Study|Physician Decision|4|||
149913357|NCT01661933|540814882|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
149913358|NCT01661933|540814882|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
149913359|NCT03448939|540814884|FG000|Overall Study|Adverse Event|5|||
149913360|NCT03448939|540814885|FG001|Overall Study|Adverse Event|1|||
149913361|NCT03448939|540814884|FG000|Overall Study|Lost to Follow-up|6|||
149913362|NCT03448939|540814885|FG001|Overall Study|Lost to Follow-up|6|||
149913363|NCT03448939|540814884|FG000|Overall Study|Pregnancy|1|||
149913364|NCT03448939|540814885|FG001|Overall Study|Pregnancy|1|||
149913365|NCT03448939|540814884|FG000|Overall Study|Withdrawal by Subject|9|||
149913366|NCT03448939|540814885|FG001|Overall Study|Withdrawal by Subject|3|||
149913367|NCT02332239|540814886|FG000|Overall Study|Lost to Follow-up|4|||
149913368|NCT02332239|540814887|FG001|Overall Study|Lost to Follow-up|6|||
149913369|NCT03488225|540814888|FG000|Overall Study|Off Protocol Therapy|2|||
149913370|NCT03488225|540814888|FG000|Overall Study|Stem Cell Transplant|2|||
149913371|NCT01472965|540814891|FG000|Overall Study|Withdrawal by Subject|1|||
149913372|NCT01472965|540814892|FG001|Overall Study|Withdrawal by Subject|0|||
149913373|NCT00087126|540814898|FG000|Overall Study|Ineligible - second primary|1|||
149913374|NCT00087126|540814898|FG000|Overall Study|Never treated|1|||
149913375|NCT01432275|540814899|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
149913376|NCT01432275|540814900|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
149913377|NCT01432275|540814899|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
149913378|NCT01432275|540814900|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
149913379|NCT01432275|540814899|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
149913380|NCT01432275|540814900|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
149913381|NCT01432275|540814899|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
149913382|NCT01432275|540814900|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
149913383|NCT01432275|540814899|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
149913384|NCT01432275|540814900|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
149913385|NCT01432275|540814899|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
149913386|NCT01432275|540814900|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
149913387|NCT01432275|540814899|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
149913388|NCT01432275|540814900|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
149913389|NCT01432275|540814899|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
149913390|NCT01432275|540814900|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
149913391|NCT01432275|540814899|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
149913392|NCT01432275|540814900|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
149913393|NCT01935700|540814903|FG000|Overall Study|Withdrawal by Subject|1|||
149913394|NCT01935700|540814904|FG001|Overall Study|Withdrawal by Subject|0|||
149913395|NCT01935700|540814903|FG000|Overall Study|Physician Decision|4|||
149913396|NCT01935700|540814904|FG001|Overall Study|Physician Decision|0|||
149913397|NCT01935128|540814905|FG000|Overall Study|Death|1|||
149913398|NCT01935128|540814905|FG000|Overall Study|Adverse Event|6|||
149913399|NCT00772005|540814907|FG000|Overall Study|Adverse Event|9|||
149913400|NCT00772005|540814908|FG001|Overall Study|Adverse Event|14|||
149913401|NCT00772005|540814909|FG002|Overall Study|Adverse Event|10|||
149913402|NCT00772005|540814910|FG003|Overall Study|Adverse Event|13|||
149913403|NCT00772005|540814907|FG000|Overall Study|Lack of Efficacy|0|||
149913404|NCT00772005|540814908|FG001|Overall Study|Lack of Efficacy|1|||
149913405|NCT00772005|540814909|FG002|Overall Study|Lack of Efficacy|0|||
149913406|NCT00772005|540814910|FG003|Overall Study|Lack of Efficacy|0|||
149913407|NCT00772005|540814907|FG000|Overall Study|Withdrawal by Subject|3|||
149913408|NCT00772005|540814908|FG001|Overall Study|Withdrawal by Subject|7|||
149913409|NCT00772005|540814909|FG002|Overall Study|Withdrawal by Subject|10|||
149913410|NCT00772005|540814910|FG003|Overall Study|Withdrawal by Subject|2|||
149913411|NCT00772005|540814907|FG000|Overall Study|Protocol Violation|2|||
149913412|NCT00772005|540814908|FG001|Overall Study|Protocol Violation|4|||
149913413|NCT00772005|540814909|FG002|Overall Study|Protocol Violation|1|||
149913414|NCT00772005|540814910|FG003|Overall Study|Protocol Violation|6|||
149913415|NCT00772005|540814907|FG000|Overall Study|Lost to Follow-up|7|||
149913416|NCT00772005|540814908|FG001|Overall Study|Lost to Follow-up|3|||
149913417|NCT00772005|540814909|FG002|Overall Study|Lost to Follow-up|6|||
149913418|NCT00772005|540814910|FG003|Overall Study|Lost to Follow-up|3|||
149913419|NCT00772005|540814907|FG000|Overall Study|Non-compliance with study procedures|1|||
149913420|NCT00772005|540814908|FG001|Overall Study|Non-compliance with study procedures|1|||
149913421|NCT00772005|540814909|FG002|Overall Study|Non-compliance with study procedures|0|||
149913422|NCT00772005|540814910|FG003|Overall Study|Non-compliance with study procedures|1|||
149913423|NCT00772005|540814907|FG000|Overall Study|Non-compliance with drug administration|3|||
149913424|NCT00772005|540814908|FG001|Overall Study|Non-compliance with drug administration|0|||
149913425|NCT00772005|540814909|FG002|Overall Study|Non-compliance with drug administration|1|||
149913426|NCT00772005|540814910|FG003|Overall Study|Non-compliance with drug administration|1|||
149913427|NCT02584959|540814919|FG000|Period 1|Withdrawn from study|3|||
149913428|NCT02584959|540814920|FG001|Period 1|Withdrawn from study|4|||
149913429|NCT02584959|540814921|FG002|Period 1|Withdrawn from study|0|||
149913430|NCT02584959|540814919|FG000|Period 2|Withdrawn from study|6|||
149913431|NCT02584959|540814920|FG001|Period 2|Withdrawn from study|1|||
149913432|NCT02584959|540814921|FG002|Period 2|Withdrawn from study|2|||
149913433|NCT00204477|540814924|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
149913434|NCT00204477|540814925|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
149913435|NCT00204477|540814924|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
149913436|NCT00204477|540814925|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
149913437|NCT00150800|540814926|FG000|Overall Study|Adverse Event|89|||
149913438|NCT00150800|540814926|FG000|Overall Study|Death|18|||
149913439|NCT00150800|540814926|FG000|Overall Study|Lack of Efficacy|166|||
149913440|NCT00150800|540814926|FG000|Overall Study|Lost to Follow-up|58|||
149913441|NCT00150800|540814926|FG000|Overall Study|Subject's choice|90|||
149913442|NCT00150800|540814926|FG000|Overall Study|No compliance|18|||
149913443|NCT00150800|540814926|FG000|Overall Study|IP misshandling|1|||
149913444|NCT00150800|540814926|FG000|Overall Study|Site closure|24|||
149913445|NCT00150800|540814926|FG000|Overall Study|Protocol non-adherence|2|||
149913446|NCT00150800|540814926|FG000|Overall Study|Nobody to accompany patient|1|||
149913447|NCT00150800|540814926|FG000|Overall Study|Distance too long for patient|1|||
149913448|NCT00150800|540814926|FG000|Overall Study|Neurosurgery|2|||
149913449|NCT00150800|540814926|FG000|Overall Study|BRV monotherapy|1|||
149913450|NCT00150800|540814926|FG000|Overall Study|Visit refusal|3|||
149913451|NCT00150800|540814926|FG000|Overall Study|Sponsor's request|2|||
149913452|NCT00150800|540814926|FG000|Overall Study|Generalized Epilepsy|1|||
149913453|NCT00150800|540814926|FG000|Overall Study|Moved from area/country|8|||
149913454|NCT00150800|540814926|FG000|Overall Study|PI retiring|2|||
149913455|NCT00150800|540814926|FG000|Overall Study|PI leaving site|2|||
149913456|NCT00150800|540814926|FG000|Overall Study|Patient insurance|1|||
149913457|NCT00150800|540814926|FG000|Overall Study|Surgical intervention|4|||
149913458|NCT00150800|540814926|FG000|Overall Study|Pregnancy planned|1|||
149913459|NCT00150800|540814926|FG000|Overall Study|PI discontinuation request|1|||
149913460|NCT01966068|540814929|FG000|Overall Study|Withdrawal by Subject|57|||
149913461|NCT01966068|540814929|FG000|Overall Study|Lost to Follow-up|81|||
149913462|NCT01790828|540814931|FG000|Overall Study|Other|34|||
149913463|NCT02637713|540814942|FG000|Overall Study|Screen Failure|2|||
149913464|NCT02847182|540814943|FG000|Overall Study|Withdrawal by Subject|0|||
149913465|NCT02847182|540814944|FG001|Overall Study|Withdrawal by Subject|1|||
149913466|NCT02345889|540814945|FG000|Overall Study|Inadequate Bowel Prep|17|||
149913467|NCT02345889|540814946|FG001|Overall Study|Inadequate Bowel Prep|16|||
149913468|NCT02345889|540814947|FG002|Overall Study|Inadequate Bowel Prep|18|||
149913469|NCT02345889|540814948|FG003|Overall Study|Inadequate Bowel Prep|14|||
149913470|NCT02345889|540814945|FG000|Overall Study|Polyposis identified during procedure|1|||
149913471|NCT02345889|540814946|FG001|Overall Study|Polyposis identified during procedure|1|||
149913472|NCT02345889|540814947|FG002|Overall Study|Polyposis identified during procedure|0|||
149913473|NCT02345889|540814948|FG003|Overall Study|Polyposis identified during procedure|1|||
149913474|NCT02345889|540814945|FG000|Overall Study|Recognized ineligible post-randomization|1|||
149913475|NCT02345889|540814946|FG001|Overall Study|Recognized ineligible post-randomization|0|||
149913476|NCT02345889|540814947|FG002|Overall Study|Recognized ineligible post-randomization|2|||
149913477|NCT02345889|540814948|FG003|Overall Study|Recognized ineligible post-randomization|1|||
149913478|NCT02345889|540814945|FG000|Overall Study|Ulcerative Colitis identified|1|||
149913479|NCT02345889|540814946|FG001|Overall Study|Ulcerative Colitis identified|0|||
149913480|NCT02345889|540814947|FG002|Overall Study|Ulcerative Colitis identified|0|||
149913481|NCT02345889|540814948|FG003|Overall Study|Ulcerative Colitis identified|0|||
149913482|NCT02345889|540814945|FG000|Overall Study|Cecum not intubated|1|||
149972392|NCT01816295|541036869|FG000|OLE Phase|Lack of Efficacy|3|||
149972393|NCT01816295|541036870|FG001|OLE Phase|Lack of Efficacy|7|||
149972394|NCT01076010|541036871|FG000|Overall Study|Death|15|||
149972395|NCT01076010|541036872|FG001|Overall Study|Death|1|||
149972396|NCT01076010|541036873|FG002|Overall Study|Death|0|||
149972397|NCT01076010|541036871|FG000|Overall Study|Adverse Event|7|||
149972398|NCT01076010|541036872|FG001|Overall Study|Adverse Event|2|||
149972399|NCT01076010|541036873|FG002|Overall Study|Adverse Event|0|||
149972400|NCT01076010|541036871|FG000|Overall Study|Progressive disease|90|||
149913483|NCT02345889|540814946|FG001|Overall Study|Cecum not intubated|0|||
149913484|NCT02345889|540814947|FG002|Overall Study|Cecum not intubated|0|||
149913485|NCT02345889|540814948|FG003|Overall Study|Cecum not intubated|0|||
149913486|NCT04325698|540814949|FG000|Overall Study|Study Terminated By Sponsor|1|||
149913487|NCT04325698|540814950|FG001|Overall Study|Study Terminated By Sponsor|1|||
149913488|NCT04325698|540814949|FG000|Overall Study|Withdrawal by Subject|0|||
149913489|NCT04325698|540814950|FG001|Overall Study|Withdrawal by Subject|2|||
149913490|NCT00962091|540814951|FG000|Overall Study|Withdrawal by Subject|1|||
149913491|NCT00962091|540814952|FG001|Overall Study|Withdrawal by Subject|2|||
149913492|NCT00962091|540814953|FG002|Overall Study|Withdrawal by Subject|1|||
149913493|NCT00962091|540814954|FG003|Overall Study|Withdrawal by Subject|1|||
149913494|NCT00962091|540814955|FG004|Overall Study|Withdrawal by Subject|0|||
149913495|NCT00962091|540814956|FG005|Overall Study|Withdrawal by Subject|1|||
149913496|NCT00962091|540814957|FG006|Overall Study|Withdrawal by Subject|0|||
149913497|NCT00962091|540814951|FG000|Overall Study|Adverse Event|0|||
149913498|NCT00962091|540814952|FG001|Overall Study|Adverse Event|0|||
149913499|NCT00962091|540814953|FG002|Overall Study|Adverse Event|0|||
149913500|NCT00962091|540814954|FG003|Overall Study|Adverse Event|0|||
149913501|NCT00962091|540814955|FG004|Overall Study|Adverse Event|0|||
149913502|NCT00962091|540814956|FG005|Overall Study|Adverse Event|0|||
149913503|NCT00962091|540814957|FG006|Overall Study|Adverse Event|1|||
149913504|NCT02326298|540814960|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913505|NCT02326298|540814961|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913506|NCT02326298|540814962|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
149913507|NCT02326298|540814963|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913508|NCT02326298|540814964|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913509|NCT02326298|540814965|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913510|NCT02326298|540814966|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913511|NCT02326298|540814967|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913512|NCT02326298|540814968|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913513|NCT02326298|540814969|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913514|NCT02326298|540814970|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913515|NCT02326298|540814971|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913516|NCT02326298|540814972|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913517|NCT02326298|540814973|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149913518|NCT02326298|540814960|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
149913519|NCT02326298|540814961|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913520|NCT02326298|540814962|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913521|NCT02326298|540814963|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913522|NCT02326298|540814964|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913523|NCT02326298|540814965|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913524|NCT02326298|540814966|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913525|NCT02326298|540814967|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913526|NCT02326298|540814968|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913527|NCT02326298|540814969|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913528|NCT02326298|540814970|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913529|NCT02326298|540814971|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913530|NCT02326298|540814972|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913531|NCT02326298|540814973|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
149913532|NCT02326298|540814960|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
149913533|NCT02326298|540814961|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
149913534|NCT02326298|540814962|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913535|NCT02326298|540814963|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913536|NCT02326298|540814964|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913537|NCT02326298|540814965|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
150050663|NCT00776919|541327611|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
149913538|NCT02326298|540814966|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913539|NCT02326298|540814967|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913540|NCT02326298|540814968|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913541|NCT02326298|540814969|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913542|NCT02326298|540814970|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913543|NCT02326298|540814971|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913544|NCT02326298|540814972|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913545|NCT02326298|540814973|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
149913546|NCT02326298|540814960|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
149913547|NCT02326298|540814961|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
149913548|NCT02326298|540814962|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913549|NCT02326298|540814963|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913550|NCT02326298|540814964|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
150050664|NCT00776919|541327612|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
149913551|NCT02326298|540814965|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913552|NCT02326298|540814966|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913553|NCT02326298|540814967|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913554|NCT02326298|540814968|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913555|NCT02326298|540814969|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913556|NCT02326298|540814970|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913557|NCT02326298|540814971|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913558|NCT02326298|540814972|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913559|NCT02326298|540814973|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149913560|NCT02326298|540814960|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913561|NCT02326298|540814961|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913562|NCT02326298|540814962|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
149913563|NCT02326298|540814963|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913564|NCT02326298|540814964|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913565|NCT02326298|540814965|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913566|NCT02326298|540814966|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913567|NCT02326298|540814967|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913568|NCT02326298|540814968|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913569|NCT02326298|540814969|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913570|NCT02326298|540814970|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913571|NCT02326298|540814971|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913572|NCT02326298|540814972|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913573|NCT02326298|540814973|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
149913574|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913575|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913576|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913577|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913578|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913579|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149913580|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
149913581|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149913582|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149913583|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
149913584|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913585|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913586|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913587|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
149913588|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913589|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913590|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913591|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913592|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913593|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
149913594|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
149913595|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913596|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
149913597|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913598|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913599|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913600|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913601|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
149913602|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913603|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913604|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913605|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913606|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149972401|NCT01076010|541036872|FG001|Overall Study|Progressive disease|30|||
149972402|NCT01076010|541036873|FG002|Overall Study|Progressive disease|1|||
149972403|NCT01076010|541036871|FG000|Overall Study|Lack of Efficacy|4|||
149972404|NCT01076010|541036872|FG001|Overall Study|Lack of Efficacy|0|||
149913607|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
149913608|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913609|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913610|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913611|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913612|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913613|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913614|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913615|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
149913616|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913617|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913618|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913619|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913620|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913621|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913622|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
149913623|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913624|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913625|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913626|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913627|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913628|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913629|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
149913630|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913631|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913632|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913633|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913634|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913635|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913636|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913637|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
149913638|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913639|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913640|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913641|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913642|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913643|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
149913644|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913645|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913646|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913647|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913648|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913649|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913650|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
149913651|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
149972405|NCT01076010|541036873|FG002|Overall Study|Lack of Efficacy|0|||
149972406|NCT01076010|541036871|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
149972407|NCT01076010|541036872|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
149972408|NCT01076010|541036873|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
149972409|NCT01076010|541036871|FG000|Overall Study|Significant Surgical Procedure|0|||
149972410|NCT01076010|541036872|FG001|Overall Study|Significant Surgical Procedure|1|||
149972411|NCT01076010|541036873|FG002|Overall Study|Significant Surgical Procedure|0|||
149972412|NCT01076010|541036871|FG000|Overall Study|Protocol Violation|0|||
149972413|NCT01076010|541036872|FG001|Overall Study|Protocol Violation|1|||
149972414|NCT01076010|541036873|FG002|Overall Study|Protocol Violation|0|||
149972415|NCT01076010|541036871|FG000|Overall Study|Noncompliance|1|||
149972416|NCT01076010|541036872|FG001|Overall Study|Noncompliance|1|||
149972417|NCT01076010|541036873|FG002|Overall Study|Noncompliance|0|||
149972418|NCT01076010|541036871|FG000|Overall Study|Withdrawal by Subject|3|||
149972419|NCT01076010|541036872|FG001|Overall Study|Withdrawal by Subject|0|||
149972420|NCT01076010|541036873|FG002|Overall Study|Withdrawal by Subject|1|||
149972421|NCT01076010|541036871|FG000|Overall Study|Other|5|||
149972422|NCT01076010|541036872|FG001|Overall Study|Other|2|||
149972423|NCT01076010|541036873|FG002|Overall Study|Other|0|||
149972424|NCT01612676|541036874|FG000|Overall Study|Adverse Event|2|||
149972425|NCT01612676|541036875|FG001|Overall Study|Adverse Event|3|||
149972426|NCT01612676|541036876|FG002|Overall Study|Adverse Event|1|||
149913652|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913653|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913654|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913655|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913656|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913657|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149913658|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913659|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913660|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913661|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913662|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913663|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913664|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913665|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
149913666|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913667|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913668|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913669|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913670|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149913671|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150177126|NCT02767765|541786131|FG000|Overall Study|Non-Compliance|1|||
150177127|NCT02767765|541786131|FG000|Overall Study|Withdrawal by Subject|1|||
149913672|NCT02326298|540814960|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913673|NCT02326298|540814961|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913674|NCT02326298|540814962|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913675|NCT02326298|540814963|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913676|NCT02326298|540814964|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913677|NCT02326298|540814965|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
149913678|NCT02326298|540814966|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913679|NCT02326298|540814967|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913680|NCT02326298|540814968|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913681|NCT02326298|540814969|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913682|NCT02326298|540814970|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913683|NCT02326298|540814971|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913684|NCT02326298|540814972|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913685|NCT02326298|540814973|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
149913686|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
149913687|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
149913688|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
149913689|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
149913690|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
149913691|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
149913692|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
149913693|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
149913694|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
149913695|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
149913696|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
149913697|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
149913698|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
149913699|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
149972427|NCT01612676|541036877|FG003|Overall Study|Adverse Event|3|||
149972428|NCT01612676|541036874|FG000|Overall Study|Protocol Violation|0|||
149972429|NCT01612676|541036875|FG001|Overall Study|Protocol Violation|1|||
149972430|NCT01612676|541036876|FG002|Overall Study|Protocol Violation|0|||
149972431|NCT01612676|541036877|FG003|Overall Study|Protocol Violation|0|||
149972432|NCT05200845|541036881|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
149972433|NCT05200845|541036882|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
149972434|NCT05200845|541036883|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
149972435|NCT05200845|541036884|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
149972436|NCT05200845|541036881|FG000|Overall Study|Withdrawal by Subject|0|||
149972437|NCT05200845|541036882|FG001|Overall Study|Withdrawal by Subject|1|||
149972438|NCT05200845|541036883|FG002|Overall Study|Withdrawal by Subject|1|||
149972439|NCT05200845|541036884|FG003|Overall Study|Withdrawal by Subject|0|||
149972440|NCT02412670|541036885|FG000|Overall Study|Adverse Event|4|||
150177128|NCT01951170|541786133|FG000|Overall Study|Investigator decision|1|||
150177129|NCT04723394|541786144|FG000|Overall Study|Adverse Event|0|||
149913700|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913701|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913702|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913703|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913704|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913705|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913706|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913707|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913708|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913709|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913710|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913711|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
149913712|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
149913713|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
149913714|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913715|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913716|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913717|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913718|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913719|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913720|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913721|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913722|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913723|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913724|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913725|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
149913726|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
149913727|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
149913728|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913729|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913730|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913731|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913732|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913733|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913734|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913735|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913736|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913737|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913738|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913739|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913740|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
149913741|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
149913742|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913743|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913744|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913745|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913746|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913747|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913748|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913749|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913750|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913751|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913752|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149913753|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
150050665|NCT00776919|541327613|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
150050666|NCT00776919|541327614|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
150050667|NCT03116152|541327615|FG000|Overall Study|Disease Progression|49|||
150050668|NCT03116152|541327616|FG001|Overall Study|Disease Progression|47|||
150050669|NCT03116152|541327615|FG000|Overall Study|Death|5|||
150050670|NCT03116152|541327616|FG001|Overall Study|Death|2|||
150050671|NCT03116152|541327615|FG000|Overall Study|Adverse Event|21|||
150050672|NCT03116152|541327616|FG001|Overall Study|Adverse Event|7|||
150050673|NCT03116152|541327615|FG000|Overall Study|Protocol Violation|2|||
150050674|NCT03116152|541327616|FG001|Overall Study|Protocol Violation|2|||
150050675|NCT03116152|541327615|FG000|Overall Study|Withdrawal by Subject|0|||
150050676|NCT03116152|541327616|FG001|Overall Study|Withdrawal by Subject|1|||
149913754|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
149913755|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
149913756|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913757|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913758|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913759|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913760|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913761|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913762|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913763|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913764|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913765|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913766|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
149913767|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
149913768|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
149913769|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
149913770|NCT02326298|540814960|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913771|NCT02326298|540814961|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913772|NCT02326298|540814962|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913773|NCT02326298|540814963|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913774|NCT02326298|540814964|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913775|NCT02326298|540814965|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913776|NCT02326298|540814966|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913777|NCT02326298|540814967|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913778|NCT02326298|540814968|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913779|NCT02326298|540814969|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913780|NCT02326298|540814970|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
149913781|NCT02326298|540814971|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
149913782|NCT02326298|540814972|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
149913783|NCT02326298|540814973|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
149913784|NCT02044874|540814977|FG000|Overall Study|Adverse Event|5|||
149913785|NCT02044874|540814978|FG001|Overall Study|Adverse Event|6|||
149913786|NCT02044874|540814979|FG002|Overall Study|Adverse Event|6|||
149913787|NCT02044874|540814977|FG000|Overall Study|Withdrawal by Subject|8|||
149913788|NCT02044874|540814978|FG001|Overall Study|Withdrawal by Subject|16|||
149913789|NCT02044874|540814979|FG002|Overall Study|Withdrawal by Subject|23|||
149913790|NCT02044874|540814977|FG000|Overall Study|Physician Decision|0|||
149913791|NCT02044874|540814978|FG001|Overall Study|Physician Decision|2|||
149913792|NCT02044874|540814979|FG002|Overall Study|Physician Decision|1|||
149913793|NCT02044874|540814977|FG000|Overall Study|Lost to Follow-up|10|||
149913794|NCT02044874|540814978|FG001|Overall Study|Lost to Follow-up|27|||
149913795|NCT02044874|540814979|FG002|Overall Study|Lost to Follow-up|21|||
149913796|NCT02044874|540814977|FG000|Overall Study|Sponsor Decision|0|||
149913797|NCT02044874|540814978|FG001|Overall Study|Sponsor Decision|1|||
149913798|NCT02044874|540814979|FG002|Overall Study|Sponsor Decision|1|||
149913799|NCT02044874|540814977|FG000|Overall Study|Other|7|||
149913800|NCT02044874|540814978|FG001|Overall Study|Other|3|||
149913801|NCT02044874|540814979|FG002|Overall Study|Other|8|||
149913802|NCT02889835|540814980|FG000|Overall Study|Lost to Follow-up|13|||
149913803|NCT02889835|540814981|FG001|Overall Study|Lost to Follow-up|13|||
149913804|NCT02889835|540814982|FG002|Overall Study|Lost to Follow-up|13|||
149913805|NCT02889835|540814980|FG000|Overall Study|Withdrawal by Subject|2|||
149913806|NCT02889835|540814981|FG001|Overall Study|Withdrawal by Subject|2|||
149913807|NCT02889835|540814982|FG002|Overall Study|Withdrawal by Subject|2|||
149913808|NCT02889835|540814980|FG000|Overall Study|Protocol Violation|1|||
149913809|NCT02889835|540814981|FG001|Overall Study|Protocol Violation|1|||
149913810|NCT02889835|540814982|FG002|Overall Study|Protocol Violation|1|||
149913811|NCT02889835|540814980|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
149913812|NCT02889835|540814981|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
149913813|NCT02889835|540814982|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
149913814|NCT02889835|540814980|FG000|Overall Study|Death|1|||
149913815|NCT02889835|540814981|FG001|Overall Study|Death|1|||
149913816|NCT02889835|540814982|FG002|Overall Study|Death|1|||
149913817|NCT02987972|540814983|FG000|Overall Study|Adverse Event|1|||
149913818|NCT02987972|540814984|FG001|Overall Study|Adverse Event|1|||
149913819|NCT02987972|540814985|FG002|Overall Study|Adverse Event|0|||
149913820|NCT02987972|540814983|FG000|Overall Study|Death|1|||
149913821|NCT02987972|540814984|FG001|Overall Study|Death|0|||
149913822|NCT02987972|540814985|FG002|Overall Study|Death|0|||
149913823|NCT02987972|540814983|FG000|Overall Study|Lack of Efficacy|9|||
149972441|NCT02412670|541036886|FG001|Overall Study|Adverse Event|1|||
149972442|NCT02412670|541036885|FG000|Overall Study|Physician Decision|1|||
149972443|NCT02412670|541036886|FG001|Overall Study|Physician Decision|0|||
150177130|NCT04723394|541786145|FG001|Overall Study|Adverse Event|3|||
150177131|NCT04723394|541786144|FG000|Overall Study|Death|8|||
149913824|NCT02987972|540814984|FG001|Overall Study|Lack of Efficacy|12|||
149913825|NCT02987972|540814985|FG002|Overall Study|Lack of Efficacy|12|||
149913826|NCT02987972|540814983|FG000|Overall Study|Lost to Follow-up|7|||
149972444|NCT02412670|541036885|FG000|Overall Study|Withdrawal by Subject|1|||
149972445|NCT02412670|541036886|FG001|Overall Study|Withdrawal by Subject|0|||
149972446|NCT02412670|541036885|FG000|Overall Study|Ineligible|1|||
149972447|NCT02412670|541036886|FG001|Overall Study|Ineligible|0|||
149972448|NCT00565409|541036889|FG000|Period 1 Open Label|Adverse Event|17|||
149972449|NCT00565409|541036890|FG001|Period 1 Open Label|Adverse Event|0|||
149972450|NCT00565409|541036891|FG002|Period 1 Open Label|Adverse Event|0|||
149972451|NCT00565409|541036892|FG003|Period 1 Open Label|Adverse Event|0|||
149913827|NCT02987972|540814984|FG001|Overall Study|Lost to Follow-up|8|||
149913828|NCT02987972|540814985|FG002|Overall Study|Lost to Follow-up|4|||
149913829|NCT02987972|540814983|FG000|Overall Study|Physician Decision|1|||
149913830|NCT02987972|540814984|FG001|Overall Study|Physician Decision|6|||
149913831|NCT02987972|540814985|FG002|Overall Study|Physician Decision|0|||
149913832|NCT02987972|540814983|FG000|Overall Study|Protocol Violation|2|||
149913833|NCT02987972|540814984|FG001|Overall Study|Protocol Violation|1|||
149913834|NCT02987972|540814985|FG002|Overall Study|Protocol Violation|5|||
149913835|NCT02987972|540814983|FG000|Overall Study|Withdrawal by Subject|22|||
149972452|NCT00565409|541036889|FG000|Period 1 Open Label|Death|2|||
149972453|NCT00565409|541036890|FG001|Period 1 Open Label|Death|0|||
149972454|NCT00565409|541036891|FG002|Period 1 Open Label|Death|0|||
149972455|NCT00565409|541036892|FG003|Period 1 Open Label|Death|0|||
149972456|NCT00565409|541036889|FG000|Period 1 Open Label|Lost to Follow-up|1|||
149972457|NCT00565409|541036890|FG001|Period 1 Open Label|Lost to Follow-up|0|||
149972458|NCT00565409|541036891|FG002|Period 1 Open Label|Lost to Follow-up|0|||
149972459|NCT00565409|541036892|FG003|Period 1 Open Label|Lost to Follow-up|0|||
149972460|NCT00565409|541036889|FG000|Period 1 Open Label|Other|21|||
149972461|NCT00565409|541036890|FG001|Period 1 Open Label|Other|0|||
149972462|NCT00565409|541036891|FG002|Period 1 Open Label|Other|0|||
149972463|NCT00565409|541036892|FG003|Period 1 Open Label|Other|0|||
149972464|NCT00565409|541036889|FG000|Period 1 Open Label|Protocol Violation|14|||
149972465|NCT00565409|541036890|FG001|Period 1 Open Label|Protocol Violation|0|||
149972466|NCT00565409|541036891|FG002|Period 1 Open Label|Protocol Violation|0|||
149972467|NCT00565409|541036892|FG003|Period 1 Open Label|Protocol Violation|0|||
149972468|NCT00565409|541036889|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
149972469|NCT00565409|541036890|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
149972470|NCT00565409|541036891|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
149972471|NCT00565409|541036892|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
149972472|NCT00565409|541036889|FG000|Period 1 Open Label|no conclusion of participation record|1|||
149972473|NCT00565409|541036890|FG001|Period 1 Open Label|no conclusion of participation record|0|||
149972474|NCT00565409|541036891|FG002|Period 1 Open Label|no conclusion of participation record|0|||
149972475|NCT00565409|541036892|FG003|Period 1 Open Label|no conclusion of participation record|0|||
149972476|NCT00565409|541036889|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
149972477|NCT00565409|541036890|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
149972478|NCT00565409|541036891|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
149972479|NCT00565409|541036892|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
149972480|NCT00565409|541036889|FG000|Period 2 Double-Blind|Adverse Event|0|||
149972481|NCT00565409|541036890|FG001|Period 2 Double-Blind|Adverse Event|7|||
149972482|NCT00565409|541036891|FG002|Period 2 Double-Blind|Adverse Event|4|||
149972483|NCT00565409|541036892|FG003|Period 2 Double-Blind|Adverse Event|5|||
149972484|NCT00565409|541036889|FG000|Period 2 Double-Blind|Death|0|||
149972485|NCT00565409|541036890|FG001|Period 2 Double-Blind|Death|2|||
149972486|NCT00565409|541036891|FG002|Period 2 Double-Blind|Death|0|||
149972487|NCT00565409|541036892|FG003|Period 2 Double-Blind|Death|0|||
149972488|NCT00565409|541036889|FG000|Period 2 Double-Blind|Protocol Violation|0|||
149972489|NCT00565409|541036890|FG001|Period 2 Double-Blind|Protocol Violation|4|||
149972490|NCT00565409|541036891|FG002|Period 2 Double-Blind|Protocol Violation|6|||
149972491|NCT00565409|541036892|FG003|Period 2 Double-Blind|Protocol Violation|2|||
149972492|NCT00565409|541036889|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
150050677|NCT03116152|541327615|FG000|Overall Study|Physician Decision|3|||
149913836|NCT02987972|540814984|FG001|Overall Study|Withdrawal by Subject|17|||
149913837|NCT02987972|540814985|FG002|Overall Study|Withdrawal by Subject|21|||
149913838|NCT01328548|540814987|FG000|Overall Study|Death|3|||
149913839|NCT01328548|540814988|FG001|Overall Study|Death|0|||
149972493|NCT00565409|541036890|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
149972494|NCT00565409|541036891|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
149972495|NCT00565409|541036892|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
149972496|NCT00565409|541036889|FG000|Period 2 Double-Blind|Other|0|||
149972497|NCT00565409|541036890|FG001|Period 2 Double-Blind|Other|4|||
149972498|NCT00565409|541036891|FG002|Period 2 Double-Blind|Other|5|||
149972499|NCT00565409|541036892|FG003|Period 2 Double-Blind|Other|9|||
149972500|NCT00565409|541036889|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
150177132|NCT04723394|541786145|FG001|Overall Study|Death|8|||
150177133|NCT04723394|541786144|FG000|Overall Study|Lost to Follow-up|20|||
150177134|NCT04723394|541786145|FG001|Overall Study|Lost to Follow-up|17|||
150177135|NCT04723394|541786144|FG000|Overall Study|Physician Decision|1|||
150177136|NCT04723394|541786145|FG001|Overall Study|Physician Decision|0|||
150177137|NCT04723394|541786144|FG000|Overall Study|Withdrawal by Subject|20|||
150177138|NCT04723394|541786145|FG001|Overall Study|Withdrawal by Subject|34|||
150177139|NCT04723394|541786144|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
150177140|NCT04723394|541786145|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
150177141|NCT00446459|541786146|FG000|8 Months|Protocol Violation|12|||
150177142|NCT00446459|541786146|FG000|12 Months|Protocol Violation|4|||
150177143|NCT00446459|541786146|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
150177144|NCT00858117|541786150|FG000|Treatment on Study|Adverse Event|2|||
150177145|NCT00858117|541786150|FG000|Follow up for 5 Years|Death|4|||
150177146|NCT00858117|541786150|FG000|Follow up for 5 Years|No further data collected for study|9|||
150177147|NCT00371787|541786151|FG000|Overall Study|Withdrawal by Subject|3|||
150177148|NCT00371787|541786152|FG001|Overall Study|Withdrawal by Subject|1|||
150177149|NCT01972724|541786155|FG000|Double-Blind|Rescue Criteria Met|1|||
150177150|NCT01972724|541786156|FG001|Double-Blind|Rescue Criteria Met|0|||
150177151|NCT01972724|541786157|FG002|Double-Blind|Rescue Criteria Met|0|||
150177152|NCT01972724|541786155|FG000|Double-Blind|Adverse Event|1|||
150177153|NCT01972724|541786156|FG001|Double-Blind|Adverse Event|0|||
150177154|NCT01972724|541786157|FG002|Double-Blind|Adverse Event|0|||
150177155|NCT01972724|541786155|FG000|Double-Blind|Withdrawal of Consent|2|||
150177156|NCT01972724|541786156|FG001|Double-Blind|Withdrawal of Consent|1|||
150177157|NCT01972724|541786157|FG002|Double-Blind|Withdrawal of Consent|0|||
150177158|NCT01972724|541786155|FG000|Double-Blind|Significant Protocol Deviation|5|||
150177159|NCT01972724|541786156|FG001|Double-Blind|Significant Protocol Deviation|8|||
150177160|NCT01972724|541786157|FG002|Double-Blind|Significant Protocol Deviation|0|||
150177161|NCT01972724|541786155|FG000|Open-Label|Withdrew Consent|0|||
150177162|NCT01972724|541786156|FG001|Open-Label|Withdrew Consent|0|||
150177163|NCT01972724|541786157|FG002|Open-Label|Withdrew Consent|3|||
150177164|NCT01972724|541786155|FG000|Open-Label|Significant Protocol Deviation|0|||
150177165|NCT01972724|541786156|FG001|Open-Label|Significant Protocol Deviation|0|||
150177166|NCT01972724|541786157|FG002|Open-Label|Significant Protocol Deviation|2|||
150177167|NCT02765100|541786158|FG000|Overall Study|subject found ineligible after baseline|1|||
150177168|NCT02765100|541786159|FG001|Overall Study|subject found ineligible after baseline|1|||
150177169|NCT02765100|541786158|FG000|Overall Study|Lost to Follow-up|0|||
150177170|NCT02765100|541786159|FG001|Overall Study|Lost to Follow-up|1|||
150177171|NCT02652442|541786165|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
150177172|NCT00244855|541786166|FG000|Overall Study|Withdrawal by Subject|0|||
150177173|NCT00244855|541786167|FG001|Overall Study|Withdrawal by Subject|1|||
150177174|NCT02529995|541786168|FG000|Part A|Ongoing Study at Data Cut-off|14|||
150177175|NCT02529995|541786169|FG001|Part A|Ongoing Study at Data Cut-off|16|||
150177176|NCT02529995|541786168|FG000|Part A|Discontinued Study|1|||
150177177|NCT02529995|541786169|FG001|Part A|Discontinued Study|0|||
150177178|NCT02529995|541786168|FG000|Part B|Ongoing Study at Data Cut-off|0|||
150177179|NCT02529995|541786169|FG001|Part B|Ongoing Study at Data Cut-off|7|||
150177180|NCT02529995|541786168|FG000|Part B|Discontinued Study|6|||
150177181|NCT02529995|541786169|FG001|Part B|Discontinued Study|5|||
150177182|NCT00364013|541786174|FG000|Overall Study|Ineligibility determined|4|||
149972501|NCT00565409|541036890|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
149972502|NCT00565409|541036891|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
149972503|NCT00565409|541036892|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
149972504|NCT01038323|541036893|FG000|Overall Study|Withdrawal by Subject|3|||
149972505|NCT01038323|541036894|FG001|Overall Study|Withdrawal by Subject|2|||
149972506|NCT01038323|541036895|FG002|Overall Study|Withdrawal by Subject|4|||
149972507|NCT00431964|541036896|FG000|Overall Study|Adverse Event|1|||
150177183|NCT00364013|541786175|FG001|Overall Study|Ineligibility determined|2|||
150177184|NCT00364013|541786174|FG000|Overall Study|Adverse Event|4|||
150177185|NCT00364013|541786175|FG001|Overall Study|Adverse Event|3|||
150177186|NCT00364013|541786174|FG000|Overall Study|Withdrawal by Subject|13|||
150177187|NCT00364013|541786175|FG001|Overall Study|Withdrawal by Subject|18|||
150177188|NCT00364013|541786174|FG000|Overall Study|Physician Decision|3|||
149972508|NCT00431964|541036897|FG001|Overall Study|Adverse Event|0|||
149972509|NCT00431964|541036896|FG000|Overall Study|Lost to Follow-up|1|||
150177189|NCT00364013|541786175|FG001|Overall Study|Physician Decision|3|||
150177190|NCT00364013|541786174|FG000|Overall Study|Lost to Follow-up|10|||
149972510|NCT00431964|541036897|FG001|Overall Study|Lost to Follow-up|2|||
149972511|NCT00431964|541036896|FG000|Overall Study|Physician Decision|2|||
150177191|NCT00364013|541786175|FG001|Overall Study|Lost to Follow-up|3|||
150177192|NCT00364013|541786174|FG000|Overall Study|Protocol-specified criteria|6|||
150177193|NCT00364013|541786175|FG001|Overall Study|Protocol-specified criteria|6|||
150177194|NCT00364013|541786174|FG000|Overall Study|Other|41|||
149913840|NCT01328548|540814987|FG000|Overall Study|Protocol Violation|1|||
149913841|NCT01328548|540814988|FG001|Overall Study|Protocol Violation|0|||
149913842|NCT03800836|540814989|FG000|Overall Study|Other|2|||
149913843|NCT03800836|540814990|FG001|Overall Study|Other|1|||
149913844|NCT03800836|540814991|FG002|Overall Study|Other|0|||
149913845|NCT03800836|540814992|FG003|Overall Study|Other|2|||
149913846|NCT03800836|540814993|FG004|Overall Study|Other|0|||
149913847|NCT03800836|540814994|FG005|Overall Study|Other|1|||
149913848|NCT03800836|540814989|FG000|Overall Study|Lost to Follow-up|2|||
149913849|NCT03800836|540814990|FG001|Overall Study|Lost to Follow-up|0|||
149913850|NCT03800836|540814991|FG002|Overall Study|Lost to Follow-up|1|||
149913851|NCT03800836|540814992|FG003|Overall Study|Lost to Follow-up|1|||
149913852|NCT03800836|540814993|FG004|Overall Study|Lost to Follow-up|3|||
149913853|NCT03800836|540814994|FG005|Overall Study|Lost to Follow-up|0|||
149913854|NCT03800836|540814989|FG000|Overall Study|Withdrawal by Subject|1|||
149913855|NCT03800836|540814990|FG001|Overall Study|Withdrawal by Subject|0|||
149913856|NCT03800836|540814991|FG002|Overall Study|Withdrawal by Subject|0|||
149913857|NCT03800836|540814992|FG003|Overall Study|Withdrawal by Subject|0|||
149913858|NCT03800836|540814993|FG004|Overall Study|Withdrawal by Subject|0|||
149913859|NCT03800836|540814994|FG005|Overall Study|Withdrawal by Subject|0|||
149913860|NCT03800836|540814989|FG000|Overall Study|Physician Decision|31|||
149913861|NCT03800836|540814990|FG001|Overall Study|Physician Decision|3|||
149913862|NCT03800836|540814991|FG002|Overall Study|Physician Decision|6|||
149913863|NCT03800836|540814992|FG003|Overall Study|Physician Decision|4|||
149913864|NCT03800836|540814993|FG004|Overall Study|Physician Decision|4|||
149913865|NCT03800836|540814994|FG005|Overall Study|Physician Decision|5|||
149913866|NCT03800836|540814989|FG000|Overall Study|Death|34|||
149913867|NCT03800836|540814990|FG001|Overall Study|Death|16|||
149913868|NCT03800836|540814991|FG002|Overall Study|Death|5|||
149913869|NCT03800836|540814992|FG003|Overall Study|Death|5|||
149913870|NCT03800836|540814993|FG004|Overall Study|Death|10|||
149913871|NCT03800836|540814994|FG005|Overall Study|Death|0|||
149913872|NCT03800836|540814989|FG000|Overall Study|Symptomatic Deterioration|1|||
149913873|NCT03800836|540814990|FG001|Overall Study|Symptomatic Deterioration|0|||
149913874|NCT03800836|540814991|FG002|Overall Study|Symptomatic Deterioration|1|||
149913875|NCT03800836|540814992|FG003|Overall Study|Symptomatic Deterioration|0|||
149913876|NCT03800836|540814993|FG004|Overall Study|Symptomatic Deterioration|0|||
149913877|NCT03800836|540814994|FG005|Overall Study|Symptomatic Deterioration|0|||
149913878|NCT00549601|540816853|FG000|Randomized|Protocol Violation|0|||
149913879|NCT00549601|540816854|FG001|Randomized|Protocol Violation|0|||
149913880|NCT00549601|540816855|FG002|Randomized|Protocol Violation|1|||
149913881|NCT00549601|540816853|FG000|Randomized|Withdrawal by Subject|0|||
149913882|NCT00549601|540816854|FG001|Randomized|Withdrawal by Subject|1|||
149913883|NCT00549601|540816855|FG002|Randomized|Withdrawal by Subject|1|||
149913884|NCT00549601|540816853|FG000|Received Study Drug|Adverse Event|2|||
149913885|NCT00549601|540816854|FG001|Received Study Drug|Adverse Event|5|||
149913886|NCT00549601|540816855|FG002|Received Study Drug|Adverse Event|1|||
149913887|NCT00549601|540816853|FG000|Received Study Drug|Death|0|||
149913888|NCT00549601|540816854|FG001|Received Study Drug|Death|1|||
149913889|NCT00549601|540816855|FG002|Received Study Drug|Death|0|||
149913890|NCT00549601|540816853|FG000|Received Study Drug|Lost to Follow-up|0|||
150050678|NCT03116152|541327616|FG001|Overall Study|Physician Decision|2|||
150050679|NCT03116152|541327615|FG000|Overall Study|other|11|||
149913891|NCT00549601|540816854|FG001|Received Study Drug|Lost to Follow-up|1|||
149913892|NCT00549601|540816855|FG002|Received Study Drug|Lost to Follow-up|1|||
149913893|NCT00549601|540816853|FG000|Received Study Drug|Protocol Violation|3|||
149913894|NCT00549601|540816854|FG001|Received Study Drug|Protocol Violation|4|||
149913895|NCT00549601|540816855|FG002|Received Study Drug|Protocol Violation|1|||
149913896|NCT00549601|540816853|FG000|Received Study Drug|Withdrawal by Subject|2|||
149913897|NCT00549601|540816854|FG001|Received Study Drug|Withdrawal by Subject|0|||
149913898|NCT00549601|540816855|FG002|Received Study Drug|Withdrawal by Subject|1|||
149913899|NCT00224406|540816856|FG000|Overall Study|Re-transplant|0|||
149913900|NCT00224406|540816857|FG001|Overall Study|Re-transplant|2|||
149913901|NCT00224406|540816856|FG000|Overall Study|Death|0|||
149913902|NCT00224406|540816857|FG001|Overall Study|Death|1|||
149913903|NCT00224406|540816856|FG000|Overall Study|Transplant cancelled|0|||
149913904|NCT00224406|540816857|FG001|Overall Study|Transplant cancelled|4|||
149913905|NCT00224406|540816856|FG000|Overall Study|Drug not delivered|2|||
149913906|NCT00224406|540816857|FG001|Overall Study|Drug not delivered|0|||
149913907|NCT00224406|540816856|FG000|Overall Study|Other|4|||
149913908|NCT00224406|540816857|FG001|Overall Study|Other|0|||
149913909|NCT00224406|540816856|FG000|Overall Study|Transplant cancelled|3|||
149913910|NCT00224406|540816857|FG001|Overall Study|Transplant cancelled|0|||
149913911|NCT01556997|540816860|FG000|Overall Study|Adverse Event|10|||
149913912|NCT01556997|540816861|FG001|Overall Study|Adverse Event|12|||
149913913|NCT01556997|540816862|FG002|Overall Study|Adverse Event|12|||
149913914|NCT01556997|540816860|FG000|Overall Study|Lost to Follow-up|6|||
149913915|NCT01556997|540816861|FG001|Overall Study|Lost to Follow-up|6|||
149913916|NCT01556997|540816862|FG002|Overall Study|Lost to Follow-up|4|||
149913917|NCT01556997|540816860|FG000|Overall Study|Physician Decision|1|||
150050680|NCT03116152|541327616|FG001|Overall Study|other|34|||
150050681|NCT02410343|541327617|FG000|Core Period (24 Weeks)|Adverse Event|1|||
150050682|NCT02410343|541327618|FG001|Core Period (24 Weeks)|Adverse Event|0|||
150050683|NCT02410343|541327617|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
150050684|NCT02410343|541327618|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
150050685|NCT02410343|541327617|FG000|Extension Period (12 Months)|Adverse Event|1|||
150050686|NCT02410343|541327618|FG001|Extension Period (12 Months)|Adverse Event|0|||
150050687|NCT02410343|541327617|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
149913918|NCT01556997|540816861|FG001|Overall Study|Physician Decision|1|||
149913919|NCT01556997|540816862|FG002|Overall Study|Physician Decision|1|||
149913920|NCT01556997|540816860|FG000|Overall Study|Withdrawal by Subject|7|||
149913921|NCT01556997|540816861|FG001|Overall Study|Withdrawal by Subject|6|||
149913922|NCT01556997|540816862|FG002|Overall Study|Withdrawal by Subject|8|||
149913923|NCT01556997|540816860|FG000|Overall Study|Other|2|||
149913924|NCT01556997|540816861|FG001|Overall Study|Other|3|||
149913925|NCT01556997|540816862|FG002|Overall Study|Other|7|||
149913926|NCT01250171|540816867|FG000|Overall Study|Administrative reasons|1|||
149913927|NCT01250171|540816868|FG001|Overall Study|Administrative reasons|0|||
149913928|NCT01250171|540816869|FG002|Overall Study|Administrative reasons|0|||
150050688|NCT02410343|541327618|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
150050689|NCT02036853|541327619|FG000|Overall Study|Adverse Event|0|||
150050690|NCT02036853|541327620|FG001|Overall Study|Adverse Event|2|||
150050691|NCT02036853|541327619|FG000|Overall Study|Lack of Efficacy|0|||
149913929|NCT03309696|540816870|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
149913930|NCT03309696|540816871|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
149913931|NCT03309696|540816872|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
149913932|NCT03309696|540816873|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
149913933|NCT02607280|540816876|FG000|Overall Study|Adverse Event|4|||
149913934|NCT02607280|540816877|FG001|Overall Study|Adverse Event|0|||
149913935|NCT02607280|540816876|FG000|Overall Study|Decrease in CrCl <15|0|||
149913936|NCT02607280|540816877|FG001|Overall Study|Decrease in CrCl <15|1|||
149913937|NCT00078949|540816878|FG000|Overall Study|No treated|4|||
149913938|NCT00078949|540816879|FG001|Overall Study|No treated|5|||
149913939|NCT00078949|540816880|FG002|Overall Study|No treated|3|||
149913940|NCT00078949|540816881|FG003|Overall Study|No treated|3|||
149913941|NCT00577005|540816882|FG000|Overall Study|Lost to Follow-up|3|||
149913942|NCT00577005|540816883|FG001|Overall Study|Lost to Follow-up|2|||
149913943|NCT00577005|540816882|FG000|Overall Study|Withdrawal by Subject|2|||
149913944|NCT00577005|540816883|FG001|Overall Study|Withdrawal by Subject|1|||
150050692|NCT02036853|541327620|FG001|Overall Study|Lack of Efficacy|2|||
150050693|NCT02036853|541327619|FG000|Overall Study|Physician Decision|0|||
150050694|NCT02036853|541327620|FG001|Overall Study|Physician Decision|1|||
150050695|NCT02036853|541327619|FG000|Overall Study|Withdrawal by Subject|0|||
150050696|NCT02036853|541327620|FG001|Overall Study|Withdrawal by Subject|1|||
150050697|NCT02660983|541327625|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
150050698|NCT02660983|541327626|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
150050699|NCT02660983|541327625|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
150050700|NCT02660983|541327626|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
150050701|NCT02660983|541327625|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
150050702|NCT02660983|541327626|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
150050703|NCT02660983|541327625|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
150050704|NCT02660983|541327626|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
150050705|NCT02660983|541327625|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
150050706|NCT02660983|541327626|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
150050707|NCT02660983|541327625|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
150050708|NCT02660983|541327626|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
150050709|NCT02660983|541327625|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
150050710|NCT02660983|541327626|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
150050711|NCT01253577|541327630|FG000|Overall Study|Lost to Follow-up|3|||
150050712|NCT00721968|541327631|FG000|Overall Study|Lost to Follow-up|2|||
150050713|NCT00721968|541327632|FG001|Overall Study|Lost to Follow-up|0|||
149913945|NCT01004432|540816884|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
149913946|NCT01004432|540816885|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
149913947|NCT01004432|540816886|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
149913948|NCT01004432|540816887|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
149913949|NCT01004432|540816888|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
150050714|NCT05601544|541327633|FG000|Phase 2 Period 1|Adverse Event|0|||
150050715|NCT05601544|541327634|FG001|Phase 2 Period 1|Adverse Event|1|||
150177195|NCT00364013|541786175|FG001|Overall Study|Other|47|||
149913950|NCT01004432|540816884|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
149913951|NCT01004432|540816885|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
149913952|NCT01004432|540816886|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
149913953|NCT01004432|540816887|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
149913954|NCT01004432|540816888|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
149913955|NCT01004432|540816884|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
149913956|NCT01004432|540816885|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
149913957|NCT01004432|540816886|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
149913958|NCT01004432|540816887|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
149913959|NCT01004432|540816888|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
149913960|NCT01004432|540816884|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
149913961|NCT01004432|540816885|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
149913962|NCT01004432|540816886|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
149913963|NCT01004432|540816887|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
149913964|NCT01004432|540816888|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
149913965|NCT01004432|540816884|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
149913966|NCT01004432|540816885|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
149913967|NCT01004432|540816886|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
149913968|NCT01004432|540816887|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
149913969|NCT01004432|540816888|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
149913970|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
150050716|NCT05601544|541327635|FG002|Phase 2 Period 1|Adverse Event|0|||
150050717|NCT05601544|541327636|FG003|Phase 2 Period 1|Adverse Event|0|||
150050718|NCT05601544|541327637|FG004|Phase 2 Period 1|Adverse Event|0|||
149913971|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
149913972|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
149913973|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
149913974|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
149913975|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
149913976|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
149913977|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
149913978|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
149913979|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
149913980|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
149913981|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
149913982|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
149913983|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
149913984|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
149913985|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
149913986|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
149913987|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
149913988|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
149913989|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
149913990|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
149913991|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
149913992|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
149913993|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
149913994|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
149913995|NCT01004432|540816884|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
149913996|NCT01004432|540816885|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
149913997|NCT01004432|540816886|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
149913998|NCT01004432|540816887|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
149913999|NCT01004432|540816888|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
149914000|NCT01004432|540816884|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
149914001|NCT01004432|540816885|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
149914002|NCT01004432|540816886|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
149914003|NCT01004432|540816887|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
149914004|NCT01004432|540816888|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
149914005|NCT01004432|540816884|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
149914006|NCT01004432|540816885|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
149914007|NCT01004432|540816886|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
149914008|NCT01004432|540816887|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
150177196|NCT00364013|541786174|FG000|Overall Study|Ongoing|20|||
149914009|NCT01004432|540816888|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
149914010|NCT01004432|540816884|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
150050719|NCT05601544|541327638|FG005|Phase 2 Period 1|Adverse Event|0|||
149972512|NCT00431964|541036897|FG001|Overall Study|Physician Decision|2|||
149972513|NCT00431964|541036896|FG000|Overall Study|Withdrawal by Subject|2|||
149972514|NCT00431964|541036897|FG001|Overall Study|Withdrawal by Subject|1|||
149972515|NCT00431964|541036896|FG000|Overall Study|Parental Consent Withdrawn|0|||
149972516|NCT00431964|541036897|FG001|Overall Study|Parental Consent Withdrawn|2|||
149972517|NCT00431964|541036896|FG000|Overall Study|Due to Unstable Health|0|||
149972518|NCT00431964|541036897|FG001|Overall Study|Due to Unstable Health|1|||
149972519|NCT02170064|541036898|FG000|Overall Study|Withdrawal by Subject|5|||
149972520|NCT02170064|541036899|FG001|Overall Study|Withdrawal by Subject|1|||
149972521|NCT02170064|541036900|FG002|Overall Study|Withdrawal by Subject|1|||
149972522|NCT02170064|541036898|FG000|Overall Study|Physician Decision|1|||
149972523|NCT02170064|541036899|FG001|Overall Study|Physician Decision|1|||
149972524|NCT02170064|541036900|FG002|Overall Study|Physician Decision|0|||
149972525|NCT01734902|541036903|FG000|Overall Study|Other than listed|0|||
149972526|NCT01734902|541036904|FG001|Overall Study|Other than listed|2|||
149972527|NCT03961308|541036907|FG000|Overall Study|Withdrawal by Subject|1|||
149972528|NCT03961308|541036908|FG001|Overall Study|Withdrawal by Subject|0|||
149972529|NCT03961308|541036907|FG000|Overall Study|Other|1|||
149972530|NCT03961308|541036908|FG001|Overall Study|Other|0|||
149972531|NCT03961308|541036907|FG000|Overall Study|Lost to Follow-up|0|||
149972532|NCT03961308|541036908|FG001|Overall Study|Lost to Follow-up|1|||
149972533|NCT03961308|541036907|FG000|Overall Study|Adverse Event|0|||
149972534|NCT03961308|541036908|FG001|Overall Study|Adverse Event|1|||
149972535|NCT00659425|541036911|FG000|Overall Study|Disease progression|1|||
149972536|NCT00659425|541036912|FG001|Overall Study|Disease progression|0|||
149972537|NCT00659425|541036913|FG002|Overall Study|Disease progression|0|||
149972538|NCT00659425|541036914|FG003|Overall Study|Disease progression|1|||
149972539|NCT00659425|541036915|FG004|Overall Study|Disease progression|0|||
149972540|NCT00659425|541036916|FG005|Overall Study|Disease progression|2|||
149972541|NCT00659425|541036917|FG006|Overall Study|Disease progression|4|||
149972542|NCT00659425|541036918|FG007|Overall Study|Disease progression|3|||
149972543|NCT00659425|541036919|FG008|Overall Study|Disease progression|5|||
149972544|NCT00659425|541036920|FG009|Overall Study|Disease progression|3|||
149972545|NCT00659425|541036911|FG000|Overall Study|Death|0|||
149972546|NCT00659425|541036912|FG001|Overall Study|Death|0|||
149972547|NCT00659425|541036913|FG002|Overall Study|Death|0|||
149972548|NCT00659425|541036914|FG003|Overall Study|Death|1|||
149972549|NCT00659425|541036915|FG004|Overall Study|Death|0|||
149972550|NCT00659425|541036916|FG005|Overall Study|Death|0|||
149972551|NCT00659425|541036917|FG006|Overall Study|Death|1|||
149972552|NCT00659425|541036918|FG007|Overall Study|Death|0|||
149972553|NCT00659425|541036919|FG008|Overall Study|Death|0|||
149972554|NCT00659425|541036920|FG009|Overall Study|Death|0|||
149972555|NCT00659425|541036911|FG000|Overall Study|Adverse Event|0|||
149972556|NCT00659425|541036912|FG001|Overall Study|Adverse Event|0|||
149972557|NCT00659425|541036913|FG002|Overall Study|Adverse Event|0|||
149972558|NCT00659425|541036914|FG003|Overall Study|Adverse Event|0|||
149972559|NCT00659425|541036915|FG004|Overall Study|Adverse Event|0|||
149972560|NCT00659425|541036916|FG005|Overall Study|Adverse Event|1|||
149972561|NCT00659425|541036917|FG006|Overall Study|Adverse Event|0|||
149972562|NCT00659425|541036918|FG007|Overall Study|Adverse Event|3|||
149972563|NCT00659425|541036919|FG008|Overall Study|Adverse Event|1|||
149972564|NCT00659425|541036920|FG009|Overall Study|Adverse Event|4|||
149972565|NCT00659425|541036911|FG000|Overall Study|Investigator Discretion|0|||
149972566|NCT00659425|541036912|FG001|Overall Study|Investigator Discretion|0|||
149972567|NCT00659425|541036913|FG002|Overall Study|Investigator Discretion|0|||
149972568|NCT00659425|541036914|FG003|Overall Study|Investigator Discretion|0|||
149972569|NCT00659425|541036915|FG004|Overall Study|Investigator Discretion|0|||
149972570|NCT00659425|541036916|FG005|Overall Study|Investigator Discretion|1|||
149972571|NCT00659425|541036917|FG006|Overall Study|Investigator Discretion|0|||
149972572|NCT00659425|541036918|FG007|Overall Study|Investigator Discretion|3|||
149972573|NCT00659425|541036919|FG008|Overall Study|Investigator Discretion|0|||
149972574|NCT00659425|541036920|FG009|Overall Study|Investigator Discretion|0|||
149972575|NCT00659425|541036911|FG000|Overall Study|Other|0|||
149972576|NCT00659425|541036912|FG001|Overall Study|Other|1|||
149972577|NCT00659425|541036913|FG002|Overall Study|Other|1|||
149972578|NCT00659425|541036914|FG003|Overall Study|Other|2|||
150050720|NCT04303195|541327639|FG000|Overall Study|Adverse Event|1|||
149972579|NCT00659425|541036915|FG004|Overall Study|Other|4|||
149972580|NCT00659425|541036916|FG005|Overall Study|Other|0|||
150177197|NCT00364013|541786175|FG001|Overall Study|Ongoing|13|||
150177198|NCT00293293|541786176|FG000|Overall Study|Withdrawal by Subject|1|||
150177199|NCT00293293|541786177|FG001|Overall Study|Withdrawal by Subject|1|||
150177200|NCT00293293|541786176|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
150177201|NCT00293293|541786177|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
150177202|NCT00293293|541786176|FG000|Overall Study|Patient discontinued chemotherapy|0|||
150177203|NCT00293293|541786177|FG001|Overall Study|Patient discontinued chemotherapy|1|||
150177204|NCT03740009|541786183|FG000|Overall Study|Physician Decision|9|||
150177205|NCT03740009|541786183|FG000|Overall Study|Lost to Follow-up|1|||
150177206|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
150177207|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
150177208|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
150177209|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
150177210|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
150177211|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
150177212|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
150177213|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
150177214|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
150177215|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
150177216|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
150177217|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
150177218|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
150177219|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
150177220|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
150177221|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
150177222|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
150177223|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
150050721|NCT04303195|541327640|FG001|Overall Study|Adverse Event|3|||
150050722|NCT04303195|541327641|FG002|Overall Study|Adverse Event|7|||
150050723|NCT04303195|541327642|FG003|Overall Study|Adverse Event|0|||
150050724|NCT04303195|541327639|FG000|Overall Study|Lost to Follow-up|1|||
150050725|NCT04303195|541327640|FG001|Overall Study|Lost to Follow-up|0|||
149914011|NCT01004432|540816885|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
149914012|NCT01004432|540816886|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
149914013|NCT01004432|540816887|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
149914014|NCT01004432|540816888|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
149914015|NCT01004432|540816884|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
150050726|NCT04303195|541327641|FG002|Overall Study|Lost to Follow-up|1|||
150050727|NCT04303195|541327642|FG003|Overall Study|Lost to Follow-up|4|||
150050728|NCT04303195|541327639|FG000|Overall Study|Withdrawal by Subject|3|||
150050729|NCT04303195|541327640|FG001|Overall Study|Withdrawal by Subject|1|||
150050730|NCT04303195|541327641|FG002|Overall Study|Withdrawal by Subject|1|||
150050731|NCT04303195|541327642|FG003|Overall Study|Withdrawal by Subject|1|||
150050732|NCT04303195|541327639|FG000|Overall Study|No study drug administered or protocol deviation|0|||
150050733|NCT04303195|541327640|FG001|Overall Study|No study drug administered or protocol deviation|2|||
150050734|NCT04303195|541327641|FG002|Overall Study|No study drug administered or protocol deviation|0|||
150050735|NCT04303195|541327642|FG003|Overall Study|No study drug administered or protocol deviation|2|||
150050736|NCT01064947|541327643|FG000|Overall Study|negative culture|41|||
150050737|NCT02970942|541327644|FG000|Overall Study|Death|0|||
150050738|NCT02970942|541327645|FG001|Overall Study|Death|1|||
150050739|NCT02970942|541327646|FG002|Overall Study|Death|0|||
150050740|NCT02970942|541327647|FG003|Overall Study|Death|0|||
150050741|NCT02970942|541327644|FG000|Overall Study|Lost to Follow-up|1|||
150050742|NCT02970942|541327645|FG001|Overall Study|Lost to Follow-up|0|||
150050743|NCT02970942|541327646|FG002|Overall Study|Lost to Follow-up|2|||
150050744|NCT02970942|541327647|FG003|Overall Study|Lost to Follow-up|1|||
150050745|NCT02970942|541327644|FG000|Overall Study|Withdrawal by Subject|3|||
150050746|NCT02970942|541327645|FG001|Overall Study|Withdrawal by Subject|5|||
150050747|NCT02970942|541327646|FG002|Overall Study|Withdrawal by Subject|3|||
150050748|NCT02970942|541327647|FG003|Overall Study|Withdrawal by Subject|2|||
150050749|NCT01065454|541327650|FG000|Treatment|Adverse Event|7|||
150050750|NCT01065454|541327651|FG001|Treatment|Adverse Event|4|||
150050751|NCT01065454|541327652|FG002|Treatment|Adverse Event|3|||
150050752|NCT01065454|541327653|FG003|Treatment|Adverse Event|6|||
150050753|NCT01065454|541327650|FG000|Treatment|Death|1|||
150050754|NCT01065454|541327651|FG001|Treatment|Death|0|||
150050755|NCT01065454|541327652|FG002|Treatment|Death|0|||
149914016|NCT01004432|540816885|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
149914017|NCT01004432|540816886|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
150050756|NCT01065454|541327653|FG003|Treatment|Death|0|||
150050757|NCT01065454|541327650|FG000|Treatment|Non-compliance|1|||
150050758|NCT01065454|541327651|FG001|Treatment|Non-compliance|0|||
150050759|NCT01065454|541327652|FG002|Treatment|Non-compliance|0|||
150050760|NCT01065454|541327653|FG003|Treatment|Non-compliance|1|||
150050761|NCT01065454|541327650|FG000|Treatment|Protocol Decision|0|||
150050762|NCT01065454|541327651|FG001|Treatment|Protocol Decision|0|||
150050763|NCT01065454|541327652|FG002|Treatment|Protocol Decision|3|||
150050764|NCT01065454|541327653|FG003|Treatment|Protocol Decision|2|||
150050765|NCT01065454|541327650|FG000|Treatment|Protocol Violation|1|||
150050766|NCT01065454|541327651|FG001|Treatment|Protocol Violation|0|||
150050767|NCT01065454|541327652|FG002|Treatment|Protocol Violation|1|||
150050768|NCT01065454|541327653|FG003|Treatment|Protocol Violation|0|||
150050769|NCT01065454|541327650|FG000|Treatment|Withdrawal by Subject|3|||
150050770|NCT01065454|541327651|FG001|Treatment|Withdrawal by Subject|1|||
150050771|NCT01065454|541327652|FG002|Treatment|Withdrawal by Subject|2|||
150050772|NCT01065454|541327653|FG003|Treatment|Withdrawal by Subject|3|||
150050773|NCT01065454|541327650|FG000|Follow up|Adverse Event|1|||
150050774|NCT01065454|541327651|FG001|Follow up|Adverse Event|0|||
150050775|NCT01065454|541327652|FG002|Follow up|Adverse Event|0|||
150050776|NCT01065454|541327653|FG003|Follow up|Adverse Event|1|||
150050777|NCT01065454|541327650|FG000|Follow up|Death|0|||
150050778|NCT01065454|541327651|FG001|Follow up|Death|1|||
150050779|NCT01065454|541327652|FG002|Follow up|Death|1|||
150050780|NCT01065454|541327653|FG003|Follow up|Death|0|||
150050781|NCT01065454|541327650|FG000|Follow up|Lost to Follow-up|0|||
150050782|NCT01065454|541327651|FG001|Follow up|Lost to Follow-up|0|||
150050783|NCT01065454|541327652|FG002|Follow up|Lost to Follow-up|0|||
150050784|NCT01065454|541327653|FG003|Follow up|Lost to Follow-up|1|||
150050785|NCT01065454|541327650|FG000|Follow up|Progressive disease|0|||
150050786|NCT01065454|541327651|FG001|Follow up|Progressive disease|0|||
150050787|NCT01065454|541327652|FG002|Follow up|Progressive disease|0|||
150050788|NCT01065454|541327653|FG003|Follow up|Progressive disease|1|||
150050789|NCT01065454|541327650|FG000|Follow up|Withdrawal by Subject|1|||
150050790|NCT01065454|541327651|FG001|Follow up|Withdrawal by Subject|1|||
150050791|NCT01065454|541327652|FG002|Follow up|Withdrawal by Subject|1|||
149914018|NCT01004432|540816887|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
149914019|NCT01004432|540816888|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
149914020|NCT00590538|540816889|FG000|Overall Study|Study terminated before completed|2|||
149914021|NCT02309723|540816890|FG000|Overall Study|Withdrawal by Subject|24|||
149914022|NCT02309723|540816891|FG001|Overall Study|Withdrawal by Subject|23|||
149914023|NCT02309723|540816892|FG002|Overall Study|Withdrawal by Subject|24|||
149914024|NCT01125813|540816893|FG000|Overall Study|Death|1|||
149914025|NCT01125813|540816893|FG000|Overall Study|Withdrawal by Subject|1|||
149914026|NCT01125813|540816893|FG000|Overall Study|Screen Failures|4|||
149914027|NCT02453282|540816896|FG000|Overall Study|Death|275|||
149914028|NCT02453282|540816897|FG001|Overall Study|Death|277|||
149914029|NCT02453282|540816898|FG002|Overall Study|Death|296|||
149914030|NCT02453282|540816896|FG000|Overall Study|Lost to Follow-up|1|||
149914031|NCT02453282|540816897|FG001|Overall Study|Lost to Follow-up|0|||
149914032|NCT02453282|540816898|FG002|Overall Study|Lost to Follow-up|2|||
149914033|NCT02453282|540816896|FG000|Overall Study|Withdrawal by Subject|12|||
149914034|NCT02453282|540816897|FG001|Overall Study|Withdrawal by Subject|10|||
149914035|NCT02453282|540816898|FG002|Overall Study|Withdrawal by Subject|11|||
149914036|NCT02453282|540816896|FG000|Overall Study|Participants ongoing at data cut-off|85|||
149914037|NCT02453282|540816897|FG001|Overall Study|Participants ongoing at data cut-off|84|||
149914038|NCT02453282|540816898|FG002|Overall Study|Participants ongoing at data cut-off|62|||
149914039|NCT02453282|540816896|FG000|Overall Study|Other|1|||
149914040|NCT02453282|540816897|FG001|Overall Study|Other|1|||
149914041|NCT02453282|540816898|FG002|Overall Study|Other|1|||
149972581|NCT00659425|541036917|FG006|Overall Study|Other|3|||
149972582|NCT00659425|541036918|FG007|Overall Study|Other|2|||
149972583|NCT00659425|541036919|FG008|Overall Study|Other|0|||
149972584|NCT00659425|541036920|FG009|Overall Study|Other|6|||
149972585|NCT03358030|541036921|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
149972586|NCT03358030|541036922|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
149972587|NCT03358030|541036923|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
149972588|NCT03358030|541036924|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
149972589|NCT03358030|541036921|FG000|Overall Study|Ineligibility|0|||
149972590|NCT03358030|541036922|FG001|Overall Study|Ineligibility|0|||
149972591|NCT03358030|541036923|FG002|Overall Study|Ineligibility|0|||
149972592|NCT03358030|541036924|FG003|Overall Study|Ineligibility|2|||
149972593|NCT03358030|541036921|FG000|Overall Study|Voluntary Withdrawal|1|||
149972594|NCT03358030|541036922|FG001|Overall Study|Voluntary Withdrawal|1|||
149972595|NCT03358030|541036923|FG002|Overall Study|Voluntary Withdrawal|3|||
149972596|NCT03358030|541036924|FG003|Overall Study|Voluntary Withdrawal|1|||
149972597|NCT03358030|541036921|FG000|Overall Study|Other|0|||
149972598|NCT03358030|541036922|FG001|Overall Study|Other|0|||
149914042|NCT02327013|540816899|FG000|Overall Study|Adverse Event|4|||
149972599|NCT03358030|541036923|FG002|Overall Study|Other|1|||
150050792|NCT01065454|541327653|FG003|Follow up|Withdrawal by Subject|0|||
150050793|NCT01065454|541327650|FG000|Follow up|study ongoing|37|||
150050794|NCT01065454|541327651|FG001|Follow up|study ongoing|22|||
150050795|NCT01065454|541327652|FG002|Follow up|study ongoing|15|||
150050796|NCT01065454|541327653|FG003|Follow up|study ongoing|41|||
150050797|NCT01601652|541327655|FG000|Overall Study|Death|1|||
150050798|NCT05688670|541327656|FG000|Overall Study|Change in surgery plan|1|||
149914043|NCT02327013|540816900|FG001|Overall Study|Adverse Event|4|||
149914044|NCT02327013|540816901|FG002|Overall Study|Adverse Event|3|||
149914045|NCT02327013|540816902|FG003|Overall Study|Adverse Event|0|||
149914046|NCT02327013|540816903|FG004|Overall Study|Adverse Event|1|||
149914047|NCT02327013|540816899|FG000|Overall Study|Lack of Efficacy|2|||
149914048|NCT02327013|540816900|FG001|Overall Study|Lack of Efficacy|0|||
149914049|NCT02327013|540816901|FG002|Overall Study|Lack of Efficacy|5|||
149914050|NCT02327013|540816902|FG003|Overall Study|Lack of Efficacy|0|||
149914051|NCT02327013|540816903|FG004|Overall Study|Lack of Efficacy|1|||
149914052|NCT02327013|540816899|FG000|Overall Study|Non-compliance with IMP|1|||
149914053|NCT02327013|540816900|FG001|Overall Study|Non-compliance with IMP|2|||
149914054|NCT02327013|540816901|FG002|Overall Study|Non-compliance with IMP|7|||
149914055|NCT02327013|540816902|FG003|Overall Study|Non-compliance with IMP|0|||
149914056|NCT02327013|540816903|FG004|Overall Study|Non-compliance with IMP|0|||
149914057|NCT02327013|540816899|FG000|Overall Study|Withdrawal of Consent|1|||
149914058|NCT02327013|540816900|FG001|Overall Study|Withdrawal of Consent|0|||
149914059|NCT02327013|540816901|FG002|Overall Study|Withdrawal of Consent|3|||
149914060|NCT02327013|540816902|FG003|Overall Study|Withdrawal of Consent|0|||
149914061|NCT02327013|540816903|FG004|Overall Study|Withdrawal of Consent|0|||
149914062|NCT02327013|540816899|FG000|Overall Study|Lost to Follow-up|2|||
149914063|NCT02327013|540816900|FG001|Overall Study|Lost to Follow-up|4|||
149914064|NCT02327013|540816901|FG002|Overall Study|Lost to Follow-up|5|||
149914065|NCT02327013|540816902|FG003|Overall Study|Lost to Follow-up|0|||
149914066|NCT02327013|540816903|FG004|Overall Study|Lost to Follow-up|0|||
149914067|NCT02327013|540816899|FG000|Overall Study|Administrative or other reason(s)|1|||
149914068|NCT02327013|540816900|FG001|Overall Study|Administrative or other reason(s)|5|||
149914069|NCT02327013|540816901|FG002|Overall Study|Administrative or other reason(s)|11|||
149914070|NCT02327013|540816902|FG003|Overall Study|Administrative or other reason(s)|1|||
149914071|NCT02327013|540816903|FG004|Overall Study|Administrative or other reason(s)|1|||
149914072|NCT02327013|540816899|FG000|Overall Study|Protocol Violation|0|||
149914073|NCT02327013|540816900|FG001|Overall Study|Protocol Violation|0|||
149914074|NCT02327013|540816901|FG002|Overall Study|Protocol Violation|3|||
149914075|NCT02327013|540816902|FG003|Overall Study|Protocol Violation|0|||
149914076|NCT02327013|540816903|FG004|Overall Study|Protocol Violation|1|||
149914077|NCT02327013|540816899|FG000|Overall Study|Withdrawal before treatment|2|||
149914078|NCT02327013|540816900|FG001|Overall Study|Withdrawal before treatment|1|||
149914079|NCT02327013|540816901|FG002|Overall Study|Withdrawal before treatment|5|||
149914080|NCT02327013|540816902|FG003|Overall Study|Withdrawal before treatment|0|||
149914081|NCT02327013|540816903|FG004|Overall Study|Withdrawal before treatment|0|||
149914082|NCT02380859|540816906|FG000|Overall Study|Withdrawal by Subject|2|||
149914083|NCT02380859|540816907|FG001|Overall Study|Withdrawal by Subject|0|||
149914084|NCT01565668|540816908|FG000|Overall Study|Death|2|||
149972600|NCT03358030|541036924|FG003|Overall Study|Other|0|||
149972601|NCT03342560|541036925|FG000|Overall Study|Lost to Follow-up|2|||
149972602|NCT02604511|541036926|FG000|Overall Study|Adverse Event|3|||
149972603|NCT02604511|541036926|FG000|Overall Study|Disease Progression|4|||
149972604|NCT02604511|541036926|FG000|Overall Study|Withdrawal by Subject|3|||
149972605|NCT02604511|541036926|FG000|Overall Study|Participant ineligible|1|||
149972606|NCT02604511|541036926|FG000|Overall Study|Intercurrent illness|1|||
149972607|NCT03770286|541036927|FG000|Overall Study|Lost to Follow-up|6|||
149972608|NCT03770286|541036928|FG001|Overall Study|Lost to Follow-up|4|||
149972609|NCT03770286|541036929|FG002|Overall Study|Lost to Follow-up|3|||
149972610|NCT03770286|541036927|FG000|Overall Study|Protocol Violation|1|||
149972611|NCT03770286|541036928|FG001|Overall Study|Protocol Violation|0|||
149972612|NCT03770286|541036929|FG002|Overall Study|Protocol Violation|2|||
149972613|NCT02293551|541036932|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
149972614|NCT02293551|541036933|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
149972615|NCT02293551|541036934|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
149972616|NCT02293551|541036935|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
149972617|NCT02293551|541036936|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
149914085|NCT01565668|540816909|FG001|Overall Study|Death|1|||
149914086|NCT01565668|540816908|FG000|Overall Study|Lack of Efficacy|4|||
149914087|NCT01565668|540816909|FG001|Overall Study|Lack of Efficacy|2|||
149914088|NCT01565668|540816908|FG000|Overall Study|Participant went on Hospice Care|1|||
149914089|NCT01565668|540816909|FG001|Overall Study|Participant went on Hospice Care|0|||
149914090|NCT01565668|540816908|FG000|Overall Study|Adverse Event|6|||
149914091|NCT01565668|540816909|FG001|Overall Study|Adverse Event|1|||
149972618|NCT02293551|541036937|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
149972619|NCT02293551|541036932|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
149914092|NCT01565668|540816908|FG000|Overall Study|Randomized, but never received drug|0|||
149914093|NCT01565668|540816909|FG001|Overall Study|Randomized, but never received drug|2|||
149914094|NCT01565668|540816908|FG000|Overall Study|Progressive disease|13|||
149914095|NCT01565668|540816909|FG001|Overall Study|Progressive disease|14|||
149972620|NCT02293551|541036933|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
149972621|NCT02293551|541036934|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
149972622|NCT02293551|541036935|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
149972623|NCT02293551|541036936|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
149972624|NCT02293551|541036937|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
149972625|NCT02293551|541036932|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
149972626|NCT02293551|541036933|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
149972627|NCT02293551|541036934|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
149972628|NCT02293551|541036935|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
149972629|NCT02293551|541036936|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
149972630|NCT02293551|541036937|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
149972631|NCT02936323|541036938|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972632|NCT02936323|541036939|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
149972633|NCT02936323|541036940|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972634|NCT02936323|541036941|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
149972635|NCT02936323|541036942|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
149972636|NCT02936323|541036943|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
149972637|NCT02936323|541036944|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972638|NCT02936323|541036945|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972639|NCT02936323|541036946|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972640|NCT02936323|541036947|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
149972641|NCT02936323|541036938|FG000|Phase 1 Dose Escalation|Death|2|||
149972642|NCT02936323|541036939|FG001|Phase 1 Dose Escalation|Death|1|||
149972643|NCT02936323|541036940|FG002|Phase 1 Dose Escalation|Death|3|||
149972644|NCT02936323|541036941|FG003|Phase 1 Dose Escalation|Death|1|||
149972645|NCT02936323|541036942|FG004|Phase 1 Dose Escalation|Death|2|||
149972646|NCT02936323|541036943|FG005|Phase 1 Dose Escalation|Death|3|||
149972647|NCT02936323|541036944|FG006|Phase 1 Dose Escalation|Death|3|||
149972648|NCT02936323|541036945|FG007|Phase 1 Dose Escalation|Death|0|||
149972649|NCT02936323|541036946|FG008|Phase 1 Dose Escalation|Death|0|||
149972650|NCT02936323|541036947|FG009|Phase 1 Dose Escalation|Death|0|||
149972651|NCT02936323|541036938|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
150177224|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
150177225|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
150177226|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
149972652|NCT02936323|541036939|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972653|NCT02936323|541036940|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972654|NCT02936323|541036941|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972655|NCT02936323|541036942|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972656|NCT02936323|541036943|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
149972657|NCT02936323|541036944|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972658|NCT02936323|541036945|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972659|NCT02936323|541036946|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972660|NCT02936323|541036947|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
149972661|NCT02936323|541036938|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972662|NCT02936323|541036939|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972663|NCT02936323|541036940|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972664|NCT02936323|541036941|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972665|NCT02936323|541036942|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972666|NCT02936323|541036943|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972667|NCT02936323|541036944|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
149972668|NCT02936323|541036945|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
149972669|NCT02936323|541036946|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
149972670|NCT02936323|541036947|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
149972671|NCT02936323|541036938|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
149972672|NCT02936323|541036939|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
149972673|NCT02936323|541036940|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
149972674|NCT02936323|541036941|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
149972675|NCT02936323|541036942|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
149972676|NCT02936323|541036943|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
149972677|NCT02936323|541036944|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
150177227|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
149972678|NCT02936323|541036945|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
149972679|NCT02936323|541036946|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
149972680|NCT02936323|541036947|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
149972681|NCT02936323|541036938|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972682|NCT02936323|541036939|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149914096|NCT01565668|540816908|FG000|Overall Study|Withdrawal by Subject|1|||
149914097|NCT01565668|540816909|FG001|Overall Study|Withdrawal by Subject|3|||
149914098|NCT01565668|540816908|FG000|Overall Study|HSCT Transplant|11|||
149914099|NCT01565668|540816909|FG001|Overall Study|HSCT Transplant|15|||
149914100|NCT04258254|540816910|FG000|Overall Study|Withdrawal by Subject|0|||
149914101|NCT04258254|540816911|FG001|Overall Study|Withdrawal by Subject|1|||
149914102|NCT04258254|540816912|FG002|Overall Study|Withdrawal by Subject|0|||
149914103|NCT02255552|540816913|FG000|Overall Study|Participants enrolled into another study|0|||
149914104|NCT02255552|540816914|FG001|Overall Study|Participants enrolled into another study|11|||
149914105|NCT02255552|540816913|FG000|Overall Study|Withdrawal by Subject|1|||
149914106|NCT02255552|540816914|FG001|Overall Study|Withdrawal by Subject|4|||
149914107|NCT01447446|540816915|FG000|Overall Study|Death|6|||
149914108|NCT01447446|540816916|FG001|Overall Study|Death|3|||
149914109|NCT01447446|540816917|FG002|Overall Study|Death|2|||
149914110|NCT01447446|540816918|FG003|Overall Study|Death|1|||
149914111|NCT01447446|540816919|FG004|Overall Study|Death|7|||
149914112|NCT01447446|540816920|FG005|Overall Study|Death|0|||
149914113|NCT01447446|540816915|FG000|Overall Study|Adverse Event|3|||
149914114|NCT01447446|540816916|FG001|Overall Study|Adverse Event|0|||
149914115|NCT01447446|540816917|FG002|Overall Study|Adverse Event|1|||
149914116|NCT01447446|540816918|FG003|Overall Study|Adverse Event|0|||
149914117|NCT01447446|540816919|FG004|Overall Study|Adverse Event|2|||
149914118|NCT01447446|540816920|FG005|Overall Study|Adverse Event|0|||
149914119|NCT01447446|540816915|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
149914120|NCT01447446|540816916|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
149914121|NCT01447446|540816917|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
149914122|NCT01447446|540816918|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
149914123|NCT01447446|540816919|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
149914124|NCT01447446|540816920|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
149972683|NCT02936323|541036940|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972684|NCT02936323|541036941|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972685|NCT02936323|541036942|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972686|NCT02936323|541036943|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972687|NCT02936323|541036944|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972688|NCT02936323|541036945|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
149972689|NCT02936323|541036946|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
149972690|NCT02936323|541036947|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
149972691|NCT02936323|541036938|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972692|NCT02936323|541036939|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972693|NCT02936323|541036940|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972694|NCT02936323|541036941|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972695|NCT02936323|541036942|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972696|NCT02936323|541036943|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972697|NCT02936323|541036944|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972698|NCT02936323|541036945|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972699|NCT02936323|541036946|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
149972700|NCT02936323|541036947|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
149972701|NCT02936323|541036938|FG000|Phase 2a Dose Expansion|Death|0|||
149972702|NCT02936323|541036939|FG001|Phase 2a Dose Expansion|Death|0|||
149972703|NCT02936323|541036940|FG002|Phase 2a Dose Expansion|Death|0|||
149972704|NCT02936323|541036941|FG003|Phase 2a Dose Expansion|Death|0|||
149972705|NCT02936323|541036942|FG004|Phase 2a Dose Expansion|Death|0|||
149972706|NCT02936323|541036943|FG005|Phase 2a Dose Expansion|Death|0|||
149972707|NCT02936323|541036944|FG006|Phase 2a Dose Expansion|Death|0|||
149972708|NCT02936323|541036945|FG007|Phase 2a Dose Expansion|Death|4|||
149972709|NCT02936323|541036946|FG008|Phase 2a Dose Expansion|Death|8|||
149972710|NCT02936323|541036947|FG009|Phase 2a Dose Expansion|Death|10|||
149972711|NCT02781558|541036948|FG000|Overall Study|Lost to Follow-up|2|||
149972712|NCT02781558|541036949|FG001|Overall Study|Lost to Follow-up|2|||
149972713|NCT02781558|541036948|FG000|Overall Study|Adverse Event|1|||
149972714|NCT02781558|541036949|FG001|Overall Study|Adverse Event|0|||
149972715|NCT02257528|541036952|FG000|Overall Study|Never received study treatment|1|||
149972716|NCT00404248|541036953|FG000|Overall Study|pts declining status|0|||
149972717|NCT00404248|541036954|FG001|Overall Study|pts declining status|1|||
149972718|NCT00404248|541036955|FG002|Overall Study|pts declining status|0|||
149972719|NCT00404248|541036956|FG003|Overall Study|pts declining status|0|||
149972720|NCT00404248|541036957|FG004|Overall Study|pts declining status|0|||
149972721|NCT00404248|541036958|FG005|Overall Study|pts declining status|0|||
149914125|NCT01447446|540816915|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
149914126|NCT01447446|540816916|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
149914127|NCT01447446|540816917|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
149914128|NCT01447446|540816918|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
149972722|NCT00404248|541036959|FG006|Overall Study|pts declining status|0|||
149972723|NCT00404248|541036960|FG007|Overall Study|pts declining status|0|||
149972724|NCT00404248|541036961|FG008|Overall Study|pts declining status|0|||
150050799|NCT05688670|541327657|FG001|Overall Study|Change in surgery plan|4|||
150050800|NCT05688670|541327656|FG000|Overall Study|Inability to extubate|1|||
149914129|NCT01447446|540816919|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
149914130|NCT01447446|540816920|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
149914131|NCT01447446|540816915|FG000|Overall Study|Administrative/Other|34|||
150050801|NCT05688670|541327657|FG001|Overall Study|Inability to extubate|2|||
150050802|NCT05688670|541327656|FG000|Overall Study|Day of surgery cancellation|0|||
150050803|NCT05688670|541327657|FG001|Overall Study|Day of surgery cancellation|1|||
150050804|NCT05688670|541327656|FG000|Overall Study|Reintubated on PCICU arrival|0|||
150050805|NCT05688670|541327657|FG001|Overall Study|Reintubated on PCICU arrival|1|||
150050806|NCT00488683|541327664|FG000|Overall Study|Withdrawal by Subject|1|||
150050807|NCT00488683|541327665|FG001|Overall Study|Withdrawal by Subject|2|||
150050808|NCT00488683|541327666|FG002|Overall Study|Withdrawal by Subject|2|||
150050809|NCT00488683|541327664|FG000|Overall Study|Lost to Follow-up|5|||
150050810|NCT00488683|541327665|FG001|Overall Study|Lost to Follow-up|3|||
150050811|NCT00488683|541327666|FG002|Overall Study|Lost to Follow-up|0|||
150050812|NCT00488683|541327664|FG000|Overall Study|Protocol Violation|5|||
150050813|NCT00488683|541327665|FG001|Overall Study|Protocol Violation|1|||
150050814|NCT00488683|541327666|FG002|Overall Study|Protocol Violation|0|||
150050815|NCT00488683|541327664|FG000|Overall Study|Unable to Classify|1|||
150050816|NCT00488683|541327665|FG001|Overall Study|Unable to Classify|0|||
150050817|NCT00488683|541327666|FG002|Overall Study|Unable to Classify|0|||
150050818|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
150050819|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
150050820|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
150050821|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
150050822|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
150050823|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
150050824|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
150050825|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
150050826|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
149914132|NCT01447446|540816916|FG001|Overall Study|Administrative/Other|9|||
149914133|NCT01447446|540816917|FG002|Overall Study|Administrative/Other|10|||
149914134|NCT01447446|540816918|FG003|Overall Study|Administrative/Other|2|||
149914135|NCT01447446|540816919|FG004|Overall Study|Administrative/Other|33|||
149914136|NCT01447446|540816920|FG005|Overall Study|Administrative/Other|4|||
149972725|NCT00698841|541036962|FG000|Overall Study|Withdrawal by Subject|2|||
149972726|NCT00698841|541036962|FG000|Overall Study|Adverse Event|3|||
149972727|NCT00698841|541036962|FG000|Overall Study|Disease progression|7|||
149972728|NCT00698841|541036962|FG000|Overall Study|Failure to meet eligibility criteria|2|||
149972729|NCT00698841|541036962|FG000|Overall Study|Study drug toxicity|2|||
149972730|NCT00698841|541036962|FG000|Overall Study|Other|2|||
150050827|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
150050828|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
150050829|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
150050830|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
150050831|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
150050832|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
150050833|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
150050834|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
150050835|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
150050836|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
150050837|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
150050838|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
150050839|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
150050840|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
150050841|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
149972731|NCT00789555|541036963|FG000|Overall Study|Protocol Amendment|78|||
149972732|NCT00789555|541036964|FG001|Overall Study|Protocol Amendment|76|||
149972733|NCT00789555|541036965|FG002|Overall Study|Protocol Amendment|80|||
149972734|NCT00789555|541036963|FG000|Overall Study|Adverse Event|17|||
150050842|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
150050843|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
150050844|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
150050845|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
150050846|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
150050847|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
150050848|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
149914137|NCT01447446|540816915|FG000|Overall Study|SVR12 Assessment|13|||
149914138|NCT01447446|540816916|FG001|Overall Study|SVR12 Assessment|1|||
149914139|NCT01447446|540816917|FG002|Overall Study|SVR12 Assessment|2|||
149914140|NCT01447446|540816918|FG003|Overall Study|SVR12 Assessment|1|||
149914141|NCT01447446|540816919|FG004|Overall Study|SVR12 Assessment|5|||
149914142|NCT01447446|540816920|FG005|Overall Study|SVR12 Assessment|5|||
149914143|NCT01447446|540816915|FG000|Overall Study|New Treatment Started|8|||
149914144|NCT01447446|540816916|FG001|Overall Study|New Treatment Started|2|||
149914145|NCT01447446|540816917|FG002|Overall Study|New Treatment Started|1|||
149914146|NCT01447446|540816918|FG003|Overall Study|New Treatment Started|0|||
149914147|NCT01447446|540816919|FG004|Overall Study|New Treatment Started|2|||
149914148|NCT01447446|540816920|FG005|Overall Study|New Treatment Started|0|||
149914149|NCT01447446|540816915|FG000|Overall Study|Reason not Specified|1|||
149914150|NCT01447446|540816916|FG001|Overall Study|Reason not Specified|1|||
149914151|NCT01447446|540816917|FG002|Overall Study|Reason not Specified|1|||
149914152|NCT01447446|540816918|FG003|Overall Study|Reason not Specified|1|||
149914153|NCT01447446|540816919|FG004|Overall Study|Reason not Specified|1|||
149914154|NCT01447446|540816920|FG005|Overall Study|Reason not Specified|0|||
149914155|NCT04829331|540816923|FG000|Overall Study|Lost to Follow-up|1|||
149914156|NCT04829331|540816924|FG001|Overall Study|Lost to Follow-up|0|||
149914157|NCT02604550|540816928|FG000|Overall Study|Lost to Follow-up|7|||
149914158|NCT02604550|540816929|FG001|Overall Study|Lost to Follow-up|6|||
149914159|NCT02604550|540816928|FG000|Overall Study|Withdrawal by Subject|0|||
149914160|NCT02604550|540816929|FG001|Overall Study|Withdrawal by Subject|1|||
149914161|NCT02604550|540816928|FG000|Overall Study|Incomplete data using paper journal|18|||
149914162|NCT02604550|540816929|FG001|Overall Study|Incomplete data using paper journal|19|||
149914163|NCT01404208|540816930|FG000|Overall Study|Discontinued|3|||
149914164|NCT01404208|540816931|FG001|Overall Study|Discontinued|0|||
149914165|NCT03747302|540816932|FG000|Overall Study|Withdrawal by Subject|1|||
149914166|NCT03747302|540816933|FG001|Overall Study|Withdrawal by Subject|2|||
149914167|NCT01032070|540816934|FG000|Overall Study|Disease progression|13|||
149914168|NCT01032070|540816935|FG001|Overall Study|Disease progression|8|||
149914169|NCT01032070|540816934|FG000|Overall Study|Medical or ethical reasons|0|||
149914170|NCT01032070|540816935|FG001|Overall Study|Medical or ethical reasons|2|||
149914171|NCT01032070|540816934|FG000|Overall Study|Withdrawal by Subject|0|||
149914172|NCT01032070|540816935|FG001|Overall Study|Withdrawal by Subject|2|||
149914173|NCT03769675|540816938|FG000|Overall Study|Lost to Follow-up|1|||
149914174|NCT02772276|540816939|FG000|Overall Study|Lost to Follow-up|0|||
149914175|NCT02772276|540816940|FG001|Overall Study|Lost to Follow-up|0|||
149914176|NCT02772276|540816941|FG002|Overall Study|Lost to Follow-up|0|||
149914177|NCT02772276|540816942|FG003|Overall Study|Lost to Follow-up|0|||
149914178|NCT02772276|540816943|FG004|Overall Study|Lost to Follow-up|0|||
149914179|NCT02772276|540816944|FG005|Overall Study|Lost to Follow-up|0|||
149914180|NCT02772276|540816945|FG006|Overall Study|Lost to Follow-up|1|||
149914181|NCT02772276|540816946|FG007|Overall Study|Lost to Follow-up|0|||
150177228|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
149914182|NCT02772276|540816947|FG008|Overall Study|Lost to Follow-up|0|||
149914183|NCT02772276|540816948|FG009|Overall Study|Lost to Follow-up|0|||
149914184|NCT02772276|540816949|FG010|Overall Study|Lost to Follow-up|0|||
149914185|NCT02772276|540816950|FG011|Overall Study|Lost to Follow-up|0|||
149914186|NCT02772276|540816951|FG012|Overall Study|Lost to Follow-up|0|||
149914187|NCT02772276|540816939|FG000|Overall Study|Withdrew consent|0|||
149914188|NCT02772276|540816940|FG001|Overall Study|Withdrew consent|0|||
149914189|NCT02772276|540816941|FG002|Overall Study|Withdrew consent|0|||
149914190|NCT02772276|540816942|FG003|Overall Study|Withdrew consent|0|||
149914191|NCT02772276|540816943|FG004|Overall Study|Withdrew consent|0|||
149914192|NCT02772276|540816944|FG005|Overall Study|Withdrew consent|0|||
149914193|NCT02772276|540816945|FG006|Overall Study|Withdrew consent|0|||
149914194|NCT02772276|540816946|FG007|Overall Study|Withdrew consent|1|||
149914195|NCT02772276|540816947|FG008|Overall Study|Withdrew consent|0|||
149914196|NCT02772276|540816948|FG009|Overall Study|Withdrew consent|0|||
149914197|NCT02772276|540816949|FG010|Overall Study|Withdrew consent|0|||
149914198|NCT02772276|540816950|FG011|Overall Study|Withdrew consent|0|||
149914199|NCT02772276|540816951|FG012|Overall Study|Withdrew consent|0|||
149914200|NCT00738062|540816952|FG000|Open Label Treatment|Lack of Efficacy|5|||
149914201|NCT00738062|540816953|FG001|Open Label Treatment|Lack of Efficacy|0|||
149914202|NCT00738062|540816954|FG002|Open Label Treatment|Lack of Efficacy|0|||
149914203|NCT00738062|540816952|FG000|Open Label Treatment|Adverse Event|11|||
149914204|NCT00738062|540816953|FG001|Open Label Treatment|Adverse Event|0|||
149914205|NCT00738062|540816954|FG002|Open Label Treatment|Adverse Event|0|||
149914206|NCT00738062|540816952|FG000|Open Label Treatment|Protocol Violation|2|||
149914207|NCT00738062|540816953|FG001|Open Label Treatment|Protocol Violation|0|||
149914208|NCT00738062|540816954|FG002|Open Label Treatment|Protocol Violation|0|||
149914209|NCT00738062|540816952|FG000|Open Label Treatment|Withdrawal by Subject|9|||
149914210|NCT00738062|540816953|FG001|Open Label Treatment|Withdrawal by Subject|0|||
149914211|NCT00738062|540816954|FG002|Open Label Treatment|Withdrawal by Subject|0|||
149914212|NCT00738062|540816952|FG000|Open Label Treatment|Investigator Decision|1|||
149914213|NCT00738062|540816953|FG001|Open Label Treatment|Investigator Decision|0|||
149914214|NCT00738062|540816954|FG002|Open Label Treatment|Investigator Decision|0|||
149914215|NCT00738062|540816952|FG000|Open-Label Extension|Adverse Event|5|||
149914216|NCT00738062|540816953|FG001|Open-Label Extension|Adverse Event|0|||
149914217|NCT00738062|540816954|FG002|Open-Label Extension|Adverse Event|0|||
150050849|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
150050850|NCT03818035|541327668|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
150050851|NCT03818035|541327669|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
150050852|NCT03818035|541327670|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
150050853|NCT03818035|541327671|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
150050854|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
149914218|NCT00738062|540816952|FG000|Open-Label Extension|Physician Decision|1|||
149914219|NCT00738062|540816953|FG001|Open-Label Extension|Physician Decision|0|||
149914220|NCT00738062|540816954|FG002|Open-Label Extension|Physician Decision|0|||
149914221|NCT00738062|540816952|FG000|Open-Label Extension|Lack of Efficacy|2|||
149914222|NCT00738062|540816953|FG001|Open-Label Extension|Lack of Efficacy|0|||
149914223|NCT00738062|540816954|FG002|Open-Label Extension|Lack of Efficacy|0|||
149914224|NCT00738062|540816952|FG000|Open-Label Extension|Withdrawal by Subject|6|||
149914225|NCT00738062|540816953|FG001|Open-Label Extension|Withdrawal by Subject|0|||
149914226|NCT00738062|540816954|FG002|Open-Label Extension|Withdrawal by Subject|0|||
149914227|NCT00738062|540816952|FG000|Open-Label Extension|Protocol Violation|1|||
149914228|NCT00738062|540816953|FG001|Open-Label Extension|Protocol Violation|0|||
149914229|NCT00738062|540816954|FG002|Open-Label Extension|Protocol Violation|0|||
149914230|NCT00738062|540816952|FG000|Open-Label Extension|Study Terminated|2|||
149914231|NCT00738062|540816953|FG001|Open-Label Extension|Study Terminated|0|||
149914232|NCT00738062|540816954|FG002|Open-Label Extension|Study Terminated|0|||
149914233|NCT02248974|540816957|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
149914234|NCT02248974|540816958|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
149914235|NCT02248974|540816957|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
149914236|NCT02248974|540816958|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
149914237|NCT02248974|540816957|FG000|1-Day Follow-Up|Enrolled in another study|1|||
149914238|NCT02248974|540816958|FG001|1-Day Follow-Up|Enrolled in another study|0|||
149914239|NCT02248974|540816957|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
149914240|NCT02248974|540816958|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
149914241|NCT02248974|540816957|FG000|1-Week Follow-Up|Enrolled in another study|1|||
149914242|NCT02248974|540816958|FG001|1-Week Follow-Up|Enrolled in another study|1|||
149914243|NCT02248974|540816957|FG000|1-Week Follow-Up|Transferred to another facility|1|||
149914244|NCT02248974|540816958|FG001|1-Week Follow-Up|Transferred to another facility|0|||
149914245|NCT02248974|540816957|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
149914246|NCT02248974|540816958|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
149914247|NCT02248974|540816957|FG000|1-Week Follow-Up|Death|1|||
149914248|NCT02248974|540816958|FG001|1-Week Follow-Up|Death|1|||
149914249|NCT02248974|540816957|FG000|1-Week Follow-Up|Excluded because of age|0|||
149914250|NCT02248974|540816958|FG001|1-Week Follow-Up|Excluded because of age|1|||
149914251|NCT02248974|540816957|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
149914252|NCT02248974|540816958|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
149914253|NCT02248974|540816957|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
149914254|NCT02248974|540816958|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
149914255|NCT02248974|540816957|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
149914256|NCT02248974|540816958|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
149914257|NCT02248974|540816957|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
149914258|NCT02248974|540816958|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
149914259|NCT02248974|540816957|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
149914260|NCT02248974|540816958|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
149914261|NCT00894790|540816959|FG000|Overall Study|Protocol Violation|0|||
149914262|NCT00894790|540816960|FG001|Overall Study|Protocol Violation|1|||
149914263|NCT00894790|540816959|FG000|Overall Study|Lost to Follow-up|0|||
149914264|NCT00894790|540816960|FG001|Overall Study|Lost to Follow-up|1|||
149914265|NCT00894790|540816959|FG000|Overall Study|Did not meet entrance criteria|1|||
149914266|NCT00894790|540816960|FG001|Overall Study|Did not meet entrance criteria|0|||
149914267|NCT04093492|540816961|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
149914268|NCT04093492|540816962|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
149914269|NCT04093492|540816963|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
149914270|NCT04093492|540816964|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
149914271|NCT04093492|540816961|FG000|25 Weeks Gestational Age (GA)|No response|5|||
149914272|NCT04093492|540816962|FG001|25 Weeks Gestational Age (GA)|No response|5|||
149914273|NCT04093492|540816963|FG002|25 Weeks Gestational Age (GA)|No response|5|||
149914274|NCT04093492|540816964|FG003|25 Weeks Gestational Age (GA)|No response|2|||
149914275|NCT04093492|540816961|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
149914276|NCT04093492|540816962|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
149914277|NCT04093492|540816963|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
149914278|NCT04093492|540816964|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
149914279|NCT04093492|540816961|FG000|30 Weeks GA|Delivered before assessment|1|||
149914280|NCT04093492|540816962|FG001|30 Weeks GA|Delivered before assessment|2|||
149914281|NCT04093492|540816963|FG002|30 Weeks GA|Delivered before assessment|0|||
149914282|NCT04093492|540816964|FG003|30 Weeks GA|Delivered before assessment|0|||
149914283|NCT04093492|540816961|FG000|30 Weeks GA|No response|7|||
149914284|NCT04093492|540816962|FG001|30 Weeks GA|No response|5|||
149914285|NCT04093492|540816963|FG002|30 Weeks GA|No response|5|||
149914286|NCT04093492|540816964|FG003|30 Weeks GA|No response|2|||
149914287|NCT04093492|540816961|FG000|30 Weeks GA|Lost to Follow-up|0|||
149914288|NCT04093492|540816962|FG001|30 Weeks GA|Lost to Follow-up|1|||
149914289|NCT04093492|540816963|FG002|30 Weeks GA|Lost to Follow-up|0|||
149914290|NCT04093492|540816964|FG003|30 Weeks GA|Lost to Follow-up|0|||
149914291|NCT04093492|540816961|FG000|34 Weeks GA|Delivered before assessment|6|||
149914292|NCT04093492|540816962|FG001|34 Weeks GA|Delivered before assessment|3|||
149914293|NCT04093492|540816963|FG002|34 Weeks GA|Delivered before assessment|0|||
149914294|NCT04093492|540816964|FG003|34 Weeks GA|Delivered before assessment|0|||
149914295|NCT04093492|540816961|FG000|34 Weeks GA|No response|0|||
149914296|NCT04093492|540816962|FG001|34 Weeks GA|No response|7|||
149914297|NCT04093492|540816963|FG002|34 Weeks GA|No response|5|||
149914298|NCT04093492|540816964|FG003|34 Weeks GA|No response|3|||
149914299|NCT04093492|540816961|FG000|34 Weeks GA|Lost to Follow-up|0|||
149914300|NCT04093492|540816962|FG001|34 Weeks GA|Lost to Follow-up|1|||
149914301|NCT04093492|540816963|FG002|34 Weeks GA|Lost to Follow-up|0|||
149914302|NCT04093492|540816964|FG003|34 Weeks GA|Lost to Follow-up|0|||
149914303|NCT02945254|540816965|FG000|Overall Study|Lost to Follow-up|1|||
149914304|NCT02945254|540816966|FG001|Overall Study|Lost to Follow-up|0|||
149914305|NCT02945254|540816965|FG000|Overall Study|Withdrawal by Subject|1|||
149914306|NCT02945254|540816966|FG001|Overall Study|Withdrawal by Subject|0|||
149914307|NCT00783224|540816967|FG000|Overall Study|Adverse Event|0|||
149914308|NCT00783224|540816968|FG001|Overall Study|Adverse Event|0|||
149914309|NCT00783224|540816969|FG002|Overall Study|Adverse Event|1|||
149914310|NCT00783224|540816970|FG003|Overall Study|Adverse Event|0|||
149914311|NCT00783224|540816967|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
149914312|NCT00783224|540816968|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
149914313|NCT00783224|540816969|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
149914314|NCT00783224|540816970|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
149914315|NCT00783224|540816967|FG000|Overall Study|Inappropriate as a study subject|0|||
149914316|NCT00783224|540816968|FG001|Overall Study|Inappropriate as a study subject|0|||
149914317|NCT00783224|540816969|FG002|Overall Study|Inappropriate as a study subject|0|||
149914318|NCT00783224|540816970|FG003|Overall Study|Inappropriate as a study subject|1|||
149914319|NCT01711619|540816971|FG000|Overall Study|Early study termination|10|||
149914320|NCT01711619|540816972|FG001|Overall Study|Early study termination|14|||
149914321|NCT01711619|540816971|FG000|Overall Study|Withdrawal by Subject|3|||
149914322|NCT01711619|540816972|FG001|Overall Study|Withdrawal by Subject|7|||
149914323|NCT01711619|540816971|FG000|Overall Study|Protocol Violation|2|||
149914324|NCT01711619|540816972|FG001|Overall Study|Protocol Violation|3|||
149914325|NCT01711619|540816971|FG000|Overall Study|Adverse Event|2|||
149914326|NCT01711619|540816972|FG001|Overall Study|Adverse Event|0|||
149914327|NCT01711619|540816971|FG000|Overall Study|Lost to Follow-up|1|||
149914328|NCT01711619|540816972|FG001|Overall Study|Lost to Follow-up|0|||
149914329|NCT00334802|540816973|FG000|Overall Study|Progressive Disease|2|||
149914330|NCT00334802|540816974|FG001|Overall Study|Progressive Disease|24|||
149914331|NCT00334802|540816973|FG000|Overall Study|Toxicity|1|||
149914332|NCT00334802|540816974|FG001|Overall Study|Toxicity|5|||
149914333|NCT00334802|540816973|FG000|Overall Study|Lack of Efficacy|1|||
149914334|NCT00334802|540816974|FG001|Overall Study|Lack of Efficacy|3|||
149914335|NCT00334802|540816973|FG000|Overall Study|Patient Condition Aggrevated|1|||
149914336|NCT00334802|540816974|FG001|Overall Study|Patient Condition Aggrevated|0|||
149914337|NCT00334802|540816973|FG000|Overall Study|Physician Decision|1|||
149914338|NCT00334802|540816974|FG001|Overall Study|Physician Decision|0|||
149914339|NCT00334802|540816973|FG000|Overall Study|Withdrawal by Subject|0|||
149914340|NCT00334802|540816974|FG001|Overall Study|Withdrawal by Subject|4|||
149914341|NCT00334802|540816973|FG000|Overall Study|Adverse Event|0|||
149914342|NCT00334802|540816974|FG001|Overall Study|Adverse Event|3|||
149914343|NCT00334802|540816973|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
149914344|NCT00334802|540816974|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
149914345|NCT03422159|540816975|FG000|Overall Study|Exclusion due to terminal disease|2|||
149914346|NCT03422159|540816976|FG001|Overall Study|Exclusion due to terminal disease|1|||
149914347|NCT03436199|540816977|FG000|Overall Study|Adverse Event|15|||
149914348|NCT03436199|540816978|FG001|Overall Study|Adverse Event|40|||
149914349|NCT03436199|540816979|FG002|Overall Study|Adverse Event|7|||
149914350|NCT03436199|540816977|FG000|Overall Study|Withdrawal by Subject|4|||
149914351|NCT03436199|540816978|FG001|Overall Study|Withdrawal by Subject|10|||
149914352|NCT03436199|540816979|FG002|Overall Study|Withdrawal by Subject|3|||
149914353|NCT03436199|540816977|FG000|Overall Study|Lost to Follow-up|1|||
149914354|NCT03436199|540816978|FG001|Overall Study|Lost to Follow-up|0|||
149914355|NCT03436199|540816979|FG002|Overall Study|Lost to Follow-up|2|||
149914356|NCT03436199|540816977|FG000|Overall Study|Protocol Violation|1|||
149914357|NCT03436199|540816978|FG001|Overall Study|Protocol Violation|1|||
149914358|NCT03436199|540816979|FG002|Overall Study|Protocol Violation|0|||
149914359|NCT03436199|540816977|FG000|Overall Study|Physician Decision|0|||
149914360|NCT03436199|540816978|FG001|Overall Study|Physician Decision|1|||
149914361|NCT03436199|540816979|FG002|Overall Study|Physician Decision|0|||
149914362|NCT03436199|540816977|FG000|Overall Study|Could not return to clinic|1|||
149914363|NCT03436199|540816978|FG001|Overall Study|Could not return to clinic|0|||
149914364|NCT03436199|540816979|FG002|Overall Study|Could not return to clinic|0|||
149914365|NCT03436199|540816977|FG000|Overall Study|Withdrawn per physician|0|||
149914366|NCT03436199|540816978|FG001|Overall Study|Withdrawn per physician|1|||
149914367|NCT03436199|540816979|FG002|Overall Study|Withdrawn per physician|0|||
149914368|NCT00503997|540816982|FG000|Overall Study|disease progression|1|||
149914369|NCT00503997|540816982|FG000|Overall Study|Adverse Event|5|||
149914370|NCT00503997|540816982|FG000|Overall Study|Death|1|||
149914371|NCT00503997|540816982|FG000|Overall Study|Withdrawal by Subject|1|||
149914372|NCT01195844|540816983|FG000|Overall Study|Fecal sample not collected|40|||
149914373|NCT01037127|540816998|FG000|Overall Study|Lost to Follow-up|2|||
149914374|NCT01037127|540816999|FG001|Overall Study|Lost to Follow-up|4|||
149914375|NCT01037127|540816998|FG000|Overall Study|Physician Decision|1|||
149914376|NCT01037127|540816999|FG001|Overall Study|Physician Decision|0|||
149914377|NCT01037127|540816998|FG000|Overall Study|Study Closed Terminated|2|||
149914378|NCT01037127|540816999|FG001|Overall Study|Study Closed Terminated|17|||
149914379|NCT05072964|540817002|FG000|Overall Study|Withdrawal by Subject|4|||
149914380|NCT05072964|540817002|FG000|Overall Study|Death|1|||
149914381|NCT01047332|540817005|FG000|Overall Study|SEMS Obstruction|11|||
149914382|NCT01047332|540817006|FG001|Overall Study|SEMS Obstruction|20|||
149914383|NCT01047332|540817005|FG000|Overall Study|Died Unobstructed|38|||
149914384|NCT01047332|540817006|FG001|Overall Study|Died Unobstructed|41|||
149914385|NCT01047332|540817005|FG000|Overall Study|Lost to Follow-up|8|||
149914386|NCT01047332|540817006|FG001|Overall Study|Lost to Follow-up|3|||
149914387|NCT03521817|540817011|FG000|Overall Study|Protocol Violation|0|||
149914388|NCT03521817|540817012|FG001|Overall Study|Protocol Violation|1|||
149914389|NCT00778102|540817013|FG000|Overall Study|Adverse Event|8|||
149914390|NCT00778102|540817014|FG001|Overall Study|Adverse Event|5|||
149914391|NCT00778102|540817013|FG000|Overall Study|Death|1|||
149914392|NCT00778102|540817014|FG001|Overall Study|Death|1|||
149914393|NCT00778102|540817013|FG000|Overall Study|Lost to Follow-up|1|||
149914394|NCT00778102|540817014|FG001|Overall Study|Lost to Follow-up|0|||
149914395|NCT00778102|540817013|FG000|Overall Study|Violation of Selection Criteria|1|||
149914396|NCT00778102|540817014|FG001|Overall Study|Violation of Selection Criteria|1|||
149914397|NCT00778102|540817013|FG000|Overall Study|Protocol Violation|0|||
149914398|NCT00778102|540817014|FG001|Overall Study|Protocol Violation|1|||
149914399|NCT00778102|540817013|FG000|Overall Study|Refused Treatment|2|||
149914400|NCT00778102|540817014|FG001|Overall Study|Refused Treatment|3|||
149914401|NCT00778102|540817013|FG000|Overall Study|Withdrawal by Subject|1|||
149914402|NCT00778102|540817014|FG001|Overall Study|Withdrawal by Subject|1|||
149914403|NCT00778102|540817013|FG000|Overall Study|Administrative Reason|7|||
149914404|NCT00778102|540817014|FG001|Overall Study|Administrative Reason|10|||
149914405|NCT04506905|540817017|FG000|Overall Study|Lost to Follow-up|1|||
149914406|NCT04506905|540817018|FG001|Overall Study|Lost to Follow-up|0|||
149914407|NCT04506905|540817019|FG002|Overall Study|Lost to Follow-up|0|||
149914408|NCT04506905|540817020|FG003|Overall Study|Lost to Follow-up|1|||
149914409|NCT04506905|540817021|FG004|Overall Study|Lost to Follow-up|0|||
149914410|NCT04506905|540817022|FG005|Overall Study|Lost to Follow-up|0|||
149914411|NCT04506905|540817023|FG006|Overall Study|Lost to Follow-up|0|||
149914412|NCT04506905|540817024|FG007|Overall Study|Lost to Follow-up|0|||
149914413|NCT04506905|540817025|FG008|Overall Study|Lost to Follow-up|0|||
149914414|NCT04506905|540817017|FG000|Overall Study|Withdrawal by Subject|0|||
149914415|NCT04506905|540817018|FG001|Overall Study|Withdrawal by Subject|0|||
149914416|NCT04506905|540817019|FG002|Overall Study|Withdrawal by Subject|0|||
149914417|NCT04506905|540817020|FG003|Overall Study|Withdrawal by Subject|2|||
149914418|NCT04506905|540817021|FG004|Overall Study|Withdrawal by Subject|0|||
149914419|NCT04506905|540817022|FG005|Overall Study|Withdrawal by Subject|0|||
149914420|NCT04506905|540817023|FG006|Overall Study|Withdrawal by Subject|0|||
149914421|NCT04506905|540817024|FG007|Overall Study|Withdrawal by Subject|0|||
149972735|NCT00789555|541036964|FG001|Overall Study|Adverse Event|7|||
149972736|NCT00789555|541036965|FG002|Overall Study|Adverse Event|10|||
149914422|NCT04506905|540817025|FG008|Overall Study|Withdrawal by Subject|0|||
149914423|NCT00073983|540817026|FG000|Overall Study|not evaluable|1|||
149914424|NCT03976323|540817029|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
149914425|NCT03976323|540817030|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
149914426|NCT03976323|540817031|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
149914427|NCT03976323|540817029|FG000|Induction Phase|Death|80|||
149914428|NCT03976323|540817030|FG001|Induction Phase|Death|0|||
149914429|NCT03976323|540817031|FG002|Induction Phase|Death|0|||
149914430|NCT03976323|540817029|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
149914431|NCT03976323|540817030|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
149914432|NCT03976323|540817031|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
149914433|NCT03976323|540817029|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149914434|NCT03976323|540817030|FG001|Maintenance Phase|Withdrawal by Subject|9|||
149914435|NCT03976323|540817031|FG002|Maintenance Phase|Withdrawal by Subject|3|||
149914436|NCT03976323|540817029|FG000|Maintenance Phase|Physician Decision|0|||
149914437|NCT03976323|540817030|FG001|Maintenance Phase|Physician Decision|0|||
149914438|NCT03976323|540817031|FG002|Maintenance Phase|Physician Decision|1|||
149972737|NCT00789555|541036963|FG000|Overall Study|Lost to Follow-up|9|||
149972738|NCT00789555|541036964|FG001|Overall Study|Lost to Follow-up|10|||
149972739|NCT00789555|541036965|FG002|Overall Study|Lost to Follow-up|18|||
149972740|NCT00789555|541036963|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
149972741|NCT00789555|541036964|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
149972742|NCT00789555|541036965|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
149972743|NCT00789555|541036963|FG000|Overall Study|Treatment failure|11|||
149972744|NCT00789555|541036964|FG001|Overall Study|Treatment failure|8|||
149972745|NCT00789555|541036965|FG002|Overall Study|Treatment failure|12|||
149972746|NCT00789555|541036963|FG000|Overall Study|Protocol Violation|6|||
149972747|NCT00789555|541036964|FG001|Overall Study|Protocol Violation|9|||
149972748|NCT00789555|541036965|FG002|Overall Study|Protocol Violation|13|||
149972749|NCT04646005|541036966|FG000|Overall Study|Adverse Event|1|||
149972750|NCT04646005|541036966|FG000|Overall Study|Progressive Disease|71|||
149972751|NCT04646005|541036966|FG000|Overall Study|Death|20|||
149972752|NCT04646005|541036966|FG000|Overall Study|Withdrawal by Subject|12|||
149972753|NCT04646005|541036966|FG000|Overall Study|Sponsor Request|9|||
149972754|NCT03802396|541036967|FG000|Overall Study|Withdrawal by Subject|2|||
149972755|NCT03802396|541036968|FG001|Overall Study|Withdrawal by Subject|0|||
149972756|NCT03802396|541036967|FG000|Overall Study|Surgery Cancelled|1|||
149972757|NCT03802396|541036968|FG001|Overall Study|Surgery Cancelled|0|||
149972758|NCT01150357|541036972|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
149972759|NCT01150357|541036973|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
149972760|NCT01150357|541036974|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
149972761|NCT01150357|541036972|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
149972762|NCT01150357|541036973|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
149972763|NCT01150357|541036974|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
149972764|NCT01150357|541036972|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
149972765|NCT01150357|541036973|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
149972766|NCT01150357|541036974|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
149972767|NCT01150357|541036972|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
149972768|NCT01150357|541036973|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
149972769|NCT01150357|541036974|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
149972770|NCT01150357|541036972|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
149972771|NCT01150357|541036973|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
149972772|NCT01150357|541036974|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
149972773|NCT01150357|541036972|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
149972774|NCT01150357|541036973|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
149972775|NCT01150357|541036974|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
149972776|NCT01150357|541036972|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
149972777|NCT01150357|541036973|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
149972778|NCT01150357|541036974|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
149972779|NCT02114177|541038492|FG000|Overall Study|Lost to Follow-up|1|||
149972780|NCT02114177|541038493|FG001|Overall Study|Lost to Follow-up|2|||
149972781|NCT02114177|541038492|FG000|Overall Study|Withdrawal by Subject|6|||
149972782|NCT02114177|541038493|FG001|Overall Study|Withdrawal by Subject|1|||
149972783|NCT02114177|541038492|FG000|Overall Study|Other|2|||
149972784|NCT02114177|541038493|FG001|Overall Study|Other|1|||
149972785|NCT02336815|541038496|FG000|Overall Study|Disease Progression|45|||
149972786|NCT02336815|541038497|FG001|Overall Study|Disease Progression|70|||
149972787|NCT02336815|541038496|FG000|Overall Study|Adverse Event|18|||
149972788|NCT02336815|541038497|FG001|Overall Study|Adverse Event|39|||
149972789|NCT02336815|541038496|FG000|Overall Study|Physician Decision|11|||
149972790|NCT02336815|541038497|FG001|Overall Study|Physician Decision|4|||
149972791|NCT02336815|541038496|FG000|Overall Study|Withdrawal by Subject|3|||
149972792|NCT02336815|541038497|FG001|Overall Study|Withdrawal by Subject|2|||
149972793|NCT02336815|541038496|FG000|Overall Study|Lost to Follow-up|1|||
149972794|NCT02336815|541038497|FG001|Overall Study|Lost to Follow-up|3|||
149972795|NCT02336815|541038496|FG000|Overall Study|Other|1|||
149972796|NCT02336815|541038497|FG001|Overall Study|Other|5|||
149972797|NCT03376516|541038498|FG000|Overall Study|Not treated|1|||
149972798|NCT03376516|541038498|FG000|Overall Study|Consent withdrawn|1|||
149972799|NCT01581684|541038499|FG000|Overall Study|Other reason not defined|0|||
149972800|NCT01581684|541038500|FG001|Overall Study|Other reason not defined|0|||
149972801|NCT01581684|541038501|FG002|Overall Study|Other reason not defined|0|||
149972802|NCT01581684|541038502|FG003|Overall Study|Other reason not defined|0|||
149972803|NCT01581684|541038503|FG004|Overall Study|Other reason not defined|0|||
149972804|NCT01581684|541038504|FG005|Overall Study|Other reason not defined|0|||
149972805|NCT01581684|541038505|FG006|Overall Study|Other reason not defined|0|||
149972806|NCT01581684|541038506|FG007|Overall Study|Other reason not defined|0|||
150177229|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
149972807|NCT01581684|541038507|FG008|Overall Study|Other reason not defined|1|||
149972808|NCT01581684|541038508|FG009|Overall Study|Other reason not defined|0|||
149972809|NCT02986074|541038509|FG000|First Trial Period|Adverse Event|1|||
149914439|NCT03976323|540817029|FG000|Maintenance Phase|Death|0|||
149914440|NCT03976323|540817030|FG001|Maintenance Phase|Death|228|||
149914441|NCT03976323|540817031|FG002|Maintenance Phase|Death|234|||
149914442|NCT02554318|540818779|FG000|Overall Study|Withdrawal by Subject|10|||
149914443|NCT02554318|540818780|FG001|Overall Study|Withdrawal by Subject|8|||
149914444|NCT00085098|540818783|FG000|Overall Study|Withdrawal by Subject|0|||
149914445|NCT00085098|540818784|FG001|Overall Study|Withdrawal by Subject|1|||
149914446|NCT00085098|540818783|FG000|Overall Study|Ineligible|1|||
149914447|NCT00085098|540818784|FG001|Overall Study|Ineligible|1|||
149914448|NCT01886781|540818785|FG000|Overall Study|Protocol Violation|5|||
149914449|NCT01886781|540818786|FG001|Overall Study|Protocol Violation|0|||
149914450|NCT01886781|540818785|FG000|Overall Study|Adverse Event|1|||
149914451|NCT01886781|540818786|FG001|Overall Study|Adverse Event|0|||
149914452|NCT01886781|540818785|FG000|Overall Study|Lost to Follow-up|5|||
149914453|NCT01886781|540818786|FG001|Overall Study|Lost to Follow-up|0|||
149914454|NCT01886781|540818785|FG000|Overall Study|Withdrawal by Subject|2|||
149914455|NCT01886781|540818786|FG001|Overall Study|Withdrawal by Subject|1|||
149914456|NCT01886781|540818785|FG000|Overall Study|Worsening of symptoms|1|||
149914457|NCT01886781|540818786|FG001|Overall Study|Worsening of symptoms|1|||
149914458|NCT03887117|540818791|FG000|Overall Study|Discontinued prematurely|0|||
149914459|NCT03887117|540818792|FG001|Overall Study|Discontinued prematurely|1|||
149914460|NCT03887117|540818793|FG002|Overall Study|Discontinued prematurely|1|||
149914461|NCT03887117|540818794|FG003|Overall Study|Discontinued prematurely|2|||
149914462|NCT00513357|540818797|FG000|Overall Study|did not receive allocated placebo|2|||
149914463|NCT00513357|540818798|FG001|Overall Study|did not receive allocated placebo|3|||
149914464|NCT00513357|540818797|FG000|Overall Study|Adverse Event|4|||
149914465|NCT00513357|540818798|FG001|Overall Study|Adverse Event|2|||
149914466|NCT00513357|540818797|FG000|Overall Study|Death|2|||
149914467|NCT00513357|540818798|FG001|Overall Study|Death|0|||
149914468|NCT00513357|540818797|FG000|Overall Study|Withdrawal by Subject|5|||
149914469|NCT00513357|540818798|FG001|Overall Study|Withdrawal by Subject|4|||
149914470|NCT00513357|540818797|FG000|Overall Study|Disease Progression|2|||
149914471|NCT00513357|540818798|FG001|Overall Study|Disease Progression|1|||
149914472|NCT01162122|540818799|FG000|Overall Study|Withdrawal by Subject|52|||
149914473|NCT01162122|540818800|FG001|Overall Study|Withdrawal by Subject|43|||
149914474|NCT01162122|540818799|FG000|Overall Study|Lost to Follow-up|73|||
149914475|NCT01162122|540818800|FG001|Overall Study|Lost to Follow-up|91|||
149914476|NCT01162122|540818799|FG000|Overall Study|Adverse Event|3|||
149914477|NCT01162122|540818800|FG001|Overall Study|Adverse Event|2|||
149914478|NCT01162122|540818799|FG000|Overall Study|Death|51|||
149914479|NCT01162122|540818800|FG001|Overall Study|Death|46|||
149914480|NCT01162122|540818799|FG000|Overall Study|Protocol Violation|2|||
149914481|NCT01162122|540818800|FG001|Overall Study|Protocol Violation|2|||
149914482|NCT01162122|540818799|FG000|Overall Study|Inappropriate enrollment|5|||
149914483|NCT01162122|540818800|FG001|Overall Study|Inappropriate enrollment|4|||
149914484|NCT01162122|540818799|FG000|Overall Study|Administrative reason|1|||
149914485|NCT01162122|540818800|FG001|Overall Study|Administrative reason|1|||
149914486|NCT01162122|540818799|FG000|Overall Study|Unable to classify|3|||
149914487|NCT01162122|540818800|FG001|Overall Study|Unable to classify|7|||
149914488|NCT01162122|540818799|FG000|Overall Study|Missing primary reason|1|||
149914489|NCT01162122|540818800|FG001|Overall Study|Missing primary reason|0|||
149914490|NCT02020512|540818801|FG000|Overall Study|Adverse Event|1|||
149914491|NCT02020512|540818801|FG000|Overall Study|Lost to Follow-up|3|||
149914492|NCT02020512|540818801|FG000|Overall Study|Protocol Violation|4|||
149914493|NCT03301844|540818812|FG000|Overall Study|suspected colon cancer|1|||
149914494|NCT03301844|540818813|FG001|Overall Study|suspected colon cancer|1|||
149914495|NCT05087966|540818814|FG000|Overall Study|Lost to Follow-up|1|||
149914496|NCT05087966|540818814|FG000|Overall Study|Withdrawal by Subject|5|||
149914497|NCT00483704|540818818|FG000|Randomization|Withdrawal by Subject|19|||
149914498|NCT00483704|540818819|FG001|Randomization|Withdrawal by Subject|28|||
149914499|NCT00483704|540818820|FG002|Randomization|Withdrawal by Subject|18|||
149914500|NCT00483704|540818818|FG000|Randomization|Protocol Violation|14|||
149914501|NCT00483704|540818819|FG001|Randomization|Protocol Violation|25|||
149972810|NCT02986074|541038510|FG001|First Trial Period|Adverse Event|0|||
149914502|NCT00483704|540818820|FG002|Randomization|Protocol Violation|22|||
149914503|NCT00483704|540818818|FG000|Randomization|Lost to Follow-up|14|||
149914504|NCT00483704|540818819|FG001|Randomization|Lost to Follow-up|14|||
149914505|NCT00483704|540818820|FG002|Randomization|Lost to Follow-up|19|||
149914506|NCT00483704|540818818|FG000|Randomization|Pregnancy|1|||
149914507|NCT00483704|540818819|FG001|Randomization|Pregnancy|0|||
149914508|NCT00483704|540818820|FG002|Randomization|Pregnancy|0|||
149914509|NCT00483704|540818818|FG000|Randomization|Physician Decision|2|||
149914510|NCT00483704|540818819|FG001|Randomization|Physician Decision|4|||
149914511|NCT00483704|540818820|FG002|Randomization|Physician Decision|0|||
149914512|NCT00483704|540818818|FG000|Randomization|Progressive disease|0|||
149914513|NCT00483704|540818819|FG001|Randomization|Progressive disease|0|||
149914514|NCT00483704|540818820|FG002|Randomization|Progressive disease|1|||
149972811|NCT02986074|541038511|FG002|First Trial Period|Adverse Event|0|||
149914515|NCT00483704|540818818|FG000|Randomization|Lack of qualifying migraines|21|||
149914516|NCT00483704|540818819|FG001|Randomization|Lack of qualifying migraines|25|||
149914517|NCT00483704|540818820|FG002|Randomization|Lack of qualifying migraines|31|||
149914518|NCT00483704|540818818|FG000|Treatment|Lack of qualifying migraines|101|||
149914519|NCT00483704|540818819|FG001|Treatment|Lack of qualifying migraines|99|||
149914520|NCT00483704|540818820|FG002|Treatment|Lack of qualifying migraines|116|||
149914521|NCT00483704|540818818|FG000|Treatment|Adverse Event|3|||
149914522|NCT00483704|540818819|FG001|Treatment|Adverse Event|5|||
149914523|NCT00483704|540818820|FG002|Treatment|Adverse Event|4|||
149914524|NCT00483704|540818818|FG000|Treatment|Withdrawal by Subject|16|||
149914525|NCT00483704|540818819|FG001|Treatment|Withdrawal by Subject|12|||
149914526|NCT00483704|540818820|FG002|Treatment|Withdrawal by Subject|21|||
149914527|NCT00483704|540818818|FG000|Treatment|Protocol Violation|6|||
149914528|NCT00483704|540818819|FG001|Treatment|Protocol Violation|3|||
149914529|NCT00483704|540818820|FG002|Treatment|Protocol Violation|5|||
149914530|NCT00483704|540818818|FG000|Treatment|Lost to Follow-up|2|||
149914531|NCT00483704|540818819|FG001|Treatment|Lost to Follow-up|7|||
149914532|NCT00483704|540818820|FG002|Treatment|Lost to Follow-up|5|||
149914533|NCT00483704|540818818|FG000|Treatment|Lack of Efficacy|1|||
149914534|NCT00483704|540818819|FG001|Treatment|Lack of Efficacy|1|||
149914535|NCT00483704|540818820|FG002|Treatment|Lack of Efficacy|1|||
149914536|NCT00483704|540818818|FG000|Treatment|Pregnancy|0|||
149914537|NCT00483704|540818819|FG001|Treatment|Pregnancy|1|||
149914538|NCT00483704|540818820|FG002|Treatment|Pregnancy|0|||
149914539|NCT00483704|540818818|FG000|Treatment|Physician Decision|0|||
149914540|NCT00483704|540818819|FG001|Treatment|Physician Decision|1|||
149914541|NCT00483704|540818820|FG002|Treatment|Physician Decision|4|||
149914542|NCT03689543|540818822|FG000|Overall Study|Adverse Event|0|||
149914543|NCT03689543|540818823|FG001|Overall Study|Adverse Event|0|||
149914544|NCT03689543|540818824|FG002|Overall Study|Adverse Event|1|||
149914545|NCT05619536|540818825|FG000|Overall Study|Withdrawal by Subject|0|||
149914546|NCT05619536|540818826|FG001|Overall Study|Withdrawal by Subject|1|||
149914547|NCT05619536|540818827|FG002|Overall Study|Withdrawal by Subject|0|||
149914548|NCT05619536|540818828|FG003|Overall Study|Withdrawal by Subject|1|||
149914549|NCT05619536|540818825|FG000|Overall Study|Lost to Follow-up|0|||
149914550|NCT05619536|540818826|FG001|Overall Study|Lost to Follow-up|1|||
149914551|NCT05619536|540818827|FG002|Overall Study|Lost to Follow-up|1|||
149914552|NCT05619536|540818828|FG003|Overall Study|Lost to Follow-up|0|||
149914553|NCT00819780|540818833|FG000|Overall Study|Did not receive study drug|3|||
149914554|NCT00819780|540818834|FG001|Overall Study|Did not receive study drug|4|||
149914555|NCT00819780|540818833|FG000|Overall Study|Still in treatment|25|||
149914556|NCT00819780|540818834|FG001|Overall Study|Still in treatment|17|||
149914557|NCT00948506|540818835|FG000|Overall Study|Withdrawal by Subject|3|||
149914558|NCT00948506|540818836|FG001|Overall Study|Withdrawal by Subject|1|||
149914559|NCT03912428|540818837|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
149914560|NCT03912428|540818838|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
149914561|NCT03912428|540818839|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
149914562|NCT03912428|540818840|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
149914563|NCT03912428|540818837|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
149914564|NCT03912428|540818838|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
149914565|NCT03912428|540818839|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
149914566|NCT03912428|540818840|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
149914567|NCT03912428|540818837|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
149914568|NCT03912428|540818838|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
150050855|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
150050856|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
149914569|NCT03912428|540818839|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
149914570|NCT03912428|540818840|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
149914571|NCT03233204|540818841|FG000|Overall Study|Adverse Event|1|||
149914572|NCT03233204|540818841|FG000|Overall Study|Death|1|||
149914573|NCT03233204|540818841|FG000|Overall Study|Withdrawal by Subject|1|||
149914574|NCT03233204|540818841|FG000|Overall Study|Progressive Disease|3|||
149914575|NCT02520427|540818843|FG000|Overall Study|Decision by sponsor|0|||
149914576|NCT02520427|540818844|FG001|Overall Study|Decision by sponsor|0|||
149914577|NCT02520427|540818845|FG002|Overall Study|Decision by sponsor|0|||
149914578|NCT02520427|540818846|FG003|Overall Study|Decision by sponsor|0|||
149914579|NCT02520427|540818847|FG004|Overall Study|Decision by sponsor|0|||
149914580|NCT02520427|540818848|FG005|Overall Study|Decision by sponsor|0|||
149914581|NCT02520427|540818849|FG006|Overall Study|Decision by sponsor|0|||
149914582|NCT02520427|540818850|FG007|Overall Study|Decision by sponsor|0|||
149914583|NCT02520427|540818851|FG008|Overall Study|Decision by sponsor|1|||
149914584|NCT02520427|540818852|FG009|Overall Study|Decision by sponsor|1|||
149914585|NCT02520427|540818853|FG010|Overall Study|Decision by sponsor|0|||
149914586|NCT02520427|540818854|FG011|Overall Study|Decision by sponsor|0|||
149914587|NCT02520427|540818855|FG012|Overall Study|Decision by sponsor|0|||
149914588|NCT02520427|540818856|FG013|Overall Study|Decision by sponsor|0|||
149914589|NCT02520427|540818857|FG014|Overall Study|Decision by sponsor|0|||
149914590|NCT02520427|540818858|FG015|Overall Study|Decision by sponsor|0|||
149914591|NCT02520427|540818859|FG016|Overall Study|Decision by sponsor|0|||
149914592|NCT02520427|540818860|FG017|Overall Study|Decision by sponsor|0|||
149914593|NCT02520427|540818861|FG018|Overall Study|Decision by sponsor|0|||
149914594|NCT02520427|540818862|FG019|Overall Study|Decision by sponsor|0|||
149914595|NCT02520427|540818863|FG020|Overall Study|Decision by sponsor|0|||
149914596|NCT02520427|540818864|FG021|Overall Study|Decision by sponsor|0|||
149914597|NCT02520427|540818865|FG022|Overall Study|Decision by sponsor|0|||
149914598|NCT02520427|540818866|FG023|Overall Study|Decision by sponsor|0|||
149914599|NCT02520427|540818867|FG024|Overall Study|Decision by sponsor|0|||
149914600|NCT02520427|540818868|FG025|Overall Study|Decision by sponsor|0|||
149914601|NCT02520427|540818843|FG000|Overall Study|Withdrawal by Subject|0|||
149914602|NCT02520427|540818844|FG001|Overall Study|Withdrawal by Subject|0|||
149914603|NCT02520427|540818845|FG002|Overall Study|Withdrawal by Subject|1|||
149914604|NCT02520427|540818846|FG003|Overall Study|Withdrawal by Subject|0|||
149914605|NCT02520427|540818847|FG004|Overall Study|Withdrawal by Subject|0|||
149914606|NCT02520427|540818848|FG005|Overall Study|Withdrawal by Subject|0|||
149914607|NCT02520427|540818849|FG006|Overall Study|Withdrawal by Subject|0|||
149914608|NCT02520427|540818850|FG007|Overall Study|Withdrawal by Subject|0|||
149914609|NCT02520427|540818851|FG008|Overall Study|Withdrawal by Subject|0|||
149914610|NCT02520427|540818852|FG009|Overall Study|Withdrawal by Subject|0|||
149914611|NCT02520427|540818853|FG010|Overall Study|Withdrawal by Subject|0|||
149914612|NCT02520427|540818854|FG011|Overall Study|Withdrawal by Subject|0|||
149914613|NCT02520427|540818855|FG012|Overall Study|Withdrawal by Subject|1|||
149914614|NCT02520427|540818856|FG013|Overall Study|Withdrawal by Subject|1|||
149914615|NCT02520427|540818857|FG014|Overall Study|Withdrawal by Subject|1|||
149914616|NCT02520427|540818858|FG015|Overall Study|Withdrawal by Subject|0|||
149914617|NCT02520427|540818859|FG016|Overall Study|Withdrawal by Subject|1|||
149914618|NCT02520427|540818860|FG017|Overall Study|Withdrawal by Subject|0|||
149914619|NCT02520427|540818861|FG018|Overall Study|Withdrawal by Subject|0|||
149914620|NCT02520427|540818862|FG019|Overall Study|Withdrawal by Subject|3|||
149914621|NCT02520427|540818863|FG020|Overall Study|Withdrawal by Subject|2|||
149914622|NCT02520427|540818864|FG021|Overall Study|Withdrawal by Subject|0|||
149914623|NCT02520427|540818865|FG022|Overall Study|Withdrawal by Subject|0|||
149914624|NCT02520427|540818866|FG023|Overall Study|Withdrawal by Subject|0|||
149914625|NCT02520427|540818867|FG024|Overall Study|Withdrawal by Subject|0|||
149914626|NCT02520427|540818868|FG025|Overall Study|Withdrawal by Subject|0|||
149914627|NCT02520427|540818843|FG000|Overall Study|Death|1|||
149914628|NCT02520427|540818844|FG001|Overall Study|Death|0|||
149914629|NCT02520427|540818845|FG002|Overall Study|Death|0|||
149914630|NCT02520427|540818846|FG003|Overall Study|Death|0|||
149914631|NCT02520427|540818847|FG004|Overall Study|Death|0|||
149914632|NCT02520427|540818848|FG005|Overall Study|Death|0|||
149914633|NCT02520427|540818849|FG006|Overall Study|Death|0|||
149914634|NCT02520427|540818850|FG007|Overall Study|Death|0|||
149914635|NCT02520427|540818851|FG008|Overall Study|Death|0|||
149914636|NCT02520427|540818852|FG009|Overall Study|Death|0|||
149914637|NCT02520427|540818853|FG010|Overall Study|Death|0|||
149914638|NCT02520427|540818854|FG011|Overall Study|Death|0|||
149914639|NCT02520427|540818855|FG012|Overall Study|Death|0|||
149914640|NCT02520427|540818856|FG013|Overall Study|Death|0|||
149914641|NCT02520427|540818857|FG014|Overall Study|Death|0|||
149914642|NCT02520427|540818858|FG015|Overall Study|Death|0|||
149914643|NCT02520427|540818859|FG016|Overall Study|Death|2|||
149914644|NCT02520427|540818860|FG017|Overall Study|Death|1|||
149914645|NCT02520427|540818861|FG018|Overall Study|Death|3|||
149914646|NCT02520427|540818862|FG019|Overall Study|Death|2|||
149914647|NCT02520427|540818863|FG020|Overall Study|Death|0|||
149914648|NCT02520427|540818864|FG021|Overall Study|Death|0|||
149914649|NCT02520427|540818865|FG022|Overall Study|Death|1|||
149914650|NCT02520427|540818866|FG023|Overall Study|Death|0|||
149972812|NCT02986074|541038512|FG003|First Trial Period|Adverse Event|0|||
149972813|NCT02986074|541038509|FG000|Follow up Period|system explant|0|||
149972814|NCT02986074|541038510|FG001|Follow up Period|system explant|0|||
149972815|NCT02986074|541038511|FG002|Follow up Period|system explant|1|||
149914651|NCT02520427|540818867|FG024|Overall Study|Death|1|||
149914652|NCT02520427|540818868|FG025|Overall Study|Death|0|||
149914653|NCT00793624|540818869|FG000|Overall Study|Adverse Event|18|||
149914654|NCT00793624|540818870|FG001|Overall Study|Adverse Event|16|||
149914655|NCT00793624|540818871|FG002|Overall Study|Adverse Event|15|||
149914656|NCT00793624|540818872|FG003|Overall Study|Adverse Event|20|||
149914657|NCT00793624|540818869|FG000|Overall Study|Lost to Follow-up|2|||
149914658|NCT00793624|540818870|FG001|Overall Study|Lost to Follow-up|2|||
149914659|NCT00793624|540818871|FG002|Overall Study|Lost to Follow-up|4|||
149914660|NCT00793624|540818872|FG003|Overall Study|Lost to Follow-up|0|||
149914661|NCT00793624|540818869|FG000|Overall Study|Withdrawal by Subject|20|||
149914662|NCT00793624|540818870|FG001|Overall Study|Withdrawal by Subject|9|||
149914663|NCT00793624|540818871|FG002|Overall Study|Withdrawal by Subject|11|||
149914664|NCT00793624|540818872|FG003|Overall Study|Withdrawal by Subject|14|||
149914665|NCT00793624|540818869|FG000|Overall Study|Lack of Efficacy|9|||
149914666|NCT00793624|540818870|FG001|Overall Study|Lack of Efficacy|2|||
149914667|NCT00793624|540818871|FG002|Overall Study|Lack of Efficacy|1|||
149914668|NCT00793624|540818872|FG003|Overall Study|Lack of Efficacy|3|||
149914669|NCT00793624|540818869|FG000|Overall Study|Non compliance with protocol|2|||
149914670|NCT00793624|540818870|FG001|Overall Study|Non compliance with protocol|3|||
149914671|NCT00793624|540818871|FG002|Overall Study|Non compliance with protocol|2|||
149914672|NCT00793624|540818872|FG003|Overall Study|Non compliance with protocol|3|||
149914673|NCT00793624|540818869|FG000|Overall Study|Other reason not described above|6|||
149914674|NCT00793624|540818870|FG001|Overall Study|Other reason not described above|4|||
149914675|NCT00793624|540818871|FG002|Overall Study|Other reason not described above|6|||
149914676|NCT00793624|540818872|FG003|Overall Study|Other reason not described above|3|||
149914677|NCT00157248|540818873|FG000|Overall Study|Adverse Event|36|||
149914678|NCT00157248|540818874|FG001|Overall Study|Adverse Event|25|||
149914679|NCT00157248|540818875|FG002|Overall Study|Adverse Event|13|||
149914680|NCT00157248|540818876|FG003|Overall Study|Adverse Event|33|||
149914681|NCT00157248|540818873|FG000|Overall Study|Protocol Violation|4|||
149914682|NCT00157248|540818874|FG001|Overall Study|Protocol Violation|0|||
149914683|NCT00157248|540818875|FG002|Overall Study|Protocol Violation|2|||
149914684|NCT00157248|540818876|FG003|Overall Study|Protocol Violation|2|||
149914685|NCT00157248|540818873|FG000|Overall Study|Lost to Follow-up|0|||
149914686|NCT00157248|540818874|FG001|Overall Study|Lost to Follow-up|1|||
149914687|NCT00157248|540818875|FG002|Overall Study|Lost to Follow-up|0|||
149914688|NCT00157248|540818876|FG003|Overall Study|Lost to Follow-up|0|||
149914689|NCT00157248|540818873|FG000|Overall Study|Withdrawal by Subject|1|||
149914690|NCT00157248|540818874|FG001|Overall Study|Withdrawal by Subject|4|||
149914691|NCT00157248|540818875|FG002|Overall Study|Withdrawal by Subject|3|||
149914692|NCT00157248|540818876|FG003|Overall Study|Withdrawal by Subject|3|||
149914693|NCT00157248|540818873|FG000|Overall Study|site closures, subject moving|7|||
149914694|NCT00157248|540818874|FG001|Overall Study|site closures, subject moving|7|||
149914695|NCT00157248|540818875|FG002|Overall Study|site closures, subject moving|3|||
149914696|NCT00157248|540818876|FG003|Overall Study|site closures, subject moving|9|||
149914697|NCT03191864|540818877|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
149914698|NCT03191864|540818878|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
149914699|NCT03191864|540818879|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
149914700|NCT03191864|540818880|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
149914701|NCT03191864|540818881|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
149914702|NCT03191864|540818882|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
149914703|NCT03191864|540818877|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
149914704|NCT03191864|540818878|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
149914705|NCT03191864|540818879|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
149914706|NCT03191864|540818880|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
149914707|NCT03191864|540818881|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
149914708|NCT03191864|540818882|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
149914709|NCT03191864|540818877|FG000|Baseline Symptom Assessment|Adverse Event|0|||
149914710|NCT03191864|540818878|FG001|Baseline Symptom Assessment|Adverse Event|0|||
149914711|NCT03191864|540818879|FG002|Baseline Symptom Assessment|Adverse Event|0|||
149914712|NCT03191864|540818880|FG003|Baseline Symptom Assessment|Adverse Event|0|||
149914713|NCT03191864|540818881|FG004|Baseline Symptom Assessment|Adverse Event|0|||
149914714|NCT03191864|540818882|FG005|Baseline Symptom Assessment|Adverse Event|2|||
149914715|NCT03191864|540818877|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
149914716|NCT03191864|540818878|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
149914717|NCT03191864|540818879|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
149914718|NCT03191864|540818880|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
149914719|NCT03191864|540818881|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
149914720|NCT03191864|540818882|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
149914721|NCT03191864|540818877|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
149914722|NCT03191864|540818878|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
149914723|NCT03191864|540818879|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
150177230|NCT01061151|541786184|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
150177231|NCT01061151|541786185|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
150177232|NCT01061151|541786186|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
150177233|NCT01061151|541786187|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
150177234|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
150177235|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
150177236|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
149914724|NCT03191864|540818880|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
149914725|NCT03191864|540818881|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
149914726|NCT03191864|540818882|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
149914727|NCT03191864|540818877|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
149914728|NCT03191864|540818878|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
149914729|NCT03191864|540818879|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
149914730|NCT03191864|540818880|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
149914731|NCT03191864|540818881|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
149914732|NCT03191864|540818882|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
149914733|NCT03191864|540818877|FG000|Part 1 - Induction|Adverse Event|0|||
149914734|NCT03191864|540818878|FG001|Part 1 - Induction|Adverse Event|2|||
149914735|NCT03191864|540818879|FG002|Part 1 - Induction|Adverse Event|0|||
149914736|NCT03191864|540818880|FG003|Part 1 - Induction|Adverse Event|1|||
149914737|NCT03191864|540818881|FG004|Part 1 - Induction|Adverse Event|0|||
149914738|NCT03191864|540818882|FG005|Part 1 - Induction|Adverse Event|2|||
149914739|NCT03191864|540818877|FG000|Part 1 - Induction|Randomized but never dosed|0|||
149914740|NCT03191864|540818878|FG001|Part 1 - Induction|Randomized but never dosed|0|||
149914741|NCT03191864|540818879|FG002|Part 1 - Induction|Randomized but never dosed|1|||
149914742|NCT03191864|540818880|FG003|Part 1 - Induction|Randomized but never dosed|0|||
149914743|NCT03191864|540818881|FG004|Part 1 - Induction|Randomized but never dosed|0|||
149914744|NCT03191864|540818882|FG005|Part 1 - Induction|Randomized but never dosed|0|||
149914745|NCT03191864|540818877|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
149914746|NCT03191864|540818878|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
149914747|NCT03191864|540818879|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
149914748|NCT03191864|540818880|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
149914749|NCT03191864|540818881|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
149914750|NCT03191864|540818882|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
149914751|NCT03191864|540818877|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
149914752|NCT03191864|540818878|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
149914753|NCT03191864|540818879|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
149914754|NCT03191864|540818880|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
149914755|NCT03191864|540818881|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
149914756|NCT03191864|540818882|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
149914757|NCT03191864|540818877|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
149914758|NCT03191864|540818878|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
149914759|NCT03191864|540818879|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
149914760|NCT03191864|540818880|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
149914761|NCT03191864|540818881|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
150050857|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
150050858|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
150050859|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
150050860|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
150050861|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
150050862|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
150050863|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
150050864|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
150050865|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
150050866|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
150050867|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
150050868|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
150050869|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
150050870|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
150050871|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
150050872|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
150050873|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
150050874|NCT03818035|541327668|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
150050875|NCT03818035|541327669|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
150050876|NCT03818035|541327670|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
150050877|NCT03818035|541327671|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
150050878|NCT03374202|541327674|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
150050879|NCT03374202|541327675|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
150050880|NCT03374202|541327676|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
150050881|NCT03374202|541327674|FG000|Five Year Long Term Follow Up|Death|0|||
150050882|NCT03374202|541327675|FG001|Five Year Long Term Follow Up|Death|1|||
150050883|NCT03374202|541327676|FG002|Five Year Long Term Follow Up|Death|0|||
150050884|NCT03680742|541329034|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
150050885|NCT02894502|541329037|FG000|Baseline|Withdrawal by Subject|24|||
150050886|NCT02894502|541329038|FG001|Baseline|Withdrawal by Subject|31|||
149914762|NCT03191864|540818882|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
149914763|NCT03191864|540818877|FG000|Part 2 - Maintenance|Physician Decision|1|||
150050887|NCT02894502|541329039|FG002|Baseline|Withdrawal by Subject|36|||
150050888|NCT02894502|541329037|FG000|Baseline|Death|3|||
149972816|NCT02986074|541038512|FG003|Follow up Period|system explant|2|||
149972817|NCT02986074|541038509|FG000|Follow up Period|Physician Decision|0|||
149972818|NCT02986074|541038510|FG001|Follow up Period|Physician Decision|0|||
149972819|NCT02986074|541038511|FG002|Follow up Period|Physician Decision|0|||
149972820|NCT02986074|541038512|FG003|Follow up Period|Physician Decision|1|||
149972821|NCT00598650|541038513|FG000|Overall Study|Withdrawal by Subject|3|||
149972822|NCT00598650|541038513|FG000|Overall Study|Adverse Event|18|||
149972823|NCT00598650|541038513|FG000|Overall Study|No treatment for 3 weeks|1|||
149914764|NCT03191864|540818878|FG001|Part 2 - Maintenance|Physician Decision|0|||
149914765|NCT03191864|540818879|FG002|Part 2 - Maintenance|Physician Decision|0|||
149914766|NCT03191864|540818880|FG003|Part 2 - Maintenance|Physician Decision|0|||
149914767|NCT03191864|540818881|FG004|Part 2 - Maintenance|Physician Decision|0|||
149914768|NCT03191864|540818882|FG005|Part 2 - Maintenance|Physician Decision|0|||
149914769|NCT03191864|540818877|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
149914770|NCT03191864|540818878|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
149914771|NCT03191864|540818879|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
149914772|NCT03191864|540818880|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
149914773|NCT03191864|540818881|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
149914774|NCT03191864|540818882|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
149914775|NCT03191864|540818877|FG000|Part 2 - Maintenance|Adverse Event|0|||
149914776|NCT03191864|540818878|FG001|Part 2 - Maintenance|Adverse Event|0|||
149914777|NCT03191864|540818879|FG002|Part 2 - Maintenance|Adverse Event|0|||
149914778|NCT03191864|540818880|FG003|Part 2 - Maintenance|Adverse Event|0|||
149914779|NCT03191864|540818881|FG004|Part 2 - Maintenance|Adverse Event|1|||
149914780|NCT03191864|540818882|FG005|Part 2 - Maintenance|Adverse Event|0|||
149914781|NCT03191864|540818877|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
149914782|NCT03191864|540818878|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
149914783|NCT03191864|540818879|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
149914784|NCT03191864|540818880|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
149914785|NCT03191864|540818881|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
149914786|NCT03191864|540818882|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
149914787|NCT03191864|540818877|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
149914788|NCT03191864|540818878|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
149914789|NCT03191864|540818879|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
149914790|NCT03191864|540818880|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
149914791|NCT03191864|540818881|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
149914792|NCT03191864|540818882|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
149914793|NCT01447927|540818883|FG000|Overall Study|Adverse Event|4|||
149914794|NCT01447927|540818884|FG001|Overall Study|Adverse Event|3|||
149914795|NCT01447927|540818883|FG000|Overall Study|Withdrawal by Subject|1|||
149914796|NCT01447927|540818884|FG001|Overall Study|Withdrawal by Subject|0|||
149914797|NCT02342548|540818885|FG000|Overall Study|Adverse Event|12|||
149914798|NCT02342548|540818886|FG001|Overall Study|Adverse Event|17|||
149914799|NCT02342548|540818887|FG002|Overall Study|Adverse Event|13|||
149914800|NCT02342548|540818885|FG000|Overall Study|Lost to Follow-up|0|||
149914801|NCT02342548|540818886|FG001|Overall Study|Lost to Follow-up|1|||
149914802|NCT02342548|540818887|FG002|Overall Study|Lost to Follow-up|0|||
149914803|NCT02342548|540818885|FG000|Overall Study|Study terminated by sponsor|20|||
149914804|NCT02342548|540818886|FG001|Overall Study|Study terminated by sponsor|39|||
149914805|NCT02342548|540818887|FG002|Overall Study|Study terminated by sponsor|25|||
149914806|NCT02342548|540818885|FG000|Overall Study|Protocol Violation|0|||
149972824|NCT00598650|541038513|FG000|Overall Study|Not eligible|1|||
149972825|NCT00598650|541038513|FG000|Overall Study|Prohibited Concomitant Medication|2|||
149972826|NCT00598650|541038513|FG000|Overall Study|Physician Decision|2|||
149972827|NCT02415556|541038514|FG000|Overall Study|Adverse Event|3|||
149972828|NCT02415556|541038515|FG001|Overall Study|Adverse Event|4|||
149972829|NCT02415556|541038516|FG002|Overall Study|Adverse Event|2|||
149972830|NCT02415556|541038517|FG003|Overall Study|Adverse Event|4|||
149972831|NCT02415556|541038514|FG000|Overall Study|Lost to Follow-up|4|||
149972832|NCT02415556|541038515|FG001|Overall Study|Lost to Follow-up|5|||
149972833|NCT02415556|541038516|FG002|Overall Study|Lost to Follow-up|4|||
149972834|NCT02415556|541038517|FG003|Overall Study|Lost to Follow-up|1|||
149972835|NCT02415556|541038514|FG000|Overall Study|Withdrawal by Subject|13|||
149914807|NCT02342548|540818886|FG001|Overall Study|Protocol Violation|1|||
149914808|NCT02342548|540818887|FG002|Overall Study|Protocol Violation|0|||
149914809|NCT02342548|540818885|FG000|Overall Study|Withdrawal by Subject|1|||
149914810|NCT02342548|540818886|FG001|Overall Study|Withdrawal by Subject|3|||
149914811|NCT02342548|540818887|FG002|Overall Study|Withdrawal by Subject|4|||
149972836|NCT02415556|541038515|FG001|Overall Study|Withdrawal by Subject|4|||
149972837|NCT02415556|541038516|FG002|Overall Study|Withdrawal by Subject|14|||
149972838|NCT02415556|541038517|FG003|Overall Study|Withdrawal by Subject|12|||
149972839|NCT02415556|541038514|FG000|Overall Study|Physician Decision|1|||
149972840|NCT02415556|541038515|FG001|Overall Study|Physician Decision|3|||
149914812|NCT02342548|540818885|FG000|Overall Study|Other|1|||
149914813|NCT02342548|540818886|FG001|Overall Study|Other|1|||
149914814|NCT02342548|540818887|FG002|Overall Study|Other|1|||
149914815|NCT00787917|540818889|FG000|Blinded Treatment|Adverse Event|1|||
149914816|NCT00787917|540818890|FG001|Blinded Treatment|Adverse Event|0|||
149914817|NCT00787917|540818889|FG000|Blinded Treatment|Lack of Efficacy|1|||
149914818|NCT00787917|540818890|FG001|Blinded Treatment|Lack of Efficacy|0|||
149914819|NCT00787917|540818889|FG000|Blinded Treatment|Administrative problems|3|||
149914820|NCT00787917|540818890|FG001|Blinded Treatment|Administrative problems|2|||
149914821|NCT00787917|540818889|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
149914822|NCT00787917|540818890|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
149914823|NCT00787917|540818889|FG000|Open Label|Administrative problems|3|||
149914824|NCT00787917|540818890|FG001|Open Label|Administrative problems|0|||
149914825|NCT02172040|540818891|FG000|Overall Study|Adverse Event|0|||
149914826|NCT02172040|540818892|FG001|Overall Study|Adverse Event|2|||
149914827|NCT02172040|540818893|FG002|Overall Study|Adverse Event|0|||
149914828|NCT02172040|540818894|FG003|Overall Study|Adverse Event|0|||
149914829|NCT02172040|540818891|FG000|Overall Study|Protocol Violation|0|||
149914830|NCT02172040|540818892|FG001|Overall Study|Protocol Violation|1|||
149914831|NCT02172040|540818893|FG002|Overall Study|Protocol Violation|0|||
149914832|NCT02172040|540818894|FG003|Overall Study|Protocol Violation|0|||
149914833|NCT02172040|540818891|FG000|Overall Study|Withdrawal by Subject|0|||
149914834|NCT02172040|540818892|FG001|Overall Study|Withdrawal by Subject|0|||
149914835|NCT02172040|540818893|FG002|Overall Study|Withdrawal by Subject|1|||
149914836|NCT02172040|540818894|FG003|Overall Study|Withdrawal by Subject|0|||
149914837|NCT02172040|540818891|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
149914838|NCT02172040|540818892|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
149914839|NCT02172040|540818893|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
149914840|NCT02172040|540818894|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
149914841|NCT02172040|540818891|FG000|Overall Study|Family emergency abroad|0|||
149914842|NCT02172040|540818892|FG001|Overall Study|Family emergency abroad|0|||
149914843|NCT02172040|540818893|FG002|Overall Study|Family emergency abroad|0|||
149914844|NCT02172040|540818894|FG003|Overall Study|Family emergency abroad|1|||
149914845|NCT03334422|540820376|FG000|Overall Study|Adverse Event|1|||
149914846|NCT03334422|540820377|FG001|Overall Study|Adverse Event|3|||
149914847|NCT03334422|540820378|FG002|Overall Study|Adverse Event|2|||
149914848|NCT03334422|540820379|FG003|Overall Study|Adverse Event|2|||
149914849|NCT03334422|540820376|FG000|Overall Study|Lack of Efficacy|10|||
149914850|NCT03334422|540820377|FG001|Overall Study|Lack of Efficacy|2|||
149914851|NCT03334422|540820378|FG002|Overall Study|Lack of Efficacy|7|||
149914852|NCT03334422|540820379|FG003|Overall Study|Lack of Efficacy|3|||
149914853|NCT03334422|540820376|FG000|Overall Study|Withdrawal by Subject|8|||
149914854|NCT03334422|540820377|FG001|Overall Study|Withdrawal by Subject|3|||
149914855|NCT03334422|540820378|FG002|Overall Study|Withdrawal by Subject|1|||
149914856|NCT03334422|540820379|FG003|Overall Study|Withdrawal by Subject|0|||
149914857|NCT03334422|540820376|FG000|Overall Study|Lost to Follow-up|0|||
149914858|NCT03334422|540820377|FG001|Overall Study|Lost to Follow-up|0|||
149914859|NCT03334422|540820378|FG002|Overall Study|Lost to Follow-up|0|||
149914860|NCT03334422|540820379|FG003|Overall Study|Lost to Follow-up|1|||
149914861|NCT03334422|540820376|FG000|Overall Study|Inability to obtain laboratory samples|0|||
149914862|NCT03334422|540820377|FG001|Overall Study|Inability to obtain laboratory samples|1|||
149914863|NCT03334422|540820378|FG002|Overall Study|Inability to obtain laboratory samples|0|||
149914864|NCT03334422|540820379|FG003|Overall Study|Inability to obtain laboratory samples|0|||
149914865|NCT03334422|540820376|FG000|Overall Study|Pregnancy|0|||
149914866|NCT03334422|540820377|FG001|Overall Study|Pregnancy|1|||
149914867|NCT03334422|540820378|FG002|Overall Study|Pregnancy|0|||
149914868|NCT03334422|540820379|FG003|Overall Study|Pregnancy|0|||
149914869|NCT01472939|540820380|FG000|Overall Study|Adverse Event|3|||
149914870|NCT01472939|540820381|FG001|Overall Study|Adverse Event|7|||
149914871|NCT01472939|540820382|FG002|Overall Study|Adverse Event|7|||
149914872|NCT01472939|540820383|FG003|Overall Study|Adverse Event|14|||
149914873|NCT01472939|540820380|FG000|Overall Study|Lack of Efficacy|1|||
149914874|NCT01472939|540820381|FG001|Overall Study|Lack of Efficacy|0|||
150050889|NCT02894502|541329038|FG001|Baseline|Death|1|||
149914875|NCT01472939|540820382|FG002|Overall Study|Lack of Efficacy|0|||
150050890|NCT02894502|541329039|FG002|Baseline|Death|9|||
149914876|NCT01472939|540820383|FG003|Overall Study|Lack of Efficacy|1|||
149914877|NCT01472939|540820380|FG000|Overall Study|Lost to Follow-up|3|||
149914878|NCT01472939|540820381|FG001|Overall Study|Lost to Follow-up|0|||
149914879|NCT01472939|540820382|FG002|Overall Study|Lost to Follow-up|2|||
149914880|NCT01472939|540820383|FG003|Overall Study|Lost to Follow-up|0|||
149914881|NCT01472939|540820380|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
149914882|NCT01472939|540820381|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
149914883|NCT01472939|540820382|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
149914884|NCT01472939|540820383|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
149914885|NCT01472939|540820380|FG000|Overall Study|Prohibited Medication|0|||
149914886|NCT01472939|540820381|FG001|Overall Study|Prohibited Medication|1|||
149914887|NCT01472939|540820382|FG002|Overall Study|Prohibited Medication|0|||
149914888|NCT01472939|540820383|FG003|Overall Study|Prohibited Medication|0|||
149914889|NCT01472939|540820380|FG000|Overall Study|Withdrawal By PI|1|||
149914890|NCT01472939|540820381|FG001|Overall Study|Withdrawal By PI|0|||
149914891|NCT01472939|540820382|FG002|Overall Study|Withdrawal By PI|0|||
149914892|NCT01472939|540820383|FG003|Overall Study|Withdrawal By PI|0|||
149914893|NCT01472939|540820380|FG000|Overall Study|Protocol Violation|3|||
149914894|NCT01472939|540820381|FG001|Overall Study|Protocol Violation|3|||
149914895|NCT01472939|540820382|FG002|Overall Study|Protocol Violation|0|||
149914896|NCT01472939|540820383|FG003|Overall Study|Protocol Violation|1|||
149914897|NCT01472939|540820380|FG000|Overall Study|Withdrawal by Subject|9|||
149914898|NCT01472939|540820381|FG001|Overall Study|Withdrawal by Subject|3|||
149914899|NCT01472939|540820382|FG002|Overall Study|Withdrawal by Subject|1|||
149914900|NCT01472939|540820383|FG003|Overall Study|Withdrawal by Subject|4|||
149914901|NCT02539134|540820384|FG000|Overall Study|Lost to Follow-up|1|||
149914902|NCT02539134|540820385|FG001|Overall Study|Lost to Follow-up|0|||
149914903|NCT02539134|540820386|FG002|Overall Study|Lost to Follow-up|0|||
149914904|NCT02539134|540820387|FG003|Overall Study|Lost to Follow-up|0|||
149914905|NCT02539134|540820388|FG004|Overall Study|Lost to Follow-up|0|||
149914906|NCT02539134|540820389|FG005|Overall Study|Lost to Follow-up|0|||
149914907|NCT01675154|540820390|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
149914908|NCT01675154|540820391|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
149914909|NCT01675154|540820392|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
149914910|NCT01675154|540820393|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
149914911|NCT02971800|540820394|FG000|Overall Study|Protocol Violation|1|||
149914912|NCT02971800|540820394|FG000|Overall Study|Withdrawal by Subject|1|||
149914913|NCT02971800|540820394|FG000|Overall Study|Exclusion criteria prior intervention|1|||
149914914|NCT02971800|540820394|FG000|Overall Study|Number evaluable participant already reached|4|||
149914915|NCT05323994|540820395|FG000|Overall Study|Protocol Violation|1|||
149914916|NCT00616603|540820399|FG000|Overall Study|Physician Decision|2|||
149914917|NCT00616603|540820400|FG001|Overall Study|Physician Decision|0|||
149914918|NCT00616603|540820401|FG002|Overall Study|Physician Decision|2|||
149914919|NCT03435224|540820411|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
149914920|NCT00367484|540820414|FG000|Overall Study|Adverse Event|7|||
149914921|NCT00367484|540820414|FG000|Overall Study|Withdrew informed consent|5|||
149914922|NCT00367484|540820414|FG000|Overall Study|Travel to USA|1|||
149914923|NCT00367484|540820414|FG000|Overall Study|Lost to Follow-up|1|||
149914924|NCT00367484|540820414|FG000|Overall Study|Protocol Violation|1|||
149914925|NCT00367484|540820414|FG000|Overall Study|The choice of the patient|1|||
149914926|NCT00367484|540820414|FG000|Overall Study|Lack of Efficacy|1|||
149914927|NCT04472026|540820415|FG000|Overall Study|Lost to Follow-up|5|||
149914928|NCT00908076|540820418|FG000|Overall Study|Lack of Efficacy|1|||
149914929|NCT00908076|540820419|FG001|Overall Study|Lack of Efficacy|1|||
149914930|NCT02609724|540820420|FG000|Overall Study|Death|2|||
149914931|NCT02609724|540820421|FG001|Overall Study|Death|0|||
149914932|NCT02609724|540820422|FG002|Overall Study|Death|1|||
149914933|NCT02609724|540820420|FG000|Overall Study|Withdrawal by Subject|1|||
149914934|NCT02609724|540820421|FG001|Overall Study|Withdrawal by Subject|2|||
149914935|NCT02609724|540820422|FG002|Overall Study|Withdrawal by Subject|3|||
149914936|NCT02609724|540820420|FG000|Overall Study|Illness|2|||
149914937|NCT02609724|540820421|FG001|Overall Study|Illness|1|||
149914938|NCT02609724|540820422|FG002|Overall Study|Illness|0|||
149914939|NCT02382796|540820423|FG000|Overall Study|Global deterioration of health status|1|||
149914940|NCT02382796|540820423|FG000|Overall Study|Objective progression or relapse|3|||
149914941|NCT02382796|540820423|FG000|Overall Study|Commercial dacomitinib became available|3|||
149914942|NCT03077659|540820424|FG000|Overall Study|Withdrawal by Subject|0|||
149914943|NCT03077659|540820425|FG001|Overall Study|Withdrawal by Subject|0|||
149914944|NCT03077659|540820426|FG002|Overall Study|Withdrawal by Subject|1|||
149914945|NCT04007107|540820433|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
149914946|NCT04007107|540820434|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
149914947|NCT04007107|540820435|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
149914948|NCT04007107|540820436|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
149914949|NCT04526574|540820437|FG000|Overall Study|Protocol Violation|3|||
149914950|NCT04526574|540820438|FG001|Overall Study|Protocol Violation|1|||
149914951|NCT04526574|540820437|FG000|Overall Study|Withdrawal by Subject|12|||
149914952|NCT04526574|540820438|FG001|Overall Study|Withdrawal by Subject|9|||
149914953|NCT04526574|540820437|FG000|Overall Study|Other|1|||
149914954|NCT04526574|540820438|FG001|Overall Study|Other|2|||
149914955|NCT04526574|540820437|FG000|Overall Study|Adverse Event|1|||
149914956|NCT04526574|540820438|FG001|Overall Study|Adverse Event|1|||
149914957|NCT04526574|540820437|FG000|Overall Study|Death|2|||
149914958|NCT04526574|540820438|FG001|Overall Study|Death|3|||
149914959|NCT04526574|540820437|FG000|Overall Study|Lost to Follow-up|9|||
149972841|NCT02415556|541038516|FG002|Overall Study|Physician Decision|1|||
149972842|NCT02415556|541038517|FG003|Overall Study|Physician Decision|2|||
149972843|NCT02415556|541038514|FG000|Overall Study|Censored - study completion|4|||
149914960|NCT04526574|540820438|FG001|Overall Study|Lost to Follow-up|9|||
149914961|NCT04526574|540820437|FG000|Overall Study|No longer meets eligibility criteria|8|||
149914962|NCT04526574|540820438|FG001|Overall Study|No longer meets eligibility criteria|8|||
149914963|NCT04068688|540820439|FG000|Overall Study|Lost to Follow-up|1|||
149914964|NCT04068688|540820440|FG001|Overall Study|Lost to Follow-up|1|||
149914965|NCT04068688|540820441|FG002|Overall Study|Lost to Follow-up|0|||
149914966|NCT04068688|540820442|FG003|Overall Study|Lost to Follow-up|0|||
149914967|NCT04068688|540820443|FG004|Overall Study|Lost to Follow-up|5|||
149914968|NCT04068688|540820444|FG005|Overall Study|Lost to Follow-up|5|||
149914969|NCT04068688|540820445|FG006|Overall Study|Lost to Follow-up|0|||
149914970|NCT04068688|540820446|FG007|Overall Study|Lost to Follow-up|0|||
149914971|NCT04068688|540820447|FG008|Overall Study|Lost to Follow-up|1|||
149914972|NCT04068688|540820448|FG009|Overall Study|Lost to Follow-up|0|||
149914973|NCT04068688|540820439|FG000|Overall Study|Withdrawal by Subject|1|||
149914974|NCT04068688|540820440|FG001|Overall Study|Withdrawal by Subject|1|||
149914975|NCT04068688|540820441|FG002|Overall Study|Withdrawal by Subject|0|||
149914976|NCT04068688|540820442|FG003|Overall Study|Withdrawal by Subject|0|||
149914977|NCT04068688|540820443|FG004|Overall Study|Withdrawal by Subject|0|||
149914978|NCT04068688|540820444|FG005|Overall Study|Withdrawal by Subject|0|||
149914979|NCT04068688|540820445|FG006|Overall Study|Withdrawal by Subject|0|||
149914980|NCT04068688|540820446|FG007|Overall Study|Withdrawal by Subject|0|||
149914981|NCT04068688|540820447|FG008|Overall Study|Withdrawal by Subject|0|||
149914982|NCT04068688|540820448|FG009|Overall Study|Withdrawal by Subject|0|||
149914983|NCT04068688|540820439|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
149914984|NCT04068688|540820440|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
149914985|NCT04068688|540820441|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914986|NCT04068688|540820442|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914987|NCT04068688|540820443|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914988|NCT04068688|540820444|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914989|NCT04068688|540820445|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914990|NCT04068688|540820446|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914991|NCT04068688|540820447|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914992|NCT04068688|540820448|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
149914993|NCT04679051|540820449|FG000|Overall Study|felt tired after restricted time in bed|3|||
149914994|NCT04679051|540820450|FG001|Overall Study|felt tired after restricted time in bed|0|||
149914995|NCT04679051|540820449|FG000|Overall Study|discomfort with blood pressure cuff|2|||
149914996|NCT04679051|540820450|FG001|Overall Study|discomfort with blood pressure cuff|0|||
149914997|NCT04679051|540820449|FG000|Overall Study|scheduling conflict|1|||
149914998|NCT04679051|540820450|FG001|Overall Study|scheduling conflict|1|||
149914999|NCT04679051|540820449|FG000|Overall Study|Protocol Violation|0|||
149915000|NCT04679051|540820450|FG001|Overall Study|Protocol Violation|4|||
149915001|NCT00006305|540820451|FG000|Overall Study|Withdrawal by Subject|17|||
149915002|NCT00006305|540820452|FG001|Overall Study|Withdrawal by Subject|10|||
149915003|NCT00006305|540820453|FG002|Overall Study|Withdrawal by Subject|15|||
149915004|NCT00006305|540820454|FG003|Overall Study|Withdrawal by Subject|14|||
149915005|NCT00662558|540820455|FG000|Overall Study|Adverse Event|21|||
149915006|NCT00662558|540820456|FG001|Overall Study|Adverse Event|59|||
149915007|NCT00662558|540820455|FG000|Overall Study|Lack of Efficacy|4|||
149915008|NCT00662558|540820456|FG001|Overall Study|Lack of Efficacy|7|||
149915009|NCT00662558|540820455|FG000|Overall Study|Lost to Follow-up|13|||
149915010|NCT00662558|540820456|FG001|Overall Study|Lost to Follow-up|10|||
149915011|NCT00662558|540820455|FG000|Overall Study|Other|9|||
149915012|NCT00662558|540820456|FG001|Overall Study|Other|14|||
149915013|NCT00662558|540820455|FG000|Overall Study|Withdrawal by Subject|7|||
149915014|NCT00662558|540820456|FG001|Overall Study|Withdrawal by Subject|12|||
149915015|NCT00662558|540820455|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
149915016|NCT00662558|540820456|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
149972844|NCT02415556|541038515|FG001|Overall Study|Censored - study completion|5|||
149972845|NCT02415556|541038516|FG002|Overall Study|Censored - study completion|1|||
149972846|NCT02415556|541038517|FG003|Overall Study|Censored - study completion|0|||
149972847|NCT02415556|541038514|FG000|Overall Study|Family-related issues|0|||
149972848|NCT02415556|541038515|FG001|Overall Study|Family-related issues|0|||
149972849|NCT02415556|541038516|FG002|Overall Study|Family-related issues|0|||
149972850|NCT02415556|541038517|FG003|Overall Study|Family-related issues|1|||
149972851|NCT00524121|541038518|FG000|Overall Study|Disease progression|6|||
149972852|NCT00524121|541038518|FG000|Overall Study|Adverse Event|4|||
149972853|NCT00524121|541038518|FG000|Overall Study|Patient refused|2|||
149972854|NCT00524121|541038518|FG000|Overall Study|Other|1|||
149972855|NCT00524121|541038518|FG000|Overall Study|Death|1|||
149972856|NCT00524121|541038518|FG000|Overall Study|Not treated (became ineligible)|4|||
149972857|NCT00524121|541038518|FG000|Overall Study|Not treated (changed mind)|1|||
149972858|NCT01146613|541038519|FG000|Overall Study|Lost to Follow-up|3|||
149972859|NCT01146613|541038520|FG001|Overall Study|Lost to Follow-up|8|||
149915017|NCT00329641|540820457|FG000|Overall Study|Did not start treatment|1|||
149915018|NCT00329641|540820457|FG000|Overall Study|Not eligible|1|||
149915019|NCT00329641|540820457|FG000|Overall Study|Adverse Event|3|||
149915020|NCT00329641|540820457|FG000|Overall Study|Other reason, not protocol specified|1|||
149915021|NCT00396877|540820459|FG000|Overall Study|Lost to Follow-up|2|||
149915022|NCT00396877|540820460|FG001|Overall Study|Lost to Follow-up|1|||
149915023|NCT00396877|540820459|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
149915024|NCT00396877|540820460|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
149915025|NCT02470403|540820461|FG000|Overall Study|Adverse Event|1|||
149915026|NCT02470403|540820462|FG001|Overall Study|Adverse Event|0|||
149915027|NCT02470403|540820463|FG002|Overall Study|Adverse Event|0|||
149915028|NCT02470403|540820464|FG003|Overall Study|Adverse Event|0|||
149915029|NCT02470403|540820465|FG004|Overall Study|Adverse Event|0|||
149915030|NCT02470403|540820461|FG000|Overall Study|Lost to Follow-up|0|||
149915031|NCT02470403|540820462|FG001|Overall Study|Lost to Follow-up|1|||
149915032|NCT02470403|540820463|FG002|Overall Study|Lost to Follow-up|0|||
149915033|NCT02470403|540820464|FG003|Overall Study|Lost to Follow-up|0|||
149915034|NCT02470403|540820465|FG004|Overall Study|Lost to Follow-up|0|||
149915035|NCT02470403|540820461|FG000|Overall Study|Subject/guardian decision|1|||
149915036|NCT02470403|540820462|FG001|Overall Study|Subject/guardian decision|0|||
149915037|NCT02470403|540820463|FG002|Overall Study|Subject/guardian decision|0|||
149915038|NCT02470403|540820464|FG003|Overall Study|Subject/guardian decision|4|||
149915039|NCT02470403|540820465|FG004|Overall Study|Subject/guardian decision|0|||
149915040|NCT02631070|540820473|FG000|Overall Study|Withdrawal by Subject|35|||
149915041|NCT02631070|540820474|FG001|Overall Study|Withdrawal by Subject|13|||
149915042|NCT02631070|540820473|FG000|Overall Study|Death|45|||
149915043|NCT02631070|540820474|FG001|Overall Study|Death|24|||
149915044|NCT02631070|540820473|FG000|Overall Study|Lost to Follow-up|5|||
149915045|NCT02631070|540820474|FG001|Overall Study|Lost to Follow-up|1|||
149915046|NCT02631070|540820473|FG000|Overall Study|Transition to rollover protocol|52|||
149915047|NCT02631070|540820474|FG001|Overall Study|Transition to rollover protocol|21|||
150050891|NCT02894502|541329037|FG000|First Follow up|Withdrawal by Subject|32|||
150050892|NCT02894502|541329038|FG001|First Follow up|Withdrawal by Subject|29|||
150050893|NCT02894502|541329039|FG002|First Follow up|Withdrawal by Subject|37|||
150050894|NCT02894502|541329037|FG000|First Follow up|Death|2|||
150050895|NCT02894502|541329038|FG001|First Follow up|Death|2|||
150050896|NCT02894502|541329039|FG002|First Follow up|Death|3|||
150050897|NCT02894502|541329037|FG000|Second Follow up|Withdrawal by Subject|13|||
150050898|NCT02894502|541329038|FG001|Second Follow up|Withdrawal by Subject|15|||
150050899|NCT02894502|541329039|FG002|Second Follow up|Withdrawal by Subject|13|||
150050900|NCT02894502|541329037|FG000|Second Follow up|Death|2|||
150050901|NCT02894502|541329038|FG001|Second Follow up|Death|3|||
150050902|NCT02894502|541329039|FG002|Second Follow up|Death|1|||
150050903|NCT02894502|541329037|FG000|Third Follow up|Withdrawal by Subject|5|||
150050904|NCT02894502|541329038|FG001|Third Follow up|Withdrawal by Subject|6|||
150050905|NCT02894502|541329039|FG002|Third Follow up|Withdrawal by Subject|3|||
150050906|NCT02894502|541329037|FG000|Third Follow up|Death|1|||
150050907|NCT02894502|541329038|FG001|Third Follow up|Death|1|||
150050908|NCT02894502|541329039|FG002|Third Follow up|Death|0|||
150050909|NCT00615901|541329040|FG000|Overall Study|Withdrawal by Subject|2|||
149915048|NCT02631070|540820473|FG000|Overall Study|Other reasons|12|||
149915049|NCT02631070|540820474|FG001|Overall Study|Other reasons|5|||
149915050|NCT00980018|540820478|FG000|Overall Study|Adverse Event|8|||
150050910|NCT00615901|541329040|FG000|Overall Study|Adverse Event|7|||
150050911|NCT03700684|541329041|FG000|Overall Study|COVID-19|0|||
150050912|NCT03700684|541329042|FG001|Overall Study|COVID-19|0|||
150050913|NCT03700684|541329043|FG002|Overall Study|COVID-19|2|||
150050914|NCT01120782|541329044|FG000|Overall Study|Test article shipping error|11|||
150050915|NCT04140227|541329045|FG000|Overall Study|Withdrawal by Subject|26|||
150050916|NCT04140227|541329045|FG000|Overall Study|Lost to Follow-up|8|||
150050917|NCT04140227|541329045|FG000|Overall Study|Adverse Event|8|||
150050918|NCT04140227|541329045|FG000|Overall Study|Death|1|||
150050919|NCT04140227|541329045|FG000|Overall Study|Other|3|||
150050920|NCT04140227|541329045|FG000|Overall Study|Protocol Violation|2|||
150050921|NCT00635219|541329046|FG000|Overall Study|Adverse Event|12|||
150050922|NCT00635219|541329047|FG001|Overall Study|Adverse Event|10|||
149915051|NCT00980018|540820478|FG000|Overall Study|Patient withdrew consent|3|||
149915052|NCT00980018|540820478|FG000|Overall Study|Lost to Follow-up|1|||
149915053|NCT00987402|540820479|FG000|Overall Study|Insufficient data entry|86|||
149915054|NCT00987402|540820480|FG001|Overall Study|Insufficient data entry|98|||
149915055|NCT01362517|540820482|FG000|Overall Study|Protocol Violation|1|||
149915056|NCT01362517|540820482|FG000|Overall Study|Lost to Follow-up|1|||
149915057|NCT01133288|540820485|FG000|Eligibility Assessment|met exclusion criteria|5|||
149915058|NCT01133288|540820485|FG000|Intervention Allocation|study terminated|2|||
149915059|NCT00551161|540820486|FG000|Overall Study|Withdrawal by Subject|1|||
149915060|NCT00934856|540820487|FG000|Feasibility Part|Progressive disease|4|||
149915061|NCT00934856|540820488|FG001|Feasibility Part|Progressive disease|4|||
150050923|NCT00635219|541329048|FG002|Overall Study|Adverse Event|18|||
149972860|NCT01146613|541038519|FG000|Overall Study|Lack of Efficacy|0|||
149972861|NCT01146613|541038520|FG001|Overall Study|Lack of Efficacy|1|||
149972862|NCT01146613|541038519|FG000|Overall Study|Death|1|||
149972863|NCT01146613|541038520|FG001|Overall Study|Death|0|||
149972864|NCT01146613|541038519|FG000|Overall Study|Physician Decision|1|||
149972865|NCT01146613|541038520|FG001|Overall Study|Physician Decision|0|||
149972866|NCT01146613|541038519|FG000|Overall Study|Withdrawal by Subject|0|||
149972867|NCT01146613|541038520|FG001|Overall Study|Withdrawal by Subject|3|||
149972868|NCT01146613|541038519|FG000|Overall Study|schedule conflict|1|||
149972869|NCT01146613|541038520|FG001|Overall Study|schedule conflict|0|||
149972870|NCT01146613|541038519|FG000|Overall Study|Outpatient detox|1|||
149972871|NCT01146613|541038520|FG001|Overall Study|Outpatient detox|0|||
149972872|NCT00320606|541038521|FG000|Overall Study|Adverse Event|1|||
149972873|NCT00320606|541038521|FG000|Overall Study|Protocol Violation|1|||
149972874|NCT00320606|541038521|FG000|Overall Study|Withdrawal by Subject|1|||
149972875|NCT03984825|541038522|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
149972876|NCT03984825|541038522|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
149972877|NCT03984825|541038522|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
149972878|NCT02115321|541038527|FG000|Overall Study|Death|1|||
149972879|NCT02115321|541038528|FG001|Overall Study|Death|0|||
149972880|NCT02639390|541038529|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
149972881|NCT02639390|541038530|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
149972882|NCT01908140|541038531|FG000|Overall Study|Other or Progressive Disease|5|||
149972883|NCT01908140|541038532|FG001|Overall Study|Other or Progressive Disease|12|||
149972884|NCT01908140|541038531|FG000|Overall Study|Lack of Efficacy|7|||
149972885|NCT01908140|541038532|FG001|Overall Study|Lack of Efficacy|5|||
149972886|NCT01908140|541038531|FG000|Overall Study|Withdrawal by Subject|23|||
149972887|NCT01908140|541038532|FG001|Overall Study|Withdrawal by Subject|24|||
149972888|NCT01908140|541038531|FG000|Overall Study|Lost to Follow-up|1|||
149972889|NCT01908140|541038532|FG001|Overall Study|Lost to Follow-up|6|||
149972890|NCT01908140|541038531|FG000|Overall Study|Protocol Violation|8|||
149972891|NCT01908140|541038532|FG001|Overall Study|Protocol Violation|9|||
149972892|NCT01908140|541038531|FG000|Overall Study|Adverse Event|22|||
149972893|NCT01908140|541038532|FG001|Overall Study|Adverse Event|23|||
149972894|NCT01119287|541038533|FG000|Overall Study|Patient Decision, not related to AE|0|||
149972895|NCT01119287|541038534|FG001|Overall Study|Patient Decision, not related to AE|0|||
149972896|NCT01119287|541038535|FG002|Overall Study|Patient Decision, not related to AE|2|||
149972897|NCT01119287|541038536|FG003|Overall Study|Patient Decision, not related to AE|2|||
149972898|NCT01119287|541038537|FG004|Overall Study|Patient Decision, not related to AE|1|||
149972899|NCT01119287|541038538|FG005|Overall Study|Patient Decision, not related to AE|0|||
149972900|NCT01156844|541038541|FG000|Overall Study|Adverse Event|0|||
149972901|NCT01156844|541038542|FG001|Overall Study|Adverse Event|0|||
149972902|NCT01156844|541038543|FG002|Overall Study|Adverse Event|1|||
149972903|NCT01156844|541038544|FG003|Overall Study|Adverse Event|1|||
149972904|NCT01156844|541038541|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149972905|NCT01156844|541038542|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149972906|NCT01156844|541038543|FG002|Overall Study|Abnormal test procedure result(s)|2|||
149972907|NCT01156844|541038544|FG003|Overall Study|Abnormal test procedure result(s)|2|||
149972908|NCT01156844|541038541|FG000|Overall Study|Withdrawal by Subject|0|||
149972909|NCT01156844|541038542|FG001|Overall Study|Withdrawal by Subject|0|||
149972910|NCT01156844|541038543|FG002|Overall Study|Withdrawal by Subject|2|||
149972911|NCT01156844|541038544|FG003|Overall Study|Withdrawal by Subject|2|||
149972912|NCT01156844|541038541|FG000|Overall Study|Lost to Follow-up|0|||
149972913|NCT01156844|541038542|FG001|Overall Study|Lost to Follow-up|0|||
149972914|NCT01156844|541038543|FG002|Overall Study|Lost to Follow-up|1|||
149972915|NCT01156844|541038544|FG003|Overall Study|Lost to Follow-up|0|||
149972916|NCT01156844|541038541|FG000|Overall Study|Administrative problems|0|||
149972917|NCT01156844|541038542|FG001|Overall Study|Administrative problems|1|||
149972918|NCT01156844|541038543|FG002|Overall Study|Administrative problems|0|||
149972919|NCT01156844|541038544|FG003|Overall Study|Administrative problems|1|||
149972920|NCT01156844|541038541|FG000|Overall Study|Protocol deviation|2|||
149972921|NCT01156844|541038542|FG001|Overall Study|Protocol deviation|0|||
149972922|NCT01156844|541038543|FG002|Overall Study|Protocol deviation|0|||
149972923|NCT01156844|541038544|FG003|Overall Study|Protocol deviation|0|||
149972924|NCT00945659|541038546|FG000|Overall Study|Lost to Follow-up|7|||
149972925|NCT00945659|541038547|FG001|Overall Study|Lost to Follow-up|20|||
149972926|NCT00945659|541038548|FG002|Overall Study|Lost to Follow-up|17|||
149972927|NCT04067011|541038549|FG000|Overall Study|Not Treated|8|||
149972928|NCT04067011|541038550|FG001|Overall Study|Not Treated|7|||
149972929|NCT04067011|541038551|FG002|Overall Study|Not Treated|5|||
149972930|NCT04067011|541038549|FG000|Overall Study|Adverse Event|2|||
149972931|NCT04067011|541038550|FG001|Overall Study|Adverse Event|1|||
149972932|NCT04067011|541038551|FG002|Overall Study|Adverse Event|0|||
149972933|NCT04067011|541038549|FG000|Overall Study|Withdrawal by Subject|6|||
149972934|NCT04067011|541038550|FG001|Overall Study|Withdrawal by Subject|2|||
149972935|NCT04067011|541038551|FG002|Overall Study|Withdrawal by Subject|1|||
149972936|NCT04067011|541038549|FG000|Overall Study|Lost to Follow-up|0|||
150050924|NCT00635219|541329049|FG003|Overall Study|Adverse Event|15|||
150050925|NCT00635219|541329050|FG004|Overall Study|Adverse Event|19|||
150050926|NCT00635219|541329046|FG000|Overall Study|Lack of Efficacy|5|||
150050927|NCT00635219|541329047|FG001|Overall Study|Lack of Efficacy|6|||
150050928|NCT00635219|541329048|FG002|Overall Study|Lack of Efficacy|3|||
150050929|NCT00635219|541329049|FG003|Overall Study|Lack of Efficacy|4|||
150050930|NCT00635219|541329050|FG004|Overall Study|Lack of Efficacy|6|||
150050931|NCT00635219|541329046|FG000|Overall Study|Non-compliance With Study Product|0|||
150050932|NCT00635219|541329047|FG001|Overall Study|Non-compliance With Study Product|0|||
150050933|NCT00635219|541329048|FG002|Overall Study|Non-compliance With Study Product|0|||
150050934|NCT00635219|541329049|FG003|Overall Study|Non-compliance With Study Product|2|||
150050935|NCT00635219|541329050|FG004|Overall Study|Non-compliance With Study Product|1|||
150050936|NCT00635219|541329046|FG000|Overall Study|Protocol Violation|0|||
150050937|NCT00635219|541329047|FG001|Overall Study|Protocol Violation|2|||
150050938|NCT00635219|541329048|FG002|Overall Study|Protocol Violation|3|||
150050939|NCT00635219|541329049|FG003|Overall Study|Protocol Violation|2|||
150050940|NCT00635219|541329050|FG004|Overall Study|Protocol Violation|4|||
150050941|NCT00635219|541329046|FG000|Overall Study|Withdrawal of Consent|8|||
150050942|NCT00635219|541329047|FG001|Overall Study|Withdrawal of Consent|6|||
150050943|NCT00635219|541329048|FG002|Overall Study|Withdrawal of Consent|8|||
150050944|NCT00635219|541329049|FG003|Overall Study|Withdrawal of Consent|11|||
150050945|NCT00635219|541329050|FG004|Overall Study|Withdrawal of Consent|8|||
150050946|NCT00635219|541329046|FG000|Overall Study|Lost to Follow-up|0|||
150050947|NCT00635219|541329047|FG001|Overall Study|Lost to Follow-up|0|||
150050948|NCT00635219|541329048|FG002|Overall Study|Lost to Follow-up|2|||
150050949|NCT00635219|541329049|FG003|Overall Study|Lost to Follow-up|0|||
150050950|NCT00635219|541329050|FG004|Overall Study|Lost to Follow-up|3|||
150050951|NCT00635219|541329046|FG000|Overall Study|Administrative or Other Reasons|0|||
150050952|NCT00635219|541329047|FG001|Overall Study|Administrative or Other Reasons|1|||
150050953|NCT00635219|541329048|FG002|Overall Study|Administrative or Other Reasons|1|||
150050954|NCT00635219|541329049|FG003|Overall Study|Administrative or Other Reasons|0|||
150050955|NCT00635219|541329050|FG004|Overall Study|Administrative or Other Reasons|1|||
150050956|NCT00796445|541329053|FG000|Overall Study|Protocol Violation|5|||
150050957|NCT00796445|541329054|FG001|Overall Study|Protocol Violation|3|||
150050958|NCT00796445|541329053|FG000|Overall Study|Adverse event, serious fatal|10|||
150050959|NCT00796445|541329054|FG001|Overall Study|Adverse event, serious fatal|5|||
150050960|NCT00796445|541329053|FG000|Overall Study|Adverse event, non-fatal|4|||
150050961|NCT00796445|541329054|FG001|Overall Study|Adverse event, non-fatal|0|||
150050962|NCT00796445|541329053|FG000|Overall Study|Disease progression/recurrence|537|||
150050963|NCT00796445|541329054|FG001|Overall Study|Disease progression/recurrence|268|||
150050964|NCT00796445|541329053|FG000|Overall Study|Other|10|||
150050965|NCT00796445|541329054|FG001|Overall Study|Other|7|||
150050966|NCT00796445|541329053|FG000|Overall Study|Withdrawal by Subject|18|||
150050967|NCT00796445|541329054|FG001|Overall Study|Withdrawal by Subject|9|||
150050968|NCT00796445|541329053|FG000|Overall Study|Invalid Informed Consent Form|1|||
150050969|NCT00796445|541329054|FG001|Overall Study|Invalid Informed Consent Form|0|||
150050970|NCT00388583|541329057|FG000|Overall Study|Protocol Violation|1|||
150050971|NCT00388583|541329058|FG001|Overall Study|Protocol Violation|0|||
150050972|NCT00388583|541329057|FG000|Overall Study|Withdrawal by Subject|3|||
150050973|NCT00388583|541329058|FG001|Overall Study|Withdrawal by Subject|3|||
150050974|NCT00388583|541329057|FG000|Overall Study|Serious Adverse Event|2|||
150050975|NCT00388583|541329058|FG001|Overall Study|Serious Adverse Event|0|||
150050976|NCT00388583|541329057|FG000|Overall Study|Did not receive vaccine|0|||
150050977|NCT00388583|541329058|FG001|Overall Study|Did not receive vaccine|1|||
150050978|NCT05194579|541329059|FG000|Overall Study|Lost to Follow-up|2|||
150050979|NCT05194579|541329060|FG001|Overall Study|Lost to Follow-up|3|||
150050980|NCT05194579|541329059|FG000|Overall Study|Withdrawal by Subject|3|||
150050981|NCT05194579|541329060|FG001|Overall Study|Withdrawal by Subject|4|||
150050982|NCT05194579|541329059|FG000|Overall Study|Refused further study procedures|0|||
150050983|NCT05194579|541329060|FG001|Overall Study|Refused further study procedures|1|||
150050984|NCT05194579|541329059|FG000|Overall Study|Protocol deviation|1|||
150050985|NCT05194579|541329060|FG001|Overall Study|Protocol deviation|0|||
150050986|NCT03595228|541329065|FG000|Overall Study|Death|2|||
150050987|NCT03595228|541329065|FG000|Overall Study|Lack of Efficacy|13|||
150050988|NCT03595228|541329065|FG000|Overall Study|Withdrawal by Subject|3|||
150177237|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
150050989|NCT03595228|541329065|FG000|Overall Study|Withdrawal by Sponsor|1|||
150050990|NCT01639729|541329066|FG000|Overall Study|Withdrawal by Subject|1|||
150050991|NCT01639729|541329067|FG001|Overall Study|Withdrawal by Subject|0|||
150050992|NCT01639729|541329068|FG002|Overall Study|Withdrawal by Subject|1|||
150050993|NCT01639729|541329069|FG003|Overall Study|Withdrawal by Subject|1|||
150050994|NCT01639729|541329070|FG004|Overall Study|Withdrawal by Subject|0|||
150050995|NCT01639729|541329071|FG005|Overall Study|Withdrawal by Subject|0|||
150050996|NCT03232333|541329072|FG000|Overall Study|Infection or Osteomyelitis|9|||
149915062|NCT00934856|540820489|FG002|Feasibility Part|Progressive disease|2|||
149915063|NCT00934856|540820490|FG003|Feasibility Part|Progressive disease|3|||
149915064|NCT00934856|540820491|FG004|Feasibility Part|Progressive disease|0|||
149915065|NCT00934856|540820492|FG005|Feasibility Part|Progressive disease|0|||
149915066|NCT00934856|540820487|FG000|Feasibility Part|Physician Decision|0|||
149915067|NCT00934856|540820488|FG001|Feasibility Part|Physician Decision|0|||
149915068|NCT00934856|540820489|FG002|Feasibility Part|Physician Decision|1|||
149915069|NCT00934856|540820490|FG003|Feasibility Part|Physician Decision|0|||
149915070|NCT00934856|540820491|FG004|Feasibility Part|Physician Decision|0|||
149915071|NCT00934856|540820492|FG005|Feasibility Part|Physician Decision|0|||
149915072|NCT00934856|540820487|FG000|Feasibility Part|Adverse Event|1|||
149915073|NCT00934856|540820488|FG001|Feasibility Part|Adverse Event|1|||
149915074|NCT00934856|540820489|FG002|Feasibility Part|Adverse Event|0|||
149915075|NCT00934856|540820490|FG003|Feasibility Part|Adverse Event|1|||
149915076|NCT00934856|540820491|FG004|Feasibility Part|Adverse Event|0|||
149915077|NCT00934856|540820492|FG005|Feasibility Part|Adverse Event|2|||
149915078|NCT00934856|540820487|FG000|Feasibility Part|Withdrawal by Subject|0|||
149915079|NCT00934856|540820488|FG001|Feasibility Part|Withdrawal by Subject|0|||
149915080|NCT00934856|540820489|FG002|Feasibility Part|Withdrawal by Subject|0|||
149915081|NCT00934856|540820490|FG003|Feasibility Part|Withdrawal by Subject|1|||
149915082|NCT00934856|540820491|FG004|Feasibility Part|Withdrawal by Subject|0|||
149915083|NCT00934856|540820492|FG005|Feasibility Part|Withdrawal by Subject|1|||
149915084|NCT00934856|540820487|FG000|Extension Part|Adverse Event|0|||
149915085|NCT00934856|540820488|FG001|Extension Part|Adverse Event|0|||
149915086|NCT00934856|540820489|FG002|Extension Part|Adverse Event|0|||
149915087|NCT00934856|540820490|FG003|Extension Part|Adverse Event|1|||
149915088|NCT00934856|540820491|FG004|Extension Part|Adverse Event|4|||
149915089|NCT00934856|540820492|FG005|Extension Part|Adverse Event|4|||
149915090|NCT00934856|540820487|FG000|Extension Part|Progressive disease|0|||
149915091|NCT00934856|540820488|FG001|Extension Part|Progressive disease|0|||
149915092|NCT00934856|540820489|FG002|Extension Part|Progressive disease|0|||
149915093|NCT00934856|540820490|FG003|Extension Part|Progressive disease|1|||
149915094|NCT00934856|540820491|FG004|Extension Part|Progressive disease|0|||
149915095|NCT00934856|540820492|FG005|Extension Part|Progressive disease|0|||
149915096|NCT00934856|540820487|FG000|Extension Part|Non-compliance with drug|0|||
149915097|NCT00934856|540820488|FG001|Extension Part|Non-compliance with drug|0|||
149915098|NCT00934856|540820489|FG002|Extension Part|Non-compliance with drug|0|||
149915099|NCT00934856|540820490|FG003|Extension Part|Non-compliance with drug|0|||
149915100|NCT00934856|540820491|FG004|Extension Part|Non-compliance with drug|0|||
149915101|NCT00934856|540820492|FG005|Extension Part|Non-compliance with drug|1|||
149915102|NCT01273155|540820493|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
149915103|NCT01273155|540820494|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
149915104|NCT01273155|540820495|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
149915105|NCT01273155|540820496|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
149915106|NCT01273155|540820497|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
149915107|NCT01273155|540820498|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
149972937|NCT04067011|541038550|FG001|Overall Study|Lost to Follow-up|0|||
149972938|NCT04067011|541038551|FG002|Overall Study|Lost to Follow-up|1|||
149972939|NCT04067011|541038549|FG000|Overall Study|Physician Decision|1|||
149972940|NCT04067011|541038550|FG001|Overall Study|Physician Decision|1|||
149972941|NCT04067011|541038551|FG002|Overall Study|Physician Decision|0|||
149972942|NCT04067011|541038549|FG000|Overall Study|Other Reasons|2|||
149972943|NCT04067011|541038550|FG001|Overall Study|Other Reasons|0|||
149972944|NCT04067011|541038551|FG002|Overall Study|Other Reasons|1|||
149972945|NCT04067011|541038549|FG000|Overall Study|Missing|0|||
149972946|NCT04067011|541038550|FG001|Overall Study|Missing|2|||
149972947|NCT04067011|541038551|FG002|Overall Study|Missing|0|||
149972948|NCT02284191|541038556|FG000|Overall Study|Withdrawal by Subject|1|||
149972949|NCT02284191|541038557|FG001|Overall Study|Withdrawal by Subject|3|||
149972950|NCT02284191|541038556|FG000|Overall Study|Lost to Follow-up|1|||
149972951|NCT02284191|541038557|FG001|Overall Study|Lost to Follow-up|0|||
149972952|NCT04064905|541038558|FG000|Overall Study|Lost to Follow-up|0|||
149972953|NCT04064905|541038559|FG001|Overall Study|Lost to Follow-up|3|||
149972954|NCT04064905|541038560|FG002|Overall Study|Lost to Follow-up|1|||
149972955|NCT04064905|541038561|FG003|Overall Study|Lost to Follow-up|4|||
149972956|NCT04064905|541038562|FG004|Overall Study|Lost to Follow-up|2|||
149972957|NCT02257684|541038563|FG000|Overall Study|Adverse Event|2|||
149972958|NCT02257684|541038563|FG000|Overall Study|Lack of Efficacy|1|||
149972959|NCT02257684|541038563|FG000|Overall Study|Sponsor's Decision|1|||
149972960|NCT01448616|541038564|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
149972961|NCT01448616|541038565|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
149972962|NCT01448616|541038566|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
149972963|NCT01448616|541038567|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
149972964|NCT01448616|541038564|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
149972965|NCT01448616|541038565|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
149972966|NCT01448616|541038566|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
149915108|NCT01273155|540820499|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
149915109|NCT01273155|540820493|FG000|Overall Study|Change in liver function/no longer eval.|0|||
149915110|NCT01273155|540820494|FG001|Overall Study|Change in liver function/no longer eval.|1|||
149915111|NCT01273155|540820495|FG002|Overall Study|Change in liver function/no longer eval.|0|||
149915112|NCT01273155|540820496|FG003|Overall Study|Change in liver function/no longer eval.|0|||
149915113|NCT01273155|540820497|FG004|Overall Study|Change in liver function/no longer eval.|1|||
149915114|NCT01273155|540820498|FG005|Overall Study|Change in liver function/no longer eval.|0|||
149915115|NCT01273155|540820499|FG006|Overall Study|Change in liver function/no longer eval.|0|||
149915116|NCT01273155|540820493|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
149915117|NCT01273155|540820494|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
149915118|NCT01273155|540820495|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
149915119|NCT01273155|540820496|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
149915120|NCT01273155|540820497|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
149915121|NCT01273155|540820498|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
149915122|NCT01273155|540820499|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
149915123|NCT01273155|540820493|FG000|Overall Study|Died during Cycle 1|0|||
149915124|NCT01273155|540820494|FG001|Overall Study|Died during Cycle 1|0|||
149915125|NCT01273155|540820495|FG002|Overall Study|Died during Cycle 1|1|||
149915126|NCT01273155|540820496|FG003|Overall Study|Died during Cycle 1|1|||
149915127|NCT01273155|540820497|FG004|Overall Study|Died during Cycle 1|0|||
149915128|NCT01273155|540820498|FG005|Overall Study|Died during Cycle 1|2|||
149915129|NCT01273155|540820499|FG006|Overall Study|Died during Cycle 1|2|||
149915130|NCT01273155|540820493|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
149915131|NCT01273155|540820494|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
149915132|NCT01273155|540820495|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
149915133|NCT01273155|540820496|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
149915134|NCT01273155|540820497|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
149915135|NCT01273155|540820498|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
149915136|NCT01273155|540820499|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
149915137|NCT01256385|540820500|FG000|Overall Study|Physician Decision|1|||
149915138|NCT01256385|540820501|FG001|Overall Study|Physician Decision|1|||
149915139|NCT01256385|540820500|FG000|Overall Study|Withdrawal by Subject|2|||
149915140|NCT01256385|540820501|FG001|Overall Study|Withdrawal by Subject|2|||
149915141|NCT01438814|540820502|FG000|Overall Study|Adverse Event|3|||
149915142|NCT01438814|540820503|FG001|Overall Study|Adverse Event|3|||
149915143|NCT01438814|540820502|FG000|Overall Study|Protocol Violation|1|||
149915144|NCT01438814|540820503|FG001|Overall Study|Protocol Violation|2|||
149915145|NCT01438814|540820502|FG000|Overall Study|Lost to Follow-up|4|||
149915146|NCT01438814|540820503|FG001|Overall Study|Lost to Follow-up|3|||
149915147|NCT01438814|540820502|FG000|Overall Study|Withdrawal by Subject|4|||
149915148|NCT01438814|540820503|FG001|Overall Study|Withdrawal by Subject|2|||
149915149|NCT01438814|540820502|FG000|Overall Study|Other|2|||
149915150|NCT01438814|540820503|FG001|Overall Study|Other|4|||
149972967|NCT01448616|541038567|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
149972968|NCT01448616|541038564|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
149972969|NCT01448616|541038565|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
149972970|NCT01448616|541038566|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
149972971|NCT01448616|541038567|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
149972972|NCT01448616|541038564|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
149972973|NCT01448616|541038565|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
149972974|NCT01448616|541038566|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
149972975|NCT01448616|541038567|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
149972976|NCT01448616|541038564|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
149972977|NCT01448616|541038565|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
149972978|NCT01448616|541038566|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
149972979|NCT01448616|541038567|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
149972980|NCT00760552|541038568|FG000|Overall Study|Death|2|||
149972981|NCT00760552|541038569|FG001|Overall Study|Death|0|||
149972982|NCT00760552|541038568|FG000|Overall Study|Lost to Follow-up|11|||
149972983|NCT00760552|541038569|FG001|Overall Study|Lost to Follow-up|10|||
149972984|NCT02943473|541038570|FG000|Overall Study|enrolled but not dosed|1|||
149972985|NCT02943473|541038570|FG000|Overall Study|screen failure|1|||
149972986|NCT02943473|541038570|FG000|Overall Study|Physician Decision|4|||
149972987|NCT04211363|541038571|FG000|Overall Study|Adverse Event|5|||
149972988|NCT04211363|541038572|FG001|Overall Study|Adverse Event|2|||
149972989|NCT04211363|541038571|FG000|Overall Study|Physician Decision|0|||
149972990|NCT04211363|541038572|FG001|Overall Study|Physician Decision|1|||
149972991|NCT04211363|541038571|FG000|Overall Study|Protocol Violation|1|||
149915151|NCT00404924|540820506|FG000|Overall Study|Adverse Event|75|||
149915152|NCT00404924|540820507|FG001|Overall Study|Adverse Event|16|||
150050997|NCT03232333|541329072|FG000|Overall Study|Lost to Follow-up|4|||
150050998|NCT03232333|541329072|FG000|Overall Study|Withdrawal by Subject|2|||
150050999|NCT01253811|541329073|FG000|Overall Study|Withdrawal criteria|1|||
150051000|NCT01087736|541329074|FG000|Overall Study|Lost to Follow-up|1|||
150051001|NCT01087736|541329075|FG001|Overall Study|Lost to Follow-up|0|||
150051002|NCT01087736|541329074|FG000|Overall Study|Death|0|||
150051003|NCT01087736|541329075|FG001|Overall Study|Death|1|||
150051004|NCT01087736|541329074|FG000|Overall Study|Withdrawal by Subject|0|||
150051005|NCT01087736|541329075|FG001|Overall Study|Withdrawal by Subject|1|||
150051006|NCT00759564|541329076|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
150051007|NCT00759564|541329077|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
150051008|NCT00759564|541329078|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
150051009|NCT00759564|541329079|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
150051010|NCT00759564|541329080|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
150051011|NCT00435045|541329082|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
150051012|NCT00435045|541329083|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
150051013|NCT00435045|541329082|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
150051014|NCT00435045|541329083|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
150051015|NCT00435045|541329082|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
150051016|NCT00435045|541329083|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
150051017|NCT00435045|541329082|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
150051018|NCT00435045|541329083|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
150051019|NCT00435045|541329082|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
150051020|NCT00435045|541329083|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
150051021|NCT00435045|541329082|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
150051022|NCT00435045|541329083|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
150051023|NCT00435045|541329082|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
150051024|NCT00435045|541329083|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
150051025|NCT00435045|541329082|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
150051026|NCT00435045|541329083|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
150051027|NCT00435045|541329082|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
150051028|NCT00435045|541329083|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
150051029|NCT00435045|541329082|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
150051030|NCT00435045|541329083|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
150051031|NCT00435045|541329082|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
150051032|NCT00435045|541329083|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
150051033|NCT00567255|541329084|FG000|Overall Study|Adverse Event|241|||
150051034|NCT00567255|541329085|FG001|Overall Study|Adverse Event|68|||
150051035|NCT00567255|541329084|FG000|Overall Study|Lost to Follow-up|77|||
150051036|NCT00567255|541329085|FG001|Overall Study|Lost to Follow-up|48|||
150051037|NCT00567255|541329084|FG000|Overall Study|Withdrawal by Subject|75|||
150051038|NCT00567255|541329085|FG001|Overall Study|Withdrawal by Subject|56|||
150051039|NCT00567255|541329084|FG000|Overall Study|Lack of Efficacy|19|||
150051040|NCT00567255|541329085|FG001|Overall Study|Lack of Efficacy|33|||
150051041|NCT00567255|541329084|FG000|Overall Study|Protocol Violation|20|||
150051042|NCT00567255|541329085|FG001|Overall Study|Protocol Violation|8|||
150051043|NCT00567255|541329084|FG000|Overall Study|Pregnancy|6|||
150051044|NCT00567255|541329085|FG001|Overall Study|Pregnancy|0|||
150051045|NCT00567255|541329084|FG000|Overall Study|Drug noncompliance,moved,other|25|||
150051046|NCT00567255|541329085|FG001|Overall Study|Drug noncompliance,moved,other|15|||
150051047|NCT01853839|541329094|FG000|Overall Study|Violated inclusion criteria|2|||
150051048|NCT01853839|541329094|FG000|Overall Study|Not meet ITT population definition|58|||
150051049|NCT01853839|541329094|FG000|Overall Study|End of treatment visit too early|33|||
150051050|NCT01853839|541329094|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
150051051|NCT04145219|541329095|FG000|Overall Study|Adverse Event|18|||
150051052|NCT04145219|541329096|FG001|Overall Study|Adverse Event|6|||
150051053|NCT04145219|541329095|FG000|Overall Study|Lost to Follow-up|2|||
150051054|NCT04145219|541329096|FG001|Overall Study|Lost to Follow-up|3|||
150051055|NCT04145219|541329095|FG000|Overall Study|Physician Decision|0|||
150051056|NCT04145219|541329096|FG001|Overall Study|Physician Decision|2|||
150051057|NCT04145219|541329095|FG000|Overall Study|Withdrawal by Subject|12|||
150051058|NCT04145219|541329096|FG001|Overall Study|Withdrawal by Subject|8|||
150051059|NCT04145219|541329095|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
150051060|NCT04145219|541329096|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
150051061|NCT01640314|541329097|FG000|Overall Study|Protocol Violation|0|||
150051062|NCT01640314|541329098|FG001|Overall Study|Protocol Violation|1|||
150051063|NCT03672097|541329099|FG000|Period 1|Withdrawal by Subject|2|||
150051064|NCT03672097|541329099|FG000|Period 1|Adverse Event|1|||
150051065|NCT03672097|541329099|FG000|Period 1|Did not receive treatment|1|||
150051066|NCT03672097|541329099|FG000|Period 2|Withdrawal by Subject|3|||
150051067|NCT03672097|541329099|FG000|Period 2|Other|1|||
150051068|NCT01290796|541329100|FG000|Overall Study|Lost to Follow-up|21|||
150051069|NCT01290796|541329100|FG000|Overall Study|Withdrawal by Subject|4|||
150051070|NCT01290796|541329100|FG000|Overall Study|Physician Decision|2|||
149972992|NCT04211363|541038572|FG001|Overall Study|Protocol Violation|0|||
149972993|NCT04211363|541038571|FG000|Overall Study|Pregnancy|1|||
149972994|NCT04211363|541038572|FG001|Overall Study|Pregnancy|0|||
149972995|NCT04211363|541038571|FG000|Overall Study|Lost to Follow-up|12|||
149972996|NCT04211363|541038572|FG001|Overall Study|Lost to Follow-up|4|||
149972997|NCT04211363|541038571|FG000|Overall Study|Withdrawal by Subject|11|||
149972998|NCT04211363|541038572|FG001|Overall Study|Withdrawal by Subject|11|||
149972999|NCT04211363|541038571|FG000|Overall Study|Other|1|||
149973000|NCT04211363|541038572|FG001|Overall Study|Other|2|||
149973001|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
149973002|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
149973003|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
149973004|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Death|0|||
149973005|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Death|0|||
149973006|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Death|1|||
149973007|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
149973008|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
149973009|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
149973010|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
149973011|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
149973012|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
149973013|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
149973014|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
149973015|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
149973016|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Graft loss|0|||
149973017|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Graft loss|0|||
149973018|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Graft loss|7|||
149973019|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
149973020|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
149973021|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
149973022|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
149973023|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
149973024|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
149973025|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
149973026|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
149973027|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
149973028|NCT00956293|541038576|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
149973029|NCT00956293|541038577|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
149973030|NCT00956293|541038578|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
149973031|NCT00956293|541038576|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
149973032|NCT00956293|541038577|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
149973033|NCT00956293|541038578|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
149973034|NCT00956293|541038576|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
149973035|NCT00956293|541038577|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
149973036|NCT00956293|541038578|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
149973037|NCT00956293|541038576|FG000|Main Period (Randomization)|Adverse Event|0|||
149973038|NCT00956293|541038577|FG001|Main Period (Randomization)|Adverse Event|15|||
149973039|NCT00956293|541038578|FG002|Main Period (Randomization)|Adverse Event|0|||
149973040|NCT00956293|541038576|FG000|Follow-up Period|Follow-up period was terminated.|20|||
149973041|NCT00956293|541038577|FG001|Follow-up Period|Follow-up period was terminated.|32|||
149973042|NCT00956293|541038578|FG002|Follow-up Period|Follow-up period was terminated.|0|||
149973043|NCT02359903|541038579|FG000|Overall Study|Adverse Event|0|||
149973044|NCT02359903|541038580|FG001|Overall Study|Adverse Event|2|||
149973045|NCT03383666|541038581|FG000|Overall Study|Withdrawal by Subject|2|||
149973046|NCT03383666|541038581|FG000|Overall Study|Lost to Follow-up|2|||
149973047|NCT02536664|541038582|FG000|Overall Study|Inadequate completion of documentation|2|||
149973048|NCT02536664|541038583|FG001|Overall Study|Inadequate completion of documentation|4|||
149973049|NCT02536664|541038582|FG000|Overall Study|Progression|13|||
149973050|NCT02536664|541038583|FG001|Overall Study|Progression|18|||
149973051|NCT02536664|541038582|FG000|Overall Study|Death due to lymphoma|2|||
149973052|NCT02536664|541038583|FG001|Overall Study|Death due to lymphoma|1|||
149973053|NCT02536664|541038582|FG000|Overall Study|Death due to other reason|3|||
149973054|NCT02536664|541038583|FG001|Overall Study|Death due to other reason|2|||
149973055|NCT02536664|541038582|FG000|Overall Study|Intolerability|8|||
149973056|NCT02536664|541038583|FG001|Overall Study|Intolerability|6|||
149973057|NCT02536664|541038582|FG000|Overall Study|Withdrawal by Subject|8|||
149973058|NCT02536664|541038583|FG001|Overall Study|Withdrawal by Subject|5|||
149973059|NCT02536664|541038582|FG000|Overall Study|Other|18|||
149973060|NCT02536664|541038583|FG001|Overall Study|Other|24|||
149973061|NCT02536664|541038582|FG000|Overall Study|Missing|53|||
149973062|NCT02536664|541038583|FG001|Overall Study|Missing|20|||
149973063|NCT03507127|541038591|FG000|Overall Study|Withdrawal by Subject|1|||
149915153|NCT00404924|540820506|FG000|Overall Study|Condition under investigation worsened|475|||
149915154|NCT00404924|540820507|FG001|Overall Study|Condition under investigation worsened|264|||
149915155|NCT00404924|540820506|FG000|Overall Study|Lost to Follow-up|1|||
149915156|NCT00404924|540820507|FG001|Overall Study|Lost to Follow-up|1|||
149915157|NCT00404924|540820506|FG000|Overall Study|Withdrawal by Subject|26|||
149915158|NCT00404924|540820507|FG001|Overall Study|Withdrawal by Subject|13|||
149915159|NCT00404924|540820506|FG000|Overall Study|Other|25|||
149915160|NCT00404924|540820507|FG001|Overall Study|Other|11|||
149915161|NCT00404924|540820506|FG000|Overall Study|Randomised but not received treatment|1|||
149915162|NCT00404924|540820507|FG001|Overall Study|Randomised but not received treatment|1|||
149915163|NCT00195494|540820514|FG000|Year 1|Adverse Event|0|||
149915164|NCT00195494|540820515|FG001|Year 1|Adverse Event|0|||
149915165|NCT00195494|540820516|FG002|Year 1|Adverse Event|0|||
149915166|NCT00195494|540820517|FG003|Year 1|Adverse Event|0|||
149915167|NCT00195494|540820518|FG004|Year 1|Adverse Event|34|||
149915168|NCT00195494|540820519|FG005|Year 1|Adverse Event|27|||
149915169|NCT00195494|540820514|FG000|Year 1|System Toxicity|0|||
149915170|NCT00195494|540820515|FG001|Year 1|System Toxicity|0|||
149915171|NCT00195494|540820516|FG002|Year 1|System Toxicity|0|||
149915172|NCT00195494|540820517|FG003|Year 1|System Toxicity|0|||
149915173|NCT00195494|540820518|FG004|Year 1|System Toxicity|0|||
149915174|NCT00195494|540820519|FG005|Year 1|System Toxicity|1|||
149915175|NCT00195494|540820514|FG000|Year 1|Lack of Efficacy|0|||
149915176|NCT00195494|540820515|FG001|Year 1|Lack of Efficacy|0|||
149915177|NCT00195494|540820516|FG002|Year 1|Lack of Efficacy|0|||
149915178|NCT00195494|540820517|FG003|Year 1|Lack of Efficacy|0|||
149915179|NCT00195494|540820518|FG004|Year 1|Lack of Efficacy|24|||
149915180|NCT00195494|540820519|FG005|Year 1|Lack of Efficacy|9|||
149915181|NCT00195494|540820514|FG000|Year 1|Compliance|0|||
149915182|NCT00195494|540820515|FG001|Year 1|Compliance|0|||
149915183|NCT00195494|540820516|FG002|Year 1|Compliance|0|||
149915184|NCT00195494|540820517|FG003|Year 1|Compliance|0|||
149915185|NCT00195494|540820518|FG004|Year 1|Compliance|5|||
149915186|NCT00195494|540820519|FG005|Year 1|Compliance|1|||
149915187|NCT00195494|540820514|FG000|Year 1|Lost to Follow-up|0|||
149915188|NCT00195494|540820515|FG001|Year 1|Lost to Follow-up|0|||
149915189|NCT00195494|540820516|FG002|Year 1|Lost to Follow-up|0|||
149915190|NCT00195494|540820517|FG003|Year 1|Lost to Follow-up|0|||
149915191|NCT00195494|540820518|FG004|Year 1|Lost to Follow-up|1|||
149915192|NCT00195494|540820519|FG005|Year 1|Lost to Follow-up|0|||
149915193|NCT00195494|540820514|FG000|Year 1|Missed >4 consecutive doses|0|||
149915194|NCT00195494|540820515|FG001|Year 1|Missed >4 consecutive doses|0|||
149915195|NCT00195494|540820516|FG002|Year 1|Missed >4 consecutive doses|0|||
149915196|NCT00195494|540820517|FG003|Year 1|Missed >4 consecutive doses|0|||
149915197|NCT00195494|540820518|FG004|Year 1|Missed >4 consecutive doses|3|||
149915198|NCT00195494|540820519|FG005|Year 1|Missed >4 consecutive doses|2|||
149915199|NCT00195494|540820514|FG000|Year 1|Protocol deviation|0|||
149915200|NCT00195494|540820515|FG001|Year 1|Protocol deviation|0|||
149915201|NCT00195494|540820516|FG002|Year 1|Protocol deviation|0|||
149915202|NCT00195494|540820517|FG003|Year 1|Protocol deviation|0|||
149915203|NCT00195494|540820518|FG004|Year 1|Protocol deviation|2|||
149915204|NCT00195494|540820519|FG005|Year 1|Protocol deviation|3|||
149915205|NCT00195494|540820514|FG000|Year 1|Physician Decision|0|||
149915206|NCT00195494|540820515|FG001|Year 1|Physician Decision|0|||
149915207|NCT00195494|540820516|FG002|Year 1|Physician Decision|0|||
149915208|NCT00195494|540820517|FG003|Year 1|Physician Decision|0|||
149915209|NCT00195494|540820518|FG004|Year 1|Physician Decision|1|||
149915210|NCT00195494|540820519|FG005|Year 1|Physician Decision|0|||
149915211|NCT00195494|540820514|FG000|Year 1|Withdrawal by Subject|0|||
149915212|NCT00195494|540820515|FG001|Year 1|Withdrawal by Subject|0|||
149915213|NCT00195494|540820516|FG002|Year 1|Withdrawal by Subject|0|||
149915214|NCT00195494|540820517|FG003|Year 1|Withdrawal by Subject|0|||
149915215|NCT00195494|540820518|FG004|Year 1|Withdrawal by Subject|8|||
149915216|NCT00195494|540820519|FG005|Year 1|Withdrawal by Subject|9|||
149915217|NCT00195494|540820514|FG000|Year 1|Protocol Violation|0|||
149915218|NCT00195494|540820515|FG001|Year 1|Protocol Violation|0|||
149915219|NCT00195494|540820516|FG002|Year 1|Protocol Violation|0|||
149915220|NCT00195494|540820517|FG003|Year 1|Protocol Violation|0|||
149915221|NCT00195494|540820518|FG004|Year 1|Protocol Violation|1|||
149915222|NCT00195494|540820519|FG005|Year 1|Protocol Violation|1|||
149915223|NCT00195494|540820514|FG000|Year 2|Adverse Event|3|||
149915224|NCT00195494|540820515|FG001|Year 2|Adverse Event|7|||
149915225|NCT00195494|540820516|FG002|Year 2|Adverse Event|5|||
149915226|NCT00195494|540820517|FG003|Year 2|Adverse Event|9|||
149915227|NCT00195494|540820518|FG004|Year 2|Adverse Event|0|||
149915228|NCT00195494|540820519|FG005|Year 2|Adverse Event|0|||
149915229|NCT00195494|540820514|FG000|Year 2|Lack of Efficacy|0|||
149915230|NCT00195494|540820515|FG001|Year 2|Lack of Efficacy|1|||
149915231|NCT00195494|540820516|FG002|Year 2|Lack of Efficacy|7|||
149915232|NCT00195494|540820517|FG003|Year 2|Lack of Efficacy|7|||
149915233|NCT00195494|540820518|FG004|Year 2|Lack of Efficacy|0|||
149915234|NCT00195494|540820519|FG005|Year 2|Lack of Efficacy|0|||
149915235|NCT00195494|540820514|FG000|Year 2|Compliance|1|||
149915236|NCT00195494|540820515|FG001|Year 2|Compliance|0|||
149915237|NCT00195494|540820516|FG002|Year 2|Compliance|0|||
149915238|NCT00195494|540820517|FG003|Year 2|Compliance|2|||
150051071|NCT01290796|541329100|FG000|Overall Study|Secondary Surgical Intervention|2|||
150051072|NCT01290796|541329100|FG000|Overall Study|Withdrawal by Sponsor|1|||
150051073|NCT02709538|541329102|FG000|Overall Study|Adverse Event|13|||
150051074|NCT02709538|541329103|FG001|Overall Study|Adverse Event|2|||
150051075|NCT02709538|541329104|FG002|Overall Study|Adverse Event|3|||
150051076|NCT02709538|541329102|FG000|Overall Study|Lack of Efficacy|1|||
150051077|NCT02709538|541329103|FG001|Overall Study|Lack of Efficacy|0|||
150051078|NCT02709538|541329104|FG002|Overall Study|Lack of Efficacy|0|||
150051079|NCT02709538|541329102|FG000|Overall Study|Lost to Follow-up|24|||
150051080|NCT02709538|541329103|FG001|Overall Study|Lost to Follow-up|8|||
150051081|NCT02709538|541329104|FG002|Overall Study|Lost to Follow-up|4|||
150051082|NCT02709538|541329102|FG000|Overall Study|Physician Decision|1|||
150051083|NCT02709538|541329103|FG001|Overall Study|Physician Decision|0|||
150051084|NCT02709538|541329104|FG002|Overall Study|Physician Decision|0|||
150051085|NCT02709538|541329102|FG000|Overall Study|Withdrawal by Subject|40|||
150051086|NCT02709538|541329103|FG001|Overall Study|Withdrawal by Subject|7|||
150051087|NCT02709538|541329104|FG002|Overall Study|Withdrawal by Subject|4|||
150051088|NCT02709538|541329102|FG000|Overall Study|Non-compliance with study procedures|5|||
150051089|NCT02709538|541329103|FG001|Overall Study|Non-compliance with study procedures|0|||
150051090|NCT02709538|541329104|FG002|Overall Study|Non-compliance with study procedures|0|||
150051091|NCT02709538|541329102|FG000|Overall Study|Non-compliance with study drug|2|||
150051092|NCT02709538|541329103|FG001|Overall Study|Non-compliance with study drug|0|||
150051093|NCT02709538|541329104|FG002|Overall Study|Non-compliance with study drug|0|||
150051094|NCT02709538|541329102|FG000|Overall Study|Protocol deviation|10|||
150051095|NCT02709538|541329103|FG001|Overall Study|Protocol deviation|4|||
150051096|NCT02709538|541329104|FG002|Overall Study|Protocol deviation|4|||
150051097|NCT02709538|541329102|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
150051098|NCT02709538|541329103|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
150051099|NCT02709538|541329104|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
150051100|NCT02709538|541329102|FG000|Overall Study|Other|16|||
150051101|NCT02709538|541329103|FG001|Overall Study|Other|7|||
150051102|NCT02709538|541329104|FG002|Overall Study|Other|5|||
150051103|NCT00835211|541329106|FG000|First Intervention|Withdrawal by Subject|0|||
150051104|NCT00835211|541329107|FG001|First Intervention|Withdrawal by Subject|1|||
150051105|NCT00835211|541329106|FG000|Washout: 7 Days|Adverse Event|2|||
150051106|NCT00835211|541329107|FG001|Washout: 7 Days|Adverse Event|1|||
150051107|NCT00835211|541329106|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
150051108|NCT00835211|541329107|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
150051109|NCT02343549|541329109|FG000|Overall Study|Death|11|||
150051110|NCT02343549|541329109|FG000|Overall Study|Withdrawal by Subject|2|||
150051111|NCT03087617|541329110|FG000|Overall Study|Lost to Follow-up|32|||
150051112|NCT03087617|541329111|FG001|Overall Study|Lost to Follow-up|30|||
150051113|NCT03087617|541329112|FG002|Overall Study|Lost to Follow-up|30|||
150051114|NCT03087617|541329113|FG003|Overall Study|Lost to Follow-up|39|||
150051115|NCT02160041|541329115|FG000|Overall Study|Adverse Event|11|||
150051116|NCT02160041|541329115|FG000|Overall Study|Death|2|||
150051117|NCT02160041|541329115|FG000|Overall Study|disease progression|57|||
150051118|NCT02160041|541329115|FG000|Overall Study|Protocol Violation|1|||
150051119|NCT02160041|541329115|FG000|Overall Study|non-compliance with study|1|||
150051120|NCT02160041|541329115|FG000|Overall Study|Physician Decision|3|||
150051121|NCT02160041|541329115|FG000|Overall Study|Withdrawal by Subject|8|||
150051122|NCT02160041|541329115|FG000|Overall Study|study terminated by by sponsor|1|||
150051123|NCT01403948|541329116|FG000|Overall Study|Progressive disease|0|||
150051124|NCT01403948|541329117|FG001|Overall Study|Progressive disease|2|||
150051125|NCT01403948|541329118|FG002|Overall Study|Progressive disease|2|||
150051126|NCT01403948|541329119|FG003|Overall Study|Progressive disease|4|||
150051127|NCT01403948|541329120|FG004|Overall Study|Progressive disease|2|||
150051128|NCT01403948|541329121|FG005|Overall Study|Progressive disease|6|||
150051129|NCT01403948|541329122|FG006|Overall Study|Progressive disease|2|||
150051130|NCT01403948|541329123|FG007|Overall Study|Progressive disease|4|||
150051131|NCT01403948|541329124|FG008|Overall Study|Progressive disease|5|||
150051132|NCT01403948|541329125|FG009|Overall Study|Progressive disease|5|||
150051133|NCT01403948|541329116|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051134|NCT01403948|541329117|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051135|NCT01403948|541329118|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051136|NCT01403948|541329119|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051137|NCT01403948|541329120|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
150051138|NCT01403948|541329121|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051139|NCT01403948|541329122|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
150051140|NCT01403948|541329123|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051141|NCT01403948|541329124|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
150051142|NCT01403948|541329125|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
150051143|NCT01403948|541329116|FG000|Overall Study|Lost to Follow-up|0|||
150051144|NCT01403948|541329117|FG001|Overall Study|Lost to Follow-up|0|||
150051145|NCT01403948|541329118|FG002|Overall Study|Lost to Follow-up|0|||
150051146|NCT01403948|541329119|FG003|Overall Study|Lost to Follow-up|0|||
150051147|NCT01403948|541329120|FG004|Overall Study|Lost to Follow-up|0|||
150051148|NCT01403948|541329121|FG005|Overall Study|Lost to Follow-up|0|||
150051149|NCT01403948|541329122|FG006|Overall Study|Lost to Follow-up|0|||
150051150|NCT01403948|541329123|FG007|Overall Study|Lost to Follow-up|0|||
150051151|NCT01403948|541329124|FG008|Overall Study|Lost to Follow-up|0|||
150051152|NCT01403948|541329125|FG009|Overall Study|Lost to Follow-up|1|||
149915239|NCT00195494|540820518|FG004|Year 2|Compliance|0|||
149915240|NCT00195494|540820519|FG005|Year 2|Compliance|0|||
149915241|NCT00195494|540820514|FG000|Year 2|Lost to Follow-up|0|||
149915242|NCT00195494|540820515|FG001|Year 2|Lost to Follow-up|0|||
149915243|NCT00195494|540820516|FG002|Year 2|Lost to Follow-up|1|||
149915244|NCT00195494|540820517|FG003|Year 2|Lost to Follow-up|1|||
149915245|NCT00195494|540820518|FG004|Year 2|Lost to Follow-up|0|||
149915246|NCT00195494|540820519|FG005|Year 2|Lost to Follow-up|0|||
149915247|NCT00195494|540820514|FG000|Year 2|Missed >4 consecutive doses|1|||
149915248|NCT00195494|540820515|FG001|Year 2|Missed >4 consecutive doses|1|||
149915249|NCT00195494|540820516|FG002|Year 2|Missed >4 consecutive doses|1|||
149915250|NCT00195494|540820517|FG003|Year 2|Missed >4 consecutive doses|0|||
149915251|NCT00195494|540820518|FG004|Year 2|Missed >4 consecutive doses|0|||
149915252|NCT00195494|540820519|FG005|Year 2|Missed >4 consecutive doses|0|||
149915253|NCT00195494|540820514|FG000|Year 2|Protocol deviation|0|||
149915254|NCT00195494|540820515|FG001|Year 2|Protocol deviation|1|||
149915255|NCT00195494|540820516|FG002|Year 2|Protocol deviation|0|||
150051153|NCT01403948|541329116|FG000|Overall Study|Refused cont. medication|0|||
150051154|NCT01403948|541329117|FG001|Overall Study|Refused cont. medication|0|||
150051155|NCT01403948|541329118|FG002|Overall Study|Refused cont. medication|0|||
150051156|NCT01403948|541329119|FG003|Overall Study|Refused cont. medication|0|||
150051157|NCT01403948|541329120|FG004|Overall Study|Refused cont. medication|1|||
150051158|NCT01403948|541329121|FG005|Overall Study|Refused cont. medication|0|||
150051159|NCT01403948|541329122|FG006|Overall Study|Refused cont. medication|0|||
150051160|NCT01403948|541329123|FG007|Overall Study|Refused cont. medication|0|||
150051161|NCT01403948|541329124|FG008|Overall Study|Refused cont. medication|0|||
150051162|NCT01403948|541329125|FG009|Overall Study|Refused cont. medication|1|||
150051163|NCT01403948|541329116|FG000|Overall Study|other than above|1|||
150051164|NCT01403948|541329117|FG001|Overall Study|other than above|2|||
150051165|NCT01403948|541329118|FG002|Overall Study|other than above|1|||
150051166|NCT01403948|541329119|FG003|Overall Study|other than above|0|||
150051167|NCT01403948|541329120|FG004|Overall Study|other than above|1|||
150051168|NCT01403948|541329121|FG005|Overall Study|other than above|1|||
150051169|NCT01403948|541329122|FG006|Overall Study|other than above|2|||
150051170|NCT01403948|541329123|FG007|Overall Study|other than above|0|||
150051171|NCT01403948|541329124|FG008|Overall Study|other than above|0|||
150051172|NCT01403948|541329125|FG009|Overall Study|other than above|0|||
150051173|NCT04450381|541329126|FG000|Overall Study|Protocol Violation|4|||
150051174|NCT04450381|541329126|FG000|Overall Study|Wrong device setting|2|||
150051175|NCT01090323|541329127|FG000|Overall Study|Adverse Event|12|||
150051176|NCT01090323|541329128|FG001|Overall Study|Adverse Event|2|||
150051177|NCT01090323|541329127|FG000|Overall Study|Abnormal Lab Values|3|||
150051178|NCT01090323|541329128|FG001|Overall Study|Abnormal Lab Values|1|||
150051179|NCT01090323|541329127|FG000|Overall Study|Abnormal Test Procedure Results|2|||
150051180|NCT01090323|541329128|FG001|Overall Study|Abnormal Test Procedure Results|0|||
150051181|NCT01090323|541329127|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149915256|NCT00195494|540820517|FG003|Year 2|Protocol deviation|0|||
149915257|NCT00195494|540820518|FG004|Year 2|Protocol deviation|0|||
150051182|NCT01090323|541329128|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150051183|NCT01090323|541329127|FG000|Overall Study|Condition no longer requires drug|5|||
150051184|NCT01090323|541329128|FG001|Overall Study|Condition no longer requires drug|4|||
150051185|NCT01090323|541329127|FG000|Overall Study|Protocol Violation|2|||
150051186|NCT01090323|541329128|FG001|Overall Study|Protocol Violation|1|||
150051187|NCT01090323|541329127|FG000|Overall Study|Withdrew consent|33|||
150051188|NCT01090323|541329128|FG001|Overall Study|Withdrew consent|11|||
150051189|NCT01090323|541329127|FG000|Overall Study|Lost to Follow-up|11|||
150051190|NCT01090323|541329128|FG001|Overall Study|Lost to Follow-up|6|||
150051191|NCT01090323|541329127|FG000|Overall Study|Administrative problems|6|||
150051192|NCT01090323|541329128|FG001|Overall Study|Administrative problems|4|||
150051193|NCT01090323|541329127|FG000|Overall Study|Death|1|||
150051194|NCT01090323|541329128|FG001|Overall Study|Death|2|||
150051195|NCT01090323|541329127|FG000|Overall Study|Stopped end of core|7|||
150051196|NCT01090323|541329128|FG001|Overall Study|Stopped end of core|0|||
150051197|NCT01090323|541329127|FG000|Overall Study|Stopped end of extension 1#|3|||
150051198|NCT01090323|541329128|FG001|Overall Study|Stopped end of extension 1#|1|||
150051199|NCT05498701|541329129|FG000|Period 3|Adverse Event|1|||
150051200|NCT05498701|541329130|FG001|Period 3|Adverse Event|0|||
149915258|NCT00195494|540820519|FG005|Year 2|Protocol deviation|0|||
149915259|NCT00195494|540820514|FG000|Year 2|Physician Decision|1|||
149915260|NCT00195494|540820515|FG001|Year 2|Physician Decision|1|||
150051201|NCT01864005|541329131|FG000|Overall Study|Protocol Violation|0|||
149915261|NCT00195494|540820516|FG002|Year 2|Physician Decision|0|||
149915262|NCT00195494|540820517|FG003|Year 2|Physician Decision|0|||
149915263|NCT00195494|540820518|FG004|Year 2|Physician Decision|0|||
150051202|NCT01864005|541329132|FG001|Overall Study|Protocol Violation|1|||
150051203|NCT01864005|541329131|FG000|Overall Study|Withdrawal by Subject|0|||
150051204|NCT01864005|541329132|FG001|Overall Study|Withdrawal by Subject|1|||
149915264|NCT00195494|540820519|FG005|Year 2|Physician Decision|0|||
149915265|NCT00195494|540820514|FG000|Year 2|Withdrawal by Subject|1|||
149915266|NCT00195494|540820515|FG001|Year 2|Withdrawal by Subject|5|||
149915267|NCT00195494|540820516|FG002|Year 2|Withdrawal by Subject|4|||
150051205|NCT01864005|541329131|FG000|Overall Study|Incorrect enrolment|1|||
150051206|NCT01864005|541329132|FG001|Overall Study|Incorrect enrolment|0|||
150051207|NCT01864005|541329131|FG000|Overall Study|Disease need|1|||
150051208|NCT01864005|541329132|FG001|Overall Study|Disease need|1|||
150051209|NCT01864005|541329131|FG000|Overall Study|Need GP IIb/IIIa|1|||
150051210|NCT01864005|541329132|FG001|Overall Study|Need GP IIb/IIIa|3|||
150051211|NCT00763698|541329138|FG000|Overall Study|Unsuccessful Implant|5|||
150051212|NCT00763698|541329138|FG000|Overall Study|Death|4|||
150051213|NCT00763698|541329138|FG000|Overall Study|Withdrawal by Subject|1|||
150051214|NCT02184572|541329139|FG000|Overall Study|Lost to Follow-up|29|||
150051215|NCT02184572|541329140|FG001|Overall Study|Lost to Follow-up|21|||
150051216|NCT02184572|541329139|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
150051217|NCT02184572|541329140|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
150051218|NCT02184572|541329139|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
150051219|NCT02184572|541329140|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
150051220|NCT02184572|541329139|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
150051221|NCT02184572|541329140|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
150051222|NCT02184572|541329139|FG000|Overall Study|Traveling Outside The Country|1|||
150051223|NCT02184572|541329140|FG001|Overall Study|Traveling Outside The Country|0|||
150051224|NCT02184572|541329139|FG000|Overall Study|Withdrawal by Subject|14|||
150051225|NCT02184572|541329140|FG001|Overall Study|Withdrawal by Subject|9|||
150051226|NCT00006409|541329144|FG000|Baseline|Protocol Violation|48|||
150051227|NCT00006409|541329145|FG001|Baseline|Protocol Violation|70|||
149915268|NCT00195494|540820517|FG003|Year 2|Withdrawal by Subject|3|||
149915269|NCT00195494|540820518|FG004|Year 2|Withdrawal by Subject|0|||
149915270|NCT00195494|540820519|FG005|Year 2|Withdrawal by Subject|0|||
149915271|NCT00195494|540820514|FG000|Year 2|System toxicity|0|||
149915272|NCT00195494|540820515|FG001|Year 2|System toxicity|0|||
149915273|NCT00195494|540820516|FG002|Year 2|System toxicity|0|||
149915274|NCT00195494|540820517|FG003|Year 2|System toxicity|1|||
149915275|NCT00195494|540820518|FG004|Year 2|System toxicity|0|||
149915276|NCT00195494|540820519|FG005|Year 2|System toxicity|0|||
149915277|NCT00926536|540820523|FG000|Overall Study|Physician Decision|1|||
149915278|NCT00926536|540820524|FG001|Overall Study|Physician Decision|2|||
149915279|NCT01267201|540820525|FG000|First Intervention Period|Withdrawal by Subject|1|||
149915280|NCT01267201|540820526|FG001|First Intervention Period|Withdrawal by Subject|0|||
149915281|NCT01267201|540820527|FG002|First Intervention Period|Withdrawal by Subject|0|||
149915282|NCT01267201|540820528|FG003|First Intervention Period|Withdrawal by Subject|0|||
149915283|NCT01267201|540820529|FG004|First Intervention Period|Withdrawal by Subject|0|||
149915284|NCT01267201|540820530|FG005|First Intervention Period|Withdrawal by Subject|0|||
149915285|NCT01267201|540820525|FG000|Second Intervention Period|Withdrawal by Subject|0|||
149915286|NCT01267201|540820526|FG001|Second Intervention Period|Withdrawal by Subject|1|||
149915287|NCT01267201|540820527|FG002|Second Intervention Period|Withdrawal by Subject|0|||
149915288|NCT01267201|540820528|FG003|Second Intervention Period|Withdrawal by Subject|0|||
149915289|NCT01267201|540820529|FG004|Second Intervention Period|Withdrawal by Subject|0|||
149915290|NCT01267201|540820530|FG005|Second Intervention Period|Withdrawal by Subject|0|||
149915291|NCT00501059|540820531|FG000|Overall Study|Protocol Violation|80|||
149915292|NCT00501059|540820532|FG001|Overall Study|Protocol Violation|69|||
149915293|NCT00501059|540820531|FG000|Overall Study|Death|140|||
150051228|NCT00006409|541329146|FG002|Baseline|Protocol Violation|0|||
149915294|NCT00501059|540820532|FG001|Overall Study|Death|137|||
149915295|NCT00501059|540820531|FG000|Overall Study|Other|236|||
149915296|NCT00501059|540820532|FG001|Overall Study|Other|239|||
149915297|NCT00501059|540820531|FG000|Overall Study|Missing end-of-study page|91|||
149915298|NCT00501059|540820532|FG001|Overall Study|Missing end-of-study page|92|||
150051229|NCT00006409|541329147|FG003|Baseline|Protocol Violation|0|||
150051230|NCT00006409|541329148|FG004|Baseline|Protocol Violation|0|||
150051231|NCT00006409|541329149|FG005|Baseline|Protocol Violation|0|||
149915299|NCT00501059|540820531|FG000|Overall Study|Clinical endpoint reached|110|||
150051232|NCT00006409|541329144|FG000|Post-2 Year Intervention|Protocol Violation|0|||
150051233|NCT00006409|541329145|FG001|Post-2 Year Intervention|Protocol Violation|0|||
150051234|NCT00006409|541329146|FG002|Post-2 Year Intervention|Protocol Violation|251|||
150051235|NCT00006409|541329147|FG003|Post-2 Year Intervention|Protocol Violation|168|||
150051236|NCT00006409|541329148|FG004|Post-2 Year Intervention|Protocol Violation|0|||
149915300|NCT00501059|540820532|FG001|Overall Study|Clinical endpoint reached|123|||
149915301|NCT00501059|540820531|FG000|Overall Study|Insufficient therapeutic effect|4|||
149915302|NCT00501059|540820532|FG001|Overall Study|Insufficient therapeutic effect|5|||
149915303|NCT00501059|540820531|FG000|Overall Study|Consent withdrawn by subject|817|||
149915304|NCT00501059|540820532|FG001|Overall Study|Consent withdrawn by subject|873|||
149915305|NCT00501059|540820531|FG000|Overall Study|Non-compliant with study treatment|23|||
149915306|NCT00501059|540820532|FG001|Overall Study|Non-compliant with study treatment|16|||
149915307|NCT00501059|540820531|FG000|Overall Study|Reason not given|3|||
149915308|NCT00501059|540820532|FG001|Overall Study|Reason not given|1|||
149915309|NCT00501059|540820531|FG000|Overall Study|Adverse Event|129|||
149915310|NCT00501059|540820532|FG001|Overall Study|Adverse Event|122|||
149915311|NCT00501059|540820531|FG000|Overall Study|Lost to Follow-up|210|||
149915312|NCT00501059|540820532|FG001|Overall Study|Lost to Follow-up|198|||
149915313|NCT00501059|540820531|FG000|Overall Study|Not treated|25|||
149915314|NCT00501059|540820532|FG001|Overall Study|Not treated|17|||
149915315|NCT02124759|540820533|FG000|Overall Study|Withdrawal by Subject|3|||
149915316|NCT02124759|540820534|FG001|Overall Study|Withdrawal by Subject|1|||
149915317|NCT02124759|540820535|FG002|Overall Study|Withdrawal by Subject|1|||
149915318|NCT02124759|540820533|FG000|Overall Study|Screen Fail|2|||
149915319|NCT02124759|540820534|FG001|Overall Study|Screen Fail|2|||
149915320|NCT02124759|540820535|FG002|Overall Study|Screen Fail|3|||
149915321|NCT04249622|540820538|FG000|Overall Study|Withdrawal by Subject|1|||
149915322|NCT04249622|540820539|FG001|Overall Study|Withdrawal by Subject|1|||
149915323|NCT04249622|540820538|FG000|Overall Study|Alternative therapy|1|||
149915324|NCT04249622|540820539|FG001|Overall Study|Alternative therapy|0|||
149915325|NCT04249622|540820538|FG000|Overall Study|Discontinuation of pertuzumab|1|||
149915326|NCT04249622|540820539|FG001|Overall Study|Discontinuation of pertuzumab|0|||
149915327|NCT03627416|540820540|FG000|Overall Study|Adverse Event|0|||
149915328|NCT03627416|540820541|FG001|Overall Study|Adverse Event|1|||
149915329|NCT00875433|540820542|FG000|Overall Study|Progressive disease|41|||
149915330|NCT00875433|540820542|FG000|Overall Study|Other Adverse Event|14|||
149915331|NCT00875433|540820542|FG000|Overall Study|Withdrawal by Subject|2|||
149915332|NCT00875433|540820542|FG000|Overall Study|Other|3|||
149915333|NCT02923245|540820543|FG000|Overall Study|ultrasound order was cancelled|2|||
149915334|NCT02923245|540820544|FG001|Overall Study|ultrasound order was cancelled|1|||
149915335|NCT02093390|540820547|FG000|Overall Study|Withdrawal by Subject|0|||
149915336|NCT02093390|540820548|FG001|Overall Study|Withdrawal by Subject|1|||
149915337|NCT02824562|540822146|FG000|Overall Study|Lost to Follow-up|3|||
149915338|NCT02824562|540822147|FG001|Overall Study|Lost to Follow-up|4|||
149915339|NCT02824562|540822146|FG000|Overall Study|Death|0|||
149915340|NCT02824562|540822147|FG001|Overall Study|Death|1|||
149915341|NCT03246061|540822148|FG000|Overall Study|Still in follow-up|15|||
149915342|NCT03246061|540822149|FG001|Overall Study|Still in follow-up|21|||
149915343|NCT02864316|540822154|FG000|Overall Study|Progressive Disease|2|||
149915344|NCT02864316|540822155|FG001|Overall Study|Progressive Disease|1|||
149915345|NCT02864316|540822154|FG000|Overall Study|Adverse Event|0|||
149915346|NCT02864316|540822155|FG001|Overall Study|Adverse Event|1|||
149915347|NCT04710368|540822156|FG000|Overall Study|Withdrawal by Subject|9|||
149915348|NCT04710368|540822156|FG000|Overall Study|Lost to Follow-up|4|||
149915349|NCT04710368|540822156|FG000|Overall Study|Death|2|||
149915350|NCT04710368|540822156|FG000|Overall Study|Patient preference|11|||
149915351|NCT04710368|540822156|FG000|Overall Study|Treatment discontinuation|1|||
149915352|NCT05459558|540822157|FG000|Overall Study|Adverse Event|1|||
149915353|NCT05459558|540822158|FG001|Overall Study|Adverse Event|0|||
149915354|NCT05459558|540822159|FG002|Overall Study|Adverse Event|0|||
149915355|NCT05459558|540822157|FG000|Overall Study|Scheduling issue|0|||
149915356|NCT05459558|540822158|FG001|Overall Study|Scheduling issue|1|||
149915357|NCT05459558|540822159|FG002|Overall Study|Scheduling issue|3|||
149915358|NCT05459558|540822157|FG000|Overall Study|Withdrawal by Subject|0|||
149915359|NCT05459558|540822158|FG001|Overall Study|Withdrawal by Subject|0|||
149915360|NCT05459558|540822159|FG002|Overall Study|Withdrawal by Subject|2|||
149915361|NCT01887288|540822164|FG000|Overall Study|The study was terminated and the PI has|16|||
149915362|NCT01092637|540822165|FG000|Overall Study|Death|47|||
149915363|NCT01092637|540822166|FG001|Overall Study|Death|49|||
149915364|NCT02921750|540822167|FG000|Overall Study|Adverse Event|1|||
149915365|NCT02921750|540822168|FG001|Overall Study|Adverse Event|2|||
149915366|NCT02921750|540822167|FG000|Overall Study|Withdrawal by Subject|1|||
149915367|NCT02921750|540822168|FG001|Overall Study|Withdrawal by Subject|1|||
149915368|NCT02921750|540822167|FG000|Overall Study|Lost to Follow-up|3|||
149915369|NCT02921750|540822168|FG001|Overall Study|Lost to Follow-up|3|||
149915370|NCT02921750|540822167|FG000|Overall Study|Wound healed|3|||
149915371|NCT02921750|540822168|FG001|Overall Study|Wound healed|3|||
149915372|NCT02921750|540822167|FG000|Overall Study|Serious Adverse Event|1|||
149915373|NCT02921750|540822168|FG001|Overall Study|Serious Adverse Event|2|||
149915374|NCT00114738|540822173|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
149915375|NCT00114738|540822174|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
149915376|NCT00114738|540822175|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
149915377|NCT00114738|540822173|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
149915378|NCT00114738|540822174|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
149915379|NCT00114738|540822175|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
149915380|NCT00114738|540822173|FG000|Screening for Randomization|Neuropathy|17|||
149915381|NCT00114738|540822174|FG001|Screening for Randomization|Neuropathy|0|||
149915382|NCT00114738|540822175|FG002|Screening for Randomization|Neuropathy|0|||
149915383|NCT00114738|540822173|FG000|Screening for Randomization|Progressive disease|2|||
149915384|NCT00114738|540822174|FG001|Screening for Randomization|Progressive disease|0|||
149915385|NCT00114738|540822175|FG002|Screening for Randomization|Progressive disease|0|||
149915386|NCT00114738|540822173|FG000|Screening for Randomization|CNS Hemorrhage|1|||
149915387|NCT00114738|540822174|FG001|Screening for Randomization|CNS Hemorrhage|0|||
149915388|NCT00114738|540822175|FG002|Screening for Randomization|CNS Hemorrhage|0|||
149915389|NCT00114738|540822173|FG000|Screening for Randomization|Other|1|||
149915390|NCT00114738|540822174|FG001|Screening for Randomization|Other|0|||
149915391|NCT00114738|540822175|FG002|Screening for Randomization|Other|0|||
149915392|NCT01149421|540822176|FG000|Overall Study|Adverse Event|22|||
149915393|NCT01149421|540822177|FG001|Overall Study|Adverse Event|6|||
149915394|NCT01149421|540822178|FG002|Overall Study|Adverse Event|11|||
149915395|NCT01149421|540822176|FG000|Overall Study|Withdrawal by Subject|20|||
149915396|NCT01149421|540822177|FG001|Overall Study|Withdrawal by Subject|12|||
149915397|NCT01149421|540822178|FG002|Overall Study|Withdrawal by Subject|13|||
149915398|NCT01149421|540822176|FG000|Overall Study|Sponsor Decision|0|||
149915399|NCT01149421|540822177|FG001|Overall Study|Sponsor Decision|1|||
149915400|NCT01149421|540822178|FG002|Overall Study|Sponsor Decision|1|||
149915401|NCT01149421|540822176|FG000|Overall Study|Lost to Follow-up|2|||
149915402|NCT01149421|540822177|FG001|Overall Study|Lost to Follow-up|4|||
149915403|NCT01149421|540822178|FG002|Overall Study|Lost to Follow-up|5|||
149915404|NCT01149421|540822176|FG000|Overall Study|Physician Decision|5|||
149915405|NCT01149421|540822177|FG001|Overall Study|Physician Decision|3|||
149915406|NCT01149421|540822178|FG002|Overall Study|Physician Decision|6|||
149915407|NCT01149421|540822176|FG000|Overall Study|Entry Criteria Not Met|1|||
149915408|NCT01149421|540822177|FG001|Overall Study|Entry Criteria Not Met|1|||
149915409|NCT01149421|540822178|FG002|Overall Study|Entry Criteria Not Met|2|||
149973064|NCT03507127|541038592|FG001|Overall Study|Withdrawal by Subject|0|||
149973065|NCT03507127|541038591|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
149973066|NCT03507127|541038592|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
149973067|NCT01240863|541038593|FG000|Open-label Titration Period|Adverse Event|47|||
149973068|NCT01240863|541038594|FG001|Open-label Titration Period|Adverse Event|0|||
149973069|NCT01240863|541038595|FG002|Open-label Titration Period|Adverse Event|0|||
149973070|NCT01240863|541038593|FG000|Open-label Titration Period|Lack of Efficacy|19|||
149973071|NCT01240863|541038594|FG001|Open-label Titration Period|Lack of Efficacy|0|||
149973072|NCT01240863|541038595|FG002|Open-label Titration Period|Lack of Efficacy|0|||
149973073|NCT01240863|541038593|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
149973074|NCT01240863|541038594|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
149973075|NCT01240863|541038595|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
149973076|NCT01240863|541038593|FG000|Open-label Titration Period|Protocol Violation|7|||
149973077|NCT01240863|541038594|FG001|Open-label Titration Period|Protocol Violation|0|||
149973078|NCT01240863|541038595|FG002|Open-label Titration Period|Protocol Violation|0|||
149973079|NCT01240863|541038593|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
149973080|NCT01240863|541038594|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
149973081|NCT01240863|541038595|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
149973082|NCT01240863|541038593|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
149973083|NCT01240863|541038594|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
149973084|NCT01240863|541038595|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
149973085|NCT01240863|541038593|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
149973086|NCT01240863|541038594|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
149973087|NCT01240863|541038595|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
149973088|NCT01240863|541038593|FG000|Open-label Titration Period|Other|7|||
149973089|NCT01240863|541038594|FG001|Open-label Titration Period|Other|0|||
149973090|NCT01240863|541038595|FG002|Open-label Titration Period|Other|0|||
149973091|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
149973092|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
149973093|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
149973094|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149973095|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
149973096|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
149973097|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149973098|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
149973099|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
149973100|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
149973101|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
149973102|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
149973103|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
149915410|NCT01149421|540822176|FG000|Overall Study|Protocol Violation|2|||
149915411|NCT01149421|540822177|FG001|Overall Study|Protocol Violation|2|||
149915412|NCT01149421|540822178|FG002|Overall Study|Protocol Violation|6|||
149915413|NCT03738800|540822179|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
149915414|NCT03738800|540822180|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
149915415|NCT03738800|540822181|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149915416|NCT03738800|540822179|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
149915417|NCT03738800|540822180|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
149915418|NCT03738800|540822181|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
149915419|NCT03738800|540822179|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
149915420|NCT03738800|540822180|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
149915421|NCT03738800|540822181|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
149915422|NCT00766467|540822182|FG000|Overall Study|Withdrawal by Subject|7|||
149915423|NCT00766467|540822183|FG001|Overall Study|Withdrawal by Subject|2|||
149915424|NCT00766467|540822182|FG000|Overall Study|Adverse Event|1|||
149915425|NCT00766467|540822183|FG001|Overall Study|Adverse Event|1|||
149915426|NCT00766467|540822182|FG000|Overall Study|Protocol Violation|2|||
149915427|NCT00766467|540822183|FG001|Overall Study|Protocol Violation|4|||
149915428|NCT00766467|540822182|FG000|Overall Study|Tumor Progression on Study|0|||
149915429|NCT00766467|540822183|FG001|Overall Study|Tumor Progression on Study|1|||
149915430|NCT00766467|540822182|FG000|Overall Study|Physician Decision|1|||
149915431|NCT00766467|540822183|FG001|Overall Study|Physician Decision|0|||
149915432|NCT02223819|540822186|FG000|Overall Study|Lost to Follow-up|2|||
149915433|NCT03329248|540822199|FG000|Overall Study|Progressive Disease|6|||
149915434|NCT01522235|540822200|FG000|Overall Study|Physician Decision|1|||
149915435|NCT01522235|540822201|FG001|Overall Study|Physician Decision|1|||
149915436|NCT03769194|540822202|FG000|Overall Study|Withdrawal by Subject|0|||
149915437|NCT03769194|540822203|FG001|Overall Study|Withdrawal by Subject|7|||
149915438|NCT03769194|540822204|FG002|Overall Study|Withdrawal by Subject|4|||
149915439|NCT03769194|540822205|FG003|Overall Study|Withdrawal by Subject|1|||
149915440|NCT03769194|540822202|FG000|Overall Study|moved from study area|0|||
149915441|NCT03769194|540822203|FG001|Overall Study|moved from study area|2|||
149915442|NCT03769194|540822204|FG002|Overall Study|moved from study area|1|||
149915443|NCT03769194|540822205|FG003|Overall Study|moved from study area|1|||
149915444|NCT03769194|540822202|FG000|Overall Study|Lost to Follow-up|3|||
149915445|NCT03769194|540822203|FG001|Overall Study|Lost to Follow-up|6|||
149973104|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
149973105|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
149973106|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
149973107|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
149973108|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
149973109|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
149973110|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
149973111|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
149973112|NCT01240863|541038593|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
149973113|NCT01240863|541038594|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
149973114|NCT01240863|541038595|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
149973115|NCT00746811|541038600|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
149973116|NCT00746811|541038601|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
149973117|NCT02505425|541038605|FG000|Overall Study|Lost to Follow-up|41|||
149973118|NCT02505425|541038606|FG001|Overall Study|Lost to Follow-up|61|||
149973119|NCT02505425|541038607|FG002|Overall Study|Lost to Follow-up|31|||
149973120|NCT02505425|541038608|FG003|Overall Study|Lost to Follow-up|19|||
149973121|NCT02505425|541038605|FG000|Overall Study|Withdrawal by Subject|39|||
149973122|NCT02505425|541038606|FG001|Overall Study|Withdrawal by Subject|9|||
149973123|NCT02505425|541038607|FG002|Overall Study|Withdrawal by Subject|19|||
149973124|NCT02505425|541038608|FG003|Overall Study|Withdrawal by Subject|7|||
149973125|NCT02505425|541038605|FG000|Overall Study|Death|8|||
149973126|NCT02505425|541038606|FG001|Overall Study|Death|12|||
149973127|NCT02505425|541038607|FG002|Overall Study|Death|0|||
149973128|NCT02505425|541038608|FG003|Overall Study|Death|0|||
149973129|NCT02031302|541038609|FG000|Overall Study|Death|115|||
149973130|NCT02031302|541038610|FG001|Overall Study|Death|0|||
149973131|NCT02031302|541038609|FG000|Overall Study|Not treated with study valve system|18|||
149973132|NCT02031302|541038610|FG001|Overall Study|Not treated with study valve system|0|||
149973133|NCT02031302|541038609|FG000|Overall Study|Missed Follow Up|27|||
149973134|NCT02031302|541038610|FG001|Overall Study|Missed Follow Up|0|||
149973135|NCT02031302|541038609|FG000|Overall Study|Lost to Follow-up|4|||
149973136|NCT02031302|541038610|FG001|Overall Study|Lost to Follow-up|0|||
150051237|NCT00006409|541329149|FG005|Post-2 Year Intervention|Protocol Violation|0|||
150051238|NCT00006409|541329144|FG000|Post-3 Year Intervention|Protocol Violation|0|||
149915446|NCT03769194|540822204|FG002|Overall Study|Lost to Follow-up|3|||
149915447|NCT03769194|540822205|FG003|Overall Study|Lost to Follow-up|6|||
149915448|NCT03769194|540822202|FG000|Overall Study|other|1|||
149915449|NCT03769194|540822203|FG001|Overall Study|other|3|||
149973137|NCT00545779|541038618|FG000|Overall Study|Violation of selection criteria at entry|8|||
149915450|NCT03769194|540822204|FG002|Overall Study|other|0|||
149915451|NCT03769194|540822205|FG003|Overall Study|other|1|||
149915452|NCT03000530|540822209|FG000|Overall Study|Adverse Event|0|||
149915453|NCT03000530|540822210|FG001|Overall Study|Adverse Event|0|||
149915454|NCT03000530|540822211|FG002|Overall Study|Adverse Event|2|||
149915455|NCT03000530|540822209|FG000|Overall Study|Lost to Follow-up|0|||
149915456|NCT03000530|540822210|FG001|Overall Study|Lost to Follow-up|3|||
149915457|NCT03000530|540822211|FG002|Overall Study|Lost to Follow-up|1|||
149915458|NCT03000530|540822209|FG000|Overall Study|Withdrawal by Subject|0|||
149915459|NCT03000530|540822210|FG001|Overall Study|Withdrawal by Subject|2|||
149915460|NCT03000530|540822211|FG002|Overall Study|Withdrawal by Subject|1|||
149915461|NCT01430624|540822214|FG000|Overall Study|Lost to Follow-up|23|||
149915462|NCT01430624|540822215|FG001|Overall Study|Lost to Follow-up|29|||
149915463|NCT01430624|540822216|FG002|Overall Study|Lost to Follow-up|27|||
149915464|NCT01430624|540822214|FG000|Overall Study|technical or eligibility|5|||
149915465|NCT01430624|540822215|FG001|Overall Study|technical or eligibility|5|||
149915466|NCT01430624|540822216|FG002|Overall Study|technical or eligibility|2|||
149915467|NCT02565706|540822221|FG000|Overall Study|Withdrawal by Subject|5|||
149915468|NCT02565706|540822222|FG001|Overall Study|Withdrawal by Subject|7|||
149915469|NCT02565706|540822223|FG002|Overall Study|Withdrawal by Subject|7|||
149915470|NCT02565706|540822224|FG003|Overall Study|Withdrawal by Subject|11|||
149915471|NCT02565706|540822221|FG000|Overall Study|Lost to Follow-up|72|||
149915472|NCT02565706|540822222|FG001|Overall Study|Lost to Follow-up|75|||
149915473|NCT02565706|540822223|FG002|Overall Study|Lost to Follow-up|82|||
149915474|NCT02565706|540822224|FG003|Overall Study|Lost to Follow-up|74|||
149915475|NCT01672294|540822226|FG000|Overall Study|Withdrawal by Subject|4|||
149915476|NCT01672294|540822227|FG001|Overall Study|Withdrawal by Subject|4|||
149915477|NCT01672294|540822228|FG002|Overall Study|Withdrawal by Subject|4|||
149915478|NCT01672294|540822229|FG003|Overall Study|Withdrawal by Subject|4|||
149915479|NCT01672294|540822226|FG000|Overall Study|Excluded by study|1|||
149915480|NCT01672294|540822227|FG001|Overall Study|Excluded by study|1|||
149915481|NCT01672294|540822228|FG002|Overall Study|Excluded by study|0|||
149915482|NCT01672294|540822229|FG003|Overall Study|Excluded by study|0|||
149915483|NCT01672294|540822226|FG000|Overall Study|Lost to Follow-up|1|||
149915484|NCT01672294|540822227|FG001|Overall Study|Lost to Follow-up|16|||
149915485|NCT01672294|540822228|FG002|Overall Study|Lost to Follow-up|7|||
149973138|NCT00545779|541038618|FG000|Overall Study|Other protocol violation|1|||
149973139|NCT00545779|541038618|FG000|Overall Study|Did not cooperate|7|||
149973140|NCT00545779|541038618|FG000|Overall Study|Withdrawal by Subject|20|||
149973141|NCT00545779|541038618|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
149973142|NCT00545779|541038618|FG000|Overall Study|Failure to return|3|||
149973143|NCT01405196|541038619|FG000|Overall Study|Study Terminated by Sponsor|0|||
149973144|NCT01405196|541038620|FG001|Overall Study|Study Terminated by Sponsor|0|||
149973145|NCT01405196|541038621|FG002|Overall Study|Study Terminated by Sponsor|9|||
149973146|NCT01405196|541038622|FG003|Overall Study|Study Terminated by Sponsor|0|||
149973147|NCT01405196|541038619|FG000|Overall Study|Other|2|||
149973148|NCT01405196|541038620|FG001|Overall Study|Other|2|||
149973149|NCT01405196|541038621|FG002|Overall Study|Other|5|||
149973150|NCT01405196|541038622|FG003|Overall Study|Other|0|||
150051239|NCT00006409|541329145|FG001|Post-3 Year Intervention|Protocol Violation|0|||
150051240|NCT00006409|541329146|FG002|Post-3 Year Intervention|Protocol Violation|0|||
149973151|NCT01405196|541038619|FG000|Overall Study|Withdrawal by Subject|4|||
150051241|NCT00006409|541329147|FG003|Post-3 Year Intervention|Protocol Violation|0|||
150051242|NCT00006409|541329148|FG004|Post-3 Year Intervention|Protocol Violation|62|||
150051243|NCT00006409|541329149|FG005|Post-3 Year Intervention|Protocol Violation|62|||
150051244|NCT02636361|541329151|FG000|Period 4|Physician Decision|0|||
150051245|NCT02636361|541329152|FG001|Period 4|Physician Decision|0|||
150051246|NCT02636361|541329153|FG002|Period 4|Physician Decision|0|||
150051247|NCT02636361|541329154|FG003|Period 4|Physician Decision|1|||
150051248|NCT02636361|541329155|FG004|Period 4|Physician Decision|0|||
150051249|NCT00228553|541329161|FG000|Overall Study|Adverse Event|112|||
150051250|NCT00228553|541329161|FG000|Overall Study|Lack of Efficacy|34|||
150051251|NCT00228553|541329161|FG000|Overall Study|Lost to Follow-up|67|||
150051252|NCT00228553|541329161|FG000|Overall Study|Physician Decision|48|||
150051253|NCT00228553|541329161|FG000|Overall Study|Protocol Violation|6|||
150051254|NCT00228553|541329161|FG000|Overall Study|Withdrawal by Subject|115|||
150051255|NCT00228553|541329161|FG000|Overall Study|Pregnancy|2|||
150051256|NCT00228553|541329161|FG000|Overall Study|Miscellaneous|46|||
150051257|NCT04556383|541329164|FG000|PCP|Lack of Efficacy|28|||
150051258|NCT04556383|541329165|FG001|PCP|Lack of Efficacy|23|||
150051259|NCT04556383|541329166|FG002|PCP|Lack of Efficacy|23|||
150051260|NCT04556383|541329167|FG003|PCP|Lack of Efficacy|0|||
149915486|NCT01672294|540822229|FG003|Overall Study|Lost to Follow-up|9|||
149915487|NCT03379792|540822230|FG000|Overall Study|Physician Decision|0|||
149915488|NCT03379792|540822231|FG001|Overall Study|Physician Decision|0|||
149915489|NCT03379792|540822232|FG002|Overall Study|Physician Decision|0|||
149915490|NCT03379792|540822233|FG003|Overall Study|Physician Decision|1|||
149915491|NCT03379792|540822234|FG004|Overall Study|Physician Decision|0|||
149915492|NCT03379792|540822235|FG005|Overall Study|Physician Decision|0|||
149973152|NCT01405196|541038620|FG001|Overall Study|Withdrawal by Subject|6|||
150051261|NCT04556383|541329164|FG000|PCP|Study terminated by sponsor|15|||
149915493|NCT03379792|540822230|FG000|Overall Study|Withdrawal by Subject|0|||
149915494|NCT03379792|540822231|FG001|Overall Study|Withdrawal by Subject|0|||
149915495|NCT03379792|540822232|FG002|Overall Study|Withdrawal by Subject|0|||
149915496|NCT03379792|540822233|FG003|Overall Study|Withdrawal by Subject|0|||
149915497|NCT03379792|540822234|FG004|Overall Study|Withdrawal by Subject|1|||
149915498|NCT03379792|540822235|FG005|Overall Study|Withdrawal by Subject|1|||
149915499|NCT01285492|540822236|FG000|Overall Study|Adverse Event|11|||
149915500|NCT01285492|540822237|FG001|Overall Study|Adverse Event|0|||
149915501|NCT01285492|540822236|FG000|Overall Study|Protocol Violation|3|||
149915502|NCT01285492|540822237|FG001|Overall Study|Protocol Violation|0|||
149915503|NCT01285492|540822236|FG000|Overall Study|Withdrawal by Subject|2|||
149915504|NCT01285492|540822237|FG001|Overall Study|Withdrawal by Subject|1|||
149915505|NCT01285492|540822236|FG000|Overall Study|Death|1|||
149915506|NCT01285492|540822237|FG001|Overall Study|Death|0|||
149915507|NCT01121536|540822239|FG000|Overall Study|Adverse Event|63|||
149915508|NCT01121536|540822239|FG000|Overall Study|Lack of Efficacy|35|||
149915509|NCT01121536|540822239|FG000|Overall Study|Withdrawal by Subject|65|||
149915510|NCT01121536|540822239|FG000|Overall Study|Protocol Violation|20|||
149915511|NCT01121536|540822239|FG000|Overall Study|Noncompliance with study medication|12|||
149915512|NCT01121536|540822239|FG000|Overall Study|Noncompliance with study procedures|9|||
149915513|NCT01121536|540822239|FG000|Overall Study|Lost to Follow-up|39|||
149915514|NCT01121536|540822239|FG000|Overall Study|Other|118|||
149915515|NCT00401960|540822240|FG000|Overall Study|Lost to Follow-up|3|||
149915516|NCT00401960|540822241|FG001|Overall Study|Lost to Follow-up|0|||
149915517|NCT00401960|540822240|FG000|Overall Study|Death|2|||
149915518|NCT00401960|540822241|FG001|Overall Study|Death|0|||
149915519|NCT02649426|540822242|FG000|Overall Study|Follow-up on going|1|||
149915520|NCT02649426|540822243|FG001|Overall Study|Follow-up on going|26|||
149915521|NCT02649426|540822244|FG002|Overall Study|Follow-up on going|28|||
149915522|NCT02649426|540822245|FG003|Overall Study|Follow-up on going|31|||
149915523|NCT01606202|540822246|FG000|Overall Study|Adverse Event|5|||
149915524|NCT01606202|540822247|FG001|Overall Study|Adverse Event|0|||
149915525|NCT01606202|540822246|FG000|Overall Study|Withdrawal by Subject|2|||
149915526|NCT01606202|540822247|FG001|Overall Study|Withdrawal by Subject|1|||
149915527|NCT01606202|540822246|FG000|Overall Study|Personal problems|0|||
149915528|NCT01606202|540822247|FG001|Overall Study|Personal problems|1|||
149915529|NCT01606202|540822246|FG000|Overall Study|Problems with administration|0|||
149915530|NCT01606202|540822247|FG001|Overall Study|Problems with administration|1|||
149915531|NCT00306787|540822248|FG000|Overall Study|Discontinued without taking study drug|208|||
149915532|NCT00306787|540822249|FG001|Overall Study|Discontinued without taking study drug|215|||
149915533|NCT00306787|540822248|FG000|Overall Study|Adverse Event|1|||
149915534|NCT00306787|540822249|FG001|Overall Study|Adverse Event|1|||
149915535|NCT00306787|540822248|FG000|Overall Study|Lack of Efficacy|1|||
149915536|NCT00306787|540822249|FG001|Overall Study|Lack of Efficacy|0|||
149915537|NCT00306787|540822248|FG000|Overall Study|Protocol Violation|8|||
149915538|NCT00306787|540822249|FG001|Overall Study|Protocol Violation|10|||
149915539|NCT00306787|540822248|FG000|Overall Study|Withdrawal by Subject|2|||
149915540|NCT00306787|540822249|FG001|Overall Study|Withdrawal by Subject|9|||
149915541|NCT00306787|540822248|FG000|Overall Study|Lost to Follow-up|9|||
149915542|NCT00306787|540822249|FG001|Overall Study|Lost to Follow-up|6|||
149915543|NCT00306787|540822248|FG000|Overall Study|Administrative problems|4|||
149973153|NCT01405196|541038621|FG002|Overall Study|Withdrawal by Subject|3|||
149973154|NCT01405196|541038622|FG003|Overall Study|Withdrawal by Subject|6|||
149915544|NCT00306787|540822249|FG001|Overall Study|Administrative problems|0|||
149915545|NCT00306787|540822248|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149973155|NCT01405196|541038619|FG000|Overall Study|Adverse Event|2|||
149973156|NCT01405196|541038620|FG001|Overall Study|Adverse Event|2|||
149973157|NCT01405196|541038621|FG002|Overall Study|Adverse Event|0|||
149973158|NCT01405196|541038622|FG003|Overall Study|Adverse Event|2|||
149973159|NCT01405196|541038619|FG000|Overall Study|Death|1|||
149973160|NCT01405196|541038620|FG001|Overall Study|Death|0|||
149973161|NCT01405196|541038621|FG002|Overall Study|Death|3|||
149973162|NCT01405196|541038622|FG003|Overall Study|Death|0|||
150051262|NCT04556383|541329165|FG001|PCP|Study terminated by sponsor|13|||
150051263|NCT04556383|541329166|FG002|PCP|Study terminated by sponsor|16|||
150051264|NCT04556383|541329167|FG003|PCP|Study terminated by sponsor|0|||
149915546|NCT00306787|540822249|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149915547|NCT02273908|540822250|FG000|Overall Study|Adverse Event|16|||
149973163|NCT01405196|541038619|FG000|Overall Study|Lost to Follow-up|2|||
150051265|NCT04556383|541329164|FG000|PCP|Withdrawal by Subject|8|||
150051266|NCT04556383|541329165|FG001|PCP|Withdrawal by Subject|6|||
149915548|NCT02273908|540822251|FG001|Overall Study|Adverse Event|0|||
149915549|NCT02273908|540822250|FG000|Overall Study|Lost to Follow-up|10|||
149915550|NCT02273908|540822251|FG001|Overall Study|Lost to Follow-up|1|||
149915551|NCT02273908|540822250|FG000|Overall Study|Did not meet entrance criteria|3|||
149915552|NCT02273908|540822251|FG001|Overall Study|Did not meet entrance criteria|2|||
149973164|NCT01405196|541038620|FG001|Overall Study|Lost to Follow-up|2|||
149973165|NCT01405196|541038621|FG002|Overall Study|Lost to Follow-up|3|||
150051267|NCT04556383|541329166|FG002|PCP|Withdrawal by Subject|6|||
149915553|NCT02273908|540822250|FG000|Overall Study|Withdrawal by Subject|4|||
149915554|NCT02273908|540822251|FG001|Overall Study|Withdrawal by Subject|2|||
149915555|NCT00369161|540822252|FG000|Overall Study|Adverse Event|15|||
149915556|NCT00369161|540822253|FG001|Overall Study|Adverse Event|13|||
149915557|NCT00369161|540822252|FG000|Overall Study|Abnormal laboratory value|0|||
149915558|NCT00369161|540822253|FG001|Overall Study|Abnormal laboratory value|1|||
149915559|NCT00369161|540822252|FG000|Overall Study|Lack of Efficacy|3|||
149915560|NCT00369161|540822253|FG001|Overall Study|Lack of Efficacy|1|||
149915561|NCT00369161|540822252|FG000|Overall Study|Protocol Violation|0|||
149915562|NCT00369161|540822253|FG001|Overall Study|Protocol Violation|2|||
149915563|NCT00369161|540822252|FG000|Overall Study|Withdrawal by Subject|2|||
149915564|NCT00369161|540822253|FG001|Overall Study|Withdrawal by Subject|3|||
149915565|NCT00369161|540822252|FG000|Overall Study|Death|1|||
149915566|NCT00369161|540822253|FG001|Overall Study|Death|2|||
149915567|NCT00369161|540822252|FG000|Overall Study|Graft loss|4|||
149915568|NCT00369161|540822253|FG001|Overall Study|Graft loss|0|||
149915569|NCT00369161|540822252|FG000|Overall Study|Administrative Problem|2|||
149915570|NCT00369161|540822253|FG001|Overall Study|Administrative Problem|2|||
149915571|NCT04908475|540822254|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
149915572|NCT04908475|540822255|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
149915573|NCT04908475|540822256|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
149915574|NCT04908475|540822257|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
149915575|NCT04908475|540822258|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
149915576|NCT04908475|540822259|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
149915577|NCT04908475|540822254|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
149915578|NCT04908475|540822255|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149915579|NCT04908475|540822256|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149915580|NCT04908475|540822257|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149915581|NCT04908475|540822258|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149915582|NCT04908475|540822259|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149915583|NCT04908475|540822254|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
149915584|NCT04908475|540822255|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
149915585|NCT04908475|540822256|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
149915586|NCT04908475|540822257|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
149915587|NCT04908475|540822258|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
149915588|NCT04908475|540822259|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
149915589|NCT04908475|540822254|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149915590|NCT04908475|540822255|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
149915591|NCT04908475|540822256|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
149915592|NCT04908475|540822257|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
149915593|NCT04908475|540822258|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149915594|NCT04908475|540822259|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149915595|NCT04908475|540822254|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
149915596|NCT04908475|540822255|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
149915597|NCT04908475|540822256|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
149915598|NCT04908475|540822257|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
149915599|NCT04908475|540822258|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
149915600|NCT04908475|540822259|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
149973166|NCT01405196|541038622|FG003|Overall Study|Lost to Follow-up|1|||
149973167|NCT01542788|541038623|FG000|Overall Study|Randomized but Not Treated|2|||
149973168|NCT01542788|541038624|FG001|Overall Study|Randomized but Not Treated|0|||
150051268|NCT04556383|541329167|FG003|PCP|Withdrawal by Subject|0|||
149973169|NCT01542788|541038623|FG000|Overall Study|Lack of Efficacy|41|||
149973170|NCT01542788|541038624|FG001|Overall Study|Lack of Efficacy|71|||
149973171|NCT01542788|541038623|FG000|Overall Study|Lost to Follow-up|5|||
149973172|NCT01542788|541038624|FG001|Overall Study|Lost to Follow-up|0|||
149973173|NCT01542788|541038623|FG000|Overall Study|Death|3|||
149973174|NCT01542788|541038624|FG001|Overall Study|Death|0|||
149973175|NCT01542788|541038623|FG000|Overall Study|Protocol Violation|2|||
149973176|NCT01542788|541038624|FG001|Overall Study|Protocol Violation|0|||
149973177|NCT01542788|541038623|FG000|Overall Study|Physician Decision|1|||
149973178|NCT01542788|541038624|FG001|Overall Study|Physician Decision|0|||
149973179|NCT01542788|541038623|FG000|Overall Study|Withdrawal by Subject|1|||
149973180|NCT01542788|541038624|FG001|Overall Study|Withdrawal by Subject|0|||
150051269|NCT04556383|541329164|FG000|PCP|Adverse Event|1|||
149915601|NCT04908475|540822254|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
149915602|NCT04908475|540822255|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
149915603|NCT04908475|540822256|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
149915604|NCT04908475|540822257|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
149915605|NCT04908475|540822258|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
149915606|NCT04908475|540822259|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
149915607|NCT01870297|540822262|FG000|Overall Study|Adverse Event|0|||
149915608|NCT01870297|540822263|FG001|Overall Study|Adverse Event|0|||
149915609|NCT01870297|540822264|FG002|Overall Study|Adverse Event|0|||
149915610|NCT01870297|540822265|FG003|Overall Study|Adverse Event|0|||
149915611|NCT01870297|540822266|FG004|Overall Study|Adverse Event|2|||
149915612|NCT01870297|540822267|FG005|Overall Study|Adverse Event|0|||
149915613|NCT01870297|540822268|FG006|Overall Study|Adverse Event|0|||
149915614|NCT01870297|540822262|FG000|Overall Study|Lost to Follow-up|0|||
149915615|NCT01870297|540822263|FG001|Overall Study|Lost to Follow-up|1|||
149915616|NCT01870297|540822264|FG002|Overall Study|Lost to Follow-up|1|||
149915617|NCT01870297|540822265|FG003|Overall Study|Lost to Follow-up|0|||
149915618|NCT01870297|540822266|FG004|Overall Study|Lost to Follow-up|0|||
149915619|NCT01870297|540822267|FG005|Overall Study|Lost to Follow-up|0|||
149915620|NCT01870297|540822268|FG006|Overall Study|Lost to Follow-up|0|||
149915621|NCT01870297|540822262|FG000|Overall Study|Withdrawal by Subject|0|||
149915622|NCT01870297|540822263|FG001|Overall Study|Withdrawal by Subject|0|||
149915623|NCT01870297|540822264|FG002|Overall Study|Withdrawal by Subject|0|||
149915624|NCT01870297|540822265|FG003|Overall Study|Withdrawal by Subject|0|||
149915625|NCT01870297|540822266|FG004|Overall Study|Withdrawal by Subject|1|||
149915626|NCT01870297|540822267|FG005|Overall Study|Withdrawal by Subject|1|||
149915627|NCT01870297|540822268|FG006|Overall Study|Withdrawal by Subject|1|||
149915628|NCT01870297|540822262|FG000|Overall Study|Sponsor Decision|0|||
149915629|NCT01870297|540822263|FG001|Overall Study|Sponsor Decision|6|||
149915630|NCT01870297|540822264|FG002|Overall Study|Sponsor Decision|0|||
149915631|NCT01870297|540822265|FG003|Overall Study|Sponsor Decision|0|||
149915632|NCT01870297|540822266|FG004|Overall Study|Sponsor Decision|0|||
149915633|NCT01870297|540822267|FG005|Overall Study|Sponsor Decision|0|||
149915634|NCT01870297|540822268|FG006|Overall Study|Sponsor Decision|1|||
149915635|NCT01739764|540822269|FG000|Overall Study|Adverse Event|0|||
149915636|NCT01739764|540822270|FG001|Overall Study|Adverse Event|3|||
149915637|NCT01739764|540822271|FG002|Overall Study|Adverse Event|4|||
149915638|NCT01739764|540822269|FG000|Overall Study|Death|4|||
149915639|NCT01739764|540822270|FG001|Overall Study|Death|6|||
149915640|NCT01739764|540822271|FG002|Overall Study|Death|38|||
149915641|NCT01739764|540822269|FG000|Overall Study|Lost to Follow-up|0|||
149915642|NCT01739764|540822270|FG001|Overall Study|Lost to Follow-up|0|||
149915643|NCT01739764|540822271|FG002|Overall Study|Lost to Follow-up|5|||
149915644|NCT01739764|540822269|FG000|Overall Study|Non-Compliance|0|||
149915645|NCT01739764|540822270|FG001|Overall Study|Non-Compliance|0|||
149915646|NCT01739764|540822271|FG002|Overall Study|Non-Compliance|1|||
149915647|NCT01739764|540822269|FG000|Overall Study|Multiple Reasons|3|||
149915648|NCT01739764|540822270|FG001|Overall Study|Multiple Reasons|2|||
149915649|NCT01739764|540822271|FG002|Overall Study|Multiple Reasons|3|||
149915650|NCT01739764|540822269|FG000|Overall Study|Physician Decision|2|||
149915651|NCT01739764|540822270|FG001|Overall Study|Physician Decision|2|||
149915652|NCT01739764|540822271|FG002|Overall Study|Physician Decision|4|||
149915653|NCT01739764|540822269|FG000|Overall Study|Progressive Disease|3|||
149915654|NCT01739764|540822270|FG001|Overall Study|Progressive Disease|5|||
149915655|NCT01739764|540822271|FG002|Overall Study|Progressive Disease|16|||
149915656|NCT01739764|540822269|FG000|Overall Study|Protocol Violation|0|||
149915657|NCT01739764|540822270|FG001|Overall Study|Protocol Violation|0|||
149915658|NCT01739764|540822271|FG002|Overall Study|Protocol Violation|2|||
149915659|NCT01739764|540822269|FG000|Overall Study|Study Terminated by Sponsor|8|||
149915660|NCT01739764|540822270|FG001|Overall Study|Study Terminated by Sponsor|13|||
149915661|NCT01739764|540822271|FG002|Overall Study|Study Terminated by Sponsor|26|||
149915662|NCT01739764|540822269|FG000|Overall Study|Withdrawal by Subject|6|||
149915663|NCT01739764|540822270|FG001|Overall Study|Withdrawal by Subject|5|||
149915664|NCT01739764|540822271|FG002|Overall Study|Withdrawal by Subject|27|||
149915665|NCT03008278|540822272|FG000|Overall Study|Progressive Disease|0|||
149915666|NCT03008278|540822273|FG001|Overall Study|Progressive Disease|0|||
149915667|NCT03008278|540822274|FG002|Overall Study|Progressive Disease|32|||
149915668|NCT03008278|540822272|FG000|Overall Study|Adverse Event|0|||
149915669|NCT03008278|540822273|FG001|Overall Study|Adverse Event|0|||
149915670|NCT03008278|540822274|FG002|Overall Study|Adverse Event|4|||
149915671|NCT03008278|540822272|FG000|Overall Study|Withdrawal by Subject|0|||
149915672|NCT03008278|540822273|FG001|Overall Study|Withdrawal by Subject|0|||
149915673|NCT03008278|540822274|FG002|Overall Study|Withdrawal by Subject|3|||
149915674|NCT03008278|540822272|FG000|Overall Study|Physician Decision|0|||
149915675|NCT03008278|540822273|FG001|Overall Study|Physician Decision|2|||
150177238|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
150177239|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
150177240|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
150177241|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
150177242|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
150177243|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
150177244|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
150177245|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
150177246|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
150177247|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
150177248|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
150177249|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
150177250|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
150177251|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
150177252|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
150177253|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
150177254|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
150177255|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
150177256|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
150177257|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
150177258|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
150177259|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
150177260|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
150177261|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
150177262|NCT01061151|541786184|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
150177263|NCT01061151|541786185|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
150177264|NCT01061151|541786186|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
150177265|NCT01061151|541786187|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
150177266|NCT01236001|541786189|FG000|Overall Study|Adverse Event|5|||
150177267|NCT01236001|541786190|FG001|Overall Study|Adverse Event|14|||
150177268|NCT01236001|541786189|FG000|Overall Study|Lack of Efficacy|6|||
150177269|NCT01236001|541786190|FG001|Overall Study|Lack of Efficacy|6|||
150177270|NCT01236001|541786189|FG000|Overall Study|Lost to Follow-up|6|||
150177271|NCT01236001|541786190|FG001|Overall Study|Lost to Follow-up|1|||
150177272|NCT01236001|541786189|FG000|Overall Study|Incompliance|1|||
150177273|NCT01236001|541786190|FG001|Overall Study|Incompliance|0|||
150177274|NCT01236001|541786189|FG000|Overall Study|Planned Visit After End of Study|0|||
150177275|NCT01236001|541786190|FG001|Overall Study|Planned Visit After End of Study|1|||
150177276|NCT04530747|541786193|FG000|Overall Study|Withdrawal by Subject|1|||
150177277|NCT04530747|541786194|FG001|Overall Study|Withdrawal by Subject|0|||
150177278|NCT03292913|541786195|FG000|Overall Study|Death|9|||
150177279|NCT03292913|541786196|FG001|Overall Study|Death|3|||
149973181|NCT01729039|541038627|FG000|Overall Study|disqualified|2|||
149973182|NCT01729039|541038628|FG001|Overall Study|disqualified|5|||
149973183|NCT01729039|541038627|FG000|Overall Study|Withdrawal by Subject|8|||
149973184|NCT01729039|541038628|FG001|Overall Study|Withdrawal by Subject|7|||
149915676|NCT03008278|540822274|FG002|Overall Study|Physician Decision|0|||
149915677|NCT01074255|540822275|FG000|Overall Study|Did not receive EMEND|2|||
149915678|NCT00932451|540822287|FG000|Overall Study|Withdrawal by Subject|69|||
149915679|NCT00932451|540822287|FG000|Overall Study|Lost to Follow-up|22|||
149915680|NCT00932451|540822287|FG000|Overall Study|Death|726|||
149915681|NCT00932451|540822287|FG000|Overall Study|Other reasons|5|||
149973185|NCT05788991|541038632|FG000|Overall Study|Not treated with study medication|1|||
149973186|NCT05788991|541038633|FG001|Overall Study|Not treated with study medication|3|||
150177280|NCT03292913|541786195|FG000|Overall Study|Lost to Follow-up|49|||
149915682|NCT01634659|540822295|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
149915683|NCT01634659|540822296|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
149915684|NCT01634659|540822295|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
149973187|NCT05788991|541038632|FG000|Overall Study|Withdrawal by Subject|1|||
149973188|NCT05788991|541038633|FG001|Overall Study|Withdrawal by Subject|0|||
149973189|NCT05788991|541038632|FG000|Overall Study|Lack of Efficacy|0|||
149973190|NCT05788991|541038633|FG001|Overall Study|Lack of Efficacy|1|||
149973191|NCT05788991|541038632|FG000|Overall Study|Protocol Violation|1|||
149973192|NCT05788991|541038633|FG001|Overall Study|Protocol Violation|2|||
149973193|NCT04464473|541038634|FG000|Overall Study|New piercing could not be removed for scanning|0|||
149973194|NCT04464473|541038635|FG001|Overall Study|New piercing could not be removed for scanning|0|||
149973195|NCT04464473|541038636|FG002|Overall Study|New piercing could not be removed for scanning|0|||
149973196|NCT04464473|541038637|FG003|Overall Study|New piercing could not be removed for scanning|1|||
149973197|NCT04464473|541038638|FG004|Overall Study|New piercing could not be removed for scanning|0|||
149973198|NCT04464473|541038639|FG005|Overall Study|New piercing could not be removed for scanning|0|||
149915685|NCT01634659|540822296|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
149973199|NCT04464473|541038634|FG000|Overall Study|Adverse Event|0|||
149973200|NCT04464473|541038635|FG001|Overall Study|Adverse Event|0|||
149973201|NCT04464473|541038636|FG002|Overall Study|Adverse Event|0|||
149973202|NCT04464473|541038637|FG003|Overall Study|Adverse Event|1|||
149973203|NCT04464473|541038638|FG004|Overall Study|Adverse Event|0|||
149973204|NCT04464473|541038639|FG005|Overall Study|Adverse Event|0|||
149973205|NCT04464473|541038634|FG000|Overall Study|Lost to Follow-up|0|||
149973206|NCT04464473|541038635|FG001|Overall Study|Lost to Follow-up|0|||
149973207|NCT04464473|541038636|FG002|Overall Study|Lost to Follow-up|0|||
149973208|NCT04464473|541038637|FG003|Overall Study|Lost to Follow-up|1|||
149973209|NCT04464473|541038638|FG004|Overall Study|Lost to Follow-up|0|||
149973210|NCT04464473|541038639|FG005|Overall Study|Lost to Follow-up|0|||
149973211|NCT03586973|541038644|FG000|Overall Study|Death|15|||
149973212|NCT03586973|541038645|FG001|Overall Study|Death|8|||
149915686|NCT02968433|540822297|FG000|Overall Study|Withdrawal by Subject|1|||
149915687|NCT01294371|540822298|FG000|Overall Study|Adverse Event|1|||
149973213|NCT03586973|541038644|FG000|Overall Study|Site Terminated by Sponsor|3|||
149973214|NCT03586973|541038645|FG001|Overall Study|Site Terminated by Sponsor|6|||
149973215|NCT03586973|541038644|FG000|Overall Study|Withdrawal by Subject|1|||
149973216|NCT03586973|541038645|FG001|Overall Study|Withdrawal by Subject|0|||
149973217|NCT03586973|541038644|FG000|Overall Study|Lost to Follow-up|1|||
150051270|NCT04556383|541329165|FG001|PCP|Adverse Event|7|||
150051271|NCT04556383|541329166|FG002|PCP|Adverse Event|7|||
150051272|NCT04556383|541329167|FG003|PCP|Adverse Event|0|||
150051273|NCT04556383|541329164|FG000|PCP|Other, Not Specified|1|||
150051274|NCT04556383|541329165|FG001|PCP|Other, Not Specified|2|||
150051275|NCT04556383|541329166|FG002|PCP|Other, Not Specified|1|||
150051276|NCT04556383|541329167|FG003|PCP|Other, Not Specified|0|||
150051277|NCT04556383|541329164|FG000|PCP|Protocol Violation|1|||
150051278|NCT04556383|541329165|FG001|PCP|Protocol Violation|0|||
150051279|NCT04556383|541329166|FG002|PCP|Protocol Violation|1|||
150051280|NCT04556383|541329167|FG003|PCP|Protocol Violation|0|||
150051281|NCT04556383|541329164|FG000|PCP|Lost to Follow-up|1|||
150051282|NCT04556383|541329165|FG001|PCP|Lost to Follow-up|0|||
150051283|NCT04556383|541329166|FG002|PCP|Lost to Follow-up|0|||
150051284|NCT04556383|541329167|FG003|PCP|Lost to Follow-up|0|||
150051285|NCT04556383|541329164|FG000|PCP|Physician Decision|0|||
150051286|NCT04556383|541329165|FG001|PCP|Physician Decision|1|||
150051287|NCT04556383|541329166|FG002|PCP|Physician Decision|0|||
150051288|NCT04556383|541329167|FG003|PCP|Physician Decision|0|||
150051289|NCT04556383|541329164|FG000|PCP|Site terminated by sponsor|0|||
149915688|NCT01294371|540822298|FG000|Overall Study|Withdrawal by Subject|12|||
149915689|NCT01294371|540822298|FG000|Overall Study|Lost to Follow-up|6|||
149973218|NCT03586973|541038645|FG001|Overall Study|Lost to Follow-up|0|||
149975776|NCT00980148|541049416|FG000|Overall Study|Discharged from facility|89|||
149975777|NCT00980148|541049417|FG001|Overall Study|Discharged from facility|96|||
149975778|NCT00980148|541049416|FG000|Overall Study|Received other antichlamydia treatment|20|||
149975779|NCT00980148|541049417|FG001|Overall Study|Received other antichlamydia treatment|14|||
149975780|NCT00980148|541049416|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
149975781|NCT00980148|541049417|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
149975782|NCT00980148|541049416|FG000|Overall Study|Various other reasons|8|||
149975783|NCT00980148|541049417|FG001|Overall Study|Various other reasons|9|||
149975784|NCT01747915|541049424|FG000|Overall Study|Other|1|||
149975785|NCT01747915|541049425|FG001|Overall Study|Other|1|||
149975786|NCT01747915|541049426|FG002|Overall Study|Other|1|||
149975787|NCT01747915|541049424|FG000|Overall Study|Adverse Event|8|||
149975788|NCT01747915|541049425|FG001|Overall Study|Adverse Event|5|||
149975789|NCT01747915|541049426|FG002|Overall Study|Adverse Event|2|||
149975790|NCT01747915|541049424|FG000|Overall Study|Death|0|||
149975791|NCT01747915|541049425|FG001|Overall Study|Death|0|||
149975792|NCT01747915|541049426|FG002|Overall Study|Death|1|||
150051290|NCT04556383|541329165|FG001|PCP|Site terminated by sponsor|1|||
149915690|NCT01294371|540822298|FG000|Overall Study|Administrative Reason|1|||
149975793|NCT01747915|541049424|FG000|Overall Study|Lack of Efficacy|0|||
149975794|NCT01747915|541049425|FG001|Overall Study|Lack of Efficacy|1|||
149975795|NCT01747915|541049426|FG002|Overall Study|Lack of Efficacy|0|||
150051291|NCT04556383|541329166|FG002|PCP|Site terminated by sponsor|0|||
149915691|NCT01294371|540822298|FG000|Overall Study|Other|14|||
149915692|NCT00637806|540822299|FG000|Double-blind Phase|Study Discontinued|2|||
149915693|NCT00637806|540822300|FG001|Double-blind Phase|Study Discontinued|0|||
149975796|NCT01747915|541049424|FG000|Overall Study|Lost to Follow-up|1|||
149975797|NCT01747915|541049425|FG001|Overall Study|Lost to Follow-up|0|||
149975798|NCT01747915|541049426|FG002|Overall Study|Lost to Follow-up|0|||
149975799|NCT01747915|541049424|FG000|Overall Study|Withdrawal by Subject|4|||
149975800|NCT01747915|541049425|FG001|Overall Study|Withdrawal by Subject|4|||
150051292|NCT04556383|541329167|FG003|PCP|Site terminated by sponsor|0|||
150051293|NCT04556383|541329164|FG000|OLE|Study terminated by sponsor|0|||
150051294|NCT04556383|541329165|FG001|OLE|Study terminated by sponsor|0|||
150051295|NCT04556383|541329166|FG002|OLE|Study terminated by sponsor|0|||
150051296|NCT04556383|541329167|FG003|OLE|Study terminated by sponsor|68|||
149915694|NCT00637806|540822301|FG002|Double-blind Phase|Study Discontinued|1|||
149915695|NCT00637806|540822302|FG003|Double-blind Phase|Study Discontinued|0|||
150051297|NCT04556383|541329164|FG000|OLE|Withdrawal by Subject|0|||
150051298|NCT04556383|541329165|FG001|OLE|Withdrawal by Subject|0|||
149915696|NCT00637806|540822299|FG000|Extension Phase|Study Discontinued|0|||
149915697|NCT00637806|540822300|FG001|Extension Phase|Study Discontinued|0|||
149915698|NCT00637806|540822301|FG002|Extension Phase|Study Discontinued|0|||
149915699|NCT00637806|540822302|FG003|Extension Phase|Study Discontinued|1|||
149915700|NCT04272606|540822303|FG000|Overall Study|Protocol Violation|1|||
149915701|NCT04272606|540822304|FG001|Overall Study|Protocol Violation|1|||
149915702|NCT04272606|540822303|FG000|Overall Study|Physician Decision|0|||
149915703|NCT04272606|540822304|FG001|Overall Study|Physician Decision|1|||
149915704|NCT00725101|540822305|FG000|Overall Study|Death|3|||
149915705|NCT00725101|540822305|FG000|Overall Study|Lost to Follow-up|353|||
149915706|NCT00725101|540822305|FG000|Overall Study|Protocol Violation|1|||
149915707|NCT00725101|540822305|FG000|Overall Study|Withdrawal by Subject|127|||
149915708|NCT00725101|540822305|FG000|Overall Study|not specified/no reason given|11|||
149915709|NCT00622336|540822306|FG000|Treatment Phase|Progression of Disease|181|||
149915710|NCT00622336|540822306|FG000|Treatment Phase|Adverse Event|46|||
149915711|NCT00622336|540822306|FG000|Treatment Phase|Other|40|||
149915712|NCT00622336|540822306|FG000|Treatment Phase|Death|14|||
149915713|NCT00622336|540822306|FG000|Treatment Phase|Lack of therapeutic effect|13|||
149915714|NCT00622336|540822306|FG000|Treatment Phase|Withdrawal by Subject|13|||
149915715|NCT00622336|540822306|FG000|Treatment Phase|Lost to Follow-up|2|||
150051299|NCT04556383|541329166|FG002|OLE|Withdrawal by Subject|0|||
150051300|NCT04556383|541329167|FG003|OLE|Withdrawal by Subject|10|||
150051301|NCT04556383|541329164|FG000|OLE|Lack of Efficacy|0|||
150051302|NCT04556383|541329165|FG001|OLE|Lack of Efficacy|0|||
150051303|NCT04556383|541329166|FG002|OLE|Lack of Efficacy|0|||
150051304|NCT04556383|541329167|FG003|OLE|Lack of Efficacy|7|||
150051305|NCT04556383|541329164|FG000|OLE|Adverse Event|0|||
150051306|NCT04556383|541329165|FG001|OLE|Adverse Event|0|||
150051307|NCT04556383|541329166|FG002|OLE|Adverse Event|0|||
150051308|NCT04556383|541329167|FG003|OLE|Adverse Event|2|||
149915716|NCT00622336|540822306|FG000|Extension Phase|Adverse Event|2|||
149915717|NCT00622336|540822306|FG000|Extension Phase|Progressive Disease|6|||
149915718|NCT00622336|540822306|FG000|Extension Phase|Lack of therapeutic effect|2|||
149915719|NCT00622336|540822306|FG000|Extension Phase|Withdrawal by Subject|1|||
149915720|NCT00622336|540822306|FG000|Extension Phase|Lost to Follow-up|1|||
149915721|NCT00622336|540822306|FG000|Extension Phase|Other|9|||
149915722|NCT00824382|540822307|FG000|Overall Study|Adverse Event|4|||
149915723|NCT00824382|540822308|FG001|Overall Study|Adverse Event|1|||
149973219|NCT01770743|541040077|FG000|Overall Study|Adverse Event|1|||
150051309|NCT04556383|541329164|FG000|OLE|Other, Not Specified|0|||
150051310|NCT04556383|541329165|FG001|OLE|Other, Not Specified|0|||
150051311|NCT04556383|541329166|FG002|OLE|Other, Not Specified|0|||
150051312|NCT04556383|541329167|FG003|OLE|Other, Not Specified|2|||
150051313|NCT04556383|541329164|FG000|OLE|Death|0|||
150051314|NCT04556383|541329165|FG001|OLE|Death|0|||
150051315|NCT04556383|541329166|FG002|OLE|Death|0|||
150051316|NCT04556383|541329167|FG003|OLE|Death|1|||
149973220|NCT01770743|541040078|FG001|Overall Study|Adverse Event|0|||
149973221|NCT01770743|541040079|FG002|Overall Study|Adverse Event|0|||
149973222|NCT01770743|541040080|FG003|Overall Study|Adverse Event|0|||
149973223|NCT01770743|541040081|FG004|Overall Study|Adverse Event|0|||
149973224|NCT01770743|541040077|FG000|Overall Study|Withdrawal by Subject|0|||
149973225|NCT01770743|541040078|FG001|Overall Study|Withdrawal by Subject|0|||
149973226|NCT01770743|541040079|FG002|Overall Study|Withdrawal by Subject|1|||
149973227|NCT01770743|541040080|FG003|Overall Study|Withdrawal by Subject|1|||
149973228|NCT01770743|541040081|FG004|Overall Study|Withdrawal by Subject|1|||
150051317|NCT04556383|541329164|FG000|OLE|Lost to Follow-up|0|||
150051318|NCT04556383|541329165|FG001|OLE|Lost to Follow-up|0|||
150051319|NCT04556383|541329166|FG002|OLE|Lost to Follow-up|0|||
149915724|NCT00824382|540822309|FG002|Overall Study|Adverse Event|1|||
149973229|NCT01770743|541040077|FG000|Overall Study|Lost to Follow-up|0|||
149973230|NCT01770743|541040078|FG001|Overall Study|Lost to Follow-up|2|||
149973231|NCT01770743|541040079|FG002|Overall Study|Lost to Follow-up|0|||
150051320|NCT04556383|541329167|FG003|OLE|Lost to Follow-up|1|||
150051321|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
149915725|NCT00824382|540822310|FG003|Overall Study|Adverse Event|4|||
149915726|NCT00824382|540822307|FG000|Overall Study|Protocol Violation|1|||
149915727|NCT00824382|540822308|FG001|Overall Study|Protocol Violation|0|||
149915728|NCT00824382|540822309|FG002|Overall Study|Protocol Violation|0|||
149915729|NCT00824382|540822310|FG003|Overall Study|Protocol Violation|1|||
149973232|NCT01770743|541040080|FG003|Overall Study|Lost to Follow-up|0|||
150051322|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
150051323|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
150051324|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
150051325|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Death|3|||
150051326|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Death|0|||
150051327|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Death|0|||
150177281|NCT03292913|541786196|FG001|Overall Study|Lost to Follow-up|49|||
150177282|NCT03292913|541786195|FG000|Overall Study|Withdrawal by Subject|2|||
150177283|NCT03292913|541786196|FG001|Overall Study|Withdrawal by Subject|0|||
150177284|NCT03292913|541786195|FG000|Overall Study|Clinic closed due to COVID|22|||
150177285|NCT03292913|541786196|FG001|Overall Study|Clinic closed due to COVID|36|||
149915730|NCT00824382|540822307|FG000|Overall Study|Investigator's decision|0|||
149915731|NCT00824382|540822308|FG001|Overall Study|Investigator's decision|1|||
149915732|NCT00824382|540822309|FG002|Overall Study|Investigator's decision|2|||
149915733|NCT00824382|540822310|FG003|Overall Study|Investigator's decision|0|||
149915734|NCT02680834|540822311|FG000|Overall Study|Physician Decision|5|||
149915735|NCT02680834|540822312|FG001|Overall Study|Physician Decision|2|||
149915736|NCT02680834|540822311|FG000|Overall Study|Withdrawal by Subject|6|||
149915737|NCT02680834|540822312|FG001|Overall Study|Withdrawal by Subject|0|||
150177286|NCT03950622|541786197|FG000|Overall Study|Withdrawal by Subject|1|||
150177287|NCT03950622|541786198|FG001|Overall Study|Withdrawal by Subject|0|||
150177288|NCT03950622|541786197|FG000|Overall Study|Protocol Deviation|0|||
150177289|NCT03950622|541786198|FG001|Overall Study|Protocol Deviation|1|||
150177290|NCT03950622|541786197|FG000|Overall Study|Physician Decision|1|||
150177291|NCT03950622|541786198|FG001|Overall Study|Physician Decision|0|||
150177292|NCT03950622|541786197|FG000|Overall Study|Lost to Follow-up|5|||
150177293|NCT03950622|541786198|FG001|Overall Study|Lost to Follow-up|5|||
150177294|NCT03950622|541786197|FG000|Overall Study|Death|1|||
150177295|NCT03950622|541786198|FG001|Overall Study|Death|1|||
150177296|NCT04056624|541786199|FG000|Overall Study|Withdrawal by Subject|0|||
150177297|NCT04056624|541786200|FG001|Overall Study|Withdrawal by Subject|0|||
150177298|NCT04056624|541786201|FG002|Overall Study|Withdrawal by Subject|1|||
150177299|NCT04056624|541786199|FG000|Overall Study|Protocol Violation|1|||
150177300|NCT04056624|541786200|FG001|Overall Study|Protocol Violation|2|||
150177301|NCT04056624|541786201|FG002|Overall Study|Protocol Violation|0|||
150177302|NCT02092116|541786206|FG000|Overall Study|Withdrawal by Subject|0|||
150177303|NCT02092116|541786207|FG001|Overall Study|Withdrawal by Subject|3|||
150177304|NCT02092116|541786206|FG000|Overall Study|Adverse Event|0|||
150177305|NCT02092116|541786207|FG001|Overall Study|Adverse Event|1|||
149915738|NCT02680834|540822311|FG000|Overall Study|Lost to Follow-up|0|||
149915739|NCT02680834|540822312|FG001|Overall Study|Lost to Follow-up|1|||
150177306|NCT03531840|541786208|FG000|Overall Study|Death on study|3|||
150177307|NCT03531840|541786209|FG001|Overall Study|Death on study|2|||
150177308|NCT03531840|541786210|FG002|Overall Study|Death on study|1|||
150177309|NCT03531840|541786211|FG003|Overall Study|Death on study|2|||
150177310|NCT03531840|541786208|FG000|Overall Study|Death during follow up|2|||
150177311|NCT03531840|541786209|FG001|Overall Study|Death during follow up|3|||
150177312|NCT03531840|541786210|FG002|Overall Study|Death during follow up|4|||
150177313|NCT03531840|541786211|FG003|Overall Study|Death during follow up|1|||
150177314|NCT02267824|541786213|FG000|Overall Study|Pregnancy|1|||
149915740|NCT00415597|540822313|FG000|Enrollment|Withdrawal by Subject|1|||
149915741|NCT00415597|540822313|FG000|Enrollment|Protocol Violation|1|||
149915742|NCT00415597|540822313|FG000|Treatment|Adverse Event|110|||
149915743|NCT00415597|540822313|FG000|Treatment|Lack of Efficacy|39|||
149915744|NCT00415597|540822313|FG000|Treatment|Protocol Violation|67|||
149915745|NCT00415597|540822313|FG000|Treatment|Physician Decision|3|||
149915746|NCT00415597|540822313|FG000|Treatment|Withdrawal by Subject|51|||
149915747|NCT00415597|540822313|FG000|Treatment|Lost to Follow-up|28|||
149915748|NCT00415597|540822313|FG000|Treatment|Drug Screen|2|||
149915749|NCT00415597|540822313|FG000|Treatment|Administrative|3|||
149915750|NCT00415597|540822313|FG000|Treatment|Sponsor Decision|1|||
149915751|NCT00415597|540822313|FG000|Treatment|Multiple Reasons|1|||
150051328|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Death|0|||
150051329|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
150051330|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
150051331|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
150051332|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
150051333|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
150051334|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
150051335|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
150051336|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
150051337|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
150051338|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
150051339|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
150051340|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
150051341|NCT00884741|541329168|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
150051342|NCT00884741|541329169|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
150177315|NCT02267824|541786214|FG001|Overall Study|Pregnancy|1|||
150177316|NCT02267824|541786213|FG000|Overall Study|Lost to Follow-up|4|||
149915752|NCT04102865|540822315|FG000|Overall Study|Adverse Event|4|||
149915753|NCT04102865|540822316|FG001|Overall Study|Adverse Event|0|||
149915754|NCT04102865|540822315|FG000|Overall Study|Lost to Follow-up|1|||
150177317|NCT02267824|541786214|FG001|Overall Study|Lost to Follow-up|0|||
150177318|NCT02267824|541786213|FG000|Overall Study|Protocol Violation|3|||
150177319|NCT02267824|541786214|FG001|Overall Study|Protocol Violation|0|||
150177320|NCT02267824|541786213|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
150177321|NCT02267824|541786214|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
150177322|NCT00939510|541786215|FG000|Overall Study|Withdrawal by Subject|1|||
150177323|NCT02261467|541786217|FG000|Overall Study|Enrolled in Error|1|||
150177324|NCT02261467|541786218|FG001|Overall Study|Enrolled in Error|0|||
150177325|NCT02261467|541786217|FG000|Overall Study|Protocol Violation|0|||
150177326|NCT02261467|541786218|FG001|Overall Study|Protocol Violation|1|||
150177327|NCT02261467|541786217|FG000|Overall Study|Personal Reasons|17|||
150177328|NCT02261467|541786218|FG001|Overall Study|Personal Reasons|22|||
150177329|NCT02261467|541786217|FG000|Overall Study|Lost to Follow-up|2|||
150177330|NCT02261467|541786218|FG001|Overall Study|Lost to Follow-up|13|||
150051343|NCT00884741|541329170|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
150051344|NCT00884741|541329171|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
150051345|NCT00884741|541329168|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
150051346|NCT00884741|541329169|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
150051347|NCT00884741|541329170|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
150051348|NCT00884741|541329171|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
150051349|NCT00884741|541329168|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
150051350|NCT00884741|541329169|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
150051351|NCT00884741|541329170|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
150051352|NCT00884741|541329171|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
150051353|NCT00884741|541329168|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
150051354|NCT00884741|541329169|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
150051355|NCT00884741|541329170|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
150051356|NCT00884741|541329171|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
150051357|NCT00884741|541329168|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
150051358|NCT00884741|541329169|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
150051359|NCT00884741|541329170|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
150051360|NCT00884741|541329171|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
150051361|NCT00884741|541329168|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
150051362|NCT00884741|541329169|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
150051363|NCT00884741|541329170|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
150051364|NCT00884741|541329171|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
150051365|NCT00884741|541329168|FG000|Randomization|Protocol Violation|0|||
150051366|NCT00884741|541329169|FG001|Randomization|Protocol Violation|0|||
150051367|NCT00884741|541329170|FG002|Randomization|Protocol Violation|8|||
150051368|NCT00884741|541329171|FG003|Randomization|Protocol Violation|8|||
150051369|NCT02537015|541329173|FG000|Overall Study|Adverse Event|3|||
150051370|NCT02537015|541329173|FG000|Overall Study|Withdrawal by Subject|2|||
150051371|NCT02537015|541329173|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150051372|NCT01097005|541329179|FG000|Overall Study|Case Report Form not collected|18|||
150051373|NCT01097005|541329179|FG000|Overall Study|Subjects cannot visit the hospital|1|||
150051374|NCT01097005|541329179|FG000|Overall Study|Poor medication compliance|1|||
150051375|NCT01097005|541329179|FG000|Overall Study|No examination data available|244|||
150051376|NCT01097005|541329179|FG000|Overall Study|Deviation from exclusion criteria|37|||
150051377|NCT01097005|541329179|FG000|Overall Study|Adverse Event|14|||
150051378|NCT01097005|541329179|FG000|Overall Study|Discontinuance by complication|50|||
150051379|NCT04627285|541329180|FG000|Overall Study|Adverse Event|0|||
150051380|NCT04627285|541329181|FG001|Overall Study|Adverse Event|2|||
150051381|NCT04627285|541329180|FG000|Overall Study|Lost to Follow-up|1|||
150051382|NCT04627285|541329181|FG001|Overall Study|Lost to Follow-up|0|||
150051383|NCT04627285|541329180|FG000|Overall Study|Withdrawal by Subject|1|||
150051384|NCT04627285|541329181|FG001|Overall Study|Withdrawal by Subject|1|||
150051385|NCT04627285|541329180|FG000|Overall Study|Sponsor decision|5|||
150051386|NCT04627285|541329181|FG001|Overall Study|Sponsor decision|0|||
150051387|NCT04627285|541329180|FG000|Overall Study|Participant left country; aunt informed the site|0|||
150051388|NCT04627285|541329181|FG001|Overall Study|Participant left country; aunt informed the site|1|||
150177331|NCT02261467|541786217|FG000|Overall Study|Adverse Event|1|||
150177332|NCT02261467|541786218|FG001|Overall Study|Adverse Event|1|||
150051389|NCT01948193|541331315|FG000|Overall Study|Serious event|2|||
150051390|NCT01948193|541331315|FG000|Overall Study|Lost to Follow-up|7|||
150051391|NCT03338959|541331316|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
150177333|NCT01199705|541786219|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
150051392|NCT03338959|541331316|FG000|Overall Study|Physician Decision|1|||
150051393|NCT00409331|541331317|FG000|Overall Study|Physician Decision|1|||
150051394|NCT02184455|541331318|FG000|Overall Study|Lost to Follow-up|1|||
150051395|NCT00668733|541331325|FG000|Overall Study|Lost to Follow-up|2|||
150177334|NCT01415349|541786220|FG000|Treatment Period 1|Adverse Event|0|||
150177335|NCT01415349|541786221|FG001|Treatment Period 1|Adverse Event|1|||
150177336|NCT01415349|541786220|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149915755|NCT04102865|540822316|FG001|Overall Study|Lost to Follow-up|0|||
149915756|NCT04102865|540822315|FG000|Overall Study|Withdrawal by Subject|2|||
149915757|NCT04102865|540822316|FG001|Overall Study|Withdrawal by Subject|0|||
149915758|NCT01764997|540822317|FG000|Run-in Period|Adverse Event|15|||
149915759|NCT01764997|540822318|FG001|Run-in Period|Adverse Event|0|||
149915760|NCT01764997|540822319|FG002|Run-in Period|Adverse Event|0|||
149915761|NCT01764997|540822320|FG003|Run-in Period|Adverse Event|0|||
149915762|NCT01764997|540822321|FG004|Run-in Period|Adverse Event|0|||
149915763|NCT01764997|540822317|FG000|Run-in Period|Lack of Efficacy|5|||
149973233|NCT01770743|541040081|FG004|Overall Study|Lost to Follow-up|1|||
149973234|NCT01770743|541040077|FG000|Overall Study|Sponsor Terminated Subject|1|||
149973235|NCT01770743|541040078|FG001|Overall Study|Sponsor Terminated Subject|0|||
149973236|NCT01770743|541040079|FG002|Overall Study|Sponsor Terminated Subject|0|||
149973237|NCT01770743|541040080|FG003|Overall Study|Sponsor Terminated Subject|1|||
149973238|NCT01770743|541040081|FG004|Overall Study|Sponsor Terminated Subject|0|||
149973239|NCT01770743|541040077|FG000|Overall Study|Moving Out of State|0|||
149973240|NCT01770743|541040078|FG001|Overall Study|Moving Out of State|1|||
149973241|NCT01770743|541040079|FG002|Overall Study|Moving Out of State|0|||
149973242|NCT01770743|541040080|FG003|Overall Study|Moving Out of State|0|||
149973243|NCT01770743|541040081|FG004|Overall Study|Moving Out of State|0|||
149973244|NCT00652743|541040082|FG000|Months 12-18|Lost to Follow-up|1|||
149973245|NCT00652743|541040083|FG001|Months 12-18|Lost to Follow-up|2|||
149973246|NCT00652743|541040084|FG002|Months 12-18|Lost to Follow-up|7|||
149973247|NCT00652743|541040082|FG000|Months 24-30|Other|5|||
149973248|NCT00652743|541040083|FG001|Months 24-30|Other|1|||
149973249|NCT00652743|541040084|FG002|Months 24-30|Other|11|||
149973250|NCT00652743|541040082|FG000|Months 36-42|Serious Adverse Events|0|||
149973251|NCT00652743|541040083|FG001|Months 36-42|Serious Adverse Events|1|||
149973252|NCT00652743|541040084|FG002|Months 36-42|Serious Adverse Events|1|||
149973253|NCT00652743|541040082|FG000|Months 36-42|Withdrawal by Subject|1|||
149973254|NCT00652743|541040083|FG001|Months 36-42|Withdrawal by Subject|1|||
149973255|NCT00652743|541040084|FG002|Months 36-42|Withdrawal by Subject|0|||
149973256|NCT00652743|541040082|FG000|Months 36-42|Lost to Follow-up|0|||
149973257|NCT00652743|541040083|FG001|Months 36-42|Lost to Follow-up|1|||
149973258|NCT00652743|541040084|FG002|Months 36-42|Lost to Follow-up|0|||
149973259|NCT00652743|541040082|FG000|Months 36-42|Migrated/moved from study area|1|||
149973260|NCT00652743|541040083|FG001|Months 36-42|Migrated/moved from study area|0|||
149973261|NCT00652743|541040084|FG002|Months 36-42|Migrated/moved from study area|0|||
149973262|NCT00652743|541040082|FG000|Months 36-42|Other|4|||
149973263|NCT00652743|541040083|FG001|Months 36-42|Other|2|||
149973264|NCT00652743|541040084|FG002|Months 36-42|Other|8|||
149973265|NCT01585025|541040089|FG000|Overall Study|Withdrawal by Subject|0|||
149973266|NCT01585025|541040090|FG001|Overall Study|Withdrawal by Subject|3|||
149973267|NCT01585025|541040091|FG002|Overall Study|Withdrawal by Subject|4|||
149973268|NCT00503984|541040092|FG000|Overall Study|Protocol Violation|0|||
149973269|NCT00503984|541040093|FG001|Overall Study|Protocol Violation|1|||
149973270|NCT00503984|541040094|FG002|Overall Study|Protocol Violation|0|||
149973271|NCT00503984|541040095|FG003|Overall Study|Protocol Violation|0|||
149973272|NCT00503984|541040096|FG004|Overall Study|Protocol Violation|0|||
149973273|NCT00503984|541040097|FG005|Overall Study|Protocol Violation|0|||
149973274|NCT00503984|541040092|FG000|Overall Study|Adverse Event|0|||
149973275|NCT00503984|541040093|FG001|Overall Study|Adverse Event|1|||
149973276|NCT00503984|541040094|FG002|Overall Study|Adverse Event|0|||
149973277|NCT00503984|541040095|FG003|Overall Study|Adverse Event|0|||
149973278|NCT00503984|541040096|FG004|Overall Study|Adverse Event|0|||
149973279|NCT00503984|541040097|FG005|Overall Study|Adverse Event|0|||
149973280|NCT00503984|541040092|FG000|Overall Study|Death|0|||
149973281|NCT00503984|541040093|FG001|Overall Study|Death|0|||
149973282|NCT00503984|541040094|FG002|Overall Study|Death|0|||
149973283|NCT00503984|541040095|FG003|Overall Study|Death|0|||
149973284|NCT00503984|541040096|FG004|Overall Study|Death|1|||
149973285|NCT00503984|541040097|FG005|Overall Study|Death|0|||
149973286|NCT01246960|541040098|FG000|Overall Study|Lost to Follow-up|3|||
149973287|NCT01246960|541040099|FG001|Overall Study|Lost to Follow-up|1|||
149973288|NCT01246960|541040098|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
149973289|NCT01246960|541040099|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
149915764|NCT01764997|540822318|FG001|Run-in Period|Lack of Efficacy|0|||
149973290|NCT02122380|541040103|FG000|First Intervention (30 Days)|Adverse Event|1|||
149973291|NCT02122380|541040104|FG001|First Intervention (30 Days)|Adverse Event|0|||
149915765|NCT01764997|540822319|FG002|Run-in Period|Lack of Efficacy|0|||
149973292|NCT02122380|541040103|FG000|First Intervention (30 Days)|Physician Decision|0|||
149973293|NCT02122380|541040104|FG001|First Intervention (30 Days)|Physician Decision|1|||
149973294|NCT02122380|541040103|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
149973295|NCT02122380|541040104|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
149973296|NCT02122380|541040103|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
149973297|NCT02122380|541040104|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
150177337|NCT01415349|541786221|FG001|Treatment Period 1|Withdrawal by Subject|1|||
150177338|NCT01041417|541786222|FG000|Overall Study|Adverse Event|5|||
150177339|NCT01041417|541786223|FG001|Overall Study|Adverse Event|2|||
150177340|NCT01041417|541786222|FG000|Overall Study|Lost to Follow-up|1|||
150177341|NCT01041417|541786223|FG001|Overall Study|Lost to Follow-up|1|||
150177342|NCT01041417|541786222|FG000|Overall Study|Death|1|||
150177343|NCT01041417|541786223|FG001|Overall Study|Death|0|||
150177344|NCT02918071|541786224|FG000|Overall Study|Withdrawal by Subject|2|||
150177345|NCT02918071|541786224|FG000|Overall Study|Lost to Follow-up|1|||
150177346|NCT01616459|541786225|FG000|Overall Study|Adverse Event|1|||
150177347|NCT01616459|541786226|FG001|Overall Study|Adverse Event|1|||
150177348|NCT01616459|541786227|FG002|Overall Study|Adverse Event|2|||
150177349|NCT01616459|541786228|FG003|Overall Study|Adverse Event|0|||
150177350|NCT01616459|541786225|FG000|Overall Study|Lost to Follow-up|1|||
149915766|NCT01764997|540822320|FG003|Run-in Period|Lack of Efficacy|0|||
149915767|NCT01764997|540822321|FG004|Run-in Period|Lack of Efficacy|0|||
149915768|NCT01764997|540822317|FG000|Run-in Period|Poor compliance to protocol|1|||
149915769|NCT01764997|540822318|FG001|Run-in Period|Poor compliance to protocol|0|||
150177351|NCT01616459|541786226|FG001|Overall Study|Lost to Follow-up|11|||
150177352|NCT01616459|541786227|FG002|Overall Study|Lost to Follow-up|3|||
150177353|NCT01616459|541786228|FG003|Overall Study|Lost to Follow-up|2|||
149915770|NCT01764997|540822319|FG002|Run-in Period|Poor compliance to protocol|0|||
149915771|NCT01764997|540822320|FG003|Run-in Period|Poor compliance to protocol|0|||
149915772|NCT01764997|540822321|FG004|Run-in Period|Poor compliance to protocol|0|||
149915773|NCT01764997|540822317|FG000|Run-in Period|Other than specified above|17|||
149915774|NCT01764997|540822318|FG001|Run-in Period|Other than specified above|0|||
149915775|NCT01764997|540822319|FG002|Run-in Period|Other than specified above|0|||
149915776|NCT01764997|540822320|FG003|Run-in Period|Other than specified above|0|||
149915777|NCT01764997|540822321|FG004|Run-in Period|Other than specified above|0|||
150177354|NCT01616459|541786225|FG000|Overall Study|Protocol Violation|0|||
150177355|NCT01616459|541786226|FG001|Overall Study|Protocol Violation|0|||
150177356|NCT01616459|541786227|FG002|Overall Study|Protocol Violation|0|||
149915778|NCT01764997|540822317|FG000|Study Drug Treatment Period|Adverse Event|0|||
149915779|NCT01764997|540822318|FG001|Study Drug Treatment Period|Adverse Event|1|||
149915780|NCT01764997|540822319|FG002|Study Drug Treatment Period|Adverse Event|0|||
149915781|NCT01764997|540822320|FG003|Study Drug Treatment Period|Adverse Event|0|||
149915782|NCT01764997|540822321|FG004|Study Drug Treatment Period|Adverse Event|24|||
149915783|NCT01764997|540822317|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
149915784|NCT01764997|540822318|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
149915785|NCT01764997|540822319|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
149915786|NCT01764997|540822320|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
149915787|NCT01764997|540822321|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
149915788|NCT01764997|540822317|FG000|Study Drug Treatment Period|Other than specified above|0|||
149915789|NCT01764997|540822318|FG001|Study Drug Treatment Period|Other than specified above|0|||
149915790|NCT01764997|540822319|FG002|Study Drug Treatment Period|Other than specified above|0|||
149915791|NCT01764997|540822320|FG003|Study Drug Treatment Period|Other than specified above|0|||
149915792|NCT01764997|540822321|FG004|Study Drug Treatment Period|Other than specified above|10|||
149973298|NCT02122380|541040103|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
149973299|NCT02122380|541040104|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
149973300|NCT00952705|541040105|FG000|Overall Study|Lost to Follow-up|24|||
149973301|NCT00952705|541040106|FG001|Overall Study|Lost to Follow-up|8|||
149973302|NCT00952705|541040107|FG002|Overall Study|Lost to Follow-up|9|||
149973303|NCT00952705|541040105|FG000|Overall Study|Withdrawal by Subject|2|||
149973304|NCT00952705|541040106|FG001|Overall Study|Withdrawal by Subject|1|||
149973305|NCT00952705|541040107|FG002|Overall Study|Withdrawal by Subject|1|||
149973306|NCT00952705|541040105|FG000|Overall Study|Death|2|||
149973307|NCT00952705|541040106|FG001|Overall Study|Death|0|||
149973308|NCT00952705|541040107|FG002|Overall Study|Death|0|||
149973309|NCT00952705|541040105|FG000|Overall Study|Incarcerated post dose|5|||
149973310|NCT00952705|541040106|FG001|Overall Study|Incarcerated post dose|0|||
149973311|NCT00952705|541040107|FG002|Overall Study|Incarcerated post dose|0|||
149973312|NCT00952705|541040105|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
149973313|NCT00952705|541040106|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
149973314|NCT00952705|541040107|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
149973315|NCT00140140|541040108|FG000|Overall Study|Unacceptable toxicity|1|||
150177357|NCT01616459|541786228|FG003|Overall Study|Protocol Violation|2|||
150177358|NCT01616459|541786225|FG000|Overall Study|Withdrawal by Subject|2|||
149973316|NCT00140140|541040109|FG001|Overall Study|Unacceptable toxicity|1|||
149973317|NCT00140140|541040110|FG002|Overall Study|Unacceptable toxicity|2|||
149973318|NCT00140140|541040108|FG000|Overall Study|Physician Decision|1|||
149973319|NCT00140140|541040109|FG001|Overall Study|Physician Decision|1|||
149973320|NCT00140140|541040110|FG002|Overall Study|Physician Decision|0|||
149973321|NCT04102007|541040111|FG000|Overall Study|Adverse Event|4|||
149973322|NCT04102007|541040111|FG000|Overall Study|Lost to Follow-up|3|||
150177359|NCT01616459|541786226|FG001|Overall Study|Withdrawal by Subject|4|||
150177360|NCT01616459|541786227|FG002|Overall Study|Withdrawal by Subject|4|||
150051396|NCT00668733|541331326|FG001|Overall Study|Lost to Follow-up|3|||
150051397|NCT00668733|541331325|FG000|Overall Study|Withdrawal by Subject|0|||
150051398|NCT00668733|541331326|FG001|Overall Study|Withdrawal by Subject|4|||
150051399|NCT00538785|541331327|FG000|Overall Study|Death|9|||
150051400|NCT00538785|541331328|FG001|Overall Study|Death|10|||
150051401|NCT00538785|541331327|FG000|Overall Study|Withdrawal of consent|9|||
150051402|NCT00538785|541331328|FG001|Overall Study|Withdrawal of consent|7|||
150051403|NCT00538785|541331327|FG000|Overall Study|Lost to Follow-up|1|||
150051404|NCT00538785|541331328|FG001|Overall Study|Lost to Follow-up|0|||
150051405|NCT05315908|541331336|FG000|Overall Study|Lost to Follow-up|4477|||
150051406|NCT05315908|541331337|FG001|Overall Study|Lost to Follow-up|4606|||
150051407|NCT00294762|541331338|FG000|Overall Study|Did not receive study treatment|3|||
150051408|NCT00294762|541331339|FG001|Overall Study|Did not receive study treatment|3|||
150051409|NCT02937584|541331340|FG000|Period 1|Adverse Event|1|||
150051410|NCT02937584|541331341|FG001|Period 1|Adverse Event|2|||
150051411|NCT02937584|541331340|FG000|Washout|Adverse Event|0|||
150051412|NCT02937584|541331341|FG001|Washout|Adverse Event|1|||
150051413|NCT02238080|541331350|FG000|Overall Study|Death|13|||
150051414|NCT02238080|541331350|FG000|Overall Study|Treatment interrupted|6|||
150051415|NCT02238080|541331350|FG000|Overall Study|Withdrawal by Subject|2|||
150051416|NCT02238080|541331350|FG000|Overall Study|Other|4|||
150051417|NCT01738646|541331351|FG000|Overall Study|Still Receiving Treatment|2|||
150051418|NCT01598129|541331352|FG000|Overall Study|Disease progression|6|||
150051419|NCT01598129|541331352|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
150051420|NCT01598129|541331352|FG000|Overall Study|Withdrawal by Subject|1|||
150051421|NCT00505076|541331353|FG000|Overall Study|Adverse Event|1|||
150051422|NCT00505076|541331354|FG001|Overall Study|Adverse Event|0|||
150051423|NCT00505076|541331355|FG002|Overall Study|Adverse Event|1|||
150051424|NCT00505076|541331353|FG000|Overall Study|Protocol Violation|2|||
150051425|NCT00505076|541331354|FG001|Overall Study|Protocol Violation|1|||
150051426|NCT00505076|541331355|FG002|Overall Study|Protocol Violation|2|||
150051427|NCT00505076|541331353|FG000|Overall Study|Withdrawal by Subject|0|||
150051428|NCT00505076|541331354|FG001|Overall Study|Withdrawal by Subject|1|||
150051429|NCT00505076|541331355|FG002|Overall Study|Withdrawal by Subject|2|||
150051430|NCT04093024|541331358|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
150051431|NCT04093024|541331359|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
150051432|NCT04093024|541331358|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
150051433|NCT04093024|541331359|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
150051434|NCT04093024|541331358|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
150051435|NCT04093024|541331359|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
150051436|NCT04093024|541331358|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
150051437|NCT04093024|541331359|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
150051438|NCT00647270|541331364|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
150051439|NCT00647270|541331365|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
150051440|NCT00647270|541331366|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
150051441|NCT00647270|541331364|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
150051442|NCT00647270|541331365|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
150051443|NCT00647270|541331366|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
150051444|NCT00647270|541331364|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
150051445|NCT00647270|541331365|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
150051446|NCT00647270|541331366|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
150051447|NCT00647270|541331364|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
150051448|NCT00647270|541331365|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
150051449|NCT00647270|541331366|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
149973323|NCT04102007|541040111|FG000|Overall Study|Withdrawal by Subject|12|||
149973324|NCT04102007|541040111|FG000|Overall Study|Eligibility Violation|5|||
149973325|NCT04102007|541040111|FG000|Overall Study|Lack of Efficacy|6|||
149973326|NCT04102007|541040111|FG000|Overall Study|Protocol Deviation|5|||
149973327|NCT04102007|541040111|FG000|Overall Study|Protocol Compliance|1|||
149973328|NCT04102007|541040111|FG000|Overall Study|Withdrew Treatment|2|||
149973329|NCT04102007|541040111|FG000|Overall Study|Pregnancy|1|||
149973330|NCT05173974|541040112|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
149973331|NCT05173974|541040113|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
149973332|NCT05173974|541040114|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
149973333|NCT05173974|541040115|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
150051450|NCT00647270|541331364|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
150051451|NCT00647270|541331365|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
150051452|NCT00647270|541331366|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
150051453|NCT00647270|541331364|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
149973334|NCT05173974|541040112|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
149973335|NCT05173974|541040113|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
149973336|NCT05173974|541040114|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
149973337|NCT05173974|541040115|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
149973338|NCT03289143|541040116|FG000|Overall Study|Caregiver Unavailability|1|||
149973339|NCT03289143|541040117|FG001|Overall Study|Caregiver Unavailability|1|||
149973340|NCT03289143|541040118|FG002|Overall Study|Caregiver Unavailability|0|||
149973341|NCT03289143|541040119|FG003|Overall Study|Caregiver Unavailability|0|||
149973342|NCT03289143|541040116|FG000|Overall Study|Research Department Closure|0|||
149973343|NCT03289143|541040117|FG001|Overall Study|Research Department Closure|0|||
149973344|NCT03289143|541040118|FG002|Overall Study|Research Department Closure|1|||
149973345|NCT03289143|541040119|FG003|Overall Study|Research Department Closure|0|||
149973346|NCT03289143|541040116|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
149973347|NCT03289143|541040117|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
149973348|NCT03289143|541040118|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
149973349|NCT03289143|541040119|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
149973350|NCT03289143|541040116|FG000|Overall Study|Medical Monitor Decision|1|||
149973351|NCT03289143|541040117|FG001|Overall Study|Medical Monitor Decision|0|||
149973352|NCT03289143|541040118|FG002|Overall Study|Medical Monitor Decision|0|||
149973353|NCT03289143|541040119|FG003|Overall Study|Medical Monitor Decision|0|||
149973354|NCT03289143|541040116|FG000|Overall Study|Participant Non-Compliance|0|||
149973355|NCT03289143|541040117|FG001|Overall Study|Participant Non-Compliance|0|||
149973356|NCT03289143|541040118|FG002|Overall Study|Participant Non-Compliance|1|||
149973357|NCT03289143|541040119|FG003|Overall Study|Participant Non-Compliance|0|||
149973358|NCT03289143|541040116|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
149973359|NCT03289143|541040117|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
149973360|NCT03289143|541040118|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
149973361|NCT03289143|541040119|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
149973362|NCT03289143|541040116|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
149973363|NCT03289143|541040117|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
149973364|NCT03289143|541040118|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
149973365|NCT03289143|541040119|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
149973366|NCT03289143|541040116|FG000|Overall Study|Caregiver Passed Away|1|||
149973367|NCT03289143|541040117|FG001|Overall Study|Caregiver Passed Away|0|||
149973368|NCT03289143|541040118|FG002|Overall Study|Caregiver Passed Away|0|||
149973369|NCT03289143|541040119|FG003|Overall Study|Caregiver Passed Away|0|||
149973370|NCT03289143|541040116|FG000|Overall Study|Physician Decision|0|||
149973371|NCT03289143|541040117|FG001|Overall Study|Physician Decision|2|||
149973372|NCT03289143|541040118|FG002|Overall Study|Physician Decision|2|||
150051454|NCT00647270|541331365|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
150051455|NCT00647270|541331366|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
150051456|NCT00647270|541331364|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
150051457|NCT00647270|541331365|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
150051458|NCT00647270|541331366|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
150051459|NCT01565343|541331367|FG000|Overall Study|Administrative decision/technical issues|1|||
150051460|NCT01565343|541331368|FG001|Overall Study|Administrative decision/technical issues|0|||
150051461|NCT01565343|541331369|FG002|Overall Study|Administrative decision/technical issues|0|||
150051462|NCT00638183|541331371|FG000|Overall Study|Adverse Event|23|||
150051463|NCT00638183|541331371|FG000|Overall Study|Lack of Efficacy|14|||
150051464|NCT00638183|541331371|FG000|Overall Study|Physician Decision|9|||
150051465|NCT00638183|541331371|FG000|Overall Study|Lost to Follow-up|46|||
150051466|NCT00638183|541331371|FG000|Overall Study|Other reason not defined above|27|||
150051467|NCT02059291|541331372|FG000|Epoch 2|Lack of Efficacy|0|||
150051468|NCT02059291|541331373|FG001|Epoch 2|Lack of Efficacy|0|||
150051469|NCT02059291|541331374|FG002|Epoch 2|Lack of Efficacy|0|||
150051470|NCT02059291|541331375|FG003|Epoch 2|Lack of Efficacy|1|||
150051471|NCT02059291|541331376|FG004|Epoch 2|Lack of Efficacy|0|||
150051472|NCT02059291|541331377|FG005|Epoch 2|Lack of Efficacy|1|||
150051473|NCT02059291|541331378|FG006|Epoch 2|Lack of Efficacy|0|||
150051474|NCT02059291|541331379|FG007|Epoch 2|Lack of Efficacy|0|||
150051475|NCT02059291|541331380|FG008|Epoch 2|Lack of Efficacy|0|||
150051476|NCT02059291|541331381|FG009|Epoch 2|Lack of Efficacy|0|||
150051477|NCT02059291|541331382|FG010|Epoch 2|Lack of Efficacy|0|||
150051478|NCT02059291|541331383|FG011|Epoch 2|Lack of Efficacy|0|||
150051479|NCT02059291|541331384|FG012|Epoch 2|Lack of Efficacy|0|||
150051480|NCT02059291|541331385|FG013|Epoch 2|Lack of Efficacy|0|||
150051481|NCT02059291|541331386|FG014|Epoch 2|Lack of Efficacy|0|||
150051482|NCT02059291|541331387|FG015|Epoch 2|Lack of Efficacy|0|||
150051483|NCT02059291|541331388|FG016|Epoch 2|Lack of Efficacy|0|||
150051484|NCT02059291|541331389|FG017|Epoch 2|Lack of Efficacy|0|||
150051485|NCT02059291|541331390|FG018|Epoch 2|Lack of Efficacy|0|||
150051486|NCT02059291|541331391|FG019|Epoch 2|Lack of Efficacy|0|||
150051487|NCT02059291|541331392|FG020|Epoch 2|Lack of Efficacy|0|||
150051488|NCT02059291|541331393|FG021|Epoch 2|Lack of Efficacy|0|||
150051489|NCT02059291|541331394|FG022|Epoch 2|Lack of Efficacy|0|||
150051490|NCT02059291|541331395|FG023|Epoch 2|Lack of Efficacy|0|||
150051491|NCT02059291|541331396|FG024|Epoch 2|Lack of Efficacy|0|||
149973373|NCT03289143|541040119|FG003|Overall Study|Physician Decision|2|||
149973374|NCT03289143|541040116|FG000|Overall Study|Protocol Deviation|2|||
149973375|NCT03289143|541040117|FG001|Overall Study|Protocol Deviation|1|||
149973376|NCT03289143|541040118|FG002|Overall Study|Protocol Deviation|3|||
149973377|NCT03289143|541040119|FG003|Overall Study|Protocol Deviation|1|||
149973378|NCT03289143|541040116|FG000|Overall Study|Study Terminated By Sponsor|101|||
149973379|NCT03289143|541040117|FG001|Overall Study|Study Terminated By Sponsor|75|||
149973380|NCT03289143|541040118|FG002|Overall Study|Study Terminated By Sponsor|100|||
150051492|NCT02059291|541331372|FG000|Epoch 2|Adverse Event|0|||
150051493|NCT02059291|541331373|FG001|Epoch 2|Adverse Event|0|||
150051494|NCT02059291|541331374|FG002|Epoch 2|Adverse Event|1|||
150051495|NCT02059291|541331375|FG003|Epoch 2|Adverse Event|1|||
150051496|NCT02059291|541331376|FG004|Epoch 2|Adverse Event|0|||
150051497|NCT02059291|541331377|FG005|Epoch 2|Adverse Event|0|||
150051498|NCT02059291|541331378|FG006|Epoch 2|Adverse Event|0|||
150051499|NCT02059291|541331379|FG007|Epoch 2|Adverse Event|1|||
150051500|NCT02059291|541331380|FG008|Epoch 2|Adverse Event|1|||
150051501|NCT02059291|541331381|FG009|Epoch 2|Adverse Event|0|||
150051502|NCT02059291|541331382|FG010|Epoch 2|Adverse Event|0|||
150051503|NCT02059291|541331383|FG011|Epoch 2|Adverse Event|0|||
150051504|NCT02059291|541331384|FG012|Epoch 2|Adverse Event|0|||
149973381|NCT03289143|541040119|FG003|Overall Study|Study Terminated By Sponsor|69|||
149973382|NCT03289143|541040116|FG000|Overall Study|Withdrawal by Subject|14|||
149973383|NCT03289143|541040117|FG001|Overall Study|Withdrawal by Subject|6|||
149973384|NCT03289143|541040118|FG002|Overall Study|Withdrawal by Subject|14|||
150051505|NCT02059291|541331385|FG013|Epoch 2|Adverse Event|0|||
149973385|NCT03289143|541040119|FG003|Overall Study|Withdrawal by Subject|12|||
149973386|NCT03289143|541040116|FG000|Overall Study|Adverse Event|10|||
149973387|NCT03289143|541040117|FG001|Overall Study|Adverse Event|7|||
149973388|NCT03289143|541040118|FG002|Overall Study|Adverse Event|6|||
149973389|NCT03289143|541040119|FG003|Overall Study|Adverse Event|5|||
149973390|NCT03289143|541040116|FG000|Overall Study|Death|2|||
149973391|NCT03289143|541040117|FG001|Overall Study|Death|0|||
149973392|NCT03289143|541040118|FG002|Overall Study|Death|2|||
149973393|NCT03289143|541040119|FG003|Overall Study|Death|1|||
149973394|NCT03289143|541040116|FG000|Overall Study|Lost to Follow-up|2|||
149973395|NCT03289143|541040117|FG001|Overall Study|Lost to Follow-up|1|||
149973396|NCT03289143|541040118|FG002|Overall Study|Lost to Follow-up|1|||
149973397|NCT03289143|541040119|FG003|Overall Study|Lost to Follow-up|0|||
149973398|NCT03289143|541040116|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
149973399|NCT03289143|541040117|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
149973400|NCT03289143|541040118|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
149973401|NCT03289143|541040119|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
149973402|NCT03289143|541040116|FG000|Overall Study|Withdrawal by Caregiver|0|||
149973403|NCT03289143|541040117|FG001|Overall Study|Withdrawal by Caregiver|1|||
149973404|NCT03289143|541040118|FG002|Overall Study|Withdrawal by Caregiver|0|||
149973405|NCT03289143|541040119|FG003|Overall Study|Withdrawal by Caregiver|0|||
149973406|NCT03289143|541040116|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
149973407|NCT03289143|541040117|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
149973408|NCT03289143|541040118|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
149973409|NCT03289143|541040119|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
149973410|NCT03289143|541040116|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
149973411|NCT03289143|541040117|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
149973412|NCT03289143|541040118|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
149973413|NCT03289143|541040119|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
149973414|NCT00948688|541040120|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
149973415|NCT00948688|541040121|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
149973416|NCT00948688|541040120|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
149973417|NCT00948688|541040121|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
149973418|NCT00948688|541040120|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
149973419|NCT00948688|541040121|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
149973420|NCT00730756|541040122|FG000|Overall Study|Adverse Event|2|||
149973421|NCT00730756|541040123|FG001|Overall Study|Adverse Event|0|||
149973422|NCT00730756|541040122|FG000|Overall Study|Lack of Efficacy|1|||
149973423|NCT00730756|541040123|FG001|Overall Study|Lack of Efficacy|1|||
149973424|NCT00730756|541040122|FG000|Overall Study|Protocol Deviation|1|||
149973425|NCT00730756|541040123|FG001|Overall Study|Protocol Deviation|2|||
149973426|NCT00730756|541040122|FG000|Overall Study|Lost to Follow-up|0|||
149973427|NCT00730756|541040123|FG001|Overall Study|Lost to Follow-up|1|||
149973428|NCT00730756|541040122|FG000|Overall Study|Withdrew Consent|0|||
150051506|NCT02059291|541331386|FG014|Epoch 2|Adverse Event|0|||
150051507|NCT02059291|541331387|FG015|Epoch 2|Adverse Event|0|||
149973429|NCT00730756|541040123|FG001|Overall Study|Withdrew Consent|1|||
149973430|NCT01840943|541040126|FG000|Overall Study|Withdrawal by Subject|5|||
150051508|NCT02059291|541331388|FG016|Epoch 2|Adverse Event|0|||
150051509|NCT02059291|541331389|FG017|Epoch 2|Adverse Event|0|||
150051510|NCT02059291|541331390|FG018|Epoch 2|Adverse Event|0|||
150051511|NCT02059291|541331391|FG019|Epoch 2|Adverse Event|0|||
149973431|NCT01840943|541040127|FG001|Overall Study|Withdrawal by Subject|6|||
150177361|NCT01616459|541786228|FG003|Overall Study|Withdrawal by Subject|4|||
150177362|NCT01616459|541786225|FG000|Overall Study|Other reason|0|||
150177363|NCT01616459|541786226|FG001|Overall Study|Other reason|1|||
150177364|NCT01616459|541786227|FG002|Overall Study|Other reason|1|||
150177365|NCT01616459|541786228|FG003|Overall Study|Other reason|0|||
150177366|NCT03394885|541786229|FG000|Overall Study|Adverse Event|4|||
150177367|NCT03394885|541786229|FG000|Overall Study|Lack of Efficacy|1|||
150177368|NCT03394885|541786229|FG000|Overall Study|Physician Decision|1|||
150177369|NCT03394885|541786229|FG000|Overall Study|Withdrawal by Subject|8|||
150177370|NCT03394885|541786229|FG000|Overall Study|Alternative Therapy|1|||
150177371|NCT00203411|541786233|FG000|Follow-up|Progressive Disease|4|||
150177372|NCT04980755|541786234|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
150177373|NCT04980755|541786234|FG000|Body Reprogramming Courses|Work commitment|2|||
150177374|NCT04980755|541786234|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
150177375|NCT04980755|541786234|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
150177376|NCT01212991|541786235|FG000|Double-blind|Lost to Follow-up|8|||
150177377|NCT01212991|541786236|FG001|Double-blind|Lost to Follow-up|4|||
150177378|NCT01212991|541786237|FG002|Double-blind|Lost to Follow-up|0|||
150177379|NCT01212991|541786235|FG000|Double-blind|Death|699|||
150177380|NCT01212991|541786236|FG001|Double-blind|Death|550|||
150177381|NCT01212991|541786237|FG002|Double-blind|Death|0|||
150177382|NCT01212991|541786235|FG000|Double-blind|Withdrawal by Subject|16|||
150177383|NCT01212991|541786236|FG001|Double-blind|Withdrawal by Subject|19|||
150177384|NCT01212991|541786237|FG002|Double-blind|Withdrawal by Subject|0|||
150177385|NCT01212991|541786235|FG000|Double-blind|Other|7|||
150177386|NCT01212991|541786236|FG001|Double-blind|Other|0|||
150177387|NCT01212991|541786237|FG002|Double-blind|Other|0|||
150177388|NCT01212991|541786235|FG000|Double-blind|Sponsor decision|142|||
150177389|NCT01212991|541786236|FG001|Double-blind|Sponsor decision|38|||
150177390|NCT01212991|541786237|FG002|Double-blind|Sponsor decision|0|||
150177391|NCT01212991|541786235|FG000|Open-label|Death|0|||
150177392|NCT01212991|541786236|FG001|Open-label|Death|0|||
150177393|NCT01212991|541786237|FG002|Open-label|Death|166|||
150177394|NCT01212991|541786235|FG000|Open-label|Lost to Follow-up|0|||
150177395|NCT01212991|541786236|FG001|Open-label|Lost to Follow-up|0|||
150177396|NCT01212991|541786237|FG002|Open-label|Lost to Follow-up|5|||
150177397|NCT01212991|541786235|FG000|Open-label|Withdrawal by Subject|0|||
150177398|NCT01212991|541786236|FG001|Open-label|Withdrawal by Subject|0|||
150177399|NCT01212991|541786237|FG002|Open-label|Withdrawal by Subject|7|||
150177400|NCT01212991|541786235|FG000|Open-label|Sponsor decision|0|||
150177401|NCT01212991|541786236|FG001|Open-label|Sponsor decision|0|||
150177402|NCT01212991|541786237|FG002|Open-label|Sponsor decision|53|||
150177403|NCT01212991|541786235|FG000|Open-label|Other|0|||
150177404|NCT01212991|541786236|FG001|Open-label|Other|0|||
149973432|NCT01840943|541040126|FG000|Overall Study|Physician Decision|4|||
149973433|NCT01840943|541040127|FG001|Overall Study|Physician Decision|2|||
150177405|NCT01212991|541786237|FG002|Open-label|Other|3|||
150177406|NCT02531113|541786244|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
149973434|NCT01840943|541040126|FG000|Overall Study|Lost to Follow-up|4|||
149973435|NCT01840943|541040127|FG001|Overall Study|Lost to Follow-up|4|||
149973436|NCT01446874|541040128|FG000|Overall Study|Not eligible|1|||
149973437|NCT01446874|541040129|FG001|Overall Study|Not eligible|0|||
149973438|NCT01446874|541040130|FG002|Overall Study|Not eligible|0|||
149973439|NCT01446874|541040128|FG000|Overall Study|No surgery/No qualifying surgery|1|||
149973440|NCT01446874|541040129|FG001|Overall Study|No surgery/No qualifying surgery|0|||
149973441|NCT01446874|541040130|FG002|Overall Study|No surgery/No qualifying surgery|12|||
149973442|NCT01446874|541040128|FG000|Overall Study|Non-compliance|0|||
149973443|NCT01446874|541040129|FG001|Overall Study|Non-compliance|4|||
149973444|NCT01446874|541040130|FG002|Overall Study|Non-compliance|0|||
149973445|NCT01446874|541040128|FG000|Overall Study|Antibiotics for pre-op infection|0|||
149973446|NCT01446874|541040129|FG001|Overall Study|Antibiotics for pre-op infection|0|||
149973447|NCT01446874|541040130|FG002|Overall Study|Antibiotics for pre-op infection|2|||
149973448|NCT01446874|541040128|FG000|Overall Study|Withdrawal by Subject|0|||
149973449|NCT01446874|541040129|FG001|Overall Study|Withdrawal by Subject|0|||
149973450|NCT01446874|541040130|FG002|Overall Study|Withdrawal by Subject|4|||
149973451|NCT01135992|541040131|FG000|Overall Study|Adverse Event|1|||
149973452|NCT01135992|541040131|FG000|Overall Study|Lack of Efficacy|1|||
149973453|NCT01135992|541040131|FG000|Overall Study|Protocol Violation|2|||
149973454|NCT01135992|541040131|FG000|Overall Study|Withdrawal criteria|10|||
150177407|NCT02531113|541786244|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
150177408|NCT02531113|541786244|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
150177409|NCT02531113|541786244|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
150177410|NCT02531113|541786244|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
150177411|NCT02531113|541786244|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
150177412|NCT02531113|541786244|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
150177413|NCT02531113|541786244|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
150177414|NCT00632424|541786245|FG000|Overall Study|Disease Progression|17|||
150177415|NCT00632424|541786245|FG000|Overall Study|Study Drug Toxicity|1|||
150177416|NCT00801983|541786246|FG000|Period 1|Lost to Follow-up|2|||
150177417|NCT00801983|541786247|FG001|Period 1|Lost to Follow-up|0|||
150177418|NCT00801983|541786246|FG000|Period 1|Withdrawal by Subject|2|||
150177419|NCT00801983|541786247|FG001|Period 1|Withdrawal by Subject|8|||
150177420|NCT00801983|541786246|FG000|Period 2|Withdrawal by Subject|2|||
150177421|NCT00801983|541786247|FG001|Period 2|Withdrawal by Subject|1|||
150177422|NCT03122886|541788084|FG000|Overall Study|Withdrawal by Subject|1|||
150177423|NCT03122886|541788085|FG001|Overall Study|Withdrawal by Subject|2|||
150177424|NCT03312907|541788086|FG000|Overall Study|Adverse Event|1|||
150177425|NCT03312907|541788087|FG001|Overall Study|Adverse Event|6|||
150177426|NCT03312907|541788088|FG002|Overall Study|Adverse Event|1|||
150177427|NCT03312907|541788086|FG000|Overall Study|Protocol Violation|2|||
150177428|NCT03312907|541788087|FG001|Overall Study|Protocol Violation|3|||
150177429|NCT03312907|541788088|FG002|Overall Study|Protocol Violation|4|||
150177430|NCT03312907|541788086|FG000|Overall Study|Lost to Follow-up|2|||
150177431|NCT03312907|541788087|FG001|Overall Study|Lost to Follow-up|3|||
150177432|NCT03312907|541788088|FG002|Overall Study|Lost to Follow-up|2|||
150177433|NCT03312907|541788086|FG000|Overall Study|Physician Decision|3|||
150177434|NCT03312907|541788087|FG001|Overall Study|Physician Decision|4|||
150177435|NCT03312907|541788088|FG002|Overall Study|Physician Decision|2|||
150177436|NCT03312907|541788086|FG000|Overall Study|Withdrawal by Subject|9|||
150177437|NCT03312907|541788087|FG001|Overall Study|Withdrawal by Subject|14|||
150177438|NCT03312907|541788088|FG002|Overall Study|Withdrawal by Subject|10|||
150177439|NCT04688450|541788091|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
150177440|NCT04688450|541788091|FG000|Overall Study|Withdrawal by Subject|1|||
150177441|NCT02544074|541788092|FG000|Overall Study|Withdrawal by Subject|0|||
150177442|NCT02544074|541788093|FG001|Overall Study|Withdrawal by Subject|1|||
150177443|NCT02544074|541788094|FG002|Overall Study|Withdrawal by Subject|0|||
150177444|NCT02544074|541788095|FG003|Overall Study|Withdrawal by Subject|0|||
150177445|NCT02544074|541788096|FG004|Overall Study|Withdrawal by Subject|0|||
150177446|NCT02544074|541788097|FG005|Overall Study|Withdrawal by Subject|0|||
150177447|NCT02544074|541788098|FG006|Overall Study|Withdrawal by Subject|0|||
150177448|NCT02544074|541788099|FG007|Overall Study|Withdrawal by Subject|0|||
150177449|NCT02544074|541788100|FG008|Overall Study|Withdrawal by Subject|0|||
150177450|NCT02544074|541788101|FG009|Overall Study|Withdrawal by Subject|0|||
150177451|NCT02544074|541788102|FG010|Overall Study|Withdrawal by Subject|0|||
150177452|NCT02544074|541788103|FG011|Overall Study|Withdrawal by Subject|0|||
150177453|NCT02544074|541788104|FG012|Overall Study|Withdrawal by Subject|0|||
150177454|NCT02544074|541788105|FG013|Overall Study|Withdrawal by Subject|0|||
150177455|NCT02544074|541788106|FG014|Overall Study|Withdrawal by Subject|0|||
150177456|NCT02544074|541788107|FG015|Overall Study|Withdrawal by Subject|0|||
150177457|NCT02544074|541788108|FG016|Overall Study|Withdrawal by Subject|0|||
150177458|NCT02544074|541788109|FG017|Overall Study|Withdrawal by Subject|0|||
150177459|NCT02544074|541788110|FG018|Overall Study|Withdrawal by Subject|0|||
150177460|NCT02544074|541788111|FG019|Overall Study|Withdrawal by Subject|0|||
150177461|NCT02544074|541788112|FG020|Overall Study|Withdrawal by Subject|0|||
150177462|NCT02544074|541788092|FG000|Overall Study|Tablet error|0|||
150177463|NCT02544074|541788093|FG001|Overall Study|Tablet error|0|||
150177464|NCT02544074|541788094|FG002|Overall Study|Tablet error|0|||
150177465|NCT02544074|541788095|FG003|Overall Study|Tablet error|0|||
150177466|NCT02544074|541788096|FG004|Overall Study|Tablet error|0|||
150177467|NCT02544074|541788097|FG005|Overall Study|Tablet error|1|||
150177468|NCT02544074|541788098|FG006|Overall Study|Tablet error|0|||
150177469|NCT02544074|541788099|FG007|Overall Study|Tablet error|0|||
150177470|NCT02544074|541788100|FG008|Overall Study|Tablet error|0|||
150177471|NCT02544074|541788101|FG009|Overall Study|Tablet error|1|||
150177472|NCT02544074|541788102|FG010|Overall Study|Tablet error|0|||
150177473|NCT02544074|541788103|FG011|Overall Study|Tablet error|0|||
150177474|NCT02544074|541788104|FG012|Overall Study|Tablet error|0|||
150177475|NCT02544074|541788105|FG013|Overall Study|Tablet error|0|||
150177476|NCT02544074|541788106|FG014|Overall Study|Tablet error|0|||
150177477|NCT02544074|541788107|FG015|Overall Study|Tablet error|0|||
150177478|NCT02544074|541788108|FG016|Overall Study|Tablet error|0|||
150177479|NCT02544074|541788109|FG017|Overall Study|Tablet error|0|||
150177480|NCT02544074|541788110|FG018|Overall Study|Tablet error|0|||
150177481|NCT02544074|541788111|FG019|Overall Study|Tablet error|0|||
150177482|NCT02544074|541788112|FG020|Overall Study|Tablet error|0|||
150177483|NCT03189524|541788114|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
150177484|NCT03189524|541788115|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
150177485|NCT03189524|541788116|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
150051512|NCT02059291|541331392|FG020|Epoch 2|Adverse Event|0|||
150051513|NCT02059291|541331393|FG021|Epoch 2|Adverse Event|0|||
150051514|NCT02059291|541331394|FG022|Epoch 2|Adverse Event|0|||
150051515|NCT02059291|541331395|FG023|Epoch 2|Adverse Event|0|||
150051516|NCT02059291|541331396|FG024|Epoch 2|Adverse Event|0|||
150051517|NCT02059291|541331372|FG000|Epoch 2|Withdrawal by Subject|0|||
150051518|NCT02059291|541331373|FG001|Epoch 2|Withdrawal by Subject|1|||
150051519|NCT02059291|541331374|FG002|Epoch 2|Withdrawal by Subject|0|||
150051520|NCT02059291|541331375|FG003|Epoch 2|Withdrawal by Subject|0|||
150051521|NCT02059291|541331376|FG004|Epoch 2|Withdrawal by Subject|0|||
150051522|NCT02059291|541331377|FG005|Epoch 2|Withdrawal by Subject|1|||
150051523|NCT02059291|541331378|FG006|Epoch 2|Withdrawal by Subject|0|||
150051524|NCT02059291|541331379|FG007|Epoch 2|Withdrawal by Subject|0|||
150051525|NCT02059291|541331380|FG008|Epoch 2|Withdrawal by Subject|1|||
150051526|NCT02059291|541331381|FG009|Epoch 2|Withdrawal by Subject|0|||
150051527|NCT02059291|541331382|FG010|Epoch 2|Withdrawal by Subject|0|||
150051528|NCT02059291|541331383|FG011|Epoch 2|Withdrawal by Subject|0|||
150051529|NCT02059291|541331384|FG012|Epoch 2|Withdrawal by Subject|0|||
150051530|NCT02059291|541331385|FG013|Epoch 2|Withdrawal by Subject|0|||
150051531|NCT02059291|541331386|FG014|Epoch 2|Withdrawal by Subject|0|||
150051532|NCT02059291|541331387|FG015|Epoch 2|Withdrawal by Subject|0|||
150051533|NCT02059291|541331388|FG016|Epoch 2|Withdrawal by Subject|0|||
150051534|NCT02059291|541331389|FG017|Epoch 2|Withdrawal by Subject|0|||
150051535|NCT02059291|541331390|FG018|Epoch 2|Withdrawal by Subject|0|||
150051536|NCT02059291|541331391|FG019|Epoch 2|Withdrawal by Subject|0|||
150051537|NCT02059291|541331392|FG020|Epoch 2|Withdrawal by Subject|0|||
150051538|NCT02059291|541331393|FG021|Epoch 2|Withdrawal by Subject|0|||
150051539|NCT02059291|541331394|FG022|Epoch 2|Withdrawal by Subject|0|||
150051540|NCT02059291|541331395|FG023|Epoch 2|Withdrawal by Subject|0|||
150051541|NCT02059291|541331396|FG024|Epoch 2|Withdrawal by Subject|0|||
150051542|NCT02059291|541331372|FG000|Epoch 3|Physician Decision|0|||
150051543|NCT02059291|541331373|FG001|Epoch 3|Physician Decision|0|||
150051544|NCT02059291|541331374|FG002|Epoch 3|Physician Decision|0|||
150051545|NCT02059291|541331375|FG003|Epoch 3|Physician Decision|0|||
150051546|NCT02059291|541331376|FG004|Epoch 3|Physician Decision|0|||
150051547|NCT02059291|541331377|FG005|Epoch 3|Physician Decision|0|||
150051548|NCT02059291|541331378|FG006|Epoch 3|Physician Decision|0|||
150051549|NCT02059291|541331379|FG007|Epoch 3|Physician Decision|0|||
150051550|NCT02059291|541331380|FG008|Epoch 3|Physician Decision|0|||
150051551|NCT02059291|541331381|FG009|Epoch 3|Physician Decision|0|||
150051552|NCT02059291|541331382|FG010|Epoch 3|Physician Decision|0|||
150051553|NCT02059291|541331383|FG011|Epoch 3|Physician Decision|0|||
150051554|NCT02059291|541331384|FG012|Epoch 3|Physician Decision|0|||
150051555|NCT02059291|541331385|FG013|Epoch 3|Physician Decision|1|||
150051556|NCT02059291|541331386|FG014|Epoch 3|Physician Decision|0|||
150051557|NCT02059291|541331387|FG015|Epoch 3|Physician Decision|1|||
150051558|NCT02059291|541331388|FG016|Epoch 3|Physician Decision|0|||
150051559|NCT02059291|541331389|FG017|Epoch 3|Physician Decision|0|||
150051560|NCT02059291|541331390|FG018|Epoch 3|Physician Decision|0|||
150051561|NCT02059291|541331391|FG019|Epoch 3|Physician Decision|0|||
150051562|NCT02059291|541331392|FG020|Epoch 3|Physician Decision|0|||
150051563|NCT02059291|541331393|FG021|Epoch 3|Physician Decision|0|||
150051564|NCT02059291|541331394|FG022|Epoch 3|Physician Decision|0|||
150051565|NCT02059291|541331395|FG023|Epoch 3|Physician Decision|0|||
150051566|NCT02059291|541331396|FG024|Epoch 3|Physician Decision|0|||
150051567|NCT02059291|541331372|FG000|Epoch 3|Adverse Event|0|||
150051568|NCT02059291|541331373|FG001|Epoch 3|Adverse Event|0|||
150051569|NCT02059291|541331374|FG002|Epoch 3|Adverse Event|0|||
150051570|NCT02059291|541331375|FG003|Epoch 3|Adverse Event|0|||
150051571|NCT02059291|541331376|FG004|Epoch 3|Adverse Event|0|||
150051572|NCT02059291|541331377|FG005|Epoch 3|Adverse Event|0|||
150051573|NCT02059291|541331378|FG006|Epoch 3|Adverse Event|0|||
150051574|NCT02059291|541331379|FG007|Epoch 3|Adverse Event|0|||
150051575|NCT02059291|541331380|FG008|Epoch 3|Adverse Event|0|||
150051576|NCT02059291|541331381|FG009|Epoch 3|Adverse Event|0|||
150051577|NCT02059291|541331382|FG010|Epoch 3|Adverse Event|0|||
150051578|NCT02059291|541331383|FG011|Epoch 3|Adverse Event|0|||
150051579|NCT02059291|541331384|FG012|Epoch 3|Adverse Event|0|||
150051580|NCT02059291|541331385|FG013|Epoch 3|Adverse Event|0|||
150051581|NCT02059291|541331386|FG014|Epoch 3|Adverse Event|0|||
150051582|NCT02059291|541331387|FG015|Epoch 3|Adverse Event|1|||
150051583|NCT02059291|541331388|FG016|Epoch 3|Adverse Event|0|||
150051584|NCT02059291|541331389|FG017|Epoch 3|Adverse Event|0|||
150051585|NCT02059291|541331390|FG018|Epoch 3|Adverse Event|0|||
150051586|NCT02059291|541331391|FG019|Epoch 3|Adverse Event|0|||
150051587|NCT02059291|541331392|FG020|Epoch 3|Adverse Event|0|||
150051588|NCT02059291|541331393|FG021|Epoch 3|Adverse Event|0|||
150051589|NCT02059291|541331394|FG022|Epoch 3|Adverse Event|0|||
150051590|NCT02059291|541331395|FG023|Epoch 3|Adverse Event|0|||
150051591|NCT02059291|541331396|FG024|Epoch 3|Adverse Event|0|||
150051592|NCT02059291|541331372|FG000|Epoch 3|Lack of Efficacy|0|||
150051593|NCT02059291|541331373|FG001|Epoch 3|Lack of Efficacy|0|||
150051594|NCT02059291|541331374|FG002|Epoch 3|Lack of Efficacy|0|||
150051595|NCT02059291|541331375|FG003|Epoch 3|Lack of Efficacy|0|||
149973455|NCT01135992|541040131|FG000|Overall Study|Unclassified|7|||
149973456|NCT01977898|541040132|FG000|Overall Study|Non functioning catheter|1|||
149973457|NCT01977898|541040133|FG001|Overall Study|Non functioning catheter|1|||
149973458|NCT02660229|541040137|FG000|Overall Study|Adverse Event|2|||
149973459|NCT02660229|541040138|FG001|Overall Study|Adverse Event|0|||
149973460|NCT02660229|541040137|FG000|Overall Study|Withdrawal by Subject|0|||
149973461|NCT02660229|541040138|FG001|Overall Study|Withdrawal by Subject|1|||
149973462|NCT01466491|541040142|FG000|Overall Study|Protocol Violation|0|||
149973463|NCT01466491|541040143|FG001|Overall Study|Protocol Violation|3|||
149973464|NCT01466491|541040144|FG002|Overall Study|Protocol Violation|2|||
149973465|NCT01466491|541040145|FG003|Overall Study|Protocol Violation|0|||
149973466|NCT01466491|541040142|FG000|Overall Study|Missing Data|0|||
149973467|NCT01466491|541040143|FG001|Overall Study|Missing Data|0|||
149973468|NCT01466491|541040144|FG002|Overall Study|Missing Data|1|||
149973469|NCT01466491|541040145|FG003|Overall Study|Missing Data|0|||
149973470|NCT01049373|541040146|FG000|Overall Study|Protocol Violation|9|||
149973471|NCT01049373|541040147|FG001|Overall Study|Protocol Violation|9|||
149973472|NCT01049373|541040146|FG000|Overall Study|Withdrawal by Subject|8|||
149973473|NCT01049373|541040147|FG001|Overall Study|Withdrawal by Subject|5|||
149973474|NCT01049373|541040146|FG000|Overall Study|Adverse Event|3|||
149973475|NCT01049373|541040147|FG001|Overall Study|Adverse Event|3|||
149973476|NCT01049373|541040146|FG000|Overall Study|Lost to Follow-up|9|||
149973477|NCT01049373|541040147|FG001|Overall Study|Lost to Follow-up|4|||
149973478|NCT01049373|541040146|FG000|Overall Study|no evaluable study values|9|||
149973479|NCT01049373|541040147|FG001|Overall Study|no evaluable study values|21|||
149973480|NCT01049373|541040146|FG000|Overall Study|Other|1|||
149973481|NCT01049373|541040147|FG001|Overall Study|Other|1|||
149973482|NCT01049373|541040146|FG000|Overall Study|Non-cooperation|0|||
149973483|NCT01049373|541040147|FG001|Overall Study|Non-cooperation|1|||
149973484|NCT01693367|541040148|FG000|Overall Study|Withdrawal by Subject|1|||
149973485|NCT01693367|541040149|FG001|Overall Study|Withdrawal by Subject|1|||
149973486|NCT01693367|541040148|FG000|Overall Study|Physician Decision|0|||
149973487|NCT01693367|541040149|FG001|Overall Study|Physician Decision|1|||
149973488|NCT03610048|541040150|FG000|Overall Study|Study terminated by sponsor|84|||
149973489|NCT03610048|541040150|FG000|Overall Study|Adverse Event|32|||
149973490|NCT03610048|541040150|FG000|Overall Study|Withdrawal by Subject|31|||
149973491|NCT03610048|541040150|FG000|Overall Study|Lost to Follow-up|8|||
149973492|NCT03610048|541040150|FG000|Overall Study|Other|4|||
149973493|NCT03610048|541040150|FG000|Overall Study|Physician Decision|1|||
149973494|NCT03610048|541040150|FG000|Overall Study|Pregnancy|1|||
149973495|NCT01155050|541040151|FG000|Overall Study|Lost to Follow-up|15|||
149973496|NCT01155050|541040152|FG001|Overall Study|Lost to Follow-up|20|||
149973497|NCT01155050|541040153|FG002|Overall Study|Lost to Follow-up|19|||
149973498|NCT01155050|541040154|FG003|Overall Study|Lost to Follow-up|22|||
149973499|NCT02136914|541040155|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
149973500|NCT02136914|541040156|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
149973501|NCT02136914|541040155|FG000|Overall Study|Withdrawal by Subject|3|||
149973502|NCT02136914|541040156|FG001|Overall Study|Withdrawal by Subject|10|||
149973503|NCT02136914|541040155|FG000|Overall Study|Subject Unwilling to Proceed|7|||
149973504|NCT02136914|541040156|FG001|Overall Study|Subject Unwilling to Proceed|2|||
149973505|NCT02136914|541040155|FG000|Overall Study|Lost to Follow-up|1|||
149973506|NCT02136914|541040156|FG001|Overall Study|Lost to Follow-up|1|||
149973507|NCT02136914|541040155|FG000|Overall Study|Did Not Receive Study Drug|2|||
149973508|NCT02136914|541040156|FG001|Overall Study|Did Not Receive Study Drug|0|||
149973509|NCT02136914|541040155|FG000|Overall Study|Lack of Efficacy|1|||
149973510|NCT02136914|541040156|FG001|Overall Study|Lack of Efficacy|0|||
149973511|NCT02136914|541040155|FG000|Overall Study|Death|0|||
149973512|NCT02136914|541040156|FG001|Overall Study|Death|1|||
149973513|NCT00329030|541040159|FG000|Overall Study|Withdrawal by Subject|1|||
149973514|NCT00329030|541040160|FG001|Overall Study|Withdrawal by Subject|3|||
149973515|NCT00329030|541040159|FG000|Overall Study|Progressive Disease|6|||
149973516|NCT00329030|541040160|FG001|Overall Study|Progressive Disease|2|||
150051596|NCT02059291|541331376|FG004|Epoch 3|Lack of Efficacy|0|||
149973517|NCT00329030|541040159|FG000|Overall Study|Ineligible Pathology|1|||
149973518|NCT00329030|541040160|FG001|Overall Study|Ineligible Pathology|1|||
149973519|NCT01213082|541040162|FG000|Overall Study|Lost to Follow-up|6|||
149973520|NCT01213082|541040163|FG001|Overall Study|Lost to Follow-up|7|||
149973521|NCT01213082|541040164|FG002|Overall Study|Lost to Follow-up|4|||
149973522|NCT01213082|541040162|FG000|Overall Study|Physician Decision|0|||
149973523|NCT01213082|541040163|FG001|Overall Study|Physician Decision|0|||
149973524|NCT01213082|541040164|FG002|Overall Study|Physician Decision|1|||
149973525|NCT01627691|541040168|FG000|Overall Study|Death|11|||
149973526|NCT01627691|541040168|FG000|Overall Study|Lost to Follow-up|3|||
149973527|NCT01627691|541040168|FG000|Overall Study|Withdrawal by Subject|1|||
149973528|NCT01627691|541040168|FG000|Overall Study|Missed the visit|3|||
149973529|NCT03218917|541040169|FG000|Overall Study|Adverse Event|3|||
150051597|NCT02059291|541331377|FG005|Epoch 3|Lack of Efficacy|0|||
150051598|NCT02059291|541331378|FG006|Epoch 3|Lack of Efficacy|0|||
150051599|NCT02059291|541331379|FG007|Epoch 3|Lack of Efficacy|0|||
150051600|NCT02059291|541331380|FG008|Epoch 3|Lack of Efficacy|0|||
150051601|NCT02059291|541331381|FG009|Epoch 3|Lack of Efficacy|0|||
150051602|NCT02059291|541331382|FG010|Epoch 3|Lack of Efficacy|0|||
150051603|NCT02059291|541331383|FG011|Epoch 3|Lack of Efficacy|0|||
150051604|NCT02059291|541331384|FG012|Epoch 3|Lack of Efficacy|0|||
150051605|NCT02059291|541331385|FG013|Epoch 3|Lack of Efficacy|0|||
150051606|NCT02059291|541331386|FG014|Epoch 3|Lack of Efficacy|0|||
150051607|NCT02059291|541331387|FG015|Epoch 3|Lack of Efficacy|3|||
150051608|NCT02059291|541331388|FG016|Epoch 3|Lack of Efficacy|0|||
150051609|NCT02059291|541331389|FG017|Epoch 3|Lack of Efficacy|0|||
150051610|NCT02059291|541331390|FG018|Epoch 3|Lack of Efficacy|0|||
150051611|NCT02059291|541331391|FG019|Epoch 3|Lack of Efficacy|0|||
150051612|NCT02059291|541331392|FG020|Epoch 3|Lack of Efficacy|0|||
150051613|NCT02059291|541331393|FG021|Epoch 3|Lack of Efficacy|0|||
149973530|NCT03218917|541040170|FG001|Overall Study|Adverse Event|3|||
149973531|NCT03218917|541040171|FG002|Overall Study|Adverse Event|2|||
149973532|NCT03218917|541040169|FG000|Overall Study|Subject withdrew consent|2|||
149973533|NCT03218917|541040170|FG001|Overall Study|Subject withdrew consent|4|||
150051614|NCT02059291|541331394|FG022|Epoch 3|Lack of Efficacy|0|||
149973534|NCT03218917|541040171|FG002|Overall Study|Subject withdrew consent|10|||
149973535|NCT03218917|541040169|FG000|Overall Study|Physician Decision|0|||
149973536|NCT03218917|541040170|FG001|Overall Study|Physician Decision|1|||
149973537|NCT03218917|541040171|FG002|Overall Study|Physician Decision|1|||
149973538|NCT03218917|541040169|FG000|Overall Study|Lost to Follow-up|1|||
149973539|NCT03218917|541040170|FG001|Overall Study|Lost to Follow-up|0|||
149973540|NCT03218917|541040171|FG002|Overall Study|Lost to Follow-up|0|||
149973541|NCT03218917|541040169|FG000|Overall Study|Reason Missing|0|||
149973542|NCT03218917|541040170|FG001|Overall Study|Reason Missing|2|||
149973543|NCT03218917|541040171|FG002|Overall Study|Reason Missing|0|||
149973544|NCT03218917|541040169|FG000|Overall Study|Death|0|||
150051615|NCT02059291|541331395|FG023|Epoch 3|Lack of Efficacy|0|||
150051616|NCT02059291|541331396|FG024|Epoch 3|Lack of Efficacy|0|||
150051617|NCT02059291|541331372|FG000|Epoch 3|Withdrawal by Subject|0|||
150051618|NCT02059291|541331373|FG001|Epoch 3|Withdrawal by Subject|0|||
150051619|NCT02059291|541331374|FG002|Epoch 3|Withdrawal by Subject|0|||
150051620|NCT02059291|541331375|FG003|Epoch 3|Withdrawal by Subject|0|||
150051621|NCT02059291|541331376|FG004|Epoch 3|Withdrawal by Subject|0|||
150051622|NCT02059291|541331377|FG005|Epoch 3|Withdrawal by Subject|0|||
150051623|NCT02059291|541331378|FG006|Epoch 3|Withdrawal by Subject|0|||
150051624|NCT02059291|541331379|FG007|Epoch 3|Withdrawal by Subject|0|||
150051625|NCT02059291|541331380|FG008|Epoch 3|Withdrawal by Subject|0|||
150051626|NCT02059291|541331381|FG009|Epoch 3|Withdrawal by Subject|0|||
150051627|NCT02059291|541331382|FG010|Epoch 3|Withdrawal by Subject|0|||
150051628|NCT02059291|541331383|FG011|Epoch 3|Withdrawal by Subject|0|||
150051629|NCT02059291|541331384|FG012|Epoch 3|Withdrawal by Subject|0|||
150051630|NCT02059291|541331385|FG013|Epoch 3|Withdrawal by Subject|0|||
150051631|NCT02059291|541331386|FG014|Epoch 3|Withdrawal by Subject|0|||
150051632|NCT02059291|541331387|FG015|Epoch 3|Withdrawal by Subject|1|||
150051633|NCT02059291|541331388|FG016|Epoch 3|Withdrawal by Subject|0|||
150051634|NCT02059291|541331389|FG017|Epoch 3|Withdrawal by Subject|0|||
150051635|NCT02059291|541331390|FG018|Epoch 3|Withdrawal by Subject|0|||
150051636|NCT02059291|541331391|FG019|Epoch 3|Withdrawal by Subject|0|||
150051637|NCT02059291|541331392|FG020|Epoch 3|Withdrawal by Subject|0|||
150051638|NCT02059291|541331393|FG021|Epoch 3|Withdrawal by Subject|0|||
150051639|NCT02059291|541331394|FG022|Epoch 3|Withdrawal by Subject|0|||
150051640|NCT02059291|541331395|FG023|Epoch 3|Withdrawal by Subject|0|||
150051641|NCT02059291|541331396|FG024|Epoch 3|Withdrawal by Subject|0|||
150051642|NCT02059291|541331372|FG000|Epoch 4|Adverse Event|0|||
150051643|NCT02059291|541331373|FG001|Epoch 4|Adverse Event|0|||
150051644|NCT02059291|541331374|FG002|Epoch 4|Adverse Event|0|||
150051645|NCT02059291|541331375|FG003|Epoch 4|Adverse Event|0|||
150051646|NCT02059291|541331376|FG004|Epoch 4|Adverse Event|0|||
150051647|NCT02059291|541331377|FG005|Epoch 4|Adverse Event|0|||
150051648|NCT02059291|541331378|FG006|Epoch 4|Adverse Event|0|||
150051649|NCT02059291|541331379|FG007|Epoch 4|Adverse Event|0|||
150051650|NCT02059291|541331380|FG008|Epoch 4|Adverse Event|0|||
150051651|NCT02059291|541331381|FG009|Epoch 4|Adverse Event|0|||
150051652|NCT02059291|541331382|FG010|Epoch 4|Adverse Event|0|||
150051653|NCT02059291|541331383|FG011|Epoch 4|Adverse Event|0|||
150051654|NCT02059291|541331384|FG012|Epoch 4|Adverse Event|0|||
149973545|NCT03218917|541040170|FG001|Overall Study|Death|1|||
149973546|NCT03218917|541040171|FG002|Overall Study|Death|0|||
149973547|NCT03218917|541040169|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150051655|NCT02059291|541331385|FG013|Epoch 4|Adverse Event|0|||
150051656|NCT02059291|541331386|FG014|Epoch 4|Adverse Event|0|||
150051657|NCT02059291|541331387|FG015|Epoch 4|Adverse Event|0|||
150051658|NCT02059291|541331388|FG016|Epoch 4|Adverse Event|1|||
150051659|NCT02059291|541331389|FG017|Epoch 4|Adverse Event|0|||
150051660|NCT02059291|541331390|FG018|Epoch 4|Adverse Event|0|||
150051661|NCT02059291|541331391|FG019|Epoch 4|Adverse Event|0|||
149973548|NCT03218917|541040170|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149973549|NCT03218917|541040171|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149973550|NCT05209386|541040172|FG000|Overall Study|Withdrawal by Subject|8|||
149973551|NCT05209386|541040172|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
149973552|NCT03440008|541040175|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
149973553|NCT03440008|541040176|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
149973554|NCT03440008|541040175|FG000|Overall Study|Withdrawal by Subject|1|||
150177486|NCT03189524|541788114|FG000|Overall Study|Death|2|||
149973555|NCT03440008|541040176|FG001|Overall Study|Withdrawal by Subject|0|||
149973556|NCT01570387|541040186|FG000|Overall Study|Adverse Event|1|||
149973557|NCT01570387|541040187|FG001|Overall Study|Adverse Event|0|||
149973558|NCT01570387|541040188|FG002|Overall Study|Adverse Event|0|||
149973559|NCT01570387|541040189|FG003|Overall Study|Adverse Event|0|||
149973560|NCT01570387|541040186|FG000|Overall Study|Death|0|||
149973561|NCT01570387|541040187|FG001|Overall Study|Death|0|||
149973562|NCT01570387|541040188|FG002|Overall Study|Death|0|||
149973563|NCT01570387|541040189|FG003|Overall Study|Death|1|||
149973564|NCT01570387|541040186|FG000|Overall Study|Withdrawal by Subject|0|||
149973565|NCT01570387|541040187|FG001|Overall Study|Withdrawal by Subject|0|||
149973566|NCT01570387|541040188|FG002|Overall Study|Withdrawal by Subject|0|||
149973567|NCT01570387|541040189|FG003|Overall Study|Withdrawal by Subject|1|||
149973568|NCT03139448|541040190|FG000|Overall Study|Lack of Efficacy|6|||
149973569|NCT03139448|541040191|FG001|Overall Study|Lack of Efficacy|7|||
149973570|NCT03139448|541040190|FG000|Overall Study|Location of procedure changed|2|||
149973571|NCT03139448|541040191|FG001|Overall Study|Location of procedure changed|8|||
149973572|NCT03139448|541040190|FG000|Overall Study|Withdrawal by Subject|3|||
149973573|NCT03139448|541040191|FG001|Overall Study|Withdrawal by Subject|6|||
149973574|NCT03139448|541040190|FG000|Overall Study|Screen fail|1|||
149973575|NCT03139448|541040191|FG001|Overall Study|Screen fail|3|||
149973576|NCT03139448|541040190|FG000|Overall Study|Physician Decision|0|||
149973577|NCT03139448|541040191|FG001|Overall Study|Physician Decision|2|||
149973578|NCT01567722|541040200|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
149973579|NCT01567722|541040201|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
149973580|NCT01567722|541040202|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
149973581|NCT01567722|541040200|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
149973582|NCT01567722|541040201|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
149973583|NCT01567722|541040202|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
149973584|NCT01567722|541040200|FG000|Overall Study|Protocol closure by the OCG|2|||
149973585|NCT01567722|541040201|FG001|Overall Study|Protocol closure by the OCG|0|||
149973586|NCT01567722|541040202|FG002|Overall Study|Protocol closure by the OCG|0|||
149973587|NCT01567722|541040200|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
149973588|NCT01567722|541040201|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
149973589|NCT01567722|541040202|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
149973590|NCT03323164|541040206|FG000|Overall Study|Poor quality imaging/scans|2|||
149973591|NCT03323164|541040207|FG001|Overall Study|Poor quality imaging/scans|2|||
149973592|NCT01823289|541040208|FG000|Overall Study|Lost to Follow-up|5|||
149973593|NCT01823289|541040208|FG000|Overall Study|Adverse Event|5|||
149973594|NCT01823289|541040208|FG000|Overall Study|Lack of Efficacy|1|||
149973595|NCT01823289|541040208|FG000|Overall Study|Physician Decision|9|||
149973596|NCT01823289|541040208|FG000|Overall Study|Administered contraindicated medicine|1|||
149973597|NCT01823289|541040208|FG000|Overall Study|Transaminase increased more than 3 times|1|||
149973598|NCT01823289|541040208|FG000|Overall Study|Drug affected efficacy and safety|1|||
149973599|NCT01823289|541040208|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
149973600|NCT01736917|541040213|FG000|Overall Study|Adverse Event|1|||
149973601|NCT01736917|541040213|FG000|Overall Study|Protocol Violation|10|||
149973602|NCT01911260|541040216|FG000|Supplementation Period|transference or evasion of school|7|||
149973603|NCT01911260|541040217|FG001|Supplementation Period|transference or evasion of school|9|||
149973604|NCT01911260|541040218|FG002|Supplementation Period|transference or evasion of school|7|||
149973605|NCT01911260|541040219|FG003|Supplementation Period|transference or evasion of school|6|||
149973606|NCT01911260|541040216|FG000|Supplementation Period|Adverse Event|2|||
149973607|NCT01911260|541040217|FG001|Supplementation Period|Adverse Event|0|||
149973608|NCT01911260|541040218|FG002|Supplementation Period|Adverse Event|1|||
149973609|NCT01911260|541040219|FG003|Supplementation Period|Adverse Event|0|||
149973610|NCT01911260|541040216|FG000|Supplementation Period|refused to receive supplement|1|||
149973611|NCT01911260|541040217|FG001|Supplementation Period|refused to receive supplement|0|||
149973612|NCT01911260|541040218|FG002|Supplementation Period|refused to receive supplement|1|||
150051662|NCT02059291|541331392|FG020|Epoch 4|Adverse Event|0|||
150051663|NCT02059291|541331393|FG021|Epoch 4|Adverse Event|0|||
150051664|NCT02059291|541331394|FG022|Epoch 4|Adverse Event|1|||
150051665|NCT02059291|541331395|FG023|Epoch 4|Adverse Event|0|||
150051666|NCT02059291|541331396|FG024|Epoch 4|Adverse Event|0|||
150051667|NCT02059291|541331372|FG000|Epoch 4|Pregnancy|0|||
150051668|NCT02059291|541331373|FG001|Epoch 4|Pregnancy|0|||
150051669|NCT02059291|541331374|FG002|Epoch 4|Pregnancy|0|||
150051670|NCT02059291|541331375|FG003|Epoch 4|Pregnancy|0|||
150051671|NCT02059291|541331376|FG004|Epoch 4|Pregnancy|0|||
150051672|NCT02059291|541331377|FG005|Epoch 4|Pregnancy|0|||
150051673|NCT02059291|541331378|FG006|Epoch 4|Pregnancy|0|||
150051674|NCT02059291|541331379|FG007|Epoch 4|Pregnancy|0|||
150051675|NCT02059291|541331380|FG008|Epoch 4|Pregnancy|0|||
150051676|NCT02059291|541331381|FG009|Epoch 4|Pregnancy|0|||
150051677|NCT02059291|541331382|FG010|Epoch 4|Pregnancy|0|||
150051678|NCT02059291|541331383|FG011|Epoch 4|Pregnancy|0|||
150051679|NCT02059291|541331384|FG012|Epoch 4|Pregnancy|0|||
150051680|NCT02059291|541331385|FG013|Epoch 4|Pregnancy|0|||
150051681|NCT02059291|541331386|FG014|Epoch 4|Pregnancy|0|||
150051682|NCT02059291|541331387|FG015|Epoch 4|Pregnancy|0|||
150051683|NCT02059291|541331388|FG016|Epoch 4|Pregnancy|1|||
150051684|NCT02059291|541331389|FG017|Epoch 4|Pregnancy|0|||
150051685|NCT02059291|541331390|FG018|Epoch 4|Pregnancy|0|||
150051686|NCT02059291|541331391|FG019|Epoch 4|Pregnancy|0|||
150051687|NCT02059291|541331392|FG020|Epoch 4|Pregnancy|0|||
150051688|NCT02059291|541331393|FG021|Epoch 4|Pregnancy|0|||
150051689|NCT02059291|541331394|FG022|Epoch 4|Pregnancy|0|||
150051690|NCT02059291|541331395|FG023|Epoch 4|Pregnancy|0|||
150051691|NCT02059291|541331396|FG024|Epoch 4|Pregnancy|0|||
150051692|NCT02059291|541331372|FG000|Epoch 4|Withdrawal by Subject|0|||
150051693|NCT02059291|541331373|FG001|Epoch 4|Withdrawal by Subject|0|||
150051694|NCT02059291|541331374|FG002|Epoch 4|Withdrawal by Subject|0|||
150051695|NCT02059291|541331375|FG003|Epoch 4|Withdrawal by Subject|0|||
150051696|NCT02059291|541331376|FG004|Epoch 4|Withdrawal by Subject|0|||
150051697|NCT02059291|541331377|FG005|Epoch 4|Withdrawal by Subject|0|||
150051698|NCT02059291|541331378|FG006|Epoch 4|Withdrawal by Subject|0|||
150177487|NCT03189524|541788115|FG001|Overall Study|Death|2|||
150177488|NCT03189524|541788116|FG002|Overall Study|Death|1|||
150177489|NCT03189524|541788114|FG000|Overall Study|Lost to Follow-up|1|||
150051699|NCT02059291|541331379|FG007|Epoch 4|Withdrawal by Subject|0|||
150051700|NCT02059291|541331380|FG008|Epoch 4|Withdrawal by Subject|0|||
150177490|NCT03189524|541788115|FG001|Overall Study|Lost to Follow-up|0|||
150177491|NCT03189524|541788116|FG002|Overall Study|Lost to Follow-up|8|||
150177492|NCT03189524|541788114|FG000|Overall Study|Withdrawal by Subject|1|||
150051701|NCT02059291|541331381|FG009|Epoch 4|Withdrawal by Subject|0|||
150051702|NCT02059291|541331382|FG010|Epoch 4|Withdrawal by Subject|0|||
150051703|NCT02059291|541331383|FG011|Epoch 4|Withdrawal by Subject|0|||
150051704|NCT02059291|541331384|FG012|Epoch 4|Withdrawal by Subject|0|||
150051705|NCT02059291|541331385|FG013|Epoch 4|Withdrawal by Subject|0|||
150051706|NCT02059291|541331386|FG014|Epoch 4|Withdrawal by Subject|0|||
150051707|NCT02059291|541331387|FG015|Epoch 4|Withdrawal by Subject|0|||
150051708|NCT02059291|541331388|FG016|Epoch 4|Withdrawal by Subject|0|||
150051709|NCT02059291|541331389|FG017|Epoch 4|Withdrawal by Subject|0|||
150051710|NCT02059291|541331390|FG018|Epoch 4|Withdrawal by Subject|0|||
150051711|NCT02059291|541331391|FG019|Epoch 4|Withdrawal by Subject|0|||
150051712|NCT02059291|541331392|FG020|Epoch 4|Withdrawal by Subject|1|||
150051713|NCT02059291|541331393|FG021|Epoch 4|Withdrawal by Subject|0|||
150051714|NCT02059291|541331394|FG022|Epoch 4|Withdrawal by Subject|0|||
150051715|NCT02059291|541331395|FG023|Epoch 4|Withdrawal by Subject|0|||
150051716|NCT02059291|541331396|FG024|Epoch 4|Withdrawal by Subject|0|||
150051717|NCT02059291|541331372|FG000|Epoch 4|Lack of Efficacy|0|||
150051718|NCT02059291|541331373|FG001|Epoch 4|Lack of Efficacy|0|||
150051719|NCT02059291|541331374|FG002|Epoch 4|Lack of Efficacy|0|||
150051720|NCT02059291|541331375|FG003|Epoch 4|Lack of Efficacy|0|||
150177493|NCT03189524|541788115|FG001|Overall Study|Withdrawal by Subject|1|||
150051721|NCT02059291|541331376|FG004|Epoch 4|Lack of Efficacy|0|||
150051722|NCT02059291|541331377|FG005|Epoch 4|Lack of Efficacy|0|||
150051723|NCT02059291|541331378|FG006|Epoch 4|Lack of Efficacy|0|||
150051724|NCT02059291|541331379|FG007|Epoch 4|Lack of Efficacy|0|||
150051725|NCT02059291|541331380|FG008|Epoch 4|Lack of Efficacy|0|||
150051726|NCT02059291|541331381|FG009|Epoch 4|Lack of Efficacy|0|||
150051727|NCT02059291|541331382|FG010|Epoch 4|Lack of Efficacy|0|||
150051728|NCT02059291|541331383|FG011|Epoch 4|Lack of Efficacy|0|||
150051729|NCT02059291|541331384|FG012|Epoch 4|Lack of Efficacy|0|||
150051730|NCT02059291|541331385|FG013|Epoch 4|Lack of Efficacy|0|||
150051731|NCT02059291|541331386|FG014|Epoch 4|Lack of Efficacy|0|||
150051732|NCT02059291|541331387|FG015|Epoch 4|Lack of Efficacy|0|||
150051733|NCT02059291|541331388|FG016|Epoch 4|Lack of Efficacy|0|||
150051734|NCT02059291|541331389|FG017|Epoch 4|Lack of Efficacy|0|||
150051735|NCT02059291|541331390|FG018|Epoch 4|Lack of Efficacy|0|||
150051736|NCT02059291|541331391|FG019|Epoch 4|Lack of Efficacy|0|||
150051737|NCT02059291|541331392|FG020|Epoch 4|Lack of Efficacy|0|||
150051738|NCT02059291|541331393|FG021|Epoch 4|Lack of Efficacy|0|||
150051739|NCT02059291|541331394|FG022|Epoch 4|Lack of Efficacy|0|||
150051740|NCT02059291|541331395|FG023|Epoch 4|Lack of Efficacy|1|||
150177494|NCT03189524|541788116|FG002|Overall Study|Withdrawal by Subject|3|||
149973613|NCT01911260|541040219|FG003|Supplementation Period|refused to receive supplement|0|||
149973614|NCT01911260|541040216|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
150051741|NCT02059291|541331396|FG024|Epoch 4|Lack of Efficacy|0|||
150051742|NCT03180619|541331397|FG000|Overall Study|Withdrew Consent|5|||
150051743|NCT03180619|541331398|FG001|Overall Study|Withdrew Consent|0|||
149973615|NCT01911260|541040217|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
149973616|NCT01911260|541040218|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
149973617|NCT01911260|541040219|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
149973618|NCT01911260|541040216|FG000|Follow-up Period|transference or evasion of school|13|||
149973619|NCT01911260|541040217|FG001|Follow-up Period|transference or evasion of school|20|||
149973620|NCT01911260|541040218|FG002|Follow-up Period|transference or evasion of school|15|||
149973621|NCT01911260|541040219|FG003|Follow-up Period|transference or evasion of school|12|||
149973622|NCT00654732|541040220|FG000|Overall Study|Adverse Event|4|||
149973623|NCT00654732|541040221|FG001|Overall Study|Adverse Event|6|||
149973624|NCT00060944|541040224|FG000|Overall Study|Adverse Event|12|||
149973625|NCT00060944|541040225|FG001|Overall Study|Adverse Event|10|||
149973626|NCT00060944|541040224|FG000|Overall Study|Death|2|||
149973627|NCT00060944|541040225|FG001|Overall Study|Death|3|||
149973628|NCT00060944|541040224|FG000|Overall Study|Withdrawal by Subject|18|||
149973629|NCT00060944|541040225|FG001|Overall Study|Withdrawal by Subject|5|||
149973630|NCT00060944|541040224|FG000|Overall Study|Disease Progression|93|||
149973631|NCT00060944|541040225|FG001|Overall Study|Disease Progression|94|||
149973632|NCT00060944|541040224|FG000|Overall Study|Lost to Follow-up|1|||
149973633|NCT00060944|541040225|FG001|Overall Study|Lost to Follow-up|0|||
149973634|NCT00060944|541040224|FG000|Overall Study|Subject Ineligible To Continue|2|||
149973635|NCT00060944|541040225|FG001|Overall Study|Subject Ineligible To Continue|1|||
149973636|NCT00060944|541040224|FG000|Overall Study|Treatment Switch|0|||
149973637|NCT00060944|541040225|FG001|Overall Study|Treatment Switch|13|||
149973638|NCT00060944|541040224|FG000|Overall Study|Other|2|||
149973639|NCT00060944|541040225|FG001|Overall Study|Other|4|||
149973640|NCT00060944|541040224|FG000|Overall Study|randomized but not treated|6|||
149973641|NCT00060944|541040225|FG001|Overall Study|randomized but not treated|4|||
149973642|NCT05270863|541040227|FG000|Visit 2 First Intervention|Randomization error|0|||
149973643|NCT05270863|541040228|FG001|Visit 2 First Intervention|Randomization error|0|||
149973644|NCT05270863|541040229|FG002|Visit 2 First Intervention|Randomization error|0|||
149973645|NCT05270863|541040230|FG003|Visit 2 First Intervention|Randomization error|1|||
149973646|NCT05270863|541040231|FG004|Visit 2 First Intervention|Randomization error|0|||
150051744|NCT03180619|541331399|FG002|Overall Study|Withdrew Consent|2|||
150051745|NCT03180619|541331397|FG000|Overall Study|Death|2|||
150051746|NCT03180619|541331398|FG001|Overall Study|Death|1|||
150051747|NCT03180619|541331399|FG002|Overall Study|Death|2|||
150051748|NCT03180619|541331397|FG000|Overall Study|Adverse Event|2|||
150051749|NCT03180619|541331398|FG001|Overall Study|Adverse Event|0|||
149973647|NCT05270863|541040232|FG005|Visit 2 First Intervention|Randomization error|0|||
149973648|NCT05270863|541040227|FG000|First Washout|Withdrawal by Subject|0|||
149973649|NCT05270863|541040228|FG001|First Washout|Withdrawal by Subject|0|||
149973650|NCT05270863|541040229|FG002|First Washout|Withdrawal by Subject|0|||
150051750|NCT03180619|541331399|FG002|Overall Study|Adverse Event|1|||
150051751|NCT03180619|541331397|FG000|Overall Study|Investigator's discretion|2|||
149973651|NCT05270863|541040230|FG003|First Washout|Withdrawal by Subject|0|||
149973652|NCT05270863|541040231|FG004|First Washout|Withdrawal by Subject|1|||
149973653|NCT05270863|541040232|FG005|First Washout|Withdrawal by Subject|1|||
149973654|NCT05270863|541040227|FG000|First Washout|Lost to Follow-up|0|||
149973655|NCT05270863|541040228|FG001|First Washout|Lost to Follow-up|0|||
149973656|NCT05270863|541040229|FG002|First Washout|Lost to Follow-up|0|||
149973657|NCT05270863|541040230|FG003|First Washout|Lost to Follow-up|0|||
149973658|NCT05270863|541040231|FG004|First Washout|Lost to Follow-up|0|||
149973659|NCT05270863|541040232|FG005|First Washout|Lost to Follow-up|1|||
149973660|NCT05270863|541040227|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
149973661|NCT05270863|541040228|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
149973662|NCT05270863|541040229|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
149973663|NCT05270863|541040230|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
149973664|NCT05270863|541040231|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
149973665|NCT05270863|541040232|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
149973666|NCT05270863|541040227|FG000|Second Washout|Withdrawal by Subject|1|||
149973667|NCT05270863|541040228|FG001|Second Washout|Withdrawal by Subject|1|||
149973668|NCT05270863|541040229|FG002|Second Washout|Withdrawal by Subject|0|||
149973669|NCT05270863|541040230|FG003|Second Washout|Withdrawal by Subject|0|||
149973670|NCT05270863|541040231|FG004|Second Washout|Withdrawal by Subject|0|||
149973671|NCT05270863|541040232|FG005|Second Washout|Withdrawal by Subject|0|||
149973672|NCT05270863|541040227|FG000|Second Washout|Lost to Follow-up|0|||
149973673|NCT05270863|541040228|FG001|Second Washout|Lost to Follow-up|0|||
149973674|NCT05270863|541040229|FG002|Second Washout|Lost to Follow-up|0|||
149973675|NCT05270863|541040230|FG003|Second Washout|Lost to Follow-up|1|||
149973676|NCT05270863|541040231|FG004|Second Washout|Lost to Follow-up|0|||
149973677|NCT05270863|541040232|FG005|Second Washout|Lost to Follow-up|0|||
149973678|NCT04712669|541040233|FG000|Double Blind Phase|Adverse Event|4|||
149973679|NCT04712669|541040234|FG001|Double Blind Phase|Adverse Event|4|||
149973680|NCT04712669|541040235|FG002|Double Blind Phase|Adverse Event|3|||
149973681|NCT04712669|541040236|FG003|Double Blind Phase|Adverse Event|0|||
149973682|NCT04712669|541040237|FG004|Double Blind Phase|Adverse Event|0|||
149973683|NCT04712669|541040238|FG005|Double Blind Phase|Adverse Event|0|||
149973684|NCT04712669|541040239|FG006|Double Blind Phase|Adverse Event|0|||
149973685|NCT04712669|541040240|FG007|Double Blind Phase|Adverse Event|0|||
149973686|NCT04712669|541040233|FG000|Double Blind Phase|Physician Decision|1|||
149973687|NCT04712669|541040234|FG001|Double Blind Phase|Physician Decision|0|||
149973688|NCT04712669|541040235|FG002|Double Blind Phase|Physician Decision|0|||
149973689|NCT04712669|541040236|FG003|Double Blind Phase|Physician Decision|0|||
149973690|NCT04712669|541040237|FG004|Double Blind Phase|Physician Decision|0|||
149973691|NCT04712669|541040238|FG005|Double Blind Phase|Physician Decision|0|||
149973692|NCT04712669|541040239|FG006|Double Blind Phase|Physician Decision|0|||
149973693|NCT04712669|541040240|FG007|Double Blind Phase|Physician Decision|0|||
149973694|NCT04712669|541040233|FG000|Double Blind Phase|Withdrawal by Subject|3|||
149973695|NCT04712669|541040234|FG001|Double Blind Phase|Withdrawal by Subject|6|||
149973696|NCT04712669|541040235|FG002|Double Blind Phase|Withdrawal by Subject|0|||
149973697|NCT04712669|541040236|FG003|Double Blind Phase|Withdrawal by Subject|0|||
149973698|NCT04712669|541040237|FG004|Double Blind Phase|Withdrawal by Subject|0|||
149973699|NCT04712669|541040238|FG005|Double Blind Phase|Withdrawal by Subject|0|||
149973700|NCT04712669|541040239|FG006|Double Blind Phase|Withdrawal by Subject|0|||
149973701|NCT04712669|541040240|FG007|Double Blind Phase|Withdrawal by Subject|0|||
149973702|NCT04712669|541040233|FG000|Double Blind Phase|Termination by Sponsor|0|||
149973703|NCT04712669|541040234|FG001|Double Blind Phase|Termination by Sponsor|0|||
149973704|NCT04712669|541040235|FG002|Double Blind Phase|Termination by Sponsor|1|||
150051752|NCT03180619|541331398|FG001|Overall Study|Investigator's discretion|0|||
149973705|NCT04712669|541040236|FG003|Double Blind Phase|Termination by Sponsor|0|||
149973706|NCT04712669|541040237|FG004|Double Blind Phase|Termination by Sponsor|0|||
149973707|NCT04712669|541040238|FG005|Double Blind Phase|Termination by Sponsor|0|||
149973708|NCT04712669|541040239|FG006|Double Blind Phase|Termination by Sponsor|0|||
149973709|NCT04712669|541040240|FG007|Double Blind Phase|Termination by Sponsor|0|||
149973710|NCT04712669|541040233|FG000|Open Label Phase|Adverse Event|0|||
149973711|NCT04712669|541040234|FG001|Open Label Phase|Adverse Event|0|||
149973712|NCT04712669|541040235|FG002|Open Label Phase|Adverse Event|0|||
149973713|NCT04712669|541040236|FG003|Open Label Phase|Adverse Event|1|||
149973714|NCT04712669|541040237|FG004|Open Label Phase|Adverse Event|1|||
149973715|NCT04712669|541040238|FG005|Open Label Phase|Adverse Event|3|||
149973716|NCT04712669|541040239|FG006|Open Label Phase|Adverse Event|1|||
149973717|NCT04712669|541040240|FG007|Open Label Phase|Adverse Event|2|||
149973718|NCT04712669|541040233|FG000|Open Label Phase|Death|0|||
149973719|NCT04712669|541040234|FG001|Open Label Phase|Death|0|||
149973720|NCT04712669|541040235|FG002|Open Label Phase|Death|0|||
149973721|NCT04712669|541040236|FG003|Open Label Phase|Death|1|||
149973722|NCT04712669|541040237|FG004|Open Label Phase|Death|0|||
149973723|NCT04712669|541040238|FG005|Open Label Phase|Death|0|||
149973724|NCT04712669|541040239|FG006|Open Label Phase|Death|0|||
149973725|NCT04712669|541040240|FG007|Open Label Phase|Death|0|||
149973726|NCT04712669|541040233|FG000|Open Label Phase|Lack of Efficacy|0|||
149973727|NCT04712669|541040234|FG001|Open Label Phase|Lack of Efficacy|0|||
149973728|NCT04712669|541040235|FG002|Open Label Phase|Lack of Efficacy|0|||
149973729|NCT04712669|541040236|FG003|Open Label Phase|Lack of Efficacy|0|||
149973730|NCT04712669|541040237|FG004|Open Label Phase|Lack of Efficacy|1|||
149973731|NCT04712669|541040238|FG005|Open Label Phase|Lack of Efficacy|0|||
149973732|NCT04712669|541040239|FG006|Open Label Phase|Lack of Efficacy|0|||
149973733|NCT04712669|541040240|FG007|Open Label Phase|Lack of Efficacy|0|||
149973734|NCT04712669|541040233|FG000|Open Label Phase|Lost to Follow-up|0|||
149973735|NCT04712669|541040234|FG001|Open Label Phase|Lost to Follow-up|0|||
149973736|NCT04712669|541040235|FG002|Open Label Phase|Lost to Follow-up|0|||
149973737|NCT04712669|541040236|FG003|Open Label Phase|Lost to Follow-up|0|||
149973738|NCT04712669|541040237|FG004|Open Label Phase|Lost to Follow-up|0|||
149973739|NCT04712669|541040238|FG005|Open Label Phase|Lost to Follow-up|0|||
149973740|NCT04712669|541040239|FG006|Open Label Phase|Lost to Follow-up|1|||
149973741|NCT04712669|541040240|FG007|Open Label Phase|Lost to Follow-up|1|||
149973742|NCT04712669|541040233|FG000|Open Label Phase|Physician Decision|0|||
149973743|NCT04712669|541040234|FG001|Open Label Phase|Physician Decision|0|||
149973744|NCT04712669|541040235|FG002|Open Label Phase|Physician Decision|0|||
149973745|NCT04712669|541040236|FG003|Open Label Phase|Physician Decision|1|||
149973746|NCT04712669|541040237|FG004|Open Label Phase|Physician Decision|0|||
149973747|NCT04712669|541040238|FG005|Open Label Phase|Physician Decision|0|||
149973748|NCT04712669|541040239|FG006|Open Label Phase|Physician Decision|0|||
149973749|NCT04712669|541040240|FG007|Open Label Phase|Physician Decision|0|||
149973750|NCT04712669|541040233|FG000|Open Label Phase|Withdrawal by Subject|0|||
149973751|NCT04712669|541040234|FG001|Open Label Phase|Withdrawal by Subject|0|||
149973752|NCT04712669|541040235|FG002|Open Label Phase|Withdrawal by Subject|0|||
149973753|NCT04712669|541040236|FG003|Open Label Phase|Withdrawal by Subject|1|||
149973754|NCT04712669|541040237|FG004|Open Label Phase|Withdrawal by Subject|5|||
149973755|NCT04712669|541040238|FG005|Open Label Phase|Withdrawal by Subject|5|||
150051753|NCT03180619|541331399|FG002|Overall Study|Investigator's discretion|1|||
150051754|NCT01433289|541331400|FG000|Overall Study|Pregnancy|0|||
150051755|NCT01433289|541331401|FG001|Overall Study|Pregnancy|1|||
150051756|NCT01433289|541331402|FG002|Overall Study|Pregnancy|0|||
150051757|NCT01433289|541331403|FG003|Overall Study|Pregnancy|0|||
150051758|NCT00729469|541331404|FG000|Overall Study|Adverse Event|14|||
150051759|NCT00729469|541331405|FG001|Overall Study|Adverse Event|25|||
150051760|NCT00729469|541331404|FG000|Overall Study|Lost to Follow-up|9|||
150051761|NCT00729469|541331405|FG001|Overall Study|Lost to Follow-up|9|||
150051762|NCT00729469|541331404|FG000|Overall Study|Protocol Violation|2|||
150051763|NCT00729469|541331405|FG001|Overall Study|Protocol Violation|1|||
150051764|NCT00729469|541331404|FG000|Overall Study|Withdrawal by Subject|19|||
150051765|NCT00729469|541331405|FG001|Overall Study|Withdrawal by Subject|8|||
150051766|NCT00729469|541331404|FG000|Overall Study|Other-Not mentioned|9|||
150051767|NCT00729469|541331405|FG001|Overall Study|Other-Not mentioned|4|||
150051768|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
150051769|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
150051770|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Adverse Event|7|||
150051771|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Adverse Event|6|||
150051772|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
150051773|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
149973756|NCT04712669|541040239|FG006|Open Label Phase|Withdrawal by Subject|0|||
149973757|NCT04712669|541040240|FG007|Open Label Phase|Withdrawal by Subject|4|||
149973758|NCT04712669|541040233|FG000|Open Label Phase|Termination by Sponsor|0|||
149973759|NCT04712669|541040234|FG001|Open Label Phase|Termination by Sponsor|0|||
149973760|NCT04712669|541040235|FG002|Open Label Phase|Termination by Sponsor|0|||
150177495|NCT03189524|541788114|FG000|Overall Study|Progressive Disease|0|||
149973761|NCT04712669|541040236|FG003|Open Label Phase|Termination by Sponsor|11|||
149973762|NCT04712669|541040237|FG004|Open Label Phase|Termination by Sponsor|9|||
149973763|NCT04712669|541040238|FG005|Open Label Phase|Termination by Sponsor|14|||
149973764|NCT04712669|541040239|FG006|Open Label Phase|Termination by Sponsor|0|||
149973765|NCT04712669|541040240|FG007|Open Label Phase|Termination by Sponsor|14|||
149973766|NCT04577404|541040241|FG000|Overall Study|Adverse Event|31|||
149973767|NCT04577404|541040241|FG000|Overall Study|Death|1|||
149973768|NCT04577404|541040241|FG000|Overall Study|Lack of Efficacy|3|||
149973769|NCT04577404|541040241|FG000|Overall Study|Physician Decision|7|||
149973770|NCT04577404|541040241|FG000|Overall Study|Withdrawal by Subject|21|||
149973771|NCT04577404|541040241|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
149973772|NCT00639457|541041896|FG000|Overall Study|Withdrawal by Subject|2|||
149973773|NCT00639457|541041897|FG001|Overall Study|Withdrawal by Subject|3|||
149973774|NCT03235050|541041898|FG000|Overall Study|Adverse Event|0|||
149973775|NCT03235050|541041899|FG001|Overall Study|Adverse Event|0|||
149973776|NCT03235050|541041900|FG002|Overall Study|Adverse Event|1|||
149973777|NCT03235050|541041901|FG003|Overall Study|Adverse Event|4|||
149973778|NCT03235050|541041902|FG004|Overall Study|Adverse Event|1|||
149973779|NCT03235050|541041898|FG000|Overall Study|Death|0|||
149973780|NCT03235050|541041899|FG001|Overall Study|Death|0|||
149973781|NCT03235050|541041900|FG002|Overall Study|Death|0|||
149973782|NCT03235050|541041901|FG003|Overall Study|Death|2|||
149973783|NCT03235050|541041902|FG004|Overall Study|Death|1|||
149973784|NCT03235050|541041898|FG000|Overall Study|Lost to Follow-up|1|||
149973785|NCT03235050|541041899|FG001|Overall Study|Lost to Follow-up|2|||
149973786|NCT03235050|541041900|FG002|Overall Study|Lost to Follow-up|1|||
149973787|NCT03235050|541041901|FG003|Overall Study|Lost to Follow-up|2|||
149973788|NCT03235050|541041902|FG004|Overall Study|Lost to Follow-up|0|||
149973789|NCT03235050|541041898|FG000|Overall Study|Withdrawal by Subject|3|||
149973790|NCT03235050|541041899|FG001|Overall Study|Withdrawal by Subject|2|||
149973791|NCT03235050|541041900|FG002|Overall Study|Withdrawal by Subject|2|||
149973792|NCT03235050|541041901|FG003|Overall Study|Withdrawal by Subject|5|||
149973793|NCT03235050|541041902|FG004|Overall Study|Withdrawal by Subject|7|||
149973794|NCT03235050|541041898|FG000|Overall Study|Other reasons|0|||
149973795|NCT03235050|541041899|FG001|Overall Study|Other reasons|1|||
149973796|NCT03235050|541041900|FG002|Overall Study|Other reasons|0|||
149973797|NCT03235050|541041901|FG003|Overall Study|Other reasons|1|||
149973798|NCT03235050|541041902|FG004|Overall Study|Other reasons|2|||
149973799|NCT00105534|541041906|FG000|Overall Study|Adverse Event|2|||
149973800|NCT00105534|541041907|FG001|Overall Study|Adverse Event|5|||
149973801|NCT00105534|541041906|FG000|Overall Study|Protocol Violation|1|||
149973802|NCT00105534|541041907|FG001|Overall Study|Protocol Violation|4|||
149973803|NCT00105534|541041906|FG000|Overall Study|Withdrawal by Subject|6|||
149973804|NCT00105534|541041907|FG001|Overall Study|Withdrawal by Subject|6|||
149973805|NCT00105534|541041906|FG000|Overall Study|Lost to Follow-up|5|||
149973806|NCT00105534|541041907|FG001|Overall Study|Lost to Follow-up|1|||
149973807|NCT00105534|541041906|FG000|Overall Study|Lack of Efficacy|7|||
149973808|NCT00105534|541041907|FG001|Overall Study|Lack of Efficacy|15|||
149973809|NCT00105534|541041906|FG000|Overall Study|Treatment unmasked|1|||
149973810|NCT00105534|541041907|FG001|Overall Study|Treatment unmasked|0|||
149973811|NCT00105534|541041906|FG000|Overall Study|Other Reason|0|||
149973812|NCT00105534|541041907|FG001|Overall Study|Other Reason|2|||
149973813|NCT02935192|541041908|FG000|Overall Study|Withdrawal by Subject|8|||
149973814|NCT02935192|541041909|FG001|Overall Study|Withdrawal by Subject|4|||
149973815|NCT02465931|541041911|FG000|Overall Study|Lost to Follow-up|9|||
149973816|NCT02465931|541041912|FG001|Overall Study|Lost to Follow-up|11|||
149973817|NCT02465931|541041911|FG000|Overall Study|Protocol Violation|1|||
149973818|NCT02465931|541041912|FG001|Overall Study|Protocol Violation|0|||
149973819|NCT02465931|541041911|FG000|Overall Study|Withdrawal by Subject|1|||
149973820|NCT02465931|541041912|FG001|Overall Study|Withdrawal by Subject|0|||
149973821|NCT00492557|541041913|FG000|Overall Study|Subject request|12|||
149973822|NCT00492557|541041914|FG001|Overall Study|Subject request|11|||
149973823|NCT00492557|541041913|FG000|Overall Study|Protocol Violation|7|||
149973824|NCT00492557|541041914|FG001|Overall Study|Protocol Violation|8|||
149973825|NCT00492557|541041913|FG000|Overall Study|Other|2|||
149973826|NCT00492557|541041914|FG001|Overall Study|Other|2|||
149973827|NCT00492557|541041913|FG000|Overall Study|Death|1|||
149973828|NCT00492557|541041914|FG001|Overall Study|Death|1|||
149973829|NCT00492557|541041913|FG000|Overall Study|Adverse Event|1|||
149973830|NCT00492557|541041914|FG001|Overall Study|Adverse Event|0|||
149973831|NCT00492557|541041913|FG000|Overall Study|Failed to return|1|||
149973832|NCT00492557|541041914|FG001|Overall Study|Failed to return|0|||
149973833|NCT00492557|541041913|FG000|Overall Study|Lost to Follow-up|0|||
149973834|NCT00492557|541041914|FG001|Overall Study|Lost to Follow-up|1|||
149973835|NCT03423121|541041919|FG000|Overall Study|Lost to Follow-up|2|||
149973836|NCT03423121|541041920|FG001|Overall Study|Lost to Follow-up|6|||
149973837|NCT03423121|541041919|FG000|Overall Study|Adverse Event|1|||
149973838|NCT03423121|541041920|FG001|Overall Study|Adverse Event|0|||
149973839|NCT01354223|541041921|FG000|Overall Study|Withdrawal by Subject|3|||
149973840|NCT01354223|541041922|FG001|Overall Study|Withdrawal by Subject|1|||
149973841|NCT02727322|541041925|FG000|Overall Study|Withdrawal by Subject|1|||
149973842|NCT02727322|541041926|FG001|Overall Study|Withdrawal by Subject|1|||
149973843|NCT02727322|541041925|FG000|Overall Study|Protocol Violation|1|||
149973844|NCT02727322|541041926|FG001|Overall Study|Protocol Violation|0|||
149973845|NCT02852967|541041927|FG000|Overall Study|Adverse Event|3|||
149973846|NCT02852967|541041928|FG001|Overall Study|Adverse Event|1|||
149973847|NCT02852967|541041929|FG002|Overall Study|Adverse Event|0|||
150177496|NCT03189524|541788115|FG001|Overall Study|Progressive Disease|2|||
149973848|NCT02852967|541041930|FG003|Overall Study|Adverse Event|1|||
149973849|NCT02852967|541041931|FG004|Overall Study|Adverse Event|0|||
149973850|NCT02852967|541041927|FG000|Overall Study|Death|1|||
149973851|NCT02852967|541041928|FG001|Overall Study|Death|0|||
149973852|NCT02852967|541041929|FG002|Overall Study|Death|0|||
149973853|NCT02852967|541041930|FG003|Overall Study|Death|0|||
149973854|NCT02852967|541041931|FG004|Overall Study|Death|0|||
149973855|NCT02852967|541041927|FG000|Overall Study|Lost to Follow-up|1|||
150051774|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Physician Decision|4|||
149973856|NCT02852967|541041928|FG001|Overall Study|Lost to Follow-up|2|||
149973857|NCT02852967|541041929|FG002|Overall Study|Lost to Follow-up|3|||
149973858|NCT02852967|541041930|FG003|Overall Study|Lost to Follow-up|4|||
149973859|NCT02852967|541041931|FG004|Overall Study|Lost to Follow-up|4|||
149973860|NCT02852967|541041927|FG000|Overall Study|Withdrawal by Subject|6|||
149973861|NCT02852967|541041928|FG001|Overall Study|Withdrawal by Subject|12|||
149973862|NCT02852967|541041929|FG002|Overall Study|Withdrawal by Subject|7|||
149973863|NCT02852967|541041930|FG003|Overall Study|Withdrawal by Subject|10|||
149973864|NCT02852967|541041931|FG004|Overall Study|Withdrawal by Subject|10|||
149973865|NCT02852967|541041927|FG000|Overall Study|SAE|0|||
149973866|NCT02852967|541041928|FG001|Overall Study|SAE|0|||
149973867|NCT02852967|541041929|FG002|Overall Study|SAE|0|||
149973868|NCT02852967|541041930|FG003|Overall Study|SAE|3|||
149973869|NCT02852967|541041931|FG004|Overall Study|SAE|0|||
149973870|NCT02852967|541041927|FG000|Overall Study|Elevated Liver Enzymes|2|||
149973871|NCT02852967|541041928|FG001|Overall Study|Elevated Liver Enzymes|0|||
149973872|NCT02852967|541041929|FG002|Overall Study|Elevated Liver Enzymes|0|||
149973873|NCT02852967|541041930|FG003|Overall Study|Elevated Liver Enzymes|2|||
149973874|NCT02852967|541041931|FG004|Overall Study|Elevated Liver Enzymes|2|||
149973875|NCT02852967|541041927|FG000|Overall Study|Physician Decision|0|||
149973876|NCT02852967|541041928|FG001|Overall Study|Physician Decision|0|||
149973877|NCT02852967|541041929|FG002|Overall Study|Physician Decision|0|||
149973878|NCT02852967|541041930|FG003|Overall Study|Physician Decision|1|||
149973879|NCT02852967|541041931|FG004|Overall Study|Physician Decision|0|||
149973880|NCT02852967|541041927|FG000|Overall Study|Lack of Efficacy|0|||
149973881|NCT02852967|541041928|FG001|Overall Study|Lack of Efficacy|1|||
149973882|NCT02852967|541041929|FG002|Overall Study|Lack of Efficacy|0|||
149973883|NCT02852967|541041930|FG003|Overall Study|Lack of Efficacy|0|||
149973884|NCT02852967|541041931|FG004|Overall Study|Lack of Efficacy|0|||
149973885|NCT02852967|541041927|FG000|Overall Study|Non-compliance|0|||
149973886|NCT02852967|541041928|FG001|Overall Study|Non-compliance|0|||
149973887|NCT02852967|541041929|FG002|Overall Study|Non-compliance|1|||
149973888|NCT02852967|541041930|FG003|Overall Study|Non-compliance|1|||
149973889|NCT02852967|541041931|FG004|Overall Study|Non-compliance|0|||
149973890|NCT02852967|541041927|FG000|Overall Study|Dispensing Drug Violation|0|||
150177497|NCT03189524|541788116|FG002|Overall Study|Progressive Disease|0|||
150177498|NCT01780298|541788118|FG000|Overall Study|Physician Decision|1|||
150177499|NCT01780298|541788119|FG001|Overall Study|Physician Decision|5|||
150177500|NCT01780298|541788120|FG002|Overall Study|Physician Decision|1|||
150177501|NCT01780298|541788121|FG003|Overall Study|Physician Decision|1|||
150177502|NCT01780298|541788118|FG000|Overall Study|Subject not matched|1|||
150177503|NCT01780298|541788119|FG001|Overall Study|Subject not matched|0|||
150177504|NCT01780298|541788120|FG002|Overall Study|Subject not matched|1|||
150177505|NCT01780298|541788121|FG003|Overall Study|Subject not matched|0|||
150177506|NCT01780298|541788118|FG000|Overall Study|Adverse Event|0|||
150177507|NCT01780298|541788119|FG001|Overall Study|Adverse Event|0|||
150177508|NCT01780298|541788120|FG002|Overall Study|Adverse Event|2|||
150177509|NCT01780298|541788121|FG003|Overall Study|Adverse Event|0|||
150177510|NCT04252586|541788127|FG000|Overall Study|Withdrawal by parent/guardian|3|||
150177511|NCT04252586|541788127|FG000|Overall Study|Adverse Event|1|||
150177512|NCT04252586|541788127|FG000|Overall Study|Death|2|||
150177513|NCT04252586|541788127|FG000|Overall Study|Study terminated by sponsor|4|||
150177514|NCT04252586|541788127|FG000|Overall Study|Sponsor request|10|||
150177515|NCT04252586|541788127|FG000|Overall Study|Did not complete treatment period|1|||
150177516|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Death|186|||
150177517|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Death|222|||
150177518|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Death|0|||
150177519|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
150177520|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
150177521|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
150177522|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
150177523|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
150177524|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
150177525|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
150177526|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
150177527|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
150177528|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Adverse Event|83|||
150177529|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Adverse Event|100|||
150177530|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Adverse Event|0|||
150177531|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Other|70|||
150177532|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Other|75|||
150177533|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Other|0|||
150177534|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
150177535|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
150177536|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
150177537|NCT00232180|541788128|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
150177538|NCT00232180|541788129|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
150177539|NCT00232180|541788130|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
150177540|NCT00232180|541788128|FG000|Open Label Phase|Death|0|||
150177541|NCT00232180|541788129|FG001|Open Label Phase|Death|0|||
149973891|NCT02852967|541041928|FG001|Overall Study|Dispensing Drug Violation|0|||
150177542|NCT00232180|541788130|FG002|Open Label Phase|Death|48|||
150177543|NCT00232180|541788128|FG000|Open Label Phase|Lost to Follow-up|0|||
150177544|NCT00232180|541788129|FG001|Open Label Phase|Lost to Follow-up|0|||
149973892|NCT02852967|541041929|FG002|Overall Study|Dispensing Drug Violation|1|||
149973893|NCT02852967|541041930|FG003|Overall Study|Dispensing Drug Violation|0|||
149973894|NCT02852967|541041931|FG004|Overall Study|Dispensing Drug Violation|0|||
149973895|NCT02852967|541041927|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
149973896|NCT02852967|541041928|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
149973897|NCT02852967|541041929|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
149973898|NCT02852967|541041930|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
149973899|NCT02852967|541041931|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
149973900|NCT02903823|541041932|FG000|Overall Study|Physician Decision|5|||
149973901|NCT02903823|541041932|FG000|Overall Study|Could not advance catheter|1|||
149973902|NCT02903823|541041932|FG000|Overall Study|Catheter dislodgement|1|||
149973903|NCT00325143|541041933|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
149973904|NCT00325143|541041933|FG000|Overall Study|Migrated/moved from study area|1|||
149973905|NCT00325143|541041933|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
149973906|NCT00325143|541041933|FG000|Overall Study|Withdrawal by Subject|8|||
149973907|NCT02286895|541041934|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
149973908|NCT02286895|541041935|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
149973909|NCT02286895|541041934|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
149973910|NCT02286895|541041935|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
149973911|NCT02286895|541041934|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
149973912|NCT02286895|541041935|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
149973913|NCT03036852|541041936|FG000|Overall Study|Death|2|||
149973914|NCT03036852|541041936|FG000|Overall Study|Lack of Efficacy|2|||
149973915|NCT03036852|541041936|FG000|Overall Study|Adverse Event|1|||
149973916|NCT03036852|541041936|FG000|Overall Study|Lost to Follow-up|1|||
149973917|NCT00399035|541041939|FG000|Overall Study|Death|289|||
149973918|NCT00399035|541041940|FG001|Overall Study|Death|141|||
149973919|NCT00399035|541041941|FG002|Overall Study|Death|234|||
149973920|NCT00399035|541041939|FG000|Overall Study|Lost to Follow-up|2|||
149973921|NCT00399035|541041940|FG001|Overall Study|Lost to Follow-up|1|||
149973922|NCT00399035|541041941|FG002|Overall Study|Lost to Follow-up|5|||
149973923|NCT00399035|541041939|FG000|Overall Study|Withdrawal by Subject|19|||
149973924|NCT00399035|541041940|FG001|Overall Study|Withdrawal by Subject|15|||
149973925|NCT00399035|541041941|FG002|Overall Study|Withdrawal by Subject|12|||
149973926|NCT00399035|541041939|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
149973927|NCT00399035|541041940|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
149973928|NCT00399035|541041941|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
149973929|NCT00399035|541041939|FG000|Overall Study|Severe non-compliance with protocol|2|||
149973930|NCT00399035|541041940|FG001|Overall Study|Severe non-compliance with protocol|1|||
149973931|NCT00399035|541041941|FG002|Overall Study|Severe non-compliance with protocol|0|||
149973932|NCT02949011|541041948|FG000|Overall Study|Adverse Event|6|||
149973933|NCT02949011|541041949|FG001|Overall Study|Adverse Event|7|||
149973934|NCT02949011|541041950|FG002|Overall Study|Adverse Event|3|||
149973935|NCT02949011|541041948|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
149973936|NCT02949011|541041949|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
149973937|NCT02949011|541041950|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
149973938|NCT02949011|541041948|FG000|Overall Study|Protocol Deviation|5|||
149973939|NCT02949011|541041949|FG001|Overall Study|Protocol Deviation|3|||
149973940|NCT02949011|541041950|FG002|Overall Study|Protocol Deviation|3|||
149973941|NCT02949011|541041948|FG000|Overall Study|Lack of Efficacy|0|||
149973942|NCT02949011|541041949|FG001|Overall Study|Lack of Efficacy|2|||
149973943|NCT02949011|541041950|FG002|Overall Study|Lack of Efficacy|0|||
149973944|NCT02949011|541041948|FG000|Overall Study|Withdrawal by Subject|13|||
150177545|NCT00232180|541788130|FG002|Open Label Phase|Lost to Follow-up|5|||
150177546|NCT00232180|541788128|FG000|Open Label Phase|Protocol Violation|0|||
150177547|NCT00232180|541788129|FG001|Open Label Phase|Protocol Violation|0|||
150177548|NCT00232180|541788130|FG002|Open Label Phase|Protocol Violation|3|||
150177549|NCT00232180|541788128|FG000|Open Label Phase|Study terminated by sponsor|0|||
150177550|NCT00232180|541788129|FG001|Open Label Phase|Study terminated by sponsor|0|||
150177551|NCT00232180|541788130|FG002|Open Label Phase|Study terminated by sponsor|3|||
150177552|NCT00232180|541788128|FG000|Open Label Phase|Withdrawal by Subject|0|||
150177553|NCT00232180|541788129|FG001|Open Label Phase|Withdrawal by Subject|0|||
150177554|NCT00232180|541788130|FG002|Open Label Phase|Withdrawal by Subject|37|||
150177555|NCT00232180|541788128|FG000|Open Label Phase|Other|0|||
150177556|NCT00232180|541788129|FG001|Open Label Phase|Other|0|||
150177557|NCT00232180|541788130|FG002|Open Label Phase|Other|16|||
150177558|NCT00232180|541788128|FG000|Open Label Phase|Adverse Event|0|||
150177559|NCT00232180|541788129|FG001|Open Label Phase|Adverse Event|0|||
150177560|NCT00232180|541788130|FG002|Open Label Phase|Adverse Event|25|||
150177561|NCT00232180|541788128|FG000|Open Label Phase|Laboratory abnormality|0|||
150177562|NCT00232180|541788129|FG001|Open Label Phase|Laboratory abnormality|0|||
150177563|NCT00232180|541788130|FG002|Open Label Phase|Laboratory abnormality|10|||
150177564|NCT00232180|541788128|FG000|Open Label Phase|Randomized but not treated|0|||
150177565|NCT00232180|541788129|FG001|Open Label Phase|Randomized but not treated|0|||
150177566|NCT00232180|541788130|FG002|Open Label Phase|Randomized but not treated|1|||
150177567|NCT02748317|541788131|FG000|Overall Study|Withdrawal by Subject|14|||
150177568|NCT02748317|541788131|FG000|Overall Study|Lost to Follow-up|8|||
150177569|NCT02748317|541788131|FG000|Overall Study|Death|1|||
150177570|NCT00414544|541788132|FG000|Overall Study|Lost to Follow-up|14|||
150177571|NCT04259450|541788133|FG000|Overall Study|Adverse event/ Toxicity|0|||
150177572|NCT04259450|541788134|FG001|Overall Study|Adverse event/ Toxicity|3|||
150177573|NCT04259450|541788135|FG002|Overall Study|Adverse event/ Toxicity|0|||
150177574|NCT04259450|541788136|FG003|Overall Study|Adverse event/ Toxicity|1|||
150177575|NCT04259450|541788137|FG004|Overall Study|Adverse event/ Toxicity|0|||
150177576|NCT04259450|541788138|FG005|Overall Study|Adverse event/ Toxicity|0|||
150177577|NCT04259450|541788139|FG006|Overall Study|Adverse event/ Toxicity|0|||
150177578|NCT04259450|541788140|FG007|Overall Study|Adverse event/ Toxicity|1|||
150177579|NCT04259450|541788141|FG008|Overall Study|Adverse event/ Toxicity|0|||
150177580|NCT04259450|541788142|FG009|Overall Study|Adverse event/ Toxicity|3|||
150177581|NCT04259450|541788133|FG000|Overall Study|Disease progression|2|||
150177582|NCT04259450|541788134|FG001|Overall Study|Disease progression|3|||
150177583|NCT04259450|541788135|FG002|Overall Study|Disease progression|4|||
150177584|NCT04259450|541788136|FG003|Overall Study|Disease progression|4|||
150177585|NCT04259450|541788137|FG004|Overall Study|Disease progression|6|||
150177586|NCT04259450|541788138|FG005|Overall Study|Disease progression|6|||
150177587|NCT04259450|541788139|FG006|Overall Study|Disease progression|6|||
150177588|NCT04259450|541788140|FG007|Overall Study|Disease progression|15|||
150177589|NCT04259450|541788141|FG008|Overall Study|Disease progression|6|||
150177590|NCT04259450|541788142|FG009|Overall Study|Disease progression|18|||
150177591|NCT04259450|541788133|FG000|Overall Study|Death|0|||
150177592|NCT04259450|541788134|FG001|Overall Study|Death|0|||
150177593|NCT04259450|541788135|FG002|Overall Study|Death|0|||
150177594|NCT04259450|541788136|FG003|Overall Study|Death|0|||
149973945|NCT02949011|541041949|FG001|Overall Study|Withdrawal by Subject|13|||
149973946|NCT02949011|541041950|FG002|Overall Study|Withdrawal by Subject|21|||
149973947|NCT02949011|541041948|FG000|Overall Study|Lost to Follow-up|7|||
149973948|NCT02949011|541041949|FG001|Overall Study|Lost to Follow-up|5|||
149973949|NCT02949011|541041950|FG002|Overall Study|Lost to Follow-up|5|||
149973950|NCT02949011|541041948|FG000|Overall Study|Death|0|||
149973951|NCT02949011|541041949|FG001|Overall Study|Death|0|||
149973952|NCT02949011|541041950|FG002|Overall Study|Death|1|||
149973953|NCT02949011|541041948|FG000|Overall Study|Miscellaneous|2|||
149973954|NCT02949011|541041949|FG001|Overall Study|Miscellaneous|4|||
150177595|NCT04259450|541788137|FG004|Overall Study|Death|0|||
150177596|NCT04259450|541788138|FG005|Overall Study|Death|0|||
150177597|NCT04259450|541788139|FG006|Overall Study|Death|0|||
150177598|NCT04259450|541788140|FG007|Overall Study|Death|1|||
150177599|NCT04259450|541788141|FG008|Overall Study|Death|1|||
150177600|NCT04259450|541788142|FG009|Overall Study|Death|0|||
150177601|NCT04259450|541788133|FG000|Overall Study|Withdrawal by Subject|0|||
149973955|NCT02949011|541041950|FG002|Overall Study|Miscellaneous|6|||
150177602|NCT04259450|541788134|FG001|Overall Study|Withdrawal by Subject|0|||
150177603|NCT04259450|541788135|FG002|Overall Study|Withdrawal by Subject|0|||
149973956|NCT01541371|541041951|FG000|Overall Study|Withdrawal by Subject|14|||
149973957|NCT01541371|541041951|FG000|Overall Study|Lost to Follow-up|21|||
149973958|NCT01541371|541041951|FG000|Overall Study|Adverse Event|15|||
149973959|NCT01541371|541041951|FG000|Overall Study|Lack of Efficacy|12|||
149973960|NCT01541371|541041951|FG000|Overall Study|Protocol Violation|6|||
149973961|NCT01541371|541041951|FG000|Overall Study|Study medication non-compliance|3|||
149973962|NCT01541371|541041951|FG000|Overall Study|Other|6|||
149973963|NCT02441218|541041952|FG000|Overall Study|Death|503|||
150177604|NCT04259450|541788136|FG003|Overall Study|Withdrawal by Subject|0|||
150177605|NCT04259450|541788137|FG004|Overall Study|Withdrawal by Subject|0|||
150177606|NCT04259450|541788138|FG005|Overall Study|Withdrawal by Subject|0|||
150177607|NCT04259450|541788139|FG006|Overall Study|Withdrawal by Subject|0|||
150177608|NCT04259450|541788140|FG007|Overall Study|Withdrawal by Subject|1|||
150177609|NCT04259450|541788141|FG008|Overall Study|Withdrawal by Subject|0|||
150177610|NCT04259450|541788142|FG009|Overall Study|Withdrawal by Subject|0|||
150177611|NCT04259450|541788133|FG000|Overall Study|Other than listed|0|||
150177612|NCT04259450|541788134|FG001|Overall Study|Other than listed|0|||
150177613|NCT04259450|541788135|FG002|Overall Study|Other than listed|0|||
150177614|NCT04259450|541788136|FG003|Overall Study|Other than listed|0|||
150177615|NCT04259450|541788137|FG004|Overall Study|Other than listed|0|||
150177616|NCT04259450|541788138|FG005|Overall Study|Other than listed|0|||
150177617|NCT04259450|541788139|FG006|Overall Study|Other than listed|0|||
150177618|NCT04259450|541788140|FG007|Overall Study|Other than listed|1|||
150177619|NCT04259450|541788141|FG008|Overall Study|Other than listed|1|||
150051775|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Physician Decision|4|||
150051776|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
150051777|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
150051778|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
150051779|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
150051780|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
150051781|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
150051782|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Non-compliance|1|||
150051783|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Non-compliance|0|||
150051784|NCT00470834|541331408|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
150051785|NCT00470834|541331409|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
150051786|NCT00470834|541331408|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
150051787|NCT00470834|541331409|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
150051788|NCT00470834|541331408|FG000|Extension Period (24 Months)|Adverse Event|3|||
150051789|NCT00470834|541331409|FG001|Extension Period (24 Months)|Adverse Event|4|||
150051790|NCT00470834|541331408|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
150051791|NCT00470834|541331409|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
150051792|NCT00470834|541331408|FG000|Extension Period (24 Months)|Physician Decision|4|||
150051793|NCT00470834|541331409|FG001|Extension Period (24 Months)|Physician Decision|3|||
150051794|NCT00470834|541331408|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
150051795|NCT00470834|541331409|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
150051796|NCT00470834|541331408|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
150051797|NCT00470834|541331409|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
150051798|NCT00470834|541331408|FG000|Extension Period (24 Months)|Non-compliance|0|||
150051799|NCT00470834|541331409|FG001|Extension Period (24 Months)|Non-compliance|1|||
150051800|NCT00470834|541331408|FG000|Extension Period (24 Months)|Disease Progression|0|||
150051801|NCT00470834|541331409|FG001|Extension Period (24 Months)|Disease Progression|1|||
150177620|NCT04259450|541788142|FG009|Overall Study|Other than listed|2|||
150051802|NCT01989208|541331415|FG000|200 mg (7 Days)|Protocol Violation|0|||
150051803|NCT01989208|541331416|FG001|200 mg (7 Days)|Protocol Violation|1|||
150051804|NCT04975438|541331417|FG000|Overall Study|Lost to Follow-up|1|||
150051805|NCT04975438|541331418|FG001|Overall Study|Lost to Follow-up|0|||
150051806|NCT04975438|541331419|FG002|Overall Study|Lost to Follow-up|1|||
150051807|NCT04975438|541331420|FG003|Overall Study|Lost to Follow-up|0|||
150051808|NCT04975438|541331417|FG000|Overall Study|Withdrawal by Subject|1|||
150051809|NCT04975438|541331418|FG001|Overall Study|Withdrawal by Subject|0|||
150051810|NCT04975438|541331419|FG002|Overall Study|Withdrawal by Subject|0|||
150051811|NCT04975438|541331420|FG003|Overall Study|Withdrawal by Subject|0|||
150051812|NCT04973436|541331421|FG000|Overall Study|Lost to Follow-up|3|||
150051813|NCT04973436|541331421|FG000|Overall Study|Withdrawal by Subject|1|||
150051814|NCT04973436|541331421|FG000|Overall Study|Death|2|||
150051815|NCT01276054|541331427|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
150051816|NCT01276054|541331428|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
150051817|NCT04343235|541331429|FG000|Overall Study|Lost to Follow-up|3|||
150051818|NCT04343235|541331430|FG001|Overall Study|Lost to Follow-up|2|||
150051819|NCT00787267|541331431|FG000|Overall Study|Screen failure/Ineligible|10|||
150051820|NCT00787267|541331431|FG000|Overall Study|No Reason Provided|1|||
150051821|NCT00787267|541331431|FG000|Overall Study|Withdrawal by Subject|1|||
150051822|NCT01763996|541331432|FG000|Treatment Period 2|Adverse Event|0|||
150051823|NCT01763996|541331433|FG001|Treatment Period 2|Adverse Event|1|||
150051824|NCT00865280|541331434|FG000|Overall Study|Withdrawal by Subject|4|||
150051825|NCT00865280|541331435|FG001|Overall Study|Withdrawal by Subject|1|||
150051826|NCT00865280|541331434|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
150051827|NCT00865280|541331435|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
150051828|NCT00865280|541331434|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
150051829|NCT00865280|541331435|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
150051830|NCT00865280|541331434|FG000|Overall Study|Exclusion Condition|1|||
150051831|NCT00865280|541331435|FG001|Overall Study|Exclusion Condition|0|||
150051832|NCT00865280|541331434|FG000|Overall Study|Adverse Event|0|||
150051833|NCT00865280|541331435|FG001|Overall Study|Adverse Event|1|||
150051834|NCT01788215|541331443|FG000|Overall Study|Withdrawal by Subject|0|||
150051835|NCT01788215|541331444|FG001|Overall Study|Withdrawal by Subject|1|||
150051836|NCT01788215|541331443|FG000|Overall Study|Lost to Follow-up|2|||
150051837|NCT01788215|541331444|FG001|Overall Study|Lost to Follow-up|0|||
150051838|NCT03091348|541331449|FG000|Overall Study|Lost to Follow-up|2|||
150051839|NCT03091348|541331450|FG001|Overall Study|Lost to Follow-up|1|||
150051840|NCT04534686|541331451|FG000|Baseline Measurement|Lost to Follow-up|4|||
150051841|NCT04534686|541331452|FG001|Baseline Measurement|Lost to Follow-up|6|||
150051842|NCT04534686|541331451|FG000|Baseline Measurement|Withdrawal by Subject|3|||
150051843|NCT04534686|541331452|FG001|Baseline Measurement|Withdrawal by Subject|1|||
150051844|NCT04534686|541331451|FG000|Intervention|Withdrawal by Subject|2|||
150051845|NCT04534686|541331452|FG001|Intervention|Withdrawal by Subject|2|||
150051846|NCT01419197|541331453|FG000|Overall Study|Death|247|||
150051847|NCT01419197|541331454|FG001|Overall Study|Death|122|||
150051848|NCT01419197|541331453|FG000|Overall Study|Physician Decision|4|||
150051849|NCT01419197|541331454|FG001|Overall Study|Physician Decision|4|||
150051850|NCT01419197|541331453|FG000|Overall Study|Non-compliance|3|||
150051851|NCT01419197|541331454|FG001|Overall Study|Non-compliance|1|||
150051852|NCT01419197|541331453|FG000|Overall Study|Withdrawal by Subject|33|||
150051853|NCT01419197|541331454|FG001|Overall Study|Withdrawal by Subject|32|||
150051854|NCT01419197|541331453|FG000|Overall Study|Study Completed by Sponsor|103|||
150051855|NCT01419197|541331454|FG001|Overall Study|Study Completed by Sponsor|34|||
150051856|NCT01419197|541331453|FG000|Overall Study|Reason Not Specified|0|||
150051857|NCT01419197|541331454|FG001|Overall Study|Reason Not Specified|1|||
150051858|NCT01419197|541331453|FG000|Overall Study|Lost to Follow-up|14|||
150051859|NCT01419197|541331454|FG001|Overall Study|Lost to Follow-up|4|||
150051860|NCT00146848|541331455|FG000|Pre-randomization|Death|19|||
150051861|NCT00146848|541331456|FG001|Pre-randomization|Death|0|||
150051862|NCT00146848|541331457|FG002|Pre-randomization|Death|0|||
150051863|NCT00146848|541331455|FG000|Pre-randomization|Lost to Follow-up|70|||
150051864|NCT00146848|541331456|FG001|Pre-randomization|Lost to Follow-up|0|||
150051865|NCT00146848|541331457|FG002|Pre-randomization|Lost to Follow-up|0|||
150051866|NCT00146848|541331455|FG000|Pre-randomization|Physician Decision|8|||
150051867|NCT00146848|541331456|FG001|Pre-randomization|Physician Decision|0|||
150051868|NCT00146848|541331457|FG002|Pre-randomization|Physician Decision|0|||
150051869|NCT00146848|541331455|FG000|Pre-randomization|Protocol Violation|172|||
150051870|NCT00146848|541331456|FG001|Pre-randomization|Protocol Violation|0|||
150051871|NCT00146848|541331457|FG002|Pre-randomization|Protocol Violation|0|||
150051872|NCT00146848|541331455|FG000|Pre-randomization|Withdrawal by Subject|40|||
150051873|NCT00146848|541331456|FG001|Pre-randomization|Withdrawal by Subject|0|||
149973964|NCT02441218|541041953|FG001|Overall Study|Death|553|||
149973965|NCT02441218|541041952|FG000|Overall Study|Withdrawal by Subject|73|||
150051874|NCT00146848|541331457|FG002|Pre-randomization|Withdrawal by Subject|0|||
150051875|NCT00146848|541331455|FG000|Post-randomization|Lost to Follow-up|12|||
150051876|NCT00146848|541331456|FG001|Post-randomization|Lost to Follow-up|15|||
150051877|NCT00146848|541331457|FG002|Post-randomization|Lost to Follow-up|12|||
150051878|NCT00146848|541331455|FG000|Post-randomization|Withdrawn|26|||
150051879|NCT00146848|541331456|FG001|Post-randomization|Withdrawn|32|||
150051880|NCT00146848|541331457|FG002|Post-randomization|Withdrawn|27|||
150051881|NCT01798849|541331458|FG000|Overall Study|Physician Decision|0|||
150051882|NCT01798849|541331459|FG001|Overall Study|Physician Decision|0|||
149973966|NCT02441218|541041953|FG001|Overall Study|Withdrawal by Subject|58|||
149973967|NCT02441218|541041952|FG000|Overall Study|Lost to Follow-up|2|||
149973968|NCT02441218|541041953|FG001|Overall Study|Lost to Follow-up|1|||
149973969|NCT00163189|541041956|FG000|Overall Study|Other|6|||
149973970|NCT00163189|541041956|FG000|Overall Study|Lost to Follow-up|1|||
149973971|NCT00163189|541041956|FG000|Overall Study|Protocol Violation|2|||
149973972|NCT00163189|541041956|FG000|Overall Study|Death|3|||
149973973|NCT00163189|541041956|FG000|Overall Study|Adverse Event|6|||
149973974|NCT00163189|541041956|FG000|Overall Study|Lack of Efficacy|7|||
149973975|NCT00163189|541041956|FG000|Overall Study|Study terminated by sponsor|11|||
149973976|NCT00163189|541041956|FG000|Overall Study|Withdrawal by Subject|11|||
149973977|NCT00163189|541041956|FG000|Overall Study|Did not meet continuation criterion|16|||
149973978|NCT03435380|541041957|FG000|Overall Study|Death|1|||
149973979|NCT03435380|541041958|FG001|Overall Study|Death|2|||
149973980|NCT03435380|541041959|FG002|Overall Study|Death|1|||
149973981|NCT03435380|541041957|FG000|Overall Study|Lost to Follow-up|12|||
149973982|NCT03435380|541041958|FG001|Overall Study|Lost to Follow-up|8|||
149973983|NCT03435380|541041959|FG002|Overall Study|Lost to Follow-up|6|||
149973984|NCT03435380|541041957|FG000|Overall Study|Physician Decision|1|||
149973985|NCT03435380|541041958|FG001|Overall Study|Physician Decision|0|||
149973986|NCT03435380|541041959|FG002|Overall Study|Physician Decision|0|||
149973987|NCT03435380|541041957|FG000|Overall Study|Withdrawal by Subject|0|||
149973988|NCT03435380|541041958|FG001|Overall Study|Withdrawal by Subject|1|||
149973989|NCT03435380|541041959|FG002|Overall Study|Withdrawal by Subject|1|||
149973990|NCT03435380|541041957|FG000|Overall Study|Ineligible|0|||
149973991|NCT03435380|541041958|FG001|Overall Study|Ineligible|1|||
149973992|NCT03435380|541041959|FG002|Overall Study|Ineligible|1|||
149973993|NCT02431325|541041960|FG000|Overall Study|Adverse Event|3|||
149973994|NCT02431325|541041961|FG001|Overall Study|Adverse Event|0|||
149973995|NCT02431325|541041960|FG000|Overall Study|Lost to Follow-up|0|||
149973996|NCT02431325|541041961|FG001|Overall Study|Lost to Follow-up|1|||
149973997|NCT02431325|541041960|FG000|Overall Study|Withdrawal by Subject|1|||
149973998|NCT02431325|541041961|FG001|Overall Study|Withdrawal by Subject|2|||
149973999|NCT02431325|541041960|FG000|Overall Study|Declined to take study medication|1|||
149974000|NCT02431325|541041961|FG001|Overall Study|Declined to take study medication|0|||
149974001|NCT02431325|541041960|FG000|Overall Study|Withdrew before starting study medication|1|||
149974002|NCT02431325|541041961|FG001|Overall Study|Withdrew before starting study medication|0|||
149974003|NCT02431325|541041960|FG000|Overall Study|Placebo shortage|2|||
149974004|NCT02431325|541041961|FG001|Overall Study|Placebo shortage|0|||
149974005|NCT01008618|541041962|FG000|Period 1 (Titration Period)|Physician Decision|2|||
149974006|NCT01008618|541041963|FG001|Period 1 (Titration Period)|Physician Decision|0|||
149974007|NCT01008618|541041964|FG002|Period 1 (Titration Period)|Physician Decision|0|||
149974008|NCT01008618|541041962|FG000|Period 1 (Titration Period)|Adverse Event|33|||
149974009|NCT01008618|541041963|FG001|Period 1 (Titration Period)|Adverse Event|0|||
149974010|NCT01008618|541041964|FG002|Period 1 (Titration Period)|Adverse Event|0|||
149974011|NCT01008618|541041962|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
149974012|NCT01008618|541041963|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
149974013|NCT01008618|541041964|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
149974014|NCT01008618|541041962|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
149974015|NCT01008618|541041963|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
149974016|NCT01008618|541041964|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
149974017|NCT01008618|541041962|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
149974018|NCT01008618|541041963|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
149974019|NCT01008618|541041964|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
149974020|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
150051883|NCT01798849|541331460|FG002|Overall Study|Physician Decision|1|||
150051884|NCT00743106|541331461|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
150051885|NCT00743106|541331462|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
150177621|NCT03452189|541788143|FG000|First Intervention (3 Months)|Adverse Event|1|||
149974021|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
149974022|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
149974023|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
149974024|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
150177622|NCT03452189|541788144|FG001|First Intervention (3 Months)|Adverse Event|0|||
149974025|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
149974026|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
149974027|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
149974028|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
149974029|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
149974030|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
149974031|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
149974032|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
149974033|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
149974034|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
149974035|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
149974036|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
149974037|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
149974038|NCT01008618|541041962|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
149974039|NCT01008618|541041963|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
149974040|NCT01008618|541041964|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
149974041|NCT01128569|541041965|FG000|Washout Period 1|Adverse Event|0|||
149974042|NCT01128569|541041966|FG001|Washout Period 1|Adverse Event|0|||
149974043|NCT01128569|541041967|FG002|Washout Period 1|Adverse Event|1|||
149974044|NCT01128569|541041968|FG003|Washout Period 1|Adverse Event|0|||
149974045|NCT01128569|541041969|FG004|Washout Period 1|Adverse Event|0|||
149974046|NCT01128569|541041970|FG005|Washout Period 1|Adverse Event|0|||
149974047|NCT01128569|541041965|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150051886|NCT00145977|541331471|FG000|Overall Study|Lack of Efficacy|0|||
150051887|NCT00145977|541331472|FG001|Overall Study|Lack of Efficacy|4|||
150051888|NCT00145977|541331471|FG000|Overall Study|Lost to Follow-up|1|||
150051889|NCT00145977|541331472|FG001|Overall Study|Lost to Follow-up|0|||
150051890|NCT00145977|541331471|FG000|Overall Study|Withdrawal by Subject|1|||
150051891|NCT00145977|541331472|FG001|Overall Study|Withdrawal by Subject|0|||
150051892|NCT03060551|541331473|FG000|Overall Study|Withdrawal by Subject|1|||
150051893|NCT03060551|541331473|FG000|Overall Study|Adverse Event|1|||
150051894|NCT04629066|541331474|FG000|Overall Study|Lost to Follow-up|3|||
150051895|NCT04629066|541331475|FG001|Overall Study|Lost to Follow-up|2|||
150051896|NCT05477108|541331481|FG000|Overall Study|Participants randomized, not treated|1|||
150177623|NCT03452189|541788143|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
150177624|NCT03452189|541788144|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
150177625|NCT02724592|541788151|FG000|Overall Study|Lost to Follow-up|4|||
150177626|NCT02724592|541788152|FG001|Overall Study|Lost to Follow-up|1|||
150177627|NCT02584829|541788154|FG000|Overall Study|Physician Decision|1|||
150177628|NCT02584829|541788155|FG001|Overall Study|Physician Decision|0|||
150177629|NCT02584829|541788154|FG000|Overall Study|Withdrawal by Subject|0|||
150177630|NCT02584829|541788155|FG001|Overall Study|Withdrawal by Subject|1|||
150177631|NCT02584829|541788154|FG000|Overall Study|Progressive Disease|0|||
150177632|NCT02584829|541788155|FG001|Overall Study|Progressive Disease|3|||
150177633|NCT02988817|541788164|FG000|Overall Study|Withdrawal by Subject|1|||
150177634|NCT02988817|541788165|FG001|Overall Study|Withdrawal by Subject|0|||
150177635|NCT02988817|541788166|FG002|Overall Study|Withdrawal by Subject|0|||
150177636|NCT02988817|541788167|FG003|Overall Study|Withdrawal by Subject|1|||
150177637|NCT02988817|541788168|FG004|Overall Study|Withdrawal by Subject|3|||
150177638|NCT02988817|541788169|FG005|Overall Study|Withdrawal by Subject|1|||
150177639|NCT02988817|541788170|FG006|Overall Study|Withdrawal by Subject|2|||
150177640|NCT02988817|541788171|FG007|Overall Study|Withdrawal by Subject|1|||
150051897|NCT05477108|541331482|FG001|Overall Study|Participants randomized, not treated|1|||
150051898|NCT05477108|541331483|FG002|Overall Study|Participants randomized, not treated|1|||
150051899|NCT05477108|541331481|FG000|Overall Study|Physician Decision|0|||
150051900|NCT05477108|541331482|FG001|Overall Study|Physician Decision|0|||
150051901|NCT05477108|541331483|FG002|Overall Study|Physician Decision|1|||
150051902|NCT05477108|541331481|FG000|Overall Study|withdrawn from study|0|||
150051903|NCT05477108|541331482|FG001|Overall Study|withdrawn from study|0|||
150051904|NCT05477108|541331483|FG002|Overall Study|withdrawn from study|1|||
150051905|NCT00334113|541331485|FG000|Overall Study|Lost to Follow-up|2|||
150051906|NCT00334113|541331486|FG001|Overall Study|Lost to Follow-up|2|||
150051907|NCT00334113|541331485|FG000|Overall Study|Withdrawal by Subject|0|||
150177641|NCT02988817|541788172|FG008|Overall Study|Withdrawal by Subject|1|||
150177642|NCT02988817|541788173|FG009|Overall Study|Withdrawal by Subject|1|||
150177643|NCT02988817|541788174|FG010|Overall Study|Withdrawal by Subject|1|||
150177644|NCT02988817|541788175|FG011|Overall Study|Withdrawal by Subject|12|||
150051908|NCT00334113|541331486|FG001|Overall Study|Withdrawal by Subject|1|||
150177645|NCT02988817|541788176|FG012|Overall Study|Withdrawal by Subject|6|||
149974048|NCT01128569|541041966|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149974049|NCT01128569|541041967|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149974050|NCT01128569|541041968|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149974051|NCT01128569|541041969|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149974052|NCT01128569|541041970|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149974053|NCT03338400|541041971|FG000|Overall Study|Lost to Follow-up|1|||
149974054|NCT03338400|541041972|FG001|Overall Study|Lost to Follow-up|2|||
149974055|NCT01865487|541041975|FG000|Overall Study|Lost to Follow-up|0|||
149974056|NCT01865487|541041976|FG001|Overall Study|Lost to Follow-up|0|||
149974057|NCT01865487|541041977|FG002|Overall Study|Lost to Follow-up|0|||
149974058|NCT01865487|541041978|FG003|Overall Study|Lost to Follow-up|1|||
149974059|NCT01865487|541041979|FG004|Overall Study|Lost to Follow-up|0|||
149974060|NCT01865487|541041980|FG005|Overall Study|Lost to Follow-up|0|||
149974061|NCT01865487|541041981|FG006|Overall Study|Lost to Follow-up|1|||
149974062|NCT01865487|541041982|FG007|Overall Study|Lost to Follow-up|0|||
149974063|NCT01865487|541041983|FG008|Overall Study|Lost to Follow-up|0|||
149974064|NCT01865487|541041984|FG009|Overall Study|Lost to Follow-up|0|||
149974065|NCT01865487|541041975|FG000|Overall Study|Withdrawal by Subject|0|||
149974066|NCT01865487|541041976|FG001|Overall Study|Withdrawal by Subject|0|||
149974067|NCT01865487|541041977|FG002|Overall Study|Withdrawal by Subject|0|||
149974068|NCT01865487|541041978|FG003|Overall Study|Withdrawal by Subject|0|||
149974069|NCT01865487|541041979|FG004|Overall Study|Withdrawal by Subject|1|||
149974070|NCT01865487|541041980|FG005|Overall Study|Withdrawal by Subject|0|||
149974071|NCT01865487|541041981|FG006|Overall Study|Withdrawal by Subject|0|||
149974072|NCT01865487|541041982|FG007|Overall Study|Withdrawal by Subject|0|||
149974073|NCT01865487|541041983|FG008|Overall Study|Withdrawal by Subject|0|||
149974074|NCT01865487|541041984|FG009|Overall Study|Withdrawal by Subject|0|||
149974075|NCT01307449|541041987|FG000|Overall Study|Adverse Event|1|||
149974076|NCT01307449|541041988|FG001|Overall Study|Adverse Event|0|||
149974077|NCT01307449|541041989|FG002|Overall Study|Adverse Event|0|||
149974078|NCT01307449|541041990|FG003|Overall Study|Adverse Event|0|||
149974079|NCT01531998|541041996|FG000|Overall Study|Withdrawal by Subject|3|||
149974080|NCT02927795|541042001|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
149974081|NCT02927795|541042001|FG000|Overall Study|Not Treated|4|||
149974082|NCT02581891|541042002|FG000|Overall Study|Adverse Event|4|||
149974083|NCT02581891|541042003|FG001|Overall Study|Adverse Event|6|||
149974084|NCT02581891|541042002|FG000|Overall Study|Death|3|||
149974085|NCT02581891|541042003|FG001|Overall Study|Death|4|||
149974086|NCT02581891|541042002|FG000|Overall Study|Lost to Follow-up|1|||
149974087|NCT02581891|541042003|FG001|Overall Study|Lost to Follow-up|2|||
149974088|NCT02581891|541042002|FG000|Overall Study|Physician Decision|0|||
149974089|NCT02581891|541042003|FG001|Overall Study|Physician Decision|1|||
149974090|NCT02581891|541042002|FG000|Overall Study|Withdrawal by Subject|4|||
149974091|NCT02581891|541042003|FG001|Overall Study|Withdrawal by Subject|5|||
149974092|NCT02581891|541042002|FG000|Overall Study|Other Reasons|3|||
149974093|NCT02581891|541042003|FG001|Overall Study|Other Reasons|1|||
149974094|NCT02581891|541042002|FG000|Overall Study|Discontinued during followup|1|||
149974095|NCT02581891|541042003|FG001|Overall Study|Discontinued during followup|0|||
149974096|NCT01130337|541042007|FG000|Overall Study|Withdrawal by Subject|3|||
149974097|NCT01130337|541042007|FG000|Overall Study|Principal investigator decision|1|||
149974098|NCT01130337|541042007|FG000|Overall Study|Death|1|||
149974099|NCT01130337|541042007|FG000|Overall Study|Disease progression|1|||
149974100|NCT01130337|541042007|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
149974101|NCT01130337|541042007|FG000|Overall Study|Surgical resection (R2)|1|||
149974102|NCT03886493|541042008|FG000|Overall Study|Adverse Event|1|||
149974103|NCT00181844|541042009|FG000|Signed Consent|Withdrawal by Subject|5|||
149974104|NCT00181844|541042009|FG000|Signed Consent|Did not meet entrance criteria|7|||
149974105|NCT00181844|541042009|FG000|Exposed to Study Medication|Adverse Event|10|||
149974106|NCT00181844|541042009|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
149974107|NCT00181844|541042009|FG000|Exposed to Study Medication|Non-compliance|2|||
149974108|NCT00181844|541042009|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
149974109|NCT00181844|541042009|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
149974110|NCT00107276|541042011|FG000|Overall Study|Progression|46|||
149974111|NCT00107276|541042011|FG000|Overall Study|Adverse Event|6|||
149974112|NCT00107276|541042011|FG000|Overall Study|M.D. decision|2|||
149974113|NCT00107276|541042011|FG000|Overall Study|Patient refusal|1|||
149974114|NCT00107276|541042011|FG000|Overall Study|Death|1|||
149974115|NCT00107276|541042011|FG000|Overall Study|Ineligible|16|||
150051909|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
149974116|NCT03179761|541042012|FG000|Overall Study|Death|2|||
149974117|NCT03179761|541042013|FG001|Overall Study|Death|5|||
149974118|NCT03179761|541042012|FG000|Overall Study|Lost to Follow-up|2|||
149974119|NCT03179761|541042013|FG001|Overall Study|Lost to Follow-up|2|||
149974120|NCT03179761|541042012|FG000|Overall Study|Protocol Violation|1|||
149974121|NCT03179761|541042013|FG001|Overall Study|Protocol Violation|0|||
149974122|NCT03179761|541042012|FG000|Overall Study|Withdrawal by Subject|1|||
149974123|NCT03179761|541042013|FG001|Overall Study|Withdrawal by Subject|4|||
149974124|NCT03179761|541042012|FG000|Overall Study|Investigator Request|0|||
149974125|NCT03179761|541042013|FG001|Overall Study|Investigator Request|2|||
149974126|NCT04661033|541042014|FG000|Overall Study|Adverse Event|0|||
149974127|NCT04661033|541042015|FG001|Overall Study|Adverse Event|0|||
149974128|NCT04661033|541042016|FG002|Overall Study|Adverse Event|1|||
149974129|NCT04661033|541042017|FG003|Overall Study|Adverse Event|0|||
149974130|NCT04661033|541042014|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
149974131|NCT04661033|541042015|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
149974132|NCT04661033|541042016|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
149974133|NCT04661033|541042017|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
149974134|NCT04661033|541042014|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
149974135|NCT04661033|541042015|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
149974136|NCT04661033|541042016|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
149974137|NCT04661033|541042017|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
149974138|NCT04661033|541042014|FG000|Overall Study|Early discontinuation as per PI|1|||
149974139|NCT04661033|541042015|FG001|Overall Study|Early discontinuation as per PI|0|||
149974140|NCT04661033|541042016|FG002|Overall Study|Early discontinuation as per PI|0|||
149974141|NCT04661033|541042017|FG003|Overall Study|Early discontinuation as per PI|0|||
149974142|NCT03498716|541042019|FG000|Overall Study|Withdrawal by Subject|88|||
149974143|NCT03498716|541042020|FG001|Overall Study|Withdrawal by Subject|73|||
149974144|NCT03498716|541042019|FG000|Overall Study|Study Terminated By Sponsor|933|||
149974145|NCT03498716|541042020|FG001|Overall Study|Study Terminated By Sponsor|927|||
149974146|NCT03498716|541042019|FG000|Overall Study|Lost to Follow-up|15|||
149974147|NCT03498716|541042020|FG001|Overall Study|Lost to Follow-up|26|||
149974148|NCT03498716|541042019|FG000|Overall Study|Disease Relapse|0|||
149974149|NCT03498716|541042020|FG001|Overall Study|Disease Relapse|1|||
149974150|NCT03498716|541042019|FG000|Overall Study|Death|58|||
149974151|NCT03498716|541042020|FG001|Overall Study|Death|72|||
149974152|NCT03498716|541042019|FG000|Overall Study|Physician Decision|4|||
150051910|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
149974153|NCT03498716|541042020|FG001|Overall Study|Physician Decision|2|||
149974154|NCT01812057|541042033|FG000|Overall Study|Protocol Violation|1|||
149974155|NCT01812057|541042034|FG001|Overall Study|Protocol Violation|0|||
149974156|NCT01812057|541042033|FG000|Overall Study|Physician Decision|1|||
149974157|NCT01812057|541042034|FG001|Overall Study|Physician Decision|0|||
149974158|NCT01880957|541042035|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
149974159|NCT01880957|541042036|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
149974160|NCT01880957|541042035|FG000|Overall Study|Lost to Follow-up|11|||
149974161|NCT01880957|541042036|FG001|Overall Study|Lost to Follow-up|0|||
149974162|NCT01880957|541042035|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
149974163|NCT01880957|541042036|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
149974164|NCT02951780|541042037|FG000|Period 1|Adverse Event|0|||
149974165|NCT02951780|541042038|FG001|Period 1|Adverse Event|0|||
149974166|NCT02951780|541042039|FG002|Period 1|Adverse Event|0|||
149974167|NCT02951780|541042040|FG003|Period 1|Adverse Event|1|||
149974168|NCT02951780|541042041|FG004|Period 1|Adverse Event|0|||
149974169|NCT02951780|541042042|FG005|Period 1|Adverse Event|0|||
149974170|NCT02951780|541042043|FG006|Period 1|Adverse Event|0|||
149974171|NCT02951780|541042044|FG007|Period 1|Adverse Event|0|||
149974172|NCT02951780|541042045|FG008|Period 1|Adverse Event|0|||
149974173|NCT02951780|541042037|FG000|Period 1|Scheduling Conflicts|0|||
149974174|NCT02951780|541042038|FG001|Period 1|Scheduling Conflicts|0|||
149974175|NCT02951780|541042039|FG002|Period 1|Scheduling Conflicts|0|||
149974176|NCT02951780|541042040|FG003|Period 1|Scheduling Conflicts|0|||
149974177|NCT02951780|541042041|FG004|Period 1|Scheduling Conflicts|0|||
149974178|NCT02951780|541042042|FG005|Period 1|Scheduling Conflicts|0|||
149974179|NCT02951780|541042043|FG006|Period 1|Scheduling Conflicts|0|||
149974180|NCT02951780|541042044|FG007|Period 1|Scheduling Conflicts|1|||
149974181|NCT02951780|541042045|FG008|Period 1|Scheduling Conflicts|0|||
149974182|NCT02951780|541042037|FG000|Period 2|Scheduling Conflicts|0|||
149974183|NCT02951780|541042038|FG001|Period 2|Scheduling Conflicts|0|||
149974184|NCT02951780|541042039|FG002|Period 2|Scheduling Conflicts|0|||
149974185|NCT02951780|541042040|FG003|Period 2|Scheduling Conflicts|0|||
149974186|NCT02951780|541042041|FG004|Period 2|Scheduling Conflicts|0|||
149974187|NCT02951780|541042042|FG005|Period 2|Scheduling Conflicts|0|||
149974188|NCT02951780|541042043|FG006|Period 2|Scheduling Conflicts|0|||
149974189|NCT02951780|541042044|FG007|Period 2|Scheduling Conflicts|1|||
149974190|NCT02951780|541042045|FG008|Period 2|Scheduling Conflicts|0|||
149974191|NCT02289469|541042048|FG000|Overall Study|Unable to match a control|6|||
149974192|NCT02289469|541042049|FG001|Overall Study|Unable to match a control|0|||
149974193|NCT04704193|541042052|FG000|Overall Study|Withdrawal by Subject|1|||
149974194|NCT00542178|541042053|FG000|Overall Study|did not complete year 4 follow-up|75|||
149974195|NCT00542178|541042054|FG001|Overall Study|did not complete year 4 follow-up|80|||
149974196|NCT00542178|541042055|FG002|Overall Study|did not complete year 4 follow-up|74|||
149974197|NCT00542178|541042056|FG003|Overall Study|did not complete year 4 follow-up|62|||
149974198|NCT00542178|541042057|FG004|Overall Study|did not complete year 4 follow-up|64|||
149974199|NCT00542178|541042058|FG005|Overall Study|did not complete year 4 follow-up|89|||
149974200|NCT00542178|541042059|FG006|Overall Study|did not complete year 4 follow-up|87|||
149974201|NCT00542178|541042060|FG007|Overall Study|did not complete year 4 follow-up|85|||
149974202|NCT02611037|541042061|FG000|Overall Study|Withdrawal prior to treatment|2|||
149974203|NCT02611037|541042062|FG001|Overall Study|Withdrawal prior to treatment|0|||
149974204|NCT00829998|541042063|FG000|Washout|Adverse Event|0|||
149974205|NCT00829998|541042064|FG001|Washout|Adverse Event|1|||
149974206|NCT02561962|541042070|FG000|Overall Study|Withdrawal by Subject|1|||
149974207|NCT02561962|541042071|FG001|Overall Study|Withdrawal by Subject|0|||
149974208|NCT02561962|541042072|FG002|Overall Study|Withdrawal by Subject|0|||
149974209|NCT02561962|541042073|FG003|Overall Study|Withdrawal by Subject|0|||
149974210|NCT02561962|541042074|FG004|Overall Study|Withdrawal by Subject|1|||
149974211|NCT02561962|541042075|FG005|Overall Study|Withdrawal by Subject|1|||
149974212|NCT02561962|541042076|FG006|Overall Study|Withdrawal by Subject|2|||
149974213|NCT02561962|541042077|FG007|Overall Study|Withdrawal by Subject|1|||
149974214|NCT02561962|541042078|FG008|Overall Study|Withdrawal by Subject|0|||
149974215|NCT02561962|541042070|FG000|Overall Study|Decision by sponsor|0|||
149974216|NCT02561962|541042071|FG001|Overall Study|Decision by sponsor|0|||
149974217|NCT02561962|541042072|FG002|Overall Study|Decision by sponsor|0|||
149974218|NCT02561962|541042073|FG003|Overall Study|Decision by sponsor|0|||
149974219|NCT02561962|541042074|FG004|Overall Study|Decision by sponsor|1|||
149974220|NCT02561962|541042075|FG005|Overall Study|Decision by sponsor|1|||
149974221|NCT02561962|541042076|FG006|Overall Study|Decision by sponsor|0|||
149974222|NCT02561962|541042077|FG007|Overall Study|Decision by sponsor|3|||
149974223|NCT02561962|541042078|FG008|Overall Study|Decision by sponsor|0|||
149974224|NCT02561962|541042070|FG000|Overall Study|Lost to Follow-up|0|||
149974225|NCT02561962|541042071|FG001|Overall Study|Lost to Follow-up|0|||
149974226|NCT02561962|541042072|FG002|Overall Study|Lost to Follow-up|0|||
149974227|NCT02561962|541042073|FG003|Overall Study|Lost to Follow-up|0|||
149974228|NCT02561962|541042074|FG004|Overall Study|Lost to Follow-up|0|||
149974229|NCT02561962|541042075|FG005|Overall Study|Lost to Follow-up|1|||
149974230|NCT02561962|541042076|FG006|Overall Study|Lost to Follow-up|0|||
149974231|NCT02561962|541042077|FG007|Overall Study|Lost to Follow-up|0|||
149974232|NCT02561962|541042078|FG008|Overall Study|Lost to Follow-up|0|||
149974233|NCT01492426|541043826|FG000|Treatment|Death|0|||
149974234|NCT01492426|541043827|FG001|Treatment|Death|1|||
149974235|NCT01492426|541043826|FG000|Treatment|Other|1|||
149974236|NCT01492426|541043827|FG001|Treatment|Other|0|||
149974237|NCT01492426|541043826|FG000|Treatment|Adverse Event|25|||
149974238|NCT01492426|541043827|FG001|Treatment|Adverse Event|25|||
149974239|NCT01492426|541043826|FG000|Treatment|Lack of Efficacy|38|||
149974240|NCT01492426|541043827|FG001|Treatment|Lack of Efficacy|5|||
149974241|NCT01492426|541043826|FG000|Treatment|Participant withdrew consent|1|||
149974242|NCT01492426|541043827|FG001|Treatment|Participant withdrew consent|2|||
149974243|NCT01492426|541043826|FG000|Treatment|Poor compliance/noncompliance|1|||
149974244|NCT01492426|541043827|FG001|Treatment|Poor compliance/noncompliance|0|||
149974245|NCT01492426|541043826|FG000|Treatment|Subject requested discontinue study drug|7|||
149974246|NCT01492426|541043827|FG001|Treatment|Subject requested discontinue study drug|3|||
149974247|NCT01492426|541043826|FG000|Treatment|Lost to Follow-up|9|||
149974248|NCT01492426|541043827|FG001|Treatment|Lost to Follow-up|4|||
149974249|NCT01492426|541043826|FG000|Treatment|Participant does not meet study criteria|1|||
149974250|NCT01492426|541043827|FG001|Treatment|Participant does not meet study criteria|0|||
149974251|NCT01492426|541043826|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
149974252|NCT01492426|541043827|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
149974253|NCT01492426|541043826|FG000|Follow-Up|Death|1|||
149974254|NCT01492426|541043827|FG001|Follow-Up|Death|0|||
149974255|NCT01492426|541043826|FG000|Follow-Up|Other|4|||
149974256|NCT01492426|541043827|FG001|Follow-Up|Other|2|||
149974257|NCT01492426|541043826|FG000|Follow-Up|Participant Withdrew Consent|6|||
149974258|NCT01492426|541043827|FG001|Follow-Up|Participant Withdrew Consent|1|||
149974259|NCT01492426|541043826|FG000|Follow-Up|Lost to Follow-up|12|||
149974260|NCT01492426|541043827|FG001|Follow-Up|Lost to Follow-up|6|||
149974261|NCT03549338|541043828|FG000|Overall Study|Progressive Disease|1|||
149974262|NCT03549338|541043829|FG001|Overall Study|Progressive Disease|0|||
149974263|NCT03549338|541043830|FG002|Overall Study|Progressive Disease|0|||
149974264|NCT03549338|541043828|FG000|Overall Study|Clinical Progression|0|||
149974265|NCT03549338|541043829|FG001|Overall Study|Clinical Progression|1|||
149974266|NCT03549338|541043830|FG002|Overall Study|Clinical Progression|0|||
149974267|NCT00322049|541043831|FG000|Overall Study|Moved out of area|0|||
149974268|NCT00322049|541043832|FG001|Overall Study|Moved out of area|0|||
149974269|NCT00322049|541043833|FG002|Overall Study|Moved out of area|0|||
149974270|NCT00322049|541043834|FG003|Overall Study|Moved out of area|1|||
149974271|NCT00322049|541043831|FG000|Overall Study|Infected with Dengue during study|0|||
149974272|NCT00322049|541043832|FG001|Overall Study|Infected with Dengue during study|1|||
149974273|NCT00322049|541043833|FG002|Overall Study|Infected with Dengue during study|0|||
149974274|NCT00322049|541043834|FG003|Overall Study|Infected with Dengue during study|0|||
149974275|NCT00939107|541043837|FG000|Overall Study|Lost to Follow-up|14|||
149974276|NCT00939107|541043838|FG001|Overall Study|Lost to Follow-up|12|||
149974277|NCT04099277|541043839|FG000|Overall Study|Physician Decision|1|||
149974278|NCT04099277|541043839|FG000|Overall Study|Withdrawal by Subject|1|||
149974279|NCT01621178|541043840|FG000|Overall Study|Adverse Event|5|||
149974280|NCT01621178|541043841|FG001|Overall Study|Adverse Event|2|||
149974281|NCT01621178|541043842|FG002|Overall Study|Adverse Event|8|||
149974282|NCT01621178|541043840|FG000|Overall Study|Death|6|||
149974283|NCT01621178|541043841|FG001|Overall Study|Death|7|||
149974284|NCT01621178|541043842|FG002|Overall Study|Death|2|||
149974285|NCT01621178|541043840|FG000|Overall Study|Lost to Follow-up|1|||
149974286|NCT01621178|541043841|FG001|Overall Study|Lost to Follow-up|2|||
149974287|NCT01621178|541043842|FG002|Overall Study|Lost to Follow-up|1|||
149974288|NCT01621178|541043840|FG000|Overall Study|Withdrawal by Subject|14|||
149974289|NCT01621178|541043841|FG001|Overall Study|Withdrawal by Subject|17|||
149974290|NCT01621178|541043842|FG002|Overall Study|Withdrawal by Subject|18|||
149974291|NCT01621178|541043840|FG000|Overall Study|Physician Decision|5|||
149974292|NCT01621178|541043841|FG001|Overall Study|Physician Decision|2|||
149974293|NCT01621178|541043842|FG002|Overall Study|Physician Decision|7|||
149974294|NCT04778592|541043843|FG000|Overall Study|Adverse Event|1|||
149974295|NCT04778592|541043844|FG001|Overall Study|Adverse Event|2|||
149974296|NCT04778592|541043843|FG000|Overall Study|Withdrawal by Subject|1|||
149974297|NCT04778592|541043844|FG001|Overall Study|Withdrawal by Subject|2|||
149974298|NCT01126190|541043852|FG000|Double-Blind Phase|Death|0|||
149974299|NCT01126190|541043853|FG001|Double-Blind Phase|Death|1|||
150051911|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
150051912|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
150051913|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Other|2|||
150051914|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
150051915|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
150051916|NCT02509026|541331494|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
150051917|NCT02509026|541331494|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
150051918|NCT02509026|541331494|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
150051919|NCT02509026|541331494|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
150051920|NCT02509026|541331494|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
150051921|NCT02509026|541331494|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
150051922|NCT00243841|541331498|FG000|Overall Study|Physician Decision|0|||
150051923|NCT00243841|541331499|FG001|Overall Study|Physician Decision|0|||
150051924|NCT00243841|541331500|FG002|Overall Study|Physician Decision|1|||
150051925|NCT00243841|541331501|FG003|Overall Study|Physician Decision|0|||
149974300|NCT01126190|541043854|FG002|Double-Blind Phase|Death|0|||
149974301|NCT01126190|541043852|FG000|Double-Blind Phase|Adverse Event|1|||
149974302|NCT01126190|541043853|FG001|Double-Blind Phase|Adverse Event|2|||
149974303|NCT01126190|541043854|FG002|Double-Blind Phase|Adverse Event|0|||
149974304|NCT01126190|541043852|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
149974305|NCT01126190|541043853|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
149974306|NCT01126190|541043854|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
149974307|NCT01126190|541043852|FG000|Double-Blind Phase|Request of Investigator|1|||
149974308|NCT01126190|541043853|FG001|Double-Blind Phase|Request of Investigator|0|||
149974309|NCT01126190|541043854|FG002|Double-Blind Phase|Request of Investigator|0|||
149974310|NCT01126190|541043852|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
149974311|NCT01126190|541043853|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
149974312|NCT01126190|541043854|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
149974313|NCT01126190|541043852|FG000|Double-Blind Phase|Non-compliance|1|||
149974314|NCT01126190|541043853|FG001|Double-Blind Phase|Non-compliance|0|||
149974315|NCT01126190|541043854|FG002|Double-Blind Phase|Non-compliance|0|||
149974316|NCT01126190|541043852|FG000|Double-Blind Phase|Lost to Follow-up|1|||
149974317|NCT01126190|541043853|FG001|Double-Blind Phase|Lost to Follow-up|3|||
149974318|NCT01126190|541043854|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149974319|NCT01126190|541043852|FG000|Open-Label Phase|Death|0|||
149974320|NCT01126190|541043853|FG001|Open-Label Phase|Death|0|||
149974321|NCT01126190|541043854|FG002|Open-Label Phase|Death|1|||
149974322|NCT01126190|541043852|FG000|Open-Label Phase|Adverse Event|0|||
149974323|NCT01126190|541043853|FG001|Open-Label Phase|Adverse Event|0|||
149974324|NCT01126190|541043854|FG002|Open-Label Phase|Adverse Event|4|||
149974325|NCT01126190|541043852|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149974326|NCT01126190|541043853|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149974327|NCT01126190|541043854|FG002|Open-Label Phase|Withdrawal by Subject|6|||
149974328|NCT01114737|541043855|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
149974329|NCT01114737|541043856|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
149974330|NCT01114737|541043855|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
149974331|NCT01114737|541043856|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
149974332|NCT01114737|541043855|FG000|Randomized Treatment Period|Pregnancy|1|||
149974333|NCT01114737|541043856|FG001|Randomized Treatment Period|Pregnancy|0|||
149974334|NCT01114737|541043855|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
149974335|NCT01114737|541043856|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
149974336|NCT01114737|541043855|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
149974337|NCT01114737|541043856|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
149974338|NCT01114737|541043855|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
149974339|NCT01114737|541043856|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
149974340|NCT01123148|541043857|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
150051926|NCT00243841|541331502|FG004|Overall Study|Physician Decision|0|||
150051927|NCT00243841|541331503|FG005|Overall Study|Physician Decision|2|||
150051928|NCT01808092|541331504|FG000|Overall Study|Death|39|||
150051929|NCT01808092|541331505|FG001|Overall Study|Death|29|||
149974341|NCT01123148|541043857|FG000|Overall Study|Didn't meet milestone criteria|1|||
149974342|NCT02808897|541043858|FG000|Overall Study|Lost to Follow-up|9|||
149974343|NCT02808897|541043859|FG001|Overall Study|Lost to Follow-up|11|||
149974344|NCT01496287|541043860|FG000|Overall Study|Lost to Follow-up|1|||
149974345|NCT01496287|541043860|FG000|Overall Study|Incomplete anesthesia|5|||
149974346|NCT01823107|541043861|FG000|Overall Study|Withdrawal by Subject|1|||
149974347|NCT00256126|541043862|FG000|Overall Study|Adverse Event|1|||
149974348|NCT00256126|541043863|FG001|Overall Study|Adverse Event|0|||
149974349|NCT00256126|541043862|FG000|Overall Study|Other|1|||
149974350|NCT00256126|541043863|FG001|Overall Study|Other|2|||
149974351|NCT00506142|541043866|FG000|Overall Study|Adverse Event|8|||
149974352|NCT00506142|541043867|FG001|Overall Study|Adverse Event|7|||
149974353|NCT00506142|541043866|FG000|Overall Study|Lack of Efficacy|21|||
149974354|NCT00506142|541043867|FG001|Overall Study|Lack of Efficacy|7|||
149974355|NCT00506142|541043866|FG000|Overall Study|Withdrawal by Subject|4|||
149974356|NCT00506142|541043867|FG001|Overall Study|Withdrawal by Subject|5|||
149974357|NCT00506142|541043866|FG000|Overall Study|Physician Decision|1|||
149974358|NCT00506142|541043867|FG001|Overall Study|Physician Decision|0|||
149974359|NCT00506142|541043866|FG000|Overall Study|New health condition|1|||
149974360|NCT00506142|541043867|FG001|Overall Study|New health condition|0|||
149974361|NCT02133573|541043868|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
149974362|NCT02133573|541043869|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
149974363|NCT02133573|541043868|FG000|Overall Study|Child Deaths|3|||
149974364|NCT02133573|541043869|FG001|Overall Study|Child Deaths|5|||
149974365|NCT02133573|541043868|FG000|Overall Study|Child Declined Follow Ups|2|||
149974366|NCT02133573|541043869|FG001|Overall Study|Child Declined Follow Ups|1|||
149974367|NCT02133573|541043868|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
149974368|NCT02133573|541043869|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
149974369|NCT00454116|541043870|FG000|Overall Study|Adverse Event|5|||
149974370|NCT00454116|541043871|FG001|Overall Study|Adverse Event|11|||
149974371|NCT00454116|541043872|FG002|Overall Study|Adverse Event|9|||
149974372|NCT00454116|541043870|FG000|Overall Study|Condition under investigation worsened|17|||
149974373|NCT00454116|541043871|FG001|Overall Study|Condition under investigation worsened|13|||
149974374|NCT00454116|541043872|FG002|Overall Study|Condition under investigation worsened|18|||
149974375|NCT00454116|541043870|FG000|Overall Study|Withdrawal by Subject|3|||
149974376|NCT00454116|541043871|FG001|Overall Study|Withdrawal by Subject|3|||
149974377|NCT00454116|541043872|FG002|Overall Study|Withdrawal by Subject|1|||
149974378|NCT00454116|541043870|FG000|Overall Study|Other|2|||
149974379|NCT00454116|541043871|FG001|Overall Study|Other|2|||
149974380|NCT00454116|541043872|FG002|Overall Study|Other|0|||
149974381|NCT03500211|541043879|FG000|Overall Study|Withdrawal by Subject|1|||
149974382|NCT03500211|541043880|FG001|Overall Study|Withdrawal by Subject|1|||
149974383|NCT01917318|541043881|FG000|First Treatment|Withdrawal by Subject|0|||
149974384|NCT01917318|541043882|FG001|First Treatment|Withdrawal by Subject|1|||
149974385|NCT04460183|541043883|FG000|Overall Study|Lost to Follow-up|3|||
149974386|NCT04460183|541043884|FG001|Overall Study|Lost to Follow-up|1|||
149974387|NCT04460183|541043883|FG000|Overall Study|Withdrawal by Subject|1|||
149974388|NCT04460183|541043884|FG001|Overall Study|Withdrawal by Subject|0|||
149974389|NCT01534481|541043889|FG000|Overall Study|Lost to Follow-up|29|||
149974390|NCT01534481|541043890|FG001|Overall Study|Lost to Follow-up|24|||
149974391|NCT01534481|541043889|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
149974392|NCT01534481|541043890|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
149974393|NCT05525910|541043891|FG000|Period 4|Per sponsor due to study timelines|0|||
149974394|NCT05525910|541043892|FG001|Period 4|Per sponsor due to study timelines|0|||
149974395|NCT05525910|541043893|FG002|Period 4|Per sponsor due to study timelines|1|||
149974396|NCT05525910|541043894|FG003|Period 4|Per sponsor due to study timelines|1|||
149974397|NCT05525910|541043895|FG004|Period 4|Per sponsor due to study timelines|1|||
149974398|NCT01987557|541043905|FG000|Overall Study|Protocol Violation|1|||
149974399|NCT01987557|541043906|FG001|Overall Study|Protocol Violation|0|||
149974400|NCT01987557|541043907|FG002|Overall Study|Protocol Violation|1|||
149974401|NCT01987557|541043905|FG000|Overall Study|Withdrawal by Subject|2|||
149974402|NCT01987557|541043906|FG001|Overall Study|Withdrawal by Subject|1|||
149974403|NCT01987557|541043907|FG002|Overall Study|Withdrawal by Subject|2|||
149974404|NCT01987557|541043905|FG000|Overall Study|Adverse Event|0|||
149974405|NCT01987557|541043906|FG001|Overall Study|Adverse Event|2|||
149974406|NCT01987557|541043907|FG002|Overall Study|Adverse Event|0|||
149974407|NCT01832727|541043908|FG000|Overall Study|Adverse Event|4|||
149974408|NCT01832727|541043909|FG001|Overall Study|Adverse Event|6|||
149974409|NCT01832727|541043910|FG002|Overall Study|Adverse Event|1|||
149974410|NCT01832727|541043911|FG003|Overall Study|Adverse Event|0|||
149974411|NCT01832727|541043912|FG004|Overall Study|Adverse Event|1|||
150051930|NCT01808092|541331504|FG000|Overall Study|Lost to Follow-up|3|||
149974412|NCT01832727|541043913|FG005|Overall Study|Adverse Event|1|||
149974413|NCT01832727|541043914|FG006|Overall Study|Adverse Event|2|||
149974414|NCT01832727|541043915|FG007|Overall Study|Adverse Event|1|||
149974415|NCT01832727|541043916|FG008|Overall Study|Adverse Event|9|||
149974416|NCT01832727|541043908|FG000|Overall Study|Disease progression|3|||
149974417|NCT01832727|541043909|FG001|Overall Study|Disease progression|0|||
149974418|NCT01832727|541043910|FG002|Overall Study|Disease progression|2|||
149974419|NCT01832727|541043911|FG003|Overall Study|Disease progression|1|||
149974420|NCT01832727|541043912|FG004|Overall Study|Disease progression|3|||
149974421|NCT01832727|541043913|FG005|Overall Study|Disease progression|3|||
149974422|NCT01832727|541043914|FG006|Overall Study|Disease progression|6|||
149974423|NCT01832727|541043915|FG007|Overall Study|Disease progression|2|||
149974424|NCT01832727|541043916|FG008|Overall Study|Disease progression|7|||
149974425|NCT01832727|541043908|FG000|Overall Study|Lost to Follow-up|0|||
149974426|NCT01832727|541043909|FG001|Overall Study|Lost to Follow-up|0|||
149974427|NCT01832727|541043910|FG002|Overall Study|Lost to Follow-up|0|||
149974428|NCT01832727|541043911|FG003|Overall Study|Lost to Follow-up|1|||
149974429|NCT01832727|541043912|FG004|Overall Study|Lost to Follow-up|0|||
149974430|NCT01832727|541043913|FG005|Overall Study|Lost to Follow-up|0|||
149974431|NCT01832727|541043914|FG006|Overall Study|Lost to Follow-up|0|||
149974432|NCT01832727|541043915|FG007|Overall Study|Lost to Follow-up|0|||
149974433|NCT01832727|541043916|FG008|Overall Study|Lost to Follow-up|0|||
149974434|NCT01832727|541043908|FG000|Overall Study|Physician Decision|1|||
149974435|NCT01832727|541043909|FG001|Overall Study|Physician Decision|0|||
149974436|NCT01832727|541043910|FG002|Overall Study|Physician Decision|0|||
149974437|NCT01832727|541043911|FG003|Overall Study|Physician Decision|1|||
149974438|NCT01832727|541043912|FG004|Overall Study|Physician Decision|0|||
149974439|NCT01832727|541043913|FG005|Overall Study|Physician Decision|1|||
149974440|NCT01832727|541043914|FG006|Overall Study|Physician Decision|0|||
149974441|NCT01832727|541043915|FG007|Overall Study|Physician Decision|0|||
149974442|NCT01832727|541043916|FG008|Overall Study|Physician Decision|0|||
149974443|NCT01832727|541043908|FG000|Overall Study|Withdrawal by Subject|1|||
149974444|NCT01832727|541043909|FG001|Overall Study|Withdrawal by Subject|1|||
149974445|NCT01832727|541043910|FG002|Overall Study|Withdrawal by Subject|0|||
149974446|NCT01832727|541043911|FG003|Overall Study|Withdrawal by Subject|1|||
149974447|NCT01832727|541043912|FG004|Overall Study|Withdrawal by Subject|0|||
149974448|NCT01832727|541043913|FG005|Overall Study|Withdrawal by Subject|1|||
149974449|NCT01832727|541043914|FG006|Overall Study|Withdrawal by Subject|0|||
149974450|NCT01832727|541043915|FG007|Overall Study|Withdrawal by Subject|2|||
149974451|NCT01832727|541043916|FG008|Overall Study|Withdrawal by Subject|1|||
149974452|NCT01832727|541043908|FG000|Overall Study|Study terminated by sponsor|0|||
149974453|NCT01832727|541043909|FG001|Overall Study|Study terminated by sponsor|0|||
149974454|NCT01832727|541043910|FG002|Overall Study|Study terminated by sponsor|0|||
150051931|NCT01808092|541331505|FG001|Overall Study|Lost to Follow-up|7|||
150051932|NCT01808092|541331504|FG000|Overall Study|Withdrawal by Subject|9|||
150051933|NCT01808092|541331505|FG001|Overall Study|Withdrawal by Subject|4|||
150051934|NCT01808092|541331504|FG000|Overall Study|Other Eligibility criteria|3|||
150051935|NCT01808092|541331505|FG001|Overall Study|Other Eligibility criteria|5|||
150051936|NCT03615040|541332824|FG000|Overall Study|Withdrawal by Subject|2|||
150051937|NCT03615040|541332825|FG001|Overall Study|Withdrawal by Subject|1|||
150051938|NCT03615040|541332824|FG000|Overall Study|Physician Decision|2|||
149974455|NCT01832727|541043911|FG003|Overall Study|Study terminated by sponsor|0|||
149974456|NCT01832727|541043912|FG004|Overall Study|Study terminated by sponsor|0|||
149974457|NCT01832727|541043913|FG005|Overall Study|Study terminated by sponsor|0|||
149974458|NCT01832727|541043914|FG006|Overall Study|Study terminated by sponsor|0|||
149974459|NCT01832727|541043915|FG007|Overall Study|Study terminated by sponsor|1|||
149974460|NCT01832727|541043916|FG008|Overall Study|Study terminated by sponsor|1|||
149974461|NCT01538199|541043925|FG000|Overall Study|Lost to Follow-up|1|||
149974462|NCT01538199|541043926|FG001|Overall Study|Lost to Follow-up|2|||
150051939|NCT03615040|541332825|FG001|Overall Study|Physician Decision|2|||
149974463|NCT01538199|541043927|FG002|Overall Study|Lost to Follow-up|1|||
149974464|NCT01538199|541043928|FG003|Overall Study|Lost to Follow-up|0|||
149974465|NCT01538199|541043925|FG000|Overall Study|participant did not have time|1|||
149974466|NCT01538199|541043926|FG001|Overall Study|participant did not have time|0|||
149974467|NCT01538199|541043927|FG002|Overall Study|participant did not have time|0|||
149974468|NCT01538199|541043928|FG003|Overall Study|participant did not have time|2|||
149974469|NCT01538199|541043925|FG000|Overall Study|Lack of Efficacy|0|||
149974470|NCT01538199|541043926|FG001|Overall Study|Lack of Efficacy|1|||
149974471|NCT01538199|541043927|FG002|Overall Study|Lack of Efficacy|0|||
149974472|NCT01538199|541043928|FG003|Overall Study|Lack of Efficacy|0|||
149974473|NCT02081586|541043929|FG000|Overall Study|Lost to Follow-up|0|||
150051940|NCT03615040|541332824|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
150177646|NCT02988817|541788177|FG013|Overall Study|Withdrawal by Subject|6|||
150177647|NCT02988817|541788178|FG014|Overall Study|Withdrawal by Subject|4|||
150177648|NCT02988817|541788179|FG015|Overall Study|Withdrawal by Subject|5|||
150177649|NCT02988817|541788180|FG016|Overall Study|Withdrawal by Subject|4|||
150177650|NCT02988817|541788181|FG017|Overall Study|Withdrawal by Subject|11|||
150177651|NCT02988817|541788182|FG018|Overall Study|Withdrawal by Subject|4|||
150177652|NCT02988817|541788183|FG019|Overall Study|Withdrawal by Subject|2|||
150177653|NCT02988817|541788164|FG000|Overall Study|Death|0|||
150177654|NCT02988817|541788165|FG001|Overall Study|Death|1|||
150177655|NCT02988817|541788166|FG002|Overall Study|Death|3|||
150177656|NCT02988817|541788167|FG003|Overall Study|Death|1|||
150177657|NCT02988817|541788168|FG004|Overall Study|Death|6|||
150177658|NCT02988817|541788169|FG005|Overall Study|Death|10|||
150177659|NCT02988817|541788170|FG006|Overall Study|Death|1|||
150177660|NCT02988817|541788171|FG007|Overall Study|Death|2|||
150177661|NCT02988817|541788172|FG008|Overall Study|Death|1|||
150177662|NCT02988817|541788173|FG009|Overall Study|Death|5|||
150177663|NCT02988817|541788174|FG010|Overall Study|Death|1|||
150177664|NCT02988817|541788175|FG011|Overall Study|Death|8|||
150177665|NCT02988817|541788176|FG012|Overall Study|Death|9|||
150177666|NCT02988817|541788177|FG013|Overall Study|Death|17|||
150177667|NCT02988817|541788178|FG014|Overall Study|Death|18|||
150177668|NCT02988817|541788179|FG015|Overall Study|Death|30|||
150177669|NCT02988817|541788180|FG016|Overall Study|Death|17|||
150177670|NCT02988817|541788181|FG017|Overall Study|Death|38|||
150177671|NCT02988817|541788182|FG018|Overall Study|Death|14|||
150177672|NCT02988817|541788183|FG019|Overall Study|Death|16|||
150177673|NCT02988817|541788164|FG000|Overall Study|Other|0|||
150177674|NCT02988817|541788165|FG001|Overall Study|Other|0|||
150177675|NCT02988817|541788166|FG002|Overall Study|Other|0|||
150177676|NCT02988817|541788167|FG003|Overall Study|Other|1|||
150177677|NCT02988817|541788168|FG004|Overall Study|Other|1|||
150177678|NCT02988817|541788169|FG005|Overall Study|Other|0|||
150177679|NCT02988817|541788170|FG006|Overall Study|Other|0|||
150177680|NCT02988817|541788171|FG007|Overall Study|Other|0|||
150177681|NCT02988817|541788172|FG008|Overall Study|Other|0|||
150177682|NCT02988817|541788173|FG009|Overall Study|Other|0|||
150177683|NCT02988817|541788174|FG010|Overall Study|Other|0|||
150177684|NCT02988817|541788175|FG011|Overall Study|Other|0|||
150177685|NCT02988817|541788176|FG012|Overall Study|Other|0|||
150177686|NCT02988817|541788177|FG013|Overall Study|Other|0|||
150177687|NCT02988817|541788178|FG014|Overall Study|Other|0|||
150177688|NCT02988817|541788179|FG015|Overall Study|Other|1|||
150177689|NCT02988817|541788180|FG016|Overall Study|Other|0|||
149974474|NCT02081586|541043930|FG001|Overall Study|Lost to Follow-up|1|||
149974475|NCT02081586|541043931|FG002|Overall Study|Lost to Follow-up|0|||
149974476|NCT02081586|541043932|FG003|Overall Study|Lost to Follow-up|1|||
149974477|NCT02081586|541043929|FG000|Overall Study|Head injury not related to study|0|||
149974478|NCT02081586|541043930|FG001|Overall Study|Head injury not related to study|0|||
149974479|NCT02081586|541043931|FG002|Overall Study|Head injury not related to study|1|||
149974480|NCT02081586|541043932|FG003|Overall Study|Head injury not related to study|0|||
149974481|NCT04540367|541043938|FG000|Overall Study|Withdrawal by Subject|0|||
149974482|NCT04540367|541043939|FG001|Overall Study|Withdrawal by Subject|0|||
149974483|NCT04540367|541043940|FG002|Overall Study|Withdrawal by Subject|0|||
149974484|NCT04540367|541043941|FG003|Overall Study|Withdrawal by Subject|2|||
149974485|NCT04540367|541043938|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
149974486|NCT04540367|541043939|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
149974487|NCT04540367|541043940|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
149974488|NCT04540367|541043941|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
149974489|NCT04540367|541043938|FG000|Overall Study|Adverse Event|0|||
149974490|NCT04540367|541043939|FG001|Overall Study|Adverse Event|0|||
149974491|NCT04540367|541043940|FG002|Overall Study|Adverse Event|1|||
149974492|NCT04540367|541043941|FG003|Overall Study|Adverse Event|1|||
149974493|NCT01816048|541043945|FG000|Overall Study|Adverse Event|1|||
149974494|NCT01816048|541043945|FG000|Overall Study|Death|1|||
149974495|NCT01816048|541043945|FG000|Overall Study|Withdrawal by Subject|1|||
149974496|NCT01816048|541043945|FG000|Overall Study|Disease Progression|3|||
150177690|NCT02988817|541788181|FG017|Overall Study|Other|0|||
150177691|NCT02988817|541788182|FG018|Overall Study|Other|0|||
150177692|NCT02988817|541788183|FG019|Overall Study|Other|0|||
150177693|NCT02988817|541788164|FG000|Overall Study|Lost to Follow-up|0|||
150177694|NCT02988817|541788165|FG001|Overall Study|Lost to Follow-up|0|||
150177695|NCT02988817|541788166|FG002|Overall Study|Lost to Follow-up|0|||
150177696|NCT02988817|541788167|FG003|Overall Study|Lost to Follow-up|0|||
150177697|NCT02988817|541788168|FG004|Overall Study|Lost to Follow-up|0|||
150177698|NCT02988817|541788169|FG005|Overall Study|Lost to Follow-up|0|||
150177699|NCT02988817|541788170|FG006|Overall Study|Lost to Follow-up|0|||
150177700|NCT02988817|541788171|FG007|Overall Study|Lost to Follow-up|0|||
149974497|NCT01816984|541043946|FG000|Overall Study|declining health status|1|||
149974498|NCT05899829|541043947|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
149974499|NCT05899829|541043948|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
149974500|NCT05899829|541043947|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
149974501|NCT05899829|541043948|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
149974502|NCT02121509|541043951|FG000|Washout Period (35 Days)|Adverse Event|1|||
149974503|NCT02121509|541043952|FG001|Washout Period (35 Days)|Adverse Event|1|||
149974504|NCT02121509|541043953|FG002|Washout Period (35 Days)|Adverse Event|0|||
149974505|NCT02121509|541043954|FG003|Washout Period (35 Days)|Adverse Event|0|||
149974506|NCT02121509|541043951|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
149974507|NCT02121509|541043952|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
149974508|NCT02121509|541043953|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
149974509|NCT02121509|541043954|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
149974510|NCT02121509|541043951|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
149974511|NCT02121509|541043952|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
149974512|NCT02121509|541043953|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
149974513|NCT02121509|541043954|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
149974514|NCT00636181|541043957|FG000|Overall Study|Withdrawal by Subject|8|||
149974515|NCT00636181|541043958|FG001|Overall Study|Withdrawal by Subject|6|||
149974516|NCT00636181|541043959|FG002|Overall Study|Withdrawal by Subject|10|||
149974517|NCT04549454|541043967|FG000|T1 to T2|Lost to Follow-up|22|||
149974518|NCT04549454|541043968|FG001|T1 to T2|Lost to Follow-up|26|||
149974519|NCT04549454|541043967|FG000|T1 to T3|Lost to Follow-up|31|||
149974520|NCT04549454|541043968|FG001|T1 to T3|Lost to Follow-up|36|||
149974521|NCT00867035|541043969|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
149974522|NCT00867035|541043970|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
149974523|NCT00867035|541043969|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
149974524|NCT00867035|541043970|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
149974525|NCT05076045|541043977|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
149974526|NCT05076045|541043978|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
149974527|NCT03402841|541043989|FG000|Overall Study|Withdrawal by Subject|3|||
149974528|NCT03402841|541043989|FG000|Overall Study|Lost to Follow-up|2|||
149974529|NCT03402841|541043989|FG000|Overall Study|Death|146|||
149974530|NCT02993263|541043990|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
149974531|NCT02735421|541045927|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
149974532|NCT02735421|541045927|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
149974533|NCT02735421|541045927|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
149974534|NCT02735421|541045927|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
149974535|NCT02735421|541045927|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
149974536|NCT02735421|541045927|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
149974537|NCT02735421|541045927|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
149974538|NCT00427011|541045928|FG000|Overall Study|Adverse Event|10|||
149974539|NCT00427011|541045928|FG000|Overall Study|Withdrawal by Subject|1|||
149974540|NCT00427011|541045928|FG000|Overall Study|Lack of Efficacy|2|||
149974541|NCT00427011|541045928|FG000|Overall Study|Other|12|||
149974542|NCT02921789|541045929|FG000|Overall Study|Adverse Event|0|||
149974543|NCT02921789|541045930|FG001|Overall Study|Adverse Event|1|||
149974544|NCT02921789|541045929|FG000|Overall Study|Lost to Follow-up|1|||
149974545|NCT02921789|541045930|FG001|Overall Study|Lost to Follow-up|0|||
149974546|NCT02921789|541045929|FG000|Overall Study|Protocol Deviation|2|||
149974547|NCT02921789|541045930|FG001|Overall Study|Protocol Deviation|0|||
149974548|NCT02921789|541045929|FG000|Overall Study|Withdrawal by Subject|2|||
149974549|NCT02921789|541045930|FG001|Overall Study|Withdrawal by Subject|1|||
149974550|NCT02921789|541045929|FG000|Overall Study|Miscellaneous|3|||
149974551|NCT02921789|541045930|FG001|Overall Study|Miscellaneous|2|||
149974552|NCT02896257|541045931|FG000|Providers|Without eligible patients|21|||
149974553|NCT02896257|541045932|FG001|Providers|Without eligible patients|28|||
149974554|NCT02896257|541045931|FG000|Patients|PFT entry criteria not met|43|||
149974555|NCT02896257|541045932|FG001|Patients|PFT entry criteria not met|50|||
149974556|NCT02896257|541045931|FG000|Patients|No capacity to review|8|||
149974557|NCT02896257|541045932|FG001|Patients|No capacity to review|11|||
149974558|NCT02896257|541045931|FG000|Patients|Appointment rescheduled/cancelled|5|||
149974559|NCT02896257|541045932|FG001|Patients|Appointment rescheduled/cancelled|7|||
149974560|NCT02896257|541045931|FG000|Patients|PCP not assigned a clinic|4|||
149974561|NCT02896257|541045932|FG001|Patients|PCP not assigned a clinic|0|||
149974562|NCT02896257|541045931|FG000|Patients|No history of COPD|0|||
149974563|NCT02896257|541045932|FG001|Patients|No history of COPD|1|||
149974564|NCT02896257|541045931|FG000|Patients|Deceased between review and index date|0|||
149974565|NCT02896257|541045932|FG001|Patients|Deceased between review and index date|1|||
149974566|NCT02896257|541045931|FG000|Patients|No ICS Rx upon review|1|||
149974567|NCT02896257|541045932|FG001|Patients|No ICS Rx upon review|1|||
149974568|NCT02896257|541045931|FG000|Patients|Protocol Violation|2|||
149974569|NCT02896257|541045932|FG001|Patients|Protocol Violation|1|||
149974570|NCT02896257|541045931|FG000|Patients|Hospice care|0|||
149974571|NCT02896257|541045932|FG001|Patients|Hospice care|1|||
149974572|NCT03423602|541045937|FG000|Overall Study|Death|1|||
149974573|NCT03423602|541045937|FG000|Overall Study|Lost to Follow-up|6|||
149974574|NCT03423602|541045937|FG000|Overall Study|Protocol Violation|1|||
149974575|NCT03423602|541045937|FG000|Overall Study|Withdrawal by Subject|4|||
149974576|NCT01192126|541045938|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
149974577|NCT01192126|541045939|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
149974578|NCT01192126|541045938|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
149974579|NCT01192126|541045939|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
149974580|NCT03759600|541045940|FG000|Overall Study|Adverse Event|2|||
149974581|NCT03759600|541045940|FG000|Overall Study|Progressive Disease|15|||
149974582|NCT03759600|541045940|FG000|Overall Study|Site Terminated by Sponsor|3|||
149974583|NCT03257358|541045941|FG000|Overall Study|Adverse Event|25|||
149974584|NCT03257358|541045942|FG001|Overall Study|Adverse Event|12|||
149974585|NCT03257358|541045941|FG000|Overall Study|Lack of Efficacy|1|||
149974586|NCT03257358|541045942|FG001|Overall Study|Lack of Efficacy|1|||
149974587|NCT03257358|541045941|FG000|Overall Study|Lost to Follow-up|12|||
149974588|NCT03257358|541045942|FG001|Overall Study|Lost to Follow-up|4|||
149974589|NCT03257358|541045941|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
150177701|NCT02988817|541788172|FG008|Overall Study|Lost to Follow-up|1|||
149974590|NCT03257358|541045942|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
149974591|NCT03257358|541045941|FG000|Overall Study|Physician Decision|2|||
149974592|NCT03257358|541045942|FG001|Overall Study|Physician Decision|2|||
149974593|NCT03257358|541045941|FG000|Overall Study|Protocol Violation|5|||
149974594|NCT03257358|541045942|FG001|Overall Study|Protocol Violation|3|||
149974595|NCT03257358|541045941|FG000|Overall Study|Technical problems|4|||
149974596|NCT03257358|541045942|FG001|Overall Study|Technical problems|1|||
149974597|NCT03257358|541045941|FG000|Overall Study|Withdrawal by Subject|8|||
149974598|NCT03257358|541045942|FG001|Overall Study|Withdrawal by Subject|3|||
149974599|NCT03257358|541045941|FG000|Overall Study|Withdrawal of informed consent|9|||
149974600|NCT03257358|541045942|FG001|Overall Study|Withdrawal of informed consent|5|||
149974601|NCT03257358|541045941|FG000|Overall Study|New therapy for study indication|1|||
149974602|NCT03257358|541045942|FG001|Overall Study|New therapy for study indication|0|||
149974603|NCT03257358|541045941|FG000|Overall Study|No longer requires treatment|0|||
149974604|NCT03257358|541045942|FG001|Overall Study|No longer requires treatment|1|||
149974605|NCT01248793|541045943|FG000|Overall Study|Lost to Follow-up|0|||
149974606|NCT01248793|541045944|FG001|Overall Study|Lost to Follow-up|1|||
149974607|NCT01248793|541045943|FG000|Overall Study|Adverse Event|1|||
149974608|NCT01248793|541045944|FG001|Overall Study|Adverse Event|1|||
149974609|NCT01248793|541045943|FG000|Overall Study|Protocol Violation|0|||
149974610|NCT01248793|541045944|FG001|Overall Study|Protocol Violation|1|||
149974611|NCT01248793|541045943|FG000|Overall Study|Withdrawal by Subject|3|||
149974612|NCT01248793|541045944|FG001|Overall Study|Withdrawal by Subject|3|||
149974613|NCT02580877|541045945|FG000|Overall Study|Withdrawal by Subject|1|||
149974614|NCT02580877|541045946|FG001|Overall Study|Withdrawal by Subject|3|||
149974615|NCT02580877|541045945|FG000|Overall Study|Adverse Event|0|||
149974616|NCT02580877|541045946|FG001|Overall Study|Adverse Event|1|||
149974617|NCT00355030|541045947|FG000|Study Period 1 Treatment|Adverse Event|1|||
149974618|NCT00355030|541045948|FG001|Study Period 1 Treatment|Adverse Event|1|||
149974619|NCT00355030|541045947|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
149974620|NCT00355030|541045948|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
149974621|NCT00355030|541045947|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
149974622|NCT00355030|541045948|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
149974623|NCT00355030|541045947|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
149974624|NCT00355030|541045948|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
149974625|NCT00355030|541045947|FG000|Study Period 1 Treatment|Physician Decision|0|||
149974626|NCT00355030|541045948|FG001|Study Period 1 Treatment|Physician Decision|1|||
149974627|NCT00355030|541045947|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
149974628|NCT00355030|541045948|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
149974629|NCT00355030|541045947|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
149974630|NCT00355030|541045948|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
149974631|NCT00355030|541045947|FG000|Study Period 1 Treatment|Other|2|||
149974632|NCT00355030|541045948|FG001|Study Period 1 Treatment|Other|6|||
149974633|NCT00355030|541045947|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
149974634|NCT00355030|541045948|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
149974635|NCT00355030|541045947|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
149974636|NCT00355030|541045948|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
149974637|NCT00339040|541045949|FG000|Stage I|Not able to attend clinic|1|||
149974638|NCT00339040|541045950|FG001|Stage I|Not able to attend clinic|0|||
149974639|NCT00339040|541045949|FG000|Stage I|Protocol Violation|1|||
149974640|NCT00339040|541045950|FG001|Stage I|Protocol Violation|1|||
149974641|NCT00339040|541045949|FG000|Stage II|Lost to Follow-up|3|||
149974642|NCT00339040|541045950|FG001|Stage II|Lost to Follow-up|0|||
149974643|NCT00339040|541045949|FG000|Stage II|Withdrawal by Subject|1|||
149974644|NCT00339040|541045950|FG001|Stage II|Withdrawal by Subject|2|||
149974645|NCT00339040|541045949|FG000|Stage II|Protocol Violation|3|||
149974646|NCT00339040|541045950|FG001|Stage II|Protocol Violation|0|||
149974647|NCT00339040|541045949|FG000|Stage II|Not able to attend clinic|1|||
149974648|NCT00339040|541045950|FG001|Stage II|Not able to attend clinic|0|||
149974649|NCT00339040|541045949|FG000|Stage II|Site closing|2|||
149974650|NCT00339040|541045950|FG001|Stage II|Site closing|0|||
149974651|NCT01462929|541045951|FG000|Overall Study|Adverse Event|3|||
149974652|NCT01462929|541045952|FG001|Overall Study|Adverse Event|3|||
149974653|NCT01462929|541045953|FG002|Overall Study|Adverse Event|4|||
149974654|NCT01462929|541045951|FG000|Overall Study|Withdrawal by Subject|2|||
149974655|NCT01462929|541045952|FG001|Overall Study|Withdrawal by Subject|1|||
149974656|NCT01462929|541045953|FG002|Overall Study|Withdrawal by Subject|0|||
149974657|NCT01462929|541045951|FG000|Overall Study|Lack of Efficacy|0|||
149974658|NCT01462929|541045952|FG001|Overall Study|Lack of Efficacy|0|||
149974659|NCT01462929|541045953|FG002|Overall Study|Lack of Efficacy|1|||
149974660|NCT03046446|541045958|FG000|Overall Study|Lack of Efficacy|7|||
149974661|NCT03046446|541045958|FG000|Overall Study|Adverse Event|6|||
149974662|NCT03046446|541045958|FG000|Overall Study|Lost to Follow-up|3|||
149974663|NCT03046446|541045958|FG000|Overall Study|Withdrawal by Subject|14|||
149974664|NCT03046446|541045958|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
149974665|NCT03046446|541045958|FG000|Overall Study|Disease Progression (see caveats)|25|||
149974666|NCT03046446|541045958|FG000|Overall Study|Non OA related knee surgery|1|||
149974667|NCT00688467|541045959|FG000|Treatment Period 1|Adverse Event|2|||
149974668|NCT00688467|541045960|FG001|Treatment Period 1|Adverse Event|1|||
149974669|NCT00688467|541045959|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
149974670|NCT00688467|541045960|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
149974671|NCT00688467|541045959|FG000|Treatment Period 2|Protocol Violation|0|||
149974672|NCT00688467|541045960|FG001|Treatment Period 2|Protocol Violation|1|||
149974673|NCT00688467|541045959|FG000|Treatment Period 2|Adverse Event|0|||
149974674|NCT00688467|541045960|FG001|Treatment Period 2|Adverse Event|1|||
149974675|NCT00690794|541045963|FG000|Overall Study|Adverse Event|12|||
149974676|NCT00690794|541045964|FG001|Overall Study|Adverse Event|10|||
149974677|NCT00690794|541045963|FG000|Overall Study|Lost to Follow-up|1|||
149974678|NCT00690794|541045964|FG001|Overall Study|Lost to Follow-up|4|||
149974679|NCT00690794|541045963|FG000|Overall Study|Withdrawal by Subject|0|||
149974680|NCT00690794|541045964|FG001|Overall Study|Withdrawal by Subject|9|||
149974681|NCT00690794|541045963|FG000|Overall Study|Protocol Violation|6|||
149974682|NCT00690794|541045964|FG001|Overall Study|Protocol Violation|7|||
149974683|NCT00690794|541045963|FG000|Overall Study|Noncompliance|1|||
149974684|NCT00690794|541045964|FG001|Overall Study|Noncompliance|2|||
149974685|NCT00690794|541045963|FG000|Overall Study|Other not specified|1|||
149974686|NCT00690794|541045964|FG001|Overall Study|Other not specified|3|||
149974687|NCT03012334|541045965|FG000|Period 1|Withdrawal by Subject|0|||
149974688|NCT03012334|541045966|FG001|Period 1|Withdrawal by Subject|0|||
149974689|NCT03012334|541045967|FG002|Period 1|Withdrawal by Subject|0|||
149974690|NCT03012334|541045968|FG003|Period 1|Withdrawal by Subject|0|||
149974691|NCT03012334|541045969|FG004|Period 1|Withdrawal by Subject|0|||
149974692|NCT03012334|541045970|FG005|Period 1|Withdrawal by Subject|0|||
149974693|NCT03012334|541045971|FG006|Period 1|Withdrawal by Subject|0|||
149974694|NCT03012334|541045972|FG007|Period 1|Withdrawal by Subject|0|||
149974695|NCT03012334|541045973|FG008|Period 1|Withdrawal by Subject|0|||
149974696|NCT03012334|541045974|FG009|Period 1|Withdrawal by Subject|1|||
149974697|NCT03012334|541045965|FG000|Period 2|Withdrawal by Subject|0|||
149974698|NCT03012334|541045966|FG001|Period 2|Withdrawal by Subject|1|||
149974699|NCT03012334|541045967|FG002|Period 2|Withdrawal by Subject|0|||
149974700|NCT03012334|541045968|FG003|Period 2|Withdrawal by Subject|0|||
149974701|NCT03012334|541045969|FG004|Period 2|Withdrawal by Subject|0|||
149974702|NCT03012334|541045970|FG005|Period 2|Withdrawal by Subject|0|||
149974703|NCT03012334|541045971|FG006|Period 2|Withdrawal by Subject|0|||
149974704|NCT03012334|541045972|FG007|Period 2|Withdrawal by Subject|0|||
149974705|NCT03012334|541045973|FG008|Period 2|Withdrawal by Subject|0|||
149974706|NCT03012334|541045974|FG009|Period 2|Withdrawal by Subject|0|||
149974707|NCT03012334|541045965|FG000|Period 2|Protocol Violation|0|||
149974708|NCT03012334|541045966|FG001|Period 2|Protocol Violation|0|||
149974709|NCT03012334|541045967|FG002|Period 2|Protocol Violation|1|||
149974710|NCT03012334|541045968|FG003|Period 2|Protocol Violation|0|||
149974711|NCT03012334|541045969|FG004|Period 2|Protocol Violation|0|||
149974712|NCT03012334|541045970|FG005|Period 2|Protocol Violation|0|||
149974713|NCT03012334|541045971|FG006|Period 2|Protocol Violation|0|||
149974714|NCT03012334|541045972|FG007|Period 2|Protocol Violation|1|||
149974715|NCT03012334|541045973|FG008|Period 2|Protocol Violation|0|||
149974716|NCT03012334|541045974|FG009|Period 2|Protocol Violation|0|||
149974717|NCT03012334|541045965|FG000|Period 4|Non-Compliance|0|||
149974718|NCT03012334|541045966|FG001|Period 4|Non-Compliance|0|||
149974719|NCT03012334|541045967|FG002|Period 4|Non-Compliance|0|||
149974720|NCT03012334|541045968|FG003|Period 4|Non-Compliance|0|||
149974721|NCT03012334|541045969|FG004|Period 4|Non-Compliance|0|||
149974722|NCT03012334|541045970|FG005|Period 4|Non-Compliance|0|||
149974723|NCT03012334|541045971|FG006|Period 4|Non-Compliance|1|||
149974724|NCT03012334|541045972|FG007|Period 4|Non-Compliance|0|||
149974725|NCT03012334|541045973|FG008|Period 4|Non-Compliance|0|||
149974726|NCT03012334|541045974|FG009|Period 4|Non-Compliance|0|||
149974727|NCT03012334|541045965|FG000|Period 4|Adverse Event|0|||
149974728|NCT03012334|541045966|FG001|Period 4|Adverse Event|0|||
149974729|NCT03012334|541045967|FG002|Period 4|Adverse Event|0|||
149974730|NCT03012334|541045968|FG003|Period 4|Adverse Event|0|||
149974731|NCT03012334|541045969|FG004|Period 4|Adverse Event|0|||
149974732|NCT03012334|541045970|FG005|Period 4|Adverse Event|0|||
149974733|NCT03012334|541045971|FG006|Period 4|Adverse Event|0|||
149974734|NCT03012334|541045972|FG007|Period 4|Adverse Event|0|||
149974735|NCT03012334|541045973|FG008|Period 4|Adverse Event|1|||
149974736|NCT03012334|541045974|FG009|Period 4|Adverse Event|0|||
149974737|NCT00305448|541045975|FG000|Overall Study|Protocol Violation|0|||
149974738|NCT00305448|541045976|FG001|Overall Study|Protocol Violation|1|||
149974739|NCT00305448|541045977|FG002|Overall Study|Protocol Violation|0|||
149974740|NCT00305448|541045975|FG000|Overall Study|Withdrawal by Subject|2|||
149974741|NCT00305448|541045976|FG001|Overall Study|Withdrawal by Subject|0|||
149974742|NCT00305448|541045977|FG002|Overall Study|Withdrawal by Subject|1|||
149974743|NCT00305448|541045975|FG000|Overall Study|Adverse Event|1|||
149974744|NCT00305448|541045976|FG001|Overall Study|Adverse Event|0|||
149974745|NCT00305448|541045977|FG002|Overall Study|Adverse Event|1|||
149974746|NCT00305448|541045975|FG000|Overall Study|Disease Progression|27|||
149974747|NCT00305448|541045976|FG001|Overall Study|Disease Progression|31|||
149974748|NCT00305448|541045977|FG002|Overall Study|Disease Progression|28|||
149974749|NCT00305448|541045975|FG000|Overall Study|Subjective Disease Progression|1|||
149974750|NCT00305448|541045976|FG001|Overall Study|Subjective Disease Progression|2|||
149974751|NCT00305448|541045977|FG002|Overall Study|Subjective Disease Progression|2|||
149974752|NCT00305448|541045975|FG000|Overall Study|Tumor Marker Elevation|0|||
149974753|NCT00305448|541045976|FG001|Overall Study|Tumor Marker Elevation|0|||
149974754|NCT00305448|541045977|FG002|Overall Study|Tumor Marker Elevation|1|||
149974755|NCT01343888|541045978|FG000|Overall Study|Adverse Event|12|||
149974756|NCT01343888|541045979|FG001|Overall Study|Adverse Event|22|||
149974757|NCT01343888|541045980|FG002|Overall Study|Adverse Event|5|||
149974758|NCT01343888|541045978|FG000|Overall Study|Lack of Efficacy|9|||
149974759|NCT01343888|541045979|FG001|Overall Study|Lack of Efficacy|9|||
149974760|NCT01343888|541045980|FG002|Overall Study|Lack of Efficacy|13|||
149974761|NCT01343888|541045978|FG000|Overall Study|Lost to Follow-up|0|||
149974762|NCT01343888|541045979|FG001|Overall Study|Lost to Follow-up|2|||
149974763|NCT01343888|541045980|FG002|Overall Study|Lost to Follow-up|1|||
149974764|NCT01343888|541045978|FG000|Overall Study|Protocol Violation|0|||
149974765|NCT01343888|541045979|FG001|Overall Study|Protocol Violation|2|||
149974766|NCT01343888|541045980|FG002|Overall Study|Protocol Violation|0|||
149974767|NCT01343888|541045978|FG000|Overall Study|Withdrawal by Subject|4|||
149974768|NCT01343888|541045979|FG001|Overall Study|Withdrawal by Subject|4|||
149974769|NCT01343888|541045980|FG002|Overall Study|Withdrawal by Subject|2|||
149974770|NCT01343888|541045978|FG000|Overall Study|other than stated above|0|||
149974771|NCT01343888|541045979|FG001|Overall Study|other than stated above|0|||
149974772|NCT01343888|541045980|FG002|Overall Study|other than stated above|1|||
149974773|NCT00558636|541045990|FG000|Treatment|Adverse Event|9|||
149974774|NCT00558636|541045991|FG001|Treatment|Adverse Event|2|||
149974775|NCT00558636|541045990|FG000|Treatment|Withdrawal by Subject|2|||
149974776|NCT00558636|541045991|FG001|Treatment|Withdrawal by Subject|0|||
149974777|NCT00558636|541045990|FG000|Treatment|Premature termination of the study|35|||
149974778|NCT00558636|541045991|FG001|Treatment|Premature termination of the study|37|||
149974779|NCT00558636|541045990|FG000|Treatment|Disease progression|1|||
149974780|NCT00558636|541045991|FG001|Treatment|Disease progression|5|||
149974781|NCT00558636|541045990|FG000|Follow-up|Premature termination of the study|12|||
149974782|NCT00558636|541045991|FG001|Follow-up|Premature termination of the study|7|||
149974783|NCT04108273|541045992|FG000|Overall Study|COVID Pandemic|1|||
149974784|NCT04108273|541045993|FG001|Overall Study|COVID Pandemic|0|||
149974785|NCT00800735|541045995|FG000|Overall Study|Administrative/Other|2|||
149974786|NCT00800735|541045995|FG000|Overall Study|Insufficient Therapeutic Response|2|||
149974787|NCT00800735|541045995|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
149974788|NCT00800735|541045995|FG000|Overall Study|Withdrew Consent|3|||
149974789|NCT02154061|541045996|FG000|Overall Study|Pregnancy|1|||
149974790|NCT02154061|541045997|FG001|Overall Study|Pregnancy|0|||
149974791|NCT02154061|541045996|FG000|Overall Study|enrolled but not vaccinated|1|||
149974792|NCT02154061|541045997|FG001|Overall Study|enrolled but not vaccinated|0|||
149974793|NCT01936831|541046003|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974794|NCT01936831|541046004|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974795|NCT01936831|541046005|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974796|NCT01936831|541046006|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974797|NCT01936831|541046007|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974798|NCT01936831|541046008|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
149974799|NCT01936831|541046009|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974800|NCT01936831|541046010|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974801|NCT01936831|541046011|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
149974802|NCT00487981|541046013|FG000|Overall Study|Hypothyroidism diagnosis|1|||
149974803|NCT02808429|541046018|FG000|Overall Study|Lost to Follow-up|1|||
149974804|NCT02808429|541046019|FG001|Overall Study|Lost to Follow-up|0|||
149974805|NCT02808429|541046020|FG002|Overall Study|Lost to Follow-up|0|||
149974806|NCT02808429|541046018|FG000|Overall Study|Protocol Violation|0|||
149974807|NCT02808429|541046019|FG001|Overall Study|Protocol Violation|1|||
149974808|NCT02808429|541046020|FG002|Overall Study|Protocol Violation|0|||
149974809|NCT02808429|541046018|FG000|Overall Study|Premature study termination by sponsor|2|||
149974810|NCT02808429|541046019|FG001|Overall Study|Premature study termination by sponsor|0|||
149974811|NCT02808429|541046020|FG002|Overall Study|Premature study termination by sponsor|1|||
149974812|NCT02808429|541046018|FG000|Overall Study|Relocation|0|||
149974813|NCT02808429|541046019|FG001|Overall Study|Relocation|0|||
149974814|NCT02808429|541046020|FG002|Overall Study|Relocation|1|||
149974815|NCT01133847|541046025|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
149974816|NCT01133847|541046026|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
149974817|NCT01133847|541046027|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
149974818|NCT01133847|541046025|FG000|Follow-Up Phase|Lost to Follow-up|1|||
149974819|NCT01133847|541046026|FG001|Follow-Up Phase|Lost to Follow-up|3|||
149974820|NCT01133847|541046027|FG002|Follow-Up Phase|Lost to Follow-up|7|||
149974821|NCT04436744|541046028|FG000|Overall Study|Adverse Event|1|||
149974822|NCT04436744|541046029|FG001|Overall Study|Adverse Event|1|||
149974823|NCT04436744|541046028|FG000|Overall Study|Death|1|||
149974824|NCT04436744|541046029|FG001|Overall Study|Death|0|||
149974825|NCT04436744|541046028|FG000|Overall Study|Lost to Follow-up|0|||
149974826|NCT04436744|541046029|FG001|Overall Study|Lost to Follow-up|2|||
149974827|NCT04436744|541046028|FG000|Overall Study|Physician Decision|0|||
149974828|NCT04436744|541046029|FG001|Overall Study|Physician Decision|1|||
149974829|NCT04436744|541046028|FG000|Overall Study|Progressive Disease|0|||
149974830|NCT04436744|541046029|FG001|Overall Study|Progressive Disease|4|||
149974831|NCT04436744|541046028|FG000|Overall Study|Protocol Deviation|1|||
149974832|NCT04436744|541046029|FG001|Overall Study|Protocol Deviation|1|||
149974833|NCT04436744|541046028|FG000|Overall Study|Withdrawal by Subject|1|||
149974834|NCT04436744|541046029|FG001|Overall Study|Withdrawal by Subject|2|||
149974835|NCT01854528|541046032|FG000|Overall Study|Adverse Event|0|||
149974836|NCT01854528|541046033|FG001|Overall Study|Adverse Event|4|||
149974837|NCT01854528|541046032|FG000|Overall Study|Withdrawal by Subject|0|||
149974838|NCT01854528|541046033|FG001|Overall Study|Withdrawal by Subject|2|||
149974839|NCT01854528|541046032|FG000|Overall Study|Virologic Failure|0|||
149974840|NCT01854528|541046033|FG001|Overall Study|Virologic Failure|9|||
149974841|NCT02961244|541046034|FG000|Overall Study|Protocol Violation|0|||
150051941|NCT03615040|541332825|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
150051942|NCT03615040|541332824|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
150051943|NCT03615040|541332825|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
150051944|NCT03615040|541332824|FG000|Overall Study|Death|0|||
150051945|NCT03615040|541332825|FG001|Overall Study|Death|2|||
150051946|NCT01541397|541332826|FG000|Overall Study|Study ended prior to data collection|4|||
150051947|NCT01541397|541332827|FG001|Overall Study|Study ended prior to data collection|2|||
150051948|NCT02365480|541332830|FG000|Overall Study|Withdrawal by Subject|2|||
150051949|NCT02365480|541332831|FG001|Overall Study|Withdrawal by Subject|0|||
150051950|NCT00706342|541332832|FG000|Overall Study|Adverse Event|3|||
150051951|NCT00706342|541332832|FG000|Overall Study|Not responding to treatment|2|||
150051952|NCT00706342|541332832|FG000|Overall Study|Withdrawn due to failure to respond|1|||
150051953|NCT00706342|541332832|FG000|Overall Study|Death|1|||
150051954|NCT00706342|541332832|FG000|Overall Study|Withdrew from the study on his own.|1|||
149974842|NCT02961244|541046035|FG001|Overall Study|Protocol Violation|1|||
149974843|NCT02961244|541046034|FG000|Overall Study|Withdrawal by Subject|1|||
149974844|NCT02961244|541046035|FG001|Overall Study|Withdrawal by Subject|2|||
149974845|NCT02961244|541046034|FG000|Overall Study|Surgery plan change after study approval|0|||
149974846|NCT02961244|541046035|FG001|Overall Study|Surgery plan change after study approval|2|||
149974847|NCT02961244|541046034|FG000|Overall Study|Lost to Follow-up|0|||
150051955|NCT00706342|541332832|FG000|Overall Study|Investigator discretion|2|||
149974848|NCT02961244|541046035|FG001|Overall Study|Lost to Follow-up|2|||
149974849|NCT02961244|541046034|FG000|Overall Study|İnadequate data|0|||
149974850|NCT02961244|541046035|FG001|Overall Study|İnadequate data|2|||
149974851|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
149974852|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
149974853|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
149974854|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
149974855|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
149974856|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
149974857|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
149974858|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
149974859|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
149974860|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
149974861|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
149974862|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
149974863|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
149974864|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
149974865|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
149974866|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
149974867|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
149974868|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
149974869|NCT03789292|541046036|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
149974870|NCT03789292|541046037|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
149974871|NCT03789292|541046038|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
149974872|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
149974873|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
149974874|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
149974875|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
149974876|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
149974877|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
149974878|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
149974879|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
149974880|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
149974881|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
149974882|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
149974883|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
149974884|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
149974885|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
149974886|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
149974887|NCT03789292|541046036|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
149974888|NCT03789292|541046037|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
149974889|NCT03789292|541046038|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
149974890|NCT00967616|541046039|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
149974891|NCT00967616|541046040|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
149974892|NCT00967616|541046039|FG000|Overall Study|Death|0|||
149974893|NCT00967616|541046040|FG001|Overall Study|Death|3|||
149974894|NCT00967616|541046039|FG000|Overall Study|Withdrawal by Subject|8|||
149974895|NCT00967616|541046040|FG001|Overall Study|Withdrawal by Subject|4|||
149974896|NCT00967616|541046039|FG000|Overall Study|Progressive Disease|31|||
149974897|NCT00967616|541046040|FG001|Overall Study|Progressive Disease|18|||
149974898|NCT00967616|541046039|FG000|Overall Study|Other|8|||
149974899|NCT00967616|541046040|FG001|Overall Study|Other|8|||
149974900|NCT00967616|541046039|FG000|Overall Study|Protocol Violation|1|||
149974901|NCT00967616|541046040|FG001|Overall Study|Protocol Violation|0|||
149974902|NCT01696643|541046041|FG000|Overall Study|Adverse Event|15|||
149974903|NCT01696643|541046042|FG001|Overall Study|Adverse Event|7|||
149974904|NCT01696643|541046041|FG000|Overall Study|Death|1|||
149974905|NCT01696643|541046042|FG001|Overall Study|Death|2|||
149974906|NCT01696643|541046041|FG000|Overall Study|Lack of Efficacy|3|||
149974907|NCT01696643|541046042|FG001|Overall Study|Lack of Efficacy|0|||
149974908|NCT01696643|541046041|FG000|Overall Study|Lost to Follow-up|67|||
149974909|NCT01696643|541046042|FG001|Overall Study|Lost to Follow-up|67|||
149974910|NCT01696643|541046041|FG000|Overall Study|Physician Decision|3|||
149974911|NCT01696643|541046042|FG001|Overall Study|Physician Decision|2|||
149974912|NCT01696643|541046041|FG000|Overall Study|Pregnancy|0|||
149974913|NCT01696643|541046042|FG001|Overall Study|Pregnancy|1|||
149974914|NCT01696643|541046041|FG000|Overall Study|Protocol Violation|7|||
149974915|NCT01696643|541046042|FG001|Overall Study|Protocol Violation|7|||
149974916|NCT01696643|541046041|FG000|Overall Study|Study Terminated by Sponsor|286|||
149974917|NCT01696643|541046042|FG001|Overall Study|Study Terminated by Sponsor|294|||
149974918|NCT01696643|541046041|FG000|Overall Study|Withdrawal by Subject|142|||
149974919|NCT01696643|541046042|FG001|Overall Study|Withdrawal by Subject|149|||
149974920|NCT01696643|541046041|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
149974921|NCT01696643|541046042|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
149974922|NCT01696643|541046041|FG000|Overall Study|Site Error|2|||
149974923|NCT01696643|541046042|FG001|Overall Study|Site Error|1|||
149974924|NCT01696643|541046041|FG000|Overall Study|Participant Incarcerated|0|||
149974925|NCT01696643|541046042|FG001|Overall Study|Participant Incarcerated|1|||
149974926|NCT01696643|541046041|FG000|Overall Study|Medical Monitor Decision|0|||
149974927|NCT01696643|541046042|FG001|Overall Study|Medical Monitor Decision|2|||
149974928|NCT01696643|541046041|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
149974929|NCT01696643|541046042|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
149974930|NCT00518180|541046043|FG000|Overall Study|Withdrawal by Subject|29|||
149974931|NCT00518180|541046044|FG001|Overall Study|Withdrawal by Subject|30|||
149974932|NCT00518180|541046045|FG002|Overall Study|Withdrawal by Subject|42|||
149974933|NCT00518180|541046043|FG000|Overall Study|Lost to Follow-up|30|||
149974934|NCT00518180|541046044|FG001|Overall Study|Lost to Follow-up|28|||
149974935|NCT00518180|541046045|FG002|Overall Study|Lost to Follow-up|34|||
149974936|NCT00518180|541046043|FG000|Overall Study|Administrative reason|0|||
149974937|NCT00518180|541046044|FG001|Overall Study|Administrative reason|2|||
149974938|NCT00518180|541046045|FG002|Overall Study|Administrative reason|2|||
149974939|NCT00518180|541046043|FG000|Overall Study|Protocol Violation|5|||
149974940|NCT00518180|541046044|FG001|Overall Study|Protocol Violation|7|||
149974941|NCT00518180|541046045|FG002|Overall Study|Protocol Violation|4|||
149974942|NCT00518180|541046043|FG000|Overall Study|Unable to classify|0|||
149974943|NCT00518180|541046044|FG001|Overall Study|Unable to classify|2|||
149974944|NCT00518180|541046045|FG002|Overall Study|Unable to classify|0|||
149974945|NCT00518180|541046043|FG000|Overall Study|Adverse Event|1|||
149974946|NCT00518180|541046044|FG001|Overall Study|Adverse Event|0|||
149974947|NCT00518180|541046045|FG002|Overall Study|Adverse Event|0|||
149974948|NCT00575666|541046046|FG000|Overall Study|Withdrawal by Subject|3|||
149974949|NCT00575666|541046047|FG001|Overall Study|Withdrawal by Subject|2|||
149974950|NCT00575666|541046046|FG000|Overall Study|Physician Decision|1|||
149974951|NCT00575666|541046047|FG001|Overall Study|Physician Decision|1|||
149974952|NCT00508482|541046048|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
149974953|NCT00508482|541046049|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
149974954|NCT00508482|541046050|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
149974955|NCT00508482|541046048|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
149974956|NCT00508482|541046049|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
149974957|NCT00508482|541046050|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
149974958|NCT00508482|541046048|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
149974959|NCT00508482|541046049|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
149974960|NCT00508482|541046050|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
149974961|NCT03508050|541046053|FG000|Overall Study|Pleural adhesions|1|||
149974962|NCT03508050|541046054|FG001|Overall Study|Pleural adhesions|0|||
149974963|NCT03508050|541046053|FG000|Overall Study|Mucus plug|1|||
149974964|NCT03508050|541046054|FG001|Overall Study|Mucus plug|0|||
149974965|NCT03508050|541046053|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
149974966|NCT03508050|541046054|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
149974967|NCT03508050|541046053|FG000|Overall Study|Sustained desaturation|0|||
149974968|NCT03508050|541046054|FG001|Overall Study|Sustained desaturation|1|||
149974969|NCT01082614|541046055|FG000|Overall Study|Adverse Event|1|||
149974970|NCT01082614|541046056|FG001|Overall Study|Adverse Event|4|||
149974971|NCT01082614|541046055|FG000|Overall Study|Equipment Malfunction|0|||
149974972|NCT01082614|541046056|FG001|Overall Study|Equipment Malfunction|1|||
149974973|NCT01082614|541046055|FG000|Overall Study|Physician Decision|2|||
149974974|NCT01082614|541046056|FG001|Overall Study|Physician Decision|0|||
149974975|NCT03710889|541046057|FG000|Overall Study|Adverse Event|2|||
149974976|NCT03710889|541046057|FG000|Overall Study|Protocol Deviation|1|||
149974977|NCT00421148|541046058|FG000|Overall Study|Lost to Follow-up|0|||
149974978|NCT00421148|541046059|FG001|Overall Study|Lost to Follow-up|0|||
149974979|NCT00421148|541046060|FG002|Overall Study|Lost to Follow-up|0|||
149974980|NCT00421148|541046061|FG003|Overall Study|Lost to Follow-up|0|||
149974981|NCT00421148|541046062|FG004|Overall Study|Lost to Follow-up|0|||
149974982|NCT00421148|541046063|FG005|Overall Study|Lost to Follow-up|0|||
149974983|NCT00421148|541046064|FG006|Overall Study|Lost to Follow-up|0|||
149974984|NCT00421148|541046065|FG007|Overall Study|Lost to Follow-up|0|||
149974985|NCT00421148|541046066|FG008|Overall Study|Lost to Follow-up|0|||
149974986|NCT00421148|541046067|FG009|Overall Study|Lost to Follow-up|0|||
149974987|NCT00421148|541046068|FG010|Overall Study|Lost to Follow-up|0|||
149974988|NCT00421148|541046069|FG011|Overall Study|Lost to Follow-up|0|||
149974989|NCT00421148|541046070|FG012|Overall Study|Lost to Follow-up|0|||
149974990|NCT00421148|541046071|FG013|Overall Study|Lost to Follow-up|0|||
149974991|NCT00421148|541046072|FG014|Overall Study|Lost to Follow-up|0|||
149974992|NCT00421148|541046073|FG015|Overall Study|Lost to Follow-up|0|||
149974993|NCT00421148|541046074|FG016|Overall Study|Lost to Follow-up|0|||
149974994|NCT00421148|541046075|FG017|Overall Study|Lost to Follow-up|1|||
149974995|NCT00421148|541046076|FG018|Overall Study|Lost to Follow-up|0|||
149974996|NCT00421148|541046077|FG019|Overall Study|Lost to Follow-up|0|||
149974997|NCT00421148|541046058|FG000|Overall Study|Withdrawal by Subject|0|||
149974998|NCT00421148|541046059|FG001|Overall Study|Withdrawal by Subject|0|||
149974999|NCT00421148|541046060|FG002|Overall Study|Withdrawal by Subject|0|||
149975000|NCT00421148|541046061|FG003|Overall Study|Withdrawal by Subject|0|||
149975001|NCT00421148|541046062|FG004|Overall Study|Withdrawal by Subject|0|||
149975002|NCT00421148|541046063|FG005|Overall Study|Withdrawal by Subject|0|||
149975003|NCT00421148|541046064|FG006|Overall Study|Withdrawal by Subject|0|||
149975004|NCT00421148|541046065|FG007|Overall Study|Withdrawal by Subject|0|||
149975005|NCT00421148|541046066|FG008|Overall Study|Withdrawal by Subject|0|||
149975006|NCT00421148|541046067|FG009|Overall Study|Withdrawal by Subject|0|||
149975007|NCT00421148|541046068|FG010|Overall Study|Withdrawal by Subject|0|||
149975008|NCT00421148|541046069|FG011|Overall Study|Withdrawal by Subject|0|||
149975009|NCT00421148|541046070|FG012|Overall Study|Withdrawal by Subject|0|||
149975010|NCT00421148|541046071|FG013|Overall Study|Withdrawal by Subject|0|||
149975011|NCT00421148|541046072|FG014|Overall Study|Withdrawal by Subject|0|||
149975012|NCT00421148|541046073|FG015|Overall Study|Withdrawal by Subject|0|||
149975013|NCT00421148|541046074|FG016|Overall Study|Withdrawal by Subject|0|||
149975014|NCT00421148|541046075|FG017|Overall Study|Withdrawal by Subject|1|||
149975015|NCT00421148|541046076|FG018|Overall Study|Withdrawal by Subject|0|||
149975016|NCT00421148|541046077|FG019|Overall Study|Withdrawal by Subject|0|||
149975017|NCT00421148|541046058|FG000|Overall Study|Protocol Violation|0|||
149975018|NCT00421148|541046059|FG001|Overall Study|Protocol Violation|0|||
149975019|NCT00421148|541046060|FG002|Overall Study|Protocol Violation|0|||
149975020|NCT00421148|541046061|FG003|Overall Study|Protocol Violation|0|||
149975021|NCT00421148|541046062|FG004|Overall Study|Protocol Violation|0|||
149975022|NCT00421148|541046063|FG005|Overall Study|Protocol Violation|1|||
149975023|NCT00421148|541046064|FG006|Overall Study|Protocol Violation|0|||
149975024|NCT00421148|541046065|FG007|Overall Study|Protocol Violation|0|||
149975025|NCT00421148|541046066|FG008|Overall Study|Protocol Violation|0|||
149975026|NCT00421148|541046067|FG009|Overall Study|Protocol Violation|0|||
149975027|NCT00421148|541046068|FG010|Overall Study|Protocol Violation|0|||
149975028|NCT00421148|541046069|FG011|Overall Study|Protocol Violation|0|||
149975029|NCT00421148|541046070|FG012|Overall Study|Protocol Violation|0|||
149975030|NCT00421148|541046071|FG013|Overall Study|Protocol Violation|0|||
149975031|NCT00421148|541046072|FG014|Overall Study|Protocol Violation|0|||
149975032|NCT00421148|541046073|FG015|Overall Study|Protocol Violation|0|||
149975033|NCT00421148|541046074|FG016|Overall Study|Protocol Violation|0|||
149975034|NCT00421148|541046075|FG017|Overall Study|Protocol Violation|0|||
149975035|NCT00421148|541046076|FG018|Overall Study|Protocol Violation|1|||
149975036|NCT00421148|541046077|FG019|Overall Study|Protocol Violation|0|||
149975037|NCT04881760|541046078|FG000|Overall Study|Adverse Event|0|||
149975038|NCT04881760|541046079|FG001|Overall Study|Adverse Event|1|||
149975039|NCT04881760|541046080|FG002|Overall Study|Adverse Event|1|||
149975040|NCT04881760|541046081|FG003|Overall Study|Adverse Event|0|||
149975041|NCT04881760|541046082|FG004|Overall Study|Adverse Event|1|||
149975042|NCT04881760|541046083|FG005|Overall Study|Adverse Event|1|||
149975043|NCT04881760|541046084|FG006|Overall Study|Adverse Event|2|||
149975044|NCT04881760|541046078|FG000|Overall Study|Death|0|||
149975045|NCT04881760|541046079|FG001|Overall Study|Death|0|||
149975046|NCT04881760|541046080|FG002|Overall Study|Death|0|||
149975047|NCT04881760|541046081|FG003|Overall Study|Death|1|||
149975048|NCT04881760|541046082|FG004|Overall Study|Death|0|||
149975049|NCT04881760|541046083|FG005|Overall Study|Death|0|||
149975050|NCT04881760|541046084|FG006|Overall Study|Death|0|||
149975051|NCT04881760|541046078|FG000|Overall Study|Lost to Follow-up|5|||
149975052|NCT04881760|541046079|FG001|Overall Study|Lost to Follow-up|7|||
149975053|NCT04881760|541046080|FG002|Overall Study|Lost to Follow-up|5|||
149975054|NCT04881760|541046081|FG003|Overall Study|Lost to Follow-up|1|||
149975055|NCT04881760|541046082|FG004|Overall Study|Lost to Follow-up|2|||
149975056|NCT04881760|541046083|FG005|Overall Study|Lost to Follow-up|4|||
149975057|NCT04881760|541046084|FG006|Overall Study|Lost to Follow-up|4|||
149975058|NCT04881760|541046078|FG000|Overall Study|Withdrawal by Subject|13|||
149975059|NCT04881760|541046079|FG001|Overall Study|Withdrawal by Subject|1|||
149975060|NCT04881760|541046080|FG002|Overall Study|Withdrawal by Subject|1|||
149975061|NCT04881760|541046081|FG003|Overall Study|Withdrawal by Subject|4|||
149975062|NCT04881760|541046082|FG004|Overall Study|Withdrawal by Subject|2|||
149975063|NCT04881760|541046083|FG005|Overall Study|Withdrawal by Subject|1|||
149975064|NCT04881760|541046084|FG006|Overall Study|Withdrawal by Subject|2|||
149975065|NCT04881760|541046078|FG000|Overall Study|Randomized but Never Treated|0|||
149975066|NCT04881760|541046079|FG001|Overall Study|Randomized but Never Treated|0|||
149975067|NCT04881760|541046080|FG002|Overall Study|Randomized but Never Treated|0|||
149975068|NCT04881760|541046081|FG003|Overall Study|Randomized but Never Treated|1|||
149975069|NCT04881760|541046082|FG004|Overall Study|Randomized but Never Treated|0|||
149975070|NCT04881760|541046083|FG005|Overall Study|Randomized but Never Treated|0|||
149975071|NCT04881760|541046084|FG006|Overall Study|Randomized but Never Treated|0|||
149975072|NCT04881760|541046078|FG000|Overall Study|Inadvertent Enrollment|2|||
149975073|NCT04881760|541046079|FG001|Overall Study|Inadvertent Enrollment|0|||
149975074|NCT04881760|541046080|FG002|Overall Study|Inadvertent Enrollment|0|||
149975075|NCT04881760|541046081|FG003|Overall Study|Inadvertent Enrollment|0|||
149975076|NCT04881760|541046082|FG004|Overall Study|Inadvertent Enrollment|0|||
149975077|NCT04881760|541046083|FG005|Overall Study|Inadvertent Enrollment|0|||
149975078|NCT04881760|541046084|FG006|Overall Study|Inadvertent Enrollment|0|||
149975079|NCT04881760|541046078|FG000|Overall Study|Site Closure|0|||
149975080|NCT04881760|541046079|FG001|Overall Study|Site Closure|0|||
149975081|NCT04881760|541046080|FG002|Overall Study|Site Closure|0|||
149975082|NCT04881760|541046081|FG003|Overall Study|Site Closure|1|||
149975083|NCT04881760|541046082|FG004|Overall Study|Site Closure|0|||
149975084|NCT04881760|541046083|FG005|Overall Study|Site Closure|0|||
149975085|NCT04881760|541046084|FG006|Overall Study|Site Closure|0|||
149975086|NCT00902330|541046090|FG000|Overall Study|Too overwhelmed by treatment|2|||
149975087|NCT00902330|541046091|FG001|Overall Study|Too overwhelmed by treatment|5|||
149975088|NCT00902330|541046090|FG000|Overall Study|Adverse Event|1|||
149975089|NCT00902330|541046091|FG001|Overall Study|Adverse Event|0|||
149975090|NCT00902330|541046090|FG000|Overall Study|No post baseline data|1|||
149975091|NCT00902330|541046091|FG001|Overall Study|No post baseline data|0|||
149975092|NCT00165789|541046092|FG000|Overall Study|Adverse Event|0|||
149975093|NCT00165789|541046093|FG001|Overall Study|Adverse Event|3|||
149975094|NCT00165789|541046094|FG002|Overall Study|Adverse Event|0|||
149975095|NCT00165789|541046095|FG003|Overall Study|Adverse Event|12|||
149975096|NCT00165789|541046092|FG000|Overall Study|Withdrawal by Subject|0|||
150177702|NCT02988817|541788173|FG009|Overall Study|Lost to Follow-up|0|||
149975097|NCT00165789|541046093|FG001|Overall Study|Withdrawal by Subject|1|||
149975098|NCT00165789|541046094|FG002|Overall Study|Withdrawal by Subject|1|||
149975099|NCT00165789|541046095|FG003|Overall Study|Withdrawal by Subject|2|||
149975100|NCT04290624|541046096|FG000|Overall Study|Adverse Event|1|||
149975101|NCT04290624|541046097|FG001|Overall Study|Adverse Event|0|||
149975102|NCT01847443|541046098|FG000|Study Period 1|Withdrawal by Subject|0|||
149975103|NCT01847443|541046099|FG001|Study Period 1|Withdrawal by Subject|1|||
149975104|NCT01847443|541046100|FG002|Study Period 1|Withdrawal by Subject|0|||
149975105|NCT01847443|541046101|FG003|Study Period 1|Withdrawal by Subject|0|||
149975106|NCT01847443|541046098|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
149975107|NCT01847443|541046099|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
149975108|NCT01847443|541046100|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
149975109|NCT01847443|541046101|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
149975110|NCT01847443|541046098|FG000|Washout Period Before Study Period 2|Other reason|1|||
149975111|NCT01847443|541046099|FG001|Washout Period Before Study Period 2|Other reason|0|||
149975112|NCT01847443|541046100|FG002|Washout Period Before Study Period 2|Other reason|0|||
149975113|NCT01847443|541046101|FG003|Washout Period Before Study Period 2|Other reason|0|||
149975114|NCT01847443|541046098|FG000|Washout Period Before Study Period 3|Other reason|1|||
150177703|NCT02988817|541788174|FG010|Overall Study|Lost to Follow-up|1|||
149975115|NCT01847443|541046099|FG001|Washout Period Before Study Period 3|Other reason|0|||
149975116|NCT01847443|541046100|FG002|Washout Period Before Study Period 3|Other reason|0|||
149975117|NCT01847443|541046101|FG003|Washout Period Before Study Period 3|Other reason|0|||
149975118|NCT01847443|541046098|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
149975119|NCT01847443|541046099|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
149975120|NCT01847443|541046100|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
149975121|NCT01847443|541046101|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
149975122|NCT01847443|541046098|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
149975123|NCT01847443|541046099|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
149975124|NCT01847443|541046100|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
149975125|NCT01847443|541046101|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
149975126|NCT03571971|541046102|FG000|Overall Study|Lost to Follow-up|2|||
149975127|NCT03571971|541046103|FG001|Overall Study|Lost to Follow-up|2|||
149975128|NCT03571971|541046102|FG000|Overall Study|Protocol Violation|2|||
149975129|NCT03571971|541046103|FG001|Overall Study|Protocol Violation|3|||
149975130|NCT03571971|541046102|FG000|Overall Study|Withdrawal by Subject|2|||
149975131|NCT03571971|541046103|FG001|Overall Study|Withdrawal by Subject|0|||
149975132|NCT03571971|541046102|FG000|Overall Study|Incomplete primary outcome data|2|||
149975133|NCT03571971|541046103|FG001|Overall Study|Incomplete primary outcome data|0|||
149975134|NCT04067492|541046104|FG000|Overall Study|Lost to Follow-up|0|||
149975135|NCT04067492|541046105|FG001|Overall Study|Lost to Follow-up|0|||
149975136|NCT04067492|541046106|FG002|Overall Study|Lost to Follow-up|0|||
149975137|NCT04067492|541046107|FG003|Overall Study|Lost to Follow-up|0|||
149975138|NCT04067492|541046108|FG004|Overall Study|Lost to Follow-up|0|||
149975139|NCT04067492|541046109|FG005|Overall Study|Lost to Follow-up|1|||
149975140|NCT04067492|541046104|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
149975141|NCT04067492|541046105|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
149975142|NCT04067492|541046106|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
149975143|NCT04067492|541046107|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
149975144|NCT04067492|541046108|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
149975145|NCT04067492|541046109|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
149975146|NCT04067492|541046104|FG000|Overall Study|COVID-19 epidemiological situation|0|||
149975147|NCT04067492|541046105|FG001|Overall Study|COVID-19 epidemiological situation|0|||
149975148|NCT04067492|541046106|FG002|Overall Study|COVID-19 epidemiological situation|0|||
149975149|NCT04067492|541046107|FG003|Overall Study|COVID-19 epidemiological situation|1|||
149975150|NCT04067492|541046108|FG004|Overall Study|COVID-19 epidemiological situation|0|||
149975151|NCT04067492|541046109|FG005|Overall Study|COVID-19 epidemiological situation|0|||
149975152|NCT03950856|541046117|FG000|Overall Study|Death|1|||
149975153|NCT03950856|541046118|FG001|Overall Study|Death|2|||
149975154|NCT03950856|541046119|FG002|Overall Study|Death|0|||
149975155|NCT03950856|541046120|FG003|Overall Study|Death|0|||
149975156|NCT03950856|541046117|FG000|Overall Study|Lost to Follow-up|5|||
149975157|NCT03950856|541046118|FG001|Overall Study|Lost to Follow-up|6|||
149975158|NCT03950856|541046119|FG002|Overall Study|Lost to Follow-up|8|||
149975159|NCT03950856|541046120|FG003|Overall Study|Lost to Follow-up|2|||
149975160|NCT03950856|541046117|FG000|Overall Study|Protocol Violation|2|||
149975161|NCT03950856|541046118|FG001|Overall Study|Protocol Violation|0|||
149975162|NCT03950856|541046119|FG002|Overall Study|Protocol Violation|0|||
149975163|NCT03950856|541046120|FG003|Overall Study|Protocol Violation|1|||
149975164|NCT03950856|541046117|FG000|Overall Study|Withdrawal by Subject|4|||
149975165|NCT03950856|541046118|FG001|Overall Study|Withdrawal by Subject|1|||
149975166|NCT03950856|541046119|FG002|Overall Study|Withdrawal by Subject|3|||
149975167|NCT03950856|541046120|FG003|Overall Study|Withdrawal by Subject|1|||
149975168|NCT03950856|541046117|FG000|Overall Study|Unable to phone|7|||
149975169|NCT03950856|541046118|FG001|Overall Study|Unable to phone|6|||
149975170|NCT03950856|541046119|FG002|Overall Study|Unable to phone|7|||
149975171|NCT03950856|541046120|FG003|Overall Study|Unable to phone|2|||
149975172|NCT00656370|541046121|FG000|Overall Study|Screen Failures|7|||
149975173|NCT00656370|541046121|FG000|Overall Study|Alternates|3|||
149975174|NCT03984188|541046123|FG000|Overall Study|Death|2|||
149975175|NCT03984188|541046124|FG001|Overall Study|Death|4|||
149975176|NCT03984188|541046123|FG000|Overall Study|Physician Decision|0|||
149975177|NCT03984188|541046124|FG001|Overall Study|Physician Decision|2|||
149975178|NCT03984188|541046123|FG000|Overall Study|Lost to Follow-up|3|||
149975179|NCT03984188|541046124|FG001|Overall Study|Lost to Follow-up|2|||
149975180|NCT03984188|541046123|FG000|Overall Study|Withdrawal by Subject|6|||
149975181|NCT03984188|541046124|FG001|Overall Study|Withdrawal by Subject|0|||
149975182|NCT03384875|541046125|FG000|Overall Study|Death|1|||
149975183|NCT03384875|541046126|FG001|Overall Study|Death|1|||
149975184|NCT03384875|541046127|FG002|Overall Study|Death|0|||
150177704|NCT02988817|541788175|FG011|Overall Study|Lost to Follow-up|1|||
149975185|NCT03384875|541046125|FG000|Overall Study|Reason not provided|1|||
149975186|NCT03384875|541046126|FG001|Overall Study|Reason not provided|0|||
149975187|NCT03384875|541046127|FG002|Overall Study|Reason not provided|0|||
149975188|NCT00269113|541047770|FG000|Overall Study|Adverse Event|14|||
149975189|NCT00269113|541047771|FG001|Overall Study|Adverse Event|7|||
149975190|NCT00269113|541047770|FG000|Overall Study|Lack of Efficacy|35|||
149975191|NCT00269113|541047771|FG001|Overall Study|Lack of Efficacy|18|||
149975192|NCT00269113|541047770|FG000|Overall Study|Early Improvement|2|||
149975193|NCT00269113|541047771|FG001|Overall Study|Early Improvement|0|||
149975194|NCT00269113|541047770|FG000|Overall Study|Withdrawal by Subject|0|||
149975195|NCT00269113|541047771|FG001|Overall Study|Withdrawal by Subject|2|||
149975196|NCT00269113|541047770|FG000|Overall Study|Death|6|||
149975197|NCT00269113|541047771|FG001|Overall Study|Death|2|||
149975198|NCT00269113|541047770|FG000|Overall Study|Lost to Follow-up|2|||
149975199|NCT00269113|541047771|FG001|Overall Study|Lost to Follow-up|1|||
149975200|NCT00269113|541047770|FG000|Overall Study|Protocol Violation|15|||
149975201|NCT00269113|541047771|FG001|Overall Study|Protocol Violation|5|||
150177705|NCT02988817|541788176|FG012|Overall Study|Lost to Follow-up|0|||
149975202|NCT00269113|541047770|FG000|Overall Study|Other|0|||
149975203|NCT00269113|541047771|FG001|Overall Study|Other|2|||
149975204|NCT01978145|541047772|FG000|Treatment Period 1|Adverse Event|1|||
149975205|NCT01978145|541047773|FG001|Treatment Period 1|Adverse Event|9|||
149975206|NCT01978145|541047772|FG000|Treatment Period 1|Physician Decision|1|||
149975207|NCT01978145|541047773|FG001|Treatment Period 1|Physician Decision|0|||
149975208|NCT01978145|541047772|FG000|Treatment Period 1|Withdrawal by Subject|5|||
149975209|NCT01978145|541047773|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149975210|NCT01978145|541047772|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
149975211|NCT01978145|541047773|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
149975212|NCT01978145|541047772|FG000|Washout Period 1|Adverse Event|0|||
149975213|NCT01978145|541047773|FG001|Washout Period 1|Adverse Event|1|||
149975214|NCT01978145|541047772|FG000|Washout Period 1|Withdrawal by Subject|1|||
149975215|NCT01978145|541047773|FG001|Washout Period 1|Withdrawal by Subject|1|||
149975216|NCT01978145|541047772|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
149975217|NCT01978145|541047773|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
149975218|NCT01978145|541047772|FG000|Treatment Period 2|Adverse Event|3|||
149975219|NCT01978145|541047773|FG001|Treatment Period 2|Adverse Event|3|||
149975220|NCT01978145|541047772|FG000|Treatment Period 2|Protocol Violation|0|||
149975221|NCT01978145|541047773|FG001|Treatment Period 2|Protocol Violation|1|||
149975222|NCT01978145|541047772|FG000|Treatment Period 2|Lost to Follow-up|1|||
149975223|NCT01978145|541047773|FG001|Treatment Period 2|Lost to Follow-up|1|||
149975224|NCT01978145|541047772|FG000|Treatment Period 2|Withdrawal by Subject|7|||
149975225|NCT01978145|541047773|FG001|Treatment Period 2|Withdrawal by Subject|4|||
149975226|NCT01978145|541047772|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
149975227|NCT01978145|541047773|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
149975228|NCT01173679|541047774|FG000|Overall Study|Death|1|||
149975229|NCT01250054|541047775|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
149975230|NCT01250054|541047776|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
149975231|NCT02026011|541047777|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
149975232|NCT02026011|541047778|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
149975233|NCT02026011|541047777|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
149975234|NCT02026011|541047778|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
149975235|NCT02026011|541047777|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
149975236|NCT02026011|541047778|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
149975237|NCT02026011|541047777|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
149975238|NCT02026011|541047778|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
149975239|NCT00755807|541047783|FG000|Acute Phase|Adverse Event|16|||
149975240|NCT00755807|541047784|FG001|Acute Phase|Adverse Event|5|||
149975241|NCT00755807|541047783|FG000|Acute Phase|Protocol Violation|1|||
149975242|NCT00755807|541047784|FG001|Acute Phase|Protocol Violation|3|||
149975243|NCT00755807|541047783|FG000|Acute Phase|Withdrawal by Subject|1|||
149975244|NCT00755807|541047784|FG001|Acute Phase|Withdrawal by Subject|2|||
149975245|NCT00755807|541047783|FG000|Acute Phase|Lack of Efficacy|0|||
149975246|NCT00755807|541047784|FG001|Acute Phase|Lack of Efficacy|1|||
149975247|NCT00755807|541047783|FG000|Acute Phase|Physician Decision|0|||
149975248|NCT00755807|541047784|FG001|Acute Phase|Physician Decision|1|||
149975249|NCT00755807|541047783|FG000|Open-label Extension Phase|Adverse Event|7|||
149975250|NCT00755807|541047784|FG001|Open-label Extension Phase|Adverse Event|7|||
149975251|NCT00755807|541047783|FG000|Open-label Extension Phase|Protocol Violation|5|||
149975252|NCT00755807|541047784|FG001|Open-label Extension Phase|Protocol Violation|2|||
149975253|NCT00755807|541047783|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
149975254|NCT00755807|541047784|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
149975255|NCT00755807|541047783|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
149975256|NCT00755807|541047784|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
149975257|NCT00755807|541047783|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
149975258|NCT00755807|541047784|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
149975259|NCT00755807|541047783|FG000|Open-label Extension Phase|Sponsor Decision|0|||
149975260|NCT00755807|541047784|FG001|Open-label Extension Phase|Sponsor Decision|1|||
149975261|NCT05010070|541047785|FG000|Overall Study|Lost to Follow-up|1|||
149975262|NCT05010070|541047785|FG000|Overall Study|Withdrawal by Subject|1|||
149975263|NCT00529243|541047789|FG000|Overall Study|Adverse Event|1|||
149975264|NCT00529243|541047789|FG000|Overall Study|Death|1|||
149975265|NCT00529243|541047789|FG000|Overall Study|Relocated|1|||
149975266|NCT01788943|541047794|FG000|Overall Study|Withdrawal by Subject|1|||
149975267|NCT01788943|541047795|FG001|Overall Study|Withdrawal by Subject|0|||
149975268|NCT00811954|541047796|FG000|Overall Study|Death|10|||
149975269|NCT00811954|541047797|FG001|Overall Study|Death|6|||
149975270|NCT00811954|541047798|FG002|Overall Study|Death|13|||
149975271|NCT00811954|541047796|FG000|Overall Study|Lost to Follow-up|29|||
149975272|NCT00811954|541047797|FG001|Overall Study|Lost to Follow-up|23|||
149975273|NCT00811954|541047798|FG002|Overall Study|Lost to Follow-up|34|||
149975274|NCT00811954|541047796|FG000|Overall Study|Not able to get to clinic|28|||
149975275|NCT00811954|541047797|FG001|Overall Study|Not able to get to clinic|35|||
149975276|NCT00811954|541047798|FG002|Overall Study|Not able to get to clinic|30|||
149975277|NCT00811954|541047796|FG000|Overall Study|Not willing to adhere to requirements|12|||
149975278|NCT00811954|541047797|FG001|Overall Study|Not willing to adhere to requirements|2|||
149975279|NCT00811954|541047798|FG002|Overall Study|Not willing to adhere to requirements|16|||
149975280|NCT00811954|541047796|FG000|Overall Study|Withdraw consent prior study completion|4|||
149975281|NCT00811954|541047797|FG001|Overall Study|Withdraw consent prior study completion|6|||
149975282|NCT00811954|541047798|FG002|Overall Study|Withdraw consent prior study completion|5|||
149975283|NCT00811954|541047796|FG000|Overall Study|Site Closure|4|||
149975284|NCT00811954|541047797|FG001|Overall Study|Site Closure|0|||
149975285|NCT00811954|541047798|FG002|Overall Study|Site Closure|1|||
149975286|NCT00811954|541047796|FG000|Overall Study|Severe Debilitation|2|||
149975287|NCT00811954|541047797|FG001|Overall Study|Severe Debilitation|0|||
149975288|NCT00811954|541047798|FG002|Overall Study|Severe Debilitation|1|||
149975289|NCT00811954|541047796|FG000|Overall Study|Complete Protocol: No follow-up|0|||
149975290|NCT00811954|541047797|FG001|Overall Study|Complete Protocol: No follow-up|0|||
149975291|NCT00811954|541047798|FG002|Overall Study|Complete Protocol: No follow-up|1|||
149975292|NCT00186628|541047800|FG000|Overall Study|Death|2|||
149975293|NCT00186628|541047800|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
149975294|NCT04828707|541047803|FG000|Overall Study|Lost to Follow-up|3|||
149975295|NCT04828707|541047804|FG001|Overall Study|Lost to Follow-up|2|||
149975296|NCT04828707|541047803|FG000|Overall Study|Withdrawal by Subject|2|||
149975297|NCT04828707|541047804|FG001|Overall Study|Withdrawal by Subject|1|||
149975298|NCT01188967|541047808|FG000|Overall Study|Withdrawal by Subject|1|||
149975299|NCT01188967|541047809|FG001|Overall Study|Withdrawal by Subject|1|||
149975300|NCT01188967|541047808|FG000|Overall Study|Physician Decision|1|||
149975301|NCT01188967|541047809|FG001|Overall Study|Physician Decision|1|||
149975302|NCT01188967|541047808|FG000|Overall Study|Lost to Follow-up|3|||
149975303|NCT01188967|541047809|FG001|Overall Study|Lost to Follow-up|2|||
149975304|NCT00523978|541047812|FG000|Overall Study|Withdrawal by Subject|3|||
149975305|NCT00523978|541047813|FG001|Overall Study|Withdrawal by Subject|7|||
149975306|NCT00523978|541047812|FG000|Overall Study|Screen Failures|5|||
149975307|NCT00523978|541047813|FG001|Overall Study|Screen Failures|1|||
149975308|NCT00523978|541047812|FG000|Overall Study|Death|1|||
149975309|NCT00523978|541047813|FG001|Overall Study|Death|0|||
149975310|NCT00461708|541047814|FG000|Overall Study|Adverse Event|17|||
149975311|NCT00461708|541047815|FG001|Overall Study|Adverse Event|7|||
149975312|NCT00461708|541047814|FG000|Overall Study|Lack of Efficacy|68|||
149975313|NCT00461708|541047815|FG001|Overall Study|Lack of Efficacy|20|||
149975314|NCT00461708|541047814|FG000|Overall Study|Physician Decision|10|||
149975315|NCT00461708|541047815|FG001|Overall Study|Physician Decision|4|||
149975316|NCT00461708|541047814|FG000|Overall Study|Withdrawal by Subject|8|||
149975317|NCT00461708|541047815|FG001|Overall Study|Withdrawal by Subject|2|||
149975318|NCT00461708|541047814|FG000|Overall Study|Other|4|||
149975319|NCT00461708|541047815|FG001|Overall Study|Other|4|||
149975320|NCT00461708|541047814|FG000|Overall Study|Death|8|||
149975321|NCT00461708|541047815|FG001|Overall Study|Death|1|||
149975322|NCT02394561|541047816|FG000|CORE Phase|Adverse Event|7|||
149975323|NCT02394561|541047817|FG001|CORE Phase|Adverse Event|9|||
149975324|NCT02394561|541047816|FG000|CORE Phase|Death|0|||
149975325|NCT02394561|541047817|FG001|CORE Phase|Death|1|||
149975326|NCT02394561|541047816|FG000|CORE Phase|Pregnancy|1|||
149975327|NCT02394561|541047817|FG001|CORE Phase|Pregnancy|0|||
149975328|NCT02394561|541047816|FG000|CORE Phase|Lost to Follow-up|1|||
149975329|NCT02394561|541047817|FG001|CORE Phase|Lost to Follow-up|0|||
149975330|NCT02394561|541047816|FG000|CORE Phase|Physician Decision|1|||
149975331|NCT02394561|541047817|FG001|CORE Phase|Physician Decision|1|||
149975332|NCT02394561|541047816|FG000|CORE Phase|Withdrawal by Subject|2|||
149975333|NCT02394561|541047817|FG001|CORE Phase|Withdrawal by Subject|2|||
149975334|NCT02394561|541047816|FG000|CORE Phase|Lack of Efficacy|1|||
149975335|NCT02394561|541047817|FG001|CORE Phase|Lack of Efficacy|6|||
149975336|NCT02394561|541047816|FG000|Extension Phase|Adverse Event|6|||
149975337|NCT02394561|541047817|FG001|Extension Phase|Adverse Event|1|||
149975338|NCT02394561|541047816|FG000|Extension Phase|Death|0|||
149975339|NCT02394561|541047817|FG001|Extension Phase|Death|1|||
149975340|NCT02394561|541047816|FG000|Extension Phase|Protocol Violation|1|||
149975341|NCT02394561|541047817|FG001|Extension Phase|Protocol Violation|0|||
149975342|NCT02394561|541047816|FG000|Extension Phase|Lost to Follow-up|1|||
149975343|NCT02394561|541047817|FG001|Extension Phase|Lost to Follow-up|0|||
149975344|NCT02394561|541047816|FG000|Extension Phase|Physician Decision|0|||
149975345|NCT02394561|541047817|FG001|Extension Phase|Physician Decision|2|||
149975346|NCT02394561|541047816|FG000|Extension Phase|Withdrawal by Subject|0|||
149975347|NCT02394561|541047817|FG001|Extension Phase|Withdrawal by Subject|5|||
149975348|NCT02394561|541047816|FG000|Extension Phase|Lack of Efficacy|3|||
149975349|NCT02394561|541047817|FG001|Extension Phase|Lack of Efficacy|3|||
149975350|NCT00501644|541047818|FG000|Overall Study|Adverse Event|4|||
149975351|NCT00501644|541047818|FG000|Overall Study|Withdrawal by Subject|1|||
149975352|NCT02553629|541047819|FG000|Overall Study|Logistic reasons|3|||
149975353|NCT02553629|541047820|FG001|Overall Study|Logistic reasons|6|||
149975354|NCT03434834|541047821|FG000|Overall Study|unable to swallow OCT probe|16|||
149975355|NCT04577781|541047825|FG000|Overall Study|Adverse Event|2|||
149975356|NCT04577781|541047826|FG001|Overall Study|Adverse Event|2|||
149975357|NCT04577781|541047825|FG000|Overall Study|Physician Decision|1|||
149975358|NCT04577781|541047826|FG001|Overall Study|Physician Decision|0|||
150051956|NCT00706342|541332832|FG000|Overall Study|Non-responder Week 12|1|||
149975359|NCT01657305|541047828|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
149975360|NCT01657305|541047828|FG000|Overall Study|Withdrawal by Subject|4|||
149975361|NCT01657305|541047828|FG000|Overall Study|Adverse Event|1|||
149975362|NCT01657305|541047828|FG000|Overall Study|Lost to Follow-up|1|||
149975363|NCT01657305|541047828|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
149975364|NCT00696878|541047832|FG000|Overall Study|Adverse Event|8|||
149975365|NCT00696878|541047832|FG000|Overall Study|Withdrawal by Subject|87|||
149975366|NCT00696878|541047832|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
149975367|NCT00696878|541047832|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
149975368|NCT00696878|541047832|FG000|Overall Study|Trial stopped|32|||
149975369|NCT00696878|541047832|FG000|Overall Study|Other reason (not specified)|55|||
149975370|NCT04103450|541047833|FG000|Overall Study|Adverse Event|4|||
149975371|NCT04103450|541047834|FG001|Overall Study|Adverse Event|2|||
149975372|NCT04103450|541047833|FG000|Overall Study|Lack of Efficacy|3|||
149975373|NCT04103450|541047834|FG001|Overall Study|Lack of Efficacy|0|||
149975374|NCT04103450|541047833|FG000|Overall Study|Withdrawal by Subject|5|||
149975375|NCT04103450|541047834|FG001|Overall Study|Withdrawal by Subject|3|||
149975376|NCT04103450|541047833|FG000|Overall Study|Lost to Follow-up|1|||
149975377|NCT04103450|541047834|FG001|Overall Study|Lost to Follow-up|2|||
149975378|NCT04103450|541047833|FG000|Overall Study|Physician Decision|1|||
149975379|NCT04103450|541047834|FG001|Overall Study|Physician Decision|2|||
149975380|NCT04103450|541047833|FG000|Overall Study|Protocol Violation|1|||
149975381|NCT04103450|541047834|FG001|Overall Study|Protocol Violation|0|||
149975382|NCT04103450|541047833|FG000|Overall Study|Other|1|||
149975383|NCT04103450|541047834|FG001|Overall Study|Other|1|||
149975384|NCT02259114|541047835|FG000|Overall Study|Progressive Disease|14|||
149975385|NCT02259114|541047836|FG001|Overall Study|Progressive Disease|2|||
149975386|NCT02259114|541047837|FG002|Overall Study|Progressive Disease|10|||
149975387|NCT02259114|541047838|FG003|Overall Study|Progressive Disease|2|||
149975388|NCT02259114|541047839|FG004|Overall Study|Progressive Disease|5|||
149975389|NCT02259114|541047835|FG000|Overall Study|Adverse Event|2|||
149975390|NCT02259114|541047836|FG001|Overall Study|Adverse Event|1|||
149975391|NCT02259114|541047837|FG002|Overall Study|Adverse Event|0|||
150051957|NCT00706342|541332832|FG000|Overall Study|Ongoing|6|||
150051958|NCT00706342|541332832|FG000|Overall Study|WIthdrawal of consent|1|||
150051959|NCT01781299|541332837|FG000|Overall Study|Withdrawal by Subject|0|||
149975392|NCT02259114|541047838|FG003|Overall Study|Adverse Event|0|||
149975393|NCT02259114|541047839|FG004|Overall Study|Adverse Event|1|||
149975394|NCT02259114|541047835|FG000|Overall Study|Death|3|||
149975395|NCT02259114|541047836|FG001|Overall Study|Death|0|||
149975396|NCT02259114|541047837|FG002|Overall Study|Death|1|||
149975397|NCT02259114|541047838|FG003|Overall Study|Death|0|||
149975398|NCT02259114|541047839|FG004|Overall Study|Death|0|||
149975399|NCT02259114|541047835|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
149975400|NCT02259114|541047836|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
149975401|NCT02259114|541047837|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
149975402|NCT02259114|541047838|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
149975403|NCT02259114|541047839|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
149975404|NCT02259114|541047835|FG000|Overall Study|Withdrawal by Subject|0|||
149975405|NCT02259114|541047836|FG001|Overall Study|Withdrawal by Subject|0|||
149975406|NCT02259114|541047837|FG002|Overall Study|Withdrawal by Subject|1|||
149975407|NCT02259114|541047838|FG003|Overall Study|Withdrawal by Subject|1|||
149975408|NCT02259114|541047839|FG004|Overall Study|Withdrawal by Subject|0|||
149975409|NCT02259114|541047835|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
149975410|NCT02259114|541047836|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
149975411|NCT02259114|541047837|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
149975412|NCT02259114|541047838|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
149975413|NCT02259114|541047839|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
149975414|NCT02259114|541047835|FG000|Overall Study|Not Treated|1|||
149975415|NCT02259114|541047836|FG001|Overall Study|Not Treated|0|||
149975416|NCT02259114|541047837|FG002|Overall Study|Not Treated|0|||
149975417|NCT02259114|541047838|FG003|Overall Study|Not Treated|0|||
149975418|NCT02259114|541047839|FG004|Overall Study|Not Treated|0|||
149975419|NCT03937479|541047840|FG000|Overall Study|Adverse Event|2|||
149975420|NCT03937479|541047841|FG001|Overall Study|Adverse Event|3|||
149975421|NCT03937479|541047842|FG002|Overall Study|Adverse Event|0|||
149975422|NCT03937479|541047843|FG003|Overall Study|Adverse Event|0|||
149975423|NCT03937479|541047844|FG004|Overall Study|Adverse Event|1|||
149975424|NCT03937479|541047840|FG000|Overall Study|Withdrawal by Subject|3|||
149975425|NCT03937479|541047841|FG001|Overall Study|Withdrawal by Subject|5|||
149975426|NCT03937479|541047842|FG002|Overall Study|Withdrawal by Subject|2|||
149975427|NCT03937479|541047843|FG003|Overall Study|Withdrawal by Subject|2|||
149975428|NCT03937479|541047844|FG004|Overall Study|Withdrawal by Subject|1|||
149975429|NCT03937479|541047840|FG000|Overall Study|Protocol Violation|5|||
149975430|NCT03937479|541047841|FG001|Overall Study|Protocol Violation|6|||
149975431|NCT03937479|541047842|FG002|Overall Study|Protocol Violation|4|||
149975432|NCT03937479|541047843|FG003|Overall Study|Protocol Violation|3|||
149975433|NCT03937479|541047844|FG004|Overall Study|Protocol Violation|2|||
149975434|NCT03937479|541047840|FG000|Overall Study|Lost to Follow-up|0|||
149975435|NCT03937479|541047841|FG001|Overall Study|Lost to Follow-up|1|||
149975436|NCT03937479|541047842|FG002|Overall Study|Lost to Follow-up|0|||
149975437|NCT03937479|541047843|FG003|Overall Study|Lost to Follow-up|1|||
149975438|NCT03937479|541047844|FG004|Overall Study|Lost to Follow-up|0|||
149975439|NCT03937479|541047840|FG000|Overall Study|Physician Decision|0|||
149975440|NCT03937479|541047841|FG001|Overall Study|Physician Decision|0|||
149975441|NCT03937479|541047842|FG002|Overall Study|Physician Decision|1|||
149975442|NCT03937479|541047843|FG003|Overall Study|Physician Decision|0|||
149975443|NCT03937479|541047844|FG004|Overall Study|Physician Decision|1|||
149975444|NCT00940602|541047850|FG000|Overall Study|Administrative problems|1|||
149975445|NCT00940602|541047851|FG001|Overall Study|Administrative problems|1|||
149975446|NCT00940602|541047850|FG000|Overall Study|Patient/guardian decision|13|||
149975447|NCT00940602|541047851|FG001|Overall Study|Patient/guardian decision|28|||
149975448|NCT00940602|541047850|FG000|Overall Study|Physician Decision|8|||
149975449|NCT00940602|541047851|FG001|Overall Study|Physician Decision|5|||
149975450|NCT00940602|541047850|FG000|Overall Study|Pregnancy|1|||
149975451|NCT00940602|541047851|FG001|Overall Study|Pregnancy|0|||
149975452|NCT00940602|541047850|FG000|Overall Study|Protocol Deviation (untreated)|1|||
149975453|NCT00940602|541047851|FG001|Overall Study|Protocol Deviation (untreated)|0|||
149975454|NCT00940602|541047850|FG000|Overall Study|Disease progression|8|||
149975455|NCT00940602|541047851|FG001|Overall Study|Disease progression|2|||
149975456|NCT00940602|541047850|FG000|Overall Study|Death|38|||
150051960|NCT01781299|541332838|FG001|Overall Study|Withdrawal by Subject|1|||
149975457|NCT00940602|541047851|FG001|Overall Study|Death|19|||
149975458|NCT00940602|541047850|FG000|Overall Study|Lost to Follow-up|3|||
149975459|NCT00940602|541047851|FG001|Overall Study|Lost to Follow-up|1|||
149975460|NCT00940602|541047850|FG000|Overall Study|Patient withdrew consent|26|||
150051961|NCT02032238|541332843|FG000|Overall Study|Lost to Follow-up|2|||
150051962|NCT02032238|541332844|FG001|Overall Study|Lost to Follow-up|0|||
149975461|NCT00940602|541047851|FG001|Overall Study|Patient withdrew consent|13|||
149975462|NCT00940602|541047850|FG000|Overall Study|Adverse Event|7|||
149975463|NCT00940602|541047851|FG001|Overall Study|Adverse Event|2|||
150051963|NCT00653939|541332845|FG000|Overall Study|Adverse Event|1|||
150051964|NCT00653939|541332846|FG001|Overall Study|Adverse Event|3|||
150051965|NCT00653939|541332845|FG000|Overall Study|Withdrawal by Subject|3|||
150051966|NCT00653939|541332846|FG001|Overall Study|Withdrawal by Subject|3|||
150051967|NCT00653939|541332845|FG000|Overall Study|Physician Decision|4|||
150051968|NCT00653939|541332846|FG001|Overall Study|Physician Decision|0|||
150051969|NCT00653939|541332845|FG000|Overall Study|Disease Progression|2|||
150051970|NCT00653939|541332846|FG001|Overall Study|Disease Progression|3|||
150051971|NCT00653939|541332845|FG000|Overall Study|Other|2|||
150051972|NCT00653939|541332846|FG001|Overall Study|Other|6|||
150051973|NCT00717236|541332847|FG000|Double-Blind Period|Adverse Event|33|||
150051974|NCT00717236|541332848|FG001|Double-Blind Period|Adverse Event|6|||
150051975|NCT00717236|541332847|FG000|Double-Blind Period|Lack of Efficacy|6|||
150177706|NCT02988817|541788177|FG013|Overall Study|Lost to Follow-up|0|||
150177707|NCT02988817|541788178|FG014|Overall Study|Lost to Follow-up|1|||
150051976|NCT00717236|541332848|FG001|Double-Blind Period|Lack of Efficacy|6|||
150051977|NCT00717236|541332847|FG000|Double-Blind Period|Lost to Follow-up|3|||
150051978|NCT00717236|541332848|FG001|Double-Blind Period|Lost to Follow-up|5|||
150051979|NCT00717236|541332847|FG000|Double-Blind Period|Withdrawal by Subject|10|||
149975464|NCT00940602|541047850|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
150177975|NCT02824029|541790320|FG000|Overall Study|Possible progression per treating physician|1|||
150177976|NCT03873779|541790321|FG000|Overall Study|Withdrawal by Subject|1|||
150177977|NCT02581215|541790322|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
150177978|NCT02581215|541790323|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
150177979|NCT02581215|541790322|FG000|Overall Study|Eligibility Criteria Not Met|0|||
150177980|NCT02581215|541790323|FG001|Overall Study|Eligibility Criteria Not Met|1|||
150177981|NCT02566902|541790331|FG000|Overall Study|Protocol Violation|2|||
150177982|NCT02566902|541790332|FG001|Overall Study|Protocol Violation|1|||
150177983|NCT04425629|541790335|FG000|Overall Study|Adverse Event|0|||
150177984|NCT04425629|541790336|FG001|Overall Study|Adverse Event|0|||
150177985|NCT04425629|541790337|FG002|Overall Study|Adverse Event|0|||
150177986|NCT04425629|541790338|FG003|Overall Study|Adverse Event|0|||
150177987|NCT04425629|541790339|FG004|Overall Study|Adverse Event|1|||
150177988|NCT04425629|541790340|FG005|Overall Study|Adverse Event|0|||
150177989|NCT04425629|541790341|FG006|Overall Study|Adverse Event|0|||
150177990|NCT04425629|541790342|FG007|Overall Study|Adverse Event|0|||
149975801|NCT01747915|541049426|FG002|Overall Study|Withdrawal by Subject|1|||
150177991|NCT04425629|541790343|FG008|Overall Study|Adverse Event|0|||
149975802|NCT01747915|541049424|FG000|Overall Study|Protocol Violation|1|||
149975803|NCT01747915|541049425|FG001|Overall Study|Protocol Violation|0|||
149975804|NCT01747915|541049426|FG002|Overall Study|Protocol Violation|0|||
149975805|NCT01747915|541049424|FG000|Overall Study|Pregnancy|0|||
149975806|NCT01747915|541049425|FG001|Overall Study|Pregnancy|0|||
149975807|NCT01747915|541049426|FG002|Overall Study|Pregnancy|1|||
149975808|NCT00887159|541049430|FG000|Overall Study|Disease progression|6|||
149975809|NCT00887159|541049431|FG001|Overall Study|Disease progression|39|||
149975810|NCT00887159|541049432|FG002|Overall Study|Disease progression|33|||
149975811|NCT00887159|541049430|FG000|Overall Study|Adverse Event|3|||
149975812|NCT00887159|541049431|FG001|Overall Study|Adverse Event|4|||
149975813|NCT00887159|541049432|FG002|Overall Study|Adverse Event|17|||
149975814|NCT00887159|541049430|FG000|Overall Study|Death|2|||
149975815|NCT00887159|541049431|FG001|Overall Study|Death|2|||
149975816|NCT00887159|541049432|FG002|Overall Study|Death|0|||
150051997|NCT00717236|541332847|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
150051998|NCT00717236|541332848|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
150051999|NCT00717236|541332847|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
150052000|NCT00717236|541332848|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
150052001|NCT00717236|541332847|FG000|Double-Blind Period|Other: History of cancer|1|||
150052002|NCT00717236|541332848|FG001|Double-Blind Period|Other: History of cancer|0|||
150052003|NCT00717236|541332847|FG000|Double-Blind Period|Other: Sponsor request|1|||
150052004|NCT00717236|541332848|FG001|Double-Blind Period|Other: Sponsor request|0|||
150052005|NCT00717236|541332847|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
150052006|NCT00717236|541332848|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
150052007|NCT00717236|541332847|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
150052008|NCT00717236|541332848|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
150052009|NCT00717236|541332847|FG000|Double-Blind Period|Other: Subject moved|1|||
150052010|NCT00717236|541332848|FG001|Double-Blind Period|Other: Subject moved|1|||
150052011|NCT00717236|541332847|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
150052012|NCT00717236|541332848|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
150052013|NCT00717236|541332847|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
150052014|NCT00717236|541332848|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
150052015|NCT00717236|541332847|FG000|Double-Blind Period|Other: Transportation problems|0|||
150052016|NCT00717236|541332848|FG001|Double-Blind Period|Other: Transportation problems|1|||
150052017|NCT00717236|541332847|FG000|Double-Blind Period|Other: Investigator Decision|0|||
150052018|NCT00717236|541332848|FG001|Double-Blind Period|Other: Investigator Decision|1|||
150052019|NCT00717236|541332847|FG000|Open-Label Period|Adverse Event|29|||
150052020|NCT00717236|541332848|FG001|Open-Label Period|Adverse Event|4|||
150052021|NCT00717236|541332847|FG000|Open-Label Period|Lack of Efficacy|30|||
150177992|NCT04425629|541790344|FG009|Overall Study|Adverse Event|3|||
149975817|NCT00887159|541049430|FG000|Overall Study|Withdrawal by Subject|4|||
149975818|NCT00887159|541049431|FG001|Overall Study|Withdrawal by Subject|4|||
150177993|NCT04425629|541790345|FG010|Overall Study|Adverse Event|2|||
150177994|NCT04425629|541790346|FG011|Overall Study|Adverse Event|1|||
150177995|NCT04425629|541790347|FG012|Overall Study|Adverse Event|1|||
150177996|NCT04425629|541790348|FG013|Overall Study|Adverse Event|0|||
150177997|NCT04425629|541790349|FG014|Overall Study|Adverse Event|0|||
150177998|NCT04425629|541790350|FG015|Overall Study|Adverse Event|0|||
150177999|NCT04425629|541790351|FG016|Overall Study|Adverse Event|0|||
150178000|NCT04425629|541790352|FG017|Overall Study|Adverse Event|0|||
150178001|NCT04425629|541790353|FG018|Overall Study|Adverse Event|0|||
150178002|NCT04425629|541790335|FG000|Overall Study|Lost to Follow-up|1|||
150178003|NCT04425629|541790336|FG001|Overall Study|Lost to Follow-up|3|||
150178004|NCT04425629|541790337|FG002|Overall Study|Lost to Follow-up|1|||
150178005|NCT04425629|541790338|FG003|Overall Study|Lost to Follow-up|7|||
150178006|NCT04425629|541790339|FG004|Overall Study|Lost to Follow-up|1|||
149975819|NCT00887159|541049432|FG002|Overall Study|Withdrawal by Subject|2|||
149975820|NCT00887159|541049430|FG000|Overall Study|Alternative therapy|2|||
150052022|NCT00717236|541332848|FG001|Open-Label Period|Lack of Efficacy|8|||
150052023|NCT00717236|541332847|FG000|Open-Label Period|Lost to Follow-up|28|||
150052024|NCT00717236|541332848|FG001|Open-Label Period|Lost to Follow-up|4|||
150178007|NCT04425629|541790340|FG005|Overall Study|Lost to Follow-up|2|||
149975821|NCT00887159|541049431|FG001|Overall Study|Alternative therapy|0|||
149975822|NCT00887159|541049432|FG002|Overall Study|Alternative therapy|0|||
149975823|NCT00887159|541049430|FG000|Overall Study|Physician Decision|1|||
149975824|NCT00887159|541049431|FG001|Overall Study|Physician Decision|1|||
149975825|NCT00887159|541049432|FG002|Overall Study|Physician Decision|0|||
149975826|NCT00887159|541049430|FG000|Overall Study|Sympomatic deterioration|1|||
149975827|NCT00887159|541049431|FG001|Overall Study|Sympomatic deterioration|0|||
149975828|NCT00887159|541049432|FG002|Overall Study|Sympomatic deterioration|0|||
149975829|NCT00887159|541049430|FG000|Overall Study|Treatment delayed|1|||
149975830|NCT00887159|541049431|FG001|Overall Study|Treatment delayed|1|||
149975831|NCT00887159|541049432|FG002|Overall Study|Treatment delayed|0|||
149975832|NCT00887159|541049430|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
149975833|NCT00887159|541049431|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
149975834|NCT00887159|541049432|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
149975835|NCT00887159|541049430|FG000|Overall Study|Received more tx instead of observation|1|||
149975836|NCT00887159|541049431|FG001|Overall Study|Received more tx instead of observation|0|||
149975837|NCT00887159|541049432|FG002|Overall Study|Received more tx instead of observation|0|||
149975838|NCT00887159|541049430|FG000|Overall Study|Ineligible|5|||
149975839|NCT00887159|541049431|FG001|Overall Study|Ineligible|1|||
149975840|NCT00887159|541049432|FG002|Overall Study|Ineligible|0|||
149975841|NCT00887159|541049430|FG000|Overall Study|Never started assigned therapy|3|||
149975842|NCT00887159|541049431|FG001|Overall Study|Never started assigned therapy|3|||
149975843|NCT00887159|541049432|FG002|Overall Study|Never started assigned therapy|4|||
149975844|NCT06164691|541049434|FG000|Overall Study|Withdrawal by Subject|2|||
149975845|NCT06164691|541049435|FG001|Overall Study|Withdrawal by Subject|0|||
149975846|NCT06164691|541049436|FG002|Overall Study|Withdrawal by Subject|0|||
149975847|NCT00812955|541049437|FG000|Overall Study|Adverse Event|7|||
149975848|NCT00812955|541049438|FG001|Overall Study|Adverse Event|6|||
149975849|NCT00812955|541049439|FG002|Overall Study|Adverse Event|3|||
149975850|NCT00812955|541049440|FG003|Overall Study|Adverse Event|4|||
149975851|NCT00812955|541049437|FG000|Overall Study|Lost to Follow-up|2|||
149975852|NCT00812955|541049438|FG001|Overall Study|Lost to Follow-up|1|||
149975853|NCT00812955|541049439|FG002|Overall Study|Lost to Follow-up|1|||
149975854|NCT00812955|541049440|FG003|Overall Study|Lost to Follow-up|2|||
149975855|NCT00812955|541049437|FG000|Overall Study|Withdrawal by Subject|1|||
149975856|NCT00812955|541049438|FG001|Overall Study|Withdrawal by Subject|0|||
149975857|NCT00812955|541049439|FG002|Overall Study|Withdrawal by Subject|1|||
149975858|NCT00812955|541049440|FG003|Overall Study|Withdrawal by Subject|2|||
149975859|NCT00812955|541049437|FG000|Overall Study|randomized in error|0|||
149975860|NCT00812955|541049438|FG001|Overall Study|randomized in error|0|||
149975861|NCT00812955|541049439|FG002|Overall Study|randomized in error|1|||
149975862|NCT00812955|541049440|FG003|Overall Study|randomized in error|0|||
149975863|NCT02391311|541049441|FG000|Overall Study|Lost to Follow-up|2|||
149975864|NCT02391311|541049442|FG001|Overall Study|Lost to Follow-up|1|||
149975865|NCT02391311|541049441|FG000|Overall Study|deemed ineligible after baseline|1|||
149975866|NCT02391311|541049442|FG001|Overall Study|deemed ineligible after baseline|1|||
149975867|NCT01309204|541049443|FG000|Overall Study|Adverse Event|48|||
149975868|NCT01309204|541049444|FG001|Overall Study|Adverse Event|58|||
150178008|NCT04425629|541790341|FG006|Overall Study|Lost to Follow-up|1|||
150178009|NCT04425629|541790342|FG007|Overall Study|Lost to Follow-up|0|||
149975869|NCT01309204|541049443|FG000|Overall Study|Lost to Follow-up|2|||
149975870|NCT01309204|541049444|FG001|Overall Study|Lost to Follow-up|2|||
149975871|NCT01309204|541049443|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
149975872|NCT01309204|541049444|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
149975873|NCT01309204|541049443|FG000|Overall Study|Inadequate control of IOP|4|||
149975874|NCT01309204|541049444|FG001|Overall Study|Inadequate control of IOP|4|||
149975875|NCT01309204|541049443|FG000|Overall Study|Other|4|||
149975876|NCT01309204|541049444|FG001|Overall Study|Other|1|||
149737492|NCT02601950|540170378|FG001|Overall Study|Non-compliance|1|||
150178010|NCT04425629|541790343|FG008|Overall Study|Lost to Follow-up|1|||
150178011|NCT04425629|541790344|FG009|Overall Study|Lost to Follow-up|64|||
150178012|NCT04425629|541790345|FG010|Overall Study|Lost to Follow-up|70|||
150178013|NCT04425629|541790346|FG011|Overall Study|Lost to Follow-up|98|||
150178014|NCT04425629|541790347|FG012|Overall Study|Lost to Follow-up|30|||
150178015|NCT04425629|541790348|FG013|Overall Study|Lost to Follow-up|0|||
150178016|NCT04425629|541790349|FG014|Overall Study|Lost to Follow-up|5|||
150178017|NCT04425629|541790350|FG015|Overall Study|Lost to Follow-up|4|||
150178018|NCT04425629|541790351|FG016|Overall Study|Lost to Follow-up|0|||
150178019|NCT04425629|541790352|FG017|Overall Study|Lost to Follow-up|3|||
150178020|NCT04425629|541790353|FG018|Overall Study|Lost to Follow-up|1|||
150178021|NCT04425629|541790335|FG000|Overall Study|Subject Decision|0|||
150178022|NCT04425629|541790336|FG001|Overall Study|Subject Decision|2|||
150178023|NCT04425629|541790337|FG002|Overall Study|Subject Decision|1|||
149975877|NCT03183063|541049445|FG000|Overall Study|Withdrawal by Subject|2|||
149975878|NCT03183063|541049446|FG001|Overall Study|Withdrawal by Subject|0|||
150052025|NCT00717236|541332847|FG000|Open-Label Period|Withdrawal by Subject|20|||
150052026|NCT00717236|541332848|FG001|Open-Label Period|Withdrawal by Subject|2|||
150052027|NCT00717236|541332847|FG000|Open-Label Period|Loss of Efficacy|6|||
150052028|NCT00717236|541332848|FG001|Open-Label Period|Loss of Efficacy|1|||
150052029|NCT00717236|541332847|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
150052030|NCT00717236|541332848|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
150052031|NCT00717236|541332847|FG000|Open-Label Period|Other: Lack of Compliance|1|||
150052032|NCT00717236|541332848|FG001|Open-Label Period|Other: Lack of Compliance|1|||
150178024|NCT04425629|541790338|FG003|Overall Study|Subject Decision|3|||
150178025|NCT04425629|541790339|FG004|Overall Study|Subject Decision|6|||
150178026|NCT04425629|541790340|FG005|Overall Study|Subject Decision|6|||
150178027|NCT04425629|541790341|FG006|Overall Study|Subject Decision|3|||
150178028|NCT04425629|541790342|FG007|Overall Study|Subject Decision|3|||
150178029|NCT04425629|541790343|FG008|Overall Study|Subject Decision|1|||
150178030|NCT04425629|541790344|FG009|Overall Study|Subject Decision|70|||
150178031|NCT04425629|541790345|FG010|Overall Study|Subject Decision|95|||
150178032|NCT04425629|541790346|FG011|Overall Study|Subject Decision|124|||
150178033|NCT04425629|541790347|FG012|Overall Study|Subject Decision|25|||
150178034|NCT04425629|541790348|FG013|Overall Study|Subject Decision|0|||
150178035|NCT04425629|541790349|FG014|Overall Study|Subject Decision|1|||
150178036|NCT04425629|541790350|FG015|Overall Study|Subject Decision|4|||
150178037|NCT04425629|541790351|FG016|Overall Study|Subject Decision|1|||
150178038|NCT04425629|541790352|FG017|Overall Study|Subject Decision|0|||
150178039|NCT04425629|541790353|FG018|Overall Study|Subject Decision|2|||
150178040|NCT04425629|541790335|FG000|Overall Study|Death|0|||
150178041|NCT04425629|541790336|FG001|Overall Study|Death|0|||
150178042|NCT04425629|541790337|FG002|Overall Study|Death|0|||
150178043|NCT04425629|541790338|FG003|Overall Study|Death|0|||
150178044|NCT04425629|541790339|FG004|Overall Study|Death|0|||
150178045|NCT04425629|541790340|FG005|Overall Study|Death|0|||
150178046|NCT04425629|541790341|FG006|Overall Study|Death|0|||
150178047|NCT04425629|541790342|FG007|Overall Study|Death|0|||
150178048|NCT04425629|541790343|FG008|Overall Study|Death|0|||
150178049|NCT04425629|541790344|FG009|Overall Study|Death|11|||
150178050|NCT04425629|541790345|FG010|Overall Study|Death|2|||
150178051|NCT04425629|541790346|FG011|Overall Study|Death|4|||
150178052|NCT04425629|541790347|FG012|Overall Study|Death|0|||
150178053|NCT04425629|541790348|FG013|Overall Study|Death|0|||
150178054|NCT04425629|541790349|FG014|Overall Study|Death|0|||
150178055|NCT04425629|541790350|FG015|Overall Study|Death|0|||
150178056|NCT04425629|541790351|FG016|Overall Study|Death|0|||
150178057|NCT04425629|541790352|FG017|Overall Study|Death|0|||
150178058|NCT04425629|541790353|FG018|Overall Study|Death|0|||
150178059|NCT04425629|541790335|FG000|Overall Study|Sponsor Request|0|||
150178060|NCT04425629|541790336|FG001|Overall Study|Sponsor Request|0|||
150178061|NCT04425629|541790337|FG002|Overall Study|Sponsor Request|0|||
150178062|NCT04425629|541790338|FG003|Overall Study|Sponsor Request|2|||
150178063|NCT04425629|541790339|FG004|Overall Study|Sponsor Request|2|||
150178064|NCT04425629|541790340|FG005|Overall Study|Sponsor Request|2|||
150178065|NCT04425629|541790341|FG006|Overall Study|Sponsor Request|1|||
150178066|NCT04425629|541790342|FG007|Overall Study|Sponsor Request|0|||
150178067|NCT04425629|541790343|FG008|Overall Study|Sponsor Request|0|||
150178068|NCT04425629|541790344|FG009|Overall Study|Sponsor Request|9|||
149975879|NCT03183063|541049447|FG002|Overall Study|Withdrawal by Subject|0|||
149975880|NCT03183063|541049445|FG000|Overall Study|Physician Decision|3|||
149975881|NCT03183063|541049446|FG001|Overall Study|Physician Decision|4|||
149975882|NCT03183063|541049447|FG002|Overall Study|Physician Decision|4|||
149975883|NCT00925002|541049448|FG000|Overall Study|Other|1|||
149975884|NCT00925002|541049449|FG001|Overall Study|Other|4|||
149975885|NCT00925002|541049450|FG002|Overall Study|Other|0|||
149975886|NCT00925002|541049448|FG000|Overall Study|Death|1|||
149975887|NCT00925002|541049449|FG001|Overall Study|Death|1|||
149975888|NCT00925002|541049450|FG002|Overall Study|Death|5|||
149975889|NCT00925002|541049448|FG000|Overall Study|Adverse Event|3|||
149975890|NCT00925002|541049449|FG001|Overall Study|Adverse Event|1|||
150178069|NCT04425629|541790345|FG010|Overall Study|Sponsor Request|9|||
150178070|NCT04425629|541790346|FG011|Overall Study|Sponsor Request|10|||
150178071|NCT04425629|541790347|FG012|Overall Study|Sponsor Request|8|||
150178072|NCT04425629|541790348|FG013|Overall Study|Sponsor Request|0|||
150178073|NCT04425629|541790349|FG014|Overall Study|Sponsor Request|0|||
150178074|NCT04425629|541790350|FG015|Overall Study|Sponsor Request|1|||
149975891|NCT00925002|541049450|FG002|Overall Study|Adverse Event|2|||
149975892|NCT00925002|541049448|FG000|Overall Study|Participant withdrew consent|1|||
149975893|NCT00925002|541049449|FG001|Overall Study|Participant withdrew consent|3|||
150178075|NCT04425629|541790351|FG016|Overall Study|Sponsor Request|0|||
150178076|NCT04425629|541790352|FG017|Overall Study|Sponsor Request|0|||
150178077|NCT04425629|541790353|FG018|Overall Study|Sponsor Request|0|||
150178078|NCT04425629|541790335|FG000|Overall Study|Physician Decision|0|||
150178079|NCT04425629|541790336|FG001|Overall Study|Physician Decision|0|||
150178080|NCT04425629|541790337|FG002|Overall Study|Physician Decision|0|||
150178081|NCT04425629|541790338|FG003|Overall Study|Physician Decision|0|||
150178082|NCT04425629|541790339|FG004|Overall Study|Physician Decision|0|||
150178083|NCT04425629|541790340|FG005|Overall Study|Physician Decision|0|||
150178084|NCT04425629|541790341|FG006|Overall Study|Physician Decision|0|||
150178085|NCT04425629|541790342|FG007|Overall Study|Physician Decision|0|||
150178086|NCT04425629|541790343|FG008|Overall Study|Physician Decision|0|||
150178087|NCT04425629|541790344|FG009|Overall Study|Physician Decision|4|||
150178088|NCT04425629|541790345|FG010|Overall Study|Physician Decision|3|||
150178089|NCT04425629|541790346|FG011|Overall Study|Physician Decision|5|||
150178090|NCT04425629|541790347|FG012|Overall Study|Physician Decision|1|||
150178091|NCT04425629|541790348|FG013|Overall Study|Physician Decision|0|||
150178092|NCT04425629|541790349|FG014|Overall Study|Physician Decision|0|||
150178093|NCT04425629|541790350|FG015|Overall Study|Physician Decision|1|||
150178094|NCT04425629|541790351|FG016|Overall Study|Physician Decision|0|||
150178095|NCT04425629|541790352|FG017|Overall Study|Physician Decision|0|||
150178096|NCT04425629|541790353|FG018|Overall Study|Physician Decision|0|||
150178097|NCT04425629|541790335|FG000|Overall Study|Lack of Efficacy|0|||
150178098|NCT04425629|541790336|FG001|Overall Study|Lack of Efficacy|0|||
150178099|NCT04425629|541790337|FG002|Overall Study|Lack of Efficacy|0|||
150178100|NCT04425629|541790338|FG003|Overall Study|Lack of Efficacy|0|||
150178101|NCT04425629|541790339|FG004|Overall Study|Lack of Efficacy|0|||
150178102|NCT04425629|541790340|FG005|Overall Study|Lack of Efficacy|0|||
150178103|NCT04425629|541790341|FG006|Overall Study|Lack of Efficacy|0|||
150178104|NCT04425629|541790342|FG007|Overall Study|Lack of Efficacy|0|||
150178105|NCT04425629|541790343|FG008|Overall Study|Lack of Efficacy|0|||
150178106|NCT04425629|541790344|FG009|Overall Study|Lack of Efficacy|0|||
150178107|NCT04425629|541790345|FG010|Overall Study|Lack of Efficacy|1|||
150052033|NCT00717236|541332847|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
150052034|NCT00717236|541332848|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
150052035|NCT00717236|541332847|FG000|Open-Label Period|Other: Moved|1|||
150052036|NCT00717236|541332848|FG001|Open-Label Period|Other: Moved|0|||
150052037|NCT00717236|541332847|FG000|Open-Label Period|Other: Investigator Decision|1|||
150052038|NCT00717236|541332848|FG001|Open-Label Period|Other: Investigator Decision|0|||
150052039|NCT00717236|541332847|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
150052040|NCT00717236|541332848|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
150052041|NCT00717236|541332847|FG000|Open-Label Period|Other: Sponsor Request|3|||
150052042|NCT00717236|541332848|FG001|Open-Label Period|Other: Sponsor Request|0|||
150052043|NCT00717236|541332847|FG000|Open-Label Period|Other: Cataract Surgery|1|||
150178108|NCT04425629|541790346|FG011|Overall Study|Lack of Efficacy|0|||
149975894|NCT00925002|541049450|FG002|Overall Study|Participant withdrew consent|3|||
149975895|NCT01073293|541049453|FG000|Overall Study|Lost to Follow-up|0|||
149975896|NCT01073293|541049454|FG001|Overall Study|Lost to Follow-up|1|||
149975897|NCT01073293|541049453|FG000|Overall Study|Withdrawal by Subject|5|||
149975898|NCT01073293|541049454|FG001|Overall Study|Withdrawal by Subject|10|||
149975899|NCT00002766|541049455|FG000|Overall Study|Withdrawal by Subject|0|||
149975900|NCT00002766|541049456|FG001|Overall Study|Withdrawal by Subject|1|||
149975901|NCT00002766|541049455|FG000|Overall Study|Patient Not Treated|1|||
149975902|NCT00002766|541049456|FG001|Overall Study|Patient Not Treated|2|||
149975903|NCT00002766|541049455|FG000|Overall Study|Adverse Event|1|||
149975904|NCT00002766|541049456|FG001|Overall Study|Adverse Event|1|||
149975905|NCT00002766|541049455|FG000|Overall Study|Protocol Violation|1|||
149975906|NCT00002766|541049456|FG001|Overall Study|Protocol Violation|0|||
149975907|NCT00328172|541049459|FG000|Overall Study|Adverse Event|3|||
149975908|NCT00328172|541049460|FG001|Overall Study|Adverse Event|2|||
149975909|NCT00328172|541049461|FG002|Overall Study|Adverse Event|1|||
149975910|NCT00328172|541049462|FG003|Overall Study|Adverse Event|2|||
149975911|NCT00328172|541049463|FG004|Overall Study|Adverse Event|1|||
149975912|NCT00328172|541049459|FG000|Overall Study|Protocol Violation|0|||
149975913|NCT00328172|541049460|FG001|Overall Study|Protocol Violation|1|||
149975914|NCT00328172|541049461|FG002|Overall Study|Protocol Violation|1|||
149975915|NCT00328172|541049462|FG003|Overall Study|Protocol Violation|0|||
149975916|NCT00328172|541049463|FG004|Overall Study|Protocol Violation|0|||
149975917|NCT00328172|541049459|FG000|Overall Study|Lost to Follow-up|1|||
149975918|NCT00328172|541049460|FG001|Overall Study|Lost to Follow-up|1|||
149975919|NCT00328172|541049461|FG002|Overall Study|Lost to Follow-up|2|||
149975920|NCT00328172|541049462|FG003|Overall Study|Lost to Follow-up|1|||
149975921|NCT00328172|541049463|FG004|Overall Study|Lost to Follow-up|1|||
149975922|NCT00328172|541049459|FG000|Overall Study|Withdrawal by Subject|1|||
149975923|NCT00328172|541049460|FG001|Overall Study|Withdrawal by Subject|1|||
149975924|NCT00328172|541049461|FG002|Overall Study|Withdrawal by Subject|1|||
149975925|NCT00328172|541049462|FG003|Overall Study|Withdrawal by Subject|6|||
149975926|NCT00328172|541049463|FG004|Overall Study|Withdrawal by Subject|0|||
149975927|NCT00328172|541049459|FG000|Overall Study|Lack of Efficacy|14|||
149975928|NCT00328172|541049460|FG001|Overall Study|Lack of Efficacy|9|||
149975929|NCT00328172|541049461|FG002|Overall Study|Lack of Efficacy|4|||
149975930|NCT00328172|541049462|FG003|Overall Study|Lack of Efficacy|4|||
149975931|NCT00328172|541049463|FG004|Overall Study|Lack of Efficacy|3|||
149975932|NCT00328172|541049459|FG000|Overall Study|Other reason (not specified)|3|||
149975933|NCT00328172|541049460|FG001|Overall Study|Other reason (not specified)|0|||
149975934|NCT00328172|541049461|FG002|Overall Study|Other reason (not specified)|1|||
149975935|NCT00328172|541049462|FG003|Overall Study|Other reason (not specified)|0|||
149975936|NCT00328172|541049463|FG004|Overall Study|Other reason (not specified)|0|||
149975937|NCT00077974|541049464|FG000|Overall Study|Adverse Event|22|||
150178109|NCT04425629|541790347|FG012|Overall Study|Lack of Efficacy|0|||
149975938|NCT00077974|541049464|FG000|Overall Study|Protocol Violation|1|||
150178110|NCT04425629|541790348|FG013|Overall Study|Lack of Efficacy|0|||
150178111|NCT04425629|541790349|FG014|Overall Study|Lack of Efficacy|0|||
150178112|NCT04425629|541790350|FG015|Overall Study|Lack of Efficacy|0|||
150178113|NCT04425629|541790351|FG016|Overall Study|Lack of Efficacy|0|||
150178114|NCT04425629|541790352|FG017|Overall Study|Lack of Efficacy|0|||
150178115|NCT04425629|541790353|FG018|Overall Study|Lack of Efficacy|0|||
150178116|NCT01102231|541790360|FG000|Overall Study|Protocol Violation|3|||
150178117|NCT01102231|541790360|FG000|Overall Study|Lack of Efficacy|2|||
150178118|NCT01102231|541790360|FG000|Overall Study|Death|2|||
150178119|NCT01102231|541790360|FG000|Overall Study|Adverse Event|3|||
150178120|NCT01102231|541790360|FG000|Overall Study|Withdrawal by Subject|1|||
150178121|NCT01102231|541790360|FG000|Overall Study|Did not received the treatment|4|||
150178122|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
150178123|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
150178124|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
150178125|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
150178126|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
150178127|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
150178128|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
150178129|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
150178130|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178131|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178132|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178133|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178134|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
150178135|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
150178136|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178137|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
150178138|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178139|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178140|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178141|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178142|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178143|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
150178144|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
150178145|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
150178146|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178147|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
150178148|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178149|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178150|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178151|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178152|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178153|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
150178154|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178155|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178156|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178157|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
150178158|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
150178159|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178160|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178161|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
150178162|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178163|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178164|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178165|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
150178166|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178167|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178168|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178169|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
150178170|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
150178171|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
150178172|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
150178173|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
150178174|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
150178175|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
150178176|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
150178177|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
150178178|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
150178179|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178180|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178181|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178182|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178183|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
150178184|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178185|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
150178186|NCT03903822|541790361|FG000|Treatment Phase (6 Weeks)|Other|2|||
150178187|NCT03903822|541790362|FG001|Treatment Phase (6 Weeks)|Other|1|||
150178188|NCT03903822|541790363|FG002|Treatment Phase (6 Weeks)|Other|0|||
150178189|NCT03903822|541790364|FG003|Treatment Phase (6 Weeks)|Other|0|||
150178190|NCT03903822|541790365|FG004|Treatment Phase (6 Weeks)|Other|1|||
150178191|NCT03903822|541790366|FG005|Treatment Phase (6 Weeks)|Other|1|||
150178192|NCT03903822|541790367|FG006|Treatment Phase (6 Weeks)|Other|0|||
150178193|NCT03903822|541790368|FG007|Treatment Phase (6 Weeks)|Other|0|||
149975939|NCT00077974|541049464|FG000|Overall Study|Withdrawal by Subject|3|||
149975940|NCT00077974|541049464|FG000|Overall Study|Lack of Efficacy|76|||
149975941|NCT00077974|541049464|FG000|Overall Study|Decision of Sponsor|2|||
149975942|NCT01990742|541049465|FG000|Overall Study|Withdrawal by facility|407|||
149975943|NCT01990742|541049466|FG001|Overall Study|Withdrawal by facility|1083|||
149975944|NCT01990742|541049465|FG000|Overall Study|Facility closed|0|||
149975945|NCT01990742|541049466|FG001|Overall Study|Facility closed|270|||
149975946|NCT03443687|541049467|FG000|Overall Study|Lost to Follow-up|3|||
149975947|NCT03443687|541049468|FG001|Overall Study|Lost to Follow-up|5|||
149975948|NCT03443687|541049467|FG000|Overall Study|Withdrawal by Subject|1|||
149975949|NCT03443687|541049468|FG001|Overall Study|Withdrawal by Subject|0|||
149975950|NCT03443687|541049467|FG000|Overall Study|Discontinued intervention|1|||
149975951|NCT03443687|541049468|FG001|Overall Study|Discontinued intervention|1|||
149975952|NCT03848416|541049474|FG000|Overall Study|Withdrawal by Subject|1|||
149975953|NCT03848416|541049475|FG001|Overall Study|Withdrawal by Subject|0|||
149975954|NCT03848416|541049476|FG002|Overall Study|Withdrawal by Subject|0|||
150178194|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
150178195|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
150178196|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
150178197|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
150178198|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
150178199|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
150178200|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
150178201|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
150178202|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178203|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178204|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178205|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178206|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
150178207|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178208|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178209|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
150178210|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
150178211|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
150178212|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
150178213|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
150178214|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
150178215|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
150178216|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
150178217|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
150178218|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178219|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178220|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178221|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
150178222|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
150178223|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178224|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178225|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
150178226|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
150178227|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
150178228|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
150178229|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
150178230|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
150178231|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
150178232|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
150178233|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
150178234|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178235|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178236|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178237|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178238|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178239|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
150178240|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178241|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
150178242|NCT03903822|541790361|FG000|Follow up Phase (4 Weeks)|Other|1|||
150178243|NCT03903822|541790362|FG001|Follow up Phase (4 Weeks)|Other|1|||
150178244|NCT03903822|541790363|FG002|Follow up Phase (4 Weeks)|Other|0|||
150178245|NCT03903822|541790364|FG003|Follow up Phase (4 Weeks)|Other|0|||
150178246|NCT03903822|541790365|FG004|Follow up Phase (4 Weeks)|Other|0|||
150178247|NCT03903822|541790366|FG005|Follow up Phase (4 Weeks)|Other|0|||
150178248|NCT03903822|541790367|FG006|Follow up Phase (4 Weeks)|Other|0|||
150178249|NCT03903822|541790368|FG007|Follow up Phase (4 Weeks)|Other|0|||
150178250|NCT01792830|541790375|FG000|Overall Study|Withdrawal by Subject|22|||
150178251|NCT01792830|541790376|FG001|Overall Study|Withdrawal by Subject|0|||
150178252|NCT01792830|541790377|FG002|Overall Study|Withdrawal by Subject|0|||
150178253|NCT01792830|541790378|FG003|Overall Study|Withdrawal by Subject|2|||
150178254|NCT01792830|541790379|FG004|Overall Study|Withdrawal by Subject|1|||
150178255|NCT01792830|541790380|FG005|Overall Study|Withdrawal by Subject|1|||
150178256|NCT01792830|541790381|FG006|Overall Study|Withdrawal by Subject|1|||
150178257|NCT01792830|541790382|FG007|Overall Study|Withdrawal by Subject|1|||
150178258|NCT01792830|541790383|FG008|Overall Study|Withdrawal by Subject|7|||
150178259|NCT01792830|541790384|FG009|Overall Study|Withdrawal by Subject|0|||
150178260|NCT01792830|541790385|FG010|Overall Study|Withdrawal by Subject|2|||
150178261|NCT01792830|541790375|FG000|Overall Study|Death|3|||
150178262|NCT01792830|541790376|FG001|Overall Study|Death|0|||
150178263|NCT01792830|541790377|FG002|Overall Study|Death|0|||
150178264|NCT01792830|541790378|FG003|Overall Study|Death|1|||
150178265|NCT01792830|541790379|FG004|Overall Study|Death|0|||
150178266|NCT01792830|541790380|FG005|Overall Study|Death|0|||
149975955|NCT03848416|541049474|FG000|Overall Study|Death|0|||
149975956|NCT03848416|541049475|FG001|Overall Study|Death|0|||
149975957|NCT03848416|541049476|FG002|Overall Study|Death|1|||
149975958|NCT00856609|541049483|FG000|Overall Study|Adverse Event|1|||
149975959|NCT00856609|541049484|FG001|Overall Study|Adverse Event|0|||
149975960|NCT00783432|541049485|FG000|Overall Study|Adverse Event|22|||
149975961|NCT00783432|541049486|FG001|Overall Study|Adverse Event|17|||
149975962|NCT00783432|541049485|FG000|Overall Study|Lack of Efficacy|20|||
149975963|NCT00783432|541049486|FG001|Overall Study|Lack of Efficacy|21|||
149975964|NCT00783432|541049485|FG000|Overall Study|Lost to Follow-up|11|||
149975965|NCT00783432|541049486|FG001|Overall Study|Lost to Follow-up|6|||
149975966|NCT00783432|541049485|FG000|Overall Study|Withdrawal by Subject|23|||
149975967|NCT00783432|541049486|FG001|Overall Study|Withdrawal by Subject|20|||
149975968|NCT00783432|541049485|FG000|Overall Study|subject moved|3|||
149975969|NCT00783432|541049486|FG001|Overall Study|subject moved|5|||
149975970|NCT00783432|541049485|FG000|Overall Study|Protocol Violation|6|||
149975971|NCT00783432|541049486|FG001|Overall Study|Protocol Violation|9|||
149975972|NCT01436110|541049487|FG000|Overall Study|Lack of Efficacy|23|||
149975973|NCT01436110|541049488|FG001|Overall Study|Lack of Efficacy|14|||
149975974|NCT01436110|541049489|FG002|Overall Study|Lack of Efficacy|9|||
149975975|NCT01436110|541049487|FG000|Overall Study|Withdrawal by Subject|6|||
149975976|NCT01436110|541049488|FG001|Overall Study|Withdrawal by Subject|8|||
149975977|NCT01436110|541049489|FG002|Overall Study|Withdrawal by Subject|4|||
149975978|NCT01436110|541049487|FG000|Overall Study|Adverse Event|2|||
149975979|NCT01436110|541049488|FG001|Overall Study|Adverse Event|1|||
149975980|NCT01436110|541049489|FG002|Overall Study|Adverse Event|2|||
149975981|NCT01436110|541049487|FG000|Overall Study|Physician Decision|3|||
149975982|NCT01436110|541049488|FG001|Overall Study|Physician Decision|1|||
149975983|NCT01436110|541049489|FG002|Overall Study|Physician Decision|1|||
149975984|NCT01436110|541049487|FG000|Overall Study|Lost to Follow-up|1|||
149975985|NCT01436110|541049488|FG001|Overall Study|Lost to Follow-up|1|||
149975986|NCT01436110|541049489|FG002|Overall Study|Lost to Follow-up|3|||
150052044|NCT00717236|541332848|FG001|Open-Label Period|Other: Cataract Surgery|0|||
150052045|NCT00717236|541332847|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
150052046|NCT00717236|541332848|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
150052047|NCT00717236|541332847|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
150052048|NCT00717236|541332848|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
150052049|NCT00717236|541332847|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
150052050|NCT00717236|541332848|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
150052051|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
150052052|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
150052053|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
150178267|NCT01792830|541790381|FG006|Overall Study|Death|1|||
150178268|NCT01792830|541790382|FG007|Overall Study|Death|0|||
150178269|NCT01792830|541790383|FG008|Overall Study|Death|1|||
150178270|NCT01792830|541790384|FG009|Overall Study|Death|0|||
150178271|NCT01792830|541790385|FG010|Overall Study|Death|1|||
150178272|NCT01792830|541790375|FG000|Overall Study|Adverse Event|0|||
150178273|NCT01792830|541790376|FG001|Overall Study|Adverse Event|0|||
150178274|NCT01792830|541790377|FG002|Overall Study|Adverse Event|0|||
150178275|NCT01792830|541790378|FG003|Overall Study|Adverse Event|0|||
150178276|NCT01792830|541790379|FG004|Overall Study|Adverse Event|0|||
150178277|NCT01792830|541790380|FG005|Overall Study|Adverse Event|0|||
150178278|NCT01792830|541790381|FG006|Overall Study|Adverse Event|0|||
150178279|NCT01792830|541790382|FG007|Overall Study|Adverse Event|0|||
150178280|NCT01792830|541790383|FG008|Overall Study|Adverse Event|1|||
150178281|NCT01792830|541790384|FG009|Overall Study|Adverse Event|0|||
150178282|NCT01792830|541790385|FG010|Overall Study|Adverse Event|0|||
150178283|NCT05274217|541790386|FG000|Overall Study|Study terminated.|11|||
150178284|NCT05274217|541790387|FG001|Overall Study|Study terminated.|0|||
150178285|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
150178286|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
150178287|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
150178288|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
150178289|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
150178290|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
150178291|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
150178292|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
150178293|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
150178294|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
150178295|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
150178296|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
150178297|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
150178298|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
150178299|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
150178300|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
150178301|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
150178302|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
150178303|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
149975987|NCT01436110|541049487|FG000|Overall Study|Protocol Violation|3|||
150178304|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
150052054|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
149975988|NCT01436110|541049488|FG001|Overall Study|Protocol Violation|1|||
149975989|NCT01436110|541049489|FG002|Overall Study|Protocol Violation|1|||
149975990|NCT01436110|541049487|FG000|Overall Study|Did Not Receive Trial Medication|1|||
149975991|NCT01436110|541049488|FG001|Overall Study|Did Not Receive Trial Medication|0|||
149975992|NCT01436110|541049489|FG002|Overall Study|Did Not Receive Trial Medication|3|||
149975993|NCT03273907|541049490|FG000|Overall Study|Death|1|||
149975994|NCT03273907|541049490|FG000|Overall Study|Lost to Follow-up|4|||
149975995|NCT03273907|541049490|FG000|Overall Study|Withdrawal by Subject|2|||
149975996|NCT03273907|541049490|FG000|Overall Study|COVID 19|2|||
149975997|NCT00110214|541049491|FG000|Overall Study|Never started treatment|21|||
149975998|NCT00110214|541049492|FG001|Overall Study|Never started treatment|20|||
149975999|NCT00110214|541049491|FG000|Overall Study|Disease progression or death|260|||
149976000|NCT00110214|541049492|FG001|Overall Study|Disease progression or death|151|||
149976001|NCT00110214|541049491|FG000|Overall Study|Adverse Event|115|||
149976002|NCT00110214|541049492|FG001|Overall Study|Adverse Event|192|||
150052055|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
150052056|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
150052057|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
150052058|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
150052059|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
150052060|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
150052061|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
150052062|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
150052063|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
150052064|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
150052065|NCT00612105|541332849|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
150052066|NCT00612105|541332850|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
150052067|NCT00612105|541332849|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
150052068|NCT00612105|541332850|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
150052069|NCT00612105|541332849|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
150052070|NCT00612105|541332850|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
150052071|NCT00612105|541332849|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
150052072|NCT00612105|541332850|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
150178305|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
150178306|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
150178307|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
150178308|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
150178309|NCT00311363|541790388|FG000|24-Week Single-Blind Treatment Period|Death|1|||
150178310|NCT00311363|541790389|FG001|24-Week Single-Blind Treatment Period|Death|0|||
150178311|NCT00311363|541790390|FG002|24-Week Single-Blind Treatment Period|Death|0|||
150178312|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
150178313|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
150178314|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
150178315|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
150178316|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
150178317|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
150178318|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
150178319|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
150178320|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
150178321|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
150178322|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
150178323|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
150178324|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
150178325|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
150178326|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
150178327|NCT00311363|541790388|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
150178328|NCT00311363|541790389|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
150178329|NCT00311363|541790390|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
150178330|NCT03811574|541790391|FG000|Overall Study|Withdrawal by Subject|2|||
150178331|NCT03811574|541790392|FG001|Overall Study|Withdrawal by Subject|4|||
149976003|NCT00110214|541049491|FG000|Overall Study|Refused further treatment|52|||
149976004|NCT00110214|541049492|FG001|Overall Study|Refused further treatment|65|||
150178332|NCT03811574|541790393|FG002|Overall Study|Withdrawal by Subject|0|||
150178333|NCT01697969|541790394|FG000|Overall Study|Did not meet inc/exc criteria|3|||
150178334|NCT05609032|541790398|FG000|Overall Study|Lost to Follow-up|3|||
150178335|NCT05609032|541790399|FG001|Overall Study|Lost to Follow-up|1|||
150178336|NCT05609032|541790398|FG000|Overall Study|Withdrawal by Subject|1|||
150178337|NCT05609032|541790399|FG001|Overall Study|Withdrawal by Subject|0|||
149976005|NCT00110214|541049491|FG000|Overall Study|Other (not specified)|61|||
149976006|NCT00110214|541049492|FG001|Overall Study|Other (not specified)|75|||
149976007|NCT01088503|541049493|FG000|Overall Study|Withdrawal by Subject|118|||
149976008|NCT01088503|541049494|FG001|Overall Study|Withdrawal by Subject|327|||
149976009|NCT01088503|541049495|FG002|Overall Study|Withdrawal by Subject|10|||
149976010|NCT01088503|541049493|FG000|Overall Study|Death|64|||
149976011|NCT01088503|541049494|FG001|Overall Study|Death|358|||
149976012|NCT01088503|541049495|FG002|Overall Study|Death|7|||
149976013|NCT01847092|541049496|FG000|Overall Study|Adverse Event|12|||
149976014|NCT01847092|541049497|FG001|Overall Study|Adverse Event|3|||
149976015|NCT01847092|541049496|FG000|Overall Study|Withdrawal by Subject|5|||
149976016|NCT01847092|541049497|FG001|Overall Study|Withdrawal by Subject|5|||
149976017|NCT01847092|541049496|FG000|Overall Study|Protocol Specified|8|||
149976018|NCT01847092|541049497|FG001|Overall Study|Protocol Specified|0|||
149976019|NCT01847092|541049496|FG000|Overall Study|Physician Decision|1|||
149976020|NCT01847092|541049497|FG001|Overall Study|Physician Decision|1|||
150178338|NCT03764475|541790400|FG000|Overall Study|Adverse Event|11|||
149976021|NCT01847092|541049496|FG000|Overall Study|Protocol Violation|0|||
149976022|NCT01847092|541049497|FG001|Overall Study|Protocol Violation|2|||
149976023|NCT03604497|541049499|FG000|Overall Study|Protocol Violation|52|||
149976024|NCT01016067|541049500|FG000|Overall Study|Lost to Follow-up|1|||
149976025|NCT01016067|541049501|FG001|Overall Study|Lost to Follow-up|2|||
149976026|NCT01016067|541049500|FG000|Overall Study|Physician Decision|1|||
149976027|NCT01016067|541049501|FG001|Overall Study|Physician Decision|1|||
149976028|NCT01016067|541049500|FG000|Overall Study|Withdrew due to Relocation|0|||
149976029|NCT01016067|541049501|FG001|Overall Study|Withdrew due to Relocation|1|||
149976030|NCT01331681|541049503|FG000|Overall Study|Adverse Event|10|||
149976031|NCT01331681|541049504|FG001|Overall Study|Adverse Event|13|||
149976032|NCT01331681|541049505|FG002|Overall Study|Adverse Event|10|||
149976033|NCT01331681|541049503|FG000|Overall Study|Death|6|||
149976034|NCT01331681|541049504|FG001|Overall Study|Death|6|||
149976035|NCT01331681|541049505|FG002|Overall Study|Death|2|||
150178339|NCT03764475|541790401|FG001|Overall Study|Adverse Event|2|||
149976036|NCT01331681|541049503|FG000|Overall Study|Lack of Efficacy|0|||
149976037|NCT01331681|541049504|FG001|Overall Study|Lack of Efficacy|1|||
149976038|NCT01331681|541049505|FG002|Overall Study|Lack of Efficacy|0|||
149976039|NCT01331681|541049503|FG000|Overall Study|Withdrawal by Subject|12|||
149976040|NCT01331681|541049504|FG001|Overall Study|Withdrawal by Subject|8|||
150052073|NCT00612105|541332849|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
150052074|NCT00612105|541332850|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
150052075|NCT01105767|541332851|FG000|Overall Study|Lost to Follow-up|1160|||
150052076|NCT01105767|541332852|FG001|Overall Study|Lost to Follow-up|1614|||
150052077|NCT01105767|541332853|FG002|Overall Study|Lost to Follow-up|1184|||
150052078|NCT00475982|541332854|FG000|Overall Study|surgery rescheduled|7|||
150052079|NCT00475982|541332855|FG001|Overall Study|surgery rescheduled|3|||
150052080|NCT00271505|541332860|FG000|Overall Study|Screen Failure|3|||
150052081|NCT00271505|541332860|FG000|Overall Study|Adverse Event|1|||
150052082|NCT00271505|541332860|FG000|Overall Study|Death|1|||
150178340|NCT03764475|541790400|FG000|Overall Study|Lost to Follow-up|24|||
150178341|NCT03764475|541790401|FG001|Overall Study|Lost to Follow-up|10|||
150178342|NCT03764475|541790400|FG000|Overall Study|Withdrawal by Subject|26|||
150052083|NCT00119678|541332861|FG000|Double-blind Treatment Period|Death|1|||
150052084|NCT00119678|541332862|FG001|Double-blind Treatment Period|Death|0|||
149976041|NCT01331681|541049505|FG002|Overall Study|Withdrawal by Subject|15|||
149976042|NCT01331681|541049503|FG000|Overall Study|Protocol Violation|1|||
149976043|NCT01331681|541049504|FG001|Overall Study|Protocol Violation|1|||
149976044|NCT01331681|541049505|FG002|Overall Study|Protocol Violation|0|||
149976045|NCT01331681|541049503|FG000|Overall Study|Lost to Follow-up|2|||
149976046|NCT01331681|541049504|FG001|Overall Study|Lost to Follow-up|4|||
149976047|NCT01331681|541049505|FG002|Overall Study|Lost to Follow-up|1|||
149976048|NCT01331681|541049503|FG000|Overall Study|Physician Decision|2|||
149976049|NCT01331681|541049504|FG001|Overall Study|Physician Decision|0|||
149976050|NCT01331681|541049505|FG002|Overall Study|Physician Decision|4|||
149976051|NCT01331681|541049503|FG000|Overall Study|Therapeutic procedure required|1|||
149976052|NCT01331681|541049504|FG001|Overall Study|Therapeutic procedure required|0|||
149976053|NCT01331681|541049505|FG002|Overall Study|Therapeutic procedure required|0|||
149976054|NCT01331681|541049503|FG000|Overall Study|Sponsor decision|1|||
149976055|NCT01331681|541049504|FG001|Overall Study|Sponsor decision|1|||
149976056|NCT01331681|541049505|FG002|Overall Study|Sponsor decision|0|||
149976057|NCT01331681|541049503|FG000|Overall Study|Switching to other therapy|0|||
149976058|NCT01331681|541049504|FG001|Overall Study|Switching to other therapy|0|||
149976059|NCT01331681|541049505|FG002|Overall Study|Switching to other therapy|1|||
149976060|NCT01331681|541049503|FG000|Overall Study|Not Received Study Treatment|0|||
149976061|NCT01331681|541049504|FG001|Overall Study|Not Received Study Treatment|0|||
149976062|NCT01331681|541049505|FG002|Overall Study|Not Received Study Treatment|2|||
149976063|NCT01673646|541049507|FG000|Overall Study|Adverse Event|2|||
149976064|NCT01673646|541049508|FG001|Overall Study|Adverse Event|1|||
149976065|NCT01673646|541049509|FG002|Overall Study|Adverse Event|1|||
149976066|NCT01673646|541049507|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149976067|NCT01673646|541049508|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149976068|NCT01673646|541049509|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149976069|NCT01673646|541049507|FG000|Overall Study|Condition no longer requires study drug|0|||
149976070|NCT01673646|541049508|FG001|Overall Study|Condition no longer requires study drug|1|||
149976071|NCT01673646|541049509|FG002|Overall Study|Condition no longer requires study drug|0|||
149976072|NCT01673646|541049507|FG000|Overall Study|Withdrawal by Subject|0|||
149976073|NCT01673646|541049508|FG001|Overall Study|Withdrawal by Subject|2|||
149976074|NCT01673646|541049509|FG002|Overall Study|Withdrawal by Subject|2|||
149976075|NCT01673646|541049507|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
149976076|NCT01673646|541049508|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
149976077|NCT01673646|541049509|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
149976078|NCT00658541|541049512|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149976079|NCT00658541|541049513|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149976080|NCT00658541|541049512|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149976081|NCT00658541|541049513|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149976082|NCT01063348|541049514|FG000|Overall Study|Lost to Follow-up|3|||
149976083|NCT01063348|541049515|FG001|Overall Study|Lost to Follow-up|10|||
149976084|NCT00269087|541049516|FG000|Overall Study|Adverse Event|20|||
149976085|NCT00269087|541049516|FG000|Overall Study|Withdrawal by Subject|1|||
149976086|NCT00269087|541049516|FG000|Overall Study|Exacerbation of COPD|13|||
149976087|NCT01876381|541049519|FG000|Overall Study|Lack of Efficacy|5|||
149976088|NCT01876381|541049519|FG000|Overall Study|Physician Decision|1|||
149976089|NCT01876381|541049519|FG000|Overall Study|Withdrawal by Subject|1|||
149976090|NCT00332696|541049520|FG000|Overall Study|Death|24|||
149976091|NCT00332696|541049521|FG001|Overall Study|Death|14|||
149976092|NCT00332696|541049520|FG000|Overall Study|Insufficient therapeutic effect|4|||
149976093|NCT00332696|541049521|FG001|Overall Study|Insufficient therapeutic effect|11|||
149976094|NCT00332696|541049520|FG000|Overall Study|Adverse Event|1|||
149976095|NCT00332696|541049521|FG001|Overall Study|Adverse Event|2|||
149976096|NCT00332696|541049520|FG000|Overall Study|Condition does not justify treatment|0|||
149976097|NCT00332696|541049521|FG001|Overall Study|Condition does not justify treatment|2|||
149976098|NCT00332696|541049520|FG000|Overall Study|Lost to Follow-up|0|||
149976099|NCT00332696|541049521|FG001|Overall Study|Lost to Follow-up|1|||
149976100|NCT00332696|541049520|FG000|Overall Study|Withdrawal by Subject|1|||
149976101|NCT00332696|541049521|FG001|Overall Study|Withdrawal by Subject|0|||
149976102|NCT01464879|541049524|FG000|Overall Study|Physician Decision|1|||
149976103|NCT01464879|541049524|FG000|Overall Study|Non-compliance|1|||
149976104|NCT02712788|541049529|FG000|Overall Study|Physician Decision|1|||
149976105|NCT02712788|541049530|FG001|Overall Study|Physician Decision|0|||
149976106|NCT02712788|541049529|FG000|Overall Study|Protocol Violation|1|||
149976107|NCT02712788|541049530|FG001|Overall Study|Protocol Violation|0|||
149976108|NCT01368614|541049531|FG000|Screening Period|Screen Failure|58|||
149976109|NCT01368614|541049532|FG001|Screening Period|Screen Failure|0|||
149976110|NCT01368614|541049533|FG002|Screening Period|Screen Failure|0|||
149976111|NCT01368614|541049534|FG003|Screening Period|Screen Failure|0|||
149976112|NCT01368614|541049531|FG000|Study Period|Withdrawal by Subject|0|||
149976113|NCT01368614|541049532|FG001|Study Period|Withdrawal by Subject|1|||
150052085|NCT00119678|541332861|FG000|Double-blind Treatment Period|Adverse Event|7|||
150052086|NCT00119678|541332862|FG001|Double-blind Treatment Period|Adverse Event|1|||
149976114|NCT01368614|541049533|FG002|Study Period|Withdrawal by Subject|1|||
149976115|NCT01368614|541049534|FG003|Study Period|Withdrawal by Subject|3|||
149976116|NCT01368614|541049531|FG000|Study Period|Lost to Follow-up|0|||
149976117|NCT01368614|541049532|FG001|Study Period|Lost to Follow-up|0|||
149976118|NCT01368614|541049533|FG002|Study Period|Lost to Follow-up|1|||
149976119|NCT01368614|541049534|FG003|Study Period|Lost to Follow-up|0|||
149976120|NCT00244621|541049535|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149976121|NCT00244621|541049536|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149976122|NCT00244621|541049537|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
149976123|NCT00244621|541049535|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
149976124|NCT00244621|541049536|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
149976125|NCT00244621|541049537|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149976126|NCT00244621|541049535|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
149976127|NCT00244621|541049536|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
149976128|NCT00244621|541049537|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
149976129|NCT00244621|541049535|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
149976130|NCT00244621|541049536|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
149976131|NCT00244621|541049537|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
149976132|NCT00244621|541049535|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
149976133|NCT00244621|541049536|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
149976134|NCT00244621|541049537|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
149976135|NCT00244621|541049535|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
149976136|NCT00244621|541049536|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
149976137|NCT00244621|541049537|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
149976138|NCT00244621|541049535|FG000|Open-label Treatment Period|Adverse Event|0|||
149976139|NCT00244621|541049536|FG001|Open-label Treatment Period|Adverse Event|0|||
149976140|NCT00244621|541049537|FG002|Open-label Treatment Period|Adverse Event|1|||
149976141|NCT00244621|541049535|FG000|Open-label Treatment Period|Moved abroad|0|||
149976142|NCT00244621|541049536|FG001|Open-label Treatment Period|Moved abroad|0|||
149976143|NCT00244621|541049537|FG002|Open-label Treatment Period|Moved abroad|1|||
149976144|NCT02271529|541049538|FG000|Overall Study|Withdrawal by Subject|1|||
149976145|NCT01904721|541049540|FG000|Overall Study|Other Reasons|0|||
149976146|NCT01904721|541049541|FG001|Overall Study|Other Reasons|0|||
149976147|NCT01904721|541049542|FG002|Overall Study|Other Reasons|1|||
149976148|NCT01904721|541049543|FG003|Overall Study|Other Reasons|1|||
149976149|NCT01904721|541049544|FG004|Overall Study|Other Reasons|2|||
149976150|NCT01904721|541049545|FG005|Overall Study|Other Reasons|2|||
149976151|NCT01904721|541049546|FG006|Overall Study|Other Reasons|2|||
149976152|NCT01904721|541049540|FG000|Overall Study|Personal Reasons|0|||
149976153|NCT01904721|541049541|FG001|Overall Study|Personal Reasons|0|||
149976154|NCT01904721|541049542|FG002|Overall Study|Personal Reasons|0|||
149976155|NCT01904721|541049543|FG003|Overall Study|Personal Reasons|0|||
149976156|NCT01904721|541049544|FG004|Overall Study|Personal Reasons|2|||
149976157|NCT01904721|541049545|FG005|Overall Study|Personal Reasons|3|||
149976158|NCT01904721|541049546|FG006|Overall Study|Personal Reasons|3|||
149976159|NCT01904721|541049540|FG000|Overall Study|Lost to Follow-up|0|||
149976160|NCT01904721|541049541|FG001|Overall Study|Lost to Follow-up|0|||
149976161|NCT01904721|541049542|FG002|Overall Study|Lost to Follow-up|0|||
149976162|NCT01904721|541049543|FG003|Overall Study|Lost to Follow-up|0|||
149976163|NCT01904721|541049544|FG004|Overall Study|Lost to Follow-up|1|||
149976164|NCT01904721|541049545|FG005|Overall Study|Lost to Follow-up|3|||
149976165|NCT01904721|541049546|FG006|Overall Study|Lost to Follow-up|1|||
149976166|NCT01904721|541049540|FG000|Overall Study|Lack of Efficacy|0|||
149976167|NCT01904721|541049541|FG001|Overall Study|Lack of Efficacy|0|||
149976168|NCT01904721|541049542|FG002|Overall Study|Lack of Efficacy|0|||
149976169|NCT01904721|541049543|FG003|Overall Study|Lack of Efficacy|0|||
149976170|NCT01904721|541049544|FG004|Overall Study|Lack of Efficacy|0|||
149976171|NCT01904721|541049545|FG005|Overall Study|Lack of Efficacy|0|||
149976172|NCT01904721|541049546|FG006|Overall Study|Lack of Efficacy|1|||
149976173|NCT01904721|541049540|FG000|Overall Study|Adverse Event|0|||
149976174|NCT01904721|541049541|FG001|Overall Study|Adverse Event|0|||
149976175|NCT01904721|541049542|FG002|Overall Study|Adverse Event|0|||
149976176|NCT01904721|541049543|FG003|Overall Study|Adverse Event|0|||
149976177|NCT01904721|541049544|FG004|Overall Study|Adverse Event|3|||
149976178|NCT01904721|541049545|FG005|Overall Study|Adverse Event|1|||
149976179|NCT01904721|541049546|FG006|Overall Study|Adverse Event|0|||
149976180|NCT01957865|541049547|FG000|Overall Study|Found HIV negative|0|||
149976181|NCT01957865|541049548|FG001|Overall Study|Found HIV negative|0|||
149976182|NCT01957865|541049549|FG002|Overall Study|Found HIV negative|1|||
149976183|NCT01957865|541049547|FG000|Overall Study|Lost to Follow-up|0|||
149976184|NCT01957865|541049548|FG001|Overall Study|Lost to Follow-up|2|||
149976185|NCT01957865|541049549|FG002|Overall Study|Lost to Follow-up|2|||
149976186|NCT00811720|541049553|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
149976187|NCT00811720|541049554|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
150052087|NCT00119678|541332861|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
149976188|NCT00811720|541049553|FG000|All Treated Patients|Adverse Event|20|||
149976189|NCT00811720|541049554|FG001|All Treated Patients|Adverse Event|62|||
149976190|NCT00811720|541049553|FG000|All Treated Patients|Lack of Efficacy|22|||
149976191|NCT00811720|541049554|FG001|All Treated Patients|Lack of Efficacy|18|||
150255072|NCT01302067|542070544|FG002|Overall Study|Adverse Event|45|||
150052088|NCT00119678|541332862|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
150052089|NCT00119678|541332861|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
150052090|NCT00119678|541332862|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
150052091|NCT00119678|541332861|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
150052092|NCT00119678|541332862|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
150052093|NCT00119678|541332861|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
150052094|NCT00119678|541332862|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
150052095|NCT00119678|541332861|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
150052096|NCT00119678|541332862|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
150052097|NCT00119678|541332861|FG000|Double-blind Treatment Period|Pregnancy|0|||
150052098|NCT00119678|541332862|FG001|Double-blind Treatment Period|Pregnancy|2|||
150052099|NCT00119678|541332861|FG000|Double-blind Treatment Period|Not treated|1|||
150052100|NCT00119678|541332862|FG001|Double-blind Treatment Period|Not treated|2|||
150052101|NCT00119678|541332861|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
150052102|NCT00119678|541332862|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
150052103|NCT00119678|541332861|FG000|Open-label Treatment Period|Death|1|||
150052104|NCT00119678|541332862|FG001|Open-label Treatment Period|Death|0|||
150052105|NCT00119678|541332861|FG000|Open-label Treatment Period|Adverse Event|3|||
150052106|NCT00119678|541332862|FG001|Open-label Treatment Period|Adverse Event|0|||
150052107|NCT00119678|541332861|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
150052108|NCT00119678|541332862|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
150052109|NCT00119678|541332861|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
150052110|NCT00119678|541332862|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
150052111|NCT00119678|541332861|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
150052112|NCT00119678|541332862|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
150052113|NCT00119678|541332861|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
150052114|NCT00119678|541332862|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
150052115|NCT00119678|541332861|FG000|Open-label Treatment Period|Pregnancy|1|||
150052116|NCT00119678|541332862|FG001|Open-label Treatment Period|Pregnancy|0|||
150052117|NCT00119678|541332861|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
150052118|NCT00119678|541332862|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
150052119|NCT02720042|541332863|FG000|Overall Study|Death|3|||
150052120|NCT02720042|541332863|FG000|Overall Study|Lost to Follow-up|4|||
150052121|NCT02720042|541332863|FG000|Overall Study|Withdrawal by Subject|1|||
150052122|NCT02720042|541332863|FG000|Overall Study|Physician Decision|3|||
150052123|NCT02720042|541332863|FG000|Overall Study|Phasix Mesh explanted|1|||
150052124|NCT02720042|541332863|FG000|Overall Study|unable due to non-study-related illness|3|||
150052125|NCT03704636|541332864|FG000|Overall Study|Inadequate Venous Flow|3|||
150052126|NCT01134705|541332869|FG000|Overall Study|Adverse Event|1|||
150052127|NCT01134705|541332870|FG001|Overall Study|Adverse Event|7|||
150052128|NCT01134705|541332869|FG000|Overall Study|Withdrawal by Subject|6|||
150052129|NCT01134705|541332870|FG001|Overall Study|Withdrawal by Subject|6|||
150052130|NCT01134705|541332869|FG000|Overall Study|Pregnancy|1|||
150052131|NCT01134705|541332870|FG001|Overall Study|Pregnancy|0|||
150052132|NCT01134705|541332869|FG000|Overall Study|Lost to Follow-up|5|||
150052133|NCT01134705|541332870|FG001|Overall Study|Lost to Follow-up|2|||
150052134|NCT01134705|541332869|FG000|Overall Study|Protocol Violation|1|||
150052135|NCT01134705|541332870|FG001|Overall Study|Protocol Violation|1|||
150052136|NCT01134705|541332869|FG000|Overall Study|Other|1|||
150052137|NCT01134705|541332870|FG001|Overall Study|Other|6|||
150052138|NCT00509145|541332871|FG000|Overall Study|Death|0|||
150052139|NCT00509145|541332872|FG001|Overall Study|Death|2|||
150052140|NCT00509145|541332871|FG000|Overall Study|Adverse Event|42|||
150052141|NCT00509145|541332872|FG001|Overall Study|Adverse Event|28|||
150052142|NCT00509145|541332871|FG000|Overall Study|Withdrawal by Subject|32|||
150052143|NCT00509145|541332872|FG001|Overall Study|Withdrawal by Subject|38|||
150052144|NCT00509145|541332871|FG000|Overall Study|Physician Decision|11|||
150052145|NCT00509145|541332872|FG001|Overall Study|Physician Decision|14|||
150052146|NCT00509145|541332871|FG000|Overall Study|Protocol Violation|1|||
150052147|NCT00509145|541332872|FG001|Overall Study|Protocol Violation|6|||
150052148|NCT00509145|541332871|FG000|Overall Study|Pregnancy|3|||
150052149|NCT00509145|541332872|FG001|Overall Study|Pregnancy|8|||
150052150|NCT00509145|541332871|FG000|Overall Study|Lost to Follow-up|6|||
150052151|NCT00509145|541332872|FG001|Overall Study|Lost to Follow-up|5|||
150052152|NCT00509145|541332871|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
150052153|NCT00509145|541332872|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
150052154|NCT00509145|541332871|FG000|Overall Study|Other|6|||
150052155|NCT00509145|541332872|FG001|Overall Study|Other|6|||
150052156|NCT00246740|541332873|FG000|Initial Enrollment|Death|1|||
150052157|NCT00246740|541332874|FG001|Initial Enrollment|Death|0|||
150052158|NCT00246740|541332873|FG000|Initial Enrollment|Additional surgery scheduled|0|||
150052159|NCT00246740|541332874|FG001|Initial Enrollment|Additional surgery scheduled|2|||
150052160|NCT00246740|541332873|FG000|Initial Enrollment|Surgery schedule change|4|||
150052161|NCT00246740|541332874|FG001|Initial Enrollment|Surgery schedule change|4|||
150052162|NCT00246740|541332873|FG000|Initial Enrollment|Other|1|||
150052163|NCT00246740|541332874|FG001|Initial Enrollment|Other|2|||
150052164|NCT00101452|541332877|FG000|Overall Study|Adverse Event|2|||
150052165|NCT00101452|541332878|FG001|Overall Study|Adverse Event|0|||
150052166|NCT00101452|541332879|FG002|Overall Study|Adverse Event|1|||
150052167|NCT00101452|541332877|FG000|Overall Study|Lost to Follow-up|13|||
150052168|NCT00101452|541332878|FG001|Overall Study|Lost to Follow-up|8|||
150052169|NCT00101452|541332879|FG002|Overall Study|Lost to Follow-up|14|||
150052170|NCT00101452|541332877|FG000|Overall Study|Withdrawal by Subject|10|||
150052171|NCT00101452|541332878|FG001|Overall Study|Withdrawal by Subject|14|||
150052172|NCT00101452|541332879|FG002|Overall Study|Withdrawal by Subject|9|||
150052173|NCT00101452|541332877|FG000|Overall Study|Baseline Fail|2|||
150052174|NCT00101452|541332878|FG001|Overall Study|Baseline Fail|1|||
150052175|NCT00101452|541332879|FG002|Overall Study|Baseline Fail|2|||
150052176|NCT00101452|541332877|FG000|Overall Study|Physician Decision|0|||
150052177|NCT00101452|541332878|FG001|Overall Study|Physician Decision|3|||
150052178|NCT00101452|541332879|FG002|Overall Study|Physician Decision|2|||
150052179|NCT00101452|541332877|FG000|Overall Study|Protocol Violation|2|||
150052180|NCT00101452|541332878|FG001|Overall Study|Protocol Violation|1|||
150052181|NCT00101452|541332879|FG002|Overall Study|Protocol Violation|3|||
150052182|NCT00101452|541332877|FG000|Overall Study|Other|15|||
150052183|NCT00101452|541332878|FG001|Overall Study|Other|16|||
149976192|NCT00811720|541049553|FG000|All Treated Patients|Non-compliance|0|||
149976193|NCT00811720|541049554|FG001|All Treated Patients|Non-compliance|14|||
149976194|NCT00811720|541049553|FG000|All Treated Patients|Protocol Violation|9|||
149976195|NCT00811720|541049554|FG001|All Treated Patients|Protocol Violation|16|||
149976196|NCT00811720|541049553|FG000|All Treated Patients|Withdrawal by Subject|28|||
149976197|NCT00811720|541049554|FG001|All Treated Patients|Withdrawal by Subject|34|||
149976198|NCT00811720|541049553|FG000|All Treated Patients|Lost to Follow-up|10|||
149976199|NCT00811720|541049554|FG001|All Treated Patients|Lost to Follow-up|16|||
149976200|NCT00811720|541049553|FG000|All Treated Patients|Other Reason|7|||
149976201|NCT00811720|541049554|FG001|All Treated Patients|Other Reason|4|||
149976202|NCT01077063|541049555|FG000|Overall Study|Adverse Event|3|||
149976203|NCT01077063|541049556|FG001|Overall Study|Adverse Event|0|||
149976204|NCT01077063|541049555|FG000|Overall Study|Death|1|||
149976205|NCT01077063|541049556|FG001|Overall Study|Death|1|||
149976206|NCT01077063|541049555|FG000|Overall Study|Withdrawal by Subject|0|||
149976207|NCT01077063|541049556|FG001|Overall Study|Withdrawal by Subject|2|||
149976208|NCT02750930|541049557|FG000|Overall Study|Study closed/terminated|8|||
149976209|NCT00553631|541049558|FG000|Overall Study|Withdrawal by Subject|0|||
149976210|NCT00553631|541049559|FG001|Overall Study|Withdrawal by Subject|1|||
149976211|NCT00553631|541049558|FG000|Overall Study|Lost to Follow-up|1|||
149976212|NCT00553631|541049559|FG001|Overall Study|Lost to Follow-up|0|||
149976213|NCT00552071|541051289|FG000|Overall Study|Adverse Event|1|||
149976214|NCT00552071|541051290|FG001|Overall Study|Adverse Event|0|||
149976215|NCT00552071|541051289|FG000|Overall Study|Lack of Efficacy|1|||
149976216|NCT00552071|541051290|FG001|Overall Study|Lack of Efficacy|0|||
149976217|NCT00552071|541051289|FG000|Overall Study|Physician Decision|1|||
149976218|NCT00552071|541051290|FG001|Overall Study|Physician Decision|0|||
149976219|NCT00552071|541051289|FG000|Overall Study|Pregnancy|1|||
149976220|NCT00552071|541051290|FG001|Overall Study|Pregnancy|0|||
149976221|NCT00552071|541051289|FG000|Overall Study|Death|0|||
149976222|NCT00552071|541051290|FG001|Overall Study|Death|1|||
149976223|NCT00552071|541051289|FG000|Overall Study|Withdrawal by Subject|0|||
150178343|NCT03764475|541790401|FG001|Overall Study|Withdrawal by Subject|10|||
150178344|NCT03764475|541790400|FG000|Overall Study|Lack of Efficacy|3|||
150178345|NCT03764475|541790401|FG001|Overall Study|Lack of Efficacy|0|||
150178346|NCT03764475|541790400|FG000|Overall Study|COVID-19 Disruption|2|||
150178347|NCT03764475|541790401|FG001|Overall Study|COVID-19 Disruption|0|||
150178348|NCT02574455|541790402|FG000|Overall Study|Death|197|||
150178349|NCT02574455|541790403|FG001|Overall Study|Death|210|||
150178350|NCT02574455|541790402|FG000|Overall Study|Withdrawal of Consent|11|||
150178351|NCT02574455|541790403|FG001|Overall Study|Withdrawal of Consent|28|||
150178352|NCT02574455|541790402|FG000|Overall Study|Lost to Follow-up|4|||
150178353|NCT02574455|541790403|FG001|Overall Study|Lost to Follow-up|4|||
150178354|NCT02574455|541790402|FG000|Overall Study|Sponsor's Decision|55|||
150178355|NCT02574455|541790403|FG001|Overall Study|Sponsor's Decision|20|||
150178356|NCT01373346|541790410|FG000|Overall Study|Death|1|||
150178357|NCT01198028|541790411|FG000|Overall Study|Adverse Event|5|||
150178358|NCT01198028|541790411|FG000|Overall Study|Death|3|||
150178359|NCT01198028|541790411|FG000|Overall Study|Physician Decision|2|||
150178360|NCT00970359|541790413|FG000|Overall Study|Not Treated|4|||
150178361|NCT01759771|541790414|FG000|Overall Study|Withdrawal by Subject|1|||
150178362|NCT01759771|541790415|FG001|Overall Study|Withdrawal by Subject|1|||
150178363|NCT03887650|541790418|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
150178364|NCT03887650|541790419|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
150178365|NCT03887650|541790418|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
150178366|NCT03887650|541790419|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
150178367|NCT03887650|541790418|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
150178368|NCT03887650|541790419|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
150178369|NCT01170962|541790420|FG000|Treatment Period|Lack of Efficacy|96|||
149976224|NCT00552071|541051290|FG001|Overall Study|Withdrawal by Subject|1|||
149976225|NCT00937495|541051295|FG000|Overall Study|Protocol Violation|2|||
149976226|NCT00441272|541051296|FG000|Overall Study|Study terminated prior to enrollment|25|||
149976227|NCT00441272|541051297|FG001|Overall Study|Study terminated prior to enrollment|25|||
149976228|NCT05518461|541051298|FG000|Overall Study|Lost to Follow-up|25|||
149976229|NCT00382174|541051300|FG000|Overall Study|Lost to Follow-up|1|||
149976230|NCT00382174|541051301|FG001|Overall Study|Lost to Follow-up|4|||
150052184|NCT00101452|541332879|FG002|Overall Study|Other|12|||
150052185|NCT01994889|541332880|FG000|Overall Study|Adverse Event|5|||
150178370|NCT01170962|541790421|FG001|Treatment Period|Lack of Efficacy|91|||
150178371|NCT01170962|541790422|FG002|Treatment Period|Lack of Efficacy|7|||
150178372|NCT01170962|541790420|FG000|Treatment Period|Adverse Event|11|||
150178373|NCT01170962|541790421|FG001|Treatment Period|Adverse Event|12|||
149976231|NCT00382174|541051302|FG002|Overall Study|Lost to Follow-up|5|||
149976232|NCT00382174|541051300|FG000|Overall Study|Adverse Event|1|||
149976233|NCT00382174|541051301|FG001|Overall Study|Adverse Event|4|||
149976234|NCT00382174|541051302|FG002|Overall Study|Adverse Event|5|||
149976235|NCT00382174|541051300|FG000|Overall Study|Withdrawal by Subject|1|||
149976236|NCT00382174|541051301|FG001|Overall Study|Withdrawal by Subject|4|||
149976237|NCT00382174|541051302|FG002|Overall Study|Withdrawal by Subject|5|||
149976238|NCT00382174|541051300|FG000|Overall Study|Non compliance|1|||
149976239|NCT00382174|541051301|FG001|Overall Study|Non compliance|0|||
149976240|NCT00382174|541051302|FG002|Overall Study|Non compliance|1|||
149976241|NCT00382174|541051300|FG000|Overall Study|Physician Decision|0|||
149976242|NCT00382174|541051301|FG001|Overall Study|Physician Decision|2|||
149976243|NCT00382174|541051302|FG002|Overall Study|Physician Decision|2|||
149976244|NCT00382174|541051300|FG000|Overall Study|Failed to meet criteria|0|||
149976245|NCT00382174|541051301|FG001|Overall Study|Failed to meet criteria|1|||
149976246|NCT00382174|541051302|FG002|Overall Study|Failed to meet criteria|1|||
149976247|NCT00382174|541051300|FG000|Overall Study|Wounds merged|0|||
149976248|NCT00382174|541051301|FG001|Overall Study|Wounds merged|2|||
149976249|NCT00382174|541051302|FG002|Overall Study|Wounds merged|2|||
149976250|NCT03894891|541051306|FG000|Overall Study|Withdrawal by Subject|1|||
149976251|NCT03894891|541051306|FG000|Overall Study|Completed protocol treatment per protocol|5|||
149976252|NCT03768427|541051311|FG000|Overall Study|Death|0|||
149976253|NCT03768427|541051312|FG001|Overall Study|Death|0|||
149976254|NCT03768427|541051313|FG002|Overall Study|Death|1|||
149976255|NCT03768427|541051314|FG003|Overall Study|Death|0|||
149976256|NCT03768427|541051311|FG000|Overall Study|Lost to Follow-up|2|||
149976257|NCT03768427|541051312|FG001|Overall Study|Lost to Follow-up|0|||
149976258|NCT03768427|541051313|FG002|Overall Study|Lost to Follow-up|0|||
149976259|NCT03768427|541051314|FG003|Overall Study|Lost to Follow-up|0|||
149976260|NCT03768427|541051311|FG000|Overall Study|Physician Decision|3|||
149976261|NCT03768427|541051312|FG001|Overall Study|Physician Decision|2|||
149976262|NCT03768427|541051313|FG002|Overall Study|Physician Decision|4|||
149976263|NCT03768427|541051314|FG003|Overall Study|Physician Decision|4|||
149976264|NCT03768427|541051311|FG000|Overall Study|Withdrawal by Subject|7|||
149976265|NCT03768427|541051312|FG001|Overall Study|Withdrawal by Subject|2|||
149976266|NCT03768427|541051313|FG002|Overall Study|Withdrawal by Subject|6|||
149976267|NCT03768427|541051314|FG003|Overall Study|Withdrawal by Subject|7|||
149976268|NCT01644643|541051317|FG000|Overall Study|Death|1|||
149976269|NCT01644643|541051318|FG001|Overall Study|Death|0|||
149976270|NCT01644643|541051319|FG002|Overall Study|Death|3|||
149976271|NCT01644643|541051320|FG003|Overall Study|Death|3|||
149976272|NCT01644643|541051317|FG000|Overall Study|Lost to Follow-up|0|||
149976273|NCT01644643|541051318|FG001|Overall Study|Lost to Follow-up|0|||
149976274|NCT01644643|541051319|FG002|Overall Study|Lost to Follow-up|0|||
149976275|NCT01644643|541051320|FG003|Overall Study|Lost to Follow-up|4|||
149976276|NCT01644643|541051317|FG000|Overall Study|Withdrawal by Subject|1|||
149976277|NCT01644643|541051318|FG001|Overall Study|Withdrawal by Subject|0|||
149976278|NCT01644643|541051319|FG002|Overall Study|Withdrawal by Subject|2|||
149976279|NCT01644643|541051320|FG003|Overall Study|Withdrawal by Subject|1|||
149976280|NCT01644643|541051317|FG000|Overall Study|Other Eligibility criteria|0|||
149976281|NCT01644643|541051318|FG001|Overall Study|Other Eligibility criteria|0|||
149976282|NCT01644643|541051319|FG002|Overall Study|Other Eligibility criteria|0|||
149976283|NCT01644643|541051320|FG003|Overall Study|Other Eligibility criteria|2|||
149976284|NCT02756403|541051321|FG000|Overall Study|Unable to swallow medication|0|||
149976285|NCT02756403|541051322|FG001|Overall Study|Unable to swallow medication|1|||
149976286|NCT02756403|541051323|FG002|Overall Study|Unable to swallow medication|1|||
149976287|NCT02756403|541051324|FG003|Overall Study|Unable to swallow medication|1|||
149976288|NCT02756403|541051321|FG000|Overall Study|Did not complete Procedure|0|||
149976289|NCT02756403|541051322|FG001|Overall Study|Did not complete Procedure|1|||
149976290|NCT02756403|541051323|FG002|Overall Study|Did not complete Procedure|0|||
149976291|NCT02756403|541051324|FG003|Overall Study|Did not complete Procedure|0|||
149976292|NCT02756403|541051321|FG000|Overall Study|Changed Mind About Procedure|0|||
149976293|NCT02756403|541051322|FG001|Overall Study|Changed Mind About Procedure|0|||
149976294|NCT02756403|541051323|FG002|Overall Study|Changed Mind About Procedure|1|||
149976295|NCT02756403|541051324|FG003|Overall Study|Changed Mind About Procedure|0|||
149976296|NCT02756403|541051321|FG000|Overall Study|Protocol Violation|0|||
149976297|NCT02756403|541051322|FG001|Overall Study|Protocol Violation|1|||
149976298|NCT02756403|541051323|FG002|Overall Study|Protocol Violation|0|||
149976299|NCT02756403|541051324|FG003|Overall Study|Protocol Violation|1|||
149976300|NCT00527618|541051325|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
149976301|NCT00527618|541051326|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
149976302|NCT00527618|541051325|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
149976303|NCT00527618|541051326|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
149976304|NCT00527618|541051325|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
149976305|NCT00527618|541051326|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
149976306|NCT00527618|541051325|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
149976307|NCT00527618|541051326|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
149976308|NCT00527618|541051325|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
149976309|NCT00527618|541051326|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
149976310|NCT00527618|541051325|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
149976311|NCT00527618|541051326|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
149976312|NCT01490918|541051329|FG000|Overall Study|Lost to Follow-up|2|||
150178374|NCT01170962|541790422|FG002|Treatment Period|Adverse Event|3|||
150178375|NCT01170962|541790420|FG000|Treatment Period|Withdrawal by Subject|2|||
150178376|NCT01170962|541790421|FG001|Treatment Period|Withdrawal by Subject|1|||
150178377|NCT01170962|541790422|FG002|Treatment Period|Withdrawal by Subject|0|||
150178378|NCT01170962|541790420|FG000|Treatment Period|Lost to Follow-up|1|||
149976313|NCT01490918|541051330|FG001|Overall Study|Lost to Follow-up|1|||
149976314|NCT01490918|541051331|FG002|Overall Study|Lost to Follow-up|0|||
149976315|NCT01490918|541051329|FG000|Overall Study|Withdrawal by Subject|7|||
149976316|NCT01490918|541051330|FG001|Overall Study|Withdrawal by Subject|8|||
149976317|NCT01490918|541051331|FG002|Overall Study|Withdrawal by Subject|3|||
149976318|NCT01490918|541051329|FG000|Overall Study|Adverse Event|0|||
149976319|NCT01490918|541051330|FG001|Overall Study|Adverse Event|0|||
149976320|NCT01490918|541051331|FG002|Overall Study|Adverse Event|1|||
149976321|NCT01490918|541051329|FG000|Overall Study|other cause|4|||
149976322|NCT01490918|541051330|FG001|Overall Study|other cause|5|||
149976323|NCT01490918|541051331|FG002|Overall Study|other cause|8|||
149976324|NCT00776789|541051332|FG000|Overall Study|Consent refusal|2|||
149976325|NCT00776789|541051333|FG001|Overall Study|Consent refusal|2|||
149976326|NCT00776789|541051332|FG000|Overall Study|Poor quality video|1|||
149976327|NCT00776789|541051333|FG001|Overall Study|Poor quality video|1|||
149976328|NCT00648037|541051336|FG000|Overall Study|Not Treated|1|||
149976329|NCT00648037|541051336|FG000|Overall Study|Withdrawal by Subject|1|||
149976330|NCT00648037|541051336|FG000|Overall Study|Adverse Event|11|||
149976331|NCT00648037|541051336|FG000|Overall Study|Relapse|2|||
149976332|NCT00648037|541051336|FG000|Overall Study|Other|1|||
149976333|NCT02967679|541051337|FG000|Overall Study|Adverse Event|1|||
149976334|NCT03188263|541051342|FG000|Overall Study|Withdrawal by Subject|3|||
149976335|NCT03188263|541051343|FG001|Overall Study|Withdrawal by Subject|0|||
149976336|NCT03188263|541051342|FG000|Overall Study|Physician Decision|1|||
149976337|NCT03188263|541051343|FG001|Overall Study|Physician Decision|0|||
149976338|NCT00699413|541051344|FG000|Overall Study|Withdrawal by Subject|0|||
149976339|NCT00699413|541051345|FG001|Overall Study|Withdrawal by Subject|2|||
149976340|NCT00699413|541051344|FG000|Overall Study|Study terminated by sponsor|4|||
149976341|NCT00699413|541051345|FG001|Overall Study|Study terminated by sponsor|2|||
149976342|NCT02779777|541051346|FG000|Overall Study|Disease Progression|1|||
149976343|NCT02779777|541051347|FG001|Overall Study|Disease Progression|0|||
149976344|NCT02779777|541051348|FG002|Overall Study|Disease Progression|0|||
149976345|NCT02779777|541051346|FG000|Overall Study|Adverse Event|3|||
149976346|NCT02779777|541051347|FG001|Overall Study|Adverse Event|1|||
149976347|NCT02779777|541051348|FG002|Overall Study|Adverse Event|0|||
149976348|NCT02779777|541051346|FG000|Overall Study|Physician Decision|9|||
149976349|NCT02779777|541051347|FG001|Overall Study|Physician Decision|0|||
149976350|NCT02779777|541051348|FG002|Overall Study|Physician Decision|1|||
149976351|NCT02779777|541051346|FG000|Overall Study|Withdrawal by Subject|1|||
149976352|NCT02779777|541051347|FG001|Overall Study|Withdrawal by Subject|0|||
149976353|NCT02779777|541051348|FG002|Overall Study|Withdrawal by Subject|0|||
149976354|NCT00881894|541051349|FG000|Overall Study|Consent withdrawn|0|||
149976355|NCT00881894|541051350|FG001|Overall Study|Consent withdrawn|1|||
149976356|NCT00881894|541051349|FG000|Overall Study|Other reasons for premature termination|1|||
149976357|NCT00881894|541051350|FG001|Overall Study|Other reasons for premature termination|2|||
149976358|NCT00469833|541051352|FG000|Overall Study|No IV access|2|||
150178379|NCT01170962|541790421|FG001|Treatment Period|Lost to Follow-up|1|||
149976359|NCT01253369|541051353|FG000|Overall Study|Adverse Event|4|||
149976360|NCT01253369|541051353|FG000|Overall Study|Withdrawal by Subject|2|||
149976361|NCT01253369|541051353|FG000|Overall Study|Death|1|||
149976362|NCT01253369|541051353|FG000|Overall Study|Progressive disease|23|||
149976363|NCT01253369|541051353|FG000|Overall Study|Not Evaluable|3|||
149976364|NCT03289533|541051354|FG000|Overall Study|Death|12|||
149976365|NCT03289533|541051354|FG000|Overall Study|Terminated from study by sponsor|10|||
149976366|NCT00539240|541051355|FG000|Overall Study|Withdrawal by Subject|0|||
150178380|NCT01170962|541790422|FG002|Treatment Period|Lost to Follow-up|1|||
149976367|NCT00539240|541051356|FG001|Overall Study|Withdrawal by Subject|2|||
149976368|NCT00539240|541051357|FG002|Overall Study|Withdrawal by Subject|0|||
149976369|NCT00539240|541051355|FG000|Overall Study|Protocol Violation|1|||
149976370|NCT00539240|541051356|FG001|Overall Study|Protocol Violation|1|||
149976371|NCT00539240|541051357|FG002|Overall Study|Protocol Violation|4|||
149976372|NCT00539240|541051355|FG000|Overall Study|Lost to Follow-up|2|||
150178381|NCT01170962|541790420|FG000|Treatment Period|Participant no longer meets criteria|0|||
150178382|NCT01170962|541790421|FG001|Treatment Period|Participant no longer meets criteria|1|||
150178383|NCT01170962|541790422|FG002|Treatment Period|Participant no longer meets criteria|0|||
150178384|NCT01170962|541790420|FG000|Treatment Period|Request to discontinue treatment|7|||
150178385|NCT01170962|541790421|FG001|Treatment Period|Request to discontinue treatment|3|||
149976373|NCT00539240|541051356|FG001|Overall Study|Lost to Follow-up|3|||
149976374|NCT00539240|541051357|FG002|Overall Study|Lost to Follow-up|1|||
149976375|NCT00539240|541051355|FG000|Overall Study|Adverse Event|3|||
149976376|NCT00539240|541051356|FG001|Overall Study|Adverse Event|1|||
149976377|NCT00539240|541051357|FG002|Overall Study|Adverse Event|10|||
149976378|NCT01284959|541051359|FG000|Overall Study|Withdrawal by Subject|1|||
149976379|NCT01284959|541051360|FG001|Overall Study|Withdrawal by Subject|0|||
149976380|NCT01284959|541051361|FG002|Overall Study|Withdrawal by Subject|0|||
149976381|NCT01284959|541051359|FG000|Overall Study|Adverse Event|0|||
149976382|NCT01284959|541051360|FG001|Overall Study|Adverse Event|0|||
149976383|NCT01284959|541051361|FG002|Overall Study|Adverse Event|1|||
150178386|NCT01170962|541790422|FG002|Treatment Period|Request to discontinue treatment|1|||
150178387|NCT01170962|541790420|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
150178388|NCT01170962|541790421|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
150178389|NCT01170962|541790422|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
150178390|NCT01170962|541790420|FG000|Follow up Period|Withdrawal by Subject|14|||
150178391|NCT01170962|541790421|FG001|Follow up Period|Withdrawal by Subject|10|||
150178392|NCT01170962|541790422|FG002|Follow up Period|Withdrawal by Subject|2|||
150178393|NCT01170962|541790420|FG000|Follow up Period|Lost to Follow-up|13|||
150178394|NCT01170962|541790421|FG001|Follow up Period|Lost to Follow-up|8|||
150178395|NCT01170962|541790422|FG002|Follow up Period|Lost to Follow-up|1|||
150178396|NCT01170962|541790420|FG000|Follow up Period|Death|2|||
150178397|NCT01170962|541790421|FG001|Follow up Period|Death|2|||
150178398|NCT01170962|541790422|FG002|Follow up Period|Death|0|||
150178399|NCT01170962|541790420|FG000|Follow up Period|Others|10|||
150178400|NCT01170962|541790421|FG001|Follow up Period|Others|7|||
150178401|NCT01170962|541790422|FG002|Follow up Period|Others|3|||
150178402|NCT00716859|541790429|FG000|Overall Study|Adverse Event|4|||
150178403|NCT00716859|541790430|FG001|Overall Study|Adverse Event|1|||
150178404|NCT00716859|541790429|FG000|Overall Study|Lack of Efficacy|3|||
150178405|NCT00716859|541790430|FG001|Overall Study|Lack of Efficacy|0|||
150178406|NCT00716859|541790429|FG000|Overall Study|Withdrawal by Subject|1|||
150178407|NCT00716859|541790430|FG001|Overall Study|Withdrawal by Subject|3|||
150178408|NCT00716859|541790429|FG000|Overall Study|Not treated|1|||
150178409|NCT00716859|541790430|FG001|Overall Study|Not treated|1|||
150178410|NCT00411216|541790441|FG000|Overall Study|Ten participants were entered into the c|0|||
150178411|NCT00411216|541790442|FG001|Overall Study|Ten participants were entered into the c|2|||
150178412|NCT01251354|541790446|FG000|Overall Study|Adverse Event|1|||
150178413|NCT01251354|541790446|FG000|Overall Study|Investigator's Decision|1|||
150178414|NCT01251354|541790446|FG000|Overall Study|Disease Progression|4|||
150178415|NCT03422276|541791909|FG000|Overall Study|Withdrawal by Subject|21|||
150178416|NCT03422276|541791910|FG001|Overall Study|Withdrawal by Subject|25|||
150178417|NCT03422276|541791911|FG002|Overall Study|Withdrawal by Subject|14|||
150178418|NCT03422276|541791912|FG003|Overall Study|Withdrawal by Subject|16|||
150178419|NCT03422276|541791909|FG000|Overall Study|Death|14|||
150178420|NCT03422276|541791910|FG001|Overall Study|Death|21|||
150178421|NCT03422276|541791911|FG002|Overall Study|Death|3|||
150178422|NCT03422276|541791912|FG003|Overall Study|Death|1|||
150178423|NCT03422276|541791909|FG000|Overall Study|Discontinued, ineligible|4|||
150178424|NCT03422276|541791910|FG001|Overall Study|Discontinued, ineligible|3|||
150178425|NCT03422276|541791911|FG002|Overall Study|Discontinued, ineligible|0|||
150178426|NCT03422276|541791912|FG003|Overall Study|Discontinued, ineligible|0|||
150178427|NCT03422276|541791909|FG000|Overall Study|Lost to Follow-up|15|||
149976384|NCT01055613|541051362|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
149976385|NCT01055613|541051363|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150178428|NCT03422276|541791910|FG001|Overall Study|Lost to Follow-up|8|||
150178429|NCT03422276|541791911|FG002|Overall Study|Lost to Follow-up|13|||
150178430|NCT03422276|541791912|FG003|Overall Study|Lost to Follow-up|4|||
150178431|NCT03422276|541791909|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
150178432|NCT03422276|541791910|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
150178433|NCT03422276|541791911|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
150178434|NCT03422276|541791912|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
150178435|NCT03422276|541791909|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
150178436|NCT03422276|541791910|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
149976386|NCT01055613|541051362|FG000|Overall Study|Unacceptable lens fit|1|||
149976387|NCT01055613|541051363|FG001|Overall Study|Unacceptable lens fit|0|||
149976388|NCT01055613|541051362|FG000|Overall Study|Discomfort|2|||
149976389|NCT01055613|541051363|FG001|Overall Study|Discomfort|1|||
149976390|NCT01055613|541051362|FG000|Overall Study|Lost to Follow-up|1|||
149976391|NCT01055613|541051363|FG001|Overall Study|Lost to Follow-up|1|||
150178437|NCT03422276|541791911|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
150178438|NCT03422276|541791912|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
150178439|NCT03422276|541791909|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
150178440|NCT03422276|541791910|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
150178441|NCT03422276|541791911|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
150178442|NCT03422276|541791912|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
150178443|NCT03422276|541791909|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
150178444|NCT03422276|541791910|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
150178445|NCT03422276|541791911|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
150178446|NCT03422276|541791912|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
150178447|NCT03422276|541791909|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
149976392|NCT01055613|541051362|FG000|Overall Study|Protocol Violation|1|||
149976393|NCT01055613|541051363|FG001|Overall Study|Protocol Violation|1|||
149976394|NCT01055613|541051362|FG000|Overall Study|Subject Disinterest|1|||
149976395|NCT01055613|541051363|FG001|Overall Study|Subject Disinterest|1|||
149976396|NCT00363311|541051364|FG000|Overall Study|Adverse Event|6|||
149976397|NCT00363311|541051365|FG001|Overall Study|Adverse Event|4|||
149976398|NCT00363311|541051364|FG000|Overall Study|Lost to Follow-up|3|||
149976399|NCT00363311|541051365|FG001|Overall Study|Lost to Follow-up|0|||
149976400|NCT00363311|541051364|FG000|Overall Study|Protocol Violation|1|||
149976401|NCT00363311|541051365|FG001|Overall Study|Protocol Violation|2|||
149976402|NCT00363311|541051364|FG000|Overall Study|Withdrawal by Subject|12|||
149976403|NCT00363311|541051365|FG001|Overall Study|Withdrawal by Subject|6|||
149976404|NCT00363311|541051364|FG000|Overall Study|Physician Decision|1|||
149976405|NCT00363311|541051365|FG001|Overall Study|Physician Decision|1|||
149976406|NCT00363311|541051364|FG000|Overall Study|Sponsor Terminated Study|2|||
149976407|NCT00363311|541051365|FG001|Overall Study|Sponsor Terminated Study|2|||
149976408|NCT00363311|541051364|FG000|Overall Study|Disease Progression|46|||
149976409|NCT00363311|541051365|FG001|Overall Study|Disease Progression|26|||
149976410|NCT00363311|541051364|FG000|Overall Study|Non-Compliance|1|||
149976411|NCT00363311|541051365|FG001|Overall Study|Non-Compliance|1|||
149976412|NCT00363311|541051364|FG000|Overall Study|Participant Refused Biopsy|1|||
150178448|NCT03422276|541791910|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
150178449|NCT03422276|541791911|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
150178450|NCT03422276|541791912|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
150178451|NCT03237481|541791919|FG000|Overall Study|Lost to Follow-up|1|||
150178452|NCT03237481|541791920|FG001|Overall Study|Lost to Follow-up|0|||
150178453|NCT03237481|541791921|FG002|Overall Study|Lost to Follow-up|0|||
150178454|NCT03237481|541791919|FG000|Overall Study|Protocol Violation|1|||
150178455|NCT03237481|541791920|FG001|Overall Study|Protocol Violation|0|||
150178456|NCT03237481|541791921|FG002|Overall Study|Protocol Violation|0|||
150178457|NCT03237481|541791919|FG000|Overall Study|Withdrawal by Subject|3|||
150178458|NCT03237481|541791920|FG001|Overall Study|Withdrawal by Subject|2|||
150178459|NCT03237481|541791921|FG002|Overall Study|Withdrawal by Subject|1|||
150178460|NCT03481777|541791922|FG000|Overall Study|Withdrawal by Subject|36|||
150178461|NCT03481777|541791923|FG001|Overall Study|Withdrawal by Subject|31|||
150178462|NCT03481777|541791922|FG000|Overall Study|Non stroke = non target population|277|||
150178463|NCT03481777|541791923|FG001|Overall Study|Non stroke = non target population|254|||
149737493|NCT02601950|540170379|FG002|Overall Study|Non-compliance|0|||
149976413|NCT00363311|541051365|FG001|Overall Study|Participant Refused Biopsy|0|||
149976414|NCT00363311|541051364|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
149976415|NCT00363311|541051365|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
149976416|NCT00363311|541051364|FG000|Overall Study|Participant Opted for Treatment|1|||
149976417|NCT00363311|541051365|FG001|Overall Study|Participant Opted for Treatment|0|||
149976418|NCT00363311|541051364|FG000|Overall Study|Participant Moved to Another Country|1|||
149976419|NCT00363311|541051365|FG001|Overall Study|Participant Moved to Another Country|0|||
149976420|NCT00363311|541051364|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
150178464|NCT04139668|541791928|FG000|Overall Study|Withdrawal by Subject|1|||
149976421|NCT00363311|541051365|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
149976422|NCT00363311|541051364|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
149976423|NCT00363311|541051365|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
149976424|NCT00363311|541051364|FG000|Overall Study|Participant Moved to Louisiana|0|||
149976425|NCT00363311|541051365|FG001|Overall Study|Participant Moved to Louisiana|1|||
149976426|NCT00401843|541051366|FG000|Overall Study|Achieved Complete Response|1|||
149976427|NCT00401843|541051367|FG001|Overall Study|Achieved Complete Response|5|||
149976428|NCT00401843|541051368|FG002|Overall Study|Achieved Complete Response|11|||
149976429|NCT00401843|541051366|FG000|Overall Study|Adverse Event|7|||
149976430|NCT00401843|541051367|FG001|Overall Study|Adverse Event|26|||
149976431|NCT00401843|541051368|FG002|Overall Study|Adverse Event|27|||
149976432|NCT00401843|541051366|FG000|Overall Study|Death|0|||
149976433|NCT00401843|541051367|FG001|Overall Study|Death|8|||
149976434|NCT00401843|541051368|FG002|Overall Study|Death|10|||
149976435|NCT00401843|541051366|FG000|Overall Study|Disease progression|10|||
149976436|NCT00401843|541051367|FG001|Overall Study|Disease progression|60|||
149976437|NCT00401843|541051368|FG002|Overall Study|Disease progression|49|||
149976438|NCT00401843|541051366|FG000|Overall Study|End of Study|1|||
149976439|NCT00401843|541051367|FG001|Overall Study|End of Study|1|||
149976440|NCT00401843|541051368|FG002|Overall Study|End of Study|2|||
149976441|NCT00401843|541051366|FG000|Overall Study|Lost to Follow-up|0|||
149976442|NCT00401843|541051367|FG001|Overall Study|Lost to Follow-up|0|||
149976443|NCT00401843|541051368|FG002|Overall Study|Lost to Follow-up|2|||
149976444|NCT00401843|541051366|FG000|Overall Study|Other Unspecified|0|||
149976445|NCT00401843|541051367|FG001|Overall Study|Other Unspecified|3|||
149976446|NCT00401843|541051368|FG002|Overall Study|Other Unspecified|5|||
149976447|NCT00401843|541051366|FG000|Overall Study|Physician Decision|0|||
149976448|NCT00401843|541051367|FG001|Overall Study|Physician Decision|16|||
149976449|NCT00401843|541051368|FG002|Overall Study|Physician Decision|10|||
149976450|NCT00401843|541051366|FG000|Overall Study|Protocol Violation|0|||
149976451|NCT00401843|541051367|FG001|Overall Study|Protocol Violation|0|||
149976452|NCT00401843|541051368|FG002|Overall Study|Protocol Violation|1|||
149976453|NCT00401843|541051366|FG000|Overall Study|Withdrawal by Subject|1|||
149976454|NCT00401843|541051367|FG001|Overall Study|Withdrawal by Subject|5|||
149976455|NCT00401843|541051368|FG002|Overall Study|Withdrawal by Subject|5|||
149976456|NCT00401843|541051366|FG000|Overall Study|Withdrawal of consent to study agent|1|||
149976457|NCT00401843|541051367|FG001|Overall Study|Withdrawal of consent to study agent|15|||
149976458|NCT00401843|541051368|FG002|Overall Study|Withdrawal of consent to study agent|17|||
149976459|NCT00401843|541051366|FG000|Overall Study|Randomized but not Treated|0|||
149976460|NCT00401843|541051367|FG001|Overall Study|Randomized but not Treated|2|||
149976461|NCT00401843|541051368|FG002|Overall Study|Randomized but not Treated|3|||
149976462|NCT00401843|541051366|FG000|Overall Study|Received incorrect treatment|0|||
149976463|NCT00401843|541051367|FG001|Overall Study|Received incorrect treatment|3|||
149976464|NCT00401843|541051368|FG002|Overall Study|Received incorrect treatment|0|||
149976465|NCT02629861|541051372|FG000|Overall Study|Adverse Event|7|||
149976466|NCT02629861|541051373|FG001|Overall Study|Adverse Event|5|||
149976467|NCT02629861|541051374|FG002|Overall Study|Adverse Event|4|||
149976468|NCT02629861|541051372|FG000|Overall Study|Withdrawal by Subject|5|||
149976469|NCT02629861|541051373|FG001|Overall Study|Withdrawal by Subject|8|||
149976470|NCT02629861|541051374|FG002|Overall Study|Withdrawal by Subject|13|||
149976471|NCT02629861|541051372|FG000|Overall Study|Protocol Violation|2|||
149976472|NCT02629861|541051373|FG001|Overall Study|Protocol Violation|3|||
149976473|NCT02629861|541051374|FG002|Overall Study|Protocol Violation|7|||
149976474|NCT02629861|541051372|FG000|Overall Study|Lost to Follow-up|12|||
149976475|NCT02629861|541051373|FG001|Overall Study|Lost to Follow-up|9|||
149976476|NCT02629861|541051374|FG002|Overall Study|Lost to Follow-up|4|||
149976477|NCT02629861|541051372|FG000|Overall Study|Other|1|||
149976478|NCT02629861|541051373|FG001|Overall Study|Other|1|||
149976479|NCT02629861|541051374|FG002|Overall Study|Other|0|||
149976480|NCT02629861|541051372|FG000|Overall Study|Pregnancy|2|||
149976481|NCT02629861|541051373|FG001|Overall Study|Pregnancy|1|||
149976482|NCT02629861|541051374|FG002|Overall Study|Pregnancy|0|||
149976483|NCT00959907|541051387|FG000|Overall Study|Protocol Violation|0|||
149976484|NCT00959907|541051388|FG001|Overall Study|Protocol Violation|1|||
149976485|NCT00959907|541051387|FG000|Overall Study|Adverse Event|1|||
149976486|NCT00959907|541051388|FG001|Overall Study|Adverse Event|0|||
149976487|NCT00959907|541051387|FG000|Overall Study|Withdrawal by Subject|2|||
149976488|NCT00959907|541051388|FG001|Overall Study|Withdrawal by Subject|0|||
149976489|NCT03958331|541051389|FG000|Overall Study|Withdrawal by Subject|3|||
149976490|NCT03958331|541051390|FG001|Overall Study|Withdrawal by Subject|1|||
149976491|NCT03958331|541051391|FG002|Overall Study|Withdrawal by Subject|5|||
149976492|NCT03958331|541051389|FG000|Overall Study|Weaned from medicine|2|||
149976493|NCT03958331|541051390|FG001|Overall Study|Weaned from medicine|0|||
149976494|NCT03958331|541051391|FG002|Overall Study|Weaned from medicine|0|||
149976495|NCT03958331|541051389|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
149976496|NCT03958331|541051390|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
149976497|NCT03958331|541051391|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
149976498|NCT00730886|541051392|FG000|Overall Study|Lost to Follow-up|1|||
149976499|NCT00730886|541051393|FG001|Overall Study|Lost to Follow-up|0|||
149976500|NCT00730886|541051392|FG000|Overall Study|Physician Decision|1|||
149976501|NCT00730886|541051393|FG001|Overall Study|Physician Decision|0|||
149976502|NCT01991483|541051394|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
149976503|NCT01991483|541051395|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
149976504|NCT01991483|541051396|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
149976505|NCT01991483|541051397|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
149976506|NCT01991483|541051394|FG000|Dose Level 600 mg|Physician Decision|0|||
149976507|NCT01991483|541051395|FG001|Dose Level 600 mg|Physician Decision|0|||
149976508|NCT01991483|541051396|FG002|Dose Level 600 mg|Physician Decision|1|||
149976509|NCT01991483|541051397|FG003|Dose Level 600 mg|Physician Decision|0|||
149976510|NCT01991483|541051394|FG000|Dose Level 1000 mg|Protocol Violation|0|||
149976511|NCT01991483|541051395|FG001|Dose Level 1000 mg|Protocol Violation|0|||
149976512|NCT01991483|541051396|FG002|Dose Level 1000 mg|Protocol Violation|0|||
149976513|NCT01991483|541051397|FG003|Dose Level 1000 mg|Protocol Violation|1|||
149976514|NCT02030821|541051400|FG000|Overall Study|Physician Decision|2|||
149976515|NCT02030821|541051401|FG001|Overall Study|Physician Decision|2|||
149976516|NCT02030821|541051402|FG002|Overall Study|Physician Decision|5|||
149976517|NCT02030821|541051403|FG003|Overall Study|Physician Decision|2|||
149976518|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
149976519|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
149976520|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
149976521|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
149976522|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
149976523|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
149976524|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
149976525|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
149976526|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
149976527|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
149976528|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
149976529|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
150052186|NCT01994889|541332881|FG001|Overall Study|Adverse Event|12|||
149976530|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
149976531|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
149976532|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
149976533|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
149976534|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
149976535|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
149976536|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
149976537|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
149976538|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
149976539|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
149976540|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
150052187|NCT01994889|541332882|FG002|Overall Study|Adverse Event|11|||
150052188|NCT01994889|541332880|FG000|Overall Study|Cardiac Device Implantation|0|||
149976541|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
150052189|NCT01994889|541332881|FG001|Overall Study|Cardiac Device Implantation|2|||
150052190|NCT01994889|541332882|FG002|Overall Study|Cardiac Device Implantation|0|||
150052191|NCT01994889|541332880|FG000|Overall Study|Organ Transplantation|1|||
149976542|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
150052192|NCT01994889|541332881|FG001|Overall Study|Organ Transplantation|5|||
149976543|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
149976544|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
149976545|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
149976546|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
149976547|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
149976548|NCT00716274|541051409|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
149976549|NCT00716274|541051410|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
149976550|NCT00716274|541051411|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
149976551|NCT00716274|541051412|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
149976552|NCT00716274|541051413|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
149976553|NCT00716274|541051414|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
149976554|NCT00716274|541051409|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
149976555|NCT00716274|541051410|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
149976556|NCT00716274|541051411|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
149976557|NCT00716274|541051412|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
149976558|NCT00716274|541051413|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
149976559|NCT00716274|541051414|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
149976560|NCT00716274|541051409|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
149976561|NCT00716274|541051410|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
149976562|NCT00716274|541051411|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
149976563|NCT00716274|541051412|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
149976564|NCT00716274|541051413|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
149976565|NCT00716274|541051414|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
149976566|NCT00716274|541051409|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
149976567|NCT00716274|541051410|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
149976568|NCT00716274|541051411|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
149976569|NCT00716274|541051412|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
149976570|NCT00716274|541051413|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
149976571|NCT00716274|541051414|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
149976572|NCT00716274|541051409|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
149976573|NCT00716274|541051410|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
149976574|NCT00716274|541051411|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
149976575|NCT00716274|541051412|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
149976576|NCT00716274|541051413|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
149976577|NCT00716274|541051414|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
149976578|NCT01932788|541051415|FG000|Overall Study|Protocol Violation|18|||
149976579|NCT01932788|541051416|FG001|Overall Study|Protocol Violation|0|||
149976580|NCT01932788|541051415|FG000|Overall Study|Lost to Follow-up|18|||
149976581|NCT01932788|541051416|FG001|Overall Study|Lost to Follow-up|46|||
150178465|NCT05386238|541791934|FG000|Overall Study|Lost to Follow-up|3|||
149976582|NCT01932788|541051415|FG000|Overall Study|Lack of Efficacy|2|||
149976583|NCT01932788|541051416|FG001|Overall Study|Lack of Efficacy|0|||
149976584|NCT01932788|541051415|FG000|Overall Study|Withdrawal by Subject|0|||
149976585|NCT01932788|541051416|FG001|Overall Study|Withdrawal by Subject|5|||
149976586|NCT01171677|541051417|FG000|Overall Study|Withdrawal by Subject|0|||
149976587|NCT01171677|541051418|FG001|Overall Study|Withdrawal by Subject|3|||
149976588|NCT01171677|541051417|FG000|Overall Study|Adverse Event|1|||
149976589|NCT01171677|541051418|FG001|Overall Study|Adverse Event|0|||
149976590|NCT01171677|541051417|FG000|Overall Study|completed <70% IntenSati classes|5|||
149976591|NCT01171677|541051418|FG001|Overall Study|completed <70% IntenSati classes|0|||
149976592|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
149976593|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
149976594|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
150178466|NCT05386238|541791935|FG001|Overall Study|Lost to Follow-up|2|||
149976595|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
149976596|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
149976597|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
149976598|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
149976599|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
149976600|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
149976601|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
149976602|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
149976603|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
149976604|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
149976605|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
149976606|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
149976607|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
149976608|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
149976609|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
149976610|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
149976611|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
149976612|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
149976613|NCT04021290|541051424|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
149976614|NCT04021290|541051425|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
149976615|NCT04021290|541051426|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
149976616|NCT04021290|541051424|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
149976617|NCT04021290|541051425|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
149976618|NCT04021290|541051426|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
149976619|NCT04021290|541051424|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
149976620|NCT04021290|541051425|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
149976621|NCT04021290|541051426|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
149976622|NCT04021290|541051424|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
149976623|NCT04021290|541051425|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
149976624|NCT04021290|541051426|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
149976625|NCT04021290|541051424|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
149976626|NCT04021290|541051425|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
149976627|NCT04021290|541051426|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
149976628|NCT03391882|541051429|FG000|Study Overall|Adverse Event|3|||
149976629|NCT03391882|541051430|FG001|Study Overall|Adverse Event|6|||
149976630|NCT03391882|541051431|FG002|Study Overall|Adverse Event|1|||
149976631|NCT03391882|541051432|FG003|Study Overall|Adverse Event|1|||
149976632|NCT03391882|541051433|FG004|Study Overall|Adverse Event|3|||
149976633|NCT03391882|541051434|FG005|Study Overall|Adverse Event|1|||
149976634|NCT03391882|541051429|FG000|Study Overall|Lack of Efficacy|13|||
149976635|NCT03391882|541051430|FG001|Study Overall|Lack of Efficacy|9|||
149976636|NCT03391882|541051431|FG002|Study Overall|Lack of Efficacy|0|||
149976637|NCT03391882|541051432|FG003|Study Overall|Lack of Efficacy|0|||
149976638|NCT03391882|541051433|FG004|Study Overall|Lack of Efficacy|0|||
149976639|NCT03391882|541051434|FG005|Study Overall|Lack of Efficacy|0|||
149976640|NCT03391882|541051429|FG000|Study Overall|Withdrawal by Subject|3|||
149976641|NCT03391882|541051430|FG001|Study Overall|Withdrawal by Subject|3|||
149976642|NCT03391882|541051431|FG002|Study Overall|Withdrawal by Subject|2|||
149976643|NCT03391882|541051432|FG003|Study Overall|Withdrawal by Subject|2|||
149976644|NCT03391882|541051433|FG004|Study Overall|Withdrawal by Subject|1|||
149976645|NCT03391882|541051434|FG005|Study Overall|Withdrawal by Subject|3|||
149976646|NCT03391882|541051429|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
149976647|NCT03391882|541051430|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
149976648|NCT03391882|541051431|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
149976649|NCT03391882|541051432|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
149976650|NCT03391882|541051433|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
149976651|NCT03391882|541051434|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
149976652|NCT03391882|541051429|FG000|Study Overall|Protocol Violation|1|||
149976653|NCT03391882|541051430|FG001|Study Overall|Protocol Violation|0|||
150052193|NCT01994889|541332882|FG002|Overall Study|Organ Transplantation|5|||
150052194|NCT01994889|541332880|FG000|Overall Study|No longer willing to participate|8|||
150052195|NCT01994889|541332881|FG001|Overall Study|No longer willing to participate|17|||
150052196|NCT01994889|541332882|FG002|Overall Study|No longer willing to participate|37|||
150052197|NCT01994889|541332880|FG000|Overall Study|Lost to Follow-up|0|||
150052198|NCT01994889|541332881|FG001|Overall Study|Lost to Follow-up|1|||
150052199|NCT01994889|541332882|FG002|Overall Study|Lost to Follow-up|0|||
150052200|NCT01994889|541332880|FG000|Overall Study|Protocol Violation|0|||
149976654|NCT03391882|541051431|FG002|Study Overall|Protocol Violation|0|||
149976655|NCT03391882|541051432|FG003|Study Overall|Protocol Violation|0|||
150052201|NCT01994889|541332881|FG001|Overall Study|Protocol Violation|1|||
150052202|NCT01994889|541332882|FG002|Overall Study|Protocol Violation|1|||
150052203|NCT01994889|541332880|FG000|Overall Study|Death|14|||
150052204|NCT01994889|541332881|FG001|Overall Study|Death|25|||
150052205|NCT01994889|541332882|FG002|Overall Study|Death|38|||
150052206|NCT02969655|541332883|FG000|Overall Study|Withdrawal by Subject|3|||
150052207|NCT02969655|541332884|FG001|Overall Study|Withdrawal by Subject|2|||
150052208|NCT02969655|541332883|FG000|Overall Study|Physician Decision|4|||
150052209|NCT02969655|541332884|FG001|Overall Study|Physician Decision|3|||
150052210|NCT02969655|541332883|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
150052211|NCT02969655|541332884|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
150052212|NCT02969655|541332883|FG000|Overall Study|Adverse Event|10|||
150052213|NCT02969655|541332884|FG001|Overall Study|Adverse Event|8|||
150052214|NCT01510769|541332885|FG000|Overall Study|Adverse Event|7|||
150052215|NCT01510769|541332886|FG001|Overall Study|Adverse Event|6|||
150052216|NCT01510769|541332887|FG002|Overall Study|Adverse Event|4|||
150052217|NCT01510769|541332885|FG000|Overall Study|Gout Flare|0|||
150052218|NCT01510769|541332886|FG001|Overall Study|Gout Flare|3|||
150052219|NCT01510769|541332887|FG002|Overall Study|Gout Flare|1|||
150052220|NCT01510769|541332885|FG000|Overall Study|Protocol Violation|11|||
150052221|NCT01510769|541332886|FG001|Overall Study|Protocol Violation|10|||
150052222|NCT01510769|541332887|FG002|Overall Study|Protocol Violation|9|||
150052223|NCT01510769|541332885|FG000|Overall Study|Lost to Follow-up|5|||
150052224|NCT01510769|541332886|FG001|Overall Study|Lost to Follow-up|1|||
150052225|NCT01510769|541332887|FG002|Overall Study|Lost to Follow-up|5|||
150052226|NCT01510769|541332885|FG000|Overall Study|Withdrawal by Subject|3|||
150052227|NCT01510769|541332886|FG001|Overall Study|Withdrawal by Subject|4|||
149976656|NCT03391882|541051433|FG004|Study Overall|Protocol Violation|0|||
149976657|NCT03391882|541051434|FG005|Study Overall|Protocol Violation|0|||
149976658|NCT03391882|541051429|FG000|Part A - Titration Phase|Adverse Event|3|||
149976659|NCT03391882|541051430|FG001|Part A - Titration Phase|Adverse Event|6|||
149976660|NCT03391882|541051431|FG002|Part A - Titration Phase|Adverse Event|0|||
149976661|NCT03391882|541051432|FG003|Part A - Titration Phase|Adverse Event|0|||
149976662|NCT03391882|541051433|FG004|Part A - Titration Phase|Adverse Event|0|||
149976663|NCT03391882|541051434|FG005|Part A - Titration Phase|Adverse Event|0|||
149976664|NCT03391882|541051429|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
149976665|NCT03391882|541051430|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
149976666|NCT03391882|541051431|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
149976667|NCT03391882|541051432|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
149976668|NCT03391882|541051433|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
149976669|NCT03391882|541051434|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
149976670|NCT03391882|541051429|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
149976671|NCT03391882|541051430|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
149976672|NCT03391882|541051431|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
149976673|NCT03391882|541051432|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
149976674|NCT03391882|541051433|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
149976675|NCT03391882|541051434|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
149976676|NCT03391882|541051429|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
149976677|NCT03391882|541051430|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
149976678|NCT03391882|541051431|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
149976679|NCT03391882|541051432|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
149976680|NCT03391882|541051433|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
149976681|NCT03391882|541051434|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
149976682|NCT03391882|541051429|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
149976683|NCT03391882|541051430|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
149976684|NCT03391882|541051431|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
149976685|NCT03391882|541051432|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
149976686|NCT03391882|541051433|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
149976687|NCT03391882|541051434|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
149976688|NCT03391882|541051429|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
149976689|NCT03391882|541051430|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
149976690|NCT03391882|541051431|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
149976691|NCT03391882|541051432|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
149976692|NCT03391882|541051433|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
149976693|NCT03391882|541051434|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
149976694|NCT03391882|541051429|FG000|Part B - Treatment Phase|Adverse Event|0|||
149976695|NCT03391882|541051430|FG001|Part B - Treatment Phase|Adverse Event|0|||
149976696|NCT03391882|541051431|FG002|Part B - Treatment Phase|Adverse Event|1|||
149976697|NCT03391882|541051432|FG003|Part B - Treatment Phase|Adverse Event|1|||
149976698|NCT03391882|541051433|FG004|Part B - Treatment Phase|Adverse Event|3|||
150052228|NCT01510769|541332887|FG002|Overall Study|Withdrawal by Subject|3|||
150052229|NCT01510769|541332885|FG000|Overall Study|Death|1|||
150052230|NCT01510769|541332886|FG001|Overall Study|Death|1|||
150052231|NCT01510769|541332887|FG002|Overall Study|Death|0|||
150052232|NCT02674204|541332888|FG000|Overall Study|Adverse Event|1|||
150052233|NCT02674204|541332889|FG001|Overall Study|Adverse Event|0|||
149976699|NCT03391882|541051434|FG005|Part B - Treatment Phase|Adverse Event|1|||
149976700|NCT03391882|541051429|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
149976701|NCT03391882|541051430|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
149976702|NCT03391882|541051431|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
149976703|NCT03391882|541051432|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
149976704|NCT03391882|541051433|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
149976705|NCT03391882|541051434|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
149976706|NCT03092479|541051435|FG000|Overall Study|Lost to Follow-up|3|||
149976707|NCT03092479|541051436|FG001|Overall Study|Lost to Follow-up|2|||
149976708|NCT03092479|541051435|FG000|Overall Study|Withdrawal by Subject|4|||
149976709|NCT03092479|541051436|FG001|Overall Study|Withdrawal by Subject|0|||
149976710|NCT04422431|541051439|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
149976711|NCT04422431|541051439|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
149976712|NCT04422431|541051439|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
149976713|NCT04422431|541051439|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
149976714|NCT04422431|541051439|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
150178467|NCT05386238|541791934|FG000|Overall Study|Withdrawal by Subject|0|||
150178468|NCT05386238|541791935|FG001|Overall Study|Withdrawal by Subject|1|||
150178469|NCT04907474|541791936|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
150178470|NCT04907474|541791937|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
150178471|NCT01353313|541791938|FG000|Overall Study|Lost to Follow-up|22|||
150178472|NCT01353313|541791939|FG001|Overall Study|Lost to Follow-up|23|||
150178473|NCT01353313|541791938|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
150178474|NCT01353313|541791939|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
150178475|NCT03613740|541791940|FG000|Overall Study|Lost to Follow-up|1|||
150178476|NCT03613740|541791941|FG001|Overall Study|Lost to Follow-up|1|||
150178477|NCT00610649|541791945|FG000|Overall Study|Adverse Event|1|||
150178478|NCT00610649|541791946|FG001|Overall Study|Adverse Event|0|||
150178479|NCT00610649|541791947|FG002|Overall Study|Adverse Event|0|||
150178480|NCT00610649|541791948|FG003|Overall Study|Adverse Event|0|||
150178481|NCT00610649|541791949|FG004|Overall Study|Adverse Event|0|||
150178482|NCT00610649|541791950|FG005|Overall Study|Adverse Event|0|||
150178483|NCT00610649|541791951|FG006|Overall Study|Adverse Event|0|||
150178484|NCT00610649|541791952|FG007|Overall Study|Adverse Event|0|||
150178485|NCT00610649|541791953|FG008|Overall Study|Adverse Event|0|||
150178486|NCT00610649|541791954|FG009|Overall Study|Adverse Event|0|||
150178487|NCT00610649|541791955|FG010|Overall Study|Adverse Event|1|||
150178488|NCT00610649|541791945|FG000|Overall Study|Family Emergency|0|||
150178489|NCT00610649|541791946|FG001|Overall Study|Family Emergency|1|||
150178490|NCT00610649|541791947|FG002|Overall Study|Family Emergency|0|||
150178491|NCT00610649|541791948|FG003|Overall Study|Family Emergency|0|||
150178492|NCT00610649|541791949|FG004|Overall Study|Family Emergency|0|||
150178493|NCT00610649|541791950|FG005|Overall Study|Family Emergency|0|||
150178494|NCT00610649|541791951|FG006|Overall Study|Family Emergency|0|||
150178495|NCT00610649|541791952|FG007|Overall Study|Family Emergency|0|||
150178496|NCT00610649|541791953|FG008|Overall Study|Family Emergency|0|||
150178497|NCT00610649|541791954|FG009|Overall Study|Family Emergency|0|||
150178498|NCT00610649|541791955|FG010|Overall Study|Family Emergency|0|||
150178499|NCT00610649|541791945|FG000|Overall Study|Withdrawal by Subject|0|||
150178500|NCT00610649|541791946|FG001|Overall Study|Withdrawal by Subject|0|||
149976715|NCT04422431|541051439|FG000|Extension Period (48 Weeks)|Other than specified|2|||
149976716|NCT03913130|541051440|FG000|Overall Study|Sponsor Decision|1|||
149976717|NCT01174563|541051441|FG000|Overall Study|Progressive Disease|45|||
149976718|NCT01174563|541051441|FG000|Overall Study|Death|5|||
149976719|NCT01174563|541051441|FG000|Overall Study|Investigator's Discretion|5|||
149976720|NCT01174563|541051441|FG000|Overall Study|Participant Withdrew Consent|3|||
149976721|NCT01174563|541051441|FG000|Overall Study|Rash Adverse Event|1|||
149976722|NCT01174563|541051441|FG000|Overall Study|Sponsor's decision|1|||
149976723|NCT00444106|541051442|FG000|Overall Study|Lost to Follow-up|2|||
149976724|NCT00444106|541051443|FG001|Overall Study|Lost to Follow-up|1|||
149976725|NCT00444106|541051444|FG002|Overall Study|Lost to Follow-up|0|||
149976726|NCT00444106|541051442|FG000|Overall Study|Abnormal Test Procedure Results|0|||
149976727|NCT00444106|541051443|FG001|Overall Study|Abnormal Test Procedure Results|0|||
149976728|NCT00444106|541051444|FG002|Overall Study|Abnormal Test Procedure Results|1|||
149976729|NCT02317627|541051447|FG000|Overall Study|Withdrawal by Subject|0|||
149976730|NCT02317627|541051448|FG001|Overall Study|Withdrawal by Subject|1|||
149976731|NCT02317627|541051449|FG002|Overall Study|Withdrawal by Subject|1|||
149976732|NCT02317627|541051447|FG000|Overall Study|Lost to Follow-up|2|||
149976733|NCT02317627|541051448|FG001|Overall Study|Lost to Follow-up|0|||
149976734|NCT02317627|541051449|FG002|Overall Study|Lost to Follow-up|0|||
149976735|NCT02317627|541051447|FG000|Overall Study|Stopped by Investigator|0|||
149976736|NCT02317627|541051448|FG001|Overall Study|Stopped by Investigator|1|||
149976737|NCT02317627|541051449|FG002|Overall Study|Stopped by Investigator|0|||
149976738|NCT02317627|541051447|FG000|Overall Study|Adverse Event|0|||
149976739|NCT02317627|541051448|FG001|Overall Study|Adverse Event|2|||
149976740|NCT02317627|541051449|FG002|Overall Study|Adverse Event|3|||
149976741|NCT02317627|541051447|FG000|Overall Study|Non-compliance with study drug|0|||
149976742|NCT02317627|541051448|FG001|Overall Study|Non-compliance with study drug|1|||
149976743|NCT02317627|541051449|FG002|Overall Study|Non-compliance with study drug|0|||
149976744|NCT00279214|541051450|FG000|Overall Study|Physician Decision|3|||
149976745|NCT00279214|541051451|FG001|Overall Study|Physician Decision|2|||
149976746|NCT01280968|541051452|FG000|Overall Study|Lost to Follow-up|8|||
149976747|NCT01280968|541051453|FG001|Overall Study|Lost to Follow-up|2|||
149976748|NCT01280968|541051452|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
149976749|NCT01280968|541051453|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
149976750|NCT01280968|541051452|FG000|Overall Study|Commuting Problems|2|||
149976751|NCT01280968|541051453|FG001|Overall Study|Commuting Problems|0|||
149976752|NCT01280968|541051452|FG000|Overall Study|Anxiety|2|||
149976753|NCT01280968|541051453|FG001|Overall Study|Anxiety|0|||
149976754|NCT01280968|541051452|FG000|Overall Study|Adverse Event|1|||
150178501|NCT00610649|541791947|FG002|Overall Study|Withdrawal by Subject|0|||
150178502|NCT00610649|541791948|FG003|Overall Study|Withdrawal by Subject|0|||
150178503|NCT00610649|541791949|FG004|Overall Study|Withdrawal by Subject|0|||
149976755|NCT01280968|541051453|FG001|Overall Study|Adverse Event|0|||
149976756|NCT01280968|541051452|FG000|Overall Study|Scheduling Conflicts|1|||
149976757|NCT01280968|541051453|FG001|Overall Study|Scheduling Conflicts|1|||
149976758|NCT01280968|541051452|FG000|Overall Study|Pre-existing Neurological Condition|1|||
149976759|NCT01280968|541051453|FG001|Overall Study|Pre-existing Neurological Condition|0|||
149976760|NCT01280968|541051452|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
149976761|NCT01280968|541051453|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
149976762|NCT00954447|541053393|FG000|Overall Study|Adverse Event|33|||
149976763|NCT00954447|541053394|FG001|Overall Study|Adverse Event|25|||
149976764|NCT00954447|541053393|FG000|Overall Study|Lack of Efficacy|17|||
149976765|NCT00954447|541053394|FG001|Overall Study|Lack of Efficacy|3|||
149976766|NCT00954447|541053393|FG000|Overall Study|Protocol Violation|5|||
149976767|NCT00954447|541053394|FG001|Overall Study|Protocol Violation|7|||
149976768|NCT00954447|541053393|FG000|Overall Study|Lost to Follow-up|8|||
149976769|NCT00954447|541053394|FG001|Overall Study|Lost to Follow-up|14|||
149976770|NCT00954447|541053393|FG000|Overall Study|Withdrawal by Subject|26|||
149976771|NCT00954447|541053394|FG001|Overall Study|Withdrawal by Subject|21|||
149976772|NCT00954447|541053393|FG000|Overall Study|Other|21|||
149976773|NCT00954447|541053394|FG001|Overall Study|Other|18|||
149976774|NCT04592341|541053395|FG000|Overall Study|Physician Decision|5|||
149976775|NCT04592341|541053395|FG000|Overall Study|Study Terminated by Sponsor|5|||
149976776|NCT04592341|541053395|FG000|Overall Study|Withdrawal by Subject|53|||
149976777|NCT04592341|541053395|FG000|Overall Study|Lost to Follow-up|3|||
149976778|NCT04592341|541053395|FG000|Overall Study|Death|1|||
149976779|NCT04592341|541053395|FG000|Overall Study|Adverse Event|5|||
149976780|NCT04592341|541053395|FG000|Overall Study|other|4|||
149976781|NCT00692003|541053396|FG000|Overall Study|Sponsor Decision|5|||
149976782|NCT00692003|541053397|FG001|Overall Study|Sponsor Decision|1|||
149976783|NCT01535287|541053398|FG000|Overall Study|drug not prepared in time|5|||
149976784|NCT01535287|541053399|FG001|Overall Study|drug not prepared in time|6|||
149976785|NCT03341637|541053402|FG000|Overall Study|Lost to Follow-up|1|||
149976786|NCT03341637|541053403|FG001|Overall Study|Lost to Follow-up|0|||
150178504|NCT00610649|541791950|FG005|Overall Study|Withdrawal by Subject|0|||
149976787|NCT03341637|541053402|FG000|Overall Study|Withdrawal by Subject|3|||
149976788|NCT03341637|541053403|FG001|Overall Study|Withdrawal by Subject|3|||
149976789|NCT03341637|541053402|FG000|Overall Study|Reason not Specified|1|||
149976790|NCT03341637|541053403|FG001|Overall Study|Reason not Specified|1|||
149976791|NCT01815424|541053414|FG000|Week 0 to 16|Adverse Event|1|||
149976792|NCT01815424|541053415|FG001|Week 0 to 16|Adverse Event|3|||
149976793|NCT01815424|541053416|FG002|Week 0 to 16|Adverse Event|3|||
149976794|NCT01815424|541053417|FG003|Week 0 to 16|Adverse Event|0|||
149976795|NCT01815424|541053418|FG004|Week 0 to 16|Adverse Event|0|||
149976796|NCT01815424|541053414|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
149976797|NCT01815424|541053415|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
149976798|NCT01815424|541053416|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
149976799|NCT01815424|541053417|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
149976800|NCT01815424|541053418|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
149976801|NCT01815424|541053414|FG000|Week 0 to 16|Lost to Follow-up|0|||
149976802|NCT01815424|541053415|FG001|Week 0 to 16|Lost to Follow-up|1|||
149976803|NCT01815424|541053416|FG002|Week 0 to 16|Lost to Follow-up|0|||
149976804|NCT01815424|541053417|FG003|Week 0 to 16|Lost to Follow-up|0|||
149976805|NCT01815424|541053418|FG004|Week 0 to 16|Lost to Follow-up|0|||
149976806|NCT01815424|541053414|FG000|Week 0 to 16|Withdrawal by Subject|0|||
149976807|NCT01815424|541053415|FG001|Week 0 to 16|Withdrawal by Subject|0|||
149976808|NCT01815424|541053416|FG002|Week 0 to 16|Withdrawal by Subject|1|||
149976809|NCT01815424|541053417|FG003|Week 0 to 16|Withdrawal by Subject|0|||
149976810|NCT01815424|541053418|FG004|Week 0 to 16|Withdrawal by Subject|0|||
149976811|NCT01815424|541053414|FG000|Week 0 to 16|Other|1|||
149976812|NCT01815424|541053415|FG001|Week 0 to 16|Other|0|||
149976813|NCT01815424|541053416|FG002|Week 0 to 16|Other|3|||
149976814|NCT01815424|541053417|FG003|Week 0 to 16|Other|0|||
149976815|NCT01815424|541053418|FG004|Week 0 to 16|Other|0|||
149976816|NCT01815424|541053414|FG000|Week 0 to 16|Protocol Violation|1|||
149976817|NCT01815424|541053415|FG001|Week 0 to 16|Protocol Violation|0|||
149976818|NCT01815424|541053416|FG002|Week 0 to 16|Protocol Violation|0|||
149976819|NCT01815424|541053417|FG003|Week 0 to 16|Protocol Violation|0|||
150178505|NCT00610649|541791951|FG006|Overall Study|Withdrawal by Subject|0|||
150178506|NCT00610649|541791952|FG007|Overall Study|Withdrawal by Subject|0|||
150178507|NCT00610649|541791953|FG008|Overall Study|Withdrawal by Subject|0|||
150178508|NCT00610649|541791954|FG009|Overall Study|Withdrawal by Subject|1|||
150178509|NCT00610649|541791955|FG010|Overall Study|Withdrawal by Subject|0|||
150178510|NCT02597920|541791959|FG000|Overall Study|Worsening of other pre-existing disease|0|||
150178511|NCT02597920|541791960|FG001|Overall Study|Worsening of other pre-existing disease|1|||
150178512|NCT02597920|541791961|FG002|Overall Study|Worsening of other pre-existing disease|0|||
150178513|NCT02597920|541791959|FG000|Overall Study|Other adverse event|20|||
150178514|NCT02597920|541791960|FG001|Overall Study|Other adverse event|30|||
150178515|NCT02597920|541791961|FG002|Overall Study|Other adverse event|0|||
150178516|NCT02597920|541791959|FG000|Overall Study|Lost to Follow-up|7|||
150178517|NCT02597920|541791960|FG001|Overall Study|Lost to Follow-up|9|||
150178518|NCT02597920|541791961|FG002|Overall Study|Lost to Follow-up|0|||
150178519|NCT02597920|541791959|FG000|Overall Study|Refuse to continue in the study|3|||
150178520|NCT02597920|541791960|FG001|Overall Study|Refuse to continue in the study|13|||
150178521|NCT02597920|541791961|FG002|Overall Study|Refuse to continue in the study|1|||
150178522|NCT02597920|541791959|FG000|Overall Study|Other than specified|10|||
150178523|NCT02597920|541791960|FG001|Overall Study|Other than specified|31|||
150178524|NCT02597920|541791961|FG002|Overall Study|Other than specified|5|||
150178525|NCT02597920|541791959|FG000|Overall Study|Other|1|||
150178526|NCT02597920|541791960|FG001|Overall Study|Other|0|||
150178527|NCT02597920|541791961|FG002|Overall Study|Other|0|||
150178528|NCT00642850|541791962|FG000|Overall Study|Death|7|||
150178529|NCT00642850|541791962|FG000|Overall Study|Adverse Event|2|||
150178530|NCT00642850|541791962|FG000|Overall Study|Lack of Efficacy|1|||
150178531|NCT00642850|541791962|FG000|Overall Study|Protocol Violation|2|||
150178532|NCT00642850|541791962|FG000|Overall Study|Kidney transplantation|8|||
150178533|NCT00642850|541791962|FG000|Overall Study|Blood transfusion|6|||
150178534|NCT00642850|541791962|FG000|Overall Study|Other reasons|7|||
150178535|NCT05489484|541791967|FG000|Overall Study|withdrawn|1|||
150178536|NCT01414738|541791968|FG000|Overall Study|Death|26|||
150178537|NCT01414738|541791968|FG000|Overall Study|Refused testing|5|||
150178538|NCT01414738|541791968|FG000|Overall Study|Lost to Follow-up|2|||
150178539|NCT01414738|541791968|FG000|Overall Study|Refused, disease progression|8|||
150178540|NCT01414738|541791968|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
150178541|NCT01266122|541791970|FG000|Overall Study|Lost to Follow-up|6|||
150178542|NCT01266122|541791971|FG001|Overall Study|Lost to Follow-up|6|||
150178543|NCT00421889|541791972|FG000|Overall Study|Adverse Event|1|||
150178544|NCT00421889|541791973|FG001|Overall Study|Adverse Event|0|||
150178545|NCT00421889|541791974|FG002|Overall Study|Adverse Event|1|||
150178546|NCT00421889|541791975|FG003|Overall Study|Adverse Event|1|||
150178547|NCT00421889|541791976|FG004|Overall Study|Adverse Event|1|||
150178548|NCT00421889|541791977|FG005|Overall Study|Adverse Event|4|||
150178549|NCT00421889|541791978|FG006|Overall Study|Adverse Event|1|||
149976820|NCT01815424|541053418|FG004|Week 0 to 16|Protocol Violation|0|||
149976821|NCT01815424|541053414|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
149976822|NCT01815424|541053415|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
149976823|NCT01815424|541053416|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
149976824|NCT01815424|541053417|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
149976825|NCT01815424|541053418|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
149976826|NCT01815424|541053414|FG000|Week 16 to 52|Other|0|||
149976827|NCT01815424|541053415|FG001|Week 16 to 52|Other|1|||
149976828|NCT01815424|541053416|FG002|Week 16 to 52|Other|0|||
149976829|NCT01815424|541053417|FG003|Week 16 to 52|Other|0|||
149976830|NCT01815424|541053418|FG004|Week 16 to 52|Other|0|||
149976831|NCT01815424|541053414|FG000|Week 16 to 52|Adverse Event|0|||
149976832|NCT01815424|541053415|FG001|Week 16 to 52|Adverse Event|0|||
149976833|NCT01815424|541053416|FG002|Week 16 to 52|Adverse Event|0|||
149976834|NCT01815424|541053417|FG003|Week 16 to 52|Adverse Event|0|||
149976835|NCT01815424|541053418|FG004|Week 16 to 52|Adverse Event|1|||
149976836|NCT01815424|541053414|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
149976837|NCT01815424|541053415|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
149976838|NCT01815424|541053416|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
149976839|NCT01815424|541053417|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
149976840|NCT01815424|541053418|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
149976841|NCT01815424|541053414|FG000|Week 16 to 52|Lost to Follow-up|0|||
149976842|NCT01815424|541053415|FG001|Week 16 to 52|Lost to Follow-up|2|||
149976843|NCT01815424|541053416|FG002|Week 16 to 52|Lost to Follow-up|0|||
149976844|NCT01815424|541053417|FG003|Week 16 to 52|Lost to Follow-up|2|||
149976845|NCT01815424|541053418|FG004|Week 16 to 52|Lost to Follow-up|1|||
149976846|NCT01815424|541053414|FG000|Week 16 to 52|Withdrawal by Subject|1|||
149976847|NCT01815424|541053415|FG001|Week 16 to 52|Withdrawal by Subject|2|||
149976848|NCT01815424|541053416|FG002|Week 16 to 52|Withdrawal by Subject|0|||
149976849|NCT01815424|541053417|FG003|Week 16 to 52|Withdrawal by Subject|0|||
149976850|NCT01815424|541053418|FG004|Week 16 to 52|Withdrawal by Subject|0|||
149976851|NCT04723355|541053419|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
149976852|NCT04723355|541053419|FG000|Overall Study|Errors in the informed consent form|2|||
149976853|NCT03374358|541053420|FG000|Overall Study|Withdrawal by Subject|0|||
150052234|NCT02466659|541332892|FG000|Overall Study|Lost to Follow-up|5|||
149976854|NCT03374358|541053421|FG001|Overall Study|Withdrawal by Subject|2|||
149976855|NCT01127633|541053422|FG000|Overall Study|Adverse Event|74|||
149976856|NCT01127633|541053423|FG001|Overall Study|Adverse Event|73|||
149976857|NCT01127633|541053422|FG000|Overall Study|Death|40|||
149976858|NCT01127633|541053423|FG001|Overall Study|Death|43|||
149976859|NCT01127633|541053422|FG000|Overall Study|Lost to Follow-up|4|||
149976860|NCT01127633|541053423|FG001|Overall Study|Lost to Follow-up|0|||
149976861|NCT01127633|541053422|FG000|Overall Study|Parent/Caregiver Decision|246|||
149976862|NCT01127633|541053423|FG001|Overall Study|Parent/Caregiver Decision|228|||
149976863|NCT01127633|541053422|FG000|Overall Study|Physician Decision|60|||
149976864|NCT01127633|541053423|FG001|Overall Study|Physician Decision|45|||
149976865|NCT01127633|541053422|FG000|Overall Study|Withdrawal by Subject|57|||
149976866|NCT01127633|541053423|FG001|Overall Study|Withdrawal by Subject|72|||
149976867|NCT01127633|541053422|FG000|Overall Study|Sponsor Decision|163|||
149976868|NCT01127633|541053423|FG001|Overall Study|Sponsor Decision|195|||
149976869|NCT01127633|541053422|FG000|Overall Study|Protocol Violation|8|||
149976870|NCT01127633|541053423|FG001|Overall Study|Protocol Violation|16|||
150052235|NCT02466659|541332893|FG001|Overall Study|Lost to Follow-up|2|||
150052236|NCT00929643|541332894|FG000|Overall Study|Protocol Violation|2|||
150052237|NCT01536392|541332895|FG000|Overall Study|Adverse Event|2|||
150052238|NCT01536392|541332896|FG001|Overall Study|Adverse Event|2|||
150052239|NCT01536392|541332895|FG000|Overall Study|Physician Decision|2|||
150052240|NCT01536392|541332896|FG001|Overall Study|Physician Decision|3|||
150052241|NCT01536392|541332895|FG000|Overall Study|Withdrawal by Subject|3|||
150052242|NCT01536392|541332896|FG001|Overall Study|Withdrawal by Subject|6|||
150052243|NCT01536392|541332895|FG000|Overall Study|Non Compliance|3|||
150052244|NCT01536392|541332896|FG001|Overall Study|Non Compliance|4|||
150052245|NCT01536392|541332895|FG000|Overall Study|Completed therapy early|3|||
150052246|NCT01536392|541332896|FG001|Overall Study|Completed therapy early|0|||
150052247|NCT02874144|541332897|FG000|Overall Study|Lost to Follow-up|3|||
150052248|NCT02874144|541332898|FG001|Overall Study|Lost to Follow-up|5|||
150052249|NCT00486811|541332901|FG000|Overall Study|Adverse Event|28|||
150052250|NCT00486811|541332902|FG001|Overall Study|Adverse Event|60|||
150052251|NCT00486811|541332903|FG002|Overall Study|Adverse Event|135|||
150052252|NCT00486811|541332901|FG000|Overall Study|Lack of Efficacy|34|||
150052253|NCT00486811|541332902|FG001|Overall Study|Lack of Efficacy|14|||
150052254|NCT00486811|541332903|FG002|Overall Study|Lack of Efficacy|7|||
150052255|NCT00486811|541332901|FG000|Overall Study|Lost to Follow-up|4|||
150052256|NCT00486811|541332902|FG001|Overall Study|Lost to Follow-up|6|||
150052257|NCT00486811|541332903|FG002|Overall Study|Lost to Follow-up|4|||
150052258|NCT00486811|541332901|FG000|Overall Study|Withdrawal by Subject|33|||
150052259|NCT00486811|541332902|FG001|Overall Study|Withdrawal by Subject|44|||
150052260|NCT00486811|541332903|FG002|Overall Study|Withdrawal by Subject|58|||
150052261|NCT00486811|541332901|FG000|Overall Study|Study drug non-compliant|5|||
150052262|NCT00486811|541332902|FG001|Overall Study|Study drug non-compliant|6|||
150052263|NCT00486811|541332903|FG002|Overall Study|Study drug non-compliant|3|||
150052264|NCT00486811|541332901|FG000|Overall Study|All other|18|||
150052265|NCT00486811|541332902|FG001|Overall Study|All other|11|||
150052266|NCT00486811|541332903|FG002|Overall Study|All other|7|||
150052267|NCT03753789|541332904|FG000|Overall Study|Withdrawal by Subject|2|||
150052268|NCT01578850|541332911|FG000|Period 1|Insufficient Clinical Response|1|||
150052269|NCT01578850|541332912|FG001|Period 1|Insufficient Clinical Response|0|||
150052270|NCT01578850|541332913|FG002|Period 1|Insufficient Clinical Response|0|||
150052271|NCT01578850|541332911|FG000|Period 1|Adverse Event|11|||
150052272|NCT01578850|541332912|FG001|Period 1|Adverse Event|0|||
150052273|NCT01578850|541332913|FG002|Period 1|Adverse Event|0|||
150052274|NCT01578850|541332911|FG000|Period 1|Death|1|||
150052275|NCT01578850|541332912|FG001|Period 1|Death|0|||
150052276|NCT01578850|541332913|FG002|Period 1|Death|0|||
150052277|NCT01578850|541332911|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
150052278|NCT01578850|541332912|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
150052279|NCT01578850|541332913|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
150052280|NCT01578850|541332911|FG000|Period 1|Withdrawal by Subject|9|||
150052281|NCT01578850|541332912|FG001|Period 1|Withdrawal by Subject|0|||
150052282|NCT01578850|541332913|FG002|Period 1|Withdrawal by Subject|0|||
150052283|NCT01578850|541332911|FG000|Period 1|Study Terminated by Sponsor|3|||
150052284|NCT01578850|541332912|FG001|Period 1|Study Terminated by Sponsor|0|||
149976871|NCT01127633|541053422|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
149976872|NCT01127633|541053423|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
149976873|NCT01127633|541053422|FG000|Overall Study|Not treated|1|||
149976874|NCT01127633|541053423|FG001|Overall Study|Not treated|0|||
149976875|NCT02805790|541053425|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
150052285|NCT01578850|541332913|FG002|Period 1|Study Terminated by Sponsor|0|||
150052286|NCT01578850|541332911|FG000|Period 2|Insufficient Clinical Response|0|||
149976876|NCT02805790|541053426|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
150052287|NCT01578850|541332912|FG001|Period 2|Insufficient Clinical Response|1|||
150052288|NCT01578850|541332913|FG002|Period 2|Insufficient Clinical Response|0|||
150052289|NCT01578850|541332911|FG000|Period 2|Adverse Event|0|||
150052290|NCT01578850|541332912|FG001|Period 2|Adverse Event|3|||
150052291|NCT01578850|541332913|FG002|Period 2|Adverse Event|6|||
149976877|NCT04512001|541053432|FG000|Week 0 to Week 24|Adverse Event|14|||
149976878|NCT04512001|541053433|FG001|Week 0 to Week 24|Adverse Event|10|||
149976879|NCT04512001|541053434|FG002|Week 0 to Week 24|Adverse Event|0|||
149976880|NCT04512001|541053435|FG003|Week 0 to Week 24|Adverse Event|0|||
149976881|NCT04512001|541053436|FG004|Week 0 to Week 24|Adverse Event|0|||
149976882|NCT04512001|541053432|FG000|Week 0 to Week 24|Death|0|||
149976883|NCT04512001|541053433|FG001|Week 0 to Week 24|Death|2|||
149976884|NCT04512001|541053434|FG002|Week 0 to Week 24|Death|0|||
149976885|NCT04512001|541053435|FG003|Week 0 to Week 24|Death|0|||
149976886|NCT04512001|541053436|FG004|Week 0 to Week 24|Death|0|||
149976887|NCT04512001|541053432|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
149976888|NCT04512001|541053433|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
149976889|NCT04512001|541053434|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
149976890|NCT04512001|541053435|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
149976891|NCT04512001|541053436|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
149976892|NCT04512001|541053432|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
149976893|NCT04512001|541053433|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
149976894|NCT04512001|541053434|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
149976895|NCT04512001|541053435|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
149976896|NCT04512001|541053436|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
149976897|NCT04512001|541053432|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
149976898|NCT04512001|541053433|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
149976899|NCT04512001|541053434|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
149976900|NCT04512001|541053435|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
149976901|NCT04512001|541053436|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
149976902|NCT04512001|541053432|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
149976903|NCT04512001|541053433|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
149976904|NCT04512001|541053434|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
149976905|NCT04512001|541053435|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
149976906|NCT04512001|541053436|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
149976907|NCT04512001|541053432|FG000|Week 24 to Week 63|Adverse Event|0|||
149976908|NCT04512001|541053433|FG001|Week 24 to Week 63|Adverse Event|0|||
149976909|NCT04512001|541053434|FG002|Week 24 to Week 63|Adverse Event|13|||
149976910|NCT04512001|541053435|FG003|Week 24 to Week 63|Adverse Event|8|||
149976911|NCT04512001|541053436|FG004|Week 24 to Week 63|Adverse Event|6|||
149976912|NCT04512001|541053432|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
149976913|NCT04512001|541053433|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
149976914|NCT04512001|541053434|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
149976915|NCT04512001|541053435|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
149976916|NCT04512001|541053436|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
149976917|NCT04512001|541053432|FG000|Week 24 to Week 63|Death|0|||
149976918|NCT04512001|541053433|FG001|Week 24 to Week 63|Death|0|||
149976919|NCT04512001|541053434|FG002|Week 24 to Week 63|Death|0|||
149976920|NCT04512001|541053435|FG003|Week 24 to Week 63|Death|1|||
149976921|NCT04512001|541053436|FG004|Week 24 to Week 63|Death|1|||
149976922|NCT04512001|541053432|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
149976923|NCT04512001|541053433|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
149976924|NCT04512001|541053434|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
149976925|NCT04512001|541053435|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
149976926|NCT04512001|541053436|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
149976927|NCT04512001|541053432|FG000|Week 24 to Week 63|Miscellaneous|0|||
149976928|NCT04512001|541053433|FG001|Week 24 to Week 63|Miscellaneous|0|||
149976929|NCT04512001|541053434|FG002|Week 24 to Week 63|Miscellaneous|3|||
149976930|NCT04512001|541053435|FG003|Week 24 to Week 63|Miscellaneous|2|||
149976931|NCT04512001|541053436|FG004|Week 24 to Week 63|Miscellaneous|1|||
149976932|NCT02776683|541053437|FG000|Pre-switch Period|Protocol Violation|1|||
149976933|NCT02776683|541053438|FG001|Pre-switch Period|Protocol Violation|0|||
149976934|NCT02776683|541053437|FG000|Pre-switch Period|Adverse Event|21|||
149976935|NCT02776683|541053438|FG001|Pre-switch Period|Adverse Event|0|||
149976936|NCT02776683|541053437|FG000|Pre-switch Period|Withdrawal by Subject|9|||
149976937|NCT02776683|541053438|FG001|Pre-switch Period|Withdrawal by Subject|0|||
149976938|NCT02776683|541053437|FG000|Pre-switch Period|Physician Decision|7|||
149976939|NCT02776683|541053438|FG001|Pre-switch Period|Physician Decision|0|||
149976940|NCT02776683|541053437|FG000|Pre-switch Period|Progressive disease|39|||
149976941|NCT02776683|541053438|FG001|Pre-switch Period|Progressive disease|0|||
149976942|NCT02776683|541053437|FG000|Pre-switch Period|Other than listed|3|||
149976943|NCT02776683|541053438|FG001|Pre-switch Period|Other than listed|0|||
149976944|NCT02776683|541053437|FG000|Post-switch Period|Adverse Event|0|||
149976945|NCT02776683|541053438|FG001|Post-switch Period|Adverse Event|3|||
149976946|NCT02776683|541053437|FG000|Post-switch Period|Withdrawal by Subject|0|||
149976947|NCT02776683|541053438|FG001|Post-switch Period|Withdrawal by Subject|2|||
149976948|NCT02776683|541053437|FG000|Post-switch Period|Physician Decision|0|||
149976949|NCT02776683|541053438|FG001|Post-switch Period|Physician Decision|3|||
149976950|NCT02776683|541053437|FG000|Post-switch Period|Progressive disease|0|||
149976951|NCT02776683|541053438|FG001|Post-switch Period|Progressive disease|20|||
149976952|NCT02776683|541053437|FG000|Post-switch Period|Other than listed|0|||
149976953|NCT02776683|541053438|FG001|Post-switch Period|Other than listed|15|||
149976954|NCT00616642|541053439|FG000|Overall Study|Withdrawal by Subject|0|||
149976955|NCT00616642|541053440|FG001|Overall Study|Withdrawal by Subject|1|||
149976956|NCT01664247|541053446|FG000|Overall Study|Adverse Event|5|||
149976957|NCT01664247|541053447|FG001|Overall Study|Adverse Event|3|||
149976958|NCT01664247|541053446|FG000|Overall Study|Protocol Violation|3|||
149976959|NCT01664247|541053447|FG001|Overall Study|Protocol Violation|5|||
149976960|NCT01664247|541053446|FG000|Overall Study|Withdrawal Criteria|1|||
149976961|NCT01664247|541053447|FG001|Overall Study|Withdrawal Criteria|4|||
149976962|NCT01664247|541053446|FG000|Overall Study|Unclassified|5|||
149976963|NCT01664247|541053447|FG001|Overall Study|Unclassified|29|||
149976964|NCT01881009|541053450|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
149976965|NCT01881009|541053451|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
149976966|NCT01000506|541053452|FG000|Overall Study|Adverse Event|6|||
149976967|NCT01000506|541053453|FG001|Overall Study|Adverse Event|5|||
149976968|NCT01000506|541053454|FG002|Overall Study|Adverse Event|8|||
149976969|NCT01000506|541053455|FG003|Overall Study|Adverse Event|9|||
149976970|NCT01000506|541053452|FG000|Overall Study|Lack of Efficacy|8|||
149976971|NCT01000506|541053453|FG001|Overall Study|Lack of Efficacy|6|||
149976972|NCT01000506|541053454|FG002|Overall Study|Lack of Efficacy|4|||
149976973|NCT01000506|541053455|FG003|Overall Study|Lack of Efficacy|4|||
149976974|NCT01000506|541053452|FG000|Overall Study|Protocol Violation|1|||
149976975|NCT01000506|541053453|FG001|Overall Study|Protocol Violation|1|||
149976976|NCT01000506|541053454|FG002|Overall Study|Protocol Violation|0|||
149976977|NCT01000506|541053455|FG003|Overall Study|Protocol Violation|0|||
149976978|NCT01000506|541053452|FG000|Overall Study|Lost to Follow-up|1|||
149976979|NCT01000506|541053453|FG001|Overall Study|Lost to Follow-up|1|||
149976980|NCT01000506|541053454|FG002|Overall Study|Lost to Follow-up|4|||
149976981|NCT01000506|541053455|FG003|Overall Study|Lost to Follow-up|0|||
149976982|NCT01000506|541053452|FG000|Overall Study|Physician Decision|1|||
149976983|NCT01000506|541053453|FG001|Overall Study|Physician Decision|3|||
149976984|NCT01000506|541053454|FG002|Overall Study|Physician Decision|3|||
149976985|NCT01000506|541053455|FG003|Overall Study|Physician Decision|3|||
149976986|NCT01000506|541053452|FG000|Overall Study|Withdrawal by Subject|11|||
149976987|NCT01000506|541053453|FG001|Overall Study|Withdrawal by Subject|8|||
149976988|NCT01000506|541053454|FG002|Overall Study|Withdrawal by Subject|2|||
149976989|NCT01000506|541053455|FG003|Overall Study|Withdrawal by Subject|7|||
149976990|NCT03064074|541053456|FG000|Overall Study|Physician Decision|0|||
149976991|NCT03064074|541053457|FG001|Overall Study|Physician Decision|0|||
149976992|NCT03064074|541053458|FG002|Overall Study|Physician Decision|0|||
149976993|NCT03064074|541053459|FG003|Overall Study|Physician Decision|1|||
149976994|NCT03326063|541053463|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
149976995|NCT03326063|541053464|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
149976996|NCT02216526|541053467|FG000|Overall Study|Adverse Event|1|||
149976997|NCT02216526|541053468|FG001|Overall Study|Adverse Event|1|||
149976998|NCT02216526|541053469|FG002|Overall Study|Adverse Event|0|||
149976999|NCT02216526|541053467|FG000|Overall Study|Death|0|||
149977000|NCT02216526|541053468|FG001|Overall Study|Death|1|||
149977001|NCT02216526|541053469|FG002|Overall Study|Death|3|||
149977002|NCT02216526|541053467|FG000|Overall Study|Protocol Violation|2|||
149977003|NCT02216526|541053468|FG001|Overall Study|Protocol Violation|0|||
149977004|NCT02216526|541053469|FG002|Overall Study|Protocol Violation|2|||
149977005|NCT02216526|541053467|FG000|Overall Study|Hospitalization|2|||
149977006|NCT02216526|541053468|FG001|Overall Study|Hospitalization|1|||
149977007|NCT02216526|541053469|FG002|Overall Study|Hospitalization|3|||
149977008|NCT02750514|541053470|FG000|Track 1|Disease progression|20|||
150052292|NCT01578850|541332911|FG000|Period 2|Lost to Follow-up|0|||
150052293|NCT01578850|541332912|FG001|Period 2|Lost to Follow-up|1|||
150052294|NCT01578850|541332913|FG002|Period 2|Lost to Follow-up|2|||
150052295|NCT01578850|541332911|FG000|Period 2|Withdrawal by Subject|0|||
150052296|NCT01578850|541332912|FG001|Period 2|Withdrawal by Subject|2|||
150052297|NCT01578850|541332913|FG002|Period 2|Withdrawal by Subject|2|||
150052298|NCT01578850|541332911|FG000|Period 2|Study Terminated by Sponsor|0|||
150052299|NCT01578850|541332912|FG001|Period 2|Study Terminated by Sponsor|5|||
150052300|NCT01578850|541332913|FG002|Period 2|Study Terminated by Sponsor|4|||
150052301|NCT01578850|541332911|FG000|Period 2|Unspecified Reasons|0|||
150052302|NCT01578850|541332912|FG001|Period 2|Unspecified Reasons|1|||
150052303|NCT01578850|541332913|FG002|Period 2|Unspecified Reasons|0|||
150052304|NCT01711216|541332918|FG000|Overall Study|Adverse Event|4|||
150052305|NCT01711216|541332918|FG000|Overall Study|Pregnancy|56|||
150052306|NCT01711216|541332918|FG000|Overall Study|Withdrawal by Subject|6|||
150052307|NCT01711216|541332918|FG000|Overall Study|Lost to Follow-up|46|||
150052308|NCT01711216|541332918|FG000|Overall Study|variety of other minor reasons|83|||
150052309|NCT01711216|541332918|FG000|Overall Study|no reason specified|22|||
150178550|NCT00421889|541791979|FG007|Overall Study|Adverse Event|0|||
150178551|NCT00421889|541791980|FG008|Overall Study|Adverse Event|2|||
150178552|NCT00421889|541791972|FG000|Overall Study|Withdrawal by Subject|1|||
149977009|NCT02750514|541053471|FG001|Track 1|Disease progression|1|||
149977010|NCT02750514|541053472|FG002|Track 1|Disease progression|0|||
149977011|NCT02750514|541053473|FG003|Track 1|Disease progression|1|||
149977012|NCT02750514|541053474|FG004|Track 1|Disease progression|0|||
149977013|NCT02750514|541053470|FG000|Track 1|Adverse event unrelated to study drug|1|||
149977014|NCT02750514|541053471|FG001|Track 1|Adverse event unrelated to study drug|0|||
149977015|NCT02750514|541053472|FG002|Track 1|Adverse event unrelated to study drug|0|||
149977016|NCT02750514|541053473|FG003|Track 1|Adverse event unrelated to study drug|0|||
149977017|NCT02750514|541053474|FG004|Track 1|Adverse event unrelated to study drug|0|||
149977018|NCT02750514|541053470|FG000|Track 1|Study drug toxicity|4|||
149977019|NCT02750514|541053471|FG001|Track 1|Study drug toxicity|1|||
149977020|NCT02750514|541053472|FG002|Track 1|Study drug toxicity|0|||
149977021|NCT02750514|541053473|FG003|Track 1|Study drug toxicity|1|||
149977022|NCT02750514|541053474|FG004|Track 1|Study drug toxicity|0|||
149977023|NCT02750514|541053470|FG000|Track 1|Participant request to discontinue|1|||
149977024|NCT02750514|541053471|FG001|Track 1|Participant request to discontinue|0|||
149977025|NCT02750514|541053472|FG002|Track 1|Participant request to discontinue|0|||
149977026|NCT02750514|541053473|FG003|Track 1|Participant request to discontinue|0|||
149977027|NCT02750514|541053474|FG004|Track 1|Participant request to discontinue|0|||
149977028|NCT02750514|541053470|FG000|Track 1|Other reasons|1|||
149977029|NCT02750514|541053471|FG001|Track 1|Other reasons|0|||
149977030|NCT02750514|541053472|FG002|Track 1|Other reasons|0|||
149977031|NCT02750514|541053473|FG003|Track 1|Other reasons|0|||
149977032|NCT02750514|541053474|FG004|Track 1|Other reasons|0|||
149977033|NCT02750514|541053470|FG000|Track 2|Disease progression|4|||
149977034|NCT02750514|541053471|FG001|Track 2|Disease progression|5|||
149977035|NCT02750514|541053472|FG002|Track 2|Disease progression|2|||
149977036|NCT02750514|541053473|FG003|Track 2|Disease progression|5|||
149977037|NCT02750514|541053474|FG004|Track 2|Disease progression|0|||
150052310|NCT02929498|541332919|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
150052311|NCT02929498|541332920|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
150052312|NCT02929498|541332921|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
150178553|NCT00421889|541791973|FG001|Overall Study|Withdrawal by Subject|3|||
149977038|NCT02750514|541053470|FG000|Track 2|Adverse event unrelated to study drug|1|||
149977039|NCT02750514|541053471|FG001|Track 2|Adverse event unrelated to study drug|0|||
149977040|NCT02750514|541053472|FG002|Track 2|Adverse event unrelated to study drug|0|||
149977041|NCT02750514|541053473|FG003|Track 2|Adverse event unrelated to study drug|0|||
149977042|NCT02750514|541053474|FG004|Track 2|Adverse event unrelated to study drug|0|||
150052313|NCT02929498|541332919|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
150052314|NCT02929498|541332920|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
150178554|NCT00421889|541791974|FG002|Overall Study|Withdrawal by Subject|0|||
149977043|NCT02750514|541053470|FG000|Track 2|Study drug toxicity|1|||
149977044|NCT02750514|541053471|FG001|Track 2|Study drug toxicity|2|||
149977045|NCT02750514|541053472|FG002|Track 2|Study drug toxicity|0|||
149977046|NCT02750514|541053473|FG003|Track 2|Study drug toxicity|2|||
149977047|NCT02750514|541053474|FG004|Track 2|Study drug toxicity|0|||
149977048|NCT02750514|541053470|FG000|Track 2|Participant withdrew consent|0|||
149977049|NCT02750514|541053471|FG001|Track 2|Participant withdrew consent|1|||
149977050|NCT02750514|541053472|FG002|Track 2|Participant withdrew consent|0|||
149977051|NCT02750514|541053473|FG003|Track 2|Participant withdrew consent|0|||
149977052|NCT02750514|541053474|FG004|Track 2|Participant withdrew consent|0|||
149977053|NCT02750514|541053470|FG000|Track 3|Disease progression|0|||
149977054|NCT02750514|541053471|FG001|Track 3|Disease progression|24|||
149977055|NCT02750514|541053472|FG002|Track 3|Disease progression|13|||
149977056|NCT02750514|541053473|FG003|Track 3|Disease progression|14|||
149977057|NCT02750514|541053474|FG004|Track 3|Disease progression|0|||
149977058|NCT02750514|541053470|FG000|Track 3|Adverse event unrelated to study drug|0|||
149977059|NCT02750514|541053471|FG001|Track 3|Adverse event unrelated to study drug|1|||
149977060|NCT02750514|541053472|FG002|Track 3|Adverse event unrelated to study drug|1|||
149977061|NCT02750514|541053473|FG003|Track 3|Adverse event unrelated to study drug|1|||
149977062|NCT02750514|541053474|FG004|Track 3|Adverse event unrelated to study drug|0|||
149977063|NCT02750514|541053470|FG000|Track 3|Study drug toxicity|0|||
149977064|NCT02750514|541053471|FG001|Track 3|Study drug toxicity|3|||
149977065|NCT02750514|541053472|FG002|Track 3|Study drug toxicity|0|||
149977066|NCT02750514|541053473|FG003|Track 3|Study drug toxicity|1|||
149977067|NCT02750514|541053474|FG004|Track 3|Study drug toxicity|0|||
149977068|NCT02750514|541053470|FG000|Track 3|Participant request to discontinue|0|||
149977069|NCT02750514|541053471|FG001|Track 3|Participant request to discontinue|2|||
149977070|NCT02750514|541053472|FG002|Track 3|Participant request to discontinue|0|||
149977071|NCT02750514|541053473|FG003|Track 3|Participant request to discontinue|0|||
149977072|NCT02750514|541053474|FG004|Track 3|Participant request to discontinue|0|||
149977073|NCT02750514|541053470|FG000|Track 3|Participant withdrew consent|0|||
149977074|NCT02750514|541053471|FG001|Track 3|Participant withdrew consent|3|||
149977075|NCT02750514|541053472|FG002|Track 3|Participant withdrew consent|1|||
149977076|NCT02750514|541053473|FG003|Track 3|Participant withdrew consent|0|||
149977077|NCT02750514|541053474|FG004|Track 3|Participant withdrew consent|0|||
149977078|NCT02750514|541053470|FG000|Track 3|Other reasons|0|||
149977079|NCT02750514|541053471|FG001|Track 3|Other reasons|3|||
149977080|NCT02750514|541053472|FG002|Track 3|Other reasons|0|||
149977081|NCT02750514|541053473|FG003|Track 3|Other reasons|0|||
149977082|NCT02750514|541053474|FG004|Track 3|Other reasons|0|||
149977083|NCT02750514|541053470|FG000|Track 4|Study drug toxicity|0|||
149977084|NCT02750514|541053471|FG001|Track 4|Study drug toxicity|6|||
149977085|NCT02750514|541053472|FG002|Track 4|Study drug toxicity|0|||
149977086|NCT02750514|541053473|FG003|Track 4|Study drug toxicity|5|||
149977087|NCT02750514|541053474|FG004|Track 4|Study drug toxicity|0|||
149977088|NCT02750514|541053470|FG000|Track 4|Participant request to discontinue|0|||
149977089|NCT02750514|541053471|FG001|Track 4|Participant request to discontinue|1|||
149977090|NCT02750514|541053472|FG002|Track 4|Participant request to discontinue|0|||
149977091|NCT02750514|541053473|FG003|Track 4|Participant request to discontinue|1|||
149977092|NCT02750514|541053474|FG004|Track 4|Participant request to discontinue|0|||
149977093|NCT02750514|541053470|FG000|Track 4|Participant withdrew consent|0|||
150052315|NCT02929498|541332921|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
149977094|NCT02750514|541053471|FG001|Track 4|Participant withdrew consent|1|||
149977095|NCT02750514|541053472|FG002|Track 4|Participant withdrew consent|0|||
149977096|NCT02750514|541053473|FG003|Track 4|Participant withdrew consent|0|||
149977097|NCT02750514|541053474|FG004|Track 4|Participant withdrew consent|0|||
149977098|NCT02750514|541053470|FG000|Track 4|Other reasons|0|||
149977099|NCT02750514|541053471|FG001|Track 4|Other reasons|5|||
150178555|NCT00421889|541791975|FG003|Overall Study|Withdrawal by Subject|0|||
149977100|NCT02750514|541053472|FG002|Track 4|Other reasons|0|||
149977101|NCT02750514|541053473|FG003|Track 4|Other reasons|3|||
149977102|NCT02750514|541053474|FG004|Track 4|Other reasons|0|||
149977103|NCT02750514|541053470|FG000|Track 4|Disease progression|0|||
149977104|NCT02750514|541053471|FG001|Track 4|Disease progression|33|||
149977105|NCT02750514|541053472|FG002|Track 4|Disease progression|0|||
149977106|NCT02750514|541053473|FG003|Track 4|Disease progression|32|||
149977107|NCT02750514|541053474|FG004|Track 4|Disease progression|0|||
149977108|NCT02750514|541053470|FG000|Track 4|Adverse event unrelated to study drug|0|||
149977109|NCT02750514|541053471|FG001|Track 4|Adverse event unrelated to study drug|5|||
149977110|NCT02750514|541053472|FG002|Track 4|Adverse event unrelated to study drug|0|||
149977111|NCT02750514|541053473|FG003|Track 4|Adverse event unrelated to study drug|0|||
149977112|NCT02750514|541053474|FG004|Track 4|Adverse event unrelated to study drug|0|||
149977113|NCT02750514|541053470|FG000|Track 4|Death|0|||
149977114|NCT02750514|541053471|FG001|Track 4|Death|0|||
149977115|NCT02750514|541053472|FG002|Track 4|Death|0|||
149977116|NCT02750514|541053473|FG003|Track 4|Death|1|||
149977117|NCT02750514|541053474|FG004|Track 4|Death|0|||
149977118|NCT02750514|541053470|FG000|Track 5|Disease progression|0|||
149977119|NCT02750514|541053471|FG001|Track 5|Disease progression|0|||
149977120|NCT02750514|541053472|FG002|Track 5|Disease progression|0|||
149977121|NCT02750514|541053473|FG003|Track 5|Disease progression|0|||
149977122|NCT02750514|541053474|FG004|Track 5|Disease progression|34|||
149977123|NCT02750514|541053470|FG000|Track 5|Adverse event unrelated to study drug|0|||
149977124|NCT02750514|541053471|FG001|Track 5|Adverse event unrelated to study drug|0|||
149977125|NCT02750514|541053472|FG002|Track 5|Adverse event unrelated to study drug|0|||
149977126|NCT02750514|541053473|FG003|Track 5|Adverse event unrelated to study drug|0|||
149977127|NCT02750514|541053474|FG004|Track 5|Adverse event unrelated to study drug|2|||
149977128|NCT02750514|541053470|FG000|Track 5|Study drug toxicity|0|||
149977129|NCT02750514|541053471|FG001|Track 5|Study drug toxicity|0|||
149977130|NCT02750514|541053472|FG002|Track 5|Study drug toxicity|0|||
149977131|NCT02750514|541053473|FG003|Track 5|Study drug toxicity|0|||
149977132|NCT02750514|541053474|FG004|Track 5|Study drug toxicity|2|||
149977133|NCT02750514|541053470|FG000|Track 5|Participant request to discontinue|0|||
149977134|NCT02750514|541053471|FG001|Track 5|Participant request to discontinue|0|||
149977135|NCT02750514|541053472|FG002|Track 5|Participant request to discontinue|0|||
149977136|NCT02750514|541053473|FG003|Track 5|Participant request to discontinue|0|||
149977137|NCT02750514|541053474|FG004|Track 5|Participant request to discontinue|3|||
149977138|NCT02750514|541053470|FG000|Track 5|Other reasons|0|||
149977139|NCT02750514|541053471|FG001|Track 5|Other reasons|0|||
149977140|NCT02750514|541053472|FG002|Track 5|Other reasons|0|||
149977141|NCT02750514|541053473|FG003|Track 5|Other reasons|0|||
149977142|NCT02750514|541053474|FG004|Track 5|Other reasons|2|||
149977143|NCT01882465|541053475|FG000|Period 1|Lens Discomfort|0|||
149977144|NCT01882465|541053476|FG001|Period 1|Lens Discomfort|0|||
149977145|NCT01882465|541053477|FG002|Period 1|Lens Discomfort|0|||
149977146|NCT01882465|541053478|FG003|Period 1|Lens Discomfort|1|||
149977147|NCT01882465|541053479|FG004|Period 1|Lens Discomfort|0|||
149977148|NCT01882465|541053480|FG005|Period 1|Lens Discomfort|0|||
149977149|NCT01882465|541053481|FG006|Period 1|Lens Discomfort|0|||
149977150|NCT01882465|541053475|FG000|Period 1|Withdrawal by Subject|0|||
149977151|NCT01882465|541053476|FG001|Period 1|Withdrawal by Subject|0|||
149977152|NCT01882465|541053477|FG002|Period 1|Withdrawal by Subject|0|||
149977153|NCT01882465|541053478|FG003|Period 1|Withdrawal by Subject|0|||
149977154|NCT01882465|541053479|FG004|Period 1|Withdrawal by Subject|0|||
149977155|NCT01882465|541053480|FG005|Period 1|Withdrawal by Subject|0|||
149977156|NCT01882465|541053481|FG006|Period 1|Withdrawal by Subject|1|||
149977157|NCT01882465|541053475|FG000|Period 2|Protocol Violation|0|||
149977158|NCT01882465|541053476|FG001|Period 2|Protocol Violation|0|||
149977159|NCT01882465|541053477|FG002|Period 2|Protocol Violation|0|||
149977160|NCT01882465|541053478|FG003|Period 2|Protocol Violation|0|||
149977161|NCT01882465|541053479|FG004|Period 2|Protocol Violation|1|||
149977162|NCT01882465|541053480|FG005|Period 2|Protocol Violation|0|||
149977163|NCT01882465|541053481|FG006|Period 2|Protocol Violation|0|||
149977164|NCT03824392|541053482|FG000|Overall Study|Adverse Event|1|||
149977165|NCT03824392|541053483|FG001|Overall Study|Adverse Event|0|||
149977166|NCT03824392|541053484|FG002|Overall Study|Adverse Event|0|||
149977167|NCT03824392|541053485|FG003|Overall Study|Adverse Event|0|||
149977168|NCT03824392|541053482|FG000|Overall Study|Investigator Decision|0|||
149977169|NCT03824392|541053483|FG001|Overall Study|Investigator Decision|1|||
149977170|NCT03824392|541053484|FG002|Overall Study|Investigator Decision|0|||
149977171|NCT03824392|541053485|FG003|Overall Study|Investigator Decision|0|||
149977172|NCT03824392|541053482|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
149977173|NCT03824392|541053483|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
149977174|NCT03824392|541053484|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
149977175|NCT03824392|541053485|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
149977176|NCT02230189|541053486|FG000|Overall Study|Withdrawal by Subject|3|||
149977177|NCT02230189|541053487|FG001|Overall Study|Withdrawal by Subject|0|||
149977178|NCT02230189|541053488|FG002|Overall Study|Withdrawal by Subject|1|||
149977179|NCT02230189|541053486|FG000|Overall Study|Lost to Follow-up|1|||
149977180|NCT02230189|541053487|FG001|Overall Study|Lost to Follow-up|0|||
149977181|NCT02230189|541053488|FG002|Overall Study|Lost to Follow-up|0|||
149977182|NCT02230189|541053486|FG000|Overall Study|Physician Decision|1|||
149977183|NCT02230189|541053487|FG001|Overall Study|Physician Decision|0|||
149977184|NCT02230189|541053488|FG002|Overall Study|Physician Decision|0|||
149977185|NCT00532844|541053489|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
149977186|NCT00532844|541053490|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
149977187|NCT00532844|541053489|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
149977188|NCT00532844|541053490|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
149977189|NCT00532844|541053489|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
149977190|NCT00532844|541053490|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
149977191|NCT00532844|541053489|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
149977192|NCT00532844|541053490|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
149977193|NCT00532844|541053489|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
149977194|NCT00532844|541053490|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
149977195|NCT04389866|541053492|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
149977196|NCT04389866|541053493|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
149977197|NCT00800982|541053497|FG000|Overall Study|Lost to Follow-up|1|||
149977198|NCT00800982|541053498|FG001|Overall Study|Lost to Follow-up|2|||
149977199|NCT00800982|541053497|FG000|Overall Study|Withdrawal by Subject|0|||
149977200|NCT00800982|541053498|FG001|Overall Study|Withdrawal by Subject|1|||
149977201|NCT00800982|541053497|FG000|Overall Study|Patient moved out of state|1|||
149977202|NCT00800982|541053498|FG001|Overall Study|Patient moved out of state|0|||
149977203|NCT01824290|541053499|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
149977204|NCT01824290|541053500|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
149977205|NCT01824290|541053501|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
149977206|NCT01824290|541053502|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
149977207|NCT01824290|541053499|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
149977208|NCT01824290|541053500|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
149977209|NCT01824290|541053501|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
149977210|NCT01824290|541053502|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
149977211|NCT01824290|541053499|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
149977212|NCT01824290|541053500|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
149977213|NCT01824290|541053501|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
149977214|NCT01824290|541053502|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
149977215|NCT01824290|541053499|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
149977216|NCT01824290|541053500|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
149977217|NCT01824290|541053501|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
149977218|NCT01824290|541053502|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
149977219|NCT01824290|541053499|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
149977220|NCT01824290|541053500|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
149977221|NCT01824290|541053501|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
149977222|NCT01824290|541053502|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
149977223|NCT01824290|541053499|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
149977224|NCT01824290|541053500|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
149977225|NCT01824290|541053501|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
149977226|NCT01824290|541053502|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
149977227|NCT04940130|541053505|FG000|Overall Study|Travel|1|||
149977228|NCT04940130|541053506|FG001|Overall Study|Travel|0|||
150052316|NCT00750152|541332924|FG000|Overall Study|Adverse Event|2|||
150052317|NCT00750152|541332925|FG001|Overall Study|Adverse Event|1|||
150052318|NCT00750152|541332924|FG000|Overall Study|Lost to Follow-up|8|||
150052319|NCT00750152|541332925|FG001|Overall Study|Lost to Follow-up|13|||
150052320|NCT00750152|541332924|FG000|Overall Study|Withdrawal by Subject|3|||
150052321|NCT00750152|541332925|FG001|Overall Study|Withdrawal by Subject|3|||
149977229|NCT04940130|541053507|FG002|Overall Study|Travel|2|||
149977230|NCT04940130|541053505|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
149977231|NCT04940130|541053506|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
149977232|NCT04940130|541053507|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
149977233|NCT04940130|541053505|FG000|Overall Study|Adverse Event|0|||
150052322|NCT00750152|541332924|FG000|Overall Study|Physician Decision|1|||
150052323|NCT00750152|541332925|FG001|Overall Study|Physician Decision|1|||
150052324|NCT00750152|541332924|FG000|Overall Study|Non-compliance|0|||
150052325|NCT00750152|541332925|FG001|Overall Study|Non-compliance|1|||
150052326|NCT00750152|541332924|FG000|Overall Study|Termination by sponsor|1|||
150052327|NCT00750152|541332925|FG001|Overall Study|Termination by sponsor|0|||
150052328|NCT00750152|541332924|FG000|Overall Study|Other|7|||
149977234|NCT04940130|541053506|FG001|Overall Study|Adverse Event|0|||
149977235|NCT04940130|541053507|FG002|Overall Study|Adverse Event|2|||
149977236|NCT04940130|541053505|FG000|Overall Study|Disease progression/treatment failure|0|||
149977237|NCT04940130|541053506|FG001|Overall Study|Disease progression/treatment failure|0|||
149977238|NCT04940130|541053507|FG002|Overall Study|Disease progression/treatment failure|1|||
149977239|NCT04940130|541053505|FG000|Overall Study|Participant refusal|0|||
149977240|NCT04940130|541053506|FG001|Overall Study|Participant refusal|0|||
149977241|NCT04940130|541053507|FG002|Overall Study|Participant refusal|1|||
149977242|NCT02240121|541053508|FG000|Overall Study|Protocol Violation|1|||
149977243|NCT02240121|541053509|FG001|Overall Study|Protocol Violation|2|||
149977244|NCT02240121|541053508|FG000|Overall Study|Physician Decision|0|||
149977245|NCT02240121|541053509|FG001|Overall Study|Physician Decision|1|||
149977246|NCT02240121|541053508|FG000|Overall Study|Change in protocol interpretation|1|||
149977247|NCT02240121|541053509|FG001|Overall Study|Change in protocol interpretation|0|||
149977248|NCT02240121|541053508|FG000|Overall Study|Lack of Efficacy|2|||
149977249|NCT02240121|541053509|FG001|Overall Study|Lack of Efficacy|3|||
149977250|NCT02240121|541053508|FG000|Overall Study|Site closed|1|||
149977251|NCT02240121|541053509|FG001|Overall Study|Site closed|1|||
149977252|NCT02240121|541053508|FG000|Overall Study|Pregnancy|1|||
149977253|NCT02240121|541053509|FG001|Overall Study|Pregnancy|0|||
149977254|NCT02240121|541053508|FG000|Overall Study|Adverse Event|2|||
149977255|NCT02240121|541053509|FG001|Overall Study|Adverse Event|4|||
149977256|NCT02240121|541053508|FG000|Overall Study|Withdrawal by Subject|6|||
149977257|NCT02240121|541053509|FG001|Overall Study|Withdrawal by Subject|2|||
149977258|NCT02240121|541053508|FG000|Overall Study|Lost to Follow-up|3|||
149977259|NCT02240121|541053509|FG001|Overall Study|Lost to Follow-up|4|||
149977260|NCT02240121|541053508|FG000|Overall Study|Other than specified|1|||
149977261|NCT02240121|541053509|FG001|Overall Study|Other than specified|3|||
149977262|NCT00251693|541053513|FG000|Overall Study|Adverse Event|17|||
149977263|NCT00251693|541053514|FG001|Overall Study|Adverse Event|9|||
149977264|NCT00251693|541053515|FG002|Overall Study|Adverse Event|9|||
149977265|NCT00251693|541053513|FG000|Overall Study|Protocol Violation|2|||
149977266|NCT00251693|541053514|FG001|Overall Study|Protocol Violation|0|||
149977267|NCT00251693|541053515|FG002|Overall Study|Protocol Violation|2|||
149977268|NCT00251693|541053513|FG000|Overall Study|Lost to Follow-up|12|||
149977269|NCT00251693|541053514|FG001|Overall Study|Lost to Follow-up|7|||
149977270|NCT00251693|541053515|FG002|Overall Study|Lost to Follow-up|8|||
149977271|NCT00251693|541053513|FG000|Overall Study|Withdrawal by Subject|11|||
149977272|NCT00251693|541053514|FG001|Overall Study|Withdrawal by Subject|17|||
149977273|NCT00251693|541053515|FG002|Overall Study|Withdrawal by Subject|14|||
149977274|NCT00251693|541053513|FG000|Overall Study|Lack of Efficacy|0|||
149977275|NCT00251693|541053514|FG001|Overall Study|Lack of Efficacy|1|||
149977276|NCT00251693|541053515|FG002|Overall Study|Lack of Efficacy|0|||
149977277|NCT00251693|541053513|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
149977278|NCT00251693|541053514|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
149977279|NCT00251693|541053515|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
149977280|NCT00251693|541053513|FG000|Overall Study|Noncompliant|0|||
149977281|NCT00251693|541053514|FG001|Overall Study|Noncompliant|0|||
149977282|NCT00251693|541053515|FG002|Overall Study|Noncompliant|2|||
149977283|NCT00251693|541053513|FG000|Overall Study|Possible Barrett's esophagus|3|||
149977284|NCT00251693|541053514|FG001|Overall Study|Possible Barrett's esophagus|5|||
149977285|NCT00251693|541053515|FG002|Overall Study|Possible Barrett's esophagus|2|||
149977286|NCT00251693|541053513|FG000|Overall Study|Subject request/subject unavailable|1|||
149977287|NCT00251693|541053514|FG001|Overall Study|Subject request/subject unavailable|2|||
149977288|NCT00251693|541053515|FG002|Overall Study|Subject request/subject unavailable|0|||
149977289|NCT00251693|541053513|FG000|Overall Study|Abnormal laboratory findings|0|||
149977290|NCT00251693|541053514|FG001|Overall Study|Abnormal laboratory findings|0|||
149977291|NCT00251693|541053515|FG002|Overall Study|Abnormal laboratory findings|1|||
149977292|NCT01030822|541053516|FG000|Overall Study|Moved/migrated from study area|6|||
149977293|NCT01030822|541053517|FG001|Overall Study|Moved/migrated from study area|7|||
150052329|NCT00750152|541332925|FG001|Overall Study|Other|8|||
149977294|NCT01030822|541053518|FG002|Overall Study|Moved/migrated from study area|3|||
149977295|NCT01030822|541053516|FG000|Overall Study|Withdrawal by Subject|16|||
149977296|NCT01030822|541053517|FG001|Overall Study|Withdrawal by Subject|13|||
149977297|NCT01030822|541053518|FG002|Overall Study|Withdrawal by Subject|16|||
149977298|NCT01030822|541053516|FG000|Overall Study|Lost to Follow-up|9|||
149977299|NCT01030822|541053517|FG001|Overall Study|Lost to Follow-up|4|||
149977300|NCT01030822|541053518|FG002|Overall Study|Lost to Follow-up|7|||
149977301|NCT01508910|541053519|FG000|Treatment|Death|2|||
149977302|NCT01508910|541053520|FG001|Treatment|Death|3|||
149977303|NCT01508910|541053521|FG002|Treatment|Death|2|||
149977304|NCT01508910|541053522|FG003|Treatment|Death|0|||
149977305|NCT01508910|541053519|FG000|Treatment|Lost to Follow-up|0|||
149977306|NCT01508910|541053520|FG001|Treatment|Lost to Follow-up|0|||
149977307|NCT01508910|541053521|FG002|Treatment|Lost to Follow-up|2|||
149977308|NCT01508910|541053522|FG003|Treatment|Lost to Follow-up|1|||
149977309|NCT01508910|541053519|FG000|Treatment|Withdrawal by Subject|0|||
149977310|NCT01508910|541053520|FG001|Treatment|Withdrawal by Subject|1|||
149977311|NCT01508910|541053521|FG002|Treatment|Withdrawal by Subject|6|||
149977312|NCT01508910|541053522|FG003|Treatment|Withdrawal by Subject|1|||
149977313|NCT01508910|541053519|FG000|Treatment|Sponsor Decision|0|||
149977314|NCT01508910|541053520|FG001|Treatment|Sponsor Decision|0|||
149977315|NCT01508910|541053521|FG002|Treatment|Sponsor Decision|0|||
149977316|NCT01508910|541053522|FG003|Treatment|Sponsor Decision|1|||
149977317|NCT01595529|541053523|FG000|Overall Study|Adverse Event|2|||
149977318|NCT01595529|541053524|FG001|Overall Study|Adverse Event|0|||
149977319|NCT01595529|541053523|FG000|Overall Study|Subject Non-Compliant|2|||
149977320|NCT01595529|541053524|FG001|Overall Study|Subject Non-Compliant|0|||
149977321|NCT01595529|541053523|FG000|Overall Study|Lost to Follow-up|8|||
149977322|NCT01595529|541053524|FG001|Overall Study|Lost to Follow-up|14|||
149977323|NCT01595529|541053523|FG000|Overall Study|Protocol Violation|1|||
149977324|NCT01595529|541053524|FG001|Overall Study|Protocol Violation|2|||
149977325|NCT01595529|541053523|FG000|Overall Study|Physician Decision|1|||
149977326|NCT01595529|541053524|FG001|Overall Study|Physician Decision|0|||
149977327|NCT01595529|541053523|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
149977328|NCT01595529|541053524|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
149977329|NCT01595529|541053523|FG000|Overall Study|Administrative Decision|1|||
149977330|NCT01595529|541053524|FG001|Overall Study|Administrative Decision|0|||
149977331|NCT01595529|541053523|FG000|Overall Study|Entry Failure/Screening Failure|6|||
149977332|NCT01595529|541053524|FG001|Overall Study|Entry Failure/Screening Failure|1|||
149977333|NCT00543985|541053538|FG000|Overall Study|Withdrawal by Subject|4|||
149977334|NCT01634152|541053539|FG000|Overall Study|Adverse Event|2|||
149977335|NCT01634152|541053540|FG001|Overall Study|Adverse Event|0|||
149977336|NCT01634152|541053541|FG002|Overall Study|Adverse Event|2|||
149977337|NCT01634152|541053539|FG000|Overall Study|Consent withdrawn not due to AE|1|||
149977338|NCT01634152|541053540|FG001|Overall Study|Consent withdrawn not due to AE|0|||
149977339|NCT01634152|541053541|FG002|Overall Study|Consent withdrawn not due to AE|1|||
149977340|NCT01634152|541053539|FG000|Overall Study|Not treated|0|||
149977341|NCT01634152|541053540|FG001|Overall Study|Not treated|1|||
149977342|NCT01634152|541053541|FG002|Overall Study|Not treated|0|||
149977343|NCT01634152|541053539|FG000|Overall Study|Other reason not defined above|1|||
149977344|NCT01634152|541053540|FG001|Overall Study|Other reason not defined above|0|||
149977345|NCT01634152|541053541|FG002|Overall Study|Other reason not defined above|1|||
149977346|NCT01152437|541053542|FG000|Overall Study|Other Adverse Event|8|||
149977347|NCT01152437|541053543|FG001|Overall Study|Other Adverse Event|1|||
149977348|NCT01152437|541053544|FG002|Overall Study|Other Adverse Event|7|||
149977349|NCT01152437|541053542|FG000|Overall Study|Not treated|0|||
149977350|NCT01152437|541053543|FG001|Overall Study|Not treated|1|||
149977351|NCT01152437|541053544|FG002|Overall Study|Not treated|2|||
149977352|NCT01152437|541053542|FG000|Overall Study|Progressive disease|27|||
149977353|NCT01152437|541053543|FG001|Overall Study|Progressive disease|13|||
149977354|NCT01152437|541053544|FG002|Overall Study|Progressive disease|32|||
149977355|NCT01152437|541053542|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
149977356|NCT01152437|541053543|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
149977357|NCT01152437|541053544|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
149977358|NCT01900665|541053545|FG000|Placebo Controlled Period|Death|9|||
149977359|NCT01900665|541053546|FG001|Placebo Controlled Period|Death|16|||
150052330|NCT01030666|541332926|FG000|Overall Study|Lost to Follow-up|3|||
150178556|NCT00421889|541791976|FG004|Overall Study|Withdrawal by Subject|2|||
150178557|NCT00421889|541791977|FG005|Overall Study|Withdrawal by Subject|0|||
150178558|NCT00421889|541791978|FG006|Overall Study|Withdrawal by Subject|0|||
150178559|NCT00421889|541791979|FG007|Overall Study|Withdrawal by Subject|0|||
150178560|NCT00421889|541791980|FG008|Overall Study|Withdrawal by Subject|0|||
150178561|NCT00421889|541791972|FG000|Overall Study|Death|0|||
150178562|NCT00421889|541791973|FG001|Overall Study|Death|0|||
150178563|NCT00421889|541791974|FG002|Overall Study|Death|0|||
150178564|NCT00421889|541791975|FG003|Overall Study|Death|0|||
150178565|NCT00421889|541791976|FG004|Overall Study|Death|1|||
150178566|NCT00421889|541791977|FG005|Overall Study|Death|1|||
150178567|NCT00421889|541791978|FG006|Overall Study|Death|0|||
150178568|NCT00421889|541791979|FG007|Overall Study|Death|0|||
150178569|NCT00421889|541791980|FG008|Overall Study|Death|0|||
149977360|NCT01900665|541053545|FG000|Placebo Controlled Period|Adverse Event|48|||
149977361|NCT01900665|541053546|FG001|Placebo Controlled Period|Adverse Event|39|||
149977362|NCT01900665|541053545|FG000|Placebo Controlled Period|Protocol Violation|1|||
149977363|NCT01900665|541053546|FG001|Placebo Controlled Period|Protocol Violation|7|||
149977364|NCT01900665|541053545|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
149977365|NCT01900665|541053546|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
150178570|NCT00421889|541791972|FG000|Overall Study|Progressive disease|3|||
150178571|NCT00421889|541791973|FG001|Overall Study|Progressive disease|2|||
150178572|NCT00421889|541791974|FG002|Overall Study|Progressive disease|2|||
149977366|NCT01900665|541053545|FG000|Placebo Controlled Period|Physician Decision|11|||
149977367|NCT01900665|541053546|FG001|Placebo Controlled Period|Physician Decision|7|||
149977368|NCT01900665|541053545|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
149977369|NCT01900665|541053546|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
149977370|NCT01900665|541053545|FG000|Placebo Controlled Period|Caregiver Decision|33|||
149977371|NCT01900665|541053546|FG001|Placebo Controlled Period|Caregiver Decision|41|||
149977372|NCT01900665|541053545|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
149977373|NCT01900665|541053546|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
149977374|NCT01900665|541053545|FG000|Open Label Period|Adverse Event|16|||
149977375|NCT01900665|541053546|FG001|Open Label Period|Adverse Event|20|||
149977376|NCT01900665|541053545|FG000|Open Label Period|Death|5|||
149977377|NCT01900665|541053546|FG001|Open Label Period|Death|6|||
149977378|NCT01900665|541053545|FG000|Open Label Period|Lost to Follow-up|1|||
149977379|NCT01900665|541053546|FG001|Open Label Period|Lost to Follow-up|1|||
149977380|NCT01900665|541053545|FG000|Open Label Period|Parent/Caregiver Decision|33|||
149977381|NCT01900665|541053546|FG001|Open Label Period|Parent/Caregiver Decision|34|||
149977382|NCT01900665|541053545|FG000|Open Label Period|Physician Decision|4|||
149977383|NCT01900665|541053546|FG001|Open Label Period|Physician Decision|4|||
149977384|NCT01900665|541053545|FG000|Open Label Period|Protocol Violation|0|||
149977385|NCT01900665|541053546|FG001|Open Label Period|Protocol Violation|1|||
149977386|NCT01900665|541053545|FG000|Open Label Period|Sponsor Decision|802|||
149977387|NCT01900665|541053546|FG001|Open Label Period|Sponsor Decision|765|||
149977388|NCT01900665|541053545|FG000|Open Label Period|Withdrawal by Subject|20|||
149977389|NCT01900665|541053546|FG001|Open Label Period|Withdrawal by Subject|28|||
149977390|NCT04046939|541053548|FG000|Primary Assessment Period|Adverse Event|1|||
149977391|NCT04046939|541053549|FG001|Primary Assessment Period|Adverse Event|0|||
149977392|NCT04046939|541053550|FG002|Primary Assessment Period|Adverse Event|0|||
149977393|NCT04046939|541053551|FG003|Primary Assessment Period|Adverse Event|0|||
149977394|NCT04046939|541053548|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
149977395|NCT04046939|541053549|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
149977396|NCT04046939|541053550|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
149977397|NCT04046939|541053551|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
149977398|NCT04046939|541053548|FG000|Primary Assessment Period|Physician Decision|0|||
149977399|NCT04046939|541053549|FG001|Primary Assessment Period|Physician Decision|0|||
149977400|NCT04046939|541053550|FG002|Primary Assessment Period|Physician Decision|1|||
149977401|NCT04046939|541053551|FG003|Primary Assessment Period|Physician Decision|0|||
149977402|NCT04046939|541053548|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
149977403|NCT04046939|541053549|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
149977404|NCT04046939|541053550|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
149977405|NCT04046939|541053551|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
149977406|NCT00403130|541053552|FG000|2 Years From Start of Treatment|Not Eligible|3|||
149977407|NCT00403130|541053552|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
149977408|NCT00403130|541053552|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
149977409|NCT00403130|541053552|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
149977410|NCT00953706|541053560|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
149977411|NCT00953706|541053561|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
150052331|NCT01030666|541332927|FG001|Overall Study|Lost to Follow-up|2|||
150052332|NCT04002908|541332930|FG000|Overall Study|Death|41|||
150052333|NCT04002908|541332931|FG001|Overall Study|Death|0|||
150052334|NCT04002908|541332932|FG002|Overall Study|Death|0|||
150052335|NCT04002908|541332933|FG003|Overall Study|Death|0|||
150052336|NCT04002908|541332930|FG000|Overall Study|Withdrawal by Subject|112|||
150052337|NCT04002908|541332931|FG001|Overall Study|Withdrawal by Subject|0|||
150052338|NCT04002908|541332932|FG002|Overall Study|Withdrawal by Subject|0|||
150052339|NCT04002908|541332933|FG003|Overall Study|Withdrawal by Subject|0|||
150052340|NCT04002908|541332930|FG000|Overall Study|Lost to Follow-up|72|||
150052341|NCT04002908|541332931|FG001|Overall Study|Lost to Follow-up|0|||
150052342|NCT04002908|541332932|FG002|Overall Study|Lost to Follow-up|0|||
150052343|NCT04002908|541332933|FG003|Overall Study|Lost to Follow-up|0|||
150052344|NCT04002908|541332930|FG000|Overall Study|Infant died, so mother withdrawn|34|||
150052345|NCT04002908|541332931|FG001|Overall Study|Infant died, so mother withdrawn|0|||
150052346|NCT04002908|541332932|FG002|Overall Study|Infant died, so mother withdrawn|0|||
150052347|NCT04002908|541332933|FG003|Overall Study|Infant died, so mother withdrawn|0|||
150052348|NCT03698591|541332934|FG000|Overall Study|Withdrawal by Subject|2|||
150052349|NCT03698591|541332935|FG001|Overall Study|Withdrawal by Subject|2|||
150052350|NCT03698591|541332934|FG000|Overall Study|Failed drug screen|1|||
149977412|NCT00953706|541053562|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
149977413|NCT00953706|541053563|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
149977414|NCT00953706|541053560|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
149977415|NCT00953706|541053561|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
149977416|NCT00953706|541053562|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
149977417|NCT00953706|541053563|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
149977418|NCT00953706|541053560|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
149977419|NCT00953706|541053561|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
149977420|NCT00953706|541053562|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
149977421|NCT00953706|541053563|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
149977422|NCT00953706|541053560|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
149977423|NCT00953706|541053561|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
149977424|NCT00953706|541053562|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
149977425|NCT00953706|541053563|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
149977426|NCT00953706|541053560|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
149977427|NCT00953706|541053561|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
149977428|NCT00953706|541053562|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
149977429|NCT00953706|541053563|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
149977430|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
149977431|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
149977432|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
149977433|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
149977434|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
150052351|NCT03698591|541332935|FG001|Overall Study|Failed drug screen|1|||
150052352|NCT03698591|541332934|FG000|Overall Study|Failed health screen|0|||
150052353|NCT03698591|541332935|FG001|Overall Study|Failed health screen|1|||
150052354|NCT03698591|541332934|FG000|Overall Study|Ineligible for financial compensation|1|||
150052355|NCT03698591|541332935|FG001|Overall Study|Ineligible for financial compensation|0|||
150052356|NCT03698591|541332934|FG000|Overall Study|Equipment Error|1|||
150052357|NCT03698591|541332935|FG001|Overall Study|Equipment Error|0|||
150052358|NCT03698591|541332934|FG000|Overall Study|Could not establish TMS dosage|0|||
150052359|NCT03698591|541332935|FG001|Overall Study|Could not establish TMS dosage|1|||
150052360|NCT04359901|541332938|FG000|Overall Study|Withdrawal by Subject|0|||
150052361|NCT04359901|541332939|FG001|Overall Study|Withdrawal by Subject|1|||
150052362|NCT04359901|541332938|FG000|Overall Study|Death|6|||
150052363|NCT04359901|541332939|FG001|Overall Study|Death|2|||
150052364|NCT03425253|541332942|FG000|Overall Study|Adverse Event|2|||
150052365|NCT03425253|541332942|FG000|Overall Study|Lost to Follow-up|3|||
150052366|NCT03425253|541332942|FG000|Overall Study|Withdrew Consent|6|||
150052367|NCT03425253|541332942|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
150052368|NCT04614324|541332945|FG000|Overall Study|Lost to Follow-up|3|||
150052369|NCT04614324|541332945|FG000|Overall Study|Physician Decision|1|||
150052370|NCT04614324|541332945|FG000|Overall Study|Withdrawal by Subject|2|||
150052371|NCT04614324|541332945|FG000|Overall Study|Remaining in Follow up|123|||
150052372|NCT00336856|541334963|FG000|Overall Study|Withdrawal by Subject|3|||
150052373|NCT00336856|541334963|FG000|Overall Study|Found ineligible at time of analysis|1|||
150052374|NCT02522624|541334965|FG000|Overall Study|Technical failure|1|||
150052375|NCT02522624|541334966|FG001|Overall Study|Technical failure|0|||
150052376|NCT01325337|541334967|FG000|Overall Study|Adverse Event|0|||
150052377|NCT01325337|541334968|FG001|Overall Study|Adverse Event|2|||
150052378|NCT01325337|541334969|FG002|Overall Study|Adverse Event|2|||
150052379|NCT01325337|541334970|FG003|Overall Study|Adverse Event|1|||
149977435|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
149977436|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
149977437|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
149977438|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
149977439|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
149977440|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
149977441|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
149977442|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
149977443|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
149977444|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
149977445|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
149977446|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
149977447|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
149977448|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
149977449|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
149977450|NCT00953706|541053560|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
149977451|NCT00953706|541053561|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
149977452|NCT00953706|541053562|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
149977453|NCT00953706|541053563|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
149977454|NCT01404234|541053564|FG000|Overall Study|Withdrawal by Subject|2|||
149977455|NCT02670473|541053565|FG000|Overall Study|Withdrawal by Subject|1|||
149977456|NCT01214837|541053566|FG000|Overall Study|Death|0|||
149977457|NCT01214837|541053567|FG001|Overall Study|Death|0|||
149977458|NCT01214837|541053568|FG002|Overall Study|Death|1|||
149977459|NCT01214837|541053566|FG000|Overall Study|Adverse Event|1|||
149977460|NCT01214837|541053567|FG001|Overall Study|Adverse Event|2|||
149977461|NCT01214837|541053568|FG002|Overall Study|Adverse Event|1|||
149977462|NCT01214837|541053566|FG000|Overall Study|Withdrawal by Subject|27|||
149977463|NCT01214837|541053567|FG001|Overall Study|Withdrawal by Subject|36|||
149977464|NCT01214837|541053568|FG002|Overall Study|Withdrawal by Subject|28|||
149977465|NCT01214837|541053566|FG000|Overall Study|Lost to Follow-up|20|||
149977466|NCT01214837|541053567|FG001|Overall Study|Lost to Follow-up|15|||
149977467|NCT01214837|541053568|FG002|Overall Study|Lost to Follow-up|21|||
149977468|NCT01214837|541053566|FG000|Overall Study|Inappropriate Enrolment|0|||
149977469|NCT01214837|541053567|FG001|Overall Study|Inappropriate Enrolment|1|||
149977470|NCT01214837|541053568|FG002|Overall Study|Inappropriate Enrolment|2|||
149977471|NCT01214837|541053566|FG000|Overall Study|Administrative Reason|2|||
149977472|NCT01214837|541053567|FG001|Overall Study|Administrative Reason|6|||
149977473|NCT01214837|541053568|FG002|Overall Study|Administrative Reason|4|||
149977474|NCT01214837|541053566|FG000|Overall Study|Protocol Violation|3|||
149977475|NCT01214837|541053567|FG001|Overall Study|Protocol Violation|1|||
149977476|NCT01214837|541053568|FG002|Overall Study|Protocol Violation|5|||
149977477|NCT01214837|541053566|FG000|Overall Study|Unable to Classify|1|||
149977478|NCT01214837|541053567|FG001|Overall Study|Unable to Classify|3|||
149977479|NCT01214837|541053568|FG002|Overall Study|Unable to Classify|0|||
149977480|NCT05414175|541053569|FG000|Overall Study|Withdrawal by Subject|1|||
149977481|NCT05414175|541053569|FG000|Overall Study|Other Reasons|1|||
149977482|NCT00457626|541053571|FG000|Overall Study|Adverse Event|3|||
149977483|NCT00457626|541053571|FG000|Overall Study|Administrative Problems|2|||
149977484|NCT00457626|541053571|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
149977485|NCT03559270|541053572|FG000|Overall Study|Adverse Event|6|||
149977486|NCT03559270|541053573|FG001|Overall Study|Adverse Event|5|||
149977487|NCT03559270|541053574|FG002|Overall Study|Adverse Event|3|||
149977488|NCT03559270|541053575|FG003|Overall Study|Adverse Event|0|||
149977489|NCT03559270|541053572|FG000|Overall Study|Lack of Efficacy|34|||
149977490|NCT03559270|541053573|FG001|Overall Study|Lack of Efficacy|52|||
149977491|NCT03559270|541053574|FG002|Overall Study|Lack of Efficacy|37|||
149977492|NCT03559270|541053575|FG003|Overall Study|Lack of Efficacy|2|||
149977493|NCT03559270|541053572|FG000|Overall Study|Death|0|||
149977494|NCT03559270|541053573|FG001|Overall Study|Death|2|||
149977495|NCT03559270|541053574|FG002|Overall Study|Death|0|||
149977496|NCT03559270|541053575|FG003|Overall Study|Death|0|||
149977497|NCT03559270|541053572|FG000|Overall Study|Lost to Follow-up|16|||
149977498|NCT03559270|541053573|FG001|Overall Study|Lost to Follow-up|4|||
149977499|NCT03559270|541053574|FG002|Overall Study|Lost to Follow-up|12|||
149977500|NCT03559270|541053575|FG003|Overall Study|Lost to Follow-up|3|||
149977501|NCT03559270|541053572|FG000|Overall Study|Sponsor Decision|38|||
149977502|NCT03559270|541053573|FG001|Overall Study|Sponsor Decision|31|||
149977503|NCT03559270|541053574|FG002|Overall Study|Sponsor Decision|35|||
149977504|NCT03559270|541053575|FG003|Overall Study|Sponsor Decision|18|||
149977505|NCT03559270|541053572|FG000|Overall Study|Withdrawal by Subject|19|||
149977506|NCT03559270|541053573|FG001|Overall Study|Withdrawal by Subject|21|||
149737494|NCT02601950|540170380|FG003|Overall Study|Non-compliance|0|||
149977507|NCT03559270|541053574|FG002|Overall Study|Withdrawal by Subject|18|||
149977508|NCT03559270|541053575|FG003|Overall Study|Withdrawal by Subject|7|||
149977509|NCT03559270|541053572|FG000|Overall Study|Physician Decision|3|||
149977510|NCT03559270|541053573|FG001|Overall Study|Physician Decision|2|||
149977511|NCT03559270|541053574|FG002|Overall Study|Physician Decision|1|||
149977512|NCT03559270|541053575|FG003|Overall Study|Physician Decision|0|||
149977513|NCT03559270|541053572|FG000|Overall Study|Pregnancy|0|||
149977514|NCT03559270|541053573|FG001|Overall Study|Pregnancy|1|||
149977515|NCT03559270|541053574|FG002|Overall Study|Pregnancy|0|||
149977516|NCT03559270|541053575|FG003|Overall Study|Pregnancy|0|||
149977517|NCT03559270|541053572|FG000|Overall Study|Protocol Violation|1|||
149977518|NCT03559270|541053573|FG001|Overall Study|Protocol Violation|0|||
149977519|NCT03559270|541053574|FG002|Overall Study|Protocol Violation|2|||
149977520|NCT03559270|541053575|FG003|Overall Study|Protocol Violation|0|||
149977521|NCT04790279|541055289|FG000|Overall Study|Did not meet medication start criteria|27|||
149977522|NCT04790279|541055290|FG001|Overall Study|Did not meet medication start criteria|15|||
149977523|NCT04790279|541055289|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
149977524|NCT04790279|541055290|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
149977525|NCT04790279|541055289|FG000|Overall Study|Protocol Violation|8|||
149977526|NCT04790279|541055290|FG001|Overall Study|Protocol Violation|3|||
149977527|NCT04790279|541055289|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
149977528|NCT04790279|541055290|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
149977529|NCT00678288|541055307|FG000|Overall Study|Adverse Event|0|||
149977530|NCT00678288|541055308|FG001|Overall Study|Adverse Event|2|||
149977531|NCT00678288|541055307|FG000|Overall Study|Withdrawal by Subject|1|||
149977532|NCT00678288|541055308|FG001|Overall Study|Withdrawal by Subject|1|||
149977533|NCT00678288|541055307|FG000|Overall Study|Study terminated by the sponsor|2|||
149977534|NCT00678288|541055308|FG001|Overall Study|Study terminated by the sponsor|0|||
149977535|NCT00678288|541055307|FG000|Overall Study|Not compliant with study medication|0|||
149977536|NCT00678288|541055308|FG001|Overall Study|Not compliant with study medication|1|||
149977537|NCT00678288|541055307|FG000|Overall Study|Switch to commercial drug|0|||
149977538|NCT00678288|541055308|FG001|Overall Study|Switch to commercial drug|1|||
149977539|NCT00678288|541055307|FG000|Overall Study|Reason not reported|1|||
149977540|NCT00678288|541055308|FG001|Overall Study|Reason not reported|0|||
149977541|NCT00678288|541055307|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
149977542|NCT00678288|541055308|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
149977543|NCT04472650|541055317|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
149977544|NCT04472650|541055318|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
149977545|NCT02549989|541055323|FG000|Overall Study|Adverse Event|4|||
149977546|NCT02549989|541055323|FG000|Overall Study|Death|1|||
149977547|NCT02549989|541055323|FG000|Overall Study|Lack of Efficacy|19|||
149977548|NCT02549989|541055323|FG000|Overall Study|Withdrawal by Subject|3|||
149977549|NCT01856322|541055324|FG000|Overall Study|off study due to lack of accrual|0|||
149977550|NCT01856322|541055325|FG001|Overall Study|off study due to lack of accrual|0|||
149977551|NCT01856322|541055326|FG002|Overall Study|off study due to lack of accrual|3|||
149977552|NCT02628444|541055330|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
149977553|NCT02628444|541055331|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977554|NCT02628444|541055332|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977555|NCT02628444|541055333|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977556|NCT02628444|541055334|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977557|NCT02628444|541055335|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977558|NCT02628444|541055336|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977559|NCT02628444|541055337|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977560|NCT02628444|541055338|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149977561|NCT02628444|541055330|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977562|NCT02628444|541055331|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
149977563|NCT02628444|541055332|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
149977564|NCT02628444|541055333|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977565|NCT02628444|541055334|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977566|NCT02628444|541055335|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977567|NCT02628444|541055336|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977568|NCT02628444|541055337|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977569|NCT02628444|541055338|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149977570|NCT02628444|541055330|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
149977571|NCT02628444|541055331|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
149977572|NCT02628444|541055332|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
150052380|NCT01325337|541334971|FG004|Overall Study|Adverse Event|2|||
149737495|NCT02601950|540170381|FG004|Overall Study|Non-compliance|0|||
149977573|NCT02628444|541055333|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977574|NCT02628444|541055334|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977575|NCT02628444|541055335|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977576|NCT02628444|541055336|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977577|NCT02628444|541055337|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977578|NCT02628444|541055338|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977579|NCT02628444|541055330|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
149977580|NCT02628444|541055331|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
149977581|NCT02628444|541055332|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
150052381|NCT01325337|541334967|FG000|Overall Study|Lost to Follow-up|2|||
150052382|NCT01325337|541334968|FG001|Overall Study|Lost to Follow-up|2|||
150052383|NCT01325337|541334969|FG002|Overall Study|Lost to Follow-up|2|||
150052384|NCT01325337|541334970|FG003|Overall Study|Lost to Follow-up|1|||
150052385|NCT01325337|541334971|FG004|Overall Study|Lost to Follow-up|2|||
150052386|NCT01325337|541334967|FG000|Overall Study|Personal Reasons|2|||
150052387|NCT01325337|541334968|FG001|Overall Study|Personal Reasons|5|||
150052388|NCT01325337|541334969|FG002|Overall Study|Personal Reasons|4|||
150052389|NCT01325337|541334970|FG003|Overall Study|Personal Reasons|8|||
150052390|NCT01325337|541334971|FG004|Overall Study|Personal Reasons|3|||
150052391|NCT01325337|541334967|FG000|Overall Study|Withdrawal by Subject|1|||
150052392|NCT01325337|541334968|FG001|Overall Study|Withdrawal by Subject|0|||
150052393|NCT01325337|541334969|FG002|Overall Study|Withdrawal by Subject|1|||
150178573|NCT00421889|541791975|FG003|Overall Study|Progressive disease|3|||
149977582|NCT02628444|541055333|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977583|NCT02628444|541055334|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977584|NCT02628444|541055335|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977585|NCT02628444|541055336|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977586|NCT02628444|541055337|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977587|NCT02628444|541055338|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
149977588|NCT02628444|541055330|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
149977589|NCT02628444|541055331|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
149977590|NCT02628444|541055332|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
149977591|NCT02628444|541055333|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977592|NCT02628444|541055334|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977593|NCT02628444|541055335|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977594|NCT02628444|541055336|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977595|NCT02628444|541055337|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977596|NCT02628444|541055338|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
149977597|NCT02628444|541055330|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977598|NCT02628444|541055331|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977599|NCT02628444|541055332|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977600|NCT02628444|541055333|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
149977601|NCT02628444|541055334|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977602|NCT02628444|541055335|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977603|NCT02628444|541055336|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977604|NCT02628444|541055337|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977605|NCT02628444|541055338|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
149977606|NCT02628444|541055330|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
149977607|NCT02628444|541055331|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
149977608|NCT02628444|541055332|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
149977609|NCT02628444|541055333|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
149977610|NCT02628444|541055334|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
149977611|NCT02628444|541055335|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
149977612|NCT02628444|541055336|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
149977613|NCT02628444|541055337|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
149977614|NCT02628444|541055338|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
149977615|NCT02628444|541055330|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
150052394|NCT01325337|541334970|FG003|Overall Study|Withdrawal by Subject|0|||
150052395|NCT01325337|541334971|FG004|Overall Study|Withdrawal by Subject|1|||
150052396|NCT00843778|541334984|FG000|Overall Study|Adverse Event|15|||
150052397|NCT00843778|541334984|FG000|Overall Study|Lack of Efficacy|14|||
150052398|NCT00843778|541334984|FG000|Overall Study|Loss of efficacy|2|||
150052399|NCT00843778|541334984|FG000|Overall Study|Withdrawal by Subject|4|||
150052400|NCT00730028|541334991|FG000|Overall Study|Adverse Event|23|||
150052401|NCT00730028|541334992|FG001|Overall Study|Adverse Event|26|||
150052402|NCT00730028|541334993|FG002|Overall Study|Adverse Event|16|||
150052403|NCT00730028|541334994|FG003|Overall Study|Adverse Event|20|||
150052404|NCT00730028|541334995|FG004|Overall Study|Adverse Event|43|||
150052405|NCT00730028|541334991|FG000|Overall Study|Lost to Follow-up|13|||
150178574|NCT00421889|541791976|FG004|Overall Study|Progressive disease|2|||
150052406|NCT00730028|541334992|FG001|Overall Study|Lost to Follow-up|26|||
150052407|NCT00730028|541334993|FG002|Overall Study|Lost to Follow-up|22|||
150052408|NCT00730028|541334994|FG003|Overall Study|Lost to Follow-up|26|||
150052409|NCT00730028|541334995|FG004|Overall Study|Lost to Follow-up|25|||
150052410|NCT00730028|541334991|FG000|Overall Study|Protocol Violation|6|||
150178575|NCT00421889|541791977|FG005|Overall Study|Progressive disease|21|||
150178576|NCT00421889|541791978|FG006|Overall Study|Progressive disease|3|||
150178577|NCT00421889|541791979|FG007|Overall Study|Progressive disease|1|||
149977616|NCT02628444|541055331|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977617|NCT02628444|541055332|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
149977618|NCT02628444|541055333|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
149977619|NCT02628444|541055334|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
149977620|NCT02628444|541055335|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
149977621|NCT02628444|541055336|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
149977622|NCT02628444|541055337|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
149977623|NCT02628444|541055338|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
149977624|NCT02628444|541055330|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977625|NCT02628444|541055331|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977626|NCT02628444|541055332|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977627|NCT02628444|541055333|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977628|NCT02628444|541055334|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
149977629|NCT02628444|541055335|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977630|NCT02628444|541055336|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
149977631|NCT02628444|541055337|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
149977632|NCT02628444|541055338|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
149977633|NCT02628444|541055330|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
149977634|NCT02628444|541055331|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
149977635|NCT02628444|541055332|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
149977636|NCT02628444|541055333|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
149977637|NCT02628444|541055334|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
149977638|NCT02628444|541055335|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
149977639|NCT02628444|541055336|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
149977640|NCT02628444|541055337|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
149977641|NCT02628444|541055338|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
149977642|NCT02079909|541055339|FG000|Overall Study|Adverse Event|23|||
149977643|NCT02079909|541055340|FG001|Overall Study|Adverse Event|23|||
149977644|NCT02079909|541055341|FG002|Overall Study|Adverse Event|7|||
149977645|NCT02079909|541055339|FG000|Overall Study|Withdrawal by Subject|9|||
149977646|NCT02079909|541055340|FG001|Overall Study|Withdrawal by Subject|17|||
149977647|NCT02079909|541055341|FG002|Overall Study|Withdrawal by Subject|4|||
149977648|NCT02079909|541055339|FG000|Overall Study|Lost to Follow-up|2|||
149977649|NCT02079909|541055340|FG001|Overall Study|Lost to Follow-up|3|||
149977650|NCT02079909|541055341|FG002|Overall Study|Lost to Follow-up|1|||
149977651|NCT02079909|541055339|FG000|Overall Study|Death|2|||
149977652|NCT02079909|541055340|FG001|Overall Study|Death|2|||
149977653|NCT02079909|541055341|FG002|Overall Study|Death|0|||
149977654|NCT02079909|541055339|FG000|Overall Study|Lack of Efficacy|0|||
149977655|NCT02079909|541055340|FG001|Overall Study|Lack of Efficacy|0|||
149977656|NCT02079909|541055341|FG002|Overall Study|Lack of Efficacy|1|||
149977657|NCT02079909|541055339|FG000|Overall Study|Protocol Violation|0|||
149977658|NCT02079909|541055340|FG001|Overall Study|Protocol Violation|1|||
149977659|NCT02079909|541055341|FG002|Overall Study|Protocol Violation|1|||
149977660|NCT02079909|541055339|FG000|Overall Study|Physician Decision|0|||
149977661|NCT02079909|541055340|FG001|Overall Study|Physician Decision|1|||
149977662|NCT02079909|541055341|FG002|Overall Study|Physician Decision|1|||
149977663|NCT02079909|541055339|FG000|Overall Study|Relocation etc.|2|||
149977664|NCT02079909|541055340|FG001|Overall Study|Relocation etc.|2|||
149977665|NCT02079909|541055341|FG002|Overall Study|Relocation etc.|3|||
149977666|NCT01713582|541055342|FG000|Overall Study|Disease progression|3|||
149977667|NCT01713582|541055343|FG001|Overall Study|Disease progression|3|||
149977668|NCT01713582|541055344|FG002|Overall Study|Disease progression|3|||
149977669|NCT01713582|541055345|FG003|Overall Study|Disease progression|2|||
149977670|NCT01713582|541055346|FG004|Overall Study|Disease progression|3|||
149977671|NCT01713582|541055347|FG005|Overall Study|Disease progression|3|||
149977672|NCT01713582|541055348|FG006|Overall Study|Disease progression|3|||
149977673|NCT01713582|541055349|FG007|Overall Study|Disease progression|3|||
149977674|NCT01713582|541055350|FG008|Overall Study|Disease progression|3|||
149977675|NCT01713582|541055351|FG009|Overall Study|Disease progression|11|||
149977676|NCT01713582|541055352|FG010|Overall Study|Disease progression|10|||
149977677|NCT01713582|541055353|FG011|Overall Study|Disease progression|5|||
149977678|NCT01713582|541055354|FG012|Overall Study|Disease progression|3|||
149977679|NCT01713582|541055355|FG013|Overall Study|Disease progression|3|||
149977680|NCT01713582|541055356|FG014|Overall Study|Disease progression|6|||
149977681|NCT01713582|541055357|FG015|Overall Study|Disease progression|6|||
149977682|NCT01713582|541055358|FG016|Overall Study|Disease progression|5|||
149977683|NCT01713582|541055359|FG017|Overall Study|Disease progression|2|||
149977684|NCT01713582|541055360|FG018|Overall Study|Disease progression|3|||
149977685|NCT01713582|541055361|FG019|Overall Study|Disease progression|5|||
149977686|NCT01713582|541055362|FG020|Overall Study|Disease progression|15|||
149977687|NCT01713582|541055342|FG000|Overall Study|Death|0|||
149977688|NCT01713582|541055343|FG001|Overall Study|Death|0|||
149977689|NCT01713582|541055344|FG002|Overall Study|Death|0|||
149977690|NCT01713582|541055345|FG003|Overall Study|Death|1|||
149977691|NCT01713582|541055346|FG004|Overall Study|Death|1|||
149977692|NCT01713582|541055347|FG005|Overall Study|Death|3|||
149977693|NCT01713582|541055348|FG006|Overall Study|Death|3|||
149977694|NCT01713582|541055349|FG007|Overall Study|Death|2|||
149977695|NCT01713582|541055350|FG008|Overall Study|Death|3|||
149977696|NCT01713582|541055351|FG009|Overall Study|Death|4|||
149977697|NCT01713582|541055352|FG010|Overall Study|Death|3|||
149977698|NCT01713582|541055353|FG011|Overall Study|Death|0|||
149977699|NCT01713582|541055354|FG012|Overall Study|Death|0|||
149977700|NCT01713582|541055355|FG013|Overall Study|Death|0|||
149977701|NCT01713582|541055356|FG014|Overall Study|Death|0|||
149977702|NCT01713582|541055357|FG015|Overall Study|Death|0|||
149977703|NCT01713582|541055358|FG016|Overall Study|Death|0|||
149977704|NCT01713582|541055359|FG017|Overall Study|Death|0|||
149977705|NCT01713582|541055360|FG018|Overall Study|Death|0|||
149977706|NCT01713582|541055361|FG019|Overall Study|Death|0|||
149977707|NCT01713582|541055362|FG020|Overall Study|Death|0|||
149977708|NCT01713582|541055342|FG000|Overall Study|Adverse event-related|0|||
149977709|NCT01713582|541055343|FG001|Overall Study|Adverse event-related|0|||
149977710|NCT01713582|541055344|FG002|Overall Study|Adverse event-related|0|||
149977711|NCT01713582|541055345|FG003|Overall Study|Adverse event-related|0|||
149977712|NCT01713582|541055346|FG004|Overall Study|Adverse event-related|0|||
149977713|NCT01713582|541055347|FG005|Overall Study|Adverse event-related|0|||
149977714|NCT01713582|541055348|FG006|Overall Study|Adverse event-related|0|||
149977715|NCT01713582|541055349|FG007|Overall Study|Adverse event-related|0|||
149977716|NCT01713582|541055350|FG008|Overall Study|Adverse event-related|0|||
149977717|NCT01713582|541055351|FG009|Overall Study|Adverse event-related|1|||
149977718|NCT01713582|541055352|FG010|Overall Study|Adverse event-related|1|||
149977719|NCT01713582|541055353|FG011|Overall Study|Adverse event-related|0|||
149977720|NCT01713582|541055354|FG012|Overall Study|Adverse event-related|0|||
149977721|NCT01713582|541055355|FG013|Overall Study|Adverse event-related|0|||
149977722|NCT01713582|541055356|FG014|Overall Study|Adverse event-related|0|||
149977723|NCT01713582|541055357|FG015|Overall Study|Adverse event-related|0|||
149977724|NCT01713582|541055358|FG016|Overall Study|Adverse event-related|0|||
149977725|NCT01713582|541055359|FG017|Overall Study|Adverse event-related|0|||
149977726|NCT01713582|541055360|FG018|Overall Study|Adverse event-related|1|||
149977727|NCT01713582|541055361|FG019|Overall Study|Adverse event-related|0|||
149977728|NCT01713582|541055362|FG020|Overall Study|Adverse event-related|0|||
149977729|NCT01713582|541055342|FG000|Overall Study|Adverse event-unrelated|0|||
149977730|NCT01713582|541055343|FG001|Overall Study|Adverse event-unrelated|0|||
149977731|NCT01713582|541055344|FG002|Overall Study|Adverse event-unrelated|0|||
149977732|NCT01713582|541055345|FG003|Overall Study|Adverse event-unrelated|0|||
149977733|NCT01713582|541055346|FG004|Overall Study|Adverse event-unrelated|0|||
149977734|NCT01713582|541055347|FG005|Overall Study|Adverse event-unrelated|1|||
149977735|NCT01713582|541055348|FG006|Overall Study|Adverse event-unrelated|1|||
149977736|NCT01713582|541055349|FG007|Overall Study|Adverse event-unrelated|1|||
149977737|NCT01713582|541055350|FG008|Overall Study|Adverse event-unrelated|0|||
149977738|NCT01713582|541055351|FG009|Overall Study|Adverse event-unrelated|0|||
149977739|NCT01713582|541055352|FG010|Overall Study|Adverse event-unrelated|0|||
149977740|NCT01713582|541055353|FG011|Overall Study|Adverse event-unrelated|0|||
149977741|NCT01713582|541055354|FG012|Overall Study|Adverse event-unrelated|0|||
149977742|NCT01713582|541055355|FG013|Overall Study|Adverse event-unrelated|1|||
149977743|NCT01713582|541055356|FG014|Overall Study|Adverse event-unrelated|1|||
149977744|NCT01713582|541055357|FG015|Overall Study|Adverse event-unrelated|0|||
149977745|NCT01713582|541055358|FG016|Overall Study|Adverse event-unrelated|0|||
149977746|NCT01713582|541055359|FG017|Overall Study|Adverse event-unrelated|0|||
149977747|NCT01713582|541055360|FG018|Overall Study|Adverse event-unrelated|0|||
149977748|NCT01713582|541055361|FG019|Overall Study|Adverse event-unrelated|0|||
149977749|NCT01713582|541055362|FG020|Overall Study|Adverse event-unrelated|0|||
149977750|NCT01713582|541055342|FG000|Overall Study|Withdrawal of consent|0|||
149977751|NCT01713582|541055343|FG001|Overall Study|Withdrawal of consent|0|||
149977752|NCT01713582|541055344|FG002|Overall Study|Withdrawal of consent|1|||
149977753|NCT01713582|541055345|FG003|Overall Study|Withdrawal of consent|0|||
149977754|NCT01713582|541055346|FG004|Overall Study|Withdrawal of consent|0|||
149977755|NCT01713582|541055347|FG005|Overall Study|Withdrawal of consent|1|||
149977756|NCT01713582|541055348|FG006|Overall Study|Withdrawal of consent|0|||
149977757|NCT01713582|541055349|FG007|Overall Study|Withdrawal of consent|0|||
150052411|NCT00730028|541334992|FG001|Overall Study|Protocol Violation|1|||
150052412|NCT00730028|541334993|FG002|Overall Study|Protocol Violation|1|||
150052413|NCT00730028|541334994|FG003|Overall Study|Protocol Violation|2|||
150052414|NCT00730028|541334995|FG004|Overall Study|Protocol Violation|0|||
150052415|NCT00730028|541334991|FG000|Overall Study|Withdrawal by Subject|9|||
150052416|NCT00730028|541334992|FG001|Overall Study|Withdrawal by Subject|5|||
149977758|NCT01713582|541055350|FG008|Overall Study|Withdrawal of consent|0|||
149977759|NCT01713582|541055351|FG009|Overall Study|Withdrawal of consent|1|||
149977760|NCT01713582|541055352|FG010|Overall Study|Withdrawal of consent|0|||
149977761|NCT01713582|541055353|FG011|Overall Study|Withdrawal of consent|0|||
149977762|NCT01713582|541055354|FG012|Overall Study|Withdrawal of consent|0|||
149977763|NCT01713582|541055355|FG013|Overall Study|Withdrawal of consent|0|||
149977764|NCT01713582|541055356|FG014|Overall Study|Withdrawal of consent|0|||
149977765|NCT01713582|541055357|FG015|Overall Study|Withdrawal of consent|0|||
150052417|NCT00730028|541334993|FG002|Overall Study|Withdrawal by Subject|4|||
149977766|NCT01713582|541055358|FG016|Overall Study|Withdrawal of consent|0|||
150052418|NCT00730028|541334994|FG003|Overall Study|Withdrawal by Subject|5|||
150052419|NCT00730028|541334995|FG004|Overall Study|Withdrawal by Subject|9|||
149977767|NCT01713582|541055359|FG017|Overall Study|Withdrawal of consent|0|||
149977768|NCT01713582|541055360|FG018|Overall Study|Withdrawal of consent|1|||
149977769|NCT01713582|541055361|FG019|Overall Study|Withdrawal of consent|0|||
149977770|NCT01713582|541055362|FG020|Overall Study|Withdrawal of consent|0|||
149977771|NCT01713582|541055342|FG000|Overall Study|Lack of Efficacy|0|||
149977772|NCT01713582|541055343|FG001|Overall Study|Lack of Efficacy|0|||
149977773|NCT01713582|541055344|FG002|Overall Study|Lack of Efficacy|0|||
149977774|NCT01713582|541055345|FG003|Overall Study|Lack of Efficacy|0|||
149977775|NCT01713582|541055346|FG004|Overall Study|Lack of Efficacy|0|||
149977776|NCT01713582|541055347|FG005|Overall Study|Lack of Efficacy|0|||
149977777|NCT01713582|541055348|FG006|Overall Study|Lack of Efficacy|0|||
149977778|NCT01713582|541055349|FG007|Overall Study|Lack of Efficacy|0|||
149977779|NCT01713582|541055350|FG008|Overall Study|Lack of Efficacy|0|||
149977780|NCT01713582|541055351|FG009|Overall Study|Lack of Efficacy|1|||
149977781|NCT01713582|541055352|FG010|Overall Study|Lack of Efficacy|2|||
149977782|NCT01713582|541055353|FG011|Overall Study|Lack of Efficacy|0|||
149977783|NCT01713582|541055354|FG012|Overall Study|Lack of Efficacy|0|||
149977784|NCT01713582|541055355|FG013|Overall Study|Lack of Efficacy|0|||
149977785|NCT01713582|541055356|FG014|Overall Study|Lack of Efficacy|0|||
149977786|NCT01713582|541055357|FG015|Overall Study|Lack of Efficacy|0|||
149977787|NCT01713582|541055358|FG016|Overall Study|Lack of Efficacy|0|||
149977788|NCT01713582|541055359|FG017|Overall Study|Lack of Efficacy|0|||
149977789|NCT01713582|541055360|FG018|Overall Study|Lack of Efficacy|0|||
149977790|NCT01713582|541055361|FG019|Overall Study|Lack of Efficacy|0|||
149977791|NCT01713582|541055362|FG020|Overall Study|Lack of Efficacy|0|||
149977792|NCT01713582|541055342|FG000|Overall Study|Withdrawal by Subject|0|||
149977793|NCT01713582|541055343|FG001|Overall Study|Withdrawal by Subject|0|||
149977794|NCT01713582|541055344|FG002|Overall Study|Withdrawal by Subject|0|||
149977795|NCT01713582|541055345|FG003|Overall Study|Withdrawal by Subject|0|||
149977796|NCT01713582|541055346|FG004|Overall Study|Withdrawal by Subject|0|||
149977797|NCT01713582|541055347|FG005|Overall Study|Withdrawal by Subject|0|||
149977798|NCT01713582|541055348|FG006|Overall Study|Withdrawal by Subject|0|||
149977799|NCT01713582|541055349|FG007|Overall Study|Withdrawal by Subject|0|||
149977800|NCT01713582|541055350|FG008|Overall Study|Withdrawal by Subject|0|||
149977801|NCT01713582|541055351|FG009|Overall Study|Withdrawal by Subject|0|||
149977802|NCT01713582|541055352|FG010|Overall Study|Withdrawal by Subject|0|||
149977803|NCT01713582|541055353|FG011|Overall Study|Withdrawal by Subject|0|||
149977804|NCT01713582|541055354|FG012|Overall Study|Withdrawal by Subject|0|||
149977805|NCT01713582|541055355|FG013|Overall Study|Withdrawal by Subject|0|||
149977806|NCT01713582|541055356|FG014|Overall Study|Withdrawal by Subject|0|||
149977807|NCT01713582|541055357|FG015|Overall Study|Withdrawal by Subject|0|||
149977808|NCT01713582|541055358|FG016|Overall Study|Withdrawal by Subject|0|||
149977809|NCT01713582|541055359|FG017|Overall Study|Withdrawal by Subject|1|||
149977810|NCT01713582|541055360|FG018|Overall Study|Withdrawal by Subject|0|||
149977811|NCT01713582|541055361|FG019|Overall Study|Withdrawal by Subject|0|||
149977812|NCT01713582|541055362|FG020|Overall Study|Withdrawal by Subject|0|||
149977813|NCT01713582|541055342|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
149977814|NCT01713582|541055343|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
149977815|NCT01713582|541055344|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
149977816|NCT01713582|541055345|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
149977817|NCT01713582|541055346|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
149977818|NCT01713582|541055347|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
149977819|NCT01713582|541055348|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
149977820|NCT01713582|541055349|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
149977821|NCT01713582|541055350|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
149977822|NCT01713582|541055351|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
149977823|NCT01713582|541055352|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
149977824|NCT01713582|541055353|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
149977825|NCT01713582|541055354|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
149977826|NCT01713582|541055355|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
149977827|NCT01713582|541055356|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
149977828|NCT01713582|541055357|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
149977829|NCT01713582|541055358|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
149977830|NCT01713582|541055359|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
149977831|NCT01713582|541055360|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
149977832|NCT01713582|541055361|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
149977833|NCT01713582|541055362|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
149977834|NCT01713582|541055342|FG000|Overall Study|Disease progression and adverse event|0|||
149977835|NCT01713582|541055343|FG001|Overall Study|Disease progression and adverse event|0|||
149977836|NCT01713582|541055344|FG002|Overall Study|Disease progression and adverse event|0|||
149977837|NCT01713582|541055345|FG003|Overall Study|Disease progression and adverse event|0|||
149977838|NCT01713582|541055346|FG004|Overall Study|Disease progression and adverse event|0|||
149977839|NCT01713582|541055347|FG005|Overall Study|Disease progression and adverse event|0|||
149977840|NCT01713582|541055348|FG006|Overall Study|Disease progression and adverse event|0|||
149977841|NCT01713582|541055349|FG007|Overall Study|Disease progression and adverse event|0|||
149977842|NCT01713582|541055350|FG008|Overall Study|Disease progression and adverse event|0|||
149977843|NCT01713582|541055351|FG009|Overall Study|Disease progression and adverse event|0|||
149977844|NCT01713582|541055352|FG010|Overall Study|Disease progression and adverse event|0|||
149977845|NCT01713582|541055353|FG011|Overall Study|Disease progression and adverse event|0|||
149977846|NCT01713582|541055354|FG012|Overall Study|Disease progression and adverse event|0|||
149977847|NCT01713582|541055355|FG013|Overall Study|Disease progression and adverse event|0|||
149977848|NCT01713582|541055356|FG014|Overall Study|Disease progression and adverse event|0|||
149977849|NCT01713582|541055357|FG015|Overall Study|Disease progression and adverse event|0|||
149977850|NCT01713582|541055358|FG016|Overall Study|Disease progression and adverse event|1|||
149977851|NCT01713582|541055359|FG017|Overall Study|Disease progression and adverse event|0|||
149977852|NCT01713582|541055360|FG018|Overall Study|Disease progression and adverse event|0|||
149977853|NCT01713582|541055361|FG019|Overall Study|Disease progression and adverse event|0|||
149977854|NCT01713582|541055362|FG020|Overall Study|Disease progression and adverse event|0|||
149977855|NCT04776161|541055364|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
149977856|NCT04776161|541055365|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
149977857|NCT04776161|541055366|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
149977858|NCT04776161|541055364|FG000|Overall Study|Withdrawal by Subject|1|||
149977859|NCT04776161|541055365|FG001|Overall Study|Withdrawal by Subject|0|||
149977860|NCT04776161|541055366|FG002|Overall Study|Withdrawal by Subject|1|||
149977861|NCT04776161|541055364|FG000|Overall Study|Adverse Event|0|||
149977862|NCT04776161|541055365|FG001|Overall Study|Adverse Event|1|||
149977863|NCT04776161|541055366|FG002|Overall Study|Adverse Event|1|||
149977864|NCT01475721|541055369|FG000|Overall Study|Death|3|||
149977865|NCT01475721|541055370|FG001|Overall Study|Death|6|||
149977866|NCT01475721|541055369|FG000|Overall Study|Withdrawal by Subject|8|||
149977867|NCT01475721|541055370|FG001|Overall Study|Withdrawal by Subject|8|||
149977868|NCT02364037|541055371|FG000|Overall Study|Withdrawal by Subject|7|||
149977869|NCT02364037|541055372|FG001|Overall Study|Withdrawal by Subject|4|||
149977870|NCT02364037|541055371|FG000|Overall Study|Lost to Follow-up|37|||
149977871|NCT02364037|541055372|FG001|Overall Study|Lost to Follow-up|49|||
149977872|NCT00559104|541055373|FG000|Overall Study|Lack of Efficacy|9|||
149977873|NCT00559104|541055374|FG001|Overall Study|Lack of Efficacy|0|||
149977874|NCT00387088|541055375|FG000|Overall Study|Adverse Event|143|||
149977875|NCT00387088|541055376|FG001|Overall Study|Adverse Event|156|||
149977876|NCT00387088|541055375|FG000|Overall Study|Protocol Violation|47|||
149977877|NCT00387088|541055376|FG001|Overall Study|Protocol Violation|35|||
149977878|NCT00387088|541055375|FG000|Overall Study|Withdrawal by Subject|20|||
149977879|NCT00387088|541055376|FG001|Overall Study|Withdrawal by Subject|35|||
149977880|NCT00387088|541055375|FG000|Overall Study|Lack of Efficacy|28|||
149977881|NCT00387088|541055376|FG001|Overall Study|Lack of Efficacy|67|||
149977882|NCT00387088|541055375|FG000|Overall Study|Lost to Follow-up|22|||
149977883|NCT00387088|541055376|FG001|Overall Study|Lost to Follow-up|28|||
149977884|NCT00387088|541055375|FG000|Overall Study|Other|58|||
149977885|NCT00387088|541055376|FG001|Overall Study|Other|52|||
149977886|NCT01639469|541055379|FG000|Overall Study|Death|4|||
149977887|NCT01639469|541055380|FG001|Overall Study|Death|2|||
149977888|NCT01639469|541055379|FG000|Overall Study|Lost to Follow-up|1|||
149977889|NCT01639469|541055380|FG001|Overall Study|Lost to Follow-up|1|||
149977890|NCT01119443|541055381|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
149977891|NCT01119443|541055382|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
149977892|NCT00420381|541055383|FG000|Overall Study|Protocol Violation|1|||
149977893|NCT02329743|541055384|FG000|Overall Study|Adverse Event|1|||
149977894|NCT02329743|541055385|FG001|Overall Study|Adverse Event|1|||
149977895|NCT02329743|541055386|FG002|Overall Study|Adverse Event|3|||
149977896|NCT02329743|541055384|FG000|Overall Study|Lost to Follow-up|1|||
149977897|NCT02329743|541055385|FG001|Overall Study|Lost to Follow-up|0|||
149977898|NCT02329743|541055386|FG002|Overall Study|Lost to Follow-up|1|||
149977899|NCT02329743|541055384|FG000|Overall Study|Withdrawal by Subject|4|||
149977900|NCT02329743|541055385|FG001|Overall Study|Withdrawal by Subject|4|||
149977901|NCT02329743|541055386|FG002|Overall Study|Withdrawal by Subject|1|||
149977902|NCT02329743|541055384|FG000|Overall Study|Other|0|||
149977903|NCT02329743|541055385|FG001|Overall Study|Other|2|||
149977904|NCT02329743|541055386|FG002|Overall Study|Other|3|||
150052420|NCT00730028|541334991|FG000|Overall Study|Physician Decision|3|||
149977905|NCT01428219|541055387|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
149977906|NCT02071771|541055388|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
149977907|NCT02071771|541055389|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
149977908|NCT02071771|541055388|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
149977909|NCT02071771|541055389|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
149977910|NCT02078752|541055390|FG000|Overall Study|Death|0|||
149977911|NCT02078752|541055391|FG001|Overall Study|Death|3|||
149977912|NCT02078752|541055392|FG002|Overall Study|Death|0|||
149977913|NCT02078752|541055393|FG003|Overall Study|Death|0|||
149977914|NCT02078752|541055394|FG004|Overall Study|Death|0|||
149977915|NCT02078752|541055395|FG005|Overall Study|Death|1|||
149977916|NCT02078752|541055396|FG006|Overall Study|Death|0|||
149977917|NCT02078752|541055397|FG007|Overall Study|Death|1|||
149977918|NCT02078752|541055398|FG008|Overall Study|Death|0|||
149977919|NCT02078752|541055399|FG009|Overall Study|Death|4|||
149977920|NCT02078752|541055390|FG000|Overall Study|Lost to Follow-up|1|||
149977921|NCT02078752|541055391|FG001|Overall Study|Lost to Follow-up|0|||
149977922|NCT02078752|541055392|FG002|Overall Study|Lost to Follow-up|0|||
149977923|NCT02078752|541055393|FG003|Overall Study|Lost to Follow-up|1|||
149977924|NCT02078752|541055394|FG004|Overall Study|Lost to Follow-up|0|||
149977925|NCT02078752|541055395|FG005|Overall Study|Lost to Follow-up|0|||
149977926|NCT02078752|541055396|FG006|Overall Study|Lost to Follow-up|0|||
149977927|NCT02078752|541055397|FG007|Overall Study|Lost to Follow-up|0|||
149977928|NCT02078752|541055398|FG008|Overall Study|Lost to Follow-up|0|||
149977929|NCT02078752|541055399|FG009|Overall Study|Lost to Follow-up|0|||
149977930|NCT02078752|541055390|FG000|Overall Study|Withdrawal by Subject|1|||
149977931|NCT02078752|541055391|FG001|Overall Study|Withdrawal by Subject|1|||
149977932|NCT02078752|541055392|FG002|Overall Study|Withdrawal by Subject|1|||
149977933|NCT02078752|541055393|FG003|Overall Study|Withdrawal by Subject|1|||
149977934|NCT02078752|541055394|FG004|Overall Study|Withdrawal by Subject|0|||
149977935|NCT02078752|541055395|FG005|Overall Study|Withdrawal by Subject|3|||
149977936|NCT02078752|541055396|FG006|Overall Study|Withdrawal by Subject|2|||
149977937|NCT02078752|541055397|FG007|Overall Study|Withdrawal by Subject|1|||
149977938|NCT02078752|541055398|FG008|Overall Study|Withdrawal by Subject|0|||
149977939|NCT02078752|541055399|FG009|Overall Study|Withdrawal by Subject|1|||
149977940|NCT02078752|541055390|FG000|Overall Study|Other|0|||
149977941|NCT02078752|541055391|FG001|Overall Study|Other|3|||
149977942|NCT02078752|541055392|FG002|Overall Study|Other|0|||
149977943|NCT02078752|541055393|FG003|Overall Study|Other|0|||
149977944|NCT02078752|541055394|FG004|Overall Study|Other|1|||
149977945|NCT02078752|541055395|FG005|Overall Study|Other|0|||
149977946|NCT02078752|541055396|FG006|Overall Study|Other|0|||
149977947|NCT02078752|541055397|FG007|Overall Study|Other|1|||
149977948|NCT02078752|541055398|FG008|Overall Study|Other|0|||
149977949|NCT02078752|541055399|FG009|Overall Study|Other|0|||
149977950|NCT02078752|541055390|FG000|Overall Study|Study terminated by sponsor|0|||
149977951|NCT02078752|541055391|FG001|Overall Study|Study terminated by sponsor|0|||
149977952|NCT02078752|541055392|FG002|Overall Study|Study terminated by sponsor|0|||
149977953|NCT02078752|541055393|FG003|Overall Study|Study terminated by sponsor|0|||
149977954|NCT02078752|541055394|FG004|Overall Study|Study terminated by sponsor|0|||
149977955|NCT02078752|541055395|FG005|Overall Study|Study terminated by sponsor|0|||
149977956|NCT02078752|541055396|FG006|Overall Study|Study terminated by sponsor|0|||
149977957|NCT02078752|541055397|FG007|Overall Study|Study terminated by sponsor|0|||
149977958|NCT02078752|541055398|FG008|Overall Study|Study terminated by sponsor|0|||
149977959|NCT02078752|541055399|FG009|Overall Study|Study terminated by sponsor|5|||
149977960|NCT03432494|541055417|FG000|Overall Study|Death|1|||
149977961|NCT03432494|541055417|FG000|Overall Study|Noncompliance|1|||
149977962|NCT00775268|541055418|FG000|Baseline|Drug not synthesize dose|1|||
149977963|NCT00775268|541055419|FG001|Baseline|Drug not synthesize dose|0|||
149977964|NCT00775268|541055418|FG000|Baseline|Not treated-ineligible per CT|0|||
149977965|NCT00775268|541055419|FG001|Baseline|Not treated-ineligible per CT|1|||
149977966|NCT00775268|541055418|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
149977967|NCT00775268|541055419|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
149977968|NCT00775268|541055418|FG000|After Completion|Participant missed scan appointment|1|||
149977969|NCT00775268|541055419|FG001|After Completion|Participant missed scan appointment|0|||
149977970|NCT00825994|541055420|FG000|Overall Study|Withdrawal by Subject|2|||
149977971|NCT00825994|541055420|FG000|Overall Study|Lost to Follow-up|1|||
149977972|NCT00825994|541055420|FG000|Overall Study|Protocol Violation|1|||
149977973|NCT00825994|541055420|FG000|Overall Study|Placebo Responder at V2|1|||
149977974|NCT00592631|541055422|FG000|Overall Study|Lost to Follow-up|0|||
149977975|NCT00592631|541055423|FG001|Overall Study|Lost to Follow-up|2|||
149977976|NCT01244035|541055425|FG000|Part 1: Period 1|Adverse Event|0|||
149977977|NCT01244035|541055426|FG001|Part 1: Period 1|Adverse Event|0|||
149977978|NCT01244035|541055427|FG002|Part 1: Period 1|Adverse Event|0|||
149977979|NCT01244035|541055428|FG003|Part 1: Period 1|Adverse Event|0|||
149977980|NCT01244035|541055429|FG004|Part 1: Period 1|Adverse Event|0|||
149977981|NCT01244035|541055430|FG005|Part 1: Period 1|Adverse Event|1|||
149977982|NCT01244035|541055425|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
149977983|NCT01244035|541055426|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
149977984|NCT01244035|541055427|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
149977985|NCT01244035|541055428|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
149977986|NCT01244035|541055429|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
149977987|NCT01244035|541055430|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
149977988|NCT01244035|541055425|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
149977989|NCT01244035|541055426|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
149977990|NCT01244035|541055427|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
149977991|NCT01244035|541055428|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
149977992|NCT01244035|541055429|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
149977993|NCT01244035|541055430|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
149977994|NCT01244035|541055425|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
149977995|NCT01244035|541055426|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
149977996|NCT01244035|541055427|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
149977997|NCT01244035|541055428|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
149977998|NCT01244035|541055429|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
149977999|NCT01244035|541055430|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
149978000|NCT01244035|541055425|FG000|Part 1: Period 3|Adverse Event|0|||
149978001|NCT01244035|541055426|FG001|Part 1: Period 3|Adverse Event|0|||
149978002|NCT01244035|541055427|FG002|Part 1: Period 3|Adverse Event|0|||
149978003|NCT01244035|541055428|FG003|Part 1: Period 3|Adverse Event|0|||
149978004|NCT01244035|541055429|FG004|Part 1: Period 3|Adverse Event|0|||
149978005|NCT01244035|541055430|FG005|Part 1: Period 3|Adverse Event|1|||
149978006|NCT01244035|541055425|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
149978007|NCT01244035|541055426|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
149978008|NCT01244035|541055427|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
149978009|NCT01244035|541055428|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
149978010|NCT01244035|541055429|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
149978011|NCT01244035|541055430|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
149978012|NCT01244035|541055425|FG000|Part 1: Period 3|Protocol Deviation|0|||
149978013|NCT01244035|541055426|FG001|Part 1: Period 3|Protocol Deviation|1|||
149978014|NCT01244035|541055427|FG002|Part 1: Period 3|Protocol Deviation|0|||
149978015|NCT01244035|541055428|FG003|Part 1: Period 3|Protocol Deviation|0|||
149978016|NCT01244035|541055429|FG004|Part 1: Period 3|Protocol Deviation|0|||
149978017|NCT01244035|541055430|FG005|Part 1: Period 3|Protocol Deviation|0|||
149978018|NCT01833494|541055432|FG000|Overall Study|Adverse Event|24|||
149978019|NCT01833494|541055432|FG000|Overall Study|Physician Decision|6|||
149978020|NCT01833494|541055432|FG000|Overall Study|Withdrawal by Subject|6|||
149978021|NCT01833494|541055432|FG000|Overall Study|Decrease in serum phosphorus|4|||
149978022|NCT01833494|541055432|FG000|Overall Study|Decrease in serum calcium|4|||
149978023|NCT01833494|541055432|FG000|Overall Study|Increase in serum ferritin|1|||
149978024|NCT01694433|541055437|FG000|Overall Study|Adverse Event|7|||
149978025|NCT01694433|541055438|FG001|Overall Study|Adverse Event|0|||
149978026|NCT01694433|541055437|FG000|Overall Study|Physician Decision|1|||
149978027|NCT01694433|541055438|FG001|Overall Study|Physician Decision|0|||
149978028|NCT01694433|541055437|FG000|Overall Study|Withdrawal by Subject|3|||
149978029|NCT01694433|541055438|FG001|Overall Study|Withdrawal by Subject|4|||
149978030|NCT00374595|541055441|FG000|Overall Study|Death|23|||
149978031|NCT00374595|541055441|FG000|Overall Study|Withdrawal by Subject|39|||
149978032|NCT00374595|541055441|FG000|Overall Study|Lost to Follow-up|3|||
149978033|NCT00374595|541055441|FG000|Overall Study|too much time commitment|1|||
149978034|NCT00374595|541055441|FG000|Overall Study|transfer care to other clinical site|1|||
149978035|NCT00374595|541055441|FG000|Overall Study|relocation|3|||
149978036|NCT03745768|541055443|FG000|Overall Study|discontinued study|2|||
149978037|NCT03745768|541055444|FG001|Overall Study|discontinued study|0|||
149978038|NCT00443118|541055445|FG000|Overall Study|unknown primary outcome|3|||
149978039|NCT00443118|541055446|FG001|Overall Study|unknown primary outcome|1|||
149978040|NCT00443118|541055447|FG002|Overall Study|unknown primary outcome|0|||
150052421|NCT00730028|541334992|FG001|Overall Study|Physician Decision|3|||
150052422|NCT00730028|541334993|FG002|Overall Study|Physician Decision|2|||
150052423|NCT00730028|541334994|FG003|Overall Study|Physician Decision|3|||
150052424|NCT00730028|541334995|FG004|Overall Study|Physician Decision|2|||
150052425|NCT00730028|541334991|FG000|Overall Study|Treatment Failure|5|||
150052426|NCT00730028|541334992|FG001|Overall Study|Treatment Failure|5|||
150052427|NCT00730028|541334993|FG002|Overall Study|Treatment Failure|0|||
150052428|NCT00730028|541334994|FG003|Overall Study|Treatment Failure|0|||
150178578|NCT00421889|541791980|FG008|Overall Study|Progressive disease|5|||
150178579|NCT00421889|541791972|FG000|Overall Study|Patient/Investigator request|0|||
150178580|NCT00421889|541791973|FG001|Overall Study|Patient/Investigator request|0|||
150178581|NCT00421889|541791974|FG002|Overall Study|Patient/Investigator request|0|||
149978041|NCT00443118|541055445|FG000|Overall Study|Withdrawal by Subject|1|||
149978042|NCT00443118|541055446|FG001|Overall Study|Withdrawal by Subject|0|||
149978043|NCT00443118|541055447|FG002|Overall Study|Withdrawal by Subject|0|||
149978044|NCT04232943|541055451|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
149978045|NCT04232943|541055452|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
150052429|NCT00730028|541334995|FG004|Overall Study|Treatment Failure|1|||
150052430|NCT00730028|541334991|FG000|Overall Study|Randomization Error|1|||
150178582|NCT00421889|541791975|FG003|Overall Study|Patient/Investigator request|0|||
149978046|NCT04232943|541055453|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
149978047|NCT04232943|541055451|FG000|Overall Study|Withdrawal by Subject|1|||
149978048|NCT04232943|541055452|FG001|Overall Study|Withdrawal by Subject|1|||
149978049|NCT04232943|541055453|FG002|Overall Study|Withdrawal by Subject|0|||
149978050|NCT01023217|541055457|FG000|Overall Study|Withdrawal by Subject|1|||
149978051|NCT01023217|541055458|FG001|Overall Study|Withdrawal by Subject|0|||
149978052|NCT00400517|541055459|FG000|Overall Study|Withdrawal by Subject|1|||
149978053|NCT00400517|541055459|FG000|Overall Study|Physician Decision|1|||
149978054|NCT02298868|541055461|FG000|Overall Study|Adverse Event|1|||
149978055|NCT02298868|541055461|FG000|Overall Study|Death|1|||
149978056|NCT02298868|541055461|FG000|Overall Study|Patient underwent transplant|1|||
149978057|NCT01194245|541055462|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
149978058|NCT01194245|541055463|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
149978059|NCT01194245|541055464|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
149978060|NCT01194245|541055465|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
149978061|NCT01194245|541055466|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
149978062|NCT01194245|541055462|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
149978063|NCT01194245|541055463|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
149978064|NCT01194245|541055464|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
149978065|NCT01194245|541055465|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
149978066|NCT01194245|541055466|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
149978067|NCT01194245|541055462|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
149978068|NCT01194245|541055463|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
149978069|NCT01194245|541055464|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
149978070|NCT01194245|541055465|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
149978071|NCT01194245|541055466|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
149978072|NCT01194245|541055462|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
149978073|NCT01194245|541055463|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
149978074|NCT01194245|541055464|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
149978075|NCT01194245|541055465|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
149978076|NCT01194245|541055466|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
149978077|NCT01194245|541055462|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149978078|NCT01194245|541055463|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149978079|NCT01194245|541055464|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149978080|NCT01194245|541055465|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149978081|NCT01194245|541055466|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
149978082|NCT01194245|541055462|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149978083|NCT01194245|541055463|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149978084|NCT01194245|541055464|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
149978085|NCT01194245|541055465|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
149978086|NCT01194245|541055466|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
149978087|NCT01118780|541055467|FG000|Overall Study|Adverse Event|15|||
149978088|NCT01118780|541055468|FG001|Overall Study|Adverse Event|15|||
149978089|NCT01118780|541055467|FG000|Overall Study|Death|1|||
149978090|NCT01118780|541055468|FG001|Overall Study|Death|0|||
149978091|NCT01118780|541055467|FG000|Overall Study|Lack of Efficacy|2|||
149978092|NCT01118780|541055468|FG001|Overall Study|Lack of Efficacy|6|||
149978093|NCT01118780|541055467|FG000|Overall Study|Physician Decision|2|||
149978094|NCT01118780|541055468|FG001|Overall Study|Physician Decision|0|||
149978095|NCT01118780|541055467|FG000|Overall Study|Protocol Violation|3|||
149978096|NCT01118780|541055468|FG001|Overall Study|Protocol Violation|6|||
149978097|NCT01118780|541055467|FG000|Overall Study|Withdrawal by Subject|13|||
149978098|NCT01118780|541055468|FG001|Overall Study|Withdrawal by Subject|8|||
149978099|NCT03962855|541055469|FG000|Overall Study|Death|0|||
149978100|NCT03962855|541055470|FG001|Overall Study|Death|1|||
149978101|NCT03962855|541055469|FG000|Overall Study|Lost to Follow-up|0|||
149978102|NCT03962855|541055470|FG001|Overall Study|Lost to Follow-up|1|||
149978103|NCT03962855|541055469|FG000|Overall Study|Adverse Event|0|||
149978104|NCT03962855|541055470|FG001|Overall Study|Adverse Event|1|||
149978105|NCT03962855|541055469|FG000|Overall Study|Physician Decision|0|||
149978106|NCT03962855|541055470|FG001|Overall Study|Physician Decision|2|||
149978107|NCT02457247|541055471|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
149978108|NCT02457247|541055472|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
149978109|NCT02457247|541055473|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
149978110|NCT02457247|541055474|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
149978111|NCT02457247|541055471|FG000|Period 1|Significant Protocol Deviation|1|||
149978112|NCT02457247|541055472|FG001|Period 1|Significant Protocol Deviation|1|||
149978113|NCT02457247|541055473|FG002|Period 1|Significant Protocol Deviation|0|||
149978114|NCT02457247|541055474|FG003|Period 1|Significant Protocol Deviation|0|||
149978115|NCT02457247|541055471|FG000|Period 1|Voluntary Withdrawal|1|||
149978116|NCT02457247|541055472|FG001|Period 1|Voluntary Withdrawal|0|||
149978117|NCT02457247|541055473|FG002|Period 1|Voluntary Withdrawal|0|||
149978118|NCT02457247|541055474|FG003|Period 1|Voluntary Withdrawal|0|||
149978119|NCT02457247|541055471|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
149978120|NCT02457247|541055472|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
149978121|NCT02457247|541055473|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
149978122|NCT02457247|541055474|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
149978123|NCT02457247|541055471|FG000|Period 2|Significant Protocol Deviation|1|||
149978124|NCT02457247|541055472|FG001|Period 2|Significant Protocol Deviation|0|||
149978125|NCT02457247|541055473|FG002|Period 2|Significant Protocol Deviation|0|||
149978126|NCT02457247|541055474|FG003|Period 2|Significant Protocol Deviation|0|||
149978127|NCT02457247|541055471|FG000|Period 2|Lost to Follow-up|0|||
149978128|NCT02457247|541055472|FG001|Period 2|Lost to Follow-up|1|||
149978129|NCT02457247|541055473|FG002|Period 2|Lost to Follow-up|0|||
149978130|NCT02457247|541055474|FG003|Period 2|Lost to Follow-up|0|||
149978131|NCT02457247|541055471|FG000|Period 2|Voluntary Withdrawal|1|||
149978132|NCT02457247|541055472|FG001|Period 2|Voluntary Withdrawal|1|||
149978133|NCT02457247|541055473|FG002|Period 2|Voluntary Withdrawal|0|||
149978134|NCT02457247|541055474|FG003|Period 2|Voluntary Withdrawal|0|||
149978135|NCT02015039|541055481|FG000|Overall Study|Not eligible|0|||
149978136|NCT02015039|541055482|FG001|Overall Study|Not eligible|1|||
149978137|NCT04749914|541055487|FG000|Period 1|Adverse Event|1|||
149978138|NCT04749914|541055488|FG001|Period 1|Adverse Event|0|||
149978139|NCT04749914|541055489|FG002|Period 1|Adverse Event|0|||
149978140|NCT04749914|541055490|FG003|Period 1|Adverse Event|0|||
149978141|NCT04749914|541055487|FG000|Period 1|Withdrawal by Subject|1|||
149978142|NCT04749914|541055488|FG001|Period 1|Withdrawal by Subject|0|||
149978143|NCT04749914|541055489|FG002|Period 1|Withdrawal by Subject|1|||
149978144|NCT04749914|541055490|FG003|Period 1|Withdrawal by Subject|0|||
149978145|NCT01897532|541055491|FG000|Discontinuation From Treatment|Not Treated|7|||
149978146|NCT01897532|541055492|FG001|Discontinuation From Treatment|Not Treated|5|||
149978147|NCT01897532|541055491|FG000|Discontinuation From Treatment|Other reason than specified|196|||
149978148|NCT01897532|541055492|FG001|Discontinuation From Treatment|Other reason than specified|176|||
149978149|NCT01897532|541055491|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
149978150|NCT01897532|541055492|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
149978151|NCT01897532|541055491|FG000|Discontinuation From Treatment|Non compliance|24|||
149978152|NCT01897532|541055492|FG001|Discontinuation From Treatment|Non compliance|15|||
149978153|NCT01897532|541055491|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
149978154|NCT01897532|541055492|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
149978155|NCT01897532|541055491|FG000|Discontinuation From Trial|Not Treated|7|||
149978156|NCT01897532|541055492|FG001|Discontinuation From Trial|Not Treated|5|||
149978157|NCT01897532|541055491|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
149978158|NCT01897532|541055492|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
149978159|NCT01088906|541055493|FG000|Overall Study|Inclusion error|1|||
149978160|NCT01088906|541055493|FG000|Overall Study|Did not receive study treatment|3|||
149978161|NCT01088906|541055493|FG000|Overall Study|Missing data|1|||
149978162|NCT00027560|541055494|FG000|Overall Study|Withdrawal by Subject|1|||
149978163|NCT01333722|541057788|FG000|Overall Study|Lack of Efficacy|0|||
149978164|NCT01333722|541057789|FG001|Overall Study|Lack of Efficacy|2|||
149978165|NCT01333722|541057788|FG000|Overall Study|Withdrawal by Subject|0|||
149978166|NCT01333722|541057789|FG001|Overall Study|Withdrawal by Subject|1|||
149978167|NCT00784368|541057792|FG000|Overall Study|Physician Decision|0|||
149978168|NCT00784368|541057793|FG001|Overall Study|Physician Decision|0|||
149978169|NCT00784368|541057794|FG002|Overall Study|Physician Decision|6|||
149978170|NCT00784368|541057792|FG000|Overall Study|Lack of Efficacy|2|||
149978171|NCT00784368|541057793|FG001|Overall Study|Lack of Efficacy|0|||
149978172|NCT00784368|541057794|FG002|Overall Study|Lack of Efficacy|1|||
150052431|NCT00730028|541334992|FG001|Overall Study|Randomization Error|0|||
150052432|NCT00730028|541334993|FG002|Overall Study|Randomization Error|0|||
149978173|NCT00784368|541057792|FG000|Overall Study|Adverse Event|6|||
149978174|NCT00784368|541057793|FG001|Overall Study|Adverse Event|9|||
149978175|NCT00784368|541057794|FG002|Overall Study|Adverse Event|2|||
149978176|NCT00784368|541057792|FG000|Overall Study|Diagnosis of fever|0|||
149978177|NCT00784368|541057793|FG001|Overall Study|Diagnosis of fever|0|||
149978178|NCT00784368|541057794|FG002|Overall Study|Diagnosis of fever|1|||
149978179|NCT00784368|541057792|FG000|Overall Study|Worsening of complications|0|||
149978180|NCT00784368|541057793|FG001|Overall Study|Worsening of complications|0|||
149978181|NCT00784368|541057794|FG002|Overall Study|Worsening of complications|1|||
149978182|NCT00784368|541057792|FG000|Overall Study|Worsening of symptoms|0|||
149978183|NCT00784368|541057793|FG001|Overall Study|Worsening of symptoms|1|||
149978184|NCT00784368|541057794|FG002|Overall Study|Worsening of symptoms|0|||
149978185|NCT00784368|541057792|FG000|Overall Study|Withdrawal of informed consent|0|||
149978186|NCT00784368|541057793|FG001|Overall Study|Withdrawal of informed consent|1|||
150052433|NCT00730028|541334994|FG003|Overall Study|Randomization Error|0|||
149978187|NCT00784368|541057794|FG002|Overall Study|Withdrawal of informed consent|0|||
149978188|NCT00720356|541057799|FG000|Registration to Study|Determined to have methylated MGMT|67|||
149978189|NCT00720356|541057799|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
149978190|NCT00720356|541057799|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
149978191|NCT00720356|541057799|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
149978192|NCT00720356|541057799|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
149978193|NCT00720356|541057799|FG000|Follow up Until Death|Withdrawal by Subject|1|||
149978194|NCT00720356|541057799|FG000|Follow up Until Death|Alive at last data collection|4|||
149978195|NCT02237001|541057802|FG000|Overall Study|Lost to Follow-up|2|||
149978196|NCT02237001|541057802|FG000|Overall Study|Withdrawal by Subject|1|||
149978197|NCT02237001|541057802|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
149978198|NCT02237001|541057802|FG000|Overall Study|Re-operation|4|||
149978199|NCT02237001|541057802|FG000|Overall Study|Incarceration|1|||
149978200|NCT00342628|541057803|FG000|Overall Study|Withdrawal by Subject|19|||
149978201|NCT00342628|541057804|FG001|Overall Study|Withdrawal by Subject|19|||
149978202|NCT00342628|541057805|FG002|Overall Study|Withdrawal by Subject|18|||
149978203|NCT00342628|541057803|FG000|Overall Study|Death|1|||
149978204|NCT00342628|541057804|FG001|Overall Study|Death|1|||
149978205|NCT00342628|541057805|FG002|Overall Study|Death|0|||
149978206|NCT00342628|541057803|FG000|Overall Study|moved residence|0|||
149978207|NCT00342628|541057804|FG001|Overall Study|moved residence|1|||
149978208|NCT00342628|541057805|FG002|Overall Study|moved residence|1|||
149978209|NCT03427814|541057806|FG000|Overall Study|Withdrawal by Subject|4|||
149978210|NCT03427814|541057807|FG001|Overall Study|Withdrawal by Subject|4|||
149978211|NCT03427814|541057806|FG000|Overall Study|Lost to Follow-up|0|||
149978212|NCT03427814|541057807|FG001|Overall Study|Lost to Follow-up|2|||
149978213|NCT03427814|541057806|FG000|Overall Study|Death|42|||
149978214|NCT03427814|541057807|FG001|Overall Study|Death|31|||
149978215|NCT03427814|541057806|FG000|Overall Study|Sponsor's Decision|1|||
149978216|NCT03427814|541057807|FG001|Overall Study|Sponsor's Decision|0|||
149978217|NCT03427814|541057806|FG000|Overall Study|Investigator's Decision|1|||
149978218|NCT03427814|541057807|FG001|Overall Study|Investigator's Decision|2|||
149978219|NCT03427814|541057806|FG000|Overall Study|Disease progression|1|||
149978220|NCT03427814|541057807|FG001|Overall Study|Disease progression|0|||
149978221|NCT03427814|541057806|FG000|Overall Study|Treatment Completed|0|||
149978222|NCT03427814|541057807|FG001|Overall Study|Treatment Completed|1|||
149978223|NCT03427814|541057806|FG000|Overall Study|Sponsor's Decision to End study|21|||
149978224|NCT03427814|541057807|FG001|Overall Study|Sponsor's Decision to End study|25|||
149978225|NCT03427814|541057806|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
149978226|NCT03427814|541057807|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
149978227|NCT03846427|541057808|FG000|Overall Study|Death|13|||
149978228|NCT03846427|541057808|FG000|Overall Study|Withdrawal by Subject|3|||
149978229|NCT03846427|541057808|FG000|Overall Study|Physician Decision|1|||
149978230|NCT01334554|541057809|FG000|Overall Study|Adverse Event|4|||
149978231|NCT01334554|541057810|FG001|Overall Study|Adverse Event|2|||
149978232|NCT02393859|541057812|FG000|Overall Study|Decision by Sponsor|2|||
149978233|NCT02393859|541057813|FG001|Overall Study|Decision by Sponsor|4|||
149978234|NCT02393859|541057812|FG000|Overall Study|Withdrawal by Subject|11|||
149978235|NCT02393859|541057813|FG001|Overall Study|Withdrawal by Subject|6|||
149978236|NCT02393859|541057812|FG000|Overall Study|Death|27|||
149978237|NCT02393859|541057813|FG001|Overall Study|Death|10|||
149978238|NCT02393859|541057812|FG000|Overall Study|Lost to Follow-up|1|||
149978239|NCT02393859|541057813|FG001|Overall Study|Lost to Follow-up|1|||
149978240|NCT01944020|541057814|FG000|Overall Study|Withdrawal by Subject|5|||
149978241|NCT01944020|541057815|FG001|Overall Study|Withdrawal by Subject|0|||
149978242|NCT01979614|541057816|FG000|Overall Study|Adverse Event|1|||
149978243|NCT01979614|541057817|FG001|Overall Study|Adverse Event|1|||
149978244|NCT00661830|541057818|FG000|Overall Study|Death|37|||
149978245|NCT00661830|541057819|FG001|Overall Study|Death|33|||
149978246|NCT00661830|541057818|FG000|Overall Study|Lost to Follow-up|1|||
149978247|NCT00661830|541057819|FG001|Overall Study|Lost to Follow-up|3|||
150052434|NCT00730028|541334995|FG004|Overall Study|Randomization Error|2|||
150052435|NCT01964755|541334996|FG000|Overall Study|Death|2|||
150052436|NCT02870933|541334997|FG000|Overall Study|Death|2|||
149978248|NCT00661830|541057818|FG000|Overall Study|Withdrawal by Subject|1|||
149978249|NCT00661830|541057819|FG001|Overall Study|Withdrawal by Subject|1|||
149978250|NCT00661830|541057818|FG000|Overall Study|Other reason|1|||
149978251|NCT00661830|541057819|FG001|Overall Study|Other reason|5|||
150052437|NCT02870933|541334998|FG001|Overall Study|Death|1|||
150052438|NCT02870933|541334997|FG000|Overall Study|Withdrawal by Subject|0|||
149978252|NCT00488514|541057820|FG000|Overall Study|Adverse Event|41|||
149978253|NCT00488514|541057820|FG000|Overall Study|Lost to Follow-up|44|||
149978254|NCT00488514|541057820|FG000|Overall Study|Protocol Violation|32|||
149978255|NCT00488514|541057820|FG000|Overall Study|Withdrawal by Subject|106|||
149978256|NCT00488514|541057820|FG000|Overall Study|Lack of Efficacy|28|||
149978257|NCT00488514|541057820|FG000|Overall Study|Did not meet criteria for treatment|30|||
149978258|NCT00488514|541057820|FG000|Overall Study|Postive drug screen|1|||
149978259|NCT00488514|541057820|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
149978260|NCT00488514|541057820|FG000|Overall Study|Investigator decision|1|||
149978261|NCT00488514|541057820|FG000|Overall Study|Participant had too few migraines|5|||
149978262|NCT00488514|541057820|FG000|Overall Study|Increase in number of migraines|2|||
149978263|NCT00488514|541057820|FG000|Overall Study|Increased use of concomitant medication|1|||
149978264|NCT00628446|541057823|FG000|Overall Study|Lost to Follow-up|3|||
149978265|NCT00628446|541057823|FG000|Overall Study|Withdrawal by Subject|1|||
149978266|NCT00628446|541057823|FG000|Overall Study|Protocol Violation|3|||
149978267|NCT00756275|541057824|FG000|Overall Study|Lost to Follow-up|25|||
149978268|NCT00756275|541057825|FG001|Overall Study|Lost to Follow-up|21|||
149978269|NCT00756275|541057824|FG000|Overall Study|Withdrawal by Subject|4|||
149978270|NCT00756275|541057825|FG001|Overall Study|Withdrawal by Subject|7|||
149978271|NCT04971967|541057828|FG000|Overall Study|Lost to Follow-up|6|||
149978272|NCT04971967|541057829|FG001|Overall Study|Lost to Follow-up|7|||
149978273|NCT00682929|541057834|FG000|Overall Study|Adverse Event|4|||
149978274|NCT00682929|541057835|FG001|Overall Study|Adverse Event|1|||
149978275|NCT00682929|541057836|FG002|Overall Study|Adverse Event|1|||
149978276|NCT00682929|541057834|FG000|Overall Study|Withdrawal by Subject|1|||
149978277|NCT00682929|541057835|FG001|Overall Study|Withdrawal by Subject|2|||
149978278|NCT00682929|541057836|FG002|Overall Study|Withdrawal by Subject|1|||
149978279|NCT00682929|541057834|FG000|Overall Study|dosing compliance < 80%|0|||
149978280|NCT00682929|541057835|FG001|Overall Study|dosing compliance < 80%|2|||
149978281|NCT00682929|541057836|FG002|Overall Study|dosing compliance < 80%|0|||
149978282|NCT00682929|541057834|FG000|Overall Study|lag in DEA renewal|1|||
149978283|NCT00682929|541057835|FG001|Overall Study|lag in DEA renewal|0|||
149978284|NCT00682929|541057836|FG002|Overall Study|lag in DEA renewal|0|||
149978285|NCT00938912|541057837|FG000|Overall Study|Withdrawal by Subject|28|||
149978286|NCT00938912|541057837|FG000|Overall Study|Lost to Follow-up|4|||
149978287|NCT00938912|541057837|FG000|Overall Study|Lack of Efficacy|43|||
149978288|NCT00938912|541057837|FG000|Overall Study|Adverse event, non-fatal|24|||
149978289|NCT00938912|541057837|FG000|Overall Study|Adverse event, fatal|1|||
149978290|NCT00938912|541057837|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
149978291|NCT00938912|541057837|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
149978292|NCT00938912|541057837|FG000|Overall Study|Participant needed prohibit medication|1|||
149978293|NCT00938912|541057837|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
149978294|NCT00938912|541057837|FG000|Overall Study|Did not meet Eligibility criteria|1|||
149978295|NCT00938912|541057837|FG000|Overall Study|Participant relocated not related to AE|1|||
149978296|NCT00938912|541057837|FG000|Overall Study|Participant moved to another city|1|||
149978297|NCT00938912|541057837|FG000|Overall Study|Participant experienced break through seizures|1|||
149978298|NCT00938912|541057837|FG000|Overall Study|No longer wished to participate in the study|1|||
149978299|NCT00938912|541057837|FG000|Overall Study|Protocol Deviation|2|||
149978300|NCT00803738|541057838|FG000|Overall Study|Adverse Event|3|||
149978301|NCT00803738|541057839|FG001|Overall Study|Adverse Event|5|||
149978302|NCT00803738|541057838|FG000|Overall Study|Lost to Follow-up|4|||
149978303|NCT00803738|541057839|FG001|Overall Study|Lost to Follow-up|4|||
149978304|NCT00803738|541057838|FG000|Overall Study|Protocol Violation|18|||
149978305|NCT00803738|541057839|FG001|Overall Study|Protocol Violation|10|||
149978306|NCT00803738|541057838|FG000|Overall Study|Withdrawal by Subject|1|||
149978307|NCT00803738|541057839|FG001|Overall Study|Withdrawal by Subject|4|||
149978308|NCT00803738|541057838|FG000|Overall Study|Lack of Efficacy|10|||
149978309|NCT00803738|541057839|FG001|Overall Study|Lack of Efficacy|16|||
149978310|NCT00803738|541057838|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
149978311|NCT00803738|541057839|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
149978312|NCT00803738|541057838|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
149978313|NCT00803738|541057839|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
149978314|NCT01048242|541057840|FG000|Overall Study|See study flow chart|4|||
149978315|NCT01048242|541057841|FG001|Overall Study|See study flow chart|2|||
149978316|NCT01772550|541057842|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
149978317|NCT01772550|541057843|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
149978318|NCT01772550|541057844|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
149978319|NCT01772550|541057842|FG000|Overall Study|Adverse Event|0|||
149978320|NCT01772550|541057843|FG001|Overall Study|Adverse Event|0|||
149978321|NCT01772550|541057844|FG002|Overall Study|Adverse Event|1|||
149978322|NCT02897115|541057853|FG000|Overall Study|Early termination of study by sponsor|11|||
149978323|NCT02897115|541057854|FG001|Overall Study|Early termination of study by sponsor|8|||
149978324|NCT00856323|541057856|FG000|Overall Study|Withdrawal by Subject|2|||
149978325|NCT00856635|541057857|FG000|Overall Study|Lost to Follow-up|2|||
149978326|NCT00856635|541057858|FG001|Overall Study|Lost to Follow-up|5|||
149978327|NCT00856635|541057857|FG000|Overall Study|Pregnancy|1|||
149978328|NCT00856635|541057858|FG001|Overall Study|Pregnancy|0|||
149978329|NCT00856635|541057857|FG000|Overall Study|Withdrawal by Subject|3|||
149978330|NCT00856635|541057858|FG001|Overall Study|Withdrawal by Subject|1|||
149978331|NCT00856635|541057857|FG000|Overall Study|Serious Adverse Event|1|||
149978332|NCT00856635|541057858|FG001|Overall Study|Serious Adverse Event|0|||
149978333|NCT00856635|541057857|FG000|Overall Study|Other|1|||
149978334|NCT00856635|541057858|FG001|Overall Study|Other|0|||
149978335|NCT00856635|541057857|FG000|Overall Study|Discontinued at Randomization|2|||
149978336|NCT00856635|541057858|FG001|Overall Study|Discontinued at Randomization|2|||
149978337|NCT02383862|541057859|FG000|3 Month Follow up|Lost to Follow-up|23|||
149978338|NCT02383862|541057860|FG001|3 Month Follow up|Lost to Follow-up|21|||
149978339|NCT03389308|541057863|FG000|Overall Study|Withdrawal by Subject|5|||
149978340|NCT03389308|541057863|FG000|Overall Study|Lost to Follow-up|3|||
149978341|NCT03389308|541057863|FG000|Overall Study|Adverse Event|2|||
149978342|NCT03389308|541057863|FG000|Overall Study|Sponsor Request|2|||
149978343|NCT03198767|541057864|FG000|Overall Study|Protocol Violation|0|||
149978344|NCT03198767|541057865|FG001|Overall Study|Protocol Violation|0|||
149978345|NCT03198767|541057866|FG002|Overall Study|Protocol Violation|0|||
149978346|NCT03198767|541057867|FG003|Overall Study|Protocol Violation|6|||
149978347|NCT03198767|541057868|FG004|Overall Study|Protocol Violation|0|||
149978348|NCT03198767|541057869|FG005|Overall Study|Protocol Violation|0|||
149978349|NCT03198767|541057870|FG006|Overall Study|Protocol Violation|0|||
149978350|NCT01891396|541057871|FG000|Overall Study|Withdrawal by Subject|4|||
149978351|NCT01891396|541057872|FG001|Overall Study|Withdrawal by Subject|4|||
149978352|NCT01891396|541057873|FG002|Overall Study|Withdrawal by Subject|3|||
149978353|NCT01891396|541057871|FG000|Overall Study|Lost to Follow-up|0|||
149978354|NCT01891396|541057872|FG001|Overall Study|Lost to Follow-up|1|||
149978355|NCT01891396|541057873|FG002|Overall Study|Lost to Follow-up|0|||
149978356|NCT02820844|541057874|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
149978357|NCT02820844|541057875|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
149978358|NCT02820844|541057876|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
149978359|NCT02820844|541057877|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
149978360|NCT02820844|541057878|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
149978361|NCT02820844|541057879|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
149978362|NCT02820844|541057874|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
149978363|NCT02820844|541057875|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
149978364|NCT02820844|541057876|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
149978365|NCT02820844|541057877|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
149978366|NCT02820844|541057878|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
149978367|NCT02820844|541057879|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
149978368|NCT02820844|541057874|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
149978369|NCT02820844|541057875|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
149978370|NCT02820844|541057876|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
149978371|NCT02820844|541057877|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
149978372|NCT02820844|541057878|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
149978373|NCT02820844|541057879|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
149978374|NCT02820844|541057874|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
149978375|NCT02820844|541057875|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
149978376|NCT02820844|541057876|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
149978377|NCT02820844|541057877|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
149978378|NCT02820844|541057878|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
150052439|NCT02870933|541334998|FG001|Overall Study|Withdrawal by Subject|1|||
150052440|NCT01250496|541334999|FG000|Overall Study|Study terminated|124|||
150052441|NCT01250496|541335000|FG001|Overall Study|Study terminated|124|||
149978379|NCT02820844|541057879|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
149978380|NCT02820844|541057874|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
149978381|NCT02820844|541057875|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
149978382|NCT02820844|541057876|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
149978383|NCT02820844|541057877|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
149978384|NCT02820844|541057878|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
149978385|NCT02820844|541057879|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
149978386|NCT02820844|541057874|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
149978387|NCT02820844|541057875|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
149978388|NCT02820844|541057876|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
149978389|NCT02820844|541057877|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
149978390|NCT02820844|541057878|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
149978391|NCT02820844|541057879|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
149978392|NCT02820844|541057874|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
149978393|NCT02820844|541057875|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
149978394|NCT02820844|541057876|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
149978395|NCT02820844|541057877|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
149978396|NCT02820844|541057878|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
149978397|NCT02820844|541057879|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
149978398|NCT02820844|541057874|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978399|NCT02820844|541057875|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978400|NCT02820844|541057876|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
149978401|NCT02820844|541057877|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
149978402|NCT02820844|541057878|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978403|NCT02820844|541057879|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978404|NCT02820844|541057874|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
149978405|NCT02820844|541057875|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
149978406|NCT02820844|541057876|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
149978407|NCT02820844|541057877|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
149978408|NCT02820844|541057878|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
149978409|NCT02820844|541057879|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
149978410|NCT02820844|541057874|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978411|NCT02820844|541057875|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978412|NCT02820844|541057876|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978413|NCT02820844|541057877|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978414|NCT02820844|541057878|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
149978415|NCT02820844|541057879|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
149978416|NCT02266147|541057881|FG000|PART 1: Dose Escalation|Physician Decision|0|||
149978417|NCT02266147|541057882|FG001|PART 1: Dose Escalation|Physician Decision|0|||
149978418|NCT02266147|541057883|FG002|PART 1: Dose Escalation|Physician Decision|1|||
149978419|NCT02266147|541057884|FG003|PART 1: Dose Escalation|Physician Decision|0|||
149978420|NCT02266147|541057881|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
149978421|NCT02266147|541057882|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
149978422|NCT02266147|541057883|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
149978423|NCT02266147|541057884|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
149978424|NCT02266147|541057881|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
149978425|NCT02266147|541057882|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
149978426|NCT02266147|541057883|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
149978427|NCT02266147|541057884|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
149978428|NCT02266147|541057881|FG000|PART 1: Dose Escalation|Other|1|||
149978429|NCT02266147|541057882|FG001|PART 1: Dose Escalation|Other|1|||
149978430|NCT02266147|541057883|FG002|PART 1: Dose Escalation|Other|0|||
149978431|NCT02266147|541057884|FG003|PART 1: Dose Escalation|Other|0|||
149978432|NCT02266147|541057881|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
149978433|NCT02266147|541057882|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
149978434|NCT02266147|541057883|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
149978435|NCT02266147|541057884|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
149978436|NCT02266147|541057881|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
149978437|NCT02266147|541057882|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
149978438|NCT02266147|541057883|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
149978439|NCT02266147|541057884|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
150178583|NCT00421889|541791976|FG004|Overall Study|Patient/Investigator request|0|||
149737496|NCT02601950|540170382|FG005|Overall Study|Non-compliance|1|||
149978440|NCT00413660|541057885|FG000|Up To Week 12|Adverse Event|1|||
149978441|NCT00413660|541057886|FG001|Up To Week 12|Adverse Event|3|||
149978442|NCT00413660|541057887|FG002|Up To Week 12|Adverse Event|1|||
149978443|NCT00413660|541057888|FG003|Up To Week 12|Adverse Event|4|||
149978444|NCT00413660|541057889|FG004|Up To Week 12|Adverse Event|6|||
149978445|NCT00413660|541057890|FG005|Up To Week 12|Adverse Event|4|||
149978446|NCT00413660|541057891|FG006|Up To Week 12|Adverse Event|1|||
149978447|NCT00413660|541057892|FG007|Up To Week 12|Adverse Event|0|||
149978448|NCT00413660|541057893|FG008|Up To Week 12|Adverse Event|0|||
149978449|NCT00413660|541057894|FG009|Up To Week 12|Adverse Event|0|||
149978450|NCT00413660|541057895|FG010|Up To Week 12|Adverse Event|0|||
149978451|NCT00413660|541057885|FG000|Up To Week 12|Lack of Efficacy|2|||
149978452|NCT00413660|541057886|FG001|Up To Week 12|Lack of Efficacy|0|||
149978453|NCT00413660|541057887|FG002|Up To Week 12|Lack of Efficacy|0|||
149978454|NCT00413660|541057888|FG003|Up To Week 12|Lack of Efficacy|0|||
149978455|NCT00413660|541057889|FG004|Up To Week 12|Lack of Efficacy|0|||
149978456|NCT00413660|541057890|FG005|Up To Week 12|Lack of Efficacy|0|||
149978457|NCT00413660|541057891|FG006|Up To Week 12|Lack of Efficacy|5|||
149978458|NCT00413660|541057892|FG007|Up To Week 12|Lack of Efficacy|0|||
149978459|NCT00413660|541057893|FG008|Up To Week 12|Lack of Efficacy|0|||
149978460|NCT00413660|541057894|FG009|Up To Week 12|Lack of Efficacy|0|||
149978461|NCT00413660|541057895|FG010|Up To Week 12|Lack of Efficacy|0|||
149978462|NCT00413660|541057885|FG000|Up To Week 12|Lost to Follow-up|0|||
149978463|NCT00413660|541057886|FG001|Up To Week 12|Lost to Follow-up|1|||
149978464|NCT00413660|541057887|FG002|Up To Week 12|Lost to Follow-up|0|||
149978465|NCT00413660|541057888|FG003|Up To Week 12|Lost to Follow-up|0|||
149978466|NCT00413660|541057889|FG004|Up To Week 12|Lost to Follow-up|1|||
149978467|NCT00413660|541057890|FG005|Up To Week 12|Lost to Follow-up|0|||
149978468|NCT00413660|541057891|FG006|Up To Week 12|Lost to Follow-up|0|||
149978469|NCT00413660|541057892|FG007|Up To Week 12|Lost to Follow-up|0|||
149978470|NCT00413660|541057893|FG008|Up To Week 12|Lost to Follow-up|0|||
149978471|NCT00413660|541057894|FG009|Up To Week 12|Lost to Follow-up|0|||
149978472|NCT00413660|541057895|FG010|Up To Week 12|Lost to Follow-up|0|||
149978473|NCT00413660|541057885|FG000|Up To Week 12|Withdrawal by Subject|0|||
149978474|NCT00413660|541057886|FG001|Up To Week 12|Withdrawal by Subject|2|||
149978475|NCT00413660|541057887|FG002|Up To Week 12|Withdrawal by Subject|0|||
149978476|NCT00413660|541057888|FG003|Up To Week 12|Withdrawal by Subject|2|||
149978477|NCT00413660|541057889|FG004|Up To Week 12|Withdrawal by Subject|0|||
149978478|NCT00413660|541057890|FG005|Up To Week 12|Withdrawal by Subject|2|||
149978479|NCT00413660|541057891|FG006|Up To Week 12|Withdrawal by Subject|2|||
149978480|NCT00413660|541057892|FG007|Up To Week 12|Withdrawal by Subject|0|||
149978481|NCT00413660|541057893|FG008|Up To Week 12|Withdrawal by Subject|0|||
149978482|NCT00413660|541057894|FG009|Up To Week 12|Withdrawal by Subject|0|||
149978483|NCT00413660|541057895|FG010|Up To Week 12|Withdrawal by Subject|0|||
149978484|NCT00413660|541057885|FG000|Up To Week 12|Randomized, Not Treated|1|||
149978485|NCT00413660|541057886|FG001|Up To Week 12|Randomized, Not Treated|0|||
149978486|NCT00413660|541057887|FG002|Up To Week 12|Randomized, Not Treated|0|||
149978487|NCT00413660|541057888|FG003|Up To Week 12|Randomized, Not Treated|1|||
149978488|NCT00413660|541057889|FG004|Up To Week 12|Randomized, Not Treated|0|||
149978489|NCT00413660|541057890|FG005|Up To Week 12|Randomized, Not Treated|0|||
149978490|NCT00413660|541057891|FG006|Up To Week 12|Randomized, Not Treated|0|||
149978491|NCT00413660|541057892|FG007|Up To Week 12|Randomized, Not Treated|0|||
149978492|NCT00413660|541057893|FG008|Up To Week 12|Randomized, Not Treated|0|||
149978493|NCT00413660|541057894|FG009|Up To Week 12|Randomized, Not Treated|0|||
149978494|NCT00413660|541057895|FG010|Up To Week 12|Randomized, Not Treated|0|||
149978495|NCT00413660|541057885|FG000|Up To Week 12|Other|3|||
149978496|NCT00413660|541057886|FG001|Up To Week 12|Other|1|||
149978497|NCT00413660|541057887|FG002|Up To Week 12|Other|6|||
149978498|NCT00413660|541057888|FG003|Up To Week 12|Other|1|||
149978499|NCT00413660|541057889|FG004|Up To Week 12|Other|2|||
149978500|NCT00413660|541057890|FG005|Up To Week 12|Other|4|||
149978501|NCT00413660|541057891|FG006|Up To Week 12|Other|3|||
149978502|NCT00413660|541057892|FG007|Up To Week 12|Other|0|||
149978503|NCT00413660|541057893|FG008|Up To Week 12|Other|0|||
149978504|NCT00413660|541057894|FG009|Up To Week 12|Other|0|||
149978505|NCT00413660|541057895|FG010|Up To Week 12|Other|0|||
149978506|NCT00413660|541057885|FG000|Post Week 12|Adverse Event|2|||
149978507|NCT00413660|541057886|FG001|Post Week 12|Adverse Event|0|||
149978508|NCT00413660|541057887|FG002|Post Week 12|Adverse Event|2|||
149978509|NCT00413660|541057888|FG003|Post Week 12|Adverse Event|1|||
149978510|NCT00413660|541057889|FG004|Post Week 12|Adverse Event|4|||
149978511|NCT00413660|541057890|FG005|Post Week 12|Adverse Event|2|||
149978512|NCT00413660|541057891|FG006|Post Week 12|Adverse Event|2|||
149978513|NCT00413660|541057892|FG007|Post Week 12|Adverse Event|0|||
149978514|NCT00413660|541057893|FG008|Post Week 12|Adverse Event|0|||
149978515|NCT00413660|541057894|FG009|Post Week 12|Adverse Event|0|||
149978516|NCT00413660|541057895|FG010|Post Week 12|Adverse Event|0|||
149978517|NCT00413660|541057885|FG000|Post Week 12|Lack of Efficacy|0|||
149978518|NCT00413660|541057886|FG001|Post Week 12|Lack of Efficacy|0|||
149978519|NCT00413660|541057887|FG002|Post Week 12|Lack of Efficacy|1|||
149978520|NCT00413660|541057888|FG003|Post Week 12|Lack of Efficacy|0|||
149978521|NCT00413660|541057889|FG004|Post Week 12|Lack of Efficacy|0|||
149978522|NCT00413660|541057890|FG005|Post Week 12|Lack of Efficacy|0|||
149978523|NCT00413660|541057891|FG006|Post Week 12|Lack of Efficacy|0|||
149978524|NCT00413660|541057892|FG007|Post Week 12|Lack of Efficacy|0|||
149978525|NCT00413660|541057893|FG008|Post Week 12|Lack of Efficacy|0|||
149978526|NCT00413660|541057894|FG009|Post Week 12|Lack of Efficacy|1|||
149978527|NCT00413660|541057895|FG010|Post Week 12|Lack of Efficacy|0|||
149978528|NCT00413660|541057885|FG000|Post Week 12|Lost to Follow-up|0|||
149978529|NCT00413660|541057886|FG001|Post Week 12|Lost to Follow-up|1|||
149978530|NCT00413660|541057887|FG002|Post Week 12|Lost to Follow-up|1|||
149978531|NCT00413660|541057888|FG003|Post Week 12|Lost to Follow-up|0|||
149978532|NCT00413660|541057889|FG004|Post Week 12|Lost to Follow-up|0|||
149978533|NCT00413660|541057890|FG005|Post Week 12|Lost to Follow-up|0|||
149978534|NCT00413660|541057891|FG006|Post Week 12|Lost to Follow-up|0|||
149978535|NCT00413660|541057892|FG007|Post Week 12|Lost to Follow-up|0|||
149978536|NCT00413660|541057893|FG008|Post Week 12|Lost to Follow-up|0|||
149978537|NCT00413660|541057894|FG009|Post Week 12|Lost to Follow-up|0|||
149978538|NCT00413660|541057895|FG010|Post Week 12|Lost to Follow-up|0|||
149978539|NCT00413660|541057885|FG000|Post Week 12|Withdrawal by Subject|0|||
149978540|NCT00413660|541057886|FG001|Post Week 12|Withdrawal by Subject|1|||
149978541|NCT00413660|541057887|FG002|Post Week 12|Withdrawal by Subject|1|||
149978542|NCT00413660|541057888|FG003|Post Week 12|Withdrawal by Subject|0|||
149978543|NCT00413660|541057889|FG004|Post Week 12|Withdrawal by Subject|1|||
149978544|NCT00413660|541057890|FG005|Post Week 12|Withdrawal by Subject|0|||
149978545|NCT00413660|541057891|FG006|Post Week 12|Withdrawal by Subject|0|||
149978546|NCT00413660|541057892|FG007|Post Week 12|Withdrawal by Subject|0|||
149978547|NCT00413660|541057893|FG008|Post Week 12|Withdrawal by Subject|0|||
149978548|NCT00413660|541057894|FG009|Post Week 12|Withdrawal by Subject|0|||
149978549|NCT00413660|541057895|FG010|Post Week 12|Withdrawal by Subject|1|||
149978550|NCT00413660|541057885|FG000|Post Week 12|Other|1|||
149978551|NCT00413660|541057886|FG001|Post Week 12|Other|2|||
149978552|NCT00413660|541057887|FG002|Post Week 12|Other|3|||
149978553|NCT00413660|541057888|FG003|Post Week 12|Other|0|||
149978554|NCT00413660|541057889|FG004|Post Week 12|Other|1|||
149978555|NCT00413660|541057890|FG005|Post Week 12|Other|1|||
149978556|NCT00413660|541057891|FG006|Post Week 12|Other|1|||
149978557|NCT00413660|541057892|FG007|Post Week 12|Other|0|||
149978558|NCT00413660|541057893|FG008|Post Week 12|Other|0|||
149978559|NCT00413660|541057894|FG009|Post Week 12|Other|0|||
149978560|NCT00413660|541057895|FG010|Post Week 12|Other|0|||
149978561|NCT03896477|541057898|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
149978562|NCT03896477|541057899|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
150052442|NCT00003590|541335001|FG000|Overall Study|Ineligible Patient|1|||
149978563|NCT03896477|541057900|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
149978564|NCT03896477|541057898|FG000|Overall Study|Parent Requested Withdrawal|8|||
149978565|NCT03896477|541057899|FG001|Overall Study|Parent Requested Withdrawal|12|||
149978566|NCT03896477|541057900|FG002|Overall Study|Parent Requested Withdrawal|9|||
149978567|NCT03896477|541057898|FG000|Overall Study|Adverse Event|0|||
149978568|NCT03896477|541057899|FG001|Overall Study|Adverse Event|0|||
149978569|NCT03896477|541057900|FG002|Overall Study|Adverse Event|1|||
149978570|NCT03896477|541057898|FG000|Overall Study|Death|1|||
149978571|NCT03896477|541057899|FG001|Overall Study|Death|0|||
149978572|NCT03896477|541057900|FG002|Overall Study|Death|0|||
149978573|NCT03896477|541057898|FG000|Overall Study|Other|5|||
149978574|NCT03896477|541057899|FG001|Overall Study|Other|6|||
149978575|NCT03896477|541057900|FG002|Overall Study|Other|7|||
149978576|NCT03896477|541057898|FG000|Overall Study|Lost to Follow-up|2|||
149978577|NCT03896477|541057899|FG001|Overall Study|Lost to Follow-up|1|||
149978578|NCT03896477|541057900|FG002|Overall Study|Lost to Follow-up|1|||
149978579|NCT01106157|541057901|FG000|Overall Study|Withdrawal by Subject|1|||
149978580|NCT01106157|541057902|FG001|Overall Study|Withdrawal by Subject|0|||
149978581|NCT00846846|541057909|FG000|Overall Study|Death|56|||
149978582|NCT00846846|541057909|FG000|Overall Study|Withdrawal by Subject|19|||
149978583|NCT00600067|541057919|FG000|Overall Study|Adverse Event|0|||
149978584|NCT00600067|541057920|FG001|Overall Study|Adverse Event|1|||
149978585|NCT00600067|541057919|FG000|Overall Study|Lost to Follow-up|2|||
149978586|NCT00600067|541057920|FG001|Overall Study|Lost to Follow-up|3|||
149978587|NCT00600067|541057919|FG000|Overall Study|protocol non-compliance|0|||
149978588|NCT00600067|541057920|FG001|Overall Study|protocol non-compliance|3|||
149978589|NCT00600067|541057919|FG000|Overall Study|Lack of Efficacy|1|||
149978590|NCT00600067|541057920|FG001|Overall Study|Lack of Efficacy|0|||
149978591|NCT04571060|541057925|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
149978592|NCT04571060|541057926|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
149978593|NCT04571060|541057925|FG000|Overall Study|Never treated migraine|47|||
149978594|NCT04571060|541057926|FG001|Overall Study|Never treated migraine|36|||
149978595|NCT04571060|541057925|FG000|Overall Study|Protocol Violation|4|||
149978596|NCT04571060|541057926|FG001|Overall Study|Protocol Violation|2|||
149978597|NCT04571060|541057925|FG000|Overall Study|Withdrawal by Subject|6|||
149978598|NCT04571060|541057926|FG001|Overall Study|Withdrawal by Subject|2|||
149978599|NCT04571060|541057925|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
149978600|NCT04571060|541057926|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
149978601|NCT03192137|541057938|FG000|Overall Study|Adverse Event|10|||
149978602|NCT03192137|541057939|FG001|Overall Study|Adverse Event|11|||
149978603|NCT03192137|541057938|FG000|Overall Study|Physician Decision|1|||
149978604|NCT03192137|541057939|FG001|Overall Study|Physician Decision|0|||
149978605|NCT03192137|541057938|FG000|Overall Study|Lack of Efficacy|20|||
149978606|NCT03192137|541057939|FG001|Overall Study|Lack of Efficacy|37|||
149978607|NCT03192137|541057938|FG000|Overall Study|Withdrawal by Subject|3|||
149978608|NCT03192137|541057939|FG001|Overall Study|Withdrawal by Subject|3|||
149978609|NCT03192137|541057938|FG000|Overall Study|Protocol Violation|4|||
149978610|NCT03192137|541057939|FG001|Overall Study|Protocol Violation|3|||
149978611|NCT03192137|541057938|FG000|Overall Study|Surgery Cancelled|4|||
149978612|NCT03192137|541057939|FG001|Overall Study|Surgery Cancelled|1|||
149978613|NCT03192137|541057938|FG000|Overall Study|Other - Various Administrative Reasons|8|||
149978614|NCT03192137|541057939|FG001|Overall Study|Other - Various Administrative Reasons|3|||
149978615|NCT01261975|541057940|FG000|Overall Study|Surgical complication|1|||
149978616|NCT01342094|541057943|FG000|Overall Study|Adverse Event|5|||
149978617|NCT01342094|541057944|FG001|Overall Study|Adverse Event|0|||
149978618|NCT01342094|541057943|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149978619|NCT01342094|541057944|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149978620|NCT01342094|541057943|FG000|Overall Study|Withdrawal by Subject|0|||
149978621|NCT01342094|541057944|FG001|Overall Study|Withdrawal by Subject|2|||
149978622|NCT03069716|541057945|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
149978623|NCT03069716|541057946|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
149978624|NCT03069716|541057947|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
149978625|NCT03069716|541057945|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
149978626|NCT03069716|541057946|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
149978627|NCT03069716|541057947|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
149978628|NCT03069716|541057945|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
149978629|NCT03069716|541057946|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
149978630|NCT03069716|541057947|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
149978631|NCT03069716|541057945|FG000|Randomized Treatment|Withdrawal by Subject|0|||
149978632|NCT03069716|541057946|FG001|Randomized Treatment|Withdrawal by Subject|2|||
149978633|NCT03069716|541057947|FG002|Randomized Treatment|Withdrawal by Subject|0|||
149978634|NCT05653700|541057950|FG000|Overall Study|Non Responders|9|||
149978635|NCT05653700|541057951|FG001|Overall Study|Non Responders|0|||
149978636|NCT01085214|541057954|FG000|Overall Study|Alternate treatment required|1|||
149978637|NCT01074931|541057968|FG000|Overall Study|Economic reasons|1|||
149978638|NCT01074931|541057968|FG000|Overall Study|Death|5|||
149978639|NCT03132467|541057969|FG000|Overall Study|Adverse Event|2|||
149978640|NCT03132467|541057969|FG000|Overall Study|Withdrawal by Subject|2|||
149978641|NCT01453036|541058963|FG000|Overall Study|Lost to Follow-up|26|||
149978642|NCT01453036|541058964|FG001|Overall Study|Lost to Follow-up|115|||
149978643|NCT01453036|541058965|FG002|Overall Study|Lost to Follow-up|31|||
149978644|NCT04072835|541058966|FG000|Overall Study|Overall trial ended|603|||
149978645|NCT04072835|541058966|FG000|Overall Study|Ablation|97|||
149978646|NCT04072835|541058966|FG000|Overall Study|Withdrawal of consent|66|||
149978647|NCT04072835|541058966|FG000|Overall Study|Physician Decision|50|||
149978648|NCT04072835|541058966|FG000|Overall Study|Lost to Follow-up|39|||
149978649|NCT04072835|541058966|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
149978650|NCT04072835|541058966|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
149978651|NCT04072835|541058966|FG000|Overall Study|Adverse Event|25|||
149978652|NCT04072835|541058966|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
149978653|NCT04072835|541058966|FG000|Overall Study|Death|11|||
149978654|NCT04072835|541058966|FG000|Overall Study|Participant felt the drug did not work|8|||
149978655|NCT04072835|541058966|FG000|Overall Study|Participant tolerability|5|||
149978656|NCT04072835|541058966|FG000|Overall Study|Missing|5|||
149978657|NCT04072835|541058966|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
149978658|NCT04072835|541058966|FG000|Overall Study|Pregnancy|3|||
149978659|NCT01336712|541058967|FG000|Overall Study|Death|2|||
149978660|NCT01336712|541058967|FG000|Overall Study|Lack of Efficacy|1|||
149978661|NCT00399568|541058968|FG000|Overall Study|Adverse Event|1|||
149978662|NCT00399568|541058969|FG001|Overall Study|Adverse Event|2|||
149978663|NCT00399568|541058968|FG000|Overall Study|Withdrawal by Subject|7|||
149978664|NCT00399568|541058969|FG001|Overall Study|Withdrawal by Subject|3|||
149978665|NCT00399568|541058968|FG000|Overall Study|Protocol non-compliance|2|||
149978666|NCT00399568|541058969|FG001|Overall Study|Protocol non-compliance|2|||
149978667|NCT00399568|541058968|FG000|Overall Study|Lost to Follow-up|2|||
149978668|NCT00399568|541058969|FG001|Overall Study|Lost to Follow-up|2|||
149978669|NCT01147393|541058970|FG000|Dose Level 1|Dose limiting Toxicity|2|||
149978670|NCT01147393|541058970|FG000|Dose Level -1|Dose Limited Toxicity|1|||
149978671|NCT00570323|541058975|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
149978672|NCT00570323|541058976|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
149978673|NCT00570323|541058975|FG000|Started Treatment After Randomization|Protocol Violation|1|||
149978674|NCT00570323|541058976|FG001|Started Treatment After Randomization|Protocol Violation|0|||
149978675|NCT00570323|541058975|FG000|Started Treatment After Randomization|Physician Decision|1|||
149978676|NCT00570323|541058976|FG001|Started Treatment After Randomization|Physician Decision|0|||
149978677|NCT00570323|541058975|FG000|Complete Study After Start|Lost to Follow-up|0|||
149978678|NCT00570323|541058976|FG001|Complete Study After Start|Lost to Follow-up|1|||
149978679|NCT00570323|541058975|FG000|Complete Study After Start|Withdrawal by Subject|2|||
149978680|NCT00570323|541058976|FG001|Complete Study After Start|Withdrawal by Subject|0|||
149978681|NCT00570323|541058975|FG000|Complete Study After Start|Physician Decision|1|||
149978682|NCT00570323|541058976|FG001|Complete Study After Start|Physician Decision|0|||
150052443|NCT00003590|541335001|FG000|Overall Study|Adverse Event|7|||
150052444|NCT00003590|541335001|FG000|Overall Study|Withdrawal by Subject|1|||
150052445|NCT00003590|541335001|FG000|Overall Study|Lack of Efficacy|11|||
150052446|NCT00003590|541335001|FG000|Overall Study|Death|1|||
150052447|NCT00003590|541335001|FG000|Overall Study|Physician Decision|1|||
149978683|NCT04263766|541058977|FG000|Overall Study|Withdrawal by Subject|6|||
149978684|NCT04263766|541058978|FG001|Overall Study|Withdrawal by Subject|4|||
149978685|NCT04263766|541058977|FG000|Overall Study|Lack of Efficacy|1|||
149978686|NCT04263766|541058978|FG001|Overall Study|Lack of Efficacy|3|||
149978687|NCT02639247|541058981|FG000|Overall Study|Lost to Follow-up|2|||
149978688|NCT02639247|541058982|FG001|Overall Study|Lost to Follow-up|1|||
149978689|NCT02639247|541058981|FG000|Overall Study|Death|2|||
149978690|NCT02639247|541058982|FG001|Overall Study|Death|0|||
149978691|NCT02639247|541058981|FG000|Overall Study|Withdrew Consent|0|||
149978692|NCT02639247|541058982|FG001|Overall Study|Withdrew Consent|1|||
150052448|NCT01425463|541335002|FG000|Overall Study|Adverse Event|5|||
149978693|NCT02639247|541058981|FG000|Overall Study|Protocol Violation|1|||
149978694|NCT02639247|541058982|FG001|Overall Study|Protocol Violation|0|||
150052449|NCT01425463|541335003|FG001|Overall Study|Adverse Event|7|||
149978695|NCT03462758|541058984|FG000|Overall Study|Chose no or other method of contraception|20|||
149978696|NCT03462758|541058985|FG001|Overall Study|Chose no or other method of contraception|23|||
149978697|NCT03462758|541058984|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
149978698|NCT03462758|541058985|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
149978699|NCT03462758|541058984|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
150052450|NCT01425463|541335002|FG000|Overall Study|Lack of Efficacy|1|||
150052451|NCT01425463|541335003|FG001|Overall Study|Lack of Efficacy|1|||
150052452|NCT01425463|541335002|FG000|Overall Study|Protocol Violation|2|||
150052453|NCT01425463|541335003|FG001|Overall Study|Protocol Violation|2|||
150052454|NCT01425463|541335002|FG000|Overall Study|Lost to Follow-up|5|||
150052455|NCT01425463|541335003|FG001|Overall Study|Lost to Follow-up|2|||
149978700|NCT03462758|541058985|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
149978701|NCT03462758|541058984|FG000|Overall Study|Medical contraindication|2|||
149978702|NCT03462758|541058985|FG001|Overall Study|Medical contraindication|2|||
149978703|NCT03462758|541058984|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
149978704|NCT03462758|541058985|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
149978705|NCT00573391|541058986|FG000|Overall Study|study stopped|2|||
149978706|NCT00573391|541058987|FG001|Overall Study|study stopped|2|||
149978707|NCT00573391|541058986|FG000|Overall Study|Death|1|||
149978708|NCT00573391|541058987|FG001|Overall Study|Death|0|||
149978709|NCT02141672|541058989|FG000|Overall Study|Adverse Event|0|||
149978710|NCT02141672|541058990|FG001|Overall Study|Adverse Event|1|||
149978711|NCT02141672|541058991|FG002|Overall Study|Adverse Event|0|||
149978712|NCT02141672|541058989|FG000|Overall Study|Death|10|||
149978713|NCT02141672|541058990|FG001|Overall Study|Death|2|||
149978714|NCT02141672|541058991|FG002|Overall Study|Death|1|||
149978715|NCT02141672|541058989|FG000|Overall Study|Lack of Efficacy|0|||
149978716|NCT02141672|541058990|FG001|Overall Study|Lack of Efficacy|0|||
149978717|NCT02141672|541058991|FG002|Overall Study|Lack of Efficacy|2|||
149978718|NCT02141672|541058989|FG000|Overall Study|Lost to Follow-up|1|||
149978719|NCT02141672|541058990|FG001|Overall Study|Lost to Follow-up|1|||
149978720|NCT02141672|541058991|FG002|Overall Study|Lost to Follow-up|3|||
149978721|NCT02141672|541058989|FG000|Overall Study|Physician Decision|1|||
149978722|NCT02141672|541058990|FG001|Overall Study|Physician Decision|2|||
149978723|NCT02141672|541058991|FG002|Overall Study|Physician Decision|5|||
149978724|NCT02141672|541058989|FG000|Overall Study|Protocol Violation|0|||
149978725|NCT02141672|541058990|FG001|Overall Study|Protocol Violation|0|||
149978726|NCT02141672|541058991|FG002|Overall Study|Protocol Violation|1|||
149978727|NCT02141672|541058989|FG000|Overall Study|Withdrawal by Subject|3|||
149978728|NCT02141672|541058990|FG001|Overall Study|Withdrawal by Subject|2|||
149978729|NCT02141672|541058991|FG002|Overall Study|Withdrawal by Subject|5|||
149978730|NCT02141672|541058989|FG000|Overall Study|refused to follow-up|1|||
149978731|NCT02141672|541058990|FG001|Overall Study|refused to follow-up|0|||
149978732|NCT02141672|541058991|FG002|Overall Study|refused to follow-up|1|||
149978733|NCT00739310|541058992|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
149978734|NCT00739310|541058992|FG000|Overall Study|Withdrawal by Subject|1|||
149978735|NCT00739310|541058992|FG000|Overall Study|Lost to Follow-up|2|||
149978736|NCT02954887|541058993|FG000|Overall Study|Withdrawal by Subject|3|||
149978737|NCT02954887|541058993|FG000|Overall Study|Lack of Efficacy|3|||
149978738|NCT02954887|541058993|FG000|Overall Study|Other|1|||
149978739|NCT02803203|541058994|FG000|Overall Study|Adverse Event|4|||
149978740|NCT02803203|541058994|FG000|Overall Study|Death|4|||
149978741|NCT02803203|541058994|FG000|Overall Study|Progressive disease|29|||
149978742|NCT02803203|541058994|FG000|Overall Study|Withdrawal by Subject|8|||
149978743|NCT02803203|541058994|FG000|Overall Study|Complete resection of target disease|2|||
149978744|NCT02803203|541058994|FG000|Overall Study|Switched to commercial Osi|1|||
149978745|NCT02803203|541058994|FG000|Overall Study|Participant moved away|1|||
149978746|NCT02343302|541058995|FG000|Overall Study|Physician Decision|1|||
149978747|NCT02343302|541058996|FG001|Overall Study|Physician Decision|1|||
149978748|NCT02948582|541059001|FG000|Washout Period 1|Adverse Event|0|||
149978749|NCT02948582|541059002|FG001|Washout Period 1|Adverse Event|2|||
149978750|NCT02948582|541059003|FG002|Washout Period 1|Adverse Event|0|||
149978751|NCT02948582|541059004|FG003|Washout Period 1|Adverse Event|0|||
149978752|NCT02948582|541059005|FG004|Washout Period 1|Adverse Event|0|||
150052456|NCT01425463|541335002|FG000|Overall Study|Withdrawal by Subject|7|||
150052457|NCT01425463|541335003|FG001|Overall Study|Withdrawal by Subject|5|||
150052458|NCT01425463|541335002|FG000|Overall Study|Unknown Reason|4|||
150052459|NCT01425463|541335003|FG001|Overall Study|Unknown Reason|7|||
149978753|NCT02948582|541059006|FG005|Washout Period 1|Adverse Event|0|||
149978754|NCT02948582|541059001|FG000|Washout Period 1|Protocol Violation|0|||
150052460|NCT01332799|541335004|FG000|Overall Study|Insufficient funding|10|||
150052461|NCT01332799|541335005|FG001|Overall Study|Insufficient funding|10|||
149978755|NCT02948582|541059002|FG001|Washout Period 1|Protocol Violation|0|||
149978756|NCT02948582|541059003|FG002|Washout Period 1|Protocol Violation|0|||
149978757|NCT02948582|541059004|FG003|Washout Period 1|Protocol Violation|0|||
149978758|NCT02948582|541059005|FG004|Washout Period 1|Protocol Violation|0|||
149978759|NCT02948582|541059006|FG005|Washout Period 1|Protocol Violation|1|||
149978760|NCT02948582|541059001|FG000|Washout Period 2|Adverse Event|0|||
149978761|NCT02948582|541059002|FG001|Washout Period 2|Adverse Event|1|||
149978762|NCT02948582|541059003|FG002|Washout Period 2|Adverse Event|0|||
149978763|NCT02948582|541059004|FG003|Washout Period 2|Adverse Event|0|||
149978764|NCT02948582|541059005|FG004|Washout Period 2|Adverse Event|0|||
149978765|NCT02948582|541059006|FG005|Washout Period 2|Adverse Event|0|||
149978766|NCT02948582|541059001|FG000|Washout Period 2|personal reasons|0|||
150052462|NCT01236547|541335006|FG000|Overall Study|Protocol Violation|0|||
150052463|NCT01236547|541335007|FG001|Overall Study|Protocol Violation|1|||
150052464|NCT01236547|541335008|FG002|Overall Study|Protocol Violation|1|||
150052465|NCT01236547|541335009|FG003|Overall Study|Protocol Violation|6|||
150052466|NCT01236547|541335010|FG004|Overall Study|Protocol Violation|12|||
150052467|NCT04022733|541335011|FG000|Overall Study|conversion to open surgery|3|||
150178584|NCT00421889|541791977|FG005|Overall Study|Patient/Investigator request|9|||
150178585|NCT00421889|541791978|FG006|Overall Study|Patient/Investigator request|0|||
149978767|NCT02948582|541059002|FG001|Washout Period 2|personal reasons|0|||
149978768|NCT02948582|541059003|FG002|Washout Period 2|personal reasons|0|||
149978769|NCT02948582|541059004|FG003|Washout Period 2|personal reasons|1|||
149978770|NCT02948582|541059005|FG004|Washout Period 2|personal reasons|0|||
149978771|NCT02948582|541059006|FG005|Washout Period 2|personal reasons|0|||
149978772|NCT02948582|541059001|FG000|Washout Period 4|Adverse Event|1|||
149978773|NCT02948582|541059002|FG001|Washout Period 4|Adverse Event|0|||
149978774|NCT02948582|541059003|FG002|Washout Period 4|Adverse Event|1|||
149978775|NCT02948582|541059004|FG003|Washout Period 4|Adverse Event|0|||
149978776|NCT02948582|541059005|FG004|Washout Period 4|Adverse Event|0|||
149978777|NCT02948582|541059006|FG005|Washout Period 4|Adverse Event|0|||
149978778|NCT01635998|541059007|FG000|Overall Study|Death|1|||
150052468|NCT04022733|541335012|FG001|Overall Study|conversion to open surgery|2|||
150052469|NCT04022733|541335011|FG000|Overall Study|bradycardia|0|||
150052470|NCT04022733|541335012|FG001|Overall Study|bradycardia|1|||
150052471|NCT00361634|541335015|FG000|Overall Study|Lost to Follow-up|1|||
150052472|NCT00361634|541335015|FG000|Overall Study|Withdrawal by Subject|1|||
150052473|NCT01128621|541335018|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
150052474|NCT01128621|541335019|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
150052475|NCT00233454|541335022|FG000|Overall Study|Death|6|||
150052476|NCT04224688|541335026|FG000|Overall Study|Withdrawal by Subject|1|||
150052477|NCT04224688|541335027|FG001|Overall Study|Withdrawal by Subject|3|||
150052478|NCT04224688|541335026|FG000|Overall Study|Lack of Efficacy|1|||
150052479|NCT04224688|541335027|FG001|Overall Study|Lack of Efficacy|1|||
150052480|NCT04224688|541335026|FG000|Overall Study|Adverse event, not fatal|0|||
150052481|NCT04224688|541335027|FG001|Overall Study|Adverse event, not fatal|2|||
150052482|NCT04224688|541335026|FG000|Overall Study|COVID-19|0|||
150052483|NCT04224688|541335027|FG001|Overall Study|COVID-19|1|||
150052484|NCT04074161|541335028|FG000|Overall Study|Withdrawal by Subject|2|||
150052485|NCT04074161|541335029|FG001|Overall Study|Withdrawal by Subject|4|||
150052486|NCT04074161|541335030|FG002|Overall Study|Withdrawal by Subject|1|||
150052487|NCT04074161|541335028|FG000|Overall Study|Lost to Follow-up|4|||
150052488|NCT04074161|541335029|FG001|Overall Study|Lost to Follow-up|5|||
150052489|NCT04074161|541335030|FG002|Overall Study|Lost to Follow-up|3|||
150052490|NCT00864916|541335031|FG000|Overall Study|Lost to Follow-up|4|||
150052491|NCT00864916|541335032|FG001|Overall Study|Lost to Follow-up|4|||
150052492|NCT00864916|541335031|FG000|Overall Study|Protocol Violation|1|||
150052493|NCT00864916|541335032|FG001|Overall Study|Protocol Violation|0|||
150052494|NCT00864916|541335031|FG000|Overall Study|Withdrawal by Subject|1|||
150052495|NCT00864916|541335032|FG001|Overall Study|Withdrawal by Subject|0|||
150052496|NCT01950013|541335034|FG000|Overall Study|Withdrawal by Subject|0|||
150052497|NCT01950013|541335035|FG001|Overall Study|Withdrawal by Subject|2|||
150052498|NCT01950013|541335036|FG002|Overall Study|Withdrawal by Subject|0|||
150052499|NCT00275340|541335037|FG000|Overall Study|Lost to Follow-up|2|||
150052500|NCT00275340|541335038|FG001|Overall Study|Lost to Follow-up|4|||
150052501|NCT00783198|541335043|FG000|Overall Study|Adverse Event|15|||
150052502|NCT00783198|541335044|FG001|Overall Study|Adverse Event|19|||
150052503|NCT00783198|541335045|FG002|Overall Study|Adverse Event|3|||
150052504|NCT00783198|541335043|FG000|Overall Study|Lost to Follow-up|11|||
150052505|NCT00783198|541335044|FG001|Overall Study|Lost to Follow-up|1|||
150052506|NCT00783198|541335045|FG002|Overall Study|Lost to Follow-up|7|||
150052507|NCT00783198|541335043|FG000|Overall Study|Withdrawal by Subject|22|||
150052508|NCT00783198|541335044|FG001|Overall Study|Withdrawal by Subject|14|||
150052509|NCT00783198|541335045|FG002|Overall Study|Withdrawal by Subject|20|||
150052510|NCT00783198|541335043|FG000|Overall Study|Noncompliance with protocol|7|||
150052511|NCT00783198|541335044|FG001|Overall Study|Noncompliance with protocol|7|||
150052512|NCT00783198|541335045|FG002|Overall Study|Noncompliance with protocol|10|||
150052513|NCT00783198|541335043|FG000|Overall Study|Did not meet protocol eligibility|0|||
150052514|NCT00783198|541335044|FG001|Overall Study|Did not meet protocol eligibility|1|||
150052515|NCT00783198|541335045|FG002|Overall Study|Did not meet protocol eligibility|0|||
150052516|NCT00783198|541335043|FG000|Overall Study|Administrative|2|||
150052517|NCT00783198|541335044|FG001|Overall Study|Administrative|1|||
150052518|NCT00783198|541335045|FG002|Overall Study|Administrative|2|||
150052519|NCT00539188|541335046|FG000|Overall Study|Withdrawal by Subject|1|||
150052520|NCT00539188|541335047|FG001|Overall Study|Withdrawal by Subject|0|||
150052521|NCT00539188|541335046|FG000|Overall Study|Lost to Follow-up|2|||
150052522|NCT00539188|541335047|FG001|Overall Study|Lost to Follow-up|1|||
150052523|NCT04784442|541335048|FG000|Overall Study|Adverse Event|1|||
150052524|NCT04784442|541335049|FG001|Overall Study|Adverse Event|0|||
150052525|NCT04784442|541335050|FG002|Overall Study|Adverse Event|2|||
150052526|NCT04784442|541335051|FG003|Overall Study|Adverse Event|1|||
150052527|NCT04784442|541335048|FG000|Overall Study|Protocol Violation|1|||
150052528|NCT04784442|541335049|FG001|Overall Study|Protocol Violation|0|||
150052529|NCT04784442|541335050|FG002|Overall Study|Protocol Violation|0|||
150052530|NCT04784442|541335051|FG003|Overall Study|Protocol Violation|0|||
150052531|NCT04784442|541335048|FG000|Overall Study|Non-compliance with study drug|1|||
150052532|NCT04784442|541335049|FG001|Overall Study|Non-compliance with study drug|0|||
150052533|NCT04784442|541335050|FG002|Overall Study|Non-compliance with study drug|0|||
150052534|NCT04784442|541335051|FG003|Overall Study|Non-compliance with study drug|0|||
150052535|NCT00852371|541335052|FG000|Overall Study|Lost to Follow-up|2|||
150052536|NCT00852371|541335053|FG001|Overall Study|Lost to Follow-up|3|||
150052537|NCT00852371|541335054|FG002|Overall Study|Lost to Follow-up|4|||
150052538|NCT00852371|541335055|FG003|Overall Study|Lost to Follow-up|2|||
150052539|NCT02756806|541335056|FG000|Overall Study|Study terminated early|5|||
150052540|NCT03158285|541335057|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
150052541|NCT03158285|541335058|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
150052542|NCT03158285|541335059|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
150052543|NCT03158285|541335057|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
150052544|NCT03158285|541335058|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
149978779|NCT01635998|541059008|FG001|Overall Study|Death|1|||
150178586|NCT00421889|541791979|FG007|Overall Study|Patient/Investigator request|1|||
150178587|NCT00421889|541791980|FG008|Overall Study|Patient/Investigator request|3|||
150178588|NCT00421889|541791972|FG000|Overall Study|Lost to Follow-up|0|||
149978780|NCT01635998|541059007|FG000|Overall Study|Lost to Follow-up|2|||
149978781|NCT01635998|541059008|FG001|Overall Study|Lost to Follow-up|1|||
149978782|NCT01635998|541059007|FG000|Overall Study|Withdrawal by Subject|1|||
149978783|NCT01635998|541059008|FG001|Overall Study|Withdrawal by Subject|5|||
149978784|NCT04419467|541059009|FG000|Overall Study|Not treated with IP|0|||
149978785|NCT04419467|541059010|FG001|Overall Study|Not treated with IP|0|||
149978786|NCT04419467|541059011|FG002|Overall Study|Not treated with IP|2|||
149978787|NCT04419467|541059009|FG000|Overall Study|Adverse Event|0|||
149978788|NCT04419467|541059010|FG001|Overall Study|Adverse Event|2|||
149978789|NCT04419467|541059011|FG002|Overall Study|Adverse Event|0|||
149978790|NCT04419467|541059009|FG000|Overall Study|Death|1|||
149978791|NCT04419467|541059010|FG001|Overall Study|Death|0|||
149978792|NCT04419467|541059011|FG002|Overall Study|Death|0|||
149978793|NCT04419467|541059009|FG000|Overall Study|Lost to Follow-up|0|||
149978794|NCT04419467|541059010|FG001|Overall Study|Lost to Follow-up|1|||
149978795|NCT04419467|541059011|FG002|Overall Study|Lost to Follow-up|2|||
149978796|NCT04419467|541059009|FG000|Overall Study|Withdrawal by Subject|0|||
149978797|NCT04419467|541059010|FG001|Overall Study|Withdrawal by Subject|0|||
149978798|NCT04419467|541059011|FG002|Overall Study|Withdrawal by Subject|4|||
149978799|NCT04419467|541059009|FG000|Overall Study|Pandemic related|0|||
149978800|NCT04419467|541059010|FG001|Overall Study|Pandemic related|0|||
149978801|NCT04419467|541059011|FG002|Overall Study|Pandemic related|1|||
149978802|NCT04419467|541059009|FG000|Overall Study|Reason not known|1|||
149978803|NCT04419467|541059010|FG001|Overall Study|Reason not known|0|||
149978804|NCT04419467|541059011|FG002|Overall Study|Reason not known|0|||
149978805|NCT01220401|541059021|FG000|Overall Study|Withdrawal by Subject|2|||
149978806|NCT01220401|541059021|FG000|Overall Study|Protocol Violation|1|||
149978807|NCT03386435|541059022|FG000|Overall Study|Protocol Violation|5|||
149978808|NCT03386435|541059023|FG001|Overall Study|Protocol Violation|7|||
149978809|NCT04068922|541059024|FG000|Overall Study|Lost to Follow-up|5|||
149978810|NCT04068922|541059024|FG000|Overall Study|Withdrawal by Subject|7|||
149978811|NCT04068922|541059024|FG000|Overall Study|Adverse Event|1|||
149978812|NCT03542266|541059025|FG000|Treatment Phase|Withdrawal by Subject|1|||
149978813|NCT03542266|541059025|FG000|Treatment Phase|Adverse Event|1|||
149978814|NCT03542266|541059025|FG000|Treatment Phase|PD|1|||
149978815|NCT00625586|541059026|FG000|Overall Study|Adverse Event|1|||
149978816|NCT00625586|541059026|FG000|Overall Study|Progressive disease|1|||
149978817|NCT00657267|541059032|FG000|Overall Study|Progressive disease|45|||
149978818|NCT00657267|541059032|FG000|Overall Study|Adverse Event|9|||
149978819|NCT02737501|541059033|FG000|Randomized Phase|Died|41|||
149978820|NCT02737501|541059034|FG001|Randomized Phase|Died|29|||
149978821|NCT02737501|541059035|FG002|Randomized Phase|Died|0|||
149978822|NCT02737501|541059033|FG000|Randomized Phase|Withdrawal by Subject|16|||
149978823|NCT02737501|541059034|FG001|Randomized Phase|Withdrawal by Subject|6|||
149978824|NCT02737501|541059035|FG002|Randomized Phase|Withdrawal by Subject|0|||
149978825|NCT02737501|541059033|FG000|Randomized Phase|Lost to Follow-up|0|||
149978826|NCT02737501|541059034|FG001|Randomized Phase|Lost to Follow-up|1|||
149978827|NCT02737501|541059035|FG002|Randomized Phase|Lost to Follow-up|0|||
149978828|NCT02737501|541059033|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
149978829|NCT02737501|541059034|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
149978830|NCT02737501|541059035|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
149978831|NCT02737501|541059033|FG000|Randomized Phase|Reason not Specified|1|||
149978832|NCT02737501|541059034|FG001|Randomized Phase|Reason not Specified|1|||
149978833|NCT02737501|541059035|FG002|Randomized Phase|Reason not Specified|0|||
149978834|NCT02737501|541059033|FG000|Randomized Phase|Never Treated|1|||
149978835|NCT02737501|541059034|FG001|Randomized Phase|Never Treated|1|||
149978836|NCT02737501|541059035|FG002|Randomized Phase|Never Treated|0|||
149978837|NCT02737501|541059033|FG000|Crossover Phase|Died|0|||
149978838|NCT02737501|541059034|FG001|Crossover Phase|Died|0|||
149978839|NCT02737501|541059035|FG002|Crossover Phase|Died|22|||
149978840|NCT02737501|541059033|FG000|Crossover Phase|Withdrew Consent|0|||
149978841|NCT02737501|541059034|FG001|Crossover Phase|Withdrew Consent|0|||
149978842|NCT02737501|541059035|FG002|Crossover Phase|Withdrew Consent|9|||
149978843|NCT02737501|541059033|FG000|Crossover Phase|Physician Decision|0|||
149978844|NCT02737501|541059034|FG001|Crossover Phase|Physician Decision|0|||
149978845|NCT02737501|541059035|FG002|Crossover Phase|Physician Decision|1|||
149978846|NCT02737501|541059033|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
149978847|NCT02737501|541059034|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
150178589|NCT00421889|541791973|FG001|Overall Study|Lost to Follow-up|0|||
150178590|NCT00421889|541791974|FG002|Overall Study|Lost to Follow-up|0|||
150178591|NCT00421889|541791975|FG003|Overall Study|Lost to Follow-up|0|||
150178592|NCT00421889|541791976|FG004|Overall Study|Lost to Follow-up|0|||
150052545|NCT03158285|541335059|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
150052546|NCT03158285|541335057|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
150178593|NCT00421889|541791977|FG005|Overall Study|Lost to Follow-up|0|||
150052547|NCT03158285|541335058|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
150052548|NCT03158285|541335059|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
150052549|NCT03158285|541335057|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
150052550|NCT03158285|541335058|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
150052551|NCT03158285|541335059|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
150052552|NCT03158285|541335057|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
150052553|NCT03158285|541335058|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
150052554|NCT03158285|541335059|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
150052555|NCT03158285|541335057|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
150052556|NCT03158285|541335058|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
150052557|NCT03158285|541335059|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
150052558|NCT03158285|541335057|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
150052559|NCT03158285|541335058|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
150052560|NCT03158285|541335059|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
150052561|NCT03158285|541335057|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
150052562|NCT03158285|541335058|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
150052563|NCT03158285|541335059|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
150178594|NCT00421889|541791978|FG006|Overall Study|Lost to Follow-up|0|||
150052564|NCT03158285|541335057|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
150052565|NCT03158285|541335058|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
149978848|NCT02737501|541059035|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
149978849|NCT01070979|541059036|FG000|Overall Study|Adverse Event|2|||
149978850|NCT01070979|541059037|FG001|Overall Study|Adverse Event|3|||
149978851|NCT01070979|541059038|FG002|Overall Study|Adverse Event|3|||
149978852|NCT01070979|541059036|FG000|Overall Study|Lost to Follow-up|2|||
149978853|NCT01070979|541059037|FG001|Overall Study|Lost to Follow-up|1|||
149978854|NCT01070979|541059038|FG002|Overall Study|Lost to Follow-up|1|||
149978855|NCT01070979|541059036|FG000|Overall Study|Protocol Violation|0|||
149978856|NCT01070979|541059037|FG001|Overall Study|Protocol Violation|2|||
149978857|NCT01070979|541059038|FG002|Overall Study|Protocol Violation|6|||
149978858|NCT01070979|541059036|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
149978859|NCT01070979|541059037|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
149978860|NCT01070979|541059038|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
149978861|NCT01070979|541059036|FG000|Overall Study|Withdrawal by Subject|3|||
149978862|NCT01070979|541059037|FG001|Overall Study|Withdrawal by Subject|1|||
149978863|NCT01070979|541059038|FG002|Overall Study|Withdrawal by Subject|1|||
149978864|NCT01070979|541059036|FG000|Overall Study|No study drug taken|0|||
149978865|NCT01070979|541059037|FG001|Overall Study|No study drug taken|1|||
150052566|NCT03158285|541335059|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
150052567|NCT03158285|541335057|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
150052568|NCT03158285|541335058|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
150052569|NCT03158285|541335059|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
150052570|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
150052571|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
150052572|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
150052573|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
150052574|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
150178595|NCT00421889|541791979|FG007|Overall Study|Lost to Follow-up|0|||
150178596|NCT00421889|541791980|FG008|Overall Study|Lost to Follow-up|1|||
150178597|NCT00978042|541791981|FG000|Initial Treatment Period|Treated in Error|0|||
150052575|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
150052576|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
150052577|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
150052578|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
150052579|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
150052580|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
150052581|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
150052582|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Death|1|||
150052583|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Death|0|||
150052584|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Death|0|||
150052585|NCT03158285|541335057|FG000|Active Treatment Period: Week 52-100|Other|4|||
150052586|NCT03158285|541335058|FG001|Active Treatment Period: Week 52-100|Other|1|||
150052587|NCT03158285|541335059|FG002|Active Treatment Period: Week 52-100|Other|0|||
150052588|NCT02228980|541335062|FG000|Overall Study|Adverse Event|14|||
150052589|NCT02228980|541335063|FG001|Overall Study|Adverse Event|0|||
150052590|NCT02228980|541335064|FG002|Overall Study|Adverse Event|0|||
150052591|NCT02228980|541335065|FG003|Overall Study|Adverse Event|0|||
150052592|NCT02228980|541335062|FG000|Overall Study|Protocol Violation|7|||
150052593|NCT02228980|541335063|FG001|Overall Study|Protocol Violation|0|||
150052594|NCT02228980|541335064|FG002|Overall Study|Protocol Violation|0|||
150052595|NCT02228980|541335065|FG003|Overall Study|Protocol Violation|0|||
150052596|NCT02228980|541335062|FG000|Overall Study|Withdrawal by Subject|3|||
150052597|NCT02228980|541335063|FG001|Overall Study|Withdrawal by Subject|3|||
150052598|NCT02228980|541335064|FG002|Overall Study|Withdrawal by Subject|2|||
150052599|NCT02228980|541335065|FG003|Overall Study|Withdrawal by Subject|3|||
150052600|NCT01642615|541335066|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
150052601|NCT01642615|541335067|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
150052602|NCT01642615|541335068|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
150052603|NCT01642615|541335066|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
150052604|NCT01642615|541335067|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
150052605|NCT01642615|541335068|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
150052606|NCT01642615|541335066|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
150052607|NCT01642615|541335067|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
150052608|NCT01642615|541335068|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
150052609|NCT01642615|541335066|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
150052610|NCT01642615|541335067|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
150052611|NCT01642615|541335068|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
150052612|NCT01642615|541335066|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
150052613|NCT01642615|541335067|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
150052614|NCT01642615|541335068|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
150052615|NCT01642615|541335066|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
150052616|NCT01642615|541335067|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
150052617|NCT01642615|541335068|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
150052618|NCT01642615|541335066|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
150052619|NCT01642615|541335067|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
150052620|NCT01642615|541335068|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
150052621|NCT01642615|541335066|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
150052622|NCT01642615|541335067|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
150052623|NCT01642615|541335068|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
150052624|NCT01642615|541335066|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
150052625|NCT01642615|541335067|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
150052626|NCT01642615|541335068|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
150052627|NCT02744040|541335069|FG000|Overall Study|Withdrawal by Subject|3|||
150052628|NCT02744040|541335070|FG001|Overall Study|Withdrawal by Subject|2|||
150052629|NCT02744040|541335071|FG002|Overall Study|Withdrawal by Subject|2|||
150052630|NCT02744040|541335069|FG000|Overall Study|Physician Decision|0|||
150052631|NCT02744040|541335070|FG001|Overall Study|Physician Decision|8|||
150052632|NCT02744040|541335071|FG002|Overall Study|Physician Decision|13|||
150052633|NCT02744040|541335069|FG000|Overall Study|Lost to Follow-up|3|||
150052634|NCT02744040|541335070|FG001|Overall Study|Lost to Follow-up|1|||
150052635|NCT02744040|541335071|FG002|Overall Study|Lost to Follow-up|7|||
150052636|NCT01008423|541335072|FG000|Overall Study|Adverse Event|13|||
150052637|NCT01008423|541335073|FG001|Overall Study|Adverse Event|6|||
150052638|NCT01008423|541335072|FG000|Overall Study|Withdrawal by Subject|4|||
150052639|NCT01008423|541335073|FG001|Overall Study|Withdrawal by Subject|7|||
150052640|NCT01008423|541335072|FG000|Overall Study|Lost to Follow-up|0|||
150052641|NCT01008423|541335073|FG001|Overall Study|Lost to Follow-up|2|||
150052642|NCT01008423|541335072|FG000|Overall Study|Low Cortisol|0|||
150052643|NCT01008423|541335073|FG001|Overall Study|Low Cortisol|1|||
150052644|NCT01008423|541335072|FG000|Overall Study|Lack of Efficacy|0|||
150052645|NCT01008423|541335073|FG001|Overall Study|Lack of Efficacy|5|||
150052646|NCT01008423|541335072|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
150052647|NCT01008423|541335073|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
150052648|NCT01008423|541335072|FG000|Overall Study|Personal Conflict|1|||
150052649|NCT01008423|541335073|FG001|Overall Study|Personal Conflict|0|||
150052650|NCT01008423|541335072|FG000|Overall Study|Other|0|||
150052651|NCT01008423|541335073|FG001|Overall Study|Other|1|||
150052652|NCT01028300|541335079|FG000|Overall Study|Study Terminated|4|||
150052653|NCT00715910|541335082|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
150052654|NCT00715910|541335083|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
150052655|NCT00715910|541335084|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
150052656|NCT00715910|541335085|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
150052657|NCT00715910|541335086|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
150052658|NCT00715910|541335087|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
150052659|NCT00715910|541335082|FG000|Booster and ESFU Phase|Other|0|||
150052660|NCT00715910|541335083|FG001|Booster and ESFU Phase|Other|0|||
150052661|NCT00715910|541335084|FG002|Booster and ESFU Phase|Other|0|||
150052662|NCT00715910|541335085|FG003|Booster and ESFU Phase|Other|5|||
150052663|NCT00715910|541335086|FG004|Booster and ESFU Phase|Other|1|||
150052664|NCT00715910|541335087|FG005|Booster and ESFU Phase|Other|0|||
150052665|NCT00946153|541335091|FG000|Phase 2|Adverse Event|0|||
150052666|NCT00946153|541335092|FG001|Phase 2|Adverse Event|0|||
150052667|NCT00946153|541335093|FG002|Phase 2|Adverse Event|0|||
150052668|NCT00946153|541335094|FG003|Phase 2|Adverse Event|0|||
150052669|NCT00946153|541335095|FG004|Phase 2|Adverse Event|6|||
150052670|NCT00946153|541335091|FG000|Phase 2|Need more reduction of dose|0|||
150178598|NCT00978042|541791982|FG001|Initial Treatment Period|Treated in Error|3|||
150178599|NCT00978042|541791981|FG000|Initial Treatment Period|Ineligibility|1|||
150052671|NCT00946153|541335092|FG001|Phase 2|Need more reduction of dose|0|||
150052672|NCT00946153|541335093|FG002|Phase 2|Need more reduction of dose|0|||
150052673|NCT00946153|541335094|FG003|Phase 2|Need more reduction of dose|0|||
150052674|NCT00946153|541335095|FG004|Phase 2|Need more reduction of dose|2|||
150052675|NCT00946153|541335091|FG000|Phase 2|Physician Decision|0|||
150052676|NCT00946153|541335092|FG001|Phase 2|Physician Decision|0|||
150052677|NCT00946153|541335093|FG002|Phase 2|Physician Decision|0|||
150052678|NCT00946153|541335094|FG003|Phase 2|Physician Decision|0|||
150052679|NCT00946153|541335095|FG004|Phase 2|Physician Decision|1|||
150052680|NCT00946153|541335091|FG000|Phase 2|14 days washout for recovery due to AE|0|||
150052681|NCT00946153|541335092|FG001|Phase 2|14 days washout for recovery due to AE|0|||
150052682|NCT00946153|541335093|FG002|Phase 2|14 days washout for recovery due to AE|0|||
150052683|NCT00946153|541335094|FG003|Phase 2|14 days washout for recovery due to AE|0|||
150052684|NCT00946153|541335095|FG004|Phase 2|14 days washout for recovery due to AE|4|||
150052685|NCT01675167|541335102|FG000|Open-label Titration Phase|Adverse Event|81|||
150052686|NCT01675167|541335103|FG001|Open-label Titration Phase|Adverse Event|0|||
150178600|NCT00978042|541791982|FG001|Initial Treatment Period|Ineligibility|0|||
150178601|NCT00978042|541791981|FG000|Initial Treatment Period|Lost to Follow-up|21|||
150178602|NCT00978042|541791982|FG001|Initial Treatment Period|Lost to Follow-up|3|||
150178603|NCT00978042|541791981|FG000|Initial Treatment Period|Adverse Event|2|||
150178604|NCT00978042|541791982|FG001|Initial Treatment Period|Adverse Event|0|||
150178605|NCT00978042|541791981|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
150178606|NCT00978042|541791982|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
150178607|NCT00978042|541791981|FG000|Initial Treatment Period|Consent withdrawn|22|||
150052687|NCT01675167|541335104|FG002|Open-label Titration Phase|Adverse Event|0|||
150052688|NCT01675167|541335102|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
150052689|NCT01675167|541335103|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
150178608|NCT00978042|541791982|FG001|Initial Treatment Period|Consent withdrawn|9|||
150052690|NCT01675167|541335104|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
150052691|NCT01675167|541335102|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
150052692|NCT01675167|541335103|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
150052693|NCT01675167|541335104|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
150052694|NCT01675167|541335102|FG000|Open-label Titration Phase|Protocol Violation|43|||
150052695|NCT01675167|541335103|FG001|Open-label Titration Phase|Protocol Violation|0|||
150052696|NCT01675167|541335104|FG002|Open-label Titration Phase|Protocol Violation|0|||
150052697|NCT01675167|541335102|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
150052698|NCT01675167|541335103|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
150052699|NCT01675167|541335104|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
150052700|NCT01675167|541335102|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
150052701|NCT01675167|541335103|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
150052702|NCT01675167|541335104|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
150052703|NCT01675167|541335102|FG000|Open-label Titration Phase|Other|55|||
150052704|NCT01675167|541335103|FG001|Open-label Titration Phase|Other|0|||
150052705|NCT01675167|541335104|FG002|Open-label Titration Phase|Other|0|||
150052706|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
150052707|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
150052708|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
150052709|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150052710|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
150052711|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
150052712|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Adverse Event|0|||
150052713|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Adverse Event|5|||
150052714|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Adverse Event|13|||
150052715|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
150052716|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
150052717|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
150052718|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
150052719|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
150052720|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
150052721|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
150052722|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
150052723|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
150052724|NCT01675167|541335102|FG000|Double-blind Treatment Phase|Other|0|||
150052725|NCT01675167|541335103|FG001|Double-blind Treatment Phase|Other|7|||
150052726|NCT01675167|541335104|FG002|Double-blind Treatment Phase|Other|5|||
150052727|NCT01165216|541335105|FG000|Overall Study|Adverse Event|6|||
150052728|NCT01165216|541335106|FG001|Overall Study|Adverse Event|3|||
150052729|NCT01165216|541335105|FG000|Overall Study|Withdrawal by Subject|1|||
150052730|NCT01165216|541335106|FG001|Overall Study|Withdrawal by Subject|1|||
150052731|NCT01165216|541335105|FG000|Overall Study|Disease progression|1|||
150052732|NCT01165216|541335106|FG001|Overall Study|Disease progression|3|||
150052733|NCT01379508|541335109|FG000|Treatment to Week 104|Adverse Event|2|||
150052734|NCT01379508|541335110|FG001|Treatment to Week 104|Adverse Event|0|||
150052735|NCT01379508|541335111|FG002|Treatment to Week 104|Adverse Event|5|||
150052736|NCT01379508|541335112|FG003|Treatment to Week 104|Adverse Event|0|||
150052737|NCT01379508|541335109|FG000|Treatment to Week 104|Abnormal lab value|1|||
150052738|NCT01379508|541335110|FG001|Treatment to Week 104|Abnormal lab value|0|||
150052739|NCT01379508|541335111|FG002|Treatment to Week 104|Abnormal lab value|0|||
150052740|NCT01379508|541335112|FG003|Treatment to Week 104|Abnormal lab value|0|||
150052741|NCT01379508|541335109|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
150052742|NCT01379508|541335110|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
150052743|NCT01379508|541335111|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
150052744|NCT01379508|541335112|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
150052745|NCT01379508|541335109|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
150052746|NCT01379508|541335110|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
150178609|NCT00978042|541791981|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
150052747|NCT01379508|541335111|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
150178610|NCT00978042|541791982|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
150178611|NCT00529516|541791983|FG000|Overall Study|Adverse Event|2|||
150052748|NCT01379508|541335112|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
150052749|NCT01379508|541335109|FG000|Treatment to Week 104|Lost to Follow-up|5|||
150052750|NCT01379508|541335110|FG001|Treatment to Week 104|Lost to Follow-up|0|||
150052751|NCT01379508|541335111|FG002|Treatment to Week 104|Lost to Follow-up|3|||
150052752|NCT01379508|541335112|FG003|Treatment to Week 104|Lost to Follow-up|0|||
150052753|NCT01379508|541335109|FG000|Treatment to Week 104|Administrative problems|3|||
149737497|NCT02601950|540170383|FG006|Overall Study|Non-compliance|1|||
150178612|NCT00529516|541791984|FG001|Overall Study|Adverse Event|1|||
150178613|NCT00529516|541791985|FG002|Overall Study|Adverse Event|0|||
150052754|NCT01379508|541335110|FG001|Treatment to Week 104|Administrative problems|1|||
150052755|NCT01379508|541335111|FG002|Treatment to Week 104|Administrative problems|0|||
150052756|NCT01379508|541335112|FG003|Treatment to Week 104|Administrative problems|0|||
150052757|NCT01379508|541335109|FG000|Treatment to Week 104|Protocol Violation|1|||
150052758|NCT01379508|541335110|FG001|Treatment to Week 104|Protocol Violation|1|||
150052759|NCT01379508|541335111|FG002|Treatment to Week 104|Protocol Violation|1|||
150052760|NCT01379508|541335112|FG003|Treatment to Week 104|Protocol Violation|0|||
150052761|NCT01379508|541335109|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
150052762|NCT01379508|541335110|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
150052763|NCT01379508|541335111|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
150052764|NCT01379508|541335112|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
150052765|NCT01379508|541335109|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
150052766|NCT01379508|541335110|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
150052767|NCT01379508|541335111|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
150052768|NCT01379508|541335112|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
150052769|NCT01379508|541335109|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
150052770|NCT01379508|541335110|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
150052771|NCT01379508|541335111|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
150052772|NCT01379508|541335112|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
150052773|NCT01379508|541335109|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
150052774|NCT01379508|541335110|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
150052775|NCT01379508|541335111|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
150052776|NCT01379508|541335112|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
150052777|NCT03952039|541335115|FG000|Overall Study|Adverse Event|22|||
150052778|NCT03952039|541335116|FG001|Overall Study|Adverse Event|8|||
150052779|NCT03952039|541335115|FG000|Overall Study|Withdrawal by Participant|17|||
150052780|NCT03952039|541335116|FG001|Overall Study|Withdrawal by Participant|12|||
150052781|NCT03952039|541335115|FG000|Overall Study|Death|13|||
150052782|NCT03952039|541335116|FG001|Overall Study|Death|6|||
150052783|NCT03952039|541335115|FG000|Overall Study|Lack of Efficacy|12|||
150052784|NCT03952039|541335116|FG001|Overall Study|Lack of Efficacy|2|||
150052785|NCT03952039|541335115|FG000|Overall Study|Physician Decision|9|||
150052786|NCT03952039|541335116|FG001|Overall Study|Physician Decision|3|||
150052787|NCT03952039|541335115|FG000|Overall Study|Progressive Disease|6|||
150052788|NCT03952039|541335116|FG001|Overall Study|Progressive Disease|4|||
150052789|NCT03952039|541335115|FG000|Overall Study|Other Reasons|12|||
150052790|NCT03952039|541335116|FG001|Overall Study|Other Reasons|4|||
150052791|NCT02626624|541335117|FG000|Overall Study|Adverse Event|1|||
150052792|NCT02626624|541335117|FG000|Overall Study|Lost to Follow-up|3|||
150052793|NCT02626624|541335117|FG000|Overall Study|Protocol Violation|4|||
150052794|NCT02626624|541335117|FG000|Overall Study|Death|2|||
150052795|NCT04174365|541335118|FG000|Overall Study|Lost to Follow-up|1|||
150052796|NCT04174365|541335119|FG001|Overall Study|Lost to Follow-up|2|||
150052797|NCT04174365|541335118|FG000|Overall Study|Adverse Event|2|||
150052798|NCT04174365|541335119|FG001|Overall Study|Adverse Event|1|||
150052799|NCT04174365|541335118|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
150052800|NCT04174365|541335119|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
150052801|NCT04174365|541335118|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
150052802|NCT04174365|541335119|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
150052803|NCT04174365|541335118|FG000|Overall Study|Protocol Deviation|1|||
150052804|NCT04174365|541335119|FG001|Overall Study|Protocol Deviation|0|||
150052805|NCT04174365|541335118|FG000|Overall Study|Lack of Efficacy|0|||
150052806|NCT04174365|541335119|FG001|Overall Study|Lack of Efficacy|2|||
150052807|NCT04174365|541335118|FG000|Overall Study|Disease Relapse|1|||
150052808|NCT04174365|541335119|FG001|Overall Study|Disease Relapse|0|||
150052809|NCT04174365|541335118|FG000|Overall Study|Reason Not Specified|0|||
150052810|NCT04174365|541335119|FG001|Overall Study|Reason Not Specified|1|||
150052811|NCT03472547|541335120|FG000|Overall Study|Withdrawal by Subject|30|||
150052812|NCT05141448|541335121|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150052813|NCT05141448|541335122|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
150052814|NCT05141448|541335123|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150052815|NCT05141448|541335124|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150052816|NCT05141448|541335125|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150178614|NCT00529516|541791983|FG000|Overall Study|Withdrawal by Subject|1|||
150178615|NCT00529516|541791984|FG001|Overall Study|Withdrawal by Subject|1|||
150178616|NCT00529516|541791985|FG002|Overall Study|Withdrawal by Subject|0|||
150052817|NCT05141448|541335126|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150052818|NCT05141448|541335121|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150052819|NCT05141448|541335122|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150052820|NCT05141448|541335123|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150052821|NCT05141448|541335124|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150052822|NCT05141448|541335125|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
150052823|NCT05141448|541335126|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150052824|NCT05141448|541335121|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150052825|NCT05141448|541335122|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
150052826|NCT05141448|541335123|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150052827|NCT05141448|541335124|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150052828|NCT05141448|541335125|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150052829|NCT05141448|541335126|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150052830|NCT05141448|541335121|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150052831|NCT05141448|541335122|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150052832|NCT05141448|541335123|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150052833|NCT05141448|541335124|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150052834|NCT05141448|541335125|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150052835|NCT05141448|541335126|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
150052836|NCT05141448|541335121|FG000|Period 2|COVID-19 Related|0|||
150052837|NCT05141448|541335122|FG001|Period 2|COVID-19 Related|0|||
150052838|NCT05141448|541335123|FG002|Period 2|COVID-19 Related|0|||
150052839|NCT05141448|541335124|FG003|Period 2|COVID-19 Related|1|||
150052840|NCT05141448|541335125|FG004|Period 2|COVID-19 Related|0|||
150178617|NCT00529516|541791983|FG000|Overall Study|Lost to Follow-up|0|||
150052841|NCT05141448|541335126|FG005|Period 2|COVID-19 Related|1|||
150052842|NCT05141448|541335121|FG000|3|Covid-19 related|2|||
150052843|NCT05141448|541335122|FG001|3|Covid-19 related|0|||
150052844|NCT05141448|541335123|FG002|3|Covid-19 related|0|||
150052845|NCT05141448|541335124|FG003|3|Covid-19 related|0|||
150052846|NCT05141448|541335125|FG004|3|Covid-19 related|0|||
150052847|NCT05141448|541335126|FG005|3|Covid-19 related|1|||
150052848|NCT05141448|541335121|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
150052849|NCT05141448|541335122|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
150052850|NCT05141448|541335123|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
150052851|NCT05141448|541335124|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
150052852|NCT05141448|541335125|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
150052853|NCT05141448|541335126|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
150052854|NCT02208063|541336549|FG000|Overall Study|Death|3|||
150052855|NCT02208063|541336550|FG001|Overall Study|Death|5|||
150052856|NCT02208063|541336549|FG000|Overall Study|Not Specified in report|3|||
150052857|NCT02208063|541336550|FG001|Overall Study|Not Specified in report|4|||
150052858|NCT02208063|541336549|FG000|Overall Study|Withdrawal by Subject|5|||
150052859|NCT02208063|541336550|FG001|Overall Study|Withdrawal by Subject|2|||
150052860|NCT02208063|541336549|FG000|Overall Study|Lost to Follow-up|1|||
150052861|NCT02208063|541336550|FG001|Overall Study|Lost to Follow-up|0|||
150052862|NCT00913458|541336551|FG000|Phase 1|Non-Responder|54|||
150052863|NCT00913458|541336552|FG001|Phase 1|Non-Responder|0|||
150052864|NCT00913458|541336553|FG002|Phase 1|Non-Responder|0|||
150052865|NCT00913458|541336554|FG003|Phase 1|Non-Responder|0|||
150052866|NCT00913458|541336555|FG004|Phase 1|Non-Responder|0|||
150052867|NCT00913458|541336556|FG005|Phase 1|Non-Responder|0|||
150052868|NCT00913458|541336557|FG006|Phase 1|Non-Responder|0|||
150052869|NCT00913458|541336551|FG000|Phase 1|Subject Request|17|||
150052870|NCT00913458|541336552|FG001|Phase 1|Subject Request|0|||
150052871|NCT00913458|541336553|FG002|Phase 1|Subject Request|0|||
150052872|NCT00913458|541336554|FG003|Phase 1|Subject Request|0|||
150052873|NCT00913458|541336555|FG004|Phase 1|Subject Request|0|||
150052874|NCT00913458|541336556|FG005|Phase 1|Subject Request|0|||
150052875|NCT00913458|541336557|FG006|Phase 1|Subject Request|0|||
150052876|NCT00913458|541336551|FG000|Phase 1|Adverse Event|20|||
150052877|NCT00913458|541336552|FG001|Phase 1|Adverse Event|0|||
150052878|NCT00913458|541336553|FG002|Phase 1|Adverse Event|0|||
150052879|NCT00913458|541336554|FG003|Phase 1|Adverse Event|0|||
150052880|NCT00913458|541336555|FG004|Phase 1|Adverse Event|0|||
150052881|NCT00913458|541336556|FG005|Phase 1|Adverse Event|0|||
150052882|NCT00913458|541336557|FG006|Phase 1|Adverse Event|0|||
150052883|NCT00913458|541336551|FG000|Phase 1|Lost to Follow-up|2|||
150052884|NCT00913458|541336552|FG001|Phase 1|Lost to Follow-up|0|||
150052885|NCT00913458|541336553|FG002|Phase 1|Lost to Follow-up|0|||
150052886|NCT00913458|541336554|FG003|Phase 1|Lost to Follow-up|0|||
150052887|NCT00913458|541336555|FG004|Phase 1|Lost to Follow-up|0|||
150052888|NCT00913458|541336556|FG005|Phase 1|Lost to Follow-up|0|||
150052889|NCT00913458|541336557|FG006|Phase 1|Lost to Follow-up|0|||
150052890|NCT00913458|541336551|FG000|Phase 1|Protocol Violation|10|||
150052891|NCT00913458|541336552|FG001|Phase 1|Protocol Violation|0|||
150052892|NCT00913458|541336553|FG002|Phase 1|Protocol Violation|0|||
150052893|NCT00913458|541336554|FG003|Phase 1|Protocol Violation|0|||
150052894|NCT00913458|541336555|FG004|Phase 1|Protocol Violation|0|||
150052895|NCT00913458|541336556|FG005|Phase 1|Protocol Violation|0|||
150052896|NCT00913458|541336557|FG006|Phase 1|Protocol Violation|0|||
150052897|NCT00913458|541336551|FG000|Phase 1|Sponsor|2|||
150052898|NCT00913458|541336552|FG001|Phase 1|Sponsor|0|||
150052899|NCT00913458|541336553|FG002|Phase 1|Sponsor|0|||
150052900|NCT00913458|541336554|FG003|Phase 1|Sponsor|0|||
150052901|NCT00913458|541336555|FG004|Phase 1|Sponsor|0|||
150052902|NCT00913458|541336556|FG005|Phase 1|Sponsor|0|||
150178618|NCT00529516|541791984|FG001|Overall Study|Lost to Follow-up|0|||
150178619|NCT00529516|541791985|FG002|Overall Study|Lost to Follow-up|1|||
150052903|NCT00913458|541336557|FG006|Phase 1|Sponsor|0|||
150052904|NCT00913458|541336551|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
150052905|NCT00913458|541336552|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
150052906|NCT00913458|541336553|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
150052907|NCT00913458|541336554|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
150052908|NCT00913458|541336555|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
150052909|NCT00913458|541336556|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
150052910|NCT00913458|541336557|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
150052911|NCT00913458|541336551|FG000|Phase 2|Non-Responder|0|||
150052912|NCT00913458|541336552|FG001|Phase 2|Non-Responder|5|||
150052913|NCT00913458|541336553|FG002|Phase 2|Non-Responder|7|||
150052914|NCT00913458|541336554|FG003|Phase 2|Non-Responder|12|||
150052915|NCT00913458|541336555|FG004|Phase 2|Non-Responder|0|||
149978866|NCT01070979|541059038|FG002|Overall Study|No study drug taken|0|||
149978867|NCT00833027|541059039|FG000|Overall Study|Adverse Event|33|||
149978868|NCT00833027|541059039|FG000|Overall Study|Death|1|||
149978869|NCT00833027|541059039|FG000|Overall Study|Lack of Efficacy|12|||
149978870|NCT00833027|541059039|FG000|Overall Study|Lost to Follow-up|24|||
149978871|NCT00833027|541059039|FG000|Overall Study|Protocol Violation|115|||
149978872|NCT00833027|541059039|FG000|Overall Study|Withdrawal by Subject|16|||
149978873|NCT00833027|541059039|FG000|Overall Study|Missing|10|||
149978874|NCT02806414|541059042|FG000|Overall Study|Lost to Follow-up|2|||
149978875|NCT01985022|541059045|FG000|Overall Study|Lost to Follow-up|0|||
149978876|NCT01985022|541059046|FG001|Overall Study|Lost to Follow-up|1|||
149978877|NCT01985022|541059045|FG000|Overall Study|Protocol Violation|0|||
149978878|NCT01985022|541059046|FG001|Overall Study|Protocol Violation|1|||
149978879|NCT01985022|541059045|FG000|Overall Study|Withdrawal by Subject|4|||
149978880|NCT01985022|541059046|FG001|Overall Study|Withdrawal by Subject|1|||
149978881|NCT00806260|541059051|FG000|Period 1 (1 Day)|Adverse Event|0|||
149978882|NCT00806260|541059052|FG001|Period 1 (1 Day)|Adverse Event|0|||
150178620|NCT00703820|541791988|FG000|Overall Study|Adverse Event|12|||
150178621|NCT00703820|541791989|FG001|Overall Study|Adverse Event|17|||
150178622|NCT00703820|541791988|FG000|Overall Study|Death|5|||
149978883|NCT00806260|541059053|FG002|Period 1 (1 Day)|Adverse Event|0|||
149978884|NCT00806260|541059054|FG003|Period 1 (1 Day)|Adverse Event|0|||
149978885|NCT00806260|541059055|FG004|Period 1 (1 Day)|Adverse Event|3|||
149978886|NCT00806260|541059056|FG005|Period 1 (1 Day)|Adverse Event|0|||
149978887|NCT00806260|541059051|FG000|Period 2|Adverse Event|0|||
149978888|NCT00806260|541059052|FG001|Period 2|Adverse Event|0|||
149978889|NCT00806260|541059053|FG002|Period 2|Adverse Event|0|||
149978890|NCT00806260|541059054|FG003|Period 2|Adverse Event|1|||
149978891|NCT00806260|541059055|FG004|Period 2|Adverse Event|0|||
149978892|NCT00806260|541059056|FG005|Period 2|Adverse Event|0|||
149978893|NCT00806260|541059051|FG000|Period 2|Protocol Violation|1|||
149978894|NCT00806260|541059052|FG001|Period 2|Protocol Violation|0|||
149978895|NCT00806260|541059053|FG002|Period 2|Protocol Violation|1|||
149978896|NCT00806260|541059054|FG003|Period 2|Protocol Violation|0|||
149978897|NCT00806260|541059055|FG004|Period 2|Protocol Violation|0|||
149978898|NCT00806260|541059056|FG005|Period 2|Protocol Violation|0|||
149978899|NCT00806260|541059051|FG000|Period 2|Need to take concomitant medication|1|||
149978900|NCT00806260|541059052|FG001|Period 2|Need to take concomitant medication|0|||
149978901|NCT00806260|541059053|FG002|Period 2|Need to take concomitant medication|0|||
149978902|NCT00806260|541059054|FG003|Period 2|Need to take concomitant medication|0|||
149978903|NCT00806260|541059055|FG004|Period 2|Need to take concomitant medication|0|||
149978904|NCT00806260|541059056|FG005|Period 2|Need to take concomitant medication|0|||
149978905|NCT00806260|541059051|FG000|Period 2|sponsor request|0|||
149978906|NCT00806260|541059052|FG001|Period 2|sponsor request|0|||
149978907|NCT00806260|541059053|FG002|Period 2|sponsor request|1|||
149978908|NCT00806260|541059054|FG003|Period 2|sponsor request|1|||
149978909|NCT00806260|541059055|FG004|Period 2|sponsor request|0|||
149978910|NCT00806260|541059056|FG005|Period 2|sponsor request|0|||
149978911|NCT00806260|541059051|FG000|Period 3|Protocol Violation|0|||
149978912|NCT00806260|541059052|FG001|Period 3|Protocol Violation|1|||
149978913|NCT00806260|541059053|FG002|Period 3|Protocol Violation|1|||
149978914|NCT00806260|541059054|FG003|Period 3|Protocol Violation|0|||
149978915|NCT00806260|541059055|FG004|Period 3|Protocol Violation|0|||
149978916|NCT00806260|541059056|FG005|Period 3|Protocol Violation|0|||
149978917|NCT00806260|541059051|FG000|Period 3|Pregnancy|1|||
149978918|NCT00806260|541059052|FG001|Period 3|Pregnancy|0|||
149978919|NCT00806260|541059053|FG002|Period 3|Pregnancy|0|||
149978920|NCT00806260|541059054|FG003|Period 3|Pregnancy|0|||
149978921|NCT00806260|541059055|FG004|Period 3|Pregnancy|0|||
149978922|NCT00806260|541059056|FG005|Period 3|Pregnancy|0|||
149978923|NCT00237042|541059057|FG000|Treatment|Became ineligible post-randomization|0|||
149978924|NCT00237042|541059058|FG001|Treatment|Became ineligible post-randomization|1|||
149978925|NCT00237042|541059059|FG002|Treatment|Became ineligible post-randomization|16|||
149978926|NCT00237042|541059057|FG000|Treatment|Moved out of state|1|||
149978927|NCT00237042|541059058|FG001|Treatment|Moved out of state|1|||
149978928|NCT00237042|541059059|FG002|Treatment|Moved out of state|1|||
149978929|NCT00237042|541059057|FG000|Treatment|Completed no treatment|5|||
149978930|NCT00237042|541059058|FG001|Treatment|Completed no treatment|5|||
149978931|NCT00237042|541059059|FG002|Treatment|Completed no treatment|21|||
149978932|NCT00237042|541059057|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
149978933|NCT00237042|541059058|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
149978934|NCT00237042|541059059|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
149978935|NCT00237042|541059057|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
149978936|NCT00237042|541059058|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
149978937|NCT00237042|541059059|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
149978938|NCT05223673|541059062|FG000|Overall Study|Protocol Violation|1|||
149978939|NCT05223673|541059062|FG000|Overall Study|Study termination|6|||
149978940|NCT00810277|541060654|FG000|Overall Study|Adverse Event|1|||
149978941|NCT00532129|541060657|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
149978942|NCT00532129|541060657|FG000|Treatment Period|Physician Decision|15|||
149978943|NCT00532129|541060657|FG000|Treatment Period|Disease progression|3|||
149978944|NCT00532129|541060657|FG000|Treatment Period|Protocol Violation|1|||
149978945|NCT00532129|541060657|FG000|Treatment Period|Other|5|||
149978946|NCT00532129|541060657|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
149978947|NCT00532129|541060657|FG000|Follow-up Period|Disease progression|57|||
149978948|NCT00532129|541060657|FG000|Follow-up Period|Lost to Follow-up|1|||
149978949|NCT00532129|541060657|FG000|Follow-up Period|Other|6|||
149978950|NCT04551898|541060658|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
149978951|NCT04551898|541060659|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
149978952|NCT04551898|541060660|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
149978953|NCT04551898|541060661|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
149978954|NCT04551898|541060658|FG000|Overall Study|Withdrawal by Subject|5|||
149978955|NCT04551898|541060659|FG001|Overall Study|Withdrawal by Subject|1|||
149978956|NCT04551898|541060660|FG002|Overall Study|Withdrawal by Subject|2|||
149978957|NCT04551898|541060661|FG003|Overall Study|Withdrawal by Subject|2|||
149978958|NCT04551898|541060658|FG000|Overall Study|Lost to Follow-up|2|||
149978959|NCT04551898|541060659|FG001|Overall Study|Lost to Follow-up|1|||
149978960|NCT04551898|541060660|FG002|Overall Study|Lost to Follow-up|2|||
149978961|NCT04551898|541060661|FG003|Overall Study|Lost to Follow-up|2|||
149978962|NCT04551898|541060658|FG000|Overall Study|Death|1|||
149978963|NCT04551898|541060659|FG001|Overall Study|Death|0|||
149978964|NCT04551898|541060660|FG002|Overall Study|Death|0|||
149978965|NCT04551898|541060661|FG003|Overall Study|Death|0|||
149978966|NCT04551898|541060658|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
149978967|NCT04551898|541060659|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
149978968|NCT04551898|541060660|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
149978969|NCT04551898|541060661|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
149978970|NCT03145064|541060662|FG000|Overall Study|Death|24|||
149978971|NCT03145064|541060662|FG000|Overall Study|Lost to Follow-up|3|||
149978972|NCT03145064|541060662|FG000|Overall Study|Withdrawal by Subject|6|||
149978973|NCT03145064|541060662|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
149978974|NCT03145064|541060662|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
149978975|NCT00456755|541060671|FG000|Overall Study|Lost to Follow-up|2|||
149978976|NCT00456755|541060672|FG001|Overall Study|Lost to Follow-up|1|||
149978977|NCT02477527|541060677|FG000|Overall Study|Lost to Follow-up|2|||
149978978|NCT02477527|541060677|FG000|Overall Study|Withdrawal by Subject|1|||
149978979|NCT02477527|541060677|FG000|Overall Study|Screen Failure|3|||
149978980|NCT04567524|541060678|FG000|Overall Study|Adverse Event|1|||
149978981|NCT04567524|541060679|FG001|Overall Study|Adverse Event|1|||
149978982|NCT04567524|541060680|FG002|Overall Study|Adverse Event|0|||
150052916|NCT00913458|541336556|FG005|Phase 2|Non-Responder|0|||
149978983|NCT04567524|541060681|FG003|Overall Study|Adverse Event|0|||
150052917|NCT00913458|541336557|FG006|Phase 2|Non-Responder|0|||
149978984|NCT04567524|541060678|FG000|Overall Study|Withdrawal by Subject|2|||
149978985|NCT04567524|541060679|FG001|Overall Study|Withdrawal by Subject|0|||
149978986|NCT04567524|541060680|FG002|Overall Study|Withdrawal by Subject|0|||
149978987|NCT04567524|541060681|FG003|Overall Study|Withdrawal by Subject|1|||
149978988|NCT01349673|541060682|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
149978989|NCT01349673|541060682|FG000|Overall Study|No Longer Qualified For Study|1|||
149978990|NCT01349673|541060682|FG000|Overall Study|Site Closure|10|||
149978991|NCT01349673|541060682|FG000|Overall Study|Withdrawal by Subject|21|||
149978992|NCT01349673|541060682|FG000|Overall Study|Lost to Follow-up|6|||
149978993|NCT01349673|541060682|FG000|Overall Study|Adverse Event|17|||
150052918|NCT00913458|541336551|FG000|Phase 2|Subject Request|0|||
150052919|NCT00913458|541336552|FG001|Phase 2|Subject Request|0|||
150052920|NCT00913458|541336553|FG002|Phase 2|Subject Request|1|||
150052921|NCT00913458|541336554|FG003|Phase 2|Subject Request|2|||
150052922|NCT00913458|541336555|FG004|Phase 2|Subject Request|0|||
150052923|NCT00913458|541336556|FG005|Phase 2|Subject Request|0|||
150052924|NCT00913458|541336557|FG006|Phase 2|Subject Request|0|||
150052925|NCT00913458|541336551|FG000|Phase 2|Adverse Event|0|||
150052926|NCT00913458|541336552|FG001|Phase 2|Adverse Event|3|||
150052927|NCT00913458|541336553|FG002|Phase 2|Adverse Event|0|||
150052928|NCT00913458|541336554|FG003|Phase 2|Adverse Event|1|||
150052929|NCT00913458|541336555|FG004|Phase 2|Adverse Event|0|||
150052930|NCT00913458|541336556|FG005|Phase 2|Adverse Event|0|||
150052931|NCT00913458|541336557|FG006|Phase 2|Adverse Event|0|||
150052932|NCT00913458|541336551|FG000|Phase 2|Lost to Follow-up|0|||
150052933|NCT00913458|541336552|FG001|Phase 2|Lost to Follow-up|0|||
150052934|NCT00913458|541336553|FG002|Phase 2|Lost to Follow-up|0|||
150052935|NCT00913458|541336554|FG003|Phase 2|Lost to Follow-up|1|||
150052936|NCT00913458|541336555|FG004|Phase 2|Lost to Follow-up|0|||
150052937|NCT00913458|541336556|FG005|Phase 2|Lost to Follow-up|0|||
150052938|NCT00913458|541336557|FG006|Phase 2|Lost to Follow-up|0|||
150052939|NCT00913458|541336551|FG000|Phase 2|Protocol Violation|0|||
150052940|NCT00913458|541336552|FG001|Phase 2|Protocol Violation|2|||
150052941|NCT00913458|541336553|FG002|Phase 2|Protocol Violation|0|||
150052942|NCT00913458|541336554|FG003|Phase 2|Protocol Violation|0|||
150052943|NCT00913458|541336555|FG004|Phase 2|Protocol Violation|0|||
150052944|NCT00913458|541336556|FG005|Phase 2|Protocol Violation|0|||
150052945|NCT00913458|541336557|FG006|Phase 2|Protocol Violation|0|||
150052946|NCT00913458|541336551|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
150052947|NCT00913458|541336552|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
150052948|NCT00913458|541336553|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
150052949|NCT00913458|541336554|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
150052950|NCT00913458|541336555|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
150052951|NCT00913458|541336556|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
150052952|NCT00913458|541336557|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
150052953|NCT00913458|541336551|FG000|Phase 3|Adverse Event|0|||
150052954|NCT00913458|541336552|FG001|Phase 3|Adverse Event|0|||
150052955|NCT00913458|541336553|FG002|Phase 3|Adverse Event|0|||
150052956|NCT00913458|541336554|FG003|Phase 3|Adverse Event|0|||
150052957|NCT00913458|541336555|FG004|Phase 3|Adverse Event|5|||
150052958|NCT00913458|541336556|FG005|Phase 3|Adverse Event|4|||
150052959|NCT00913458|541336557|FG006|Phase 3|Adverse Event|1|||
150052960|NCT00913458|541336551|FG000|Phase 3|Lost to Follow-up|0|||
150052961|NCT00913458|541336552|FG001|Phase 3|Lost to Follow-up|0|||
150052962|NCT00913458|541336553|FG002|Phase 3|Lost to Follow-up|0|||
150052963|NCT00913458|541336554|FG003|Phase 3|Lost to Follow-up|0|||
150052964|NCT00913458|541336555|FG004|Phase 3|Lost to Follow-up|2|||
150052965|NCT00913458|541336556|FG005|Phase 3|Lost to Follow-up|0|||
149978994|NCT01349673|541060682|FG000|Overall Study|Study Terminated By Sponsor|50|||
150052966|NCT00913458|541336557|FG006|Phase 3|Lost to Follow-up|0|||
150178623|NCT00703820|541791989|FG001|Overall Study|Death|0|||
149978995|NCT01349673|541060682|FG000|Overall Study|Lack of Efficacy|8|||
150052967|NCT00913458|541336551|FG000|Phase 3|Non-Responder|0|||
150052968|NCT00913458|541336552|FG001|Phase 3|Non-Responder|0|||
150052969|NCT00913458|541336553|FG002|Phase 3|Non-Responder|0|||
150052970|NCT00913458|541336554|FG003|Phase 3|Non-Responder|0|||
150052971|NCT00913458|541336555|FG004|Phase 3|Non-Responder|0|||
150052972|NCT00913458|541336556|FG005|Phase 3|Non-Responder|1|||
150052973|NCT00913458|541336557|FG006|Phase 3|Non-Responder|3|||
150052974|NCT00913458|541336551|FG000|Phase 3|Withdrawal by Subject|0|||
150052975|NCT00913458|541336552|FG001|Phase 3|Withdrawal by Subject|0|||
150052976|NCT00913458|541336553|FG002|Phase 3|Withdrawal by Subject|0|||
150052977|NCT00913458|541336554|FG003|Phase 3|Withdrawal by Subject|0|||
150052978|NCT00913458|541336555|FG004|Phase 3|Withdrawal by Subject|1|||
150052979|NCT00913458|541336556|FG005|Phase 3|Withdrawal by Subject|2|||
150052980|NCT00913458|541336557|FG006|Phase 3|Withdrawal by Subject|0|||
150052981|NCT00913458|541336551|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
150052982|NCT00913458|541336552|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
150052983|NCT00913458|541336553|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
149978996|NCT01665911|541060683|FG000|Overall Study|Protocol Violation|4|||
149978997|NCT01665911|541060683|FG000|Overall Study|Withdrawal by Subject|1|||
149978998|NCT01665911|541060683|FG000|Overall Study|Adverse Event|1|||
149978999|NCT00347932|541060686|FG000|Overall Study|Adverse Event|4|||
149979000|NCT00347932|541060687|FG001|Overall Study|Adverse Event|5|||
149979001|NCT00347932|541060686|FG000|Overall Study|Lack of Efficacy|3|||
149979002|NCT00347932|541060687|FG001|Overall Study|Lack of Efficacy|14|||
149979003|NCT00347932|541060686|FG000|Overall Study|Lost to Follow-up|10|||
149979004|NCT00347932|541060687|FG001|Overall Study|Lost to Follow-up|9|||
149979005|NCT00347932|541060686|FG000|Overall Study|Withdrawal by Subject|10|||
149979006|NCT00347932|541060687|FG001|Overall Study|Withdrawal by Subject|16|||
149979007|NCT00347932|541060686|FG000|Overall Study|Did not meet inclusion criteria|4|||
149979008|NCT00347932|541060687|FG001|Overall Study|Did not meet inclusion criteria|8|||
149979009|NCT00506779|541060688|FG000|Overall Study|Withdrawal by Subject|1|||
149979010|NCT00506779|541060689|FG001|Overall Study|Withdrawal by Subject|0|||
149979011|NCT00506779|541060690|FG002|Overall Study|Withdrawal by Subject|1|||
149979012|NCT00506779|541060691|FG003|Overall Study|Withdrawal by Subject|0|||
149979013|NCT00506779|541060688|FG000|Overall Study|Adverse Event|0|||
149979014|NCT00506779|541060689|FG001|Overall Study|Adverse Event|1|||
149979015|NCT00506779|541060690|FG002|Overall Study|Adverse Event|1|||
149979016|NCT00506779|541060691|FG003|Overall Study|Adverse Event|1|||
149979017|NCT02817594|541060693|FG000|Overall Study|Withdrawal by Subject|1|||
149979018|NCT02817594|541060693|FG000|Overall Study|Other|1|||
149979019|NCT02817594|541060693|FG000|Overall Study|Did Not Receive Treatment|1|||
149979020|NCT00533429|541060696|FG000|Overall Study|Adverse Event|3|||
149979021|NCT00533429|541060697|FG001|Overall Study|Adverse Event|1|||
149979022|NCT00533429|541060696|FG000|Overall Study|Death|1|||
149979023|NCT00533429|541060697|FG001|Overall Study|Death|0|||
149979024|NCT00533429|541060696|FG000|Overall Study|Withdrawal by Subject|2|||
149979025|NCT00533429|541060697|FG001|Overall Study|Withdrawal by Subject|0|||
149979026|NCT00533429|541060696|FG000|Overall Study|Progressive Disease|12|||
149979027|NCT00533429|541060697|FG001|Overall Study|Progressive Disease|13|||
149979028|NCT00533429|541060696|FG000|Overall Study|Symptomatic deterioration|1|||
149979029|NCT00533429|541060697|FG001|Overall Study|Symptomatic deterioration|2|||
149979030|NCT00127855|541060698|FG000|Primary Vaccination Course|Adverse Event|0|||
149979031|NCT00127855|541060699|FG001|Primary Vaccination Course|Adverse Event|0|||
149979032|NCT00127855|541060700|FG002|Primary Vaccination Course|Adverse Event|1|||
149979033|NCT00127855|541060701|FG003|Primary Vaccination Course|Adverse Event|0|||
149979034|NCT00127855|541060702|FG004|Primary Vaccination Course|Adverse Event|0|||
149979035|NCT00127855|541060698|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
149979036|NCT00127855|541060699|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
149979037|NCT00127855|541060700|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
149979038|NCT00127855|541060701|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
149979039|NCT00127855|541060702|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
149979040|NCT00127855|541060698|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
149979041|NCT00127855|541060699|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
149979042|NCT00127855|541060700|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
149979043|NCT00127855|541060701|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
149979044|NCT00127855|541060702|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
149979045|NCT00127855|541060698|FG000|Primary Vaccination Course|Other|0|||
149979046|NCT00127855|541060699|FG001|Primary Vaccination Course|Other|0|||
149979047|NCT00127855|541060700|FG002|Primary Vaccination Course|Other|0|||
149979048|NCT00127855|541060701|FG003|Primary Vaccination Course|Other|0|||
149979049|NCT00127855|541060702|FG004|Primary Vaccination Course|Other|1|||
149979050|NCT00920556|541060703|FG000|Overall Study|Adverse Event|16|||
149979051|NCT00920556|541060703|FG000|Overall Study|Physician Decision|7|||
149979052|NCT00920556|541060703|FG000|Overall Study|Withdrawal by Subject|1|||
149979053|NCT01299389|541060704|FG000|Double-blind|Adverse Event|45|||
149979054|NCT01299389|541060705|FG001|Double-blind|Adverse Event|27|||
149979055|NCT01299389|541060706|FG002|Double-blind|Adverse Event|0|||
149979056|NCT01299389|541060707|FG003|Double-blind|Adverse Event|0|||
149979057|NCT01299389|541060704|FG000|Double-blind|Lack of Efficacy|45|||
149979058|NCT01299389|541060705|FG001|Double-blind|Lack of Efficacy|21|||
149979059|NCT01299389|541060706|FG002|Double-blind|Lack of Efficacy|0|||
149979060|NCT01299389|541060707|FG003|Double-blind|Lack of Efficacy|0|||
149979061|NCT01299389|541060704|FG000|Double-blind|Lost to Follow-up|2|||
149979062|NCT01299389|541060705|FG001|Double-blind|Lost to Follow-up|1|||
149979063|NCT01299389|541060706|FG002|Double-blind|Lost to Follow-up|0|||
149979064|NCT01299389|541060707|FG003|Double-blind|Lost to Follow-up|0|||
149979065|NCT01299389|541060704|FG000|Double-blind|Withdrawal by Subject|16|||
149979066|NCT01299389|541060705|FG001|Double-blind|Withdrawal by Subject|13|||
149979067|NCT01299389|541060706|FG002|Double-blind|Withdrawal by Subject|0|||
149979068|NCT01299389|541060707|FG003|Double-blind|Withdrawal by Subject|0|||
149979069|NCT01299389|541060704|FG000|Double-blind|Other|1|||
149979070|NCT01299389|541060705|FG001|Double-blind|Other|1|||
149979071|NCT01299389|541060706|FG002|Double-blind|Other|0|||
149979072|NCT01299389|541060707|FG003|Double-blind|Other|0|||
149979073|NCT01299389|541060704|FG000|Double-blind|"fail to meet study population criteria"|0|||
149979074|NCT01299389|541060705|FG001|Double-blind|"fail to meet study population criteria"|1|||
149979075|NCT01299389|541060706|FG002|Double-blind|"fail to meet study population criteria"|0|||
149979076|NCT01299389|541060707|FG003|Double-blind|"fail to meet study population criteria"|0|||
149979077|NCT01299389|541060704|FG000|Post-observational|Other|0|||
149979078|NCT01299389|541060705|FG001|Post-observational|Other|0|||
149979079|NCT01299389|541060706|FG002|Post-observational|Other|12|||
149979080|NCT01299389|541060707|FG003|Post-observational|Other|6|||
149979081|NCT02834819|541060708|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
149979082|NCT02834819|541060709|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
149979083|NCT04245709|541060710|FG000|Overall Study|Adverse Event|13|||
149979084|NCT04245709|541060710|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
149979085|NCT03637491|541060711|FG000|Overall Study|Death|9|||
149979086|NCT03637491|541060712|FG001|Overall Study|Death|9|||
149979087|NCT03637491|541060713|FG002|Overall Study|Death|5|||
149979088|NCT03637491|541060714|FG003|Overall Study|Death|3|||
149979089|NCT03637491|541060711|FG000|Overall Study|Lost to Follow-up|0|||
149979090|NCT03637491|541060712|FG001|Overall Study|Lost to Follow-up|1|||
149979091|NCT03637491|541060713|FG002|Overall Study|Lost to Follow-up|0|||
149979092|NCT03637491|541060714|FG003|Overall Study|Lost to Follow-up|1|||
149979093|NCT03637491|541060711|FG000|Overall Study|Study Terminated By Sponsor|0|||
149979094|NCT03637491|541060712|FG001|Overall Study|Study Terminated By Sponsor|2|||
149979095|NCT03637491|541060713|FG002|Overall Study|Study Terminated By Sponsor|1|||
149979096|NCT03637491|541060714|FG003|Overall Study|Study Terminated By Sponsor|0|||
149979097|NCT03637491|541060711|FG000|Overall Study|Withdrawal by Subject|1|||
149979098|NCT03637491|541060712|FG001|Overall Study|Withdrawal by Subject|0|||
149979099|NCT03637491|541060713|FG002|Overall Study|Withdrawal by Subject|1|||
149979100|NCT03637491|541060714|FG003|Overall Study|Withdrawal by Subject|2|||
149979101|NCT00889707|541060719|FG000|Overall Study|Adverse Event|1|||
149979102|NCT00889707|541060720|FG001|Overall Study|Adverse Event|0|||
149979103|NCT00889707|541060719|FG000|Overall Study|Withdrawal by Subject|4|||
149979104|NCT00889707|541060720|FG001|Overall Study|Withdrawal by Subject|3|||
149979105|NCT00889707|541060719|FG000|Overall Study|Lost to Follow-up|0|||
149979106|NCT00889707|541060720|FG001|Overall Study|Lost to Follow-up|2|||
149979107|NCT00889707|541060719|FG000|Overall Study|Lack of Efficacy|2|||
149979108|NCT00889707|541060720|FG001|Overall Study|Lack of Efficacy|5|||
149979109|NCT02185534|541060721|FG000|First Period|Withdrawal by Subject|0|||
149979110|NCT02185534|541060722|FG001|First Period|Withdrawal by Subject|0|||
149979111|NCT02185534|541060723|FG002|First Period|Withdrawal by Subject|0|||
149979112|NCT02185534|541060724|FG003|First Period|Withdrawal by Subject|1|||
149979113|NCT02185534|541060725|FG004|First Period|Withdrawal by Subject|0|||
149979114|NCT02185534|541060726|FG005|First Period|Withdrawal by Subject|0|||
149979115|NCT02185534|541060721|FG000|First Washout Period|Withdrawal by Subject|1|||
149979116|NCT02185534|541060722|FG001|First Washout Period|Withdrawal by Subject|0|||
149979117|NCT02185534|541060723|FG002|First Washout Period|Withdrawal by Subject|0|||
149979118|NCT02185534|541060724|FG003|First Washout Period|Withdrawal by Subject|0|||
149979119|NCT02185534|541060725|FG004|First Washout Period|Withdrawal by Subject|1|||
149979120|NCT02185534|541060726|FG005|First Washout Period|Withdrawal by Subject|0|||
149979121|NCT02185534|541060721|FG000|First Washout Period|Protocol Violation|0|||
149979122|NCT02185534|541060722|FG001|First Washout Period|Protocol Violation|0|||
149979123|NCT02185534|541060723|FG002|First Washout Period|Protocol Violation|0|||
149979124|NCT02185534|541060724|FG003|First Washout Period|Protocol Violation|0|||
149979125|NCT02185534|541060725|FG004|First Washout Period|Protocol Violation|0|||
149979126|NCT02185534|541060726|FG005|First Washout Period|Protocol Violation|1|||
149979127|NCT03465722|541060727|FG000|Overall Study|Withdrawal by Subject|21|||
149979128|NCT03465722|541060728|FG001|Overall Study|Withdrawal by Subject|14|||
149979129|NCT03465722|541060727|FG000|Overall Study|Death|89|||
149979130|NCT03465722|541060728|FG001|Overall Study|Death|87|||
149979131|NCT03465722|541060727|FG000|Overall Study|Lost to Follow-up|5|||
149979132|NCT03465722|541060728|FG001|Overall Study|Lost to Follow-up|3|||
149979133|NCT03465722|541060727|FG000|Overall Study|Administrative/Other|33|||
149979134|NCT03465722|541060728|FG001|Overall Study|Administrative/Other|32|||
149979135|NCT03465722|541060727|FG000|Overall Study|Not treated|1|||
149979136|NCT03465722|541060728|FG001|Overall Study|Not treated|2|||
149979137|NCT03465722|541060727|FG000|Overall Study|Sponsor decision|91|||
149979138|NCT03465722|541060728|FG001|Overall Study|Sponsor decision|98|||
149979139|NCT01151020|541060732|FG000|Overall Study|Death|25|||
149979140|NCT01151020|541060732|FG000|Overall Study|Conversion to open repair|1|||
149979141|NCT01151020|541060732|FG000|Overall Study|Lost to Follow-up|4|||
149979142|NCT01151020|541060732|FG000|Overall Study|Withdrawal by Subject|22|||
149979143|NCT01151020|541060732|FG000|Overall Study|Patients did not receive the device|2|||
149979144|NCT02041299|541060733|FG000|Overall Study|Adverse Event|9|||
149979145|NCT02041299|541060734|FG001|Overall Study|Adverse Event|3|||
149979146|NCT02041299|541060733|FG000|Overall Study|Lost to Follow-up|4|||
149979147|NCT02041299|541060734|FG001|Overall Study|Lost to Follow-up|1|||
149979148|NCT02041299|541060733|FG000|Overall Study|Physician Decision|1|||
149979149|NCT02041299|541060734|FG001|Overall Study|Physician Decision|1|||
149979150|NCT02041299|541060733|FG000|Overall Study|Withdrawal by Subject|13|||
149979151|NCT02041299|541060734|FG001|Overall Study|Withdrawal by Subject|7|||
149979152|NCT02041299|541060733|FG000|Overall Study|Protocol Violation|11|||
149979153|NCT02041299|541060734|FG001|Overall Study|Protocol Violation|4|||
149979154|NCT02041299|541060733|FG000|Overall Study|Termination of the study|7|||
149979155|NCT02041299|541060734|FG001|Overall Study|Termination of the study|3|||
149979156|NCT02041299|541060733|FG000|Overall Study|Required bone marrow transplant|0|||
149979157|NCT02041299|541060734|FG001|Overall Study|Required bone marrow transplant|1|||
149979158|NCT02041299|541060733|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
149979159|NCT02041299|541060734|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
149979160|NCT02389465|541060735|FG000|Overall Study|Lost to Follow-up|1|||
149979161|NCT02389465|541060736|FG001|Overall Study|Lost to Follow-up|3|||
149979162|NCT02389465|541060737|FG002|Overall Study|Lost to Follow-up|3|||
149979163|NCT02389465|541060738|FG003|Overall Study|Lost to Follow-up|0|||
149979164|NCT02389465|541060735|FG000|Overall Study|Physician Decision|0|||
149979165|NCT02389465|541060736|FG001|Overall Study|Physician Decision|0|||
149979166|NCT02389465|541060737|FG002|Overall Study|Physician Decision|0|||
149979167|NCT02389465|541060738|FG003|Overall Study|Physician Decision|1|||
149979168|NCT02389465|541060735|FG000|Overall Study|Withdrawal by Subject|0|||
149979169|NCT02389465|541060736|FG001|Overall Study|Withdrawal by Subject|1|||
149979170|NCT02389465|541060737|FG002|Overall Study|Withdrawal by Subject|2|||
149979171|NCT02389465|541060738|FG003|Overall Study|Withdrawal by Subject|2|||
149979172|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
149979173|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149979174|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
149979175|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
149979176|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
149979177|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
149979178|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
149979179|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
149979180|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
149979181|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
149979182|NCT01925768|541060739|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
149979183|NCT01925768|541060740|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
149979184|NCT01925768|541060739|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
149979185|NCT01925768|541060740|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
149979186|NCT01925768|541060739|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
149979187|NCT01925768|541060740|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
149979188|NCT01925768|541060739|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
149979189|NCT01925768|541060740|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
149979190|NCT01925768|541060739|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
149979191|NCT01925768|541060740|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
149979192|NCT01925768|541060739|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
149979193|NCT01925768|541060740|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
149979194|NCT00003631|541060743|FG000|Overall Study|Patient not treated|1|||
149979195|NCT00003631|541060744|FG001|Overall Study|Patient not treated|0|||
149979196|NCT00003631|541060745|FG002|Overall Study|Patient not treated|1|||
149979197|NCT00003631|541060743|FG000|Overall Study|Protocol Violation|1|||
149979198|NCT00003631|541060744|FG001|Overall Study|Protocol Violation|0|||
149979199|NCT00003631|541060745|FG002|Overall Study|Protocol Violation|0|||
149979200|NCT00003631|541060743|FG000|Overall Study|Adverse Event|1|||
149979201|NCT00003631|541060744|FG001|Overall Study|Adverse Event|1|||
149979202|NCT00003631|541060745|FG002|Overall Study|Adverse Event|5|||
150052984|NCT00913458|541336554|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
150052985|NCT00913458|541336555|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
150052986|NCT00913458|541336556|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
150052987|NCT00913458|541336557|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
150052988|NCT03595618|541336558|FG000|Overall Study|Adverse Event|16|||
149979203|NCT00003631|541060743|FG000|Overall Study|Death|0|||
149979204|NCT00003631|541060744|FG001|Overall Study|Death|0|||
149979205|NCT00003631|541060745|FG002|Overall Study|Death|1|||
149979206|NCT00003631|541060743|FG000|Overall Study|Evaluable for toxicity only|0|||
149979207|NCT00003631|541060744|FG001|Overall Study|Evaluable for toxicity only|0|||
150178624|NCT00703820|541791988|FG000|Overall Study|Lack of Efficacy|11|||
149979208|NCT00003631|541060745|FG002|Overall Study|Evaluable for toxicity only|2|||
149979209|NCT04339413|541060746|FG000|Overall Study|Reason Not Specified|2|||
149979210|NCT04339413|541060747|FG001|Overall Study|Reason Not Specified|7|||
149979211|NCT04339413|541060746|FG000|Overall Study|Study Terminated by Sponsor|30|||
149979212|NCT04339413|541060747|FG001|Overall Study|Study Terminated by Sponsor|33|||
149979213|NCT04339413|541060746|FG000|Overall Study|Progressive Disease|9|||
149979214|NCT04339413|541060747|FG001|Overall Study|Progressive Disease|6|||
149979215|NCT04339413|541060746|FG000|Overall Study|Withdrawal by Subject|9|||
149979216|NCT04339413|541060747|FG001|Overall Study|Withdrawal by Subject|10|||
150052989|NCT03595618|541336559|FG001|Overall Study|Adverse Event|17|||
150052990|NCT03595618|541336560|FG002|Overall Study|Adverse Event|20|||
150052991|NCT03595618|541336561|FG003|Overall Study|Adverse Event|8|||
150052992|NCT03595618|541336558|FG000|Overall Study|Withdrawal by Subject|12|||
150052993|NCT03595618|541336559|FG001|Overall Study|Withdrawal by Subject|14|||
150052994|NCT03595618|541336560|FG002|Overall Study|Withdrawal by Subject|14|||
150052995|NCT03595618|541336561|FG003|Overall Study|Withdrawal by Subject|10|||
150052996|NCT03595618|541336558|FG000|Overall Study|Lost to Follow-up|6|||
150052997|NCT03595618|541336559|FG001|Overall Study|Lost to Follow-up|4|||
150052998|NCT03595618|541336560|FG002|Overall Study|Lost to Follow-up|5|||
150052999|NCT03595618|541336561|FG003|Overall Study|Lost to Follow-up|6|||
150053000|NCT03595618|541336558|FG000|Overall Study|Protocol Violation|2|||
150053001|NCT03595618|541336559|FG001|Overall Study|Protocol Violation|0|||
150053002|NCT03595618|541336560|FG002|Overall Study|Protocol Violation|6|||
150053003|NCT03595618|541336561|FG003|Overall Study|Protocol Violation|2|||
150053004|NCT03595618|541336558|FG000|Overall Study|Physician Decision|0|||
150053005|NCT03595618|541336559|FG001|Overall Study|Physician Decision|0|||
150053006|NCT03595618|541336560|FG002|Overall Study|Physician Decision|1|||
150053007|NCT03595618|541336561|FG003|Overall Study|Physician Decision|2|||
150053008|NCT03595618|541336558|FG000|Overall Study|Miscellaneous|7|||
150053009|NCT03595618|541336559|FG001|Overall Study|Miscellaneous|5|||
149979217|NCT04339413|541060746|FG000|Overall Study|Physician Decision|3|||
149979218|NCT04339413|541060747|FG001|Overall Study|Physician Decision|1|||
149979219|NCT04339413|541060746|FG000|Overall Study|Death|2|||
149979220|NCT04339413|541060747|FG001|Overall Study|Death|0|||
149979221|NCT04339413|541060746|FG000|Overall Study|Adverse Event|3|||
149979222|NCT04339413|541060747|FG001|Overall Study|Adverse Event|0|||
149979223|NCT00087698|541060751|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
149979224|NCT00087698|541060751|FG000|Overall Study|Death from Other Causes|3|||
149979225|NCT00087698|541060751|FG000|Overall Study|Adverse Event|4|||
149979226|NCT00087698|541060751|FG000|Overall Study|Withdrawal by Subject|4|||
149979227|NCT00087698|541060751|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
149979228|NCT00087698|541060751|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
149979229|NCT00087698|541060751|FG000|Overall Study|Clinical Relapse|1|||
149979230|NCT00087698|541060751|FG000|Overall Study|Death from Study Disease|2|||
149979231|NCT00087698|541060751|FG000|Overall Study|Death from Study Drug Toxicity|2|||
149979232|NCT00087698|541060751|FG000|Overall Study|Protocol Violation|1|||
149979233|NCT01853462|541060754|FG000|Overall Study|Withdrawal by Subject|1|||
149979234|NCT01853462|541060755|FG001|Overall Study|Withdrawal by Subject|1|||
149979235|NCT03943290|541060759|FG000|Overall Study|Sponsor Terminated Study|6|||
149979236|NCT03943290|541060760|FG001|Overall Study|Sponsor Terminated Study|1|||
149979237|NCT03943290|541060761|FG002|Overall Study|Sponsor Terminated Study|11|||
149979238|NCT03943290|541060762|FG003|Overall Study|Sponsor Terminated Study|6|||
149979239|NCT03943290|541060763|FG004|Overall Study|Sponsor Terminated Study|7|||
149979240|NCT03943290|541060764|FG005|Overall Study|Sponsor Terminated Study|6|||
149979241|NCT03943290|541060765|FG006|Overall Study|Sponsor Terminated Study|6|||
149979242|NCT03943290|541060766|FG007|Overall Study|Sponsor Terminated Study|7|||
149979243|NCT03943290|541060767|FG008|Overall Study|Sponsor Terminated Study|8|||
149979244|NCT03943290|541060759|FG000|Overall Study|Lost to Follow-up|1|||
149979245|NCT03943290|541060760|FG001|Overall Study|Lost to Follow-up|0|||
149979246|NCT03943290|541060761|FG002|Overall Study|Lost to Follow-up|1|||
149979247|NCT03943290|541060762|FG003|Overall Study|Lost to Follow-up|0|||
150053010|NCT03595618|541336560|FG002|Overall Study|Miscellaneous|10|||
150053011|NCT03595618|541336561|FG003|Overall Study|Miscellaneous|6|||
150053012|NCT02279407|541336562|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
150053013|NCT02279407|541336563|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
150053014|NCT02279407|541336564|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
149979248|NCT03943290|541060763|FG004|Overall Study|Lost to Follow-up|0|||
149979249|NCT03943290|541060764|FG005|Overall Study|Lost to Follow-up|0|||
149979250|NCT03943290|541060765|FG006|Overall Study|Lost to Follow-up|0|||
149979251|NCT03943290|541060766|FG007|Overall Study|Lost to Follow-up|1|||
149979252|NCT03943290|541060767|FG008|Overall Study|Lost to Follow-up|0|||
149979253|NCT03943290|541060759|FG000|Overall Study|Withdrawal by Subject|0|||
149979254|NCT03943290|541060760|FG001|Overall Study|Withdrawal by Subject|0|||
149979255|NCT03943290|541060761|FG002|Overall Study|Withdrawal by Subject|1|||
149979256|NCT03943290|541060762|FG003|Overall Study|Withdrawal by Subject|0|||
149979257|NCT03943290|541060763|FG004|Overall Study|Withdrawal by Subject|0|||
149979258|NCT03943290|541060764|FG005|Overall Study|Withdrawal by Subject|0|||
150053015|NCT02279407|541336565|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
150053016|NCT02279407|541336562|FG000|Overall Study|Withdrawal by Subject|1|||
150053017|NCT02279407|541336563|FG001|Overall Study|Withdrawal by Subject|0|||
150053018|NCT02279407|541336564|FG002|Overall Study|Withdrawal by Subject|1|||
150053019|NCT02279407|541336565|FG003|Overall Study|Withdrawal by Subject|1|||
150053020|NCT02279407|541336562|FG000|Overall Study|Adverse Event|1|||
150053021|NCT02279407|541336563|FG001|Overall Study|Adverse Event|1|||
149979259|NCT03943290|541060765|FG006|Overall Study|Withdrawal by Subject|0|||
149979260|NCT03943290|541060766|FG007|Overall Study|Withdrawal by Subject|0|||
149979261|NCT03943290|541060767|FG008|Overall Study|Withdrawal by Subject|0|||
149979262|NCT00955474|541060770|FG000|Overall Study|Physician Decision|7|||
149979263|NCT00955474|541060771|FG001|Overall Study|Physician Decision|5|||
149979264|NCT04179305|541060773|FG000|Overall Study|Death|1|||
149979265|NCT04179305|541060774|FG001|Overall Study|Death|1|||
149979266|NCT04179305|541060775|FG002|Overall Study|Death|0|||
149979267|NCT04179305|541060776|FG003|Overall Study|Death|0|||
149979268|NCT04179305|541060773|FG000|Overall Study|Lost to Follow-up|1|||
149979269|NCT04179305|541060774|FG001|Overall Study|Lost to Follow-up|1|||
149979270|NCT04179305|541060775|FG002|Overall Study|Lost to Follow-up|0|||
149979271|NCT04179305|541060776|FG003|Overall Study|Lost to Follow-up|0|||
149979272|NCT04179305|541060773|FG000|Overall Study|Withdrawal by Subject|0|||
149979273|NCT04179305|541060774|FG001|Overall Study|Withdrawal by Subject|1|||
149979274|NCT04179305|541060775|FG002|Overall Study|Withdrawal by Subject|0|||
149979275|NCT04179305|541060776|FG003|Overall Study|Withdrawal by Subject|0|||
149979276|NCT04179305|541060773|FG000|Overall Study|Did not have scan|1|||
149979277|NCT04179305|541060774|FG001|Overall Study|Did not have scan|0|||
149979278|NCT04179305|541060775|FG002|Overall Study|Did not have scan|0|||
149979279|NCT04179305|541060776|FG003|Overall Study|Did not have scan|0|||
149979280|NCT04179305|541060773|FG000|Overall Study|In hospice care|3|||
149979281|NCT04179305|541060774|FG001|Overall Study|In hospice care|0|||
149979282|NCT04179305|541060775|FG002|Overall Study|In hospice care|0|||
149979283|NCT04179305|541060776|FG003|Overall Study|In hospice care|0|||
149979284|NCT00142792|541060789|FG000|Overall Study|Death|0|||
149979285|NCT00142792|541060790|FG001|Overall Study|Death|0|||
149979286|NCT00142792|541060791|FG002|Overall Study|Death|1|||
149979287|NCT00142792|541060789|FG000|Overall Study|Withdrawal by Subject|3|||
149979288|NCT00142792|541060790|FG001|Overall Study|Withdrawal by Subject|2|||
149979289|NCT00142792|541060791|FG002|Overall Study|Withdrawal by Subject|3|||
149979290|NCT00142792|541060789|FG000|Overall Study|Lost to Follow-up|8|||
149979291|NCT00142792|541060790|FG001|Overall Study|Lost to Follow-up|11|||
149979292|NCT00142792|541060791|FG002|Overall Study|Lost to Follow-up|7|||
149979293|NCT00142792|541060789|FG000|Overall Study|No category|1|||
149979294|NCT00142792|541060790|FG001|Overall Study|No category|2|||
149979295|NCT00142792|541060791|FG002|Overall Study|No category|1|||
149979296|NCT04819113|541060792|FG000|Overall Study|Withdrawal by parent/guardian|3|||
149979297|NCT04819113|541060792|FG000|Overall Study|Lost to Follow-up|1|||
149979298|NCT04819113|541060792|FG000|Overall Study|Withdrawn before vaccination|2|||
149979299|NCT00437268|541060793|FG000|Overall Study|Adverse Event|1|||
149979300|NCT00437268|541060794|FG001|Overall Study|Adverse Event|1|||
149979301|NCT00437268|541060793|FG000|Overall Study|Withdrawal by Subject|2|||
149979302|NCT00437268|541060794|FG001|Overall Study|Withdrawal by Subject|2|||
149979303|NCT00437268|541060793|FG000|Overall Study|Progressive disease|9|||
149979304|NCT00437268|541060794|FG001|Overall Study|Progressive disease|9|||
149979305|NCT00437268|541060793|FG000|Overall Study|Physician Decision|1|||
149979306|NCT00437268|541060794|FG001|Overall Study|Physician Decision|0|||
149979307|NCT00437268|541060793|FG000|Overall Study|Death|0|||
149979308|NCT00437268|541060794|FG001|Overall Study|Death|1|||
149979309|NCT02382991|541060799|FG000|Overall Study|Adverse Event|1|||
149979310|NCT02382991|541060800|FG001|Overall Study|Adverse Event|2|||
149979311|NCT02382991|541060799|FG000|Overall Study|Lost to Follow-up|1|||
149979312|NCT02382991|541060800|FG001|Overall Study|Lost to Follow-up|0|||
149979313|NCT02382991|541060799|FG000|Overall Study|Withdrawal by Subject|0|||
149979314|NCT02382991|541060800|FG001|Overall Study|Withdrawal by Subject|1|||
149979315|NCT00444925|541060801|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
149979316|NCT00444925|541060802|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
149979317|NCT00444925|541060803|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
149979318|NCT00444925|541060801|FG000|Double-blind Treatment Period|Death|2|||
149979319|NCT00444925|541060802|FG001|Double-blind Treatment Period|Death|0|||
149979320|NCT00444925|541060803|FG002|Double-blind Treatment Period|Death|0|||
149979321|NCT00444925|541060801|FG000|Double-blind Treatment Period|Adverse Event|6|||
149979322|NCT00444925|541060802|FG001|Double-blind Treatment Period|Adverse Event|28|||
149979323|NCT00444925|541060803|FG002|Double-blind Treatment Period|Adverse Event|44|||
149979324|NCT00444925|541060801|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
149979325|NCT00444925|541060802|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
149979326|NCT00444925|541060803|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
149979327|NCT00444925|541060801|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
149979328|NCT00444925|541060802|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
149979329|NCT00444925|541060803|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
149979330|NCT00444925|541060801|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
149979331|NCT00444925|541060802|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
149979332|NCT00444925|541060803|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
149979333|NCT00444925|541060801|FG000|Double-blind Treatment Period|Other|7|||
149979334|NCT00444925|541060802|FG001|Double-blind Treatment Period|Other|7|||
149979335|NCT00444925|541060803|FG002|Double-blind Treatment Period|Other|12|||
149979336|NCT02573948|541060807|FG000|Longitudinal Cohort|Death|9|||
149979337|NCT02573948|541060807|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
149979338|NCT02573948|541060807|FG000|Longitudinal Cohort|Incarcerated|25|||
149979339|NCT01673126|541060808|FG000|Overall Study|change of diagnosis|4|||
149979340|NCT01673126|541060809|FG001|Overall Study|change of diagnosis|3|||
149979341|NCT01913327|541060816|FG000|Overall Study|Withdrawal by Subject|0|||
149979342|NCT01913327|541060817|FG001|Overall Study|Withdrawal by Subject|1|||
149979343|NCT04267926|541062486|FG000|Overall Study|abnormal labs. No longer eligible|0|||
149979344|NCT04267926|541062487|FG001|Overall Study|abnormal labs. No longer eligible|0|||
149979345|NCT04267926|541062488|FG002|Overall Study|abnormal labs. No longer eligible|1|||
149979346|NCT04267926|541062486|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
149979347|NCT04267926|541062487|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
149979348|NCT04267926|541062488|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
149979349|NCT03718325|541062489|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
149979350|NCT03718325|541062490|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
149979351|NCT03718325|541062491|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
149979352|NCT03718325|541062489|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
149979353|NCT03718325|541062490|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
149979354|NCT03718325|541062491|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
149979355|NCT01396187|541062492|FG000|Overall Study|Adverse Event|0|||
149979356|NCT01396187|541062493|FG001|Overall Study|Adverse Event|1|||
149979357|NCT01396187|541062494|FG002|Overall Study|Adverse Event|0|||
149979358|NCT01396187|541062495|FG003|Overall Study|Adverse Event|0|||
149979359|NCT01396187|541062496|FG004|Overall Study|Adverse Event|0|||
149979360|NCT01396187|541062492|FG000|Overall Study|Withdrawal by Subject|0|||
149979361|NCT01396187|541062493|FG001|Overall Study|Withdrawal by Subject|1|||
149979362|NCT01396187|541062494|FG002|Overall Study|Withdrawal by Subject|1|||
149979363|NCT01396187|541062495|FG003|Overall Study|Withdrawal by Subject|0|||
149979364|NCT01396187|541062496|FG004|Overall Study|Withdrawal by Subject|0|||
149979365|NCT01396187|541062492|FG000|Overall Study|Other|1|||
149979366|NCT01396187|541062493|FG001|Overall Study|Other|1|||
149979367|NCT01396187|541062494|FG002|Overall Study|Other|0|||
149979368|NCT01396187|541062495|FG003|Overall Study|Other|0|||
149979369|NCT01396187|541062496|FG004|Overall Study|Other|1|||
149979370|NCT01898286|541062497|FG000|Overall Study|Withdrawal by Subject|1|||
149979371|NCT01898286|541062497|FG000|Overall Study|Protocol Violation|1|||
149979372|NCT01898286|541062497|FG000|Overall Study|Lost to Follow-up|1|||
149979373|NCT02257242|541062498|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
149979374|NCT02257242|541062499|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979375|NCT02257242|541062500|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979376|NCT02257242|541062501|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979377|NCT02257242|541062502|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979378|NCT02257242|541062503|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979379|NCT02257242|541062504|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979380|NCT02257242|541062505|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979381|NCT02257242|541062506|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
149979382|NCT00551031|541062510|FG000|Overall Study|Adverse Event|0|||
149979383|NCT00551031|541062511|FG001|Overall Study|Adverse Event|1|||
149979384|NCT00551031|541062512|FG002|Overall Study|Adverse Event|0|||
149979385|NCT00551031|541062513|FG003|Overall Study|Adverse Event|0|||
149979386|NCT00551031|541062514|FG004|Overall Study|Adverse Event|0|||
149979387|NCT00551031|541062510|FG000|Overall Study|Protocol Violation|1|||
149979388|NCT00551031|541062511|FG001|Overall Study|Protocol Violation|1|||
149979389|NCT00551031|541062512|FG002|Overall Study|Protocol Violation|0|||
150053022|NCT02279407|541336564|FG002|Overall Study|Adverse Event|2|||
150053023|NCT02279407|541336565|FG003|Overall Study|Adverse Event|0|||
149979390|NCT00551031|541062513|FG003|Overall Study|Protocol Violation|0|||
149979391|NCT00551031|541062514|FG004|Overall Study|Protocol Violation|0|||
150053024|NCT02500056|541336566|FG000|Overall Study|Lost to Follow-up|3|||
150053025|NCT02500056|541336567|FG001|Overall Study|Lost to Follow-up|7|||
150053026|NCT02500056|541336566|FG000|Overall Study|Recurrence|1|||
150053027|NCT02500056|541336567|FG001|Overall Study|Recurrence|0|||
150053028|NCT02500056|541336566|FG000|Overall Study|Death|3|||
150053029|NCT02500056|541336567|FG001|Overall Study|Death|1|||
150053030|NCT03890666|541336568|FG000|Overall Study|Withdrawal by Subject|0|||
150053031|NCT03890666|541336569|FG001|Overall Study|Withdrawal by Subject|1|||
150053032|NCT03890666|541336568|FG000|Overall Study|Protocol deviation|1|||
150053033|NCT03890666|541336569|FG001|Overall Study|Protocol deviation|4|||
150053034|NCT03890666|541336568|FG000|Overall Study|Lost to Follow-up|2|||
150053035|NCT03890666|541336569|FG001|Overall Study|Lost to Follow-up|5|||
150053036|NCT03890666|541336568|FG000|Overall Study|Other than specified|1|||
150053037|NCT03890666|541336569|FG001|Overall Study|Other than specified|8|||
150053038|NCT01155011|541336574|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
150053039|NCT01155011|541336575|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
150053040|NCT01155011|541336574|FG000|Baseline to 6 Months|investigator decision, moved|4|||
150053041|NCT01155011|541336575|FG001|Baseline to 6 Months|investigator decision, moved|5|||
150053042|NCT01155011|541336574|FG000|Baseline to 6 Months|Death|0|||
150053043|NCT01155011|541336575|FG001|Baseline to 6 Months|Death|1|||
150053044|NCT01155011|541336574|FG000|6 to 12 Months|Withdrawal by Subject|8|||
150053045|NCT01155011|541336575|FG001|6 to 12 Months|Withdrawal by Subject|5|||
150053046|NCT01155011|541336574|FG000|6 to 12 Months|Death|1|||
150053047|NCT01155011|541336575|FG001|6 to 12 Months|Death|5|||
150053048|NCT02122783|541336581|FG000|Overall Study|Adverse Event|0|||
150053049|NCT02122783|541336582|FG001|Overall Study|Adverse Event|1|||
150053050|NCT00329849|541336583|FG000|Overall Study|Withdrawal by Subject|6|||
150053051|NCT00329849|541336584|FG001|Overall Study|Withdrawal by Subject|4|||
150053052|NCT00653432|541336589|FG000|Overall Study|Adverse Event|4|||
150053053|NCT00653432|541336590|FG001|Overall Study|Adverse Event|1|||
150053054|NCT00653432|541336589|FG000|Overall Study|Withdrawal by Subject|4|||
150053055|NCT00653432|541336590|FG001|Overall Study|Withdrawal by Subject|5|||
150053056|NCT00653432|541336589|FG000|Overall Study|Lost to Follow-up|7|||
150053057|NCT00653432|541336590|FG001|Overall Study|Lost to Follow-up|6|||
150053058|NCT00653432|541336589|FG000|Overall Study|Use/Need of Con Therapy|2|||
150053059|NCT00653432|541336590|FG001|Overall Study|Use/Need of Con Therapy|1|||
149979392|NCT00551031|541062510|FG000|Overall Study|Lost to Follow-up|0|||
149979393|NCT00551031|541062511|FG001|Overall Study|Lost to Follow-up|1|||
149979394|NCT00551031|541062512|FG002|Overall Study|Lost to Follow-up|0|||
149979395|NCT00551031|541062513|FG003|Overall Study|Lost to Follow-up|1|||
149979396|NCT00551031|541062514|FG004|Overall Study|Lost to Follow-up|1|||
149979397|NCT00551031|541062510|FG000|Overall Study|Withdrawal by Subject|0|||
149979398|NCT00551031|541062511|FG001|Overall Study|Withdrawal by Subject|4|||
149979399|NCT00551031|541062512|FG002|Overall Study|Withdrawal by Subject|1|||
149979400|NCT00551031|541062513|FG003|Overall Study|Withdrawal by Subject|2|||
149979401|NCT00551031|541062514|FG004|Overall Study|Withdrawal by Subject|0|||
149979402|NCT00551031|541062510|FG000|Overall Study|Serious Adverse Event|0|||
149979403|NCT00551031|541062511|FG001|Overall Study|Serious Adverse Event|2|||
149979404|NCT00551031|541062512|FG002|Overall Study|Serious Adverse Event|1|||
149979405|NCT00551031|541062513|FG003|Overall Study|Serious Adverse Event|0|||
149979406|NCT00551031|541062514|FG004|Overall Study|Serious Adverse Event|0|||
149979407|NCT00551031|541062510|FG000|Overall Study|Did not receive vaccine|1|||
149979408|NCT00551031|541062511|FG001|Overall Study|Did not receive vaccine|2|||
149979409|NCT00551031|541062512|FG002|Overall Study|Did not receive vaccine|0|||
149979410|NCT00551031|541062513|FG003|Overall Study|Did not receive vaccine|0|||
149979411|NCT00551031|541062514|FG004|Overall Study|Did not receive vaccine|0|||
149979412|NCT02964273|541062516|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
149979413|NCT02964273|541062517|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
149979414|NCT02964273|541062518|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
149979415|NCT02964273|541062519|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
149979416|NCT02964273|541062516|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
149979417|NCT02964273|541062517|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
149979418|NCT02964273|541062518|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
149979419|NCT02964273|541062519|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
149979420|NCT02964273|541062516|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
149979421|NCT02964273|541062517|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
150053060|NCT00653432|541336589|FG000|Overall Study|Other - Reason Not Provided|5|||
150053061|NCT00653432|541336590|FG001|Overall Study|Other - Reason Not Provided|3|||
150053062|NCT05277337|541336591|FG000|Overall Study|Lost to Follow-up|2|||
150053063|NCT05277337|541336592|FG001|Overall Study|Lost to Follow-up|0|||
150053064|NCT05277337|541336591|FG000|Overall Study|Withdrawal by Subject|1|||
150053065|NCT05277337|541336592|FG001|Overall Study|Withdrawal by Subject|0|||
150053066|NCT00322621|541336595|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
150053067|NCT00322621|541336596|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
150053068|NCT00322621|541336597|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
150053069|NCT00322621|541336595|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
150053070|NCT00322621|541336596|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
150053071|NCT00322621|541336597|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
150053072|NCT00322621|541336595|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
150053073|NCT00322621|541336596|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
150053074|NCT00322621|541336597|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
150053075|NCT00322621|541336595|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
150053076|NCT00322621|541336596|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
150053077|NCT00322621|541336597|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
150053078|NCT00322621|541336595|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
150053079|NCT00322621|541336596|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
150053080|NCT00322621|541336597|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
150053081|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
150053082|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
150053083|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
150053084|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
150053085|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
150053086|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
150053087|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
150053088|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
150053089|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
150053090|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
150053091|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
149979422|NCT02964273|541062518|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
150053092|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
150053093|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
150053094|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
150053095|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
150053096|NCT00322621|541336595|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
150053097|NCT00322621|541336596|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
150053098|NCT00322621|541336597|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
150053099|NCT00357760|541336600|FG000|Overall Study|Disease progression|44|||
150053100|NCT00357760|541336601|FG001|Overall Study|Disease progression|17|||
150053101|NCT00357760|541336600|FG000|Overall Study|Adverse Event|10|||
150053102|NCT00357760|541336601|FG001|Overall Study|Adverse Event|7|||
150053103|NCT00357760|541336600|FG000|Overall Study|Death|0|||
150053104|NCT00357760|541336601|FG001|Overall Study|Death|3|||
150053105|NCT00357760|541336600|FG000|Overall Study|Alternative therapy|1|||
150053106|NCT00357760|541336601|FG001|Overall Study|Alternative therapy|0|||
149979423|NCT02964273|541062519|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
149979424|NCT02964273|541062516|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
149979425|NCT02964273|541062517|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
149979426|NCT02964273|541062518|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
149979427|NCT02964273|541062519|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
149979428|NCT02964273|541062516|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
149979429|NCT02964273|541062517|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
149979430|NCT02964273|541062518|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
149979431|NCT02964273|541062519|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
149979432|NCT02964273|541062516|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
149979433|NCT02964273|541062517|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
149979434|NCT02964273|541062518|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
149979435|NCT02964273|541062519|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
149979436|NCT00841776|541062521|FG000|Overall Study|Lack of Efficacy|0|||
149979437|NCT00841776|541062522|FG001|Overall Study|Lack of Efficacy|1|||
149979438|NCT00841776|541062521|FG000|Overall Study|Lost to Follow-up|2|||
149979439|NCT00841776|541062522|FG001|Overall Study|Lost to Follow-up|1|||
149979440|NCT00841776|541062521|FG000|Overall Study|Withdrawal by Subject|0|||
150053107|NCT00357760|541336600|FG000|Overall Study|Withdrawal by Subject|0|||
150053108|NCT00357760|541336601|FG001|Overall Study|Withdrawal by Subject|2|||
150053109|NCT00357760|541336600|FG000|Overall Study|Never started treatment|2|||
150053110|NCT00357760|541336601|FG001|Overall Study|Never started treatment|1|||
150053111|NCT00357760|541336600|FG000|Overall Study|Ineligible|0|||
150053112|NCT00357760|541336601|FG001|Overall Study|Ineligible|2|||
150053113|NCT00357760|541336600|FG000|Overall Study|Physician Decision|2|||
150053114|NCT00357760|541336601|FG001|Overall Study|Physician Decision|1|||
150053115|NCT00357760|541336600|FG000|Overall Study|Protocol Violation|0|||
150053116|NCT00357760|541336601|FG001|Overall Study|Protocol Violation|1|||
149979441|NCT00841776|541062522|FG001|Overall Study|Withdrawal by Subject|1|||
149979442|NCT04245449|541062523|FG000|Overall Study|COVID shutdown|7|||
149979443|NCT03073525|541062524|FG000|Overall Study|Withdrawal by Subject|0|||
149979444|NCT03073525|541062525|FG001|Overall Study|Withdrawal by Subject|0|||
149979445|NCT03073525|541062526|FG002|Overall Study|Withdrawal by Subject|3|||
149979446|NCT01976299|541062527|FG000|Overall Study|Withdrawal by Subject|3|||
149979447|NCT01976299|541062528|FG001|Overall Study|Withdrawal by Subject|1|||
149979448|NCT01976299|541062527|FG000|Overall Study|Death|4|||
149979449|NCT01976299|541062528|FG001|Overall Study|Death|2|||
149979450|NCT01976299|541062527|FG000|Overall Study|Lost to Follow-up|7|||
149979451|NCT01976299|541062528|FG001|Overall Study|Lost to Follow-up|1|||
149979452|NCT01976299|541062527|FG000|Overall Study|See clarification above in comments|9|||
149979453|NCT01976299|541062528|FG001|Overall Study|See clarification above in comments|2|||
149979454|NCT03692403|541062529|FG000|Overall Study|Withdrawal by Subject|1|||
149979455|NCT03692403|541062530|FG001|Overall Study|Withdrawal by Subject|0|||
149979456|NCT03692403|541062531|FG002|Overall Study|Withdrawal by Subject|1|||
149979457|NCT03692403|541062532|FG003|Overall Study|Withdrawal by Subject|0|||
149979458|NCT03692403|541062529|FG000|Overall Study|Adverse Event|0|||
149979459|NCT03692403|541062530|FG001|Overall Study|Adverse Event|0|||
149979460|NCT03692403|541062531|FG002|Overall Study|Adverse Event|0|||
149979461|NCT03692403|541062532|FG003|Overall Study|Adverse Event|1|||
149979462|NCT03692403|541062529|FG000|Overall Study|Pregnancy|0|||
149979463|NCT03692403|541062530|FG001|Overall Study|Pregnancy|1|||
149979464|NCT03692403|541062531|FG002|Overall Study|Pregnancy|0|||
149979465|NCT03692403|541062532|FG003|Overall Study|Pregnancy|0|||
149979466|NCT03692403|541062529|FG000|Overall Study|Other|0|||
149979467|NCT03692403|541062530|FG001|Overall Study|Other|0|||
149979468|NCT03692403|541062531|FG002|Overall Study|Other|1|||
149979469|NCT03692403|541062532|FG003|Overall Study|Other|0|||
149979470|NCT02848092|541062534|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
149979471|NCT02848092|541062535|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
149979472|NCT02848092|541062534|FG000|1-month Post-training Follow-up|Adverse Event|2|||
149979473|NCT02848092|541062535|FG001|1-month Post-training Follow-up|Adverse Event|1|||
149979474|NCT02848092|541062534|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
149979475|NCT02848092|541062535|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
149979476|NCT02848092|541062534|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
149979477|NCT02848092|541062535|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
149979478|NCT02848092|541062534|FG000|1-month Post-training Follow-up|fatigue|0|||
149979479|NCT02848092|541062535|FG001|1-month Post-training Follow-up|fatigue|1|||
149979480|NCT02848092|541062534|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
149979481|NCT02848092|541062535|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
149979482|NCT02848092|541062534|FG000|6-month Post-training Follow-up|Adverse Event|1|||
149979483|NCT02848092|541062535|FG001|6-month Post-training Follow-up|Adverse Event|1|||
149979484|NCT02848092|541062534|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
149979485|NCT02848092|541062535|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
149979486|NCT02848092|541062534|FG000|6-month Post-training Follow-up|frustrated with task|1|||
149979487|NCT02848092|541062535|FG001|6-month Post-training Follow-up|frustrated with task|0|||
149979488|NCT02848092|541062534|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
149979489|NCT02848092|541062535|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
149979490|NCT02848092|541062534|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
149979491|NCT02848092|541062535|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
149979492|NCT03688919|541062550|FG000|Overall Study|Lost to Follow-up|2|||
149979493|NCT03688919|541062551|FG001|Overall Study|Lost to Follow-up|1|||
149979494|NCT03688919|541062550|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
149979495|NCT03688919|541062551|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
149979496|NCT01724216|541062556|FG000|Overall Study|Scan was not completed|1|||
149979497|NCT00564733|541062557|FG000|Overall Study|Withdrawal by Subject|4|||
149979498|NCT00564733|541062557|FG000|Overall Study|Ineligible|5|||
149979499|NCT01484496|541062562|FG000|Period 1|Protocol Violation|3|||
149979500|NCT01484496|541062563|FG001|Period 1|Protocol Violation|4|||
149979501|NCT01484496|541062564|FG002|Period 1|Protocol Violation|0|||
149979502|NCT01484496|541062565|FG003|Period 1|Protocol Violation|0|||
149979503|NCT01484496|541062562|FG000|Period 1|Physician Decision|5|||
149979504|NCT01484496|541062563|FG001|Period 1|Physician Decision|1|||
149979505|NCT01484496|541062564|FG002|Period 1|Physician Decision|0|||
150053117|NCT00357760|541336600|FG000|Overall Study|To receive hospice care|0|||
150053118|NCT00357760|541336601|FG001|Overall Study|To receive hospice care|1|||
150053119|NCT01038869|541336602|FG000|Overall Study|Withdrawal by Subject|1|||
149979506|NCT01484496|541062565|FG003|Period 1|Physician Decision|0|||
149979507|NCT01484496|541062562|FG000|Period 1|Lack of Efficacy|10|||
149979508|NCT01484496|541062563|FG001|Period 1|Lack of Efficacy|15|||
149979509|NCT01484496|541062564|FG002|Period 1|Lack of Efficacy|0|||
149979510|NCT01484496|541062565|FG003|Period 1|Lack of Efficacy|0|||
149979511|NCT01484496|541062562|FG000|Period 1|Adverse Event|25|||
149979512|NCT01484496|541062563|FG001|Period 1|Adverse Event|40|||
149979513|NCT01484496|541062564|FG002|Period 1|Adverse Event|0|||
149979514|NCT01484496|541062565|FG003|Period 1|Adverse Event|0|||
149979515|NCT01484496|541062562|FG000|Period 1|Withdrawal by Subject|15|||
149979516|NCT01484496|541062563|FG001|Period 1|Withdrawal by Subject|12|||
149979517|NCT01484496|541062564|FG002|Period 1|Withdrawal by Subject|0|||
149979518|NCT01484496|541062565|FG003|Period 1|Withdrawal by Subject|0|||
149979519|NCT01484496|541062562|FG000|Period 1|Lost to Follow-up|2|||
149979520|NCT01484496|541062563|FG001|Period 1|Lost to Follow-up|6|||
149979521|NCT01484496|541062564|FG002|Period 1|Lost to Follow-up|0|||
149979522|NCT01484496|541062565|FG003|Period 1|Lost to Follow-up|0|||
149979523|NCT01484496|541062562|FG000|Period 1|Positive Pregnancy|1|||
149979524|NCT01484496|541062563|FG001|Period 1|Positive Pregnancy|6|||
149979525|NCT01484496|541062564|FG002|Period 1|Positive Pregnancy|0|||
149979526|NCT01484496|541062565|FG003|Period 1|Positive Pregnancy|0|||
149979527|NCT01484496|541062562|FG000|Period 1|Treatment Failure|3|||
149979528|NCT01484496|541062563|FG001|Period 1|Treatment Failure|6|||
149979529|NCT01484496|541062564|FG002|Period 1|Treatment Failure|0|||
149979530|NCT01484496|541062565|FG003|Period 1|Treatment Failure|0|||
149979531|NCT01484496|541062562|FG000|Period 1|Lack of Compliance|2|||
149979532|NCT01484496|541062563|FG001|Period 1|Lack of Compliance|1|||
149979533|NCT01484496|541062564|FG002|Period 1|Lack of Compliance|0|||
149979534|NCT01484496|541062565|FG003|Period 1|Lack of Compliance|0|||
149979535|NCT01484496|541062562|FG000|Period 1|Unable to Visit Site|0|||
149979536|NCT01484496|541062563|FG001|Period 1|Unable to Visit Site|2|||
149979537|NCT01484496|541062564|FG002|Period 1|Unable to Visit Site|0|||
149979538|NCT01484496|541062565|FG003|Period 1|Unable to Visit Site|0|||
149979539|NCT01484496|541062562|FG000|Period 2|Lack of Efficacy|0|||
149979540|NCT01484496|541062563|FG001|Period 2|Lack of Efficacy|0|||
149979541|NCT01484496|541062564|FG002|Period 2|Lack of Efficacy|1|||
149979542|NCT01484496|541062565|FG003|Period 2|Lack of Efficacy|3|||
149979543|NCT01484496|541062562|FG000|Period 2|Adverse Event|0|||
149979544|NCT01484496|541062563|FG001|Period 2|Adverse Event|0|||
149979545|NCT01484496|541062564|FG002|Period 2|Adverse Event|5|||
149979546|NCT01484496|541062565|FG003|Period 2|Adverse Event|13|||
149979547|NCT01484496|541062562|FG000|Period 2|Other|0|||
149979548|NCT01484496|541062563|FG001|Period 2|Other|0|||
149979549|NCT01484496|541062564|FG002|Period 2|Other|9|||
149979550|NCT01484496|541062565|FG003|Period 2|Other|6|||
149979551|NCT01645735|541062566|FG000|Overall Study|Physician Decision|2|||
149979552|NCT01645735|541062567|FG001|Overall Study|Physician Decision|0|||
149979553|NCT01645735|541062566|FG000|Overall Study|Withdrawal by Subject|1|||
149979554|NCT01645735|541062567|FG001|Overall Study|Withdrawal by Subject|0|||
149979555|NCT01645735|541062566|FG000|Overall Study|Protocol Violation|1|||
149979556|NCT01645735|541062567|FG001|Overall Study|Protocol Violation|0|||
149979557|NCT01645735|541062566|FG000|Overall Study|Adverse Event|0|||
149979558|NCT01645735|541062567|FG001|Overall Study|Adverse Event|1|||
149979559|NCT01456130|541062569|FG000|Overall Study|Adverse Event|4|||
149979560|NCT01456130|541062569|FG000|Overall Study|Voluntary Withdrawal|1|||
149979561|NCT01456130|541062569|FG000|Overall Study|Lack of Efficacy|4|||
149979562|NCT01456130|541062569|FG000|Overall Study|Other|1|||
149979563|NCT01791517|541062574|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
149979564|NCT01791517|541062575|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
149979565|NCT01791517|541062576|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
149979566|NCT01791517|541062577|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
149979567|NCT01791517|541062578|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
149979568|NCT01791517|541062579|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
149979569|NCT01791517|541062580|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
149979570|NCT01791517|541062581|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
149979571|NCT01791517|541062582|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
149979572|NCT01791517|541062583|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
149979573|NCT01791517|541062584|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
149979574|NCT01791517|541062585|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
149979575|NCT01791517|541062574|FG000|Phase I: Period 1|Adverse Event|0|||
149979576|NCT01791517|541062575|FG001|Phase I: Period 1|Adverse Event|0|||
149979577|NCT01791517|541062576|FG002|Phase I: Period 1|Adverse Event|1|||
149979578|NCT01791517|541062577|FG003|Phase I: Period 1|Adverse Event|1|||
149979579|NCT01791517|541062578|FG004|Phase I: Period 1|Adverse Event|0|||
149979580|NCT01791517|541062579|FG005|Phase I: Period 1|Adverse Event|0|||
149979581|NCT01791517|541062580|FG006|Phase I: Period 1|Adverse Event|0|||
149979582|NCT01791517|541062581|FG007|Phase I: Period 1|Adverse Event|0|||
149979583|NCT01791517|541062582|FG008|Phase I: Period 1|Adverse Event|0|||
149979584|NCT01791517|541062583|FG009|Phase I: Period 1|Adverse Event|0|||
149979585|NCT01791517|541062584|FG010|Phase I: Period 1|Adverse Event|0|||
149979586|NCT01791517|541062585|FG011|Phase I: Period 1|Adverse Event|0|||
149979587|NCT01791517|541062574|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
149979588|NCT01791517|541062575|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979589|NCT01791517|541062576|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979590|NCT01791517|541062577|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979591|NCT01791517|541062578|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979592|NCT01791517|541062579|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979593|NCT01791517|541062580|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979594|NCT01791517|541062581|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979595|NCT01791517|541062582|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979596|NCT01791517|541062583|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979597|NCT01791517|541062584|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979598|NCT01791517|541062585|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
149979599|NCT01791517|541062574|FG000|Phase I: Period 1|Protocol Violation|0|||
149979600|NCT01791517|541062575|FG001|Phase I: Period 1|Protocol Violation|1|||
149979601|NCT01791517|541062576|FG002|Phase I: Period 1|Protocol Violation|0|||
149979602|NCT01791517|541062577|FG003|Phase I: Period 1|Protocol Violation|0|||
149979603|NCT01791517|541062578|FG004|Phase I: Period 1|Protocol Violation|0|||
149979604|NCT01791517|541062579|FG005|Phase I: Period 1|Protocol Violation|0|||
149979605|NCT01791517|541062580|FG006|Phase I: Period 1|Protocol Violation|0|||
149979606|NCT01791517|541062581|FG007|Phase I: Period 1|Protocol Violation|0|||
149979607|NCT01791517|541062582|FG008|Phase I: Period 1|Protocol Violation|0|||
149979608|NCT01791517|541062583|FG009|Phase I: Period 1|Protocol Violation|0|||
149979609|NCT01791517|541062584|FG010|Phase I: Period 1|Protocol Violation|0|||
149979610|NCT01791517|541062585|FG011|Phase I: Period 1|Protocol Violation|0|||
149979611|NCT01791517|541062574|FG000|Phase I: Period 1|Lost to Follow-up|0|||
149979612|NCT01791517|541062575|FG001|Phase I: Period 1|Lost to Follow-up|0|||
149979613|NCT01791517|541062576|FG002|Phase I: Period 1|Lost to Follow-up|0|||
149979614|NCT01791517|541062577|FG003|Phase I: Period 1|Lost to Follow-up|1|||
149979615|NCT01791517|541062578|FG004|Phase I: Period 1|Lost to Follow-up|0|||
149979616|NCT01791517|541062579|FG005|Phase I: Period 1|Lost to Follow-up|0|||
149979617|NCT01791517|541062580|FG006|Phase I: Period 1|Lost to Follow-up|1|||
149979618|NCT01791517|541062581|FG007|Phase I: Period 1|Lost to Follow-up|0|||
149979619|NCT01791517|541062582|FG008|Phase I: Period 1|Lost to Follow-up|1|||
149979620|NCT01791517|541062583|FG009|Phase I: Period 1|Lost to Follow-up|1|||
149979621|NCT01791517|541062584|FG010|Phase I: Period 1|Lost to Follow-up|0|||
149979622|NCT01791517|541062585|FG011|Phase I: Period 1|Lost to Follow-up|0|||
149979623|NCT01791517|541062574|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979624|NCT01791517|541062575|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979625|NCT01791517|541062576|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979626|NCT01791517|541062577|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979627|NCT01791517|541062578|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979628|NCT01791517|541062579|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979629|NCT01791517|541062580|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979630|NCT01791517|541062581|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979631|NCT01791517|541062582|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979632|NCT01791517|541062583|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979633|NCT01791517|541062584|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
149979634|NCT01791517|541062585|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
149979635|NCT01791517|541062574|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
149979636|NCT01791517|541062575|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979637|NCT01791517|541062576|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979638|NCT01791517|541062577|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979639|NCT01791517|541062578|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979640|NCT01791517|541062579|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979641|NCT01791517|541062580|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979642|NCT01791517|541062581|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
150178625|NCT00703820|541791989|FG001|Overall Study|Lack of Efficacy|11|||
150178626|NCT00703820|541791988|FG000|Overall Study|Received non-protocol therapy|1|||
149979643|NCT01791517|541062582|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979644|NCT01791517|541062583|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979645|NCT01791517|541062584|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
149979646|NCT01791517|541062585|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
150178627|NCT00703820|541791989|FG001|Overall Study|Received non-protocol therapy|0|||
149979647|NCT01791517|541062574|FG000|Phase I: Period 2|Protocol Violation|0|||
149979648|NCT01791517|541062575|FG001|Phase I: Period 2|Protocol Violation|0|||
149979649|NCT01791517|541062576|FG002|Phase I: Period 2|Protocol Violation|0|||
149979650|NCT01791517|541062577|FG003|Phase I: Period 2|Protocol Violation|1|||
149979651|NCT01791517|541062578|FG004|Phase I: Period 2|Protocol Violation|0|||
149979652|NCT01791517|541062579|FG005|Phase I: Period 2|Protocol Violation|0|||
149979653|NCT01791517|541062580|FG006|Phase I: Period 2|Protocol Violation|0|||
149979654|NCT01791517|541062581|FG007|Phase I: Period 2|Protocol Violation|0|||
149979655|NCT01791517|541062582|FG008|Phase I: Period 2|Protocol Violation|0|||
149979656|NCT01791517|541062583|FG009|Phase I: Period 2|Protocol Violation|0|||
149979657|NCT01791517|541062584|FG010|Phase I: Period 2|Protocol Violation|0|||
149979658|NCT01791517|541062585|FG011|Phase I: Period 2|Protocol Violation|0|||
149979659|NCT01791517|541062574|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
149979660|NCT01791517|541062575|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
149979661|NCT01791517|541062576|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
149979662|NCT01791517|541062577|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
149979663|NCT01791517|541062578|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
149979664|NCT01791517|541062579|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
149979665|NCT01791517|541062580|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
149979666|NCT01791517|541062581|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
149979667|NCT01791517|541062582|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
149979668|NCT01791517|541062583|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
149979669|NCT01791517|541062584|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
149979670|NCT01791517|541062585|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
149979671|NCT01791517|541062574|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979672|NCT01791517|541062575|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979673|NCT01791517|541062576|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979674|NCT01791517|541062577|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979675|NCT01791517|541062578|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979676|NCT01791517|541062579|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979677|NCT01791517|541062580|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979678|NCT01791517|541062581|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979679|NCT01791517|541062582|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979680|NCT01791517|541062583|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979681|NCT01791517|541062584|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
149979682|NCT01791517|541062585|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
149979683|NCT01791517|541062574|FG000|Phase I: Period 2|Lens Discomfort|0|||
149979684|NCT01791517|541062575|FG001|Phase I: Period 2|Lens Discomfort|0|||
149979685|NCT01791517|541062576|FG002|Phase I: Period 2|Lens Discomfort|0|||
149979686|NCT01791517|541062577|FG003|Phase I: Period 2|Lens Discomfort|0|||
149979687|NCT01791517|541062578|FG004|Phase I: Period 2|Lens Discomfort|0|||
149979688|NCT01791517|541062579|FG005|Phase I: Period 2|Lens Discomfort|1|||
149979689|NCT01791517|541062580|FG006|Phase I: Period 2|Lens Discomfort|0|||
149979690|NCT01791517|541062581|FG007|Phase I: Period 2|Lens Discomfort|0|||
149979691|NCT01791517|541062582|FG008|Phase I: Period 2|Lens Discomfort|0|||
149979692|NCT01791517|541062583|FG009|Phase I: Period 2|Lens Discomfort|0|||
149979693|NCT01791517|541062584|FG010|Phase I: Period 2|Lens Discomfort|0|||
149979694|NCT01791517|541062585|FG011|Phase I: Period 2|Lens Discomfort|0|||
149979695|NCT01791517|541062574|FG000|Phase I: Period 2|Lost to Follow-up|0|||
149979696|NCT01791517|541062575|FG001|Phase I: Period 2|Lost to Follow-up|3|||
149979697|NCT01791517|541062576|FG002|Phase I: Period 2|Lost to Follow-up|2|||
149979698|NCT01791517|541062577|FG003|Phase I: Period 2|Lost to Follow-up|0|||
149979699|NCT01791517|541062578|FG004|Phase I: Period 2|Lost to Follow-up|0|||
149979700|NCT01791517|541062579|FG005|Phase I: Period 2|Lost to Follow-up|0|||
149979701|NCT01791517|541062580|FG006|Phase I: Period 2|Lost to Follow-up|0|||
149979702|NCT01791517|541062581|FG007|Phase I: Period 2|Lost to Follow-up|0|||
149979703|NCT01791517|541062582|FG008|Phase I: Period 2|Lost to Follow-up|0|||
149979704|NCT01791517|541062583|FG009|Phase I: Period 2|Lost to Follow-up|0|||
149979705|NCT01791517|541062584|FG010|Phase I: Period 2|Lost to Follow-up|0|||
149979706|NCT01791517|541062585|FG011|Phase I: Period 2|Lost to Follow-up|0|||
149979707|NCT01791517|541062574|FG000|Phase I: Period 3|Lens Discomfort|0|||
149979708|NCT01791517|541062575|FG001|Phase I: Period 3|Lens Discomfort|0|||
149979709|NCT01791517|541062576|FG002|Phase I: Period 3|Lens Discomfort|0|||
149979710|NCT01791517|541062577|FG003|Phase I: Period 3|Lens Discomfort|0|||
149979711|NCT01791517|541062578|FG004|Phase I: Period 3|Lens Discomfort|0|||
149979712|NCT01791517|541062579|FG005|Phase I: Period 3|Lens Discomfort|0|||
149979713|NCT01791517|541062580|FG006|Phase I: Period 3|Lens Discomfort|0|||
149979714|NCT01791517|541062581|FG007|Phase I: Period 3|Lens Discomfort|0|||
149979715|NCT01791517|541062582|FG008|Phase I: Period 3|Lens Discomfort|0|||
149979716|NCT01791517|541062583|FG009|Phase I: Period 3|Lens Discomfort|0|||
149979717|NCT01791517|541062584|FG010|Phase I: Period 3|Lens Discomfort|0|||
149979718|NCT01791517|541062585|FG011|Phase I: Period 3|Lens Discomfort|1|||
149979719|NCT01791517|541062574|FG000|Phase I: Period 3|Lost to Follow-up|0|||
149979720|NCT01791517|541062575|FG001|Phase I: Period 3|Lost to Follow-up|1|||
149979721|NCT01791517|541062576|FG002|Phase I: Period 3|Lost to Follow-up|0|||
149979722|NCT01791517|541062577|FG003|Phase I: Period 3|Lost to Follow-up|0|||
149979723|NCT01791517|541062578|FG004|Phase I: Period 3|Lost to Follow-up|1|||
149979724|NCT01791517|541062579|FG005|Phase I: Period 3|Lost to Follow-up|0|||
149979725|NCT01791517|541062580|FG006|Phase I: Period 3|Lost to Follow-up|0|||
149979726|NCT01791517|541062581|FG007|Phase I: Period 3|Lost to Follow-up|0|||
149979727|NCT01791517|541062582|FG008|Phase I: Period 3|Lost to Follow-up|0|||
149979728|NCT01791517|541062583|FG009|Phase I: Period 3|Lost to Follow-up|0|||
149979729|NCT01791517|541062584|FG010|Phase I: Period 3|Lost to Follow-up|0|||
149979730|NCT01791517|541062585|FG011|Phase I: Period 3|Lost to Follow-up|0|||
149979731|NCT01791517|541062574|FG000|Phase I: Period 3|Adverse Event|0|||
149979732|NCT01791517|541062575|FG001|Phase I: Period 3|Adverse Event|0|||
149979733|NCT01791517|541062576|FG002|Phase I: Period 3|Adverse Event|0|||
149979734|NCT01791517|541062577|FG003|Phase I: Period 3|Adverse Event|1|||
149979735|NCT01791517|541062578|FG004|Phase I: Period 3|Adverse Event|0|||
149979736|NCT01791517|541062579|FG005|Phase I: Period 3|Adverse Event|0|||
149979737|NCT01791517|541062580|FG006|Phase I: Period 3|Adverse Event|0|||
149979738|NCT01791517|541062581|FG007|Phase I: Period 3|Adverse Event|0|||
149979739|NCT01791517|541062582|FG008|Phase I: Period 3|Adverse Event|0|||
149979740|NCT01791517|541062583|FG009|Phase I: Period 3|Adverse Event|0|||
149979741|NCT01791517|541062584|FG010|Phase I: Period 3|Adverse Event|0|||
149979742|NCT01791517|541062585|FG011|Phase I: Period 3|Adverse Event|0|||
149979743|NCT01791517|541062574|FG000|Phase II|Lost to Follow-up|1|||
149979744|NCT01791517|541062575|FG001|Phase II|Lost to Follow-up|0|||
149979745|NCT01791517|541062576|FG002|Phase II|Lost to Follow-up|1|||
149979746|NCT01791517|541062577|FG003|Phase II|Lost to Follow-up|0|||
149979747|NCT01791517|541062578|FG004|Phase II|Lost to Follow-up|1|||
149979748|NCT01791517|541062579|FG005|Phase II|Lost to Follow-up|2|||
149979749|NCT01791517|541062580|FG006|Phase II|Lost to Follow-up|0|||
149979750|NCT01791517|541062581|FG007|Phase II|Lost to Follow-up|1|||
149979751|NCT01791517|541062582|FG008|Phase II|Lost to Follow-up|1|||
149979752|NCT01791517|541062583|FG009|Phase II|Lost to Follow-up|1|||
149979753|NCT01791517|541062584|FG010|Phase II|Lost to Follow-up|0|||
149979754|NCT01791517|541062585|FG011|Phase II|Lost to Follow-up|0|||
149979755|NCT01791517|541062574|FG000|Phase II|Withdrawal by Subject|1|||
149979756|NCT01791517|541062575|FG001|Phase II|Withdrawal by Subject|0|||
149979757|NCT01791517|541062576|FG002|Phase II|Withdrawal by Subject|0|||
149979758|NCT01791517|541062577|FG003|Phase II|Withdrawal by Subject|0|||
149979759|NCT01791517|541062578|FG004|Phase II|Withdrawal by Subject|0|||
149979760|NCT01791517|541062579|FG005|Phase II|Withdrawal by Subject|2|||
149979761|NCT01791517|541062580|FG006|Phase II|Withdrawal by Subject|0|||
149979762|NCT01791517|541062581|FG007|Phase II|Withdrawal by Subject|1|||
149979763|NCT01791517|541062582|FG008|Phase II|Withdrawal by Subject|0|||
149979764|NCT01791517|541062583|FG009|Phase II|Withdrawal by Subject|0|||
149979765|NCT01791517|541062584|FG010|Phase II|Withdrawal by Subject|1|||
149979766|NCT01791517|541062585|FG011|Phase II|Withdrawal by Subject|0|||
149979767|NCT01791517|541062574|FG000|Phase II|Lack of Efficacy|0|||
149979768|NCT01791517|541062575|FG001|Phase II|Lack of Efficacy|0|||
149979769|NCT01791517|541062576|FG002|Phase II|Lack of Efficacy|0|||
149979770|NCT01791517|541062577|FG003|Phase II|Lack of Efficacy|0|||
149979771|NCT01791517|541062578|FG004|Phase II|Lack of Efficacy|1|||
149979772|NCT01791517|541062579|FG005|Phase II|Lack of Efficacy|0|||
149979773|NCT01791517|541062580|FG006|Phase II|Lack of Efficacy|0|||
149979774|NCT01791517|541062581|FG007|Phase II|Lack of Efficacy|0|||
149979775|NCT01791517|541062582|FG008|Phase II|Lack of Efficacy|0|||
149979776|NCT01791517|541062583|FG009|Phase II|Lack of Efficacy|0|||
149979777|NCT01791517|541062584|FG010|Phase II|Lack of Efficacy|0|||
149979778|NCT01791517|541062585|FG011|Phase II|Lack of Efficacy|0|||
149979779|NCT01791517|541062574|FG000|Phase II|Adverse Event|0|||
149979780|NCT01791517|541062575|FG001|Phase II|Adverse Event|0|||
149979781|NCT01791517|541062576|FG002|Phase II|Adverse Event|0|||
149979782|NCT01791517|541062577|FG003|Phase II|Adverse Event|0|||
150053120|NCT01038869|541336602|FG000|Overall Study|Lost to Follow-up|6|||
149979783|NCT01791517|541062578|FG004|Phase II|Adverse Event|0|||
149979784|NCT01791517|541062579|FG005|Phase II|Adverse Event|0|||
149979785|NCT01791517|541062580|FG006|Phase II|Adverse Event|2|||
149979786|NCT01791517|541062581|FG007|Phase II|Adverse Event|1|||
149979787|NCT01791517|541062582|FG008|Phase II|Adverse Event|0|||
149979788|NCT01791517|541062583|FG009|Phase II|Adverse Event|1|||
149979789|NCT01791517|541062584|FG010|Phase II|Adverse Event|0|||
149979790|NCT01791517|541062585|FG011|Phase II|Adverse Event|0|||
149979791|NCT01791517|541062574|FG000|Phase II|Lens Handling Difficulties|0|||
149979792|NCT01791517|541062575|FG001|Phase II|Lens Handling Difficulties|0|||
149979793|NCT01791517|541062576|FG002|Phase II|Lens Handling Difficulties|0|||
149979794|NCT01791517|541062577|FG003|Phase II|Lens Handling Difficulties|0|||
149979795|NCT01791517|541062578|FG004|Phase II|Lens Handling Difficulties|0|||
149979796|NCT01791517|541062579|FG005|Phase II|Lens Handling Difficulties|0|||
149979797|NCT01791517|541062580|FG006|Phase II|Lens Handling Difficulties|0|||
149979798|NCT01791517|541062581|FG007|Phase II|Lens Handling Difficulties|0|||
149979799|NCT01791517|541062582|FG008|Phase II|Lens Handling Difficulties|1|||
149979800|NCT01791517|541062583|FG009|Phase II|Lens Handling Difficulties|0|||
149979801|NCT01791517|541062584|FG010|Phase II|Lens Handling Difficulties|0|||
149979802|NCT01791517|541062585|FG011|Phase II|Lens Handling Difficulties|0|||
149979803|NCT01791517|541062574|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
149979804|NCT01791517|541062575|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
149979805|NCT01791517|541062576|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
149979806|NCT01791517|541062577|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
149979807|NCT01791517|541062578|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
149979808|NCT01791517|541062579|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
149979809|NCT01791517|541062580|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
149979810|NCT01791517|541062581|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
149979811|NCT01791517|541062582|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
149979812|NCT01791517|541062583|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
149979813|NCT01791517|541062584|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
149979814|NCT01791517|541062585|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
149979815|NCT01791517|541062574|FG000|Phase II|Pre-Existing Ocular Issue|0|||
149979816|NCT01791517|541062575|FG001|Phase II|Pre-Existing Ocular Issue|0|||
149979817|NCT01791517|541062576|FG002|Phase II|Pre-Existing Ocular Issue|0|||
149979818|NCT01791517|541062577|FG003|Phase II|Pre-Existing Ocular Issue|0|||
149979819|NCT01791517|541062578|FG004|Phase II|Pre-Existing Ocular Issue|0|||
149979820|NCT01791517|541062579|FG005|Phase II|Pre-Existing Ocular Issue|0|||
149979821|NCT01791517|541062580|FG006|Phase II|Pre-Existing Ocular Issue|0|||
149979822|NCT01791517|541062581|FG007|Phase II|Pre-Existing Ocular Issue|0|||
149979823|NCT01791517|541062582|FG008|Phase II|Pre-Existing Ocular Issue|0|||
149979824|NCT01791517|541062583|FG009|Phase II|Pre-Existing Ocular Issue|0|||
149979825|NCT01791517|541062584|FG010|Phase II|Pre-Existing Ocular Issue|0|||
149979826|NCT01791517|541062585|FG011|Phase II|Pre-Existing Ocular Issue|1|||
149979827|NCT00589797|541062586|FG000|Overall Study|Death|1|||
149979828|NCT00589797|541062587|FG001|Overall Study|Death|0|||
149979829|NCT00589797|541062586|FG000|Overall Study|Lost to Follow-up|12|||
149979830|NCT00589797|541062587|FG001|Overall Study|Lost to Follow-up|9|||
149979831|NCT00589797|541062586|FG000|Overall Study|Physician Decision|8|||
149979832|NCT00589797|541062587|FG001|Overall Study|Physician Decision|3|||
149979833|NCT00589797|541062586|FG000|Overall Study|Withdrawal by Subject|6|||
149979834|NCT00589797|541062587|FG001|Overall Study|Withdrawal by Subject|5|||
149979835|NCT00589797|541062586|FG000|Overall Study|Non-Randomized Training Subjects|46|||
149979836|NCT00589797|541062587|FG001|Overall Study|Non-Randomized Training Subjects|6|||
149979837|NCT05197049|541062591|FG000|Overall Study|Death|0|||
149979838|NCT05197049|541062592|FG001|Overall Study|Death|1|||
149979839|NCT05197049|541062593|FG002|Overall Study|Death|0|||
149979840|NCT05197049|541062591|FG000|Overall Study|Lost to Follow-up|3|||
149979841|NCT05197049|541062592|FG001|Overall Study|Lost to Follow-up|1|||
149979842|NCT05197049|541062593|FG002|Overall Study|Lost to Follow-up|0|||
149979843|NCT05197049|541062591|FG000|Overall Study|Withdrawal by Subject|15|||
149979844|NCT05197049|541062592|FG001|Overall Study|Withdrawal by Subject|3|||
149979845|NCT05197049|541062593|FG002|Overall Study|Withdrawal by Subject|1|||
149979846|NCT05197049|541062591|FG000|Overall Study|GCP non-compliance|1|||
149979847|NCT05197049|541062592|FG001|Overall Study|GCP non-compliance|2|||
149979848|NCT05197049|541062593|FG002|Overall Study|GCP non-compliance|0|||
149979849|NCT03230318|541062594|FG000|Overall Study|Radiographic disease progression|72|||
149979850|NCT03230318|541062595|FG001|Overall Study|Radiographic disease progression|19|||
149979851|NCT03230318|541062594|FG000|Overall Study|Clinical progression|17|||
149979852|NCT03230318|541062595|FG001|Overall Study|Clinical progression|7|||
149979853|NCT03230318|541062594|FG000|Overall Study|Adverse Event|5|||
149979854|NCT03230318|541062595|FG001|Overall Study|Adverse Event|3|||
150178628|NCT00703820|541791988|FG000|Overall Study|Physician Decision|4|||
150178629|NCT00703820|541791989|FG001|Overall Study|Physician Decision|5|||
149979855|NCT03230318|541062594|FG000|Overall Study|Physician Decision|2|||
149979856|NCT03230318|541062595|FG001|Overall Study|Physician Decision|3|||
149979857|NCT03230318|541062594|FG000|Overall Study|Death|3|||
149979858|NCT03230318|541062595|FG001|Overall Study|Death|2|||
149979859|NCT03230318|541062594|FG000|Overall Study|Lost to Follow-up|1|||
149979860|NCT03230318|541062595|FG001|Overall Study|Lost to Follow-up|0|||
149979861|NCT03230318|541062594|FG000|Overall Study|Withdrawal by Subject|1|||
149979862|NCT03230318|541062595|FG001|Overall Study|Withdrawal by Subject|3|||
149979863|NCT03230318|541062594|FG000|Overall Study|Other|3|||
149979864|NCT03230318|541062595|FG001|Overall Study|Other|7|||
149979865|NCT04011735|541062597|FG000|Overall Study|Withdrawal by Subject|1|||
149979866|NCT04011735|541062598|FG001|Overall Study|Withdrawal by Subject|0|||
149979867|NCT04011735|541062599|FG002|Overall Study|Withdrawal by Subject|1|||
149979868|NCT04011735|541062597|FG000|Overall Study|Met exclusion criteria after study entry|0|||
149979869|NCT04011735|541062598|FG001|Overall Study|Met exclusion criteria after study entry|1|||
149979870|NCT04011735|541062599|FG002|Overall Study|Met exclusion criteria after study entry|0|||
149979871|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
149979872|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
149979873|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
149979874|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
149979875|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
149979876|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
149979877|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
149979878|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
149979879|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
149979880|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
149979881|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
149979882|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
149979883|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
149979884|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
149979885|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
149979886|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
149979887|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
149979888|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
149979889|NCT02831855|541062600|FG000|Open Label Phase (24 Weeks)|Other|4|||
149979890|NCT02831855|541062601|FG001|Open Label Phase (24 Weeks)|Other|0|||
149979891|NCT02831855|541062602|FG002|Open Label Phase (24 Weeks)|Other|0|||
149979892|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
149979893|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
149979894|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
149979895|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Death|0|||
149979896|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Death|0|||
149979897|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Death|2|||
149979898|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
149979899|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
149979900|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
149979901|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
149979902|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
149979903|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
149979904|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
149979905|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
149979906|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
149979907|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Other|0|||
149979908|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Other|2|||
149979909|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Other|5|||
149979910|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
149979911|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
149979912|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
149979913|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
149979914|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
149979915|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
149979916|NCT02831855|541062600|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
149979917|NCT02831855|541062601|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
149979918|NCT02831855|541062602|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
149979919|NCT02688192|541062604|FG000|Overall Study|Lost to Follow-up|11|||
149979920|NCT02688192|541062605|FG001|Overall Study|Lost to Follow-up|5|||
149979921|NCT02688192|541062604|FG000|Overall Study|Physician Decision|1|||
149979922|NCT02688192|541062605|FG001|Overall Study|Physician Decision|0|||
149979923|NCT00075764|541062606|FG000|Overall Study|Adverse Event|5|||
149979924|NCT00075764|541062607|FG001|Overall Study|Adverse Event|12|||
149979925|NCT00075764|541062606|FG000|Overall Study|Death|4|||
149979926|NCT00075764|541062607|FG001|Overall Study|Death|8|||
149979927|NCT00075764|541062606|FG000|Overall Study|Withdrawal by Subject|28|||
149979928|NCT00075764|541062607|FG001|Overall Study|Withdrawal by Subject|18|||
149979929|NCT00075764|541062606|FG000|Overall Study|Progression|269|||
149979930|NCT00075764|541062607|FG001|Overall Study|Progression|274|||
149979931|NCT00075764|541062606|FG000|Overall Study|Still on treatment|8|||
149979932|NCT00075764|541062607|FG001|Overall Study|Still on treatment|15|||
149979933|NCT00075764|541062606|FG000|Overall Study|Delinquent|4|||
149979934|NCT00075764|541062607|FG001|Overall Study|Delinquent|2|||
149979935|NCT00075764|541062606|FG000|Overall Study|Not protocol specified|27|||
149979936|NCT00075764|541062607|FG001|Overall Study|Not protocol specified|19|||
149979937|NCT00075764|541062606|FG000|Overall Study|Under review|0|||
149979938|NCT00075764|541062607|FG001|Overall Study|Under review|1|||
149979939|NCT02010593|541062611|FG000|Overall Study|Lost to Follow-up|1|||
149979940|NCT02010593|541062612|FG001|Overall Study|Lost to Follow-up|0|||
149979941|NCT02010593|541062611|FG000|Overall Study|Physician Decision|1|||
149979942|NCT02010593|541062612|FG001|Overall Study|Physician Decision|0|||
149979943|NCT02010593|541062611|FG000|Overall Study|Unable to adhere to visit schedule|0|||
149979944|NCT02010593|541062612|FG001|Overall Study|Unable to adhere to visit schedule|2|||
149979945|NCT01773967|541062613|FG000|Overall Study|Lost to Follow-up|15|||
149979946|NCT01773967|541062614|FG001|Overall Study|Lost to Follow-up|13|||
149979947|NCT01135459|541062615|FG000|Overall Study|Adverse Event|8|||
149979948|NCT01135459|541062616|FG001|Overall Study|Adverse Event|10|||
149979949|NCT01135459|541062615|FG000|Overall Study|Lack of Efficacy|3|||
149979950|NCT01135459|541062616|FG001|Overall Study|Lack of Efficacy|1|||
149979951|NCT01135459|541062615|FG000|Overall Study|Withdrawal by Subject|2|||
149979952|NCT01135459|541062616|FG001|Overall Study|Withdrawal by Subject|3|||
149979953|NCT01135459|541062615|FG000|Overall Study|Protocol Violation|5|||
149979954|NCT01135459|541062616|FG001|Overall Study|Protocol Violation|3|||
149979955|NCT01135459|541062615|FG000|Overall Study|Lost to Follow-up|2|||
149979956|NCT01135459|541062616|FG001|Overall Study|Lost to Follow-up|1|||
149979957|NCT01135459|541062615|FG000|Overall Study|Non-compliance to study procedures|0|||
149979958|NCT01135459|541062616|FG001|Overall Study|Non-compliance to study procedures|1|||
149979959|NCT01135459|541062615|FG000|Overall Study|Other than specified|1|||
149979960|NCT01135459|541062616|FG001|Overall Study|Other than specified|1|||
149979961|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
149979962|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
149979963|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
149979964|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
149979965|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
149979966|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
149979967|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
149979968|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
150053121|NCT02238067|541336603|FG000|Overall Study|Not completed survey at Month 6|45|||
150053122|NCT02213133|541336607|FG000|Overall Study|Participant discontinued study therapy|2|||
150053123|NCT02213133|541336608|FG001|Overall Study|Participant discontinued study therapy|0|||
150053124|NCT02213133|541336609|FG002|Overall Study|Participant discontinued study therapy|0|||
150053125|NCT02213133|541336607|FG000|Overall Study|Participant withdrew informed consent|2|||
150053126|NCT02213133|541336608|FG001|Overall Study|Participant withdrew informed consent|1|||
150053127|NCT02213133|541336609|FG002|Overall Study|Participant withdrew informed consent|2|||
150053128|NCT02213133|541336607|FG000|Overall Study|Disease progression|11|||
150053129|NCT02213133|541336608|FG001|Overall Study|Disease progression|2|||
150053130|NCT02213133|541336609|FG002|Overall Study|Disease progression|0|||
150053131|NCT02213133|541336607|FG000|Overall Study|Adverse Event (AE)|1|||
150053132|NCT02213133|541336608|FG001|Overall Study|Adverse Event (AE)|0|||
150053133|NCT02213133|541336609|FG002|Overall Study|Adverse Event (AE)|0|||
150053134|NCT02213133|541336607|FG000|Overall Study|Death|16|||
150053135|NCT02213133|541336608|FG001|Overall Study|Death|2|||
150053136|NCT02213133|541336609|FG002|Overall Study|Death|1|||
149979969|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
150053137|NCT02213133|541336607|FG000|Overall Study|Other|5|||
150053138|NCT02213133|541336608|FG001|Overall Study|Other|0|||
150053139|NCT02213133|541336609|FG002|Overall Study|Other|0|||
149979970|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
150178630|NCT00703820|541791988|FG000|Overall Study|Withdrawal by Subject|2|||
150178631|NCT00703820|541791989|FG001|Overall Study|Withdrawal by Subject|1|||
149979971|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
149979972|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
149979973|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
150053140|NCT02350764|541336610|FG000|Overall Study|Adverse Event|4|||
150053141|NCT02350764|541336610|FG000|Overall Study|Death|3|||
150053142|NCT02350764|541336610|FG000|Overall Study|Physician Decision|2|||
150053143|NCT02350764|541336610|FG000|Overall Study|Withdrawal by Subject|2|||
150053144|NCT03726996|541336611|FG000|Overall Study|Parent's decision|2|||
150053145|NCT03726996|541336611|FG000|Overall Study|Study early termination|2|||
150053146|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
150053147|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
150053148|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
150053149|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
150053150|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
150053151|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
150053152|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
150053153|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
150053154|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
150053155|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
150053156|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
150053157|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
150053158|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
150053159|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
149979974|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
150053160|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
150053161|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
150053162|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
150053163|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
150053164|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
150053165|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
150053166|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
150053167|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
150053168|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
150053169|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
150053170|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
150053171|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150053172|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150053173|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
150053174|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150053175|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
150053176|NCT01328444|541336612|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
150053177|NCT01328444|541336613|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
150053178|NCT01328444|541336614|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
150178632|NCT00761605|541791992|FG000|Overall Study|Adverse Event|26|||
150178633|NCT00761605|541791992|FG000|Overall Study|Death|2|||
149979975|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
149979976|NCT01057693|541062622|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
149979977|NCT01057693|541062623|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
149979978|NCT01057693|541062624|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
149979979|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
149979980|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
149979981|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
149979982|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
149979983|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
149979984|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
149979985|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
149979986|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
149979987|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
149979988|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
149979989|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
149979990|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
149979991|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
149979992|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
149979993|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
149979994|NCT01057693|541062622|FG000|Between Single-Blind and Double-Blind|Other|6|||
149979995|NCT01057693|541062623|FG001|Between Single-Blind and Double-Blind|Other|0|||
149979996|NCT01057693|541062624|FG002|Between Single-Blind and Double-Blind|Other|0|||
149979997|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
149979998|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
149979999|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
149980000|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
149980001|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
150053179|NCT01328444|541336615|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
150053180|NCT01328444|541336616|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
150178634|NCT00761605|541791992|FG000|Overall Study|Lack of Efficacy|26|||
149980002|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
149980003|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
149980004|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
149980005|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
149980006|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
149980007|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
149980008|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
149980009|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
149980010|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
149980011|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
149980012|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
149980013|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
149980014|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
149980015|NCT01057693|541062622|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
149980016|NCT01057693|541062623|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
149980017|NCT01057693|541062624|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
149980018|NCT02236572|541062625|FG000|Overall Study|Withdrawal by Subject|1|||
149980019|NCT02236572|541062625|FG000|Overall Study|Protocol Violation|1|||
149980020|NCT02236572|541062625|FG000|Overall Study|Lost to Follow-up|1|||
149980021|NCT02413996|541062626|FG000|Overall Study|not comfortable with the intervention|9|||
149980022|NCT02413996|541062627|FG001|Overall Study|not comfortable with the intervention|2|||
149980023|NCT02651116|541062632|FG000|Overall Study|Adverse Event|0|||
149980024|NCT02651116|541062633|FG001|Overall Study|Adverse Event|1|||
149980025|NCT02651116|541062632|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
149980026|NCT02651116|541062633|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
149980027|NCT00041470|541062641|FG000|Overall Study|Loss of Funding|38|||
149980028|NCT01459666|541062642|FG000|Overall Study|PI left institution|5|||
149980029|NCT01459666|541062643|FG001|Overall Study|PI left institution|4|||
149980030|NCT01061385|541062644|FG000|Overall Study|Lost to Follow-up|1|||
149980031|NCT01061385|541062645|FG001|Overall Study|Lost to Follow-up|0|||
149980032|NCT01061385|541062644|FG000|Overall Study|subject decision not related to AE|0|||
149980033|NCT01061385|541062645|FG001|Overall Study|subject decision not related to AE|1|||
149980034|NCT01492088|541062646|FG000|Overall Study|Withdrawal by Patient|0|||
149980035|NCT01492088|541062647|FG001|Overall Study|Withdrawal by Patient|2|||
149980036|NCT01492088|541062648|FG002|Overall Study|Withdrawal by Patient|0|||
149980037|NCT01492088|541062646|FG000|Overall Study|Death|1|||
149980038|NCT01492088|541062647|FG001|Overall Study|Death|6|||
149980039|NCT01492088|541062648|FG002|Overall Study|Death|2|||
149980040|NCT01492088|541062646|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
149980041|NCT01492088|541062647|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
149980042|NCT01492088|541062648|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
149980043|NCT01492088|541062646|FG000|Overall Study|Alive at Last Follow-up|0|||
149980044|NCT01492088|541062647|FG001|Overall Study|Alive at Last Follow-up|6|||
149980045|NCT01492088|541062648|FG002|Overall Study|Alive at Last Follow-up|11|||
149980046|NCT02379052|541062655|FG000|Overall Study|Protocol Violation|0|||
149980047|NCT02379052|541062656|FG001|Overall Study|Protocol Violation|1|||
149980048|NCT02379052|541062655|FG000|Overall Study|Adverse Event|0|||
149980049|NCT02379052|541062656|FG001|Overall Study|Adverse Event|1|||
149980050|NCT02379052|541062655|FG000|Overall Study|Physician Decision|1|||
149980051|NCT02379052|541062656|FG001|Overall Study|Physician Decision|1|||
149980052|NCT02379052|541062655|FG000|Overall Study|Withdrawal by Subject|2|||
149980053|NCT02379052|541062656|FG001|Overall Study|Withdrawal by Subject|0|||
149980054|NCT02379052|541062655|FG000|Overall Study|Lost to Follow-up|2|||
149980055|NCT02379052|541062656|FG001|Overall Study|Lost to Follow-up|1|||
149980056|NCT02379052|541062655|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
149980057|NCT02379052|541062656|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
149980058|NCT02379052|541062655|FG000|Overall Study|Subject was Incarcerated|0|||
149980059|NCT02379052|541062656|FG001|Overall Study|Subject was Incarcerated|1|||
149980060|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Death|2|||
149980061|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
149980062|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
149980063|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Physician Decision|1|||
149980064|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
149980065|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
149980066|NCT00786422|541062657|FG000|Rivaroxaban Treatment|Adverse Event|2|||
149980067|NCT00786422|541062657|FG000|Follow-up Period|Death|1|||
149980068|NCT00786422|541062657|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
149980069|NCT04466384|541062658|FG000|First Phase|Protocol Violation|1|||
149980070|NCT04466384|541062659|FG001|First Phase|Protocol Violation|0|||
149980071|NCT04466384|541062658|FG000|First Phase|Missing data|1|||
149980072|NCT04466384|541062659|FG001|First Phase|Missing data|0|||
149980073|NCT04466384|541062658|FG000|Cross Over Phase|Physician Decision|1|||
149980074|NCT04466384|541062659|FG001|Cross Over Phase|Physician Decision|0|||
149980075|NCT04466384|541062658|FG000|Cross Over Phase|Withdrawal by Subject|0|||
149980076|NCT04466384|541062659|FG001|Cross Over Phase|Withdrawal by Subject|1|||
149980077|NCT02489318|541064161|FG000|Randomized|Withdrawal by Subject|0|||
149980078|NCT02489318|541064162|FG001|Randomized|Withdrawal by Subject|1|||
149980079|NCT02489318|541064161|FG000|Treated|Adverse Event|19|||
149980080|NCT02489318|541064162|FG001|Treated|Adverse Event|62|||
149980081|NCT02489318|541064161|FG000|Treated|Death|13|||
149980082|NCT02489318|541064162|FG001|Treated|Death|11|||
149980083|NCT02489318|541064161|FG000|Treated|Physician Decision|4|||
149980084|NCT02489318|541064162|FG001|Treated|Physician Decision|6|||
149980085|NCT02489318|541064161|FG000|Treated|Protocol Violation|1|||
149980086|NCT02489318|541064162|FG001|Treated|Protocol Violation|2|||
149980087|NCT02489318|541064161|FG000|Treated|Withdrawal by Subject|37|||
149980088|NCT02489318|541064162|FG001|Treated|Withdrawal by Subject|36|||
149980089|NCT02489318|541064161|FG000|Treated|Other: Progressive Disease|245|||
149980090|NCT02489318|541064162|FG001|Treated|Other: Progressive Disease|138|||
149980091|NCT02489318|541064161|FG000|Treated|Other|0|||
149980092|NCT02489318|541064162|FG001|Treated|Other|2|||
149980093|NCT02489318|541064161|FG000|Treated|Ongoing|0|||
149980094|NCT02489318|541064162|FG001|Treated|Ongoing|267|||
149980095|NCT01306643|541064163|FG000|Overall Study|Adverse Event|5|||
149980096|NCT01306643|541064163|FG000|Overall Study|Disease Progression|7|||
149980097|NCT01306643|541064163|FG000|Overall Study|Other: Change in Eligibility Status|1|||
149980098|NCT00709319|541064164|FG000|Overall Study|Death|4|||
149980099|NCT00709319|541064164|FG000|Overall Study|Withdrawal by Subject|2|||
149980100|NCT00579553|541064168|FG000|Overall Study|Lost to Follow-up|16|||
149980101|NCT00579553|541064169|FG001|Overall Study|Lost to Follow-up|13|||
149980102|NCT00090779|541064170|FG000|Step 1|Withdrawal by Subject|4|||
149980103|NCT00090779|541064171|FG001|Step 1|Withdrawal by Subject|2|||
149980104|NCT00090779|541064170|FG000|Step 1|Lost to Follow-up|3|||
149980105|NCT00090779|541064171|FG001|Step 1|Lost to Follow-up|2|||
149980106|NCT00090779|541064170|FG000|Step 1|Death|0|||
149980107|NCT00090779|541064171|FG001|Step 1|Death|2|||
149980108|NCT00090779|541064170|FG000|Step 1|Physician Decision|1|||
149980109|NCT00090779|541064171|FG001|Step 1|Physician Decision|0|||
149980110|NCT00090779|541064170|FG000|Step 1|Pregnancy|1|||
149980111|NCT00090779|541064171|FG001|Step 1|Pregnancy|0|||
149980112|NCT00090779|541064170|FG000|Step 1|Non-compliance to study requirements|0|||
149980113|NCT00090779|541064171|FG001|Step 1|Non-compliance to study requirements|1|||
149980114|NCT00090779|541064170|FG000|Step 1|Subject relocated|2|||
149980115|NCT00090779|541064171|FG001|Step 1|Subject relocated|8|||
149980116|NCT00090779|541064170|FG000|Step 2|Off study per study closure|6|||
149980117|NCT00090779|541064171|FG001|Step 2|Off study per study closure|16|||
149980118|NCT00090779|541064170|FG000|Step 2|Subject relocated|0|||
149980119|NCT00090779|541064171|FG001|Step 2|Subject relocated|1|||
149980120|NCT00090779|541064170|FG000|Step 2|Non-compliance to study requirements|0|||
149980121|NCT00090779|541064171|FG001|Step 2|Non-compliance to study requirements|1|||
149980122|NCT00090779|541064170|FG000|Step 3|Initiation of ART and off extended study|3|||
149980123|NCT00090779|541064171|FG001|Step 3|Initiation of ART and off extended study|2|||
149980124|NCT00090779|541064170|FG000|Step 3|Off extended study due to study closure|4|||
149980125|NCT00090779|541064171|FG001|Step 3|Off extended study due to study closure|3|||
149980126|NCT04860869|541064174|FG000|Overall Study|Withdrawal by Subject|1|||
149980127|NCT04860869|541064175|FG001|Overall Study|Withdrawal by Subject|0|||
149980128|NCT00590967|541064179|FG000|Overall Study|Withdrawal by Subject|1|||
149980129|NCT00590967|541064180|FG001|Overall Study|Withdrawal by Subject|1|||
149980130|NCT00590967|541064179|FG000|Overall Study|Ineligible|1|||
149980131|NCT00590967|541064180|FG001|Overall Study|Ineligible|0|||
149980132|NCT00590967|541064179|FG000|Overall Study|Poor performance status|0|||
149980133|NCT00590967|541064180|FG001|Overall Study|Poor performance status|1|||
149980134|NCT00590967|541064179|FG000|Overall Study|Non-compliant|0|||
149980135|NCT00590967|541064180|FG001|Overall Study|Non-compliant|2|||
149980136|NCT00590967|541064179|FG000|Overall Study|Did not sign consent form|0|||
149980137|NCT00590967|541064180|FG001|Overall Study|Did not sign consent form|1|||
149980138|NCT00590967|541064179|FG000|Overall Study|Did not receive chemo per protocol|1|||
149980139|NCT00590967|541064180|FG001|Overall Study|Did not receive chemo per protocol|0|||
149980140|NCT01881789|541064181|FG000|Overall Study|Withdrawal by Subject|0|||
149980141|NCT01881789|541064182|FG001|Overall Study|Withdrawal by Subject|2|||
149980142|NCT01881789|541064183|FG002|Overall Study|Withdrawal by Subject|1|||
149980143|NCT01881789|541064184|FG003|Overall Study|Withdrawal by Subject|0|||
149980144|NCT01881789|541064185|FG004|Overall Study|Withdrawal by Subject|1|||
149980145|NCT01881789|541064186|FG005|Overall Study|Withdrawal by Subject|1|||
149980146|NCT01881789|541064181|FG000|Overall Study|Study Terminated by Sponsor|0|||
149980147|NCT01881789|541064182|FG001|Overall Study|Study Terminated by Sponsor|0|||
149980148|NCT01881789|541064183|FG002|Overall Study|Study Terminated by Sponsor|0|||
149980149|NCT01881789|541064184|FG003|Overall Study|Study Terminated by Sponsor|0|||
149980150|NCT01881789|541064185|FG004|Overall Study|Study Terminated by Sponsor|0|||
149980151|NCT01881789|541064186|FG005|Overall Study|Study Terminated by Sponsor|1|||
149980152|NCT01881789|541064181|FG000|Overall Study|Other|3|||
149980153|NCT01881789|541064182|FG001|Overall Study|Other|5|||
149980154|NCT01881789|541064183|FG002|Overall Study|Other|2|||
149980155|NCT01881789|541064184|FG003|Overall Study|Other|3|||
149980156|NCT01881789|541064185|FG004|Overall Study|Other|1|||
149980157|NCT01881789|541064186|FG005|Overall Study|Other|1|||
149980158|NCT01887717|541064187|FG000|Overall Study|Withdrawal by Subject|1|||
149980159|NCT01887717|541064188|FG001|Overall Study|Withdrawal by Subject|7|||
149980160|NCT01887717|541064187|FG000|Overall Study|Physician Decision|0|||
149980161|NCT01887717|541064188|FG001|Overall Study|Physician Decision|2|||
149980162|NCT01887717|541064187|FG000|Overall Study|Administrative reasons|5|||
149980163|NCT01887717|541064188|FG001|Overall Study|Administrative reasons|2|||
149980164|NCT02655887|541064191|FG000|Overall Study|Lost to Follow-up|3|||
149980165|NCT02655887|541064191|FG000|Overall Study|Death|4|||
149980166|NCT02655887|541064191|FG000|Overall Study|Withdrawal by Subject|3|||
149980167|NCT02655887|541064191|FG000|Overall Study|Missed 12-month follow-up visit|4|||
149980168|NCT02148263|541064195|FG000|Overall Study|Withdrawal by Subject|3|||
149980169|NCT02148263|541064196|FG001|Overall Study|Withdrawal by Subject|2|||
149980170|NCT00003869|541064197|FG000|Overall Study|Adverse Event|14|||
149980171|NCT00003869|541064198|FG001|Overall Study|Adverse Event|3|||
149980172|NCT00003869|541064197|FG000|Overall Study|Withdrawal by Subject|21|||
149980173|NCT00003869|541064198|FG001|Overall Study|Withdrawal by Subject|3|||
149980174|NCT00003869|541064197|FG000|Overall Study|Death|1|||
149980175|NCT00003869|541064198|FG001|Overall Study|Death|2|||
149980176|NCT00003869|541064197|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
149980177|NCT00003869|541064198|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
149980178|NCT01964378|541064199|FG000|Overall Study|Disc. due to death before first dosing|0|||
149980179|NCT01964378|541064200|FG001|Overall Study|Disc. due to death before first dosing|1|||
149980180|NCT01964378|541064199|FG000|Overall Study|Disc. due to AE before first dosing|1|||
149980181|NCT01964378|541064200|FG001|Overall Study|Disc. due to AE before first dosing|0|||
149980182|NCT01964378|541064199|FG000|Overall Study|Death|3|||
149980183|NCT01964378|541064200|FG001|Overall Study|Death|2|||
149980184|NCT01964378|541064199|FG000|Overall Study|Adverse Event|12|||
149980185|NCT01964378|541064200|FG001|Overall Study|Adverse Event|5|||
149980186|NCT01964378|541064199|FG000|Overall Study|Lack of Efficacy|0|||
149980187|NCT01964378|541064200|FG001|Overall Study|Lack of Efficacy|1|||
149980188|NCT01964378|541064199|FG000|Overall Study|Protocol Violation|0|||
149980189|NCT01964378|541064200|FG001|Overall Study|Protocol Violation|1|||
149980190|NCT01964378|541064199|FG000|Overall Study|Lost to Follow-up|0|||
149980191|NCT01964378|541064200|FG001|Overall Study|Lost to Follow-up|1|||
149980192|NCT01964378|541064199|FG000|Overall Study|Withdrawal by Subject|7|||
149980193|NCT01964378|541064200|FG001|Overall Study|Withdrawal by Subject|5|||
149980194|NCT01964378|541064199|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
149980195|NCT01964378|541064200|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
149980196|NCT01964378|541064199|FG000|Overall Study|Other|1|||
149980197|NCT01964378|541064200|FG001|Overall Study|Other|2|||
149980198|NCT00326599|541064201|FG000|Overall Study|Withdrawal by Subject|1|||
149980199|NCT00326599|541064202|FG001|Overall Study|Withdrawal by Subject|0|||
150178635|NCT00761605|541791992|FG000|Overall Study|Lost to Follow-up|29|||
149980200|NCT00326599|541064203|FG002|Overall Study|Withdrawal by Subject|5|||
149980201|NCT00326599|541064204|FG003|Overall Study|Withdrawal by Subject|2|||
149980202|NCT00326599|541064201|FG000|Overall Study|Adverse Event|1|||
149980203|NCT00326599|541064202|FG001|Overall Study|Adverse Event|0|||
149980204|NCT00326599|541064203|FG002|Overall Study|Adverse Event|32|||
149980205|NCT00326599|541064204|FG003|Overall Study|Adverse Event|3|||
149980206|NCT00326599|541064201|FG000|Overall Study|Disease Progression|3|||
149980207|NCT00326599|541064202|FG001|Overall Study|Disease Progression|1|||
149980208|NCT00326599|541064203|FG002|Overall Study|Disease Progression|13|||
149980209|NCT00326599|541064204|FG003|Overall Study|Disease Progression|11|||
149980210|NCT00326599|541064201|FG000|Overall Study|Alternate Treatment|1|||
149980211|NCT00326599|541064202|FG001|Overall Study|Alternate Treatment|0|||
149980212|NCT00326599|541064203|FG002|Overall Study|Alternate Treatment|0|||
149980213|NCT00326599|541064204|FG003|Overall Study|Alternate Treatment|0|||
149980214|NCT00326599|541064201|FG000|Overall Study|Death|0|||
149980215|NCT00326599|541064202|FG001|Overall Study|Death|0|||
149980216|NCT00326599|541064203|FG002|Overall Study|Death|1|||
149980217|NCT00326599|541064204|FG003|Overall Study|Death|2|||
149980218|NCT00326599|541064201|FG000|Overall Study|Other Unspecified Reason|0|||
149980219|NCT00326599|541064202|FG001|Overall Study|Other Unspecified Reason|0|||
149980220|NCT00326599|541064203|FG002|Overall Study|Other Unspecified Reason|2|||
149980221|NCT00326599|541064204|FG003|Overall Study|Other Unspecified Reason|1|||
149980222|NCT03364231|541064205|FG000|Overall Study|Adverse Event|1|||
149980223|NCT03364231|541064206|FG001|Overall Study|Adverse Event|4|||
149980224|NCT03364231|541064205|FG000|Overall Study|Death|1|||
149980225|NCT03364231|541064206|FG001|Overall Study|Death|0|||
149980226|NCT03364231|541064205|FG000|Overall Study|Investigator Decision|2|||
149980227|NCT03364231|541064206|FG001|Overall Study|Investigator Decision|2|||
149980228|NCT03364231|541064205|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
149980229|NCT03364231|541064206|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
149980230|NCT03364231|541064205|FG000|Overall Study|Withdrawal of Subject Consent|1|||
149980231|NCT03364231|541064206|FG001|Overall Study|Withdrawal of Subject Consent|0|||
149980232|NCT03364231|541064205|FG000|Overall Study|Reason Not Specified|1|||
149980233|NCT03364231|541064206|FG001|Overall Study|Reason Not Specified|0|||
149980234|NCT03364231|541064205|FG000|Overall Study|Disease Progression|0|||
149980235|NCT03364231|541064206|FG001|Overall Study|Disease Progression|6|||
149980236|NCT02012218|541064213|FG000|Overall Study|Withdrawal by Subject|1|||
149980237|NCT02012218|541064214|FG001|Overall Study|Withdrawal by Subject|0|||
149980238|NCT02012218|541064215|FG002|Overall Study|Withdrawal by Subject|1|||
149980239|NCT02012218|541064216|FG003|Overall Study|Withdrawal by Subject|1|||
149980240|NCT02012218|541064217|FG004|Overall Study|Withdrawal by Subject|1|||
149980241|NCT02012218|541064213|FG000|Overall Study|Adverse Event|1|||
149980242|NCT02012218|541064214|FG001|Overall Study|Adverse Event|0|||
149980243|NCT02012218|541064215|FG002|Overall Study|Adverse Event|0|||
149980244|NCT02012218|541064216|FG003|Overall Study|Adverse Event|1|||
149980245|NCT02012218|541064217|FG004|Overall Study|Adverse Event|0|||
149980246|NCT02012218|541064213|FG000|Overall Study|Lost to Follow-up|0|||
149980247|NCT02012218|541064214|FG001|Overall Study|Lost to Follow-up|1|||
149980248|NCT02012218|541064215|FG002|Overall Study|Lost to Follow-up|1|||
149980249|NCT02012218|541064216|FG003|Overall Study|Lost to Follow-up|0|||
149980250|NCT02012218|541064217|FG004|Overall Study|Lost to Follow-up|0|||
149980251|NCT02012218|541064213|FG000|Overall Study|Protocol Specified|1|||
149980252|NCT02012218|541064214|FG001|Overall Study|Protocol Specified|0|||
149980253|NCT02012218|541064215|FG002|Overall Study|Protocol Specified|0|||
149980254|NCT02012218|541064216|FG003|Overall Study|Protocol Specified|0|||
149980255|NCT02012218|541064217|FG004|Overall Study|Protocol Specified|0|||
149980256|NCT02012218|541064213|FG000|Overall Study|Protocol Deviation|1|||
149980257|NCT02012218|541064214|FG001|Overall Study|Protocol Deviation|0|||
149980258|NCT02012218|541064215|FG002|Overall Study|Protocol Deviation|0|||
149980259|NCT02012218|541064216|FG003|Overall Study|Protocol Deviation|0|||
149980260|NCT02012218|541064217|FG004|Overall Study|Protocol Deviation|0|||
149980261|NCT03484429|541064218|FG000|Overall Study|Withdrawal by Subject|1|||
149980262|NCT03484429|541064219|FG001|Overall Study|Withdrawal by Subject|0|||
149980263|NCT03484429|541064218|FG000|Overall Study|Adverse Event|2|||
149980264|NCT03484429|541064219|FG001|Overall Study|Adverse Event|0|||
149980265|NCT01342926|541064220|FG000|Overall Study|Adverse Event|5|||
149980266|NCT01342926|541064221|FG001|Overall Study|Adverse Event|8|||
149980267|NCT01342926|541064222|FG002|Overall Study|Adverse Event|10|||
149980268|NCT01342926|541064223|FG003|Overall Study|Adverse Event|7|||
149980269|NCT01342926|541064220|FG000|Overall Study|Lost to Follow-up|0|||
149980270|NCT01342926|541064221|FG001|Overall Study|Lost to Follow-up|1|||
149980271|NCT01342926|541064222|FG002|Overall Study|Lost to Follow-up|1|||
149980272|NCT01342926|541064223|FG003|Overall Study|Lost to Follow-up|0|||
149980273|NCT01342926|541064220|FG000|Overall Study|Investigator Discretion|2|||
149980274|NCT01342926|541064221|FG001|Overall Study|Investigator Discretion|2|||
149980275|NCT01342926|541064222|FG002|Overall Study|Investigator Discretion|0|||
149980276|NCT01342926|541064223|FG003|Overall Study|Investigator Discretion|0|||
149980277|NCT01342926|541064220|FG000|Overall Study|Withdrawal by Subject|2|||
149980278|NCT01342926|541064221|FG001|Overall Study|Withdrawal by Subject|4|||
149980279|NCT01342926|541064222|FG002|Overall Study|Withdrawal by Subject|3|||
149980280|NCT01342926|541064223|FG003|Overall Study|Withdrawal by Subject|5|||
149980281|NCT03390504|541064226|FG000|Overall Study|Lost to Follow-up|2|||
149980282|NCT03390504|541064227|FG001|Overall Study|Lost to Follow-up|4|||
149980283|NCT03390504|541064228|FG002|Overall Study|Lost to Follow-up|0|||
149980284|NCT03390504|541064229|FG003|Overall Study|Lost to Follow-up|1|||
150053181|NCT01328444|541336617|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
150053182|NCT01328444|541336612|FG000|Washout Period (14 Days)|Adverse Event|1|||
150053183|NCT01328444|541336613|FG001|Washout Period (14 Days)|Adverse Event|1|||
150053184|NCT01328444|541336614|FG002|Washout Period (14 Days)|Adverse Event|0|||
150053185|NCT01328444|541336615|FG003|Washout Period (14 Days)|Adverse Event|1|||
150053186|NCT01328444|541336616|FG004|Washout Period (14 Days)|Adverse Event|1|||
150053187|NCT01328444|541336617|FG005|Washout Period (14 Days)|Adverse Event|2|||
149980285|NCT03390504|541064226|FG000|Overall Study|Withdrawal by Subject|3|||
149980286|NCT03390504|541064227|FG001|Overall Study|Withdrawal by Subject|15|||
149980287|NCT03390504|541064228|FG002|Overall Study|Withdrawal by Subject|5|||
149980288|NCT03390504|541064229|FG003|Overall Study|Withdrawal by Subject|2|||
149980289|NCT03390504|541064226|FG000|Overall Study|Other|1|||
149980290|NCT03390504|541064227|FG001|Overall Study|Other|2|||
149980291|NCT03390504|541064228|FG002|Overall Study|Other|2|||
149980292|NCT03390504|541064229|FG003|Overall Study|Other|6|||
149980293|NCT00980538|541064230|FG000|Overall Study|Lost to Follow-up|20|||
149980294|NCT00980538|541064230|FG000|Overall Study|Sponsor's Decision|4|||
149980295|NCT00980538|541064230|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
149980296|NCT00980538|541064230|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
149980297|NCT00980538|541064230|FG000|Overall Study|Switch to Commercially Available Medication|25|||
149980298|NCT00980538|541064230|FG000|Overall Study|Participant Non-Compliant|9|||
149980299|NCT00980538|541064230|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
149980300|NCT00980538|541064230|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
149980301|NCT00980538|541064230|FG000|Overall Study|Other|60|||
149980302|NCT00980538|541064230|FG000|Overall Study|Other|1|||
149980303|NCT04570384|541064231|FG000|Overall Study|Adverse Event|2|||
149980304|NCT04570384|541064232|FG001|Overall Study|Adverse Event|1|||
149980305|NCT04570384|541064231|FG000|Overall Study|Death|2|||
149980306|NCT04570384|541064232|FG001|Overall Study|Death|5|||
149980307|NCT04570384|541064231|FG000|Overall Study|Lost to Follow-up|1|||
149980308|NCT04570384|541064232|FG001|Overall Study|Lost to Follow-up|0|||
149980309|NCT04570384|541064231|FG000|Overall Study|Other|1|||
149980310|NCT04570384|541064232|FG001|Overall Study|Other|0|||
149980311|NCT04570384|541064231|FG000|Overall Study|Protocol Violation|0|||
149980312|NCT04570384|541064232|FG001|Overall Study|Protocol Violation|1|||
149980313|NCT04570384|541064231|FG000|Overall Study|Sponsor Decision|1|||
149980314|NCT04570384|541064232|FG001|Overall Study|Sponsor Decision|0|||
149980315|NCT04570384|541064231|FG000|Overall Study|Withdrawal by Subject|4|||
149980316|NCT04570384|541064232|FG001|Overall Study|Withdrawal by Subject|2|||
149980317|NCT00707993|541064233|FG000|Overall Study|Adverse Event|16|||
149980318|NCT00707993|541064234|FG001|Overall Study|Adverse Event|20|||
149980319|NCT00707993|541064233|FG000|Overall Study|Protocol Violation|4|||
149980320|NCT00707993|541064234|FG001|Overall Study|Protocol Violation|7|||
149980321|NCT00707993|541064233|FG000|Overall Study|Lost to Follow-up|0|||
149980322|NCT00707993|541064234|FG001|Overall Study|Lost to Follow-up|4|||
149980323|NCT00707993|541064233|FG000|Overall Study|Withdrawal by Subject|12|||
149980324|NCT00707993|541064234|FG001|Overall Study|Withdrawal by Subject|16|||
149980325|NCT00707993|541064233|FG000|Overall Study|Hyperglycemic Rescue|55|||
149980326|NCT00707993|541064234|FG001|Overall Study|Hyperglycemic Rescue|47|||
149980327|NCT00707993|541064233|FG000|Overall Study|Other|2|||
149980328|NCT00707993|541064234|FG001|Overall Study|Other|0|||
149980329|NCT03654274|541064235|FG000|Overall Study|Adverse Event|19|||
150053188|NCT01328444|541336612|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
149980330|NCT03654274|541064236|FG001|Overall Study|Adverse Event|23|||
149980331|NCT03654274|541064237|FG002|Overall Study|Adverse Event|24|||
149980332|NCT03654274|541064235|FG000|Overall Study|Protocol Deviation|0|||
149980333|NCT03654274|541064236|FG001|Overall Study|Protocol Deviation|2|||
149980334|NCT03654274|541064237|FG002|Overall Study|Protocol Deviation|0|||
149980335|NCT03654274|541064235|FG000|Overall Study|Lost to Follow-up|8|||
149980336|NCT03654274|541064236|FG001|Overall Study|Lost to Follow-up|6|||
149980337|NCT03654274|541064237|FG002|Overall Study|Lost to Follow-up|5|||
149980338|NCT03654274|541064235|FG000|Overall Study|Withdrawal by Subject|46|||
150053189|NCT01328444|541336613|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
150053190|NCT01328444|541336614|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
150053191|NCT01328444|541336615|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
150053192|NCT01328444|541336616|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
150053193|NCT01328444|541336617|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
150053194|NCT01328444|541336612|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
150053195|NCT01328444|541336613|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
150053196|NCT01328444|541336614|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
150053197|NCT01328444|541336615|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
150053198|NCT01328444|541336616|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
150053199|NCT01328444|541336617|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
150053200|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
150053201|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
150053202|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150053203|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150053204|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
150053205|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149980339|NCT03654274|541064236|FG001|Overall Study|Withdrawal by Subject|25|||
149980340|NCT03654274|541064237|FG002|Overall Study|Withdrawal by Subject|33|||
149980341|NCT03654274|541064235|FG000|Overall Study|Lack of Efficacy|4|||
149980342|NCT03654274|541064236|FG001|Overall Study|Lack of Efficacy|5|||
149980343|NCT03654274|541064237|FG002|Overall Study|Lack of Efficacy|7|||
149980344|NCT03654274|541064235|FG000|Overall Study|Pregnancy|2|||
149980345|NCT03654274|541064236|FG001|Overall Study|Pregnancy|2|||
149980346|NCT03654274|541064237|FG002|Overall Study|Pregnancy|1|||
149980347|NCT03654274|541064235|FG000|Overall Study|Other|27|||
149980348|NCT03654274|541064236|FG001|Overall Study|Other|29|||
149980349|NCT03654274|541064237|FG002|Overall Study|Other|32|||
149980350|NCT03654274|541064235|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
149980351|NCT03654274|541064236|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
149980352|NCT03654274|541064237|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
149980353|NCT01102491|541064240|FG000|Overall Study|Protocol Violation|11|||
149980354|NCT01102491|541064241|FG001|Overall Study|Protocol Violation|12|||
149980355|NCT01265992|541064242|FG000|Overall Study|Lost to Follow-up|1|||
149980356|NCT01265992|541064242|FG000|Overall Study|Withdrawal by Subject|1|||
149980357|NCT01265992|541064242|FG000|Overall Study|Adverse Event|1|||
149980358|NCT01265992|541064242|FG000|Overall Study|Administrative reasons|2|||
149980359|NCT01265992|541064242|FG000|Overall Study|Stopped treatment|3|||
149980360|NCT01265992|541064242|FG000|Overall Study|Did not receive treatment|1|||
149980361|NCT02454530|541064243|FG000|Overall Study|Other|8|||
149980362|NCT02454530|541064244|FG001|Overall Study|Other|13|||
149980363|NCT02454530|541064243|FG000|Overall Study|Missing information|56|||
149980364|NCT02454530|541064244|FG001|Overall Study|Missing information|69|||
149980365|NCT02454530|541064243|FG000|Overall Study|Death|2|||
149980366|NCT02454530|541064244|FG001|Overall Study|Death|41|||
149980367|NCT02454530|541064243|FG000|Overall Study|Lost to Follow-up|4|||
149980368|NCT02454530|541064244|FG001|Overall Study|Lost to Follow-up|4|||
149980369|NCT00326001|541064245|FG000|Overall Study|Adverse Event|4|||
149980370|NCT00326001|541064246|FG001|Overall Study|Adverse Event|5|||
149980371|NCT00326001|541064245|FG000|Overall Study|Physician Decision|3|||
149980372|NCT00326001|541064246|FG001|Overall Study|Physician Decision|3|||
149980373|NCT03265145|541064247|FG000|Overall Study|Protocol Violation|2|||
149980374|NCT03265145|541064248|FG001|Overall Study|Protocol Violation|0|||
149980375|NCT03265145|541064247|FG000|Overall Study|Adverse Event|1|||
149980376|NCT03265145|541064248|FG001|Overall Study|Adverse Event|0|||
149980377|NCT03265145|541064247|FG000|Overall Study|Withdrawal by Subject|23|||
149980378|NCT03265145|541064248|FG001|Overall Study|Withdrawal by Subject|19|||
149980379|NCT03265145|541064247|FG000|Overall Study|Death|12|||
149980380|NCT03265145|541064248|FG001|Overall Study|Death|12|||
149980381|NCT03265145|541064247|FG000|Overall Study|Lost to Follow-up|13|||
149980382|NCT03265145|541064248|FG001|Overall Study|Lost to Follow-up|9|||
149980383|NCT03265145|541064247|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
149980384|NCT03265145|541064248|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
149980385|NCT03265145|541064247|FG000|Overall Study|Switched back to previous medication|1|||
149980386|NCT03265145|541064248|FG001|Overall Study|Switched back to previous medication|0|||
149980387|NCT03265145|541064247|FG000|Overall Study|Did not want to take medication|1|||
149980388|NCT03265145|541064248|FG001|Overall Study|Did not want to take medication|0|||
149980389|NCT03265145|541064247|FG000|Overall Study|Subject could not afford medication|0|||
150053206|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
149980390|NCT03265145|541064248|FG001|Overall Study|Subject could not afford medication|1|||
150053207|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149980391|NCT03265145|541064247|FG000|Overall Study|Site closed|2|||
149980392|NCT03265145|541064248|FG001|Overall Study|Site closed|3|||
149980393|NCT03265145|541064247|FG000|Overall Study|Incorrectly randomized|16|||
149980394|NCT03265145|541064248|FG001|Overall Study|Incorrectly randomized|6|||
149980395|NCT03265145|541064247|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
149980396|NCT03265145|541064248|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
149980397|NCT03265145|541064247|FG000|Overall Study|Physician Decision|0|||
149980398|NCT03265145|541064248|FG001|Overall Study|Physician Decision|3|||
149980399|NCT03265145|541064247|FG000|Overall Study|Subject transferred to another facility|0|||
149980400|NCT03265145|541064248|FG001|Overall Study|Subject transferred to another facility|1|||
149980401|NCT05005273|541064249|FG000|Overall Study|Study Terminated|1|||
149980402|NCT05005273|541064250|FG001|Overall Study|Study Terminated|0|||
149980403|NCT04409834|541064251|FG000|Overall Study|Death|55|||
149980404|NCT04409834|541064252|FG001|Overall Study|Death|62|||
149980405|NCT02137070|541064253|FG000|Overall Study|Adverse Event|12|||
149980406|NCT02137070|541064254|FG001|Overall Study|Adverse Event|3|||
149980407|NCT02137070|541064253|FG000|Overall Study|Death|2|||
149980408|NCT02137070|541064254|FG001|Overall Study|Death|0|||
149980409|NCT02137070|541064253|FG000|Overall Study|Lost to Follow-up|24|||
149980410|NCT02137070|541064254|FG001|Overall Study|Lost to Follow-up|9|||
149980411|NCT02137070|541064253|FG000|Overall Study|Physician Decision|0|||
149980412|NCT02137070|541064254|FG001|Overall Study|Physician Decision|1|||
149980413|NCT02137070|541064253|FG000|Overall Study|Protocol Violation|18|||
149980414|NCT02137070|541064254|FG001|Overall Study|Protocol Violation|4|||
149980415|NCT02137070|541064253|FG000|Overall Study|Withdrawal by Subject|18|||
149980416|NCT02137070|541064254|FG001|Overall Study|Withdrawal by Subject|1|||
149980417|NCT02151786|541064255|FG000|Overall Study|Unavailability of Case Report Form|26|||
149980418|NCT02151786|541064255|FG000|Overall Study|Outside the Contract Period|1|||
149980419|NCT02151786|541064255|FG000|Overall Study|Randomized, not Treated|1|||
149980420|NCT02151786|541064255|FG000|Overall Study|Unavailability of Information|8|||
149980421|NCT02112656|541064259|FG000|Overall Study|Death|78|||
149980422|NCT02112656|541064260|FG001|Overall Study|Death|82|||
149980423|NCT02112656|541064259|FG000|Overall Study|Withdrawal by Subject|9|||
149980424|NCT02112656|541064260|FG001|Overall Study|Withdrawal by Subject|11|||
149980425|NCT02112656|541064259|FG000|Overall Study|Lost to Follow-up|2|||
149980426|NCT02112656|541064260|FG001|Overall Study|Lost to Follow-up|4|||
149980427|NCT02112656|541064259|FG000|Overall Study|Noncompliance|1|||
149980428|NCT02112656|541064260|FG001|Overall Study|Noncompliance|2|||
149980429|NCT03941483|541064261|FG000|Overall Study|Miscellaneous|2|||
149980430|NCT03941483|541064262|FG001|Overall Study|Miscellaneous|3|||
149980431|NCT03941483|541064263|FG002|Overall Study|Miscellaneous|0|||
149980432|NCT03941483|541064261|FG000|Overall Study|Study Terminated by Sponsor|1|||
149980433|NCT03941483|541064262|FG001|Overall Study|Study Terminated by Sponsor|0|||
149980434|NCT03941483|541064263|FG002|Overall Study|Study Terminated by Sponsor|0|||
149980435|NCT03941483|541064261|FG000|Overall Study|Withdrawal by Subject|1|||
149980436|NCT03941483|541064262|FG001|Overall Study|Withdrawal by Subject|4|||
149980437|NCT03941483|541064263|FG002|Overall Study|Withdrawal by Subject|1|||
149980438|NCT03941483|541064261|FG000|Overall Study|Lost to Follow-up|2|||
149980439|NCT03941483|541064262|FG001|Overall Study|Lost to Follow-up|1|||
149980440|NCT03941483|541064263|FG002|Overall Study|Lost to Follow-up|8|||
149980441|NCT03941483|541064261|FG000|Overall Study|Death|3|||
149980442|NCT03941483|541064262|FG001|Overall Study|Death|2|||
149980443|NCT03941483|541064263|FG002|Overall Study|Death|6|||
149980444|NCT04749745|541064264|FG000|Overall Study|Withdrawal by Subject|1|||
149980445|NCT04749745|541064265|FG001|Overall Study|Withdrawal by Subject|0|||
149980446|NCT01365455|541064273|FG000|Induction Period|Adverse Event|5|||
150053208|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
150053209|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
150053210|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
150178636|NCT00761605|541791992|FG000|Overall Study|Withdrawal by Subject|37|||
150178637|NCT00761605|541791992|FG000|Overall Study|Other|21|||
150178638|NCT00785512|541791993|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
149980447|NCT01365455|541064274|FG001|Induction Period|Adverse Event|3|||
149980448|NCT01365455|541064275|FG002|Induction Period|Adverse Event|4|||
149980449|NCT01365455|541064276|FG003|Induction Period|Adverse Event|0|||
149980450|NCT01365455|541064277|FG004|Induction Period|Adverse Event|0|||
149980451|NCT01365455|541064273|FG000|Induction Period|Lack of Efficacy|1|||
149980452|NCT01365455|541064274|FG001|Induction Period|Lack of Efficacy|1|||
149980453|NCT01365455|541064275|FG002|Induction Period|Lack of Efficacy|0|||
149980454|NCT01365455|541064276|FG003|Induction Period|Lack of Efficacy|0|||
149980455|NCT01365455|541064277|FG004|Induction Period|Lack of Efficacy|0|||
149980456|NCT01365455|541064273|FG000|Induction Period|Pregnancy|0|||
149980457|NCT01365455|541064274|FG001|Induction Period|Pregnancy|1|||
149980458|NCT01365455|541064275|FG002|Induction Period|Pregnancy|0|||
150178639|NCT00785512|541791994|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
149980459|NCT01365455|541064276|FG003|Induction Period|Pregnancy|0|||
149980460|NCT01365455|541064277|FG004|Induction Period|Pregnancy|0|||
149980461|NCT01365455|541064273|FG000|Induction Period|Protocol deviation|0|||
149980462|NCT01365455|541064274|FG001|Induction Period|Protocol deviation|1|||
149980463|NCT01365455|541064275|FG002|Induction Period|Protocol deviation|1|||
149980464|NCT01365455|541064276|FG003|Induction Period|Protocol deviation|0|||
149980465|NCT01365455|541064277|FG004|Induction Period|Protocol deviation|0|||
149980466|NCT01365455|541064273|FG000|Induction Period|Subject/guardian decision|9|||
149980467|NCT01365455|541064274|FG001|Induction Period|Subject/guardian decision|1|||
149980468|NCT01365455|541064275|FG002|Induction Period|Subject/guardian decision|8|||
149980469|NCT01365455|541064276|FG003|Induction Period|Subject/guardian decision|0|||
149980470|NCT01365455|541064277|FG004|Induction Period|Subject/guardian decision|0|||
149980471|NCT01365455|541064273|FG000|Induction Period|Lost to Follow-up|0|||
149980472|NCT01365455|541064274|FG001|Induction Period|Lost to Follow-up|0|||
149980473|NCT01365455|541064275|FG002|Induction Period|Lost to Follow-up|3|||
149980474|NCT01365455|541064276|FG003|Induction Period|Lost to Follow-up|0|||
149980475|NCT01365455|541064277|FG004|Induction Period|Lost to Follow-up|0|||
149980476|NCT01365455|541064273|FG000|Maintenance Period|Adverse Event|12|||
149980477|NCT01365455|541064274|FG001|Maintenance Period|Adverse Event|5|||
149980478|NCT01365455|541064275|FG002|Maintenance Period|Adverse Event|1|||
149980479|NCT01365455|541064276|FG003|Maintenance Period|Adverse Event|2|||
149980480|NCT01365455|541064277|FG004|Maintenance Period|Adverse Event|4|||
149980481|NCT01365455|541064273|FG000|Maintenance Period|Lack of Efficacy|10|||
149980482|NCT01365455|541064274|FG001|Maintenance Period|Lack of Efficacy|2|||
149980483|NCT01365455|541064275|FG002|Maintenance Period|Lack of Efficacy|0|||
149980484|NCT01365455|541064276|FG003|Maintenance Period|Lack of Efficacy|2|||
149980485|NCT01365455|541064277|FG004|Maintenance Period|Lack of Efficacy|2|||
149980486|NCT01365455|541064273|FG000|Maintenance Period|Lost to Follow-up|2|||
149980487|NCT01365455|541064274|FG001|Maintenance Period|Lost to Follow-up|4|||
149980488|NCT01365455|541064275|FG002|Maintenance Period|Lost to Follow-up|0|||
149980489|NCT01365455|541064276|FG003|Maintenance Period|Lost to Follow-up|0|||
149980490|NCT01365455|541064277|FG004|Maintenance Period|Lost to Follow-up|3|||
149980491|NCT01365455|541064273|FG000|Maintenance Period|Non-compliance with study treatment|0|||
149980492|NCT01365455|541064274|FG001|Maintenance Period|Non-compliance with study treatment|0|||
149980493|NCT01365455|541064275|FG002|Maintenance Period|Non-compliance with study treatment|0|||
149980494|NCT01365455|541064276|FG003|Maintenance Period|Non-compliance with study treatment|1|||
149980495|NCT01365455|541064277|FG004|Maintenance Period|Non-compliance with study treatment|0|||
149980496|NCT01365455|541064273|FG000|Maintenance Period|Physician Decision|0|||
149980497|NCT01365455|541064274|FG001|Maintenance Period|Physician Decision|1|||
149980498|NCT01365455|541064275|FG002|Maintenance Period|Physician Decision|0|||
149980499|NCT01365455|541064276|FG003|Maintenance Period|Physician Decision|0|||
149980500|NCT01365455|541064277|FG004|Maintenance Period|Physician Decision|1|||
149980501|NCT01365455|541064273|FG000|Maintenance Period|Pregnancy|0|||
149980502|NCT01365455|541064274|FG001|Maintenance Period|Pregnancy|4|||
149980503|NCT01365455|541064275|FG002|Maintenance Period|Pregnancy|0|||
149980504|NCT01365455|541064276|FG003|Maintenance Period|Pregnancy|0|||
149980505|NCT01365455|541064277|FG004|Maintenance Period|Pregnancy|2|||
149980506|NCT01365455|541064273|FG000|Maintenance Period|Protocol deviation|1|||
149980507|NCT01365455|541064274|FG001|Maintenance Period|Protocol deviation|1|||
149980508|NCT01365455|541064275|FG002|Maintenance Period|Protocol deviation|0|||
149980509|NCT01365455|541064276|FG003|Maintenance Period|Protocol deviation|0|||
149980510|NCT01365455|541064277|FG004|Maintenance Period|Protocol deviation|0|||
149980511|NCT01365455|541064273|FG000|Maintenance Period|Subject/guardian decision|4|||
149980512|NCT01365455|541064274|FG001|Maintenance Period|Subject/guardian decision|6|||
149980513|NCT01365455|541064275|FG002|Maintenance Period|Subject/guardian decision|2|||
149980514|NCT01365455|541064276|FG003|Maintenance Period|Subject/guardian decision|4|||
149980515|NCT01365455|541064277|FG004|Maintenance Period|Subject/guardian decision|1|||
149980516|NCT03965403|541064279|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
149980517|NCT03154476|541064282|FG000|Overall Study|Lost to Follow-up|4|||
149980518|NCT03154476|541064283|FG001|Overall Study|Lost to Follow-up|4|||
149980519|NCT02685826|541064284|FG000|Overall Study|Adverse Event|2|||
149980520|NCT02685826|541064285|FG001|Overall Study|Adverse Event|0|||
149980521|NCT02685826|541064286|FG002|Overall Study|Adverse Event|1|||
149980522|NCT02685826|541064284|FG000|Overall Study|Progressive Disease|2|||
149980523|NCT02685826|541064285|FG001|Overall Study|Progressive Disease|1|||
149980524|NCT02685826|541064286|FG002|Overall Study|Progressive Disease|0|||
149980525|NCT02685826|541064284|FG000|Overall Study|Withdrawal by Subject|2|||
149980526|NCT02685826|541064285|FG001|Overall Study|Withdrawal by Subject|0|||
150178640|NCT00785512|541791993|FG000|Overall Study|Adverse Event|0|||
149980527|NCT02685826|541064286|FG002|Overall Study|Withdrawal by Subject|0|||
149980528|NCT02685826|541064284|FG000|Overall Study|Full Clinical Hold by FDA|19|||
149980529|NCT02685826|541064285|FG001|Overall Study|Full Clinical Hold by FDA|9|||
150178641|NCT00785512|541791994|FG001|Overall Study|Adverse Event|0|||
150178642|NCT00785512|541791993|FG000|Overall Study|Lack of Efficacy|0|||
149980530|NCT02685826|541064286|FG002|Overall Study|Full Clinical Hold by FDA|20|||
149980531|NCT01444430|541064287|FG000|Overall Study|Withdrawal by Subject|53|||
149980532|NCT01444430|541064288|FG001|Overall Study|Withdrawal by Subject|72|||
149980533|NCT01444430|541064287|FG000|Overall Study|Death|6|||
149980534|NCT01444430|541064288|FG001|Overall Study|Death|8|||
149980535|NCT01444430|541064287|FG000|Overall Study|Lost to Follow-up|2|||
149980536|NCT01444430|541064288|FG001|Overall Study|Lost to Follow-up|0|||
149980537|NCT01444430|541064287|FG000|Overall Study|CRF termination module not completed.|0|||
149980538|NCT01444430|541064288|FG001|Overall Study|CRF termination module not completed.|1|||
149980539|NCT03816176|541064289|FG000|Overall Study|Miscellaneous|5|||
149980540|NCT03816176|541064289|FG000|Overall Study|Lack of Efficacy|4|||
149980541|NCT03816176|541064289|FG000|Overall Study|Adverse Event|3|||
149980542|NCT00972023|541065437|FG000|Overall Study|Withdrawal by Subject|1|||
149980543|NCT02595879|541065439|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
149980544|NCT02595879|541065440|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
149980545|NCT01147965|541065441|FG000|Overall Study|Progressive Disease|3|||
149980546|NCT01147965|541065442|FG001|Overall Study|Progressive Disease|3|||
149980547|NCT01147965|541065443|FG002|Overall Study|Progressive Disease|5|||
149980548|NCT01147965|541065444|FG003|Overall Study|Progressive Disease|9|||
149980549|NCT01147965|541065445|FG004|Overall Study|Progressive Disease|5|||
149980550|NCT01147965|541065446|FG005|Overall Study|Progressive Disease|5|||
149980551|NCT01147965|541065441|FG000|Overall Study|Death|0|||
149980552|NCT01147965|541065442|FG001|Overall Study|Death|0|||
149980553|NCT01147965|541065443|FG002|Overall Study|Death|1|||
149980554|NCT01147965|541065444|FG003|Overall Study|Death|1|||
149980555|NCT01147965|541065445|FG004|Overall Study|Death|0|||
149980556|NCT01147965|541065446|FG005|Overall Study|Death|2|||
149980557|NCT01147965|541065441|FG000|Overall Study|Withdrawal by Subject|0|||
149980558|NCT01147965|541065442|FG001|Overall Study|Withdrawal by Subject|0|||
149980559|NCT01147965|541065443|FG002|Overall Study|Withdrawal by Subject|1|||
149980560|NCT01147965|541065444|FG003|Overall Study|Withdrawal by Subject|1|||
149980561|NCT01147965|541065445|FG004|Overall Study|Withdrawal by Subject|0|||
149980562|NCT01147965|541065446|FG005|Overall Study|Withdrawal by Subject|0|||
149980563|NCT01147965|541065441|FG000|Overall Study|Administration Of Alternative Therapy|0|||
149980564|NCT01147965|541065442|FG001|Overall Study|Administration Of Alternative Therapy|0|||
149980565|NCT01147965|541065443|FG002|Overall Study|Administration Of Alternative Therapy|0|||
149980566|NCT01147965|541065444|FG003|Overall Study|Administration Of Alternative Therapy|0|||
149980567|NCT01147965|541065445|FG004|Overall Study|Administration Of Alternative Therapy|0|||
149980568|NCT01147965|541065446|FG005|Overall Study|Administration Of Alternative Therapy|1|||
149980569|NCT01147965|541065441|FG000|Overall Study|Other|0|||
149980570|NCT01147965|541065442|FG001|Overall Study|Other|0|||
149980571|NCT01147965|541065443|FG002|Overall Study|Other|0|||
149980572|NCT01147965|541065444|FG003|Overall Study|Other|3|||
149980573|NCT01147965|541065445|FG004|Overall Study|Other|1|||
149980574|NCT01147965|541065446|FG005|Overall Study|Other|0|||
149980575|NCT01650831|541065447|FG000|Overall Study|Screen failure|1|||
149980576|NCT04988295|541065448|FG000|Overall Study|Withdrawal by Subject|9|||
149980577|NCT04988295|541065449|FG001|Overall Study|Withdrawal by Subject|29|||
149980578|NCT04988295|541065450|FG002|Overall Study|Withdrawal by Subject|6|||
149980579|NCT04988295|541065451|FG003|Overall Study|Withdrawal by Subject|0|||
149980580|NCT04988295|541065448|FG000|Overall Study|Lost to Follow-up|1|||
149980581|NCT04988295|541065449|FG001|Overall Study|Lost to Follow-up|0|||
149980582|NCT04988295|541065450|FG002|Overall Study|Lost to Follow-up|0|||
149980583|NCT04988295|541065451|FG003|Overall Study|Lost to Follow-up|0|||
149980584|NCT04988295|541065448|FG000|Overall Study|Study participation ongoing|186|||
149980585|NCT04988295|541065449|FG001|Overall Study|Study participation ongoing|169|||
149980586|NCT04988295|541065450|FG002|Overall Study|Study participation ongoing|99|||
149980587|NCT04988295|541065451|FG003|Overall Study|Study participation ongoing|119|||
149980588|NCT01465386|541065456|FG000|Overall Study|Lack of Efficacy|3|||
149980589|NCT01465386|541065456|FG000|Overall Study|Adverse Event|1|||
149980590|NCT02479880|541065459|FG000|Overall Study|Study Terminated by Sponsor|13|||
149980591|NCT02479880|541065460|FG001|Overall Study|Study Terminated by Sponsor|12|||
149980592|NCT02479880|541065459|FG000|Overall Study|Pregnancy|0|||
149980593|NCT02479880|541065460|FG001|Overall Study|Pregnancy|1|||
149980594|NCT00355368|541065461|FG000|Overall Study|Protocol Violation|8|||
149980595|NCT00355368|541065462|FG001|Overall Study|Protocol Violation|7|||
149980596|NCT00355368|541065461|FG000|Overall Study|cardiac arrest prior to intubation|2|||
149980597|NCT00355368|541065462|FG001|Overall Study|cardiac arrest prior to intubation|2|||
149980598|NCT01279044|541065463|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
149980599|NCT01279044|541065464|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
149980600|NCT01279044|541065465|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
149980601|NCT01279044|541065463|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
149980602|NCT01279044|541065464|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
149980603|NCT01279044|541065465|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
149980604|NCT01279044|541065463|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
149980605|NCT01279044|541065464|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
149980606|NCT01279044|541065465|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
149980607|NCT01408277|541065466|FG000|Overall Study|Adverse Event|3|||
149980608|NCT01408277|541065467|FG001|Overall Study|Adverse Event|4|||
149980609|NCT01408277|541065466|FG000|Overall Study|Lost to Follow-up|1|||
149980610|NCT01408277|541065467|FG001|Overall Study|Lost to Follow-up|0|||
149980611|NCT01408277|541065466|FG000|Overall Study|Withdrawal by Subject|2|||
149980612|NCT01408277|541065467|FG001|Overall Study|Withdrawal by Subject|0|||
149980613|NCT01408277|541065466|FG000|Overall Study|Protocol Violation|2|||
149980614|NCT01408277|541065467|FG001|Overall Study|Protocol Violation|0|||
149980615|NCT02840253|541065468|FG000|Overall Study|Unsuccessful block|4|||
149980616|NCT03801928|541065471|FG000|Overall Study|Adverse Event|1|||
149980617|NCT03801928|541065472|FG001|Overall Study|Adverse Event|0|||
149980618|NCT03801928|541065473|FG002|Overall Study|Adverse Event|1|||
149980619|NCT03801928|541065474|FG003|Overall Study|Adverse Event|2|||
149980620|NCT03801928|541065475|FG004|Overall Study|Adverse Event|0|||
149980621|NCT03801928|541065476|FG005|Overall Study|Adverse Event|2|||
149980622|NCT03801928|541065471|FG000|Overall Study|Lack of Efficacy|0|||
149980623|NCT03801928|541065472|FG001|Overall Study|Lack of Efficacy|0|||
149980624|NCT03801928|541065473|FG002|Overall Study|Lack of Efficacy|1|||
149980625|NCT03801928|541065474|FG003|Overall Study|Lack of Efficacy|0|||
149980626|NCT03801928|541065475|FG004|Overall Study|Lack of Efficacy|0|||
149980627|NCT03801928|541065476|FG005|Overall Study|Lack of Efficacy|0|||
149980628|NCT03801928|541065471|FG000|Overall Study|Lost to Follow-up|5|||
149980629|NCT03801928|541065472|FG001|Overall Study|Lost to Follow-up|1|||
150053211|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
150053212|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
150053213|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
149980630|NCT03801928|541065473|FG002|Overall Study|Lost to Follow-up|1|||
149980631|NCT03801928|541065474|FG003|Overall Study|Lost to Follow-up|4|||
149980632|NCT03801928|541065475|FG004|Overall Study|Lost to Follow-up|4|||
149980633|NCT03801928|541065476|FG005|Overall Study|Lost to Follow-up|2|||
149980634|NCT03801928|541065471|FG000|Overall Study|Withdrawal by Subject|0|||
149980635|NCT03801928|541065472|FG001|Overall Study|Withdrawal by Subject|0|||
149980636|NCT03801928|541065473|FG002|Overall Study|Withdrawal by Subject|2|||
149980637|NCT03801928|541065474|FG003|Overall Study|Withdrawal by Subject|1|||
149980638|NCT03801928|541065475|FG004|Overall Study|Withdrawal by Subject|0|||
149980639|NCT03801928|541065476|FG005|Overall Study|Withdrawal by Subject|0|||
149980640|NCT03801928|541065471|FG000|Overall Study|Other|0|||
149980641|NCT03801928|541065472|FG001|Overall Study|Other|2|||
149980642|NCT03801928|541065473|FG002|Overall Study|Other|0|||
149980643|NCT03801928|541065474|FG003|Overall Study|Other|1|||
149980644|NCT03801928|541065475|FG004|Overall Study|Other|0|||
149980645|NCT03801928|541065476|FG005|Overall Study|Other|1|||
149980646|NCT02763059|541065479|FG000|Overall Study|Lost to Follow-up|4|||
149980647|NCT02763059|541065480|FG001|Overall Study|Lost to Follow-up|1|||
149980648|NCT02763059|541065481|FG002|Overall Study|Lost to Follow-up|6|||
149980649|NCT02763059|541065479|FG000|Overall Study|Withdrawal by Subject|1|||
149980650|NCT02763059|541065480|FG001|Overall Study|Withdrawal by Subject|0|||
149980651|NCT02763059|541065481|FG002|Overall Study|Withdrawal by Subject|3|||
149980652|NCT02370368|541065482|FG000|Overall Study|Adverse Event|1|||
149980653|NCT02370368|541065483|FG001|Overall Study|Adverse Event|2|||
149980654|NCT02370368|541065482|FG000|Overall Study|Withdrawal by Subject|5|||
149980655|NCT02370368|541065483|FG001|Overall Study|Withdrawal by Subject|4|||
149980656|NCT03369665|541065484|FG000|Overall Study|Adverse Event|3|||
149980657|NCT03369665|541065484|FG000|Overall Study|Lost to Follow-up|7|||
149980658|NCT03369665|541065484|FG000|Overall Study|Withdrawal by Subject|15|||
149980659|NCT03369665|541065484|FG000|Overall Study|Progression Disease|2|||
149980660|NCT03369665|541065484|FG000|Overall Study|Not classified|3|||
149980661|NCT04908683|541065485|FG000|Overall Study|Failure to meet continuation criteria|34|||
149980662|NCT04908683|541065486|FG001|Overall Study|Failure to meet continuation criteria|22|||
149980663|NCT04908683|541065485|FG000|Overall Study|Initiated prohibited medication|3|||
149980664|NCT04908683|541065486|FG001|Overall Study|Initiated prohibited medication|0|||
149980665|NCT04908683|541065485|FG000|Overall Study|Randomized by mistake|1|||
149980666|NCT04908683|541065486|FG001|Overall Study|Randomized by mistake|0|||
149980667|NCT04908683|541065485|FG000|Overall Study|Lost to Follow-up|679|||
149980668|NCT04908683|541065486|FG001|Overall Study|Lost to Follow-up|341|||
149980669|NCT04908683|541065485|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
149980670|NCT04908683|541065486|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
149980671|NCT04908683|541065485|FG000|Overall Study|Physician Decision|44|||
149980672|NCT04908683|541065486|FG001|Overall Study|Physician Decision|35|||
149980673|NCT04908683|541065485|FG000|Overall Study|Technical problems|12|||
150053214|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
150053215|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
150053216|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
150053217|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
150053218|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
150053219|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
150053220|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
150053221|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
150053222|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
150053223|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
150053224|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150053225|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
150053226|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
150053227|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
150053228|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
150053229|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
150053230|NCT01328444|541336612|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150053231|NCT01328444|541336613|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150053232|NCT01328444|541336614|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150178643|NCT00785512|541791994|FG001|Overall Study|Lack of Efficacy|2|||
150178644|NCT00785512|541791993|FG000|Overall Study|Withdrawal by Subject|0|||
150178645|NCT00785512|541791994|FG001|Overall Study|Withdrawal by Subject|1|||
150178646|NCT00785512|541791993|FG000|Overall Study|Lost to Follow-up|3|||
150178647|NCT00785512|541791994|FG001|Overall Study|Lost to Follow-up|0|||
150178648|NCT00785512|541791993|FG000|Overall Study|Precedure Refused|0|||
150178649|NCT00785512|541791994|FG001|Overall Study|Precedure Refused|0|||
149980674|NCT04908683|541065486|FG001|Overall Study|Technical problems|9|||
149980675|NCT04908683|541065485|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
149980676|NCT04908683|541065486|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
149980677|NCT04908683|541065485|FG000|Overall Study|Protocol Violation|2|||
149980678|NCT04908683|541065486|FG001|Overall Study|Protocol Violation|0|||
149980679|NCT04908683|541065485|FG000|Overall Study|Withdrawal by Subject|1188|||
149980680|NCT04908683|541065486|FG001|Overall Study|Withdrawal by Subject|570|||
149980681|NCT04908683|541065485|FG000|Overall Study|Site Closure by Sponsor|6|||
149980682|NCT04908683|541065486|FG001|Overall Study|Site Closure by Sponsor|3|||
149980683|NCT04908683|541065485|FG000|Overall Study|Adverse Event|21|||
149980684|NCT04908683|541065486|FG001|Overall Study|Adverse Event|11|||
149980685|NCT04908683|541065485|FG000|Overall Study|Death|101|||
149980686|NCT04908683|541065486|FG001|Overall Study|Death|61|||
149980687|NCT04908683|541065485|FG000|Overall Study|Sponsor's decision|14398|||
149980688|NCT04908683|541065486|FG001|Overall Study|Sponsor's decision|7205|||
149980689|NCT04908683|541065485|FG000|Overall Study|Other|92|||
149980690|NCT04908683|541065486|FG001|Overall Study|Other|50|||
149980691|NCT04908683|541065485|FG000|Overall Study|Randomized not vaccinated|108|||
149980692|NCT04908683|541065486|FG001|Overall Study|Randomized not vaccinated|52|||
149980693|NCT03901963|541065487|FG000|Overall Study|Lost to Follow-up|1|||
149980694|NCT03901963|541065488|FG001|Overall Study|Lost to Follow-up|1|||
149980695|NCT03901963|541065487|FG000|Overall Study|Physician Decision|1|||
149980696|NCT03901963|541065488|FG001|Overall Study|Physician Decision|2|||
149980697|NCT03901963|541065487|FG000|Overall Study|Protocol Violation|1|||
149980698|NCT03901963|541065488|FG001|Overall Study|Protocol Violation|1|||
149980699|NCT03901963|541065487|FG000|Overall Study|Withdrawal by Subject|4|||
149980700|NCT03901963|541065488|FG001|Overall Study|Withdrawal by Subject|11|||
150053233|NCT01328444|541336615|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150053234|NCT01328444|541336616|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150053235|NCT01328444|541336617|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
150053236|NCT03531632|541336618|FG000|Overall Study|Adverse Event|0|||
150053237|NCT03531632|541336619|FG001|Overall Study|Adverse Event|0|||
150053238|NCT03531632|541336620|FG002|Overall Study|Adverse Event|1|||
150053239|NCT03531632|541336618|FG000|Overall Study|Death|4|||
150053240|NCT03531632|541336619|FG001|Overall Study|Death|0|||
150053241|NCT03531632|541336620|FG002|Overall Study|Death|14|||
150053242|NCT03531632|541336618|FG000|Overall Study|Study Terminated|1|||
150053243|NCT03531632|541336619|FG001|Overall Study|Study Terminated|3|||
150053244|NCT03531632|541336620|FG002|Overall Study|Study Terminated|11|||
150053245|NCT02743611|541336621|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
150053246|NCT02743611|541336622|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
150053247|NCT02743611|541336623|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
150053248|NCT02743611|541336624|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
150053249|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
150053250|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
150053251|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
150053252|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
150053253|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
150053254|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
150053255|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150053256|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
150053257|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
150053258|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150053259|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150053260|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150053261|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
150053262|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
150053263|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
150053264|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
150053265|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
149980701|NCT03901963|541065487|FG000|Overall Study|Ongoing|84|||
149980702|NCT03901963|541065488|FG001|Overall Study|Ongoing|73|||
149980703|NCT03901963|541065487|FG000|Overall Study|Randomized but not treated|3|||
149980704|NCT03901963|541065488|FG001|Overall Study|Randomized but not treated|3|||
149980705|NCT05226598|541065494|FG000|Overall Study|Death|186|||
149980706|NCT05226598|541065495|FG001|Overall Study|Death|191|||
149980707|NCT05226598|541065494|FG000|Overall Study|Withdrawal by Subject|6|||
149980708|NCT05226598|541065495|FG001|Overall Study|Withdrawal by Subject|6|||
149980709|NCT05226598|541065494|FG000|Overall Study|Ongoing|174|||
149980710|NCT05226598|541065495|FG001|Overall Study|Ongoing|176|||
149980711|NCT02959463|541065496|FG000|Overall Study|Adverse Event|1|||
149980712|NCT02959463|541065497|FG001|Overall Study|Adverse Event|1|||
149980713|NCT02959463|541065496|FG000|Overall Study|Death|1|||
149980714|NCT02959463|541065497|FG001|Overall Study|Death|0|||
149980715|NCT02959463|541065496|FG000|Overall Study|Withdrawal by Subject|1|||
149980716|NCT02959463|541065497|FG001|Overall Study|Withdrawal by Subject|0|||
149980717|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
149980718|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
149980719|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
149980720|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
149980721|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
149980722|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
149980723|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
149980724|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
149980725|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
149980726|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
149980727|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
149980728|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
149980729|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
149980730|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
149980731|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
150053266|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
150053267|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
150053268|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
150053269|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
150053270|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
149980732|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
150053271|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
150053272|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
150053273|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
150053274|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
150053275|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
150053276|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
150053277|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
150053278|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
150053279|NCT00600119|541336625|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
150053280|NCT00600119|541336626|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
150053281|NCT00600119|541336627|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
150053282|NCT00600119|541336628|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
150053283|NCT00600119|541336629|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
150053284|NCT00600119|541336630|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
150053285|NCT00600119|541336625|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
150053286|NCT00600119|541336626|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
150053287|NCT00600119|541336627|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
150053288|NCT00600119|541336628|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
150053289|NCT00600119|541336629|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
150053290|NCT00600119|541336630|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
150053291|NCT00600119|541336625|FG000|Double-blind Treatment Period|Other|0|||
150053292|NCT00600119|541336626|FG001|Double-blind Treatment Period|Other|0|||
150053293|NCT00600119|541336627|FG002|Double-blind Treatment Period|Other|0|||
150053294|NCT00600119|541336628|FG003|Double-blind Treatment Period|Other|0|||
150053295|NCT00600119|541336629|FG004|Double-blind Treatment Period|Other|2|||
150053296|NCT00600119|541336630|FG005|Double-blind Treatment Period|Other|1|||
150053297|NCT00600119|541336625|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
150053298|NCT00600119|541336626|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
150053299|NCT00600119|541336627|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
150053300|NCT00600119|541336628|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
150053301|NCT00600119|541336629|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
150053302|NCT00600119|541336630|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
150053303|NCT00600119|541336625|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
150053304|NCT00600119|541336626|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
150053305|NCT00600119|541336627|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
150053306|NCT00600119|541336628|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
150053307|NCT00600119|541336629|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
150053308|NCT00600119|541336630|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
150053309|NCT00600119|541336625|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
150053310|NCT00600119|541336626|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
150053311|NCT00600119|541336627|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
150053312|NCT00600119|541336628|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
150053313|NCT00600119|541336629|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
150053314|NCT00600119|541336630|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
150053315|NCT00600119|541336625|FG000|Double-blind Treatment Period|Physician Decision|2|||
150053316|NCT00600119|541336626|FG001|Double-blind Treatment Period|Physician Decision|0|||
150053317|NCT00600119|541336627|FG002|Double-blind Treatment Period|Physician Decision|0|||
150053318|NCT00600119|541336628|FG003|Double-blind Treatment Period|Physician Decision|0|||
150053319|NCT00600119|541336629|FG004|Double-blind Treatment Period|Physician Decision|0|||
150053320|NCT00600119|541336630|FG005|Double-blind Treatment Period|Physician Decision|0|||
150053321|NCT00600119|541336625|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
150178650|NCT00785512|541791993|FG000|Overall Study|IVRS Programing Error|0|||
150178651|NCT00785512|541791994|FG001|Overall Study|IVRS Programing Error|0|||
149980733|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
149980734|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
149980735|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
149980736|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
149980737|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
149980738|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
149980739|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
149980740|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
149980741|NCT01672879|541065498|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
149980742|NCT01672879|541065499|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
150053322|NCT00600119|541336626|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
150178652|NCT00785512|541791993|FG000|Overall Study|Physician Decision|0|||
150178653|NCT00785512|541791994|FG001|Overall Study|Physician Decision|0|||
149980743|NCT01672879|541065500|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
149980744|NCT01672879|541065498|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
149980745|NCT01672879|541065499|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
149980746|NCT01672879|541065500|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
149980747|NCT01672879|541065498|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
149980748|NCT01672879|541065499|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
149980749|NCT01672879|541065500|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
149980750|NCT01672879|541065498|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
149980751|NCT01672879|541065499|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
149980752|NCT01672879|541065500|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
149980753|NCT01672879|541065498|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
149980754|NCT01672879|541065499|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
149980755|NCT01672879|541065500|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
149980756|NCT01775553|541065501|FG000|Overall Study|Adverse Event|1|||
149980757|NCT01775553|541065501|FG000|Overall Study|Disease Progression|12|||
149980758|NCT03748641|541065502|FG000|Overall Study|Ongoing|155|||
149980759|NCT03748641|541065503|FG001|Overall Study|Ongoing|148|||
149980760|NCT03748641|541065504|FG002|Overall Study|Ongoing|66|||
149980761|NCT03748641|541065505|FG003|Overall Study|Ongoing|79|||
149980762|NCT03748641|541065506|FG004|Overall Study|Ongoing|84|||
149980763|NCT03748641|541065502|FG000|Overall Study|Death|54|||
149980764|NCT03748641|541065503|FG001|Overall Study|Death|59|||
149980765|NCT03748641|541065504|FG002|Overall Study|Death|51|||
149980766|NCT03748641|541065505|FG003|Overall Study|Death|42|||
149980767|NCT03748641|541065506|FG004|Overall Study|Death|9|||
149980768|NCT03748641|541065502|FG000|Overall Study|Lost to Follow-up|0|||
150053323|NCT00600119|541336627|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
150053324|NCT00600119|541336628|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
150053325|NCT00600119|541336629|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
150053326|NCT00600119|541336630|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
150053327|NCT00600119|541336625|FG000|Double-blind Treatment Period|Adverse Event|1|||
150053328|NCT00600119|541336626|FG001|Double-blind Treatment Period|Adverse Event|1|||
150053329|NCT00600119|541336627|FG002|Double-blind Treatment Period|Adverse Event|0|||
150053330|NCT00600119|541336628|FG003|Double-blind Treatment Period|Adverse Event|1|||
150053331|NCT00600119|541336629|FG004|Double-blind Treatment Period|Adverse Event|2|||
150053332|NCT00600119|541336630|FG005|Double-blind Treatment Period|Adverse Event|10|||
150053333|NCT00600119|541336625|FG000|Follow-up Period|Adverse Event|0|||
150053334|NCT00600119|541336626|FG001|Follow-up Period|Adverse Event|0|||
150053335|NCT00600119|541336627|FG002|Follow-up Period|Adverse Event|0|||
150053336|NCT00600119|541336628|FG003|Follow-up Period|Adverse Event|0|||
150053337|NCT00600119|541336629|FG004|Follow-up Period|Adverse Event|0|||
150053338|NCT00600119|541336630|FG005|Follow-up Period|Adverse Event|1|||
150053339|NCT00600119|541336625|FG000|Follow-up Period|Other|1|||
150053340|NCT00600119|541336626|FG001|Follow-up Period|Other|0|||
150053341|NCT00600119|541336627|FG002|Follow-up Period|Other|0|||
150053342|NCT00600119|541336628|FG003|Follow-up Period|Other|0|||
150053343|NCT00600119|541336629|FG004|Follow-up Period|Other|0|||
150053344|NCT00600119|541336630|FG005|Follow-up Period|Other|0|||
150053345|NCT00561977|541336631|FG000|Overall Study|Withdrawal by Subject|0|||
150053346|NCT00561977|541336632|FG001|Overall Study|Withdrawal by Subject|2|||
150053347|NCT00561977|541336633|FG002|Overall Study|Withdrawal by Subject|1|||
150053348|NCT00561977|541336631|FG000|Overall Study|Pregnancy|0|||
150053349|NCT00561977|541336632|FG001|Overall Study|Pregnancy|1|||
150053350|NCT00561977|541336633|FG002|Overall Study|Pregnancy|1|||
150053351|NCT00977080|541336634|FG000|Overall Study|Adverse Event|2|||
150053352|NCT00977080|541336635|FG001|Overall Study|Adverse Event|7|||
150053353|NCT00977080|541336636|FG002|Overall Study|Adverse Event|7|||
150053354|NCT00977080|541336637|FG003|Overall Study|Adverse Event|7|||
150053355|NCT00977080|541336634|FG000|Overall Study|Withdrawal by Subject|1|||
150053356|NCT00977080|541336635|FG001|Overall Study|Withdrawal by Subject|5|||
150053357|NCT00977080|541336636|FG002|Overall Study|Withdrawal by Subject|1|||
150053358|NCT00977080|541336637|FG003|Overall Study|Withdrawal by Subject|5|||
150053359|NCT00977080|541336634|FG000|Overall Study|Protocol Violation|7|||
150053360|NCT00977080|541336635|FG001|Overall Study|Protocol Violation|3|||
150053361|NCT00977080|541336636|FG002|Overall Study|Protocol Violation|4|||
150053362|NCT00977080|541336637|FG003|Overall Study|Protocol Violation|3|||
149737498|NCT02601950|540170384|FG007|Overall Study|Non-compliance|0|||
150053363|NCT00977080|541336634|FG000|Overall Study|Noncompliance|0|||
150053364|NCT00977080|541336635|FG001|Overall Study|Noncompliance|2|||
150053365|NCT00977080|541336636|FG002|Overall Study|Noncompliance|1|||
150053366|NCT00977080|541336637|FG003|Overall Study|Noncompliance|0|||
150053367|NCT00977080|541336634|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
149980769|NCT03748641|541065503|FG001|Overall Study|Lost to Follow-up|2|||
149980770|NCT03748641|541065504|FG002|Overall Study|Lost to Follow-up|1|||
149980771|NCT03748641|541065505|FG003|Overall Study|Lost to Follow-up|0|||
149980772|NCT03748641|541065506|FG004|Overall Study|Lost to Follow-up|0|||
149980773|NCT03748641|541065502|FG000|Overall Study|Withdrawal by Subject|3|||
149980774|NCT03748641|541065503|FG001|Overall Study|Withdrawal by Subject|2|||
149980775|NCT03748641|541065504|FG002|Overall Study|Withdrawal by Subject|5|||
149980776|NCT03748641|541065505|FG003|Overall Study|Withdrawal by Subject|3|||
149980777|NCT03748641|541065506|FG004|Overall Study|Withdrawal by Subject|2|||
149980778|NCT04834726|541065507|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
149980779|NCT04834726|541065508|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
149980780|NCT04834726|541065509|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
149980781|NCT04834726|541065510|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
149980782|NCT04834726|541065511|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
149980783|NCT04834726|541065512|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
149980784|NCT04834726|541065513|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
149980785|NCT04834726|541065514|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
149980786|NCT04834726|541065515|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
149980787|NCT03810014|541065516|FG000|Overall Study|Pregnancy|2|||
149980788|NCT03810014|541065517|FG001|Overall Study|Pregnancy|2|||
149980789|NCT03810014|541065518|FG002|Overall Study|Pregnancy|0|||
149980790|NCT03810014|541065519|FG003|Overall Study|Pregnancy|2|||
149980791|NCT03606486|541065523|FG000|Overall Study|Unable to collect sample|5|||
149980792|NCT00442416|541065524|FG000|Overall Study|Adverse Event|4|||
149980793|NCT00442416|541065525|FG001|Overall Study|Adverse Event|1|||
149980794|NCT00442416|541065524|FG000|Overall Study|Death|1|||
149980795|NCT00442416|541065525|FG001|Overall Study|Death|0|||
149980796|NCT00442416|541065524|FG000|Overall Study|Lack of Efficacy|2|||
149980797|NCT00442416|541065525|FG001|Overall Study|Lack of Efficacy|0|||
149980798|NCT00442416|541065524|FG000|Overall Study|Protocol Violation|2|||
149980799|NCT00442416|541065525|FG001|Overall Study|Protocol Violation|3|||
149980800|NCT00442416|541065524|FG000|Overall Study|Withdrew consent|1|||
149980801|NCT00442416|541065525|FG001|Overall Study|Withdrew consent|2|||
149980802|NCT00442416|541065524|FG000|Overall Study|Administrative/Other|27|||
149980803|NCT00442416|541065525|FG001|Overall Study|Administrative/Other|33|||
149980804|NCT01737762|541065528|FG000|Overall Study|Adverse Event|2|||
149980805|NCT01737762|541065529|FG001|Overall Study|Adverse Event|2|||
149980806|NCT01737762|541065528|FG000|Overall Study|Lost to Follow-up|1|||
149980807|NCT01737762|541065529|FG001|Overall Study|Lost to Follow-up|0|||
149980808|NCT01737762|541065528|FG000|Overall Study|Withdrawal by Subject|2|||
149980809|NCT01737762|541065529|FG001|Overall Study|Withdrawal by Subject|2|||
149980810|NCT01737762|541065528|FG000|Overall Study|Progressive disease|1|||
149980811|NCT01737762|541065529|FG001|Overall Study|Progressive disease|2|||
149980812|NCT01737762|541065528|FG000|Overall Study|Physician Decision|1|||
149980813|NCT01737762|541065529|FG001|Overall Study|Physician Decision|1|||
149980814|NCT01737762|541065528|FG000|Overall Study|Moved from area|2|||
149980815|NCT01737762|541065529|FG001|Overall Study|Moved from area|1|||
149980816|NCT01737762|541065528|FG000|Overall Study|Trial termination|11|||
149980817|NCT01737762|541065529|FG001|Overall Study|Trial termination|9|||
149980818|NCT00503425|541065530|FG000|Overall Study|Participant files lost|6|||
149980819|NCT00503425|541065530|FG000|Overall Study|Adverse Event|5|||
149980820|NCT00503425|541065530|FG000|Overall Study|Lack of Efficacy|25|||
149980821|NCT00503425|541065530|FG000|Overall Study|Withdrawal by Subject|8|||
149980822|NCT00503425|541065530|FG000|Overall Study|Lost to Follow-up|3|||
149980823|NCT00503425|541065530|FG000|Overall Study|Death|3|||
149980824|NCT00503425|541065530|FG000|Overall Study|Missing Data/Unknown|4|||
149980825|NCT03328832|541065531|FG000|Overall Study|Lost to Follow-up|0|||
149980826|NCT03328832|541065532|FG001|Overall Study|Lost to Follow-up|1|||
149980827|NCT04872569|541065538|FG000|Overall Study|Withdrawal by Subject|2|||
149980828|NCT02268383|541065543|FG000|Overall Study|Death|12|||
149980829|NCT02268383|541065543|FG000|Overall Study|Lost to Follow-up|2|||
149980830|NCT02268383|541065543|FG000|Overall Study|Withdrawal by Subject|9|||
149980831|NCT02268383|541065543|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
149980832|NCT02268383|541065543|FG000|Overall Study|Protocol deviation|3|||
149980833|NCT02268383|541065543|FG000|Overall Study|Sponsor decision|22|||
149980834|NCT02268383|541065543|FG000|Overall Study|Not reported|12|||
150053368|NCT00977080|541336635|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
150053369|NCT00977080|541336636|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
150053370|NCT00977080|541336637|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
149980835|NCT00943761|541065544|FG000|Overall Study|Lost to Follow-up|2|||
149980836|NCT00943761|541065545|FG001|Overall Study|Lost to Follow-up|0|||
150053371|NCT00977080|541336634|FG000|Overall Study|Required kidney transplantation|1|||
149980837|NCT00943761|541065544|FG000|Overall Study|Withdrawal by Subject|2|||
149980838|NCT00943761|541065545|FG001|Overall Study|Withdrawal by Subject|1|||
149980839|NCT00714948|541065546|FG000|Overall Study|Adverse Event|2|||
149980840|NCT02708680|541065549|FG000|Overall Study|Withdrawal by Subject|4|||
149980841|NCT02708680|541065550|FG001|Overall Study|Withdrawal by Subject|12|||
149980842|NCT02708680|541065551|FG002|Overall Study|Withdrawal by Subject|12|||
149980843|NCT02708680|541065549|FG000|Overall Study|Death|4|||
149980844|NCT02708680|541065550|FG001|Overall Study|Death|19|||
149980845|NCT02708680|541065551|FG002|Overall Study|Death|21|||
149980846|NCT02708680|541065549|FG000|Overall Study|Lost to Follow-up|0|||
150178654|NCT00785512|541791993|FG000|Overall Study|Lack of compliance|0|||
150178655|NCT00785512|541791994|FG001|Overall Study|Lack of compliance|1|||
150178656|NCT00546754|541791995|FG000|Overall Study|Serious Adverse Event|1|||
150178657|NCT00546754|541791996|FG001|Overall Study|Serious Adverse Event|1|||
150178658|NCT00546754|541791995|FG000|Overall Study|Adverse Event|11|||
150178659|NCT00546754|541791996|FG001|Overall Study|Adverse Event|16|||
150178660|NCT00546754|541791995|FG000|Overall Study|Lack of Efficacy|1|||
150178661|NCT00546754|541791996|FG001|Overall Study|Lack of Efficacy|1|||
149980847|NCT02708680|541065550|FG001|Overall Study|Lost to Follow-up|3|||
149980848|NCT02708680|541065551|FG002|Overall Study|Lost to Follow-up|3|||
149980849|NCT02708680|541065549|FG000|Overall Study|Study Terminated By Sponsor|0|||
149980850|NCT02708680|541065550|FG001|Overall Study|Study Terminated By Sponsor|5|||
149980851|NCT02708680|541065551|FG002|Overall Study|Study Terminated By Sponsor|4|||
149980852|NCT02708680|541065549|FG000|Overall Study|Other than Specified|0|||
149980853|NCT02708680|541065550|FG001|Overall Study|Other than Specified|0|||
149980854|NCT02708680|541065551|FG002|Overall Study|Other than Specified|1|||
149980855|NCT02708680|541065549|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
149980856|NCT02708680|541065550|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
149980857|NCT02708680|541065551|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
149980858|NCT04162470|541065552|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
149980859|NCT03382912|541065555|FG000|Overall Study|Physician Decision|0|||
149980860|NCT03382912|541065556|FG001|Overall Study|Physician Decision|1|||
149980861|NCT03382912|541065555|FG000|Overall Study|Sponsor Decision|6|||
149980862|NCT03382912|541065556|FG001|Overall Study|Sponsor Decision|6|||
149980863|NCT03382912|541065555|FG000|Overall Study|Withdrawal by Subject|0|||
149980864|NCT03382912|541065556|FG001|Overall Study|Withdrawal by Subject|5|||
149980865|NCT03533660|541065557|FG000|Overall Study|Withdrawal by Subject|2|||
149980866|NCT03533660|541065558|FG001|Overall Study|Withdrawal by Subject|2|||
149980867|NCT03533660|541065557|FG000|Overall Study|Death|2|||
149980868|NCT03533660|541065558|FG001|Overall Study|Death|4|||
149980869|NCT03533660|541065557|FG000|Overall Study|Adverse Event|0|||
149980870|NCT03533660|541065558|FG001|Overall Study|Adverse Event|2|||
149980871|NCT03783962|541067167|FG000|Overall Study|Lost to Follow-up|3|||
149980872|NCT03783962|541067168|FG001|Overall Study|Lost to Follow-up|6|||
149980873|NCT03783962|541067167|FG000|Overall Study|Protocol Violation|0|||
149980874|NCT03783962|541067168|FG001|Overall Study|Protocol Violation|1|||
149980875|NCT04423939|541067169|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
149980876|NCT04423939|541067170|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
149980877|NCT04423939|541067169|FG000|Overall Study|Death|3|||
149980878|NCT04423939|541067170|FG001|Overall Study|Death|0|||
149980879|NCT04423939|541067169|FG000|Overall Study|Withdrawal by Subject|3|||
149980880|NCT04423939|541067170|FG001|Overall Study|Withdrawal by Subject|0|||
149980881|NCT04423939|541067169|FG000|Overall Study|Caregiver to patient who died|0|||
149980882|NCT04423939|541067170|FG001|Overall Study|Caregiver to patient who died|3|||
149980883|NCT04423939|541067169|FG000|Overall Study|Caregiver to patient who withdrew|0|||
149980884|NCT04423939|541067170|FG001|Overall Study|Caregiver to patient who withdrew|3|||
149980885|NCT04024436|541067171|FG000|Overall Study|Death|10|||
149980886|NCT04024436|541067172|FG001|Overall Study|Death|14|||
149980887|NCT04024436|541067173|FG002|Overall Study|Death|2|||
149980888|NCT04024436|541067174|FG003|Overall Study|Death|7|||
150178662|NCT00546754|541791995|FG000|Overall Study|Lost to Follow-up|9|||
150178663|NCT00546754|541791996|FG001|Overall Study|Lost to Follow-up|15|||
150178664|NCT00546754|541791995|FG000|Overall Study|Protocol Violation|3|||
149980889|NCT04024436|541067171|FG000|Overall Study|Loss to follow up|1|||
149980890|NCT04024436|541067172|FG001|Overall Study|Loss to follow up|0|||
149980891|NCT04024436|541067173|FG002|Overall Study|Loss to follow up|0|||
149980892|NCT04024436|541067174|FG003|Overall Study|Loss to follow up|1|||
149980893|NCT04024436|541067171|FG000|Overall Study|Withdrawal of consent|2|||
149980894|NCT04024436|541067172|FG001|Overall Study|Withdrawal of consent|0|||
149980895|NCT04024436|541067173|FG002|Overall Study|Withdrawal of consent|0|||
149980896|NCT04024436|541067174|FG003|Overall Study|Withdrawal of consent|1|||
149980897|NCT04024436|541067171|FG000|Overall Study|Study termination by sponsor|4|||
149980898|NCT04024436|541067172|FG001|Overall Study|Study termination by sponsor|6|||
150178665|NCT00546754|541791996|FG001|Overall Study|Protocol Violation|0|||
149980899|NCT04024436|541067173|FG002|Overall Study|Study termination by sponsor|2|||
149980900|NCT04024436|541067174|FG003|Overall Study|Study termination by sponsor|11|||
149980901|NCT04024436|541067171|FG000|Overall Study|Reason Not Specified|0|||
149980902|NCT04024436|541067172|FG001|Overall Study|Reason Not Specified|1|||
149980903|NCT04024436|541067173|FG002|Overall Study|Reason Not Specified|0|||
149980904|NCT04024436|541067174|FG003|Overall Study|Reason Not Specified|2|||
149980905|NCT01169337|541067175|FG000|Overall Study|Lack of Efficacy|5|||
149980906|NCT01169337|541067176|FG001|Overall Study|Lack of Efficacy|7|||
149980907|NCT01169337|541067177|FG002|Overall Study|Lack of Efficacy|0|||
149980908|NCT01169337|541067175|FG000|Overall Study|Adverse Event|12|||
149980909|NCT01169337|541067176|FG001|Overall Study|Adverse Event|18|||
149980910|NCT01169337|541067177|FG002|Overall Study|Adverse Event|0|||
149980911|NCT01169337|541067175|FG000|Overall Study|Death|2|||
149980912|NCT01169337|541067176|FG001|Overall Study|Death|0|||
149980913|NCT01169337|541067177|FG002|Overall Study|Death|0|||
149980914|NCT01169337|541067175|FG000|Overall Study|Withdrawal by Subject|11|||
149980915|NCT01169337|541067176|FG001|Overall Study|Withdrawal by Subject|11|||
149980916|NCT01169337|541067177|FG002|Overall Study|Withdrawal by Subject|6|||
149980917|NCT01169337|541067175|FG000|Overall Study|Noncompliance|2|||
149980918|NCT01169337|541067176|FG001|Overall Study|Noncompliance|0|||
149980919|NCT01169337|541067177|FG002|Overall Study|Noncompliance|0|||
149980920|NCT01169337|541067175|FG000|Overall Study|Other complicating disease|1|||
149980921|NCT01169337|541067176|FG001|Overall Study|Other complicating disease|1|||
149980922|NCT01169337|541067177|FG002|Overall Study|Other complicating disease|0|||
149980923|NCT01169337|541067175|FG000|Overall Study|Physician Decision|1|||
149980924|NCT01169337|541067176|FG001|Overall Study|Physician Decision|5|||
149980925|NCT01169337|541067177|FG002|Overall Study|Physician Decision|0|||
149980926|NCT01169337|541067175|FG000|Overall Study|Alternative therapy|0|||
149980927|NCT01169337|541067176|FG001|Overall Study|Alternative therapy|2|||
149980928|NCT01169337|541067177|FG002|Overall Study|Alternative therapy|0|||
149980929|NCT01169337|541067175|FG000|Overall Study|Changed hospital|0|||
149980930|NCT01169337|541067176|FG001|Overall Study|Changed hospital|1|||
149980931|NCT01169337|541067177|FG002|Overall Study|Changed hospital|0|||
149980932|NCT01169337|541067175|FG000|Overall Study|Never started treatment|0|||
149980933|NCT01169337|541067176|FG001|Overall Study|Never started treatment|2|||
149980934|NCT01169337|541067177|FG002|Overall Study|Never started treatment|0|||
149980935|NCT01169337|541067175|FG000|Overall Study|Reason not reported|1|||
149980936|NCT01169337|541067176|FG001|Overall Study|Reason not reported|0|||
149980937|NCT01169337|541067177|FG002|Overall Study|Reason not reported|0|||
149980938|NCT01169337|541067175|FG000|Overall Study|Continuing lenalidomide|9|||
149980939|NCT01169337|541067176|FG001|Overall Study|Continuing lenalidomide|43|||
150053372|NCT00977080|541336635|FG001|Overall Study|Required kidney transplantation|3|||
150053373|NCT00977080|541336636|FG002|Overall Study|Required kidney transplantation|3|||
150053374|NCT00977080|541336637|FG003|Overall Study|Required kidney transplantation|1|||
150053375|NCT00977080|541336634|FG000|Overall Study|Travel for family reasons|1|||
150053376|NCT00977080|541336635|FG001|Overall Study|Travel for family reasons|0|||
150053377|NCT00977080|541336636|FG002|Overall Study|Travel for family reasons|0|||
150053378|NCT00977080|541336637|FG003|Overall Study|Travel for family reasons|0|||
150053379|NCT00566696|541336638|FG000|Overall Study|Met Exclusion Criteria|2|||
150053380|NCT00566696|541336638|FG000|Overall Study|Muromonab not available|1|||
150053381|NCT00566696|541336638|FG000|Overall Study|Health Status Change|1|||
149980940|NCT01169337|541067177|FG002|Overall Study|Continuing lenalidomide|0|||
149980941|NCT01134614|541067178|FG000|Overall Study|Still on treatment as of March 2013|21|||
149980942|NCT01134614|541067179|FG001|Overall Study|Still on treatment as of March 2013|13|||
149980943|NCT01134614|541067178|FG000|Overall Study|Progressive disease|60|||
149980944|NCT01134614|541067179|FG001|Overall Study|Progressive disease|54|||
149980945|NCT01134614|541067178|FG000|Overall Study|Adverse Event|26|||
149980946|NCT01134614|541067179|FG001|Overall Study|Adverse Event|39|||
149980947|NCT01134614|541067178|FG000|Overall Study|Death|5|||
149980948|NCT01134614|541067179|FG001|Overall Study|Death|8|||
149980949|NCT01134614|541067178|FG000|Overall Study|Withdrawal by Subject|3|||
149980950|NCT01134614|541067179|FG001|Overall Study|Withdrawal by Subject|2|||
149980951|NCT01134614|541067178|FG000|Overall Study|Alternative therapy|2|||
149980952|NCT01134614|541067179|FG001|Overall Study|Alternative therapy|0|||
149980953|NCT01134614|541067178|FG000|Overall Study|Complicating disease|2|||
149980954|NCT01134614|541067179|FG001|Overall Study|Complicating disease|1|||
150053382|NCT00566696|541336638|FG000|Overall Study|Physician Decision|1|||
150178666|NCT00546754|541791995|FG000|Overall Study|Withdrawal by Subject|6|||
150178667|NCT00546754|541791996|FG001|Overall Study|Withdrawal by Subject|7|||
150178668|NCT00546754|541791995|FG000|Overall Study|Dyspnea|1|||
149980955|NCT01134614|541067178|FG000|Overall Study|Physician's decision|0|||
149980956|NCT01134614|541067179|FG001|Overall Study|Physician's decision|1|||
149980957|NCT01134614|541067178|FG000|Overall Study|Never started treatment|4|||
149980958|NCT01134614|541067179|FG001|Overall Study|Never started treatment|1|||
149980959|NCT01134614|541067178|FG000|Overall Study|Pt received tx not allowed on study|0|||
149980960|NCT01134614|541067179|FG001|Overall Study|Pt received tx not allowed on study|1|||
150053383|NCT00566696|541336638|FG000|Overall Study|Non-Patient Donors|37|||
150053384|NCT01616693|541336641|FG000|Evaluated for Safety|Physician Decision|1|||
150053385|NCT01616693|541336642|FG001|Evaluated for Safety|Physician Decision|0|||
149980961|NCT01134614|541067178|FG000|Overall Study|Symptomatic deterioration|0|||
149980962|NCT01134614|541067179|FG001|Overall Study|Symptomatic deterioration|1|||
149980963|NCT01134614|541067178|FG000|Overall Study|Patient in hospice care|0|||
149980964|NCT01134614|541067179|FG001|Overall Study|Patient in hospice care|1|||
149980965|NCT00540592|541067180|FG000|Overall Study|Adverse Event|0|||
149980966|NCT00540592|541067181|FG001|Overall Study|Adverse Event|1|||
149980967|NCT00540592|541067182|FG002|Overall Study|Adverse Event|0|||
149980968|NCT00540592|541067183|FG003|Overall Study|Adverse Event|0|||
149980969|NCT00540592|541067184|FG004|Overall Study|Adverse Event|1|||
149980970|NCT00540592|541067185|FG005|Overall Study|Adverse Event|0|||
149980971|NCT00540592|541067186|FG006|Overall Study|Adverse Event|0|||
149980972|NCT00540592|541067187|FG007|Overall Study|Adverse Event|1|||
149980973|NCT00540592|541067188|FG008|Overall Study|Adverse Event|1|||
149980974|NCT00540592|541067189|FG009|Overall Study|Adverse Event|2|||
149980975|NCT00540592|541067180|FG000|Overall Study|Lost to Follow-up|2|||
149980976|NCT00540592|541067181|FG001|Overall Study|Lost to Follow-up|0|||
149980977|NCT00540592|541067182|FG002|Overall Study|Lost to Follow-up|0|||
149980978|NCT00540592|541067183|FG003|Overall Study|Lost to Follow-up|0|||
149980979|NCT00540592|541067184|FG004|Overall Study|Lost to Follow-up|0|||
149980980|NCT00540592|541067185|FG005|Overall Study|Lost to Follow-up|0|||
149980981|NCT00540592|541067186|FG006|Overall Study|Lost to Follow-up|0|||
149980982|NCT00540592|541067187|FG007|Overall Study|Lost to Follow-up|0|||
149980983|NCT00540592|541067188|FG008|Overall Study|Lost to Follow-up|0|||
149980984|NCT00540592|541067189|FG009|Overall Study|Lost to Follow-up|0|||
149980985|NCT00540592|541067180|FG000|Overall Study|Withdrawal by Subject|0|||
149980986|NCT00540592|541067181|FG001|Overall Study|Withdrawal by Subject|0|||
149980987|NCT00540592|541067182|FG002|Overall Study|Withdrawal by Subject|1|||
149980988|NCT00540592|541067183|FG003|Overall Study|Withdrawal by Subject|1|||
149980989|NCT00540592|541067184|FG004|Overall Study|Withdrawal by Subject|0|||
149980990|NCT00540592|541067185|FG005|Overall Study|Withdrawal by Subject|0|||
149980991|NCT00540592|541067186|FG006|Overall Study|Withdrawal by Subject|0|||
149980992|NCT00540592|541067187|FG007|Overall Study|Withdrawal by Subject|0|||
149980993|NCT00540592|541067188|FG008|Overall Study|Withdrawal by Subject|0|||
149980994|NCT00540592|541067189|FG009|Overall Study|Withdrawal by Subject|0|||
149980995|NCT02168101|541067194|FG000|Overall Study|Death|2|||
149980996|NCT02168101|541067195|FG001|Overall Study|Death|2|||
149980997|NCT02168101|541067196|FG002|Overall Study|Death|1|||
149980998|NCT05507567|541067197|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
149980999|NCT05507567|541067198|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
149981000|NCT05507567|541067199|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
149981001|NCT05507567|541067197|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
149981002|NCT05507567|541067198|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
149981003|NCT05507567|541067199|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
149981004|NCT05507567|541067197|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
149981005|NCT05507567|541067198|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
149981006|NCT05507567|541067199|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
149981007|NCT05507567|541067197|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
149981008|NCT05507567|541067198|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
149981009|NCT05507567|541067199|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
149981010|NCT01722994|541067202|FG000|Overall Study|Missing data|25|||
149981011|NCT01722994|541067203|FG001|Overall Study|Missing data|17|||
149981012|NCT01206140|541067204|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
149981013|NCT01206140|541067205|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
149981014|NCT01803880|541067206|FG000|Overall Study|Adverse Event|1|||
149981015|NCT01803880|541067207|FG001|Overall Study|Adverse Event|0|||
149981016|NCT01803880|541067208|FG002|Overall Study|Adverse Event|0|||
149981017|NCT01803880|541067206|FG000|Overall Study|Withdrawal by Subject|1|||
149981018|NCT01803880|541067207|FG001|Overall Study|Withdrawal by Subject|1|||
149981019|NCT01803880|541067208|FG002|Overall Study|Withdrawal by Subject|4|||
149981020|NCT01803880|541067206|FG000|Overall Study|Physician Decision|0|||
149981021|NCT01803880|541067207|FG001|Overall Study|Physician Decision|0|||
149981022|NCT01803880|541067208|FG002|Overall Study|Physician Decision|1|||
149981023|NCT01803880|541067206|FG000|Overall Study|Unable to return for follow-up visits|0|||
149981024|NCT01803880|541067207|FG001|Overall Study|Unable to return for follow-up visits|1|||
149981025|NCT01803880|541067208|FG002|Overall Study|Unable to return for follow-up visits|2|||
149981026|NCT01803880|541067206|FG000|Overall Study|Lost to Follow-up|1|||
149981027|NCT01803880|541067207|FG001|Overall Study|Lost to Follow-up|2|||
149981028|NCT01803880|541067208|FG002|Overall Study|Lost to Follow-up|3|||
149981029|NCT01803880|541067206|FG000|Overall Study|Protocol Violation|1|||
149981030|NCT01803880|541067207|FG001|Overall Study|Protocol Violation|0|||
149981031|NCT01803880|541067208|FG002|Overall Study|Protocol Violation|0|||
149981032|NCT01803880|541067206|FG000|Overall Study|Early study termination|0|||
149981033|NCT01803880|541067207|FG001|Overall Study|Early study termination|6|||
149981034|NCT01803880|541067208|FG002|Overall Study|Early study termination|5|||
149981035|NCT01803880|541067206|FG000|Overall Study|Incomplete data entry by sites|2|||
149981036|NCT01803880|541067207|FG001|Overall Study|Incomplete data entry by sites|0|||
149981037|NCT01803880|541067208|FG002|Overall Study|Incomplete data entry by sites|0|||
149981038|NCT01766037|541067210|FG000|Overall Study|Adverse Event|1|||
149981039|NCT01766037|541067211|FG001|Overall Study|Adverse Event|0|||
149981040|NCT01766037|541067210|FG000|Overall Study|Lack of Efficacy|1|||
149981041|NCT01766037|541067211|FG001|Overall Study|Lack of Efficacy|0|||
149981042|NCT01766037|541067210|FG000|Overall Study|Lost to Follow-up|0|||
149981043|NCT01766037|541067211|FG001|Overall Study|Lost to Follow-up|10|||
149981044|NCT01766037|541067210|FG000|Overall Study|Physician Decision|0|||
149981045|NCT01766037|541067211|FG001|Overall Study|Physician Decision|1|||
149981046|NCT01766037|541067210|FG000|Overall Study|Withdrawal by Subject|18|||
149981047|NCT01766037|541067211|FG001|Overall Study|Withdrawal by Subject|16|||
149981048|NCT01766037|541067210|FG000|Overall Study|Moved from area|5|||
149981049|NCT01766037|541067211|FG001|Overall Study|Moved from area|0|||
149981050|NCT01766037|541067210|FG000|Overall Study|medical - unrelated|1|||
149981051|NCT01766037|541067211|FG001|Overall Study|medical - unrelated|2|||
149981052|NCT01766037|541067210|FG000|Overall Study|nausea / discomfort|3|||
149981053|NCT01766037|541067211|FG001|Overall Study|nausea / discomfort|0|||
149981054|NCT02503085|541067230|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
149981055|NCT02503085|541067231|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
149981056|NCT02503085|541067232|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
149981057|NCT02503085|541067233|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
149981058|NCT01162473|541067238|FG000|Overall Study|Adverse Event|2|||
149981059|NCT01162473|541067239|FG001|Overall Study|Adverse Event|1|||
149981060|NCT01162473|541067238|FG000|Overall Study|Withdrawal by Subject|0|||
149981061|NCT01162473|541067239|FG001|Overall Study|Withdrawal by Subject|4|||
149981062|NCT01144416|541067240|FG000|Intervention Period|Adverse Event|5|||
149981063|NCT01144416|541067241|FG001|Intervention Period|Adverse Event|6|||
149981064|NCT01144416|541067240|FG000|Intervention Period|Insufficient ovarian response|11|||
149981065|NCT01144416|541067241|FG001|Intervention Period|Insufficient ovarian response|17|||
149981066|NCT01144416|541067240|FG000|Intervention Period|Risk of OHSS|0|||
149981067|NCT01144416|541067241|FG001|Intervention Period|Risk of OHSS|1|||
149981068|NCT01144416|541067240|FG000|Intervention Period|Too high ovarian response|4|||
149981069|NCT01144416|541067241|FG001|Intervention Period|Too high ovarian response|2|||
149981070|NCT01144416|541067240|FG000|Intervention Period|No/too few/bad oocytes|7|||
149981071|NCT01144416|541067241|FG001|Intervention Period|No/too few/bad oocytes|5|||
149981072|NCT01144416|541067240|FG000|Intervention Period|No or abnormal fertilization|25|||
149981073|NCT01144416|541067241|FG001|Intervention Period|No or abnormal fertilization|10|||
149981074|NCT01144416|541067240|FG000|Intervention Period|No/too few/bad quality embryos|3|||
149981075|NCT01144416|541067241|FG001|Intervention Period|No/too few/bad quality embryos|3|||
149981076|NCT01144416|541067240|FG000|Intervention Period|Other|7|||
149981077|NCT01144416|541067241|FG001|Intervention Period|Other|5|||
149981078|NCT00124072|541067242|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
149981079|NCT00124072|541067243|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
149981080|NCT00124072|541067244|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
149981081|NCT00124072|541067245|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
149981082|NCT00124072|541067242|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
149981083|NCT00124072|541067243|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
149981084|NCT00124072|541067244|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
149981085|NCT00124072|541067245|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
150178669|NCT00546754|541791996|FG001|Overall Study|Dyspnea|0|||
149981086|NCT00124072|541067242|FG000|Overall Study|Death|499|||
149981087|NCT00124072|541067243|FG001|Overall Study|Death|484|||
149981088|NCT00124072|541067244|FG002|Overall Study|Death|471|||
149981089|NCT00124072|541067245|FG003|Overall Study|Death|480|||
149981090|NCT02534883|541067246|FG000|Overall Study|Early Termination|8|||
149981091|NCT02534883|541067247|FG001|Overall Study|Early Termination|3|||
149981092|NCT00886769|541067248|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
149981093|NCT00886769|541067249|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
149981094|NCT00414076|541067250|FG000|Overall Study|Progression|1|||
149981095|NCT00414076|541067251|FG001|Overall Study|Progression|2|||
149981096|NCT00414076|541067250|FG000|Overall Study|Withdrawal by Subject|1|||
149981097|NCT00414076|541067251|FG001|Overall Study|Withdrawal by Subject|3|||
149981098|NCT00414076|541067250|FG000|Overall Study|Adverse Event|1|||
149981099|NCT00414076|541067251|FG001|Overall Study|Adverse Event|0|||
149981100|NCT00778336|541067252|FG000|Index Procedure-Discharge|Death|6|||
149981101|NCT00778336|541067253|FG001|Index Procedure-Discharge|Death|3|||
149981102|NCT00778336|541067254|FG002|Index Procedure-Discharge|Death|2|||
149981103|NCT00778336|541067255|FG003|Index Procedure-Discharge|Death|0|||
149981104|NCT00778336|541067252|FG000|3 Month Follow Up|Lost to Follow-up|15|||
149981105|NCT00778336|541067253|FG001|3 Month Follow Up|Lost to Follow-up|20|||
149981106|NCT00778336|541067254|FG002|3 Month Follow Up|Lost to Follow-up|3|||
149981107|NCT00778336|541067255|FG003|3 Month Follow Up|Lost to Follow-up|0|||
149981108|NCT00778336|541067252|FG000|3 Month Follow Up|Death|8|||
149981109|NCT00778336|541067253|FG001|3 Month Follow Up|Death|3|||
149981110|NCT00778336|541067254|FG002|3 Month Follow Up|Death|2|||
149981111|NCT00778336|541067255|FG003|3 Month Follow Up|Death|0|||
149981112|NCT04417257|541067256|FG000|Pilot Phase 2|Adverse Event|2|||
149981113|NCT04417257|541067257|FG001|Pilot Phase 2|Adverse Event|0|||
149981114|NCT04417257|541067256|FG000|Pilot Phase 2|Death|14|||
149981115|NCT04417257|541067257|FG001|Pilot Phase 2|Death|11|||
149981116|NCT04417257|541067256|FG000|Pilot Phase 2|Lost to Follow-up|3|||
149981117|NCT04417257|541067257|FG001|Pilot Phase 2|Lost to Follow-up|5|||
149981118|NCT04417257|541067256|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
149981119|NCT04417257|541067257|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
149981120|NCT04417257|541067256|FG000|Pilot Phase 2|Hepatic impairment|1|||
149981121|NCT04417257|541067257|FG001|Pilot Phase 2|Hepatic impairment|0|||
149981122|NCT04417257|541067256|FG000|Pilot Phase 2|Unblinding|1|||
149981123|NCT04417257|541067257|FG001|Pilot Phase 2|Unblinding|0|||
149981124|NCT04417257|541067256|FG000|Pilot Phase 2|All other|0|||
149981125|NCT04417257|541067257|FG001|Pilot Phase 2|All other|2|||
149981126|NCT04417257|541067256|FG000|Phase 3 Extension|Death|3|||
149981127|NCT04417257|541067257|FG001|Phase 3 Extension|Death|1|||
149981128|NCT04417257|541067256|FG000|Phase 3 Extension|Lost to Follow-up|4|||
149981129|NCT04417257|541067257|FG001|Phase 3 Extension|Lost to Follow-up|2|||
149981130|NCT04417257|541067256|FG000|Phase 3 Extension|Patient withdrawal|2|||
149981131|NCT04417257|541067257|FG001|Phase 3 Extension|Patient withdrawal|2|||
149981132|NCT04417257|541067256|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
149981133|NCT04417257|541067257|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
149981134|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
149981135|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
149981136|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
149981137|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
149981138|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
149981139|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
149981140|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
149981141|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
149981142|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
149981143|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
149981144|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
149981145|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
149981146|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
149981147|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
149981148|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
149981149|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
149981150|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
149981151|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
149981152|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
149981153|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
149981154|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
149981155|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
149981156|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
149981157|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
149981158|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
149981159|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
149981160|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
149981161|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
149981162|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
149981163|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
149981164|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
149981165|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
149981166|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
149981167|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
149981168|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
149981169|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
149981170|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
149981171|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
149981172|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
149981173|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
149981174|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
149981175|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
149981176|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
149981177|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
149981178|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
149981179|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
149981180|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
149981181|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
149981182|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
149981183|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
149981184|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
149981185|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
149981186|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
149981187|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
149981188|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
149981189|NCT04951622|541067258|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
149981190|NCT04951622|541067259|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
149981191|NCT04951622|541067260|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
149981192|NCT04951622|541067261|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
149981193|NCT04951622|541067262|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
149981194|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
149981195|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
149981196|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
149981197|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
149981198|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
149981199|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
149981200|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
149981201|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
149981202|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
149981203|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
149981204|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
149981205|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
149981206|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
149981207|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
149981208|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
149981209|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
149981210|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
149981211|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
149981212|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
149981213|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
149981214|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
149981215|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
149981216|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
149981217|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
149981218|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
149981219|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
149981220|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
149981221|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
149981222|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
149981223|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
149981224|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
149981225|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
149981226|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
149981227|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
149981228|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
149981229|NCT04951622|541067258|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
149981230|NCT04951622|541067259|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
149981231|NCT04951622|541067260|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
149981232|NCT04951622|541067261|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
150053386|NCT01616693|541336643|FG002|Evaluated for Safety|Physician Decision|1|||
150053387|NCT01616693|541336644|FG003|Evaluated for Safety|Physician Decision|0|||
150053388|NCT01616693|541336641|FG000|Received Both Vaccines|Adverse Event|2|||
150053389|NCT01616693|541336642|FG001|Received Both Vaccines|Adverse Event|0|||
150053390|NCT01616693|541336643|FG002|Received Both Vaccines|Adverse Event|0|||
150053391|NCT01616693|541336644|FG003|Received Both Vaccines|Adverse Event|0|||
150053392|NCT01616693|541336641|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
150053393|NCT01616693|541336642|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
150053394|NCT01616693|541336643|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
150053395|NCT01616693|541336644|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
150053396|NCT01616693|541336641|FG000|Received Both Vaccines|Lost to Follow-up|4|||
150053397|NCT01616693|541336642|FG001|Received Both Vaccines|Lost to Follow-up|3|||
150053398|NCT01616693|541336643|FG002|Received Both Vaccines|Lost to Follow-up|4|||
150053399|NCT01616693|541336644|FG003|Received Both Vaccines|Lost to Follow-up|4|||
150053400|NCT01616693|541336641|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
150053401|NCT01616693|541336642|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
150053402|NCT01616693|541336643|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
150053403|NCT01616693|541336644|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
150053404|NCT02395172|541336645|FG000|Overall Study|Participants randomized but not treated|3|||
150053405|NCT02395172|541336646|FG001|Overall Study|Participants randomized but not treated|31|||
150053406|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
149981233|NCT04951622|541067262|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
149981234|NCT04181827|541067263|FG000|Overall Study|Ongoing|124|||
149981235|NCT04181827|541067264|FG001|Overall Study|Ongoing|157|||
149981236|NCT04181827|541067263|FG000|Overall Study|Death|82|||
149981237|NCT04181827|541067264|FG001|Overall Study|Death|50|||
149981238|NCT04181827|541067263|FG000|Overall Study|Lost to Follow-up|0|||
149981239|NCT04181827|541067264|FG001|Overall Study|Lost to Follow-up|1|||
149981240|NCT04181827|541067263|FG000|Overall Study|Withdrawal by Subject|5|||
149981241|NCT04181827|541067264|FG001|Overall Study|Withdrawal by Subject|0|||
149981242|NCT04587869|541067267|FG000|Overall Study|Death|1|||
149981243|NCT04587869|541067268|FG001|Overall Study|Death|0|||
149981244|NCT04587869|541067267|FG000|Overall Study|Lost to Follow-up|27|||
149981245|NCT04587869|541067268|FG001|Overall Study|Lost to Follow-up|34|||
149981246|NCT04587869|541067267|FG000|Overall Study|Grant Termination|13|||
149981247|NCT04587869|541067268|FG001|Overall Study|Grant Termination|25|||
149981248|NCT04587869|541067267|FG000|Overall Study|too busy|2|||
149981249|NCT04587869|541067268|FG001|Overall Study|too busy|0|||
149981250|NCT04587869|541067267|FG000|Overall Study|Withdrawal by Subject|2|||
149981251|NCT04587869|541067268|FG001|Overall Study|Withdrawal by Subject|2|||
149981252|NCT04587869|541067267|FG000|Overall Study|Other|1|||
149981253|NCT04587869|541067268|FG001|Overall Study|Other|0|||
149981254|NCT04538664|541067273|FG000|Overall Study|Withdrawal by Subject|5|||
149981255|NCT04538664|541067274|FG001|Overall Study|Withdrawal by Subject|9|||
149981256|NCT04538664|541067273|FG000|Overall Study|Lost to Follow-up|2|||
149981257|NCT04538664|541067274|FG001|Overall Study|Lost to Follow-up|1|||
149981258|NCT04538664|541067273|FG000|Overall Study|Ongoing|106|||
149981259|NCT04538664|541067274|FG001|Overall Study|Ongoing|115|||
149981260|NCT03929913|541067277|FG000|Overall Study|Death|4|||
149981261|NCT03929913|541067277|FG000|Overall Study|Lost to Follow-up|1|||
149981262|NCT03929913|541067277|FG000|Overall Study|Failed Procedure|2|||
149981263|NCT01544348|541067278|FG000|Overall Study|Lost to Follow-up|1|||
149981264|NCT01544348|541067279|FG001|Overall Study|Lost to Follow-up|0|||
149981265|NCT01544348|541067280|FG002|Overall Study|Lost to Follow-up|0|||
150053407|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
150053408|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
150053409|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
150053410|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
150053411|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
150053412|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
150053413|NCT00946985|541336649|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
149981266|NCT01544348|541067281|FG003|Overall Study|Lost to Follow-up|0|||
149981267|NCT01544348|541067282|FG004|Overall Study|Lost to Follow-up|0|||
149981268|NCT01544348|541067283|FG005|Overall Study|Lost to Follow-up|0|||
149981269|NCT01544348|541067284|FG006|Overall Study|Lost to Follow-up|1|||
149981270|NCT01544348|541067285|FG007|Overall Study|Lost to Follow-up|0|||
149981271|NCT01544348|541067278|FG000|Overall Study|Withdrawal by Subject|1|||
149981272|NCT01544348|541067279|FG001|Overall Study|Withdrawal by Subject|0|||
149981273|NCT01544348|541067280|FG002|Overall Study|Withdrawal by Subject|0|||
150053414|NCT00946985|541336649|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
150053415|NCT01546623|541336650|FG000|Overall Study|Adverse Event|2|||
150053416|NCT01546623|541336651|FG001|Overall Study|Adverse Event|3|||
150053417|NCT01546623|541336650|FG000|Overall Study|Major Protocol Deviation|1|||
149981274|NCT01544348|541067281|FG003|Overall Study|Withdrawal by Subject|0|||
149981275|NCT01544348|541067282|FG004|Overall Study|Withdrawal by Subject|1|||
149981276|NCT01544348|541067283|FG005|Overall Study|Withdrawal by Subject|2|||
149981277|NCT01544348|541067284|FG006|Overall Study|Withdrawal by Subject|1|||
149981278|NCT01544348|541067285|FG007|Overall Study|Withdrawal by Subject|0|||
149981279|NCT01544348|541067278|FG000|Overall Study|Physician Decision|0|||
149981280|NCT01544348|541067279|FG001|Overall Study|Physician Decision|0|||
149981281|NCT01544348|541067280|FG002|Overall Study|Physician Decision|0|||
149981282|NCT01544348|541067281|FG003|Overall Study|Physician Decision|0|||
149981283|NCT01544348|541067282|FG004|Overall Study|Physician Decision|0|||
149981284|NCT01544348|541067283|FG005|Overall Study|Physician Decision|1|||
149981285|NCT01544348|541067284|FG006|Overall Study|Physician Decision|0|||
149981286|NCT01544348|541067285|FG007|Overall Study|Physician Decision|0|||
149981287|NCT01445847|541067286|FG000|Overall Study|Protocol Violation|13|||
149981288|NCT01445847|541067287|FG001|Overall Study|Protocol Violation|14|||
149981289|NCT01445847|541067286|FG000|Overall Study|Missed Data|1|||
149981290|NCT01445847|541067287|FG001|Overall Study|Missed Data|0|||
149981291|NCT03381287|541067292|FG000|Overall Study|Withdrawal by Subject|0|||
149981292|NCT03381287|541067293|FG001|Overall Study|Withdrawal by Subject|1|||
149981293|NCT03381287|541067294|FG002|Overall Study|Withdrawal by Subject|0|||
149981294|NCT03381287|541067295|FG003|Overall Study|Withdrawal by Subject|0|||
149981295|NCT03381287|541067292|FG000|Overall Study|Adverse Event|0|||
149981296|NCT03381287|541067293|FG001|Overall Study|Adverse Event|0|||
149981297|NCT03381287|541067294|FG002|Overall Study|Adverse Event|0|||
149981298|NCT03381287|541067295|FG003|Overall Study|Adverse Event|1|||
149981299|NCT03381287|541067292|FG000|Overall Study|Physician Decision|0|||
149981300|NCT03381287|541067293|FG001|Overall Study|Physician Decision|0|||
149981301|NCT03381287|541067294|FG002|Overall Study|Physician Decision|0|||
149981302|NCT03381287|541067295|FG003|Overall Study|Physician Decision|1|||
149981303|NCT01837680|541067298|FG000|Overall Study|Lost to Follow-up|2|||
149981304|NCT01837680|541067299|FG001|Overall Study|Lost to Follow-up|2|||
149981305|NCT01837680|541067298|FG000|Overall Study|lack of insurance|0|||
149981306|NCT01837680|541067299|FG001|Overall Study|lack of insurance|2|||
149981307|NCT01837680|541067298|FG000|Overall Study|allergic reaction|6|||
149981308|NCT01837680|541067299|FG001|Overall Study|allergic reaction|0|||
149981309|NCT01837680|541067298|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
149981310|NCT01837680|541067299|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
149981311|NCT03008070|541067300|FG000|Overall Study|Adverse Event|3|||
149981312|NCT03008070|541067301|FG001|Overall Study|Adverse Event|3|||
149981313|NCT03008070|541067302|FG002|Overall Study|Adverse Event|3|||
149981314|NCT03008070|541067300|FG000|Overall Study|Lost to Follow-up|1|||
149981315|NCT03008070|541067301|FG001|Overall Study|Lost to Follow-up|1|||
149981316|NCT03008070|541067302|FG002|Overall Study|Lost to Follow-up|0|||
149981317|NCT03008070|541067300|FG000|Overall Study|Non compliance|0|||
149981318|NCT03008070|541067301|FG001|Overall Study|Non compliance|1|||
149981319|NCT03008070|541067302|FG002|Overall Study|Non compliance|1|||
149981320|NCT03008070|541067300|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
149981321|NCT03008070|541067301|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
149981322|NCT03008070|541067302|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
149981323|NCT03008070|541067300|FG000|Overall Study|Withdrawal by Subject|2|||
149981324|NCT03008070|541067301|FG001|Overall Study|Withdrawal by Subject|0|||
149981325|NCT03008070|541067302|FG002|Overall Study|Withdrawal by Subject|1|||
149981326|NCT03008070|541067300|FG000|Overall Study|Use of prohibited drug|0|||
149981327|NCT03008070|541067301|FG001|Overall Study|Use of prohibited drug|0|||
149981328|NCT03008070|541067302|FG002|Overall Study|Use of prohibited drug|2|||
149981329|NCT03960684|541067304|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
149981330|NCT03761056|541067305|FG000|Overall Study|Death|8|||
149981331|NCT03761056|541067305|FG000|Overall Study|Enrolled but never treated|2|||
149981332|NCT03761056|541067305|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
149981333|NCT03761056|541067305|FG000|Overall Study|Investigator decision|1|||
149981334|NCT00996658|541067306|FG000|Overall Study|Adverse Event|2|||
149981335|NCT00996658|541067307|FG001|Overall Study|Adverse Event|5|||
149981336|NCT00996658|541067306|FG000|Overall Study|Protocol Violation|0|||
149981337|NCT00996658|541067307|FG001|Overall Study|Protocol Violation|1|||
149981338|NCT00996658|541067306|FG000|Overall Study|Lost to Follow-up|2|||
149981339|NCT00996658|541067307|FG001|Overall Study|Lost to Follow-up|5|||
149981340|NCT00996658|541067306|FG000|Overall Study|Non-compliance issues|3|||
149981341|NCT00996658|541067307|FG001|Overall Study|Non-compliance issues|3|||
150053418|NCT01546623|541336651|FG001|Overall Study|Major Protocol Deviation|1|||
150053419|NCT01546623|541336650|FG000|Overall Study|High Prostate specific antigen|2|||
149981342|NCT00996658|541067306|FG000|Overall Study|Other|9|||
149981343|NCT00996658|541067307|FG001|Overall Study|Other|7|||
149981344|NCT04487080|541067314|FG000|Overall Study|Withdrawal by Subject|19|||
149981345|NCT04487080|541067315|FG001|Overall Study|Withdrawal by Subject|18|||
149981346|NCT04487080|541067316|FG002|Overall Study|Withdrawal by Subject|13|||
149981347|NCT04487080|541067314|FG000|Overall Study|Lost to Follow-up|3|||
150053420|NCT01546623|541336651|FG001|Overall Study|High Prostate specific antigen|1|||
150053421|NCT01546623|541336650|FG000|Overall Study|Did Not Receive Study Drug|1|||
149981348|NCT04487080|541067315|FG001|Overall Study|Lost to Follow-up|1|||
149981349|NCT04487080|541067316|FG002|Overall Study|Lost to Follow-up|0|||
149981350|NCT04487080|541067314|FG000|Overall Study|Ongoing|313|||
149981351|NCT04487080|541067315|FG001|Overall Study|Ongoing|297|||
149981352|NCT04487080|541067316|FG002|Overall Study|Ongoing|149|||
149981353|NCT03451851|541067317|FG000|PCP: Week 0 -16|Adverse Event|1|||
149981354|NCT03451851|541067318|FG001|PCP: Week 0 -16|Adverse Event|0|||
149981355|NCT03451851|541067319|FG002|PCP: Week 0 -16|Adverse Event|0|||
149981356|NCT03451851|541067320|FG003|PCP: Week 0 -16|Adverse Event|0|||
149981357|NCT03451851|541067321|FG004|PCP: Week 0 -16|Adverse Event|0|||
149981358|NCT03451851|541067322|FG005|PCP: Week 0 -16|Adverse Event|0|||
149981359|NCT03451851|541067323|FG006|PCP: Week 0 -16|Adverse Event|1|||
149981360|NCT03451851|541067324|FG007|PCP: Week 0 -16|Adverse Event|0|||
149981361|NCT03451851|541067317|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981362|NCT03451851|541067318|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981363|NCT03451851|541067319|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
149981364|NCT03451851|541067320|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981365|NCT03451851|541067321|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981366|NCT03451851|541067322|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981367|NCT03451851|541067323|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981368|NCT03451851|541067324|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
149981369|NCT03451851|541067317|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981370|NCT03451851|541067318|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981371|NCT03451851|541067319|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
149981372|NCT03451851|541067320|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981373|NCT03451851|541067321|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981374|NCT03451851|541067322|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981375|NCT03451851|541067323|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981376|NCT03451851|541067324|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
149981377|NCT03451851|541067317|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981378|NCT03451851|541067318|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981379|NCT03451851|541067319|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981380|NCT03451851|541067320|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981381|NCT03451851|541067321|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
149981382|NCT03451851|541067322|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
149981383|NCT03451851|541067323|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981384|NCT03451851|541067324|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
149981385|NCT03451851|541067317|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981386|NCT03451851|541067318|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981387|NCT03451851|541067319|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981388|NCT03451851|541067320|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981389|NCT03451851|541067321|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
149981390|NCT03451851|541067322|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981391|NCT03451851|541067323|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981392|NCT03451851|541067324|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
149981393|NCT03451851|541067317|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981394|NCT03451851|541067318|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981395|NCT03451851|541067319|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981396|NCT03451851|541067320|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981397|NCT03451851|541067321|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
149981398|NCT03451851|541067322|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981399|NCT03451851|541067323|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981400|NCT03451851|541067324|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
149981401|NCT03581292|541067325|FG000|Overall Study|Physician Decision|9|||
149981402|NCT03581292|541067326|FG001|Overall Study|Physician Decision|5|||
149981403|NCT03581292|541067325|FG000|Overall Study|Withdrawal by Subject|3|||
150053422|NCT01546623|541336651|FG001|Overall Study|Did Not Receive Study Drug|1|||
150053423|NCT01590758|541336654|FG000|Overall Study|Withdrawal by Subject|0|||
150053424|NCT01590758|541336655|FG001|Overall Study|Withdrawal by Subject|3|||
150053425|NCT01590758|541336654|FG000|Overall Study|Physician Decision|1|||
149981404|NCT03581292|541067326|FG001|Overall Study|Withdrawal by Subject|0|||
149981405|NCT03581292|541067325|FG000|Overall Study|Withdrawal before Therapy Start|1|||
149981406|NCT03581292|541067326|FG001|Overall Study|Withdrawal before Therapy Start|0|||
149981407|NCT01142388|541068748|FG000|Overall Study|Lack of Efficacy|21|||
149981408|NCT01142388|541068749|FG001|Overall Study|Lack of Efficacy|31|||
149981409|NCT01142388|541068748|FG000|Overall Study|Adverse Event|9|||
149981410|NCT01142388|541068749|FG001|Overall Study|Adverse Event|5|||
149981411|NCT01142388|541068748|FG000|Overall Study|Death|3|||
149981412|NCT01142388|541068749|FG001|Overall Study|Death|2|||
149981413|NCT01142388|541068748|FG000|Overall Study|Withdrawal by Subject|5|||
149981414|NCT01142388|541068749|FG001|Overall Study|Withdrawal by Subject|3|||
149981415|NCT01142388|541068748|FG000|Overall Study|Alternative therapy|1|||
149981416|NCT01142388|541068749|FG001|Overall Study|Alternative therapy|0|||
149981417|NCT01142388|541068748|FG000|Overall Study|Other complications|0|||
149981418|NCT01142388|541068749|FG001|Overall Study|Other complications|2|||
149981419|NCT01142388|541068748|FG000|Overall Study|Other|1|||
149981420|NCT01142388|541068749|FG001|Overall Study|Other|1|||
149981421|NCT01142388|541068748|FG000|Overall Study|Never started therapy|7|||
149981422|NCT01142388|541068749|FG001|Overall Study|Never started therapy|3|||
149981423|NCT03052608|541068751|FG000|Treatment Phase|Adverse Event|10|||
149981424|NCT03052608|541068752|FG001|Treatment Phase|Adverse Event|12|||
149981425|NCT03052608|541068751|FG000|Treatment Phase|Death|6|||
149981426|NCT03052608|541068752|FG001|Treatment Phase|Death|4|||
149981427|NCT03052608|541068751|FG000|Treatment Phase|Withdrawal by Subject|4|||
149981428|NCT03052608|541068752|FG001|Treatment Phase|Withdrawal by Subject|12|||
149981429|NCT03052608|541068751|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
149981430|NCT03052608|541068752|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
149981431|NCT03052608|541068751|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
149981432|NCT03052608|541068752|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
149981433|NCT03052608|541068751|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
149981434|NCT03052608|541068752|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
149981435|NCT03052608|541068751|FG000|Treatment Phase|Ongoing|103|||
149981436|NCT03052608|541068752|FG001|Treatment Phase|Ongoing|31|||
149981437|NCT03052608|541068751|FG000|Long-Term Follow-up Phase|Death|23|||
149981438|NCT03052608|541068752|FG001|Long-Term Follow-up Phase|Death|28|||
149981439|NCT03052608|541068751|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
149981440|NCT03052608|541068752|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
149981441|NCT03052608|541068751|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
149981442|NCT03052608|541068752|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
149981443|NCT03052608|541068751|FG000|Long-Term Follow-up Phase|Ongoing|122|||
149981444|NCT03052608|541068752|FG001|Long-Term Follow-up Phase|Ongoing|99|||
149981445|NCT02522429|541068755|FG000|Overall Study|Lost to Follow-up|8|||
149981446|NCT02522429|541068755|FG000|Overall Study|Adverse Event|2|||
149981447|NCT02522429|541068755|FG000|Overall Study|Death|1|||
149981448|NCT02522429|541068755|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
149981449|NCT00600106|541068756|FG000|Overall Study|Withdrawal by Subject|1|||
149981450|NCT00600106|541068757|FG001|Overall Study|Withdrawal by Subject|1|||
149981451|NCT05554146|541068760|FG000|Overall Study|Adverse Event|0|||
149981452|NCT05554146|541068761|FG001|Overall Study|Adverse Event|1|||
149981453|NCT05554146|541068762|FG002|Overall Study|Adverse Event|0|||
149981454|NCT05554146|541068763|FG003|Overall Study|Adverse Event|0|||
149981455|NCT05554146|541068760|FG000|Overall Study|Protocol Violation|0|||
149981456|NCT05554146|541068761|FG001|Overall Study|Protocol Violation|1|||
149981457|NCT05554146|541068762|FG002|Overall Study|Protocol Violation|0|||
149981458|NCT05554146|541068763|FG003|Overall Study|Protocol Violation|0|||
149981459|NCT05554146|541068760|FG000|Overall Study|No longer interested in participating|0|||
149981460|NCT05554146|541068761|FG001|Overall Study|No longer interested in participating|0|||
149981461|NCT05554146|541068762|FG002|Overall Study|No longer interested in participating|1|||
149981462|NCT05554146|541068763|FG003|Overall Study|No longer interested in participating|0|||
149981463|NCT05554146|541068760|FG000|Overall Study|Lost to Follow-up|1|||
149981464|NCT05554146|541068761|FG001|Overall Study|Lost to Follow-up|0|||
149981465|NCT05554146|541068762|FG002|Overall Study|Lost to Follow-up|0|||
149981466|NCT05554146|541068763|FG003|Overall Study|Lost to Follow-up|0|||
149981467|NCT04667949|541068766|FG000|Overall Study|Adverse Event|0|||
149981468|NCT04667949|541068767|FG001|Overall Study|Adverse Event|2|||
149981469|NCT04667949|541068766|FG000|Overall Study|Lost to Follow-up|0|||
149981470|NCT04667949|541068767|FG001|Overall Study|Lost to Follow-up|1|||
149981471|NCT04667949|541068766|FG000|Overall Study|Physician Decision|0|||
149981472|NCT04667949|541068767|FG001|Overall Study|Physician Decision|2|||
149981473|NCT04667949|541068766|FG000|Overall Study|Subject decision|1|||
149981474|NCT04667949|541068767|FG001|Overall Study|Subject decision|7|||
149981475|NCT02213926|541068768|FG000|Overall Study|Death|59|||
149981476|NCT02213926|541068768|FG000|Overall Study|Withdrawal by Subject|10|||
149981477|NCT02213926|541068768|FG000|Overall Study|study terminated by sponsor|51|||
149981478|NCT02213926|541068768|FG000|Overall Study|Lost to Follow-up|3|||
149981479|NCT02213926|541068768|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
149981480|NCT01273038|541068769|FG000|Second Intervention (14 Days)|Adverse Event|0|||
149981481|NCT01273038|541068770|FG001|Second Intervention (14 Days)|Adverse Event|1|||
149981482|NCT01273038|541068769|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
149981483|NCT01273038|541068770|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
149981484|NCT05887908|541068771|FG000|Overall Study|Adverse Event|6|||
149981485|NCT05887908|541068772|FG001|Overall Study|Adverse Event|1|||
149981486|NCT05887908|541068773|FG002|Overall Study|Adverse Event|1|||
149981487|NCT05887908|541068771|FG000|Overall Study|Physician Decision|4|||
149981488|NCT05887908|541068772|FG001|Overall Study|Physician Decision|1|||
149981489|NCT05887908|541068773|FG002|Overall Study|Physician Decision|0|||
149981490|NCT05887908|541068771|FG000|Overall Study|Withdrawal by Subject|3|||
149981491|NCT05887908|541068772|FG001|Overall Study|Withdrawal by Subject|2|||
149981492|NCT05887908|541068773|FG002|Overall Study|Withdrawal by Subject|3|||
149981493|NCT05887908|541068771|FG000|Overall Study|Ineligibility after the start of the study|4|||
149981494|NCT05887908|541068772|FG001|Overall Study|Ineligibility after the start of the study|1|||
149981495|NCT05887908|541068773|FG002|Overall Study|Ineligibility after the start of the study|0|||
149981496|NCT05887908|541068771|FG000|Overall Study|Subject non-compliance|4|||
149981497|NCT05887908|541068772|FG001|Overall Study|Subject non-compliance|0|||
149981498|NCT05887908|541068773|FG002|Overall Study|Subject non-compliance|4|||
149981499|NCT05887908|541068771|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
149981500|NCT05887908|541068772|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
149981501|NCT05887908|541068773|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
149981502|NCT05887908|541068771|FG000|Overall Study|Pregnancy|0|||
149981503|NCT05887908|541068772|FG001|Overall Study|Pregnancy|1|||
149981504|NCT05887908|541068773|FG002|Overall Study|Pregnancy|0|||
149981505|NCT05887908|541068771|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
149981506|NCT05887908|541068772|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
149981507|NCT05887908|541068773|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
149981508|NCT05887908|541068771|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
149981509|NCT05887908|541068772|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
149981510|NCT05887908|541068773|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
149981511|NCT05887908|541068771|FG000|Overall Study|Other Reason|3|||
149981512|NCT05887908|541068772|FG001|Overall Study|Other Reason|3|||
149981513|NCT05887908|541068773|FG002|Overall Study|Other Reason|3|||
149981514|NCT02197572|541068778|FG000|Overall Study|Progressive Disease|28|||
149981515|NCT02197572|541068778|FG000|Overall Study|Withdrawal by Subject|9|||
149981516|NCT02197572|541068778|FG000|Overall Study|Adverse Event|3|||
149981517|NCT02197572|541068778|FG000|Overall Study|Reason Not Specified|4|||
149981518|NCT03458325|541068782|FG000|Overall Study|Withdrawal by Subject|1|||
149981519|NCT02630693|541068783|FG000|Overall Study|No receive treatment|0|||
149981520|NCT02630693|541068784|FG001|Overall Study|No receive treatment|1|||
149981521|NCT00175916|541068785|FG000|Overall Study|Death|19|||
149981522|NCT00175916|541068785|FG000|Overall Study|Adverse Event|81|||
149981523|NCT00175916|541068785|FG000|Overall Study|Lack of Efficacy|354|||
149981524|NCT00175916|541068785|FG000|Overall Study|Lost to Follow-up|17|||
149981525|NCT00175916|541068785|FG000|Overall Study|Subject Choice|98|||
149981526|NCT00175916|541068785|FG000|Overall Study|Lack of compliance|8|||
149981527|NCT00175916|541068785|FG000|Overall Study|Patient cannot record seizures|1|||
149981528|NCT00175916|541068785|FG000|Overall Study|Sponsor decision|17|||
149981529|NCT00175916|541068785|FG000|Overall Study|Vigabatrin intake|1|||
149981530|NCT00175916|541068785|FG000|Overall Study|Suicidal behaviour|1|||
149981531|NCT00175916|541068785|FG000|Overall Study|Withdrawal by Subject|1|||
149981532|NCT00175916|541068785|FG000|Overall Study|Seizure - free|4|||
149981533|NCT00175916|541068785|FG000|Overall Study|Administrative reason|1|||
149981534|NCT00175916|541068785|FG000|Overall Study|Pregnancy|1|||
149981535|NCT00175916|541068785|FG000|Overall Study|Patient's request|2|||
149981536|NCT00175916|541068785|FG000|Overall Study|Treating physiciant's choice|1|||
149981537|NCT00175916|541068785|FG000|Overall Study|Moved overseas|1|||
149981538|NCT00175916|541068785|FG000|Overall Study|Loss of job and economic burden|1|||
149981539|NCT00175916|541068785|FG000|Overall Study|Site was closed|9|||
149981540|NCT00175916|541068785|FG000|Overall Study|Patient went to prison|1|||
149981541|NCT04503551|541068786|FG000|Overall Study|Withdrawal by Subject|5|||
149981542|NCT04503551|541068787|FG001|Overall Study|Withdrawal by Subject|3|||
149981543|NCT04503551|541068786|FG000|Overall Study|Physician Decision|1|||
149981544|NCT04503551|541068787|FG001|Overall Study|Physician Decision|0|||
149981545|NCT04503551|541068786|FG000|Overall Study|Death|0|||
149981546|NCT04503551|541068787|FG001|Overall Study|Death|1|||
149981547|NCT04503551|541068786|FG000|Overall Study|Lost to Follow-up|1|||
149981548|NCT04503551|541068787|FG001|Overall Study|Lost to Follow-up|2|||
149981549|NCT04503551|541068786|FG000|Overall Study|Ongoing at Week 52|99|||
149981550|NCT04503551|541068787|FG001|Overall Study|Ongoing at Week 52|62|||
149981551|NCT05384834|541068795|FG000|Overall Study|Lost to Follow-up|43|||
149981552|NCT05384834|541068795|FG000|Overall Study|Withdrawal by Subject|5|||
149981553|NCT03951766|541068796|FG000|Treatment Phase|Lost to Follow-up|1|||
149981554|NCT03951766|541068796|FG000|Follow-up Phase|Lost to Follow-up|10|||
149981555|NCT05710640|541068799|FG000|Overall Study|Physician Decision|0|||
149981556|NCT05710640|541068800|FG001|Overall Study|Physician Decision|1|||
149981557|NCT05710640|541068799|FG000|Overall Study|Withdrawal by Subject|1|||
149981558|NCT05710640|541068800|FG001|Overall Study|Withdrawal by Subject|0|||
149981559|NCT05710640|541068799|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
149981560|NCT05710640|541068800|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
149981561|NCT04188509|541068801|FG000|Overall Study|Adverse Event|2|||
149981562|NCT04188509|541068801|FG000|Overall Study|Lost to Follow-up|1|||
149981563|NCT04188509|541068801|FG000|Overall Study|Withdrawal of Consent|1|||
149981564|NCT04188509|541068801|FG000|Overall Study|Discretion of Investigator|1|||
149981565|NCT04188509|541068801|FG000|Overall Study|Noncompliance|3|||
149981566|NCT04188509|541068801|FG000|Overall Study|Sponsor Decision|127|||
149981567|NCT04188509|541068801|FG000|Overall Study|Other|2|||
149981568|NCT04158375|541068802|FG000|Overall Study|Withdrawal by Subject|0|||
149981569|NCT04158375|541068803|FG001|Overall Study|Withdrawal by Subject|3|||
149981570|NCT04158375|541068804|FG002|Overall Study|Withdrawal by Subject|0|||
149981571|NCT04847843|541068805|FG000|Overall Study|Scheduling Conflicts|6|||
149981572|NCT04847843|541068806|FG001|Overall Study|Scheduling Conflicts|9|||
149981573|NCT04847843|541068805|FG000|Overall Study|Withdrawal by Subject|1|||
149981574|NCT04847843|541068806|FG001|Overall Study|Withdrawal by Subject|0|||
149981575|NCT04847843|541068805|FG000|Overall Study|Lost to Follow-up|1|||
149981576|NCT04847843|541068806|FG001|Overall Study|Lost to Follow-up|1|||
149981577|NCT04847843|541068805|FG000|Overall Study|Pregnancy|0|||
149981578|NCT04847843|541068806|FG001|Overall Study|Pregnancy|2|||
149981579|NCT04847843|541068805|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
149981580|NCT04847843|541068806|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
149981581|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
149981582|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
149981583|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
149981584|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
149981585|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
149981586|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
149981587|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
149981588|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
149981589|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
149981590|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
149981591|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
149981592|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
149981593|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
149981594|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
149981595|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
149981596|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
149981597|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
149981598|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
149981599|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
149981600|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
149981601|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
149981602|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
149981603|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
149981604|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
149981605|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Other|6|||
149981606|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Other|0|||
149981607|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Other|0|||
149981608|NCT05615220|541068807|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
149981609|NCT05615220|541068808|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
149981610|NCT05615220|541068809|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
149981611|NCT05615220|541068807|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
149981612|NCT05615220|541068808|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
149981613|NCT05615220|541068809|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
149981614|NCT05615220|541068807|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
149981615|NCT05615220|541068808|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
149981616|NCT05615220|541068809|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
149981617|NCT05615220|541068807|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
149981618|NCT05615220|541068808|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
149981619|NCT05615220|541068809|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
149981620|NCT05615220|541068807|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
149981621|NCT05615220|541068808|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
149981622|NCT05615220|541068809|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
149981623|NCT05615220|541068807|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
149981624|NCT05615220|541068808|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
149981625|NCT05615220|541068809|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
149981626|NCT01282866|541068819|FG000|Overall Study|Adverse Event|1|||
149981627|NCT01541865|541068820|FG000|Overall Study|Lost to Follow-up|11|||
149981628|NCT01541865|541068820|FG000|Overall Study|Withdrawal by Subject|9|||
149981629|NCT01541865|541068820|FG000|Overall Study|Adverse Event|1|||
149981630|NCT01541865|541068820|FG000|Overall Study|Protocol Violation|1|||
149981631|NCT00049257|541068826|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
149981632|NCT00049257|541068826|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
149981633|NCT00049257|541068826|FG000|Carboplatin, Paclitaxel|Death|2|||
149981634|NCT00049257|541068826|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
149981635|NCT04721158|541068827|FG000|Overall Study|Lost to Follow-up|4|||
149981636|NCT04721158|541068827|FG000|Overall Study|Device did not connect|1|||
149981637|NCT03462719|541068832|FG000|Overall Study|Withdrawal by Subject|4|||
149981638|NCT03462719|541068833|FG001|Overall Study|Withdrawal by Subject|3|||
149981639|NCT03462719|541068832|FG000|Overall Study|Ongoing|87|||
149981640|NCT03462719|541068833|FG001|Overall Study|Ongoing|72|||
149981641|NCT04108208|541068836|FG000|Overall Study|Withdrawal by Subject|2|||
149981642|NCT04108208|541068837|FG001|Overall Study|Withdrawal by Subject|6|||
149981643|NCT04108208|541068836|FG000|Overall Study|other-ongoing|20|||
149981644|NCT04108208|541068837|FG001|Overall Study|other-ongoing|40|||
149981645|NCT04108208|541068836|FG000|Overall Study|Death|1|||
149981646|NCT04108208|541068837|FG001|Overall Study|Death|4|||
149981647|NCT04108208|541068836|FG000|Overall Study|Lost to Follow-up|2|||
149981648|NCT04108208|541068837|FG001|Overall Study|Lost to Follow-up|0|||
149981649|NCT03670355|541068839|FG000|Overall Study|Adverse Event|1|||
149981650|NCT03670355|541068840|FG001|Overall Study|Adverse Event|0|||
149981651|NCT03670355|541068839|FG000|Overall Study|Unable to comply with study procedures|0|||
149981652|NCT03670355|541068840|FG001|Overall Study|Unable to comply with study procedures|1|||
149981653|NCT03670355|541068839|FG000|Overall Study|Participant refused|0|||
149981654|NCT03670355|541068840|FG001|Overall Study|Participant refused|1|||
149981655|NCT03517436|541068841|FG000|Overall Study|Death|3|||
149981656|NCT03517436|541068841|FG000|Overall Study|Withdrawal by Subject|4|||
149981657|NCT03517436|541068841|FG000|Overall Study|Did not receive study valve.|1|||
149981658|NCT04271540|541068842|FG000|Overall Study|Lost to Follow-up|1|||
149981659|NCT04271540|541068842|FG000|Overall Study|Screen Fail|5|||
149981660|NCT03307785|541068843|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
149981661|NCT03307785|541068844|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981662|NCT03307785|541068845|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981663|NCT03307785|541068846|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981664|NCT03307785|541068847|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981665|NCT03307785|541068848|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981666|NCT03307785|541068849|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981667|NCT03307785|541068850|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
150053426|NCT01590758|541336655|FG001|Overall Study|Physician Decision|2|||
149981668|NCT03307785|541068851|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981669|NCT03307785|541068852|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
150053427|NCT01590758|541336654|FG000|Overall Study|Lost to Follow-up|4|||
149981670|NCT03307785|541068853|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981671|NCT03307785|541068854|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981672|NCT03307785|541068855|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
149981673|NCT03307785|541068843|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
149981674|NCT03307785|541068844|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
149981675|NCT03307785|541068845|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981676|NCT03307785|541068846|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981677|NCT03307785|541068847|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981678|NCT03307785|541068848|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981679|NCT03307785|541068849|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981680|NCT03307785|541068850|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981681|NCT03307785|541068851|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981682|NCT03307785|541068852|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981683|NCT03307785|541068853|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981684|NCT03307785|541068854|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981685|NCT03307785|541068855|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
149981686|NCT03307785|541068843|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
149981687|NCT03307785|541068844|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
149981688|NCT03307785|541068845|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981689|NCT03307785|541068846|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981690|NCT03307785|541068847|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981691|NCT03307785|541068848|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981692|NCT03307785|541068849|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981693|NCT03307785|541068850|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981694|NCT03307785|541068851|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981695|NCT03307785|541068852|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981696|NCT03307785|541068853|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981697|NCT03307785|541068854|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981698|NCT03307785|541068855|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
149981699|NCT03307785|541068843|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
149981700|NCT03307785|541068844|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
149981701|NCT03307785|541068845|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981702|NCT03307785|541068846|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981703|NCT03307785|541068847|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981704|NCT03307785|541068848|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981705|NCT03307785|541068849|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981706|NCT03307785|541068850|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981707|NCT03307785|541068851|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981708|NCT03307785|541068852|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981709|NCT03307785|541068853|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981710|NCT03307785|541068854|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981711|NCT03307785|541068855|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
149981712|NCT03307785|541068843|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981713|NCT03307785|541068844|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981714|NCT03307785|541068845|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
149981715|NCT03307785|541068846|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981716|NCT03307785|541068847|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981717|NCT03307785|541068848|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981718|NCT03307785|541068849|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981719|NCT03307785|541068850|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981720|NCT03307785|541068851|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981721|NCT03307785|541068852|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981722|NCT03307785|541068853|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981723|NCT03307785|541068854|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981724|NCT03307785|541068855|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
149981725|NCT03307785|541068843|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981726|NCT03307785|541068844|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981727|NCT03307785|541068845|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
149981728|NCT03307785|541068846|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981729|NCT03307785|541068847|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981730|NCT03307785|541068848|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981731|NCT03307785|541068849|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981732|NCT03307785|541068850|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981733|NCT03307785|541068851|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981734|NCT03307785|541068852|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981735|NCT03307785|541068853|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981736|NCT03307785|541068854|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981737|NCT03307785|541068855|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
149981738|NCT03307785|541068843|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981739|NCT03307785|541068844|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981740|NCT03307785|541068845|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
149981741|NCT03307785|541068846|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981742|NCT03307785|541068847|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981743|NCT03307785|541068848|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981744|NCT03307785|541068849|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981745|NCT03307785|541068850|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981746|NCT03307785|541068851|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981747|NCT03307785|541068852|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981748|NCT03307785|541068853|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981749|NCT03307785|541068854|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981750|NCT03307785|541068855|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
149981751|NCT03307785|541068843|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981752|NCT03307785|541068844|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981753|NCT03307785|541068845|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
149981754|NCT03307785|541068846|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981755|NCT03307785|541068847|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981756|NCT03307785|541068848|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981757|NCT03307785|541068849|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981758|NCT03307785|541068850|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981759|NCT03307785|541068851|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981760|NCT03307785|541068852|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981761|NCT03307785|541068853|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981762|NCT03307785|541068854|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981763|NCT03307785|541068855|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
149981764|NCT03307785|541068843|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981765|NCT03307785|541068844|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981766|NCT03307785|541068845|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
149981767|NCT03307785|541068846|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981768|NCT03307785|541068847|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981769|NCT03307785|541068848|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981770|NCT03307785|541068849|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981771|NCT03307785|541068850|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981772|NCT03307785|541068851|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981773|NCT03307785|541068852|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981774|NCT03307785|541068853|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981775|NCT03307785|541068854|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981776|NCT03307785|541068855|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
149981777|NCT03307785|541068843|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981778|NCT03307785|541068844|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981779|NCT03307785|541068845|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981780|NCT03307785|541068846|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
149981781|NCT03307785|541068847|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
149981782|NCT03307785|541068848|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981783|NCT03307785|541068849|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981784|NCT03307785|541068850|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981785|NCT03307785|541068851|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981786|NCT03307785|541068852|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981787|NCT03307785|541068853|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981788|NCT03307785|541068854|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981789|NCT03307785|541068855|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
149981790|NCT03307785|541068843|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981791|NCT03307785|541068844|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981792|NCT03307785|541068845|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981793|NCT03307785|541068846|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
149981794|NCT03307785|541068847|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
149981795|NCT03307785|541068848|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981796|NCT03307785|541068849|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981797|NCT03307785|541068850|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981798|NCT03307785|541068851|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981799|NCT03307785|541068852|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981800|NCT03307785|541068853|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981801|NCT03307785|541068854|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981802|NCT03307785|541068855|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
149981803|NCT03307785|541068843|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981804|NCT03307785|541068844|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981805|NCT03307785|541068845|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981806|NCT03307785|541068846|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
149981807|NCT03307785|541068847|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981808|NCT03307785|541068848|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981809|NCT03307785|541068849|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981810|NCT03307785|541068850|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981811|NCT03307785|541068851|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981812|NCT03307785|541068852|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981813|NCT03307785|541068853|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981814|NCT03307785|541068854|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981815|NCT03307785|541068855|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
149981816|NCT03307785|541068843|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981817|NCT03307785|541068844|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981818|NCT03307785|541068845|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981819|NCT03307785|541068846|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981820|NCT03307785|541068847|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
149981821|NCT03307785|541068848|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981822|NCT03307785|541068849|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981823|NCT03307785|541068850|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981824|NCT03307785|541068851|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981825|NCT03307785|541068852|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981826|NCT03307785|541068853|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981827|NCT03307785|541068854|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981828|NCT03307785|541068855|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
149981829|NCT03307785|541068843|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981830|NCT03307785|541068844|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981831|NCT03307785|541068845|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981832|NCT03307785|541068846|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981833|NCT03307785|541068847|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981834|NCT03307785|541068848|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
149981835|NCT03307785|541068849|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981836|NCT03307785|541068850|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981837|NCT03307785|541068851|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981838|NCT03307785|541068852|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981839|NCT03307785|541068853|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981840|NCT03307785|541068854|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981841|NCT03307785|541068855|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
149981842|NCT03307785|541068843|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981843|NCT03307785|541068844|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981844|NCT03307785|541068845|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981845|NCT03307785|541068846|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981846|NCT03307785|541068847|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981847|NCT03307785|541068848|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
149981848|NCT03307785|541068849|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981849|NCT03307785|541068850|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981850|NCT03307785|541068851|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981851|NCT03307785|541068852|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981852|NCT03307785|541068853|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981853|NCT03307785|541068854|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981854|NCT03307785|541068855|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
149981855|NCT03307785|541068843|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981856|NCT03307785|541068844|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981857|NCT03307785|541068845|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981858|NCT03307785|541068846|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
150053428|NCT01590758|541336655|FG001|Overall Study|Lost to Follow-up|2|||
150053429|NCT04525885|541336656|FG000|Overall Study|Screen Failure|1|||
149981859|NCT03307785|541068847|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981860|NCT03307785|541068848|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
149981861|NCT03307785|541068849|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981862|NCT03307785|541068850|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981863|NCT03307785|541068851|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981864|NCT03307785|541068852|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981865|NCT03307785|541068853|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981866|NCT03307785|541068854|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981867|NCT03307785|541068855|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
149981868|NCT03307785|541068843|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981869|NCT03307785|541068844|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981870|NCT03307785|541068845|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981871|NCT03307785|541068846|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981872|NCT03307785|541068847|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981873|NCT03307785|541068848|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
149981874|NCT03307785|541068849|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981875|NCT03307785|541068850|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981876|NCT03307785|541068851|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981877|NCT03307785|541068852|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981878|NCT03307785|541068853|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981879|NCT03307785|541068854|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981880|NCT03307785|541068855|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
149981881|NCT03307785|541068843|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981882|NCT03307785|541068844|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981883|NCT03307785|541068845|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981884|NCT03307785|541068846|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981885|NCT03307785|541068847|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981886|NCT03307785|541068848|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
149981887|NCT03307785|541068849|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981888|NCT03307785|541068850|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981889|NCT03307785|541068851|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981890|NCT03307785|541068852|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981891|NCT03307785|541068853|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981892|NCT03307785|541068854|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981893|NCT03307785|541068855|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
149981894|NCT03307785|541068843|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981895|NCT03307785|541068844|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981896|NCT03307785|541068845|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981897|NCT03307785|541068846|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981898|NCT03307785|541068847|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981899|NCT03307785|541068848|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981900|NCT03307785|541068849|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
149981901|NCT03307785|541068850|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981902|NCT03307785|541068851|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981903|NCT03307785|541068852|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981904|NCT03307785|541068853|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981905|NCT03307785|541068854|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981906|NCT03307785|541068855|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
149981907|NCT03307785|541068843|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981908|NCT03307785|541068844|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981909|NCT03307785|541068845|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981910|NCT03307785|541068846|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981911|NCT03307785|541068847|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981912|NCT03307785|541068848|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981913|NCT03307785|541068849|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
149981914|NCT03307785|541068850|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981915|NCT03307785|541068851|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981916|NCT03307785|541068852|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981917|NCT03307785|541068853|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981918|NCT03307785|541068854|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981919|NCT03307785|541068855|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
149981920|NCT03307785|541068843|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981921|NCT03307785|541068844|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981922|NCT03307785|541068845|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981923|NCT03307785|541068846|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981924|NCT03307785|541068847|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981925|NCT03307785|541068848|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981926|NCT03307785|541068849|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981927|NCT03307785|541068850|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
149981928|NCT03307785|541068851|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981929|NCT03307785|541068852|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981930|NCT03307785|541068853|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981931|NCT03307785|541068854|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981932|NCT03307785|541068855|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
149981933|NCT03307785|541068843|FG000|PACT Phase: Up to 19 Months|Death|0|||
149981934|NCT03307785|541068844|FG001|PACT Phase: Up to 19 Months|Death|0|||
149981935|NCT03307785|541068845|FG002|PACT Phase: Up to 19 Months|Death|0|||
149981936|NCT03307785|541068846|FG003|PACT Phase: Up to 19 Months|Death|0|||
149981937|NCT03307785|541068847|FG004|PACT Phase: Up to 19 Months|Death|0|||
149981938|NCT03307785|541068848|FG005|PACT Phase: Up to 19 Months|Death|0|||
149981939|NCT03307785|541068849|FG006|PACT Phase: Up to 19 Months|Death|0|||
149981940|NCT03307785|541068850|FG007|PACT Phase: Up to 19 Months|Death|0|||
149981941|NCT03307785|541068851|FG008|PACT Phase: Up to 19 Months|Death|0|||
149981942|NCT03307785|541068852|FG009|PACT Phase: Up to 19 Months|Death|0|||
149981943|NCT03307785|541068853|FG010|PACT Phase: Up to 19 Months|Death|0|||
149981944|NCT03307785|541068854|FG011|PACT Phase: Up to 19 Months|Death|0|||
149981945|NCT03307785|541068855|FG012|PACT Phase: Up to 19 Months|Death|1|||
149981946|NCT05526521|541068859|FG000|Overall Study|Withdrawal by Subject|0|||
149981947|NCT05526521|541068860|FG001|Overall Study|Withdrawal by Subject|1|||
149981948|NCT05526521|541068861|FG002|Overall Study|Withdrawal by Subject|0|||
149981949|NCT05526521|541068862|FG003|Overall Study|Withdrawal by Subject|0|||
149981950|NCT03919929|541068863|FG000|Overall Study|Withdrawal by Subject|0|||
149981951|NCT03919929|541068864|FG001|Overall Study|Withdrawal by Subject|4|||
149981952|NCT03919929|541068863|FG000|Overall Study|Screen Failure|0|||
149981953|NCT03919929|541068864|FG001|Overall Study|Screen Failure|5|||
149981954|NCT01402869|541068865|FG000|Overall Study|Required Tooth Extraction|0|||
149981955|NCT01402869|541068866|FG001|Overall Study|Required Tooth Extraction|0|||
149981956|NCT01402869|541068867|FG002|Overall Study|Required Tooth Extraction|1|||
149981957|NCT00642707|541068868|FG000|Overall Study|Adverse Event|0|||
149981958|NCT00642707|541068869|FG001|Overall Study|Adverse Event|0|||
149981959|NCT00642707|541068870|FG002|Overall Study|Adverse Event|0|||
149981960|NCT00642707|541068871|FG003|Overall Study|Adverse Event|2|||
149981961|NCT00642707|541068868|FG000|Overall Study|Withdrawal by Subject|1|||
149981962|NCT00642707|541068869|FG001|Overall Study|Withdrawal by Subject|0|||
149981963|NCT00642707|541068870|FG002|Overall Study|Withdrawal by Subject|0|||
149981964|NCT00642707|541068871|FG003|Overall Study|Withdrawal by Subject|0|||
149981965|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
149981966|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
149981967|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
149981968|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981969|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981970|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981971|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981972|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981973|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981974|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981975|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981976|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981977|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981978|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981979|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981980|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
149981981|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
149981982|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
149981983|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981984|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981985|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981986|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981987|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981988|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981989|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981990|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981991|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981992|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981993|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981994|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981995|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981996|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
149981997|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149981998|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149981999|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982000|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
149982001|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982002|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982003|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982004|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982005|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982006|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982007|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982008|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982009|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982010|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982011|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982012|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
149982013|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982014|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982015|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
149982016|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982017|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982018|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982019|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982020|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982021|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982022|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982023|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982024|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982025|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982026|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982027|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982028|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
149982029|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982030|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982031|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982032|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
149982033|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982034|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982035|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982036|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982037|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982038|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982039|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982040|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982041|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982042|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982043|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982044|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
149982045|NCT02891226|541068872|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982046|NCT02891226|541068873|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982047|NCT02891226|541068874|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982048|NCT02891226|541068875|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
150053430|NCT04525885|541336657|FG001|Overall Study|Screen Failure|0|||
149982049|NCT02891226|541068876|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982050|NCT02891226|541068877|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982051|NCT02891226|541068878|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982052|NCT02891226|541068879|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982053|NCT02891226|541068880|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982054|NCT02891226|541068881|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982055|NCT02891226|541068882|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982056|NCT02891226|541068883|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982057|NCT02891226|541068884|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982058|NCT02891226|541068885|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982059|NCT02891226|541068886|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982060|NCT02891226|541068887|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
149982061|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982062|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982063|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982064|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982065|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982066|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982067|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
149982068|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
149982069|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
149982070|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
149982071|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982072|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982073|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982074|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982075|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982076|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
149982077|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982078|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982079|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982080|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982081|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982082|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
149982083|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982084|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982085|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982086|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
149982087|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982088|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982089|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982090|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982091|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982092|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
149982093|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982094|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982095|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982096|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982097|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982098|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982099|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
149982100|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
149982101|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
149982102|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
149982103|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982104|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982105|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982106|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982107|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982108|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
149982109|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982110|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982111|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982112|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982113|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
149982114|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982115|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982116|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982117|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982118|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982119|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982120|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
150178670|NCT00546754|541791995|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
150178671|NCT00546754|541791996|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
149982121|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982122|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982123|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982124|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
149982125|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982126|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982127|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
150178672|NCT00546754|541791995|FG000|Overall Study|Hip Replacement|1|||
149982128|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982129|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982130|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
150053431|NCT04525885|541336658|FG002|Overall Study|Screen Failure|0|||
149982131|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
149982132|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982133|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982134|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982135|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982136|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982137|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982138|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982139|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982140|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149982141|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982142|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982143|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982144|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982145|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982146|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982147|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982148|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
149982149|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
149982150|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
149982151|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982152|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982153|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982154|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982155|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982156|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
149982157|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982158|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982159|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982160|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982161|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982162|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982163|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982164|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
149982165|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982166|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982167|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982168|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982169|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982170|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982171|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982172|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
149982173|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982174|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982175|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982176|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982177|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982178|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982179|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982180|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982181|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
149982182|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982183|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982184|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982185|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982186|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982187|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
150178673|NCT00546754|541791996|FG001|Overall Study|Hip Replacement|0|||
149982188|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
149982189|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982190|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982191|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982192|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982193|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982194|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982195|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982196|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982197|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982198|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
149982199|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982200|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982201|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982202|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982203|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982204|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
149982205|NCT02891226|541068872|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982206|NCT02891226|541068873|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982207|NCT02891226|541068874|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982208|NCT02891226|541068875|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982209|NCT02891226|541068876|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982210|NCT02891226|541068877|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982211|NCT02891226|541068878|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982212|NCT02891226|541068879|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982213|NCT02891226|541068880|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982214|NCT02891226|541068881|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
149982215|NCT02891226|541068882|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982216|NCT02891226|541068883|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982217|NCT02891226|541068884|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982218|NCT02891226|541068885|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982219|NCT02891226|541068886|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982220|NCT02891226|541068887|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
149982221|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982222|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982223|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982224|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982225|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982226|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982227|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982228|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982229|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982230|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982231|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
149982232|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982233|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982234|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982235|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982236|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
149982237|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982238|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982239|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982240|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982241|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982242|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982243|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982244|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982245|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982246|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982247|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
149982248|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982249|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982250|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982251|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982252|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
149982253|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982254|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982255|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982256|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982257|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982258|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982259|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982260|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982261|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982262|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982263|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
149982264|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982265|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982266|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982267|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982268|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
149982269|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982270|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982271|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982272|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982273|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
150178674|NCT00546754|541791995|FG000|Overall Study|Suicide|1|||
149982274|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982275|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982276|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982277|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982278|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982279|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
149982280|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982281|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982282|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982283|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982284|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
149982285|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982286|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982287|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982288|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982289|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982290|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982291|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982292|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982293|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982294|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982295|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
149982296|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982297|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982298|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982299|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982300|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
149982301|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982302|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982303|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982304|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982305|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982306|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982307|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982308|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982309|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982310|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982311|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
149982312|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982313|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982314|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982315|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982316|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
149982317|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982318|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982319|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982320|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982321|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982322|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982323|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982324|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982325|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982326|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982327|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
149982328|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982329|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982330|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982331|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982332|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
149982333|NCT02891226|541068872|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982334|NCT02891226|541068873|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
150178675|NCT00546754|541791996|FG001|Overall Study|Suicide|0|||
149982335|NCT02891226|541068874|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982336|NCT02891226|541068875|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982337|NCT02891226|541068876|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982338|NCT02891226|541068877|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982339|NCT02891226|541068878|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982340|NCT02891226|541068879|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982341|NCT02891226|541068880|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982342|NCT02891226|541068881|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982343|NCT02891226|541068882|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
149982344|NCT02891226|541068883|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982345|NCT02891226|541068884|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982346|NCT02891226|541068885|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982347|NCT02891226|541068886|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982348|NCT02891226|541068887|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
149982349|NCT02891226|541068872|FG000|Follow-up Period|Withdrawal by Subject|0|||
149982350|NCT02891226|541068873|FG001|Follow-up Period|Withdrawal by Subject|0|||
149982351|NCT02891226|541068874|FG002|Follow-up Period|Withdrawal by Subject|0|||
149982352|NCT02891226|541068875|FG003|Follow-up Period|Withdrawal by Subject|0|||
149982353|NCT02891226|541068876|FG004|Follow-up Period|Withdrawal by Subject|0|||
149982354|NCT02891226|541068877|FG005|Follow-up Period|Withdrawal by Subject|0|||
149982355|NCT02891226|541068878|FG006|Follow-up Period|Withdrawal by Subject|0|||
149982356|NCT02891226|541068879|FG007|Follow-up Period|Withdrawal by Subject|0|||
149982357|NCT02891226|541068880|FG008|Follow-up Period|Withdrawal by Subject|0|||
149982358|NCT02891226|541068881|FG009|Follow-up Period|Withdrawal by Subject|0|||
149982359|NCT02891226|541068882|FG010|Follow-up Period|Withdrawal by Subject|0|||
149982360|NCT02891226|541068883|FG011|Follow-up Period|Withdrawal by Subject|1|||
149982361|NCT02891226|541068884|FG012|Follow-up Period|Withdrawal by Subject|0|||
149982362|NCT02891226|541068885|FG013|Follow-up Period|Withdrawal by Subject|0|||
149982363|NCT02891226|541068886|FG014|Follow-up Period|Withdrawal by Subject|1|||
149982364|NCT02891226|541068887|FG015|Follow-up Period|Withdrawal by Subject|1|||
149982365|NCT00325130|541068890|FG000|Overall Study|Lost to Follow-up|6|||
149982366|NCT00325130|541068891|FG001|Overall Study|Lost to Follow-up|14|||
149982367|NCT00325130|541068890|FG000|Overall Study|Withdrawal by Subject|12|||
149982368|NCT00325130|541068891|FG001|Overall Study|Withdrawal by Subject|14|||
149982369|NCT00325130|541068890|FG000|Overall Study|Protocol Deviation|0|||
149982370|NCT00325130|541068891|FG001|Overall Study|Protocol Deviation|1|||
149982371|NCT00325130|541068890|FG000|Overall Study|Moved|0|||
149982372|NCT00325130|541068891|FG001|Overall Study|Moved|1|||
149982373|NCT00325130|541068890|FG000|Overall Study|Patient Discontinued for Other|1|||
149982374|NCT00325130|541068891|FG001|Overall Study|Patient Discontinued for Other|0|||
149982375|NCT01671956|541068892|FG000|Overall Study|Disease progression|0|||
149982376|NCT01671956|541068893|FG001|Overall Study|Disease progression|1|||
149982377|NCT01671956|541068892|FG000|Overall Study|Withdrawal by Subject|1|||
149982378|NCT01671956|541068893|FG001|Overall Study|Withdrawal by Subject|1|||
149982379|NCT01671956|541068892|FG000|Overall Study|Adverse Event|1|||
149982380|NCT01671956|541068893|FG001|Overall Study|Adverse Event|0|||
149982381|NCT01566149|541069997|FG000|Overall Study|Adverse Event|0|||
149982382|NCT01566149|541069998|FG001|Overall Study|Adverse Event|1|||
149982383|NCT01566149|541069997|FG000|Overall Study|Non-compliance with study medication|2|||
149982384|NCT01566149|541069998|FG001|Overall Study|Non-compliance with study medication|0|||
149982385|NCT01566149|541069997|FG000|Overall Study|Protocol Violation|0|||
149982386|NCT01566149|541069998|FG001|Overall Study|Protocol Violation|1|||
149982387|NCT01566149|541069997|FG000|Overall Study|Withdrawal by Subject|1|||
149982388|NCT01566149|541069998|FG001|Overall Study|Withdrawal by Subject|0|||
149982389|NCT03687957|541070003|FG000|Overall Study|Withdrawal by Subject|0|||
149982390|NCT03687957|541070004|FG001|Overall Study|Withdrawal by Subject|0|||
149982391|NCT03687957|541070005|FG002|Overall Study|Withdrawal by Subject|0|||
149982392|NCT03687957|541070006|FG003|Overall Study|Withdrawal by Subject|2|||
149982393|NCT03687957|541070007|FG004|Overall Study|Withdrawal by Subject|0|||
149982394|NCT03687957|541070008|FG005|Overall Study|Withdrawal by Subject|0|||
149982395|NCT03687957|541070009|FG006|Overall Study|Withdrawal by Subject|3|||
150053432|NCT04525885|541336656|FG000|Overall Study|Withdrawal by Subject|14|||
149982396|NCT03687957|541070010|FG007|Overall Study|Withdrawal by Subject|1|||
149982397|NCT03687957|541070011|FG008|Overall Study|Withdrawal by Subject|1|||
149982398|NCT03687957|541070012|FG009|Overall Study|Withdrawal by Subject|0|||
149982399|NCT03687957|541070003|FG000|Overall Study|Disease progression|0|||
149982400|NCT03687957|541070004|FG001|Overall Study|Disease progression|1|||
149982401|NCT03687957|541070005|FG002|Overall Study|Disease progression|1|||
149982402|NCT03687957|541070006|FG003|Overall Study|Disease progression|2|||
149982403|NCT03687957|541070007|FG004|Overall Study|Disease progression|2|||
149982404|NCT03687957|541070008|FG005|Overall Study|Disease progression|0|||
149982405|NCT03687957|541070009|FG006|Overall Study|Disease progression|2|||
149982406|NCT03687957|541070010|FG007|Overall Study|Disease progression|1|||
149982407|NCT03687957|541070011|FG008|Overall Study|Disease progression|0|||
149982408|NCT03687957|541070012|FG009|Overall Study|Disease progression|0|||
149982409|NCT03687957|541070003|FG000|Overall Study|Physician Decision|0|||
149982410|NCT03687957|541070004|FG001|Overall Study|Physician Decision|0|||
149982411|NCT03687957|541070005|FG002|Overall Study|Physician Decision|0|||
149982412|NCT03687957|541070006|FG003|Overall Study|Physician Decision|2|||
149982413|NCT03687957|541070007|FG004|Overall Study|Physician Decision|1|||
149982414|NCT03687957|541070008|FG005|Overall Study|Physician Decision|0|||
149982415|NCT03687957|541070009|FG006|Overall Study|Physician Decision|1|||
149982416|NCT03687957|541070010|FG007|Overall Study|Physician Decision|0|||
149982417|NCT03687957|541070011|FG008|Overall Study|Physician Decision|0|||
149982418|NCT03687957|541070012|FG009|Overall Study|Physician Decision|0|||
149982419|NCT03687957|541070003|FG000|Overall Study|New malignancy|0|||
149982420|NCT03687957|541070004|FG001|Overall Study|New malignancy|0|||
149982421|NCT03687957|541070005|FG002|Overall Study|New malignancy|0|||
149982422|NCT03687957|541070006|FG003|Overall Study|New malignancy|0|||
149982423|NCT03687957|541070007|FG004|Overall Study|New malignancy|1|||
149982424|NCT03687957|541070008|FG005|Overall Study|New malignancy|0|||
149982425|NCT03687957|541070009|FG006|Overall Study|New malignancy|0|||
149982426|NCT03687957|541070010|FG007|Overall Study|New malignancy|0|||
149982427|NCT03687957|541070011|FG008|Overall Study|New malignancy|0|||
149982428|NCT03687957|541070012|FG009|Overall Study|New malignancy|0|||
149982429|NCT03687957|541070003|FG000|Overall Study|Adverse Event|0|||
149982430|NCT03687957|541070004|FG001|Overall Study|Adverse Event|0|||
149982431|NCT03687957|541070005|FG002|Overall Study|Adverse Event|0|||
149982432|NCT03687957|541070006|FG003|Overall Study|Adverse Event|0|||
149982433|NCT03687957|541070007|FG004|Overall Study|Adverse Event|0|||
149982434|NCT03687957|541070008|FG005|Overall Study|Adverse Event|2|||
149982435|NCT03687957|541070009|FG006|Overall Study|Adverse Event|0|||
149982436|NCT03687957|541070010|FG007|Overall Study|Adverse Event|3|||
149982437|NCT03687957|541070011|FG008|Overall Study|Adverse Event|0|||
149982438|NCT03687957|541070012|FG009|Overall Study|Adverse Event|0|||
149982439|NCT03687957|541070003|FG000|Overall Study|Patient went on hospice|0|||
149982440|NCT03687957|541070004|FG001|Overall Study|Patient went on hospice|0|||
149982441|NCT03687957|541070005|FG002|Overall Study|Patient went on hospice|0|||
149982442|NCT03687957|541070006|FG003|Overall Study|Patient went on hospice|0|||
149982443|NCT03687957|541070007|FG004|Overall Study|Patient went on hospice|0|||
149982444|NCT03687957|541070008|FG005|Overall Study|Patient went on hospice|0|||
149982445|NCT03687957|541070009|FG006|Overall Study|Patient went on hospice|1|||
149982446|NCT03687957|541070010|FG007|Overall Study|Patient went on hospice|0|||
149982447|NCT03687957|541070011|FG008|Overall Study|Patient went on hospice|0|||
149982448|NCT03687957|541070012|FG009|Overall Study|Patient went on hospice|0|||
149982449|NCT03687957|541070003|FG000|Overall Study|Death|0|||
149982450|NCT03687957|541070004|FG001|Overall Study|Death|0|||
149982451|NCT03687957|541070005|FG002|Overall Study|Death|0|||
149982452|NCT03687957|541070006|FG003|Overall Study|Death|0|||
149982453|NCT03687957|541070007|FG004|Overall Study|Death|0|||
149982454|NCT03687957|541070008|FG005|Overall Study|Death|0|||
149982455|NCT03687957|541070009|FG006|Overall Study|Death|0|||
149982456|NCT03687957|541070010|FG007|Overall Study|Death|1|||
149982457|NCT03687957|541070011|FG008|Overall Study|Death|0|||
149982458|NCT03687957|541070012|FG009|Overall Study|Death|0|||
149982459|NCT01693250|541070021|FG000|Overall Study|Lost to Follow-up|2|||
149982460|NCT01693250|541070022|FG001|Overall Study|Lost to Follow-up|2|||
149982461|NCT02297815|541070030|FG000|Overall Study|Lost to Follow-up|236|||
149982462|NCT02297815|541070031|FG001|Overall Study|Lost to Follow-up|140|||
149982463|NCT00620373|541070036|FG000|Overall Study|Unverified cancer status|33|||
149982464|NCT01897727|541070037|FG000|Overall Study|Exclusion: central sleep apnea|0|||
149982465|NCT01897727|541070038|FG001|Overall Study|Exclusion: central sleep apnea|1|||
149982466|NCT01061723|541070039|FG000|Overall Study|Adverse Event|0|||
149982467|NCT01061723|541070040|FG001|Overall Study|Adverse Event|2|||
149982468|NCT01061723|541070041|FG002|Overall Study|Adverse Event|5|||
149982469|NCT01061723|541070042|FG003|Overall Study|Adverse Event|5|||
149982470|NCT01061723|541070043|FG004|Overall Study|Adverse Event|2|||
149982471|NCT01061723|541070044|FG005|Overall Study|Adverse Event|6|||
149982472|NCT01061723|541070039|FG000|Overall Study|Lack of Efficacy|2|||
149982473|NCT01061723|541070040|FG001|Overall Study|Lack of Efficacy|3|||
149982474|NCT01061723|541070041|FG002|Overall Study|Lack of Efficacy|4|||
149982475|NCT01061723|541070042|FG003|Overall Study|Lack of Efficacy|2|||
149982476|NCT01061723|541070043|FG004|Overall Study|Lack of Efficacy|1|||
149982477|NCT01061723|541070044|FG005|Overall Study|Lack of Efficacy|1|||
149982478|NCT01061723|541070039|FG000|Overall Study|Randomized but not treated|0|||
149982479|NCT01061723|541070040|FG001|Overall Study|Randomized but not treated|0|||
150053433|NCT04525885|541336657|FG001|Overall Study|Withdrawal by Subject|6|||
149982480|NCT01061723|541070041|FG002|Overall Study|Randomized but not treated|0|||
149982481|NCT01061723|541070042|FG003|Overall Study|Randomized but not treated|0|||
149982482|NCT01061723|541070043|FG004|Overall Study|Randomized but not treated|0|||
149982483|NCT01061723|541070044|FG005|Overall Study|Randomized but not treated|1|||
149982484|NCT01061723|541070039|FG000|Overall Study|Other than specified above|2|||
149982485|NCT01061723|541070040|FG001|Overall Study|Other than specified above|1|||
149982486|NCT01061723|541070041|FG002|Overall Study|Other than specified above|1|||
149982487|NCT01061723|541070042|FG003|Overall Study|Other than specified above|1|||
149982488|NCT01061723|541070043|FG004|Overall Study|Other than specified above|0|||
149982489|NCT01061723|541070044|FG005|Overall Study|Other than specified above|1|||
149982490|NCT00293813|541070045|FG000|Overall Study|Physician Decision|0|||
149982491|NCT00293813|541070046|FG001|Overall Study|Physician Decision|1|||
149982492|NCT00293813|541070047|FG002|Overall Study|Physician Decision|0|||
149982493|NCT00293813|541070045|FG000|Overall Study|Adverse Event|3|||
149982494|NCT00293813|541070046|FG001|Overall Study|Adverse Event|1|||
149982495|NCT00293813|541070047|FG002|Overall Study|Adverse Event|1|||
149982496|NCT00293813|541070045|FG000|Overall Study|Withdrawal by Subject|7|||
149982497|NCT00293813|541070046|FG001|Overall Study|Withdrawal by Subject|4|||
149982498|NCT00293813|541070047|FG002|Overall Study|Withdrawal by Subject|4|||
149982499|NCT00293813|541070045|FG000|Overall Study|Lost to Follow-up|3|||
149982500|NCT00293813|541070046|FG001|Overall Study|Lost to Follow-up|2|||
149982501|NCT00293813|541070047|FG002|Overall Study|Lost to Follow-up|3|||
149982502|NCT00293813|541070045|FG000|Overall Study|Noncompliance|0|||
149982503|NCT00293813|541070046|FG001|Overall Study|Noncompliance|1|||
149982504|NCT00293813|541070047|FG002|Overall Study|Noncompliance|0|||
149982505|NCT00460655|541070052|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
149982506|NCT00460655|541070053|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149982507|NCT00460655|541070054|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149982508|NCT00460655|541070055|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149982509|NCT00460655|541070052|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
149982510|NCT00460655|541070053|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149982511|NCT00460655|541070054|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149982512|NCT00460655|541070055|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149982513|NCT00460655|541070052|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
149982514|NCT00460655|541070053|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
149982515|NCT00460655|541070054|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
149982516|NCT00460655|541070055|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
149982517|NCT00460655|541070052|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149982518|NCT00460655|541070053|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149982519|NCT00460655|541070054|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
149982520|NCT00460655|541070055|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
149982521|NCT00460655|541070052|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149982522|NCT00460655|541070053|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149982523|NCT00460655|541070054|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
149982524|NCT00460655|541070055|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
149982525|NCT00460655|541070052|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
149982526|NCT00460655|541070053|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
149982527|NCT00460655|541070054|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
149982528|NCT00460655|541070055|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
149982529|NCT03650413|541070056|FG000|Overall Study|Adverse Event|1|||
149982530|NCT03650413|541070056|FG000|Overall Study|Lack of Efficacy|17|||
149982531|NCT03650413|541070056|FG000|Overall Study|Other|9|||
149982532|NCT03650413|541070056|FG000|Overall Study|Physician Decision|2|||
149982533|NCT03650413|541070056|FG000|Overall Study|Study Terminated By Sponsor|16|||
149982534|NCT03650413|541070056|FG000|Overall Study|Withdrawal by Subject|16|||
149982535|NCT00910910|541070057|FG000|Overall Study|Adverse Event|63|||
149982536|NCT00910910|541070058|FG001|Overall Study|Adverse Event|35|||
149982537|NCT00910910|541070057|FG000|Overall Study|PD without histologic change|27|||
149982538|NCT00910910|541070058|FG001|Overall Study|PD without histologic change|23|||
149982539|NCT00910910|541070057|FG000|Overall Study|PD with histologic change|0|||
149982540|NCT00910910|541070058|FG001|Overall Study|PD with histologic change|2|||
149982541|NCT00910910|541070057|FG000|Overall Study|Withdrawal by Subject|7|||
149982542|NCT00910910|541070058|FG001|Overall Study|Withdrawal by Subject|5|||
149982543|NCT00910910|541070057|FG000|Overall Study|Lost to Follow-up|2|||
149982544|NCT00910910|541070058|FG001|Overall Study|Lost to Follow-up|2|||
149982545|NCT00910910|541070057|FG000|Overall Study|Death|9|||
149982546|NCT00910910|541070058|FG001|Overall Study|Death|3|||
149982547|NCT00910910|541070057|FG000|Overall Study|Protocol Violation|2|||
149982548|NCT00910910|541070058|FG001|Overall Study|Protocol Violation|2|||
149982549|NCT00910910|541070057|FG000|Overall Study|Completed 13 cycles of treatment|0|||
149982550|NCT00910910|541070058|FG001|Overall Study|Completed 13 cycles of treatment|118|||
149982551|NCT00910910|541070057|FG000|Overall Study|Other|114|||
149982552|NCT00910910|541070058|FG001|Overall Study|Other|32|||
150053434|NCT04525885|541336658|FG002|Overall Study|Withdrawal by Subject|20|||
150053435|NCT04525885|541336656|FG000|Overall Study|Physician Decision|1|||
149982553|NCT00910910|541070057|FG000|Overall Study|Untreated before cycle 1|1|||
149982554|NCT00910910|541070058|FG001|Overall Study|Untreated before cycle 1|2|||
149982555|NCT01973231|541070059|FG000|Overall Study|Protocol Violation|1|||
149982556|NCT01973231|541070060|FG001|Overall Study|Protocol Violation|1|||
149982557|NCT01973231|541070059|FG000|Overall Study|Lost to Follow-up|1|||
149982558|NCT01973231|541070060|FG001|Overall Study|Lost to Follow-up|1|||
149982559|NCT01973231|541070059|FG000|Overall Study|unclassified|2|||
149982560|NCT01973231|541070060|FG001|Overall Study|unclassified|1|||
149982561|NCT01973231|541070059|FG000|Overall Study|Withdrawal by Subject|7|||
149982562|NCT01973231|541070060|FG001|Overall Study|Withdrawal by Subject|9|||
149982563|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
149982564|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
149982565|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982566|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982567|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982568|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982569|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982570|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982571|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982572|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
149982573|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
149982574|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
149982575|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982576|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982577|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982578|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982579|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982580|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982581|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982582|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
149982583|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
149982584|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982585|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982586|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982587|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982588|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982589|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982590|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982591|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982592|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
149982593|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
149982594|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
149982595|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982596|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982597|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982598|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982599|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982600|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982601|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982602|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
149982603|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982604|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
149982605|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982606|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982607|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982608|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982609|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982610|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982611|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982612|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
149982613|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
149982614|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
149982615|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982616|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982617|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982618|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982619|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982620|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982621|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982622|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
149982623|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
149982624|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
149982625|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982626|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982627|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982628|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982629|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982630|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982631|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982632|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
149982633|NCT01194219|541070062|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
149982634|NCT01194219|541070063|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
149982635|NCT01194219|541070064|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982636|NCT01194219|541070065|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982637|NCT01194219|541070066|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982638|NCT01194219|541070067|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982639|NCT01194219|541070068|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982640|NCT01194219|541070069|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982641|NCT01194219|541070070|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982642|NCT01194219|541070071|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
149982643|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982644|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982645|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
149982646|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
149982647|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982648|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982649|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982650|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982651|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982652|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
149982653|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982654|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982655|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
149982656|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
149982657|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982658|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982659|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982660|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982661|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982662|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
149982663|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982664|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982665|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
149982666|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
149982667|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982668|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
150053436|NCT04525885|541336657|FG001|Overall Study|Physician Decision|0|||
149982669|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982670|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982671|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982672|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
149982673|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982674|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982675|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
149982676|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
149982677|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982678|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982679|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982680|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982681|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982682|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
149982683|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982684|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982685|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
149982686|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982687|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982688|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982689|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982690|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982691|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982692|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
149982693|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982694|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982695|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982696|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
149982697|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982698|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982699|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982700|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982701|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982702|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
149982703|NCT01194219|541070062|FG000|Maintenance Phase Weeks16-32|Other|0|||
149982704|NCT01194219|541070063|FG001|Maintenance Phase Weeks16-32|Other|0|||
149982705|NCT01194219|541070064|FG002|Maintenance Phase Weeks16-32|Other|2|||
149982706|NCT01194219|541070065|FG003|Maintenance Phase Weeks16-32|Other|1|||
149982707|NCT01194219|541070066|FG004|Maintenance Phase Weeks16-32|Other|0|||
149982708|NCT01194219|541070067|FG005|Maintenance Phase Weeks16-32|Other|0|||
149982709|NCT01194219|541070068|FG006|Maintenance Phase Weeks16-32|Other|0|||
149982710|NCT01194219|541070069|FG007|Maintenance Phase Weeks16-32|Other|0|||
149982711|NCT01194219|541070070|FG008|Maintenance Phase Weeks16-32|Other|0|||
149982712|NCT01194219|541070071|FG009|Maintenance Phase Weeks16-32|Other|0|||
149982713|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982714|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982715|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982716|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982717|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982718|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
149982719|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
149982720|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
149982721|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982722|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
149982723|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982724|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982725|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982726|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982727|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
149982728|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
149982729|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
149982730|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
149982731|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982732|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
149982733|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982734|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982735|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982736|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982737|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
149982738|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982739|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
149982740|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982741|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982742|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
149982743|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982744|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982745|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982746|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982747|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
149982748|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982749|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
149982750|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
149982751|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982752|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
149982753|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982754|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982755|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982756|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982757|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
149982758|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
149982759|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
149982760|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982761|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982762|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
149982763|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982764|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982765|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982766|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982767|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982768|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982769|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982770|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
149982771|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982772|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
149982773|NCT01194219|541070062|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982774|NCT01194219|541070063|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982775|NCT01194219|541070064|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982776|NCT01194219|541070065|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982777|NCT01194219|541070066|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982778|NCT01194219|541070067|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982779|NCT01194219|541070068|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
149982780|NCT01194219|541070069|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982781|NCT01194219|541070070|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982782|NCT01194219|541070071|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
149982783|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982784|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
150053437|NCT04525885|541336658|FG002|Overall Study|Physician Decision|1|||
150053438|NCT02717832|541336659|FG000|Overall Study|Inability to place IV|3|||
149982785|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982786|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982787|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982788|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982789|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982790|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149982791|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
149982792|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
149982793|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982794|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982795|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982796|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982797|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982798|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982799|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982800|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
149982801|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
149982802|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
149982803|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982804|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982805|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982806|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982807|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982808|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982809|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982810|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
149982811|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
150053439|NCT00096356|541336660|FG000|Overall Study|Adverse Event|11|||
150053440|NCT00096356|541336661|FG001|Overall Study|Adverse Event|9|||
149982812|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
149982813|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982814|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982815|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982816|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982817|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982818|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982819|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982820|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
149982821|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
149982822|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
149982823|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
149982824|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
149982825|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
149982826|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
149982827|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
149982828|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
149982829|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
149982830|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
149982831|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
149982832|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
149982833|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982834|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982835|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982836|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982837|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982838|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982839|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982840|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
149982841|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
149982842|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
149982843|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982844|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982845|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982846|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982847|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982848|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982849|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982850|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982851|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
149982852|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149982853|NCT01194219|541070062|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982854|NCT01194219|541070063|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982855|NCT01194219|541070064|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982856|NCT01194219|541070065|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982857|NCT01194219|541070066|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982858|NCT01194219|541070067|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982859|NCT01194219|541070068|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982860|NCT01194219|541070069|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
149982861|NCT01194219|541070070|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
149982862|NCT01194219|541070071|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
149982863|NCT05338710|541070072|FG000|Overall Study|Withdrawal by Subject|3|||
149982864|NCT01081951|541070073|FG000|Overall Study|Death|54|||
149982865|NCT01081951|541070074|FG001|Overall Study|Death|47|||
149982866|NCT01081951|541070073|FG000|Overall Study|Withdrawal by Subject|2|||
149982867|NCT01081951|541070074|FG001|Overall Study|Withdrawal by Subject|6|||
149982868|NCT01081951|541070073|FG000|Overall Study|Allocated treatment but did not take it|0|||
149982869|NCT01081951|541070074|FG001|Overall Study|Allocated treatment but did not take it|1|||
149982870|NCT01081951|541070073|FG000|Overall Study|Lost to Follow-up|0|||
149982871|NCT01081951|541070074|FG001|Overall Study|Lost to Follow-up|1|||
149982872|NCT01871545|541070077|FG000|Overall Study|Death|2|||
149982873|NCT01871545|541070078|FG001|Overall Study|Death|0|||
149982874|NCT01871545|541070077|FG000|Overall Study|Lack of Efficacy|11|||
149982875|NCT01871545|541070078|FG001|Overall Study|Lack of Efficacy|2|||
149982876|NCT01871545|541070077|FG000|Overall Study|Physician Decision|4|||
149982877|NCT01871545|541070078|FG001|Overall Study|Physician Decision|0|||
149982878|NCT01871545|541070077|FG000|Overall Study|Withdrawal by Subject|0|||
149982879|NCT01871545|541070078|FG001|Overall Study|Withdrawal by Subject|1|||
149982880|NCT01523743|541070079|FG000|Period 1|Adverse Event|1|||
149982881|NCT01523743|541070080|FG001|Period 1|Adverse Event|0|||
149982882|NCT01523743|541070079|FG000|Period 1|Withdrawal by Subject|6|||
149982883|NCT01523743|541070080|FG001|Period 1|Withdrawal by Subject|2|||
149982884|NCT01523743|541070079|FG000|Period 1|Lost to Follow-up|1|||
149982885|NCT01523743|541070080|FG001|Period 1|Lost to Follow-up|0|||
149982886|NCT01523743|541070079|FG000|Period 1|Lack of Efficacy|1|||
149982887|NCT01523743|541070080|FG001|Period 1|Lack of Efficacy|0|||
149982888|NCT01523743|541070079|FG000|Period 1|Felt unable to empty bladder|1|||
149982889|NCT01523743|541070080|FG001|Period 1|Felt unable to empty bladder|0|||
149982890|NCT01523743|541070079|FG000|Period 2|Withdrawal by Subject|0|||
149982891|NCT01523743|541070080|FG001|Period 2|Withdrawal by Subject|2|||
149982892|NCT01523743|541070079|FG000|Period 2|Adverse Event|1|||
149982893|NCT01523743|541070080|FG001|Period 2|Adverse Event|0|||
149982894|NCT02734004|541070081|FG000|Overall Study|Death|36|||
149982895|NCT02734004|541070082|FG001|Overall Study|Death|24|||
149982896|NCT02734004|541070083|FG002|Overall Study|Death|26|||
149982897|NCT02734004|541070084|FG003|Overall Study|Death|35|||
149982898|NCT02734004|541070085|FG004|Overall Study|Death|13|||
149982899|NCT02734004|541070086|FG005|Overall Study|Death|17|||
149982900|NCT02734004|541070087|FG006|Overall Study|Death|20|||
149982901|NCT02734004|541070081|FG000|Overall Study|Lost to Follow-up|1|||
149982902|NCT02734004|541070082|FG001|Overall Study|Lost to Follow-up|1|||
149982903|NCT02734004|541070083|FG002|Overall Study|Lost to Follow-up|0|||
149982904|NCT02734004|541070084|FG003|Overall Study|Lost to Follow-up|0|||
149982905|NCT02734004|541070085|FG004|Overall Study|Lost to Follow-up|1|||
149982906|NCT02734004|541070086|FG005|Overall Study|Lost to Follow-up|0|||
149982907|NCT02734004|541070087|FG006|Overall Study|Lost to Follow-up|0|||
149982908|NCT02734004|541070081|FG000|Overall Study|Withdrawal by Subject|3|||
149982909|NCT02734004|541070082|FG001|Overall Study|Withdrawal by Subject|1|||
149982910|NCT02734004|541070083|FG002|Overall Study|Withdrawal by Subject|1|||
149982911|NCT02734004|541070084|FG003|Overall Study|Withdrawal by Subject|1|||
149982912|NCT02734004|541070085|FG004|Overall Study|Withdrawal by Subject|3|||
149982913|NCT02734004|541070086|FG005|Overall Study|Withdrawal by Subject|0|||
149982914|NCT02734004|541070087|FG006|Overall Study|Withdrawal by Subject|2|||
149982915|NCT02734004|541070081|FG000|Overall Study|Other|0|||
149982916|NCT02734004|541070082|FG001|Overall Study|Other|8|||
149982917|NCT02734004|541070083|FG002|Overall Study|Other|7|||
149982918|NCT02734004|541070084|FG003|Overall Study|Other|4|||
149982919|NCT02734004|541070085|FG004|Overall Study|Other|34|||
149982920|NCT02734004|541070086|FG005|Overall Study|Other|14|||
149982921|NCT02734004|541070087|FG006|Overall Study|Other|10|||
149982922|NCT01393899|541070092|FG000|Overall Study|Study terminated by sponsor|1|||
149982923|NCT01393899|541070093|FG001|Overall Study|Study terminated by sponsor|0|||
149982924|NCT01393899|541070094|FG002|Overall Study|Study terminated by sponsor|1|||
149982925|NCT01393899|541070092|FG000|Overall Study|Other|1|||
149982926|NCT01393899|541070093|FG001|Overall Study|Other|0|||
149982927|NCT01393899|541070094|FG002|Overall Study|Other|0|||
149982928|NCT01393899|541070092|FG000|Overall Study|Withdrawal by Subject|2|||
149982929|NCT01393899|541070093|FG001|Overall Study|Withdrawal by Subject|2|||
149982930|NCT01393899|541070094|FG002|Overall Study|Withdrawal by Subject|1|||
149982931|NCT01393899|541070092|FG000|Overall Study|Lost to Follow-up|0|||
149982932|NCT01393899|541070093|FG001|Overall Study|Lost to Follow-up|0|||
149982933|NCT01393899|541070094|FG002|Overall Study|Lost to Follow-up|1|||
149982934|NCT01393899|541070092|FG000|Overall Study|Does not meet entrance criteria|1|||
149982935|NCT01393899|541070093|FG001|Overall Study|Does not meet entrance criteria|0|||
149982936|NCT01393899|541070094|FG002|Overall Study|Does not meet entrance criteria|1|||
149982937|NCT01393899|541070092|FG000|Overall Study|Lack of Efficacy|26|||
149982938|NCT01393899|541070093|FG001|Overall Study|Lack of Efficacy|21|||
149982939|NCT01393899|541070094|FG002|Overall Study|Lack of Efficacy|16|||
149982940|NCT01393899|541070092|FG000|Overall Study|Adverse Event|1|||
149982941|NCT01393899|541070093|FG001|Overall Study|Adverse Event|5|||
149982942|NCT01393899|541070094|FG002|Overall Study|Adverse Event|3|||
149982943|NCT00132301|541070097|FG000|Overall Study|Death|7|||
149982944|NCT00132301|541070098|FG001|Overall Study|Death|6|||
149982945|NCT00132301|541070097|FG000|Overall Study|Withdrawal by Subject|5|||
149982946|NCT00132301|541070098|FG001|Overall Study|Withdrawal by Subject|2|||
149982947|NCT00132301|541070097|FG000|Overall Study|Physician Decision|1|||
149982948|NCT00132301|541070098|FG001|Overall Study|Physician Decision|1|||
149982949|NCT00132301|541070097|FG000|Overall Study|Lost to Follow-up|5|||
149982950|NCT00132301|541070098|FG001|Overall Study|Lost to Follow-up|3|||
149982951|NCT00132301|541070097|FG000|Overall Study|Other|1|||
149982952|NCT00132301|541070098|FG001|Overall Study|Other|1|||
149982953|NCT00132301|541070097|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
149982954|NCT00132301|541070098|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
149982955|NCT04585269|541070102|FG000|Intervention|Withdrawal by Subject|9|||
149982956|NCT04585269|541070103|FG001|Intervention|Withdrawal by Subject|0|||
149982957|NCT04585269|541070102|FG000|Intervention|Unable to schedule|15|||
149982958|NCT04585269|541070103|FG001|Intervention|Unable to schedule|0|||
149982959|NCT04585269|541070102|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
149982960|NCT04585269|541070103|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
149982961|NCT04585269|541070102|FG000|FU Time 2 (3 months)|Death|2|||
149982962|NCT04585269|541070103|FG001|FU Time 2 (3 months)|Death|2|||
149982963|NCT04585269|541070102|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
149982964|NCT04585269|541070103|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
149982965|NCT04585269|541070102|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
149982966|NCT04585269|541070103|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
149982967|NCT04585269|541070102|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
149982968|NCT04585269|541070103|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
149982969|NCT04585269|541070102|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
149982970|NCT04585269|541070103|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
149982971|NCT04585269|541070102|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
149982972|NCT04585269|541070103|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
149982973|NCT02842086|541070107|FG000|Overall Study|Randomized but Never Treated|6|||
149982974|NCT02842086|541070108|FG001|Overall Study|Randomized but Never Treated|6|||
149982975|NCT02842086|541070107|FG000|Overall Study|Still in Double-Blind Phase|7|||
149982976|NCT02842086|541070108|FG001|Overall Study|Still in Double-Blind Phase|3|||
149982977|NCT02842086|541070107|FG000|Overall Study|Adverse Event|18|||
149982978|NCT02842086|541070108|FG001|Overall Study|Adverse Event|20|||
149982979|NCT02842086|541070107|FG000|Overall Study|Death|3|||
149982980|NCT02842086|541070108|FG001|Overall Study|Death|3|||
149982981|NCT02842086|541070107|FG000|Overall Study|Investigator's Discretion|9|||
149982982|NCT02842086|541070108|FG001|Overall Study|Investigator's Discretion|13|||
149982983|NCT02842086|541070107|FG000|Overall Study|Non-Compliance with Study Drug|9|||
149982984|NCT02842086|541070108|FG001|Overall Study|Non-Compliance with Study Drug|8|||
149982985|NCT02842086|541070107|FG000|Overall Study|Protocol Violation|8|||
149982986|NCT02842086|541070108|FG001|Overall Study|Protocol Violation|4|||
149982987|NCT02842086|541070107|FG000|Overall Study|Withdrew Consent|205|||
149982988|NCT02842086|541070108|FG001|Overall Study|Withdrew Consent|194|||
149982989|NCT02842086|541070107|FG000|Overall Study|Lost to Follow-up|274|||
149982990|NCT02842086|541070108|FG001|Overall Study|Lost to Follow-up|236|||
149982991|NCT02842086|541070107|FG000|Overall Study|HIV-1 Infection|5|||
149982992|NCT02842086|541070108|FG001|Overall Study|HIV-1 Infection|6|||
149982993|NCT00928187|541070109|FG000|Overall Study|Death|1|||
149982994|NCT00928187|541070110|FG001|Overall Study|Death|2|||
149982995|NCT00928187|541070111|FG002|Overall Study|Death|3|||
149982996|NCT00928187|541070109|FG000|Overall Study|Lost to Follow-up|1|||
149982997|NCT00928187|541070110|FG001|Overall Study|Lost to Follow-up|2|||
149982998|NCT00928187|541070111|FG002|Overall Study|Lost to Follow-up|1|||
149982999|NCT00928187|541070109|FG000|Overall Study|Withdrawal by Subject|0|||
149983000|NCT00928187|541070110|FG001|Overall Study|Withdrawal by Subject|1|||
149983001|NCT00928187|541070111|FG002|Overall Study|Withdrawal by Subject|1|||
149983002|NCT00928187|541070109|FG000|Overall Study|Protocol Violation|0|||
149983003|NCT00928187|541070110|FG001|Overall Study|Protocol Violation|1|||
149983004|NCT00928187|541070111|FG002|Overall Study|Protocol Violation|0|||
149983005|NCT02524145|541070115|FG000|Overall Study|Withdrawal by Subject|2|||
149983006|NCT02524145|541070116|FG001|Overall Study|Withdrawal by Subject|2|||
149983007|NCT02524145|541070117|FG002|Overall Study|Withdrawal by Subject|3|||
149983008|NCT07214935|541070118|FG000|Overall Study|Adverse Event|1|||
149983009|NCT07214935|541070119|FG001|Overall Study|Adverse Event|1|||
149983010|NCT07214935|541070120|FG002|Overall Study|Adverse Event|1|||
149983011|NCT07214935|541070121|FG003|Overall Study|Adverse Event|0|||
149983012|NCT07214935|541070118|FG000|Overall Study|Lost to Follow-up|0|||
149983013|NCT07214935|541070119|FG001|Overall Study|Lost to Follow-up|1|||
149983014|NCT07214935|541070120|FG002|Overall Study|Lost to Follow-up|0|||
149983015|NCT07214935|541070121|FG003|Overall Study|Lost to Follow-up|0|||
149983016|NCT07214935|541070118|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
149983017|NCT07214935|541070119|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
149983018|NCT07214935|541070120|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
149983019|NCT07214935|541070121|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
149983020|NCT07214935|541070118|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
149983021|NCT07214935|541070119|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
149983022|NCT07214935|541070120|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
149983023|NCT07214935|541070121|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
149983024|NCT00316706|541071801|FG000|Overall Study|Lost to Follow-up|38|||
149983025|NCT00316706|541071802|FG001|Overall Study|Lost to Follow-up|48|||
149983026|NCT03640325|541071808|FG000|Overall Study|Withdrawal by Subject|4|||
149983027|NCT03640325|541071809|FG001|Overall Study|Withdrawal by Subject|1|||
149983028|NCT03640325|541071810|FG002|Overall Study|Withdrawal by Subject|0|||
149983029|NCT03640325|541071808|FG000|Overall Study|Lost to Follow-up|4|||
149983030|NCT03640325|541071809|FG001|Overall Study|Lost to Follow-up|5|||
149983031|NCT03640325|541071810|FG002|Overall Study|Lost to Follow-up|21|||
149983032|NCT03640325|541071808|FG000|Overall Study|Death|5|||
149983033|NCT03640325|541071809|FG001|Overall Study|Death|5|||
149983034|NCT03640325|541071810|FG002|Overall Study|Death|0|||
149983035|NCT05730725|541071813|FG000|Overall Study|Withdrawal by Subject|3|||
149983036|NCT05730725|541071814|FG001|Overall Study|Withdrawal by Subject|0|||
149983037|NCT05730725|541071815|FG002|Overall Study|Withdrawal by Subject|0|||
149983038|NCT05730725|541071816|FG003|Overall Study|Withdrawal by Subject|1|||
149983039|NCT05730725|541071813|FG000|Overall Study|Not Reported|1|||
149983040|NCT05730725|541071814|FG001|Overall Study|Not Reported|1|||
149983041|NCT05730725|541071815|FG002|Overall Study|Not Reported|1|||
149983042|NCT05730725|541071816|FG003|Overall Study|Not Reported|1|||
149983043|NCT05265728|541071817|FG000|Overall Study|Adverse Event|1|||
149983044|NCT05265728|541071817|FG000|Overall Study|Study Terminated by Sponsor|5|||
149983045|NCT05265728|541071817|FG000|Overall Study|Withdrawal by Subject|2|||
149983046|NCT03493451|541071818|FG000|Overall Study|Death|11|||
149983047|NCT03493451|541071819|FG001|Overall Study|Death|26|||
149983048|NCT03493451|541071820|FG002|Overall Study|Death|3|||
149983049|NCT03493451|541071818|FG000|Overall Study|Lost to Follow-up|1|||
149983050|NCT03493451|541071819|FG001|Overall Study|Lost to Follow-up|4|||
149983051|NCT03493451|541071820|FG002|Overall Study|Lost to Follow-up|1|||
149983052|NCT03493451|541071818|FG000|Overall Study|Withdrawal by Subject|1|||
149983053|NCT03493451|541071819|FG001|Overall Study|Withdrawal by Subject|1|||
149983054|NCT03493451|541071820|FG002|Overall Study|Withdrawal by Subject|2|||
149983055|NCT03493451|541071818|FG000|Overall Study|Progressive Disease|1|||
149983056|NCT03493451|541071819|FG001|Overall Study|Progressive Disease|0|||
149983057|NCT03493451|541071820|FG002|Overall Study|Progressive Disease|0|||
149983058|NCT03493451|541071818|FG000|Overall Study|Transferred to long term extension study|8|||
149983059|NCT03493451|541071819|FG001|Overall Study|Transferred to long term extension study|13|||
149983060|NCT03493451|541071820|FG002|Overall Study|Transferred to long term extension study|5|||
149983061|NCT01133756|541071823|FG000|Overall Study|Adverse Event|1|||
149983062|NCT01133756|541071824|FG001|Overall Study|Adverse Event|2|||
149983063|NCT01133756|541071825|FG002|Overall Study|Adverse Event|1|||
149983064|NCT01133756|541071823|FG000|Overall Study|Investigator Decision|1|||
149983065|NCT01133756|541071824|FG001|Overall Study|Investigator Decision|0|||
149983066|NCT01133756|541071825|FG002|Overall Study|Investigator Decision|0|||
149983067|NCT01133756|541071823|FG000|Overall Study|Withdrawal by Subject|0|||
149983068|NCT01133756|541071824|FG001|Overall Study|Withdrawal by Subject|1|||
149983069|NCT01133756|541071825|FG002|Overall Study|Withdrawal by Subject|0|||
149983070|NCT01133756|541071823|FG000|Overall Study|Progression of Disease|0|||
149983071|NCT01133756|541071824|FG001|Overall Study|Progression of Disease|0|||
149983072|NCT01133756|541071825|FG002|Overall Study|Progression of Disease|1|||
149983073|NCT03941873|541071835|FG000|Overall Study|Death|0|||
149983074|NCT03941873|541071836|FG001|Overall Study|Death|12|||
149983075|NCT03941873|541071837|FG002|Overall Study|Death|2|||
149983076|NCT03941873|541071838|FG003|Overall Study|Death|53|||
149983077|NCT03941873|541071835|FG000|Overall Study|Withdrawal by Subject|1|||
149983078|NCT03941873|541071836|FG001|Overall Study|Withdrawal by Subject|1|||
149983079|NCT03941873|541071837|FG002|Overall Study|Withdrawal by Subject|0|||
149983080|NCT03941873|541071838|FG003|Overall Study|Withdrawal by Subject|5|||
149983081|NCT03941873|541071835|FG000|Overall Study|Lost to Follow-up|1|||
149983082|NCT03941873|541071836|FG001|Overall Study|Lost to Follow-up|2|||
149983083|NCT03941873|541071837|FG002|Overall Study|Lost to Follow-up|0|||
149983084|NCT03941873|541071838|FG003|Overall Study|Lost to Follow-up|0|||
149983085|NCT03941873|541071835|FG000|Overall Study|Sponsor Decision|0|||
149983086|NCT03941873|541071836|FG001|Overall Study|Sponsor Decision|6|||
149983087|NCT03941873|541071837|FG002|Overall Study|Sponsor Decision|0|||
149983088|NCT03941873|541071838|FG003|Overall Study|Sponsor Decision|15|||
149983089|NCT03276728|541071839|FG000|Overall Study|Lost to Follow-up|0|||
149983090|NCT03276728|541071840|FG001|Overall Study|Lost to Follow-up|0|||
149983091|NCT03276728|541071841|FG002|Overall Study|Lost to Follow-up|2|||
149983092|NCT03276728|541071842|FG003|Overall Study|Lost to Follow-up|2|||
149983093|NCT03276728|541071843|FG004|Overall Study|Lost to Follow-up|0|||
149983094|NCT03276728|541071844|FG005|Overall Study|Lost to Follow-up|0|||
149983095|NCT03276728|541071845|FG006|Overall Study|Lost to Follow-up|0|||
149983096|NCT03276728|541071846|FG007|Overall Study|Lost to Follow-up|0|||
149983097|NCT03276728|541071839|FG000|Overall Study|Withdrawal by Subject|0|||
149983098|NCT03276728|541071840|FG001|Overall Study|Withdrawal by Subject|0|||
149983099|NCT03276728|541071841|FG002|Overall Study|Withdrawal by Subject|0|||
149983100|NCT03276728|541071842|FG003|Overall Study|Withdrawal by Subject|3|||
149983101|NCT03276728|541071843|FG004|Overall Study|Withdrawal by Subject|0|||
149983102|NCT03276728|541071844|FG005|Overall Study|Withdrawal by Subject|0|||
149983103|NCT03276728|541071845|FG006|Overall Study|Withdrawal by Subject|0|||
149983104|NCT03276728|541071846|FG007|Overall Study|Withdrawal by Subject|0|||
149983105|NCT03276728|541071839|FG000|Overall Study|Decision by sponsor|0|||
149983106|NCT03276728|541071840|FG001|Overall Study|Decision by sponsor|0|||
149983107|NCT03276728|541071841|FG002|Overall Study|Decision by sponsor|0|||
149983108|NCT03276728|541071842|FG003|Overall Study|Decision by sponsor|0|||
149983109|NCT03276728|541071843|FG004|Overall Study|Decision by sponsor|1|||
149983110|NCT03276728|541071844|FG005|Overall Study|Decision by sponsor|0|||
149983111|NCT03276728|541071845|FG006|Overall Study|Decision by sponsor|2|||
149983112|NCT03276728|541071846|FG007|Overall Study|Decision by sponsor|1|||
150053441|NCT00096356|541336660|FG000|Overall Study|Physician Decision|5|||
149983113|NCT01234480|541071849|FG000|Overall Study|Pregnancy|88|||
149983114|NCT01234480|541071849|FG000|Overall Study|>36/Normal History|50|||
149983115|NCT01234480|541071849|FG000|Overall Study|Age|3|||
149983116|NCT01234480|541071849|FG000|Overall Study|HPV Vaccine History|28|||
149983117|NCT01234480|541071849|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
149983118|NCT01234480|541071849|FG000|Overall Study|Hysterectomy|2|||
149983119|NCT01234480|541071849|FG000|Overall Study|Hysterectomy post enrollment|1|||
149983120|NCT01234480|541071849|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
149983121|NCT01234480|541071849|FG000|Overall Study|Informed Consent Form Violation|30|||
149983122|NCT01234480|541071849|FG000|Overall Study|Incorrect Visit|3|||
149983123|NCT01234480|541071849|FG000|Overall Study|No Florida Lab License|20|||
149983124|NCT01234480|541071849|FG000|Overall Study|Out of Window|42|||
149983125|NCT01234480|541071849|FG000|Overall Study|Sample Processing/Storage|92|||
149983126|NCT01234480|541071849|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
149983127|NCT01234480|541071849|FG000|Overall Study|Site/Subject non-compliance|44|||
149983128|NCT01234480|541071849|FG000|Overall Study|Missing Sample|9|||
149983129|NCT02982772|541071850|FG000|Intervention|Lost to Follow-up|19|||
149983130|NCT02982772|541071851|FG001|Intervention|Lost to Follow-up|13|||
149983131|NCT02982772|541071850|FG000|1M Follow-Up|Lost to Follow-up|21|||
149983132|NCT02982772|541071851|FG001|1M Follow-Up|Lost to Follow-up|18|||
149983133|NCT02982772|541071850|FG000|3M Follow-Up|Lost to Follow-up|17|||
149983134|NCT02982772|541071851|FG001|3M Follow-Up|Lost to Follow-up|11|||
150053442|NCT00096356|541336661|FG001|Overall Study|Physician Decision|3|||
149983135|NCT02982772|541071850|FG000|6M Follow-Up|Lost to Follow-up|11|||
149983136|NCT02982772|541071851|FG001|6M Follow-Up|Lost to Follow-up|9|||
149983137|NCT02982772|541071850|FG000|12M Follow-Up|Lost to Follow-up|11|||
149983138|NCT02982772|541071851|FG001|12M Follow-Up|Lost to Follow-up|5|||
149983139|NCT02974140|541071852|FG000|Overall Study|Adverse Event|2|||
149983140|NCT02974140|541071852|FG000|Overall Study|Lost to Follow-up|1|||
149983141|NCT02974140|541071852|FG000|Overall Study|Study Terminated by Sponsor|36|||
149983142|NCT00617084|541071853|FG000|Overall Study|Withdrawal by Subject|5|||
149983143|NCT00617084|541071854|FG001|Overall Study|Withdrawal by Subject|7|||
149983144|NCT00617084|541071853|FG000|Overall Study|Missed 12 Months visit|16|||
149983145|NCT00617084|541071854|FG001|Overall Study|Missed 12 Months visit|19|||
149983146|NCT03370419|541071855|FG000|Overall Study|Lost to Follow-up|16|||
149983147|NCT00310375|541071860|FG000|Primary Reporting Phase|Adverse Event|28|||
149983148|NCT00310375|541071861|FG001|Primary Reporting Phase|Adverse Event|22|||
149983149|NCT00310375|541071862|FG002|Primary Reporting Phase|Adverse Event|0|||
149983150|NCT00310375|541071860|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
149983151|NCT00310375|541071861|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
149983152|NCT00310375|541071862|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
149983153|NCT00310375|541071860|FG000|Primary Reporting Phase|Pregnancy|2|||
149983154|NCT00310375|541071861|FG001|Primary Reporting Phase|Pregnancy|2|||
149983155|NCT00310375|541071862|FG002|Primary Reporting Phase|Pregnancy|0|||
149983156|NCT00310375|541071860|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
149983157|NCT00310375|541071861|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
149983158|NCT00310375|541071862|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
149983159|NCT00310375|541071860|FG000|Primary Reporting Phase|Protocol Violation|8|||
149983160|NCT00310375|541071861|FG001|Primary Reporting Phase|Protocol Violation|5|||
149983161|NCT00310375|541071862|FG002|Primary Reporting Phase|Protocol Violation|0|||
150053443|NCT00096356|541336660|FG000|Overall Study|Withdrawal by Subject|17|||
149983162|NCT00310375|541071860|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
149983163|NCT00310375|541071861|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
149983164|NCT00310375|541071862|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
149983165|NCT00310375|541071860|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
149983166|NCT00310375|541071861|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
149983167|NCT00310375|541071862|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
149983168|NCT00310375|541071860|FG000|Primary Reporting Phase|Physician Decision|5|||
149983169|NCT00310375|541071861|FG001|Primary Reporting Phase|Physician Decision|3|||
149983170|NCT00310375|541071862|FG002|Primary Reporting Phase|Physician Decision|0|||
149983171|NCT00310375|541071860|FG000|Primary Reporting Phase|Request of the sponsor|2|||
149983172|NCT00310375|541071861|FG001|Primary Reporting Phase|Request of the sponsor|2|||
149983173|NCT00310375|541071862|FG002|Primary Reporting Phase|Request of the sponsor|0|||
150178676|NCT00546754|541791995|FG000|Overall Study|Missing Cooperation|1|||
149983174|NCT00310375|541071860|FG000|Primary Reporting Phase|Failed to return|1|||
149983175|NCT00310375|541071861|FG001|Primary Reporting Phase|Failed to return|3|||
149983176|NCT00310375|541071862|FG002|Primary Reporting Phase|Failed to return|0|||
149983177|NCT00310375|541071860|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
149983178|NCT00310375|541071861|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
149983179|NCT00310375|541071862|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
149983180|NCT00310375|541071860|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
149983181|NCT00310375|541071861|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
149983182|NCT00310375|541071862|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
149983183|NCT00310375|541071860|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
149983184|NCT00310375|541071861|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
149983185|NCT00310375|541071862|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
149983186|NCT00310375|541071860|FG000|Primary Reporting Phase|Site closure|3|||
149983187|NCT00310375|541071861|FG001|Primary Reporting Phase|Site closure|0|||
149983188|NCT00310375|541071862|FG002|Primary Reporting Phase|Site closure|0|||
149983189|NCT00310375|541071860|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
149983190|NCT00310375|541071861|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
149983191|NCT00310375|541071862|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
149983192|NCT00310375|541071860|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
149983193|NCT00310375|541071861|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
149983194|NCT00310375|541071862|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
149983195|NCT00310375|541071860|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
149983196|NCT00310375|541071861|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
149983197|NCT00310375|541071862|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
149983198|NCT00310375|541071860|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
149983199|NCT00310375|541071861|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
149983200|NCT00310375|541071862|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
149983201|NCT03726658|541071864|FG000|Overall Study|Lost to Follow-up|0|||
149983202|NCT03726658|541071865|FG001|Overall Study|Lost to Follow-up|0|||
149983203|NCT03726658|541071866|FG002|Overall Study|Lost to Follow-up|2|||
149983204|NCT03726658|541071867|FG003|Overall Study|Lost to Follow-up|0|||
149983205|NCT03726658|541071868|FG004|Overall Study|Lost to Follow-up|0|||
149983206|NCT03726658|541071869|FG005|Overall Study|Lost to Follow-up|1|||
149983207|NCT03726658|541071870|FG006|Overall Study|Lost to Follow-up|1|||
149983208|NCT03726658|541071864|FG000|Overall Study|Withdrawal by Subject|1|||
149983209|NCT03726658|541071865|FG001|Overall Study|Withdrawal by Subject|0|||
149983210|NCT03726658|541071866|FG002|Overall Study|Withdrawal by Subject|0|||
149983211|NCT03726658|541071867|FG003|Overall Study|Withdrawal by Subject|0|||
149983212|NCT03726658|541071868|FG004|Overall Study|Withdrawal by Subject|6|||
149983213|NCT03726658|541071869|FG005|Overall Study|Withdrawal by Subject|4|||
149983214|NCT03726658|541071870|FG006|Overall Study|Withdrawal by Subject|2|||
150053444|NCT00096356|541336661|FG001|Overall Study|Withdrawal by Subject|23|||
150053445|NCT00096356|541336660|FG000|Overall Study|Lack of Efficacy|1|||
149983215|NCT03726658|541071864|FG000|Overall Study|Pregnancy|0|||
149983216|NCT03726658|541071865|FG001|Overall Study|Pregnancy|0|||
149983217|NCT03726658|541071866|FG002|Overall Study|Pregnancy|0|||
149983218|NCT03726658|541071867|FG003|Overall Study|Pregnancy|0|||
149983219|NCT03726658|541071868|FG004|Overall Study|Pregnancy|0|||
149983220|NCT03726658|541071869|FG005|Overall Study|Pregnancy|0|||
150053446|NCT00096356|541336661|FG001|Overall Study|Lack of Efficacy|0|||
150053447|NCT00096356|541336660|FG000|Overall Study|multiple reasons|10|||
150053448|NCT00096356|541336661|FG001|Overall Study|multiple reasons|18|||
150053449|NCT00978757|541336663|FG000|Overall Study|Physician Decision|1|||
150053450|NCT00978757|541336664|FG001|Overall Study|Physician Decision|3|||
149983221|NCT03726658|541071870|FG006|Overall Study|Pregnancy|1|||
149983222|NCT03726658|541071864|FG000|Overall Study|Not Reported|0|||
149983223|NCT03726658|541071865|FG001|Overall Study|Not Reported|0|||
149983224|NCT03726658|541071866|FG002|Overall Study|Not Reported|0|||
149983225|NCT03726658|541071867|FG003|Overall Study|Not Reported|0|||
149983226|NCT03726658|541071868|FG004|Overall Study|Not Reported|0|||
149983227|NCT03726658|541071869|FG005|Overall Study|Not Reported|0|||
149983228|NCT03726658|541071870|FG006|Overall Study|Not Reported|1|||
149983229|NCT00412958|541071871|FG000|Overall Study|Withdrawal by Subject|3|||
149983230|NCT00412958|541071872|FG001|Overall Study|Withdrawal by Subject|0|||
149983231|NCT00412958|541071873|FG002|Overall Study|Withdrawal by Subject|0|||
149983232|NCT00412958|541071874|FG003|Overall Study|Withdrawal by Subject|1|||
149983233|NCT00412958|541071871|FG000|Overall Study|Adverse Event|0|||
149983234|NCT00412958|541071872|FG001|Overall Study|Adverse Event|1|||
149983235|NCT00412958|541071873|FG002|Overall Study|Adverse Event|0|||
149983236|NCT00412958|541071874|FG003|Overall Study|Adverse Event|0|||
149983237|NCT00412958|541071871|FG000|Overall Study|Lost to Follow-up|0|||
149983238|NCT00412958|541071872|FG001|Overall Study|Lost to Follow-up|1|||
149983239|NCT00412958|541071873|FG002|Overall Study|Lost to Follow-up|0|||
149983240|NCT00412958|541071874|FG003|Overall Study|Lost to Follow-up|0|||
149983241|NCT00412958|541071871|FG000|Overall Study|Death|0|||
149983242|NCT00412958|541071872|FG001|Overall Study|Death|1|||
149983243|NCT00412958|541071873|FG002|Overall Study|Death|0|||
149983244|NCT00412958|541071874|FG003|Overall Study|Death|0|||
149983245|NCT00412958|541071871|FG000|Overall Study|Transport issue|0|||
149983246|NCT00412958|541071872|FG001|Overall Study|Transport issue|1|||
149983247|NCT00412958|541071873|FG002|Overall Study|Transport issue|0|||
149983248|NCT00412958|541071874|FG003|Overall Study|Transport issue|0|||
150053451|NCT00402740|541336665|FG000|Overall Study|Withdrawal by Subject|18|||
150053452|NCT00402740|541336665|FG000|Overall Study|Death|50|||
150053453|NCT00402740|541336665|FG000|Overall Study|Lost to Follow-up|6|||
150053454|NCT00402740|541336665|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
150053455|NCT00402740|541336665|FG000|Overall Study|Subject disposition unknown.|1|||
150053456|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
150053457|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
150053458|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
150053459|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
150053460|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
150053461|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
149983249|NCT01318135|541071875|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
149983250|NCT01318135|541071876|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983251|NCT01318135|541071877|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983252|NCT01318135|541071878|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983253|NCT01318135|541071879|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983254|NCT01318135|541071880|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983255|NCT01318135|541071881|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149983256|NCT01318135|541071882|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150178677|NCT00546754|541791996|FG001|Overall Study|Missing Cooperation|0|||
149983257|NCT01318135|541071875|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
149983258|NCT01318135|541071876|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983259|NCT01318135|541071877|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983260|NCT01318135|541071878|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983261|NCT01318135|541071879|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983262|NCT01318135|541071880|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983263|NCT01318135|541071881|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983264|NCT01318135|541071882|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
149983265|NCT01318135|541071875|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
149983266|NCT01318135|541071876|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
149983267|NCT01318135|541071877|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
149983268|NCT01318135|541071878|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
149983269|NCT01318135|541071879|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
149983270|NCT01318135|541071880|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
149983271|NCT01318135|541071881|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
149983272|NCT01318135|541071882|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
149983273|NCT01318135|541071875|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
149983274|NCT01318135|541071876|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
149983275|NCT01318135|541071877|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
149983276|NCT01318135|541071878|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
149983277|NCT01318135|541071879|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
149983278|NCT01318135|541071880|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
149983279|NCT01318135|541071881|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
149983280|NCT01318135|541071882|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
149983281|NCT01318135|541071875|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149983282|NCT01318135|541071876|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149983283|NCT01318135|541071877|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149983284|NCT01318135|541071878|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149983285|NCT01318135|541071879|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149983286|NCT01318135|541071880|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149983287|NCT01318135|541071881|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149983288|NCT01318135|541071882|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149983289|NCT01318135|541071875|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
149983290|NCT01318135|541071876|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
149983291|NCT01318135|541071877|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
149983292|NCT01318135|541071878|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
149983293|NCT01318135|541071879|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
149983294|NCT01318135|541071880|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
149983295|NCT01318135|541071881|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149983296|NCT01318135|541071882|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149983297|NCT01318135|541071875|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983298|NCT01318135|541071876|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983299|NCT01318135|541071877|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983300|NCT01318135|541071878|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983301|NCT01318135|541071879|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983302|NCT01318135|541071880|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983303|NCT01318135|541071881|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
149983304|NCT01318135|541071882|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
149983305|NCT01152788|541071884|FG000|Overall Study|Withdrawal by Subject|0|||
149983306|NCT01152788|541071885|FG001|Overall Study|Withdrawal by Subject|3|||
149983307|NCT01152788|541071884|FG000|Overall Study|No treatment|0|||
149983308|NCT01152788|541071885|FG001|Overall Study|No treatment|1|||
149983309|NCT03782064|541071889|FG000|Overall Study|Lack of Efficacy|2|||
149983310|NCT03782064|541071889|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
149983311|NCT00363142|541071890|FG000|Overall Study|Adverse Event|2|||
149983312|NCT00363142|541071891|FG001|Overall Study|Adverse Event|0|||
149983313|NCT00363142|541071890|FG000|Overall Study|Lack of Efficacy|0|||
149983314|NCT00363142|541071891|FG001|Overall Study|Lack of Efficacy|1|||
149983315|NCT00363142|541071890|FG000|Overall Study|Lost to Follow-up|1|||
149983316|NCT00363142|541071891|FG001|Overall Study|Lost to Follow-up|0|||
149983317|NCT00363142|541071890|FG000|Overall Study|Non-compliance|1|||
149983318|NCT00363142|541071891|FG001|Overall Study|Non-compliance|1|||
149983319|NCT00363142|541071890|FG000|Overall Study|Withdrawal by Subject|3|||
149983320|NCT00363142|541071891|FG001|Overall Study|Withdrawal by Subject|1|||
149983321|NCT00049322|541071895|FG000|Overall Study|disease burden|0|||
149983322|NCT00049322|541071896|FG001|Overall Study|disease burden|3|||
149983323|NCT00049322|541071895|FG000|Overall Study|Adverse Event|1|||
149983324|NCT00049322|541071896|FG001|Overall Study|Adverse Event|0|||
149983325|NCT00049322|541071895|FG000|Overall Study|refused angio|0|||
149983326|NCT00049322|541071896|FG001|Overall Study|refused angio|3|||
149983327|NCT03994211|541071897|FG000|Core Phase|Adverse Event|0|||
149983328|NCT03994211|541071898|FG001|Core Phase|Adverse Event|1|||
149983329|NCT03994211|541071899|FG002|Core Phase|Adverse Event|0|||
149983330|NCT03994211|541071897|FG000|Extension Phase|Adverse Event|0|||
149983331|NCT03994211|541071898|FG001|Extension Phase|Adverse Event|0|||
149983332|NCT03994211|541071899|FG002|Extension Phase|Adverse Event|1|||
149983333|NCT03994211|541071897|FG000|Extension Phase|Physician Decision|0|||
149983334|NCT03994211|541071898|FG001|Extension Phase|Physician Decision|0|||
149983335|NCT03994211|541071899|FG002|Extension Phase|Physician Decision|1|||
149983336|NCT03994211|541071897|FG000|Extension Phase|Progressive Disease|0|||
149983337|NCT03994211|541071898|FG001|Extension Phase|Progressive Disease|0|||
149983338|NCT03994211|541071899|FG002|Extension Phase|Progressive Disease|20|||
149983339|NCT03994211|541071897|FG000|Extension Phase|Withdrawal by Subject|0|||
149983340|NCT03994211|541071898|FG001|Extension Phase|Withdrawal by Subject|0|||
149983341|NCT03994211|541071899|FG002|Extension Phase|Withdrawal by Subject|2|||
149983342|NCT02625220|541071900|FG000|Overall Study|Adverse Event|2|||
149983343|NCT02625220|541071900|FG000|Overall Study|Lost to Follow-up|2|||
149983344|NCT02625220|541071900|FG000|Overall Study|Protocol Violation|1|||
149983345|NCT02625220|541071900|FG000|Overall Study|Study discontinued at site|2|||
149983346|NCT01140867|541071901|FG000|Overall Study|Adverse Event|22|||
149983347|NCT01140867|541071901|FG000|Overall Study|Lack of Efficacy|3|||
149983348|NCT01140867|541071901|FG000|Overall Study|Lost to Follow-up|2|||
149983349|NCT01140867|541071901|FG000|Overall Study|Withdrawal by Subject|1|||
149983350|NCT01140867|541071901|FG000|Overall Study|Protocol Violation|1|||
149983351|NCT01140867|541071901|FG000|Overall Study|Uncooperative patient|2|||
149983352|NCT01140867|541071901|FG000|Overall Study|Medication Noncompliance|2|||
149983353|NCT01926444|541071902|FG000|Overall Study|Colonoscopy not performed|0|||
149983354|NCT01926444|541071903|FG001|Overall Study|Colonoscopy not performed|0|||
149983355|NCT01926444|541071904|FG002|Overall Study|Colonoscopy not performed|4|||
149983356|NCT01926444|541071905|FG003|Overall Study|Colonoscopy not performed|2|||
149983357|NCT00881530|541071906|FG000|Overall Study|Adverse Event|5|||
149983358|NCT00881530|541071907|FG001|Overall Study|Adverse Event|1|||
149983359|NCT00881530|541071908|FG002|Overall Study|Adverse Event|1|||
149983360|NCT00881530|541071909|FG003|Overall Study|Adverse Event|4|||
149983361|NCT00881530|541071910|FG004|Overall Study|Adverse Event|10|||
149983362|NCT00881530|541071911|FG005|Overall Study|Adverse Event|2|||
149983363|NCT00881530|541071906|FG000|Overall Study|Lack of Efficacy|1|||
149983364|NCT00881530|541071907|FG001|Overall Study|Lack of Efficacy|0|||
149983365|NCT00881530|541071908|FG002|Overall Study|Lack of Efficacy|0|||
149983366|NCT00881530|541071909|FG003|Overall Study|Lack of Efficacy|0|||
149983367|NCT00881530|541071910|FG004|Overall Study|Lack of Efficacy|1|||
149983368|NCT00881530|541071911|FG005|Overall Study|Lack of Efficacy|1|||
149983369|NCT00881530|541071906|FG000|Overall Study|Not compliant with the protocol|0|||
149983370|NCT00881530|541071907|FG001|Overall Study|Not compliant with the protocol|0|||
149983371|NCT00881530|541071908|FG002|Overall Study|Not compliant with the protocol|0|||
149983372|NCT00881530|541071909|FG003|Overall Study|Not compliant with the protocol|0|||
149983373|NCT00881530|541071910|FG004|Overall Study|Not compliant with the protocol|2|||
149983374|NCT00881530|541071911|FG005|Overall Study|Not compliant with the protocol|0|||
149983375|NCT00881530|541071906|FG000|Overall Study|Lost to Follow-up|0|||
149983376|NCT00881530|541071907|FG001|Overall Study|Lost to Follow-up|1|||
149983377|NCT00881530|541071908|FG002|Overall Study|Lost to Follow-up|1|||
149983378|NCT00881530|541071909|FG003|Overall Study|Lost to Follow-up|3|||
149983379|NCT00881530|541071910|FG004|Overall Study|Lost to Follow-up|1|||
149983380|NCT00881530|541071911|FG005|Overall Study|Lost to Follow-up|0|||
149983381|NCT00881530|541071906|FG000|Overall Study|Refused to continue medication|7|||
149983382|NCT00881530|541071907|FG001|Overall Study|Refused to continue medication|2|||
149983383|NCT00881530|541071908|FG002|Overall Study|Refused to continue medication|1|||
149983384|NCT00881530|541071909|FG003|Overall Study|Refused to continue medication|2|||
149983385|NCT00881530|541071910|FG004|Overall Study|Refused to continue medication|0|||
149983386|NCT00881530|541071911|FG005|Overall Study|Refused to continue medication|0|||
149983387|NCT00881530|541071906|FG000|Overall Study|Other reason not defined above|1|||
149983388|NCT00881530|541071907|FG001|Overall Study|Other reason not defined above|1|||
149983389|NCT00881530|541071908|FG002|Overall Study|Other reason not defined above|2|||
149983390|NCT00881530|541071909|FG003|Overall Study|Other reason not defined above|0|||
149983391|NCT00881530|541071910|FG004|Overall Study|Other reason not defined above|0|||
149983392|NCT00881530|541071911|FG005|Overall Study|Other reason not defined above|2|||
149983393|NCT01272037|541071912|FG000|Overall Study|Death|25|||
149983394|NCT01272037|541071913|FG001|Overall Study|Death|28|||
149983395|NCT01272037|541071912|FG000|Overall Study|Adverse Event|12|||
149983396|NCT01272037|541071913|FG001|Overall Study|Adverse Event|7|||
149983397|NCT01272037|541071912|FG000|Overall Study|Withdrawal by Subject|175|||
149983398|NCT01272037|541071913|FG001|Overall Study|Withdrawal by Subject|93|||
149983399|NCT01272037|541071912|FG000|Overall Study|Disease progression|70|||
149983400|NCT01272037|541071913|FG001|Overall Study|Disease progression|111|||
149983401|NCT01272037|541071912|FG000|Overall Study|Other reason|42|||
149983402|NCT01272037|541071913|FG001|Overall Study|Other reason|41|||
149983403|NCT01272037|541071912|FG000|Overall Study|Delinquent data|24|||
149983404|NCT01272037|541071913|FG001|Overall Study|Delinquent data|19|||
149983405|NCT01272037|541071912|FG000|Overall Study|Reason under review|33|||
149983406|NCT01272037|541071913|FG001|Overall Study|Reason under review|29|||
149983407|NCT01272037|541071912|FG000|Overall Study|On treatment|626|||
149983408|NCT01272037|541071913|FG001|Overall Study|On treatment|632|||
149983409|NCT03035864|541071915|FG000|Treatment Period|Adverse Event|1|||
149983410|NCT03035864|541071916|FG001|Treatment Period|Adverse Event|0|||
149983411|NCT03035864|541071915|FG000|Treatment Period|Other|3|||
149983412|NCT03035864|541071916|FG001|Treatment Period|Other|1|||
149983413|NCT03035864|541071915|FG000|Follow-up Period|Adverse Event|1|||
149983414|NCT03035864|541071916|FG001|Follow-up Period|Adverse Event|0|||
149983415|NCT03035864|541071915|FG000|Follow-up Period|Lost to Follow-up|6|||
149983416|NCT03035864|541071916|FG001|Follow-up Period|Lost to Follow-up|2|||
149983417|NCT03035864|541071915|FG000|Follow-up Period|Physician Decision|1|||
149983418|NCT03035864|541071916|FG001|Follow-up Period|Physician Decision|0|||
149983419|NCT03035864|541071915|FG000|Follow-up Period|Other|3|||
149983420|NCT03035864|541071916|FG001|Follow-up Period|Other|2|||
149983421|NCT02720523|541071919|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
149983422|NCT02720523|541071920|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
149983423|NCT02720523|541071921|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
149983424|NCT02720523|541071922|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
149983425|NCT02720523|541071923|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
149983426|NCT02720523|541071924|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
149983427|NCT02720523|541071925|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
150053462|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
149983428|NCT02720523|541071919|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
149983429|NCT02720523|541071920|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983430|NCT02720523|541071921|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983431|NCT02720523|541071922|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983432|NCT02720523|541071923|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983433|NCT02720523|541071924|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983434|NCT02720523|541071925|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
149983435|NCT02720523|541071919|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
149983436|NCT02720523|541071920|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983437|NCT02720523|541071921|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983438|NCT02720523|541071922|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983439|NCT02720523|541071923|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983440|NCT02720523|541071924|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983441|NCT02720523|541071925|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
149983442|NCT02720523|541071919|FG000|Period 1: Placebo-controlled Period|Other|0|||
149983443|NCT02720523|541071920|FG001|Period 1: Placebo-controlled Period|Other|0|||
149983444|NCT02720523|541071921|FG002|Period 1: Placebo-controlled Period|Other|1|||
149983445|NCT02720523|541071922|FG003|Period 1: Placebo-controlled Period|Other|1|||
149983446|NCT02720523|541071923|FG004|Period 1: Placebo-controlled Period|Other|0|||
149983447|NCT02720523|541071924|FG005|Period 1: Placebo-controlled Period|Other|0|||
149983448|NCT02720523|541071925|FG006|Period 1: Placebo-controlled Period|Other|0|||
149983449|NCT02720523|541071919|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
149983450|NCT02720523|541071920|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
149983451|NCT02720523|541071921|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
149983452|NCT02720523|541071922|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
149983453|NCT02720523|541071923|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
150053463|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
150053464|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
150053465|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
149983454|NCT02720523|541071924|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
149983455|NCT02720523|541071925|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
149983456|NCT02720523|541071919|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
149983457|NCT02720523|541071920|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
149983458|NCT02720523|541071921|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
149983459|NCT02720523|541071922|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
149983460|NCT02720523|541071923|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
149983461|NCT02720523|541071924|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
149983462|NCT02720523|541071925|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
149983463|NCT02720523|541071919|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
149983464|NCT02720523|541071920|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
149983465|NCT02720523|541071921|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
149983466|NCT02720523|541071922|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
149983467|NCT02720523|541071923|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
149983468|NCT02720523|541071924|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
149983469|NCT02720523|541071925|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
149983470|NCT02720523|541071919|FG000|Period 2: Long-term Extension Period|Other|0|||
149983471|NCT02720523|541071920|FG001|Period 2: Long-term Extension Period|Other|0|||
149983472|NCT02720523|541071921|FG002|Period 2: Long-term Extension Period|Other|0|||
149983473|NCT02720523|541071922|FG003|Period 2: Long-term Extension Period|Other|0|||
149983474|NCT02720523|541071923|FG004|Period 2: Long-term Extension Period|Other|2|||
149983475|NCT02720523|541071924|FG005|Period 2: Long-term Extension Period|Other|0|||
149983476|NCT02720523|541071925|FG006|Period 2: Long-term Extension Period|Other|3|||
149983477|NCT01890265|541071927|FG000|Overall Study|Other (Unspecified reason)|0|||
149983478|NCT01890265|541071928|FG001|Overall Study|Other (Unspecified reason)|1|||
149983479|NCT01890265|541071929|FG002|Overall Study|Other (Unspecified reason)|0|||
149983480|NCT01890265|541071930|FG003|Overall Study|Other (Unspecified reason)|0|||
149983481|NCT01890265|541071931|FG004|Overall Study|Other (Unspecified reason)|0|||
149983482|NCT01890265|541071932|FG005|Overall Study|Other (Unspecified reason)|0|||
149983483|NCT01890265|541071927|FG000|Overall Study|Progressive disease|6|||
149983484|NCT01890265|541071928|FG001|Overall Study|Progressive disease|6|||
149983485|NCT01890265|541071929|FG002|Overall Study|Progressive disease|0|||
149983486|NCT01890265|541071930|FG003|Overall Study|Progressive disease|0|||
149983487|NCT01890265|541071931|FG004|Overall Study|Progressive disease|0|||
149983488|NCT01890265|541071932|FG005|Overall Study|Progressive disease|0|||
149983489|NCT01890265|541071927|FG000|Overall Study|Adverse Event|2|||
149983490|NCT01890265|541071928|FG001|Overall Study|Adverse Event|1|||
149983491|NCT01890265|541071929|FG002|Overall Study|Adverse Event|0|||
149983492|NCT01890265|541071930|FG003|Overall Study|Adverse Event|0|||
149983493|NCT01890265|541071931|FG004|Overall Study|Adverse Event|0|||
149983494|NCT01890265|541071932|FG005|Overall Study|Adverse Event|0|||
149983495|NCT01890265|541071927|FG000|Overall Study|Death|2|||
149983496|NCT01890265|541071928|FG001|Overall Study|Death|3|||
149983497|NCT01890265|541071929|FG002|Overall Study|Death|1|||
149983498|NCT01890265|541071930|FG003|Overall Study|Death|0|||
149983499|NCT01890265|541071931|FG004|Overall Study|Death|0|||
149983500|NCT01890265|541071932|FG005|Overall Study|Death|0|||
149983501|NCT01890265|541071927|FG000|Overall Study|Withdrawal by Subject|0|||
149983502|NCT01890265|541071928|FG001|Overall Study|Withdrawal by Subject|2|||
149983503|NCT01890265|541071929|FG002|Overall Study|Withdrawal by Subject|3|||
149983504|NCT01890265|541071930|FG003|Overall Study|Withdrawal by Subject|0|||
149983505|NCT01890265|541071931|FG004|Overall Study|Withdrawal by Subject|2|||
149983506|NCT01890265|541071932|FG005|Overall Study|Withdrawal by Subject|0|||
149983507|NCT00100802|541071941|FG000|Overall Study|Adverse Event|9|||
149983508|NCT00100802|541071941|FG000|Overall Study|Death|1|||
149983509|NCT00100802|541071941|FG000|Overall Study|Lack of Efficacy|47|||
149983510|NCT00100802|541071941|FG000|Overall Study|Physician Decision|5|||
149983511|NCT00100802|541071941|FG000|Overall Study|Protocol Violation|1|||
149983512|NCT00100802|541071941|FG000|Overall Study|Withdrawal by Subject|5|||
149983513|NCT00100802|541071941|FG000|Overall Study|Ineligible|12|||
149983514|NCT02709720|541071942|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
149983515|NCT02709720|541071942|FG000|Overall Study|Protocol Violation|1|||
149983516|NCT02709720|541071942|FG000|Overall Study|Not take study medication|1|||
149983517|NCT04266912|541071987|FG000|Overall Study|Withdrawal by Subject|1|||
149983518|NCT04266912|541071988|FG001|Overall Study|Withdrawal by Subject|0|||
149983519|NCT04266912|541071989|FG002|Overall Study|Withdrawal by Subject|0|||
149983520|NCT04266912|541071990|FG003|Overall Study|Withdrawal by Subject|0|||
149983521|NCT04266912|541071987|FG000|Overall Study|Progression|6|||
149983522|NCT04266912|541071988|FG001|Overall Study|Progression|6|||
149983523|NCT04266912|541071989|FG002|Overall Study|Progression|0|||
149983524|NCT04266912|541071990|FG003|Overall Study|Progression|10|||
149983525|NCT01238991|541072904|FG000|Overall Study|Adverse Event|1|||
150053466|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
149983526|NCT01238991|541072905|FG001|Overall Study|Adverse Event|0|||
149983527|NCT01238991|541072906|FG002|Overall Study|Adverse Event|3|||
149983528|NCT01238991|541072907|FG003|Overall Study|Adverse Event|1|||
149983529|NCT01238991|541072908|FG004|Overall Study|Adverse Event|1|||
149983530|NCT01238991|541072909|FG005|Overall Study|Adverse Event|0|||
149983531|NCT01238991|541072910|FG006|Overall Study|Adverse Event|1|||
149983532|NCT01238991|541072911|FG007|Overall Study|Adverse Event|1|||
149983533|NCT01238991|541072912|FG008|Overall Study|Adverse Event|0|||
149983534|NCT01238991|541072913|FG009|Overall Study|Adverse Event|0|||
149983535|NCT01238991|541072904|FG000|Overall Study|Death|0|||
149983536|NCT01238991|541072905|FG001|Overall Study|Death|0|||
149983537|NCT01238991|541072906|FG002|Overall Study|Death|0|||
149983538|NCT01238991|541072907|FG003|Overall Study|Death|1|||
149983539|NCT01238991|541072908|FG004|Overall Study|Death|0|||
149983540|NCT01238991|541072909|FG005|Overall Study|Death|0|||
149983541|NCT01238991|541072910|FG006|Overall Study|Death|0|||
149983542|NCT01238991|541072911|FG007|Overall Study|Death|0|||
149983543|NCT01238991|541072912|FG008|Overall Study|Death|0|||
149983544|NCT01238991|541072913|FG009|Overall Study|Death|0|||
149983545|NCT01238991|541072904|FG000|Overall Study|Lack of Efficacy|0|||
149983546|NCT01238991|541072905|FG001|Overall Study|Lack of Efficacy|0|||
149983547|NCT01238991|541072906|FG002|Overall Study|Lack of Efficacy|1|||
149983548|NCT01238991|541072907|FG003|Overall Study|Lack of Efficacy|0|||
149983549|NCT01238991|541072908|FG004|Overall Study|Lack of Efficacy|0|||
149983550|NCT01238991|541072909|FG005|Overall Study|Lack of Efficacy|0|||
149983551|NCT01238991|541072910|FG006|Overall Study|Lack of Efficacy|0|||
149983552|NCT01238991|541072911|FG007|Overall Study|Lack of Efficacy|0|||
149983553|NCT01238991|541072912|FG008|Overall Study|Lack of Efficacy|1|||
149983554|NCT01238991|541072913|FG009|Overall Study|Lack of Efficacy|0|||
149983555|NCT01238991|541072904|FG000|Overall Study|Withdrawal by Subject|0|||
149983556|NCT01238991|541072905|FG001|Overall Study|Withdrawal by Subject|0|||
149983557|NCT01238991|541072906|FG002|Overall Study|Withdrawal by Subject|1|||
149983558|NCT01238991|541072907|FG003|Overall Study|Withdrawal by Subject|0|||
149983559|NCT01238991|541072908|FG004|Overall Study|Withdrawal by Subject|0|||
149983560|NCT01238991|541072909|FG005|Overall Study|Withdrawal by Subject|0|||
149983561|NCT01238991|541072910|FG006|Overall Study|Withdrawal by Subject|0|||
149983562|NCT01238991|541072911|FG007|Overall Study|Withdrawal by Subject|0|||
149983563|NCT01238991|541072912|FG008|Overall Study|Withdrawal by Subject|0|||
149983564|NCT01238991|541072913|FG009|Overall Study|Withdrawal by Subject|0|||
149983565|NCT01238991|541072904|FG000|Overall Study|Study Terminated by Sponsor|0|||
149983566|NCT01238991|541072905|FG001|Overall Study|Study Terminated by Sponsor|0|||
149983567|NCT01238991|541072906|FG002|Overall Study|Study Terminated by Sponsor|0|||
149983568|NCT01238991|541072907|FG003|Overall Study|Study Terminated by Sponsor|0|||
149983569|NCT01238991|541072908|FG004|Overall Study|Study Terminated by Sponsor|1|||
149983570|NCT01238991|541072909|FG005|Overall Study|Study Terminated by Sponsor|0|||
149983571|NCT01238991|541072910|FG006|Overall Study|Study Terminated by Sponsor|7|||
149983572|NCT01238991|541072911|FG007|Overall Study|Study Terminated by Sponsor|4|||
149983573|NCT01238991|541072912|FG008|Overall Study|Study Terminated by Sponsor|2|||
149983574|NCT01238991|541072913|FG009|Overall Study|Study Terminated by Sponsor|2|||
149983575|NCT01238991|541072904|FG000|Overall Study|Caregiver's request|0|||
149983576|NCT01238991|541072905|FG001|Overall Study|Caregiver's request|0|||
149983577|NCT01238991|541072906|FG002|Overall Study|Caregiver's request|0|||
149983578|NCT01238991|541072907|FG003|Overall Study|Caregiver's request|0|||
149983579|NCT01238991|541072908|FG004|Overall Study|Caregiver's request|0|||
149983580|NCT01238991|541072909|FG005|Overall Study|Caregiver's request|0|||
149983581|NCT01238991|541072910|FG006|Overall Study|Caregiver's request|0|||
149983582|NCT01238991|541072911|FG007|Overall Study|Caregiver's request|0|||
149983583|NCT01238991|541072912|FG008|Overall Study|Caregiver's request|1|||
149983584|NCT01238991|541072913|FG009|Overall Study|Caregiver's request|0|||
149983585|NCT01238991|541072904|FG000|Overall Study|Admission to a nursing home|1|||
149983586|NCT01238991|541072905|FG001|Overall Study|Admission to a nursing home|0|||
149983587|NCT01238991|541072906|FG002|Overall Study|Admission to a nursing home|1|||
149983588|NCT01238991|541072907|FG003|Overall Study|Admission to a nursing home|0|||
149983589|NCT01238991|541072908|FG004|Overall Study|Admission to a nursing home|0|||
149983590|NCT01238991|541072909|FG005|Overall Study|Admission to a nursing home|0|||
149983591|NCT01238991|541072910|FG006|Overall Study|Admission to a nursing home|0|||
149983592|NCT01238991|541072911|FG007|Overall Study|Admission to a nursing home|0|||
149983593|NCT01238991|541072912|FG008|Overall Study|Admission to a nursing home|0|||
149983594|NCT01238991|541072913|FG009|Overall Study|Admission to a nursing home|0|||
149983595|NCT00662831|541072917|FG000|Overall Study|Death|4|||
149983596|NCT00662831|541072918|FG001|Overall Study|Death|1|||
149983597|NCT00662831|541072917|FG000|Overall Study|Lack of Efficacy|6|||
149983598|NCT00662831|541072918|FG001|Overall Study|Lack of Efficacy|6|||
149983599|NCT00662831|541072917|FG000|Overall Study|Lost to Follow-up|1|||
149983600|NCT00662831|541072918|FG001|Overall Study|Lost to Follow-up|0|||
149983601|NCT00662831|541072917|FG000|Overall Study|Withdrawal by Subject|2|||
149983602|NCT00662831|541072918|FG001|Overall Study|Withdrawal by Subject|1|||
149983603|NCT00662831|541072917|FG000|Overall Study|Other|62|||
149983604|NCT00662831|541072918|FG001|Overall Study|Other|31|||
149983605|NCT00662831|541072917|FG000|Overall Study|Protocol Violation|8|||
149983606|NCT00662831|541072918|FG001|Overall Study|Protocol Violation|4|||
149983607|NCT00662831|541072917|FG000|Overall Study|Adverse Event|23|||
149983608|NCT00662831|541072918|FG001|Overall Study|Adverse Event|16|||
149983609|NCT01961297|541072919|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
149983610|NCT01961297|541072920|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
149983611|NCT02482298|541072921|FG000|Overall Study|Withdrawal by Subject|2|||
149983612|NCT02482298|541072922|FG001|Overall Study|Withdrawal by Subject|1|||
149983613|NCT02482298|541072923|FG002|Overall Study|Withdrawal by Subject|2|||
149983614|NCT02482298|541072921|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
149983615|NCT02482298|541072922|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
149983616|NCT02482298|541072923|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
149983617|NCT02482298|541072921|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
149983618|NCT02482298|541072922|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
149983619|NCT02482298|541072923|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
149983620|NCT02482298|541072921|FG000|Overall Study|Lost to Follow-up|0|||
149983621|NCT02482298|541072922|FG001|Overall Study|Lost to Follow-up|1|||
149983622|NCT02482298|541072923|FG002|Overall Study|Lost to Follow-up|0|||
149983623|NCT01188551|541072928|FG000|Overall Study|Pharmacy issues|1|||
149983624|NCT01188551|541072929|FG001|Overall Study|Pharmacy issues|0|||
149983625|NCT01188551|541072930|FG002|Overall Study|Pharmacy issues|0|||
149983626|NCT01188551|541072931|FG003|Overall Study|Pharmacy issues|0|||
149983627|NCT02569476|541072934|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
149983628|NCT02569476|541072934|FG000|Overall Study|Death|33|||
149983629|NCT02569476|541072934|FG000|Overall Study|Withdrawal by Subject|9|||
149983630|NCT02569476|541072934|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
149983631|NCT02569476|541072934|FG000|Overall Study|Palliative care|1|||
149983632|NCT02569476|541072934|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
149983633|NCT02569476|541072934|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
149983634|NCT01071954|541072935|FG000|Overall Study|Noncompliance|4|||
149983635|NCT01071954|541072935|FG000|Overall Study|Adverse Event|1|||
149983636|NCT01071954|541072935|FG000|Overall Study|Withdrawal by Subject|11|||
149983637|NCT01071954|541072935|FG000|Overall Study|Requirement for Alternative Therapy|5|||
149983638|NCT01071954|541072935|FG000|Overall Study|Administrative Decision|5|||
149983639|NCT01071954|541072935|FG000|Overall Study|Protocol Specified Criteria|1|||
149983640|NCT01434654|541072936|FG000|Overall Study|Withdrawal by Subject|1|||
149983641|NCT01434654|541072937|FG001|Overall Study|Withdrawal by Subject|0|||
149983642|NCT01434654|541072936|FG000|Overall Study|Lost to Follow-up|1|||
149983643|NCT01434654|541072937|FG001|Overall Study|Lost to Follow-up|0|||
149983644|NCT00703963|541072938|FG000|Overall Study|Withdrawal by Subject|7|||
149983645|NCT00703963|541072939|FG001|Overall Study|Withdrawal by Subject|13|||
149983646|NCT00703963|541072938|FG000|Overall Study|Physician Decision|0|||
149983647|NCT00703963|541072939|FG001|Overall Study|Physician Decision|1|||
149983648|NCT02528942|541072940|FG000|Overall Study|Did not meet imaging criteria|9|||
149983649|NCT02528942|541072940|FG000|Overall Study|Lost to Follow-up|25|||
149983650|NCT03900728|541072941|FG000|Overall Study|No text responses|0|||
149983651|NCT03900728|541072942|FG001|Overall Study|No text responses|0|||
149983652|NCT03900728|541072943|FG002|Overall Study|No text responses|4|||
149983653|NCT00763256|541072945|FG000|Overall Study|Didn't return for appointments|7|||
149983654|NCT00763256|541072946|FG001|Overall Study|Didn't return for appointments|10|||
149983655|NCT02969915|541072952|FG000|Overall Study|Death|104|||
149983656|NCT02969915|541072953|FG001|Overall Study|Death|125|||
149983657|NCT02969915|541072952|FG000|Overall Study|Lost to Follow-up|108|||
149983658|NCT02969915|541072953|FG001|Overall Study|Lost to Follow-up|112|||
149983659|NCT02969915|541072952|FG000|Overall Study|Censored due to COVID-19|481|||
149983660|NCT02969915|541072953|FG001|Overall Study|Censored due to COVID-19|471|||
149983661|NCT00995436|541072954|FG000|Overall Study|Withdrawal by Subject|2|||
149983662|NCT00995436|541072955|FG001|Overall Study|Withdrawal by Subject|5|||
149983663|NCT00995436|541072956|FG002|Overall Study|Withdrawal by Subject|0|||
149983664|NCT00289289|541072961|FG000|Overall Study|Withdrawal by Subject|5|||
149983665|NCT00289289|541072962|FG001|Overall Study|Withdrawal by Subject|3|||
149983666|NCT00289289|541072963|FG002|Overall Study|Withdrawal by Subject|15|||
149983667|NCT00289289|541072961|FG000|Overall Study|Lost to Follow-up|1|||
149983668|NCT00289289|541072962|FG001|Overall Study|Lost to Follow-up|0|||
149983669|NCT00289289|541072963|FG002|Overall Study|Lost to Follow-up|1|||
149983670|NCT00289289|541072961|FG000|Overall Study|Death|4|||
149983671|NCT00289289|541072962|FG001|Overall Study|Death|2|||
149983672|NCT00289289|541072963|FG002|Overall Study|Death|5|||
149983673|NCT00289289|541072961|FG000|Overall Study|No implant attempted|0|||
149983674|NCT00289289|541072962|FG001|Overall Study|No implant attempted|0|||
149983675|NCT00289289|541072963|FG002|Overall Study|No implant attempted|1|||
149983676|NCT00289289|541072961|FG000|Overall Study|Physician Decision|1|||
149983677|NCT00289289|541072962|FG001|Overall Study|Physician Decision|0|||
149983678|NCT00289289|541072963|FG002|Overall Study|Physician Decision|6|||
149983679|NCT00289289|541072961|FG000|Overall Study|Non-study device implanted|2|||
149983680|NCT00289289|541072962|FG001|Overall Study|Non-study device implanted|1|||
149983681|NCT00289289|541072963|FG002|Overall Study|Non-study device implanted|3|||
149983682|NCT00289289|541072961|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
149983683|NCT00289289|541072962|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
149983684|NCT00289289|541072963|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
149983685|NCT00289289|541072961|FG000|Overall Study|Other Exit Reason|6|||
149983686|NCT00289289|541072962|FG001|Overall Study|Other Exit Reason|4|||
149983687|NCT00289289|541072963|FG002|Overall Study|Other Exit Reason|12|||
149983688|NCT00577707|541072964|FG000|Overall Study|Withdrawal by Subject|3|||
149983689|NCT03299244|541072965|FG000|Overall Study|Withdrawal by Subject|34|||
149983690|NCT03299244|541072966|FG001|Overall Study|Withdrawal by Subject|29|||
149983691|NCT03299244|541072965|FG000|Overall Study|Decision by Sponsor|4|||
149983692|NCT03299244|541072966|FG001|Overall Study|Decision by Sponsor|5|||
149983693|NCT03299244|541072965|FG000|Overall Study|Death|9|||
149983694|NCT03299244|541072966|FG001|Overall Study|Death|4|||
149983695|NCT03146663|541072967|FG000|Overall Study|Did not receive study treatment|1|||
149983696|NCT03146663|541072968|FG001|Overall Study|Did not receive study treatment|1|||
149983697|NCT03666988|541072969|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
149983698|NCT03666988|541072970|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
149983699|NCT03666988|541072971|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
149983700|NCT03666988|541072972|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
149983701|NCT03666988|541072973|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
149983702|NCT03666988|541072974|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
149983703|NCT03666988|541072969|FG000|Part 1 (Up to 28 Months)|Other|0|||
149983704|NCT03666988|541072970|FG001|Part 1 (Up to 28 Months)|Other|1|||
149983705|NCT03666988|541072971|FG002|Part 1 (Up to 28 Months)|Other|1|||
149983706|NCT03666988|541072972|FG003|Part 1 (Up to 28 Months)|Other|0|||
149983707|NCT03666988|541072973|FG004|Part 1 (Up to 28 Months)|Other|0|||
149983708|NCT03666988|541072974|FG005|Part 1 (Up to 28 Months)|Other|0|||
149983709|NCT03666988|541072969|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
149983710|NCT03666988|541072970|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
149983711|NCT03666988|541072971|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
149983712|NCT03666988|541072972|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
149983713|NCT03666988|541072973|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
149983714|NCT03666988|541072974|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
149983715|NCT03666988|541072969|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
149983716|NCT03666988|541072970|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
149983717|NCT03666988|541072971|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
149983718|NCT03666988|541072972|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
149983719|NCT03666988|541072973|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
149983720|NCT03666988|541072974|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
149983721|NCT03666988|541072969|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
149983722|NCT03666988|541072970|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
149983723|NCT03666988|541072971|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
149983724|NCT03666988|541072972|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
149983725|NCT03666988|541072973|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
149983726|NCT03666988|541072974|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
149983727|NCT05588440|541072975|FG000|Overall Study|Sponsor Decision|2|||
149983728|NCT05588440|541072976|FG001|Overall Study|Sponsor Decision|0|||
149983729|NCT05588440|541072977|FG002|Overall Study|Sponsor Decision|1|||
149983730|NCT05588440|541072975|FG000|Overall Study|Death|1|||
149983731|NCT05588440|541072976|FG001|Overall Study|Death|1|||
149983732|NCT05588440|541072977|FG002|Overall Study|Death|1|||
149983733|NCT05588440|541072975|FG000|Overall Study|Screen Fail|0|||
149983734|NCT05588440|541072976|FG001|Overall Study|Screen Fail|1|||
149983735|NCT05588440|541072977|FG002|Overall Study|Screen Fail|1|||
149983736|NCT05588440|541072975|FG000|Overall Study|Withdrawal by Subject|0|||
149983737|NCT05588440|541072976|FG001|Overall Study|Withdrawal by Subject|0|||
149983738|NCT05588440|541072977|FG002|Overall Study|Withdrawal by Subject|1|||
149983739|NCT01154452|541072978|FG000|Phase Ib|Not Treated|1|||
149983740|NCT01154452|541072979|FG001|Phase Ib|Not Treated|0|||
149983741|NCT01154452|541072980|FG002|Phase Ib|Not Treated|0|||
149983742|NCT01154452|541072981|FG003|Phase Ib|Not Treated|0|||
149983743|NCT01154452|541072978|FG000|Phase Ib|Adverse Event|2|||
149983744|NCT01154452|541072979|FG001|Phase Ib|Adverse Event|1|||
149983745|NCT01154452|541072980|FG002|Phase Ib|Adverse Event|0|||
149983746|NCT01154452|541072981|FG003|Phase Ib|Adverse Event|0|||
149983747|NCT01154452|541072978|FG000|Phase II|Withdrawal by Subject|0|||
149983748|NCT01154452|541072979|FG001|Phase II|Withdrawal by Subject|0|||
149983749|NCT01154452|541072980|FG002|Phase II|Withdrawal by Subject|1|||
149983750|NCT01154452|541072981|FG003|Phase II|Withdrawal by Subject|2|||
149983751|NCT01154452|541072978|FG000|Phase II|Adverse Event|0|||
149983752|NCT01154452|541072979|FG001|Phase II|Adverse Event|0|||
149983753|NCT01154452|541072980|FG002|Phase II|Adverse Event|4|||
149983754|NCT01154452|541072981|FG003|Phase II|Adverse Event|4|||
149983755|NCT03706430|541072986|FG000|Overall Study|No A-Line placed|5|||
149983756|NCT03706430|541072986|FG000|Overall Study|Subject had gel nail polish|1|||
149983757|NCT03706430|541072986|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
149983758|NCT03706430|541072986|FG000|Overall Study|Cancelled Case|6|||
149983759|NCT03706430|541072986|FG000|Overall Study|Physician Decision|2|||
149983760|NCT00145626|541072987|FG000|Overall Study|Did not have NK infusions|2|||
149983761|NCT00145626|541072987|FG000|Overall Study|Turned 2 years old before treatment|1|||
149983762|NCT00145626|541072987|FG000|Overall Study|Death|1|||
149983763|NCT00145626|541072987|FG000|Overall Study|Withdrawal by Subject|1|||
149983764|NCT01392573|541072988|FG000|Overall Study|Adverse Event|1|||
149983765|NCT01392573|541072989|FG001|Overall Study|Adverse Event|3|||
149983766|NCT01392573|541072988|FG000|Overall Study|Lack of Efficacy|1|||
149983767|NCT01392573|541072989|FG001|Overall Study|Lack of Efficacy|2|||
149983768|NCT01392573|541072988|FG000|Overall Study|Protocol Violation|0|||
149983769|NCT01392573|541072989|FG001|Overall Study|Protocol Violation|2|||
149983770|NCT01392573|541072988|FG000|Overall Study|Withdrawal Criteria|13|||
149983771|NCT01392573|541072989|FG001|Overall Study|Withdrawal Criteria|15|||
149983772|NCT01392573|541072988|FG000|Overall Study|Site closure|8|||
149983773|NCT01392573|541072989|FG001|Overall Study|Site closure|7|||
149983774|NCT01392573|541072988|FG000|Overall Study|Unclassified|9|||
149983775|NCT01392573|541072989|FG001|Overall Study|Unclassified|6|||
149983776|NCT00436436|541072990|FG000|Overall Study|Progression|4|||
149983777|NCT00436436|541072990|FG000|Overall Study|Adverse Event|2|||
149983778|NCT00436436|541072990|FG000|Overall Study|Death|6|||
149983779|NCT05823974|541074760|FG000|Overall Study|Lost to Follow-up|0|||
149983780|NCT05823974|541074761|FG001|Overall Study|Lost to Follow-up|3|||
149983781|NCT05823974|541074762|FG002|Overall Study|Lost to Follow-up|1|||
149983782|NCT05823974|541074763|FG003|Overall Study|Lost to Follow-up|0|||
149983783|NCT05823974|541074764|FG004|Overall Study|Lost to Follow-up|1|||
149983784|NCT05823974|541074765|FG005|Overall Study|Lost to Follow-up|0|||
149983785|NCT05823974|541074766|FG006|Overall Study|Lost to Follow-up|1|||
149983786|NCT05823974|541074767|FG007|Overall Study|Lost to Follow-up|0|||
149983787|NCT05823974|541074768|FG008|Overall Study|Lost to Follow-up|0|||
149983788|NCT05823974|541074769|FG009|Overall Study|Lost to Follow-up|1|||
149983789|NCT05823974|541074770|FG010|Overall Study|Lost to Follow-up|1|||
149983790|NCT05823974|541074771|FG011|Overall Study|Lost to Follow-up|0|||
149983791|NCT05823974|541074772|FG012|Overall Study|Lost to Follow-up|1|||
149983792|NCT05823974|541074773|FG013|Overall Study|Lost to Follow-up|2|||
149983793|NCT05823974|541074774|FG014|Overall Study|Lost to Follow-up|1|||
149983794|NCT05823974|541074775|FG015|Overall Study|Lost to Follow-up|1|||
149983795|NCT05823974|541074776|FG016|Overall Study|Lost to Follow-up|1|||
149983796|NCT05823974|541074777|FG017|Overall Study|Lost to Follow-up|0|||
149983797|NCT05823974|541074778|FG018|Overall Study|Lost to Follow-up|0|||
149983798|NCT05823974|541074779|FG019|Overall Study|Lost to Follow-up|2|||
149983799|NCT05823974|541074780|FG020|Overall Study|Lost to Follow-up|0|||
149983800|NCT05823974|541074760|FG000|Overall Study|Physician Decision|0|||
149983801|NCT05823974|541074761|FG001|Overall Study|Physician Decision|0|||
149983802|NCT05823974|541074762|FG002|Overall Study|Physician Decision|0|||
149983803|NCT05823974|541074763|FG003|Overall Study|Physician Decision|0|||
149983804|NCT05823974|541074764|FG004|Overall Study|Physician Decision|0|||
149983805|NCT05823974|541074765|FG005|Overall Study|Physician Decision|0|||
149983806|NCT05823974|541074766|FG006|Overall Study|Physician Decision|0|||
149983807|NCT05823974|541074767|FG007|Overall Study|Physician Decision|0|||
149983808|NCT05823974|541074768|FG008|Overall Study|Physician Decision|0|||
149983809|NCT05823974|541074769|FG009|Overall Study|Physician Decision|0|||
149983810|NCT05823974|541074770|FG010|Overall Study|Physician Decision|0|||
149983811|NCT05823974|541074771|FG011|Overall Study|Physician Decision|0|||
149983812|NCT05823974|541074772|FG012|Overall Study|Physician Decision|0|||
149983813|NCT05823974|541074773|FG013|Overall Study|Physician Decision|0|||
149983814|NCT05823974|541074774|FG014|Overall Study|Physician Decision|0|||
149983815|NCT05823974|541074775|FG015|Overall Study|Physician Decision|1|||
149983816|NCT05823974|541074776|FG016|Overall Study|Physician Decision|0|||
149983817|NCT05823974|541074777|FG017|Overall Study|Physician Decision|1|||
149983818|NCT05823974|541074778|FG018|Overall Study|Physician Decision|1|||
149983819|NCT05823974|541074779|FG019|Overall Study|Physician Decision|0|||
149983820|NCT05823974|541074780|FG020|Overall Study|Physician Decision|0|||
149983821|NCT05823974|541074760|FG000|Overall Study|Withdrawal by Subject|1|||
149983822|NCT05823974|541074761|FG001|Overall Study|Withdrawal by Subject|1|||
149983823|NCT05823974|541074762|FG002|Overall Study|Withdrawal by Subject|2|||
149983824|NCT05823974|541074763|FG003|Overall Study|Withdrawal by Subject|0|||
149983825|NCT05823974|541074764|FG004|Overall Study|Withdrawal by Subject|2|||
149983826|NCT05823974|541074765|FG005|Overall Study|Withdrawal by Subject|3|||
149983827|NCT05823974|541074766|FG006|Overall Study|Withdrawal by Subject|1|||
150178678|NCT00546754|541791995|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
150178679|NCT00546754|541791996|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
150178680|NCT00546754|541791995|FG000|Overall Study|Patient's Decision|0|||
150178681|NCT00546754|541791996|FG001|Overall Study|Patient's Decision|1|||
150178682|NCT00546754|541791995|FG000|Overall Study|Missing|14|||
150178683|NCT00546754|541791996|FG001|Overall Study|Missing|7|||
150178684|NCT00396084|541791997|FG000|Overall Study|Adverse Event|0|||
150178685|NCT00396084|541791998|FG001|Overall Study|Adverse Event|0|||
150178686|NCT00396084|541791999|FG002|Overall Study|Adverse Event|0|||
150178687|NCT00396084|541792000|FG003|Overall Study|Adverse Event|0|||
150178688|NCT00396084|541792001|FG004|Overall Study|Adverse Event|1|||
150178689|NCT00396084|541792002|FG005|Overall Study|Adverse Event|2|||
150178690|NCT00396084|541791997|FG000|Overall Study|Withdrawal by Subject|0|||
149983828|NCT05823974|541074767|FG007|Overall Study|Withdrawal by Subject|1|||
149983829|NCT05823974|541074768|FG008|Overall Study|Withdrawal by Subject|2|||
149983830|NCT05823974|541074769|FG009|Overall Study|Withdrawal by Subject|1|||
149983831|NCT05823974|541074770|FG010|Overall Study|Withdrawal by Subject|1|||
149983832|NCT05823974|541074771|FG011|Overall Study|Withdrawal by Subject|0|||
149983833|NCT05823974|541074772|FG012|Overall Study|Withdrawal by Subject|0|||
149983834|NCT05823974|541074773|FG013|Overall Study|Withdrawal by Subject|1|||
149983835|NCT05823974|541074774|FG014|Overall Study|Withdrawal by Subject|1|||
149983836|NCT05823974|541074775|FG015|Overall Study|Withdrawal by Subject|3|||
149983837|NCT05823974|541074776|FG016|Overall Study|Withdrawal by Subject|0|||
149983838|NCT05823974|541074777|FG017|Overall Study|Withdrawal by Subject|2|||
149983839|NCT05823974|541074778|FG018|Overall Study|Withdrawal by Subject|2|||
149983840|NCT05823974|541074779|FG019|Overall Study|Withdrawal by Subject|0|||
149983841|NCT05823974|541074780|FG020|Overall Study|Withdrawal by Subject|1|||
149983842|NCT05823974|541074760|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983843|NCT05823974|541074761|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983844|NCT05823974|541074762|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149983845|NCT05823974|541074763|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983846|NCT05823974|541074764|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983847|NCT05823974|541074765|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983848|NCT05823974|541074766|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983849|NCT05823974|541074767|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983850|NCT05823974|541074768|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983851|NCT05823974|541074769|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983852|NCT05823974|541074770|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983853|NCT05823974|541074771|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983854|NCT05823974|541074772|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983855|NCT05823974|541074773|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983856|NCT05823974|541074774|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149983857|NCT05823974|541074775|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983858|NCT05823974|541074776|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983859|NCT05823974|541074777|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983860|NCT05823974|541074778|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983861|NCT05823974|541074779|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983862|NCT05823974|541074780|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149983863|NCT05823974|541074760|FG000|Overall Study|Other|0|||
149983864|NCT05823974|541074761|FG001|Overall Study|Other|1|||
149983865|NCT05823974|541074762|FG002|Overall Study|Other|1|||
149983866|NCT05823974|541074763|FG003|Overall Study|Other|1|||
149983867|NCT05823974|541074764|FG004|Overall Study|Other|0|||
149983868|NCT05823974|541074765|FG005|Overall Study|Other|1|||
149983869|NCT05823974|541074766|FG006|Overall Study|Other|1|||
149983870|NCT05823974|541074767|FG007|Overall Study|Other|1|||
149983871|NCT05823974|541074768|FG008|Overall Study|Other|1|||
149983872|NCT05823974|541074769|FG009|Overall Study|Other|0|||
149983873|NCT05823974|541074770|FG010|Overall Study|Other|0|||
149983874|NCT05823974|541074771|FG011|Overall Study|Other|0|||
149983875|NCT05823974|541074772|FG012|Overall Study|Other|2|||
150178691|NCT00396084|541791998|FG001|Overall Study|Withdrawal by Subject|0|||
150178692|NCT00396084|541791999|FG002|Overall Study|Withdrawal by Subject|0|||
150178693|NCT00396084|541792000|FG003|Overall Study|Withdrawal by Subject|1|||
149983876|NCT05823974|541074773|FG013|Overall Study|Other|1|||
149983877|NCT05823974|541074774|FG014|Overall Study|Other|0|||
149983878|NCT05823974|541074775|FG015|Overall Study|Other|1|||
150178694|NCT00396084|541792001|FG004|Overall Study|Withdrawal by Subject|0|||
149983879|NCT05823974|541074776|FG016|Overall Study|Other|0|||
149983880|NCT05823974|541074777|FG017|Overall Study|Other|0|||
149983881|NCT05823974|541074778|FG018|Overall Study|Other|0|||
149983882|NCT05823974|541074779|FG019|Overall Study|Other|0|||
149983883|NCT05823974|541074780|FG020|Overall Study|Other|0|||
149983884|NCT02744612|541074781|FG000|Overall Study|Withdrawal by Subject|0|||
149983885|NCT02744612|541074782|FG001|Overall Study|Withdrawal by Subject|2|||
149983886|NCT00283803|541074784|FG000|Overall Study|Physician Decision|9|||
149983887|NCT00283803|541074784|FG000|Overall Study|Withdrawal by Subject|4|||
149983888|NCT01127607|541074785|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
149983889|NCT01127607|541074786|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
149983890|NCT01127607|541074785|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
149983891|NCT01127607|541074786|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
149983892|NCT02220855|541074787|FG000|Overall Study|Adverse Event|8|||
149983893|NCT02220855|541074787|FG000|Overall Study|Disease Progression|5|||
149983894|NCT02220855|541074787|FG000|Overall Study|Withdrawal by Subject|1|||
149983895|NCT03419897|541074788|FG000|Overall Study|Death|180|||
149983896|NCT03419897|541074788|FG000|Overall Study|Lost to Follow-up|1|||
149983897|NCT03419897|541074788|FG000|Overall Study|Withdrawal by Subject|6|||
149983898|NCT03419897|541074788|FG000|Overall Study|Sponsor Decision|61|||
149983899|NCT03419897|541074788|FG000|Overall Study|Physician Decision|1|||
149983900|NCT01945216|541074792|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
149983901|NCT01945216|541074792|FG000|Overall Study|Protocol Violation|42|||
149983902|NCT01945216|541074792|FG000|Overall Study|CRF not assured by investigators|5|||
149983903|NCT01905943|541074798|FG000|Overall Study|Withdrawal of consent|90|||
149983904|NCT01905943|541074798|FG000|Overall Study|Lost to Follow-up|16|||
149983905|NCT01905943|541074798|FG000|Overall Study|Investigator discretion|7|||
149983906|NCT01905943|541074798|FG000|Overall Study|Death|186|||
149983907|NCT01905943|541074798|FG000|Overall Study|Adverse Event|3|||
149983908|NCT01905943|541074798|FG000|Overall Study|Other|12|||
149983909|NCT02574078|541074801|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983910|NCT02574078|541074802|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983911|NCT02574078|541074803|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983912|NCT02574078|541074804|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983913|NCT02574078|541074805|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983914|NCT02574078|541074806|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149983915|NCT02574078|541074807|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
149983916|NCT02574078|541074808|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983917|NCT02574078|541074809|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149983918|NCT02574078|541074810|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983919|NCT02574078|541074811|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983920|NCT02574078|541074812|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983921|NCT02574078|541074813|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149983922|NCT02574078|541074801|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
149983923|NCT02574078|541074802|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
149983924|NCT02574078|541074803|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
149983925|NCT02574078|541074804|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
149983926|NCT02574078|541074805|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
149983927|NCT02574078|541074806|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
149983928|NCT02574078|541074807|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
149983929|NCT02574078|541074808|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
149983930|NCT02574078|541074809|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
149983931|NCT02574078|541074810|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
149983932|NCT02574078|541074811|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
149983933|NCT02574078|541074812|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
149983934|NCT02574078|541074813|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
149983935|NCT02574078|541074801|FG000|Pre-Treatment Period|Other reasons|0|||
149983936|NCT02574078|541074802|FG001|Pre-Treatment Period|Other reasons|0|||
149983937|NCT02574078|541074803|FG002|Pre-Treatment Period|Other reasons|0|||
149983938|NCT02574078|541074804|FG003|Pre-Treatment Period|Other reasons|0|||
149983939|NCT02574078|541074805|FG004|Pre-Treatment Period|Other reasons|0|||
149983940|NCT02574078|541074806|FG005|Pre-Treatment Period|Other reasons|0|||
149983941|NCT02574078|541074807|FG006|Pre-Treatment Period|Other reasons|2|||
149983942|NCT02574078|541074808|FG007|Pre-Treatment Period|Other reasons|0|||
149983943|NCT02574078|541074809|FG008|Pre-Treatment Period|Other reasons|0|||
149983944|NCT02574078|541074810|FG009|Pre-Treatment Period|Other reasons|0|||
149983945|NCT02574078|541074811|FG010|Pre-Treatment Period|Other reasons|2|||
149983946|NCT02574078|541074812|FG011|Pre-Treatment Period|Other reasons|0|||
149983947|NCT02574078|541074813|FG012|Pre-Treatment Period|Other reasons|0|||
149983948|NCT02574078|541074801|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
149983949|NCT02574078|541074802|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
149983950|NCT02574078|541074803|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
149983951|NCT02574078|541074804|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
149983952|NCT02574078|541074805|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
149983953|NCT02574078|541074806|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
149983954|NCT02574078|541074807|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
149983955|NCT02574078|541074808|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
149983956|NCT02574078|541074809|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
149983957|NCT02574078|541074810|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
149983958|NCT02574078|541074811|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
149983959|NCT02574078|541074812|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
149983960|NCT02574078|541074813|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
149983961|NCT02574078|541074801|FG000|Treatment Period|Disease progression|6|||
149983962|NCT02574078|541074802|FG001|Treatment Period|Disease progression|4|||
149983963|NCT02574078|541074803|FG002|Treatment Period|Disease progression|7|||
149983964|NCT02574078|541074804|FG003|Treatment Period|Disease progression|18|||
150178695|NCT00396084|541792002|FG005|Overall Study|Withdrawal by Subject|0|||
149983965|NCT02574078|541074805|FG004|Treatment Period|Disease progression|16|||
149983966|NCT02574078|541074806|FG005|Treatment Period|Disease progression|26|||
149983967|NCT02574078|541074807|FG006|Treatment Period|Disease progression|5|||
149983968|NCT02574078|541074808|FG007|Treatment Period|Disease progression|9|||
149983969|NCT02574078|541074809|FG008|Treatment Period|Disease progression|8|||
149983970|NCT02574078|541074810|FG009|Treatment Period|Disease progression|5|||
149983971|NCT02574078|541074811|FG010|Treatment Period|Disease progression|20|||
149983972|NCT02574078|541074812|FG011|Treatment Period|Disease progression|29|||
149983973|NCT02574078|541074813|FG012|Treatment Period|Disease progression|2|||
149983974|NCT02574078|541074801|FG000|Treatment Period|Study drug toxicity|1|||
149983975|NCT02574078|541074802|FG001|Treatment Period|Study drug toxicity|1|||
149983976|NCT02574078|541074803|FG002|Treatment Period|Study drug toxicity|0|||
149983977|NCT02574078|541074804|FG003|Treatment Period|Study drug toxicity|5|||
149983978|NCT02574078|541074805|FG004|Treatment Period|Study drug toxicity|3|||
149983979|NCT02574078|541074806|FG005|Treatment Period|Study drug toxicity|1|||
149983980|NCT02574078|541074807|FG006|Treatment Period|Study drug toxicity|2|||
149983981|NCT02574078|541074808|FG007|Treatment Period|Study drug toxicity|0|||
149983982|NCT02574078|541074809|FG008|Treatment Period|Study drug toxicity|2|||
149983983|NCT02574078|541074810|FG009|Treatment Period|Study drug toxicity|1|||
149983984|NCT02574078|541074811|FG010|Treatment Period|Study drug toxicity|16|||
149983985|NCT02574078|541074812|FG011|Treatment Period|Study drug toxicity|2|||
149983986|NCT02574078|541074813|FG012|Treatment Period|Study drug toxicity|4|||
149983987|NCT02574078|541074801|FG000|Treatment Period|Death|2|||
149983988|NCT02574078|541074802|FG001|Treatment Period|Death|0|||
150178696|NCT04556981|541792003|FG000|Overall Study|Death|0|||
149983989|NCT02574078|541074803|FG002|Treatment Period|Death|0|||
149983990|NCT02574078|541074804|FG003|Treatment Period|Death|0|||
149983991|NCT02574078|541074805|FG004|Treatment Period|Death|1|||
149983992|NCT02574078|541074806|FG005|Treatment Period|Death|1|||
149983993|NCT02574078|541074807|FG006|Treatment Period|Death|1|||
149983994|NCT02574078|541074808|FG007|Treatment Period|Death|1|||
149983995|NCT02574078|541074809|FG008|Treatment Period|Death|7|||
149983996|NCT02574078|541074810|FG009|Treatment Period|Death|1|||
149983997|NCT02574078|541074811|FG010|Treatment Period|Death|0|||
149983998|NCT02574078|541074812|FG011|Treatment Period|Death|2|||
149983999|NCT02574078|541074813|FG012|Treatment Period|Death|1|||
149984000|NCT02574078|541074801|FG000|Treatment Period|Adverse event unrelated to drug|0|||
149984001|NCT02574078|541074802|FG001|Treatment Period|Adverse event unrelated to drug|0|||
149984002|NCT02574078|541074803|FG002|Treatment Period|Adverse event unrelated to drug|1|||
149984003|NCT02574078|541074804|FG003|Treatment Period|Adverse event unrelated to drug|0|||
149984004|NCT02574078|541074805|FG004|Treatment Period|Adverse event unrelated to drug|2|||
149984005|NCT02574078|541074806|FG005|Treatment Period|Adverse event unrelated to drug|3|||
149984006|NCT02574078|541074807|FG006|Treatment Period|Adverse event unrelated to drug|0|||
149984007|NCT02574078|541074808|FG007|Treatment Period|Adverse event unrelated to drug|0|||
150178697|NCT04556981|541792004|FG001|Overall Study|Death|1|||
150178698|NCT04556981|541792003|FG000|Overall Study|Lost to Follow-up|2|||
150178699|NCT04556981|541792004|FG001|Overall Study|Lost to Follow-up|11|||
150178700|NCT04556981|541792003|FG000|Overall Study|Moved from the study area|1|||
149984008|NCT02574078|541074809|FG008|Treatment Period|Adverse event unrelated to drug|1|||
150178701|NCT04556981|541792004|FG001|Overall Study|Moved from the study area|4|||
149984009|NCT02574078|541074810|FG009|Treatment Period|Adverse event unrelated to drug|2|||
149984010|NCT02574078|541074811|FG010|Treatment Period|Adverse event unrelated to drug|4|||
149984011|NCT02574078|541074812|FG011|Treatment Period|Adverse event unrelated to drug|1|||
149984012|NCT02574078|541074813|FG012|Treatment Period|Adverse event unrelated to drug|0|||
149984013|NCT02574078|541074801|FG000|Treatment Period|Administrative reason by Sponsor|0|||
149984014|NCT02574078|541074802|FG001|Treatment Period|Administrative reason by Sponsor|1|||
149984015|NCT02574078|541074803|FG002|Treatment Period|Administrative reason by Sponsor|0|||
149984016|NCT02574078|541074804|FG003|Treatment Period|Administrative reason by Sponsor|0|||
149984017|NCT02574078|541074805|FG004|Treatment Period|Administrative reason by Sponsor|0|||
149984018|NCT02574078|541074806|FG005|Treatment Period|Administrative reason by Sponsor|0|||
149984019|NCT02574078|541074807|FG006|Treatment Period|Administrative reason by Sponsor|1|||
149984020|NCT02574078|541074808|FG007|Treatment Period|Administrative reason by Sponsor|0|||
149984021|NCT02574078|541074809|FG008|Treatment Period|Administrative reason by Sponsor|0|||
149984022|NCT02574078|541074810|FG009|Treatment Period|Administrative reason by Sponsor|0|||
149984023|NCT02574078|541074811|FG010|Treatment Period|Administrative reason by Sponsor|0|||
149984024|NCT02574078|541074812|FG011|Treatment Period|Administrative reason by Sponsor|0|||
149984025|NCT02574078|541074813|FG012|Treatment Period|Administrative reason by Sponsor|3|||
149984026|NCT02574078|541074801|FG000|Treatment Period|Other reasons|1|||
149984027|NCT02574078|541074802|FG001|Treatment Period|Other reasons|0|||
149984028|NCT02574078|541074803|FG002|Treatment Period|Other reasons|1|||
149984029|NCT02574078|541074804|FG003|Treatment Period|Other reasons|3|||
149984030|NCT02574078|541074805|FG004|Treatment Period|Other reasons|3|||
149984031|NCT02574078|541074806|FG005|Treatment Period|Other reasons|1|||
149984032|NCT02574078|541074807|FG006|Treatment Period|Other reasons|2|||
149984033|NCT02574078|541074808|FG007|Treatment Period|Other reasons|1|||
149984034|NCT02574078|541074809|FG008|Treatment Period|Other reasons|3|||
149984035|NCT02574078|541074810|FG009|Treatment Period|Other reasons|1|||
149984036|NCT02574078|541074811|FG010|Treatment Period|Other reasons|1|||
149984037|NCT02574078|541074812|FG011|Treatment Period|Other reasons|3|||
149984038|NCT02574078|541074813|FG012|Treatment Period|Other reasons|1|||
149984039|NCT02574078|541074801|FG000|Treatment Period|Participant request to stop drug|0|||
149984040|NCT02574078|541074802|FG001|Treatment Period|Participant request to stop drug|0|||
149984041|NCT02574078|541074803|FG002|Treatment Period|Participant request to stop drug|0|||
149984042|NCT02574078|541074804|FG003|Treatment Period|Participant request to stop drug|2|||
149984043|NCT02574078|541074805|FG004|Treatment Period|Participant request to stop drug|4|||
149984044|NCT02574078|541074806|FG005|Treatment Period|Participant request to stop drug|0|||
149984045|NCT02574078|541074807|FG006|Treatment Period|Participant request to stop drug|1|||
149984046|NCT02574078|541074808|FG007|Treatment Period|Participant request to stop drug|0|||
149984047|NCT02574078|541074809|FG008|Treatment Period|Participant request to stop drug|3|||
149984048|NCT02574078|541074810|FG009|Treatment Period|Participant request to stop drug|2|||
149984049|NCT02574078|541074811|FG010|Treatment Period|Participant request to stop drug|2|||
149984050|NCT02574078|541074812|FG011|Treatment Period|Participant request to stop drug|4|||
149984051|NCT02574078|541074813|FG012|Treatment Period|Participant request to stop drug|1|||
149984052|NCT02574078|541074801|FG000|Treatment Period|Participant withdrew consent|0|||
149984053|NCT02574078|541074802|FG001|Treatment Period|Participant withdrew consent|0|||
149984054|NCT02574078|541074803|FG002|Treatment Period|Participant withdrew consent|0|||
149984055|NCT02574078|541074804|FG003|Treatment Period|Participant withdrew consent|0|||
149984056|NCT02574078|541074805|FG004|Treatment Period|Participant withdrew consent|1|||
149984057|NCT02574078|541074806|FG005|Treatment Period|Participant withdrew consent|1|||
149984058|NCT02574078|541074807|FG006|Treatment Period|Participant withdrew consent|0|||
149984059|NCT02574078|541074808|FG007|Treatment Period|Participant withdrew consent|1|||
149984060|NCT02574078|541074809|FG008|Treatment Period|Participant withdrew consent|0|||
149984061|NCT02574078|541074810|FG009|Treatment Period|Participant withdrew consent|2|||
149984062|NCT02574078|541074811|FG010|Treatment Period|Participant withdrew consent|1|||
149984063|NCT02574078|541074812|FG011|Treatment Period|Participant withdrew consent|4|||
149984064|NCT02574078|541074813|FG012|Treatment Period|Participant withdrew consent|1|||
149984065|NCT02574078|541074801|FG000|Treatment Period|Participant no longer meets criteria|0|||
149984066|NCT02574078|541074802|FG001|Treatment Period|Participant no longer meets criteria|0|||
150178702|NCT04556981|541792003|FG000|Overall Study|Withdrawal by Subject|2|||
150178703|NCT04556981|541792004|FG001|Overall Study|Withdrawal by Subject|2|||
150178704|NCT04556981|541792003|FG000|Overall Study|Other|2|||
149984067|NCT02574078|541074803|FG002|Treatment Period|Participant no longer meets criteria|0|||
149984068|NCT02574078|541074804|FG003|Treatment Period|Participant no longer meets criteria|0|||
149984069|NCT02574078|541074805|FG004|Treatment Period|Participant no longer meets criteria|1|||
149984070|NCT02574078|541074806|FG005|Treatment Period|Participant no longer meets criteria|0|||
149984071|NCT02574078|541074807|FG006|Treatment Period|Participant no longer meets criteria|0|||
150178705|NCT04556981|541792004|FG001|Overall Study|Other|1|||
150178706|NCT05510245|541792011|FG000|Overall Study|Withdrawal by Subject|1|||
149984072|NCT02574078|541074808|FG007|Treatment Period|Participant no longer meets criteria|0|||
149984073|NCT02574078|541074809|FG008|Treatment Period|Participant no longer meets criteria|0|||
149984074|NCT02574078|541074810|FG009|Treatment Period|Participant no longer meets criteria|1|||
149984075|NCT02574078|541074811|FG010|Treatment Period|Participant no longer meets criteria|1|||
149984076|NCT02574078|541074812|FG011|Treatment Period|Participant no longer meets criteria|1|||
149984077|NCT02574078|541074813|FG012|Treatment Period|Participant no longer meets criteria|0|||
149984078|NCT02574078|541074801|FG000|Treatment Period|Lost to Follow-up|0|||
149984079|NCT02574078|541074802|FG001|Treatment Period|Lost to Follow-up|0|||
149984080|NCT02574078|541074803|FG002|Treatment Period|Lost to Follow-up|0|||
149984081|NCT02574078|541074804|FG003|Treatment Period|Lost to Follow-up|0|||
149984082|NCT02574078|541074805|FG004|Treatment Period|Lost to Follow-up|0|||
149984083|NCT02574078|541074806|FG005|Treatment Period|Lost to Follow-up|0|||
149984084|NCT02574078|541074807|FG006|Treatment Period|Lost to Follow-up|0|||
149984085|NCT02574078|541074808|FG007|Treatment Period|Lost to Follow-up|0|||
149984086|NCT02574078|541074809|FG008|Treatment Period|Lost to Follow-up|0|||
149984087|NCT02574078|541074810|FG009|Treatment Period|Lost to Follow-up|1|||
149984088|NCT02574078|541074811|FG010|Treatment Period|Lost to Follow-up|0|||
149984089|NCT02574078|541074812|FG011|Treatment Period|Lost to Follow-up|1|||
149984090|NCT02574078|541074813|FG012|Treatment Period|Lost to Follow-up|0|||
149984091|NCT02574078|541074801|FG000|Treatment Period|Maximum clinical benefit|0|||
149984092|NCT02574078|541074802|FG001|Treatment Period|Maximum clinical benefit|0|||
149984093|NCT02574078|541074803|FG002|Treatment Period|Maximum clinical benefit|0|||
149984094|NCT02574078|541074804|FG003|Treatment Period|Maximum clinical benefit|0|||
149984095|NCT02574078|541074805|FG004|Treatment Period|Maximum clinical benefit|0|||
149984096|NCT02574078|541074806|FG005|Treatment Period|Maximum clinical benefit|0|||
149984097|NCT02574078|541074807|FG006|Treatment Period|Maximum clinical benefit|0|||
149984098|NCT02574078|541074808|FG007|Treatment Period|Maximum clinical benefit|0|||
149984099|NCT02574078|541074809|FG008|Treatment Period|Maximum clinical benefit|0|||
149984100|NCT02574078|541074810|FG009|Treatment Period|Maximum clinical benefit|1|||
149984101|NCT02574078|541074811|FG010|Treatment Period|Maximum clinical benefit|0|||
149984102|NCT02574078|541074812|FG011|Treatment Period|Maximum clinical benefit|0|||
149984103|NCT02574078|541074813|FG012|Treatment Period|Maximum clinical benefit|0|||
149984104|NCT02222688|541074814|FG000|Overall Study|Withdrawal by Subject|0|||
149984105|NCT02222688|541074815|FG001|Overall Study|Withdrawal by Subject|0|||
149984106|NCT02222688|541074816|FG002|Overall Study|Withdrawal by Subject|0|||
149984107|NCT02222688|541074817|FG003|Overall Study|Withdrawal by Subject|2|||
149984108|NCT02222688|541074818|FG004|Overall Study|Withdrawal by Subject|1|||
149984109|NCT02222688|541074819|FG005|Overall Study|Withdrawal by Subject|0|||
149984110|NCT02222688|541074820|FG006|Overall Study|Withdrawal by Subject|1|||
149984111|NCT02222688|541074814|FG000|Overall Study|Disease progression|1|||
149984112|NCT02222688|541074815|FG001|Overall Study|Disease progression|0|||
149984113|NCT02222688|541074816|FG002|Overall Study|Disease progression|0|||
149984114|NCT02222688|541074817|FG003|Overall Study|Disease progression|0|||
149984115|NCT02222688|541074818|FG004|Overall Study|Disease progression|0|||
149984116|NCT02222688|541074819|FG005|Overall Study|Disease progression|0|||
149984117|NCT02222688|541074820|FG006|Overall Study|Disease progression|0|||
149984118|NCT05935878|541074821|FG000|Overall Study|Death|1|||
149984119|NCT05935878|541074822|FG001|Overall Study|Death|2|||
149984120|NCT05935878|541074821|FG000|Overall Study|Withdrawal by Subject|5|||
149984121|NCT05935878|541074822|FG001|Overall Study|Withdrawal by Subject|5|||
149984122|NCT05935878|541074821|FG000|Overall Study|Revision of implant|1|||
149984123|NCT05935878|541074822|FG001|Overall Study|Revision of implant|1|||
149984124|NCT05935878|541074821|FG000|Overall Study|Mobile bearing dislocation|0|||
149984125|NCT05935878|541074822|FG001|Overall Study|Mobile bearing dislocation|1|||
149984126|NCT00294671|541074827|FG000|Overall Study|Lack of Efficacy|11|||
149984127|NCT00294671|541074828|FG001|Overall Study|Lack of Efficacy|23|||
149984128|NCT00294671|541074827|FG000|Overall Study|Liver transplant|7|||
149984129|NCT00294671|541074828|FG001|Overall Study|Liver transplant|9|||
149984130|NCT00294671|541074827|FG000|Overall Study|Drug related adverse event (AE)|4|||
149984131|NCT00294671|541074828|FG001|Overall Study|Drug related adverse event (AE)|2|||
149984132|NCT00294671|541074827|FG000|Overall Study|Non-drug related AE|3|||
149984133|NCT00294671|541074828|FG001|Overall Study|Non-drug related AE|2|||
149984134|NCT00294671|541074827|FG000|Overall Study|Lost to Follow-up|1|||
149984135|NCT00294671|541074828|FG001|Overall Study|Lost to Follow-up|3|||
149984136|NCT00294671|541074827|FG000|Overall Study|Non-compliance|1|||
149984137|NCT00294671|541074828|FG001|Overall Study|Non-compliance|0|||
149984138|NCT00294671|541074827|FG000|Overall Study|Death|0|||
149984139|NCT00294671|541074828|FG001|Overall Study|Death|1|||
149984140|NCT02140970|541074837|FG000|Overall Study|Lost to Follow-up|1|||
149984141|NCT02140970|541074838|FG001|Overall Study|Lost to Follow-up|2|||
149984142|NCT02140970|541074837|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
149984143|NCT02140970|541074838|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
149984144|NCT02140970|541074837|FG000|Overall Study|Did not meet inclusion criteria|0|||
149984145|NCT02140970|541074838|FG001|Overall Study|Did not meet inclusion criteria|1|||
149984146|NCT05069597|541074839|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149984147|NCT05069597|541074840|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
149984148|NCT00735553|541074841|FG000|Overall Study|Study prematurely terminated|77|||
149984149|NCT02705105|541074842|FG000|Treatment|Objective Disease Progression|1|||
149984150|NCT02705105|541074843|FG001|Treatment|Objective Disease Progression|50|||
149984151|NCT02705105|541074842|FG000|Treatment|Withdrawal by Subject|3|||
149984152|NCT02705105|541074843|FG001|Treatment|Withdrawal by Subject|5|||
149984153|NCT02705105|541074842|FG000|Treatment|Adverse Event|0|||
149984154|NCT02705105|541074843|FG001|Treatment|Adverse Event|17|||
149984155|NCT02705105|541074842|FG000|Treatment|Clinical Disease Progression|0|||
149984156|NCT02705105|541074843|FG001|Treatment|Clinical Disease Progression|32|||
150053467|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
150053468|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053469|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053470|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053471|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053472|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053473|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
150053474|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
150053475|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
150053476|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
150053477|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
150053478|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
150053479|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
150053480|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
150053481|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
150053482|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
150053483|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|Other|0|||
150053484|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|Other|0|||
150053485|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|Other|1|||
150053486|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|Other|1|||
150053487|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|Other|0|||
150053488|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|Other|0|||
150053489|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|Other|0|||
150053490|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|Other|1|||
150053491|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|Other|0|||
150053492|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|Death|0|||
150053493|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|Death|0|||
150053494|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|Death|0|||
150053495|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|Death|0|||
150053496|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|Death|0|||
150053497|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|Death|1|||
150053498|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|Death|0|||
150053499|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|Death|0|||
150053500|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|Death|0|||
150053501|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053502|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053503|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053504|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053505|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053506|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
150053507|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
150053508|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053509|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
150053510|NCT00557856|541336671|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
150053511|NCT00557856|541336672|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053512|NCT00557856|541336673|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053513|NCT00557856|541336674|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053514|NCT00557856|541336675|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
149984157|NCT02705105|541074842|FG000|Treatment|Physician Decision|0|||
149984158|NCT02705105|541074843|FG001|Treatment|Physician Decision|3|||
149984159|NCT02705105|541074842|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
149984160|NCT02705105|541074843|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
149984161|NCT02705105|541074842|FG000|Follow-Up|Death|3|||
149984162|NCT02705105|541074843|FG001|Follow-Up|Death|68|||
149984163|NCT02705105|541074842|FG000|Follow-Up|Withdrawal by Subject|1|||
149984164|NCT02705105|541074843|FG001|Follow-Up|Withdrawal by Subject|14|||
149984165|NCT02705105|541074842|FG000|Follow-Up|Study Terminated|0|||
149984166|NCT02705105|541074843|FG001|Follow-Up|Study Terminated|26|||
149984167|NCT02705105|541074842|FG000|Follow-Up|Discontinued per Amendment 3|0|||
149984168|NCT02705105|541074843|FG001|Follow-Up|Discontinued per Amendment 3|2|||
149984169|NCT04556591|541074845|FG000|Overall Study|Lost to Follow-up|1|||
149984170|NCT04556591|541074846|FG001|Overall Study|Lost to Follow-up|0|||
149984171|NCT04556591|541074845|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
149984172|NCT04556591|541074846|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
149984173|NCT03332173|541074847|FG000|Overall Study|Death|7|||
149984174|NCT03332173|541074847|FG000|Overall Study|Withdrawal by Subject|6|||
149984175|NCT03332173|541074847|FG000|Overall Study|Lost to Follow-up|2|||
149984176|NCT03332173|541074847|FG000|Overall Study|Transferred to long-term extension study|29|||
149984177|NCT02553928|541074848|FG000|Overall Study|Adverse Event|2|||
149984178|NCT02553928|541074849|FG001|Overall Study|Adverse Event|1|||
149984179|NCT02553928|541074848|FG000|Overall Study|Lost to Follow-up|0|||
149984180|NCT02553928|541074849|FG001|Overall Study|Lost to Follow-up|1|||
149984181|NCT02553928|541074848|FG000|Overall Study|Administrative reason(s)|0|||
149984182|NCT02553928|541074849|FG001|Overall Study|Administrative reason(s)|1|||
149984183|NCT01485796|541074850|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
149984184|NCT01485796|541074850|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
149984185|NCT01485796|541074850|FG000|Period 2: Epoch 2|Adverse Event|3|||
149984186|NCT01485796|541074850|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
149984187|NCT01485796|541074850|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
149984188|NCT01485796|541074850|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
149984189|NCT01485796|541074850|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
149984190|NCT01485796|541074850|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
149984191|NCT04830215|541074851|FG000|Overall Study|Adverse Event|6|||
149984192|NCT04830215|541074851|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
149984193|NCT04830215|541074851|FG000|Overall Study|Withdrawal by Subject|3|||
149984194|NCT04830215|541074851|FG000|Overall Study|Protocol Deviation|1|||
149984195|NCT00211172|541074854|FG000|Overall Study|Died or lost health plan eligibility|39|||
149984196|NCT00211172|541074855|FG001|Overall Study|Died or lost health plan eligibility|32|||
149984197|NCT00770562|541074858|FG000|Overall Study|Did not take treatment|1|||
149984198|NCT00770562|541074859|FG001|Overall Study|Did not take treatment|1|||
149984199|NCT01643408|541074860|FG000|Overall Study|Adverse Event|12|||
149984200|NCT01643408|541074860|FG000|Overall Study|Other|2|||
149984201|NCT00292045|541074864|FG000|Core Study (Through Week 13)|Adverse Event|1|||
149984202|NCT00292045|541074864|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
149984203|NCT04474197|541074865|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
149984204|NCT04474197|541074866|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
149984205|NCT04474197|541074867|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
149984206|NCT04474197|541074868|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
149984207|NCT00606411|541074869|FG000|Overall Study|Adverse Event|1|||
149984208|NCT00606411|541074870|FG001|Overall Study|Adverse Event|2|||
149984209|NCT00606411|541074869|FG000|Overall Study|Lack of Adherence|1|||
149984210|NCT00606411|541074870|FG001|Overall Study|Lack of Adherence|1|||
149984211|NCT00606411|541074869|FG000|Overall Study|Lack of Efficacy|1|||
149984212|NCT00606411|541074870|FG001|Overall Study|Lack of Efficacy|1|||
149984213|NCT00606411|541074869|FG000|Overall Study|Withdrawal by Subject|2|||
149984214|NCT00606411|541074870|FG001|Overall Study|Withdrawal by Subject|0|||
149984215|NCT00606411|541074869|FG000|Overall Study|Lost to Follow-up|1|||
149984216|NCT00606411|541074870|FG001|Overall Study|Lost to Follow-up|2|||
149984217|NCT00606411|541074869|FG000|Overall Study|Move out of state|0|||
149984218|NCT00606411|541074870|FG001|Overall Study|Move out of state|1|||
149984219|NCT00624468|541074872|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
149984220|NCT00624468|541074873|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
149984221|NCT00624468|541074874|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
149984222|NCT00624468|541074875|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
149984223|NCT00624468|541074872|FG000|Double-blind Period|Withdrew Prematurely|1|||
149984224|NCT00624468|541074873|FG001|Double-blind Period|Withdrew Prematurely|1|||
149984225|NCT00624468|541074874|FG002|Double-blind Period|Withdrew Prematurely|0|||
149984226|NCT00624468|541074875|FG003|Double-blind Period|Withdrew Prematurely|0|||
149984227|NCT00624468|541074872|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
149984228|NCT00624468|541074873|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
149984229|NCT00624468|541074874|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
149984230|NCT00624468|541074875|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
149984231|NCT00624468|541074872|FG000|Safety Follow-up (SFU) Period|Other|0|||
149984232|NCT00624468|541074873|FG001|Safety Follow-up (SFU) Period|Other|0|||
149984233|NCT00624468|541074874|FG002|Safety Follow-up (SFU) Period|Other|1|||
149984234|NCT00624468|541074875|FG003|Safety Follow-up (SFU) Period|Other|1|||
149984235|NCT00635349|541074877|FG000|Overall Study|Other|8|||
149984236|NCT00635349|541074878|FG001|Overall Study|Other|6|||
149984237|NCT00635349|541074877|FG000|Overall Study|Protocol Violation|18|||
149984238|NCT00635349|541074878|FG001|Overall Study|Protocol Violation|22|||
149984239|NCT00635349|541074877|FG000|Overall Study|Withdrawal by Subject|3|||
149984240|NCT00635349|541074878|FG001|Overall Study|Withdrawal by Subject|8|||
149984241|NCT00635349|541074877|FG000|Overall Study|Lost to Follow-up|4|||
149984242|NCT00635349|541074878|FG001|Overall Study|Lost to Follow-up|3|||
149984243|NCT00635349|541074877|FG000|Overall Study|Adverse Event|11|||
149984244|NCT00635349|541074878|FG001|Overall Study|Adverse Event|9|||
149984245|NCT00645840|541074879|FG000|Overall Study|Protocol Violation|3|||
149984246|NCT01340664|541074880|FG000|Overall Study|Adverse Event|0|||
149984247|NCT01340664|541074881|FG001|Overall Study|Adverse Event|1|||
149984248|NCT01340664|541074882|FG002|Overall Study|Adverse Event|7|||
149984249|NCT01340664|541074880|FG000|Overall Study|Lost to Follow-up|2|||
149984250|NCT01340664|541074881|FG001|Overall Study|Lost to Follow-up|0|||
149984251|NCT01340664|541074882|FG002|Overall Study|Lost to Follow-up|2|||
149984252|NCT01340664|541074880|FG000|Overall Study|Withdrawal by Subject|2|||
149984253|NCT01340664|541074881|FG001|Overall Study|Withdrawal by Subject|4|||
149984254|NCT01340664|541074882|FG002|Overall Study|Withdrawal by Subject|0|||
149984255|NCT01340664|541074880|FG000|Overall Study|Glycemic withdrawal criteria|2|||
149984256|NCT01340664|541074881|FG001|Overall Study|Glycemic withdrawal criteria|0|||
149984257|NCT01340664|541074882|FG002|Overall Study|Glycemic withdrawal criteria|0|||
149984258|NCT01340664|541074880|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
149984259|NCT01340664|541074881|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
149984260|NCT01340664|541074882|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
149984261|NCT01340664|541074880|FG000|Overall Study|Other|1|||
149984262|NCT01340664|541074881|FG001|Overall Study|Other|2|||
149984263|NCT01340664|541074882|FG002|Overall Study|Other|2|||
149984264|NCT01823198|541074884|FG000|Overall Study|Physician Decision|0|||
149984265|NCT01823198|541074885|FG001|Overall Study|Physician Decision|1|||
149984266|NCT01823198|541074886|FG002|Overall Study|Physician Decision|0|||
150178707|NCT05510245|541792012|FG001|Overall Study|Withdrawal by Subject|0|||
150178708|NCT05510245|541792013|FG002|Overall Study|Withdrawal by Subject|0|||
150178709|NCT01565148|541792016|FG000|Overall Study|Withdrawal by Subject|1|||
150178710|NCT01565148|541792017|FG001|Overall Study|Withdrawal by Subject|1|||
150178711|NCT01565148|541792018|FG002|Overall Study|Withdrawal by Subject|1|||
150178712|NCT01565148|541792019|FG003|Overall Study|Withdrawal by Subject|2|||
150178713|NCT01565148|541792016|FG000|Overall Study|Lost to Follow-up|4|||
150178714|NCT01565148|541792017|FG001|Overall Study|Lost to Follow-up|4|||
149984267|NCT01823198|541074887|FG003|Overall Study|Physician Decision|0|||
149984268|NCT01823198|541074888|FG004|Overall Study|Physician Decision|0|||
149984269|NCT01823198|541074889|FG005|Overall Study|Physician Decision|3|||
149984270|NCT01823198|541074890|FG006|Overall Study|Physician Decision|3|||
149984271|NCT03012828|541074895|FG000|Overall Study|Lost to Follow-up|1|||
149984272|NCT03012828|541074896|FG001|Overall Study|Lost to Follow-up|0|||
149984273|NCT03012828|541074897|FG002|Overall Study|Lost to Follow-up|1|||
149984274|NCT03012828|541074898|FG003|Overall Study|Lost to Follow-up|0|||
149984275|NCT03012828|541074899|FG004|Overall Study|Lost to Follow-up|1|||
149984276|NCT03012828|541074900|FG005|Overall Study|Lost to Follow-up|0|||
149984277|NCT03012828|541074895|FG000|Overall Study|Withdrawal by Subject|0|||
149984278|NCT03012828|541074896|FG001|Overall Study|Withdrawal by Subject|0|||
149984279|NCT03012828|541074897|FG002|Overall Study|Withdrawal by Subject|1|||
150178715|NCT01565148|541792018|FG002|Overall Study|Lost to Follow-up|0|||
149984280|NCT03012828|541074898|FG003|Overall Study|Withdrawal by Subject|0|||
149984281|NCT03012828|541074899|FG004|Overall Study|Withdrawal by Subject|0|||
149984282|NCT03012828|541074900|FG005|Overall Study|Withdrawal by Subject|1|||
149984283|NCT03012828|541074895|FG000|Overall Study|Non-compliance with protocol|0|||
149984284|NCT03012828|541074896|FG001|Overall Study|Non-compliance with protocol|0|||
149984285|NCT03012828|541074897|FG002|Overall Study|Non-compliance with protocol|0|||
149984286|NCT03012828|541074898|FG003|Overall Study|Non-compliance with protocol|0|||
149984287|NCT03012828|541074899|FG004|Overall Study|Non-compliance with protocol|1|||
149984288|NCT03012828|541074900|FG005|Overall Study|Non-compliance with protocol|0|||
149984289|NCT03012828|541074895|FG000|Overall Study|Delay to last visit would delay DBL|0|||
149984290|NCT03012828|541074896|FG001|Overall Study|Delay to last visit would delay DBL|0|||
149984291|NCT03012828|541074897|FG002|Overall Study|Delay to last visit would delay DBL|0|||
150053515|NCT00557856|541336676|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053516|NCT00557856|541336677|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053517|NCT00557856|541336678|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
150053518|NCT00557856|541336679|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
149984292|NCT03012828|541074898|FG003|Overall Study|Delay to last visit would delay DBL|0|||
149984293|NCT03012828|541074899|FG004|Overall Study|Delay to last visit would delay DBL|0|||
149984294|NCT03012828|541074900|FG005|Overall Study|Delay to last visit would delay DBL|1|||
149984295|NCT02544750|541074901|FG000|Overall Study|Physician Decision|3|||
149984296|NCT02544750|541074902|FG001|Overall Study|Physician Decision|1|||
149984297|NCT02544750|541074901|FG000|Overall Study|Other reasons|69|||
149984298|NCT02544750|541074902|FG001|Overall Study|Other reasons|39|||
149984299|NCT02544750|541074901|FG000|Overall Study|Met withdrawal criteria|2|||
149984300|NCT02544750|541074902|FG001|Overall Study|Met withdrawal criteria|2|||
149984301|NCT02544750|541074901|FG000|Overall Study|Transition To Commercial Product|1|||
149984302|NCT02544750|541074902|FG001|Overall Study|Transition To Commercial Product|0|||
149984303|NCT02544750|541074901|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
149984304|NCT02544750|541074902|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
149984305|NCT02544750|541074901|FG000|Overall Study|Adverse Event|8|||
149984306|NCT02544750|541074902|FG001|Overall Study|Adverse Event|10|||
149984307|NCT02544750|541074901|FG000|Overall Study|Withdrawal by Subject|10|||
149984308|NCT02544750|541074902|FG001|Overall Study|Withdrawal by Subject|4|||
149984309|NCT02544750|541074901|FG000|Overall Study|Lost to Follow-up|1|||
149984310|NCT02544750|541074902|FG001|Overall Study|Lost to Follow-up|0|||
149984311|NCT04396795|541074903|FG000|Month 1|Lost to Follow-up|2|||
149984312|NCT04396795|541074904|FG001|Month 1|Lost to Follow-up|3|||
149984313|NCT04396795|541074903|FG000|Month 3|Lost to Follow-up|1|||
149984314|NCT04396795|541074904|FG001|Month 3|Lost to Follow-up|3|||
149984315|NCT04396795|541074903|FG000|Month 6|Lost to Follow-up|3|||
149984316|NCT04396795|541074904|FG001|Month 6|Lost to Follow-up|3|||
149984317|NCT01637584|541074905|FG000|Overall Study|Withdrawal by Subject|1|||
149984318|NCT01637584|541074906|FG001|Overall Study|Withdrawal by Subject|3|||
149984319|NCT02366923|541074907|FG000|Overall Study|Withdrawal by Subject|1|||
149984320|NCT02366923|541074907|FG000|Overall Study|Positive Slit Lamp Findings|2|||
149984321|NCT02366923|541074907|FG000|Overall Study|High Astigmatism|3|||
149984322|NCT02484443|541074908|FG000|Overall Study|Lack of Efficacy|28|||
149984323|NCT02484443|541074908|FG000|Overall Study|Physician Decision|2|||
149984324|NCT02484443|541074908|FG000|Overall Study|Ineligible|2|||
149984325|NCT02595866|541074909|FG000|Overall Study|Adverse Event|2|||
149984326|NCT02595866|541074910|FG001|Overall Study|Adverse Event|5|||
149984327|NCT02595866|541074909|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
149984328|NCT02595866|541074910|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
149984329|NCT02595866|541074909|FG000|Overall Study|Death|0|||
149984330|NCT02595866|541074910|FG001|Overall Study|Death|1|||
149984331|NCT02595866|541074909|FG000|Overall Study|Incarceration|1|||
149984332|NCT02595866|541074910|FG001|Overall Study|Incarceration|0|||
149984333|NCT02595866|541074909|FG000|Overall Study|Lack of Efficacy|17|||
149984334|NCT02595866|541074910|FG001|Overall Study|Lack of Efficacy|7|||
149984335|NCT02595866|541074909|FG000|Overall Study|Physician Decision|4|||
149984336|NCT02595866|541074910|FG001|Overall Study|Physician Decision|3|||
149984337|NCT02595866|541074909|FG000|Overall Study|Switched to Alternative Treatment|1|||
149984338|NCT02595866|541074910|FG001|Overall Study|Switched to Alternative Treatment|0|||
149984339|NCT02595866|541074909|FG000|Overall Study|Study Terminated|0|||
149984340|NCT02595866|541074910|FG001|Overall Study|Study Terminated|4|||
150053519|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
150053520|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
150053521|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
150053522|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
150053523|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
150178716|NCT01565148|541792019|FG003|Overall Study|Lost to Follow-up|3|||
150178717|NCT01565148|541792016|FG000|Overall Study|Rescue Therapy|8|||
150178718|NCT01565148|541792017|FG001|Overall Study|Rescue Therapy|5|||
149984341|NCT02595866|541074909|FG000|Overall Study|Withdrawal by Subject|6|||
149984342|NCT02595866|541074910|FG001|Overall Study|Withdrawal by Subject|1|||
149984343|NCT02520388|541074911|FG000|Overall Study|Physician Decision|1|||
149984344|NCT02520388|541074912|FG001|Overall Study|Physician Decision|0|||
149984345|NCT02520388|541074911|FG000|Overall Study|Subject or parent/guardian request|0|||
150178719|NCT01565148|541792018|FG002|Overall Study|Rescue Therapy|5|||
149984346|NCT02520388|541074912|FG001|Overall Study|Subject or parent/guardian request|6|||
149984347|NCT02520388|541074911|FG000|Overall Study|Adverse Event|1|||
149984348|NCT02520388|541074912|FG001|Overall Study|Adverse Event|4|||
149984349|NCT02520388|541074911|FG000|Overall Study|Lost to Follow-up|3|||
149984350|NCT02520388|541074912|FG001|Overall Study|Lost to Follow-up|2|||
149984351|NCT02520388|541074911|FG000|Overall Study|Other (reason not defined)|4|||
149984352|NCT02520388|541074912|FG001|Overall Study|Other (reason not defined)|4|||
149984353|NCT01232127|541074913|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
149984354|NCT01232127|541074914|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
149984355|NCT01232127|541074915|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
149984356|NCT02375373|541074916|FG000|Overall Study|Withdrawal by Subject|11|||
149984357|NCT00200967|541074917|FG000|First Treatment Period|Withdrawal by Subject|5|||
149984358|NCT00200967|541074918|FG001|First Treatment Period|Withdrawal by Subject|1|||
149984359|NCT00200967|541074917|FG000|First Treatment Period|Pregnancy|1|||
149984360|NCT00200967|541074918|FG001|First Treatment Period|Pregnancy|0|||
149984361|NCT00200967|541074917|FG000|Wash-out Period|Lost to Follow-up|0|||
149984362|NCT00200967|541074918|FG001|Wash-out Period|Lost to Follow-up|1|||
149984363|NCT00200967|541074917|FG000|Second Treatment Period|Withdrawal by Subject|1|||
149984364|NCT00200967|541074918|FG001|Second Treatment Period|Withdrawal by Subject|2|||
149984365|NCT00200967|541074917|FG000|Run-out Period|Lost to Follow-up|1|||
149984366|NCT00200967|541074918|FG001|Run-out Period|Lost to Follow-up|0|||
149984367|NCT00980460|541074919|FG000|Overall Study|Death|0|||
149984368|NCT00980460|541074920|FG001|Overall Study|Death|0|||
149984369|NCT00980460|541074921|FG002|Overall Study|Death|1|||
149984370|NCT00980460|541074922|FG003|Overall Study|Death|2|||
149984371|NCT00980460|541074923|FG004|Overall Study|Death|1|||
149984372|NCT00980460|541074919|FG000|Overall Study|Lack of Efficacy|0|||
149984373|NCT00980460|541074920|FG001|Overall Study|Lack of Efficacy|0|||
149984374|NCT00980460|541074921|FG002|Overall Study|Lack of Efficacy|10|||
149984375|NCT00980460|541074922|FG003|Overall Study|Lack of Efficacy|6|||
149984376|NCT00980460|541074923|FG004|Overall Study|Lack of Efficacy|8|||
149984377|NCT00980460|541074919|FG000|Overall Study|Lost to Follow-up|0|||
149984378|NCT00980460|541074920|FG001|Overall Study|Lost to Follow-up|0|||
149984379|NCT00980460|541074921|FG002|Overall Study|Lost to Follow-up|0|||
149984380|NCT00980460|541074922|FG003|Overall Study|Lost to Follow-up|1|||
149984381|NCT00980460|541074923|FG004|Overall Study|Lost to Follow-up|0|||
149984382|NCT00980460|541074919|FG000|Overall Study|Physician Decision|0|||
149984383|NCT00980460|541074920|FG001|Overall Study|Physician Decision|0|||
149984384|NCT00980460|541074921|FG002|Overall Study|Physician Decision|11|||
149984385|NCT00980460|541074922|FG003|Overall Study|Physician Decision|5|||
149984386|NCT00980460|541074923|FG004|Overall Study|Physician Decision|3|||
149984387|NCT00980460|541074919|FG000|Overall Study|Withdrawal by Subject|0|||
149984388|NCT00980460|541074920|FG001|Overall Study|Withdrawal by Subject|0|||
149984389|NCT00980460|541074921|FG002|Overall Study|Withdrawal by Subject|1|||
149984390|NCT00980460|541074922|FG003|Overall Study|Withdrawal by Subject|0|||
149984391|NCT00980460|541074923|FG004|Overall Study|Withdrawal by Subject|0|||
149984392|NCT00980460|541074919|FG000|Overall Study|Ineligible|0|||
149984393|NCT00980460|541074920|FG001|Overall Study|Ineligible|2|||
149984394|NCT00980460|541074921|FG002|Overall Study|Ineligible|3|||
149984395|NCT00980460|541074922|FG003|Overall Study|Ineligible|1|||
149984396|NCT00980460|541074923|FG004|Overall Study|Ineligible|4|||
149984397|NCT00980460|541074919|FG000|Overall Study|Refusal of further therapy|0|||
149984398|NCT00980460|541074920|FG001|Overall Study|Refusal of further therapy|2|||
149984399|NCT00980460|541074921|FG002|Overall Study|Refusal of further therapy|3|||
149984400|NCT00980460|541074922|FG003|Overall Study|Refusal of further therapy|2|||
149984401|NCT00980460|541074923|FG004|Overall Study|Refusal of further therapy|0|||
149984402|NCT00980460|541074919|FG000|Overall Study|No therapy within 42 days of resection|0|||
149984403|NCT00980460|541074920|FG001|Overall Study|No therapy within 42 days of resection|0|||
149984404|NCT00980460|541074921|FG002|Overall Study|No therapy within 42 days of resection|3|||
149984405|NCT00980460|541074922|FG003|Overall Study|No therapy within 42 days of resection|1|||
149984406|NCT00980460|541074923|FG004|Overall Study|No therapy within 42 days of resection|0|||
149984407|NCT00980460|541074919|FG000|Overall Study|No transplant by protocol timepoints|0|||
149984408|NCT00980460|541074920|FG001|Overall Study|No transplant by protocol timepoints|0|||
149984409|NCT00980460|541074921|FG002|Overall Study|No transplant by protocol timepoints|3|||
149984410|NCT00980460|541074922|FG003|Overall Study|No transplant by protocol timepoints|0|||
149984411|NCT00980460|541074923|FG004|Overall Study|No transplant by protocol timepoints|0|||
149984412|NCT05696444|541074924|FG000|Treatment|Physician Decision|0|||
149984413|NCT05696444|541074925|FG001|Treatment|Physician Decision|1|||
149984414|NCT05696444|541074926|FG002|Treatment|Physician Decision|0|||
149984415|NCT05696444|541074924|FG000|30 Days|Death|1|||
149984416|NCT05696444|541074925|FG001|30 Days|Death|1|||
149984417|NCT05696444|541074926|FG002|30 Days|Death|0|||
149984418|NCT05696444|541074924|FG000|30 Days|Missed Visit|1|||
149984419|NCT05696444|541074925|FG001|30 Days|Missed Visit|1|||
149984420|NCT05696444|541074926|FG002|30 Days|Missed Visit|1|||
149984421|NCT05200572|541074927|FG000|Overall Study|Withdrawal by Subject|14|||
149984422|NCT01734785|541076697|FG000|Open-Label Period|Adverse Event|0|||
149984423|NCT01734785|541076698|FG001|Open-Label Period|Adverse Event|0|||
149984424|NCT01734785|541076699|FG002|Open-Label Period|Adverse Event|0|||
149984425|NCT01734785|541076700|FG003|Open-Label Period|Adverse Event|9|||
149984426|NCT01734785|541076697|FG000|Open-Label Period|Lack of Efficacy|0|||
149984427|NCT01734785|541076698|FG001|Open-Label Period|Lack of Efficacy|0|||
149984428|NCT01734785|541076699|FG002|Open-Label Period|Lack of Efficacy|0|||
149984429|NCT01734785|541076700|FG003|Open-Label Period|Lack of Efficacy|1|||
149984430|NCT01734785|541076697|FG000|Open-Label Period|Protocol Violation|0|||
149984431|NCT01734785|541076698|FG001|Open-Label Period|Protocol Violation|0|||
149984432|NCT01734785|541076699|FG002|Open-Label Period|Protocol Violation|0|||
149984433|NCT01734785|541076700|FG003|Open-Label Period|Protocol Violation|13|||
149984434|NCT01734785|541076697|FG000|Open-Label Period|Lost to Follow-up|0|||
149984435|NCT01734785|541076698|FG001|Open-Label Period|Lost to Follow-up|0|||
149984436|NCT01734785|541076699|FG002|Open-Label Period|Lost to Follow-up|0|||
149984437|NCT01734785|541076700|FG003|Open-Label Period|Lost to Follow-up|14|||
149984438|NCT01734785|541076697|FG000|Open-Label Period|Withdrawal by Subject|0|||
149984439|NCT01734785|541076698|FG001|Open-Label Period|Withdrawal by Subject|0|||
149984440|NCT01734785|541076699|FG002|Open-Label Period|Withdrawal by Subject|0|||
149984441|NCT01734785|541076700|FG003|Open-Label Period|Withdrawal by Subject|12|||
149984442|NCT01734785|541076697|FG000|Open-Label Period|Other Reasons|0|||
149984443|NCT01734785|541076698|FG001|Open-Label Period|Other Reasons|0|||
149984444|NCT01734785|541076699|FG002|Open-Label Period|Other Reasons|0|||
149984445|NCT01734785|541076700|FG003|Open-Label Period|Other Reasons|224|||
149984446|NCT01734785|541076697|FG000|Double-Blind Period|Adverse Event|0|||
149984447|NCT01734785|541076698|FG001|Double-Blind Period|Adverse Event|3|||
149984448|NCT01734785|541076699|FG002|Double-Blind Period|Adverse Event|2|||
149984449|NCT01734785|541076700|FG003|Double-Blind Period|Adverse Event|0|||
149984450|NCT01734785|541076697|FG000|Double-Blind Period|Lack of Efficacy|0|||
149984451|NCT01734785|541076698|FG001|Double-Blind Period|Lack of Efficacy|1|||
149984452|NCT01734785|541076699|FG002|Double-Blind Period|Lack of Efficacy|0|||
149984453|NCT01734785|541076700|FG003|Double-Blind Period|Lack of Efficacy|0|||
149984454|NCT01734785|541076697|FG000|Double-Blind Period|Protocol Violation|0|||
149984455|NCT01734785|541076698|FG001|Double-Blind Period|Protocol Violation|1|||
149984456|NCT01734785|541076699|FG002|Double-Blind Period|Protocol Violation|1|||
149984457|NCT01734785|541076700|FG003|Double-Blind Period|Protocol Violation|0|||
149984458|NCT01734785|541076697|FG000|Double-Blind Period|Lost to Follow-up|2|||
149984459|NCT01734785|541076698|FG001|Double-Blind Period|Lost to Follow-up|4|||
149984460|NCT01734785|541076699|FG002|Double-Blind Period|Lost to Follow-up|2|||
149984461|NCT01734785|541076700|FG003|Double-Blind Period|Lost to Follow-up|0|||
149984462|NCT01734785|541076697|FG000|Double-Blind Period|Withdrawal by Subject|2|||
149984463|NCT01734785|541076698|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149984464|NCT01734785|541076699|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149984465|NCT01734785|541076700|FG003|Double-Blind Period|Withdrawal by Subject|0|||
149984466|NCT01734785|541076697|FG000|Double-Blind Period|Not treated|1|||
149984467|NCT01734785|541076698|FG001|Double-Blind Period|Not treated|0|||
149984468|NCT01734785|541076699|FG002|Double-Blind Period|Not treated|0|||
149984469|NCT01734785|541076700|FG003|Double-Blind Period|Not treated|0|||
149984470|NCT02397915|541076701|FG000|Period 1|Protocol Violation|0|||
149984471|NCT02397915|541076702|FG001|Period 1|Protocol Violation|1|||
149984472|NCT02397915|541076703|FG002|Period 1|Protocol Violation|0|||
149984473|NCT02397915|541076704|FG003|Period 1|Protocol Violation|0|||
149984474|NCT02397915|541076701|FG000|Period 1|Physician Decision|1|||
149984475|NCT02397915|541076702|FG001|Period 1|Physician Decision|0|||
149984476|NCT02397915|541076703|FG002|Period 1|Physician Decision|0|||
149984477|NCT02397915|541076704|FG003|Period 1|Physician Decision|0|||
149984478|NCT03292874|541076705|FG000|Overall Study|Due to pandemic|5|||
149984479|NCT00368745|541076706|FG000|Double-blind Treatment Period|Adverse Event|6|||
149984480|NCT00368745|541076707|FG001|Double-blind Treatment Period|Adverse Event|6|||
149984481|NCT00368745|541076706|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
149984482|NCT00368745|541076707|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
149984483|NCT00368745|541076706|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
149984484|NCT00368745|541076707|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149984485|NCT00368745|541076706|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
149984486|NCT00368745|541076707|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
149984487|NCT00368745|541076706|FG000|Double-blind Treatment Period|Other|7|||
149984488|NCT00368745|541076707|FG001|Double-blind Treatment Period|Other|6|||
149984489|NCT03053440|541076714|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
149984490|NCT03053440|541076715|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
149984491|NCT03053440|541076714|FG000|Overall Study|Death|18|||
149984492|NCT03053440|541076715|FG001|Overall Study|Death|14|||
149984493|NCT03053440|541076714|FG000|Overall Study|Withdrawal by Subject|9|||
149984494|NCT03053440|541076715|FG001|Overall Study|Withdrawal by Subject|8|||
149984495|NCT03053440|541076714|FG000|Overall Study|Lost to Follow-up|1|||
149984496|NCT03053440|541076715|FG001|Overall Study|Lost to Follow-up|0|||
149984497|NCT03053440|541076714|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
150178720|NCT01565148|541792019|FG003|Overall Study|Rescue Therapy|8|||
149984498|NCT03053440|541076715|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
149984499|NCT03053440|541076714|FG000|Overall Study|Physician Decision|2|||
149984500|NCT03053440|541076715|FG001|Overall Study|Physician Decision|1|||
149984501|NCT03053440|541076714|FG000|Overall Study|Participant Randomized but died before dosing|1|||
149984502|NCT03053440|541076715|FG001|Overall Study|Participant Randomized but died before dosing|0|||
149984503|NCT01582009|541076716|FG000|Overall Study|Withdrawal by Subject|1|||
149984504|NCT01582009|541076716|FG000|Overall Study|Physician Decision|1|||
149984505|NCT00391053|541076719|FG000|Overall Study|Serious Adverse Events|1|||
149984506|NCT00391053|541076720|FG001|Overall Study|Serious Adverse Events|0|||
149984507|NCT00391053|541076721|FG002|Overall Study|Serious Adverse Events|1|||
149984508|NCT00391053|541076722|FG003|Overall Study|Serious Adverse Events|4|||
149984509|NCT00391053|541076719|FG000|Overall Study|Protocol Violation|2|||
149984510|NCT00391053|541076720|FG001|Overall Study|Protocol Violation|0|||
149984511|NCT00391053|541076721|FG002|Overall Study|Protocol Violation|0|||
149984512|NCT00391053|541076722|FG003|Overall Study|Protocol Violation|0|||
149984513|NCT00391053|541076719|FG000|Overall Study|Lost to Follow-up|1|||
149984514|NCT00391053|541076720|FG001|Overall Study|Lost to Follow-up|0|||
149984515|NCT00391053|541076721|FG002|Overall Study|Lost to Follow-up|0|||
149984516|NCT00391053|541076722|FG003|Overall Study|Lost to Follow-up|5|||
149984517|NCT00391053|541076719|FG000|Overall Study|Withdrawal by Subject|5|||
149984518|NCT00391053|541076720|FG001|Overall Study|Withdrawal by Subject|1|||
149984519|NCT00391053|541076721|FG002|Overall Study|Withdrawal by Subject|1|||
149984520|NCT00391053|541076722|FG003|Overall Study|Withdrawal by Subject|1|||
149984521|NCT01947283|541076724|FG000|Overall Study|Death|1|||
149984522|NCT01947283|541076725|FG001|Overall Study|Death|1|||
149984523|NCT01947283|541076726|FG002|Overall Study|Death|1|||
149984524|NCT01947283|541076727|FG003|Overall Study|Death|0|||
149984525|NCT01947283|541076728|FG004|Overall Study|Death|0|||
149984526|NCT01947283|541076729|FG005|Overall Study|Death|0|||
149984527|NCT01947283|541076730|FG006|Overall Study|Death|0|||
149984528|NCT01947283|541076724|FG000|Overall Study|Lost to Follow-up|4|||
149984529|NCT01947283|541076725|FG001|Overall Study|Lost to Follow-up|6|||
149984530|NCT01947283|541076726|FG002|Overall Study|Lost to Follow-up|5|||
149984531|NCT01947283|541076727|FG003|Overall Study|Lost to Follow-up|5|||
149984532|NCT01947283|541076728|FG004|Overall Study|Lost to Follow-up|0|||
149984533|NCT01947283|541076729|FG005|Overall Study|Lost to Follow-up|2|||
149984534|NCT01947283|541076730|FG006|Overall Study|Lost to Follow-up|5|||
149984535|NCT01947283|541076724|FG000|Overall Study|Withdrawal by Subject|10|||
149984536|NCT01947283|541076725|FG001|Overall Study|Withdrawal by Subject|8|||
149984537|NCT01947283|541076726|FG002|Overall Study|Withdrawal by Subject|4|||
149984538|NCT01947283|541076727|FG003|Overall Study|Withdrawal by Subject|1|||
149984539|NCT01947283|541076728|FG004|Overall Study|Withdrawal by Subject|0|||
149984540|NCT01947283|541076729|FG005|Overall Study|Withdrawal by Subject|0|||
149984541|NCT01947283|541076730|FG006|Overall Study|Withdrawal by Subject|2|||
149984542|NCT01947283|541076724|FG000|Overall Study|No Clinical Recording|12|||
149984543|NCT01947283|541076725|FG001|Overall Study|No Clinical Recording|6|||
149984544|NCT01947283|541076726|FG002|Overall Study|No Clinical Recording|8|||
149984545|NCT01947283|541076727|FG003|Overall Study|No Clinical Recording|10|||
149984546|NCT01947283|541076728|FG004|Overall Study|No Clinical Recording|0|||
149984547|NCT01947283|541076729|FG005|Overall Study|No Clinical Recording|0|||
149984548|NCT01947283|541076730|FG006|Overall Study|No Clinical Recording|0|||
149984549|NCT01947283|541076724|FG000|Overall Study|Non-coding Clinical Recording language|0|||
149984550|NCT01947283|541076725|FG001|Overall Study|Non-coding Clinical Recording language|0|||
149984551|NCT01947283|541076726|FG002|Overall Study|Non-coding Clinical Recording language|0|||
149984552|NCT01947283|541076727|FG003|Overall Study|Non-coding Clinical Recording language|1|||
149984553|NCT01947283|541076728|FG004|Overall Study|Non-coding Clinical Recording language|0|||
149984554|NCT01947283|541076729|FG005|Overall Study|Non-coding Clinical Recording language|0|||
149984555|NCT01947283|541076730|FG006|Overall Study|Non-coding Clinical Recording language|0|||
149984556|NCT01947283|541076724|FG000|Overall Study|Missing Follow-up Assessment|2|||
149984557|NCT01947283|541076725|FG001|Overall Study|Missing Follow-up Assessment|2|||
149984558|NCT01947283|541076726|FG002|Overall Study|Missing Follow-up Assessment|3|||
149984559|NCT01947283|541076727|FG003|Overall Study|Missing Follow-up Assessment|0|||
149984560|NCT01947283|541076728|FG004|Overall Study|Missing Follow-up Assessment|0|||
149984561|NCT01947283|541076729|FG005|Overall Study|Missing Follow-up Assessment|2|||
149984562|NCT01947283|541076730|FG006|Overall Study|Missing Follow-up Assessment|0|||
149984563|NCT01947283|541076724|FG000|Overall Study|No patients were enrolled in study|0|||
149984564|NCT01947283|541076725|FG001|Overall Study|No patients were enrolled in study|0|||
149984565|NCT01947283|541076726|FG002|Overall Study|No patients were enrolled in study|0|||
149984566|NCT01947283|541076727|FG003|Overall Study|No patients were enrolled in study|0|||
149984567|NCT01947283|541076728|FG004|Overall Study|No patients were enrolled in study|0|||
149984568|NCT01947283|541076729|FG005|Overall Study|No patients were enrolled in study|3|||
149984569|NCT01947283|541076730|FG006|Overall Study|No patients were enrolled in study|1|||
149984570|NCT00430989|541076731|FG000|Overall Study|Lost to Follow-up|2|||
149984571|NCT00430989|541076732|FG001|Overall Study|Lost to Follow-up|3|||
149984572|NCT00430989|541076731|FG000|Overall Study|Withdrawal by Subject|15|||
149984573|NCT00430989|541076732|FG001|Overall Study|Withdrawal by Subject|14|||
149984574|NCT00430989|541076731|FG000|Overall Study|Protocol Violation|30|||
149984575|NCT00430989|541076732|FG001|Overall Study|Protocol Violation|37|||
150178721|NCT01565148|541792016|FG000|Overall Study|Death|0|||
150178722|NCT01565148|541792017|FG001|Overall Study|Death|0|||
150178723|NCT01565148|541792018|FG002|Overall Study|Death|1|||
150178724|NCT01565148|541792019|FG003|Overall Study|Death|0|||
149984576|NCT00430989|541076731|FG000|Overall Study|Not eligible|13|||
149984577|NCT00430989|541076732|FG001|Overall Study|Not eligible|6|||
149984578|NCT05002985|541076733|FG000|Overall Study|Withdrawal by Subject|1|||
149984579|NCT03782259|541076734|FG000|Overall Study|Lost to Follow-up|1|||
149984580|NCT03782259|541076735|FG001|Overall Study|Lost to Follow-up|1|||
149984581|NCT03782259|541076734|FG000|Overall Study|Moved out of state|0|||
149984582|NCT03782259|541076735|FG001|Overall Study|Moved out of state|2|||
149984583|NCT03782259|541076734|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
149984584|NCT03782259|541076735|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
149984585|NCT03782259|541076734|FG000|Overall Study|Subject discontinued intervention|1|||
149984586|NCT03782259|541076735|FG001|Overall Study|Subject discontinued intervention|0|||
149984587|NCT03050450|541076736|FG000|Overall Study|Physician Decision|1|||
149984588|NCT03050450|541076737|FG001|Overall Study|Physician Decision|0|||
149984589|NCT03050450|541076738|FG002|Overall Study|Physician Decision|0|||
149984590|NCT03050450|541076739|FG003|Overall Study|Physician Decision|0|||
149984591|NCT03050450|541076740|FG004|Overall Study|Physician Decision|0|||
149984592|NCT00603941|541076744|FG000|Overall Study|Disease progression|6|||
149984593|NCT00603941|541076745|FG001|Overall Study|Disease progression|7|||
149984594|NCT00603941|541076746|FG002|Overall Study|Disease progression|1|||
149984595|NCT00603941|541076744|FG000|Overall Study|Adverse Event|1|||
149984596|NCT00603941|541076745|FG001|Overall Study|Adverse Event|0|||
149984597|NCT00603941|541076746|FG002|Overall Study|Adverse Event|1|||
149984598|NCT00603941|541076744|FG000|Overall Study|Physician Decision|0|||
149984599|NCT00603941|541076745|FG001|Overall Study|Physician Decision|1|||
149984600|NCT00603941|541076746|FG002|Overall Study|Physician Decision|0|||
149984601|NCT00603941|541076744|FG000|Overall Study|Withdrawal by Subject|0|||
149984602|NCT00603941|541076745|FG001|Overall Study|Withdrawal by Subject|2|||
149984603|NCT00603941|541076746|FG002|Overall Study|Withdrawal by Subject|0|||
149984604|NCT03592771|541076747|FG000|Overall Study|Adverse Event|2|||
149984605|NCT03592771|541076748|FG001|Overall Study|Adverse Event|0|||
149984606|NCT03592771|541076749|FG002|Overall Study|Adverse Event|1|||
149984607|NCT03592771|541076747|FG000|Overall Study|Death|0|||
149984608|NCT03592771|541076748|FG001|Overall Study|Death|1|||
149984609|NCT03592771|541076749|FG002|Overall Study|Death|1|||
149984610|NCT03592771|541076747|FG000|Overall Study|Lost to Follow-up|5|||
149984611|NCT03592771|541076748|FG001|Overall Study|Lost to Follow-up|11|||
149984612|NCT03592771|541076749|FG002|Overall Study|Lost to Follow-up|15|||
149984613|NCT03592771|541076747|FG000|Overall Study|Withdrawal by Subject|0|||
149984614|NCT03592771|541076748|FG001|Overall Study|Withdrawal by Subject|2|||
149984615|NCT03592771|541076749|FG002|Overall Study|Withdrawal by Subject|0|||
149984616|NCT01642901|541076750|FG000|12-month Follow-up|Withdrawal by Subject|1|||
149984617|NCT01642901|541076751|FG001|12-month Follow-up|Withdrawal by Subject|0|||
149984618|NCT02943070|541076752|FG000|Overall Study|Physician Decision|1|||
149984619|NCT02943070|541076752|FG000|Overall Study|Adverse Event|2|||
149984620|NCT02943070|541076752|FG000|Overall Study|Death|2|||
149984621|NCT02943070|541076752|FG000|Overall Study|Withdrawal by Subject|3|||
149984622|NCT02943070|541076752|FG000|Overall Study|Lost to Follow-up|4|||
149984623|NCT02943070|541076752|FG000|Overall Study|Retreatment or TURP|13|||
149984624|NCT02943070|541076752|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
149984625|NCT01014767|541076753|FG000|Overall Study|PI left institution, data unavailable|12|||
149984626|NCT01014767|541076754|FG001|Overall Study|PI left institution, data unavailable|1|||
149984627|NCT01014767|541076755|FG002|Overall Study|PI left institution, data unavailable|4|||
149984628|NCT01014767|541076756|FG003|Overall Study|PI left institution, data unavailable|1|||
149984629|NCT00984165|541076760|FG000|Overall Study|Death on study|2|||
149984630|NCT00984165|541076761|FG001|Overall Study|Death on study|0|||
149984631|NCT00984165|541076762|FG002|Overall Study|Death on study|0|||
149984632|NCT00984165|541076763|FG003|Overall Study|Death on study|0|||
149984633|NCT00984165|541076760|FG000|Overall Study|Disease progression on study|5|||
150178725|NCT01565148|541792016|FG000|Overall Study|Physician Decision|2|||
149984634|NCT00984165|541076761|FG001|Overall Study|Disease progression on study|1|||
149984635|NCT00984165|541076762|FG002|Overall Study|Disease progression on study|0|||
150178726|NCT01565148|541792017|FG001|Overall Study|Physician Decision|5|||
150178727|NCT01565148|541792018|FG002|Overall Study|Physician Decision|0|||
150178728|NCT01565148|541792019|FG003|Overall Study|Physician Decision|0|||
149984636|NCT00984165|541076763|FG003|Overall Study|Disease progression on study|0|||
150178729|NCT05368831|541792020|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
150178730|NCT00529659|541792021|FG000|Overall Study|Adverse Event|8|||
149984637|NCT00984165|541076760|FG000|Overall Study|Death of recipient|0|||
149984638|NCT00984165|541076761|FG001|Overall Study|Death of recipient|0|||
149984639|NCT00984165|541076762|FG002|Overall Study|Death of recipient|0|||
149984640|NCT00984165|541076763|FG003|Overall Study|Death of recipient|1|||
150178731|NCT00529659|541792022|FG001|Overall Study|Adverse Event|7|||
149984641|NCT00984165|541076760|FG000|Overall Study|New protocol|0|||
149984642|NCT00984165|541076761|FG001|Overall Study|New protocol|0|||
149984643|NCT00984165|541076762|FG002|Overall Study|New protocol|0|||
149984644|NCT00984165|541076763|FG003|Overall Study|New protocol|1|||
149984645|NCT00984165|541076760|FG000|Overall Study|P+/donor pair removed from protocol|0|||
149984646|NCT00984165|541076761|FG001|Overall Study|P+/donor pair removed from protocol|0|||
149984647|NCT00984165|541076762|FG002|Overall Study|P+/donor pair removed from protocol|0|||
149984648|NCT00984165|541076763|FG003|Overall Study|P+/donor pair removed from protocol|1|||
149984649|NCT00984165|541076760|FG000|Overall Study|removed with a pair recipient|0|||
149984650|NCT00984165|541076761|FG001|Overall Study|removed with a pair recipient|0|||
149984651|NCT00984165|541076762|FG002|Overall Study|removed with a pair recipient|0|||
149984652|NCT00984165|541076763|FG003|Overall Study|removed with a pair recipient|1|||
149984653|NCT00131352|541076764|FG000|Initial Treatment Period|Adverse Event|1|||
149984654|NCT00131352|541076765|FG001|Initial Treatment Period|Adverse Event|3|||
149984655|NCT00131352|541076764|FG000|Initial Treatment Period|Non-compliant|1|||
149984656|NCT00131352|541076765|FG001|Initial Treatment Period|Non-compliant|2|||
149984657|NCT00131352|541076764|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
149984658|NCT00131352|541076765|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
149984659|NCT00131352|541076764|FG000|Initial Treatment Period|Lack of Efficacy|6|||
149984660|NCT00131352|541076765|FG001|Initial Treatment Period|Lack of Efficacy|4|||
149984661|NCT00131352|541076764|FG000|Initial Treatment Period|Other|0|||
149984662|NCT00131352|541076765|FG001|Initial Treatment Period|Other|2|||
149984663|NCT00131352|541076764|FG000|Repeat Treatment Period|Adverse Event|1|||
149984664|NCT00131352|541076765|FG001|Repeat Treatment Period|Adverse Event|0|||
149984665|NCT00131352|541076764|FG000|Repeat Treatment Period|Other|1|||
149984666|NCT00131352|541076765|FG001|Repeat Treatment Period|Other|0|||
149984667|NCT02526212|541076776|FG000|Overall Study|Incarceration|1|||
149984668|NCT02526212|541076777|FG001|Overall Study|Incarceration|0|||
149984669|NCT02526212|541076776|FG000|Overall Study|Lost to Follow-up|1|||
149984670|NCT02526212|541076777|FG001|Overall Study|Lost to Follow-up|0|||
149984671|NCT02526212|541076776|FG000|Overall Study|Death|0|||
149984672|NCT02526212|541076777|FG001|Overall Study|Death|1|||
149984673|NCT01390298|541076778|FG000|Overall Study|Death|1|||
149984674|NCT01390298|541076778|FG000|Overall Study|long term ICU admission|1|||
149984675|NCT01390298|541076778|FG000|Overall Study|Withdrawal by Subject|14|||
149984676|NCT01390298|541076778|FG000|Overall Study|Lost to Follow-up|7|||
149984677|NCT01390298|541076778|FG000|Overall Study|Surgery cancelled|1|||
149984678|NCT02443337|541076779|FG000|Overall Study|Adverse Event|0|||
149984679|NCT02443337|541076780|FG001|Overall Study|Adverse Event|1|||
149984680|NCT02443337|541076779|FG000|Overall Study|Clinical Progressive Disease|3|||
149984681|NCT02443337|541076780|FG001|Overall Study|Clinical Progressive Disease|0|||
149984682|NCT02443337|541076779|FG000|Overall Study|Withdrawal by Subject|2|||
149984683|NCT02443337|541076780|FG001|Overall Study|Withdrawal by Subject|1|||
149984684|NCT02096952|541076781|FG000|Overall Study|Adverse Event|1|||
149984685|NCT00040742|541076782|FG000|Overall Study|Death|0|||
149984686|NCT00040742|541076783|FG001|Overall Study|Death|0|||
149984687|NCT00040742|541076784|FG002|Overall Study|Death|1|||
149984688|NCT00040742|541076785|FG003|Overall Study|Death|0|||
149984689|NCT00040742|541076782|FG000|Overall Study|Adverse Event|15|||
149984690|NCT00040742|541076783|FG001|Overall Study|Adverse Event|16|||
149984691|NCT00040742|541076784|FG002|Overall Study|Adverse Event|21|||
149984692|NCT00040742|541076785|FG003|Overall Study|Adverse Event|9|||
149984693|NCT00040742|541076782|FG000|Overall Study|Withdrawal by Subject|7|||
149984694|NCT00040742|541076783|FG001|Overall Study|Withdrawal by Subject|15|||
149984695|NCT00040742|541076784|FG002|Overall Study|Withdrawal by Subject|10|||
149984696|NCT00040742|541076785|FG003|Overall Study|Withdrawal by Subject|13|||
149984697|NCT00040742|541076782|FG000|Overall Study|Chemotoxicity|4|||
149984698|NCT00040742|541076783|FG001|Overall Study|Chemotoxicity|3|||
150178732|NCT00529659|541792021|FG000|Overall Study|Lost to Follow-up|0|||
149984699|NCT00040742|541076784|FG002|Overall Study|Chemotoxicity|5|||
150178733|NCT00529659|541792022|FG001|Overall Study|Lost to Follow-up|2|||
150178734|NCT00529659|541792021|FG000|Overall Study|Physician Decision|0|||
150178735|NCT00529659|541792022|FG001|Overall Study|Physician Decision|2|||
150178736|NCT00529659|541792021|FG000|Overall Study|Protocol Violation|2|||
150178737|NCT00529659|541792022|FG001|Overall Study|Protocol Violation|6|||
150178738|NCT00529659|541792021|FG000|Overall Study|Withdrawal by Subject|1|||
150178739|NCT00529659|541792022|FG001|Overall Study|Withdrawal by Subject|6|||
150178740|NCT03565315|541792023|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
150178741|NCT03565315|541792024|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
150178742|NCT03565315|541792025|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
149984700|NCT00040742|541076785|FG003|Overall Study|Chemotoxicity|2|||
149984701|NCT00040742|541076782|FG000|Overall Study|Incomplete Forms|6|||
149984702|NCT00040742|541076783|FG001|Overall Study|Incomplete Forms|10|||
149984703|NCT00040742|541076784|FG002|Overall Study|Incomplete Forms|4|||
149984704|NCT00040742|541076785|FG003|Overall Study|Incomplete Forms|5|||
149984705|NCT00040742|541076782|FG000|Overall Study|Other medical|7|||
149984706|NCT00040742|541076783|FG001|Overall Study|Other medical|5|||
149984707|NCT00040742|541076784|FG002|Overall Study|Other medical|5|||
149984708|NCT00040742|541076785|FG003|Overall Study|Other medical|5|||
149984709|NCT02446769|541076796|FG000|Screening Period|Screen Failure|11|||
149984710|NCT02446769|541076797|FG001|Screening Period|Screen Failure|0|||
149984711|NCT02446769|541076798|FG002|Screening Period|Screen Failure|0|||
149984712|NCT02446769|541076796|FG000|Study Period|Randomized in Error|0|||
149984713|NCT02446769|541076797|FG001|Study Period|Randomized in Error|2|||
149984714|NCT02446769|541076798|FG002|Study Period|Randomized in Error|0|||
149984715|NCT04482439|541076799|FG000|Overall Study|Lost to Follow-up|1|||
149984716|NCT04482439|541076799|FG000|Overall Study|Unrelated illness|1|||
149984717|NCT03072043|541076802|FG000|Overall Study|Death|0|||
149984718|NCT03072043|541076803|FG001|Overall Study|Death|0|||
149984719|NCT03072043|541076804|FG002|Overall Study|Death|3|||
149984720|NCT03072043|541076802|FG000|Overall Study|Adverse Event|0|||
149984721|NCT03072043|541076803|FG001|Overall Study|Adverse Event|0|||
149984722|NCT03072043|541076804|FG002|Overall Study|Adverse Event|2|||
149984723|NCT03072043|541076802|FG000|Overall Study|Withdrawal by Subject|0|||
149984724|NCT03072043|541076803|FG001|Overall Study|Withdrawal by Subject|0|||
149984725|NCT03072043|541076804|FG002|Overall Study|Withdrawal by Subject|4|||
149984726|NCT00402324|541076805|FG000|Overall Study|Lost to Follow-up|11|||
149984727|NCT00402324|541076806|FG001|Overall Study|Lost to Follow-up|11|||
149984728|NCT00402324|541076805|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
149984729|NCT00402324|541076806|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
149984730|NCT00402324|541076805|FG000|Overall Study|Protocol Violation|8|||
149984731|NCT00402324|541076806|FG001|Overall Study|Protocol Violation|7|||
149984732|NCT00402324|541076805|FG000|Overall Study|Withdrawal by Subject|5|||
149984733|NCT00402324|541076806|FG001|Overall Study|Withdrawal by Subject|2|||
149984734|NCT00402324|541076805|FG000|Overall Study|Physician Decision|2|||
149984735|NCT00402324|541076806|FG001|Overall Study|Physician Decision|4|||
149984736|NCT00402324|541076805|FG000|Overall Study|Sponsor Decision|4|||
149984737|NCT00402324|541076806|FG001|Overall Study|Sponsor Decision|5|||
149984738|NCT00402324|541076805|FG000|Overall Study|Lack of Efficacy|1|||
149984739|NCT00402324|541076806|FG001|Overall Study|Lack of Efficacy|4|||
149984740|NCT00402324|541076805|FG000|Overall Study|Adverse Event|6|||
149984741|NCT00402324|541076806|FG001|Overall Study|Adverse Event|4|||
149984742|NCT00402324|541076805|FG000|Overall Study|Death|1|||
149984743|NCT00402324|541076806|FG001|Overall Study|Death|0|||
149984744|NCT01277822|541076807|FG000|Overall Study|Adverse Event|2|||
149984745|NCT01277822|541076808|FG001|Overall Study|Adverse Event|1|||
149984746|NCT01277822|541076807|FG000|Overall Study|Withdrawal by Subject|6|||
149984747|NCT01277822|541076808|FG001|Overall Study|Withdrawal by Subject|7|||
149984748|NCT01277822|541076807|FG000|Overall Study|Physician Decision|1|||
149984749|NCT01277822|541076808|FG001|Overall Study|Physician Decision|1|||
149984750|NCT01277822|541076807|FG000|Overall Study|Protocol Violation|1|||
149984751|NCT01277822|541076808|FG001|Overall Study|Protocol Violation|0|||
149984752|NCT01277822|541076807|FG000|Overall Study|Lost to Follow-up|2|||
149984753|NCT01277822|541076808|FG001|Overall Study|Lost to Follow-up|1|||
149984754|NCT01277822|541076807|FG000|Overall Study|Contraindicated medication used|2|||
149984755|NCT01277822|541076808|FG001|Overall Study|Contraindicated medication used|1|||
149984756|NCT01277822|541076807|FG000|Overall Study|Participant moved|1|||
149984757|NCT01277822|541076808|FG001|Overall Study|Participant moved|0|||
149984758|NCT02923531|541076809|FG000|Overall Study|Adverse Event|4|||
149984759|NCT02923531|541076809|FG000|Overall Study|Clinical Deterioration|1|||
149984760|NCT02923531|541076809|FG000|Overall Study|Disease Progression|3|||
149984761|NCT02923531|541076809|FG000|Overall Study|Study Termination|1|||
149984762|NCT00997984|541076810|FG000|Overall Study|Adverse Event|1|||
149984763|NCT00997984|541076811|FG001|Overall Study|Adverse Event|8|||
149984764|NCT00997984|541076812|FG002|Overall Study|Adverse Event|8|||
149984765|NCT00997984|541076810|FG000|Overall Study|Protocol Violation|1|||
149984766|NCT00997984|541076811|FG001|Overall Study|Protocol Violation|3|||
149984767|NCT00997984|541076812|FG002|Overall Study|Protocol Violation|0|||
149984768|NCT00997984|541076810|FG000|Overall Study|Withdrawal by Subject|6|||
149984769|NCT00997984|541076811|FG001|Overall Study|Withdrawal by Subject|9|||
149984770|NCT00997984|541076812|FG002|Overall Study|Withdrawal by Subject|5|||
149984771|NCT00997984|541076810|FG000|Overall Study|Lost to Follow-up|8|||
149984772|NCT00997984|541076811|FG001|Overall Study|Lost to Follow-up|5|||
149984773|NCT00997984|541076812|FG002|Overall Study|Lost to Follow-up|4|||
149984774|NCT00997984|541076810|FG000|Overall Study|Lack of Efficacy|20|||
149984775|NCT00997984|541076811|FG001|Overall Study|Lack of Efficacy|6|||
149984776|NCT00997984|541076812|FG002|Overall Study|Lack of Efficacy|3|||
149984777|NCT00997984|541076810|FG000|Overall Study|Met exclusion criteria|1|||
149984778|NCT00997984|541076811|FG001|Overall Study|Met exclusion criteria|0|||
149984779|NCT00997984|541076812|FG002|Overall Study|Met exclusion criteria|0|||
149984780|NCT00997984|541076810|FG000|Overall Study|non-compliance|0|||
149984781|NCT00997984|541076811|FG001|Overall Study|non-compliance|2|||
149984782|NCT00997984|541076812|FG002|Overall Study|non-compliance|3|||
149984783|NCT00997984|541076810|FG000|Overall Study|Wrong medication dispensed|0|||
149984784|NCT00997984|541076811|FG001|Overall Study|Wrong medication dispensed|1|||
149984785|NCT00997984|541076812|FG002|Overall Study|Wrong medication dispensed|0|||
149984786|NCT00997984|541076810|FG000|Overall Study|Suicidal ideation|0|||
149984787|NCT00997984|541076811|FG001|Overall Study|Suicidal ideation|0|||
149984788|NCT00997984|541076812|FG002|Overall Study|Suicidal ideation|1|||
149984789|NCT00997984|541076810|FG000|Overall Study|Work schedule|0|||
149984790|NCT00997984|541076811|FG001|Overall Study|Work schedule|0|||
149984791|NCT00997984|541076812|FG002|Overall Study|Work schedule|2|||
149984792|NCT00295646|541076821|FG000|Overall Study|Protocol Violation|18|||
149984793|NCT00295646|541076822|FG001|Overall Study|Protocol Violation|20|||
149984794|NCT00295646|541076823|FG002|Overall Study|Protocol Violation|20|||
149984795|NCT00295646|541076824|FG003|Overall Study|Protocol Violation|18|||
149984796|NCT00295646|541076821|FG000|Overall Study|Withdrawal by Subject|8|||
149984797|NCT00295646|541076822|FG001|Overall Study|Withdrawal by Subject|9|||
149984798|NCT00295646|541076823|FG002|Overall Study|Withdrawal by Subject|11|||
149984799|NCT00295646|541076824|FG003|Overall Study|Withdrawal by Subject|14|||
149984800|NCT00295646|541076821|FG000|Overall Study|Lost to Follow-up|0|||
149984801|NCT00295646|541076822|FG001|Overall Study|Lost to Follow-up|5|||
149984802|NCT00295646|541076823|FG002|Overall Study|Lost to Follow-up|1|||
149984803|NCT00295646|541076824|FG003|Overall Study|Lost to Follow-up|5|||
149984804|NCT00295646|541076821|FG000|Overall Study|Death|9|||
149984805|NCT00295646|541076822|FG001|Overall Study|Death|7|||
149984806|NCT00295646|541076823|FG002|Overall Study|Death|18|||
149984807|NCT00295646|541076824|FG003|Overall Study|Death|8|||
149984808|NCT02243371|541076825|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
149984809|NCT02243371|541076826|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
149984810|NCT02243371|541076825|FG000|Overall Study|Death (unrelated)|2|||
149984811|NCT02243371|541076826|FG001|Overall Study|Death (unrelated)|4|||
149984812|NCT02243371|541076825|FG000|Overall Study|Adverse Event (unrelated)|0|||
149984813|NCT02243371|541076826|FG001|Overall Study|Adverse Event (unrelated)|1|||
149984814|NCT02243371|541076825|FG000|Overall Study|Lack of Clinical Benefit|0|||
149984815|NCT02243371|541076826|FG001|Overall Study|Lack of Clinical Benefit|1|||
149984816|NCT02243371|541076825|FG000|Overall Study|Withdrawal by Subject|0|||
149984817|NCT02243371|541076826|FG001|Overall Study|Withdrawal by Subject|2|||
149984818|NCT02441101|541076827|FG000|Overall Study|Withdrawal by Subject|1|||
149984819|NCT02441101|541076828|FG001|Overall Study|Withdrawal by Subject|0|||
149984820|NCT02441101|541076827|FG000|Overall Study|Lost to Follow-up|1|||
149984821|NCT02441101|541076828|FG001|Overall Study|Lost to Follow-up|0|||
149984822|NCT02441101|541076827|FG000|Overall Study|PI relocated and study terminated|1|||
149984823|NCT02441101|541076828|FG001|Overall Study|PI relocated and study terminated|0|||
149984824|NCT02725476|541076829|FG000|Overall Study|Physician Decision|2|||
149984825|NCT02725476|541076830|FG001|Overall Study|Physician Decision|0|||
149984826|NCT02725476|541076829|FG000|Overall Study|Adverse Event|1|||
149984827|NCT02725476|541076830|FG001|Overall Study|Adverse Event|1|||
149984828|NCT01445613|541076831|FG000|30-day Follow-up|Withdrawal by Subject|6|||
149984829|NCT01445613|541076831|FG000|30-day Follow-up|Physician Decision|3|||
149984830|NCT01445613|541076831|FG000|30-day Follow-up|Missed visit|23|||
149984831|NCT01445613|541076831|FG000|30-day Follow-up|Death|3|||
149984832|NCT01445613|541076831|FG000|1-year Follow-up|Withdrawal by Subject|12|||
149984833|NCT01445613|541076831|FG000|1-year Follow-up|Missed visit|29|||
149984834|NCT01445613|541076831|FG000|1-year Follow-up|Lost to Follow-up|2|||
149984835|NCT01445613|541076831|FG000|1-year Follow-up|Death|30|||
149984836|NCT01445613|541076831|FG000|1-year Follow-up|Physician Decision|2|||
149984837|NCT01445613|541076831|FG000|1-year Follow-up|Received a non-study stent|2|||
149984838|NCT00407602|541076832|FG000|Overall Study|Death - unrelated to device|1|||
149984839|NCT00407602|541076832|FG000|Overall Study|Device explanted|5|||
149984840|NCT00407602|541076832|FG000|Overall Study|Withdrawal by Subject|1|||
149984841|NCT00431444|541076833|FG000|Overall Study|Protocol Violation|1|||
149984842|NCT00431444|541076834|FG001|Overall Study|Protocol Violation|4|||
149984843|NCT00431444|541076833|FG000|Overall Study|Adverse Event|2|||
149984844|NCT00431444|541076834|FG001|Overall Study|Adverse Event|1|||
149984845|NCT00431444|541076833|FG000|Overall Study|Withdrawal by Subject|1|||
149984846|NCT00431444|541076834|FG001|Overall Study|Withdrawal by Subject|1|||
149984847|NCT00431444|541076833|FG000|Overall Study|Lost to Follow-up|1|||
149984848|NCT00431444|541076834|FG001|Overall Study|Lost to Follow-up|0|||
149984849|NCT00431444|541076833|FG000|Overall Study|Administrative Problems|0|||
149984850|NCT00431444|541076834|FG001|Overall Study|Administrative Problems|1|||
149984851|NCT02517398|541076853|FG000|Overall Study|Death|2|||
149984852|NCT02517398|541076854|FG001|Overall Study|Death|3|||
149984853|NCT02517398|541076855|FG002|Overall Study|Death|4|||
149984854|NCT02517398|541076856|FG003|Overall Study|Death|2|||
149984855|NCT02517398|541076857|FG004|Overall Study|Death|3|||
149984856|NCT02517398|541076858|FG005|Overall Study|Death|8|||
149984857|NCT02517398|541076859|FG006|Overall Study|Death|3|||
149984858|NCT02517398|541076860|FG007|Overall Study|Death|2|||
149984859|NCT02517398|541076861|FG008|Overall Study|Death|6|||
149984860|NCT02517398|541076862|FG009|Overall Study|Death|24|||
149984861|NCT02517398|541076863|FG010|Overall Study|Death|53|||
149984862|NCT02517398|541076864|FG011|Overall Study|Death|25|||
149984863|NCT02517398|541076865|FG012|Overall Study|Death|73|||
149984864|NCT02517398|541076866|FG013|Overall Study|Death|29|||
149984865|NCT02517398|541076867|FG014|Overall Study|Death|26|||
149984866|NCT02517398|541076868|FG015|Overall Study|Death|23|||
149984867|NCT02517398|541076869|FG016|Overall Study|Death|26|||
149984868|NCT02517398|541076870|FG017|Overall Study|Death|25|||
149984869|NCT02517398|541076871|FG018|Overall Study|Death|22|||
149984870|NCT02517398|541076872|FG019|Overall Study|Death|7|||
149984871|NCT02517398|541076873|FG020|Overall Study|Death|26|||
149984872|NCT02517398|541076874|FG021|Overall Study|Death|30|||
149984873|NCT02517398|541076875|FG022|Overall Study|Death|20|||
149984874|NCT02517398|541076853|FG000|Overall Study|Other|0|||
149984875|NCT02517398|541076854|FG001|Overall Study|Other|0|||
149984876|NCT02517398|541076855|FG002|Overall Study|Other|0|||
149984877|NCT02517398|541076856|FG003|Overall Study|Other|1|||
149984878|NCT02517398|541076857|FG004|Overall Study|Other|0|||
149984879|NCT02517398|541076858|FG005|Overall Study|Other|0|||
149984880|NCT02517398|541076859|FG006|Overall Study|Other|0|||
149984881|NCT02517398|541076860|FG007|Overall Study|Other|0|||
149984882|NCT02517398|541076861|FG008|Overall Study|Other|0|||
149984883|NCT02517398|541076862|FG009|Overall Study|Other|1|||
149984884|NCT02517398|541076863|FG010|Overall Study|Other|0|||
149984885|NCT02517398|541076864|FG011|Overall Study|Other|0|||
149984886|NCT02517398|541076865|FG012|Overall Study|Other|0|||
149984887|NCT02517398|541076866|FG013|Overall Study|Other|1|||
149984888|NCT02517398|541076867|FG014|Overall Study|Other|0|||
149984889|NCT02517398|541076868|FG015|Overall Study|Other|1|||
149984890|NCT02517398|541076869|FG016|Overall Study|Other|1|||
149984891|NCT02517398|541076870|FG017|Overall Study|Other|0|||
149984892|NCT02517398|541076871|FG018|Overall Study|Other|0|||
149984893|NCT02517398|541076872|FG019|Overall Study|Other|1|||
149984894|NCT02517398|541076873|FG020|Overall Study|Other|0|||
149984895|NCT02517398|541076874|FG021|Overall Study|Other|0|||
149984896|NCT02517398|541076875|FG022|Overall Study|Other|0|||
149984897|NCT02517398|541076853|FG000|Overall Study|Lost to Follow-up|0|||
149984898|NCT02517398|541076854|FG001|Overall Study|Lost to Follow-up|0|||
149984899|NCT02517398|541076855|FG002|Overall Study|Lost to Follow-up|0|||
149984900|NCT02517398|541076856|FG003|Overall Study|Lost to Follow-up|0|||
149984901|NCT02517398|541076857|FG004|Overall Study|Lost to Follow-up|0|||
149984902|NCT02517398|541076858|FG005|Overall Study|Lost to Follow-up|0|||
149984903|NCT02517398|541076859|FG006|Overall Study|Lost to Follow-up|0|||
150178743|NCT03565315|541792026|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
150178744|NCT01083316|541792031|FG000|Overall Study|Adverse Event|2|||
150178745|NCT01083316|541792031|FG000|Overall Study|Withdrawal by Subject|1|||
149984904|NCT02517398|541076860|FG007|Overall Study|Lost to Follow-up|0|||
149984905|NCT02517398|541076861|FG008|Overall Study|Lost to Follow-up|0|||
149984906|NCT02517398|541076862|FG009|Overall Study|Lost to Follow-up|1|||
149984907|NCT02517398|541076863|FG010|Overall Study|Lost to Follow-up|0|||
149984908|NCT02517398|541076864|FG011|Overall Study|Lost to Follow-up|2|||
149984909|NCT02517398|541076865|FG012|Overall Study|Lost to Follow-up|2|||
149984910|NCT02517398|541076866|FG013|Overall Study|Lost to Follow-up|0|||
149984911|NCT02517398|541076867|FG014|Overall Study|Lost to Follow-up|1|||
149984912|NCT02517398|541076868|FG015|Overall Study|Lost to Follow-up|1|||
149984913|NCT02517398|541076869|FG016|Overall Study|Lost to Follow-up|0|||
149984914|NCT02517398|541076870|FG017|Overall Study|Lost to Follow-up|3|||
149984915|NCT02517398|541076871|FG018|Overall Study|Lost to Follow-up|1|||
150178746|NCT04200365|541792032|FG000|Overall Study|Adverse Event|2|||
150178747|NCT04200365|541792032|FG000|Overall Study|Progressive Disease|4|||
149984916|NCT02517398|541076872|FG019|Overall Study|Lost to Follow-up|0|||
149984917|NCT02517398|541076873|FG020|Overall Study|Lost to Follow-up|1|||
149984918|NCT02517398|541076874|FG021|Overall Study|Lost to Follow-up|0|||
149984919|NCT02517398|541076875|FG022|Overall Study|Lost to Follow-up|2|||
149984920|NCT02517398|541076853|FG000|Overall Study|Withdrew Consent|0|||
149984921|NCT02517398|541076854|FG001|Overall Study|Withdrew Consent|0|||
150178748|NCT04200365|541792032|FG000|Overall Study|Lack of Efficacy|1|||
150178749|NCT04200365|541792032|FG000|Overall Study|Study Closure|4|||
149984922|NCT02517398|541076855|FG002|Overall Study|Withdrew Consent|0|||
149984923|NCT02517398|541076856|FG003|Overall Study|Withdrew Consent|0|||
149984924|NCT02517398|541076857|FG004|Overall Study|Withdrew Consent|0|||
149984925|NCT02517398|541076858|FG005|Overall Study|Withdrew Consent|0|||
149984926|NCT02517398|541076859|FG006|Overall Study|Withdrew Consent|1|||
149984927|NCT02517398|541076860|FG007|Overall Study|Withdrew Consent|0|||
149984928|NCT02517398|541076861|FG008|Overall Study|Withdrew Consent|0|||
149984929|NCT02517398|541076862|FG009|Overall Study|Withdrew Consent|2|||
149984930|NCT02517398|541076863|FG010|Overall Study|Withdrew Consent|7|||
149984931|NCT02517398|541076864|FG011|Overall Study|Withdrew Consent|1|||
149984932|NCT02517398|541076865|FG012|Overall Study|Withdrew Consent|5|||
149984933|NCT02517398|541076866|FG013|Overall Study|Withdrew Consent|4|||
149984934|NCT02517398|541076867|FG014|Overall Study|Withdrew Consent|2|||
149984935|NCT02517398|541076868|FG015|Overall Study|Withdrew Consent|5|||
149984936|NCT02517398|541076869|FG016|Overall Study|Withdrew Consent|4|||
149984937|NCT02517398|541076870|FG017|Overall Study|Withdrew Consent|2|||
149984938|NCT02517398|541076871|FG018|Overall Study|Withdrew Consent|3|||
149984939|NCT02517398|541076872|FG019|Overall Study|Withdrew Consent|2|||
149984940|NCT02517398|541076873|FG020|Overall Study|Withdrew Consent|9|||
149984941|NCT02517398|541076874|FG021|Overall Study|Withdrew Consent|3|||
149984942|NCT02517398|541076875|FG022|Overall Study|Withdrew Consent|1|||
149984943|NCT02131662|541076882|FG000|Overall Study|Protocol Violation|1|||
149984944|NCT02131662|541076883|FG001|Overall Study|Protocol Violation|0|||
149984945|NCT02131662|541076884|FG002|Overall Study|Protocol Violation|0|||
149984946|NCT02131662|541076885|FG003|Overall Study|Protocol Violation|0|||
149984947|NCT02131662|541076886|FG004|Overall Study|Protocol Violation|0|||
149984948|NCT02131662|541076882|FG000|Overall Study|Other|2|||
149984949|NCT02131662|541076883|FG001|Overall Study|Other|4|||
149984950|NCT02131662|541076884|FG002|Overall Study|Other|3|||
149984951|NCT02131662|541076885|FG003|Overall Study|Other|3|||
149984952|NCT02131662|541076886|FG004|Overall Study|Other|4|||
149984953|NCT02131662|541076882|FG000|Overall Study|Adverse Event|0|||
149984954|NCT02131662|541076883|FG001|Overall Study|Adverse Event|1|||
149984955|NCT02131662|541076884|FG002|Overall Study|Adverse Event|1|||
149984956|NCT02131662|541076885|FG003|Overall Study|Adverse Event|1|||
149984957|NCT02131662|541076886|FG004|Overall Study|Adverse Event|3|||
149984958|NCT02131662|541076882|FG000|Overall Study|Pregnancy|0|||
149984959|NCT02131662|541076883|FG001|Overall Study|Pregnancy|1|||
149984960|NCT02131662|541076884|FG002|Overall Study|Pregnancy|0|||
149984961|NCT02131662|541076885|FG003|Overall Study|Pregnancy|1|||
149984962|NCT02131662|541076886|FG004|Overall Study|Pregnancy|0|||
149984963|NCT02131662|541076882|FG000|Overall Study|Wish for pregnancy|0|||
149984964|NCT02131662|541076883|FG001|Overall Study|Wish for pregnancy|0|||
149984965|NCT02131662|541076884|FG002|Overall Study|Wish for pregnancy|0|||
149984966|NCT02131662|541076885|FG003|Overall Study|Wish for pregnancy|0|||
149984967|NCT02131662|541076886|FG004|Overall Study|Wish for pregnancy|1|||
149984968|NCT02131662|541076882|FG000|Overall Study|Lack of Efficacy|1|||
149984969|NCT02131662|541076883|FG001|Overall Study|Lack of Efficacy|0|||
149984970|NCT02131662|541076884|FG002|Overall Study|Lack of Efficacy|0|||
149984971|NCT02131662|541076885|FG003|Overall Study|Lack of Efficacy|0|||
149984972|NCT02131662|541076886|FG004|Overall Study|Lack of Efficacy|1|||
149984973|NCT02131662|541076882|FG000|Overall Study|Withdrawal by Subject|1|||
149984974|NCT02131662|541076883|FG001|Overall Study|Withdrawal by Subject|5|||
149984975|NCT02131662|541076884|FG002|Overall Study|Withdrawal by Subject|1|||
149984976|NCT02131662|541076885|FG003|Overall Study|Withdrawal by Subject|5|||
149984977|NCT02131662|541076886|FG004|Overall Study|Withdrawal by Subject|6|||
149984978|NCT02131662|541076882|FG000|Overall Study|Lost to Follow-up|1|||
149984979|NCT02131662|541076883|FG001|Overall Study|Lost to Follow-up|3|||
149984980|NCT02131662|541076884|FG002|Overall Study|Lost to Follow-up|0|||
149984981|NCT02131662|541076885|FG003|Overall Study|Lost to Follow-up|9|||
149984982|NCT02131662|541076886|FG004|Overall Study|Lost to Follow-up|0|||
149984983|NCT02131662|541076882|FG000|Overall Study|Not treated|2|||
149984984|NCT02131662|541076883|FG001|Overall Study|Not treated|0|||
149984985|NCT02131662|541076884|FG002|Overall Study|Not treated|2|||
149984986|NCT02131662|541076885|FG003|Overall Study|Not treated|2|||
149984987|NCT02131662|541076886|FG004|Overall Study|Not treated|3|||
149984988|NCT03554018|541076887|FG000|Overall Study|Lost to Follow-up|3|||
149984989|NCT03554018|541076888|FG001|Overall Study|Lost to Follow-up|7|||
149984990|NCT02142803|541076890|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
149984991|NCT02142803|541076891|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
149984992|NCT02142803|541076892|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
149984993|NCT02142803|541076893|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
149984994|NCT00130039|541076894|FG000|Overall Study|Withdrawal by Subject|15|||
149984995|NCT00130039|541076895|FG001|Overall Study|Withdrawal by Subject|11|||
149984996|NCT00130039|541076894|FG000|Overall Study|Lost to Follow-up|3|||
149984997|NCT00130039|541076895|FG001|Overall Study|Lost to Follow-up|1|||
149984998|NCT00130039|541076894|FG000|Overall Study|Adverse Event|4|||
149984999|NCT00130039|541076895|FG001|Overall Study|Adverse Event|2|||
149985000|NCT00130039|541076894|FG000|Overall Study|Physician Decision|3|||
149985001|NCT00130039|541076895|FG001|Overall Study|Physician Decision|0|||
149985002|NCT00130039|541076894|FG000|Overall Study|clinical events without follow up MRI|5|||
149985003|NCT00130039|541076895|FG001|Overall Study|clinical events without follow up MRI|4|||
149985004|NCT01016132|541076897|FG000|Overall Study|Discomfort|1|||
149985005|NCT01198574|541076898|FG000|Overall Study|Resigned from schools|4|||
149985006|NCT01198574|541076899|FG001|Overall Study|Resigned from schools|1|||
149985007|NCT01198574|541076900|FG002|Overall Study|Resigned from schools|1|||
149985008|NCT01198574|541076901|FG003|Overall Study|Resigned from schools|4|||
150178750|NCT01499199|541792033|FG000|Overall Study|Adverse Event|1|||
149985009|NCT00556439|541076902|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
149985010|NCT00556439|541076903|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
149985011|NCT00556439|541076904|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
149985012|NCT00556439|541076905|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
149985013|NCT00556439|541076902|FG000|Study Entry to Week 12|Physician Decision|1|||
149985014|NCT00556439|541076903|FG001|Study Entry to Week 12|Physician Decision|0|||
149985015|NCT00556439|541076904|FG002|Study Entry to Week 12|Physician Decision|0|||
149985016|NCT00556439|541076905|FG003|Study Entry to Week 12|Physician Decision|0|||
149985017|NCT00556439|541076902|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
149985018|NCT00556439|541076903|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
149985019|NCT00556439|541076904|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
149985020|NCT00556439|541076905|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
149985021|NCT00556439|541076902|FG000|Study Entry to Week 12|Recurrent infection|1|||
149985022|NCT00556439|541076903|FG001|Study Entry to Week 12|Recurrent infection|0|||
149985023|NCT00556439|541076904|FG002|Study Entry to Week 12|Recurrent infection|0|||
149985024|NCT00556439|541076905|FG003|Study Entry to Week 12|Recurrent infection|0|||
149985025|NCT00556439|541076902|FG000|Study Entry to Week 12|Malignancy|0|||
149985026|NCT00556439|541076903|FG001|Study Entry to Week 12|Malignancy|0|||
149985027|NCT00556439|541076904|FG002|Study Entry to Week 12|Malignancy|1|||
149985028|NCT00556439|541076905|FG003|Study Entry to Week 12|Malignancy|0|||
149985029|NCT00556439|541076902|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
149985030|NCT00556439|541076903|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
149985031|NCT00556439|541076904|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
149985032|NCT00556439|541076905|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
149985033|NCT00556439|541076902|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
149985034|NCT00556439|541076903|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
149985035|NCT00556439|541076904|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
149985036|NCT00556439|541076905|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
149985037|NCT00556439|541076902|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
149985038|NCT00556439|541076903|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
149985039|NCT00556439|541076904|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
149985040|NCT00556439|541076905|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
149985041|NCT00556439|541076902|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
149985042|NCT00556439|541076903|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
149985043|NCT00556439|541076904|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
149985044|NCT00556439|541076905|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
149985045|NCT02100423|541076906|FG000|Overall Study|Death|1|||
149985046|NCT02100423|541076906|FG000|Overall Study|Withdrawal by Subject|3|||
149985047|NCT02100423|541076906|FG000|Overall Study|Adverse Event|1|||
149985048|NCT02100423|541076906|FG000|Overall Study|Physician Decision|1|||
149985049|NCT00958360|541078843|FG000|Overall Study|Withdrawal by Subject|3|||
149985050|NCT00958360|541078844|FG001|Overall Study|Withdrawal by Subject|1|||
149985051|NCT00958360|541078843|FG000|Overall Study|Death|6|||
149985052|NCT00958360|541078844|FG001|Overall Study|Death|7|||
149985053|NCT00958360|541078843|FG000|Overall Study|Physician Decision|2|||
149985054|NCT00958360|541078844|FG001|Overall Study|Physician Decision|1|||
149985055|NCT00958360|541078843|FG000|Overall Study|Lost to Follow-up|0|||
149985056|NCT00958360|541078844|FG001|Overall Study|Lost to Follow-up|1|||
149985057|NCT03107052|541078845|FG000|Overall Study|Adverse Event|6|||
149985058|NCT03107052|541078846|FG001|Overall Study|Adverse Event|1|||
149985059|NCT03107052|541078847|FG002|Overall Study|Adverse Event|2|||
149985060|NCT03107052|541078845|FG000|Overall Study|Withdrawal by Subject|9|||
149985061|NCT03107052|541078846|FG001|Overall Study|Withdrawal by Subject|5|||
149985062|NCT03107052|541078847|FG002|Overall Study|Withdrawal by Subject|8|||
149985063|NCT03107052|541078845|FG000|Overall Study|Protocol Violation|6|||
149985064|NCT03107052|541078846|FG001|Overall Study|Protocol Violation|0|||
149985065|NCT03107052|541078847|FG002|Overall Study|Protocol Violation|3|||
149985066|NCT03107052|541078845|FG000|Overall Study|Lost to Follow-up|4|||
149985067|NCT03107052|541078846|FG001|Overall Study|Lost to Follow-up|0|||
149985068|NCT03107052|541078847|FG002|Overall Study|Lost to Follow-up|1|||
149985069|NCT03107052|541078845|FG000|Overall Study|Lack of Efficacy|23|||
149985070|NCT03107052|541078846|FG001|Overall Study|Lack of Efficacy|7|||
149985071|NCT03107052|541078847|FG002|Overall Study|Lack of Efficacy|4|||
149985072|NCT03107052|541078845|FG000|Overall Study|Other than specified|4|||
149985073|NCT03107052|541078846|FG001|Overall Study|Other than specified|2|||
149985074|NCT03107052|541078847|FG002|Overall Study|Other than specified|0|||
149985075|NCT03107052|541078845|FG000|Overall Study|Study terminated due to futility|67|||
149985076|NCT03107052|541078846|FG001|Overall Study|Study terminated due to futility|31|||
149985077|NCT03107052|541078847|FG002|Overall Study|Study terminated due to futility|23|||
149985078|NCT03015363|541078848|FG000|Overall Study|Physician Decision|14|||
149985079|NCT03015363|541078848|FG000|Overall Study|Withdrawal by Subject|3|||
149985080|NCT00078806|541078849|FG000|Part 1A|Adverse Event|2|||
149985081|NCT00078806|541078850|FG001|Part 1A|Adverse Event|0|||
149985082|NCT00078806|541078851|FG002|Part 1A|Adverse Event|0|||
149985083|NCT00078806|541078852|FG003|Part 1A|Adverse Event|0|||
149985084|NCT00078806|541078849|FG000|Part 1A|Lack of Efficacy|7|||
149985085|NCT00078806|541078850|FG001|Part 1A|Lack of Efficacy|0|||
150178751|NCT01499199|541792033|FG000|Overall Study|Lack of Efficacy|1|||
149985086|NCT00078806|541078851|FG002|Part 1A|Lack of Efficacy|0|||
149985087|NCT00078806|541078852|FG003|Part 1A|Lack of Efficacy|0|||
149985088|NCT00078806|541078849|FG000|Part 1A|Other|1|||
149985089|NCT00078806|541078850|FG001|Part 1A|Other|0|||
149985090|NCT00078806|541078851|FG002|Part 1A|Other|0|||
149985091|NCT00078806|541078852|FG003|Part 1A|Other|0|||
149985092|NCT00078806|541078849|FG000|Part 1B|Adverse Event|1|||
149985093|NCT00078806|541078850|FG001|Part 1B|Adverse Event|0|||
149985094|NCT00078806|541078851|FG002|Part 1B|Adverse Event|0|||
149985095|NCT00078806|541078852|FG003|Part 1B|Adverse Event|0|||
149985096|NCT00078806|541078849|FG000|Part 1B|Lack of Efficacy|7|||
149985097|NCT00078806|541078850|FG001|Part 1B|Lack of Efficacy|0|||
149985098|NCT00078806|541078851|FG002|Part 1B|Lack of Efficacy|0|||
149985099|NCT00078806|541078852|FG003|Part 1B|Lack of Efficacy|0|||
149985100|NCT00078806|541078849|FG000|Part 2|Adverse Event|0|||
149985101|NCT00078806|541078850|FG001|Part 2|Adverse Event|1|||
149985102|NCT00078806|541078851|FG002|Part 2|Adverse Event|0|||
149985103|NCT00078806|541078852|FG003|Part 2|Adverse Event|0|||
149985104|NCT02013778|541078855|FG000|Overall Study|Death|4|||
149985105|NCT02013778|541078855|FG000|Overall Study|Withdrawal by Subject|1|||
149985106|NCT02013778|541078855|FG000|Overall Study|Physician Decision|1|||
149985107|NCT02013778|541078855|FG000|Overall Study|Adverse Event|1|||
149985108|NCT02719691|541078858|FG000|Overall Study|Physician Decision|0|||
149985109|NCT02719691|541078859|FG001|Overall Study|Physician Decision|0|||
149985110|NCT02719691|541078860|FG002|Overall Study|Physician Decision|1|||
149985111|NCT02719691|541078861|FG003|Overall Study|Physician Decision|0|||
149985112|NCT02719691|541078862|FG004|Overall Study|Physician Decision|0|||
149985113|NCT02719691|541078863|FG005|Overall Study|Physician Decision|0|||
149985114|NCT02719691|541078864|FG006|Overall Study|Physician Decision|0|||
149985115|NCT02719691|541078858|FG000|Overall Study|Withdrawal by Subject|0|||
149985116|NCT02719691|541078859|FG001|Overall Study|Withdrawal by Subject|0|||
149985117|NCT02719691|541078860|FG002|Overall Study|Withdrawal by Subject|0|||
149985118|NCT02719691|541078861|FG003|Overall Study|Withdrawal by Subject|0|||
149985119|NCT02719691|541078862|FG004|Overall Study|Withdrawal by Subject|0|||
149985120|NCT02719691|541078863|FG005|Overall Study|Withdrawal by Subject|1|||
149985121|NCT02719691|541078864|FG006|Overall Study|Withdrawal by Subject|0|||
149985122|NCT00861757|541078867|FG000|Overall Study|Adverse Event|1|||
149985123|NCT00861757|541078868|FG001|Overall Study|Adverse Event|5|||
149985124|NCT00861757|541078869|FG002|Overall Study|Adverse Event|7|||
149985125|NCT00861757|541078870|FG003|Overall Study|Adverse Event|2|||
149985126|NCT00861757|541078867|FG000|Overall Study|Entry Criteria Not Met|1|||
149985127|NCT00861757|541078868|FG001|Overall Study|Entry Criteria Not Met|2|||
149985128|NCT00861757|541078869|FG002|Overall Study|Entry Criteria Not Met|1|||
149985129|NCT00861757|541078870|FG003|Overall Study|Entry Criteria Not Met|1|||
149985130|NCT00861757|541078867|FG000|Overall Study|Lack of Efficacy|3|||
149985131|NCT00861757|541078868|FG001|Overall Study|Lack of Efficacy|1|||
149985132|NCT00861757|541078869|FG002|Overall Study|Lack of Efficacy|0|||
149985133|NCT00861757|541078870|FG003|Overall Study|Lack of Efficacy|1|||
149985134|NCT00861757|541078867|FG000|Overall Study|Lost to Follow-up|1|||
149985135|NCT00861757|541078868|FG001|Overall Study|Lost to Follow-up|0|||
149985136|NCT00861757|541078869|FG002|Overall Study|Lost to Follow-up|1|||
149985137|NCT00861757|541078870|FG003|Overall Study|Lost to Follow-up|1|||
149985138|NCT00861757|541078867|FG000|Overall Study|Physician Decision|0|||
149985139|NCT00861757|541078868|FG001|Overall Study|Physician Decision|0|||
149985140|NCT00861757|541078869|FG002|Overall Study|Physician Decision|0|||
149985141|NCT00861757|541078870|FG003|Overall Study|Physician Decision|1|||
149985142|NCT00861757|541078867|FG000|Overall Study|Protocol Violation|2|||
149985143|NCT00861757|541078868|FG001|Overall Study|Protocol Violation|2|||
149985144|NCT00861757|541078869|FG002|Overall Study|Protocol Violation|4|||
149985145|NCT00861757|541078870|FG003|Overall Study|Protocol Violation|1|||
149985146|NCT00861757|541078867|FG000|Overall Study|Withdrawal by Subject|1|||
149985147|NCT00861757|541078868|FG001|Overall Study|Withdrawal by Subject|5|||
149985148|NCT00861757|541078869|FG002|Overall Study|Withdrawal by Subject|5|||
149985149|NCT00861757|541078870|FG003|Overall Study|Withdrawal by Subject|2|||
149985150|NCT01521923|541078876|FG000|Overall Study|AE, serious fatal|1|||
149985151|NCT01521923|541078877|FG001|Overall Study|AE, serious fatal|0|||
149985152|NCT01521923|541078878|FG002|Overall Study|AE, serious fatal|0|||
149985153|NCT01521923|541078879|FG003|Overall Study|AE, serious fatal|0|||
149985154|NCT01521923|541078876|FG000|Overall Study|SAE, non-fatal|0|||
149985155|NCT01521923|541078877|FG001|Overall Study|SAE, non-fatal|2|||
149985156|NCT01521923|541078878|FG002|Overall Study|SAE, non-fatal|2|||
149985157|NCT01521923|541078879|FG003|Overall Study|SAE, non-fatal|0|||
149985158|NCT01521923|541078876|FG000|Overall Study|AE, non-serious, non-fatal|1|||
149985159|NCT01521923|541078877|FG001|Overall Study|AE, non-serious, non-fatal|3|||
149985160|NCT01521923|541078878|FG002|Overall Study|AE, non-serious, non-fatal|6|||
149985161|NCT01521923|541078879|FG003|Overall Study|AE, non-serious, non-fatal|2|||
149985162|NCT01521923|541078876|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
149985163|NCT01521923|541078877|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
149985164|NCT01521923|541078878|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
149985165|NCT01521923|541078879|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
149985166|NCT01521923|541078876|FG000|Overall Study|Lack of Efficacy|1|||
149985167|NCT01521923|541078877|FG001|Overall Study|Lack of Efficacy|1|||
149985168|NCT01521923|541078878|FG002|Overall Study|Lack of Efficacy|0|||
149985169|NCT01521923|541078879|FG003|Overall Study|Lack of Efficacy|0|||
149985170|NCT01521923|541078876|FG000|Overall Study|Protocol Violation|0|||
149985171|NCT01521923|541078877|FG001|Overall Study|Protocol Violation|0|||
149985172|NCT01521923|541078878|FG002|Overall Study|Protocol Violation|1|||
149985173|NCT01521923|541078879|FG003|Overall Study|Protocol Violation|0|||
149985174|NCT01521923|541078876|FG000|Overall Study|Lost to Follow-up|1|||
149985175|NCT01521923|541078877|FG001|Overall Study|Lost to Follow-up|0|||
149985176|NCT01521923|541078878|FG002|Overall Study|Lost to Follow-up|2|||
149985177|NCT01521923|541078879|FG003|Overall Study|Lost to Follow-up|1|||
149985178|NCT01521923|541078876|FG000|Overall Study|Withdrawal by Subject|1|||
149985179|NCT01521923|541078877|FG001|Overall Study|Withdrawal by Subject|1|||
149985180|NCT01521923|541078878|FG002|Overall Study|Withdrawal by Subject|1|||
149985181|NCT01521923|541078879|FG003|Overall Study|Withdrawal by Subject|2|||
149985182|NCT01521923|541078876|FG000|Overall Study|Other|2|||
149985183|NCT01521923|541078877|FG001|Overall Study|Other|1|||
149985184|NCT01521923|541078878|FG002|Overall Study|Other|3|||
149985185|NCT01521923|541078879|FG003|Overall Study|Other|6|||
149985186|NCT01521923|541078876|FG000|Overall Study|AE, captured in Period 1|0|||
149985187|NCT01521923|541078877|FG001|Overall Study|AE, captured in Period 1|1|||
149985188|NCT01521923|541078878|FG002|Overall Study|AE, captured in Period 1|0|||
149985189|NCT01521923|541078879|FG003|Overall Study|AE, captured in Period 1|1|||
149985190|NCT03037476|541078880|FG000|Overall Study|Lost to Follow-up|63|||
149985191|NCT03037476|541078881|FG001|Overall Study|Lost to Follow-up|46|||
149985192|NCT02141633|541078882|FG000|Overall Study|Physician Decision|1|||
149985193|NCT02141633|541078883|FG001|Overall Study|Physician Decision|0|||
149985194|NCT02403817|541078884|FG000|Overall Study|Withdrawal by Subject|5|||
149985195|NCT02403817|541078885|FG001|Overall Study|Withdrawal by Subject|0|||
149985196|NCT04908384|541078889|FG000|Overall Study|Lost to Follow-up|4|||
149985197|NCT04908384|541078890|FG001|Overall Study|Lost to Follow-up|4|||
149985198|NCT04908384|541078891|FG002|Overall Study|Lost to Follow-up|0|||
149985199|NCT04908384|541078892|FG003|Overall Study|Lost to Follow-up|0|||
149985200|NCT01498692|541078893|FG000|Overall Study|Death|4|||
149985201|NCT01498692|541078893|FG000|Overall Study|Withdrawal by Subject|1|||
149985202|NCT01498692|541078893|FG000|Overall Study|Missed 12-month visit|3|||
149985203|NCT00590122|541078894|FG000|Overall Study|swallowed oral dissolving dose|1|||
149985204|NCT00590122|541078895|FG001|Overall Study|swallowed oral dissolving dose|0|||
149985205|NCT00833469|541078896|FG000|Overall Study|Withdrawal by Subject|1|||
149985206|NCT00833469|541078896|FG000|Overall Study|Lost to Follow-up|1|||
149985207|NCT02707965|541078897|FG000|Overall Study|Withdrawal by Subject|0|||
149985208|NCT02707965|541078898|FG001|Overall Study|Withdrawal by Subject|0|||
149985209|NCT02707965|541078899|FG002|Overall Study|Withdrawal by Subject|1|||
149985210|NCT02707965|541078900|FG003|Overall Study|Withdrawal by Subject|0|||
149985211|NCT02707965|541078901|FG004|Overall Study|Withdrawal by Subject|0|||
149985212|NCT02707965|541078902|FG005|Overall Study|Withdrawal by Subject|0|||
149985213|NCT02707965|541078903|FG006|Overall Study|Withdrawal by Subject|0|||
149985214|NCT02707965|541078904|FG007|Overall Study|Withdrawal by Subject|2|||
149985215|NCT02707965|541078905|FG008|Overall Study|Withdrawal by Subject|0|||
149985216|NCT02707965|541078906|FG009|Overall Study|Withdrawal by Subject|0|||
149985217|NCT02707965|541078907|FG010|Overall Study|Withdrawal by Subject|0|||
149985218|NCT02707965|541078908|FG011|Overall Study|Withdrawal by Subject|0|||
149985219|NCT02707965|541078909|FG012|Overall Study|Withdrawal by Subject|0|||
149985220|NCT02707965|541078910|FG013|Overall Study|Withdrawal by Subject|0|||
149985221|NCT02707965|541078911|FG014|Overall Study|Withdrawal by Subject|0|||
149985222|NCT02707965|541078912|FG015|Overall Study|Withdrawal by Subject|0|||
149985223|NCT02707965|541078897|FG000|Overall Study|PI decisions|0|||
149985224|NCT02707965|541078898|FG001|Overall Study|PI decisions|0|||
150178752|NCT01692730|541792034|FG000|Overall Study|Lost to Follow-up|225|||
150178753|NCT01692730|541792035|FG001|Overall Study|Lost to Follow-up|227|||
150178754|NCT01199575|541792036|FG000|Overall Study|Withdrawal by Subject|5|||
150178755|NCT02139943|541792037|FG000|Overall Study|Adverse Event|0|||
149985225|NCT02707965|541078899|FG002|Overall Study|PI decisions|0|||
149985226|NCT02707965|541078900|FG003|Overall Study|PI decisions|0|||
149985227|NCT02707965|541078901|FG004|Overall Study|PI decisions|0|||
149985228|NCT02707965|541078902|FG005|Overall Study|PI decisions|0|||
149985229|NCT02707965|541078903|FG006|Overall Study|PI decisions|0|||
149985230|NCT02707965|541078904|FG007|Overall Study|PI decisions|0|||
149985231|NCT02707965|541078905|FG008|Overall Study|PI decisions|0|||
149985232|NCT02707965|541078906|FG009|Overall Study|PI decisions|0|||
149985233|NCT02707965|541078907|FG010|Overall Study|PI decisions|0|||
149985234|NCT02707965|541078908|FG011|Overall Study|PI decisions|0|||
149985235|NCT02707965|541078909|FG012|Overall Study|PI decisions|0|||
149985236|NCT02707965|541078910|FG013|Overall Study|PI decisions|0|||
149985237|NCT02707965|541078911|FG014|Overall Study|PI decisions|2|||
149985238|NCT02707965|541078912|FG015|Overall Study|PI decisions|0|||
149985239|NCT02707965|541078897|FG000|Overall Study|Protocol deviation|1|||
149985240|NCT02707965|541078898|FG001|Overall Study|Protocol deviation|1|||
149985241|NCT02707965|541078899|FG002|Overall Study|Protocol deviation|0|||
149985242|NCT02707965|541078900|FG003|Overall Study|Protocol deviation|0|||
149985243|NCT02707965|541078901|FG004|Overall Study|Protocol deviation|0|||
149985244|NCT02707965|541078902|FG005|Overall Study|Protocol deviation|0|||
149985245|NCT02707965|541078903|FG006|Overall Study|Protocol deviation|0|||
149985246|NCT02707965|541078904|FG007|Overall Study|Protocol deviation|1|||
149985247|NCT02707965|541078905|FG008|Overall Study|Protocol deviation|0|||
149985248|NCT02707965|541078906|FG009|Overall Study|Protocol deviation|0|||
149985249|NCT02707965|541078907|FG010|Overall Study|Protocol deviation|0|||
149985250|NCT02707965|541078908|FG011|Overall Study|Protocol deviation|0|||
149985251|NCT02707965|541078909|FG012|Overall Study|Protocol deviation|0|||
149985252|NCT02707965|541078910|FG013|Overall Study|Protocol deviation|0|||
149985253|NCT02707965|541078911|FG014|Overall Study|Protocol deviation|0|||
149985254|NCT02707965|541078912|FG015|Overall Study|Protocol deviation|0|||
149985255|NCT01701362|541078913|FG000|Overall Study|Adverse events not related to study drug|1|||
149985256|NCT01701362|541078914|FG001|Overall Study|Adverse events not related to study drug|6|||
149985257|NCT01701362|541078913|FG000|Overall Study|Adverse events related to study drug|12|||
149985258|NCT01701362|541078914|FG001|Overall Study|Adverse events related to study drug|10|||
149985259|NCT01701362|541078913|FG000|Overall Study|Protocol Violation|5|||
149985260|NCT01701362|541078914|FG001|Overall Study|Protocol Violation|3|||
149985261|NCT01701362|541078913|FG000|Overall Study|No longer willing to participate|8|||
149985262|NCT01701362|541078914|FG001|Overall Study|No longer willing to participate|14|||
149985263|NCT01701362|541078913|FG000|Overall Study|Lost to Follow-up|6|||
149985264|NCT01701362|541078914|FG001|Overall Study|Lost to Follow-up|9|||
149985265|NCT01701362|541078913|FG000|Overall Study|Insufficient clinical response|6|||
149985266|NCT01701362|541078914|FG001|Overall Study|Insufficient clinical response|6|||
149985267|NCT01701362|541078913|FG000|Overall Study|Death|0|||
149985268|NCT01701362|541078914|FG001|Overall Study|Death|1|||
149985269|NCT01701362|541078913|FG000|Overall Study|Randomized but not treated|1|||
149985270|NCT01701362|541078914|FG001|Overall Study|Randomized but not treated|2|||
150178756|NCT02139943|541792038|FG001|Overall Study|Adverse Event|1|||
149985271|NCT01701362|541078913|FG000|Overall Study|Reasons other than those mentioned above|3|||
149985272|NCT01701362|541078914|FG001|Overall Study|Reasons other than those mentioned above|5|||
149985273|NCT00570778|541078915|FG000|Overall Study|Protocol deviation|2|||
149985274|NCT00570778|541078916|FG001|Overall Study|Protocol deviation|1|||
149985275|NCT00570778|541078917|FG002|Overall Study|Protocol deviation|2|||
149985276|NCT00570778|541078918|FG003|Overall Study|Protocol deviation|2|||
149985277|NCT00570778|541078915|FG000|Overall Study|Adverse Event|0|||
149985278|NCT00570778|541078916|FG001|Overall Study|Adverse Event|1|||
149985279|NCT00570778|541078917|FG002|Overall Study|Adverse Event|4|||
149985280|NCT00570778|541078918|FG003|Overall Study|Adverse Event|1|||
149985281|NCT00570778|541078915|FG000|Overall Study|Subject withdrew consent|0|||
149985282|NCT00570778|541078916|FG001|Overall Study|Subject withdrew consent|1|||
149985283|NCT00570778|541078917|FG002|Overall Study|Subject withdrew consent|0|||
149985284|NCT00570778|541078918|FG003|Overall Study|Subject withdrew consent|1|||
149985285|NCT00570778|541078915|FG000|Overall Study|Abnormal test procedure|1|||
149985286|NCT00570778|541078916|FG001|Overall Study|Abnormal test procedure|0|||
149985287|NCT00570778|541078917|FG002|Overall Study|Abnormal test procedure|0|||
149985288|NCT00570778|541078918|FG003|Overall Study|Abnormal test procedure|0|||
149985289|NCT00570778|541078915|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149985290|NCT00570778|541078916|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149985291|NCT00570778|541078917|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149985292|NCT00570778|541078918|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149985293|NCT00570778|541078915|FG000|Overall Study|Lost to Follow-up|0|||
149985294|NCT00570778|541078916|FG001|Overall Study|Lost to Follow-up|0|||
149985295|NCT00570778|541078917|FG002|Overall Study|Lost to Follow-up|1|||
149985296|NCT00570778|541078918|FG003|Overall Study|Lost to Follow-up|0|||
149985297|NCT00570778|541078915|FG000|Overall Study|Subject no longer requires study drug|0|||
149985298|NCT00570778|541078916|FG001|Overall Study|Subject no longer requires study drug|1|||
149985299|NCT00570778|541078917|FG002|Overall Study|Subject no longer requires study drug|0|||
149985300|NCT00570778|541078918|FG003|Overall Study|Subject no longer requires study drug|0|||
149985301|NCT00249808|541078919|FG000|Overall Study|Other|27|||
149985302|NCT00249808|541078919|FG000|Overall Study|Protocol Violation|3|||
149985303|NCT00249808|541078919|FG000|Overall Study|Lost to Follow-up|8|||
149985304|NCT00249808|541078919|FG000|Overall Study|Adverse Event|81|||
149985305|NCT00249808|541078919|FG000|Overall Study|Lack of Efficacy|52|||
149985306|NCT00249808|541078919|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
149985307|NCT00711594|541078920|FG000|Overall Study|Progressive disease|2|||
149985308|NCT00711594|541078921|FG001|Overall Study|Progressive disease|2|||
149985309|NCT00711594|541078922|FG002|Overall Study|Progressive disease|6|||
149985310|NCT00711594|541078923|FG003|Overall Study|Progressive disease|44|||
149985311|NCT00711594|541078920|FG000|Overall Study|Other Adverse Event|1|||
149985312|NCT00711594|541078921|FG001|Overall Study|Other Adverse Event|0|||
149985313|NCT00711594|541078922|FG002|Overall Study|Other Adverse Event|0|||
149985314|NCT00711594|541078923|FG003|Overall Study|Other Adverse Event|16|||
149985315|NCT00711594|541078920|FG000|Overall Study|Withdrawal by Subject|0|||
149985316|NCT00711594|541078921|FG001|Overall Study|Withdrawal by Subject|1|||
149985317|NCT00711594|541078922|FG002|Overall Study|Withdrawal by Subject|0|||
149985318|NCT00711594|541078923|FG003|Overall Study|Withdrawal by Subject|2|||
149985319|NCT00443872|541078924|FG000|Overall Study|Protocol Violation|7|||
149985320|NCT00443872|541078924|FG000|Overall Study|Lost to Follow-up|2|||
149985321|NCT00443872|541078924|FG000|Overall Study|Adverse Event|8|||
149985322|NCT01709110|541078925|FG000|Overall Study|Adverse Event|56|||
149985323|NCT01709110|541078926|FG001|Overall Study|Adverse Event|48|||
149985324|NCT01709110|541078925|FG000|Overall Study|Death|14|||
149985325|NCT01709110|541078926|FG001|Overall Study|Death|6|||
149985326|NCT01709110|541078925|FG000|Overall Study|Lost to Follow-up|7|||
149985327|NCT01709110|541078926|FG001|Overall Study|Lost to Follow-up|5|||
149985328|NCT01709110|541078925|FG000|Overall Study|Protocol Violation|4|||
149985329|NCT01709110|541078926|FG001|Overall Study|Protocol Violation|6|||
149985330|NCT01709110|541078925|FG000|Overall Study|Withdrawal by Subject|96|||
149985331|NCT01709110|541078926|FG001|Overall Study|Withdrawal by Subject|89|||
149985332|NCT01709110|541078925|FG000|Overall Study|Physician Decision|4|||
149985333|NCT01709110|541078926|FG001|Overall Study|Physician Decision|10|||
149985334|NCT01709110|541078925|FG000|Overall Study|Sponsor Decision|2|||
149985335|NCT01709110|541078926|FG001|Overall Study|Sponsor Decision|2|||
149985336|NCT01709110|541078925|FG000|Overall Study|Lack of Efficacy|1|||
149985337|NCT01709110|541078926|FG001|Overall Study|Lack of Efficacy|1|||
149985338|NCT01709110|541078925|FG000|Overall Study|Caregiver Decision|1|||
149985339|NCT01709110|541078926|FG001|Overall Study|Caregiver Decision|1|||
149985340|NCT00485758|541078936|FG000|Overall Study|Adverse Event|102|||
149985341|NCT00485758|541078937|FG001|Overall Study|Adverse Event|31|||
149985342|NCT00485758|541078936|FG000|Overall Study|Death|0|||
149985343|NCT00485758|541078937|FG001|Overall Study|Death|1|||
149985344|NCT00485758|541078936|FG000|Overall Study|Lost to Follow-up|5|||
149985345|NCT00485758|541078937|FG001|Overall Study|Lost to Follow-up|1|||
149985346|NCT00485758|541078936|FG000|Overall Study|Physician Decision|3|||
149985347|NCT00485758|541078937|FG001|Overall Study|Physician Decision|3|||
149985348|NCT00485758|541078936|FG000|Overall Study|Protocol Violation|11|||
149985349|NCT00485758|541078937|FG001|Overall Study|Protocol Violation|2|||
149985350|NCT00485758|541078936|FG000|Overall Study|Withdrawal by Subject|32|||
149985351|NCT00485758|541078937|FG001|Overall Study|Withdrawal by Subject|27|||
149985352|NCT00485758|541078936|FG000|Overall Study|Study Terminated by Sponsor|3|||
149985353|NCT00485758|541078937|FG001|Overall Study|Study Terminated by Sponsor|0|||
149985354|NCT04123093|541078938|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
149985355|NCT04123093|541078939|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
149985356|NCT04123093|541078938|FG000|Phase 2|Physician Decision|0|||
149985357|NCT04123093|541078939|FG001|Phase 2|Physician Decision|1|||
149985358|NCT04123093|541078938|FG000|Phase 2|Withdrawal by Subject|0|||
149985359|NCT04123093|541078939|FG001|Phase 2|Withdrawal by Subject|1|||
149985360|NCT00135330|541078940|FG000|Overall Study|Adverse Event|2|||
149985361|NCT00135330|541078941|FG001|Overall Study|Adverse Event|5|||
149985362|NCT00135330|541078942|FG002|Overall Study|Adverse Event|1|||
149985363|NCT00135330|541078940|FG000|Overall Study|Lost to Follow-up|0|||
149985364|NCT00135330|541078941|FG001|Overall Study|Lost to Follow-up|2|||
149985365|NCT00135330|541078942|FG002|Overall Study|Lost to Follow-up|3|||
149985366|NCT00135330|541078940|FG000|Overall Study|Physician Decision|1|||
149985367|NCT00135330|541078941|FG001|Overall Study|Physician Decision|1|||
149985368|NCT00135330|541078942|FG002|Overall Study|Physician Decision|0|||
149985369|NCT00135330|541078940|FG000|Overall Study|Protocol Violation|4|||
149985370|NCT00135330|541078941|FG001|Overall Study|Protocol Violation|3|||
149985371|NCT00135330|541078942|FG002|Overall Study|Protocol Violation|3|||
149985372|NCT00135330|541078940|FG000|Overall Study|Patient Decision|5|||
149985373|NCT00135330|541078941|FG001|Overall Study|Patient Decision|1|||
149985374|NCT00135330|541078942|FG002|Overall Study|Patient Decision|4|||
149985375|NCT00135330|541078940|FG000|Overall Study|Sponsor Decision|0|||
149985376|NCT00135330|541078941|FG001|Overall Study|Sponsor Decision|1|||
149985377|NCT00135330|541078942|FG002|Overall Study|Sponsor Decision|0|||
149985378|NCT03520920|541078949|FG000|Overall Study|Death|13|||
150178757|NCT02139943|541792039|FG002|Overall Study|Adverse Event|2|||
149985379|NCT03520920|541078950|FG001|Overall Study|Death|1|||
149985380|NCT03520920|541078951|FG002|Overall Study|Death|0|||
149985381|NCT03520920|541078949|FG000|Overall Study|Withdrawal by Subject|2|||
149985382|NCT03520920|541078950|FG001|Overall Study|Withdrawal by Subject|1|||
149985383|NCT03520920|541078951|FG002|Overall Study|Withdrawal by Subject|0|||
149985384|NCT03520920|541078949|FG000|Overall Study|Study Terminated by the Sponsor|5|||
149985385|NCT03520920|541078950|FG001|Overall Study|Study Terminated by the Sponsor|14|||
149985386|NCT03520920|541078951|FG002|Overall Study|Study Terminated by the Sponsor|5|||
150178758|NCT02139943|541792037|FG000|Overall Study|Lost to Follow-up|3|||
150178759|NCT02139943|541792038|FG001|Overall Study|Lost to Follow-up|2|||
150178760|NCT02139943|541792039|FG002|Overall Study|Lost to Follow-up|2|||
149985387|NCT00988052|541078952|FG000|Overall Study|Missing|1|||
149985388|NCT00988052|541078953|FG001|Overall Study|Missing|0|||
149985389|NCT00988052|541078952|FG000|Overall Study|Teva requested subject withdrawal|3|||
149985390|NCT00988052|541078953|FG001|Overall Study|Teva requested subject withdrawal|1|||
149985391|NCT00988052|541078952|FG000|Overall Study|Death|1|||
149985392|NCT00988052|541078953|FG001|Overall Study|Death|3|||
149985393|NCT00988052|541078952|FG000|Overall Study|Protocol Violation|6|||
149985394|NCT00988052|541078953|FG001|Overall Study|Protocol Violation|5|||
149985395|NCT00988052|541078952|FG000|Overall Study|Pregnancy|6|||
149985396|NCT00988052|541078953|FG001|Overall Study|Pregnancy|6|||
149985397|NCT00988052|541078952|FG000|Overall Study|Lack of Efficacy|8|||
149985398|NCT00988052|541078953|FG001|Overall Study|Lack of Efficacy|7|||
149985399|NCT00988052|541078952|FG000|Overall Study|Lost to Follow-up|6|||
149985400|NCT00988052|541078953|FG001|Overall Study|Lost to Follow-up|11|||
149985401|NCT00988052|541078952|FG000|Overall Study|Physician Decision|27|||
149985402|NCT00988052|541078953|FG001|Overall Study|Physician Decision|28|||
149985403|NCT00988052|541078952|FG000|Overall Study|Adverse Event|35|||
149985404|NCT00988052|541078953|FG001|Overall Study|Adverse Event|28|||
149985405|NCT00988052|541078952|FG000|Overall Study|Withdrawal by Subject|90|||
149985406|NCT00988052|541078953|FG001|Overall Study|Withdrawal by Subject|91|||
149985407|NCT00988052|541078952|FG000|Overall Study|Study terminated by sponsor|240|||
149985408|NCT00988052|541078953|FG001|Overall Study|Study terminated by sponsor|236|||
149985409|NCT02997865|541078954|FG000|Overall Study|Death|2|||
149985410|NCT02997865|541078955|FG001|Overall Study|Death|1|||
149985411|NCT02997865|541078954|FG000|Overall Study|Lost to Follow-up|6|||
149985412|NCT02997865|541078955|FG001|Overall Study|Lost to Follow-up|3|||
149985413|NCT02997865|541078954|FG000|Overall Study|Withdrawal by Subject|5|||
149985414|NCT02997865|541078955|FG001|Overall Study|Withdrawal by Subject|0|||
149985415|NCT01119066|541078956|FG000|Overall Study|Withdrawal by Subject|4|||
149985416|NCT01119066|541078957|FG001|Overall Study|Withdrawal by Subject|6|||
149985417|NCT01119066|541078958|FG002|Overall Study|Withdrawal by Subject|0|||
149985418|NCT01119066|541078959|FG003|Overall Study|Withdrawal by Subject|0|||
149985419|NCT01119066|541078956|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
149985420|NCT01119066|541078957|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
149985421|NCT01119066|541078958|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
149985422|NCT01119066|541078959|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
149985423|NCT01119066|541078956|FG000|Overall Study|Relapse identified before transplant|1|||
149985424|NCT01119066|541078957|FG001|Overall Study|Relapse identified before transplant|0|||
149985425|NCT01119066|541078958|FG002|Overall Study|Relapse identified before transplant|0|||
149985426|NCT01119066|541078959|FG003|Overall Study|Relapse identified before transplant|0|||
149985427|NCT01119066|541078956|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
149985428|NCT01119066|541078957|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
149985429|NCT01119066|541078958|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
149985430|NCT01119066|541078959|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
149985431|NCT01119066|541078956|FG000|Overall Study|Relapse identified before transplant|0|||
149985432|NCT01119066|541078957|FG001|Overall Study|Relapse identified before transplant|4|||
149985433|NCT01119066|541078958|FG002|Overall Study|Relapse identified before transplant|0|||
149985434|NCT01119066|541078959|FG003|Overall Study|Relapse identified before transplant|0|||
149985435|NCT01945996|541078960|FG000|Overall Study|Lost to Follow-up|3|||
149985436|NCT01945996|541078961|FG001|Overall Study|Lost to Follow-up|5|||
149985437|NCT00271856|541078963|FG000|Overall Study|Withdrawal by Subject|1|||
149985438|NCT00271856|541078964|FG001|Overall Study|Withdrawal by Subject|7|||
149985439|NCT00271856|541078963|FG000|Overall Study|Lost to Follow-up|10|||
149985440|NCT00271856|541078964|FG001|Overall Study|Lost to Follow-up|11|||
149985441|NCT04599803|541078965|FG000|Overall Study|Withdrawal by Subject|5|||
149985442|NCT04599803|541078965|FG000|Overall Study|Lost to Follow-up|26|||
149985443|NCT01509846|541078966|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
149985444|NCT01509846|541078967|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
149985445|NCT01509846|541078968|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
149985446|NCT01509846|541078969|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
149985447|NCT01509846|541078970|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
149985448|NCT01509846|541078966|FG000|Received Vaccination 2|Illness|0|||
149985449|NCT01509846|541078967|FG001|Received Vaccination 2|Illness|0|||
149985450|NCT01509846|541078968|FG002|Received Vaccination 2|Illness|0|||
149985451|NCT01509846|541078969|FG003|Received Vaccination 2|Illness|0|||
149985452|NCT01509846|541078970|FG004|Received Vaccination 2|Illness|1|||
149985453|NCT01509846|541078966|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
150178761|NCT02139943|541792037|FG000|Overall Study|Withdrawal by Subject|4|||
150178762|NCT02139943|541792038|FG001|Overall Study|Withdrawal by Subject|3|||
149985454|NCT01509846|541078967|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
149985455|NCT01509846|541078968|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
149985456|NCT01509846|541078969|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
149985457|NCT01509846|541078970|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
149985458|NCT01509846|541078966|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
149985459|NCT01509846|541078967|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
149985460|NCT01509846|541078968|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
149985461|NCT01509846|541078969|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
149985462|NCT01509846|541078970|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
149985463|NCT01509846|541078966|FG000|Received Vaccination 3|Pregnancy|0|||
149985464|NCT01509846|541078967|FG001|Received Vaccination 3|Pregnancy|0|||
149985465|NCT01509846|541078968|FG002|Received Vaccination 3|Pregnancy|0|||
149985466|NCT01509846|541078969|FG003|Received Vaccination 3|Pregnancy|1|||
149985467|NCT01509846|541078970|FG004|Received Vaccination 3|Pregnancy|0|||
149985468|NCT01509846|541078966|FG000|Received Vaccination 3|Lost to Follow-up|0|||
149985469|NCT01509846|541078967|FG001|Received Vaccination 3|Lost to Follow-up|0|||
149985470|NCT01509846|541078968|FG002|Received Vaccination 3|Lost to Follow-up|1|||
149985471|NCT01509846|541078969|FG003|Received Vaccination 3|Lost to Follow-up|0|||
149985472|NCT01509846|541078970|FG004|Received Vaccination 3|Lost to Follow-up|0|||
149985473|NCT04677543|541078972|FG000|Overall Study|Withdrawal by Subject|4|||
149985474|NCT04677543|541078973|FG001|Overall Study|Withdrawal by Subject|1|||
149985475|NCT04677543|541078972|FG000|Overall Study|Physician Decision|0|||
149985476|NCT04677543|541078973|FG001|Overall Study|Physician Decision|1|||
149985477|NCT04677543|541078972|FG000|Overall Study|Adverse Event|0|||
149985478|NCT04677543|541078973|FG001|Overall Study|Adverse Event|1|||
149985479|NCT01437111|541078976|FG000|Overall Study|Adverse Event|2|||
149985480|NCT01437111|541078976|FG000|Overall Study|Withdrawal by Subject|4|||
149985481|NCT01437111|541078976|FG000|Overall Study|Not reported|5|||
149985482|NCT01437111|541078976|FG000|Overall Study|Physician Decision|1|||
149985483|NCT01437111|541078976|FG000|Overall Study|Lost to Follow-up|5|||
149985484|NCT01437111|541078976|FG000|Overall Study|Protocol Violation|1|||
149985485|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
149985486|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
149985487|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
149985488|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
149985489|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
149985490|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
149985491|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
149985492|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
149985493|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
149985494|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
149985495|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
149985496|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
149985497|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
149985498|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
149985499|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
149985500|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
149985501|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
149985502|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
149985503|NCT03162796|541078977|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
149985504|NCT03162796|541078978|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
149985505|NCT03162796|541078979|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
149985506|NCT03162796|541078977|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
149985507|NCT03162796|541078978|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
149985508|NCT03162796|541078979|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
149985509|NCT03162796|541078977|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
149985510|NCT03162796|541078978|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
149985511|NCT03162796|541078979|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
149985512|NCT03162796|541078977|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
149985513|NCT03162796|541078978|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
149985514|NCT03162796|541078979|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
149985515|NCT03162796|541078977|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
149985516|NCT03162796|541078978|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
149985517|NCT03162796|541078979|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
149985518|NCT02623205|541078983|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
149985519|NCT02623205|541078984|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
149985520|NCT02342288|541078985|FG000|Overall Study|no protocol anesthesiologist available|3|||
149985521|NCT02342288|541078986|FG001|Overall Study|no protocol anesthesiologist available|2|||
149985522|NCT02342288|541078985|FG000|Overall Study|anesthesia leak in system|1|||
149985523|NCT02342288|541078986|FG001|Overall Study|anesthesia leak in system|0|||
149985524|NCT02342288|541078985|FG000|Overall Study|Withdrawal by Subject|1|||
149985525|NCT02342288|541078986|FG001|Overall Study|Withdrawal by Subject|0|||
149985526|NCT02342288|541078985|FG000|Overall Study|coordinator contaminated with blood|0|||
149985527|NCT02342288|541078986|FG001|Overall Study|coordinator contaminated with blood|1|||
149985528|NCT02342288|541078985|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
149985529|NCT02342288|541078986|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
149985530|NCT02342288|541078985|FG000|Overall Study|coordinator not available|0|||
149985531|NCT02342288|541078986|FG001|Overall Study|coordinator not available|2|||
149985532|NCT01667133|541078988|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
149985533|NCT01667133|541078989|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
149985534|NCT01667133|541078990|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
149985535|NCT01667133|541078991|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
149985536|NCT01667133|541078992|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
149985537|NCT01667133|541078993|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
149985538|NCT01667133|541078994|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
149985539|NCT01667133|541078995|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
149985540|NCT01667133|541078996|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
149985541|NCT01667133|541078997|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
149985542|NCT01667133|541078998|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
149985543|NCT01667133|541078999|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
149985544|NCT01667133|541078988|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985545|NCT01667133|541078989|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985546|NCT01667133|541078990|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
149985547|NCT01667133|541078991|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985548|NCT01667133|541078992|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985549|NCT01667133|541078993|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985550|NCT01667133|541078994|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985551|NCT01667133|541078995|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985552|NCT01667133|541078996|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985553|NCT01667133|541078997|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985554|NCT01667133|541078998|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985555|NCT01667133|541078999|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
149985556|NCT01667133|541078988|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
149985557|NCT01667133|541078989|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
149985558|NCT01667133|541078990|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
149985559|NCT01667133|541078991|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
149985560|NCT01667133|541078992|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
149985561|NCT01667133|541078993|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
149985562|NCT01667133|541078994|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
149985563|NCT01667133|541078995|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
149985564|NCT01667133|541078996|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
149985565|NCT01667133|541078997|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
149985566|NCT01667133|541078998|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
149985567|NCT01667133|541078999|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
149985568|NCT01667133|541078988|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985569|NCT01667133|541078989|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985570|NCT01667133|541078990|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985571|NCT01667133|541078991|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
149985572|NCT01667133|541078992|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985573|NCT01667133|541078993|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985574|NCT01667133|541078994|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985575|NCT01667133|541078995|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985576|NCT01667133|541078996|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985577|NCT01667133|541078997|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985578|NCT01667133|541078998|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985579|NCT01667133|541078999|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
149985580|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
149985581|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
149985582|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
149985583|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
149985584|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
149985585|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
149985586|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
149985587|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
149985588|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
150178763|NCT02139943|541792039|FG002|Overall Study|Withdrawal by Subject|0|||
149985589|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
149985590|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
149985591|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
150178764|NCT02139943|541792037|FG000|Overall Study|Other|0|||
149985592|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985593|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985594|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985595|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985596|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985597|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985598|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985599|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985600|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985601|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
149985602|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985603|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
149985604|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
149985605|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
149985606|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
149985607|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
149985608|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
149985609|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
149985610|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
149985611|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
149985612|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
149985613|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
149985614|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
149985615|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
149985616|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985617|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985618|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985619|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985620|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985621|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985622|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985623|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985624|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985625|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
149985626|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985627|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
149985628|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Death|0|||
149985629|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Death|0|||
149985630|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Death|0|||
149985631|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Death|0|||
149985632|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Death|0|||
149985633|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Death|0|||
149985634|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Death|0|||
149985635|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Death|0|||
149985636|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Death|0|||
149985637|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Death|1|||
149985638|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Death|0|||
149985639|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Death|0|||
149985640|NCT01667133|541078988|FG000|Phase 2: Dose-expansion|Other|0|||
149985641|NCT01667133|541078989|FG001|Phase 2: Dose-expansion|Other|0|||
149985642|NCT01667133|541078990|FG002|Phase 2: Dose-expansion|Other|0|||
149985643|NCT01667133|541078991|FG003|Phase 2: Dose-expansion|Other|0|||
149985644|NCT01667133|541078992|FG004|Phase 2: Dose-expansion|Other|0|||
149985645|NCT01667133|541078993|FG005|Phase 2: Dose-expansion|Other|0|||
149985646|NCT01667133|541078994|FG006|Phase 2: Dose-expansion|Other|0|||
149985647|NCT01667133|541078995|FG007|Phase 2: Dose-expansion|Other|0|||
149985648|NCT01667133|541078996|FG008|Phase 2: Dose-expansion|Other|0|||
149985649|NCT01667133|541078997|FG009|Phase 2: Dose-expansion|Other|0|||
149985650|NCT01667133|541078998|FG010|Phase 2: Dose-expansion|Other|0|||
149985651|NCT01667133|541078999|FG011|Phase 2: Dose-expansion|Other|1|||
149985652|NCT00255723|541079005|FG000|Overall Study|Adverse Event|1|||
149985653|NCT00255723|541079006|FG001|Overall Study|Adverse Event|1|||
149985654|NCT00255723|541079005|FG000|Overall Study|Death|0|||
149985655|NCT00255723|541079006|FG001|Overall Study|Death|1|||
149985656|NCT00255723|541079005|FG000|Overall Study|Response Data Not Available|1|||
149985657|NCT00255723|541079006|FG001|Overall Study|Response Data Not Available|0|||
149985658|NCT03711370|541079008|FG000|Overall Study|Lost to Follow-up|16|||
149985659|NCT03711370|541079009|FG001|Overall Study|Lost to Follow-up|10|||
149985660|NCT03711370|541079008|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
149985661|NCT03711370|541079009|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
149985662|NCT04188834|541079010|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
149985663|NCT00553436|541079011|FG000|Overall Study|Conversion to another procedure|1|||
149985664|NCT01928433|541079013|FG000|Overall Study|Adverse Event|5|||
149985665|NCT01928433|541079014|FG001|Overall Study|Adverse Event|2|||
149985666|NCT01928433|541079015|FG002|Overall Study|Adverse Event|5|||
149985667|NCT01928433|541079013|FG000|Overall Study|Protocol Violation|0|||
149985668|NCT01928433|541079014|FG001|Overall Study|Protocol Violation|0|||
149985669|NCT01928433|541079015|FG002|Overall Study|Protocol Violation|2|||
149985670|NCT01928433|541079013|FG000|Overall Study|Lack of Efficacy|5|||
149985671|NCT01928433|541079014|FG001|Overall Study|Lack of Efficacy|4|||
149985672|NCT01928433|541079015|FG002|Overall Study|Lack of Efficacy|4|||
149985673|NCT01928433|541079013|FG000|Overall Study|Withdrawal by Subject|0|||
149985674|NCT01928433|541079014|FG001|Overall Study|Withdrawal by Subject|4|||
149985675|NCT01928433|541079015|FG002|Overall Study|Withdrawal by Subject|0|||
149985676|NCT01928433|541079013|FG000|Overall Study|Negative screening urine culture|7|||
149985677|NCT01928433|541079014|FG001|Overall Study|Negative screening urine culture|6|||
149985678|NCT01928433|541079015|FG002|Overall Study|Negative screening urine culture|10|||
149985679|NCT01928433|541079013|FG000|Overall Study|Lost to Follow-up|0|||
149985680|NCT01928433|541079014|FG001|Overall Study|Lost to Follow-up|2|||
149985681|NCT01928433|541079015|FG002|Overall Study|Lost to Follow-up|3|||
149985682|NCT01928433|541079013|FG000|Overall Study|Other reasons|3|||
149985683|NCT01928433|541079014|FG001|Overall Study|Other reasons|3|||
149985684|NCT01928433|541079015|FG002|Overall Study|Other reasons|4|||
149985685|NCT01740687|541079016|FG000|Overall Study|Lost to Follow-up|11|||
149985686|NCT01740687|541079016|FG000|Overall Study|Withdrawal by Subject|2|||
149985687|NCT01740687|541079016|FG000|Overall Study|other reason|22|||
149985688|NCT01740687|541079016|FG000|Overall Study|treatment not received|2|||
149985689|NCT03744910|541080591|FG000|Overall Study|Withdrew Consent|1|||
149985690|NCT03744910|541080592|FG001|Overall Study|Withdrew Consent|8|||
149985691|NCT03744910|541080591|FG000|Overall Study|Physician Decision|5|||
149985692|NCT03744910|541080592|FG001|Overall Study|Physician Decision|4|||
149985693|NCT03744910|541080591|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
149985694|NCT03744910|541080592|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
149985695|NCT03744910|541080591|FG000|Overall Study|Lost to Follow-up|0|||
149985696|NCT03744910|541080592|FG001|Overall Study|Lost to Follow-up|1|||
149985697|NCT03744910|541080591|FG000|Overall Study|Other-unspecified|4|||
149985698|NCT03744910|541080592|FG001|Overall Study|Other-unspecified|1|||
149985699|NCT00336284|541080596|FG000|Overall Study|Death|52|||
149985700|NCT00336284|541080597|FG001|Overall Study|Death|26|||
149985701|NCT00336284|541080596|FG000|Overall Study|Lost to Follow-up|82|||
149985702|NCT00336284|541080597|FG001|Overall Study|Lost to Follow-up|61|||
149985703|NCT00336284|541080596|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
149985704|NCT00336284|541080597|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
149985705|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
149985706|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
149985707|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
149985708|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
149985709|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
149985710|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
149985711|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
149985712|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
149985713|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
149985714|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
149985715|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
149985716|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
149985717|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
149985718|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
149985719|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
149985720|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
149985721|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
149985722|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
149985723|NCT03308968|541080598|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
149985724|NCT03308968|541080599|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
149985725|NCT03308968|541080600|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
149985726|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
149985727|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
149985728|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
149985729|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
149985730|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
149985731|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
149985732|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
149985733|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
149985734|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
149985735|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
149985736|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
149985737|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
149985738|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
149985739|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
149985740|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
149985741|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
149985742|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
149985743|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
149985744|NCT03308968|541080598|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
149985745|NCT03308968|541080599|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
149985746|NCT03308968|541080600|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
149985747|NCT00473889|541080602|FG000|Overall Study|Did not receive study medication|1|||
149985748|NCT00473889|541080603|FG001|Overall Study|Did not receive study medication|4|||
149985749|NCT00473889|541080602|FG000|Overall Study|Adverse Event|30|||
149985750|NCT00473889|541080603|FG001|Overall Study|Adverse Event|17|||
149985751|NCT00473889|541080602|FG000|Overall Study|Protocol Violation|4|||
149985752|NCT00473889|541080603|FG001|Overall Study|Protocol Violation|2|||
149985753|NCT00473889|541080602|FG000|Overall Study|Lack of Efficacy|28|||
149985754|NCT00473889|541080603|FG001|Overall Study|Lack of Efficacy|29|||
149985755|NCT00473889|541080602|FG000|Overall Study|Lost to Follow-up|2|||
149985756|NCT00473889|541080603|FG001|Overall Study|Lost to Follow-up|1|||
149985757|NCT00473889|541080602|FG000|Overall Study|Physician Decision|10|||
149985758|NCT00473889|541080603|FG001|Overall Study|Physician Decision|5|||
149985759|NCT00473889|541080602|FG000|Overall Study|Trial Terminated|3|||
149985760|NCT00473889|541080603|FG001|Overall Study|Trial Terminated|6|||
149985761|NCT00473889|541080602|FG000|Overall Study|Withdrawal by Subject|5|||
149985762|NCT00473889|541080603|FG001|Overall Study|Withdrawal by Subject|0|||
149985763|NCT04729972|541080604|FG000|Overall Study|Adverse Event|1|||
149985764|NCT01208324|541080605|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
149985765|NCT01208324|541080606|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
149985766|NCT01208324|541080607|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
149985767|NCT01208324|541080608|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
149985768|NCT00700622|541080615|FG000|Overall Study|Adverse Event|4|||
149985769|NCT00700622|541080616|FG001|Overall Study|Adverse Event|0|||
149985770|NCT00700622|541080615|FG000|Overall Study|Lost to Follow-up|0|||
149985771|NCT00700622|541080616|FG001|Overall Study|Lost to Follow-up|1|||
149985772|NCT00700622|541080615|FG000|Overall Study|Physician Decision|2|||
149985773|NCT00700622|541080616|FG001|Overall Study|Physician Decision|1|||
149985774|NCT00700622|541080615|FG000|Overall Study|Protocol Violation|0|||
149985775|NCT00700622|541080616|FG001|Overall Study|Protocol Violation|1|||
149985776|NCT00700622|541080615|FG000|Overall Study|Withdrawal by Subject|4|||
149985777|NCT00700622|541080616|FG001|Overall Study|Withdrawal by Subject|1|||
149985778|NCT00700622|541080615|FG000|Overall Study|Other|3|||
149985779|NCT00700622|541080616|FG001|Overall Study|Other|1|||
149985780|NCT00383331|541080617|FG000|Overall Study|Protocol Violation|0|||
149985781|NCT00383331|541080618|FG001|Overall Study|Protocol Violation|1|||
149985782|NCT02253433|541080619|FG000|Overall Study|Unable to Contact|9|||
149985783|NCT02253433|541080620|FG001|Overall Study|Unable to Contact|16|||
149985784|NCT02253433|541080619|FG000|Overall Study|Death|1|||
149985785|NCT02253433|541080620|FG001|Overall Study|Death|1|||
149985786|NCT02253433|541080619|FG000|Overall Study|No Longer Interested|3|||
149985787|NCT02253433|541080620|FG001|Overall Study|No Longer Interested|15|||
149985788|NCT02253433|541080619|FG000|Overall Study|Out of Study Area|2|||
149985789|NCT02253433|541080620|FG001|Overall Study|Out of Study Area|7|||
149985790|NCT02253433|541080619|FG000|Overall Study|Uncomfortable with home visitors|0|||
149985791|NCT02253433|541080620|FG001|Overall Study|Uncomfortable with home visitors|3|||
149985792|NCT02253433|541080619|FG000|Overall Study|Unstable Housing/Homeless|0|||
149985793|NCT02253433|541080620|FG001|Overall Study|Unstable Housing/Homeless|7|||
149985794|NCT02253433|541080619|FG000|Overall Study|Too Busy|0|||
149985795|NCT02253433|541080620|FG001|Overall Study|Too Busy|4|||
149985796|NCT02253433|541080619|FG000|Overall Study|Medical or Other Concerns|1|||
149985797|NCT02253433|541080620|FG001|Overall Study|Medical or Other Concerns|2|||
149985798|NCT02229825|541080626|FG000|Overall Study|Personal Reasons|0|||
149985799|NCT02229825|541080627|FG001|Overall Study|Personal Reasons|1|||
149985800|NCT02229825|541080626|FG000|Overall Study|Refused continuing medication|7|||
149985801|NCT02229825|541080627|FG001|Overall Study|Refused continuing medication|6|||
149985802|NCT02229825|541080626|FG000|Overall Study|Lost to Follow-up|1|||
149985803|NCT02229825|541080627|FG001|Overall Study|Lost to Follow-up|2|||
149985804|NCT02229825|541080626|FG000|Overall Study|Protocol Violation|1|||
149985805|NCT02229825|541080627|FG001|Overall Study|Protocol Violation|1|||
149985806|NCT02229825|541080626|FG000|Overall Study|Lack of Efficacy|4|||
149985807|NCT02229825|541080627|FG001|Overall Study|Lack of Efficacy|10|||
149985808|NCT02229825|541080626|FG000|Overall Study|Adverse Event|11|||
149985809|NCT02229825|541080627|FG001|Overall Study|Adverse Event|9|||
149985810|NCT02229825|541080626|FG000|Overall Study|Not treated|0|||
149985811|NCT02229825|541080627|FG001|Overall Study|Not treated|1|||
149985812|NCT00372619|541080628|FG000|Overall Study|Ineligible|0|||
149985813|NCT00372619|541080629|FG001|Overall Study|Ineligible|0|||
149985814|NCT00372619|541080630|FG002|Overall Study|Ineligible|0|||
149985815|NCT00372619|541080631|FG003|Overall Study|Ineligible|0|||
149985816|NCT00372619|541080632|FG004|Overall Study|Ineligible|0|||
149985817|NCT00372619|541080633|FG005|Overall Study|Ineligible|2|||
149985818|NCT00372619|541080634|FG006|Overall Study|Ineligible|0|||
149985819|NCT00372619|541080628|FG000|Overall Study|Inevaluable|0|||
149985820|NCT00372619|541080629|FG001|Overall Study|Inevaluable|0|||
149985821|NCT00372619|541080630|FG002|Overall Study|Inevaluable|0|||
149985822|NCT00372619|541080631|FG003|Overall Study|Inevaluable|0|||
149985823|NCT00372619|541080632|FG004|Overall Study|Inevaluable|0|||
149985824|NCT00372619|541080633|FG005|Overall Study|Inevaluable|1|||
149985825|NCT00372619|541080634|FG006|Overall Study|Inevaluable|0|||
149985826|NCT00066222|541080635|FG000|Overall Study|No protocol treatment received|1|||
149985827|NCT00405392|541080636|FG000|Overall Study|Adverse Event|15|||
149985828|NCT00405392|541080637|FG001|Overall Study|Adverse Event|14|||
149985829|NCT00405392|541080636|FG000|Overall Study|Did not meet Eligibility criteria|7|||
149985830|NCT00405392|541080637|FG001|Overall Study|Did not meet Eligibility criteria|2|||
149985831|NCT00405392|541080636|FG000|Overall Study|Withdrawal by Subject|4|||
149985832|NCT00405392|541080637|FG001|Overall Study|Withdrawal by Subject|3|||
149985833|NCT00405392|541080636|FG000|Overall Study|Lost to Follow-up|1|||
149985834|NCT00405392|541080637|FG001|Overall Study|Lost to Follow-up|2|||
149985835|NCT00405392|541080636|FG000|Overall Study|Data missing|2|||
149985836|NCT00405392|541080637|FG001|Overall Study|Data missing|0|||
149985837|NCT00405392|541080636|FG000|Overall Study|Non-compliance|0|||
149985838|NCT00405392|541080637|FG001|Overall Study|Non-compliance|1|||
149985839|NCT00405392|541080636|FG000|Overall Study|Other|1|||
149985840|NCT00405392|541080637|FG001|Overall Study|Other|5|||
149985841|NCT02689206|541080639|FG000|Overall Study|Adverse Event|0|||
149985842|NCT02689206|541080640|FG001|Overall Study|Adverse Event|0|||
149985843|NCT02689206|541080641|FG002|Overall Study|Adverse Event|1|||
149985844|NCT02689206|541080642|FG003|Overall Study|Adverse Event|0|||
149985845|NCT02689206|541080643|FG004|Overall Study|Adverse Event|2|||
149985846|NCT02689206|541080639|FG000|Overall Study|Protocol Violation|1|||
149985847|NCT02689206|541080640|FG001|Overall Study|Protocol Violation|0|||
149985848|NCT02689206|541080641|FG002|Overall Study|Protocol Violation|0|||
149985849|NCT02689206|541080642|FG003|Overall Study|Protocol Violation|1|||
149985850|NCT02689206|541080643|FG004|Overall Study|Protocol Violation|2|||
149985851|NCT02689206|541080639|FG000|Overall Study|Other: Reached stopping criteria|0|||
149985852|NCT02689206|541080640|FG001|Overall Study|Other: Reached stopping criteria|1|||
149985853|NCT02689206|541080641|FG002|Overall Study|Other: Reached stopping criteria|2|||
149985854|NCT02689206|541080642|FG003|Overall Study|Other: Reached stopping criteria|3|||
149985855|NCT02689206|541080643|FG004|Overall Study|Other: Reached stopping criteria|4|||
149985856|NCT02689206|541080639|FG000|Overall Study|Physician Decision|1|||
149985857|NCT02689206|541080640|FG001|Overall Study|Physician Decision|0|||
149985858|NCT02689206|541080641|FG002|Overall Study|Physician Decision|0|||
149985859|NCT02689206|541080642|FG003|Overall Study|Physician Decision|0|||
149985860|NCT02689206|541080643|FG004|Overall Study|Physician Decision|0|||
149985861|NCT02689206|541080639|FG000|Overall Study|Withdrawal by Subject|1|||
149985862|NCT02689206|541080640|FG001|Overall Study|Withdrawal by Subject|0|||
149985863|NCT02689206|541080641|FG002|Overall Study|Withdrawal by Subject|1|||
149985864|NCT02689206|541080642|FG003|Overall Study|Withdrawal by Subject|0|||
149985865|NCT02689206|541080643|FG004|Overall Study|Withdrawal by Subject|0|||
149985866|NCT02998671|541080644|FG000|Period 1|Study Terminated By Sponsor|2|||
149985867|NCT02998671|541080645|FG001|Period 1|Study Terminated By Sponsor|1|||
149985868|NCT02998671|541080646|FG002|Period 1|Study Terminated By Sponsor|0|||
149985869|NCT02998671|541080647|FG003|Period 1|Study Terminated By Sponsor|0|||
149985870|NCT02998671|541080648|FG004|Period 1|Study Terminated By Sponsor|1|||
149985871|NCT02998671|541080644|FG000|Period 1|Withdrawal by Subject|1|||
149985872|NCT02998671|541080645|FG001|Period 1|Withdrawal by Subject|2|||
149985873|NCT02998671|541080646|FG002|Period 1|Withdrawal by Subject|0|||
149985874|NCT02998671|541080647|FG003|Period 1|Withdrawal by Subject|0|||
149985875|NCT02998671|541080648|FG004|Period 1|Withdrawal by Subject|2|||
149985876|NCT02998671|541080644|FG000|Period 1|Pregnancy|1|||
149985877|NCT02998671|541080645|FG001|Period 1|Pregnancy|0|||
149985878|NCT02998671|541080646|FG002|Period 1|Pregnancy|0|||
149985879|NCT02998671|541080647|FG003|Period 1|Pregnancy|0|||
149985880|NCT02998671|541080648|FG004|Period 1|Pregnancy|0|||
149985881|NCT02998671|541080644|FG000|Period 1|Adverse Event|0|||
149985882|NCT02998671|541080645|FG001|Period 1|Adverse Event|0|||
149985883|NCT02998671|541080646|FG002|Period 1|Adverse Event|0|||
149985884|NCT02998671|541080647|FG003|Period 1|Adverse Event|0|||
149985885|NCT02998671|541080648|FG004|Period 1|Adverse Event|1|||
149985886|NCT02998671|541080644|FG000|Period 2|Adverse Event|0|||
149985887|NCT02998671|541080645|FG001|Period 2|Adverse Event|1|||
149985888|NCT02998671|541080646|FG002|Period 2|Adverse Event|0|||
149985889|NCT02998671|541080647|FG003|Period 2|Adverse Event|0|||
149985890|NCT02998671|541080648|FG004|Period 2|Adverse Event|0|||
149985891|NCT02998671|541080644|FG000|Period 2|Study Terminated By Sponsor|3|||
149985892|NCT02998671|541080645|FG001|Period 2|Study Terminated By Sponsor|5|||
149985893|NCT02998671|541080646|FG002|Period 2|Study Terminated By Sponsor|1|||
149985894|NCT02998671|541080647|FG003|Period 2|Study Terminated By Sponsor|3|||
149985895|NCT02998671|541080648|FG004|Period 2|Study Terminated By Sponsor|0|||
149985896|NCT02998671|541080644|FG000|Period 2|Withdrawal by Subject|0|||
149985897|NCT02998671|541080645|FG001|Period 2|Withdrawal by Subject|1|||
149985898|NCT02998671|541080646|FG002|Period 2|Withdrawal by Subject|0|||
149985899|NCT02998671|541080647|FG003|Period 2|Withdrawal by Subject|0|||
149985900|NCT02998671|541080648|FG004|Period 2|Withdrawal by Subject|0|||
149985901|NCT02998671|541080644|FG000|Period 2|Lost to Follow-up|0|||
149985902|NCT02998671|541080645|FG001|Period 2|Lost to Follow-up|0|||
149985903|NCT02998671|541080646|FG002|Period 2|Lost to Follow-up|0|||
149985904|NCT02998671|541080647|FG003|Period 2|Lost to Follow-up|1|||
149985905|NCT02998671|541080648|FG004|Period 2|Lost to Follow-up|0|||
149985906|NCT02131311|541080651|FG000|Overall Study|Adverse Event|2|||
149985907|NCT02131311|541080651|FG000|Overall Study|Protocol Violation|1|||
149985908|NCT02131311|541080651|FG000|Overall Study|Lost to Follow-up|1|||
149985909|NCT01479764|541080652|FG000|Randomized|Adverse Event|1|||
149985910|NCT01479764|541080653|FG001|Randomized|Adverse Event|1|||
149985911|NCT01479764|541080652|FG000|Randomized|Withdrawal by Subject|1|||
149985912|NCT01479764|541080653|FG001|Randomized|Withdrawal by Subject|0|||
149985913|NCT01479764|541080652|FG000|Treated|Lost to Follow-up|0|||
149985914|NCT01479764|541080653|FG001|Treated|Lost to Follow-up|2|||
149985915|NCT02473471|541080654|FG000|Overall Study|poor oral hygiene|2|||
149985916|NCT02473471|541080654|FG000|Overall Study|Lost to Follow-up|1|||
149985917|NCT03082677|541080655|FG000|Overall Study|Not Treated|2|||
149985918|NCT00191945|541080656|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
149985919|NCT00191945|541080657|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
149985920|NCT00191945|541080656|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
149985921|NCT00191945|541080657|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
149985922|NCT00191945|541080656|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
149985923|NCT00191945|541080657|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
149985924|NCT00191945|541080656|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
149985925|NCT00191945|541080657|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
149985926|NCT02063984|541080659|FG000|Overall Study|Lost to Follow-up|6|||
149985927|NCT02063984|541080660|FG001|Overall Study|Lost to Follow-up|5|||
149985928|NCT01169701|541080665|FG000|Overall Study|Lost to Follow-up|1|||
149985929|NCT01169701|541080666|FG001|Overall Study|Lost to Follow-up|1|||
149985930|NCT01169701|541080665|FG000|Overall Study|Withdrawal by Subject|1|||
149985931|NCT01169701|541080666|FG001|Overall Study|Withdrawal by Subject|3|||
149985932|NCT01169701|541080665|FG000|Overall Study|Adverse Event|1|||
149985933|NCT01169701|541080666|FG001|Overall Study|Adverse Event|2|||
149985934|NCT01169701|541080665|FG000|Overall Study|Exclusion criteria|2|||
149985935|NCT01169701|541080666|FG001|Overall Study|Exclusion criteria|0|||
149985936|NCT01169701|541080665|FG000|Overall Study|Death|0|||
149985937|NCT01169701|541080666|FG001|Overall Study|Death|1|||
149985938|NCT01169701|541080665|FG000|Overall Study|Administrative problems|0|||
149985939|NCT01169701|541080666|FG001|Overall Study|Administrative problems|1|||
149985940|NCT01169701|541080665|FG000|Overall Study|Serious adverse event|0|||
149985941|NCT01169701|541080666|FG001|Overall Study|Serious adverse event|1|||
149985942|NCT01169701|541080665|FG000|Overall Study|Sponsor decision|0|||
149985943|NCT01169701|541080666|FG001|Overall Study|Sponsor decision|1|||
149985944|NCT02455336|541080669|FG000|Overall Study|Withdrawal by Subject|0|||
149985945|NCT02455336|541080670|FG001|Overall Study|Withdrawal by Subject|2|||
149985946|NCT02455336|541080669|FG000|Overall Study|Adverse Event|3|||
149985947|NCT02455336|541080670|FG001|Overall Study|Adverse Event|0|||
149985948|NCT02455336|541080669|FG000|Overall Study|Non-responder to treatment|2|||
150053524|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
149985949|NCT02455336|541080670|FG001|Overall Study|Non-responder to treatment|0|||
149985950|NCT00391430|541080671|FG000|Overall Study|Withdrawal by Subject|3|||
149985951|NCT00391430|541080672|FG001|Overall Study|Withdrawal by Subject|0|||
149985952|NCT00391430|541080673|FG002|Overall Study|Withdrawal by Subject|12|||
149985953|NCT00429182|541080675|FG000|Overall Study|Not evaluable, Disease Progression|2|||
149985954|NCT00429182|541080675|FG000|Overall Study|Not eligible|5|||
149985955|NCT03497039|541080676|FG000|Overall Study|Withdrawal by Subject|1|||
149985956|NCT03497039|541080677|FG001|Overall Study|Withdrawal by Subject|0|||
149985957|NCT03497039|541080676|FG000|Overall Study|Protocol Violation|0|||
149985958|NCT03497039|541080677|FG001|Overall Study|Protocol Violation|1|||
149985959|NCT00861692|541080679|FG000|Overall Study|Death|6|||
149985960|NCT02712996|541080683|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
149985961|NCT02712996|541080684|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
149985962|NCT01451749|541080688|FG000|Overall Study|Protocol Violation|14|||
149985963|NCT01451749|541080689|FG001|Overall Study|Protocol Violation|7|||
149985964|NCT01451749|541080688|FG000|Overall Study|Lost to Follow-up|15|||
149985965|NCT01451749|541080689|FG001|Overall Study|Lost to Follow-up|5|||
149985966|NCT01451749|541080688|FG000|Overall Study|Meet the exclusion criteria,and|1|||
149985967|NCT01451749|541080689|FG001|Overall Study|Meet the exclusion criteria,and|1|||
149985968|NCT01451749|541080688|FG000|Overall Study|Adverse Event|2|||
149985969|NCT01451749|541080689|FG001|Overall Study|Adverse Event|0|||
149985970|NCT01451749|541080688|FG000|Overall Study|Withdrawal by Subject|0|||
149985971|NCT01451749|541080689|FG001|Overall Study|Withdrawal by Subject|1|||
149985972|NCT00972517|541080692|FG000|Overall Study|Adverse Event|0|||
149985973|NCT00972517|541080693|FG001|Overall Study|Adverse Event|0|||
149985974|NCT00972517|541080694|FG002|Overall Study|Adverse Event|0|||
149985975|NCT00972517|541080695|FG003|Overall Study|Adverse Event|1|||
149985976|NCT00972517|541080696|FG004|Overall Study|Adverse Event|0|||
149985977|NCT00972517|541080697|FG005|Overall Study|Adverse Event|0|||
149985978|NCT00972517|541080692|FG000|Overall Study|Withdrawal by Subject|0|||
149985979|NCT00972517|541080693|FG001|Overall Study|Withdrawal by Subject|1|||
149985980|NCT00972517|541080694|FG002|Overall Study|Withdrawal by Subject|0|||
149985981|NCT00972517|541080695|FG003|Overall Study|Withdrawal by Subject|2|||
149985982|NCT00972517|541080696|FG004|Overall Study|Withdrawal by Subject|1|||
149985983|NCT00972517|541080697|FG005|Overall Study|Withdrawal by Subject|0|||
149985984|NCT02311881|541080698|FG000|Overall Study|Did not meet the study criteria|2|||
149985985|NCT02311881|541080699|FG001|Overall Study|Did not meet the study criteria|2|||
149985986|NCT02311881|541080700|FG002|Overall Study|Did not meet the study criteria|0|||
149985987|NCT02311881|541080698|FG000|Overall Study|Adverse Event|7|||
149985988|NCT02311881|541080699|FG001|Overall Study|Adverse Event|15|||
149985989|NCT02311881|541080700|FG002|Overall Study|Adverse Event|8|||
149985990|NCT02311881|541080698|FG000|Overall Study|Lost to Follow-up|3|||
149985991|NCT02311881|541080699|FG001|Overall Study|Lost to Follow-up|3|||
149985992|NCT02311881|541080700|FG002|Overall Study|Lost to Follow-up|2|||
149985993|NCT02311881|541080698|FG000|Overall Study|Protocol Violation|1|||
149985994|NCT02311881|541080699|FG001|Overall Study|Protocol Violation|2|||
149985995|NCT02311881|541080700|FG002|Overall Study|Protocol Violation|3|||
149985996|NCT02311881|541080698|FG000|Overall Study|Withdrawal of consent|14|||
149985997|NCT02311881|541080699|FG001|Overall Study|Withdrawal of consent|16|||
149985998|NCT02311881|541080700|FG002|Overall Study|Withdrawal of consent|17|||
149985999|NCT02311881|541080698|FG000|Overall Study|Other|0|||
149986000|NCT02311881|541080699|FG001|Overall Study|Other|0|||
149986001|NCT02311881|541080700|FG002|Overall Study|Other|1|||
149986002|NCT02311881|541080698|FG000|Overall Study|Lack of Efficacy|1|||
149986003|NCT02311881|541080699|FG001|Overall Study|Lack of Efficacy|2|||
149986004|NCT02311881|541080700|FG002|Overall Study|Lack of Efficacy|0|||
149986005|NCT02311881|541080698|FG000|Overall Study|Subject has border line pregnancy test|1|||
149986006|NCT02311881|541080699|FG001|Overall Study|Subject has border line pregnancy test|0|||
149986007|NCT02311881|541080700|FG002|Overall Study|Subject has border line pregnancy test|0|||
149986008|NCT02311881|541080698|FG000|Overall Study|Withdrawal by Subject|3|||
149986009|NCT02311881|541080699|FG001|Overall Study|Withdrawal by Subject|1|||
149986010|NCT02311881|541080700|FG002|Overall Study|Withdrawal by Subject|4|||
149986011|NCT02311881|541080698|FG000|Overall Study|Sponsor Decision|1|||
149986012|NCT02311881|541080699|FG001|Overall Study|Sponsor Decision|1|||
149986013|NCT02311881|541080700|FG002|Overall Study|Sponsor Decision|1|||
149986014|NCT02311881|541080698|FG000|Overall Study|Protocol Deviation|1|||
149986015|NCT02311881|541080699|FG001|Overall Study|Protocol Deviation|0|||
149986016|NCT02311881|541080700|FG002|Overall Study|Protocol Deviation|0|||
149986017|NCT02311881|541080698|FG000|Overall Study|Non-Compliance|1|||
149986018|NCT02311881|541080699|FG001|Overall Study|Non-Compliance|0|||
149986019|NCT02311881|541080700|FG002|Overall Study|Non-Compliance|2|||
149986020|NCT02311881|541080698|FG000|Overall Study|Physician Decision|0|||
149986021|NCT02311881|541080699|FG001|Overall Study|Physician Decision|0|||
149986022|NCT02311881|541080700|FG002|Overall Study|Physician Decision|1|||
149986023|NCT02311881|541080698|FG000|Overall Study|Medical Monitor Discretion|0|||
149986024|NCT02311881|541080699|FG001|Overall Study|Medical Monitor Discretion|0|||
149986025|NCT02311881|541080700|FG002|Overall Study|Medical Monitor Discretion|1|||
149986026|NCT02311881|541080698|FG000|Overall Study|Participant taking another medication|0|||
149986027|NCT02311881|541080699|FG001|Overall Study|Participant taking another medication|0|||
149986028|NCT02311881|541080700|FG002|Overall Study|Participant taking another medication|1|||
149986029|NCT02311881|541080698|FG000|Overall Study|Serious Adverse Event|0|||
149986030|NCT02311881|541080699|FG001|Overall Study|Serious Adverse Event|1|||
149986031|NCT02311881|541080700|FG002|Overall Study|Serious Adverse Event|0|||
149986032|NCT02195700|541080709|FG000|Overall Study|Protocol Violation|0|||
149986033|NCT02195700|541080710|FG001|Overall Study|Protocol Violation|2|||
149986034|NCT02195700|541080709|FG000|Overall Study|Noncompliance|1|||
149986035|NCT02195700|541080710|FG001|Overall Study|Noncompliance|0|||
149986036|NCT02195700|541080709|FG000|Overall Study|Adverse Event|1|||
149986037|NCT02195700|541080710|FG001|Overall Study|Adverse Event|2|||
149986038|NCT02195700|541080709|FG000|Overall Study|Withdrawal by Subject|3|||
149986039|NCT02195700|541080710|FG001|Overall Study|Withdrawal by Subject|2|||
149986040|NCT02195700|541080709|FG000|Overall Study|Lost to Follow-up|1|||
149986041|NCT02195700|541080710|FG001|Overall Study|Lost to Follow-up|1|||
149986042|NCT01963767|541080711|FG000|Overall Study|Withdrawal by Subject|4|||
149986043|NCT01963767|541080712|FG001|Overall Study|Withdrawal by Subject|2|||
149986044|NCT01963767|541080711|FG000|Overall Study|Adverse Event|2|||
149986045|NCT01963767|541080712|FG001|Overall Study|Adverse Event|0|||
149986046|NCT02949024|541080715|FG000|Overall Study|Withdrawal by Subject|0|||
149986047|NCT02949024|541080716|FG001|Overall Study|Withdrawal by Subject|1|||
149986048|NCT01082081|541080717|FG000|Overall Study|Lost to Follow-up|0|||
149986049|NCT01082081|541080718|FG001|Overall Study|Lost to Follow-up|0|||
149986050|NCT01082081|541080719|FG002|Overall Study|Lost to Follow-up|1|||
149986051|NCT01082081|541080717|FG000|Overall Study|Withdrawal by Subject|0|||
149986052|NCT01082081|541080718|FG001|Overall Study|Withdrawal by Subject|0|||
149986053|NCT01082081|541080719|FG002|Overall Study|Withdrawal by Subject|1|||
149986054|NCT01082081|541080717|FG000|Overall Study|Other Reason|0|||
149986055|NCT01082081|541080718|FG001|Overall Study|Other Reason|1|||
149986056|NCT01082081|541080719|FG002|Overall Study|Other Reason|0|||
149986057|NCT00670930|541080720|FG000|Overall Study|Adminstrative Problem|0|||
149986058|NCT00670930|541080721|FG001|Overall Study|Adminstrative Problem|1|||
149986059|NCT00670930|541080720|FG000|Overall Study|Lost to Follow-up|1|||
149986060|NCT00670930|541080721|FG001|Overall Study|Lost to Follow-up|0|||
149986061|NCT01042158|541080722|FG000|Overall Study|Physician Decision|1|||
149986062|NCT01575808|541080724|FG000|Overall Study|Death|2|||
149986063|NCT01575808|541080725|FG001|Overall Study|Death|0|||
149986064|NCT01575808|541080724|FG000|Overall Study|Withdrawal by Subject|1|||
149986065|NCT01575808|541080725|FG001|Overall Study|Withdrawal by Subject|0|||
150178765|NCT02139943|541792038|FG001|Overall Study|Other|0|||
150178766|NCT02139943|541792039|FG002|Overall Study|Other|1|||
150178767|NCT02139943|541792037|FG000|Overall Study|Participant wishes to discontinue|2|||
150178768|NCT02139943|541792038|FG001|Overall Study|Participant wishes to discontinue|0|||
149986066|NCT03280303|541082606|FG000|Overall Study|Death|505|||
149986067|NCT03280303|541082606|FG000|Overall Study|Study terminated by sponsor|383|||
150178769|NCT02139943|541792039|FG002|Overall Study|Participant wishes to discontinue|0|||
150178770|NCT02139943|541792037|FG000|Overall Study|Participant in Poor Compliance|1|||
150178771|NCT02139943|541792038|FG001|Overall Study|Participant in Poor Compliance|0|||
150178772|NCT02139943|541792039|FG002|Overall Study|Participant in Poor Compliance|1|||
150178773|NCT02139943|541792037|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
150178774|NCT02139943|541792038|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
150178775|NCT02139943|541792039|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
150178776|NCT02299375|541792042|FG000|Overall Study|Adverse Event, serious fatal|1|||
150178777|NCT02299375|541792043|FG001|Overall Study|Adverse Event, serious fatal|3|||
150178778|NCT02299375|541792042|FG000|Overall Study|Adverse Event, non-fatal|8|||
150178779|NCT02299375|541792043|FG001|Overall Study|Adverse Event, non-fatal|9|||
150178780|NCT02299375|541792042|FG000|Overall Study|Lack of Efficacy|1|||
150178781|NCT02299375|541792043|FG001|Overall Study|Lack of Efficacy|3|||
150178782|NCT02299375|541792042|FG000|Overall Study|Protocol Violation|1|||
149986068|NCT03280303|541082606|FG000|Overall Study|Other|148|||
149986069|NCT03280303|541082606|FG000|Overall Study|No longer willing to participate in study|101|||
149986070|NCT03280303|541082606|FG000|Overall Study|Lost to follow up|39|||
149986071|NCT03280303|541082606|FG000|Overall Study|Adverse Event|20|||
149986072|NCT00948857|541082607|FG000|Overall Study|Lost to Follow-up|1|||
149986073|NCT00948857|541082608|FG001|Overall Study|Lost to Follow-up|0|||
149986074|NCT03430843|541082609|FG000|Overall Study|Death|233|||
149986075|NCT03430843|541082610|FG001|Overall Study|Death|233|||
149986076|NCT03430843|541082609|FG000|Overall Study|Sponsor Decision|17|||
149986077|NCT03430843|541082610|FG001|Overall Study|Sponsor Decision|6|||
150178783|NCT02299375|541792043|FG001|Overall Study|Protocol Violation|3|||
149986078|NCT03430843|541082609|FG000|Overall Study|Withdrawal by Subject|5|||
150178784|NCT02299375|541792042|FG000|Overall Study|Other: Met stopping criteria|1|||
149986079|NCT03430843|541082610|FG001|Overall Study|Withdrawal by Subject|14|||
149986080|NCT03430843|541082609|FG000|Overall Study|Lost to Follow-up|1|||
150178785|NCT02299375|541792043|FG001|Overall Study|Other: Met stopping criteria|0|||
149986081|NCT03430843|541082610|FG001|Overall Study|Lost to Follow-up|3|||
149986082|NCT05360966|541082615|FG000|Overall Study|Adverse Event|5|||
150178786|NCT02299375|541792042|FG000|Overall Study|Other: Study closed/terminated|66|||
150178787|NCT02299375|541792043|FG001|Overall Study|Other: Study closed/terminated|55|||
150178788|NCT02299375|541792042|FG000|Overall Study|Lost to Follow-up|0|||
149986083|NCT05360966|541082616|FG001|Overall Study|Adverse Event|5|||
149986084|NCT05360966|541082615|FG000|Overall Study|Withdrawal of Consent|5|||
149986085|NCT05360966|541082616|FG001|Overall Study|Withdrawal of Consent|3|||
149986086|NCT05360966|541082615|FG000|Overall Study|Noncompliance|2|||
150053525|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
150053526|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
149986087|NCT05360966|541082616|FG001|Overall Study|Noncompliance|1|||
149986088|NCT05360966|541082615|FG000|Overall Study|Lost to Follow-up|2|||
149986089|NCT05360966|541082616|FG001|Overall Study|Lost to Follow-up|3|||
149986090|NCT05360966|541082615|FG000|Overall Study|Protocol Deviation|2|||
149986091|NCT05360966|541082616|FG001|Overall Study|Protocol Deviation|1|||
149986092|NCT05360966|541082615|FG000|Overall Study|As specified in the Clinical Study Report|1|||
149986093|NCT05360966|541082616|FG001|Overall Study|As specified in the Clinical Study Report|3|||
149986094|NCT04439539|541082617|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
149986095|NCT04439539|541082618|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
149986096|NCT04439539|541082619|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
149986097|NCT04439539|541082617|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
149986098|NCT04439539|541082618|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
149986099|NCT04439539|541082619|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
149986100|NCT04439539|541082617|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
149986101|NCT04439539|541082618|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
149986102|NCT04439539|541082619|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
149986103|NCT05258890|541082621|FG000|Overall Study|Patient withdrawal|6|||
149986104|NCT05258890|541082622|FG001|Overall Study|Patient withdrawal|7|||
149986105|NCT05258890|541082621|FG000|Overall Study|Patient lost to follow-up|10|||
149986106|NCT05258890|541082622|FG001|Overall Study|Patient lost to follow-up|3|||
149986107|NCT05258890|541082621|FG000|Overall Study|Social network member withdrawal|1|||
149986108|NCT05258890|541082622|FG001|Overall Study|Social network member withdrawal|0|||
149986109|NCT05258890|541082621|FG000|Overall Study|Social network member lost to follow-up|5|||
149986110|NCT05258890|541082622|FG001|Overall Study|Social network member lost to follow-up|0|||
149986111|NCT05959447|541082629|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
149986112|NCT05959447|541082630|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
149986113|NCT05959447|541082629|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
149986114|NCT05959447|541082630|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
149986115|NCT05959447|541082629|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
149986116|NCT05959447|541082630|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
149986117|NCT05959447|541082629|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
149986118|NCT05959447|541082630|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
149986119|NCT00500357|541082633|FG000|Overall Study|Death|1|||
149986120|NCT02263326|541082634|FG000|Overall Study|Lost to Follow-up|1|||
149986121|NCT02263326|541082635|FG001|Overall Study|Lost to Follow-up|1|||
149986122|NCT01893411|541082636|FG000|Overall Study|Protocol Violation|1|||
149986123|NCT01893411|541082637|FG001|Overall Study|Protocol Violation|0|||
149986124|NCT01893411|541082638|FG002|Overall Study|Protocol Violation|0|||
149986125|NCT01893411|541082636|FG000|Overall Study|Physician Decision|1|||
149986126|NCT01893411|541082637|FG001|Overall Study|Physician Decision|1|||
149986127|NCT01893411|541082638|FG002|Overall Study|Physician Decision|2|||
149986128|NCT01893411|541082636|FG000|Overall Study|Lack of Efficacy|2|||
149986129|NCT01893411|541082637|FG001|Overall Study|Lack of Efficacy|1|||
149986130|NCT01893411|541082638|FG002|Overall Study|Lack of Efficacy|0|||
149986131|NCT01893411|541082636|FG000|Overall Study|Other|3|||
149986132|NCT01893411|541082637|FG001|Overall Study|Other|1|||
149986133|NCT01893411|541082638|FG002|Overall Study|Other|3|||
149986134|NCT01893411|541082636|FG000|Overall Study|Adverse Event|1|||
149986135|NCT01893411|541082637|FG001|Overall Study|Adverse Event|0|||
149986136|NCT01893411|541082638|FG002|Overall Study|Adverse Event|0|||
149986137|NCT01893411|541082636|FG000|Overall Study|Withdrawal by Subject|7|||
149986138|NCT01893411|541082637|FG001|Overall Study|Withdrawal by Subject|4|||
149986139|NCT01893411|541082638|FG002|Overall Study|Withdrawal by Subject|3|||
149986140|NCT01893411|541082636|FG000|Overall Study|Lost to Follow-up|2|||
149986141|NCT01893411|541082637|FG001|Overall Study|Lost to Follow-up|0|||
149986142|NCT01893411|541082638|FG002|Overall Study|Lost to Follow-up|1|||
149986143|NCT00566982|541082639|FG000|Overall Study|Adverse Event|6|||
149986144|NCT00566982|541082640|FG001|Overall Study|Adverse Event|48|||
149986145|NCT00566982|541082639|FG000|Overall Study|Withdrawal by Subject|1|||
149986146|NCT00566982|541082640|FG001|Overall Study|Withdrawal by Subject|14|||
149986147|NCT00566982|541082639|FG000|Overall Study|Protocol Violation|1|||
149986148|NCT00566982|541082640|FG001|Overall Study|Protocol Violation|4|||
150178789|NCT02299375|541792043|FG001|Overall Study|Lost to Follow-up|2|||
149986149|NCT00566982|541082639|FG000|Overall Study|Lost to Follow-up|0|||
149986150|NCT00566982|541082640|FG001|Overall Study|Lost to Follow-up|1|||
149986151|NCT00566982|541082639|FG000|Overall Study|Other-family problems & doctor's request|0|||
149986152|NCT00566982|541082640|FG001|Overall Study|Other-family problems & doctor's request|2|||
149986153|NCT00161616|541082641|FG000|Overall Study|Withdrawal by Subject|6|||
149986154|NCT00161616|541082642|FG001|Overall Study|Withdrawal by Subject|5|||
149986155|NCT00161616|541082641|FG000|Overall Study|Physician Decision|1|||
149986156|NCT00161616|541082642|FG001|Overall Study|Physician Decision|0|||
149986157|NCT00161616|541082641|FG000|Overall Study|Death|1|||
149986158|NCT00161616|541082642|FG001|Overall Study|Death|1|||
149986159|NCT00161616|541082641|FG000|Overall Study|Lost to Follow-up|17|||
149986160|NCT00161616|541082642|FG001|Overall Study|Lost to Follow-up|13|||
149986161|NCT00161616|541082641|FG000|Overall Study|Protocol deviation|1|||
149986162|NCT00161616|541082642|FG001|Overall Study|Protocol deviation|0|||
149986163|NCT00854724|541082643|FG000|First Intervention|Withdrawal by Subject|1|||
149986164|NCT00854724|541082644|FG001|First Intervention|Withdrawal by Subject|1|||
149986165|NCT00854724|541082643|FG000|Washout|Protocol Violation|1|||
149986166|NCT00854724|541082644|FG001|Washout|Protocol Violation|0|||
149986167|NCT00854724|541082643|FG000|Washout|Withdrawal by Subject|0|||
149986168|NCT00854724|541082644|FG001|Washout|Withdrawal by Subject|1|||
149986169|NCT00854724|541082643|FG000|Second Intervention|Protocol Violation|1|||
149986170|NCT00854724|541082644|FG001|Second Intervention|Protocol Violation|0|||
149986171|NCT00854724|541082643|FG000|Second Intervention|Physician Decision|0|||
149986172|NCT00854724|541082644|FG001|Second Intervention|Physician Decision|1|||
149986173|NCT00933608|541082646|FG000|Overall Study|Adverse Event|4|||
149986174|NCT00933608|541082647|FG001|Overall Study|Adverse Event|2|||
149986175|NCT00933608|541082646|FG000|Overall Study|Physician Decision|1|||
149986176|NCT00933608|541082647|FG001|Overall Study|Physician Decision|0|||
149986177|NCT03654040|541082654|FG000|Overall Study|Death|1|||
149986178|NCT03654040|541082655|FG001|Overall Study|Death|0|||
149986179|NCT03654040|541082654|FG000|Overall Study|Withdrawal by Subject|1|||
149986180|NCT03654040|541082655|FG001|Overall Study|Withdrawal by Subject|0|||
149986181|NCT03654040|541082654|FG000|Overall Study|Study terminated by sponsor|8|||
149986182|NCT03654040|541082655|FG001|Overall Study|Study terminated by sponsor|2|||
149986183|NCT03654040|541082654|FG000|Overall Study|Failure to initiate study therapy|2|||
149986184|NCT03654040|541082655|FG001|Overall Study|Failure to initiate study therapy|0|||
149986185|NCT03654040|541082654|FG000|Overall Study|Transplanted at another center|2|||
149986186|NCT03654040|541082655|FG001|Overall Study|Transplanted at another center|0|||
149986187|NCT03654040|541082654|FG000|Overall Study|Failure to meet eligibility criteria|14|||
149986188|NCT03654040|541082655|FG001|Overall Study|Failure to meet eligibility criteria|2|||
149986189|NCT03654040|541082654|FG000|Overall Study|No longer transplant candidate|1|||
149986190|NCT03654040|541082655|FG001|Overall Study|No longer transplant candidate|0|||
149986191|NCT03654040|541082654|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
149986192|NCT03654040|541082655|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
149986193|NCT03654040|541082654|FG000|Overall Study|Recipient ineligible|0|||
149986194|NCT03654040|541082655|FG001|Overall Study|Recipient ineligible|2|||
149986195|NCT03654040|541082654|FG000|Overall Study|Received deceased liver|0|||
149986196|NCT03654040|541082655|FG001|Overall Study|Received deceased liver|1|||
149986197|NCT01309997|541082663|FG000|Overall Study|Adverse Event|1|||
149986198|NCT01309997|541082664|FG001|Overall Study|Adverse Event|0|||
149986199|NCT01309997|541082663|FG000|Overall Study|Death|1|||
149986200|NCT01309997|541082664|FG001|Overall Study|Death|3|||
149986201|NCT01309997|541082663|FG000|Overall Study|Lack of Efficacy|2|||
149986202|NCT01309997|541082664|FG001|Overall Study|Lack of Efficacy|2|||
149986203|NCT01309997|541082663|FG000|Overall Study|Withdrawal by Subject|1|||
149986204|NCT01309997|541082664|FG001|Overall Study|Withdrawal by Subject|1|||
149986205|NCT00282087|541082665|FG000|Overall Study|Death|1|||
149986206|NCT03226249|541082666|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
149986207|NCT03226249|541082666|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
149986208|NCT03226249|541082666|FG000|Survival Follow-up|Patients still in follow-up.|30|||
149986209|NCT01532921|541082667|FG000|Overall Study|Death|3|||
149986210|NCT01532921|541082667|FG000|Overall Study|Withdrawal by Subject|2|||
149986211|NCT01532921|541082667|FG000|Overall Study|Lost to Follow-up|3|||
149986212|NCT01532921|541082667|FG000|Overall Study|Physician Decision|7|||
149986213|NCT01532921|541082667|FG000|Overall Study|Device was explanted during procedure|1|||
149986214|NCT01703091|541082683|FG000|Overall Study|Adverse Event|5|||
149986215|NCT01703091|541082684|FG001|Overall Study|Adverse Event|3|||
149986216|NCT01703091|541082683|FG000|Overall Study|Physician Decision|2|||
149986217|NCT01703091|541082684|FG001|Overall Study|Physician Decision|1|||
149986218|NCT01703091|541082683|FG000|Overall Study|Withdrawal by Subject|1|||
149986219|NCT01703091|541082684|FG001|Overall Study|Withdrawal by Subject|0|||
150053527|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
149986220|NCT01703091|541082683|FG000|Overall Study|Sponsor Decision|1|||
149986221|NCT01703091|541082684|FG001|Overall Study|Sponsor Decision|0|||
149986222|NCT02550288|541082685|FG000|Overall Study|Adverse Event|0|||
149986223|NCT02550288|541082686|FG001|Overall Study|Adverse Event|1|||
149986224|NCT02550288|541082687|FG002|Overall Study|Adverse Event|0|||
149986225|NCT02550288|541082688|FG003|Overall Study|Adverse Event|0|||
149986226|NCT02550288|541082689|FG004|Overall Study|Adverse Event|0|||
149986227|NCT02550288|541082685|FG000|Overall Study|Physician Decision|0|||
149986228|NCT02550288|541082686|FG001|Overall Study|Physician Decision|0|||
149986229|NCT02550288|541082687|FG002|Overall Study|Physician Decision|0|||
149986230|NCT02550288|541082688|FG003|Overall Study|Physician Decision|1|||
149986231|NCT02550288|541082689|FG004|Overall Study|Physician Decision|0|||
149986232|NCT02550288|541082685|FG000|Overall Study|Protocol Violation|2|||
149986233|NCT02550288|541082686|FG001|Overall Study|Protocol Violation|2|||
149986234|NCT02550288|541082687|FG002|Overall Study|Protocol Violation|1|||
149986235|NCT02550288|541082688|FG003|Overall Study|Protocol Violation|0|||
149986236|NCT02550288|541082689|FG004|Overall Study|Protocol Violation|3|||
149986237|NCT02550288|541082685|FG000|Overall Study|Participant moved|0|||
149986238|NCT02550288|541082686|FG001|Overall Study|Participant moved|0|||
149986239|NCT02550288|541082687|FG002|Overall Study|Participant moved|0|||
149986240|NCT02550288|541082688|FG003|Overall Study|Participant moved|1|||
149986241|NCT02550288|541082689|FG004|Overall Study|Participant moved|0|||
149986242|NCT02550288|541082685|FG000|Overall Study|Withdrawal by Subject|0|||
149986243|NCT02550288|541082686|FG001|Overall Study|Withdrawal by Subject|0|||
149986244|NCT02550288|541082687|FG002|Overall Study|Withdrawal by Subject|0|||
149986245|NCT02550288|541082688|FG003|Overall Study|Withdrawal by Subject|1|||
149986246|NCT02550288|541082689|FG004|Overall Study|Withdrawal by Subject|0|||
149986247|NCT05420961|541082692|FG000|Overall Study|Withdrawal by Subject|2|||
149986248|NCT05420961|541082693|FG001|Overall Study|Withdrawal by Subject|1|||
149986249|NCT05420961|541082694|FG002|Overall Study|Withdrawal by Subject|1|||
149986250|NCT05420961|541082695|FG003|Overall Study|Withdrawal by Subject|0|||
149986251|NCT05420961|541082696|FG004|Overall Study|Withdrawal by Subject|0|||
149986252|NCT05420961|541082692|FG000|Overall Study|Lost to Follow-up|0|||
149986253|NCT05420961|541082693|FG001|Overall Study|Lost to Follow-up|0|||
149986254|NCT05420961|541082694|FG002|Overall Study|Lost to Follow-up|1|||
149986255|NCT05420961|541082695|FG003|Overall Study|Lost to Follow-up|0|||
149986256|NCT05420961|541082696|FG004|Overall Study|Lost to Follow-up|0|||
149986257|NCT05420961|541082692|FG000|Overall Study|Randomized by mistake without study treatment|0|||
149986258|NCT05420961|541082693|FG001|Overall Study|Randomized by mistake without study treatment|0|||
149986259|NCT05420961|541082694|FG002|Overall Study|Randomized by mistake without study treatment|1|||
149986260|NCT05420961|541082695|FG003|Overall Study|Randomized by mistake without study treatment|0|||
149986261|NCT05420961|541082696|FG004|Overall Study|Randomized by mistake without study treatment|1|||
149986262|NCT00803361|541082697|FG000|Overall Study|Adverse Event|13|||
149986263|NCT00803361|541082698|FG001|Overall Study|Adverse Event|3|||
149986264|NCT00803361|541082697|FG000|Overall Study|Lack of Efficacy|4|||
149986265|NCT00803361|541082698|FG001|Overall Study|Lack of Efficacy|13|||
149986266|NCT00803361|541082697|FG000|Overall Study|Lost to Follow-up|1|||
149986267|NCT00803361|541082698|FG001|Overall Study|Lost to Follow-up|2|||
149986268|NCT00803361|541082697|FG000|Overall Study|Physician Decision|1|||
149986269|NCT00803361|541082698|FG001|Overall Study|Physician Decision|0|||
149986270|NCT00803361|541082697|FG000|Overall Study|Protocol Violation|2|||
149986271|NCT00803361|541082698|FG001|Overall Study|Protocol Violation|4|||
149986272|NCT00803361|541082697|FG000|Overall Study|Withdrawal by Subject|5|||
149986273|NCT00803361|541082698|FG001|Overall Study|Withdrawal by Subject|6|||
149986274|NCT04660552|541082699|FG000|Overall Study|Withdrawal by Subject|3|||
149986275|NCT04660552|541082700|FG001|Overall Study|Withdrawal by Subject|1|||
149986276|NCT00470262|541082701|FG000|Overall Study|Withdrawal by Subject|2|||
149986277|NCT00470262|541082702|FG001|Overall Study|Withdrawal by Subject|0|||
149986278|NCT03902392|541082708|FG000|Overall Study|Lost to Follow-up|7|||
149986279|NCT03902392|541082709|FG001|Overall Study|Lost to Follow-up|7|||
149986280|NCT03799952|541082710|FG000|Overall Study|Program was too easy, discontinued|1|||
149986281|NCT03799952|541082711|FG001|Overall Study|Program was too easy, discontinued|0|||
149986282|NCT03799952|541082710|FG000|Overall Study|Lost to Follow-up|0|||
149986283|NCT03799952|541082711|FG001|Overall Study|Lost to Follow-up|2|||
149986284|NCT03248167|541082712|FG000|Overall Study|Withdrawal by Subject|2|||
149986285|NCT03248167|541082713|FG001|Overall Study|Withdrawal by Subject|2|||
149986286|NCT03248167|541082712|FG000|Overall Study|Physician Decision|0|||
149986287|NCT03248167|541082713|FG001|Overall Study|Physician Decision|1|||
149986288|NCT03248167|541082712|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
149986289|NCT03248167|541082713|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
149986290|NCT03248167|541082712|FG000|Overall Study|Lost to Follow-up|1|||
149986291|NCT03248167|541082713|FG001|Overall Study|Lost to Follow-up|0|||
149986292|NCT01107392|541082714|FG000|Overall Study|Adverse Event|2|||
149986293|NCT01107392|541082715|FG001|Overall Study|Adverse Event|0|||
149986294|NCT01107392|541082714|FG000|Overall Study|Personal Reasons|2|||
149986295|NCT01107392|541082715|FG001|Overall Study|Personal Reasons|3|||
149986296|NCT01107392|541082714|FG000|Overall Study|Administrative decision|1|||
149986297|NCT01107392|541082715|FG001|Overall Study|Administrative decision|0|||
149986298|NCT00851552|541082716|FG000|Overall Study|Death|2|||
149986299|NCT00851552|541082716|FG000|Overall Study|Adverse Event|1|||
149986300|NCT00851552|541082716|FG000|Overall Study|Disease Progression|4|||
149986301|NCT00177294|541082717|FG000|Overall Study|Withdrawal by Subject|7|||
149986302|NCT00177294|541082718|FG001|Overall Study|Withdrawal by Subject|5|||
149986303|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
149986304|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
149986305|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
149986306|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
149986307|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
149986308|NCT01536561|541082719|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
149986309|NCT01030952|541082720|FG000|Overall Study|Protocol Violation|0|||
149986310|NCT01030952|541082721|FG001|Overall Study|Protocol Violation|1|||
149986311|NCT01030952|541082720|FG000|Overall Study|Informed consent withdrawal|1|||
149986312|NCT01030952|541082721|FG001|Overall Study|Informed consent withdrawal|0|||
149986313|NCT01030952|541082720|FG000|Overall Study|Lost to Follow-up|0|||
149986314|NCT01030952|541082721|FG001|Overall Study|Lost to Follow-up|1|||
149986315|NCT01030952|541082720|FG000|Overall Study|Unexplained|1|||
149986316|NCT01030952|541082721|FG001|Overall Study|Unexplained|1|||
149986317|NCT02467192|541082722|FG000|Overall Study|Death|1|||
149986318|NCT02467192|541082722|FG000|Overall Study|revealed to have pneumonia before|2|||
149986319|NCT00958347|541082723|FG000|Overall Study|Death|43|||
149986320|NCT00958347|541082723|FG000|Overall Study|Withdrawal by Subject|23|||
149986321|NCT00958347|541082723|FG000|Overall Study|Lost to Follow-up|15|||
149986322|NCT00958347|541082723|FG000|Overall Study|revision/removal|10|||
149986323|NCT00958347|541082723|FG000|Overall Study|study termination|135|||
149986324|NCT01603043|541082724|FG000|Overall Study|Study Futility|7|||
149986325|NCT01603043|541082725|FG001|Overall Study|Study Futility|3|||
149986326|NCT05111002|541082728|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
149986327|NCT05111002|541082729|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
149986328|NCT05111002|541082728|FG000|Secondary Outcome|Lost to Follow-up|1|||
149986329|NCT05111002|541082729|FG001|Secondary Outcome|Lost to Follow-up|0|||
149986330|NCT00809926|541082730|FG000|Overall Study|Adverse Event|18|||
149986331|NCT00809926|541082731|FG001|Overall Study|Adverse Event|10|||
149986332|NCT00809926|541082730|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
149986333|NCT00809926|541082731|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149986334|NCT00809926|541082730|FG000|Overall Study|Patient withdrew consent|8|||
149986335|NCT00809926|541082731|FG001|Overall Study|Patient withdrew consent|6|||
149986336|NCT00809926|541082730|FG000|Overall Study|Lost to Follow-up|2|||
149986337|NCT00809926|541082731|FG001|Overall Study|Lost to Follow-up|1|||
149986338|NCT00809926|541082730|FG000|Overall Study|Administrative Problems|0|||
149986339|NCT00809926|541082731|FG001|Overall Study|Administrative Problems|1|||
149986340|NCT00809926|541082730|FG000|Overall Study|Protocol deviation|0|||
149986341|NCT00809926|541082731|FG001|Overall Study|Protocol deviation|2|||
149986342|NCT04776720|541082751|FG000|Overall Study|COVID Related|4|||
149986343|NCT04776720|541082752|FG001|Overall Study|COVID Related|2|||
149986344|NCT04776720|541082751|FG000|Overall Study|Adverse Event|2|||
149986345|NCT04776720|541082752|FG001|Overall Study|Adverse Event|0|||
149986346|NCT04776720|541082751|FG000|Overall Study|Serious Adverse Event|0|||
149986347|NCT04776720|541082752|FG001|Overall Study|Serious Adverse Event|1|||
149986348|NCT04776720|541082751|FG000|Overall Study|Too Busy|3|||
149986349|NCT04776720|541082752|FG001|Overall Study|Too Busy|1|||
149986350|NCT04776720|541082751|FG000|Overall Study|Lost to Follow-up|1|||
149986351|NCT04776720|541082752|FG001|Overall Study|Lost to Follow-up|2|||
149986352|NCT04776720|541082751|FG000|Overall Study|Family|2|||
149986353|NCT04776720|541082752|FG001|Overall Study|Family|2|||
149986354|NCT04776720|541082751|FG000|Overall Study|No remote technology access|0|||
149986355|NCT04776720|541082752|FG001|Overall Study|No remote technology access|1|||
149986356|NCT04776720|541082751|FG000|Overall Study|Withdrawal by Subject|1|||
149986357|NCT04776720|541082752|FG001|Overall Study|Withdrawal by Subject|0|||
149986358|NCT04776720|541082751|FG000|Overall Study|Cannot tolerate intervention|1|||
149986359|NCT04776720|541082752|FG001|Overall Study|Cannot tolerate intervention|0|||
149986360|NCT04776720|541082751|FG000|Overall Study|Incomplete outcome data|6|||
149986361|NCT04776720|541082752|FG001|Overall Study|Incomplete outcome data|1|||
149986362|NCT00790582|541082756|FG000|Overall Study|Death|14|||
149986363|NCT00790582|541082757|FG001|Overall Study|Death|32|||
149986364|NCT00790582|541082756|FG000|Overall Study|Physician Decision|7|||
149986365|NCT00790582|541082757|FG001|Overall Study|Physician Decision|1|||
149986366|NCT00790582|541082756|FG000|Overall Study|Lost to Follow-up|3|||
149986367|NCT00790582|541082757|FG001|Overall Study|Lost to Follow-up|3|||
149986368|NCT00790582|541082756|FG000|Overall Study|Withdrawal by Subject|7|||
149986369|NCT00790582|541082757|FG001|Overall Study|Withdrawal by Subject|51|||
149986370|NCT00803595|541082758|FG000|Overall Study|Adverse Event|3|||
149986371|NCT00803595|541082759|FG001|Overall Study|Adverse Event|4|||
149986372|NCT00803595|541082760|FG002|Overall Study|Adverse Event|1|||
149986373|NCT00803595|541082758|FG000|Overall Study|Protocol Violation|7|||
149986374|NCT00803595|541082759|FG001|Overall Study|Protocol Violation|2|||
149986375|NCT00803595|541082760|FG002|Overall Study|Protocol Violation|12|||
150178790|NCT02299375|541792042|FG000|Overall Study|Physician Decision|1|||
149986376|NCT00803595|541082758|FG000|Overall Study|Withdrawal by Subject|5|||
149986377|NCT00803595|541082759|FG001|Overall Study|Withdrawal by Subject|2|||
149986378|NCT00803595|541082760|FG002|Overall Study|Withdrawal by Subject|3|||
149986379|NCT01027650|541082762|FG000|Overall Study|Personal Reasons|0|||
149986380|NCT01027650|541082763|FG001|Overall Study|Personal Reasons|0|||
149986381|NCT01027650|541082764|FG002|Overall Study|Personal Reasons|0|||
149986382|NCT01027650|541082765|FG003|Overall Study|Personal Reasons|0|||
149986383|NCT01027650|541082766|FG004|Overall Study|Personal Reasons|2|||
149986384|NCT01027650|541082767|FG005|Overall Study|Personal Reasons|1|||
149986385|NCT01027650|541082768|FG006|Overall Study|Personal Reasons|0|||
149986386|NCT01027650|541082769|FG007|Overall Study|Personal Reasons|0|||
149986387|NCT01027650|541082762|FG000|Overall Study|Lost to Follow-up|0|||
149986388|NCT01027650|541082763|FG001|Overall Study|Lost to Follow-up|0|||
149986389|NCT01027650|541082764|FG002|Overall Study|Lost to Follow-up|0|||
149986390|NCT01027650|541082765|FG003|Overall Study|Lost to Follow-up|0|||
149986391|NCT01027650|541082766|FG004|Overall Study|Lost to Follow-up|0|||
149986392|NCT01027650|541082767|FG005|Overall Study|Lost to Follow-up|0|||
149986393|NCT01027650|541082768|FG006|Overall Study|Lost to Follow-up|1|||
149986394|NCT01027650|541082769|FG007|Overall Study|Lost to Follow-up|0|||
149986395|NCT01027650|541082762|FG000|Overall Study|Lack of Efficacy|0|||
149986396|NCT01027650|541082763|FG001|Overall Study|Lack of Efficacy|0|||
149986397|NCT01027650|541082764|FG002|Overall Study|Lack of Efficacy|0|||
149986398|NCT01027650|541082765|FG003|Overall Study|Lack of Efficacy|0|||
149986399|NCT01027650|541082766|FG004|Overall Study|Lack of Efficacy|0|||
149986400|NCT01027650|541082767|FG005|Overall Study|Lack of Efficacy|1|||
149986401|NCT01027650|541082768|FG006|Overall Study|Lack of Efficacy|0|||
149986402|NCT01027650|541082769|FG007|Overall Study|Lack of Efficacy|0|||
149986403|NCT03159468|541082770|FG000|Overall Study|Withdrawal by Subject|0|||
149986404|NCT03159468|541082771|FG001|Overall Study|Withdrawal by Subject|0|||
149986405|NCT03159468|541082772|FG002|Overall Study|Withdrawal by Subject|3|||
149986406|NCT03159468|541082773|FG003|Overall Study|Withdrawal by Subject|0|||
149986407|NCT03159468|541082774|FG004|Overall Study|Withdrawal by Subject|0|||
149986408|NCT03159468|541082775|FG005|Overall Study|Withdrawal by Subject|0|||
149986409|NCT00912782|541082776|FG000|Overall Study|Death|2|||
149986410|NCT00912782|541082777|FG001|Overall Study|Death|1|||
149986411|NCT00912782|541082776|FG000|Overall Study|Lost to Follow-up|0|||
149986412|NCT00912782|541082777|FG001|Overall Study|Lost to Follow-up|1|||
149986413|NCT00912782|541082776|FG000|Overall Study|Did not receive vascular access type|1|||
149986414|NCT00912782|541082777|FG001|Overall Study|Did not receive vascular access type|2|||
149986415|NCT00912782|541082776|FG000|Overall Study|Relocated before study completion|0|||
149986416|NCT00912782|541082777|FG001|Overall Study|Relocated before study completion|1|||
149986417|NCT02712983|541084957|FG000|Treatment Phase|Adverse Event|3|||
149986418|NCT02712983|541084958|FG001|Treatment Phase|Adverse Event|1|||
149986419|NCT02712983|541084959|FG002|Treatment Phase|Adverse Event|1|||
149986420|NCT02712983|541084960|FG003|Treatment Phase|Adverse Event|4|||
149986421|NCT02712983|541084961|FG004|Treatment Phase|Adverse Event|3|||
149986422|NCT02712983|541084962|FG005|Treatment Phase|Adverse Event|0|||
149986423|NCT02712983|541084963|FG006|Treatment Phase|Adverse Event|6|||
149986424|NCT02712983|541084964|FG007|Treatment Phase|Adverse Event|6|||
149986425|NCT02712983|541084965|FG008|Treatment Phase|Adverse Event|1|||
149986426|NCT02712983|541084957|FG000|Treatment Phase|Protocol Deviation|0|||
149986427|NCT02712983|541084958|FG001|Treatment Phase|Protocol Deviation|0|||
149986428|NCT02712983|541084959|FG002|Treatment Phase|Protocol Deviation|0|||
149986429|NCT02712983|541084960|FG003|Treatment Phase|Protocol Deviation|2|||
149986430|NCT02712983|541084961|FG004|Treatment Phase|Protocol Deviation|0|||
149986431|NCT02712983|541084962|FG005|Treatment Phase|Protocol Deviation|0|||
149986432|NCT02712983|541084963|FG006|Treatment Phase|Protocol Deviation|1|||
149986433|NCT02712983|541084964|FG007|Treatment Phase|Protocol Deviation|0|||
149986434|NCT02712983|541084965|FG008|Treatment Phase|Protocol Deviation|0|||
149986435|NCT02712983|541084957|FG000|Treatment Phase|Technical Problems|0|||
149986436|NCT02712983|541084958|FG001|Treatment Phase|Technical Problems|0|||
149986437|NCT02712983|541084959|FG002|Treatment Phase|Technical Problems|0|||
149986438|NCT02712983|541084960|FG003|Treatment Phase|Technical Problems|0|||
149986439|NCT02712983|541084961|FG004|Treatment Phase|Technical Problems|0|||
149986440|NCT02712983|541084962|FG005|Treatment Phase|Technical Problems|0|||
149986441|NCT02712983|541084963|FG006|Treatment Phase|Technical Problems|1|||
149986442|NCT02712983|541084964|FG007|Treatment Phase|Technical Problems|0|||
149986443|NCT02712983|541084965|FG008|Treatment Phase|Technical Problems|0|||
149986444|NCT02712983|541084957|FG000|Treatment Phase|Physician Decision|0|||
149986445|NCT02712983|541084958|FG001|Treatment Phase|Physician Decision|0|||
149986446|NCT02712983|541084959|FG002|Treatment Phase|Physician Decision|0|||
149986447|NCT02712983|541084960|FG003|Treatment Phase|Physician Decision|0|||
149986448|NCT02712983|541084961|FG004|Treatment Phase|Physician Decision|0|||
149986449|NCT02712983|541084962|FG005|Treatment Phase|Physician Decision|0|||
149986450|NCT02712983|541084963|FG006|Treatment Phase|Physician Decision|0|||
149986451|NCT02712983|541084964|FG007|Treatment Phase|Physician Decision|1|||
149986452|NCT02712983|541084965|FG008|Treatment Phase|Physician Decision|1|||
149986453|NCT02712983|541084957|FG000|Treatment Phase|Subject Decision|2|||
149986454|NCT02712983|541084958|FG001|Treatment Phase|Subject Decision|0|||
149986455|NCT02712983|541084959|FG002|Treatment Phase|Subject Decision|0|||
149986456|NCT02712983|541084960|FG003|Treatment Phase|Subject Decision|2|||
149986457|NCT02712983|541084961|FG004|Treatment Phase|Subject Decision|1|||
149986458|NCT02712983|541084962|FG005|Treatment Phase|Subject Decision|0|||
149986459|NCT02712983|541084963|FG006|Treatment Phase|Subject Decision|1|||
149986460|NCT02712983|541084964|FG007|Treatment Phase|Subject Decision|2|||
149986461|NCT02712983|541084965|FG008|Treatment Phase|Subject Decision|0|||
149986462|NCT02712983|541084957|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986463|NCT02712983|541084958|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
149986464|NCT02712983|541084959|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986465|NCT02712983|541084960|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986466|NCT02712983|541084961|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986467|NCT02712983|541084962|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986468|NCT02712983|541084963|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
149986469|NCT02712983|541084964|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
149986470|NCT02712983|541084965|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149986471|NCT02712983|541084957|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986472|NCT02712983|541084958|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986473|NCT02712983|541084959|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986474|NCT02712983|541084960|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
149986475|NCT02712983|541084961|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986476|NCT02712983|541084962|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986477|NCT02712983|541084963|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
150053528|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053529|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053530|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053531|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053532|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
149986478|NCT02712983|541084964|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986479|NCT02712983|541084965|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
149986480|NCT02712983|541084957|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
149986481|NCT02712983|541084958|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
149986482|NCT02712983|541084959|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
149986483|NCT02712983|541084960|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
149986484|NCT02712983|541084961|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
149986485|NCT02712983|541084962|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
149986486|NCT02712983|541084963|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
149986487|NCT02712983|541084964|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
150053533|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
149986488|NCT02712983|541084965|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
149986489|NCT05396014|541084966|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
149986490|NCT05396014|541084967|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986491|NCT05396014|541084968|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986492|NCT05396014|541084969|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986493|NCT05396014|541084970|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986494|NCT05396014|541084971|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986495|NCT05396014|541084972|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986496|NCT05396014|541084973|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986497|NCT05396014|541084974|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
150053534|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053535|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
150053536|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
150053537|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
150053538|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
150053539|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
150053540|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
150053541|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
150053542|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
150053543|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
150053544|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
150053545|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
150053546|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|Other|0|||
149986498|NCT05396014|541084975|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986499|NCT05396014|541084976|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986500|NCT05396014|541084977|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986501|NCT05396014|541084978|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986502|NCT05396014|541084979|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
149986503|NCT05396014|541084980|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986504|NCT05396014|541084981|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986505|NCT05396014|541084982|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986506|NCT05396014|541084983|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986507|NCT05396014|541084984|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986508|NCT05396014|541084985|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986509|NCT05396014|541084986|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986510|NCT05396014|541084987|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986511|NCT05396014|541084988|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986512|NCT05396014|541084989|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986513|NCT05396014|541084990|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986514|NCT05396014|541084991|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986515|NCT05396014|541084992|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
149986516|NCT05396014|541084993|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986517|NCT05396014|541084994|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986518|NCT05396014|541084995|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986519|NCT05396014|541084996|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986520|NCT05396014|541084997|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986521|NCT05396014|541084998|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986522|NCT05396014|541084999|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986523|NCT05396014|541085000|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986524|NCT05396014|541085001|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986525|NCT05396014|541085002|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986526|NCT05396014|541085003|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986527|NCT05396014|541085004|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986528|NCT05396014|541085005|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
149986529|NCT05396014|541085006|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986530|NCT05396014|541085007|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986531|NCT05396014|541085008|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
149986532|NCT05396014|541084966|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
149986533|NCT05396014|541084967|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986534|NCT05396014|541084968|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986535|NCT05396014|541084969|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986536|NCT05396014|541084970|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986537|NCT05396014|541084971|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986538|NCT05396014|541084972|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986539|NCT05396014|541084973|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986540|NCT05396014|541084974|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986541|NCT05396014|541084975|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986542|NCT05396014|541084976|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986543|NCT05396014|541084977|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986544|NCT05396014|541084978|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986545|NCT05396014|541084979|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
149986546|NCT05396014|541084980|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
150053547|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|Other|0|||
149986547|NCT05396014|541084981|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986548|NCT05396014|541084982|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986549|NCT05396014|541084983|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986550|NCT05396014|541084984|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986551|NCT05396014|541084985|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986552|NCT05396014|541084986|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986553|NCT05396014|541084987|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986554|NCT05396014|541084988|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986555|NCT05396014|541084989|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986556|NCT05396014|541084990|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986557|NCT05396014|541084991|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986558|NCT05396014|541084992|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
149986559|NCT05396014|541084993|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986560|NCT05396014|541084994|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986561|NCT05396014|541084995|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986562|NCT05396014|541084996|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986563|NCT05396014|541084997|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986564|NCT05396014|541084998|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986565|NCT05396014|541084999|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986566|NCT05396014|541085000|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986567|NCT05396014|541085001|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986568|NCT05396014|541085002|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986569|NCT05396014|541085003|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986570|NCT05396014|541085004|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986571|NCT05396014|541085005|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
149986572|NCT05396014|541085006|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986573|NCT05396014|541085007|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986574|NCT05396014|541085008|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
149986575|NCT05396014|541084966|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
149986576|NCT05396014|541084967|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986577|NCT05396014|541084968|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986578|NCT05396014|541084969|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986579|NCT05396014|541084970|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986580|NCT05396014|541084971|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986581|NCT05396014|541084972|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986582|NCT05396014|541084973|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986583|NCT05396014|541084974|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986584|NCT05396014|541084975|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986585|NCT05396014|541084976|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986586|NCT05396014|541084977|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986587|NCT05396014|541084978|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986588|NCT05396014|541084979|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
149986589|NCT05396014|541084980|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986590|NCT05396014|541084981|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986591|NCT05396014|541084982|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986592|NCT05396014|541084983|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986593|NCT05396014|541084984|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
150053548|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|Other|0|||
150053549|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|Other|0|||
150053550|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|Other|0|||
150053551|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|Other|0|||
149986594|NCT05396014|541084985|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
150053552|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|Other|0|||
150053553|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|Other|0|||
150053554|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|Other|1|||
150053555|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|Death|0|||
150053556|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|Death|0|||
150053557|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|Death|0|||
150053558|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|Death|0|||
150053559|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|Death|0|||
150053560|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|Death|0|||
150053561|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|Death|0|||
150053562|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|Death|0|||
150053563|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|Death|2|||
150053564|NCT00557856|541336671|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
149986595|NCT05396014|541084986|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986596|NCT05396014|541084987|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986597|NCT05396014|541084988|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986598|NCT05396014|541084989|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986599|NCT05396014|541084990|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986600|NCT05396014|541084991|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986601|NCT05396014|541084992|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
149986602|NCT05396014|541084993|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986603|NCT05396014|541084994|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986604|NCT05396014|541084995|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986605|NCT05396014|541084996|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986606|NCT05396014|541084997|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986607|NCT05396014|541084998|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986608|NCT05396014|541084999|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986609|NCT05396014|541085000|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986610|NCT05396014|541085001|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986611|NCT05396014|541085002|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986612|NCT05396014|541085003|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986613|NCT05396014|541085004|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986614|NCT05396014|541085005|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
149986615|NCT05396014|541085006|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986616|NCT05396014|541085007|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986617|NCT05396014|541085008|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
149986618|NCT05396014|541084966|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986619|NCT05396014|541084967|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986620|NCT05396014|541084968|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986621|NCT05396014|541084969|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986622|NCT05396014|541084970|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986623|NCT05396014|541084971|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986624|NCT05396014|541084972|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986625|NCT05396014|541084973|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986626|NCT05396014|541084974|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
150053565|NCT00557856|541336672|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053566|NCT00557856|541336673|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053567|NCT00557856|541336674|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053568|NCT00557856|541336675|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053569|NCT00557856|541336676|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
149986627|NCT05396014|541084975|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986628|NCT05396014|541084976|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986629|NCT05396014|541084977|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986630|NCT05396014|541084978|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986631|NCT05396014|541084979|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986632|NCT05396014|541084980|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986633|NCT05396014|541084981|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986634|NCT05396014|541084982|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986635|NCT05396014|541084983|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986636|NCT05396014|541084984|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986637|NCT05396014|541084985|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986638|NCT05396014|541084986|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986639|NCT05396014|541084987|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986640|NCT05396014|541084988|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986641|NCT05396014|541084989|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986642|NCT05396014|541084990|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986643|NCT05396014|541084991|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986644|NCT05396014|541084992|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
149986645|NCT05396014|541084993|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986646|NCT05396014|541084994|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986647|NCT05396014|541084995|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986648|NCT05396014|541084996|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986649|NCT05396014|541084997|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986650|NCT05396014|541084998|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986651|NCT05396014|541084999|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986652|NCT05396014|541085000|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986653|NCT05396014|541085001|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986654|NCT05396014|541085002|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986655|NCT05396014|541085003|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986656|NCT05396014|541085004|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986657|NCT05396014|541085005|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
149986658|NCT05396014|541085006|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986659|NCT05396014|541085007|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986660|NCT05396014|541085008|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149986661|NCT05396014|541084966|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986662|NCT05396014|541084967|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986663|NCT05396014|541084968|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986664|NCT05396014|541084969|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986665|NCT05396014|541084970|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986666|NCT05396014|541084971|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986667|NCT05396014|541084972|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986668|NCT05396014|541084973|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986669|NCT05396014|541084974|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986670|NCT05396014|541084975|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986671|NCT05396014|541084976|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986672|NCT05396014|541084977|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986673|NCT05396014|541084978|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986674|NCT05396014|541084979|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986675|NCT05396014|541084980|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
150053570|NCT00557856|541336677|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053571|NCT00557856|541336678|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
150053572|NCT00557856|541336679|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
150053573|NCT03255083|541336680|FG000|Overall Study|Clinical progression|1|||
149986676|NCT05396014|541084981|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986677|NCT05396014|541084982|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986678|NCT05396014|541084983|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986679|NCT05396014|541084984|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986680|NCT05396014|541084985|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986681|NCT05396014|541084986|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986682|NCT05396014|541084987|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986683|NCT05396014|541084988|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986684|NCT05396014|541084989|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986685|NCT05396014|541084990|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986686|NCT05396014|541084991|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986687|NCT05396014|541084992|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
149986688|NCT05396014|541084993|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986689|NCT05396014|541084994|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986690|NCT05396014|541084995|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986691|NCT05396014|541084996|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986692|NCT05396014|541084997|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986693|NCT05396014|541084998|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986694|NCT05396014|541084999|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986695|NCT05396014|541085000|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986696|NCT05396014|541085001|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986697|NCT05396014|541085002|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986698|NCT05396014|541085003|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986699|NCT05396014|541085004|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986700|NCT05396014|541085005|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986701|NCT05396014|541085006|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986702|NCT05396014|541085007|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986703|NCT05396014|541085008|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149986704|NCT05396014|541084966|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986705|NCT05396014|541084967|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986706|NCT05396014|541084968|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986707|NCT05396014|541084969|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986708|NCT05396014|541084970|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986709|NCT05396014|541084971|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986710|NCT05396014|541084972|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986711|NCT05396014|541084973|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986712|NCT05396014|541084974|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986713|NCT05396014|541084975|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986714|NCT05396014|541084976|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986715|NCT05396014|541084977|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986716|NCT05396014|541084978|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986717|NCT05396014|541084979|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
149986718|NCT05396014|541084980|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986719|NCT05396014|541084981|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986720|NCT05396014|541084982|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986721|NCT05396014|541084983|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986722|NCT05396014|541084984|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986723|NCT05396014|541084985|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986724|NCT05396014|541084986|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986725|NCT05396014|541084987|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986726|NCT05396014|541084988|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986727|NCT05396014|541084989|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986728|NCT05396014|541084990|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986729|NCT05396014|541084991|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986730|NCT05396014|541084992|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986731|NCT05396014|541084993|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986732|NCT05396014|541084994|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986733|NCT05396014|541084995|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986734|NCT05396014|541084996|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986735|NCT05396014|541084997|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986736|NCT05396014|541084998|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986737|NCT05396014|541084999|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986738|NCT05396014|541085000|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986739|NCT05396014|541085001|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986740|NCT05396014|541085002|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986741|NCT05396014|541085003|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986742|NCT05396014|541085004|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986743|NCT05396014|541085005|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986744|NCT05396014|541085006|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986745|NCT05396014|541085007|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986746|NCT05396014|541085008|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
149986747|NCT05396014|541084966|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
149986748|NCT05396014|541084967|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986749|NCT05396014|541084968|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986750|NCT05396014|541084969|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986751|NCT05396014|541084970|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986752|NCT05396014|541084971|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986753|NCT05396014|541084972|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986754|NCT05396014|541084973|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986755|NCT05396014|541084974|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986756|NCT05396014|541084975|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986757|NCT05396014|541084976|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986758|NCT05396014|541084977|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986759|NCT05396014|541084978|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986760|NCT05396014|541084979|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
149986761|NCT05396014|541084980|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986762|NCT05396014|541084981|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986763|NCT05396014|541084982|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986764|NCT05396014|541084983|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986765|NCT05396014|541084984|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986766|NCT05396014|541084985|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986767|NCT05396014|541084986|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986768|NCT05396014|541084987|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986769|NCT05396014|541084988|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986770|NCT05396014|541084989|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986771|NCT05396014|541084990|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986772|NCT05396014|541084991|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986773|NCT05396014|541084992|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986774|NCT05396014|541084993|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
150178791|NCT02299375|541792043|FG001|Overall Study|Physician Decision|1|||
149986775|NCT05396014|541084994|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986776|NCT05396014|541084995|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986777|NCT05396014|541084996|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986778|NCT05396014|541084997|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986779|NCT05396014|541084998|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986780|NCT05396014|541084999|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986781|NCT05396014|541085000|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986782|NCT05396014|541085001|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986783|NCT05396014|541085002|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986784|NCT05396014|541085003|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986785|NCT05396014|541085004|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986786|NCT05396014|541085005|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
149986787|NCT05396014|541085006|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986788|NCT05396014|541085007|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986789|NCT05396014|541085008|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
149986790|NCT05396014|541084966|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
149986791|NCT05396014|541084967|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986792|NCT05396014|541084968|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986793|NCT05396014|541084969|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986794|NCT05396014|541084970|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986795|NCT05396014|541084971|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986796|NCT05396014|541084972|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986797|NCT05396014|541084973|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986798|NCT05396014|541084974|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986799|NCT05396014|541084975|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986800|NCT05396014|541084976|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986801|NCT05396014|541084977|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986802|NCT05396014|541084978|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986803|NCT05396014|541084979|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986804|NCT05396014|541084980|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986805|NCT05396014|541084981|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986806|NCT05396014|541084982|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986807|NCT05396014|541084983|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986808|NCT05396014|541084984|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986809|NCT05396014|541084985|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986810|NCT05396014|541084986|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986811|NCT05396014|541084987|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986812|NCT05396014|541084988|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986813|NCT05396014|541084989|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986814|NCT05396014|541084990|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986815|NCT05396014|541084991|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986816|NCT05396014|541084992|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
149986817|NCT05396014|541084993|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986818|NCT05396014|541084994|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986819|NCT05396014|541084995|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986820|NCT05396014|541084996|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986821|NCT05396014|541084997|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986822|NCT05396014|541084998|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986823|NCT05396014|541084999|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986824|NCT05396014|541085000|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986825|NCT05396014|541085001|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986826|NCT05396014|541085002|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986827|NCT05396014|541085003|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986828|NCT05396014|541085004|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986829|NCT05396014|541085005|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986830|NCT05396014|541085006|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986831|NCT05396014|541085007|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
150053574|NCT03255083|541336681|FG001|Overall Study|Clinical progression|0|||
150178792|NCT02299375|541792042|FG000|Overall Study|Withdrawal by Subject|1|||
150178793|NCT02299375|541792043|FG001|Overall Study|Withdrawal by Subject|4|||
150178794|NCT00704184|541792048|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
150178795|NCT00704184|541792049|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
149986832|NCT05396014|541085008|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149986833|NCT05396014|541084966|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986834|NCT05396014|541084967|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986835|NCT05396014|541084968|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986836|NCT05396014|541084969|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986837|NCT05396014|541084970|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986838|NCT05396014|541084971|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986839|NCT05396014|541084972|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986840|NCT05396014|541084973|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986841|NCT05396014|541084974|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986842|NCT05396014|541084975|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986843|NCT05396014|541084976|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986844|NCT05396014|541084977|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986845|NCT05396014|541084978|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986846|NCT05396014|541084979|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
149986847|NCT05396014|541084980|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986848|NCT05396014|541084981|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986849|NCT05396014|541084982|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986850|NCT05396014|541084983|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986851|NCT05396014|541084984|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986852|NCT05396014|541084985|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986853|NCT05396014|541084986|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986854|NCT05396014|541084987|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986855|NCT05396014|541084988|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986856|NCT05396014|541084989|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986857|NCT05396014|541084990|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986858|NCT05396014|541084991|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986859|NCT05396014|541084992|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986860|NCT05396014|541084993|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986861|NCT05396014|541084994|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986862|NCT05396014|541084995|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986863|NCT05396014|541084996|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986864|NCT05396014|541084997|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986865|NCT05396014|541084998|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986866|NCT05396014|541084999|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986867|NCT05396014|541085000|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986868|NCT05396014|541085001|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986869|NCT05396014|541085002|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986870|NCT05396014|541085003|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986871|NCT05396014|541085004|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
150178796|NCT00704184|541792050|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
150178797|NCT00704184|541792051|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
150178798|NCT00704184|541792052|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
149986872|NCT05396014|541085005|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986873|NCT05396014|541085006|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986874|NCT05396014|541085007|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986875|NCT05396014|541085008|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
149986876|NCT05396014|541084966|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986877|NCT05396014|541084967|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986878|NCT05396014|541084968|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986879|NCT05396014|541084969|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
150178799|NCT00704184|541792048|FG000|Open-Label Treatment|Adverse Event|0|||
150178800|NCT00704184|541792049|FG001|Open-Label Treatment|Adverse Event|0|||
149986880|NCT05396014|541084970|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986881|NCT05396014|541084971|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986882|NCT05396014|541084972|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986883|NCT05396014|541084973|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986884|NCT05396014|541084974|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
149986885|NCT05396014|541084975|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986886|NCT05396014|541084976|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986887|NCT05396014|541084977|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986888|NCT05396014|541084978|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986889|NCT05396014|541084979|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986890|NCT05396014|541084980|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986891|NCT05396014|541084981|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986892|NCT05396014|541084982|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986893|NCT05396014|541084983|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986894|NCT05396014|541084984|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986895|NCT05396014|541084985|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986896|NCT05396014|541084986|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986897|NCT05396014|541084987|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986898|NCT05396014|541084988|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986899|NCT05396014|541084989|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986900|NCT05396014|541084990|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986901|NCT05396014|541084991|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
149986902|NCT05396014|541084992|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986903|NCT05396014|541084993|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986904|NCT05396014|541084994|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986905|NCT05396014|541084995|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986906|NCT05396014|541084996|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986907|NCT05396014|541084997|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986908|NCT05396014|541084998|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986909|NCT05396014|541084999|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986910|NCT05396014|541085000|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986911|NCT05396014|541085001|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986912|NCT05396014|541085002|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
150053575|NCT03255083|541336682|FG002|Overall Study|Clinical progression|0|||
149986913|NCT05396014|541085003|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986914|NCT05396014|541085004|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986915|NCT05396014|541085005|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149986916|NCT05396014|541085006|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
149986917|NCT05396014|541085007|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
149986918|NCT05396014|541085008|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
149986919|NCT05396014|541084966|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986920|NCT05396014|541084967|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986921|NCT05396014|541084968|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986922|NCT05396014|541084969|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986923|NCT05396014|541084970|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986924|NCT05396014|541084971|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986925|NCT05396014|541084972|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986926|NCT05396014|541084973|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986927|NCT05396014|541084974|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
149986928|NCT05396014|541084975|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986929|NCT05396014|541084976|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986930|NCT05396014|541084977|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986931|NCT05396014|541084978|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986932|NCT05396014|541084979|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986933|NCT05396014|541084980|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986934|NCT05396014|541084981|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986935|NCT05396014|541084982|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986936|NCT05396014|541084983|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986937|NCT05396014|541084984|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986938|NCT05396014|541084985|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986939|NCT05396014|541084986|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986940|NCT05396014|541084987|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986941|NCT05396014|541084988|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
149986942|NCT05396014|541084989|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986943|NCT05396014|541084990|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986944|NCT05396014|541084991|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986945|NCT05396014|541084992|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986946|NCT05396014|541084993|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986947|NCT05396014|541084994|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986948|NCT05396014|541084995|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
150053576|NCT03255083|541336683|FG003|Overall Study|Clinical progression|0|||
150053577|NCT03255083|541336680|FG000|Overall Study|Adverse Event|0|||
150053578|NCT03255083|541336681|FG001|Overall Study|Adverse Event|1|||
149986949|NCT05396014|541084996|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986950|NCT05396014|541084997|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986951|NCT05396014|541084998|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986952|NCT05396014|541084999|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986953|NCT05396014|541085000|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986954|NCT05396014|541085001|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
149986955|NCT05396014|541085002|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986956|NCT05396014|541085003|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986957|NCT05396014|541085004|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986958|NCT05396014|541085005|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
149986959|NCT05396014|541085006|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986960|NCT05396014|541085007|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
149986961|NCT05396014|541085008|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
149986962|NCT05396014|541084966|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986963|NCT05396014|541084967|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986964|NCT05396014|541084968|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986965|NCT05396014|541084969|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986966|NCT05396014|541084970|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986967|NCT05396014|541084971|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986968|NCT05396014|541084972|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986969|NCT05396014|541084973|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986970|NCT05396014|541084974|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986971|NCT05396014|541084975|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986972|NCT05396014|541084976|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986973|NCT05396014|541084977|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986974|NCT05396014|541084978|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986975|NCT05396014|541084979|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
149986976|NCT05396014|541084980|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986977|NCT05396014|541084981|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986978|NCT05396014|541084982|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986979|NCT05396014|541084983|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986980|NCT05396014|541084984|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986981|NCT05396014|541084985|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986982|NCT05396014|541084986|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986983|NCT05396014|541084987|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986984|NCT05396014|541084988|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986985|NCT05396014|541084989|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986986|NCT05396014|541084990|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986987|NCT05396014|541084991|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986988|NCT05396014|541084992|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
149986989|NCT05396014|541084993|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986990|NCT05396014|541084994|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986991|NCT05396014|541084995|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986992|NCT05396014|541084996|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986993|NCT05396014|541084997|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986994|NCT05396014|541084998|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986995|NCT05396014|541084999|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986996|NCT05396014|541085000|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
149986997|NCT05396014|541085001|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986998|NCT05396014|541085002|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149986999|NCT05396014|541085003|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149987000|NCT05396014|541085004|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149987001|NCT05396014|541085005|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149987002|NCT05396014|541085006|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149987003|NCT05396014|541085007|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
149987004|NCT05396014|541085008|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
149987005|NCT05396014|541084966|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987006|NCT05396014|541084967|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987007|NCT05396014|541084968|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
150178801|NCT00704184|541792050|FG002|Open-Label Treatment|Adverse Event|2|||
150178802|NCT00704184|541792051|FG003|Open-Label Treatment|Adverse Event|0|||
149987008|NCT05396014|541084969|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987009|NCT05396014|541084970|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987010|NCT05396014|541084971|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987011|NCT05396014|541084972|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987012|NCT05396014|541084973|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987013|NCT05396014|541084974|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987014|NCT05396014|541084975|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
150053579|NCT03255083|541336682|FG002|Overall Study|Adverse Event|0|||
149987015|NCT05396014|541084976|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987016|NCT05396014|541084977|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987017|NCT05396014|541084978|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987018|NCT05396014|541084979|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987019|NCT05396014|541084980|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987020|NCT05396014|541084981|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987021|NCT05396014|541084982|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987022|NCT05396014|541084983|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987023|NCT05396014|541084984|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987024|NCT05396014|541084985|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987025|NCT05396014|541084986|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987026|NCT05396014|541084987|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987027|NCT05396014|541084988|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987028|NCT05396014|541084989|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987029|NCT05396014|541084990|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987030|NCT05396014|541084991|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987031|NCT05396014|541084992|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
149987032|NCT05396014|541084993|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987033|NCT05396014|541084994|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987034|NCT05396014|541084995|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987035|NCT05396014|541084996|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987036|NCT05396014|541084997|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987037|NCT05396014|541084998|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987038|NCT05396014|541084999|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987039|NCT05396014|541085000|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987040|NCT05396014|541085001|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987041|NCT05396014|541085002|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987042|NCT05396014|541085003|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987043|NCT05396014|541085004|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987044|NCT05396014|541085005|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987045|NCT05396014|541085006|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987046|NCT05396014|541085007|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987047|NCT05396014|541085008|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
149987048|NCT02789345|541085014|FG000|Overall Study|Adverse Event|0|||
149987049|NCT02789345|541085015|FG001|Overall Study|Adverse Event|0|||
149987050|NCT02789345|541085016|FG002|Overall Study|Adverse Event|1|||
149987051|NCT02789345|541085014|FG000|Overall Study|Death|0|||
149987052|NCT02789345|541085015|FG001|Overall Study|Death|0|||
149987053|NCT02789345|541085016|FG002|Overall Study|Death|1|||
149987054|NCT02789345|541085014|FG000|Overall Study|Physician Decision|2|||
149987055|NCT02789345|541085015|FG001|Overall Study|Physician Decision|0|||
149987056|NCT02789345|541085016|FG002|Overall Study|Physician Decision|1|||
149987057|NCT02789345|541085014|FG000|Overall Study|Progressive Disease|1|||
149987058|NCT02789345|541085015|FG001|Overall Study|Progressive Disease|3|||
149987059|NCT02789345|541085016|FG002|Overall Study|Progressive Disease|14|||
149987060|NCT03379259|541085017|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
149987061|NCT03379259|541085018|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
149987062|NCT03379259|541085019|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
149987063|NCT03379259|541085020|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
149987064|NCT03379259|541085021|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
149987065|NCT03379259|541085022|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
149987066|NCT03379259|541085017|FG000|Overall Study|Death|0|||
149987067|NCT03379259|541085018|FG001|Overall Study|Death|1|||
149987068|NCT03379259|541085019|FG002|Overall Study|Death|2|||
149987069|NCT03379259|541085020|FG003|Overall Study|Death|1|||
149987070|NCT03379259|541085021|FG004|Overall Study|Death|4|||
149987071|NCT03379259|541085022|FG005|Overall Study|Death|2|||
149987072|NCT03379259|541085017|FG000|Overall Study|Withdrawal by Subject|0|||
149987073|NCT03379259|541085018|FG001|Overall Study|Withdrawal by Subject|0|||
149987074|NCT03379259|541085019|FG002|Overall Study|Withdrawal by Subject|1|||
149987075|NCT03379259|541085020|FG003|Overall Study|Withdrawal by Subject|0|||
149987076|NCT03379259|541085021|FG004|Overall Study|Withdrawal by Subject|2|||
149987077|NCT03379259|541085022|FG005|Overall Study|Withdrawal by Subject|0|||
149987078|NCT03379259|541085017|FG000|Overall Study|Study terminated by sponsor|0|||
149987079|NCT03379259|541085018|FG001|Overall Study|Study terminated by sponsor|0|||
150053580|NCT03255083|541336683|FG003|Overall Study|Adverse Event|0|||
149987080|NCT03379259|541085019|FG002|Overall Study|Study terminated by sponsor|0|||
149987081|NCT03379259|541085020|FG003|Overall Study|Study terminated by sponsor|1|||
149987082|NCT03379259|541085021|FG004|Overall Study|Study terminated by sponsor|1|||
149987083|NCT03379259|541085022|FG005|Overall Study|Study terminated by sponsor|4|||
149987084|NCT03379259|541085017|FG000|Overall Study|Disease progression|0|||
149987085|NCT03379259|541085018|FG001|Overall Study|Disease progression|0|||
149987086|NCT03379259|541085019|FG002|Overall Study|Disease progression|0|||
149987087|NCT03379259|541085020|FG003|Overall Study|Disease progression|1|||
149987088|NCT03379259|541085021|FG004|Overall Study|Disease progression|0|||
149987089|NCT03379259|541085022|FG005|Overall Study|Disease progression|1|||
149987090|NCT03379259|541085017|FG000|Overall Study|Lost to Follow-up|0|||
149987091|NCT03379259|541085018|FG001|Overall Study|Lost to Follow-up|0|||
149987092|NCT03379259|541085019|FG002|Overall Study|Lost to Follow-up|0|||
149987093|NCT03379259|541085020|FG003|Overall Study|Lost to Follow-up|0|||
149987094|NCT03379259|541085021|FG004|Overall Study|Lost to Follow-up|1|||
149987095|NCT03379259|541085022|FG005|Overall Study|Lost to Follow-up|0|||
149987096|NCT03379259|541085017|FG000|Overall Study|Deteriorating condition|0|||
149987097|NCT03379259|541085018|FG001|Overall Study|Deteriorating condition|0|||
149987098|NCT03379259|541085019|FG002|Overall Study|Deteriorating condition|0|||
149987099|NCT03379259|541085020|FG003|Overall Study|Deteriorating condition|0|||
149987100|NCT03379259|541085021|FG004|Overall Study|Deteriorating condition|1|||
149987101|NCT03379259|541085022|FG005|Overall Study|Deteriorating condition|0|||
149987102|NCT02836717|541085023|FG000|Test Phase|Lack of Efficacy|14|||
149987103|NCT02836717|541085024|FG001|Test Phase|Lack of Efficacy|8|||
149987104|NCT02836717|541085025|FG002|Test Phase|Lack of Efficacy|0|||
149987105|NCT02836717|541085023|FG000|Study Phase|Adverse Event|2|||
149987106|NCT02836717|541085024|FG001|Study Phase|Adverse Event|0|||
149987107|NCT02836717|541085025|FG002|Study Phase|Adverse Event|0|||
149987108|NCT02836717|541085023|FG000|Study Phase|Lack of Efficacy|8|||
149987109|NCT02836717|541085024|FG001|Study Phase|Lack of Efficacy|6|||
149987110|NCT02836717|541085025|FG002|Study Phase|Lack of Efficacy|1|||
149987111|NCT02836717|541085023|FG000|Study Phase|Withdrawal by Subject|1|||
149987112|NCT02836717|541085024|FG001|Study Phase|Withdrawal by Subject|0|||
149987113|NCT02836717|541085025|FG002|Study Phase|Withdrawal by Subject|0|||
149987114|NCT02836717|541085023|FG000|Study Phase|Death|1|||
149987115|NCT02836717|541085024|FG001|Study Phase|Death|0|||
149987116|NCT02836717|541085025|FG002|Study Phase|Death|0|||
149987117|NCT02836717|541085023|FG000|Study Phase|abdominal surgeries|2|||
149987118|NCT02836717|541085024|FG001|Study Phase|abdominal surgeries|1|||
149987119|NCT02836717|541085025|FG002|Study Phase|abdominal surgeries|0|||
149987120|NCT03462641|541085026|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
149987121|NCT03462641|541085027|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
149987122|NCT03462641|541085026|FG000|Visit 2|Withdrawal by Subject|0|||
149987123|NCT03462641|541085027|FG001|Visit 2|Withdrawal by Subject|1|||
149987124|NCT01804049|541085028|FG000|Overall Study|Adverse Event|2|||
149987125|NCT01804049|541085029|FG001|Overall Study|Adverse Event|10|||
149987126|NCT01804049|541085028|FG000|Overall Study|Lost to Follow-up|2|||
149987127|NCT01804049|541085029|FG001|Overall Study|Lost to Follow-up|1|||
149987128|NCT01804049|541085028|FG000|Overall Study|Decreased interest/personal|4|||
149987129|NCT01804049|541085029|FG001|Overall Study|Decreased interest/personal|5|||
149987130|NCT01804049|541085028|FG000|Overall Study|Other health concerns|2|||
149987131|NCT01804049|541085029|FG001|Overall Study|Other health concerns|7|||
149987132|NCT01804049|541085028|FG000|Overall Study|Moved out of area|0|||
149987133|NCT01804049|541085029|FG001|Overall Study|Moved out of area|7|||
149987134|NCT01804049|541085028|FG000|Overall Study|other MD recommended|1|||
149987135|NCT01804049|541085029|FG001|Overall Study|other MD recommended|1|||
149987136|NCT01804049|541085028|FG000|Overall Study|Enrollment in dual studies|0|||
149987137|NCT01804049|541085029|FG001|Overall Study|Enrollment in dual studies|1|||
149987138|NCT02201329|541085037|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
149987139|NCT02201329|541085037|FG000|Overall Study|Withdrawal by Subject|2|||
149987140|NCT01262638|541085038|FG000|Overall Study|Adverse Event|3|||
149987141|NCT01262638|541085039|FG001|Overall Study|Adverse Event|4|||
149987142|NCT01262638|541085040|FG002|Overall Study|Adverse Event|3|||
149987143|NCT01262638|541085041|FG003|Overall Study|Adverse Event|4|||
149987144|NCT01262638|541085038|FG000|Overall Study|Protocol Violation|1|||
149987145|NCT01262638|541085039|FG001|Overall Study|Protocol Violation|0|||
149987146|NCT01262638|541085040|FG002|Overall Study|Protocol Violation|0|||
149987147|NCT01262638|541085041|FG003|Overall Study|Protocol Violation|1|||
149987148|NCT01262638|541085038|FG000|Overall Study|Withdrawal by Subject|2|||
149987149|NCT01262638|541085039|FG001|Overall Study|Withdrawal by Subject|1|||
149987150|NCT01262638|541085040|FG002|Overall Study|Withdrawal by Subject|0|||
149987151|NCT01262638|541085041|FG003|Overall Study|Withdrawal by Subject|1|||
149987152|NCT01262638|541085038|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
149987153|NCT01262638|541085039|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
150178803|NCT00704184|541792052|FG004|Open-Label Treatment|Adverse Event|1|||
150178804|NCT00704184|541792048|FG000|Open-Label Treatment|Lack of Efficacy|0|||
150178805|NCT00704184|541792049|FG001|Open-Label Treatment|Lack of Efficacy|2|||
150178806|NCT00704184|541792050|FG002|Open-Label Treatment|Lack of Efficacy|2|||
150178807|NCT00704184|541792051|FG003|Open-Label Treatment|Lack of Efficacy|2|||
150178808|NCT00704184|541792052|FG004|Open-Label Treatment|Lack of Efficacy|1|||
150178809|NCT00704184|541792048|FG000|Open-Label Treatment|Physician Decision|0|||
150178810|NCT00704184|541792049|FG001|Open-Label Treatment|Physician Decision|0|||
150178811|NCT00704184|541792050|FG002|Open-Label Treatment|Physician Decision|0|||
150178812|NCT00704184|541792051|FG003|Open-Label Treatment|Physician Decision|0|||
150178813|NCT00704184|541792052|FG004|Open-Label Treatment|Physician Decision|1|||
150178814|NCT00704184|541792048|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
150178815|NCT00704184|541792049|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
150178816|NCT00704184|541792050|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
150178817|NCT00704184|541792051|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
150178818|NCT00704184|541792052|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
150178819|NCT01998984|541793839|FG000|Overall Study|Adverse Event|0|||
150178820|NCT01998984|541793840|FG001|Overall Study|Adverse Event|0|||
150178821|NCT01998984|541793841|FG002|Overall Study|Adverse Event|0|||
150178822|NCT01998984|541793842|FG003|Overall Study|Adverse Event|1|||
150178823|NCT01998984|541793839|FG000|Overall Study|Lost to Follow-up|0|||
150178824|NCT01998984|541793840|FG001|Overall Study|Lost to Follow-up|1|||
150178825|NCT01998984|541793841|FG002|Overall Study|Lost to Follow-up|0|||
150178826|NCT01998984|541793842|FG003|Overall Study|Lost to Follow-up|1|||
150178827|NCT01998984|541793839|FG000|Overall Study|Withdrawal by Subject|0|||
150178828|NCT01998984|541793840|FG001|Overall Study|Withdrawal by Subject|0|||
149987154|NCT01262638|541085040|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
149987155|NCT01262638|541085041|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
149987156|NCT01262638|541085038|FG000|Overall Study|Lost to Follow-up|1|||
149987157|NCT01262638|541085039|FG001|Overall Study|Lost to Follow-up|1|||
149987158|NCT01262638|541085040|FG002|Overall Study|Lost to Follow-up|1|||
149987159|NCT01262638|541085041|FG003|Overall Study|Lost to Follow-up|1|||
149987160|NCT01262638|541085038|FG000|Overall Study|Participant Went Out of Town|0|||
149987161|NCT01262638|541085039|FG001|Overall Study|Participant Went Out of Town|0|||
149987162|NCT01262638|541085040|FG002|Overall Study|Participant Went Out of Town|1|||
149987163|NCT01262638|541085041|FG003|Overall Study|Participant Went Out of Town|0|||
149987164|NCT01369199|541085044|FG000|Overall Study|Withdrawal by Subject|1|||
149987165|NCT01369199|541085044|FG000|Overall Study|Lost to Follow-up|2|||
149987166|NCT01071252|541085045|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
149987167|NCT01071252|541085046|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
149987168|NCT01071252|541085047|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
149987169|NCT01071252|541085048|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
149987170|NCT01071252|541085049|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
149987171|NCT01071252|541085045|FG000|Overall Study|Withdrawal by Subject|8|||
149987172|NCT01071252|541085046|FG001|Overall Study|Withdrawal by Subject|2|||
149987173|NCT01071252|541085047|FG002|Overall Study|Withdrawal by Subject|1|||
149987174|NCT01071252|541085048|FG003|Overall Study|Withdrawal by Subject|2|||
149987175|NCT01071252|541085049|FG004|Overall Study|Withdrawal by Subject|3|||
149987176|NCT01071252|541085045|FG000|Overall Study|administrative problems|1|||
149987177|NCT01071252|541085046|FG001|Overall Study|administrative problems|1|||
149987178|NCT01071252|541085047|FG002|Overall Study|administrative problems|0|||
150178829|NCT01998984|541793841|FG002|Overall Study|Withdrawal by Subject|1|||
150178830|NCT01998984|541793842|FG003|Overall Study|Withdrawal by Subject|0|||
150178831|NCT01998984|541793839|FG000|Overall Study|Other|0|||
150178832|NCT01998984|541793840|FG001|Overall Study|Other|0|||
150178833|NCT01998984|541793841|FG002|Overall Study|Other|0|||
150178834|NCT01998984|541793842|FG003|Overall Study|Other|1|||
150178835|NCT03346538|541793844|FG000|Overall Study|Physician Decision|0|||
150178836|NCT03346538|541793845|FG001|Overall Study|Physician Decision|1|||
150178837|NCT03346538|541793846|FG002|Overall Study|Physician Decision|0|||
150178838|NCT03346538|541793844|FG000|Overall Study|Withdrawal by Subject|3|||
150178839|NCT03346538|541793845|FG001|Overall Study|Withdrawal by Subject|2|||
150178840|NCT03346538|541793846|FG002|Overall Study|Withdrawal by Subject|0|||
150178841|NCT03346538|541793844|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
150178842|NCT03346538|541793845|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
150178843|NCT03346538|541793846|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
150178844|NCT05672667|541793847|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
149987179|NCT01071252|541085048|FG003|Overall Study|administrative problems|2|||
150178845|NCT04279574|541793851|FG000|Overall Study|Death|1|||
150178846|NCT04279574|541793852|FG001|Overall Study|Death|0|||
149987180|NCT01071252|541085049|FG004|Overall Study|administrative problems|1|||
149987181|NCT01071252|541085045|FG000|Overall Study|Lost to Follow-up|1|||
149987182|NCT01071252|541085046|FG001|Overall Study|Lost to Follow-up|0|||
149987183|NCT01071252|541085047|FG002|Overall Study|Lost to Follow-up|1|||
149987184|NCT01071252|541085048|FG003|Overall Study|Lost to Follow-up|2|||
149987185|NCT01071252|541085049|FG004|Overall Study|Lost to Follow-up|0|||
149987186|NCT01071252|541085045|FG000|Overall Study|Adverse Event|1|||
149987187|NCT01071252|541085046|FG001|Overall Study|Adverse Event|1|||
149987188|NCT01071252|541085047|FG002|Overall Study|Adverse Event|0|||
149987189|NCT01071252|541085048|FG003|Overall Study|Adverse Event|1|||
149987190|NCT01071252|541085049|FG004|Overall Study|Adverse Event|0|||
149987191|NCT01071252|541085045|FG000|Overall Study|Death|0|||
149987192|NCT01071252|541085046|FG001|Overall Study|Death|0|||
149987193|NCT01071252|541085047|FG002|Overall Study|Death|0|||
149987194|NCT01071252|541085048|FG003|Overall Study|Death|0|||
149987195|NCT01071252|541085049|FG004|Overall Study|Death|1|||
149987196|NCT01066104|541085050|FG000|Overall Study|Adverse Event|1|||
149987197|NCT01066104|541085051|FG001|Overall Study|Adverse Event|1|||
149987198|NCT01066104|541085050|FG000|Overall Study|Protocol Violation|1|||
149987199|NCT01066104|541085051|FG001|Overall Study|Protocol Violation|0|||
149987200|NCT00244725|541085054|FG000|Overall Study|Lost to Follow-up|3|||
149987201|NCT00244725|541085055|FG001|Overall Study|Lost to Follow-up|4|||
149987202|NCT00244725|541085056|FG002|Overall Study|Lost to Follow-up|9|||
149987203|NCT00244725|541085057|FG003|Overall Study|Lost to Follow-up|2|||
149987204|NCT00244725|541085054|FG000|Overall Study|Withdrawal by Subject|9|||
149987205|NCT00244725|541085055|FG001|Overall Study|Withdrawal by Subject|7|||
149987206|NCT00244725|541085056|FG002|Overall Study|Withdrawal by Subject|7|||
149987207|NCT00244725|541085057|FG003|Overall Study|Withdrawal by Subject|8|||
149987208|NCT00244725|541085054|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
149987209|NCT00244725|541085055|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
149987210|NCT00244725|541085056|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
149987211|NCT00244725|541085057|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
149987212|NCT00244725|541085054|FG000|Overall Study|Physician Decision|3|||
149987213|NCT00244725|541085055|FG001|Overall Study|Physician Decision|0|||
149987214|NCT00244725|541085056|FG002|Overall Study|Physician Decision|1|||
149987215|NCT00244725|541085057|FG003|Overall Study|Physician Decision|2|||
149987216|NCT00244725|541085054|FG000|Overall Study|Adverse Events|3|||
149987217|NCT00244725|541085055|FG001|Overall Study|Adverse Events|1|||
149987218|NCT00244725|541085056|FG002|Overall Study|Adverse Events|4|||
149987219|NCT00244725|541085057|FG003|Overall Study|Adverse Events|4|||
149987220|NCT00244725|541085054|FG000|Overall Study|Withdrwal by participant|1|||
149987221|NCT00244725|541085055|FG001|Overall Study|Withdrwal by participant|0|||
149987222|NCT00244725|541085056|FG002|Overall Study|Withdrwal by participant|0|||
149987223|NCT00244725|541085057|FG003|Overall Study|Withdrwal by participant|1|||
149987224|NCT00244725|541085054|FG000|Overall Study|Liver function test abnormality|2|||
149987225|NCT00244725|541085055|FG001|Overall Study|Liver function test abnormality|0|||
149987226|NCT00244725|541085056|FG002|Overall Study|Liver function test abnormality|0|||
149987227|NCT00244725|541085057|FG003|Overall Study|Liver function test abnormality|1|||
149987228|NCT00244725|541085054|FG000|Overall Study|Sponsor withdrew the participant|1|||
149987229|NCT00244725|541085055|FG001|Overall Study|Sponsor withdrew the participant|0|||
149987230|NCT00244725|541085056|FG002|Overall Study|Sponsor withdrew the participant|0|||
149987231|NCT00244725|541085057|FG003|Overall Study|Sponsor withdrew the participant|1|||
149987232|NCT00244725|541085054|FG000|Overall Study|Mediciation Error|0|||
149987233|NCT00244725|541085055|FG001|Overall Study|Mediciation Error|1|||
149987234|NCT00244725|541085056|FG002|Overall Study|Mediciation Error|0|||
149987235|NCT00244725|541085057|FG003|Overall Study|Mediciation Error|0|||
149987236|NCT00244725|541085054|FG000|Overall Study|Rehab Refused to allow participantion|0|||
149987237|NCT00244725|541085055|FG001|Overall Study|Rehab Refused to allow participantion|1|||
149987238|NCT00244725|541085056|FG002|Overall Study|Rehab Refused to allow participantion|0|||
149987239|NCT00244725|541085057|FG003|Overall Study|Rehab Refused to allow participantion|0|||
149987240|NCT00244725|541085054|FG000|Overall Study|Headache|0|||
149987241|NCT00244725|541085055|FG001|Overall Study|Headache|1|||
149987242|NCT00244725|541085056|FG002|Overall Study|Headache|0|||
149987243|NCT00244725|541085057|FG003|Overall Study|Headache|0|||
149987244|NCT00244725|541085054|FG000|Overall Study|Received prohibited medication|0|||
149987245|NCT00244725|541085055|FG001|Overall Study|Received prohibited medication|1|||
149987246|NCT00244725|541085056|FG002|Overall Study|Received prohibited medication|0|||
149987247|NCT00244725|541085057|FG003|Overall Study|Received prohibited medication|1|||
149987248|NCT00244725|541085054|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
149987249|NCT00244725|541085055|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
149987250|NCT00244725|541085056|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
149987251|NCT00244725|541085057|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
149987252|NCT00244725|541085054|FG000|Overall Study|Administrative reason|0|||
149987253|NCT00244725|541085055|FG001|Overall Study|Administrative reason|0|||
149987254|NCT00244725|541085056|FG002|Overall Study|Administrative reason|1|||
149987255|NCT00244725|541085057|FG003|Overall Study|Administrative reason|0|||
149987256|NCT00244725|541085054|FG000|Overall Study|Vomit|0|||
149987257|NCT00244725|541085055|FG001|Overall Study|Vomit|0|||
149987258|NCT00244725|541085056|FG002|Overall Study|Vomit|1|||
149987259|NCT00244725|541085057|FG003|Overall Study|Vomit|0|||
149987260|NCT00244725|541085054|FG000|Overall Study|Failed to follow-up|0|||
149987261|NCT00244725|541085055|FG001|Overall Study|Failed to follow-up|0|||
149987262|NCT00244725|541085056|FG002|Overall Study|Failed to follow-up|1|||
149987263|NCT00244725|541085057|FG003|Overall Study|Failed to follow-up|1|||
149987264|NCT04004221|541085058|FG000|Overall Study|Death|89|||
149987265|NCT04004221|541085058|FG000|Overall Study|Withdrawal by Subject|5|||
149987266|NCT04004221|541085058|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
149987267|NCT04004221|541085058|FG000|Overall Study|Sponsor Decision|9|||
149987268|NCT04004221|541085058|FG000|Overall Study|Participant refused to enter LTE|1|||
149987269|NCT02122146|541085059|FG000|Part 1: Dose Escalation|Death|0|||
149987270|NCT02122146|541085060|FG001|Part 1: Dose Escalation|Death|1|||
149987271|NCT02122146|541085061|FG002|Part 1: Dose Escalation|Death|1|||
149987272|NCT02122146|541085062|FG003|Part 1: Dose Escalation|Death|0|||
149987273|NCT02122146|541085063|FG004|Part 1: Dose Escalation|Death|0|||
149987274|NCT02122146|541085064|FG005|Part 1: Dose Escalation|Death|0|||
149987275|NCT02122146|541085065|FG006|Part 1: Dose Escalation|Death|0|||
149987276|NCT02122146|541085066|FG007|Part 1: Dose Escalation|Death|0|||
149987277|NCT02122146|541085059|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987278|NCT02122146|541085060|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987279|NCT02122146|541085061|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
150178847|NCT04279574|541793851|FG000|Overall Study|lost restoration, tooth fracture|1|||
149987280|NCT02122146|541085062|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987281|NCT02122146|541085063|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
149987282|NCT02122146|541085064|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987283|NCT02122146|541085065|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987284|NCT02122146|541085066|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
149987285|NCT02122146|541085059|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987286|NCT02122146|541085060|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987287|NCT02122146|541085061|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987288|NCT02122146|541085062|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
149987289|NCT02122146|541085063|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987290|NCT02122146|541085064|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987291|NCT02122146|541085065|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987292|NCT02122146|541085066|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149987293|NCT02122146|541085059|FG000|Part 1: Dose Escalation|Other|1|||
149987294|NCT02122146|541085060|FG001|Part 1: Dose Escalation|Other|0|||
149987295|NCT02122146|541085061|FG002|Part 1: Dose Escalation|Other|0|||
149987296|NCT02122146|541085062|FG003|Part 1: Dose Escalation|Other|0|||
149987297|NCT02122146|541085063|FG004|Part 1: Dose Escalation|Other|0|||
149987298|NCT02122146|541085064|FG005|Part 1: Dose Escalation|Other|1|||
149987299|NCT02122146|541085065|FG006|Part 1: Dose Escalation|Other|1|||
149987300|NCT02122146|541085066|FG007|Part 1: Dose Escalation|Other|2|||
149987301|NCT01970241|541085067|FG000|Overall Study|Withdrawal by Subject|2|||
149987302|NCT01970241|541085068|FG001|Overall Study|Withdrawal by Subject|0|||
149987303|NCT01970241|541085067|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
149987304|NCT01970241|541085068|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
149987305|NCT03472495|541085069|FG000|Overall Study|Treatment no longer indicated|1|||
149987306|NCT03472495|541085070|FG001|Overall Study|Treatment no longer indicated|2|||
149987307|NCT03472495|541085069|FG000|Overall Study|Physician Decision|0|||
150178848|NCT04279574|541793852|FG001|Overall Study|lost restoration, tooth fracture|0|||
149987308|NCT03472495|541085070|FG001|Overall Study|Physician Decision|2|||
149987309|NCT00992056|541085073|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
149987310|NCT00992056|541085074|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
149987311|NCT00992056|541085073|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
149987312|NCT00992056|541085074|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
149987313|NCT01001767|541085077|FG000|Overall Study|no baseline study performed|1|||
149987314|NCT01001767|541085078|FG001|Overall Study|no baseline study performed|0|||
149987315|NCT01001767|541085077|FG000|Overall Study|Protocol Violation|1|||
149987316|NCT01001767|541085078|FG001|Overall Study|Protocol Violation|0|||
149987317|NCT01001767|541085077|FG000|Overall Study|Lost to Follow-up|1|||
149987318|NCT01001767|541085078|FG001|Overall Study|Lost to Follow-up|0|||
149987319|NCT01001767|541085077|FG000|Overall Study|Physician Decision|1|||
149987320|NCT01001767|541085078|FG001|Overall Study|Physician Decision|0|||
149987321|NCT02584452|541085079|FG000|Overall Study|Physician Decision|1|||
149987322|NCT02584452|541085080|FG001|Overall Study|Physician Decision|1|||
149987323|NCT02584452|541085079|FG000|Overall Study|Lost to Follow-up|1|||
149987324|NCT02584452|541085080|FG001|Overall Study|Lost to Follow-up|1|||
149987325|NCT02038946|541085081|FG000|Overall Study|Death|5|||
149987326|NCT02038946|541085081|FG000|Overall Study|Withdrawal by Subject|3|||
149987327|NCT02038946|541085081|FG000|Overall Study|Lost to Follow-up|2|||
149987328|NCT02038946|541085081|FG000|Overall Study|Other reasons|2|||
149987329|NCT01558596|541085084|FG000|Overall Study|Withdrawal by Subject|1|||
149987330|NCT01558596|541085085|FG001|Overall Study|Withdrawal by Subject|0|||
149987331|NCT01558596|541085084|FG000|Overall Study|surgery elsewhere or cancelled|1|||
149987332|NCT01558596|541085085|FG001|Overall Study|surgery elsewhere or cancelled|1|||
149987333|NCT01558596|541085084|FG000|Overall Study|Protocol Violation|1|||
149987334|NCT01558596|541085085|FG001|Overall Study|Protocol Violation|0|||
149987335|NCT01916824|541085088|FG000|Overall Study|Lost to Follow-up|3|||
149987336|NCT01916824|541085089|FG001|Overall Study|Lost to Follow-up|6|||
149987337|NCT01916824|541085088|FG000|Overall Study|Physician Decision|2|||
149987338|NCT01916824|541085089|FG001|Overall Study|Physician Decision|0|||
149987339|NCT01916824|541085088|FG000|Overall Study|Withdrawal by Subject|2|||
149987340|NCT01916824|541085089|FG001|Overall Study|Withdrawal by Subject|3|||
149987341|NCT00771927|541085094|FG000|Overall Study|Adverse Event|100|||
149987342|NCT00771927|541085095|FG001|Overall Study|Adverse Event|105|||
149987343|NCT00771927|541085094|FG000|Overall Study|Lack of Efficacy|70|||
149987344|NCT00771927|541085095|FG001|Overall Study|Lack of Efficacy|42|||
149987345|NCT00771927|541085094|FG000|Overall Study|Lost to Follow-up|46|||
149987346|NCT00771927|541085095|FG001|Overall Study|Lost to Follow-up|46|||
149987347|NCT00771927|541085094|FG000|Overall Study|Withdrawal by Subject|16|||
149987348|NCT00771927|541085095|FG001|Overall Study|Withdrawal by Subject|17|||
149987349|NCT00771927|541085094|FG000|Overall Study|Other reason|23|||
149987350|NCT00771927|541085095|FG001|Overall Study|Other reason|27|||
149987351|NCT03835481|541085096|FG000|Double-blind Period|Other not stated below|0|||
149987352|NCT03835481|541085097|FG001|Double-blind Period|Other not stated below|0|||
149987353|NCT03835481|541085098|FG002|Double-blind Period|Other not stated below|0|||
149987354|NCT03835481|541085099|FG003|Double-blind Period|Other not stated below|1|||
149987355|NCT03835481|541085100|FG004|Double-blind Period|Other not stated below|1|||
149987356|NCT03835481|541085096|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
149987357|NCT03835481|541085097|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
149987358|NCT03835481|541085098|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
149987359|NCT03835481|541085099|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
149987360|NCT03835481|541085100|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
149987361|NCT03835481|541085096|FG000|Double-blind Period|Withdrawal by Subject|0|||
149987362|NCT03835481|541085097|FG001|Double-blind Period|Withdrawal by Subject|0|||
149987363|NCT03835481|541085098|FG002|Double-blind Period|Withdrawal by Subject|1|||
149987364|NCT03835481|541085099|FG003|Double-blind Period|Withdrawal by Subject|0|||
149987365|NCT03835481|541085100|FG004|Double-blind Period|Withdrawal by Subject|5|||
149987366|NCT03835481|541085096|FG000|Double-blind Period|Lost to Follow-up|0|||
149987367|NCT03835481|541085097|FG001|Double-blind Period|Lost to Follow-up|0|||
149987368|NCT03835481|541085098|FG002|Double-blind Period|Lost to Follow-up|0|||
149987369|NCT03835481|541085099|FG003|Double-blind Period|Lost to Follow-up|1|||
149987370|NCT03835481|541085100|FG004|Double-blind Period|Lost to Follow-up|0|||
149987371|NCT03835481|541085096|FG000|Double-blind Period|Protocol Violation|0|||
149987372|NCT03835481|541085097|FG001|Double-blind Period|Protocol Violation|2|||
149987373|NCT03835481|541085098|FG002|Double-blind Period|Protocol Violation|0|||
149987374|NCT03835481|541085099|FG003|Double-blind Period|Protocol Violation|1|||
149987375|NCT03835481|541085100|FG004|Double-blind Period|Protocol Violation|0|||
149987376|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
149987377|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
149987378|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
149987379|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
149987380|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
149987381|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
149987382|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
149987383|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
150178849|NCT04279574|541793851|FG000|Overall Study|Lost to Follow-up|0|||
149987384|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
149987385|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
149987386|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
149987387|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
149987388|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
149987389|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
149987390|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
149987391|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
149987392|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
149987393|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
149987394|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
149987395|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
149987396|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
149987397|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
149987398|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
149987399|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
149987400|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
149987401|NCT03835481|541085096|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
149987402|NCT03835481|541085097|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
149987403|NCT03835481|541085098|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
149987404|NCT03835481|541085099|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
149987405|NCT03835481|541085100|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
149987406|NCT01270880|541085107|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
149987407|NCT01221753|541085114|FG000|Overall Study|Adverse Event|1|||
149987408|NCT04552288|541085115|FG000|Overall Study|Death|3|||
149987409|NCT04552288|541085115|FG000|Overall Study|Lost to Follow-up|6|||
149987410|NCT04552288|541085115|FG000|Overall Study|Physician Decision|3|||
149987411|NCT04552288|541085115|FG000|Overall Study|Protocol Violation|9|||
149987412|NCT04552288|541085115|FG000|Overall Study|Withdrawal by Subject|6|||
149987413|NCT04552288|541085115|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
149987414|NCT04532294|541085116|FG000|Overall Study|Withdrawal by Subject|0|||
149987415|NCT04532294|541085117|FG001|Overall Study|Withdrawal by Subject|0|||
149987416|NCT04532294|541085118|FG002|Overall Study|Withdrawal by Subject|1|||
149987417|NCT04532294|541085116|FG000|Overall Study|Participants Not Dosed|0|||
149987418|NCT04532294|541085117|FG001|Overall Study|Participants Not Dosed|0|||
149987419|NCT04532294|541085118|FG002|Overall Study|Participants Not Dosed|2|||
149987420|NCT03089047|541085119|FG000|Overall Study|Lost to Follow-up|1|||
149987421|NCT03089047|541085120|FG001|Overall Study|Lost to Follow-up|0|||
149987422|NCT03599518|541085121|FG000|Overall Study|Clinical progression|0|||
149987423|NCT03599518|541085122|FG001|Overall Study|Clinical progression|0|||
149987424|NCT03599518|541085123|FG002|Overall Study|Clinical progression|0|||
149987425|NCT03599518|541085124|FG003|Overall Study|Clinical progression|0|||
149987426|NCT03599518|541085125|FG004|Overall Study|Clinical progression|1|||
149987427|NCT03599518|541085121|FG000|Overall Study|Adverse Event|0|||
149987428|NCT03599518|541085122|FG001|Overall Study|Adverse Event|0|||
149987429|NCT03599518|541085123|FG002|Overall Study|Adverse Event|0|||
149987430|NCT03599518|541085124|FG003|Overall Study|Adverse Event|0|||
149987431|NCT03599518|541085125|FG004|Overall Study|Adverse Event|1|||
149987432|NCT03599518|541085121|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
149987433|NCT03599518|541085122|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
149987434|NCT03599518|541085123|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
149987435|NCT03599518|541085124|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
149987436|NCT03599518|541085125|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
149987437|NCT03599518|541085121|FG000|Overall Study|Participant withdrawal from study treatment|0|||
149987438|NCT03599518|541085122|FG001|Overall Study|Participant withdrawal from study treatment|0|||
149987439|NCT03599518|541085123|FG002|Overall Study|Participant withdrawal from study treatment|1|||
149987440|NCT03599518|541085124|FG003|Overall Study|Participant withdrawal from study treatment|0|||
149987441|NCT03599518|541085125|FG004|Overall Study|Participant withdrawal from study treatment|0|||
149987442|NCT00375505|541085129|FG000|Overall Study|Adverse Event|1|||
149987443|NCT00375505|541085130|FG001|Overall Study|Adverse Event|2|||
149987444|NCT00005947|541085135|FG000|Overall Study|Death|54|||
149987445|NCT00005947|541085136|FG001|Overall Study|Death|40|||
149987446|NCT00005947|541085135|FG000|Overall Study|Patient Refused to Continue|2|||
149987447|NCT00005947|541085136|FG001|Overall Study|Patient Refused to Continue|1|||
149987448|NCT00005947|541085135|FG000|Overall Study|Site Closure|1|||
149987449|NCT00005947|541085136|FG001|Overall Study|Site Closure|0|||
149987450|NCT02146131|541085137|FG000|Overall Study|Physician Decision|61|||
149987451|NCT02146131|541085138|FG001|Overall Study|Physician Decision|56|||
149987452|NCT02567799|541085139|FG000|Concurrent Chemoradiotherapy|Death|1|||
149987453|NCT02567799|541085140|FG001|Concurrent Chemoradiotherapy|Death|0|||
149987454|NCT02567799|541085141|FG002|Concurrent Chemoradiotherapy|Death|0|||
149987455|NCT02567799|541085139|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
149987456|NCT02567799|541085140|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
149987457|NCT02567799|541085141|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
149987458|NCT02567799|541085139|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
149987459|NCT02567799|541085140|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
149987460|NCT02567799|541085141|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
149987461|NCT02567799|541085139|FG000|Follow-up|Death|1|||
149987462|NCT02567799|541085140|FG001|Follow-up|Death|0|||
149987463|NCT02567799|541085141|FG002|Follow-up|Death|1|||
149987464|NCT02567799|541085139|FG000|Follow-up|Progressive Disease|1|||
149987465|NCT02567799|541085140|FG001|Follow-up|Progressive Disease|1|||
149987466|NCT02567799|541085141|FG002|Follow-up|Progressive Disease|3|||
149987467|NCT03335150|541085142|FG000|Overall Study|Withdrawal by Subject|10|||
149987468|NCT03335150|541085143|FG001|Overall Study|Withdrawal by Subject|4|||
149987469|NCT03335150|541085142|FG000|Overall Study|Adverse Event|0|||
149987470|NCT03335150|541085143|FG001|Overall Study|Adverse Event|1|||
149987471|NCT02218697|541085145|FG000|Overall Study|Adverse Event|0|||
149987472|NCT02218697|541085146|FG001|Overall Study|Adverse Event|2|||
149987473|NCT02218697|541085145|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
149987474|NCT02218697|541085146|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
149987475|NCT02218697|541085145|FG000|Overall Study|Withdrawal by Subject|2|||
149987476|NCT02218697|541085146|FG001|Overall Study|Withdrawal by Subject|3|||
149987477|NCT04380753|541085149|FG000|Overall Study|Participants continuing study|4|||
149987478|NCT04380753|541085149|FG000|Overall Study|Death|2|||
149987479|NCT05356910|541085150|FG000|Overall Study|Lost to Follow-up|10|||
149987480|NCT05356910|541085151|FG001|Overall Study|Lost to Follow-up|19|||
149987481|NCT05356910|541085152|FG002|Overall Study|Lost to Follow-up|0|||
149987482|NCT05356910|541085153|FG003|Overall Study|Lost to Follow-up|0|||
149987483|NCT05356910|541085150|FG000|Overall Study|Withdrawal by Subject|4|||
149987484|NCT05356910|541085151|FG001|Overall Study|Withdrawal by Subject|2|||
149987485|NCT05356910|541085152|FG002|Overall Study|Withdrawal by Subject|0|||
149987486|NCT05356910|541085153|FG003|Overall Study|Withdrawal by Subject|0|||
149987487|NCT03306433|541085154|FG000|Overall Study|Lost to Follow-up|3|||
149987488|NCT03306433|541085154|FG000|Overall Study|Patient did not have teeth extracted|1|||
149987489|NCT03306433|541085154|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
149987490|NCT00819156|541085155|FG000|Overall Study|Adverse Event|1|||
149987491|NCT00819156|541085156|FG001|Overall Study|Adverse Event|4|||
149987492|NCT00819156|541085157|FG002|Overall Study|Adverse Event|2|||
149987493|NCT00819156|541085158|FG003|Overall Study|Adverse Event|1|||
149987494|NCT00819156|541085159|FG004|Overall Study|Adverse Event|2|||
149987495|NCT00819156|541085160|FG005|Overall Study|Adverse Event|3|||
149987496|NCT00819156|541085155|FG000|Overall Study|Withdrawal by Subject|0|||
149987497|NCT00819156|541085156|FG001|Overall Study|Withdrawal by Subject|3|||
149987498|NCT00819156|541085157|FG002|Overall Study|Withdrawal by Subject|2|||
149987499|NCT00819156|541085158|FG003|Overall Study|Withdrawal by Subject|0|||
149987500|NCT00819156|541085159|FG004|Overall Study|Withdrawal by Subject|1|||
149987501|NCT00819156|541085160|FG005|Overall Study|Withdrawal by Subject|0|||
149987502|NCT00819156|541085155|FG000|Overall Study|Protocol Violation|1|||
149987503|NCT00819156|541085156|FG001|Overall Study|Protocol Violation|0|||
150178850|NCT04279574|541793852|FG001|Overall Study|Lost to Follow-up|1|||
150178851|NCT03575052|541793853|FG000|Overall Study|Adverse Event|6|||
150178852|NCT03575052|541793854|FG001|Overall Study|Adverse Event|10|||
150178853|NCT03575052|541793853|FG000|Overall Study|Not further specified|5|||
149987504|NCT00819156|541085157|FG002|Overall Study|Protocol Violation|1|||
149987505|NCT00819156|541085158|FG003|Overall Study|Protocol Violation|0|||
149987506|NCT00819156|541085159|FG004|Overall Study|Protocol Violation|0|||
149987507|NCT00819156|541085160|FG005|Overall Study|Protocol Violation|1|||
149987508|NCT00819156|541085155|FG000|Overall Study|Lost to Follow-up|0|||
150178854|NCT03575052|541793854|FG001|Overall Study|Not further specified|7|||
150178855|NCT03575052|541793853|FG000|Overall Study|Withdrawal by Subject|5|||
150178856|NCT03575052|541793854|FG001|Overall Study|Withdrawal by Subject|6|||
150178857|NCT03575052|541793853|FG000|Overall Study|Lost to Follow-up|3|||
150178858|NCT03575052|541793854|FG001|Overall Study|Lost to Follow-up|0|||
149987509|NCT00819156|541085156|FG001|Overall Study|Lost to Follow-up|1|||
149987510|NCT00819156|541085157|FG002|Overall Study|Lost to Follow-up|0|||
149987511|NCT00819156|541085158|FG003|Overall Study|Lost to Follow-up|0|||
149987512|NCT00819156|541085159|FG004|Overall Study|Lost to Follow-up|0|||
149987513|NCT00819156|541085160|FG005|Overall Study|Lost to Follow-up|2|||
149987514|NCT00819156|541085155|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
149987515|NCT00819156|541085156|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
149987516|NCT00819156|541085157|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
150178859|NCT03575052|541793853|FG000|Overall Study|Death|2|||
149987517|NCT00819156|541085158|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
149987518|NCT00819156|541085159|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
149987519|NCT00819156|541085160|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
149987520|NCT00819156|541085155|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
149987521|NCT00819156|541085156|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
149987522|NCT00819156|541085157|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
149987523|NCT00819156|541085158|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
149987524|NCT00819156|541085159|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
149987525|NCT00819156|541085160|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
149987526|NCT00819156|541085155|FG000|Overall Study|Prostate-specific antigen progression|0|||
149987527|NCT00819156|541085156|FG001|Overall Study|Prostate-specific antigen progression|0|||
149987528|NCT00819156|541085157|FG002|Overall Study|Prostate-specific antigen progression|0|||
149987529|NCT00819156|541085158|FG003|Overall Study|Prostate-specific antigen progression|0|||
149987530|NCT00819156|541085159|FG004|Overall Study|Prostate-specific antigen progression|1|||
149987531|NCT00819156|541085160|FG005|Overall Study|Prostate-specific antigen progression|0|||
149987532|NCT00703846|541085161|FG000|Overall Study|Adverse Event|8|||
149987533|NCT00703846|541085161|FG000|Overall Study|Lost to Follow-up|55|||
149987534|NCT00703846|541085161|FG000|Overall Study|Lack of Efficacy|15|||
149987535|NCT00703846|541085161|FG000|Overall Study|Noncompliance with Study Treatment|2|||
149987536|NCT00703846|541085161|FG000|Overall Study|Withdrawal by Subject|40|||
149987537|NCT00703846|541085161|FG000|Overall Study|Death|1|||
149987538|NCT00703846|541085161|FG000|Overall Study|Other|14|||
149987539|NCT00703846|541085161|FG000|Overall Study|Did Not Receive Study Drug|2|||
149987540|NCT04601532|541085162|FG000|Overall Study|Lost to Follow-up|1|||
149987541|NCT04601532|541085163|FG001|Overall Study|Lost to Follow-up|2|||
149987542|NCT04601532|541085162|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
149987543|NCT04601532|541085163|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
149987544|NCT02566785|541085164|FG000|Overall Study|Lost to Follow-up|0|||
149987545|NCT02566785|541085165|FG001|Overall Study|Lost to Follow-up|2|||
149987546|NCT02566785|541085164|FG000|Overall Study|Worsening condition|1|||
149987547|NCT02566785|541085165|FG001|Overall Study|Worsening condition|1|||
149987548|NCT01597908|541085166|FG000|Randomized Phase|Death|217|||
149987549|NCT01597908|541085167|FG001|Randomized Phase|Death|238|||
149987550|NCT01597908|541085168|FG002|Randomized Phase|Death|0|||
149987551|NCT01597908|541085166|FG000|Randomized Phase|Sponsor Decision|93|||
149987552|NCT01597908|541085167|FG001|Randomized Phase|Sponsor Decision|39|||
149987553|NCT01597908|541085168|FG002|Randomized Phase|Sponsor Decision|0|||
149987554|NCT01597908|541085166|FG000|Randomized Phase|Lost to Follow-up|9|||
149987555|NCT01597908|541085167|FG001|Randomized Phase|Lost to Follow-up|16|||
149987556|NCT01597908|541085168|FG002|Randomized Phase|Lost to Follow-up|0|||
149987557|NCT01597908|541085166|FG000|Randomized Phase|Physician Decision|6|||
149987558|NCT01597908|541085167|FG001|Randomized Phase|Physician Decision|3|||
149987559|NCT01597908|541085168|FG002|Randomized Phase|Physician Decision|0|||
149987560|NCT01597908|541085166|FG000|Randomized Phase|Withdrawal by Subject|26|||
149987561|NCT01597908|541085167|FG001|Randomized Phase|Withdrawal by Subject|22|||
149987562|NCT01597908|541085168|FG002|Randomized Phase|Withdrawal by Subject|0|||
149987563|NCT01597908|541085166|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
149987564|NCT01597908|541085167|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
149987565|NCT01597908|541085168|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
149987566|NCT01597908|541085166|FG000|Crossover Phase|Death|0|||
149987567|NCT01597908|541085167|FG001|Crossover Phase|Death|0|||
149987568|NCT01597908|541085168|FG002|Crossover Phase|Death|11|||
149987569|NCT01597908|541085166|FG000|Crossover Phase|Withdrawal by Subject|0|||
149987570|NCT01597908|541085167|FG001|Crossover Phase|Withdrawal by Subject|0|||
149987571|NCT01597908|541085168|FG002|Crossover Phase|Withdrawal by Subject|3|||
149987572|NCT01597908|541085166|FG000|Crossover Phase|Sponsor Decision|0|||
149987573|NCT01597908|541085167|FG001|Crossover Phase|Sponsor Decision|0|||
149987574|NCT01597908|541085168|FG002|Crossover Phase|Sponsor Decision|20|||
149987575|NCT00837161|541085169|FG000|Overall Study|refused hysterectomy|2|||
149987576|NCT02931838|541085170|FG000|Overall Study|Reason not provided by investigator|1|||
149987577|NCT02931838|541085171|FG001|Overall Study|Reason not provided by investigator|0|||
149987578|NCT02931838|541085172|FG002|Overall Study|Reason not provided by investigator|1|||
149987579|NCT02931838|541085173|FG003|Overall Study|Reason not provided by investigator|0|||
149987580|NCT02931838|541085174|FG004|Overall Study|Reason not provided by investigator|0|||
149987581|NCT02931838|541085175|FG005|Overall Study|Reason not provided by investigator|0|||
149987582|NCT02931838|541085170|FG000|Overall Study|Poor/non-compliance|0|||
149987583|NCT02931838|541085171|FG001|Overall Study|Poor/non-compliance|0|||
149987584|NCT02931838|541085172|FG002|Overall Study|Poor/non-compliance|1|||
149987585|NCT02931838|541085173|FG003|Overall Study|Poor/non-compliance|0|||
149987586|NCT02931838|541085174|FG004|Overall Study|Poor/non-compliance|0|||
149987587|NCT02931838|541085175|FG005|Overall Study|Poor/non-compliance|0|||
149987588|NCT02931838|541085170|FG000|Overall Study|Lack of Efficacy|5|||
149987589|NCT02931838|541085171|FG001|Overall Study|Lack of Efficacy|4|||
149987590|NCT02931838|541085172|FG002|Overall Study|Lack of Efficacy|0|||
149987591|NCT02931838|541085173|FG003|Overall Study|Lack of Efficacy|0|||
149987592|NCT02931838|541085174|FG004|Overall Study|Lack of Efficacy|0|||
149987593|NCT02931838|541085175|FG005|Overall Study|Lack of Efficacy|1|||
149987594|NCT02931838|541085170|FG000|Overall Study|Lost to Follow-up|1|||
149987595|NCT02931838|541085171|FG001|Overall Study|Lost to Follow-up|0|||
149987596|NCT02931838|541085172|FG002|Overall Study|Lost to Follow-up|1|||
149987597|NCT02931838|541085173|FG003|Overall Study|Lost to Follow-up|1|||
149987598|NCT02931838|541085174|FG004|Overall Study|Lost to Follow-up|2|||
149987599|NCT02931838|541085175|FG005|Overall Study|Lost to Follow-up|0|||
149987600|NCT02931838|541085170|FG000|Overall Study|Subject request to discontinue treatment|4|||
149987601|NCT02931838|541085171|FG001|Overall Study|Subject request to discontinue treatment|3|||
149987602|NCT02931838|541085172|FG002|Overall Study|Subject request to discontinue treatment|3|||
149987603|NCT02931838|541085173|FG003|Overall Study|Subject request to discontinue treatment|0|||
149987604|NCT02931838|541085174|FG004|Overall Study|Subject request to discontinue treatment|1|||
149987605|NCT02931838|541085175|FG005|Overall Study|Subject request to discontinue treatment|0|||
149987606|NCT02931838|541085170|FG000|Overall Study|Withdrawal by Subject|1|||
149987607|NCT02931838|541085171|FG001|Overall Study|Withdrawal by Subject|2|||
149987608|NCT02931838|541085172|FG002|Overall Study|Withdrawal by Subject|0|||
149987609|NCT02931838|541085173|FG003|Overall Study|Withdrawal by Subject|1|||
149987610|NCT02931838|541085174|FG004|Overall Study|Withdrawal by Subject|0|||
149987611|NCT02931838|541085175|FG005|Overall Study|Withdrawal by Subject|0|||
149987612|NCT02931838|541085170|FG000|Overall Study|Adverse Event|2|||
149987613|NCT02931838|541085171|FG001|Overall Study|Adverse Event|1|||
149987614|NCT02931838|541085172|FG002|Overall Study|Adverse Event|2|||
149987615|NCT02931838|541085173|FG003|Overall Study|Adverse Event|1|||
149987616|NCT02931838|541085174|FG004|Overall Study|Adverse Event|3|||
149987617|NCT02931838|541085175|FG005|Overall Study|Adverse Event|1|||
149987618|NCT00104728|541085176|FG000|Overall Study|screen failures|19|||
149987619|NCT02709577|541085177|FG000|Overall Study|non-accommodating anatomy|0|||
149987620|NCT02709577|541085178|FG001|Overall Study|non-accommodating anatomy|1|||
149987621|NCT02709577|541085179|FG002|Overall Study|non-accommodating anatomy|0|||
149987622|NCT02709577|541085180|FG003|Overall Study|non-accommodating anatomy|0|||
149987623|NCT02709577|541085177|FG000|Overall Study|procedural complication|0|||
149987624|NCT02709577|541085178|FG001|Overall Study|procedural complication|1|||
149987625|NCT02709577|541085179|FG002|Overall Study|procedural complication|0|||
149987626|NCT02709577|541085180|FG003|Overall Study|procedural complication|0|||
149987627|NCT02709577|541085177|FG000|Overall Study|Withdrawal by Subject|2|||
149987628|NCT02709577|541085178|FG001|Overall Study|Withdrawal by Subject|3|||
149987629|NCT02709577|541085179|FG002|Overall Study|Withdrawal by Subject|2|||
149987630|NCT02709577|541085180|FG003|Overall Study|Withdrawal by Subject|0|||
149987631|NCT01059864|541085181|FG000|Open-Label Run-In Phase|Adverse Event|7|||
149987632|NCT01059864|541085182|FG001|Open-Label Run-In Phase|Adverse Event|0|||
149987633|NCT01059864|541085183|FG002|Open-Label Run-In Phase|Adverse Event|0|||
149987634|NCT01059864|541085181|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
149987635|NCT01059864|541085182|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
149987636|NCT01059864|541085183|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
149987637|NCT01059864|541085181|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
149987638|NCT01059864|541085182|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
149987639|NCT01059864|541085183|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
149987640|NCT01059864|541085181|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
149987641|NCT01059864|541085182|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
149987642|NCT01059864|541085183|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
149987643|NCT01059864|541085181|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
149987644|NCT01059864|541085182|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
149987645|NCT01059864|541085183|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
149987646|NCT01059864|541085181|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149987647|NCT01059864|541085182|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
149987648|NCT01059864|541085183|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
149987649|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Adverse Event|21|||
149987650|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Adverse Event|34|||
149987651|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Adverse Event|14|||
149987652|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Adverse Event|17|||
149987653|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Adverse Event|0|||
149987654|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
149987655|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
149987656|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
149987657|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
149987658|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
149987659|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
149987660|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
149987661|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
149987662|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
149987663|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
149987664|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Physician Decision|2|||
149987665|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Physician Decision|4|||
149987666|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Physician Decision|4|||
149987667|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Physician Decision|4|||
149987668|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Physician Decision|0|||
149987669|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
149987670|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
149987671|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
149987672|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
149987673|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
149987674|NCT00451958|541085184|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
149987675|NCT00451958|541085185|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
149987676|NCT00451958|541085186|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
149987677|NCT00451958|541085187|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
149987678|NCT00451958|541085188|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
149987679|NCT02175277|541085189|FG000|Overall Study|Protocol-specified Criteria|1|||
149987680|NCT00064259|541086535|FG000|Overall Study|Adverse Event|1|||
149987681|NCT00064259|541086536|FG001|Overall Study|Adverse Event|0|||
149987682|NCT00064259|541086537|FG002|Overall Study|Adverse Event|0|||
149987683|NCT00064259|541086538|FG003|Overall Study|Adverse Event|1|||
149987684|NCT03062280|541086544|FG000|Overall Study|Adverse Event|1|||
149987685|NCT03062280|541086544|FG000|Overall Study|Death|1|||
149987686|NCT03062280|541086544|FG000|Overall Study|Fertility Treatment|2|||
149987687|NCT03062280|541086544|FG000|Overall Study|Physician Decision|2|||
150178860|NCT03575052|541793854|FG001|Overall Study|Death|1|||
149987688|NCT03062280|541086544|FG000|Overall Study|Pregnancy|5|||
149987689|NCT03062280|541086544|FG000|Overall Study|Withdrawal by Subject|11|||
149987690|NCT00516893|541086545|FG000|Overall Study|Lost to Follow-up|4|||
149987691|NCT00516893|541086545|FG000|Overall Study|Adverse Event|3|||
149987692|NCT00516893|541086545|FG000|Overall Study|Withdrawal by Subject|2|||
149987693|NCT00516893|541086545|FG000|Overall Study|Noncompliance|2|||
149987694|NCT00516893|541086545|FG000|Overall Study|Death|1|||
149987695|NCT00516893|541086545|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
149987696|NCT00516893|541086545|FG000|Overall Study|Relocated|1|||
149987697|NCT00516893|541086545|FG000|Overall Study|Pregnancy|1|||
149987698|NCT00516893|541086545|FG000|Overall Study|Received Medication From Another Study|1|||
149987699|NCT01519791|541086546|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
149987700|NCT01519791|541086547|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
149987701|NCT01519791|541086546|FG000|Overall Study|Protocol Violation|6|||
149987702|NCT01519791|541086547|FG001|Overall Study|Protocol Violation|19|||
149987703|NCT01519791|541086546|FG000|Overall Study|Other Reason|87|||
149987704|NCT01519791|541086547|FG001|Overall Study|Other Reason|222|||
149987705|NCT01519791|541086546|FG000|Overall Study|subjects randomized in error|2|||
149987706|NCT01519791|541086547|FG001|Overall Study|subjects randomized in error|0|||
149987707|NCT01519791|541086546|FG000|Overall Study|Lack of Efficacy|16|||
149987708|NCT01519791|541086547|FG001|Overall Study|Lack of Efficacy|20|||
149987709|NCT01519791|541086546|FG000|Overall Study|SAE, non-fatal|6|||
149987710|NCT01519791|541086547|FG001|Overall Study|SAE, non-fatal|22|||
149987711|NCT01519791|541086546|FG000|Overall Study|AE, serious fatal|0|||
149987712|NCT01519791|541086547|FG001|Overall Study|AE, serious fatal|1|||
149987713|NCT01519791|541086546|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
149987714|NCT01519791|541086547|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
149987715|NCT01519791|541086546|FG000|Overall Study|AE, non-serious non-fatal|12|||
149987716|NCT01519791|541086547|FG001|Overall Study|AE, non-serious non-fatal|31|||
149987717|NCT01519791|541086546|FG000|Overall Study|Withdrawal by Subject|15|||
149987718|NCT01519791|541086547|FG001|Overall Study|Withdrawal by Subject|37|||
149987719|NCT01519791|541086546|FG000|Overall Study|Lost to Follow-up|6|||
149987720|NCT01519791|541086547|FG001|Overall Study|Lost to Follow-up|14|||
149987721|NCT04551963|541086549|FG000|Overall Study|Physician Decision|1|||
149987722|NCT04551963|541086550|FG001|Overall Study|Physician Decision|1|||
149987723|NCT04551963|541086549|FG000|Overall Study|Death|1|||
149987724|NCT04551963|541086550|FG001|Overall Study|Death|0|||
149987725|NCT00375427|541086551|FG000|Overall Study|Adverse Event|21|||
149987726|NCT00375427|541086552|FG001|Overall Study|Adverse Event|27|||
149987727|NCT00375427|541086551|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149987728|NCT00375427|541086552|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149987729|NCT00375427|541086551|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149987730|NCT00375427|541086552|FG001|Overall Study|Abnormal laboratory value(s)|2|||
149987731|NCT00375427|541086551|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149987732|NCT00375427|541086552|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
149987733|NCT00375427|541086551|FG000|Overall Study|Patient no longer requires study drug|3|||
149987734|NCT00375427|541086552|FG001|Overall Study|Patient no longer requires study drug|7|||
149987735|NCT00375427|541086551|FG000|Overall Study|Protocol Violation|10|||
149987736|NCT00375427|541086552|FG001|Overall Study|Protocol Violation|8|||
149987737|NCT00375427|541086551|FG000|Overall Study|Withdrawal by Subject|9|||
149987738|NCT00375427|541086552|FG001|Overall Study|Withdrawal by Subject|13|||
149987739|NCT00375427|541086551|FG000|Overall Study|Lost to Follow-up|1|||
149987740|NCT00375427|541086552|FG001|Overall Study|Lost to Follow-up|1|||
149987741|NCT00375427|541086551|FG000|Overall Study|Administrative reasons|0|||
149987742|NCT00375427|541086552|FG001|Overall Study|Administrative reasons|1|||
149987743|NCT00375427|541086551|FG000|Overall Study|Death|11|||
149987744|NCT00375427|541086552|FG001|Overall Study|Death|10|||
149987745|NCT03850093|541086553|FG000|Overall Study|Withdrawal by Subject|1|||
149987746|NCT03850093|541086554|FG001|Overall Study|Withdrawal by Subject|0|||
149987747|NCT03850093|541086555|FG002|Overall Study|Withdrawal by Subject|2|||
149987748|NCT00588237|541086559|FG000|Overall Study|Evaluable for toxicity only|3|||
149987749|NCT00588237|541086559|FG000|Overall Study|Patien not treated|1|||
149987750|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
149987751|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
149987752|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
149987753|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
149987754|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
149987755|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
149987756|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
149987757|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
149987758|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149987759|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149987760|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149987761|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149987762|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
150053581|NCT03255083|541336680|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
149987763|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
149987764|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149987765|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149987766|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149987767|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149987768|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
149987769|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
149987770|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
149987771|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
149987772|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
149987773|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
149987774|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149987775|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
149987776|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149987777|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149987778|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149987779|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149987780|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
149987781|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
149987782|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
149987783|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
149987784|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
149987785|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
149987786|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
149987787|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
149987788|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
149987789|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
149987790|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
149987791|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
149987792|NCT03985943|541086561|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
149987793|NCT03985943|541086562|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
149987794|NCT03985943|541086563|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
149987795|NCT03985943|541086564|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
149987796|NCT03985943|541086565|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
149987797|NCT03985943|541086566|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
150178861|NCT03575052|541793853|FG000|Overall Study|Lack of Efficacy|2|||
150178862|NCT03575052|541793854|FG001|Overall Study|Lack of Efficacy|1|||
149987798|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149987799|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149987800|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
149987801|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
149987802|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
149987803|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
149987804|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149987805|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149987806|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
149987807|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
149987808|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
149987809|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
149987810|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
149987811|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
149987812|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
149987813|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
149987814|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
149987815|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
149987816|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149987817|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149987818|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149987819|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
149987820|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
149987821|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
149987822|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
149987823|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
149987824|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
149987825|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
149987826|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
149987827|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
149987828|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
149987829|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
149987830|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
149987831|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
149987832|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
149987833|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
149987834|NCT03985943|541086561|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
149987835|NCT03985943|541086562|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
149987836|NCT03985943|541086563|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
149987837|NCT03985943|541086564|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
149987838|NCT03985943|541086565|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
149987839|NCT03985943|541086566|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
149987840|NCT01265563|541086567|FG000|Overall Study|Withdrawal by Subject|0|||
149987841|NCT01265563|541086568|FG001|Overall Study|Withdrawal by Subject|1|||
149987842|NCT01265563|541086569|FG002|Overall Study|Withdrawal by Subject|1|||
149987843|NCT01265563|541086570|FG003|Overall Study|Withdrawal by Subject|0|||
149987844|NCT01265563|541086571|FG004|Overall Study|Withdrawal by Subject|2|||
149987845|NCT00716482|541086578|FG000|Overall Study|Lost to Follow-up|6|||
149987846|NCT00716482|541086578|FG000|Overall Study|Inadequate acquisition or analysis|50|||
149987847|NCT00716482|541086578|FG000|Overall Study|no pathology obtained|10|||
149987848|NCT00716482|541086578|FG000|Overall Study|technical/machine error|28|||
149987849|NCT00716482|541086578|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
149987850|NCT03248531|541086579|FG000|Overall Study|Adverse Event|0|||
149987851|NCT03248531|541086580|FG001|Overall Study|Adverse Event|0|||
149987852|NCT03248531|541086581|FG002|Overall Study|Adverse Event|1|||
149987853|NCT03248531|541086579|FG000|Overall Study|Lost to Follow-up|1|||
149987854|NCT03248531|541086580|FG001|Overall Study|Lost to Follow-up|0|||
149987855|NCT03248531|541086581|FG002|Overall Study|Lost to Follow-up|5|||
149987856|NCT03248531|541086579|FG000|Overall Study|Withdrawal by Subject|3|||
149987857|NCT03248531|541086580|FG001|Overall Study|Withdrawal by Subject|3|||
149987858|NCT03248531|541086581|FG002|Overall Study|Withdrawal by Subject|2|||
149987859|NCT03248531|541086579|FG000|Overall Study|Sponsor Request|0|||
149987860|NCT03248531|541086580|FG001|Overall Study|Sponsor Request|2|||
149987861|NCT03248531|541086581|FG002|Overall Study|Sponsor Request|0|||
149987862|NCT04908865|541086582|FG000|Overall Study|Adverse Event|2|||
149987863|NCT04908865|541086582|FG000|Overall Study|Lack of Efficacy|5|||
149987864|NCT04908865|541086582|FG000|Overall Study|Lost to Follow-up|1|||
149987865|NCT04075513|541086585|FG000|Overall Study|Withdrawal by Subject|2|||
149987866|NCT04075513|541086586|FG001|Overall Study|Withdrawal by Subject|2|||
149987867|NCT04075513|541086585|FG000|Overall Study|Lack of Efficacy|1|||
149987868|NCT04075513|541086586|FG001|Overall Study|Lack of Efficacy|0|||
149987869|NCT04075513|541086585|FG000|Overall Study|Lost to Follow-up|4|||
149987870|NCT04075513|541086586|FG001|Overall Study|Lost to Follow-up|2|||
149987871|NCT04075513|541086585|FG000|Overall Study|Switch to insulin pump|1|||
149987872|NCT04075513|541086586|FG001|Overall Study|Switch to insulin pump|0|||
149987873|NCT01524224|541086587|FG000|Overall Study|Progressive Disease|1|||
149987874|NCT01524224|541086588|FG001|Overall Study|Progressive Disease|0|||
149987875|NCT01524224|541086589|FG002|Overall Study|Progressive Disease|2|||
149987876|NCT01524224|541086590|FG003|Overall Study|Progressive Disease|1|||
149987877|NCT01524224|541086591|FG004|Overall Study|Progressive Disease|2|||
149987878|NCT01524224|541086592|FG005|Overall Study|Progressive Disease|1|||
149987879|NCT01524224|541086593|FG006|Overall Study|Progressive Disease|1|||
149987880|NCT01524224|541086594|FG007|Overall Study|Progressive Disease|5|||
149987881|NCT01524224|541086587|FG000|Overall Study|Withdrawal by Subject|2|||
149987882|NCT01524224|541086588|FG001|Overall Study|Withdrawal by Subject|0|||
149987883|NCT01524224|541086589|FG002|Overall Study|Withdrawal by Subject|0|||
149987884|NCT01524224|541086590|FG003|Overall Study|Withdrawal by Subject|0|||
149987885|NCT01524224|541086591|FG004|Overall Study|Withdrawal by Subject|0|||
149987886|NCT01524224|541086592|FG005|Overall Study|Withdrawal by Subject|0|||
149987887|NCT01524224|541086593|FG006|Overall Study|Withdrawal by Subject|2|||
149987888|NCT01524224|541086594|FG007|Overall Study|Withdrawal by Subject|0|||
149987889|NCT01524224|541086587|FG000|Overall Study|Adverse Event|0|||
149987890|NCT01524224|541086588|FG001|Overall Study|Adverse Event|1|||
149987891|NCT01524224|541086589|FG002|Overall Study|Adverse Event|0|||
149987892|NCT01524224|541086590|FG003|Overall Study|Adverse Event|0|||
149987893|NCT01524224|541086591|FG004|Overall Study|Adverse Event|0|||
149987894|NCT01524224|541086592|FG005|Overall Study|Adverse Event|1|||
149987895|NCT01524224|541086593|FG006|Overall Study|Adverse Event|0|||
149987896|NCT01524224|541086594|FG007|Overall Study|Adverse Event|0|||
149987897|NCT01524224|541086587|FG000|Overall Study|Physician Decision|0|||
149987898|NCT01524224|541086588|FG001|Overall Study|Physician Decision|0|||
149987899|NCT01524224|541086589|FG002|Overall Study|Physician Decision|0|||
149987900|NCT01524224|541086590|FG003|Overall Study|Physician Decision|1|||
149987901|NCT01524224|541086591|FG004|Overall Study|Physician Decision|1|||
149987902|NCT01524224|541086592|FG005|Overall Study|Physician Decision|0|||
149987903|NCT01524224|541086593|FG006|Overall Study|Physician Decision|0|||
149987904|NCT01524224|541086594|FG007|Overall Study|Physician Decision|1|||
149987905|NCT01524224|541086587|FG000|Overall Study|Sponsor Decision|0|||
149987906|NCT01524224|541086588|FG001|Overall Study|Sponsor Decision|0|||
149987907|NCT01524224|541086589|FG002|Overall Study|Sponsor Decision|0|||
149987908|NCT01524224|541086590|FG003|Overall Study|Sponsor Decision|0|||
149987909|NCT01524224|541086591|FG004|Overall Study|Sponsor Decision|1|||
149987910|NCT01524224|541086592|FG005|Overall Study|Sponsor Decision|0|||
149987911|NCT01524224|541086593|FG006|Overall Study|Sponsor Decision|0|||
149987912|NCT01524224|541086594|FG007|Overall Study|Sponsor Decision|0|||
149987913|NCT03517371|541086597|FG000|Overall Study|Adverse Event|8|||
149987914|NCT03517371|541086598|FG001|Overall Study|Adverse Event|9|||
149987915|NCT03517371|541086597|FG000|Overall Study|Lost to Follow-up|1|||
149987916|NCT03517371|541086598|FG001|Overall Study|Lost to Follow-up|2|||
149987917|NCT03517371|541086597|FG000|Overall Study|Withdrawal by Subject|4|||
149987918|NCT03517371|541086598|FG001|Overall Study|Withdrawal by Subject|4|||
149987919|NCT03517371|541086597|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
149987920|NCT03517371|541086598|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
149987921|NCT03517371|541086597|FG000|Overall Study|COVID restrictions|2|||
149987922|NCT03517371|541086598|FG001|Overall Study|COVID restrictions|0|||
149987923|NCT03517371|541086597|FG000|Overall Study|Receiving DBS Surgery|0|||
149987924|NCT03517371|541086598|FG001|Overall Study|Receiving DBS Surgery|1|||
149987925|NCT05411822|541086599|FG000|Overall Study|Withdrawal by Subject|2|||
149987926|NCT05411822|541086600|FG001|Overall Study|Withdrawal by Subject|1|||
149987927|NCT05312697|541086601|FG000|Overall Study|Sponsor Terminated Trial|2|||
149987928|NCT04283656|541086602|FG000|Overall Study|Adverse Event|1|||
149987929|NCT04283656|541086603|FG001|Overall Study|Adverse Event|0|||
149987930|NCT04283656|541086602|FG000|Overall Study|Lost to Follow-up|0|||
149987931|NCT04283656|541086603|FG001|Overall Study|Lost to Follow-up|1|||
149987932|NCT04445519|541086604|FG000|Overall Study|Due to adaptive design|3|||
149987933|NCT04445519|541086605|FG001|Overall Study|Due to adaptive design|0|||
149987934|NCT04445519|541086606|FG002|Overall Study|Due to adaptive design|0|||
149987935|NCT04445519|541086604|FG000|Overall Study|Lost to Follow-up|0|||
149987936|NCT04445519|541086605|FG001|Overall Study|Lost to Follow-up|1|||
149987937|NCT04445519|541086606|FG002|Overall Study|Lost to Follow-up|4|||
149987938|NCT04445519|541086604|FG000|Overall Study|Sponsor or IRB Decision|0|||
149987939|NCT04445519|541086605|FG001|Overall Study|Sponsor or IRB Decision|1|||
149987940|NCT04445519|541086606|FG002|Overall Study|Sponsor or IRB Decision|2|||
149987941|NCT04445519|541086604|FG000|Overall Study|Withdrawal by Subject|0|||
149987942|NCT04445519|541086605|FG001|Overall Study|Withdrawal by Subject|3|||
149987943|NCT04445519|541086606|FG002|Overall Study|Withdrawal by Subject|3|||
149987944|NCT04445519|541086604|FG000|Overall Study|Adverse Event|0|||
149987945|NCT04445519|541086605|FG001|Overall Study|Adverse Event|8|||
149987946|NCT04445519|541086606|FG002|Overall Study|Adverse Event|6|||
149987947|NCT04445519|541086604|FG000|Overall Study|Other Reason|0|||
149987948|NCT04445519|541086605|FG001|Overall Study|Other Reason|1|||
149987949|NCT04445519|541086606|FG002|Overall Study|Other Reason|1|||
149987950|NCT04445519|541086604|FG000|Overall Study|Protocol Violation|0|||
149987951|NCT04445519|541086605|FG001|Overall Study|Protocol Violation|0|||
149987952|NCT04445519|541086606|FG002|Overall Study|Protocol Violation|1|||
149987953|NCT02318368|541086607|FG000|Overall Study|Withdrawal by Subject|2|||
149987954|NCT02318368|541086608|FG001|Overall Study|Withdrawal by Subject|0|||
149987955|NCT02318368|541086607|FG000|Overall Study|Study terminated by the sponsor|5|||
149987956|NCT02318368|541086608|FG001|Overall Study|Study terminated by the sponsor|2|||
149987957|NCT02318368|541086607|FG000|Overall Study|Death|0|||
149987958|NCT02318368|541086608|FG001|Overall Study|Death|1|||
149987959|NCT01901614|541086609|FG000|Overall Study|Adverse Event|0|||
149987960|NCT01901614|541086610|FG001|Overall Study|Adverse Event|1|||
149987961|NCT01901614|541086609|FG000|Overall Study|Lost to Follow-up|1|||
149987962|NCT01901614|541086610|FG001|Overall Study|Lost to Follow-up|0|||
149987963|NCT01901614|541086609|FG000|Overall Study|Screen Fail|1|||
149987964|NCT01901614|541086610|FG001|Overall Study|Screen Fail|0|||
149987965|NCT03629223|541086611|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
149987966|NCT03629223|541086612|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
149987967|NCT03629223|541086613|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
149987968|NCT03629223|541086614|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
149987969|NCT03629223|541086615|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
149987970|NCT03629223|541086616|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
149987971|NCT03629223|541086611|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
149987972|NCT03629223|541086612|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
149987973|NCT03629223|541086613|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
149987974|NCT03629223|541086614|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
149987975|NCT03629223|541086615|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
150053582|NCT03255083|541336681|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
150053583|NCT03255083|541336682|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
150053584|NCT03255083|541336683|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
150053585|NCT03255083|541336680|FG000|Overall Study|Withdrawal by Subject|1|||
150053586|NCT03255083|541336681|FG001|Overall Study|Withdrawal by Subject|1|||
150053587|NCT03255083|541336682|FG002|Overall Study|Withdrawal by Subject|1|||
150053588|NCT03255083|541336683|FG003|Overall Study|Withdrawal by Subject|0|||
150053589|NCT00363545|541336684|FG000|Overall Study|Serious Adverse Event|0|||
150178863|NCT03575052|541793853|FG000|Overall Study|Study drug noncompliance|1|||
149987976|NCT03629223|541086616|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
149987977|NCT03629223|541086611|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
149987978|NCT03629223|541086612|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
149987979|NCT03629223|541086613|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
150053590|NCT00363545|541336685|FG001|Overall Study|Serious Adverse Event|1|||
150178864|NCT03575052|541793854|FG001|Overall Study|Study drug noncompliance|2|||
150053591|NCT00363545|541336684|FG000|Overall Study|Withdrawal by Subject|12|||
150053592|NCT00363545|541336685|FG001|Overall Study|Withdrawal by Subject|15|||
150053593|NCT00363545|541336684|FG000|Overall Study|Migrated/moved from study area|3|||
150053594|NCT00363545|541336685|FG001|Overall Study|Migrated/moved from study area|6|||
150053595|NCT00363545|541336684|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
150053596|NCT00363545|541336685|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
150053597|NCT00363545|541336684|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
149987980|NCT03629223|541086614|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
149987981|NCT03629223|541086615|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
149987982|NCT03629223|541086616|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
149987983|NCT03629223|541086611|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
149987984|NCT03629223|541086612|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
149987985|NCT03629223|541086613|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
149987986|NCT03629223|541086614|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
149987987|NCT03629223|541086615|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
149987988|NCT03629223|541086616|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
149987989|NCT03629223|541086611|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
149987990|NCT03629223|541086612|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
149987991|NCT03629223|541086613|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
149987992|NCT03629223|541086614|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
149987993|NCT03629223|541086615|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
149987994|NCT03629223|541086616|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
149987995|NCT02674464|541086617|FG000|Overall Study|Death|10|||
149987996|NCT02674464|541086618|FG001|Overall Study|Death|21|||
149987997|NCT02674464|541086617|FG000|Overall Study|Withdrawal by Subject|24|||
149987998|NCT02674464|541086618|FG001|Overall Study|Withdrawal by Subject|44|||
149987999|NCT02674464|541086617|FG000|Overall Study|Lost to Follow-up|97|||
149988000|NCT02674464|541086618|FG001|Overall Study|Lost to Follow-up|92|||
149988001|NCT02674464|541086617|FG000|Overall Study|Outside survey window|6|||
149988002|NCT02674464|541086618|FG001|Overall Study|Outside survey window|3|||
149988003|NCT00783835|541086619|FG000|Overall Study|Adverse Event|3|||
149988004|NCT00783835|541086619|FG000|Overall Study|Medical Criteria|1|||
149988005|NCT00783835|541086619|FG000|Overall Study|Withdrawal by Subject|2|||
149988006|NCT00783835|541086619|FG000|Overall Study|Lost to Follow-up|1|||
149988007|NCT00783835|541086619|FG000|Overall Study|Participant not Adherent|3|||
149988008|NCT01555073|541086620|FG000|Overall Study|Lost to Follow-up|1|||
149988009|NCT01555073|541086621|FG001|Overall Study|Lost to Follow-up|2|||
149988010|NCT01555073|541086622|FG002|Overall Study|Lost to Follow-up|0|||
149988011|NCT01555073|541086623|FG003|Overall Study|Lost to Follow-up|5|||
149988012|NCT00976716|541086627|FG000|Overall Study|Adverse Event|1|||
149988013|NCT04222699|541086628|FG000|Overall Study|Lost to Follow-up|2|||
150053598|NCT00363545|541336685|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
150053599|NCT00363545|541336684|FG000|Overall Study|Others|1|||
150053600|NCT00363545|541336685|FG001|Overall Study|Others|0|||
150053601|NCT01457352|541336686|FG000|Period 1|Adverse Event|2|||
150053602|NCT01457352|541336687|FG001|Period 1|Adverse Event|0|||
150053603|NCT01457352|541336686|FG000|Period 1|Withdrawal by Subject|2|||
149988014|NCT01814046|541086640|FG000|Drug Administration|Death due to complications of RSV|1|||
149988015|NCT01814046|541086641|FG001|Drug Administration|Death due to complications of RSV|0|||
149988016|NCT01814046|541086642|FG002|Drug Administration|Death due to complications of RSV|0|||
149988017|NCT00564902|541086643|FG000|Overall Study|Withdrawal by Subject|0|||
149988018|NCT00564902|541086644|FG001|Overall Study|Withdrawal by Subject|3|||
149988019|NCT00564902|541086645|FG002|Overall Study|Withdrawal by Subject|4|||
149988020|NCT00564902|541086643|FG000|Overall Study|Death|1|||
149988021|NCT00564902|541086644|FG001|Overall Study|Death|1|||
149988022|NCT00564902|541086645|FG002|Overall Study|Death|0|||
149988023|NCT03583359|541086648|FG000|Overall Study|Withdrawal by Subject|15|||
149988024|NCT03583359|541086649|FG001|Overall Study|Withdrawal by Subject|6|||
149988025|NCT03583359|541086648|FG000|Overall Study|Lost to Follow-up|12|||
149988026|NCT03583359|541086649|FG001|Overall Study|Lost to Follow-up|3|||
149988027|NCT03583359|541086648|FG000|Overall Study|Adverse Event|0|||
149988028|NCT03583359|541086649|FG001|Overall Study|Adverse Event|1|||
149988029|NCT03583359|541086648|FG000|Overall Study|Protocol Violation|0|||
149988030|NCT03583359|541086649|FG001|Overall Study|Protocol Violation|1|||
149988031|NCT03583359|541086648|FG000|Overall Study|Other|2|||
149988032|NCT03583359|541086649|FG001|Overall Study|Other|1|||
149988033|NCT01831466|541086652|FG000|Overall Study|Protocol Violation|1|||
149988034|NCT01831466|541086653|FG001|Overall Study|Protocol Violation|1|||
149988035|NCT01831466|541086654|FG002|Overall Study|Protocol Violation|2|||
149988036|NCT01831466|541086655|FG003|Overall Study|Protocol Violation|0|||
149988037|NCT01831466|541086656|FG004|Overall Study|Protocol Violation|0|||
149988038|NCT01831466|541086657|FG005|Overall Study|Protocol Violation|1|||
149988039|NCT01831466|541086658|FG006|Overall Study|Protocol Violation|0|||
149988040|NCT01831466|541086659|FG007|Overall Study|Protocol Violation|0|||
149988041|NCT01831466|541086660|FG008|Overall Study|Protocol Violation|0|||
149988042|NCT01831466|541086661|FG009|Overall Study|Protocol Violation|0|||
149988043|NCT01831466|541086662|FG010|Overall Study|Protocol Violation|0|||
149988044|NCT01831466|541086663|FG011|Overall Study|Protocol Violation|0|||
149988045|NCT01831466|541086652|FG000|Overall Study|Other|2|||
149988046|NCT01831466|541086653|FG001|Overall Study|Other|3|||
149988047|NCT01831466|541086654|FG002|Overall Study|Other|2|||
149988048|NCT01831466|541086655|FG003|Overall Study|Other|2|||
149988049|NCT01831466|541086656|FG004|Overall Study|Other|2|||
149988050|NCT01831466|541086657|FG005|Overall Study|Other|1|||
149988051|NCT01831466|541086658|FG006|Overall Study|Other|0|||
149988052|NCT01831466|541086659|FG007|Overall Study|Other|0|||
149988053|NCT01831466|541086660|FG008|Overall Study|Other|0|||
149988054|NCT01831466|541086661|FG009|Overall Study|Other|0|||
149988055|NCT01831466|541086662|FG010|Overall Study|Other|0|||
149988056|NCT01831466|541086663|FG011|Overall Study|Other|0|||
149988057|NCT01831466|541086652|FG000|Overall Study|Non-compliance with study treatment|2|||
149988058|NCT01831466|541086653|FG001|Overall Study|Non-compliance with study treatment|1|||
149988059|NCT01831466|541086654|FG002|Overall Study|Non-compliance with study treatment|1|||
149988060|NCT01831466|541086655|FG003|Overall Study|Non-compliance with study treatment|0|||
149988061|NCT01831466|541086656|FG004|Overall Study|Non-compliance with study treatment|0|||
149988062|NCT01831466|541086657|FG005|Overall Study|Non-compliance with study treatment|1|||
149988063|NCT01831466|541086658|FG006|Overall Study|Non-compliance with study treatment|0|||
149988064|NCT01831466|541086659|FG007|Overall Study|Non-compliance with study treatment|0|||
149988065|NCT01831466|541086660|FG008|Overall Study|Non-compliance with study treatment|0|||
149988066|NCT01831466|541086661|FG009|Overall Study|Non-compliance with study treatment|0|||
149988067|NCT01831466|541086662|FG010|Overall Study|Non-compliance with study treatment|0|||
149988068|NCT01831466|541086663|FG011|Overall Study|Non-compliance with study treatment|0|||
149988069|NCT01831466|541086652|FG000|Overall Study|Death|0|||
149988070|NCT01831466|541086653|FG001|Overall Study|Death|1|||
149988071|NCT01831466|541086654|FG002|Overall Study|Death|0|||
149988072|NCT01831466|541086655|FG003|Overall Study|Death|0|||
149988073|NCT01831466|541086656|FG004|Overall Study|Death|0|||
149988074|NCT01831466|541086657|FG005|Overall Study|Death|0|||
149988075|NCT01831466|541086658|FG006|Overall Study|Death|0|||
149988076|NCT01831466|541086659|FG007|Overall Study|Death|0|||
149988077|NCT01831466|541086660|FG008|Overall Study|Death|0|||
149988078|NCT01831466|541086661|FG009|Overall Study|Death|0|||
149988079|NCT01831466|541086662|FG010|Overall Study|Death|0|||
149988080|NCT01831466|541086663|FG011|Overall Study|Death|0|||
149988081|NCT01831466|541086652|FG000|Overall Study|Withdrawal by Subject|6|||
149988082|NCT01831466|541086653|FG001|Overall Study|Withdrawal by Subject|3|||
149988083|NCT01831466|541086654|FG002|Overall Study|Withdrawal by Subject|3|||
149988084|NCT01831466|541086655|FG003|Overall Study|Withdrawal by Subject|3|||
150053604|NCT01457352|541336687|FG001|Period 1|Withdrawal by Subject|0|||
149988085|NCT01831466|541086656|FG004|Overall Study|Withdrawal by Subject|3|||
150053605|NCT01457352|541336686|FG000|Period 1|Physician Decision|2|||
150053606|NCT01457352|541336687|FG001|Period 1|Physician Decision|0|||
149988086|NCT01831466|541086657|FG005|Overall Study|Withdrawal by Subject|5|||
149988087|NCT01831466|541086658|FG006|Overall Study|Withdrawal by Subject|0|||
149988088|NCT01831466|541086659|FG007|Overall Study|Withdrawal by Subject|0|||
149988089|NCT01831466|541086660|FG008|Overall Study|Withdrawal by Subject|0|||
149988090|NCT01831466|541086661|FG009|Overall Study|Withdrawal by Subject|1|||
149988091|NCT01831466|541086662|FG010|Overall Study|Withdrawal by Subject|0|||
149988092|NCT01831466|541086663|FG011|Overall Study|Withdrawal by Subject|1|||
149988093|NCT01831466|541086652|FG000|Overall Study|Lost to Follow-up|0|||
149988094|NCT01831466|541086653|FG001|Overall Study|Lost to Follow-up|1|||
149988095|NCT01831466|541086654|FG002|Overall Study|Lost to Follow-up|4|||
149988096|NCT01831466|541086655|FG003|Overall Study|Lost to Follow-up|2|||
149988097|NCT01831466|541086656|FG004|Overall Study|Lost to Follow-up|0|||
149988098|NCT01831466|541086657|FG005|Overall Study|Lost to Follow-up|3|||
149988099|NCT01831466|541086658|FG006|Overall Study|Lost to Follow-up|0|||
149988100|NCT01831466|541086659|FG007|Overall Study|Lost to Follow-up|0|||
149988101|NCT01831466|541086660|FG008|Overall Study|Lost to Follow-up|0|||
149988102|NCT01831466|541086661|FG009|Overall Study|Lost to Follow-up|1|||
149988103|NCT01831466|541086662|FG010|Overall Study|Lost to Follow-up|0|||
149988104|NCT01831466|541086663|FG011|Overall Study|Lost to Follow-up|1|||
149988105|NCT01831466|541086652|FG000|Overall Study|Lack of Efficacy|5|||
149988106|NCT01831466|541086653|FG001|Overall Study|Lack of Efficacy|8|||
149988107|NCT01831466|541086654|FG002|Overall Study|Lack of Efficacy|7|||
149988108|NCT01831466|541086655|FG003|Overall Study|Lack of Efficacy|6|||
149988109|NCT01831466|541086656|FG004|Overall Study|Lack of Efficacy|9|||
149988110|NCT01831466|541086657|FG005|Overall Study|Lack of Efficacy|8|||
149988111|NCT01831466|541086658|FG006|Overall Study|Lack of Efficacy|1|||
149988112|NCT01831466|541086659|FG007|Overall Study|Lack of Efficacy|1|||
149988113|NCT01831466|541086660|FG008|Overall Study|Lack of Efficacy|2|||
149988114|NCT01831466|541086661|FG009|Overall Study|Lack of Efficacy|2|||
149988115|NCT01831466|541086662|FG010|Overall Study|Lack of Efficacy|2|||
149988116|NCT01831466|541086663|FG011|Overall Study|Lack of Efficacy|0|||
149988117|NCT01831466|541086652|FG000|Overall Study|Adverse Event|0|||
149988118|NCT01831466|541086653|FG001|Overall Study|Adverse Event|0|||
149988119|NCT01831466|541086654|FG002|Overall Study|Adverse Event|4|||
149988120|NCT01831466|541086655|FG003|Overall Study|Adverse Event|6|||
149988121|NCT01831466|541086656|FG004|Overall Study|Adverse Event|3|||
149988122|NCT01831466|541086657|FG005|Overall Study|Adverse Event|7|||
149988123|NCT01831466|541086658|FG006|Overall Study|Adverse Event|0|||
149988124|NCT01831466|541086659|FG007|Overall Study|Adverse Event|1|||
149988125|NCT01831466|541086660|FG008|Overall Study|Adverse Event|1|||
149988126|NCT01831466|541086661|FG009|Overall Study|Adverse Event|1|||
149988127|NCT01831466|541086662|FG010|Overall Study|Adverse Event|0|||
149988128|NCT01831466|541086663|FG011|Overall Study|Adverse Event|2|||
149988129|NCT02798315|541086664|FG000|Overall Study|Failure to return|1|||
149988130|NCT03292640|541086674|FG000|Overall Study|Withdrawal by Subject|17|||
149988131|NCT03292640|541086675|FG001|Overall Study|Withdrawal by Subject|16|||
149988132|NCT03292640|541086674|FG000|Overall Study|Adverse Event|20|||
149988133|NCT03292640|541086675|FG001|Overall Study|Adverse Event|2|||
149988134|NCT03292640|541086674|FG000|Overall Study|Lost to Follow-up|24|||
149988135|NCT03292640|541086675|FG001|Overall Study|Lost to Follow-up|24|||
149988136|NCT01132651|541088441|FG000|Overall Study|Lost to Follow-up|1|||
149988137|NCT01132651|541088442|FG001|Overall Study|Lost to Follow-up|1|||
149988138|NCT03522246|541088450|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
149988139|NCT03522246|541088451|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
149988140|NCT03522246|541088452|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
149988141|NCT03522246|541088453|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
149988142|NCT03522246|541088454|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
149988143|NCT04299308|541088455|FG000|Overall Study|Withdrawal by Subject|1|||
149988144|NCT04299308|541088456|FG001|Overall Study|Withdrawal by Subject|0|||
149988145|NCT04299308|541088455|FG000|Overall Study|issue with PET image (1)|1|||
149988146|NCT04299308|541088456|FG001|Overall Study|issue with PET image (1)|0|||
149988147|NCT00814580|541088457|FG000|Overall Study|Adverse Event|6|||
149988148|NCT00814580|541088458|FG001|Overall Study|Adverse Event|15|||
149988149|NCT00814580|541088457|FG000|Overall Study|Lack of Efficacy|18|||
149988150|NCT00814580|541088458|FG001|Overall Study|Lack of Efficacy|25|||
149988151|NCT00814580|541088457|FG000|Overall Study|Protocol Violation|2|||
149988152|NCT00814580|541088458|FG001|Overall Study|Protocol Violation|0|||
149988153|NCT00814580|541088457|FG000|Overall Study|Withdrawal by Subject|2|||
149988154|NCT00814580|541088458|FG001|Overall Study|Withdrawal by Subject|2|||
149988155|NCT00814580|541088457|FG000|Overall Study|Other|1|||
149988156|NCT00814580|541088458|FG001|Overall Study|Other|3|||
149988157|NCT00814580|541088457|FG000|Overall Study|Did Not Take Drug|2|||
149988158|NCT00814580|541088458|FG001|Overall Study|Did Not Take Drug|2|||
150053607|NCT01457352|541336686|FG000|Period 1|MS related disease progression|1|||
149988159|NCT02482428|541088459|FG000|Overall Study|Lost to Follow-up|4|||
149988160|NCT02482428|541088460|FG001|Overall Study|Lost to Follow-up|9|||
149988161|NCT02482428|541088461|FG002|Overall Study|Lost to Follow-up|1|||
149988162|NCT02482428|541088462|FG003|Overall Study|Lost to Follow-up|2|||
149988163|NCT02482428|541088463|FG004|Overall Study|Lost to Follow-up|4|||
149988164|NCT02482428|541088459|FG000|Overall Study|Physician Decision|0|||
149988165|NCT02482428|541088460|FG001|Overall Study|Physician Decision|0|||
149988166|NCT02482428|541088461|FG002|Overall Study|Physician Decision|0|||
149988167|NCT02482428|541088462|FG003|Overall Study|Physician Decision|0|||
149988168|NCT02482428|541088463|FG004|Overall Study|Physician Decision|1|||
149988169|NCT02482428|541088459|FG000|Overall Study|protocol deviation|1|||
149988170|NCT02482428|541088460|FG001|Overall Study|protocol deviation|1|||
149988171|NCT02482428|541088461|FG002|Overall Study|protocol deviation|0|||
149988172|NCT02482428|541088462|FG003|Overall Study|protocol deviation|0|||
149988173|NCT02482428|541088463|FG004|Overall Study|protocol deviation|0|||
149988174|NCT02482428|541088459|FG000|Overall Study|subject/guardian decision|4|||
149988175|NCT02482428|541088460|FG001|Overall Study|subject/guardian decision|2|||
149988176|NCT02482428|541088461|FG002|Overall Study|subject/guardian decision|0|||
149988177|NCT02482428|541088462|FG003|Overall Study|subject/guardian decision|0|||
149988178|NCT02482428|541088463|FG004|Overall Study|subject/guardian decision|2|||
149988179|NCT02547038|541088464|FG000|Overall Study|Lost to Follow-up|3|||
149988180|NCT02547038|541088465|FG001|Overall Study|Lost to Follow-up|2|||
149988181|NCT01340625|541088468|FG000|First Intervention|Adverse Event|1|||
149988182|NCT01340625|541088469|FG001|First Intervention|Adverse Event|0|||
149988183|NCT01340625|541088468|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
149988184|NCT01340625|541088469|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
149988185|NCT00301262|541088470|FG000|Double Blind Phase (DB)|Adverse Event|1|||
149988186|NCT00301262|541088471|FG001|Double Blind Phase (DB)|Adverse Event|0|||
149988187|NCT00301262|541088470|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
149988188|NCT00301262|541088471|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
149988189|NCT00301262|541088470|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
149988190|NCT00301262|541088471|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
149988191|NCT00301262|541088470|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
149988192|NCT00301262|541088471|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
149988193|NCT00301262|541088470|FG000|Double Blind Phase (DB)|Other|1|||
149988194|NCT00301262|541088471|FG001|Double Blind Phase (DB)|Other|4|||
149988195|NCT00301262|541088470|FG000|Open Label Phase (OL)|Adverse Event|1|||
149988196|NCT00301262|541088471|FG001|Open Label Phase (OL)|Adverse Event|0|||
149988197|NCT00301262|541088470|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
149988198|NCT00301262|541088471|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
149988199|NCT00301262|541088470|FG000|Open Label Phase (OL)|Other|2|||
149988200|NCT00301262|541088471|FG001|Open Label Phase (OL)|Other|0|||
149988201|NCT01443364|541088472|FG000|Overall Study|Lack of Efficacy|14|||
149988202|NCT01443364|541088472|FG000|Overall Study|Lost to Follow-up|3|||
149988203|NCT01443364|541088472|FG000|Overall Study|Withdrawal by Subject|5|||
149988204|NCT01443364|541088472|FG000|Overall Study|Other Reason|4|||
149988205|NCT01443364|541088472|FG000|Overall Study|SAE, non-fatal|6|||
149988206|NCT01443364|541088472|FG000|Overall Study|AE, non-serious non-fatal|8|||
149988207|NCT01443364|541088472|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
149988208|NCT00623233|541088473|FG000|Overall Study|Adverse Event|10|||
149988209|NCT00623233|541088473|FG000|Overall Study|Physician Decision|10|||
149988210|NCT00623233|541088473|FG000|Overall Study|Lost to Follow-up|1|||
149988211|NCT00623233|541088473|FG000|Overall Study|Withdrawal by Subject|3|||
149988212|NCT00559845|541088474|FG000|Overall Study|Withdrew Consent|1|||
149988213|NCT00559845|541088474|FG000|Overall Study|Disease Progression|1|||
149988214|NCT00559845|541088474|FG000|Overall Study|Adverse Event|3|||
149988215|NCT00559845|541088474|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
149988216|NCT00559845|541088474|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
149988217|NCT00459875|541088475|FG000|Overall Study|Ineligible participant|1|||
149988218|NCT00459875|541088475|FG000|Overall Study|Adverse Event|2|||
149988219|NCT03206970|541088478|FG000|Overall Study|Death|21|||
149988220|NCT03206970|541088478|FG000|Overall Study|Withdrawal by Subject|13|||
149988221|NCT03206970|541088478|FG000|Overall Study|Lost to Follow-up|3|||
149988222|NCT03206970|541088478|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
149988223|NCT03645421|541088479|FG000|Overall Study|Adverse Event|0|||
149988224|NCT03645421|541088480|FG001|Overall Study|Adverse Event|0|||
149988225|NCT03645421|541088481|FG002|Overall Study|Adverse Event|4|||
149988226|NCT03645421|541088482|FG003|Overall Study|Adverse Event|1|||
149988227|NCT03645421|541088479|FG000|Overall Study|Withdrawal by patient|0|||
149988228|NCT03645421|541088480|FG001|Overall Study|Withdrawal by patient|0|||
149988229|NCT03645421|541088481|FG002|Overall Study|Withdrawal by patient|0|||
149988230|NCT03645421|541088482|FG003|Overall Study|Withdrawal by patient|3|||
149988231|NCT03645421|541088479|FG000|Overall Study|Study specific withdrawal criteria|0|||
149988232|NCT03645421|541088480|FG001|Overall Study|Study specific withdrawal criteria|0|||
149988233|NCT03645421|541088481|FG002|Overall Study|Study specific withdrawal criteria|1|||
149988234|NCT03645421|541088482|FG003|Overall Study|Study specific withdrawal criteria|0|||
149988235|NCT00224120|541088484|FG000|Overall Study|Adverse Event|10|||
149988236|NCT00224120|541088485|FG001|Overall Study|Adverse Event|4|||
149988237|NCT00224120|541088484|FG000|Overall Study|Protocol Violation|1|||
149988238|NCT00224120|541088485|FG001|Overall Study|Protocol Violation|0|||
149988239|NCT00224120|541088484|FG000|Overall Study|Withdrawal by Subject|5|||
149988240|NCT00224120|541088485|FG001|Overall Study|Withdrawal by Subject|10|||
149988241|NCT00224120|541088484|FG000|Overall Study|Lack of Efficacy|0|||
149988242|NCT00224120|541088485|FG001|Overall Study|Lack of Efficacy|2|||
149988243|NCT00224120|541088484|FG000|Overall Study|Lost to Follow-up|2|||
149988244|NCT00224120|541088485|FG001|Overall Study|Lost to Follow-up|3|||
149988245|NCT00224120|541088484|FG000|Overall Study|Other|4|||
149988246|NCT00224120|541088485|FG001|Overall Study|Other|5|||
150053608|NCT01457352|541336687|FG001|Period 1|MS related disease progression|0|||
150053609|NCT01457352|541336686|FG000|Period 1|Withdrawn|1|||
149988247|NCT00104416|541088486|FG000|Double-Blind Phase|Adverse Event|2|||
150053610|NCT01457352|541336687|FG001|Period 1|Withdrawn|0|||
149988248|NCT00104416|541088487|FG001|Double-Blind Phase|Adverse Event|1|||
149988249|NCT00104416|541088488|FG002|Double-Blind Phase|Adverse Event|0|||
149988250|NCT00104416|541088489|FG003|Double-Blind Phase|Adverse Event|0|||
149988251|NCT00104416|541088490|FG004|Double-Blind Phase|Adverse Event|0|||
149988252|NCT00104416|541088486|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149988253|NCT00104416|541088487|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149988254|NCT00104416|541088488|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149988255|NCT00104416|541088489|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149988256|NCT00104416|541088490|FG004|Double-Blind Phase|Lost to Follow-up|0|||
149988257|NCT00104416|541088486|FG000|Double-Blind Phase|Protocol Violation|0|||
149988258|NCT00104416|541088487|FG001|Double-Blind Phase|Protocol Violation|1|||
149988259|NCT00104416|541088488|FG002|Double-Blind Phase|Protocol Violation|0|||
149988260|NCT00104416|541088489|FG003|Double-Blind Phase|Protocol Violation|0|||
149988261|NCT00104416|541088490|FG004|Double-Blind Phase|Protocol Violation|0|||
149988262|NCT00104416|541088486|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
149988263|NCT00104416|541088487|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
149988264|NCT00104416|541088488|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
149988265|NCT00104416|541088489|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
149988266|NCT00104416|541088490|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149988267|NCT00104416|541088486|FG000|Double-Blind Phase|Pregnancy|1|||
149988268|NCT00104416|541088487|FG001|Double-Blind Phase|Pregnancy|0|||
149988269|NCT00104416|541088488|FG002|Double-Blind Phase|Pregnancy|0|||
149988270|NCT00104416|541088489|FG003|Double-Blind Phase|Pregnancy|0|||
149988271|NCT00104416|541088490|FG004|Double-Blind Phase|Pregnancy|0|||
149988272|NCT00104416|541088486|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
149988273|NCT00104416|541088487|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
149988274|NCT00104416|541088488|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
149988275|NCT00104416|541088489|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
149988276|NCT00104416|541088490|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
149988277|NCT00104416|541088486|FG000|Continuation Phase|Adverse Event|0|||
149988278|NCT00104416|541088487|FG001|Continuation Phase|Adverse Event|0|||
149988279|NCT00104416|541088488|FG002|Continuation Phase|Adverse Event|2|||
149988280|NCT00104416|541088489|FG003|Continuation Phase|Adverse Event|0|||
149988281|NCT00104416|541088490|FG004|Continuation Phase|Adverse Event|2|||
149988282|NCT00104416|541088486|FG000|Continuation Phase|Lost to Follow-up|0|||
149988283|NCT00104416|541088487|FG001|Continuation Phase|Lost to Follow-up|0|||
149988284|NCT00104416|541088488|FG002|Continuation Phase|Lost to Follow-up|1|||
149988285|NCT00104416|541088489|FG003|Continuation Phase|Lost to Follow-up|0|||
149988286|NCT00104416|541088490|FG004|Continuation Phase|Lost to Follow-up|1|||
149988287|NCT00104416|541088486|FG000|Continuation Phase|Withdrawal by Subject|0|||
149988288|NCT00104416|541088487|FG001|Continuation Phase|Withdrawal by Subject|0|||
149988289|NCT00104416|541088488|FG002|Continuation Phase|Withdrawal by Subject|2|||
149988290|NCT00104416|541088489|FG003|Continuation Phase|Withdrawal by Subject|1|||
149988291|NCT00104416|541088490|FG004|Continuation Phase|Withdrawal by Subject|1|||
149988292|NCT00104416|541088486|FG000|Continuation Phase|Pregnancy|0|||
149988293|NCT00104416|541088487|FG001|Continuation Phase|Pregnancy|0|||
149988294|NCT00104416|541088488|FG002|Continuation Phase|Pregnancy|1|||
149988295|NCT00104416|541088489|FG003|Continuation Phase|Pregnancy|1|||
149988296|NCT00104416|541088490|FG004|Continuation Phase|Pregnancy|0|||
149988297|NCT00104416|541088486|FG000|Continuation Phase|Non-compliance|0|||
149988298|NCT00104416|541088487|FG001|Continuation Phase|Non-compliance|0|||
149988299|NCT00104416|541088488|FG002|Continuation Phase|Non-compliance|0|||
149988300|NCT00104416|541088489|FG003|Continuation Phase|Non-compliance|0|||
149988301|NCT00104416|541088490|FG004|Continuation Phase|Non-compliance|1|||
149988302|NCT00070109|541088492|FG000|Overall Study|Death|1|||
149988303|NCT00070109|541088493|FG001|Overall Study|Death|1|||
149988304|NCT00070109|541088494|FG002|Overall Study|Death|0|||
149988305|NCT00070109|541088495|FG003|Overall Study|Death|0|||
149988306|NCT00070109|541088496|FG004|Overall Study|Death|1|||
149988307|NCT00070109|541088492|FG000|Overall Study|Lack of Efficacy|6|||
149988308|NCT00070109|541088493|FG001|Overall Study|Lack of Efficacy|4|||
149988309|NCT00070109|541088494|FG002|Overall Study|Lack of Efficacy|5|||
149988310|NCT00070109|541088495|FG003|Overall Study|Lack of Efficacy|15|||
149988311|NCT00070109|541088496|FG004|Overall Study|Lack of Efficacy|5|||
149988312|NCT00070109|541088492|FG000|Overall Study|Physician Decision|1|||
149988313|NCT00070109|541088493|FG001|Overall Study|Physician Decision|0|||
149988314|NCT00070109|541088494|FG002|Overall Study|Physician Decision|0|||
149988315|NCT00070109|541088495|FG003|Overall Study|Physician Decision|0|||
149988316|NCT00070109|541088496|FG004|Overall Study|Physician Decision|0|||
149988317|NCT00070109|541088492|FG000|Overall Study|Withdrawal by Subject|0|||
150178865|NCT03575052|541793853|FG000|Overall Study|Protocol Violation|0|||
149988318|NCT00070109|541088493|FG001|Overall Study|Withdrawal by Subject|1|||
150178866|NCT03575052|541793854|FG001|Overall Study|Protocol Violation|2|||
149988319|NCT00070109|541088494|FG002|Overall Study|Withdrawal by Subject|1|||
149988320|NCT00070109|541088495|FG003|Overall Study|Withdrawal by Subject|0|||
149988321|NCT00070109|541088496|FG004|Overall Study|Withdrawal by Subject|0|||
149988322|NCT00070109|541088492|FG000|Overall Study|Adverse Event|0|||
149988323|NCT00070109|541088493|FG001|Overall Study|Adverse Event|0|||
149988324|NCT00070109|541088494|FG002|Overall Study|Adverse Event|2|||
149988325|NCT00070109|541088495|FG003|Overall Study|Adverse Event|4|||
149988326|NCT00070109|541088496|FG004|Overall Study|Adverse Event|2|||
149988327|NCT00070109|541088492|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
149988328|NCT00070109|541088493|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
149988329|NCT00070109|541088494|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
149988330|NCT00070109|541088495|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
149988331|NCT00070109|541088496|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
149988332|NCT01164891|541088499|FG000|Overall Study|Disease Progression|5|||
149988333|NCT01164891|541088499|FG000|Overall Study|Adverse Event|1|||
149988334|NCT00441142|541088500|FG000|Overall Study|Adverse Event|2|||
149988335|NCT00441142|541088501|FG001|Overall Study|Adverse Event|3|||
149988336|NCT00441142|541088502|FG002|Overall Study|Adverse Event|3|||
149988337|NCT00441142|541088503|FG003|Overall Study|Adverse Event|22|||
149988338|NCT00441142|541088500|FG000|Overall Study|Lack of Efficacy|3|||
149988339|NCT00441142|541088501|FG001|Overall Study|Lack of Efficacy|3|||
149988340|NCT00441142|541088502|FG002|Overall Study|Lack of Efficacy|17|||
149988341|NCT00441142|541088503|FG003|Overall Study|Lack of Efficacy|32|||
149988342|NCT00441142|541088500|FG000|Overall Study|Withdrawal by Subject|0|||
149988343|NCT00441142|541088501|FG001|Overall Study|Withdrawal by Subject|0|||
149988344|NCT00441142|541088502|FG002|Overall Study|Withdrawal by Subject|2|||
149988345|NCT00441142|541088503|FG003|Overall Study|Withdrawal by Subject|10|||
149988346|NCT00441142|541088500|FG000|Overall Study|Patient still receiving active study tx|1|||
149988347|NCT00441142|541088501|FG001|Overall Study|Patient still receiving active study tx|0|||
149988348|NCT00441142|541088502|FG002|Overall Study|Patient still receiving active study tx|0|||
149988349|NCT00441142|541088503|FG003|Overall Study|Patient still receiving active study tx|2|||
149988350|NCT00441142|541088500|FG000|Overall Study|Physician Decision|0|||
149988351|NCT00441142|541088501|FG001|Overall Study|Physician Decision|1|||
149988352|NCT00441142|541088502|FG002|Overall Study|Physician Decision|0|||
149988353|NCT00441142|541088503|FG003|Overall Study|Physician Decision|1|||
149988354|NCT00441142|541088500|FG000|Overall Study|Death|0|||
149988355|NCT00441142|541088501|FG001|Overall Study|Death|0|||
149988356|NCT00441142|541088502|FG002|Overall Study|Death|0|||
149988357|NCT00441142|541088503|FG003|Overall Study|Death|1|||
149988358|NCT00338286|541088504|FG000|Overall Study|Withdrawal by Subject|50|||
149988359|NCT00338286|541088505|FG001|Overall Study|Withdrawal by Subject|54|||
149988360|NCT00338286|541088504|FG000|Overall Study|Lost to Follow-up|80|||
149988361|NCT00338286|541088505|FG001|Overall Study|Lost to Follow-up|66|||
149988362|NCT00338286|541088504|FG000|Overall Study|Other|103|||
149988363|NCT00338286|541088505|FG001|Overall Study|Other|93|||
149988364|NCT00022763|541088510|FG000|Overall Study|Adverse Event|1|||
149988365|NCT00022763|541088511|FG001|Overall Study|Adverse Event|2|||
149988366|NCT00022763|541088510|FG000|Overall Study|Injection Site Reactions|0|||
149988367|NCT00022763|541088511|FG001|Overall Study|Injection Site Reactions|2|||
149988368|NCT00022763|541088510|FG000|Overall Study|Death|0|||
149988369|NCT00022763|541088511|FG001|Overall Study|Death|1|||
149988370|NCT00022763|541088510|FG000|Overall Study|Lost to Follow-up|0|||
149988371|NCT00022763|541088511|FG001|Overall Study|Lost to Follow-up|3|||
149988372|NCT00022763|541088510|FG000|Overall Study|Withdrawal by Subject|4|||
149988373|NCT00022763|541088511|FG001|Overall Study|Withdrawal by Subject|7|||
149988374|NCT00022763|541088510|FG000|Overall Study|Insufficient Therapy|1|||
149988375|NCT00022763|541088511|FG001|Overall Study|Insufficient Therapy|0|||
149988376|NCT00022763|541088510|FG000|Overall Study|Admin|3|||
149988377|NCT00022763|541088511|FG001|Overall Study|Admin|2|||
149988378|NCT02141399|541088512|FG000|Overall Study|Adverse Event|158|||
149988379|NCT02141399|541088512|FG000|Overall Study|Lack of Efficacy|62|||
149988380|NCT02141399|541088512|FG000|Overall Study|Lost to Follow-up|151|||
149988381|NCT02141399|541088512|FG000|Overall Study|Non-compliance with study drug|18|||
149988382|NCT02141399|541088512|FG000|Overall Study|Other|45|||
149988383|NCT02141399|541088512|FG000|Overall Study|Physician Decision|17|||
149988384|NCT02141399|541088512|FG000|Overall Study|Pregnancy|3|||
150053611|NCT01457352|541336686|FG000|Period 1|withdrew per sponsor|1|||
150053612|NCT01457352|541336687|FG001|Period 1|withdrew per sponsor|0|||
149988385|NCT02141399|541088512|FG000|Overall Study|Protocol Violation|38|||
149988386|NCT02141399|541088512|FG000|Overall Study|Withdrawal by Subject|238|||
149988387|NCT02141399|541088512|FG000|Overall Study|Failure to meet eligibility criteria|14|||
149988388|NCT01345929|541088513|FG000|Overall Study|Withdrawal by Subject|9|||
149988389|NCT01345929|541088514|FG001|Overall Study|Withdrawal by Subject|8|||
149988390|NCT01345929|541088513|FG000|Overall Study|Lost to Follow-up|9|||
149988391|NCT01345929|541088514|FG001|Overall Study|Lost to Follow-up|9|||
149988392|NCT01345929|541088513|FG000|Overall Study|Adverse Event|0|||
149988393|NCT01345929|541088514|FG001|Overall Study|Adverse Event|1|||
149988394|NCT01345929|541088513|FG000|Overall Study|Didn't meet eligibility criteria|2|||
149988395|NCT01345929|541088514|FG001|Overall Study|Didn't meet eligibility criteria|0|||
150178867|NCT03575052|541793853|FG000|Overall Study|Physician Decision|1|||
149988396|NCT01345929|541088513|FG000|Overall Study|40,000 CFU/ML|1|||
149988397|NCT01345929|541088514|FG001|Overall Study|40,000 CFU/ML|0|||
149988398|NCT01345929|541088513|FG000|Overall Study|Patient withdrawal|0|||
149988399|NCT01345929|541088514|FG001|Overall Study|Patient withdrawal|1|||
149988400|NCT02819297|541088519|FG000|Overall Study|Withdrawal by Subject|25|||
149988401|NCT02819297|541088520|FG001|Overall Study|Withdrawal by Subject|13|||
149988402|NCT02819297|541088519|FG000|Overall Study|Lost to Follow-up|12|||
149988403|NCT02819297|541088520|FG001|Overall Study|Lost to Follow-up|14|||
149988404|NCT02819297|541088519|FG000|Overall Study|Adverse Event|12|||
149988405|NCT02819297|541088520|FG001|Overall Study|Adverse Event|10|||
149988406|NCT02819297|541088519|FG000|Overall Study|Physician Decision|5|||
149988407|NCT02819297|541088520|FG001|Overall Study|Physician Decision|5|||
149988408|NCT02819297|541088519|FG000|Overall Study|Lack of Efficacy|5|||
149988409|NCT02819297|541088520|FG001|Overall Study|Lack of Efficacy|8|||
149988410|NCT02819297|541088519|FG000|Overall Study|Protocol Violation|1|||
149988411|NCT02819297|541088520|FG001|Overall Study|Protocol Violation|2|||
149988412|NCT02858440|541088521|FG000|Overall Study|Lost to Follow-up|3|||
149988413|NCT02858440|541088521|FG000|Overall Study|Protocol Violation|2|||
149988414|NCT02858440|541088521|FG000|Overall Study|Consent withdrawal|3|||
149988415|NCT02858440|541088521|FG000|Overall Study|Migrated/moved from study area|4|||
149988416|NCT01670279|541088522|FG000|Overall Study|Adverse Event|0|||
149988417|NCT01670279|541088523|FG001|Overall Study|Adverse Event|1|||
149988418|NCT01670279|541088524|FG002|Overall Study|Adverse Event|0|||
149988419|NCT01670279|541088525|FG003|Overall Study|Adverse Event|0|||
149988420|NCT01670279|541088522|FG000|Overall Study|Physician Decision|0|||
149988421|NCT01670279|541088523|FG001|Overall Study|Physician Decision|1|||
149988422|NCT01670279|541088524|FG002|Overall Study|Physician Decision|0|||
149988423|NCT01670279|541088525|FG003|Overall Study|Physician Decision|0|||
149988424|NCT01670279|541088522|FG000|Overall Study|Participant met withdrawal criteria|0|||
149988425|NCT01670279|541088523|FG001|Overall Study|Participant met withdrawal criteria|0|||
149988426|NCT01670279|541088524|FG002|Overall Study|Participant met withdrawal criteria|0|||
149988427|NCT01670279|541088525|FG003|Overall Study|Participant met withdrawal criteria|1|||
149988428|NCT01534351|541088528|FG000|Overall Study|Study Terminated Early|1|||
149988429|NCT01534351|541088529|FG001|Overall Study|Study Terminated Early|0|||
149988430|NCT01534351|541088530|FG002|Overall Study|Study Terminated Early|0|||
149988431|NCT02702609|541088531|FG000|Overall Study|Lost to Follow-up|8|||
149988432|NCT02702609|541088532|FG001|Overall Study|Lost to Follow-up|4|||
149988433|NCT02702609|541088531|FG000|Overall Study|Physician Decision|1|||
149988434|NCT02702609|541088532|FG001|Overall Study|Physician Decision|0|||
149988435|NCT04153981|541088533|FG000|Overall Study|Death|1|||
149988436|NCT04153981|541088533|FG000|Overall Study|Withdrawal by Subject|24|||
149988437|NCT04153981|541088533|FG000|Overall Study|Lost to Follow-up|1|||
149988438|NCT04153981|541088533|FG000|Overall Study|Physician Decision|1|||
149988439|NCT04153981|541088533|FG000|Overall Study|Due to Unavailable Glucometer|1|||
149988440|NCT04153981|541088533|FG000|Overall Study|Covid 19|52|||
149988441|NCT04153981|541088533|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
149988442|NCT04153981|541088533|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
149988443|NCT02027311|541088534|FG000|Overall Study|Protocol Violation|3|||
149988444|NCT02027311|541088535|FG001|Overall Study|Protocol Violation|2|||
149988445|NCT03928418|541088536|FG000|Overall Study|Lost to Follow-up|5|||
149988446|NCT03928418|541088537|FG001|Overall Study|Lost to Follow-up|3|||
149988447|NCT03928418|541088538|FG002|Overall Study|Lost to Follow-up|5|||
149988448|NCT03928418|541088536|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
149988449|NCT03928418|541088537|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
149988450|NCT03928418|541088538|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
149988451|NCT00964002|541088541|FG000|Overall Study|Protocol Violation|8|||
149988452|NCT02036580|541088553|FG000|Overall Study|Withdrawal by Subject|0|||
149988453|NCT02036580|541088554|FG001|Overall Study|Withdrawal by Subject|1|||
149988454|NCT02036580|541088555|FG002|Overall Study|Withdrawal by Subject|0|||
149988455|NCT02036580|541088553|FG000|Overall Study|Adverse Event|1|||
149988456|NCT02036580|541088554|FG001|Overall Study|Adverse Event|0|||
149988457|NCT02036580|541088555|FG002|Overall Study|Adverse Event|0|||
149988458|NCT00260832|541088556|FG000|Overall Study|Adverse Event|26|||
149988459|NCT00260832|541088557|FG001|Overall Study|Adverse Event|19|||
149988460|NCT00260832|541088556|FG000|Overall Study|Progression|116|||
149988461|NCT00260832|541088557|FG001|Overall Study|Progression|96|||
149988462|NCT00260832|541088556|FG000|Overall Study|Withdrawal by Subject|15|||
149988463|NCT00260832|541088557|FG001|Overall Study|Withdrawal by Subject|17|||
149988464|NCT00260832|541088556|FG000|Overall Study|Physician Decision|15|||
149988465|NCT00260832|541088557|FG001|Overall Study|Physician Decision|9|||
149988466|NCT00260832|541088556|FG000|Overall Study|Death|43|||
149988467|NCT00260832|541088557|FG001|Overall Study|Death|62|||
149988468|NCT00260832|541088556|FG000|Overall Study|Other|10|||
149988469|NCT00260832|541088557|FG001|Overall Study|Other|7|||
149988470|NCT00260832|541088556|FG000|Overall Study|Protocol Violation|3|||
149988471|NCT00260832|541088557|FG001|Overall Study|Protocol Violation|1|||
150053613|NCT01457352|541336686|FG000|Period 1|Protocol Violation|4|||
149988472|NCT02993822|541088558|FG000|Overall Study|Lack of Efficacy|1|||
149988473|NCT02993822|541088559|FG001|Overall Study|Lack of Efficacy|1|||
149988474|NCT02993822|541088560|FG002|Overall Study|Lack of Efficacy|0|||
149988475|NCT02993822|541088561|FG003|Overall Study|Lack of Efficacy|0|||
149988476|NCT02993822|541088558|FG000|Overall Study|Protocol Violation|1|||
149988477|NCT02993822|541088559|FG001|Overall Study|Protocol Violation|0|||
149988478|NCT02993822|541088560|FG002|Overall Study|Protocol Violation|0|||
149988479|NCT02993822|541088561|FG003|Overall Study|Protocol Violation|0|||
149988480|NCT02993822|541088558|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
149988481|NCT02993822|541088559|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
149988482|NCT02993822|541088560|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
149988483|NCT02993822|541088561|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
149988484|NCT02993822|541088558|FG000|Overall Study|Adverse Event|3|||
149988485|NCT02993822|541088559|FG001|Overall Study|Adverse Event|1|||
149988486|NCT02993822|541088560|FG002|Overall Study|Adverse Event|7|||
149988487|NCT02993822|541088561|FG003|Overall Study|Adverse Event|0|||
149988488|NCT02993822|541088558|FG000|Overall Study|Withdrawal by Subject|4|||
149988489|NCT02993822|541088559|FG001|Overall Study|Withdrawal by Subject|2|||
149988490|NCT02993822|541088560|FG002|Overall Study|Withdrawal by Subject|2|||
149988491|NCT02993822|541088561|FG003|Overall Study|Withdrawal by Subject|3|||
149988492|NCT02993822|541088558|FG000|Overall Study|Lost to Follow-up|1|||
149988493|NCT02993822|541088559|FG001|Overall Study|Lost to Follow-up|0|||
149988494|NCT02993822|541088560|FG002|Overall Study|Lost to Follow-up|1|||
149988495|NCT02993822|541088561|FG003|Overall Study|Lost to Follow-up|0|||
149988496|NCT01854775|541088562|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
149988497|NCT01854775|541088563|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
149988498|NCT01854775|541088564|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
149988499|NCT01854775|541088562|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
149988500|NCT01854775|541088563|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
149988501|NCT01854775|541088564|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
149988502|NCT01854775|541088562|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
149988503|NCT01854775|541088563|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
149988504|NCT01854775|541088564|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
149988505|NCT01854775|541088562|FG000|Extension Phase|Pregnancy|3|||
149988506|NCT01854775|541088563|FG001|Extension Phase|Pregnancy|0|||
149988507|NCT01854775|541088564|FG002|Extension Phase|Pregnancy|0|||
149988508|NCT01854775|541088562|FG000|Extension Phase|Investigator's Discretion|1|||
149988509|NCT01854775|541088563|FG001|Extension Phase|Investigator's Discretion|0|||
149988510|NCT01854775|541088564|FG002|Extension Phase|Investigator's Discretion|0|||
149988511|NCT01854775|541088562|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
149988512|NCT01854775|541088563|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
149988513|NCT01854775|541088564|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
149988514|NCT01854775|541088562|FG000|Extension Phase|Lost to Follow-up|2|||
149988515|NCT01854775|541088563|FG001|Extension Phase|Lost to Follow-up|0|||
149988516|NCT01854775|541088564|FG002|Extension Phase|Lost to Follow-up|0|||
149988517|NCT01854775|541088562|FG000|Extension Phase|Still on Study|32|||
149988518|NCT01854775|541088563|FG001|Extension Phase|Still on Study|47|||
149988519|NCT01854775|541088564|FG002|Extension Phase|Still on Study|18|||
149988520|NCT00984594|541088565|FG000|Overall Study|Lost to Follow-up|1|||
149988521|NCT00984594|541088566|FG001|Overall Study|Lost to Follow-up|0|||
149988522|NCT00984594|541088565|FG000|Overall Study|Withdrawal by Subject|0|||
149988523|NCT00984594|541088566|FG001|Overall Study|Withdrawal by Subject|1|||
149988524|NCT01659996|541088567|FG000|Overall Study|Protocol Violation|3|||
149988525|NCT01659996|541088568|FG001|Overall Study|Protocol Violation|3|||
149988526|NCT01659996|541088569|FG002|Overall Study|Protocol Violation|3|||
149988527|NCT01659996|541088567|FG000|Overall Study|Lost to Follow-up|1|||
149988528|NCT01659996|541088568|FG001|Overall Study|Lost to Follow-up|3|||
149988529|NCT01659996|541088569|FG002|Overall Study|Lost to Follow-up|2|||
149988530|NCT01659996|541088567|FG000|Overall Study|Adverse Event|0|||
149988531|NCT01659996|541088568|FG001|Overall Study|Adverse Event|0|||
149988532|NCT01659996|541088569|FG002|Overall Study|Adverse Event|1|||
149988533|NCT01659996|541088567|FG000|Overall Study|Withdrawal by Subject|4|||
149988534|NCT01659996|541088568|FG001|Overall Study|Withdrawal by Subject|1|||
149988535|NCT01659996|541088569|FG002|Overall Study|Withdrawal by Subject|5|||
149988536|NCT03206918|541088570|FG000|Overall Study|Death|11|||
149988537|NCT03206918|541088570|FG000|Overall Study|Withdrawal by Subject|5|||
149988538|NCT03206918|541088570|FG000|Overall Study|Study terminated by sponsor|12|||
149988539|NCT03206918|541088570|FG000|Overall Study|Lost to Follow-up|3|||
150053614|NCT01457352|541336687|FG001|Period 1|Protocol Violation|0|||
150053615|NCT01457352|541336686|FG000|Period 1|Did not meet eligibility criteria|3|||
150053616|NCT01457352|541336687|FG001|Period 1|Did not meet eligibility criteria|0|||
150053617|NCT01457352|541336686|FG000|Period 2|Withdrawal by Subject|23|||
149988540|NCT03206918|541088570|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
149988541|NCT02701764|541088571|FG000|Overall Study|Lost to Follow-up|0|||
149988542|NCT02701764|541088572|FG001|Overall Study|Lost to Follow-up|1|||
149988543|NCT03823287|541088573|FG000|Overall Study|Withdrawal by Subject|25|||
149988544|NCT03823287|541088574|FG001|Overall Study|Withdrawal by Subject|17|||
149988545|NCT03823287|541088573|FG000|Overall Study|Death|13|||
149988546|NCT03823287|541088574|FG001|Overall Study|Death|7|||
149988547|NCT03823287|541088573|FG000|Overall Study|Lost to Follow-up|7|||
149988548|NCT03823287|541088574|FG001|Overall Study|Lost to Follow-up|8|||
149988549|NCT03823287|541088573|FG000|Overall Study|Adverse Event|6|||
149988550|NCT03823287|541088574|FG001|Overall Study|Adverse Event|8|||
149988551|NCT03823287|541088573|FG000|Overall Study|Physician Decision|5|||
149988552|NCT03823287|541088574|FG001|Overall Study|Physician Decision|2|||
149988553|NCT03823287|541088573|FG000|Overall Study|Lack of Efficacy|2|||
149988554|NCT03823287|541088574|FG001|Overall Study|Lack of Efficacy|0|||
149988555|NCT03823287|541088573|FG000|Overall Study|Other|2|||
149988556|NCT03823287|541088574|FG001|Overall Study|Other|4|||
149988557|NCT06899737|541088581|FG000|Overall Study|Lost to Follow-up|19|||
149988558|NCT06899737|541088582|FG001|Overall Study|Lost to Follow-up|7|||
149988559|NCT03110029|541088584|FG000|Overall Study|Withdrawal by Subject|1|||
149988560|NCT03110029|541088585|FG001|Overall Study|Withdrawal by Subject|1|||
149988561|NCT03281629|541088586|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
149988562|NCT03281629|541088587|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
149988563|NCT03281629|541088586|FG000|Overall Study|Death|0|||
149988564|NCT03281629|541088587|FG001|Overall Study|Death|1|||
149988565|NCT03281629|541088586|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
149988566|NCT03281629|541088587|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
149988567|NCT00334737|541088588|FG000|Hospital Phase|Death|1|||
149988568|NCT00334737|541088589|FG001|Hospital Phase|Death|2|||
149988569|NCT00334737|541088590|FG002|Hospital Phase|Death|3|||
149988570|NCT00334737|541088588|FG000|Hospital Phase|Withdrawal by Subject|0|||
149988571|NCT00334737|541088589|FG001|Hospital Phase|Withdrawal by Subject|0|||
149988572|NCT00334737|541088590|FG002|Hospital Phase|Withdrawal by Subject|1|||
149988573|NCT00334737|541088588|FG000|Hospital Phase|Did not receive study drug|1|||
149988574|NCT00334737|541088589|FG001|Hospital Phase|Did not receive study drug|0|||
149988575|NCT00334737|541088590|FG002|Hospital Phase|Did not receive study drug|0|||
149988576|NCT00334737|541088588|FG000|Follow up Phase|Lost to Follow-up|5|||
149988577|NCT00334737|541088589|FG001|Follow up Phase|Lost to Follow-up|3|||
149988578|NCT00334737|541088590|FG002|Follow up Phase|Lost to Follow-up|6|||
149988579|NCT02954406|541090918|FG000|Overall Study|Adverse Event|0|||
149988580|NCT02954406|541090919|FG001|Overall Study|Adverse Event|1|||
149988581|NCT02954406|541090920|FG002|Overall Study|Adverse Event|0|||
149988582|NCT02954406|541090921|FG003|Overall Study|Adverse Event|0|||
149988583|NCT02954406|541090922|FG004|Overall Study|Adverse Event|1|||
149988584|NCT02954406|541090923|FG005|Overall Study|Adverse Event|0|||
149988585|NCT02954406|541090924|FG006|Overall Study|Adverse Event|0|||
149988586|NCT02954406|541090925|FG007|Overall Study|Adverse Event|0|||
149988587|NCT02954406|541090926|FG008|Overall Study|Adverse Event|1|||
149988588|NCT02954406|541090927|FG009|Overall Study|Adverse Event|1|||
149988589|NCT02954406|541090928|FG010|Overall Study|Adverse Event|0|||
149988590|NCT02954406|541090918|FG000|Overall Study|Progressive Disease|3|||
149988591|NCT02954406|541090919|FG001|Overall Study|Progressive Disease|4|||
149988592|NCT02954406|541090920|FG002|Overall Study|Progressive Disease|3|||
149988593|NCT02954406|541090921|FG003|Overall Study|Progressive Disease|4|||
149988594|NCT02954406|541090922|FG004|Overall Study|Progressive Disease|3|||
149988595|NCT02954406|541090923|FG005|Overall Study|Progressive Disease|3|||
149988596|NCT02954406|541090924|FG006|Overall Study|Progressive Disease|2|||
149988597|NCT02954406|541090925|FG007|Overall Study|Progressive Disease|2|||
149988598|NCT02954406|541090926|FG008|Overall Study|Progressive Disease|1|||
149988599|NCT02954406|541090927|FG009|Overall Study|Progressive Disease|1|||
149988600|NCT02954406|541090928|FG010|Overall Study|Progressive Disease|0|||
149988601|NCT02954406|541090918|FG000|Overall Study|Symptomatic Deterioration|0|||
149988602|NCT02954406|541090919|FG001|Overall Study|Symptomatic Deterioration|1|||
149988603|NCT02954406|541090920|FG002|Overall Study|Symptomatic Deterioration|0|||
149988604|NCT02954406|541090921|FG003|Overall Study|Symptomatic Deterioration|0|||
149988605|NCT02954406|541090922|FG004|Overall Study|Symptomatic Deterioration|0|||
149988606|NCT02954406|541090923|FG005|Overall Study|Symptomatic Deterioration|0|||
149988607|NCT02954406|541090924|FG006|Overall Study|Symptomatic Deterioration|0|||
149988608|NCT02954406|541090925|FG007|Overall Study|Symptomatic Deterioration|0|||
149988609|NCT02954406|541090926|FG008|Overall Study|Symptomatic Deterioration|0|||
149988610|NCT02954406|541090927|FG009|Overall Study|Symptomatic Deterioration|0|||
149988611|NCT02954406|541090928|FG010|Overall Study|Symptomatic Deterioration|0|||
149988612|NCT02954406|541090918|FG000|Overall Study|Death|0|||
149988613|NCT02954406|541090919|FG001|Overall Study|Death|0|||
149988614|NCT02954406|541090920|FG002|Overall Study|Death|0|||
149988615|NCT02954406|541090921|FG003|Overall Study|Death|0|||
149988616|NCT02954406|541090922|FG004|Overall Study|Death|1|||
150178868|NCT03575052|541793854|FG001|Overall Study|Physician Decision|0|||
149988617|NCT02954406|541090923|FG005|Overall Study|Death|0|||
149988618|NCT02954406|541090924|FG006|Overall Study|Death|0|||
149988619|NCT02954406|541090925|FG007|Overall Study|Death|0|||
149988620|NCT02954406|541090926|FG008|Overall Study|Death|1|||
149988621|NCT02954406|541090927|FG009|Overall Study|Death|1|||
149988622|NCT02954406|541090928|FG010|Overall Study|Death|0|||
149988623|NCT02954406|541090918|FG000|Overall Study|Reason Not Specified|0|||
149988624|NCT02954406|541090919|FG001|Overall Study|Reason Not Specified|0|||
149988625|NCT02954406|541090920|FG002|Overall Study|Reason Not Specified|3|||
149988626|NCT02954406|541090921|FG003|Overall Study|Reason Not Specified|2|||
149988627|NCT02954406|541090922|FG004|Overall Study|Reason Not Specified|2|||
149988628|NCT02954406|541090923|FG005|Overall Study|Reason Not Specified|0|||
149988629|NCT02954406|541090924|FG006|Overall Study|Reason Not Specified|1|||
149988630|NCT02954406|541090925|FG007|Overall Study|Reason Not Specified|0|||
149988631|NCT02954406|541090926|FG008|Overall Study|Reason Not Specified|1|||
149988632|NCT02954406|541090927|FG009|Overall Study|Reason Not Specified|0|||
149988633|NCT02954406|541090928|FG010|Overall Study|Reason Not Specified|0|||
149988634|NCT00782171|541090929|FG000|Overall Study|Lost to Follow-up|2|||
149988635|NCT00782171|541090930|FG001|Overall Study|Lost to Follow-up|2|||
149988636|NCT00782171|541090929|FG000|Overall Study|Withdrawal by Subject|2|||
149988637|NCT00782171|541090930|FG001|Overall Study|Withdrawal by Subject|1|||
149988638|NCT00782171|541090929|FG000|Overall Study|complications|3|||
149988639|NCT00782171|541090930|FG001|Overall Study|complications|1|||
149988640|NCT00782171|541090929|FG000|Overall Study|others|7|||
149988641|NCT00782171|541090930|FG001|Overall Study|others|9|||
149988642|NCT00782171|541090929|FG000|Overall Study|not eligible|8|||
149988643|NCT00782171|541090930|FG001|Overall Study|not eligible|6|||
149988644|NCT01986231|541090933|FG000|Overall Study|Adverse Event|1|||
149988645|NCT02150057|541090934|FG000|Overall Study|Lost to Follow-up|6|||
149988646|NCT02150057|541090935|FG001|Overall Study|Lost to Follow-up|4|||
149988647|NCT00489424|541090936|FG000|Overall Study|Adverse Event|3|||
149988648|NCT00489424|541090937|FG001|Overall Study|Adverse Event|3|||
149988649|NCT00489424|541090938|FG002|Overall Study|Adverse Event|4|||
149988650|NCT00489424|541090936|FG000|Overall Study|Lack of Efficacy|1|||
149988651|NCT00489424|541090937|FG001|Overall Study|Lack of Efficacy|0|||
149988652|NCT00489424|541090938|FG002|Overall Study|Lack of Efficacy|0|||
149988653|NCT00489424|541090936|FG000|Overall Study|Administrative problems|0|||
149988654|NCT00489424|541090937|FG001|Overall Study|Administrative problems|2|||
149988655|NCT00489424|541090938|FG002|Overall Study|Administrative problems|1|||
149988656|NCT01558115|541090939|FG000|Overall Study|Withdrawal by Subject|3|||
149988657|NCT01558115|541090939|FG000|Overall Study|Study closed due to poor enrollment|4|||
149988658|NCT01436656|541090940|FG000|Dose Escalation|Death|1|||
149988659|NCT01436656|541090941|FG001|Dose Escalation|Death|3|||
149988660|NCT01436656|541090942|FG002|Dose Escalation|Death|1|||
149988661|NCT01436656|541090943|FG003|Dose Escalation|Death|0|||
149988662|NCT01436656|541090944|FG004|Dose Escalation|Death|2|||
149988663|NCT01436656|541090945|FG005|Dose Escalation|Death|1|||
149988664|NCT01436656|541090946|FG006|Dose Escalation|Death|1|||
149988665|NCT01436656|541090947|FG007|Dose Escalation|Death|1|||
149988666|NCT01436656|541090948|FG008|Dose Escalation|Death|1|||
149988667|NCT01436656|541090949|FG009|Dose Escalation|Death|0|||
149988668|NCT01436656|541090950|FG010|Dose Escalation|Death|0|||
149988669|NCT01436656|541090951|FG011|Dose Escalation|Death|0|||
149988670|NCT01436656|541090952|FG012|Dose Escalation|Death|0|||
149988671|NCT01436656|541090953|FG013|Dose Escalation|Death|0|||
149988672|NCT01436656|541090954|FG014|Dose Escalation|Death|0|||
149988673|NCT01436656|541090955|FG015|Dose Escalation|Death|0|||
149988674|NCT01436656|541090956|FG016|Dose Escalation|Death|0|||
149988675|NCT01436656|541090957|FG017|Dose Escalation|Death|0|||
149988676|NCT01436656|541090940|FG000|Dose Escalation|Protocol Violation|0|||
149988677|NCT01436656|541090941|FG001|Dose Escalation|Protocol Violation|0|||
149988678|NCT01436656|541090942|FG002|Dose Escalation|Protocol Violation|0|||
149988679|NCT01436656|541090943|FG003|Dose Escalation|Protocol Violation|0|||
149988680|NCT01436656|541090944|FG004|Dose Escalation|Protocol Violation|0|||
149988681|NCT01436656|541090945|FG005|Dose Escalation|Protocol Violation|1|||
149988682|NCT01436656|541090946|FG006|Dose Escalation|Protocol Violation|0|||
149988683|NCT01436656|541090947|FG007|Dose Escalation|Protocol Violation|0|||
149988684|NCT01436656|541090948|FG008|Dose Escalation|Protocol Violation|0|||
149988685|NCT01436656|541090949|FG009|Dose Escalation|Protocol Violation|0|||
150053618|NCT01457352|541336687|FG001|Period 2|Withdrawal by Subject|0|||
150053619|NCT01457352|541336686|FG000|Period 2|Adverse Event|22|||
150053620|NCT01457352|541336687|FG001|Period 2|Adverse Event|0|||
149988686|NCT01436656|541090950|FG010|Dose Escalation|Protocol Violation|0|||
149988687|NCT01436656|541090951|FG011|Dose Escalation|Protocol Violation|0|||
149988688|NCT01436656|541090952|FG012|Dose Escalation|Protocol Violation|0|||
149988689|NCT01436656|541090953|FG013|Dose Escalation|Protocol Violation|0|||
149988690|NCT01436656|541090954|FG014|Dose Escalation|Protocol Violation|0|||
149988691|NCT01436656|541090955|FG015|Dose Escalation|Protocol Violation|0|||
149988692|NCT01436656|541090956|FG016|Dose Escalation|Protocol Violation|0|||
149988693|NCT01436656|541090957|FG017|Dose Escalation|Protocol Violation|0|||
150053621|NCT01457352|541336686|FG000|Period 2|no analysis|10|||
149988694|NCT01436656|541090940|FG000|Dose Escalation|Withdrawal by Subject|0|||
149988695|NCT01436656|541090941|FG001|Dose Escalation|Withdrawal by Subject|0|||
149988696|NCT01436656|541090942|FG002|Dose Escalation|Withdrawal by Subject|0|||
149988697|NCT01436656|541090943|FG003|Dose Escalation|Withdrawal by Subject|0|||
149988698|NCT01436656|541090944|FG004|Dose Escalation|Withdrawal by Subject|1|||
149988699|NCT01436656|541090945|FG005|Dose Escalation|Withdrawal by Subject|0|||
149988700|NCT01436656|541090946|FG006|Dose Escalation|Withdrawal by Subject|0|||
149988701|NCT01436656|541090947|FG007|Dose Escalation|Withdrawal by Subject|2|||
149988702|NCT01436656|541090948|FG008|Dose Escalation|Withdrawal by Subject|0|||
149988703|NCT01436656|541090949|FG009|Dose Escalation|Withdrawal by Subject|1|||
149988704|NCT01436656|541090950|FG010|Dose Escalation|Withdrawal by Subject|1|||
149988705|NCT01436656|541090951|FG011|Dose Escalation|Withdrawal by Subject|0|||
149988706|NCT01436656|541090952|FG012|Dose Escalation|Withdrawal by Subject|0|||
149988707|NCT01436656|541090953|FG013|Dose Escalation|Withdrawal by Subject|0|||
149988708|NCT01436656|541090954|FG014|Dose Escalation|Withdrawal by Subject|0|||
149988709|NCT01436656|541090955|FG015|Dose Escalation|Withdrawal by Subject|0|||
149988710|NCT01436656|541090956|FG016|Dose Escalation|Withdrawal by Subject|0|||
149988711|NCT01436656|541090957|FG017|Dose Escalation|Withdrawal by Subject|0|||
149988712|NCT01436656|541090940|FG000|Dose Escalation|Administrative problems|0|||
149988713|NCT01436656|541090941|FG001|Dose Escalation|Administrative problems|1|||
149988714|NCT01436656|541090942|FG002|Dose Escalation|Administrative problems|0|||
149988715|NCT01436656|541090943|FG003|Dose Escalation|Administrative problems|0|||
149988716|NCT01436656|541090944|FG004|Dose Escalation|Administrative problems|0|||
149988717|NCT01436656|541090945|FG005|Dose Escalation|Administrative problems|0|||
149988718|NCT01436656|541090946|FG006|Dose Escalation|Administrative problems|0|||
149988719|NCT01436656|541090947|FG007|Dose Escalation|Administrative problems|0|||
149988720|NCT01436656|541090948|FG008|Dose Escalation|Administrative problems|0|||
149988721|NCT01436656|541090949|FG009|Dose Escalation|Administrative problems|0|||
149988722|NCT01436656|541090950|FG010|Dose Escalation|Administrative problems|0|||
149988723|NCT01436656|541090951|FG011|Dose Escalation|Administrative problems|0|||
149988724|NCT01436656|541090952|FG012|Dose Escalation|Administrative problems|0|||
149988725|NCT01436656|541090953|FG013|Dose Escalation|Administrative problems|0|||
149988726|NCT01436656|541090954|FG014|Dose Escalation|Administrative problems|0|||
149988727|NCT01436656|541090955|FG015|Dose Escalation|Administrative problems|0|||
149988728|NCT01436656|541090956|FG016|Dose Escalation|Administrative problems|0|||
149988729|NCT01436656|541090957|FG017|Dose Escalation|Administrative problems|0|||
149988730|NCT01436656|541090940|FG000|Dose Escalation|Lost to Follow-up|1|||
149988731|NCT01436656|541090941|FG001|Dose Escalation|Lost to Follow-up|0|||
149988732|NCT01436656|541090942|FG002|Dose Escalation|Lost to Follow-up|0|||
149988733|NCT01436656|541090943|FG003|Dose Escalation|Lost to Follow-up|0|||
149988734|NCT01436656|541090944|FG004|Dose Escalation|Lost to Follow-up|1|||
149988735|NCT01436656|541090945|FG005|Dose Escalation|Lost to Follow-up|0|||
149988736|NCT01436656|541090946|FG006|Dose Escalation|Lost to Follow-up|0|||
149988737|NCT01436656|541090947|FG007|Dose Escalation|Lost to Follow-up|0|||
149988738|NCT01436656|541090948|FG008|Dose Escalation|Lost to Follow-up|0|||
149988739|NCT01436656|541090949|FG009|Dose Escalation|Lost to Follow-up|0|||
149988740|NCT01436656|541090950|FG010|Dose Escalation|Lost to Follow-up|0|||
149988741|NCT01436656|541090951|FG011|Dose Escalation|Lost to Follow-up|0|||
149988742|NCT01436656|541090952|FG012|Dose Escalation|Lost to Follow-up|0|||
149988743|NCT01436656|541090953|FG013|Dose Escalation|Lost to Follow-up|0|||
149988744|NCT01436656|541090954|FG014|Dose Escalation|Lost to Follow-up|0|||
149988745|NCT01436656|541090955|FG015|Dose Escalation|Lost to Follow-up|0|||
149988746|NCT01436656|541090956|FG016|Dose Escalation|Lost to Follow-up|0|||
149988747|NCT01436656|541090957|FG017|Dose Escalation|Lost to Follow-up|0|||
149988748|NCT01436656|541090940|FG000|Dose Escalation|New anti-cancer therapy|1|||
149988749|NCT01436656|541090941|FG001|Dose Escalation|New anti-cancer therapy|0|||
149988750|NCT01436656|541090942|FG002|Dose Escalation|New anti-cancer therapy|0|||
149988751|NCT01436656|541090943|FG003|Dose Escalation|New anti-cancer therapy|0|||
149988752|NCT01436656|541090944|FG004|Dose Escalation|New anti-cancer therapy|0|||
149988753|NCT01436656|541090945|FG005|Dose Escalation|New anti-cancer therapy|0|||
149988754|NCT01436656|541090946|FG006|Dose Escalation|New anti-cancer therapy|0|||
149988755|NCT01436656|541090947|FG007|Dose Escalation|New anti-cancer therapy|0|||
149988756|NCT01436656|541090948|FG008|Dose Escalation|New anti-cancer therapy|1|||
149988757|NCT01436656|541090949|FG009|Dose Escalation|New anti-cancer therapy|1|||
149988758|NCT01436656|541090950|FG010|Dose Escalation|New anti-cancer therapy|0|||
149988759|NCT01436656|541090951|FG011|Dose Escalation|New anti-cancer therapy|0|||
149988760|NCT01436656|541090952|FG012|Dose Escalation|New anti-cancer therapy|0|||
149988761|NCT01436656|541090953|FG013|Dose Escalation|New anti-cancer therapy|0|||
149988762|NCT01436656|541090954|FG014|Dose Escalation|New anti-cancer therapy|0|||
149988763|NCT01436656|541090955|FG015|Dose Escalation|New anti-cancer therapy|0|||
149988764|NCT01436656|541090956|FG016|Dose Escalation|New anti-cancer therapy|0|||
149988765|NCT01436656|541090957|FG017|Dose Escalation|New anti-cancer therapy|0|||
149988766|NCT01436656|541090940|FG000|Dose Expansion|Adverse Event|0|||
149988767|NCT01436656|541090941|FG001|Dose Expansion|Adverse Event|0|||
149988768|NCT01436656|541090942|FG002|Dose Expansion|Adverse Event|0|||
149988769|NCT01436656|541090943|FG003|Dose Expansion|Adverse Event|0|||
149988770|NCT01436656|541090944|FG004|Dose Expansion|Adverse Event|0|||
149988771|NCT01436656|541090945|FG005|Dose Expansion|Adverse Event|0|||
149988772|NCT01436656|541090946|FG006|Dose Expansion|Adverse Event|0|||
150053622|NCT01457352|541336687|FG001|Period 2|no analysis|0|||
149988773|NCT01436656|541090947|FG007|Dose Expansion|Adverse Event|0|||
149988774|NCT01436656|541090948|FG008|Dose Expansion|Adverse Event|0|||
149988775|NCT01436656|541090949|FG009|Dose Expansion|Adverse Event|0|||
149988776|NCT01436656|541090950|FG010|Dose Expansion|Adverse Event|0|||
149988777|NCT01436656|541090951|FG011|Dose Expansion|Adverse Event|1|||
149988778|NCT01436656|541090952|FG012|Dose Expansion|Adverse Event|0|||
149988779|NCT01436656|541090953|FG013|Dose Expansion|Adverse Event|0|||
149988780|NCT01436656|541090954|FG014|Dose Expansion|Adverse Event|0|||
149988781|NCT01436656|541090955|FG015|Dose Expansion|Adverse Event|0|||
149988782|NCT01436656|541090956|FG016|Dose Expansion|Adverse Event|0|||
149988783|NCT01436656|541090957|FG017|Dose Expansion|Adverse Event|0|||
149988784|NCT01436656|541090940|FG000|Dose Expansion|Withdrawal by Subject|0|||
149988785|NCT01436656|541090941|FG001|Dose Expansion|Withdrawal by Subject|0|||
149988786|NCT01436656|541090942|FG002|Dose Expansion|Withdrawal by Subject|0|||
149988787|NCT01436656|541090943|FG003|Dose Expansion|Withdrawal by Subject|0|||
149988788|NCT01436656|541090944|FG004|Dose Expansion|Withdrawal by Subject|0|||
149988789|NCT01436656|541090945|FG005|Dose Expansion|Withdrawal by Subject|0|||
149988790|NCT01436656|541090946|FG006|Dose Expansion|Withdrawal by Subject|0|||
149988791|NCT01436656|541090947|FG007|Dose Expansion|Withdrawal by Subject|0|||
149988792|NCT01436656|541090948|FG008|Dose Expansion|Withdrawal by Subject|0|||
149988793|NCT01436656|541090949|FG009|Dose Expansion|Withdrawal by Subject|0|||
149988794|NCT01436656|541090950|FG010|Dose Expansion|Withdrawal by Subject|0|||
149988795|NCT01436656|541090951|FG011|Dose Expansion|Withdrawal by Subject|1|||
149988796|NCT01436656|541090952|FG012|Dose Expansion|Withdrawal by Subject|3|||
149988797|NCT01436656|541090953|FG013|Dose Expansion|Withdrawal by Subject|1|||
149988798|NCT01436656|541090954|FG014|Dose Expansion|Withdrawal by Subject|2|||
149988799|NCT01436656|541090955|FG015|Dose Expansion|Withdrawal by Subject|0|||
149988800|NCT01436656|541090956|FG016|Dose Expansion|Withdrawal by Subject|1|||
149988801|NCT01436656|541090957|FG017|Dose Expansion|Withdrawal by Subject|1|||
149988802|NCT01436656|541090940|FG000|Dose Expansion|Death|0|||
149988803|NCT01436656|541090941|FG001|Dose Expansion|Death|0|||
149988804|NCT01436656|541090942|FG002|Dose Expansion|Death|0|||
149988805|NCT01436656|541090943|FG003|Dose Expansion|Death|0|||
149988806|NCT01436656|541090944|FG004|Dose Expansion|Death|0|||
149988807|NCT01436656|541090945|FG005|Dose Expansion|Death|0|||
149988808|NCT01436656|541090946|FG006|Dose Expansion|Death|0|||
149988809|NCT01436656|541090947|FG007|Dose Expansion|Death|0|||
149988810|NCT01436656|541090948|FG008|Dose Expansion|Death|0|||
149988811|NCT01436656|541090949|FG009|Dose Expansion|Death|0|||
149988812|NCT01436656|541090950|FG010|Dose Expansion|Death|0|||
149988813|NCT01436656|541090951|FG011|Dose Expansion|Death|0|||
149988814|NCT01436656|541090952|FG012|Dose Expansion|Death|1|||
149988815|NCT01436656|541090953|FG013|Dose Expansion|Death|0|||
149988816|NCT01436656|541090954|FG014|Dose Expansion|Death|3|||
149988817|NCT01436656|541090955|FG015|Dose Expansion|Death|0|||
149988818|NCT01436656|541090956|FG016|Dose Expansion|Death|3|||
149988819|NCT01436656|541090957|FG017|Dose Expansion|Death|3|||
149988820|NCT01436656|541090940|FG000|Dose Expansion|Lost to Follow-up|0|||
149988821|NCT01436656|541090941|FG001|Dose Expansion|Lost to Follow-up|0|||
149988822|NCT01436656|541090942|FG002|Dose Expansion|Lost to Follow-up|0|||
149988823|NCT01436656|541090943|FG003|Dose Expansion|Lost to Follow-up|0|||
149988824|NCT01436656|541090944|FG004|Dose Expansion|Lost to Follow-up|0|||
149988825|NCT01436656|541090945|FG005|Dose Expansion|Lost to Follow-up|0|||
149988826|NCT01436656|541090946|FG006|Dose Expansion|Lost to Follow-up|0|||
149988827|NCT01436656|541090947|FG007|Dose Expansion|Lost to Follow-up|0|||
149988828|NCT01436656|541090948|FG008|Dose Expansion|Lost to Follow-up|0|||
149988829|NCT01436656|541090949|FG009|Dose Expansion|Lost to Follow-up|0|||
149988830|NCT01436656|541090950|FG010|Dose Expansion|Lost to Follow-up|0|||
149988831|NCT01436656|541090951|FG011|Dose Expansion|Lost to Follow-up|0|||
149988832|NCT01436656|541090952|FG012|Dose Expansion|Lost to Follow-up|0|||
149988833|NCT01436656|541090953|FG013|Dose Expansion|Lost to Follow-up|0|||
149988834|NCT01436656|541090954|FG014|Dose Expansion|Lost to Follow-up|0|||
149988835|NCT01436656|541090955|FG015|Dose Expansion|Lost to Follow-up|0|||
149988836|NCT01436656|541090956|FG016|Dose Expansion|Lost to Follow-up|0|||
149988837|NCT01436656|541090957|FG017|Dose Expansion|Lost to Follow-up|3|||
149988838|NCT01436656|541090940|FG000|Dose Expansion|Disease progression|0|||
149988839|NCT01436656|541090941|FG001|Dose Expansion|Disease progression|0|||
149988840|NCT01436656|541090942|FG002|Dose Expansion|Disease progression|0|||
149988841|NCT01436656|541090943|FG003|Dose Expansion|Disease progression|0|||
149988842|NCT01436656|541090944|FG004|Dose Expansion|Disease progression|0|||
149988843|NCT01436656|541090945|FG005|Dose Expansion|Disease progression|0|||
149988844|NCT01436656|541090946|FG006|Dose Expansion|Disease progression|0|||
149988845|NCT01436656|541090947|FG007|Dose Expansion|Disease progression|0|||
149988846|NCT01436656|541090948|FG008|Dose Expansion|Disease progression|0|||
150053623|NCT01457352|541336686|FG000|Period 2|Lack of Efficacy|8|||
149988847|NCT01436656|541090949|FG009|Dose Expansion|Disease progression|0|||
149988848|NCT01436656|541090950|FG010|Dose Expansion|Disease progression|0|||
149988849|NCT01436656|541090951|FG011|Dose Expansion|Disease progression|3|||
149988850|NCT01436656|541090952|FG012|Dose Expansion|Disease progression|1|||
149988851|NCT01436656|541090953|FG013|Dose Expansion|Disease progression|0|||
149988852|NCT01436656|541090954|FG014|Dose Expansion|Disease progression|1|||
149988853|NCT01436656|541090955|FG015|Dose Expansion|Disease progression|0|||
149988854|NCT01436656|541090956|FG016|Dose Expansion|Disease progression|0|||
149988855|NCT01436656|541090957|FG017|Dose Expansion|Disease progression|1|||
149988856|NCT01436656|541090940|FG000|Dose Expansion|New cancer therapy|0|||
149988857|NCT01436656|541090941|FG001|Dose Expansion|New cancer therapy|0|||
149988858|NCT01436656|541090942|FG002|Dose Expansion|New cancer therapy|0|||
149988859|NCT01436656|541090943|FG003|Dose Expansion|New cancer therapy|0|||
149988860|NCT01436656|541090944|FG004|Dose Expansion|New cancer therapy|0|||
149988861|NCT01436656|541090945|FG005|Dose Expansion|New cancer therapy|0|||
149988862|NCT01436656|541090946|FG006|Dose Expansion|New cancer therapy|0|||
149988863|NCT01436656|541090947|FG007|Dose Expansion|New cancer therapy|0|||
149988864|NCT01436656|541090948|FG008|Dose Expansion|New cancer therapy|0|||
149988865|NCT01436656|541090949|FG009|Dose Expansion|New cancer therapy|0|||
149988866|NCT01436656|541090950|FG010|Dose Expansion|New cancer therapy|0|||
149988867|NCT01436656|541090951|FG011|Dose Expansion|New cancer therapy|1|||
149988868|NCT01436656|541090952|FG012|Dose Expansion|New cancer therapy|1|||
149988869|NCT01436656|541090953|FG013|Dose Expansion|New cancer therapy|0|||
149988870|NCT01436656|541090954|FG014|Dose Expansion|New cancer therapy|2|||
149988871|NCT01436656|541090955|FG015|Dose Expansion|New cancer therapy|0|||
149988872|NCT01436656|541090956|FG016|Dose Expansion|New cancer therapy|0|||
149988873|NCT01436656|541090957|FG017|Dose Expansion|New cancer therapy|0|||
149988874|NCT01696994|541090958|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
149988875|NCT01696994|541090959|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
149988876|NCT01696994|541090958|FG000|Overall Study|Died Before Randomization|1|||
149988877|NCT01696994|541090959|FG001|Overall Study|Died Before Randomization|2|||
149988878|NCT01696994|541090958|FG000|Overall Study|Died Before ASU (Control)|73|||
149988879|NCT01696994|541090959|FG001|Overall Study|Died Before ASU (Control)|0|||
149988880|NCT01696994|541090958|FG000|Overall Study|No Ovaries at Baseline|4807|||
149988881|NCT01696994|541090959|FG001|Overall Study|No Ovaries at Baseline|4851|||
149988882|NCT01696994|541090958|FG000|Overall Study|Refused ASU (Control)|311|||
149988883|NCT01696994|541090959|FG001|Overall Study|Refused ASU (Control)|0|||
149988884|NCT01696994|541090958|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
149988885|NCT01696994|541090959|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
149988886|NCT00880269|541090962|FG000|Overall Study|Protocol Violation|1|||
149988887|NCT00880269|541090963|FG001|Overall Study|Protocol Violation|0|||
149988888|NCT00880269|541090962|FG000|Overall Study|Disease Progression|13|||
149988889|NCT00880269|541090963|FG001|Overall Study|Disease Progression|11|||
149988890|NCT00880269|541090962|FG000|Overall Study|New Cancer Therapy|1|||
149988891|NCT00880269|541090963|FG001|Overall Study|New Cancer Therapy|0|||
149988892|NCT00880269|541090962|FG000|Overall Study|Death|4|||
149988893|NCT00880269|541090963|FG001|Overall Study|Death|2|||
149988894|NCT00880269|541090962|FG000|Overall Study|Lost to Follow-up|0|||
149988895|NCT00880269|541090963|FG001|Overall Study|Lost to Follow-up|1|||
149988896|NCT00880269|541090962|FG000|Overall Study|Withdrawal by Subject|3|||
149988897|NCT00880269|541090963|FG001|Overall Study|Withdrawal by Subject|4|||
149988898|NCT00880269|541090962|FG000|Overall Study|Adverse Event|10|||
149988899|NCT00880269|541090963|FG001|Overall Study|Adverse Event|9|||
149988900|NCT00576628|541090964|FG000|Overall Study|Adverse Event|11|||
149988901|NCT00576628|541090964|FG000|Overall Study|Death|2|||
149988902|NCT00576628|541090964|FG000|Overall Study|Failure to return|1|||
149988903|NCT00576628|541090964|FG000|Overall Study|Refused Treatment|8|||
149988904|NCT00576628|541090964|FG000|Overall Study|Pregnancy|1|||
149988905|NCT00576628|541090964|FG000|Overall Study|RBC transfusion|1|||
149988906|NCT00576628|541090964|FG000|Overall Study|Progression of Kidney Disease|1|||
149988907|NCT00576628|541090964|FG000|Overall Study|Progression of Renal Failure|1|||
149988908|NCT00576628|541090964|FG000|Overall Study|The patient move into other town|1|||
149988909|NCT00576628|541090964|FG000|Overall Study|Transplantation|1|||
149988910|NCT00576628|541090964|FG000|Overall Study|Dialysis|15|||
149988911|NCT02516982|541090968|FG000|Overall Study|Called in to antenatal appointment|32|||
149988912|NCT02516982|541090969|FG001|Overall Study|Called in to antenatal appointment|35|||
149988913|NCT02516982|541090970|FG002|Overall Study|Called in to antenatal appointment|0|||
149988914|NCT02516982|541090971|FG003|Overall Study|Called in to antenatal appointment|0|||
149988915|NCT02516982|541090968|FG000|Overall Study|Withdrawal by Subject|0|||
149988916|NCT02516982|541090969|FG001|Overall Study|Withdrawal by Subject|0|||
149988917|NCT02516982|541090970|FG002|Overall Study|Withdrawal by Subject|1|||
149988918|NCT02516982|541090971|FG003|Overall Study|Withdrawal by Subject|2|||
149988919|NCT02516982|541090968|FG000|Overall Study|Protocol Violation|0|||
149988920|NCT02516982|541090969|FG001|Overall Study|Protocol Violation|0|||
149988921|NCT02516982|541090970|FG002|Overall Study|Protocol Violation|1|||
149988922|NCT02516982|541090971|FG003|Overall Study|Protocol Violation|1|||
149988923|NCT02516982|541090968|FG000|Overall Study|Did not install the app|0|||
149988924|NCT02516982|541090969|FG001|Overall Study|Did not install the app|0|||
149988925|NCT02516982|541090970|FG002|Overall Study|Did not install the app|46|||
149988926|NCT02516982|541090971|FG003|Overall Study|Did not install the app|47|||
149988927|NCT01951586|541090978|FG000|Overall Study|Death|61|||
149988928|NCT01951586|541090979|FG001|Overall Study|Death|120|||
149988929|NCT01951586|541090978|FG000|Overall Study|Withdrawal by Subject|8|||
149988930|NCT01951586|541090979|FG001|Overall Study|Withdrawal by Subject|17|||
149988931|NCT01951586|541090978|FG000|Overall Study|Lost to Follow-up|0|||
149988932|NCT01951586|541090979|FG001|Overall Study|Lost to Follow-up|1|||
149988933|NCT01951586|541090978|FG000|Overall Study|Sponsor Decision|9|||
149988934|NCT01951586|541090979|FG001|Overall Study|Sponsor Decision|10|||
149988935|NCT00962741|541090980|FG000|Overall Study|Failed to return|3|||
149988936|NCT00962741|541090980|FG000|Overall Study|Lost to Follow-up|2|||
149988937|NCT00962741|541090980|FG000|Overall Study|Withdrawal by Subject|1|||
149988938|NCT00962741|541090980|FG000|Overall Study|Lack of Efficacy|1|||
149988939|NCT00962741|541090980|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
149988940|NCT02120781|541090981|FG000|Overall Study|Physician Decision|2|||
149988941|NCT02120781|541090982|FG001|Overall Study|Physician Decision|0|||
149988942|NCT02120781|541090981|FG000|Overall Study|Completion not documented|2|||
149988943|NCT02120781|541090982|FG001|Overall Study|Completion not documented|1|||
149988944|NCT02003638|541090985|FG000|Overall Study|Withdrawal by Subject|1|||
149988945|NCT02003638|541090986|FG001|Overall Study|Withdrawal by Subject|0|||
149988946|NCT00654745|541090989|FG000|Overall Study|Adverse Event|12|||
149988947|NCT00654745|541090989|FG000|Overall Study|Lost to Follow-up|7|||
149988948|NCT00654745|541090989|FG000|Overall Study|Protocol Violation|11|||
149988949|NCT00654745|541090989|FG000|Overall Study|Withdrawal by Subject|10|||
149988950|NCT00654745|541090989|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
149988951|NCT00748618|541090990|FG000|Overall Study|Adverse Event|1|||
149988952|NCT00748618|541090991|FG001|Overall Study|Adverse Event|0|||
149988953|NCT00466947|541090992|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
149988954|NCT00466947|541090993|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
149988955|NCT00466947|541090992|FG000|Study End Analysis Period|Adverse Event|35|||
149988956|NCT00466947|541090993|FG001|Study End Analysis Period|Adverse Event|43|||
149988957|NCT00466947|541090992|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
149988958|NCT00466947|541090993|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
149988959|NCT00466947|541090992|FG000|Study End Analysis Period|Physician Decision|29|||
149988960|NCT00466947|541090993|FG001|Study End Analysis Period|Physician Decision|29|||
149988961|NCT00466947|541090992|FG000|Study End Analysis Period|Protocol Violation|9|||
149988962|NCT00466947|541090993|FG001|Study End Analysis Period|Protocol Violation|17|||
149988963|NCT00466947|541090992|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
149988964|NCT00466947|541090993|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
149988965|NCT00466947|541090992|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
149988966|NCT00466947|541090993|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
149988967|NCT00466947|541090992|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
149988968|NCT00466947|541090993|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
149988969|NCT00466947|541090992|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
149988970|NCT00466947|541090993|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
149988971|NCT01995526|541090994|FG000|Overall Study|Physician Decision|1|||
149988972|NCT01977729|541091002|FG000|Overall Study|Study terminated|1|||
149988973|NCT03286543|541091003|FG000|Consented|Screen failure before randomization|2|||
149988974|NCT03286543|541091004|FG001|Consented|Screen failure before randomization|0|||
149988975|NCT03286543|541091005|FG002|Consented|Screen failure before randomization|0|||
149988976|NCT03286543|541091003|FG000|Consented|Screen failure before enrollment|4|||
149988977|NCT03286543|541091004|FG001|Consented|Screen failure before enrollment|0|||
149988978|NCT03286543|541091005|FG002|Consented|Screen failure before enrollment|0|||
149988979|NCT03286543|541091003|FG000|Consented|TKA cancelled after enrollment|1|||
149988980|NCT03286543|541091004|FG001|Consented|TKA cancelled after enrollment|0|||
149988981|NCT03286543|541091005|FG002|Consented|TKA cancelled after enrollment|0|||
149988982|NCT03286543|541091003|FG000|Consented|Withdrawn from study|12|||
149988983|NCT03286543|541091004|FG001|Consented|Withdrawn from study|0|||
149988984|NCT03286543|541091005|FG002|Consented|Withdrawn from study|0|||
149988985|NCT03286543|541091003|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
149988986|NCT03286543|541091004|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
149988987|NCT03286543|541091005|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
149988988|NCT03286543|541091003|FG000|Study Enrollment|Withdrawn from study|0|||
149988989|NCT03286543|541091004|FG001|Study Enrollment|Withdrawn from study|6|||
149988990|NCT03286543|541091005|FG002|Study Enrollment|Withdrawn from study|6|||
149988991|NCT05332392|541091006|FG000|Overall Study|Did not meet inclusion criteria|25|||
149988992|NCT05332392|541091006|FG000|Overall Study|Principal Investigator's decision|17|||
149988993|NCT05332392|541091006|FG000|Overall Study|Adverse Event|1|||
149988994|NCT05332392|541091006|FG000|Overall Study|Subject's decision|1|||
150053624|NCT01457352|541336687|FG001|Period 2|Lack of Efficacy|0|||
150053625|NCT01457352|541336686|FG000|Period 2|Protocol Violation|4|||
149988995|NCT03636893|541091007|FG000|Overall Study|Death|0|||
149988996|NCT03636893|541091008|FG001|Overall Study|Death|1|||
149988997|NCT03636893|541091007|FG000|Overall Study|Protocol Violation|0|||
149988998|NCT03636893|541091008|FG001|Overall Study|Protocol Violation|3|||
149988999|NCT03636893|541091007|FG000|Overall Study|Withdrawal by Subject|1|||
149989000|NCT03636893|541091008|FG001|Overall Study|Withdrawal by Subject|2|||
149989001|NCT03636893|541091007|FG000|Overall Study|Refusal to surgery|4|||
149989002|NCT03636893|541091008|FG001|Overall Study|Refusal to surgery|3|||
149989003|NCT03636893|541091007|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
149989004|NCT03636893|541091008|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
149989005|NCT03636893|541091007|FG000|Overall Study|Adverse Event|1|||
149989006|NCT03636893|541091008|FG001|Overall Study|Adverse Event|1|||
149989007|NCT00438360|541091009|FG000|Overall Study|Adverse Event|6|||
149989008|NCT00438360|541091010|FG001|Overall Study|Adverse Event|1|||
149989009|NCT00438360|541091009|FG000|Overall Study|Lack of Efficacy|42|||
149989010|NCT00438360|541091010|FG001|Overall Study|Lack of Efficacy|27|||
149989011|NCT00438360|541091009|FG000|Overall Study|Other|24|||
149989012|NCT00438360|541091010|FG001|Overall Study|Other|15|||
149989013|NCT00758069|541091011|FG000|Overall Study|Lack of Efficacy|0|||
149989014|NCT00758069|541091012|FG001|Overall Study|Lack of Efficacy|0|||
149989015|NCT00758069|541091013|FG002|Overall Study|Lack of Efficacy|1|||
149989016|NCT00758069|541091011|FG000|Overall Study|Incorrect Study Drug|1|||
149989017|NCT00758069|541091012|FG001|Overall Study|Incorrect Study Drug|0|||
149989018|NCT00758069|541091013|FG002|Overall Study|Incorrect Study Drug|0|||
149989019|NCT04560816|541091014|FG000|Overall Study|Withdrawal by Subject|1|||
149989020|NCT04560816|541091015|FG001|Overall Study|Withdrawal by Subject|1|||
149989021|NCT04560816|541091016|FG002|Overall Study|Withdrawal by Subject|1|||
149989022|NCT04560816|541091017|FG003|Overall Study|Withdrawal by Subject|0|||
149989023|NCT04560816|541091018|FG004|Overall Study|Withdrawal by Subject|3|||
149989024|NCT04560816|541091019|FG005|Overall Study|Withdrawal by Subject|0|||
149989025|NCT04560816|541091014|FG000|Overall Study|Lost to Follow-up|1|||
149989026|NCT04560816|541091015|FG001|Overall Study|Lost to Follow-up|0|||
149989027|NCT04560816|541091016|FG002|Overall Study|Lost to Follow-up|0|||
149989028|NCT04560816|541091017|FG003|Overall Study|Lost to Follow-up|0|||
149989029|NCT04560816|541091018|FG004|Overall Study|Lost to Follow-up|0|||
149989030|NCT04560816|541091019|FG005|Overall Study|Lost to Follow-up|0|||
149989031|NCT04560816|541091014|FG000|Overall Study|Protocol Violation|1|||
149989032|NCT04560816|541091015|FG001|Overall Study|Protocol Violation|0|||
149989033|NCT04560816|541091016|FG002|Overall Study|Protocol Violation|0|||
149989034|NCT04560816|541091017|FG003|Overall Study|Protocol Violation|0|||
149989035|NCT04560816|541091018|FG004|Overall Study|Protocol Violation|0|||
149989036|NCT04560816|541091019|FG005|Overall Study|Protocol Violation|0|||
149989037|NCT02277691|541091020|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
149989038|NCT02277691|541091020|FG000|Overall Study|Voluntary Withdrawal|7|||
149989039|NCT02277691|541091020|FG000|Overall Study|Lack of Efficacy|5|||
149989040|NCT02277691|541091020|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
149989041|NCT01147250|541091024|FG000|Overall Study|Lost to Follow-up|14|||
149989042|NCT01147250|541091025|FG001|Overall Study|Lost to Follow-up|11|||
149989043|NCT01147250|541091024|FG000|Overall Study|Withdrawal by Subject|83|||
149989044|NCT01147250|541091025|FG001|Overall Study|Withdrawal by Subject|88|||
149989045|NCT01147250|541091024|FG000|Overall Study|Site termination by sponsor|13|||
149989046|NCT01147250|541091025|FG001|Overall Study|Site termination by sponsor|5|||
149989047|NCT01147250|541091024|FG000|Overall Study|Other than specified|0|||
149989048|NCT01147250|541091025|FG001|Overall Study|Other than specified|1|||
149989049|NCT00615719|541091029|FG000|Overall Study|Physician Decision|5|||
149989050|NCT00842153|541091032|FG000|Overall Study|Adverse Event|0|||
149989051|NCT00842153|541091033|FG001|Overall Study|Adverse Event|1|||
149989052|NCT00842153|541091032|FG000|Overall Study|Lost to Follow-up|1|||
149989053|NCT00842153|541091033|FG001|Overall Study|Lost to Follow-up|2|||
149989054|NCT02091362|541091037|FG000|Period 1|Protocol Violation|1|||
149989055|NCT02091362|541091038|FG001|Period 1|Protocol Violation|0|||
149989056|NCT02091362|541091037|FG000|Period 1|Withdrawal by Subject|2|||
149989057|NCT02091362|541091038|FG001|Period 1|Withdrawal by Subject|3|||
149989058|NCT02091362|541091037|FG000|Period 1|Lost to Follow-up|0|||
149989059|NCT02091362|541091038|FG001|Period 1|Lost to Follow-up|1|||
149989060|NCT02091362|541091037|FG000|Period 1|Adverse Event|2|||
149989061|NCT02091362|541091038|FG001|Period 1|Adverse Event|0|||
149989062|NCT02091362|541091037|FG000|Wash-out|Lost to Follow-up|1|||
149989063|NCT02091362|541091038|FG001|Wash-out|Lost to Follow-up|1|||
149989064|NCT02091362|541091037|FG000|Wash-out|Withdrawal by Subject|0|||
149989065|NCT02091362|541091038|FG001|Wash-out|Withdrawal by Subject|2|||
149989066|NCT02091362|541091037|FG000|Period 2|Adverse Event|1|||
149989067|NCT02091362|541091038|FG001|Period 2|Adverse Event|0|||
149989068|NCT02091362|541091037|FG000|Period 2|Lost to Follow-up|0|||
149989069|NCT02091362|541091038|FG001|Period 2|Lost to Follow-up|1|||
149989070|NCT02091362|541091037|FG000|Period 2|Withdrawal by Subject|1|||
149989071|NCT02091362|541091038|FG001|Period 2|Withdrawal by Subject|1|||
149989072|NCT00690430|541091039|FG000|Core Phase|Abnormal Laboratory value|0|||
149989073|NCT00690430|541091040|FG001|Core Phase|Abnormal Laboratory value|1|||
149989074|NCT00690430|541091041|FG002|Core Phase|Abnormal Laboratory value|0|||
149989075|NCT00690430|541091039|FG000|Core Phase|Adverse Event|5|||
149989076|NCT00690430|541091040|FG001|Core Phase|Adverse Event|1|||
149989077|NCT00690430|541091041|FG002|Core Phase|Adverse Event|0|||
149989078|NCT00690430|541091039|FG000|Core Phase|Death|0|||
149989079|NCT00690430|541091040|FG001|Core Phase|Death|2|||
149989080|NCT00690430|541091041|FG002|Core Phase|Death|0|||
149989081|NCT00690430|541091039|FG000|Core Phase|Protocol Violation|1|||
149989082|NCT00690430|541091040|FG001|Core Phase|Protocol Violation|0|||
149989083|NCT00690430|541091041|FG002|Core Phase|Protocol Violation|0|||
149989084|NCT00690430|541091039|FG000|Core Phase|Withdrawal by Subject|3|||
149989085|NCT00690430|541091040|FG001|Core Phase|Withdrawal by Subject|3|||
149989086|NCT00690430|541091041|FG002|Core Phase|Withdrawal by Subject|0|||
149989087|NCT00690430|541091039|FG000|Core Phase|Subject no longer requires study drug|1|||
149989088|NCT00690430|541091040|FG001|Core Phase|Subject no longer requires study drug|0|||
149989089|NCT00690430|541091041|FG002|Core Phase|Subject no longer requires study drug|0|||
149989090|NCT00690430|541091039|FG000|Core Phase|Lack of Efficacy|8|||
149989091|NCT00690430|541091040|FG001|Core Phase|Lack of Efficacy|10|||
149989092|NCT00690430|541091041|FG002|Core Phase|Lack of Efficacy|0|||
149989093|NCT00690430|541091039|FG000|Core Phase|Administrative Problems|0|||
149989094|NCT00690430|541091040|FG001|Core Phase|Administrative Problems|1|||
149989095|NCT00690430|541091041|FG002|Core Phase|Administrative Problems|0|||
149989096|NCT00690430|541091039|FG000|Core Phase|Early Termination|0|||
149989097|NCT00690430|541091040|FG001|Core Phase|Early Termination|5|||
149989098|NCT00690430|541091041|FG002|Core Phase|Early Termination|0|||
149989099|NCT00690430|541091039|FG000|Extension Phase|Lack of Efficacy|3|||
149989100|NCT00690430|541091040|FG001|Extension Phase|Lack of Efficacy|1|||
149989101|NCT00690430|541091041|FG002|Extension Phase|Lack of Efficacy|4|||
149989102|NCT00690430|541091039|FG000|Extension Phase|Abnormal Lab Values|1|||
149989103|NCT00690430|541091040|FG001|Extension Phase|Abnormal Lab Values|0|||
149989104|NCT00690430|541091041|FG002|Extension Phase|Abnormal Lab Values|0|||
149989105|NCT00690430|541091039|FG000|Extension Phase|Abnormal test procedure results|1|||
149989106|NCT00690430|541091040|FG001|Extension Phase|Abnormal test procedure results|0|||
149989107|NCT00690430|541091041|FG002|Extension Phase|Abnormal test procedure results|0|||
149989108|NCT00690430|541091039|FG000|Extension Phase|Administrative Problems|0|||
149989109|NCT00690430|541091040|FG001|Extension Phase|Administrative Problems|1|||
149989110|NCT00690430|541091041|FG002|Extension Phase|Administrative Problems|1|||
149989111|NCT00690430|541091039|FG000|Extension Phase|Adverse Event|2|||
149989112|NCT00690430|541091040|FG001|Extension Phase|Adverse Event|1|||
149989113|NCT00690430|541091041|FG002|Extension Phase|Adverse Event|2|||
149989114|NCT00690430|541091039|FG000|Extension Phase|Death|1|||
149989115|NCT00690430|541091040|FG001|Extension Phase|Death|1|||
149989116|NCT00690430|541091041|FG002|Extension Phase|Death|1|||
149989117|NCT00690430|541091039|FG000|Extension Phase|Withdrawal by Subject|0|||
149989118|NCT00690430|541091040|FG001|Extension Phase|Withdrawal by Subject|0|||
149989119|NCT00690430|541091041|FG002|Extension Phase|Withdrawal by Subject|2|||
149989120|NCT00690430|541091039|FG000|Extension Phase|Early Termination|10|||
149989121|NCT00690430|541091040|FG001|Extension Phase|Early Termination|1|||
149989122|NCT00690430|541091041|FG002|Extension Phase|Early Termination|3|||
149989123|NCT02125838|541091044|FG000|Overall Study|Lost to Follow-up|4|||
149989124|NCT02125838|541091045|FG001|Overall Study|Lost to Follow-up|4|||
149989125|NCT02565147|541091046|FG000|Overall Study|Withdrawal by Subject|5|||
149989126|NCT02565147|541091047|FG001|Overall Study|Withdrawal by Subject|1|||
149989127|NCT02565147|541091046|FG000|Overall Study|Lost to Follow-up|0|||
149989128|NCT02565147|541091047|FG001|Overall Study|Lost to Follow-up|1|||
149989129|NCT02565147|541091046|FG000|Overall Study|Death|1|||
149989130|NCT02565147|541091047|FG001|Overall Study|Death|1|||
149989131|NCT00787839|541091048|FG000|Overall Study|Failure to have the OGTT was most common|404|||
149989132|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
149989133|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
149989134|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
149989135|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
149989136|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Death|58|||
149989137|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Death|65|||
149989138|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Adverse Event|28|||
149989139|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Adverse Event|40|||
149989140|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Disease Progression|22|||
149989141|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Disease Progression|35|||
149989142|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Other|25|||
149989143|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Other|33|||
149989144|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
149989145|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
149989146|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Noncompliance|8|||
149989147|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Noncompliance|8|||
149989148|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
149989149|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
149989150|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
149989151|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
149989152|NCT00286091|541091049|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
149989153|NCT00286091|541091050|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
149989154|NCT00286091|541091049|FG000|Open-label Treatment Phase|Physician Decision|24|||
149989155|NCT00286091|541091050|FG001|Open-label Treatment Phase|Physician Decision|21|||
149989156|NCT00286091|541091049|FG000|Open-label Treatment Phase|Adverse Event|5|||
149989157|NCT00286091|541091050|FG001|Open-label Treatment Phase|Adverse Event|16|||
149989158|NCT00286091|541091049|FG000|Open-label Treatment Phase|Other|11|||
149989159|NCT00286091|541091050|FG001|Open-label Treatment Phase|Other|11|||
149989160|NCT00286091|541091049|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
149989161|NCT00286091|541091050|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
149989162|NCT00286091|541091049|FG000|Open-label Treatment Phase|Death|10|||
149989163|NCT00286091|541091050|FG001|Open-label Treatment Phase|Death|7|||
149989164|NCT00286091|541091049|FG000|Open-label Treatment Phase|Disease Progression|9|||
149989165|NCT00286091|541091050|FG001|Open-label Treatment Phase|Disease Progression|3|||
149989166|NCT00286091|541091049|FG000|Open-label Treatment Phase|Noncompliance|3|||
149989167|NCT00286091|541091050|FG001|Open-label Treatment Phase|Noncompliance|1|||
149989168|NCT00286091|541091049|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
149989169|NCT00286091|541091050|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
149989170|NCT00286091|541091049|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
149989171|NCT00286091|541091050|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
149989172|NCT00286091|541091049|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
149989173|NCT00286091|541091050|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
149989174|NCT02936869|541091053|FG000|Overall Study|Lost to Follow-up|1|||
149989175|NCT02936869|541091054|FG001|Overall Study|Lost to Follow-up|3|||
149989176|NCT02936869|541091053|FG000|Overall Study|Death|0|||
149989177|NCT02936869|541091054|FG001|Overall Study|Death|1|||
149989178|NCT02936869|541091053|FG000|Overall Study|Legal Case|0|||
149989179|NCT02936869|541091054|FG001|Overall Study|Legal Case|1|||
149989180|NCT02936869|541091053|FG000|Overall Study|Protocol Violation|1|||
149989181|NCT02936869|541091054|FG001|Overall Study|Protocol Violation|0|||
149989182|NCT00335738|541091055|FG000|Overall Study|Physician Decision|6|||
149989183|NCT00335738|541091056|FG001|Overall Study|Physician Decision|0|||
149989184|NCT00335738|541091055|FG000|Overall Study|Withdrawal by Subject|2|||
149989185|NCT00335738|541091056|FG001|Overall Study|Withdrawal by Subject|0|||
149989186|NCT00335738|541091055|FG000|Overall Study|Ineligible|3|||
149989187|NCT00335738|541091056|FG001|Overall Study|Ineligible|4|||
149989188|NCT03423238|541091063|FG000|Overall Study|Lost to Follow-up|1|||
149989189|NCT03423238|541091064|FG001|Overall Study|Lost to Follow-up|0|||
149989190|NCT03423238|541091063|FG000|Overall Study|Withdrawal by Subject|1|||
149989191|NCT03423238|541091064|FG001|Overall Study|Withdrawal by Subject|0|||
149989192|NCT00506454|541091068|FG000|Overall Study|Withdrawal by Subject|1|||
149989193|NCT00506454|541091069|FG001|Overall Study|Withdrawal by Subject|1|||
149989194|NCT00902850|541091071|FG000|Overall Study|Physician Decision|2|||
149989195|NCT00902850|541091072|FG001|Overall Study|Physician Decision|2|||
149989196|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
149989197|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
149989198|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
149989199|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149989200|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149989201|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149989202|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149989203|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
149989204|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989205|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989206|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989207|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989208|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989209|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149989210|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
149989211|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
149989212|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
149989213|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149989214|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149989215|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149989216|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149989217|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
149989218|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
149989219|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149989220|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149989221|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149989222|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149989223|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149989224|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
150053626|NCT01457352|541336687|FG001|Period 2|Protocol Violation|0|||
149989225|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989226|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989227|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989228|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989229|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989230|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
149989231|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989232|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
149989233|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989234|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989235|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989236|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989237|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149989238|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
149989239|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
149989240|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
149989241|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149989242|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149989243|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149989244|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149989245|NCT03745638|541091075|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
149989246|NCT03745638|541091076|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
149989247|NCT03745638|541091077|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
149989248|NCT03745638|541091078|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
149989249|NCT03745638|541091079|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
149989250|NCT03745638|541091080|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
149989251|NCT03745638|541091081|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
149989252|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149989253|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149989254|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149989255|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149989256|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149989257|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
149989258|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
149989259|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149989260|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149989261|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149989262|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
149989263|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149989264|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
149989265|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
149989266|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149989267|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149989268|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149989269|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
149989270|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
149989271|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
149989272|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
149989273|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149989274|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149989275|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149989276|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149989277|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
149989278|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
149989279|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149989280|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149989281|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149989282|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149989283|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149989284|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149989285|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
149989286|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150053627|NCT01457352|541336686|FG000|Period 2|Sponsor's withdrawal|7|||
149989287|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149989288|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149989289|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149989290|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
149989291|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
149989292|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
149989293|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
149989294|NCT03745638|541091075|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
149989295|NCT03745638|541091076|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
149989296|NCT03745638|541091077|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
149989297|NCT03745638|541091078|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
149989298|NCT03745638|541091079|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
149989299|NCT03745638|541091080|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
149989300|NCT03745638|541091081|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
149989301|NCT03098433|541091082|FG000|Overall Study|Withdrawal by Subject|10|||
149989302|NCT04470050|541091083|FG000|Double-blind Treatment Phase|Adverse Event|0|||
149989303|NCT04470050|541091084|FG001|Double-blind Treatment Phase|Adverse Event|0|||
149989304|NCT04470050|541091085|FG002|Double-blind Treatment Phase|Adverse Event|0|||
149989305|NCT04470050|541091086|FG003|Double-blind Treatment Phase|Adverse Event|1|||
149989306|NCT04470050|541091087|FG004|Double-blind Treatment Phase|Adverse Event|0|||
149989307|NCT04470050|541091088|FG005|Double-blind Treatment Phase|Adverse Event|0|||
149989308|NCT04470050|541091089|FG006|Double-blind Treatment Phase|Adverse Event|0|||
149989309|NCT04470050|541091083|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989310|NCT04470050|541091084|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989311|NCT04470050|541091085|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989312|NCT04470050|541091086|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989313|NCT04470050|541091087|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
149989314|NCT04470050|541091088|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989315|NCT04470050|541091089|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
149989316|NCT04470050|541091083|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
149989317|NCT04470050|541091084|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
149989318|NCT04470050|541091085|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
149989319|NCT04470050|541091086|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
149989320|NCT04470050|541091087|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
149989321|NCT04470050|541091088|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
149989322|NCT04470050|541091089|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
149989323|NCT01104545|541091090|FG000|Overall Study|Adverse Event|0|||
149989324|NCT01104545|541091091|FG001|Overall Study|Adverse Event|1|||
149989325|NCT01104545|541091092|FG002|Overall Study|Adverse Event|2|||
149989326|NCT03640507|541091093|FG000|Overall Study|Withdrawal by Subject|0|||
149989327|NCT03640507|541091094|FG001|Overall Study|Withdrawal by Subject|0|||
149989328|NCT03640507|541091095|FG002|Overall Study|Withdrawal by Subject|1|||
149989329|NCT03604172|541091097|FG000|Overall Study|Lost to Follow-up|1|||
149989330|NCT03604172|541091098|FG001|Overall Study|Lost to Follow-up|2|||
149989331|NCT00182078|541091102|FG000|Overall Study|Withdrawal by Subject|1|||
149989332|NCT00182078|541091103|FG001|Overall Study|Withdrawal by Subject|0|||
149989333|NCT00395486|541091104|FG000|Overall Study|Adverse Event|1|||
149989334|NCT00395486|541091105|FG001|Overall Study|Adverse Event|2|||
149989335|NCT00395486|541091104|FG000|Overall Study|Withdrawal by Subject|5|||
149989336|NCT00395486|541091105|FG001|Overall Study|Withdrawal by Subject|2|||
149989337|NCT00395486|541091104|FG000|Overall Study|Lost to Follow-up|0|||
149989338|NCT00395486|541091105|FG001|Overall Study|Lost to Follow-up|1|||
149989339|NCT01076205|541091106|FG000|Overall Study|Adverse Drug Reaction|299|||
149989340|NCT01076205|541091106|FG000|Overall Study|Lack of Effectiveness|1423|||
149989341|NCT01076205|541091106|FG000|Overall Study|Other Reason|1075|||
149989342|NCT01076205|541091106|FG000|Overall Study|Unknown Reason|71|||
149989343|NCT01076205|541091106|FG000|Overall Study|Lost to Follow-up|3151|||
149989344|NCT01939977|541091109|FG000|Overall Study|Adverse Event|4|||
149989345|NCT01939977|541091110|FG001|Overall Study|Adverse Event|3|||
149989346|NCT01939977|541091109|FG000|Overall Study|Lack of Efficacy|3|||
149989347|NCT01939977|541091110|FG001|Overall Study|Lack of Efficacy|0|||
149989348|NCT01939977|541091109|FG000|Overall Study|Physician Decision|1|||
149989349|NCT01939977|541091110|FG001|Overall Study|Physician Decision|1|||
149989350|NCT01939977|541091109|FG000|Overall Study|Withdrawal by Subject|0|||
149989351|NCT01939977|541091110|FG001|Overall Study|Withdrawal by Subject|2|||
149989352|NCT01939977|541091109|FG000|Overall Study|Did not meet inclusion criteria|1|||
149989353|NCT01939977|541091110|FG001|Overall Study|Did not meet inclusion criteria|0|||
149989354|NCT01939977|541091109|FG000|Overall Study|Did not receive study medication|0|||
149989355|NCT01939977|541091110|FG001|Overall Study|Did not receive study medication|1|||
149989356|NCT02097719|541091113|FG000|Overall Study|Subject Withdrew Consent|1|||
149989357|NCT02097719|541091114|FG001|Overall Study|Subject Withdrew Consent|0|||
149989358|NCT02097719|541091113|FG000|Overall Study|Lost to Follow-up|0|||
149989359|NCT02097719|541091114|FG001|Overall Study|Lost to Follow-up|1|||
149989360|NCT02097719|541091113|FG000|Overall Study|Adverse Event|2|||
149989361|NCT02097719|541091114|FG001|Overall Study|Adverse Event|0|||
149989362|NCT02597452|541091116|FG000|Overall Study|testing incomplete|30|||
149989363|NCT01352221|541091117|FG000|Double-blind Phase|Adverse Event|6|||
149989364|NCT01352221|541091118|FG001|Double-blind Phase|Adverse Event|4|||
149989365|NCT01352221|541091119|FG002|Double-blind Phase|Adverse Event|0|||
149989366|NCT01352221|541091120|FG003|Double-blind Phase|Adverse Event|0|||
149989367|NCT01352221|541091117|FG000|Double-blind Phase|Withdrawal by Subject|3|||
149989368|NCT01352221|541091118|FG001|Double-blind Phase|Withdrawal by Subject|5|||
149989369|NCT01352221|541091119|FG002|Double-blind Phase|Withdrawal by Subject|0|||
149989370|NCT01352221|541091120|FG003|Double-blind Phase|Withdrawal by Subject|0|||
149989371|NCT01352221|541091117|FG000|Double-blind Phase|Lost to Follow-up|0|||
149989372|NCT01352221|541091118|FG001|Double-blind Phase|Lost to Follow-up|1|||
149989373|NCT01352221|541091119|FG002|Double-blind Phase|Lost to Follow-up|0|||
149989374|NCT01352221|541091120|FG003|Double-blind Phase|Lost to Follow-up|0|||
149989375|NCT01352221|541091117|FG000|Double-blind Phase|Protocol Violation|0|||
149989376|NCT01352221|541091118|FG001|Double-blind Phase|Protocol Violation|1|||
149989377|NCT01352221|541091119|FG002|Double-blind Phase|Protocol Violation|0|||
149989378|NCT01352221|541091120|FG003|Double-blind Phase|Protocol Violation|0|||
149989379|NCT01352221|541091117|FG000|Open-label Phase|Physician Decision|0|||
149989380|NCT01352221|541091118|FG001|Open-label Phase|Physician Decision|0|||
149989381|NCT01352221|541091119|FG002|Open-label Phase|Physician Decision|2|||
149989382|NCT01352221|541091120|FG003|Open-label Phase|Physician Decision|1|||
149989383|NCT01352221|541091117|FG000|Open-label Phase|Pregnancy|0|||
149989384|NCT01352221|541091118|FG001|Open-label Phase|Pregnancy|0|||
149989385|NCT01352221|541091119|FG002|Open-label Phase|Pregnancy|1|||
149989386|NCT01352221|541091120|FG003|Open-label Phase|Pregnancy|0|||
149989387|NCT01352221|541091117|FG000|Open-label Phase|Adverse Event|0|||
149989388|NCT01352221|541091118|FG001|Open-label Phase|Adverse Event|0|||
149989389|NCT01352221|541091119|FG002|Open-label Phase|Adverse Event|8|||
149989390|NCT01352221|541091120|FG003|Open-label Phase|Adverse Event|4|||
149989391|NCT01352221|541091117|FG000|Open-label Phase|Withdrawal by Subject|0|||
149989392|NCT01352221|541091118|FG001|Open-label Phase|Withdrawal by Subject|0|||
149989393|NCT01352221|541091119|FG002|Open-label Phase|Withdrawal by Subject|1|||
149989394|NCT01352221|541091120|FG003|Open-label Phase|Withdrawal by Subject|6|||
149989395|NCT01352221|541091117|FG000|Open-label Phase|Worsening of IBD|0|||
149989396|NCT01352221|541091118|FG001|Open-label Phase|Worsening of IBD|0|||
149989397|NCT01352221|541091119|FG002|Open-label Phase|Worsening of IBD|1|||
149989398|NCT01352221|541091120|FG003|Open-label Phase|Worsening of IBD|0|||
149989399|NCT00281099|541091121|FG000|Overall Study|Death|46|||
149989400|NCT00281099|541091122|FG001|Overall Study|Death|57|||
149989401|NCT00281099|541091121|FG000|Overall Study|Lost to Follow-up|10|||
149989402|NCT00281099|541091122|FG001|Overall Study|Lost to Follow-up|19|||
149989403|NCT00281099|541091121|FG000|Overall Study|Withdrawal by Subject|65|||
149989404|NCT00281099|541091122|FG001|Overall Study|Withdrawal by Subject|70|||
149989405|NCT00281099|541091121|FG000|Overall Study|Physician Decision|79|||
149989406|NCT00281099|541091122|FG001|Overall Study|Physician Decision|72|||
149989407|NCT00281099|541091121|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
149989408|NCT00281099|541091122|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
149989409|NCT01456195|541093124|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149989410|NCT01456195|541093125|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
149989411|NCT01456195|541093126|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
149989412|NCT01456195|541093124|FG000|Overall Study|Lost to Follow-up|3|||
149989413|NCT01456195|541093125|FG001|Overall Study|Lost to Follow-up|1|||
149989414|NCT01456195|541093126|FG002|Overall Study|Lost to Follow-up|3|||
149989415|NCT01456195|541093124|FG000|Overall Study|Voluntary Withdrawal|5|||
149989416|NCT01456195|541093125|FG001|Overall Study|Voluntary Withdrawal|3|||
149989417|NCT01456195|541093126|FG002|Overall Study|Voluntary Withdrawal|7|||
149989418|NCT01456195|541093124|FG000|Overall Study|Lack of Efficacy|0|||
149989419|NCT01456195|541093125|FG001|Overall Study|Lack of Efficacy|1|||
149989420|NCT01456195|541093126|FG002|Overall Study|Lack of Efficacy|0|||
149989421|NCT01456195|541093124|FG000|Overall Study|Other Reasons|2|||
149989422|NCT01456195|541093125|FG001|Overall Study|Other Reasons|1|||
149989423|NCT01456195|541093126|FG002|Overall Study|Other Reasons|3|||
149989424|NCT02908685|541093127|FG000|Part 1 OLE|Withdrawal by Subject|0|||
149989425|NCT02908685|541093128|FG001|Part 1 OLE|Withdrawal by Subject|0|||
149989426|NCT02908685|541093129|FG002|Part 1 OLE|Withdrawal by Subject|0|||
149989427|NCT02908685|541093130|FG003|Part 1 OLE|Withdrawal by Subject|0|||
149989428|NCT02908685|541093131|FG004|Part 1 OLE|Withdrawal by Subject|0|||
149989429|NCT02908685|541093132|FG005|Part 1 OLE|Withdrawal by Subject|0|||
149989430|NCT02908685|541093133|FG006|Part 1 OLE|Withdrawal by Subject|0|||
149989431|NCT02908685|541093134|FG007|Part 1 OLE|Withdrawal by Subject|0|||
149989432|NCT02908685|541093135|FG008|Part 1 OLE|Withdrawal by Subject|0|||
149989433|NCT02908685|541093136|FG009|Part 1 OLE|Withdrawal by Subject|0|||
149989434|NCT02908685|541093137|FG010|Part 1 OLE|Withdrawal by Subject|2|||
149989435|NCT02908685|541093138|FG011|Part 1 OLE|Withdrawal by Subject|1|||
149989436|NCT02908685|541093139|FG012|Part 1 OLE|Withdrawal by Subject|0|||
149989437|NCT02908685|541093140|FG013|Part 1 OLE|Withdrawal by Subject|0|||
149989438|NCT02908685|541093127|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989439|NCT02908685|541093128|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989440|NCT02908685|541093129|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989441|NCT02908685|541093130|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989442|NCT02908685|541093131|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989443|NCT02908685|541093132|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989444|NCT02908685|541093133|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989445|NCT02908685|541093134|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989446|NCT02908685|541093135|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989447|NCT02908685|541093136|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989448|NCT02908685|541093137|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989449|NCT02908685|541093138|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
149989450|NCT02908685|541093139|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
149989451|NCT02908685|541093140|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
149989452|NCT02908685|541093127|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989453|NCT02908685|541093128|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989454|NCT02908685|541093129|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989455|NCT02908685|541093130|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989456|NCT02908685|541093131|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989457|NCT02908685|541093132|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989458|NCT02908685|541093133|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989459|NCT02908685|541093134|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989460|NCT02908685|541093135|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989461|NCT02908685|541093136|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989462|NCT02908685|541093137|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989463|NCT02908685|541093138|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989464|NCT02908685|541093139|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
149989465|NCT02908685|541093140|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
149989466|NCT02908685|541093127|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989467|NCT02908685|541093128|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989468|NCT02908685|541093129|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989469|NCT02908685|541093130|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989470|NCT02908685|541093131|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989471|NCT02908685|541093132|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989472|NCT02908685|541093133|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989473|NCT02908685|541093134|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989474|NCT02908685|541093135|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989475|NCT02908685|541093136|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989476|NCT02908685|541093137|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989477|NCT02908685|541093138|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989478|NCT02908685|541093139|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
149989479|NCT02908685|541093140|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
149989480|NCT02908685|541093127|FG000|Part 2 OLE: > Month 24|Death|0|||
149989481|NCT02908685|541093128|FG001|Part 2 OLE: > Month 24|Death|0|||
149989482|NCT02908685|541093129|FG002|Part 2 OLE: > Month 24|Death|0|||
149989483|NCT02908685|541093130|FG003|Part 2 OLE: > Month 24|Death|0|||
149989484|NCT02908685|541093131|FG004|Part 2 OLE: > Month 24|Death|0|||
149989485|NCT02908685|541093132|FG005|Part 2 OLE: > Month 24|Death|0|||
149989486|NCT02908685|541093133|FG006|Part 2 OLE: > Month 24|Death|0|||
149989487|NCT02908685|541093134|FG007|Part 2 OLE: > Month 24|Death|0|||
149989488|NCT02908685|541093135|FG008|Part 2 OLE: > Month 24|Death|0|||
149989489|NCT02908685|541093136|FG009|Part 2 OLE: > Month 24|Death|0|||
149989490|NCT02908685|541093137|FG010|Part 2 OLE: > Month 24|Death|0|||
149989491|NCT02908685|541093138|FG011|Part 2 OLE: > Month 24|Death|0|||
149989492|NCT02908685|541093139|FG012|Part 2 OLE: > Month 24|Death|1|||
149989493|NCT02908685|541093140|FG013|Part 2 OLE: > Month 24|Death|0|||
149989494|NCT02908685|541093127|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
149989495|NCT02908685|541093128|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
149989496|NCT02908685|541093129|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
149989497|NCT02908685|541093130|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
149989498|NCT02908685|541093131|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
149989499|NCT02908685|541093132|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
149989500|NCT02908685|541093133|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
149989501|NCT02908685|541093134|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
149989502|NCT02908685|541093135|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
150053628|NCT01457352|541336687|FG001|Period 2|Sponsor's withdrawal|0|||
150053629|NCT01457352|541336686|FG000|Period 2|Lost to Follow-up|1|||
149989503|NCT02908685|541093136|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
149989504|NCT02908685|541093137|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
149989505|NCT02908685|541093138|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
149989506|NCT02908685|541093139|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
149989507|NCT02908685|541093140|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
149989508|NCT02908685|541093127|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989509|NCT02908685|541093128|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989510|NCT02908685|541093129|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989511|NCT02908685|541093130|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989512|NCT02908685|541093131|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989513|NCT02908685|541093132|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989514|NCT02908685|541093133|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989515|NCT02908685|541093134|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989516|NCT02908685|541093135|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989517|NCT02908685|541093136|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989518|NCT02908685|541093137|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989519|NCT02908685|541093138|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
149989520|NCT02908685|541093139|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
149989521|NCT02908685|541093140|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
149989522|NCT01691014|541093141|FG000|Overall Study|Premature Termination|1|||
149989523|NCT01691014|541093142|FG001|Overall Study|Premature Termination|6|||
149989524|NCT01691014|541093143|FG002|Overall Study|Premature Termination|0|||
150178869|NCT04188379|541793855|FG000|Overall Study|Withdrawal by Subject|10|||
150178870|NCT04188379|541793856|FG001|Overall Study|Withdrawal by Subject|3|||
150178871|NCT04188379|541793855|FG000|Overall Study|Physician Decision|0|||
150178872|NCT04188379|541793856|FG001|Overall Study|Physician Decision|1|||
150178873|NCT04188379|541793855|FG000|Overall Study|Adverse Event|3|||
150178874|NCT04188379|541793856|FG001|Overall Study|Adverse Event|1|||
150178875|NCT04188379|541793855|FG000|Overall Study|Pregnancy|1|||
150178876|NCT04188379|541793856|FG001|Overall Study|Pregnancy|0|||
150178877|NCT04188379|541793855|FG000|Overall Study|Lack of Efficacy|8|||
150178878|NCT04188379|541793856|FG001|Overall Study|Lack of Efficacy|5|||
150178879|NCT04188379|541793855|FG000|Overall Study|Other|0|||
150178880|NCT04188379|541793856|FG001|Overall Study|Other|3|||
150178881|NCT01693120|541793859|FG000|Enrollment|Lost to Follow-up|1|||
150178882|NCT01693120|541793859|FG000|Enrollment|Withdrawal by Subject|10|||
150178883|NCT01693120|541793859|FG000|Enrollment|Protocol Violation|46|||
150178884|NCT01693120|541793859|FG000|Enrollment|Physician Decision|3|||
150178885|NCT01693120|541793859|FG000|Enrollment|Adverse Event|1|||
150178886|NCT01693120|541793859|FG000|Enrollment|Study closed|8|||
150178887|NCT01693120|541793859|FG000|Enrollment|Other|1|||
150178888|NCT01693120|541793859|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
150178889|NCT01693120|541793859|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
150178890|NCT01693120|541793859|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
150178891|NCT01693120|541793859|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
150178892|NCT01693120|541793859|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
150178893|NCT02411084|541793869|FG000|Overall Study|Lack of Efficacy|6|||
150178894|NCT02411084|541793870|FG001|Overall Study|Lack of Efficacy|3|||
150178895|NCT02411084|541793869|FG000|Overall Study|Death|5|||
149989525|NCT01691014|541093144|FG003|Overall Study|Premature Termination|3|||
149989526|NCT01691014|541093141|FG000|Overall Study|Other|0|||
149989527|NCT01691014|541093142|FG001|Overall Study|Other|0|||
149989528|NCT01691014|541093143|FG002|Overall Study|Other|2|||
149989529|NCT01691014|541093144|FG003|Overall Study|Other|0|||
149989530|NCT01691014|541093141|FG000|Overall Study|Withdrawal by Subject|0|||
149989531|NCT01691014|541093142|FG001|Overall Study|Withdrawal by Subject|1|||
149989532|NCT01691014|541093143|FG002|Overall Study|Withdrawal by Subject|1|||
149989533|NCT01691014|541093144|FG003|Overall Study|Withdrawal by Subject|1|||
149989534|NCT01691014|541093141|FG000|Overall Study|Adverse Event|0|||
149989535|NCT01691014|541093142|FG001|Overall Study|Adverse Event|5|||
150178896|NCT02411084|541793870|FG001|Overall Study|Death|4|||
150178897|NCT02411084|541793869|FG000|Overall Study|Adverse Event|2|||
150178898|NCT02411084|541793870|FG001|Overall Study|Adverse Event|1|||
150178899|NCT02411084|541793869|FG000|Overall Study|Other reasons|0|||
150178900|NCT02411084|541793870|FG001|Overall Study|Other reasons|5|||
150178901|NCT03624972|541793871|FG000|Overall Study|Lost to Follow-up|2|||
150053630|NCT01457352|541336687|FG001|Period 2|Lost to Follow-up|0|||
150178902|NCT03624972|541793872|FG001|Overall Study|Lost to Follow-up|0|||
150178903|NCT03624972|541793873|FG002|Overall Study|Lost to Follow-up|0|||
150178904|NCT03624972|541793871|FG000|Overall Study|Withdrawal by Subject|0|||
150178905|NCT03624972|541793872|FG001|Overall Study|Withdrawal by Subject|2|||
150178906|NCT03624972|541793873|FG002|Overall Study|Withdrawal by Subject|0|||
150178907|NCT03112174|541793874|FG000|Overall Study|Withdrawal by Subject|3|||
150178908|NCT03112174|541793875|FG001|Overall Study|Withdrawal by Subject|0|||
149989536|NCT01691014|541093143|FG002|Overall Study|Adverse Event|1|||
149989537|NCT01691014|541093144|FG003|Overall Study|Adverse Event|1|||
149989538|NCT01691014|541093141|FG000|Overall Study|Lack of Efficacy|2|||
149989539|NCT01691014|541093142|FG001|Overall Study|Lack of Efficacy|3|||
149989540|NCT01691014|541093143|FG002|Overall Study|Lack of Efficacy|7|||
149989541|NCT01691014|541093144|FG003|Overall Study|Lack of Efficacy|0|||
149989542|NCT04683029|541093153|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
149989543|NCT04683029|541093154|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
149989544|NCT04683029|541093155|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
149989545|NCT04683029|541093156|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
149989546|NCT04683029|541093153|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
149989547|NCT04683029|541093154|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
149989548|NCT04683029|541093155|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
149989549|NCT04683029|541093156|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
149989550|NCT04683029|541093153|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
149989551|NCT04683029|541093154|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
149989552|NCT04683029|541093155|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
149989553|NCT04683029|541093156|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
149989554|NCT02920528|541093159|FG000|Overall Study|Incomplete Data|1|||
149989555|NCT02920528|541093160|FG001|Overall Study|Incomplete Data|1|||
149989556|NCT02920528|541093161|FG002|Overall Study|Incomplete Data|1|||
149989557|NCT02920528|541093159|FG000|Overall Study|Adverse Event|0|||
149989558|NCT02920528|541093160|FG001|Overall Study|Adverse Event|0|||
149989559|NCT02920528|541093161|FG002|Overall Study|Adverse Event|3|||
149989560|NCT02920528|541093159|FG000|Overall Study|Did not meet inclusion criteria|2|||
149989561|NCT02920528|541093160|FG001|Overall Study|Did not meet inclusion criteria|0|||
149989562|NCT02920528|541093161|FG002|Overall Study|Did not meet inclusion criteria|1|||
149989563|NCT00066703|541093162|FG000|Overall Study|Adverse Event|80|||
149989564|NCT00066703|541093163|FG001|Overall Study|Adverse Event|111|||
149989565|NCT00066703|541093162|FG000|Overall Study|Death|3|||
149989566|NCT00066703|541093163|FG001|Overall Study|Death|0|||
149989567|NCT00066703|541093162|FG000|Overall Study|Lack of Efficacy|114|||
149989568|NCT00066703|541093163|FG001|Overall Study|Lack of Efficacy|69|||
149989569|NCT00066703|541093162|FG000|Overall Study|Lost to Follow-up|31|||
149989570|NCT00066703|541093163|FG001|Overall Study|Lost to Follow-up|28|||
149989571|NCT00066703|541093162|FG000|Overall Study|Withdrawal by Subject|38|||
149989572|NCT00066703|541093163|FG001|Overall Study|Withdrawal by Subject|63|||
149989573|NCT00066703|541093162|FG000|Overall Study|Treatment ongoing|346|||
149989574|NCT00066703|541093163|FG001|Overall Study|Treatment ongoing|311|||
149989575|NCT01696968|541093164|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
149989576|NCT01696968|541093165|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
149989577|NCT01696968|541093164|FG000|Overall Study|Died Before Randomization|3|||
149989578|NCT01696968|541093165|FG001|Overall Study|Died Before Randomization|8|||
149989579|NCT01696968|541093164|FG000|Overall Study|Died Before ASU (Control)|278|||
149989580|NCT01696968|541093165|FG001|Overall Study|Died Before ASU (Control)|0|||
149989581|NCT01696968|541093164|FG000|Overall Study|Refused ASU (Control)|920|||
149989582|NCT01696968|541093165|FG001|Overall Study|Refused ASU (Control)|0|||
149989583|NCT01696968|541093164|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
149989584|NCT01696968|541093165|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
149989585|NCT05659719|541093166|FG000|Overall Study|At sponsor's request|0|||
149989586|NCT05659719|541093167|FG001|Overall Study|At sponsor's request|0|||
149989587|NCT05659719|541093168|FG002|Overall Study|At sponsor's request|0|||
149989588|NCT05659719|541093169|FG003|Overall Study|At sponsor's request|95|||
149989589|NCT05659719|541093166|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
149989590|NCT05659719|541093167|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
149989591|NCT05659719|541093168|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
149989592|NCT05659719|541093169|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
149989593|NCT05659719|541093166|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
149989594|NCT05659719|541093167|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
149989595|NCT05659719|541093168|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
149989596|NCT05659719|541093169|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
149989597|NCT05659719|541093166|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
149989598|NCT05659719|541093167|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
149989599|NCT05659719|541093168|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
149989600|NCT05659719|541093169|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
149989601|NCT05659719|541093166|FG000|Overall Study|Lost to Follow-up|0|||
149989602|NCT05659719|541093167|FG001|Overall Study|Lost to Follow-up|0|||
149989603|NCT05659719|541093168|FG002|Overall Study|Lost to Follow-up|0|||
150178909|NCT03112174|541793876|FG002|Overall Study|Withdrawal by Subject|11|||
149989604|NCT05659719|541093169|FG003|Overall Study|Lost to Follow-up|2|||
149989605|NCT05659719|541093166|FG000|Overall Study|Moved to another observational study|0|||
149989606|NCT05659719|541093167|FG001|Overall Study|Moved to another observational study|0|||
149989607|NCT05659719|541093168|FG002|Overall Study|Moved to another observational study|0|||
149989608|NCT05659719|541093169|FG003|Overall Study|Moved to another observational study|1|||
149989609|NCT05659719|541093166|FG000|Overall Study|The child was enrolled in an interventional study|0|||
149989610|NCT05659719|541093167|FG001|Overall Study|The child was enrolled in an interventional study|0|||
149989611|NCT05659719|541093168|FG002|Overall Study|The child was enrolled in an interventional study|0|||
149989612|NCT05659719|541093169|FG003|Overall Study|The child was enrolled in an interventional study|55|||
149989613|NCT05659719|541093166|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
149989614|NCT05659719|541093167|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
149989615|NCT05659719|541093168|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
149989616|NCT05659719|541093169|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
149989617|NCT05659719|541093166|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
149989618|NCT05659719|541093167|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
149989619|NCT05659719|541093168|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
149989620|NCT05659719|541093169|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
149989621|NCT01681186|541093170|FG000|Washout Period From Second Intervention|Adverse Event|0|||
149989622|NCT01681186|541093171|FG001|Washout Period From Second Intervention|Adverse Event|0|||
149989623|NCT01681186|541093172|FG002|Washout Period From Second Intervention|Adverse Event|0|||
149989624|NCT01681186|541093173|FG003|Washout Period From Second Intervention|Adverse Event|0|||
149989625|NCT01681186|541093174|FG004|Washout Period From Second Intervention|Adverse Event|0|||
149989626|NCT01681186|541093175|FG005|Washout Period From Second Intervention|Adverse Event|0|||
149989627|NCT01681186|541093176|FG006|Washout Period From Second Intervention|Adverse Event|1|||
149989628|NCT01681186|541093177|FG007|Washout Period From Second Intervention|Adverse Event|0|||
149989629|NCT01681186|541093170|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
149989630|NCT01681186|541093171|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
149989631|NCT01681186|541093172|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
149989632|NCT01681186|541093173|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
149989633|NCT01681186|541093174|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
149989634|NCT01681186|541093175|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
149989635|NCT01681186|541093176|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
149989636|NCT01681186|541093177|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
149989637|NCT01681186|541093170|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989638|NCT01681186|541093171|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989639|NCT01681186|541093172|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989640|NCT01681186|541093173|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989641|NCT01681186|541093174|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989642|NCT01681186|541093175|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989643|NCT01681186|541093176|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
149989644|NCT01681186|541093177|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
149989645|NCT01681186|541093170|FG000|Fourth Intervention|Protocol Violation|0|||
149989646|NCT01681186|541093171|FG001|Fourth Intervention|Protocol Violation|0|||
149989647|NCT01681186|541093172|FG002|Fourth Intervention|Protocol Violation|0|||
149989648|NCT01681186|541093173|FG003|Fourth Intervention|Protocol Violation|0|||
149989649|NCT01681186|541093174|FG004|Fourth Intervention|Protocol Violation|0|||
149989650|NCT01681186|541093175|FG005|Fourth Intervention|Protocol Violation|0|||
149989651|NCT01681186|541093176|FG006|Fourth Intervention|Protocol Violation|0|||
149989652|NCT01681186|541093177|FG007|Fourth Intervention|Protocol Violation|1|||
149989653|NCT05160415|541093178|FG000|Overall Study|Withdrawal by Subject|3|||
149989654|NCT02582814|541093185|FG000|Overall Study|Study-specific withdrawal criteria|1|||
149989655|NCT02582814|541093186|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149989656|NCT02582814|541093185|FG000|Overall Study|Withdrawal by Subject|4|||
149989657|NCT02582814|541093186|FG001|Overall Study|Withdrawal by Subject|3|||
149989658|NCT02582814|541093185|FG000|Overall Study|Adverse Event|4|||
149989659|NCT02582814|541093186|FG001|Overall Study|Adverse Event|4|||
149989660|NCT03530995|541093190|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
149989661|NCT03530995|541093191|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
150053631|NCT01457352|541336686|FG000|Period 2|dose change|1|||
150053632|NCT01457352|541336687|FG001|Period 2|dose change|0|||
149989662|NCT03530995|541093190|FG000|Part 1 Period 3|Protocol Violation|1|||
149989663|NCT03530995|541093191|FG001|Part 1 Period 3|Protocol Violation|0|||
149989664|NCT03530995|541093190|FG000|Part 1 Period 4|Physician Decision|1|||
149989665|NCT03530995|541093191|FG001|Part 1 Period 4|Physician Decision|0|||
149989666|NCT03530995|541093190|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
149989667|NCT03530995|541093191|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
149989668|NCT04308239|541093196|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
149989669|NCT04308239|541093197|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
149989670|NCT04308239|541093196|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
149989671|NCT04308239|541093197|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
149989672|NCT04308239|541093196|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
149989673|NCT04308239|541093197|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
149989674|NCT04308239|541093196|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
149989675|NCT04308239|541093197|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
149989676|NCT04848220|541093202|FG000|Overall Study|Unable to proceed to study procedure|0|||
149989677|NCT04848220|541093203|FG001|Overall Study|Unable to proceed to study procedure|1|||
149989678|NCT04848220|541093204|FG002|Overall Study|Unable to proceed to study procedure|0|||
149989679|NCT04848220|541093202|FG000|Overall Study|Fractional flow not significant|0|||
149989680|NCT04848220|541093203|FG001|Overall Study|Fractional flow not significant|1|||
149989681|NCT04848220|541093204|FG002|Overall Study|Fractional flow not significant|0|||
149989682|NCT02557100|541093215|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
149989683|NCT02557100|541093216|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
149989684|NCT02557100|541093217|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
149989685|NCT02557100|541093215|FG000|Single Blind Treatment Period|Death|0|||
149989686|NCT02557100|541093216|FG001|Single Blind Treatment Period|Death|1|||
149989687|NCT02557100|541093217|FG002|Single Blind Treatment Period|Death|0|||
149989688|NCT02557100|541093215|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
149989689|NCT02557100|541093216|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
149989690|NCT02557100|541093217|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
149989691|NCT02557100|541093215|FG000|Single Blind Treatment Period|Adverse Event|0|||
149989692|NCT02557100|541093216|FG001|Single Blind Treatment Period|Adverse Event|1|||
149989693|NCT02557100|541093217|FG002|Single Blind Treatment Period|Adverse Event|0|||
149989694|NCT02557100|541093215|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
149989695|NCT02557100|541093216|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
149989696|NCT02557100|541093217|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
149989697|NCT02557100|541093215|FG000|Cumulative Abatacept Period|Other Reasons|0|||
149989698|NCT02557100|541093216|FG001|Cumulative Abatacept Period|Other Reasons|0|||
149989699|NCT02557100|541093217|FG002|Cumulative Abatacept Period|Other Reasons|1|||
149989700|NCT02557100|541093215|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
149989701|NCT02557100|541093216|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
149989702|NCT02557100|541093217|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
149989703|NCT02557100|541093215|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
149989704|NCT02557100|541093216|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
149989705|NCT02557100|541093217|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
149989706|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
149989707|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
149989708|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
149989709|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
149989710|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
149989711|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
149989712|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
149989713|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
149989714|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
149989715|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
149989716|NCT00510718|541093218|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
149989717|NCT00510718|541093219|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
149989718|NCT05791565|541093229|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
149989719|NCT05791565|541093230|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
149989720|NCT00705250|541093231|FG000|Overall Study|Withdrawal by Subject|1|||
149989721|NCT00705250|541093231|FG000|Overall Study|Patient died in car accident|1|||
149989722|NCT01406938|541093232|FG000|Induction Period|Subject/guardian decision|6|||
149989723|NCT01406938|541093233|FG001|Induction Period|Subject/guardian decision|8|||
149989724|NCT01406938|541093234|FG002|Induction Period|Subject/guardian decision|0|||
149989725|NCT01406938|541093235|FG003|Induction Period|Subject/guardian decision|0|||
149989726|NCT01406938|541093236|FG004|Induction Period|Subject/guardian decision|0|||
149989727|NCT01406938|541093237|FG005|Induction Period|Subject/guardian decision|0|||
149989728|NCT01406938|541093232|FG000|Induction Period|Protocol deviation|1|||
149989729|NCT01406938|541093233|FG001|Induction Period|Protocol deviation|0|||
149989730|NCT01406938|541093234|FG002|Induction Period|Protocol deviation|0|||
149989731|NCT01406938|541093235|FG003|Induction Period|Protocol deviation|0|||
149989732|NCT01406938|541093236|FG004|Induction Period|Protocol deviation|0|||
149989733|NCT01406938|541093237|FG005|Induction Period|Protocol deviation|0|||
149989734|NCT01406938|541093232|FG000|Induction Period|Adverse Event|8|||
149989735|NCT01406938|541093233|FG001|Induction Period|Adverse Event|9|||
149989736|NCT01406938|541093234|FG002|Induction Period|Adverse Event|0|||
149989737|NCT01406938|541093235|FG003|Induction Period|Adverse Event|0|||
149989738|NCT01406938|541093236|FG004|Induction Period|Adverse Event|0|||
149989739|NCT01406938|541093237|FG005|Induction Period|Adverse Event|0|||
149989740|NCT01406938|541093232|FG000|Induction Period|Lack of Efficacy|1|||
149989741|NCT01406938|541093233|FG001|Induction Period|Lack of Efficacy|0|||
149989742|NCT01406938|541093234|FG002|Induction Period|Lack of Efficacy|0|||
149989743|NCT01406938|541093235|FG003|Induction Period|Lack of Efficacy|0|||
149989744|NCT01406938|541093236|FG004|Induction Period|Lack of Efficacy|0|||
149989745|NCT01406938|541093237|FG005|Induction Period|Lack of Efficacy|0|||
149989746|NCT01406938|541093232|FG000|Induction Period|Lost to Follow-up|2|||
149989747|NCT01406938|541093233|FG001|Induction Period|Lost to Follow-up|3|||
149989748|NCT01406938|541093234|FG002|Induction Period|Lost to Follow-up|0|||
149989749|NCT01406938|541093235|FG003|Induction Period|Lost to Follow-up|0|||
149989750|NCT01406938|541093236|FG004|Induction Period|Lost to Follow-up|0|||
149989751|NCT01406938|541093237|FG005|Induction Period|Lost to Follow-up|0|||
149989752|NCT01406938|541093232|FG000|Maintenance Period|Adverse Event|0|||
149989753|NCT01406938|541093233|FG001|Maintenance Period|Adverse Event|0|||
149989754|NCT01406938|541093234|FG002|Maintenance Period|Adverse Event|2|||
149989755|NCT01406938|541093235|FG003|Maintenance Period|Adverse Event|8|||
149989756|NCT01406938|541093236|FG004|Maintenance Period|Adverse Event|4|||
149989757|NCT01406938|541093237|FG005|Maintenance Period|Adverse Event|2|||
149989758|NCT01406938|541093232|FG000|Maintenance Period|Death|0|||
149989759|NCT01406938|541093233|FG001|Maintenance Period|Death|0|||
149989760|NCT01406938|541093234|FG002|Maintenance Period|Death|0|||
149989761|NCT01406938|541093235|FG003|Maintenance Period|Death|0|||
149989762|NCT01406938|541093236|FG004|Maintenance Period|Death|1|||
149989763|NCT01406938|541093237|FG005|Maintenance Period|Death|0|||
149989764|NCT01406938|541093232|FG000|Maintenance Period|Subject/guardian decision|0|||
149989765|NCT01406938|541093233|FG001|Maintenance Period|Subject/guardian decision|0|||
149989766|NCT01406938|541093234|FG002|Maintenance Period|Subject/guardian decision|11|||
149989767|NCT01406938|541093235|FG003|Maintenance Period|Subject/guardian decision|7|||
149989768|NCT01406938|541093236|FG004|Maintenance Period|Subject/guardian decision|10|||
149989769|NCT01406938|541093237|FG005|Maintenance Period|Subject/guardian decision|7|||
149989770|NCT01406938|541093232|FG000|Maintenance Period|Protocol Violation|0|||
149989771|NCT01406938|541093233|FG001|Maintenance Period|Protocol Violation|0|||
149989772|NCT01406938|541093234|FG002|Maintenance Period|Protocol Violation|2|||
149989773|NCT01406938|541093235|FG003|Maintenance Period|Protocol Violation|2|||
149989774|NCT01406938|541093236|FG004|Maintenance Period|Protocol Violation|2|||
149989775|NCT01406938|541093237|FG005|Maintenance Period|Protocol Violation|2|||
149989776|NCT01406938|541093232|FG000|Maintenance Period|Pregnancy|0|||
149989777|NCT01406938|541093233|FG001|Maintenance Period|Pregnancy|0|||
149989778|NCT01406938|541093234|FG002|Maintenance Period|Pregnancy|0|||
149989779|NCT01406938|541093235|FG003|Maintenance Period|Pregnancy|0|||
149989780|NCT01406938|541093236|FG004|Maintenance Period|Pregnancy|1|||
149989781|NCT01406938|541093237|FG005|Maintenance Period|Pregnancy|0|||
149989782|NCT01406938|541093232|FG000|Maintenance Period|Lost to Follow-up|0|||
149989783|NCT01406938|541093233|FG001|Maintenance Period|Lost to Follow-up|0|||
149989784|NCT01406938|541093234|FG002|Maintenance Period|Lost to Follow-up|0|||
149989785|NCT01406938|541093235|FG003|Maintenance Period|Lost to Follow-up|0|||
149989786|NCT01406938|541093236|FG004|Maintenance Period|Lost to Follow-up|4|||
149989787|NCT01406938|541093237|FG005|Maintenance Period|Lost to Follow-up|0|||
149989788|NCT01406938|541093232|FG000|Maintenance Period|Lack of Efficacy|0|||
149989789|NCT01406938|541093233|FG001|Maintenance Period|Lack of Efficacy|0|||
149989790|NCT01406938|541093234|FG002|Maintenance Period|Lack of Efficacy|2|||
149989791|NCT01406938|541093235|FG003|Maintenance Period|Lack of Efficacy|1|||
149989792|NCT01406938|541093236|FG004|Maintenance Period|Lack of Efficacy|3|||
149989793|NCT01406938|541093237|FG005|Maintenance Period|Lack of Efficacy|5|||
149989794|NCT01406938|541093232|FG000|Follow up|Lack of Efficacy|3|||
149989795|NCT01406938|541093233|FG001|Follow up|Lack of Efficacy|2|||
149989796|NCT01406938|541093234|FG002|Follow up|Lack of Efficacy|1|||
149989797|NCT01406938|541093235|FG003|Follow up|Lack of Efficacy|0|||
149989798|NCT01406938|541093236|FG004|Follow up|Lack of Efficacy|0|||
149989799|NCT01406938|541093237|FG005|Follow up|Lack of Efficacy|0|||
149989800|NCT01406938|541093232|FG000|Follow up|Patient/guardian decision|4|||
149989801|NCT01406938|541093233|FG001|Follow up|Patient/guardian decision|2|||
149989802|NCT01406938|541093234|FG002|Follow up|Patient/guardian decision|4|||
149989803|NCT01406938|541093235|FG003|Follow up|Patient/guardian decision|2|||
149989804|NCT01406938|541093236|FG004|Follow up|Patient/guardian decision|4|||
149989805|NCT01406938|541093237|FG005|Follow up|Patient/guardian decision|1|||
149989806|NCT01406938|541093232|FG000|Follow up|Protocol Violation|0|||
149989807|NCT01406938|541093233|FG001|Follow up|Protocol Violation|0|||
149989808|NCT01406938|541093234|FG002|Follow up|Protocol Violation|1|||
149989809|NCT01406938|541093235|FG003|Follow up|Protocol Violation|0|||
149989810|NCT01406938|541093236|FG004|Follow up|Protocol Violation|0|||
149989811|NCT01406938|541093237|FG005|Follow up|Protocol Violation|0|||
149989812|NCT01406938|541093232|FG000|Follow up|Physician Decision|0|||
149989813|NCT01406938|541093233|FG001|Follow up|Physician Decision|0|||
149989814|NCT01406938|541093234|FG002|Follow up|Physician Decision|2|||
149989815|NCT01406938|541093235|FG003|Follow up|Physician Decision|0|||
149989816|NCT01406938|541093236|FG004|Follow up|Physician Decision|3|||
149989817|NCT01406938|541093237|FG005|Follow up|Physician Decision|1|||
149989818|NCT01406938|541093232|FG000|Follow up|Lost to Follow-up|1|||
149989819|NCT01406938|541093233|FG001|Follow up|Lost to Follow-up|1|||
149989820|NCT01406938|541093234|FG002|Follow up|Lost to Follow-up|0|||
149989821|NCT01406938|541093235|FG003|Follow up|Lost to Follow-up|1|||
149989822|NCT01406938|541093236|FG004|Follow up|Lost to Follow-up|2|||
149989823|NCT01406938|541093237|FG005|Follow up|Lost to Follow-up|1|||
149989824|NCT00316225|541093240|FG000|Overall Study|Adverse Event|2|||
149989825|NCT00316225|541093240|FG000|Overall Study|Physician Decision|3|||
149989826|NCT00316225|541093240|FG000|Overall Study|Progressive Disease|15|||
149989827|NCT00316225|541093240|FG000|Overall Study|Withdrawal by Subject|3|||
149989828|NCT00316225|541093240|FG000|Overall Study|Death|2|||
149989829|NCT01814878|541093241|FG000|Overall Study|Adverse Event|16|||
149989830|NCT01814878|541093242|FG001|Overall Study|Adverse Event|5|||
149989831|NCT01814878|541093241|FG000|Overall Study|Withdrawal by Subject|20|||
149989832|NCT01814878|541093242|FG001|Overall Study|Withdrawal by Subject|16|||
149989833|NCT01814878|541093241|FG000|Overall Study|Protocol Violation|5|||
149989834|NCT01814878|541093242|FG001|Overall Study|Protocol Violation|5|||
149989835|NCT01814878|541093241|FG000|Overall Study|Physician Decision|3|||
149989836|NCT01814878|541093242|FG001|Overall Study|Physician Decision|1|||
149989837|NCT01814878|541093241|FG000|Overall Study|Screening failure (drop-out)|0|||
149989838|NCT01814878|541093242|FG001|Overall Study|Screening failure (drop-out)|3|||
149989839|NCT01814878|541093241|FG000|Overall Study|Other|2|||
149989840|NCT01814878|541093242|FG001|Overall Study|Other|0|||
149989841|NCT03818607|541093246|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
149989842|NCT03818607|541093247|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
149989843|NCT03818607|541093246|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
149989844|NCT03818607|541093247|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
149989845|NCT03818607|541093246|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
149989846|NCT03818607|541093247|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
149989847|NCT02684617|541093248|FG000|Overall Study|Adverse Event|1|||
149989848|NCT02684617|541093249|FG001|Overall Study|Adverse Event|0|||
149989849|NCT02684617|541093250|FG002|Overall Study|Adverse Event|1|||
149989850|NCT02684617|541093248|FG000|Overall Study|Death|8|||
149989851|NCT02684617|541093249|FG001|Overall Study|Death|16|||
149989852|NCT02684617|541093250|FG002|Overall Study|Death|28|||
149989853|NCT02684617|541093248|FG000|Overall Study|Withdrawal by Subject|2|||
149989854|NCT02684617|541093249|FG001|Overall Study|Withdrawal by Subject|0|||
149989855|NCT02684617|541093250|FG002|Overall Study|Withdrawal by Subject|4|||
149989856|NCT02684617|541093248|FG000|Overall Study|Screen Failure|1|||
149989857|NCT02684617|541093249|FG001|Overall Study|Screen Failure|0|||
149989858|NCT02684617|541093250|FG002|Overall Study|Screen Failure|2|||
149989859|NCT02684617|541093248|FG000|Overall Study|Study Terminated by Sponsor|6|||
149989860|NCT02684617|541093249|FG001|Overall Study|Study Terminated by Sponsor|1|||
149989861|NCT02684617|541093250|FG002|Overall Study|Study Terminated by Sponsor|5|||
149989862|NCT04952597|541093251|FG000|Overall Study|Death|12|||
149989863|NCT04952597|541093252|FG001|Overall Study|Death|13|||
149989864|NCT04952597|541093253|FG002|Overall Study|Death|14|||
149989865|NCT04952597|541093251|FG000|Overall Study|Withdrawal by Subject|1|||
149989866|NCT04952597|541093252|FG001|Overall Study|Withdrawal by Subject|0|||
149989867|NCT04952597|541093253|FG002|Overall Study|Withdrawal by Subject|3|||
149989868|NCT04952597|541093251|FG000|Overall Study|Lost to Follow-up|0|||
149989869|NCT04952597|541093252|FG001|Overall Study|Lost to Follow-up|1|||
149989870|NCT04952597|541093253|FG002|Overall Study|Lost to Follow-up|1|||
149989871|NCT03249909|541093254|FG000|Overall Study|Withdrawal by Subject|3|||
149989872|NCT03249909|541093255|FG001|Overall Study|Withdrawal by Subject|0|||
149989873|NCT03249909|541093256|FG002|Overall Study|Withdrawal by Subject|0|||
149989874|NCT03249909|541093254|FG000|Overall Study|Adverse Event|3|||
149989875|NCT03249909|541093255|FG001|Overall Study|Adverse Event|0|||
149989876|NCT03249909|541093256|FG002|Overall Study|Adverse Event|0|||
149989877|NCT03249909|541093254|FG000|Overall Study|Lost to Follow-up|0|||
149989878|NCT03249909|541093255|FG001|Overall Study|Lost to Follow-up|1|||
149989879|NCT03249909|541093256|FG002|Overall Study|Lost to Follow-up|0|||
149989880|NCT00606034|541093257|FG000|Overall Study|incarceration|1|||
149989881|NCT05286658|541093259|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
149989882|NCT05286658|541093259|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
149989883|NCT00935493|541093260|FG000|Overall Study|Lost to Follow-up|1|||
149989884|NCT00935493|541093261|FG001|Overall Study|Lost to Follow-up|1|||
149989885|NCT00935493|541093262|FG002|Overall Study|Lost to Follow-up|1|||
149989886|NCT00935493|541093260|FG000|Overall Study|Treatment Discontinued|0|||
149989887|NCT00935493|541093261|FG001|Overall Study|Treatment Discontinued|1|||
149989888|NCT00935493|541093262|FG002|Overall Study|Treatment Discontinued|0|||
149989889|NCT01355679|541093263|FG000|Overall Study|benign tumor types found at biopsy|2|||
149989890|NCT02676895|541093264|FG000|Overall Study|Administrative reason|1|||
149989891|NCT02676895|541093265|FG001|Overall Study|Administrative reason|0|||
149989892|NCT02676895|541093266|FG002|Overall Study|Administrative reason|0|||
149989893|NCT02676895|541093264|FG000|Overall Study|Protocol Violation|1|||
149989894|NCT02676895|541093265|FG001|Overall Study|Protocol Violation|0|||
149989895|NCT02676895|541093266|FG002|Overall Study|Protocol Violation|0|||
149989896|NCT02676895|541093264|FG000|Overall Study|Adverse Event|0|||
149989897|NCT02676895|541093265|FG001|Overall Study|Adverse Event|3|||
149989898|NCT02676895|541093266|FG002|Overall Study|Adverse Event|1|||
149989899|NCT02676895|541093264|FG000|Overall Study|Lost to Follow-up|0|||
149989900|NCT02676895|541093265|FG001|Overall Study|Lost to Follow-up|0|||
149989901|NCT02676895|541093266|FG002|Overall Study|Lost to Follow-up|1|||
149989902|NCT02676895|541093264|FG000|Overall Study|Withdrawal by Subject|0|||
149989903|NCT02676895|541093265|FG001|Overall Study|Withdrawal by Subject|0|||
149989904|NCT02676895|541093266|FG002|Overall Study|Withdrawal by Subject|1|||
149989905|NCT03028129|541093269|FG000|Overall Study|Adverse Event|13|||
149989906|NCT03028129|541093270|FG001|Overall Study|Adverse Event|2|||
149989907|NCT03028129|541093269|FG000|Overall Study|Lost to Follow-up|50|||
149989908|NCT03028129|541093270|FG001|Overall Study|Lost to Follow-up|38|||
149989909|NCT03028129|541093269|FG000|Overall Study|Physician Decision|0|||
149989910|NCT03028129|541093270|FG001|Overall Study|Physician Decision|1|||
149989911|NCT03028129|541093269|FG000|Overall Study|Protocol Violation|1|||
149989912|NCT03028129|541093270|FG001|Overall Study|Protocol Violation|1|||
149989913|NCT03028129|541093269|FG000|Overall Study|Withdrawal by Subject|62|||
149989914|NCT03028129|541093270|FG001|Overall Study|Withdrawal by Subject|45|||
149989915|NCT00923351|541093271|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
149989916|NCT00923351|541093272|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
149989917|NCT00923351|541093273|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
149989918|NCT02443116|541093280|FG000|Part 1|Adverse Event|2|||
149989919|NCT02443116|541093281|FG001|Part 1|Adverse Event|3|||
149989920|NCT02443116|541093282|FG002|Part 1|Adverse Event|0|||
149989921|NCT02443116|541093283|FG003|Part 1|Adverse Event|0|||
149989922|NCT02443116|541093284|FG004|Part 1|Adverse Event|0|||
149989923|NCT02443116|541093285|FG005|Part 1|Adverse Event|0|||
149989924|NCT02443116|541093286|FG006|Part 1|Adverse Event|0|||
149989925|NCT02443116|541093287|FG007|Part 1|Adverse Event|0|||
149989926|NCT02443116|541093288|FG008|Part 1|Adverse Event|0|||
149989927|NCT02443116|541093280|FG000|Part 1|Withdrew informed consent|0|||
149989928|NCT02443116|541093281|FG001|Part 1|Withdrew informed consent|1|||
149989929|NCT02443116|541093282|FG002|Part 1|Withdrew informed consent|0|||
149989930|NCT02443116|541093283|FG003|Part 1|Withdrew informed consent|0|||
149989931|NCT02443116|541093284|FG004|Part 1|Withdrew informed consent|0|||
149989932|NCT02443116|541093285|FG005|Part 1|Withdrew informed consent|0|||
149989933|NCT02443116|541093286|FG006|Part 1|Withdrew informed consent|0|||
149989934|NCT02443116|541093287|FG007|Part 1|Withdrew informed consent|0|||
149989935|NCT02443116|541093288|FG008|Part 1|Withdrew informed consent|0|||
149989936|NCT02443116|541093280|FG000|Part 1|Lost to Follow-up|0|||
149989937|NCT02443116|541093281|FG001|Part 1|Lost to Follow-up|0|||
149989938|NCT02443116|541093282|FG002|Part 1|Lost to Follow-up|2|||
149989939|NCT02443116|541093283|FG003|Part 1|Lost to Follow-up|0|||
149989940|NCT02443116|541093284|FG004|Part 1|Lost to Follow-up|0|||
149989941|NCT02443116|541093285|FG005|Part 1|Lost to Follow-up|0|||
150053633|NCT01457352|541336686|FG000|Period 2|Physician Decision|1|||
149989942|NCT02443116|541093286|FG006|Part 1|Lost to Follow-up|0|||
149989943|NCT02443116|541093287|FG007|Part 1|Lost to Follow-up|0|||
149989944|NCT02443116|541093288|FG008|Part 1|Lost to Follow-up|0|||
150053634|NCT01457352|541336687|FG001|Period 2|Physician Decision|0|||
149989945|NCT02443116|541093280|FG000|Part 1|Participant moved out of state|0|||
149989946|NCT02443116|541093281|FG001|Part 1|Participant moved out of state|0|||
149989947|NCT02443116|541093282|FG002|Part 1|Participant moved out of state|1|||
149989948|NCT02443116|541093283|FG003|Part 1|Participant moved out of state|0|||
149989949|NCT02443116|541093284|FG004|Part 1|Participant moved out of state|0|||
149989950|NCT02443116|541093285|FG005|Part 1|Participant moved out of state|0|||
149989951|NCT02443116|541093286|FG006|Part 1|Participant moved out of state|0|||
149989952|NCT02443116|541093287|FG007|Part 1|Participant moved out of state|0|||
149989953|NCT02443116|541093288|FG008|Part 1|Participant moved out of state|0|||
149989954|NCT02443116|541093280|FG000|Part 1|Participant enrolled in another clinical trial|0|||
149989955|NCT02443116|541093281|FG001|Part 1|Participant enrolled in another clinical trial|0|||
149989956|NCT02443116|541093282|FG002|Part 1|Participant enrolled in another clinical trial|1|||
149989957|NCT02443116|541093283|FG003|Part 1|Participant enrolled in another clinical trial|0|||
149989958|NCT02443116|541093284|FG004|Part 1|Participant enrolled in another clinical trial|0|||
149989959|NCT02443116|541093285|FG005|Part 1|Participant enrolled in another clinical trial|0|||
149989960|NCT02443116|541093286|FG006|Part 1|Participant enrolled in another clinical trial|0|||
149989961|NCT02443116|541093287|FG007|Part 1|Participant enrolled in another clinical trial|0|||
149989962|NCT02443116|541093288|FG008|Part 1|Participant enrolled in another clinical trial|0|||
149989963|NCT02443116|541093280|FG000|Part 2|Adverse Event|0|||
149989964|NCT02443116|541093281|FG001|Part 2|Adverse Event|0|||
149989965|NCT02443116|541093282|FG002|Part 2|Adverse Event|0|||
149989966|NCT02443116|541093283|FG003|Part 2|Adverse Event|0|||
149989967|NCT02443116|541093284|FG004|Part 2|Adverse Event|1|||
149989968|NCT02443116|541093285|FG005|Part 2|Adverse Event|1|||
149989969|NCT02443116|541093286|FG006|Part 2|Adverse Event|2|||
149989970|NCT02443116|541093287|FG007|Part 2|Adverse Event|0|||
149989971|NCT02443116|541093288|FG008|Part 2|Adverse Event|0|||
149989972|NCT02443116|541093280|FG000|Part 2|Withdrew informed consent|0|||
149989973|NCT02443116|541093281|FG001|Part 2|Withdrew informed consent|0|||
149989974|NCT02443116|541093282|FG002|Part 2|Withdrew informed consent|0|||
149989975|NCT02443116|541093283|FG003|Part 2|Withdrew informed consent|0|||
149989976|NCT02443116|541093284|FG004|Part 2|Withdrew informed consent|0|||
149989977|NCT02443116|541093285|FG005|Part 2|Withdrew informed consent|1|||
149989978|NCT02443116|541093286|FG006|Part 2|Withdrew informed consent|1|||
149989979|NCT02443116|541093287|FG007|Part 2|Withdrew informed consent|0|||
149989980|NCT02443116|541093288|FG008|Part 2|Withdrew informed consent|0|||
149989981|NCT02443116|541093280|FG000|Part 2|Inability to comply with protocol|0|||
149989982|NCT02443116|541093281|FG001|Part 2|Inability to comply with protocol|0|||
149989983|NCT02443116|541093282|FG002|Part 2|Inability to comply with protocol|0|||
149989984|NCT02443116|541093283|FG003|Part 2|Inability to comply with protocol|1|||
149989985|NCT02443116|541093284|FG004|Part 2|Inability to comply with protocol|0|||
149989986|NCT02443116|541093285|FG005|Part 2|Inability to comply with protocol|0|||
149989987|NCT02443116|541093286|FG006|Part 2|Inability to comply with protocol|0|||
149989988|NCT02443116|541093287|FG007|Part 2|Inability to comply with protocol|0|||
149989989|NCT02443116|541093288|FG008|Part 2|Inability to comply with protocol|0|||
149989990|NCT02443116|541093280|FG000|Part 2|Lost to Follow-up|0|||
149989991|NCT02443116|541093281|FG001|Part 2|Lost to Follow-up|0|||
149989992|NCT02443116|541093282|FG002|Part 2|Lost to Follow-up|0|||
149989993|NCT02443116|541093283|FG003|Part 2|Lost to Follow-up|1|||
149989994|NCT02443116|541093284|FG004|Part 2|Lost to Follow-up|0|||
149989995|NCT02443116|541093285|FG005|Part 2|Lost to Follow-up|0|||
149989996|NCT02443116|541093286|FG006|Part 2|Lost to Follow-up|0|||
149989997|NCT02443116|541093287|FG007|Part 2|Lost to Follow-up|0|||
149989998|NCT02443116|541093288|FG008|Part 2|Lost to Follow-up|0|||
149989999|NCT02443116|541093280|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990000|NCT02443116|541093281|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990001|NCT02443116|541093282|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990002|NCT02443116|541093283|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990003|NCT02443116|541093284|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990004|NCT02443116|541093285|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
149990005|NCT02443116|541093286|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990006|NCT02443116|541093287|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990007|NCT02443116|541093288|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
149990008|NCT02443116|541093280|FG000|Part 3|Adverse Event|0|||
149990009|NCT02443116|541093281|FG001|Part 3|Adverse Event|0|||
149990010|NCT02443116|541093282|FG002|Part 3|Adverse Event|0|||
149990011|NCT02443116|541093283|FG003|Part 3|Adverse Event|0|||
149990012|NCT02443116|541093284|FG004|Part 3|Adverse Event|0|||
149990013|NCT02443116|541093285|FG005|Part 3|Adverse Event|0|||
149990014|NCT02443116|541093286|FG006|Part 3|Adverse Event|0|||
149990015|NCT02443116|541093287|FG007|Part 3|Adverse Event|0|||
149990016|NCT02443116|541093288|FG008|Part 3|Adverse Event|1|||
150053635|NCT01457352|541336686|FG000|Period 2|Did not meet eligibility criteria|3|||
149990017|NCT02443116|541093280|FG000|Part 3|Withdrew informed consent|0|||
149990018|NCT02443116|541093281|FG001|Part 3|Withdrew informed consent|0|||
149990019|NCT02443116|541093282|FG002|Part 3|Withdrew informed consent|0|||
149990020|NCT02443116|541093283|FG003|Part 3|Withdrew informed consent|0|||
149990021|NCT02443116|541093284|FG004|Part 3|Withdrew informed consent|0|||
149990022|NCT02443116|541093285|FG005|Part 3|Withdrew informed consent|0|||
149990023|NCT02443116|541093286|FG006|Part 3|Withdrew informed consent|0|||
149990024|NCT02443116|541093287|FG007|Part 3|Withdrew informed consent|3|||
149990025|NCT02443116|541093288|FG008|Part 3|Withdrew informed consent|2|||
149990026|NCT02443116|541093280|FG000|Part 3|Lost to Follow-up|0|||
149990027|NCT02443116|541093281|FG001|Part 3|Lost to Follow-up|0|||
149990028|NCT02443116|541093282|FG002|Part 3|Lost to Follow-up|0|||
149990029|NCT02443116|541093283|FG003|Part 3|Lost to Follow-up|0|||
149990030|NCT02443116|541093284|FG004|Part 3|Lost to Follow-up|0|||
149990031|NCT02443116|541093285|FG005|Part 3|Lost to Follow-up|0|||
149990032|NCT02443116|541093286|FG006|Part 3|Lost to Follow-up|0|||
149990033|NCT02443116|541093287|FG007|Part 3|Lost to Follow-up|1|||
149990034|NCT02443116|541093288|FG008|Part 3|Lost to Follow-up|2|||
149990035|NCT01696981|541093289|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
149990036|NCT01696981|541093290|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
149990037|NCT01696981|541093289|FG000|Overall Study|Died Before Randomization|3|||
149990038|NCT01696981|541093290|FG001|Overall Study|Died Before Randomization|8|||
149990039|NCT01696981|541093289|FG000|Overall Study|Died Before ASU (Control)|278|||
149990040|NCT01696981|541093290|FG001|Overall Study|Died Before ASU (Control)|0|||
149990041|NCT01696981|541093289|FG000|Overall Study|Refused ASU (Control)|920|||
149990042|NCT01696981|541093290|FG001|Overall Study|Refused ASU (Control)|0|||
149990043|NCT01696981|541093289|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
149990044|NCT01696981|541093290|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
149990045|NCT00851890|541093297|FG000|Overall Study|Lost to Follow-up|0|||
149990046|NCT00851890|541093298|FG001|Overall Study|Lost to Follow-up|1|||
149990047|NCT00851890|541093299|FG002|Overall Study|Lost to Follow-up|0|||
149990048|NCT00851890|541093300|FG003|Overall Study|Lost to Follow-up|1|||
149990049|NCT03135431|541093301|FG000|Overall Study|Study Surgeon not available|2|||
149990050|NCT03135431|541093302|FG001|Overall Study|Study Surgeon not available|0|||
149990051|NCT01063062|541093303|FG000|Overall Study|Patient withdrew consent|0|||
149990052|NCT01063062|541093304|FG001|Overall Study|Patient withdrew consent|1|||
149990053|NCT01063062|541093303|FG000|Overall Study|Adverse Event|2|||
149990054|NCT01063062|541093304|FG001|Overall Study|Adverse Event|4|||
149990055|NCT01063062|541093303|FG000|Overall Study|Protocol Violation|5|||
149990056|NCT01063062|541093304|FG001|Overall Study|Protocol Violation|4|||
149990057|NCT01063062|541093303|FG000|Overall Study|Investigator's request|1|||
149990058|NCT01063062|541093304|FG001|Overall Study|Investigator's request|0|||
149990059|NCT01063062|541093303|FG000|Overall Study|Lost to Follow-up|0|||
149990060|NCT01063062|541093304|FG001|Overall Study|Lost to Follow-up|2|||
149990061|NCT01063062|541093303|FG000|Overall Study|Miscellaneous reason|0|||
149990062|NCT01063062|541093304|FG001|Overall Study|Miscellaneous reason|1|||
149990063|NCT02015481|541093305|FG000|Overall Study|Death|1|||
149990064|NCT03122145|541093308|FG000|Overall Study|Concurrent respiratory disease|3|||
149990065|NCT03122145|541093309|FG001|Overall Study|Concurrent respiratory disease|0|||
149990066|NCT03108521|541093314|FG000|Overall Study|Lost to Follow-up|3|||
149990067|NCT03108521|541093315|FG001|Overall Study|Lost to Follow-up|0|||
149990068|NCT03108521|541093314|FG000|Overall Study|Lack of Efficacy|2|||
149990069|NCT03108521|541093315|FG001|Overall Study|Lack of Efficacy|0|||
149990070|NCT03108521|541093314|FG000|Overall Study|Physician Decision|4|||
149990071|NCT03108521|541093315|FG001|Overall Study|Physician Decision|0|||
149990072|NCT03108521|541093314|FG000|Overall Study|Adverse Event|3|||
149990073|NCT03108521|541093315|FG001|Overall Study|Adverse Event|0|||
149990074|NCT01170273|541093326|FG000|Overall Study|Lost to Follow-up|6|||
149990075|NCT01170273|541093327|FG001|Overall Study|Lost to Follow-up|8|||
149990076|NCT01170273|541093326|FG000|Overall Study|Protocol Violation|1|||
149990077|NCT01170273|541093327|FG001|Overall Study|Protocol Violation|0|||
149990078|NCT01170273|541093326|FG000|Overall Study|Death|1|||
149990079|NCT01170273|541093327|FG001|Overall Study|Death|0|||
149990080|NCT01170273|541093326|FG000|Overall Study|Adverse Event|0|||
149990081|NCT01170273|541093327|FG001|Overall Study|Adverse Event|1|||
149990082|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
149990083|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
149990084|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
149990085|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
149990086|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
149990087|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
149990088|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
149990089|NCT01673854|541093328|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
150178910|NCT03112174|541793877|FG003|Overall Study|Withdrawal by Subject|9|||
149990090|NCT01673854|541093328|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
149990091|NCT01673854|541093328|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
149990092|NCT01673854|541093328|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
149990093|NCT01673854|541093328|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
149990094|NCT02316353|541093329|FG000|Overall Study|Pregnancy|1|||
149990095|NCT02316353|541093330|FG001|Overall Study|Pregnancy|3|||
149990096|NCT02316353|541093329|FG000|Overall Study|Adverse Event|1|||
149990097|NCT02316353|541093330|FG001|Overall Study|Adverse Event|3|||
150178911|NCT03112174|541793878|FG004|Overall Study|Withdrawal by Subject|7|||
149990098|NCT02316353|541093329|FG000|Overall Study|Withdrawal by Subject|6|||
149990099|NCT02316353|541093330|FG001|Overall Study|Withdrawal by Subject|2|||
149990100|NCT00375674|541093331|FG000|Overall Study|Other|26|||
149990101|NCT00375674|541093332|FG001|Overall Study|Other|18|||
149990102|NCT00375674|541093331|FG000|Overall Study|Death|67|||
149990103|NCT00375674|541093332|FG001|Overall Study|Death|76|||
149990104|NCT00375674|541093331|FG000|Overall Study|Participants refused further follow-up|31|||
149990105|NCT00375674|541093332|FG001|Overall Study|Participants refused further follow-up|30|||
149990106|NCT00375674|541093331|FG000|Overall Study|Lost to Follow-up|17|||
149990107|NCT00375674|541093332|FG001|Overall Study|Lost to Follow-up|15|||
149990108|NCT00375674|541093331|FG000|Overall Study|Enrolled but not treated|3|||
149990109|NCT00375674|541093332|FG001|Overall Study|Enrolled but not treated|2|||
149990110|NCT00875485|541094765|FG000|Challenge Dose Epoch|Pregnancy|1|||
149990111|NCT00875485|541094766|FG001|Challenge Dose Epoch|Pregnancy|0|||
149990112|NCT01271010|541094767|FG000|Overall Study|Reason not specified|11|||
149990113|NCT01271010|541094767|FG000|Overall Study|Start of new CLL therapy|1|||
149990114|NCT01271010|541094767|FG000|Overall Study|Protocol Violation|1|||
149990115|NCT01271010|541094767|FG000|Overall Study|Death|2|||
149990116|NCT01271010|541094767|FG000|Overall Study|Progression and relapse of disease|1|||
149990117|NCT01271010|541094767|FG000|Overall Study|Withdrawal by Subject|18|||
149990118|NCT01271010|541094767|FG000|Overall Study|Disease progression|27|||
149990119|NCT01631747|541094768|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
149990120|NCT01631747|541094769|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
149990121|NCT01631747|541094768|FG000|Live Birth|Pregnancy Termination|1|||
149990122|NCT01631747|541094769|FG001|Live Birth|Pregnancy Termination|0|||
149990123|NCT01631747|541094768|FG000|Live Birth|MIscarriage|2|||
149990124|NCT01631747|541094769|FG001|Live Birth|MIscarriage|0|||
149990125|NCT01631747|541094768|FG000|Live Birth|Stillbirth|1|||
149990126|NCT01631747|541094769|FG001|Live Birth|Stillbirth|1|||
149990127|NCT01631747|541094768|FG000|One Year Infant Outcomes|Patient Refused|13|||
149990128|NCT01631747|541094769|FG001|One Year Infant Outcomes|Patient Refused|9|||
149990129|NCT02109432|541094770|FG000|Overall Study|Withdrawal by Subject|1|||
149990130|NCT03372551|541094771|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
149990131|NCT03372551|541094772|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
149990132|NCT05897242|541094773|FG000|Overall Study|Lost to Follow-up|6|||
149990133|NCT05897242|541094774|FG001|Overall Study|Lost to Follow-up|1|||
149990134|NCT05897242|541094773|FG000|Overall Study|Incomplete|1|||
149990135|NCT05897242|541094774|FG001|Overall Study|Incomplete|0|||
149990136|NCT05897242|541094773|FG000|Overall Study|Withdrawal by Subject|1|||
149990137|NCT05897242|541094774|FG001|Overall Study|Withdrawal by Subject|0|||
149990138|NCT00809835|541094775|FG000|Overall Study|Lost to Follow-up|7|||
149990139|NCT00809835|541094776|FG001|Overall Study|Lost to Follow-up|6|||
149990140|NCT00809835|541094777|FG002|Overall Study|Lost to Follow-up|10|||
149990141|NCT00809835|541094778|FG003|Overall Study|Lost to Follow-up|2|||
149990142|NCT00809835|541094775|FG000|Overall Study|Withdrawal by Subject|1|||
149990143|NCT00809835|541094776|FG001|Overall Study|Withdrawal by Subject|1|||
149990144|NCT00809835|541094777|FG002|Overall Study|Withdrawal by Subject|1|||
149990145|NCT00809835|541094778|FG003|Overall Study|Withdrawal by Subject|0|||
149990146|NCT03727646|541094779|FG000|Overall Study|Adverse Event|1|||
150178912|NCT03112174|541793874|FG000|Overall Study|Lost to Follow-up|1|||
149990147|NCT03727646|541094780|FG001|Overall Study|Adverse Event|0|||
149990148|NCT04753658|541094783|FG000|Overall Study|Progressive disease|7|||
149990149|NCT04753658|541094783|FG000|Overall Study|Other|7|||
150178913|NCT03112174|541793875|FG001|Overall Study|Lost to Follow-up|1|||
149990150|NCT04753658|541094783|FG000|Overall Study|Adverse Event|1|||
149990151|NCT05924165|541094790|FG000|Overall Study|Physician Decision|2|||
149990152|NCT05924165|541094791|FG001|Overall Study|Physician Decision|3|||
149990153|NCT02388165|541094792|FG000|Overall Study|Study terminated by sponsor|5|||
149990154|NCT02388165|541094793|FG001|Overall Study|Study terminated by sponsor|5|||
149990155|NCT02388165|541094792|FG000|Overall Study|Other|11|||
149990156|NCT02388165|541094793|FG001|Overall Study|Other|13|||
149990157|NCT02388165|541094792|FG000|Overall Study|No longer meet eligibility criteria|40|||
149990158|NCT02388165|541094793|FG001|Overall Study|No longer meet eligibility criteria|43|||
149990159|NCT02388165|541094792|FG000|Overall Study|Withdrawal of consent|31|||
150178914|NCT03112174|541793876|FG002|Overall Study|Lost to Follow-up|2|||
149990160|NCT02388165|541094793|FG001|Overall Study|Withdrawal of consent|32|||
149990161|NCT02388165|541094792|FG000|Overall Study|Lost to Follow-up|19|||
149990162|NCT02388165|541094793|FG001|Overall Study|Lost to Follow-up|20|||
149990163|NCT02388165|541094792|FG000|Overall Study|Death|13|||
149990164|NCT02388165|541094793|FG001|Overall Study|Death|10|||
149990165|NCT02388165|541094792|FG000|Overall Study|Adverse Event|3|||
149990166|NCT02388165|541094793|FG001|Overall Study|Adverse Event|5|||
149990167|NCT02388165|541094792|FG000|Overall Study|Did not meet entrance criteria|5|||
149990168|NCT02388165|541094793|FG001|Overall Study|Did not meet entrance criteria|2|||
149990169|NCT01576146|541094798|FG000|Extension Period 1|Adverse Event|2|||
149990170|NCT01576146|541094798|FG000|Extension Period 1|Death|2|||
149990171|NCT01576146|541094798|FG000|Extension Period 1|Physician Decision|2|||
149990172|NCT01576146|541094798|FG000|Extension Period 1|Withdrawal by Subject|1|||
149990173|NCT01576146|541094798|FG000|Extension Period 1|Lost to Follow-up|1|||
149990174|NCT01576146|541094798|FG000|Extension Period 1|Parathyroidectomy|1|||
149990175|NCT01576146|541094798|FG000|Extension Period 1|Renal Transplant|1|||
149990176|NCT01576146|541094798|FG000|Extension Period 2|Sponsor Decision|13|||
149990177|NCT01576146|541094798|FG000|Extension Period 2|Death|1|||
149990178|NCT01576146|541094798|FG000|Extension Period 2|Adverse Event|1|||
149990179|NCT01576146|541094798|FG000|Extension Period 2|Renal Transplant|1|||
149990180|NCT01576146|541094798|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
149990181|NCT01545934|541094801|FG000|Overall Study|Withdrawal by Subject|4|||
149990182|NCT01545934|541094802|FG001|Overall Study|Withdrawal by Subject|3|||
149990183|NCT01545934|541094801|FG000|Overall Study|Lost to Follow-up|1|||
149990184|NCT01545934|541094802|FG001|Overall Study|Lost to Follow-up|0|||
149990185|NCT03654404|541094803|FG000|Overall Study|Death|1|||
149990186|NCT03654404|541094803|FG000|Overall Study|Lost to Follow-up|2|||
149990187|NCT03654404|541094803|FG000|Overall Study|Withdrawal by Subject|5|||
149990188|NCT03299881|541094806|FG000|Overall Study|Study Termination|17|||
149990189|NCT03299881|541094807|FG001|Overall Study|Study Termination|13|||
149990190|NCT01474772|541094808|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
149990191|NCT01474772|541094809|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
149990192|NCT01474772|541094808|FG000|Period 1|AE not Related to Study Drug|1|||
149990193|NCT01474772|541094809|FG001|Period 1|AE not Related to Study Drug|0|||
149990194|NCT01474772|541094808|FG000|Period 1|Withdrawal by Subject|3|||
149990195|NCT01474772|541094809|FG001|Period 1|Withdrawal by Subject|1|||
149990196|NCT01474772|541094808|FG000|Period 1|Lost to Follow-up|1|||
149990197|NCT01474772|541094809|FG001|Period 1|Lost to Follow-up|0|||
149990198|NCT01474772|541094808|FG000|Period 1|Reason not Specified|1|||
149990199|NCT01474772|541094809|FG001|Period 1|Reason not Specified|1|||
149990200|NCT01474772|541094808|FG000|Washout|AE not Related to Study Drug|2|||
149990201|NCT01474772|541094809|FG001|Washout|AE not Related to Study Drug|0|||
149990202|NCT01474772|541094808|FG000|Washout|Withdrawal by Subject|1|||
149990203|NCT01474772|541094809|FG001|Washout|Withdrawal by Subject|0|||
149990204|NCT01474772|541094808|FG000|Washout|Lost to Follow-up|0|||
149990205|NCT01474772|541094809|FG001|Washout|Lost to Follow-up|1|||
149990206|NCT01474772|541094808|FG000|Washout|Reason not Specified|0|||
149990207|NCT01474772|541094809|FG001|Washout|Reason not Specified|1|||
149990208|NCT01474772|541094808|FG000|Period 2|Death|0|||
149990209|NCT01474772|541094809|FG001|Period 2|Death|1|||
149990210|NCT01474772|541094808|FG000|Period 2|AE Related to Study Drug|0|||
149990211|NCT01474772|541094809|FG001|Period 2|AE Related to Study Drug|1|||
149990212|NCT01474772|541094808|FG000|Period 2|AE not Related to Study Drug|4|||
149990213|NCT01474772|541094809|FG001|Period 2|AE not Related to Study Drug|1|||
149990214|NCT01474772|541094808|FG000|Period 2|Lack of Efficacy|1|||
149990215|NCT01474772|541094809|FG001|Period 2|Lack of Efficacy|0|||
149990216|NCT01474772|541094808|FG000|Period 2|Withdrawal by Subject|3|||
149990217|NCT01474772|541094809|FG001|Period 2|Withdrawal by Subject|4|||
150178915|NCT03112174|541793877|FG003|Overall Study|Lost to Follow-up|3|||
150178916|NCT03112174|541793878|FG004|Overall Study|Lost to Follow-up|2|||
150178917|NCT03112174|541793874|FG000|Overall Study|Death|8|||
150178918|NCT03112174|541793875|FG001|Overall Study|Death|3|||
149990218|NCT01474772|541094808|FG000|Period 2|Lost to Follow-up|1|||
149990219|NCT01474772|541094809|FG001|Period 2|Lost to Follow-up|1|||
149990220|NCT01474772|541094808|FG000|Period 2|Reason not Specified|0|||
149990221|NCT01474772|541094809|FG001|Period 2|Reason not Specified|2|||
149990222|NCT01474772|541094808|FG000|Follow-up|AE not Related to Study Drug|0|||
149990223|NCT01474772|541094809|FG001|Follow-up|AE not Related to Study Drug|1|||
149990224|NCT03195660|541094810|FG000|Overall Study|The study was terminated|2|||
150178919|NCT03112174|541793876|FG002|Overall Study|Death|67|||
149990225|NCT00878254|541094811|FG000|Overall Study|Physician Decision|1|||
149990226|NCT00878254|541094811|FG000|Overall Study|Death|1|||
150178920|NCT03112174|541793877|FG003|Overall Study|Death|73|||
149990227|NCT00878254|541094811|FG000|Overall Study|Withdrawal by Subject|1|||
149990228|NCT03367403|541094815|FG000|Overall Study|Adverse Event|20|||
149990229|NCT03367403|541094816|FG001|Overall Study|Adverse Event|6|||
149990230|NCT03367403|541094817|FG002|Overall Study|Adverse Event|2|||
149990231|NCT03367403|541094815|FG000|Overall Study|Withdrawal by Subject|12|||
149990232|NCT03367403|541094816|FG001|Overall Study|Withdrawal by Subject|13|||
150178921|NCT03112174|541793878|FG004|Overall Study|Death|18|||
149990233|NCT03367403|541094817|FG002|Overall Study|Withdrawal by Subject|1|||
149990234|NCT03367403|541094815|FG000|Overall Study|Death|1|||
149990235|NCT03367403|541094816|FG001|Overall Study|Death|2|||
149990236|NCT03367403|541094817|FG002|Overall Study|Death|0|||
149990237|NCT03367403|541094815|FG000|Overall Study|Physician Decision|0|||
149990238|NCT03367403|541094816|FG001|Overall Study|Physician Decision|1|||
149990239|NCT03367403|541094817|FG002|Overall Study|Physician Decision|0|||
149990240|NCT03367403|541094815|FG000|Overall Study|Protocol Violation|1|||
149990241|NCT03367403|541094816|FG001|Overall Study|Protocol Violation|1|||
149990242|NCT03367403|541094817|FG002|Overall Study|Protocol Violation|0|||
149990243|NCT03367403|541094815|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149990244|NCT03367403|541094816|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
149990245|NCT03367403|541094817|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149990246|NCT03367403|541094815|FG000|Overall Study|COVID-19|3|||
149990247|NCT03367403|541094816|FG001|Overall Study|COVID-19|6|||
149990248|NCT03367403|541094817|FG002|Overall Study|COVID-19|0|||
149990249|NCT03367403|541094815|FG000|Overall Study|Abuse of Alcohol Intake|0|||
149990250|NCT03367403|541094816|FG001|Overall Study|Abuse of Alcohol Intake|1|||
149990251|NCT03367403|541094817|FG002|Overall Study|Abuse of Alcohol Intake|0|||
149990252|NCT03367403|541094815|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
149990253|NCT03367403|541094816|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
149990254|NCT03367403|541094817|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
149990255|NCT00194077|541094818|FG000|Overall Study|Lack of Efficacy|22|||
149990256|NCT00194077|541094819|FG001|Overall Study|Lack of Efficacy|29|||
149990257|NCT00194077|541094818|FG000|Overall Study|Study nonadherence|1|||
149990258|NCT00194077|541094819|FG001|Overall Study|Study nonadherence|0|||
149990259|NCT00194077|541094818|FG000|Overall Study|Withdrawal by Subject|1|||
149990260|NCT00194077|541094819|FG001|Overall Study|Withdrawal by Subject|1|||
149990261|NCT03470194|541094822|FG000|Overall Study|Lost to Follow-up|11|||
149990262|NCT03470194|541094823|FG001|Overall Study|Lost to Follow-up|17|||
149990263|NCT01822899|541094824|FG000|Overall Study|Adverse Event|6|||
149990264|NCT01822899|541094825|FG001|Overall Study|Adverse Event|5|||
149990265|NCT01822899|541094824|FG000|Overall Study|Lack of Efficacy|6|||
149990266|NCT01822899|541094825|FG001|Overall Study|Lack of Efficacy|3|||
149990267|NCT01822899|541094824|FG000|Overall Study|Protocol Violation|6|||
149990268|NCT01822899|541094825|FG001|Overall Study|Protocol Violation|3|||
149990269|NCT01822899|541094824|FG000|Overall Study|Lost to Follow-up|1|||
149990270|NCT01822899|541094825|FG001|Overall Study|Lost to Follow-up|0|||
149990271|NCT01822899|541094824|FG000|Overall Study|Withdrawal by Subject|5|||
149990272|NCT01822899|541094825|FG001|Overall Study|Withdrawal by Subject|7|||
149990273|NCT01268046|541094826|FG000|Overall Study|Withdrawal by Subject|1|||
149990274|NCT01268046|541094827|FG001|Overall Study|Withdrawal by Subject|0|||
149990275|NCT01268046|541094828|FG002|Overall Study|Withdrawal by Subject|0|||
149990276|NCT01268046|541094829|FG003|Overall Study|Withdrawal by Subject|1|||
149990277|NCT01268046|541094826|FG000|Overall Study|Lost to Follow-up|0|||
149990278|NCT01268046|541094827|FG001|Overall Study|Lost to Follow-up|0|||
149990279|NCT01268046|541094828|FG002|Overall Study|Lost to Follow-up|1|||
149990280|NCT01268046|541094829|FG003|Overall Study|Lost to Follow-up|0|||
149990281|NCT00759876|541094830|FG000|Overall Study|Sponsor terminated study early|36|||
149990282|NCT02314156|541094831|FG000|Overall Study|Adverse Event|1|||
149990283|NCT02314156|541094832|FG001|Overall Study|Adverse Event|0|||
149990284|NCT02314156|541094831|FG000|Overall Study|Withdrawal by Subject|1|||
149990285|NCT02314156|541094832|FG001|Overall Study|Withdrawal by Subject|0|||
149990286|NCT02846389|541094833|FG000|Overall Study|Withdrawal by Subject|1|||
149990287|NCT02846389|541094834|FG001|Overall Study|Withdrawal by Subject|1|||
149990288|NCT01450696|541094835|FG000|Overall Study|Never Treated|1|||
149990289|NCT01450696|541094836|FG001|Overall Study|Never Treated|1|||
149990290|NCT01450696|541094835|FG000|Overall Study|Death|77|||
149990291|NCT01450696|541094836|FG001|Overall Study|Death|84|||
149990292|NCT01450696|541094835|FG000|Overall Study|Lost to Follow-up|3|||
149990293|NCT01450696|541094836|FG001|Overall Study|Lost to Follow-up|3|||
149990294|NCT01450696|541094835|FG000|Overall Study|Non-Compliance|1|||
149990295|NCT01450696|541094836|FG001|Overall Study|Non-Compliance|0|||
149990296|NCT01450696|541094835|FG000|Overall Study|Withdrawal by Subject|13|||
149990297|NCT01450696|541094836|FG001|Overall Study|Withdrawal by Subject|2|||
149990298|NCT01450696|541094835|FG000|Overall Study|Study Terminated by Sponsor|53|||
149990299|NCT01450696|541094836|FG001|Overall Study|Study Terminated by Sponsor|58|||
150178922|NCT03112174|541793874|FG000|Overall Study|Other, Not Specified|1|||
149990300|NCT02321319|541094838|FG000|Overall Study|Product discontinued|5|||
149990301|NCT02249091|541094841|FG000|Overall Study|Lack of Efficacy|8|||
149990302|NCT02249091|541094842|FG001|Overall Study|Lack of Efficacy|3|||
149990303|NCT02249091|541094841|FG000|Overall Study|Physician Decision|4|||
149990304|NCT02249091|541094842|FG001|Overall Study|Physician Decision|1|||
149990305|NCT02249091|541094841|FG000|Overall Study|Withdrawal by Subject|2|||
149990306|NCT02249091|541094842|FG001|Overall Study|Withdrawal by Subject|2|||
149990307|NCT02249091|541094841|FG000|Overall Study|Death|3|||
149990308|NCT02249091|541094842|FG001|Overall Study|Death|4|||
149990309|NCT02249091|541094841|FG000|Overall Study|Adverse Event|1|||
149990310|NCT02249091|541094842|FG001|Overall Study|Adverse Event|0|||
149990311|NCT02249091|541094841|FG000|Overall Study|Stable disease with following SCT|0|||
149990312|NCT02249091|541094842|FG001|Overall Study|Stable disease with following SCT|1|||
149990313|NCT02249091|541094841|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
149990314|NCT02249091|541094842|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
149990315|NCT02249091|541094841|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
149990316|NCT02249091|541094842|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
149990317|NCT02249091|541094841|FG000|Overall Study|Refractory AML|1|||
149990318|NCT02249091|541094842|FG001|Overall Study|Refractory AML|1|||
149990319|NCT05059301|541094843|FG000|Overall Study|Adverse Event|0|||
149990320|NCT05059301|541094844|FG001|Overall Study|Adverse Event|2|||
149990321|NCT05059301|541094845|FG002|Overall Study|Adverse Event|2|||
149990322|NCT05059301|541094843|FG000|Overall Study|Lost to Follow-up|2|||
149990323|NCT05059301|541094844|FG001|Overall Study|Lost to Follow-up|3|||
149990324|NCT05059301|541094845|FG002|Overall Study|Lost to Follow-up|3|||
149990325|NCT00853242|541094846|FG000|Overall Study|Adverse Event|0|||
149990326|NCT00853242|541094847|FG001|Overall Study|Adverse Event|1|||
149990327|NCT00853242|541094848|FG002|Overall Study|Adverse Event|1|||
149990328|NCT00853242|541094849|FG003|Overall Study|Adverse Event|0|||
149990329|NCT00853242|541094850|FG004|Overall Study|Adverse Event|3|||
149990330|NCT00853242|541094851|FG005|Overall Study|Adverse Event|1|||
149990331|NCT00853242|541094852|FG006|Overall Study|Adverse Event|1|||
149990332|NCT00853242|541094846|FG000|Overall Study|Noncompliant|0|||
149990333|NCT00853242|541094847|FG001|Overall Study|Noncompliant|0|||
149990334|NCT00853242|541094848|FG002|Overall Study|Noncompliant|0|||
149990335|NCT00853242|541094849|FG003|Overall Study|Noncompliant|0|||
149990336|NCT00853242|541094850|FG004|Overall Study|Noncompliant|1|||
149990337|NCT00853242|541094851|FG005|Overall Study|Noncompliant|0|||
149990338|NCT00853242|541094852|FG006|Overall Study|Noncompliant|0|||
149990339|NCT00853242|541094846|FG000|Overall Study|Withdrawal by Subject|1|||
149990340|NCT00853242|541094847|FG001|Overall Study|Withdrawal by Subject|2|||
149990341|NCT00853242|541094848|FG002|Overall Study|Withdrawal by Subject|0|||
149990342|NCT00853242|541094849|FG003|Overall Study|Withdrawal by Subject|4|||
149990343|NCT00853242|541094850|FG004|Overall Study|Withdrawal by Subject|0|||
149990344|NCT00853242|541094851|FG005|Overall Study|Withdrawal by Subject|0|||
149990345|NCT00853242|541094852|FG006|Overall Study|Withdrawal by Subject|2|||
149990346|NCT00853242|541094846|FG000|Overall Study|Other|2|||
149990347|NCT00853242|541094847|FG001|Overall Study|Other|0|||
149990348|NCT00853242|541094848|FG002|Overall Study|Other|2|||
149990349|NCT00853242|541094849|FG003|Overall Study|Other|0|||
149990350|NCT00853242|541094850|FG004|Overall Study|Other|0|||
149990351|NCT00853242|541094851|FG005|Overall Study|Other|1|||
149990352|NCT00853242|541094852|FG006|Overall Study|Other|2|||
149990353|NCT05730335|541094855|FG000|Overall Study|Lost to Follow-up|8|||
149990354|NCT05730335|541094855|FG000|Overall Study|Withdrawal by Subject|6|||
149990355|NCT05319600|541094860|FG000|Overall Study|Withdrawal by Subject|1|||
149990356|NCT05319600|541094861|FG001|Overall Study|Withdrawal by Subject|0|||
149990357|NCT05319600|541094860|FG000|Overall Study|Lost to Follow-up|0|||
149990358|NCT05319600|541094861|FG001|Overall Study|Lost to Follow-up|4|||
149990359|NCT02466425|541094862|FG000|Overall Study|Adverse Event|3|||
149990360|NCT02466425|541094863|FG001|Overall Study|Adverse Event|11|||
149990361|NCT02466425|541094862|FG000|Overall Study|Lack of Efficacy|4|||
149990362|NCT02466425|541094863|FG001|Overall Study|Lack of Efficacy|1|||
149990363|NCT02466425|541094862|FG000|Overall Study|Lost to Follow-up|3|||
149990364|NCT02466425|541094863|FG001|Overall Study|Lost to Follow-up|0|||
149990365|NCT02466425|541094862|FG000|Overall Study|Protocol Violation|1|||
149990366|NCT02466425|541094863|FG001|Overall Study|Protocol Violation|0|||
149990367|NCT02466425|541094862|FG000|Overall Study|Withdrawal by Subject|0|||
149990368|NCT02466425|541094863|FG001|Overall Study|Withdrawal by Subject|1|||
149990369|NCT02466425|541094862|FG000|Overall Study|Other|1|||
149990370|NCT02466425|541094863|FG001|Overall Study|Other|3|||
149990371|NCT02466425|541094862|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149990372|NCT02466425|541094863|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149990373|NCT05141175|541094878|FG000|Overall Study|Withdrawal by Subject|1|||
149990374|NCT01813058|541094885|FG000|Overall Study|Withdrawal by Subject|5|||
149990375|NCT01813058|541094886|FG001|Overall Study|Withdrawal by Subject|4|||
149990376|NCT03585764|541094887|FG000|Overall Study|Death|3|||
149990377|NCT03585764|541094888|FG001|Overall Study|Death|2|||
149990378|NCT03585764|541094889|FG002|Overall Study|Death|3|||
149990379|NCT03585764|541094890|FG003|Overall Study|Death|0|||
149990380|NCT03585764|541094887|FG000|Overall Study|Lost to Follow-up|0|||
149990381|NCT03585764|541094888|FG001|Overall Study|Lost to Follow-up|1|||
149990382|NCT03585764|541094889|FG002|Overall Study|Lost to Follow-up|0|||
149990383|NCT03585764|541094890|FG003|Overall Study|Lost to Follow-up|0|||
149990384|NCT03585764|541094887|FG000|Overall Study|Physician Decision|0|||
149990385|NCT03585764|541094888|FG001|Overall Study|Physician Decision|0|||
149990386|NCT03585764|541094889|FG002|Overall Study|Physician Decision|2|||
149990387|NCT03585764|541094890|FG003|Overall Study|Physician Decision|0|||
149990388|NCT01581021|541094891|FG000|Overall Study|Lost to Follow-up|4|||
149990389|NCT01581021|541094892|FG001|Overall Study|Lost to Follow-up|6|||
149990390|NCT01581021|541094891|FG000|Overall Study|More than 2 hooks in thoracic|3|||
149990391|NCT01581021|541094892|FG001|Overall Study|More than 2 hooks in thoracic|0|||
149990392|NCT01581021|541094891|FG000|Overall Study|Neuromuscular|2|||
149990393|NCT01581021|541094892|FG001|Overall Study|Neuromuscular|1|||
149990394|NCT01581021|541094891|FG000|Overall Study|Not Randomized|1|||
149990395|NCT01581021|541094892|FG001|Overall Study|Not Randomized|2|||
149990396|NCT01581021|541094891|FG000|Overall Study|Lenke 6 Classification|0|||
149990397|NCT01581021|541094892|FG001|Overall Study|Lenke 6 Classification|1|||
149990398|NCT01581021|541094891|FG000|Overall Study|Lack of Efficacy|0|||
149990399|NCT01581021|541094892|FG001|Overall Study|Lack of Efficacy|1|||
149990400|NCT01262560|541094902|FG000|Overall Study|Protocol Violation|0|||
149990401|NCT01262560|541094903|FG001|Overall Study|Protocol Violation|1|||
149990402|NCT01262560|541094904|FG002|Overall Study|Protocol Violation|2|||
149990403|NCT04295759|541094907|FG000|Overall Study|Lack of Efficacy|9|||
149990404|NCT04295759|541094907|FG000|Overall Study|Death|1|||
149990405|NCT04295759|541094907|FG000|Overall Study|Withdrawal by Subject|2|||
149990406|NCT04295759|541094907|FG000|Overall Study|Deemed ineligible|1|||
149990407|NCT00465972|541094910|FG000|Overall Study|Withdrawal by Subject|2|||
149990408|NCT00465972|541094911|FG001|Overall Study|Withdrawal by Subject|1|||
149990409|NCT00349349|541094912|FG000|Overall Study|Adverse Event|5|||
149990410|NCT00349349|541094913|FG001|Overall Study|Adverse Event|6|||
149990411|NCT00349349|541094914|FG002|Overall Study|Adverse Event|2|||
149990412|NCT00349349|541094912|FG000|Overall Study|Withdrawal by Subject|5|||
149990413|NCT00349349|541094913|FG001|Overall Study|Withdrawal by Subject|2|||
149990414|NCT00349349|541094914|FG002|Overall Study|Withdrawal by Subject|1|||
149990415|NCT00349349|541094912|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
149990416|NCT00349349|541094913|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
149990417|NCT00349349|541094914|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
149990418|NCT00349349|541094912|FG000|Overall Study|Death|13|||
149990419|NCT00349349|541094913|FG001|Overall Study|Death|10|||
149990420|NCT00349349|541094914|FG002|Overall Study|Death|1|||
149990421|NCT00349349|541094912|FG000|Overall Study|Other Treatment Selected|2|||
149990422|NCT00349349|541094913|FG001|Overall Study|Other Treatment Selected|0|||
149990423|NCT00349349|541094914|FG002|Overall Study|Other Treatment Selected|0|||
149990424|NCT00349349|541094912|FG000|Overall Study|Participant Reduced General Condition|0|||
149990425|NCT00349349|541094913|FG001|Overall Study|Participant Reduced General Condition|1|||
149990426|NCT00349349|541094914|FG002|Overall Study|Participant Reduced General Condition|0|||
149990427|NCT00349349|541094912|FG000|Overall Study|Physician Decision|1|||
149990428|NCT00349349|541094913|FG001|Overall Study|Physician Decision|2|||
149990429|NCT00349349|541094914|FG002|Overall Study|Physician Decision|1|||
149990430|NCT00349349|541094912|FG000|Overall Study|No Response|0|||
149990431|NCT00349349|541094913|FG001|Overall Study|No Response|3|||
149990432|NCT00349349|541094914|FG002|Overall Study|No Response|0|||
149990433|NCT00349349|541094912|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
149990434|NCT00349349|541094913|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
149990435|NCT00349349|541094914|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
149990436|NCT01108731|541094916|FG000|Overall Study|Withdrawal by Subject|1|||
149990437|NCT01108731|541094917|FG001|Overall Study|Withdrawal by Subject|1|||
149990438|NCT01108731|541094916|FG000|Overall Study|Adverse Event|3|||
149990439|NCT01108731|541094917|FG001|Overall Study|Adverse Event|3|||
149990440|NCT00923975|541096725|FG000|Overall Study|Did not meet inclusion criteria|1|||
149990441|NCT01005316|541096728|FG000|Overall Study|Adverse Event|0|||
149990442|NCT01005316|541096729|FG001|Overall Study|Adverse Event|0|||
149990443|NCT01005316|541096730|FG002|Overall Study|Adverse Event|0|||
149990444|NCT01005316|541096731|FG003|Overall Study|Adverse Event|1|||
149990445|NCT01005316|541096728|FG000|Overall Study|Death|20|||
149990446|NCT01005316|541096729|FG001|Overall Study|Death|5|||
149990447|NCT01005316|541096730|FG002|Overall Study|Death|1|||
149990448|NCT01005316|541096731|FG003|Overall Study|Death|15|||
149990449|NCT01005316|541096728|FG000|Overall Study|Study Termination|5|||
149990450|NCT01005316|541096729|FG001|Overall Study|Study Termination|63|||
149990451|NCT01005316|541096730|FG002|Overall Study|Study Termination|9|||
149990452|NCT01005316|541096731|FG003|Overall Study|Study Termination|85|||
149990453|NCT01005316|541096728|FG000|Overall Study|Lost to Follow-up|1|||
149990454|NCT01005316|541096729|FG001|Overall Study|Lost to Follow-up|3|||
149990455|NCT01005316|541096730|FG002|Overall Study|Lost to Follow-up|0|||
149990456|NCT01005316|541096731|FG003|Overall Study|Lost to Follow-up|2|||
149990457|NCT01005316|541096728|FG000|Overall Study|Physician Decision|6|||
149990458|NCT01005316|541096729|FG001|Overall Study|Physician Decision|0|||
149990459|NCT01005316|541096730|FG002|Overall Study|Physician Decision|0|||
149990460|NCT01005316|541096731|FG003|Overall Study|Physician Decision|0|||
149990461|NCT01005316|541096728|FG000|Overall Study|Sponsor Decision|6|||
149990462|NCT01005316|541096729|FG001|Overall Study|Sponsor Decision|3|||
149990463|NCT01005316|541096730|FG002|Overall Study|Sponsor Decision|0|||
149990464|NCT01005316|541096731|FG003|Overall Study|Sponsor Decision|0|||
149990465|NCT01005316|541096728|FG000|Overall Study|Withdrawal by Subject|1|||
149990466|NCT01005316|541096729|FG001|Overall Study|Withdrawal by Subject|1|||
149990467|NCT01005316|541096730|FG002|Overall Study|Withdrawal by Subject|0|||
149990468|NCT01005316|541096731|FG003|Overall Study|Withdrawal by Subject|2|||
149990469|NCT01005316|541096728|FG000|Overall Study|Consented to Another Study|2|||
149990470|NCT01005316|541096729|FG001|Overall Study|Consented to Another Study|0|||
149990471|NCT01005316|541096730|FG002|Overall Study|Consented to Another Study|0|||
149990472|NCT01005316|541096731|FG003|Overall Study|Consented to Another Study|0|||
149990473|NCT01005316|541096728|FG000|Overall Study|Delisted|8|||
149990474|NCT01005316|541096729|FG001|Overall Study|Delisted|0|||
149990475|NCT01005316|541096730|FG002|Overall Study|Delisted|0|||
149990476|NCT01005316|541096731|FG003|Overall Study|Delisted|0|||
149990477|NCT01005316|541096728|FG000|Overall Study|Transferred Care|1|||
149990478|NCT01005316|541096729|FG001|Overall Study|Transferred Care|0|||
149990479|NCT01005316|541096730|FG002|Overall Study|Transferred Care|1|||
149990480|NCT01005316|541096731|FG003|Overall Study|Transferred Care|3|||
149990481|NCT01005316|541096728|FG000|Overall Study|Retransplanted|0|||
149990482|NCT01005316|541096729|FG001|Overall Study|Retransplanted|1|||
149990483|NCT01005316|541096730|FG002|Overall Study|Retransplanted|0|||
149990484|NCT01005316|541096731|FG003|Overall Study|Retransplanted|0|||
149990485|NCT01734395|541096734|FG000|Overall Study|Other|65|||
149990486|NCT01734395|541096734|FG000|Overall Study|Lost to Follow-up|287|||
149990487|NCT01734395|541096734|FG000|Overall Study|Lack of Efficacy|5|||
149990488|NCT01734395|541096734|FG000|Overall Study|Adverse Event|40|||
149990489|NCT01734395|541096734|FG000|Overall Study|Withdrawal by Subject|10|||
149990490|NCT01734395|541096734|FG000|Overall Study|Missing the reasons for not completed|3|||
149990491|NCT01205061|541096735|FG000|Overall Study|Adverse Event|4|||
149990492|NCT01205061|541096735|FG000|Overall Study|Withdrawal by Subject|11|||
149990493|NCT01205061|541096735|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
149990494|NCT01205061|541096735|FG000|Overall Study|Lost to Follow-up|9|||
149990495|NCT01205061|541096735|FG000|Overall Study|Other|1|||
149990496|NCT00765037|541096736|FG000|Overall Study|Lost to Follow-up|5|||
149990497|NCT00765037|541096736|FG000|Overall Study|Adverse Event|1|||
149990498|NCT04026009|541096737|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149990499|NCT04026009|541096738|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149990500|NCT04026009|541096739|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
149990501|NCT04026009|541096740|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
149990502|NCT04026009|541096741|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
149990503|NCT04026009|541096737|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
149990504|NCT04026009|541096738|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
149990505|NCT04026009|541096739|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
149990506|NCT04026009|541096740|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
150178923|NCT03112174|541793875|FG001|Overall Study|Other, Not Specified|0|||
149990507|NCT04026009|541096741|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
149990508|NCT03748706|541096742|FG000|Overall Study|Lost to Follow-up|1|||
149990509|NCT02300558|541096748|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
149990510|NCT02300558|541096748|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
149990511|NCT02300558|541096748|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
149990512|NCT02300558|541096748|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
149990513|NCT01471028|541096749|FG000|VTI-208|Adverse Event|39|||
149990514|NCT01471028|541096750|FG001|VTI-208|Adverse Event|41|||
149990515|NCT01471028|541096749|FG000|VTI-208|Withdrawal by Subject|0|||
149990516|NCT01471028|541096750|FG001|VTI-208|Withdrawal by Subject|2|||
149990517|NCT01471028|541096749|FG000|VTI-208|Lost to Follow-up|1|||
149990518|NCT01471028|541096750|FG001|VTI-208|Lost to Follow-up|1|||
149990519|NCT01471028|541096749|FG000|VTI-208E|Death|7|||
149990520|NCT01471028|541096750|FG001|VTI-208E|Death|10|||
149990521|NCT01471028|541096749|FG000|VTI-208E|Withdrawal by Subject|1|||
149990522|NCT01471028|541096750|FG001|VTI-208E|Withdrawal by Subject|0|||
149990523|NCT01471028|541096749|FG000|VTI-208E|Lost to Follow-up|0|||
149990524|NCT01471028|541096750|FG001|VTI-208E|Lost to Follow-up|2|||
149990525|NCT00695955|541096751|FG000|Cohort 1|Adverse Event|26|||
149990526|NCT00695955|541096751|FG000|Cohort 1|Protocol Violation|2|||
149990527|NCT00695955|541096751|FG000|Cohort 1|Lost to Follow-up|30|||
149990528|NCT00695955|541096751|FG000|Cohort 1|Withdrawal by Subject|25|||
149990529|NCT00695955|541096751|FG000|Cohort 1|Lack of Efficacy|3|||
149990530|NCT00695955|541096751|FG000|Cohort 1|Other|16|||
149990531|NCT00695955|541096751|FG000|Cohort 2|Adverse Event|24|||
149990532|NCT00695955|541096751|FG000|Cohort 2|Protocol Violation|5|||
149990533|NCT00695955|541096751|FG000|Cohort 2|Lost to Follow-up|38|||
149990534|NCT00695955|541096751|FG000|Cohort 2|Withdrawal by Subject|28|||
149990535|NCT00695955|541096751|FG000|Cohort 2|Lack of Efficacy|4|||
149990536|NCT00695955|541096751|FG000|Cohort 2|Other|5|||
149990537|NCT02957747|541096754|FG000|Overall Study|Withdrawal by Subject|0|||
149990538|NCT02957747|541096755|FG001|Overall Study|Withdrawal by Subject|3|||
149990539|NCT02957747|541096754|FG000|Overall Study|Lost to Follow-up|10|||
149990540|NCT02957747|541096755|FG001|Overall Study|Lost to Follow-up|5|||
149990541|NCT01177553|541096756|FG000|Overall Study|babies not yet 6 months of age|1|||
149990542|NCT01177553|541096757|FG001|Overall Study|babies not yet 6 months of age|0|||
149990543|NCT00610857|541096759|FG000|Overall Study|Not evaluable for response|2|||
149990544|NCT04826094|541096760|FG000|Overall Study|Lost to Follow-up|2|||
149990545|NCT04826094|541096761|FG001|Overall Study|Lost to Follow-up|1|||
149990546|NCT04826094|541096762|FG002|Overall Study|Lost to Follow-up|0|||
149990547|NCT04826094|541096763|FG003|Overall Study|Lost to Follow-up|0|||
149990548|NCT04826094|541096764|FG004|Overall Study|Lost to Follow-up|1|||
149990549|NCT04826094|541096765|FG005|Overall Study|Lost to Follow-up|3|||
149990550|NCT04826094|541096766|FG006|Overall Study|Lost to Follow-up|1|||
149990551|NCT04826094|541096767|FG007|Overall Study|Lost to Follow-up|1|||
149990552|NCT04826094|541096760|FG000|Overall Study|Participant withdrew consent|1|||
149990553|NCT04826094|541096761|FG001|Overall Study|Participant withdrew consent|0|||
149990554|NCT04826094|541096762|FG002|Overall Study|Participant withdrew consent|0|||
149990555|NCT04826094|541096763|FG003|Overall Study|Participant withdrew consent|1|||
149990556|NCT04826094|541096764|FG004|Overall Study|Participant withdrew consent|1|||
149990557|NCT04826094|541096765|FG005|Overall Study|Participant withdrew consent|1|||
149990558|NCT04826094|541096766|FG006|Overall Study|Participant withdrew consent|0|||
149990559|NCT04826094|541096767|FG007|Overall Study|Participant withdrew consent|1|||
149990560|NCT04826094|541096760|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
149990561|NCT04826094|541096761|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
149990562|NCT04826094|541096762|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
149990563|NCT04826094|541096763|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
149990564|NCT04826094|541096764|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
149990565|NCT04826094|541096765|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
149990566|NCT04826094|541096766|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
150053636|NCT01457352|541336687|FG001|Period 2|Did not meet eligibility criteria|0|||
150053637|NCT01457352|541336686|FG000|Period 3|Adverse Event|1|||
150053638|NCT01457352|541336687|FG001|Period 3|Adverse Event|1|||
150053639|NCT01457352|541336686|FG000|Period 3|Withdrawal by Subject|0|||
150053640|NCT01457352|541336687|FG001|Period 3|Withdrawal by Subject|2|||
150053641|NCT01457352|541336686|FG000|Period 3|incorrect treatment|0|||
149990567|NCT04826094|541096767|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
149990568|NCT04826094|541096760|FG000|Overall Study|Withdrawn by Investigator|0|||
149990569|NCT04826094|541096761|FG001|Overall Study|Withdrawn by Investigator|0|||
149990570|NCT04826094|541096762|FG002|Overall Study|Withdrawn by Investigator|0|||
149990571|NCT04826094|541096763|FG003|Overall Study|Withdrawn by Investigator|0|||
149990572|NCT04826094|541096764|FG004|Overall Study|Withdrawn by Investigator|0|||
149990573|NCT04826094|541096765|FG005|Overall Study|Withdrawn by Investigator|1|||
149990574|NCT04826094|541096766|FG006|Overall Study|Withdrawn by Investigator|0|||
149990575|NCT04826094|541096767|FG007|Overall Study|Withdrawn by Investigator|1|||
149990576|NCT04826094|541096760|FG000|Overall Study|Other: Moved from area|1|||
149990577|NCT04826094|541096761|FG001|Overall Study|Other: Moved from area|1|||
149990578|NCT04826094|541096762|FG002|Overall Study|Other: Moved from area|1|||
149990579|NCT04826094|541096763|FG003|Overall Study|Other: Moved from area|0|||
149990580|NCT04826094|541096764|FG004|Overall Study|Other: Moved from area|0|||
149990581|NCT04826094|541096765|FG005|Overall Study|Other: Moved from area|0|||
149990582|NCT04826094|541096766|FG006|Overall Study|Other: Moved from area|0|||
149990583|NCT04826094|541096767|FG007|Overall Study|Other: Moved from area|0|||
149990584|NCT04826094|541096760|FG000|Overall Study|Other: Declined|0|||
149990585|NCT04826094|541096761|FG001|Overall Study|Other: Declined|0|||
149990586|NCT04826094|541096762|FG002|Overall Study|Other: Declined|0|||
149990587|NCT04826094|541096763|FG003|Overall Study|Other: Declined|0|||
149990588|NCT04826094|541096764|FG004|Overall Study|Other: Declined|1|||
149990589|NCT04826094|541096765|FG005|Overall Study|Other: Declined|0|||
149990590|NCT04826094|541096766|FG006|Overall Study|Other: Declined|0|||
149990591|NCT04826094|541096767|FG007|Overall Study|Other: Declined|0|||
149990592|NCT04826094|541096760|FG000|Overall Study|Other: Vaccine not administered|0|||
149990593|NCT04826094|541096761|FG001|Overall Study|Other: Vaccine not administered|0|||
149990594|NCT04826094|541096762|FG002|Overall Study|Other: Vaccine not administered|1|||
149990595|NCT04826094|541096763|FG003|Overall Study|Other: Vaccine not administered|0|||
149990596|NCT04826094|541096764|FG004|Overall Study|Other: Vaccine not administered|0|||
149990597|NCT04826094|541096765|FG005|Overall Study|Other: Vaccine not administered|1|||
149990598|NCT04826094|541096766|FG006|Overall Study|Other: Vaccine not administered|1|||
149990599|NCT04826094|541096767|FG007|Overall Study|Other: Vaccine not administered|3|||
149990600|NCT02151903|541096768|FG000|Overall Study|Withdrawal by Subject|1|||
149990601|NCT02151903|541096769|FG001|Overall Study|Withdrawal by Subject|0|||
149990602|NCT02151903|541096768|FG000|Overall Study|Progressive disease|2|||
149990603|NCT02151903|541096769|FG001|Overall Study|Progressive disease|1|||
149990604|NCT06003777|541096772|FG000|Period 1|Adverse Event|0|||
149990605|NCT06003777|541096773|FG001|Period 1|Adverse Event|0|||
149990606|NCT06003777|541096774|FG002|Period 1|Adverse Event|1|||
149990607|NCT06003777|541096775|FG003|Period 1|Adverse Event|0|||
149990608|NCT06003777|541096776|FG004|Period 1|Adverse Event|0|||
149990609|NCT06003777|541096777|FG005|Period 1|Adverse Event|0|||
149990610|NCT06003777|541096778|FG006|Period 1|Adverse Event|0|||
149990611|NCT06003777|541096779|FG007|Period 1|Adverse Event|0|||
149990612|NCT06003777|541096780|FG008|Period 1|Adverse Event|0|||
149990613|NCT06003777|541096781|FG009|Period 1|Adverse Event|0|||
149990614|NCT06003777|541096782|FG010|Period 1|Adverse Event|0|||
149990615|NCT06003777|541096783|FG011|Period 1|Adverse Event|0|||
149990616|NCT06003777|541096772|FG000|Period 1|Withdrawal by Subject|0|||
149990617|NCT06003777|541096773|FG001|Period 1|Withdrawal by Subject|0|||
149990618|NCT06003777|541096774|FG002|Period 1|Withdrawal by Subject|0|||
149990619|NCT06003777|541096775|FG003|Period 1|Withdrawal by Subject|0|||
149990620|NCT06003777|541096776|FG004|Period 1|Withdrawal by Subject|1|||
149990621|NCT06003777|541096777|FG005|Period 1|Withdrawal by Subject|0|||
149990622|NCT06003777|541096778|FG006|Period 1|Withdrawal by Subject|0|||
149990623|NCT06003777|541096779|FG007|Period 1|Withdrawal by Subject|0|||
149990624|NCT06003777|541096780|FG008|Period 1|Withdrawal by Subject|0|||
149990625|NCT06003777|541096781|FG009|Period 1|Withdrawal by Subject|0|||
149990626|NCT06003777|541096782|FG010|Period 1|Withdrawal by Subject|0|||
149990627|NCT06003777|541096783|FG011|Period 1|Withdrawal by Subject|0|||
149990628|NCT06003777|541096772|FG000|Period 2|Withdrawal by Subject|0|||
149990629|NCT06003777|541096773|FG001|Period 2|Withdrawal by Subject|0|||
149990630|NCT06003777|541096774|FG002|Period 2|Withdrawal by Subject|0|||
149990631|NCT06003777|541096775|FG003|Period 2|Withdrawal by Subject|0|||
149990632|NCT06003777|541096776|FG004|Period 2|Withdrawal by Subject|0|||
149990633|NCT06003777|541096777|FG005|Period 2|Withdrawal by Subject|0|||
149990634|NCT06003777|541096778|FG006|Period 2|Withdrawal by Subject|0|||
149990635|NCT06003777|541096779|FG007|Period 2|Withdrawal by Subject|0|||
149990636|NCT06003777|541096780|FG008|Period 2|Withdrawal by Subject|1|||
149990637|NCT06003777|541096781|FG009|Period 2|Withdrawal by Subject|0|||
149990638|NCT06003777|541096782|FG010|Period 2|Withdrawal by Subject|0|||
149990639|NCT06003777|541096783|FG011|Period 2|Withdrawal by Subject|0|||
149990640|NCT06003777|541096772|FG000|Period 3|Adverse Event|0|||
149990641|NCT06003777|541096773|FG001|Period 3|Adverse Event|0|||
149990642|NCT06003777|541096774|FG002|Period 3|Adverse Event|0|||
149990643|NCT06003777|541096775|FG003|Period 3|Adverse Event|0|||
149990644|NCT06003777|541096776|FG004|Period 3|Adverse Event|0|||
149990645|NCT06003777|541096777|FG005|Period 3|Adverse Event|0|||
149990646|NCT06003777|541096778|FG006|Period 3|Adverse Event|1|||
149990647|NCT06003777|541096779|FG007|Period 3|Adverse Event|0|||
149990648|NCT06003777|541096780|FG008|Period 3|Adverse Event|0|||
149990649|NCT06003777|541096781|FG009|Period 3|Adverse Event|0|||
149990650|NCT06003777|541096782|FG010|Period 3|Adverse Event|0|||
149990651|NCT06003777|541096783|FG011|Period 3|Adverse Event|0|||
149990652|NCT06003777|541096772|FG000|Period 4|No longer met eligibility criteria|0|||
149990653|NCT06003777|541096773|FG001|Period 4|No longer met eligibility criteria|0|||
149990654|NCT06003777|541096774|FG002|Period 4|No longer met eligibility criteria|1|||
149990655|NCT06003777|541096775|FG003|Period 4|No longer met eligibility criteria|0|||
149990656|NCT06003777|541096776|FG004|Period 4|No longer met eligibility criteria|0|||
149990657|NCT06003777|541096777|FG005|Period 4|No longer met eligibility criteria|0|||
149990658|NCT06003777|541096778|FG006|Period 4|No longer met eligibility criteria|0|||
149990659|NCT06003777|541096779|FG007|Period 4|No longer met eligibility criteria|0|||
149990660|NCT06003777|541096780|FG008|Period 4|No longer met eligibility criteria|0|||
149990661|NCT06003777|541096781|FG009|Period 4|No longer met eligibility criteria|0|||
149990662|NCT06003777|541096782|FG010|Period 4|No longer met eligibility criteria|0|||
149990663|NCT06003777|541096783|FG011|Period 4|No longer met eligibility criteria|0|||
149990664|NCT06003777|541096772|FG000|Period 4|Withdrawal by Subject|0|||
149990665|NCT06003777|541096773|FG001|Period 4|Withdrawal by Subject|1|||
149990666|NCT06003777|541096774|FG002|Period 4|Withdrawal by Subject|0|||
149990667|NCT06003777|541096775|FG003|Period 4|Withdrawal by Subject|0|||
149990668|NCT06003777|541096776|FG004|Period 4|Withdrawal by Subject|0|||
149990669|NCT06003777|541096777|FG005|Period 4|Withdrawal by Subject|0|||
149990670|NCT06003777|541096778|FG006|Period 4|Withdrawal by Subject|0|||
149990671|NCT06003777|541096779|FG007|Period 4|Withdrawal by Subject|0|||
149990672|NCT06003777|541096780|FG008|Period 4|Withdrawal by Subject|0|||
149990673|NCT06003777|541096781|FG009|Period 4|Withdrawal by Subject|0|||
149990674|NCT06003777|541096782|FG010|Period 4|Withdrawal by Subject|0|||
149990675|NCT06003777|541096783|FG011|Period 4|Withdrawal by Subject|0|||
149990676|NCT01721486|541096788|FG000|Overall Study|Protocol Violation|1|||
149990677|NCT01721486|541096789|FG001|Overall Study|Protocol Violation|0|||
149990678|NCT01721486|541096788|FG000|Overall Study|Physician Decision|0|||
149990679|NCT01721486|541096789|FG001|Overall Study|Physician Decision|1|||
149990680|NCT00582712|541096790|FG000|Overall Study|Adverse Event|1|||
149990681|NCT00582712|541096790|FG000|Overall Study|Lack of Efficacy|1|||
149990682|NCT00582712|541096790|FG000|Overall Study|Withdrawal by Subject|1|||
149990683|NCT00582712|541096790|FG000|Overall Study|Complicating disease requiring treatment|1|||
149990684|NCT04731298|541096793|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
149990685|NCT04731298|541096794|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
149990686|NCT03403361|541096795|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
149990687|NCT03213938|541096796|FG000|Overall Study|Lost to Follow-up|4|||
149990688|NCT03213938|541096797|FG001|Overall Study|Lost to Follow-up|3|||
149990689|NCT03213938|541096796|FG000|Overall Study|Lack of Efficacy|1|||
149990690|NCT03213938|541096797|FG001|Overall Study|Lack of Efficacy|0|||
149990691|NCT03213938|541096796|FG000|Overall Study|Decline to participate|5|||
149990692|NCT03213938|541096797|FG001|Overall Study|Decline to participate|4|||
149990693|NCT03213938|541096796|FG000|Overall Study|Without reason|4|||
149990694|NCT03213938|541096797|FG001|Overall Study|Without reason|5|||
149990695|NCT02487654|541096799|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
149990696|NCT02487654|541096800|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
149990697|NCT02487654|541096799|FG000|Overall Study|Withdrawal by Subject|3|||
149990698|NCT02487654|541096800|FG001|Overall Study|Withdrawal by Subject|7|||
149990699|NCT04238481|541096801|FG000|Overall Study|Miscellaneous|0|||
149990700|NCT04238481|541096802|FG001|Overall Study|Miscellaneous|1|||
149990701|NCT04238481|541096803|FG002|Overall Study|Miscellaneous|0|||
149990702|NCT04238481|541096804|FG003|Overall Study|Miscellaneous|0|||
150053642|NCT01457352|541336687|FG001|Period 3|incorrect treatment|1|||
150053643|NCT01457352|541336686|FG000|Period 3|Sponsor's withdrawal|0|||
150053644|NCT01457352|541336687|FG001|Period 3|Sponsor's withdrawal|1|||
150053645|NCT03865316|541338327|FG000|Overall Study|Procedure Cancelled|4|||
150053646|NCT03865316|541338327|FG000|Overall Study|Equipment failure|4|||
150053647|NCT03137069|541338332|FG000|Overall Study|Withdrawal by Subject|1|||
150053648|NCT03137069|541338333|FG001|Overall Study|Withdrawal by Subject|2|||
150053649|NCT03137069|541338334|FG002|Overall Study|Withdrawal by Subject|2|||
150053650|NCT03137069|541338335|FG003|Overall Study|Withdrawal by Subject|2|||
150053651|NCT03137069|541338336|FG004|Overall Study|Withdrawal by Subject|0|||
150053652|NCT03137069|541338337|FG005|Overall Study|Withdrawal by Subject|0|||
150053653|NCT03137069|541338332|FG000|Overall Study|Adverse Event|0|||
150053654|NCT03137069|541338333|FG001|Overall Study|Adverse Event|3|||
150053655|NCT03137069|541338334|FG002|Overall Study|Adverse Event|1|||
150178924|NCT03112174|541793876|FG002|Overall Study|Other, Not Specified|1|||
149990703|NCT02152371|541096805|FG000|Overall Study|Adverse Event|6|||
149990704|NCT02152371|541096806|FG001|Overall Study|Adverse Event|2|||
149990705|NCT02152371|541096805|FG000|Overall Study|Withdrawal by Subject|3|||
149990706|NCT02152371|541096806|FG001|Overall Study|Withdrawal by Subject|7|||
149990707|NCT02152371|541096805|FG000|Overall Study|Protocol Violation|2|||
149990708|NCT02152371|541096806|FG001|Overall Study|Protocol Violation|3|||
149990709|NCT02152371|541096805|FG000|Overall Study|Lost to Follow-up|1|||
149990710|NCT02152371|541096806|FG001|Overall Study|Lost to Follow-up|0|||
149990711|NCT02152371|541096805|FG000|Overall Study|Lack of Efficacy|0|||
149990712|NCT02152371|541096806|FG001|Overall Study|Lack of Efficacy|1|||
149990713|NCT02152371|541096805|FG000|Overall Study|Physician Decision|0|||
149990714|NCT02152371|541096806|FG001|Overall Study|Physician Decision|2|||
149990715|NCT02152371|541096805|FG000|Overall Study|Reason Not Given|0|||
149990716|NCT02152371|541096806|FG001|Overall Study|Reason Not Given|1|||
149990717|NCT00350870|541096807|FG000|Overall Study|Withdrawal by Subject|21|||
149990718|NCT00350870|541096808|FG001|Overall Study|Withdrawal by Subject|17|||
149990719|NCT00350870|541096809|FG002|Overall Study|Withdrawal by Subject|15|||
149990720|NCT00350870|541096810|FG003|Overall Study|Withdrawal by Subject|14|||
149990721|NCT00350870|541096807|FG000|Overall Study|Physician Decision|1|||
149990722|NCT00350870|541096808|FG001|Overall Study|Physician Decision|0|||
149990723|NCT00350870|541096809|FG002|Overall Study|Physician Decision|1|||
149990724|NCT00350870|541096810|FG003|Overall Study|Physician Decision|1|||
149990725|NCT00349921|541096811|FG000|First Spinal Injection|Physician Decision|1|||
149990726|NCT00349921|541096812|FG001|First Spinal Injection|Physician Decision|0|||
149990727|NCT00349921|541096813|FG002|First Spinal Injection|Physician Decision|0|||
149990728|NCT00349921|541096814|FG003|First Spinal Injection|Physician Decision|0|||
149990729|NCT00349921|541096811|FG000|First Spinal Injection|Adverse Event|0|||
149990730|NCT00349921|541096812|FG001|First Spinal Injection|Adverse Event|0|||
149990731|NCT00349921|541096813|FG002|First Spinal Injection|Adverse Event|1|||
149990732|NCT00349921|541096814|FG003|First Spinal Injection|Adverse Event|0|||
149990733|NCT01932372|541096815|FG000|Overall Study|Not meeting eligibility criteria|33|||
149990734|NCT01932372|541096816|FG001|Overall Study|Not meeting eligibility criteria|179|||
149990735|NCT01917929|541096821|FG000|Overall Study|Death|8|||
149990736|NCT01917929|541096821|FG000|Overall Study|Lost to Follow-up|19|||
149990737|NCT01917929|541096821|FG000|Overall Study|Withdrawal by Subject|33|||
149990738|NCT01917929|541096821|FG000|Overall Study|Adverse Event|6|||
149990739|NCT01917929|541096821|FG000|Overall Study|Investigative Site Terminated|35|||
149990740|NCT01917929|541096821|FG000|Overall Study|Censored because study device not implanted|6|||
149990741|NCT01917929|541096821|FG000|Overall Study|Censored because surgery not performed|3|||
149990742|NCT01917929|541096821|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
149990743|NCT01917929|541096821|FG000|Overall Study|Sponsor terminated study|175|||
149990744|NCT05285644|541096822|FG000|Overall Study|Adverse Event|3|||
149990745|NCT05285644|541096823|FG001|Overall Study|Adverse Event|3|||
149990746|NCT05285644|541096822|FG000|Overall Study|Withdrawal of Consent|2|||
149990747|NCT05285644|541096823|FG001|Overall Study|Withdrawal of Consent|5|||
149990748|NCT05285644|541096822|FG000|Overall Study|Noncompliance|0|||
149990749|NCT05285644|541096823|FG001|Overall Study|Noncompliance|4|||
149990750|NCT05285644|541096822|FG000|Overall Study|Lost to Follow-up|4|||
149990751|NCT05285644|541096823|FG001|Overall Study|Lost to Follow-up|6|||
149990752|NCT05285644|541096822|FG000|Overall Study|Disallowed Concurrent Medication|1|||
149990753|NCT05285644|541096823|FG001|Overall Study|Disallowed Concurrent Medication|1|||
149990754|NCT05285644|541096822|FG000|Overall Study|Investigator Decision|2|||
149990755|NCT05285644|541096823|FG001|Overall Study|Investigator Decision|0|||
149990756|NCT05285644|541096822|FG000|Overall Study|Protocol Deviation|1|||
149990757|NCT05285644|541096823|FG001|Overall Study|Protocol Deviation|0|||
149990758|NCT05285644|541096822|FG000|Overall Study|As specified in the Clinical Study Report|7|||
149990759|NCT05285644|541096823|FG001|Overall Study|As specified in the Clinical Study Report|3|||
149990760|NCT00673231|541096824|FG000|Overall Study|Withdrawal by Subject|14|||
149990761|NCT00673231|541096825|FG001|Overall Study|Withdrawal by Subject|10|||
149990762|NCT00673231|541096826|FG002|Overall Study|Withdrawal by Subject|8|||
149990763|NCT00673231|541096827|FG003|Overall Study|Withdrawal by Subject|6|||
149990764|NCT00673231|541096824|FG000|Overall Study|Adverse Event|6|||
149990765|NCT00673231|541096825|FG001|Overall Study|Adverse Event|5|||
149990766|NCT00673231|541096826|FG002|Overall Study|Adverse Event|9|||
149990767|NCT00673231|541096827|FG003|Overall Study|Adverse Event|6|||
149990768|NCT00673231|541096824|FG000|Overall Study|Lost to Follow-up|1|||
149990769|NCT00673231|541096825|FG001|Overall Study|Lost to Follow-up|2|||
149990770|NCT00673231|541096826|FG002|Overall Study|Lost to Follow-up|1|||
149990771|NCT00673231|541096827|FG003|Overall Study|Lost to Follow-up|2|||
149990772|NCT00673231|541096824|FG000|Overall Study|Death|0|||
149990773|NCT00673231|541096825|FG001|Overall Study|Death|0|||
149990774|NCT00673231|541096826|FG002|Overall Study|Death|1|||
149990775|NCT00673231|541096827|FG003|Overall Study|Death|0|||
149990776|NCT00673231|541096824|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
149990777|NCT00673231|541096825|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
149990778|NCT00673231|541096826|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
149990779|NCT00673231|541096827|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
149990780|NCT03594747|541096831|FG000|Overall Study|Death|78|||
149990781|NCT03594747|541096832|FG001|Overall Study|Death|86|||
149990782|NCT03594747|541096833|FG002|Overall Study|Death|87|||
149990783|NCT03594747|541096831|FG000|Overall Study|Withdrawal by Subject|5|||
149990784|NCT03594747|541096832|FG001|Overall Study|Withdrawal by Subject|2|||
149990785|NCT03594747|541096833|FG002|Overall Study|Withdrawal by Subject|11|||
149990786|NCT03594747|541096831|FG000|Overall Study|Lost to Follow-up|4|||
149990787|NCT03594747|541096832|FG001|Overall Study|Lost to Follow-up|1|||
149990788|NCT03594747|541096833|FG002|Overall Study|Lost to Follow-up|1|||
149990789|NCT03594747|541096831|FG000|Overall Study|Physician Decision|0|||
149990790|NCT03594747|541096832|FG001|Overall Study|Physician Decision|1|||
149990791|NCT03594747|541096833|FG002|Overall Study|Physician Decision|0|||
149990792|NCT03594747|541096831|FG000|Overall Study|Sponsor decision|23|||
149990793|NCT03594747|541096832|FG001|Overall Study|Sponsor decision|17|||
149990794|NCT03594747|541096833|FG002|Overall Study|Sponsor decision|16|||
149990795|NCT03594747|541096831|FG000|Overall Study|Did not meet inclusion criteria|0|||
149990796|NCT03594747|541096832|FG001|Overall Study|Did not meet inclusion criteria|0|||
149990797|NCT03594747|541096833|FG002|Overall Study|Did not meet inclusion criteria|1|||
149990798|NCT03594747|541096831|FG000|Overall Study|Transfer to long term extension study|10|||
149990799|NCT03594747|541096832|FG001|Overall Study|Transfer to long term extension study|12|||
149990800|NCT03594747|541096833|FG002|Overall Study|Transfer to long term extension study|5|||
149990801|NCT04382586|541096834|FG000|Overall Study|Death|3|||
149990802|NCT04382586|541096835|FG001|Overall Study|Death|4|||
149990803|NCT04382586|541096834|FG000|Overall Study|Lost to Follow-up|11|||
149990804|NCT04382586|541096835|FG001|Overall Study|Lost to Follow-up|8|||
149990805|NCT04382586|541096834|FG000|Overall Study|Withdrawal by Subject|3|||
149990806|NCT04382586|541096835|FG001|Overall Study|Withdrawal by Subject|1|||
149990807|NCT04382586|541096834|FG000|Overall Study|Physician Decision|0|||
149990808|NCT04382586|541096835|FG001|Overall Study|Physician Decision|3|||
149990809|NCT02265536|541096837|FG000|Overall Study|Adverse Event|1|||
149990810|NCT02265536|541096838|FG001|Overall Study|Adverse Event|0|||
149990811|NCT02265536|541096839|FG002|Overall Study|Adverse Event|0|||
149990812|NCT02265536|541096840|FG003|Overall Study|Adverse Event|0|||
149990813|NCT02265536|541096841|FG004|Overall Study|Adverse Event|1|||
149990814|NCT02265536|541096842|FG005|Overall Study|Adverse Event|0|||
149990815|NCT02265536|541096837|FG000|Overall Study|Physician Decision|0|||
149990816|NCT02265536|541096838|FG001|Overall Study|Physician Decision|0|||
149990817|NCT02265536|541096839|FG002|Overall Study|Physician Decision|0|||
149990818|NCT02265536|541096840|FG003|Overall Study|Physician Decision|0|||
149990819|NCT02265536|541096841|FG004|Overall Study|Physician Decision|2|||
149990820|NCT02265536|541096842|FG005|Overall Study|Physician Decision|0|||
149990821|NCT02265536|541096837|FG000|Overall Study|Withdrawal by Subject|0|||
149990822|NCT02265536|541096838|FG001|Overall Study|Withdrawal by Subject|3|||
149990823|NCT02265536|541096839|FG002|Overall Study|Withdrawal by Subject|0|||
149990824|NCT02265536|541096840|FG003|Overall Study|Withdrawal by Subject|0|||
149990825|NCT02265536|541096841|FG004|Overall Study|Withdrawal by Subject|0|||
149990826|NCT02265536|541096842|FG005|Overall Study|Withdrawal by Subject|0|||
149990827|NCT02470585|541096845|FG000|Overall Study|Death|224|||
149990828|NCT02470585|541096846|FG001|Overall Study|Death|227|||
149990829|NCT02470585|541096847|FG002|Overall Study|Death|199|||
149990830|NCT02470585|541096845|FG000|Overall Study|Withdrew consent|21|||
149990831|NCT02470585|541096846|FG001|Overall Study|Withdrew consent|22|||
149990832|NCT02470585|541096847|FG002|Overall Study|Withdrew consent|31|||
149990833|NCT02470585|541096845|FG000|Overall Study|Lost to Follow-up|8|||
149990834|NCT02470585|541096846|FG001|Overall Study|Lost to Follow-up|15|||
149990835|NCT02470585|541096847|FG002|Overall Study|Lost to Follow-up|13|||
149990836|NCT02470585|541096845|FG000|Overall Study|Sponsor discontinued study|117|||
149990837|NCT02470585|541096846|FG001|Overall Study|Sponsor discontinued study|110|||
149990838|NCT02470585|541096847|FG002|Overall Study|Sponsor discontinued study|122|||
149990839|NCT02470585|541096845|FG000|Overall Study|Other, not specified|5|||
149990840|NCT02470585|541096846|FG001|Overall Study|Other, not specified|7|||
149990841|NCT02470585|541096847|FG002|Overall Study|Other, not specified|14|||
149990842|NCT02470585|541096845|FG000|Overall Study|Missing due to site non-compliance|0|||
149990843|NCT02470585|541096846|FG001|Overall Study|Missing due to site non-compliance|2|||
149990844|NCT02470585|541096847|FG002|Overall Study|Missing due to site non-compliance|3|||
149990845|NCT03028415|541096848|FG000|Overall Study|Lost to Follow-up|6|||
149990846|NCT03028415|541096849|FG001|Overall Study|Lost to Follow-up|3|||
149990847|NCT03028415|541096848|FG000|Overall Study|Withdrawal by Subject|1|||
149990848|NCT03028415|541096849|FG001|Overall Study|Withdrawal by Subject|0|||
149990849|NCT03028415|541096848|FG000|Overall Study|Discontinued due to COVID-19|1|||
149990850|NCT03028415|541096849|FG001|Overall Study|Discontinued due to COVID-19|0|||
149990851|NCT02907216|541096850|FG000|Overall Study|No benefit to be obtained by continuing|0|||
150053656|NCT03137069|541338335|FG003|Overall Study|Adverse Event|1|||
150053657|NCT03137069|541338336|FG004|Overall Study|Adverse Event|0|||
149990852|NCT02907216|541096851|FG001|Overall Study|No benefit to be obtained by continuing|1|||
149990853|NCT02907216|541096850|FG000|Overall Study|Withdrawal by Subject|1|||
149990854|NCT02907216|541096851|FG001|Overall Study|Withdrawal by Subject|0|||
150053658|NCT03137069|541338337|FG005|Overall Study|Adverse Event|1|||
149990855|NCT02095873|541096853|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
149990856|NCT02095873|541096854|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
149990857|NCT02095873|541096853|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
149990858|NCT02095873|541096854|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
149990859|NCT02095873|541096853|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
149990860|NCT02095873|541096854|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
149990861|NCT00792740|541096855|FG000|Overall Study|Disease Worsening|3|||
149990862|NCT00792740|541096856|FG001|Overall Study|Disease Worsening|2|||
149990863|NCT00792740|541096855|FG000|Overall Study|Personal Reason|1|||
149990864|NCT00792740|541096856|FG001|Overall Study|Personal Reason|0|||
149990865|NCT00792740|541096855|FG000|Overall Study|Adverse Event|1|||
149990866|NCT00792740|541096856|FG001|Overall Study|Adverse Event|3|||
149990867|NCT00792740|541096855|FG000|Overall Study|Patient's withdrawal of consent|0|||
149990868|NCT00792740|541096856|FG001|Overall Study|Patient's withdrawal of consent|1|||
149990869|NCT00792740|541096855|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
149990870|NCT00792740|541096856|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
149990871|NCT00792740|541096855|FG000|Overall Study|Other reasons|0|||
149990872|NCT00792740|541096856|FG001|Overall Study|Other reasons|1|||
149990873|NCT02485639|541096861|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
149990874|NCT02485639|541096861|FG000|Overall Study|Early termination|4|||
149990875|NCT02485639|541096861|FG000|Overall Study|Withdrawal by Subject|4|||
149990876|NCT02016716|541096862|FG000|Overall Study|Withdrawal by Subject|5|||
149990877|NCT02016716|541096863|FG001|Overall Study|Withdrawal by Subject|5|||
149990878|NCT02016716|541096864|FG002|Overall Study|Withdrawal by Subject|5|||
149990879|NCT02016716|541096862|FG000|Overall Study|Protocol-specified Criteria|0|||
149990880|NCT02016716|541096863|FG001|Overall Study|Protocol-specified Criteria|1|||
149990881|NCT02016716|541096864|FG002|Overall Study|Protocol-specified Criteria|0|||
149990882|NCT02016716|541096862|FG000|Overall Study|Lost to Follow-up|1|||
149990883|NCT02016716|541096863|FG001|Overall Study|Lost to Follow-up|2|||
149990884|NCT02016716|541096864|FG002|Overall Study|Lost to Follow-up|1|||
149990885|NCT00079391|541096865|FG000|Overall Study|Withdrawal by Subject|1|||
149990886|NCT03763656|541096870|FG000|Overall Study|Physician Decision|1|||
149990887|NCT03763656|541096870|FG000|Overall Study|Protocol Violation|1|||
149990888|NCT03763656|541096870|FG000|Overall Study|Withdrawal by Subject|7|||
149990889|NCT03479541|541096871|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
149990890|NCT03479541|541096872|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
149990891|NCT03479541|541096873|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
149990892|NCT03479541|541096874|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
149990893|NCT03479541|541096871|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
149990894|NCT03479541|541096872|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
149990895|NCT03479541|541096873|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
149990896|NCT03479541|541096874|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
149990897|NCT03479541|541096871|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
149990898|NCT03479541|541096872|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
149990899|NCT03479541|541096873|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
149990900|NCT03479541|541096874|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
149990901|NCT03479541|541096871|FG000|Home Monitoring|Lost to Follow-up|0|||
149990902|NCT03479541|541096872|FG001|Home Monitoring|Lost to Follow-up|0|||
149990903|NCT03479541|541096873|FG002|Home Monitoring|Lost to Follow-up|8|||
149990904|NCT03479541|541096874|FG003|Home Monitoring|Lost to Follow-up|12|||
149990905|NCT03479541|541096871|FG000|Home Monitoring|Withdrawal by Subject|0|||
149990906|NCT03479541|541096872|FG001|Home Monitoring|Withdrawal by Subject|0|||
149990907|NCT03479541|541096873|FG002|Home Monitoring|Withdrawal by Subject|17|||
149990908|NCT03479541|541096874|FG003|Home Monitoring|Withdrawal by Subject|30|||
149990909|NCT03479541|541096871|FG000|Home Monitoring|Early Termination - PI Decision|0|||
149990910|NCT03479541|541096872|FG001|Home Monitoring|Early Termination - PI Decision|0|||
149990911|NCT03479541|541096873|FG002|Home Monitoring|Early Termination - PI Decision|4|||
149990912|NCT03479541|541096874|FG003|Home Monitoring|Early Termination - PI Decision|6|||
149990913|NCT00107900|541096875|FG000|Overall Study|Adverse Event|3|||
149990914|NCT00107900|541096876|FG001|Overall Study|Adverse Event|2|||
149990915|NCT00107900|541096877|FG002|Overall Study|Adverse Event|10|||
149990916|NCT00107900|541096878|FG003|Overall Study|Adverse Event|3|||
149990917|NCT00107900|541096879|FG004|Overall Study|Adverse Event|5|||
149990918|NCT00107900|541096880|FG005|Overall Study|Adverse Event|3|||
149990919|NCT00107900|541096875|FG000|Overall Study|Death|0|||
149990920|NCT00107900|541096876|FG001|Overall Study|Death|0|||
149990921|NCT00107900|541096877|FG002|Overall Study|Death|0|||
149990922|NCT00107900|541096878|FG003|Overall Study|Death|0|||
149990923|NCT00107900|541096879|FG004|Overall Study|Death|1|||
149990924|NCT00107900|541096880|FG005|Overall Study|Death|0|||
149990925|NCT00107900|541096875|FG000|Overall Study|Lost to Follow-up|4|||
149990926|NCT00107900|541096876|FG001|Overall Study|Lost to Follow-up|1|||
149990927|NCT00107900|541096877|FG002|Overall Study|Lost to Follow-up|3|||
149990928|NCT00107900|541096878|FG003|Overall Study|Lost to Follow-up|2|||
149990929|NCT00107900|541096879|FG004|Overall Study|Lost to Follow-up|5|||
149990930|NCT00107900|541096880|FG005|Overall Study|Lost to Follow-up|5|||
149990931|NCT00107900|541096875|FG000|Overall Study|Protocol Violation|1|||
149990932|NCT00107900|541096876|FG001|Overall Study|Protocol Violation|0|||
149990933|NCT00107900|541096877|FG002|Overall Study|Protocol Violation|5|||
149990934|NCT00107900|541096878|FG003|Overall Study|Protocol Violation|5|||
149990935|NCT00107900|541096879|FG004|Overall Study|Protocol Violation|7|||
149990936|NCT00107900|541096880|FG005|Overall Study|Protocol Violation|0|||
149990937|NCT00107900|541096875|FG000|Overall Study|Withdrawal by Subject|1|||
149990938|NCT00107900|541096876|FG001|Overall Study|Withdrawal by Subject|0|||
149990939|NCT00107900|541096877|FG002|Overall Study|Withdrawal by Subject|5|||
149990940|NCT00107900|541096878|FG003|Overall Study|Withdrawal by Subject|0|||
149990941|NCT00107900|541096879|FG004|Overall Study|Withdrawal by Subject|1|||
149990942|NCT00107900|541096880|FG005|Overall Study|Withdrawal by Subject|1|||
149990943|NCT00107900|541096875|FG000|Overall Study|Administrative Reasons|1|||
149990944|NCT00107900|541096876|FG001|Overall Study|Administrative Reasons|0|||
149990945|NCT00107900|541096877|FG002|Overall Study|Administrative Reasons|2|||
149990946|NCT00107900|541096878|FG003|Overall Study|Administrative Reasons|2|||
149990947|NCT00107900|541096879|FG004|Overall Study|Administrative Reasons|2|||
149990948|NCT00107900|541096880|FG005|Overall Study|Administrative Reasons|0|||
149990949|NCT02513485|541099399|FG000|Overall Study|Adverse Event|1|||
149990950|NCT02513485|541099400|FG001|Overall Study|Adverse Event|0|||
149990951|NCT00394251|541099401|FG000|Overall Study|Adverse Event|7|||
149990952|NCT00394251|541099402|FG001|Overall Study|Adverse Event|5|||
149990953|NCT00394251|541099401|FG000|Overall Study|Unacceptable Toxicity|20|||
149990954|NCT00394251|541099402|FG001|Overall Study|Unacceptable Toxicity|18|||
149990955|NCT00394251|541099401|FG000|Overall Study|Physician Decision|1|||
149990956|NCT00394251|541099402|FG001|Overall Study|Physician Decision|1|||
149990957|NCT00394251|541099401|FG000|Overall Study|Protocol Violation|0|||
149990958|NCT00394251|541099402|FG001|Overall Study|Protocol Violation|1|||
149990959|NCT00394251|541099401|FG000|Overall Study|Withdrawal by Subject|7|||
149990960|NCT00394251|541099402|FG001|Overall Study|Withdrawal by Subject|11|||
149990961|NCT00394251|541099401|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
149990962|NCT00394251|541099402|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
149990963|NCT04644276|541099403|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
149990964|NCT04644276|541099404|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
149990965|NCT04644276|541099405|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
149990966|NCT01667224|541099406|FG000|Overall Study|Withdrawal by Subject|3|||
149990967|NCT01667224|541099407|FG001|Overall Study|Withdrawal by Subject|1|||
149990968|NCT01667224|541099406|FG000|Overall Study|Protocol Violation|1|||
149990969|NCT01667224|541099407|FG001|Overall Study|Protocol Violation|1|||
149990970|NCT03350035|541099408|FG000|Overall Study|Lack of Efficacy|2|||
149990971|NCT03350035|541099409|FG001|Overall Study|Lack of Efficacy|0|||
149990972|NCT03350035|541099410|FG002|Overall Study|Lack of Efficacy|0|||
149990973|NCT03350035|541099408|FG000|Overall Study|Subject discharged to hospice|0|||
149990974|NCT03350035|541099409|FG001|Overall Study|Subject discharged to hospice|0|||
149990975|NCT03350035|541099410|FG002|Overall Study|Subject discharged to hospice|1|||
149990976|NCT01811485|541099411|FG000|Overall Study|Adverse Event|1|||
149990977|NCT01811485|541099412|FG001|Overall Study|Adverse Event|3|||
149990978|NCT01811485|541099413|FG002|Overall Study|Adverse Event|2|||
149990979|NCT01811485|541099411|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149990980|NCT01811485|541099412|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149990981|NCT01811485|541099413|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
149990982|NCT01811485|541099411|FG000|Overall Study|Administrative problems|1|||
149990983|NCT01811485|541099412|FG001|Overall Study|Administrative problems|0|||
149990984|NCT01811485|541099413|FG002|Overall Study|Administrative problems|0|||
149990985|NCT01811485|541099411|FG000|Overall Study|Protocol Deviation|0|||
149990986|NCT01811485|541099412|FG001|Overall Study|Protocol Deviation|1|||
149990987|NCT01811485|541099413|FG002|Overall Study|Protocol Deviation|0|||
149990988|NCT04115748|541099414|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
149990989|NCT04115748|541099415|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
149990990|NCT04115748|541099416|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
149990991|NCT04115748|541099417|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
149990992|NCT04115748|541099418|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990993|NCT04115748|541099419|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990994|NCT04115748|541099420|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990995|NCT04115748|541099421|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990996|NCT04115748|541099422|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990997|NCT04115748|541099423|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
149990998|NCT04115748|541099414|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149990999|NCT04115748|541099415|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991000|NCT04115748|541099416|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991001|NCT04115748|541099417|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
149991002|NCT04115748|541099418|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991003|NCT04115748|541099419|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991004|NCT04115748|541099420|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991005|NCT04115748|541099421|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
150178925|NCT03112174|541793877|FG003|Overall Study|Other, Not Specified|2|||
149991006|NCT04115748|541099422|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991007|NCT04115748|541099423|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
149991008|NCT04115748|541099414|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
149991009|NCT04115748|541099415|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
149991010|NCT04115748|541099416|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
149991011|NCT04115748|541099417|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
149991012|NCT04115748|541099418|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
149991013|NCT04115748|541099419|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
149991014|NCT04115748|541099420|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
149991015|NCT04115748|541099421|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
149991016|NCT04115748|541099422|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
149991017|NCT04115748|541099423|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
149991018|NCT04115748|541099414|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991019|NCT04115748|541099415|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991020|NCT04115748|541099416|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991021|NCT04115748|541099417|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991022|NCT04115748|541099418|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991023|NCT04115748|541099419|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991024|NCT04115748|541099420|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991025|NCT04115748|541099421|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991026|NCT04115748|541099422|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
149991027|NCT04115748|541099423|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
149991028|NCT00713349|541099424|FG000|Overall Study|Protocol Violation|1|||
149991029|NCT03764631|541099425|FG000|Overall Study|Personal Reasons|3|||
149991030|NCT03764631|541099426|FG001|Overall Study|Personal Reasons|2|||
149991031|NCT03764631|541099425|FG000|Overall Study|Switching Therapy|3|||
149991032|NCT03764631|541099426|FG001|Overall Study|Switching Therapy|3|||
149991033|NCT03764631|541099425|FG000|Overall Study|Adverse Event|0|||
149991034|NCT03764631|541099426|FG001|Overall Study|Adverse Event|1|||
149991035|NCT03764631|541099425|FG000|Overall Study|Lost to Follow-up|33|||
149991036|NCT03764631|541099426|FG001|Overall Study|Lost to Follow-up|41|||
149991037|NCT03764631|541099425|FG000|Overall Study|No data as study site was closed|2|||
149991038|NCT03764631|541099426|FG001|Overall Study|No data as study site was closed|6|||
149991039|NCT01200407|541099427|FG000|Overall Study|Lost to Follow-up|56|||
149991040|NCT01200407|541099427|FG000|Overall Study|Adverse Event|3|||
149991041|NCT01200407|541099427|FG000|Overall Study|Withdrawal by Subject|4|||
149991042|NCT01200407|541099427|FG000|Overall Study|Other|19|||
149991043|NCT02974855|541099430|FG000|Overall Study|Adverse Event|0|||
149991044|NCT02974855|541099431|FG001|Overall Study|Adverse Event|1|||
149991045|NCT02974855|541099432|FG002|Overall Study|Adverse Event|0|||
149991046|NCT02974855|541099433|FG003|Overall Study|Adverse Event|1|||
149991047|NCT00633074|541099434|FG000|Overall Study|Adverse Event|1|||
149991048|NCT00633074|541099435|FG001|Overall Study|Adverse Event|0|||
149991049|NCT02752633|541099437|FG000|Overall Study|Withdrawal by Subject|1|||
149991050|NCT01843673|541099438|FG000|Overall Study|Lack of Efficacy|2|||
149991051|NCT01843673|541099438|FG000|Overall Study|Withdrawal by Subject|4|||
149991052|NCT03275246|541099439|FG000|Overall Study|Protocol Violation|5|||
149991053|NCT03275246|541099439|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
149991054|NCT00433966|541099442|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
149991055|NCT00433966|541099443|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
149991056|NCT00433966|541099444|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
149991057|NCT00433966|541099445|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
149991058|NCT00433966|541099442|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
149991059|NCT00433966|541099443|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
149991060|NCT00433966|541099444|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
149991061|NCT00433966|541099445|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
149991062|NCT00433966|541099442|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
149991063|NCT00433966|541099443|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
149991064|NCT00433966|541099444|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
149991065|NCT00433966|541099445|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
149991066|NCT00433966|541099442|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
149991067|NCT00433966|541099443|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
149991068|NCT00433966|541099444|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
149991069|NCT00433966|541099445|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
150053659|NCT03137069|541338332|FG000|Overall Study|Protocol Violation|0|||
149991070|NCT00433966|541099442|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
149991071|NCT00433966|541099443|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
149991072|NCT00433966|541099444|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
149991073|NCT00433966|541099445|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
149991074|NCT02570152|541099446|FG000|Overall Study|Protocol Violation|2|||
149991075|NCT02570152|541099446|FG000|Overall Study|Migrated/moved from study area|13|||
149991076|NCT03497975|541099448|FG000|Overall Study|Withdrew Consent|34|||
149991077|NCT03497975|541099449|FG001|Overall Study|Withdrew Consent|35|||
149991078|NCT03497975|541099448|FG000|Overall Study|Lost to Follow-up|7|||
149991079|NCT03497975|541099449|FG001|Overall Study|Lost to Follow-up|7|||
149991080|NCT03497975|541099448|FG000|Overall Study|Physician Decision|4|||
149991081|NCT03497975|541099449|FG001|Overall Study|Physician Decision|5|||
149991082|NCT03497975|541099448|FG000|Overall Study|Discontinued|42|||
149991083|NCT03497975|541099449|FG001|Overall Study|Discontinued|39|||
149991084|NCT03497975|541099448|FG000|Overall Study|Reason Not Specified|15|||
149991085|NCT03497975|541099449|FG001|Overall Study|Reason Not Specified|14|||
149991086|NCT01296711|541099450|FG000|Overall Study|Adverse Event|3|||
149991087|NCT01296711|541099451|FG001|Overall Study|Adverse Event|1|||
149991088|NCT01296711|541099452|FG002|Overall Study|Adverse Event|4|||
149991089|NCT01296711|541099453|FG003|Overall Study|Adverse Event|3|||
149991090|NCT01296711|541099454|FG004|Overall Study|Adverse Event|1|||
149991091|NCT01296711|541099455|FG005|Overall Study|Adverse Event|6|||
149991092|NCT01296711|541099456|FG006|Overall Study|Adverse Event|11|||
149991093|NCT01296711|541099457|FG007|Overall Study|Adverse Event|3|||
149991094|NCT01296711|541099450|FG000|Overall Study|Lack of Efficacy|1|||
149991095|NCT01296711|541099451|FG001|Overall Study|Lack of Efficacy|4|||
149991096|NCT01296711|541099452|FG002|Overall Study|Lack of Efficacy|1|||
149991097|NCT01296711|541099453|FG003|Overall Study|Lack of Efficacy|1|||
149991098|NCT01296711|541099454|FG004|Overall Study|Lack of Efficacy|1|||
149991099|NCT01296711|541099455|FG005|Overall Study|Lack of Efficacy|0|||
149991100|NCT01296711|541099456|FG006|Overall Study|Lack of Efficacy|2|||
149991101|NCT01296711|541099457|FG007|Overall Study|Lack of Efficacy|3|||
149991102|NCT01296711|541099450|FG000|Overall Study|Lost to Follow-up|0|||
149991103|NCT01296711|541099451|FG001|Overall Study|Lost to Follow-up|0|||
149991104|NCT01296711|541099452|FG002|Overall Study|Lost to Follow-up|1|||
149991105|NCT01296711|541099453|FG003|Overall Study|Lost to Follow-up|1|||
149991106|NCT01296711|541099454|FG004|Overall Study|Lost to Follow-up|2|||
149991107|NCT01296711|541099455|FG005|Overall Study|Lost to Follow-up|0|||
149991108|NCT01296711|541099456|FG006|Overall Study|Lost to Follow-up|4|||
149991109|NCT01296711|541099457|FG007|Overall Study|Lost to Follow-up|2|||
149991110|NCT01296711|541099450|FG000|Overall Study|Protocol Violation|0|||
149991111|NCT01296711|541099451|FG001|Overall Study|Protocol Violation|0|||
149991112|NCT01296711|541099452|FG002|Overall Study|Protocol Violation|0|||
149991113|NCT01296711|541099453|FG003|Overall Study|Protocol Violation|1|||
149991114|NCT01296711|541099454|FG004|Overall Study|Protocol Violation|1|||
149991115|NCT01296711|541099455|FG005|Overall Study|Protocol Violation|0|||
149991116|NCT01296711|541099456|FG006|Overall Study|Protocol Violation|0|||
149991117|NCT01296711|541099457|FG007|Overall Study|Protocol Violation|0|||
149991118|NCT01296711|541099450|FG000|Overall Study|Withdrawal by Subject|4|||
149991119|NCT01296711|541099451|FG001|Overall Study|Withdrawal by Subject|2|||
149991120|NCT01296711|541099452|FG002|Overall Study|Withdrawal by Subject|2|||
149991121|NCT01296711|541099453|FG003|Overall Study|Withdrawal by Subject|1|||
149991122|NCT01296711|541099454|FG004|Overall Study|Withdrawal by Subject|1|||
149991123|NCT01296711|541099455|FG005|Overall Study|Withdrawal by Subject|1|||
149991124|NCT01296711|541099456|FG006|Overall Study|Withdrawal by Subject|2|||
149991125|NCT01296711|541099457|FG007|Overall Study|Withdrawal by Subject|1|||
149991126|NCT01296711|541099450|FG000|Overall Study|Study termination|8|||
149991127|NCT01296711|541099451|FG001|Overall Study|Study termination|1|||
149991128|NCT01296711|541099452|FG002|Overall Study|Study termination|5|||
149991129|NCT01296711|541099453|FG003|Overall Study|Study termination|4|||
149991130|NCT01296711|541099454|FG004|Overall Study|Study termination|4|||
149991131|NCT01296711|541099455|FG005|Overall Study|Study termination|4|||
149991132|NCT01296711|541099456|FG006|Overall Study|Study termination|8|||
149991133|NCT01296711|541099457|FG007|Overall Study|Study termination|10|||
149991134|NCT01296711|541099450|FG000|Overall Study|Continued elevated liver enzymes|0|||
149991135|NCT01296711|541099451|FG001|Overall Study|Continued elevated liver enzymes|0|||
149991136|NCT01296711|541099452|FG002|Overall Study|Continued elevated liver enzymes|0|||
149991137|NCT01296711|541099453|FG003|Overall Study|Continued elevated liver enzymes|1|||
150053660|NCT03137069|541338333|FG001|Overall Study|Protocol Violation|1|||
150053661|NCT03137069|541338334|FG002|Overall Study|Protocol Violation|0|||
149991138|NCT01296711|541099454|FG004|Overall Study|Continued elevated liver enzymes|0|||
149991139|NCT01296711|541099455|FG005|Overall Study|Continued elevated liver enzymes|0|||
149991140|NCT01296711|541099456|FG006|Overall Study|Continued elevated liver enzymes|0|||
149991141|NCT01296711|541099457|FG007|Overall Study|Continued elevated liver enzymes|0|||
149991142|NCT01296711|541099450|FG000|Overall Study|Methotrexate discontinued|0|||
149991143|NCT01296711|541099451|FG001|Overall Study|Methotrexate discontinued|0|||
150053662|NCT03137069|541338335|FG003|Overall Study|Protocol Violation|1|||
150178926|NCT03112174|541793878|FG004|Overall Study|Other, Not Specified|0|||
149991144|NCT01296711|541099452|FG002|Overall Study|Methotrexate discontinued|0|||
149991145|NCT01296711|541099453|FG003|Overall Study|Methotrexate discontinued|1|||
149991146|NCT01296711|541099454|FG004|Overall Study|Methotrexate discontinued|0|||
149991147|NCT01296711|541099455|FG005|Overall Study|Methotrexate discontinued|0|||
149991148|NCT01296711|541099456|FG006|Overall Study|Methotrexate discontinued|0|||
149991149|NCT01296711|541099457|FG007|Overall Study|Methotrexate discontinued|0|||
149991150|NCT01296711|541099450|FG000|Overall Study|Investigator discretion|0|||
149991151|NCT01296711|541099451|FG001|Overall Study|Investigator discretion|0|||
149991152|NCT01296711|541099452|FG002|Overall Study|Investigator discretion|0|||
149991153|NCT01296711|541099453|FG003|Overall Study|Investigator discretion|0|||
150053663|NCT03137069|541338336|FG004|Overall Study|Protocol Violation|1|||
150053664|NCT03137069|541338337|FG005|Overall Study|Protocol Violation|1|||
150053665|NCT03137069|541338332|FG000|Overall Study|Physician Decision|0|||
150053666|NCT03137069|541338333|FG001|Overall Study|Physician Decision|0|||
150053667|NCT03137069|541338334|FG002|Overall Study|Physician Decision|0|||
150053668|NCT03137069|541338335|FG003|Overall Study|Physician Decision|1|||
150053669|NCT03137069|541338336|FG004|Overall Study|Physician Decision|0|||
150053670|NCT03137069|541338337|FG005|Overall Study|Physician Decision|0|||
150053671|NCT03137069|541338332|FG000|Overall Study|Study Terminated by Sponsor|0|||
150053672|NCT03137069|541338333|FG001|Overall Study|Study Terminated by Sponsor|0|||
150053673|NCT03137069|541338334|FG002|Overall Study|Study Terminated by Sponsor|0|||
150053674|NCT03137069|541338335|FG003|Overall Study|Study Terminated by Sponsor|0|||
150053675|NCT03137069|541338336|FG004|Overall Study|Study Terminated by Sponsor|1|||
150053676|NCT03137069|541338337|FG005|Overall Study|Study Terminated by Sponsor|0|||
150053677|NCT03137069|541338332|FG000|Overall Study|Data Entry Error|0|||
150053678|NCT03137069|541338333|FG001|Overall Study|Data Entry Error|0|||
150053679|NCT03137069|541338334|FG002|Overall Study|Data Entry Error|0|||
150053680|NCT03137069|541338335|FG003|Overall Study|Data Entry Error|1|||
150053681|NCT03137069|541338336|FG004|Overall Study|Data Entry Error|0|||
150053682|NCT03137069|541338337|FG005|Overall Study|Data Entry Error|0|||
150053683|NCT02600871|541338338|FG000|Overall Study|Lost to Follow-up|13|||
150053684|NCT02600871|541338339|FG001|Overall Study|Lost to Follow-up|10|||
150053685|NCT01604278|541338340|FG000|Overall Study|Lack of Efficacy|0|||
150053686|NCT01604278|541338341|FG001|Overall Study|Lack of Efficacy|1|||
150053687|NCT01604278|541338340|FG000|Overall Study|Lost to Follow-up|1|||
150053688|NCT01604278|541338341|FG001|Overall Study|Lost to Follow-up|0|||
150053689|NCT01604278|541338340|FG000|Overall Study|Administrative problems|2|||
150053690|NCT01604278|541338341|FG001|Overall Study|Administrative problems|1|||
150053691|NCT01604278|541338340|FG000|Overall Study|Withdrawal by Subject|3|||
150053692|NCT01604278|541338341|FG001|Overall Study|Withdrawal by Subject|3|||
150053693|NCT01604278|541338340|FG000|Overall Study|Adverse Event|3|||
150053694|NCT01604278|541338341|FG001|Overall Study|Adverse Event|5|||
150053695|NCT01604278|541338340|FG000|Overall Study|Protocol Deviation|5|||
150053696|NCT01604278|541338341|FG001|Overall Study|Protocol Deviation|3|||
150053697|NCT00640224|541338343|FG000|Overall Study|Lost to Follow-up|5|||
150053698|NCT00640224|541338344|FG001|Overall Study|Lost to Follow-up|2|||
150053699|NCT00640224|541338345|FG002|Overall Study|Lost to Follow-up|0|||
150053700|NCT00640224|541338346|FG003|Overall Study|Lost to Follow-up|0|||
150053701|NCT00640224|541338343|FG000|Overall Study|Withdrawal by Subject|1|||
150053702|NCT00640224|541338344|FG001|Overall Study|Withdrawal by Subject|0|||
150053703|NCT00640224|541338345|FG002|Overall Study|Withdrawal by Subject|0|||
150053704|NCT00640224|541338346|FG003|Overall Study|Withdrawal by Subject|0|||
150053705|NCT00640224|541338343|FG000|Overall Study|Headaches|0|||
150053706|NCT00640224|541338344|FG001|Overall Study|Headaches|1|||
150053707|NCT00640224|541338345|FG002|Overall Study|Headaches|0|||
150053708|NCT00640224|541338346|FG003|Overall Study|Headaches|0|||
150053709|NCT00422513|541338347|FG000|Overall Study|Lack of Efficacy|4|||
150053710|NCT00422513|541338348|FG001|Overall Study|Lack of Efficacy|5|||
150053711|NCT00422513|541338347|FG000|Overall Study|Protocol Violation|23|||
150053712|NCT00422513|541338348|FG001|Overall Study|Protocol Violation|7|||
150053713|NCT00422513|541338347|FG000|Overall Study|Refused Treatment|4|||
150053714|NCT00422513|541338348|FG001|Overall Study|Refused Treatment|2|||
150053715|NCT00422513|541338347|FG000|Overall Study|Withdrawal by Subject|2|||
150053716|NCT00422513|541338348|FG001|Overall Study|Withdrawal by Subject|1|||
150053717|NCT00422513|541338347|FG000|Overall Study|early termination of the study|67|||
150053718|NCT00422513|541338348|FG001|Overall Study|early termination of the study|80|||
150053719|NCT00422513|541338347|FG000|Overall Study|Adverse Event|4|||
150053720|NCT00422513|541338348|FG001|Overall Study|Adverse Event|4|||
150053721|NCT00422513|541338347|FG000|Overall Study|Death|3|||
149991154|NCT01296711|541099454|FG004|Overall Study|Investigator discretion|0|||
149991155|NCT01296711|541099455|FG005|Overall Study|Investigator discretion|0|||
150053722|NCT00422513|541338348|FG001|Overall Study|Death|7|||
150053723|NCT03135119|541338349|FG000|Overall Study|Lost to Follow-up|2|||
150053724|NCT03135119|541338350|FG001|Overall Study|Lost to Follow-up|0|||
149991156|NCT01296711|541099456|FG006|Overall Study|Investigator discretion|1|||
149991157|NCT01296711|541099457|FG007|Overall Study|Investigator discretion|0|||
149991158|NCT01296711|541099450|FG000|Overall Study|Other|0|||
149991159|NCT01296711|541099451|FG001|Overall Study|Other|0|||
149991160|NCT01296711|541099452|FG002|Overall Study|Other|0|||
149991161|NCT01296711|541099453|FG003|Overall Study|Other|0|||
149991162|NCT01296711|541099454|FG004|Overall Study|Other|0|||
149991163|NCT01296711|541099455|FG005|Overall Study|Other|0|||
149991164|NCT01296711|541099456|FG006|Overall Study|Other|1|||
149991165|NCT01296711|541099457|FG007|Overall Study|Other|0|||
149991166|NCT01296711|541099450|FG000|Overall Study|Required restricted steroid injections|0|||
149991167|NCT01296711|541099451|FG001|Overall Study|Required restricted steroid injections|0|||
149991168|NCT01296711|541099452|FG002|Overall Study|Required restricted steroid injections|0|||
149991169|NCT01296711|541099453|FG003|Overall Study|Required restricted steroid injections|0|||
149991170|NCT01296711|541099454|FG004|Overall Study|Required restricted steroid injections|0|||
149991171|NCT01296711|541099455|FG005|Overall Study|Required restricted steroid injections|0|||
149991172|NCT01296711|541099456|FG006|Overall Study|Required restricted steroid injections|1|||
149991173|NCT01296711|541099457|FG007|Overall Study|Required restricted steroid injections|0|||
149991174|NCT01296711|541099450|FG000|Overall Study|Ongoing missed appointments|0|||
149991175|NCT01296711|541099451|FG001|Overall Study|Ongoing missed appointments|0|||
149991176|NCT01296711|541099452|FG002|Overall Study|Ongoing missed appointments|0|||
149991177|NCT01296711|541099453|FG003|Overall Study|Ongoing missed appointments|0|||
149991178|NCT01296711|541099454|FG004|Overall Study|Ongoing missed appointments|0|||
149991179|NCT01296711|541099455|FG005|Overall Study|Ongoing missed appointments|0|||
149991180|NCT01296711|541099456|FG006|Overall Study|Ongoing missed appointments|1|||
149991181|NCT01296711|541099457|FG007|Overall Study|Ongoing missed appointments|0|||
149991182|NCT01296711|541099450|FG000|Overall Study|Failure to comply with visits|0|||
149991183|NCT01296711|541099451|FG001|Overall Study|Failure to comply with visits|0|||
149991184|NCT01296711|541099452|FG002|Overall Study|Failure to comply with visits|0|||
149991185|NCT01296711|541099453|FG003|Overall Study|Failure to comply with visits|0|||
149991186|NCT01296711|541099454|FG004|Overall Study|Failure to comply with visits|0|||
149991187|NCT01296711|541099455|FG005|Overall Study|Failure to comply with visits|0|||
149991188|NCT01296711|541099456|FG006|Overall Study|Failure to comply with visits|0|||
149991189|NCT01296711|541099457|FG007|Overall Study|Failure to comply with visits|1|||
149991190|NCT01296711|541099450|FG000|Overall Study|Patient decision due to transport|0|||
149991191|NCT01296711|541099451|FG001|Overall Study|Patient decision due to transport|0|||
149991192|NCT01296711|541099452|FG002|Overall Study|Patient decision due to transport|0|||
149991193|NCT01296711|541099453|FG003|Overall Study|Patient decision due to transport|0|||
149991194|NCT01296711|541099454|FG004|Overall Study|Patient decision due to transport|0|||
149991195|NCT01296711|541099455|FG005|Overall Study|Patient decision due to transport|0|||
149991196|NCT01296711|541099456|FG006|Overall Study|Patient decision due to transport|0|||
149991197|NCT01296711|541099457|FG007|Overall Study|Patient decision due to transport|1|||
149991198|NCT00632827|541099458|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
149991199|NCT00632827|541099458|FG000|Overall Study|Death|2|||
149991200|NCT00632827|541099458|FG000|Overall Study|Adverse Event|5|||
149991201|NCT00632827|541099458|FG000|Overall Study|Lost to Follow-up|1|||
149991202|NCT01035463|541099459|FG000|Overall Study|Adverse Event|0|||
149991203|NCT01035463|541099460|FG001|Overall Study|Adverse Event|0|||
149991204|NCT01035463|541099461|FG002|Overall Study|Adverse Event|4|||
149991205|NCT01035463|541099462|FG003|Overall Study|Adverse Event|1|||
149991206|NCT01035463|541099463|FG004|Overall Study|Adverse Event|5|||
149991207|NCT01035463|541099464|FG005|Overall Study|Adverse Event|7|||
149991208|NCT01035463|541099459|FG000|Overall Study|Withdrawal by Subject|0|||
149991209|NCT01035463|541099460|FG001|Overall Study|Withdrawal by Subject|2|||
149991210|NCT01035463|541099461|FG002|Overall Study|Withdrawal by Subject|1|||
149991211|NCT01035463|541099462|FG003|Overall Study|Withdrawal by Subject|0|||
149991212|NCT01035463|541099463|FG004|Overall Study|Withdrawal by Subject|1|||
149991213|NCT01035463|541099464|FG005|Overall Study|Withdrawal by Subject|4|||
149991214|NCT01035463|541099459|FG000|Overall Study|Disease progression|0|||
149991215|NCT01035463|541099460|FG001|Overall Study|Disease progression|0|||
149991216|NCT01035463|541099461|FG002|Overall Study|Disease progression|0|||
149991217|NCT01035463|541099462|FG003|Overall Study|Disease progression|0|||
149991218|NCT01035463|541099463|FG004|Overall Study|Disease progression|0|||
149991219|NCT01035463|541099464|FG005|Overall Study|Disease progression|3|||
149991220|NCT01035463|541099459|FG000|Overall Study|Other Malignancy|0|||
149991221|NCT01035463|541099460|FG001|Overall Study|Other Malignancy|0|||
149991222|NCT01035463|541099461|FG002|Overall Study|Other Malignancy|0|||
149991223|NCT01035463|541099462|FG003|Overall Study|Other Malignancy|0|||
149991224|NCT01035463|541099463|FG004|Overall Study|Other Malignancy|0|||
149991225|NCT01035463|541099464|FG005|Overall Study|Other Malignancy|2|||
149991226|NCT01035463|541099459|FG000|Overall Study|Other|0|||
149991227|NCT01035463|541099460|FG001|Overall Study|Other|0|||
149991228|NCT01035463|541099461|FG002|Overall Study|Other|0|||
149991229|NCT01035463|541099462|FG003|Overall Study|Other|1|||
149991230|NCT01035463|541099463|FG004|Overall Study|Other|0|||
149991231|NCT01035463|541099464|FG005|Overall Study|Other|2|||
149991232|NCT02516098|541099467|FG000|Period 1|Protocol Violation|1|||
149991233|NCT02516098|541099468|FG001|Period 1|Protocol Violation|0|||
149991234|NCT02516098|541099467|FG000|Washout After Period 1|Adverse Event|0|||
149991235|NCT02516098|541099468|FG001|Washout After Period 1|Adverse Event|1|||
149991236|NCT02516098|541099467|FG000|Period 2|Withdrawal by Subject|0|||
149991237|NCT02516098|541099468|FG001|Period 2|Withdrawal by Subject|1|||
149991238|NCT01092780|541099469|FG000|Washout Period 1|Adverse Event|0|||
149991239|NCT01092780|541099470|FG001|Washout Period 1|Adverse Event|1|||
149991240|NCT01092780|541099471|FG002|Washout Period 1|Adverse Event|0|||
149991241|NCT01092780|541099472|FG003|Washout Period 1|Adverse Event|0|||
149991242|NCT01092780|541099469|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
149991243|NCT01092780|541099470|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
149991244|NCT01092780|541099471|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
149991245|NCT01092780|541099472|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
149991246|NCT01092780|541099469|FG000|Washout Period 2|Adverse Event|0|||
149991247|NCT01092780|541099470|FG001|Washout Period 2|Adverse Event|1|||
149991248|NCT01092780|541099471|FG002|Washout Period 2|Adverse Event|1|||
149991249|NCT01092780|541099472|FG003|Washout Period 2|Adverse Event|0|||
149991250|NCT01257230|541099473|FG000|Overall Study|Not Treated|0|||
149991251|NCT01257230|541099474|FG001|Overall Study|Not Treated|0|||
149991252|NCT01257230|541099475|FG002|Overall Study|Not Treated|1|||
149991253|NCT01257230|541099473|FG000|Overall Study|Adverse Event|2|||
149991254|NCT01257230|541099474|FG001|Overall Study|Adverse Event|0|||
149991255|NCT01257230|541099475|FG002|Overall Study|Adverse Event|0|||
149991256|NCT01257230|541099473|FG000|Overall Study|Lack of Efficacy|0|||
149991257|NCT01257230|541099474|FG001|Overall Study|Lack of Efficacy|1|||
149991258|NCT01257230|541099475|FG002|Overall Study|Lack of Efficacy|0|||
149991259|NCT01257230|541099473|FG000|Overall Study|Protocol Violation|3|||
149991260|NCT01257230|541099474|FG001|Overall Study|Protocol Violation|0|||
149991261|NCT01257230|541099475|FG002|Overall Study|Protocol Violation|1|||
149991262|NCT01257230|541099473|FG000|Overall Study|Withdrawal by Subject|0|||
149991263|NCT01257230|541099474|FG001|Overall Study|Withdrawal by Subject|4|||
149991264|NCT01257230|541099475|FG002|Overall Study|Withdrawal by Subject|1|||
149991265|NCT01257230|541099473|FG000|Overall Study|Other reason not defined above|1|||
149991266|NCT01257230|541099474|FG001|Overall Study|Other reason not defined above|5|||
149991267|NCT01257230|541099475|FG002|Overall Study|Other reason not defined above|3|||
149991268|NCT01126268|541099483|FG000|Overall Study|Adverse Event|1|||
149991269|NCT01988662|541099488|FG000|Overall Study|Subject/guardian decision|1|||
149991270|NCT01988662|541099489|FG001|Overall Study|Subject/guardian decision|1|||
149991271|NCT01988662|541099488|FG000|Overall Study|Adverse Event|3|||
149991272|NCT01988662|541099489|FG001|Overall Study|Adverse Event|1|||
149991273|NCT03425006|541099490|FG000|Overall Study|Withdrawal by Subject|1|||
149991274|NCT03425006|541099490|FG000|Overall Study|Physician Decision|1|||
149991275|NCT03425006|541099490|FG000|Overall Study|Death|1|||
149991276|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
149991277|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
149991278|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
149991279|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
149991280|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
149991281|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
149991282|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
149991283|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
149991284|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
149991285|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
149991286|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
150053725|NCT03135119|541338349|FG000|Overall Study|Physician Decision|1|||
150053726|NCT03135119|541338350|FG001|Overall Study|Physician Decision|1|||
149991287|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
149991288|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
149991289|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
149991290|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
149991291|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
149991292|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
149991293|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991294|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991295|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
150053727|NCT03135119|541338349|FG000|Overall Study|COVID-19 Shutdown|2|||
149991296|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991297|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991298|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991299|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991300|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991301|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991302|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991303|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991304|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991305|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149991306|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
149991307|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
149991308|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
150053728|NCT03135119|541338350|FG001|Overall Study|COVID-19 Shutdown|2|||
150053729|NCT01478048|541338351|FG000|Overall Study|Disease Progression|52|||
150053730|NCT01478048|541338352|FG001|Overall Study|Disease Progression|35|||
150053731|NCT01478048|541338351|FG000|Overall Study|study drug toxicity|11|||
150053732|NCT01478048|541338352|FG001|Overall Study|study drug toxicity|14|||
150053733|NCT01478048|541338351|FG000|Overall Study|Adverse Event|2|||
150053734|NCT01478048|541338352|FG001|Overall Study|Adverse Event|11|||
150053735|NCT01478048|541338351|FG000|Overall Study|subject request to discontinue treatment|3|||
150053736|NCT01478048|541338352|FG001|Overall Study|subject request to discontinue treatment|5|||
150053737|NCT01478048|541338351|FG000|Overall Study|Withdrawal by Subject|2|||
150053738|NCT01478048|541338352|FG001|Overall Study|Withdrawal by Subject|5|||
150053739|NCT01478048|541338351|FG000|Overall Study|non-specified|6|||
150053740|NCT01478048|541338352|FG001|Overall Study|non-specified|4|||
150053741|NCT01478048|541338351|FG000|Overall Study|poor/non-compliance|0|||
150178927|NCT00802464|541793881|FG000|Month 0 - Month 8|Adverse Event|0|||
150178928|NCT00802464|541793882|FG001|Month 0 - Month 8|Adverse Event|1|||
150053742|NCT01478048|541338352|FG001|Overall Study|poor/non-compliance|1|||
150053743|NCT01478048|541338351|FG000|Overall Study|no longer meets study criteria|1|||
150053744|NCT01478048|541338352|FG001|Overall Study|no longer meets study criteria|0|||
150053745|NCT01252667|541338357|FG000|Overall Study|Transplant aborted post-conditioning|0|||
150053746|NCT01252667|541338358|FG001|Overall Study|Transplant aborted post-conditioning|0|||
150053747|NCT01252667|541338359|FG002|Overall Study|Transplant aborted post-conditioning|0|||
150053748|NCT01252667|541338360|FG003|Overall Study|Transplant aborted post-conditioning|0|||
150053749|NCT01252667|541338361|FG004|Overall Study|Transplant aborted post-conditioning|0|||
150053750|NCT01252667|541338362|FG005|Overall Study|Transplant aborted post-conditioning|1|||
150053751|NCT04644315|541338363|FG000|Overall Study|Subject withdrawal of consent|1|||
150053752|NCT03032380|541338364|FG000|Overall Study|Adverse Event|0|||
150053753|NCT03032380|541338365|FG001|Overall Study|Adverse Event|1|||
150053754|NCT03032380|541338364|FG000|Overall Study|Lack of Efficacy|1|||
150053755|NCT03032380|541338365|FG001|Overall Study|Lack of Efficacy|0|||
149991309|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
149991310|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
149991311|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
149991312|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
149991313|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
149991314|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
149991315|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
149991316|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
149991317|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
149991318|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
149991319|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
149991320|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
149991321|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
149991322|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
149991323|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
149991324|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
149991325|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
149991326|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
149991327|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
149991328|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
149991329|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
149991330|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
149991331|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
149991332|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
149991333|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
149991334|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
149991335|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
149991336|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
149991337|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
149991338|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
149991339|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
149991340|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150053756|NCT03032380|541338364|FG000|Overall Study|Withdrawal by Subject|2|||
150053757|NCT03032380|541338365|FG001|Overall Study|Withdrawal by Subject|3|||
150053758|NCT03032380|541338364|FG000|Overall Study|Recovery|0|||
150053759|NCT03032380|541338365|FG001|Overall Study|Recovery|1|||
150053760|NCT03032380|541338364|FG000|Overall Study|Death|39|||
149991341|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991342|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991343|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991344|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150053761|NCT03032380|541338365|FG001|Overall Study|Death|34|||
150053762|NCT03032380|541338364|FG000|Overall Study|Other - Miscellaneous|0|||
150053763|NCT03032380|541338365|FG001|Overall Study|Other - Miscellaneous|1|||
149991345|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991346|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991347|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991348|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991349|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991350|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149991351|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
149991352|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
149991353|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
149991354|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
149991355|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991356|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991357|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991358|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991359|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991360|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991361|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991362|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991363|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991364|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991365|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149991366|NCT03831191|541099492|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991367|NCT03831191|541099493|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991368|NCT03831191|541099494|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991369|NCT03831191|541099495|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
149991370|NCT03831191|541099496|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991371|NCT03831191|541099497|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991372|NCT03831191|541099498|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991373|NCT03831191|541099499|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991374|NCT03831191|541099500|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991375|NCT03831191|541099501|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991376|NCT03831191|541099502|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991377|NCT03831191|541099503|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991378|NCT03831191|541099504|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991379|NCT03831191|541099505|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991380|NCT03831191|541099506|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
149991381|NCT03831191|541099492|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
149991382|NCT03831191|541099493|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
149991383|NCT03831191|541099494|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
149991384|NCT03831191|541099495|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
150053764|NCT01836276|541338366|FG000|Overall Study|Lost to Follow-up|28|||
150053765|NCT01836276|541338367|FG001|Overall Study|Lost to Follow-up|51|||
150053766|NCT01561898|541338368|FG000|Overall Study|Withdrawal by Subject|0|||
149991385|NCT03831191|541099496|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
149991386|NCT03831191|541099497|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
149991387|NCT03831191|541099498|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
149991388|NCT03831191|541099499|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
149991389|NCT03831191|541099500|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
149991390|NCT03831191|541099501|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
149991391|NCT03831191|541099502|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
149991392|NCT03831191|541099503|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
149991393|NCT03831191|541099504|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
149991394|NCT03831191|541099505|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
149991395|NCT03831191|541099506|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
149991396|NCT03831191|541099492|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991397|NCT03831191|541099493|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991398|NCT03831191|541099494|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991399|NCT03831191|541099495|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991400|NCT03831191|541099496|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991401|NCT03831191|541099497|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991402|NCT03831191|541099498|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991403|NCT03831191|541099499|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991404|NCT03831191|541099500|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991405|NCT03831191|541099501|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991406|NCT03831191|541099502|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991407|NCT03831191|541099503|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991408|NCT03831191|541099504|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991409|NCT03831191|541099505|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149991410|NCT03831191|541099506|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
149991411|NCT03831191|541099492|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991412|NCT03831191|541099493|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991413|NCT03831191|541099494|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991414|NCT03831191|541099495|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991415|NCT03831191|541099496|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991416|NCT03831191|541099497|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991417|NCT03831191|541099498|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991418|NCT03831191|541099499|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991419|NCT03831191|541099500|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991420|NCT03831191|541099501|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991421|NCT03831191|541099502|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991422|NCT03831191|541099503|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991423|NCT03831191|541099504|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991424|NCT03831191|541099505|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149991425|NCT03831191|541099506|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
149991426|NCT03070171|541099507|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
149991427|NCT03070171|541099508|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
149991428|NCT03070171|541099507|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
149991429|NCT03070171|541099508|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
149991430|NCT00054327|541099514|FG000|Overall Study|Engraftment failure|1|||
149991431|NCT00054327|541099515|FG001|Overall Study|Engraftment failure|0|||
149991432|NCT00054327|541099516|FG002|Overall Study|Engraftment failure|0|||
149991433|NCT00054327|541099517|FG003|Overall Study|Engraftment failure|0|||
149991434|NCT00054327|541099518|FG004|Overall Study|Engraftment failure|0|||
149991435|NCT00054327|541099519|FG005|Overall Study|Engraftment failure|0|||
149991436|NCT00613327|541099520|FG000|Overall Study|Adverse Event|38|||
149991437|NCT00613327|541099520|FG000|Overall Study|Lost to Follow-up|8|||
149991438|NCT00613327|541099520|FG000|Overall Study|Withdrawal by Subject|6|||
149991439|NCT00613327|541099520|FG000|Overall Study|Protocol Violation|2|||
149991440|NCT00613327|541099520|FG000|Overall Study|Other|47|||
149991441|NCT00344318|541099521|FG000|Overall Study|Adverse Event|0|||
149991442|NCT00344318|541099522|FG001|Overall Study|Adverse Event|3|||
149991443|NCT00344318|541099523|FG002|Overall Study|Adverse Event|0|||
149991444|NCT00344318|541099524|FG003|Overall Study|Adverse Event|1|||
149991445|NCT00344318|541099521|FG000|Overall Study|Withdrawal by Subject|2|||
149991446|NCT00344318|541099522|FG001|Overall Study|Withdrawal by Subject|2|||
149991447|NCT00344318|541099523|FG002|Overall Study|Withdrawal by Subject|0|||
149991448|NCT00344318|541099524|FG003|Overall Study|Withdrawal by Subject|2|||
149991449|NCT00344318|541099521|FG000|Overall Study|Lost to Follow-up|2|||
149991450|NCT00344318|541099522|FG001|Overall Study|Lost to Follow-up|0|||
149991451|NCT00344318|541099523|FG002|Overall Study|Lost to Follow-up|1|||
149991452|NCT00344318|541099524|FG003|Overall Study|Lost to Follow-up|0|||
149991453|NCT01606176|541099531|FG000|Overall Study|Adverse Event|2|||
149991454|NCT01606176|541099532|FG001|Overall Study|Adverse Event|3|||
149991455|NCT01606176|541099531|FG000|Overall Study|Disease progression|1|||
149991456|NCT01606176|541099532|FG001|Overall Study|Disease progression|0|||
149991457|NCT01606176|541099531|FG000|Overall Study|Withdrawal by Subject|1|||
149991458|NCT01606176|541099532|FG001|Overall Study|Withdrawal by Subject|0|||
149991459|NCT00361231|541099534|FG000|Overall Study|Physician Decision|3|||
149991460|NCT00361231|541099534|FG000|Overall Study|Symptomatic deterioration|5|||
149991461|NCT00361231|541099534|FG000|Overall Study|Radiographic disease progression|16|||
149991462|NCT00361231|541099534|FG000|Overall Study|Withdrawal by Subject|4|||
149991463|NCT00361231|541099534|FG000|Overall Study|Adverse Event|6|||
149991464|NCT01814397|541099537|FG000|Overall Study|Adverse Event|7|||
149991465|NCT01814397|541099537|FG000|Overall Study|Withdrawal by Subject|7|||
149991466|NCT01732510|541099538|FG000|Overall Study|Adverse Event|0|||
149991467|NCT01732510|541099539|FG001|Overall Study|Adverse Event|1|||
149991468|NCT01732510|541099540|FG002|Overall Study|Adverse Event|1|||
149991469|NCT01732510|541099541|FG003|Overall Study|Adverse Event|0|||
149991470|NCT01732510|541099542|FG004|Overall Study|Adverse Event|0|||
149991471|NCT01732510|541099543|FG005|Overall Study|Adverse Event|0|||
149991472|NCT01732510|541099544|FG006|Overall Study|Adverse Event|1|||
149991473|NCT01732510|541099538|FG000|Overall Study|Protocol Violation|0|||
149991474|NCT01732510|541099539|FG001|Overall Study|Protocol Violation|0|||
149991475|NCT01732510|541099540|FG002|Overall Study|Protocol Violation|0|||
149991476|NCT01732510|541099541|FG003|Overall Study|Protocol Violation|1|||
149991477|NCT01732510|541099542|FG004|Overall Study|Protocol Violation|0|||
149991478|NCT01732510|541099543|FG005|Overall Study|Protocol Violation|0|||
149991479|NCT01732510|541099544|FG006|Overall Study|Protocol Violation|0|||
149991480|NCT01732510|541099538|FG000|Overall Study|Withdrawal by Subject|1|||
149991481|NCT01732510|541099539|FG001|Overall Study|Withdrawal by Subject|3|||
149991482|NCT01732510|541099540|FG002|Overall Study|Withdrawal by Subject|2|||
149991483|NCT01732510|541099541|FG003|Overall Study|Withdrawal by Subject|1|||
149991484|NCT01732510|541099542|FG004|Overall Study|Withdrawal by Subject|5|||
149991485|NCT01732510|541099543|FG005|Overall Study|Withdrawal by Subject|0|||
149991486|NCT01732510|541099544|FG006|Overall Study|Withdrawal by Subject|1|||
149991487|NCT01732510|541099538|FG000|Overall Study|Lost to Follow-up|0|||
149991488|NCT01732510|541099539|FG001|Overall Study|Lost to Follow-up|0|||
149991489|NCT01732510|541099540|FG002|Overall Study|Lost to Follow-up|1|||
149991490|NCT01732510|541099541|FG003|Overall Study|Lost to Follow-up|1|||
149991491|NCT01732510|541099542|FG004|Overall Study|Lost to Follow-up|0|||
149991492|NCT01732510|541099543|FG005|Overall Study|Lost to Follow-up|1|||
149991493|NCT01732510|541099544|FG006|Overall Study|Lost to Follow-up|0|||
149991494|NCT01732510|541099538|FG000|Overall Study|Physician Decision|0|||
149991495|NCT01732510|541099539|FG001|Overall Study|Physician Decision|1|||
149991496|NCT01732510|541099540|FG002|Overall Study|Physician Decision|0|||
149991497|NCT01732510|541099541|FG003|Overall Study|Physician Decision|0|||
149991498|NCT01732510|541099542|FG004|Overall Study|Physician Decision|0|||
149991499|NCT01732510|541099543|FG005|Overall Study|Physician Decision|0|||
149991500|NCT01732510|541099544|FG006|Overall Study|Physician Decision|0|||
149991501|NCT01732510|541099538|FG000|Overall Study|Pregnancy|0|||
149991502|NCT01732510|541099539|FG001|Overall Study|Pregnancy|0|||
150053767|NCT01561898|541338369|FG001|Overall Study|Withdrawal by Subject|8|||
150053768|NCT01561898|541338370|FG002|Overall Study|Withdrawal by Subject|12|||
150053769|NCT01561898|541338371|FG003|Overall Study|Withdrawal by Subject|5|||
150053770|NCT01561898|541338368|FG000|Overall Study|Lack of Efficacy|0|||
150053771|NCT01561898|541338369|FG001|Overall Study|Lack of Efficacy|8|||
150053772|NCT01561898|541338370|FG002|Overall Study|Lack of Efficacy|10|||
150053773|NCT01561898|541338371|FG003|Overall Study|Lack of Efficacy|5|||
150053774|NCT01561898|541338368|FG000|Overall Study|Worsening of complications|0|||
150053775|NCT01561898|541338369|FG001|Overall Study|Worsening of complications|1|||
150053776|NCT01561898|541338370|FG002|Overall Study|Worsening of complications|0|||
150053777|NCT01561898|541338371|FG003|Overall Study|Worsening of complications|0|||
150053778|NCT01561898|541338368|FG000|Overall Study|Lost to Follow-up|0|||
150053779|NCT01561898|541338369|FG001|Overall Study|Lost to Follow-up|0|||
150053780|NCT01561898|541338370|FG002|Overall Study|Lost to Follow-up|1|||
150053781|NCT01561898|541338371|FG003|Overall Study|Lost to Follow-up|0|||
150053782|NCT01561898|541338368|FG000|Overall Study|Adverse Event|1|||
150053783|NCT01561898|541338369|FG001|Overall Study|Adverse Event|19|||
150053784|NCT01561898|541338370|FG002|Overall Study|Adverse Event|14|||
149991503|NCT01732510|541099540|FG002|Overall Study|Pregnancy|0|||
149991504|NCT01732510|541099541|FG003|Overall Study|Pregnancy|1|||
149991505|NCT01732510|541099542|FG004|Overall Study|Pregnancy|0|||
149991506|NCT01732510|541099543|FG005|Overall Study|Pregnancy|0|||
149991507|NCT01732510|541099544|FG006|Overall Study|Pregnancy|0|||
149991508|NCT01732510|541099538|FG000|Overall Study|Study Terminated By Sponsor|0|||
149991509|NCT01732510|541099539|FG001|Overall Study|Study Terminated By Sponsor|0|||
149991510|NCT01732510|541099540|FG002|Overall Study|Study Terminated By Sponsor|0|||
149991511|NCT01732510|541099541|FG003|Overall Study|Study Terminated By Sponsor|1|||
149991512|NCT01732510|541099542|FG004|Overall Study|Study Terminated By Sponsor|0|||
149991513|NCT01732510|541099543|FG005|Overall Study|Study Terminated By Sponsor|12|||
149991514|NCT01732510|541099544|FG006|Overall Study|Study Terminated By Sponsor|6|||
149991515|NCT00244933|541099545|FG000|Overall Study|Not response evaluable|2|||
150053785|NCT01561898|541338371|FG003|Overall Study|Adverse Event|9|||
150053786|NCT01561898|541338368|FG000|Overall Study|Physician Decision|1|||
149991516|NCT01208961|541099546|FG000|High-Fat Period III|Protocol Violation|1|||
150053787|NCT01561898|541338369|FG001|Overall Study|Physician Decision|5|||
150053788|NCT01561898|541338370|FG002|Overall Study|Physician Decision|7|||
149991517|NCT01208961|541099547|FG001|High-Fat Period III|Protocol Violation|0|||
149991518|NCT02791516|541099550|FG000|Overall Study|Withdrawal by Subject|1|||
149991519|NCT02791516|541099551|FG001|Overall Study|Withdrawal by Subject|1|||
149991520|NCT02524275|541099552|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
149991521|NCT01439971|541099553|FG000|Overall Study|Required number in cohort dosed|0|||
149991522|NCT01439971|541099554|FG001|Overall Study|Required number in cohort dosed|1|||
149991523|NCT01439971|541099555|FG002|Overall Study|Required number in cohort dosed|2|||
149991524|NCT01439971|541099556|FG003|Overall Study|Required number in cohort dosed|0|||
149991525|NCT01439971|541099557|FG004|Overall Study|Required number in cohort dosed|1|||
149991526|NCT02147197|541099561|FG000|Overall Study|Adverse Event|1|||
149991527|NCT02147197|541099562|FG001|Overall Study|Adverse Event|0|||
149991528|NCT02147197|541099563|FG002|Overall Study|Adverse Event|0|||
149991529|NCT02147197|541099561|FG000|Overall Study|Withdrawal of Consent|4|||
149991530|NCT02147197|541099562|FG001|Overall Study|Withdrawal of Consent|3|||
149991531|NCT02147197|541099563|FG002|Overall Study|Withdrawal of Consent|2|||
149991532|NCT02147197|541099561|FG000|Overall Study|Lost to Follow-up|2|||
149991533|NCT02147197|541099562|FG001|Overall Study|Lost to Follow-up|3|||
149991534|NCT02147197|541099563|FG002|Overall Study|Lost to Follow-up|1|||
149991535|NCT02147197|541099561|FG000|Overall Study|Protocol Violation|1|||
149991536|NCT02147197|541099562|FG001|Overall Study|Protocol Violation|0|||
149991537|NCT02147197|541099563|FG002|Overall Study|Protocol Violation|3|||
149991538|NCT02147197|541099561|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149991539|NCT02147197|541099562|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149991540|NCT02147197|541099563|FG002|Overall Study|Other Miscellaneous Reasons|3|||
149991541|NCT02640625|541101975|FG000|Overall Study|Adverse Event|1|||
149991542|NCT00197145|541101977|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
149991543|NCT00197145|541101978|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
149991544|NCT00197145|541101977|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
149991545|NCT00197145|541101978|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
149991546|NCT00197145|541101977|FG000|Period 1: Randomized Treatment Phase|Other|2|||
149991547|NCT00197145|541101978|FG001|Period 1: Randomized Treatment Phase|Other|2|||
149991548|NCT00197145|541101977|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
149991549|NCT00197145|541101978|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
149991550|NCT00197145|541101977|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
149991551|NCT00197145|541101978|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
149991552|NCT00197145|541101977|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
149991553|NCT00197145|541101978|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
149991554|NCT00197145|541101977|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
149991555|NCT00197145|541101978|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
149991556|NCT00197145|541101977|FG000|Period 2 : Open Label Phase|Other|1|||
149991557|NCT00197145|541101978|FG001|Period 2 : Open Label Phase|Other|0|||
149991558|NCT03596047|541101984|FG000|Overall Study|Withdrawal by Subject|7|||
149991559|NCT03596047|541101985|FG001|Overall Study|Withdrawal by Subject|4|||
149991560|NCT03596047|541101984|FG000|Overall Study|Lost to Follow-up|0|||
149991561|NCT03596047|541101985|FG001|Overall Study|Lost to Follow-up|2|||
149991562|NCT00306293|541101986|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
149991563|NCT00306293|541101987|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
149991564|NCT00306293|541101986|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
149991565|NCT00306293|541101987|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
150053789|NCT01561898|541338371|FG003|Overall Study|Physician Decision|1|||
149991566|NCT00306293|541101986|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
149991567|NCT00306293|541101987|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
149991568|NCT00306293|541101986|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
149991569|NCT00306293|541101987|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
149991570|NCT00306293|541101986|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
149991571|NCT00306293|541101987|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
150053790|NCT00331552|541338374|FG000|Period 3: Phase II|Neurological Symptoms|1|||
150053791|NCT00331552|541338375|FG001|Period 3: Phase II|Neurological Symptoms|0|||
149991572|NCT00306293|541101986|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
149991573|NCT00306293|541101987|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
149991574|NCT00306293|541101986|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
149991575|NCT00306293|541101987|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
149991576|NCT00306293|541101986|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
149991577|NCT00306293|541101987|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
149991578|NCT00185380|541101988|FG000|Overall Study|Adverse Event|41|||
149991579|NCT00185380|541101989|FG001|Overall Study|Adverse Event|43|||
149991580|NCT00185380|541101990|FG002|Overall Study|Adverse Event|48|||
149991581|NCT00185380|541101988|FG000|Overall Study|Lost to Follow-up|0|||
149991582|NCT00185380|541101989|FG001|Overall Study|Lost to Follow-up|4|||
149991583|NCT00185380|541101990|FG002|Overall Study|Lost to Follow-up|3|||
149991584|NCT00185380|541101988|FG000|Overall Study|Pregnancy|1|||
149991585|NCT00185380|541101989|FG001|Overall Study|Pregnancy|4|||
149991586|NCT00185380|541101990|FG002|Overall Study|Pregnancy|0|||
149991587|NCT00185380|541101988|FG000|Overall Study|Protocol Violation|2|||
149991588|NCT00185380|541101989|FG001|Overall Study|Protocol Violation|2|||
149991589|NCT00185380|541101990|FG002|Overall Study|Protocol Violation|1|||
149991590|NCT00185380|541101988|FG000|Overall Study|Withdrawal by Subject|1|||
149991591|NCT00185380|541101989|FG001|Overall Study|Withdrawal by Subject|2|||
149991592|NCT00185380|541101990|FG002|Overall Study|Withdrawal by Subject|0|||
149991593|NCT00185380|541101988|FG000|Overall Study|Failed insertion|1|||
149991594|NCT00185380|541101989|FG001|Overall Study|Failed insertion|1|||
149991595|NCT00185380|541101990|FG002|Overall Study|Failed insertion|2|||
149991596|NCT00185380|541101988|FG000|Overall Study|Planned pregnancy|9|||
149991597|NCT00185380|541101989|FG001|Overall Study|Planned pregnancy|12|||
149991598|NCT00185380|541101990|FG002|Overall Study|Planned pregnancy|12|||
149991599|NCT00185380|541101988|FG000|Overall Study|No need for contraception|3|||
149991600|NCT00185380|541101989|FG001|Overall Study|No need for contraception|3|||
149991601|NCT00185380|541101990|FG002|Overall Study|No need for contraception|3|||
149991602|NCT00185380|541101988|FG000|Overall Study|Could not attend visits|2|||
149991603|NCT00185380|541101989|FG001|Overall Study|Could not attend visits|0|||
149991604|NCT00185380|541101990|FG002|Overall Study|Could not attend visits|4|||
149991605|NCT00185380|541101988|FG000|Overall Study|personal reason|6|||
149991606|NCT00185380|541101989|FG001|Overall Study|personal reason|1|||
149991607|NCT00185380|541101990|FG002|Overall Study|personal reason|1|||
149991608|NCT02589665|541101992|FG000|Induction Period|Did not receive drug|0|||
149991609|NCT02589665|541101993|FG001|Induction Period|Did not receive drug|0|||
149991610|NCT02589665|541101994|FG002|Induction Period|Did not receive drug|0|||
149991611|NCT02589665|541101995|FG003|Induction Period|Did not receive drug|1|||
149991612|NCT02589665|541101996|FG004|Induction Period|Did not receive drug|0|||
149991613|NCT02589665|541101997|FG005|Induction Period|Did not receive drug|0|||
149991614|NCT02589665|541101998|FG006|Induction Period|Did not receive drug|0|||
149991615|NCT02589665|541101999|FG007|Induction Period|Did not receive drug|0|||
149991616|NCT02589665|541102000|FG008|Induction Period|Did not receive drug|0|||
149991617|NCT02589665|541102001|FG009|Induction Period|Did not receive drug|0|||
149991618|NCT02589665|541101992|FG000|Induction Period|Adverse Event|3|||
149991619|NCT02589665|541101993|FG001|Induction Period|Adverse Event|0|||
149991620|NCT02589665|541101994|FG002|Induction Period|Adverse Event|2|||
149991621|NCT02589665|541101995|FG003|Induction Period|Adverse Event|2|||
149991622|NCT02589665|541101996|FG004|Induction Period|Adverse Event|0|||
149991623|NCT02589665|541101997|FG005|Induction Period|Adverse Event|0|||
149991624|NCT02589665|541101998|FG006|Induction Period|Adverse Event|0|||
149991625|NCT02589665|541101999|FG007|Induction Period|Adverse Event|0|||
149991626|NCT02589665|541102000|FG008|Induction Period|Adverse Event|0|||
149991627|NCT02589665|541102001|FG009|Induction Period|Adverse Event|0|||
149991628|NCT02589665|541101992|FG000|Induction Period|Withdrawal by Subject|0|||
149991629|NCT02589665|541101993|FG001|Induction Period|Withdrawal by Subject|1|||
149991630|NCT02589665|541101994|FG002|Induction Period|Withdrawal by Subject|0|||
149991631|NCT02589665|541101995|FG003|Induction Period|Withdrawal by Subject|1|||
149991632|NCT02589665|541101996|FG004|Induction Period|Withdrawal by Subject|0|||
149991633|NCT02589665|541101997|FG005|Induction Period|Withdrawal by Subject|0|||
149991634|NCT02589665|541101998|FG006|Induction Period|Withdrawal by Subject|0|||
149991635|NCT02589665|541101999|FG007|Induction Period|Withdrawal by Subject|0|||
149991636|NCT02589665|541102000|FG008|Induction Period|Withdrawal by Subject|0|||
149991637|NCT02589665|541102001|FG009|Induction Period|Withdrawal by Subject|0|||
149991638|NCT02589665|541101992|FG000|Induction Period|Protocol Violation|0|||
149991639|NCT02589665|541101993|FG001|Induction Period|Protocol Violation|1|||
149991640|NCT02589665|541101994|FG002|Induction Period|Protocol Violation|0|||
149991641|NCT02589665|541101995|FG003|Induction Period|Protocol Violation|0|||
149991642|NCT02589665|541101996|FG004|Induction Period|Protocol Violation|0|||
149991643|NCT02589665|541101997|FG005|Induction Period|Protocol Violation|0|||
149991644|NCT02589665|541101998|FG006|Induction Period|Protocol Violation|0|||
149991645|NCT02589665|541101999|FG007|Induction Period|Protocol Violation|0|||
149991646|NCT02589665|541102000|FG008|Induction Period|Protocol Violation|0|||
149991647|NCT02589665|541102001|FG009|Induction Period|Protocol Violation|0|||
149991648|NCT02589665|541101992|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991649|NCT02589665|541101993|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991650|NCT02589665|541101994|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991651|NCT02589665|541101995|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991652|NCT02589665|541101996|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
149991653|NCT02589665|541101997|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
149991654|NCT02589665|541101998|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
149991655|NCT02589665|541101999|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991656|NCT02589665|541102000|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991657|NCT02589665|541102001|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991658|NCT02589665|541101992|FG000|Maintenance Period|Withdrawal by Subject|0|||
149991659|NCT02589665|541101993|FG001|Maintenance Period|Withdrawal by Subject|0|||
149991660|NCT02589665|541101994|FG002|Maintenance Period|Withdrawal by Subject|0|||
149991661|NCT02589665|541101995|FG003|Maintenance Period|Withdrawal by Subject|0|||
149991662|NCT02589665|541101996|FG004|Maintenance Period|Withdrawal by Subject|4|||
149991663|NCT02589665|541101997|FG005|Maintenance Period|Withdrawal by Subject|2|||
149991664|NCT02589665|541101998|FG006|Maintenance Period|Withdrawal by Subject|4|||
149991665|NCT02589665|541101999|FG007|Maintenance Period|Withdrawal by Subject|0|||
149991666|NCT02589665|541102000|FG008|Maintenance Period|Withdrawal by Subject|0|||
149991667|NCT02589665|541102001|FG009|Maintenance Period|Withdrawal by Subject|0|||
149991668|NCT02589665|541101992|FG000|Maintenance Period|Lack of Efficacy|0|||
149991669|NCT02589665|541101993|FG001|Maintenance Period|Lack of Efficacy|0|||
149991670|NCT02589665|541101994|FG002|Maintenance Period|Lack of Efficacy|0|||
149991671|NCT02589665|541101995|FG003|Maintenance Period|Lack of Efficacy|0|||
149991672|NCT02589665|541101996|FG004|Maintenance Period|Lack of Efficacy|2|||
149991673|NCT02589665|541101997|FG005|Maintenance Period|Lack of Efficacy|1|||
149991674|NCT02589665|541101998|FG006|Maintenance Period|Lack of Efficacy|0|||
149991675|NCT02589665|541101999|FG007|Maintenance Period|Lack of Efficacy|0|||
149991676|NCT02589665|541102000|FG008|Maintenance Period|Lack of Efficacy|0|||
149991677|NCT02589665|541102001|FG009|Maintenance Period|Lack of Efficacy|0|||
149991678|NCT02589665|541101992|FG000|Maintenance Period|Adverse Event|0|||
149991679|NCT02589665|541101993|FG001|Maintenance Period|Adverse Event|0|||
149991680|NCT02589665|541101994|FG002|Maintenance Period|Adverse Event|0|||
149991681|NCT02589665|541101995|FG003|Maintenance Period|Adverse Event|0|||
149991682|NCT02589665|541101996|FG004|Maintenance Period|Adverse Event|0|||
149991683|NCT02589665|541101997|FG005|Maintenance Period|Adverse Event|0|||
149991684|NCT02589665|541101998|FG006|Maintenance Period|Adverse Event|2|||
149991685|NCT02589665|541101999|FG007|Maintenance Period|Adverse Event|0|||
149991686|NCT02589665|541102000|FG008|Maintenance Period|Adverse Event|0|||
149991687|NCT02589665|541102001|FG009|Maintenance Period|Adverse Event|0|||
149991688|NCT02589665|541101992|FG000|Maintenance Period|Lost to Follow-up|0|||
149991689|NCT02589665|541101993|FG001|Maintenance Period|Lost to Follow-up|0|||
149991690|NCT02589665|541101994|FG002|Maintenance Period|Lost to Follow-up|0|||
149991691|NCT02589665|541101995|FG003|Maintenance Period|Lost to Follow-up|0|||
149991692|NCT02589665|541101996|FG004|Maintenance Period|Lost to Follow-up|0|||
149991693|NCT02589665|541101997|FG005|Maintenance Period|Lost to Follow-up|1|||
149991694|NCT02589665|541101998|FG006|Maintenance Period|Lost to Follow-up|0|||
149991695|NCT02589665|541101999|FG007|Maintenance Period|Lost to Follow-up|0|||
149991696|NCT02589665|541102000|FG008|Maintenance Period|Lost to Follow-up|0|||
149991697|NCT02589665|541102001|FG009|Maintenance Period|Lost to Follow-up|0|||
149991698|NCT02589665|541101992|FG000|Maintenance Period|Physician Decision|0|||
149991699|NCT02589665|541101993|FG001|Maintenance Period|Physician Decision|0|||
149991700|NCT02589665|541101994|FG002|Maintenance Period|Physician Decision|0|||
150053792|NCT00331552|541338374|FG000|Period 3: Phase II|Severe Nausea|1|||
150053793|NCT00331552|541338375|FG001|Period 3: Phase II|Severe Nausea|0|||
149991701|NCT02589665|541101995|FG003|Maintenance Period|Physician Decision|0|||
149991702|NCT02589665|541101996|FG004|Maintenance Period|Physician Decision|0|||
149991703|NCT02589665|541101997|FG005|Maintenance Period|Physician Decision|1|||
149991704|NCT02589665|541101998|FG006|Maintenance Period|Physician Decision|0|||
149991705|NCT02589665|541101999|FG007|Maintenance Period|Physician Decision|0|||
149991706|NCT02589665|541102000|FG008|Maintenance Period|Physician Decision|0|||
149991707|NCT02589665|541102001|FG009|Maintenance Period|Physician Decision|0|||
149991708|NCT02589665|541101992|FG000|Maintenance Period|Reason Not Collected|0|||
149991709|NCT02589665|541101993|FG001|Maintenance Period|Reason Not Collected|0|||
149991710|NCT02589665|541101994|FG002|Maintenance Period|Reason Not Collected|0|||
149991711|NCT02589665|541101995|FG003|Maintenance Period|Reason Not Collected|0|||
149991712|NCT02589665|541101996|FG004|Maintenance Period|Reason Not Collected|0|||
149991713|NCT02589665|541101997|FG005|Maintenance Period|Reason Not Collected|1|||
149991714|NCT02589665|541101998|FG006|Maintenance Period|Reason Not Collected|1|||
149991715|NCT02589665|541101999|FG007|Maintenance Period|Reason Not Collected|0|||
149991716|NCT02589665|541102000|FG008|Maintenance Period|Reason Not Collected|0|||
149991717|NCT02589665|541102001|FG009|Maintenance Period|Reason Not Collected|0|||
149991718|NCT02589665|541101992|FG000|Induction Extension Period|Adverse Event|0|||
149991719|NCT02589665|541101993|FG001|Induction Extension Period|Adverse Event|0|||
149991720|NCT02589665|541101994|FG002|Induction Extension Period|Adverse Event|0|||
149991721|NCT02589665|541101995|FG003|Induction Extension Period|Adverse Event|0|||
149991722|NCT02589665|541101996|FG004|Induction Extension Period|Adverse Event|0|||
149991723|NCT02589665|541101997|FG005|Induction Extension Period|Adverse Event|0|||
149991724|NCT02589665|541101998|FG006|Induction Extension Period|Adverse Event|0|||
149991725|NCT02589665|541101999|FG007|Induction Extension Period|Adverse Event|0|||
149991726|NCT02589665|541102000|FG008|Induction Extension Period|Adverse Event|4|||
149991727|NCT02589665|541102001|FG009|Induction Extension Period|Adverse Event|0|||
149991728|NCT02589665|541101992|FG000|Induction Extension Period|Lack of Efficacy|0|||
149991729|NCT02589665|541101993|FG001|Induction Extension Period|Lack of Efficacy|0|||
149991730|NCT02589665|541101994|FG002|Induction Extension Period|Lack of Efficacy|0|||
149991731|NCT02589665|541101995|FG003|Induction Extension Period|Lack of Efficacy|0|||
149991732|NCT02589665|541101996|FG004|Induction Extension Period|Lack of Efficacy|0|||
149991733|NCT02589665|541101997|FG005|Induction Extension Period|Lack of Efficacy|0|||
149991734|NCT02589665|541101998|FG006|Induction Extension Period|Lack of Efficacy|0|||
149991735|NCT02589665|541101999|FG007|Induction Extension Period|Lack of Efficacy|0|||
149991736|NCT02589665|541102000|FG008|Induction Extension Period|Lack of Efficacy|3|||
149991737|NCT02589665|541102001|FG009|Induction Extension Period|Lack of Efficacy|0|||
149991738|NCT02589665|541101992|FG000|Induction Extension Period|Withdrawal by Subject|0|||
149991739|NCT02589665|541101993|FG001|Induction Extension Period|Withdrawal by Subject|0|||
149991740|NCT02589665|541101994|FG002|Induction Extension Period|Withdrawal by Subject|0|||
149991741|NCT02589665|541101995|FG003|Induction Extension Period|Withdrawal by Subject|0|||
149991742|NCT02589665|541101996|FG004|Induction Extension Period|Withdrawal by Subject|0|||
149991743|NCT02589665|541101997|FG005|Induction Extension Period|Withdrawal by Subject|0|||
149991744|NCT02589665|541101998|FG006|Induction Extension Period|Withdrawal by Subject|0|||
149991745|NCT02589665|541101999|FG007|Induction Extension Period|Withdrawal by Subject|2|||
149991746|NCT02589665|541102000|FG008|Induction Extension Period|Withdrawal by Subject|3|||
149991747|NCT02589665|541102001|FG009|Induction Extension Period|Withdrawal by Subject|0|||
149991748|NCT02589665|541101992|FG000|Induction Extension Period|Physician Decision|0|||
149991749|NCT02589665|541101993|FG001|Induction Extension Period|Physician Decision|0|||
149991750|NCT02589665|541101994|FG002|Induction Extension Period|Physician Decision|0|||
149991751|NCT02589665|541101995|FG003|Induction Extension Period|Physician Decision|0|||
149991752|NCT02589665|541101996|FG004|Induction Extension Period|Physician Decision|0|||
149991753|NCT02589665|541101997|FG005|Induction Extension Period|Physician Decision|0|||
149991754|NCT02589665|541101998|FG006|Induction Extension Period|Physician Decision|0|||
149991755|NCT02589665|541101999|FG007|Induction Extension Period|Physician Decision|0|||
149991756|NCT02589665|541102000|FG008|Induction Extension Period|Physician Decision|1|||
149991757|NCT02589665|541102001|FG009|Induction Extension Period|Physician Decision|0|||
149991758|NCT02589665|541101992|FG000|Induction Extension Period|Reason Not Collected|0|||
149991759|NCT02589665|541101993|FG001|Induction Extension Period|Reason Not Collected|0|||
149991760|NCT02589665|541101994|FG002|Induction Extension Period|Reason Not Collected|0|||
149991761|NCT02589665|541101995|FG003|Induction Extension Period|Reason Not Collected|0|||
149991762|NCT02589665|541101996|FG004|Induction Extension Period|Reason Not Collected|0|||
149991763|NCT02589665|541101997|FG005|Induction Extension Period|Reason Not Collected|0|||
149991764|NCT02589665|541101998|FG006|Induction Extension Period|Reason Not Collected|0|||
149991765|NCT02589665|541101999|FG007|Induction Extension Period|Reason Not Collected|0|||
149991766|NCT02589665|541102000|FG008|Induction Extension Period|Reason Not Collected|1|||
149991767|NCT02589665|541102001|FG009|Induction Extension Period|Reason Not Collected|0|||
149991768|NCT02589665|541101992|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991769|NCT02589665|541101993|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991770|NCT02589665|541101994|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991771|NCT02589665|541101995|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991772|NCT02589665|541101996|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991773|NCT02589665|541101997|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991774|NCT02589665|541101998|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991775|NCT02589665|541101999|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991776|NCT02589665|541102000|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
149991777|NCT02589665|541102001|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
149991778|NCT02589665|541101992|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
149991779|NCT02589665|541101993|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
149991780|NCT02589665|541101994|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
149991781|NCT02589665|541101995|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
149991782|NCT02589665|541101996|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
149991783|NCT02589665|541101997|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
149991784|NCT02589665|541101998|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
149991785|NCT02589665|541101999|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
149991786|NCT02589665|541102000|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
149991787|NCT02589665|541102001|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
149991788|NCT02589665|541101992|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
149991789|NCT02589665|541101993|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
149991790|NCT02589665|541101994|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
149991791|NCT02589665|541101995|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
149991792|NCT02589665|541101996|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
149991793|NCT02589665|541101997|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
149991794|NCT02589665|541101998|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
149991795|NCT02589665|541101999|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
149991796|NCT02589665|541102000|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
149991797|NCT02589665|541102001|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
149991798|NCT02589665|541101992|FG000|Maintenance Extension Period|Adverse Event|0|||
149991799|NCT02589665|541101993|FG001|Maintenance Extension Period|Adverse Event|0|||
149991800|NCT02589665|541101994|FG002|Maintenance Extension Period|Adverse Event|0|||
149991801|NCT02589665|541101995|FG003|Maintenance Extension Period|Adverse Event|0|||
149991802|NCT02589665|541101996|FG004|Maintenance Extension Period|Adverse Event|0|||
149991803|NCT02589665|541101997|FG005|Maintenance Extension Period|Adverse Event|0|||
149991804|NCT02589665|541101998|FG006|Maintenance Extension Period|Adverse Event|0|||
149991805|NCT02589665|541101999|FG007|Maintenance Extension Period|Adverse Event|0|||
149991806|NCT02589665|541102000|FG008|Maintenance Extension Period|Adverse Event|0|||
149991807|NCT02589665|541102001|FG009|Maintenance Extension Period|Adverse Event|2|||
149991808|NCT02589665|541101992|FG000|Maintenance Extension Period|Non-responder|0|||
149991809|NCT02589665|541101993|FG001|Maintenance Extension Period|Non-responder|0|||
149991810|NCT02589665|541101994|FG002|Maintenance Extension Period|Non-responder|0|||
149991811|NCT02589665|541101995|FG003|Maintenance Extension Period|Non-responder|0|||
149991812|NCT02589665|541101996|FG004|Maintenance Extension Period|Non-responder|0|||
149991813|NCT02589665|541101997|FG005|Maintenance Extension Period|Non-responder|0|||
149991814|NCT02589665|541101998|FG006|Maintenance Extension Period|Non-responder|0|||
149991815|NCT02589665|541101999|FG007|Maintenance Extension Period|Non-responder|0|||
149991816|NCT02589665|541102000|FG008|Maintenance Extension Period|Non-responder|0|||
149991817|NCT02589665|541102001|FG009|Maintenance Extension Period|Non-responder|1|||
149991818|NCT00978380|541102004|FG000|Overall Study|Protocol Violation|2|||
149991819|NCT00978380|541102004|FG000|Overall Study|Withdrawal criteria|9|||
149991820|NCT00978380|541102004|FG000|Overall Study|Unclassified|8|||
149991821|NCT02199314|541102005|FG000|Overall Study|Withdrawal by Subject|6|||
149991822|NCT02199314|541102005|FG000|Overall Study|Physician Decision|10|||
149991823|NCT00176488|541102006|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
149991824|NCT00327015|541102007|FG000|Overall Study|Lack of Efficacy|18|||
149991825|NCT00327015|541102008|FG001|Overall Study|Lack of Efficacy|18|||
149991826|NCT00327015|541102009|FG002|Overall Study|Lack of Efficacy|35|||
149991827|NCT00327015|541102010|FG003|Overall Study|Lack of Efficacy|29|||
149991828|NCT00327015|541102007|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
149991829|NCT00327015|541102008|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
149991830|NCT00327015|541102009|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
149991831|NCT00327015|541102010|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
149991832|NCT00327015|541102007|FG000|Overall Study|Lost to Follow-up|22|||
149991833|NCT00327015|541102008|FG001|Overall Study|Lost to Follow-up|23|||
149991834|NCT00327015|541102009|FG002|Overall Study|Lost to Follow-up|29|||
149991835|NCT00327015|541102010|FG003|Overall Study|Lost to Follow-up|22|||
149991836|NCT00327015|541102007|FG000|Overall Study|Adverse Event|14|||
150053794|NCT01445548|541338376|FG000|Overall Study|Adverse Event|1|||
150053795|NCT01883453|541338377|FG000|Overall Study|No episode of common cold|25|||
150053796|NCT01883453|541338378|FG001|Overall Study|No episode of common cold|23|||
150053797|NCT03642132|541338383|FG000|Chemotherapy Period|Adverse Event|1|||
149991837|NCT00327015|541102008|FG001|Overall Study|Adverse Event|10|||
149991838|NCT00327015|541102009|FG002|Overall Study|Adverse Event|14|||
149991839|NCT00327015|541102010|FG003|Overall Study|Adverse Event|14|||
149991840|NCT00327015|541102007|FG000|Overall Study|Subject no longer meets study criteria|4|||
149991841|NCT00327015|541102008|FG001|Overall Study|Subject no longer meets study criteria|2|||
150053798|NCT03642132|541338384|FG001|Chemotherapy Period|Adverse Event|1|||
149991842|NCT00327015|541102009|FG002|Overall Study|Subject no longer meets study criteria|8|||
150053799|NCT03642132|541338385|FG002|Chemotherapy Period|Adverse Event|0|||
149991843|NCT00327015|541102010|FG003|Overall Study|Subject no longer meets study criteria|7|||
149991844|NCT00327015|541102007|FG000|Overall Study|Poor/Noncompliance|11|||
149991845|NCT00327015|541102008|FG001|Overall Study|Poor/Noncompliance|8|||
149991846|NCT00327015|541102009|FG002|Overall Study|Poor/Noncompliance|4|||
149991847|NCT00327015|541102010|FG003|Overall Study|Poor/Noncompliance|5|||
149991848|NCT00327015|541102007|FG000|Overall Study|Physician Decision|0|||
149991849|NCT00327015|541102008|FG001|Overall Study|Physician Decision|1|||
149991850|NCT00327015|541102009|FG002|Overall Study|Physician Decision|3|||
149991851|NCT00327015|541102010|FG003|Overall Study|Physician Decision|2|||
149991852|NCT00327015|541102007|FG000|Overall Study|Death|1|||
149991853|NCT00327015|541102008|FG001|Overall Study|Death|2|||
149991854|NCT00327015|541102009|FG002|Overall Study|Death|2|||
149991855|NCT00327015|541102010|FG003|Overall Study|Death|3|||
149991856|NCT00327015|541102007|FG000|Overall Study|Pregnancy|0|||
149991857|NCT00327015|541102008|FG001|Overall Study|Pregnancy|2|||
149991858|NCT00327015|541102009|FG002|Overall Study|Pregnancy|1|||
149991859|NCT00327015|541102010|FG003|Overall Study|Pregnancy|1|||
149991860|NCT00327015|541102007|FG000|Overall Study|Administrative Reason by Sponsor|1|||
149991861|NCT00327015|541102008|FG001|Overall Study|Administrative Reason by Sponsor|2|||
149991862|NCT00327015|541102009|FG002|Overall Study|Administrative Reason by Sponsor|2|||
149991863|NCT00327015|541102010|FG003|Overall Study|Administrative Reason by Sponsor|1|||
149991864|NCT02650804|541102011|FG000|Overall Study|Adverse Event|3|||
149991865|NCT02650804|541102012|FG001|Overall Study|Adverse Event|2|||
149991866|NCT02650804|541102011|FG000|Overall Study|Death|1|||
149991867|NCT02650804|541102012|FG001|Overall Study|Death|2|||
149991868|NCT02650804|541102011|FG000|Overall Study|Progressive Disease|7|||
149991869|NCT02650804|541102012|FG001|Overall Study|Progressive Disease|10|||
149991870|NCT02650804|541102011|FG000|Overall Study|Physician Decision|0|||
149991871|NCT02650804|541102012|FG001|Overall Study|Physician Decision|2|||
149991872|NCT02650804|541102011|FG000|Overall Study|Withdrawal by Subject|1|||
149991873|NCT02650804|541102012|FG001|Overall Study|Withdrawal by Subject|4|||
149991874|NCT02650804|541102011|FG000|Overall Study|Symptomatic deterioration|5|||
149991875|NCT02650804|541102012|FG001|Overall Study|Symptomatic deterioration|7|||
149991876|NCT02650804|541102011|FG000|Overall Study|Protocol Violation|0|||
149991877|NCT02650804|541102012|FG001|Overall Study|Protocol Violation|1|||
149991878|NCT02242435|541102017|FG000|Overall Study|Lost to Follow-up|3|||
149991879|NCT02242435|541102018|FG001|Overall Study|Lost to Follow-up|4|||
149991880|NCT02242435|541102017|FG000|Overall Study|Adverse Event|3|||
149991881|NCT02242435|541102018|FG001|Overall Study|Adverse Event|2|||
149991882|NCT02242435|541102017|FG000|Overall Study|Withdrawal by Subject|13|||
149991883|NCT02242435|541102018|FG001|Overall Study|Withdrawal by Subject|8|||
149991884|NCT02242435|541102017|FG000|Overall Study|Death|0|||
150053800|NCT03642132|541338383|FG000|Chemotherapy Period|Physician's decision|4|||
150053801|NCT03642132|541338384|FG001|Chemotherapy Period|Physician's decision|1|||
150053802|NCT03642132|541338385|FG002|Chemotherapy Period|Physician's decision|0|||
149991885|NCT02242435|541102018|FG001|Overall Study|Death|1|||
149991886|NCT02242435|541102017|FG000|Overall Study|Protocol Violation|1|||
149991887|NCT02242435|541102018|FG001|Overall Study|Protocol Violation|0|||
149991888|NCT02242435|541102017|FG000|Overall Study|Physician Decision|0|||
149991889|NCT02242435|541102018|FG001|Overall Study|Physician Decision|1|||
149991890|NCT01110330|541102021|FG000|Overall Study|Adverse Event|0|||
149991891|NCT01110330|541102022|FG001|Overall Study|Adverse Event|4|||
150053803|NCT03642132|541338383|FG000|Chemotherapy Period|Progressive disease|0|||
149991892|NCT01110330|541102023|FG002|Overall Study|Adverse Event|3|||
149991893|NCT01110330|541102021|FG000|Overall Study|Lack of Efficacy|3|||
149991894|NCT01110330|541102022|FG001|Overall Study|Lack of Efficacy|1|||
149991895|NCT01110330|541102023|FG002|Overall Study|Lack of Efficacy|1|||
149991896|NCT01110330|541102021|FG000|Overall Study|Lost to Follow-up|9|||
149991897|NCT01110330|541102022|FG001|Overall Study|Lost to Follow-up|10|||
149991898|NCT01110330|541102023|FG002|Overall Study|Lost to Follow-up|15|||
149991899|NCT01110330|541102021|FG000|Overall Study|Physician Decision|0|||
149991900|NCT01110330|541102022|FG001|Overall Study|Physician Decision|1|||
149991901|NCT01110330|541102023|FG002|Overall Study|Physician Decision|0|||
149991902|NCT01110330|541102021|FG000|Overall Study|Protocol Violation|2|||
149991903|NCT01110330|541102022|FG001|Overall Study|Protocol Violation|0|||
149991904|NCT01110330|541102023|FG002|Overall Study|Protocol Violation|4|||
149991905|NCT01110330|541102021|FG000|Overall Study|Withdrawal by Subject|0|||
149991906|NCT01110330|541102022|FG001|Overall Study|Withdrawal by Subject|6|||
149991907|NCT01110330|541102023|FG002|Overall Study|Withdrawal by Subject|2|||
149991908|NCT01110330|541102021|FG000|Overall Study|Other|1|||
149991909|NCT01110330|541102022|FG001|Overall Study|Other|1|||
149991910|NCT01110330|541102023|FG002|Overall Study|Other|1|||
149991911|NCT02759107|541102028|FG000|Overall Study|Adverse Event|0|||
149991912|NCT02759107|541102029|FG001|Overall Study|Adverse Event|0|||
149991913|NCT02759107|541102030|FG002|Overall Study|Adverse Event|0|||
149991914|NCT02759107|541102031|FG003|Overall Study|Adverse Event|0|||
149991915|NCT02759107|541102032|FG004|Overall Study|Adverse Event|0|||
149991916|NCT02759107|541102033|FG005|Overall Study|Adverse Event|0|||
149991917|NCT02759107|541102034|FG006|Overall Study|Adverse Event|0|||
149991918|NCT02759107|541102035|FG007|Overall Study|Adverse Event|0|||
149991919|NCT02759107|541102036|FG008|Overall Study|Adverse Event|0|||
149991920|NCT02759107|541102037|FG009|Overall Study|Adverse Event|0|||
149991921|NCT02759107|541102038|FG010|Overall Study|Adverse Event|0|||
149991922|NCT02759107|541102039|FG011|Overall Study|Adverse Event|0|||
149991923|NCT02759107|541102040|FG012|Overall Study|Adverse Event|2|||
149991924|NCT02759107|541102041|FG013|Overall Study|Adverse Event|0|||
149991925|NCT02759107|541102042|FG014|Overall Study|Adverse Event|0|||
149991926|NCT02759107|541102043|FG015|Overall Study|Adverse Event|1|||
149991927|NCT02759107|541102044|FG016|Overall Study|Adverse Event|0|||
149991928|NCT02759107|541102045|FG017|Overall Study|Adverse Event|2|||
149991929|NCT02759107|541102028|FG000|Overall Study|Scheduling Conflict|0|||
149991930|NCT02759107|541102029|FG001|Overall Study|Scheduling Conflict|0|||
149991931|NCT02759107|541102030|FG002|Overall Study|Scheduling Conflict|0|||
149991932|NCT02759107|541102031|FG003|Overall Study|Scheduling Conflict|0|||
149991933|NCT02759107|541102032|FG004|Overall Study|Scheduling Conflict|0|||
149991934|NCT02759107|541102033|FG005|Overall Study|Scheduling Conflict|0|||
149991935|NCT02759107|541102034|FG006|Overall Study|Scheduling Conflict|0|||
149991936|NCT02759107|541102035|FG007|Overall Study|Scheduling Conflict|0|||
149991937|NCT02759107|541102036|FG008|Overall Study|Scheduling Conflict|0|||
149991938|NCT02759107|541102037|FG009|Overall Study|Scheduling Conflict|1|||
149991939|NCT02759107|541102038|FG010|Overall Study|Scheduling Conflict|0|||
149991940|NCT02759107|541102039|FG011|Overall Study|Scheduling Conflict|0|||
149991941|NCT02759107|541102040|FG012|Overall Study|Scheduling Conflict|0|||
149991942|NCT02759107|541102041|FG013|Overall Study|Scheduling Conflict|0|||
149991943|NCT02759107|541102042|FG014|Overall Study|Scheduling Conflict|0|||
149991944|NCT02759107|541102043|FG015|Overall Study|Scheduling Conflict|0|||
149991945|NCT02759107|541102044|FG016|Overall Study|Scheduling Conflict|0|||
149991946|NCT02759107|541102045|FG017|Overall Study|Scheduling Conflict|0|||
149991947|NCT01089413|541102051|FG000|Overall Study|Lost to Follow-up|1|||
149991948|NCT01089413|541102051|FG000|Overall Study|Progressive Disease|93|||
149991949|NCT01089413|541102051|FG000|Overall Study|Participant Withdrew Consent|1|||
149991950|NCT01089413|541102051|FG000|Overall Study|Unacceptable Toxicity|12|||
149991951|NCT01089413|541102051|FG000|Overall Study|Death|10|||
149991952|NCT01089413|541102051|FG000|Overall Study|Metastasectomy|13|||
149991953|NCT01089413|541102051|FG000|Overall Study|Other|71|||
149991954|NCT00420004|541102064|FG000|Overall Study|Adverse Event|4|||
149991955|NCT00420004|541102065|FG001|Overall Study|Adverse Event|1|||
149991956|NCT00420004|541102066|FG002|Overall Study|Adverse Event|1|||
149991957|NCT00420004|541102064|FG000|Overall Study|Lack of Efficacy|5|||
149991958|NCT00420004|541102065|FG001|Overall Study|Lack of Efficacy|4|||
149991959|NCT00420004|541102066|FG002|Overall Study|Lack of Efficacy|1|||
149991960|NCT00420004|541102064|FG000|Overall Study|Lost to Follow-up|31|||
149991961|NCT00420004|541102065|FG001|Overall Study|Lost to Follow-up|12|||
149991962|NCT00420004|541102066|FG002|Overall Study|Lost to Follow-up|10|||
149991963|NCT00420004|541102064|FG000|Overall Study|Entry Criteria Not Met|0|||
149991964|NCT00420004|541102065|FG001|Overall Study|Entry Criteria Not Met|1|||
149991965|NCT00420004|541102066|FG002|Overall Study|Entry Criteria Not Met|0|||
149991966|NCT00420004|541102064|FG000|Overall Study|Physician Decision|14|||
149991967|NCT00420004|541102065|FG001|Overall Study|Physician Decision|4|||
149991968|NCT00420004|541102066|FG002|Overall Study|Physician Decision|2|||
149991969|NCT00420004|541102064|FG000|Overall Study|Protocol Violation|5|||
149991970|NCT00420004|541102065|FG001|Overall Study|Protocol Violation|4|||
149991971|NCT00420004|541102066|FG002|Overall Study|Protocol Violation|3|||
149991972|NCT00420004|541102064|FG000|Overall Study|Withdrawal by Subject|67|||
149991973|NCT00420004|541102065|FG001|Overall Study|Withdrawal by Subject|42|||
149991974|NCT00420004|541102066|FG002|Overall Study|Withdrawal by Subject|14|||
149991975|NCT00420004|541102064|FG000|Overall Study|Sponsor Decision|3|||
149991976|NCT00420004|541102065|FG001|Overall Study|Sponsor Decision|3|||
149991977|NCT00420004|541102066|FG002|Overall Study|Sponsor Decision|1|||
149991978|NCT01626118|541102083|FG000|Overall Study|Lack of Efficacy|1|||
149991979|NCT01626118|541102084|FG001|Overall Study|Lack of Efficacy|0|||
149991980|NCT01626118|541102085|FG002|Overall Study|Lack of Efficacy|1|||
149991981|NCT01626118|541102086|FG003|Overall Study|Lack of Efficacy|3|||
149991982|NCT01626118|541102083|FG000|Overall Study|Lost to Follow-up|1|||
149991983|NCT01626118|541102084|FG001|Overall Study|Lost to Follow-up|0|||
149991984|NCT01626118|541102085|FG002|Overall Study|Lost to Follow-up|0|||
149991985|NCT01626118|541102086|FG003|Overall Study|Lost to Follow-up|0|||
149991986|NCT01626118|541102083|FG000|Overall Study|Adverse Event|0|||
149991987|NCT01626118|541102084|FG001|Overall Study|Adverse Event|1|||
149991988|NCT01626118|541102085|FG002|Overall Study|Adverse Event|1|||
149991989|NCT01626118|541102086|FG003|Overall Study|Adverse Event|0|||
149991990|NCT01626118|541102083|FG000|Overall Study|Investigator Decision|0|||
149991991|NCT01626118|541102084|FG001|Overall Study|Investigator Decision|1|||
149991992|NCT01626118|541102085|FG002|Overall Study|Investigator Decision|0|||
149991993|NCT01626118|541102086|FG003|Overall Study|Investigator Decision|0|||
149991994|NCT00888329|541102087|FG000|Overall Study|Physician Decision|6|||
149991995|NCT00888329|541102088|FG001|Overall Study|Physician Decision|9|||
149991996|NCT00002540|541102089|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
149991997|NCT00002540|541102090|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
149991998|NCT00002540|541102089|FG000|Overall Study|Died Before Randomization|2|||
149991999|NCT00002540|541102090|FG001|Overall Study|Died Before Randomization|6|||
149992000|NCT00002540|541102089|FG000|Overall Study|Died Before ASU (Control)|202|||
149992001|NCT00002540|541102090|FG001|Overall Study|Died Before ASU (Control)|0|||
149992002|NCT00002540|541102089|FG000|Overall Study|Refused ASU (Control)|597|||
149992003|NCT00002540|541102090|FG001|Overall Study|Refused ASU (Control)|0|||
149992004|NCT00002540|541102089|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
149992005|NCT00002540|541102090|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
149992006|NCT01864148|541102091|FG000|Overall Study|Other|2|||
149992007|NCT01864148|541102092|FG001|Overall Study|Other|1|||
149992008|NCT01864148|541102093|FG002|Overall Study|Other|1|||
149992009|NCT01864148|541102094|FG003|Overall Study|Other|3|||
149992010|NCT01864148|541102095|FG004|Overall Study|Other|1|||
149992011|NCT01864148|541102091|FG000|Overall Study|Death|0|||
149992012|NCT01864148|541102092|FG001|Overall Study|Death|0|||
149992013|NCT01864148|541102093|FG002|Overall Study|Death|0|||
149992014|NCT01864148|541102094|FG003|Overall Study|Death|1|||
149992015|NCT01864148|541102095|FG004|Overall Study|Death|0|||
149992016|NCT01864148|541102091|FG000|Overall Study|Investigator Decision|5|||
149992017|NCT01864148|541102092|FG001|Overall Study|Investigator Decision|0|||
149992018|NCT01864148|541102093|FG002|Overall Study|Investigator Decision|0|||
149992019|NCT01864148|541102094|FG003|Overall Study|Investigator Decision|4|||
149992020|NCT01864148|541102095|FG004|Overall Study|Investigator Decision|6|||
149992021|NCT01864148|541102091|FG000|Overall Study|Withdrawal by Subject|9|||
149992022|NCT01864148|541102092|FG001|Overall Study|Withdrawal by Subject|2|||
149992023|NCT01864148|541102093|FG002|Overall Study|Withdrawal by Subject|6|||
149992024|NCT01864148|541102094|FG003|Overall Study|Withdrawal by Subject|8|||
149992025|NCT01864148|541102095|FG004|Overall Study|Withdrawal by Subject|8|||
149992026|NCT01864148|541102091|FG000|Overall Study|Lost to Follow-up|0|||
149992027|NCT01864148|541102092|FG001|Overall Study|Lost to Follow-up|0|||
149992028|NCT01864148|541102093|FG002|Overall Study|Lost to Follow-up|0|||
149992029|NCT01864148|541102094|FG003|Overall Study|Lost to Follow-up|2|||
149992030|NCT01864148|541102095|FG004|Overall Study|Lost to Follow-up|1|||
149992031|NCT01864148|541102091|FG000|Overall Study|Adverse Event|4|||
149992032|NCT01864148|541102092|FG001|Overall Study|Adverse Event|2|||
149992033|NCT01864148|541102093|FG002|Overall Study|Adverse Event|4|||
149992034|NCT01864148|541102094|FG003|Overall Study|Adverse Event|7|||
149992035|NCT01864148|541102095|FG004|Overall Study|Adverse Event|7|||
149992036|NCT01864148|541102091|FG000|Overall Study|Not Dosed|0|||
149992037|NCT01864148|541102092|FG001|Overall Study|Not Dosed|0|||
149992038|NCT01864148|541102093|FG002|Overall Study|Not Dosed|0|||
149992039|NCT01864148|541102094|FG003|Overall Study|Not Dosed|1|||
149992040|NCT01864148|541102095|FG004|Overall Study|Not Dosed|0|||
149992041|NCT01500252|541102096|FG000|Overall Study|Death|4|||
149992042|NCT01500252|541102097|FG001|Overall Study|Death|2|||
149992043|NCT01500252|541102096|FG000|Overall Study|Lost to Follow-up|5|||
149992044|NCT01500252|541102097|FG001|Overall Study|Lost to Follow-up|4|||
149992045|NCT00778375|541102098|FG000|Overall Study|Ineligible|3|||
149992046|NCT03490292|541102099|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
149992047|NCT03490292|541102100|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
149992048|NCT03490292|541102099|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
149992049|NCT03490292|541102100|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
149992050|NCT03490292|541102099|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
149992051|NCT03490292|541102100|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
149992052|NCT03490292|541102099|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
149992053|NCT03490292|541102100|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
149992054|NCT03490292|541102099|FG000|1 Year Follow Up Post Last Dose|Death|1|||
149992055|NCT03490292|541102100|FG001|1 Year Follow Up Post Last Dose|Death|1|||
149992056|NCT01421303|541102101|FG000|Overall Study|Lost to Follow-up|13|||
149992057|NCT01421303|541102101|FG000|Overall Study|Non compliance with study procedure|1|||
149992058|NCT01421303|541102101|FG000|Overall Study|Other|7|||
150053804|NCT03642132|541338384|FG001|Chemotherapy Period|Progressive disease|0|||
150178929|NCT00802464|541793883|FG002|Month 0 - Month 8|Adverse Event|1|||
149992059|NCT01421303|541102101|FG000|Overall Study|Withdrawal by Subject|1|||
149992060|NCT00904670|541102102|FG000|Open Label Phase|Withdrawal by Subject|2|||
149992061|NCT00904670|541102103|FG001|Open Label Phase|Withdrawal by Subject|0|||
149992062|NCT00904670|541102102|FG000|Open Label Phase|Adverse Event|2|||
149992063|NCT00904670|541102103|FG001|Open Label Phase|Adverse Event|0|||
149992064|NCT00904670|541102102|FG000|Open Label Phase|Lack of Efficacy|1|||
149992065|NCT00904670|541102103|FG001|Open Label Phase|Lack of Efficacy|0|||
149992066|NCT00904670|541102102|FG000|Open Label Phase|Lost to Follow-up|1|||
149992067|NCT00904670|541102103|FG001|Open Label Phase|Lost to Follow-up|0|||
149992068|NCT02120300|541102106|FG000|Overall Study|Enrolled but Never Treated|2|||
149992069|NCT02120300|541102107|FG001|Overall Study|Enrolled but Never Treated|0|||
149992070|NCT02120300|541102108|FG002|Overall Study|Enrolled but Never Treated|0|||
149992071|NCT02120300|541102109|FG003|Overall Study|Enrolled but Never Treated|0|||
149992072|NCT02120300|541102106|FG000|Overall Study|Lack of Efficacy|0|||
149992073|NCT02120300|541102107|FG001|Overall Study|Lack of Efficacy|0|||
149992074|NCT02120300|541102108|FG002|Overall Study|Lack of Efficacy|0|||
149992075|NCT02120300|541102109|FG003|Overall Study|Lack of Efficacy|1|||
149992076|NCT02120300|541102106|FG000|Overall Study|Lost to Follow-up|1|||
149992077|NCT02120300|541102107|FG001|Overall Study|Lost to Follow-up|0|||
149992078|NCT02120300|541102108|FG002|Overall Study|Lost to Follow-up|0|||
149992079|NCT02120300|541102109|FG003|Overall Study|Lost to Follow-up|0|||
149992080|NCT01901289|541102110|FG000|Overall Study|Death|32|||
149992081|NCT01901289|541102110|FG000|Overall Study|Lost to Follow-up|16|||
149992082|NCT01901289|541102110|FG000|Overall Study|Withdrawal by Subject|35|||
149992083|NCT01901289|541102110|FG000|Overall Study|Other type of endpoint met|2|||
149992084|NCT00700882|541102113|FG000|Overall Study|Never received treatment|6|||
149992085|NCT00700882|541102113|FG000|Overall Study|Ineligible|2|||
149992086|NCT00700882|541102113|FG000|Overall Study|No KIT mutation|51|||
149992087|NCT01832493|541102114|FG000|Overall Study|Physician Decision|2|||
149992088|NCT01832493|541102114|FG000|Overall Study|Protocol Violation|4|||
149992089|NCT01832493|541102114|FG000|Overall Study|Unable to place LV lead|2|||
149992090|NCT00290771|541102117|FG000|Overall Study|Disease progression|95|||
149992091|NCT00290771|541102118|FG001|Overall Study|Disease progression|73|||
149992092|NCT00290771|541102117|FG000|Overall Study|Death|11|||
149992093|NCT00290771|541102118|FG001|Overall Study|Death|10|||
149992094|NCT00290771|541102117|FG000|Overall Study|Adverse Event|12|||
149992095|NCT00290771|541102118|FG001|Overall Study|Adverse Event|6|||
149992096|NCT00290771|541102117|FG000|Overall Study|Withdrawal by Subject|5|||
149992097|NCT00290771|541102118|FG001|Overall Study|Withdrawal by Subject|6|||
149992098|NCT00290771|541102117|FG000|Overall Study|Administrative problems|2|||
149992099|NCT00290771|541102118|FG001|Overall Study|Administrative problems|1|||
150178930|NCT00802464|541793884|FG003|Month 0 - Month 8|Adverse Event|2|||
150178931|NCT00802464|541793881|FG000|Month 0 - Month 8|Protocol Violation|0|||
149992100|NCT00290771|541102117|FG000|Overall Study|Protocol Violation|2|||
149992101|NCT00290771|541102118|FG001|Overall Study|Protocol Violation|0|||
149992102|NCT00290771|541102117|FG000|Overall Study|Lost to Follow-up|0|||
149992103|NCT00290771|541102118|FG001|Overall Study|Lost to Follow-up|1|||
149992104|NCT04154293|541102119|FG000|Overall Study|Withdrawal by Subject|2|||
149992105|NCT04154293|541102120|FG001|Overall Study|Withdrawal by Subject|3|||
149992106|NCT04154293|541102121|FG002|Overall Study|Withdrawal by Subject|1|||
149992107|NCT04154293|541102119|FG000|Overall Study|Physician Decision|0|||
149992108|NCT04154293|541102120|FG001|Overall Study|Physician Decision|0|||
149992109|NCT04154293|541102121|FG002|Overall Study|Physician Decision|1|||
149992110|NCT03703817|541102123|FG000|Overall Study|Not meeting eligibility criteria|7|||
149992111|NCT03703817|541102124|FG001|Overall Study|Not meeting eligibility criteria|4|||
149992112|NCT00656058|541102127|FG000|Overall Study|Withdrawal by Subject|2|||
149992113|NCT00656058|541102127|FG000|Overall Study|Withdrawal by Subject|4|||
149992114|NCT00404755|541102130|FG000|Phase I (Bupropion)|Adverse Event|3|||
149992115|NCT00404755|541102130|FG000|Phase I (Bupropion)|Other|1|||
149992116|NCT00404755|541102130|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
149992117|NCT05145322|541102133|FG000|Overall Study|Lost to Follow-up|4|||
149992118|NCT05145322|541102134|FG001|Overall Study|Lost to Follow-up|5|||
149992119|NCT06359028|541102135|FG000|Overall Study|Adverse Event|1|||
149992120|NCT06359028|541102136|FG001|Overall Study|Adverse Event|0|||
149992121|NCT06359028|541102135|FG000|Overall Study|Withdrawal by Subject|1|||
149992122|NCT06359028|541102136|FG001|Overall Study|Withdrawal by Subject|0|||
149992123|NCT04700540|541102137|FG000|Overall Study|Withdrawal by Subject|12|||
149992124|NCT04700540|541102138|FG001|Overall Study|Withdrawal by Subject|8|||
149992125|NCT04700540|541102137|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
149992126|NCT04700540|541102138|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
149992127|NCT03194568|541102139|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
149992128|NCT02952313|541102140|FG000|Primary Endpoint|Lost to Follow-up|4|||
149992129|NCT02952313|541102140|FG000|Primary Endpoint|Withdrawal by Subject|1|||
149992130|NCT02952313|541102140|FG000|Primary Endpoint|Lack of Efficacy|1|||
149992131|NCT02952313|541102140|FG000|Primary Endpoint|Missed visit|1|||
149992132|NCT02952313|541102140|FG000|Long-term Follow-up|Lost to Follow-up|12|||
149992133|NCT02952313|541102140|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
149992134|NCT02952313|541102140|FG000|Long-term Follow-up|Lack of Efficacy|6|||
149992135|NCT02952313|541102140|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
149992136|NCT02952313|541102140|FG000|Long-term Follow-up|Physician Decision|1|||
149992137|NCT02952313|541102140|FG000|Long-term Follow-up|Death|1|||
149992138|NCT02628600|541102147|FG000|Overall Study|Death|2|||
149992139|NCT02628600|541102148|FG001|Overall Study|Death|1|||
149992140|NCT02628600|541102147|FG000|Overall Study|Adverse Event|3|||
149992141|NCT02628600|541102148|FG001|Overall Study|Adverse Event|20|||
149992142|NCT02628600|541102147|FG000|Overall Study|Protocol Violation|0|||
149992143|NCT02628600|541102148|FG001|Overall Study|Protocol Violation|1|||
149992144|NCT02628600|541102147|FG000|Overall Study|Lack of Efficacy|2|||
149992145|NCT02628600|541102148|FG001|Overall Study|Lack of Efficacy|0|||
149992146|NCT02628600|541102147|FG000|Overall Study|Withdrawal by Subject|13|||
149992147|NCT02628600|541102148|FG001|Overall Study|Withdrawal by Subject|8|||
149992148|NCT02628600|541102147|FG000|Overall Study|Lost to Follow-up|1|||
149992149|NCT02628600|541102148|FG001|Overall Study|Lost to Follow-up|0|||
149992150|NCT02628600|541102147|FG000|Overall Study|Physician Decision|2|||
149992151|NCT02628600|541102148|FG001|Overall Study|Physician Decision|2|||
149992152|NCT02628600|541102147|FG000|Overall Study|Other not specified|1|||
149992153|NCT02628600|541102148|FG001|Overall Study|Other not specified|0|||
149992154|NCT00583752|541102149|FG000|Overall Study|Lost to Follow-up|5|||
149992155|NCT00583752|541102150|FG001|Overall Study|Lost to Follow-up|5|||
149992156|NCT00830375|541102151|FG000|Overall Study|Lost to Follow-up|1|||
149992157|NCT01700959|541102152|FG000|Overall Study|Adverse Event|0|||
149992158|NCT01700959|541102153|FG001|Overall Study|Adverse Event|1|||
149992159|NCT01700959|541102154|FG002|Overall Study|Adverse Event|1|||
149992160|NCT01700959|541102155|FG003|Overall Study|Adverse Event|2|||
149992161|NCT01700959|541102156|FG004|Overall Study|Adverse Event|0|||
149992162|NCT01700959|541102157|FG005|Overall Study|Adverse Event|2|||
149992163|NCT01700959|541102152|FG000|Overall Study|Withdrawal by Subject|15|||
149992164|NCT01700959|541102153|FG001|Overall Study|Withdrawal by Subject|9|||
149992165|NCT01700959|541102154|FG002|Overall Study|Withdrawal by Subject|12|||
149992166|NCT01700959|541102155|FG003|Overall Study|Withdrawal by Subject|11|||
149992167|NCT01700959|541102156|FG004|Overall Study|Withdrawal by Subject|8|||
149992168|NCT01700959|541102157|FG005|Overall Study|Withdrawal by Subject|12|||
149992169|NCT01700959|541102152|FG000|Overall Study|Ineligible|2|||
149992170|NCT01700959|541102153|FG001|Overall Study|Ineligible|1|||
149992171|NCT01700959|541102154|FG002|Overall Study|Ineligible|2|||
149992172|NCT01700959|541102155|FG003|Overall Study|Ineligible|0|||
149992173|NCT01700959|541102156|FG004|Overall Study|Ineligible|0|||
149992174|NCT01700959|541102157|FG005|Overall Study|Ineligible|1|||
149992175|NCT01700959|541102152|FG000|Overall Study|Noncompliant|9|||
149992176|NCT01700959|541102153|FG001|Overall Study|Noncompliant|9|||
149992177|NCT01700959|541102154|FG002|Overall Study|Noncompliant|17|||
149992178|NCT01700959|541102155|FG003|Overall Study|Noncompliant|18|||
149992179|NCT01700959|541102156|FG004|Overall Study|Noncompliant|15|||
149992180|NCT01700959|541102157|FG005|Overall Study|Noncompliant|9|||
149992181|NCT01700959|541102152|FG000|Overall Study|Side effects|1|||
149992182|NCT01700959|541102153|FG001|Overall Study|Side effects|4|||
149992183|NCT01700959|541102154|FG002|Overall Study|Side effects|8|||
149992184|NCT01700959|541102155|FG003|Overall Study|Side effects|4|||
149992185|NCT01700959|541102156|FG004|Overall Study|Side effects|4|||
149992186|NCT01700959|541102157|FG005|Overall Study|Side effects|1|||
149992187|NCT01331837|541102158|FG000|Overall Study|Death|30|||
149992188|NCT01331837|541102159|FG001|Overall Study|Death|34|||
149992189|NCT01331837|541102158|FG000|Overall Study|Lost to Follow-up|3|||
149992190|NCT01331837|541102159|FG001|Overall Study|Lost to Follow-up|1|||
149992191|NCT01331837|541102158|FG000|Overall Study|Info not recorded|10|||
149992192|NCT01331837|541102159|FG001|Overall Study|Info not recorded|16|||
149992193|NCT01331837|541102158|FG000|Overall Study|Withdrawal by Subject|13|||
149992194|NCT01331837|541102159|FG001|Overall Study|Withdrawal by Subject|16|||
149992195|NCT03724981|541103907|FG000|First Device|Protocol Violation|1|||
149992196|NCT03724981|541103908|FG001|First Device|Protocol Violation|1|||
149992197|NCT00511433|541103909|FG000|Overall Study|Adverse Event|5|||
149992198|NCT00511433|541103910|FG001|Overall Study|Adverse Event|0|||
149992199|NCT00511433|541103909|FG000|Overall Study|Other Reason|1|||
149992200|NCT00511433|541103910|FG001|Overall Study|Other Reason|1|||
149992201|NCT01380535|541103911|FG000|Overall Study|Adverse Event|3|||
149992202|NCT01380535|541103912|FG001|Overall Study|Adverse Event|3|||
149992203|NCT01380535|541103911|FG000|Overall Study|Death|3|||
149992204|NCT01380535|541103912|FG001|Overall Study|Death|0|||
149992205|NCT01380535|541103911|FG000|Overall Study|Study site closed|0|||
149992206|NCT01380535|541103912|FG001|Overall Study|Study site closed|5|||
149992207|NCT01380535|541103911|FG000|Overall Study|Withdrawal by Subject|1|||
149992208|NCT01380535|541103912|FG001|Overall Study|Withdrawal by Subject|2|||
149992209|NCT01380535|541103911|FG000|Overall Study|Protocol Violation|0|||
149992210|NCT01380535|541103912|FG001|Overall Study|Protocol Violation|2|||
149992211|NCT01380535|541103911|FG000|Overall Study|Lack of Efficacy|0|||
149992212|NCT01380535|541103912|FG001|Overall Study|Lack of Efficacy|3|||
149992213|NCT02791191|541103915|FG000|Overall Study|Adverse Event|2|||
149992214|NCT02791191|541103916|FG001|Overall Study|Adverse Event|4|||
149992215|NCT02791191|541103917|FG002|Overall Study|Adverse Event|5|||
149992216|NCT02791191|541103915|FG000|Overall Study|Lack of Efficacy|0|||
149992217|NCT02791191|541103916|FG001|Overall Study|Lack of Efficacy|1|||
149992218|NCT02791191|541103917|FG002|Overall Study|Lack of Efficacy|0|||
149992219|NCT02791191|541103915|FG000|Overall Study|Study Drug Non-Compliance|0|||
149992220|NCT02791191|541103916|FG001|Overall Study|Study Drug Non-Compliance|2|||
149992221|NCT02791191|541103917|FG002|Overall Study|Study Drug Non-Compliance|0|||
149992222|NCT02791191|541103915|FG000|Overall Study|Site Closed by Sponsor|1|||
149992223|NCT02791191|541103916|FG001|Overall Study|Site Closed by Sponsor|1|||
149992224|NCT02791191|541103917|FG002|Overall Study|Site Closed by Sponsor|3|||
149992225|NCT02791191|541103915|FG000|Overall Study|Progressive Disease|1|||
150053805|NCT03642132|541338385|FG002|Chemotherapy Period|Progressive disease|1|||
150053806|NCT03642132|541338383|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
150053807|NCT03642132|541338384|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
150053808|NCT03642132|541338385|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
150053809|NCT03642132|541338383|FG000|Chemotherapy Period|Other|1|||
150053810|NCT03642132|541338384|FG001|Chemotherapy Period|Other|0|||
150053811|NCT03642132|541338385|FG002|Chemotherapy Period|Other|2|||
150053812|NCT03642132|541338383|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
150053813|NCT03642132|541338384|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
150053814|NCT03642132|541338385|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
150053815|NCT03642132|541338383|FG000|Maintenance Period|Adverse Event|1|||
150053816|NCT03642132|541338384|FG001|Maintenance Period|Adverse Event|2|||
150053817|NCT03642132|541338385|FG002|Maintenance Period|Adverse Event|0|||
150053818|NCT03642132|541338383|FG000|Maintenance Period|Non-compliance with study drug|0|||
150053819|NCT03642132|541338384|FG001|Maintenance Period|Non-compliance with study drug|0|||
150053820|NCT03642132|541338385|FG002|Maintenance Period|Non-compliance with study drug|1|||
150053821|NCT03642132|541338383|FG000|Maintenance Period|Physician's decision|2|||
150053822|NCT03642132|541338384|FG001|Maintenance Period|Physician's decision|2|||
150053823|NCT03642132|541338385|FG002|Maintenance Period|Physician's decision|2|||
150053824|NCT03642132|541338383|FG000|Maintenance Period|Progressive disease|9|||
150053825|NCT03642132|541338384|FG001|Maintenance Period|Progressive disease|3|||
150053826|NCT03642132|541338385|FG002|Maintenance Period|Progressive disease|6|||
150053827|NCT03642132|541338383|FG000|Maintenance Period|Other|0|||
150053828|NCT03642132|541338384|FG001|Maintenance Period|Other|0|||
150053829|NCT03642132|541338385|FG002|Maintenance Period|Other|3|||
150053830|NCT03642132|541338383|FG000|Maintenance Period|Withdrawal by Subject|1|||
150053831|NCT03642132|541338384|FG001|Maintenance Period|Withdrawal by Subject|1|||
150053832|NCT03642132|541338385|FG002|Maintenance Period|Withdrawal by Subject|2|||
150053833|NCT03642132|541338383|FG000|Follow-up Period|Other|0|||
150053834|NCT03642132|541338384|FG001|Follow-up Period|Other|0|||
150053835|NCT03642132|541338385|FG002|Follow-up Period|Other|1|||
149992226|NCT02791191|541103916|FG001|Overall Study|Progressive Disease|0|||
149992227|NCT02791191|541103917|FG002|Overall Study|Progressive Disease|0|||
149992228|NCT02791191|541103915|FG000|Overall Study|Study Terminated by Sponsor|29|||
149992229|NCT02791191|541103916|FG001|Overall Study|Study Terminated by Sponsor|101|||
149992230|NCT02791191|541103917|FG002|Overall Study|Study Terminated by Sponsor|109|||
149992231|NCT02791191|541103915|FG000|Overall Study|Withdrawal by Subject|3|||
149992232|NCT02791191|541103916|FG001|Overall Study|Withdrawal by Subject|1|||
150053836|NCT03642132|541338383|FG000|Follow-up Period|Withdrawal by Subject|1|||
150053837|NCT03642132|541338384|FG001|Follow-up Period|Withdrawal by Subject|2|||
150053838|NCT03642132|541338385|FG002|Follow-up Period|Withdrawal by Subject|0|||
150053839|NCT03642132|541338383|FG000|Follow-up Period|Study terminated by sponsor|1|||
150053840|NCT03642132|541338384|FG001|Follow-up Period|Study terminated by sponsor|0|||
149992233|NCT02791191|541103917|FG002|Overall Study|Withdrawal by Subject|3|||
149992234|NCT02791191|541103915|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
149992235|NCT02791191|541103916|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
149992236|NCT02791191|541103917|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
149992237|NCT02370537|541103918|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
149992238|NCT02370537|541103919|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
149992239|NCT02370537|541103920|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
149992240|NCT02370537|541103918|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
149992241|NCT02370537|541103919|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
149992242|NCT02370537|541103920|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
149992243|NCT02370537|541103918|FG000|Part B|Not randomised to receive treatment|1|||
149992244|NCT02370537|541103919|FG001|Part B|Not randomised to receive treatment|2|||
149992245|NCT02370537|541103920|FG002|Part B|Not randomised to receive treatment|259|||
149992246|NCT02370537|541103918|FG000|Part B|Withdrawal by Subject|0|||
149992247|NCT02370537|541103919|FG001|Part B|Withdrawal by Subject|1|||
149992248|NCT02370537|541103920|FG002|Part B|Withdrawal by Subject|0|||
149992249|NCT03100539|541103925|FG000|Overall Study|Lost to Follow-up|60|||
149992250|NCT03100539|541103926|FG001|Overall Study|Lost to Follow-up|54|||
149992251|NCT03100539|541103927|FG002|Overall Study|Lost to Follow-up|17|||
149992252|NCT03100539|541103925|FG000|Overall Study|Uncollected|8|||
149992253|NCT03100539|541103926|FG001|Overall Study|Uncollected|8|||
149992254|NCT03100539|541103927|FG002|Overall Study|Uncollected|0|||
149992255|NCT03100539|541103925|FG000|Overall Study|Ally Health|0|||
149992256|NCT03100539|541103926|FG001|Overall Study|Ally Health|0|||
149992257|NCT03100539|541103927|FG002|Overall Study|Ally Health|3|||
149992258|NCT03100539|541103925|FG000|Overall Study|Disinterest|0|||
149992259|NCT03100539|541103926|FG001|Overall Study|Disinterest|0|||
149992260|NCT03100539|541103927|FG002|Overall Study|Disinterest|22|||
149992261|NCT03100539|541103925|FG000|Overall Study|Veteran Health|0|||
149992262|NCT03100539|541103926|FG001|Overall Study|Veteran Health|0|||
149992263|NCT03100539|541103927|FG002|Overall Study|Veteran Health|8|||
149992264|NCT03100539|541103925|FG000|Overall Study|Moved|0|||
149992265|NCT03100539|541103926|FG001|Overall Study|Moved|0|||
149992266|NCT03100539|541103927|FG002|Overall Study|Moved|1|||
149992267|NCT03100539|541103925|FG000|Overall Study|Scheduling Conflicts|0|||
149992268|NCT03100539|541103926|FG001|Overall Study|Scheduling Conflicts|0|||
149992269|NCT03100539|541103927|FG002|Overall Study|Scheduling Conflicts|12|||
149992270|NCT02578680|541103931|FG000|Overall Study|Death|329|||
149992271|NCT02578680|541103932|FG001|Overall Study|Death|181|||
149992272|NCT02578680|541103931|FG000|Overall Study|Lost to Follow-up|3|||
149992273|NCT02578680|541103932|FG001|Overall Study|Lost to Follow-up|1|||
149992274|NCT02578680|541103931|FG000|Overall Study|Physician Decision|0|||
149992275|NCT02578680|541103932|FG001|Overall Study|Physician Decision|1|||
149992276|NCT02578680|541103931|FG000|Overall Study|Protocol Violation|1|||
149992277|NCT02578680|541103932|FG001|Overall Study|Protocol Violation|1|||
149992278|NCT02578680|541103931|FG000|Overall Study|Sponsor Decision|64|||
149992279|NCT02578680|541103932|FG001|Overall Study|Sponsor Decision|13|||
149992280|NCT02578680|541103931|FG000|Overall Study|Withdrawal by Subject|13|||
149992281|NCT02578680|541103932|FG001|Overall Study|Withdrawal by Subject|9|||
149992282|NCT00882583|541103933|FG000|Overall Study|Physician Decision|1|||
149992283|NCT00882583|541103934|FG001|Overall Study|Physician Decision|0|||
149992284|NCT00882583|541103933|FG000|Overall Study|Adverse Event|0|||
149992285|NCT00882583|541103934|FG001|Overall Study|Adverse Event|1|||
149992286|NCT02596958|541103935|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
149992287|NCT02596958|541103935|FG000|Overall Study|Cancer Progression|441|||
149992288|NCT02596958|541103935|FG000|Overall Study|Death From Cancer|112|||
149992289|NCT02596958|541103935|FG000|Overall Study|Death From Other Cause|33|||
149992290|NCT02596958|541103935|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
149992291|NCT02596958|541103935|FG000|Overall Study|Administrative Reasons/Other|231|||
149992292|NCT02596958|541103935|FG000|Overall Study|Lost to Follow-up|33|||
149992293|NCT02596958|541103935|FG000|Overall Study|Missing|32|||
149992294|NCT02596958|541103935|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
149992295|NCT02290691|541103936|FG000|Overall Study|Noncompliance|0|||
149992296|NCT02290691|541103937|FG001|Overall Study|Noncompliance|1|||
149992297|NCT02290691|541103936|FG000|Overall Study|Withdrawal by Subject|1|||
149992298|NCT02290691|541103937|FG001|Overall Study|Withdrawal by Subject|1|||
149992299|NCT02290691|541103936|FG000|Overall Study|Lost to Follow-up|7|||
149992300|NCT02290691|541103937|FG001|Overall Study|Lost to Follow-up|7|||
149992301|NCT00733291|541103951|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
149992302|NCT00733291|541103952|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
149992303|NCT00733291|541103953|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
149992304|NCT00733291|541103954|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
149992305|NCT01610557|541103955|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
149992306|NCT01610557|541103956|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
149992307|NCT01610557|541103957|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
149992308|NCT01610557|541103958|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
149992309|NCT01610557|541103959|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
149992310|NCT01610557|541103955|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
149992311|NCT01610557|541103956|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
149992312|NCT01610557|541103957|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
149992313|NCT01610557|541103958|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
149992314|NCT01610557|541103959|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
149992315|NCT03215758|541103960|FG000|Overall Study|Technical Problems|1|||
149992316|NCT03215758|541103961|FG001|Overall Study|Technical Problems|0|||
149992317|NCT03215758|541103960|FG000|Overall Study|Protocol deviation|0|||
149992318|NCT03215758|541103961|FG001|Overall Study|Protocol deviation|1|||
149992319|NCT03215758|541103960|FG000|Overall Study|Physician Decision|0|||
149992320|NCT03215758|541103961|FG001|Overall Study|Physician Decision|1|||
149992321|NCT03215758|541103960|FG000|Overall Study|Death|0|||
149992322|NCT03215758|541103961|FG001|Overall Study|Death|1|||
149992323|NCT03215758|541103960|FG000|Overall Study|Adverse Event|1|||
149992324|NCT03215758|541103961|FG001|Overall Study|Adverse Event|2|||
149992325|NCT03215758|541103960|FG000|Overall Study|Subject/Guardian Decision|3|||
149992326|NCT03215758|541103961|FG001|Overall Study|Subject/Guardian Decision|3|||
149992327|NCT01289353|541103962|FG000|Overall Study|Lost to Follow-up|2|||
149992328|NCT01549886|541103963|FG000|Overall Study|Sponsor's decision|2|||
149992329|NCT01549886|541103964|FG001|Overall Study|Sponsor's decision|3|||
149992330|NCT00473668|541103965|FG000|Overall Study|Withdrawal by Subject|0|||
149992331|NCT00473668|541103966|FG001|Overall Study|Withdrawal by Subject|2|||
149992332|NCT00473668|541103967|FG002|Overall Study|Withdrawal by Subject|0|||
149992333|NCT00473668|541103965|FG000|Overall Study|Migrated/moved from study area|3|||
149992334|NCT00473668|541103966|FG001|Overall Study|Migrated/moved from study area|2|||
149992335|NCT00473668|541103967|FG002|Overall Study|Migrated/moved from study area|0|||
149992336|NCT00473668|541103965|FG000|Overall Study|Lost to Follow-up|0|||
149992337|NCT00473668|541103966|FG001|Overall Study|Lost to Follow-up|4|||
149992338|NCT00473668|541103967|FG002|Overall Study|Lost to Follow-up|6|||
150053841|NCT03642132|541338385|FG002|Follow-up Period|Study terminated by sponsor|1|||
150053842|NCT03642132|541338383|FG000|Follow-up Period|Lack of Efficacy|1|||
150053843|NCT03642132|541338384|FG001|Follow-up Period|Lack of Efficacy|0|||
150053844|NCT03642132|541338385|FG002|Follow-up Period|Lack of Efficacy|0|||
150053845|NCT03642132|541338383|FG000|Follow-up Period|Death|1|||
150053846|NCT03642132|541338384|FG001|Follow-up Period|Death|0|||
150053847|NCT03642132|541338385|FG002|Follow-up Period|Death|2|||
150053848|NCT03642132|541338383|FG000|Follow-up Period|Adverse Event|1|||
150053849|NCT03642132|541338384|FG001|Follow-up Period|Adverse Event|0|||
150053850|NCT03642132|541338385|FG002|Follow-up Period|Adverse Event|0|||
149992339|NCT00473668|541103965|FG000|Overall Study|Other|2|||
149992340|NCT00473668|541103966|FG001|Overall Study|Other|3|||
149992341|NCT00473668|541103967|FG002|Overall Study|Other|4|||
149992342|NCT02039219|541103968|FG000|Treatment|Withdrawal by Subject|1|||
149992343|NCT02039219|541103969|FG001|Treatment|Withdrawal by Subject|0|||
149992344|NCT02039219|541103968|FG000|Treatment|Adverse Event|0|||
149992345|NCT02039219|541103969|FG001|Treatment|Adverse Event|1|||
149992346|NCT02039219|541103968|FG000|Treatment|Physician Decision|1|||
149992347|NCT02039219|541103969|FG001|Treatment|Physician Decision|0|||
149992348|NCT02039219|541103968|FG000|Treatment|Lost to Follow-up|0|||
150053851|NCT04493892|541338386|FG000|Overall Study|Withdrawal by Subject|15|||
150053852|NCT02577887|541338387|FG000|Overall Study|Death|93|||
150053853|NCT02577887|541338387|FG000|Overall Study|Protocol Violation|125|||
150053854|NCT02577887|541338387|FG000|Overall Study|Withdrawal by Subject|80|||
150053855|NCT02267317|541338388|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
150053856|NCT02267317|541338389|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
150053857|NCT02267317|541338390|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
150053858|NCT02267317|541338391|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
149992349|NCT02039219|541103969|FG001|Treatment|Lost to Follow-up|1|||
149992350|NCT02039219|541103968|FG000|Treatment|Protocol Violation|1|||
150053859|NCT02267317|541338392|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
150053860|NCT02267317|541338393|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
150053861|NCT02267317|541338388|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
149992351|NCT02039219|541103969|FG001|Treatment|Protocol Violation|0|||
149992352|NCT02039219|541103968|FG000|Treatment|Death|1|||
149992353|NCT02039219|541103969|FG001|Treatment|Death|0|||
149992354|NCT02039219|541103968|FG000|Follow up|Adverse Event|0|||
149992355|NCT02039219|541103969|FG001|Follow up|Adverse Event|1|||
149992356|NCT02226562|541103970|FG000|Overall Study|Lost to Follow-up|0|||
149992357|NCT02226562|541103971|FG001|Overall Study|Lost to Follow-up|1|||
149992358|NCT04569136|541103972|FG000|Overall Study|Lost to Follow-up|2|||
149992359|NCT04569136|541103973|FG001|Overall Study|Lost to Follow-up|0|||
149992360|NCT04569136|541103974|FG002|Overall Study|Lost to Follow-up|1|||
149992361|NCT01466660|541103980|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
149992362|NCT01466660|541103981|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
149992363|NCT01466660|541103980|FG000|Overall Study|Worsening of underlying cancer disease|5|||
149992364|NCT01466660|541103981|FG001|Overall Study|Worsening of underlying cancer disease|2|||
149992365|NCT01466660|541103980|FG000|Overall Study|Other adverse event|19|||
149992366|NCT01466660|541103981|FG001|Overall Study|Other adverse event|18|||
149992367|NCT01466660|541103980|FG000|Overall Study|Protocol Violation|2|||
149992368|NCT01466660|541103981|FG001|Overall Study|Protocol Violation|1|||
149992369|NCT01466660|541103980|FG000|Overall Study|Refused continuation of trial medication|4|||
149992370|NCT01466660|541103981|FG001|Overall Study|Refused continuation of trial medication|3|||
149992371|NCT01466660|541103980|FG000|Overall Study|Other reason not defined above|10|||
149992372|NCT01466660|541103981|FG001|Overall Study|Other reason not defined above|8|||
149992373|NCT00129701|541103982|FG000|Overall Study|Withdrawal by Subject|33|||
149992374|NCT03576066|541103983|FG000|Overall Study|Noncompliance with study drug|0|||
149992375|NCT03576066|541103984|FG001|Overall Study|Noncompliance with study drug|1|||
149992376|NCT00006164|541103985|FG000|Overall Study|Withdrew or lost to follow-up|70|||
149992377|NCT00006164|541103986|FG001|Overall Study|Withdrew or lost to follow-up|81|||
149992378|NCT02750345|541103987|FG000|Intervention 1|Adverse Event|0|||
149992379|NCT02750345|541103988|FG001|Intervention 1|Adverse Event|0|||
149992380|NCT02750345|541103989|FG002|Intervention 1|Adverse Event|0|||
149992381|NCT02750345|541103990|FG003|Intervention 1|Adverse Event|0|||
149992382|NCT02750345|541103991|FG004|Intervention 1|Adverse Event|1|||
149992383|NCT02750345|541103992|FG005|Intervention 1|Adverse Event|0|||
149992384|NCT00223808|541103993|FG000|Overall Study|<5 hrs therapy before discharge|3|||
149992385|NCT00223808|541103994|FG001|Overall Study|<5 hrs therapy before discharge|5|||
149992386|NCT00223808|541103995|FG002|Overall Study|<5 hrs therapy before discharge|5|||
149992387|NCT00365105|541103996|FG000|Overall Study|Protocol Violation|5|||
149992388|NCT00365105|541103997|FG001|Overall Study|Protocol Violation|8|||
149992389|NCT06004895|541103998|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
149992390|NCT06004895|541103998|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
149992391|NCT00152477|541103999|FG000|Chemotherapy Period|Adverse Event|9|||
149992392|NCT00152477|541104000|FG001|Chemotherapy Period|Adverse Event|4|||
149992393|NCT00152477|541104001|FG002|Chemotherapy Period|Adverse Event|5|||
149992394|NCT00152477|541103999|FG000|Chemotherapy Period|Death|1|||
149992395|NCT00152477|541104000|FG001|Chemotherapy Period|Death|3|||
149992396|NCT00152477|541104001|FG002|Chemotherapy Period|Death|3|||
149992397|NCT00152477|541103999|FG000|Chemotherapy Period|Lack of Efficacy|4|||
149992398|NCT00152477|541104000|FG001|Chemotherapy Period|Lack of Efficacy|5|||
149992399|NCT00152477|541104001|FG002|Chemotherapy Period|Lack of Efficacy|6|||
149992400|NCT00152477|541103999|FG000|Chemotherapy Period|Lost to Follow-up|1|||
149992401|NCT00152477|541104000|FG001|Chemotherapy Period|Lost to Follow-up|0|||
149992402|NCT00152477|541104001|FG002|Chemotherapy Period|Lost to Follow-up|1|||
149992403|NCT00152477|541103999|FG000|Chemotherapy Period|Protocol Violation|1|||
149992404|NCT00152477|541104000|FG001|Chemotherapy Period|Protocol Violation|1|||
149992405|NCT00152477|541104001|FG002|Chemotherapy Period|Protocol Violation|0|||
149992406|NCT00152477|541103999|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
149992407|NCT00152477|541104000|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
149992408|NCT00152477|541104001|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
149992409|NCT00152477|541103999|FG000|Chemotherapy Period|Progression of Disease|6|||
149992410|NCT00152477|541104000|FG001|Chemotherapy Period|Progression of Disease|8|||
149992411|NCT00152477|541104001|FG002|Chemotherapy Period|Progression of Disease|4|||
149992412|NCT00152477|541103999|FG000|Chemotherapy Period|Investigator decision|0|||
149992413|NCT00152477|541104000|FG001|Chemotherapy Period|Investigator decision|0|||
149992414|NCT00152477|541104001|FG002|Chemotherapy Period|Investigator decision|1|||
149992415|NCT00152477|541103999|FG000|Chemotherapy Period|Patient condition worsened|1|||
149992416|NCT00152477|541104000|FG001|Chemotherapy Period|Patient condition worsened|0|||
149992417|NCT00152477|541104001|FG002|Chemotherapy Period|Patient condition worsened|0|||
149992418|NCT00152477|541103999|FG000|Monotherapy Period|Adverse Event|1|||
149992419|NCT00152477|541104000|FG001|Monotherapy Period|Adverse Event|0|||
149992420|NCT00152477|541104001|FG002|Monotherapy Period|Adverse Event|5|||
149992421|NCT00152477|541103999|FG000|Monotherapy Period|Death|2|||
149992422|NCT00152477|541104000|FG001|Monotherapy Period|Death|0|||
149992423|NCT00152477|541104001|FG002|Monotherapy Period|Death|1|||
149992424|NCT00152477|541103999|FG000|Monotherapy Period|Lack of Efficacy|7|||
149992425|NCT00152477|541104000|FG001|Monotherapy Period|Lack of Efficacy|16|||
149992426|NCT00152477|541104001|FG002|Monotherapy Period|Lack of Efficacy|10|||
149992427|NCT00152477|541103999|FG000|Monotherapy Period|Protocol Violation|0|||
149992428|NCT00152477|541104000|FG001|Monotherapy Period|Protocol Violation|1|||
149992429|NCT00152477|541104001|FG002|Monotherapy Period|Protocol Violation|0|||
149992430|NCT00152477|541103999|FG000|Monotherapy Period|Withdrawal by Subject|0|||
149992431|NCT00152477|541104000|FG001|Monotherapy Period|Withdrawal by Subject|0|||
149992432|NCT00152477|541104001|FG002|Monotherapy Period|Withdrawal by Subject|4|||
149992433|NCT00152477|541103999|FG000|Monotherapy Period|Progression of Disease|5|||
149992434|NCT00152477|541104000|FG001|Monotherapy Period|Progression of Disease|11|||
149992435|NCT00152477|541104001|FG002|Monotherapy Period|Progression of Disease|12|||
149992436|NCT00152477|541103999|FG000|Monotherapy Period|Patient decision|0|||
149992437|NCT00152477|541104000|FG001|Monotherapy Period|Patient decision|1|||
149992438|NCT00152477|541104001|FG002|Monotherapy Period|Patient decision|1|||
149992439|NCT00152477|541103999|FG000|Monotherapy Period|Study personel decision|0|||
149992440|NCT00152477|541104000|FG001|Monotherapy Period|Study personel decision|0|||
149992441|NCT00152477|541104001|FG002|Monotherapy Period|Study personel decision|1|||
149992442|NCT00425698|541104002|FG000|Overall Study|Adverse Event|3|||
149992443|NCT00425698|541104003|FG001|Overall Study|Adverse Event|1|||
149992444|NCT00425698|541104002|FG000|Overall Study|Withdrawal by Subject|0|||
149992445|NCT00425698|541104003|FG001|Overall Study|Withdrawal by Subject|1|||
149992446|NCT01328535|541104004|FG000|Overall Study|Ineligible|1|||
149992447|NCT03655054|541104007|FG000|Overall Study|Lost to Follow-up|1|||
149992448|NCT03931382|541104008|FG000|Overall Study|Equipment malfunction|2|||
149992449|NCT03931382|541104009|FG001|Overall Study|Equipment malfunction|0|||
149992450|NCT03931382|541104010|FG002|Overall Study|Equipment malfunction|2|||
149992451|NCT03931382|541104008|FG000|Overall Study|Withdrawal by Subject|0|||
149992452|NCT03931382|541104009|FG001|Overall Study|Withdrawal by Subject|1|||
149992453|NCT03931382|541104010|FG002|Overall Study|Withdrawal by Subject|0|||
149992454|NCT01106651|541104016|FG000|Overall Study|Adverse Event|17|||
149992455|NCT01106651|541104017|FG001|Overall Study|Adverse Event|9|||
149992456|NCT01106651|541104018|FG002|Overall Study|Adverse Event|23|||
149992457|NCT01106651|541104016|FG000|Overall Study|Lost to Follow-up|8|||
149992458|NCT01106651|541104017|FG001|Overall Study|Lost to Follow-up|2|||
149992459|NCT01106651|541104018|FG002|Overall Study|Lost to Follow-up|6|||
149992460|NCT01106651|541104016|FG000|Overall Study|Physician Decision|4|||
149992461|NCT01106651|541104017|FG001|Overall Study|Physician Decision|3|||
149992462|NCT01106651|541104018|FG002|Overall Study|Physician Decision|1|||
149992463|NCT01106651|541104016|FG000|Overall Study|Protocol Violation|1|||
149992464|NCT01106651|541104017|FG001|Overall Study|Protocol Violation|2|||
149992465|NCT01106651|541104018|FG002|Overall Study|Protocol Violation|1|||
149992466|NCT01106651|541104016|FG000|Overall Study|Withdrawal by Subject|14|||
149992467|NCT01106651|541104017|FG001|Overall Study|Withdrawal by Subject|7|||
149992468|NCT01106651|541104018|FG002|Overall Study|Withdrawal by Subject|4|||
149992469|NCT01106651|541104016|FG000|Overall Study|Noncompliance with study drug|1|||
149992470|NCT01106651|541104017|FG001|Overall Study|Noncompliance with study drug|0|||
149992471|NCT01106651|541104018|FG002|Overall Study|Noncompliance with study drug|2|||
149992472|NCT01106651|541104016|FG000|Overall Study|Other|34|||
149992473|NCT01106651|541104017|FG001|Overall Study|Other|31|||
149992474|NCT01106651|541104018|FG002|Overall Study|Other|21|||
149992475|NCT01106651|541104016|FG000|Overall Study|Death|0|||
149992476|NCT01106651|541104017|FG001|Overall Study|Death|3|||
149992477|NCT01106651|541104018|FG002|Overall Study|Death|0|||
149992478|NCT00712725|541104021|FG000|Overall Study|Adverse Event|1|||
149992479|NCT00712725|541104022|FG001|Overall Study|Adverse Event|0|||
149992480|NCT00712725|541104023|FG002|Overall Study|Adverse Event|0|||
149992481|NCT00712725|541104024|FG003|Overall Study|Adverse Event|1|||
149992482|NCT00712725|541104025|FG004|Overall Study|Adverse Event|0|||
149992483|NCT00712725|541104026|FG005|Overall Study|Adverse Event|0|||
149992484|NCT00712725|541104027|FG006|Overall Study|Adverse Event|0|||
149992485|NCT00712725|541104028|FG007|Overall Study|Adverse Event|0|||
149992486|NCT00712725|541104021|FG000|Overall Study|Lost to Follow-up|3|||
149992487|NCT00712725|541104022|FG001|Overall Study|Lost to Follow-up|2|||
149992488|NCT00712725|541104023|FG002|Overall Study|Lost to Follow-up|1|||
149992489|NCT00712725|541104024|FG003|Overall Study|Lost to Follow-up|1|||
149992490|NCT00712725|541104025|FG004|Overall Study|Lost to Follow-up|2|||
149992491|NCT00712725|541104026|FG005|Overall Study|Lost to Follow-up|2|||
149992492|NCT00712725|541104027|FG006|Overall Study|Lost to Follow-up|3|||
149992493|NCT00712725|541104028|FG007|Overall Study|Lost to Follow-up|1|||
149992494|NCT00712725|541104021|FG000|Overall Study|Physician Decision|2|||
149992495|NCT00712725|541104022|FG001|Overall Study|Physician Decision|0|||
149992496|NCT00712725|541104023|FG002|Overall Study|Physician Decision|0|||
149992497|NCT00712725|541104024|FG003|Overall Study|Physician Decision|0|||
149992498|NCT00712725|541104025|FG004|Overall Study|Physician Decision|1|||
149992499|NCT00712725|541104026|FG005|Overall Study|Physician Decision|0|||
149992500|NCT00712725|541104027|FG006|Overall Study|Physician Decision|2|||
149992501|NCT00712725|541104028|FG007|Overall Study|Physician Decision|0|||
149992502|NCT00712725|541104021|FG000|Overall Study|Pregnancy|0|||
149992503|NCT00712725|541104022|FG001|Overall Study|Pregnancy|1|||
149992504|NCT00712725|541104023|FG002|Overall Study|Pregnancy|0|||
149992505|NCT00712725|541104024|FG003|Overall Study|Pregnancy|0|||
149992506|NCT00712725|541104025|FG004|Overall Study|Pregnancy|1|||
149992507|NCT00712725|541104026|FG005|Overall Study|Pregnancy|0|||
149992508|NCT00712725|541104027|FG006|Overall Study|Pregnancy|2|||
149992509|NCT00712725|541104028|FG007|Overall Study|Pregnancy|0|||
149992510|NCT00712725|541104021|FG000|Overall Study|Protocol Violation|2|||
149992511|NCT00712725|541104022|FG001|Overall Study|Protocol Violation|0|||
149992512|NCT00712725|541104023|FG002|Overall Study|Protocol Violation|1|||
149992513|NCT00712725|541104024|FG003|Overall Study|Protocol Violation|3|||
149992514|NCT00712725|541104025|FG004|Overall Study|Protocol Violation|2|||
149992515|NCT00712725|541104026|FG005|Overall Study|Protocol Violation|0|||
149992516|NCT00712725|541104027|FG006|Overall Study|Protocol Violation|1|||
149992517|NCT00712725|541104028|FG007|Overall Study|Protocol Violation|1|||
149992518|NCT00712725|541104021|FG000|Overall Study|Withdrawal by Subject|2|||
149992519|NCT00712725|541104022|FG001|Overall Study|Withdrawal by Subject|1|||
149992520|NCT00712725|541104023|FG002|Overall Study|Withdrawal by Subject|1|||
149992521|NCT00712725|541104024|FG003|Overall Study|Withdrawal by Subject|2|||
149992522|NCT00712725|541104025|FG004|Overall Study|Withdrawal by Subject|1|||
149992523|NCT00712725|541104026|FG005|Overall Study|Withdrawal by Subject|1|||
149992524|NCT00712725|541104027|FG006|Overall Study|Withdrawal by Subject|1|||
149992525|NCT00712725|541104028|FG007|Overall Study|Withdrawal by Subject|2|||
149992526|NCT00712725|541104021|FG000|Overall Study|Lack of Qualifying Event|16|||
149992527|NCT00712725|541104022|FG001|Overall Study|Lack of Qualifying Event|2|||
149992528|NCT00712725|541104023|FG002|Overall Study|Lack of Qualifying Event|6|||
149992529|NCT00712725|541104024|FG003|Overall Study|Lack of Qualifying Event|8|||
149992530|NCT00712725|541104025|FG004|Overall Study|Lack of Qualifying Event|11|||
149992531|NCT00712725|541104026|FG005|Overall Study|Lack of Qualifying Event|13|||
149992532|NCT00712725|541104027|FG006|Overall Study|Lack of Qualifying Event|11|||
149992533|NCT00712725|541104028|FG007|Overall Study|Lack of Qualifying Event|6|||
149992534|NCT00712725|541104021|FG000|Overall Study|Protocol Specified Criteria|3|||
149992535|NCT00712725|541104022|FG001|Overall Study|Protocol Specified Criteria|0|||
149992536|NCT00712725|541104023|FG002|Overall Study|Protocol Specified Criteria|1|||
149992537|NCT00712725|541104024|FG003|Overall Study|Protocol Specified Criteria|2|||
149992538|NCT00712725|541104025|FG004|Overall Study|Protocol Specified Criteria|1|||
149992539|NCT00712725|541104026|FG005|Overall Study|Protocol Specified Criteria|0|||
149992540|NCT00712725|541104027|FG006|Overall Study|Protocol Specified Criteria|2|||
149992541|NCT00712725|541104028|FG007|Overall Study|Protocol Specified Criteria|1|||
149992542|NCT04154605|541104029|FG000|Overall Study|Procedure Canceled|1|||
149992543|NCT04154605|541104030|FG001|Overall Study|Procedure Canceled|1|||
149992544|NCT04154605|541104029|FG000|Overall Study|Missed follow up|1|||
149992545|NCT04154605|541104030|FG001|Overall Study|Missed follow up|1|||
149992546|NCT04154605|541104029|FG000|Overall Study|Withdrawal by Subject|1|||
149992547|NCT04154605|541104030|FG001|Overall Study|Withdrawal by Subject|0|||
149992548|NCT00675441|541104031|FG000|Overall Study|Withdrawal by Subject|2|||
149992549|NCT00675441|541104031|FG000|Overall Study|Death|1|||
149992550|NCT00313144|541104032|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
149992551|NCT00313144|541104032|FG000|Overall Study|Death|7|||
149992552|NCT00313144|541104032|FG000|Overall Study|Lost to Follow-up|5|||
149992553|NCT00313144|541104032|FG000|Overall Study|Withdrawal by Subject|4|||
149992554|NCT00313144|541104032|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
149992555|NCT00313144|541104032|FG000|Overall Study|Physician Decision|4|||
149992556|NCT00313144|541104032|FG000|Overall Study|Adverse event - transient|5|||
149992557|NCT00313144|541104032|FG000|Overall Study|Liver transplant|1|||
149992558|NCT00313144|541104032|FG000|Overall Study|Insurance (homecare provider) change|1|||
149992559|NCT00313144|541104032|FG000|Overall Study|Change to different product|1|||
149992560|NCT00313144|541104032|FG000|Overall Study|Due to termination of the study|66|||
149992561|NCT05129449|541104034|FG000|Overall Study|Protocol Violation|1|||
149992562|NCT02901054|541104037|FG000|Overall Study|Physician Decision|1|||
149992563|NCT02901054|541104037|FG000|Overall Study|Withdrawal by Subject|3|||
149992564|NCT00616018|541104038|FG000|Overall Study|Protocol Violation|3|||
149992565|NCT01818258|541104039|FG000|Overall Study|Death|3|||
149992566|NCT01818258|541104040|FG001|Overall Study|Death|0|||
149992567|NCT01818258|541104039|FG000|Overall Study|Withdrawal by Subject|0|||
149992568|NCT01818258|541104040|FG001|Overall Study|Withdrawal by Subject|1|||
149992569|NCT01818258|541104039|FG000|Overall Study|Lost to Follow-up|0|||
149992570|NCT01818258|541104040|FG001|Overall Study|Lost to Follow-up|1|||
149992571|NCT01818258|541104039|FG000|Overall Study|Unable to Travel to Clinic|0|||
149992572|NCT01818258|541104040|FG001|Overall Study|Unable to Travel to Clinic|1|||
150178932|NCT00802464|541793882|FG001|Month 0 - Month 8|Protocol Violation|0|||
150178933|NCT00802464|541793883|FG002|Month 0 - Month 8|Protocol Violation|1|||
150178934|NCT00802464|541793884|FG003|Month 0 - Month 8|Protocol Violation|0|||
150178935|NCT00802464|541793881|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
150178936|NCT00802464|541793882|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
150178937|NCT00802464|541793883|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
150178938|NCT00802464|541793884|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
150178939|NCT00802464|541793881|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
150178940|NCT00802464|541793882|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
150178941|NCT00802464|541793883|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
150178942|NCT00802464|541793884|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
150178943|NCT00802464|541793881|FG000|Month 0 - Month 8|Other|0|||
150178944|NCT00802464|541793882|FG001|Month 0 - Month 8|Other|0|||
150178945|NCT00802464|541793883|FG002|Month 0 - Month 8|Other|1|||
150178946|NCT00802464|541793884|FG003|Month 0 - Month 8|Other|0|||
150178947|NCT00802464|541793881|FG000|Month 8 - Month 14|Adverse Event|0|||
150178948|NCT00802464|541793882|FG001|Month 8 - Month 14|Adverse Event|1|||
150178949|NCT00802464|541793883|FG002|Month 8 - Month 14|Adverse Event|0|||
150178950|NCT00802464|541793884|FG003|Month 8 - Month 14|Adverse Event|0|||
150178951|NCT00802464|541793881|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
150178952|NCT00802464|541793882|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
150178953|NCT00802464|541793883|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
150178954|NCT00802464|541793884|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
150178955|NCT00802464|541793881|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
150178956|NCT00802464|541793882|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
150178957|NCT00802464|541793883|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
150178958|NCT00802464|541793884|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
150178959|NCT02706717|541793893|FG000|Overall Study|Withdrawal by Subject|1|||
149992573|NCT03515551|541104041|FG000|Overall Study|Death|4|||
149992574|NCT03515551|541104042|FG001|Overall Study|Death|1|||
149992575|NCT03515551|541104043|FG002|Overall Study|Death|2|||
149992576|NCT03515551|541104044|FG003|Overall Study|Death|2|||
149992577|NCT03515551|541104045|FG004|Overall Study|Death|2|||
149992578|NCT03515551|541104046|FG005|Overall Study|Death|4|||
149992579|NCT03515551|541104047|FG006|Overall Study|Death|1|||
149992580|NCT03515551|541104041|FG000|Overall Study|Lost to Follow-up|0|||
149992581|NCT03515551|541104042|FG001|Overall Study|Lost to Follow-up|0|||
149992582|NCT03515551|541104043|FG002|Overall Study|Lost to Follow-up|1|||
149992583|NCT03515551|541104044|FG003|Overall Study|Lost to Follow-up|0|||
149992584|NCT03515551|541104045|FG004|Overall Study|Lost to Follow-up|0|||
149992585|NCT03515551|541104046|FG005|Overall Study|Lost to Follow-up|0|||
149992586|NCT03515551|541104047|FG006|Overall Study|Lost to Follow-up|0|||
149992587|NCT03515551|541104041|FG000|Overall Study|Withdrawal by Subject|0|||
149992588|NCT03515551|541104042|FG001|Overall Study|Withdrawal by Subject|1|||
149992589|NCT03515551|541104043|FG002|Overall Study|Withdrawal by Subject|0|||
149992590|NCT03515551|541104044|FG003|Overall Study|Withdrawal by Subject|0|||
149992591|NCT03515551|541104045|FG004|Overall Study|Withdrawal by Subject|0|||
149992592|NCT03515551|541104046|FG005|Overall Study|Withdrawal by Subject|0|||
149992593|NCT03515551|541104047|FG006|Overall Study|Withdrawal by Subject|1|||
149992594|NCT03515551|541104041|FG000|Overall Study|Study ended by sponsor|0|||
149992595|NCT03515551|541104042|FG001|Overall Study|Study ended by sponsor|0|||
149992596|NCT03515551|541104043|FG002|Overall Study|Study ended by sponsor|2|||
149992597|NCT03515551|541104044|FG003|Overall Study|Study ended by sponsor|1|||
150178960|NCT02706717|541793894|FG001|Overall Study|Withdrawal by Subject|8|||
150178961|NCT02706717|541793893|FG000|Overall Study|Lost to Follow-up|0|||
150178962|NCT02706717|541793894|FG001|Overall Study|Lost to Follow-up|1|||
150178963|NCT02706717|541793893|FG000|Overall Study|Physician Decision|0|||
150178964|NCT02706717|541793894|FG001|Overall Study|Physician Decision|1|||
150178965|NCT02706717|541793893|FG000|Overall Study|Death|0|||
149992598|NCT03515551|541104045|FG004|Overall Study|Study ended by sponsor|3|||
149992599|NCT03515551|541104046|FG005|Overall Study|Study ended by sponsor|0|||
150178966|NCT02706717|541793894|FG001|Overall Study|Death|1|||
150178967|NCT00444600|541793898|FG000|Overall Study|Death|7|||
150178968|NCT00444600|541793899|FG001|Overall Study|Death|5|||
150178969|NCT00444600|541793900|FG002|Overall Study|Death|3|||
149992600|NCT03515551|541104047|FG006|Overall Study|Study ended by sponsor|3|||
149992601|NCT03515551|541104041|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
150178970|NCT00444600|541793901|FG003|Overall Study|Death|2|||
149992602|NCT03515551|541104042|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
150178971|NCT00444600|541793898|FG000|Overall Study|Dropped|11|||
150178972|NCT00444600|541793899|FG001|Overall Study|Dropped|11|||
149992603|NCT03515551|541104043|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
149992604|NCT03515551|541104044|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
149992605|NCT03515551|541104045|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
149992606|NCT03515551|541104046|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
149992607|NCT03515551|541104047|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
149992608|NCT00920387|541104048|FG000|Stage 1|Adverse Event|1|||
149992609|NCT00920387|541104049|FG001|Stage 1|Adverse Event|0|||
149992610|NCT00920387|541104050|FG002|Stage 1|Adverse Event|0|||
149992611|NCT02241733|541104061|FG000|Overall Study|Lost to Follow-up|9|||
149992612|NCT02241733|541104062|FG001|Overall Study|Lost to Follow-up|4|||
149992613|NCT02241733|541104061|FG000|Overall Study|Physician Decision|6|||
149992614|NCT02241733|541104062|FG001|Overall Study|Physician Decision|2|||
149992615|NCT02241733|541104061|FG000|Overall Study|Withdrawal by Subject|0|||
149992616|NCT02241733|541104062|FG001|Overall Study|Withdrawal by Subject|2|||
149992617|NCT02241733|541104061|FG000|Overall Study|Death|0|||
149992618|NCT02241733|541104062|FG001|Overall Study|Death|2|||
149992619|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
149992620|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
149992621|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
149992622|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
149992623|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
149992624|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
149992625|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
149992626|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
149992627|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
149992628|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
149992629|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
149992630|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
149992631|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
149992632|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
149992633|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
149992634|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
149992635|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
149992636|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
149992637|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
149992638|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
149992639|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
149992640|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
149992641|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
149992642|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
149992643|NCT01866111|541104063|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
149992644|NCT01866111|541104064|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
149992645|NCT01866111|541104065|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
149992646|NCT01866111|541104066|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
149992647|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
149992648|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
149992649|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
149992650|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
149992651|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
149992652|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
149992653|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
149992654|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
149992655|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
149992656|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
149992657|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
149992658|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
149992659|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
149992660|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
149992661|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
149992662|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
150053862|NCT02267317|541338389|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
149992663|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Death|1|||
149992664|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Death|1|||
150053863|NCT02267317|541338390|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
149992665|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Death|3|||
149992666|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Death|2|||
149992667|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
149992668|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
149992669|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
149992670|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
149992671|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
149992672|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
149992673|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
149992674|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
149992675|NCT01866111|541104063|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
149992676|NCT01866111|541104064|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
149992677|NCT01866111|541104065|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
149992678|NCT01866111|541104066|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
149992679|NCT03802630|541104067|FG000|Overall Study|Study terminated by sponsor|130|||
149992680|NCT03802630|541104068|FG001|Overall Study|Study terminated by sponsor|134|||
149992681|NCT03802630|541104067|FG000|Overall Study|Subject decision|16|||
149992682|NCT03802630|541104068|FG001|Overall Study|Subject decision|9|||
149992683|NCT03802630|541104067|FG000|Overall Study|Adverse Event|3|||
149992684|NCT03802630|541104068|FG001|Overall Study|Adverse Event|1|||
149992685|NCT03802630|541104067|FG000|Overall Study|Lost to Follow-up|2|||
149992686|NCT03802630|541104068|FG001|Overall Study|Lost to Follow-up|2|||
149992687|NCT03802630|541104067|FG000|Overall Study|Physician Decision|2|||
149992688|NCT03802630|541104068|FG001|Overall Study|Physician Decision|0|||
149992689|NCT03802630|541104067|FG000|Overall Study|Death|0|||
149992690|NCT03802630|541104068|FG001|Overall Study|Death|2|||
149992691|NCT00157196|541104069|FG000|Overall Study|Ongoing at data cut-off|9|||
149992692|NCT01252186|541104070|FG000|Overall Study|Adverse Event|9|||
149992693|NCT01252186|541104071|FG001|Overall Study|Adverse Event|6|||
149992694|NCT01252186|541104072|FG002|Overall Study|Adverse Event|8|||
149992695|NCT01252186|541104070|FG000|Overall Study|Withdrawal by Subject|2|||
149992696|NCT01252186|541104071|FG001|Overall Study|Withdrawal by Subject|5|||
149992697|NCT01252186|541104072|FG002|Overall Study|Withdrawal by Subject|2|||
149992698|NCT01252186|541104070|FG000|Overall Study|Physician Decision|0|||
149992699|NCT01252186|541104071|FG001|Overall Study|Physician Decision|0|||
149992700|NCT01252186|541104072|FG002|Overall Study|Physician Decision|1|||
149992701|NCT01252186|541104070|FG000|Overall Study|Non-compliance|0|||
149992702|NCT01252186|541104071|FG001|Overall Study|Non-compliance|3|||
149992703|NCT01252186|541104072|FG002|Overall Study|Non-compliance|4|||
149992704|NCT01252186|541104070|FG000|Overall Study|Protocol Violation|0|||
149992705|NCT01252186|541104071|FG001|Overall Study|Protocol Violation|0|||
149992706|NCT01252186|541104072|FG002|Overall Study|Protocol Violation|1|||
149992707|NCT01252186|541104070|FG000|Overall Study|Pregnancy|2|||
149992708|NCT01252186|541104071|FG001|Overall Study|Pregnancy|2|||
149992709|NCT01252186|541104072|FG002|Overall Study|Pregnancy|0|||
149992710|NCT01252186|541104070|FG000|Overall Study|Sponsor Request|2|||
149992711|NCT01252186|541104071|FG001|Overall Study|Sponsor Request|1|||
149992712|NCT01252186|541104072|FG002|Overall Study|Sponsor Request|0|||
149992713|NCT01252186|541104070|FG000|Overall Study|Lost to Follow-up|10|||
149992714|NCT01252186|541104071|FG001|Overall Study|Lost to Follow-up|10|||
149992715|NCT01252186|541104072|FG002|Overall Study|Lost to Follow-up|11|||
149992716|NCT01252186|541104070|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
149992717|NCT01252186|541104071|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
149992718|NCT01252186|541104072|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
149992719|NCT04283994|541104079|FG000|Overall Study|Death|11|||
149992720|NCT04283994|541104080|FG001|Overall Study|Death|20|||
149992721|NCT04283994|541104081|FG002|Overall Study|Death|11|||
149992722|NCT04283994|541104082|FG003|Overall Study|Death|0|||
149992723|NCT04283994|541104083|FG004|Overall Study|Death|0|||
149992724|NCT04283994|541104084|FG005|Overall Study|Death|0|||
149992725|NCT04283994|541104085|FG006|Overall Study|Death|0|||
149992726|NCT04283994|541104079|FG000|Overall Study|Withdrawal by Subject|16|||
149992727|NCT04283994|541104080|FG001|Overall Study|Withdrawal by Subject|4|||
149992728|NCT04283994|541104081|FG002|Overall Study|Withdrawal by Subject|6|||
149992729|NCT04283994|541104082|FG003|Overall Study|Withdrawal by Subject|1|||
149992730|NCT04283994|541104083|FG004|Overall Study|Withdrawal by Subject|0|||
149992731|NCT04283994|541104084|FG005|Overall Study|Withdrawal by Subject|1|||
149992732|NCT04283994|541104085|FG006|Overall Study|Withdrawal by Subject|0|||
149992733|NCT01159171|541105487|FG000|Overall Study|Adverse Event|11|||
149992734|NCT01159171|541105487|FG000|Overall Study|Progression of Disease|28|||
149992735|NCT01159171|541105487|FG000|Overall Study|Protocol Violation|1|||
149992736|NCT01159171|541105487|FG000|Overall Study|Need for Surgery|5|||
149992737|NCT01159171|541105487|FG000|Overall Study|Medical Decision|4|||
149992738|NCT01159171|541105487|FG000|Overall Study|Death|1|||
149992739|NCT01892436|541105488|FG000|Overall Study|Withdrawal by Subject|8|||
149992740|NCT01892436|541105489|FG001|Overall Study|Withdrawal by Subject|15|||
149992741|NCT01892436|541105490|FG002|Overall Study|Withdrawal by Subject|4|||
149992742|NCT01892436|541105491|FG003|Overall Study|Withdrawal by Subject|4|||
149992743|NCT01892436|541105488|FG000|Overall Study|Death|1|||
149992744|NCT01892436|541105489|FG001|Overall Study|Death|1|||
149992745|NCT01892436|541105490|FG002|Overall Study|Death|0|||
149992746|NCT01892436|541105491|FG003|Overall Study|Death|0|||
149992747|NCT01892436|541105488|FG000|Overall Study|Physician Decision|2|||
149992748|NCT01892436|541105489|FG001|Overall Study|Physician Decision|1|||
149992749|NCT01892436|541105490|FG002|Overall Study|Physician Decision|0|||
149992750|NCT01892436|541105491|FG003|Overall Study|Physician Decision|1|||
149992751|NCT01892436|541105488|FG000|Overall Study|Pregnancy|0|||
149992752|NCT01892436|541105489|FG001|Overall Study|Pregnancy|2|||
149992753|NCT01892436|541105490|FG002|Overall Study|Pregnancy|1|||
149992754|NCT01892436|541105491|FG003|Overall Study|Pregnancy|0|||
149992755|NCT01892436|541105488|FG000|Overall Study|Technical problems|2|||
149992756|NCT01892436|541105489|FG001|Overall Study|Technical problems|1|||
149992757|NCT01892436|541105490|FG002|Overall Study|Technical problems|1|||
149992758|NCT01892436|541105491|FG003|Overall Study|Technical problems|1|||
149992759|NCT01892436|541105488|FG000|Overall Study|Lack of Efficacy|1|||
149992760|NCT01892436|541105489|FG001|Overall Study|Lack of Efficacy|2|||
149992761|NCT01892436|541105490|FG002|Overall Study|Lack of Efficacy|2|||
149992762|NCT01892436|541105491|FG003|Overall Study|Lack of Efficacy|2|||
149992763|NCT01892436|541105488|FG000|Overall Study|Lost to Follow-up|1|||
149992764|NCT01892436|541105489|FG001|Overall Study|Lost to Follow-up|1|||
149992765|NCT01892436|541105490|FG002|Overall Study|Lost to Follow-up|1|||
149992766|NCT01892436|541105491|FG003|Overall Study|Lost to Follow-up|3|||
149992767|NCT01892436|541105488|FG000|Overall Study|non-compliance with treatment|1|||
149992768|NCT01892436|541105489|FG001|Overall Study|non-compliance with treatment|0|||
149992769|NCT01892436|541105490|FG002|Overall Study|non-compliance with treatment|0|||
149992770|NCT01892436|541105491|FG003|Overall Study|non-compliance with treatment|0|||
149992771|NCT01892436|541105488|FG000|Overall Study|Adverse Event|7|||
149992772|NCT01892436|541105489|FG001|Overall Study|Adverse Event|6|||
149992773|NCT01892436|541105490|FG002|Overall Study|Adverse Event|2|||
149992774|NCT01892436|541105491|FG003|Overall Study|Adverse Event|3|||
149992775|NCT02923830|541105492|FG000|Overall Study|Physician Decision|13|||
149992776|NCT02923830|541105493|FG001|Overall Study|Physician Decision|15|||
149992777|NCT00837265|541105494|FG000|Pilot Phase|Withdrawal by Subject|0|||
149992778|NCT00837265|541105495|FG001|Pilot Phase|Withdrawal by Subject|2|||
149992779|NCT00837265|541105496|FG002|Pilot Phase|Withdrawal by Subject|3|||
149992780|NCT00837265|541105497|FG003|Pilot Phase|Withdrawal by Subject|2|||
149992781|NCT00837265|541105498|FG004|Pilot Phase|Withdrawal by Subject|0|||
149992782|NCT00837265|541105499|FG005|Pilot Phase|Withdrawal by Subject|0|||
149992783|NCT00837265|541105500|FG006|Pilot Phase|Withdrawal by Subject|0|||
149992784|NCT00837265|541105494|FG000|Pilot Phase|Decision of the investigator|2|||
149992785|NCT00837265|541105495|FG001|Pilot Phase|Decision of the investigator|1|||
149992786|NCT00837265|541105496|FG002|Pilot Phase|Decision of the investigator|0|||
149992787|NCT00837265|541105497|FG003|Pilot Phase|Decision of the investigator|0|||
150178973|NCT00444600|541793900|FG002|Overall Study|Dropped|7|||
149992788|NCT00837265|541105498|FG004|Pilot Phase|Decision of the investigator|0|||
149992789|NCT00837265|541105499|FG005|Pilot Phase|Decision of the investigator|0|||
149992790|NCT00837265|541105500|FG006|Pilot Phase|Decision of the investigator|0|||
149992791|NCT00837265|541105494|FG000|Pilot Phase|Adverse Event|1|||
149992792|NCT00837265|541105495|FG001|Pilot Phase|Adverse Event|0|||
149992793|NCT00837265|541105496|FG002|Pilot Phase|Adverse Event|0|||
149992794|NCT00837265|541105497|FG003|Pilot Phase|Adverse Event|0|||
149992795|NCT00837265|541105498|FG004|Pilot Phase|Adverse Event|0|||
149992796|NCT00837265|541105499|FG005|Pilot Phase|Adverse Event|0|||
150178974|NCT00444600|541793901|FG003|Overall Study|Dropped|7|||
149992797|NCT00837265|541105500|FG006|Pilot Phase|Adverse Event|0|||
149992798|NCT00837265|541105494|FG000|Pilot Phase|Disease progression|0|||
149992799|NCT00837265|541105495|FG001|Pilot Phase|Disease progression|0|||
149992800|NCT00837265|541105496|FG002|Pilot Phase|Disease progression|0|||
149992801|NCT00837265|541105497|FG003|Pilot Phase|Disease progression|1|||
149992802|NCT00837265|541105498|FG004|Pilot Phase|Disease progression|0|||
149992803|NCT00837265|541105499|FG005|Pilot Phase|Disease progression|0|||
149992804|NCT00837265|541105500|FG006|Pilot Phase|Disease progression|0|||
149992805|NCT00837265|541105494|FG000|Pilot Phase|Participant left the city|0|||
149992806|NCT00837265|541105495|FG001|Pilot Phase|Participant left the city|0|||
149992807|NCT00837265|541105496|FG002|Pilot Phase|Participant left the city|0|||
149992808|NCT00837265|541105497|FG003|Pilot Phase|Participant left the city|1|||
149992809|NCT00837265|541105498|FG004|Pilot Phase|Participant left the city|0|||
149992810|NCT00837265|541105499|FG005|Pilot Phase|Participant left the city|0|||
149992811|NCT00837265|541105500|FG006|Pilot Phase|Participant left the city|0|||
149992812|NCT00837265|541105494|FG000|Main Phase|Withdrawal by Subject|0|||
149992813|NCT00837265|541105495|FG001|Main Phase|Withdrawal by Subject|0|||
149992814|NCT00837265|541105496|FG002|Main Phase|Withdrawal by Subject|0|||
149992815|NCT00837265|541105497|FG003|Main Phase|Withdrawal by Subject|0|||
149992816|NCT00837265|541105498|FG004|Main Phase|Withdrawal by Subject|4|||
149992817|NCT00837265|541105499|FG005|Main Phase|Withdrawal by Subject|2|||
149992818|NCT00837265|541105500|FG006|Main Phase|Withdrawal by Subject|1|||
149992819|NCT00837265|541105494|FG000|Main Phase|Decision of the investigator|0|||
149992820|NCT00837265|541105495|FG001|Main Phase|Decision of the investigator|0|||
149992821|NCT00837265|541105496|FG002|Main Phase|Decision of the investigator|0|||
149992822|NCT00837265|541105497|FG003|Main Phase|Decision of the investigator|0|||
149992823|NCT00837265|541105498|FG004|Main Phase|Decision of the investigator|0|||
149992824|NCT00837265|541105499|FG005|Main Phase|Decision of the investigator|2|||
149992825|NCT00837265|541105500|FG006|Main Phase|Decision of the investigator|1|||
149992826|NCT00837265|541105494|FG000|Main Phase|Adverse Event|0|||
149992827|NCT00837265|541105495|FG001|Main Phase|Adverse Event|0|||
149992828|NCT00837265|541105496|FG002|Main Phase|Adverse Event|0|||
149992829|NCT00837265|541105497|FG003|Main Phase|Adverse Event|0|||
149992830|NCT00837265|541105498|FG004|Main Phase|Adverse Event|0|||
149992831|NCT00837265|541105499|FG005|Main Phase|Adverse Event|1|||
149992832|NCT00837265|541105500|FG006|Main Phase|Adverse Event|0|||
149992833|NCT00837265|541105494|FG000|Main Phase|Death|0|||
149992834|NCT00837265|541105495|FG001|Main Phase|Death|0|||
149992835|NCT00837265|541105496|FG002|Main Phase|Death|0|||
149992836|NCT00837265|541105497|FG003|Main Phase|Death|0|||
149992837|NCT00837265|541105498|FG004|Main Phase|Death|2|||
149992838|NCT00837265|541105499|FG005|Main Phase|Death|0|||
149992839|NCT00837265|541105500|FG006|Main Phase|Death|1|||
149992840|NCT00837265|541105494|FG000|Main Phase|Lost to Follow-up|0|||
149992841|NCT00837265|541105495|FG001|Main Phase|Lost to Follow-up|0|||
149992842|NCT00837265|541105496|FG002|Main Phase|Lost to Follow-up|0|||
149992843|NCT00837265|541105497|FG003|Main Phase|Lost to Follow-up|0|||
149992844|NCT00837265|541105498|FG004|Main Phase|Lost to Follow-up|1|||
149992845|NCT00837265|541105499|FG005|Main Phase|Lost to Follow-up|0|||
149992846|NCT00837265|541105500|FG006|Main Phase|Lost to Follow-up|0|||
149992847|NCT00837265|541105494|FG000|Main Phase|Principal investigator resignation|0|||
149992848|NCT00837265|541105495|FG001|Main Phase|Principal investigator resignation|0|||
149992849|NCT00837265|541105496|FG002|Main Phase|Principal investigator resignation|0|||
149992850|NCT00837265|541105497|FG003|Main Phase|Principal investigator resignation|0|||
149992851|NCT00837265|541105498|FG004|Main Phase|Principal investigator resignation|2|||
149992852|NCT00837265|541105499|FG005|Main Phase|Principal investigator resignation|0|||
149992853|NCT00837265|541105500|FG006|Main Phase|Principal investigator resignation|0|||
149992854|NCT00837265|541105494|FG000|Main Phase|Participant's personal reason|0|||
149992855|NCT00837265|541105495|FG001|Main Phase|Participant's personal reason|0|||
149992856|NCT00837265|541105496|FG002|Main Phase|Participant's personal reason|0|||
149992857|NCT00837265|541105497|FG003|Main Phase|Participant's personal reason|0|||
149992858|NCT00837265|541105498|FG004|Main Phase|Participant's personal reason|1|||
149992859|NCT00837265|541105499|FG005|Main Phase|Participant's personal reason|0|||
149992860|NCT00837265|541105500|FG006|Main Phase|Participant's personal reason|0|||
149992861|NCT01751906|541105501|FG000|Overall Study|Lost to Follow-up|151|||
149992862|NCT01751906|541105502|FG001|Overall Study|Lost to Follow-up|68|||
149992863|NCT01751906|541105501|FG000|Overall Study|Withdrawal by Subject|22|||
149992864|NCT01751906|541105502|FG001|Overall Study|Withdrawal by Subject|18|||
149992865|NCT01751906|541105501|FG000|Overall Study|Physician Decision|5|||
149992866|NCT01751906|541105502|FG001|Overall Study|Physician Decision|2|||
149992867|NCT01751906|541105501|FG000|Overall Study|Death|84|||
150053864|NCT02267317|541338391|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
150178975|NCT00444600|541793898|FG000|Overall Study|Missed visit|1|||
149992868|NCT01751906|541105502|FG001|Overall Study|Death|43|||
149992869|NCT01751906|541105501|FG000|Overall Study|Denied on premises for follow-up by law|1|||
150178976|NCT00444600|541793899|FG001|Overall Study|Missed visit|0|||
150178977|NCT00444600|541793900|FG002|Overall Study|Missed visit|0|||
149992870|NCT01751906|541105502|FG001|Overall Study|Denied on premises for follow-up by law|0|||
149992871|NCT00470093|541105509|FG000|Overall Study|Adverse Event|2|||
149992872|NCT00191724|541105512|FG000|Overall Study|Adverse Event|0|||
149992873|NCT00191724|541105513|FG001|Overall Study|Adverse Event|0|||
149992874|NCT00191724|541105514|FG002|Overall Study|Adverse Event|1|||
149992875|NCT00191724|541105515|FG003|Overall Study|Adverse Event|0|||
149992876|NCT00191724|541105516|FG004|Overall Study|Adverse Event|0|||
149992877|NCT00191724|541105512|FG000|Overall Study|Lost to Follow-up|1|||
149992878|NCT00191724|541105513|FG001|Overall Study|Lost to Follow-up|1|||
149992879|NCT00191724|541105514|FG002|Overall Study|Lost to Follow-up|0|||
149992880|NCT00191724|541105515|FG003|Overall Study|Lost to Follow-up|2|||
149992881|NCT00191724|541105516|FG004|Overall Study|Lost to Follow-up|3|||
149992882|NCT00191724|541105512|FG000|Overall Study|Withdrawal by Subject|0|||
149992883|NCT00191724|541105513|FG001|Overall Study|Withdrawal by Subject|0|||
149992884|NCT00191724|541105514|FG002|Overall Study|Withdrawal by Subject|0|||
149992885|NCT00191724|541105515|FG003|Overall Study|Withdrawal by Subject|1|||
149992886|NCT00191724|541105516|FG004|Overall Study|Withdrawal by Subject|0|||
149992887|NCT00608023|541105517|FG000|Overall Study|Withdrawal by Subject|8|||
149992888|NCT00608023|541105518|FG001|Overall Study|Withdrawal by Subject|10|||
149992889|NCT00608023|541105519|FG002|Overall Study|Withdrawal by Subject|7|||
149992890|NCT00608023|541105517|FG000|Overall Study|Adverse Event|1|||
149992891|NCT00608023|541105518|FG001|Overall Study|Adverse Event|4|||
149992892|NCT00608023|541105519|FG002|Overall Study|Adverse Event|5|||
149992893|NCT00608023|541105517|FG000|Overall Study|Lost to Follow-up|2|||
149992894|NCT00608023|541105518|FG001|Overall Study|Lost to Follow-up|2|||
149992895|NCT00608023|541105519|FG002|Overall Study|Lost to Follow-up|1|||
149992896|NCT00608023|541105517|FG000|Overall Study|Protocol Violation|1|||
149992897|NCT00608023|541105518|FG001|Overall Study|Protocol Violation|3|||
149992898|NCT00608023|541105519|FG002|Overall Study|Protocol Violation|1|||
149992899|NCT00608023|541105517|FG000|Overall Study|Unknown reason|0|||
149992900|NCT00608023|541105518|FG001|Overall Study|Unknown reason|3|||
149992901|NCT00608023|541105519|FG002|Overall Study|Unknown reason|0|||
149992902|NCT06422364|541105520|FG000|Overall Study|Withdrawn due to study closure|0|||
149992903|NCT06422364|541105521|FG001|Overall Study|Withdrawn due to study closure|2|||
149992904|NCT03458910|541105523|FG000|Overall Study|Withdrawal by Subject|7|||
149992905|NCT03458910|541105524|FG001|Overall Study|Withdrawal by Subject|8|||
149992906|NCT03458910|541105525|FG002|Overall Study|Withdrawal by Subject|6|||
149992907|NCT03458910|541105526|FG003|Overall Study|Withdrawal by Subject|4|||
149992908|NCT03458910|541105523|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
149992909|NCT03458910|541105524|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
149992910|NCT03458910|541105525|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
149992911|NCT03458910|541105526|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
149992912|NCT03768089|541105544|FG000|Part A|Lost to Follow-up|0|||
149992913|NCT03768089|541105545|FG001|Part A|Lost to Follow-up|0|||
149992914|NCT03768089|541105546|FG002|Part A|Lost to Follow-up|0|||
149992915|NCT03768089|541105547|FG003|Part A|Lost to Follow-up|0|||
149992916|NCT03768089|541105548|FG004|Part A|Lost to Follow-up|1|||
149992917|NCT03768089|541105549|FG005|Part A|Lost to Follow-up|0|||
149992918|NCT03768089|541105550|FG006|Part A|Lost to Follow-up|0|||
149992919|NCT03768089|541105551|FG007|Part A|Lost to Follow-up|0|||
149992920|NCT03768089|541105552|FG008|Part A|Lost to Follow-up|0|||
149992921|NCT03768089|541105553|FG009|Part A|Lost to Follow-up|0|||
149992922|NCT03768089|541105554|FG010|Part A|Lost to Follow-up|0|||
149992923|NCT03768089|541105555|FG011|Part A|Lost to Follow-up|0|||
149992924|NCT03768089|541105556|FG012|Part A|Lost to Follow-up|0|||
149992925|NCT03768089|541105557|FG013|Part A|Lost to Follow-up|0|||
149992926|NCT03768089|541105558|FG014|Part A|Lost to Follow-up|0|||
149992927|NCT03768089|541105559|FG015|Part A|Lost to Follow-up|0|||
149992928|NCT03768089|541105560|FG016|Part A|Lost to Follow-up|0|||
149992929|NCT03768089|541105561|FG017|Part A|Lost to Follow-up|0|||
149992930|NCT03768089|541105544|FG000|Part C|Randomized, Never Dosed|0|||
149992931|NCT03768089|541105545|FG001|Part C|Randomized, Never Dosed|0|||
149992932|NCT03768089|541105546|FG002|Part C|Randomized, Never Dosed|0|||
149992933|NCT03768089|541105547|FG003|Part C|Randomized, Never Dosed|0|||
149992934|NCT03768089|541105548|FG004|Part C|Randomized, Never Dosed|0|||
149992935|NCT03768089|541105549|FG005|Part C|Randomized, Never Dosed|0|||
149992936|NCT03768089|541105550|FG006|Part C|Randomized, Never Dosed|0|||
149992937|NCT03768089|541105551|FG007|Part C|Randomized, Never Dosed|0|||
149992938|NCT03768089|541105552|FG008|Part C|Randomized, Never Dosed|0|||
149992939|NCT03768089|541105553|FG009|Part C|Randomized, Never Dosed|0|||
149992940|NCT03768089|541105554|FG010|Part C|Randomized, Never Dosed|0|||
149992941|NCT03768089|541105555|FG011|Part C|Randomized, Never Dosed|0|||
149992942|NCT03768089|541105556|FG012|Part C|Randomized, Never Dosed|0|||
149992943|NCT03768089|541105557|FG013|Part C|Randomized, Never Dosed|0|||
149992944|NCT03768089|541105558|FG014|Part C|Randomized, Never Dosed|1|||
149992945|NCT03768089|541105559|FG015|Part C|Randomized, Never Dosed|0|||
149992946|NCT03768089|541105560|FG016|Part C|Randomized, Never Dosed|0|||
149992947|NCT03768089|541105561|FG017|Part C|Randomized, Never Dosed|0|||
149992948|NCT02135029|541105562|FG000|Overall Study|Adverse Event|2|||
149992949|NCT02135029|541105563|FG001|Overall Study|Adverse Event|2|||
149992950|NCT02135029|541105564|FG002|Overall Study|Adverse Event|2|||
149992951|NCT02135029|541105562|FG000|Overall Study|Lost to Follow-up|0|||
149992952|NCT02135029|541105563|FG001|Overall Study|Lost to Follow-up|1|||
149992953|NCT02135029|541105564|FG002|Overall Study|Lost to Follow-up|0|||
149992954|NCT02135029|541105562|FG000|Overall Study|Withdrawal by Subject|2|||
149992955|NCT02135029|541105563|FG001|Overall Study|Withdrawal by Subject|0|||
149992956|NCT02135029|541105564|FG002|Overall Study|Withdrawal by Subject|1|||
149992957|NCT02135029|541105562|FG000|Overall Study|Other|0|||
149992958|NCT02135029|541105563|FG001|Overall Study|Other|1|||
149992959|NCT02135029|541105564|FG002|Overall Study|Other|0|||
149992960|NCT02135029|541105562|FG000|Overall Study|Death|0|||
149992961|NCT02135029|541105563|FG001|Overall Study|Death|1|||
149992962|NCT02135029|541105564|FG002|Overall Study|Death|0|||
149992963|NCT03466099|541105565|FG000|Overall Study|Adverse Event|1|||
149992964|NCT03466099|541105566|FG001|Overall Study|Adverse Event|1|||
149992965|NCT03466099|541105567|FG002|Overall Study|Adverse Event|1|||
149992966|NCT03466099|541105565|FG000|Overall Study|Withdrawal by Subject|2|||
149992967|NCT03466099|541105566|FG001|Overall Study|Withdrawal by Subject|3|||
149992968|NCT03466099|541105567|FG002|Overall Study|Withdrawal by Subject|1|||
149992969|NCT03466099|541105565|FG000|Overall Study|Use of rescue medication|8|||
149992970|NCT03466099|541105566|FG001|Overall Study|Use of rescue medication|9|||
149992971|NCT03466099|541105567|FG002|Overall Study|Use of rescue medication|13|||
149992972|NCT03466099|541105565|FG000|Overall Study|Rescued without meeting criteria|4|||
149992973|NCT03466099|541105566|FG001|Overall Study|Rescued without meeting criteria|1|||
149992974|NCT03466099|541105567|FG002|Overall Study|Rescued without meeting criteria|1|||
149992975|NCT03466099|541105565|FG000|Overall Study|Subject compliance|2|||
149992976|NCT03466099|541105566|FG001|Overall Study|Subject compliance|0|||
149992977|NCT03466099|541105567|FG002|Overall Study|Subject compliance|0|||
149992978|NCT03466099|541105565|FG000|Overall Study|Worsening disease|0|||
149992979|NCT03466099|541105566|FG001|Overall Study|Worsening disease|0|||
149992980|NCT03466099|541105567|FG002|Overall Study|Worsening disease|1|||
149992981|NCT00889603|541105570|FG000|Overall Study|Adverse Event|7|||
149992982|NCT00889603|541105570|FG000|Overall Study|Death|3|||
149992983|NCT00889603|541105570|FG000|Overall Study|Lost to Follow-up|19|||
149992984|NCT00889603|541105570|FG000|Overall Study|No longer willing to participant in stud|4|||
149992985|NCT00889603|541105570|FG000|Overall Study|Other|4|||
149992986|NCT03525600|541105573|FG000|Overall Study|Adverse Event|9|||
149992987|NCT03525600|541105574|FG001|Overall Study|Adverse Event|6|||
149992988|NCT03525600|541105575|FG002|Overall Study|Adverse Event|5|||
149992989|NCT03525600|541105576|FG003|Overall Study|Adverse Event|3|||
149992990|NCT03525600|541105573|FG000|Overall Study|Lost to Follow-up|2|||
149992991|NCT03525600|541105574|FG001|Overall Study|Lost to Follow-up|4|||
149992992|NCT03525600|541105575|FG002|Overall Study|Lost to Follow-up|4|||
149992993|NCT03525600|541105576|FG003|Overall Study|Lost to Follow-up|0|||
149992994|NCT03525600|541105573|FG000|Overall Study|Physician Decision|1|||
149992995|NCT03525600|541105574|FG001|Overall Study|Physician Decision|0|||
149992996|NCT03525600|541105575|FG002|Overall Study|Physician Decision|2|||
149992997|NCT03525600|541105576|FG003|Overall Study|Physician Decision|0|||
149992998|NCT03525600|541105573|FG000|Overall Study|Consent withdrawal|36|||
149992999|NCT03525600|541105574|FG001|Overall Study|Consent withdrawal|20|||
149993000|NCT03525600|541105575|FG002|Overall Study|Consent withdrawal|6|||
149993001|NCT03525600|541105576|FG003|Overall Study|Consent withdrawal|13|||
149993002|NCT03525600|541105573|FG000|Overall Study|Death|7|||
149993003|NCT03525600|541105574|FG001|Overall Study|Death|6|||
149993004|NCT03525600|541105575|FG002|Overall Study|Death|4|||
149993005|NCT03525600|541105576|FG003|Overall Study|Death|3|||
149993006|NCT03525600|541105573|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
149993007|NCT03525600|541105574|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
149993008|NCT03525600|541105575|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
149993009|NCT03525600|541105576|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
149993010|NCT03525600|541105573|FG000|Overall Study|Other|0|||
149993011|NCT03525600|541105574|FG001|Overall Study|Other|1|||
149993012|NCT03525600|541105575|FG002|Overall Study|Other|0|||
149993013|NCT03525600|541105576|FG003|Overall Study|Other|0|||
149993014|NCT01923363|541105579|FG000|Overall Study|Protocol Violation|1|||
149993015|NCT03718884|541105587|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
149993016|NCT03718884|541105588|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
149993017|NCT03718884|541105587|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
149993018|NCT03718884|541105588|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
149993019|NCT02099344|541105589|FG000|Overall Study|Physician Decision|1|||
149993020|NCT02099344|541105590|FG001|Overall Study|Physician Decision|0|||
149993021|NCT02839720|541105591|FG000|Overall Study|Adverse Event|2|||
149993022|NCT02839720|541105591|FG000|Overall Study|Non-compliance|2|||
149993023|NCT02839720|541105591|FG000|Overall Study|Intercurrent Illness|1|||
149993024|NCT02839720|541105591|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
149993025|NCT05248997|541105596|FG000|Overall Study|Lost to Follow-up|1|||
149993026|NCT05248997|541105597|FG001|Overall Study|Lost to Follow-up|1|||
149993027|NCT05248997|541105596|FG000|Overall Study|Randomized but not treated|32|||
149993028|NCT05248997|541105597|FG001|Overall Study|Randomized but not treated|25|||
149993029|NCT01453205|541105598|FG000|Overall Study|Lost to Follow-up|3|||
149993030|NCT01453205|541105599|FG001|Overall Study|Lost to Follow-up|0|||
149993031|NCT01453205|541105600|FG002|Overall Study|Lost to Follow-up|1|||
149993032|NCT01453205|541105598|FG000|Overall Study|Withdrawal by Subject|8|||
149993033|NCT01453205|541105599|FG001|Overall Study|Withdrawal by Subject|3|||
149993034|NCT01453205|541105600|FG002|Overall Study|Withdrawal by Subject|0|||
149993035|NCT01453205|541105598|FG000|Overall Study|Death|24|||
149993036|NCT01453205|541105599|FG001|Overall Study|Death|22|||
149993037|NCT01453205|541105600|FG002|Overall Study|Death|18|||
149993038|NCT01453205|541105598|FG000|Overall Study|Other|45|||
149993039|NCT01453205|541105599|FG001|Overall Study|Other|27|||
149993040|NCT01453205|541105600|FG002|Overall Study|Other|35|||
149993041|NCT05593913|541105601|FG000|Overall Study|Insufficient image quality|39|||
149993042|NCT02602275|541105602|FG000|Day 1|Physician Decision|0|||
149993043|NCT02602275|541105603|FG001|Day 1|Physician Decision|1|||
149993044|NCT04113018|541105608|FG000|Overall Study|Death|2|||
149993045|NCT04113018|541105608|FG000|Overall Study|Lost to Follow-up|1|||
149993046|NCT04113018|541105608|FG000|Overall Study|Still On Study (on study treatment)|24|||
149993047|NCT04113018|541105608|FG000|Overall Study|Still On Study (in follow up)|12|||
149993048|NCT05005013|541105609|FG000|Overall Study|Withdrawal by Subject|5|||
149993049|NCT05005013|541105610|FG001|Overall Study|Withdrawal by Subject|1|||
149993050|NCT05005013|541105609|FG000|Overall Study|Lost to Follow-up|3|||
149993051|NCT05005013|541105610|FG001|Overall Study|Lost to Follow-up|1|||
149993052|NCT05005013|541105609|FG000|Overall Study|Ineligibility|1|||
149993053|NCT05005013|541105610|FG001|Overall Study|Ineligibility|1|||
149993054|NCT06099223|541105611|FG000|Overall Study|Preoperative surveys missed|0|||
149993055|NCT06099223|541105612|FG001|Overall Study|Preoperative surveys missed|1|||
149993056|NCT01221623|541105613|FG000|Overall Study|Withdrawal by Subject|19|||
149993057|NCT01221623|541105614|FG001|Overall Study|Withdrawal by Subject|8|||
149993058|NCT01221623|541105613|FG000|Overall Study|Lost to Follow-up|7|||
149993059|NCT01221623|541105614|FG001|Overall Study|Lost to Follow-up|1|||
149993060|NCT01221623|541105613|FG000|Overall Study|Adverse Event|6|||
149993061|NCT01221623|541105614|FG001|Overall Study|Adverse Event|3|||
149993062|NCT01221623|541105613|FG000|Overall Study|Death|1|||
149993063|NCT01221623|541105614|FG001|Overall Study|Death|0|||
149993064|NCT01221623|541105613|FG000|Overall Study|Other|5|||
149993065|NCT01221623|541105614|FG001|Overall Study|Other|2|||
149993066|NCT00661726|541105615|FG000|Overall Study|Adverse Event|1|||
149993067|NCT00780143|541105616|FG000|Overall Study|Progressive disease|1|||
149993068|NCT00780143|541105616|FG000|Overall Study|Toxicity|1|||
149993069|NCT00780143|541105616|FG000|Overall Study|Adverse Event|1|||
149993070|NCT02644096|541105617|FG000|Overall Study|Withdrawal by Subject|28|||
149993071|NCT02644096|541105618|FG001|Overall Study|Withdrawal by Subject|25|||
149993072|NCT02461290|541105619|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
149993073|NCT02461290|541105619|FG000|Overall Study|Lost to Follow-up|3|||
149993074|NCT01457014|541105620|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
149993075|NCT01457014|541105621|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
149993076|NCT01457014|541105622|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
149993077|NCT01457014|541105623|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
149993078|NCT01457014|541105620|FG000|First Night|Withdrawal by Subject|3|||
149993079|NCT01457014|541105621|FG001|First Night|Withdrawal by Subject|0|||
149993080|NCT01457014|541105622|FG002|First Night|Withdrawal by Subject|0|||
149993081|NCT01457014|541105623|FG003|First Night|Withdrawal by Subject|0|||
149993082|NCT00322452|541105624|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149993083|NCT00322452|541105625|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149993084|NCT00322452|541105624|FG000|Overall Study|Lost to Follow-up|5|||
149993085|NCT00322452|541105625|FG001|Overall Study|Lost to Follow-up|2|||
149993086|NCT00322452|541105624|FG000|Overall Study|Withdrawal by Subject|19|||
149993087|NCT00322452|541105625|FG001|Overall Study|Withdrawal by Subject|46|||
149993088|NCT00322452|541105624|FG000|Overall Study|Death|223|||
149993089|NCT00322452|541105625|FG001|Overall Study|Death|227|||
149993090|NCT00526656|541105626|FG000|Overall Study|Death|1|||
149993091|NCT00526656|541105626|FG000|Overall Study|Refused surgery|1|||
149993092|NCT00790868|541107419|FG000|Overall Study|Withdrawal by Subject|4|||
149993093|NCT00790868|541107420|FG001|Overall Study|Withdrawal by Subject|5|||
149993094|NCT00790868|541107419|FG000|Overall Study|Lost to Follow-up|2|||
149993095|NCT00790868|541107420|FG001|Overall Study|Lost to Follow-up|12|||
149993096|NCT02013206|541107421|FG000|Overall Study|Progressive disease (PD)|14|||
149993097|NCT02013206|541107422|FG001|Overall Study|Progressive disease (PD)|17|||
149993098|NCT02013206|541107421|FG000|Overall Study|Symptomatic deterioration|3|||
149993099|NCT02013206|541107422|FG001|Overall Study|Symptomatic deterioration|1|||
149993100|NCT02013206|541107421|FG000|Overall Study|Adverse Event|1|||
149993101|NCT02013206|541107422|FG001|Overall Study|Adverse Event|0|||
149993102|NCT02013206|541107421|FG000|Overall Study|Patient refusal|2|||
149993103|NCT02013206|541107422|FG001|Overall Study|Patient refusal|0|||
149993104|NCT02013206|541107421|FG000|Overall Study|Patient non-compliance|1|||
149993105|NCT02013206|541107422|FG001|Overall Study|Patient non-compliance|0|||
149993106|NCT02013206|541107421|FG000|Overall Study|Death|1|||
149993107|NCT02013206|541107422|FG001|Overall Study|Death|2|||
149993108|NCT02013206|541107421|FG000|Overall Study|Other reasons off treatment|5|||
149993109|NCT02013206|541107422|FG001|Overall Study|Other reasons off treatment|2|||
149993110|NCT01952665|541107423|FG000|Overall Study|Physician Decision|3|||
149993111|NCT01952665|541107424|FG001|Overall Study|Physician Decision|2|||
149993112|NCT01952665|541107423|FG000|Overall Study|Lost to Follow-up|1|||
149993113|NCT01952665|541107424|FG001|Overall Study|Lost to Follow-up|2|||
149993114|NCT01952665|541107423|FG000|Overall Study|Adverse Event|2|||
149993115|NCT01952665|541107424|FG001|Overall Study|Adverse Event|1|||
149993116|NCT01952665|541107423|FG000|Overall Study|Protocol Violation|0|||
149993117|NCT01952665|541107424|FG001|Overall Study|Protocol Violation|1|||
149993118|NCT01537081|541107425|FG000|Overall Study|Adverse Event|5|||
149993119|NCT01537081|541107426|FG001|Overall Study|Adverse Event|2|||
149993120|NCT01537081|541107427|FG002|Overall Study|Adverse Event|2|||
149993121|NCT01537081|541107425|FG000|Overall Study|Lack of Efficacy|2|||
149993122|NCT01537081|541107426|FG001|Overall Study|Lack of Efficacy|1|||
149993123|NCT01537081|541107427|FG002|Overall Study|Lack of Efficacy|0|||
149993124|NCT01537081|541107425|FG000|Overall Study|Lost to Follow-up|17|||
149993125|NCT01537081|541107426|FG001|Overall Study|Lost to Follow-up|15|||
149993126|NCT01537081|541107427|FG002|Overall Study|Lost to Follow-up|9|||
149993127|NCT01537081|541107425|FG000|Overall Study|Protocol Violation|3|||
149993128|NCT01537081|541107426|FG001|Overall Study|Protocol Violation|2|||
149993129|NCT01537081|541107427|FG002|Overall Study|Protocol Violation|2|||
149993130|NCT01537081|541107425|FG000|Overall Study|Withdrawal by Subject|6|||
149993131|NCT01537081|541107426|FG001|Overall Study|Withdrawal by Subject|11|||
149993132|NCT01537081|541107427|FG002|Overall Study|Withdrawal by Subject|3|||
149993133|NCT01537081|541107425|FG000|Overall Study|Physician Decision|5|||
149993134|NCT01537081|541107426|FG001|Overall Study|Physician Decision|6|||
149993135|NCT01537081|541107427|FG002|Overall Study|Physician Decision|0|||
149993136|NCT01537081|541107425|FG000|Overall Study|Sponsor decision|0|||
149993137|NCT01537081|541107426|FG001|Overall Study|Sponsor decision|1|||
149993138|NCT01537081|541107427|FG002|Overall Study|Sponsor decision|0|||
149993139|NCT01537081|541107425|FG000|Overall Study|Assigned but never dosed|1|||
149993140|NCT01537081|541107426|FG001|Overall Study|Assigned but never dosed|0|||
149993141|NCT01537081|541107427|FG002|Overall Study|Assigned but never dosed|0|||
149993142|NCT00664560|541107434|FG000|Overall Study|Adverse Event|19|||
149993143|NCT00664560|541107435|FG001|Overall Study|Adverse Event|16|||
149993144|NCT00664560|541107436|FG002|Overall Study|Adverse Event|7|||
149993145|NCT00664560|541107434|FG000|Overall Study|Withdrawal by Subject|9|||
149993146|NCT00664560|541107435|FG001|Overall Study|Withdrawal by Subject|13|||
149993147|NCT00664560|541107436|FG002|Overall Study|Withdrawal by Subject|7|||
149993148|NCT00664560|541107434|FG000|Overall Study|Lost to Follow-up|0|||
149993149|NCT00664560|541107435|FG001|Overall Study|Lost to Follow-up|2|||
149993150|NCT00664560|541107436|FG002|Overall Study|Lost to Follow-up|0|||
149993151|NCT00664560|541107434|FG000|Overall Study|Other|11|||
149993152|NCT00664560|541107435|FG001|Overall Study|Other|4|||
149993153|NCT00664560|541107436|FG002|Overall Study|Other|5|||
149993154|NCT02379221|541107437|FG000|Overall Study|Lost to Follow-up|1|||
149993155|NCT02019108|541107438|FG000|Overall Study|Lost to Follow-up|5|||
149993156|NCT02019108|541107439|FG001|Overall Study|Lost to Follow-up|7|||
149993157|NCT05260073|541107440|FG000|Overall Study|Physician Decision|1|||
149993158|NCT05260073|541107440|FG000|Overall Study|Withdrawal by Subject|6|||
149993159|NCT05260073|541107440|FG000|Overall Study|Lost to Follow-up|14|||
149993160|NCT04484649|541107441|FG000|Overall Study|Lost to Follow-up|2|||
149993161|NCT04484649|541107442|FG001|Overall Study|Lost to Follow-up|1|||
149993162|NCT04484649|541107441|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
149993163|NCT04484649|541107442|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
149993164|NCT01463696|541107450|FG000|Overall Study|Adverse Event|0|||
149993165|NCT01463696|541107451|FG001|Overall Study|Adverse Event|1|||
149993166|NCT01463696|541107452|FG002|Overall Study|Adverse Event|0|||
149993167|NCT01463696|541107453|FG003|Overall Study|Adverse Event|2|||
149993168|NCT01463696|541107454|FG004|Overall Study|Adverse Event|0|||
149993169|NCT01463696|541107455|FG005|Overall Study|Adverse Event|1|||
149993170|NCT01463696|541107456|FG006|Overall Study|Adverse Event|3|||
149993171|NCT01463696|541107457|FG007|Overall Study|Adverse Event|2|||
150053865|NCT02267317|541338392|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
150053866|NCT02267317|541338393|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
149993172|NCT01463696|541107450|FG000|Overall Study|Lost to Follow-up|0|||
149993173|NCT01463696|541107451|FG001|Overall Study|Lost to Follow-up|0|||
149993174|NCT01463696|541107452|FG002|Overall Study|Lost to Follow-up|1|||
149993175|NCT01463696|541107453|FG003|Overall Study|Lost to Follow-up|0|||
149993176|NCT01463696|541107454|FG004|Overall Study|Lost to Follow-up|0|||
149993177|NCT01463696|541107455|FG005|Overall Study|Lost to Follow-up|0|||
149993178|NCT01463696|541107456|FG006|Overall Study|Lost to Follow-up|0|||
149993179|NCT01463696|541107457|FG007|Overall Study|Lost to Follow-up|0|||
149993180|NCT01463696|541107450|FG000|Overall Study|Progressive Disease|0|||
149993181|NCT01463696|541107451|FG001|Overall Study|Progressive Disease|1|||
149993182|NCT01463696|541107452|FG002|Overall Study|Progressive Disease|0|||
149993183|NCT01463696|541107453|FG003|Overall Study|Progressive Disease|1|||
150053867|NCT02366091|541338396|FG000|Overall Study|Withdrawal by Subject|3|||
150053868|NCT02366091|541338397|FG001|Overall Study|Withdrawal by Subject|7|||
150053869|NCT02366091|541338398|FG002|Overall Study|Withdrawal by Subject|3|||
150053870|NCT02366091|541338399|FG003|Overall Study|Withdrawal by Subject|1|||
150053871|NCT02338232|541338400|FG000|Overall Study|Screen Failure|3|||
150053872|NCT02338232|541338400|FG000|Overall Study|Withdrawal by Subject|6|||
150053873|NCT02338232|541338400|FG000|Overall Study|Adverse Event|2|||
150053874|NCT01105065|541338401|FG000|Overall Study|Adverse Event|5|||
150053875|NCT01105065|541338401|FG000|Overall Study|Technical Problems|1|||
150053876|NCT00422084|541338402|FG000|Overall Study|Adverse Event|21|||
150053877|NCT00422084|541338403|FG001|Overall Study|Adverse Event|7|||
150053878|NCT00422084|541338402|FG000|Overall Study|Withdrawal by Subject|12|||
150053879|NCT00422084|541338403|FG001|Overall Study|Withdrawal by Subject|9|||
150053880|NCT00422084|541338402|FG000|Overall Study|Lost to Follow-up|14|||
150053881|NCT00422084|541338403|FG001|Overall Study|Lost to Follow-up|9|||
150053882|NCT00422084|541338402|FG000|Overall Study|Protocol Violation|4|||
150053883|NCT00422084|541338403|FG001|Overall Study|Protocol Violation|1|||
150053884|NCT00422084|541338402|FG000|Overall Study|Lack of Efficacy|40|||
150178978|NCT00444600|541793901|FG003|Overall Study|Missed visit|1|||
149993184|NCT01463696|541107454|FG004|Overall Study|Progressive Disease|0|||
149993185|NCT01463696|541107455|FG005|Overall Study|Progressive Disease|1|||
149993186|NCT01463696|541107456|FG006|Overall Study|Progressive Disease|4|||
149993187|NCT01463696|541107457|FG007|Overall Study|Progressive Disease|2|||
149993188|NCT01463696|541107450|FG000|Overall Study|Withdrawal by Subject|0|||
149993189|NCT01463696|541107451|FG001|Overall Study|Withdrawal by Subject|0|||
149993190|NCT01463696|541107452|FG002|Overall Study|Withdrawal by Subject|0|||
149993191|NCT01463696|541107453|FG003|Overall Study|Withdrawal by Subject|1|||
149993192|NCT01463696|541107454|FG004|Overall Study|Withdrawal by Subject|1|||
149993193|NCT01463696|541107455|FG005|Overall Study|Withdrawal by Subject|1|||
149993194|NCT01463696|541107456|FG006|Overall Study|Withdrawal by Subject|2|||
149993195|NCT01463696|541107457|FG007|Overall Study|Withdrawal by Subject|0|||
149993196|NCT01463696|541107450|FG000|Overall Study|Not Treated|0|||
149993197|NCT01463696|541107451|FG001|Overall Study|Not Treated|0|||
149993198|NCT01463696|541107452|FG002|Overall Study|Not Treated|0|||
149993199|NCT01463696|541107453|FG003|Overall Study|Not Treated|0|||
149993200|NCT01463696|541107454|FG004|Overall Study|Not Treated|0|||
149993201|NCT01463696|541107455|FG005|Overall Study|Not Treated|0|||
149993202|NCT01463696|541107456|FG006|Overall Study|Not Treated|1|||
149993203|NCT01463696|541107457|FG007|Overall Study|Not Treated|0|||
149993204|NCT00967694|541107463|FG000|Overall Study|Withdrawal by Subject|6|||
149993205|NCT03905265|541107467|FG000|Overall Study|Withdrawal by Subject|1|||
149993206|NCT03905265|541107468|FG001|Overall Study|Withdrawal by Subject|1|||
149993207|NCT03905265|541107469|FG002|Overall Study|Withdrawal by Subject|0|||
149993208|NCT03905265|541107470|FG003|Overall Study|Withdrawal by Subject|0|||
149993209|NCT00960011|541107471|FG000|Overall Study|Death|5|||
149993210|NCT00960011|541107472|FG001|Overall Study|Death|0|||
149993211|NCT00960011|541107471|FG000|Overall Study|Lost to Follow-up|6|||
149993212|NCT00960011|541107472|FG001|Overall Study|Lost to Follow-up|2|||
149993213|NCT04417218|541107473|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
149993214|NCT04417218|541107474|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
149993215|NCT00758264|541107477|FG000|Active Phase|Withdrawal by Subject|0|||
149993216|NCT00758264|541107478|FG001|Active Phase|Withdrawal by Subject|0|||
149993217|NCT00758264|541107479|FG002|Active Phase|Withdrawal by Subject|1|||
149993218|NCT00758264|541107477|FG000|Active Phase|Lost to Follow-up|1|||
149993219|NCT00758264|541107478|FG001|Active Phase|Lost to Follow-up|0|||
149993220|NCT00758264|541107479|FG002|Active Phase|Lost to Follow-up|0|||
149993221|NCT00758264|541107477|FG000|Active Phase|Other|0|||
149993222|NCT00758264|541107478|FG001|Active Phase|Other|0|||
149993223|NCT00758264|541107479|FG002|Active Phase|Other|4|||
149993224|NCT01054560|541107491|FG000|Overall Study|Death|10|||
149993225|NCT01054560|541107492|FG001|Overall Study|Death|21|||
149993226|NCT01054560|541107491|FG000|Overall Study|Lost to Follow-up|2|||
150053885|NCT00422084|541338403|FG001|Overall Study|Lack of Efficacy|42|||
150053886|NCT00422084|541338402|FG000|Overall Study|P. vivax infection|3|||
150053887|NCT00422084|541338403|FG001|Overall Study|P. vivax infection|6|||
150053888|NCT00422084|541338402|FG000|Overall Study|Cyesis|1|||
150053889|NCT00422084|541338403|FG001|Overall Study|Cyesis|0|||
149993227|NCT01054560|541107492|FG001|Overall Study|Lost to Follow-up|5|||
149993228|NCT01054560|541107491|FG000|Overall Study|Withdrawal by Subject|0|||
149993229|NCT01054560|541107492|FG001|Overall Study|Withdrawal by Subject|2|||
149993230|NCT01054560|541107491|FG000|Overall Study|Physician Decision|1|||
149993231|NCT01054560|541107492|FG001|Overall Study|Physician Decision|0|||
149993232|NCT00939029|541107495|FG000|Overall Study|Withdrawal by Subject|3|||
149993233|NCT00939029|541107496|FG001|Overall Study|Withdrawal by Subject|7|||
149993234|NCT00939029|541107495|FG000|Overall Study|Lost to Follow-up|3|||
149993235|NCT00939029|541107496|FG001|Overall Study|Lost to Follow-up|4|||
149993236|NCT00939029|541107495|FG000|Overall Study|Adverse Event|0|||
149993237|NCT00939029|541107496|FG001|Overall Study|Adverse Event|1|||
150053890|NCT00422084|541338402|FG000|Overall Study|Withdrawn from study accidentally|1|||
149993238|NCT01535599|541107497|FG000|Overall Study|Adverse Event|6|||
149993239|NCT01535599|541107498|FG001|Overall Study|Adverse Event|15|||
149993240|NCT01535599|541107497|FG000|Overall Study|Lost to Follow-up|3|||
149993241|NCT01535599|541107498|FG001|Overall Study|Lost to Follow-up|4|||
149993242|NCT01535599|541107497|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
149993243|NCT01535599|541107498|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
149993244|NCT01535599|541107497|FG000|Overall Study|Treatment Failure|33|||
149993245|NCT01535599|541107498|FG001|Overall Study|Treatment Failure|66|||
149993246|NCT01535599|541107497|FG000|Overall Study|BL Culture + for Group A Strep|0|||
149993247|NCT01535599|541107498|FG001|Overall Study|BL Culture + for Group A Strep|1|||
149993248|NCT01535599|541107497|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
149993249|NCT01535599|541107498|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
149993250|NCT01535599|541107497|FG000|Overall Study|Randomized in Error|2|||
149993251|NCT01535599|541107498|FG001|Overall Study|Randomized in Error|4|||
149993252|NCT01535599|541107497|FG000|Overall Study|Did not use product|1|||
149993253|NCT01535599|541107498|FG001|Overall Study|Did not use product|0|||
149993254|NCT01535599|541107497|FG000|Overall Study|Other|1|||
149993255|NCT01535599|541107498|FG001|Overall Study|Other|0|||
149993256|NCT01535599|541107497|FG000|Overall Study|Stopped medication|0|||
149993257|NCT01535599|541107498|FG001|Overall Study|Stopped medication|1|||
149993258|NCT01535599|541107497|FG000|Overall Study|Noncompliance|0|||
149993259|NCT01535599|541107498|FG001|Overall Study|Noncompliance|1|||
149993260|NCT03305419|541107503|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993261|NCT03305419|541107504|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
149993262|NCT03305419|541107505|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993263|NCT03305419|541107506|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993264|NCT03305419|541107507|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993265|NCT03305419|541107508|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993266|NCT03305419|541107509|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993267|NCT03305419|541107510|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
149993268|NCT03305419|541107503|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
149993269|NCT03305419|541107504|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993270|NCT03305419|541107505|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993271|NCT03305419|541107506|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993272|NCT03305419|541107507|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993273|NCT03305419|541107508|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993274|NCT03305419|541107509|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993275|NCT03305419|541107510|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
149993276|NCT03305419|541107503|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
149993277|NCT03305419|541107504|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993278|NCT03305419|541107505|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993279|NCT03305419|541107506|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993280|NCT03305419|541107507|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993281|NCT03305419|541107508|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993282|NCT03305419|541107509|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993283|NCT03305419|541107510|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
149993284|NCT03305419|541107503|FG000|Part B (14 Days)|Adverse Event|0|||
149993285|NCT03305419|541107504|FG001|Part B (14 Days)|Adverse Event|0|||
149993286|NCT03305419|541107505|FG002|Part B (14 Days)|Adverse Event|0|||
149993287|NCT03305419|541107506|FG003|Part B (14 Days)|Adverse Event|0|||
149993288|NCT03305419|541107507|FG004|Part B (14 Days)|Adverse Event|1|||
149993289|NCT03305419|541107508|FG005|Part B (14 Days)|Adverse Event|2|||
149993290|NCT03305419|541107509|FG006|Part B (14 Days)|Adverse Event|4|||
149993291|NCT03305419|541107510|FG007|Part B (14 Days)|Adverse Event|0|||
149993292|NCT03305419|541107503|FG000|Part B (14 Days)|Physician Decision|0|||
149993293|NCT03305419|541107504|FG001|Part B (14 Days)|Physician Decision|0|||
149993294|NCT03305419|541107505|FG002|Part B (14 Days)|Physician Decision|0|||
149993295|NCT03305419|541107506|FG003|Part B (14 Days)|Physician Decision|0|||
149993296|NCT03305419|541107507|FG004|Part B (14 Days)|Physician Decision|2|||
149993297|NCT03305419|541107508|FG005|Part B (14 Days)|Physician Decision|8|||
149993298|NCT03305419|541107509|FG006|Part B (14 Days)|Physician Decision|1|||
149993299|NCT03305419|541107510|FG007|Part B (14 Days)|Physician Decision|0|||
149993300|NCT02210689|541107511|FG000|Overall Study|Withdrawal by Subject|7|||
149993301|NCT02210689|541107512|FG001|Overall Study|Withdrawal by Subject|4|||
149993302|NCT02210689|541107513|FG002|Overall Study|Withdrawal by Subject|2|||
149993303|NCT02210689|541107511|FG000|Overall Study|Adverse Event|0|||
149993304|NCT02210689|541107512|FG001|Overall Study|Adverse Event|1|||
149993305|NCT02210689|541107513|FG002|Overall Study|Adverse Event|0|||
149993306|NCT02210689|541107511|FG000|Overall Study|Protocol Violation|1|||
149993307|NCT02210689|541107512|FG001|Overall Study|Protocol Violation|0|||
149993308|NCT02210689|541107513|FG002|Overall Study|Protocol Violation|0|||
149993309|NCT02210689|541107511|FG000|Overall Study|Lost to Follow-up|11|||
149993310|NCT02210689|541107512|FG001|Overall Study|Lost to Follow-up|9|||
149993311|NCT02210689|541107513|FG002|Overall Study|Lost to Follow-up|5|||
149993312|NCT02210689|541107511|FG000|Overall Study|Pregnancy|0|||
149993313|NCT02210689|541107512|FG001|Overall Study|Pregnancy|1|||
149993314|NCT02210689|541107513|FG002|Overall Study|Pregnancy|0|||
149993315|NCT02210689|541107511|FG000|Overall Study|Lack of Efficacy|0|||
149993316|NCT02210689|541107512|FG001|Overall Study|Lack of Efficacy|1|||
149993317|NCT02210689|541107513|FG002|Overall Study|Lack of Efficacy|5|||
149993318|NCT02210689|541107511|FG000|Overall Study|Prohibited medication|2|||
149993319|NCT02210689|541107512|FG001|Overall Study|Prohibited medication|8|||
149993320|NCT02210689|541107513|FG002|Overall Study|Prohibited medication|1|||
149993321|NCT02210689|541107511|FG000|Overall Study|Negative Nugent score at baseline|6|||
149993322|NCT02210689|541107512|FG001|Overall Study|Negative Nugent score at baseline|2|||
149993323|NCT02210689|541107513|FG002|Overall Study|Negative Nugent score at baseline|2|||
149993324|NCT02210689|541107511|FG000|Overall Study|Other|25|||
149993325|NCT02210689|541107512|FG001|Overall Study|Other|21|||
149993326|NCT02210689|541107513|FG002|Overall Study|Other|8|||
149993327|NCT00075946|541107514|FG000|Overall Study|Path ineligible: undetermined histology|0|||
149993328|NCT00075946|541107515|FG001|Overall Study|Path ineligible: undetermined histology|0|||
149993329|NCT00075946|541107516|FG002|Overall Study|Path ineligible: undetermined histology|0|||
149993330|NCT00075946|541107517|FG003|Overall Study|Path ineligible: undetermined histology|0|||
149993331|NCT00075946|541107518|FG004|Overall Study|Path ineligible: undetermined histology|6|||
149993332|NCT00075946|541107514|FG000|Overall Study|Did not achieve response after induction|0|||
149993333|NCT00075946|541107515|FG001|Overall Study|Did not achieve response after induction|0|||
149993334|NCT00075946|541107516|FG002|Overall Study|Did not achieve response after induction|0|||
149993335|NCT00075946|541107517|FG003|Overall Study|Did not achieve response after induction|0|||
149993336|NCT00075946|541107518|FG004|Overall Study|Did not achieve response after induction|182|||
149993337|NCT00075946|541107514|FG000|Overall Study|Incorrectly randomized (no response)|5|||
149993338|NCT00075946|541107515|FG001|Overall Study|Incorrectly randomized (no response)|5|||
149993339|NCT00075946|541107516|FG002|Overall Study|Incorrectly randomized (no response)|5|||
149993340|NCT00075946|541107517|FG003|Overall Study|Incorrectly randomized (no response)|1|||
149993341|NCT00075946|541107518|FG004|Overall Study|Incorrectly randomized (no response)|0|||
149993342|NCT00075946|541107514|FG000|Overall Study|Adverse Event|2|||
149993343|NCT00075946|541107515|FG001|Overall Study|Adverse Event|10|||
149993344|NCT00075946|541107516|FG002|Overall Study|Adverse Event|0|||
149993345|NCT00075946|541107517|FG003|Overall Study|Adverse Event|2|||
149993346|NCT00075946|541107518|FG004|Overall Study|Adverse Event|0|||
149993347|NCT00075946|541107514|FG000|Overall Study|Death|0|||
149993348|NCT00075946|541107515|FG001|Overall Study|Death|1|||
149993349|NCT00075946|541107516|FG002|Overall Study|Death|0|||
149993350|NCT00075946|541107517|FG003|Overall Study|Death|0|||
149993351|NCT00075946|541107518|FG004|Overall Study|Death|0|||
149993352|NCT00075946|541107514|FG000|Overall Study|Withdrawal by Subject|23|||
149993353|NCT00075946|541107515|FG001|Overall Study|Withdrawal by Subject|58|||
149993354|NCT00075946|541107516|FG002|Overall Study|Withdrawal by Subject|4|||
149993355|NCT00075946|541107517|FG003|Overall Study|Withdrawal by Subject|9|||
149993356|NCT00075946|541107518|FG004|Overall Study|Withdrawal by Subject|0|||
149993357|NCT00075946|541107514|FG000|Overall Study|Alternative therapy|16|||
149993358|NCT00075946|541107515|FG001|Overall Study|Alternative therapy|2|||
149993359|NCT00075946|541107516|FG002|Overall Study|Alternative therapy|5|||
149993360|NCT00075946|541107517|FG003|Overall Study|Alternative therapy|0|||
149993361|NCT00075946|541107518|FG004|Overall Study|Alternative therapy|0|||
149993362|NCT00075946|541107514|FG000|Overall Study|Other complicating disease|7|||
150053891|NCT00422084|541338403|FG001|Overall Study|Withdrawn from study accidentally|0|||
150053892|NCT00422084|541338402|FG000|Overall Study|Non-compliance|1|||
149993363|NCT00075946|541107515|FG001|Overall Study|Other complicating disease|13|||
149993364|NCT00075946|541107516|FG002|Overall Study|Other complicating disease|1|||
149993365|NCT00075946|541107517|FG003|Overall Study|Other complicating disease|4|||
149993366|NCT00075946|541107518|FG004|Overall Study|Other complicating disease|0|||
149993367|NCT00075946|541107514|FG000|Overall Study|No response to retreatment|23|||
149993368|NCT00075946|541107515|FG001|Overall Study|No response to retreatment|0|||
150053893|NCT00422084|541338403|FG001|Overall Study|Non-compliance|0|||
149993369|NCT00075946|541107516|FG002|Overall Study|No response to retreatment|2|||
149993370|NCT00075946|541107517|FG003|Overall Study|No response to retreatment|0|||
149993371|NCT00075946|541107518|FG004|Overall Study|No response to retreatment|0|||
149993372|NCT00075946|541107514|FG000|Overall Study|Time to progression less than 6 months|15|||
149993373|NCT00075946|541107515|FG001|Overall Study|Time to progression less than 6 months|30|||
149993374|NCT00075946|541107516|FG002|Overall Study|Time to progression less than 6 months|8|||
149993375|NCT00075946|541107517|FG003|Overall Study|Time to progression less than 6 months|3|||
149993376|NCT00075946|541107518|FG004|Overall Study|Time to progression less than 6 months|0|||
149993377|NCT00075946|541107514|FG000|Overall Study|Other|57|||
149993378|NCT00075946|541107515|FG001|Overall Study|Other|32|||
149993379|NCT00075946|541107516|FG002|Overall Study|Other|3|||
149993380|NCT00075946|541107517|FG003|Overall Study|Other|11|||
149993381|NCT00075946|541107518|FG004|Overall Study|Other|0|||
149993382|NCT02231892|541107519|FG000|Overall Study|Lost to Follow-up|1|||
149993383|NCT02231892|541107520|FG001|Overall Study|Lost to Follow-up|0|||
149993384|NCT02231892|541107521|FG002|Overall Study|Lost to Follow-up|3|||
149993385|NCT02231892|541107519|FG000|Overall Study|Withdrawal by Subject|4|||
149993386|NCT02231892|541107520|FG001|Overall Study|Withdrawal by Subject|3|||
149993387|NCT02231892|541107521|FG002|Overall Study|Withdrawal by Subject|15|||
149993388|NCT02231892|541107519|FG000|Overall Study|Physician Decision|0|||
149993389|NCT02231892|541107520|FG001|Overall Study|Physician Decision|2|||
149993390|NCT02231892|541107521|FG002|Overall Study|Physician Decision|4|||
149993391|NCT02231892|541107519|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
149993392|NCT02231892|541107520|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
149993393|NCT02231892|541107521|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
149993394|NCT02231892|541107519|FG000|Overall Study|Participant motor threshold was >83%|0|||
149993395|NCT02231892|541107520|FG001|Overall Study|Participant motor threshold was >83%|0|||
149993396|NCT02231892|541107521|FG002|Overall Study|Participant motor threshold was >83%|9|||
149993397|NCT02231892|541107519|FG000|Overall Study|Could not find motor threshold|2|||
149993398|NCT02231892|541107520|FG001|Overall Study|Could not find motor threshold|0|||
149993399|NCT02231892|541107521|FG002|Overall Study|Could not find motor threshold|1|||
149993400|NCT02231892|541107519|FG000|Overall Study|Could not find reliable motor hotspot|0|||
149993401|NCT02231892|541107520|FG001|Overall Study|Could not find reliable motor hotspot|0|||
149993402|NCT02231892|541107521|FG002|Overall Study|Could not find reliable motor hotspot|1|||
149993403|NCT03832322|541107522|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
149993404|NCT03832322|541107523|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
149993405|NCT02186652|541107532|FG000|Overall Study|Lost to Follow-up|2|||
149993406|NCT02186652|541107533|FG001|Overall Study|Lost to Follow-up|0|||
149993407|NCT05427539|541107536|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
149993408|NCT05427539|541107537|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
149993409|NCT05427539|541107536|FG000|Period 1|Withdrawal by Subject|1|||
149993410|NCT05427539|541107537|FG001|Period 1|Withdrawal by Subject|0|||
149993411|NCT02247011|541107540|FG000|Overall Study|Poor quality of radiological results|125|||
149993412|NCT04470908|541107545|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
149993413|NCT04621240|541107546|FG000|Overall Study|Withdrawal by Subject|36|||
149993414|NCT01202188|541107547|FG000|Overall Study|Protocol deviation|14|||
149993415|NCT01202188|541107548|FG001|Overall Study|Protocol deviation|8|||
149993416|NCT01202188|541107549|FG002|Overall Study|Protocol deviation|12|||
149993417|NCT01202188|541107550|FG003|Overall Study|Protocol deviation|10|||
149993418|NCT01202188|541107551|FG004|Overall Study|Protocol deviation|11|||
149993419|NCT01202188|541107547|FG000|Overall Study|Subject withdrew consent|12|||
149993420|NCT01202188|541107548|FG001|Overall Study|Subject withdrew consent|13|||
149993421|NCT01202188|541107549|FG002|Overall Study|Subject withdrew consent|22|||
149993422|NCT01202188|541107550|FG003|Overall Study|Subject withdrew consent|11|||
149993423|NCT01202188|541107551|FG004|Overall Study|Subject withdrew consent|13|||
149993424|NCT01202188|541107547|FG000|Overall Study|Adverse Event|5|||
149993425|NCT01202188|541107548|FG001|Overall Study|Adverse Event|23|||
149993426|NCT01202188|541107549|FG002|Overall Study|Adverse Event|13|||
149993427|NCT01202188|541107550|FG003|Overall Study|Adverse Event|10|||
149993428|NCT01202188|541107551|FG004|Overall Study|Adverse Event|10|||
149993429|NCT01202188|541107547|FG000|Overall Study|Administrative problems|3|||
149993430|NCT01202188|541107548|FG001|Overall Study|Administrative problems|2|||
149993431|NCT01202188|541107549|FG002|Overall Study|Administrative problems|1|||
150053894|NCT00422084|541338402|FG000|Overall Study|Re-location|0|||
149993432|NCT01202188|541107550|FG003|Overall Study|Administrative problems|1|||
149993433|NCT01202188|541107551|FG004|Overall Study|Administrative problems|2|||
149993434|NCT01202188|541107547|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149993435|NCT01202188|541107548|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
149993436|NCT01202188|541107549|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149993437|NCT01202188|541107550|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
150178979|NCT05132478|541793902|FG000|Overall Study|did not complete survey after consent|1|||
150178980|NCT05132478|541793903|FG001|Overall Study|did not complete survey after consent|1|||
149993438|NCT01202188|541107551|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
149993439|NCT01202188|541107547|FG000|Overall Study|Lost to Follow-up|1|||
149993440|NCT01202188|541107548|FG001|Overall Study|Lost to Follow-up|1|||
149993441|NCT01202188|541107549|FG002|Overall Study|Lost to Follow-up|0|||
149993442|NCT01202188|541107550|FG003|Overall Study|Lost to Follow-up|4|||
149993443|NCT01202188|541107551|FG004|Overall Study|Lost to Follow-up|1|||
149993444|NCT01202188|541107547|FG000|Overall Study|Death|1|||
149993445|NCT01202188|541107548|FG001|Overall Study|Death|1|||
149993446|NCT01202188|541107549|FG002|Overall Study|Death|1|||
149993447|NCT01202188|541107550|FG003|Overall Study|Death|1|||
149993448|NCT01202188|541107551|FG004|Overall Study|Death|0|||
149993449|NCT01202188|541107547|FG000|Overall Study|Abnormal test procedure result (s)|0|||
149993450|NCT01202188|541107548|FG001|Overall Study|Abnormal test procedure result (s)|0|||
149993451|NCT01202188|541107549|FG002|Overall Study|Abnormal test procedure result (s)|2|||
149993452|NCT01202188|541107550|FG003|Overall Study|Abnormal test procedure result (s)|0|||
149993453|NCT01202188|541107551|FG004|Overall Study|Abnormal test procedure result (s)|0|||
149993454|NCT00487942|541107553|FG000|Overall Study|Adverse Event|1|||
149993455|NCT00487942|541107554|FG001|Overall Study|Adverse Event|1|||
149993456|NCT00487942|541107555|FG002|Overall Study|Adverse Event|1|||
149993457|NCT00487942|541107556|FG003|Overall Study|Adverse Event|1|||
149993458|NCT00487942|541107553|FG000|Overall Study|Lost to Follow-up|1|||
149993459|NCT00487942|541107554|FG001|Overall Study|Lost to Follow-up|0|||
149993460|NCT00487942|541107555|FG002|Overall Study|Lost to Follow-up|0|||
149993461|NCT00487942|541107556|FG003|Overall Study|Lost to Follow-up|1|||
149993462|NCT00487942|541107553|FG000|Overall Study|Protocol Violation|1|||
149993463|NCT00487942|541107554|FG001|Overall Study|Protocol Violation|1|||
149993464|NCT00487942|541107555|FG002|Overall Study|Protocol Violation|0|||
149993465|NCT00487942|541107556|FG003|Overall Study|Protocol Violation|0|||
149993466|NCT00487942|541107553|FG000|Overall Study|Withdrawal by Subject|0|||
149993467|NCT00487942|541107554|FG001|Overall Study|Withdrawal by Subject|1|||
149993468|NCT00487942|541107555|FG002|Overall Study|Withdrawal by Subject|2|||
149993469|NCT00487942|541107556|FG003|Overall Study|Withdrawal by Subject|0|||
149993470|NCT00211757|541107557|FG000|Overall Study|Withdrawal by Subject|1|||
149993471|NCT00211757|541107558|FG001|Overall Study|Withdrawal by Subject|1|||
149993472|NCT00211757|541107557|FG000|Overall Study|Lack of Efficacy|0|||
149993473|NCT00211757|541107558|FG001|Overall Study|Lack of Efficacy|1|||
149993474|NCT04091581|541107562|FG000|Overall Study|Lost to Follow-up|0|||
149993475|NCT04091581|541107563|FG001|Overall Study|Lost to Follow-up|1|||
149993476|NCT03319953|541107564|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
149993477|NCT03319953|541107565|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
149993478|NCT03319953|541107566|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
149993479|NCT03319953|541107567|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
149993480|NCT03319953|541107564|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
149993481|NCT03319953|541107565|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
149993482|NCT03319953|541107566|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
149993483|NCT03319953|541107567|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
149993484|NCT01795495|541107569|FG000|Overall Study|Protocol Violation|1|||
149993485|NCT01795495|541107570|FG001|Overall Study|Protocol Violation|0|||
149993486|NCT01795495|541107571|FG002|Overall Study|Protocol Violation|1|||
149993487|NCT01795495|541107569|FG000|Overall Study|Physician Decision|0|||
149993488|NCT01795495|541107570|FG001|Overall Study|Physician Decision|0|||
149993489|NCT01795495|541107571|FG002|Overall Study|Physician Decision|1|||
149993490|NCT03315793|541107572|FG000|Overall Study|Adverse Event|4|||
149993491|NCT03315793|541107573|FG001|Overall Study|Adverse Event|2|||
149993492|NCT03315793|541107572|FG000|Overall Study|Protocol Deviation|1|||
149993493|NCT03315793|541107573|FG001|Overall Study|Protocol Deviation|0|||
149993494|NCT03315793|541107572|FG000|Overall Study|Difficult for regular visit|0|||
149993495|NCT03315793|541107573|FG001|Overall Study|Difficult for regular visit|1|||
149993496|NCT04027049|541107574|FG000|Overall Study|Withdrawn by family|1|||
149993497|NCT04027049|541107575|FG001|Overall Study|Withdrawn by family|0|||
149993498|NCT04027049|541107574|FG000|Overall Study|Participant safety|1|||
149993499|NCT04027049|541107575|FG001|Overall Study|Participant safety|0|||
149993500|NCT01740089|541109454|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
149993501|NCT01740089|541109455|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
149993502|NCT01740089|541109456|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
149993503|NCT01740089|541109454|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
149993504|NCT01740089|541109455|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
149993505|NCT01740089|541109456|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
149993506|NCT01740089|541109454|FG000|After 12 Weeks|Lack of Efficacy|3|||
149993507|NCT01740089|541109455|FG001|After 12 Weeks|Lack of Efficacy|1|||
149993508|NCT01740089|541109456|FG002|After 12 Weeks|Lack of Efficacy|4|||
149993509|NCT01740089|541109454|FG000|After 12 Weeks|Adverse Event|2|||
149993510|NCT01740089|541109455|FG001|After 12 Weeks|Adverse Event|0|||
149993511|NCT01740089|541109456|FG002|After 12 Weeks|Adverse Event|5|||
149993512|NCT01740089|541109454|FG000|After 12 Weeks|Protocol Violation|1|||
149993513|NCT01740089|541109455|FG001|After 12 Weeks|Protocol Violation|1|||
149993514|NCT01740089|541109456|FG002|After 12 Weeks|Protocol Violation|1|||
149993515|NCT01740089|541109454|FG000|After 12 Weeks|Withdrawal by Subject|1|||
149993516|NCT01740089|541109455|FG001|After 12 Weeks|Withdrawal by Subject|1|||
149993517|NCT01740089|541109456|FG002|After 12 Weeks|Withdrawal by Subject|1|||
149993518|NCT01579565|541109459|FG000|Randomized|Adverse Event|1|||
149993519|NCT01579565|541109460|FG001|Randomized|Adverse Event|3|||
149993520|NCT01579565|541109459|FG000|Randomized|Withdrawal by Subject|3|||
149993521|NCT01579565|541109460|FG001|Randomized|Withdrawal by Subject|0|||
149993522|NCT01579565|541109459|FG000|Randomized|inadequate preoperative pupil dilation|0|||
149993523|NCT01579565|541109460|FG001|Randomized|inadequate preoperative pupil dilation|1|||
149993524|NCT01579565|541109459|FG000|Randomized|prohibited preoperative eating|1|||
149993525|NCT01579565|541109460|FG001|Randomized|prohibited preoperative eating|0|||
149993526|NCT01579565|541109459|FG000|Randomized|prohibited preoperative medication|0|||
149993527|NCT01579565|541109460|FG001|Randomized|prohibited preoperative medication|1|||
149993528|NCT01579565|541109459|FG000|Treated|Physician Decision|0|||
149993529|NCT01579565|541109460|FG001|Treated|Physician Decision|1|||
149993530|NCT01579565|541109459|FG000|Treated|Lost to Follow-up|2|||
149993531|NCT01579565|541109460|FG001|Treated|Lost to Follow-up|1|||
149993532|NCT01579565|541109459|FG000|Treated|declined to return for final visit|0|||
149993533|NCT01579565|541109460|FG001|Treated|declined to return for final visit|1|||
149993534|NCT02867813|541109461|FG000|Overall Study|Withdrawal by Subject|57|||
149993535|NCT02867813|541109462|FG001|Overall Study|Withdrawal by Subject|56|||
149993536|NCT02867813|541109461|FG000|Overall Study|Decision by Sponsor|7|||
149993537|NCT02867813|541109462|FG001|Overall Study|Decision by Sponsor|7|||
149993538|NCT02867813|541109461|FG000|Overall Study|Lost to Follow-up|91|||
149993539|NCT02867813|541109462|FG001|Overall Study|Lost to Follow-up|78|||
149993540|NCT02867813|541109461|FG000|Overall Study|Missing|2|||
149993541|NCT02867813|541109462|FG001|Overall Study|Missing|1|||
149993542|NCT02867813|541109461|FG000|Overall Study|Death|294|||
149993543|NCT02867813|541109462|FG001|Overall Study|Death|268|||
149993544|NCT01448824|541109466|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993545|NCT01448824|541109467|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993546|NCT01448824|541109468|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993547|NCT01448824|541109469|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993548|NCT01448824|541109470|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993549|NCT01448824|541109471|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993550|NCT01448824|541109472|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
149993551|NCT01448824|541109473|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
149993552|NCT01448824|541109466|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
149993553|NCT01448824|541109467|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
149993554|NCT01448824|541109468|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
149993555|NCT01448824|541109469|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
149993556|NCT01448824|541109470|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
149993557|NCT01448824|541109471|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
149993558|NCT01448824|541109472|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
149993559|NCT01448824|541109473|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
149993560|NCT01448824|541109466|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993561|NCT01448824|541109467|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993562|NCT01448824|541109468|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993563|NCT01448824|541109469|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993564|NCT01448824|541109470|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993565|NCT01448824|541109471|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
149993566|NCT01448824|541109472|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993567|NCT01448824|541109473|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
149993568|NCT01448824|541109466|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
150178981|NCT05132478|541793902|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
150178982|NCT05132478|541793903|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
149993569|NCT01448824|541109467|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
149993570|NCT01448824|541109468|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
149993571|NCT01448824|541109469|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
149993572|NCT01448824|541109470|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
149993573|NCT01448824|541109471|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
149993574|NCT01448824|541109472|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
149993575|NCT01448824|541109473|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
149993576|NCT01448824|541109466|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993577|NCT01448824|541109467|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993578|NCT01448824|541109468|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993579|NCT01448824|541109469|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993580|NCT01448824|541109470|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993581|NCT01448824|541109471|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993582|NCT01448824|541109472|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
149993583|NCT01448824|541109473|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
149993584|NCT01448824|541109466|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993585|NCT01448824|541109467|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993586|NCT01448824|541109468|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993587|NCT01448824|541109469|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993588|NCT01448824|541109470|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993589|NCT01448824|541109471|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993590|NCT01448824|541109472|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
149993591|NCT01448824|541109473|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
149993592|NCT01448824|541109466|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993593|NCT01448824|541109467|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993594|NCT01448824|541109468|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993595|NCT01448824|541109469|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993596|NCT01448824|541109470|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993597|NCT01448824|541109471|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993598|NCT01448824|541109472|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
149993599|NCT01448824|541109473|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
149993600|NCT01448824|541109466|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993601|NCT01448824|541109467|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993602|NCT01448824|541109468|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993603|NCT01448824|541109469|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993604|NCT01448824|541109470|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993605|NCT01448824|541109471|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993606|NCT01448824|541109472|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
149993607|NCT01448824|541109473|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
149993608|NCT01463111|541109475|FG000|Overall Study|Withdrawal by Subject|2|||
149993609|NCT01463111|541109475|FG000|Overall Study|Lost to Follow-up|5|||
149993610|NCT01463111|541109475|FG000|Overall Study|Physician Decision|2|||
149993611|NCT01559259|541109486|FG000|Overall Study|Withdrawal by Subject|0|||
149993612|NCT01559259|541109487|FG001|Overall Study|Withdrawal by Subject|0|||
149993613|NCT01559259|541109488|FG002|Overall Study|Withdrawal by Subject|0|||
149993614|NCT01559259|541109489|FG003|Overall Study|Withdrawal by Subject|1|||
149993615|NCT01559259|541109490|FG004|Overall Study|Withdrawal by Subject|0|||
149993616|NCT01559259|541109486|FG000|Overall Study|Adverse Event|0|||
149993617|NCT01559259|541109487|FG001|Overall Study|Adverse Event|1|||
149993618|NCT01559259|541109488|FG002|Overall Study|Adverse Event|1|||
149993619|NCT01559259|541109489|FG003|Overall Study|Adverse Event|0|||
149993620|NCT01559259|541109490|FG004|Overall Study|Adverse Event|0|||
149993621|NCT01995669|541109491|FG000|Overall Study|Progression|2|||
149993622|NCT01995669|541109492|FG001|Overall Study|Progression|1|||
149993623|NCT01995669|541109493|FG002|Overall Study|Progression|1|||
149993624|NCT01995669|541109494|FG003|Overall Study|Progression|13|||
149993625|NCT01995669|541109491|FG000|Overall Study|Adverse Event|0|||
149993626|NCT01995669|541109492|FG001|Overall Study|Adverse Event|0|||
149993627|NCT01995669|541109493|FG002|Overall Study|Adverse Event|0|||
149993628|NCT01995669|541109494|FG003|Overall Study|Adverse Event|3|||
149993629|NCT01995669|541109491|FG000|Overall Study|Death|0|||
149993630|NCT01995669|541109492|FG001|Overall Study|Death|0|||
149993631|NCT01995669|541109493|FG002|Overall Study|Death|0|||
149993632|NCT01995669|541109494|FG003|Overall Study|Death|6|||
149993633|NCT01995669|541109491|FG000|Overall Study|Withdrawal by Subject|0|||
149993634|NCT01995669|541109492|FG001|Overall Study|Withdrawal by Subject|0|||
149993635|NCT01995669|541109493|FG002|Overall Study|Withdrawal by Subject|0|||
149993636|NCT01995669|541109494|FG003|Overall Study|Withdrawal by Subject|6|||
149993637|NCT01995669|541109491|FG000|Overall Study|Insurance Expired|0|||
149993638|NCT01995669|541109492|FG001|Overall Study|Insurance Expired|0|||
149993639|NCT01995669|541109493|FG002|Overall Study|Insurance Expired|0|||
149993640|NCT01995669|541109494|FG003|Overall Study|Insurance Expired|1|||
149993641|NCT05425732|541109495|FG000|Overall Study|Death|4|||
149993642|NCT05425732|541109496|FG001|Overall Study|Death|2|||
149993643|NCT05425732|541109497|FG002|Overall Study|Death|0|||
149993644|NCT05425732|541109498|FG003|Overall Study|Death|0|||
149993645|NCT05425732|541109495|FG000|Overall Study|Lost to Follow-up|10|||
149993646|NCT05425732|541109496|FG001|Overall Study|Lost to Follow-up|15|||
149993647|NCT05425732|541109497|FG002|Overall Study|Lost to Follow-up|5|||
149993648|NCT05425732|541109498|FG003|Overall Study|Lost to Follow-up|3|||
149993649|NCT05425732|541109495|FG000|Overall Study|Physician Decision|0|||
149993650|NCT05425732|541109496|FG001|Overall Study|Physician Decision|2|||
149993651|NCT05425732|541109497|FG002|Overall Study|Physician Decision|0|||
149993652|NCT05425732|541109498|FG003|Overall Study|Physician Decision|0|||
149993653|NCT05425732|541109495|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149993654|NCT05425732|541109496|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
149993655|NCT05425732|541109497|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149993656|NCT05425732|541109498|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149993657|NCT05425732|541109495|FG000|Overall Study|Withdrawal by Subject|4|||
150053895|NCT00422084|541338403|FG001|Overall Study|Re-location|1|||
150053896|NCT00422084|541338402|FG000|Overall Study|Not defined|1|||
150053897|NCT00422084|541338403|FG001|Overall Study|Not defined|1|||
150053898|NCT03996369|541338404|FG000|Overall Study|Protocol deviation|1|||
150053899|NCT03996369|541338405|FG001|Overall Study|Protocol deviation|1|||
150053900|NCT03996369|541338404|FG000|Overall Study|Physician Decision|4|||
150053901|NCT03996369|541338405|FG001|Overall Study|Physician Decision|2|||
150053902|NCT03996369|541338404|FG000|Overall Study|Participant decision|0|||
149993658|NCT05425732|541109496|FG001|Overall Study|Withdrawal by Subject|8|||
149993659|NCT05425732|541109497|FG002|Overall Study|Withdrawal by Subject|1|||
149993660|NCT05425732|541109498|FG003|Overall Study|Withdrawal by Subject|1|||
149993661|NCT05425732|541109495|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
149993662|NCT05425732|541109496|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
149993663|NCT05425732|541109497|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
149993664|NCT05425732|541109498|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
149993665|NCT00218634|541109500|FG000|Overall Study|Lost to Follow-up|8|||
149993666|NCT00218634|541109501|FG001|Overall Study|Lost to Follow-up|15|||
149993667|NCT00734604|541109502|FG000|Overall Study|Adverse Event|0|||
149993668|NCT00734604|541109503|FG001|Overall Study|Adverse Event|2|||
149993669|NCT00734604|541109504|FG002|Overall Study|Adverse Event|0|||
149993670|NCT00734604|541109505|FG003|Overall Study|Adverse Event|2|||
149993671|NCT00734604|541109506|FG004|Overall Study|Adverse Event|1|||
149993672|NCT00734604|541109507|FG005|Overall Study|Adverse Event|1|||
149993673|NCT00734604|541109502|FG000|Overall Study|Serious Adverse Event|1|||
149993674|NCT00734604|541109503|FG001|Overall Study|Serious Adverse Event|0|||
149993675|NCT00734604|541109504|FG002|Overall Study|Serious Adverse Event|1|||
149993676|NCT00734604|541109505|FG003|Overall Study|Serious Adverse Event|2|||
149993677|NCT00734604|541109506|FG004|Overall Study|Serious Adverse Event|0|||
149993678|NCT00734604|541109507|FG005|Overall Study|Serious Adverse Event|1|||
149993679|NCT00734604|541109502|FG000|Overall Study|Lost to Follow-up|1|||
149993680|NCT00734604|541109503|FG001|Overall Study|Lost to Follow-up|2|||
149993681|NCT00734604|541109504|FG002|Overall Study|Lost to Follow-up|2|||
149993682|NCT00734604|541109505|FG003|Overall Study|Lost to Follow-up|4|||
149993683|NCT00734604|541109506|FG004|Overall Study|Lost to Follow-up|2|||
149993684|NCT00734604|541109507|FG005|Overall Study|Lost to Follow-up|3|||
149993685|NCT00734604|541109502|FG000|Overall Study|Physician Decision|0|||
149993686|NCT00734604|541109503|FG001|Overall Study|Physician Decision|1|||
149993687|NCT00734604|541109504|FG002|Overall Study|Physician Decision|1|||
149993688|NCT00734604|541109505|FG003|Overall Study|Physician Decision|0|||
149993689|NCT00734604|541109506|FG004|Overall Study|Physician Decision|0|||
149993690|NCT00734604|541109507|FG005|Overall Study|Physician Decision|0|||
149993691|NCT00734604|541109502|FG000|Overall Study|Protocol Violation|0|||
149993692|NCT00734604|541109503|FG001|Overall Study|Protocol Violation|2|||
149993693|NCT00734604|541109504|FG002|Overall Study|Protocol Violation|0|||
149993694|NCT00734604|541109505|FG003|Overall Study|Protocol Violation|0|||
149993695|NCT00734604|541109506|FG004|Overall Study|Protocol Violation|1|||
149993696|NCT00734604|541109507|FG005|Overall Study|Protocol Violation|0|||
149993697|NCT00734604|541109502|FG000|Overall Study|Sponsor Decision|1|||
149993698|NCT00734604|541109503|FG001|Overall Study|Sponsor Decision|2|||
149993699|NCT00734604|541109504|FG002|Overall Study|Sponsor Decision|1|||
149993700|NCT00734604|541109505|FG003|Overall Study|Sponsor Decision|0|||
149993701|NCT00734604|541109506|FG004|Overall Study|Sponsor Decision|2|||
149993702|NCT00734604|541109507|FG005|Overall Study|Sponsor Decision|0|||
149993703|NCT00734604|541109502|FG000|Overall Study|Withdrawal by Subject|0|||
149993704|NCT00734604|541109503|FG001|Overall Study|Withdrawal by Subject|2|||
149993705|NCT00734604|541109504|FG002|Overall Study|Withdrawal by Subject|0|||
149993706|NCT00734604|541109505|FG003|Overall Study|Withdrawal by Subject|1|||
149993707|NCT00734604|541109506|FG004|Overall Study|Withdrawal by Subject|2|||
149993708|NCT00734604|541109507|FG005|Overall Study|Withdrawal by Subject|1|||
149993709|NCT00734604|541109502|FG000|Overall Study|Lack of Efficacy|0|||
149993710|NCT00734604|541109503|FG001|Overall Study|Lack of Efficacy|1|||
149993711|NCT00734604|541109504|FG002|Overall Study|Lack of Efficacy|1|||
149993712|NCT00734604|541109505|FG003|Overall Study|Lack of Efficacy|0|||
149993713|NCT00734604|541109506|FG004|Overall Study|Lack of Efficacy|0|||
149993714|NCT00734604|541109507|FG005|Overall Study|Lack of Efficacy|0|||
149993715|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Adverse Event|76|||
149993716|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Adverse Event|0|||
149993717|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Adverse Event|0|||
149993718|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Death|3|||
149993719|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Death|0|||
149993720|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Death|0|||
149993721|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
149993722|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
149993723|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
150053903|NCT03996369|541338405|FG001|Overall Study|Participant decision|1|||
150053904|NCT03996369|541338404|FG000|Overall Study|Lack of Efficacy|4|||
150053905|NCT03996369|541338405|FG001|Overall Study|Lack of Efficacy|0|||
149993724|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Physician Decision|9|||
149993725|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Physician Decision|0|||
149993726|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Physician Decision|0|||
149993727|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
149993728|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
149993729|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
149993730|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Disease progression|45|||
149993731|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Disease progression|0|||
149993732|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Disease progression|0|||
149993733|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
149993734|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
149993735|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
149993736|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
149993737|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
149993738|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
149993739|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
149993740|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
149993741|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
149993742|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
149993743|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
149993744|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
149993745|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
149993746|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
149993747|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
149993748|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
149993749|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
149993750|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
149993751|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
149993752|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
149993753|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
149993754|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
149993755|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
149993756|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
149993757|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
149993758|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
149993759|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
149993760|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Promotor request|1|||
149993761|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Promotor request|0|||
149993762|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Promotor request|0|||
149993763|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
149993764|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
149993765|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
149993766|NCT01461928|541109508|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
149993767|NCT01461928|541109509|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
149993768|NCT01461928|541109510|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
149993769|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Death|3|||
149993770|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Death|0|||
149993771|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Death|0|||
149993772|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
149993773|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
149993774|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
149993775|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
149993776|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
149993777|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
149993778|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Diseases progression|91|||
149993779|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Diseases progression|0|||
150178983|NCT00106080|541793904|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
149993780|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Diseases progression|0|||
149993781|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Adverse Event|70|||
149993782|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Adverse Event|0|||
149993783|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Adverse Event|0|||
149993784|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Physician Decision|9|||
149993785|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Physician Decision|0|||
149993786|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Physician Decision|0|||
149993787|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
149993788|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
149993789|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
149993790|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
149993791|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
149993792|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
149993793|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
149993794|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
149993795|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
149993796|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Not compliant|1|||
149993797|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Not compliant|0|||
149993798|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Not compliant|0|||
149993799|NCT01461928|541109508|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
149993800|NCT01461928|541109509|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
149993801|NCT01461928|541109510|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
149993802|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Adverse Event|0|||
149993803|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Adverse Event|2|||
149993804|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Adverse Event|0|||
149993805|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Death|0|||
149993806|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Death|10|||
149993807|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Death|8|||
149993808|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Physician Decision|0|||
149993809|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Physician Decision|0|||
149993810|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Physician Decision|4|||
149993811|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
149993812|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
149993813|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
149993814|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Moved to another town|0|||
149993815|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Moved to another town|1|||
149993816|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Moved to another town|0|||
149993817|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Disease progression|0|||
149993818|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Disease progression|0|||
149993819|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Disease progression|3|||
149993820|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
149993821|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
149993822|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
149993823|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
149993824|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
149993825|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
149993826|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
149993827|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
149993828|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
149993829|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
149993830|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
149993831|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
149993832|NCT01461928|541109508|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
149993833|NCT01461928|541109509|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
149993834|NCT01461928|541109510|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
149993835|NCT02526524|541109512|FG000|Overall Study|Withdrawal by Subject|3|||
149993836|NCT02526524|541109513|FG001|Overall Study|Withdrawal by Subject|3|||
149993837|NCT02526524|541109514|FG002|Overall Study|Withdrawal by Subject|6|||
149993838|NCT02526524|541109515|FG003|Overall Study|Withdrawal by Subject|1|||
149993839|NCT02526524|541109516|FG004|Overall Study|Withdrawal by Subject|9|||
149993840|NCT02526524|541109517|FG005|Overall Study|Withdrawal by Subject|5|||
149993841|NCT02526524|541109512|FG000|Overall Study|Adverse Event|3|||
149993842|NCT02526524|541109513|FG001|Overall Study|Adverse Event|2|||
149993843|NCT02526524|541109514|FG002|Overall Study|Adverse Event|4|||
149993844|NCT02526524|541109515|FG003|Overall Study|Adverse Event|2|||
149993845|NCT02526524|541109516|FG004|Overall Study|Adverse Event|6|||
149993846|NCT02526524|541109517|FG005|Overall Study|Adverse Event|8|||
149993847|NCT02526524|541109512|FG000|Overall Study|Lost to Follow-up|2|||
149993848|NCT02526524|541109513|FG001|Overall Study|Lost to Follow-up|3|||
149993849|NCT02526524|541109514|FG002|Overall Study|Lost to Follow-up|8|||
149993850|NCT02526524|541109515|FG003|Overall Study|Lost to Follow-up|1|||
149993851|NCT02526524|541109516|FG004|Overall Study|Lost to Follow-up|2|||
149993852|NCT02526524|541109517|FG005|Overall Study|Lost to Follow-up|5|||
149993853|NCT02526524|541109512|FG000|Overall Study|Protocol Violation|3|||
149993854|NCT02526524|541109513|FG001|Overall Study|Protocol Violation|1|||
149993855|NCT02526524|541109514|FG002|Overall Study|Protocol Violation|5|||
149993856|NCT02526524|541109515|FG003|Overall Study|Protocol Violation|3|||
149993857|NCT02526524|541109516|FG004|Overall Study|Protocol Violation|4|||
149993858|NCT02526524|541109517|FG005|Overall Study|Protocol Violation|3|||
149993859|NCT02526524|541109512|FG000|Overall Study|Loss of Glucose Control|0|||
149993860|NCT02526524|541109513|FG001|Overall Study|Loss of Glucose Control|0|||
149993861|NCT02526524|541109514|FG002|Overall Study|Loss of Glucose Control|3|||
149993862|NCT02526524|541109515|FG003|Overall Study|Loss of Glucose Control|0|||
149993863|NCT02526524|541109516|FG004|Overall Study|Loss of Glucose Control|2|||
149993864|NCT02526524|541109517|FG005|Overall Study|Loss of Glucose Control|0|||
149993865|NCT02526524|541109512|FG000|Overall Study|Physician Decision|0|||
149993866|NCT02526524|541109513|FG001|Overall Study|Physician Decision|0|||
149993867|NCT02526524|541109514|FG002|Overall Study|Physician Decision|0|||
149993868|NCT02526524|541109515|FG003|Overall Study|Physician Decision|0|||
149993869|NCT02526524|541109516|FG004|Overall Study|Physician Decision|1|||
149993870|NCT02526524|541109517|FG005|Overall Study|Physician Decision|0|||
149993871|NCT02526524|541109512|FG000|Overall Study|Sponsor Decision|1|||
149993872|NCT02526524|541109513|FG001|Overall Study|Sponsor Decision|0|||
149993873|NCT02526524|541109514|FG002|Overall Study|Sponsor Decision|0|||
149993874|NCT02526524|541109515|FG003|Overall Study|Sponsor Decision|0|||
149993875|NCT02526524|541109516|FG004|Overall Study|Sponsor Decision|0|||
149993876|NCT02526524|541109517|FG005|Overall Study|Sponsor Decision|0|||
149993877|NCT00591149|541109521|FG000|Overall Study|Adverse Event|4|||
149993878|NCT00591149|541109521|FG000|Overall Study|Withdrawal by Subject|1|||
149993879|NCT00539513|541109522|FG000|Overall Study|Withdrawal by Subject|2|||
149993880|NCT00539513|541109523|FG001|Overall Study|Withdrawal by Subject|1|||
149993881|NCT00539513|541109522|FG000|Overall Study|Lost to Follow-up|0|||
149993882|NCT00539513|541109523|FG001|Overall Study|Lost to Follow-up|1|||
149993883|NCT03002818|541109524|FG000|Overall Study|Decision of the investigator|1|||
149993884|NCT01328041|541109525|FG000|Overall Study|Adverse Event|7|||
149993885|NCT01328041|541109525|FG000|Overall Study|Lack of Efficacy|27|||
149993886|NCT01328041|541109525|FG000|Overall Study|Protocol Violation|7|||
149993887|NCT01328041|541109525|FG000|Overall Study|Lost to Follow-up|7|||
149993888|NCT01328041|541109525|FG000|Overall Study|Physician Decision|2|||
149993889|NCT01328041|541109525|FG000|Overall Study|Withdrawal by Subject|7|||
149993890|NCT00711113|541109529|FG000|Overall Study|Lost to Follow-up|9|||
149993891|NCT00711113|541109529|FG000|Overall Study|Implant lost|2|||
149993892|NCT02456636|541109530|FG000|Overall Study|Death|0|||
149993893|NCT02456636|541109531|FG001|Overall Study|Death|3|||
149993894|NCT02456636|541109532|FG002|Overall Study|Death|0|||
149993895|NCT02456636|541109530|FG000|Overall Study|Pregnancy|1|||
149993896|NCT02456636|541109531|FG001|Overall Study|Pregnancy|3|||
149993897|NCT02456636|541109532|FG002|Overall Study|Pregnancy|5|||
149993898|NCT02456636|541109530|FG000|Overall Study|Physician Decision|4|||
149993899|NCT02456636|541109531|FG001|Overall Study|Physician Decision|5|||
149993900|NCT02456636|541109532|FG002|Overall Study|Physician Decision|4|||
149993901|NCT02456636|541109530|FG000|Overall Study|Withdrawal by Subject|13|||
149993902|NCT02456636|541109531|FG001|Overall Study|Withdrawal by Subject|14|||
149993903|NCT02456636|541109532|FG002|Overall Study|Withdrawal by Subject|16|||
149993904|NCT02456636|541109530|FG000|Overall Study|Lost to Follow-up|50|||
149993905|NCT02456636|541109531|FG001|Overall Study|Lost to Follow-up|44|||
149993906|NCT02456636|541109532|FG002|Overall Study|Lost to Follow-up|50|||
149993907|NCT01606787|541109536|FG000|Overall Study|Withdrawal by Subject|4|||
149993908|NCT01606787|541109537|FG001|Overall Study|Withdrawal by Subject|5|||
149993909|NCT01606787|541109536|FG000|Overall Study|Surgery canceled|0|||
149993910|NCT01606787|541109537|FG001|Overall Study|Surgery canceled|2|||
149993911|NCT05312632|541109540|FG000|Overall Study|Adverse Event|12|||
149993912|NCT05312632|541109540|FG000|Overall Study|Withdrawal by Subject|10|||
149993913|NCT05312632|541109540|FG000|Overall Study|Lack of Efficacy|4|||
149993914|NCT05312632|541109540|FG000|Overall Study|Non-compliance with study procedures|9|||
149993915|NCT05312632|541109540|FG000|Overall Study|Other|4|||
149993916|NCT00519376|541109544|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993917|NCT00519376|541109545|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993918|NCT00519376|541109546|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993919|NCT00519376|541109547|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993920|NCT00519376|541109548|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993921|NCT00519376|541109549|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993922|NCT00519376|541109550|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993923|NCT00519376|541109551|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993924|NCT00519376|541109552|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993925|NCT00519376|541109553|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993926|NCT00519376|541109554|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993927|NCT00519376|541109555|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993928|NCT00519376|541109556|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
149993929|NCT00519376|541109557|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993930|NCT00519376|541109558|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993931|NCT00519376|541109559|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
149993932|NCT00519376|541109544|FG000|Treatment Period 4|Lost to Follow-up|0|||
149993933|NCT00519376|541109545|FG001|Treatment Period 4|Lost to Follow-up|0|||
149993934|NCT00519376|541109546|FG002|Treatment Period 4|Lost to Follow-up|1|||
149993935|NCT00519376|541109547|FG003|Treatment Period 4|Lost to Follow-up|0|||
149993936|NCT00519376|541109548|FG004|Treatment Period 4|Lost to Follow-up|0|||
149993937|NCT00519376|541109549|FG005|Treatment Period 4|Lost to Follow-up|0|||
149993938|NCT00519376|541109550|FG006|Treatment Period 4|Lost to Follow-up|0|||
149993939|NCT00519376|541109551|FG007|Treatment Period 4|Lost to Follow-up|0|||
149993940|NCT00519376|541109552|FG008|Treatment Period 4|Lost to Follow-up|0|||
149993941|NCT00519376|541109553|FG009|Treatment Period 4|Lost to Follow-up|0|||
149993942|NCT00519376|541109554|FG010|Treatment Period 4|Lost to Follow-up|0|||
149993943|NCT00519376|541109555|FG011|Treatment Period 4|Lost to Follow-up|0|||
149993944|NCT00519376|541109556|FG012|Treatment Period 4|Lost to Follow-up|0|||
149993945|NCT00519376|541109557|FG013|Treatment Period 4|Lost to Follow-up|0|||
149993946|NCT00519376|541109558|FG014|Treatment Period 4|Lost to Follow-up|0|||
149993947|NCT00519376|541109559|FG015|Treatment Period 4|Lost to Follow-up|0|||
149993948|NCT02688088|541109568|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
149993949|NCT02688088|541109569|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
149993950|NCT02688088|541109570|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
149993951|NCT02688088|541109571|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
149993952|NCT02688088|541109572|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
149993953|NCT02688088|541109568|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
149993954|NCT02688088|541109569|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
149993955|NCT02688088|541109570|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
149993956|NCT02688088|541109571|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
149993957|NCT02688088|541109572|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
149993958|NCT02688088|541109568|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
149993959|NCT02688088|541109569|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
149993960|NCT02688088|541109570|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
149993961|NCT02688088|541109571|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
149993962|NCT02688088|541109572|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
149993963|NCT02688088|541109568|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
149993964|NCT02688088|541109569|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
149993965|NCT02688088|541109570|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
149993966|NCT02688088|541109571|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
149993967|NCT02688088|541109572|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
149993968|NCT02688088|541109568|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
149993969|NCT02688088|541109569|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
149993970|NCT02688088|541109570|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
149993971|NCT02688088|541109571|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
149993972|NCT02688088|541109572|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
149993973|NCT02688088|541109568|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
149993974|NCT02688088|541109569|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
149993975|NCT02688088|541109570|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
149993976|NCT02688088|541109571|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
149993977|NCT02688088|541109572|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
149993978|NCT02688088|541109568|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
149993979|NCT02688088|541109569|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
149993980|NCT02688088|541109570|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
149993981|NCT02688088|541109571|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
149993982|NCT02688088|541109572|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
149993983|NCT02688088|541109568|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
149993984|NCT02688088|541109569|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
149993985|NCT02688088|541109570|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
149993986|NCT02688088|541109571|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
149993987|NCT02688088|541109572|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
149993988|NCT02688088|541109568|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
149993989|NCT02688088|541109569|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
149993990|NCT02688088|541109570|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
149993991|NCT02688088|541109571|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
149993992|NCT02688088|541109572|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
149993993|NCT01231321|541109577|FG000|Overall Study|Adverse Event|3|||
149993994|NCT01231321|541109577|FG000|Overall Study|Lack of Efficacy|2|||
149993995|NCT00489736|541109578|FG000|Overall Study|Lack of Efficacy|53|||
149993996|NCT00489736|541109579|FG001|Overall Study|Lack of Efficacy|14|||
149993997|NCT00489736|541109578|FG000|Overall Study|Adverse Event|32|||
149993998|NCT00489736|541109579|FG001|Overall Study|Adverse Event|45|||
149993999|NCT00489736|541109578|FG000|Overall Study|Poor compliance|6|||
149994000|NCT00489736|541109579|FG001|Overall Study|Poor compliance|2|||
149994001|NCT00489736|541109578|FG000|Overall Study|Not coded/ Not pre-specified|5|||
149994002|NCT00489736|541109579|FG001|Overall Study|Not coded/ Not pre-specified|8|||
149994003|NCT04021524|541109580|FG000|Overall Study|Change in surgical intervention|0|||
149994004|NCT04021524|541109581|FG001|Overall Study|Change in surgical intervention|1|||
149994005|NCT05275010|541109582|FG000|Overall Study|Reason Not Specified|4|||
149994006|NCT05275010|541109583|FG001|Overall Study|Reason Not Specified|1|||
149994007|NCT05275010|541109582|FG000|Overall Study|Withdrawal by Subject|1|||
150178984|NCT00106080|541793905|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
150178985|NCT03756571|541793909|FG000|Overall Study|Lost to Follow-up|1|||
150178986|NCT03756571|541793910|FG001|Overall Study|Lost to Follow-up|1|||
150178987|NCT01007396|541793914|FG000|Overall Study|Lost to Follow-up|47|||
150178988|NCT03283371|541793919|FG000|Placebo-controlled|Adverse Event|1|||
150178989|NCT03283371|541793920|FG001|Placebo-controlled|Adverse Event|1|||
150178990|NCT03283371|541793921|FG002|Placebo-controlled|Adverse Event|0|||
150178991|NCT03283371|541793922|FG003|Placebo-controlled|Adverse Event|0|||
150178992|NCT03283371|541793919|FG000|Placebo-controlled|Lack of Efficacy|1|||
150178993|NCT03283371|541793920|FG001|Placebo-controlled|Lack of Efficacy|0|||
150178994|NCT03283371|541793921|FG002|Placebo-controlled|Lack of Efficacy|0|||
150178995|NCT03283371|541793922|FG003|Placebo-controlled|Lack of Efficacy|0|||
150178996|NCT03283371|541793919|FG000|Placebo-controlled|Withdrawal by Subject|1|||
150178997|NCT03283371|541793920|FG001|Placebo-controlled|Withdrawal by Subject|1|||
150178998|NCT03283371|541793921|FG002|Placebo-controlled|Withdrawal by Subject|0|||
150178999|NCT03283371|541793922|FG003|Placebo-controlled|Withdrawal by Subject|0|||
150179000|NCT03283371|541793919|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
150179001|NCT03283371|541793920|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
150179002|NCT03283371|541793921|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
150179003|NCT03283371|541793922|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
150179004|NCT03283371|541793919|FG000|Open-label Phase|Adverse Event|0|||
150179005|NCT03283371|541793920|FG001|Open-label Phase|Adverse Event|0|||
150179006|NCT03283371|541793921|FG002|Open-label Phase|Adverse Event|2|||
150179007|NCT03283371|541793922|FG003|Open-label Phase|Adverse Event|0|||
150179008|NCT03283371|541793919|FG000|Open-label Phase|Withdrawal by Subject|0|||
150179009|NCT03283371|541793920|FG001|Open-label Phase|Withdrawal by Subject|0|||
150179010|NCT03283371|541793921|FG002|Open-label Phase|Withdrawal by Subject|1|||
150179011|NCT03283371|541793922|FG003|Open-label Phase|Withdrawal by Subject|0|||
150179012|NCT03283371|541793919|FG000|Open-label Phase|Other|0|||
150179013|NCT03283371|541793920|FG001|Open-label Phase|Other|0|||
150179014|NCT03283371|541793921|FG002|Open-label Phase|Other|1|||
150179015|NCT03283371|541793922|FG003|Open-label Phase|Other|1|||
150179016|NCT01985334|541793923|FG000|Overall Study|Administrative problems|1|||
150179017|NCT01985334|541793924|FG001|Overall Study|Administrative problems|1|||
150179018|NCT01985334|541793925|FG002|Overall Study|Administrative problems|0|||
150179019|NCT01985334|541793926|FG003|Overall Study|Administrative problems|2|||
150179020|NCT01985334|541793927|FG004|Overall Study|Administrative problems|0|||
150179021|NCT01985334|541793928|FG005|Overall Study|Administrative problems|1|||
150179022|NCT01985334|541793929|FG006|Overall Study|Administrative problems|1|||
150179023|NCT01985334|541793930|FG007|Overall Study|Administrative problems|3|||
149994008|NCT05275010|541109583|FG001|Overall Study|Withdrawal by Subject|0|||
149994009|NCT05275010|541109582|FG000|Overall Study|Lost to Follow-up|0|||
149994010|NCT05275010|541109583|FG001|Overall Study|Lost to Follow-up|1|||
149994011|NCT03883165|541109586|FG000|Overall Study|Withdrawal by Subject|4|||
149994012|NCT03883165|541109587|FG001|Overall Study|Withdrawal by Subject|3|||
149994013|NCT00730041|541109591|FG000|Overall Study|Lost to Follow-up|0|||
150179024|NCT01985334|541793923|FG000|Overall Study|Death|1|||
150179025|NCT01985334|541793924|FG001|Overall Study|Death|0|||
150179026|NCT01985334|541793925|FG002|Overall Study|Death|0|||
150179027|NCT01985334|541793926|FG003|Overall Study|Death|3|||
150179028|NCT01985334|541793927|FG004|Overall Study|Death|0|||
150179029|NCT01985334|541793928|FG005|Overall Study|Death|0|||
150179030|NCT01985334|541793929|FG006|Overall Study|Death|1|||
150179031|NCT01985334|541793930|FG007|Overall Study|Death|2|||
149994014|NCT00730041|541109592|FG001|Overall Study|Lost to Follow-up|2|||
149994015|NCT01801436|541109595|FG000|Overall Study|Withdrawal by Subject|3|||
149994016|NCT01801436|541109595|FG000|Overall Study|Adverse Event|2|||
149994017|NCT01801436|541109595|FG000|Overall Study|Progressive disease|4|||
149994018|NCT02447250|541109598|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
149994019|NCT02447250|541109598|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
149994020|NCT02447250|541109598|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
149994021|NCT03632993|541109599|FG000|Overall Study|Withdrawal by Subject|1|||
149994022|NCT03632993|541109600|FG001|Overall Study|Withdrawal by Subject|0|||
149994023|NCT03632993|541109601|FG002|Overall Study|Withdrawal by Subject|0|||
149994024|NCT03632993|541109602|FG003|Overall Study|Withdrawal by Subject|0|||
149994025|NCT03632993|541109603|FG004|Overall Study|Withdrawal by Subject|0|||
149994026|NCT03632993|541109604|FG005|Overall Study|Withdrawal by Subject|0|||
149994027|NCT03632993|541109605|FG006|Overall Study|Withdrawal by Subject|0|||
149994028|NCT03632993|541109606|FG007|Overall Study|Withdrawal by Subject|0|||
149994029|NCT03632993|541109607|FG008|Overall Study|Withdrawal by Subject|0|||
149994030|NCT03632993|541109608|FG009|Overall Study|Withdrawal by Subject|1|||
149994031|NCT03632993|541109599|FG000|Overall Study|Protocol Non-compliance|0|||
149994032|NCT03632993|541109600|FG001|Overall Study|Protocol Non-compliance|1|||
149994033|NCT03632993|541109601|FG002|Overall Study|Protocol Non-compliance|0|||
149994034|NCT03632993|541109602|FG003|Overall Study|Protocol Non-compliance|0|||
149994035|NCT03632993|541109603|FG004|Overall Study|Protocol Non-compliance|0|||
149994036|NCT03632993|541109604|FG005|Overall Study|Protocol Non-compliance|0|||
149994037|NCT03632993|541109605|FG006|Overall Study|Protocol Non-compliance|0|||
149994038|NCT03632993|541109606|FG007|Overall Study|Protocol Non-compliance|0|||
149994039|NCT03632993|541109607|FG008|Overall Study|Protocol Non-compliance|0|||
149994040|NCT03632993|541109608|FG009|Overall Study|Protocol Non-compliance|0|||
149994041|NCT03632993|541109599|FG000|Overall Study|Lost to Follow-up|0|||
149994042|NCT03632993|541109600|FG001|Overall Study|Lost to Follow-up|0|||
149994043|NCT03632993|541109601|FG002|Overall Study|Lost to Follow-up|0|||
149994044|NCT03632993|541109602|FG003|Overall Study|Lost to Follow-up|0|||
149994045|NCT03632993|541109603|FG004|Overall Study|Lost to Follow-up|0|||
149994046|NCT03632993|541109604|FG005|Overall Study|Lost to Follow-up|1|||
149994047|NCT03632993|541109605|FG006|Overall Study|Lost to Follow-up|0|||
149994048|NCT03632993|541109606|FG007|Overall Study|Lost to Follow-up|1|||
149994049|NCT03632993|541109607|FG008|Overall Study|Lost to Follow-up|0|||
149994050|NCT03632993|541109608|FG009|Overall Study|Lost to Follow-up|0|||
149994051|NCT03632993|541109599|FG000|Overall Study|Adverse Event|0|||
149994052|NCT03632993|541109600|FG001|Overall Study|Adverse Event|0|||
149994053|NCT03632993|541109601|FG002|Overall Study|Adverse Event|0|||
149994054|NCT03632993|541109602|FG003|Overall Study|Adverse Event|0|||
149994055|NCT03632993|541109603|FG004|Overall Study|Adverse Event|0|||
149994056|NCT03632993|541109604|FG005|Overall Study|Adverse Event|1|||
149994057|NCT03632993|541109605|FG006|Overall Study|Adverse Event|0|||
149994058|NCT03632993|541109606|FG007|Overall Study|Adverse Event|1|||
149994059|NCT03632993|541109607|FG008|Overall Study|Adverse Event|0|||
149994060|NCT03632993|541109608|FG009|Overall Study|Adverse Event|0|||
149994061|NCT01082874|541109610|FG000|Overall Study|Lost to Follow-up|10|||
149994062|NCT01082874|541109611|FG001|Overall Study|Lost to Follow-up|10|||
149994063|NCT01082874|541109612|FG002|Overall Study|Lost to Follow-up|6|||
149994064|NCT01082874|541109613|FG003|Overall Study|Lost to Follow-up|10|||
149994065|NCT01082874|541109610|FG000|Overall Study|Withdrawal by Subject|1|||
149994066|NCT01082874|541109611|FG001|Overall Study|Withdrawal by Subject|2|||
149994067|NCT01082874|541109612|FG002|Overall Study|Withdrawal by Subject|5|||
149994068|NCT01082874|541109613|FG003|Overall Study|Withdrawal by Subject|3|||
149994069|NCT02059499|541109626|FG000|Upto Week 20|Lost to Follow-up|2|||
149994070|NCT02059499|541109627|FG001|Upto Week 20|Lost to Follow-up|6|||
149994071|NCT02059499|541109628|FG002|Upto Week 20|Lost to Follow-up|0|||
149994072|NCT02059499|541109626|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
149994073|NCT02059499|541109627|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
149994074|NCT02059499|541109628|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
149994075|NCT02059499|541109626|FG000|Upto Week 20|Withdrawal by Subject|1|||
149994076|NCT02059499|541109627|FG001|Upto Week 20|Withdrawal by Subject|1|||
149994077|NCT02059499|541109628|FG002|Upto Week 20|Withdrawal by Subject|0|||
149994078|NCT02059499|541109626|FG000|Upto Week 20|No treatment per protocol criteria|0|||
149994079|NCT02059499|541109627|FG001|Upto Week 20|No treatment per protocol criteria|0|||
149994080|NCT02059499|541109628|FG002|Upto Week 20|No treatment per protocol criteria|5|||
149994081|NCT02059499|541109626|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
149994082|NCT02059499|541109627|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
149994083|NCT02059499|541109628|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
149994084|NCT02059499|541109626|FG000|Post-week 20|Lost to Follow-up|0|||
149994085|NCT02059499|541109627|FG001|Post-week 20|Lost to Follow-up|2|||
149994086|NCT02059499|541109628|FG002|Post-week 20|Lost to Follow-up|0|||
149994087|NCT02059499|541109626|FG000|Post-week 20|Withdrawal by Subject|0|||
149994088|NCT02059499|541109627|FG001|Post-week 20|Withdrawal by Subject|1|||
149994089|NCT02059499|541109628|FG002|Post-week 20|Withdrawal by Subject|0|||
149994090|NCT02059499|541109626|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
149994091|NCT02059499|541109627|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
149994092|NCT02059499|541109628|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
149994093|NCT04210245|541109629|FG000|Overall Study|Adverse Event|0|||
149994094|NCT04210245|541109630|FG001|Overall Study|Adverse Event|3|||
149994095|NCT04210245|541109631|FG002|Overall Study|Adverse Event|6|||
149994096|NCT04210245|541109632|FG003|Overall Study|Adverse Event|0|||
149994097|NCT04210245|541109629|FG000|Overall Study|Withdrawal by Subject|0|||
149994098|NCT04210245|541109630|FG001|Overall Study|Withdrawal by Subject|1|||
149994099|NCT04210245|541109631|FG002|Overall Study|Withdrawal by Subject|4|||
149994100|NCT04210245|541109632|FG003|Overall Study|Withdrawal by Subject|4|||
149994101|NCT04210245|541109629|FG000|Overall Study|Lost to Follow-up|0|||
149994102|NCT04210245|541109630|FG001|Overall Study|Lost to Follow-up|1|||
149994103|NCT04210245|541109631|FG002|Overall Study|Lost to Follow-up|1|||
149994104|NCT04210245|541109632|FG003|Overall Study|Lost to Follow-up|1|||
149994105|NCT04210245|541109629|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
149994106|NCT04210245|541109630|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
149994107|NCT04210245|541109631|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
149994108|NCT04210245|541109632|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
149994109|NCT01802580|541109633|FG000|Overall Study|Physician Decision|1|||
149994110|NCT01802580|541109634|FG001|Overall Study|Physician Decision|0|||
149994111|NCT01802580|541109633|FG000|Overall Study|Protocol Violation|2|||
149994112|NCT01802580|541109634|FG001|Overall Study|Protocol Violation|0|||
149994113|NCT01802580|541109633|FG000|Overall Study|Withdrawal by Subject|5|||
149994114|NCT01802580|541109634|FG001|Overall Study|Withdrawal by Subject|6|||
149994115|NCT01802580|541109633|FG000|Overall Study|Other|1|||
149994116|NCT01802580|541109634|FG001|Overall Study|Other|3|||
149994117|NCT01802580|541109633|FG000|Overall Study|Lack of Efficacy|0|||
149994118|NCT01802580|541109634|FG001|Overall Study|Lack of Efficacy|2|||
149994119|NCT03255967|541109635|FG000|Overall Study|Adverse Event|26|||
149994120|NCT03255967|541109636|FG001|Overall Study|Adverse Event|30|||
149994121|NCT03255967|541109635|FG000|Overall Study|Withdrawal by Subject|6|||
149994122|NCT03255967|541109636|FG001|Overall Study|Withdrawal by Subject|6|||
149994123|NCT03255967|541109635|FG000|Overall Study|Schedule conflict|6|||
149994124|NCT03255967|541109636|FG001|Overall Study|Schedule conflict|4|||
149994125|NCT03255967|541109635|FG000|Overall Study|POA did not sign consent form|2|||
149994126|NCT03255967|541109636|FG001|Overall Study|POA did not sign consent form|0|||
149994127|NCT00778258|541109642|FG000|Overall Study|Adverse Event|1|||
149994128|NCT00778258|541109643|FG001|Overall Study|Adverse Event|0|||
149994129|NCT00778258|541109644|FG002|Overall Study|Adverse Event|0|||
149994130|NCT00778258|541109645|FG003|Overall Study|Adverse Event|0|||
149994131|NCT00778258|541109646|FG004|Overall Study|Adverse Event|0|||
149994132|NCT00778258|541109647|FG005|Overall Study|Adverse Event|1|||
149994133|NCT00778258|541109648|FG006|Overall Study|Adverse Event|0|||
149994134|NCT00778258|541109649|FG007|Overall Study|Adverse Event|0|||
149994135|NCT00778258|541109650|FG008|Overall Study|Adverse Event|0|||
149994136|NCT00778258|541109642|FG000|Overall Study|Lost to Follow-up|0|||
149994137|NCT00778258|541109643|FG001|Overall Study|Lost to Follow-up|0|||
149994138|NCT00778258|541109644|FG002|Overall Study|Lost to Follow-up|2|||
149994139|NCT00778258|541109645|FG003|Overall Study|Lost to Follow-up|0|||
149994140|NCT00778258|541109646|FG004|Overall Study|Lost to Follow-up|0|||
149994141|NCT00778258|541109647|FG005|Overall Study|Lost to Follow-up|3|||
149994142|NCT00778258|541109648|FG006|Overall Study|Lost to Follow-up|2|||
149994143|NCT00778258|541109649|FG007|Overall Study|Lost to Follow-up|2|||
149994144|NCT00778258|541109650|FG008|Overall Study|Lost to Follow-up|0|||
149994145|NCT00778258|541109642|FG000|Overall Study|Withdrawal by Subject|6|||
149994146|NCT00778258|541109643|FG001|Overall Study|Withdrawal by Subject|2|||
149994147|NCT00778258|541109644|FG002|Overall Study|Withdrawal by Subject|8|||
150179032|NCT01985334|541793923|FG000|Overall Study|Worsening of disease|0|||
149994148|NCT00778258|541109645|FG003|Overall Study|Withdrawal by Subject|2|||
149994149|NCT00778258|541109646|FG004|Overall Study|Withdrawal by Subject|0|||
149994150|NCT00778258|541109647|FG005|Overall Study|Withdrawal by Subject|6|||
149994151|NCT00778258|541109648|FG006|Overall Study|Withdrawal by Subject|12|||
149994152|NCT00778258|541109649|FG007|Overall Study|Withdrawal by Subject|12|||
149994153|NCT00778258|541109650|FG008|Overall Study|Withdrawal by Subject|4|||
149994154|NCT00778258|541109642|FG000|Overall Study|New Contraindication|0|||
149994155|NCT00778258|541109643|FG001|Overall Study|New Contraindication|0|||
149994156|NCT00778258|541109644|FG002|Overall Study|New Contraindication|0|||
149994157|NCT00778258|541109645|FG003|Overall Study|New Contraindication|0|||
149994158|NCT00778258|541109646|FG004|Overall Study|New Contraindication|0|||
149994159|NCT00778258|541109647|FG005|Overall Study|New Contraindication|0|||
149994160|NCT00778258|541109648|FG006|Overall Study|New Contraindication|0|||
149994161|NCT00778258|541109649|FG007|Overall Study|New Contraindication|1|||
149994162|NCT00778258|541109650|FG008|Overall Study|New Contraindication|0|||
149994163|NCT00778258|541109642|FG000|Overall Study|Non-compliance|0|||
149994164|NCT00778258|541109643|FG001|Overall Study|Non-compliance|0|||
149994165|NCT00778258|541109644|FG002|Overall Study|Non-compliance|0|||
149994166|NCT00778258|541109645|FG003|Overall Study|Non-compliance|1|||
149994167|NCT00778258|541109646|FG004|Overall Study|Non-compliance|0|||
149994168|NCT00778258|541109647|FG005|Overall Study|Non-compliance|0|||
149994169|NCT00778258|541109648|FG006|Overall Study|Non-compliance|0|||
149994170|NCT00778258|541109649|FG007|Overall Study|Non-compliance|0|||
149994171|NCT00778258|541109650|FG008|Overall Study|Non-compliance|0|||
149994172|NCT00778258|541109642|FG000|Overall Study|Other|0|||
149994173|NCT00778258|541109643|FG001|Overall Study|Other|0|||
149994174|NCT00778258|541109644|FG002|Overall Study|Other|0|||
149994175|NCT00778258|541109645|FG003|Overall Study|Other|0|||
149994176|NCT00778258|541109646|FG004|Overall Study|Other|0|||
149994177|NCT00778258|541109647|FG005|Overall Study|Other|0|||
149994178|NCT00778258|541109648|FG006|Overall Study|Other|1|||
149994179|NCT00778258|541109649|FG007|Overall Study|Other|0|||
149994180|NCT00778258|541109650|FG008|Overall Study|Other|0|||
149994181|NCT02438384|541109654|FG000|Overall Study|Lost to Follow-up|8|||
149994182|NCT02438384|541109655|FG001|Overall Study|Lost to Follow-up|6|||
149994183|NCT02438384|541109656|FG002|Overall Study|Lost to Follow-up|4|||
149994184|NCT02650128|541109657|FG000|Overall Study|Death|2|||
149994185|NCT05526781|541111997|FG000|Overall Study|Lost to Follow-up|1|||
149994186|NCT04085458|541111998|FG000|Overall Study|Other|1|||
149994187|NCT04085458|541111998|FG000|Overall Study|Withdrawal by Subject|2|||
149994188|NCT04085458|541111998|FG000|Overall Study|Adverse Event|2|||
149994189|NCT02743949|541111999|FG000|Overall Study|Adverse Event|0|||
149994190|NCT02743949|541112000|FG001|Overall Study|Adverse Event|0|||
149994191|NCT02743949|541112001|FG002|Overall Study|Adverse Event|2|||
149994192|NCT02743949|541111999|FG000|Overall Study|Significant Protocol Deviation|2|||
149994193|NCT02743949|541112000|FG001|Overall Study|Significant Protocol Deviation|0|||
149994194|NCT02743949|541112001|FG002|Overall Study|Significant Protocol Deviation|1|||
149994195|NCT02743949|541111999|FG000|Overall Study|Voluntary Withdrawal|2|||
149994196|NCT02743949|541112000|FG001|Overall Study|Voluntary Withdrawal|1|||
149994197|NCT02743949|541112001|FG002|Overall Study|Voluntary Withdrawal|0|||
149994198|NCT01921218|541112002|FG000|Overall Study|Death|2|||
149994199|NCT01921218|541112003|FG001|Overall Study|Death|1|||
149994200|NCT01921218|541112002|FG000|Overall Study|Withdrawal by Subject|0|||
149994201|NCT01921218|541112003|FG001|Overall Study|Withdrawal by Subject|2|||
149994202|NCT01921218|541112002|FG000|Overall Study|Kidney transplant|1|||
149994203|NCT01921218|541112003|FG001|Overall Study|Kidney transplant|1|||
149994204|NCT03389555|541112004|FG000|Overall Study|Protocol Violation|1|||
150179033|NCT01985334|541793924|FG001|Overall Study|Worsening of disease|0|||
149994205|NCT03389555|541112005|FG001|Overall Study|Protocol Violation|3|||
149994206|NCT03389555|541112004|FG000|Overall Study|Death|1|||
149994207|NCT03389555|541112005|FG001|Overall Study|Death|0|||
149994208|NCT01885208|541112006|FG000|Overall Study|Unclassified|32|||
149994209|NCT01885208|541112007|FG001|Overall Study|Unclassified|38|||
149994210|NCT00920218|541112008|FG000|Overall Study|Serious Adverse Event|2|||
149994211|NCT00920218|541112009|FG001|Overall Study|Serious Adverse Event|0|||
149994212|NCT00920218|541112010|FG002|Overall Study|Serious Adverse Event|2|||
149994213|NCT00920218|541112011|FG003|Overall Study|Serious Adverse Event|1|||
149994214|NCT00920218|541112008|FG000|Overall Study|Withdrawal by Subject|0|||
149994215|NCT00920218|541112009|FG001|Overall Study|Withdrawal by Subject|3|||
149994216|NCT00920218|541112010|FG002|Overall Study|Withdrawal by Subject|2|||
149994217|NCT00920218|541112011|FG003|Overall Study|Withdrawal by Subject|0|||
149994218|NCT00920218|541112008|FG000|Overall Study|Migrated/moved from study area|0|||
149994219|NCT00920218|541112009|FG001|Overall Study|Migrated/moved from study area|0|||
149994220|NCT00920218|541112010|FG002|Overall Study|Migrated/moved from study area|1|||
149994221|NCT00920218|541112011|FG003|Overall Study|Migrated/moved from study area|0|||
149994222|NCT00920218|541112008|FG000|Overall Study|Lost to Follow-up|0|||
149994223|NCT00920218|541112009|FG001|Overall Study|Lost to Follow-up|1|||
149994224|NCT00920218|541112010|FG002|Overall Study|Lost to Follow-up|0|||
149994225|NCT00920218|541112011|FG003|Overall Study|Lost to Follow-up|3|||
149994226|NCT00920218|541112008|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
149994227|NCT00920218|541112009|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
149994228|NCT00920218|541112010|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
149994229|NCT00920218|541112011|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
149994230|NCT00920218|541112008|FG000|Overall Study|Other|0|||
149994231|NCT00920218|541112009|FG001|Overall Study|Other|0|||
149994232|NCT00920218|541112010|FG002|Overall Study|Other|1|||
149994233|NCT00920218|541112011|FG003|Overall Study|Other|0|||
149994234|NCT00873041|541112012|FG000|Core Study|Adverse Event|2|||
149994235|NCT00873041|541112013|FG001|Core Study|Adverse Event|3|||
149994236|NCT00873041|541112014|FG002|Core Study|Adverse Event|1|||
149994237|NCT00873041|541112012|FG000|Core Study|Withdrawal by Subject|1|||
149994238|NCT00873041|541112013|FG001|Core Study|Withdrawal by Subject|2|||
149994239|NCT00873041|541112014|FG002|Core Study|Withdrawal by Subject|2|||
149994240|NCT00873041|541112012|FG000|Core Study|Lost to Follow-up|3|||
149994241|NCT00873041|541112013|FG001|Core Study|Lost to Follow-up|1|||
149994242|NCT00873041|541112014|FG002|Core Study|Lost to Follow-up|0|||
149994243|NCT00873041|541112012|FG000|Core Study|Abnormal laboratory value|0|||
149994244|NCT00873041|541112013|FG001|Core Study|Abnormal laboratory value|0|||
149994245|NCT00873041|541112014|FG002|Core Study|Abnormal laboratory value|1|||
149994246|NCT00873041|541112012|FG000|Core Study|Protocol deviation|1|||
149994247|NCT00873041|541112013|FG001|Core Study|Protocol deviation|0|||
149994248|NCT00873041|541112014|FG002|Core Study|Protocol deviation|1|||
149994249|NCT00873041|541112012|FG000|Extension Study|Adverse Event|1|||
149994250|NCT00873041|541112013|FG001|Extension Study|Adverse Event|0|||
149994251|NCT00873041|541112014|FG002|Extension Study|Adverse Event|1|||
149994252|NCT00873041|541112012|FG000|Extension Study|Administrative reasons|0|||
149994253|NCT00873041|541112013|FG001|Extension Study|Administrative reasons|0|||
149994254|NCT00873041|541112014|FG002|Extension Study|Administrative reasons|1|||
149994255|NCT00313313|541112015|FG000|Overall Study|Lack of Efficacy|14|||
149994256|NCT00313313|541112016|FG001|Overall Study|Lack of Efficacy|9|||
149994257|NCT00313313|541112017|FG002|Overall Study|Lack of Efficacy|20|||
149994258|NCT00313313|541112015|FG000|Overall Study|Withdrawal of consent by subject|18|||
149994259|NCT00313313|541112016|FG001|Overall Study|Withdrawal of consent by subject|17|||
149994260|NCT00313313|541112017|FG002|Overall Study|Withdrawal of consent by subject|31|||
149994261|NCT00313313|541112015|FG000|Overall Study|Lost to Follow-up|10|||
149994262|NCT00313313|541112016|FG001|Overall Study|Lost to Follow-up|7|||
149994263|NCT00313313|541112017|FG002|Overall Study|Lost to Follow-up|9|||
149994264|NCT00313313|541112015|FG000|Overall Study|Adverse Event|15|||
149994265|NCT00313313|541112016|FG001|Overall Study|Adverse Event|16|||
149994266|NCT00313313|541112017|FG002|Overall Study|Adverse Event|12|||
149994267|NCT00313313|541112015|FG000|Overall Study|Physician Decision|2|||
149994268|NCT00313313|541112016|FG001|Overall Study|Physician Decision|6|||
149994269|NCT00313313|541112017|FG002|Overall Study|Physician Decision|4|||
149994270|NCT00313313|541112015|FG000|Overall Study|Poor/Noncompliance|3|||
149994271|NCT00313313|541112016|FG001|Overall Study|Poor/Noncompliance|6|||
149994272|NCT00313313|541112017|FG002|Overall Study|Poor/Noncompliance|2|||
149994273|NCT00313313|541112015|FG000|Overall Study|Pregnancy|1|||
149994274|NCT00313313|541112016|FG001|Overall Study|Pregnancy|2|||
149994275|NCT00313313|541112017|FG002|Overall Study|Pregnancy|0|||
149994276|NCT00313313|541112015|FG000|Overall Study|Death|0|||
149994277|NCT00313313|541112016|FG001|Overall Study|Death|0|||
149994278|NCT00313313|541112017|FG002|Overall Study|Death|2|||
149994279|NCT00313313|541112015|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
149994280|NCT00313313|541112016|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
149994281|NCT00313313|541112017|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
149994282|NCT00368836|541112020|FG000|Phase II|Screen Failure|1|||
149994283|NCT00368836|541112020|FG000|Phase II|Withdrawal by Subject|1|||
149994284|NCT00368836|541112020|FG000|Phase II|unable to collect blood and/or breath|17|||
149994285|NCT00368836|541112020|FG000|Phase II|Protocol Violation|2|||
149994286|NCT01345591|541112025|FG000|Overall Study|Lost to Follow-up|1|||
149994287|NCT00090142|541112026|FG000|Treatment Period I|Lost to Follow-up|1|||
149994288|NCT00090142|541112027|FG001|Treatment Period I|Lost to Follow-up|2|||
149994289|NCT00090142|541112026|FG000|Treatment Period I|Protocol Violation|2|||
149994290|NCT00090142|541112027|FG001|Treatment Period I|Protocol Violation|0|||
149994291|NCT00090142|541112026|FG000|Treatment Period I|Withdrawal by Subject|2|||
149994292|NCT00090142|541112027|FG001|Treatment Period I|Withdrawal by Subject|0|||
149994293|NCT00090142|541112026|FG000|Treatment Period I|Other|0|||
149994294|NCT00090142|541112027|FG001|Treatment Period I|Other|1|||
149994295|NCT00090142|541112026|FG000|Treatment Period II|Other|1|||
149994296|NCT00090142|541112027|FG001|Treatment Period II|Other|0|||
149994297|NCT02442310|541112028|FG000|Overall Study|Adverse Event|2|||
149994298|NCT02442310|541112028|FG000|Overall Study|Withdrawal by Subject|1|||
149994299|NCT01126437|541112029|FG000|Overall Study|Not treated|11|||
150053906|NCT03996369|541338404|FG000|Overall Study|Adverse Event|9|||
150053907|NCT03996369|541338405|FG001|Overall Study|Adverse Event|0|||
150053908|NCT03996369|541338404|FG000|Overall Study|Withdrawal by Subject|6|||
150053909|NCT03996369|541338405|FG001|Overall Study|Withdrawal by Subject|8|||
150053910|NCT03996369|541338404|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
150053911|NCT03996369|541338405|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
150053912|NCT03996369|541338404|FG000|Overall Study|Lost to Follow-up|0|||
150053913|NCT03996369|541338405|FG001|Overall Study|Lost to Follow-up|1|||
150053914|NCT01782469|541338406|FG000|Overall Study|Lost to Follow-up|1|||
150053915|NCT04620798|541338411|FG000|Overall Study|Lost to Follow-up|126|||
150053916|NCT04620798|541338412|FG001|Overall Study|Lost to Follow-up|138|||
150053917|NCT01224782|541338415|FG000|Overall Study|Lost to Follow-up|177|||
150053918|NCT01224782|541338415|FG000|Overall Study|Withdrawal by Subject|16|||
150053919|NCT01224782|541338415|FG000|Overall Study|Death|14|||
150053920|NCT01224782|541338415|FG000|Overall Study|Improvement|13|||
150053921|NCT01224782|541338415|FG000|Overall Study|Adverse Event|12|||
150053922|NCT01224782|541338415|FG000|Overall Study|Adverse Reaction|11|||
150053923|NCT01224782|541338415|FG000|Overall Study|Noncompliance|10|||
150053924|NCT01224782|541338415|FG000|Overall Study|Other|4|||
150053925|NCT01224782|541338415|FG000|Overall Study|Start of Dialysis|3|||
150053926|NCT01224782|541338415|FG000|Overall Study|Change of Treatment|1|||
150053927|NCT01224782|541338415|FG000|Overall Study|Financial Reasons|1|||
150053928|NCT01224782|541338415|FG000|Overall Study|Deterioration|1|||
150053929|NCT01224782|541338415|FG000|Overall Study|Transplantation|1|||
150053930|NCT01960907|541338416|FG000|Overall Study|Death|4|||
150053931|NCT01960907|541338417|FG001|Overall Study|Death|3|||
150053932|NCT01960907|541338416|FG000|Overall Study|Withdrawal by Subject|32|||
150053933|NCT01960907|541338417|FG001|Overall Study|Withdrawal by Subject|42|||
150053934|NCT00441116|541338420|FG000|Overall Study|Adverse Event|1|||
150053935|NCT00441116|541338421|FG001|Overall Study|Adverse Event|1|||
149994300|NCT01126437|541112030|FG001|Overall Study|Not treated|18|||
149994301|NCT01126437|541112031|FG002|Overall Study|Not treated|19|||
149994302|NCT01126437|541112029|FG000|Overall Study|Sites with data irregularities/fraud|6|||
149994303|NCT01126437|541112030|FG001|Overall Study|Sites with data irregularities/fraud|6|||
149994304|NCT01126437|541112031|FG002|Overall Study|Sites with data irregularities/fraud|7|||
149994305|NCT01126437|541112029|FG000|Overall Study|Adverse Event|602|||
149994306|NCT01126437|541112030|FG001|Overall Study|Adverse Event|606|||
149994307|NCT01126437|541112031|FG002|Overall Study|Adverse Event|635|||
149994308|NCT01126437|541112029|FG000|Overall Study|Lack of Efficacy|65|||
149994309|NCT01126437|541112030|FG001|Overall Study|Lack of Efficacy|60|||
149994310|NCT01126437|541112031|FG002|Overall Study|Lack of Efficacy|59|||
149994311|NCT01126437|541112029|FG000|Overall Study|Protocol Violation|64|||
149994312|NCT01126437|541112030|FG001|Overall Study|Protocol Violation|66|||
149994313|NCT01126437|541112031|FG002|Overall Study|Protocol Violation|41|||
149994314|NCT01126437|541112029|FG000|Overall Study|Lost to Follow-up|52|||
149994315|NCT01126437|541112030|FG001|Overall Study|Lost to Follow-up|63|||
149994316|NCT01126437|541112031|FG002|Overall Study|Lost to Follow-up|55|||
149994317|NCT01126437|541112029|FG000|Overall Study|Withdrawal by Subject|331|||
149994318|NCT01126437|541112030|FG001|Overall Study|Withdrawal by Subject|335|||
149994319|NCT01126437|541112031|FG002|Overall Study|Withdrawal by Subject|319|||
149994320|NCT01126437|541112029|FG000|Overall Study|Other reason not specified|210|||
149994321|NCT01126437|541112030|FG001|Overall Study|Other reason not specified|176|||
149994322|NCT01126437|541112031|FG002|Overall Study|Other reason not specified|178|||
149994323|NCT00006046|541112037|FG000|Overall Study|Adverse Event|3|||
149994324|NCT00006046|541112038|FG001|Overall Study|Adverse Event|0|||
149994325|NCT00006046|541112039|FG002|Overall Study|Adverse Event|0|||
149994326|NCT00006046|541112040|FG003|Overall Study|Adverse Event|0|||
150053936|NCT00441116|541338420|FG000|Overall Study|Withdrawal by Subject|1|||
150053937|NCT00441116|541338421|FG001|Overall Study|Withdrawal by Subject|0|||
150053938|NCT00441116|541338420|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
150053939|NCT00441116|541338421|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
150053940|NCT02925338|541338422|FG000|Overall Study|Death|0|||
149994327|NCT00006046|541112041|FG004|Overall Study|Adverse Event|0|||
149994328|NCT00006046|541112037|FG000|Overall Study|Disease Progression|2|||
149994329|NCT00006046|541112038|FG001|Overall Study|Disease Progression|0|||
149994330|NCT00006046|541112039|FG002|Overall Study|Disease Progression|0|||
149994331|NCT00006046|541112040|FG003|Overall Study|Disease Progression|0|||
149994332|NCT00006046|541112041|FG004|Overall Study|Disease Progression|0|||
150053941|NCT02925338|541338423|FG001|Overall Study|Death|2|||
149994333|NCT00596154|541112042|FG000|Overall Study|Not Evaluable|2|||
150053942|NCT02925338|541338424|FG002|Overall Study|Death|1|||
150053943|NCT02925338|541338425|FG003|Overall Study|Death|0|||
149994334|NCT01846663|541112043|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
149994335|NCT01846663|541112044|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
149994336|NCT01846663|541112043|FG000|Overall Study|Withdrawal by Subject|1|||
149994337|NCT01846663|541112044|FG001|Overall Study|Withdrawal by Subject|0|||
149994338|NCT01846663|541112043|FG000|Overall Study|Adverse Event|1|||
149994339|NCT01846663|541112044|FG001|Overall Study|Adverse Event|2|||
149994340|NCT00585546|541112056|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
149994341|NCT00585546|541112056|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
149994342|NCT02851797|541112057|FG000|Overall Study|Withdrawal by Subject|4|||
149994343|NCT02851797|541112058|FG001|Overall Study|Withdrawal by Subject|2|||
149994344|NCT02851797|541112057|FG000|Overall Study|Adverse Event|3|||
149994345|NCT02851797|541112058|FG001|Overall Study|Adverse Event|0|||
149994346|NCT03077438|541112059|FG000|Overall Study|Protocol Violation|3|||
149994347|NCT03077438|541112060|FG001|Overall Study|Protocol Violation|5|||
149994348|NCT03077438|541112059|FG000|Overall Study|Withdrawal by Subject|3|||
149994349|NCT03077438|541112060|FG001|Overall Study|Withdrawal by Subject|6|||
149994350|NCT03077438|541112059|FG000|Overall Study|Lost to Follow-up|6|||
149994351|NCT03077438|541112060|FG001|Overall Study|Lost to Follow-up|3|||
149994352|NCT00813865|541112061|FG000|Overall Study|Failure to Respond|3|||
150053944|NCT02925338|541338426|FG004|Overall Study|Death|0|||
150053945|NCT02925338|541338422|FG000|Overall Study|Lost to Follow-up|30|||
149994353|NCT00813865|541112061|FG000|Overall Study|Lost to Follow-up|3|||
149994354|NCT00813865|541112061|FG000|Overall Study|Withdrawal by Subject|1|||
149994355|NCT03888235|541112073|FG000|Overall Study|Lost to Follow-up|1|||
149994356|NCT03888235|541112074|FG001|Overall Study|Lost to Follow-up|1|||
149994357|NCT03888235|541112075|FG002|Overall Study|Lost to Follow-up|0|||
149994358|NCT00676520|541112076|FG000|Overall Study|Withdrawal by Subject|163|||
149994359|NCT00676520|541112076|FG000|Overall Study|Lost to Follow-up|162|||
149994360|NCT00676520|541112076|FG000|Overall Study|Death|159|||
149994361|NCT00676520|541112076|FG000|Overall Study|Physician Decision|20|||
149994362|NCT00676520|541112076|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
149994363|NCT00676520|541112076|FG000|Overall Study|Other Reason|18|||
149994364|NCT01425359|541112077|FG000|Overall Study|Randomized but Not Treated|2|||
149994365|NCT01425359|541112078|FG001|Overall Study|Randomized but Not Treated|3|||
149994366|NCT01425359|541112077|FG000|Overall Study|Adverse Event|9|||
149994367|NCT01425359|541112078|FG001|Overall Study|Adverse Event|8|||
149994368|NCT01425359|541112077|FG000|Overall Study|Revascularization|0|||
149994369|NCT01425359|541112078|FG001|Overall Study|Revascularization|1|||
149994370|NCT01425359|541112077|FG000|Overall Study|Death|0|||
149994371|NCT01425359|541112078|FG001|Overall Study|Death|1|||
149994372|NCT01425359|541112077|FG000|Overall Study|Unsatisfactory Response|1|||
149994373|NCT01425359|541112078|FG001|Overall Study|Unsatisfactory Response|0|||
149994374|NCT01425359|541112077|FG000|Overall Study|Protocol Violation|1|||
149994375|NCT01425359|541112078|FG001|Overall Study|Protocol Violation|2|||
149994376|NCT01425359|541112077|FG000|Overall Study|Subject Withdrew Consent|1|||
149994377|NCT01425359|541112078|FG001|Overall Study|Subject Withdrew Consent|2|||
149994378|NCT01425359|541112077|FG000|Overall Study|Investigator's Discretion|2|||
149994379|NCT01425359|541112078|FG001|Overall Study|Investigator's Discretion|0|||
149994380|NCT01425359|541112077|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
149994381|NCT01425359|541112078|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
149994382|NCT02928029|541112083|FG000|Overall Study|Withdrawal by Subject|0|||
149994383|NCT02928029|541112084|FG001|Overall Study|Withdrawal by Subject|1|||
149994384|NCT02928029|541112083|FG000|Overall Study|Radiological progression|1|||
149994385|NCT02928029|541112084|FG001|Overall Study|Radiological progression|0|||
149994386|NCT02928029|541112083|FG000|Overall Study|Clinical progression|1|||
149994387|NCT02928029|541112084|FG001|Overall Study|Clinical progression|2|||
149994388|NCT02928029|541112083|FG000|Overall Study|AE not related to clinical progression|1|||
150053946|NCT02925338|541338423|FG001|Overall Study|Lost to Follow-up|10|||
150053947|NCT02925338|541338424|FG002|Overall Study|Lost to Follow-up|1|||
150053948|NCT02925338|541338425|FG003|Overall Study|Lost to Follow-up|16|||
150053949|NCT02925338|541338426|FG004|Overall Study|Lost to Follow-up|3|||
150053950|NCT02925338|541338422|FG000|Overall Study|Withdrawal by Subject|3|||
150053951|NCT02925338|541338423|FG001|Overall Study|Withdrawal by Subject|0|||
150053952|NCT02925338|541338424|FG002|Overall Study|Withdrawal by Subject|3|||
150053953|NCT02925338|541338425|FG003|Overall Study|Withdrawal by Subject|2|||
149994389|NCT02928029|541112084|FG001|Overall Study|AE not related to clinical progression|1|||
149994390|NCT00223977|541112087|FG000|Overall Study|Adverse Event|7|||
149994391|NCT00223977|541112088|FG001|Overall Study|Adverse Event|10|||
149994392|NCT00223977|541112089|FG002|Overall Study|Adverse Event|0|||
149994393|NCT00223977|541112087|FG000|Overall Study|Protocol Violation|0|||
149994394|NCT00223977|541112088|FG001|Overall Study|Protocol Violation|0|||
149994395|NCT00223977|541112089|FG002|Overall Study|Protocol Violation|1|||
149994396|NCT00223977|541112087|FG000|Overall Study|Withdrawal by Subject|1|||
149994397|NCT00223977|541112088|FG001|Overall Study|Withdrawal by Subject|1|||
149994398|NCT00223977|541112089|FG002|Overall Study|Withdrawal by Subject|2|||
149994399|NCT00223977|541112087|FG000|Overall Study|Other|1|||
149994400|NCT00223977|541112088|FG001|Overall Study|Other|0|||
150053954|NCT02925338|541338426|FG004|Overall Study|Withdrawal by Subject|2|||
150053955|NCT02925338|541338422|FG000|Overall Study|Missing|38|||
150053956|NCT02925338|541338423|FG001|Overall Study|Missing|27|||
150053957|NCT02925338|541338424|FG002|Overall Study|Missing|0|||
150053958|NCT02925338|541338425|FG003|Overall Study|Missing|3|||
150053959|NCT02925338|541338426|FG004|Overall Study|Missing|2|||
149994401|NCT00223977|541112089|FG002|Overall Study|Other|0|||
149994402|NCT03650803|541112092|FG000|Overall Study|Lost to Follow-up|6|||
149994403|NCT02359045|541112093|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
149994404|NCT02359045|541112094|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149994405|NCT02359045|541112093|FG000|Overall Study|Lost to Follow-up|1|||
149994406|NCT02359045|541112094|FG001|Overall Study|Lost to Follow-up|1|||
149994407|NCT02359045|541112093|FG000|Overall Study|Adverse Event|0|||
149994408|NCT02359045|541112094|FG001|Overall Study|Adverse Event|1|||
149994409|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
149994410|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
149994411|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
149994412|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
149994413|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
149994414|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
149994415|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
149994416|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
149994417|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
149994418|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
149994419|NCT01639339|541112102|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
149994420|NCT01639339|541112103|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
149994421|NCT01639339|541112102|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
149994422|NCT01639339|541112103|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
149994423|NCT01639339|541112102|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
149994424|NCT01639339|541112103|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
149994425|NCT01639339|541112102|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
149994426|NCT01639339|541112103|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
149994427|NCT01639339|541112102|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
149994428|NCT01639339|541112103|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
149994429|NCT02649218|541112104|FG000|Overall Study|Adverse Event|8|||
149994430|NCT02649218|541112104|FG000|Overall Study|Lack of Efficacy|8|||
149994431|NCT02649218|541112104|FG000|Overall Study|Pregnancy|3|||
149994432|NCT02649218|541112104|FG000|Overall Study|Protocol Violation|3|||
149994433|NCT02649218|541112104|FG000|Overall Study|Physician Decision|1|||
149994434|NCT02649218|541112104|FG000|Overall Study|Withdrawal by Subject|2|||
149994435|NCT00367744|541112105|FG000|Overall Study|Lost to Follow-up|4|||
149994436|NCT00367744|541112106|FG001|Overall Study|Lost to Follow-up|5|||
149994437|NCT04376684|541112115|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
149994438|NCT04376684|541112116|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
149994439|NCT04376684|541112117|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
149994440|NCT04376684|541112118|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
149994441|NCT04376684|541112115|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
149994442|NCT04376684|541112116|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
149994443|NCT04376684|541112117|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
149994444|NCT04376684|541112118|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
149994445|NCT04376684|541112115|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
149994446|NCT04376684|541112116|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
149994447|NCT04376684|541112117|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
149994448|NCT04376684|541112118|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
149994449|NCT04376684|541112115|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
149994450|NCT04376684|541112116|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
149994451|NCT04376684|541112117|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
149994452|NCT04376684|541112118|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
149994453|NCT04376684|541112115|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
149994454|NCT04376684|541112116|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
149994455|NCT04376684|541112117|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
149994456|NCT04376684|541112118|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
149994457|NCT04376684|541112115|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
149994458|NCT04376684|541112116|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
149994459|NCT04376684|541112117|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
149994460|NCT04376684|541112118|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
149994461|NCT04376684|541112115|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
150053960|NCT02925338|541338422|FG000|Overall Study|Participant's Decision|11|||
150053961|NCT02925338|541338423|FG001|Overall Study|Participant's Decision|7|||
149994462|NCT04376684|541112116|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
149994463|NCT04376684|541112117|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
149994464|NCT04376684|541112118|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
149994465|NCT01666119|541112119|FG000|Overall Study|Adverse Event|6|||
149994466|NCT01666119|541112119|FG000|Overall Study|Withdrawal by Subject|16|||
149994467|NCT01666119|541112119|FG000|Overall Study|Lost to Follow-up|7|||
149994468|NCT01666119|541112119|FG000|Overall Study|non compliance with study medication, pa|18|||
149994469|NCT01666119|541112119|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
149994470|NCT02979093|541112136|FG000|First Scan Session|Scanning data problems|1|||
149994471|NCT02979093|541112137|FG001|First Scan Session|Scanning data problems|2|||
149994472|NCT02979093|541112138|FG002|First Scan Session|Scanning data problems|2|||
149994473|NCT02979093|541112139|FG003|First Scan Session|Scanning data problems|0|||
149994474|NCT02979093|541112136|FG000|Second Scan Session|Scanning data problems|3|||
149994475|NCT02979093|541112137|FG001|Second Scan Session|Scanning data problems|0|||
149994476|NCT02979093|541112138|FG002|Second Scan Session|Scanning data problems|1|||
149994477|NCT02979093|541112139|FG003|Second Scan Session|Scanning data problems|3|||
149994478|NCT06107803|541112140|FG000|Overall Study|Adverse Event|1|||
149994479|NCT06107803|541112140|FG000|Overall Study|Withdrawal by Subject|2|||
149994480|NCT06107803|541112140|FG000|Overall Study|Protocol Violation|1|||
149994481|NCT05596734|541112141|FG000|Substudy A|Withdrawal by Subject|1|||
149994482|NCT05596734|541112142|FG001|Substudy A|Withdrawal by Subject|0|||
149994483|NCT05596734|541112143|FG002|Substudy A|Withdrawal by Subject|0|||
149994484|NCT05596734|541112144|FG003|Substudy A|Withdrawal by Subject|0|||
149994485|NCT05596734|541112145|FG004|Substudy A|Withdrawal by Subject|0|||
149994486|NCT05596734|541112146|FG005|Substudy A|Withdrawal by Subject|0|||
149994487|NCT05596734|541112147|FG006|Substudy A|Withdrawal by Subject|1|||
149994488|NCT05596734|541112148|FG007|Substudy A|Withdrawal by Subject|0|||
149994489|NCT05596734|541112149|FG008|Substudy A|Withdrawal by Subject|0|||
149994490|NCT05596734|541112150|FG009|Substudy A|Withdrawal by Subject|0|||
149994491|NCT05596734|541112151|FG010|Substudy A|Withdrawal by Subject|0|||
149994492|NCT05596734|541112152|FG011|Substudy A|Withdrawal by Subject|0|||
149994493|NCT05596734|541112153|FG012|Substudy A|Withdrawal by Subject|0|||
149994494|NCT05596734|541112154|FG013|Substudy A|Withdrawal by Subject|0|||
149994495|NCT05596734|541112155|FG014|Substudy A|Withdrawal by Subject|0|||
149994496|NCT05596734|541112156|FG015|Substudy A|Withdrawal by Subject|0|||
149994497|NCT05596734|541112157|FG016|Substudy A|Withdrawal by Subject|0|||
149994498|NCT05596734|541112158|FG017|Substudy A|Withdrawal by Subject|0|||
149994499|NCT05596734|541112159|FG018|Substudy A|Withdrawal by Subject|0|||
149994500|NCT05596734|541112160|FG019|Substudy A|Withdrawal by Subject|0|||
149994501|NCT05596734|541112161|FG020|Substudy A|Withdrawal by Subject|0|||
149994502|NCT05596734|541112162|FG021|Substudy A|Withdrawal by Subject|0|||
149994503|NCT05596734|541112163|FG022|Substudy A|Withdrawal by Subject|0|||
149994504|NCT05596734|541112164|FG023|Substudy A|Withdrawal by Subject|0|||
149994505|NCT05596734|541112141|FG000|Substudy A|Lost to Follow-up|1|||
149994506|NCT05596734|541112142|FG001|Substudy A|Lost to Follow-up|0|||
149994507|NCT05596734|541112143|FG002|Substudy A|Lost to Follow-up|1|||
149994508|NCT05596734|541112144|FG003|Substudy A|Lost to Follow-up|0|||
149994509|NCT05596734|541112145|FG004|Substudy A|Lost to Follow-up|0|||
149994510|NCT05596734|541112146|FG005|Substudy A|Lost to Follow-up|0|||
149994511|NCT05596734|541112147|FG006|Substudy A|Lost to Follow-up|0|||
149994512|NCT05596734|541112148|FG007|Substudy A|Lost to Follow-up|0|||
149994513|NCT05596734|541112149|FG008|Substudy A|Lost to Follow-up|0|||
149994514|NCT05596734|541112150|FG009|Substudy A|Lost to Follow-up|0|||
149994515|NCT05596734|541112151|FG010|Substudy A|Lost to Follow-up|0|||
149994516|NCT05596734|541112152|FG011|Substudy A|Lost to Follow-up|0|||
149994517|NCT05596734|541112153|FG012|Substudy A|Lost to Follow-up|0|||
149994518|NCT05596734|541112154|FG013|Substudy A|Lost to Follow-up|0|||
149994519|NCT05596734|541112155|FG014|Substudy A|Lost to Follow-up|0|||
149994520|NCT05596734|541112156|FG015|Substudy A|Lost to Follow-up|0|||
149994521|NCT05596734|541112157|FG016|Substudy A|Lost to Follow-up|0|||
149994522|NCT05596734|541112158|FG017|Substudy A|Lost to Follow-up|0|||
149994523|NCT05596734|541112159|FG018|Substudy A|Lost to Follow-up|0|||
149994524|NCT05596734|541112160|FG019|Substudy A|Lost to Follow-up|0|||
149994525|NCT05596734|541112161|FG020|Substudy A|Lost to Follow-up|0|||
149994526|NCT05596734|541112162|FG021|Substudy A|Lost to Follow-up|0|||
149994527|NCT05596734|541112163|FG022|Substudy A|Lost to Follow-up|0|||
149994528|NCT05596734|541112164|FG023|Substudy A|Lost to Follow-up|0|||
149994529|NCT05596734|541112141|FG000|Substudy B|Withdrawal by Subject|0|||
149994530|NCT05596734|541112142|FG001|Substudy B|Withdrawal by Subject|0|||
149994531|NCT05596734|541112143|FG002|Substudy B|Withdrawal by Subject|0|||
149994532|NCT05596734|541112144|FG003|Substudy B|Withdrawal by Subject|0|||
149994533|NCT05596734|541112145|FG004|Substudy B|Withdrawal by Subject|0|||
149994534|NCT05596734|541112146|FG005|Substudy B|Withdrawal by Subject|0|||
149994535|NCT05596734|541112147|FG006|Substudy B|Withdrawal by Subject|0|||
149994536|NCT05596734|541112148|FG007|Substudy B|Withdrawal by Subject|0|||
149994537|NCT05596734|541112149|FG008|Substudy B|Withdrawal by Subject|0|||
149994538|NCT05596734|541112150|FG009|Substudy B|Withdrawal by Subject|0|||
149994539|NCT05596734|541112151|FG010|Substudy B|Withdrawal by Subject|0|||
149994540|NCT05596734|541112152|FG011|Substudy B|Withdrawal by Subject|0|||
149994541|NCT05596734|541112153|FG012|Substudy B|Withdrawal by Subject|1|||
149994542|NCT05596734|541112154|FG013|Substudy B|Withdrawal by Subject|0|||
149994543|NCT05596734|541112155|FG014|Substudy B|Withdrawal by Subject|1|||
149994544|NCT05596734|541112156|FG015|Substudy B|Withdrawal by Subject|2|||
149994545|NCT05596734|541112157|FG016|Substudy B|Withdrawal by Subject|2|||
149994546|NCT05596734|541112158|FG017|Substudy B|Withdrawal by Subject|1|||
149994547|NCT05596734|541112159|FG018|Substudy B|Withdrawal by Subject|2|||
149994548|NCT05596734|541112160|FG019|Substudy B|Withdrawal by Subject|0|||
149994549|NCT05596734|541112161|FG020|Substudy B|Withdrawal by Subject|0|||
149994550|NCT05596734|541112162|FG021|Substudy B|Withdrawal by Subject|0|||
149994551|NCT05596734|541112163|FG022|Substudy B|Withdrawal by Subject|0|||
149994552|NCT05596734|541112164|FG023|Substudy B|Withdrawal by Subject|1|||
149994553|NCT05596734|541112141|FG000|Substudy B|Physician Decision|0|||
149994554|NCT05596734|541112142|FG001|Substudy B|Physician Decision|0|||
149994555|NCT05596734|541112143|FG002|Substudy B|Physician Decision|0|||
149994556|NCT05596734|541112144|FG003|Substudy B|Physician Decision|0|||
149994557|NCT05596734|541112145|FG004|Substudy B|Physician Decision|0|||
149994558|NCT05596734|541112146|FG005|Substudy B|Physician Decision|0|||
149994559|NCT05596734|541112147|FG006|Substudy B|Physician Decision|0|||
149994560|NCT05596734|541112148|FG007|Substudy B|Physician Decision|0|||
149994561|NCT05596734|541112149|FG008|Substudy B|Physician Decision|0|||
149994562|NCT05596734|541112150|FG009|Substudy B|Physician Decision|0|||
149994563|NCT05596734|541112151|FG010|Substudy B|Physician Decision|0|||
149994564|NCT05596734|541112152|FG011|Substudy B|Physician Decision|0|||
149994565|NCT05596734|541112153|FG012|Substudy B|Physician Decision|0|||
149994566|NCT05596734|541112154|FG013|Substudy B|Physician Decision|0|||
149994567|NCT05596734|541112155|FG014|Substudy B|Physician Decision|0|||
149994568|NCT05596734|541112156|FG015|Substudy B|Physician Decision|1|||
149994569|NCT05596734|541112157|FG016|Substudy B|Physician Decision|0|||
149994570|NCT05596734|541112158|FG017|Substudy B|Physician Decision|0|||
149994571|NCT05596734|541112159|FG018|Substudy B|Physician Decision|0|||
149994572|NCT05596734|541112160|FG019|Substudy B|Physician Decision|0|||
149994573|NCT05596734|541112161|FG020|Substudy B|Physician Decision|0|||
149994574|NCT05596734|541112162|FG021|Substudy B|Physician Decision|0|||
149994575|NCT05596734|541112163|FG022|Substudy B|Physician Decision|0|||
149994576|NCT05596734|541112164|FG023|Substudy B|Physician Decision|0|||
149994577|NCT05596734|541112141|FG000|Substudy B|Lost to Follow-up|0|||
149994578|NCT05596734|541112142|FG001|Substudy B|Lost to Follow-up|0|||
149994579|NCT05596734|541112143|FG002|Substudy B|Lost to Follow-up|0|||
149994580|NCT05596734|541112144|FG003|Substudy B|Lost to Follow-up|0|||
149994581|NCT05596734|541112145|FG004|Substudy B|Lost to Follow-up|0|||
149994582|NCT05596734|541112146|FG005|Substudy B|Lost to Follow-up|0|||
149994583|NCT05596734|541112147|FG006|Substudy B|Lost to Follow-up|0|||
149994584|NCT05596734|541112148|FG007|Substudy B|Lost to Follow-up|0|||
149994585|NCT05596734|541112149|FG008|Substudy B|Lost to Follow-up|0|||
149994586|NCT05596734|541112150|FG009|Substudy B|Lost to Follow-up|0|||
149994587|NCT05596734|541112151|FG010|Substudy B|Lost to Follow-up|0|||
149994588|NCT05596734|541112152|FG011|Substudy B|Lost to Follow-up|0|||
149994589|NCT05596734|541112153|FG012|Substudy B|Lost to Follow-up|1|||
149994590|NCT05596734|541112154|FG013|Substudy B|Lost to Follow-up|0|||
149994591|NCT05596734|541112155|FG014|Substudy B|Lost to Follow-up|1|||
149994592|NCT05596734|541112156|FG015|Substudy B|Lost to Follow-up|1|||
149994593|NCT05596734|541112157|FG016|Substudy B|Lost to Follow-up|0|||
149994594|NCT05596734|541112158|FG017|Substudy B|Lost to Follow-up|0|||
149994595|NCT05596734|541112159|FG018|Substudy B|Lost to Follow-up|0|||
149994596|NCT05596734|541112160|FG019|Substudy B|Lost to Follow-up|0|||
149994597|NCT05596734|541112161|FG020|Substudy B|Lost to Follow-up|0|||
149994598|NCT05596734|541112162|FG021|Substudy B|Lost to Follow-up|0|||
149994599|NCT05596734|541112163|FG022|Substudy B|Lost to Follow-up|0|||
149994600|NCT05596734|541112164|FG023|Substudy B|Lost to Follow-up|0|||
149994601|NCT01974206|541112165|FG000|Overall Study|Did Not Take Study Drug|0|||
149994602|NCT01974206|541112166|FG001|Overall Study|Did Not Take Study Drug|1|||
149994603|NCT01974206|541112165|FG000|Overall Study|Physician Decision|1|||
149994604|NCT01974206|541112166|FG001|Overall Study|Physician Decision|0|||
149994605|NCT01974206|541112165|FG000|Overall Study|Withdrawal by Subject|3|||
149994606|NCT01974206|541112166|FG001|Overall Study|Withdrawal by Subject|0|||
149994607|NCT01974206|541112165|FG000|Overall Study|Lost to Follow-up|1|||
149994608|NCT01974206|541112166|FG001|Overall Study|Lost to Follow-up|0|||
149994609|NCT01974206|541112165|FG000|Overall Study|Death|1|||
149994610|NCT01974206|541112166|FG001|Overall Study|Death|0|||
149994611|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
149994612|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149994613|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149994614|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149994615|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149994616|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
149994617|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
149994618|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
149994619|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149994620|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149994621|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149994622|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
149994623|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
150053962|NCT02925338|541338424|FG002|Overall Study|Participant's Decision|3|||
150053963|NCT02925338|541338425|FG003|Overall Study|Participant's Decision|8|||
150053964|NCT02925338|541338426|FG004|Overall Study|Participant's Decision|1|||
150053965|NCT02925338|541338422|FG000|Overall Study|Treatment Discontinuation|144|||
150053966|NCT02925338|541338423|FG001|Overall Study|Treatment Discontinuation|65|||
150053967|NCT02925338|541338424|FG002|Overall Study|Treatment Discontinuation|56|||
150053968|NCT02925338|541338425|FG003|Overall Study|Treatment Discontinuation|131|||
150053969|NCT02925338|541338426|FG004|Overall Study|Treatment Discontinuation|22|||
150053970|NCT00029146|541338429|FG000|Overall Study|Lost to Follow-up|2|||
150053971|NCT00029146|541338430|FG001|Overall Study|Lost to Follow-up|1|||
149994624|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
149994625|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
149994626|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
149994627|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
149994628|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
149994629|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
149994630|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
149994631|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149994632|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149994633|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149994634|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
149994635|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
149994636|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
149994637|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
149994638|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
149994639|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
149994640|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
149994641|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
149994642|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
149994643|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
149994644|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
149994645|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
149994646|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
149994647|NCT03989349|541112169|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
149994648|NCT03989349|541112170|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
149994649|NCT03989349|541112171|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
149994650|NCT03989349|541112172|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
149994651|NCT03989349|541112173|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
149994652|NCT03989349|541112174|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
149994653|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149994654|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149994655|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
149994656|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
149994657|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
149994658|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
149994659|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149994660|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149994661|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
149994662|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
149994663|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
149994664|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
149994665|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149994666|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149994667|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
149994668|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
149994669|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
149994670|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
149994671|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149994672|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149994673|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
150053972|NCT01765218|541338431|FG000|Overall Study|Protocol Violation|1|||
150053973|NCT01765218|541338432|FG001|Overall Study|Protocol Violation|2|||
150053974|NCT00313781|541338433|FG000|Before Crossover|Death|22|||
150179034|NCT01985334|541793925|FG002|Overall Study|Worsening of disease|0|||
149994674|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149994675|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
149994676|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149994677|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149994678|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149994679|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
149994680|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
149994681|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149994682|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
149994683|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
149994684|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
149994685|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
149994686|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
149994687|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
149994688|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
149994689|NCT03989349|541112169|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
149994690|NCT03989349|541112170|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
149994691|NCT03989349|541112171|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
149994692|NCT03989349|541112172|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
149994693|NCT03989349|541112173|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
149994694|NCT03989349|541112174|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
149994695|NCT02248649|541112177|FG000|Overall Study|Death|7|||
149994696|NCT02248649|541112178|FG001|Overall Study|Death|11|||
149994697|NCT02248649|541112177|FG000|Overall Study|Lost to Follow-up|14|||
149994698|NCT02248649|541112178|FG001|Overall Study|Lost to Follow-up|10|||
149994699|NCT02438683|541112181|FG000|Overall Study|Adverse Event|1|||
149994700|NCT02438683|541112182|FG001|Overall Study|Adverse Event|0|||
149994701|NCT02438683|541112183|FG002|Overall Study|Adverse Event|0|||
149994702|NCT02438683|541112184|FG003|Overall Study|Adverse Event|0|||
149994703|NCT02438683|541112185|FG004|Overall Study|Adverse Event|0|||
149994704|NCT02438683|541112186|FG005|Overall Study|Adverse Event|0|||
149994705|NCT00082368|541112193|FG000|Overall Study|Not treated-pt had poor IV access|1|||
149994706|NCT03559517|541112194|FG000|Overall Study|Withdrawal by Subject|1|||
149994707|NCT03559517|541112195|FG001|Overall Study|Withdrawal by Subject|0|||
149994708|NCT03559517|541112196|FG002|Overall Study|Withdrawal by Subject|0|||
149994709|NCT01846299|541112197|FG000|Overall Study|Physician Decision|4|||
149994710|NCT01846299|541112198|FG001|Overall Study|Physician Decision|2|||
149994711|NCT01846299|541112197|FG000|Overall Study|Protocol deviation|1|||
149994712|NCT01846299|541112198|FG001|Overall Study|Protocol deviation|0|||
149994713|NCT01846299|541112197|FG000|Overall Study|Death|1|||
149994714|NCT01846299|541112198|FG001|Overall Study|Death|2|||
149994715|NCT01846299|541112197|FG000|Overall Study|Lost to Follow-up|3|||
149994716|NCT01846299|541112198|FG001|Overall Study|Lost to Follow-up|0|||
149994717|NCT01846299|541112197|FG000|Overall Study|Withdrawal by Subject|1|||
149994718|NCT01846299|541112198|FG001|Overall Study|Withdrawal by Subject|6|||
149994719|NCT01846299|541112197|FG000|Overall Study|Adverse Event|2|||
149994720|NCT01846299|541112198|FG001|Overall Study|Adverse Event|0|||
149994721|NCT01330628|541112199|FG000|Overall Study|Death|2|||
149994722|NCT01330628|541112200|FG001|Overall Study|Death|3|||
150179035|NCT01985334|541793926|FG003|Overall Study|Worsening of disease|1|||
149994723|NCT01330628|541112199|FG000|Overall Study|Lost to Follow-up|5|||
149994724|NCT01330628|541112200|FG001|Overall Study|Lost to Follow-up|6|||
150179036|NCT01985334|541793927|FG004|Overall Study|Worsening of disease|0|||
150179037|NCT01985334|541793928|FG005|Overall Study|Worsening of disease|3|||
149994725|NCT01330628|541112199|FG000|Overall Study|Adverse Event|44|||
149994726|NCT01330628|541112200|FG001|Overall Study|Adverse Event|25|||
149994727|NCT01330628|541112199|FG000|Overall Study|Withdrawn|18|||
149994728|NCT01330628|541112200|FG001|Overall Study|Withdrawn|6|||
149994729|NCT01330628|541112199|FG000|Overall Study|Didn't receive study treatment|1|||
149994730|NCT01330628|541112200|FG001|Overall Study|Didn't receive study treatment|0|||
149994731|NCT03285958|541113934|FG000|Overall Study|Lost to Follow-up|1|||
149994732|NCT03285958|541113935|FG001|Overall Study|Lost to Follow-up|1|||
149994733|NCT03285958|541113934|FG000|Overall Study|Withdrawal by Subject|1|||
149994734|NCT03285958|541113935|FG001|Overall Study|Withdrawal by Subject|0|||
149994735|NCT03285958|541113934|FG000|Overall Study|Not able to attend required orientation|3|||
149994736|NCT03285958|541113935|FG001|Overall Study|Not able to attend required orientation|0|||
149994737|NCT03116828|541113936|FG000|Overall Study|Adverse Event|1|||
149994738|NCT03116828|541113937|FG001|Overall Study|Adverse Event|10|||
149994739|NCT03116828|541113936|FG000|Overall Study|Withdrawal by Subject|4|||
149994740|NCT03116828|541113937|FG001|Overall Study|Withdrawal by Subject|8|||
149994741|NCT03116828|541113936|FG000|Overall Study|OTHER|3|||
149994742|NCT03116828|541113937|FG001|Overall Study|OTHER|3|||
149994743|NCT05243745|541113938|FG000|Overall Study|Withdrawal by Subject|0|||
149994744|NCT05243745|541113939|FG001|Overall Study|Withdrawal by Subject|0|||
149994745|NCT05243745|541113940|FG002|Overall Study|Withdrawal by Subject|0|||
149994746|NCT05243745|541113941|FG003|Overall Study|Withdrawal by Subject|1|||
149994747|NCT05243745|541113938|FG000|Overall Study|Unable to Attend Visit 6|0|||
149994748|NCT05243745|541113939|FG001|Overall Study|Unable to Attend Visit 6|0|||
149994749|NCT05243745|541113940|FG002|Overall Study|Unable to Attend Visit 6|1|||
149994750|NCT05243745|541113941|FG003|Overall Study|Unable to Attend Visit 6|0|||
150179038|NCT01985334|541793929|FG006|Overall Study|Worsening of disease|0|||
150179039|NCT01985334|541793930|FG007|Overall Study|Worsening of disease|1|||
150179040|NCT01985334|541793923|FG000|Overall Study|Other|2|||
150179041|NCT01985334|541793924|FG001|Overall Study|Other|9|||
149994751|NCT02998203|541113942|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
149994752|NCT02998203|541113943|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
149994753|NCT02998203|541113942|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
149994754|NCT02998203|541113943|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
149994755|NCT04187144|541113954|FG000|Overall Study|Lost to Follow-up|12|||
149994756|NCT04187144|541113955|FG001|Overall Study|Lost to Follow-up|11|||
149994757|NCT04187144|541113954|FG000|Overall Study|Withdrawal by Subject|20|||
149994758|NCT04187144|541113955|FG001|Overall Study|Withdrawal by Subject|18|||
149994759|NCT04187144|541113954|FG000|Overall Study|Adverse Event|19|||
150179042|NCT01985334|541793925|FG002|Overall Study|Other|7|||
150179043|NCT01985334|541793926|FG003|Overall Study|Other|17|||
150179044|NCT01985334|541793927|FG004|Overall Study|Other|4|||
150179045|NCT01985334|541793928|FG005|Overall Study|Other|8|||
150179046|NCT01985334|541793929|FG006|Overall Study|Other|4|||
150179047|NCT01985334|541793930|FG007|Overall Study|Other|7|||
150179048|NCT01985334|541793923|FG000|Overall Study|Protocol deviation|6|||
150179049|NCT01985334|541793924|FG001|Overall Study|Protocol deviation|31|||
150179050|NCT01985334|541793925|FG002|Overall Study|Protocol deviation|25|||
150179051|NCT01985334|541793926|FG003|Overall Study|Protocol deviation|84|||
150179052|NCT01985334|541793927|FG004|Overall Study|Protocol deviation|17|||
150179053|NCT01985334|541793928|FG005|Overall Study|Protocol deviation|47|||
150179054|NCT01985334|541793929|FG006|Overall Study|Protocol deviation|15|||
150179055|NCT01985334|541793930|FG007|Overall Study|Protocol deviation|42|||
150179056|NCT01985334|541793923|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
150179057|NCT01985334|541793924|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
150179058|NCT01985334|541793925|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
150179059|NCT01985334|541793926|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
150179060|NCT01985334|541793927|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
150179061|NCT01985334|541793928|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
150179062|NCT01985334|541793929|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
150179063|NCT01985334|541793930|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
150179064|NCT01985334|541793923|FG000|Overall Study|Subject withdrawal of consent|3|||
150179065|NCT01985334|541793924|FG001|Overall Study|Subject withdrawal of consent|6|||
150179066|NCT01985334|541793925|FG002|Overall Study|Subject withdrawal of consent|2|||
150179067|NCT01985334|541793926|FG003|Overall Study|Subject withdrawal of consent|28|||
150179068|NCT01985334|541793927|FG004|Overall Study|Subject withdrawal of consent|4|||
149994760|NCT04187144|541113955|FG001|Overall Study|Adverse Event|4|||
149994761|NCT04187144|541113954|FG000|Overall Study|Physician Decision|5|||
149994762|NCT04187144|541113955|FG001|Overall Study|Physician Decision|3|||
149994763|NCT04187144|541113954|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
149994764|NCT04187144|541113955|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
149994765|NCT04187144|541113954|FG000|Overall Study|Protocol Deviation|1|||
149994766|NCT04187144|541113955|FG001|Overall Study|Protocol Deviation|4|||
149994767|NCT01044745|541113956|FG000|Overall Study|Ineiligible|2|||
149994768|NCT00789581|541113959|FG000|AC Therapy|Adverse Event|2|||
149994769|NCT00789581|541113960|FG001|AC Therapy|Adverse Event|3|||
150179069|NCT01985334|541793928|FG005|Overall Study|Subject withdrawal of consent|19|||
149994770|NCT00789581|541113959|FG000|AC Therapy|Withdrawal by Subject|4|||
149994771|NCT00789581|541113960|FG001|AC Therapy|Withdrawal by Subject|7|||
149994772|NCT00789581|541113959|FG000|AC Therapy|Disease recurrence|3|||
150179070|NCT01985334|541793929|FG006|Overall Study|Subject withdrawal of consent|0|||
150179071|NCT01985334|541793930|FG007|Overall Study|Subject withdrawal of consent|20|||
150179072|NCT01985334|541793923|FG000|Overall Study|Adverse Event|0|||
150179073|NCT01985334|541793924|FG001|Overall Study|Adverse Event|8|||
150179074|NCT01985334|541793925|FG002|Overall Study|Adverse Event|2|||
150179075|NCT01985334|541793926|FG003|Overall Study|Adverse Event|26|||
150179076|NCT01985334|541793927|FG004|Overall Study|Adverse Event|3|||
149994773|NCT00789581|541113960|FG001|AC Therapy|Disease recurrence|1|||
150179077|NCT01985334|541793928|FG005|Overall Study|Adverse Event|18|||
150179078|NCT01985334|541793929|FG006|Overall Study|Adverse Event|3|||
149994774|NCT00789581|541113959|FG000|AC Therapy|Intercurrent Illness|1|||
149994775|NCT00789581|541113960|FG001|AC Therapy|Intercurrent Illness|0|||
149994776|NCT00789581|541113959|FG000|AC Therapy|Never Treated|1|||
150179079|NCT01985334|541793930|FG007|Overall Study|Adverse Event|15|||
150179080|NCT01985334|541793923|FG000|Overall Study|Other|4|||
150179081|NCT01985334|541793924|FG001|Overall Study|Other|2|||
150179082|NCT01985334|541793925|FG002|Overall Study|Other|3|||
150179083|NCT01985334|541793926|FG003|Overall Study|Other|10|||
149994777|NCT00789581|541113960|FG001|AC Therapy|Never Treated|4|||
149994778|NCT00789581|541113959|FG000|AC Therapy|Other|0|||
149994779|NCT00789581|541113960|FG001|AC Therapy|Other|2|||
149994780|NCT00789581|541113959|FG000|Adjuvant Therapy|Never treated|2|||
149994781|NCT00789581|541113960|FG001|Adjuvant Therapy|Never treated|2|||
149994782|NCT00789581|541113959|FG000|Adjuvant Therapy|Adverse Event|20|||
149994783|NCT00789581|541113960|FG001|Adjuvant Therapy|Adverse Event|44|||
149994784|NCT00789581|541113959|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
149994785|NCT00789581|541113960|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
149994786|NCT00789581|541113959|FG000|Adjuvant Therapy|Disease recurrence|2|||
149994787|NCT00789581|541113960|FG001|Adjuvant Therapy|Disease recurrence|1|||
149994788|NCT00789581|541113959|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
149994789|NCT00789581|541113960|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
149994790|NCT00789581|541113959|FG000|Adjuvant Therapy|Protocol Violation|1|||
149994791|NCT00789581|541113960|FG001|Adjuvant Therapy|Protocol Violation|1|||
149994792|NCT00789581|541113959|FG000|Adjuvant Therapy|Other|0|||
149994793|NCT00789581|541113960|FG001|Adjuvant Therapy|Other|1|||
149994794|NCT03812185|541113964|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
149994795|NCT01681069|541113967|FG000|Overall Study|Withdrawal by Subject|4|||
149994796|NCT01681069|541113968|FG001|Overall Study|Withdrawal by Subject|5|||
149994797|NCT01681069|541113967|FG000|Overall Study|Protocol Violation|1|||
149994798|NCT01681069|541113968|FG001|Overall Study|Protocol Violation|1|||
149994799|NCT01681069|541113967|FG000|Overall Study|Adverse Event|0|||
149994800|NCT01681069|541113968|FG001|Overall Study|Adverse Event|1|||
149994801|NCT00245050|541113969|FG000|Overall Study|Adverse Event|3|||
149994802|NCT00245050|541113970|FG001|Overall Study|Adverse Event|2|||
149994803|NCT02301546|541113971|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
149994804|NCT02301546|541113972|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
149994805|NCT02301546|541113971|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
149994806|NCT02301546|541113972|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
149994807|NCT02301546|541113971|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
149994808|NCT02301546|541113972|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
149994809|NCT02301546|541113971|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
149994810|NCT02301546|541113972|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
149994811|NCT02301546|541113971|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
149994812|NCT02301546|541113972|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
149994813|NCT02301546|541113971|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
149994814|NCT02301546|541113972|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
149994815|NCT02301546|541113971|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
149994816|NCT02301546|541113972|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
149994817|NCT02449889|541113978|FG000|Overall Study|Adverse Event|1|||
149994818|NCT02449889|541113979|FG001|Overall Study|Adverse Event|2|||
149994819|NCT02449889|541113980|FG002|Overall Study|Adverse Event|0|||
149994820|NCT02449889|541113978|FG000|Overall Study|Protocol Violation|0|||
149994821|NCT02449889|541113979|FG001|Overall Study|Protocol Violation|4|||
149994822|NCT02449889|541113980|FG002|Overall Study|Protocol Violation|1|||
149994823|NCT01973387|541113981|FG000|Overall Study|Adverse Event|14|||
149994824|NCT01973387|541113982|FG001|Overall Study|Adverse Event|4|||
149994825|NCT01973387|541113981|FG000|Overall Study|Withdrawal by Subject|7|||
149994826|NCT01973387|541113982|FG001|Overall Study|Withdrawal by Subject|4|||
149994827|NCT01973387|541113981|FG000|Overall Study|Study terminated by sponsor|63|||
149994828|NCT01973387|541113982|FG001|Overall Study|Study terminated by sponsor|0|||
149994829|NCT01973387|541113981|FG000|Overall Study|Progressive disease or relapse|16|||
149994830|NCT01973387|541113982|FG001|Overall Study|Progressive disease or relapse|5|||
149994831|NCT01973387|541113981|FG000|Overall Study|Death|4|||
149994832|NCT01973387|541113982|FG001|Overall Study|Death|3|||
149994833|NCT01973387|541113981|FG000|Overall Study|Randomized, not treated|2|||
149994834|NCT01973387|541113982|FG001|Overall Study|Randomized, not treated|2|||
149994835|NCT01498575|541113983|FG000|Overall Sample|Withdrawal by Subject|60|||
149994836|NCT01498575|541113984|FG001|Overall Sample|Withdrawal by Subject|14|||
149994837|NCT01498575|541113983|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
149994838|NCT01498575|541113984|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
149994839|NCT01498575|541113983|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
149994840|NCT01498575|541113984|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
149994841|NCT03272828|541113992|FG000|Overall Study|Lost to Follow-up|7|||
150053975|NCT00313781|541338434|FG001|Before Crossover|Death|8|||
150053976|NCT00313781|541338435|FG002|Before Crossover|Death|0|||
149994842|NCT03272828|541113993|FG001|Overall Study|Lost to Follow-up|7|||
149994843|NCT03272828|541113992|FG000|Overall Study|Withdrawal by Subject|2|||
149994844|NCT03272828|541113993|FG001|Overall Study|Withdrawal by Subject|0|||
149994845|NCT03272828|541113992|FG000|Overall Study|Deceased|1|||
150053977|NCT00313781|541338433|FG000|Before Crossover|Lost to Follow-up|0|||
149994846|NCT03272828|541113993|FG001|Overall Study|Deceased|1|||
149994847|NCT03272828|541113992|FG000|Overall Study|Failed implant|1|||
149994848|NCT03272828|541113993|FG001|Overall Study|Failed implant|2|||
149994849|NCT03176472|541113994|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
150053978|NCT00313781|541338434|FG001|Before Crossover|Lost to Follow-up|3|||
149994850|NCT03176472|541113995|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
149994851|NCT03176472|541113994|FG000|Double Blind Treatment Period|Adverse Event|0|||
149994852|NCT03176472|541113995|FG001|Double Blind Treatment Period|Adverse Event|5|||
149994853|NCT03176472|541113994|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
149994854|NCT03176472|541113995|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149994855|NCT03176472|541113994|FG000|Double Blind Treatment Period|Physician Decision|0|||
149994856|NCT03176472|541113995|FG001|Double Blind Treatment Period|Physician Decision|1|||
149994857|NCT03176472|541113994|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149994858|NCT03176472|541113995|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149994859|NCT03176472|541113994|FG000|Double Blind Treatment Period|Not Provided|1|||
149994860|NCT03176472|541113995|FG001|Double Blind Treatment Period|Not Provided|0|||
149994861|NCT03176472|541113994|FG000|Open Label Extension|Withdrawal by Subject|3|||
149994862|NCT03176472|541113995|FG001|Open Label Extension|Withdrawal by Subject|4|||
149994863|NCT03176472|541113994|FG000|Open Label Extension|Adverse Event|2|||
149994864|NCT03176472|541113995|FG001|Open Label Extension|Adverse Event|4|||
149994865|NCT03176472|541113994|FG000|Open Label Extension|Lost to Follow-up|1|||
149994866|NCT03176472|541113995|FG001|Open Label Extension|Lost to Follow-up|2|||
149994867|NCT03176472|541113994|FG000|Open Label Extension|Protocol Violation|0|||
149994868|NCT03176472|541113995|FG001|Open Label Extension|Protocol Violation|1|||
149994869|NCT03176472|541113994|FG000|Open Label Extension|Not Provided|2|||
149994870|NCT03176472|541113995|FG001|Open Label Extension|Not Provided|1|||
149994871|NCT00847665|541113996|FG000|Overall Study|Withdrawal by Subject|1|||
149994872|NCT00847665|541113997|FG001|Overall Study|Withdrawal by Subject|0|||
149994873|NCT00624585|541114008|FG000|Overall Study|Death|3|||
149994874|NCT00624585|541114008|FG000|Overall Study|Disease Progression|6|||
149994875|NCT00624585|541114008|FG000|Overall Study|Adverse Event|3|||
149994876|NCT04295681|541114009|FG000|Overall Study|Eligibility error|1|||
149994877|NCT04295681|541114010|FG001|Overall Study|Eligibility error|3|||
149994878|NCT04154345|541114011|FG000|Overall Study|Covid-19 pandemic|4|||
149994879|NCT04686084|541114016|FG000|Overall Study|Lost to Follow-up|1|||
149994880|NCT03172325|541114021|FG000|Overall Study|Adverse Event|2|||
149994881|NCT03172325|541114022|FG001|Overall Study|Adverse Event|3|||
149994882|NCT03172325|541114021|FG000|Overall Study|Positive PPD|1|||
149994883|NCT03172325|541114022|FG001|Overall Study|Positive PPD|0|||
149994884|NCT03172325|541114021|FG000|Overall Study|Poor Compliance|1|||
149994885|NCT03172325|541114022|FG001|Overall Study|Poor Compliance|1|||
149994886|NCT01694121|541114026|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
149994887|NCT01694121|541114027|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
149994888|NCT00744978|541114028|FG000|Period 1|Lost to Follow-up|1|||
149994889|NCT00744978|541114029|FG001|Period 1|Lost to Follow-up|0|||
149994890|NCT00744978|541114028|FG000|Period 1|Withdrawal by Subject|0|||
149994891|NCT00744978|541114029|FG001|Period 1|Withdrawal by Subject|2|||
149994892|NCT00744978|541114028|FG000|Period 1|Other|0|||
149994893|NCT00744978|541114029|FG001|Period 1|Other|2|||
149994894|NCT00744978|541114028|FG000|Period 1|Adverse Event|4|||
149994895|NCT00744978|541114029|FG001|Period 1|Adverse Event|0|||
149994896|NCT00744978|541114028|FG000|Period 1|Randomized but not Treated|1|||
149994897|NCT00744978|541114029|FG001|Period 1|Randomized but not Treated|1|||
149994898|NCT00744978|541114028|FG000|Period 2|Adverse Event|0|||
149994899|NCT00744978|541114029|FG001|Period 2|Adverse Event|1|||
149994900|NCT03773133|541114033|FG000|Overall Study|Screen Failure|8|||
149994901|NCT00866047|541114034|FG000|Treatment Period|Progressive disease|13|||
149994902|NCT00866047|541114034|FG000|Treatment Period|Adverse Event|16|||
149994903|NCT00866047|541114034|FG000|Treatment Period|Physician Decision|14|||
149994904|NCT00866047|541114034|FG000|Treatment Period|Withdrawal by Subject|5|||
149994905|NCT00866047|541114034|FG000|Follow-up Period|Lost to Follow-up|5|||
149994906|NCT00503776|541114035|FG000|Overall Study|Withdrawal by Subject|1|||
149994907|NCT00503776|541114036|FG001|Overall Study|Withdrawal by Subject|0|||
149994908|NCT00503776|541114037|FG002|Overall Study|Withdrawal by Subject|1|||
149994909|NCT00503776|541114038|FG003|Overall Study|Withdrawal by Subject|1|||
149994910|NCT00503776|541114035|FG000|Overall Study|Physician Decision|0|||
149994911|NCT00503776|541114036|FG001|Overall Study|Physician Decision|0|||
149994912|NCT00503776|541114037|FG002|Overall Study|Physician Decision|1|||
149994913|NCT00503776|541114038|FG003|Overall Study|Physician Decision|1|||
149994914|NCT01895543|541114041|FG000|Overall Study|Withdrawal by Subject|43|||
149994915|NCT01895543|541114041|FG000|Overall Study|Lost to Follow-up|25|||
149994916|NCT01895543|541114041|FG000|Overall Study|Adverse Event|28|||
149994917|NCT01895543|541114041|FG000|Overall Study|Subject's substantial non-compliance|6|||
150053979|NCT00313781|541338435|FG002|Before Crossover|Lost to Follow-up|0|||
150053980|NCT00313781|541338433|FG000|Before Crossover|Withdrawal by Subject|3|||
150053981|NCT00313781|541338434|FG001|Before Crossover|Withdrawal by Subject|1|||
149994918|NCT01895543|541114041|FG000|Overall Study|Protocol Violation|1|||
149994919|NCT01895543|541114041|FG000|Overall Study|Physician Decision|2|||
149994920|NCT01895543|541114041|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
149994921|NCT04659174|541114046|FG000|Overall Study|Sponsor decision to discontinue study|0|||
150053982|NCT00313781|541338435|FG002|Before Crossover|Withdrawal by Subject|0|||
149994922|NCT04659174|541114047|FG001|Overall Study|Sponsor decision to discontinue study|2|||
149994923|NCT04659174|541114046|FG000|Overall Study|Lost to Follow-up|9|||
149994924|NCT04659174|541114047|FG001|Overall Study|Lost to Follow-up|11|||
149994925|NCT04659174|541114046|FG000|Overall Study|Adverse Event|8|||
149994926|NCT04659174|541114047|FG001|Overall Study|Adverse Event|5|||
149994927|NCT04659174|541114046|FG000|Overall Study|Withdrawal by Subject|17|||
149994928|NCT04659174|541114047|FG001|Overall Study|Withdrawal by Subject|33|||
149994929|NCT04659174|541114046|FG000|Overall Study|Progressive disease|0|||
149994930|NCT04659174|541114047|FG001|Overall Study|Progressive disease|2|||
149994931|NCT04659174|541114046|FG000|Overall Study|Other reasons|0|||
149994932|NCT04659174|541114047|FG001|Overall Study|Other reasons|2|||
149994933|NCT04659174|541114046|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
149994934|NCT04659174|541114047|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
149994935|NCT04659174|541114046|FG000|Overall Study|Alcohol or illegal drug use|0|||
149994936|NCT04659174|541114047|FG001|Overall Study|Alcohol or illegal drug use|3|||
149994937|NCT04659174|541114046|FG000|Overall Study|Violation of entry criteria|1|||
149994938|NCT04659174|541114047|FG001|Overall Study|Violation of entry criteria|0|||
149994939|NCT04659174|541114046|FG000|Overall Study|Death|0|||
149994940|NCT04659174|541114047|FG001|Overall Study|Death|1|||
149994941|NCT03276026|541114050|FG000|Overall Study|Protocol Violation|1|||
149994942|NCT03276026|541114051|FG001|Overall Study|Protocol Violation|0|||
149994943|NCT01534260|541114052|FG000|Overall Study|Adverse Event|1|||
149994944|NCT01534260|541114053|FG001|Overall Study|Adverse Event|8|||
149994945|NCT01534260|541114052|FG000|Overall Study|Death|2|||
149994946|NCT01534260|541114053|FG001|Overall Study|Death|0|||
149994947|NCT01534260|541114052|FG000|Overall Study|Lack of Efficacy|1|||
149994948|NCT01534260|541114053|FG001|Overall Study|Lack of Efficacy|1|||
149994949|NCT01534260|541114052|FG000|Overall Study|Withdrawal by Subject|1|||
149994950|NCT01534260|541114053|FG001|Overall Study|Withdrawal by Subject|3|||
149994951|NCT01534260|541114052|FG000|Overall Study|Disease Progression|8|||
149994952|NCT01534260|541114053|FG001|Overall Study|Disease Progression|6|||
149994953|NCT01534260|541114052|FG000|Overall Study|Physician Decision|3|||
149994954|NCT01534260|541114053|FG001|Overall Study|Physician Decision|1|||
149994955|NCT01534260|541114052|FG000|Overall Study|No treatment, per protocol|0|||
149994956|NCT01534260|541114053|FG001|Overall Study|No treatment, per protocol|1|||
149994957|NCT00503581|541114054|FG000|Overall Study|Study closed|3|||
149994958|NCT00503581|541114055|FG001|Overall Study|Study closed|4|||
149994959|NCT00503581|541114056|FG002|Overall Study|Study closed|2|||
149994960|NCT01301066|541114058|FG000|Overall Study|Lost to Follow-up|5|||
149994961|NCT01301066|541114059|FG001|Overall Study|Lost to Follow-up|11|||
149994962|NCT01301066|541114058|FG000|Overall Study|Protocol Violation|8|||
149994963|NCT01301066|541114059|FG001|Overall Study|Protocol Violation|7|||
149994964|NCT01301066|541114058|FG000|Overall Study|Withdrawal by Subject|4|||
149994965|NCT01301066|541114059|FG001|Overall Study|Withdrawal by Subject|9|||
149994966|NCT01301066|541114058|FG000|Overall Study|Adverse Event|6|||
149994967|NCT01301066|541114059|FG001|Overall Study|Adverse Event|6|||
149994968|NCT01301066|541114058|FG000|Overall Study|Sponsor Decision|2|||
149994969|NCT01301066|541114059|FG001|Overall Study|Sponsor Decision|1|||
149994970|NCT01301066|541114058|FG000|Overall Study|Physician Decision|0|||
149994971|NCT01301066|541114059|FG001|Overall Study|Physician Decision|1|||
149994972|NCT01301066|541114058|FG000|Overall Study|Other|2|||
149994973|NCT01301066|541114059|FG001|Overall Study|Other|0|||
149994974|NCT04934800|541114062|FG000|Overall Study|Other|1|||
149994975|NCT04934800|541114062|FG000|Overall Study|Withdrawal by Subject|5|||
149994976|NCT04934800|541114062|FG000|Overall Study|Lack of Efficacy|1|||
149994977|NCT04934800|541114062|FG000|Overall Study|Adverse Event|9|||
149994978|NCT04934800|541114062|FG000|Overall Study|Lost to Follow-up|5|||
149994979|NCT04934800|541114062|FG000|Overall Study|Enrolled but not treated|1|||
149994980|NCT02684058|541114066|FG000|Treatment Period|Progressive disease|4|||
149994981|NCT02684058|541114067|FG001|Treatment Period|Progressive disease|10|||
149994982|NCT02684058|541114068|FG002|Treatment Period|Progressive disease|19|||
149994983|NCT02684058|541114066|FG000|Treatment Period|Adverse Event|3|||
149994984|NCT02684058|541114067|FG001|Treatment Period|Adverse Event|8|||
149994985|NCT02684058|541114068|FG002|Treatment Period|Adverse Event|1|||
149994986|NCT02684058|541114066|FG000|Treatment Period|Physician Decision|5|||
149994987|NCT02684058|541114067|FG001|Treatment Period|Physician Decision|1|||
149994988|NCT02684058|541114068|FG002|Treatment Period|Physician Decision|2|||
149994989|NCT02684058|541114066|FG000|Treatment Period|New therapy for study indication|1|||
149994990|NCT02684058|541114067|FG001|Treatment Period|New therapy for study indication|0|||
149994991|NCT02684058|541114068|FG002|Treatment Period|New therapy for study indication|0|||
149994992|NCT02684058|541114066|FG000|Treatment Period|Protocol deviation|0|||
149994993|NCT02684058|541114067|FG001|Treatment Period|Protocol deviation|1|||
149994994|NCT02684058|541114068|FG002|Treatment Period|Protocol deviation|0|||
149994995|NCT02684058|541114066|FG000|Treatment Period|Subject/guardian decision|4|||
149994996|NCT02684058|541114067|FG001|Treatment Period|Subject/guardian decision|3|||
149994997|NCT02684058|541114068|FG002|Treatment Period|Subject/guardian decision|0|||
149994998|NCT02684058|541114066|FG000|Treatment Period|Death|0|||
149994999|NCT02684058|541114067|FG001|Treatment Period|Death|0|||
149995000|NCT02684058|541114068|FG002|Treatment Period|Death|2|||
149995001|NCT02684058|541114066|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149995002|NCT02684058|541114067|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
149995003|NCT02684058|541114068|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
149995004|NCT02684058|541114066|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
149995005|NCT02684058|541114067|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
149995006|NCT02684058|541114068|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
149995007|NCT02684058|541114066|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
149995008|NCT02684058|541114067|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
149995009|NCT02684058|541114068|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
149995010|NCT02684058|541114066|FG000|Post-treatment Efficacy Follow-up|Death|0|||
149995011|NCT02684058|541114067|FG001|Post-treatment Efficacy Follow-up|Death|0|||
149995012|NCT02684058|541114068|FG002|Post-treatment Efficacy Follow-up|Death|3|||
149995013|NCT02684058|541114066|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
149995014|NCT02684058|541114067|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
149995015|NCT02684058|541114068|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
149995016|NCT02684058|541114066|FG000|Post-treatment Survival Follow-up|Death|0|||
149995017|NCT02684058|541114067|FG001|Post-treatment Survival Follow-up|Death|0|||
149995018|NCT02684058|541114068|FG002|Post-treatment Survival Follow-up|Death|7|||
149995019|NCT02684058|541114066|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
149995020|NCT02684058|541114067|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
149995021|NCT02684058|541114068|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
149995022|NCT02684058|541114066|FG000|Crossover Treatment Period|Progressive disease|0|||
149995023|NCT02684058|541114067|FG001|Crossover Treatment Period|Progressive disease|1|||
149995024|NCT02684058|541114068|FG002|Crossover Treatment Period|Progressive disease|0|||
149995025|NCT03219034|541114069|FG000|Overall Study|Lost to Follow-up|9|||
149995026|NCT03219034|541114070|FG001|Overall Study|Lost to Follow-up|13|||
149995027|NCT03219034|541114069|FG000|Overall Study|Additional dental work needed|1|||
149995028|NCT03219034|541114070|FG001|Overall Study|Additional dental work needed|0|||
149995029|NCT03219034|541114069|FG000|Overall Study|UPPP Surgery|1|||
149995030|NCT03219034|541114070|FG001|Overall Study|UPPP Surgery|0|||
149995031|NCT03219034|541114069|FG000|Overall Study|Dental sensitivity|0|||
149995032|NCT03219034|541114070|FG001|Overall Study|Dental sensitivity|1|||
149995033|NCT03219034|541114069|FG000|Overall Study|Death in family|0|||
149995034|NCT03219034|541114070|FG001|Overall Study|Death in family|1|||
149995035|NCT01327053|541114071|FG000|Overall Study|Adverse Event|23|||
149995036|NCT01327053|541114072|FG001|Overall Study|Adverse Event|57|||
149995037|NCT01327053|541114071|FG000|Overall Study|Patient/guardian decision|11|||
149995038|NCT01327053|541114072|FG001|Overall Study|Patient/guardian decision|35|||
149995039|NCT01327053|541114071|FG000|Overall Study|Physician Decision|10|||
149995040|NCT01327053|541114072|FG001|Overall Study|Physician Decision|14|||
149995041|NCT01327053|541114071|FG000|Overall Study|Death|1|||
149995042|NCT01327053|541114072|FG001|Overall Study|Death|5|||
149995043|NCT01327053|541114071|FG000|Overall Study|Lost to Follow-up|2|||
149995044|NCT01327053|541114072|FG001|Overall Study|Lost to Follow-up|4|||
149995045|NCT01327053|541114071|FG000|Overall Study|Non-compliance with study treatment|0|||
149995046|NCT01327053|541114072|FG001|Overall Study|Non-compliance with study treatment|5|||
149995047|NCT01327053|541114071|FG000|Overall Study|Study terminated by Sponsor|1|||
149995048|NCT01327053|541114072|FG001|Overall Study|Study terminated by Sponsor|3|||
149995049|NCT01327053|541114071|FG000|Overall Study|Progressive disease|31|||
149995050|NCT01327053|541114072|FG001|Overall Study|Progressive disease|26|||
149995051|NCT01327053|541114071|FG000|Overall Study|Protocol Violation|0|||
149995052|NCT01327053|541114072|FG001|Overall Study|Protocol Violation|1|||
149995053|NCT01327053|541114071|FG000|Overall Study|Untreated|0|||
149995054|NCT01327053|541114072|FG001|Overall Study|Untreated|1|||
149995055|NCT00983515|541115679|FG000|Ritonavir Alone|liver panel out of range|6|||
149995056|NCT00983515|541115679|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
149995057|NCT02264665|541115682|FG000|Overall Study|Other|0|||
149995058|NCT02264665|541115683|FG001|Overall Study|Other|0|||
149995059|NCT02264665|541115684|FG002|Overall Study|Other|3|||
149995060|NCT02264665|541115685|FG003|Overall Study|Other|0|||
149995061|NCT02264665|541115686|FG004|Overall Study|Other|0|||
149995062|NCT02264665|541115687|FG005|Overall Study|Other|0|||
149995063|NCT02264665|541115688|FG006|Overall Study|Other|0|||
149995064|NCT02264665|541115682|FG000|Overall Study|Death|9|||
149995065|NCT02264665|541115683|FG001|Overall Study|Death|8|||
149995066|NCT02264665|541115684|FG002|Overall Study|Death|13|||
149995067|NCT02264665|541115685|FG003|Overall Study|Death|5|||
149995068|NCT02264665|541115686|FG004|Overall Study|Death|0|||
149995069|NCT02264665|541115687|FG005|Overall Study|Death|0|||
149995070|NCT02264665|541115688|FG006|Overall Study|Death|1|||
149995071|NCT02264665|541115682|FG000|Overall Study|Lost to Follow-up|1|||
149995072|NCT02264665|541115683|FG001|Overall Study|Lost to Follow-up|0|||
149995073|NCT02264665|541115684|FG002|Overall Study|Lost to Follow-up|2|||
149995074|NCT02264665|541115685|FG003|Overall Study|Lost to Follow-up|1|||
149995075|NCT02264665|541115686|FG004|Overall Study|Lost to Follow-up|0|||
149995076|NCT02264665|541115687|FG005|Overall Study|Lost to Follow-up|0|||
149995077|NCT02264665|541115688|FG006|Overall Study|Lost to Follow-up|0|||
149995078|NCT02264665|541115682|FG000|Overall Study|Participant decision|0|||
149995079|NCT02264665|541115683|FG001|Overall Study|Participant decision|0|||
149995080|NCT02264665|541115684|FG002|Overall Study|Participant decision|0|||
149995081|NCT02264665|541115685|FG003|Overall Study|Participant decision|1|||
149995082|NCT02264665|541115686|FG004|Overall Study|Participant decision|0|||
149995083|NCT02264665|541115687|FG005|Overall Study|Participant decision|0|||
149995084|NCT02264665|541115688|FG006|Overall Study|Participant decision|0|||
149995085|NCT02264665|541115682|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
149995086|NCT02264665|541115683|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
149995087|NCT02264665|541115684|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
149995088|NCT02264665|541115685|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
149995089|NCT02264665|541115686|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
149995090|NCT02264665|541115687|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
149995091|NCT02264665|541115688|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
149995092|NCT02264665|541115682|FG000|Overall Study|Data Missing|0|||
149995093|NCT02264665|541115683|FG001|Overall Study|Data Missing|0|||
149995094|NCT02264665|541115684|FG002|Overall Study|Data Missing|1|||
149995095|NCT02264665|541115685|FG003|Overall Study|Data Missing|0|||
149995096|NCT02264665|541115686|FG004|Overall Study|Data Missing|0|||
149995097|NCT02264665|541115687|FG005|Overall Study|Data Missing|0|||
149995098|NCT02264665|541115688|FG006|Overall Study|Data Missing|0|||
149995099|NCT01468207|541115689|FG000|Treatment Period 1|Adverse Event|1|||
149995100|NCT01468207|541115690|FG001|Treatment Period 1|Adverse Event|0|||
149995101|NCT01468207|541115691|FG002|Treatment Period 1|Adverse Event|0|||
149995102|NCT01468207|541115692|FG003|Treatment Period 1|Adverse Event|0|||
149995103|NCT01468207|541115693|FG004|Treatment Period 1|Adverse Event|0|||
149995104|NCT01468207|541115694|FG005|Treatment Period 1|Adverse Event|0|||
149995105|NCT01468207|541115689|FG000|Treatment Period 1|Protocol Violation|1|||
149995106|NCT01468207|541115690|FG001|Treatment Period 1|Protocol Violation|1|||
149995107|NCT01468207|541115691|FG002|Treatment Period 1|Protocol Violation|0|||
149995108|NCT01468207|541115692|FG003|Treatment Period 1|Protocol Violation|0|||
149995109|NCT01468207|541115693|FG004|Treatment Period 1|Protocol Violation|0|||
149995110|NCT01468207|541115694|FG005|Treatment Period 1|Protocol Violation|0|||
149995111|NCT01468207|541115689|FG000|Treatment Period 1|Withdrawal by Subject|5|||
149995112|NCT01468207|541115690|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149995113|NCT01468207|541115691|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149995114|NCT01468207|541115692|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149995115|NCT01468207|541115693|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149995116|NCT01468207|541115694|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149995117|NCT01468207|541115689|FG000|Treatment Period 1|Lost to Follow-up|2|||
149995118|NCT01468207|541115690|FG001|Treatment Period 1|Lost to Follow-up|1|||
149995119|NCT01468207|541115691|FG002|Treatment Period 1|Lost to Follow-up|0|||
149995120|NCT01468207|541115692|FG003|Treatment Period 1|Lost to Follow-up|0|||
149995121|NCT01468207|541115693|FG004|Treatment Period 1|Lost to Follow-up|0|||
149995122|NCT01468207|541115694|FG005|Treatment Period 1|Lost to Follow-up|0|||
149995123|NCT01468207|541115689|FG000|Treatment Period 1|Other|0|||
149995124|NCT01468207|541115690|FG001|Treatment Period 1|Other|2|||
149995125|NCT01468207|541115691|FG002|Treatment Period 1|Other|0|||
149995126|NCT01468207|541115692|FG003|Treatment Period 1|Other|0|||
149995127|NCT01468207|541115693|FG004|Treatment Period 1|Other|0|||
149995128|NCT01468207|541115694|FG005|Treatment Period 1|Other|0|||
149995129|NCT01468207|541115689|FG000|Treatment Period 2|Adverse Event|0|||
149995130|NCT01468207|541115690|FG001|Treatment Period 2|Adverse Event|0|||
149995131|NCT01468207|541115691|FG002|Treatment Period 2|Adverse Event|6|||
149995132|NCT01468207|541115692|FG003|Treatment Period 2|Adverse Event|1|||
149995133|NCT01468207|541115693|FG004|Treatment Period 2|Adverse Event|2|||
149995134|NCT01468207|541115694|FG005|Treatment Period 2|Adverse Event|1|||
149995135|NCT01468207|541115689|FG000|Treatment Period 2|Lack of Efficacy|0|||
149995136|NCT01468207|541115690|FG001|Treatment Period 2|Lack of Efficacy|0|||
149995137|NCT01468207|541115691|FG002|Treatment Period 2|Lack of Efficacy|1|||
150053983|NCT00313781|541338433|FG000|Before Crossover|Other|45|||
150179084|NCT01985334|541793927|FG004|Overall Study|Other|1|||
149995138|NCT01468207|541115692|FG003|Treatment Period 2|Lack of Efficacy|1|||
149995139|NCT01468207|541115693|FG004|Treatment Period 2|Lack of Efficacy|0|||
149995140|NCT01468207|541115694|FG005|Treatment Period 2|Lack of Efficacy|2|||
149995141|NCT01468207|541115689|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149995142|NCT01468207|541115690|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149995143|NCT01468207|541115691|FG002|Treatment Period 2|Withdrawal by Subject|5|||
149995144|NCT01468207|541115692|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150053984|NCT00313781|541338434|FG001|Before Crossover|Other|30|||
150053985|NCT00313781|541338435|FG002|Before Crossover|Other|0|||
150053986|NCT00313781|541338433|FG000|Before Crossover|Crossover|0|||
150053987|NCT00313781|541338434|FG001|Before Crossover|Crossover|37|||
150053988|NCT00313781|541338435|FG002|Before Crossover|Crossover|0|||
149995145|NCT01468207|541115693|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149995146|NCT01468207|541115694|FG005|Treatment Period 2|Withdrawal by Subject|2|||
149995147|NCT01468207|541115689|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
149995148|NCT01468207|541115690|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
149995149|NCT01468207|541115691|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
149995150|NCT01468207|541115692|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
149995151|NCT01468207|541115693|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
149995152|NCT01468207|541115694|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
149995153|NCT01468207|541115689|FG000|Treatment Period 2|Lost to Follow-up|0|||
149995154|NCT01468207|541115690|FG001|Treatment Period 2|Lost to Follow-up|0|||
149995155|NCT01468207|541115691|FG002|Treatment Period 2|Lost to Follow-up|5|||
149995156|NCT01468207|541115692|FG003|Treatment Period 2|Lost to Follow-up|1|||
149995157|NCT01468207|541115693|FG004|Treatment Period 2|Lost to Follow-up|0|||
149995158|NCT01468207|541115694|FG005|Treatment Period 2|Lost to Follow-up|0|||
149995159|NCT01468207|541115689|FG000|Treatment Period 2|Other|0|||
149995160|NCT01468207|541115690|FG001|Treatment Period 2|Other|0|||
149995161|NCT01468207|541115691|FG002|Treatment Period 2|Other|5|||
149995162|NCT01468207|541115692|FG003|Treatment Period 2|Other|1|||
149995163|NCT01468207|541115693|FG004|Treatment Period 2|Other|1|||
149995164|NCT01468207|541115694|FG005|Treatment Period 2|Other|2|||
149995165|NCT01967823|541115697|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
149995166|NCT00413894|541115702|FG000|Overall Study|Withdrawal by Subject|10|||
149995167|NCT00413894|541115702|FG000|Overall Study|Administrative Reasons|1|||
149995168|NCT00413894|541115702|FG000|Overall Study|Hb <10 grams/deciliter|12|||
149995169|NCT00413894|541115702|FG000|Overall Study|Adverse Event|28|||
149995170|NCT00413894|541115702|FG000|Overall Study|Protocol Violation|11|||
149995171|NCT00413894|541115702|FG000|Overall Study|Other|18|||
149995172|NCT04225676|541115703|FG000|Overall Study|Physician Decision|1|||
149995173|NCT04225676|541115703|FG000|Overall Study|Lack of Efficacy|1|||
149995174|NCT04225676|541115703|FG000|Overall Study|Study terminated by sponsor|3|||
149995175|NCT05289271|541115708|FG000|Overall Study|Mistakenly allocated, untreated|1|||
149995176|NCT05289271|541115709|FG001|Overall Study|Mistakenly allocated, untreated|0|||
149995177|NCT03356977|541115712|FG000|Overall Study|Lost to Follow-up|3|||
149995178|NCT03356977|541115712|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149995179|NCT00515294|541115726|FG000|Overall Study|Lost to Follow-up|3|||
149995180|NCT00515294|541115727|FG001|Overall Study|Lost to Follow-up|2|||
149995181|NCT00515294|541115728|FG002|Overall Study|Lost to Follow-up|3|||
149995182|NCT00515294|541115729|FG003|Overall Study|Lost to Follow-up|1|||
149995183|NCT00515294|541115726|FG000|Overall Study|Driver simulator problems|1|||
149995184|NCT00515294|541115727|FG001|Overall Study|Driver simulator problems|1|||
149995185|NCT00515294|541115728|FG002|Overall Study|Driver simulator problems|1|||
149995186|NCT00515294|541115729|FG003|Overall Study|Driver simulator problems|3|||
149995187|NCT00515294|541115726|FG000|Overall Study|Caffeine amount inaccurate|5|||
149995188|NCT00515294|541115727|FG001|Overall Study|Caffeine amount inaccurate|0|||
149995189|NCT00515294|541115728|FG002|Overall Study|Caffeine amount inaccurate|7|||
149995190|NCT00515294|541115729|FG003|Overall Study|Caffeine amount inaccurate|0|||
149995191|NCT03770728|541115734|FG000|Overall Study|Adverse Event|1|||
149995192|NCT03770728|541115735|FG001|Overall Study|Adverse Event|0|||
149995193|NCT03770728|541115736|FG002|Overall Study|Adverse Event|1|||
149995194|NCT03770728|541115737|FG003|Overall Study|Adverse Event|0|||
149995195|NCT03770728|541115734|FG000|Overall Study|Poor compliance to protocol|0|||
149995196|NCT03770728|541115735|FG001|Overall Study|Poor compliance to protocol|0|||
149995197|NCT03770728|541115736|FG002|Overall Study|Poor compliance to protocol|1|||
149995198|NCT03770728|541115737|FG003|Overall Study|Poor compliance to protocol|0|||
149995199|NCT03770728|541115734|FG000|Overall Study|Withdrawal by Subject|13|||
150053989|NCT00313781|541338433|FG000|Before Crossover|Randomized, not treated|5|||
149995200|NCT03770728|541115735|FG001|Overall Study|Withdrawal by Subject|8|||
150053990|NCT00313781|541338434|FG001|Before Crossover|Randomized, not treated|0|||
149995201|NCT03770728|541115736|FG002|Overall Study|Withdrawal by Subject|9|||
149995202|NCT03770728|541115737|FG003|Overall Study|Withdrawal by Subject|13|||
149995203|NCT03770728|541115734|FG000|Overall Study|Other than specified|24|||
149995204|NCT03770728|541115735|FG001|Overall Study|Other than specified|23|||
149995205|NCT03770728|541115736|FG002|Overall Study|Other than specified|21|||
150053991|NCT00313781|541338435|FG002|Before Crossover|Randomized, not treated|0|||
149995206|NCT03770728|541115737|FG003|Overall Study|Other than specified|22|||
149995207|NCT02778555|541115738|FG000|Overall Study|Withdrawal by Subject|55|||
149995208|NCT02778555|541115739|FG001|Overall Study|Withdrawal by Subject|32|||
150053992|NCT00313781|541338433|FG000|After Crossover|Death|0|||
149995209|NCT02778555|541115740|FG002|Overall Study|Withdrawal by Subject|107|||
149995210|NCT02379988|541115741|FG000|Overall Study|Not eligible|1|||
149995211|NCT00107315|541115742|FG000|Overall Study|Disease Progression|9|||
149995212|NCT00107315|541115742|FG000|Overall Study|Adverse Event|4|||
149995213|NCT00107315|541115742|FG000|Overall Study|Withdrawal by Subject|2|||
149995214|NCT02509039|541115745|FG000|Overall Study|Adverse Event|0|||
149995215|NCT02509039|541115746|FG001|Overall Study|Adverse Event|1|||
149995216|NCT02509039|541115747|FG002|Overall Study|Adverse Event|1|||
149995217|NCT02509039|541115748|FG003|Overall Study|Adverse Event|1|||
149995218|NCT02509039|541115745|FG000|Overall Study|Withdrawal by Subject|0|||
149995219|NCT02509039|541115746|FG001|Overall Study|Withdrawal by Subject|0|||
149995220|NCT02509039|541115747|FG002|Overall Study|Withdrawal by Subject|1|||
149995221|NCT02509039|541115748|FG003|Overall Study|Withdrawal by Subject|0|||
149995222|NCT02509039|541115745|FG000|Overall Study|Progressive disease|2|||
149995223|NCT02509039|541115746|FG001|Overall Study|Progressive disease|2|||
149995224|NCT02509039|541115747|FG002|Overall Study|Progressive disease|1|||
149995225|NCT02509039|541115748|FG003|Overall Study|Progressive disease|5|||
149995226|NCT02509039|541115745|FG000|Overall Study|Study terminated by Sponsor|1|||
149995227|NCT02509039|541115746|FG001|Overall Study|Study terminated by Sponsor|0|||
149995228|NCT02509039|541115747|FG002|Overall Study|Study terminated by Sponsor|0|||
149995229|NCT02509039|541115748|FG003|Overall Study|Study terminated by Sponsor|0|||
149995230|NCT03943550|541115751|FG000|Overall Study|Adverse Event|0|||
149995231|NCT03943550|541115752|FG001|Overall Study|Adverse Event|0|||
149995232|NCT03943550|541115753|FG002|Overall Study|Adverse Event|1|||
149995233|NCT03943550|541115751|FG000|Overall Study|Lost to Follow-up|0|||
149995234|NCT03943550|541115752|FG001|Overall Study|Lost to Follow-up|0|||
149995235|NCT03943550|541115753|FG002|Overall Study|Lost to Follow-up|1|||
149995236|NCT03943550|541115751|FG000|Overall Study|Progressive Disease|0|||
149995237|NCT03943550|541115752|FG001|Overall Study|Progressive Disease|0|||
149995238|NCT03943550|541115753|FG002|Overall Study|Progressive Disease|2|||
149995239|NCT03943550|541115751|FG000|Overall Study|Participant Moved Out of the Country|0|||
149995240|NCT03943550|541115752|FG001|Overall Study|Participant Moved Out of the Country|1|||
149995241|NCT03943550|541115753|FG002|Overall Study|Participant Moved Out of the Country|0|||
149995242|NCT03359785|541115754|FG000|Overall Study|Protocol Violation|0|||
149995243|NCT03359785|541115755|FG001|Overall Study|Protocol Violation|1|||
149995244|NCT03359785|541115756|FG002|Overall Study|Protocol Violation|0|||
149995245|NCT03359785|541115757|FG003|Overall Study|Protocol Violation|0|||
149995246|NCT03359785|541115754|FG000|Overall Study|Early study termination due to study pause|0|||
149995247|NCT03359785|541115755|FG001|Overall Study|Early study termination due to study pause|0|||
149995248|NCT03359785|541115756|FG002|Overall Study|Early study termination due to study pause|2|||
149995249|NCT03359785|541115757|FG003|Overall Study|Early study termination due to study pause|0|||
149995250|NCT03359785|541115754|FG000|Overall Study|Withdrawal by Subject|2|||
149995251|NCT03359785|541115755|FG001|Overall Study|Withdrawal by Subject|2|||
149995252|NCT03359785|541115756|FG002|Overall Study|Withdrawal by Subject|0|||
149995253|NCT03359785|541115757|FG003|Overall Study|Withdrawal by Subject|0|||
149995254|NCT04262882|541115759|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
149995255|NCT04262882|541115760|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
149995256|NCT04262882|541115759|FG000|Overall Study|Lost to Follow-up|1|||
149995257|NCT04262882|541115760|FG001|Overall Study|Lost to Follow-up|0|||
149995258|NCT03099174|541115761|FG000|Overall Study|Withdrawal by Subject|0|||
149995259|NCT03099174|541115762|FG001|Overall Study|Withdrawal by Subject|0|||
149995260|NCT03099174|541115763|FG002|Overall Study|Withdrawal by Subject|1|||
149995261|NCT03099174|541115764|FG003|Overall Study|Withdrawal by Subject|0|||
149995262|NCT03099174|541115765|FG004|Overall Study|Withdrawal by Subject|2|||
149995263|NCT03099174|541115766|FG005|Overall Study|Withdrawal by Subject|2|||
149995264|NCT03099174|541115767|FG006|Overall Study|Withdrawal by Subject|1|||
149995265|NCT03099174|541115768|FG007|Overall Study|Withdrawal by Subject|4|||
149995266|NCT03099174|541115761|FG000|Overall Study|Adverse Event|0|||
149995267|NCT03099174|541115762|FG001|Overall Study|Adverse Event|1|||
149995268|NCT03099174|541115763|FG002|Overall Study|Adverse Event|1|||
149995269|NCT03099174|541115764|FG003|Overall Study|Adverse Event|2|||
149995270|NCT03099174|541115765|FG004|Overall Study|Adverse Event|5|||
149995271|NCT03099174|541115766|FG005|Overall Study|Adverse Event|3|||
149995272|NCT03099174|541115767|FG006|Overall Study|Adverse Event|6|||
149995273|NCT03099174|541115768|FG007|Overall Study|Adverse Event|4|||
149995274|NCT03099174|541115761|FG000|Overall Study|Other than listed|6|||
149995275|NCT03099174|541115762|FG001|Overall Study|Other than listed|6|||
149995276|NCT03099174|541115763|FG002|Overall Study|Other than listed|5|||
149995277|NCT03099174|541115764|FG003|Overall Study|Other than listed|6|||
149995278|NCT03099174|541115765|FG004|Overall Study|Other than listed|19|||
149995279|NCT03099174|541115766|FG005|Overall Study|Other than listed|10|||
149995280|NCT03099174|541115767|FG006|Overall Study|Other than listed|26|||
149995281|NCT03099174|541115768|FG007|Overall Study|Other than listed|23|||
149995282|NCT04730635|541115769|FG000|Overall Study|Lost to Follow-up|1|||
149995283|NCT04730635|541115770|FG001|Overall Study|Lost to Follow-up|0|||
149995284|NCT04730635|541115769|FG000|Overall Study|Withdrawal by Subject|0|||
149995285|NCT04730635|541115770|FG001|Overall Study|Withdrawal by Subject|1|||
149995286|NCT03070223|541115771|FG000|Overall Study|Lost to Follow-up|34|||
149995287|NCT03070223|541115772|FG001|Overall Study|Lost to Follow-up|27|||
149995288|NCT03070223|541115771|FG000|Overall Study|Withdrawal by Subject|12|||
149995289|NCT03070223|541115772|FG001|Overall Study|Withdrawal by Subject|22|||
149995290|NCT03070223|541115771|FG000|Overall Study|Protocol Violation|0|||
149995291|NCT03070223|541115772|FG001|Overall Study|Protocol Violation|1|||
149995292|NCT00516906|541115773|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
149995293|NCT00516906|541115774|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
149995294|NCT00721578|541115782|FG000|Overall Study|Death|1|||
149995295|NCT00721578|541115783|FG001|Overall Study|Death|1|||
149995296|NCT00721578|541115782|FG000|Overall Study|Withdrawal by Subject|1|||
149995297|NCT00721578|541115783|FG001|Overall Study|Withdrawal by Subject|1|||
149995298|NCT02136680|541115794|FG000|Overall Study|No Longer Interested|1|||
149995299|NCT02136680|541115795|FG001|Overall Study|No Longer Interested|1|||
149995300|NCT02136680|541115794|FG000|Overall Study|No longer receiving care at clinic|3|||
149995301|NCT02136680|541115795|FG001|Overall Study|No longer receiving care at clinic|5|||
149995302|NCT02136680|541115794|FG000|Overall Study|Moved away|5|||
149995303|NCT02136680|541115795|FG001|Overall Study|Moved away|4|||
149995304|NCT02136680|541115794|FG000|Overall Study|Unable to schedule|17|||
149995305|NCT02136680|541115795|FG001|Overall Study|Unable to schedule|16|||
149995306|NCT02136680|541115794|FG000|Overall Study|Study ended before interview due|6|||
149995307|NCT02136680|541115795|FG001|Overall Study|Study ended before interview due|3|||
149995308|NCT05032690|541115796|FG000|Period 1|Adverse Event|0|||
149995309|NCT05032690|541115797|FG001|Period 1|Adverse Event|1|||
149995310|NCT05032690|541115798|FG002|Period 1|Adverse Event|0|||
149995311|NCT05032690|541115799|FG003|Period 1|Adverse Event|0|||
149995312|NCT05032690|541115796|FG000|Period 1|Withdrawal by Subject|1|||
149995313|NCT05032690|541115797|FG001|Period 1|Withdrawal by Subject|0|||
149995314|NCT05032690|541115798|FG002|Period 1|Withdrawal by Subject|0|||
149995315|NCT05032690|541115799|FG003|Period 1|Withdrawal by Subject|0|||
149995316|NCT05032690|541115796|FG000|Period 1|No longer meets eligibility criteria|0|||
149995317|NCT05032690|541115797|FG001|Period 1|No longer meets eligibility criteria|1|||
149995318|NCT05032690|541115798|FG002|Period 1|No longer meets eligibility criteria|0|||
149995319|NCT05032690|541115799|FG003|Period 1|No longer meets eligibility criteria|0|||
149995320|NCT05032690|541115796|FG000|Period 2|Adverse Event|1|||
149995321|NCT05032690|541115797|FG001|Period 2|Adverse Event|0|||
149995322|NCT05032690|541115798|FG002|Period 2|Adverse Event|0|||
149995323|NCT05032690|541115799|FG003|Period 2|Adverse Event|0|||
149995324|NCT05032690|541115796|FG000|Period 2|Withdrawal by Subject|0|||
149995325|NCT05032690|541115797|FG001|Period 2|Withdrawal by Subject|1|||
149995326|NCT05032690|541115798|FG002|Period 2|Withdrawal by Subject|0|||
149995327|NCT05032690|541115799|FG003|Period 2|Withdrawal by Subject|0|||
149995328|NCT05032690|541115796|FG000|Period 2|No longer meets eligibility criteria|0|||
149995329|NCT05032690|541115797|FG001|Period 2|No longer meets eligibility criteria|1|||
149995330|NCT05032690|541115798|FG002|Period 2|No longer meets eligibility criteria|0|||
149995331|NCT05032690|541115799|FG003|Period 2|No longer meets eligibility criteria|0|||
149995332|NCT05032690|541115796|FG000|Period 3|Adverse Event|0|||
149995333|NCT05032690|541115797|FG001|Period 3|Adverse Event|1|||
149995334|NCT05032690|541115798|FG002|Period 3|Adverse Event|0|||
149995335|NCT05032690|541115799|FG003|Period 3|Adverse Event|0|||
149995336|NCT05151445|541115800|FG000|Overall Study|Withdrawal by Subject|3|||
149995337|NCT02298179|541115801|FG000|Overall Study|Lost to Follow-up|0|||
149995338|NCT02298179|541115802|FG001|Overall Study|Lost to Follow-up|0|||
149995339|NCT02298179|541115803|FG002|Overall Study|Lost to Follow-up|1|||
149995340|NCT02298179|541115804|FG003|Overall Study|Lost to Follow-up|0|||
149995341|NCT02298179|541115805|FG004|Overall Study|Lost to Follow-up|0|||
149995342|NCT02298179|541115806|FG005|Overall Study|Lost to Follow-up|0|||
149995343|NCT02298179|541115807|FG006|Overall Study|Lost to Follow-up|0|||
149995344|NCT02298179|541115808|FG007|Overall Study|Lost to Follow-up|1|||
149995345|NCT02298179|541115809|FG008|Overall Study|Lost to Follow-up|0|||
149995346|NCT02298179|541115810|FG009|Overall Study|Lost to Follow-up|0|||
149995347|NCT02298179|541115811|FG010|Overall Study|Lost to Follow-up|0|||
149995348|NCT02298179|541115812|FG011|Overall Study|Lost to Follow-up|0|||
149995349|NCT02825420|541115819|FG000|Overall Study|Death|30|||
149995350|NCT02825420|541115820|FG001|Overall Study|Death|12|||
149995351|NCT02825420|541115819|FG000|Overall Study|Progressive disease|6|||
149995352|NCT02825420|541115820|FG001|Overall Study|Progressive disease|1|||
149995353|NCT02825420|541115819|FG000|Overall Study|Lost to Follow-up|2|||
149995354|NCT02825420|541115820|FG001|Overall Study|Lost to Follow-up|2|||
149995355|NCT02825420|541115819|FG000|Overall Study|Withdrawal by Subject|1|||
149995356|NCT02825420|541115820|FG001|Overall Study|Withdrawal by Subject|1|||
149995357|NCT02825420|541115819|FG000|Overall Study|Protocol amendment not signed|1|||
149995358|NCT02825420|541115820|FG001|Overall Study|Protocol amendment not signed|1|||
149995359|NCT02825420|541115819|FG000|Overall Study|Physician Decision|1|||
149995360|NCT02825420|541115820|FG001|Overall Study|Physician Decision|0|||
149995361|NCT02825420|541115819|FG000|Overall Study|Did not receive PLD|2|||
149995362|NCT02825420|541115820|FG001|Overall Study|Did not receive PLD|0|||
149995363|NCT02226198|541117840|FG000|Lead-in Phase|Protocol Violation|1|||
149995364|NCT02226198|541117841|FG001|Lead-in Phase|Protocol Violation|0|||
149995365|NCT02226198|541117842|FG002|Lead-in Phase|Protocol Violation|0|||
149995366|NCT02226198|541117840|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
149995367|NCT02226198|541117841|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
149995368|NCT02226198|541117842|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
149995369|NCT01440517|541117846|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
149995370|NCT01288612|541117847|FG000|Overall Study|Unable to contact|11|||
149995371|NCT01288612|541117848|FG001|Overall Study|Unable to contact|16|||
149995372|NCT01288612|541117849|FG002|Overall Study|Unable to contact|20|||
149995373|NCT01288612|541117847|FG000|Overall Study|Declined|78|||
149995374|NCT01288612|541117848|FG001|Overall Study|Declined|63|||
149995375|NCT01288612|541117849|FG002|Overall Study|Declined|62|||
149995376|NCT01288612|541117847|FG000|Overall Study|Unable to intubate|0|||
149995377|NCT01288612|541117848|FG001|Overall Study|Unable to intubate|3|||
149995378|NCT01288612|541117849|FG002|Overall Study|Unable to intubate|0|||
149995379|NCT00871923|541117850|FG000|Overall Study|Death|1|||
149995380|NCT00871923|541117850|FG000|Overall Study|Withdrawal by Subject|1|||
149995381|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
149995382|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
149995383|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
149995384|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
149995385|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
149995386|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
149995387|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
149995388|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
149995389|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
149995390|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
149995391|NCT01263015|541117855|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
149995392|NCT01263015|541117856|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
149995393|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
149995394|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
149995395|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
149995396|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
149995397|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
149995398|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
149995399|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
149995400|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
149995401|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
149995402|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
149995403|NCT01263015|541117855|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
149995404|NCT01263015|541117856|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
149995405|NCT05599451|541117857|FG000|Overall Study|Not randomized|11|||
149995406|NCT05599451|541117858|FG001|Overall Study|Not randomized|0|||
149995407|NCT05599451|541117859|FG002|Overall Study|Not randomized|0|||
149995408|NCT05599451|541117860|FG003|Overall Study|Not randomized|0|||
149995409|NCT05599451|541117861|FG004|Overall Study|Not randomized|0|||
149995410|NCT05599451|541117857|FG000|Overall Study|Physician Decision|0|||
149995411|NCT05599451|541117858|FG001|Overall Study|Physician Decision|0|||
149995412|NCT05599451|541117859|FG002|Overall Study|Physician Decision|0|||
149995413|NCT05599451|541117860|FG003|Overall Study|Physician Decision|1|||
149995414|NCT05599451|541117861|FG004|Overall Study|Physician Decision|0|||
149995415|NCT02723006|541117862|FG000|Overall Study|Withdrawal by Subject|0|||
149995416|NCT02723006|541117863|FG001|Overall Study|Withdrawal by Subject|1|||
149995417|NCT02723006|541117864|FG002|Overall Study|Withdrawal by Subject|1|||
149995418|NCT02723006|541117862|FG000|Overall Study|Study Terminated by Sponsor|1|||
149995419|NCT02723006|541117863|FG001|Overall Study|Study Terminated by Sponsor|6|||
149995420|NCT02723006|541117864|FG002|Overall Study|Study Terminated by Sponsor|6|||
149995421|NCT00303446|541117865|FG000|Overall Study|Withdrawal by Subject|2|||
149995422|NCT00303446|541117866|FG001|Overall Study|Withdrawal by Subject|2|||
149995423|NCT00303446|541117865|FG000|Overall Study|Death|0|||
149995424|NCT00303446|541117866|FG001|Overall Study|Death|1|||
149995425|NCT00303446|541117865|FG000|Overall Study|Physician Decision|0|||
149995426|NCT00303446|541117866|FG001|Overall Study|Physician Decision|1|||
149995427|NCT04258995|541117867|FG000|Overall Study|Lost to Follow-up|1|||
149995428|NCT04258995|541117868|FG001|Overall Study|Lost to Follow-up|1|||
149995429|NCT03842969|541117871|FG000|Overall Study|Participant declined follow-up visit|0|||
149995430|NCT03842969|541117872|FG001|Overall Study|Participant declined follow-up visit|1|||
149995431|NCT03842969|541117873|FG002|Overall Study|Participant declined follow-up visit|0|||
149995432|NCT03842969|541117871|FG000|Overall Study|Sponsor's decision|12|||
149995433|NCT03842969|541117872|FG001|Overall Study|Sponsor's decision|99|||
149995434|NCT03842969|541117873|FG002|Overall Study|Sponsor's decision|61|||
150053993|NCT00313781|541338434|FG001|After Crossover|Death|0|||
150053994|NCT00313781|541338435|FG002|After Crossover|Death|6|||
150053995|NCT00313781|541338433|FG000|After Crossover|Withdrawal by Subject|0|||
150053996|NCT00313781|541338434|FG001|After Crossover|Withdrawal by Subject|0|||
150053997|NCT00313781|541338435|FG002|After Crossover|Withdrawal by Subject|3|||
150053998|NCT00313781|541338433|FG000|After Crossover|Other|0|||
149995435|NCT03842969|541117871|FG000|Overall Study|Pregnancy|0|||
149995436|NCT03842969|541117872|FG001|Overall Study|Pregnancy|0|||
149995437|NCT03842969|541117873|FG002|Overall Study|Pregnancy|1|||
149995438|NCT03842969|541117871|FG000|Overall Study|Death|1|||
149995439|NCT03842969|541117872|FG001|Overall Study|Death|0|||
149995440|NCT03842969|541117873|FG002|Overall Study|Death|1|||
149995441|NCT03842969|541117871|FG000|Overall Study|Withdrawal by Subject|3|||
149995442|NCT03842969|541117872|FG001|Overall Study|Withdrawal by Subject|30|||
149995443|NCT03842969|541117873|FG002|Overall Study|Withdrawal by Subject|18|||
149995444|NCT03842969|541117871|FG000|Overall Study|Protocol Violation|1|||
149995445|NCT03842969|541117872|FG001|Overall Study|Protocol Violation|1|||
149995446|NCT03842969|541117873|FG002|Overall Study|Protocol Violation|0|||
149995447|NCT03842969|541117871|FG000|Overall Study|Physician Decision|0|||
149995448|NCT03842969|541117872|FG001|Overall Study|Physician Decision|3|||
149995449|NCT03842969|541117873|FG002|Overall Study|Physician Decision|0|||
149995450|NCT03842969|541117871|FG000|Overall Study|Lost to Follow-up|0|||
149995451|NCT03842969|541117872|FG001|Overall Study|Lost to Follow-up|2|||
149995452|NCT03842969|541117873|FG002|Overall Study|Lost to Follow-up|0|||
149995453|NCT03842969|541117871|FG000|Overall Study|Adverse Event|0|||
149995454|NCT03842969|541117872|FG001|Overall Study|Adverse Event|2|||
149995455|NCT03842969|541117873|FG002|Overall Study|Adverse Event|0|||
149995456|NCT01942161|541117874|FG000|Overall Study|Adverse Event|1|||
149995457|NCT01942161|541117875|FG001|Overall Study|Adverse Event|2|||
149995458|NCT01942161|541117876|FG002|Overall Study|Adverse Event|5|||
149995459|NCT01942161|541117874|FG000|Overall Study|Physician Decision|3|||
149995460|NCT01942161|541117875|FG001|Overall Study|Physician Decision|1|||
149995461|NCT01942161|541117876|FG002|Overall Study|Physician Decision|0|||
149995462|NCT01942161|541117874|FG000|Overall Study|Protocol Violation|1|||
149995463|NCT01942161|541117875|FG001|Overall Study|Protocol Violation|0|||
149995464|NCT01942161|541117876|FG002|Overall Study|Protocol Violation|0|||
149995465|NCT01942161|541117874|FG000|Overall Study|Withdrawal by Subject|3|||
149995466|NCT01942161|541117875|FG001|Overall Study|Withdrawal by Subject|3|||
149995467|NCT01942161|541117876|FG002|Overall Study|Withdrawal by Subject|1|||
149995468|NCT01257568|541117877|FG000|Overall Study|Lost to Follow-up|2|||
149995469|NCT01257568|541117877|FG000|Overall Study|Withdrawal by Subject|6|||
149995470|NCT01257568|541117877|FG000|Overall Study|Terminated|1|||
149995471|NCT01257568|541117877|FG000|Overall Study|Component Revision|24|||
149995472|NCT03392883|541117879|FG000|Overall Study|Lost to Follow-up|122|||
149995473|NCT03392883|541117880|FG001|Overall Study|Lost to Follow-up|13|||
149995474|NCT03392883|541117881|FG002|Overall Study|Lost to Follow-up|9|||
149995475|NCT03392883|541117879|FG000|Overall Study|Death|4|||
149995476|NCT03392883|541117880|FG001|Overall Study|Death|0|||
149995477|NCT03392883|541117881|FG002|Overall Study|Death|0|||
149995478|NCT03392883|541117879|FG000|Overall Study|Lack of Efficacy|29|||
149995479|NCT03392883|541117880|FG001|Overall Study|Lack of Efficacy|0|||
149995480|NCT03392883|541117881|FG002|Overall Study|Lack of Efficacy|0|||
149995481|NCT03392883|541117879|FG000|Overall Study|Withdrawal by Subject|180|||
149995482|NCT03392883|541117880|FG001|Overall Study|Withdrawal by Subject|0|||
149995483|NCT03392883|541117881|FG002|Overall Study|Withdrawal by Subject|0|||
149995484|NCT03392883|541117879|FG000|Overall Study|Adverse Event|1|||
149995485|NCT03392883|541117880|FG001|Overall Study|Adverse Event|0|||
149995486|NCT03392883|541117881|FG002|Overall Study|Adverse Event|0|||
149995487|NCT01739933|541117891|FG000|Overall Study|Death|89|||
149995488|NCT01739933|541117892|FG001|Overall Study|Death|86|||
149995489|NCT01739933|541117891|FG000|Overall Study|Withdrawal by Subject|10|||
149995490|NCT01739933|541117892|FG001|Overall Study|Withdrawal by Subject|8|||
149995491|NCT01739933|541117891|FG000|Overall Study|Lost to Follow-up|3|||
149995492|NCT01739933|541117892|FG001|Overall Study|Lost to Follow-up|10|||
150053999|NCT00313781|541338434|FG001|After Crossover|Other|0|||
149995493|NCT01739933|541117891|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
149995494|NCT01739933|541117892|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
149995495|NCT00908115|541117898|FG000|Overall Study|Other|14|||
149995496|NCT01728077|541117899|FG000|Overall Study|Lack of Efficacy|3|||
149995497|NCT01728077|541117900|FG001|Overall Study|Lack of Efficacy|1|||
149995498|NCT01728077|541117899|FG000|Overall Study|Lost to Follow-up|1|||
149995499|NCT01728077|541117900|FG001|Overall Study|Lost to Follow-up|0|||
150054000|NCT00313781|541338435|FG002|After Crossover|Other|18|||
149995500|NCT01728077|541117899|FG000|Overall Study|Subject choice|2|||
149995501|NCT01728077|541117900|FG001|Overall Study|Subject choice|3|||
149995502|NCT01728077|541117899|FG000|Overall Study|Death|0|||
149995503|NCT01728077|541117900|FG001|Overall Study|Death|1|||
149995504|NCT01728077|541117899|FG000|Overall Study|Patient moving|1|||
150054001|NCT03567343|541338436|FG000|Overall Study|Lost to Follow-up|2|||
149995505|NCT01728077|541117900|FG001|Overall Study|Patient moving|0|||
150054002|NCT03567343|541338437|FG001|Overall Study|Lost to Follow-up|1|||
150054003|NCT03567343|541338436|FG000|Overall Study|No longer eligible|2|||
150054004|NCT03567343|541338437|FG001|Overall Study|No longer eligible|1|||
150054005|NCT03567343|541338436|FG000|Overall Study|Adverse Event|1|||
149995506|NCT01728077|541117899|FG000|Overall Study|Non compliance|1|||
149995507|NCT01728077|541117900|FG001|Overall Study|Non compliance|0|||
149995508|NCT00378599|541117904|FG000|Overall Study|Adverse Event|38|||
149995509|NCT00378599|541117904|FG000|Overall Study|Protocol Violation|2|||
149995510|NCT00378599|541117904|FG000|Overall Study|Treatment failure|7|||
149995511|NCT00378599|541117904|FG000|Overall Study|Withdrawal by Subject|5|||
149995512|NCT00416715|541117905|FG000|Overall Study|Not evaluable for joint aches|7|||
149995513|NCT00416715|541117905|FG000|Overall Study|Vitamin D levels not evaluable|8|||
149995514|NCT03224507|541117908|FG000|Overall Study|Death|3|||
149995515|NCT03224507|541117909|FG001|Overall Study|Death|0|||
149995516|NCT03224507|541117908|FG000|Overall Study|Lack of Efficacy|6|||
149995517|NCT03224507|541117909|FG001|Overall Study|Lack of Efficacy|0|||
149995518|NCT03224507|541117908|FG000|Overall Study|Withdrawal by Subject|6|||
149995519|NCT03224507|541117909|FG001|Overall Study|Withdrawal by Subject|0|||
150054006|NCT03567343|541338437|FG001|Overall Study|Adverse Event|0|||
149995520|NCT01007435|541117910|FG000|Overall Study|Adverse Event|16|||
149995521|NCT01007435|541117911|FG001|Overall Study|Adverse Event|25|||
149995522|NCT01007435|541117912|FG002|Overall Study|Adverse Event|47|||
149995523|NCT01007435|541117913|FG003|Overall Study|Adverse Event|31|||
149995524|NCT01007435|541117910|FG000|Overall Study|Death|2|||
149995525|NCT01007435|541117911|FG001|Overall Study|Death|4|||
149995526|NCT01007435|541117912|FG002|Overall Study|Death|2|||
149995527|NCT01007435|541117913|FG003|Overall Study|Death|1|||
149995528|NCT01007435|541117910|FG000|Overall Study|Insufficient Therapeutic Response|21|||
149995529|NCT01007435|541117911|FG001|Overall Study|Insufficient Therapeutic Response|7|||
149995530|NCT01007435|541117912|FG002|Overall Study|Insufficient Therapeutic Response|2|||
149995531|NCT01007435|541117913|FG003|Overall Study|Insufficient Therapeutic Response|9|||
149995532|NCT01007435|541117910|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
149995533|NCT01007435|541117911|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
149995534|NCT01007435|541117912|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
149995535|NCT01007435|541117913|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
149995536|NCT01007435|541117910|FG000|Overall Study|Other Protocol Violation|2|||
149995537|NCT01007435|541117911|FG001|Overall Study|Other Protocol Violation|0|||
149995538|NCT01007435|541117912|FG002|Overall Study|Other Protocol Violation|1|||
149995539|NCT01007435|541117913|FG003|Overall Study|Other Protocol Violation|0|||
149995540|NCT01007435|541117910|FG000|Overall Study|Refused Treatment|13|||
149995541|NCT01007435|541117911|FG001|Overall Study|Refused Treatment|13|||
149995542|NCT01007435|541117912|FG002|Overall Study|Refused Treatment|5|||
149995543|NCT01007435|541117913|FG003|Overall Study|Refused Treatment|8|||
149995544|NCT01007435|541117910|FG000|Overall Study|Failure to Return|5|||
149995545|NCT01007435|541117911|FG001|Overall Study|Failure to Return|4|||
149995546|NCT01007435|541117912|FG002|Overall Study|Failure to Return|3|||
149995547|NCT01007435|541117913|FG003|Overall Study|Failure to Return|6|||
149995548|NCT01007435|541117910|FG000|Overall Study|Reason not Specified|1|||
149995549|NCT01007435|541117911|FG001|Overall Study|Reason not Specified|1|||
149995550|NCT01007435|541117912|FG002|Overall Study|Reason not Specified|2|||
149995551|NCT01007435|541117913|FG003|Overall Study|Reason not Specified|1|||
149995552|NCT01032291|541117914|FG000|Safety Lead-in|Adverse Event|1|||
149995553|NCT01032291|541117915|FG001|Safety Lead-in|Adverse Event|0|||
149995554|NCT01032291|541117916|FG002|Safety Lead-in|Adverse Event|0|||
149995555|NCT01032291|541117914|FG000|Safety Lead-in|Death|1|||
149995556|NCT01032291|541117915|FG001|Safety Lead-in|Death|0|||
149995557|NCT01032291|541117916|FG002|Safety Lead-in|Death|0|||
149995558|NCT01032291|541117914|FG000|Proof of Concept|Adverse Event|0|||
149995559|NCT01032291|541117915|FG001|Proof of Concept|Adverse Event|5|||
149995560|NCT01032291|541117916|FG002|Proof of Concept|Adverse Event|1|||
149995561|NCT01032291|541117914|FG000|Proof of Concept|Death|0|||
149995562|NCT01032291|541117915|FG001|Proof of Concept|Death|1|||
149995563|NCT01032291|541117916|FG002|Proof of Concept|Death|2|||
149995564|NCT01032291|541117914|FG000|Proof of Concept|Lack of Efficacy|0|||
149995565|NCT01032291|541117915|FG001|Proof of Concept|Lack of Efficacy|1|||
149995566|NCT01032291|541117916|FG002|Proof of Concept|Lack of Efficacy|0|||
149995567|NCT01032291|541117914|FG000|Proof of Concept|Never Received Study Drug|0|||
149995568|NCT01032291|541117915|FG001|Proof of Concept|Never Received Study Drug|1|||
149995569|NCT01032291|541117916|FG002|Proof of Concept|Never Received Study Drug|0|||
149995570|NCT00347438|541117917|FG000|Overall Study|Withdrawal by Subject|1|||
150054007|NCT03567343|541338436|FG000|Overall Study|Protocol Violation|1|||
149995571|NCT00347438|541117917|FG000|Overall Study|Physician Decision|1|||
149995572|NCT02545517|541117918|FG000|Overall Study|Death|2|||
150054008|NCT03567343|541338437|FG001|Overall Study|Protocol Violation|1|||
149995573|NCT02545517|541117919|FG001|Overall Study|Death|2|||
149995574|NCT02545517|541117920|FG002|Overall Study|Death|1|||
149995575|NCT02545517|541117918|FG000|Overall Study|Lost to Follow-up|14|||
149995576|NCT02545517|541117919|FG001|Overall Study|Lost to Follow-up|13|||
149995577|NCT02545517|541117920|FG002|Overall Study|Lost to Follow-up|17|||
150054009|NCT03288142|541338440|FG000|Overall Study|Lost to Follow-up|22|||
149995578|NCT02545517|541117918|FG000|Overall Study|Protocol Violation|0|||
149995579|NCT02545517|541117919|FG001|Overall Study|Protocol Violation|1|||
149995580|NCT02545517|541117920|FG002|Overall Study|Protocol Violation|1|||
149995581|NCT02545517|541117918|FG000|Overall Study|Withdrawal by Subject|5|||
149995582|NCT02545517|541117919|FG001|Overall Study|Withdrawal by Subject|8|||
149995583|NCT02545517|541117920|FG002|Overall Study|Withdrawal by Subject|9|||
149995584|NCT02545517|541117918|FG000|Overall Study|Administrative reason|5|||
149995585|NCT02545517|541117919|FG001|Overall Study|Administrative reason|6|||
149995586|NCT02545517|541117920|FG002|Overall Study|Administrative reason|10|||
149995587|NCT02545517|541117918|FG000|Overall Study|Other|2|||
149995588|NCT02545517|541117919|FG001|Overall Study|Other|4|||
149995589|NCT02545517|541117920|FG002|Overall Study|Other|3|||
149995590|NCT01529515|541117921|FG000|TRANSITION PHASE|Adverse Event|16|||
149995591|NCT01529515|541117922|FG001|TRANSITION PHASE|Adverse Event|0|||
149995592|NCT01529515|541117923|FG002|TRANSITION PHASE|Adverse Event|0|||
149995593|NCT01529515|541117924|FG003|TRANSITION PHASE|Adverse Event|0|||
149995594|NCT01529515|541117921|FG000|TRANSITION PHASE|Death|1|||
149995595|NCT01529515|541117922|FG001|TRANSITION PHASE|Death|0|||
149995596|NCT01529515|541117923|FG002|TRANSITION PHASE|Death|0|||
149995597|NCT01529515|541117924|FG003|TRANSITION PHASE|Death|0|||
149995598|NCT01529515|541117921|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
149995599|NCT01529515|541117922|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
149995600|NCT01529515|541117923|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
149995601|NCT01529515|541117924|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
149995602|NCT01529515|541117921|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
149995603|NCT01529515|541117922|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
149995604|NCT01529515|541117923|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
149995605|NCT01529515|541117924|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
150054010|NCT03288142|541338441|FG001|Overall Study|Lost to Follow-up|15|||
149995606|NCT01529515|541117921|FG000|TRANSITION PHASE|Protocol Violation|4|||
149995607|NCT01529515|541117922|FG001|TRANSITION PHASE|Protocol Violation|0|||
149995608|NCT01529515|541117923|FG002|TRANSITION PHASE|Protocol Violation|0|||
149995609|NCT01529515|541117924|FG003|TRANSITION PHASE|Protocol Violation|0|||
149995610|NCT01529515|541117921|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
149995611|NCT01529515|541117922|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
149995612|NCT01529515|541117923|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
149995613|NCT01529515|541117924|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
149995614|NCT01529515|541117921|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
149995615|NCT01529515|541117922|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
149995616|NCT01529515|541117923|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
149995617|NCT01529515|541117924|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
149995618|NCT01529515|541117921|FG000|TRANSITION PHASE|Other|9|||
149995619|NCT01529515|541117922|FG001|TRANSITION PHASE|Other|0|||
149995620|NCT01529515|541117923|FG002|TRANSITION PHASE|Other|0|||
149995621|NCT01529515|541117924|FG003|TRANSITION PHASE|Other|0|||
149995622|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Adverse Event|0|||
149995623|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Adverse Event|10|||
149995624|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Adverse Event|0|||
149995625|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Adverse Event|0|||
149995626|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
149995627|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
149995628|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
149995629|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
149995630|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
149995631|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
149995632|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
149995633|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
149995634|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
149995635|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
149995636|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
149995637|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
149995638|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
149995639|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
149995640|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
149995641|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
149995642|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
149995643|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
149995644|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
149995645|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
149995646|NCT01529515|541117921|FG000|MAINTENANCE PHASE|Other|0|||
149995647|NCT01529515|541117922|FG001|MAINTENANCE PHASE|Other|10|||
149995648|NCT01529515|541117923|FG002|MAINTENANCE PHASE|Other|0|||
150054011|NCT01214395|541338444|FG000|Overall Study|All patients had infection|5|||
150054012|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
150054013|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
149995649|NCT01529515|541117924|FG003|MAINTENANCE PHASE|Other|0|||
149995650|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
150054014|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
149995651|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
149995652|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
149995653|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
149995654|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
149995655|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
149995656|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
149995657|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
149995658|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
149995659|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
149995660|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
149995661|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
149995662|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
149995663|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
149995664|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
149995665|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
150054015|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
150054016|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
150054017|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
149995666|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
149995667|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
149995668|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
149995669|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
149995670|NCT01529515|541117921|FG000|DOUBLE BLIND PHASE|Other|0|||
149995671|NCT01529515|541117922|FG001|DOUBLE BLIND PHASE|Other|0|||
149995672|NCT01529515|541117923|FG002|DOUBLE BLIND PHASE|Other|9|||
149995673|NCT01529515|541117924|FG003|DOUBLE BLIND PHASE|Other|2|||
149995674|NCT03334851|541117926|FG000|Overall Study|Other|0|||
149995675|NCT03334851|541117927|FG001|Overall Study|Other|0|||
149995676|NCT03334851|541117928|FG002|Overall Study|Other|0|||
149995677|NCT03334851|541117929|FG003|Overall Study|Other|0|||
149995678|NCT03334851|541117930|FG004|Overall Study|Other|0|||
149995679|NCT03334851|541117931|FG005|Overall Study|Other|0|||
149995680|NCT03334851|541117932|FG006|Overall Study|Other|0|||
149995681|NCT03334851|541117933|FG007|Overall Study|Other|1|||
149995682|NCT03334851|541117934|FG008|Overall Study|Other|0|||
149995683|NCT03334851|541117935|FG009|Overall Study|Other|0|||
149995684|NCT03334851|541117936|FG010|Overall Study|Other|0|||
149995685|NCT03334851|541117937|FG011|Overall Study|Other|0|||
149995686|NCT03334851|541117938|FG012|Overall Study|Other|0|||
149995687|NCT03334851|541117926|FG000|Overall Study|Adverse Event|0|||
149995688|NCT03334851|541117927|FG001|Overall Study|Adverse Event|0|||
149995689|NCT03334851|541117928|FG002|Overall Study|Adverse Event|0|||
149995690|NCT03334851|541117929|FG003|Overall Study|Adverse Event|0|||
149995691|NCT03334851|541117930|FG004|Overall Study|Adverse Event|0|||
149995692|NCT03334851|541117931|FG005|Overall Study|Adverse Event|0|||
149995693|NCT03334851|541117932|FG006|Overall Study|Adverse Event|0|||
149995694|NCT03334851|541117933|FG007|Overall Study|Adverse Event|1|||
149995695|NCT03334851|541117934|FG008|Overall Study|Adverse Event|0|||
149995696|NCT03334851|541117935|FG009|Overall Study|Adverse Event|0|||
149995697|NCT03334851|541117936|FG010|Overall Study|Adverse Event|0|||
149995698|NCT03334851|541117937|FG011|Overall Study|Adverse Event|0|||
149995699|NCT03334851|541117938|FG012|Overall Study|Adverse Event|0|||
149995700|NCT03334851|541117926|FG000|Overall Study|Withdrawal by Subject|0|||
149995701|NCT03334851|541117927|FG001|Overall Study|Withdrawal by Subject|0|||
149995702|NCT03334851|541117928|FG002|Overall Study|Withdrawal by Subject|0|||
149995703|NCT03334851|541117929|FG003|Overall Study|Withdrawal by Subject|0|||
149995704|NCT03334851|541117930|FG004|Overall Study|Withdrawal by Subject|0|||
149995705|NCT03334851|541117931|FG005|Overall Study|Withdrawal by Subject|0|||
149995706|NCT03334851|541117932|FG006|Overall Study|Withdrawal by Subject|0|||
149995707|NCT03334851|541117933|FG007|Overall Study|Withdrawal by Subject|0|||
149995708|NCT03334851|541117934|FG008|Overall Study|Withdrawal by Subject|0|||
149995709|NCT03334851|541117935|FG009|Overall Study|Withdrawal by Subject|0|||
149995710|NCT03334851|541117936|FG010|Overall Study|Withdrawal by Subject|1|||
149995711|NCT03334851|541117937|FG011|Overall Study|Withdrawal by Subject|0|||
149995712|NCT03334851|541117938|FG012|Overall Study|Withdrawal by Subject|1|||
149995713|NCT03334851|541117926|FG000|Overall Study|Lost to Follow-up|0|||
149995714|NCT03334851|541117927|FG001|Overall Study|Lost to Follow-up|0|||
149995715|NCT03334851|541117928|FG002|Overall Study|Lost to Follow-up|0|||
149995716|NCT03334851|541117929|FG003|Overall Study|Lost to Follow-up|0|||
149995717|NCT03334851|541117930|FG004|Overall Study|Lost to Follow-up|0|||
150054018|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
149995718|NCT03334851|541117931|FG005|Overall Study|Lost to Follow-up|0|||
149995719|NCT03334851|541117932|FG006|Overall Study|Lost to Follow-up|0|||
149995720|NCT03334851|541117933|FG007|Overall Study|Lost to Follow-up|0|||
149995721|NCT03334851|541117934|FG008|Overall Study|Lost to Follow-up|0|||
149995722|NCT03334851|541117935|FG009|Overall Study|Lost to Follow-up|0|||
149995723|NCT03334851|541117936|FG010|Overall Study|Lost to Follow-up|2|||
149995724|NCT03334851|541117937|FG011|Overall Study|Lost to Follow-up|1|||
149995725|NCT03334851|541117938|FG012|Overall Study|Lost to Follow-up|0|||
150054019|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
149995726|NCT03327220|541117939|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
149995727|NCT03327220|541117940|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
149995728|NCT03327220|541117939|FG000|Overall Study|Investigator Decision|2|||
149995729|NCT03327220|541117940|FG001|Overall Study|Investigator Decision|0|||
149995730|NCT03327220|541117939|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
149995731|NCT03327220|541117940|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
149995732|NCT03327220|541117939|FG000|Overall Study|Fungal infection|1|||
149995733|NCT03327220|541117940|FG001|Overall Study|Fungal infection|0|||
149995734|NCT03327220|541117939|FG000|Overall Study|Discharged to Rehabilitation|0|||
149995735|NCT03327220|541117940|FG001|Overall Study|Discharged to Rehabilitation|1|||
149995736|NCT03327220|541117939|FG000|Overall Study|Missing|1|||
149995737|NCT03327220|541117940|FG001|Overall Study|Missing|0|||
149995738|NCT00523705|541117941|FG000|Overall Study|No time for study.|0|||
149995739|NCT00523705|541117942|FG001|Overall Study|No time for study.|1|||
149995740|NCT00693017|541117943|FG000|Overall Study|Sponsor Decision|2|||
149995741|NCT00693017|541117944|FG001|Overall Study|Sponsor Decision|1|||
149995742|NCT00693017|541117943|FG000|Overall Study|Death|0|||
149995743|NCT00693017|541117944|FG001|Overall Study|Death|1|||
149995744|NCT01691885|541117945|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
149995745|NCT01691885|541117946|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
149995746|NCT01691885|541117945|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
150054020|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
150054021|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
150054022|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054023|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054024|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054025|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054026|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
150054027|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054028|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054029|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054030|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054031|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
150054032|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
150054033|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054034|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054035|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054036|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
150054037|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054038|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054039|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054040|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054041|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
150054042|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054043|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054044|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
150054045|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054046|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
150054047|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054048|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054049|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054050|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054051|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
150054052|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054053|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054054|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054055|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054056|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
150054057|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054058|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054059|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054060|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054061|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
150054062|NCT01185353|541338445|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
150054063|NCT01185353|541338446|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
150054064|NCT01185353|541338447|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
150054065|NCT01185353|541338448|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
150054066|NCT01185353|541338449|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
150054067|NCT01185353|541338450|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
149995747|NCT01691885|541117946|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
149995748|NCT00688324|541117948|FG000|Overall Study|Withdrawal by Subject|2|||
149995749|NCT00688324|541117948|FG000|Overall Study|Physician Decision|5|||
149995750|NCT00688324|541117948|FG000|Overall Study|Lost to Follow-up|1|||
149995751|NCT01972308|541117951|FG000|Overall Study|Withdrawal by Subject|0|||
149995752|NCT01972308|541117952|FG001|Overall Study|Withdrawal by Subject|1|||
149995753|NCT01972308|541117951|FG000|Overall Study|Lost to Follow-up|4|||
149995754|NCT01972308|541117952|FG001|Overall Study|Lost to Follow-up|6|||
149995755|NCT01972308|541117951|FG000|Overall Study|Death|4|||
149995756|NCT01972308|541117952|FG001|Overall Study|Death|1|||
149995757|NCT00642369|541117954|FG000|Overall Study|Adverse Event|2|||
149995758|NCT00642369|541117955|FG001|Overall Study|Adverse Event|3|||
149995759|NCT00642369|541117954|FG000|Overall Study|Withdrawal by Subject|1|||
149995760|NCT00642369|541117955|FG001|Overall Study|Withdrawal by Subject|0|||
149995761|NCT00642369|541117954|FG000|Overall Study|misdiagnosis|0|||
149995762|NCT00642369|541117955|FG001|Overall Study|misdiagnosis|1|||
149995763|NCT00642369|541117954|FG000|Overall Study|Lack of Efficacy|2|||
149995764|NCT00642369|541117955|FG001|Overall Study|Lack of Efficacy|2|||
149995765|NCT01562314|541117956|FG000|Overall Study|Adverse Event|10|||
149995766|NCT01562314|541117957|FG001|Overall Study|Adverse Event|5|||
149995767|NCT01562314|541117956|FG000|Overall Study|Met Withdrawal Criteria|3|||
149995768|NCT01562314|541117957|FG001|Overall Study|Met Withdrawal Criteria|2|||
149995769|NCT01562314|541117956|FG000|Overall Study|Withdrawal by Subject|0|||
149995770|NCT01562314|541117957|FG001|Overall Study|Withdrawal by Subject|1|||
149995771|NCT00543803|541117964|FG000|Overall Study|Adverse Event|14|||
149995772|NCT00543803|541117964|FG000|Overall Study|Lack of Efficacy|22|||
149995773|NCT00543803|541117964|FG000|Overall Study|Lost to Follow-up|20|||
149995774|NCT00543803|541117964|FG000|Overall Study|Other|86|||
149995775|NCT01190475|541117965|FG000|Overall Study|Withdrawal by Subject|0|||
149995776|NCT01190475|541117966|FG001|Overall Study|Withdrawal by Subject|0|||
149995777|NCT01190475|541117967|FG002|Overall Study|Withdrawal by Subject|1|||
149995778|NCT02256384|541117970|FG000|Overall Study|Withdrawal by Subject|12|||
149995779|NCT02256384|541117970|FG000|Overall Study|Equipment not capturing data|2|||
149995780|NCT00666588|541117972|FG000|Overall Study|ineligible|2|||
149995781|NCT00666588|541117973|FG001|Overall Study|ineligible|0|||
149995782|NCT00666588|541117974|FG002|Overall Study|ineligible|0|||
149995783|NCT00666588|541117975|FG003|Overall Study|ineligible|2|||
149995784|NCT00666588|541117972|FG000|Overall Study|inevaluable|2|||
149995785|NCT00666588|541117973|FG001|Overall Study|inevaluable|0|||
149995786|NCT00666588|541117974|FG002|Overall Study|inevaluable|0|||
149995787|NCT00666588|541117975|FG003|Overall Study|inevaluable|0|||
149995788|NCT04043234|541117976|FG000|Overall Study|Lost to Follow-up|1|||
149995789|NCT04043234|541117976|FG000|Overall Study|Withdrawal by Subject|1|||
149995790|NCT03622112|541117978|FG000|Overall Study|Withdrawal by Subject|6|||
149995791|NCT03622112|541117979|FG001|Overall Study|Withdrawal by Subject|2|||
149995792|NCT03622112|541117980|FG002|Overall Study|Withdrawal by Subject|4|||
149995793|NCT03622112|541117981|FG003|Overall Study|Withdrawal by Subject|2|||
149995794|NCT03622112|541117982|FG004|Overall Study|Withdrawal by Subject|1|||
149995795|NCT03622112|541117983|FG005|Overall Study|Withdrawal by Subject|2|||
149995796|NCT03622112|541117984|FG006|Overall Study|Withdrawal by Subject|2|||
149995797|NCT03622112|541117978|FG000|Overall Study|Death|0|||
149995798|NCT03622112|541117979|FG001|Overall Study|Death|0|||
149995799|NCT03622112|541117980|FG002|Overall Study|Death|0|||
149995800|NCT03622112|541117981|FG003|Overall Study|Death|1|||
149995801|NCT03622112|541117982|FG004|Overall Study|Death|0|||
149995802|NCT03622112|541117983|FG005|Overall Study|Death|0|||
149995803|NCT03622112|541117984|FG006|Overall Study|Death|0|||
149995804|NCT03622112|541117978|FG000|Overall Study|Lost to Follow-up|1|||
149995805|NCT03622112|541117979|FG001|Overall Study|Lost to Follow-up|1|||
149995806|NCT03622112|541117980|FG002|Overall Study|Lost to Follow-up|0|||
149995807|NCT03622112|541117981|FG003|Overall Study|Lost to Follow-up|0|||
149995808|NCT03622112|541117982|FG004|Overall Study|Lost to Follow-up|0|||
149995809|NCT03622112|541117983|FG005|Overall Study|Lost to Follow-up|0|||
149995810|NCT03622112|541117984|FG006|Overall Study|Lost to Follow-up|0|||
149995811|NCT03622112|541117978|FG000|Overall Study|Study-specific withdrawal criteria|10|||
149995812|NCT03622112|541117979|FG001|Overall Study|Study-specific withdrawal criteria|8|||
149995813|NCT03622112|541117980|FG002|Overall Study|Study-specific withdrawal criteria|7|||
149995814|NCT03622112|541117981|FG003|Overall Study|Study-specific withdrawal criteria|6|||
149995815|NCT03622112|541117982|FG004|Overall Study|Study-specific withdrawal criteria|4|||
149995816|NCT03622112|541117983|FG005|Overall Study|Study-specific withdrawal criteria|18|||
149995817|NCT03622112|541117984|FG006|Overall Study|Study-specific withdrawal criteria|4|||
149995818|NCT03622112|541117978|FG000|Overall Study|Protocol Violation|2|||
149995819|NCT03622112|541117979|FG001|Overall Study|Protocol Violation|0|||
149995820|NCT03622112|541117980|FG002|Overall Study|Protocol Violation|1|||
149995821|NCT03622112|541117981|FG003|Overall Study|Protocol Violation|1|||
149995822|NCT03622112|541117982|FG004|Overall Study|Protocol Violation|0|||
149995823|NCT03622112|541117983|FG005|Overall Study|Protocol Violation|0|||
149995824|NCT03622112|541117984|FG006|Overall Study|Protocol Violation|0|||
149995825|NCT03622112|541117978|FG000|Overall Study|Adverse Event|6|||
149995826|NCT03622112|541117979|FG001|Overall Study|Adverse Event|8|||
149995827|NCT03622112|541117980|FG002|Overall Study|Adverse Event|4|||
149995828|NCT03622112|541117981|FG003|Overall Study|Adverse Event|11|||
149995829|NCT03622112|541117982|FG004|Overall Study|Adverse Event|4|||
149995830|NCT03622112|541117983|FG005|Overall Study|Adverse Event|20|||
149995831|NCT03622112|541117984|FG006|Overall Study|Adverse Event|2|||
149995832|NCT03622112|541117978|FG000|Overall Study|Reason not specified|0|||
149995833|NCT03622112|541117979|FG001|Overall Study|Reason not specified|1|||
149995834|NCT03622112|541117980|FG002|Overall Study|Reason not specified|0|||
149995835|NCT03622112|541117981|FG003|Overall Study|Reason not specified|1|||
149995836|NCT03622112|541117982|FG004|Overall Study|Reason not specified|1|||
149995837|NCT03622112|541117983|FG005|Overall Study|Reason not specified|2|||
149995838|NCT03622112|541117984|FG006|Overall Study|Reason not specified|1|||
149995839|NCT01165320|541117985|FG000|Overall Study|Clinical adverse experience|2|||
149995840|NCT01165320|541117986|FG001|Overall Study|Clinical adverse experience|1|||
149995841|NCT01165320|541117987|FG002|Overall Study|Clinical adverse experience|0|||
149995842|NCT01165320|541117985|FG000|Overall Study|Laboratory adverse experience|1|||
149995843|NCT01165320|541117986|FG001|Overall Study|Laboratory adverse experience|0|||
149995844|NCT01165320|541117987|FG002|Overall Study|Laboratory adverse experience|0|||
149995845|NCT01165320|541117985|FG000|Overall Study|Lack of Efficacy|0|||
149995846|NCT01165320|541117986|FG001|Overall Study|Lack of Efficacy|2|||
149995847|NCT01165320|541117987|FG002|Overall Study|Lack of Efficacy|0|||
149995848|NCT01165320|541117985|FG000|Overall Study|Reason unknown|0|||
149995849|NCT01165320|541117986|FG001|Overall Study|Reason unknown|1|||
149995850|NCT01165320|541117987|FG002|Overall Study|Reason unknown|0|||
149995851|NCT00385944|541117989|FG000|1st Maintenance Dose Period|Physician Decision|1|||
149995852|NCT00385944|541117990|FG001|1st Maintenance Dose Period|Physician Decision|0|||
149995853|NCT00385944|541117991|FG002|1st Maintenance Dose Period|Physician Decision|0|||
149995854|NCT00385944|541117989|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
149995855|NCT00385944|541117990|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
149995856|NCT00385944|541117991|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
149995857|NCT00385944|541117989|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
149995858|NCT00385944|541117990|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
149995859|NCT00385944|541117991|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
149995860|NCT00385944|541117989|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
149995861|NCT00385944|541117990|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
149995862|NCT00385944|541117991|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
149995863|NCT01155466|541117992|FG000|Overall Study|Adverse Event|13|||
149995864|NCT01155466|541117993|FG001|Overall Study|Adverse Event|15|||
149995865|NCT01155466|541117994|FG002|Overall Study|Adverse Event|6|||
149995866|NCT01155466|541117995|FG003|Overall Study|Adverse Event|17|||
149995867|NCT01155466|541117996|FG004|Overall Study|Adverse Event|18|||
149995868|NCT01155466|541117992|FG000|Overall Study|Lost to Follow-up|0|||
149995869|NCT01155466|541117993|FG001|Overall Study|Lost to Follow-up|0|||
149995870|NCT01155466|541117994|FG002|Overall Study|Lost to Follow-up|0|||
149995871|NCT01155466|541117995|FG003|Overall Study|Lost to Follow-up|0|||
149995872|NCT01155466|541117996|FG004|Overall Study|Lost to Follow-up|2|||
149995873|NCT01155466|541117992|FG000|Overall Study|Withdrawal by Subject|7|||
149995874|NCT01155466|541117993|FG001|Overall Study|Withdrawal by Subject|5|||
149995875|NCT01155466|541117994|FG002|Overall Study|Withdrawal by Subject|9|||
149995876|NCT01155466|541117995|FG003|Overall Study|Withdrawal by Subject|4|||
149995877|NCT01155466|541117996|FG004|Overall Study|Withdrawal by Subject|4|||
149995878|NCT01155466|541117992|FG000|Overall Study|Protocol Violation|0|||
149995879|NCT01155466|541117993|FG001|Overall Study|Protocol Violation|0|||
149995880|NCT01155466|541117994|FG002|Overall Study|Protocol Violation|2|||
149995881|NCT01155466|541117995|FG003|Overall Study|Protocol Violation|0|||
149995882|NCT01155466|541117996|FG004|Overall Study|Protocol Violation|1|||
149995883|NCT01155466|541117992|FG000|Overall Study|Administrative|0|||
149995884|NCT01155466|541117993|FG001|Overall Study|Administrative|3|||
149995885|NCT01155466|541117994|FG002|Overall Study|Administrative|0|||
149995886|NCT01155466|541117995|FG003|Overall Study|Administrative|0|||
149995887|NCT01155466|541117996|FG004|Overall Study|Administrative|0|||
149995888|NCT01155466|541117992|FG000|Overall Study|Randomized not treated|2|||
149995889|NCT01155466|541117993|FG001|Overall Study|Randomized not treated|2|||
149995890|NCT01155466|541117994|FG002|Overall Study|Randomized not treated|3|||
149995891|NCT01155466|541117995|FG003|Overall Study|Randomized not treated|0|||
149995892|NCT01155466|541117996|FG004|Overall Study|Randomized not treated|2|||
149995893|NCT00590824|541117997|FG000|Overall Study|Disease could not be resected|0|||
149995894|NCT00590824|541117998|FG001|Overall Study|Disease could not be resected|2|||
149995895|NCT00590824|541117999|FG002|Overall Study|Disease could not be resected|1|||
149995896|NCT00590824|541118000|FG003|Overall Study|Disease could not be resected|0|||
149995897|NCT00590824|541117997|FG000|Overall Study|Adverse Event|0|||
149995898|NCT00590824|541117998|FG001|Overall Study|Adverse Event|0|||
149995899|NCT00590824|541117999|FG002|Overall Study|Adverse Event|0|||
149995900|NCT00590824|541118000|FG003|Overall Study|Adverse Event|1|||
149995901|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
149995902|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
149995903|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
149995904|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
149995905|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
149995906|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
149995907|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
149995908|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
149995909|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
150179085|NCT01985334|541793928|FG005|Overall Study|Other|6|||
150179086|NCT01985334|541793929|FG006|Overall Study|Other|2|||
150179087|NCT01985334|541793930|FG007|Overall Study|Other|2|||
150179088|NCT01985334|541793923|FG000|Overall Study|Medication non-compliance|0|||
150179089|NCT01985334|541793924|FG001|Overall Study|Medication non-compliance|4|||
150179090|NCT01985334|541793925|FG002|Overall Study|Medication non-compliance|1|||
150179091|NCT01985334|541793926|FG003|Overall Study|Medication non-compliance|6|||
150179092|NCT01985334|541793927|FG004|Overall Study|Medication non-compliance|2|||
150179093|NCT01985334|541793928|FG005|Overall Study|Medication non-compliance|3|||
150179094|NCT01985334|541793929|FG006|Overall Study|Medication non-compliance|1|||
150179095|NCT01985334|541793930|FG007|Overall Study|Medication non-compliance|3|||
150179096|NCT01985334|541793923|FG000|Overall Study|Use of prohibited treatment|1|||
150054068|NCT01185353|541338451|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
150054069|NCT01185353|541338452|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
149995910|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
149995911|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Other|1|||
149995912|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Other|1|||
149995913|NCT02075047|541118001|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
149995914|NCT02075047|541118002|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
149995915|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
149995916|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
149995917|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
149995918|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
149995919|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
149995920|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
149995921|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
149995922|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
149995923|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
149995924|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
149995925|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Other|1|||
149995926|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Other|2|||
149995927|NCT02075047|541118001|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
149995928|NCT02075047|541118002|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
149995929|NCT01229254|541118003|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
149995930|NCT01229254|541118004|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
149995931|NCT01229254|541118005|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
149995932|NCT01229254|541118003|FG000|Overall Study|Adverse Event|4|||
149995933|NCT01229254|541118004|FG001|Overall Study|Adverse Event|5|||
149995934|NCT01229254|541118005|FG002|Overall Study|Adverse Event|3|||
149995935|NCT01229254|541118003|FG000|Overall Study|Lost to Follow-up|3|||
149995936|NCT01229254|541118004|FG001|Overall Study|Lost to Follow-up|0|||
149995937|NCT01229254|541118005|FG002|Overall Study|Lost to Follow-up|1|||
149995938|NCT01229254|541118003|FG000|Overall Study|Physician Decision|0|||
150054070|NCT01185353|541338453|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
150054071|NCT01185353|541338454|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
149995939|NCT01229254|541118004|FG001|Overall Study|Physician Decision|3|||
149995940|NCT01229254|541118005|FG002|Overall Study|Physician Decision|0|||
149995941|NCT01229254|541118003|FG000|Overall Study|Protocol Violation|4|||
150054072|NCT01185353|541338445|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
150054073|NCT01185353|541338446|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
150054074|NCT01185353|541338447|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
149995942|NCT01229254|541118004|FG001|Overall Study|Protocol Violation|6|||
149995943|NCT01229254|541118005|FG002|Overall Study|Protocol Violation|5|||
149995944|NCT01229254|541118003|FG000|Overall Study|Withdrawal by Subject|1|||
149995945|NCT01229254|541118004|FG001|Overall Study|Withdrawal by Subject|0|||
149995946|NCT01229254|541118005|FG002|Overall Study|Withdrawal by Subject|1|||
149995947|NCT01229254|541118003|FG000|Overall Study|Non-compliance with Study Drug|0|||
150179097|NCT01985334|541793924|FG001|Overall Study|Use of prohibited treatment|4|||
150179098|NCT01985334|541793925|FG002|Overall Study|Use of prohibited treatment|1|||
150179099|NCT01985334|541793926|FG003|Overall Study|Use of prohibited treatment|2|||
150179100|NCT01985334|541793927|FG004|Overall Study|Use of prohibited treatment|1|||
150054075|NCT01185353|541338448|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149995948|NCT01229254|541118004|FG001|Overall Study|Non-compliance with Study Drug|1|||
149995949|NCT01229254|541118005|FG002|Overall Study|Non-compliance with Study Drug|1|||
149995950|NCT01778049|541118006|FG000|Open Label Treatment Period|Adverse Event|5|||
149995951|NCT01778049|541118007|FG001|Open Label Treatment Period|Adverse Event|15|||
149995952|NCT01778049|541118008|FG002|Open Label Treatment Period|Adverse Event|0|||
149995953|NCT01778049|541118009|FG003|Open Label Treatment Period|Adverse Event|0|||
149995954|NCT01778049|541118010|FG004|Open Label Treatment Period|Adverse Event|0|||
149995955|NCT01778049|541118011|FG005|Open Label Treatment Period|Adverse Event|0|||
149995956|NCT01778049|541118006|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
149995957|NCT01778049|541118007|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
149995958|NCT01778049|541118008|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
149995959|NCT01778049|541118009|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
149995960|NCT01778049|541118010|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
149995961|NCT01778049|541118011|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
149995962|NCT01778049|541118006|FG000|Open Label Treatment Period|Protocol Violation|5|||
149995963|NCT01778049|541118007|FG001|Open Label Treatment Period|Protocol Violation|5|||
149995964|NCT01778049|541118008|FG002|Open Label Treatment Period|Protocol Violation|0|||
149995965|NCT01778049|541118009|FG003|Open Label Treatment Period|Protocol Violation|0|||
149995966|NCT01778049|541118010|FG004|Open Label Treatment Period|Protocol Violation|0|||
149995967|NCT01778049|541118011|FG005|Open Label Treatment Period|Protocol Violation|0|||
149995968|NCT01778049|541118006|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
149995969|NCT01778049|541118007|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
149995970|NCT01778049|541118008|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
149995971|NCT01778049|541118009|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
149995972|NCT01778049|541118010|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
149995973|NCT01778049|541118011|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
149995974|NCT01778049|541118006|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
149995975|NCT01778049|541118007|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
149995976|NCT01778049|541118008|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
149995977|NCT01778049|541118009|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
149995978|NCT01778049|541118010|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
149995979|NCT01778049|541118011|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
149995980|NCT01778049|541118006|FG000|Open Label Treatment Period|Not treated|2|||
149995981|NCT01778049|541118007|FG001|Open Label Treatment Period|Not treated|1|||
149995982|NCT01778049|541118008|FG002|Open Label Treatment Period|Not treated|0|||
149995983|NCT01778049|541118009|FG003|Open Label Treatment Period|Not treated|0|||
149995984|NCT01778049|541118010|FG004|Open Label Treatment Period|Not treated|0|||
149995985|NCT01778049|541118011|FG005|Open Label Treatment Period|Not treated|0|||
149995986|NCT01778049|541118006|FG000|Open Label Treatment Period|Other reason not defined above|77|||
149995987|NCT01778049|541118007|FG001|Open Label Treatment Period|Other reason not defined above|94|||
149995988|NCT01778049|541118008|FG002|Open Label Treatment Period|Other reason not defined above|0|||
149995989|NCT01778049|541118009|FG003|Open Label Treatment Period|Other reason not defined above|0|||
149995990|NCT01778049|541118010|FG004|Open Label Treatment Period|Other reason not defined above|0|||
149995991|NCT01778049|541118011|FG005|Open Label Treatment Period|Other reason not defined above|0|||
149995992|NCT01778049|541118006|FG000|Double Blind Treatment Period|Adverse Event|0|||
149995993|NCT01778049|541118007|FG001|Double Blind Treatment Period|Adverse Event|0|||
149995994|NCT01778049|541118008|FG002|Double Blind Treatment Period|Adverse Event|4|||
149995995|NCT01778049|541118009|FG003|Double Blind Treatment Period|Adverse Event|5|||
150054076|NCT01185353|541338449|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
150054077|NCT01185353|541338450|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
150054078|NCT01185353|541338451|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149995996|NCT01778049|541118010|FG004|Double Blind Treatment Period|Adverse Event|3|||
149995997|NCT01778049|541118011|FG005|Double Blind Treatment Period|Adverse Event|2|||
149995998|NCT01778049|541118006|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
149995999|NCT01778049|541118007|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
149996000|NCT01778049|541118008|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
149996001|NCT01778049|541118009|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
149996002|NCT01778049|541118010|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
149996003|NCT01778049|541118011|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
149996004|NCT01778049|541118006|FG000|Double Blind Treatment Period|Protocol Violation|0|||
149996005|NCT01778049|541118007|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149996006|NCT01778049|541118008|FG002|Double Blind Treatment Period|Protocol Violation|2|||
149996007|NCT01778049|541118009|FG003|Double Blind Treatment Period|Protocol Violation|0|||
149996008|NCT01778049|541118010|FG004|Double Blind Treatment Period|Protocol Violation|0|||
149996009|NCT01778049|541118011|FG005|Double Blind Treatment Period|Protocol Violation|0|||
149996010|NCT01778049|541118006|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
149996011|NCT01778049|541118007|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149996012|NCT01778049|541118008|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
150054079|NCT01185353|541338452|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149996013|NCT01778049|541118009|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
149996014|NCT01778049|541118010|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
149996015|NCT01778049|541118011|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
149996016|NCT01778049|541118006|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
149996017|NCT01778049|541118007|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
149996018|NCT01778049|541118008|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
149996019|NCT01778049|541118009|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
149996020|NCT01778049|541118010|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149996021|NCT01778049|541118011|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
149996022|NCT01778049|541118006|FG000|Double Blind Treatment Period|Not treated|0|||
149996023|NCT01778049|541118007|FG001|Double Blind Treatment Period|Not treated|0|||
149996024|NCT01778049|541118008|FG002|Double Blind Treatment Period|Not treated|0|||
149996025|NCT01778049|541118009|FG003|Double Blind Treatment Period|Not treated|2|||
149996026|NCT01778049|541118010|FG004|Double Blind Treatment Period|Not treated|2|||
149996027|NCT01778049|541118011|FG005|Double Blind Treatment Period|Not treated|0|||
149996028|NCT01778049|541118006|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
149996029|NCT01778049|541118007|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
149996030|NCT01778049|541118008|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
149996031|NCT01778049|541118009|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
149996032|NCT01778049|541118010|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
149996033|NCT01778049|541118011|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
149996034|NCT02118766|541118016|FG000|Overall Study|Adverse Event|7|||
149996035|NCT02118766|541118017|FG001|Overall Study|Adverse Event|2|||
149996036|NCT02118766|541118016|FG000|Overall Study|Withdrawal by Subject|3|||
149996037|NCT02118766|541118017|FG001|Overall Study|Withdrawal by Subject|6|||
149996038|NCT02118766|541118016|FG000|Overall Study|Lost to Follow-up|5|||
149996039|NCT02118766|541118017|FG001|Overall Study|Lost to Follow-up|4|||
149996040|NCT02118766|541118016|FG000|Overall Study|Withdrawal by parent/guardian|12|||
149996041|NCT02118766|541118017|FG001|Overall Study|Withdrawal by parent/guardian|18|||
149996042|NCT02118766|541118016|FG000|Overall Study|Other|3|||
149996043|NCT02118766|541118017|FG001|Overall Study|Other|1|||
149996044|NCT00541866|541118020|FG000|Overall Study|Adverse Event|3|||
149996045|NCT00541866|541118021|FG001|Overall Study|Adverse Event|0|||
149996046|NCT00541866|541118022|FG002|Overall Study|Adverse Event|0|||
149996047|NCT00541866|541118023|FG003|Overall Study|Adverse Event|0|||
149996048|NCT00541866|541118024|FG004|Overall Study|Adverse Event|0|||
149996049|NCT00541866|541118020|FG000|Overall Study|Death|1|||
149996050|NCT00541866|541118021|FG001|Overall Study|Death|0|||
149996051|NCT00541866|541118022|FG002|Overall Study|Death|0|||
149996052|NCT00541866|541118023|FG003|Overall Study|Death|0|||
149996053|NCT00541866|541118024|FG004|Overall Study|Death|0|||
149996054|NCT00541866|541118020|FG000|Overall Study|Lack of Efficacy|19|||
149996055|NCT00541866|541118021|FG001|Overall Study|Lack of Efficacy|15|||
149996056|NCT00541866|541118022|FG002|Overall Study|Lack of Efficacy|10|||
150179101|NCT01985334|541793928|FG005|Overall Study|Use of prohibited treatment|6|||
150179102|NCT01985334|541793929|FG006|Overall Study|Use of prohibited treatment|2|||
149996057|NCT00541866|541118023|FG003|Overall Study|Lack of Efficacy|12|||
149996058|NCT00541866|541118024|FG004|Overall Study|Lack of Efficacy|14|||
149996059|NCT00541866|541118020|FG000|Overall Study|Not Reported or Other|11|||
149996060|NCT00541866|541118021|FG001|Overall Study|Not Reported or Other|3|||
149996061|NCT00541866|541118022|FG002|Overall Study|Not Reported or Other|3|||
149996062|NCT00541866|541118023|FG003|Overall Study|Not Reported or Other|3|||
149996063|NCT00541866|541118024|FG004|Overall Study|Not Reported or Other|1|||
149996064|NCT00541866|541118020|FG000|Overall Study|Physician Decision|0|||
149996065|NCT00541866|541118021|FG001|Overall Study|Physician Decision|0|||
149996066|NCT00541866|541118022|FG002|Overall Study|Physician Decision|2|||
149996067|NCT00541866|541118023|FG003|Overall Study|Physician Decision|1|||
149996068|NCT00541866|541118024|FG004|Overall Study|Physician Decision|0|||
149996069|NCT01638013|541118025|FG000|Overall Study|Adverse Event|36|||
149996070|NCT01638013|541118026|FG001|Overall Study|Adverse Event|29|||
149996071|NCT01638013|541118027|FG002|Overall Study|Adverse Event|48|||
149996072|NCT01638013|541118025|FG000|Overall Study|Lack of Efficacy|39|||
150179103|NCT01985334|541793930|FG007|Overall Study|Use of prohibited treatment|0|||
149996073|NCT01638013|541118026|FG001|Overall Study|Lack of Efficacy|11|||
149996074|NCT01638013|541118027|FG002|Overall Study|Lack of Efficacy|14|||
149996075|NCT01638013|541118025|FG000|Overall Study|Protocol Violation|10|||
149996076|NCT01638013|541118026|FG001|Overall Study|Protocol Violation|7|||
149996077|NCT01638013|541118027|FG002|Overall Study|Protocol Violation|11|||
149996078|NCT01638013|541118025|FG000|Overall Study|Met discontinuation criteria|4|||
149996079|NCT01638013|541118026|FG001|Overall Study|Met discontinuation criteria|0|||
149996080|NCT01638013|541118027|FG002|Overall Study|Met discontinuation criteria|7|||
149996081|NCT01638013|541118025|FG000|Overall Study|Subject Lost to Follow up|1|||
150179104|NCT01985334|541793923|FG000|Overall Study|Investigator decision|0|||
150179105|NCT01985334|541793924|FG001|Overall Study|Investigator decision|3|||
149996082|NCT01638013|541118026|FG001|Overall Study|Subject Lost to Follow up|0|||
149996083|NCT01638013|541118027|FG002|Overall Study|Subject Lost to Follow up|1|||
149996084|NCT01638013|541118025|FG000|Overall Study|Miscellaneous|25|||
149996085|NCT01638013|541118026|FG001|Overall Study|Miscellaneous|19|||
149996086|NCT01638013|541118027|FG002|Overall Study|Miscellaneous|23|||
149996087|NCT01638013|541118025|FG000|Overall Study|Withdrawal of Consent|16|||
149996088|NCT01638013|541118026|FG001|Overall Study|Withdrawal of Consent|12|||
149996089|NCT01638013|541118027|FG002|Overall Study|Withdrawal of Consent|16|||
149996090|NCT01638013|541118025|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
149996091|NCT01638013|541118026|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
149996092|NCT01638013|541118027|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
149996093|NCT01824823|541118028|FG000|Overall Study|Lack of Efficacy|1|||
149996094|NCT01824823|541118029|FG001|Overall Study|Lack of Efficacy|1|||
149996095|NCT01824823|541118028|FG000|Overall Study|Off-treatment reason not submitted|1|||
149996096|NCT01824823|541118029|FG001|Overall Study|Off-treatment reason not submitted|0|||
149996097|NCT02576535|541119541|FG000|Overall Study|Withdrawal by Subject|2|||
149996098|NCT04035564|541119543|FG000|Overall Study|Protocol Violation|1|||
149996099|NCT04035564|541119544|FG001|Overall Study|Protocol Violation|2|||
149996100|NCT04035564|541119543|FG000|Overall Study|No laboratory available|2|||
149996101|NCT04035564|541119544|FG001|Overall Study|No laboratory available|2|||
149996102|NCT04035564|541119543|FG000|Overall Study|Guardian declined consent|1|||
149996103|NCT04035564|541119544|FG001|Overall Study|Guardian declined consent|2|||
149996104|NCT00996281|541119545|FG000|Overall Study|Adverse Event|75|||
149996105|NCT00996281|541119546|FG001|Overall Study|Adverse Event|37|||
149996106|NCT00996281|541119545|FG000|Overall Study|Major Protocol Deviation|6|||
149996107|NCT00996281|541119546|FG001|Overall Study|Major Protocol Deviation|7|||
149996108|NCT00996281|541119545|FG000|Overall Study|Lost to Follow-up|14|||
149996109|NCT00996281|541119546|FG001|Overall Study|Lost to Follow-up|16|||
149996110|NCT00996281|541119545|FG000|Overall Study|Withdrawal by Subject|31|||
149996111|NCT00996281|541119546|FG001|Overall Study|Withdrawal by Subject|20|||
149996112|NCT00996281|541119545|FG000|Overall Study|Lack of Efficacy|0|||
149996113|NCT00996281|541119546|FG001|Overall Study|Lack of Efficacy|2|||
149996114|NCT00996281|541119545|FG000|Overall Study|Other|5|||
149996115|NCT00996281|541119546|FG001|Overall Study|Other|7|||
149996116|NCT03505788|541119549|FG000|Overall Study|Lost to Follow-up|2|||
149996117|NCT03505788|541119550|FG001|Overall Study|Lost to Follow-up|1|||
149996118|NCT03505788|541119549|FG000|Overall Study|Withdrawal by Subject|1|||
149996119|NCT03505788|541119550|FG001|Overall Study|Withdrawal by Subject|3|||
149996120|NCT03505788|541119549|FG000|Overall Study|Physician Decision|0|||
149996121|NCT03505788|541119550|FG001|Overall Study|Physician Decision|1|||
149996122|NCT03575065|541119551|FG000|Overall Study|Death|31|||
149996123|NCT03575065|541119552|FG001|Overall Study|Death|12|||
149996124|NCT03575065|541119551|FG000|Overall Study|Sponsor's Decision|28|||
149996125|NCT03575065|541119552|FG001|Overall Study|Sponsor's Decision|13|||
149996126|NCT03575065|541119551|FG000|Overall Study|Withdrawal by Subject|2|||
149996127|NCT03575065|541119552|FG001|Overall Study|Withdrawal by Subject|1|||
149996128|NCT03575065|541119551|FG000|Overall Study|Lost to Follow-up|1|||
149996129|NCT03575065|541119552|FG001|Overall Study|Lost to Follow-up|0|||
149996130|NCT02323126|541119557|FG000|Overall Study|Patient / guardian decision|0|||
149996131|NCT02323126|541119558|FG001|Overall Study|Patient / guardian decision|1|||
149996132|NCT02323126|541119559|FG002|Overall Study|Patient / guardian decision|2|||
149996133|NCT02323126|541119557|FG000|Overall Study|Progressive disease|14|||
149996134|NCT02323126|541119558|FG001|Overall Study|Progressive disease|8|||
149996135|NCT02323126|541119559|FG002|Overall Study|Progressive disease|14|||
149996136|NCT02323126|541119557|FG000|Overall Study|Physician Decision|0|||
149996137|NCT02323126|541119558|FG001|Overall Study|Physician Decision|1|||
149996138|NCT02323126|541119559|FG002|Overall Study|Physician Decision|3|||
149996139|NCT02323126|541119557|FG000|Overall Study|Death|1|||
149996140|NCT02323126|541119558|FG001|Overall Study|Death|1|||
149996141|NCT02323126|541119559|FG002|Overall Study|Death|4|||
149996142|NCT02323126|541119557|FG000|Overall Study|Adverse Event|3|||
149996143|NCT02323126|541119558|FG001|Overall Study|Adverse Event|5|||
149996144|NCT02323126|541119559|FG002|Overall Study|Adverse Event|7|||
149996145|NCT03333252|541119560|FG000|Overall Study|Adverse Event|10|||
149996146|NCT03333252|541119561|FG001|Overall Study|Adverse Event|6|||
149996147|NCT03333252|541119562|FG002|Overall Study|Adverse Event|5|||
149996148|NCT03333252|541119563|FG003|Overall Study|Adverse Event|2|||
149996149|NCT03333252|541119560|FG000|Overall Study|Death|1|||
149996150|NCT03333252|541119561|FG001|Overall Study|Death|3|||
149996151|NCT03333252|541119562|FG002|Overall Study|Death|0|||
149996152|NCT03333252|541119563|FG003|Overall Study|Death|0|||
149996153|NCT03333252|541119560|FG000|Overall Study|Lack of Efficacy|8|||
149996154|NCT03333252|541119561|FG001|Overall Study|Lack of Efficacy|4|||
149996155|NCT03333252|541119562|FG002|Overall Study|Lack of Efficacy|0|||
149996156|NCT03333252|541119563|FG003|Overall Study|Lack of Efficacy|7|||
149996157|NCT03333252|541119560|FG000|Overall Study|Lost to Follow-up|0|||
149996158|NCT03333252|541119561|FG001|Overall Study|Lost to Follow-up|5|||
149996159|NCT03333252|541119562|FG002|Overall Study|Lost to Follow-up|9|||
149996160|NCT03333252|541119563|FG003|Overall Study|Lost to Follow-up|3|||
149996161|NCT03333252|541119560|FG000|Overall Study|Withdrawal by Subject|14|||
149996162|NCT03333252|541119561|FG001|Overall Study|Withdrawal by Subject|24|||
149996163|NCT03333252|541119562|FG002|Overall Study|Withdrawal by Subject|11|||
149996164|NCT03333252|541119563|FG003|Overall Study|Withdrawal by Subject|17|||
149996165|NCT00113399|541119564|FG000|Overall Study|Death|1|||
149996166|NCT00113399|541119565|FG001|Overall Study|Death|1|||
149996167|NCT00113399|541119564|FG000|Overall Study|Withdrawal by Subject|1|||
149996168|NCT00113399|541119565|FG001|Overall Study|Withdrawal by Subject|2|||
149996169|NCT00113399|541119564|FG000|Overall Study|Complete Response|0|||
149996170|NCT00113399|541119565|FG001|Overall Study|Complete Response|1|||
149996171|NCT00113399|541119564|FG000|Overall Study|Other|0|||
149996172|NCT00113399|541119565|FG001|Overall Study|Other|1|||
149996173|NCT00396136|541119566|FG000|Overall Study|Death|43|||
149996174|NCT00396136|541119566|FG000|Overall Study|Withdrawal by Subject|59|||
149996175|NCT00396136|541119566|FG000|Overall Study|Lost to Follow-up|15|||
149996176|NCT00396136|541119566|FG000|Overall Study|Study device explanted|8|||
149996177|NCT01779856|541119567|FG000|Overall Study|Withdrawal by Subject|15|||
149996178|NCT01779856|541119567|FG000|Overall Study|Death|3|||
149996179|NCT01779856|541119567|FG000|Overall Study|Physician Decision|1|||
149996180|NCT01779856|541119567|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
149996181|NCT01779856|541119567|FG000|Overall Study|Delays in scheduling implant|1|||
149996182|NCT01779856|541119567|FG000|Overall Study|Subject ineligible for Implant|2|||
149996183|NCT03960580|541119568|FG000|Overall Study|Adverse Event|2|||
149996184|NCT03960580|541119569|FG001|Overall Study|Adverse Event|1|||
149996185|NCT03960580|541119570|FG002|Overall Study|Adverse Event|1|||
149996186|NCT03960580|541119568|FG000|Overall Study|Lost to Follow-up|1|||
149996187|NCT03960580|541119569|FG001|Overall Study|Lost to Follow-up|0|||
149996188|NCT03960580|541119570|FG002|Overall Study|Lost to Follow-up|0|||
149996189|NCT03960580|541119568|FG000|Overall Study|Lack of Efficacy|2|||
149996190|NCT03960580|541119569|FG001|Overall Study|Lack of Efficacy|1|||
149996191|NCT03960580|541119570|FG002|Overall Study|Lack of Efficacy|0|||
149996192|NCT03960580|541119568|FG000|Overall Study|Protocol Violation|0|||
149996193|NCT03960580|541119569|FG001|Overall Study|Protocol Violation|0|||
149996194|NCT03960580|541119570|FG002|Overall Study|Protocol Violation|1|||
149996195|NCT03960580|541119568|FG000|Overall Study|Withdrawal by Subject|1|||
149996196|NCT03960580|541119569|FG001|Overall Study|Withdrawal by Subject|1|||
149996197|NCT03960580|541119570|FG002|Overall Study|Withdrawal by Subject|1|||
150054080|NCT01185353|541338453|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
150054081|NCT01185353|541338454|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149996198|NCT03960580|541119568|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
149996199|NCT03960580|541119569|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
149996200|NCT03960580|541119570|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
149996201|NCT02680041|541119580|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
149996202|NCT02680041|541119580|FG000|Overall Study|Lost to Follow-up|2|||
149996203|NCT00521599|541119581|FG000|Overall Study|Adverse Event|5|||
149996204|NCT00521599|541119582|FG001|Overall Study|Adverse Event|7|||
150054082|NCT01185353|541338445|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
150054083|NCT01185353|541338446|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
150054084|NCT01185353|541338447|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
150054085|NCT01185353|541338448|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
150054086|NCT01185353|541338449|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
149996205|NCT00521599|541119583|FG002|Overall Study|Adverse Event|6|||
149996206|NCT00521599|541119581|FG000|Overall Study|Treatment Failure|8|||
149996207|NCT00521599|541119582|FG001|Overall Study|Treatment Failure|9|||
150054087|NCT01185353|541338450|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
150054088|NCT01185353|541338451|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
149996208|NCT00521599|541119583|FG002|Overall Study|Treatment Failure|22|||
149996209|NCT00521599|541119581|FG000|Overall Study|Lost to Follow-up|2|||
149996210|NCT00521599|541119582|FG001|Overall Study|Lost to Follow-up|1|||
149996211|NCT00521599|541119583|FG002|Overall Study|Lost to Follow-up|2|||
149996212|NCT00521599|541119581|FG000|Overall Study|Withdrawal by Subject|3|||
149996213|NCT00521599|541119582|FG001|Overall Study|Withdrawal by Subject|5|||
149996214|NCT00521599|541119583|FG002|Overall Study|Withdrawal by Subject|1|||
149996215|NCT00521599|541119581|FG000|Overall Study|Withdrawal by subject treatment related|3|||
149996216|NCT00521599|541119582|FG001|Overall Study|Withdrawal by subject treatment related|1|||
149996217|NCT00521599|541119583|FG002|Overall Study|Withdrawal by subject treatment related|2|||
149996218|NCT00521599|541119581|FG000|Overall Study|Protocol Violation|2|||
149996219|NCT00521599|541119582|FG001|Overall Study|Protocol Violation|4|||
149996220|NCT00521599|541119583|FG002|Overall Study|Protocol Violation|2|||
149996221|NCT00521599|541119581|FG000|Overall Study|Did not meet protocol eligibility|2|||
149996222|NCT00521599|541119582|FG001|Overall Study|Did not meet protocol eligibility|2|||
149996223|NCT00521599|541119583|FG002|Overall Study|Did not meet protocol eligibility|1|||
149996224|NCT00791479|541119584|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
149996225|NCT00791479|541119585|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
150054089|NCT01185353|541338452|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
149996226|NCT00791479|541119586|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
149996227|NCT00791479|541119587|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
149996228|NCT00791479|541119588|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
149996229|NCT00791479|541119589|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
149996230|NCT00791479|541119584|FG000|Overall Study|Adverse Event|0|||
149996231|NCT00791479|541119585|FG001|Overall Study|Adverse Event|1|||
149996232|NCT00791479|541119586|FG002|Overall Study|Adverse Event|0|||
149996233|NCT00791479|541119587|FG003|Overall Study|Adverse Event|2|||
149996234|NCT00791479|541119588|FG004|Overall Study|Adverse Event|0|||
149996235|NCT00791479|541119589|FG005|Overall Study|Adverse Event|1|||
149996236|NCT00791479|541119584|FG000|Overall Study|Lost to Follow-up|0|||
149996237|NCT00791479|541119585|FG001|Overall Study|Lost to Follow-up|1|||
149996238|NCT00791479|541119586|FG002|Overall Study|Lost to Follow-up|0|||
149996239|NCT00791479|541119587|FG003|Overall Study|Lost to Follow-up|0|||
149996240|NCT00791479|541119588|FG004|Overall Study|Lost to Follow-up|0|||
149996241|NCT00791479|541119589|FG005|Overall Study|Lost to Follow-up|1|||
149996242|NCT00791479|541119584|FG000|Overall Study|Protocol Violation|2|||
149996243|NCT00791479|541119585|FG001|Overall Study|Protocol Violation|1|||
149996244|NCT00791479|541119586|FG002|Overall Study|Protocol Violation|0|||
149996245|NCT00791479|541119587|FG003|Overall Study|Protocol Violation|1|||
149996246|NCT00791479|541119588|FG004|Overall Study|Protocol Violation|0|||
149996247|NCT00791479|541119589|FG005|Overall Study|Protocol Violation|0|||
149996248|NCT00791479|541119584|FG000|Overall Study|Withdrawal by Subject|0|||
149996249|NCT00791479|541119585|FG001|Overall Study|Withdrawal by Subject|0|||
149996250|NCT00791479|541119586|FG002|Overall Study|Withdrawal by Subject|0|||
149996251|NCT00791479|541119587|FG003|Overall Study|Withdrawal by Subject|1|||
149996252|NCT00791479|541119588|FG004|Overall Study|Withdrawal by Subject|0|||
149996253|NCT00791479|541119589|FG005|Overall Study|Withdrawal by Subject|1|||
149996254|NCT01610713|541119590|FG000|Overall Study|Adverse Event|3|||
149996255|NCT01610713|541119591|FG001|Overall Study|Adverse Event|0|||
149996256|NCT01610713|541119590|FG000|Overall Study|Lack of Efficacy|1|||
149996257|NCT01610713|541119591|FG001|Overall Study|Lack of Efficacy|0|||
149996258|NCT01610713|541119590|FG000|Overall Study|low mood and poor motivation|1|||
149996259|NCT01610713|541119591|FG001|Overall Study|low mood and poor motivation|0|||
149996260|NCT01610713|541119590|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
149996261|NCT01610713|541119591|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
149996262|NCT01610713|541119590|FG000|Overall Study|Lost to Follow-up|0|||
149996263|NCT01610713|541119591|FG001|Overall Study|Lost to Follow-up|1|||
149996264|NCT01774097|541119597|FG000|Overall Study|Withdrawal by Subject|1|||
149996265|NCT01774097|541119598|FG001|Overall Study|Withdrawal by Subject|1|||
149996266|NCT01774097|541119597|FG000|Overall Study|Adverse Event|1|||
149996267|NCT01774097|541119598|FG001|Overall Study|Adverse Event|1|||
149996268|NCT00557310|541119599|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
149996269|NCT00557310|541119599|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
149996270|NCT00557310|541119599|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
149996271|NCT00557310|541119599|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
149996272|NCT00557310|541119599|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
149996273|NCT00557310|541119599|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
149996274|NCT01920568|541119601|FG000|Overall Study|Adverse Event|27|||
150054090|NCT01185353|541338453|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
150054091|NCT01185353|541338454|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
150054092|NCT01185353|541338445|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
150054093|NCT01185353|541338446|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
150054094|NCT01185353|541338447|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
149996275|NCT01920568|541119602|FG001|Overall Study|Adverse Event|8|||
149996276|NCT01920568|541119601|FG000|Overall Study|Protocol Violation|5|||
149996277|NCT01920568|541119602|FG001|Overall Study|Protocol Violation|3|||
149996278|NCT01920568|541119601|FG000|Overall Study|Lost to Follow-up|2|||
149996279|NCT01920568|541119602|FG001|Overall Study|Lost to Follow-up|2|||
149996280|NCT01920568|541119601|FG000|Overall Study|Physician Decision|13|||
149996281|NCT01920568|541119602|FG001|Overall Study|Physician Decision|4|||
149996282|NCT01920568|541119601|FG000|Overall Study|Withdrawal by Subject|79|||
149996283|NCT01920568|541119602|FG001|Overall Study|Withdrawal by Subject|55|||
149996284|NCT01920568|541119601|FG000|Overall Study|Death due to disease progression|25|||
149996285|NCT01920568|541119602|FG001|Overall Study|Death due to disease progression|12|||
149996286|NCT01703208|541119604|FG000|Overall Study|Death|61|||
149996287|NCT01703208|541119605|FG001|Overall Study|Death|48|||
149996288|NCT01703208|541119604|FG000|Overall Study|Lack of Efficacy|1|||
149996289|NCT01703208|541119605|FG001|Overall Study|Lack of Efficacy|2|||
149996290|NCT01703208|541119604|FG000|Overall Study|Lost to Follow-up|68|||
149996291|NCT01703208|541119605|FG001|Overall Study|Lost to Follow-up|62|||
149996292|NCT01703208|541119604|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149996293|NCT01703208|541119605|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149996294|NCT01703208|541119604|FG000|Overall Study|Excluded Medication|1|||
149996295|NCT01703208|541119605|FG001|Overall Study|Excluded Medication|2|||
149996296|NCT01703208|541119604|FG000|Overall Study|Site Discontinued Study Participation|23|||
149996297|NCT01703208|541119605|FG001|Overall Study|Site Discontinued Study Participation|27|||
149996298|NCT01703208|541119604|FG000|Overall Study|Physician Decision|11|||
149996299|NCT01703208|541119605|FG001|Overall Study|Physician Decision|13|||
149996300|NCT01703208|541119604|FG000|Overall Study|Progressive disease|2|||
149996301|NCT01703208|541119605|FG001|Overall Study|Progressive disease|2|||
149996302|NCT01703208|541119604|FG000|Overall Study|Protocol Violation|1|||
149996303|NCT01703208|541119605|FG001|Overall Study|Protocol Violation|1|||
149996304|NCT01703208|541119604|FG000|Overall Study|Study Terminated by Sponsor|1710|||
149996305|NCT01703208|541119605|FG001|Overall Study|Study Terminated by Sponsor|1716|||
149996306|NCT01703208|541119604|FG000|Overall Study|Withdrawal by Subject|205|||
149996307|NCT01703208|541119605|FG001|Overall Study|Withdrawal by Subject|209|||
149996308|NCT01703208|541119604|FG000|Overall Study|Adverse Event|14|||
149996309|NCT01703208|541119605|FG001|Overall Study|Adverse Event|19|||
149996310|NCT01703208|541119604|FG000|Overall Study|Technical Problems|0|||
149996311|NCT01703208|541119605|FG001|Overall Study|Technical Problems|1|||
149996312|NCT01703208|541119604|FG000|Overall Study|Protocol Deviation|2|||
149996313|NCT01703208|541119605|FG001|Overall Study|Protocol Deviation|0|||
149996314|NCT00252694|541119606|FG000|Overall Study|Withdrawal by Subject|83|||
149996315|NCT00252694|541119607|FG001|Overall Study|Withdrawal by Subject|91|||
149996316|NCT00252694|541119606|FG000|Overall Study|Death|36|||
149996317|NCT00252694|541119607|FG001|Overall Study|Death|34|||
149996318|NCT00252694|541119606|FG000|Overall Study|Mostly Lost to Follow Up|8|||
149996319|NCT00252694|541119607|FG001|Overall Study|Mostly Lost to Follow Up|13|||
149996320|NCT00252694|541119606|FG000|Overall Study|Patient Moving|17|||
149996321|NCT00252694|541119607|FG001|Overall Study|Patient Moving|16|||
149996322|NCT01271712|541119612|FG000|Double Blind Treatment|Death|2|||
149996323|NCT01271712|541119613|FG001|Double Blind Treatment|Death|0|||
149996324|NCT01271712|541119612|FG000|Double Blind Treatment|Lack of Efficacy|1|||
149996325|NCT01271712|541119613|FG001|Double Blind Treatment|Lack of Efficacy|0|||
149996326|NCT01271712|541119612|FG000|Double Blind Treatment|Adverse Event|9|||
149996327|NCT01271712|541119613|FG001|Double Blind Treatment|Adverse Event|4|||
149996328|NCT01271712|541119612|FG000|Double Blind Treatment|Progressive disease|23|||
149996329|NCT01271712|541119613|FG001|Double Blind Treatment|Progressive disease|3|||
149996330|NCT01271712|541119612|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
149996331|NCT01271712|541119613|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
149996332|NCT01271712|541119612|FG000|Double Blind Treatment|Non compliance with study drug|2|||
149996333|NCT01271712|541119613|FG001|Double Blind Treatment|Non compliance with study drug|0|||
149996334|NCT01271712|541119612|FG000|Double Blind Treatment|receive no study drug|1|||
149996335|NCT01271712|541119613|FG001|Double Blind Treatment|receive no study drug|0|||
149996336|NCT01271712|541119612|FG000|Open Label Treatment|Death|6|||
149996337|NCT01271712|541119613|FG001|Open Label Treatment|Death|5|||
149996338|NCT01271712|541119612|FG000|Open Label Treatment|Withdrawal by Subject|6|||
149996339|NCT01271712|541119613|FG001|Open Label Treatment|Withdrawal by Subject|11|||
149996340|NCT01271712|541119612|FG000|Open Label Treatment|Physician Decision|2|||
149996341|NCT01271712|541119613|FG001|Open Label Treatment|Physician Decision|0|||
149996342|NCT01271712|541119612|FG000|Open Label Treatment|Adverse Event|14|||
149996343|NCT01271712|541119613|FG001|Open Label Treatment|Adverse Event|8|||
149996344|NCT01271712|541119612|FG000|Open Label Treatment|Progressive disease|59|||
149996345|NCT01271712|541119613|FG001|Open Label Treatment|Progressive disease|32|||
149996346|NCT01271712|541119612|FG000|Open Label Treatment|transferred to rollover study|1|||
149996347|NCT01271712|541119613|FG001|Open Label Treatment|transferred to rollover study|0|||
150054095|NCT01185353|541338448|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
150054096|NCT01185353|541338449|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
150054097|NCT01185353|541338450|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
150054098|NCT01185353|541338451|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
150054099|NCT01185353|541338452|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
150054100|NCT01185353|541338453|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
149996348|NCT01271712|541119612|FG000|Open Label Treatment|Non-compliance with study drug|1|||
149996349|NCT01271712|541119613|FG001|Open Label Treatment|Non-compliance with study drug|0|||
149996350|NCT01271712|541119612|FG000|Open Label Treatment|Protocol Violation|0|||
149996351|NCT01271712|541119613|FG001|Open Label Treatment|Protocol Violation|1|||
149996352|NCT01271712|541119612|FG000|Open Label Treatment|Switching to other therapy|2|||
149996353|NCT01271712|541119613|FG001|Open Label Treatment|Switching to other therapy|1|||
149996354|NCT01271712|541119612|FG000|Safety Follow-up|Death|11|||
149996355|NCT01271712|541119613|FG001|Safety Follow-up|Death|7|||
149996356|NCT01271712|541119612|FG000|Safety Follow-up|Withdrawal by Subject|4|||
149996357|NCT01271712|541119613|FG001|Safety Follow-up|Withdrawal by Subject|2|||
150054101|NCT01185353|541338454|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
149996358|NCT01271712|541119612|FG000|Safety Follow-up|Protocol Violation|1|||
149996359|NCT01271712|541119613|FG001|Safety Follow-up|Protocol Violation|1|||
149996360|NCT01271712|541119612|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
149996361|NCT01271712|541119613|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
149996362|NCT01271712|541119612|FG000|Safety Follow-up|No follow-up|1|||
149996363|NCT01271712|541119613|FG001|Safety Follow-up|No follow-up|1|||
149996364|NCT01271712|541119612|FG000|Safety Follow-up|Progressive disease|1|||
149996365|NCT01271712|541119613|FG001|Safety Follow-up|Progressive disease|0|||
149996366|NCT01271712|541119612|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
149996367|NCT01271712|541119613|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
149996368|NCT00096226|541119614|FG000|Overall Study|Ineligible|2|||
149996369|NCT00096226|541119614|FG000|Overall Study|Protocol treatment not started|1|||
149996370|NCT04003207|541119615|FG000|Overall Study|Protocol Violation|1|||
149996371|NCT00468676|541119616|FG000|Overall Study|Lost to Follow-up|14|||
149996372|NCT00468676|541119617|FG001|Overall Study|Lost to Follow-up|11|||
149996373|NCT00468676|541119616|FG000|Overall Study|Death|2|||
149996374|NCT00468676|541119617|FG001|Overall Study|Death|1|||
149996375|NCT04173260|541119618|FG000|Overall Study|Early termination|4|||
149996376|NCT03941964|541119619|FG000|Overall Study|Adverse Event|1|||
149996377|NCT03941964|541119620|FG001|Overall Study|Adverse Event|8|||
149996378|NCT03941964|541119619|FG000|Overall Study|Progressive disease|7|||
149996379|NCT03941964|541119620|FG001|Overall Study|Progressive disease|3|||
149996380|NCT03941964|541119619|FG000|Overall Study|Lack of Efficacy|0|||
149996381|NCT03941964|541119620|FG001|Overall Study|Lack of Efficacy|1|||
149996382|NCT03941964|541119619|FG000|Overall Study|Death|3|||
149996383|NCT03941964|541119620|FG001|Overall Study|Death|1|||
149996384|NCT03941964|541119619|FG000|Overall Study|Withdrew consent|1|||
149996385|NCT03941964|541119620|FG001|Overall Study|Withdrew consent|3|||
149996386|NCT03941964|541119619|FG000|Overall Study|Physician Decision|9|||
149996387|NCT03941964|541119620|FG001|Overall Study|Physician Decision|2|||
149996388|NCT03941964|541119619|FG000|Overall Study|Other, not specified|2|||
149996389|NCT03941964|541119620|FG001|Overall Study|Other, not specified|1|||
149996390|NCT00443053|541119621|FG000|Overall Study|Adverse Event|2|||
149996391|NCT00443053|541119622|FG001|Overall Study|Adverse Event|1|||
149996392|NCT00443053|541119621|FG000|Overall Study|Withdrawal by Subject|9|||
149996393|NCT00443053|541119622|FG001|Overall Study|Withdrawal by Subject|18|||
149996394|NCT00443053|541119621|FG000|Overall Study|Lost to Follow-up|4|||
149996395|NCT00443053|541119622|FG001|Overall Study|Lost to Follow-up|5|||
149996396|NCT00443053|541119621|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
149996397|NCT00443053|541119622|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
149996398|NCT00443053|541119621|FG000|Overall Study|Noncompliance|2|||
149996399|NCT00443053|541119622|FG001|Overall Study|Noncompliance|1|||
149996400|NCT00443053|541119621|FG000|Overall Study|Other|3|||
149996401|NCT00443053|541119622|FG001|Overall Study|Other|4|||
149996402|NCT00443053|541119621|FG000|Overall Study|Physician Decision|0|||
149996403|NCT00443053|541119622|FG001|Overall Study|Physician Decision|4|||
149996404|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
149996405|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
149996406|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
149996407|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
149996408|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
149996409|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
149996410|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
149996411|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
149996412|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
149996413|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
149996414|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
149996415|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
150054102|NCT01185353|541338445|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
149996416|NCT01632241|541119623|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
149996417|NCT01632241|541119624|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
149996418|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
149996419|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
149996420|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
150054103|NCT01185353|541338446|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
150054104|NCT01185353|541338447|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
149996421|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
149996422|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
149996423|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
149996424|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
149996425|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
149996426|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
149996427|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
149996428|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
149996429|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
149996430|NCT01632241|541119623|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
149996431|NCT01632241|541119624|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
149996432|NCT05463744|541119625|FG000|Treatment Period|Withdrawal by Subject|19|||
149996433|NCT05463744|541119626|FG001|Treatment Period|Withdrawal by Subject|16|||
149996434|NCT05463744|541119625|FG000|Treatment Period|Adverse Event|4|||
149996435|NCT05463744|541119626|FG001|Treatment Period|Adverse Event|4|||
149996436|NCT05463744|541119625|FG000|Treatment Period|Pregnancy|0|||
149996437|NCT05463744|541119626|FG001|Treatment Period|Pregnancy|3|||
149996438|NCT05463744|541119625|FG000|Treatment Period|Lost to Follow-up|1|||
149996439|NCT05463744|541119626|FG001|Treatment Period|Lost to Follow-up|3|||
149996440|NCT05463744|541119625|FG000|Treatment Period|Inadvertent enrollment|2|||
149996441|NCT05463744|541119626|FG001|Treatment Period|Inadvertent enrollment|1|||
149996442|NCT05463744|541119625|FG000|Treatment Period|Death|0|||
149996443|NCT05463744|541119626|FG001|Treatment Period|Death|1|||
149996444|NCT05463744|541119625|FG000|Treatment Period|Non-compliance with Study Drug|1|||
149996445|NCT05463744|541119626|FG001|Treatment Period|Non-compliance with Study Drug|0|||
149996446|NCT05463744|541119625|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
149996447|NCT05463744|541119626|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
149996448|NCT05463744|541119625|FG000|Treatment Period|Physician Decision|0|||
149996449|NCT05463744|541119626|FG001|Treatment Period|Physician Decision|1|||
149996450|NCT05463744|541119625|FG000|Follow-Up Period|Withdrawal by Subject|3|||
149996451|NCT05463744|541119626|FG001|Follow-Up Period|Withdrawal by Subject|1|||
149996452|NCT05463744|541119625|FG000|Follow-Up Period|Lost to Follow-up|1|||
149996453|NCT05463744|541119626|FG001|Follow-Up Period|Lost to Follow-up|1|||
149996454|NCT00068250|541119629|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
149996455|NCT00068250|541119630|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
149996456|NCT00068250|541119631|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
149996457|NCT00068250|541119632|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
149996458|NCT01774253|541119636|FG000|Overall Study|Lack of Efficacy|4|||
149996459|NCT01774253|541119636|FG000|Overall Study|Physician Decision|2|||
149996460|NCT01774253|541119636|FG000|Overall Study|Withdrawal by Subject|2|||
149996461|NCT01774253|541119636|FG000|Overall Study|Death|1|||
149996462|NCT02240368|541119637|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
149996463|NCT02240368|541119638|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
149996464|NCT02240368|541119639|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
149996465|NCT02240368|541119637|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
149996466|NCT02240368|541119638|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
149996467|NCT02240368|541119639|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
149996468|NCT00871117|541119644|FG000|Overall Study|Lost to Follow-up|5|||
149996469|NCT00871117|541119645|FG001|Overall Study|Lost to Follow-up|6|||
149996470|NCT00871117|541119644|FG000|Overall Study|Other|0|||
149996471|NCT00871117|541119645|FG001|Overall Study|Other|4|||
149996472|NCT02080481|541119646|FG000|Overall Study|Never received a block.|1|||
149996473|NCT02080481|541119647|FG001|Overall Study|Never received a block.|0|||
149996474|NCT00840060|541121323|FG000|Overall Study|Withdrawal by Subject|1|||
149996475|NCT00840060|541121324|FG001|Overall Study|Withdrawal by Subject|0|||
149996476|NCT00840060|541121323|FG000|Overall Study|Change in emotional/behavioral status|0|||
149996477|NCT00840060|541121324|FG001|Overall Study|Change in emotional/behavioral status|1|||
149996478|NCT03095027|541121326|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
149996479|NCT03095027|541121327|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
149996480|NCT01962987|541121330|FG000|Overall Study|Adverse Event|4|||
149996481|NCT01962987|541121331|FG001|Overall Study|Adverse Event|4|||
149996482|NCT01962987|541121332|FG002|Overall Study|Adverse Event|0|||
149996483|NCT01962987|541121330|FG000|Overall Study|Lost to Follow-up|0|||
149996484|NCT01962987|541121331|FG001|Overall Study|Lost to Follow-up|0|||
149996485|NCT01962987|541121332|FG002|Overall Study|Lost to Follow-up|1|||
149996486|NCT01962987|541121330|FG000|Overall Study|Non compliance with dosing requirements|4|||
149996487|NCT01962987|541121331|FG001|Overall Study|Non compliance with dosing requirements|2|||
149996488|NCT01962987|541121332|FG002|Overall Study|Non compliance with dosing requirements|0|||
149996489|NCT01962987|541121330|FG000|Overall Study|Miscellaneous|1|||
149996490|NCT01962987|541121331|FG001|Overall Study|Miscellaneous|9|||
149996491|NCT01962987|541121332|FG002|Overall Study|Miscellaneous|2|||
149996492|NCT01962987|541121330|FG000|Overall Study|Restricted medication|5|||
149996493|NCT01962987|541121331|FG001|Overall Study|Restricted medication|1|||
149996494|NCT01962987|541121332|FG002|Overall Study|Restricted medication|1|||
149996495|NCT01962987|541121330|FG000|Overall Study|Serious Adverse Event|1|||
149996496|NCT01962987|541121331|FG001|Overall Study|Serious Adverse Event|0|||
149996497|NCT01962987|541121332|FG002|Overall Study|Serious Adverse Event|0|||
149996498|NCT01962987|541121330|FG000|Overall Study|Withdrawal by Subject|11|||
149996499|NCT01962987|541121331|FG001|Overall Study|Withdrawal by Subject|10|||
149996500|NCT01962987|541121332|FG002|Overall Study|Withdrawal by Subject|6|||
149996501|NCT01962987|541121330|FG000|Overall Study|Randomized in Error|4|||
149996502|NCT01962987|541121331|FG001|Overall Study|Randomized in Error|2|||
149996503|NCT01962987|541121332|FG002|Overall Study|Randomized in Error|2|||
149996504|NCT00316693|541121333|FG000|Overall Study|Adverse Event|6|||
149996505|NCT00316693|541121334|FG001|Overall Study|Adverse Event|1|||
149996506|NCT00316693|541121333|FG000|Overall Study|Protocol Violation|1|||
149996507|NCT00316693|541121334|FG001|Overall Study|Protocol Violation|0|||
149996508|NCT00316693|541121333|FG000|Overall Study|Withdrawal by Subject|6|||
149996509|NCT00316693|541121334|FG001|Overall Study|Withdrawal by Subject|6|||
149996510|NCT00316693|541121333|FG000|Overall Study|Lost to Follow-up|26|||
149996511|NCT00316693|541121334|FG001|Overall Study|Lost to Follow-up|34|||
149996512|NCT00316693|541121333|FG000|Overall Study|Other|38|||
149996513|NCT00316693|541121334|FG001|Overall Study|Other|44|||
149996514|NCT02982018|541121335|FG000|Overall Study|Incorrect Lens Dispensed|1|||
149996515|NCT02982018|541121336|FG001|Overall Study|Incorrect Lens Dispensed|0|||
149996516|NCT02982018|541121335|FG000|Overall Study|Protocol Violation|1|||
149996517|NCT02982018|541121336|FG001|Overall Study|Protocol Violation|1|||
149996518|NCT02982018|541121335|FG000|Overall Study|Adverse Event|1|||
149996519|NCT02982018|541121336|FG001|Overall Study|Adverse Event|1|||
149996520|NCT02982018|541121335|FG000|Overall Study|Lens Discomfort|2|||
149996521|NCT02982018|541121336|FG001|Overall Study|Lens Discomfort|0|||
149996522|NCT02982018|541121335|FG000|Overall Study|Withdrawal by Subject|0|||
149996523|NCT02982018|541121336|FG001|Overall Study|Withdrawal by Subject|1|||
149996524|NCT03245736|541121340|FG000|Overall Study|Adverse Event|1|||
149996525|NCT03245736|541121340|FG000|Overall Study|Progressive Disease|4|||
149996526|NCT00132691|541121342|FG000|Overall Study|Lost to Follow-up|5|||
149996527|NCT00132691|541121343|FG001|Overall Study|Lost to Follow-up|8|||
149996528|NCT00132691|541121342|FG000|Overall Study|Missed 2-year visit|4|||
149996529|NCT00132691|541121343|FG001|Overall Study|Missed 2-year visit|4|||
149996530|NCT00132691|541121342|FG000|Overall Study|Death|2|||
149996531|NCT00132691|541121343|FG001|Overall Study|Death|0|||
149996532|NCT02251717|541121344|FG000|Overall Study|Adverse Event|0|||
149996533|NCT02251717|541121345|FG001|Overall Study|Adverse Event|1|||
149996534|NCT02251717|541121344|FG000|Overall Study|Withdrew Consent|1|||
149996535|NCT02251717|541121345|FG001|Overall Study|Withdrew Consent|0|||
149996536|NCT04098367|541121346|FG000|Overall Study|Adverse Event|0|||
149996537|NCT04098367|541121347|FG001|Overall Study|Adverse Event|0|||
149996538|NCT04098367|541121348|FG002|Overall Study|Adverse Event|1|||
149996539|NCT04098367|541121346|FG000|Overall Study|Lost to Follow-up|1|||
149996540|NCT04098367|541121347|FG001|Overall Study|Lost to Follow-up|5|||
149996541|NCT04098367|541121348|FG002|Overall Study|Lost to Follow-up|2|||
149996542|NCT04098367|541121346|FG000|Overall Study|Withdrawal by Subject|0|||
149996543|NCT04098367|541121347|FG001|Overall Study|Withdrawal by Subject|0|||
149996544|NCT04098367|541121348|FG002|Overall Study|Withdrawal by Subject|1|||
149996545|NCT04098367|541121346|FG000|Overall Study|Sick . Could not attend visit|1|||
149996546|NCT04098367|541121347|FG001|Overall Study|Sick . Could not attend visit|0|||
149996547|NCT04098367|541121348|FG002|Overall Study|Sick . Could not attend visit|0|||
149996548|NCT00445939|541121349|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
149996549|NCT00445939|541121350|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
149996550|NCT00445939|541121351|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
149996551|NCT00445939|541121352|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
149996552|NCT00445939|541121349|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
149996553|NCT00445939|541121350|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
149996554|NCT00445939|541121351|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
149996555|NCT00445939|541121352|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
149996556|NCT00322023|541121360|FG000|Overall Study|various|0|||
149996557|NCT00322023|541121361|FG001|Overall Study|various|2|||
149996558|NCT00322023|541121362|FG002|Overall Study|various|6|||
149996559|NCT00354107|541121367|FG000|Overall Study|Adverse Event|2|||
149996560|NCT00354107|541121367|FG000|Overall Study|Physician Decision|2|||
149996561|NCT00354107|541121367|FG000|Overall Study|Withdrawal by Subject|1|||
149996562|NCT03361189|541121371|FG000|Overall Study|Received heart transplant|1|||
149996563|NCT03361189|541121372|FG001|Overall Study|Received heart transplant|0|||
149996564|NCT03361189|541121371|FG000|Overall Study|Pacemake replacement|0|||
149996565|NCT03361189|541121372|FG001|Overall Study|Pacemake replacement|1|||
149996566|NCT04600076|541121375|FG000|Overall Study|Lost to Follow-up|3|||
149996567|NCT01342965|541121376|FG000|Overall Study|Death|58|||
149996568|NCT01342965|541121377|FG001|Overall Study|Death|57|||
149996569|NCT01342965|541121376|FG000|Overall Study|Lost to Follow-up|5|||
149996570|NCT01342965|541121377|FG001|Overall Study|Lost to Follow-up|3|||
149996571|NCT01342965|541121376|FG000|Overall Study|Other Reasons- Unspecified|44|||
149996572|NCT01342965|541121377|FG001|Overall Study|Other Reasons- Unspecified|38|||
149996573|NCT01342965|541121376|FG000|Overall Study|Withdrawal by Subject|2|||
149996574|NCT01342965|541121377|FG001|Overall Study|Withdrawal by Subject|9|||
149996575|NCT01170598|541121378|FG000|Overall Study|Withdrawal by Subject|1|||
149996576|NCT01170598|541121378|FG000|Overall Study|Death|3|||
149996577|NCT01170598|541121378|FG000|Overall Study|Lost to Follow-up|1|||
149996578|NCT01170598|541121378|FG000|Overall Study|Refused|1|||
149996579|NCT02780856|541121385|FG000|Overall Study|Lost to Follow-up|1|||
149996580|NCT03894969|541121392|FG000|Overall Study|Adverse Event|0|||
149996581|NCT03894969|541121393|FG001|Overall Study|Adverse Event|2|||
149996582|NCT03894969|541121394|FG002|Overall Study|Adverse Event|0|||
149996583|NCT03894969|541121395|FG003|Overall Study|Adverse Event|1|||
149996584|NCT03894969|541121396|FG004|Overall Study|Adverse Event|2|||
149996585|NCT03894969|541121392|FG000|Overall Study|Lost to Follow-up|3|||
149996586|NCT03894969|541121393|FG001|Overall Study|Lost to Follow-up|1|||
149996587|NCT03894969|541121394|FG002|Overall Study|Lost to Follow-up|1|||
149996588|NCT03894969|541121395|FG003|Overall Study|Lost to Follow-up|0|||
149996589|NCT03894969|541121396|FG004|Overall Study|Lost to Follow-up|0|||
149996590|NCT03894969|541121392|FG000|Overall Study|Withdrawal by Subject|2|||
149996591|NCT03894969|541121393|FG001|Overall Study|Withdrawal by Subject|1|||
149996592|NCT03894969|541121394|FG002|Overall Study|Withdrawal by Subject|3|||
149996593|NCT03894969|541121395|FG003|Overall Study|Withdrawal by Subject|4|||
149996594|NCT03894969|541121396|FG004|Overall Study|Withdrawal by Subject|8|||
149996595|NCT03894969|541121392|FG000|Overall Study|Other|0|||
149996596|NCT03894969|541121393|FG001|Overall Study|Other|0|||
149996597|NCT03894969|541121394|FG002|Overall Study|Other|0|||
149996598|NCT03894969|541121395|FG003|Overall Study|Other|0|||
149996599|NCT03894969|541121396|FG004|Overall Study|Other|3|||
149996600|NCT03894969|541121392|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
149996601|NCT03894969|541121393|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
149996602|NCT03894969|541121394|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
149996603|NCT03894969|541121395|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
149996604|NCT03894969|541121396|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
149996605|NCT03894969|541121392|FG000|Overall Study|Solicited Adverse Event|0|||
149996606|NCT03894969|541121393|FG001|Overall Study|Solicited Adverse Event|1|||
149996607|NCT03894969|541121394|FG002|Overall Study|Solicited Adverse Event|0|||
149996608|NCT03894969|541121395|FG003|Overall Study|Solicited Adverse Event|0|||
149996609|NCT03894969|541121396|FG004|Overall Study|Solicited Adverse Event|0|||
149996610|NCT02378298|541121399|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
149996611|NCT02378298|541121400|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
149996612|NCT02378298|541121401|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
149996613|NCT02378298|541121399|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
149996614|NCT02378298|541121400|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
149996615|NCT02378298|541121401|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
149996616|NCT02378298|541121399|FG000|Surveillance (19-68 Weeks)|Death|1|||
149996617|NCT02378298|541121400|FG001|Surveillance (19-68 Weeks)|Death|0|||
149996618|NCT02378298|541121401|FG002|Surveillance (19-68 Weeks)|Death|0|||
149996619|NCT02308163|541121404|FG000|Overall Study|Not fulfill eligible criteria|1|||
149996620|NCT02308163|541121405|FG001|Overall Study|Not fulfill eligible criteria|2|||
149996621|NCT02308163|541121406|FG002|Overall Study|Not fulfill eligible criteria|0|||
149996622|NCT02308163|541121407|FG003|Overall Study|Not fulfill eligible criteria|1|||
149996623|NCT02308163|541121408|FG004|Overall Study|Not fulfill eligible criteria|1|||
149996624|NCT02308163|541121404|FG000|Overall Study|Adverse Event|9|||
149996625|NCT02308163|541121405|FG001|Overall Study|Adverse Event|5|||
149996626|NCT02308163|541121406|FG002|Overall Study|Adverse Event|2|||
149996627|NCT02308163|541121407|FG003|Overall Study|Adverse Event|2|||
149996628|NCT02308163|541121408|FG004|Overall Study|Adverse Event|11|||
149996629|NCT02308163|541121404|FG000|Overall Study|Lack of Efficacy|11|||
149996630|NCT02308163|541121405|FG001|Overall Study|Lack of Efficacy|3|||
149996631|NCT02308163|541121406|FG002|Overall Study|Lack of Efficacy|8|||
149996632|NCT02308163|541121407|FG003|Overall Study|Lack of Efficacy|4|||
149996633|NCT02308163|541121408|FG004|Overall Study|Lack of Efficacy|6|||
149996634|NCT02308163|541121404|FG000|Overall Study|Withdrawal of consent|2|||
149996635|NCT02308163|541121405|FG001|Overall Study|Withdrawal of consent|3|||
149996636|NCT02308163|541121406|FG002|Overall Study|Withdrawal of consent|0|||
149996637|NCT02308163|541121407|FG003|Overall Study|Withdrawal of consent|2|||
149996638|NCT02308163|541121408|FG004|Overall Study|Withdrawal of consent|6|||
149996639|NCT02308163|541121404|FG000|Overall Study|Protocol Violation|3|||
149996640|NCT02308163|541121405|FG001|Overall Study|Protocol Violation|3|||
149996641|NCT02308163|541121406|FG002|Overall Study|Protocol Violation|3|||
149996642|NCT02308163|541121407|FG003|Overall Study|Protocol Violation|2|||
149996643|NCT02308163|541121408|FG004|Overall Study|Protocol Violation|5|||
149996644|NCT02308163|541121404|FG000|Overall Study|Lab data met discontinuation criteria|3|||
149996645|NCT02308163|541121405|FG001|Overall Study|Lab data met discontinuation criteria|0|||
149996646|NCT02308163|541121406|FG002|Overall Study|Lab data met discontinuation criteria|0|||
149996647|NCT02308163|541121407|FG003|Overall Study|Lab data met discontinuation criteria|2|||
149996648|NCT02308163|541121408|FG004|Overall Study|Lab data met discontinuation criteria|0|||
149996649|NCT02308163|541121404|FG000|Overall Study|Miscellaneous|2|||
149996650|NCT02308163|541121405|FG001|Overall Study|Miscellaneous|2|||
149996651|NCT02308163|541121406|FG002|Overall Study|Miscellaneous|1|||
149996652|NCT02308163|541121407|FG003|Overall Study|Miscellaneous|0|||
149996653|NCT02308163|541121408|FG004|Overall Study|Miscellaneous|5|||
149996654|NCT00118846|541121415|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
149996655|NCT00118846|541121416|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
149996656|NCT00118846|541121415|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
149996657|NCT00118846|541121416|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
149996658|NCT00118846|541121415|FG000|Overall Study|Physician Decision|1|||
149996659|NCT00118846|541121416|FG001|Overall Study|Physician Decision|0|||
149996660|NCT00118846|541121415|FG000|Overall Study|Medical condition|2|||
149996661|NCT00118846|541121416|FG001|Overall Study|Medical condition|2|||
149996662|NCT00118846|541121415|FG000|Overall Study|Lost to Follow-up|0|||
149996663|NCT00118846|541121416|FG001|Overall Study|Lost to Follow-up|2|||
149996664|NCT00118846|541121415|FG000|Overall Study|Personal reason|4|||
149996665|NCT00118846|541121416|FG001|Overall Study|Personal reason|5|||
149996666|NCT00522418|541121417|FG000|Overall Study|Local IRB Consent Violation|5|||
149996667|NCT00522418|541121418|FG001|Overall Study|Local IRB Consent Violation|5|||
149996668|NCT00522418|541121417|FG000|Overall Study|Early Study Termination|46|||
149996669|NCT00522418|541121418|FG001|Overall Study|Early Study Termination|47|||
149996670|NCT00522418|541121417|FG000|Overall Study|Noncompliance|2|||
149996671|NCT00522418|541121418|FG001|Overall Study|Noncompliance|2|||
149996672|NCT00522418|541121417|FG000|Overall Study|Reason Not Specified|3|||
149996673|NCT00522418|541121418|FG001|Overall Study|Reason Not Specified|1|||
149996674|NCT00522418|541121417|FG000|Overall Study|Consent Withdraw|1|||
149996675|NCT00522418|541121418|FG001|Overall Study|Consent Withdraw|2|||
149996676|NCT00522418|541121417|FG000|Overall Study|Lack of Efficacy|0|||
149996677|NCT00522418|541121418|FG001|Overall Study|Lack of Efficacy|1|||
149996678|NCT01574157|541121419|FG000|Overall Study|Withdrawal by Subject|4|||
149996679|NCT01574157|541121420|FG001|Overall Study|Withdrawal by Subject|5|||
149996680|NCT01574157|541121419|FG000|Overall Study|Lost to Follow-up|0|||
149996681|NCT01574157|541121420|FG001|Overall Study|Lost to Follow-up|3|||
149996682|NCT00578877|541121423|FG000|Overall Study|Lost to Follow-up|8|||
149996683|NCT00578877|541121424|FG001|Overall Study|Lost to Follow-up|10|||
149996684|NCT00578877|541121423|FG000|Overall Study|early discontinue|61|||
149996685|NCT00578877|541121424|FG001|Overall Study|early discontinue|101|||
149996686|NCT00578877|541121423|FG000|Overall Study|did not provide follow-up data|12|||
149996687|NCT00578877|541121424|FG001|Overall Study|did not provide follow-up data|17|||
149996688|NCT01944098|541121429|FG000|Overall Study|Physician Decision|1|||
149996689|NCT01944098|541121430|FG001|Overall Study|Physician Decision|0|||
149996690|NCT04669262|541121431|FG000|Overall Study|Withdrawal by Subject|0|||
149996691|NCT04669262|541121432|FG001|Overall Study|Withdrawal by Subject|0|||
149996692|NCT04669262|541121433|FG002|Overall Study|Withdrawal by Subject|0|||
149996693|NCT04669262|541121434|FG003|Overall Study|Withdrawal by Subject|1|||
149996694|NCT04669262|541121431|FG000|Overall Study|Randomized but Not Treated|0|||
149996695|NCT04669262|541121432|FG001|Overall Study|Randomized but Not Treated|1|||
149996696|NCT04669262|541121433|FG002|Overall Study|Randomized but Not Treated|0|||
149996697|NCT04669262|541121434|FG003|Overall Study|Randomized but Not Treated|0|||
149996698|NCT01357161|541121435|FG000|Part 1 (Open Label Run-in)|Death|5|||
149996699|NCT01357161|541121436|FG001|Part 1 (Open Label Run-in)|Death|0|||
149996700|NCT01357161|541121437|FG002|Part 1 (Open Label Run-in)|Death|0|||
149996701|NCT01357161|541121435|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
149996702|NCT01357161|541121436|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
149996703|NCT01357161|541121437|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
149996704|NCT01357161|541121435|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
149996705|NCT01357161|541121436|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
149996706|NCT01357161|541121437|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
149996707|NCT01357161|541121435|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
149996708|NCT01357161|541121436|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
149996709|NCT01357161|541121437|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
149996710|NCT01357161|541121435|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
149996711|NCT01357161|541121436|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
149996712|NCT01357161|541121437|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
150054105|NCT01185353|541338448|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
150054106|NCT01185353|541338449|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
150054107|NCT01185353|541338450|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
149996713|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
149996714|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
149996715|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
149996716|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
150054108|NCT01185353|541338451|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
150054109|NCT01185353|541338452|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
150054110|NCT01185353|541338453|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
150054111|NCT01185353|541338454|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
150179106|NCT01985334|541793925|FG002|Overall Study|Investigator decision|0|||
149996717|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
150179107|NCT01985334|541793926|FG003|Overall Study|Investigator decision|7|||
149996718|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
149996719|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
149996720|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
149996721|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
149996722|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
149996723|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
149996724|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
149996725|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
149996726|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
149996727|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
149996728|NCT01357161|541121435|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
149996729|NCT01357161|541121436|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
149996730|NCT01357161|541121437|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
149996731|NCT02910401|541121447|FG000|Overall Study|Study closure Study closure|0|||
149996732|NCT02910401|541121448|FG001|Overall Study|Study closure Study closure|0|||
149996733|NCT02910401|541121449|FG002|Overall Study|Study closure Study closure|2|||
149996734|NCT02910401|541121447|FG000|Overall Study|Physician Decision|1|||
149996735|NCT02910401|541121448|FG001|Overall Study|Physician Decision|0|||
149996736|NCT02910401|541121449|FG002|Overall Study|Physician Decision|0|||
149996737|NCT00098748|541121451|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
149996738|NCT00098748|541121452|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
149996739|NCT00098748|541121453|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
149996740|NCT00098748|541121451|FG000|Received Study Treatment|Death|2|||
149996741|NCT00098748|541121452|FG001|Received Study Treatment|Death|1|||
149996742|NCT00098748|541121453|FG002|Received Study Treatment|Death|2|||
149996743|NCT00098748|541121451|FG000|Received Study Treatment|Adverse Event|1|||
149996744|NCT00098748|541121452|FG001|Received Study Treatment|Adverse Event|2|||
149996745|NCT00098748|541121453|FG002|Received Study Treatment|Adverse Event|5|||
149996746|NCT00098748|541121451|FG000|Received Study Treatment|Lack of Efficacy|40|||
149996747|NCT00098748|541121452|FG001|Received Study Treatment|Lack of Efficacy|27|||
149996748|NCT00098748|541121453|FG002|Received Study Treatment|Lack of Efficacy|27|||
149996749|NCT00098748|541121451|FG000|Received Study Treatment|Other|2|||
149996750|NCT00098748|541121452|FG001|Received Study Treatment|Other|2|||
149996751|NCT00098748|541121453|FG002|Received Study Treatment|Other|6|||
149996752|NCT00098748|541121451|FG000|Received Study Treatment|Subject defaulted|3|||
149996753|NCT00098748|541121452|FG001|Received Study Treatment|Subject defaulted|4|||
149996754|NCT00098748|541121453|FG002|Received Study Treatment|Subject defaulted|4|||
149996755|NCT00098748|541121451|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
149996756|NCT00098748|541121452|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
149996757|NCT00098748|541121453|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
149996758|NCT00098748|541121451|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
149996759|NCT00098748|541121452|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
149996760|NCT00098748|541121453|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
149996761|NCT00098748|541121451|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
149996762|NCT00098748|541121452|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
149996763|NCT00098748|541121453|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
149996764|NCT00098748|541121451|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
149996765|NCT00098748|541121452|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
149996766|NCT00098748|541121453|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
149996767|NCT00098748|541121451|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
149996768|NCT00098748|541121452|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
149996769|NCT00098748|541121453|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
149996770|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
149996771|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
149996772|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Death|0|||
149996773|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Death|0|||
149996774|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
149996775|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
149996776|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
149996777|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
149996778|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
149996779|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
149996780|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
149996781|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
149996782|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
149996783|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
149996784|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
149996785|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
149996786|NCT00433160|541121454|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
149996787|NCT00433160|541121455|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
149996788|NCT00433160|541121454|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
149996789|NCT00433160|541121455|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
149996790|NCT00433160|541121454|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
149996791|NCT00433160|541121455|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
149996792|NCT00433160|541121454|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
149996793|NCT00433160|541121455|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
149996794|NCT00433160|541121454|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
149996795|NCT00433160|541121455|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
149996796|NCT00433160|541121454|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
149996797|NCT00433160|541121455|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
149996798|NCT00433160|541121454|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
149996799|NCT00433160|541121455|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
149996800|NCT00433160|541121454|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
149996801|NCT00433160|541121455|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
149996802|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
149996803|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
149996804|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
149996805|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
149996806|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
149996807|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
149996808|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
149996809|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
149996810|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
149996811|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
149996812|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
149996813|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
149996814|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
149996815|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
149996816|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
149996817|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
149996818|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
149996819|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
149996820|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
149996821|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
149996822|NCT03222973|541121460|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
149996823|NCT03222973|541121461|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
149996824|NCT03222973|541121462|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
149996825|NCT03222973|541121463|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
149996826|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
149996827|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
149996828|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
149996829|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
149996830|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
149996831|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
149996832|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
149996833|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
149996834|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
149996835|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
149996836|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
149996837|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
149996838|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
149996839|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
149996840|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
149996841|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
149996842|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
149996843|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
149996844|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
149996845|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
149996846|NCT03222973|541121460|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
149996847|NCT03222973|541121461|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
149996848|NCT03222973|541121462|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
149996849|NCT03222973|541121463|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
149996850|NCT00496483|541123495|FG000|Overall Study|Not dosed|9|||
149996851|NCT00496483|541123495|FG000|Overall Study|Adverse Event|2|||
149996852|NCT00496483|541123495|FG000|Overall Study|Lack of Efficacy|1|||
149996853|NCT00428220|541123496|FG000|Overall Study|Participant died|8|||
149996854|NCT00428220|541123496|FG000|Overall Study|Global deterioration of health status|7|||
149996855|NCT00428220|541123496|FG000|Overall Study|Lost to Follow-up|4|||
149996856|NCT00428220|541123496|FG000|Overall Study|Objective progression or relapse|123|||
150054112|NCT01185353|541338445|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054113|NCT01185353|541338446|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150179108|NCT01985334|541793927|FG004|Overall Study|Investigator decision|1|||
149996857|NCT00428220|541123496|FG000|Overall Study|Participant refused continued treatment|7|||
149996858|NCT00428220|541123496|FG000|Overall Study|Adverse Event|51|||
149996859|NCT00428220|541123496|FG000|Overall Study|Other|23|||
149996860|NCT00642174|541123503|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
149996861|NCT00642174|541123504|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
149996862|NCT00896363|541123505|FG000|Overall Study|Adverse Event|3|||
149996863|NCT00896363|541123506|FG001|Overall Study|Adverse Event|4|||
149996864|NCT00896363|541123507|FG002|Overall Study|Adverse Event|2|||
149996865|NCT00896363|541123505|FG000|Overall Study|Lack of Efficacy|0|||
149996866|NCT00896363|541123506|FG001|Overall Study|Lack of Efficacy|2|||
149996867|NCT00896363|541123507|FG002|Overall Study|Lack of Efficacy|1|||
149996868|NCT00896363|541123505|FG000|Overall Study|Withdrawal by Subject|3|||
149996869|NCT00896363|541123506|FG001|Overall Study|Withdrawal by Subject|5|||
149996870|NCT00896363|541123507|FG002|Overall Study|Withdrawal by Subject|5|||
149996871|NCT01730339|541123508|FG000|Overall Study|Withdrawal by Subject|3|||
149996872|NCT01730339|541123509|FG001|Overall Study|Withdrawal by Subject|2|||
149996873|NCT01730339|541123508|FG000|Overall Study|Lost to Follow-up|1|||
149996874|NCT01730339|541123509|FG001|Overall Study|Lost to Follow-up|1|||
149996875|NCT01730339|541123508|FG000|Overall Study|Un-specified|1|||
149996876|NCT01730339|541123509|FG001|Overall Study|Un-specified|0|||
149996877|NCT00919867|541123514|FG000|First Intervention|Withdrawal by Subject|0|||
149996878|NCT00919867|541123515|FG001|First Intervention|Withdrawal by Subject|0|||
149996879|NCT00919867|541123516|FG002|First Intervention|Withdrawal by Subject|1|||
149996880|NCT00919867|541123517|FG003|First Intervention|Withdrawal by Subject|0|||
149996881|NCT00919867|541123518|FG004|First Intervention|Withdrawal by Subject|0|||
149996882|NCT00919867|541123519|FG005|First Intervention|Withdrawal by Subject|0|||
149996883|NCT00919867|541123514|FG000|First Intervention|Physician Decision|0|||
149996884|NCT00919867|541123515|FG001|First Intervention|Physician Decision|0|||
149996885|NCT00919867|541123516|FG002|First Intervention|Physician Decision|0|||
149996886|NCT00919867|541123517|FG003|First Intervention|Physician Decision|0|||
149996887|NCT00919867|541123518|FG004|First Intervention|Physician Decision|0|||
149996888|NCT00919867|541123519|FG005|First Intervention|Physician Decision|1|||
149996889|NCT03920293|541123520|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
149996890|NCT03920293|541123521|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
149996891|NCT03920293|541123520|FG000|Randomized-Controlled Period|Physician Decision|1|||
149996892|NCT03920293|541123521|FG001|Randomized-Controlled Period|Physician Decision|2|||
149996893|NCT03920293|541123520|FG000|Randomized-Controlled Period|Adverse Event|0|||
149996894|NCT03920293|541123521|FG001|Randomized-Controlled Period|Adverse Event|2|||
149996895|NCT03920293|541123520|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
149996896|NCT03920293|541123521|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
149996897|NCT03920293|541123520|FG000|Randomized-Controlled Period|Death|2|||
149996898|NCT03920293|541123521|FG001|Randomized-Controlled Period|Death|0|||
149996899|NCT03920293|541123520|FG000|Randomized-Controlled Period|Protocol Violation|1|||
149996900|NCT03920293|541123521|FG001|Randomized-Controlled Period|Protocol Violation|0|||
149996901|NCT03920293|541123520|FG000|Randomized-Controlled Period|Noncompliance|1|||
149996902|NCT03920293|541123521|FG001|Randomized-Controlled Period|Noncompliance|0|||
149996903|NCT03920293|541123520|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
149996904|NCT03920293|541123521|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
149996905|NCT03920293|541123520|FG000|Open- Label Extension Period|Death|3|||
149996906|NCT03920293|541123521|FG001|Open- Label Extension Period|Death|3|||
149996907|NCT03920293|541123520|FG000|Open- Label Extension Period|Physician Decision|5|||
149996908|NCT03920293|541123521|FG001|Open- Label Extension Period|Physician Decision|3|||
149996909|NCT03920293|541123520|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
149996910|NCT03920293|541123521|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
149996911|NCT03555981|541123522|FG000|Overall Study|Lost to Follow-up|0|||
149996912|NCT03555981|541123523|FG001|Overall Study|Lost to Follow-up|2|||
149996913|NCT03344549|541123524|FG000|Overall Study|Withdrawal by Subject|3|||
149996914|NCT03344549|541123525|FG001|Overall Study|Withdrawal by Subject|2|||
149996915|NCT03344549|541123524|FG000|Overall Study|Dialysis|2|||
149996916|NCT03344549|541123525|FG001|Overall Study|Dialysis|0|||
149996917|NCT03344549|541123524|FG000|Overall Study|Cancer|1|||
149996918|NCT03344549|541123525|FG001|Overall Study|Cancer|0|||
149996919|NCT03344549|541123524|FG000|Overall Study|Lack of electronic device|1|||
149996920|NCT03344549|541123525|FG001|Overall Study|Lack of electronic device|0|||
149996921|NCT03344549|541123524|FG000|Overall Study|Transportation difficulty|0|||
149996922|NCT03344549|541123525|FG001|Overall Study|Transportation difficulty|13|||
149996923|NCT01685801|541123531|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
149996924|NCT01685801|541123532|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
150054114|NCT01185353|541338447|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054115|NCT01185353|541338448|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
149996925|NCT01685801|541123533|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
149996926|NCT01685801|541123534|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
149996927|NCT01685801|541123531|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
149996928|NCT01685801|541123532|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
149996929|NCT01685801|541123533|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
149996930|NCT01685801|541123534|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
149996931|NCT03350256|541123535|FG000|Overall Study|Inclusion/exclusion violation|4|||
149996932|NCT03350256|541123535|FG000|Overall Study|Recommended for other therapies|2|||
149996933|NCT03350256|541123535|FG000|Overall Study|Protocol Violation|3|||
149996934|NCT03350256|541123535|FG000|Overall Study|Non compliance|2|||
149996935|NCT03350256|541123535|FG000|Overall Study|Denial by insurance|1|||
149996936|NCT03350256|541123535|FG000|Overall Study|Adverse Event|2|||
149996937|NCT03350256|541123535|FG000|Overall Study|Trial failure|12|||
149996938|NCT03350256|541123535|FG000|Overall Study|Did not proceed to permanent implant|3|||
149996939|NCT03350256|541123535|FG000|Overall Study|Withdrawal by Subject|3|||
149996940|NCT03350256|541123535|FG000|Overall Study|Subject moving out of state|1|||
149996941|NCT03350256|541123535|FG000|Overall Study|Lost to Follow-up|1|||
149996942|NCT03350256|541123535|FG000|Overall Study|Lack of Efficacy|2|||
149996943|NCT00543296|541123538|FG000|Overall Study|Physician Decision|7|||
149996944|NCT00934947|541123541|FG000|Overall Study|Adverse Event|0|||
149996945|NCT00934947|541123542|FG001|Overall Study|Adverse Event|2|||
149996946|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
149996947|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
149996948|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
149996949|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
149996950|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
149996951|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
149996952|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
149996953|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996954|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996955|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996956|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
149996957|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
149996958|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996959|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996960|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996961|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996962|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996963|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
149996964|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
149996965|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996966|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
149996967|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996968|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996969|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
149996970|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
149996971|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996972|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996973|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996974|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996975|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996976|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996977|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996978|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996979|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996980|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996981|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
149996982|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996983|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996984|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
150054116|NCT01185353|541338449|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054117|NCT01185353|541338450|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054118|NCT01185353|541338451|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
150054119|NCT01185353|541338452|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054120|NCT01185353|541338453|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054121|NCT01185353|541338454|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
150054122|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054123|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
149996985|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996986|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996987|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996988|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
150054124|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054125|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054126|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054127|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054128|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
150054129|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
150054130|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
150054131|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
150054132|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
149996989|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996990|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996991|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996992|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996993|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996994|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996995|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996996|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996997|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996998|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149996999|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
149997000|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997001|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997002|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
149997003|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997004|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997005|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997006|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997007|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997008|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997009|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997010|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997011|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997012|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997013|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997014|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997015|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997016|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997017|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
149997018|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997019|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997020|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997021|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997022|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997023|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997024|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997025|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997026|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997027|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997028|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
150054133|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
150054134|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
150054135|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
150054136|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
149997029|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997030|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997031|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997032|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997033|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997034|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997035|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
149997036|NCT03447314|541123543|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997037|NCT03447314|541123544|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997038|NCT03447314|541123545|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997039|NCT03447314|541123546|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
149997040|NCT03447314|541123547|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997041|NCT03447314|541123548|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
149997042|NCT03447314|541123549|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997043|NCT03447314|541123550|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997044|NCT03447314|541123551|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997045|NCT03447314|541123552|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997046|NCT03447314|541123553|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997047|NCT03447314|541123554|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997048|NCT03447314|541123555|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997049|NCT03447314|541123556|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997050|NCT03447314|541123557|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997051|NCT03447314|541123558|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997052|NCT03447314|541123559|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997053|NCT03447314|541123560|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149997054|NCT00856206|541123562|FG000|Overall Study|Protocol Violation|6|||
149997055|NCT00856206|541123563|FG001|Overall Study|Protocol Violation|18|||
149997056|NCT00856206|541123562|FG000|Overall Study|Adverse Event|10|||
149997057|NCT00856206|541123563|FG001|Overall Study|Adverse Event|46|||
149997058|NCT00856206|541123562|FG000|Overall Study|Lack of Efficacy|1|||
149997059|NCT00856206|541123563|FG001|Overall Study|Lack of Efficacy|2|||
149997060|NCT00856206|541123562|FG000|Overall Study|Withdrawal by Subject|15|||
149997061|NCT00856206|541123563|FG001|Overall Study|Withdrawal by Subject|36|||
149997062|NCT00856206|541123562|FG000|Overall Study|Lost to Follow-up|13|||
149997063|NCT00856206|541123563|FG001|Overall Study|Lost to Follow-up|39|||
149997064|NCT00856206|541123562|FG000|Overall Study|Death|2|||
149997065|NCT00856206|541123563|FG001|Overall Study|Death|2|||
149997066|NCT00856206|541123562|FG000|Overall Study|Decision by the Sponsor|4|||
149997067|NCT00856206|541123563|FG001|Overall Study|Decision by the Sponsor|8|||
149997068|NCT00856206|541123562|FG000|Overall Study|Other than specified above|3|||
149997069|NCT00856206|541123563|FG001|Overall Study|Other than specified above|10|||
149997070|NCT03022097|541123577|FG000|Overall Study|Adverse Event|3|||
149997071|NCT03022097|541123578|FG001|Overall Study|Adverse Event|4|||
149997072|NCT03022097|541123579|FG002|Overall Study|Adverse Event|1|||
149997073|NCT03022097|541123580|FG003|Overall Study|Adverse Event|3|||
149997074|NCT03022097|541123577|FG000|Overall Study|Progressive Disease|2|||
149997075|NCT03022097|541123578|FG001|Overall Study|Progressive Disease|0|||
149997076|NCT03022097|541123579|FG002|Overall Study|Progressive Disease|5|||
149997077|NCT03022097|541123580|FG003|Overall Study|Progressive Disease|2|||
149997078|NCT03022097|541123577|FG000|Overall Study|Lack of Efficacy|0|||
149997079|NCT03022097|541123578|FG001|Overall Study|Lack of Efficacy|0|||
149997080|NCT03022097|541123579|FG002|Overall Study|Lack of Efficacy|3|||
149997081|NCT03022097|541123580|FG003|Overall Study|Lack of Efficacy|3|||
149997082|NCT03022097|541123577|FG000|Overall Study|Protocol Violation|1|||
149997083|NCT03022097|541123578|FG001|Overall Study|Protocol Violation|0|||
149997084|NCT03022097|541123579|FG002|Overall Study|Protocol Violation|1|||
149997085|NCT03022097|541123580|FG003|Overall Study|Protocol Violation|0|||
149997086|NCT03022097|541123577|FG000|Overall Study|Withdrawal by Subject|11|||
149997087|NCT03022097|541123578|FG001|Overall Study|Withdrawal by Subject|13|||
149997088|NCT03022097|541123579|FG002|Overall Study|Withdrawal by Subject|15|||
149997089|NCT03022097|541123580|FG003|Overall Study|Withdrawal by Subject|21|||
149997090|NCT03022097|541123577|FG000|Overall Study|Lost to Follow-up|0|||
149997091|NCT03022097|541123578|FG001|Overall Study|Lost to Follow-up|0|||
149997092|NCT03022097|541123579|FG002|Overall Study|Lost to Follow-up|1|||
149997093|NCT03022097|541123580|FG003|Overall Study|Lost to Follow-up|1|||
149997094|NCT03022097|541123577|FG000|Overall Study|Other|4|||
149997095|NCT03022097|541123578|FG001|Overall Study|Other|1|||
149997096|NCT03022097|541123579|FG002|Overall Study|Other|6|||
149997097|NCT03022097|541123580|FG003|Overall Study|Other|4|||
149997098|NCT03022097|541123577|FG000|Overall Study|Due to COVID-19 pandemic|0|||
149997099|NCT03022097|541123578|FG001|Overall Study|Due to COVID-19 pandemic|1|||
149997100|NCT03022097|541123579|FG002|Overall Study|Due to COVID-19 pandemic|0|||
149997101|NCT03022097|541123580|FG003|Overall Study|Due to COVID-19 pandemic|0|||
149997102|NCT01451931|541123581|FG000|Overall Study|Lost to Follow-up|17|||
149997103|NCT01451931|541123582|FG001|Overall Study|Lost to Follow-up|36|||
149997104|NCT01451931|541123583|FG002|Overall Study|Lost to Follow-up|21|||
149997105|NCT01451931|541123581|FG000|Overall Study|Withdrawal by Subject|16|||
149997106|NCT01451931|541123582|FG001|Overall Study|Withdrawal by Subject|22|||
149997107|NCT01451931|541123583|FG002|Overall Study|Withdrawal by Subject|22|||
149997108|NCT04584346|541123584|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
149997109|NCT04584346|541123585|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
149997110|NCT05479097|541123590|FG000|Overall Study|Withdrawal by Subject|2|||
149997111|NCT03006458|541123593|FG000|First Intervention|Unsatisfied Vision|0|||
149997112|NCT03006458|541123594|FG001|First Intervention|Unsatisfied Vision|3|||
149997113|NCT01468233|541123595|FG000|Treatment Period 1|Adverse Event|5|||
149997114|NCT01468233|541123596|FG001|Treatment Period 1|Adverse Event|3|||
149997115|NCT01468233|541123597|FG002|Treatment Period 1|Adverse Event|0|||
149997116|NCT01468233|541123598|FG003|Treatment Period 1|Adverse Event|0|||
149997117|NCT01468233|541123599|FG004|Treatment Period 1|Adverse Event|0|||
149997118|NCT01468233|541123600|FG005|Treatment Period 1|Adverse Event|0|||
149997119|NCT01468233|541123595|FG000|Treatment Period 1|Withdrawal by Subject|3|||
149997120|NCT01468233|541123596|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149997121|NCT01468233|541123597|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149997122|NCT01468233|541123598|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149997123|NCT01468233|541123599|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149997124|NCT01468233|541123600|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149997125|NCT01468233|541123595|FG000|Treatment Period 1|Lost to Follow-up|3|||
149997126|NCT01468233|541123596|FG001|Treatment Period 1|Lost to Follow-up|0|||
149997127|NCT01468233|541123597|FG002|Treatment Period 1|Lost to Follow-up|0|||
149997128|NCT01468233|541123598|FG003|Treatment Period 1|Lost to Follow-up|0|||
149997129|NCT01468233|541123599|FG004|Treatment Period 1|Lost to Follow-up|0|||
149997130|NCT01468233|541123600|FG005|Treatment Period 1|Lost to Follow-up|0|||
149997131|NCT01468233|541123595|FG000|Treatment Period 1|Other|1|||
149997132|NCT01468233|541123596|FG001|Treatment Period 1|Other|1|||
149997133|NCT01468233|541123597|FG002|Treatment Period 1|Other|0|||
149997134|NCT01468233|541123598|FG003|Treatment Period 1|Other|0|||
149997135|NCT01468233|541123599|FG004|Treatment Period 1|Other|0|||
149997136|NCT01468233|541123600|FG005|Treatment Period 1|Other|0|||
149997137|NCT01468233|541123595|FG000|Treatment Period 2|Adverse Event|0|||
149997138|NCT01468233|541123596|FG001|Treatment Period 2|Adverse Event|0|||
149997139|NCT01468233|541123597|FG002|Treatment Period 2|Adverse Event|3|||
149997140|NCT01468233|541123598|FG003|Treatment Period 2|Adverse Event|0|||
149997141|NCT01468233|541123599|FG004|Treatment Period 2|Adverse Event|2|||
149997142|NCT01468233|541123600|FG005|Treatment Period 2|Adverse Event|1|||
150054137|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
150054138|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
150054139|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
150054140|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
150054141|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
150054142|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150179109|NCT01985334|541793928|FG005|Overall Study|Investigator decision|1|||
150179110|NCT01985334|541793929|FG006|Overall Study|Investigator decision|0|||
149997143|NCT01468233|541123595|FG000|Treatment Period 2|Lack of Efficacy|0|||
150054143|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150054144|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150179111|NCT01985334|541793930|FG007|Overall Study|Investigator decision|4|||
150179112|NCT01985334|541793923|FG000|Overall Study|Lost to Follow-up|0|||
150179113|NCT01985334|541793924|FG001|Overall Study|Lost to Follow-up|2|||
150179114|NCT01985334|541793925|FG002|Overall Study|Lost to Follow-up|0|||
150179115|NCT01985334|541793926|FG003|Overall Study|Lost to Follow-up|3|||
150179116|NCT01985334|541793927|FG004|Overall Study|Lost to Follow-up|1|||
150179117|NCT01985334|541793928|FG005|Overall Study|Lost to Follow-up|4|||
150179118|NCT01985334|541793929|FG006|Overall Study|Lost to Follow-up|0|||
150179119|NCT01985334|541793930|FG007|Overall Study|Lost to Follow-up|3|||
150179120|NCT01290341|541793931|FG000|Overall Study|Protocol Violation|7|||
150179121|NCT01290341|541793932|FG001|Overall Study|Protocol Violation|3|||
149997144|NCT01468233|541123596|FG001|Treatment Period 2|Lack of Efficacy|0|||
149997145|NCT01468233|541123597|FG002|Treatment Period 2|Lack of Efficacy|9|||
149997146|NCT01468233|541123598|FG003|Treatment Period 2|Lack of Efficacy|2|||
149997147|NCT01468233|541123599|FG004|Treatment Period 2|Lack of Efficacy|0|||
149997148|NCT01468233|541123600|FG005|Treatment Period 2|Lack of Efficacy|1|||
149997149|NCT01468233|541123595|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149997150|NCT01468233|541123596|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149997151|NCT01468233|541123597|FG002|Treatment Period 2|Withdrawal by Subject|9|||
149997152|NCT01468233|541123598|FG003|Treatment Period 2|Withdrawal by Subject|1|||
149997153|NCT01468233|541123599|FG004|Treatment Period 2|Withdrawal by Subject|1|||
150179122|NCT01290341|541793931|FG000|Overall Study|Adverse Event|1|||
150179123|NCT01290341|541793932|FG001|Overall Study|Adverse Event|0|||
150179124|NCT01290341|541793931|FG000|Overall Study|Lost to Follow-up|21|||
150179125|NCT01290341|541793932|FG001|Overall Study|Lost to Follow-up|10|||
150179126|NCT01290341|541793931|FG000|Overall Study|Withdrawal by Subject|19|||
150179127|NCT01290341|541793932|FG001|Overall Study|Withdrawal by Subject|5|||
150179128|NCT01290341|541793931|FG000|Overall Study|Negative baseline culture and others|44|||
150179129|NCT01290341|541793932|FG001|Overall Study|Negative baseline culture and others|11|||
150179130|NCT00580866|541793945|FG000|Overall Study|Lost to Follow-up|2|||
150054145|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150054146|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150054147|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150054148|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
150054149|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
150054150|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
150054151|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
150054152|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054153|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054154|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
149997154|NCT01468233|541123600|FG005|Treatment Period 2|Withdrawal by Subject|1|||
149997155|NCT01468233|541123595|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
149997156|NCT01468233|541123596|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
149997157|NCT01468233|541123597|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
149997158|NCT01468233|541123598|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
149997159|NCT01468233|541123599|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
149997160|NCT01468233|541123600|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
149997161|NCT01468233|541123595|FG000|Treatment Period 2|Lost to Follow-up|0|||
149997162|NCT01468233|541123596|FG001|Treatment Period 2|Lost to Follow-up|0|||
149997163|NCT01468233|541123597|FG002|Treatment Period 2|Lost to Follow-up|3|||
149997164|NCT01468233|541123598|FG003|Treatment Period 2|Lost to Follow-up|0|||
149997165|NCT01468233|541123599|FG004|Treatment Period 2|Lost to Follow-up|2|||
149997166|NCT01468233|541123600|FG005|Treatment Period 2|Lost to Follow-up|0|||
149997167|NCT01468233|541123595|FG000|Treatment Period 2|Other|0|||
149997168|NCT01468233|541123596|FG001|Treatment Period 2|Other|0|||
149997169|NCT01468233|541123597|FG002|Treatment Period 2|Other|3|||
149997170|NCT01468233|541123598|FG003|Treatment Period 2|Other|0|||
149997171|NCT01468233|541123599|FG004|Treatment Period 2|Other|1|||
149997172|NCT01468233|541123600|FG005|Treatment Period 2|Other|0|||
149997173|NCT00457821|541123604|FG000|Part 2|Withdrawal by Subject|0|||
149997174|NCT00457821|541123605|FG001|Part 2|Withdrawal by Subject|0|||
149997175|NCT00457821|541123606|FG002|Part 2|Withdrawal by Subject|0|||
149997176|NCT00457821|541123607|FG003|Part 2|Withdrawal by Subject|0|||
149997177|NCT00457821|541123608|FG004|Part 2|Withdrawal by Subject|0|||
149997178|NCT00457821|541123609|FG005|Part 2|Withdrawal by Subject|0|||
149997179|NCT00457821|541123610|FG006|Part 2|Withdrawal by Subject|0|||
149997180|NCT00457821|541123611|FG007|Part 2|Withdrawal by Subject|1|||
149997181|NCT02437409|541123614|FG000|Overall Study|Withdrawal by Subject|3|||
149997182|NCT02437409|541123614|FG000|Overall Study|Screening failure|12|||
149997183|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
149997184|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
149997185|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
149997186|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
149997187|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
149997188|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
149997189|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
149997190|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
149997191|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
149997192|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
150054155|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150179131|NCT00580866|541793946|FG001|Overall Study|Lost to Follow-up|2|||
150179132|NCT01388361|541793947|FG000|Overall Study|Adverse Event|0|||
150179133|NCT01388361|541793948|FG001|Overall Study|Adverse Event|5|||
150179134|NCT01388361|541793949|FG002|Overall Study|Adverse Event|1|||
149997193|NCT03549871|541123625|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
150054156|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054157|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054158|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150179135|NCT01388361|541793947|FG000|Overall Study|Protocol Violation|0|||
149997194|NCT03549871|541123626|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
149997195|NCT03549871|541123625|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
149997196|NCT03549871|541123626|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
150179136|NCT01388361|541793948|FG001|Overall Study|Protocol Violation|0|||
150054159|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054160|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
150054161|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
150054162|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Death|0|||
150054163|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Death|0|||
149997197|NCT03549871|541123625|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
149997198|NCT03549871|541123626|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
149997199|NCT03549871|541123625|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
149997200|NCT03549871|541123626|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
149997201|NCT03549871|541123625|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
149997202|NCT03549871|541123626|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
149997203|NCT03549871|541123625|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
149997204|NCT03549871|541123626|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
150054164|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Death|0|||
149997205|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
149997206|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
149997207|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
149997208|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
149997209|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
149997210|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
149997211|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
149997212|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
149997213|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
149997214|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
149997215|NCT00737568|541123627|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
149997216|NCT00737568|541123628|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
149997217|NCT00737568|541123627|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
149997218|NCT00737568|541123628|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
149997219|NCT00737568|541123627|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
149997220|NCT00737568|541123628|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
149997221|NCT00737568|541123627|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
149997222|NCT00737568|541123628|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
149997223|NCT01133626|541123630|FG000|Overall Study|Adverse Event|0|||
149997224|NCT01133626|541123631|FG001|Overall Study|Adverse Event|1|||
149997225|NCT01133626|541123632|FG002|Overall Study|Adverse Event|0|||
149997226|NCT01133626|541123630|FG000|Overall Study|Withdrawal by Subject|1|||
149997227|NCT01133626|541123631|FG001|Overall Study|Withdrawal by Subject|2|||
149997228|NCT01133626|541123632|FG002|Overall Study|Withdrawal by Subject|2|||
149997229|NCT01133626|541123630|FG000|Overall Study|Other|0|||
149997230|NCT01133626|541123631|FG001|Overall Study|Other|2|||
149997231|NCT01133626|541123632|FG002|Overall Study|Other|0|||
149997232|NCT00855933|541123633|FG000|Overall Study|Withdrawal by Subject|0|||
149997233|NCT00855933|541123634|FG001|Overall Study|Withdrawal by Subject|1|||
149997234|NCT00951080|541123635|FG000|Overall Study|Adverse Event|3|||
149997235|NCT00951080|541123636|FG001|Overall Study|Adverse Event|3|||
149997236|NCT00951080|541123635|FG000|Overall Study|Lost to Follow-up|0|||
149997237|NCT00951080|541123636|FG001|Overall Study|Lost to Follow-up|1|||
149997238|NCT00951080|541123635|FG000|Overall Study|Physician Decision|4|||
149997239|NCT00951080|541123636|FG001|Overall Study|Physician Decision|1|||
149997240|NCT00951080|541123635|FG000|Overall Study|Other|19|||
149997241|NCT00951080|541123636|FG001|Overall Study|Other|22|||
149997242|NCT01960998|541123637|FG000|Overall Study|Lost to Follow-up|3|||
149997243|NCT01960998|541123638|FG001|Overall Study|Lost to Follow-up|7|||
149997244|NCT01960998|541123637|FG000|Overall Study|Death|0|||
149997245|NCT01960998|541123638|FG001|Overall Study|Death|1|||
149997246|NCT01960998|541123637|FG000|Overall Study|Withdrawal by Subject|8|||
149997247|NCT01960998|541123638|FG001|Overall Study|Withdrawal by Subject|2|||
149997248|NCT01960998|541123637|FG000|Overall Study|lost computer access|0|||
150054165|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Death|0|||
150054166|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Death|0|||
150054167|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Death|0|||
150054168|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Death|0|||
150054169|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Death|0|||
150054170|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Death|0|||
149997249|NCT01960998|541123638|FG001|Overall Study|lost computer access|1|||
149997250|NCT00835640|541123642|FG000|Second Intervention|Protocol Violation|1|||
149997251|NCT00835640|541123643|FG001|Second Intervention|Protocol Violation|0|||
149997252|NCT01904149|541123644|FG000|Overall Study|Adverse Event|3|||
149997253|NCT01904149|541123645|FG001|Overall Study|Adverse Event|4|||
149997254|NCT01904149|541123646|FG002|Overall Study|Adverse Event|0|||
150054171|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Death|1|||
150179137|NCT01388361|541793949|FG002|Overall Study|Protocol Violation|2|||
149997255|NCT01904149|541123647|FG003|Overall Study|Adverse Event|1|||
149997256|NCT01904149|541123648|FG004|Overall Study|Adverse Event|1|||
149997257|NCT01904149|541123649|FG005|Overall Study|Adverse Event|2|||
149997258|NCT01904149|541123644|FG000|Overall Study|Lack of Efficacy|0|||
149997259|NCT01904149|541123645|FG001|Overall Study|Lack of Efficacy|3|||
149997260|NCT01904149|541123646|FG002|Overall Study|Lack of Efficacy|1|||
149997261|NCT01904149|541123647|FG003|Overall Study|Lack of Efficacy|3|||
149997262|NCT01904149|541123648|FG004|Overall Study|Lack of Efficacy|3|||
149997263|NCT01904149|541123649|FG005|Overall Study|Lack of Efficacy|1|||
149997264|NCT01904149|541123644|FG000|Overall Study|Withdrawal by Subject|1|||
149997265|NCT01904149|541123645|FG001|Overall Study|Withdrawal by Subject|3|||
149997266|NCT01904149|541123646|FG002|Overall Study|Withdrawal by Subject|1|||
149997267|NCT01904149|541123647|FG003|Overall Study|Withdrawal by Subject|0|||
149997268|NCT01904149|541123648|FG004|Overall Study|Withdrawal by Subject|1|||
149997269|NCT01904149|541123649|FG005|Overall Study|Withdrawal by Subject|0|||
149997270|NCT01904149|541123644|FG000|Overall Study|Protocol Violation|0|||
149997271|NCT01904149|541123645|FG001|Overall Study|Protocol Violation|1|||
149997272|NCT01904149|541123646|FG002|Overall Study|Protocol Violation|0|||
149997273|NCT01904149|541123647|FG003|Overall Study|Protocol Violation|0|||
149997274|NCT01904149|541123648|FG004|Overall Study|Protocol Violation|0|||
149997275|NCT01904149|541123649|FG005|Overall Study|Protocol Violation|0|||
149997276|NCT01904149|541123644|FG000|Overall Study|non compliance with study drug|1|||
149997277|NCT01904149|541123645|FG001|Overall Study|non compliance with study drug|0|||
149997278|NCT01904149|541123646|FG002|Overall Study|non compliance with study drug|0|||
149997279|NCT01904149|541123647|FG003|Overall Study|non compliance with study drug|0|||
149997280|NCT01904149|541123648|FG004|Overall Study|non compliance with study drug|0|||
149997281|NCT01904149|541123649|FG005|Overall Study|non compliance with study drug|0|||
149997282|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
149997283|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
149997284|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Death|1|||
149997285|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Death|0|||
150054172|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150054173|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150054174|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150054175|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
149997286|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
149997287|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
149997288|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
149997289|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
149997290|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
149997291|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
149997292|NCT00350272|541123650|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
149997293|NCT00350272|541123651|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
149997294|NCT00350272|541123650|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
149997295|NCT00350272|541123651|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
149997296|NCT00350272|541123650|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
149997297|NCT00350272|541123651|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
149997298|NCT00350272|541123650|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
149997299|NCT00350272|541123651|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
149997300|NCT00350272|541123650|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
149997301|NCT00350272|541123651|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
149997302|NCT00350272|541123650|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
149997303|NCT00350272|541123651|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
149997304|NCT00812006|541123652|FG000|Overall Study|Lost to Follow-up|0|||
149997305|NCT00812006|541123653|FG001|Overall Study|Lost to Follow-up|0|||
149997306|NCT00812006|541123654|FG002|Overall Study|Lost to Follow-up|2|||
149997307|NCT00812006|541123652|FG000|Overall Study|Physician Decision|0|||
149997308|NCT00812006|541123653|FG001|Overall Study|Physician Decision|0|||
150054176|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
149997309|NCT00812006|541123654|FG002|Overall Study|Physician Decision|1|||
149997310|NCT00812006|541123652|FG000|Overall Study|Withdrawal by Subject|2|||
149997311|NCT00812006|541123653|FG001|Overall Study|Withdrawal by Subject|1|||
149997312|NCT00812006|541123654|FG002|Overall Study|Withdrawal by Subject|1|||
149997313|NCT00812006|541123652|FG000|Overall Study|Lack of Qualifying Event|4|||
149997314|NCT00812006|541123653|FG001|Overall Study|Lack of Qualifying Event|2|||
149997315|NCT00812006|541123654|FG002|Overall Study|Lack of Qualifying Event|2|||
149997316|NCT03349645|541123658|FG000|Overall Study|Sponsor Terminated Study|75|||
149997317|NCT03349645|541123658|FG000|Overall Study|Withdrawal by Subject|4|||
149997318|NCT03349645|541123658|FG000|Overall Study|Protocol Violation|1|||
149997319|NCT03349645|541123658|FG000|Overall Study|Other|2|||
149997320|NCT03761394|541123659|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
149997321|NCT03761394|541123660|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
150054177|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150054178|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
149997322|NCT03761394|541123661|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
149997323|NCT03761394|541123662|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
149997324|NCT03761394|541123659|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
149997325|NCT03761394|541123660|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
149997326|NCT03761394|541123661|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
149997327|NCT03761394|541123662|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
149997328|NCT03761394|541123659|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
149997329|NCT03761394|541123660|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
149997330|NCT03761394|541123661|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
149997331|NCT03761394|541123662|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
149997332|NCT03761394|541123659|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
149997333|NCT03761394|541123660|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
149997334|NCT03761394|541123661|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
149997335|NCT03761394|541123662|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
149997336|NCT02927925|541123669|FG000|Overall Study|Death|16|||
149997337|NCT02927925|541123669|FG000|Overall Study|Physician Decision|1|||
149997338|NCT02927925|541123669|FG000|Overall Study|Withdrawal by Subject|11|||
149997339|NCT02927925|541123669|FG000|Overall Study|Other|3|||
149997340|NCT02927925|541123669|FG000|Overall Study|Disease progression at clinical cutoff|1|||
149997341|NCT01080768|541123670|FG000|Overall Study|Protocol Deviation|2|||
149997342|NCT01080768|541123671|FG001|Overall Study|Protocol Deviation|1|||
149997343|NCT01939002|541123674|FG000|Overall Study|Adverse Event|13|||
149997344|NCT01939002|541123675|FG001|Overall Study|Adverse Event|13|||
149997345|NCT01939002|541123674|FG000|Overall Study|Withdrawal by Subject|5|||
149997346|NCT01939002|541123675|FG001|Overall Study|Withdrawal by Subject|3|||
149997347|NCT01939002|541123674|FG000|Overall Study|Other|1|||
149997348|NCT01939002|541123675|FG001|Overall Study|Other|2|||
149997349|NCT02323204|541123679|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
149997350|NCT02323204|541123680|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
149997351|NCT02323204|541123681|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
149997352|NCT02323204|541123682|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
149997353|NCT02323204|541123679|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
149997354|NCT02323204|541123680|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
149997355|NCT02323204|541123681|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
149997356|NCT02323204|541123682|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
149997357|NCT02323204|541123679|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
149997358|NCT02323204|541123680|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
149997359|NCT02323204|541123681|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
149997360|NCT02323204|541123682|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
149997361|NCT02323204|541123679|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
149997362|NCT02323204|541123680|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
149997363|NCT02323204|541123681|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
149997364|NCT02323204|541123682|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
149997365|NCT02323204|541123679|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
149997366|NCT02323204|541123680|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
149997367|NCT02323204|541123681|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
149997368|NCT02323204|541123682|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
149997369|NCT02323204|541123679|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
149997370|NCT02323204|541123680|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
149997371|NCT02323204|541123681|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
149997372|NCT02323204|541123682|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
149997373|NCT02323204|541123679|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
149997374|NCT02323204|541123680|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
149997375|NCT02323204|541123681|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
149997376|NCT02323204|541123682|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
149997377|NCT02323204|541123679|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
149997378|NCT02323204|541123680|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
149997379|NCT02323204|541123681|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
149997380|NCT02323204|541123682|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
149997381|NCT02323204|541123679|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
149997382|NCT02323204|541123680|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
149997383|NCT02323204|541123681|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
149997384|NCT02323204|541123682|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
149997385|NCT04508751|541123685|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
149997386|NCT04508751|541123686|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
149997387|NCT04508751|541123687|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
149997388|NCT03023826|541123688|FG000|Period 1|Withdrawal by Subject|0|||
149997389|NCT03023826|541123689|FG001|Period 1|Withdrawal by Subject|0|||
149997390|NCT03023826|541123690|FG002|Period 1|Withdrawal by Subject|0|||
149997391|NCT03023826|541123691|FG003|Period 1|Withdrawal by Subject|0|||
149997392|NCT03023826|541123692|FG004|Period 1|Withdrawal by Subject|1|||
149997393|NCT03023826|541123693|FG005|Period 1|Withdrawal by Subject|0|||
149997394|NCT00717522|541123694|FG000|Overall Study|Disease Progression|5|||
149997395|NCT00717522|541123694|FG000|Overall Study|Adverse Event|1|||
149997396|NCT00717522|541123694|FG000|Overall Study|Death|1|||
149997397|NCT00072293|541123695|FG000|Overall Study|Lost to Follow-up|1|||
149997398|NCT00072293|541123696|FG001|Overall Study|Lost to Follow-up|1|||
149997399|NCT00072293|541123695|FG000|Overall Study|Withdrawal by Subject|0|||
149997400|NCT00072293|541123696|FG001|Overall Study|Withdrawal by Subject|1|||
149997401|NCT01444027|541123703|FG000|Overall Study|Withdrawal by Subject|4|||
149997402|NCT01444027|541123704|FG001|Overall Study|Withdrawal by Subject|10|||
149997403|NCT01444027|541123705|FG002|Overall Study|Withdrawal by Subject|24|||
149997404|NCT01444027|541123703|FG000|Overall Study|Lost to Follow-up|26|||
149997405|NCT01444027|541123704|FG001|Overall Study|Lost to Follow-up|20|||
149997406|NCT01444027|541123705|FG002|Overall Study|Lost to Follow-up|14|||
149997407|NCT03551665|541123707|FG000|Overall Study|Lost to Follow-up|11|||
149997408|NCT03551665|541123708|FG001|Overall Study|Lost to Follow-up|2|||
149997409|NCT01514240|541125288|FG000|Overall Study|Adverse Event|4|||
149997410|NCT01514240|541125289|FG001|Overall Study|Adverse Event|4|||
149997411|NCT01514240|541125288|FG000|Overall Study|Subject Decision|2|||
149997412|NCT01514240|541125289|FG001|Overall Study|Subject Decision|7|||
149997413|NCT01145352|541125290|FG000|Overall Study|Found to have been registered twice|6|||
149997414|NCT01145352|541125290|FG000|Overall Study|Treated before marketing approval|4|||
149997415|NCT01145352|541125290|FG000|Overall Study|Syringe formulation was used|1|||
149997416|NCT04143217|541125291|FG000|Overall Study|Withdrawal by Subject|42|||
149997417|NCT04143217|541125291|FG000|Overall Study|Adverse Event|29|||
149997418|NCT04143217|541125291|FG000|Overall Study|Lost to Follow-up|29|||
149997419|NCT04143217|541125291|FG000|Overall Study|Lack of Efficacy|15|||
149997420|NCT04143217|541125291|FG000|Overall Study|Physician Decision|1|||
149997421|NCT04143217|541125291|FG000|Overall Study|Non-Compliance With Study Drug|6|||
149997422|NCT04143217|541125291|FG000|Overall Study|Other, Multiple Categories|11|||
149997423|NCT00496197|541125294|FG000|Overall Study|Discontinued study due to death|43|||
149997424|NCT00496197|541125294|FG000|Overall Study|Adverse Event|13|||
149997425|NCT00496197|541125294|FG000|Overall Study|Does not meet entrance criteria|5|||
149997426|NCT00496197|541125294|FG000|Overall Study|Insufficient clinical response|3|||
149997427|NCT00496197|541125294|FG000|Overall Study|Insufficient bacteriological response|10|||
149997428|NCT00496197|541125294|FG000|Overall Study|Lost to Follow-up|11|||
149997429|NCT00496197|541125294|FG000|Overall Study|Withdrawal by Subject|11|||
149997430|NCT00496197|541125294|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
149997431|NCT00496197|541125294|FG000|Overall Study|Other|14|||
149997432|NCT00496197|541125294|FG000|Overall Study|Protocol Violation|8|||
149997433|NCT04431713|541125295|FG000|Overall Study|Withdrawal by Subject|2|||
149997434|NCT04431713|541125296|FG001|Overall Study|Withdrawal by Subject|0|||
149997435|NCT04431713|541125295|FG000|Overall Study|Death|2|||
149997436|NCT04431713|541125296|FG001|Overall Study|Death|2|||
149997437|NCT01655381|541125297|FG000|Overall Study|Investigator Decision|1|||
149997438|NCT01655381|541125297|FG000|Overall Study|Moved to Another City|1|||
149997439|NCT01655381|541125297|FG000|Overall Study|Insufficient Treatment Response|1|||
149997440|NCT03405935|541125301|FG000|Overall Study|Adverse Event|3|||
149997441|NCT03405935|541125301|FG000|Overall Study|Death|2|||
149997442|NCT03405935|541125301|FG000|Overall Study|Withdrawal by Subject|1|||
150054179|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150054180|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
150179138|NCT01388361|541793947|FG000|Overall Study|Withdrawal criteria|12|||
149997443|NCT03405935|541125301|FG000|Overall Study|Lost to Follow-up|2|||
149997444|NCT04979897|541125302|FG000|Overall Study|Death|1|||
149997445|NCT04979897|541125303|FG001|Overall Study|Death|8|||
149997446|NCT04979897|541125302|FG000|Overall Study|Lost to Follow-up|111|||
149997447|NCT04979897|541125303|FG001|Overall Study|Lost to Follow-up|56|||
149997448|NCT04979897|541125302|FG000|Overall Study|Withdrawal by Subject|7|||
149997449|NCT04979897|541125303|FG001|Overall Study|Withdrawal by Subject|2|||
149997450|NCT04195438|541125304|FG000|Overall Study|Withdrawal by Subject|1|||
149997451|NCT00613925|541125309|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
149997452|NCT00613925|541125310|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
149997453|NCT03136497|541125312|FG000|Overall Study|Screen Failure|1|||
149997454|NCT03136497|541125313|FG001|Overall Study|Screen Failure|0|||
150179139|NCT01388361|541793948|FG001|Overall Study|Withdrawal criteria|7|||
149997455|NCT03136497|541125314|FG002|Overall Study|Screen Failure|0|||
149997456|NCT02781792|541125317|FG000|Overall Study|Adverse Event|1|||
149997457|NCT02781792|541125318|FG001|Overall Study|Adverse Event|2|||
149997458|NCT02781792|541125317|FG000|Overall Study|Withdrawal by Subject|3|||
149997459|NCT02781792|541125318|FG001|Overall Study|Withdrawal by Subject|1|||
149997460|NCT02781792|541125317|FG000|Overall Study|Lack of Efficacy|1|||
149997461|NCT02781792|541125318|FG001|Overall Study|Lack of Efficacy|1|||
149997462|NCT02781792|541125317|FG000|Overall Study|Hospice|0|||
149997463|NCT02781792|541125318|FG001|Overall Study|Hospice|1|||
150179140|NCT01388361|541793949|FG002|Overall Study|Withdrawal criteria|10|||
150179141|NCT01388361|541793947|FG000|Overall Study|Unclassified|0|||
150179142|NCT01388361|541793948|FG001|Overall Study|Unclassified|0|||
150179143|NCT01388361|541793949|FG002|Overall Study|Unclassified|1|||
150179144|NCT02528188|541793951|FG000|Overall Study|Adverse Event|23|||
150179145|NCT02528188|541793952|FG001|Overall Study|Adverse Event|22|||
150179146|NCT02528188|541793953|FG002|Overall Study|Adverse Event|8|||
150179147|NCT02528188|541793951|FG000|Overall Study|Protocol Violation|4|||
150179148|NCT02528188|541793952|FG001|Overall Study|Protocol Violation|6|||
150179149|NCT02528188|541793953|FG002|Overall Study|Protocol Violation|4|||
150179150|NCT02528188|541793951|FG000|Overall Study|Lack of Efficacy|19|||
150179151|NCT02528188|541793952|FG001|Overall Study|Lack of Efficacy|21|||
150179152|NCT02528188|541793953|FG002|Overall Study|Lack of Efficacy|22|||
149997464|NCT04049266|541125320|FG000|Overall Study|Adverse Event|16|||
149997465|NCT04049266|541125321|FG001|Overall Study|Adverse Event|9|||
149997466|NCT04049266|541125320|FG000|Overall Study|Non-compliance with study drug|0|||
149997467|NCT04049266|541125321|FG001|Overall Study|Non-compliance with study drug|3|||
149997468|NCT04049266|541125320|FG000|Overall Study|Withdrawal by Subject|6|||
149997469|NCT04049266|541125321|FG001|Overall Study|Withdrawal by Subject|10|||
149997470|NCT04049266|541125320|FG000|Overall Study|Lost to Follow-up|2|||
149997471|NCT04049266|541125321|FG001|Overall Study|Lost to Follow-up|2|||
149997472|NCT04049266|541125320|FG000|Overall Study|Progressive disease|11|||
149997473|NCT04049266|541125321|FG001|Overall Study|Progressive disease|2|||
149997474|NCT04049266|541125320|FG000|Overall Study|Physician Decision|1|||
149997475|NCT04049266|541125321|FG001|Overall Study|Physician Decision|0|||
149997476|NCT04049266|541125320|FG000|Overall Study|Patient moved out of state|1|||
149997477|NCT04049266|541125321|FG001|Overall Study|Patient moved out of state|0|||
149997478|NCT03664674|541125323|FG000|Overall Study|Adverse Event|1|||
149997479|NCT03664674|541125324|FG001|Overall Study|Adverse Event|1|||
149997480|NCT03664674|541125323|FG000|Overall Study|Physician Decision|0|||
150179153|NCT02528188|541793951|FG000|Overall Study|Withdrawal by Subject|97|||
149997481|NCT03664674|541125324|FG001|Overall Study|Physician Decision|1|||
149997482|NCT03664674|541125323|FG000|Overall Study|Withdrawal by Subject|2|||
149997483|NCT03664674|541125324|FG001|Overall Study|Withdrawal by Subject|0|||
149997484|NCT02174523|541125325|FG000|Overall Study|Withdrawal by Subject|1|||
149997485|NCT02174523|541125326|FG001|Overall Study|Withdrawal by Subject|0|||
149997486|NCT00794365|541125327|FG000|Overall Study|Lost to Follow-up|38|||
149997487|NCT00794365|541125327|FG000|Overall Study|Other|17|||
149997488|NCT00794365|541125327|FG000|Overall Study|Poor Compliance|11|||
149997489|NCT00794365|541125327|FG000|Overall Study|Adverse Event|10|||
149997490|NCT00794365|541125327|FG000|Overall Study|Lack of Efficacy|3|||
149997491|NCT03640052|541125328|FG000|Overall Study|Lost to Follow-up|0|||
149997492|NCT03640052|541125329|FG001|Overall Study|Lost to Follow-up|1|||
149997493|NCT03640052|541125330|FG002|Overall Study|Lost to Follow-up|0|||
149997494|NCT03640052|541125331|FG003|Overall Study|Lost to Follow-up|0|||
149997495|NCT03640052|541125332|FG004|Overall Study|Lost to Follow-up|0|||
149997496|NCT01369680|541125335|FG000|Overall Study|Lost to Follow-up|0|||
149997497|NCT01369680|541125336|FG001|Overall Study|Lost to Follow-up|0|||
149997498|NCT01369680|541125337|FG002|Overall Study|Lost to Follow-up|1|||
149997499|NCT01369680|541125338|FG003|Overall Study|Lost to Follow-up|2|||
149997500|NCT02851407|541125339|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149997501|NCT02851407|541125340|FG001|Overall Study|Withdrawal by parent/guardian|7|||
149997502|NCT02851407|541125339|FG000|Overall Study|Protocol deviation|0|||
149997503|NCT02851407|541125340|FG001|Overall Study|Protocol deviation|1|||
149997504|NCT02851407|541125339|FG000|Overall Study|Transferred to another hospital to continue|1|||
149997505|NCT02851407|541125340|FG001|Overall Study|Transferred to another hospital to continue|0|||
149997506|NCT02851407|541125339|FG000|Overall Study|Other Death|30|||
149997507|NCT02851407|541125340|FG001|Overall Study|Other Death|20|||
149997508|NCT02851407|541125339|FG000|Overall Study|Adverse event, serious fatal|6|||
149997509|NCT02851407|541125340|FG001|Overall Study|Adverse event, serious fatal|8|||
149997510|NCT02851407|541125339|FG000|Overall Study|Consent withdrawn by participant|5|||
149997511|NCT02851407|541125340|FG001|Overall Study|Consent withdrawn by participant|3|||
149997512|NCT02851407|541125339|FG000|Overall Study|Screen failure|2|||
149997513|NCT02851407|541125340|FG001|Overall Study|Screen failure|1|||
149997514|NCT02851407|541125339|FG000|Overall Study|Disease relapse|9|||
149997515|NCT02851407|541125340|FG001|Overall Study|Disease relapse|6|||
149997516|NCT02851407|541125339|FG000|Overall Study|Physician Decision|7|||
149997517|NCT02851407|541125340|FG001|Overall Study|Physician Decision|6|||
149997518|NCT02851407|541125339|FG000|Overall Study|Transferred to hospital closer to home|0|||
149997519|NCT02851407|541125340|FG001|Overall Study|Transferred to hospital closer to home|1|||
149997520|NCT02851407|541125339|FG000|Overall Study|Enrolled in an investigational study|0|||
149997521|NCT02851407|541125340|FG001|Overall Study|Enrolled in an investigational study|1|||
149997522|NCT02851407|541125339|FG000|Overall Study|Early recovery|1|||
149997523|NCT02851407|541125340|FG001|Overall Study|Early recovery|0|||
149997524|NCT02851407|541125339|FG000|Overall Study|Adverse event, non-fatal|7|||
150179154|NCT02528188|541793952|FG001|Overall Study|Withdrawal by Subject|104|||
150179155|NCT02528188|541793953|FG002|Overall Study|Withdrawal by Subject|100|||
150179156|NCT02528188|541793951|FG000|Overall Study|Lost to Follow-up|25|||
150179157|NCT02528188|541793952|FG001|Overall Study|Lost to Follow-up|21|||
150179158|NCT02528188|541793953|FG002|Overall Study|Lost to Follow-up|31|||
150179159|NCT02528188|541793951|FG000|Overall Study|Death|4|||
150179160|NCT02528188|541793952|FG001|Overall Study|Death|4|||
150179161|NCT02528188|541793953|FG002|Overall Study|Death|0|||
150179162|NCT02528188|541793951|FG000|Overall Study|Other|89|||
150179163|NCT02528188|541793952|FG001|Overall Study|Other|91|||
150179164|NCT02528188|541793953|FG002|Overall Study|Other|74|||
150179165|NCT02528188|541793951|FG000|Overall Study|Randomized but not treated|6|||
150179166|NCT02528188|541793952|FG001|Overall Study|Randomized but not treated|7|||
150179167|NCT02528188|541793953|FG002|Overall Study|Randomized but not treated|12|||
150179168|NCT00440011|541793955|FG000|Overall Study|Adverse Event|2|||
150179169|NCT00440011|541793956|FG001|Overall Study|Adverse Event|0|||
150179170|NCT00440011|541793955|FG000|Overall Study|Lost to Follow-up|0|||
150179171|NCT00440011|541793956|FG001|Overall Study|Lost to Follow-up|2|||
150179172|NCT00440011|541793955|FG000|Overall Study|Protocol Violation|1|||
150179173|NCT00440011|541793956|FG001|Overall Study|Protocol Violation|1|||
150179174|NCT00440011|541793955|FG000|Overall Study|Withdrawal by Subject|1|||
150179175|NCT00440011|541793956|FG001|Overall Study|Withdrawal by Subject|0|||
150179176|NCT00419341|541793957|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
150179177|NCT00419341|541793957|FG000|Wash in/Wash Out Period|Adverse Event|2|||
150179178|NCT00419341|541793957|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
150179179|NCT00419341|541793957|FG000|Efficacy Period|Withdrawal by Subject|6|||
150179180|NCT00419341|541793957|FG000|Efficacy Period|Protocol Violation|1|||
150179181|NCT00419341|541793957|FG000|Efficacy Period|Lost to Follow-up|1|||
150179182|NCT00419341|541793957|FG000|Efficacy Period|Non-compliance|1|||
150179183|NCT00419341|541793957|FG000|Efficacy Period|Termination of study site|1|||
150179184|NCT01849055|541793965|FG000|Overall Study|Withdrawal by Subject|0|||
150179185|NCT01849055|541793966|FG001|Overall Study|Withdrawal by Subject|0|||
150179186|NCT01849055|541793967|FG002|Overall Study|Withdrawal by Subject|1|||
150179187|NCT01849055|541793968|FG003|Overall Study|Withdrawal by Subject|0|||
150179188|NCT01849055|541793969|FG004|Overall Study|Withdrawal by Subject|0|||
150179189|NCT01849055|541793970|FG005|Overall Study|Withdrawal by Subject|0|||
150179190|NCT00223795|541793971|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
150179191|NCT00223795|541793972|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
150179192|NCT00223795|541793971|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
150179193|NCT00223795|541793972|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
150179194|NCT01239316|541793978|FG000|Overall Study|Progression/Relapse|11|||
150179195|NCT01239316|541793978|FG000|Overall Study|Adverse Event|1|||
150179196|NCT03960463|541795290|FG000|Overall Study|Withdrawal by Subject|2|||
150179197|NCT03960463|541795291|FG001|Overall Study|Withdrawal by Subject|0|||
150179198|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
150179199|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
150179200|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
150179201|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
150179202|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
150179203|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
150179204|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
150179205|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
150179206|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
150179207|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
150179208|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
150179209|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
150179210|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
150179211|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
150179212|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
150179213|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
150179214|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
150179215|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
150179216|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
150179217|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
150179218|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
150179219|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
150179220|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
150179221|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
150179222|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
150179223|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
149997525|NCT02851407|541125340|FG001|Overall Study|Adverse event, non-fatal|5|||
149997526|NCT02851407|541125339|FG000|Overall Study|Lost to Follow-up|0|||
149997527|NCT02851407|541125340|FG001|Overall Study|Lost to Follow-up|2|||
149997528|NCT01713283|541125341|FG000|Overall Study|Lack of Efficacy|10|||
149997529|NCT01713283|541125342|FG001|Overall Study|Lack of Efficacy|2|||
149997530|NCT01713283|541125341|FG000|Overall Study|Lost to Follow-up|1|||
149997531|NCT01713283|541125342|FG001|Overall Study|Lost to Follow-up|1|||
149997532|NCT00235391|541125343|FG000|Overall Study|Adverse Event|4|||
149997533|NCT00235391|541125344|FG001|Overall Study|Adverse Event|5|||
149997534|NCT00235391|541125345|FG002|Overall Study|Adverse Event|10|||
149997535|NCT00235391|541125346|FG003|Overall Study|Adverse Event|72|||
149997536|NCT00235391|541125347|FG004|Overall Study|Adverse Event|5|||
149997537|NCT00235391|541125348|FG005|Overall Study|Adverse Event|2|||
149997538|NCT00235391|541125343|FG000|Overall Study|Abnormal laboratory value(s)|3|||
149997539|NCT00235391|541125344|FG001|Overall Study|Abnormal laboratory value(s)|5|||
149997540|NCT00235391|541125345|FG002|Overall Study|Abnormal laboratory value(s)|4|||
149997541|NCT00235391|541125346|FG003|Overall Study|Abnormal laboratory value(s)|27|||
149997542|NCT00235391|541125347|FG004|Overall Study|Abnormal laboratory value(s)|1|||
149997543|NCT00235391|541125348|FG005|Overall Study|Abnormal laboratory value(s)|2|||
149997544|NCT00235391|541125343|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149997545|NCT00235391|541125344|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149997546|NCT00235391|541125345|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149997547|NCT00235391|541125346|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
149997548|NCT00235391|541125347|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
149997549|NCT00235391|541125348|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
149997550|NCT00235391|541125343|FG000|Overall Study|Condition no longer requires treatment|3|||
149997551|NCT00235391|541125344|FG001|Overall Study|Condition no longer requires treatment|0|||
149997552|NCT00235391|541125345|FG002|Overall Study|Condition no longer requires treatment|0|||
149997553|NCT00235391|541125346|FG003|Overall Study|Condition no longer requires treatment|11|||
149997554|NCT00235391|541125347|FG004|Overall Study|Condition no longer requires treatment|1|||
149997555|NCT00235391|541125348|FG005|Overall Study|Condition no longer requires treatment|0|||
149997556|NCT00235391|541125343|FG000|Overall Study|Protocol deviation|0|||
149997557|NCT00235391|541125344|FG001|Overall Study|Protocol deviation|0|||
149997558|NCT00235391|541125345|FG002|Overall Study|Protocol deviation|1|||
149997559|NCT00235391|541125346|FG003|Overall Study|Protocol deviation|11|||
149997560|NCT00235391|541125347|FG004|Overall Study|Protocol deviation|0|||
149997561|NCT00235391|541125348|FG005|Overall Study|Protocol deviation|0|||
149997562|NCT00235391|541125343|FG000|Overall Study|Withdrawal by Subject|2|||
149997563|NCT00235391|541125344|FG001|Overall Study|Withdrawal by Subject|3|||
149997564|NCT00235391|541125345|FG002|Overall Study|Withdrawal by Subject|3|||
149997565|NCT00235391|541125346|FG003|Overall Study|Withdrawal by Subject|61|||
149997566|NCT00235391|541125347|FG004|Overall Study|Withdrawal by Subject|5|||
149997567|NCT00235391|541125348|FG005|Overall Study|Withdrawal by Subject|0|||
149997568|NCT00235391|541125343|FG000|Overall Study|Lost to Follow-up|0|||
149997569|NCT00235391|541125344|FG001|Overall Study|Lost to Follow-up|3|||
149997570|NCT00235391|541125345|FG002|Overall Study|Lost to Follow-up|3|||
149997571|NCT00235391|541125346|FG003|Overall Study|Lost to Follow-up|16|||
149997572|NCT00235391|541125347|FG004|Overall Study|Lost to Follow-up|0|||
149997573|NCT00235391|541125348|FG005|Overall Study|Lost to Follow-up|0|||
149997574|NCT00235391|541125343|FG000|Overall Study|Administrative problems|0|||
149997575|NCT00235391|541125344|FG001|Overall Study|Administrative problems|0|||
149997576|NCT00235391|541125345|FG002|Overall Study|Administrative problems|0|||
149997577|NCT00235391|541125346|FG003|Overall Study|Administrative problems|1|||
149997578|NCT00235391|541125347|FG004|Overall Study|Administrative problems|0|||
149997579|NCT00235391|541125348|FG005|Overall Study|Administrative problems|0|||
149997580|NCT00235391|541125343|FG000|Overall Study|Death|0|||
150179224|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149997581|NCT00235391|541125344|FG001|Overall Study|Death|0|||
149997582|NCT00235391|541125345|FG002|Overall Study|Death|1|||
149997583|NCT00235391|541125346|FG003|Overall Study|Death|4|||
149997584|NCT00235391|541125347|FG004|Overall Study|Death|0|||
149997585|NCT00235391|541125348|FG005|Overall Study|Death|0|||
149997586|NCT00580034|541125350|FG000|Overall Study|Toxicity|10|||
149997587|NCT00580034|541125351|FG001|Overall Study|Toxicity|0|||
149997588|NCT00772369|541125353|FG000|Overall Study|Did not return record release form|1|||
149997589|NCT03372460|541125354|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
149997590|NCT03372460|541125355|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
150179225|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149997591|NCT02499900|541125356|FG000|Core Study Period|Other|1|||
149997592|NCT02499900|541125357|FG001|Core Study Period|Other|4|||
149997593|NCT02499900|541125356|FG000|Core Study Period|Lost to Follow-up|1|||
149997594|NCT02499900|541125357|FG001|Core Study Period|Lost to Follow-up|2|||
149997595|NCT02499900|541125356|FG000|Core Study Period|Per sponsor request|0|||
149997596|NCT02499900|541125357|FG001|Core Study Period|Per sponsor request|1|||
149997597|NCT02499900|541125356|FG000|Core Study Period|Pregnancy|1|||
149997598|NCT02499900|541125357|FG001|Core Study Period|Pregnancy|0|||
150054181|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
150054182|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
150054183|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149997599|NCT02499900|541125356|FG000|Core Study Period|Protocol Violation|3|||
149997600|NCT02499900|541125357|FG001|Core Study Period|Protocol Violation|0|||
149997601|NCT02499900|541125356|FG000|Core Study Period|Withdrawal by Subject|11|||
149997602|NCT02499900|541125357|FG001|Core Study Period|Withdrawal by Subject|10|||
149997603|NCT02499900|541125356|FG000|Core Study Period|Adverse Event|18|||
149997604|NCT02499900|541125357|FG001|Core Study Period|Adverse Event|14|||
149997605|NCT02499900|541125356|FG000|Core Study Period|Death|0|||
149997606|NCT02499900|541125357|FG001|Core Study Period|Death|1|||
149997607|NCT02499900|541125356|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
149997608|NCT02499900|541125357|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
149997609|NCT02499900|541125356|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
149997610|NCT02499900|541125357|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
149997611|NCT02499900|541125356|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
149997612|NCT02499900|541125357|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
149997613|NCT02499900|541125356|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
149997614|NCT02499900|541125357|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
149997615|NCT02499900|541125356|FG000|Extension Study Period|Adverse Event|2|||
149997616|NCT02499900|541125357|FG001|Extension Study Period|Adverse Event|4|||
149997617|NCT02499900|541125356|FG000|Extension Study Period|Withdrawal by Subject|5|||
149997618|NCT02499900|541125357|FG001|Extension Study Period|Withdrawal by Subject|2|||
149997619|NCT02499900|541125356|FG000|Extension Study Period|Physician Decision|2|||
149997620|NCT02499900|541125357|FG001|Extension Study Period|Physician Decision|5|||
149997621|NCT02499900|541125356|FG000|Extension Study Period|Pregnancy|1|||
149997622|NCT02499900|541125357|FG001|Extension Study Period|Pregnancy|2|||
149997623|NCT02499900|541125356|FG000|Extension Study Period|Lost to Follow-up|2|||
149997624|NCT02499900|541125357|FG001|Extension Study Period|Lost to Follow-up|5|||
149997625|NCT02499900|541125356|FG000|Extension Study Period|Other|0|||
149997626|NCT02499900|541125357|FG001|Extension Study Period|Other|2|||
149997627|NCT00916058|541125360|FG000|Phase 1|Screen Failure|0|||
149997628|NCT00916058|541125361|FG001|Phase 1|Screen Failure|0|||
149997629|NCT00916058|541125362|FG002|Phase 1|Screen Failure|0|||
149997630|NCT00916058|541125363|FG003|Phase 1|Screen Failure|0|||
149997631|NCT00916058|541125364|FG004|Phase 1|Screen Failure|0|||
149997632|NCT00916058|541125365|FG005|Phase 1|Screen Failure|1|||
149997633|NCT00916058|541125366|FG006|Phase 1|Screen Failure|0|||
149997634|NCT00916058|541125360|FG000|Phase 2|Screen Failure|0|||
149997635|NCT00916058|541125361|FG001|Phase 2|Screen Failure|0|||
149997636|NCT00916058|541125362|FG002|Phase 2|Screen Failure|0|||
150054184|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149997637|NCT00916058|541125363|FG003|Phase 2|Screen Failure|0|||
150054185|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
150054186|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149997638|NCT00916058|541125364|FG004|Phase 2|Screen Failure|0|||
149997639|NCT00916058|541125365|FG005|Phase 2|Screen Failure|0|||
149997640|NCT00916058|541125366|FG006|Phase 2|Screen Failure|3|||
150054187|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
150054188|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149997641|NCT03385265|541125368|FG000|Overall Study|Withdrawal by Subject|5|||
149997642|NCT03385265|541125369|FG001|Overall Study|Withdrawal by Subject|2|||
149997643|NCT03385265|541125370|FG002|Overall Study|Withdrawal by Subject|5|||
149997644|NCT03385265|541125371|FG003|Overall Study|Withdrawal by Subject|2|||
149997645|NCT02439450|541125373|FG000|Overall Study|Adverse Event|4|||
149997646|NCT02439450|541125374|FG001|Overall Study|Adverse Event|1|||
149997647|NCT02439450|541125375|FG002|Overall Study|Adverse Event|0|||
149997648|NCT02439450|541125376|FG003|Overall Study|Adverse Event|0|||
149997649|NCT02439450|541125373|FG000|Overall Study|Withdrawal by Subject|1|||
149997650|NCT02439450|541125374|FG001|Overall Study|Withdrawal by Subject|2|||
149997651|NCT02439450|541125375|FG002|Overall Study|Withdrawal by Subject|0|||
149997652|NCT02439450|541125376|FG003|Overall Study|Withdrawal by Subject|0|||
149997653|NCT02439450|541125373|FG000|Overall Study|Death|3|||
149997654|NCT02439450|541125374|FG001|Overall Study|Death|0|||
149997655|NCT02439450|541125375|FG002|Overall Study|Death|0|||
149997656|NCT02439450|541125376|FG003|Overall Study|Death|1|||
149997657|NCT02439450|541125373|FG000|Overall Study|Progressive Disease|18|||
149997658|NCT02439450|541125374|FG001|Overall Study|Progressive Disease|41|||
149997659|NCT02439450|541125375|FG002|Overall Study|Progressive Disease|2|||
149997660|NCT02439450|541125376|FG003|Overall Study|Progressive Disease|3|||
149997661|NCT01170065|541125393|FG000|Overall Study|Adverse Event|17|||
149997662|NCT01170065|541125394|FG001|Overall Study|Adverse Event|50|||
149997663|NCT01170065|541125395|FG002|Overall Study|Adverse Event|10|||
149997664|NCT01170065|541125393|FG000|Overall Study|Lost to Follow-up|1|||
149997665|NCT01170065|541125394|FG001|Overall Study|Lost to Follow-up|4|||
149997666|NCT01170065|541125395|FG002|Overall Study|Lost to Follow-up|1|||
149997667|NCT01170065|541125393|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
149997668|NCT01170065|541125394|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
149997669|NCT01170065|541125395|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
149997670|NCT01170065|541125393|FG000|Overall Study|Reason other than specified|3|||
149997671|NCT01170065|541125394|FG001|Overall Study|Reason other than specified|8|||
149997672|NCT01170065|541125395|FG002|Overall Study|Reason other than specified|3|||
149997673|NCT01170065|541125393|FG000|Overall Study|Ongoing after planned observation time|5|||
149997674|NCT01170065|541125394|FG001|Overall Study|Ongoing after planned observation time|26|||
149997675|NCT01170065|541125395|FG002|Overall Study|Ongoing after planned observation time|10|||
149997676|NCT01071200|541125400|FG000|Overall Study|Lack of ovarian response|1|||
149997677|NCT01071200|541125401|FG001|Overall Study|Lack of ovarian response|1|||
149997678|NCT01071200|541125400|FG000|Overall Study|No fertilization|4|||
149997679|NCT01071200|541125401|FG001|Overall Study|No fertilization|0|||
149997680|NCT01071200|541125400|FG000|Overall Study|No oocytes retrieved|1|||
149997681|NCT01071200|541125401|FG001|Overall Study|No oocytes retrieved|1|||
149997682|NCT01071200|541125400|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
149997683|NCT01071200|541125401|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
149997684|NCT01071200|541125400|FG000|Overall Study|No viable embryos|0|||
149997685|NCT01071200|541125401|FG001|Overall Study|No viable embryos|1|||
150054189|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
150054190|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
150054191|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
150054192|NCT01185353|541338445|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054193|NCT01185353|541338446|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054194|NCT01185353|541338447|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054195|NCT01185353|541338448|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054196|NCT01185353|541338449|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054197|NCT01185353|541338450|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054198|NCT01185353|541338451|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054199|NCT01185353|541338452|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054200|NCT01185353|541338453|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
150054201|NCT01185353|541338454|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
150054202|NCT01185353|541338445|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054203|NCT01185353|541338446|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054204|NCT01185353|541338447|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054205|NCT01185353|541338448|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054206|NCT01185353|541338449|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054207|NCT01185353|541338450|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054208|NCT01185353|541338451|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054209|NCT01185353|541338452|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
150054210|NCT01185353|541338453|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
149997686|NCT02434354|541125402|FG000|Overall Study|screen fail|3|||
149997687|NCT03730961|541125403|FG000|Overall Study|Adverse Event|0|||
150054211|NCT01185353|541338454|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
150054212|NCT01185353|541338445|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054213|NCT01185353|541338446|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
149997688|NCT03730961|541125404|FG001|Overall Study|Adverse Event|1|||
149997689|NCT01920893|541125407|FG000|Overall Study|Adverse Event|5|||
149997690|NCT01920893|541125408|FG001|Overall Study|Adverse Event|2|||
149997691|NCT01920893|541125407|FG000|Overall Study|Lack of Efficacy|2|||
149997692|NCT01920893|541125408|FG001|Overall Study|Lack of Efficacy|0|||
149997693|NCT01767493|541125409|FG000|Overall Study|screen failures|3|||
149997694|NCT02752958|541125412|FG000|Overall Study|Adverse Event|3|||
149997695|NCT02752958|541125412|FG000|Overall Study|Lost to Follow-up|1|||
149997696|NCT02752958|541125412|FG000|Overall Study|Protocol Violation|1|||
149997697|NCT02752958|541125412|FG000|Overall Study|Withdrawal by Subject|2|||
149997698|NCT02752958|541125412|FG000|Overall Study|Other (Reason not specified)|2|||
149997699|NCT00853125|541125413|FG000|Overall Study|Study participant's donor was CMV +|1|||
149997700|NCT01646645|541125415|FG000|Overall Study|No Treated|1|||
149997701|NCT01646645|541125415|FG000|Overall Study|Inevaluable Donor|29|||
149997702|NCT00884039|541125416|FG000|Overall Study|Withdrawal by Subject|0|||
149997703|NCT00884039|541125417|FG001|Overall Study|Withdrawal by Subject|1|||
149997704|NCT00884039|541125416|FG000|Overall Study|Lack of Efficacy|2|||
149997705|NCT00884039|541125417|FG001|Overall Study|Lack of Efficacy|0|||
149997706|NCT04209114|541125420|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
149997707|NCT04209114|541125421|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
149997708|NCT04209114|541125422|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
149997709|NCT04209114|541125420|FG000|Pre-Treatment Phase|Other reasons|0|||
149997710|NCT04209114|541125421|FG001|Pre-Treatment Phase|Other reasons|0|||
149997711|NCT04209114|541125422|FG002|Pre-Treatment Phase|Other reasons|1|||
149997712|NCT04209114|541125420|FG000|Pre-Treatment Phase|Death|0|||
149997713|NCT04209114|541125421|FG001|Pre-Treatment Phase|Death|0|||
149997714|NCT04209114|541125422|FG002|Pre-Treatment Phase|Death|1|||
149997715|NCT04209114|541125420|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
149997716|NCT04209114|541125421|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
149997717|NCT04209114|541125422|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
149997718|NCT04209114|541125420|FG000|Treatment Phase|Other reasons|5|||
149997719|NCT04209114|541125421|FG001|Treatment Phase|Other reasons|3|||
149997720|NCT04209114|541125422|FG002|Treatment Phase|Other reasons|0|||
149997721|NCT04209114|541125420|FG000|Treatment Phase|Lost to Follow-up|1|||
149997722|NCT04209114|541125421|FG001|Treatment Phase|Lost to Follow-up|0|||
149997723|NCT04209114|541125422|FG002|Treatment Phase|Lost to Follow-up|0|||
149997724|NCT04209114|541125420|FG000|Treatment Phase|Participant withdrew consent|1|||
149997725|NCT04209114|541125421|FG001|Treatment Phase|Participant withdrew consent|0|||
149997726|NCT04209114|541125422|FG002|Treatment Phase|Participant withdrew consent|0|||
149997727|NCT04209114|541125420|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
149997728|NCT04209114|541125421|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
149997729|NCT04209114|541125422|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
150054214|NCT01185353|541338447|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054215|NCT01185353|541338448|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054216|NCT01185353|541338449|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054217|NCT01185353|541338450|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054218|NCT01185353|541338451|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
150054219|NCT01185353|541338452|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
150054220|NCT01185353|541338453|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
150054221|NCT01185353|541338454|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
150054222|NCT01185353|541338445|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054223|NCT01185353|541338446|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054224|NCT01185353|541338447|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054225|NCT01185353|541338448|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054226|NCT01185353|541338449|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054227|NCT01185353|541338450|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054228|NCT01185353|541338451|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
149997730|NCT04209114|541125420|FG000|Treatment Phase|Death|4|||
149997731|NCT04209114|541125421|FG001|Treatment Phase|Death|1|||
149997732|NCT04209114|541125422|FG002|Treatment Phase|Death|0|||
149997733|NCT04209114|541125420|FG000|Treatment Phase|Study drug toxicity|4|||
149997734|NCT04209114|541125421|FG001|Treatment Phase|Study drug toxicity|6|||
149997735|NCT04209114|541125422|FG002|Treatment Phase|Study drug toxicity|0|||
149997736|NCT04209114|541125420|FG000|Treatment Phase|Disease progression|6|||
149997737|NCT04209114|541125421|FG001|Treatment Phase|Disease progression|9|||
149997738|NCT04209114|541125422|FG002|Treatment Phase|Disease progression|0|||
149997739|NCT00681564|541125425|FG000|Overall Study|Lost to Follow-up|6|||
149997740|NCT00681564|541125426|FG001|Overall Study|Lost to Follow-up|6|||
149997741|NCT00681564|541125425|FG000|Overall Study|Withdrawal by Subject|0|||
149997742|NCT00681564|541125426|FG001|Overall Study|Withdrawal by Subject|1|||
149997743|NCT00681564|541125425|FG000|Overall Study|Death|0|||
149997744|NCT00681564|541125426|FG001|Overall Study|Death|1|||
149997745|NCT02826421|541125427|FG000|Overall Study|Adverse Event|1|||
149997746|NCT02826421|541125428|FG001|Overall Study|Adverse Event|0|||
149997747|NCT02826421|541125429|FG002|Overall Study|Adverse Event|0|||
149997748|NCT02826421|541125430|FG003|Overall Study|Adverse Event|1|||
149997749|NCT02826421|541125427|FG000|Overall Study|Withdrawal by Subject|1|||
150054229|NCT01185353|541338452|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
150054230|NCT01185353|541338453|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
150054231|NCT01185353|541338454|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
150054232|NCT02270944|541338458|FG000|Overall Study|Lost to Follow-up|9|||
150054233|NCT02270944|541338459|FG001|Overall Study|Lost to Follow-up|4|||
150054234|NCT02270944|541338458|FG000|Overall Study|Withdrawal by Subject|2|||
150054235|NCT02270944|541338459|FG001|Overall Study|Withdrawal by Subject|1|||
150054236|NCT01699867|541338460|FG000|Overall Study|Screening Failure|3|||
150054237|NCT00530504|541338473|FG000|Overall Study|Death|54|||
150054238|NCT00530504|541338473|FG000|Overall Study|Lost to Follow-up|26|||
150054239|NCT00530504|541338473|FG000|Overall Study|Withdrawal by Subject|39|||
150054240|NCT00530504|541338473|FG000|Overall Study|Exited study due to other reasons|33|||
150054241|NCT00006289|541338474|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
150054242|NCT00006289|541338475|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
150054243|NCT00006289|541338474|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
150054244|NCT00006289|541338475|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
150054245|NCT00576420|541340189|FG000|Overall Study|Death|0|||
150054246|NCT00576420|541340190|FG001|Overall Study|Death|0|||
150054247|NCT00576420|541340191|FG002|Overall Study|Death|1|||
150054248|NCT02043899|541340195|FG000|Overall Study|Adverse Event|3|||
150054249|NCT02043899|541340195|FG000|Overall Study|Physician Decision|1|||
150054250|NCT02043899|541340195|FG000|Overall Study|Withdrawal by Subject|2|||
150054251|NCT02043899|541340195|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
150054252|NCT02043899|541340195|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
150054253|NCT02043899|541340195|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
150054254|NCT02043899|541340195|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
150054255|NCT02043899|541340195|FG000|Overall Study|Treatment delayed|1|||
150054256|NCT03254108|541340196|FG000|Overall Study|Adverse Event|0|||
150054257|NCT03254108|541340197|FG001|Overall Study|Adverse Event|2|||
150054258|NCT03254108|541340198|FG002|Overall Study|Adverse Event|0|||
150054259|NCT03254108|541340199|FG003|Overall Study|Adverse Event|1|||
150054260|NCT03254108|541340200|FG004|Overall Study|Adverse Event|1|||
150054261|NCT03254108|541340196|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
150054262|NCT03254108|541340197|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
150054263|NCT03254108|541340198|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
150054264|NCT03254108|541340199|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
150054265|NCT03254108|541340200|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
150054266|NCT01771809|541340201|FG000|Overall Study|Adverse Event|4|||
150054267|NCT01771809|541340202|FG001|Overall Study|Adverse Event|12|||
150054268|NCT01771809|541340201|FG000|Overall Study|Protocol Violation|0|||
150054269|NCT01771809|541340202|FG001|Overall Study|Protocol Violation|1|||
150054270|NCT01771809|541340201|FG000|Overall Study|Withdrawal by Subject|34|||
150054271|NCT01771809|541340202|FG001|Overall Study|Withdrawal by Subject|42|||
150054272|NCT01771809|541340201|FG000|Overall Study|Lost to Follow-up|1|||
150054273|NCT01771809|541340202|FG001|Overall Study|Lost to Follow-up|3|||
150054274|NCT01771809|541340201|FG000|Overall Study|Other (Insufficient clinical response)|22|||
150054275|NCT01771809|541340202|FG001|Overall Study|Other (Insufficient clinical response)|20|||
150054276|NCT01771809|541340201|FG000|Overall Study|Death|1|||
150054277|NCT01771809|541340202|FG001|Overall Study|Death|0|||
150054278|NCT01771809|541340201|FG000|Overall Study|Other (other)|9|||
149997750|NCT02826421|541125428|FG001|Overall Study|Withdrawal by Subject|3|||
150054279|NCT01771809|541340202|FG001|Overall Study|Other (other)|5|||
150179226|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149997751|NCT02826421|541125429|FG002|Overall Study|Withdrawal by Subject|1|||
149997752|NCT02826421|541125430|FG003|Overall Study|Withdrawal by Subject|1|||
149997753|NCT02826421|541125427|FG000|Overall Study|Reason not given|1|||
149997754|NCT02826421|541125428|FG001|Overall Study|Reason not given|0|||
149997755|NCT02826421|541125429|FG002|Overall Study|Reason not given|1|||
150179227|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
150179228|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
150179229|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
150179230|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
150179231|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
150179232|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
150179233|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
150179234|NCT04043455|541795292|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
150179235|NCT04043455|541795293|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
150179236|NCT04043455|541795294|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
150179237|NCT04043455|541795295|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
150179238|NCT04043455|541795296|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
150179239|NCT04043455|541795297|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
150179240|NCT04043455|541795292|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
150179241|NCT04043455|541795293|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
150179242|NCT04043455|541795294|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
150179243|NCT04043455|541795295|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
150179244|NCT04043455|541795296|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
150179245|NCT04043455|541795297|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
150179246|NCT04043455|541795292|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
150179247|NCT04043455|541795293|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
150179248|NCT04043455|541795294|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
150179249|NCT04043455|541795295|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
150179250|NCT04043455|541795296|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
150179251|NCT04043455|541795297|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
150179252|NCT04043455|541795292|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
150179253|NCT04043455|541795293|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
150179254|NCT04043455|541795294|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
150179255|NCT04043455|541795295|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
150179256|NCT04043455|541795296|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
150179257|NCT04043455|541795297|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
150179258|NCT04043455|541795292|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
150179259|NCT04043455|541795293|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
150179260|NCT04043455|541795294|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
150179261|NCT04043455|541795295|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
150179262|NCT04043455|541795296|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
150179263|NCT04043455|541795297|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
150179264|NCT05568615|541795298|FG000|Overall Study|Death|1|||
150179265|NCT05568615|541795298|FG000|Overall Study|Physician Decision|1|||
150179266|NCT05194917|541795299|FG000|Overall Study|Lost to Follow-up|7|||
150179267|NCT05194917|541795300|FG001|Overall Study|Lost to Follow-up|5|||
150179268|NCT05194917|541795301|FG002|Overall Study|Lost to Follow-up|6|||
150179269|NCT05194917|541795302|FG003|Overall Study|Lost to Follow-up|5|||
150179270|NCT05505045|541795310|FG000|Overall Study|Withdrawal by Subject|2|||
150179271|NCT05505045|541795311|FG001|Overall Study|Withdrawal by Subject|1|||
150179272|NCT01643070|541795312|FG000|Overall Study|Withdrawal by Subject|3|||
150179273|NCT01643070|541795313|FG001|Overall Study|Withdrawal by Subject|1|||
150179274|NCT01643070|541795312|FG000|Overall Study|Death|1|||
150179275|NCT01643070|541795313|FG001|Overall Study|Death|0|||
150179276|NCT01643070|541795312|FG000|Overall Study|Pregressive disease|0|||
150179277|NCT01643070|541795313|FG001|Overall Study|Pregressive disease|2|||
150179278|NCT04941287|541795317|FG000|Overall Study|Rapid decline before starting treatment|3|||
150179279|NCT04941287|541795318|FG001|Overall Study|Rapid decline before starting treatment|1|||
150179280|NCT03025789|541795319|FG000|Overall Study|Lack of Efficacy|6|||
150179281|NCT03025789|541795320|FG001|Overall Study|Lack of Efficacy|1|||
150179282|NCT03025789|541795319|FG000|Overall Study|Death|1|||
150179283|NCT03025789|541795320|FG001|Overall Study|Death|0|||
150179284|NCT03025789|541795319|FG000|Overall Study|Withdrawal by Subject|0|||
150179285|NCT03025789|541795320|FG001|Overall Study|Withdrawal by Subject|2|||
150179286|NCT05057897|541795321|FG000|Overall Study|Site closure|2|||
150179287|NCT05057897|541795322|FG001|Overall Study|Site closure|2|||
150179288|NCT05057897|541795321|FG000|Overall Study|Death|1|||
149997756|NCT02826421|541125430|FG003|Overall Study|Reason not given|0|||
149997757|NCT00405964|541125431|FG000|Overall Study|Treatment Failure|17|||
149997758|NCT00405964|541125432|FG001|Overall Study|Treatment Failure|45|||
150179289|NCT05057897|541795322|FG001|Overall Study|Death|0|||
150179290|NCT04524390|541795323|FG000|Double Blind|Consent Withdrawal by subject|2|||
150179291|NCT04524390|541795324|FG001|Double Blind|Consent Withdrawal by subject|1|||
149997759|NCT00405964|541125431|FG000|Overall Study|Adverse Event|7|||
149997760|NCT00405964|541125432|FG001|Overall Study|Adverse Event|16|||
149997761|NCT00405964|541125431|FG000|Overall Study|Lost to Follow-up|5|||
149997762|NCT00405964|541125432|FG001|Overall Study|Lost to Follow-up|5|||
149997763|NCT00405964|541125431|FG000|Overall Study|Withdrawal by Subject|19|||
149997764|NCT00405964|541125432|FG001|Overall Study|Withdrawal by Subject|23|||
149997765|NCT00405964|541125431|FG000|Overall Study|Protocol Violation|11|||
149997766|NCT00405964|541125432|FG001|Overall Study|Protocol Violation|6|||
149997767|NCT02981407|541125435|FG000|Overall Study|Withdrawal by Subject|2|||
149997768|NCT02981407|541125436|FG001|Overall Study|Withdrawal by Subject|0|||
149997769|NCT01300819|541125437|FG000|Overall Study|Adverse Event|9|||
149997770|NCT01300819|541125438|FG001|Overall Study|Adverse Event|27|||
149997771|NCT01300819|541125437|FG000|Overall Study|Lack of Efficacy|2|||
149997772|NCT01300819|541125438|FG001|Overall Study|Lack of Efficacy|1|||
149997773|NCT01300819|541125437|FG000|Overall Study|Withdrawal by Subject|10|||
149997774|NCT01300819|541125438|FG001|Overall Study|Withdrawal by Subject|12|||
149997775|NCT01300819|541125437|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
149997776|NCT01300819|541125438|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
149997777|NCT01300819|541125437|FG000|Overall Study|Refusal to down titrate study drug|0|||
149997778|NCT01300819|541125438|FG001|Overall Study|Refusal to down titrate study drug|1|||
149997779|NCT01300819|541125437|FG000|Overall Study|Administrative reason|0|||
149997780|NCT01300819|541125438|FG001|Overall Study|Administrative reason|1|||
149997781|NCT01300819|541125437|FG000|Overall Study|Safety follow up not done by mistake|0|||
149997782|NCT01300819|541125438|FG001|Overall Study|Safety follow up not done by mistake|1|||
149997783|NCT01300819|541125437|FG000|Overall Study|Follow up call was not done|1|||
149997784|NCT01300819|541125438|FG001|Overall Study|Follow up call was not done|0|||
149997785|NCT00509093|541127688|FG000|Overall Study|Adverse Event|10|||
149997786|NCT00509093|541127688|FG000|Overall Study|Disease Progression|9|||
149997787|NCT00509093|541127688|FG000|Overall Study|Transformed into MDS|1|||
149997788|NCT00509093|541127688|FG000|Overall Study|Withdrawal by Subject|3|||
149997789|NCT00509093|541127688|FG000|Overall Study|Physician Decision|1|||
149997790|NCT01103063|541127689|FG000|Overall Study|Adverse Event|3|||
149997791|NCT01103063|541127690|FG001|Overall Study|Adverse Event|1|||
149997792|NCT01103063|541127689|FG000|Overall Study|Lost to Follow-up|68|||
149997793|NCT01103063|541127690|FG001|Overall Study|Lost to Follow-up|51|||
149997794|NCT01103063|541127689|FG000|Overall Study|Withdrawal by Subject|60|||
149997795|NCT01103063|541127690|FG001|Overall Study|Withdrawal by Subject|15|||
149997796|NCT01103063|541127689|FG000|Overall Study|Other|16|||
149997797|NCT01103063|541127690|FG001|Overall Study|Other|11|||
149997798|NCT01103063|541127689|FG000|Overall Study|Protocol Violation|1|||
149997799|NCT01103063|541127690|FG001|Overall Study|Protocol Violation|0|||
149997800|NCT01103063|541127689|FG000|Overall Study|Study terminated by Sponsor|326|||
149997801|NCT01103063|541127690|FG001|Overall Study|Study terminated by Sponsor|342|||
149997802|NCT01103063|541127689|FG000|Overall Study|Death|3|||
149997803|NCT01103063|541127690|FG001|Overall Study|Death|1|||
149997804|NCT05320393|541127691|FG000|Overall Study|Withdrawal by Subject|1|||
149997805|NCT05320393|541127692|FG001|Overall Study|Withdrawal by Subject|0|||
149997806|NCT05320393|541127693|FG002|Overall Study|Withdrawal by Subject|2|||
149997807|NCT05320393|541127691|FG000|Overall Study|Lost to Follow-up|1|||
149997808|NCT05320393|541127692|FG001|Overall Study|Lost to Follow-up|2|||
149997809|NCT05320393|541127693|FG002|Overall Study|Lost to Follow-up|1|||
149997810|NCT05320393|541127691|FG000|Overall Study|Moved; too much driving|0|||
149997811|NCT05320393|541127692|FG001|Overall Study|Moved; too much driving|0|||
149997812|NCT05320393|541127693|FG002|Overall Study|Moved; too much driving|2|||
149997813|NCT05320393|541127691|FG000|Overall Study|Did not receive treatment|0|||
149997814|NCT05320393|541127692|FG001|Overall Study|Did not receive treatment|0|||
149997815|NCT05320393|541127693|FG002|Overall Study|Did not receive treatment|1|||
149997816|NCT03283098|541127694|FG000|Overall Study|Withdrawal by Subject|0|||
149997817|NCT03283098|541127695|FG001|Overall Study|Withdrawal by Subject|1|||
149997818|NCT02210832|541127696|FG000|Overall Study|Pregnancy termination .|3|||
149997819|NCT02210832|541127697|FG001|Overall Study|Pregnancy termination .|4|||
149997820|NCT02210832|541127698|FG002|Overall Study|Pregnancy termination .|1|||
150054280|NCT00362180|541340203|FG000|Treated Period|Withdrawal by Subject|1|||
149997821|NCT02210832|541127696|FG000|Overall Study|Lost to Follow-up|26|||
149997822|NCT02210832|541127697|FG001|Overall Study|Lost to Follow-up|32|||
149997823|NCT02210832|541127698|FG002|Overall Study|Lost to Follow-up|17|||
149997824|NCT00798317|541127701|FG000|Overall Study|Physician Decision|0|||
149997825|NCT00798317|541127702|FG001|Overall Study|Physician Decision|1|||
149997826|NCT00798317|541127701|FG000|Overall Study|Withdrawal by Subject|5|||
149997827|NCT00798317|541127702|FG001|Overall Study|Withdrawal by Subject|4|||
149997828|NCT00798317|541127701|FG000|Overall Study|Lost to Follow-up|2|||
149997829|NCT00798317|541127702|FG001|Overall Study|Lost to Follow-up|2|||
150054281|NCT00362180|541340204|FG001|Treated Period|Withdrawal by Subject|0|||
149997830|NCT00798317|541127701|FG000|Overall Study|Adverse Event|2|||
149997831|NCT00798317|541127702|FG001|Overall Study|Adverse Event|0|||
149997832|NCT00798317|541127701|FG000|Overall Study|Death|1|||
149997833|NCT00798317|541127702|FG001|Overall Study|Death|0|||
149997834|NCT01069861|541127704|FG000|Overall Study|Death|1|||
149997835|NCT01069861|541127704|FG000|Overall Study|Adverse Event|1|||
149997836|NCT01069861|541127704|FG000|Overall Study|Did not meet entrance criteria|1|||
149997837|NCT00149994|541127707|FG000|Overall Study|Administrative problems:|1|||
149997838|NCT00149994|541127708|FG001|Overall Study|Administrative problems:|0|||
149997839|NCT00149994|541127707|FG000|Overall Study|Protocol Violation|0|||
149997840|NCT00149994|541127708|FG001|Overall Study|Protocol Violation|1|||
149997841|NCT01344538|541127709|FG000|Overall Study|Adverse Event|1|||
149997842|NCT01344538|541127710|FG001|Overall Study|Adverse Event|1|||
149997843|NCT01344538|541127709|FG000|Overall Study|Lost to Follow-up|1|||
149997844|NCT01344538|541127710|FG001|Overall Study|Lost to Follow-up|0|||
149997845|NCT02324205|541127713|FG000|Overall Study|Withdrawal by Subject|37|||
149997846|NCT02891681|541127726|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
149997847|NCT02891681|541127727|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
149997848|NCT02891681|541127728|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
149997849|NCT02891681|541127726|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
149997850|NCT02891681|541127727|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
149997851|NCT02891681|541127728|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
149997852|NCT02891681|541127726|FG000|Overall Study|Taken off study after first imaging appointment|1|||
149997853|NCT02891681|541127727|FG001|Overall Study|Taken off study after first imaging appointment|0|||
149997854|NCT02891681|541127728|FG002|Overall Study|Taken off study after first imaging appointment|0|||
149997855|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
149997856|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
149997857|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
149997858|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
149997859|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
149997860|NCT01224821|541127729|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
149997861|NCT01224821|541127729|FG000|Long-Term Follow-Up|Death|2|||
149997862|NCT01224821|541127729|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
149997863|NCT00683917|541127730|FG000|Overall Study|Study prematurely terminated|10|||
149997864|NCT03538444|541127734|FG000|Overall Study|opioid withdrawal|1|||
149997865|NCT03538444|541127735|FG001|Overall Study|opioid withdrawal|0|||
149997866|NCT01779869|541127740|FG000|Overall Study|Physician Decision|2|||
149997867|NCT01691105|541127746|FG000|1 Month Follow-up|Lost to Follow-up|41|||
149997868|NCT01691105|541127747|FG001|1 Month Follow-up|Lost to Follow-up|38|||
149997869|NCT01691105|541127746|FG000|1 Month Follow-up|Death|2|||
149997870|NCT01691105|541127747|FG001|1 Month Follow-up|Death|3|||
149997871|NCT01691105|541127746|FG000|6 Month Follow-up|Lost to Follow-up|39|||
149997872|NCT01691105|541127747|FG001|6 Month Follow-up|Lost to Follow-up|58|||
149997873|NCT01691105|541127746|FG000|6 Month Follow-up|Death|13|||
150054282|NCT00362180|541340205|FG002|Treated Period|Withdrawal by Subject|0|||
150054283|NCT00362180|541340206|FG003|Treated Period|Withdrawal by Subject|0|||
150054284|NCT00362180|541340207|FG004|Treated Period|Withdrawal by Subject|0|||
150054285|NCT00362180|541340208|FG005|Treated Period|Withdrawal by Subject|0|||
150054286|NCT00362180|541340209|FG006|Treated Period|Withdrawal by Subject|0|||
150054287|NCT00362180|541340210|FG007|Treated Period|Withdrawal by Subject|0|||
150054288|NCT00362180|541340211|FG008|Treated Period|Withdrawal by Subject|0|||
150054289|NCT00362180|541340203|FG000|Treated Period|Adverse Event|0|||
150054290|NCT00362180|541340204|FG001|Treated Period|Adverse Event|0|||
150054291|NCT00362180|541340205|FG002|Treated Period|Adverse Event|0|||
150054292|NCT00362180|541340206|FG003|Treated Period|Adverse Event|0|||
150054293|NCT00362180|541340207|FG004|Treated Period|Adverse Event|0|||
150054294|NCT00362180|541340208|FG005|Treated Period|Adverse Event|1|||
150054295|NCT00362180|541340209|FG006|Treated Period|Adverse Event|0|||
150054296|NCT00362180|541340210|FG007|Treated Period|Adverse Event|1|||
150054297|NCT00362180|541340211|FG008|Treated Period|Adverse Event|0|||
150054298|NCT01106092|541340212|FG000|Overall Study|Withdrawal by Subject|0|||
150054299|NCT01106092|541340213|FG001|Overall Study|Withdrawal by Subject|0|||
150054300|NCT01106092|541340214|FG002|Overall Study|Withdrawal by Subject|0|||
150054301|NCT01106092|541340215|FG003|Overall Study|Withdrawal by Subject|1|||
150054302|NCT02434471|541340220|FG000|Overall Study|Physician Decision|9|||
150054303|NCT00369629|541340225|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
150054304|NCT00369629|541340226|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
150054305|NCT00369629|541340227|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
150054306|NCT00369629|541340228|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
149997874|NCT01691105|541127747|FG001|6 Month Follow-up|Death|13|||
149997875|NCT01691105|541127746|FG000|12 Month Follow-up|Lost to Follow-up|50|||
149997876|NCT01691105|541127747|FG001|12 Month Follow-up|Lost to Follow-up|71|||
149997877|NCT01691105|541127746|FG000|12 Month Follow-up|Death|22|||
149997878|NCT01691105|541127747|FG001|12 Month Follow-up|Death|30|||
149997879|NCT01691105|541127746|FG000|12 Month Biochemical Verification|Death|22|||
149997880|NCT01691105|541127747|FG001|12 Month Biochemical Verification|Death|30|||
149997881|NCT01691105|541127746|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
149997882|NCT01691105|541127747|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
149997883|NCT01691105|541127746|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
149997884|NCT01691105|541127747|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
149997885|NCT00957944|541127748|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
149997886|NCT00957944|541127749|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
149997887|NCT01482169|541127751|FG000|Overall Study|Physician Decision|2|||
149997888|NCT00445848|541127754|FG000|Overall Study|Adverse Event|14|||
149997889|NCT00445848|541127754|FG000|Overall Study|Withdrawal by Subject|4|||
149997890|NCT00445848|541127754|FG000|Overall Study|Progression|62|||
149997891|NCT00445848|541127754|FG000|Overall Study|Other-Not protocol specified|5|||
149997892|NCT00790647|541127755|FG000|Overall Study|Adverse Event|1|||
149997893|NCT00027378|541127756|FG000|Overall Study|Physician Decision|0|||
149997894|NCT00027378|541127757|FG001|Overall Study|Physician Decision|3|||
149997895|NCT00759356|541127765|FG000|Overall Study|Adverse Event|0|||
149997896|NCT00759356|541127766|FG001|Overall Study|Adverse Event|1|||
149997897|NCT00759356|541127765|FG000|Overall Study|Withdrawal by Subject|0|||
149997898|NCT00759356|541127766|FG001|Overall Study|Withdrawal by Subject|2|||
149997899|NCT00759356|541127765|FG000|Overall Study|Subject was unable to return|1|||
149997900|NCT00759356|541127766|FG001|Overall Study|Subject was unable to return|0|||
149997901|NCT02585830|541127767|FG000|Overall Study|Withdrawal by Subject|3|||
149997902|NCT03054350|541127775|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
149997903|NCT03054350|541127776|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
149997904|NCT03054350|541127777|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
149997905|NCT03054350|541127778|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
149997906|NCT03054350|541127779|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
149997907|NCT03054350|541127780|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
149997908|NCT03054350|541127775|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
149997909|NCT03054350|541127776|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
149997910|NCT03054350|541127777|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
149997911|NCT03054350|541127778|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
149997912|NCT03054350|541127779|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
149997913|NCT03054350|541127780|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
149997914|NCT03054350|541127775|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
149997915|NCT03054350|541127776|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
149997916|NCT03054350|541127777|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
149997917|NCT03054350|541127778|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
149997918|NCT03054350|541127779|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
149997919|NCT03054350|541127780|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
149997920|NCT03054350|541127775|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
149997921|NCT03054350|541127776|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
149997922|NCT03054350|541127777|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
149997923|NCT03054350|541127778|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
149997924|NCT03054350|541127779|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
149997925|NCT03054350|541127780|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
149997926|NCT03510468|541127781|FG000|Overall Study|Lost to Follow-up|1|||
149997927|NCT03510468|541127781|FG000|Overall Study|Adverse Event|5|||
149997928|NCT03510468|541127781|FG000|Overall Study|Physician Decision|1|||
149997929|NCT03510468|541127781|FG000|Overall Study|non-compliant with treatment|2|||
149997930|NCT03510468|541127781|FG000|Overall Study|Missed visit|1|||
149997931|NCT03576755|541127784|FG000|Overall Study|Withdrawal by Subject|1|||
149997932|NCT03576755|541127785|FG001|Overall Study|Withdrawal by Subject|0|||
149997933|NCT03576755|541127786|FG002|Overall Study|Withdrawal by Subject|0|||
149997934|NCT03576755|541127787|FG003|Overall Study|Withdrawal by Subject|0|||
149997935|NCT03444766|541127788|FG000|Overall Study|Other Reasons|2|||
149997936|NCT03444766|541127788|FG000|Overall Study|Participant Withdrew Consent|5|||
149997937|NCT03444766|541127788|FG000|Overall Study|Lost to Follow-up|2|||
149997938|NCT03444766|541127788|FG000|Overall Study|Death|2|||
149997939|NCT03444766|541127788|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
149997940|NCT03444766|541127788|FG000|Overall Study|Disease Progression|49|||
149997941|NCT04346108|541127789|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
149997942|NCT04346108|541127790|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
149997943|NCT04346108|541127791|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
149997944|NCT04346108|541127789|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
149997945|NCT04346108|541127790|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
149997946|NCT04346108|541127791|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
149997947|NCT01081301|541127792|FG000|Overall Study|Bereaved|3|||
150054307|NCT00369629|541340225|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
150054308|NCT00369629|541340226|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
150054309|NCT00369629|541340227|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
150054310|NCT00369629|541340228|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
150054311|NCT00369629|541340225|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
150054312|NCT00369629|541340226|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
149997948|NCT01081301|541127792|FG000|Overall Study|Too busy|5|||
149997949|NCT01081301|541127792|FG000|Overall Study|Patient too ill|2|||
149997950|NCT01081301|541127792|FG000|Overall Study|Lost to Follow-up|4|||
149997951|NCT00724854|541127793|FG000|Overall Study|Lack of Efficacy|187|||
149997952|NCT00724854|541127794|FG001|Overall Study|Lack of Efficacy|13|||
149997953|NCT00724854|541127793|FG000|Overall Study|Lost to Follow-up|87|||
149997954|NCT00724854|541127794|FG001|Overall Study|Lost to Follow-up|10|||
149997955|NCT00724854|541127793|FG000|Overall Study|Adverse Event|62|||
149997956|NCT00724854|541127794|FG001|Overall Study|Adverse Event|4|||
149997957|NCT00724854|541127793|FG000|Overall Study|Other|42|||
149997958|NCT00724854|541127794|FG001|Overall Study|Other|3|||
149997959|NCT00724854|541127793|FG000|Overall Study|Death|11|||
149997960|NCT00724854|541127794|FG001|Overall Study|Death|0|||
149997961|NCT00724854|541127793|FG000|Overall Study|Change of treatment|7|||
149997962|NCT00724854|541127794|FG001|Overall Study|Change of treatment|0|||
149997963|NCT00724854|541127793|FG000|Overall Study|Withdrawal by Subject|5|||
149997964|NCT00724854|541127794|FG001|Overall Study|Withdrawal by Subject|0|||
149997965|NCT00724854|541127793|FG000|Overall Study|Adverse event + lack of efficacy|2|||
149997966|NCT00724854|541127794|FG001|Overall Study|Adverse event + lack of efficacy|1|||
149997967|NCT01095653|541127795|FG000|Overall Study|Lack of Efficacy|3|||
149997968|NCT01095653|541127796|FG001|Overall Study|Lack of Efficacy|0|||
149997969|NCT01095653|541127797|FG002|Overall Study|Lack of Efficacy|0|||
149997970|NCT01095653|541127795|FG000|Overall Study|Adverse Event|1|||
149997971|NCT01095653|541127796|FG001|Overall Study|Adverse Event|4|||
149997972|NCT01095653|541127797|FG002|Overall Study|Adverse Event|4|||
149997973|NCT01095653|541127795|FG000|Overall Study|Lost to Follow-up|1|||
149997974|NCT01095653|541127796|FG001|Overall Study|Lost to Follow-up|0|||
149997975|NCT01095653|541127797|FG002|Overall Study|Lost to Follow-up|4|||
149997976|NCT01095653|541127795|FG000|Overall Study|Withdrawal by Subject|4|||
149997977|NCT01095653|541127796|FG001|Overall Study|Withdrawal by Subject|5|||
149997978|NCT01095653|541127797|FG002|Overall Study|Withdrawal by Subject|3|||
149997979|NCT01095653|541127795|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
149997980|NCT01095653|541127796|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
149997981|NCT01095653|541127797|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
149997982|NCT02046226|541127798|FG000|Overall Study|Lost to Follow-up|7|||
149997983|NCT00171925|541127799|FG000|Overall Study|Adverse Event|10|||
149997984|NCT00171925|541127800|FG001|Overall Study|Adverse Event|6|||
149997985|NCT00171925|541127799|FG000|Overall Study|Protocol Violation|1|||
149997986|NCT00171925|541127800|FG001|Overall Study|Protocol Violation|1|||
149997987|NCT00171925|541127799|FG000|Overall Study|Withdrawal by Subject|6|||
149997988|NCT00171925|541127800|FG001|Overall Study|Withdrawal by Subject|9|||
149997989|NCT00171925|541127799|FG000|Overall Study|Lost to Follow-up|2|||
149997990|NCT00171925|541127800|FG001|Overall Study|Lost to Follow-up|2|||
149997991|NCT00171925|541127799|FG000|Overall Study|Administrative problems|10|||
150054313|NCT00369629|541340227|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
150054314|NCT00369629|541340228|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
150054315|NCT00369629|541340225|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
150054316|NCT00369629|541340226|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
150054317|NCT00369629|541340227|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
150054318|NCT00369629|541340228|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
150054319|NCT00369629|541340225|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
150054320|NCT00369629|541340226|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
150054321|NCT00369629|541340227|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
150054322|NCT00369629|541340228|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
150054323|NCT00369629|541340225|FG000|Completed 4 More Cycles|Progressive disease|2|||
150054324|NCT00369629|541340226|FG001|Completed 4 More Cycles|Progressive disease|1|||
150054325|NCT00369629|541340227|FG002|Completed 4 More Cycles|Progressive disease|2|||
149997992|NCT00171925|541127800|FG001|Overall Study|Administrative problems|11|||
149997993|NCT00171925|541127799|FG000|Overall Study|Death|1|||
149997994|NCT00171925|541127800|FG001|Overall Study|Death|2|||
149997995|NCT03746600|541127801|FG000|Overall Study|Withdrawal by Subject|3|||
149997996|NCT03746600|541127802|FG001|Overall Study|Withdrawal by Subject|3|||
149997997|NCT03746600|541127801|FG000|Overall Study|dismissed from study|1|||
149997998|NCT03746600|541127802|FG001|Overall Study|dismissed from study|0|||
149997999|NCT03746600|541127801|FG000|Overall Study|Lost to Follow-up|1|||
149998000|NCT03746600|541127802|FG001|Overall Study|Lost to Follow-up|0|||
149998001|NCT02374814|541127805|FG000|Overall Study|Lost to Follow-up|1|||
149998002|NCT02374814|541127806|FG001|Overall Study|Lost to Follow-up|1|||
149998003|NCT02374814|541127807|FG002|Overall Study|Lost to Follow-up|0|||
149998004|NCT02374814|541127808|FG003|Overall Study|Lost to Follow-up|1|||
149998005|NCT02374814|541127809|FG004|Overall Study|Lost to Follow-up|0|||
149998006|NCT02374814|541127810|FG005|Overall Study|Lost to Follow-up|0|||
149998007|NCT02374814|541127805|FG000|Overall Study|Withdrawal by Subject|0|||
149998008|NCT02374814|541127806|FG001|Overall Study|Withdrawal by Subject|0|||
149998009|NCT02374814|541127807|FG002|Overall Study|Withdrawal by Subject|1|||
149998010|NCT02374814|541127808|FG003|Overall Study|Withdrawal by Subject|1|||
149998011|NCT02374814|541127809|FG004|Overall Study|Withdrawal by Subject|0|||
149998012|NCT02374814|541127810|FG005|Overall Study|Withdrawal by Subject|0|||
149998013|NCT02182440|541127811|FG000|Overall Study|Adverse Event|0|||
149998014|NCT02182440|541127812|FG001|Overall Study|Adverse Event|1|||
149998015|NCT02182440|541127813|FG002|Overall Study|Adverse Event|0|||
149998016|NCT02182440|541127814|FG003|Overall Study|Adverse Event|0|||
149998017|NCT02182440|541127811|FG000|Overall Study|Death|31|||
149998018|NCT02182440|541127812|FG001|Overall Study|Death|8|||
149998019|NCT02182440|541127813|FG002|Overall Study|Death|5|||
149998020|NCT02182440|541127814|FG003|Overall Study|Death|16|||
149998021|NCT02182440|541127811|FG000|Overall Study|Protocol Violation|0|||
149998022|NCT02182440|541127812|FG001|Overall Study|Protocol Violation|1|||
149998023|NCT02182440|541127813|FG002|Overall Study|Protocol Violation|0|||
149998024|NCT02182440|541127814|FG003|Overall Study|Protocol Violation|0|||
149998025|NCT02182440|541127811|FG000|Overall Study|Physician Decision|1|||
149998026|NCT02182440|541127812|FG001|Overall Study|Physician Decision|0|||
149998027|NCT02182440|541127813|FG002|Overall Study|Physician Decision|0|||
149998028|NCT02182440|541127814|FG003|Overall Study|Physician Decision|0|||
149998029|NCT02182440|541127811|FG000|Overall Study|Withdrawal by Subject|1|||
149998030|NCT02182440|541127812|FG001|Overall Study|Withdrawal by Subject|1|||
149998031|NCT02182440|541127813|FG002|Overall Study|Withdrawal by Subject|3|||
149998032|NCT02182440|541127814|FG003|Overall Study|Withdrawal by Subject|4|||
149998033|NCT02182440|541127811|FG000|Overall Study|different, e.g adm other hospital|12|||
149998034|NCT02182440|541127812|FG001|Overall Study|different, e.g adm other hospital|3|||
149998035|NCT02182440|541127813|FG002|Overall Study|different, e.g adm other hospital|3|||
149998036|NCT02182440|541127814|FG003|Overall Study|different, e.g adm other hospital|10|||
149998037|NCT03754582|541127815|FG000|Treatment Phase|Adverse Event|0|||
149998038|NCT03754582|541127816|FG001|Treatment Phase|Adverse Event|1|||
149998039|NCT03754582|541127817|FG002|Treatment Phase|Adverse Event|0|||
149998040|NCT03754582|541127815|FG000|Follow-up Phase|Other|0|||
149998041|NCT03754582|541127816|FG001|Follow-up Phase|Other|0|||
149998042|NCT03754582|541127817|FG002|Follow-up Phase|Other|1|||
149998043|NCT01799239|541127818|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
149998044|NCT01799239|541127819|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
149998045|NCT01799239|541127818|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
149998046|NCT01799239|541127819|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
149998047|NCT01799239|541127818|FG000|Period 1 (7 Days)|Protocol Violation|0|||
149998048|NCT01799239|541127819|FG001|Period 1 (7 Days)|Protocol Violation|1|||
149998049|NCT01799239|541127818|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
149998050|NCT01799239|541127819|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
149998051|NCT01799239|541127818|FG000|Period 2 (7 Days)|Protocol Violation|1|||
149998052|NCT01799239|541127819|FG001|Period 2 (7 Days)|Protocol Violation|0|||
149998053|NCT01561755|541127822|FG000|Overall Study|Lost to Follow-up|0|||
149998054|NCT01561755|541127823|FG001|Overall Study|Lost to Follow-up|1|||
149998055|NCT02680574|541127824|FG000|Overall Study|Death|137|||
149998056|NCT02680574|541127825|FG001|Overall Study|Death|137|||
149998057|NCT02680574|541127824|FG000|Overall Study|Withdrawal by Subject|17|||
149998058|NCT02680574|541127825|FG001|Overall Study|Withdrawal by Subject|9|||
149998059|NCT02680574|541127824|FG000|Overall Study|Lost to Follow-up|4|||
149998060|NCT02680574|541127825|FG001|Overall Study|Lost to Follow-up|6|||
149998061|NCT01166958|541127826|FG000|Overall Study|Withdrawal by Subject|1|||
149998062|NCT01166958|541127827|FG001|Overall Study|Withdrawal by Subject|0|||
149998063|NCT01286987|541127829|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
149998064|NCT01286987|541127830|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
149998065|NCT01286987|541127831|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
149998066|NCT01286987|541127832|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
149998067|NCT01286987|541127833|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
149998068|NCT01286987|541127834|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
149998069|NCT01286987|541127835|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
150054326|NCT00369629|541340228|FG003|Completed 4 More Cycles|Progressive disease|0|||
150054327|NCT00369629|541340225|FG000|Follow up for 1 Year|Death|2|||
149998070|NCT01286987|541127836|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
149998071|NCT01286987|541127837|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
149998072|NCT01286987|541127838|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
149998073|NCT01286987|541127839|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
149998074|NCT01286987|541127840|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
149998075|NCT01286987|541127841|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
149998076|NCT01286987|541127842|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
149998077|NCT01286987|541127843|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
150054328|NCT00369629|541340226|FG001|Follow up for 1 Year|Death|1|||
149998078|NCT01286987|541127829|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
149998079|NCT01286987|541127830|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
149998080|NCT01286987|541127831|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
149998081|NCT01286987|541127832|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
149998082|NCT01286987|541127833|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
149998083|NCT01286987|541127834|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
149998084|NCT01286987|541127835|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
149998085|NCT01286987|541127836|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
149998086|NCT01286987|541127837|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
149998087|NCT01286987|541127838|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
149998088|NCT01286987|541127839|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
149998089|NCT01286987|541127840|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
149998090|NCT01286987|541127841|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
149998091|NCT01286987|541127842|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
149998092|NCT01286987|541127843|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
149998093|NCT01286987|541127829|FG000|Part 1: Dose Escalation|Physician Decision|0|||
149998094|NCT01286987|541127830|FG001|Part 1: Dose Escalation|Physician Decision|0|||
149998095|NCT01286987|541127831|FG002|Part 1: Dose Escalation|Physician Decision|0|||
149998096|NCT01286987|541127832|FG003|Part 1: Dose Escalation|Physician Decision|0|||
149998097|NCT01286987|541127833|FG004|Part 1: Dose Escalation|Physician Decision|1|||
149998098|NCT01286987|541127834|FG005|Part 1: Dose Escalation|Physician Decision|0|||
149998099|NCT01286987|541127835|FG006|Part 1: Dose Escalation|Physician Decision|0|||
149998100|NCT01286987|541127836|FG007|Part 1: Dose Escalation|Physician Decision|0|||
149998101|NCT01286987|541127837|FG008|Part 1: Dose Escalation|Physician Decision|0|||
149998102|NCT01286987|541127838|FG009|Part 1: Dose Escalation|Physician Decision|0|||
149998103|NCT01286987|541127839|FG010|Part 1: Dose Escalation|Physician Decision|0|||
149998104|NCT01286987|541127840|FG011|Part 1: Dose Escalation|Physician Decision|0|||
149998105|NCT01286987|541127841|FG012|Part 1: Dose Escalation|Physician Decision|0|||
149998106|NCT01286987|541127842|FG013|Part 1: Dose Escalation|Physician Decision|0|||
149998107|NCT01286987|541127843|FG014|Part 1: Dose Escalation|Physician Decision|0|||
149998108|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Death|0|||
149998109|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Death|0|||
149998110|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Death|0|||
149998111|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Death|0|||
149998112|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Death|0|||
149998113|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Death|0|||
149998114|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Death|0|||
149998115|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Death|0|||
149998116|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Death|0|||
149998117|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Death|0|||
149998118|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Death|0|||
149998119|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Death|0|||
149998120|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Death|1|||
149998121|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Death|1|||
149998122|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Death|0|||
149998123|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Physician Decision|0|||
149998124|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Physician Decision|0|||
149998125|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Physician Decision|0|||
149998126|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Physician Decision|0|||
149998127|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Physician Decision|0|||
149998128|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Physician Decision|0|||
149998129|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Physician Decision|0|||
149998130|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Physician Decision|0|||
149998131|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Physician Decision|0|||
149998132|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Physician Decision|0|||
149998133|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Physician Decision|1|||
149998134|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Physician Decision|1|||
149998135|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Physician Decision|0|||
149998136|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Physician Decision|1|||
149998137|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Physician Decision|0|||
149998138|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Other|0|||
149998139|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Other|0|||
149998140|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Other|0|||
149998141|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Other|0|||
149998142|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Other|0|||
149998143|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Other|0|||
149998144|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Other|0|||
149998145|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Other|0|||
149998146|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Other|0|||
149998147|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Other|0|||
149998148|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Other|0|||
149998149|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Other|0|||
149998150|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Other|0|||
149998151|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Other|1|||
149998152|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Other|0|||
149998153|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
149998154|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
149998155|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
149998156|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
149998157|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
149998158|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
149998159|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
149998160|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
149998161|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
149998162|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
149998163|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
149998164|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
149998165|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
149998166|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
149998167|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
149998168|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
149998169|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
149998170|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
149998171|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
149998172|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
149998173|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
149998174|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
149998175|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
149998176|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
149998177|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
149998178|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
149998179|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
149998180|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
149998181|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
149998182|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
149998183|NCT01286987|541127829|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998184|NCT01286987|541127830|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998185|NCT01286987|541127831|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998186|NCT01286987|541127832|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998187|NCT01286987|541127833|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998188|NCT01286987|541127834|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998189|NCT01286987|541127835|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998190|NCT01286987|541127836|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998191|NCT01286987|541127837|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998192|NCT01286987|541127838|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998193|NCT01286987|541127839|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
149998194|NCT01286987|541127840|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998195|NCT01286987|541127841|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998196|NCT01286987|541127842|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998197|NCT01286987|541127843|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149998198|NCT02210221|541127850|FG000|Overall Study|Lack of Efficacy|7|||
149998199|NCT02210221|541127850|FG000|Overall Study|Withdrawal by Subject|43|||
149998200|NCT02818036|541127856|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
150179292|NCT04524390|541795325|FG002|Double Blind|Consent Withdrawal by subject|0|||
150179293|NCT04524390|541795323|FG000|Double Blind|Adverse Event|5|||
149998201|NCT02818036|541127857|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
149998202|NCT02818036|541127856|FG000|Overall Study|Withdrawal by Subject|1|||
149998203|NCT02818036|541127857|FG001|Overall Study|Withdrawal by Subject|0|||
149998204|NCT01319721|541127867|FG000|Overall Study|Lost to Follow-up|1|||
149998205|NCT01319721|541127868|FG001|Overall Study|Lost to Follow-up|6|||
149998206|NCT00468845|541127869|FG000|Overall Study|Adverse Event|9|||
149998207|NCT00468845|541127870|FG001|Overall Study|Adverse Event|14|||
149998208|NCT00468845|541127871|FG002|Overall Study|Adverse Event|11|||
149998209|NCT00468845|541127869|FG000|Overall Study|Lost to Follow-up|2|||
149998210|NCT00468845|541127870|FG001|Overall Study|Lost to Follow-up|1|||
149998211|NCT00468845|541127871|FG002|Overall Study|Lost to Follow-up|2|||
149998212|NCT00468845|541127869|FG000|Overall Study|Other|4|||
149998213|NCT00468845|541127870|FG001|Overall Study|Other|9|||
149998214|NCT00468845|541127871|FG002|Overall Study|Other|5|||
149998215|NCT00468845|541127869|FG000|Overall Study|No longer willing to participate|5|||
149998216|NCT00468845|541127870|FG001|Overall Study|No longer willing to participate|6|||
149998217|NCT00468845|541127871|FG002|Overall Study|No longer willing to participate|10|||
149998218|NCT00468845|541127869|FG000|Overall Study|Randomized, not treated|1|||
149998219|NCT00468845|541127870|FG001|Overall Study|Randomized, not treated|4|||
149998220|NCT00468845|541127871|FG002|Overall Study|Randomized, not treated|2|||
149998221|NCT00461305|541127872|FG000|Treatment|Adverse Event|26|||
149998222|NCT00461305|541127873|FG001|Treatment|Adverse Event|3|||
150179294|NCT04524390|541795324|FG001|Double Blind|Adverse Event|3|||
149998223|NCT00461305|541127872|FG000|Treatment|Lost to Follow-up|4|||
149998224|NCT00461305|541127873|FG001|Treatment|Lost to Follow-up|2|||
149998225|NCT00461305|541127872|FG000|Treatment|Protocol Violation|13|||
149998226|NCT00461305|541127873|FG001|Treatment|Protocol Violation|2|||
149998227|NCT00461305|541127872|FG000|Treatment|Withdrawal by Subject|48|||
149998228|NCT00461305|541127873|FG001|Treatment|Withdrawal by Subject|2|||
149998229|NCT00461305|541127872|FG000|Treatment|Never dispensed|5|||
149998230|NCT00461305|541127873|FG001|Treatment|Never dispensed|0|||
149998231|NCT00461305|541127872|FG000|Treatment|Study drug not taken|1|||
149998232|NCT00461305|541127873|FG001|Treatment|Study drug not taken|0|||
149998233|NCT00461305|541127872|FG000|Treatment|Partially missing diary|2|||
149998234|NCT00461305|541127873|FG001|Treatment|Partially missing diary|0|||
149998235|NCT00461305|541127872|FG000|Treatment|Other (missing drug etc)|2|||
149998236|NCT00461305|541127873|FG001|Treatment|Other (missing drug etc)|0|||
149998237|NCT00461305|541127872|FG000|Continued Treatment|Adverse Event|26|||
149998238|NCT00461305|541127873|FG001|Continued Treatment|Adverse Event|0|||
149998239|NCT00461305|541127872|FG000|Continued Treatment|Lost to Follow-up|4|||
149998240|NCT00461305|541127873|FG001|Continued Treatment|Lost to Follow-up|0|||
149998241|NCT00461305|541127872|FG000|Continued Treatment|Protocol Violation|13|||
149998242|NCT00461305|541127873|FG001|Continued Treatment|Protocol Violation|0|||
149998243|NCT00461305|541127872|FG000|Continued Treatment|Withdrawal by Subject|48|||
149998244|NCT00461305|541127873|FG001|Continued Treatment|Withdrawal by Subject|0|||
149998245|NCT00461305|541127872|FG000|Continued Treatment|Partially missing diary|2|||
149998246|NCT00461305|541127873|FG001|Continued Treatment|Partially missing diary|0|||
149998247|NCT00461305|541127872|FG000|Continued Treatment|Other (missing drug etc)|2|||
149998248|NCT00461305|541127873|FG001|Continued Treatment|Other (missing drug etc)|0|||
149998249|NCT01896271|541127875|FG000|Overall Study|Physician Decision|10|||
149998250|NCT03966885|541130310|FG000|Overall Study|Death|1|||
149998251|NCT03966885|541130311|FG001|Overall Study|Death|0|||
149998252|NCT03966885|541130310|FG000|Overall Study|Lost to Follow-up|1|||
149998253|NCT03966885|541130311|FG001|Overall Study|Lost to Follow-up|2|||
149998254|NCT03966885|541130310|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
149998255|NCT03966885|541130311|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
149998256|NCT03966885|541130310|FG000|Overall Study|Moved from study area.|0|||
149998257|NCT03966885|541130311|FG001|Overall Study|Moved from study area.|2|||
149998258|NCT00549900|541130312|FG000|Overall Study|Adverse Event|1|||
149998259|NCT03187834|541130314|FG000|Overall Study|Lost to Follow-up|0|||
149998260|NCT03187834|541130315|FG001|Overall Study|Lost to Follow-up|1|||
149998261|NCT03187834|541130316|FG002|Overall Study|Lost to Follow-up|2|||
149998262|NCT03187834|541130317|FG003|Overall Study|Lost to Follow-up|2|||
149998263|NCT03187834|541130314|FG000|Overall Study|Had invalid anthropometric measurements|5|||
149998264|NCT03187834|541130315|FG001|Overall Study|Had invalid anthropometric measurements|3|||
149998265|NCT03187834|541130316|FG002|Overall Study|Had invalid anthropometric measurements|4|||
149998266|NCT03187834|541130317|FG003|Overall Study|Had invalid anthropometric measurements|2|||
149998267|NCT02754141|541130318|FG000|Overall Study|Disease progression|11|||
149998268|NCT02754141|541130319|FG001|Overall Study|Disease progression|7|||
149998269|NCT02754141|541130320|FG002|Overall Study|Disease progression|8|||
149998270|NCT02754141|541130321|FG003|Overall Study|Disease progression|5|||
149998271|NCT02754141|541130322|FG004|Overall Study|Disease progression|7|||
149998272|NCT02754141|541130323|FG005|Overall Study|Disease progression|7|||
149998273|NCT02754141|541130324|FG006|Overall Study|Disease progression|7|||
149998274|NCT02754141|541130325|FG007|Overall Study|Disease progression|6|||
149998275|NCT02754141|541130326|FG008|Overall Study|Disease progression|11|||
149998276|NCT02754141|541130327|FG009|Overall Study|Disease progression|16|||
149998277|NCT02754141|541130328|FG010|Overall Study|Disease progression|18|||
149998278|NCT02754141|541130329|FG011|Overall Study|Disease progression|13|||
149998279|NCT02754141|541130330|FG012|Overall Study|Disease progression|10|||
149998280|NCT02754141|541130331|FG013|Overall Study|Disease progression|12|||
149998281|NCT02754141|541130332|FG014|Overall Study|Disease progression|12|||
149998282|NCT02754141|541130333|FG015|Overall Study|Disease progression|14|||
149998283|NCT02754141|541130334|FG016|Overall Study|Disease progression|0|||
149998284|NCT02754141|541130335|FG017|Overall Study|Disease progression|1|||
149998285|NCT02754141|541130318|FG000|Overall Study|Study drug toxicity|1|||
149998286|NCT02754141|541130319|FG001|Overall Study|Study drug toxicity|1|||
149998287|NCT02754141|541130320|FG002|Overall Study|Study drug toxicity|0|||
149998288|NCT02754141|541130321|FG003|Overall Study|Study drug toxicity|0|||
149998289|NCT02754141|541130322|FG004|Overall Study|Study drug toxicity|0|||
149998290|NCT02754141|541130323|FG005|Overall Study|Study drug toxicity|0|||
149998291|NCT02754141|541130324|FG006|Overall Study|Study drug toxicity|0|||
149998292|NCT02754141|541130325|FG007|Overall Study|Study drug toxicity|0|||
149998293|NCT02754141|541130326|FG008|Overall Study|Study drug toxicity|0|||
149998294|NCT02754141|541130327|FG009|Overall Study|Study drug toxicity|0|||
149998295|NCT02754141|541130328|FG010|Overall Study|Study drug toxicity|2|||
149998296|NCT02754141|541130329|FG011|Overall Study|Study drug toxicity|1|||
150054329|NCT00369629|541340227|FG002|Follow up for 1 Year|Death|1|||
149998297|NCT02754141|541130330|FG012|Overall Study|Study drug toxicity|1|||
149998298|NCT02754141|541130331|FG013|Overall Study|Study drug toxicity|0|||
149998299|NCT02754141|541130332|FG014|Overall Study|Study drug toxicity|0|||
149998300|NCT02754141|541130333|FG015|Overall Study|Study drug toxicity|0|||
149998301|NCT02754141|541130334|FG016|Overall Study|Study drug toxicity|0|||
149998302|NCT02754141|541130335|FG017|Overall Study|Study drug toxicity|0|||
149998303|NCT02754141|541130318|FG000|Overall Study|AE unrelated to study drug|1|||
149998304|NCT02754141|541130319|FG001|Overall Study|AE unrelated to study drug|1|||
149998305|NCT02754141|541130320|FG002|Overall Study|AE unrelated to study drug|0|||
149998306|NCT02754141|541130321|FG003|Overall Study|AE unrelated to study drug|1|||
149998307|NCT02754141|541130322|FG004|Overall Study|AE unrelated to study drug|3|||
149998308|NCT02754141|541130323|FG005|Overall Study|AE unrelated to study drug|2|||
149998309|NCT02754141|541130324|FG006|Overall Study|AE unrelated to study drug|1|||
149998310|NCT02754141|541130325|FG007|Overall Study|AE unrelated to study drug|0|||
149998311|NCT02754141|541130326|FG008|Overall Study|AE unrelated to study drug|0|||
149998312|NCT02754141|541130327|FG009|Overall Study|AE unrelated to study drug|0|||
149998313|NCT02754141|541130328|FG010|Overall Study|AE unrelated to study drug|0|||
149998314|NCT02754141|541130329|FG011|Overall Study|AE unrelated to study drug|0|||
149998315|NCT02754141|541130330|FG012|Overall Study|AE unrelated to study drug|0|||
149998316|NCT02754141|541130331|FG013|Overall Study|AE unrelated to study drug|0|||
149998317|NCT02754141|541130332|FG014|Overall Study|AE unrelated to study drug|0|||
149998318|NCT02754141|541130333|FG015|Overall Study|AE unrelated to study drug|0|||
149998319|NCT02754141|541130334|FG016|Overall Study|AE unrelated to study drug|0|||
149998320|NCT02754141|541130335|FG017|Overall Study|AE unrelated to study drug|0|||
149998321|NCT02754141|541130318|FG000|Overall Study|Request to discontinue|0|||
149998322|NCT02754141|541130319|FG001|Overall Study|Request to discontinue|0|||
149998323|NCT02754141|541130320|FG002|Overall Study|Request to discontinue|0|||
149998324|NCT02754141|541130321|FG003|Overall Study|Request to discontinue|0|||
149998325|NCT02754141|541130322|FG004|Overall Study|Request to discontinue|0|||
149998326|NCT02754141|541130323|FG005|Overall Study|Request to discontinue|0|||
149998327|NCT02754141|541130324|FG006|Overall Study|Request to discontinue|0|||
149998328|NCT02754141|541130325|FG007|Overall Study|Request to discontinue|0|||
149998329|NCT02754141|541130326|FG008|Overall Study|Request to discontinue|1|||
149998330|NCT02754141|541130327|FG009|Overall Study|Request to discontinue|0|||
149998331|NCT02754141|541130328|FG010|Overall Study|Request to discontinue|0|||
149998332|NCT02754141|541130329|FG011|Overall Study|Request to discontinue|0|||
149998333|NCT02754141|541130330|FG012|Overall Study|Request to discontinue|0|||
149998334|NCT02754141|541130331|FG013|Overall Study|Request to discontinue|1|||
149998335|NCT02754141|541130332|FG014|Overall Study|Request to discontinue|1|||
149998336|NCT02754141|541130333|FG015|Overall Study|Request to discontinue|0|||
149998337|NCT02754141|541130334|FG016|Overall Study|Request to discontinue|0|||
149998338|NCT02754141|541130335|FG017|Overall Study|Request to discontinue|0|||
149998339|NCT02754141|541130318|FG000|Overall Study|Withdrew consent|0|||
149998340|NCT02754141|541130319|FG001|Overall Study|Withdrew consent|0|||
149998341|NCT02754141|541130320|FG002|Overall Study|Withdrew consent|0|||
149998342|NCT02754141|541130321|FG003|Overall Study|Withdrew consent|0|||
149998343|NCT02754141|541130322|FG004|Overall Study|Withdrew consent|0|||
149998344|NCT02754141|541130323|FG005|Overall Study|Withdrew consent|0|||
149998345|NCT02754141|541130324|FG006|Overall Study|Withdrew consent|0|||
149998346|NCT02754141|541130325|FG007|Overall Study|Withdrew consent|0|||
149998347|NCT02754141|541130326|FG008|Overall Study|Withdrew consent|0|||
149998348|NCT02754141|541130327|FG009|Overall Study|Withdrew consent|1|||
149998349|NCT02754141|541130328|FG010|Overall Study|Withdrew consent|0|||
149998350|NCT02754141|541130329|FG011|Overall Study|Withdrew consent|0|||
149998351|NCT02754141|541130330|FG012|Overall Study|Withdrew consent|0|||
149998352|NCT02754141|541130331|FG013|Overall Study|Withdrew consent|0|||
149998353|NCT02754141|541130332|FG014|Overall Study|Withdrew consent|0|||
149998354|NCT02754141|541130333|FG015|Overall Study|Withdrew consent|0|||
149998355|NCT02754141|541130334|FG016|Overall Study|Withdrew consent|0|||
149998356|NCT02754141|541130335|FG017|Overall Study|Withdrew consent|0|||
149998357|NCT02754141|541130318|FG000|Overall Study|Maximum clinical benefit|0|||
149998358|NCT02754141|541130319|FG001|Overall Study|Maximum clinical benefit|0|||
149998359|NCT02754141|541130320|FG002|Overall Study|Maximum clinical benefit|0|||
149998360|NCT02754141|541130321|FG003|Overall Study|Maximum clinical benefit|1|||
149998361|NCT02754141|541130322|FG004|Overall Study|Maximum clinical benefit|0|||
149998362|NCT02754141|541130323|FG005|Overall Study|Maximum clinical benefit|0|||
149998363|NCT02754141|541130324|FG006|Overall Study|Maximum clinical benefit|0|||
149998364|NCT02754141|541130325|FG007|Overall Study|Maximum clinical benefit|0|||
149998365|NCT02754141|541130326|FG008|Overall Study|Maximum clinical benefit|0|||
150179295|NCT04524390|541795325|FG002|Double Blind|Adverse Event|0|||
149998366|NCT02754141|541130327|FG009|Overall Study|Maximum clinical benefit|0|||
149998367|NCT02754141|541130328|FG010|Overall Study|Maximum clinical benefit|0|||
149998368|NCT02754141|541130329|FG011|Overall Study|Maximum clinical benefit|0|||
149998369|NCT02754141|541130330|FG012|Overall Study|Maximum clinical benefit|0|||
149998370|NCT02754141|541130331|FG013|Overall Study|Maximum clinical benefit|0|||
149998371|NCT02754141|541130332|FG014|Overall Study|Maximum clinical benefit|0|||
150054330|NCT00369629|541340228|FG003|Follow up for 1 Year|Death|0|||
150179296|NCT04524390|541795323|FG000|Double Blind|Liver Transplant|5|||
150179297|NCT04524390|541795324|FG001|Double Blind|Liver Transplant|6|||
149998372|NCT02754141|541130333|FG015|Overall Study|Maximum clinical benefit|0|||
149998373|NCT02754141|541130334|FG016|Overall Study|Maximum clinical benefit|0|||
149998374|NCT02754141|541130335|FG017|Overall Study|Maximum clinical benefit|0|||
149998375|NCT02754141|541130318|FG000|Overall Study|No longer meets study criteria|0|||
149998376|NCT02754141|541130319|FG001|Overall Study|No longer meets study criteria|0|||
149998377|NCT02754141|541130320|FG002|Overall Study|No longer meets study criteria|0|||
149998378|NCT02754141|541130321|FG003|Overall Study|No longer meets study criteria|1|||
149998379|NCT02754141|541130322|FG004|Overall Study|No longer meets study criteria|0|||
149998380|NCT02754141|541130323|FG005|Overall Study|No longer meets study criteria|0|||
149998381|NCT02754141|541130324|FG006|Overall Study|No longer meets study criteria|0|||
149998382|NCT02754141|541130325|FG007|Overall Study|No longer meets study criteria|0|||
149998383|NCT02754141|541130326|FG008|Overall Study|No longer meets study criteria|0|||
149998384|NCT02754141|541130327|FG009|Overall Study|No longer meets study criteria|0|||
149998385|NCT02754141|541130328|FG010|Overall Study|No longer meets study criteria|0|||
149998386|NCT02754141|541130329|FG011|Overall Study|No longer meets study criteria|0|||
149998387|NCT02754141|541130330|FG012|Overall Study|No longer meets study criteria|0|||
149998388|NCT02754141|541130331|FG013|Overall Study|No longer meets study criteria|0|||
149998389|NCT02754141|541130332|FG014|Overall Study|No longer meets study criteria|0|||
149998390|NCT02754141|541130333|FG015|Overall Study|No longer meets study criteria|0|||
149998391|NCT02754141|541130334|FG016|Overall Study|No longer meets study criteria|0|||
149998392|NCT02754141|541130335|FG017|Overall Study|No longer meets study criteria|0|||
149998393|NCT02754141|541130318|FG000|Overall Study|Other reasons|0|||
149998394|NCT02754141|541130319|FG001|Overall Study|Other reasons|0|||
149998395|NCT02754141|541130320|FG002|Overall Study|Other reasons|0|||
149998396|NCT02754141|541130321|FG003|Overall Study|Other reasons|0|||
149998397|NCT02754141|541130322|FG004|Overall Study|Other reasons|0|||
149998398|NCT02754141|541130323|FG005|Overall Study|Other reasons|0|||
149998399|NCT02754141|541130324|FG006|Overall Study|Other reasons|0|||
149998400|NCT02754141|541130325|FG007|Overall Study|Other reasons|1|||
149998401|NCT02754141|541130326|FG008|Overall Study|Other reasons|0|||
149998402|NCT02754141|541130327|FG009|Overall Study|Other reasons|0|||
149998403|NCT02754141|541130328|FG010|Overall Study|Other reasons|0|||
149998404|NCT02754141|541130329|FG011|Overall Study|Other reasons|0|||
149998405|NCT02754141|541130330|FG012|Overall Study|Other reasons|2|||
149998406|NCT02754141|541130331|FG013|Overall Study|Other reasons|0|||
149998407|NCT02754141|541130332|FG014|Overall Study|Other reasons|0|||
149998408|NCT02754141|541130333|FG015|Overall Study|Other reasons|0|||
149998409|NCT02754141|541130334|FG016|Overall Study|Other reasons|0|||
149998410|NCT02754141|541130335|FG017|Overall Study|Other reasons|0|||
149998411|NCT02754141|541130318|FG000|Overall Study|Completed treatment as per protocol|0|||
149998412|NCT02754141|541130319|FG001|Overall Study|Completed treatment as per protocol|1|||
149998413|NCT02754141|541130320|FG002|Overall Study|Completed treatment as per protocol|0|||
149998414|NCT02754141|541130321|FG003|Overall Study|Completed treatment as per protocol|0|||
149998415|NCT02754141|541130322|FG004|Overall Study|Completed treatment as per protocol|0|||
149998416|NCT02754141|541130323|FG005|Overall Study|Completed treatment as per protocol|0|||
149998417|NCT02754141|541130324|FG006|Overall Study|Completed treatment as per protocol|0|||
149998418|NCT02754141|541130325|FG007|Overall Study|Completed treatment as per protocol|0|||
149998419|NCT02754141|541130326|FG008|Overall Study|Completed treatment as per protocol|0|||
149998420|NCT02754141|541130327|FG009|Overall Study|Completed treatment as per protocol|0|||
149998421|NCT02754141|541130328|FG010|Overall Study|Completed treatment as per protocol|0|||
149998422|NCT02754141|541130329|FG011|Overall Study|Completed treatment as per protocol|0|||
149998423|NCT02754141|541130330|FG012|Overall Study|Completed treatment as per protocol|1|||
150179298|NCT04524390|541795325|FG002|Double Blind|Liver Transplant|0|||
150179299|NCT04524390|541795323|FG000|Double Blind|Disease Progression|0|||
150179300|NCT04524390|541795324|FG001|Double Blind|Disease Progression|1|||
150179301|NCT04524390|541795325|FG002|Double Blind|Disease Progression|0|||
150179302|NCT04524390|541795323|FG000|Open-Label|Drug interruption criteria|0|||
150179303|NCT04524390|541795324|FG001|Open-Label|Drug interruption criteria|0|||
150179304|NCT04524390|541795325|FG002|Open-Label|Drug interruption criteria|1|||
150179305|NCT04524390|541795323|FG000|Open-Label|Liver Transplant|0|||
149998424|NCT02754141|541130331|FG013|Overall Study|Completed treatment as per protocol|0|||
149998425|NCT02754141|541130332|FG014|Overall Study|Completed treatment as per protocol|0|||
149998426|NCT02754141|541130333|FG015|Overall Study|Completed treatment as per protocol|0|||
149998427|NCT02754141|541130334|FG016|Overall Study|Completed treatment as per protocol|0|||
149998428|NCT02754141|541130335|FG017|Overall Study|Completed treatment as per protocol|0|||
149998429|NCT02754141|541130318|FG000|Overall Study|Not completing monotherapy|0|||
149998430|NCT02754141|541130319|FG001|Overall Study|Not completing monotherapy|0|||
150179306|NCT04524390|541795324|FG001|Open-Label|Liver Transplant|0|||
150179307|NCT04524390|541795325|FG002|Open-Label|Liver Transplant|1|||
149998431|NCT02754141|541130320|FG002|Overall Study|Not completing monotherapy|0|||
149998432|NCT02754141|541130321|FG003|Overall Study|Not completing monotherapy|0|||
150179308|NCT04524390|541795323|FG000|Open-Label|Disease Progression|0|||
149998433|NCT02754141|541130322|FG004|Overall Study|Not completing monotherapy|0|||
149998434|NCT02754141|541130323|FG005|Overall Study|Not completing monotherapy|0|||
149998435|NCT02754141|541130324|FG006|Overall Study|Not completing monotherapy|0|||
150054331|NCT00369629|541340225|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
150054332|NCT00369629|541340226|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
150054333|NCT00369629|541340227|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
150054334|NCT00369629|541340228|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
150054335|NCT00369629|541340225|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
150054336|NCT00369629|541340226|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
150054337|NCT00369629|541340227|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
150054338|NCT00369629|541340228|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
150054339|NCT04839562|541340229|FG000|Overall Study|Withdrawal by Subject|0|||
150054340|NCT04839562|541340230|FG001|Overall Study|Withdrawal by Subject|1|||
150054341|NCT04839562|541340229|FG000|Overall Study|Physician Decision|0|||
150054342|NCT04839562|541340230|FG001|Overall Study|Physician Decision|1|||
150054343|NCT01347580|541340238|FG000|Overall Study|Withdrawal by Subject|13|||
150054344|NCT01347580|541340239|FG001|Overall Study|Withdrawal by Subject|23|||
150054345|NCT01347580|541340238|FG000|Overall Study|Death|30|||
150054346|NCT01347580|541340239|FG001|Overall Study|Death|19|||
150054347|NCT01347580|541340238|FG000|Overall Study|Protocol Violation|10|||
150054348|NCT01347580|541340239|FG001|Overall Study|Protocol Violation|7|||
150054349|NCT01347580|541340238|FG000|Overall Study|Lost to Follow-up|3|||
150054350|NCT01347580|541340239|FG001|Overall Study|Lost to Follow-up|1|||
150054351|NCT01347580|541340238|FG000|Overall Study|Had other reason|9|||
150054352|NCT01347580|541340239|FG001|Overall Study|Had other reason|6|||
150054353|NCT00003472|541340242|FG000|Overall Study|Not evaluable|3|||
150054354|NCT01012219|541340243|FG000|Period 1|Withdrawal by Subject|1|||
150054355|NCT01012219|541340243|FG000|Period 2|Withdrawal by Subject|1|||
150054356|NCT00874939|541340244|FG000|Overall Study|Study terminated|4|||
150054357|NCT01909791|541340245|FG000|Overall Study|Death|9|||
149998436|NCT02754141|541130325|FG007|Overall Study|Not completing monotherapy|0|||
149998437|NCT02754141|541130326|FG008|Overall Study|Not completing monotherapy|0|||
149998438|NCT02754141|541130327|FG009|Overall Study|Not completing monotherapy|0|||
149998439|NCT02754141|541130328|FG010|Overall Study|Not completing monotherapy|0|||
149998440|NCT02754141|541130329|FG011|Overall Study|Not completing monotherapy|0|||
149998441|NCT02754141|541130330|FG012|Overall Study|Not completing monotherapy|0|||
149998442|NCT02754141|541130331|FG013|Overall Study|Not completing monotherapy|1|||
149998443|NCT02754141|541130332|FG014|Overall Study|Not completing monotherapy|0|||
149998444|NCT02754141|541130333|FG015|Overall Study|Not completing monotherapy|0|||
149998445|NCT02754141|541130334|FG016|Overall Study|Not completing monotherapy|0|||
149998446|NCT02754141|541130335|FG017|Overall Study|Not completing monotherapy|0|||
149998447|NCT01187446|541130336|FG000|Overall Study|Patient started non-protocol therapy|0|||
149998448|NCT01187446|541130337|FG001|Overall Study|Patient started non-protocol therapy|1|||
149998449|NCT01007123|541130342|FG000|Overall Study|Adverse Event|3|||
149998450|NCT01007123|541130343|FG001|Overall Study|Adverse Event|4|||
149998451|NCT01007123|541130344|FG002|Overall Study|Adverse Event|7|||
149998452|NCT01007123|541130345|FG003|Overall Study|Adverse Event|1|||
149998453|NCT01007123|541130342|FG000|Overall Study|Lack of Efficacy|1|||
149998454|NCT01007123|541130343|FG001|Overall Study|Lack of Efficacy|0|||
149998455|NCT01007123|541130344|FG002|Overall Study|Lack of Efficacy|1|||
149998456|NCT01007123|541130345|FG003|Overall Study|Lack of Efficacy|4|||
149998457|NCT01007123|541130342|FG000|Overall Study|Protocol Violation|1|||
149998458|NCT01007123|541130343|FG001|Overall Study|Protocol Violation|1|||
149998459|NCT01007123|541130344|FG002|Overall Study|Protocol Violation|2|||
149998460|NCT01007123|541130345|FG003|Overall Study|Protocol Violation|1|||
149998461|NCT01007123|541130342|FG000|Overall Study|Withdrawal by Subject|1|||
149998462|NCT01007123|541130343|FG001|Overall Study|Withdrawal by Subject|0|||
149998463|NCT01007123|541130344|FG002|Overall Study|Withdrawal by Subject|1|||
149998464|NCT01007123|541130345|FG003|Overall Study|Withdrawal by Subject|0|||
149998465|NCT01007123|541130342|FG000|Overall Study|Lost to Follow-up|0|||
149998466|NCT01007123|541130343|FG001|Overall Study|Lost to Follow-up|1|||
150054358|NCT01909791|541340246|FG001|Overall Study|Death|8|||
150054359|NCT01909791|541340247|FG002|Overall Study|Death|4|||
150054360|NCT01909791|541340245|FG000|Overall Study|Withdrawal by Subject|5|||
150054361|NCT01909791|541340246|FG001|Overall Study|Withdrawal by Subject|9|||
149998467|NCT01007123|541130344|FG002|Overall Study|Lost to Follow-up|0|||
150054362|NCT01909791|541340247|FG002|Overall Study|Withdrawal by Subject|13|||
150054363|NCT01909791|541340245|FG000|Overall Study|Lost to Follow-up|5|||
150054364|NCT01909791|541340246|FG001|Overall Study|Lost to Follow-up|11|||
149998468|NCT01007123|541130345|FG003|Overall Study|Lost to Follow-up|0|||
149998469|NCT00823212|541130346|FG000|Overall Study|Death|8|||
149998470|NCT00823212|541130347|FG001|Overall Study|Death|10|||
149998471|NCT00823212|541130346|FG000|Overall Study|Withdrawal by Subject|6|||
149998472|NCT00823212|541130347|FG001|Overall Study|Withdrawal by Subject|1|||
149998473|NCT00823212|541130346|FG000|Overall Study|Incarcerated|0|||
149998474|NCT00823212|541130347|FG001|Overall Study|Incarcerated|1|||
149998475|NCT00823212|541130346|FG000|Overall Study|Missed 12-month visit|21|||
149998476|NCT00823212|541130347|FG001|Overall Study|Missed 12-month visit|21|||
149998477|NCT00320255|541130348|FG000|Overall Study|Lack of Efficacy|1|||
149998478|NCT00320255|541130349|FG001|Overall Study|Lack of Efficacy|0|||
149998479|NCT00320255|541130350|FG002|Overall Study|Lack of Efficacy|0|||
149998480|NCT00320255|541130351|FG003|Overall Study|Lack of Efficacy|0|||
149998481|NCT00320255|541130352|FG004|Overall Study|Lack of Efficacy|0|||
149998482|NCT00320255|541130353|FG005|Overall Study|Lack of Efficacy|0|||
149998483|NCT00320255|541130348|FG000|Overall Study|Adverse Event|5|||
149998484|NCT00320255|541130349|FG001|Overall Study|Adverse Event|2|||
149998485|NCT00320255|541130350|FG002|Overall Study|Adverse Event|3|||
149998486|NCT00320255|541130351|FG003|Overall Study|Adverse Event|2|||
149998487|NCT00320255|541130352|FG004|Overall Study|Adverse Event|0|||
149998488|NCT00320255|541130353|FG005|Overall Study|Adverse Event|0|||
149998489|NCT00320255|541130348|FG000|Overall Study|Withdrawal by Subject|1|||
149998490|NCT00320255|541130349|FG001|Overall Study|Withdrawal by Subject|2|||
149998491|NCT00320255|541130350|FG002|Overall Study|Withdrawal by Subject|2|||
149998492|NCT00320255|541130351|FG003|Overall Study|Withdrawal by Subject|4|||
149998493|NCT00320255|541130352|FG004|Overall Study|Withdrawal by Subject|0|||
149998494|NCT00320255|541130353|FG005|Overall Study|Withdrawal by Subject|0|||
149998495|NCT00320255|541130348|FG000|Overall Study|Poor compliance/noncompliance|1|||
149998496|NCT00320255|541130349|FG001|Overall Study|Poor compliance/noncompliance|1|||
149998497|NCT00320255|541130350|FG002|Overall Study|Poor compliance/noncompliance|0|||
149998498|NCT00320255|541130351|FG003|Overall Study|Poor compliance/noncompliance|1|||
149998499|NCT00320255|541130352|FG004|Overall Study|Poor compliance/noncompliance|0|||
149998500|NCT00320255|541130353|FG005|Overall Study|Poor compliance/noncompliance|0|||
149998501|NCT00320255|541130348|FG000|Overall Study|No longer meets study criteria|0|||
149998502|NCT00320255|541130349|FG001|Overall Study|No longer meets study criteria|0|||
149998503|NCT00320255|541130350|FG002|Overall Study|No longer meets study criteria|0|||
149998504|NCT00320255|541130351|FG003|Overall Study|No longer meets study criteria|1|||
149998505|NCT00320255|541130352|FG004|Overall Study|No longer meets study criteria|0|||
149998506|NCT00320255|541130353|FG005|Overall Study|No longer meets study criteria|0|||
149998507|NCT00320255|541130348|FG000|Overall Study|Other|3|||
149998508|NCT00320255|541130349|FG001|Overall Study|Other|2|||
149998509|NCT00320255|541130350|FG002|Overall Study|Other|1|||
149998510|NCT00320255|541130351|FG003|Overall Study|Other|0|||
149998511|NCT00320255|541130352|FG004|Overall Study|Other|0|||
149998512|NCT00320255|541130353|FG005|Overall Study|Other|0|||
149998513|NCT04422561|541130354|FG000|Overall Study|Lost to Follow-up|25|||
149998514|NCT04422561|541130355|FG001|Overall Study|Lost to Follow-up|11|||
149998515|NCT00623545|541130356|FG000|Overall Study|Adverse Event|6|||
149998516|NCT00623545|541130356|FG000|Overall Study|Withdrawal by Subject|4|||
149998517|NCT04239222|541130357|FG000|Baseline|Withdrawal by Subject|0|||
149998518|NCT04239222|541130358|FG001|Baseline|Withdrawal by Subject|0|||
149998519|NCT04239222|541130359|FG002|Baseline|Withdrawal by Subject|1|||
149998520|NCT04239222|541130360|FG003|Baseline|Withdrawal by Subject|1|||
149998521|NCT04239222|541130357|FG000|First Foot Assignment|Withdrawal by Subject|0|||
149998522|NCT04239222|541130358|FG001|First Foot Assignment|Withdrawal by Subject|0|||
149998523|NCT04239222|541130359|FG002|First Foot Assignment|Withdrawal by Subject|1|||
149998524|NCT04239222|541130360|FG003|First Foot Assignment|Withdrawal by Subject|0|||
149998525|NCT04239222|541130357|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
149998526|NCT04239222|541130358|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
149998527|NCT04239222|541130359|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
149998528|NCT04239222|541130360|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
149998529|NCT02685748|541130366|FG000|Overall Study|Withdrawal by Subject|3|||
149998530|NCT02685748|541130367|FG001|Overall Study|Withdrawal by Subject|2|||
149998531|NCT00937404|541130371|FG000|Overall Study|Protocol Violation|1|||
149998532|NCT00937404|541130371|FG000|Overall Study|Withdrawal by Subject|1|||
149998533|NCT00230282|541130375|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
149998534|NCT00230282|541130375|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
149998535|NCT00230282|541130375|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
149998536|NCT00230282|541130375|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
149998537|NCT00090233|541130377|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
149998538|NCT00090233|541130378|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
149998539|NCT00090233|541130377|FG000|Overall Study|Adverse Event|214|||
149998540|NCT00090233|541130378|FG001|Overall Study|Adverse Event|198|||
149998541|NCT00090233|541130377|FG000|Overall Study|Lost to Follow-up|68|||
149998542|NCT00090233|541130378|FG001|Overall Study|Lost to Follow-up|95|||
149998543|NCT00090233|541130377|FG000|Overall Study|Protocol Violation|960|||
149998544|NCT00090233|541130378|FG001|Overall Study|Protocol Violation|1022|||
149998545|NCT00090233|541130377|FG000|Overall Study|Withdrawal by Subject|182|||
149998546|NCT00090233|541130378|FG001|Overall Study|Withdrawal by Subject|211|||
149998547|NCT00090233|541130377|FG000|Overall Study|Moved|203|||
149998548|NCT00090233|541130378|FG001|Overall Study|Moved|189|||
149998549|NCT00090233|541130377|FG000|Overall Study|Other|1211|||
149998550|NCT00090233|541130378|FG001|Overall Study|Other|1160|||
149998551|NCT00090233|541130377|FG000|Overall Study|Data not available at data cut-off point|1552|||
149998552|NCT00090233|541130378|FG001|Overall Study|Data not available at data cut-off point|1563|||
149998553|NCT04863248|541130379|FG000|Overall Study|Sponsor Terminated|4|||
149998554|NCT04863248|541130380|FG001|Overall Study|Sponsor Terminated|1|||
149998555|NCT04863248|541130379|FG000|Overall Study|Death|0|||
149998556|NCT04863248|541130380|FG001|Overall Study|Death|1|||
149998557|NCT04863248|541130379|FG000|Overall Study|Withdrawal by Subject|0|||
149998558|NCT04863248|541130380|FG001|Overall Study|Withdrawal by Subject|1|||
149998559|NCT01777542|541130385|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
149998560|NCT01777542|541130386|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
149998561|NCT04706273|541130389|FG000|Overall Study|Withdrawal by Subject|27|||
149998562|NCT04706273|541130389|FG000|Overall Study|Physician Decision|1|||
149998563|NCT04706273|541130389|FG000|Overall Study|Lost to Follow-up|42|||
149998564|NCT04706273|541130389|FG000|Overall Study|Death|85|||
149998565|NCT04706273|541130389|FG000|Overall Study|Amputation that removes study device|2|||
149998566|NCT04706273|541130389|FG000|Overall Study|Surgical bypass|3|||
149998567|NCT04706273|541130389|FG000|Overall Study|Changing hospital|23|||
149998568|NCT04706273|541130389|FG000|Overall Study|Unable to attend hospital|2|||
149998569|NCT02701777|541130390|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
149998570|NCT02701777|541130391|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
149998571|NCT02701777|541130392|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
149998572|NCT02701777|541130393|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
149998573|NCT02701777|541130390|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
149998574|NCT02701777|541130391|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
149998575|NCT02701777|541130392|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
149998576|NCT02701777|541130393|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
149998577|NCT00869050|541130394|FG000|Overall Study|Screen Failure|3|||
149998578|NCT03199053|541130397|FG000|ST Period|Withdrawal by Subject|2|||
149998579|NCT03199053|541130398|FG001|ST Period|Withdrawal by Subject|4|||
149998580|NCT03199053|541130399|FG002|ST Period|Withdrawal by Subject|6|||
149998581|NCT03199053|541130397|FG000|ST Period|Withdrawal by parent/guardian|1|||
149998582|NCT03199053|541130398|FG001|ST Period|Withdrawal by parent/guardian|1|||
149998583|NCT03199053|541130399|FG002|ST Period|Withdrawal by parent/guardian|1|||
149998584|NCT03199053|541130397|FG000|ST Period|Lost to Follow-up|2|||
149998585|NCT03199053|541130398|FG001|ST Period|Lost to Follow-up|0|||
149998586|NCT03199053|541130399|FG002|ST Period|Lost to Follow-up|1|||
149998587|NCT03199053|541130397|FG000|LT Period|Withdrawal by Subject|1|||
149998588|NCT03199053|541130398|FG001|LT Period|Withdrawal by Subject|3|||
149998589|NCT03199053|541130399|FG002|LT Period|Withdrawal by Subject|3|||
149998590|NCT03199053|541130397|FG000|LT Period|Withdrawal by parent/guardian|0|||
149998591|NCT03199053|541130398|FG001|LT Period|Withdrawal by parent/guardian|0|||
149998592|NCT03199053|541130399|FG002|LT Period|Withdrawal by parent/guardian|1|||
149998593|NCT03199053|541130397|FG000|LT Period|Lost to Follow-up|0|||
149998594|NCT03199053|541130398|FG001|LT Period|Lost to Follow-up|1|||
149998595|NCT03199053|541130399|FG002|LT Period|Lost to Follow-up|1|||
149998596|NCT03199053|541130397|FG000|LT Period|Miscellaneous|0|||
149998597|NCT03199053|541130398|FG001|LT Period|Miscellaneous|0|||
149998598|NCT03199053|541130399|FG002|LT Period|Miscellaneous|2|||
149998599|NCT03199053|541130397|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
149998600|NCT03199053|541130398|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
149998601|NCT03199053|541130399|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
149998602|NCT03199053|541130397|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
149998603|NCT03199053|541130398|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
149998604|NCT03199053|541130399|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
149998605|NCT03199053|541130397|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
149998606|NCT03199053|541130398|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
149998607|NCT03199053|541130399|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
149998608|NCT03199053|541130397|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
149998609|NCT03199053|541130398|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
149998610|NCT03199053|541130399|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
149998611|NCT03298984|541130400|FG000|Overall Study|Physician Decision|1|||
149998612|NCT03298984|541130401|FG001|Overall Study|Physician Decision|0|||
149998613|NCT03298984|541130402|FG002|Overall Study|Physician Decision|0|||
150054365|NCT01909791|541340247|FG002|Overall Study|Lost to Follow-up|10|||
150054366|NCT01909791|541340245|FG000|Overall Study|Missed Visit|2|||
150054367|NCT01909791|541340246|FG001|Overall Study|Missed Visit|0|||
149998614|NCT03298984|541130403|FG003|Overall Study|Physician Decision|6|||
149998615|NCT03298984|541130400|FG000|Overall Study|Lack of Efficacy|0|||
149998616|NCT03298984|541130401|FG001|Overall Study|Lack of Efficacy|1|||
149998617|NCT03298984|541130402|FG002|Overall Study|Lack of Efficacy|1|||
149998618|NCT03298984|541130403|FG003|Overall Study|Lack of Efficacy|4|||
149998619|NCT03298984|541130400|FG000|Overall Study|Relapsed disease (following remission)|0|||
150054368|NCT01909791|541340247|FG002|Overall Study|Missed Visit|1|||
149998620|NCT03298984|541130401|FG001|Overall Study|Relapsed disease (following remission)|0|||
149998621|NCT03298984|541130402|FG002|Overall Study|Relapsed disease (following remission)|1|||
149998622|NCT03298984|541130403|FG003|Overall Study|Relapsed disease (following remission)|1|||
149998623|NCT03298984|541130400|FG000|Overall Study|Adverse Event|0|||
149998624|NCT03298984|541130401|FG001|Overall Study|Adverse Event|0|||
150179309|NCT04524390|541795324|FG001|Open-Label|Disease Progression|0|||
150179310|NCT04524390|541795325|FG002|Open-Label|Disease Progression|1|||
150179311|NCT04524390|541795323|FG000|Open-Label|Adverse Event|0|||
150179312|NCT04524390|541795324|FG001|Open-Label|Adverse Event|0|||
150179313|NCT04524390|541795325|FG002|Open-Label|Adverse Event|3|||
150179314|NCT04524390|541795323|FG000|Open-Label|Study Termination by sponsor|0|||
150179315|NCT04524390|541795324|FG001|Open-Label|Study Termination by sponsor|0|||
150179316|NCT04524390|541795325|FG002|Open-Label|Study Termination by sponsor|45|||
150179317|NCT01631214|541795326|FG000|Overall Study|Withdrawal by Subject|276|||
150179318|NCT01631214|541795327|FG001|Overall Study|Withdrawal by Subject|290|||
150179319|NCT01631214|541795326|FG000|Overall Study|Death|113|||
150179320|NCT01631214|541795327|FG001|Overall Study|Death|106|||
150179321|NCT01631214|541795326|FG000|Overall Study|Lost to Follow-up|54|||
150179322|NCT01631214|541795327|FG001|Overall Study|Lost to Follow-up|40|||
150179323|NCT01631214|541795326|FG000|Overall Study|Adverse Event|45|||
150179324|NCT01631214|541795327|FG001|Overall Study|Adverse Event|45|||
150179325|NCT01631214|541795326|FG000|Overall Study|Other|22|||
150179326|NCT01631214|541795327|FG001|Overall Study|Other|19|||
150179327|NCT01631214|541795326|FG000|Overall Study|Noncompliance|16|||
150179328|NCT01631214|541795327|FG001|Overall Study|Noncompliance|15|||
150179329|NCT01631214|541795326|FG000|Overall Study|Requirement for Alternative Therapy|8|||
150179330|NCT01631214|541795327|FG001|Overall Study|Requirement for Alternative Therapy|3|||
150179331|NCT01631214|541795326|FG000|Overall Study|Protocol Deviation|4|||
150179332|NCT01631214|541795327|FG001|Overall Study|Protocol Deviation|3|||
150179333|NCT01631214|541795326|FG000|Overall Study|Ineligibility determined|5|||
150179334|NCT01631214|541795327|FG001|Overall Study|Ineligibility determined|2|||
150179335|NCT01631214|541795326|FG000|Overall Study|Administrative Decision|1|||
150179336|NCT01631214|541795327|FG001|Overall Study|Administrative Decision|0|||
150179337|NCT05288283|541795328|FG000|Overall Study|Study Terminated Early|1|||
150179338|NCT05288283|541795329|FG001|Overall Study|Study Terminated Early|1|||
150179339|NCT03285763|541795330|FG000|Overall Study|Death|470|||
150179340|NCT03285763|541795330|FG000|Overall Study|Lost to Follow-up|18|||
150179341|NCT03285763|541795330|FG000|Overall Study|Physician Decision|2|||
150179342|NCT03285763|541795330|FG000|Overall Study|Study Terminated By Sponsor|79|||
150179343|NCT03285763|541795330|FG000|Overall Study|Withdrawal by Subject|33|||
150179344|NCT00332241|541795332|FG000|Overall Study|Lack of Efficacy|6|||
150179345|NCT00332241|541795333|FG001|Overall Study|Lack of Efficacy|1|||
150179346|NCT00332241|541795332|FG000|Overall Study|Adverse Event|3|||
150179347|NCT00332241|541795333|FG001|Overall Study|Adverse Event|5|||
150179348|NCT00332241|541795332|FG000|Overall Study|Withdrawal by Subject|2|||
150179349|NCT00332241|541795333|FG001|Overall Study|Withdrawal by Subject|1|||
150179350|NCT00332241|541795332|FG000|Overall Study|Lost to Follow-up|4|||
150179351|NCT00332241|541795333|FG001|Overall Study|Lost to Follow-up|1|||
150179352|NCT01534494|541795334|FG000|Overall Study|Withdrawal by Subject|1|||
150179353|NCT05137236|541795335|FG000|Part A|Other than Specified|1|||
150179354|NCT05137236|541795336|FG001|Part A|Other than Specified|0|||
150179355|NCT05137236|541795337|FG002|Part A|Other than Specified|0|||
150179356|NCT05137236|541795338|FG003|Part A|Other than Specified|0|||
150179357|NCT05137236|541795339|FG004|Part A|Other than Specified|0|||
150179358|NCT05137236|541795340|FG005|Part A|Other than Specified|0|||
150179359|NCT05137236|541795341|FG006|Part A|Other than Specified|0|||
150179360|NCT05137236|541795342|FG007|Part A|Other than Specified|0|||
150179361|NCT05137236|541795335|FG000|Part A|Withdrawal by Subject|0|||
150179362|NCT05137236|541795336|FG001|Part A|Withdrawal by Subject|4|||
150179363|NCT05137236|541795337|FG002|Part A|Withdrawal by Subject|1|||
150179364|NCT05137236|541795338|FG003|Part A|Withdrawal by Subject|1|||
150179365|NCT05137236|541795339|FG004|Part A|Withdrawal by Subject|3|||
150179366|NCT05137236|541795340|FG005|Part A|Withdrawal by Subject|2|||
150179367|NCT05137236|541795341|FG006|Part A|Withdrawal by Subject|0|||
150179368|NCT05137236|541795342|FG007|Part A|Withdrawal by Subject|0|||
150179369|NCT05137236|541795335|FG000|Part A|Lost to Follow-up|5|||
150179370|NCT05137236|541795336|FG001|Part A|Lost to Follow-up|7|||
150179371|NCT05137236|541795337|FG002|Part A|Lost to Follow-up|1|||
150179372|NCT05137236|541795338|FG003|Part A|Lost to Follow-up|3|||
150179373|NCT05137236|541795339|FG004|Part A|Lost to Follow-up|3|||
150179374|NCT05137236|541795340|FG005|Part A|Lost to Follow-up|8|||
150179375|NCT05137236|541795341|FG006|Part A|Lost to Follow-up|0|||
150179376|NCT05137236|541795342|FG007|Part A|Lost to Follow-up|0|||
150179377|NCT05137236|541795335|FG000|Part B|Withdrawal by Subject|0|||
150179378|NCT05137236|541795336|FG001|Part B|Withdrawal by Subject|0|||
150179379|NCT05137236|541795337|FG002|Part B|Withdrawal by Subject|0|||
150179380|NCT05137236|541795338|FG003|Part B|Withdrawal by Subject|0|||
150179381|NCT05137236|541795339|FG004|Part B|Withdrawal by Subject|0|||
150179382|NCT05137236|541795340|FG005|Part B|Withdrawal by Subject|0|||
150179383|NCT05137236|541795341|FG006|Part B|Withdrawal by Subject|0|||
150179384|NCT05137236|541795342|FG007|Part B|Withdrawal by Subject|2|||
150179385|NCT05137236|541795335|FG000|Part B|Lost to Follow-up|0|||
150179386|NCT05137236|541795336|FG001|Part B|Lost to Follow-up|0|||
150179387|NCT05137236|541795337|FG002|Part B|Lost to Follow-up|0|||
150179388|NCT05137236|541795338|FG003|Part B|Lost to Follow-up|0|||
150179389|NCT05137236|541795339|FG004|Part B|Lost to Follow-up|0|||
150179390|NCT05137236|541795340|FG005|Part B|Lost to Follow-up|0|||
150179391|NCT05137236|541795341|FG006|Part B|Lost to Follow-up|5|||
150179392|NCT05137236|541795342|FG007|Part B|Lost to Follow-up|5|||
150179393|NCT05137236|541795335|FG000|Part B|Death|0|||
150179394|NCT05137236|541795336|FG001|Part B|Death|0|||
150179395|NCT05137236|541795337|FG002|Part B|Death|0|||
150179396|NCT05137236|541795338|FG003|Part B|Death|0|||
150179397|NCT05137236|541795339|FG004|Part B|Death|0|||
150179398|NCT05137236|541795340|FG005|Part B|Death|0|||
150179399|NCT05137236|541795341|FG006|Part B|Death|0|||
150179400|NCT05137236|541795342|FG007|Part B|Death|2|||
150179401|NCT00431834|541795347|FG000|Overall Study|Withdrawal by Subject|7|||
150179402|NCT00431834|541795347|FG000|Overall Study|Death|3|||
150179403|NCT00431834|541795347|FG000|Overall Study|Missed Endpoint Visit|2|||
150179404|NCT00431834|541795347|FG000|Overall Study|Lost to Follow-up|1|||
150179405|NCT02622568|541795355|FG000|Overall Study|Lost to Follow-up|5|||
150179406|NCT02622568|541795356|FG001|Overall Study|Lost to Follow-up|5|||
150179407|NCT04512482|541795357|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
150179408|NCT04512482|541795358|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
150179409|NCT01939899|541795359|FG000|Lead-in Dose Finding Phase|Death|0|||
149998625|NCT03298984|541130402|FG002|Overall Study|Adverse Event|0|||
149998626|NCT03298984|541130403|FG003|Overall Study|Adverse Event|1|||
149998627|NCT03298984|541130400|FG000|Overall Study|Death|0|||
149998628|NCT03298984|541130401|FG001|Overall Study|Death|0|||
149998629|NCT03298984|541130402|FG002|Overall Study|Death|0|||
149998630|NCT03298984|541130403|FG003|Overall Study|Death|2|||
149998631|NCT03298984|541130400|FG000|Overall Study|Insurance Company Decision|0|||
149998632|NCT03298984|541130401|FG001|Overall Study|Insurance Company Decision|0|||
149998633|NCT03298984|541130402|FG002|Overall Study|Insurance Company Decision|0|||
149998634|NCT03298984|541130403|FG003|Overall Study|Insurance Company Decision|1|||
149998635|NCT00585221|541130406|FG000|Overall Study|Protocol Violation|8|||
149998636|NCT03263923|541130407|FG000|Overall Study|Withdrawal by Subject|10|||
149998637|NCT03263923|541130408|FG001|Overall Study|Withdrawal by Subject|8|||
149998638|NCT03263923|541130407|FG000|Overall Study|Lost to Follow-up|15|||
149998639|NCT03263923|541130408|FG001|Overall Study|Lost to Follow-up|13|||
149998640|NCT01323270|541130409|FG000|Overall Study|Withdrawal by Subject|19|||
149998641|NCT01323270|541130410|FG001|Overall Study|Withdrawal by Subject|10|||
149998642|NCT01323270|541130409|FG000|Overall Study|Protocol Violation|9|||
149998643|NCT01323270|541130410|FG001|Overall Study|Protocol Violation|7|||
149998644|NCT01323270|541130409|FG000|Overall Study|Lost to Follow-up|4|||
149998645|NCT01323270|541130410|FG001|Overall Study|Lost to Follow-up|6|||
149998646|NCT01323270|541130409|FG000|Overall Study|Adverse Event|8|||
149998647|NCT01323270|541130410|FG001|Overall Study|Adverse Event|0|||
149998648|NCT01323270|541130409|FG000|Overall Study|Other|0|||
149998649|NCT01323270|541130410|FG001|Overall Study|Other|3|||
149998650|NCT01323270|541130409|FG000|Overall Study|Physician Decision|0|||
149998651|NCT01323270|541130410|FG001|Overall Study|Physician Decision|2|||
149998652|NCT01323270|541130409|FG000|Overall Study|Not eligible|1|||
149998653|NCT01323270|541130410|FG001|Overall Study|Not eligible|1|||
149998654|NCT01323270|541130409|FG000|Overall Study|Death|1|||
149998655|NCT01323270|541130410|FG001|Overall Study|Death|0|||
149998656|NCT01323270|541130409|FG000|Overall Study|Randomized, but not vaccinated|1|||
149998657|NCT01323270|541130410|FG001|Overall Study|Randomized, but not vaccinated|0|||
149998658|NCT02229214|541130421|FG000|Overall Study|Adverse Event|2|||
149998659|NCT02229214|541130422|FG001|Overall Study|Adverse Event|0|||
149998660|NCT02229214|541130421|FG000|Overall Study|Withdrawal by Subject|4|||
149998661|NCT02229214|541130422|FG001|Overall Study|Withdrawal by Subject|0|||
149998662|NCT00246025|541130423|FG000|Overall Study|Adverse Event|7|||
149998663|NCT00246025|541130424|FG001|Overall Study|Adverse Event|9|||
149998664|NCT00246025|541130425|FG002|Overall Study|Adverse Event|9|||
150179410|NCT01939899|541795360|FG001|Lead-in Dose Finding Phase|Death|3|||
150179411|NCT01939899|541795361|FG002|Lead-in Dose Finding Phase|Death|1|||
150179412|NCT01939899|541795362|FG003|Lead-in Dose Finding Phase|Death|0|||
150179413|NCT01939899|541795363|FG004|Lead-in Dose Finding Phase|Death|0|||
150179414|NCT01939899|541795359|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
149998665|NCT00246025|541130426|FG003|Overall Study|Adverse Event|10|||
149998666|NCT00246025|541130423|FG000|Overall Study|Withdrawal by Subject|3|||
149998667|NCT00246025|541130424|FG001|Overall Study|Withdrawal by Subject|0|||
149998668|NCT00246025|541130425|FG002|Overall Study|Withdrawal by Subject|1|||
149998669|NCT00246025|541130426|FG003|Overall Study|Withdrawal by Subject|2|||
150179415|NCT01939899|541795360|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
150179416|NCT01939899|541795361|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
150179417|NCT01939899|541795362|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
150179418|NCT01939899|541795363|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
150179419|NCT01939899|541795359|FG000|Lead-in Dose Finding Phase|Other|0|||
150054369|NCT02168387|541340248|FG000|Overall Study|Planned exubation|6|||
149998670|NCT00246025|541130423|FG000|Overall Study|unsuitable medical history was found|0|||
149998671|NCT00246025|541130424|FG001|Overall Study|unsuitable medical history was found|0|||
149998672|NCT00246025|541130425|FG002|Overall Study|unsuitable medical history was found|0|||
149998673|NCT00246025|541130426|FG003|Overall Study|unsuitable medical history was found|1|||
149998674|NCT01643850|541130427|FG000|Overall Study|Withdrawal by Subject|0|||
149998675|NCT01643850|541130428|FG001|Overall Study|Withdrawal by Subject|0|||
149998676|NCT01643850|541130429|FG002|Overall Study|Withdrawal by Subject|0|||
149998677|NCT01643850|541130430|FG003|Overall Study|Withdrawal by Subject|0|||
149998678|NCT01643850|541130431|FG004|Overall Study|Withdrawal by Subject|1|||
149998679|NCT01643850|541130432|FG005|Overall Study|Withdrawal by Subject|0|||
149998680|NCT01643850|541130433|FG006|Overall Study|Withdrawal by Subject|0|||
149998681|NCT01643850|541130434|FG007|Overall Study|Withdrawal by Subject|0|||
149998682|NCT01643850|541130435|FG008|Overall Study|Withdrawal by Subject|0|||
149998683|NCT01643850|541130427|FG000|Overall Study|Lost to Follow-up|0|||
149998684|NCT01643850|541130428|FG001|Overall Study|Lost to Follow-up|0|||
149998685|NCT01643850|541130429|FG002|Overall Study|Lost to Follow-up|0|||
149998686|NCT01643850|541130430|FG003|Overall Study|Lost to Follow-up|0|||
149998687|NCT01643850|541130431|FG004|Overall Study|Lost to Follow-up|0|||
149998688|NCT01643850|541130432|FG005|Overall Study|Lost to Follow-up|0|||
149998689|NCT01643850|541130433|FG006|Overall Study|Lost to Follow-up|1|||
149998690|NCT01643850|541130434|FG007|Overall Study|Lost to Follow-up|0|||
149998691|NCT01643850|541130435|FG008|Overall Study|Lost to Follow-up|1|||
149998692|NCT01643850|541130427|FG000|Overall Study|Adverse Event|0|||
149998693|NCT01643850|541130428|FG001|Overall Study|Adverse Event|0|||
149998694|NCT01643850|541130429|FG002|Overall Study|Adverse Event|0|||
149998695|NCT01643850|541130430|FG003|Overall Study|Adverse Event|0|||
149998696|NCT01643850|541130431|FG004|Overall Study|Adverse Event|1|||
149998697|NCT01643850|541130432|FG005|Overall Study|Adverse Event|0|||
149998698|NCT01643850|541130433|FG006|Overall Study|Adverse Event|0|||
149998699|NCT01643850|541130434|FG007|Overall Study|Adverse Event|0|||
149998700|NCT01643850|541130435|FG008|Overall Study|Adverse Event|0|||
149998701|NCT01643850|541130427|FG000|Overall Study|Administrative Problems|0|||
149998702|NCT01643850|541130428|FG001|Overall Study|Administrative Problems|0|||
149998703|NCT01643850|541130429|FG002|Overall Study|Administrative Problems|1|||
149998704|NCT01643850|541130430|FG003|Overall Study|Administrative Problems|0|||
149998705|NCT01643850|541130431|FG004|Overall Study|Administrative Problems|1|||
149998706|NCT01643850|541130432|FG005|Overall Study|Administrative Problems|0|||
149998707|NCT01643850|541130433|FG006|Overall Study|Administrative Problems|0|||
149998708|NCT01643850|541130434|FG007|Overall Study|Administrative Problems|0|||
149998709|NCT01643850|541130435|FG008|Overall Study|Administrative Problems|0|||
149998710|NCT00931723|541130438|FG000|Overall Study|Withdrawal by Subject|11|||
149998711|NCT00931723|541130439|FG001|Overall Study|Withdrawal by Subject|13|||
149998712|NCT00931723|541130438|FG000|Overall Study|Adverse Event|6|||
149998713|NCT00931723|541130439|FG001|Overall Study|Adverse Event|13|||
149998714|NCT00931723|541130438|FG000|Overall Study|Lithium found in blood|0|||
149998715|NCT00931723|541130439|FG001|Overall Study|Lithium found in blood|1|||
149998716|NCT00931723|541130438|FG000|Overall Study|Condition under investigation worsened|1|||
149998717|NCT00931723|541130439|FG001|Overall Study|Condition under investigation worsened|2|||
149998718|NCT00931723|541130438|FG000|Overall Study|Lost to Follow-up|1|||
149998719|NCT00931723|541130439|FG001|Overall Study|Lost to Follow-up|2|||
149998720|NCT00931723|541130438|FG000|Overall Study|Study-specific discontinuation criteria|1|||
149998721|NCT00931723|541130439|FG001|Overall Study|Study-specific discontinuation criteria|1|||
149998722|NCT00931723|541130438|FG000|Overall Study|Severe non-compliance to protocol|2|||
149998723|NCT00931723|541130439|FG001|Overall Study|Severe non-compliance to protocol|0|||
149998724|NCT00931723|541130438|FG000|Overall Study|Safety reasons|0|||
149998725|NCT00931723|541130439|FG001|Overall Study|Safety reasons|1|||
149998726|NCT00931723|541130438|FG000|Overall Study|Took prohibited concomitant medication|0|||
150054370|NCT02168387|541340249|FG001|Overall Study|Planned exubation|3|||
150054371|NCT02168387|541340248|FG000|Overall Study|Death|1|||
150054372|NCT02168387|541340249|FG001|Overall Study|Death|0|||
149998727|NCT00931723|541130439|FG001|Overall Study|Took prohibited concomitant medication|1|||
149998728|NCT00931723|541130438|FG000|Overall Study|Lack or insufficient theraputic response|2|||
149998729|NCT00931723|541130439|FG001|Overall Study|Lack or insufficient theraputic response|5|||
149998730|NCT00931723|541130438|FG000|Overall Study|Sponsor decision|1|||
149998731|NCT00931723|541130439|FG001|Overall Study|Sponsor decision|0|||
149998732|NCT00931723|541130438|FG000|Overall Study|Late hospital discharge|1|||
149998733|NCT00931723|541130439|FG001|Overall Study|Late hospital discharge|0|||
149998734|NCT03305081|541130440|FG000|Overall Study|Lost to Follow-up|10|||
149998735|NCT03305081|541130441|FG001|Overall Study|Lost to Follow-up|15|||
149998736|NCT01571284|541130442|FG000|Overall Study|Participant's decision|84|||
149998737|NCT01571284|541130442|FG000|Overall Study|Lost to Follow-up|3|||
149998738|NCT01571284|541130442|FG000|Overall Study|Enrolled but not treated|2|||
149998739|NCT01571284|541130442|FG000|Overall Study|Other than specified above|80|||
149998740|NCT00075725|541130443|FG000|Overall Study|Adverse Event|6|||
149998741|NCT00075725|541130444|FG001|Overall Study|Adverse Event|6|||
150054373|NCT01659554|541340250|FG000|Overall Study|Study Termination|4|||
150054374|NCT01350544|541340257|FG000|Overall Study|Administrative Withdrawal|0|||
150054375|NCT01350544|541340258|FG001|Overall Study|Administrative Withdrawal|1|||
150054376|NCT01350544|541340257|FG000|Overall Study|Death|1|||
150054377|NCT01350544|541340258|FG001|Overall Study|Death|2|||
149998742|NCT00075725|541130445|FG002|Overall Study|Adverse Event|20|||
149998743|NCT00075725|541130446|FG003|Overall Study|Adverse Event|8|||
149998744|NCT00075725|541130447|FG004|Overall Study|Adverse Event|4|||
149998745|NCT00075725|541130448|FG005|Overall Study|Adverse Event|38|||
149998746|NCT00075725|541130449|FG006|Overall Study|Adverse Event|3|||
149998747|NCT00075725|541130450|FG007|Overall Study|Adverse Event|51|||
149998748|NCT00075725|541130451|FG008|Overall Study|Adverse Event|15|||
149998749|NCT00075725|541130452|FG009|Overall Study|Adverse Event|4|||
149998750|NCT00075725|541130453|FG010|Overall Study|Adverse Event|2|||
149998751|NCT00075725|541130454|FG011|Overall Study|Adverse Event|2|||
149998752|NCT00075725|541130443|FG000|Overall Study|Death|3|||
149998753|NCT00075725|541130444|FG001|Overall Study|Death|5|||
149998754|NCT00075725|541130445|FG002|Overall Study|Death|10|||
149998755|NCT00075725|541130446|FG003|Overall Study|Death|2|||
149998756|NCT00075725|541130447|FG004|Overall Study|Death|3|||
149998757|NCT00075725|541130448|FG005|Overall Study|Death|25|||
149998758|NCT00075725|541130449|FG006|Overall Study|Death|4|||
149998759|NCT00075725|541130450|FG007|Overall Study|Death|22|||
149998760|NCT00075725|541130451|FG008|Overall Study|Death|14|||
149998761|NCT00075725|541130452|FG009|Overall Study|Death|4|||
149998762|NCT00075725|541130453|FG010|Overall Study|Death|3|||
149998763|NCT00075725|541130454|FG011|Overall Study|Death|0|||
149998764|NCT00075725|541130443|FG000|Overall Study|Lost to Follow-up|1|||
149998765|NCT00075725|541130444|FG001|Overall Study|Lost to Follow-up|1|||
150054378|NCT01350544|541340257|FG000|Overall Study|Moved out of LA County|2|||
150054379|NCT01350544|541340258|FG001|Overall Study|Moved out of LA County|2|||
150054380|NCT01350544|541340257|FG000|Overall Study|Medical Issues|1|||
149998766|NCT00075725|541130445|FG002|Overall Study|Lost to Follow-up|4|||
149998767|NCT00075725|541130446|FG003|Overall Study|Lost to Follow-up|1|||
149998768|NCT00075725|541130447|FG004|Overall Study|Lost to Follow-up|0|||
149998769|NCT00075725|541130448|FG005|Overall Study|Lost to Follow-up|13|||
149998770|NCT00075725|541130449|FG006|Overall Study|Lost to Follow-up|2|||
149998771|NCT00075725|541130450|FG007|Overall Study|Lost to Follow-up|4|||
149998772|NCT00075725|541130451|FG008|Overall Study|Lost to Follow-up|1|||
149998773|NCT00075725|541130452|FG009|Overall Study|Lost to Follow-up|0|||
149998774|NCT00075725|541130453|FG010|Overall Study|Lost to Follow-up|0|||
149998775|NCT00075725|541130454|FG011|Overall Study|Lost to Follow-up|0|||
149998776|NCT00075725|541130443|FG000|Overall Study|Physician Decision|2|||
149998777|NCT00075725|541130444|FG001|Overall Study|Physician Decision|6|||
149998778|NCT00075725|541130445|FG002|Overall Study|Physician Decision|5|||
149998779|NCT00075725|541130446|FG003|Overall Study|Physician Decision|8|||
149998780|NCT00075725|541130447|FG004|Overall Study|Physician Decision|4|||
149998781|NCT00075725|541130448|FG005|Overall Study|Physician Decision|19|||
149998782|NCT00075725|541130449|FG006|Overall Study|Physician Decision|3|||
149998783|NCT00075725|541130450|FG007|Overall Study|Physician Decision|17|||
149998784|NCT00075725|541130451|FG008|Overall Study|Physician Decision|5|||
149998785|NCT00075725|541130452|FG009|Overall Study|Physician Decision|0|||
149998786|NCT00075725|541130453|FG010|Overall Study|Physician Decision|1|||
149998787|NCT00075725|541130454|FG011|Overall Study|Physician Decision|0|||
149998788|NCT00075725|541130443|FG000|Overall Study|Pregnancy|0|||
149998789|NCT00075725|541130444|FG001|Overall Study|Pregnancy|0|||
149998790|NCT00075725|541130445|FG002|Overall Study|Pregnancy|0|||
149998791|NCT00075725|541130446|FG003|Overall Study|Pregnancy|0|||
149998792|NCT00075725|541130447|FG004|Overall Study|Pregnancy|0|||
149998793|NCT00075725|541130448|FG005|Overall Study|Pregnancy|1|||
149998794|NCT00075725|541130449|FG006|Overall Study|Pregnancy|0|||
149998795|NCT00075725|541130450|FG007|Overall Study|Pregnancy|1|||
149998796|NCT00075725|541130451|FG008|Overall Study|Pregnancy|0|||
149998797|NCT00075725|541130452|FG009|Overall Study|Pregnancy|0|||
149998798|NCT00075725|541130453|FG010|Overall Study|Pregnancy|0|||
149998799|NCT00075725|541130454|FG011|Overall Study|Pregnancy|0|||
149998800|NCT00075725|541130443|FG000|Overall Study|Protocol Violation|1|||
149998801|NCT00075725|541130444|FG001|Overall Study|Protocol Violation|1|||
149998802|NCT00075725|541130445|FG002|Overall Study|Protocol Violation|0|||
149998803|NCT00075725|541130446|FG003|Overall Study|Protocol Violation|3|||
149998804|NCT00075725|541130447|FG004|Overall Study|Protocol Violation|3|||
149998805|NCT00075725|541130448|FG005|Overall Study|Protocol Violation|2|||
149998806|NCT00075725|541130449|FG006|Overall Study|Protocol Violation|1|||
149998807|NCT00075725|541130450|FG007|Overall Study|Protocol Violation|2|||
149998808|NCT00075725|541130451|FG008|Overall Study|Protocol Violation|3|||
149998809|NCT00075725|541130452|FG009|Overall Study|Protocol Violation|0|||
149998810|NCT00075725|541130453|FG010|Overall Study|Protocol Violation|0|||
149998811|NCT00075725|541130454|FG011|Overall Study|Protocol Violation|1|||
149998812|NCT00075725|541130443|FG000|Overall Study|Withdrawal by Subject|12|||
149998813|NCT00075725|541130444|FG001|Overall Study|Withdrawal by Subject|3|||
149998814|NCT00075725|541130445|FG002|Overall Study|Withdrawal by Subject|6|||
149998815|NCT00075725|541130446|FG003|Overall Study|Withdrawal by Subject|10|||
149998816|NCT00075725|541130447|FG004|Overall Study|Withdrawal by Subject|6|||
149998817|NCT00075725|541130448|FG005|Overall Study|Withdrawal by Subject|27|||
149998818|NCT00075725|541130449|FG006|Overall Study|Withdrawal by Subject|7|||
149998819|NCT00075725|541130450|FG007|Overall Study|Withdrawal by Subject|31|||
149998820|NCT00075725|541130451|FG008|Overall Study|Withdrawal by Subject|10|||
149998821|NCT00075725|541130452|FG009|Overall Study|Withdrawal by Subject|2|||
149998822|NCT00075725|541130453|FG010|Overall Study|Withdrawal by Subject|0|||
149998823|NCT00075725|541130454|FG011|Overall Study|Withdrawal by Subject|0|||
149998824|NCT00075725|541130443|FG000|Overall Study|Disease Progression, all other reasons|17|||
149998825|NCT00075725|541130444|FG001|Overall Study|Disease Progression, all other reasons|5|||
149998826|NCT00075725|541130445|FG002|Overall Study|Disease Progression, all other reasons|33|||
149998827|NCT00075725|541130446|FG003|Overall Study|Disease Progression, all other reasons|6|||
149998828|NCT00075725|541130447|FG004|Overall Study|Disease Progression, all other reasons|21|||
149998829|NCT00075725|541130448|FG005|Overall Study|Disease Progression, all other reasons|59|||
149998830|NCT00075725|541130449|FG006|Overall Study|Disease Progression, all other reasons|20|||
149998831|NCT00075725|541130450|FG007|Overall Study|Disease Progression, all other reasons|46|||
149998832|NCT00075725|541130451|FG008|Overall Study|Disease Progression, all other reasons|21|||
149998833|NCT00075725|541130452|FG009|Overall Study|Disease Progression, all other reasons|4|||
149998834|NCT00075725|541130453|FG010|Overall Study|Disease Progression, all other reasons|0|||
149998835|NCT00075725|541130454|FG011|Overall Study|Disease Progression, all other reasons|5|||
150054381|NCT01350544|541340258|FG001|Overall Study|Medical Issues|1|||
150054382|NCT01350544|541340257|FG000|Overall Study|Withdrawal by Subject|0|||
149998836|NCT00075725|541130443|FG000|Overall Study|Patient off treatment|0|||
149998837|NCT00075725|541130444|FG001|Overall Study|Patient off treatment|0|||
149998838|NCT00075725|541130445|FG002|Overall Study|Patient off treatment|1|||
149998839|NCT00075725|541130446|FG003|Overall Study|Patient off treatment|2|||
149998840|NCT00075725|541130447|FG004|Overall Study|Patient off treatment|1|||
149998841|NCT00075725|541130448|FG005|Overall Study|Patient off treatment|0|||
149998842|NCT00075725|541130449|FG006|Overall Study|Patient off treatment|0|||
149998843|NCT00075725|541130450|FG007|Overall Study|Patient off treatment|2|||
149998844|NCT00075725|541130451|FG008|Overall Study|Patient off treatment|1|||
149998845|NCT00075725|541130452|FG009|Overall Study|Patient off treatment|0|||
149998846|NCT00075725|541130453|FG010|Overall Study|Patient off treatment|0|||
149998847|NCT00075725|541130454|FG011|Overall Study|Patient off treatment|0|||
149998848|NCT00075725|541130443|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
149998849|NCT00075725|541130444|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
149998850|NCT00075725|541130445|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
149998851|NCT00075725|541130446|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
149998852|NCT00075725|541130447|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
149998853|NCT00075725|541130448|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
149998854|NCT00075725|541130449|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
149998855|NCT00075725|541130450|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
149998856|NCT00075725|541130451|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
149998857|NCT00075725|541130452|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
149998858|NCT00075725|541130453|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
149998859|NCT00075725|541130454|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
149998860|NCT00075725|541130443|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
149998861|NCT00075725|541130444|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
149998862|NCT00075725|541130445|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
149998863|NCT00075725|541130446|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
149998864|NCT00075725|541130447|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
149998865|NCT00075725|541130448|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
149998866|NCT00075725|541130449|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
149998867|NCT00075725|541130450|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
149998868|NCT00075725|541130451|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
149998869|NCT00075725|541130452|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
149998870|NCT00075725|541130453|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
149998871|NCT00075725|541130454|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
149998872|NCT00075725|541130443|FG000|Overall Study|Pt non compliant with therapy|2|||
149998873|NCT00075725|541130444|FG001|Overall Study|Pt non compliant with therapy|1|||
149998874|NCT00075725|541130445|FG002|Overall Study|Pt non compliant with therapy|1|||
149998875|NCT00075725|541130446|FG003|Overall Study|Pt non compliant with therapy|0|||
149998876|NCT00075725|541130447|FG004|Overall Study|Pt non compliant with therapy|2|||
149998877|NCT00075725|541130448|FG005|Overall Study|Pt non compliant with therapy|14|||
149998878|NCT00075725|541130449|FG006|Overall Study|Pt non compliant with therapy|2|||
149998879|NCT00075725|541130450|FG007|Overall Study|Pt non compliant with therapy|5|||
149998880|NCT00075725|541130451|FG008|Overall Study|Pt non compliant with therapy|3|||
149998881|NCT00075725|541130452|FG009|Overall Study|Pt non compliant with therapy|0|||
149998882|NCT00075725|541130453|FG010|Overall Study|Pt non compliant with therapy|0|||
149998883|NCT00075725|541130454|FG011|Overall Study|Pt non compliant with therapy|0|||
149998884|NCT00075725|541130443|FG000|Overall Study|Pt age out of range for treatment|0|||
149998885|NCT00075725|541130444|FG001|Overall Study|Pt age out of range for treatment|1|||
149998886|NCT00075725|541130445|FG002|Overall Study|Pt age out of range for treatment|0|||
149998887|NCT00075725|541130446|FG003|Overall Study|Pt age out of range for treatment|0|||
149998888|NCT00075725|541130447|FG004|Overall Study|Pt age out of range for treatment|0|||
149998889|NCT00075725|541130448|FG005|Overall Study|Pt age out of range for treatment|1|||
149998890|NCT00075725|541130449|FG006|Overall Study|Pt age out of range for treatment|0|||
149998891|NCT00075725|541130450|FG007|Overall Study|Pt age out of range for treatment|1|||
149998892|NCT00075725|541130451|FG008|Overall Study|Pt age out of range for treatment|0|||
149998893|NCT00075725|541130452|FG009|Overall Study|Pt age out of range for treatment|0|||
149998894|NCT00075725|541130453|FG010|Overall Study|Pt age out of range for treatment|0|||
149998895|NCT00075725|541130454|FG011|Overall Study|Pt age out of range for treatment|0|||
149998896|NCT00075725|541130443|FG000|Overall Study|Insurance issues|0|||
149998897|NCT00075725|541130444|FG001|Overall Study|Insurance issues|1|||
149998898|NCT00075725|541130445|FG002|Overall Study|Insurance issues|0|||
149998899|NCT00075725|541130446|FG003|Overall Study|Insurance issues|1|||
149998900|NCT00075725|541130447|FG004|Overall Study|Insurance issues|1|||
149998901|NCT00075725|541130448|FG005|Overall Study|Insurance issues|1|||
149998902|NCT00075725|541130449|FG006|Overall Study|Insurance issues|0|||
149998903|NCT00075725|541130450|FG007|Overall Study|Insurance issues|1|||
149998904|NCT00075725|541130451|FG008|Overall Study|Insurance issues|0|||
149998905|NCT00075725|541130452|FG009|Overall Study|Insurance issues|0|||
149998906|NCT00075725|541130453|FG010|Overall Study|Insurance issues|0|||
149998907|NCT00075725|541130454|FG011|Overall Study|Insurance issues|0|||
149998908|NCT00075725|541130443|FG000|Overall Study|MRD positive after extended ind|0|||
149998909|NCT00075725|541130444|FG001|Overall Study|MRD positive after extended ind|1|||
149998910|NCT00075725|541130445|FG002|Overall Study|MRD positive after extended ind|1|||
149998911|NCT00075725|541130446|FG003|Overall Study|MRD positive after extended ind|0|||
149998912|NCT00075725|541130447|FG004|Overall Study|MRD positive after extended ind|1|||
149998913|NCT00075725|541130448|FG005|Overall Study|MRD positive after extended ind|2|||
149998914|NCT00075725|541130449|FG006|Overall Study|MRD positive after extended ind|0|||
149998915|NCT00075725|541130450|FG007|Overall Study|MRD positive after extended ind|1|||
149998916|NCT00075725|541130451|FG008|Overall Study|MRD positive after extended ind|0|||
149998917|NCT00075725|541130452|FG009|Overall Study|MRD positive after extended ind|0|||
149998918|NCT00075725|541130453|FG010|Overall Study|MRD positive after extended ind|0|||
149998919|NCT00075725|541130454|FG011|Overall Study|MRD positive after extended ind|0|||
149998920|NCT00075725|541130443|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
149998921|NCT00075725|541130444|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
149998922|NCT00075725|541130445|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
149998923|NCT00075725|541130446|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
149998924|NCT00075725|541130447|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
149998925|NCT00075725|541130448|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
149998926|NCT00075725|541130449|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
149998927|NCT00075725|541130450|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
149998928|NCT00075725|541130451|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
149998929|NCT00075725|541130452|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
149998930|NCT00075725|541130453|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
149998931|NCT00075725|541130454|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
149998932|NCT00075725|541130443|FG000|Overall Study|Inevaluable|1|||
149998933|NCT00075725|541130444|FG001|Overall Study|Inevaluable|1|||
149998934|NCT00075725|541130445|FG002|Overall Study|Inevaluable|4|||
149998935|NCT00075725|541130446|FG003|Overall Study|Inevaluable|2|||
149998936|NCT00075725|541130447|FG004|Overall Study|Inevaluable|2|||
149998937|NCT00075725|541130448|FG005|Overall Study|Inevaluable|9|||
150054383|NCT01350544|541340258|FG001|Overall Study|Withdrawal by Subject|1|||
150054384|NCT01350544|541340257|FG000|Overall Study|Incarceration|1|||
150054385|NCT01350544|541340258|FG001|Overall Study|Incarceration|0|||
150054386|NCT01350544|541340257|FG000|Overall Study|Lost to Follow-up|18|||
150054387|NCT01350544|541340258|FG001|Overall Study|Lost to Follow-up|15|||
150054388|NCT01444092|541340259|FG000|Overall Study|Adverse Event|8|||
150054389|NCT01444092|541340259|FG000|Overall Study|Protocol Violation|1|||
150054390|NCT01444092|541340259|FG000|Overall Study|Withdrawal by Subject|1|||
150054391|NCT01444092|541340259|FG000|Overall Study|Other Eligibility criteria|7|||
150054392|NCT01328366|541340262|FG000|Overall Study|Death|1|||
150054393|NCT01328366|541340262|FG000|Overall Study|Withdrawal by Subject|2|||
150054394|NCT01328366|541340262|FG000|Overall Study|Lost to Follow-up|7|||
150054395|NCT00097981|541340274|FG000|Overall Study|Adverse Event|31|||
150054396|NCT00097981|541340275|FG001|Overall Study|Adverse Event|44|||
150054397|NCT00097981|541340274|FG000|Overall Study|Withdrawal by Subject|10|||
150054398|NCT00097981|541340275|FG001|Overall Study|Withdrawal by Subject|8|||
149998938|NCT00075725|541130449|FG006|Overall Study|Inevaluable|1|||
149998939|NCT00075725|541130450|FG007|Overall Study|Inevaluable|11|||
149998940|NCT00075725|541130451|FG008|Overall Study|Inevaluable|2|||
149998941|NCT00075725|541130452|FG009|Overall Study|Inevaluable|0|||
149998942|NCT00075725|541130453|FG010|Overall Study|Inevaluable|1|||
149998943|NCT00075725|541130454|FG011|Overall Study|Inevaluable|0|||
149998944|NCT00075725|541130443|FG000|Overall Study|Other|4|||
149998945|NCT00075725|541130444|FG001|Overall Study|Other|2|||
149998946|NCT00075725|541130445|FG002|Overall Study|Other|1|||
149998947|NCT00075725|541130446|FG003|Overall Study|Other|1|||
149998948|NCT00075725|541130447|FG004|Overall Study|Other|1|||
149998949|NCT00075725|541130448|FG005|Overall Study|Other|4|||
149998950|NCT00075725|541130449|FG006|Overall Study|Other|2|||
149998951|NCT00075725|541130450|FG007|Overall Study|Other|9|||
150054399|NCT00097981|541340274|FG000|Overall Study|Protocol Violation|1|||
150054400|NCT00097981|541340275|FG001|Overall Study|Protocol Violation|1|||
149998952|NCT00075725|541130451|FG008|Overall Study|Other|2|||
149998953|NCT00075725|541130452|FG009|Overall Study|Other|1|||
150054401|NCT00097981|541340274|FG000|Overall Study|Death|2|||
150054402|NCT00097981|541340275|FG001|Overall Study|Death|4|||
150054403|NCT00097981|541340274|FG000|Overall Study|Physician Decision|7|||
150054404|NCT00097981|541340275|FG001|Overall Study|Physician Decision|1|||
149998954|NCT00075725|541130453|FG010|Overall Study|Other|0|||
149998955|NCT00075725|541130454|FG011|Overall Study|Other|3|||
149998956|NCT00075725|541130443|FG000|Overall Study|Pt trying to find a BM donor|0|||
150054405|NCT00097981|541340274|FG000|Overall Study|Disease Progression|8|||
149998957|NCT00075725|541130444|FG001|Overall Study|Pt trying to find a BM donor|1|||
149998958|NCT00075725|541130445|FG002|Overall Study|Pt trying to find a BM donor|0|||
149998959|NCT00075725|541130446|FG003|Overall Study|Pt trying to find a BM donor|0|||
149998960|NCT00075725|541130447|FG004|Overall Study|Pt trying to find a BM donor|0|||
149998961|NCT00075725|541130448|FG005|Overall Study|Pt trying to find a BM donor|0|||
149998962|NCT00075725|541130449|FG006|Overall Study|Pt trying to find a BM donor|0|||
149998963|NCT00075725|541130450|FG007|Overall Study|Pt trying to find a BM donor|0|||
149998964|NCT00075725|541130451|FG008|Overall Study|Pt trying to find a BM donor|0|||
149998965|NCT00075725|541130452|FG009|Overall Study|Pt trying to find a BM donor|0|||
149998966|NCT00075725|541130453|FG010|Overall Study|Pt trying to find a BM donor|0|||
149998967|NCT00075725|541130454|FG011|Overall Study|Pt trying to find a BM donor|0|||
149998968|NCT00075725|541130443|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
149998969|NCT00075725|541130444|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
149998970|NCT00075725|541130445|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
149998971|NCT00075725|541130446|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
149998972|NCT00075725|541130447|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
149998973|NCT00075725|541130448|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
149998974|NCT00075725|541130449|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
149998975|NCT00075725|541130450|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
149998976|NCT00075725|541130451|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
149998977|NCT00075725|541130452|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
149998978|NCT00075725|541130453|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
149998979|NCT00075725|541130454|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
149998980|NCT00075725|541130443|FG000|Overall Study|Unsuccessful institutional transfer|0|||
149998981|NCT00075725|541130444|FG001|Overall Study|Unsuccessful institutional transfer|0|||
149998982|NCT00075725|541130445|FG002|Overall Study|Unsuccessful institutional transfer|2|||
149998983|NCT00075725|541130446|FG003|Overall Study|Unsuccessful institutional transfer|0|||
149998984|NCT00075725|541130447|FG004|Overall Study|Unsuccessful institutional transfer|0|||
149998985|NCT00075725|541130448|FG005|Overall Study|Unsuccessful institutional transfer|0|||
149998986|NCT00075725|541130449|FG006|Overall Study|Unsuccessful institutional transfer|0|||
149998987|NCT00075725|541130450|FG007|Overall Study|Unsuccessful institutional transfer|0|||
149998988|NCT00075725|541130451|FG008|Overall Study|Unsuccessful institutional transfer|0|||
149998989|NCT00075725|541130452|FG009|Overall Study|Unsuccessful institutional transfer|1|||
149998990|NCT00075725|541130453|FG010|Overall Study|Unsuccessful institutional transfer|0|||
149998991|NCT00075725|541130454|FG011|Overall Study|Unsuccessful institutional transfer|0|||
149998992|NCT00075725|541130443|FG000|Overall Study|specimen(s) not submitted|0|||
149998993|NCT00075725|541130444|FG001|Overall Study|specimen(s) not submitted|0|||
149998994|NCT00075725|541130445|FG002|Overall Study|specimen(s) not submitted|2|||
149998995|NCT00075725|541130446|FG003|Overall Study|specimen(s) not submitted|0|||
149998996|NCT00075725|541130447|FG004|Overall Study|specimen(s) not submitted|0|||
149998997|NCT00075725|541130448|FG005|Overall Study|specimen(s) not submitted|0|||
149998998|NCT00075725|541130449|FG006|Overall Study|specimen(s) not submitted|0|||
149998999|NCT00075725|541130450|FG007|Overall Study|specimen(s) not submitted|0|||
149999000|NCT00075725|541130451|FG008|Overall Study|specimen(s) not submitted|0|||
149999001|NCT00075725|541130452|FG009|Overall Study|specimen(s) not submitted|0|||
149999002|NCT00075725|541130453|FG010|Overall Study|specimen(s) not submitted|0|||
149999003|NCT00075725|541130454|FG011|Overall Study|specimen(s) not submitted|0|||
149999004|NCT00075725|541130443|FG000|Overall Study|Pt went to transplant|0|||
149999005|NCT00075725|541130444|FG001|Overall Study|Pt went to transplant|0|||
149999006|NCT00075725|541130445|FG002|Overall Study|Pt went to transplant|0|||
149999007|NCT00075725|541130446|FG003|Overall Study|Pt went to transplant|1|||
149999008|NCT00075725|541130447|FG004|Overall Study|Pt went to transplant|0|||
149999009|NCT00075725|541130448|FG005|Overall Study|Pt went to transplant|1|||
149999010|NCT00075725|541130449|FG006|Overall Study|Pt went to transplant|0|||
149999011|NCT00075725|541130450|FG007|Overall Study|Pt went to transplant|0|||
149999012|NCT00075725|541130451|FG008|Overall Study|Pt went to transplant|0|||
149999013|NCT00075725|541130452|FG009|Overall Study|Pt went to transplant|0|||
149999014|NCT00075725|541130453|FG010|Overall Study|Pt went to transplant|0|||
149999015|NCT00075725|541130454|FG011|Overall Study|Pt went to transplant|0|||
149999016|NCT00075725|541130443|FG000|Overall Study|Pt received additional steroids|0|||
149999017|NCT00075725|541130444|FG001|Overall Study|Pt received additional steroids|0|||
149999018|NCT00075725|541130445|FG002|Overall Study|Pt received additional steroids|0|||
149999019|NCT00075725|541130446|FG003|Overall Study|Pt received additional steroids|1|||
149999020|NCT00075725|541130447|FG004|Overall Study|Pt received additional steroids|0|||
149999021|NCT00075725|541130448|FG005|Overall Study|Pt received additional steroids|0|||
149999022|NCT00075725|541130449|FG006|Overall Study|Pt received additional steroids|0|||
149999023|NCT00075725|541130450|FG007|Overall Study|Pt received additional steroids|0|||
149999024|NCT00075725|541130451|FG008|Overall Study|Pt received additional steroids|0|||
149999025|NCT00075725|541130452|FG009|Overall Study|Pt received additional steroids|0|||
150054406|NCT00097981|541340275|FG001|Overall Study|Disease Progression|2|||
149999026|NCT00075725|541130453|FG010|Overall Study|Pt received additional steroids|0|||
149999027|NCT00075725|541130454|FG011|Overall Study|Pt received additional steroids|0|||
149999028|NCT00075725|541130443|FG000|Overall Study|Pt relocated|0|||
149999029|NCT00075725|541130444|FG001|Overall Study|Pt relocated|0|||
149999030|NCT00075725|541130445|FG002|Overall Study|Pt relocated|0|||
149999031|NCT00075725|541130446|FG003|Overall Study|Pt relocated|2|||
149999032|NCT00075725|541130447|FG004|Overall Study|Pt relocated|0|||
149999033|NCT00075725|541130448|FG005|Overall Study|Pt relocated|1|||
149999034|NCT00075725|541130449|FG006|Overall Study|Pt relocated|1|||
149999035|NCT00075725|541130450|FG007|Overall Study|Pt relocated|2|||
149999036|NCT00075725|541130451|FG008|Overall Study|Pt relocated|1|||
149999037|NCT00075725|541130452|FG009|Overall Study|Pt relocated|0|||
149999038|NCT00075725|541130453|FG010|Overall Study|Pt relocated|0|||
149999039|NCT00075725|541130454|FG011|Overall Study|Pt relocated|0|||
149999040|NCT00075725|541130443|FG000|Overall Study|Institution Terminated|0|||
149999041|NCT00075725|541130444|FG001|Overall Study|Institution Terminated|0|||
149999042|NCT00075725|541130445|FG002|Overall Study|Institution Terminated|0|||
149999043|NCT00075725|541130446|FG003|Overall Study|Institution Terminated|0|||
149999044|NCT00075725|541130447|FG004|Overall Study|Institution Terminated|1|||
149999045|NCT00075725|541130448|FG005|Overall Study|Institution Terminated|0|||
149999046|NCT00075725|541130449|FG006|Overall Study|Institution Terminated|0|||
149999047|NCT00075725|541130450|FG007|Overall Study|Institution Terminated|3|||
149999048|NCT00075725|541130451|FG008|Overall Study|Institution Terminated|0|||
149999049|NCT00075725|541130452|FG009|Overall Study|Institution Terminated|0|||
149999050|NCT00075725|541130453|FG010|Overall Study|Institution Terminated|0|||
149999051|NCT00075725|541130454|FG011|Overall Study|Institution Terminated|0|||
149999052|NCT00075725|541130443|FG000|Overall Study|Study Closure|1|||
149999053|NCT00075725|541130444|FG001|Overall Study|Study Closure|0|||
149999054|NCT00075725|541130445|FG002|Overall Study|Study Closure|0|||
149999055|NCT00075725|541130446|FG003|Overall Study|Study Closure|0|||
149999056|NCT00075725|541130447|FG004|Overall Study|Study Closure|1|||
149999057|NCT00075725|541130448|FG005|Overall Study|Study Closure|3|||
149999058|NCT00075725|541130449|FG006|Overall Study|Study Closure|0|||
149999059|NCT00075725|541130450|FG007|Overall Study|Study Closure|1|||
149999060|NCT00075725|541130451|FG008|Overall Study|Study Closure|0|||
149999061|NCT00075725|541130452|FG009|Overall Study|Study Closure|0|||
149999062|NCT00075725|541130453|FG010|Overall Study|Study Closure|0|||
149999063|NCT00075725|541130454|FG011|Overall Study|Study Closure|0|||
149999064|NCT00075725|541130443|FG000|Overall Study|Other complications|0|||
149999065|NCT00075725|541130444|FG001|Overall Study|Other complications|0|||
149999066|NCT00075725|541130445|FG002|Overall Study|Other complications|0|||
149999067|NCT00075725|541130446|FG003|Overall Study|Other complications|0|||
149999068|NCT00075725|541130447|FG004|Overall Study|Other complications|0|||
149999069|NCT00075725|541130448|FG005|Overall Study|Other complications|1|||
149999070|NCT00075725|541130449|FG006|Overall Study|Other complications|0|||
149999071|NCT00075725|541130450|FG007|Overall Study|Other complications|0|||
149999072|NCT00075725|541130451|FG008|Overall Study|Other complications|0|||
149999073|NCT00075725|541130452|FG009|Overall Study|Other complications|0|||
149999074|NCT00075725|541130453|FG010|Overall Study|Other complications|0|||
149999075|NCT00075725|541130454|FG011|Overall Study|Other complications|0|||
149999076|NCT00075725|541130443|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
149999077|NCT00075725|541130444|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
149999078|NCT00075725|541130445|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
149999079|NCT00075725|541130446|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
149999080|NCT00075725|541130447|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
149999081|NCT00075725|541130448|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
149999082|NCT00075725|541130449|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
149999083|NCT00075725|541130450|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
149999084|NCT00075725|541130451|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
149999085|NCT00075725|541130452|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
149999086|NCT00075725|541130453|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
149999087|NCT00075725|541130454|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
149999088|NCT00075725|541130443|FG000|Overall Study|Pt incarcerated|0|||
149999089|NCT00075725|541130444|FG001|Overall Study|Pt incarcerated|0|||
149999090|NCT00075725|541130445|FG002|Overall Study|Pt incarcerated|0|||
150054407|NCT00097981|541340274|FG000|Overall Study|Transplant planned|28|||
150054408|NCT00097981|541340275|FG001|Overall Study|Transplant planned|27|||
150054409|NCT00097981|541340274|FG000|Overall Study|Other|19|||
150054410|NCT00097981|541340275|FG001|Overall Study|Other|13|||
149999091|NCT00075725|541130446|FG003|Overall Study|Pt incarcerated|0|||
149999092|NCT00075725|541130447|FG004|Overall Study|Pt incarcerated|0|||
149999093|NCT00075725|541130448|FG005|Overall Study|Pt incarcerated|0|||
149999094|NCT00075725|541130449|FG006|Overall Study|Pt incarcerated|0|||
149999095|NCT00075725|541130450|FG007|Overall Study|Pt incarcerated|1|||
149999096|NCT00075725|541130451|FG008|Overall Study|Pt incarcerated|0|||
149999097|NCT00075725|541130452|FG009|Overall Study|Pt incarcerated|0|||
149999098|NCT00075725|541130453|FG010|Overall Study|Pt incarcerated|0|||
149999099|NCT00075725|541130454|FG011|Overall Study|Pt incarcerated|0|||
149999100|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Death|1|||
149999101|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Death|1|||
149999102|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Death|0|||
149999103|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Death|0|||
149999104|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Death|1|||
149999105|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Death|0|||
149999106|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Death|0|||
149999107|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Death|0|||
149999108|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Death|0|||
149999109|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Death|0|||
149999110|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
149999111|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
149999112|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
149999113|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999114|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
149999115|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999116|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999117|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999118|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999119|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
149999120|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999121|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999122|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999123|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999124|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
150054411|NCT00412373|541340276|FG000|Overall Study|Adverse Event|8|||
150054412|NCT00412373|541340277|FG001|Overall Study|Adverse Event|13|||
150054413|NCT00412373|541340276|FG000|Overall Study|Lack of Efficacy|16|||
150054414|NCT00412373|541340277|FG001|Overall Study|Lack of Efficacy|22|||
150054415|NCT00412373|541340276|FG000|Overall Study|Lost to Follow-up|7|||
150054416|NCT00412373|541340277|FG001|Overall Study|Lost to Follow-up|13|||
150054417|NCT00412373|541340276|FG000|Overall Study|Withdrawal by Subject|8|||
150054418|NCT00412373|541340277|FG001|Overall Study|Withdrawal by Subject|27|||
150054419|NCT00412373|541340276|FG000|Overall Study|Other|2|||
150054420|NCT00412373|541340277|FG001|Overall Study|Other|2|||
150054421|NCT01002820|541340278|FG000|Overall Study|Adverse Event|1|||
150054422|NCT01002820|541340278|FG000|Overall Study|Withdrawal by Subject|2|||
150054423|NCT01002820|541340278|FG000|Overall Study|Lack of Efficacy|1|||
150054424|NCT01673347|541340279|FG000|Overall Study|failure of allograft|7|||
150054425|NCT00895011|541340285|FG000|Overall Study|Withdrawal by Subject|14|||
150054426|NCT00895011|541340286|FG001|Overall Study|Withdrawal by Subject|7|||
150054427|NCT00895011|541340287|FG002|Overall Study|Withdrawal by Subject|2|||
150054428|NCT00895011|541340285|FG000|Overall Study|Lost to Follow-up|5|||
150054429|NCT00895011|541340286|FG001|Overall Study|Lost to Follow-up|4|||
150054430|NCT00895011|541340287|FG002|Overall Study|Lost to Follow-up|1|||
150054431|NCT00895011|541340285|FG000|Overall Study|Protocol Violation|3|||
150054432|NCT00895011|541340286|FG001|Overall Study|Protocol Violation|1|||
150054433|NCT00895011|541340287|FG002|Overall Study|Protocol Violation|3|||
150054434|NCT00895011|541340285|FG000|Overall Study|Adverse Event|1|||
150054435|NCT00895011|541340286|FG001|Overall Study|Adverse Event|2|||
150054436|NCT00895011|541340287|FG002|Overall Study|Adverse Event|2|||
150054437|NCT00895011|541340285|FG000|Overall Study|schedule conflict|1|||
150054438|NCT00895011|541340286|FG001|Overall Study|schedule conflict|0|||
150054439|NCT00895011|541340287|FG002|Overall Study|schedule conflict|0|||
150054440|NCT03774823|541340288|FG000|Overall Study|Withdrawal by Subject|1|||
150054441|NCT03774823|541340289|FG001|Overall Study|Withdrawal by Subject|1|||
150054442|NCT03241368|541340293|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
150054443|NCT03241368|541340293|FG000|Overall Study|Lost to Follow-up|1|||
150054444|NCT03241368|541340293|FG000|Overall Study|Physician Decision|6|||
150054445|NCT03241368|541340293|FG000|Overall Study|Withdrawal by Subject|6|||
149999125|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999126|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
150054446|NCT03241368|541340293|FG000|Overall Study|Protocol Violation|1|||
150054447|NCT04740905|541340294|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
149999127|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999128|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
149999129|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
150054448|NCT04740905|541340295|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
150054449|NCT04740905|541340294|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
149999130|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
149999131|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999132|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999133|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999134|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999135|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999136|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999137|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999138|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999139|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
149999140|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
149999141|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999142|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999143|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
149999144|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
149999145|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999146|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999147|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999148|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999149|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
149999150|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
149999151|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999152|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999153|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
149999154|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999155|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999156|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999157|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999158|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999159|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149999160|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
149999161|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
149999162|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
149999163|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
149999164|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
149999165|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
149999166|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
149999167|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
149999168|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
149999169|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
149999170|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
149999171|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
149999172|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
149999173|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999174|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
149999175|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999176|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999177|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999178|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999179|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999180|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
149999181|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999182|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999183|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
149999184|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
149999185|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999186|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999187|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999188|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
150179420|NCT01939899|541795360|FG001|Lead-in Dose Finding Phase|Other|0|||
150179421|NCT01939899|541795361|FG002|Lead-in Dose Finding Phase|Other|1|||
150179422|NCT01939899|541795362|FG003|Lead-in Dose Finding Phase|Other|0|||
150179423|NCT01939899|541795363|FG004|Lead-in Dose Finding Phase|Other|0|||
150179424|NCT01939899|541795359|FG000|Phase 2|Withdrawal by Subject|0|||
150179425|NCT01939899|541795360|FG001|Phase 2|Withdrawal by Subject|0|||
150179426|NCT01939899|541795361|FG002|Phase 2|Withdrawal by Subject|0|||
150179427|NCT01939899|541795362|FG003|Phase 2|Withdrawal by Subject|2|||
150179428|NCT01939899|541795363|FG004|Phase 2|Withdrawal by Subject|0|||
149999189|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
149999190|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999191|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999192|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999193|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999194|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999195|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999196|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999197|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999198|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999199|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999200|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999201|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999202|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
149999203|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999204|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
149999205|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999206|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999207|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999208|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999209|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999210|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
149999211|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
149999212|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
149999213|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
149999214|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
149999215|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
149999216|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
149999217|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
149999218|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
149999219|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
149999220|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999221|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999222|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999223|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
149999224|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
149999225|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999226|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999227|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999228|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999229|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999230|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
150179429|NCT01939899|541795359|FG000|Phase 2|Disease Progression|0|||
150179430|NCT01939899|541795360|FG001|Phase 2|Disease Progression|0|||
150179431|NCT01939899|541795361|FG002|Phase 2|Disease Progression|0|||
150179432|NCT01939899|541795362|FG003|Phase 2|Disease Progression|9|||
150179433|NCT01939899|541795363|FG004|Phase 2|Disease Progression|1|||
150179434|NCT02647905|541795366|FG000|Overall Study|Lost to Follow-up|1|||
150179435|NCT02647905|541795366|FG000|Overall Study|Withdrawal by Subject|2|||
150179436|NCT05119855|541795370|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
149999231|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999232|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
149999233|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
149999234|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
149999235|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999236|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999237|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999238|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999239|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999240|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
149999241|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999242|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999243|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999244|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
149999245|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999246|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999247|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999248|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999249|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
149999250|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999251|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999252|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999253|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999254|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
149999255|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999256|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999257|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999258|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999259|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999260|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999261|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
149999262|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999263|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999264|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
149999265|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999266|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999267|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999268|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999269|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
149999270|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
149999271|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999272|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999273|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999274|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
149999275|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999276|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999277|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999278|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999279|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
149999280|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
149999281|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999282|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
149999283|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
150179437|NCT05119855|541795371|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
150179438|NCT05119855|541795370|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
150179439|NCT05119855|541795371|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
150179440|NCT05119855|541795370|FG000|Overall Study|Lost to Follow-up|6|||
149999284|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
149999285|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999286|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999287|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999288|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999289|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
149999290|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Other|5|||
149999291|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Other|1|||
149999292|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Other|0|||
149999293|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Other|3|||
149999294|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Other|0|||
150179441|NCT05119855|541795371|FG001|Overall Study|Lost to Follow-up|8|||
150179442|NCT02932579|541795372|FG000|Overall Study|Withdrawal by Subject|4|||
150179443|NCT02932579|541795373|FG001|Overall Study|Withdrawal by Subject|1|||
150179444|NCT02549170|541795376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
150179445|NCT02549170|541795377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
150179446|NCT02549170|541795378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
150179447|NCT02549170|541795379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
149999295|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Other|0|||
149999296|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Other|0|||
149999297|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Other|0|||
149999298|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Other|0|||
149999299|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Other|0|||
149999300|NCT03352557|541130455|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999301|NCT03352557|541130456|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999302|NCT03352557|541130457|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999303|NCT03352557|541130458|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999304|NCT03352557|541130459|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
150179448|NCT02549170|541795380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
150179449|NCT02549170|541795376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
150179450|NCT02549170|541795377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
150179451|NCT02549170|541795378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
150179452|NCT02549170|541795379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
150179453|NCT02549170|541795380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
150179454|NCT02549170|541795376|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
150179455|NCT02549170|541795377|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
150179456|NCT02549170|541795378|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
150179457|NCT02549170|541795379|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
150179458|NCT02549170|541795380|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
150179459|NCT00111813|541795381|FG000|Overall Study|Adverse Event|1|||
150179460|NCT00111813|541795382|FG001|Overall Study|Adverse Event|2|||
150179461|NCT00111813|541795383|FG002|Overall Study|Adverse Event|4|||
150179462|NCT00111813|541795384|FG003|Overall Study|Adverse Event|2|||
150179463|NCT00111813|541795385|FG004|Overall Study|Adverse Event|2|||
150179464|NCT00111813|541795386|FG005|Overall Study|Adverse Event|2|||
150179465|NCT00111813|541795381|FG000|Overall Study|Progressive disease|2|||
150179466|NCT00111813|541795382|FG001|Overall Study|Progressive disease|1|||
150179467|NCT00111813|541795383|FG002|Overall Study|Progressive disease|5|||
150179468|NCT00111813|541795384|FG003|Overall Study|Progressive disease|3|||
150179469|NCT00111813|541795385|FG004|Overall Study|Progressive disease|4|||
150179470|NCT00111813|541795386|FG005|Overall Study|Progressive disease|3|||
150179471|NCT00111813|541795381|FG000|Overall Study|Lack of Efficacy|0|||
150179472|NCT00111813|541795382|FG001|Overall Study|Lack of Efficacy|0|||
150179473|NCT00111813|541795383|FG002|Overall Study|Lack of Efficacy|0|||
150179474|NCT00111813|541795384|FG003|Overall Study|Lack of Efficacy|0|||
150179475|NCT00111813|541795385|FG004|Overall Study|Lack of Efficacy|0|||
150179476|NCT00111813|541795386|FG005|Overall Study|Lack of Efficacy|1|||
150179477|NCT00111813|541795381|FG000|Overall Study|Other|0|||
150179478|NCT00111813|541795382|FG001|Overall Study|Other|0|||
150179479|NCT00111813|541795383|FG002|Overall Study|Other|1|||
150179480|NCT00111813|541795384|FG003|Overall Study|Other|0|||
149999305|NCT03352557|541130460|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999306|NCT03352557|541130461|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999307|NCT03352557|541130462|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999308|NCT03352557|541130463|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999309|NCT03352557|541130464|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
149999310|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Death|0|||
149999311|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Death|0|||
149999312|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Death|0|||
149999313|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Death|0|||
149999314|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Death|0|||
149999315|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Death|1|||
149999316|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Death|0|||
149999317|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Death|1|||
149999318|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Death|1|||
149999319|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Death|1|||
149999320|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999321|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999322|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999323|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999324|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999325|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
149999326|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999327|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999328|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999329|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
149999330|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999331|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999332|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999333|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999334|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999335|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999336|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999337|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999338|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
149999339|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
149999340|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
149999341|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
149999342|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
149999343|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
149999344|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
149999345|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
149999346|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
149999347|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
149999348|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
149999349|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
149999350|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999351|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999352|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999353|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999354|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999355|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
149999356|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
149999357|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
149999358|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
149999359|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
149999360|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999361|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999362|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999363|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999364|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999365|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999366|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999367|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999368|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
149999369|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
149999370|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
149999371|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
149999372|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
150179481|NCT00111813|541795385|FG004|Overall Study|Other|0|||
150179482|NCT00111813|541795386|FG005|Overall Study|Other|0|||
150179483|NCT03051165|541795387|FG000|Overall Study|Withdrawal by Subject|1|||
150179484|NCT03051165|541795387|FG000|Overall Study|Early termination of study|12|||
150179485|NCT00818246|541795388|FG000|Overall Study|Impossible to match pictures|5|||
150179486|NCT02121002|541795392|FG000|Overall Study|Physician Decision|2|||
150179487|NCT02121002|541795393|FG001|Overall Study|Physician Decision|0|||
150179488|NCT02121002|541795394|FG002|Overall Study|Physician Decision|0|||
150179489|NCT02121002|541795392|FG000|Overall Study|Withdrawal by Subject|3|||
150179490|NCT02121002|541795393|FG001|Overall Study|Withdrawal by Subject|1|||
150179491|NCT02121002|541795394|FG002|Overall Study|Withdrawal by Subject|4|||
150179492|NCT02121002|541795392|FG000|Overall Study|Protocol Violation|1|||
150179493|NCT02121002|541795393|FG001|Overall Study|Protocol Violation|2|||
150179494|NCT02121002|541795394|FG002|Overall Study|Protocol Violation|4|||
150179495|NCT02121002|541795392|FG000|Overall Study|Concomitant therapy|0|||
150179496|NCT02121002|541795393|FG001|Overall Study|Concomitant therapy|1|||
150179497|NCT02121002|541795394|FG002|Overall Study|Concomitant therapy|1|||
150179498|NCT02121002|541795392|FG000|Overall Study|Others|1|||
150179499|NCT02121002|541795393|FG001|Overall Study|Others|0|||
150179500|NCT02121002|541795394|FG002|Overall Study|Others|1|||
150179501|NCT01250769|541795395|FG000|Overall Study|Withdrawal by Subject|0|||
150179502|NCT01250769|541795396|FG001|Overall Study|Withdrawal by Subject|1|||
150179503|NCT01250769|541795397|FG002|Overall Study|Withdrawal by Subject|1|||
150179504|NCT01250769|541795398|FG003|Overall Study|Withdrawal by Subject|0|||
150179505|NCT01250769|541795395|FG000|Overall Study|Adverse Event|0|||
150179506|NCT01250769|541795396|FG001|Overall Study|Adverse Event|0|||
150179507|NCT01250769|541795397|FG002|Overall Study|Adverse Event|1|||
150179508|NCT01250769|541795398|FG003|Overall Study|Adverse Event|0|||
150179509|NCT00914589|541795399|FG000|Overall Study|Adverse Event|1|||
150179510|NCT00914589|541795400|FG001|Overall Study|Adverse Event|0|||
150179511|NCT00914589|541795401|FG002|Overall Study|Adverse Event|1|||
150179512|NCT00914589|541795399|FG000|Overall Study|Protocol Violation|8|||
150179513|NCT00914589|541795400|FG001|Overall Study|Protocol Violation|6|||
150179514|NCT00914589|541795401|FG002|Overall Study|Protocol Violation|3|||
150179515|NCT00914589|541795399|FG000|Overall Study|unclassified|16|||
149999373|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
149999374|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
149999375|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
149999376|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
149999377|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
149999378|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
149999379|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
149999380|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999381|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999382|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999383|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999384|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999385|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999386|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999387|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
149999388|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
149999389|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
150179516|NCT00914589|541795400|FG001|Overall Study|unclassified|9|||
150179517|NCT00914589|541795401|FG002|Overall Study|unclassified|7|||
150179518|NCT00914589|541795399|FG000|Overall Study|Death|0|||
150179519|NCT00914589|541795400|FG001|Overall Study|Death|1|||
150179520|NCT00914589|541795401|FG002|Overall Study|Death|1|||
150179521|NCT00174382|541795406|FG000|Overall Study|Death|2|||
150179522|NCT00174382|541795406|FG000|Overall Study|Adverse Event|19|||
150179523|NCT00174382|541795406|FG000|Overall Study|Withdrawal by Subject|6|||
149999390|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999391|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999392|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999393|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999394|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999395|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999396|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999397|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
149999398|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999399|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
149999400|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999401|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999402|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999403|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999404|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999405|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999406|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999407|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
149999408|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999409|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
149999410|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999411|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999412|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999413|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999414|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999415|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999416|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999417|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
149999418|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
149999419|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
149999420|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999421|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999422|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999423|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999424|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999425|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
149999426|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999427|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999428|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
149999429|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
149999430|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999431|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999432|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999433|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999434|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999435|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999436|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999437|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999438|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
149999439|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
149999440|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999441|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
150179524|NCT00174382|541795406|FG000|Overall Study|Protocol Violation|3|||
149999442|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999443|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999444|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999445|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
150054450|NCT04740905|541340295|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
150054451|NCT04740905|541340294|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
150054452|NCT04740905|541340295|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
150054453|NCT04740905|541340294|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
150054454|NCT04740905|541340295|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
150054455|NCT04740905|541340294|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
150054456|NCT04740905|541340295|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
150054457|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
150054458|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
150054459|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
150054460|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
150054461|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
150054462|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
150054463|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
150054464|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
150179525|NCT00174382|541795406|FG000|Overall Study|Arrived early for last visit in error|1|||
150179526|NCT00174382|541795406|FG000|Overall Study|Subject felt pill not effective enough|1|||
150179527|NCT00174382|541795406|FG000|Overall Study|Lost to Follow-up|1|||
149999446|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999447|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
149999448|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
149999449|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
149999450|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999451|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999452|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999453|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999454|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999455|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999456|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999457|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
149999458|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
149999459|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
149999460|NCT03352557|541130455|FG000|LTE Period: Week 80 to Week 173|Other|0|||
149999461|NCT03352557|541130456|FG001|LTE Period: Week 80 to Week 173|Other|0|||
149999462|NCT03352557|541130457|FG002|LTE Period: Week 80 to Week 173|Other|0|||
149999463|NCT03352557|541130458|FG003|LTE Period: Week 80 to Week 173|Other|0|||
149999464|NCT03352557|541130459|FG004|LTE Period: Week 80 to Week 173|Other|0|||
149999465|NCT03352557|541130460|FG005|LTE Period: Week 80 to Week 173|Other|0|||
149999466|NCT03352557|541130461|FG006|LTE Period: Week 80 to Week 173|Other|0|||
149999467|NCT03352557|541130462|FG007|LTE Period: Week 80 to Week 173|Other|1|||
149999468|NCT03352557|541130463|FG008|LTE Period: Week 80 to Week 173|Other|0|||
149999469|NCT03352557|541130464|FG009|LTE Period: Week 80 to Week 173|Other|0|||
149999470|NCT03242772|541130465|FG000|Overall Study|Lost to Follow-up|2|||
149999471|NCT03242772|541130466|FG001|Overall Study|Lost to Follow-up|0|||
149999472|NCT03242772|541130465|FG000|Overall Study|Physician Decision|0|||
149999473|NCT03242772|541130466|FG001|Overall Study|Physician Decision|1|||
149999474|NCT03242772|541130465|FG000|Overall Study|Withdrawal by Subject|1|||
149999475|NCT03242772|541130466|FG001|Overall Study|Withdrawal by Subject|0|||
149999476|NCT04677660|541130467|FG000|Overall Study|Lost to Follow-up|0|||
149999477|NCT04677660|541130468|FG001|Overall Study|Lost to Follow-up|2|||
149999478|NCT04677660|541130467|FG000|Overall Study|Withdrawal by Subject|0|||
149999479|NCT04677660|541130468|FG001|Overall Study|Withdrawal by Subject|1|||
149999480|NCT04677660|541130467|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
149999481|NCT04677660|541130468|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
149999482|NCT02437305|541130472|FG000|Overall Study|Lost to Follow-up|18|||
149999483|NCT02437305|541130473|FG001|Overall Study|Lost to Follow-up|12|||
149999484|NCT01560637|541130476|FG000|Overall Study|Adverse Event|63|||
149999485|NCT01560637|541130476|FG000|Overall Study|Death|69|||
149999486|NCT01560637|541130476|FG000|Overall Study|Lost to Follow-up|8|||
149999487|NCT01560637|541130476|FG000|Overall Study|Protocol Violation|8|||
149999488|NCT01560637|541130476|FG000|Overall Study|Withdrawal by Subject|24|||
149999489|NCT01560637|541130476|FG000|Overall Study|Progressive Disease|20|||
149999490|NCT01560637|541130476|FG000|Overall Study|Other Reason Not Specified|6|||
149999491|NCT01089023|541130479|FG000|Overall Study|Lost to Follow-up|3|||
150179528|NCT00807937|541795407|FG000|Overall Study|Adverse Event|12|||
149999492|NCT01089023|541130479|FG000|Overall Study|Adverse Event|1|||
150054465|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
150054466|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
149999493|NCT01089023|541130479|FG000|Overall Study|Withdrawal by Subject|1|||
149999494|NCT01089023|541130479|FG000|Overall Study|Protocol Violation|1|||
149999495|NCT01089023|541130479|FG000|Overall Study|Lack of Efficacy|1|||
149999496|NCT03220581|541130481|FG000|Overall Study|Withdrawal by Subject|0|||
149999497|NCT03220581|541130482|FG001|Overall Study|Withdrawal by Subject|1|||
149999498|NCT03220581|541130481|FG000|Overall Study|Lost to Follow-up|3|||
149999499|NCT03220581|541130482|FG001|Overall Study|Lost to Follow-up|6|||
149999500|NCT01185964|541130484|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
149999501|NCT01185964|541130485|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
149999502|NCT01185964|541130486|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
149999503|NCT01185964|541130487|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
149999504|NCT01185964|541130484|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
149999505|NCT01185964|541130485|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
149999506|NCT01185964|541130486|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
149999507|NCT01185964|541130487|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
149999508|NCT01185964|541130484|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
149999509|NCT01185964|541130485|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
149999510|NCT01185964|541130486|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
149999511|NCT01185964|541130487|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
149999512|NCT01185964|541130484|FG000|Phase 1b and Phase 2|Adverse Event|1|||
149999513|NCT01185964|541130485|FG001|Phase 1b and Phase 2|Adverse Event|0|||
149999514|NCT01185964|541130486|FG002|Phase 1b and Phase 2|Adverse Event|2|||
149999515|NCT01185964|541130487|FG003|Phase 1b and Phase 2|Adverse Event|0|||
149999516|NCT01185964|541130484|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
149999517|NCT01185964|541130485|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
149999518|NCT01185964|541130486|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
149999519|NCT01185964|541130487|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
149999520|NCT01185964|541130484|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
149999521|NCT01185964|541130485|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
149999522|NCT01185964|541130486|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
149999523|NCT01185964|541130487|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
149999524|NCT01185964|541130484|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
149999525|NCT01185964|541130485|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
149999526|NCT01185964|541130486|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
149999527|NCT01185964|541130487|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
149999528|NCT01185964|541130484|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
149999529|NCT01185964|541130485|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
149999530|NCT01185964|541130486|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
149999531|NCT01185964|541130487|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
149999532|NCT03883113|541130488|FG000|Overall Study|Physician Decision|4|||
149999533|NCT03883113|541130489|FG001|Overall Study|Physician Decision|2|||
149999534|NCT03883113|541130488|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
150054467|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
150054468|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
150054469|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
150054470|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
150054471|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
150054472|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
150054473|NCT04740905|541340294|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
150054474|NCT04740905|541340295|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
150054475|NCT00065429|541340301|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054476|NCT00065429|541340302|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054477|NCT00065429|541340303|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054478|NCT00065429|541340304|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054479|NCT00065429|541340305|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054480|NCT00065429|541340306|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
150054481|NCT00065429|541340307|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
150054482|NCT00065429|541340301|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
150054483|NCT00065429|541340302|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
150054484|NCT00065429|541340303|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
150054485|NCT00065429|541340304|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
149999535|NCT03883113|541130489|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
149999536|NCT03883113|541130488|FG000|Overall Study|Pregnancy|1|||
149999537|NCT03883113|541130489|FG001|Overall Study|Pregnancy|0|||
149999538|NCT03883113|541130488|FG000|Overall Study|Adverse Event|0|||
149999539|NCT03883113|541130489|FG001|Overall Study|Adverse Event|1|||
149999540|NCT03883113|541130488|FG000|Overall Study|Withdrawal by Subject|1|||
149999541|NCT03883113|541130489|FG001|Overall Study|Withdrawal by Subject|2|||
149999542|NCT03883113|541130488|FG000|Overall Study|Lost to Follow-up|1|||
149999543|NCT03883113|541130489|FG001|Overall Study|Lost to Follow-up|0|||
149999544|NCT04465877|541130490|FG000|Overall Study|Noncompliant with study requirements|0|||
149999545|NCT04465877|541130491|FG001|Overall Study|Noncompliant with study requirements|0|||
149999546|NCT04465877|541130492|FG002|Overall Study|Noncompliant with study requirements|1|||
149999547|NCT04465877|541130493|FG003|Overall Study|Noncompliant with study requirements|0|||
149999548|NCT03440918|541130499|FG000|Overall Study|Protocol Violation|0|||
149999549|NCT03440918|541130500|FG001|Overall Study|Protocol Violation|16|||
149999550|NCT04962230|541130512|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
149999551|NCT04962230|541130512|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
149999552|NCT01396265|541130513|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
149999553|NCT01598753|541130514|FG000|Overall Study|Adverse Event|1|||
149999554|NCT01598753|541130515|FG001|Overall Study|Adverse Event|9|||
149999555|NCT01598753|541130516|FG002|Overall Study|Adverse Event|1|||
149999556|NCT01598753|541130517|FG003|Overall Study|Adverse Event|7|||
150179529|NCT00807937|541795408|FG001|Overall Study|Adverse Event|12|||
150179530|NCT00807937|541795409|FG002|Overall Study|Adverse Event|5|||
149999557|NCT01598753|541130514|FG000|Overall Study|Lost to Follow-up|4|||
149999558|NCT01598753|541130515|FG001|Overall Study|Lost to Follow-up|3|||
149999559|NCT01598753|541130516|FG002|Overall Study|Lost to Follow-up|7|||
149999560|NCT01598753|541130517|FG003|Overall Study|Lost to Follow-up|5|||
149999561|NCT01598753|541130514|FG000|Overall Study|Physician Decision|0|||
149999562|NCT01598753|541130515|FG001|Overall Study|Physician Decision|1|||
149999563|NCT01598753|541130516|FG002|Overall Study|Physician Decision|0|||
149999564|NCT01598753|541130517|FG003|Overall Study|Physician Decision|2|||
149999565|NCT01598753|541130514|FG000|Overall Study|Withdrawal by Subject|7|||
149999566|NCT01598753|541130515|FG001|Overall Study|Withdrawal by Subject|2|||
149999567|NCT01598753|541130516|FG002|Overall Study|Withdrawal by Subject|0|||
149999568|NCT01598753|541130517|FG003|Overall Study|Withdrawal by Subject|1|||
149999569|NCT02275117|541130518|FG000|Overall Study|Adverse Event|0|||
149999570|NCT02275117|541130519|FG001|Overall Study|Adverse Event|0|||
149999571|NCT02275117|541130520|FG002|Overall Study|Adverse Event|0|||
149999572|NCT02275117|541130521|FG003|Overall Study|Adverse Event|0|||
149999573|NCT02275117|541130522|FG004|Overall Study|Adverse Event|1|||
149999574|NCT02275117|541130518|FG000|Overall Study|Lack of Efficacy|6|||
149999575|NCT02275117|541130519|FG001|Overall Study|Lack of Efficacy|7|||
149999576|NCT02275117|541130520|FG002|Overall Study|Lack of Efficacy|5|||
149999577|NCT02275117|541130521|FG003|Overall Study|Lack of Efficacy|2|||
149999578|NCT02275117|541130522|FG004|Overall Study|Lack of Efficacy|10|||
149999579|NCT02275117|541130518|FG000|Overall Study|Lost to Follow-up|11|||
149999580|NCT02275117|541130519|FG001|Overall Study|Lost to Follow-up|16|||
149999581|NCT02275117|541130520|FG002|Overall Study|Lost to Follow-up|15|||
149999582|NCT02275117|541130521|FG003|Overall Study|Lost to Follow-up|16|||
149999583|NCT02275117|541130522|FG004|Overall Study|Lost to Follow-up|8|||
149999584|NCT02275117|541130518|FG000|Overall Study|Physician Decision|0|||
149999585|NCT02275117|541130519|FG001|Overall Study|Physician Decision|1|||
149999586|NCT02275117|541130520|FG002|Overall Study|Physician Decision|1|||
149999587|NCT02275117|541130521|FG003|Overall Study|Physician Decision|0|||
149999588|NCT02275117|541130522|FG004|Overall Study|Physician Decision|1|||
149999589|NCT02275117|541130518|FG000|Overall Study|Protocol Violation|1|||
150179531|NCT00807937|541795410|FG003|Overall Study|Adverse Event|4|||
150179532|NCT00807937|541795407|FG000|Overall Study|Protocol Violation|4|||
150179533|NCT00807937|541795408|FG001|Overall Study|Protocol Violation|5|||
150179534|NCT00807937|541795409|FG002|Overall Study|Protocol Violation|3|||
150179535|NCT00807937|541795410|FG003|Overall Study|Protocol Violation|3|||
149999590|NCT02275117|541130519|FG001|Overall Study|Protocol Violation|0|||
149999591|NCT02275117|541130520|FG002|Overall Study|Protocol Violation|1|||
150179536|NCT00807937|541795407|FG000|Overall Study|Withdrawal by Subject|5|||
150179537|NCT00807937|541795408|FG001|Overall Study|Withdrawal by Subject|4|||
150179538|NCT00807937|541795409|FG002|Overall Study|Withdrawal by Subject|1|||
149999592|NCT02275117|541130521|FG003|Overall Study|Protocol Violation|1|||
149999593|NCT02275117|541130522|FG004|Overall Study|Protocol Violation|0|||
149999594|NCT02275117|541130518|FG000|Overall Study|Withdrawal by Subject|6|||
149999595|NCT02275117|541130519|FG001|Overall Study|Withdrawal by Subject|4|||
149999596|NCT02275117|541130520|FG002|Overall Study|Withdrawal by Subject|7|||
149999597|NCT02275117|541130521|FG003|Overall Study|Withdrawal by Subject|3|||
149999598|NCT02275117|541130522|FG004|Overall Study|Withdrawal by Subject|3|||
149999599|NCT02275117|541130518|FG000|Overall Study|Terminated by Sponsor|4|||
149999600|NCT02275117|541130519|FG001|Overall Study|Terminated by Sponsor|4|||
150179539|NCT00807937|541795410|FG003|Overall Study|Withdrawal by Subject|4|||
149999601|NCT02275117|541130520|FG002|Overall Study|Terminated by Sponsor|4|||
149999602|NCT02275117|541130521|FG003|Overall Study|Terminated by Sponsor|6|||
149999603|NCT02275117|541130522|FG004|Overall Study|Terminated by Sponsor|4|||
149999604|NCT02275117|541130518|FG000|Overall Study|Worsening of Study Indication|0|||
149999605|NCT02275117|541130519|FG001|Overall Study|Worsening of Study Indication|1|||
149999606|NCT02275117|541130520|FG002|Overall Study|Worsening of Study Indication|2|||
149999607|NCT02275117|541130521|FG003|Overall Study|Worsening of Study Indication|0|||
149999608|NCT02275117|541130522|FG004|Overall Study|Worsening of Study Indication|0|||
149999609|NCT02275117|541130518|FG000|Overall Study|Study Burden|5|||
149999610|NCT02275117|541130519|FG001|Overall Study|Study Burden|4|||
149999611|NCT02275117|541130520|FG002|Overall Study|Study Burden|7|||
149999612|NCT02275117|541130521|FG003|Overall Study|Study Burden|5|||
149999613|NCT02275117|541130522|FG004|Overall Study|Study Burden|7|||
149999614|NCT02275117|541130518|FG000|Overall Study|Other|1|||
149999615|NCT02275117|541130519|FG001|Overall Study|Other|0|||
149999616|NCT02275117|541130520|FG002|Overall Study|Other|0|||
149999617|NCT02275117|541130521|FG003|Overall Study|Other|0|||
149999618|NCT02275117|541130522|FG004|Overall Study|Other|2|||
149999619|NCT02014480|541130525|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
149999620|NCT02014480|541130526|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
149999621|NCT02014480|541130527|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
149999622|NCT02014480|541130528|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
149999623|NCT02014480|541130529|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
149999624|NCT02014480|541130530|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
149999625|NCT02014480|541130525|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149999626|NCT02014480|541130526|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149999627|NCT02014480|541130527|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149999628|NCT02014480|541130528|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
149999629|NCT02014480|541130529|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149999630|NCT02014480|541130530|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149999631|NCT02014480|541130525|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149999632|NCT02014480|541130526|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149999633|NCT02014480|541130527|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
149999634|NCT02014480|541130528|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149999635|NCT02014480|541130529|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149999636|NCT02014480|541130530|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
149999637|NCT02014480|541130525|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149999638|NCT02014480|541130526|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149999639|NCT02014480|541130527|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
149999640|NCT02014480|541130528|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149999641|NCT02014480|541130529|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149999642|NCT02014480|541130530|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149999643|NCT02014480|541130525|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149999644|NCT02014480|541130526|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
149999645|NCT02014480|541130527|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149999646|NCT02014480|541130528|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149999647|NCT02014480|541130529|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149999648|NCT02014480|541130530|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
149999649|NCT02014480|541130525|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
149999650|NCT02014480|541130526|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
149999651|NCT02014480|541130527|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
149999652|NCT02014480|541130528|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
149999653|NCT02014480|541130529|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
149999654|NCT02014480|541130530|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
149999655|NCT02014480|541130525|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149999656|NCT02014480|541130526|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149999657|NCT02014480|541130527|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149999658|NCT02014480|541130528|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149999659|NCT02014480|541130529|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149999660|NCT02014480|541130530|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
149999661|NCT01338610|541130531|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
149999662|NCT01338610|541130532|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
149999663|NCT01338610|541130533|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
149999664|NCT01338610|541130531|FG000|Overall Study|Protocol Violation|1|||
149999665|NCT01338610|541130532|FG001|Overall Study|Protocol Violation|0|||
150179540|NCT00807937|541795407|FG000|Overall Study|Lost to Follow-up|4|||
149999666|NCT01338610|541130533|FG002|Overall Study|Protocol Violation|1|||
149999667|NCT01338610|541130531|FG000|Overall Study|Adverse Event|3|||
149999668|NCT01338610|541130532|FG001|Overall Study|Adverse Event|0|||
149999669|NCT01338610|541130533|FG002|Overall Study|Adverse Event|0|||
149999670|NCT01865812|541130534|FG000|Primary Treatment Phase|Adverse Event|2|||
150179541|NCT00807937|541795408|FG001|Overall Study|Lost to Follow-up|0|||
149999671|NCT01865812|541130535|FG001|Primary Treatment Phase|Adverse Event|0|||
149999672|NCT01865812|541130534|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
149999673|NCT01865812|541130535|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
149999674|NCT01865812|541130534|FG000|Long-term Safety Extension Phase|Pruritus|0|||
149999675|NCT01865812|541130535|FG001|Long-term Safety Extension Phase|Pruritus|3|||
149999676|NCT01865812|541130534|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
149999677|NCT01865812|541130535|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
149999678|NCT01865812|541130534|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
149999679|NCT01865812|541130535|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
149999680|NCT02692040|541130536|FG000|Overall Study|Protocol Violation|0|||
149999681|NCT02692040|541130537|FG001|Overall Study|Protocol Violation|0|||
149999682|NCT02692040|541130538|FG002|Overall Study|Protocol Violation|0|||
149999683|NCT02692040|541130539|FG003|Overall Study|Protocol Violation|0|||
149999684|NCT02692040|541130540|FG004|Overall Study|Protocol Violation|0|||
149999685|NCT02692040|541130541|FG005|Overall Study|Protocol Violation|0|||
149999686|NCT02692040|541130542|FG006|Overall Study|Protocol Violation|0|||
149999687|NCT02692040|541130543|FG007|Overall Study|Protocol Violation|0|||
149999688|NCT02692040|541130544|FG008|Overall Study|Protocol Violation|0|||
149999689|NCT02692040|541130545|FG009|Overall Study|Protocol Violation|0|||
149999690|NCT02692040|541130546|FG010|Overall Study|Protocol Violation|0|||
149999691|NCT02692040|541130547|FG011|Overall Study|Protocol Violation|0|||
149999692|NCT02692040|541130548|FG012|Overall Study|Protocol Violation|1|||
149999693|NCT02692040|541130549|FG013|Overall Study|Protocol Violation|0|||
149999694|NCT02692040|541130550|FG014|Overall Study|Protocol Violation|0|||
149999695|NCT02692040|541130551|FG015|Overall Study|Protocol Violation|0|||
149999696|NCT02692040|541130552|FG016|Overall Study|Protocol Violation|0|||
149999697|NCT02692040|541130536|FG000|Overall Study|Adverse Event|0|||
149999698|NCT02692040|541130537|FG001|Overall Study|Adverse Event|0|||
149999699|NCT02692040|541130538|FG002|Overall Study|Adverse Event|0|||
149999700|NCT02692040|541130539|FG003|Overall Study|Adverse Event|0|||
149999701|NCT02692040|541130540|FG004|Overall Study|Adverse Event|0|||
149999702|NCT02692040|541130541|FG005|Overall Study|Adverse Event|0|||
149999703|NCT02692040|541130542|FG006|Overall Study|Adverse Event|0|||
149999704|NCT02692040|541130543|FG007|Overall Study|Adverse Event|0|||
149999705|NCT02692040|541130544|FG008|Overall Study|Adverse Event|0|||
149999706|NCT02692040|541130545|FG009|Overall Study|Adverse Event|0|||
149999707|NCT02692040|541130546|FG010|Overall Study|Adverse Event|0|||
149999708|NCT02692040|541130547|FG011|Overall Study|Adverse Event|0|||
149999709|NCT02692040|541130548|FG012|Overall Study|Adverse Event|0|||
149999710|NCT02692040|541130549|FG013|Overall Study|Adverse Event|3|||
149999711|NCT02692040|541130550|FG014|Overall Study|Adverse Event|1|||
149999712|NCT02692040|541130551|FG015|Overall Study|Adverse Event|1|||
149999713|NCT02692040|541130552|FG016|Overall Study|Adverse Event|0|||
149999714|NCT00953680|541130556|FG000|Period 1|Withdrawal by Subject|0|||
149999715|NCT00953680|541130557|FG001|Period 1|Withdrawal by Subject|1|||
149999716|NCT04030247|541132477|FG000|Overall Study|Withdrawal by Subject|4|||
149999717|NCT04030247|541132477|FG000|Overall Study|Lost to Follow-up|13|||
149999718|NCT03559699|541132478|FG000|Overall Study|Withdrawal by Subject|6|||
149999719|NCT03559699|541132478|FG000|Overall Study|Lost to Follow-up|1|||
149999720|NCT01930890|541132482|FG000|Overall Study|Study Termination|14|||
149999721|NCT01930890|541132483|FG001|Overall Study|Study Termination|28|||
149999722|NCT01930890|541132484|FG002|Overall Study|Study Termination|13|||
149999723|NCT01930890|541132485|FG003|Overall Study|Study Termination|25|||
149999724|NCT01930890|541132482|FG000|Overall Study|Death|0|||
149999725|NCT01930890|541132483|FG001|Overall Study|Death|0|||
149999726|NCT01930890|541132484|FG002|Overall Study|Death|0|||
149999727|NCT01930890|541132485|FG003|Overall Study|Death|1|||
149999728|NCT01930890|541132482|FG000|Overall Study|Investigator Decision|0|||
149999729|NCT01930890|541132483|FG001|Overall Study|Investigator Decision|1|||
149999730|NCT01930890|541132484|FG002|Overall Study|Investigator Decision|0|||
149999731|NCT01930890|541132485|FG003|Overall Study|Investigator Decision|0|||
149999732|NCT01930890|541132482|FG000|Overall Study|Consent Withdrawn|0|||
149999733|NCT01930890|541132483|FG001|Overall Study|Consent Withdrawn|3|||
149999734|NCT01930890|541132484|FG002|Overall Study|Consent Withdrawn|0|||
149999735|NCT01930890|541132485|FG003|Overall Study|Consent Withdrawn|1|||
149999736|NCT01930890|541132482|FG000|Overall Study|Adverse Event|0|||
149999737|NCT01930890|541132483|FG001|Overall Study|Adverse Event|1|||
149999738|NCT01930890|541132484|FG002|Overall Study|Adverse Event|0|||
149999739|NCT01930890|541132485|FG003|Overall Study|Adverse Event|0|||
149999740|NCT03710876|541132486|FG000|Overall Study|Death|0|||
149999741|NCT03710876|541132487|FG001|Overall Study|Death|2|||
149999742|NCT03710876|541132486|FG000|Overall Study|Withdrawal by Subject|0|||
149999743|NCT03710876|541132487|FG001|Overall Study|Withdrawal by Subject|2|||
149999744|NCT02534935|541132488|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
149999745|NCT02534935|541132489|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
149999746|NCT02534935|541132490|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
149999747|NCT02534935|541132488|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
149999748|NCT02534935|541132489|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
149999749|NCT02534935|541132490|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
149999750|NCT02534935|541132488|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
149999751|NCT02534935|541132489|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
149999752|NCT02534935|541132490|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
149999753|NCT02534935|541132488|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
149999754|NCT02534935|541132489|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
149999755|NCT02534935|541132490|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
149999756|NCT02534935|541132488|FG000|Stage 1: 24 Months|Adverse Event|0|||
149999757|NCT02534935|541132489|FG001|Stage 1: 24 Months|Adverse Event|2|||
149999758|NCT02534935|541132490|FG002|Stage 1: 24 Months|Adverse Event|0|||
149999759|NCT02534935|541132488|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
149999760|NCT02534935|541132489|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
149999761|NCT02534935|541132490|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
149999762|NCT02534935|541132488|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
149999763|NCT02534935|541132489|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
149999764|NCT02534935|541132490|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
149999765|NCT04065074|541132497|FG000|Overall Study|Adverse Event|1|||
149999766|NCT04065074|541132497|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
149999767|NCT01218100|541132498|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
149999768|NCT01218100|541132499|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
149999769|NCT01218100|541132500|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
149999770|NCT01218100|541132501|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
149999771|NCT01218100|541132498|FG000|Overall Study|Adverse Event|4|||
149999772|NCT01218100|541132499|FG001|Overall Study|Adverse Event|6|||
149999773|NCT01218100|541132500|FG002|Overall Study|Adverse Event|6|||
149999774|NCT01218100|541132501|FG003|Overall Study|Adverse Event|7|||
149999775|NCT01218100|541132498|FG000|Overall Study|Lack of Efficacy|9|||
149999776|NCT01218100|541132499|FG001|Overall Study|Lack of Efficacy|6|||
149999777|NCT01218100|541132500|FG002|Overall Study|Lack of Efficacy|5|||
149999778|NCT01218100|541132501|FG003|Overall Study|Lack of Efficacy|12|||
149999779|NCT01218100|541132498|FG000|Overall Study|Protocol Violation|0|||
149999780|NCT01218100|541132499|FG001|Overall Study|Protocol Violation|0|||
149999781|NCT01218100|541132500|FG002|Overall Study|Protocol Violation|1|||
149999782|NCT01218100|541132501|FG003|Overall Study|Protocol Violation|1|||
149999783|NCT01218100|541132498|FG000|Overall Study|Withdrawal by Subject|5|||
149999784|NCT01218100|541132499|FG001|Overall Study|Withdrawal by Subject|2|||
149999785|NCT01218100|541132500|FG002|Overall Study|Withdrawal by Subject|6|||
149999786|NCT01218100|541132501|FG003|Overall Study|Withdrawal by Subject|7|||
149999787|NCT01218100|541132498|FG000|Overall Study|Lost to Follow-up|3|||
149999788|NCT01218100|541132499|FG001|Overall Study|Lost to Follow-up|8|||
149999789|NCT01218100|541132500|FG002|Overall Study|Lost to Follow-up|2|||
149999790|NCT01218100|541132501|FG003|Overall Study|Lost to Follow-up|1|||
149999791|NCT01218100|541132498|FG000|Overall Study|Other Reason|2|||
149999792|NCT01218100|541132499|FG001|Overall Study|Other Reason|2|||
149999793|NCT01218100|541132500|FG002|Overall Study|Other Reason|6|||
149999794|NCT01218100|541132501|FG003|Overall Study|Other Reason|4|||
149999795|NCT01852825|541132504|FG000|Overall Study|Withdrawal by Subject|2|||
149999796|NCT01852825|541132505|FG001|Overall Study|Withdrawal by Subject|0|||
149999797|NCT01852825|541132506|FG002|Overall Study|Withdrawal by Subject|0|||
149999798|NCT02446418|541132510|FG000|Overall Study|Adverse Event|4|||
149999799|NCT02446418|541132511|FG001|Overall Study|Adverse Event|8|||
149999800|NCT02446418|541132510|FG000|Overall Study|Physician Decision|5|||
149999801|NCT02446418|541132511|FG001|Overall Study|Physician Decision|1|||
149999802|NCT02446418|541132510|FG000|Overall Study|Withdrawal by Subject|3|||
149999803|NCT02446418|541132511|FG001|Overall Study|Withdrawal by Subject|3|||
149999804|NCT02446418|541132510|FG000|Overall Study|Lost to Follow-up|2|||
149999805|NCT02446418|541132511|FG001|Overall Study|Lost to Follow-up|2|||
149999806|NCT02446418|541132510|FG000|Overall Study|Protocol Violation|1|||
149999807|NCT02446418|541132511|FG001|Overall Study|Protocol Violation|2|||
149999808|NCT02446418|541132510|FG000|Overall Study|Lack of Efficacy|2|||
149999809|NCT02446418|541132511|FG001|Overall Study|Lack of Efficacy|0|||
149999810|NCT02446418|541132510|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
149999811|NCT02446418|541132511|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
149999812|NCT03421743|541132516|FG000|Overall Study|Lack of Efficacy|1|||
149999813|NCT03421743|541132517|FG001|Overall Study|Lack of Efficacy|0|||
149999814|NCT03421743|541132516|FG000|Overall Study|Adverse Event|2|||
149999815|NCT03421743|541132517|FG001|Overall Study|Adverse Event|1|||
149999816|NCT03421743|541132516|FG000|Overall Study|Withdrawal by Subject|0|||
149999817|NCT03421743|541132517|FG001|Overall Study|Withdrawal by Subject|1|||
149999818|NCT00435162|541132518|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
149999819|NCT00435162|541132519|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
149999820|NCT00435162|541132520|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
149999821|NCT00435162|541132521|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
149999822|NCT00435162|541132522|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
149999823|NCT00435162|541132523|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
149999824|NCT01819129|541132524|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
149999825|NCT01819129|541132525|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
149999826|NCT01819129|541132524|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
149999827|NCT01819129|541132525|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
149999828|NCT01819129|541132524|FG000|Overall Study|Other, Subject moved out of the country|0|||
149999829|NCT01819129|541132525|FG001|Overall Study|Other, Subject moved out of the country|1|||
149999830|NCT01819129|541132524|FG000|Overall Study|Withdrawal by Subject|15|||
149999831|NCT01819129|541132525|FG001|Overall Study|Withdrawal by Subject|15|||
149999832|NCT01819129|541132524|FG000|Overall Study|Lost to Follow-up|5|||
149999833|NCT01819129|541132525|FG001|Overall Study|Lost to Follow-up|2|||
149999834|NCT01819129|541132524|FG000|Overall Study|Lack of Efficacy|0|||
149999835|NCT01819129|541132525|FG001|Overall Study|Lack of Efficacy|1|||
149999836|NCT01819129|541132524|FG000|Overall Study|Adverse Event|1|||
149999837|NCT01819129|541132525|FG001|Overall Study|Adverse Event|4|||
149999838|NCT01819129|541132524|FG000|Overall Study|Death|1|||
149999839|NCT01819129|541132525|FG001|Overall Study|Death|1|||
149999840|NCT01819129|541132524|FG000|Overall Study|Withdrawal Criteria|20|||
149999841|NCT01819129|541132525|FG001|Overall Study|Withdrawal Criteria|15|||
149999842|NCT00054691|541132531|FG000|Overall Study|Unmeasurable Disease|2|||
149999843|NCT00054691|541132531|FG000|Overall Study|Noncompliant|1|||
149999844|NCT02836873|541132538|FG000|Overall Study|Protocol Violation|0|||
149999845|NCT02836873|541132539|FG001|Overall Study|Protocol Violation|1|||
149999846|NCT02836873|541132538|FG000|Overall Study|Adverse Event|1|||
149999847|NCT02836873|541132539|FG001|Overall Study|Adverse Event|4|||
149999848|NCT02836873|541132538|FG000|Overall Study|Withdrawal by Subject|2|||
149999849|NCT02836873|541132539|FG001|Overall Study|Withdrawal by Subject|2|||
149999850|NCT02836873|541132538|FG000|Overall Study|Lost to Follow-up|1|||
149999851|NCT02836873|541132539|FG001|Overall Study|Lost to Follow-up|3|||
149999852|NCT02836873|541132538|FG000|Overall Study|Physician Decision|0|||
149999853|NCT02836873|541132539|FG001|Overall Study|Physician Decision|1|||
149999854|NCT02836873|541132538|FG000|Overall Study|Other|1|||
149999855|NCT02836873|541132539|FG001|Overall Study|Other|0|||
149999856|NCT00694096|541132540|FG000|Overall Study|Withdrawal by Subject|5|||
149999857|NCT02914548|541132550|FG000|Overall Study|Adverse Event|15|||
149999858|NCT02914548|541132551|FG001|Overall Study|Adverse Event|7|||
149999859|NCT02914548|541132552|FG002|Overall Study|Adverse Event|15|||
149999860|NCT02914548|541132550|FG000|Overall Study|Physician Decision|2|||
149999861|NCT02914548|541132551|FG001|Overall Study|Physician Decision|2|||
149999862|NCT02914548|541132552|FG002|Overall Study|Physician Decision|0|||
149999863|NCT02914548|541132550|FG000|Overall Study|Protocol Violation|1|||
149999864|NCT02914548|541132551|FG001|Overall Study|Protocol Violation|0|||
149999865|NCT02914548|541132552|FG002|Overall Study|Protocol Violation|0|||
149999866|NCT02914548|541132550|FG000|Overall Study|Withdrawal by Subject|3|||
149999867|NCT02914548|541132551|FG001|Overall Study|Withdrawal by Subject|4|||
149999868|NCT02914548|541132552|FG002|Overall Study|Withdrawal by Subject|4|||
149999869|NCT02914548|541132550|FG000|Overall Study|>40% of body surface area|0|||
149999870|NCT02914548|541132551|FG001|Overall Study|>40% of body surface area|1|||
149999871|NCT02914548|541132552|FG002|Overall Study|>40% of body surface area|1|||
149999872|NCT00977938|541132558|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
149999873|NCT00977938|541132559|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
149999874|NCT00977938|541132560|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
149999875|NCT00977938|541132561|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
149999876|NCT00977938|541132558|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
149999877|NCT00977938|541132559|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
149999878|NCT00977938|541132560|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
149999879|NCT00977938|541132561|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
149999880|NCT00977938|541132558|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
150054486|NCT00065429|541340305|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
150054487|NCT00065429|541340306|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
150179542|NCT00807937|541795409|FG002|Overall Study|Lost to Follow-up|2|||
149999881|NCT00977938|541132559|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
149999882|NCT00977938|541132560|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
149999883|NCT00977938|541132561|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
149999884|NCT00977938|541132558|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
149999885|NCT00977938|541132559|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
149999886|NCT00977938|541132560|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
149999887|NCT00977938|541132561|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
149999888|NCT00977938|541132558|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
149999889|NCT00977938|541132559|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
149999890|NCT00977938|541132560|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
149999891|NCT00977938|541132561|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
149999892|NCT00977938|541132558|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
149999893|NCT00977938|541132559|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
149999894|NCT00977938|541132560|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
149999895|NCT00977938|541132561|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
149999896|NCT02142283|541132564|FG000|Overall Study|Death|20|||
149999897|NCT02142283|541132565|FG001|Overall Study|Death|18|||
149999898|NCT02142283|541132564|FG000|Overall Study|Withdrawal by Subject|1|||
149999899|NCT02142283|541132565|FG001|Overall Study|Withdrawal by Subject|3|||
149999900|NCT00747344|541132568|FG000|Controlled Period|Adverse Event|3|||
149999901|NCT00747344|541132569|FG001|Controlled Period|Adverse Event|0|||
149999902|NCT00747344|541132570|FG002|Controlled Period|Adverse Event|0|||
149999903|NCT00747344|541132571|FG003|Controlled Period|Adverse Event|0|||
149999904|NCT00747344|541132568|FG000|Controlled Period|Lack of Efficacy|2|||
149999905|NCT00747344|541132569|FG001|Controlled Period|Lack of Efficacy|1|||
149999906|NCT00747344|541132570|FG002|Controlled Period|Lack of Efficacy|0|||
149999907|NCT00747344|541132571|FG003|Controlled Period|Lack of Efficacy|0|||
149999908|NCT00747344|541132568|FG000|Controlled Period|Other|0|||
149999909|NCT00747344|541132569|FG001|Controlled Period|Other|3|||
149999910|NCT00747344|541132570|FG002|Controlled Period|Other|0|||
149999911|NCT00747344|541132571|FG003|Controlled Period|Other|0|||
149999912|NCT00747344|541132568|FG000|After Controlled Period|Adverse Event|0|||
149999913|NCT00747344|541132569|FG001|After Controlled Period|Adverse Event|0|||
149999914|NCT00747344|541132570|FG002|After Controlled Period|Adverse Event|0|||
149999915|NCT00747344|541132571|FG003|After Controlled Period|Adverse Event|1|||
149999916|NCT02460783|541132572|FG000|Overall Study|Withdrawal by Subject|1|||
149999917|NCT02460783|541132573|FG001|Overall Study|Withdrawal by Subject|3|||
149999918|NCT02460783|541132572|FG000|Overall Study|Lost to Follow-up|1|||
149999919|NCT02460783|541132573|FG001|Overall Study|Lost to Follow-up|1|||
149999920|NCT01484834|541132574|FG000|Overall Study|Lost to Follow-up|5|||
149999921|NCT01484834|541132575|FG001|Overall Study|Lost to Follow-up|8|||
149999922|NCT01484834|541132576|FG002|Overall Study|Lost to Follow-up|1|||
149999923|NCT01484834|541132577|FG003|Overall Study|Lost to Follow-up|4|||
149999924|NCT01371643|541132582|FG000|Overall Study|Withdrawal by Subject|3|||
149999925|NCT01371643|541132583|FG001|Overall Study|Withdrawal by Subject|0|||
149999926|NCT02214225|541132588|FG000|Overall Study|Lost to Follow-up|46|||
149999927|NCT02214225|541132589|FG001|Overall Study|Lost to Follow-up|18|||
149999928|NCT02214225|541132590|FG002|Overall Study|Lost to Follow-up|18|||
149999929|NCT02214225|541132588|FG000|Overall Study|Withdrawal by Subject|2|||
149999930|NCT02214225|541132589|FG001|Overall Study|Withdrawal by Subject|0|||
149999931|NCT02214225|541132590|FG002|Overall Study|Withdrawal by Subject|2|||
149999932|NCT02214225|541132588|FG000|Overall Study|Death|5|||
149999933|NCT02214225|541132589|FG001|Overall Study|Death|0|||
149999934|NCT02214225|541132590|FG002|Overall Study|Death|1|||
149999935|NCT02214225|541132588|FG000|Overall Study|randomized in error, not vaccinated|2|||
149999936|NCT02214225|541132589|FG001|Overall Study|randomized in error, not vaccinated|1|||
149999937|NCT02214225|541132590|FG002|Overall Study|randomized in error, not vaccinated|1|||
149999938|NCT03987932|541132592|FG000|Overall Study|Lost to Follow-up|2|||
149999939|NCT03987932|541132593|FG001|Overall Study|Lost to Follow-up|1|||
149999940|NCT03987932|541132594|FG002|Overall Study|Lost to Follow-up|1|||
149999941|NCT03987932|541132592|FG000|Overall Study|Non-study related elective surgery|0|||
149999942|NCT03987932|541132593|FG001|Overall Study|Non-study related elective surgery|0|||
149999943|NCT03987932|541132594|FG002|Overall Study|Non-study related elective surgery|1|||
149999944|NCT01605227|541132598|FG000|Overall Study|Did not receive study treatment|2|||
149999945|NCT01605227|541132599|FG001|Overall Study|Did not receive study treatment|3|||
149999946|NCT01605227|541132598|FG000|Overall Study|Adverse Event|228|||
149999947|NCT01605227|541132599|FG001|Overall Study|Adverse Event|42|||
149999948|NCT01605227|541132598|FG000|Overall Study|Progressive Disease|132|||
149999949|NCT01605227|541132599|FG001|Overall Study|Progressive Disease|128|||
149999950|NCT01605227|541132598|FG000|Overall Study|Clinical Deterioration|227|||
149999951|NCT01605227|541132599|FG001|Overall Study|Clinical Deterioration|133|||
149999952|NCT01605227|541132598|FG000|Overall Study|Lost to Follow-up|1|||
149999953|NCT01605227|541132599|FG001|Overall Study|Lost to Follow-up|0|||
149999954|NCT01605227|541132598|FG000|Overall Study|Protocol Violation|1|||
149999955|NCT01605227|541132599|FG001|Overall Study|Protocol Violation|0|||
149999956|NCT01605227|541132598|FG000|Overall Study|Physician Decision|9|||
149999957|NCT01605227|541132599|FG001|Overall Study|Physician Decision|7|||
149999958|NCT01605227|541132598|FG000|Overall Study|Withdrawal by Subject|18|||
149999959|NCT01605227|541132599|FG001|Overall Study|Withdrawal by Subject|14|||
149999960|NCT01605227|541132598|FG000|Overall Study|Sponsor Decision|2|||
149999961|NCT01605227|541132599|FG001|Overall Study|Sponsor Decision|0|||
149999962|NCT01605227|541132598|FG000|Overall Study|Started New Therapy|1|||
149999963|NCT01605227|541132599|FG001|Overall Study|Started New Therapy|0|||
149999964|NCT01605227|541132598|FG000|Overall Study|Subject Decision|0|||
149999965|NCT01605227|541132599|FG001|Overall Study|Subject Decision|1|||
149999966|NCT01605227|541132598|FG000|Overall Study|Dose Held >6 weeks|0|||
149999967|NCT01605227|541132599|FG001|Overall Study|Dose Held >6 weeks|1|||
149999968|NCT00624819|541132601|FG000|Follow-up Period: Year 4|Parents decision|0|||
149999969|NCT00624819|541132602|FG001|Follow-up Period: Year 4|Parents decision|0|||
149999970|NCT00624819|541132603|FG002|Follow-up Period: Year 4|Parents decision|1|||
149999971|NCT00624819|541132604|FG003|Follow-up Period: Year 4|Parents decision|0|||
149999972|NCT00624819|541132601|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
149999973|NCT00624819|541132602|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
150179543|NCT00807937|541795410|FG003|Overall Study|Lost to Follow-up|1|||
150179544|NCT00807937|541795407|FG000|Overall Study|Lack of Efficacy|0|||
150179545|NCT00807937|541795408|FG001|Overall Study|Lack of Efficacy|0|||
150179546|NCT00807937|541795409|FG002|Overall Study|Lack of Efficacy|1|||
150179547|NCT00807937|541795410|FG003|Overall Study|Lack of Efficacy|2|||
149999974|NCT00624819|541132603|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
149999975|NCT00624819|541132604|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
149999976|NCT02847858|541132605|FG000|Overall Study|Lost to Follow-up|401|||
149999977|NCT02847858|541132606|FG001|Overall Study|Lost to Follow-up|269|||
149999978|NCT02185014|541132609|FG000|Overall Study|Adverse Event|18|||
149999979|NCT02185014|541132609|FG000|Overall Study|Withdrew Consent|8|||
149999980|NCT02185014|541132609|FG000|Overall Study|Lost to Follow-up|4|||
149999981|NCT02185014|541132609|FG000|Overall Study|Lack of Efficacy|14|||
149999982|NCT02185014|541132609|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
149999983|NCT02185014|541132609|FG000|Overall Study|Subject Noncompliance|1|||
149999984|NCT02185014|541132609|FG000|Overall Study|Other|4|||
149999985|NCT03093974|541132610|FG000|Overall Study|Withdrawal by Subject|32|||
149999986|NCT03093974|541132611|FG001|Overall Study|Withdrawal by Subject|27|||
150179548|NCT00807937|541795407|FG000|Overall Study|Intake of prohibited medicine|0|||
150179549|NCT00807937|541795408|FG001|Overall Study|Intake of prohibited medicine|0|||
149999987|NCT03093974|541132610|FG000|Overall Study|Adverse Event|17|||
149999988|NCT03093974|541132611|FG001|Overall Study|Adverse Event|24|||
149999989|NCT03093974|541132610|FG000|Overall Study|Death|0|||
149999990|NCT03093974|541132611|FG001|Overall Study|Death|1|||
150179550|NCT00807937|541795409|FG002|Overall Study|Intake of prohibited medicine|2|||
149999991|NCT03093974|541132610|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149999992|NCT03093974|541132611|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149999993|NCT03093974|541132610|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
149999994|NCT03093974|541132611|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
149999995|NCT03093974|541132610|FG000|Overall Study|Lost to Follow-up|0|||
149999996|NCT03093974|541132611|FG001|Overall Study|Lost to Follow-up|1|||
149999997|NCT03093974|541132610|FG000|Overall Study|Other|1|||
149999998|NCT03093974|541132611|FG001|Overall Study|Other|2|||
149999999|NCT02141490|541132612|FG000|Overall Study|Screening failures|4|||
150000000|NCT02141490|541132613|FG001|Overall Study|Screening failures|0|||
150000001|NCT02141490|541132614|FG002|Overall Study|Screening failures|0|||
150000002|NCT02387164|541132615|FG000|Overall Study|Lost to Follow-up|2|||
150000003|NCT02387164|541132616|FG001|Overall Study|Lost to Follow-up|0|||
150000004|NCT02387164|541132615|FG000|Overall Study|Diagnosed|1|||
150000005|NCT02387164|541132616|FG001|Overall Study|Diagnosed|2|||
150000006|NCT00033540|541132619|FG000|Overall Study|Adverse Event|14|||
150000007|NCT00033540|541132619|FG000|Overall Study|Death|1|||
150000008|NCT00033540|541132619|FG000|Overall Study|Progression|26|||
150000009|NCT00033540|541132619|FG000|Overall Study|Withdrawal by Subject|6|||
150000010|NCT00033540|541132619|FG000|Overall Study|Other|5|||
150000011|NCT00033540|541132619|FG000|Overall Study|Ineligible|3|||
150000012|NCT00033540|541132619|FG000|Overall Study|Never received treatment|2|||
150000013|NCT01253265|541132622|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
150000014|NCT01253265|541132623|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
150000015|NCT01253265|541132624|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
150000016|NCT01253265|541132625|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
150000017|NCT01253265|541132626|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
150000018|NCT01253265|541132622|FG000|Overall Study|Withdrawal by Subject|0|||
150000019|NCT01253265|541132623|FG001|Overall Study|Withdrawal by Subject|0|||
150000020|NCT01253265|541132624|FG002|Overall Study|Withdrawal by Subject|0|||
150000021|NCT01253265|541132625|FG003|Overall Study|Withdrawal by Subject|0|||
150000022|NCT01253265|541132626|FG004|Overall Study|Withdrawal by Subject|1|||
150054488|NCT00065429|541340307|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
150054489|NCT00065429|541340301|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
150054490|NCT00065429|541340302|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150054491|NCT00065429|541340303|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150054492|NCT00065429|541340304|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150000023|NCT03271047|541132627|FG000|Phase 1b: Dose Finding Period|Death|8|||
150000024|NCT03271047|541132628|FG001|Phase 1b: Dose Finding Period|Death|8|||
150000025|NCT03271047|541132629|FG002|Phase 1b: Dose Finding Period|Death|0|||
150000026|NCT03271047|541132630|FG003|Phase 1b: Dose Finding Period|Death|0|||
150000027|NCT03271047|541132627|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
150000028|NCT03271047|541132628|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
150000029|NCT03271047|541132629|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
150000030|NCT03271047|541132630|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
150000031|NCT03271047|541132627|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
150000032|NCT03271047|541132628|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
150000033|NCT03271047|541132629|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
150000034|NCT03271047|541132630|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
150000035|NCT03271047|541132627|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
150000036|NCT03271047|541132628|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
150000037|NCT03271047|541132629|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
150000038|NCT03271047|541132630|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
150000039|NCT03271047|541132627|FG000|Randomized Phase 2 Period|Other|0|||
150000040|NCT03271047|541132628|FG001|Randomized Phase 2 Period|Other|0|||
150000041|NCT03271047|541132629|FG002|Randomized Phase 2 Period|Other|0|||
150000042|NCT03271047|541132630|FG003|Randomized Phase 2 Period|Other|1|||
150000043|NCT03271047|541132627|FG000|Randomized Phase 2 Period|Death|0|||
150000044|NCT03271047|541132628|FG001|Randomized Phase 2 Period|Death|0|||
150000045|NCT03271047|541132629|FG002|Randomized Phase 2 Period|Death|20|||
150000046|NCT03271047|541132630|FG003|Randomized Phase 2 Period|Death|21|||
150000047|NCT03271047|541132627|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
150000048|NCT03271047|541132628|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
150000049|NCT03271047|541132629|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
150000050|NCT03271047|541132630|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
150000051|NCT03271047|541132627|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
150000052|NCT03271047|541132628|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
150000053|NCT03271047|541132629|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
150000054|NCT03271047|541132630|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
150000055|NCT03271047|541132627|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
150000056|NCT03271047|541132628|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
150000057|NCT03271047|541132629|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
150000058|NCT03271047|541132630|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
150000059|NCT00434759|541132632|FG000|Overall Study|Lack of Efficacy|5|||
150000060|NCT00434759|541132633|FG001|Overall Study|Lack of Efficacy|4|||
150000061|NCT00434759|541132632|FG000|Overall Study|Withdrawal by Subject|17|||
150000062|NCT00434759|541132633|FG001|Overall Study|Withdrawal by Subject|1|||
150000063|NCT00434759|541132632|FG000|Overall Study|family affairs|2|||
150000064|NCT00434759|541132633|FG001|Overall Study|family affairs|0|||
150000065|NCT00495521|541132634|FG000|Overall Study|Physician Decision|0|||
150000066|NCT00495521|541132635|FG001|Overall Study|Physician Decision|1|||
150000067|NCT02410824|541132636|FG000|First Intervention (One Week)|Headache|0|||
150000068|NCT02410824|541132637|FG001|First Intervention (One Week)|Headache|1|||
150000069|NCT00392808|541132638|FG000|Overall Study|Lost to Follow-up|3|||
150000070|NCT00392808|541132639|FG001|Overall Study|Lost to Follow-up|2|||
150000071|NCT00392808|541132640|FG002|Overall Study|Lost to Follow-up|1|||
150000072|NCT00392808|541132641|FG003|Overall Study|Lost to Follow-up|2|||
150000073|NCT00392808|541132638|FG000|Overall Study|Unable to withdraw blood|3|||
150000074|NCT00392808|541132639|FG001|Overall Study|Unable to withdraw blood|1|||
150000075|NCT00392808|541132640|FG002|Overall Study|Unable to withdraw blood|1|||
150000076|NCT00392808|541132641|FG003|Overall Study|Unable to withdraw blood|2|||
150000077|NCT02649855|541132642|FG000|Overall Study|Refused further treatment|2|||
150000078|NCT02649855|541132643|FG001|Overall Study|Refused further treatment|1|||
150000079|NCT02649855|541132644|FG002|Overall Study|Refused further treatment|1|||
150000080|NCT02649855|541132642|FG000|Overall Study|Withdrew consent|0|||
150000081|NCT02649855|541132643|FG001|Overall Study|Withdrew consent|1|||
150000082|NCT02649855|541132644|FG002|Overall Study|Withdrew consent|0|||
150000083|NCT02649855|541132642|FG000|Overall Study|Switched to alternative treatment|0|||
150000084|NCT02649855|541132643|FG001|Overall Study|Switched to alternative treatment|1|||
150000085|NCT02649855|541132644|FG002|Overall Study|Switched to alternative treatment|1|||
150000086|NCT02649855|541132642|FG000|Overall Study|Principal investigator discretion|0|||
150000087|NCT02649855|541132643|FG001|Overall Study|Principal investigator discretion|1|||
150000088|NCT02649855|541132644|FG002|Overall Study|Principal investigator discretion|1|||
150000089|NCT02649855|541132642|FG000|Overall Study|No treatment, per protocol|1|||
150000090|NCT02649855|541132643|FG001|Overall Study|No treatment, per protocol|0|||
150000091|NCT02649855|541132644|FG002|Overall Study|No treatment, per protocol|0|||
150000092|NCT02649855|541132642|FG000|Overall Study|Initiate new treatment|1|||
150000093|NCT02649855|541132643|FG001|Overall Study|Initiate new treatment|0|||
150000094|NCT02649855|541132644|FG002|Overall Study|Initiate new treatment|0|||
150000095|NCT01038713|541132645|FG000|Overall Study|Patient to hospice|1|||
150000096|NCT01038713|541132646|FG001|Overall Study|Patient to hospice|1|||
150000097|NCT01038713|541132647|FG002|Overall Study|Patient to hospice|1|||
150000098|NCT01038713|541132645|FG000|Overall Study|Lost to Follow-up|3|||
150000099|NCT01038713|541132646|FG001|Overall Study|Lost to Follow-up|0|||
150000100|NCT01038713|541132647|FG002|Overall Study|Lost to Follow-up|0|||
150000101|NCT01038713|541132645|FG000|Overall Study|Neuroendocrine Tumor|0|||
150000102|NCT01038713|541132646|FG001|Overall Study|Neuroendocrine Tumor|1|||
150179551|NCT00807937|541795410|FG003|Overall Study|Intake of prohibited medicine|0|||
150179552|NCT00807937|541795407|FG000|Overall Study|All other reasons (not provided)|2|||
150179553|NCT00807937|541795408|FG001|Overall Study|All other reasons (not provided)|4|||
150179554|NCT00807937|541795409|FG002|Overall Study|All other reasons (not provided)|0|||
150179555|NCT00807937|541795410|FG003|Overall Study|All other reasons (not provided)|1|||
150179556|NCT03233633|541795411|FG000|Overall Study|Adverse Event|2|||
150179557|NCT03233633|541795411|FG000|Overall Study|Less Than 3 Days of Data|6|||
150179558|NCT02088853|541795412|FG000|Overall Study|Pregnancy|1|||
150000103|NCT01038713|541132647|FG002|Overall Study|Neuroendocrine Tumor|0|||
150000104|NCT01038713|541132645|FG000|Overall Study|died from PEP|0|||
150000105|NCT01038713|541132646|FG001|Overall Study|died from PEP|1|||
150000106|NCT01038713|541132647|FG002|Overall Study|died from PEP|0|||
150000107|NCT01038713|541132645|FG000|Overall Study|Autoimmune Pancreatitis|1|||
150000108|NCT01038713|541132646|FG001|Overall Study|Autoimmune Pancreatitis|0|||
150000109|NCT01038713|541132647|FG002|Overall Study|Autoimmune Pancreatitis|0|||
150000110|NCT03777917|541132648|FG000|Overall Study|Withdrawal by Subject|1|||
150000111|NCT03777917|541132649|FG001|Overall Study|Withdrawal by Subject|0|||
150000112|NCT03777917|541132648|FG000|Overall Study|Physician Decision|1|||
150000113|NCT03777917|541132649|FG001|Overall Study|Physician Decision|0|||
150000114|NCT03777917|541132648|FG000|Overall Study|Lost to Follow-up|6|||
150000115|NCT03777917|541132649|FG001|Overall Study|Lost to Follow-up|2|||
150000116|NCT03777917|541132648|FG000|Overall Study|Other|1|||
150000117|NCT03777917|541132649|FG001|Overall Study|Other|0|||
150000118|NCT02966795|541132650|FG000|Overall Study|Patient Left the Country|0|||
150000119|NCT02966795|541132651|FG001|Overall Study|Patient Left the Country|1|||
150000120|NCT00432744|541132652|FG000|Months 0-6|Withdrawal by Subject|4|||
150000121|NCT00432744|541132653|FG001|Months 0-6|Withdrawal by Subject|4|||
150000122|NCT00432744|541132652|FG000|Months 0-6|Too disabled to score|1|||
150000123|NCT00432744|541132653|FG001|Months 0-6|Too disabled to score|0|||
150000124|NCT00432744|541132652|FG000|Months 7 - 12|Withdrawal by Subject|1|||
150000125|NCT00432744|541132653|FG001|Months 7 - 12|Withdrawal by Subject|0|||
150000126|NCT00432744|541132652|FG000|Months 7 - 12|Too disabled to score|0|||
150000127|NCT00432744|541132653|FG001|Months 7 - 12|Too disabled to score|1|||
150000128|NCT01416441|541132654|FG000|Overall Study|Lost to Follow-up|5|||
150000129|NCT01416441|541132654|FG000|Overall Study|Adverse Event|6|||
150000130|NCT01416441|541132654|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
150000131|NCT01416441|541132654|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
150000132|NCT01416441|541132654|FG000|Overall Study|Investigator Withdrew Subject|2|||
150000133|NCT01416441|541132654|FG000|Overall Study|Subject Withdrew Consent|12|||
150000134|NCT01416441|541132654|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
150000135|NCT02653495|541132657|FG000|Overall Study|Lost to Follow-up|2|||
150000136|NCT02653495|541132658|FG001|Overall Study|Lost to Follow-up|0|||
150000137|NCT02653495|541132657|FG000|Overall Study|Screening Failure|10|||
150000138|NCT02653495|541132658|FG001|Overall Study|Screening Failure|0|||
150000139|NCT00526110|541132659|FG000|Overall Study|Adverse Event|2|||
150000140|NCT00526110|541132660|FG001|Overall Study|Adverse Event|9|||
150000141|NCT00526110|541132659|FG000|Overall Study|Disease Progression|0|||
150000142|NCT00526110|541132660|FG001|Overall Study|Disease Progression|19|||
150000143|NCT00526110|541132659|FG000|Overall Study|Maximal Response|0|||
150000144|NCT00526110|541132660|FG001|Overall Study|Maximal Response|6|||
150000145|NCT00526110|541132659|FG000|Overall Study|Withdrawal by Subject|0|||
150000146|NCT00526110|541132660|FG001|Overall Study|Withdrawal by Subject|2|||
150000147|NCT00526110|541132659|FG000|Overall Study|Poor Tolerance|0|||
150000148|NCT00526110|541132660|FG001|Overall Study|Poor Tolerance|5|||
150000149|NCT01400243|541132661|FG000|Overall Study|Protocol Violation|8|||
150000150|NCT01400243|541132662|FG001|Overall Study|Protocol Violation|11|||
150000151|NCT00031460|541134279|FG000|Overall Study|Lost to Follow-up|0|||
150000152|NCT00031460|541134280|FG001|Overall Study|Lost to Follow-up|1|||
150000153|NCT00031460|541134279|FG000|Overall Study|Withdrawal by Subject|1|||
150000154|NCT00031460|541134280|FG001|Overall Study|Withdrawal by Subject|1|||
150000155|NCT00031460|541134279|FG000|Overall Study|Non-Compliant|1|||
150000156|NCT00031460|541134280|FG001|Overall Study|Non-Compliant|1|||
150000157|NCT00031460|541134279|FG000|Overall Study|Death|0|||
150000158|NCT00031460|541134280|FG001|Overall Study|Death|1|||
150000159|NCT00031460|541134279|FG000|Overall Study|Reactivation of Disease|5|||
150000160|NCT00031460|541134280|FG001|Overall Study|Reactivation of Disease|9|||
150000161|NCT00031460|541134279|FG000|Overall Study|Disruption of blinded drug supply|2|||
150179559|NCT02088853|541795413|FG001|Overall Study|Pregnancy|0|||
150179560|NCT00603954|541795416|FG000|Overall Study|Protocol Violation|1|||
150179561|NCT00603954|541795417|FG001|Overall Study|Protocol Violation|2|||
150179562|NCT02708108|541795418|FG000|Overall Study|Death|1|||
150179563|NCT02708108|541795419|FG001|Overall Study|Death|2|||
150000162|NCT00031460|541134280|FG001|Overall Study|Disruption of blinded drug supply|0|||
150000163|NCT00031460|541134279|FG000|Overall Study|Confirmed unevaluable|0|||
150000164|NCT00031460|541134280|FG001|Overall Study|Confirmed unevaluable|1|||
150000165|NCT01278407|541134281|FG000|Confirmatory Phase|Adverse Event|5|||
150179564|NCT02708108|541795418|FG000|Overall Study|Regimen change|1|||
150000166|NCT01278407|541134282|FG001|Confirmatory Phase|Adverse Event|10|||
150000167|NCT01278407|541134283|FG002|Confirmatory Phase|Adverse Event|1|||
150000168|NCT01278407|541134284|FG003|Confirmatory Phase|Adverse Event|0|||
150000169|NCT01278407|541134285|FG004|Confirmatory Phase|Adverse Event|0|||
150000170|NCT01278407|541134281|FG000|Confirmatory Phase|Participant's Choice|3|||
150000171|NCT01278407|541134282|FG001|Confirmatory Phase|Participant's Choice|5|||
150000172|NCT01278407|541134283|FG002|Confirmatory Phase|Participant's Choice|3|||
150000173|NCT01278407|541134284|FG003|Confirmatory Phase|Participant's Choice|0|||
150000174|NCT01278407|541134285|FG004|Confirmatory Phase|Participant's Choice|0|||
150000175|NCT01278407|541134281|FG000|Confirmatory Phase|Other|1|||
150000176|NCT01278407|541134282|FG001|Confirmatory Phase|Other|1|||
150000177|NCT01278407|541134283|FG002|Confirmatory Phase|Other|2|||
150000178|NCT01278407|541134284|FG003|Confirmatory Phase|Other|0|||
150000179|NCT01278407|541134285|FG004|Confirmatory Phase|Other|0|||
150000180|NCT01278407|541134281|FG000|Extension Phase|Adverse Event|0|||
150000181|NCT01278407|541134282|FG001|Extension Phase|Adverse Event|0|||
150000182|NCT01278407|541134283|FG002|Extension Phase|Adverse Event|0|||
150000183|NCT01278407|541134284|FG003|Extension Phase|Adverse Event|7|||
150000184|NCT01278407|541134285|FG004|Extension Phase|Adverse Event|16|||
150000185|NCT01278407|541134281|FG000|Extension Phase|Participant's Choice|0|||
150000186|NCT01278407|541134282|FG001|Extension Phase|Participant's Choice|0|||
150000187|NCT01278407|541134283|FG002|Extension Phase|Participant's Choice|0|||
150000188|NCT01278407|541134284|FG003|Extension Phase|Participant's Choice|4|||
150000189|NCT01278407|541134285|FG004|Extension Phase|Participant's Choice|11|||
150000190|NCT01278407|541134281|FG000|Extension Phase|Other|0|||
150000191|NCT01278407|541134282|FG001|Extension Phase|Other|0|||
150000192|NCT01278407|541134283|FG002|Extension Phase|Other|0|||
150000193|NCT01278407|541134284|FG003|Extension Phase|Other|1|||
150000194|NCT01278407|541134285|FG004|Extension Phase|Other|3|||
150000195|NCT01596335|541134286|FG000|Overall Study|exacerbation of primary disease|5|||
150000196|NCT01596335|541134287|FG001|Overall Study|exacerbation of primary disease|9|||
150000197|NCT01460719|541134288|FG000|Overall Study|Adverse Event|1|||
150000198|NCT01460719|541134288|FG000|Overall Study|Withdrawal by Subject|1|||
150000199|NCT01176565|541134289|FG000|Overall Study|Lost to Follow-up|12|||
150000200|NCT01176565|541134290|FG001|Overall Study|Lost to Follow-up|16|||
150000201|NCT01176565|541134289|FG000|Overall Study|Withdrawal by Subject|7|||
150000202|NCT01176565|541134290|FG001|Overall Study|Withdrawal by Subject|1|||
150000203|NCT01176565|541134289|FG000|Overall Study|Not Analyzed (any other reason)|1|||
150000204|NCT01176565|541134290|FG001|Overall Study|Not Analyzed (any other reason)|2|||
150000205|NCT03602885|541134292|FG000|Overall Study|Lost to Follow-up|3|||
150000206|NCT03602885|541134293|FG001|Overall Study|Lost to Follow-up|0|||
150000207|NCT02838901|541134297|FG000|Overall Study|Withdrawal by Subject|1|||
150000208|NCT02838901|541134298|FG001|Overall Study|Withdrawal by Subject|1|||
150000209|NCT02838901|541134297|FG000|Overall Study|Lost to Follow-up|1|||
150000210|NCT02838901|541134298|FG001|Overall Study|Lost to Follow-up|1|||
150000211|NCT02285114|541134300|FG000|Main Phase|Investigator's Discretion|0|||
150000212|NCT02285114|541134301|FG001|Main Phase|Investigator's Discretion|2|||
150000213|NCT02285114|541134302|FG002|Main Phase|Investigator's Discretion|0|||
150000214|NCT02285114|541134303|FG003|Main Phase|Investigator's Discretion|0|||
150000215|NCT02285114|541134304|FG004|Main Phase|Investigator's Discretion|0|||
150000216|NCT02285114|541134305|FG005|Main Phase|Investigator's Discretion|0|||
150000217|NCT02285114|541134300|FG000|Main Phase|Enrolled but Never Treated|1|||
150000218|NCT02285114|541134301|FG001|Main Phase|Enrolled but Never Treated|0|||
150000219|NCT02285114|541134302|FG002|Main Phase|Enrolled but Never Treated|0|||
150000220|NCT02285114|541134303|FG003|Main Phase|Enrolled but Never Treated|0|||
150000221|NCT02285114|541134304|FG004|Main Phase|Enrolled but Never Treated|0|||
150000222|NCT02285114|541134305|FG005|Main Phase|Enrolled but Never Treated|0|||
150000223|NCT02285114|541134300|FG000|Main Phase|Withdrew Consent|0|||
150000224|NCT02285114|541134301|FG001|Main Phase|Withdrew Consent|0|||
150000225|NCT02285114|541134302|FG002|Main Phase|Withdrew Consent|1|||
150000226|NCT02285114|541134303|FG003|Main Phase|Withdrew Consent|0|||
150000227|NCT02285114|541134304|FG004|Main Phase|Withdrew Consent|0|||
150000228|NCT02285114|541134305|FG005|Main Phase|Withdrew Consent|0|||
150000229|NCT02285114|541134300|FG000|Extension Phase|Investigator's Discretion|0|||
150000230|NCT02285114|541134301|FG001|Extension Phase|Investigator's Discretion|0|||
150000231|NCT02285114|541134302|FG002|Extension Phase|Investigator's Discretion|0|||
150179565|NCT02708108|541795419|FG001|Overall Study|Regimen change|0|||
150000232|NCT02285114|541134303|FG003|Extension Phase|Investigator's Discretion|14|||
150000233|NCT02285114|541134304|FG004|Extension Phase|Investigator's Discretion|1|||
150000234|NCT02285114|541134305|FG005|Extension Phase|Investigator's Discretion|0|||
150000235|NCT02285114|541134300|FG000|Extension Phase|Lost to Follow-up|0|||
150000236|NCT02285114|541134301|FG001|Extension Phase|Lost to Follow-up|0|||
150000237|NCT02285114|541134302|FG002|Extension Phase|Lost to Follow-up|0|||
150000238|NCT02285114|541134303|FG003|Extension Phase|Lost to Follow-up|1|||
150000239|NCT02285114|541134304|FG004|Extension Phase|Lost to Follow-up|1|||
150000240|NCT02285114|541134305|FG005|Extension Phase|Lost to Follow-up|0|||
150000241|NCT02285114|541134300|FG000|Extension Phase|Non-compliance with Study Drug|0|||
150000242|NCT02285114|541134301|FG001|Extension Phase|Non-compliance with Study Drug|0|||
150000243|NCT02285114|541134302|FG002|Extension Phase|Non-compliance with Study Drug|0|||
150000244|NCT02285114|541134303|FG003|Extension Phase|Non-compliance with Study Drug|2|||
150000245|NCT02285114|541134304|FG004|Extension Phase|Non-compliance with Study Drug|0|||
150000246|NCT02285114|541134305|FG005|Extension Phase|Non-compliance with Study Drug|0|||
150000247|NCT02285114|541134300|FG000|Extension Phase|Pregnancy|0|||
150000248|NCT02285114|541134301|FG001|Extension Phase|Pregnancy|0|||
150000249|NCT02285114|541134302|FG002|Extension Phase|Pregnancy|0|||
150000250|NCT02285114|541134303|FG003|Extension Phase|Pregnancy|1|||
150000251|NCT02285114|541134304|FG004|Extension Phase|Pregnancy|0|||
150000252|NCT02285114|541134305|FG005|Extension Phase|Pregnancy|0|||
150000253|NCT03383783|541134306|FG000|Overall Study|Withdrawal by Subject|2|||
150000254|NCT01156389|541134307|FG000|Overall Study|Elevated liver enzymes|4|||
150000255|NCT01156389|541134308|FG001|Overall Study|Elevated liver enzymes|0|||
150000256|NCT01156389|541134307|FG000|Overall Study|Vomiting|0|||
150000257|NCT01156389|541134308|FG001|Overall Study|Vomiting|1|||
150000258|NCT00350623|541134312|FG000|Overall Study|Lost to Follow-up|8|||
150000259|NCT00350623|541134313|FG001|Overall Study|Lost to Follow-up|3|||
150000260|NCT00350623|541134314|FG002|Overall Study|Lost to Follow-up|4|||
150000261|NCT00350623|541134312|FG000|Overall Study|Withdrawal by Subject|0|||
150000262|NCT00350623|541134313|FG001|Overall Study|Withdrawal by Subject|1|||
150000263|NCT00350623|541134314|FG002|Overall Study|Withdrawal by Subject|1|||
150000264|NCT00350623|541134312|FG000|Overall Study|patient traveling outside the country|0|||
150000265|NCT00350623|541134313|FG001|Overall Study|patient traveling outside the country|0|||
150000266|NCT00350623|541134314|FG002|Overall Study|patient traveling outside the country|1|||
150000267|NCT04126564|541134318|FG000|Overall Study|Withdrawal by Subject|0|||
150000268|NCT04126564|541134319|FG001|Overall Study|Withdrawal by Subject|2|||
150000269|NCT04126564|541134318|FG000|Overall Study|Lost to Follow-up|0|||
150000270|NCT04126564|541134319|FG001|Overall Study|Lost to Follow-up|1|||
150000271|NCT02536300|541134323|FG000|Overall Study|Investigator's Discretion|17|||
150000272|NCT02536300|541134324|FG001|Overall Study|Investigator's Discretion|11|||
150000273|NCT02536300|541134325|FG002|Overall Study|Investigator's Discretion|2|||
150000274|NCT02536300|541134323|FG000|Overall Study|Progressive Disease|11|||
150000275|NCT02536300|541134324|FG001|Overall Study|Progressive Disease|7|||
150000276|NCT02536300|541134325|FG002|Overall Study|Progressive Disease|6|||
150000277|NCT02536300|541134323|FG000|Overall Study|Study Terminated by Sponsor|6|||
150000278|NCT02536300|541134324|FG001|Overall Study|Study Terminated by Sponsor|4|||
150000279|NCT02536300|541134325|FG002|Overall Study|Study Terminated by Sponsor|7|||
150000280|NCT02536300|541134323|FG000|Overall Study|Death|7|||
150000281|NCT02536300|541134324|FG001|Overall Study|Death|0|||
150000282|NCT02536300|541134325|FG002|Overall Study|Death|5|||
150000283|NCT02536300|541134323|FG000|Overall Study|Withdrew Consent|4|||
150000284|NCT02536300|541134324|FG001|Overall Study|Withdrew Consent|2|||
150000285|NCT02536300|541134325|FG002|Overall Study|Withdrew Consent|0|||
150000286|NCT02536300|541134323|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
150000287|NCT02536300|541134324|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
150000288|NCT02536300|541134325|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
150000289|NCT02536300|541134323|FG000|Overall Study|Enrolled but Never Treated|0|||
150000290|NCT02536300|541134324|FG001|Overall Study|Enrolled but Never Treated|0|||
150000291|NCT02536300|541134325|FG002|Overall Study|Enrolled but Never Treated|1|||
150000292|NCT02536300|541134323|FG000|Overall Study|Non-compliance With Study Drug|1|||
150000293|NCT02536300|541134324|FG001|Overall Study|Non-compliance With Study Drug|0|||
150000294|NCT02536300|541134325|FG002|Overall Study|Non-compliance With Study Drug|0|||
150000295|NCT02536300|541134323|FG000|Overall Study|Protocol Violation|0|||
150000296|NCT02536300|541134324|FG001|Overall Study|Protocol Violation|1|||
150000297|NCT02536300|541134325|FG002|Overall Study|Protocol Violation|0|||
150000298|NCT02233738|541134330|FG000|Overall Study|Lost to Follow-up|5|||
150000299|NCT02233738|541134331|FG001|Overall Study|Lost to Follow-up|12|||
150000300|NCT02233738|541134330|FG000|Overall Study|Death|0|||
150000301|NCT02233738|541134331|FG001|Overall Study|Death|1|||
150000302|NCT02233738|541134330|FG000|Overall Study|Withdrawal by Subject|0|||
150000303|NCT02233738|541134331|FG001|Overall Study|Withdrawal by Subject|1|||
150000304|NCT02233738|541134330|FG000|Overall Study|Did not return after Baseline|3|||
150000305|NCT02233738|541134331|FG001|Overall Study|Did not return after Baseline|2|||
150000306|NCT00096174|541134332|FG000|Overall Study|Lack of Efficacy|9|||
150000307|NCT00096174|541134332|FG000|Overall Study|Adverse Event|15|||
150000308|NCT00096174|541134332|FG000|Overall Study|Death|6|||
150000309|NCT00096174|541134332|FG000|Overall Study|Withdrawal by Subject|15|||
150000310|NCT00096174|541134332|FG000|Overall Study|Not started protocol therapy|3|||
150000311|NCT00096174|541134332|FG000|Overall Study|Ineligible|6|||
150000312|NCT00096174|541134332|FG000|Overall Study|other reason|8|||
150000313|NCT00330928|541134336|FG000|Overall Study|Lost to Follow-up|6|||
150000314|NCT00330928|541134336|FG000|Overall Study|Physician Decision|9|||
150000315|NCT00330928|541134336|FG000|Overall Study|Death|1|||
150000316|NCT00330928|541134336|FG000|Overall Study|IVUS could not be performed.|1|||
150000317|NCT03028480|541134339|FG000|Overall Study|No revisit after the first prescription date|2|||
150000318|NCT03028480|541134339|FG000|Overall Study|Did not use the drug|1|||
150000319|NCT03028480|541134339|FG000|Overall Study|Violation of the enrollment deadline|10|||
150000320|NCT03028480|541134339|FG000|Overall Study|Case report forms were not collected|21|||
150000321|NCT05605691|541134340|FG000|Overall Study|Lost to Follow-up|1|||
150000322|NCT01030874|541134341|FG000|Overall Study|Withdrawal by Subject|1|||
150000323|NCT01030874|541134342|FG001|Overall Study|Withdrawal by Subject|0|||
150000324|NCT01030874|541134341|FG000|Overall Study|Discharged in first 2 weeks|17|||
150000325|NCT01030874|541134342|FG001|Overall Study|Discharged in first 2 weeks|16|||
150000326|NCT02279719|541134343|FG000|Overall Study|Patients randomized but never treated|0|||
150000327|NCT02279719|541134344|FG001|Overall Study|Patients randomized but never treated|0|||
150000328|NCT02279719|541134345|FG002|Overall Study|Patients randomized but never treated|0|||
150000329|NCT02279719|541134346|FG003|Overall Study|Patients randomized but never treated|0|||
150000330|NCT02279719|541134347|FG004|Overall Study|Patients randomized but never treated|3|||
150000331|NCT02279719|541134348|FG005|Overall Study|Patients randomized but never treated|0|||
150000332|NCT02279719|541134349|FG006|Overall Study|Patients randomized but never treated|3|||
150000333|NCT03541187|541134352|FG000|Overall Study|Lost to Follow-up|2|||
150000334|NCT03541187|541134353|FG001|Overall Study|Lost to Follow-up|6|||
150000335|NCT03541187|541134352|FG000|Overall Study|Pregnancy|0|||
150000336|NCT03541187|541134353|FG001|Overall Study|Pregnancy|1|||
150000337|NCT03541187|541134352|FG000|Overall Study|Withdrawal by Subject|6|||
150000338|NCT03541187|541134353|FG001|Overall Study|Withdrawal by Subject|2|||
150000339|NCT03541187|541134352|FG000|Overall Study|Moved out of town|1|||
150000340|NCT03541187|541134353|FG001|Overall Study|Moved out of town|0|||
150000341|NCT03541187|541134352|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
150000342|NCT03541187|541134353|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
150000343|NCT03541187|541134352|FG000|Overall Study|Did not meet randomization criteria|1|||
150000344|NCT03541187|541134353|FG001|Overall Study|Did not meet randomization criteria|1|||
150000345|NCT03541187|541134352|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
150000346|NCT03541187|541134353|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
150000347|NCT03541187|541134352|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
150000348|NCT03541187|541134353|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
150000349|NCT00294645|541134360|FG000|Overall Study|Death|10|||
150000350|NCT00294645|541134361|FG001|Overall Study|Death|18|||
150000351|NCT00294645|541134360|FG000|Overall Study|Lost to Follow-up|1|||
150000352|NCT00294645|541134361|FG001|Overall Study|Lost to Follow-up|10|||
150000353|NCT00294645|541134360|FG000|Overall Study|Withdrawal by Subject|18|||
150000354|NCT00294645|541134361|FG001|Overall Study|Withdrawal by Subject|34|||
150000355|NCT00294645|541134360|FG000|Overall Study|Physician Decision|15|||
150000356|NCT00294645|541134361|FG001|Overall Study|Physician Decision|20|||
150000357|NCT00294645|541134360|FG000|Overall Study|Other|4|||
150000358|NCT00294645|541134361|FG001|Overall Study|Other|10|||
150000359|NCT02403635|541134362|FG000|Overall Study|Not eligible|9|||
150000360|NCT02509052|541134366|FG000|Overall Study|Non compliance|0|||
150000361|NCT02509052|541134367|FG001|Overall Study|Non compliance|0|||
150000362|NCT02509052|541134368|FG002|Overall Study|Non compliance|1|||
150000363|NCT03554772|541134372|FG000|Overall Study|Lost to Follow-up|0|||
150000364|NCT03554772|541134373|FG001|Overall Study|Lost to Follow-up|0|||
150000365|NCT03554772|541134374|FG002|Overall Study|Lost to Follow-up|0|||
150000366|NCT03554772|541134375|FG003|Overall Study|Lost to Follow-up|2|||
150000367|NCT02098369|541134377|FG000|Overall Study|Withdrawal by Subject|1|||
150000368|NCT02098369|541134378|FG001|Overall Study|Withdrawal by Subject|5|||
150000369|NCT02098369|541134379|FG002|Overall Study|Withdrawal by Subject|0|||
150000370|NCT02098369|541134377|FG000|Overall Study|Lost to Follow-up|5|||
150000371|NCT02098369|541134378|FG001|Overall Study|Lost to Follow-up|1|||
150000372|NCT02098369|541134379|FG002|Overall Study|Lost to Follow-up|3|||
150000373|NCT02098369|541134377|FG000|Overall Study|Death|1|||
150000374|NCT02098369|541134378|FG001|Overall Study|Death|1|||
150000375|NCT02098369|541134379|FG002|Overall Study|Death|1|||
150000376|NCT02098369|541134377|FG000|Overall Study|Other|0|||
150000377|NCT02098369|541134378|FG001|Overall Study|Other|2|||
150000378|NCT02098369|541134379|FG002|Overall Study|Other|1|||
150000379|NCT03362931|541134380|FG000|Overall Study|Adverse Event|1|||
150000380|NCT03362931|541134380|FG000|Overall Study|Death|2|||
150000381|NCT01133405|541134385|FG000|Period 1|Withdrawal by Subject|0|||
150000382|NCT01133405|541134386|FG001|Period 1|Withdrawal by Subject|1|||
150000383|NCT01133405|541134387|FG002|Period 1|Withdrawal by Subject|0|||
150000384|NCT01133405|541134388|FG003|Period 1|Withdrawal by Subject|1|||
150000385|NCT01133405|541134389|FG004|Period 1|Withdrawal by Subject|0|||
150000386|NCT01133405|541134390|FG005|Period 1|Withdrawal by Subject|1|||
150000387|NCT01133405|541134391|FG006|Period 1|Withdrawal by Subject|0|||
150000388|NCT01133405|541134392|FG007|Period 1|Withdrawal by Subject|0|||
150000389|NCT01133405|541134393|FG008|Period 1|Withdrawal by Subject|0|||
150000390|NCT01133405|541134394|FG009|Period 1|Withdrawal by Subject|0|||
150000391|NCT01133405|541134385|FG000|Period 1|Physician Decision|0|||
150000392|NCT01133405|541134386|FG001|Period 1|Physician Decision|0|||
150000393|NCT01133405|541134387|FG002|Period 1|Physician Decision|0|||
150000394|NCT01133405|541134388|FG003|Period 1|Physician Decision|1|||
150000395|NCT01133405|541134389|FG004|Period 1|Physician Decision|0|||
150000396|NCT01133405|541134390|FG005|Period 1|Physician Decision|0|||
150000397|NCT01133405|541134391|FG006|Period 1|Physician Decision|0|||
150000398|NCT01133405|541134392|FG007|Period 1|Physician Decision|0|||
150000399|NCT01133405|541134393|FG008|Period 1|Physician Decision|0|||
150000400|NCT01133405|541134394|FG009|Period 1|Physician Decision|0|||
150000401|NCT01133405|541134385|FG000|Period 1|Discontinued after randomization|1|||
150000402|NCT01133405|541134386|FG001|Period 1|Discontinued after randomization|0|||
150000403|NCT01133405|541134387|FG002|Period 1|Discontinued after randomization|0|||
150000404|NCT01133405|541134388|FG003|Period 1|Discontinued after randomization|0|||
150000405|NCT01133405|541134389|FG004|Period 1|Discontinued after randomization|0|||
150000406|NCT01133405|541134390|FG005|Period 1|Discontinued after randomization|0|||
150000407|NCT01133405|541134391|FG006|Period 1|Discontinued after randomization|1|||
150000408|NCT01133405|541134392|FG007|Period 1|Discontinued after randomization|0|||
150000409|NCT01133405|541134393|FG008|Period 1|Discontinued after randomization|0|||
150000410|NCT01133405|541134394|FG009|Period 1|Discontinued after randomization|0|||
150000411|NCT01133405|541134385|FG000|Period 1|Received drug only in period 2|0|||
150000412|NCT01133405|541134386|FG001|Period 1|Received drug only in period 2|1|||
150000413|NCT01133405|541134387|FG002|Period 1|Received drug only in period 2|0|||
150000414|NCT01133405|541134388|FG003|Period 1|Received drug only in period 2|2|||
150000415|NCT01133405|541134389|FG004|Period 1|Received drug only in period 2|0|||
150000416|NCT01133405|541134390|FG005|Period 1|Received drug only in period 2|1|||
150000417|NCT01133405|541134391|FG006|Period 1|Received drug only in period 2|0|||
150000418|NCT01133405|541134392|FG007|Period 1|Received drug only in period 2|0|||
150000419|NCT01133405|541134393|FG008|Period 1|Received drug only in period 2|0|||
150000420|NCT01133405|541134394|FG009|Period 1|Received drug only in period 2|0|||
150000421|NCT01133405|541134385|FG000|Period 1|Received drug only in period 3|0|||
150000422|NCT01133405|541134386|FG001|Period 1|Received drug only in period 3|1|||
150000423|NCT01133405|541134387|FG002|Period 1|Received drug only in period 3|1|||
150000424|NCT01133405|541134388|FG003|Period 1|Received drug only in period 3|0|||
150000425|NCT01133405|541134389|FG004|Period 1|Received drug only in period 3|0|||
150000426|NCT01133405|541134390|FG005|Period 1|Received drug only in period 3|0|||
150000427|NCT01133405|541134391|FG006|Period 1|Received drug only in period 3|0|||
150000428|NCT01133405|541134392|FG007|Period 1|Received drug only in period 3|0|||
150000429|NCT01133405|541134393|FG008|Period 1|Received drug only in period 3|0|||
150000430|NCT01133405|541134394|FG009|Period 1|Received drug only in period 3|0|||
150000431|NCT01133405|541134385|FG000|Period 2|Adverse Event|0|||
150000432|NCT01133405|541134386|FG001|Period 2|Adverse Event|0|||
150000433|NCT01133405|541134387|FG002|Period 2|Adverse Event|1|||
150000434|NCT01133405|541134388|FG003|Period 2|Adverse Event|0|||
150000435|NCT01133405|541134389|FG004|Period 2|Adverse Event|0|||
150000436|NCT01133405|541134390|FG005|Period 2|Adverse Event|0|||
150000437|NCT01133405|541134391|FG006|Period 2|Adverse Event|0|||
150000438|NCT01133405|541134392|FG007|Period 2|Adverse Event|0|||
150000439|NCT01133405|541134393|FG008|Period 2|Adverse Event|0|||
150000440|NCT01133405|541134394|FG009|Period 2|Adverse Event|0|||
150000441|NCT01133405|541134385|FG000|Period 2|Withdrawal by Subject|0|||
150000442|NCT01133405|541134386|FG001|Period 2|Withdrawal by Subject|0|||
150000443|NCT01133405|541134387|FG002|Period 2|Withdrawal by Subject|0|||
150000444|NCT01133405|541134388|FG003|Period 2|Withdrawal by Subject|1|||
150000445|NCT01133405|541134389|FG004|Period 2|Withdrawal by Subject|0|||
150000446|NCT01133405|541134390|FG005|Period 2|Withdrawal by Subject|1|||
150000447|NCT01133405|541134391|FG006|Period 2|Withdrawal by Subject|0|||
150000448|NCT01133405|541134392|FG007|Period 2|Withdrawal by Subject|0|||
150000449|NCT01133405|541134393|FG008|Period 2|Withdrawal by Subject|0|||
150000450|NCT01133405|541134394|FG009|Period 2|Withdrawal by Subject|0|||
150000451|NCT01133405|541134385|FG000|Period 2|Entry Criteria Not Met|0|||
150000452|NCT01133405|541134386|FG001|Period 2|Entry Criteria Not Met|1|||
150000453|NCT01133405|541134387|FG002|Period 2|Entry Criteria Not Met|0|||
150000454|NCT01133405|541134388|FG003|Period 2|Entry Criteria Not Met|0|||
150000455|NCT01133405|541134389|FG004|Period 2|Entry Criteria Not Met|0|||
150000456|NCT01133405|541134390|FG005|Period 2|Entry Criteria Not Met|0|||
150000457|NCT01133405|541134391|FG006|Period 2|Entry Criteria Not Met|0|||
150000458|NCT01133405|541134392|FG007|Period 2|Entry Criteria Not Met|0|||
150000459|NCT01133405|541134393|FG008|Period 2|Entry Criteria Not Met|0|||
150000460|NCT01133405|541134394|FG009|Period 2|Entry Criteria Not Met|0|||
150000461|NCT01133405|541134385|FG000|Period 2|Physician Decision|0|||
150000462|NCT01133405|541134386|FG001|Period 2|Physician Decision|0|||
150000463|NCT01133405|541134387|FG002|Period 2|Physician Decision|0|||
150000464|NCT01133405|541134388|FG003|Period 2|Physician Decision|0|||
150000465|NCT01133405|541134389|FG004|Period 2|Physician Decision|0|||
150000466|NCT01133405|541134390|FG005|Period 2|Physician Decision|1|||
150000467|NCT01133405|541134391|FG006|Period 2|Physician Decision|0|||
150000468|NCT01133405|541134392|FG007|Period 2|Physician Decision|0|||
150000469|NCT01133405|541134393|FG008|Period 2|Physician Decision|0|||
150000470|NCT01133405|541134394|FG009|Period 2|Physician Decision|0|||
150000471|NCT03300024|541134397|FG000|Overall Study|Physician Decision|4|||
150000472|NCT03300024|541134398|FG001|Overall Study|Physician Decision|6|||
150000473|NCT01238835|541134405|FG000|Overall Study|Death|124|||
150000474|NCT01238835|541134405|FG000|Overall Study|Withdrawal by Subject|9|||
150000475|NCT01238835|541134405|FG000|Overall Study|Lost to Follow-up|1|||
150000476|NCT01238835|541134405|FG000|Overall Study|Site early discontinuation|2|||
150000477|NCT00570037|541134406|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
150000478|NCT00570037|541134407|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
150000479|NCT00554619|541134408|FG000|Overall Study|Adverse Event|1|||
150000480|NCT00554619|541134408|FG000|Overall Study|Physician Decision|1|||
150000481|NCT00554619|541134408|FG000|Overall Study|Liver Function Test Abnormality|1|||
150000482|NCT00907803|541134412|FG000|Overall Study|Withdrawal of consent - long commute|1|||
150000483|NCT00907803|541134413|FG001|Overall Study|Withdrawal of consent - long commute|0|||
150000484|NCT00907803|541134414|FG002|Overall Study|Withdrawal of consent - long commute|0|||
150000485|NCT00907803|541134412|FG000|Overall Study|Adverse Event|2|||
150000486|NCT00907803|541134413|FG001|Overall Study|Adverse Event|0|||
150000487|NCT00907803|541134414|FG002|Overall Study|Adverse Event|0|||
150000488|NCT00907803|541134412|FG000|Overall Study|Withdrawal by Subject|0|||
150000489|NCT00907803|541134413|FG001|Overall Study|Withdrawal by Subject|1|||
150000490|NCT00907803|541134414|FG002|Overall Study|Withdrawal by Subject|0|||
150000491|NCT00907803|541134412|FG000|Overall Study|Lost to Follow-up|0|||
150000492|NCT00907803|541134413|FG001|Overall Study|Lost to Follow-up|1|||
150000493|NCT00907803|541134414|FG002|Overall Study|Lost to Follow-up|0|||
150000494|NCT00907803|541134412|FG000|Overall Study|Protocol Violation|0|||
150000495|NCT00907803|541134413|FG001|Overall Study|Protocol Violation|1|||
150000496|NCT00907803|541134414|FG002|Overall Study|Protocol Violation|0|||
150000497|NCT04612842|541134415|FG000|Overall Study|Lost to Follow-up|20|||
150000498|NCT04612842|541134416|FG001|Overall Study|Lost to Follow-up|11|||
150000499|NCT04612842|541134415|FG000|Overall Study|Withdrawal by Subject|26|||
150000500|NCT04612842|541134416|FG001|Overall Study|Withdrawal by Subject|15|||
150000501|NCT04612842|541134415|FG000|Overall Study|Death|2|||
150000502|NCT04612842|541134416|FG001|Overall Study|Death|2|||
150000503|NCT01118520|541134417|FG000|Overall Study|AAA repair|9|||
150000504|NCT01118520|541134418|FG001|Overall Study|AAA repair|7|||
150000505|NCT01118520|541134419|FG002|Overall Study|AAA repair|9|||
150000506|NCT01118520|541134417|FG000|Overall Study|Adverse Event|3|||
150000507|NCT01118520|541134418|FG001|Overall Study|Adverse Event|3|||
150000508|NCT01118520|541134419|FG002|Overall Study|Adverse Event|3|||
150000509|NCT01118520|541134417|FG000|Overall Study|Withdrawal by Subject|8|||
150000510|NCT01118520|541134418|FG001|Overall Study|Withdrawal by Subject|13|||
150000511|NCT01118520|541134419|FG002|Overall Study|Withdrawal by Subject|8|||
150000512|NCT03958656|541134422|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
150000513|NCT03958656|541134423|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
150000514|NCT03958656|541134424|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
150000515|NCT03958656|541134425|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
150000516|NCT03958656|541134422|FG000|Overall Study|No longer meets eligibility criteria|0|||
150000517|NCT03958656|541134423|FG001|Overall Study|No longer meets eligibility criteria|0|||
150000518|NCT03958656|541134424|FG002|Overall Study|No longer meets eligibility criteria|1|||
150000519|NCT03958656|541134425|FG003|Overall Study|No longer meets eligibility criteria|0|||
150000520|NCT03958656|541134422|FG000|Overall Study|Started anti-cancer treatment|0|||
150000521|NCT03958656|541134423|FG001|Overall Study|Started anti-cancer treatment|0|||
150179566|NCT02708108|541795418|FG000|Overall Study|No MRD and no imaging available|0|||
150179567|NCT02708108|541795419|FG001|Overall Study|No MRD and no imaging available|1|||
150179568|NCT03783026|541796753|FG000|Treatment Phase|Adverse Event|15|||
150179569|NCT03783026|541796753|FG000|Treatment Phase|Lack of Efficacy|11|||
150179570|NCT03783026|541796753|FG000|Treatment Phase|Withdrawal by Subject|6|||
150179571|NCT03783026|541796753|FG000|Treatment Phase|Lost to Follow-up|2|||
150179572|NCT03783026|541796753|FG000|Treatment Phase|Protocol Deviation|8|||
150179573|NCT03783026|541796753|FG000|Treatment Phase|Did Not Receive Treatment|1|||
150179574|NCT03783026|541796753|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
150179575|NCT04814186|541796754|FG000|Treatment Phase|Adverse Event|1|||
150179576|NCT04814186|541796754|FG000|Treatment Phase|Death|6|||
150179577|NCT04814186|541796754|FG000|Treatment Phase|Withdrawal by Subject|2|||
150179578|NCT04814186|541796754|FG000|Treatment Phase|Other|1|||
150179579|NCT04814186|541796754|FG000|Follow-Up Phase|Adverse Event|1|||
150179580|NCT04814186|541796754|FG000|Follow-Up Phase|Death|6|||
150179581|NCT04814186|541796754|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
150179582|NCT04814186|541796754|FG000|Follow-Up Phase|Other|1|||
150179583|NCT01853748|541796755|FG000|Allocation|Withdrawal by Subject|1|||
150179584|NCT01853748|541796756|FG001|Allocation|Withdrawal by Subject|13|||
150179585|NCT01853748|541796755|FG000|Allocation|not sufficient to receive intervention|0|||
150179586|NCT01853748|541796756|FG001|Allocation|not sufficient to receive intervention|1|||
150000522|NCT03958656|541134424|FG002|Overall Study|Started anti-cancer treatment|1|||
150000523|NCT03958656|541134425|FG003|Overall Study|Started anti-cancer treatment|0|||
150000524|NCT03158012|541134426|FG000|Overall Study|Withdrawal by Subject|0|||
150000525|NCT03158012|541134427|FG001|Overall Study|Withdrawal by Subject|1|||
150000526|NCT00541099|541134429|FG000|Overall Study|Ineligible|3|||
150000527|NCT05291936|541134430|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
150000528|NCT05291936|541134431|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
150000529|NCT05291936|541134430|FG000|Period 1|Withdrew Consent during study|1|||
150000530|NCT05291936|541134431|FG001|Period 1|Withdrew Consent during study|0|||
150000531|NCT05291936|541134430|FG000|Period 2|Adverse Event|0|||
150000532|NCT05291936|541134431|FG001|Period 2|Adverse Event|1|||
150000533|NCT05291936|541134430|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
150179587|NCT01853748|541796755|FG000|Follow-Up|Withdrawal by Subject|7|||
150179588|NCT01853748|541796756|FG001|Follow-Up|Withdrawal by Subject|6|||
150179589|NCT01853748|541796755|FG000|Follow-Up|Adverse Event|67|||
150179590|NCT01853748|541796756|FG001|Follow-Up|Adverse Event|7|||
150179591|NCT01853748|541796755|FG000|Follow-Up|not available for data collection|16|||
150179592|NCT01853748|541796756|FG001|Follow-Up|not available for data collection|4|||
150179593|NCT03088813|541796763|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
150179594|NCT03088813|541796764|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
150179595|NCT03088813|541796765|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
150179596|NCT03088813|541796766|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
150179597|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
150179598|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
150000534|NCT05291936|541134431|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150000535|NCT01287221|541134432|FG000|Overall Study|Lack of Perceived Benefit|1|||
150000536|NCT01287221|541134433|FG001|Overall Study|Lack of Perceived Benefit|1|||
150000537|NCT01287221|541134432|FG000|Overall Study|Adverse Event|3|||
150000538|NCT01287221|541134433|FG001|Overall Study|Adverse Event|3|||
150000539|NCT01287221|541134432|FG000|Overall Study|Withdrawal by Subject|0|||
150000540|NCT01287221|541134433|FG001|Overall Study|Withdrawal by Subject|1|||
150000541|NCT00930969|541134434|FG000|Overall Study|Death|5|||
150000542|NCT00930969|541134434|FG000|Overall Study|Lost to Follow-up|1|||
150000543|NCT00930969|541134434|FG000|Overall Study|Physician Decision|13|||
150000544|NCT00930969|541134434|FG000|Overall Study|Withdrawal by Subject|19|||
150000545|NCT00657150|541134435|FG000|Overall Study|Adverse Event|19|||
150000546|NCT00657150|541134436|FG001|Overall Study|Adverse Event|10|||
150000547|NCT00657150|541134435|FG000|Overall Study|Non-compliant with protocol|5|||
150000548|NCT00657150|541134436|FG001|Overall Study|Non-compliant with protocol|9|||
150000549|NCT00657150|541134435|FG000|Overall Study|Lost to Follow-up|2|||
150000550|NCT00657150|541134436|FG001|Overall Study|Lost to Follow-up|0|||
150000551|NCT00657150|541134435|FG000|Overall Study|Withdrawal by Subject|51|||
150000552|NCT00657150|541134436|FG001|Overall Study|Withdrawal by Subject|36|||
150000553|NCT00657150|541134435|FG000|Overall Study|Other|38|||
150000554|NCT00657150|541134436|FG001|Overall Study|Other|38|||
150000555|NCT00657150|541134435|FG000|Treatment|Adverse Event|60|||
150000556|NCT00657150|541134436|FG001|Treatment|Adverse Event|53|||
150000557|NCT00657150|541134435|FG000|Treatment|Non-compliant with protocol|10|||
150000558|NCT00657150|541134436|FG001|Treatment|Non-compliant with protocol|9|||
150000559|NCT00657150|541134435|FG000|Treatment|Lost to Follow-up|1|||
150000560|NCT00657150|541134436|FG001|Treatment|Lost to Follow-up|0|||
150000561|NCT00657150|541134435|FG000|Treatment|Withdrawal by Subject|23|||
150000562|NCT00657150|541134436|FG001|Treatment|Withdrawal by Subject|20|||
150000563|NCT00657150|541134435|FG000|Treatment|Other|13|||
150000564|NCT00657150|541134436|FG001|Treatment|Other|15|||
150000565|NCT02278614|541134450|FG000|Overall Study|Withdrawal by Subject|3|||
150000566|NCT02278614|541134451|FG001|Overall Study|Withdrawal by Subject|5|||
150000567|NCT02278614|541134450|FG000|Overall Study|Adverse Event|1|||
150000568|NCT02278614|541134451|FG001|Overall Study|Adverse Event|0|||
150054493|NCT00065429|541340305|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150054494|NCT00065429|541340306|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150000569|NCT02278614|541134450|FG000|Overall Study|left eye was not eligible|1|||
150000570|NCT02278614|541134451|FG001|Overall Study|left eye was not eligible|0|||
150000571|NCT03762616|541134452|FG000|Overall Study|Protocol Violation|2|||
150000572|NCT03081858|541136373|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
150000573|NCT03081858|541136374|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
150000574|NCT03081858|541136375|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
150000575|NCT03081858|541136376|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
150000576|NCT02032407|541136377|FG000|Overall Study|Lost to Follow-up|2|||
150000577|NCT02032407|541136377|FG000|Overall Study|Pregnancy|1|||
150000578|NCT02032407|541136377|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150000579|NCT01309269|541136378|FG000|Overall Study|Adverse Event|56|||
150000580|NCT01309269|541136378|FG000|Overall Study|Withdrawal by Subject|25|||
150000581|NCT01309269|541136378|FG000|Overall Study|Lack of Acceptance|15|||
150179599|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
150000582|NCT01309269|541136378|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
150000583|NCT01309269|541136378|FG000|Overall Study|Kidney Transplant|25|||
150000584|NCT01309269|541136378|FG000|Overall Study|Administrative Problems|141|||
150054495|NCT00065429|541340307|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
150054496|NCT00065429|541340301|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
150054497|NCT00065429|541340302|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
150054498|NCT00065429|541340303|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
150054499|NCT00065429|541340304|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
150054500|NCT00065429|541340305|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
150054501|NCT00065429|541340306|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
150054502|NCT00065429|541340307|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
150054503|NCT00065429|541340301|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
150054504|NCT00065429|541340302|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
150054505|NCT00065429|541340303|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
150054506|NCT00065429|541340304|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
150054507|NCT00065429|541340305|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
150054508|NCT00065429|541340306|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
150054509|NCT00065429|541340307|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
150054510|NCT00065429|541340301|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054511|NCT00065429|541340302|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054512|NCT00065429|541340303|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054513|NCT00065429|541340304|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054514|NCT00065429|541340305|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
150054515|NCT00065429|541340306|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054516|NCT00065429|541340307|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
150054517|NCT00065429|541340301|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054518|NCT00065429|541340302|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054519|NCT00065429|541340303|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054520|NCT00065429|541340304|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054521|NCT00065429|541340305|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
150054522|NCT00065429|541340306|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054523|NCT00065429|541340307|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
150054524|NCT00548184|541340311|FG000|Overall Study|Adverse Event|3|||
150054525|NCT00548184|541340311|FG000|Overall Study|took other drug|1|||
150054526|NCT00548184|541340311|FG000|Overall Study|Found Her2 negative|1|||
150054527|NCT00636363|541340312|FG000|Overall Study|Conjunctivitis|0|||
150054528|NCT00636363|541340313|FG001|Overall Study|Conjunctivitis|0|||
150054529|NCT00636363|541340314|FG002|Overall Study|Conjunctivitis|1|||
150054530|NCT00636363|541340312|FG000|Overall Study|Adverse Event|0|||
150054531|NCT00636363|541340313|FG001|Overall Study|Adverse Event|0|||
150054532|NCT00636363|541340314|FG002|Overall Study|Adverse Event|1|||
150054533|NCT00636363|541340312|FG000|Overall Study|Positive slit lamp finding|0|||
150054534|NCT00636363|541340313|FG001|Overall Study|Positive slit lamp finding|2|||
150179600|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
150179601|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
150179602|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
150179603|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
150179604|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
150179605|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
150179606|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
150000585|NCT01309269|541136378|FG000|Overall Study|Other|256|||
150000586|NCT01309269|541136378|FG000|Overall Study|Other|1|||
150000587|NCT01309269|541136378|FG000|Overall Study|Study Completion Data Not Recorded|95|||
150000588|NCT01309269|541136378|FG000|Overall Study|Enrolled but not Treated|107|||
150000589|NCT05013424|541136395|FG000|Overall Study|Lost to Follow-up|1|||
150000590|NCT05013424|541136396|FG001|Overall Study|Lost to Follow-up|1|||
150000591|NCT05013424|541136397|FG002|Overall Study|Lost to Follow-up|1|||
150000592|NCT05013424|541136395|FG000|Overall Study|Withdrawal by Subject|0|||
150000593|NCT05013424|541136396|FG001|Overall Study|Withdrawal by Subject|1|||
150000594|NCT05013424|541136397|FG002|Overall Study|Withdrawal by Subject|0|||
150000595|NCT04411420|541136398|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
150000596|NCT04411420|541136399|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
150000597|NCT04411420|541136398|FG000|Survey Subset|Lost to Follow-up|134|||
150054535|NCT00636363|541340314|FG002|Overall Study|Positive slit lamp finding|1|||
150054536|NCT00636363|541340312|FG000|Overall Study|Study related symptoms/complaints|8|||
150179607|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
150179608|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
150000598|NCT04411420|541136399|FG001|Survey Subset|Lost to Follow-up|120|||
150000599|NCT03899064|541136402|FG000|Overall Study|Lost to Follow-up|1|||
150000600|NCT03899064|541136402|FG000|Overall Study|Protocol Violation|2|||
150000601|NCT03899064|541136402|FG000|Overall Study|Withdrawal by Subject|2|||
150054537|NCT00636363|541340313|FG001|Overall Study|Study related symptoms/complaints|7|||
150000602|NCT03899064|541136402|FG000|Overall Study|Other|2|||
150000603|NCT00471887|541136408|FG000|Overall Study|Adverse Event|9|||
150000604|NCT05438602|541136409|FG000|Treatment (15 Days)|Adverse Event|2|||
150000605|NCT05438602|541136410|FG001|Treatment (15 Days)|Adverse Event|1|||
150000606|NCT05438602|541136411|FG002|Treatment (15 Days)|Adverse Event|3|||
150000607|NCT05438602|541136409|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
150000608|NCT05438602|541136410|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
150000609|NCT05438602|541136411|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
150000610|NCT05438602|541136409|FG000|Treatment (15 Days)|Other|0|||
150000611|NCT05438602|541136410|FG001|Treatment (15 Days)|Other|0|||
150000612|NCT05438602|541136411|FG002|Treatment (15 Days)|Other|1|||
150000613|NCT05438602|541136409|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
150000614|NCT05438602|541136410|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
150000615|NCT05438602|541136411|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
150000616|NCT05438602|541136409|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
150000617|NCT05438602|541136410|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
150000618|NCT05438602|541136411|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
150000619|NCT05438602|541136409|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
150000620|NCT05438602|541136410|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
150000621|NCT05438602|541136411|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
150000622|NCT05438602|541136409|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
150000623|NCT05438602|541136410|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
150000624|NCT05438602|541136411|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
150000625|NCT05438602|541136409|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
150000626|NCT05438602|541136410|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
150000627|NCT05438602|541136411|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
150000628|NCT05438602|541136409|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
150000629|NCT05438602|541136410|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
150000630|NCT05438602|541136411|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
150000631|NCT05438602|541136409|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
150000632|NCT05438602|541136410|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
150000633|NCT05438602|541136411|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
150000634|NCT02091284|541136412|FG000|Overall Study|Withdrawal by Subject|2|||
150000635|NCT02091284|541136413|FG001|Overall Study|Withdrawal by Subject|1|||
150000636|NCT02091284|541136412|FG000|Overall Study|unreliable data|1|||
150000637|NCT02091284|541136413|FG001|Overall Study|unreliable data|0|||
150000638|NCT02351349|541136419|FG000|Overall Study|Withdrawal by Subject|2|||
150000639|NCT02351349|541136420|FG001|Overall Study|Withdrawal by Subject|3|||
150000640|NCT01703117|541136421|FG000|Overall Study|Adverse Event|4|||
150000641|NCT01703117|541136422|FG001|Overall Study|Adverse Event|3|||
150000642|NCT01703117|541136421|FG000|Overall Study|Withdrawal by Subject|0|||
150000643|NCT01703117|541136422|FG001|Overall Study|Withdrawal by Subject|1|||
150000644|NCT01340937|541136424|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
150000645|NCT01340937|541136425|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
150000646|NCT01340937|541136426|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
150000647|NCT01340937|541136427|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
150000648|NCT01340937|541136424|FG000|Period 1: Infant Series|Adverse Event|0|||
150000649|NCT01340937|541136425|FG001|Period 1: Infant Series|Adverse Event|1|||
150000650|NCT01340937|541136426|FG002|Period 1: Infant Series|Adverse Event|4|||
150000651|NCT01340937|541136427|FG003|Period 1: Infant Series|Adverse Event|0|||
150000652|NCT01340937|541136424|FG000|Period 1: Infant Series|Death|2|||
150000653|NCT01340937|541136425|FG001|Period 1: Infant Series|Death|0|||
150000654|NCT01340937|541136426|FG002|Period 1: Infant Series|Death|2|||
150000655|NCT01340937|541136427|FG003|Period 1: Infant Series|Death|0|||
150000656|NCT01340937|541136424|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
150000657|NCT01340937|541136425|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
150000658|NCT01340937|541136426|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
150000659|NCT01340937|541136427|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
150000660|NCT01340937|541136424|FG000|Period 1: Infant Series|Physician Decision|2|||
150000661|NCT01340937|541136425|FG001|Period 1: Infant Series|Physician Decision|3|||
150000662|NCT01340937|541136426|FG002|Period 1: Infant Series|Physician Decision|1|||
150000663|NCT01340937|541136427|FG003|Period 1: Infant Series|Physician Decision|0|||
150000664|NCT01340937|541136424|FG000|Period 1: Infant Series|Protocol Violation|1|||
150000665|NCT01340937|541136425|FG001|Period 1: Infant Series|Protocol Violation|4|||
150000666|NCT01340937|541136426|FG002|Period 1: Infant Series|Protocol Violation|4|||
150000667|NCT01340937|541136427|FG003|Period 1: Infant Series|Protocol Violation|3|||
150000668|NCT01340937|541136424|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
150000669|NCT01340937|541136425|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
150000670|NCT01340937|541136426|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
150000671|NCT01340937|541136427|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
150000672|NCT01340937|541136424|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
150000673|NCT01340937|541136425|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
150000674|NCT01340937|541136426|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
150000675|NCT01340937|541136427|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
150000676|NCT01340937|541136424|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
150000677|NCT01340937|541136425|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
150000678|NCT01340937|541136426|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
150000679|NCT01340937|541136427|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
150000680|NCT01340937|541136424|FG000|Period 2: Interim Period|Adverse Event|1|||
150000681|NCT01340937|541136425|FG001|Period 2: Interim Period|Adverse Event|0|||
150000682|NCT01340937|541136426|FG002|Period 2: Interim Period|Adverse Event|1|||
150000683|NCT01340937|541136427|FG003|Period 2: Interim Period|Adverse Event|0|||
150000684|NCT01340937|541136424|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
150000685|NCT01340937|541136425|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
150000686|NCT01340937|541136426|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
150000687|NCT01340937|541136427|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
150000688|NCT01340937|541136424|FG000|Period 2: Interim Period|Physician Decision|0|||
150000689|NCT01340937|541136425|FG001|Period 2: Interim Period|Physician Decision|1|||
150000690|NCT01340937|541136426|FG002|Period 2: Interim Period|Physician Decision|1|||
150000691|NCT01340937|541136427|FG003|Period 2: Interim Period|Physician Decision|0|||
150000692|NCT01340937|541136424|FG000|Period 2: Interim Period|Protocol Violation|5|||
150000693|NCT01340937|541136425|FG001|Period 2: Interim Period|Protocol Violation|3|||
150000694|NCT01340937|541136426|FG002|Period 2: Interim Period|Protocol Violation|6|||
150000695|NCT01340937|541136427|FG003|Period 2: Interim Period|Protocol Violation|3|||
150000696|NCT01340937|541136424|FG000|Period 2: Interim Period|Technical problems|4|||
150000697|NCT01340937|541136425|FG001|Period 2: Interim Period|Technical problems|4|||
150000698|NCT01340937|541136426|FG002|Period 2: Interim Period|Technical problems|6|||
150000699|NCT01340937|541136427|FG003|Period 2: Interim Period|Technical problems|3|||
150000700|NCT01340937|541136424|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
150000701|NCT01340937|541136425|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
150000702|NCT01340937|541136426|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
150000703|NCT01340937|541136427|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
150000704|NCT01340937|541136424|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
150000705|NCT01340937|541136425|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
150000706|NCT01340937|541136426|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
150000707|NCT01340937|541136427|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
150000708|NCT01340937|541136424|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
150000709|NCT01340937|541136425|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
150000710|NCT01340937|541136426|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
150000711|NCT01340937|541136427|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
150000712|NCT01340937|541136424|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
150000713|NCT01340937|541136425|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
150000714|NCT01340937|541136426|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
150000715|NCT01340937|541136427|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
150000716|NCT00440310|541136428|FG000|Overall Study|Lost to Follow-up|4|||
150000717|NCT00440310|541136429|FG001|Overall Study|Lost to Follow-up|5|||
150000718|NCT00440310|541136428|FG000|Overall Study|Protocol Violation|0|||
150054538|NCT00636363|541340314|FG002|Overall Study|Study related symptoms/complaints|4|||
150054539|NCT00636363|541340312|FG000|Overall Study|Met ineligibility criteria|0|||
150054540|NCT00636363|541340313|FG001|Overall Study|Met ineligibility criteria|0|||
150054541|NCT00636363|541340314|FG002|Overall Study|Met ineligibility criteria|3|||
150000719|NCT00440310|541136429|FG001|Overall Study|Protocol Violation|1|||
150000720|NCT00440310|541136428|FG000|Overall Study|Withdrawal by Subject|15|||
150000721|NCT00440310|541136429|FG001|Overall Study|Withdrawal by Subject|14|||
150000722|NCT00440310|541136428|FG000|Overall Study|No Reply at EOS|7|||
150000723|NCT00440310|541136429|FG001|Overall Study|No Reply at EOS|7|||
150000724|NCT00440310|541136428|FG000|Overall Study|Other|1|||
150000725|NCT00440310|541136429|FG001|Overall Study|Other|0|||
150000726|NCT00440310|541136428|FG000|Overall Study|Status Unknown|1|||
150000727|NCT00440310|541136429|FG001|Overall Study|Status Unknown|3|||
150000728|NCT02469415|541136430|FG000|Overall Study|Withdrawal by Subject|1|||
150000729|NCT02469415|541136430|FG000|Overall Study|Investigational agent placed on hold|2|||
150000730|NCT02119156|541136431|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
150000731|NCT02119156|541136432|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
150000732|NCT02119156|541136433|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
150000733|NCT02119156|541136431|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
150000734|NCT02119156|541136432|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
150000735|NCT02119156|541136433|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
150000736|NCT02119156|541136431|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
150000737|NCT02119156|541136432|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
150000738|NCT02119156|541136433|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
150000739|NCT02119156|541136431|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
150000740|NCT02119156|541136432|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
150000741|NCT02119156|541136433|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
150000742|NCT02119156|541136431|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
150000743|NCT02119156|541136432|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
150000744|NCT02119156|541136433|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
150000745|NCT01998893|541136442|FG000|Overall Study|Adverse Event|2|||
150000746|NCT01998893|541136442|FG000|Overall Study|Death|1|||
150054542|NCT00636363|541340312|FG000|Overall Study|Missed > 1 visit|0|||
150054543|NCT00636363|541340313|FG001|Overall Study|Missed > 1 visit|1|||
150054544|NCT00636363|541340314|FG002|Overall Study|Missed > 1 visit|3|||
150054545|NCT00636363|541340312|FG000|Overall Study|Lack of motivation|1|||
150054546|NCT00636363|541340313|FG001|Overall Study|Lack of motivation|0|||
150054547|NCT00636363|541340314|FG002|Overall Study|Lack of motivation|1|||
150054548|NCT00636363|541340312|FG000|Overall Study|Protocol Violation|0|||
150054549|NCT00636363|541340313|FG001|Overall Study|Protocol Violation|3|||
150054550|NCT00636363|541340314|FG002|Overall Study|Protocol Violation|0|||
150054551|NCT00636363|541340312|FG000|Overall Study|Lost to Follow-up|3|||
150054552|NCT00636363|541340313|FG001|Overall Study|Lost to Follow-up|4|||
150054553|NCT00636363|541340314|FG002|Overall Study|Lost to Follow-up|2|||
150054554|NCT00636363|541340312|FG000|Overall Study|Withdrawal by Subject|1|||
150054555|NCT00636363|541340313|FG001|Overall Study|Withdrawal by Subject|3|||
150054556|NCT00636363|541340314|FG002|Overall Study|Withdrawal by Subject|2|||
150054557|NCT00280748|541340315|FG000|Overall Study|Decline in performance|3|||
150054558|NCT00280748|541340315|FG000|Overall Study|Extra-cranial disease progression|1|||
150054559|NCT02034409|541340316|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
150054560|NCT02034409|541340317|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
150054561|NCT02034409|541340316|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
150054562|NCT02034409|541340317|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
150054563|NCT02034409|541340316|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
150054564|NCT02034409|541340317|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
150054565|NCT02034409|541340316|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
150054566|NCT02034409|541340317|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
150054567|NCT02034409|541340316|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
150054568|NCT02034409|541340317|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
150054569|NCT02034409|541340316|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
150054570|NCT02034409|541340317|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
150054571|NCT01144299|541340318|FG000|Overall Study|Lost to Follow-up|1|||
150054572|NCT01144299|541340319|FG001|Overall Study|Lost to Follow-up|0|||
150054573|NCT01144299|541340318|FG000|Overall Study|Withdrawal by Subject|1|||
150054574|NCT01144299|541340319|FG001|Overall Study|Withdrawal by Subject|0|||
150054575|NCT02342418|541340322|FG000|Overall Study|Adverse Event|0|||
150054576|NCT02342418|541340323|FG001|Overall Study|Adverse Event|1|||
150054577|NCT04255394|541340324|FG000|Overall Study|Death|35|||
150054578|NCT04255394|541340325|FG001|Overall Study|Death|25|||
150054579|NCT04255394|541340324|FG000|Overall Study|Device removed|2|||
150054580|NCT04255394|541340325|FG001|Overall Study|Device removed|10|||
150054581|NCT04255394|541340324|FG000|Overall Study|Withdrawal by Subject|9|||
150054582|NCT04255394|541340325|FG001|Overall Study|Withdrawal by Subject|8|||
150054583|NCT04255394|541340324|FG000|Overall Study|Screen Failure/Not treated|12|||
150054584|NCT04255394|541340325|FG001|Overall Study|Screen Failure/Not treated|8|||
150054585|NCT04255394|541340324|FG000|Overall Study|Lost to Follow-up|123|||
150054586|NCT04255394|541340325|FG001|Overall Study|Lost to Follow-up|265|||
150000747|NCT01998893|541136442|FG000|Overall Study|Lost to Follow-up|8|||
150054587|NCT04255394|541340324|FG000|Overall Study|Adverse Event|1|||
150054588|NCT04255394|541340325|FG001|Overall Study|Adverse Event|3|||
150054589|NCT03612856|541340333|FG000|Pre-dose Period|Physician Decision|0|||
150054590|NCT03612856|541340334|FG001|Pre-dose Period|Physician Decision|1|||
150054591|NCT03612856|541340335|FG002|Pre-dose Period|Physician Decision|1|||
150000748|NCT01998893|541136442|FG000|Overall Study|Physician Decision|2|||
150000749|NCT01998893|541136442|FG000|Overall Study|Protocol Violation|2|||
150000750|NCT01998893|541136442|FG000|Overall Study|Withdrawal by Subject|1|||
150000751|NCT01998893|541136442|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
150000752|NCT05136898|541136443|FG000|Overall Study|Adverse Event|2|||
150000753|NCT00867087|541136444|FG000|Overall Study|Other|1|||
150000754|NCT00867087|541136444|FG000|Overall Study|Withdrawal by Subject|4|||
150000755|NCT00867087|541136444|FG000|Overall Study|Death|37|||
150000756|NCT05426031|541136449|FG000|Overall Study|Circulatory Arrest|3|||
150000757|NCT05426031|541136450|FG001|Overall Study|Circulatory Arrest|2|||
150000758|NCT02419131|541136451|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
150000759|NCT02419131|541136452|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
150000760|NCT02419131|541136453|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
150000761|NCT02419131|541136451|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
150000762|NCT02419131|541136452|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
150000763|NCT02419131|541136453|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
150000764|NCT03060512|541136454|FG000|Overall Study|Adverse Event|4|||
150000765|NCT03060512|541136455|FG001|Overall Study|Adverse Event|6|||
150000766|NCT03060512|541136454|FG000|Overall Study|Lost to Follow-up|1|||
150000767|NCT03060512|541136455|FG001|Overall Study|Lost to Follow-up|1|||
150000768|NCT03060512|541136454|FG000|Overall Study|Withdrawal by Subject|1|||
150000769|NCT03060512|541136455|FG001|Overall Study|Withdrawal by Subject|0|||
150000770|NCT03060512|541136454|FG000|Overall Study|Non-compliance with study medication|1|||
150000771|NCT03060512|541136455|FG001|Overall Study|Non-compliance with study medication|2|||
150000772|NCT00089986|541136456|FG000|Overall Study|Adverse Event|6|||
150000773|NCT00089986|541136457|FG001|Overall Study|Adverse Event|9|||
150000774|NCT00089986|541136458|FG002|Overall Study|Adverse Event|6|||
150000775|NCT00089986|541136456|FG000|Overall Study|Lost to Follow-up|3|||
150000776|NCT00089986|541136457|FG001|Overall Study|Lost to Follow-up|1|||
150000777|NCT00089986|541136458|FG002|Overall Study|Lost to Follow-up|1|||
150000778|NCT00089986|541136456|FG000|Overall Study|Protocol Violation|0|||
150000779|NCT00089986|541136457|FG001|Overall Study|Protocol Violation|1|||
150000780|NCT00089986|541136458|FG002|Overall Study|Protocol Violation|0|||
150000781|NCT00089986|541136456|FG000|Overall Study|Patient transferred to another hospital|2|||
150000782|NCT00089986|541136457|FG001|Overall Study|Patient transferred to another hospital|1|||
150000783|NCT00089986|541136458|FG002|Overall Study|Patient transferred to another hospital|0|||
150000784|NCT00089986|541136456|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
150000785|NCT00089986|541136457|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
150000786|NCT00089986|541136458|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
150000787|NCT00089986|541136456|FG000|Overall Study|Hemohlobin stopping rule|0|||
150000788|NCT00089986|541136457|FG001|Overall Study|Hemohlobin stopping rule|1|||
150000789|NCT00089986|541136458|FG002|Overall Study|Hemohlobin stopping rule|0|||
150000790|NCT00089986|541136456|FG000|Overall Study|Investigator decision to withdrew|0|||
150000791|NCT00089986|541136457|FG001|Overall Study|Investigator decision to withdrew|1|||
150000792|NCT00089986|541136458|FG002|Overall Study|Investigator decision to withdrew|0|||
150000793|NCT00089986|541136456|FG000|Overall Study|Enrollment in another study|0|||
150000794|NCT00089986|541136457|FG001|Overall Study|Enrollment in another study|1|||
150000795|NCT00089986|541136458|FG002|Overall Study|Enrollment in another study|0|||
150000796|NCT00089986|541136456|FG000|Overall Study|Family decision|0|||
150000797|NCT00089986|541136457|FG001|Overall Study|Family decision|1|||
150000798|NCT00089986|541136458|FG002|Overall Study|Family decision|0|||
150000799|NCT00089986|541136456|FG000|Overall Study|Do not resuscitate (DNR)|0|||
150000800|NCT00089986|541136457|FG001|Overall Study|Do not resuscitate (DNR)|0|||
150000801|NCT00089986|541136458|FG002|Overall Study|Do not resuscitate (DNR)|1|||
150000802|NCT00089986|541136456|FG000|Overall Study|Withdrawal by Subject|3|||
150000803|NCT00089986|541136457|FG001|Overall Study|Withdrawal by Subject|6|||
150000804|NCT00089986|541136458|FG002|Overall Study|Withdrawal by Subject|2|||
150000805|NCT03946124|541136459|FG000|Overall Study|Withdrawal by Subject|19|||
150000806|NCT02334683|541136464|FG000|First 12 Week Period|Lost to Follow-up|1|||
150000807|NCT02334683|541136465|FG001|First 12 Week Period|Lost to Follow-up|0|||
150000808|NCT02334683|541136464|FG000|Second 12 Week Period|Adverse Event|0|||
150000809|NCT02334683|541136465|FG001|Second 12 Week Period|Adverse Event|1|||
150000810|NCT00241631|541136466|FG000|Run in (2 Weeks)|Physician Decision|3|||
150000811|NCT00241631|541136467|FG001|Run in (2 Weeks)|Physician Decision|3|||
150000812|NCT00241631|541136466|FG000|Phase 1 (4 Weeks)|sore throat|1|||
150000813|NCT00241631|541136467|FG001|Phase 1 (4 Weeks)|sore throat|0|||
150000814|NCT00241631|541136466|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
150000815|NCT00241631|541136467|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
150000816|NCT00241631|541136466|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
150000817|NCT00241631|541136467|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
150000818|NCT00241631|541136466|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
150000819|NCT00241631|541136467|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
150000820|NCT00413920|541136471|FG000|Overall Study|Adverse Event|9|||
150000821|NCT00413920|541136472|FG001|Overall Study|Adverse Event|11|||
150000822|NCT00413920|541136471|FG000|Overall Study|Lack of Efficacy|11|||
150000823|NCT00413920|541136472|FG001|Overall Study|Lack of Efficacy|9|||
150000824|NCT00413920|541136471|FG000|Overall Study|Death|3|||
150000825|NCT00413920|541136472|FG001|Overall Study|Death|5|||
150000826|NCT00413920|541136471|FG000|Overall Study|Graft Loss|5|||
150000827|NCT00413920|541136472|FG001|Overall Study|Graft Loss|3|||
150000828|NCT03831880|541136473|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
150000829|NCT03831880|541136474|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
150000830|NCT03831880|541136473|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
150000831|NCT03831880|541136474|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
150000832|NCT01891344|541136475|FG000|Overall Study|Ongoing|6|||
150000833|NCT01891344|541136476|FG001|Overall Study|Ongoing|2|||
150000834|NCT01891344|541136477|FG002|Overall Study|Ongoing|0|||
150000835|NCT01891344|541136478|FG003|Overall Study|Ongoing|1|||
150000836|NCT01891344|541136479|FG004|Overall Study|Ongoing|4|||
150000837|NCT01891344|541136480|FG005|Overall Study|Ongoing|1|||
150000838|NCT01891344|541136481|FG006|Overall Study|Ongoing|0|||
150000839|NCT01891344|541136482|FG007|Overall Study|Ongoing|0|||
150000840|NCT02788201|541136483|FG000|Overall Study|Death|1|||
150000841|NCT02788201|541136484|FG001|Overall Study|Death|1|||
150000842|NCT02788201|541136485|FG002|Overall Study|Death|1|||
150000843|NCT02788201|541136486|FG003|Overall Study|Death|1|||
150000844|NCT02788201|541136487|FG004|Overall Study|Death|0|||
150000845|NCT02788201|541136488|FG005|Overall Study|Death|1|||
150000846|NCT02788201|541136483|FG000|Overall Study|Ineligible|0|||
150000847|NCT02788201|541136484|FG001|Overall Study|Ineligible|0|||
150000848|NCT02788201|541136485|FG002|Overall Study|Ineligible|0|||
150000849|NCT02788201|541136486|FG003|Overall Study|Ineligible|0|||
150000850|NCT02788201|541136487|FG004|Overall Study|Ineligible|0|||
150000851|NCT02788201|541136488|FG005|Overall Study|Ineligible|1|||
150000852|NCT02788201|541136483|FG000|Overall Study|Withdrawal by Subject|0|||
150000853|NCT02788201|541136484|FG001|Overall Study|Withdrawal by Subject|0|||
150000854|NCT02788201|541136485|FG002|Overall Study|Withdrawal by Subject|0|||
150000855|NCT02788201|541136486|FG003|Overall Study|Withdrawal by Subject|0|||
150000856|NCT02788201|541136487|FG004|Overall Study|Withdrawal by Subject|0|||
150000857|NCT02788201|541136488|FG005|Overall Study|Withdrawal by Subject|1|||
150000858|NCT02969590|541136489|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
150000859|NCT02969590|541136490|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
150000860|NCT02969590|541136491|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
150000861|NCT01414205|541136494|FG000|Overall Study|Death|5|||
150000862|NCT01414205|541136495|FG001|Overall Study|Death|1|||
150000863|NCT01414205|541136494|FG000|Overall Study|Lost to Follow-up|1|||
150000864|NCT01414205|541136495|FG001|Overall Study|Lost to Follow-up|4|||
150000865|NCT01414205|541136494|FG000|Overall Study|Physician Decision|0|||
150000866|NCT01414205|541136495|FG001|Overall Study|Physician Decision|1|||
150000867|NCT01414205|541136494|FG000|Overall Study|Randomized but not Treated|1|||
150000868|NCT01414205|541136495|FG001|Overall Study|Randomized but not Treated|1|||
150000869|NCT01457950|541136496|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
150000870|NCT01457950|541136497|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
150000871|NCT01457950|541136498|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
150000872|NCT01457950|541136499|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
150000873|NCT01457950|541136496|FG000|Double-Blind Phase|Protocol Violation|2|||
150000874|NCT01457950|541136497|FG001|Double-Blind Phase|Protocol Violation|1|||
150000875|NCT01457950|541136498|FG002|Double-Blind Phase|Protocol Violation|0|||
150000876|NCT01457950|541136499|FG003|Double-Blind Phase|Protocol Violation|0|||
150000877|NCT01457950|541136496|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
150000878|NCT01457950|541136497|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
150000879|NCT01457950|541136498|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
150000880|NCT01457950|541136499|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
150000881|NCT01457950|541136496|FG000|Open-Label Phase|Adverse Event|0|||
150000882|NCT01457950|541136497|FG001|Open-Label Phase|Adverse Event|0|||
150000883|NCT01457950|541136498|FG002|Open-Label Phase|Adverse Event|0|||
150000884|NCT01457950|541136499|FG003|Open-Label Phase|Adverse Event|1|||
150000885|NCT01457950|541136496|FG000|Open-Label Phase|Protocol Violation|0|||
150000886|NCT01457950|541136497|FG001|Open-Label Phase|Protocol Violation|0|||
150000887|NCT01457950|541136498|FG002|Open-Label Phase|Protocol Violation|0|||
150000888|NCT01457950|541136499|FG003|Open-Label Phase|Protocol Violation|1|||
150000889|NCT01457950|541136496|FG000|Open-Label Phase|Withdrawal by Subject|0|||
150000890|NCT01457950|541136497|FG001|Open-Label Phase|Withdrawal by Subject|0|||
150000891|NCT01457950|541136498|FG002|Open-Label Phase|Withdrawal by Subject|2|||
150000892|NCT01457950|541136499|FG003|Open-Label Phase|Withdrawal by Subject|0|||
150000893|NCT01765426|541136500|FG000|Overall Study|Lost to Follow-up|0|||
150000894|NCT01765426|541136501|FG001|Overall Study|Lost to Follow-up|1|||
150000895|NCT01765426|541136502|FG002|Overall Study|Lost to Follow-up|0|||
150000896|NCT01765426|541136503|FG003|Overall Study|Lost to Follow-up|0|||
150000897|NCT01166373|541136504|FG000|Overall Study|Lost to Follow-up|3|||
150000898|NCT01166373|541136505|FG001|Overall Study|Lost to Follow-up|2|||
150000899|NCT01166373|541136506|FG002|Overall Study|Lost to Follow-up|2|||
150000900|NCT01166373|541136507|FG003|Overall Study|Lost to Follow-up|2|||
150000901|NCT01166373|541136504|FG000|Overall Study|Withdrawal by Subject|1|||
150000902|NCT01166373|541136505|FG001|Overall Study|Withdrawal by Subject|2|||
150000903|NCT01166373|541136506|FG002|Overall Study|Withdrawal by Subject|2|||
150000904|NCT01166373|541136507|FG003|Overall Study|Withdrawal by Subject|3|||
150054592|NCT03612856|541340333|FG000|Pre-dose Period|Withdrawal by Subject|0|||
150000905|NCT01166373|541136504|FG000|Overall Study|Physician Decision|1|||
150000906|NCT01166373|541136505|FG001|Overall Study|Physician Decision|0|||
150000907|NCT01166373|541136506|FG002|Overall Study|Physician Decision|0|||
150000908|NCT01166373|541136507|FG003|Overall Study|Physician Decision|0|||
150000909|NCT01510184|541136508|FG000|Overall Study|Sponsor discretion|28|||
150000910|NCT01510184|541136509|FG001|Overall Study|Sponsor discretion|28|||
150000911|NCT01510184|541136508|FG000|Overall Study|Death|1|||
150000912|NCT01510184|541136509|FG001|Overall Study|Death|2|||
150000913|NCT01510184|541136508|FG000|Overall Study|Withdrawal by Subject|1|||
150000914|NCT01510184|541136509|FG001|Overall Study|Withdrawal by Subject|4|||
150000915|NCT01510184|541136508|FG000|Overall Study|Other|0|||
150000916|NCT01510184|541136509|FG001|Overall Study|Other|1|||
150000917|NCT02498067|541136510|FG000|Overall Study|Lost to Follow-up|22|||
150000918|NCT02498067|541136510|FG000|Overall Study|Did not meet inclusion criteria|11|||
150000919|NCT02310230|541136511|FG000|Overall Study|Physician Decision|1|||
150000920|NCT02310230|541136512|FG001|Overall Study|Physician Decision|3|||
150000921|NCT02310230|541136511|FG000|Overall Study|monitor baseline taken after induction|2|||
150000922|NCT02310230|541136512|FG001|Overall Study|monitor baseline taken after induction|7|||
150000923|NCT02310230|541136511|FG000|Overall Study|Poor signal quality|5|||
150000924|NCT02310230|541136512|FG001|Overall Study|Poor signal quality|8|||
150000925|NCT02310230|541136511|FG000|Overall Study|Case cancelled|1|||
150000926|NCT02310230|541136512|FG001|Overall Study|Case cancelled|0|||
150000927|NCT03593681|541136513|FG000|Overall Study|Inadequate sample collected|12|||
150000928|NCT03593681|541136513|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
150000929|NCT03593681|541136513|FG000|Overall Study|Protocol Violation|3|||
150000930|NCT03593681|541136513|FG000|Overall Study|Withdrawal by Subject|3|||
150000931|NCT03593681|541136513|FG000|Overall Study|Procedure not attempted|3|||
150000932|NCT03593681|541136513|FG000|Overall Study|Adverse Event|2|||
150000933|NCT03593681|541136513|FG000|Overall Study|Physician Decision|1|||
150000934|NCT04662073|541136519|FG000|Overall Study|Withdrawal by Subject|1|||
150000935|NCT04662073|541136520|FG001|Overall Study|Withdrawal by Subject|0|||
150000936|NCT02961790|541136521|FG000|Overall Study|Canceled|4|||
150000937|NCT02961790|541136522|FG001|Overall Study|Canceled|5|||
150000938|NCT02961790|541136523|FG002|Overall Study|Canceled|1|||
150000939|NCT02961790|541136524|FG003|Overall Study|Canceled|4|||
150000940|NCT02961790|541136521|FG000|Overall Study|without baseline data|4|||
150000941|NCT02961790|541136522|FG001|Overall Study|without baseline data|0|||
150000942|NCT02961790|541136523|FG002|Overall Study|without baseline data|1|||
150000943|NCT02961790|541136524|FG003|Overall Study|without baseline data|0|||
150000944|NCT02961790|541136521|FG000|Overall Study|without post baseline data|7|||
150000945|NCT02961790|541136522|FG001|Overall Study|without post baseline data|6|||
150000946|NCT02961790|541136523|FG002|Overall Study|without post baseline data|4|||
150000947|NCT02961790|541136524|FG003|Overall Study|without post baseline data|1|||
150000948|NCT02594098|541136525|FG000|Overall Study|Lack of Efficacy|17|||
150000949|NCT02594098|541136526|FG001|Overall Study|Lack of Efficacy|6|||
150000950|NCT02594098|541136525|FG000|Overall Study|Withdrawal by Subject|1|||
150000951|NCT02594098|541136526|FG001|Overall Study|Withdrawal by Subject|3|||
150000952|NCT02594098|541136525|FG000|Overall Study|Terminated participation|6|||
150000953|NCT02594098|541136526|FG001|Overall Study|Terminated participation|2|||
150000954|NCT02594098|541136525|FG000|Overall Study|Seek alternative treatment|2|||
150000955|NCT02594098|541136526|FG001|Overall Study|Seek alternative treatment|1|||
150000956|NCT02594098|541136525|FG000|Overall Study|Other|0|||
150000957|NCT02594098|541136526|FG001|Overall Study|Other|1|||
150000958|NCT02078102|541136527|FG000|Overall Study|Adverse Event|1|||
150000959|NCT02078102|541136528|FG001|Overall Study|Adverse Event|0|||
150000960|NCT02078102|541136527|FG000|Overall Study|Withdrawal by Subject|1|||
150000961|NCT02078102|541136528|FG001|Overall Study|Withdrawal by Subject|0|||
150000962|NCT02078102|541136527|FG000|Overall Study|Physician Decision|0|||
150000963|NCT02078102|541136528|FG001|Overall Study|Physician Decision|1|||
150000964|NCT02370641|541136532|FG000|Overall Study|dropped study|4|||
150000965|NCT02370641|541136533|FG001|Overall Study|dropped study|2|||
150000966|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
150000967|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
150000968|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
150000969|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
150000970|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
150000971|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
150000972|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
150000973|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
150000974|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
150000975|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
150000976|NCT03906656|541136537|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
150000977|NCT03906656|541136538|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
150000978|NCT03906656|541136537|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
150000979|NCT03906656|541136538|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
150000980|NCT03906656|541136537|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
150000981|NCT03906656|541136538|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
150000982|NCT03906656|541136537|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
150000983|NCT03906656|541136538|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
150000984|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
150000985|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
150000986|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
150000987|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
150000988|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
150000989|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
150000990|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
150000991|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
150000992|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
150000993|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
150000994|NCT03906656|541136537|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
150000995|NCT03906656|541136538|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
150000996|NCT03906656|541136537|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
150000997|NCT03906656|541136538|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
150000998|NCT03906656|541136537|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
150000999|NCT03906656|541136538|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
150001000|NCT03906656|541136537|FG000|Home Use 2 (3 Months)|Death|2|||
150001001|NCT03906656|541136538|FG001|Home Use 2 (3 Months)|Death|0|||
150001002|NCT03906656|541136537|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
150001003|NCT03906656|541136538|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
150001004|NCT03906656|541136537|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
150001005|NCT03906656|541136538|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
150001006|NCT01036529|541136539|FG000|Overall Study|Adverse Event|0|||
150001007|NCT01036529|541136540|FG001|Overall Study|Adverse Event|1|||
150001008|NCT01036529|541136539|FG000|Overall Study|Lost to Follow-up|0|||
150001009|NCT01036529|541136540|FG001|Overall Study|Lost to Follow-up|1|||
150001010|NCT01036529|541136539|FG000|Overall Study|Physician Decision|1|||
150001011|NCT01036529|541136540|FG001|Overall Study|Physician Decision|0|||
150001012|NCT01036529|541136539|FG000|Overall Study|Withdrawal by Subject|1|||
150001013|NCT01036529|541136540|FG001|Overall Study|Withdrawal by Subject|1|||
150001014|NCT01036529|541136539|FG000|Overall Study|Sponsor study termination|11|||
150001015|NCT01036529|541136540|FG001|Overall Study|Sponsor study termination|12|||
150179609|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
150179610|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
150001016|NCT00066469|541136542|FG000|Overall Study|Death|3|||
150001017|NCT00066469|541136542|FG000|Overall Study|Lack of Efficacy|9|||
150001018|NCT00066469|541136542|FG000|Overall Study|Lost to Follow-up|1|||
150001019|NCT00066469|541136542|FG000|Overall Study|Physician Decision|1|||
150001020|NCT00066469|541136542|FG000|Overall Study|Withdrawal by Subject|1|||
150001021|NCT00066469|541136542|FG000|Overall Study|ineligible|1|||
150001022|NCT00711802|541136543|FG000|Overall Study|Not treated (no further detail)|2|||
150001023|NCT00711802|541136544|FG001|Overall Study|Not treated (no further detail)|1|||
150001024|NCT00711802|541136545|FG002|Overall Study|Not treated (no further detail)|2|||
150001025|NCT00711802|541136546|FG003|Overall Study|Not treated (no further detail)|0|||
150001026|NCT00711802|541136547|FG004|Overall Study|Not treated (no further detail)|2|||
150001027|NCT00711802|541136548|FG005|Overall Study|Not treated (no further detail)|0|||
150001028|NCT00711802|541136549|FG006|Overall Study|Not treated (no further detail)|0|||
150001029|NCT00711802|541136550|FG007|Overall Study|Not treated (no further detail)|0|||
150001030|NCT00711802|541136543|FG000|Overall Study|Adverse Event|0|||
150001031|NCT00711802|541136544|FG001|Overall Study|Adverse Event|0|||
150001032|NCT00711802|541136545|FG002|Overall Study|Adverse Event|0|||
150001033|NCT00711802|541136546|FG003|Overall Study|Adverse Event|0|||
150001034|NCT00711802|541136547|FG004|Overall Study|Adverse Event|1|||
150001035|NCT00711802|541136548|FG005|Overall Study|Adverse Event|1|||
150001036|NCT00711802|541136549|FG006|Overall Study|Adverse Event|0|||
150001037|NCT00711802|541136550|FG007|Overall Study|Adverse Event|0|||
150001038|NCT00711802|541136543|FG000|Overall Study|Microbiological failure|0|||
150001039|NCT00711802|541136544|FG001|Overall Study|Microbiological failure|1|||
150001040|NCT00711802|541136545|FG002|Overall Study|Microbiological failure|0|||
150179611|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
150001041|NCT00711802|541136546|FG003|Overall Study|Microbiological failure|0|||
150001042|NCT00711802|541136547|FG004|Overall Study|Microbiological failure|0|||
150001043|NCT00711802|541136548|FG005|Overall Study|Microbiological failure|1|||
150001044|NCT00711802|541136549|FG006|Overall Study|Microbiological failure|0|||
150001045|NCT00711802|541136550|FG007|Overall Study|Microbiological failure|0|||
150001046|NCT00711802|541136543|FG000|Overall Study|Protocol Violation|0|||
150001047|NCT00711802|541136544|FG001|Overall Study|Protocol Violation|0|||
150001048|NCT00711802|541136545|FG002|Overall Study|Protocol Violation|0|||
150001049|NCT00711802|541136546|FG003|Overall Study|Protocol Violation|1|||
150001050|NCT00711802|541136547|FG004|Overall Study|Protocol Violation|0|||
150001051|NCT00711802|541136548|FG005|Overall Study|Protocol Violation|0|||
150179612|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
150001052|NCT00711802|541136549|FG006|Overall Study|Protocol Violation|0|||
150001053|NCT00711802|541136550|FG007|Overall Study|Protocol Violation|0|||
150001054|NCT00711802|541136543|FG000|Overall Study|Physician Decision|0|||
150001055|NCT00711802|541136544|FG001|Overall Study|Physician Decision|2|||
150001056|NCT00711802|541136545|FG002|Overall Study|Physician Decision|0|||
150001057|NCT00711802|541136546|FG003|Overall Study|Physician Decision|0|||
150001058|NCT00711802|541136547|FG004|Overall Study|Physician Decision|0|||
150001059|NCT00711802|541136548|FG005|Overall Study|Physician Decision|0|||
150001060|NCT00711802|541136549|FG006|Overall Study|Physician Decision|0|||
150001061|NCT00711802|541136550|FG007|Overall Study|Physician Decision|0|||
150001062|NCT00711802|541136543|FG000|Overall Study|Withdrawal by Subject|0|||
150001063|NCT00711802|541136544|FG001|Overall Study|Withdrawal by Subject|1|||
150001064|NCT00711802|541136545|FG002|Overall Study|Withdrawal by Subject|0|||
150001065|NCT00711802|541136546|FG003|Overall Study|Withdrawal by Subject|1|||
150001066|NCT00711802|541136547|FG004|Overall Study|Withdrawal by Subject|0|||
150001067|NCT00711802|541136548|FG005|Overall Study|Withdrawal by Subject|0|||
150001068|NCT00711802|541136549|FG006|Overall Study|Withdrawal by Subject|0|||
150001069|NCT00711802|541136550|FG007|Overall Study|Withdrawal by Subject|0|||
150001070|NCT00711802|541136543|FG000|Overall Study|Lost to Follow-up|0|||
150001071|NCT00711802|541136544|FG001|Overall Study|Lost to Follow-up|0|||
150001072|NCT00711802|541136545|FG002|Overall Study|Lost to Follow-up|3|||
150001073|NCT00711802|541136546|FG003|Overall Study|Lost to Follow-up|1|||
150001074|NCT00711802|541136547|FG004|Overall Study|Lost to Follow-up|10|||
150001075|NCT00711802|541136548|FG005|Overall Study|Lost to Follow-up|6|||
150001076|NCT00711802|541136549|FG006|Overall Study|Lost to Follow-up|4|||
150001077|NCT00711802|541136550|FG007|Overall Study|Lost to Follow-up|2|||
150001078|NCT00711802|541136543|FG000|Overall Study|Reason not reported|0|||
150001079|NCT00711802|541136544|FG001|Overall Study|Reason not reported|1|||
150001080|NCT00711802|541136545|FG002|Overall Study|Reason not reported|1|||
150001081|NCT00711802|541136546|FG003|Overall Study|Reason not reported|0|||
150001082|NCT00711802|541136547|FG004|Overall Study|Reason not reported|1|||
150001083|NCT00711802|541136548|FG005|Overall Study|Reason not reported|0|||
150001084|NCT00711802|541136549|FG006|Overall Study|Reason not reported|1|||
150001085|NCT00711802|541136550|FG007|Overall Study|Reason not reported|0|||
150001086|NCT02084238|541136555|FG000|Overall Study|Lost to Follow-up|2|||
150001087|NCT02436408|541136556|FG000|Overall Study|Death|1|||
150001088|NCT02782325|541136557|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
150001089|NCT02782325|541136558|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
150001090|NCT02782325|541136559|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
150001091|NCT02782325|541136557|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
150054593|NCT03612856|541340334|FG001|Pre-dose Period|Withdrawal by Subject|1|||
150054594|NCT03612856|541340335|FG002|Pre-dose Period|Withdrawal by Subject|0|||
150054595|NCT01181986|541340336|FG000|Phase 1|Lost to Follow-up|0|||
150054596|NCT01181986|541340337|FG001|Phase 1|Lost to Follow-up|1|||
150054597|NCT01181986|541340338|FG002|Phase 1|Lost to Follow-up|1|||
150054598|NCT01181986|541340336|FG000|Phase 1|Adverse Event|0|||
150054599|NCT01181986|541340337|FG001|Phase 1|Adverse Event|0|||
150054600|NCT01181986|541340338|FG002|Phase 1|Adverse Event|1|||
150054601|NCT01181986|541340336|FG000|Phase 1|Protocol Violation|1|||
150054602|NCT01181986|541340337|FG001|Phase 1|Protocol Violation|0|||
150054603|NCT01181986|541340338|FG002|Phase 1|Protocol Violation|0|||
150054604|NCT01181986|541340336|FG000|Phase 2|Adverse Event|0|||
150054605|NCT01181986|541340337|FG001|Phase 2|Adverse Event|3|||
150054606|NCT01181986|541340338|FG002|Phase 2|Adverse Event|0|||
150054607|NCT01181986|541340336|FG000|Phase 2|Medical condition|0|||
150054608|NCT01181986|541340337|FG001|Phase 2|Medical condition|1|||
150054609|NCT01181986|541340338|FG002|Phase 2|Medical condition|0|||
150054610|NCT01011309|541340339|FG000|Overall Study|Adverse Event|2|||
150054611|NCT01011309|541340340|FG001|Overall Study|Adverse Event|1|||
150054612|NCT01011309|541340341|FG002|Overall Study|Adverse Event|2|||
150054613|NCT01011309|541340339|FG000|Overall Study|Lack of Efficacy|0|||
150054614|NCT01011309|541340340|FG001|Overall Study|Lack of Efficacy|1|||
150054615|NCT01011309|541340341|FG002|Overall Study|Lack of Efficacy|0|||
150054616|NCT01011309|541340339|FG000|Overall Study|Protocol Violation|0|||
150054617|NCT01011309|541340340|FG001|Overall Study|Protocol Violation|1|||
150001092|NCT02782325|541136558|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
150001093|NCT02782325|541136559|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
150001094|NCT01154283|541136560|FG000|0-6 Weeks|Withdrawal by Subject|7|||
150001095|NCT01154283|541136561|FG001|0-6 Weeks|Withdrawal by Subject|2|||
150001096|NCT01154283|541136560|FG000|0-6 Weeks|Death|0|||
150001097|NCT01154283|541136561|FG001|0-6 Weeks|Death|1|||
150001098|NCT01154283|541136560|FG000|7-12 Weeks|Death|1|||
150054618|NCT01011309|541340341|FG002|Overall Study|Protocol Violation|3|||
150054619|NCT00831493|541340344|FG000|Overall Study|Intractable nausea and vomiting|1|||
150054620|NCT05092360|541340352|FG000|Overall Study|Withdrawal by Subject|21|||
150054621|NCT05092360|541340353|FG001|Overall Study|Withdrawal by Subject|4|||
150054622|NCT05092360|541340354|FG002|Overall Study|Withdrawal by Subject|9|||
150054623|NCT05092360|541340355|FG003|Overall Study|Withdrawal by Subject|26|||
150054624|NCT05092360|541340352|FG000|Overall Study|Death|97|||
150054625|NCT05092360|541340353|FG001|Overall Study|Death|14|||
150001099|NCT01154283|541136561|FG001|7-12 Weeks|Death|0|||
150001100|NCT01154283|541136560|FG000|7-12 Weeks|Withdrawal by Subject|0|||
150001101|NCT01154283|541136561|FG001|7-12 Weeks|Withdrawal by Subject|1|||
150001102|NCT00042432|541136562|FG000|Overall Study|Adverse Event|4|||
150001103|NCT00042432|541136563|FG001|Overall Study|Adverse Event|1|||
150001104|NCT00042432|541136562|FG000|Overall Study|Withdrawal by Subject|1|||
150001105|NCT00042432|541136563|FG001|Overall Study|Withdrawal by Subject|3|||
150001106|NCT00042432|541136562|FG000|Overall Study|Death|0|||
150001107|NCT00042432|541136563|FG001|Overall Study|Death|2|||
150001108|NCT00042432|541136562|FG000|Overall Study|Ineligibility determined|1|||
150001109|NCT00042432|541136563|FG001|Overall Study|Ineligibility determined|0|||
150001110|NCT00042432|541136562|FG000|Overall Study|Initiation of maintenance dialysis|1|||
150001111|NCT00042432|541136563|FG001|Overall Study|Initiation of maintenance dialysis|1|||
150001112|NCT00042432|541136562|FG000|Overall Study|Other|2|||
150001113|NCT00042432|541136563|FG001|Overall Study|Other|0|||
150001114|NCT00320372|541136564|FG000|Overall Study|Physician Decision|4|||
150001115|NCT00320372|541136565|FG001|Overall Study|Physician Decision|7|||
150001116|NCT00320372|541136564|FG000|Overall Study|Death|7|||
150001117|NCT00320372|541136565|FG001|Overall Study|Death|8|||
150001118|NCT00320372|541136564|FG000|Overall Study|Withdrawal by Subject|55|||
150001119|NCT00320372|541136565|FG001|Overall Study|Withdrawal by Subject|37|||
150001120|NCT00320372|541136564|FG000|Overall Study|Non-Compliance|40|||
150001121|NCT00320372|541136565|FG001|Overall Study|Non-Compliance|39|||
150001122|NCT00320372|541136564|FG000|Overall Study|Did not Meet (I/E)|3|||
150001123|NCT00320372|541136565|FG001|Overall Study|Did not Meet (I/E)|1|||
150001124|NCT00320372|541136564|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
150001125|NCT00320372|541136565|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
150001126|NCT01853072|541136566|FG000|Overall Study|Adverse event prior to treatment|0|||
150001127|NCT01853072|541136567|FG001|Overall Study|Adverse event prior to treatment|1|||
150001128|NCT01853072|541136566|FG000|Overall Study|Adverse Event|0|||
150001129|NCT01853072|541136567|FG001|Overall Study|Adverse Event|3|||
150001130|NCT01853072|541136566|FG000|Overall Study|Death|1|||
150001131|NCT01853072|541136567|FG001|Overall Study|Death|4|||
150001132|NCT01853072|541136566|FG000|Overall Study|Lost to Follow-up|0|||
150001133|NCT01853072|541136567|FG001|Overall Study|Lost to Follow-up|3|||
150001134|NCT01853072|541136566|FG000|Overall Study|Non-compliance with study drug|0|||
150001135|NCT01853072|541136567|FG001|Overall Study|Non-compliance with study drug|1|||
150001136|NCT01853072|541136566|FG000|Overall Study|Physician Decision|1|||
150001137|NCT01853072|541136567|FG001|Overall Study|Physician Decision|1|||
150001138|NCT01853072|541136566|FG000|Overall Study|Withdrawal by Subject|1|||
150001139|NCT01853072|541136567|FG001|Overall Study|Withdrawal by Subject|2|||
150001140|NCT01853072|541136566|FG000|Overall Study|Reason not specified|9|||
150001141|NCT01853072|541136567|FG001|Overall Study|Reason not specified|6|||
150001142|NCT03959982|541138752|FG000|Overall Study|Withdrawal by Subject|1|||
150001143|NCT03959982|541138753|FG001|Overall Study|Withdrawal by Subject|0|||
150001144|NCT03959982|541138752|FG000|Overall Study|Physician Decision|2|||
150001145|NCT03959982|541138753|FG001|Overall Study|Physician Decision|0|||
150001146|NCT03959982|541138752|FG000|Overall Study|Lost to Follow-up|1|||
150001147|NCT03959982|541138753|FG001|Overall Study|Lost to Follow-up|0|||
150001148|NCT00262847|541138754|FG000|Overall Study|Disease Progression|309|||
150001149|NCT00262847|541138755|FG001|Overall Study|Disease Progression|274|||
150001150|NCT00262847|541138756|FG002|Overall Study|Disease Progression|195|||
150001151|NCT00262847|541138754|FG000|Overall Study|Patient Refusal|41|||
150001152|NCT00262847|541138755|FG001|Overall Study|Patient Refusal|52|||
150001153|NCT00262847|541138756|FG002|Overall Study|Patient Refusal|47|||
150001154|NCT00262847|541138754|FG000|Overall Study|Adverse Event|74|||
150001155|NCT00262847|541138755|FG001|Overall Study|Adverse Event|88|||
150001156|NCT00262847|541138756|FG002|Overall Study|Adverse Event|108|||
150001157|NCT00262847|541138754|FG000|Overall Study|Death|8|||
150001158|NCT00262847|541138755|FG001|Overall Study|Death|8|||
150001159|NCT00262847|541138756|FG002|Overall Study|Death|11|||
150001160|NCT00262847|541138754|FG000|Overall Study|Concomitant disease|3|||
150001161|NCT00262847|541138755|FG001|Overall Study|Concomitant disease|2|||
150001162|NCT00262847|541138756|FG002|Overall Study|Concomitant disease|4|||
150001163|NCT00262847|541138754|FG000|Overall Study|Other Reasons|79|||
150001164|NCT00262847|541138755|FG001|Overall Study|Other Reasons|88|||
150001165|NCT00262847|541138756|FG002|Overall Study|Other Reasons|27|||
150001166|NCT00262847|541138754|FG000|Overall Study|Did not receive study treatment|4|||
150001167|NCT00262847|541138755|FG001|Overall Study|Did not receive study treatment|1|||
150001168|NCT00262847|541138756|FG002|Overall Study|Did not receive study treatment|4|||
150001169|NCT02231762|541138761|FG000|Combination Phase|Adverse Event|10|||
150001170|NCT02231762|541138762|FG001|Combination Phase|Adverse Event|0|||
150001171|NCT02231762|541138763|FG002|Combination Phase|Adverse Event|0|||
150001172|NCT02231762|541138764|FG003|Combination Phase|Adverse Event|0|||
150001173|NCT02231762|541138761|FG000|Combination Phase|Withdrawal by Subject|2|||
150001174|NCT02231762|541138762|FG001|Combination Phase|Withdrawal by Subject|0|||
150001175|NCT02231762|541138763|FG002|Combination Phase|Withdrawal by Subject|0|||
150001176|NCT02231762|541138764|FG003|Combination Phase|Withdrawal by Subject|0|||
150001177|NCT02231762|541138761|FG000|Combination Phase|Disease Progression|6|||
150001178|NCT02231762|541138762|FG001|Combination Phase|Disease Progression|0|||
150001179|NCT02231762|541138763|FG002|Combination Phase|Disease Progression|0|||
150001180|NCT02231762|541138764|FG003|Combination Phase|Disease Progression|0|||
150001181|NCT02231762|541138761|FG000|Combination Phase|Did not meet inclusion criteria|1|||
150001182|NCT02231762|541138762|FG001|Combination Phase|Did not meet inclusion criteria|0|||
150001183|NCT02231762|541138763|FG002|Combination Phase|Did not meet inclusion criteria|0|||
150001184|NCT02231762|541138764|FG003|Combination Phase|Did not meet inclusion criteria|0|||
150001185|NCT02231762|541138761|FG000|Combination Phase|Protocol Violation|1|||
150001186|NCT02231762|541138762|FG001|Combination Phase|Protocol Violation|0|||
150001187|NCT02231762|541138763|FG002|Combination Phase|Protocol Violation|0|||
150001188|NCT02231762|541138764|FG003|Combination Phase|Protocol Violation|0|||
150001189|NCT02231762|541138761|FG000|Maintenance Phase|Disease progression|0|||
150001190|NCT02231762|541138762|FG001|Maintenance Phase|Disease progression|3|||
150001191|NCT02231762|541138763|FG002|Maintenance Phase|Disease progression|4|||
150001192|NCT02231762|541138764|FG003|Maintenance Phase|Disease progression|3|||
150001193|NCT02231762|541138761|FG000|Maintenance Phase|Adverse Event|0|||
150001194|NCT02231762|541138762|FG001|Maintenance Phase|Adverse Event|0|||
150001195|NCT02231762|541138763|FG002|Maintenance Phase|Adverse Event|1|||
150001196|NCT02231762|541138764|FG003|Maintenance Phase|Adverse Event|2|||
150001197|NCT00989235|541138769|FG000|Overall Study|Death|0|||
150001198|NCT00989235|541138770|FG001|Overall Study|Death|1|||
150001199|NCT00989235|541138769|FG000|Overall Study|Adverse Event|0|||
150001200|NCT00989235|541138770|FG001|Overall Study|Adverse Event|1|||
150001201|NCT00989235|541138769|FG000|Overall Study|Lack of Efficacy|1|||
150001202|NCT00989235|541138770|FG001|Overall Study|Lack of Efficacy|0|||
150001203|NCT00989235|541138769|FG000|Overall Study|Withdrawal of Consent|1|||
150001204|NCT00989235|541138770|FG001|Overall Study|Withdrawal of Consent|1|||
150001205|NCT00989235|541138769|FG000|Overall Study|Desire to Become Pregnant|1|||
150001206|NCT00989235|541138770|FG001|Overall Study|Desire to Become Pregnant|0|||
150001207|NCT00989235|541138769|FG000|Overall Study|Randomized by Mistake|0|||
150001208|NCT00989235|541138770|FG001|Overall Study|Randomized by Mistake|2|||
150001209|NCT00989235|541138769|FG000|Overall Study|Lost to Follow-up|0|||
150001210|NCT00989235|541138770|FG001|Overall Study|Lost to Follow-up|1|||
150001211|NCT03249935|541138771|FG000|Overall Study|Discharged from facility early|36|||
150001212|NCT03249935|541138771|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
150001213|NCT03249935|541138771|FG000|Overall Study|Protocol Violation|5|||
150001214|NCT01669421|541138774|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
150001215|NCT01669421|541138774|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
150001216|NCT01149486|541138775|FG000|First Intervention|Adverse Event|0|||
150001217|NCT01149486|541138776|FG001|First Intervention|Adverse Event|1|||
150001218|NCT02813668|541138781|FG000|Overall Study|Death|4|||
150001219|NCT02813668|541138781|FG000|Overall Study|Lost to Follow-up|509|||
150001220|NCT02813668|541138781|FG000|Overall Study|Withdrawal by Subject|148|||
150001221|NCT02813668|541138781|FG000|Overall Study|No longer at worksite|85|||
150001222|NCT02813668|541138781|FG000|Overall Study|Medical reasons not related to the study|4|||
150001223|NCT01135914|541138782|FG000|Overall Study|Withdrawal by Subject|1|||
150001224|NCT01135914|541138783|FG001|Overall Study|Withdrawal by Subject|3|||
150001225|NCT01135914|541138784|FG002|Overall Study|Withdrawal by Subject|6|||
150001226|NCT01135914|541138782|FG000|Overall Study|Lost to Follow-up|1|||
150001227|NCT01135914|541138783|FG001|Overall Study|Lost to Follow-up|0|||
150001228|NCT01135914|541138784|FG002|Overall Study|Lost to Follow-up|1|||
150001229|NCT01135914|541138782|FG000|Overall Study|Protocol Violation|0|||
150001230|NCT01135914|541138783|FG001|Overall Study|Protocol Violation|0|||
150001231|NCT01135914|541138784|FG002|Overall Study|Protocol Violation|3|||
150001232|NCT01135914|541138782|FG000|Overall Study|Lack of Efficacy|2|||
150001233|NCT01135914|541138783|FG001|Overall Study|Lack of Efficacy|1|||
150001234|NCT01135914|541138784|FG002|Overall Study|Lack of Efficacy|10|||
150001235|NCT01135914|541138782|FG000|Overall Study|Adverse Event|0|||
150001236|NCT01135914|541138783|FG001|Overall Study|Adverse Event|1|||
150001237|NCT01135914|541138784|FG002|Overall Study|Adverse Event|2|||
150001238|NCT02133664|541138795|FG000|Overall Study|Lost to Follow-up|2|||
150001239|NCT02133664|541138796|FG001|Overall Study|Lost to Follow-up|1|||
150001240|NCT02133664|541138795|FG000|Overall Study|Adverse Event|3|||
150001241|NCT02133664|541138796|FG001|Overall Study|Adverse Event|6|||
150001242|NCT03366103|541138797|FG000|Overall Study|Disease Progression|3|||
150001243|NCT03366103|541138798|FG001|Overall Study|Disease Progression|1|||
150001244|NCT03366103|541138799|FG002|Overall Study|Disease Progression|0|||
150001245|NCT03366103|541138797|FG000|Overall Study|Adverse Event|0|||
150001246|NCT03366103|541138798|FG001|Overall Study|Adverse Event|1|||
150001247|NCT03366103|541138799|FG002|Overall Study|Adverse Event|0|||
150001248|NCT02370095|541138807|FG000|Overall Study|Withdrawal by Subject|0|||
150001249|NCT02370095|541138808|FG001|Overall Study|Withdrawal by Subject|1|||
150001250|NCT00581828|541138809|FG000|Overall Study|Protocol Violation|1|||
150001251|NCT01667562|541138810|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
150001252|NCT01667562|541138811|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
150001253|NCT01667562|541138810|FG000|Erlotinib Phase|Lost to Follow-up|0|||
150001254|NCT01667562|541138811|FG001|Erlotinib Phase|Lost to Follow-up|1|||
150001255|NCT01667562|541138810|FG000|Erlotinib Phase|Adverse Event|0|||
150001256|NCT01667562|541138811|FG001|Erlotinib Phase|Adverse Event|1|||
150001257|NCT01667562|541138810|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
150001258|NCT01667562|541138811|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
150001259|NCT02130986|541138812|FG000|Overall Study|Withdrawal by Subject|4|||
150001260|NCT02130986|541138813|FG001|Overall Study|Withdrawal by Subject|4|||
150001261|NCT02130986|541138812|FG000|Overall Study|Lost to Follow-up|151|||
150001262|NCT02130986|541138813|FG001|Overall Study|Lost to Follow-up|160|||
150001263|NCT01129882|541138814|FG000|Overall Study|Adverse Event|39|||
150001264|NCT01129882|541138814|FG000|Overall Study|Death|6|||
150001265|NCT01129882|541138814|FG000|Overall Study|Lack of Efficacy|5|||
150001266|NCT01129882|541138814|FG000|Overall Study|Lost to Follow-up|13|||
150001267|NCT01129882|541138814|FG000|Overall Study|Physician Decision|27|||
150001268|NCT01129882|541138814|FG000|Overall Study|Protocol Deviation|3|||
150001269|NCT01129882|541138814|FG000|Overall Study|Withdrawal Criteria Met|19|||
150001270|NCT01129882|541138814|FG000|Overall Study|Trial Termination by Sponsor|6|||
150001271|NCT01129882|541138814|FG000|Overall Study|Withdrawal by Subject|160|||
150001272|NCT02305849|541138815|FG000|Overall Study|Adverse Event|10|||
150001273|NCT02305849|541138816|FG001|Overall Study|Adverse Event|12|||
150001274|NCT02305849|541138817|FG002|Overall Study|Adverse Event|7|||
150001275|NCT02305849|541138818|FG003|Overall Study|Adverse Event|3|||
150001276|NCT02305849|541138815|FG000|Overall Study|Lack of Efficacy|10|||
150001277|NCT02305849|541138816|FG001|Overall Study|Lack of Efficacy|6|||
150001278|NCT02305849|541138817|FG002|Overall Study|Lack of Efficacy|3|||
150001279|NCT02305849|541138818|FG003|Overall Study|Lack of Efficacy|9|||
150001280|NCT02305849|541138815|FG000|Overall Study|Withdrawal by Subject|2|||
150001281|NCT02305849|541138816|FG001|Overall Study|Withdrawal by Subject|2|||
150001282|NCT02305849|541138817|FG002|Overall Study|Withdrawal by Subject|1|||
150001283|NCT02305849|541138818|FG003|Overall Study|Withdrawal by Subject|4|||
150001284|NCT02305849|541138815|FG000|Overall Study|Lost to Follow-up|0|||
150001285|NCT02305849|541138816|FG001|Overall Study|Lost to Follow-up|2|||
150001286|NCT02305849|541138817|FG002|Overall Study|Lost to Follow-up|0|||
150001287|NCT02305849|541138818|FG003|Overall Study|Lost to Follow-up|0|||
150001288|NCT02305849|541138815|FG000|Overall Study|Protocol Violation|3|||
150001289|NCT02305849|541138816|FG001|Overall Study|Protocol Violation|2|||
150001290|NCT02305849|541138817|FG002|Overall Study|Protocol Violation|1|||
150001291|NCT02305849|541138818|FG003|Overall Study|Protocol Violation|1|||
150001292|NCT02305849|541138815|FG000|Overall Study|Lab data met discontinuation criteria|0|||
150001293|NCT02305849|541138816|FG001|Overall Study|Lab data met discontinuation criteria|1|||
150001294|NCT02305849|541138817|FG002|Overall Study|Lab data met discontinuation criteria|2|||
150001295|NCT02305849|541138818|FG003|Overall Study|Lab data met discontinuation criteria|1|||
150001296|NCT02305849|541138815|FG000|Overall Study|Miscellaneous|1|||
150001297|NCT02305849|541138816|FG001|Overall Study|Miscellaneous|2|||
150001298|NCT02305849|541138817|FG002|Overall Study|Miscellaneous|4|||
150001299|NCT02305849|541138818|FG003|Overall Study|Miscellaneous|1|||
150001300|NCT02305849|541138815|FG000|Overall Study|Not fulfill eligibility criteria|1|||
150001301|NCT02305849|541138816|FG001|Overall Study|Not fulfill eligibility criteria|1|||
150001302|NCT02305849|541138817|FG002|Overall Study|Not fulfill eligibility criteria|0|||
150001303|NCT02305849|541138818|FG003|Overall Study|Not fulfill eligibility criteria|0|||
150001304|NCT00355342|541138819|FG000|Overall Study|Adverse Event|13|||
150001305|NCT00355342|541138820|FG001|Overall Study|Adverse Event|15|||
150001306|NCT00355342|541138819|FG000|Overall Study|Lost to Follow-up|4|||
150054626|NCT05092360|541340354|FG002|Overall Study|Death|31|||
150054627|NCT05092360|541340355|FG003|Overall Study|Death|101|||
150054628|NCT05092360|541340352|FG000|Overall Study|Lost to Follow-up|1|||
150054629|NCT05092360|541340353|FG001|Overall Study|Lost to Follow-up|2|||
150054630|NCT05092360|541340354|FG002|Overall Study|Lost to Follow-up|2|||
150001307|NCT00355342|541138820|FG001|Overall Study|Lost to Follow-up|2|||
150001308|NCT00355342|541138819|FG000|Overall Study|Withdrawal by Subject|14|||
150001309|NCT00355342|541138820|FG001|Overall Study|Withdrawal by Subject|11|||
150054631|NCT05092360|541340355|FG003|Overall Study|Lost to Follow-up|2|||
150054632|NCT05092360|541340352|FG000|Overall Study|Study terminated by sponsor|65|||
150001310|NCT00355342|541138819|FG000|Overall Study|Sponsor terminated study|2|||
150001311|NCT00355342|541138820|FG001|Overall Study|Sponsor terminated study|2|||
150001312|NCT00355342|541138819|FG000|Overall Study|Overcompliant-PI discretion|1|||
150001313|NCT00355342|541138820|FG001|Overall Study|Overcompliant-PI discretion|0|||
150001314|NCT00355342|541138819|FG000|Overall Study|Use of prohibited medication|1|||
150001315|NCT00355342|541138820|FG001|Overall Study|Use of prohibited medication|0|||
150001316|NCT00355342|541138819|FG000|Overall Study|COPD exacerbation|1|||
150001317|NCT00355342|541138820|FG001|Overall Study|COPD exacerbation|1|||
150001318|NCT00355342|541138819|FG000|Overall Study|Dispensed wrong study drug kit|1|||
150001319|NCT00355342|541138820|FG001|Overall Study|Dispensed wrong study drug kit|0|||
150001320|NCT00355342|541138819|FG000|Overall Study|Non-compliance with Dexa scans|1|||
150054633|NCT05092360|541340353|FG001|Overall Study|Study terminated by sponsor|7|||
150054634|NCT05092360|541340354|FG002|Overall Study|Study terminated by sponsor|13|||
150001321|NCT00355342|541138820|FG001|Overall Study|Non-compliance with Dexa scans|0|||
150001322|NCT00355342|541138819|FG000|Overall Study|Withdrawal by participant and physician|1|||
150001323|NCT00355342|541138820|FG001|Overall Study|Withdrawal by participant and physician|0|||
150001324|NCT00355342|541138819|FG000|Overall Study|Participant relocated|0|||
150001325|NCT00355342|541138820|FG001|Overall Study|Participant relocated|1|||
150001326|NCT00355342|541138819|FG000|Overall Study|Participant discontinued study drug|0|||
150001327|NCT00355342|541138820|FG001|Overall Study|Participant discontinued study drug|1|||
150001328|NCT00355342|541138819|FG000|Overall Study|Study management|0|||
150001329|NCT00355342|541138820|FG001|Overall Study|Study management|1|||
150001330|NCT00355342|541138819|FG000|Overall Study|Protocol Violation|0|||
150001331|NCT00355342|541138820|FG001|Overall Study|Protocol Violation|1|||
150001332|NCT00355342|541138819|FG000|Overall Study|Use of protocol excluded medication|0|||
150001333|NCT00355342|541138820|FG001|Overall Study|Use of protocol excluded medication|1|||
150001334|NCT00536874|541138821|FG000|Overall Study|Adverse Event|1|||
150001335|NCT00536874|541138821|FG000|Overall Study|Death|2|||
150001336|NCT00536874|541138821|FG000|Overall Study|Withdrawal by Subject|1|||
150001337|NCT00391391|541138823|FG000|Overall Study|Adverse Event|0|||
150001338|NCT00391391|541138824|FG001|Overall Study|Adverse Event|0|||
150001339|NCT00391391|541138825|FG002|Overall Study|Adverse Event|0|||
150001340|NCT00391391|541138826|FG003|Overall Study|Adverse Event|1|||
150001341|NCT00391391|541138823|FG000|Overall Study|Lost to Follow-up|1|||
150001342|NCT00391391|541138824|FG001|Overall Study|Lost to Follow-up|3|||
150001343|NCT00391391|541138825|FG002|Overall Study|Lost to Follow-up|7|||
150054635|NCT05092360|541340355|FG003|Overall Study|Study terminated by sponsor|61|||
150054636|NCT01525225|541340356|FG000|Enrollment|No longer met study criteria|1|||
150054637|NCT01525225|541340356|FG000|Enrollment|Other|1|||
150054638|NCT01182844|541340357|FG000|Overall Study|Withdrawal by Subject|0|||
150054639|NCT01182844|541340358|FG001|Overall Study|Withdrawal by Subject|2|||
150054640|NCT05009979|541340362|FG000|Overall Study|Withdrawal by Subject|1|||
150054641|NCT01330017|541342019|FG000|Overall Study|Adverse Event|0|||
150054642|NCT01330017|541342020|FG001|Overall Study|Adverse Event|1|||
150054643|NCT01330017|541342021|FG002|Overall Study|Adverse Event|1|||
150054644|NCT01330017|541342022|FG003|Overall Study|Adverse Event|4|||
150179613|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
150179614|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
150179615|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
150001344|NCT00391391|541138826|FG003|Overall Study|Lost to Follow-up|4|||
150001345|NCT00391391|541138823|FG000|Overall Study|Protocol Violation|2|||
150179616|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
150001346|NCT00391391|541138824|FG001|Overall Study|Protocol Violation|3|||
150001347|NCT00391391|541138825|FG002|Overall Study|Protocol Violation|6|||
150001348|NCT00391391|541138826|FG003|Overall Study|Protocol Violation|7|||
150179617|NCT03088813|541796763|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
150054645|NCT01330017|541342023|FG004|Overall Study|Adverse Event|0|||
150054646|NCT01330017|541342019|FG000|Overall Study|Withdrawal by Subject|0|||
150001349|NCT00391391|541138823|FG000|Overall Study|Withdrawal by Subject|6|||
150001350|NCT00391391|541138824|FG001|Overall Study|Withdrawal by Subject|4|||
150001351|NCT00391391|541138825|FG002|Overall Study|Withdrawal by Subject|10|||
150001352|NCT00391391|541138826|FG003|Overall Study|Withdrawal by Subject|7|||
150001353|NCT00693472|541138827|FG000|Part 1|Adverse Event|1|||
150001354|NCT00693472|541138828|FG001|Part 1|Adverse Event|1|||
150001355|NCT00693472|541138829|FG002|Part 1|Adverse Event|0|||
150001356|NCT00693472|541138830|FG003|Part 1|Adverse Event|0|||
150001357|NCT00693472|541138827|FG000|Part 1|Lost to Follow-up|0|||
150001358|NCT00693472|541138828|FG001|Part 1|Lost to Follow-up|1|||
150054647|NCT01330017|541342020|FG001|Overall Study|Withdrawal by Subject|0|||
150054648|NCT01330017|541342021|FG002|Overall Study|Withdrawal by Subject|1|||
150054649|NCT01330017|541342022|FG003|Overall Study|Withdrawal by Subject|0|||
150054650|NCT01330017|541342023|FG004|Overall Study|Withdrawal by Subject|1|||
150054651|NCT01330017|541342019|FG000|Overall Study|Lost to Follow-up|0|||
150054652|NCT01330017|541342020|FG001|Overall Study|Lost to Follow-up|0|||
150054653|NCT01330017|541342021|FG002|Overall Study|Lost to Follow-up|1|||
150054654|NCT01330017|541342022|FG003|Overall Study|Lost to Follow-up|0|||
150054655|NCT01330017|541342023|FG004|Overall Study|Lost to Follow-up|0|||
150054656|NCT01330017|541342019|FG000|Overall Study|Protocol Violation|0|||
150054657|NCT01330017|541342020|FG001|Overall Study|Protocol Violation|0|||
150054658|NCT01330017|541342021|FG002|Overall Study|Protocol Violation|0|||
150054659|NCT01330017|541342022|FG003|Overall Study|Protocol Violation|1|||
150054660|NCT01330017|541342023|FG004|Overall Study|Protocol Violation|0|||
150054661|NCT01330017|541342019|FG000|Overall Study|Unknown Reason|5|||
150054662|NCT01330017|541342020|FG001|Overall Study|Unknown Reason|3|||
150054663|NCT01330017|541342021|FG002|Overall Study|Unknown Reason|5|||
150054664|NCT01330017|541342022|FG003|Overall Study|Unknown Reason|7|||
150001359|NCT00693472|541138829|FG002|Part 1|Lost to Follow-up|0|||
150001360|NCT00693472|541138830|FG003|Part 1|Lost to Follow-up|0|||
150001361|NCT00693472|541138827|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
150054665|NCT01330017|541342023|FG004|Overall Study|Unknown Reason|2|||
150054666|NCT01221272|541342024|FG000|Period 1|Adverse Event|2|||
150054667|NCT01221272|541342025|FG001|Period 1|Adverse Event|0|||
150001362|NCT00693472|541138828|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
150001363|NCT00693472|541138829|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
150001364|NCT00693472|541138830|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
150001365|NCT00693472|541138827|FG000|Part 2|Adverse Event|0|||
150001366|NCT00693472|541138828|FG001|Part 2|Adverse Event|0|||
150001367|NCT00693472|541138829|FG002|Part 2|Adverse Event|1|||
150001368|NCT00693472|541138830|FG003|Part 2|Adverse Event|0|||
150001369|NCT00693472|541138827|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
150001370|NCT00693472|541138828|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
150001371|NCT00693472|541138829|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
150001372|NCT00693472|541138830|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
150001373|NCT02761694|541138833|FG000|Overall Study|Lack of Efficacy|0|||
150001374|NCT02761694|541138834|FG001|Overall Study|Lack of Efficacy|0|||
150001375|NCT02761694|541138835|FG002|Overall Study|Lack of Efficacy|0|||
150001376|NCT02761694|541138836|FG003|Overall Study|Lack of Efficacy|0|||
150001377|NCT02761694|541138837|FG004|Overall Study|Lack of Efficacy|0|||
150001378|NCT02761694|541138838|FG005|Overall Study|Lack of Efficacy|0|||
150001379|NCT02761694|541138839|FG006|Overall Study|Lack of Efficacy|6|||
150001380|NCT02761694|541138840|FG007|Overall Study|Lack of Efficacy|0|||
150001381|NCT02761694|541138841|FG008|Overall Study|Lack of Efficacy|0|||
150001382|NCT02761694|541138842|FG009|Overall Study|Lack of Efficacy|1|||
150001383|NCT02761694|541138843|FG010|Overall Study|Lack of Efficacy|1|||
150001384|NCT02761694|541138844|FG011|Overall Study|Lack of Efficacy|4|||
150001385|NCT02761694|541138833|FG000|Overall Study|Death|0|||
150001386|NCT02761694|541138834|FG001|Overall Study|Death|0|||
150001387|NCT02761694|541138835|FG002|Overall Study|Death|0|||
150001388|NCT02761694|541138836|FG003|Overall Study|Death|0|||
150001389|NCT02761694|541138837|FG004|Overall Study|Death|0|||
150001390|NCT02761694|541138838|FG005|Overall Study|Death|0|||
150001391|NCT02761694|541138839|FG006|Overall Study|Death|2|||
150001392|NCT02761694|541138840|FG007|Overall Study|Death|0|||
150001393|NCT02761694|541138841|FG008|Overall Study|Death|2|||
150001394|NCT02761694|541138842|FG009|Overall Study|Death|2|||
150001395|NCT02761694|541138843|FG010|Overall Study|Death|1|||
150001396|NCT02761694|541138844|FG011|Overall Study|Death|0|||
150001397|NCT02761694|541138833|FG000|Overall Study|Physician Decision|0|||
150001398|NCT02761694|541138834|FG001|Overall Study|Physician Decision|0|||
150001399|NCT02761694|541138835|FG002|Overall Study|Physician Decision|0|||
150001400|NCT02761694|541138836|FG003|Overall Study|Physician Decision|0|||
150001401|NCT02761694|541138837|FG004|Overall Study|Physician Decision|0|||
150001402|NCT02761694|541138838|FG005|Overall Study|Physician Decision|0|||
150001403|NCT02761694|541138839|FG006|Overall Study|Physician Decision|1|||
150001404|NCT02761694|541138840|FG007|Overall Study|Physician Decision|0|||
150001405|NCT02761694|541138841|FG008|Overall Study|Physician Decision|0|||
150001406|NCT02761694|541138842|FG009|Overall Study|Physician Decision|0|||
150001407|NCT02761694|541138843|FG010|Overall Study|Physician Decision|0|||
150001408|NCT02761694|541138844|FG011|Overall Study|Physician Decision|0|||
150001409|NCT02761694|541138833|FG000|Overall Study|Withdrawal by Subject|0|||
150001410|NCT02761694|541138834|FG001|Overall Study|Withdrawal by Subject|0|||
150001411|NCT02761694|541138835|FG002|Overall Study|Withdrawal by Subject|0|||
150001412|NCT02761694|541138836|FG003|Overall Study|Withdrawal by Subject|1|||
150001413|NCT02761694|541138837|FG004|Overall Study|Withdrawal by Subject|0|||
150001414|NCT02761694|541138838|FG005|Overall Study|Withdrawal by Subject|0|||
150001415|NCT02761694|541138839|FG006|Overall Study|Withdrawal by Subject|4|||
150001416|NCT02761694|541138840|FG007|Overall Study|Withdrawal by Subject|0|||
150001417|NCT02761694|541138841|FG008|Overall Study|Withdrawal by Subject|2|||
150001418|NCT02761694|541138842|FG009|Overall Study|Withdrawal by Subject|1|||
150001419|NCT02761694|541138843|FG010|Overall Study|Withdrawal by Subject|0|||
150001420|NCT02761694|541138844|FG011|Overall Study|Withdrawal by Subject|0|||
150001421|NCT02761694|541138833|FG000|Overall Study|Lost to Follow-up|0|||
150001422|NCT02761694|541138834|FG001|Overall Study|Lost to Follow-up|0|||
150001423|NCT02761694|541138835|FG002|Overall Study|Lost to Follow-up|0|||
150001424|NCT02761694|541138836|FG003|Overall Study|Lost to Follow-up|0|||
150001425|NCT02761694|541138837|FG004|Overall Study|Lost to Follow-up|0|||
150001426|NCT02761694|541138838|FG005|Overall Study|Lost to Follow-up|0|||
150001427|NCT02761694|541138839|FG006|Overall Study|Lost to Follow-up|1|||
150001428|NCT02761694|541138840|FG007|Overall Study|Lost to Follow-up|0|||
150001429|NCT02761694|541138841|FG008|Overall Study|Lost to Follow-up|0|||
150001430|NCT02761694|541138842|FG009|Overall Study|Lost to Follow-up|0|||
150001431|NCT02761694|541138843|FG010|Overall Study|Lost to Follow-up|0|||
150001432|NCT02761694|541138844|FG011|Overall Study|Lost to Follow-up|1|||
150001433|NCT02761694|541138833|FG000|Overall Study|Adverse Event|0|||
150001434|NCT02761694|541138834|FG001|Overall Study|Adverse Event|0|||
150001435|NCT02761694|541138835|FG002|Overall Study|Adverse Event|0|||
150001436|NCT02761694|541138836|FG003|Overall Study|Adverse Event|0|||
150001437|NCT02761694|541138837|FG004|Overall Study|Adverse Event|0|||
150001438|NCT02761694|541138838|FG005|Overall Study|Adverse Event|0|||
150001439|NCT02761694|541138839|FG006|Overall Study|Adverse Event|1|||
150054668|NCT01221272|541342024|FG000|Period 1|Consent Withdrawal|0|||
150054669|NCT01221272|541342025|FG001|Period 1|Consent Withdrawal|1|||
150054670|NCT01221272|541342024|FG000|Period 1|Significant Dosing Noncompliance|0|||
150054671|NCT01221272|541342025|FG001|Period 1|Significant Dosing Noncompliance|1|||
150054672|NCT01221272|541342024|FG000|Period 2|Adverse Event|0|||
150054673|NCT01221272|541342025|FG001|Period 2|Adverse Event|2|||
150054674|NCT02656680|541342026|FG000|Overall Study|Lost to Follow-up|0|||
150054675|NCT02656680|541342027|FG001|Overall Study|Lost to Follow-up|1|||
150054676|NCT02656680|541342028|FG002|Overall Study|Lost to Follow-up|7|||
150054677|NCT01246466|541342031|FG000|Overall Study|Death|1|||
150054678|NCT01246466|541342031|FG000|Overall Study|Withdrawal by Subject|1|||
150054679|NCT00877773|541342032|FG000|Overall Study|Disease Progression|44|||
150054680|NCT00603590|541342033|FG000|Overall Study|Did not attend study clinic|39|||
150054681|NCT00603590|541342034|FG001|Overall Study|Did not attend study clinic|30|||
150054682|NCT00603590|541342033|FG000|Overall Study|Refused blood test|5|||
150054683|NCT00603590|541342034|FG001|Overall Study|Refused blood test|1|||
150054684|NCT00603590|541342033|FG000|Overall Study|Patient discontinued study drug|22|||
150054685|NCT00603590|541342034|FG001|Overall Study|Patient discontinued study drug|15|||
150054686|NCT00603590|541342033|FG000|Overall Study|Adverse Event|2|||
150054687|NCT00603590|541342034|FG001|Overall Study|Adverse Event|0|||
150054688|NCT00603590|541342033|FG000|Overall Study|Lost to Follow-up|8|||
150054689|NCT00603590|541342034|FG001|Overall Study|Lost to Follow-up|4|||
150054690|NCT00603590|541342033|FG000|Overall Study|Cardiovascular event|0|||
150054691|NCT00603590|541342034|FG001|Overall Study|Cardiovascular event|1|||
150054692|NCT00910624|541342035|FG000|Treatment Phase|Adverse Event|2|||
150054693|NCT00910624|541342036|FG001|Treatment Phase|Adverse Event|6|||
150054694|NCT00910624|541342037|FG002|Treatment Phase|Adverse Event|6|||
150054695|NCT00910624|541342038|FG003|Treatment Phase|Adverse Event|0|||
150054696|NCT00910624|541342035|FG000|Treatment Phase|Treatment Failure|23|||
150054697|NCT00910624|541342036|FG001|Treatment Phase|Treatment Failure|10|||
150054698|NCT00910624|541342037|FG002|Treatment Phase|Treatment Failure|0|||
150054699|NCT00910624|541342038|FG003|Treatment Phase|Treatment Failure|0|||
150054700|NCT00910624|541342035|FG000|Treatment Phase|Lost to Follow-up|0|||
150054701|NCT00910624|541342036|FG001|Treatment Phase|Lost to Follow-up|0|||
150054702|NCT00910624|541342037|FG002|Treatment Phase|Lost to Follow-up|1|||
150054703|NCT00910624|541342038|FG003|Treatment Phase|Lost to Follow-up|0|||
150054704|NCT00910624|541342035|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
150054705|NCT00910624|541342036|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
150054706|NCT00910624|541342037|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
150001440|NCT02761694|541138840|FG007|Overall Study|Adverse Event|0|||
150054707|NCT00910624|541342038|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
150054708|NCT00910624|541342035|FG000|Treatment Phase|Withdrawal by Subject|2|||
150054709|NCT00910624|541342036|FG001|Treatment Phase|Withdrawal by Subject|1|||
150054710|NCT00910624|541342037|FG002|Treatment Phase|Withdrawal by Subject|0|||
150054711|NCT00910624|541342038|FG003|Treatment Phase|Withdrawal by Subject|0|||
150054712|NCT00910624|541342035|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
150054713|NCT00910624|541342036|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
150054714|NCT00910624|541342037|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
150054715|NCT00910624|541342038|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
150054716|NCT00910624|541342035|FG000|Follow-Up Phase|Adverse Event|0|||
150054717|NCT00910624|541342036|FG001|Follow-Up Phase|Adverse Event|0|||
150054718|NCT00910624|541342037|FG002|Follow-Up Phase|Adverse Event|1|||
150001441|NCT02761694|541138841|FG008|Overall Study|Adverse Event|1|||
150001442|NCT02761694|541138842|FG009|Overall Study|Adverse Event|0|||
150001443|NCT02761694|541138843|FG010|Overall Study|Adverse Event|0|||
150001444|NCT02761694|541138844|FG011|Overall Study|Adverse Event|1|||
150001445|NCT02761694|541138833|FG000|Overall Study|Other|4|||
150001446|NCT02761694|541138834|FG001|Overall Study|Other|4|||
150001447|NCT02761694|541138835|FG002|Overall Study|Other|1|||
150001448|NCT02761694|541138836|FG003|Overall Study|Other|2|||
150001449|NCT02761694|541138837|FG004|Overall Study|Other|3|||
150001450|NCT02761694|541138838|FG005|Overall Study|Other|3|||
150001451|NCT02761694|541138839|FG006|Overall Study|Other|18|||
150001452|NCT02761694|541138840|FG007|Overall Study|Other|8|||
150001453|NCT02761694|541138841|FG008|Overall Study|Other|0|||
150001454|NCT02761694|541138842|FG009|Overall Study|Other|1|||
150001455|NCT02761694|541138843|FG010|Overall Study|Other|1|||
150001456|NCT02761694|541138844|FG011|Overall Study|Other|0|||
150001457|NCT00787930|541138849|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
150179618|NCT03088813|541796764|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
150054719|NCT00910624|541342038|FG003|Follow-Up Phase|Adverse Event|0|||
150001458|NCT02395055|541138850|FG000|Overall Study|Withdrawal by Subject|7|||
150001459|NCT02395055|541138851|FG001|Overall Study|Withdrawal by Subject|3|||
150001460|NCT02513823|541138852|FG000|Overall Study|Lost to Follow-up|4|||
150001461|NCT02513823|541138852|FG000|Overall Study|Physician Decision|1|||
150001462|NCT02743780|541138854|FG000|Part 3 (7 Days)|Adverse Event|0|||
150001463|NCT02743780|541138855|FG001|Part 3 (7 Days)|Adverse Event|0|||
150001464|NCT02743780|541138856|FG002|Part 3 (7 Days)|Adverse Event|1|||
150001465|NCT02743780|541138857|FG003|Part 3 (7 Days)|Adverse Event|0|||
150001466|NCT02743780|541138858|FG004|Part 3 (7 Days)|Adverse Event|0|||
150001467|NCT01294462|541138859|FG000|Overall Study|Lost to Follow-up|1|||
150001468|NCT01294462|541138860|FG001|Overall Study|Lost to Follow-up|0|||
150001469|NCT01294462|541138859|FG000|Overall Study|Withdrawal by Subject|65|||
150001470|NCT01294462|541138860|FG001|Overall Study|Withdrawal by Subject|63|||
150001471|NCT04342689|541138871|FG000|Overall Study|Withdrawal by Subject|32|||
150001472|NCT04342689|541138872|FG001|Overall Study|Withdrawal by Subject|33|||
150054720|NCT00910624|541342035|FG000|Follow-Up Phase|Lost to Follow-up|3|||
150054721|NCT00910624|541342036|FG001|Follow-Up Phase|Lost to Follow-up|1|||
150054722|NCT00910624|541342037|FG002|Follow-Up Phase|Lost to Follow-up|2|||
150054723|NCT00910624|541342038|FG003|Follow-Up Phase|Lost to Follow-up|0|||
150054724|NCT00910624|541342035|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
150054725|NCT00910624|541342036|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
150054726|NCT00910624|541342037|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
150054727|NCT00910624|541342038|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
150054728|NCT00910624|541342035|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
150054729|NCT00910624|541342036|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
150054730|NCT00910624|541342037|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
150054731|NCT00910624|541342038|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
150054732|NCT00910624|541342035|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
150054733|NCT00910624|541342036|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
150054734|NCT00910624|541342037|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
150054735|NCT00910624|541342038|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
150054736|NCT00910624|541342035|FG000|Follow-Up Phase|Administrative|0|||
150054737|NCT00910624|541342036|FG001|Follow-Up Phase|Administrative|1|||
150054738|NCT00910624|541342037|FG002|Follow-Up Phase|Administrative|1|||
150054739|NCT00910624|541342038|FG003|Follow-Up Phase|Administrative|0|||
150054740|NCT01122264|541342039|FG000|Overall Study|Adverse Event|6|||
150054741|NCT01122264|541342040|FG001|Overall Study|Adverse Event|5|||
150054742|NCT01122264|541342041|FG002|Overall Study|Adverse Event|7|||
150054743|NCT01122264|541342039|FG000|Overall Study|Death|1|||
150001473|NCT04342689|541138871|FG000|Overall Study|Lost to Follow-up|10|||
150054744|NCT01122264|541342040|FG001|Overall Study|Death|0|||
150054745|NCT01122264|541342041|FG002|Overall Study|Death|0|||
150001474|NCT04342689|541138872|FG001|Overall Study|Lost to Follow-up|12|||
150001475|NCT01460407|541138873|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
150054746|NCT01122264|541342039|FG000|Overall Study|Lost to Follow-up|5|||
150054747|NCT01122264|541342040|FG001|Overall Study|Lost to Follow-up|9|||
150001476|NCT01460407|541138874|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
150001477|NCT00844805|541138877|FG000|Treatment Phase|Adverse Event|5|||
150001478|NCT00844805|541138878|FG001|Treatment Phase|Adverse Event|1|||
150001479|NCT00844805|541138879|FG002|Treatment Phase|Adverse Event|0|||
150001480|NCT00844805|541138880|FG003|Treatment Phase|Adverse Event|0|||
150001481|NCT00844805|541138877|FG000|Treatment Phase|Withdrawal by Subject|3|||
150001482|NCT00844805|541138878|FG001|Treatment Phase|Withdrawal by Subject|4|||
150001483|NCT00844805|541138879|FG002|Treatment Phase|Withdrawal by Subject|0|||
150054748|NCT01122264|541342041|FG002|Overall Study|Lost to Follow-up|13|||
150054749|NCT01122264|541342039|FG000|Overall Study|Entry Criteria Not Met|1|||
150054750|NCT01122264|541342040|FG001|Overall Study|Entry Criteria Not Met|0|||
150054751|NCT01122264|541342041|FG002|Overall Study|Entry Criteria Not Met|0|||
150054752|NCT01122264|541342039|FG000|Overall Study|Protocol Violation|7|||
150054753|NCT01122264|541342040|FG001|Overall Study|Protocol Violation|7|||
150054754|NCT01122264|541342041|FG002|Overall Study|Protocol Violation|9|||
150001484|NCT00844805|541138880|FG003|Treatment Phase|Withdrawal by Subject|0|||
150001485|NCT00844805|541138877|FG000|Treatment Phase|Noncompliance With Protocol|1|||
150001486|NCT00844805|541138878|FG001|Treatment Phase|Noncompliance With Protocol|0|||
150001487|NCT00844805|541138879|FG002|Treatment Phase|Noncompliance With Protocol|0|||
150001488|NCT00844805|541138880|FG003|Treatment Phase|Noncompliance With Protocol|0|||
150001489|NCT00844805|541138877|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
150001490|NCT00844805|541138878|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
150001491|NCT00844805|541138879|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
150001492|NCT00844805|541138880|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
150001493|NCT00844805|541138877|FG000|Follow-Up Phase|Adverse Event|0|||
150001494|NCT00844805|541138878|FG001|Follow-Up Phase|Adverse Event|0|||
150001495|NCT00844805|541138879|FG002|Follow-Up Phase|Adverse Event|1|||
150001496|NCT00844805|541138880|FG003|Follow-Up Phase|Adverse Event|0|||
150001497|NCT00844805|541138877|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
150054755|NCT01122264|541342039|FG000|Overall Study|Withdrawal by Subject|6|||
150001498|NCT00844805|541138878|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
150001499|NCT00844805|541138879|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
150054756|NCT01122264|541342040|FG001|Overall Study|Withdrawal by Subject|6|||
150054757|NCT01122264|541342041|FG002|Overall Study|Withdrawal by Subject|16|||
150001500|NCT00844805|541138880|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
150001501|NCT00844805|541138877|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
150001502|NCT00844805|541138878|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
150001503|NCT00844805|541138879|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
150001504|NCT00844805|541138880|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
150001505|NCT00844805|541138877|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
150001506|NCT00844805|541138878|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
150001507|NCT00844805|541138879|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
150001508|NCT00844805|541138880|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
150001509|NCT00844805|541138877|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
150001510|NCT00844805|541138878|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
150001511|NCT00844805|541138879|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
150001512|NCT00844805|541138880|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
150001513|NCT04070326|541138881|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
150001514|NCT04070326|541138882|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
150001515|NCT02193087|541138887|FG000|Overall Study|Adverse Event|2|||
150001516|NCT02193087|541138888|FG001|Overall Study|Adverse Event|0|||
150001517|NCT02193087|541138889|FG002|Overall Study|Adverse Event|0|||
150001518|NCT02193087|541138890|FG003|Overall Study|Adverse Event|11|||
150001519|NCT02193087|541138887|FG000|Overall Study|Lost to Follow-up|14|||
150001520|NCT02193087|541138888|FG001|Overall Study|Lost to Follow-up|6|||
150001521|NCT02193087|541138889|FG002|Overall Study|Lost to Follow-up|4|||
150001522|NCT02193087|541138890|FG003|Overall Study|Lost to Follow-up|37|||
150001523|NCT02193087|541138887|FG000|Overall Study|Protocol Violation|2|||
150001524|NCT02193087|541138888|FG001|Overall Study|Protocol Violation|0|||
150001525|NCT02193087|541138889|FG002|Overall Study|Protocol Violation|1|||
150001526|NCT02193087|541138890|FG003|Overall Study|Protocol Violation|2|||
150001527|NCT02193087|541138887|FG000|Overall Study|Withdrawal by Subject|10|||
150001528|NCT02193087|541138888|FG001|Overall Study|Withdrawal by Subject|3|||
150001529|NCT02193087|541138889|FG002|Overall Study|Withdrawal by Subject|1|||
150001530|NCT02193087|541138890|FG003|Overall Study|Withdrawal by Subject|19|||
150001531|NCT02193087|541138887|FG000|Overall Study|Other Reason Not Specified|7|||
150001532|NCT02193087|541138888|FG001|Overall Study|Other Reason Not Specified|2|||
150001533|NCT02193087|541138889|FG002|Overall Study|Other Reason Not Specified|1|||
150001534|NCT02193087|541138890|FG003|Overall Study|Other Reason Not Specified|9|||
150001535|NCT02193087|541138887|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
150001536|NCT02193087|541138888|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
150001537|NCT02193087|541138889|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
150001538|NCT02193087|541138890|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
150001539|NCT00475865|541138891|FG000|Overall Study|Adverse Event|0|||
150001540|NCT00475865|541138892|FG001|Overall Study|Adverse Event|3|||
150001541|NCT00475865|541138893|FG002|Overall Study|Adverse Event|4|||
150001542|NCT00475865|541138891|FG000|Overall Study|Lack of Efficacy|1|||
150001543|NCT00475865|541138892|FG001|Overall Study|Lack of Efficacy|0|||
150001544|NCT00475865|541138893|FG002|Overall Study|Lack of Efficacy|0|||
150001545|NCT00475865|541138891|FG000|Overall Study|Progressive disease|0|||
150001546|NCT00475865|541138892|FG001|Overall Study|Progressive disease|1|||
150001547|NCT00475865|541138893|FG002|Overall Study|Progressive disease|2|||
150001548|NCT00475865|541138891|FG000|Overall Study|Participant did not wish to continue|1|||
150001549|NCT00475865|541138892|FG001|Overall Study|Participant did not wish to continue|0|||
150001550|NCT00475865|541138893|FG002|Overall Study|Participant did not wish to continue|0|||
150001551|NCT00475865|541138891|FG000|Overall Study|Other than above|0|||
150001552|NCT00475865|541138892|FG001|Overall Study|Other than above|1|||
150001553|NCT00475865|541138893|FG002|Overall Study|Other than above|0|||
150001554|NCT04316741|541138894|FG000|Baseline Enrollment|Lost to Follow-up|1|||
150001555|NCT04316741|541138895|FG001|Baseline Enrollment|Lost to Follow-up|1|||
150001556|NCT04316741|541138894|FG000|Immediate Post-Test|Lost to Follow-up|5|||
150001557|NCT04316741|541138895|FG001|Immediate Post-Test|Lost to Follow-up|1|||
150001558|NCT04316741|541138894|FG000|1-month Post-test|Lost to Follow-up|7|||
150001559|NCT04316741|541138895|FG001|1-month Post-test|Lost to Follow-up|2|||
150001560|NCT04316741|541138894|FG000|3-month Follow-up|Lost to Follow-up|10|||
150001561|NCT04316741|541138895|FG001|3-month Follow-up|Lost to Follow-up|2|||
150001562|NCT02279498|541138899|FG000|Overall Study|Adverse Event|3|||
150001563|NCT02279498|541138900|FG001|Overall Study|Adverse Event|0|||
150001564|NCT02279498|541138899|FG000|Overall Study|Lack of Efficacy|4|||
150001565|NCT02279498|541138900|FG001|Overall Study|Lack of Efficacy|0|||
150001566|NCT02279498|541138899|FG000|Overall Study|Lost to Follow-up|0|||
150001567|NCT02279498|541138900|FG001|Overall Study|Lost to Follow-up|1|||
150001568|NCT02279498|541138899|FG000|Overall Study|Withdrawal by Subject|9|||
150001569|NCT02279498|541138900|FG001|Overall Study|Withdrawal by Subject|2|||
150001570|NCT02279498|541138899|FG000|Overall Study|Undefined|2|||
150001571|NCT02279498|541138900|FG001|Overall Study|Undefined|1|||
150001572|NCT00737711|541138901|FG000|Overall Study|Adverse Event|2|||
150001573|NCT00737711|541138901|FG000|Overall Study|Death|8|||
150054758|NCT01122264|541342039|FG000|Overall Study|Physician Decision|3|||
150054759|NCT01122264|541342040|FG001|Overall Study|Physician Decision|1|||
150054760|NCT01122264|541342041|FG002|Overall Study|Physician Decision|1|||
150054761|NCT01122264|541342039|FG000|Overall Study|Lack of Efficacy|3|||
150054762|NCT01122264|541342040|FG001|Overall Study|Lack of Efficacy|1|||
150054763|NCT01122264|541342041|FG002|Overall Study|Lack of Efficacy|1|||
150054764|NCT03005873|541342042|FG000|Overall Study|Prohibited medication use post radnomization|1|||
150054765|NCT03005873|541342043|FG001|Overall Study|Prohibited medication use post radnomization|1|||
150054766|NCT03005873|541342044|FG002|Overall Study|Prohibited medication use post radnomization|1|||
150054767|NCT03005873|541342042|FG000|Overall Study|Withdrew consent|0|||
150054768|NCT03005873|541342043|FG001|Overall Study|Withdrew consent|1|||
150054769|NCT03005873|541342044|FG002|Overall Study|Withdrew consent|2|||
150179619|NCT03088813|541796765|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
150179620|NCT03088813|541796766|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
150054770|NCT03005873|541342042|FG000|Overall Study|Lost to Follow-up|0|||
150054771|NCT03005873|541342043|FG001|Overall Study|Lost to Follow-up|1|||
150054772|NCT03005873|541342044|FG002|Overall Study|Lost to Follow-up|0|||
150054773|NCT03005873|541342042|FG000|Overall Study|Ineligible post randomization|0|||
150054774|NCT03005873|541342043|FG001|Overall Study|Ineligible post randomization|0|||
150054775|NCT03005873|541342044|FG002|Overall Study|Ineligible post randomization|1|||
150179621|NCT01903811|541796775|FG000|Overall Study|No measurable disease|1|||
150179622|NCT01903811|541796776|FG001|Overall Study|No measurable disease|1|||
150179623|NCT01903811|541796775|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
150179624|NCT01903811|541796776|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
150179625|NCT01903811|541796775|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
150054776|NCT04585009|541342045|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
150179626|NCT01903811|541796776|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
150054777|NCT04585009|541342046|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054778|NCT04585009|541342047|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150001574|NCT00737711|541138901|FG000|Overall Study|Failure to return|4|||
150001575|NCT00737711|541138901|FG000|Overall Study|Protocol Violation|1|||
150001576|NCT00737711|541138901|FG000|Overall Study|Withdrawal by Subject|5|||
150001577|NCT00737711|541138901|FG000|Overall Study|Blood transfusion|6|||
150001578|NCT00737711|541138901|FG000|Overall Study|Other|5|||
150001579|NCT00624780|541138902|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
150001580|NCT00624780|541138903|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
150001581|NCT00624780|541138904|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
150001582|NCT00624780|541138905|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
150001583|NCT00624780|541138906|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
150054779|NCT04585009|541342048|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054780|NCT04585009|541342049|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054781|NCT04585009|541342050|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054782|NCT04585009|541342051|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054783|NCT04585009|541342052|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054784|NCT04585009|541342053|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054785|NCT04585009|541342054|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054786|NCT04585009|541342055|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054787|NCT04585009|541342056|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
150054788|NCT04585009|541342045|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
150054789|NCT04585009|541342046|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054790|NCT04585009|541342047|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054791|NCT04585009|541342048|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054792|NCT04585009|541342049|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054793|NCT04585009|541342050|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054794|NCT04585009|541342051|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054795|NCT04585009|541342052|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054796|NCT04585009|541342053|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054797|NCT04585009|541342054|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054798|NCT04585009|541342055|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054799|NCT04585009|541342056|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
150054800|NCT04585009|541342045|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054801|NCT04585009|541342046|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054802|NCT04585009|541342047|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054803|NCT04585009|541342048|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054804|NCT04585009|541342049|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054805|NCT04585009|541342050|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054806|NCT04585009|541342051|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054807|NCT04585009|541342052|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
150054808|NCT04585009|541342053|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054809|NCT04585009|541342054|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054810|NCT04585009|541342055|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054811|NCT04585009|541342056|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
150054812|NCT04585009|541342045|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054813|NCT04585009|541342046|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054814|NCT04585009|541342047|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054815|NCT04585009|541342048|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054816|NCT04585009|541342049|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
150054817|NCT04585009|541342050|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054818|NCT04585009|541342051|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054819|NCT04585009|541342052|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054820|NCT04585009|541342053|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054821|NCT04585009|541342054|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054822|NCT04585009|541342055|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054823|NCT04585009|541342056|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
150054824|NCT04585009|541342045|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054825|NCT04585009|541342046|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054826|NCT04585009|541342047|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054827|NCT04585009|541342048|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054828|NCT04585009|541342049|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054829|NCT04585009|541342050|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150001584|NCT00624780|541138907|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
150001585|NCT00624780|541138902|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
150001586|NCT00624780|541138903|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
150001587|NCT00624780|541138904|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
150001588|NCT00624780|541138905|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
150001589|NCT00624780|541138906|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
150001590|NCT00624780|541138907|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
150001591|NCT00624780|541138902|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
150001592|NCT00624780|541138903|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
150001593|NCT00624780|541138904|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
150001594|NCT00624780|541138905|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
150001595|NCT00624780|541138906|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
150001596|NCT00624780|541138907|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
150001597|NCT00624780|541138902|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
150001598|NCT00624780|541138903|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
150001599|NCT00624780|541138904|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
150001600|NCT00624780|541138905|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
150001601|NCT00624780|541138906|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
150001602|NCT00624780|541138907|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
150001603|NCT00624780|541138902|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
150001604|NCT00624780|541138903|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
150001605|NCT00624780|541138904|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
150054830|NCT04585009|541342051|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054831|NCT04585009|541342052|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054832|NCT04585009|541342053|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054833|NCT04585009|541342054|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
150054834|NCT04585009|541342055|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054835|NCT04585009|541342056|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
150054836|NCT04585009|541342045|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054837|NCT04585009|541342046|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054838|NCT04585009|541342047|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054839|NCT04585009|541342048|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054840|NCT04585009|541342049|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054841|NCT04585009|541342050|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054842|NCT04585009|541342051|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054843|NCT04585009|541342052|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054844|NCT04585009|541342053|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054845|NCT04585009|541342054|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054846|NCT04585009|541342055|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
150054847|NCT04585009|541342056|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
150054848|NCT01713933|541342057|FG000|Overall Study|Lost to Follow-up|2|||
150001606|NCT00624780|541138905|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
150001607|NCT00624780|541138906|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
150001608|NCT00624780|541138907|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
150001609|NCT00624780|541138902|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
150001610|NCT00624780|541138903|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
150001611|NCT00624780|541138904|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
150001612|NCT00624780|541138905|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
150001613|NCT00624780|541138906|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
150001614|NCT00624780|541138907|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
150001615|NCT00624780|541138902|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
150001616|NCT00624780|541138903|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
150001617|NCT00624780|541138904|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
150001618|NCT00624780|541138905|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
150001619|NCT00624780|541138906|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
150001620|NCT00624780|541138907|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
150001621|NCT00624780|541138902|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
150001622|NCT00624780|541138903|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
150001623|NCT00624780|541138904|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
150001624|NCT00624780|541138905|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
150001625|NCT00624780|541138906|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
150001626|NCT00624780|541138907|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
150001627|NCT00624780|541138902|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
150001628|NCT00624780|541138903|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
150001629|NCT00624780|541138904|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
150001630|NCT00624780|541138905|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
150001631|NCT00624780|541138906|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
150001632|NCT00624780|541138907|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
150001633|NCT00624780|541138902|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
150001634|NCT00624780|541138903|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
150001635|NCT00624780|541138904|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
150001636|NCT00624780|541138905|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
150001637|NCT00624780|541138906|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
150001638|NCT00624780|541138907|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
150001639|NCT00624780|541138902|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
150001640|NCT00624780|541138903|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
150001641|NCT00624780|541138904|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
150001642|NCT00624780|541138905|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
150001643|NCT00624780|541138906|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
150001644|NCT00624780|541138907|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
150001645|NCT00624780|541138902|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
150001646|NCT00624780|541138903|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
150001647|NCT00624780|541138904|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
150001648|NCT00624780|541138905|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
150001649|NCT00624780|541138906|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
150001650|NCT00624780|541138907|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
150001651|NCT00624780|541138902|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
150001652|NCT00624780|541138903|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
150001653|NCT00624780|541138904|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
150001654|NCT00624780|541138905|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
150001655|NCT00624780|541138906|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
150001656|NCT00624780|541138907|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
150001657|NCT00624780|541138902|FG000|Follow-up (Week 26)|Death|0|||
150001658|NCT00624780|541138903|FG001|Follow-up (Week 26)|Death|0|||
150001659|NCT00624780|541138904|FG002|Follow-up (Week 26)|Death|1|||
150001660|NCT00624780|541138905|FG003|Follow-up (Week 26)|Death|0|||
150001661|NCT00624780|541138906|FG004|Follow-up (Week 26)|Death|0|||
150001662|NCT00624780|541138907|FG005|Follow-up (Week 26)|Death|0|||
150001663|NCT00624780|541138902|FG000|Follow-up (Week 26)|Adverse Event|0|||
150001664|NCT00624780|541138903|FG001|Follow-up (Week 26)|Adverse Event|0|||
150001665|NCT00624780|541138904|FG002|Follow-up (Week 26)|Adverse Event|0|||
150001666|NCT00624780|541138905|FG003|Follow-up (Week 26)|Adverse Event|0|||
150001667|NCT00624780|541138906|FG004|Follow-up (Week 26)|Adverse Event|1|||
150001668|NCT00624780|541138907|FG005|Follow-up (Week 26)|Adverse Event|0|||
150001669|NCT00624780|541138902|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
150001670|NCT00624780|541138903|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
150001671|NCT00624780|541138904|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
150001672|NCT00624780|541138905|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
150001673|NCT00624780|541138906|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
150001674|NCT00624780|541138907|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
150001675|NCT00624780|541138902|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
150001676|NCT00624780|541138903|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
150001677|NCT00624780|541138904|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
150001678|NCT00624780|541138905|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
150001679|NCT00624780|541138906|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
150001680|NCT00624780|541138907|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
150001681|NCT00624780|541138902|FG000|Follow-up (Week 26)|Other|1|||
150001682|NCT00624780|541138903|FG001|Follow-up (Week 26)|Other|1|||
150001683|NCT00624780|541138904|FG002|Follow-up (Week 26)|Other|0|||
150001684|NCT00624780|541138905|FG003|Follow-up (Week 26)|Other|0|||
150001685|NCT00624780|541138906|FG004|Follow-up (Week 26)|Other|0|||
150001686|NCT00624780|541138907|FG005|Follow-up (Week 26)|Other|0|||
150001687|NCT04068519|541138908|FG000|Dose Verification|Death|15|||
150001688|NCT04068519|541138908|FG000|Dose Verification|Withdrawal by Subject|1|||
150001689|NCT04068519|541138908|FG000|Pharmacokinetic Sub-study|Death|35|||
150001690|NCT04068519|541138908|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
150001691|NCT04068519|541138908|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
150001692|NCT04068519|541138908|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
150001693|NCT04068519|541138908|FG000|Indication Expansion|Death|152|||
150001694|NCT04068519|541138908|FG000|Indication Expansion|Withdrawal by Subject|10|||
150001695|NCT04068519|541138908|FG000|Indication Expansion|Lost to Follow-up|7|||
150001696|NCT00969761|541138909|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
150001697|NCT00969761|541138910|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001698|NCT00969761|541138911|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001699|NCT00969761|541138912|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
150001700|NCT00969761|541138913|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001701|NCT00969761|541138914|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001702|NCT00969761|541138915|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001703|NCT00969761|541138916|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001704|NCT00969761|541138917|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
150054849|NCT01713933|541342057|FG000|Overall Study|Withdrawal by Subject|3|||
150054850|NCT01713933|541342057|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
150054851|NCT02882152|541342060|FG000|Overall Study|Lost to Follow-up|1|||
150054852|NCT02882152|541342061|FG001|Overall Study|Lost to Follow-up|0|||
150054853|NCT01009840|541342064|FG000|Overall Study|Lost to Follow-up|1|||
150054854|NCT01009840|541342064|FG000|Overall Study|Adverse Event|4|||
150054855|NCT01009840|541342064|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
150054856|NCT01009840|541342064|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
150054857|NCT01009840|541342064|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
150054858|NCT01104376|541342069|FG000|Overall Study|Withdrawal by Subject|15|||
150054859|NCT01104376|541342069|FG000|Overall Study|Consented but excluded after labs|13|||
150054860|NCT00797966|541342070|FG000|Phase A|Lost to Follow-up|0|||
150054861|NCT00797966|541342071|FG001|Phase A|Lost to Follow-up|0|||
150054862|NCT00797966|541342072|FG002|Phase A|Lost to Follow-up|0|||
150054863|NCT00797966|541342073|FG003|Phase A|Lost to Follow-up|0|||
150054864|NCT00797966|541342074|FG004|Phase A|Lost to Follow-up|33|||
150054865|NCT00797966|541342075|FG005|Phase A|Lost to Follow-up|0|||
150054866|NCT00797966|541342070|FG000|Phase A|Adverse Event|0|||
150054867|NCT00797966|541342071|FG001|Phase A|Adverse Event|0|||
150054868|NCT00797966|541342072|FG002|Phase A|Adverse Event|0|||
150054869|NCT00797966|541342073|FG003|Phase A|Adverse Event|0|||
150054870|NCT00797966|541342074|FG004|Phase A|Adverse Event|46|||
150054871|NCT00797966|541342075|FG005|Phase A|Adverse Event|0|||
150054872|NCT00797966|541342070|FG000|Phase A|Met withdrawal criteria|0|||
150054873|NCT00797966|541342071|FG001|Phase A|Met withdrawal criteria|0|||
150054874|NCT00797966|541342072|FG002|Phase A|Met withdrawal criteria|0|||
150054875|NCT00797966|541342073|FG003|Phase A|Met withdrawal criteria|0|||
150054876|NCT00797966|541342074|FG004|Phase A|Met withdrawal criteria|4|||
150054877|NCT00797966|541342075|FG005|Phase A|Met withdrawal criteria|0|||
150054878|NCT00797966|541342070|FG000|Phase A|Physician Decision|0|||
150054879|NCT00797966|541342071|FG001|Phase A|Physician Decision|0|||
150054880|NCT00797966|541342072|FG002|Phase A|Physician Decision|0|||
150054881|NCT00797966|541342073|FG003|Phase A|Physician Decision|0|||
150054882|NCT00797966|541342074|FG004|Phase A|Physician Decision|13|||
150054883|NCT00797966|541342075|FG005|Phase A|Physician Decision|0|||
150054884|NCT00797966|541342070|FG000|Phase A|Withdrawal by Subject|0|||
150179627|NCT01903811|541796775|FG000|Overall Study|Withdrawal by Subject|0|||
150054885|NCT00797966|541342071|FG001|Phase A|Withdrawal by Subject|0|||
150054886|NCT00797966|541342072|FG002|Phase A|Withdrawal by Subject|0|||
150054887|NCT00797966|541342073|FG003|Phase A|Withdrawal by Subject|0|||
150054888|NCT00797966|541342074|FG004|Phase A|Withdrawal by Subject|33|||
150054889|NCT00797966|541342075|FG005|Phase A|Withdrawal by Subject|0|||
150054890|NCT00797966|541342070|FG000|Phase A|Protocol deviation|0|||
150054891|NCT00797966|541342071|FG001|Phase A|Protocol deviation|0|||
150054892|NCT00797966|541342072|FG002|Phase A|Protocol deviation|0|||
150001705|NCT00969761|541138918|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
150001706|NCT00969761|541138919|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001707|NCT00969761|541138920|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
150001708|NCT00969761|541138909|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001709|NCT00969761|541138910|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001710|NCT00969761|541138911|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
150001711|NCT00969761|541138912|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001712|NCT00969761|541138913|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001713|NCT00969761|541138914|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001714|NCT00969761|541138915|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150054893|NCT00797966|541342073|FG003|Phase A|Protocol deviation|0|||
150054894|NCT00797966|541342074|FG004|Phase A|Protocol deviation|56|||
150054895|NCT00797966|541342075|FG005|Phase A|Protocol deviation|0|||
150054896|NCT00797966|541342070|FG000|Phase B|Lost to Follow-up|0|||
150001715|NCT00969761|541138916|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001716|NCT00969761|541138917|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001717|NCT00969761|541138918|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001718|NCT00969761|541138919|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001719|NCT00969761|541138920|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
150001720|NCT00969761|541138909|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150054897|NCT00797966|541342071|FG001|Phase B|Lost to Follow-up|1|||
150054898|NCT00797966|541342072|FG002|Phase B|Lost to Follow-up|3|||
150054899|NCT00797966|541342073|FG003|Phase B|Lost to Follow-up|0|||
150054900|NCT00797966|541342074|FG004|Phase B|Lost to Follow-up|0|||
150054901|NCT00797966|541342075|FG005|Phase B|Lost to Follow-up|0|||
150054902|NCT00797966|541342070|FG000|Phase B|Adverse Event|2|||
150054903|NCT00797966|541342071|FG001|Phase B|Adverse Event|1|||
150054904|NCT00797966|541342072|FG002|Phase B|Adverse Event|3|||
150054905|NCT00797966|541342073|FG003|Phase B|Adverse Event|1|||
150179628|NCT01903811|541796776|FG001|Overall Study|Withdrawal by Subject|1|||
150179629|NCT04540913|541796777|FG000|Overall Study|Withdrawal by Subject|14|||
150179630|NCT04540913|541796778|FG001|Overall Study|Withdrawal by Subject|3|||
150179631|NCT04440176|541796779|FG000|Overall Study|Withdrawal by Subject|5|||
150179632|NCT04440176|541796780|FG001|Overall Study|Withdrawal by Subject|3|||
150179633|NCT04440176|541796779|FG000|Overall Study|Withdrawal by parent/guardian|4|||
150179634|NCT04440176|541796780|FG001|Overall Study|Withdrawal by parent/guardian|5|||
150179635|NCT04440176|541796779|FG000|Overall Study|Adverse Event|2|||
150179636|NCT04440176|541796780|FG001|Overall Study|Adverse Event|6|||
150179637|NCT04440176|541796779|FG000|Overall Study|Lost to Follow-up|22|||
150179638|NCT04440176|541796780|FG001|Overall Study|Lost to Follow-up|23|||
150179639|NCT04440176|541796779|FG000|Overall Study|Medication error without associated adverse event|0|||
150179640|NCT04440176|541796780|FG001|Overall Study|Medication error without associated adverse event|1|||
150179641|NCT04440176|541796779|FG000|Overall Study|No longer met eligibility criteria|7|||
150179642|NCT04440176|541796780|FG001|Overall Study|No longer met eligibility criteria|1|||
150179643|NCT04440176|541796779|FG000|Overall Study|Other|1|||
150179644|NCT04440176|541796780|FG001|Overall Study|Other|2|||
150179645|NCT04440176|541796779|FG000|Overall Study|Protocol deviation|6|||
150179646|NCT04440176|541796780|FG001|Overall Study|Protocol deviation|8|||
150179647|NCT04440176|541796779|FG000|Overall Study|Randomized but not vaccinated|6|||
150179648|NCT04440176|541796780|FG001|Overall Study|Randomized but not vaccinated|3|||
150179649|NCT04153565|541796781|FG000|Overall Study|Death|13|||
150179650|NCT02991807|541796782|FG000|Overall Study|Withdrawal by Subject|2|||
150179651|NCT02991807|541796783|FG001|Overall Study|Withdrawal by Subject|1|||
150179652|NCT02991807|541796782|FG000|Overall Study|Physician Decision|0|||
150179653|NCT02991807|541796783|FG001|Overall Study|Physician Decision|1|||
150179654|NCT02991807|541796782|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
150255073|NCT02738203|542070546|FG000|Overall Study|Failed IUD Insertion|2|||
150255074|NCT02738203|542070547|FG001|Overall Study|Failed IUD Insertion|2|||
150054906|NCT00797966|541342074|FG004|Phase B|Adverse Event|0|||
150054907|NCT00797966|541342075|FG005|Phase B|Adverse Event|0|||
150255075|NCT02738203|542070546|FG000|Overall Study|Protocol Violation|0|||
150255076|NCT02738203|542070547|FG001|Overall Study|Protocol Violation|1|||
150255077|NCT00266227|542070548|FG000|Initial Treatment|Adverse Event|0|||
150255078|NCT00266227|542070549|FG001|Initial Treatment|Adverse Event|0|||
150255079|NCT00266227|542070550|FG002|Initial Treatment|Adverse Event|13|||
150255080|NCT00266227|542070548|FG000|Initial Treatment|Lost to Follow-up|0|||
150255081|NCT00266227|542070549|FG001|Initial Treatment|Lost to Follow-up|0|||
150255082|NCT00266227|542070550|FG002|Initial Treatment|Lost to Follow-up|6|||
150255083|NCT00266227|542070548|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
150255084|NCT00266227|542070549|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
150255085|NCT00266227|542070550|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
150255086|NCT00266227|542070548|FG000|Initial Treatment|Physician decision to withdraw|0|||
150001721|NCT00969761|541138910|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001722|NCT00969761|541138911|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
150001723|NCT00969761|541138912|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001724|NCT00969761|541138913|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001725|NCT00969761|541138914|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001726|NCT00969761|541138915|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001727|NCT00969761|541138916|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001728|NCT00969761|541138917|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001729|NCT00969761|541138918|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001730|NCT00969761|541138919|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001731|NCT00969761|541138920|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
150001732|NCT00969761|541138909|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001733|NCT00969761|541138910|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001734|NCT00969761|541138911|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001735|NCT00969761|541138912|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001736|NCT00969761|541138913|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001737|NCT00969761|541138914|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001738|NCT00969761|541138915|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001739|NCT00969761|541138916|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001740|NCT00969761|541138917|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
150001741|NCT00969761|541138918|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001742|NCT00969761|541138919|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001743|NCT00969761|541138920|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
150001744|NCT00969761|541138909|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
150001745|NCT00969761|541138910|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001746|NCT00969761|541138911|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
150001747|NCT00969761|541138912|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001748|NCT00969761|541138913|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
150001749|NCT00969761|541138914|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001750|NCT00969761|541138915|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001751|NCT00969761|541138916|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
150001752|NCT00969761|541138917|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
150001753|NCT00969761|541138918|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
150001754|NCT00969761|541138919|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001755|NCT00969761|541138920|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
150001756|NCT00969761|541138909|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001757|NCT00969761|541138910|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001758|NCT00969761|541138911|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001759|NCT00969761|541138912|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
150001760|NCT00969761|541138913|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
150001761|NCT00969761|541138914|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001762|NCT00969761|541138915|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001763|NCT00969761|541138916|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001764|NCT00969761|541138917|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
150001765|NCT00969761|541138918|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001766|NCT00969761|541138919|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150001767|NCT00969761|541138920|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
150054908|NCT00797966|541342070|FG000|Phase B|Met Withdrawal Criteria|3|||
150054909|NCT00797966|541342071|FG001|Phase B|Met Withdrawal Criteria|3|||
150054910|NCT00797966|541342072|FG002|Phase B|Met Withdrawal Criteria|6|||
150054911|NCT00797966|541342073|FG003|Phase B|Met Withdrawal Criteria|1|||
150054912|NCT00797966|541342074|FG004|Phase B|Met Withdrawal Criteria|0|||
150054913|NCT00797966|541342075|FG005|Phase B|Met Withdrawal Criteria|0|||
150054914|NCT00797966|541342070|FG000|Phase B|Physician Decision|1|||
150054915|NCT00797966|541342071|FG001|Phase B|Physician Decision|0|||
150054916|NCT00797966|541342072|FG002|Phase B|Physician Decision|3|||
150054917|NCT00797966|541342073|FG003|Phase B|Physician Decision|1|||
150054918|NCT00797966|541342074|FG004|Phase B|Physician Decision|0|||
150054919|NCT00797966|541342075|FG005|Phase B|Physician Decision|0|||
150054920|NCT00797966|541342070|FG000|Phase B|Withdrawal by Subject|1|||
150054921|NCT00797966|541342071|FG001|Phase B|Withdrawal by Subject|4|||
150054922|NCT00797966|541342072|FG002|Phase B|Withdrawal by Subject|3|||
150054923|NCT00797966|541342073|FG003|Phase B|Withdrawal by Subject|3|||
150054924|NCT00797966|541342074|FG004|Phase B|Withdrawal by Subject|0|||
150054925|NCT00797966|541342075|FG005|Phase B|Withdrawal by Subject|0|||
150054926|NCT00797966|541342070|FG000|Phase B|Protocol Deviation|4|||
150054927|NCT00797966|541342071|FG001|Phase B|Protocol Deviation|8|||
150054928|NCT00797966|541342072|FG002|Phase B|Protocol Deviation|2|||
150001768|NCT00387647|541140634|FG000|Overall Study|Death|18|||
150001769|NCT00758589|541140635|FG000|Overall Study|Adverse Event|3|||
150001770|NCT00758589|541140636|FG001|Overall Study|Adverse Event|2|||
150001771|NCT00758589|541140637|FG002|Overall Study|Adverse Event|5|||
150001772|NCT00758589|541140638|FG003|Overall Study|Adverse Event|4|||
150001773|NCT00758589|541140635|FG000|Overall Study|Withdrawal by Subject|0|||
150001774|NCT00758589|541140636|FG001|Overall Study|Withdrawal by Subject|1|||
150001775|NCT00758589|541140637|FG002|Overall Study|Withdrawal by Subject|1|||
150001776|NCT00758589|541140638|FG003|Overall Study|Withdrawal by Subject|1|||
150001777|NCT00758589|541140635|FG000|Overall Study|Palm stopped to work|0|||
150001778|NCT00758589|541140636|FG001|Overall Study|Palm stopped to work|0|||
150001779|NCT00758589|541140637|FG002|Overall Study|Palm stopped to work|0|||
150001780|NCT00758589|541140638|FG003|Overall Study|Palm stopped to work|1|||
150001781|NCT02191605|541140639|FG000|Overall Study|Lost to Follow-up|9|||
150001782|NCT02191605|541140640|FG001|Overall Study|Lost to Follow-up|4|||
150001783|NCT02191605|541140641|FG002|Overall Study|Lost to Follow-up|7|||
150001784|NCT02191605|541140642|FG003|Overall Study|Lost to Follow-up|3|||
150001785|NCT02191605|541140643|FG004|Overall Study|Lost to Follow-up|4|||
150001786|NCT05275582|541140644|FG000|Overall Study|Lost to Follow-up|1|||
150001787|NCT05275582|541140645|FG001|Overall Study|Lost to Follow-up|0|||
150001788|NCT05275582|541140644|FG000|Overall Study|Withdrawal by Subject|0|||
150001789|NCT05275582|541140645|FG001|Overall Study|Withdrawal by Subject|2|||
150001790|NCT05275582|541140644|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
150001791|NCT05275582|541140645|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
150001792|NCT05275582|541140644|FG000|Overall Study|Death|1|||
150001793|NCT05275582|541140645|FG001|Overall Study|Death|0|||
150001794|NCT05275582|541140644|FG000|Overall Study|Protocol Violation|1|||
150001795|NCT05275582|541140645|FG001|Overall Study|Protocol Violation|0|||
150001796|NCT04524455|541140657|FG000|Overall Study|Death|3|||
150001797|NCT04524455|541140658|FG001|Overall Study|Death|3|||
150001798|NCT04524455|541140657|FG000|Overall Study|Decision by Sponsor|0|||
150001799|NCT04524455|541140658|FG001|Overall Study|Decision by Sponsor|2|||
150001800|NCT04524455|541140657|FG000|Overall Study|Withdrawal of Consent From Study|1|||
150001801|NCT04524455|541140658|FG001|Overall Study|Withdrawal of Consent From Study|0|||
150001802|NCT04524455|541140657|FG000|Overall Study|Lost to Follow-up|0|||
150054929|NCT00797966|541342073|FG003|Phase B|Protocol Deviation|6|||
150054930|NCT00797966|541342074|FG004|Phase B|Protocol Deviation|0|||
150001803|NCT04524455|541140658|FG001|Overall Study|Lost to Follow-up|1|||
150001804|NCT00076336|541140661|FG000|Overall Study|Death|13|||
150001805|NCT00076336|541140662|FG001|Overall Study|Death|17|||
150001806|NCT00076336|541140661|FG000|Overall Study|Adverse Event|4|||
150054931|NCT00797966|541342075|FG005|Phase B|Protocol Deviation|0|||
150054932|NCT00797966|541342070|FG000|Phase B|Lack of Efficacy|0|||
150054933|NCT00797966|541342071|FG001|Phase B|Lack of Efficacy|1|||
150054934|NCT00797966|541342072|FG002|Phase B|Lack of Efficacy|1|||
150001807|NCT00076336|541140662|FG001|Overall Study|Adverse Event|4|||
150001808|NCT00076336|541140661|FG000|Overall Study|Lost to Follow-up|4|||
150001809|NCT00076336|541140662|FG001|Overall Study|Lost to Follow-up|4|||
150001810|NCT00076336|541140661|FG000|Overall Study|Non-Compliance|2|||
150001811|NCT00076336|541140662|FG001|Overall Study|Non-Compliance|0|||
150001812|NCT00076336|541140661|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
150001813|NCT00076336|541140662|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
150001814|NCT00076336|541140661|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
150001815|NCT00076336|541140662|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
150001816|NCT00076336|541140661|FG000|Overall Study|Liver Transplantation|3|||
150001817|NCT00076336|541140662|FG001|Overall Study|Liver Transplantation|3|||
150001818|NCT00076336|541140661|FG000|Overall Study|Virologic Breakthrough|14|||
150001819|NCT00076336|541140662|FG001|Overall Study|Virologic Breakthrough|16|||
150001820|NCT00076336|541140661|FG000|Overall Study|Treatment failure|4|||
150001821|NCT00076336|541140662|FG001|Overall Study|Treatment failure|5|||
150001822|NCT01266317|541140666|FG000|Overall Study|Withdrawal by Subject|2|||
150001823|NCT00098722|541140669|FG000|Double Blind Phase|Adverse Event|7|||
150001824|NCT00098722|541140670|FG001|Double Blind Phase|Adverse Event|7|||
150001825|NCT00098722|541140671|FG002|Double Blind Phase|Adverse Event|3|||
150001826|NCT00098722|541140672|FG003|Double Blind Phase|Adverse Event|0|||
150001827|NCT00098722|541140673|FG004|Double Blind Phase|Adverse Event|0|||
150001828|NCT00098722|541140674|FG005|Double Blind Phase|Adverse Event|0|||
150001829|NCT00098722|541140675|FG006|Double Blind Phase|Adverse Event|0|||
150001830|NCT00098722|541140669|FG000|Double Blind Phase|Death|2|||
150001831|NCT00098722|541140670|FG001|Double Blind Phase|Death|5|||
150001832|NCT00098722|541140671|FG002|Double Blind Phase|Death|0|||
150001833|NCT00098722|541140672|FG003|Double Blind Phase|Death|0|||
150001834|NCT00098722|541140673|FG004|Double Blind Phase|Death|0|||
150001835|NCT00098722|541140674|FG005|Double Blind Phase|Death|0|||
150001836|NCT00098722|541140675|FG006|Double Blind Phase|Death|0|||
150001837|NCT00098722|541140669|FG000|Double Blind Phase|Lack of Efficacy|21|||
150001838|NCT00098722|541140670|FG001|Double Blind Phase|Lack of Efficacy|23|||
150001839|NCT00098722|541140671|FG002|Double Blind Phase|Lack of Efficacy|15|||
150001840|NCT00098722|541140672|FG003|Double Blind Phase|Lack of Efficacy|0|||
150001841|NCT00098722|541140673|FG004|Double Blind Phase|Lack of Efficacy|0|||
150001842|NCT00098722|541140674|FG005|Double Blind Phase|Lack of Efficacy|0|||
150001843|NCT00098722|541140675|FG006|Double Blind Phase|Lack of Efficacy|0|||
150001844|NCT00098722|541140669|FG000|Double Blind Phase|Participant defaulted|16|||
150001845|NCT00098722|541140670|FG001|Double Blind Phase|Participant defaulted|11|||
150001846|NCT00098722|541140671|FG002|Double Blind Phase|Participant defaulted|9|||
150001847|NCT00098722|541140672|FG003|Double Blind Phase|Participant defaulted|0|||
150001848|NCT00098722|541140673|FG004|Double Blind Phase|Participant defaulted|0|||
150054935|NCT00797966|541342073|FG003|Phase B|Lack of Efficacy|4|||
150054936|NCT00797966|541342074|FG004|Phase B|Lack of Efficacy|0|||
150054937|NCT00797966|541342075|FG005|Phase B|Lack of Efficacy|0|||
150054938|NCT00797966|541342070|FG000|Phase A+|Lost to Follow-up|0|||
150054939|NCT00797966|541342071|FG001|Phase A+|Lost to Follow-up|0|||
150001849|NCT00098722|541140674|FG005|Double Blind Phase|Participant defaulted|0|||
150001850|NCT00098722|541140675|FG006|Double Blind Phase|Participant defaulted|0|||
150001851|NCT00098722|541140669|FG000|Double Blind Phase|Pregnancy|1|||
150001852|NCT00098722|541140670|FG001|Double Blind Phase|Pregnancy|0|||
150001853|NCT00098722|541140671|FG002|Double Blind Phase|Pregnancy|0|||
150001854|NCT00098722|541140672|FG003|Double Blind Phase|Pregnancy|0|||
150001855|NCT00098722|541140673|FG004|Double Blind Phase|Pregnancy|0|||
150001856|NCT00098722|541140674|FG005|Double Blind Phase|Pregnancy|0|||
150001857|NCT00098722|541140675|FG006|Double Blind Phase|Pregnancy|0|||
150001858|NCT00098722|541140669|FG000|Double Blind Phase|Randomized, not treated|4|||
150001859|NCT00098722|541140670|FG001|Double Blind Phase|Randomized, not treated|3|||
150054940|NCT00797966|541342072|FG002|Phase A+|Lost to Follow-up|0|||
150054941|NCT00797966|541342073|FG003|Phase A+|Lost to Follow-up|0|||
150001860|NCT00098722|541140671|FG002|Double Blind Phase|Randomized, not treated|3|||
150001861|NCT00098722|541140672|FG003|Double Blind Phase|Randomized, not treated|0|||
150001862|NCT00098722|541140673|FG004|Double Blind Phase|Randomized, not treated|0|||
150001863|NCT00098722|541140674|FG005|Double Blind Phase|Randomized, not treated|0|||
150001864|NCT00098722|541140675|FG006|Double Blind Phase|Randomized, not treated|0|||
150001865|NCT00098722|541140669|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
150001866|NCT00098722|541140670|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
150001867|NCT00098722|541140671|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
150001868|NCT00098722|541140672|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
150001869|NCT00098722|541140673|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
150255087|NCT00266227|542070549|FG001|Initial Treatment|Physician decision to withdraw|0|||
150001870|NCT00098722|541140674|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
150255088|NCT00266227|542070550|FG002|Initial Treatment|Physician decision to withdraw|12|||
150255089|NCT00266227|542070548|FG000|Initial Treatment|Pregnancy|0|||
150255090|NCT00266227|542070549|FG001|Initial Treatment|Pregnancy|0|||
150255091|NCT00266227|542070550|FG002|Initial Treatment|Pregnancy|1|||
150255092|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Death|1|||
150255093|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Death|0|||
150255094|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Death|0|||
150255095|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
150255096|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
150255097|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
150255098|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
150255099|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
150255100|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
150255101|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
150255102|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
150255103|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
150255104|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
150255105|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
150255106|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
150255107|NCT00266227|542070548|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
150255108|NCT00266227|542070549|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
150255109|NCT00266227|542070550|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
150255110|NCT00266227|542070548|FG000|Retreatment: Week 48 to Week 72|Death|1|||
150255111|NCT00266227|542070549|FG001|Retreatment: Week 48 to Week 72|Death|1|||
150255112|NCT00266227|542070550|FG002|Retreatment: Week 48 to Week 72|Death|0|||
150255113|NCT00266227|542070548|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
150255114|NCT00266227|542070549|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
150255115|NCT00266227|542070550|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
150255116|NCT00266227|542070548|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
150255117|NCT00266227|542070549|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
150255118|NCT00266227|542070550|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
150255119|NCT00266227|542070548|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
150255120|NCT00266227|542070549|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
150255121|NCT00266227|542070550|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
150255122|NCT00266227|542070548|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
150255123|NCT00266227|542070549|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
150255124|NCT00266227|542070550|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
150255125|NCT03573583|542070551|FG000|Overall Study|Lost to Follow-up|1|||
150255126|NCT03573583|542070552|FG001|Overall Study|Lost to Follow-up|0|||
150255127|NCT03573583|542070551|FG000|Overall Study|Withdrawal by Subject|1|||
150255128|NCT03573583|542070552|FG001|Overall Study|Withdrawal by Subject|1|||
150255129|NCT01290315|542070554|FG000|Overall Study|Adverse Event|0|||
150255130|NCT01290315|542070555|FG001|Overall Study|Adverse Event|0|||
150255131|NCT01290315|542070556|FG002|Overall Study|Adverse Event|0|||
150255132|NCT01290315|542070557|FG003|Overall Study|Adverse Event|3|||
150255133|NCT01290315|542070554|FG000|Overall Study|Selection criteria/compliance|2|||
150255134|NCT01290315|542070555|FG001|Overall Study|Selection criteria/compliance|1|||
150255135|NCT01290315|542070556|FG002|Overall Study|Selection criteria/compliance|0|||
150255136|NCT01290315|542070557|FG003|Overall Study|Selection criteria/compliance|2|||
150255137|NCT01290315|542070554|FG000|Overall Study|Lost to Follow-up|0|||
150255138|NCT01290315|542070555|FG001|Overall Study|Lost to Follow-up|1|||
150255139|NCT01290315|542070556|FG002|Overall Study|Lost to Follow-up|0|||
150255140|NCT01290315|542070557|FG003|Overall Study|Lost to Follow-up|0|||
150255141|NCT01290315|542070554|FG000|Overall Study|Withdrawal by Subject|1|||
150255142|NCT01290315|542070555|FG001|Overall Study|Withdrawal by Subject|1|||
150001871|NCT00098722|541140675|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
150001872|NCT00098722|541140669|FG000|Double Blind Phase|Other|7|||
150001873|NCT00098722|541140670|FG001|Double Blind Phase|Other|8|||
150001874|NCT00098722|541140671|FG002|Double Blind Phase|Other|7|||
150001875|NCT00098722|541140672|FG003|Double Blind Phase|Other|0|||
150001876|NCT00098722|541140673|FG004|Double Blind Phase|Other|0|||
150001877|NCT00098722|541140674|FG005|Double Blind Phase|Other|0|||
150001878|NCT00098722|541140675|FG006|Double Blind Phase|Other|0|||
150001879|NCT00098722|541140669|FG000|Open Label Phase|Adverse Event|0|||
150054942|NCT00797966|541342074|FG004|Phase A+|Lost to Follow-up|0|||
150054943|NCT00797966|541342075|FG005|Phase A+|Lost to Follow-up|9|||
150054944|NCT00797966|541342070|FG000|Phase A+|Met withdrawal criteria|0|||
150054945|NCT00797966|541342071|FG001|Phase A+|Met withdrawal criteria|0|||
150054946|NCT00797966|541342072|FG002|Phase A+|Met withdrawal criteria|0|||
150054947|NCT00797966|541342073|FG003|Phase A+|Met withdrawal criteria|0|||
150054948|NCT00797966|541342074|FG004|Phase A+|Met withdrawal criteria|0|||
150054949|NCT00797966|541342075|FG005|Phase A+|Met withdrawal criteria|5|||
150054950|NCT00797966|541342070|FG000|Phase A+|Withdrawal by Subject|0|||
150001880|NCT00098722|541140670|FG001|Open Label Phase|Adverse Event|0|||
150001881|NCT00098722|541140671|FG002|Open Label Phase|Adverse Event|0|||
150001882|NCT00098722|541140672|FG003|Open Label Phase|Adverse Event|5|||
150001883|NCT00098722|541140673|FG004|Open Label Phase|Adverse Event|0|||
150001884|NCT00098722|541140674|FG005|Open Label Phase|Adverse Event|0|||
150001885|NCT00098722|541140675|FG006|Open Label Phase|Adverse Event|0|||
150001886|NCT00098722|541140669|FG000|Open Label Phase|Death|0|||
150001887|NCT00098722|541140670|FG001|Open Label Phase|Death|0|||
150001888|NCT00098722|541140671|FG002|Open Label Phase|Death|0|||
150001889|NCT00098722|541140672|FG003|Open Label Phase|Death|2|||
150001890|NCT00098722|541140673|FG004|Open Label Phase|Death|0|||
150001891|NCT00098722|541140674|FG005|Open Label Phase|Death|0|||
150054951|NCT00797966|541342071|FG001|Phase A+|Withdrawal by Subject|0|||
150054952|NCT00797966|541342072|FG002|Phase A+|Withdrawal by Subject|0|||
150054953|NCT00797966|541342073|FG003|Phase A+|Withdrawal by Subject|0|||
150179655|NCT02991807|541796783|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
150179656|NCT02300298|541796784|FG000|Disposition for Nintedanib|Progressive disease|10|||
150179657|NCT02300298|541796785|FG001|Disposition for Nintedanib|Progressive disease|0|||
150179658|NCT02300298|541796784|FG000|Disposition for Docetaxel|Progressive disease|0|||
150179659|NCT02300298|541796785|FG001|Disposition for Docetaxel|Progressive disease|6|||
150179660|NCT02300298|541796784|FG000|Disposition for Docetaxel|other adverse event|0|||
150179661|NCT02300298|541796785|FG001|Disposition for Docetaxel|other adverse event|4|||
150179662|NCT00402246|541796786|FG000|Overall Study|Death|62|||
150179663|NCT00402246|541796787|FG001|Overall Study|Death|58|||
150179664|NCT00402246|541796786|FG000|Overall Study|Lost to Follow-up|20|||
150179665|NCT00402246|541796787|FG001|Overall Study|Lost to Follow-up|28|||
150179666|NCT00402246|541796786|FG000|Overall Study|Withdrawal by Subject|72|||
150179667|NCT00402246|541796787|FG001|Overall Study|Withdrawal by Subject|87|||
150179668|NCT00402246|541796786|FG000|Overall Study|Physician Decision|24|||
150179669|NCT00402246|541796787|FG001|Overall Study|Physician Decision|26|||
150179670|NCT00402246|541796786|FG000|Overall Study|Protocol Violation|25|||
150179671|NCT00402246|541796787|FG001|Overall Study|Protocol Violation|24|||
150179672|NCT00402246|541796786|FG000|Overall Study|Missed Final Visit|1|||
150179673|NCT00402246|541796787|FG001|Overall Study|Missed Final Visit|2|||
150179674|NCT00402246|541796786|FG000|Overall Study|Insurance Issues|2|||
150179675|NCT00402246|541796787|FG001|Overall Study|Insurance Issues|1|||
150179676|NCT00402246|541796786|FG000|Overall Study|Heart Transplant|0|||
150179677|NCT00402246|541796787|FG001|Overall Study|Heart Transplant|1|||
150179678|NCT00402246|541796786|FG000|Overall Study|Patient's device explanted|6|||
150179679|NCT00402246|541796787|FG001|Overall Study|Patient's device explanted|2|||
150179680|NCT00402246|541796786|FG000|Overall Study|Center Closure|5|||
150179681|NCT00402246|541796787|FG001|Overall Study|Center Closure|3|||
150179682|NCT00402246|541796786|FG000|Overall Study|Deterioriating Condition|3|||
150179683|NCT00402246|541796787|FG001|Overall Study|Deterioriating Condition|2|||
150179684|NCT01808339|541796788|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179685|NCT01808339|541796789|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179686|NCT01808339|541796790|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179687|NCT01808339|541796791|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
150179688|NCT01808339|541796792|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
150179689|NCT01808339|541796793|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
150001892|NCT00098722|541140675|FG006|Open Label Phase|Death|0|||
150001893|NCT00098722|541140669|FG000|Open Label Phase|Lack of Efficacy|0|||
150001894|NCT00098722|541140670|FG001|Open Label Phase|Lack of Efficacy|0|||
150179690|NCT01808339|541796788|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150179691|NCT01808339|541796789|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
150179692|NCT01808339|541796790|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150179693|NCT01808339|541796791|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
150179694|NCT01808339|541796792|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150001895|NCT00098722|541140671|FG002|Open Label Phase|Lack of Efficacy|0|||
150001896|NCT00098722|541140672|FG003|Open Label Phase|Lack of Efficacy|8|||
150054954|NCT00797966|541342074|FG004|Phase A+|Withdrawal by Subject|0|||
150054955|NCT00797966|541342075|FG005|Phase A+|Withdrawal by Subject|6|||
150054956|NCT00797966|541342070|FG000|Phase A+|Adverse Event|0|||
150054957|NCT00797966|541342071|FG001|Phase A+|Adverse Event|0|||
150179695|NCT01808339|541796793|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150054958|NCT00797966|541342072|FG002|Phase A+|Adverse Event|0|||
150054959|NCT00797966|541342073|FG003|Phase A+|Adverse Event|0|||
150054960|NCT00797966|541342074|FG004|Phase A+|Adverse Event|0|||
150054961|NCT00797966|541342075|FG005|Phase A+|Adverse Event|4|||
150054962|NCT00797966|541342070|FG000|Phase A+|Protocol deviation|0|||
150054963|NCT00797966|541342071|FG001|Phase A+|Protocol deviation|0|||
150054964|NCT00797966|541342072|FG002|Phase A+|Protocol deviation|0|||
150001897|NCT00098722|541140673|FG004|Open Label Phase|Lack of Efficacy|0|||
150001898|NCT00098722|541140674|FG005|Open Label Phase|Lack of Efficacy|0|||
150001899|NCT00098722|541140675|FG006|Open Label Phase|Lack of Efficacy|0|||
150001900|NCT00098722|541140669|FG000|Open Label Phase|Pregnancy|0|||
150001901|NCT00098722|541140670|FG001|Open Label Phase|Pregnancy|0|||
150001902|NCT00098722|541140671|FG002|Open Label Phase|Pregnancy|0|||
150001903|NCT00098722|541140672|FG003|Open Label Phase|Pregnancy|1|||
150001904|NCT00098722|541140673|FG004|Open Label Phase|Pregnancy|0|||
150001905|NCT00098722|541140674|FG005|Open Label Phase|Pregnancy|0|||
150001906|NCT00098722|541140675|FG006|Open Label Phase|Pregnancy|0|||
150001907|NCT00098722|541140669|FG000|Open Label Phase|Participant defaulted|0|||
150001908|NCT00098722|541140670|FG001|Open Label Phase|Participant defaulted|0|||
150001909|NCT00098722|541140671|FG002|Open Label Phase|Participant defaulted|0|||
150001910|NCT00098722|541140672|FG003|Open Label Phase|Participant defaulted|18|||
150001911|NCT00098722|541140673|FG004|Open Label Phase|Participant defaulted|0|||
150001912|NCT00098722|541140674|FG005|Open Label Phase|Participant defaulted|0|||
150001913|NCT00098722|541140675|FG006|Open Label Phase|Participant defaulted|0|||
150001914|NCT00098722|541140669|FG000|Open Label Phase|Ongoing at cut-off date|0|||
150001915|NCT00098722|541140670|FG001|Open Label Phase|Ongoing at cut-off date|0|||
150001916|NCT00098722|541140671|FG002|Open Label Phase|Ongoing at cut-off date|0|||
150001917|NCT00098722|541140672|FG003|Open Label Phase|Ongoing at cut-off date|220|||
150001918|NCT00098722|541140673|FG004|Open Label Phase|Ongoing at cut-off date|50|||
150001919|NCT00098722|541140674|FG005|Open Label Phase|Ongoing at cut-off date|0|||
150001920|NCT00098722|541140675|FG006|Open Label Phase|Ongoing at cut-off date|0|||
150001921|NCT00098722|541140669|FG000|Open Label Phase|Other|0|||
150001922|NCT00098722|541140670|FG001|Open Label Phase|Other|0|||
150001923|NCT00098722|541140671|FG002|Open Label Phase|Other|0|||
150001924|NCT00098722|541140672|FG003|Open Label Phase|Other|18|||
150001925|NCT00098722|541140673|FG004|Open Label Phase|Other|0|||
150001926|NCT00098722|541140674|FG005|Open Label Phase|Other|0|||
150001927|NCT00098722|541140675|FG006|Open Label Phase|Other|0|||
150001928|NCT00098722|541140669|FG000|Observation Phase|Death|0|||
150001929|NCT00098722|541140670|FG001|Observation Phase|Death|0|||
150001930|NCT00098722|541140671|FG002|Observation Phase|Death|0|||
150001931|NCT00098722|541140672|FG003|Observation Phase|Death|0|||
150001932|NCT00098722|541140673|FG004|Observation Phase|Death|0|||
150001933|NCT00098722|541140674|FG005|Observation Phase|Death|5|||
150001934|NCT00098722|541140675|FG006|Observation Phase|Death|3|||
150001935|NCT00098722|541140669|FG000|Observation Phase|Lack of Efficacy|0|||
150001936|NCT00098722|541140670|FG001|Observation Phase|Lack of Efficacy|0|||
150001937|NCT00098722|541140671|FG002|Observation Phase|Lack of Efficacy|0|||
150001938|NCT00098722|541140672|FG003|Observation Phase|Lack of Efficacy|0|||
150001939|NCT00098722|541140673|FG004|Observation Phase|Lack of Efficacy|0|||
150001940|NCT00098722|541140674|FG005|Observation Phase|Lack of Efficacy|2|||
150001941|NCT00098722|541140675|FG006|Observation Phase|Lack of Efficacy|0|||
150001942|NCT00098722|541140669|FG000|Observation Phase|Participant defaulted|0|||
150001943|NCT00098722|541140670|FG001|Observation Phase|Participant defaulted|0|||
150001944|NCT00098722|541140671|FG002|Observation Phase|Participant defaulted|0|||
150054965|NCT00797966|541342073|FG003|Phase A+|Protocol deviation|0|||
150054966|NCT00797966|541342074|FG004|Phase A+|Protocol deviation|0|||
150001945|NCT00098722|541140672|FG003|Observation Phase|Participant defaulted|0|||
150001946|NCT00098722|541140673|FG004|Observation Phase|Participant defaulted|0|||
150001947|NCT00098722|541140674|FG005|Observation Phase|Participant defaulted|17|||
150001948|NCT00098722|541140675|FG006|Observation Phase|Participant defaulted|4|||
150001949|NCT00098722|541140669|FG000|Observation Phase|Other|0|||
150001950|NCT00098722|541140670|FG001|Observation Phase|Other|0|||
150001951|NCT00098722|541140671|FG002|Observation Phase|Other|0|||
150001952|NCT00098722|541140672|FG003|Observation Phase|Other|0|||
150001953|NCT00098722|541140673|FG004|Observation Phase|Other|0|||
150001954|NCT00098722|541140674|FG005|Observation Phase|Other|21|||
150001955|NCT00098722|541140675|FG006|Observation Phase|Other|10|||
150001956|NCT01610596|541140684|FG000|Overall Study|Lost to Follow-up|0|||
150001957|NCT01610596|541140685|FG001|Overall Study|Lost to Follow-up|1|||
150001958|NCT01519674|541140686|FG000|Overall Study|Adverse Event|3|||
150001959|NCT01519674|541140687|FG001|Overall Study|Adverse Event|3|||
150001960|NCT01519674|541140688|FG002|Overall Study|Adverse Event|0|||
150001961|NCT01519674|541140686|FG000|Overall Study|Lack of Efficacy|1|||
150001962|NCT01519674|541140687|FG001|Overall Study|Lack of Efficacy|1|||
150001963|NCT01519674|541140688|FG002|Overall Study|Lack of Efficacy|1|||
150001964|NCT01519674|541140686|FG000|Overall Study|Protocol Violation|0|||
150001965|NCT01519674|541140687|FG001|Overall Study|Protocol Violation|3|||
150001966|NCT01519674|541140688|FG002|Overall Study|Protocol Violation|1|||
150001967|NCT01519674|541140686|FG000|Overall Study|Withdrawal Criteria|7|||
150001968|NCT01519674|541140687|FG001|Overall Study|Withdrawal Criteria|2|||
150001969|NCT01519674|541140688|FG002|Overall Study|Withdrawal Criteria|7|||
150001970|NCT01519674|541140686|FG000|Overall Study|Unsclassified|10|||
150054967|NCT00797966|541342075|FG005|Phase A+|Protocol deviation|4|||
150054968|NCT01430754|541342083|FG000|Run-In Phase|Circadian Period Ineligible|24|||
150054969|NCT01430754|541342084|FG001|Run-In Phase|Circadian Period Ineligible|0|||
150054970|NCT01430754|541342083|FG000|Run-In Phase|Protocol Violation|6|||
150054971|NCT01430754|541342084|FG001|Run-In Phase|Protocol Violation|0|||
150054972|NCT01430754|541342083|FG000|Run-In Phase|Adverse Event|2|||
150054973|NCT01430754|541342084|FG001|Run-In Phase|Adverse Event|0|||
150054974|NCT01430754|541342083|FG000|Run-In Phase|Other|2|||
150054975|NCT01430754|541342084|FG001|Run-In Phase|Other|0|||
150054976|NCT01430754|541342083|FG000|Run-In Phase|Withdrawal by Subject|2|||
150054977|NCT01430754|541342084|FG001|Run-In Phase|Withdrawal by Subject|0|||
150054978|NCT01430754|541342083|FG000|Run-In Phase|Lost to Follow-up|1|||
150054979|NCT01430754|541342084|FG001|Run-In Phase|Lost to Follow-up|0|||
150054980|NCT02661178|541342087|FG000|Part 1|Protocol Violation|1|||
150054981|NCT02661178|541342088|FG001|Part 1|Protocol Violation|0|||
150054982|NCT02661178|541342089|FG002|Part 1|Protocol Violation|0|||
150001971|NCT01519674|541140687|FG001|Overall Study|Unsclassified|4|||
150054983|NCT02661178|541342090|FG003|Part 1|Protocol Violation|0|||
150054984|NCT02661178|541342091|FG004|Part 1|Protocol Violation|0|||
150054985|NCT02661178|541342092|FG005|Part 1|Protocol Violation|0|||
150054986|NCT02661178|541342093|FG006|Part 1|Protocol Violation|0|||
150054987|NCT02661178|541342094|FG007|Part 1|Protocol Violation|0|||
150054988|NCT02661178|541342095|FG008|Part 1|Protocol Violation|0|||
150054989|NCT02661178|541342096|FG009|Part 1|Protocol Violation|0|||
150054990|NCT02661178|541342097|FG010|Part 1|Protocol Violation|0|||
150054991|NCT02661178|541342098|FG011|Part 1|Protocol Violation|0|||
150054992|NCT02661178|541342099|FG012|Part 1|Protocol Violation|0|||
150054993|NCT02661178|541342100|FG013|Part 1|Protocol Violation|0|||
150054994|NCT02661178|541342101|FG014|Part 1|Protocol Violation|0|||
150001972|NCT01519674|541140688|FG002|Overall Study|Unsclassified|3|||
150001973|NCT00799591|541140689|FG000|Overall Study|De-escalation of doses|20|||
150001974|NCT00799591|541140689|FG000|Overall Study|Death|14|||
150001975|NCT00799591|541140689|FG000|Overall Study|Technical failure|12|||
150001976|NCT00799591|541140689|FG000|Overall Study|Resistant germ|11|||
150001977|NCT00799591|541140689|FG000|Overall Study|New infection|4|||
150001978|NCT00799591|541140689|FG000|Overall Study|Resistance germ and technical failure|2|||
150001979|NCT00799591|541140689|FG000|Overall Study|Persistance of fever undetermined origin|1|||
150001980|NCT00799591|541140689|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
150001981|NCT00799591|541140689|FG000|Overall Study|Infectious origin not probable|1|||
150001982|NCT04599166|541140690|FG000|Overall Study|Technological failure connecting to study app|80|||
150001983|NCT02317809|541140691|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
150001984|NCT02317809|541140692|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
150001985|NCT02317809|541140691|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
150001986|NCT02317809|541140692|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
150001987|NCT01974752|541140693|FG000|Overall Study|Death|33|||
150001988|NCT01974752|541140694|FG001|Overall Study|Death|11|||
150001989|NCT01974752|541140693|FG000|Overall Study|Lost to Follow-up|2|||
150001990|NCT01974752|541140694|FG001|Overall Study|Lost to Follow-up|0|||
150001991|NCT01974752|541140693|FG000|Overall Study|Withdrawal by Subject|2|||
150001992|NCT01974752|541140694|FG001|Overall Study|Withdrawal by Subject|3|||
150001993|NCT01974752|541140693|FG000|Overall Study|Other Eligibility Criteria|0|||
150001994|NCT01974752|541140694|FG001|Overall Study|Other Eligibility Criteria|1|||
150001995|NCT02435680|541140695|FG000|Overall Study|Physician Decision|3|||
150001996|NCT02435680|541140696|FG001|Overall Study|Physician Decision|0|||
150001997|NCT02435680|541140697|FG002|Overall Study|Physician Decision|0|||
150001998|NCT02435680|541140695|FG000|Overall Study|subject / guardian decision|0|||
150001999|NCT02435680|541140696|FG001|Overall Study|subject / guardian decision|3|||
150002000|NCT02435680|541140697|FG002|Overall Study|subject / guardian decision|2|||
150002001|NCT02435680|541140695|FG000|Overall Study|Adverse Event|8|||
150002002|NCT02435680|541140696|FG001|Overall Study|Adverse Event|3|||
150002003|NCT02435680|541140697|FG002|Overall Study|Adverse Event|2|||
150002004|NCT02435680|541140695|FG000|Overall Study|progressive disease|10|||
150002005|NCT02435680|541140696|FG001|Overall Study|progressive disease|7|||
150002006|NCT02435680|541140697|FG002|Overall Study|progressive disease|11|||
150002007|NCT02435680|541140695|FG000|Overall Study|not treated|0|||
150002008|NCT02435680|541140696|FG001|Overall Study|not treated|0|||
150002009|NCT02435680|541140697|FG002|Overall Study|not treated|1|||
150002010|NCT00953524|541140699|FG000|Overall Study|Adverse Event|2|||
150002011|NCT00953524|541140700|FG001|Overall Study|Adverse Event|0|||
150002012|NCT00953524|541140701|FG002|Overall Study|Adverse Event|1|||
150002013|NCT00953524|541140702|FG003|Overall Study|Adverse Event|2|||
150002014|NCT00953524|541140699|FG000|Overall Study|Protocol Violation|18|||
150002015|NCT00953524|541140700|FG001|Overall Study|Protocol Violation|10|||
150002016|NCT00953524|541140701|FG002|Overall Study|Protocol Violation|11|||
150002017|NCT00953524|541140702|FG003|Overall Study|Protocol Violation|6|||
150002018|NCT00953524|541140699|FG000|Overall Study|Lost to Follow-up|0|||
150002019|NCT00953524|541140700|FG001|Overall Study|Lost to Follow-up|1|||
150002020|NCT00953524|541140701|FG002|Overall Study|Lost to Follow-up|1|||
150002021|NCT00953524|541140702|FG003|Overall Study|Lost to Follow-up|0|||
150002022|NCT00953524|541140699|FG000|Overall Study|Withdrawal by Subject|2|||
150002023|NCT00953524|541140700|FG001|Overall Study|Withdrawal by Subject|4|||
150002024|NCT00953524|541140701|FG002|Overall Study|Withdrawal by Subject|1|||
150002025|NCT00953524|541140702|FG003|Overall Study|Withdrawal by Subject|0|||
150002026|NCT03276052|541140707|FG000|Overall Study|Withdrawal by Subject|5|||
150002027|NCT03276052|541140707|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
150002028|NCT01994863|541140708|FG000|Period 1|Adverse Event|4|||
150002029|NCT01994863|541140709|FG001|Period 1|Adverse Event|0|||
150002030|NCT01994863|541140708|FG000|Period 1|Withdrawal by Subject|1|||
150002031|NCT01994863|541140709|FG001|Period 1|Withdrawal by Subject|0|||
150002032|NCT01994863|541140708|FG000|Period 1|Trial stopped by sponsor|1|||
150002033|NCT01994863|541140709|FG001|Period 1|Trial stopped by sponsor|3|||
150002034|NCT01994863|541140708|FG000|Period 1|Lack of Efficacy|1|||
150002035|NCT01994863|541140709|FG001|Period 1|Lack of Efficacy|0|||
150002036|NCT01994863|541140708|FG000|Period 2|Adverse Event|0|||
150002037|NCT01994863|541140709|FG001|Period 2|Adverse Event|1|||
150002038|NCT01994863|541140708|FG000|Period 2|Lack of Efficacy|0|||
150002039|NCT01994863|541140709|FG001|Period 2|Lack of Efficacy|2|||
150002040|NCT01994863|541140708|FG000|Period 2|Withdrawal by Subject|1|||
150002041|NCT01994863|541140709|FG001|Period 2|Withdrawal by Subject|1|||
150002042|NCT03784846|541140710|FG000|Pre-COVID Study|Lost to Follow-up|3|||
150002043|NCT03784846|541140711|FG001|Pre-COVID Study|Lost to Follow-up|3|||
150002044|NCT03784846|541140712|FG002|Pre-COVID Study|Lost to Follow-up|2|||
150002045|NCT03784846|541140710|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
150002046|NCT03784846|541140711|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
150002047|NCT03784846|541140712|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
150002048|NCT03784846|541140710|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
150002049|NCT03784846|541140711|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
150002050|NCT03784846|541140712|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
150002051|NCT03784846|541140710|FG000|Post-COVID Study|Lost to Follow-up|3|||
150002052|NCT03784846|541140711|FG001|Post-COVID Study|Lost to Follow-up|5|||
150002053|NCT03784846|541140712|FG002|Post-COVID Study|Lost to Follow-up|1|||
150002054|NCT03784846|541140710|FG000|Post-COVID Study|Withdrawal by Subject|1|||
150002055|NCT03784846|541140711|FG001|Post-COVID Study|Withdrawal by Subject|2|||
150002056|NCT03784846|541140712|FG002|Post-COVID Study|Withdrawal by Subject|0|||
150002057|NCT01062841|541140717|FG000|Overall Study|Indwelling Device Removed|41|||
150002058|NCT01062841|541140718|FG001|Overall Study|Indwelling Device Removed|48|||
150002059|NCT01062841|541140717|FG000|Overall Study|Death|3|||
150002060|NCT01062841|541140718|FG001|Overall Study|Death|5|||
150002061|NCT01062841|541140717|FG000|Overall Study|Withdrawal by Subject|2|||
150002062|NCT01062841|541140718|FG001|Overall Study|Withdrawal by Subject|0|||
150002063|NCT01062841|541140717|FG000|Overall Study|Withdrawal by Study|3|||
150002064|NCT01062841|541140718|FG001|Overall Study|Withdrawal by Study|0|||
150002065|NCT02046174|541140719|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
150002066|NCT02046174|541140720|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
150002067|NCT00186537|541140725|FG000|Overall Study|Withdrawal by Subject|4|||
150002068|NCT00186537|541140726|FG001|Overall Study|Withdrawal by Subject|0|||
150002069|NCT00186537|541140727|FG002|Overall Study|Withdrawal by Subject|3|||
150002070|NCT00186537|541140725|FG000|Overall Study|ALT > 1.5 x ULN|3|||
150002071|NCT00186537|541140726|FG001|Overall Study|ALT > 1.5 x ULN|0|||
150002072|NCT00186537|541140727|FG002|Overall Study|ALT > 1.5 x ULN|0|||
150002073|NCT01143051|541140729|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
150002074|NCT01143051|541140730|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
150002075|NCT01143051|541140731|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
150002076|NCT01143051|541140732|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
150002077|NCT01143051|541140733|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
150002078|NCT01143051|541140734|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
150002079|NCT01143051|541140729|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
150002080|NCT01143051|541140730|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
150002081|NCT01143051|541140731|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
150002082|NCT01143051|541140732|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
150002083|NCT01143051|541140733|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
150002084|NCT01143051|541140734|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
150002085|NCT03351114|541140738|FG000|Overall Study|Withdrawal by Subject|1|||
150002086|NCT01874275|541140739|FG000|Overall Study|Lost to Follow-up|1|||
150002087|NCT01874275|541140740|FG001|Overall Study|Lost to Follow-up|0|||
150002088|NCT02120365|541140743|FG000|Overall Study|Withdrawal by Subject|0|||
150002089|NCT02120365|541140744|FG001|Overall Study|Withdrawal by Subject|0|||
150002090|NCT02120365|541140745|FG002|Overall Study|Withdrawal by Subject|2|||
150002091|NCT02120365|541140746|FG003|Overall Study|Withdrawal by Subject|4|||
150002092|NCT02120365|541140747|FG004|Overall Study|Withdrawal by Subject|0|||
150002093|NCT02120365|541140748|FG005|Overall Study|Withdrawal by Subject|2|||
150002094|NCT00343915|541140749|FG000|Primary Study|Withdrawal by Subject|1|||
150002095|NCT00343915|541140750|FG001|Primary Study|Withdrawal by Subject|0|||
150002096|NCT00343915|541140749|FG000|Primary Study|Lost to Follow-up|2|||
150002097|NCT00343915|541140750|FG001|Primary Study|Lost to Follow-up|3|||
150002098|NCT00343915|541140749|FG000|Primary Study|Other|1|||
150002099|NCT00343915|541140750|FG001|Primary Study|Other|0|||
150002100|NCT01719003|541140758|FG000|Overall Study|Non compliant with protocol|1|||
150002101|NCT01719003|541140759|FG001|Overall Study|Non compliant with protocol|1|||
150002102|NCT01719003|541140760|FG002|Overall Study|Non compliant with protocol|0|||
150002103|NCT01719003|541140761|FG003|Overall Study|Non compliant with protocol|1|||
150002104|NCT01719003|541140762|FG004|Overall Study|Non compliant with protocol|2|||
150002105|NCT01719003|541140763|FG005|Overall Study|Non compliant with protocol|1|||
150002106|NCT01719003|541140764|FG006|Overall Study|Non compliant with protocol|2|||
150002107|NCT01719003|541140765|FG007|Overall Study|Non compliant with protocol|3|||
150002108|NCT01719003|541140766|FG008|Overall Study|Non compliant with protocol|0|||
150002109|NCT01719003|541140758|FG000|Overall Study|Adverse Event|6|||
150002110|NCT01719003|541140759|FG001|Overall Study|Adverse Event|5|||
150002111|NCT01719003|541140760|FG002|Overall Study|Adverse Event|4|||
150002112|NCT01719003|541140761|FG003|Overall Study|Adverse Event|3|||
150002113|NCT01719003|541140762|FG004|Overall Study|Adverse Event|4|||
150002114|NCT01719003|541140763|FG005|Overall Study|Adverse Event|3|||
150002115|NCT01719003|541140764|FG006|Overall Study|Adverse Event|6|||
150002116|NCT01719003|541140765|FG007|Overall Study|Adverse Event|5|||
150002117|NCT01719003|541140766|FG008|Overall Study|Adverse Event|0|||
150002118|NCT01719003|541140758|FG000|Overall Study|Lost to Follow-up|0|||
150002119|NCT01719003|541140759|FG001|Overall Study|Lost to Follow-up|6|||
150002120|NCT01719003|541140760|FG002|Overall Study|Lost to Follow-up|7|||
150002121|NCT01719003|541140761|FG003|Overall Study|Lost to Follow-up|2|||
150002122|NCT01719003|541140762|FG004|Overall Study|Lost to Follow-up|3|||
150002123|NCT01719003|541140763|FG005|Overall Study|Lost to Follow-up|4|||
150002124|NCT01719003|541140764|FG006|Overall Study|Lost to Follow-up|3|||
150002125|NCT01719003|541140765|FG007|Overall Study|Lost to Follow-up|2|||
150002126|NCT01719003|541140766|FG008|Overall Study|Lost to Follow-up|2|||
150002127|NCT01719003|541140758|FG000|Overall Study|Refusal to continue, not due to AE|2|||
150002128|NCT01719003|541140759|FG001|Overall Study|Refusal to continue, not due to AE|5|||
150002129|NCT01719003|541140760|FG002|Overall Study|Refusal to continue, not due to AE|4|||
150002130|NCT01719003|541140761|FG003|Overall Study|Refusal to continue, not due to AE|4|||
150002131|NCT01719003|541140762|FG004|Overall Study|Refusal to continue, not due to AE|4|||
150002132|NCT01719003|541140763|FG005|Overall Study|Refusal to continue, not due to AE|3|||
150002133|NCT01719003|541140764|FG006|Overall Study|Refusal to continue, not due to AE|8|||
150054995|NCT03859973|541342104|FG000|Overall Study|Other reason than listed|3|||
150054996|NCT03859973|541342105|FG001|Overall Study|Other reason than listed|2|||
150054997|NCT03859973|541342104|FG000|Overall Study|COVID-19 related, not due to AE|3|||
150054998|NCT03859973|541342105|FG001|Overall Study|COVID-19 related, not due to AE|4|||
150054999|NCT03859973|541342104|FG000|Overall Study|Withdrawal by Subject|8|||
150055000|NCT03859973|541342105|FG001|Overall Study|Withdrawal by Subject|9|||
150055001|NCT03859973|541342104|FG000|Overall Study|Lost to Follow-up|2|||
150055002|NCT03859973|541342105|FG001|Overall Study|Lost to Follow-up|3|||
150055003|NCT03859973|541342104|FG000|Overall Study|Protocol Violation|1|||
150055004|NCT03859973|541342105|FG001|Overall Study|Protocol Violation|3|||
150055005|NCT03859973|541342104|FG000|Overall Study|Adverse Event|3|||
150055006|NCT03859973|541342105|FG001|Overall Study|Adverse Event|5|||
150055007|NCT02855541|541342106|FG000|Overall Study|Change in health status|2|||
150055008|NCT02855541|541342106|FG000|Overall Study|Withdrawal by Subject|2|||
150055009|NCT01242813|541342107|FG000|Overall Study|Lost to Follow-up|2|||
150002134|NCT01719003|541140765|FG007|Overall Study|Refusal to continue, not due to AE|7|||
150002135|NCT01719003|541140766|FG008|Overall Study|Refusal to continue, not due to AE|1|||
150002136|NCT01719003|541140758|FG000|Overall Study|Reason other than those specified|0|||
150002137|NCT01719003|541140759|FG001|Overall Study|Reason other than those specified|0|||
150055010|NCT00701662|541342110|FG000|Overall Study|Lack of Efficacy|1|||
150055011|NCT03337490|541342116|FG000|Overall Study|Withdrawal by Subject|1|||
150002138|NCT01719003|541140760|FG002|Overall Study|Reason other than those specified|2|||
150002139|NCT01719003|541140761|FG003|Overall Study|Reason other than those specified|3|||
150055012|NCT03337490|541342117|FG001|Overall Study|Withdrawal by Subject|0|||
150055013|NCT03337490|541342118|FG002|Overall Study|Withdrawal by Subject|0|||
150002140|NCT01719003|541140762|FG004|Overall Study|Reason other than those specified|4|||
150002141|NCT01719003|541140763|FG005|Overall Study|Reason other than those specified|1|||
150002142|NCT01719003|541140764|FG006|Overall Study|Reason other than those specified|0|||
150002143|NCT01719003|541140765|FG007|Overall Study|Reason other than those specified|3|||
150002144|NCT01719003|541140766|FG008|Overall Study|Reason other than those specified|1|||
150002145|NCT01719003|541140758|FG000|Overall Study|Lack of Efficacy|0|||
150002146|NCT01719003|541140759|FG001|Overall Study|Lack of Efficacy|0|||
150002147|NCT01719003|541140760|FG002|Overall Study|Lack of Efficacy|0|||
150002148|NCT01719003|541140761|FG003|Overall Study|Lack of Efficacy|0|||
150002149|NCT01719003|541140762|FG004|Overall Study|Lack of Efficacy|0|||
150002150|NCT01719003|541140763|FG005|Overall Study|Lack of Efficacy|0|||
150002151|NCT01719003|541140764|FG006|Overall Study|Lack of Efficacy|1|||
150002152|NCT01719003|541140765|FG007|Overall Study|Lack of Efficacy|0|||
150002153|NCT01719003|541140766|FG008|Overall Study|Lack of Efficacy|0|||
150002154|NCT01344629|541140768|FG000|Crossover Period 2|Withdrawal by Subject|0|||
150002155|NCT01344629|541140769|FG001|Crossover Period 2|Withdrawal by Subject|1|||
150002156|NCT00762996|541140770|FG000|Period One|Protocol Violation|0|||
150002157|NCT00762996|541140771|FG001|Period One|Protocol Violation|0|||
150002158|NCT00762996|541140772|FG002|Period One|Protocol Violation|1|||
150002159|NCT00762996|541140773|FG003|Period One|Protocol Violation|0|||
150002160|NCT00762996|541140770|FG000|Period One|ineligible|0|||
150002161|NCT00762996|541140771|FG001|Period One|ineligible|0|||
150002162|NCT00762996|541140772|FG002|Period One|ineligible|1|||
150002163|NCT00762996|541140773|FG003|Period One|ineligible|1|||
150002164|NCT00762996|541140770|FG000|Period One|Adverse Event|0|||
150002165|NCT00762996|541140771|FG001|Period One|Adverse Event|0|||
150002166|NCT00762996|541140772|FG002|Period One|Adverse Event|1|||
150002167|NCT00762996|541140773|FG003|Period One|Adverse Event|0|||
150002168|NCT00762996|541140770|FG000|Period One|Withdrawal by Subject|0|||
150002169|NCT00762996|541140771|FG001|Period One|Withdrawal by Subject|0|||
150002170|NCT00762996|541140772|FG002|Period One|Withdrawal by Subject|1|||
150002171|NCT00762996|541140773|FG003|Period One|Withdrawal by Subject|0|||
150002172|NCT04063787|541140779|FG000|Overall Study|Inadequate Doppler data|4|||
150002173|NCT04063787|541140779|FG000|Overall Study|Lost to Follow-up|2|||
150002174|NCT04063787|541140779|FG000|Overall Study|Death|3|||
150002175|NCT00746733|541140780|FG000|Second Intervention|Adverse Event|1|||
150002176|NCT00746733|541140781|FG001|Second Intervention|Adverse Event|0|||
150002177|NCT00746733|541140780|FG000|Third Intervention|Withdrawal by Subject|1|||
150002178|NCT00746733|541140781|FG001|Third Intervention|Withdrawal by Subject|1|||
150002179|NCT01527383|541140782|FG000|Overall Study|Adverse Event|5|||
150002180|NCT01527383|541140783|FG001|Overall Study|Adverse Event|0|||
150002181|NCT01527383|541140782|FG000|Overall Study|Lost to Follow-up|3|||
150002182|NCT01527383|541140783|FG001|Overall Study|Lost to Follow-up|0|||
150002183|NCT01527383|541140782|FG000|Overall Study|Physician Decision|2|||
150055014|NCT03337490|541342116|FG000|Overall Study|Lack of Efficacy|10|||
150055015|NCT03337490|541342117|FG001|Overall Study|Lack of Efficacy|12|||
150055016|NCT03337490|541342118|FG002|Overall Study|Lack of Efficacy|35|||
150055017|NCT03337490|541342116|FG000|Overall Study|Physician Decision|0|||
150055018|NCT03337490|541342117|FG001|Overall Study|Physician Decision|1|||
150055019|NCT03337490|541342118|FG002|Overall Study|Physician Decision|0|||
150055020|NCT03337490|541342116|FG000|Overall Study|Lost to Follow-up|0|||
150055021|NCT03337490|541342117|FG001|Overall Study|Lost to Follow-up|1|||
150055022|NCT03337490|541342118|FG002|Overall Study|Lost to Follow-up|0|||
150055023|NCT03560518|541342119|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
150055024|NCT03560518|541342120|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
150055025|NCT03560518|541342121|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
150055026|NCT03560518|541342119|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
150055027|NCT03560518|541342120|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
150055028|NCT03560518|541342121|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
150055029|NCT03560518|541342119|FG000|Double Blind Treatment Period|Protocol Violation|1|||
150055030|NCT03560518|541342120|FG001|Double Blind Treatment Period|Protocol Violation|2|||
150055031|NCT03560518|541342121|FG002|Double Blind Treatment Period|Protocol Violation|0|||
150055032|NCT03560518|541342119|FG000|Double Blind Treatment Period|Pregnancy|0|||
150055033|NCT03560518|541342120|FG001|Double Blind Treatment Period|Pregnancy|2|||
150055034|NCT03560518|541342121|FG002|Double Blind Treatment Period|Pregnancy|0|||
150002184|NCT01527383|541140783|FG001|Overall Study|Physician Decision|0|||
150002185|NCT01527383|541140782|FG000|Overall Study|Pregnancy|1|||
150055035|NCT03560518|541342119|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
150055036|NCT03560518|541342120|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
150002186|NCT01527383|541140783|FG001|Overall Study|Pregnancy|0|||
150002187|NCT01527383|541140782|FG000|Overall Study|Protocol Violation|1|||
150002188|NCT01527383|541140783|FG001|Overall Study|Protocol Violation|0|||
150002189|NCT01527383|541140782|FG000|Overall Study|Screen failure|1|||
150002190|NCT01527383|541140783|FG001|Overall Study|Screen failure|0|||
150002191|NCT01527383|541140782|FG000|Overall Study|Participant moved|0|||
150002192|NCT01527383|541140783|FG001|Overall Study|Participant moved|1|||
150002193|NCT01527383|541140782|FG000|Overall Study|Withdrawal by Subject|2|||
150002194|NCT01527383|541140783|FG001|Overall Study|Withdrawal by Subject|3|||
150002195|NCT00849875|541140784|FG000|Overall Study|Death|28|||
150002196|NCT00849875|541140784|FG000|Overall Study|Ongoing (unknown completion status)|11|||
150002197|NCT00849875|541140784|FG000|Overall Study|Others|6|||
150002198|NCT00849875|541140784|FG000|Overall Study|Lost to Follow-up|2|||
150002199|NCT03515941|541140789|FG000|Overall Study|Adverse Event|1|||
150002200|NCT03515941|541140790|FG001|Overall Study|Adverse Event|0|||
150179696|NCT01808339|541796788|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150002201|NCT01367704|541140791|FG000|Overall Study|Lost to Follow-up|47|||
150002202|NCT01367704|541140792|FG001|Overall Study|Lost to Follow-up|161|||
150002203|NCT04096820|541140793|FG000|Overall Study|Did not return for intervention|2|||
150002204|NCT04096820|541140793|FG000|Overall Study|Death|1|||
150002205|NCT02726880|541140794|FG000|Overall Study|Withdrawal by Subject|2|||
150002206|NCT02726880|541140795|FG001|Overall Study|Withdrawal by Subject|0|||
150002207|NCT02726880|541140794|FG000|Overall Study|Lost to Follow-up|1|||
150002208|NCT02726880|541140795|FG001|Overall Study|Lost to Follow-up|3|||
150002209|NCT00787202|541140796|FG000|Overall Study|Adverse Event|3|||
150002210|NCT00787202|541140797|FG001|Overall Study|Adverse Event|2|||
150002211|NCT00787202|541140798|FG002|Overall Study|Adverse Event|0|||
150002212|NCT00787202|541140799|FG003|Overall Study|Adverse Event|0|||
150002213|NCT00787202|541140800|FG004|Overall Study|Adverse Event|2|||
150002214|NCT00787202|541140796|FG000|Overall Study|Lack of Efficacy|5|||
150002215|NCT00787202|541140797|FG001|Overall Study|Lack of Efficacy|6|||
150002216|NCT00787202|541140798|FG002|Overall Study|Lack of Efficacy|5|||
150002217|NCT00787202|541140799|FG003|Overall Study|Lack of Efficacy|2|||
150002218|NCT00787202|541140800|FG004|Overall Study|Lack of Efficacy|1|||
150002219|NCT00787202|541140796|FG000|Overall Study|Lost to Follow-up|1|||
150002220|NCT00787202|541140797|FG001|Overall Study|Lost to Follow-up|0|||
150002221|NCT00787202|541140798|FG002|Overall Study|Lost to Follow-up|0|||
150002222|NCT00787202|541140799|FG003|Overall Study|Lost to Follow-up|0|||
150002223|NCT00787202|541140800|FG004|Overall Study|Lost to Follow-up|0|||
150002224|NCT00787202|541140796|FG000|Overall Study|Withdrawal by Subject|2|||
150002225|NCT00787202|541140797|FG001|Overall Study|Withdrawal by Subject|2|||
150002226|NCT00787202|541140798|FG002|Overall Study|Withdrawal by Subject|2|||
150002227|NCT00787202|541140799|FG003|Overall Study|Withdrawal by Subject|0|||
150002228|NCT00787202|541140800|FG004|Overall Study|Withdrawal by Subject|0|||
150002229|NCT00787202|541140796|FG000|Overall Study|Protocol Violation|2|||
150002230|NCT00787202|541140797|FG001|Overall Study|Protocol Violation|1|||
150002231|NCT00787202|541140798|FG002|Overall Study|Protocol Violation|0|||
150002232|NCT00787202|541140799|FG003|Overall Study|Protocol Violation|0|||
150002233|NCT00787202|541140800|FG004|Overall Study|Protocol Violation|1|||
150002234|NCT00787202|541140796|FG000|Overall Study|Randomized, not treated|1|||
150002235|NCT00787202|541140797|FG001|Overall Study|Randomized, not treated|0|||
150002236|NCT00787202|541140798|FG002|Overall Study|Randomized, not treated|0|||
150002237|NCT00787202|541140799|FG003|Overall Study|Randomized, not treated|0|||
150002238|NCT00787202|541140800|FG004|Overall Study|Randomized, not treated|0|||
150002239|NCT01510145|541140801|FG000|Overall Study|Adverse Event|6|||
150002240|NCT01510145|541140801|FG000|Overall Study|Lost to Follow-up|5|||
150002241|NCT01510145|541140801|FG000|Overall Study|Withdrawal by Subject|6|||
150002242|NCT01510145|541140801|FG000|Overall Study|Relative reported subject withdrew|1|||
150002243|NCT01360398|541140802|FG000|Overall Study|Withdrawal by Subject|14|||
150002244|NCT01360398|541140802|FG000|Overall Study|Other|7|||
150002245|NCT01360398|541140802|FG000|Overall Study|Migrated/moved from study area|1|||
150002246|NCT01453946|541140803|FG000|Overall Study|Did not receive drug for the taper phase|1|||
150002247|NCT01453946|541140803|FG000|Overall Study|Protocol Violation|2|||
150002248|NCT01453946|541140803|FG000|Overall Study|Lack of Efficacy|3|||
150002249|NCT01453946|541140803|FG000|Overall Study|Adverse Event|3|||
150002250|NCT00846040|541140804|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
150002251|NCT00846040|541140805|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
150002252|NCT00846040|541140806|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
150002253|NCT00846040|541140804|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
150002254|NCT00846040|541140805|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
150002255|NCT00846040|541140806|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
150002256|NCT03158272|541140807|FG000|Overall Study|Disease progression|3|||
150002257|NCT03158272|541140808|FG001|Overall Study|Disease progression|3|||
150002258|NCT03158272|541140809|FG002|Overall Study|Disease progression|4|||
150002259|NCT03158272|541140810|FG003|Overall Study|Disease progression|6|||
150002260|NCT03158272|541140807|FG000|Overall Study|Death|0|||
150002261|NCT03158272|541140808|FG001|Overall Study|Death|0|||
150002262|NCT03158272|541140809|FG002|Overall Study|Death|1|||
150002263|NCT03158272|541140810|FG003|Overall Study|Death|0|||
150002264|NCT03158272|541140807|FG000|Overall Study|Other reasons|0|||
150002265|NCT03158272|541140808|FG001|Overall Study|Other reasons|0|||
150002266|NCT03158272|541140809|FG002|Overall Study|Other reasons|1|||
150002267|NCT03158272|541140810|FG003|Overall Study|Other reasons|0|||
150002268|NCT03158272|541140807|FG000|Overall Study|Adverse event unrelated to the drug|0|||
150002269|NCT03158272|541140808|FG001|Overall Study|Adverse event unrelated to the drug|1|||
150002270|NCT03158272|541140809|FG002|Overall Study|Adverse event unrelated to the drug|0|||
150002271|NCT03158272|541140810|FG003|Overall Study|Adverse event unrelated to the drug|0|||
150002272|NCT01822535|541140811|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
150002273|NCT01822535|541140812|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
150002274|NCT01822535|541140811|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
150002275|NCT01822535|541140812|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
150002276|NCT01822535|541140811|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
150002277|NCT01822535|541140812|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
150002278|NCT01591863|541140815|FG000|Overall Study|Adverse Event|3|||
150002279|NCT01591863|541140815|FG000|Overall Study|Withdrawal by Subject|1|||
150002280|NCT01591863|541140815|FG000|Overall Study|recurrence|9|||
150002281|NCT01591863|541140815|FG000|Overall Study|Lack of Efficacy|1|||
150002282|NCT02558400|541140816|FG000|Overall Study|Adverse Event|47|||
150002283|NCT02558400|541140817|FG001|Overall Study|Adverse Event|53|||
150002284|NCT02558400|541140818|FG002|Overall Study|Adverse Event|4|||
150002285|NCT02558400|541140816|FG000|Overall Study|Withdrawal by Subject|13|||
150002286|NCT02558400|541140817|FG001|Overall Study|Withdrawal by Subject|9|||
150002287|NCT02558400|541140818|FG002|Overall Study|Withdrawal by Subject|8|||
150002288|NCT02558400|541140816|FG000|Overall Study|Non-Compliant|0|||
150002289|NCT02558400|541140817|FG001|Overall Study|Non-Compliant|1|||
150002290|NCT02558400|541140818|FG002|Overall Study|Non-Compliant|3|||
150002291|NCT02558400|541140816|FG000|Overall Study|Lost to Follow-up|5|||
150002292|NCT02558400|541140817|FG001|Overall Study|Lost to Follow-up|5|||
150002293|NCT02558400|541140818|FG002|Overall Study|Lost to Follow-up|4|||
150002294|NCT02558400|541140816|FG000|Overall Study|Lack of Efficacy|0|||
150002295|NCT02558400|541140817|FG001|Overall Study|Lack of Efficacy|13|||
150002296|NCT02558400|541140818|FG002|Overall Study|Lack of Efficacy|1|||
150002297|NCT02558400|541140816|FG000|Overall Study|Disallowed Concurrent Medication|6|||
150002298|NCT02558400|541140817|FG001|Overall Study|Disallowed Concurrent Medication|7|||
150002299|NCT02558400|541140818|FG002|Overall Study|Disallowed Concurrent Medication|5|||
150002300|NCT02558400|541140816|FG000|Overall Study|Physician Decision|2|||
150002301|NCT02558400|541140817|FG001|Overall Study|Physician Decision|2|||
150002302|NCT02558400|541140818|FG002|Overall Study|Physician Decision|0|||
150002303|NCT02558400|541140816|FG000|Overall Study|Protocol Violation|6|||
150002304|NCT02558400|541140817|FG001|Overall Study|Protocol Violation|3|||
150002305|NCT02558400|541140818|FG002|Overall Study|Protocol Violation|8|||
150002306|NCT02558400|541140816|FG000|Overall Study|Death|0|||
150002307|NCT02558400|541140817|FG001|Overall Study|Death|1|||
150002308|NCT02558400|541140818|FG002|Overall Study|Death|0|||
150002309|NCT02558400|541140816|FG000|Overall Study|Ineligible for the study|0|||
150002310|NCT02558400|541140817|FG001|Overall Study|Ineligible for the study|2|||
150002311|NCT02558400|541140818|FG002|Overall Study|Ineligible for the study|0|||
150002312|NCT00240110|541142717|FG000|Overall Study|Lost to Follow-up|6|||
150002313|NCT00240110|541142718|FG001|Overall Study|Lost to Follow-up|7|||
150002314|NCT03747120|541142723|FG000|Overall Study|treatment related toxicity|3|||
150002315|NCT03747120|541142724|FG001|Overall Study|treatment related toxicity|0|||
150002316|NCT03747120|541142725|FG002|Overall Study|treatment related toxicity|0|||
150002317|NCT03747120|541142723|FG000|Overall Study|Withdrawal by Subject|0|||
150002318|NCT03747120|541142724|FG001|Overall Study|Withdrawal by Subject|1|||
150002319|NCT03747120|541142725|FG002|Overall Study|Withdrawal by Subject|2|||
150002320|NCT01688739|541142726|FG000|Overall Study|Administrative Decision|1|||
150002321|NCT01688739|541142727|FG001|Overall Study|Administrative Decision|0|||
150002322|NCT01688739|541142728|FG002|Overall Study|Administrative Decision|0|||
150002323|NCT01688739|541142729|FG003|Overall Study|Administrative Decision|0|||
150002324|NCT01688739|541142730|FG004|Overall Study|Administrative Decision|0|||
150002325|NCT01688739|541142731|FG005|Overall Study|Administrative Decision|0|||
150002326|NCT01688739|541142732|FG006|Overall Study|Administrative Decision|0|||
150002327|NCT01688739|541142733|FG007|Overall Study|Administrative Decision|0|||
150002328|NCT01688739|541142734|FG008|Overall Study|Administrative Decision|0|||
150002329|NCT01688739|541142735|FG009|Overall Study|Administrative Decision|0|||
150002330|NCT00765882|541142743|FG000|Overall Study|Adverse Event|10|||
150002331|NCT00765882|541142744|FG001|Overall Study|Adverse Event|21|||
150002332|NCT00765882|541142745|FG002|Overall Study|Adverse Event|20|||
150002333|NCT00765882|541142743|FG000|Overall Study|Lack of Efficacy|4|||
150002334|NCT00765882|541142744|FG001|Overall Study|Lack of Efficacy|0|||
150002335|NCT00765882|541142745|FG002|Overall Study|Lack of Efficacy|1|||
150002336|NCT00765882|541142743|FG000|Overall Study|Protocol Violation|4|||
150002337|NCT00765882|541142744|FG001|Overall Study|Protocol Violation|3|||
150002338|NCT00765882|541142745|FG002|Overall Study|Protocol Violation|1|||
150002339|NCT00765882|541142743|FG000|Overall Study|Withdrawal by Subject|2|||
150002340|NCT00765882|541142744|FG001|Overall Study|Withdrawal by Subject|6|||
150002341|NCT00765882|541142745|FG002|Overall Study|Withdrawal by Subject|6|||
150002342|NCT00765882|541142743|FG000|Overall Study|Lost to Follow-up|1|||
150002343|NCT00765882|541142744|FG001|Overall Study|Lost to Follow-up|9|||
150002344|NCT00765882|541142745|FG002|Overall Study|Lost to Follow-up|6|||
150002345|NCT00765882|541142743|FG000|Overall Study|Other Reason|3|||
150002346|NCT00765882|541142744|FG001|Overall Study|Other Reason|1|||
150002347|NCT00765882|541142745|FG002|Overall Study|Other Reason|2|||
150002348|NCT01665430|541142746|FG000|Overall Study|Adverse Event|1|||
150002349|NCT01665430|541142746|FG000|Overall Study|Withdrawal by Subject|6|||
150002350|NCT01665430|541142746|FG000|Overall Study|Other Unspecified|2|||
150002351|NCT00598078|541142747|FG000|Period 2 (Day 2)|Adverse Event|1|||
150002352|NCT00598078|541142748|FG001|Period 2 (Day 2)|Adverse Event|0|||
150002353|NCT01866423|541142749|FG000|Overall Study|Lack of Efficacy|3|||
150002354|NCT01866423|541142749|FG000|Overall Study|Sponsor Decision|1|||
150002355|NCT01813721|541142750|FG000|Overall Study|Ineligibility determined|63|||
150002356|NCT01813721|541142750|FG000|Overall Study|Withdrawal by Subject|1|||
150002357|NCT01479595|541142751|FG000|Overall Study|Protocol deviation|0|||
150002358|NCT01479595|541142752|FG001|Overall Study|Protocol deviation|1|||
150002359|NCT01479595|541142751|FG000|Overall Study|Adverse Event|2|||
150002360|NCT01479595|541142752|FG001|Overall Study|Adverse Event|1|||
150002361|NCT02699450|541142753|FG000|Overall Study|Death|2|||
150002362|NCT02699450|541142754|FG001|Overall Study|Death|1|||
150002363|NCT02699450|541142755|FG002|Overall Study|Death|2|||
150002364|NCT02699450|541142753|FG000|Overall Study|Met Criteria for Study Exit|0|||
150002365|NCT02699450|541142754|FG001|Overall Study|Met Criteria for Study Exit|0|||
150002366|NCT02699450|541142755|FG002|Overall Study|Met Criteria for Study Exit|1|||
150002367|NCT02699450|541142753|FG000|Overall Study|Protocol Violation|4|||
150002368|NCT02699450|541142754|FG001|Overall Study|Protocol Violation|3|||
150002369|NCT02699450|541142755|FG002|Overall Study|Protocol Violation|5|||
150002370|NCT02699450|541142753|FG000|Overall Study|Lost to Follow-up|3|||
150002371|NCT02699450|541142754|FG001|Overall Study|Lost to Follow-up|0|||
150002372|NCT02699450|541142755|FG002|Overall Study|Lost to Follow-up|5|||
150002373|NCT02699450|541142753|FG000|Overall Study|Physician Decision|2|||
150002374|NCT02699450|541142754|FG001|Overall Study|Physician Decision|0|||
150002375|NCT02699450|541142755|FG002|Overall Study|Physician Decision|0|||
150002376|NCT02699450|541142753|FG000|Overall Study|Withdrawal by Subject|3|||
150002377|NCT02699450|541142754|FG001|Overall Study|Withdrawal by Subject|1|||
150002378|NCT02699450|541142755|FG002|Overall Study|Withdrawal by Subject|2|||
150002379|NCT02699450|541142753|FG000|Overall Study|Adverse Event|1|||
150002380|NCT02699450|541142754|FG001|Overall Study|Adverse Event|0|||
150002381|NCT02699450|541142755|FG002|Overall Study|Adverse Event|0|||
150002382|NCT00810901|541142756|FG000|Overall Study|Lost to Follow-up|88|||
150002383|NCT00810901|541142757|FG001|Overall Study|Lost to Follow-up|58|||
150002384|NCT01009346|541142758|FG000|Overall Study|Adverse Event|4|||
150002385|NCT00882908|541142761|FG000|Overall Study|Adverse Event|0|||
150002386|NCT00882908|541142762|FG001|Overall Study|Adverse Event|0|||
150002387|NCT00882908|541142763|FG002|Overall Study|Adverse Event|1|||
150002388|NCT00882908|541142764|FG003|Overall Study|Adverse Event|0|||
150002389|NCT00882908|541142765|FG004|Overall Study|Adverse Event|1|||
150002390|NCT00882908|541142761|FG000|Overall Study|Lost to Follow-up|3|||
150055037|NCT03560518|541342121|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
150055038|NCT03560518|541342119|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
150055039|NCT03560518|541342120|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
150055040|NCT03560518|541342121|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
150055041|NCT03560518|541342119|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
150055042|NCT03560518|541342120|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
150055043|NCT03560518|541342121|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
150002391|NCT00882908|541142762|FG001|Overall Study|Lost to Follow-up|5|||
150002392|NCT00882908|541142763|FG002|Overall Study|Lost to Follow-up|3|||
150002393|NCT00882908|541142764|FG003|Overall Study|Lost to Follow-up|1|||
150002394|NCT00882908|541142765|FG004|Overall Study|Lost to Follow-up|2|||
150002395|NCT00882908|541142761|FG000|Overall Study|Protocol Violation|0|||
150002396|NCT00882908|541142762|FG001|Overall Study|Protocol Violation|1|||
150002397|NCT00882908|541142763|FG002|Overall Study|Protocol Violation|0|||
150002398|NCT00882908|541142764|FG003|Overall Study|Protocol Violation|0|||
150002399|NCT00882908|541142765|FG004|Overall Study|Protocol Violation|0|||
150055044|NCT03560518|541342119|FG000|Double Blind Treatment Period|Adverse Event|0|||
150055045|NCT03560518|541342120|FG001|Double Blind Treatment Period|Adverse Event|3|||
150002400|NCT00882908|541142761|FG000|Overall Study|Withdrawal by Subject|0|||
150002401|NCT00882908|541142762|FG001|Overall Study|Withdrawal by Subject|0|||
150002402|NCT00882908|541142763|FG002|Overall Study|Withdrawal by Subject|3|||
150002403|NCT00882908|541142764|FG003|Overall Study|Withdrawal by Subject|5|||
150002404|NCT00882908|541142765|FG004|Overall Study|Withdrawal by Subject|2|||
150002405|NCT00882908|541142761|FG000|Overall Study|Subject reached a virologic endpoint|0|||
150002406|NCT00882908|541142762|FG001|Overall Study|Subject reached a virologic endpoint|0|||
150002407|NCT00882908|541142763|FG002|Overall Study|Subject reached a virologic endpoint|0|||
150002408|NCT00882908|541142764|FG003|Overall Study|Subject reached a virologic endpoint|0|||
150002409|NCT00882908|541142765|FG004|Overall Study|Subject reached a virologic endpoint|1|||
150002410|NCT00882908|541142761|FG000|Overall Study|Study terminated in error|0|||
150002411|NCT00882908|541142762|FG001|Overall Study|Study terminated in error|0|||
150002412|NCT00882908|541142763|FG002|Overall Study|Study terminated in error|0|||
150002413|NCT00882908|541142764|FG003|Overall Study|Study terminated in error|1|||
150002414|NCT00882908|541142765|FG004|Overall Study|Study terminated in error|0|||
150002415|NCT03283150|541142766|FG000|Overall Study|Withdrawal by Subject|6|||
150002416|NCT03283150|541142767|FG001|Overall Study|Withdrawal by Subject|0|||
150002417|NCT03283150|541142768|FG002|Overall Study|Withdrawal by Subject|0|||
150002418|NCT00900146|541142769|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
150002419|NCT00900146|541142770|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
150002420|NCT00900146|541142771|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
150002421|NCT00900146|541142772|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
150002422|NCT00900146|541142773|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
150002423|NCT00900146|541142769|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
150002424|NCT00900146|541142770|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
150002425|NCT00900146|541142771|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
150002426|NCT00900146|541142772|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
150002427|NCT00900146|541142773|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
150055046|NCT03560518|541342121|FG002|Double Blind Treatment Period|Adverse Event|1|||
150055047|NCT01363349|541342122|FG000|Overall Study|Adverse Event|6|||
150055048|NCT01363349|541342123|FG001|Overall Study|Adverse Event|7|||
150055049|NCT01363349|541342122|FG000|Overall Study|Lack of Efficacy|3|||
150055050|NCT01363349|541342123|FG001|Overall Study|Lack of Efficacy|10|||
150055051|NCT01363349|541342122|FG000|Overall Study|Non compliance/Protocol deviations|2|||
150055052|NCT01363349|541342123|FG001|Overall Study|Non compliance/Protocol deviations|2|||
150055053|NCT01363349|541342122|FG000|Overall Study|Withdrawal by Subject|14|||
150055054|NCT01363349|541342123|FG001|Overall Study|Withdrawal by Subject|6|||
150055055|NCT01363349|541342122|FG000|Overall Study|Lost to Follow-up|5|||
150055056|NCT01363349|541342123|FG001|Overall Study|Lost to Follow-up|6|||
150055057|NCT01363349|541342122|FG000|Overall Study|Not reported|36|||
150055058|NCT01363349|541342123|FG001|Overall Study|Not reported|37|||
150055059|NCT01363349|541342122|FG000|Overall Study|missing|1|||
150055060|NCT01363349|541342123|FG001|Overall Study|missing|2|||
150055061|NCT00917644|541342124|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
150055062|NCT00917644|541342125|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
150055063|NCT00917644|541342124|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
150055064|NCT00917644|541342125|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
150055065|NCT00917644|541342124|FG000|Period 2: Second Intervention|family emergency|1|||
150055066|NCT00917644|541342125|FG001|Period 2: Second Intervention|family emergency|0|||
150055067|NCT01579812|541342130|FG000|Overall Study|Ineligible after treatment start|40|||
150055068|NCT01579812|541342130|FG000|Overall Study|Patient choice|3|||
150055069|NCT01579812|541342130|FG000|Overall Study|Noncompliance|3|||
150055070|NCT01579812|541342130|FG000|Overall Study|Withdrawal by Subject|6|||
150055071|NCT01133990|541342132|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
150055072|NCT01133990|541342133|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150055073|NCT01133990|541342134|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150055074|NCT01133990|541342135|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150055075|NCT01133990|541342136|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150055076|NCT01133990|541342137|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150055077|NCT01133990|541342132|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
150055078|NCT01133990|541342133|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
150055079|NCT01133990|541342134|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
150055080|NCT01133990|541342135|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
150055081|NCT01133990|541342136|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
150055082|NCT01133990|541342137|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
150055083|NCT01133990|541342132|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
150055084|NCT01133990|541342133|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150055085|NCT01133990|541342134|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150055086|NCT01133990|541342135|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150055087|NCT01133990|541342136|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150055088|NCT01133990|541342137|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150055089|NCT01133990|541342132|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
150055090|NCT01133990|541342133|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
150055091|NCT01133990|541342134|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
150055092|NCT01133990|541342135|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
150002428|NCT00900146|541142769|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
150002429|NCT00900146|541142770|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
150002430|NCT00900146|541142771|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
150002431|NCT00900146|541142772|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
150002432|NCT00900146|541142773|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
150002433|NCT00900146|541142769|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
150002434|NCT00900146|541142770|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
150002435|NCT00900146|541142771|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
150002436|NCT00900146|541142772|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
150002437|NCT00900146|541142773|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
150002438|NCT00900146|541142769|FG000|Intermediate: Period III|Lost to Follow-up|2|||
150002439|NCT00900146|541142770|FG001|Intermediate: Period III|Lost to Follow-up|0|||
150002440|NCT00900146|541142771|FG002|Intermediate: Period III|Lost to Follow-up|0|||
150002441|NCT00900146|541142772|FG003|Intermediate: Period III|Lost to Follow-up|0|||
150002442|NCT00900146|541142773|FG004|Intermediate: Period III|Lost to Follow-up|1|||
150002443|NCT00900146|541142769|FG000|Intermediate: Period III|Administrative problems|85|||
150002444|NCT00900146|541142770|FG001|Intermediate: Period III|Administrative problems|92|||
150002445|NCT00900146|541142771|FG002|Intermediate: Period III|Administrative problems|84|||
150002446|NCT00900146|541142772|FG003|Intermediate: Period III|Administrative problems|90|||
150002447|NCT00900146|541142773|FG004|Intermediate: Period III|Administrative problems|163|||
150002448|NCT00700102|541142774|FG000|Overall Study|Died|394|||
150002449|NCT00700102|541142775|FG001|Overall Study|Died|385|||
150002450|NCT00700102|541142774|FG000|Overall Study|Lost to Follow-up|8|||
150002451|NCT00700102|541142775|FG001|Overall Study|Lost to Follow-up|10|||
150002452|NCT02525939|541142780|FG000|Overall Study|Lost to Follow-up|27|||
150002453|NCT02525939|541142781|FG001|Overall Study|Lost to Follow-up|24|||
150002454|NCT02525939|541142780|FG000|Overall Study|Physician Decision|0|||
150002455|NCT02525939|541142781|FG001|Overall Study|Physician Decision|1|||
150002456|NCT02525939|541142780|FG000|Overall Study|Withdrawal by Subject|24|||
150002457|NCT02525939|541142781|FG001|Overall Study|Withdrawal by Subject|39|||
150002458|NCT02525939|541142780|FG000|Overall Study|Death|180|||
150002459|NCT02525939|541142781|FG001|Overall Study|Death|179|||
150002460|NCT01028716|541142785|FG000|Overall Study|Physician Decision|1|||
150002461|NCT01635764|541142786|FG000|Overall Study|Adverse Event|46|||
150002462|NCT01635764|541142786|FG000|Overall Study|Lack of Efficacy|76|||
150002463|NCT01635764|541142786|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
150002464|NCT01635764|541142786|FG000|Overall Study|Protocol Deviation|1|||
150002465|NCT01635764|541142786|FG000|Overall Study|Withdrew Consent|67|||
150002466|NCT01635764|541142786|FG000|Overall Study|Lost to Follow-up|53|||
150002467|NCT01635764|541142786|FG000|Overall Study|Other|28|||
150002468|NCT05590000|541142787|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
150002469|NCT02689076|541142789|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
150002470|NCT02689076|541142790|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
150002471|NCT02689076|541142791|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
150002472|NCT02689076|541142789|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
150002473|NCT02689076|541142790|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
150002474|NCT02689076|541142791|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
150002475|NCT02689076|541142789|FG000|Overall Study|Did not have an HIE match|2|||
150002476|NCT02689076|541142790|FG001|Overall Study|Did not have an HIE match|0|||
150002477|NCT02689076|541142791|FG002|Overall Study|Did not have an HIE match|0|||
150002478|NCT02689076|541142789|FG000|Overall Study|Death during non-VA encounter|2|||
150002479|NCT02689076|541142790|FG001|Overall Study|Death during non-VA encounter|5|||
150002480|NCT02689076|541142791|FG002|Overall Study|Death during non-VA encounter|0|||
150002481|NCT02689076|541142789|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
150002482|NCT02689076|541142790|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
150002483|NCT02689076|541142791|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
150002484|NCT02689076|541142789|FG000|Overall Study|Participant no longer active in VA system|1|||
150002485|NCT02689076|541142790|FG001|Overall Study|Participant no longer active in VA system|0|||
150002486|NCT02689076|541142791|FG002|Overall Study|Participant no longer active in VA system|0|||
150002487|NCT02689076|541142789|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
150002488|NCT02689076|541142790|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
150002489|NCT02689076|541142791|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
150002490|NCT02266875|541142793|FG000|Overall Study|Withdrawal by Subject|9|||
150002491|NCT02266875|541142794|FG001|Overall Study|Withdrawal by Subject|0|||
150002492|NCT02266875|541142793|FG000|Overall Study|Lost to Follow-up|2|||
150002493|NCT02266875|541142794|FG001|Overall Study|Lost to Follow-up|0|||
150002494|NCT01816906|541142797|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
150002495|NCT01816906|541142798|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
150002496|NCT01816906|541142797|FG000|Six Months|Lost to Follow-up|14|||
150002497|NCT01816906|541142798|FG001|Six Months|Lost to Follow-up|16|||
150002498|NCT01816906|541142797|FG000|12 Months|Adverse Event|2|||
150002499|NCT01816906|541142798|FG001|12 Months|Adverse Event|2|||
150002500|NCT01816906|541142797|FG000|12 Months|Death|0|||
150002501|NCT01816906|541142798|FG001|12 Months|Death|2|||
150002502|NCT01816906|541142797|FG000|12 Months|Lost to Follow-up|2|||
150002503|NCT01816906|541142798|FG001|12 Months|Lost to Follow-up|1|||
150002504|NCT03412604|541142799|FG000|Overall Study|Withdrawal by Subject|1|||
150002505|NCT00993499|541142811|FG000|Run-in Period (8 Days)|Adverse Event|0|||
150002506|NCT00993499|541142812|FG001|Run-in Period (8 Days)|Adverse Event|1|||
150002507|NCT00993499|541142813|FG002|Run-in Period (8 Days)|Adverse Event|0|||
150002508|NCT00993499|541142814|FG003|Run-in Period (8 Days)|Adverse Event|0|||
150002509|NCT00993499|541142815|FG004|Run-in Period (8 Days)|Adverse Event|0|||
150002510|NCT00993499|541142816|FG005|Run-in Period (8 Days)|Adverse Event|0|||
150002511|NCT00993499|541142811|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
150002512|NCT00993499|541142812|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
150002513|NCT00993499|541142813|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
150002514|NCT00993499|541142814|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
150002515|NCT00993499|541142815|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
150002516|NCT00993499|541142816|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
150002517|NCT00993499|541142811|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
150002518|NCT00993499|541142812|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
150002519|NCT00993499|541142813|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
150002520|NCT00993499|541142814|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
150002521|NCT00993499|541142815|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
150002522|NCT00993499|541142816|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
150002523|NCT00993499|541142811|FG000|Run-in Period (8 Days)|Progressive disease|0|||
150002524|NCT00993499|541142812|FG001|Run-in Period (8 Days)|Progressive disease|1|||
150002525|NCT00993499|541142813|FG002|Run-in Period (8 Days)|Progressive disease|1|||
150002526|NCT00993499|541142814|FG003|Run-in Period (8 Days)|Progressive disease|0|||
150002527|NCT00993499|541142815|FG004|Run-in Period (8 Days)|Progressive disease|0|||
150002528|NCT00993499|541142816|FG005|Run-in Period (8 Days)|Progressive disease|0|||
150002529|NCT00993499|541142811|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
150002530|NCT00993499|541142812|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
150002531|NCT00993499|541142813|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
150002532|NCT00993499|541142814|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
150002533|NCT00993499|541142815|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
150002534|NCT00993499|541142816|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
150055093|NCT01133990|541342136|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
150055094|NCT01133990|541342137|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
150055095|NCT02282345|541342139|FG000|Overall Study|Progression|0|||
150055096|NCT02282345|541342140|FG001|Overall Study|Progression|1|||
150055097|NCT01185301|541342141|FG000|Overall Study|Adverse Event|3|||
150055098|NCT01185301|541342142|FG001|Overall Study|Adverse Event|0|||
150055099|NCT01185301|541342143|FG002|Overall Study|Adverse Event|2|||
150002535|NCT00993499|541142811|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
150002536|NCT00993499|541142812|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
150002537|NCT00993499|541142813|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
150002538|NCT00993499|541142814|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
150002539|NCT00993499|541142815|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
150002540|NCT00993499|541142816|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
150002541|NCT00993499|541142811|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
150002542|NCT00993499|541142812|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
150002543|NCT00993499|541142813|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
150002544|NCT00993499|541142814|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
150002545|NCT00993499|541142815|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
150002546|NCT00993499|541142816|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
150002547|NCT00993499|541142811|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
150002548|NCT00993499|541142812|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
150002549|NCT00993499|541142813|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
150002550|NCT00993499|541142814|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
150002551|NCT00993499|541142815|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
150002552|NCT00993499|541142816|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
150002553|NCT00993499|541142811|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
150002554|NCT00993499|541142812|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
150002555|NCT00993499|541142813|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
150002556|NCT00993499|541142814|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
150002557|NCT00993499|541142815|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
150002558|NCT00993499|541142816|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
150002559|NCT00993499|541142811|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
150002560|NCT00993499|541142812|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
150002561|NCT00993499|541142813|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
150002562|NCT00993499|541142814|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
150002563|NCT00993499|541142815|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
150002564|NCT00993499|541142816|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
150002565|NCT00993499|541142811|FG000|Discontinued After Starting Course 3|DLT|1|||
150002566|NCT00993499|541142812|FG001|Discontinued After Starting Course 3|DLT|0|||
150002567|NCT00993499|541142813|FG002|Discontinued After Starting Course 3|DLT|2|||
150002568|NCT00993499|541142814|FG003|Discontinued After Starting Course 3|DLT|1|||
150002569|NCT00993499|541142815|FG004|Discontinued After Starting Course 3|DLT|0|||
150002570|NCT00993499|541142816|FG005|Discontinued After Starting Course 3|DLT|0|||
150002571|NCT00993499|541142811|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
150002572|NCT00993499|541142812|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
150002573|NCT00993499|541142813|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
150002574|NCT00993499|541142814|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
150002575|NCT00993499|541142815|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
150002576|NCT00993499|541142816|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
150002577|NCT01945775|541142817|FG000|Overall Study|Death|214|||
150002578|NCT01945775|541142818|FG001|Overall Study|Death|98|||
150002579|NCT01945775|541142817|FG000|Overall Study|Lost to Follow-up|12|||
150002580|NCT01945775|541142818|FG001|Overall Study|Lost to Follow-up|7|||
150002581|NCT01945775|541142817|FG000|Overall Study|Withdrawal by Subject|11|||
150002582|NCT01945775|541142818|FG001|Overall Study|Withdrawal by Subject|21|||
150002583|NCT01945775|541142817|FG000|Overall Study|Other|50|||
150002584|NCT01945775|541142818|FG001|Overall Study|Other|18|||
150002585|NCT02876328|541142819|FG000|Overall Study|Death|2|||
150002586|NCT02876328|541142820|FG001|Overall Study|Death|1|||
150002587|NCT02876328|541142821|FG002|Overall Study|Death|3|||
150002588|NCT02876328|541142822|FG003|Overall Study|Death|0|||
150002589|NCT02876328|541142823|FG004|Overall Study|Death|0|||
150002590|NCT02876328|541142824|FG005|Overall Study|Death|0|||
150002591|NCT02876328|541142825|FG006|Overall Study|Death|1|||
150002592|NCT02876328|541142826|FG007|Overall Study|Death|3|||
150002593|NCT02876328|541142827|FG008|Overall Study|Death|0|||
150002594|NCT02876328|541142828|FG009|Overall Study|Death|1|||
150002595|NCT02876328|541142829|FG010|Overall Study|Death|1|||
150002596|NCT02876328|541142830|FG011|Overall Study|Death|0|||
150002597|NCT02876328|541142831|FG012|Overall Study|Death|0|||
150002598|NCT02876328|541142832|FG013|Overall Study|Death|0|||
150002599|NCT02876328|541142833|FG014|Overall Study|Death|0|||
150002600|NCT02876328|541142834|FG015|Overall Study|Death|0|||
150002601|NCT02876328|541142835|FG016|Overall Study|Death|1|||
150002602|NCT02876328|541142836|FG017|Overall Study|Death|1|||
150055100|NCT01185301|541342144|FG003|Overall Study|Adverse Event|3|||
150055101|NCT01185301|541342141|FG000|Overall Study|Withdrawal by Subject|7|||
150055102|NCT01185301|541342142|FG001|Overall Study|Withdrawal by Subject|5|||
150002603|NCT02876328|541142837|FG018|Overall Study|Death|0|||
150002604|NCT02876328|541142838|FG019|Overall Study|Death|0|||
150002605|NCT02876328|541142839|FG020|Overall Study|Death|0|||
150002606|NCT02876328|541142840|FG021|Overall Study|Death|1|||
150002607|NCT02876328|541142841|FG022|Overall Study|Death|0|||
150002608|NCT02876328|541142842|FG023|Overall Study|Death|0|||
150002609|NCT02876328|541142819|FG000|Overall Study|Withdrawal by Subject|0|||
150002610|NCT02876328|541142820|FG001|Overall Study|Withdrawal by Subject|2|||
150002611|NCT02876328|541142821|FG002|Overall Study|Withdrawal by Subject|3|||
150002612|NCT02876328|541142822|FG003|Overall Study|Withdrawal by Subject|3|||
150002613|NCT02876328|541142823|FG004|Overall Study|Withdrawal by Subject|0|||
150002614|NCT02876328|541142824|FG005|Overall Study|Withdrawal by Subject|1|||
150002615|NCT02876328|541142825|FG006|Overall Study|Withdrawal by Subject|0|||
150002616|NCT02876328|541142826|FG007|Overall Study|Withdrawal by Subject|1|||
150002617|NCT02876328|541142827|FG008|Overall Study|Withdrawal by Subject|1|||
150002618|NCT02876328|541142828|FG009|Overall Study|Withdrawal by Subject|2|||
150002619|NCT02876328|541142829|FG010|Overall Study|Withdrawal by Subject|0|||
150002620|NCT02876328|541142830|FG011|Overall Study|Withdrawal by Subject|0|||
150002621|NCT02876328|541142831|FG012|Overall Study|Withdrawal by Subject|0|||
150002622|NCT02876328|541142832|FG013|Overall Study|Withdrawal by Subject|0|||
150002623|NCT02876328|541142833|FG014|Overall Study|Withdrawal by Subject|0|||
150002624|NCT02876328|541142834|FG015|Overall Study|Withdrawal by Subject|0|||
150002625|NCT02876328|541142835|FG016|Overall Study|Withdrawal by Subject|1|||
150002626|NCT02876328|541142836|FG017|Overall Study|Withdrawal by Subject|3|||
150002627|NCT02876328|541142837|FG018|Overall Study|Withdrawal by Subject|0|||
150002628|NCT02876328|541142838|FG019|Overall Study|Withdrawal by Subject|0|||
150002629|NCT02876328|541142839|FG020|Overall Study|Withdrawal by Subject|1|||
150002630|NCT02876328|541142840|FG021|Overall Study|Withdrawal by Subject|0|||
150002631|NCT02876328|541142841|FG022|Overall Study|Withdrawal by Subject|0|||
150002632|NCT02876328|541142842|FG023|Overall Study|Withdrawal by Subject|0|||
150002633|NCT02876328|541142819|FG000|Overall Study|Missed 12 Month Visit|15|||
150002634|NCT02876328|541142820|FG001|Overall Study|Missed 12 Month Visit|10|||
150002635|NCT02876328|541142821|FG002|Overall Study|Missed 12 Month Visit|11|||
150002636|NCT02876328|541142822|FG003|Overall Study|Missed 12 Month Visit|6|||
150002637|NCT02876328|541142823|FG004|Overall Study|Missed 12 Month Visit|10|||
150002638|NCT02876328|541142824|FG005|Overall Study|Missed 12 Month Visit|14|||
150002639|NCT02876328|541142825|FG006|Overall Study|Missed 12 Month Visit|3|||
150002640|NCT02876328|541142826|FG007|Overall Study|Missed 12 Month Visit|8|||
150002641|NCT02876328|541142827|FG008|Overall Study|Missed 12 Month Visit|9|||
150002642|NCT02876328|541142828|FG009|Overall Study|Missed 12 Month Visit|5|||
150002643|NCT02876328|541142829|FG010|Overall Study|Missed 12 Month Visit|4|||
150002644|NCT02876328|541142830|FG011|Overall Study|Missed 12 Month Visit|1|||
150002645|NCT02876328|541142831|FG012|Overall Study|Missed 12 Month Visit|5|||
150002646|NCT02876328|541142832|FG013|Overall Study|Missed 12 Month Visit|4|||
150002647|NCT02876328|541142833|FG014|Overall Study|Missed 12 Month Visit|4|||
150002648|NCT02876328|541142834|FG015|Overall Study|Missed 12 Month Visit|4|||
150002649|NCT02876328|541142835|FG016|Overall Study|Missed 12 Month Visit|3|||
150002650|NCT02876328|541142836|FG017|Overall Study|Missed 12 Month Visit|6|||
150002651|NCT02876328|541142837|FG018|Overall Study|Missed 12 Month Visit|2|||
150002652|NCT02876328|541142838|FG019|Overall Study|Missed 12 Month Visit|2|||
150002653|NCT02876328|541142839|FG020|Overall Study|Missed 12 Month Visit|11|||
150002654|NCT02876328|541142840|FG021|Overall Study|Missed 12 Month Visit|7|||
150002655|NCT02876328|541142841|FG022|Overall Study|Missed 12 Month Visit|1|||
150002656|NCT02876328|541142842|FG023|Overall Study|Missed 12 Month Visit|0|||
150002657|NCT00276094|541142847|FG000|Overall Study|Adverse Event|15|||
150002658|NCT00276094|541142848|FG001|Overall Study|Adverse Event|13|||
150002659|NCT00276094|541142849|FG002|Overall Study|Adverse Event|11|||
150002660|NCT00276094|541142847|FG000|Overall Study|Withdrawal by Subject|14|||
150002661|NCT00276094|541142848|FG001|Overall Study|Withdrawal by Subject|14|||
150002662|NCT00276094|541142849|FG002|Overall Study|Withdrawal by Subject|12|||
150002663|NCT00276094|541142847|FG000|Overall Study|Protocol Violation|16|||
150002664|NCT00276094|541142848|FG001|Overall Study|Protocol Violation|7|||
150002665|NCT00276094|541142849|FG002|Overall Study|Protocol Violation|10|||
150002666|NCT00276094|541142847|FG000|Overall Study|Lost to Follow-up|8|||
150002667|NCT00276094|541142848|FG001|Overall Study|Lost to Follow-up|6|||
150002668|NCT00276094|541142849|FG002|Overall Study|Lost to Follow-up|4|||
150002669|NCT00276094|541142847|FG000|Overall Study|Other-Subject moved out of country|1|||
150002670|NCT00276094|541142848|FG001|Overall Study|Other-Subject moved out of country|0|||
150002671|NCT00276094|541142849|FG002|Overall Study|Other-Subject moved out of country|0|||
150002672|NCT00276094|541142847|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
150002673|NCT00276094|541142848|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
150002674|NCT00276094|541142849|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
150002675|NCT00276094|541142847|FG000|Overall Study|Other-Lack of efficacy|1|||
150002676|NCT00276094|541142848|FG001|Overall Study|Other-Lack of efficacy|0|||
150002677|NCT00276094|541142849|FG002|Overall Study|Other-Lack of efficacy|0|||
150002678|NCT00276094|541142847|FG000|Overall Study|Other-Refused follow-up visit|1|||
150002679|NCT00276094|541142848|FG001|Overall Study|Other-Refused follow-up visit|0|||
150002680|NCT00276094|541142849|FG002|Overall Study|Other-Refused follow-up visit|0|||
150002681|NCT00276094|541142847|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
150002682|NCT00276094|541142848|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
150002683|NCT00276094|541142849|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
150002684|NCT00276094|541142847|FG000|Overall Study|Other-Relocation|0|||
150002685|NCT00276094|541142848|FG001|Overall Study|Other-Relocation|1|||
150002686|NCT00276094|541142849|FG002|Overall Study|Other-Relocation|0|||
150002687|NCT00276094|541142847|FG000|Overall Study|Other-Study medication lost|0|||
150002688|NCT00276094|541142848|FG001|Overall Study|Other-Study medication lost|0|||
150002689|NCT00276094|541142849|FG002|Overall Study|Other-Study medication lost|1|||
150002690|NCT02759315|541142850|FG000|Overall Study|Adverse Event|0|||
150002691|NCT02759315|541142851|FG001|Overall Study|Adverse Event|0|||
150002692|NCT02759315|541142852|FG002|Overall Study|Adverse Event|0|||
150002693|NCT02759315|541142853|FG003|Overall Study|Adverse Event|1|||
150002694|NCT02759315|541142854|FG004|Overall Study|Adverse Event|0|||
150002695|NCT02759315|541142850|FG000|Overall Study|Death|0|||
150002696|NCT02759315|541142851|FG001|Overall Study|Death|0|||
150002697|NCT02759315|541142852|FG002|Overall Study|Death|1|||
150002698|NCT02759315|541142853|FG003|Overall Study|Death|0|||
150002699|NCT02759315|541142854|FG004|Overall Study|Death|0|||
150002700|NCT02759315|541142850|FG000|Overall Study|Lost to Follow-up|2|||
150002701|NCT02759315|541142851|FG001|Overall Study|Lost to Follow-up|0|||
150002702|NCT02759315|541142852|FG002|Overall Study|Lost to Follow-up|4|||
150002703|NCT02759315|541142853|FG003|Overall Study|Lost to Follow-up|0|||
150002704|NCT02759315|541142854|FG004|Overall Study|Lost to Follow-up|0|||
150002705|NCT02759315|541142850|FG000|Overall Study|Protocol Violation|0|||
150002706|NCT02759315|541142851|FG001|Overall Study|Protocol Violation|1|||
150002707|NCT02759315|541142852|FG002|Overall Study|Protocol Violation|0|||
150002708|NCT02759315|541142853|FG003|Overall Study|Protocol Violation|0|||
150002709|NCT02759315|541142854|FG004|Overall Study|Protocol Violation|0|||
150002710|NCT02759315|541142850|FG000|Overall Study|Study terminated prior to completion|2|||
150002711|NCT02759315|541142851|FG001|Overall Study|Study terminated prior to completion|0|||
150002712|NCT02759315|541142852|FG002|Overall Study|Study terminated prior to completion|5|||
150002713|NCT02759315|541142853|FG003|Overall Study|Study terminated prior to completion|0|||
150002714|NCT02759315|541142854|FG004|Overall Study|Study terminated prior to completion|1|||
150002715|NCT01406015|541142857|FG000|Overall Study|Withdrawal by Subject|3|||
150002716|NCT01406015|541142858|FG001|Overall Study|Withdrawal by Subject|3|||
150002717|NCT00787137|541142859|FG000|Overall Study|Study Termination|0|||
150002718|NCT00787137|541142860|FG001|Overall Study|Study Termination|0|||
150002719|NCT00787137|541142861|FG002|Overall Study|Study Termination|1|||
150002720|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
150002721|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
150002722|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
150002723|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
150002724|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
150002725|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
150002726|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
150002727|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150002728|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
150002729|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
150002730|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
150002731|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
150002732|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
150002733|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
150002734|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
150002735|NCT00554099|541142865|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
150002736|NCT00554099|541142866|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
150002737|NCT00554099|541142867|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
150002738|NCT00554099|541142865|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
150002739|NCT00554099|541142866|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
150002740|NCT00554099|541142867|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
150002741|NCT00554099|541142865|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
150002742|NCT00554099|541142866|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
150002743|NCT00554099|541142867|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
150002744|NCT00554099|541142865|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
150002745|NCT00554099|541142866|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
150002746|NCT00554099|541142867|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
150002747|NCT02075632|541142868|FG000|Overall Study|Adverse Event|1|||
150002748|NCT02075632|541142869|FG001|Overall Study|Adverse Event|1|||
150002749|NCT02075632|541142868|FG000|Overall Study|Lost to Follow-up|0|||
150002750|NCT02075632|541142869|FG001|Overall Study|Lost to Follow-up|3|||
150002751|NCT02075632|541142868|FG000|Overall Study|Withdrawal by Subject|0|||
150002752|NCT02075632|541142869|FG001|Overall Study|Withdrawal by Subject|1|||
150055103|NCT01185301|541342143|FG002|Overall Study|Withdrawal by Subject|2|||
150055104|NCT01185301|541342144|FG003|Overall Study|Withdrawal by Subject|3|||
150055105|NCT01185301|541342141|FG000|Overall Study|Lost to Follow-up|2|||
150002753|NCT03464422|541142873|FG000|Overall Study|Lost to Follow-up|2|||
150002754|NCT03464422|541142873|FG000|Overall Study|Withdrawal by Subject|2|||
150002755|NCT01628367|541142881|FG000|Overall Study|Adverse Event|1|||
150002756|NCT01628367|541142882|FG001|Overall Study|Adverse Event|0|||
150002757|NCT03353922|541142883|FG000|Overall Study|Withdrawal by Subject|1|||
150002758|NCT03353922|541142884|FG001|Overall Study|Withdrawal by Subject|0|||
150002759|NCT03353922|541142885|FG002|Overall Study|Withdrawal by Subject|1|||
150002760|NCT03353922|541142886|FG003|Overall Study|Withdrawal by Subject|1|||
150002761|NCT03353922|541142887|FG004|Overall Study|Withdrawal by Subject|0|||
150002762|NCT03353922|541142888|FG005|Overall Study|Withdrawal by Subject|0|||
150002763|NCT03353922|541142883|FG000|Overall Study|Adverse Event|0|||
150002764|NCT03353922|541142884|FG001|Overall Study|Adverse Event|1|||
150002765|NCT03353922|541142885|FG002|Overall Study|Adverse Event|0|||
150002766|NCT03353922|541142886|FG003|Overall Study|Adverse Event|0|||
150002767|NCT03353922|541142887|FG004|Overall Study|Adverse Event|0|||
150002768|NCT03353922|541142888|FG005|Overall Study|Adverse Event|0|||
150002769|NCT00740714|541142889|FG000|Overall Study|Withdrawal by Subject|17|||
150002770|NCT00740714|541142890|FG001|Overall Study|Withdrawal by Subject|19|||
150002771|NCT00740714|541142891|FG002|Overall Study|Withdrawal by Subject|29|||
150002772|NCT03688555|541142892|FG000|Treatment Period|Adverse Event|0|||
150002773|NCT03688555|541142893|FG001|Treatment Period|Adverse Event|0|||
150002774|NCT03688555|541142894|FG002|Treatment Period|Adverse Event|1|||
150002775|NCT00612508|541142895|FG000|Overall Study|Withdrawal by Subject|3|||
150002776|NCT00612508|541142896|FG001|Overall Study|Withdrawal by Subject|4|||
150002777|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
150002778|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
150002779|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
150002780|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
150002781|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
150002782|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
150002783|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
150002784|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
150002785|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
150002786|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
150002787|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
150002788|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
150002789|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
150002790|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
150002791|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
150002792|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
150002793|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
150002794|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
150002795|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
150002796|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
150002797|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
150002798|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
150002799|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
150002800|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
150002801|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
150002802|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
150002803|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
150055106|NCT01185301|541342142|FG001|Overall Study|Lost to Follow-up|0|||
150055107|NCT01185301|541342143|FG002|Overall Study|Lost to Follow-up|0|||
150002804|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
150002805|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
150002806|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
150002807|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
150002808|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
150002809|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
150002810|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
150002811|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
150002812|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
150002813|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
150002814|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
150002815|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
150002816|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
150002817|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
150002818|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
150002819|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
150002820|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
150002821|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
150002822|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
150002823|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
150002824|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
150002825|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
150055108|NCT01185301|541342144|FG003|Overall Study|Lost to Follow-up|1|||
150055109|NCT01185301|541342141|FG000|Overall Study|Other Reason|3|||
150055110|NCT01185301|541342142|FG001|Overall Study|Other Reason|2|||
150055111|NCT01185301|541342143|FG002|Overall Study|Other Reason|2|||
150055112|NCT01185301|541342144|FG003|Overall Study|Other Reason|2|||
150055113|NCT02683746|541342145|FG000|Overall Study|Adverse Event|3|||
150002826|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
150002827|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
150055114|NCT02683746|541342146|FG001|Overall Study|Adverse Event|2|||
150055115|NCT02683746|541342145|FG000|Overall Study|Lost to Follow-up|5|||
150055116|NCT02683746|541342146|FG001|Overall Study|Lost to Follow-up|6|||
150055117|NCT02683746|541342145|FG000|Overall Study|Withdrawal by Subject|6|||
150055118|NCT02683746|541342146|FG001|Overall Study|Withdrawal by Subject|5|||
150055119|NCT02683746|541342145|FG000|Overall Study|Physician Decision|2|||
150055120|NCT02683746|541342146|FG001|Overall Study|Physician Decision|1|||
150055121|NCT04987944|541342151|FG000|Overall Study|Adverse Event|0|||
150055122|NCT04987944|541342152|FG001|Overall Study|Adverse Event|1|||
150055123|NCT04987944|541342151|FG000|Overall Study|Withdrawal by Subject|0|||
150055124|NCT04987944|541342152|FG001|Overall Study|Withdrawal by Subject|1|||
150055125|NCT04136444|541342158|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
150055126|NCT04136444|541342159|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
150055127|NCT03051620|541342170|FG000|Overall Study|Lost to Follow-up|6|||
150055128|NCT03051620|541342170|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
150055129|NCT01073462|541342171|FG000|Overall Study|Death|14|||
150055130|NCT01073462|541342171|FG000|Overall Study|Kidney transplant|10|||
150055131|NCT01073462|541342171|FG000|Overall Study|Low parathyroid hormone levels|8|||
150055132|NCT01073462|541342171|FG000|Overall Study|Serious adverse event|2|||
150055133|NCT01073462|541342171|FG000|Overall Study|Lost to Follow-up|7|||
150055134|NCT03554486|541342172|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
150055135|NCT03554486|541342173|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
150002828|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
150002829|NCT02008357|541142897|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
150002830|NCT02008357|541142898|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
150002831|NCT02008357|541142897|FG000|Open-label Extension Period|Adverse Event|8|||
150002832|NCT02008357|541142898|FG001|Open-label Extension Period|Adverse Event|7|||
150002833|NCT02008357|541142897|FG000|Open-label Extension Period|Death|7|||
150002834|NCT02008357|541142898|FG001|Open-label Extension Period|Death|4|||
150002835|NCT02008357|541142897|FG000|Open-label Extension Period|Lack of Efficacy|9|||
150002836|NCT02008357|541142898|FG001|Open-label Extension Period|Lack of Efficacy|5|||
150002837|NCT02008357|541142897|FG000|Open-label Extension Period|Lost to Follow-up|2|||
150002838|NCT02008357|541142898|FG001|Open-label Extension Period|Lost to Follow-up|2|||
150002839|NCT02008357|541142897|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
150002840|NCT02008357|541142898|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
150002841|NCT02008357|541142897|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
150002842|NCT02008357|541142898|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
150002843|NCT02008357|541142897|FG000|Open-label Extension Period|Safety Risk|2|||
150002844|NCT02008357|541142898|FG001|Open-label Extension Period|Safety Risk|1|||
150002845|NCT02008357|541142897|FG000|Open-label Extension Period|Non-Compliance|0|||
150002846|NCT02008357|541142898|FG001|Open-label Extension Period|Non-Compliance|1|||
150002847|NCT02008357|541142897|FG000|Open-label Extension Period|Investigator Recommendation|0|||
150002848|NCT02008357|541142898|FG001|Open-label Extension Period|Investigator Recommendation|1|||
150002849|NCT02008357|541142897|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
150002850|NCT02008357|541142898|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
150002851|NCT02008357|541142897|FG000|Open-label Extension Period|Coordinating Center Request|2|||
150002852|NCT02008357|541142898|FG001|Open-label Extension Period|Coordinating Center Request|4|||
150002853|NCT02008357|541142897|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
150002854|NCT02008357|541142898|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
150002855|NCT02008357|541142897|FG000|Open-label Extension Period|Study Ended|20|||
150002856|NCT02008357|541142898|FG001|Open-label Extension Period|Study Ended|25|||
150002857|NCT02008357|541142897|FG000|Open-label Extension Period|Personal Reasons|0|||
150002858|NCT02008357|541142898|FG001|Open-label Extension Period|Personal Reasons|1|||
150002859|NCT02008357|541142897|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
150002860|NCT02008357|541142898|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
150002861|NCT02008357|541142897|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
150002862|NCT02008357|541142898|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
150002863|NCT02008357|541142897|FG000|Open-label Extension Period|Other|2|||
150002864|NCT02008357|541142898|FG001|Open-label Extension Period|Other|0|||
150002865|NCT01442064|541142900|FG000|Overall Study|Adverse Event|2|||
150002866|NCT01442064|541142901|FG001|Overall Study|Adverse Event|2|||
150002867|NCT01442064|541142902|FG002|Overall Study|Adverse Event|2|||
150002868|NCT01442064|541142903|FG003|Overall Study|Adverse Event|1|||
150002869|NCT01442064|541142904|FG004|Overall Study|Adverse Event|2|||
150002870|NCT01442064|541142905|FG005|Overall Study|Adverse Event|0|||
150002871|NCT01442064|541142900|FG000|Overall Study|Death|0|||
150002872|NCT01442064|541142901|FG001|Overall Study|Death|1|||
150002873|NCT01442064|541142902|FG002|Overall Study|Death|3|||
150002874|NCT01442064|541142903|FG003|Overall Study|Death|3|||
150002875|NCT01442064|541142904|FG004|Overall Study|Death|1|||
150002876|NCT01442064|541142905|FG005|Overall Study|Death|3|||
150002877|NCT01442064|541142900|FG000|Overall Study|Lost to Follow-up|5|||
150002878|NCT01442064|541142901|FG001|Overall Study|Lost to Follow-up|5|||
150002879|NCT01442064|541142902|FG002|Overall Study|Lost to Follow-up|1|||
150002880|NCT01442064|541142903|FG003|Overall Study|Lost to Follow-up|1|||
150002881|NCT01442064|541142904|FG004|Overall Study|Lost to Follow-up|3|||
150002882|NCT01442064|541142905|FG005|Overall Study|Lost to Follow-up|3|||
150002883|NCT01442064|541142900|FG000|Overall Study|Physician Decision|1|||
150002884|NCT01442064|541142901|FG001|Overall Study|Physician Decision|1|||
150002885|NCT01442064|541142902|FG002|Overall Study|Physician Decision|2|||
150002886|NCT01442064|541142903|FG003|Overall Study|Physician Decision|3|||
150002887|NCT01442064|541142904|FG004|Overall Study|Physician Decision|3|||
150002888|NCT01442064|541142905|FG005|Overall Study|Physician Decision|1|||
150002889|NCT01442064|541142900|FG000|Overall Study|Withdrawal by Subject|6|||
150002890|NCT01442064|541142901|FG001|Overall Study|Withdrawal by Subject|3|||
150002891|NCT01442064|541142902|FG002|Overall Study|Withdrawal by Subject|2|||
150002892|NCT01442064|541142903|FG003|Overall Study|Withdrawal by Subject|2|||
150002893|NCT01442064|541142904|FG004|Overall Study|Withdrawal by Subject|2|||
150002894|NCT01442064|541142905|FG005|Overall Study|Withdrawal by Subject|1|||
150002895|NCT01442064|541142900|FG000|Overall Study|Sponsor decision|82|||
150002896|NCT01442064|541142901|FG001|Overall Study|Sponsor decision|88|||
150002897|NCT01442064|541142902|FG002|Overall Study|Sponsor decision|92|||
150002898|NCT01442064|541142903|FG003|Overall Study|Sponsor decision|88|||
150002899|NCT01442064|541142904|FG004|Overall Study|Sponsor decision|95|||
150002900|NCT01442064|541142905|FG005|Overall Study|Sponsor decision|87|||
150002901|NCT01442064|541142900|FG000|Overall Study|Subject non-compliance|0|||
150002902|NCT01442064|541142901|FG001|Overall Study|Subject non-compliance|0|||
150002903|NCT01442064|541142902|FG002|Overall Study|Subject non-compliance|0|||
150002904|NCT01442064|541142903|FG003|Overall Study|Subject non-compliance|0|||
150002905|NCT01442064|541142904|FG004|Overall Study|Subject non-compliance|0|||
150002906|NCT01442064|541142905|FG005|Overall Study|Subject non-compliance|2|||
150002907|NCT01442064|541142900|FG000|Overall Study|Condition mandated other intervention|1|||
150002908|NCT01442064|541142901|FG001|Overall Study|Condition mandated other intervention|1|||
150002909|NCT01442064|541142902|FG002|Overall Study|Condition mandated other intervention|2|||
150002910|NCT01442064|541142903|FG003|Overall Study|Condition mandated other intervention|0|||
150002911|NCT01442064|541142904|FG004|Overall Study|Condition mandated other intervention|0|||
150002912|NCT01442064|541142905|FG005|Overall Study|Condition mandated other intervention|2|||
150002913|NCT02312219|541142906|FG000|Overall Study|Withdrawal by Subject|1|||
150002914|NCT02312219|541142907|FG001|Overall Study|Withdrawal by Subject|2|||
150002915|NCT02312219|541142906|FG000|Overall Study|could not schedule imaging in time|0|||
150002916|NCT02312219|541142907|FG001|Overall Study|could not schedule imaging in time|2|||
150002917|NCT02312219|541142906|FG000|Overall Study|Other|0|||
150002918|NCT02312219|541142907|FG001|Overall Study|Other|1|||
150002919|NCT02312219|541142906|FG000|Overall Study|Not randomized. Ineligible|0|||
150002920|NCT02312219|541142907|FG001|Overall Study|Not randomized. Ineligible|1|||
150002921|NCT02153346|541142908|FG000|Overall Study|Lost to Follow-up|11|||
150002922|NCT03697993|541142912|FG000|Overall Study|Became Ineligible after Enrollment|1|||
150002923|NCT03697993|541142913|FG001|Overall Study|Became Ineligible after Enrollment|3|||
150002924|NCT03697993|541142912|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
150002925|NCT03697993|541142913|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
150002926|NCT03697993|541142912|FG000|Overall Study|Lost to Follow-up|3|||
150002927|NCT03697993|541142913|FG001|Overall Study|Lost to Follow-up|0|||
150002928|NCT03697993|541142912|FG000|Overall Study|Physician Decision|4|||
150002929|NCT03697993|541142913|FG001|Overall Study|Physician Decision|0|||
150002930|NCT03697993|541142912|FG000|Overall Study|Initial Urine Culture Negative|0|||
150002931|NCT03697993|541142913|FG001|Overall Study|Initial Urine Culture Negative|1|||
150055136|NCT03554486|541342174|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
150055137|NCT03554486|541342172|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
150055138|NCT03554486|541342173|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
150055139|NCT03554486|541342174|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
150055140|NCT03554486|541342172|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
150055141|NCT03554486|541342173|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
150055142|NCT03554486|541342174|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
150055143|NCT02509117|541342177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055144|NCT02509117|541342178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
150055145|NCT02509117|541342179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055146|NCT02509117|541342180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055147|NCT02509117|541342181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055148|NCT02509117|541342182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055149|NCT02509117|541342183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055150|NCT02509117|541342184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055151|NCT02509117|541342185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055152|NCT02509117|541342186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
150055153|NCT02509117|541342177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055154|NCT02509117|541342178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055155|NCT02509117|541342179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055156|NCT02509117|541342180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055157|NCT02509117|541342181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055158|NCT02509117|541342182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055159|NCT02509117|541342183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055160|NCT02509117|541342184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055161|NCT02509117|541342185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
150055162|NCT02509117|541342186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
150055163|NCT02509117|541342177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055164|NCT02509117|541342178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150002932|NCT03582813|541142916|FG000|Overall Study|Lost to Follow-up|18|||
150055165|NCT02509117|541342179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055166|NCT02509117|541342180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055167|NCT02509117|541342181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055168|NCT02509117|541342182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150002933|NCT03582813|541142917|FG001|Overall Study|Lost to Follow-up|21|||
150002934|NCT03582813|541142916|FG000|Overall Study|Withdrawal by Subject|1|||
150002935|NCT03582813|541142917|FG001|Overall Study|Withdrawal by Subject|0|||
150002936|NCT01048866|541142918|FG000|Overall Study|Adverse Event|1|||
150002937|NCT01048866|541142919|FG001|Overall Study|Adverse Event|0|||
150002938|NCT01048866|541142918|FG000|Overall Study|Protocol Violation|1|||
150002939|NCT01048866|541142919|FG001|Overall Study|Protocol Violation|0|||
150002940|NCT01048866|541142918|FG000|Overall Study|Physician Decision|1|||
150002941|NCT01048866|541142919|FG001|Overall Study|Physician Decision|0|||
150002942|NCT01048866|541142918|FG000|Overall Study|Withdrawal by Subject|0|||
150002943|NCT01048866|541142919|FG001|Overall Study|Withdrawal by Subject|2|||
150002944|NCT01048866|541142918|FG000|Overall Study|Lost to Follow-up|0|||
150002945|NCT01048866|541142919|FG001|Overall Study|Lost to Follow-up|2|||
150002946|NCT01048866|541142918|FG000|Overall Study|Other|1|||
150002947|NCT01048866|541142919|FG001|Overall Study|Other|1|||
150002948|NCT02366767|541142922|FG000|Overall Study|left for home after 1 day at camp|1|||
150002949|NCT02366767|541142923|FG001|Overall Study|left for home after 1 day at camp|0|||
150002950|NCT02230683|541142929|FG000|Overall Study|Adverse Event|1|||
150002951|NCT00456599|541142930|FG000|Overall Study|Non-compliance|1|||
150002952|NCT00456599|541142930|FG000|Overall Study|Withdrawal by Subject|2|||
150002953|NCT00260065|541142931|FG000|Overall Study|Progressive Disease|22|||
150002954|NCT00260065|541142931|FG000|Overall Study|Adverse Event|17|||
150002955|NCT00260065|541142931|FG000|Overall Study|Death|13|||
150002956|NCT00260065|541142931|FG000|Overall Study|Withdrawal by Subject|13|||
150002957|NCT00260065|541142931|FG000|Overall Study|Physician Decision|19|||
150002958|NCT00260065|541142931|FG000|Overall Study|Not otherwise specified|8|||
150002959|NCT00260065|541142931|FG000|Overall Study|Medication Noncompliance|1|||
150002960|NCT04573881|541142933|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
150002961|NCT00664326|541145238|FG000|Overall Study|Adverse Event|14|||
150002962|NCT00664326|541145238|FG000|Overall Study|Noncompliance with study medication|3|||
150002963|NCT00664326|541145238|FG000|Overall Study|Withdrawal by Subject|1|||
150002964|NCT00664326|541145238|FG000|Overall Study|Physician Decision|1|||
150002965|NCT00664326|541145238|FG000|Overall Study|Other Reasons|3|||
150002966|NCT00664326|541145238|FG000|Overall Study|Death|2|||
150002967|NCT00664326|541145238|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
150002968|NCT03647267|541145243|FG000|Overall Study|Lost to Follow-up|1|||
150002969|NCT03647267|541145244|FG001|Overall Study|Lost to Follow-up|0|||
150002970|NCT05079477|541145245|FG000|Overall Study|Lost to Follow-up|2|||
150002971|NCT05079477|541145246|FG001|Overall Study|Lost to Follow-up|0|||
150055169|NCT02509117|541342183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055170|NCT02509117|541342184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055171|NCT02509117|541342185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
150055172|NCT02509117|541342186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
150055173|NCT00832624|541342187|FG000|Overall Study|Study Terminated|10|||
150002972|NCT05079477|541145245|FG000|Overall Study|Withdrawal by Subject|1|||
150002973|NCT05079477|541145246|FG001|Overall Study|Withdrawal by Subject|0|||
150055174|NCT00934843|541342194|FG000|Overall Study|Protocol Violation|0|||
150055175|NCT00934843|541342195|FG001|Overall Study|Protocol Violation|1|||
150055176|NCT01576159|541342198|FG000|Overall Study|Withdrawal by Subject|0|||
150055177|NCT01576159|541342199|FG001|Overall Study|Withdrawal by Subject|1|||
150055178|NCT01576159|541342200|FG002|Overall Study|Withdrawal by Subject|0|||
150055179|NCT01576159|541342201|FG003|Overall Study|Withdrawal by Subject|0|||
150055180|NCT01576159|541342198|FG000|Overall Study|Physician Decision|0|||
150055181|NCT01576159|541342199|FG001|Overall Study|Physician Decision|0|||
150055182|NCT01576159|541342200|FG002|Overall Study|Physician Decision|1|||
150002974|NCT05079477|541145245|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
150002975|NCT05079477|541145246|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
150002976|NCT05079477|541145245|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
150002977|NCT05079477|541145246|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
150002978|NCT00734071|541145249|FG000|Overall Study|Adverse Event|4|||
150002979|NCT00734071|541145250|FG001|Overall Study|Adverse Event|3|||
150002980|NCT00734071|541145249|FG000|Overall Study|Lack of Efficacy|3|||
150002981|NCT00734071|541145250|FG001|Overall Study|Lack of Efficacy|1|||
150002982|NCT00734071|541145249|FG000|Overall Study|Noncompliance|2|||
150055183|NCT01576159|541342201|FG003|Overall Study|Physician Decision|0|||
150055184|NCT01576159|541342198|FG000|Overall Study|Lost to Follow-up|0|||
150002983|NCT00734071|541145250|FG001|Overall Study|Noncompliance|2|||
150002984|NCT00734071|541145249|FG000|Overall Study|Protocol Deviations|3|||
150002985|NCT00734071|541145250|FG001|Overall Study|Protocol Deviations|4|||
150002986|NCT00734071|541145249|FG000|Overall Study|Voluntary Withdrawal|9|||
150002987|NCT00734071|541145250|FG001|Overall Study|Voluntary Withdrawal|7|||
150002988|NCT00734071|541145249|FG000|Overall Study|Lost to Follow-up|16|||
150002989|NCT00734071|541145250|FG001|Overall Study|Lost to Follow-up|8|||
150002990|NCT00734071|541145249|FG000|Overall Study|Other|1|||
150002991|NCT00734071|541145250|FG001|Overall Study|Other|2|||
150002992|NCT03654885|541145251|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
150002993|NCT03654885|541145252|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
150002994|NCT03654885|541145251|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
150002995|NCT03654885|541145252|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
150002996|NCT03654885|541145251|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
150002997|NCT03654885|541145252|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
150002998|NCT03654885|541145251|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
150002999|NCT03654885|541145252|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
150003000|NCT03654885|541145251|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
150003001|NCT03654885|541145252|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
150003002|NCT03654885|541145251|FG000|Overall Study|Adverse Event in Study Eye|3|||
150003003|NCT03654885|541145252|FG001|Overall Study|Adverse Event in Study Eye|0|||
150003004|NCT03654885|541145251|FG000|Overall Study|Consent Withdrawn|1|||
150003005|NCT03654885|541145252|FG001|Overall Study|Consent Withdrawn|0|||
150003006|NCT03654885|541145251|FG000|Overall Study|Death|3|||
150003007|NCT03654885|541145252|FG001|Overall Study|Death|1|||
150003008|NCT03654885|541145251|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
150003009|NCT03654885|541145252|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
150003010|NCT03654885|541145251|FG000|Overall Study|Lost to Follow-up|3|||
150003011|NCT03654885|541145252|FG001|Overall Study|Lost to Follow-up|3|||
150003012|NCT00583791|541145256|FG000|Overall Study|Other|67|||
150003013|NCT00583791|541145256|FG000|Overall Study|Death|6|||
150003014|NCT00203021|541145257|FG000|Overall Study|Death|4|||
150003015|NCT00203021|541145258|FG001|Overall Study|Death|1|||
150003016|NCT00203021|541145257|FG000|Overall Study|Adverse Event|10|||
150003017|NCT00203021|541145258|FG001|Overall Study|Adverse Event|5|||
150003018|NCT00203021|541145257|FG000|Overall Study|Withdrawal by Subject|45|||
150003019|NCT00203021|541145258|FG001|Overall Study|Withdrawal by Subject|48|||
150003020|NCT00203021|541145257|FG000|Overall Study|Lost to Follow-up|9|||
150003021|NCT00203021|541145258|FG001|Overall Study|Lost to Follow-up|7|||
150003022|NCT00203021|541145257|FG000|Overall Study|Other than specified|11|||
150003023|NCT00203021|541145258|FG001|Overall Study|Other than specified|16|||
150003024|NCT02080260|541145260|FG000|Overall Study|Death|18|||
150003025|NCT02080260|541145260|FG000|Overall Study|Withdrawal by Subject|1|||
150003026|NCT03204890|541145261|FG000|Overall Study|Withdrawal by Subject|1|||
150003027|NCT03769311|541145262|FG000|Overall Study|Withdrawal by Subject|1|||
150003028|NCT02853435|541145263|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
150003029|NCT02853435|541145264|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
150003030|NCT02853435|541145265|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
150003031|NCT02853435|541145266|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
150003032|NCT02853435|541145267|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
150003033|NCT02853435|541145268|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
150003034|NCT03627065|541145269|FG000|Overall Study|Study Terminated by sponsor|1|||
150003035|NCT03627065|541145269|FG000|Overall Study|Withdrawal by Subject|2|||
150003036|NCT00996801|541145276|FG000|Overall Study|Adverse Event|6|||
150003037|NCT00996801|541145277|FG001|Overall Study|Adverse Event|4|||
150003038|NCT00996801|541145278|FG002|Overall Study|Adverse Event|12|||
150003039|NCT00996801|541145279|FG003|Overall Study|Adverse Event|17|||
150003040|NCT00996801|541145280|FG004|Overall Study|Adverse Event|31|||
150003041|NCT00996801|541145281|FG005|Overall Study|Adverse Event|3|||
150003042|NCT00996801|541145276|FG000|Overall Study|Lack of Efficacy|3|||
150003043|NCT00996801|541145277|FG001|Overall Study|Lack of Efficacy|0|||
150003044|NCT00996801|541145278|FG002|Overall Study|Lack of Efficacy|1|||
150003045|NCT00996801|541145279|FG003|Overall Study|Lack of Efficacy|3|||
150003046|NCT00996801|541145280|FG004|Overall Study|Lack of Efficacy|0|||
150003047|NCT00996801|541145281|FG005|Overall Study|Lack of Efficacy|1|||
150003048|NCT00996801|541145276|FG000|Overall Study|Lost to Follow-up|0|||
150003049|NCT00996801|541145277|FG001|Overall Study|Lost to Follow-up|0|||
150003050|NCT00996801|541145278|FG002|Overall Study|Lost to Follow-up|0|||
150055185|NCT01576159|541342199|FG001|Overall Study|Lost to Follow-up|0|||
150055186|NCT01576159|541342200|FG002|Overall Study|Lost to Follow-up|0|||
150055187|NCT01576159|541342201|FG003|Overall Study|Lost to Follow-up|1|||
150055188|NCT01576159|541342198|FG000|Overall Study|Protocol Violation|1|||
150055189|NCT01576159|541342199|FG001|Overall Study|Protocol Violation|0|||
150055190|NCT01576159|541342200|FG002|Overall Study|Protocol Violation|0|||
150055191|NCT01576159|541342201|FG003|Overall Study|Protocol Violation|0|||
150055192|NCT03658876|541344099|FG000|Overall Study|Protocol Violation|3|||
150055193|NCT03658876|541344100|FG001|Overall Study|Protocol Violation|2|||
150055194|NCT03658876|541344099|FG000|Overall Study|Withdrawal by Subject|2|||
150055195|NCT03658876|541344100|FG001|Overall Study|Withdrawal by Subject|0|||
150055196|NCT03658876|541344099|FG000|Overall Study|Death|0|||
150055197|NCT03658876|541344100|FG001|Overall Study|Death|1|||
150055198|NCT03658876|541344099|FG000|Overall Study|Intercurrent illness|6|||
150055199|NCT03658876|541344100|FG001|Overall Study|Intercurrent illness|4|||
150055200|NCT03658876|541344099|FG000|Overall Study|Transplantation/other operation|1|||
150055201|NCT03658876|541344100|FG001|Overall Study|Transplantation/other operation|5|||
150055202|NCT02616146|541344101|FG000|Overall Study|Adverse Event|64|||
150055203|NCT02616146|541344102|FG001|Overall Study|Adverse Event|24|||
150055204|NCT02616146|541344101|FG000|Overall Study|Lost to Follow-up|23|||
150055205|NCT02616146|541344102|FG001|Overall Study|Lost to Follow-up|13|||
150055206|NCT02616146|541344101|FG000|Overall Study|Non-compliance with study protocol|2|||
150055207|NCT02616146|541344102|FG001|Overall Study|Non-compliance with study protocol|0|||
150055208|NCT02616146|541344101|FG000|Overall Study|Non-compliance with study drug|4|||
150055209|NCT02616146|541344102|FG001|Overall Study|Non-compliance with study drug|2|||
150055210|NCT02616146|541344101|FG000|Overall Study|Pregnancy|2|||
150055211|NCT02616146|541344102|FG001|Overall Study|Pregnancy|2|||
150055212|NCT02616146|541344101|FG000|Overall Study|Pregnancy wish|3|||
150003051|NCT00996801|541145279|FG003|Overall Study|Lost to Follow-up|3|||
150003052|NCT00996801|541145280|FG004|Overall Study|Lost to Follow-up|3|||
150003053|NCT00996801|541145281|FG005|Overall Study|Lost to Follow-up|2|||
150003054|NCT00996801|541145276|FG000|Overall Study|Physician Decision|0|||
150003055|NCT00996801|541145277|FG001|Overall Study|Physician Decision|0|||
150003056|NCT00996801|541145278|FG002|Overall Study|Physician Decision|0|||
150003057|NCT00996801|541145279|FG003|Overall Study|Physician Decision|1|||
150003058|NCT00996801|541145280|FG004|Overall Study|Physician Decision|0|||
150003059|NCT00996801|541145281|FG005|Overall Study|Physician Decision|0|||
150003060|NCT00996801|541145276|FG000|Overall Study|Progressive Disease|0|||
150003061|NCT00996801|541145277|FG001|Overall Study|Progressive Disease|1|||
150003062|NCT00996801|541145278|FG002|Overall Study|Progressive Disease|0|||
150003063|NCT00996801|541145279|FG003|Overall Study|Progressive Disease|0|||
150003064|NCT00996801|541145280|FG004|Overall Study|Progressive Disease|0|||
150003065|NCT00996801|541145281|FG005|Overall Study|Progressive Disease|0|||
150003066|NCT00996801|541145276|FG000|Overall Study|Protocol Violation|3|||
150003067|NCT00996801|541145277|FG001|Overall Study|Protocol Violation|4|||
150003068|NCT00996801|541145278|FG002|Overall Study|Protocol Violation|1|||
150003069|NCT00996801|541145279|FG003|Overall Study|Protocol Violation|2|||
150003070|NCT00996801|541145280|FG004|Overall Study|Protocol Violation|3|||
150003071|NCT00996801|541145281|FG005|Overall Study|Protocol Violation|4|||
150003072|NCT00996801|541145276|FG000|Overall Study|Study Terminated by Sponsor|0|||
150003073|NCT00996801|541145277|FG001|Overall Study|Study Terminated by Sponsor|1|||
150003074|NCT00996801|541145278|FG002|Overall Study|Study Terminated by Sponsor|0|||
150003075|NCT00996801|541145279|FG003|Overall Study|Study Terminated by Sponsor|0|||
150003076|NCT00996801|541145280|FG004|Overall Study|Study Terminated by Sponsor|46|||
150003077|NCT00996801|541145281|FG005|Overall Study|Study Terminated by Sponsor|0|||
150003078|NCT00996801|541145276|FG000|Overall Study|Withdrawal by Subject|8|||
150003079|NCT00996801|541145277|FG001|Overall Study|Withdrawal by Subject|6|||
150003080|NCT00996801|541145278|FG002|Overall Study|Withdrawal by Subject|9|||
150055213|NCT02616146|541344102|FG001|Overall Study|Pregnancy wish|0|||
150055214|NCT02616146|541344101|FG000|Overall Study|Protocol Violation|6|||
150055215|NCT02616146|541344102|FG001|Overall Study|Protocol Violation|3|||
150003081|NCT00996801|541145279|FG003|Overall Study|Withdrawal by Subject|5|||
150003082|NCT00996801|541145280|FG004|Overall Study|Withdrawal by Subject|5|||
150003083|NCT00996801|541145281|FG005|Overall Study|Withdrawal by Subject|9|||
150003084|NCT00289198|541145282|FG000|Overall Study|Adverse Event|0|||
150003085|NCT00289198|541145283|FG001|Overall Study|Adverse Event|2|||
150003086|NCT00289198|541145282|FG000|Overall Study|Protocol Violation|2|||
150003087|NCT00289198|541145283|FG001|Overall Study|Protocol Violation|1|||
150003088|NCT00289198|541145282|FG000|Overall Study|Withdrawal by Subject|4|||
150055216|NCT02616146|541344101|FG000|Overall Study|Study terminated by sponsor|1372|||
150055217|NCT02616146|541344102|FG001|Overall Study|Study terminated by sponsor|432|||
150055218|NCT02616146|541344101|FG000|Overall Study|Participant moved|4|||
150055219|NCT02616146|541344102|FG001|Overall Study|Participant moved|3|||
150055220|NCT02616146|541344101|FG000|Overall Study|Withdrawal by Subject|30|||
150055221|NCT02616146|541344102|FG001|Overall Study|Withdrawal by Subject|24|||
150055222|NCT02616146|541344101|FG000|Overall Study|Physician Decision|2|||
150055223|NCT02616146|541344102|FG001|Overall Study|Physician Decision|1|||
150003089|NCT00289198|541145283|FG001|Overall Study|Withdrawal by Subject|1|||
150003090|NCT00289198|541145282|FG000|Overall Study|Lack of Efficacy|2|||
150003091|NCT00289198|541145283|FG001|Overall Study|Lack of Efficacy|0|||
150003092|NCT00289198|541145282|FG000|Overall Study|Other: Low compliance|0|||
150003093|NCT00289198|541145283|FG001|Overall Study|Other: Low compliance|1|||
150003094|NCT00289198|541145282|FG000|Overall Study|Other: Physician's decision|0|||
150003095|NCT00289198|541145283|FG001|Overall Study|Other: Physician's decision|1|||
150003096|NCT00289198|541145282|FG000|Overall Study|Other: Unable to attend on schedule|2|||
150003097|NCT00289198|541145283|FG001|Overall Study|Other: Unable to attend on schedule|1|||
150003098|NCT00289198|541145282|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
150003099|NCT00289198|541145283|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
150003100|NCT00289198|541145282|FG000|Overall Study|Other: Impossible to come on visit|0|||
150003101|NCT00289198|541145283|FG001|Overall Study|Other: Impossible to come on visit|1|||
150003102|NCT03369431|541145285|FG000|Overall Study|Lost to Follow-up|1|||
150003103|NCT03369431|541145286|FG001|Overall Study|Lost to Follow-up|3|||
150003104|NCT03369431|541145285|FG000|Overall Study|Withdrawal by Subject|2|||
150003105|NCT03369431|541145286|FG001|Overall Study|Withdrawal by Subject|3|||
150003106|NCT03369431|541145285|FG000|Overall Study|Protocol Violation|1|||
150003107|NCT03369431|541145286|FG001|Overall Study|Protocol Violation|1|||
150003108|NCT01062061|541145287|FG000|Overall Study|Enrolled more than once|2|||
150003109|NCT01062061|541145287|FG000|Overall Study|Investigated before study start|13|||
150003110|NCT01062061|541145287|FG000|Overall Study|Outside chief indications|10|||
150003111|NCT01062061|541145287|FG000|Overall Study|Failed to meet inclusion criteria|2|||
150003112|NCT00524589|541145288|FG000|Overall Study|Withdrawal by Subject|2|||
150003113|NCT00524589|541145288|FG000|Overall Study|Disease Progression|16|||
150003114|NCT00490776|541145289|FG000|Overall Study|Withdrawal by Subject|1|||
150003115|NCT00490776|541145289|FG000|Overall Study|Administrative Problems|1|||
150003116|NCT00490776|541145289|FG000|Overall Study|Death|1|||
150003117|NCT00490776|541145289|FG000|Overall Study|New Cancer Therapy|1|||
150003118|NCT00490776|541145289|FG000|Overall Study|Disease Progression|5|||
150003119|NCT00046930|541145290|FG000|Overall Study|Ineligible|12|||
150003120|NCT00046930|541145291|FG001|Overall Study|Ineligible|4|||
150003121|NCT01657760|541145292|FG000|Overall Study|Withdrawal by Subject|0|||
150003122|NCT01657760|541145293|FG001|Overall Study|Withdrawal by Subject|0|||
150003123|NCT01657760|541145294|FG002|Overall Study|Withdrawal by Subject|0|||
150003124|NCT01657760|541145295|FG003|Overall Study|Withdrawal by Subject|1|||
150003125|NCT01657760|541145292|FG000|Overall Study|Physician Decision|1|||
150003126|NCT01657760|541145293|FG001|Overall Study|Physician Decision|1|||
150003127|NCT01657760|541145294|FG002|Overall Study|Physician Decision|1|||
150003128|NCT01657760|541145295|FG003|Overall Study|Physician Decision|2|||
150003129|NCT01113580|541145302|FG000|Overall Study|Protocol Violation|1|||
150003130|NCT01113580|541145303|FG001|Overall Study|Protocol Violation|0|||
150003131|NCT01145053|541145306|FG000|Overall Study|Adverse Event|22|||
150003132|NCT01145053|541145306|FG000|Overall Study|Lost to Follow-up|28|||
150003133|NCT01145053|541145306|FG000|Overall Study|Withdrawal by Subject|25|||
150003134|NCT01145053|541145306|FG000|Overall Study|Other|18|||
150003135|NCT01146652|541145307|FG000|Overall Study|Adverse Event|506|||
150003136|NCT01146652|541145308|FG001|Overall Study|Adverse Event|15|||
150003137|NCT01146652|541145307|FG000|Overall Study|Lack of Efficacy|91|||
150003138|NCT01146652|541145308|FG001|Overall Study|Lack of Efficacy|7|||
150003139|NCT01146652|541145307|FG000|Overall Study|Poor compliance to protocol|38|||
150003140|NCT01146652|541145308|FG001|Overall Study|Poor compliance to protocol|1|||
150003141|NCT01146652|541145307|FG000|Overall Study|Other unspecified reasons|314|||
150003142|NCT01146652|541145308|FG001|Overall Study|Other unspecified reasons|22|||
150003143|NCT01146652|541145307|FG000|Overall Study|Enrolled but not treated|2|||
150003144|NCT01146652|541145308|FG001|Overall Study|Enrolled but not treated|0|||
150003145|NCT03294135|541145309|FG000|Overall Study|Serious Adverse Event|1|||
150003146|NCT03294135|541145310|FG001|Overall Study|Serious Adverse Event|0|||
150003147|NCT03294135|541145311|FG002|Overall Study|Serious Adverse Event|0|||
150003148|NCT03294135|541145309|FG000|Overall Study|Lost to Follow-up|1|||
150003149|NCT03294135|541145310|FG001|Overall Study|Lost to Follow-up|0|||
150003150|NCT03294135|541145311|FG002|Overall Study|Lost to Follow-up|1|||
150003151|NCT03294135|541145309|FG000|Overall Study|Withdrawal by Subject|0|||
150003152|NCT03294135|541145310|FG001|Overall Study|Withdrawal by Subject|0|||
150003153|NCT03294135|541145311|FG002|Overall Study|Withdrawal by Subject|1|||
150003154|NCT03294135|541145309|FG000|Overall Study|Other|2|||
150003155|NCT03294135|541145310|FG001|Overall Study|Other|0|||
150003156|NCT03294135|541145311|FG002|Overall Study|Other|0|||
150055224|NCT01340872|541344104|FG000|Double-blind Phase|Adverse Event|6|||
150055225|NCT01340872|541344105|FG001|Double-blind Phase|Adverse Event|4|||
150003157|NCT02763254|541145316|FG000|Overall Study|Adverse Event|1|||
150003158|NCT03684304|541145319|FG000|Overall Study|Lost to Follow-up|19|||
150003159|NCT03684304|541145320|FG001|Overall Study|Lost to Follow-up|17|||
150003160|NCT01146288|541145321|FG000|First Intervention(1 Day)|Adverse Event|0|||
150003161|NCT01146288|541145322|FG001|First Intervention(1 Day)|Adverse Event|1|||
150003162|NCT03532932|541145326|FG000|Overall Study|Protocol Deviation|33|||
150003163|NCT03532932|541145327|FG001|Overall Study|Protocol Deviation|31|||
150003164|NCT03532932|541145326|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
150003165|NCT03532932|541145327|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
150003166|NCT03532932|541145326|FG000|Overall Study|Withdrawal by Subject|2|||
150003167|NCT03532932|541145327|FG001|Overall Study|Withdrawal by Subject|0|||
150003168|NCT03532932|541145326|FG000|Overall Study|Lost to Follow-up|15|||
150003169|NCT03532932|541145327|FG001|Overall Study|Lost to Follow-up|9|||
150003170|NCT03532932|541145326|FG000|Overall Study|Adverse Event|4|||
150003171|NCT03532932|541145327|FG001|Overall Study|Adverse Event|3|||
150003172|NCT03532932|541145326|FG000|Overall Study|Death|0|||
150003173|NCT03532932|541145327|FG001|Overall Study|Death|2|||
150003174|NCT03532932|541145326|FG000|Overall Study|Other|11|||
150003175|NCT03532932|541145327|FG001|Overall Study|Other|16|||
150003176|NCT02255565|541145328|FG000|Overall Study|Withdrawal by Subject|0|||
150003177|NCT02255565|541145329|FG001|Overall Study|Withdrawal by Subject|1|||
150003178|NCT02255565|541145330|FG002|Overall Study|Withdrawal by Subject|0|||
150003179|NCT00931801|541145331|FG000|Overall Study|Adverse Event|0|||
150003180|NCT00931801|541145332|FG001|Overall Study|Adverse Event|0|||
150003181|NCT00931801|541145333|FG002|Overall Study|Adverse Event|1|||
150003182|NCT00931801|541145331|FG000|Overall Study|Lost to Follow-up|0|||
150003183|NCT00931801|541145332|FG001|Overall Study|Lost to Follow-up|1|||
150003184|NCT00931801|541145333|FG002|Overall Study|Lost to Follow-up|0|||
150003185|NCT00931801|541145331|FG000|Overall Study|Withdrawal by Subject|1|||
150003186|NCT00931801|541145332|FG001|Overall Study|Withdrawal by Subject|0|||
150003187|NCT00931801|541145333|FG002|Overall Study|Withdrawal by Subject|0|||
150003188|NCT00931801|541145331|FG000|Overall Study|Confirmed Virologic Failure|0|||
150003189|NCT00931801|541145332|FG001|Overall Study|Confirmed Virologic Failure|0|||
150003190|NCT00931801|541145333|FG002|Overall Study|Confirmed Virologic Failure|3|||
150003191|NCT01174004|541145334|FG000|Overall Study|Adverse Event|2|||
150003192|NCT01174004|541145335|FG001|Overall Study|Adverse Event|10|||
150003193|NCT01174004|541145334|FG000|Overall Study|Withdrawal by Subject|2|||
150003194|NCT01174004|541145335|FG001|Overall Study|Withdrawal by Subject|3|||
150003195|NCT01174004|541145334|FG000|Overall Study|At Discretion of Sponsor|2|||
150003196|NCT01174004|541145335|FG001|Overall Study|At Discretion of Sponsor|2|||
150003197|NCT01174004|541145334|FG000|Overall Study|Protocol Violation|0|||
150003198|NCT01174004|541145335|FG001|Overall Study|Protocol Violation|1|||
150003199|NCT01174004|541145334|FG000|Overall Study|Physician Decision|1|||
150003200|NCT01174004|541145335|FG001|Overall Study|Physician Decision|0|||
150003201|NCT00933244|541145336|FG000|Overall Study|Withdrawal by Subject|5|||
150003202|NCT00933244|541145337|FG001|Overall Study|Withdrawal by Subject|1|||
150003203|NCT00933244|541145338|FG002|Overall Study|Withdrawal by Subject|3|||
150003204|NCT02956850|541145341|FG000|Overall Study|Withdrawal by Subject|0|||
150003205|NCT02956850|541145342|FG001|Overall Study|Withdrawal by Subject|0|||
150003206|NCT02956850|541145343|FG002|Overall Study|Withdrawal by Subject|0|||
150003207|NCT02956850|541145344|FG003|Overall Study|Withdrawal by Subject|0|||
150003208|NCT02956850|541145345|FG004|Overall Study|Withdrawal by Subject|0|||
150003209|NCT02956850|541145346|FG005|Overall Study|Withdrawal by Subject|0|||
150003210|NCT02956850|541145347|FG006|Overall Study|Withdrawal by Subject|0|||
150003211|NCT02956850|541145348|FG007|Overall Study|Withdrawal by Subject|0|||
150003212|NCT02956850|541145349|FG008|Overall Study|Withdrawal by Subject|0|||
150003213|NCT02956850|541145350|FG009|Overall Study|Withdrawal by Subject|0|||
150003214|NCT02956850|541145351|FG010|Overall Study|Withdrawal by Subject|0|||
150003215|NCT02956850|541145352|FG011|Overall Study|Withdrawal by Subject|0|||
150003216|NCT02956850|541145353|FG012|Overall Study|Withdrawal by Subject|0|||
150003217|NCT02956850|541145354|FG013|Overall Study|Withdrawal by Subject|0|||
150055226|NCT01340872|541344106|FG002|Double-blind Phase|Adverse Event|0|||
150055227|NCT01340872|541344107|FG003|Double-blind Phase|Adverse Event|0|||
150055228|NCT01340872|541344104|FG000|Double-blind Phase|Withdrawal by Subject|3|||
150003218|NCT02956850|541145355|FG014|Overall Study|Withdrawal by Subject|0|||
150055229|NCT01340872|541344105|FG001|Double-blind Phase|Withdrawal by Subject|5|||
150003219|NCT02956850|541145356|FG015|Overall Study|Withdrawal by Subject|0|||
150003220|NCT02956850|541145357|FG016|Overall Study|Withdrawal by Subject|0|||
150003221|NCT02956850|541145358|FG017|Overall Study|Withdrawal by Subject|1|||
150003222|NCT01920152|541145359|FG000|Overall Study|Withdrawal by Subject|1|||
150003223|NCT01920152|541145360|FG001|Overall Study|Withdrawal by Subject|2|||
150003224|NCT00886119|541145366|FG000|Period 1|Did not meet inclusion criteria|1|||
150003225|NCT00886119|541145367|FG001|Period 1|Did not meet inclusion criteria|0|||
150003226|NCT00394901|541145368|FG000|Baseline Phase|Protocol Violation|0|||
150003227|NCT00394901|541145369|FG001|Baseline Phase|Protocol Violation|0|||
150003228|NCT00394901|541145370|FG002|Baseline Phase|Protocol Violation|1|||
150003229|NCT00394901|541145371|FG003|Baseline Phase|Protocol Violation|0|||
150003230|NCT00394901|541145368|FG000|Double-blind Phase|Adverse Event|5|||
150003231|NCT00394901|541145369|FG001|Double-blind Phase|Adverse Event|7|||
150003232|NCT00394901|541145370|FG002|Double-blind Phase|Adverse Event|16|||
150003233|NCT00394901|541145371|FG003|Double-blind Phase|Adverse Event|20|||
150003234|NCT00394901|541145368|FG000|Double-blind Phase|Lack of Efficacy|6|||
150003235|NCT00394901|541145369|FG001|Double-blind Phase|Lack of Efficacy|4|||
150003236|NCT00394901|541145370|FG002|Double-blind Phase|Lack of Efficacy|1|||
150003237|NCT00394901|541145371|FG003|Double-blind Phase|Lack of Efficacy|3|||
150003238|NCT00394901|541145368|FG000|Double-blind Phase|Withdrawal by Subject|2|||
150003239|NCT00394901|541145369|FG001|Double-blind Phase|Withdrawal by Subject|0|||
150003240|NCT00394901|541145370|FG002|Double-blind Phase|Withdrawal by Subject|0|||
150003241|NCT00394901|541145371|FG003|Double-blind Phase|Withdrawal by Subject|0|||
150003242|NCT00394901|541145368|FG000|Double-blind Phase|Lost to Follow-up|0|||
150003243|NCT00394901|541145369|FG001|Double-blind Phase|Lost to Follow-up|0|||
150003244|NCT00394901|541145370|FG002|Double-blind Phase|Lost to Follow-up|0|||
150003245|NCT00394901|541145371|FG003|Double-blind Phase|Lost to Follow-up|1|||
150003246|NCT00394901|541145368|FG000|Double-blind Phase|Protocol Violation|0|||
150003247|NCT00394901|541145369|FG001|Double-blind Phase|Protocol Violation|0|||
150003248|NCT00394901|541145370|FG002|Double-blind Phase|Protocol Violation|0|||
150003249|NCT00394901|541145371|FG003|Double-blind Phase|Protocol Violation|1|||
150003250|NCT00394901|541145368|FG000|Double-blind Phase|Death|1|||
150003251|NCT00394901|541145369|FG001|Double-blind Phase|Death|0|||
150003252|NCT00394901|541145370|FG002|Double-blind Phase|Death|0|||
150003253|NCT00394901|541145371|FG003|Double-blind Phase|Death|0|||
150003254|NCT00394901|541145368|FG000|Double-blind Phase|Subject's Personal Reason|1|||
150003255|NCT00394901|541145369|FG001|Double-blind Phase|Subject's Personal Reason|0|||
150003256|NCT00394901|541145370|FG002|Double-blind Phase|Subject's Personal Reason|0|||
150003257|NCT00394901|541145371|FG003|Double-blind Phase|Subject's Personal Reason|1|||
150003258|NCT00394901|541145368|FG000|Double-blind Phase|Lack of Compliance|0|||
150003259|NCT00394901|541145369|FG001|Double-blind Phase|Lack of Compliance|3|||
150003260|NCT00394901|541145370|FG002|Double-blind Phase|Lack of Compliance|0|||
150003261|NCT00394901|541145371|FG003|Double-blind Phase|Lack of Compliance|0|||
150003262|NCT00394901|541145368|FG000|Double-blind Phase|Entry into another study was found|0|||
150003263|NCT00394901|541145369|FG001|Double-blind Phase|Entry into another study was found|0|||
150003264|NCT00394901|541145370|FG002|Double-blind Phase|Entry into another study was found|1|||
150003265|NCT00394901|541145371|FG003|Double-blind Phase|Entry into another study was found|0|||
150003266|NCT00394901|541145368|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
150003267|NCT00394901|541145369|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
150003268|NCT00394901|541145370|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
150003269|NCT00394901|541145371|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
150003270|NCT03002623|541145372|FG000|Overall Study|Lost to Follow-up|1|||
150003271|NCT03002623|541145373|FG001|Overall Study|Lost to Follow-up|0|||
150003272|NCT03002623|541145372|FG000|Overall Study|Physician Decision|1|||
150003273|NCT03002623|541145373|FG001|Overall Study|Physician Decision|1|||
150003274|NCT02256267|541145374|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
150003275|NCT02256267|541145374|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
150003276|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
150003277|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
150003278|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
150003279|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
150003280|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
150003281|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
150003282|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
150003283|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
150003284|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
150003285|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
150003286|NCT01352741|541145378|FG000|Open-label Tapentadol Titration Period|Other|4|||
150003287|NCT01352741|541145379|FG001|Open-label Tapentadol Titration Period|Other|0|||
150003288|NCT01352741|541145378|FG000|Double-blind Comparative Period|Protocol Violation|2|||
150003289|NCT01352741|541145379|FG001|Double-blind Comparative Period|Protocol Violation|0|||
150055230|NCT01340872|541344106|FG002|Double-blind Phase|Withdrawal by Subject|0|||
150003290|NCT01352741|541145378|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
150003291|NCT01352741|541145379|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
150003292|NCT01352741|541145378|FG000|Double-blind Comparative Period|Adverse Event|16|||
150003293|NCT01352741|541145379|FG001|Double-blind Comparative Period|Adverse Event|17|||
150003294|NCT01352741|541145378|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
150003295|NCT01352741|541145379|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
150003296|NCT01352741|541145378|FG000|Double-blind Comparative Period|Death|0|||
150003297|NCT01352741|541145379|FG001|Double-blind Comparative Period|Death|1|||
150003298|NCT01352741|541145378|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
150055231|NCT01340872|541344107|FG003|Double-blind Phase|Withdrawal by Subject|0|||
150003299|NCT01352741|541145379|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
150003300|NCT01352741|541145378|FG000|Double-blind Comparative Period|Other|1|||
150003301|NCT01352741|541145379|FG001|Double-blind Comparative Period|Other|2|||
150003302|NCT01352741|541145378|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
150003303|NCT01352741|541145379|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
150003304|NCT01352741|541145378|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
150003305|NCT01352741|541145379|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
150003306|NCT01352741|541145378|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
150003307|NCT01352741|541145379|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
150003308|NCT01352741|541145378|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
150003309|NCT01352741|541145379|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
150003310|NCT00259298|541145380|FG000|Overall Study|Withdrawal by Subject|1|||
150003311|NCT00259298|541145380|FG000|Overall Study|Physician Decision|2|||
150003312|NCT00645528|541145381|FG000|Overall Study|Did not show up for Visit 2|7|||
150003313|NCT03131596|541146758|FG000|Overall Study|Protocol Violation|3|||
150003314|NCT03131596|541146759|FG001|Overall Study|Protocol Violation|3|||
150003315|NCT03131596|541146758|FG000|Overall Study|Lost to Follow-up|3|||
150003316|NCT03131596|541146759|FG001|Overall Study|Lost to Follow-up|0|||
150003317|NCT00004445|541146767|FG000|Overall Study|Physician Decision|2|||
150003318|NCT00004445|541146767|FG000|Overall Study|Withdrawal by Subject|1|||
150003319|NCT02753127|541146768|FG000|Overall Study|Lost to Follow-up|13|||
150003320|NCT02753127|541146769|FG001|Overall Study|Lost to Follow-up|11|||
150003321|NCT02753127|541146768|FG000|Overall Study|Withdrawal by Subject|37|||
150003322|NCT02753127|541146769|FG001|Overall Study|Withdrawal by Subject|47|||
150003323|NCT02753127|541146768|FG000|Overall Study|Other|3|||
150003324|NCT02753127|541146769|FG001|Overall Study|Other|8|||
150003325|NCT02753127|541146768|FG000|Overall Study|Hospice|0|||
150003326|NCT02753127|541146769|FG001|Overall Study|Hospice|2|||
150003327|NCT00940485|541146770|FG000|Overall Study|HBeAb positive at Baseline|3|||
150003328|NCT00940485|541146771|FG001|Overall Study|HBeAb positive at Baseline|2|||
150003329|NCT00940485|541146770|FG000|Overall Study|Lost to Follow-up|2|||
150003330|NCT00940485|541146771|FG001|Overall Study|Lost to Follow-up|3|||
150003331|NCT00940485|541146770|FG000|Overall Study|Adverse Event|8|||
150003332|NCT00940485|541146771|FG001|Overall Study|Adverse Event|0|||
150003333|NCT00940485|541146770|FG000|Overall Study|Withdrawal by Subject|1|||
150003334|NCT00940485|541146771|FG001|Overall Study|Withdrawal by Subject|1|||
150003335|NCT00940485|541146770|FG000|Overall Study|Others|1|||
150003336|NCT00940485|541146771|FG001|Overall Study|Others|1|||
150003337|NCT02936284|541146772|FG000|Overall Study|Withdrawal by Subject|3|||
150003338|NCT02936284|541146773|FG001|Overall Study|Withdrawal by Subject|1|||
150003339|NCT02936284|541146772|FG000|Overall Study|Lost to Follow-up|7|||
150003340|NCT02936284|541146773|FG001|Overall Study|Lost to Follow-up|8|||
150003341|NCT04912895|541146774|FG000|Overall Study|Unable to provide specimen|2|||
150003342|NCT04912895|541146775|FG001|Overall Study|Unable to provide specimen|0|||
150003343|NCT04912895|541146776|FG002|Overall Study|Unable to provide specimen|0|||
150003344|NCT02088073|541146781|FG000|Acute Phase|Withdrawal by Subject|5|||
150003345|NCT02088073|541146782|FG001|Acute Phase|Withdrawal by Subject|0|||
150003346|NCT02088073|541146783|FG002|Acute Phase|Withdrawal by Subject|0|||
150003347|NCT02088073|541146784|FG003|Acute Phase|Withdrawal by Subject|0|||
150003348|NCT02088073|541146785|FG004|Acute Phase|Withdrawal by Subject|0|||
150003349|NCT02088073|541146781|FG000|Acute Phase|Hyperkalemia|2|||
150003350|NCT02088073|541146782|FG001|Acute Phase|Hyperkalemia|0|||
150003351|NCT02088073|541146783|FG002|Acute Phase|Hyperkalemia|0|||
150003352|NCT02088073|541146784|FG003|Acute Phase|Hyperkalemia|0|||
150003353|NCT02088073|541146785|FG004|Acute Phase|Hyperkalemia|0|||
150003354|NCT02088073|541146781|FG000|Maintanance Phase|Withdrawal by Subject|0|||
150003355|NCT02088073|541146782|FG001|Maintanance Phase|Withdrawal by Subject|2|||
150003356|NCT02088073|541146783|FG002|Maintanance Phase|Withdrawal by Subject|0|||
150003357|NCT02088073|541146784|FG003|Maintanance Phase|Withdrawal by Subject|0|||
150003358|NCT02088073|541146785|FG004|Maintanance Phase|Withdrawal by Subject|0|||
150003359|NCT02088073|541146781|FG000|Maintanance Phase|Adverse Event|0|||
150003360|NCT02088073|541146782|FG001|Maintanance Phase|Adverse Event|0|||
150003361|NCT02088073|541146783|FG002|Maintanance Phase|Adverse Event|3|||
150003362|NCT02088073|541146784|FG003|Maintanance Phase|Adverse Event|0|||
150003363|NCT02088073|541146785|FG004|Maintanance Phase|Adverse Event|1|||
150003364|NCT02088073|541146781|FG000|Maintanance Phase|Physician Decision|0|||
150003365|NCT02088073|541146782|FG001|Maintanance Phase|Physician Decision|0|||
150003366|NCT02088073|541146783|FG002|Maintanance Phase|Physician Decision|0|||
150003367|NCT02088073|541146784|FG003|Maintanance Phase|Physician Decision|0|||
150003368|NCT02088073|541146785|FG004|Maintanance Phase|Physician Decision|1|||
150003369|NCT02088073|541146781|FG000|Maintanance Phase|Sponsor's decision|0|||
150003370|NCT02088073|541146782|FG001|Maintanance Phase|Sponsor's decision|2|||
150003371|NCT02088073|541146783|FG002|Maintanance Phase|Sponsor's decision|0|||
150003372|NCT02088073|541146784|FG003|Maintanance Phase|Sponsor's decision|2|||
150003373|NCT02088073|541146785|FG004|Maintanance Phase|Sponsor's decision|1|||
150003374|NCT02088073|541146781|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
150003375|NCT02088073|541146782|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
150003376|NCT02088073|541146783|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
150003377|NCT02088073|541146784|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
150003378|NCT02088073|541146785|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
150003379|NCT02088073|541146781|FG000|Maintanance Phase|Miscellaneous|0|||
150003380|NCT02088073|541146782|FG001|Maintanance Phase|Miscellaneous|2|||
150003381|NCT02088073|541146783|FG002|Maintanance Phase|Miscellaneous|1|||
150003382|NCT02088073|541146784|FG003|Maintanance Phase|Miscellaneous|2|||
150003383|NCT02088073|541146785|FG004|Maintanance Phase|Miscellaneous|1|||
150003384|NCT02088073|541146781|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
150003385|NCT02088073|541146782|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
150003386|NCT02088073|541146783|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
150003387|NCT02088073|541146784|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
150003388|NCT02088073|541146785|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
150003389|NCT02088073|541146781|FG000|Maintanance Phase|Subject compliance|0|||
150003390|NCT02088073|541146782|FG001|Maintanance Phase|Subject compliance|1|||
150003391|NCT02088073|541146783|FG002|Maintanance Phase|Subject compliance|0|||
150003392|NCT02088073|541146784|FG003|Maintanance Phase|Subject compliance|0|||
150003393|NCT02088073|541146785|FG004|Maintanance Phase|Subject compliance|0|||
150003394|NCT02785458|541146786|FG000|1 Month|Withdrawal by Subject|2|||
150003395|NCT02785458|541146787|FG001|1 Month|Withdrawal by Subject|1|||
150003396|NCT02785458|541146786|FG000|1 Month|Lost to Follow-up|38|||
150003397|NCT02785458|541146787|FG001|1 Month|Lost to Follow-up|31|||
150003398|NCT02785458|541146786|FG000|1 Month|Deemed Ineligible|1|||
150003399|NCT02785458|541146787|FG001|1 Month|Deemed Ineligible|0|||
150003400|NCT02785458|541146786|FG000|1 Month|Completed Evaluation by Baseline|42|||
150003401|NCT02785458|541146787|FG001|1 Month|Completed Evaluation by Baseline|39|||
150003402|NCT02785458|541146786|FG000|1 Month|Partial Interview|0|||
150003403|NCT02785458|541146787|FG001|1 Month|Partial Interview|4|||
150003404|NCT02785458|541146786|FG000|3 Months|Withdrawal by Subject|3|||
150003405|NCT02785458|541146787|FG001|3 Months|Withdrawal by Subject|1|||
150003406|NCT02785458|541146786|FG000|3 Months|Lost to Follow-up|25|||
150003407|NCT02785458|541146787|FG001|3 Months|Lost to Follow-up|21|||
150003408|NCT02785458|541146786|FG000|3 Months|Completed Evaluation at 1 Month|100|||
150003409|NCT02785458|541146787|FG001|3 Months|Completed Evaluation at 1 Month|89|||
150003410|NCT02981524|541146789|FG000|Overall Study|Progressive Disease|14|||
150003411|NCT02981524|541146789|FG000|Overall Study|Death (unrelated)|1|||
150003412|NCT02981524|541146789|FG000|Overall Study|Treatment Related Toxicity|1|||
150003413|NCT02981524|541146789|FG000|Overall Study|Withdrawal by Subject|1|||
150003414|NCT00520013|541146790|FG000|Overall Study|Withdrawal by Subject|0|||
150003415|NCT00520013|541146791|FG001|Overall Study|Withdrawal by Subject|0|||
150003416|NCT00520013|541146792|FG002|Overall Study|Withdrawal by Subject|1|||
150003417|NCT00520013|541146790|FG000|Overall Study|Adverse Event|2|||
150003418|NCT00520013|541146791|FG001|Overall Study|Adverse Event|10|||
150003419|NCT00520013|541146792|FG002|Overall Study|Adverse Event|7|||
150003420|NCT00520013|541146790|FG000|Overall Study|Progressive Disease|7|||
150003421|NCT00520013|541146791|FG001|Overall Study|Progressive Disease|3|||
150003422|NCT00520013|541146792|FG002|Overall Study|Progressive Disease|0|||
150003423|NCT00520013|541146790|FG000|Overall Study|Clinical Progression|3|||
150003424|NCT00520013|541146791|FG001|Overall Study|Clinical Progression|1|||
150003425|NCT00520013|541146792|FG002|Overall Study|Clinical Progression|0|||
150003426|NCT00520013|541146790|FG000|Overall Study|Death|0|||
150003427|NCT00520013|541146791|FG001|Overall Study|Death|1|||
150003428|NCT00520013|541146792|FG002|Overall Study|Death|0|||
150003429|NCT00520013|541146790|FG000|Overall Study|Physician Decision|0|||
150003430|NCT00520013|541146791|FG001|Overall Study|Physician Decision|0|||
150003431|NCT00520013|541146792|FG002|Overall Study|Physician Decision|3|||
150003432|NCT02118597|541146793|FG000|Overall Study|Sponsor terminated the study|14|||
150003433|NCT02118597|541146793|FG000|Overall Study|Serious Adverse Event|1|||
150003434|NCT02118597|541146793|FG000|Overall Study|Investigator's decision|1|||
150003435|NCT02590562|541146795|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
150003436|NCT00824005|541146796|FG000|Overall Study|Death|0|||
150003437|NCT00824005|541146797|FG001|Overall Study|Death|1|||
150003438|NCT00824005|541146796|FG000|Overall Study|Lost to Follow-up|0|||
150003439|NCT00824005|541146797|FG001|Overall Study|Lost to Follow-up|1|||
150003440|NCT02677844|541146798|FG000|Period 3|Withdrawal by Subject|0|||
150003441|NCT02677844|541146799|FG001|Period 3|Withdrawal by Subject|0|||
150003442|NCT02677844|541146800|FG002|Period 3|Withdrawal by Subject|0|||
150003443|NCT02677844|541146801|FG003|Period 3|Withdrawal by Subject|1|||
150003444|NCT02677844|541146802|FG004|Period 3|Withdrawal by Subject|0|||
150003445|NCT02677844|541146803|FG005|Period 3|Withdrawal by Subject|0|||
150003446|NCT02677844|541146804|FG006|Period 3|Withdrawal by Subject|0|||
150003447|NCT03458702|541146805|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
150003448|NCT03458702|541146806|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
150003449|NCT03458702|541146805|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
150003450|NCT03458702|541146806|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
150003451|NCT01697462|541146807|FG000|Overall Study|Disease Progression|1|||
150003452|NCT01697462|541146807|FG000|Overall Study|Adverse Event|6|||
150003453|NCT01697462|541146807|FG000|Overall Study|Lost to Follow-up|21|||
150003454|NCT01697462|541146807|FG000|Overall Study|Withdrawal by Subject|12|||
150003455|NCT01697462|541146807|FG000|Overall Study|Investigator Decision|21|||
150003456|NCT01697462|541146807|FG000|Overall Study|Death|1|||
150003457|NCT01697462|541146807|FG000|Overall Study|Other|10|||
150003458|NCT01697462|541146807|FG000|Overall Study|Missing|5|||
150003459|NCT00168103|541146808|FG000|Overall Study|Withdrawal by Subject|1|||
150003460|NCT00168103|541146809|FG001|Overall Study|Withdrawal by Subject|2|||
150003461|NCT00168103|541146810|FG002|Overall Study|Withdrawal by Subject|1|||
150003462|NCT00168103|541146811|FG003|Overall Study|Withdrawal by Subject|0|||
150003463|NCT00168103|541146808|FG000|Overall Study|Lost to Follow-up|1|||
150003464|NCT00168103|541146809|FG001|Overall Study|Lost to Follow-up|3|||
150003465|NCT00168103|541146810|FG002|Overall Study|Lost to Follow-up|0|||
150003466|NCT00168103|541146811|FG003|Overall Study|Lost to Follow-up|0|||
150003467|NCT00545532|541146812|FG000|Overall Study|Withdrawal by Subject|1|||
150003468|NCT00545532|541146813|FG001|Overall Study|Withdrawal by Subject|3|||
150003469|NCT00545532|541146812|FG000|Overall Study|Lost to Follow-up|5|||
150003470|NCT00545532|541146813|FG001|Overall Study|Lost to Follow-up|6|||
150003471|NCT00545532|541146812|FG000|Overall Study|Death|0|||
150003472|NCT00545532|541146813|FG001|Overall Study|Death|1|||
150003473|NCT03630302|541146814|FG000|Surgery|hardware issue prevented LFP recordings|1|||
150003474|NCT03630302|541146814|FG000|3 Month Visit|Adverse Event|2|||
150003475|NCT03630302|541146814|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
150003476|NCT01133275|541146816|FG000|Overall Study|Withdrawal by Subject|1|||
150003477|NCT01133275|541146816|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
150003478|NCT01143896|541146817|FG000|Overall Study|Did not complete Baseline Interview|5|||
150003479|NCT01143896|541146818|FG001|Overall Study|Did not complete Baseline Interview|4|||
150003480|NCT01143896|541146817|FG000|Overall Study|Lost to Follow-up|18|||
150003481|NCT01143896|541146818|FG001|Overall Study|Lost to Follow-up|13|||
150003482|NCT01143896|541146817|FG000|Overall Study|Withdrawal by Subject|13|||
150003483|NCT01143896|541146818|FG001|Overall Study|Withdrawal by Subject|5|||
150003484|NCT01143896|541146817|FG000|Overall Study|Death|6|||
150003485|NCT01143896|541146818|FG001|Overall Study|Death|3|||
150003486|NCT01318070|541146819|FG000|Overall Study|Adverse Event|1|||
150003487|NCT01318070|541146820|FG001|Overall Study|Adverse Event|1|||
150003488|NCT01318070|541146821|FG002|Overall Study|Adverse Event|5|||
150003489|NCT01318070|541146819|FG000|Overall Study|Withdrawal by Subject|0|||
150003490|NCT01318070|541146820|FG001|Overall Study|Withdrawal by Subject|1|||
150003491|NCT01318070|541146821|FG002|Overall Study|Withdrawal by Subject|1|||
150003492|NCT01318070|541146819|FG000|Overall Study|Lack of Efficacy|0|||
150003493|NCT01318070|541146820|FG001|Overall Study|Lack of Efficacy|0|||
150003494|NCT01318070|541146821|FG002|Overall Study|Lack of Efficacy|1|||
150003495|NCT01318070|541146819|FG000|Overall Study|Principal Investigator Discretion|1|||
150003496|NCT01318070|541146820|FG001|Overall Study|Principal Investigator Discretion|0|||
150003497|NCT01318070|541146821|FG002|Overall Study|Principal Investigator Discretion|0|||
150003498|NCT04375397|541146824|FG000|Overall Study|Death|1|||
150003499|NCT04375397|541146825|FG001|Overall Study|Death|1|||
150003500|NCT04375397|541146824|FG000|Overall Study|Withdrew consent|2|||
150003501|NCT04375397|541146825|FG001|Overall Study|Withdrew consent|0|||
150003502|NCT04375397|541146824|FG000|Overall Study|Lost to Follow-up|6|||
150003503|NCT04375397|541146825|FG001|Overall Study|Lost to Follow-up|4|||
150003504|NCT04375397|541146824|FG000|Overall Study|Other, not specified|0|||
150003505|NCT04375397|541146825|FG001|Overall Study|Other, not specified|1|||
150003506|NCT05545644|541146827|FG000|Overall Study|Lost to Follow-up|4|||
150003507|NCT05545644|541146828|FG001|Overall Study|Lost to Follow-up|3|||
150003508|NCT00610441|541146829|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
150003509|NCT00610441|541146830|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
150003510|NCT00610441|541146831|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
150003511|NCT00610441|541146832|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
150003512|NCT00610441|541146829|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
150003513|NCT00610441|541146830|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
150003514|NCT00610441|541146831|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
150003515|NCT00610441|541146832|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
150003516|NCT00610441|541146829|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
150003517|NCT00610441|541146830|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
150055232|NCT01340872|541344104|FG000|Double-blind Phase|Lost to Follow-up|0|||
150003518|NCT00610441|541146831|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
150003519|NCT00610441|541146832|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
150003520|NCT00610441|541146829|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
150003521|NCT00610441|541146830|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
150003522|NCT00610441|541146831|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
150003523|NCT00610441|541146832|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
150003524|NCT00610441|541146829|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
150003525|NCT00610441|541146830|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
150003526|NCT00610441|541146831|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
150003527|NCT00610441|541146832|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
150003528|NCT00610441|541146829|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
150003529|NCT00610441|541146830|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
150003530|NCT00610441|541146831|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
150003531|NCT00610441|541146832|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
150003532|NCT00610441|541146829|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
150003533|NCT00610441|541146830|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
150003534|NCT00610441|541146831|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
150003535|NCT00610441|541146832|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
150003536|NCT00610441|541146829|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
150003537|NCT00610441|541146830|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
150003538|NCT00610441|541146831|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
150003539|NCT00610441|541146832|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
150003540|NCT00610441|541146829|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
150003541|NCT00610441|541146830|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
150003542|NCT00610441|541146831|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
150003543|NCT00610441|541146832|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
150003544|NCT00334282|541146836|FG000|Overall Study|Lost to Follow-up|11|||
150003545|NCT00334282|541146837|FG001|Overall Study|Lost to Follow-up|5|||
150003546|NCT00334282|541146836|FG000|Overall Study|Withdrawal by Subject|17|||
150003547|NCT00334282|541146837|FG001|Overall Study|Withdrawal by Subject|3|||
150003548|NCT00334282|541146836|FG000|Overall Study|Death|194|||
150003549|NCT00334282|541146837|FG001|Overall Study|Death|100|||
150003550|NCT04957758|541146845|FG000|Overall Study|Adverse Event|1|||
150003551|NCT04957758|541146846|FG001|Overall Study|Adverse Event|0|||
150003552|NCT04957758|541146845|FG000|Overall Study|Lost to Follow-up|0|||
150003553|NCT04957758|541146846|FG001|Overall Study|Lost to Follow-up|2|||
150003554|NCT04957758|541146845|FG000|Overall Study|Withdrawal by Subject|4|||
150003555|NCT04957758|541146846|FG001|Overall Study|Withdrawal by Subject|2|||
150003556|NCT04957758|541146845|FG000|Overall Study|Protocol Violation|0|||
150003557|NCT04957758|541146846|FG001|Overall Study|Protocol Violation|1|||
150003558|NCT01685983|541146847|FG000|Overall Study|Adverse Event|7|||
150003559|NCT01685983|541146847|FG000|Overall Study|Death|1|||
150003560|NCT01685983|541146847|FG000|Overall Study|Withdrawal by Subject|19|||
150003561|NCT01685983|541146847|FG000|Overall Study|Protocol Violation|2|||
150003562|NCT01685983|541146847|FG000|Overall Study|Physician Decision|13|||
150003563|NCT01685983|541146847|FG000|Overall Study|Other|7|||
150003564|NCT01685983|541146847|FG000|Overall Study|Progressive Disease|32|||
150003565|NCT01685983|541146847|FG000|Overall Study|Noncompliance with Study Drug|1|||
150003566|NCT01167907|541146854|FG000|Overall Study|Protocol Violation|1|||
150003567|NCT01167907|541146855|FG001|Overall Study|Protocol Violation|0|||
150003568|NCT01167907|541146854|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
150003569|NCT01167907|541146855|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
150003570|NCT01886690|541146858|FG000|Overall Study|Protocol Violation|0|||
150003571|NCT01886690|541146859|FG001|Overall Study|Protocol Violation|1|||
150003572|NCT01886690|541146858|FG000|Overall Study|Personal Reasons|0|||
150003573|NCT01886690|541146859|FG001|Overall Study|Personal Reasons|1|||
150003574|NCT03077698|541146862|FG000|Progestin Monotherapy|Stable Disease|8|||
150003575|NCT03077698|541146863|FG001|Progestin Monotherapy|Stable Disease|0|||
150003576|NCT03077698|541146862|FG000|Progestin Monotherapy|Adverse Event|1|||
150003577|NCT03077698|541146863|FG001|Progestin Monotherapy|Adverse Event|0|||
150003578|NCT03077698|541146862|FG000|Progestin Monotherapy|Death|1|||
150003579|NCT03077698|541146863|FG001|Progestin Monotherapy|Death|0|||
150003580|NCT03077698|541146862|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
150003581|NCT03077698|541146863|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
150003582|NCT03077698|541146862|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
150003583|NCT03077698|541146863|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
150003584|NCT03077698|541146862|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
150003585|NCT03077698|541146863|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
150003586|NCT03077698|541146862|FG000|Safety Follow Up|Withdrawal by Subject|2|||
150003587|NCT03077698|541146863|FG001|Safety Follow Up|Withdrawal by Subject|1|||
150003588|NCT03077698|541146862|FG000|Safety Follow Up|Transfer of care to hospice|1|||
150003589|NCT03077698|541146863|FG001|Safety Follow Up|Transfer of care to hospice|0|||
150003590|NCT03461406|541146864|FG000|Overall Study|Death|1|||
150003591|NCT03461406|541146865|FG001|Overall Study|Death|2|||
150003592|NCT03461406|541146864|FG000|Overall Study|Consent Withdrawn by Participant|0|||
150003593|NCT03461406|541146865|FG001|Overall Study|Consent Withdrawn by Participant|1|||
150003594|NCT03461406|541146864|FG000|Overall Study|Screen Failure|3|||
150003595|NCT03461406|541146865|FG001|Overall Study|Screen Failure|1|||
150003596|NCT03461406|541146864|FG000|Overall Study|Reason not Specified|1|||
150003597|NCT03461406|541146865|FG001|Overall Study|Reason not Specified|3|||
150003598|NCT03461406|541146864|FG000|Overall Study|Lost to Follow-up|3|||
150003599|NCT03461406|541146865|FG001|Overall Study|Lost to Follow-up|0|||
150003600|NCT01140568|541146866|FG000|Overall Study|disease progression|31|||
150003601|NCT01140568|541146866|FG000|Overall Study|Withdrawal by Subject|1|||
150003602|NCT01140568|541146866|FG000|Overall Study|Screen Fail|4|||
150003603|NCT03618628|541146867|FG000|Overall Study|Death|1|||
150003604|NCT03618628|541146867|FG000|Overall Study|Lost to Follow-up|1|||
150003605|NCT01969500|541146868|FG000|Overall Study|Death|0|||
150003606|NCT01969500|541146869|FG001|Overall Study|Death|1|||
150003607|NCT01969500|541146868|FG000|Overall Study|extended hospitalization|1|||
150003608|NCT01969500|541146869|FG001|Overall Study|extended hospitalization|1|||
150003609|NCT01873729|541146873|FG000|Overall Study|Withdrawal by Subject|1|||
150003610|NCT02463032|541146874|FG000|Overall Study|Lack of Efficacy|61|||
150003611|NCT02463032|541146875|FG001|Overall Study|Lack of Efficacy|50|||
150003612|NCT02463032|541146874|FG000|Overall Study|Death|8|||
150003613|NCT02463032|541146875|FG001|Overall Study|Death|8|||
150003614|NCT02463032|541146874|FG000|Overall Study|Adverse Event|2|||
150003615|NCT02463032|541146875|FG001|Overall Study|Adverse Event|6|||
150003616|NCT01741532|541146876|FG000|Overall Study|Adverse Event|4|||
150003617|NCT01741532|541146877|FG001|Overall Study|Adverse Event|0|||
150003618|NCT01741532|541146876|FG000|Overall Study|Withdrawal by Subject|1|||
150003619|NCT01741532|541146877|FG001|Overall Study|Withdrawal by Subject|1|||
150003620|NCT01741532|541146876|FG000|Overall Study|Protocol Violation|0|||
150003621|NCT01741532|541146877|FG001|Overall Study|Protocol Violation|1|||
150003622|NCT01741532|541146876|FG000|Overall Study|Worsening of the disease|3|||
150003623|NCT01741532|541146877|FG001|Overall Study|Worsening of the disease|1|||
150003624|NCT01741532|541146876|FG000|Overall Study|Sponsor decision|1|||
150003625|NCT01741532|541146877|FG001|Overall Study|Sponsor decision|0|||
150055233|NCT01340872|541344105|FG001|Double-blind Phase|Lost to Follow-up|1|||
150055234|NCT01340872|541344106|FG002|Double-blind Phase|Lost to Follow-up|0|||
150055235|NCT01340872|541344107|FG003|Double-blind Phase|Lost to Follow-up|0|||
150055236|NCT01340872|541344104|FG000|Double-blind Phase|Protocol Violation|0|||
150055237|NCT01340872|541344105|FG001|Double-blind Phase|Protocol Violation|1|||
150055238|NCT01340872|541344106|FG002|Double-blind Phase|Protocol Violation|0|||
150055239|NCT01340872|541344107|FG003|Double-blind Phase|Protocol Violation|0|||
150055240|NCT01340872|541344104|FG000|Open-label Phase|Physician Decision|0|||
150055241|NCT01340872|541344105|FG001|Open-label Phase|Physician Decision|0|||
150055242|NCT01340872|541344106|FG002|Open-label Phase|Physician Decision|2|||
150055243|NCT01340872|541344107|FG003|Open-label Phase|Physician Decision|1|||
150055244|NCT01340872|541344104|FG000|Open-label Phase|Pregnancy|0|||
150055245|NCT01340872|541344105|FG001|Open-label Phase|Pregnancy|0|||
150055246|NCT01340872|541344106|FG002|Open-label Phase|Pregnancy|1|||
150055247|NCT01340872|541344107|FG003|Open-label Phase|Pregnancy|0|||
150055248|NCT01340872|541344104|FG000|Open-label Phase|Adverse Event|0|||
150055249|NCT01340872|541344105|FG001|Open-label Phase|Adverse Event|0|||
150055250|NCT01340872|541344106|FG002|Open-label Phase|Adverse Event|8|||
150055251|NCT01340872|541344107|FG003|Open-label Phase|Adverse Event|4|||
150055252|NCT01340872|541344104|FG000|Open-label Phase|Withdrawal by Subject|0|||
150055253|NCT01340872|541344105|FG001|Open-label Phase|Withdrawal by Subject|0|||
150055254|NCT01340872|541344106|FG002|Open-label Phase|Withdrawal by Subject|1|||
150055255|NCT01340872|541344107|FG003|Open-label Phase|Withdrawal by Subject|6|||
150055256|NCT01340872|541344104|FG000|Open-label Phase|Worsening of IBD|0|||
150055257|NCT01340872|541344105|FG001|Open-label Phase|Worsening of IBD|0|||
150055258|NCT01340872|541344106|FG002|Open-label Phase|Worsening of IBD|1|||
150055259|NCT01340872|541344107|FG003|Open-label Phase|Worsening of IBD|0|||
150055260|NCT03039621|541344110|FG000|Overall Study|Violation of inclusion criteria|3|||
150003626|NCT01741532|541146876|FG000|Overall Study|Medical event|1|||
150055261|NCT03039621|541344111|FG001|Overall Study|Violation of inclusion criteria|2|||
150055262|NCT03039621|541344110|FG000|Overall Study|Non-compliance with protocol requirement|4|||
150055263|NCT03039621|541344111|FG001|Overall Study|Non-compliance with protocol requirement|5|||
150055264|NCT03039621|541344110|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
150055265|NCT03039621|541344111|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
150055266|NCT03039621|541344110|FG000|Overall Study|Violation of non-inclusion criteria|1|||
150055267|NCT03039621|541344111|FG001|Overall Study|Violation of non-inclusion criteria|2|||
150055268|NCT01142089|541344114|FG000|Overall Study|Physician Decision|1|||
150003627|NCT01741532|541146877|FG001|Overall Study|Medical event|0|||
150003628|NCT01066780|541146878|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
150003629|NCT01066780|541146879|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
150003630|NCT00613080|541146880|FG000|Overall Study|Ineligible / no protocol treatment|11|||
150003631|NCT02360293|541146881|FG000|Overall Study|Lost to Follow-up|73|||
150003632|NCT02360293|541146882|FG001|Overall Study|Lost to Follow-up|95|||
150003633|NCT02360293|541146881|FG000|Overall Study|Withdrawal by Subject|2|||
150003634|NCT02360293|541146882|FG001|Overall Study|Withdrawal by Subject|1|||
150003635|NCT02360293|541146881|FG000|Overall Study|Excluded|1|||
150003636|NCT02360293|541146882|FG001|Overall Study|Excluded|0|||
150003637|NCT02226549|541146883|FG000|Overall Study|Randomized but Never Treated|1|||
150003638|NCT02226549|541146884|FG001|Overall Study|Randomized but Never Treated|0|||
150003639|NCT02226549|541146883|FG000|Overall Study|Lost to Follow-up|0|||
150003640|NCT02226549|541146884|FG001|Overall Study|Lost to Follow-up|1|||
150003641|NCT03099148|541146886|FG000|Wash-out|scheduling conflict|0|||
150003642|NCT03099148|541146887|FG001|Wash-out|scheduling conflict|1|||
150003643|NCT03099148|541146888|FG002|Wash-out|scheduling conflict|0|||
150003644|NCT03099148|541146889|FG003|Wash-out|scheduling conflict|0|||
150003645|NCT03099148|541146886|FG000|Wash-out|Adverse Event|0|||
150003646|NCT03099148|541146887|FG001|Wash-out|Adverse Event|1|||
150179697|NCT01808339|541796789|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179698|NCT01808339|541796790|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
150003647|NCT03099148|541146888|FG002|Wash-out|Adverse Event|0|||
150003648|NCT03099148|541146889|FG003|Wash-out|Adverse Event|0|||
150003649|NCT01269385|541146890|FG000|Overall Study|Adverse Event|1|||
150003650|NCT01269385|541146891|FG001|Overall Study|Adverse Event|1|||
150003651|NCT01269385|541146892|FG002|Overall Study|Adverse Event|0|||
150003652|NCT01269385|541146893|FG003|Overall Study|Adverse Event|0|||
150003653|NCT02741570|541146895|FG000|Pre-Treatment Period|Other reasons|0|||
150003654|NCT02741570|541146896|FG001|Pre-Treatment Period|Other reasons|3|||
150003655|NCT02741570|541146895|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
150003656|NCT02741570|541146896|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
150003657|NCT02741570|541146895|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
150003658|NCT02741570|541146896|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
150003659|NCT02741570|541146895|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
150003660|NCT02741570|541146896|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
150003661|NCT02741570|541146895|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
150003662|NCT02741570|541146896|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
150003663|NCT02741570|541146895|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
150003664|NCT02741570|541146896|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
150003665|NCT02741570|541146895|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
150003666|NCT02741570|541146896|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150003667|NCT02741570|541146895|FG000|Pre-Treatment Period|Death|0|||
150003668|NCT02741570|541146896|FG001|Pre-Treatment Period|Death|1|||
150003669|NCT02741570|541146895|FG000|Pre-Treatment Period|Disease progression|0|||
150003670|NCT02741570|541146896|FG001|Pre-Treatment Period|Disease progression|1|||
150003671|NCT02741570|541146895|FG000|Treatment Period|Other reasons|47|||
150003672|NCT02741570|541146896|FG001|Treatment Period|Other reasons|12|||
150003673|NCT02741570|541146895|FG000|Treatment Period|Poor/non-compliance|0|||
150003674|NCT02741570|541146896|FG001|Treatment Period|Poor/non-compliance|2|||
150003675|NCT02741570|541146895|FG000|Treatment Period|Maximum clinical benefit|4|||
150003676|NCT02741570|541146896|FG001|Treatment Period|Maximum clinical benefit|6|||
150003677|NCT02741570|541146895|FG000|Treatment Period|Lost to Follow-up|1|||
150003678|NCT02741570|541146896|FG001|Treatment Period|Lost to Follow-up|3|||
150003679|NCT02741570|541146895|FG000|Treatment Period|Participant withdrew consent|9|||
150003680|NCT02741570|541146896|FG001|Treatment Period|Participant withdrew consent|13|||
150003681|NCT02741570|541146895|FG000|Treatment Period|Participant request to discontinue treatment|8|||
150003682|NCT02741570|541146896|FG001|Treatment Period|Participant request to discontinue treatment|23|||
150003683|NCT02741570|541146895|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
150003684|NCT02741570|541146896|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
150003685|NCT02741570|541146895|FG000|Treatment Period|Death|9|||
150003686|NCT02741570|541146896|FG001|Treatment Period|Death|7|||
150003687|NCT02741570|541146895|FG000|Treatment Period|Study drug toxicity|55|||
150003688|NCT02741570|541146896|FG001|Treatment Period|Study drug toxicity|47|||
150003689|NCT02741570|541146895|FG000|Treatment Period|Disease progression|294|||
150003690|NCT02741570|541146896|FG001|Treatment Period|Disease progression|301|||
150003691|NCT02741570|541146895|FG000|Treatment Period|Administrative reason by sponsor|0|||
150003692|NCT02741570|541146896|FG001|Treatment Period|Administrative reason by sponsor|1|||
150003693|NCT01498185|541146897|FG000|Overall Study|Adverse Event|0|||
150003694|NCT01498185|541146898|FG001|Overall Study|Adverse Event|0|||
150003695|NCT01498185|541146899|FG002|Overall Study|Adverse Event|0|||
150003696|NCT01498185|541146900|FG003|Overall Study|Adverse Event|1|||
150003697|NCT01498185|541146901|FG004|Overall Study|Adverse Event|0|||
150003698|NCT01498185|541146897|FG000|Overall Study|Withdrawal by Subject|1|||
150003699|NCT01498185|541146898|FG001|Overall Study|Withdrawal by Subject|1|||
150055269|NCT01142089|541344115|FG001|Overall Study|Physician Decision|0|||
150003700|NCT01498185|541146899|FG002|Overall Study|Withdrawal by Subject|0|||
150003701|NCT01498185|541146900|FG003|Overall Study|Withdrawal by Subject|2|||
150003702|NCT01498185|541146901|FG004|Overall Study|Withdrawal by Subject|1|||
150003703|NCT01498185|541146897|FG000|Overall Study|No longer met criteria, etc|0|||
150003704|NCT01498185|541146898|FG001|Overall Study|No longer met criteria, etc|0|||
150003705|NCT01498185|541146899|FG002|Overall Study|No longer met criteria, etc|0|||
150003706|NCT01498185|541146900|FG003|Overall Study|No longer met criteria, etc|0|||
150003707|NCT01498185|541146901|FG004|Overall Study|No longer met criteria, etc|2|||
150003708|NCT00946322|541146902|FG000|Pre-treatment|participant failure to follow up|1|||
150003709|NCT00946322|541146902|FG000|Post-treatment|participant failure to follow up|2|||
150003710|NCT01710527|541146903|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
150003711|NCT01710527|541146904|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
150003712|NCT01688921|541146908|FG000|Overall Study|Lost to Follow-up|7|||
150003713|NCT01688921|541146909|FG001|Overall Study|Lost to Follow-up|13|||
150003714|NCT01688921|541146908|FG000|Overall Study|Physician Decision|6|||
150003715|NCT01688921|541146909|FG001|Overall Study|Physician Decision|1|||
150003716|NCT01688921|541146908|FG000|Overall Study|Protocol Violation|0|||
150003717|NCT01688921|541146909|FG001|Overall Study|Protocol Violation|1|||
150003718|NCT01688921|541146908|FG000|Overall Study|informed consent|3|||
150003719|NCT01688921|541146909|FG001|Overall Study|informed consent|0|||
150003720|NCT04384107|541146913|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
150003721|NCT04384107|541146914|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
150003722|NCT04384107|541146913|FG000|Overall Study|Lost to Follow-up|1|||
150003723|NCT04384107|541146914|FG001|Overall Study|Lost to Follow-up|0|||
150003724|NCT00459537|541146915|FG000|Overall Study|Adverse Event|1|||
150003725|NCT00459537|541146916|FG001|Overall Study|Adverse Event|6|||
150003726|NCT00459537|541146915|FG000|Overall Study|Lack of Efficacy|10|||
150003727|NCT00459537|541146916|FG001|Overall Study|Lack of Efficacy|11|||
150003728|NCT00459537|541146915|FG000|Overall Study|Withdrawal by Subject|20|||
150003729|NCT00459537|541146916|FG001|Overall Study|Withdrawal by Subject|26|||
150003730|NCT00459537|541146915|FG000|Overall Study|Lost to Follow-up|27|||
150003731|NCT00459537|541146916|FG001|Overall Study|Lost to Follow-up|30|||
150003732|NCT00459537|541146915|FG000|Overall Study|Administrative problems|3|||
150003733|NCT00459537|541146916|FG001|Overall Study|Administrative problems|0|||
150003734|NCT00459537|541146915|FG000|Overall Study|Protocol Violation|4|||
150003735|NCT00459537|541146916|FG001|Overall Study|Protocol Violation|3|||
150003736|NCT00459537|541146915|FG000|Overall Study|Missing|1|||
150003737|NCT00459537|541146916|FG001|Overall Study|Missing|0|||
150003738|NCT00528996|541148301|FG000|Overall Study|Other reasons than listing|6|||
150003739|NCT00528996|541148302|FG001|Overall Study|Other reasons than listing|7|||
150003740|NCT00528996|541148303|FG002|Overall Study|Other reasons than listing|14|||
150003741|NCT00528996|541148304|FG003|Overall Study|Other reasons than listing|11|||
150003742|NCT00528996|541148305|FG004|Overall Study|Other reasons than listing|5|||
150003743|NCT00528996|541148301|FG000|Overall Study|Refused continue medication|16|||
150003744|NCT00528996|541148302|FG001|Overall Study|Refused continue medication|0|||
150003745|NCT00528996|541148303|FG002|Overall Study|Refused continue medication|3|||
150055270|NCT01142089|541344114|FG000|Overall Study|Withdrawal by Subject|1|||
150055271|NCT01142089|541344115|FG001|Overall Study|Withdrawal by Subject|2|||
150055272|NCT01142089|541344114|FG000|Overall Study|Use of prohibited medications|0|||
150055273|NCT01142089|541344115|FG001|Overall Study|Use of prohibited medications|1|||
150055274|NCT01142089|541344114|FG000|Overall Study|Noncompliance with study procedures|2|||
150055275|NCT01142089|541344115|FG001|Overall Study|Noncompliance with study procedures|1|||
150055276|NCT01142089|541344114|FG000|Overall Study|Patient required rescue medication|8|||
150055277|NCT01142089|541344115|FG001|Overall Study|Patient required rescue medication|17|||
150055278|NCT01974765|541344120|FG000|Overall Study|Withdrawal by Subject|1|||
150055279|NCT01974765|541344120|FG000|Overall Study|Death|1|||
150055280|NCT01974765|541344120|FG000|Overall Study|Adverse Event|2|||
150055281|NCT05338671|541344129|FG000|Overall Study|Lost to Follow-up|2|||
150055282|NCT05338671|541344130|FG001|Overall Study|Lost to Follow-up|2|||
150055283|NCT05338671|541344129|FG000|Overall Study|Root canal completed in a single visit|1|||
150055284|NCT05338671|541344130|FG001|Overall Study|Root canal completed in a single visit|0|||
150055285|NCT03085914|541344133|FG000|Overall Study|Death|6|||
150055286|NCT03085914|541344134|FG001|Overall Study|Death|6|||
150055287|NCT03085914|541344135|FG002|Overall Study|Death|4|||
150055288|NCT03085914|541344136|FG003|Overall Study|Death|1|||
150055289|NCT03085914|541344137|FG004|Overall Study|Death|5|||
150003746|NCT00528996|541148304|FG003|Overall Study|Refused continue medication|3|||
150003747|NCT00528996|541148305|FG004|Overall Study|Refused continue medication|6|||
150003748|NCT00528996|541148301|FG000|Overall Study|Lost to Follow-up|2|||
150055290|NCT03085914|541344138|FG005|Overall Study|Death|2|||
150055291|NCT03085914|541344139|FG006|Overall Study|Death|2|||
150003749|NCT00528996|541148302|FG001|Overall Study|Lost to Follow-up|0|||
150003750|NCT00528996|541148303|FG002|Overall Study|Lost to Follow-up|4|||
150055292|NCT03085914|541344133|FG000|Overall Study|Withdrawal by Subject|1|||
150055293|NCT03085914|541344134|FG001|Overall Study|Withdrawal by Subject|1|||
150055294|NCT03085914|541344135|FG002|Overall Study|Withdrawal by Subject|2|||
150055295|NCT03085914|541344136|FG003|Overall Study|Withdrawal by Subject|2|||
150003751|NCT00528996|541148304|FG003|Overall Study|Lost to Follow-up|1|||
150003752|NCT00528996|541148305|FG004|Overall Study|Lost to Follow-up|3|||
150003753|NCT00528996|541148301|FG000|Overall Study|Protocol Violation|1|||
150003754|NCT00528996|541148302|FG001|Overall Study|Protocol Violation|2|||
150003755|NCT00528996|541148303|FG002|Overall Study|Protocol Violation|3|||
150003756|NCT00528996|541148304|FG003|Overall Study|Protocol Violation|3|||
150003757|NCT00528996|541148305|FG004|Overall Study|Protocol Violation|2|||
150003758|NCT00528996|541148301|FG000|Overall Study|Lack of Efficacy|7|||
150003759|NCT00528996|541148302|FG001|Overall Study|Lack of Efficacy|2|||
150003760|NCT00528996|541148303|FG002|Overall Study|Lack of Efficacy|1|||
150003761|NCT00528996|541148304|FG003|Overall Study|Lack of Efficacy|3|||
150003762|NCT00528996|541148305|FG004|Overall Study|Lack of Efficacy|3|||
150003763|NCT00528996|541148301|FG000|Overall Study|Adverse Event|32|||
150003764|NCT00528996|541148302|FG001|Overall Study|Adverse Event|13|||
150003765|NCT00528996|541148303|FG002|Overall Study|Adverse Event|18|||
150003766|NCT00528996|541148304|FG003|Overall Study|Adverse Event|29|||
150003767|NCT00528996|541148305|FG004|Overall Study|Adverse Event|18|||
150003768|NCT02831933|541148307|FG000|Overall Study|Physician Decision|11|||
150003769|NCT05065190|541148311|FG000|Overall Study|Other than listed|2|||
150003770|NCT05065190|541148312|FG001|Overall Study|Other than listed|12|||
150003771|NCT05065190|541148311|FG000|Overall Study|Lack of Efficacy|4|||
150003772|NCT05065190|541148312|FG001|Overall Study|Lack of Efficacy|0|||
150003773|NCT05065190|541148311|FG000|Overall Study|Adverse Event|1|||
150003774|NCT05065190|541148312|FG001|Overall Study|Adverse Event|10|||
150003775|NCT02943915|541148313|FG000|Overall Study|Withdrawal by Subject|2|||
150003776|NCT02943915|541148314|FG001|Overall Study|Withdrawal by Subject|1|||
150003777|NCT02943915|541148315|FG002|Overall Study|Withdrawal by Subject|0|||
150003778|NCT02943915|541148316|FG003|Overall Study|Withdrawal by Subject|0|||
150003779|NCT02943915|541148313|FG000|Overall Study|Lost to Follow-up|3|||
150003780|NCT02943915|541148314|FG001|Overall Study|Lost to Follow-up|1|||
150003781|NCT02943915|541148315|FG002|Overall Study|Lost to Follow-up|0|||
150003782|NCT02943915|541148316|FG003|Overall Study|Lost to Follow-up|0|||
150003783|NCT02943915|541148313|FG000|Overall Study|excluded|0|||
150003784|NCT02943915|541148314|FG001|Overall Study|excluded|1|||
150003785|NCT02943915|541148315|FG002|Overall Study|excluded|0|||
150003786|NCT02943915|541148316|FG003|Overall Study|excluded|0|||
150003787|NCT02559414|541148319|FG000|Overall Study|Lost to Follow-up|0|||
150003788|NCT02559414|541148320|FG001|Overall Study|Lost to Follow-up|1|||
150003789|NCT02559414|541148321|FG002|Overall Study|Lost to Follow-up|0|||
150003790|NCT02559414|541148319|FG000|Overall Study|Withdrawal by Subject|1|||
150003791|NCT02559414|541148320|FG001|Overall Study|Withdrawal by Subject|0|||
150003792|NCT02559414|541148321|FG002|Overall Study|Withdrawal by Subject|1|||
150003793|NCT02559414|541148319|FG000|Overall Study|Other|0|||
150003794|NCT02559414|541148320|FG001|Overall Study|Other|1|||
150003795|NCT02559414|541148321|FG002|Overall Study|Other|1|||
150003796|NCT06250738|541148329|FG000|Overall Study|Lost to Follow-up|1|||
150003797|NCT00293709|541148333|FG000|Overall Study|Other|47|||
150003798|NCT00086502|541148334|FG000|Overall Study|Adverse Event|11|||
150003799|NCT00086502|541148335|FG001|Overall Study|Adverse Event|2|||
150003800|NCT00086502|541148334|FG000|Overall Study|Lack of Efficacy|0|||
150003801|NCT00086502|541148335|FG001|Overall Study|Lack of Efficacy|2|||
150003802|NCT00086502|541148334|FG000|Overall Study|Lost to Follow-up|3|||
150003803|NCT00086502|541148335|FG001|Overall Study|Lost to Follow-up|1|||
150003804|NCT00086502|541148334|FG000|Overall Study|Physician Decision|1|||
150003805|NCT00086502|541148335|FG001|Overall Study|Physician Decision|1|||
150003806|NCT00086502|541148334|FG000|Overall Study|Pregnancy|0|||
150003807|NCT00086502|541148335|FG001|Overall Study|Pregnancy|1|||
150003808|NCT00086502|541148334|FG000|Overall Study|Protocol Violation|3|||
150003809|NCT00086502|541148335|FG001|Overall Study|Protocol Violation|3|||
150003810|NCT00086502|541148334|FG000|Overall Study|Withdrawal by Subject|5|||
150003811|NCT00086502|541148335|FG001|Overall Study|Withdrawal by Subject|6|||
150003812|NCT00086502|541148334|FG000|Overall Study|Patient Moved|1|||
150003813|NCT00086502|541148335|FG001|Overall Study|Patient Moved|1|||
150003814|NCT00086502|541148334|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
150003815|NCT00086502|541148335|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
150003816|NCT00086502|541148334|FG000|Overall Study|Patient Accidentally Unblinded|1|||
150003817|NCT00086502|541148335|FG001|Overall Study|Patient Accidentally Unblinded|0|||
150003818|NCT01304329|541148336|FG000|Third Intervention (3 Days)|Adverse Event|0|||
150003819|NCT01304329|541148337|FG001|Third Intervention (3 Days)|Adverse Event|1|||
150003820|NCT01304329|541148338|FG002|Third Intervention (3 Days)|Adverse Event|0|||
150003821|NCT01304329|541148339|FG003|Third Intervention (3 Days)|Adverse Event|0|||
150003822|NCT01304329|541148340|FG004|Third Intervention (3 Days)|Adverse Event|0|||
150003823|NCT01304329|541148341|FG005|Third Intervention (3 Days)|Adverse Event|0|||
150003824|NCT01842581|541148346|FG000|Overall Study|Adverse Event|6|||
150003825|NCT01842581|541148347|FG001|Overall Study|Adverse Event|4|||
150003826|NCT01842581|541148346|FG000|Overall Study|HE breakthrough|26|||
150003827|NCT01842581|541148347|FG001|Overall Study|HE breakthrough|13|||
150003828|NCT01842581|541148346|FG000|Overall Study|Liver transplant|2|||
150003829|NCT01842581|541148347|FG001|Overall Study|Liver transplant|0|||
150003830|NCT01842581|541148346|FG000|Overall Study|Lost to Follow-up|2|||
150003831|NCT01842581|541148347|FG001|Overall Study|Lost to Follow-up|5|||
150003832|NCT01842581|541148346|FG000|Overall Study|Withdrawal by Subject|5|||
150003833|NCT01842581|541148347|FG001|Overall Study|Withdrawal by Subject|7|||
150003834|NCT01842581|541148346|FG000|Overall Study|Other than specified|3|||
150003835|NCT01842581|541148347|FG001|Overall Study|Other than specified|1|||
150003836|NCT01287195|541148348|FG000|Overall Study|Withdrawal by Subject|2|||
150003837|NCT01995552|541148349|FG000|Overall Study|Protocol Violation|1|||
150003838|NCT01995552|541148349|FG000|Overall Study|Lack of Efficacy|15|||
150003839|NCT01995552|541148349|FG000|Overall Study|Death|1|||
150003840|NCT02068118|541148353|FG000|18-month Comparative Study Period|Death|90|||
150003841|NCT02068118|541148354|FG001|18-month Comparative Study Period|Death|97|||
150003842|NCT02068118|541148353|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
150003843|NCT02068118|541148354|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
150003844|NCT02068118|541148353|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
150003845|NCT02068118|541148354|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
150003846|NCT02068118|541148353|FG000|18-month Comparative Study Period|Heart transplant|9|||
150003847|NCT02068118|541148354|FG001|18-month Comparative Study Period|Heart transplant|15|||
150003848|NCT02068118|541148353|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
150003849|NCT02068118|541148354|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
150003850|NCT02068118|541148353|FG000|18-month Comparative Study Period|Hemiplegia|0|||
150003851|NCT02068118|541148354|FG001|18-month Comparative Study Period|Hemiplegia|1|||
150003852|NCT02068118|541148353|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
150003853|NCT02068118|541148354|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
150003854|NCT02068118|541148353|FG000|18-month Comparative Study Period|Move|0|||
150003855|NCT02068118|541148354|FG001|18-month Comparative Study Period|Move|1|||
150003856|NCT02068118|541148353|FG000|18-month Comparative Study Period|Hearing loss|0|||
150003857|NCT02068118|541148354|FG001|18-month Comparative Study Period|Hearing loss|1|||
150003858|NCT02068118|541148353|FG000|Extension Period|Death|0|||
150003859|NCT02068118|541148354|FG001|Extension Period|Death|2|||
150003860|NCT02068118|541148353|FG000|Extension Period|Withdrawal by Subject|1|||
150003861|NCT02068118|541148354|FG001|Extension Period|Withdrawal by Subject|0|||
150003862|NCT02068118|541148353|FG000|Extension Period|Heart transplant|1|||
150003863|NCT02068118|541148354|FG001|Extension Period|Heart transplant|0|||
150003864|NCT02068118|541148353|FG000|Extension Period|Wrong device use|0|||
150003865|NCT02068118|541148354|FG001|Extension Period|Wrong device use|1|||
150003866|NCT00283868|541148357|FG000|Overall Study|Lost to Follow-up|7|||
150003867|NCT00283868|541148358|FG001|Overall Study|Lost to Follow-up|8|||
150003868|NCT01515475|541148359|FG000|Overall Study|Lost to Follow-up|20|||
150003869|NCT01515475|541148360|FG001|Overall Study|Lost to Follow-up|15|||
150003870|NCT01515475|541148361|FG002|Overall Study|Lost to Follow-up|12|||
150003871|NCT01515475|541148362|FG003|Overall Study|Lost to Follow-up|12|||
150003872|NCT01420627|541148364|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
150003873|NCT00837876|541148365|FG000|Overall Study|Death|2|||
150003874|NCT00837876|541148365|FG000|Overall Study|Adverse Event|7|||
150003875|NCT00837876|541148365|FG000|Overall Study|Physician Decision|1|||
150003876|NCT00837876|541148365|FG000|Overall Study|Withdrawal by Subject|3|||
150003877|NCT00837876|541148365|FG000|Overall Study|disease progression|24|||
150003878|NCT00453973|541148367|FG000|Overall Study|Adverse Event|4|||
150003879|NCT00453973|541148368|FG001|Overall Study|Adverse Event|9|||
150003880|NCT00453973|541148367|FG000|Overall Study|Withdrawal by Subject|7|||
150003881|NCT00453973|541148368|FG001|Overall Study|Withdrawal by Subject|6|||
150003882|NCT00453973|541148367|FG000|Overall Study|PI Decision|0|||
150003883|NCT00453973|541148368|FG001|Overall Study|PI Decision|2|||
150003884|NCT00453973|541148367|FG000|Overall Study|Relocation|1|||
150003885|NCT00453973|541148368|FG001|Overall Study|Relocation|0|||
150003886|NCT00453973|541148367|FG000|Overall Study|Renal transplant|1|||
150003887|NCT00453973|541148368|FG001|Overall Study|Renal transplant|1|||
150003888|NCT00453973|541148367|FG000|Overall Study|Site closed by sponsor|3|||
150003889|NCT00453973|541148368|FG001|Overall Study|Site closed by sponsor|0|||
150003890|NCT00453973|541148367|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
150003891|NCT00453973|541148368|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
150003892|NCT01996592|541148369|FG000|Overall Study|no response to text/no diary entry|32|||
150003893|NCT01996592|541148369|FG000|Overall Study|change in surgical date|4|||
150003894|NCT01996592|541148369|FG000|Overall Study|Withdrawal by Subject|5|||
150003895|NCT01996592|541148369|FG000|Overall Study|change in mode of delivery|4|||
150003896|NCT00870194|541148370|FG000|Overall Study|Adverse Event|10|||
150003897|NCT00870194|541148371|FG001|Overall Study|Adverse Event|5|||
150003898|NCT00870194|541148370|FG000|Overall Study|Lack of Efficacy|0|||
150003899|NCT00870194|541148371|FG001|Overall Study|Lack of Efficacy|1|||
150003900|NCT00870194|541148370|FG000|Overall Study|Lost to Follow-up|2|||
150003901|NCT00870194|541148371|FG001|Overall Study|Lost to Follow-up|0|||
150003902|NCT00870194|541148370|FG000|Overall Study|Physician Decision|3|||
150003903|NCT00870194|541148371|FG001|Overall Study|Physician Decision|1|||
150003904|NCT00870194|541148370|FG000|Overall Study|Protocol Violation|3|||
150003905|NCT00870194|541148371|FG001|Overall Study|Protocol Violation|3|||
150003906|NCT00870194|541148370|FG000|Overall Study|Entry Criteria Not Met|1|||
150003907|NCT00870194|541148371|FG001|Overall Study|Entry Criteria Not Met|2|||
150003908|NCT00870194|541148370|FG000|Overall Study|Subject Decision|7|||
150003909|NCT00870194|541148371|FG001|Overall Study|Subject Decision|2|||
150003910|NCT00707746|541148372|FG000|Treatment Period|Adverse Event|2|||
150003911|NCT00707746|541148373|FG001|Treatment Period|Adverse Event|4|||
150003912|NCT00707746|541148372|FG000|Treatment Period|Ineligibility|0|||
150003913|NCT00707746|541148373|FG001|Treatment Period|Ineligibility|1|||
150003914|NCT01219933|541148377|FG000|Overall Study|Adverse Event|8|||
150003915|NCT01219933|541148377|FG000|Overall Study|No LDA reached|5|||
150003916|NCT01219933|541148377|FG000|Overall Study|No LDA maintained|7|||
150003917|NCT01219933|541148377|FG000|Overall Study|Lost to Follow-up|3|||
150003918|NCT01219933|541148377|FG000|Overall Study|GC free|1|||
150003919|NCT01219933|541148377|FG000|Overall Study|Withdrawal by Subject|5|||
150003920|NCT01219933|541148377|FG000|Overall Study|Protocol Violation|8|||
150003921|NCT01219933|541148377|FG000|Overall Study|Lack of Efficacy|1|||
150003922|NCT01902888|541148378|FG000|Overall Study|Study Terminated|3|||
150003923|NCT03149003|541148379|FG000|Overall Study|Randomized but not treated|0|||
150003924|NCT03149003|541148380|FG001|Overall Study|Randomized but not treated|1|||
150003925|NCT03149003|541148381|FG002|Overall Study|Randomized but not treated|18|||
150003926|NCT01443130|541148382|FG000|Overall Study|Lost to Follow-up|44|||
150003927|NCT01443130|541148383|FG001|Overall Study|Lost to Follow-up|42|||
150003928|NCT01443130|541148384|FG002|Overall Study|Lost to Follow-up|50|||
150003929|NCT01443130|541148385|FG003|Overall Study|Lost to Follow-up|23|||
150003930|NCT01443130|541148386|FG004|Overall Study|Lost to Follow-up|25|||
150003931|NCT01443130|541148387|FG005|Overall Study|Lost to Follow-up|21|||
150003932|NCT01443130|541148382|FG000|Overall Study|Death|0|||
150003933|NCT01443130|541148383|FG001|Overall Study|Death|1|||
150003934|NCT01443130|541148384|FG002|Overall Study|Death|0|||
150003935|NCT01443130|541148385|FG003|Overall Study|Death|7|||
150003936|NCT01443130|541148386|FG004|Overall Study|Death|10|||
150003937|NCT01443130|541148387|FG005|Overall Study|Death|8|||
150003938|NCT01443130|541148382|FG000|Overall Study|Adverse Event|2|||
150055296|NCT03085914|541344137|FG004|Overall Study|Withdrawal by Subject|2|||
150055297|NCT03085914|541344138|FG005|Overall Study|Withdrawal by Subject|0|||
150055298|NCT03085914|541344139|FG006|Overall Study|Withdrawal by Subject|1|||
150055299|NCT03085914|541344133|FG000|Overall Study|Lost to Follow-up|0|||
150055300|NCT03085914|541344134|FG001|Overall Study|Lost to Follow-up|0|||
150055301|NCT03085914|541344135|FG002|Overall Study|Lost to Follow-up|1|||
150055302|NCT03085914|541344136|FG003|Overall Study|Lost to Follow-up|0|||
150055303|NCT03085914|541344137|FG004|Overall Study|Lost to Follow-up|0|||
150055304|NCT03085914|541344138|FG005|Overall Study|Lost to Follow-up|1|||
150055305|NCT03085914|541344139|FG006|Overall Study|Lost to Follow-up|1|||
150055306|NCT03085914|541344133|FG000|Overall Study|Reason was not specified,|2|||
150055307|NCT03085914|541344134|FG001|Overall Study|Reason was not specified,|2|||
150055308|NCT03085914|541344135|FG002|Overall Study|Reason was not specified,|2|||
150055309|NCT03085914|541344136|FG003|Overall Study|Reason was not specified,|3|||
150055310|NCT03085914|541344137|FG004|Overall Study|Reason was not specified,|3|||
150055311|NCT03085914|541344138|FG005|Overall Study|Reason was not specified,|3|||
150055312|NCT03085914|541344139|FG006|Overall Study|Reason was not specified,|6|||
150055313|NCT03085914|541344133|FG000|Overall Study|Progressive Disease|0|||
150055314|NCT03085914|541344134|FG001|Overall Study|Progressive Disease|0|||
150055315|NCT03085914|541344135|FG002|Overall Study|Progressive Disease|2|||
150055316|NCT03085914|541344136|FG003|Overall Study|Progressive Disease|2|||
150055317|NCT03085914|541344137|FG004|Overall Study|Progressive Disease|1|||
150055318|NCT03085914|541344138|FG005|Overall Study|Progressive Disease|1|||
150055319|NCT03085914|541344139|FG006|Overall Study|Progressive Disease|1|||
150055320|NCT03085914|541344133|FG000|Overall Study|Study Terminated by the Sponsor|0|||
150055321|NCT03085914|541344134|FG001|Overall Study|Study Terminated by the Sponsor|0|||
150055322|NCT03085914|541344135|FG002|Overall Study|Study Terminated by the Sponsor|0|||
150055323|NCT03085914|541344136|FG003|Overall Study|Study Terminated by the Sponsor|1|||
150055324|NCT03085914|541344137|FG004|Overall Study|Study Terminated by the Sponsor|2|||
150055325|NCT03085914|541344138|FG005|Overall Study|Study Terminated by the Sponsor|1|||
150003939|NCT01443130|541148383|FG001|Overall Study|Adverse Event|1|||
150003940|NCT01443130|541148384|FG002|Overall Study|Adverse Event|1|||
150055326|NCT03085914|541344139|FG006|Overall Study|Study Terminated by the Sponsor|0|||
150055327|NCT01369329|541344140|FG000|Overall Study|Withdrawal by Subject|8|||
150055328|NCT01369329|541344141|FG001|Overall Study|Withdrawal by Subject|6|||
150003941|NCT01443130|541148385|FG003|Overall Study|Adverse Event|0|||
150055329|NCT01369329|541344142|FG002|Overall Study|Withdrawal by Subject|10|||
150055330|NCT01369329|541344140|FG000|Overall Study|Lost to Follow-up|2|||
150055331|NCT01369329|541344141|FG001|Overall Study|Lost to Follow-up|2|||
150055332|NCT01369329|541344142|FG002|Overall Study|Lost to Follow-up|2|||
150003942|NCT01443130|541148386|FG004|Overall Study|Adverse Event|0|||
150003943|NCT01443130|541148387|FG005|Overall Study|Adverse Event|0|||
150003944|NCT01443130|541148382|FG000|Overall Study|Protocol Violation|2|||
150003945|NCT01443130|541148383|FG001|Overall Study|Protocol Violation|1|||
150003946|NCT01443130|541148384|FG002|Overall Study|Protocol Violation|3|||
150003947|NCT01443130|541148385|FG003|Overall Study|Protocol Violation|2|||
150003948|NCT01443130|541148386|FG004|Overall Study|Protocol Violation|2|||
150003949|NCT01443130|541148387|FG005|Overall Study|Protocol Violation|3|||
150003950|NCT01443130|541148382|FG000|Overall Study|Withdrawal by Subject|15|||
150003951|NCT01443130|541148383|FG001|Overall Study|Withdrawal by Subject|14|||
150003952|NCT01443130|541148384|FG002|Overall Study|Withdrawal by Subject|12|||
150003953|NCT01443130|541148385|FG003|Overall Study|Withdrawal by Subject|7|||
150003954|NCT01443130|541148386|FG004|Overall Study|Withdrawal by Subject|7|||
150003955|NCT01443130|541148387|FG005|Overall Study|Withdrawal by Subject|2|||
150003956|NCT01443130|541148382|FG000|Overall Study|Death of Subject's Infant|5|||
150003957|NCT01443130|541148383|FG001|Overall Study|Death of Subject's Infant|10|||
150003958|NCT01443130|541148384|FG002|Overall Study|Death of Subject's Infant|11|||
150003959|NCT01443130|541148385|FG003|Overall Study|Death of Subject's Infant|0|||
150003960|NCT01443130|541148386|FG004|Overall Study|Death of Subject's Infant|0|||
150003961|NCT01443130|541148387|FG005|Overall Study|Death of Subject's Infant|0|||
150003962|NCT00685373|541148388|FG000|Overall Study|Adverse Event|3|||
150003963|NCT00685373|541148388|FG000|Overall Study|Withdrawal by Subject|5|||
150003964|NCT00685373|541148388|FG000|Overall Study|Lack of Efficacy|3|||
150003965|NCT00685373|541148388|FG000|Overall Study|Condition no longer requires study drug|1|||
150003966|NCT00685373|541148388|FG000|Overall Study|Lost to Follow-up|2|||
150003967|NCT00685373|541148388|FG000|Overall Study|Protocol Violation|1|||
150003968|NCT00364533|541148389|FG000|Overall Study|Adverse Event|8|||
150003969|NCT00364533|541148390|FG001|Overall Study|Adverse Event|7|||
150003970|NCT00364533|541148391|FG002|Overall Study|Adverse Event|15|||
150003971|NCT00364533|541148392|FG003|Overall Study|Adverse Event|5|||
150003972|NCT00364533|541148393|FG004|Overall Study|Adverse Event|2|||
150003973|NCT00364533|541148389|FG000|Overall Study|Withdrawal by Subject|4|||
150003974|NCT00364533|541148390|FG001|Overall Study|Withdrawal by Subject|8|||
150003975|NCT00364533|541148391|FG002|Overall Study|Withdrawal by Subject|6|||
150003976|NCT00364533|541148392|FG003|Overall Study|Withdrawal by Subject|6|||
150003977|NCT00364533|541148393|FG004|Overall Study|Withdrawal by Subject|6|||
150003978|NCT00364533|541148389|FG000|Overall Study|Lack of Efficacy|22|||
150003979|NCT00364533|541148390|FG001|Overall Study|Lack of Efficacy|22|||
150003980|NCT00364533|541148391|FG002|Overall Study|Lack of Efficacy|21|||
150003981|NCT00364533|541148392|FG003|Overall Study|Lack of Efficacy|17|||
150003982|NCT00364533|541148393|FG004|Overall Study|Lack of Efficacy|42|||
150003983|NCT00364533|541148389|FG000|Overall Study|Subject discharged from hospital|4|||
150055333|NCT01369329|541344140|FG000|Overall Study|Other|2|||
150055334|NCT01369329|541344141|FG001|Overall Study|Other|3|||
150055335|NCT01369329|541344142|FG002|Overall Study|Other|2|||
150055336|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
150055337|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Adverse Event|9|||
150055338|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Death|4|||
150055339|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
150055340|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
150055341|NCT00159822|541344143|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
150055342|NCT00159822|541344143|FG000|Post-treatment Follow-up Period|Death|1|||
150055343|NCT00159822|541344143|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
150055344|NCT00159822|541344143|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
150055345|NCT01689532|541344144|FG000|Overall Study|Adverse Event|9|||
150055346|NCT01689532|541344145|FG001|Overall Study|Adverse Event|5|||
150055347|NCT01689532|541344144|FG000|Overall Study|Lack of Efficacy|2|||
150055348|NCT01689532|541344145|FG001|Overall Study|Lack of Efficacy|2|||
150055349|NCT01689532|541344144|FG000|Overall Study|Withdrawal by Subject|1|||
150055350|NCT01689532|541344145|FG001|Overall Study|Withdrawal by Subject|2|||
150055351|NCT01689532|541344144|FG000|Overall Study|Physician Decision|2|||
150055352|NCT01689532|541344145|FG001|Overall Study|Physician Decision|0|||
150055353|NCT01958489|541344146|FG000|Period 2|Adverse Event|0|||
150003984|NCT00364533|541148390|FG001|Overall Study|Subject discharged from hospital|1|||
150003985|NCT00364533|541148391|FG002|Overall Study|Subject discharged from hospital|2|||
150003986|NCT00364533|541148392|FG003|Overall Study|Subject discharged from hospital|3|||
150003987|NCT00364533|541148393|FG004|Overall Study|Subject discharged from hospital|1|||
150003988|NCT00364533|541148389|FG000|Overall Study|Variations in drug compliance|2|||
150179699|NCT01808339|541796791|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150003989|NCT00364533|541148390|FG001|Overall Study|Variations in drug compliance|1|||
150003990|NCT00364533|541148391|FG002|Overall Study|Variations in drug compliance|1|||
150003991|NCT00364533|541148392|FG003|Overall Study|Variations in drug compliance|0|||
150003992|NCT00364533|541148393|FG004|Overall Study|Variations in drug compliance|0|||
150003993|NCT00364533|541148389|FG000|Overall Study|Non-compliance|1|||
150003994|NCT00364533|541148390|FG001|Overall Study|Non-compliance|0|||
150055354|NCT01958489|541344147|FG001|Period 2|Adverse Event|1|||
150055355|NCT00275821|541344149|FG000|Overall Study|Adverse Event|4|||
150055356|NCT00275821|541344150|FG001|Overall Study|Adverse Event|12|||
150055357|NCT00275821|541344151|FG002|Overall Study|Adverse Event|5|||
150055358|NCT00275821|541344149|FG000|Overall Study|Administrative problems|3|||
150003995|NCT00364533|541148391|FG002|Overall Study|Non-compliance|0|||
150003996|NCT00364533|541148392|FG003|Overall Study|Non-compliance|0|||
150003997|NCT00364533|541148393|FG004|Overall Study|Non-compliance|0|||
150003998|NCT00364533|541148389|FG000|Overall Study|Protocol Violation|1|||
150003999|NCT00364533|541148390|FG001|Overall Study|Protocol Violation|1|||
150004000|NCT00364533|541148391|FG002|Overall Study|Protocol Violation|0|||
150004001|NCT00364533|541148392|FG003|Overall Study|Protocol Violation|0|||
150004002|NCT00364533|541148393|FG004|Overall Study|Protocol Violation|0|||
150004003|NCT00582738|541148394|FG000|Overall Study|Administrative Problems|7|||
150004004|NCT00582738|541148395|FG001|Overall Study|Administrative Problems|8|||
150004005|NCT00582738|541148394|FG000|Overall Study|Adverse Event|0|||
150004006|NCT00582738|541148395|FG001|Overall Study|Adverse Event|5|||
150004007|NCT00582738|541148394|FG000|Overall Study|Graft Lost|0|||
150004008|NCT00582738|541148395|FG001|Overall Study|Graft Lost|1|||
150004009|NCT00582738|541148394|FG000|Overall Study|Other|1|||
150004010|NCT00582738|541148395|FG001|Overall Study|Other|0|||
150004011|NCT00582738|541148394|FG000|Overall Study|Protocol Violation|1|||
150004012|NCT00582738|541148395|FG001|Overall Study|Protocol Violation|1|||
150004013|NCT00582738|541148394|FG000|Overall Study|Withdrawal by Subject|0|||
150004014|NCT00582738|541148395|FG001|Overall Study|Withdrawal by Subject|3|||
150004015|NCT02758301|541148396|FG000|Overall Study|Death|12|||
150004016|NCT02758301|541148397|FG001|Overall Study|Death|0|||
150004017|NCT02758301|541148396|FG000|Overall Study|Physician Decision|10|||
150004018|NCT02758301|541148397|FG001|Overall Study|Physician Decision|1|||
150004019|NCT02758301|541148396|FG000|Overall Study|Withdrawal by Subject|5|||
150004020|NCT02758301|541148397|FG001|Overall Study|Withdrawal by Subject|6|||
150004021|NCT02758301|541148396|FG000|Overall Study|Lost to Follow-up|7|||
150004022|NCT02758301|541148397|FG001|Overall Study|Lost to Follow-up|0|||
150004023|NCT02758301|541148396|FG000|Overall Study|Protocol Violation|0|||
150004024|NCT02758301|541148397|FG001|Overall Study|Protocol Violation|1|||
150004025|NCT02642965|541148399|FG000|Overall Study|Lack of Efficacy|4|||
150004026|NCT02642965|541148399|FG000|Overall Study|Physician Decision|9|||
150004027|NCT01827332|541148407|FG000|Overall Study|Lost to Follow-up|2|||
150004028|NCT01827332|541148408|FG001|Overall Study|Lost to Follow-up|1|||
150004029|NCT00276614|541148410|FG000|Overall Study|Progression of disease under study|3|||
150004030|NCT01522404|541148411|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
150004031|NCT01522404|541148412|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
150004032|NCT01522404|541148411|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
150004033|NCT01522404|541148412|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
150055359|NCT00275821|541344150|FG001|Overall Study|Administrative problems|4|||
150055360|NCT00275821|541344151|FG002|Overall Study|Administrative problems|4|||
150055361|NCT00275821|541344149|FG000|Overall Study|Withdrawal by Subject|0|||
150055362|NCT00275821|541344150|FG001|Overall Study|Withdrawal by Subject|2|||
150055363|NCT00275821|541344151|FG002|Overall Study|Withdrawal by Subject|1|||
150055364|NCT00275821|541344149|FG000|Overall Study|Lost to Follow-up|0|||
150055365|NCT00275821|541344150|FG001|Overall Study|Lost to Follow-up|1|||
150055366|NCT00275821|541344151|FG002|Overall Study|Lost to Follow-up|1|||
150055367|NCT00275821|541344149|FG000|Overall Study|Death|0|||
150055368|NCT00275821|541344150|FG001|Overall Study|Death|2|||
150055369|NCT00275821|541344151|FG002|Overall Study|Death|1|||
150055370|NCT00275821|541344149|FG000|Overall Study|Lack of Efficacy|2|||
150055371|NCT00275821|541344150|FG001|Overall Study|Lack of Efficacy|1|||
150055372|NCT00275821|541344151|FG002|Overall Study|Lack of Efficacy|0|||
150055373|NCT00275821|541344149|FG000|Overall Study|Protocol Violation|5|||
150055374|NCT00275821|541344150|FG001|Overall Study|Protocol Violation|1|||
150055375|NCT00275821|541344151|FG002|Overall Study|Protocol Violation|0|||
150055376|NCT01215916|541344152|FG000|Overall Study|Progressive Disease|0|||
150055377|NCT01215916|541344153|FG001|Overall Study|Progressive Disease|2|||
150055378|NCT01215916|541344154|FG002|Overall Study|Progressive Disease|1|||
150055379|NCT01215916|541344155|FG003|Overall Study|Progressive Disease|2|||
150004034|NCT01522404|541148411|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
150004035|NCT01522404|541148412|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
150004036|NCT01831817|541148419|FG000|Overall Study|Lost to Follow-up|1|||
150004037|NCT01831817|541148420|FG001|Overall Study|Lost to Follow-up|0|||
150004038|NCT01831817|541148421|FG002|Overall Study|Lost to Follow-up|0|||
150004039|NCT01831817|541148422|FG003|Overall Study|Lost to Follow-up|0|||
150004040|NCT01831817|541148419|FG000|Overall Study|Withdrawl of Consent|3|||
150004041|NCT01831817|541148420|FG001|Overall Study|Withdrawl of Consent|0|||
150004042|NCT01831817|541148421|FG002|Overall Study|Withdrawl of Consent|0|||
150004043|NCT01831817|541148422|FG003|Overall Study|Withdrawl of Consent|0|||
150004044|NCT00958217|541148423|FG000|Overall Study|Death|2|||
150055380|NCT01215916|541344156|FG004|Overall Study|Progressive Disease|5|||
150055381|NCT01215916|541344157|FG005|Overall Study|Progressive Disease|4|||
150055382|NCT01215916|541344158|FG006|Overall Study|Progressive Disease|5|||
150004045|NCT00958217|541148424|FG001|Overall Study|Death|1|||
150004046|NCT00958217|541148423|FG000|Overall Study|Withdrawal by Subject|4|||
150004047|NCT00958217|541148424|FG001|Overall Study|Withdrawal by Subject|3|||
150055383|NCT01215916|541344159|FG007|Overall Study|Progressive Disease|3|||
150055384|NCT01215916|541344160|FG008|Overall Study|Progressive Disease|1|||
150004048|NCT00958217|541148423|FG000|Overall Study|Lost to Follow-up|17|||
150004049|NCT00958217|541148424|FG001|Overall Study|Lost to Follow-up|19|||
150004050|NCT00958217|541148423|FG000|Overall Study|Moved out of area|1|||
150004051|NCT00958217|541148424|FG001|Overall Study|Moved out of area|1|||
150004052|NCT00958217|541148423|FG000|Overall Study|Inpatient hospitalization|0|||
150004053|NCT00958217|541148424|FG001|Overall Study|Inpatient hospitalization|1|||
150004054|NCT02198235|541148426|FG000|Overall Study|Lost to Follow-up|3|||
150004055|NCT02198235|541148427|FG001|Overall Study|Lost to Follow-up|2|||
150004056|NCT02198235|541148428|FG002|Overall Study|Lost to Follow-up|2|||
150004057|NCT01999218|541148430|FG000|Overall Study|Hyperglycemia|18|||
150004058|NCT01999218|541148431|FG001|Overall Study|Hyperglycemia|17|||
150004059|NCT01999218|541148432|FG002|Overall Study|Hyperglycemia|17|||
150004060|NCT01999218|541148430|FG000|Overall Study|Lack of Efficacy|1|||
150004061|NCT01999218|541148431|FG001|Overall Study|Lack of Efficacy|0|||
150004062|NCT01999218|541148432|FG002|Overall Study|Lack of Efficacy|1|||
150004063|NCT01999218|541148430|FG000|Overall Study|Lost to Follow-up|22|||
150004064|NCT01999218|541148431|FG001|Overall Study|Lost to Follow-up|17|||
150004065|NCT01999218|541148432|FG002|Overall Study|Lost to Follow-up|18|||
150004066|NCT01999218|541148430|FG000|Overall Study|Non-Compliance With Study Drug|6|||
150004067|NCT01999218|541148431|FG001|Overall Study|Non-Compliance With Study Drug|4|||
150004068|NCT01999218|541148432|FG002|Overall Study|Non-Compliance With Study Drug|1|||
150004069|NCT01999218|541148430|FG000|Overall Study|Physician Decision|1|||
150004070|NCT01999218|541148431|FG001|Overall Study|Physician Decision|4|||
150004071|NCT01999218|541148432|FG002|Overall Study|Physician Decision|6|||
150004072|NCT01999218|541148430|FG000|Overall Study|Protocol Violation|4|||
150004073|NCT01999218|541148431|FG001|Overall Study|Protocol Violation|5|||
150004074|NCT01999218|541148432|FG002|Overall Study|Protocol Violation|4|||
150004075|NCT01999218|541148430|FG000|Overall Study|Screen failure|0|||
150004076|NCT01999218|541148431|FG001|Overall Study|Screen failure|1|||
150004077|NCT01999218|541148432|FG002|Overall Study|Screen failure|0|||
150004078|NCT01999218|541148430|FG000|Overall Study|Study Terminated By Sponsor|7|||
150004079|NCT01999218|541148431|FG001|Overall Study|Study Terminated By Sponsor|5|||
150004080|NCT01999218|541148432|FG002|Overall Study|Study Terminated By Sponsor|12|||
150004081|NCT01999218|541148430|FG000|Overall Study|Participant moves|2|||
150004082|NCT01999218|541148431|FG001|Overall Study|Participant moves|5|||
150004083|NCT01999218|541148432|FG002|Overall Study|Participant moves|3|||
150004084|NCT01999218|541148430|FG000|Overall Study|Withdrawal by Subject|28|||
150004085|NCT01999218|541148431|FG001|Overall Study|Withdrawal by Subject|29|||
150004086|NCT01999218|541148432|FG002|Overall Study|Withdrawal by Subject|34|||
150004087|NCT01999218|541148430|FG000|Overall Study|Creatinine/eGFR|0|||
150004088|NCT01999218|541148431|FG001|Overall Study|Creatinine/eGFR|0|||
150004089|NCT01999218|541148432|FG002|Overall Study|Creatinine/eGFR|1|||
150004090|NCT01999218|541148430|FG000|Overall Study|Death|7|||
150004091|NCT01999218|541148431|FG001|Overall Study|Death|1|||
150004092|NCT01999218|541148432|FG002|Overall Study|Death|2|||
150004093|NCT01999218|541148430|FG000|Overall Study|Excluded Medication|1|||
150004094|NCT01999218|541148431|FG001|Overall Study|Excluded Medication|1|||
150004095|NCT01999218|541148432|FG002|Overall Study|Excluded Medication|2|||
150004096|NCT01999218|541148430|FG000|Overall Study|Adverse Event|9|||
150004097|NCT01999218|541148431|FG001|Overall Study|Adverse Event|7|||
150004098|NCT01999218|541148432|FG002|Overall Study|Adverse Event|7|||
150004099|NCT01999218|541148430|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
150004100|NCT01999218|541148431|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
150004101|NCT01999218|541148432|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
150004102|NCT00546260|541148433|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
150004103|NCT00546260|541148434|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
150004104|NCT03780959|541148435|FG000|Part 1|Adverse Event|1|||
150004105|NCT03780959|541148436|FG001|Part 1|Adverse Event|0|||
150004106|NCT03780959|541148437|FG002|Part 1|Adverse Event|0|||
150004107|NCT03780959|541148435|FG000|Part 1|Withdrawal by Subject|1|||
150004108|NCT03780959|541148436|FG001|Part 1|Withdrawal by Subject|0|||
150004109|NCT03780959|541148437|FG002|Part 1|Withdrawal by Subject|0|||
150004110|NCT03780959|541148435|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
150004111|NCT03780959|541148436|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
150004112|NCT03780959|541148437|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
150004113|NCT03780959|541148435|FG000|Part 1|Response Status|2|||
150004114|NCT03780959|541148436|FG001|Part 1|Response Status|0|||
150004115|NCT03780959|541148437|FG002|Part 1|Response Status|0|||
150004116|NCT03780959|541148435|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
150004117|NCT03780959|541148436|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
150004118|NCT03780959|541148437|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
150004119|NCT03780959|541148435|FG000|Part 2|Response Status|0|||
150004120|NCT03780959|541148436|FG001|Part 2|Response Status|18|||
150004121|NCT03780959|541148437|FG002|Part 2|Response Status|6|||
150004122|NCT03681678|541150276|FG000|Overall Study|Lost to Follow-up|20|||
150004123|NCT04619004|541150277|FG000|Overall Study|Death|114|||
150004124|NCT04619004|541150278|FG001|Overall Study|Death|28|||
150004125|NCT04619004|541150277|FG000|Overall Study|Lost to Follow-up|1|||
150004126|NCT04619004|541150278|FG001|Overall Study|Lost to Follow-up|1|||
150004127|NCT04619004|541150277|FG000|Overall Study|Withdrawal by Subject|24|||
150004128|NCT04619004|541150278|FG001|Overall Study|Withdrawal by Subject|7|||
150004129|NCT04619004|541150277|FG000|Overall Study|Other - Not specified|0|||
150004130|NCT04619004|541150278|FG001|Overall Study|Other - Not specified|1|||
150004131|NCT04030962|541150279|FG000|Stage 2|Adverse Event|0|||
150004132|NCT04030962|541150280|FG001|Stage 2|Adverse Event|0|||
150004133|NCT04030962|541150281|FG002|Stage 2|Adverse Event|0|||
150004134|NCT04030962|541150282|FG003|Stage 2|Adverse Event|0|||
150004135|NCT04030962|541150283|FG004|Stage 2|Adverse Event|0|||
150004136|NCT04030962|541150284|FG005|Stage 2|Adverse Event|0|||
150004137|NCT04030962|541150285|FG006|Stage 2|Adverse Event|0|||
150004138|NCT04030962|541150286|FG007|Stage 2|Adverse Event|0|||
150004139|NCT04030962|541150287|FG008|Stage 2|Adverse Event|1|||
150004140|NCT04030962|541150288|FG009|Stage 2|Adverse Event|0|||
150004141|NCT04030962|541150289|FG010|Stage 2|Adverse Event|1|||
150004142|NCT04030962|541150290|FG011|Stage 2|Adverse Event|1|||
150004143|NCT04030962|541150291|FG012|Stage 2|Adverse Event|1|||
150004144|NCT04030962|541150279|FG000|Stage 2|Withdrawal by Subject|0|||
150004145|NCT04030962|541150280|FG001|Stage 2|Withdrawal by Subject|0|||
150004146|NCT04030962|541150281|FG002|Stage 2|Withdrawal by Subject|0|||
150004147|NCT04030962|541150282|FG003|Stage 2|Withdrawal by Subject|0|||
150004148|NCT04030962|541150283|FG004|Stage 2|Withdrawal by Subject|0|||
150004149|NCT04030962|541150284|FG005|Stage 2|Withdrawal by Subject|0|||
150004150|NCT04030962|541150285|FG006|Stage 2|Withdrawal by Subject|0|||
150004151|NCT04030962|541150286|FG007|Stage 2|Withdrawal by Subject|0|||
150004152|NCT04030962|541150287|FG008|Stage 2|Withdrawal by Subject|1|||
150004153|NCT04030962|541150288|FG009|Stage 2|Withdrawal by Subject|0|||
150004154|NCT04030962|541150289|FG010|Stage 2|Withdrawal by Subject|0|||
150004155|NCT04030962|541150290|FG011|Stage 2|Withdrawal by Subject|2|||
150004156|NCT04030962|541150291|FG012|Stage 2|Withdrawal by Subject|1|||
150004157|NCT04030962|541150279|FG000|Stage 2|Lost to Follow-up|0|||
150004158|NCT04030962|541150280|FG001|Stage 2|Lost to Follow-up|0|||
150004159|NCT04030962|541150281|FG002|Stage 2|Lost to Follow-up|0|||
150004160|NCT04030962|541150282|FG003|Stage 2|Lost to Follow-up|0|||
150004161|NCT04030962|541150283|FG004|Stage 2|Lost to Follow-up|0|||
150004162|NCT04030962|541150284|FG005|Stage 2|Lost to Follow-up|0|||
150004163|NCT04030962|541150285|FG006|Stage 2|Lost to Follow-up|0|||
150004164|NCT04030962|541150286|FG007|Stage 2|Lost to Follow-up|0|||
150004165|NCT04030962|541150287|FG008|Stage 2|Lost to Follow-up|1|||
150004166|NCT04030962|541150288|FG009|Stage 2|Lost to Follow-up|0|||
150004167|NCT04030962|541150289|FG010|Stage 2|Lost to Follow-up|0|||
150004168|NCT04030962|541150290|FG011|Stage 2|Lost to Follow-up|0|||
150004169|NCT04030962|541150291|FG012|Stage 2|Lost to Follow-up|0|||
150004170|NCT04030962|541150279|FG000|Stage 2|Technical Problems|0|||
150004171|NCT04030962|541150280|FG001|Stage 2|Technical Problems|0|||
150004172|NCT04030962|541150281|FG002|Stage 2|Technical Problems|0|||
150004173|NCT04030962|541150282|FG003|Stage 2|Technical Problems|0|||
150004174|NCT04030962|541150283|FG004|Stage 2|Technical Problems|0|||
150004175|NCT04030962|541150284|FG005|Stage 2|Technical Problems|0|||
150004176|NCT04030962|541150285|FG006|Stage 2|Technical Problems|0|||
150004177|NCT04030962|541150286|FG007|Stage 2|Technical Problems|0|||
150004178|NCT04030962|541150287|FG008|Stage 2|Technical Problems|0|||
150004179|NCT04030962|541150288|FG009|Stage 2|Technical Problems|0|||
150004180|NCT04030962|541150289|FG010|Stage 2|Technical Problems|0|||
150004181|NCT04030962|541150290|FG011|Stage 2|Technical Problems|1|||
150004182|NCT04030962|541150291|FG012|Stage 2|Technical Problems|0|||
150004183|NCT05288166|541150301|FG000|Overall Study|Adverse Event|1|||
150004184|NCT05288166|541150302|FG001|Overall Study|Adverse Event|0|||
150004185|NCT05288166|541150301|FG000|Overall Study|Lost to Follow-up|2|||
150004186|NCT05288166|541150302|FG001|Overall Study|Lost to Follow-up|0|||
150004187|NCT05288166|541150301|FG000|Overall Study|Physician Decision|0|||
150004188|NCT05288166|541150302|FG001|Overall Study|Physician Decision|2|||
150004189|NCT05288166|541150301|FG000|Overall Study|Screen Failure|1|||
150004190|NCT05288166|541150302|FG001|Overall Study|Screen Failure|1|||
150004191|NCT05288166|541150301|FG000|Overall Study|Withdrawal by Subject|4|||
150179700|NCT01808339|541796792|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179701|NCT01808339|541796793|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
150179702|NCT00409838|541796796|FG000|Short-term Period|Adverse Event|0|||
150179703|NCT00409838|541796797|FG001|Short-term Period|Adverse Event|1|||
150179704|NCT00409838|541796796|FG000|Short-term Period|Lost to Follow-up|0|||
150004192|NCT05288166|541150302|FG001|Overall Study|Withdrawal by Subject|2|||
150004193|NCT05288166|541150301|FG000|Overall Study|On Study Treatment|408|||
150004194|NCT05288166|541150302|FG001|Overall Study|On Study Treatment|418|||
150004195|NCT01114360|541150303|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
150179705|NCT00409838|541796797|FG001|Short-term Period|Lost to Follow-up|1|||
150179706|NCT00409838|541796796|FG000|Short-term Period|Withdrawal by Subject|2|||
150004196|NCT01114360|541150304|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
150004197|NCT01804582|541150305|FG000|Overall Study|Lost to Follow-up|47|||
150055385|NCT01215916|541344152|FG000|Overall Study|Adverse Event|1|||
150004198|NCT01804582|541150306|FG001|Overall Study|Lost to Follow-up|56|||
150004199|NCT01804582|541150305|FG000|Overall Study|Physician Decision|2|||
150004200|NCT01804582|541150306|FG001|Overall Study|Physician Decision|0|||
150004201|NCT00159913|541150307|FG000|Overall Study|Adverse Event|1|||
150004202|NCT00159913|541150308|FG001|Overall Study|Adverse Event|0|||
150004203|NCT00159913|541150309|FG002|Overall Study|Adverse Event|1|||
150004204|NCT00159913|541150310|FG003|Overall Study|Adverse Event|0|||
150004205|NCT00159913|541150307|FG000|Overall Study|Withdrawal by Subject|0|||
150004206|NCT00159913|541150308|FG001|Overall Study|Withdrawal by Subject|0|||
150004207|NCT00159913|541150309|FG002|Overall Study|Withdrawal by Subject|0|||
150004208|NCT00159913|541150310|FG003|Overall Study|Withdrawal by Subject|1|||
150004209|NCT00159913|541150307|FG000|Overall Study|Lost to Follow-up|0|||
150004210|NCT00159913|541150308|FG001|Overall Study|Lost to Follow-up|0|||
150004211|NCT00159913|541150309|FG002|Overall Study|Lost to Follow-up|0|||
150004212|NCT00159913|541150310|FG003|Overall Study|Lost to Follow-up|1|||
150004213|NCT00159913|541150307|FG000|Overall Study|Protocol Violation|1|||
150004214|NCT00159913|541150308|FG001|Overall Study|Protocol Violation|0|||
150004215|NCT00159913|541150309|FG002|Overall Study|Protocol Violation|1|||
150004216|NCT00159913|541150310|FG003|Overall Study|Protocol Violation|0|||
150004217|NCT03455829|541150311|FG000|Overall Study|Death|2|||
150004218|NCT03455829|541150312|FG001|Overall Study|Death|3|||
150004219|NCT03455829|541150313|FG002|Overall Study|Death|2|||
150004220|NCT03455829|541150314|FG003|Overall Study|Death|4|||
150004221|NCT03455829|541150315|FG004|Overall Study|Death|2|||
150004222|NCT03455829|541150311|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
150004223|NCT03455829|541150312|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
150004224|NCT03455829|541150313|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
150004225|NCT03455829|541150314|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
150004226|NCT03455829|541150315|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
150004227|NCT03455829|541150311|FG000|Overall Study|Disease progression|0|||
150004228|NCT03455829|541150312|FG001|Overall Study|Disease progression|0|||
150004229|NCT03455829|541150313|FG002|Overall Study|Disease progression|0|||
150004230|NCT03455829|541150314|FG003|Overall Study|Disease progression|1|||
150004231|NCT03455829|541150315|FG004|Overall Study|Disease progression|1|||
150004232|NCT00689793|541150319|FG000|Overall Study|Lost to Follow-up|4|||
150004233|NCT00689793|541150320|FG001|Overall Study|Lost to Follow-up|5|||
150004234|NCT00875056|541150321|FG000|Overall Study|Adverse Event|6|||
150004235|NCT00875056|541150322|FG001|Overall Study|Adverse Event|1|||
150004236|NCT00875056|541150323|FG002|Overall Study|Adverse Event|2|||
150004237|NCT00875056|541150321|FG000|Overall Study|Progressive Disease|14|||
150004238|NCT00875056|541150322|FG001|Overall Study|Progressive Disease|8|||
150004239|NCT00875056|541150323|FG002|Overall Study|Progressive Disease|3|||
150004240|NCT00875056|541150321|FG000|Overall Study|Withdrawal by Subject|3|||
150004241|NCT00875056|541150322|FG001|Overall Study|Withdrawal by Subject|0|||
150004242|NCT00875056|541150323|FG002|Overall Study|Withdrawal by Subject|1|||
150004243|NCT00357656|541150324|FG000|Overall Study|Other, No surgery performed|0|||
150004244|NCT00357656|541150325|FG001|Overall Study|Other, No surgery performed|3|||
150004245|NCT02573246|541150326|FG000|Overall Study|Lost to Follow-up|2|||
150004246|NCT02573246|541150327|FG001|Overall Study|Lost to Follow-up|0|||
150004247|NCT02573246|541150328|FG002|Overall Study|Lost to Follow-up|0|||
150004248|NCT02573246|541150329|FG003|Overall Study|Lost to Follow-up|0|||
150004249|NCT02573246|541150330|FG004|Overall Study|Lost to Follow-up|1|||
150004250|NCT02573246|541150326|FG000|Overall Study|Withdrawal by Subject|0|||
150004251|NCT02573246|541150327|FG001|Overall Study|Withdrawal by Subject|0|||
150004252|NCT02573246|541150328|FG002|Overall Study|Withdrawal by Subject|0|||
150004253|NCT02573246|541150329|FG003|Overall Study|Withdrawal by Subject|0|||
150004254|NCT02573246|541150330|FG004|Overall Study|Withdrawal by Subject|1|||
150004255|NCT02573246|541150326|FG000|Overall Study|Physician Decision|1|||
150004256|NCT02573246|541150327|FG001|Overall Study|Physician Decision|1|||
150004257|NCT02573246|541150328|FG002|Overall Study|Physician Decision|3|||
150004258|NCT02573246|541150329|FG003|Overall Study|Physician Decision|2|||
150004259|NCT02573246|541150330|FG004|Overall Study|Physician Decision|2|||
150004260|NCT01011933|541150333|FG000|Overall Study|Wrong cell type|1|||
150004261|NCT01011933|541150333|FG000|Overall Study|Improper pre-protocol Rx|1|||
150004262|NCT01011933|541150333|FG000|Overall Study|Inadequate pathology|1|||
150004263|NCT01011933|541150333|FG000|Overall Study|Never treated|1|||
150004264|NCT01439074|541150334|FG000|Overall Study|Lost to Follow-up|3|||
150004265|NCT01439074|541150335|FG001|Overall Study|Lost to Follow-up|4|||
150004266|NCT01439074|541150334|FG000|Overall Study|Subject shedding|1|||
150004267|NCT01439074|541150335|FG001|Overall Study|Subject shedding|0|||
150004268|NCT01439074|541150334|FG000|Overall Study|Withdrawal by Subject|1|||
150004269|NCT01439074|541150335|FG001|Overall Study|Withdrawal by Subject|5|||
150004270|NCT01439074|541150334|FG000|Overall Study|Other|4|||
150004271|NCT01439074|541150335|FG001|Overall Study|Other|4|||
150004272|NCT00815191|541150336|FG000|Overall Study|Protocol Violation|1|||
150004273|NCT00815191|541150337|FG001|Overall Study|Protocol Violation|1|||
150004274|NCT02639338|541150338|FG000|Overall Study|Lost to Follow-up|2|||
150004275|NCT02639338|541150339|FG001|Overall Study|Lost to Follow-up|2|||
150004276|NCT02639338|541150338|FG000|Overall Study|Withdrew Consent|1|||
150004277|NCT02639338|541150339|FG001|Overall Study|Withdrew Consent|2|||
150004278|NCT02639338|541150338|FG000|Overall Study|Death|1|||
150004279|NCT02639338|541150339|FG001|Overall Study|Death|0|||
150004280|NCT02639338|541150338|FG000|Overall Study|Randomized but Not Treated|0|||
150004281|NCT02639338|541150339|FG001|Overall Study|Randomized but Not Treated|1|||
150004282|NCT00493636|541150341|FG000|Overall Study|Withdrawal by Subject|1|||
150004283|NCT00493636|541150342|FG001|Overall Study|Withdrawal by Subject|0|||
150004284|NCT00493636|541150341|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
150004285|NCT00493636|541150342|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
150004286|NCT00493636|541150341|FG000|Overall Study|Mis-randomization|1|||
150004287|NCT00493636|541150342|FG001|Overall Study|Mis-randomization|1|||
150004288|NCT02900170|541150343|FG000|Overall Study|Lost to Follow-up|8|||
150004289|NCT01814670|541150349|FG000|Overall Study|Protocol Violation|12|||
150004290|NCT02012686|541150350|FG000|Overall Study|muscle contraction|0|||
150004291|NCT02012686|541150351|FG001|Overall Study|muscle contraction|1|||
150004292|NCT02012686|541150350|FG000|Overall Study|electrocardiography monitoring noise|0|||
150004293|NCT02012686|541150351|FG001|Overall Study|electrocardiography monitoring noise|1|||
150004294|NCT01703065|541150354|FG000|Overall Study|Lack of Efficacy|1|||
150004295|NCT01703065|541150355|FG001|Overall Study|Lack of Efficacy|0|||
150004296|NCT03352453|541150358|FG000|Overall Study|Miscellaneous Reasons|1|||
150004297|NCT03352453|541150359|FG001|Overall Study|Miscellaneous Reasons|2|||
150004298|NCT03352453|541150358|FG000|Overall Study|Lack of Efficacy|1|||
150004299|NCT03352453|541150359|FG001|Overall Study|Lack of Efficacy|0|||
150004300|NCT03352453|541150358|FG000|Overall Study|Withdrawal by Subject|8|||
150004301|NCT03352453|541150359|FG001|Overall Study|Withdrawal by Subject|14|||
150004302|NCT03352453|541150358|FG000|Overall Study|Study Terminated by Sponsor|2|||
150004303|NCT03352453|541150359|FG001|Overall Study|Study Terminated by Sponsor|1|||
150004304|NCT03352453|541150358|FG000|Overall Study|Protocol Deviation|1|||
150004305|NCT03352453|541150359|FG001|Overall Study|Protocol Deviation|0|||
150004306|NCT03352453|541150358|FG000|Overall Study|Lost to Follow-up|7|||
150004307|NCT03352453|541150359|FG001|Overall Study|Lost to Follow-up|6|||
150004308|NCT03352453|541150358|FG000|Overall Study|Adverse Event|2|||
150004309|NCT03352453|541150359|FG001|Overall Study|Adverse Event|9|||
150004310|NCT02827500|541150360|FG000|Overall Study|Death|7|||
150004311|NCT02827500|541150361|FG001|Overall Study|Death|3|||
150004312|NCT02827500|541150360|FG000|Overall Study|Lost to Follow-up|1|||
150004313|NCT02827500|541150361|FG001|Overall Study|Lost to Follow-up|1|||
150004314|NCT02827500|541150360|FG000|Overall Study|Withdrawal by Subject|3|||
150004315|NCT02827500|541150361|FG001|Overall Study|Withdrawal by Subject|1|||
150004316|NCT02827500|541150360|FG000|Overall Study|Missing primary endpoint data|3|||
150004317|NCT02827500|541150361|FG001|Overall Study|Missing primary endpoint data|1|||
150004318|NCT02827500|541150360|FG000|Overall Study|Other|5|||
150004319|NCT02827500|541150361|FG001|Overall Study|Other|1|||
150004320|NCT01241760|541150362|FG000|Overall Study|Adverse Event|1|||
150004321|NCT01241760|541150363|FG001|Overall Study|Adverse Event|0|||
150004322|NCT01241760|541150362|FG000|Overall Study|Lost to Follow-up|18|||
150004323|NCT01241760|541150363|FG001|Overall Study|Lost to Follow-up|22|||
150004324|NCT01241760|541150362|FG000|Overall Study|Withdrawal by Subject|13|||
150004325|NCT01241760|541150363|FG001|Overall Study|Withdrawal by Subject|13|||
150004326|NCT01241760|541150362|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
150004327|NCT01241760|541150363|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
150004328|NCT01241760|541150362|FG000|Overall Study|Other|1|||
150004329|NCT01241760|541150363|FG001|Overall Study|Other|1|||
150004330|NCT02725593|541150364|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
150004331|NCT02725593|541150365|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
150004332|NCT02725593|541150364|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
150004333|NCT02725593|541150365|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
150004334|NCT02725593|541150364|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
150004335|NCT02725593|541150365|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
150004336|NCT02725593|541150364|FG000|Long Term Extension|Withdrawal by Subject|1|||
150004337|NCT02725593|541150365|FG001|Long Term Extension|Withdrawal by Subject|3|||
150004338|NCT00514020|541150366|FG000|Overall Study|Adverse Event|6|||
150004339|NCT00514020|541150366|FG000|Overall Study|Withdrawal by Subject|3|||
150004340|NCT00514020|541150366|FG000|Overall Study|Physician Decision|1|||
150004341|NCT00514020|541150366|FG000|Overall Study|disease progression|9|||
150004342|NCT00514020|541150366|FG000|Overall Study|other complicating disease|2|||
150055386|NCT01215916|541344153|FG001|Overall Study|Adverse Event|1|||
150004343|NCT00514020|541150366|FG000|Overall Study|patient went to radiation treatment|1|||
150004344|NCT00514020|541150366|FG000|Overall Study|"patients moved to the no tx group"|6|||
150004345|NCT01490294|541150390|FG000|Overall Study|Prematurely discontinuation|4|||
150004346|NCT01490294|541150391|FG001|Overall Study|Prematurely discontinuation|0|||
150004347|NCT01490294|541150392|FG002|Overall Study|Prematurely discontinuation|1|||
150004348|NCT01490294|541150393|FG003|Overall Study|Prematurely discontinuation|1|||
150004349|NCT01490294|541150390|FG000|Overall Study|Adverse Event|1|||
150004350|NCT01490294|541150391|FG001|Overall Study|Adverse Event|0|||
150004351|NCT01490294|541150392|FG002|Overall Study|Adverse Event|0|||
150004352|NCT01490294|541150393|FG003|Overall Study|Adverse Event|0|||
150004353|NCT01751776|541150396|FG000|Overall Study|Adverse Event|0|||
150004354|NCT01751776|541150397|FG001|Overall Study|Adverse Event|0|||
150004355|NCT01751776|541150398|FG002|Overall Study|Adverse Event|0|||
150004356|NCT01751776|541150399|FG003|Overall Study|Adverse Event|0|||
150004357|NCT01751776|541150400|FG004|Overall Study|Adverse Event|0|||
150004358|NCT01751776|541150401|FG005|Overall Study|Adverse Event|0|||
150004359|NCT01751776|541150402|FG006|Overall Study|Adverse Event|4|||
150004360|NCT01751776|541150403|FG007|Overall Study|Adverse Event|2|||
150004361|NCT01751776|541150396|FG000|Overall Study|Consent withdrawn|0|||
150004362|NCT01751776|541150397|FG001|Overall Study|Consent withdrawn|0|||
150004363|NCT01751776|541150398|FG002|Overall Study|Consent withdrawn|0|||
150004364|NCT01751776|541150399|FG003|Overall Study|Consent withdrawn|0|||
150004365|NCT01751776|541150400|FG004|Overall Study|Consent withdrawn|0|||
150004366|NCT01751776|541150401|FG005|Overall Study|Consent withdrawn|0|||
150004367|NCT01751776|541150402|FG006|Overall Study|Consent withdrawn|0|||
150004368|NCT01751776|541150403|FG007|Overall Study|Consent withdrawn|1|||
150004369|NCT01751776|541150396|FG000|Overall Study|Other reason not specified above|0|||
150004370|NCT01751776|541150397|FG001|Overall Study|Other reason not specified above|0|||
150004371|NCT01751776|541150398|FG002|Overall Study|Other reason not specified above|0|||
150004372|NCT01751776|541150399|FG003|Overall Study|Other reason not specified above|0|||
150004373|NCT01751776|541150400|FG004|Overall Study|Other reason not specified above|0|||
150004374|NCT01751776|541150401|FG005|Overall Study|Other reason not specified above|0|||
150004375|NCT01751776|541150402|FG006|Overall Study|Other reason not specified above|0|||
150004376|NCT01751776|541150403|FG007|Overall Study|Other reason not specified above|1|||
150004377|NCT00160654|541150404|FG000|Overall Study|Adverse Event|14|||
150004378|NCT00160654|541150404|FG000|Overall Study|Lack of Efficacy|4|||
150004379|NCT00160654|541150404|FG000|Overall Study|Lost to Follow-up|2|||
150004380|NCT00160654|541150404|FG000|Overall Study|Intake of expired drug|7|||
150004381|NCT00160654|541150404|FG000|Overall Study|Psychological trauma|1|||
150004382|NCT00160654|541150404|FG000|Overall Study|Sponsor decision|1|||
150004383|NCT00160654|541150404|FG000|Overall Study|Patient met exclusion criteria|1|||
150004384|NCT00160654|541150404|FG000|Overall Study|Patient decision|1|||
150004385|NCT00160654|541150404|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
150004386|NCT00160654|541150404|FG000|Overall Study|Met exclusion criteria|1|||
150004387|NCT00831701|541150407|FG000|Overall Study|Withdrawal by Subject|2|||
150004388|NCT00831701|541150408|FG001|Overall Study|Withdrawal by Subject|0|||
150004389|NCT00831701|541150407|FG000|Overall Study|Stone expulsion before first medication|2|||
150004390|NCT00831701|541150408|FG001|Overall Study|Stone expulsion before first medication|2|||
150004391|NCT00831701|541150407|FG000|Overall Study|Lost to Follow-up|1|||
150004392|NCT00831701|541150408|FG001|Overall Study|Lost to Follow-up|3|||
150004393|NCT02117349|541150409|FG000|Overall Study|Withdrawal by Subject|1|||
150004394|NCT02117349|541150410|FG001|Overall Study|Withdrawal by Subject|0|||
150004395|NCT02117349|541150409|FG000|Overall Study|Lost to Follow-up|1|||
150004396|NCT02117349|541150410|FG001|Overall Study|Lost to Follow-up|1|||
150004397|NCT02117349|541150409|FG000|Overall Study|Death|1|||
150004398|NCT02117349|541150410|FG001|Overall Study|Death|0|||
150004399|NCT01440881|541150411|FG000|Overall Study|Death|0|||
150004400|NCT01440881|541150412|FG001|Overall Study|Death|1|||
150004401|NCT02242981|541150413|FG000|Overall Study|Withdrawal by Subject|1|||
150004402|NCT02535416|541150416|FG000|Overall Study|Family bereavement overseas|1|||
150004403|NCT02535416|541150417|FG001|Overall Study|Family bereavement overseas|0|||
150004404|NCT02535416|541150418|FG002|Overall Study|Family bereavement overseas|0|||
150004405|NCT02535416|541150419|FG003|Overall Study|Family bereavement overseas|0|||
150004406|NCT02535416|541150420|FG004|Overall Study|Family bereavement overseas|0|||
150004407|NCT02535416|541150421|FG005|Overall Study|Family bereavement overseas|0|||
150004408|NCT02535416|541150422|FG006|Overall Study|Family bereavement overseas|0|||
150004409|NCT02535416|541150423|FG007|Overall Study|Family bereavement overseas|0|||
150004410|NCT02535416|541150424|FG008|Overall Study|Family bereavement overseas|0|||
150004411|NCT03474081|541150425|FG000|Overall Study|Adverse Event|6|||
150004412|NCT03474081|541150426|FG001|Overall Study|Adverse Event|3|||
150004413|NCT03474081|541150425|FG000|Overall Study|Lost to Follow-up|2|||
150004414|NCT03474081|541150426|FG001|Overall Study|Lost to Follow-up|1|||
150004415|NCT03474081|541150425|FG000|Overall Study|Physician Decision|3|||
150004416|NCT03474081|541150426|FG001|Overall Study|Physician Decision|2|||
150004417|NCT03474081|541150425|FG000|Overall Study|Withdrawal by Subject|5|||
150004418|NCT03474081|541150426|FG001|Overall Study|Withdrawal by Subject|7|||
150004419|NCT03474081|541150425|FG000|Overall Study|Investigator site closed|1|||
150004420|NCT03474081|541150426|FG001|Overall Study|Investigator site closed|0|||
150004421|NCT01977690|541150429|FG000|Overall Study|Withdrawal by Subject|0|||
150004422|NCT01977690|541150430|FG001|Overall Study|Withdrawal by Subject|4|||
150004423|NCT02644356|541150435|FG000|Overall Study|Withdrawal by Subject|2|||
150004424|NCT02210091|541150436|FG000|Overall Study|Physician Decision|0|||
150004425|NCT02210091|541150437|FG001|Overall Study|Physician Decision|1|||
150004426|NCT02210091|541150436|FG000|Overall Study|Withdrawal by Sponsor|0|||
150004427|NCT02210091|541150437|FG001|Overall Study|Withdrawal by Sponsor|1|||
150004428|NCT02739321|541150438|FG000|Overall Study|Lack of Efficacy|1|||
150004429|NCT02739321|541150439|FG001|Overall Study|Lack of Efficacy|1|||
150004430|NCT02739321|541150438|FG000|Overall Study|Lost to Follow-up|1|||
150004431|NCT02739321|541150439|FG001|Overall Study|Lost to Follow-up|1|||
150004432|NCT02739321|541150438|FG000|Overall Study|Withdrawal by Subject|1|||
150004433|NCT02739321|541150439|FG001|Overall Study|Withdrawal by Subject|2|||
150004434|NCT01711866|541150440|FG000|Overall Study|Noncompliant|3|||
150004435|NCT01711866|541150440|FG000|Overall Study|Withdrawal by Subject|3|||
150004436|NCT01711866|541150440|FG000|Overall Study|Adverse Event|2|||
150004437|NCT00897390|541150441|FG000|Overall Study|Adverse Event|2|||
150004438|NCT00897390|541150441|FG000|Overall Study|No Longer Met Study Criteria|1|||
150004439|NCT00897390|541150441|FG000|Overall Study|Personal Reasons|1|||
150004440|NCT00897390|541150441|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
150004441|NCT03159104|541150442|FG000|Overall Study|Violation of inclusion criteria|1|||
150004442|NCT03159104|541150443|FG001|Overall Study|Violation of inclusion criteria|2|||
150004443|NCT02440789|541150446|FG000|Overall Study|Withdrawal by Subject|3|||
150004444|NCT02440789|541150446|FG000|Overall Study|Not willing to adhere to reqs|1|||
150004445|NCT04938037|541151673|FG000|Overall Study|Lost to Follow-up|4|||
150004446|NCT04938037|541151674|FG001|Overall Study|Lost to Follow-up|3|||
150004447|NCT05160766|541151678|FG000|Overall Study|Adverse Event|0|||
150004448|NCT05160766|541151679|FG001|Overall Study|Adverse Event|1|||
150004449|NCT05160766|541151680|FG002|Overall Study|Adverse Event|0|||
150004450|NCT05160766|541151681|FG003|Overall Study|Adverse Event|0|||
150004451|NCT05160766|541151678|FG000|Overall Study|COVID-19 infection|0|||
150004452|NCT05160766|541151679|FG001|Overall Study|COVID-19 infection|1|||
150004453|NCT05160766|541151680|FG002|Overall Study|COVID-19 infection|0|||
150004454|NCT05160766|541151681|FG003|Overall Study|COVID-19 infection|0|||
150004455|NCT05160766|541151678|FG000|Overall Study|travel time|1|||
150004456|NCT05160766|541151679|FG001|Overall Study|travel time|0|||
150004457|NCT05160766|541151680|FG002|Overall Study|travel time|0|||
150004458|NCT05160766|541151681|FG003|Overall Study|travel time|1|||
150004459|NCT05160766|541151678|FG000|Overall Study|Withdrawal by Subject|3|||
150004460|NCT05160766|541151679|FG001|Overall Study|Withdrawal by Subject|5|||
150004461|NCT05160766|541151680|FG002|Overall Study|Withdrawal by Subject|4|||
150004462|NCT05160766|541151681|FG003|Overall Study|Withdrawal by Subject|2|||
150004463|NCT05160766|541151678|FG000|Overall Study|Death|0|||
150004464|NCT05160766|541151679|FG001|Overall Study|Death|0|||
150004465|NCT05160766|541151680|FG002|Overall Study|Death|2|||
150004466|NCT05160766|541151681|FG003|Overall Study|Death|5|||
150004467|NCT05160766|541151678|FG000|Overall Study|Lost to Follow-up|0|||
150004468|NCT05160766|541151679|FG001|Overall Study|Lost to Follow-up|0|||
150004469|NCT05160766|541151680|FG002|Overall Study|Lost to Follow-up|1|||
150004470|NCT05160766|541151681|FG003|Overall Study|Lost to Follow-up|2|||
150004471|NCT05160766|541151678|FG000|Overall Study|No show|0|||
150004472|NCT05160766|541151679|FG001|Overall Study|No show|0|||
150004473|NCT05160766|541151680|FG002|Overall Study|No show|1|||
150004474|NCT05160766|541151681|FG003|Overall Study|No show|1|||
150004475|NCT05160766|541151678|FG000|Overall Study|Physician Decision|0|||
150004476|NCT05160766|541151679|FG001|Overall Study|Physician Decision|0|||
150004477|NCT05160766|541151680|FG002|Overall Study|Physician Decision|0|||
150004478|NCT05160766|541151681|FG003|Overall Study|Physician Decision|1|||
150004479|NCT05160766|541151678|FG000|Overall Study|Protocol Violation|0|||
150004480|NCT05160766|541151679|FG001|Overall Study|Protocol Violation|0|||
150004481|NCT05160766|541151680|FG002|Overall Study|Protocol Violation|1|||
150055387|NCT01215916|541344154|FG002|Overall Study|Adverse Event|0|||
150004482|NCT05160766|541151681|FG003|Overall Study|Protocol Violation|0|||
150004483|NCT02654236|541151682|FG000|Overall Study|Withdrawal by Subject|0|||
150004484|NCT02654236|541151683|FG001|Overall Study|Withdrawal by Subject|0|||
150004485|NCT02654236|541151684|FG002|Overall Study|Withdrawal by Subject|2|||
150004486|NCT01549873|541151685|FG000|Overall Study|Physician Decision|0|||
150004487|NCT01549873|541151686|FG001|Overall Study|Physician Decision|1|||
150004488|NCT04271475|541151691|FG000|DB Period: Day 1 up to EODBT|Death|1|||
150004489|NCT04271475|541151692|FG001|DB Period: Day 1 up to EODBT|Death|0|||
150055388|NCT01215916|541344155|FG003|Overall Study|Adverse Event|1|||
150004490|NCT04271475|541151693|FG002|DB Period: Day 1 up to EODBT|Death|0|||
150004491|NCT04271475|541151694|FG003|DB Period: Day 1 up to EODBT|Death|0|||
150055389|NCT01215916|541344156|FG004|Overall Study|Adverse Event|0|||
150004492|NCT04271475|541151691|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
150004493|NCT04271475|541151692|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
150004494|NCT04271475|541151693|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
150004495|NCT04271475|541151694|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
150004496|NCT04271475|541151691|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
150004497|NCT04271475|541151692|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
150004498|NCT04271475|541151693|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
150004499|NCT04271475|541151694|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
150004500|NCT04271475|541151691|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
150004501|NCT04271475|541151692|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
150004502|NCT04271475|541151693|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
150004503|NCT04271475|541151694|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
150004504|NCT04271475|541151691|FG000|DB Period: Day 1 up to EODBT|Other|8|||
150004505|NCT04271475|541151692|FG001|DB Period: Day 1 up to EODBT|Other|5|||
150004506|NCT04271475|541151693|FG002|DB Period: Day 1 up to EODBT|Other|0|||
150004507|NCT04271475|541151694|FG003|DB Period: Day 1 up to EODBT|Other|0|||
150004508|NCT04271475|541151691|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
150004509|NCT04271475|541151692|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
150004510|NCT04271475|541151693|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
150004511|NCT04271475|541151694|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
150004512|NCT04271475|541151691|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
150004513|NCT04271475|541151692|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
150004514|NCT04271475|541151693|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
150004515|NCT04271475|541151694|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
150004516|NCT02212678|541151697|FG000|Overall Study|Adverse Event|1|||
150004517|NCT02337634|541151698|FG000|Overall Study|Protocol Violation|3|||
150004518|NCT02337634|541151699|FG001|Overall Study|Protocol Violation|1|||
150004519|NCT02337634|541151698|FG000|Overall Study|Lost to Follow-up|1|||
150004520|NCT02337634|541151699|FG001|Overall Study|Lost to Follow-up|0|||
150004521|NCT02046070|541151701|FG000|Overall Study|Progressive Disease|18|||
150004522|NCT02046070|541151702|FG001|Overall Study|Progressive Disease|11|||
150004523|NCT02046070|541151703|FG002|Overall Study|Progressive Disease|40|||
150004524|NCT02046070|541151701|FG000|Overall Study|Adverse Event|8|||
150004525|NCT02046070|541151702|FG001|Overall Study|Adverse Event|10|||
150004526|NCT02046070|541151703|FG002|Overall Study|Adverse Event|17|||
150004527|NCT02046070|541151701|FG000|Overall Study|Withdrawal by Subject|1|||
150004528|NCT02046070|541151702|FG001|Overall Study|Withdrawal by Subject|2|||
150004529|NCT02046070|541151703|FG002|Overall Study|Withdrawal by Subject|6|||
150004530|NCT02046070|541151701|FG000|Overall Study|Study Terminated by Sponsor|1|||
150004531|NCT02046070|541151702|FG001|Overall Study|Study Terminated by Sponsor|1|||
150004532|NCT02046070|541151703|FG002|Overall Study|Study Terminated by Sponsor|1|||
150004533|NCT02046070|541151701|FG000|Overall Study|Reason not Specified|4|||
150004534|NCT02046070|541151702|FG001|Overall Study|Reason not Specified|4|||
150004535|NCT02046070|541151703|FG002|Overall Study|Reason not Specified|6|||
150004536|NCT01818284|541151704|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
150004537|NCT01818284|541151705|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
150004538|NCT01818284|541151704|FG000|Overall Study|Death|0|||
150004539|NCT01818284|541151705|FG001|Overall Study|Death|2|||
150004540|NCT05601102|541151706|FG000|Overall Study|Death|1|||
150004541|NCT05601102|541151707|FG001|Overall Study|Death|2|||
150004542|NCT05601102|541151706|FG000|Overall Study|Withdrawal by Subject|1|||
150004543|NCT05601102|541151707|FG001|Overall Study|Withdrawal by Subject|1|||
150004544|NCT05601102|541151706|FG000|Overall Study|Lost to Follow-up|0|||
150004545|NCT05601102|541151707|FG001|Overall Study|Lost to Follow-up|2|||
150004546|NCT04284813|541151708|FG000|Overall Study|Withdrawal by Subject|1|||
150004547|NCT03106415|541151709|FG000|Phase 1|Withdrawal by Subject|1|||
150004548|NCT03106415|541151710|FG001|Phase 1|Withdrawal by Subject|0|||
150004549|NCT03106415|541151711|FG002|Phase 1|Withdrawal by Subject|0|||
150004550|NCT03106415|541151709|FG000|Phase 1|Adverse Event|1|||
150004551|NCT03106415|541151710|FG001|Phase 1|Adverse Event|1|||
150004552|NCT03106415|541151711|FG002|Phase 1|Adverse Event|0|||
150004553|NCT03106415|541151709|FG000|Phase 1|Protocol Violation|0|||
150004554|NCT03106415|541151710|FG001|Phase 1|Protocol Violation|1|||
150004555|NCT03106415|541151711|FG002|Phase 1|Protocol Violation|0|||
150004556|NCT00385723|541151714|FG000|Overall Study|Lost to Follow-up|1|||
150004557|NCT00385723|541151715|FG001|Overall Study|Lost to Follow-up|1|||
150004558|NCT00385723|541151716|FG002|Overall Study|Lost to Follow-up|0|||
150004559|NCT00385723|541151714|FG000|Overall Study|Withdrawal by Subject|1|||
150179707|NCT00409838|541796797|FG001|Short-term Period|Withdrawal by Subject|3|||
150179708|NCT00409838|541796796|FG000|Short-term Period|Never Treated|1|||
150004560|NCT00385723|541151715|FG001|Overall Study|Withdrawal by Subject|0|||
150004561|NCT00385723|541151716|FG002|Overall Study|Withdrawal by Subject|2|||
150004562|NCT01390779|541151717|FG000|Overall Study|Physician Decision|1|||
150004563|NCT03689712|541151718|FG000|Overall Study|Adverse Event|1|||
150004564|NCT03689712|541151719|FG001|Overall Study|Adverse Event|0|||
150004565|NCT03689712|541151718|FG000|Overall Study|Death|20|||
150004566|NCT03689712|541151719|FG001|Overall Study|Death|10|||
150004567|NCT03689712|541151718|FG000|Overall Study|Lost to Follow-up|6|||
150004568|NCT03689712|541151719|FG001|Overall Study|Lost to Follow-up|6|||
150004569|NCT03689712|541151718|FG000|Overall Study|Other|1|||
150004570|NCT03689712|541151719|FG001|Overall Study|Other|0|||
150004571|NCT03689712|541151718|FG000|Overall Study|Patient Non-Compliance|0|||
150004572|NCT03689712|541151719|FG001|Overall Study|Patient Non-Compliance|1|||
150004573|NCT03689712|541151718|FG000|Overall Study|Withdrawal by Subject|20|||
150004574|NCT03689712|541151719|FG001|Overall Study|Withdrawal by Subject|4|||
150004575|NCT03689712|541151718|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
150004576|NCT03689712|541151719|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
150004577|NCT03689712|541151718|FG000|Overall Study|Randomized but not Treated|13|||
150004578|NCT03689712|541151719|FG001|Overall Study|Randomized but not Treated|7|||
150004579|NCT03689712|541151718|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
150004580|NCT03689712|541151719|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
150004581|NCT00353873|541151722|FG000|Overall Study|Protocol Violation|1|||
150004582|NCT00353873|541151723|FG001|Overall Study|Protocol Violation|2|||
150004583|NCT00353873|541151722|FG000|Overall Study|Exacerbation|1|||
150004584|NCT00353873|541151723|FG001|Overall Study|Exacerbation|0|||
150004585|NCT00353873|541151722|FG000|Overall Study|Adverse Event|1|||
150004586|NCT00353873|541151723|FG001|Overall Study|Adverse Event|0|||
150004587|NCT00353873|541151722|FG000|Overall Study|Physician Decision|2|||
150004588|NCT00353873|541151723|FG001|Overall Study|Physician Decision|0|||
150004589|NCT00353873|541151722|FG000|Overall Study|Withdrawal by Subject|1|||
150004590|NCT00353873|541151723|FG001|Overall Study|Withdrawal by Subject|1|||
150004591|NCT03743064|541151724|FG000|Overall Study|Adverse Event|7|||
150004592|NCT03743064|541151725|FG001|Overall Study|Adverse Event|9|||
150004593|NCT03743064|541151724|FG000|Overall Study|Death|25|||
150004594|NCT03743064|541151725|FG001|Overall Study|Death|28|||
150004595|NCT03743064|541151724|FG000|Overall Study|Lost to Follow-up|3|||
150004596|NCT03743064|541151725|FG001|Overall Study|Lost to Follow-up|6|||
150004597|NCT03743064|541151724|FG000|Overall Study|Withdrawal by Subject|28|||
150004598|NCT03743064|541151725|FG001|Overall Study|Withdrawal by Subject|25|||
150004599|NCT03743064|541151724|FG000|Overall Study|Physician Decision|2|||
150004600|NCT03743064|541151725|FG001|Overall Study|Physician Decision|4|||
150004601|NCT03743064|541151724|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
150004602|NCT03743064|541151725|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
150004603|NCT00973102|541151731|FG000|Overall Study|Protocol Violation|1|||
150004604|NCT00973102|541151732|FG001|Overall Study|Protocol Violation|0|||
150004605|NCT00973102|541151731|FG000|Overall Study|Prisoner|0|||
150004606|NCT00973102|541151732|FG001|Overall Study|Prisoner|1|||
150004607|NCT00966719|541151733|FG000|Overall Study|Lost to Follow-up|6|||
150004608|NCT00966719|541151734|FG001|Overall Study|Lost to Follow-up|11|||
150004609|NCT04941807|541151735|FG000|Overall Study|Lost to Follow-up|1|||
150004610|NCT04941807|541151736|FG001|Overall Study|Lost to Follow-up|1|||
150004611|NCT03553498|541151737|FG000|Overall Study|Missing primary outcome|1|||
150004612|NCT03553498|541151738|FG001|Overall Study|Missing primary outcome|2|||
150055390|NCT01215916|541344157|FG005|Overall Study|Adverse Event|0|||
150055391|NCT01215916|541344158|FG006|Overall Study|Adverse Event|3|||
150055392|NCT01215916|541344159|FG007|Overall Study|Adverse Event|0|||
150004613|NCT01100567|541151739|FG000|Overall Study|Withdrawal by Subject|5|||
150004614|NCT01100567|541151740|FG001|Overall Study|Withdrawal by Subject|8|||
150004615|NCT01100567|541151739|FG000|Overall Study|Early Hospital Discharge|6|||
150004616|NCT01100567|541151740|FG001|Overall Study|Early Hospital Discharge|4|||
150004617|NCT01100567|541151739|FG000|Overall Study|Lost to Follow-up|1|||
150004618|NCT01100567|541151740|FG001|Overall Study|Lost to Follow-up|2|||
150004619|NCT01100567|541151739|FG000|Overall Study|Physician Decision|0|||
150004620|NCT01100567|541151740|FG001|Overall Study|Physician Decision|1|||
150004621|NCT01100567|541151739|FG000|Overall Study|Deemed ineligible after consent|0|||
150004622|NCT01100567|541151740|FG001|Overall Study|Deemed ineligible after consent|1|||
150004623|NCT00160199|541151741|FG000|Overall Study|Adverse Event|5|||
150004624|NCT00160199|541151742|FG001|Overall Study|Adverse Event|14|||
150004625|NCT00160199|541151741|FG000|Overall Study|Lack of Efficacy|0|||
150055393|NCT01215916|541344160|FG008|Overall Study|Adverse Event|0|||
150055394|NCT01215916|541344152|FG000|Overall Study|Withdrawal by Subject|0|||
150055395|NCT01215916|541344153|FG001|Overall Study|Withdrawal by Subject|1|||
150004626|NCT00160199|541151742|FG001|Overall Study|Lack of Efficacy|1|||
150004627|NCT00160199|541151741|FG000|Overall Study|Lost to Follow-up|7|||
150055396|NCT01215916|541344154|FG002|Overall Study|Withdrawal by Subject|1|||
150055397|NCT01215916|541344155|FG003|Overall Study|Withdrawal by Subject|2|||
150004628|NCT00160199|541151742|FG001|Overall Study|Lost to Follow-up|7|||
150004629|NCT00160199|541151741|FG000|Overall Study|Withdrawal by Subject|4|||
150004630|NCT00160199|541151742|FG001|Overall Study|Withdrawal by Subject|6|||
150004631|NCT00160199|541151741|FG000|Overall Study|Administrative|0|||
150004632|NCT00160199|541151742|FG001|Overall Study|Administrative|1|||
150004633|NCT00160199|541151741|FG000|Overall Study|Protocol Violation|8|||
150004634|NCT00160199|541151742|FG001|Overall Study|Protocol Violation|8|||
150004635|NCT02124772|541151743|FG000|Overall Study|Lack of Efficacy|2|||
150004636|NCT02124772|541151744|FG001|Overall Study|Lack of Efficacy|0|||
150004637|NCT02124772|541151745|FG002|Overall Study|Lack of Efficacy|0|||
150004638|NCT02124772|541151746|FG003|Overall Study|Lack of Efficacy|1|||
150055398|NCT01215916|541344156|FG004|Overall Study|Withdrawal by Subject|0|||
150004639|NCT02124772|541151747|FG004|Overall Study|Lack of Efficacy|2|||
150004640|NCT02124772|541151748|FG005|Overall Study|Lack of Efficacy|3|||
150004641|NCT02124772|541151749|FG006|Overall Study|Lack of Efficacy|0|||
150004642|NCT02124772|541151750|FG007|Overall Study|Lack of Efficacy|2|||
150004643|NCT02124772|541151751|FG008|Overall Study|Lack of Efficacy|0|||
150004644|NCT02124772|541151752|FG009|Overall Study|Lack of Efficacy|1|||
150004645|NCT02124772|541151753|FG010|Overall Study|Lack of Efficacy|0|||
150004646|NCT02124772|541151754|FG011|Overall Study|Lack of Efficacy|0|||
150004647|NCT02124772|541151755|FG012|Overall Study|Lack of Efficacy|1|||
150004648|NCT02124772|541151743|FG000|Overall Study|Adverse Event|1|||
150004649|NCT02124772|541151744|FG001|Overall Study|Adverse Event|4|||
150004650|NCT02124772|541151745|FG002|Overall Study|Adverse Event|1|||
150004651|NCT02124772|541151746|FG003|Overall Study|Adverse Event|5|||
150004652|NCT02124772|541151747|FG004|Overall Study|Adverse Event|2|||
150004653|NCT02124772|541151748|FG005|Overall Study|Adverse Event|1|||
150004654|NCT02124772|541151749|FG006|Overall Study|Adverse Event|1|||
150004655|NCT02124772|541151750|FG007|Overall Study|Adverse Event|5|||
150004656|NCT02124772|541151751|FG008|Overall Study|Adverse Event|0|||
150004657|NCT02124772|541151752|FG009|Overall Study|Adverse Event|3|||
150004658|NCT02124772|541151753|FG010|Overall Study|Adverse Event|1|||
150004659|NCT02124772|541151754|FG011|Overall Study|Adverse Event|3|||
150004660|NCT02124772|541151755|FG012|Overall Study|Adverse Event|1|||
150004661|NCT02124772|541151743|FG000|Overall Study|Withdrawal consent|0|||
150004662|NCT02124772|541151744|FG001|Overall Study|Withdrawal consent|1|||
150004663|NCT02124772|541151745|FG002|Overall Study|Withdrawal consent|1|||
150004664|NCT02124772|541151746|FG003|Overall Study|Withdrawal consent|1|||
150004665|NCT02124772|541151747|FG004|Overall Study|Withdrawal consent|0|||
150004666|NCT02124772|541151748|FG005|Overall Study|Withdrawal consent|1|||
150004667|NCT02124772|541151749|FG006|Overall Study|Withdrawal consent|1|||
150004668|NCT02124772|541151750|FG007|Overall Study|Withdrawal consent|0|||
150004669|NCT02124772|541151751|FG008|Overall Study|Withdrawal consent|0|||
150004670|NCT02124772|541151752|FG009|Overall Study|Withdrawal consent|1|||
150004671|NCT02124772|541151753|FG010|Overall Study|Withdrawal consent|0|||
150004672|NCT02124772|541151754|FG011|Overall Study|Withdrawal consent|1|||
150004673|NCT02124772|541151755|FG012|Overall Study|Withdrawal consent|0|||
150004674|NCT02124772|541151743|FG000|Overall Study|Investigator discretion|0|||
150004675|NCT02124772|541151744|FG001|Overall Study|Investigator discretion|2|||
150004676|NCT02124772|541151745|FG002|Overall Study|Investigator discretion|2|||
150004677|NCT02124772|541151746|FG003|Overall Study|Investigator discretion|1|||
150004678|NCT02124772|541151747|FG004|Overall Study|Investigator discretion|1|||
150004679|NCT02124772|541151748|FG005|Overall Study|Investigator discretion|0|||
150004680|NCT02124772|541151749|FG006|Overall Study|Investigator discretion|1|||
150004681|NCT02124772|541151750|FG007|Overall Study|Investigator discretion|0|||
150004682|NCT02124772|541151751|FG008|Overall Study|Investigator discretion|0|||
150004683|NCT02124772|541151752|FG009|Overall Study|Investigator discretion|1|||
150004684|NCT02124772|541151753|FG010|Overall Study|Investigator discretion|0|||
150004685|NCT02124772|541151754|FG011|Overall Study|Investigator discretion|1|||
150004686|NCT02124772|541151755|FG012|Overall Study|Investigator discretion|0|||
150004687|NCT02124772|541151743|FG000|Overall Study|Progressive disease|0|||
150004688|NCT02124772|541151744|FG001|Overall Study|Progressive disease|0|||
150004689|NCT02124772|541151745|FG002|Overall Study|Progressive disease|0|||
150004690|NCT02124772|541151746|FG003|Overall Study|Progressive disease|0|||
150004691|NCT02124772|541151747|FG004|Overall Study|Progressive disease|0|||
150004692|NCT02124772|541151748|FG005|Overall Study|Progressive disease|0|||
150004693|NCT02124772|541151749|FG006|Overall Study|Progressive disease|1|||
150004694|NCT02124772|541151750|FG007|Overall Study|Progressive disease|1|||
150004695|NCT02124772|541151751|FG008|Overall Study|Progressive disease|0|||
150004696|NCT02124772|541151752|FG009|Overall Study|Progressive disease|0|||
150004697|NCT02124772|541151753|FG010|Overall Study|Progressive disease|0|||
150004698|NCT02124772|541151754|FG011|Overall Study|Progressive disease|0|||
150004699|NCT02124772|541151755|FG012|Overall Study|Progressive disease|0|||
150004700|NCT02124772|541151743|FG000|Overall Study|Other|0|||
150004701|NCT02124772|541151744|FG001|Overall Study|Other|7|||
150004702|NCT02124772|541151745|FG002|Overall Study|Other|2|||
150004703|NCT02124772|541151746|FG003|Overall Study|Other|5|||
150004704|NCT02124772|541151747|FG004|Overall Study|Other|4|||
150004705|NCT02124772|541151748|FG005|Overall Study|Other|3|||
150004706|NCT02124772|541151749|FG006|Overall Study|Other|4|||
150004707|NCT02124772|541151750|FG007|Overall Study|Other|1|||
150004708|NCT02124772|541151751|FG008|Overall Study|Other|1|||
150004709|NCT02124772|541151752|FG009|Overall Study|Other|1|||
150004710|NCT02124772|541151753|FG010|Overall Study|Other|1|||
150004711|NCT02124772|541151754|FG011|Overall Study|Other|1|||
150004712|NCT02124772|541151755|FG012|Overall Study|Other|0|||
150004713|NCT02713529|541151756|FG000|Overall Study|Withdrawal by Subject|3|||
150004714|NCT02713529|541151757|FG001|Overall Study|Withdrawal by Subject|1|||
150004715|NCT02713529|541151758|FG002|Overall Study|Withdrawal by Subject|4|||
150004716|NCT02713529|541151759|FG003|Overall Study|Withdrawal by Subject|2|||
150004717|NCT02713529|541151760|FG004|Overall Study|Withdrawal by Subject|0|||
150004718|NCT02713529|541151761|FG005|Overall Study|Withdrawal by Subject|1|||
150004719|NCT02713529|541151762|FG006|Overall Study|Withdrawal by Subject|1|||
150004720|NCT02713529|541151756|FG000|Overall Study|Lost to Follow-up|1|||
150004721|NCT02713529|541151757|FG001|Overall Study|Lost to Follow-up|0|||
150004722|NCT02713529|541151758|FG002|Overall Study|Lost to Follow-up|1|||
150004723|NCT02713529|541151759|FG003|Overall Study|Lost to Follow-up|0|||
150004724|NCT02713529|541151760|FG004|Overall Study|Lost to Follow-up|0|||
150004725|NCT02713529|541151761|FG005|Overall Study|Lost to Follow-up|0|||
150004726|NCT02713529|541151762|FG006|Overall Study|Lost to Follow-up|0|||
150004727|NCT02713529|541151756|FG000|Overall Study|Death|3|||
150004728|NCT02713529|541151757|FG001|Overall Study|Death|3|||
150004729|NCT02713529|541151758|FG002|Overall Study|Death|26|||
150004730|NCT02713529|541151759|FG003|Overall Study|Death|27|||
150004731|NCT02713529|541151760|FG004|Overall Study|Death|3|||
150004732|NCT02713529|541151761|FG005|Overall Study|Death|13|||
150004733|NCT02713529|541151762|FG006|Overall Study|Death|3|||
150004734|NCT03089944|541151765|FG000|Overall Study|Lost to Follow-up|8|||
150004735|NCT03089944|541151765|FG000|Overall Study|Withdrew Consent|2|||
150004736|NCT03089944|541151765|FG000|Overall Study|Adverse Event|1|||
150004737|NCT03089944|541151765|FG000|Overall Study|Other|1|||
150004738|NCT01636713|541151766|FG000|Overall Study|Adverse Event|16|||
150004739|NCT01636713|541151767|FG001|Overall Study|Adverse Event|16|||
150004740|NCT01636713|541151768|FG002|Overall Study|Adverse Event|7|||
150004741|NCT01636713|541151766|FG000|Overall Study|Lack of Efficacy|6|||
150004742|NCT01636713|541151767|FG001|Overall Study|Lack of Efficacy|6|||
150004743|NCT01636713|541151768|FG002|Overall Study|Lack of Efficacy|2|||
150004744|NCT01636713|541151766|FG000|Overall Study|Protocol Violation|3|||
150004745|NCT01636713|541151767|FG001|Overall Study|Protocol Violation|0|||
150004746|NCT01636713|541151768|FG002|Overall Study|Protocol Violation|1|||
150004747|NCT01636713|541151766|FG000|Overall Study|Lost to Follow-up|0|||
150004748|NCT01636713|541151767|FG001|Overall Study|Lost to Follow-up|0|||
150004749|NCT01636713|541151768|FG002|Overall Study|Lost to Follow-up|1|||
150004750|NCT01636713|541151766|FG000|Overall Study|Withdrawal by Subject|5|||
150004751|NCT01636713|541151767|FG001|Overall Study|Withdrawal by Subject|4|||
150004752|NCT01636713|541151768|FG002|Overall Study|Withdrawal by Subject|8|||
150004753|NCT01636713|541151766|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
150004754|NCT01636713|541151767|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
150004755|NCT01636713|541151768|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
150004756|NCT03689244|541151769|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
150004757|NCT03689244|541151770|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
150004758|NCT03689244|541151771|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
150004759|NCT03689244|541151772|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
150004760|NCT03689244|541151769|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
150004761|NCT03689244|541151770|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
150004762|NCT03689244|541151771|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
150004763|NCT03689244|541151772|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
150004764|NCT03689244|541151769|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
150004765|NCT03689244|541151770|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
150004766|NCT03689244|541151771|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
150004767|NCT03689244|541151772|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
150004768|NCT03689244|541151769|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
150004769|NCT03689244|541151770|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
150004770|NCT03689244|541151771|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
150004771|NCT03689244|541151772|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
150004772|NCT03689244|541151769|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
150004773|NCT03689244|541151770|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
150179709|NCT00409838|541796797|FG001|Short-term Period|Never Treated|0|||
150179710|NCT00409838|541796796|FG000|Long-term Extension Period|Adverse Event|10|||
150179711|NCT00409838|541796797|FG001|Long-term Extension Period|Adverse Event|0|||
150179712|NCT00409838|541796796|FG000|Long-term Extension Period|Death|1|||
150179713|NCT00409838|541796797|FG001|Long-term Extension Period|Death|0|||
150179714|NCT00409838|541796796|FG000|Long-term Extension Period|Lack of Efficacy|2|||
150179715|NCT00409838|541796797|FG001|Long-term Extension Period|Lack of Efficacy|0|||
150179716|NCT00409838|541796796|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
150179717|NCT00409838|541796797|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
150179718|NCT00409838|541796796|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
150179719|NCT00409838|541796797|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
150179720|NCT00409838|541796796|FG000|Long-term Extension Period|Pregnancy|1|||
150179721|NCT00409838|541796797|FG001|Long-term Extension Period|Pregnancy|0|||
150179722|NCT04788641|541796798|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
150179723|NCT04788641|541796799|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
150179724|NCT04788641|541796800|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
150179725|NCT04788641|541796801|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
150179726|NCT04788641|541796798|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
150179727|NCT04788641|541796799|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
150179728|NCT04788641|541796800|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
150179729|NCT04788641|541796801|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
150179730|NCT04788641|541796798|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
150004774|NCT03689244|541151771|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
150004775|NCT03689244|541151772|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
150004776|NCT03689244|541151769|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
150004777|NCT03689244|541151770|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
150004778|NCT03689244|541151771|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
150004779|NCT03689244|541151772|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
150004780|NCT03689244|541151769|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
150004781|NCT03689244|541151770|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
150004782|NCT03689244|541151771|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
150004783|NCT03689244|541151772|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
150004784|NCT03689244|541151769|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
150004785|NCT03689244|541151770|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
150004786|NCT03689244|541151771|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
150004787|NCT03689244|541151772|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
150004788|NCT01739803|541151775|FG000|Overall Study|Lost to Follow-up|9|||
150004789|NCT01739803|541151776|FG001|Overall Study|Lost to Follow-up|6|||
150004790|NCT03759041|541151780|FG000|Overall Study|Withdrawal by Subject|4|||
150004791|NCT03759041|541151781|FG001|Overall Study|Withdrawal by Subject|10|||
150004792|NCT03759041|541151782|FG002|Overall Study|Withdrawal by Subject|10|||
150004793|NCT03759041|541151780|FG000|Overall Study|Adverse Event|1|||
150004794|NCT03759041|541151781|FG001|Overall Study|Adverse Event|3|||
150004795|NCT03759041|541151782|FG002|Overall Study|Adverse Event|4|||
150004796|NCT03759041|541151780|FG000|Overall Study|Lack of Efficacy|0|||
150004797|NCT03759041|541151781|FG001|Overall Study|Lack of Efficacy|0|||
150004798|NCT03759041|541151782|FG002|Overall Study|Lack of Efficacy|1|||
150004799|NCT03759041|541151780|FG000|Overall Study|Study Terminated by Sponsor|15|||
150004800|NCT03759041|541151781|FG001|Overall Study|Study Terminated by Sponsor|16|||
150004801|NCT03759041|541151782|FG002|Overall Study|Study Terminated by Sponsor|10|||
150055399|NCT01215916|541344157|FG005|Overall Study|Withdrawal by Subject|0|||
150055400|NCT01215916|541344158|FG006|Overall Study|Withdrawal by Subject|1|||
150055401|NCT01215916|541344159|FG007|Overall Study|Withdrawal by Subject|0|||
150055402|NCT01215916|541344160|FG008|Overall Study|Withdrawal by Subject|0|||
150055403|NCT01215916|541344152|FG000|Overall Study|Death|0|||
150055404|NCT01215916|541344153|FG001|Overall Study|Death|1|||
150055405|NCT01215916|541344154|FG002|Overall Study|Death|0|||
150055406|NCT01215916|541344155|FG003|Overall Study|Death|0|||
150055407|NCT01215916|541344156|FG004|Overall Study|Death|1|||
150055408|NCT01215916|541344157|FG005|Overall Study|Death|0|||
150004802|NCT03759041|541151780|FG000|Overall Study|Other reason for discontinuation|0|||
150004803|NCT03759041|541151781|FG001|Overall Study|Other reason for discontinuation|2|||
150055409|NCT01215916|541344158|FG006|Overall Study|Death|0|||
150179731|NCT04788641|541796799|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
150004804|NCT03759041|541151782|FG002|Overall Study|Other reason for discontinuation|1|||
150004805|NCT03759041|541151780|FG000|Overall Study|Lost to Follow-up|7|||
150055410|NCT01215916|541344159|FG007|Overall Study|Death|0|||
150179732|NCT04788641|541796800|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
150004806|NCT03759041|541151781|FG001|Overall Study|Lost to Follow-up|2|||
150004807|NCT03759041|541151782|FG002|Overall Study|Lost to Follow-up|2|||
150004808|NCT03759041|541151780|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
150004809|NCT03759041|541151781|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
150004810|NCT03759041|541151782|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
150004811|NCT00525824|541151783|FG000|Overall Study|Adverse Event|7|||
150004812|NCT00525824|541151784|FG001|Overall Study|Adverse Event|11|||
150055411|NCT01215916|541344160|FG008|Overall Study|Death|1|||
150055412|NCT01215916|541344152|FG000|Overall Study|Physician Decision|0|||
150055413|NCT01215916|541344153|FG001|Overall Study|Physician Decision|0|||
150055414|NCT01215916|541344154|FG002|Overall Study|Physician Decision|1|||
150055415|NCT01215916|541344155|FG003|Overall Study|Physician Decision|1|||
150055416|NCT01215916|541344156|FG004|Overall Study|Physician Decision|0|||
150055417|NCT01215916|541344157|FG005|Overall Study|Physician Decision|0|||
150055418|NCT01215916|541344158|FG006|Overall Study|Physician Decision|0|||
150055419|NCT01215916|541344159|FG007|Overall Study|Physician Decision|0|||
150055420|NCT01215916|541344160|FG008|Overall Study|Physician Decision|0|||
150055421|NCT00958438|541344163|FG000|Overall Study|Protocol Violation|3|||
150055422|NCT00958438|541344164|FG001|Overall Study|Protocol Violation|2|||
150055423|NCT00958438|541344165|FG002|Overall Study|Protocol Violation|2|||
150055424|NCT00958438|541344163|FG000|Overall Study|Withdrawal by Subject|4|||
150055425|NCT00958438|541344164|FG001|Overall Study|Withdrawal by Subject|2|||
150055426|NCT00958438|541344165|FG002|Overall Study|Withdrawal by Subject|1|||
150055427|NCT00958438|541344163|FG000|Overall Study|Adverse Event|0|||
150055428|NCT00958438|541344164|FG001|Overall Study|Adverse Event|3|||
150055429|NCT00958438|541344165|FG002|Overall Study|Adverse Event|0|||
150055430|NCT00958438|541344163|FG000|Overall Study|Physician Decision|1|||
150055431|NCT00958438|541344164|FG001|Overall Study|Physician Decision|0|||
150055432|NCT00958438|541344165|FG002|Overall Study|Physician Decision|1|||
150055433|NCT00958438|541344163|FG000|Overall Study|Other than specified above|2|||
150055434|NCT00958438|541344164|FG001|Overall Study|Other than specified above|3|||
150055435|NCT00958438|541344165|FG002|Overall Study|Other than specified above|2|||
150055436|NCT02788279|541344167|FG000|Overall Study|Death|62|||
150055437|NCT02788279|541344168|FG001|Overall Study|Death|136|||
150055438|NCT02788279|541344169|FG002|Overall Study|Death|72|||
150055439|NCT02788279|541344167|FG000|Overall Study|Withdrawal by Subject|10|||
150004813|NCT00525824|541151785|FG002|Overall Study|Adverse Event|6|||
150004814|NCT00525824|541151786|FG003|Overall Study|Adverse Event|7|||
150004815|NCT00525824|541151783|FG000|Overall Study|Withdrawal by Subject|5|||
150004816|NCT00525824|541151784|FG001|Overall Study|Withdrawal by Subject|9|||
150004817|NCT00525824|541151785|FG002|Overall Study|Withdrawal by Subject|3|||
150055440|NCT02788279|541344168|FG001|Overall Study|Withdrawal by Subject|15|||
150055441|NCT02788279|541344169|FG002|Overall Study|Withdrawal by Subject|5|||
150055442|NCT02788279|541344167|FG000|Overall Study|Lost to Follow-up|0|||
150055443|NCT02788279|541344168|FG001|Overall Study|Lost to Follow-up|3|||
150055444|NCT02788279|541344169|FG002|Overall Study|Lost to Follow-up|2|||
150055445|NCT02788279|541344167|FG000|Overall Study|Sponsor decision|18|||
150055446|NCT02788279|541344168|FG001|Overall Study|Sponsor decision|29|||
150055447|NCT02788279|541344169|FG002|Overall Study|Sponsor decision|11|||
150055448|NCT02353143|541344170|FG000|Overall Study|Withdrawal by Subject|1|||
150055449|NCT02353143|541344171|FG001|Overall Study|Withdrawal by Subject|0|||
150055450|NCT02353143|541344172|FG002|Overall Study|Withdrawal by Subject|0|||
150055451|NCT02353143|541344173|FG003|Overall Study|Withdrawal by Subject|0|||
150055452|NCT02353143|541344174|FG004|Overall Study|Withdrawal by Subject|1|||
150055453|NCT02353143|541344175|FG005|Overall Study|Withdrawal by Subject|0|||
150055454|NCT02353143|541344176|FG006|Overall Study|Withdrawal by Subject|0|||
150055455|NCT02353143|541344177|FG007|Overall Study|Withdrawal by Subject|1|||
150055456|NCT02353143|541344178|FG008|Overall Study|Withdrawal by Subject|1|||
150055457|NCT02353143|541344170|FG000|Overall Study|Lack of Efficacy|2|||
150055458|NCT02353143|541344171|FG001|Overall Study|Lack of Efficacy|1|||
150055459|NCT02353143|541344172|FG002|Overall Study|Lack of Efficacy|2|||
150055460|NCT02353143|541344173|FG003|Overall Study|Lack of Efficacy|4|||
150055461|NCT02353143|541344174|FG004|Overall Study|Lack of Efficacy|13|||
150055462|NCT02353143|541344175|FG005|Overall Study|Lack of Efficacy|2|||
150055463|NCT02353143|541344176|FG006|Overall Study|Lack of Efficacy|2|||
150055464|NCT02353143|541344177|FG007|Overall Study|Lack of Efficacy|2|||
150055465|NCT02353143|541344178|FG008|Overall Study|Lack of Efficacy|1|||
150179733|NCT04788641|541796801|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
150179734|NCT00243503|541796802|FG000|Overall Study|Adverse Event|11|||
150004818|NCT00525824|541151786|FG003|Overall Study|Withdrawal by Subject|4|||
150055466|NCT02353143|541344170|FG000|Overall Study|reason not specified|1|||
150055467|NCT02353143|541344171|FG001|Overall Study|reason not specified|2|||
150055468|NCT02353143|541344172|FG002|Overall Study|reason not specified|0|||
150179735|NCT00243503|541796802|FG000|Overall Study|Withdrawal by Subject|1|||
150004819|NCT00525824|541151783|FG000|Overall Study|Lost to Follow-up|4|||
150055469|NCT02353143|541344173|FG003|Overall Study|reason not specified|0|||
150055470|NCT02353143|541344174|FG004|Overall Study|reason not specified|6|||
150055471|NCT02353143|541344175|FG005|Overall Study|reason not specified|1|||
150004820|NCT00525824|541151784|FG001|Overall Study|Lost to Follow-up|2|||
150004821|NCT00525824|541151785|FG002|Overall Study|Lost to Follow-up|4|||
150004822|NCT00525824|541151786|FG003|Overall Study|Lost to Follow-up|0|||
150004823|NCT00525824|541151783|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
150004824|NCT00525824|541151784|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
150004825|NCT00525824|541151785|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
150004826|NCT00525824|541151786|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
150004827|NCT00525824|541151783|FG000|Overall Study|Severe non-compliance|0|||
150004828|NCT00525824|541151784|FG001|Overall Study|Severe non-compliance|1|||
150004829|NCT00525824|541151785|FG002|Overall Study|Severe non-compliance|1|||
150004830|NCT00525824|541151786|FG003|Overall Study|Severe non-compliance|1|||
150004831|NCT00525824|541151783|FG000|Overall Study|Safety reasons|1|||
150004832|NCT00525824|541151784|FG001|Overall Study|Safety reasons|0|||
150004833|NCT00525824|541151785|FG002|Overall Study|Safety reasons|1|||
150004834|NCT00525824|541151786|FG003|Overall Study|Safety reasons|0|||
150004835|NCT00525824|541151783|FG000|Overall Study|Other|1|||
150004836|NCT00525824|541151784|FG001|Overall Study|Other|3|||
150004837|NCT00525824|541151785|FG002|Overall Study|Other|3|||
150004838|NCT00525824|541151786|FG003|Overall Study|Other|1|||
150004839|NCT02525094|541151788|FG000|Overall Study|Lost to Follow-up|2|||
150004840|NCT02525094|541151789|FG001|Overall Study|Lost to Follow-up|1|||
150004841|NCT02525094|541151788|FG000|Overall Study|Withdrawal by Subject|5|||
150004842|NCT02525094|541151789|FG001|Overall Study|Withdrawal by Subject|6|||
150004843|NCT02525094|541151788|FG000|Overall Study|Not Treated|1|||
150055472|NCT02353143|541344176|FG006|Overall Study|reason not specified|0|||
150055473|NCT02353143|541344177|FG007|Overall Study|reason not specified|3|||
150055474|NCT02353143|541344178|FG008|Overall Study|reason not specified|1|||
150055475|NCT02353143|541344170|FG000|Overall Study|Physician Decision|0|||
150004844|NCT02525094|541151789|FG001|Overall Study|Not Treated|1|||
150004845|NCT00969436|541151790|FG000|Overall Study|Protocol Violation|1|||
150004846|NCT00969436|541151791|FG001|Overall Study|Protocol Violation|3|||
150004847|NCT00969436|541151792|FG002|Overall Study|Protocol Violation|0|||
150004848|NCT00969436|541151790|FG000|Overall Study|Migrated/moved from study area|12|||
150004849|NCT00969436|541151791|FG001|Overall Study|Migrated/moved from study area|10|||
150004850|NCT00969436|541151792|FG002|Overall Study|Migrated/moved from study area|2|||
150004851|NCT00969436|541151790|FG000|Overall Study|Father - serious health problem|0|||
150004852|NCT00969436|541151791|FG001|Overall Study|Father - serious health problem|0|||
150004853|NCT00969436|541151792|FG002|Overall Study|Father - serious health problem|1|||
150004854|NCT00969436|541151790|FG000|Overall Study|Parents personal problem|0|||
150004855|NCT00969436|541151791|FG001|Overall Study|Parents personal problem|0|||
150004856|NCT00969436|541151792|FG002|Overall Study|Parents personal problem|1|||
150004857|NCT00969436|541151790|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
150004858|NCT00969436|541151791|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
150004859|NCT00969436|541151792|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
150004860|NCT00969436|541151790|FG000|Overall Study|Withdrawal by Subject|3|||
150004861|NCT00969436|541151791|FG001|Overall Study|Withdrawal by Subject|0|||
150004862|NCT00969436|541151792|FG002|Overall Study|Withdrawal by Subject|2|||
150004863|NCT00969436|541151790|FG000|Overall Study|Lost to Follow-up|8|||
150004864|NCT00969436|541151791|FG001|Overall Study|Lost to Follow-up|8|||
150004865|NCT00969436|541151792|FG002|Overall Study|Lost to Follow-up|5|||
150004866|NCT02290938|541151797|FG000|Overall Study|Lost to Follow-up|14|||
150004867|NCT02290938|541151798|FG001|Overall Study|Lost to Follow-up|43|||
150004868|NCT03172130|541153134|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
150004869|NCT03172130|541153135|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
150004870|NCT01350115|541153139|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
150004871|NCT01350115|541153140|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
150004872|NCT01350115|541153139|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
150004873|NCT01350115|541153140|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
150004874|NCT01350115|541153139|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
150004875|NCT01350115|541153140|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
150004876|NCT05565937|541153147|FG000|Overall Study|Adverse Event|0|||
150004877|NCT05565937|541153148|FG001|Overall Study|Adverse Event|1|||
150004878|NCT05565937|541153147|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
150004879|NCT05565937|541153148|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
150004880|NCT05565937|541153147|FG000|Overall Study|Lost to Follow-up|2|||
150004881|NCT05565937|541153148|FG001|Overall Study|Lost to Follow-up|0|||
150004882|NCT05565937|541153147|FG000|Overall Study|Pregnancy|0|||
150004883|NCT05565937|541153148|FG001|Overall Study|Pregnancy|2|||
150004884|NCT05565937|541153147|FG000|Overall Study|Anisometropia|0|||
150004885|NCT05565937|541153148|FG001|Overall Study|Anisometropia|1|||
150004886|NCT04544683|541153149|FG000|Overall Study|Lost to Follow-up|2|||
150004887|NCT04544683|541153149|FG000|Overall Study|Underwent cervical spine surgery|6|||
150004888|NCT00541346|541153150|FG000|Follow-up|Adverse Event|1|||
150004889|NCT03323736|541153153|FG000|Overall Study|Screen Failure|14|||
150004890|NCT03323736|541153154|FG001|Overall Study|Screen Failure|9|||
150004891|NCT03323736|541153155|FG002|Overall Study|Screen Failure|1|||
150004892|NCT03323736|541153153|FG000|Overall Study|Withdrawal Before Treatment|3|||
150004893|NCT03323736|541153154|FG001|Overall Study|Withdrawal Before Treatment|1|||
150004894|NCT03323736|541153155|FG002|Overall Study|Withdrawal Before Treatment|1|||
150004895|NCT03323736|541153153|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
150004896|NCT03323736|541153154|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
150004897|NCT03323736|541153155|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
150004898|NCT01806064|541153156|FG000|Overall Study|Randomized Not Enrolled|0|||
150004899|NCT01806064|541153157|FG001|Overall Study|Randomized Not Enrolled|0|||
150004900|NCT01806064|541153158|FG002|Overall Study|Randomized Not Enrolled|0|||
150004901|NCT01806064|541153159|FG003|Overall Study|Randomized Not Enrolled|1|||
150004902|NCT01806064|541153160|FG004|Overall Study|Randomized Not Enrolled|2|||
150004903|NCT01286077|541153161|FG000|Overall Study|Adverse Event|2|||
150004904|NCT01286077|541153162|FG001|Overall Study|Adverse Event|0|||
150004905|NCT01286077|541153161|FG000|Overall Study|Death|1|||
150004906|NCT01286077|541153162|FG001|Overall Study|Death|0|||
150004907|NCT01286077|541153161|FG000|Overall Study|Protocol Violation|1|||
150004908|NCT01286077|541153162|FG001|Overall Study|Protocol Violation|1|||
150004909|NCT01286077|541153161|FG000|Overall Study|Withdrawal by Subject|0|||
150004910|NCT01286077|541153162|FG001|Overall Study|Withdrawal by Subject|2|||
150004911|NCT01286077|541153161|FG000|Overall Study|Intercurrent illness|1|||
150004912|NCT01286077|541153162|FG001|Overall Study|Intercurrent illness|0|||
150004913|NCT01286077|541153161|FG000|Overall Study|Non-compliance|1|||
150004914|NCT01286077|541153162|FG001|Overall Study|Non-compliance|0|||
150004915|NCT01286077|541153161|FG000|Overall Study|The subject starts with alternative MMY|0|||
150004916|NCT01286077|541153162|FG001|Overall Study|The subject starts with alternative MMY|3|||
150004917|NCT01286077|541153161|FG000|Overall Study|Patient's decision to stop treatment|3|||
150004918|NCT01286077|541153162|FG001|Overall Study|Patient's decision to stop treatment|0|||
150004919|NCT01286077|541153161|FG000|Overall Study|Progression of disease|0|||
150004920|NCT01286077|541153162|FG001|Overall Study|Progression of disease|1|||
150004921|NCT01286077|541153161|FG000|Overall Study|refill medication not received in time|1|||
150004922|NCT01286077|541153162|FG001|Overall Study|refill medication not received in time|0|||
150004923|NCT00701805|541153163|FG000|Overall Study|Withdrawal by Subject|3|||
150004924|NCT00701805|541153164|FG001|Overall Study|Withdrawal by Subject|1|||
150004925|NCT00701805|541153165|FG002|Overall Study|Withdrawal by Subject|4|||
150004926|NCT00701805|541153166|FG003|Overall Study|Withdrawal by Subject|3|||
150004927|NCT00701805|541153163|FG000|Overall Study|Adverse Event|0|||
150179736|NCT00243503|541796802|FG000|Overall Study|Lack of Efficacy|44|||
150179737|NCT00243503|541796802|FG000|Overall Study|Death|1|||
150179738|NCT00243503|541796802|FG000|Overall Study|Other|1|||
150179739|NCT00093015|541796807|FG000|Overall Study|Withdrawal by Subject|194|||
150179740|NCT00093015|541796808|FG001|Overall Study|Withdrawal by Subject|171|||
150179741|NCT00093015|541796807|FG000|Overall Study|Lost to Follow-up|96|||
150179742|NCT00093015|541796808|FG001|Overall Study|Lost to Follow-up|108|||
150004928|NCT00701805|541153164|FG001|Overall Study|Adverse Event|1|||
150179743|NCT00093015|541796807|FG000|Overall Study|Death|375|||
150179744|NCT00093015|541796808|FG001|Overall Study|Death|385|||
150179745|NCT00520546|541796811|FG000|Overall Study|Withdrawal by Subject|1|||
150179746|NCT00520546|541796811|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
150179747|NCT03076515|541796812|FG000|Overall Study|DMC decision based on interim analysis|25|||
150004929|NCT00701805|541153165|FG002|Overall Study|Adverse Event|1|||
150004930|NCT00701805|541153166|FG003|Overall Study|Adverse Event|0|||
150004931|NCT00701805|541153163|FG000|Overall Study|Missed 7 consecutive doses|0|||
150004932|NCT00701805|541153164|FG001|Overall Study|Missed 7 consecutive doses|1|||
150004933|NCT00701805|541153165|FG002|Overall Study|Missed 7 consecutive doses|0|||
150004934|NCT00701805|541153166|FG003|Overall Study|Missed 7 consecutive doses|0|||
150004935|NCT00701805|541153163|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
150004936|NCT00701805|541153164|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
150004937|NCT00701805|541153165|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
150004938|NCT00701805|541153166|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
150004939|NCT00701805|541153163|FG000|Overall Study|Physician decision, change of therapy|0|||
150004940|NCT00701805|541153164|FG001|Overall Study|Physician decision, change of therapy|0|||
150004941|NCT00701805|541153165|FG002|Overall Study|Physician decision, change of therapy|0|||
150004942|NCT00701805|541153166|FG003|Overall Study|Physician decision, change of therapy|1|||
150004943|NCT00701805|541153163|FG000|Overall Study|Difficult to travel to dialysis site|0|||
150179748|NCT03076515|541796813|FG001|Overall Study|DMC decision based on interim analysis|29|||
150179749|NCT03988023|541796817|FG000|Overall Study|Non-compliance|3|||
150179750|NCT03988023|541796818|FG001|Overall Study|Non-compliance|0|||
150179751|NCT03988023|541796817|FG000|Overall Study|Withdrawal by Subject|39|||
150179752|NCT03988023|541796818|FG001|Overall Study|Withdrawal by Subject|37|||
150179753|NCT03988023|541796817|FG000|Overall Study|Adverse Event|0|||
150179754|NCT03988023|541796818|FG001|Overall Study|Adverse Event|2|||
150179755|NCT03988023|541796817|FG000|Overall Study|Physician Decision|0|||
150179756|NCT03988023|541796818|FG001|Overall Study|Physician Decision|1|||
150179757|NCT03988023|541796817|FG000|Overall Study|Lost to Follow-up|5|||
150179758|NCT03988023|541796818|FG001|Overall Study|Lost to Follow-up|8|||
150179759|NCT03988023|541796817|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
150179760|NCT03988023|541796818|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
150179761|NCT03988023|541796817|FG000|Overall Study|Lack of Efficacy|3|||
150179762|NCT03988023|541796818|FG001|Overall Study|Lack of Efficacy|1|||
150004944|NCT00701805|541153164|FG001|Overall Study|Difficult to travel to dialysis site|0|||
150004945|NCT00701805|541153165|FG002|Overall Study|Difficult to travel to dialysis site|1|||
150004946|NCT00701805|541153166|FG003|Overall Study|Difficult to travel to dialysis site|0|||
150004947|NCT00701805|541153163|FG000|Overall Study|Resumption criteria were not met|0|||
150004948|NCT00701805|541153164|FG001|Overall Study|Resumption criteria were not met|1|||
150004949|NCT00701805|541153165|FG002|Overall Study|Resumption criteria were not met|0|||
150004950|NCT00701805|541153166|FG003|Overall Study|Resumption criteria were not met|0|||
150004951|NCT02804750|541153174|FG000|Period 1|Adverse Event|0|||
150004952|NCT02804750|541153175|FG001|Period 1|Adverse Event|2|||
150004953|NCT02804750|541153174|FG000|Period 1|Withdrawal by Subject|0|||
150004954|NCT02804750|541153175|FG001|Period 1|Withdrawal by Subject|1|||
150004955|NCT02804750|541153174|FG000|Period 2|Adverse Event|1|||
150004956|NCT02804750|541153175|FG001|Period 2|Adverse Event|0|||
150004957|NCT02804750|541153174|FG000|Period 3|Adverse Event|0|||
150179763|NCT03988023|541796817|FG000|Overall Study|COVID-19 pandemic|225|||
150179764|NCT03988023|541796818|FG001|Overall Study|COVID-19 pandemic|227|||
150004958|NCT02804750|541153175|FG001|Period 3|Adverse Event|2|||
150004959|NCT02804750|541153174|FG000|Period 4|Adverse Event|0|||
150179765|NCT02101281|541796819|FG000|Overall Study|Adverse Event|0|||
150179766|NCT02101281|541796820|FG001|Overall Study|Adverse Event|1|||
150179767|NCT00296036|541796821|FG000|Overall Study|Withdrawal by Subject|1|||
150179768|NCT00296036|541796822|FG001|Overall Study|Withdrawal by Subject|0|||
150179769|NCT00296036|541796823|FG002|Overall Study|Withdrawal by Subject|2|||
150004960|NCT02804750|541153175|FG001|Period 4|Adverse Event|5|||
150179770|NCT00296036|541796824|FG003|Overall Study|Withdrawal by Subject|1|||
150179771|NCT00296036|541796825|FG004|Overall Study|Withdrawal by Subject|2|||
150179772|NCT00296036|541796826|FG005|Overall Study|Withdrawal by Subject|1|||
150004961|NCT02797184|541153187|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
150004962|NCT02797184|541153188|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
150004963|NCT04692077|541153189|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
150004964|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
150004965|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
150004966|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
150004967|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
150004968|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
150004969|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
150004970|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
150004971|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
150004972|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
150004973|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
150004974|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
150004975|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
150004976|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
150004977|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
150004978|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
150004979|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
150004980|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
150004981|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
150004982|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
150004983|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
150004984|NCT05149313|541153190|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
150004985|NCT05149313|541153191|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
150004986|NCT05149313|541153192|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
150004987|NCT05149313|541153193|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
150004988|NCT05149313|541153190|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
150004989|NCT05149313|541153191|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
150004990|NCT05149313|541153192|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
150004991|NCT05149313|541153193|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
150004992|NCT05149313|541153190|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
150004993|NCT05149313|541153191|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
150004994|NCT05149313|541153192|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
150004995|NCT05149313|541153193|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
150004996|NCT05149313|541153190|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
150004997|NCT05149313|541153191|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
150004998|NCT05149313|541153192|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
150004999|NCT05149313|541153193|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
150005000|NCT05149313|541153190|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150005001|NCT05149313|541153191|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150005002|NCT05149313|541153192|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
150005003|NCT05149313|541153193|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
150005004|NCT05149313|541153190|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
150005005|NCT05149313|541153191|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
150005006|NCT05149313|541153192|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
150005007|NCT05149313|541153193|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
150005008|NCT03199391|541153198|FG000|Overall Study|Death|1|||
150005009|NCT03199391|541153198|FG000|Overall Study|Lost to Follow-up|3|||
150005010|NCT03199391|541153198|FG000|Overall Study|Adverse Event|2|||
150055476|NCT02353143|541344171|FG001|Overall Study|Physician Decision|4|||
150055477|NCT02353143|541344172|FG002|Overall Study|Physician Decision|2|||
150055478|NCT02353143|541344173|FG003|Overall Study|Physician Decision|3|||
150055479|NCT02353143|541344174|FG004|Overall Study|Physician Decision|4|||
150055480|NCT02353143|541344175|FG005|Overall Study|Physician Decision|0|||
150055481|NCT02353143|541344176|FG006|Overall Study|Physician Decision|1|||
150055482|NCT02353143|541344177|FG007|Overall Study|Physician Decision|2|||
150055483|NCT02353143|541344178|FG008|Overall Study|Physician Decision|0|||
150055484|NCT02353143|541344170|FG000|Overall Study|Adverse Event|0|||
150005011|NCT03199391|541153198|FG000|Overall Study|Withdrawal by Subject|10|||
150005012|NCT01867086|541153199|FG000|Overall Study|Disease Progression|1|||
150005013|NCT03826342|541153209|FG000|Overall Study|Withdrawal by Subject|8|||
150005014|NCT03826342|541153210|FG001|Overall Study|Withdrawal by Subject|1|||
150005015|NCT03826342|541153209|FG000|Overall Study|Lost to Follow-up|7|||
150055485|NCT02353143|541344171|FG001|Overall Study|Adverse Event|0|||
150055486|NCT02353143|541344172|FG002|Overall Study|Adverse Event|1|||
150055487|NCT02353143|541344173|FG003|Overall Study|Adverse Event|0|||
150005016|NCT03826342|541153210|FG001|Overall Study|Lost to Follow-up|7|||
150005017|NCT03826342|541153209|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
150005018|NCT03826342|541153210|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
150005019|NCT03007745|541153212|FG000|Overall Study|Sleep test negative for OSA|53|||
150005020|NCT03007745|541153213|FG001|Overall Study|Sleep test negative for OSA|49|||
150005021|NCT03007745|541153212|FG000|Overall Study|Physician Decision|6|||
150005022|NCT03007745|541153213|FG001|Overall Study|Physician Decision|9|||
150005023|NCT03007745|541153212|FG000|Overall Study|Withdrawal by Subject|38|||
150005024|NCT03007745|541153213|FG001|Overall Study|Withdrawal by Subject|16|||
150005025|NCT03007745|541153212|FG000|Overall Study|Lost to Follow-up|19|||
150005026|NCT03007745|541153213|FG001|Overall Study|Lost to Follow-up|25|||
150005027|NCT03007745|541153212|FG000|Overall Study|Unable to login to website|17|||
150005028|NCT03007745|541153213|FG001|Overall Study|Unable to login to website|4|||
150005029|NCT03921554|541153214|FG000|Overall Study|Adverse Event|2|||
150005030|NCT03921554|541153214|FG000|Overall Study|Withdrawal by Subject|1|||
150005031|NCT03921554|541153214|FG000|Overall Study|Death|3|||
150005032|NCT00431951|541153215|FG000|Overall Study|Inability to follow study procedures|1|||
150005033|NCT00431951|541153216|FG001|Overall Study|Inability to follow study procedures|0|||
150005034|NCT00431951|541153217|FG002|Overall Study|Inability to follow study procedures|1|||
150005035|NCT00431951|541153218|FG003|Overall Study|Inability to follow study procedures|2|||
150005036|NCT00431951|541153215|FG000|Overall Study|Lost to Follow-up|0|||
150005037|NCT00431951|541153216|FG001|Overall Study|Lost to Follow-up|1|||
150005038|NCT00431951|541153217|FG002|Overall Study|Lost to Follow-up|0|||
150005039|NCT00431951|541153218|FG003|Overall Study|Lost to Follow-up|0|||
150005040|NCT00431951|541153215|FG000|Overall Study|Withdrawal by Subject|0|||
150005041|NCT00431951|541153216|FG001|Overall Study|Withdrawal by Subject|1|||
150005042|NCT00431951|541153217|FG002|Overall Study|Withdrawal by Subject|0|||
150005043|NCT00431951|541153218|FG003|Overall Study|Withdrawal by Subject|0|||
150005044|NCT00431951|541153215|FG000|Overall Study|Adverse Event|0|||
150005045|NCT00431951|541153216|FG001|Overall Study|Adverse Event|0|||
150005046|NCT00431951|541153217|FG002|Overall Study|Adverse Event|1|||
150005047|NCT00431951|541153218|FG003|Overall Study|Adverse Event|0|||
150005048|NCT01299571|541153230|FG000|Overall Study|Protocol Violation|107|||
150005049|NCT00708734|541153233|FG000|Overall Study|scheduling conflict|2|||
150005050|NCT00708734|541153233|FG000|Overall Study|moved|1|||
150005051|NCT00708734|541153233|FG000|Overall Study|leg injury|1|||
150005052|NCT00708734|541153233|FG000|Overall Study|knee replacement|1|||
150005053|NCT00708734|541153233|FG000|Overall Study|vertigo|1|||
150005054|NCT00708734|541153233|FG000|Overall Study|leg fracture|1|||
150005055|NCT02634606|541153237|FG000|Overall Study|unable to obtain the drug at start|13|||
150005056|NCT05432167|541153242|FG000|Overall Study|Adverse Event|0|||
150005057|NCT05432167|541153243|FG001|Overall Study|Adverse Event|2|||
150005058|NCT05432167|541153244|FG002|Overall Study|Adverse Event|1|||
150005059|NCT05432167|541153242|FG000|Overall Study|Lost to Follow-up|3|||
150005060|NCT05432167|541153243|FG001|Overall Study|Lost to Follow-up|3|||
150005061|NCT05432167|541153244|FG002|Overall Study|Lost to Follow-up|2|||
150005062|NCT05432167|541153242|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
150005063|NCT05432167|541153243|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
150005064|NCT05432167|541153244|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
150005065|NCT05432167|541153242|FG000|Overall Study|Physician Decision|1|||
150005066|NCT05432167|541153243|FG001|Overall Study|Physician Decision|0|||
150005067|NCT05432167|541153244|FG002|Overall Study|Physician Decision|0|||
150005068|NCT05432167|541153242|FG000|Overall Study|Withdrawal by Subject|7|||
150005069|NCT05432167|541153243|FG001|Overall Study|Withdrawal by Subject|4|||
150005070|NCT05432167|541153244|FG002|Overall Study|Withdrawal by Subject|11|||
150005071|NCT05432167|541153242|FG000|Overall Study|Other|0|||
150005072|NCT05432167|541153243|FG001|Overall Study|Other|0|||
150005073|NCT05432167|541153244|FG002|Overall Study|Other|1|||
150005074|NCT01267175|541153245|FG000|Overall Study|Withdrawal by Subject|1|||
150005075|NCT01267175|541153245|FG000|Overall Study|Lost to Follow-up|1|||
150005076|NCT00895661|541153246|FG000|Overall Study|Death|1|||
150055488|NCT02353143|541344174|FG004|Overall Study|Adverse Event|1|||
150055489|NCT02353143|541344175|FG005|Overall Study|Adverse Event|1|||
150055490|NCT02353143|541344176|FG006|Overall Study|Adverse Event|0|||
150055491|NCT02353143|541344177|FG007|Overall Study|Adverse Event|0|||
150005077|NCT00895661|541153246|FG000|Overall Study|reason unknown|2|||
150005078|NCT02006069|541153247|FG000|Overall Study|MPP other programming|239|||
150005079|NCT02006069|541153248|FG001|Overall Study|MPP other programming|0|||
150005080|NCT02006069|541153247|FG000|Overall Study|RV only pacing|0|||
150005081|NCT02006069|541153248|FG001|Overall Study|RV only pacing|3|||
150005082|NCT02553538|541153251|FG000|Overall Study|Could Not Reach by Telephone|133|||
150005083|NCT02553538|541153252|FG001|Overall Study|Could Not Reach by Telephone|0|||
150005084|NCT02553538|541153251|FG000|Overall Study|Died or Left Network|54|||
150005085|NCT02553538|541153252|FG001|Overall Study|Died or Left Network|56|||
150055492|NCT02353143|541344178|FG008|Overall Study|Adverse Event|0|||
150005086|NCT02276547|541153253|FG000|Overall Study|Death|2|||
150005087|NCT02276547|541153253|FG000|Overall Study|Explant|2|||
150179773|NCT00296036|541796821|FG000|Overall Study|Protocol Violation|0|||
150005088|NCT00791557|541153254|FG000|Overall Study|Adverse Event|1|||
150005089|NCT01439126|541153257|FG000|Overall Study|Adverse Event|2|||
150005090|NCT01439126|541153258|FG001|Overall Study|Adverse Event|0|||
150005091|NCT01439126|541153257|FG000|Overall Study|Withdrawal by Subject|5|||
150005092|NCT01439126|541153258|FG001|Overall Study|Withdrawal by Subject|21|||
150005093|NCT01439126|541153257|FG000|Overall Study|Protocol Violation|6|||
150005094|NCT01439126|541153258|FG001|Overall Study|Protocol Violation|4|||
150005095|NCT01439126|541153257|FG000|Overall Study|Lost to Follow-up|6|||
150005096|NCT01439126|541153258|FG001|Overall Study|Lost to Follow-up|3|||
150005097|NCT01439126|541153257|FG000|Overall Study|Other-Use of prohibited treatment|0|||
150005098|NCT01439126|541153258|FG001|Overall Study|Other-Use of prohibited treatment|2|||
150005099|NCT01439126|541153257|FG000|Overall Study|Other-Miscellaneous|12|||
150005100|NCT01439126|541153258|FG001|Overall Study|Other-Miscellaneous|12|||
150005101|NCT03242018|541153259|FG000|Overall Study|Adverse Event|7|||
150005102|NCT03242018|541153260|FG001|Overall Study|Adverse Event|7|||
150005103|NCT03242018|541153261|FG002|Overall Study|Adverse Event|6|||
150005104|NCT03242018|541153259|FG000|Overall Study|Lost to Follow-up|2|||
150005105|NCT03242018|541153260|FG001|Overall Study|Lost to Follow-up|2|||
150005106|NCT03242018|541153261|FG002|Overall Study|Lost to Follow-up|2|||
150005107|NCT03242018|541153259|FG000|Overall Study|At the Participant's Own Request|5|||
150005108|NCT03242018|541153260|FG001|Overall Study|At the Participant's Own Request|1|||
150005109|NCT03242018|541153261|FG002|Overall Study|At the Participant's Own Request|4|||
150005110|NCT03242018|541153259|FG000|Overall Study|Reason Not Specified|3|||
150005111|NCT03242018|541153260|FG001|Overall Study|Reason Not Specified|4|||
150005112|NCT03242018|541153261|FG002|Overall Study|Reason Not Specified|1|||
150005113|NCT03242018|541153259|FG000|Overall Study|Study Terminated by Sponsor|1|||
150005114|NCT03242018|541153260|FG001|Overall Study|Study Terminated by Sponsor|0|||
150005115|NCT03242018|541153261|FG002|Overall Study|Study Terminated by Sponsor|1|||
150005116|NCT00687609|541153262|FG000|Overall Study|Physician Decision|1|||
150005117|NCT00687609|541153262|FG000|Overall Study|Withdrawal by Subject|2|||
150005118|NCT02635347|541153263|FG000|Overall Study|Failed screening|20|||
150005119|NCT02635347|541153264|FG001|Overall Study|Failed screening|7|||
150005120|NCT02308488|541153265|FG000|Overall Study|Withdrawal by Subject|2|||
150005121|NCT01541917|541153266|FG000|Overall Study|Lost to Follow-up|2|||
150005122|NCT01541917|541153267|FG001|Overall Study|Lost to Follow-up|2|||
150005123|NCT01541917|541153266|FG000|Overall Study|Withdrawal by Subject|13|||
150005124|NCT01541917|541153267|FG001|Overall Study|Withdrawal by Subject|7|||
150005125|NCT01565564|541153275|FG000|Overall Study|Lost to Follow-up|5|||
150005126|NCT01565564|541153276|FG001|Overall Study|Lost to Follow-up|1|||
150005127|NCT02449018|541153277|FG000|Overall Study|Abnormal laboratory value|0|||
150005128|NCT02449018|541153278|FG001|Overall Study|Abnormal laboratory value|1|||
150005129|NCT02449018|541153277|FG000|Overall Study|Administrative problems|1|||
150005130|NCT02449018|541153278|FG001|Overall Study|Administrative problems|0|||
150005131|NCT02449018|541153277|FG000|Overall Study|Adverse Event|5|||
150005132|NCT02449018|541153278|FG001|Overall Study|Adverse Event|1|||
150005133|NCT02449018|541153277|FG000|Overall Study|Protocol deviation|4|||
150005134|NCT02449018|541153278|FG001|Overall Study|Protocol deviation|0|||
150005135|NCT02449018|541153277|FG000|Overall Study|Patient decision|2|||
150005136|NCT02449018|541153278|FG001|Overall Study|Patient decision|0|||
150005137|NCT03995355|541153279|FG000|Overall Study|Adverse Event|1|||
150005138|NCT03995355|541153280|FG001|Overall Study|Adverse Event|0|||
150005139|NCT03995355|541153279|FG000|Overall Study|Withdrawal by Subject|1|||
150005140|NCT03995355|541153280|FG001|Overall Study|Withdrawal by Subject|0|||
150005141|NCT03995355|541153279|FG000|Overall Study|Scheduling Issues|0|||
150005142|NCT03995355|541153280|FG001|Overall Study|Scheduling Issues|1|||
150005143|NCT02698371|541153306|FG000|All Participants Flow|Lost to Follow-up|3|||
150005144|NCT02698371|541153306|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
150055493|NCT02353143|541344170|FG000|Overall Study|patient receiving other treatment for AML|0|||
150005145|NCT02698371|541153306|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
150005146|NCT02698371|541153306|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
150005147|NCT02698371|541153306|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
150055494|NCT02353143|541344171|FG001|Overall Study|patient receiving other treatment for AML|0|||
150005148|NCT02698371|541153306|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
150055495|NCT02353143|541344172|FG002|Overall Study|patient receiving other treatment for AML|1|||
150005149|NCT02698371|541153306|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
150005150|NCT01825941|541154786|FG000|Overall Study|Lost to Follow-up|4|||
150005151|NCT01825941|541154787|FG001|Overall Study|Lost to Follow-up|1|||
150005152|NCT03495102|541154788|FG000|Overall Study|Adverse Event|5|||
150005153|NCT03495102|541154789|FG001|Overall Study|Adverse Event|7|||
150005154|NCT03495102|541154790|FG002|Overall Study|Adverse Event|10|||
150005155|NCT03495102|541154788|FG000|Overall Study|Death|3|||
150005156|NCT03495102|541154789|FG001|Overall Study|Death|4|||
150005157|NCT03495102|541154790|FG002|Overall Study|Death|4|||
150005158|NCT03495102|541154788|FG000|Overall Study|Lost to Follow-up|15|||
150005159|NCT03495102|541154789|FG001|Overall Study|Lost to Follow-up|16|||
150005160|NCT03495102|541154790|FG002|Overall Study|Lost to Follow-up|17|||
150005161|NCT03495102|541154788|FG000|Overall Study|Physician Decision|2|||
150005162|NCT03495102|541154789|FG001|Overall Study|Physician Decision|0|||
150005163|NCT03495102|541154790|FG002|Overall Study|Physician Decision|2|||
150005164|NCT03495102|541154788|FG000|Overall Study|Withdrawal by Subject|25|||
150005165|NCT03495102|541154789|FG001|Overall Study|Withdrawal by Subject|36|||
150005166|NCT03495102|541154790|FG002|Overall Study|Withdrawal by Subject|18|||
150005167|NCT03495102|541154788|FG000|Overall Study|Protocol Violation|1|||
150005168|NCT03495102|541154789|FG001|Overall Study|Protocol Violation|1|||
150005169|NCT03495102|541154790|FG002|Overall Study|Protocol Violation|0|||
150005170|NCT03495102|541154788|FG000|Overall Study|Site Closure|3|||
150005171|NCT03495102|541154789|FG001|Overall Study|Site Closure|1|||
150005172|NCT03495102|541154790|FG002|Overall Study|Site Closure|2|||
150005173|NCT03495102|541154788|FG000|Overall Study|Non-compliance|1|||
150005174|NCT03495102|541154789|FG001|Overall Study|Non-compliance|0|||
150005175|NCT03495102|541154790|FG002|Overall Study|Non-compliance|0|||
150005176|NCT03495102|541154788|FG000|Overall Study|Participant Duplicated at Another Site|0|||
150005177|NCT03495102|541154789|FG001|Overall Study|Participant Duplicated at Another Site|0|||
150005178|NCT03495102|541154790|FG002|Overall Study|Participant Duplicated at Another Site|1|||
150005179|NCT03495102|541154788|FG000|Overall Study|Primary Care Physician Recommendation|0|||
150005180|NCT03495102|541154789|FG001|Overall Study|Primary Care Physician Recommendation|1|||
150005181|NCT03495102|541154790|FG002|Overall Study|Primary Care Physician Recommendation|0|||
150005182|NCT03495102|541154788|FG000|Overall Study|Relocated to Another Country|0|||
150005183|NCT03495102|541154789|FG001|Overall Study|Relocated to Another Country|1|||
150005184|NCT03495102|541154790|FG002|Overall Study|Relocated to Another Country|0|||
150005185|NCT03495102|541154788|FG000|Overall Study|Participant was in Rehabilitation|1|||
150005186|NCT03495102|541154789|FG001|Overall Study|Participant was in Rehabilitation|0|||
150005187|NCT03495102|541154790|FG002|Overall Study|Participant was in Rehabilitation|0|||
150005188|NCT01161537|541154791|FG000|Part B|Withdrawal by Subject|2|||
150005189|NCT02769962|541154794|FG000|Overall Study|Physician Decision|0|||
150005190|NCT02769962|541154795|FG001|Overall Study|Physician Decision|0|||
150005191|NCT02769962|541154796|FG002|Overall Study|Physician Decision|0|||
150005192|NCT02769962|541154797|FG003|Overall Study|Physician Decision|0|||
150005193|NCT02769962|541154798|FG004|Overall Study|Physician Decision|0|||
150005194|NCT02769962|541154799|FG005|Overall Study|Physician Decision|1|||
150005195|NCT02769962|541154800|FG006|Overall Study|Physician Decision|0|||
150005196|NCT02769962|541154801|FG007|Overall Study|Physician Decision|1|||
150005197|NCT02769962|541154794|FG000|Overall Study|Refused further treatment|0|||
150005198|NCT02769962|541154795|FG001|Overall Study|Refused further treatment|0|||
150005199|NCT02769962|541154796|FG002|Overall Study|Refused further treatment|0|||
150005200|NCT02769962|541154797|FG003|Overall Study|Refused further treatment|0|||
150005201|NCT02769962|541154798|FG004|Overall Study|Refused further treatment|0|||
150005202|NCT02769962|541154799|FG005|Overall Study|Refused further treatment|1|||
150005203|NCT02769962|541154800|FG006|Overall Study|Refused further treatment|1|||
150005204|NCT02769962|541154801|FG007|Overall Study|Refused further treatment|0|||
150005205|NCT00151372|541154802|FG000|Overall Study|Death|12|||
150005206|NCT00151372|541154803|FG001|Overall Study|Death|11|||
150005207|NCT00151372|541154802|FG000|Overall Study|Lost to Follow-up|5|||
150005208|NCT00151372|541154803|FG001|Overall Study|Lost to Follow-up|5|||
150005209|NCT00151372|541154802|FG000|Overall Study|Too sick medically to continue|5|||
150005210|NCT00151372|541154803|FG001|Overall Study|Too sick medically to continue|6|||
150005211|NCT00151372|541154802|FG000|Overall Study|Withdrawal by Subject|7|||
150005212|NCT00151372|541154803|FG001|Overall Study|Withdrawal by Subject|7|||
150005213|NCT02783170|541154806|FG000|Overall Study|Randomized but not Vaccinated|1|||
150005214|NCT02783170|541154807|FG001|Overall Study|Randomized but not Vaccinated|0|||
150005215|NCT01282294|541154810|FG000|Overall Study|Lost to Follow-up|14|||
150005216|NCT01282294|541154810|FG000|Overall Study|Screening failure|1|||
150005217|NCT01282294|541154810|FG000|Overall Study|Adverse Event|1|||
150005218|NCT01282294|541154810|FG000|Overall Study|Patient non-compliance|2|||
150005219|NCT01282294|541154810|FG000|Overall Study|Physician Decision|1|||
150005220|NCT02408523|541154811|FG000|Overall Study|Adverse Event|4|||
150005221|NCT02408523|541154812|FG001|Overall Study|Adverse Event|10|||
150005222|NCT02408523|541154811|FG000|Overall Study|Lack of Efficacy|0|||
150005223|NCT02408523|541154812|FG001|Overall Study|Lack of Efficacy|1|||
150005224|NCT02408523|541154811|FG000|Overall Study|Protocol Violation|1|||
150005225|NCT02408523|541154812|FG001|Overall Study|Protocol Violation|2|||
150005226|NCT02408523|541154811|FG000|Overall Study|Lost to Follow-up|2|||
150005227|NCT02408523|541154812|FG001|Overall Study|Lost to Follow-up|3|||
150005228|NCT02408523|541154811|FG000|Overall Study|Withdrawal by Subject|3|||
150005229|NCT02408523|541154812|FG001|Overall Study|Withdrawal by Subject|1|||
150005230|NCT02408523|541154811|FG000|Overall Study|Sponsor request|1|||
150005231|NCT02408523|541154812|FG001|Overall Study|Sponsor request|0|||
150005232|NCT02408523|541154811|FG000|Overall Study|Did not satisfy extension conditions|0|||
150005233|NCT02408523|541154812|FG001|Overall Study|Did not satisfy extension conditions|1|||
150179774|NCT00296036|541796822|FG001|Overall Study|Protocol Violation|0|||
150055496|NCT02353143|541344173|FG003|Overall Study|patient receiving other treatment for AML|0|||
150005234|NCT03344172|541154813|FG000|Overall Study|Received <1 dose of treatment|1|||
150005235|NCT03344172|541154814|FG001|Overall Study|Received <1 dose of treatment|0|||
150005236|NCT01300351|541154818|FG000|Overall Study|Did not receive treatment|2|||
150005237|NCT01300351|541154819|FG001|Overall Study|Did not receive treatment|0|||
150005238|NCT01300351|541154818|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
150005239|NCT01300351|541154819|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
150005240|NCT01300351|541154818|FG000|Overall Study|Lost to Follow-up|0|||
150005241|NCT01300351|541154819|FG001|Overall Study|Lost to Follow-up|1|||
150005242|NCT01300351|541154818|FG000|Overall Study|Adverse Event|0|||
150005243|NCT01300351|541154819|FG001|Overall Study|Adverse Event|4|||
150005244|NCT01300351|541154818|FG000|Overall Study|Withdrawal by Subject|7|||
150005245|NCT01300351|541154819|FG001|Overall Study|Withdrawal by Subject|10|||
150005246|NCT00096018|541154823|FG000|Overall Study|Became Ineligible (not treated)|0|||
150005247|NCT00096018|541154824|FG001|Overall Study|Became Ineligible (not treated)|3|||
150055497|NCT02353143|541344174|FG004|Overall Study|patient receiving other treatment for AML|0|||
150055498|NCT02353143|541344175|FG005|Overall Study|patient receiving other treatment for AML|0|||
150055499|NCT02353143|541344176|FG006|Overall Study|patient receiving other treatment for AML|0|||
150055500|NCT02353143|541344177|FG007|Overall Study|patient receiving other treatment for AML|0|||
150055501|NCT02353143|541344178|FG008|Overall Study|patient receiving other treatment for AML|0|||
150055502|NCT02353143|541344170|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
150055503|NCT02353143|541344171|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
150055504|NCT02353143|541344172|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
150055505|NCT02353143|541344173|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
150055506|NCT02353143|541344174|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
150055507|NCT02353143|541344175|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
150055508|NCT02353143|541344176|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
150055509|NCT02353143|541344177|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
150055510|NCT02353143|541344178|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
150055511|NCT02095132|541344183|FG000|Overall Study|Adverse Event|0|||
150055512|NCT02095132|541344184|FG001|Overall Study|Adverse Event|0|||
150055513|NCT02095132|541344185|FG002|Overall Study|Adverse Event|0|||
150055514|NCT02095132|541344186|FG003|Overall Study|Adverse Event|0|||
150055515|NCT02095132|541344187|FG004|Overall Study|Adverse Event|1|||
150055516|NCT02095132|541344188|FG005|Overall Study|Adverse Event|0|||
150055517|NCT02095132|541344189|FG006|Overall Study|Adverse Event|1|||
150055518|NCT02095132|541344190|FG007|Overall Study|Adverse Event|0|||
150055519|NCT02095132|541344191|FG008|Overall Study|Adverse Event|0|||
150055520|NCT02095132|541344183|FG000|Overall Study|Death|0|||
150055521|NCT02095132|541344184|FG001|Overall Study|Death|0|||
150055522|NCT02095132|541344185|FG002|Overall Study|Death|0|||
150055523|NCT02095132|541344186|FG003|Overall Study|Death|0|||
150055524|NCT02095132|541344187|FG004|Overall Study|Death|0|||
150055525|NCT02095132|541344188|FG005|Overall Study|Death|0|||
150055526|NCT02095132|541344189|FG006|Overall Study|Death|1|||
150055527|NCT02095132|541344190|FG007|Overall Study|Death|0|||
150055528|NCT02095132|541344191|FG008|Overall Study|Death|0|||
150055529|NCT02095132|541344183|FG000|Overall Study|Lack of Efficacy|3|||
150055530|NCT02095132|541344184|FG001|Overall Study|Lack of Efficacy|5|||
150055531|NCT02095132|541344185|FG002|Overall Study|Lack of Efficacy|2|||
150055532|NCT02095132|541344186|FG003|Overall Study|Lack of Efficacy|8|||
150055533|NCT02095132|541344187|FG004|Overall Study|Lack of Efficacy|3|||
150055534|NCT02095132|541344188|FG005|Overall Study|Lack of Efficacy|6|||
150055535|NCT02095132|541344189|FG006|Overall Study|Lack of Efficacy|10|||
150055536|NCT02095132|541344190|FG007|Overall Study|Lack of Efficacy|9|||
150055537|NCT02095132|541344191|FG008|Overall Study|Lack of Efficacy|8|||
150055538|NCT02095132|541344183|FG000|Overall Study|Physician Decision|1|||
150055539|NCT02095132|541344184|FG001|Overall Study|Physician Decision|0|||
150055540|NCT02095132|541344185|FG002|Overall Study|Physician Decision|0|||
150055541|NCT02095132|541344186|FG003|Overall Study|Physician Decision|0|||
150055542|NCT02095132|541344187|FG004|Overall Study|Physician Decision|0|||
150055543|NCT02095132|541344188|FG005|Overall Study|Physician Decision|0|||
150005248|NCT00096018|541154823|FG000|Overall Study|Miscellaneous (not treated)|0|||
150005249|NCT00096018|541154824|FG001|Overall Study|Miscellaneous (not treated)|2|||
150005250|NCT00096018|541154823|FG000|Overall Study|Adverse Event|0|||
150005251|NCT00096018|541154824|FG001|Overall Study|Adverse Event|5|||
150005252|NCT00096018|541154823|FG000|Overall Study|Death|0|||
150055544|NCT02095132|541344189|FG006|Overall Study|Physician Decision|1|||
150005253|NCT00096018|541154824|FG001|Overall Study|Death|1|||
150005254|NCT00096018|541154823|FG000|Overall Study|Withdrawal by Subject|0|||
150005255|NCT00096018|541154824|FG001|Overall Study|Withdrawal by Subject|2|||
150055545|NCT02095132|541344190|FG007|Overall Study|Physician Decision|0|||
150055546|NCT02095132|541344191|FG008|Overall Study|Physician Decision|2|||
150055547|NCT02095132|541344183|FG000|Overall Study|Withdrawal by Subject|0|||
150005256|NCT00096018|541154823|FG000|Overall Study|Miscellaneous|2|||
150055548|NCT02095132|541344184|FG001|Overall Study|Withdrawal by Subject|0|||
150005257|NCT00096018|541154824|FG001|Overall Study|Miscellaneous|1|||
150005258|NCT00673881|541154825|FG000|Overall Study|Withdrawal by Subject|1|||
150005259|NCT03968159|541154828|FG000|Overall Study|Adverse Event|4|||
150005260|NCT03968159|541154829|FG001|Overall Study|Adverse Event|4|||
150005261|NCT03968159|541154828|FG000|Overall Study|Lost to Follow-up|1|||
150005262|NCT03968159|541154829|FG001|Overall Study|Lost to Follow-up|1|||
150005263|NCT03968159|541154828|FG000|Overall Study|Use of prohibited medication|0|||
150005264|NCT03968159|541154829|FG001|Overall Study|Use of prohibited medication|1|||
150005265|NCT03968159|541154828|FG000|Overall Study|Protocol Violation|2|||
150005266|NCT03968159|541154829|FG001|Overall Study|Protocol Violation|2|||
150005267|NCT03968159|541154828|FG000|Overall Study|Withdrawal by Subject|4|||
150005268|NCT03968159|541154829|FG001|Overall Study|Withdrawal by Subject|6|||
150005269|NCT03968159|541154828|FG000|Overall Study|Lack of Efficacy|0|||
150005270|NCT03968159|541154829|FG001|Overall Study|Lack of Efficacy|1|||
150005271|NCT03968159|541154828|FG000|Overall Study|Not further specified|2|||
150005272|NCT03968159|541154829|FG001|Overall Study|Not further specified|0|||
150005273|NCT00413010|541154832|FG000|Overall Study|Adverse Event|8|||
150005274|NCT00413010|541154833|FG001|Overall Study|Adverse Event|4|||
150005275|NCT00413010|541154832|FG000|Overall Study|Laboratory abnormality|0|||
150005276|NCT00413010|541154833|FG001|Overall Study|Laboratory abnormality|2|||
150005277|NCT00413010|541154832|FG000|Overall Study|Lack of Efficacy|0|||
150005278|NCT00413010|541154833|FG001|Overall Study|Lack of Efficacy|3|||
150005279|NCT00413010|541154832|FG000|Overall Study|Lost to Follow-up|3|||
150005280|NCT00413010|541154833|FG001|Overall Study|Lost to Follow-up|0|||
150005281|NCT00413010|541154832|FG000|Overall Study|Withdrawal by Subject|7|||
150005282|NCT00413010|541154833|FG001|Overall Study|Withdrawal by Subject|2|||
150005283|NCT00413010|541154832|FG000|Overall Study|Due to termination of the study|54|||
150005284|NCT00413010|541154833|FG001|Overall Study|Due to termination of the study|52|||
150005285|NCT00443781|541154834|FG000|Overall Study|Lost to Follow-up|10|||
150005286|NCT00443781|541154834|FG000|Overall Study|Physician Decision|2|||
150005287|NCT00443781|541154834|FG000|Overall Study|Protocol Violation|1|||
150005288|NCT00443781|541154834|FG000|Overall Study|Withdrawal by Subject|6|||
150005289|NCT00443781|541154834|FG000|Overall Study|Unable to comply with study follow up|2|||
150005290|NCT00443781|541154834|FG000|Overall Study|Investigator terminated participation|1|||
150005291|NCT00443781|541154834|FG000|Overall Study|Insurance not covered|2|||
150005292|NCT00443781|541154834|FG000|Overall Study|PD/FAD not done|1|||
150005293|NCT00430937|541154835|FG000|Overall Study|Adverse Event|3|||
150005294|NCT00430937|541154836|FG001|Overall Study|Adverse Event|8|||
150005295|NCT00430937|541154835|FG000|Overall Study|Death|0|||
150005296|NCT00430937|541154836|FG001|Overall Study|Death|1|||
150005297|NCT00430937|541154835|FG000|Overall Study|Lost to Follow-up|6|||
150005298|NCT00430937|541154836|FG001|Overall Study|Lost to Follow-up|6|||
150005299|NCT00430937|541154835|FG000|Overall Study|Withdrawal by Subject|5|||
150005300|NCT00430937|541154836|FG001|Overall Study|Withdrawal by Subject|2|||
150005301|NCT00430937|541154835|FG000|Overall Study|Protocol Violation|3|||
150005302|NCT00430937|541154836|FG001|Overall Study|Protocol Violation|2|||
150005303|NCT00430937|541154835|FG000|Overall Study|Lack of Efficacy|6|||
150005304|NCT00430937|541154836|FG001|Overall Study|Lack of Efficacy|5|||
150005305|NCT00430937|541154835|FG000|Overall Study|Inappropriate enrollment|2|||
150005306|NCT00430937|541154836|FG001|Overall Study|Inappropriate enrollment|1|||
150005307|NCT00430937|541154835|FG000|Overall Study|Administrative reasons|1|||
150005308|NCT00430937|541154836|FG001|Overall Study|Administrative reasons|0|||
150005309|NCT00430937|541154835|FG000|Overall Study|Protocol discontinuation criteria met|1|||
150005310|NCT00430937|541154836|FG001|Overall Study|Protocol discontinuation criteria met|2|||
150005311|NCT00430937|541154835|FG000|Overall Study|Unable to classify|0|||
150005312|NCT00430937|541154836|FG001|Overall Study|Unable to classify|1|||
150005313|NCT02989805|541154838|FG000|Overall Study|invalid consent|6|||
150005314|NCT02989805|541154839|FG001|Overall Study|invalid consent|4|||
150005315|NCT00286221|541154840|FG000|Overall Study|Protocol Violation|2|||
150005316|NCT00286221|541154841|FG001|Overall Study|Protocol Violation|1|||
150005317|NCT00286221|541154842|FG002|Overall Study|Protocol Violation|6|||
150005318|NCT00286221|541154843|FG003|Overall Study|Protocol Violation|4|||
150005319|NCT00286221|541154840|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
150005320|NCT00286221|541154841|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
150005321|NCT00286221|541154842|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
150005322|NCT00286221|541154843|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
150005323|NCT00286221|541154840|FG000|Overall Study|Inability to trigger PCA|2|||
150005324|NCT00286221|541154841|FG001|Overall Study|Inability to trigger PCA|0|||
150005325|NCT00286221|541154842|FG002|Overall Study|Inability to trigger PCA|0|||
150005326|NCT00286221|541154843|FG003|Overall Study|Inability to trigger PCA|0|||
150005327|NCT00286221|541154840|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
150005328|NCT00286221|541154841|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
150005329|NCT00286221|541154842|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
150005330|NCT00286221|541154843|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
150005331|NCT02771626|541154846|FG000|Overall Study|Adverse Event|1|||
150005332|NCT02771626|541154847|FG001|Overall Study|Adverse Event|5|||
150055549|NCT02095132|541344185|FG002|Overall Study|Withdrawal by Subject|2|||
150055550|NCT02095132|541344186|FG003|Overall Study|Withdrawal by Subject|2|||
150055551|NCT02095132|541344187|FG004|Overall Study|Withdrawal by Subject|3|||
150055552|NCT02095132|541344188|FG005|Overall Study|Withdrawal by Subject|0|||
150055553|NCT02095132|541344189|FG006|Overall Study|Withdrawal by Subject|5|||
150055554|NCT02095132|541344190|FG007|Overall Study|Withdrawal by Subject|0|||
150055555|NCT02095132|541344191|FG008|Overall Study|Withdrawal by Subject|0|||
150055556|NCT04905498|541344194|FG000|Overall Study|Lost to Follow-up|0|||
150005333|NCT02771626|541154848|FG002|Overall Study|Adverse Event|3|||
150005334|NCT02771626|541154849|FG003|Overall Study|Adverse Event|0|||
150005335|NCT02771626|541154850|FG004|Overall Study|Adverse Event|1|||
150005336|NCT02771626|541154851|FG005|Overall Study|Adverse Event|1|||
150005337|NCT02771626|541154846|FG000|Overall Study|Radiologic Disease Progression|6|||
150005338|NCT02771626|541154847|FG001|Overall Study|Radiologic Disease Progression|13|||
150005339|NCT02771626|541154848|FG002|Overall Study|Radiologic Disease Progression|10|||
150005340|NCT02771626|541154849|FG003|Overall Study|Radiologic Disease Progression|7|||
150005341|NCT02771626|541154850|FG004|Overall Study|Radiologic Disease Progression|28|||
150005342|NCT02771626|541154851|FG005|Overall Study|Radiologic Disease Progression|15|||
150005343|NCT02771626|541154846|FG000|Overall Study|Symptomatic Deterioration|0|||
150005344|NCT02771626|541154847|FG001|Overall Study|Symptomatic Deterioration|4|||
150005345|NCT02771626|541154848|FG002|Overall Study|Symptomatic Deterioration|2|||
150005346|NCT02771626|541154849|FG003|Overall Study|Symptomatic Deterioration|0|||
150005347|NCT02771626|541154850|FG004|Overall Study|Symptomatic Deterioration|5|||
150005348|NCT02771626|541154851|FG005|Overall Study|Symptomatic Deterioration|2|||
150005349|NCT02771626|541154846|FG000|Overall Study|Participant Request|0|||
150005350|NCT02771626|541154847|FG001|Overall Study|Participant Request|1|||
150005351|NCT02771626|541154848|FG002|Overall Study|Participant Request|0|||
150005352|NCT02771626|541154849|FG003|Overall Study|Participant Request|2|||
150005353|NCT02771626|541154850|FG004|Overall Study|Participant Request|0|||
150005354|NCT02771626|541154851|FG005|Overall Study|Participant Request|1|||
150005355|NCT02771626|541154846|FG000|Overall Study|Investigator Decision|0|||
150005356|NCT02771626|541154847|FG001|Overall Study|Investigator Decision|1|||
150005357|NCT02771626|541154848|FG002|Overall Study|Investigator Decision|0|||
150179775|NCT00296036|541796823|FG002|Overall Study|Protocol Violation|0|||
150179776|NCT00296036|541796824|FG003|Overall Study|Protocol Violation|0|||
150179777|NCT00296036|541796825|FG004|Overall Study|Protocol Violation|0|||
150179778|NCT00296036|541796826|FG005|Overall Study|Protocol Violation|3|||
150179779|NCT03403413|541796828|FG000|Overall Study|Lack of Efficacy|2|||
150179780|NCT00529100|541796831|FG000|Overall Study|Adverse Event|0|||
150179781|NCT00529100|541796832|FG001|Overall Study|Adverse Event|5|||
150179782|NCT00529100|541796831|FG000|Overall Study|Protocol Violation|0|||
150179783|NCT00529100|541796832|FG001|Overall Study|Protocol Violation|1|||
150179784|NCT00529100|541796831|FG000|Overall Study|Progressive Disease|0|||
150179785|NCT00529100|541796832|FG001|Overall Study|Progressive Disease|1|||
150179786|NCT00529100|541796831|FG000|Overall Study|Withdrawal by Subject|0|||
150179787|NCT00529100|541796832|FG001|Overall Study|Withdrawal by Subject|1|||
150179788|NCT00529100|541796831|FG000|Overall Study|Participant Ineligibility|0|||
150179789|NCT00529100|541796832|FG001|Overall Study|Participant Ineligibility|1|||
150179790|NCT03733119|541796833|FG000|Overall Study|Physician Decision|2|||
150179791|NCT03733119|541796834|FG001|Overall Study|Physician Decision|1|||
150179792|NCT03733119|541796833|FG000|Overall Study|ineligible to treat per protocol|0|||
150179793|NCT03733119|541796834|FG001|Overall Study|ineligible to treat per protocol|1|||
150179794|NCT03951805|541796836|FG000|Overall Study|Adverse Event|1|||
150179795|NCT03951805|541796837|FG001|Overall Study|Adverse Event|0|||
150179796|NCT03951805|541796838|FG002|Overall Study|Adverse Event|0|||
150179797|NCT03951805|541796839|FG003|Overall Study|Adverse Event|0|||
150179798|NCT03684044|541796840|FG000|Overall Study|Adverse Event|3|||
150179799|NCT03684044|541796841|FG001|Overall Study|Adverse Event|0|||
150179800|NCT03684044|541796840|FG000|Overall Study|Death|4|||
150179801|NCT03684044|541796841|FG001|Overall Study|Death|7|||
150179802|NCT03684044|541796840|FG000|Overall Study|Lost to Follow-up|3|||
150179803|NCT03684044|541796841|FG001|Overall Study|Lost to Follow-up|2|||
150005358|NCT02771626|541154849|FG003|Overall Study|Investigator Decision|0|||
150005359|NCT02771626|541154850|FG004|Overall Study|Investigator Decision|1|||
150005360|NCT02771626|541154851|FG005|Overall Study|Investigator Decision|0|||
150005361|NCT02771626|541154846|FG000|Overall Study|Study Termination by Sponsor|0|||
150179804|NCT03684044|541796840|FG000|Overall Study|Patient Not Available|0|||
150179805|NCT03684044|541796841|FG001|Overall Study|Patient Not Available|2|||
150179806|NCT03684044|541796840|FG000|Overall Study|Physician Decision|1|||
150005362|NCT02771626|541154847|FG001|Overall Study|Study Termination by Sponsor|2|||
150005363|NCT02771626|541154848|FG002|Overall Study|Study Termination by Sponsor|1|||
150005364|NCT02771626|541154849|FG003|Overall Study|Study Termination by Sponsor|0|||
150005365|NCT02771626|541154850|FG004|Overall Study|Study Termination by Sponsor|1|||
150005366|NCT02771626|541154851|FG005|Overall Study|Study Termination by Sponsor|0|||
150055557|NCT04905498|541344195|FG001|Overall Study|Lost to Follow-up|2|||
150179807|NCT03684044|541796841|FG001|Overall Study|Physician Decision|0|||
150179808|NCT03684044|541796840|FG000|Overall Study|Withdrawal by Subject|11|||
150005367|NCT02771626|541154846|FG000|Overall Study|Informed Consent Withdrawn|0|||
150005368|NCT02771626|541154847|FG001|Overall Study|Informed Consent Withdrawn|0|||
150005369|NCT02771626|541154848|FG002|Overall Study|Informed Consent Withdrawn|1|||
150005370|NCT02771626|541154849|FG003|Overall Study|Informed Consent Withdrawn|0|||
150005371|NCT02771626|541154850|FG004|Overall Study|Informed Consent Withdrawn|1|||
150005372|NCT02771626|541154851|FG005|Overall Study|Informed Consent Withdrawn|1|||
150005373|NCT02771626|541154846|FG000|Overall Study|Other, Not Specified|1|||
150005374|NCT02771626|541154847|FG001|Overall Study|Other, Not Specified|0|||
150005375|NCT02771626|541154848|FG002|Overall Study|Other, Not Specified|0|||
150005376|NCT02771626|541154849|FG003|Overall Study|Other, Not Specified|0|||
150005377|NCT02771626|541154850|FG004|Overall Study|Other, Not Specified|0|||
150005378|NCT02771626|541154851|FG005|Overall Study|Other, Not Specified|1|||
150005379|NCT02690649|541154852|FG000|Overall Study|Withdrawal by Subject|1|||
150005380|NCT02690649|541154853|FG001|Overall Study|Withdrawal by Subject|1|||
150005381|NCT02690649|541154852|FG000|Overall Study|Protocol Violation|0|||
150005382|NCT02690649|541154853|FG001|Overall Study|Protocol Violation|3|||
150005383|NCT00106691|541154854|FG000|Overall Study|Adverse Event|60|||
150005384|NCT00106691|541154855|FG001|Overall Study|Adverse Event|64|||
150005385|NCT00106691|541154854|FG000|Overall Study|Lost to Follow-up|23|||
150005386|NCT00106691|541154855|FG001|Overall Study|Lost to Follow-up|18|||
150005387|NCT00106691|541154854|FG000|Overall Study|Physician Decision|18|||
150005388|NCT00106691|541154855|FG001|Overall Study|Physician Decision|21|||
150005389|NCT00106691|541154854|FG000|Overall Study|Protocol Violation|13|||
150005390|NCT00106691|541154855|FG001|Overall Study|Protocol Violation|18|||
150005391|NCT00106691|541154854|FG000|Overall Study|Withdrawal by Subject|75|||
150005392|NCT00106691|541154855|FG001|Overall Study|Withdrawal by Subject|70|||
150005393|NCT00106691|541154854|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
150005394|NCT00106691|541154855|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
150005395|NCT00106691|541154854|FG000|Overall Study|QTc>480|3|||
150005396|NCT00106691|541154855|FG001|Overall Study|QTc>480|1|||
150005397|NCT00106691|541154854|FG000|Overall Study|mililtary deployment|2|||
150005398|NCT00106691|541154855|FG001|Overall Study|mililtary deployment|0|||
150005399|NCT00106691|541154854|FG000|Overall Study|Study Site Closing/PI Moved|1|||
150005400|NCT00106691|541154855|FG001|Overall Study|Study Site Closing/PI Moved|2|||
150005401|NCT00106691|541154854|FG000|Overall Study|Cardiologist recommendation|1|||
150005402|NCT00106691|541154855|FG001|Overall Study|Cardiologist recommendation|0|||
150005403|NCT00106691|541154854|FG000|Overall Study|Pt. moved to another state|1|||
150005404|NCT00106691|541154855|FG001|Overall Study|Pt. moved to another state|0|||
150005405|NCT00106691|541154854|FG000|Overall Study|Taking exclusionary avodart|1|||
150005406|NCT00106691|541154855|FG001|Overall Study|Taking exclusionary avodart|0|||
150005407|NCT00106691|541154854|FG000|Overall Study|Not able to discontinue plavix|0|||
150005408|NCT00106691|541154855|FG001|Overall Study|Not able to discontinue plavix|1|||
150005409|NCT01754194|541154856|FG000|Overall Study|Lost to Follow-up|39|||
150005410|NCT01754194|541154857|FG001|Overall Study|Lost to Follow-up|14|||
150005411|NCT01754194|541154856|FG000|Overall Study|Withdrawal by Subject|4|||
150005412|NCT01754194|541154857|FG001|Overall Study|Withdrawal by Subject|5|||
150005413|NCT01754194|541154856|FG000|Overall Study|Other|9|||
150005414|NCT01754194|541154857|FG001|Overall Study|Other|8|||
150005415|NCT00530920|541154858|FG000|Overall Study|Randomized but not treated|0|||
150005416|NCT00530920|541154859|FG001|Overall Study|Randomized but not treated|2|||
150005417|NCT00530920|541154860|FG002|Overall Study|Randomized but not treated|0|||
150005418|NCT00530920|541154858|FG000|Overall Study|Adverse Event|0|||
150005419|NCT00530920|541154859|FG001|Overall Study|Adverse Event|0|||
150005420|NCT00530920|541154860|FG002|Overall Study|Adverse Event|3|||
150005421|NCT00530920|541154858|FG000|Overall Study|Withdrawal by Subject|0|||
150005422|NCT00530920|541154859|FG001|Overall Study|Withdrawal by Subject|0|||
150005423|NCT00530920|541154860|FG002|Overall Study|Withdrawal by Subject|1|||
150005424|NCT00907296|541154861|FG000|Overall Study|Ineligibility Determined|1|||
150005425|NCT00907296|541154862|FG001|Overall Study|Ineligibility Determined|0|||
150005426|NCT00907296|541154863|FG002|Overall Study|Ineligibility Determined|0|||
150005427|NCT00907296|541154864|FG003|Overall Study|Ineligibility Determined|1|||
150005428|NCT00907296|541154865|FG004|Overall Study|Ineligibility Determined|0|||
150005429|NCT00907296|541154866|FG005|Overall Study|Ineligibility Determined|0|||
150005430|NCT00907296|541154867|FG006|Overall Study|Ineligibility Determined|0|||
150055558|NCT04905498|541344194|FG000|Overall Study|COVID lockdown|1|||
150055559|NCT04905498|541344195|FG001|Overall Study|COVID lockdown|0|||
150005431|NCT00907296|541154868|FG007|Overall Study|Ineligibility Determined|1|||
150005432|NCT00907296|541154869|FG008|Overall Study|Ineligibility Determined|0|||
150005433|NCT00907296|541154870|FG009|Overall Study|Ineligibility Determined|0|||
150005434|NCT00907296|541154861|FG000|Overall Study|Protocol Deviation|0|||
150005435|NCT00907296|541154862|FG001|Overall Study|Protocol Deviation|1|||
150005436|NCT00907296|541154863|FG002|Overall Study|Protocol Deviation|0|||
150005437|NCT00907296|541154864|FG003|Overall Study|Protocol Deviation|0|||
150005438|NCT00907296|541154865|FG004|Overall Study|Protocol Deviation|0|||
150005439|NCT00907296|541154866|FG005|Overall Study|Protocol Deviation|0|||
150005440|NCT00907296|541154867|FG006|Overall Study|Protocol Deviation|0|||
150005441|NCT00907296|541154868|FG007|Overall Study|Protocol Deviation|0|||
150005442|NCT00907296|541154869|FG008|Overall Study|Protocol Deviation|0|||
150005443|NCT00907296|541154870|FG009|Overall Study|Protocol Deviation|0|||
150005444|NCT00907296|541154861|FG000|Overall Study|Noncompliance|1|||
150005445|NCT00907296|541154862|FG001|Overall Study|Noncompliance|1|||
150005446|NCT00907296|541154863|FG002|Overall Study|Noncompliance|1|||
150005447|NCT00907296|541154864|FG003|Overall Study|Noncompliance|0|||
150005448|NCT00907296|541154865|FG004|Overall Study|Noncompliance|0|||
150005449|NCT00907296|541154866|FG005|Overall Study|Noncompliance|1|||
150005450|NCT00907296|541154867|FG006|Overall Study|Noncompliance|0|||
150005451|NCT00907296|541154868|FG007|Overall Study|Noncompliance|2|||
150005452|NCT00907296|541154869|FG008|Overall Study|Noncompliance|0|||
150005453|NCT00907296|541154870|FG009|Overall Study|Noncompliance|0|||
150005454|NCT00907296|541154861|FG000|Overall Study|Adverse Event|2|||
150005455|NCT00907296|541154862|FG001|Overall Study|Adverse Event|0|||
150005456|NCT00907296|541154863|FG002|Overall Study|Adverse Event|0|||
150005457|NCT00907296|541154864|FG003|Overall Study|Adverse Event|0|||
150005458|NCT00907296|541154865|FG004|Overall Study|Adverse Event|0|||
150005459|NCT00907296|541154866|FG005|Overall Study|Adverse Event|0|||
150005460|NCT00907296|541154867|FG006|Overall Study|Adverse Event|1|||
150005461|NCT00907296|541154868|FG007|Overall Study|Adverse Event|0|||
150005462|NCT00907296|541154869|FG008|Overall Study|Adverse Event|0|||
150005463|NCT00907296|541154870|FG009|Overall Study|Adverse Event|1|||
150005464|NCT00907296|541154861|FG000|Overall Study|Withdrawal by Subject|7|||
150005465|NCT00907296|541154862|FG001|Overall Study|Withdrawal by Subject|2|||
150005466|NCT00907296|541154863|FG002|Overall Study|Withdrawal by Subject|1|||
150005467|NCT00907296|541154864|FG003|Overall Study|Withdrawal by Subject|1|||
150005468|NCT00907296|541154865|FG004|Overall Study|Withdrawal by Subject|1|||
150005469|NCT00907296|541154866|FG005|Overall Study|Withdrawal by Subject|5|||
150005470|NCT00907296|541154867|FG006|Overall Study|Withdrawal by Subject|3|||
150005471|NCT00907296|541154868|FG007|Overall Study|Withdrawal by Subject|2|||
150005472|NCT00907296|541154869|FG008|Overall Study|Withdrawal by Subject|4|||
150005473|NCT00907296|541154870|FG009|Overall Study|Withdrawal by Subject|2|||
150005474|NCT00907296|541154861|FG000|Overall Study|Lost to Follow-up|9|||
150005475|NCT00907296|541154862|FG001|Overall Study|Lost to Follow-up|1|||
150005476|NCT00907296|541154863|FG002|Overall Study|Lost to Follow-up|0|||
150005477|NCT00907296|541154864|FG003|Overall Study|Lost to Follow-up|2|||
150005478|NCT00907296|541154865|FG004|Overall Study|Lost to Follow-up|0|||
150005479|NCT00907296|541154866|FG005|Overall Study|Lost to Follow-up|3|||
150005480|NCT00907296|541154867|FG006|Overall Study|Lost to Follow-up|2|||
150005481|NCT00907296|541154868|FG007|Overall Study|Lost to Follow-up|2|||
150005482|NCT00907296|541154869|FG008|Overall Study|Lost to Follow-up|0|||
150005483|NCT00907296|541154870|FG009|Overall Study|Lost to Follow-up|4|||
150005484|NCT02066129|541154872|FG000|Overall Study|Lost to Follow-up|13|||
150005485|NCT02066129|541154873|FG001|Overall Study|Lost to Follow-up|12|||
150005486|NCT02066129|541154872|FG000|Overall Study|Withdrawal by Subject|7|||
150005487|NCT02066129|541154873|FG001|Overall Study|Withdrawal by Subject|10|||
150005488|NCT02066129|541154872|FG000|Overall Study|Lack of Efficacy|8|||
150005489|NCT02066129|541154873|FG001|Overall Study|Lack of Efficacy|10|||
150005490|NCT02066129|541154872|FG000|Overall Study|Physician Decision|1|||
150005491|NCT02066129|541154873|FG001|Overall Study|Physician Decision|1|||
150005492|NCT02392403|541154874|FG000|Overall Study|Adverse Event|1|||
150005493|NCT02392403|541154874|FG000|Overall Study|Death|1|||
150005494|NCT02392403|541154874|FG000|Overall Study|Withdrawal by Subject|1|||
150005495|NCT02322190|541154878|FG000|Overall Study|Death on study|1|||
150055560|NCT01029405|541344196|FG000|Overall Study|Withdrawal by Subject|0|||
150055561|NCT01029405|541344197|FG001|Overall Study|Withdrawal by Subject|1|||
150055562|NCT01029405|541344198|FG002|Overall Study|Withdrawal by Subject|2|||
150055563|NCT01029405|541344199|FG003|Overall Study|Withdrawal by Subject|0|||
150055564|NCT01029405|541344196|FG000|Overall Study|Protocol Violation|0|||
150055565|NCT01029405|541344197|FG001|Overall Study|Protocol Violation|0|||
150055566|NCT01029405|541344198|FG002|Overall Study|Protocol Violation|0|||
150055567|NCT01029405|541344199|FG003|Overall Study|Protocol Violation|1|||
150055568|NCT01029405|541344196|FG000|Overall Study|Adverse Event|0|||
150055569|NCT01029405|541344197|FG001|Overall Study|Adverse Event|0|||
150005496|NCT02322190|541154879|FG001|Overall Study|Death on study|0|||
150005497|NCT02776033|541154883|FG000|Overall Study|Withdrawal by Subject|0|||
150005498|NCT02776033|541154884|FG001|Overall Study|Withdrawal by Subject|0|||
150005499|NCT02776033|541154885|FG002|Overall Study|Withdrawal by Subject|2|||
150005500|NCT02776033|541154883|FG000|Overall Study|Physician Decision|2|||
150005501|NCT02776033|541154884|FG001|Overall Study|Physician Decision|0|||
150055570|NCT01029405|541344198|FG002|Overall Study|Adverse Event|1|||
150055571|NCT01029405|541344199|FG003|Overall Study|Adverse Event|1|||
150055572|NCT01029405|541344196|FG000|Overall Study|Lost to Follow-up|2|||
150005502|NCT02776033|541154885|FG002|Overall Study|Physician Decision|0|||
150005503|NCT02776033|541154883|FG000|Overall Study|Lost to Follow-up|1|||
150005504|NCT02776033|541154884|FG001|Overall Study|Lost to Follow-up|0|||
150005505|NCT02776033|541154885|FG002|Overall Study|Lost to Follow-up|0|||
150005506|NCT02776033|541154883|FG000|Overall Study|Adverse Event|1|||
150005507|NCT02776033|541154884|FG001|Overall Study|Adverse Event|2|||
150005508|NCT02776033|541154885|FG002|Overall Study|Adverse Event|0|||
150055573|NCT01029405|541344197|FG001|Overall Study|Lost to Follow-up|1|||
150055574|NCT01029405|541344198|FG002|Overall Study|Lost to Follow-up|1|||
150055575|NCT01029405|541344199|FG003|Overall Study|Lost to Follow-up|2|||
150055576|NCT01029405|541344196|FG000|Overall Study|Other|0|||
150055577|NCT01029405|541344197|FG001|Overall Study|Other|1|||
150055578|NCT01029405|541344198|FG002|Overall Study|Other|0|||
150055579|NCT01029405|541344199|FG003|Overall Study|Other|1|||
150055580|NCT00409175|541344200|FG000|Overall Study|Adverse Event|4|||
150055581|NCT00409175|541344201|FG001|Overall Study|Adverse Event|3|||
150055582|NCT00409175|541344200|FG000|Overall Study|Withdrawal by Subject|1|||
150055583|NCT00409175|541344201|FG001|Overall Study|Withdrawal by Subject|2|||
150055584|NCT00409175|541344200|FG000|Overall Study|Negative genotype|0|||
150055585|NCT00409175|541344201|FG001|Overall Study|Negative genotype|1|||
150055586|NCT00409175|541344200|FG000|Overall Study|Liver transplantation|13|||
150055587|NCT00409175|541344201|FG001|Overall Study|Liver transplantation|13|||
150055588|NCT02946931|541344206|FG000|Overall Study|Did not require collection of CRFs|588|||
150055589|NCT02946931|541344206|FG000|Overall Study|Other than listed|37|||
150055590|NCT02946931|541344206|FG000|Overall Study|Discharge from hospital|118|||
150055591|NCT02946931|541344206|FG000|Overall Study|Adverse Event|81|||
150055592|NCT02946931|541344206|FG000|Overall Study|CRFs not valid|1|||
150055593|NCT02946931|541344206|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
150055594|NCT00869778|541344210|FG000|Overall Study|Adverse Event|2|||
150055595|NCT00869778|541344211|FG001|Overall Study|Adverse Event|0|||
150055596|NCT00869778|541344212|FG002|Overall Study|Adverse Event|0|||
150055597|NCT00869778|541344210|FG000|Overall Study|Withdrawal by Subject|3|||
150055598|NCT00869778|541344211|FG001|Overall Study|Withdrawal by Subject|4|||
150055599|NCT00869778|541344212|FG002|Overall Study|Withdrawal by Subject|5|||
150055600|NCT00869778|541344210|FG000|Overall Study|Pregnancy|1|||
150055601|NCT00869778|541344211|FG001|Overall Study|Pregnancy|0|||
150055602|NCT00869778|541344212|FG002|Overall Study|Pregnancy|0|||
150055603|NCT00869778|541344210|FG000|Overall Study|Protocol Violation|5|||
150055604|NCT00869778|541344211|FG001|Overall Study|Protocol Violation|3|||
150055605|NCT00869778|541344212|FG002|Overall Study|Protocol Violation|5|||
150055606|NCT00869778|541344210|FG000|Overall Study|Unblinding|1|||
150055607|NCT00869778|541344211|FG001|Overall Study|Unblinding|0|||
150055608|NCT00869778|541344212|FG002|Overall Study|Unblinding|0|||
150055609|NCT03339297|541344213|FG000|Overall Study|Relapse of Hematologic Disease|1|||
150055610|NCT03339297|541344214|FG001|Overall Study|Relapse of Hematologic Disease|0|||
150055611|NCT03339297|541344213|FG000|Overall Study|Death|10|||
150055612|NCT03339297|541344214|FG001|Overall Study|Death|7|||
150055613|NCT03339297|541344213|FG000|Overall Study|Hepatic Candidosis|1|||
150055614|NCT03339297|541344214|FG001|Overall Study|Hepatic Candidosis|0|||
150055615|NCT03339297|541344213|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
150055616|NCT03339297|541344214|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
150055617|NCT03339297|541344213|FG000|Overall Study|Consent Withdrawn by Participant|3|||
150055618|NCT03339297|541344214|FG001|Overall Study|Consent Withdrawn by Participant|3|||
150055619|NCT03339297|541344213|FG000|Overall Study|Disease Relapse|2|||
150055620|NCT03339297|541344214|FG001|Overall Study|Disease Relapse|0|||
150055621|NCT03339297|541344213|FG000|Overall Study|Physician Decision|1|||
150055622|NCT03339297|541344214|FG001|Overall Study|Physician Decision|1|||
150055623|NCT03339297|541344213|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
150179809|NCT03684044|541796841|FG001|Overall Study|Withdrawal by Subject|9|||
150055624|NCT03339297|541344214|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
150055625|NCT03339297|541344213|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
150055626|NCT03339297|541344214|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
150055627|NCT03339297|541344213|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
150055628|NCT03339297|541344214|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
150055629|NCT03339297|541344213|FG000|Overall Study|Adverse Event, Non-fatal|1|||
150055630|NCT03339297|541344214|FG001|Overall Study|Adverse Event, Non-fatal|0|||
150055631|NCT03339297|541344213|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
150055632|NCT03339297|541344214|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
150055633|NCT03339297|541344213|FG000|Overall Study|Patient Was Not Eligible|1|||
150055634|NCT03339297|541344214|FG001|Overall Study|Patient Was Not Eligible|0|||
150055635|NCT03316911|541344220|FG000|Overall Study|Lost to Follow-up|33|||
150055636|NCT03316911|541344221|FG001|Overall Study|Lost to Follow-up|29|||
150005509|NCT00316888|541154889|FG000|Overall Study|Adverse Event|4|||
150005510|NCT00316888|541154890|FG001|Overall Study|Adverse Event|5|||
150005511|NCT00316888|541154889|FG000|Overall Study|Withdrawal by Subject|2|||
150005512|NCT00316888|541154890|FG001|Overall Study|Withdrawal by Subject|2|||
150005513|NCT00316888|541154889|FG000|Overall Study|Not start protocol therapy|0|||
150005514|NCT00316888|541154890|FG001|Overall Study|Not start protocol therapy|1|||
150005515|NCT02616393|541154891|FG000|Overall Study|Death|5|||
150005516|NCT02616393|541154892|FG001|Overall Study|Death|12|||
150005517|NCT02616393|541154893|FG002|Overall Study|Death|1|||
150005518|NCT02616393|541154891|FG000|Overall Study|Termination by Sponsor|4|||
150005519|NCT02616393|541154892|FG001|Overall Study|Termination by Sponsor|5|||
150005520|NCT02616393|541154893|FG002|Overall Study|Termination by Sponsor|2|||
150005521|NCT02616393|541154891|FG000|Overall Study|Other|3|||
150005522|NCT02616393|541154892|FG001|Overall Study|Other|0|||
150005523|NCT02616393|541154893|FG002|Overall Study|Other|0|||
150005524|NCT02616393|541154891|FG000|Overall Study|Withdrawal by Subject|1|||
150005525|NCT02616393|541154892|FG001|Overall Study|Withdrawal by Subject|1|||
150005526|NCT02616393|541154893|FG002|Overall Study|Withdrawal by Subject|0|||
150005527|NCT02616393|541154891|FG000|Overall Study|Lost to Follow-up|0|||
150005528|NCT02616393|541154892|FG001|Overall Study|Lost to Follow-up|2|||
150005529|NCT02616393|541154893|FG002|Overall Study|Lost to Follow-up|0|||
150005530|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
150005531|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
150005532|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
150005533|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
150005534|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
150005535|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
150005536|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
150005537|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
150005538|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
150005539|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
150005540|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
150005541|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
150005542|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
150005543|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
150005544|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
150005545|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
150005546|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
150005547|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
150005548|NCT01302054|541154895|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
150005549|NCT01302054|541154896|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
150005550|NCT01302054|541154897|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
150005551|NCT01302054|541154895|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
150005552|NCT01302054|541154896|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
150005553|NCT01302054|541154897|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
150055637|NCT01119937|541344222|FG000|Overall Study|Adverse Event|11|||
150055638|NCT01119937|541344223|FG001|Overall Study|Adverse Event|5|||
150055639|NCT01119937|541344222|FG000|Overall Study|Protocol deviation|3|||
150005554|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
150005555|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
150005556|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
150005557|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
150005558|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
150005559|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
150005560|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
150005561|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
150005562|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
150005563|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
150005564|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
150005565|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
150005566|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
150005567|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
150005568|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
150005569|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
150005570|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
150005571|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
150005572|NCT01302054|541154895|FG000|Double-Blind Treatment Phase|Other|0|||
150005573|NCT01302054|541154896|FG001|Double-Blind Treatment Phase|Other|4|||
150005574|NCT01302054|541154897|FG002|Double-Blind Treatment Phase|Other|9|||
150005575|NCT00857948|541154898|FG000|Overall Study|Withdrawal by Subject|2|||
150005576|NCT00857948|541154899|FG001|Overall Study|Withdrawal by Subject|0|||
150005577|NCT00857948|541154900|FG002|Overall Study|Withdrawal by Subject|0|||
150005578|NCT00857948|541154901|FG003|Overall Study|Withdrawal by Subject|0|||
150005579|NCT00857948|541154898|FG000|Overall Study|Protocol Violation|1|||
150005580|NCT00857948|541154899|FG001|Overall Study|Protocol Violation|0|||
150005581|NCT00857948|541154900|FG002|Overall Study|Protocol Violation|1|||
150005582|NCT00857948|541154901|FG003|Overall Study|Protocol Violation|0|||
150005583|NCT03757130|541154906|FG000|Overall Study|Lost to Follow-up|0|||
150005584|NCT03757130|541154907|FG001|Overall Study|Lost to Follow-up|0|||
150005585|NCT03757130|541154908|FG002|Overall Study|Lost to Follow-up|0|||
150005586|NCT03757130|541154909|FG003|Overall Study|Lost to Follow-up|1|||
150005587|NCT03757130|541154910|FG004|Overall Study|Lost to Follow-up|0|||
150005588|NCT03757130|541154911|FG005|Overall Study|Lost to Follow-up|0|||
150005589|NCT03757130|541154912|FG006|Overall Study|Lost to Follow-up|0|||
150005590|NCT03757130|541154913|FG007|Overall Study|Lost to Follow-up|1|||
150005591|NCT03757130|541154906|FG000|Overall Study|Withdrawal by Subject|0|||
150005592|NCT03757130|541154907|FG001|Overall Study|Withdrawal by Subject|0|||
150005593|NCT03757130|541154908|FG002|Overall Study|Withdrawal by Subject|0|||
150005594|NCT03757130|541154909|FG003|Overall Study|Withdrawal by Subject|0|||
150005595|NCT03757130|541154910|FG004|Overall Study|Withdrawal by Subject|0|||
150005596|NCT03757130|541154911|FG005|Overall Study|Withdrawal by Subject|0|||
150005597|NCT03757130|541154912|FG006|Overall Study|Withdrawal by Subject|1|||
150005598|NCT03757130|541154913|FG007|Overall Study|Withdrawal by Subject|0|||
150005599|NCT01617447|541154919|FG000|Overall Study|Adverse Event|0|||
150005600|NCT01617447|541154920|FG001|Overall Study|Adverse Event|1|||
150005601|NCT01617447|541154919|FG000|Overall Study|Physician Decision|0|||
150005602|NCT01617447|541154920|FG001|Overall Study|Physician Decision|2|||
150005603|NCT00576472|541154921|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005604|NCT00576472|541154922|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005605|NCT00576472|541154923|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005606|NCT00576472|541154924|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
150005607|NCT00576472|541154925|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005608|NCT00576472|541154926|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005609|NCT00576472|541154927|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005610|NCT00576472|541154928|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005611|NCT00576472|541154929|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005612|NCT00576472|541154930|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005613|NCT00576472|541154931|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005614|NCT00576472|541154932|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005615|NCT00576472|541154933|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005616|NCT00576472|541154934|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005617|NCT00576472|541154935|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
150005618|NCT00576472|541154921|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
150005619|NCT00576472|541154922|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
150005620|NCT00576472|541154923|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
150005621|NCT00576472|541154924|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
150005622|NCT00576472|541154925|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
150005623|NCT00576472|541154926|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
150005624|NCT00576472|541154927|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
150005625|NCT00576472|541154928|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
150005626|NCT00576472|541154929|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
150005627|NCT00576472|541154930|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
150005628|NCT00576472|541154931|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
150005629|NCT00576472|541154932|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
150055640|NCT01119937|541344223|FG001|Overall Study|Protocol deviation|1|||
150005630|NCT00576472|541154933|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
150005631|NCT00576472|541154934|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
150005632|NCT00576472|541154935|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
150005633|NCT00576472|541154921|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005634|NCT00576472|541154922|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005635|NCT00576472|541154923|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005636|NCT00576472|541154924|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
150005637|NCT00576472|541154925|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005638|NCT00576472|541154926|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005639|NCT00576472|541154927|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005640|NCT00576472|541154928|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005641|NCT00576472|541154929|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005642|NCT00576472|541154930|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005643|NCT00576472|541154931|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005644|NCT00576472|541154932|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005645|NCT00576472|541154933|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005646|NCT00576472|541154934|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005647|NCT00576472|541154935|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
150005648|NCT00576472|541154921|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
150005649|NCT00576472|541154922|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
150005650|NCT00576472|541154923|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
150005651|NCT00576472|541154924|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
150005652|NCT00576472|541154925|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
150005653|NCT00576472|541154926|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
150005654|NCT00576472|541154927|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
150005655|NCT00576472|541154928|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
150005656|NCT00576472|541154929|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
150005657|NCT00576472|541154930|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
150005658|NCT00576472|541154931|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
150005659|NCT00576472|541154932|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
150005660|NCT00576472|541154933|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
150005661|NCT00576472|541154934|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
150005662|NCT00576472|541154935|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
150005663|NCT00576472|541154921|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005664|NCT00576472|541154922|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005665|NCT00576472|541154923|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005666|NCT00576472|541154924|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
150005667|NCT00576472|541154925|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005668|NCT00576472|541154926|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005669|NCT00576472|541154927|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
150055641|NCT01119937|541344222|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
150055642|NCT01119937|541344223|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150055643|NCT01119937|541344222|FG000|Overall Study|Withdrawal by Subject|2|||
150055644|NCT01119937|541344223|FG001|Overall Study|Withdrawal by Subject|1|||
150055645|NCT01270802|541344224|FG000|Overall Study|Withdrawal by Subject|1|||
150055646|NCT01270802|541344225|FG001|Overall Study|Withdrawal by Subject|0|||
150055647|NCT01270802|541344224|FG000|Overall Study|Adverse Event|1|||
150005670|NCT00576472|541154928|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005671|NCT00576472|541154929|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005672|NCT00576472|541154930|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005673|NCT00576472|541154931|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005674|NCT00576472|541154932|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005675|NCT00576472|541154933|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
150005676|NCT00576472|541154934|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
150055648|NCT01270802|541344225|FG001|Overall Study|Adverse Event|0|||
150055649|NCT01270802|541344224|FG000|Overall Study|Lost to Follow-up|0|||
150055650|NCT01270802|541344225|FG001|Overall Study|Lost to Follow-up|1|||
150055651|NCT01566214|541344230|FG000|Overall Study|Lost to Follow-up|3|||
150005677|NCT00576472|541154935|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
150055652|NCT01566214|541344231|FG001|Overall Study|Lost to Follow-up|0|||
150055653|NCT00393510|541344233|FG000|Overall Study|Physician Decision|3|||
150005678|NCT00576472|541154921|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005679|NCT00576472|541154922|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005680|NCT00576472|541154923|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005681|NCT00576472|541154924|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005682|NCT00576472|541154925|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005683|NCT00576472|541154926|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005684|NCT00576472|541154927|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
150005685|NCT00576472|541154928|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005686|NCT00576472|541154929|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005687|NCT00576472|541154930|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005688|NCT00576472|541154931|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005689|NCT00576472|541154932|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005690|NCT00576472|541154933|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005691|NCT00576472|541154934|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005692|NCT00576472|541154935|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
150005693|NCT00576472|541154921|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
150005694|NCT00576472|541154922|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
150005695|NCT00576472|541154923|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
150005696|NCT00576472|541154924|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
150005697|NCT00576472|541154925|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
150005698|NCT00576472|541154926|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
150005699|NCT00576472|541154927|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
150005700|NCT00576472|541154928|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
150005701|NCT00576472|541154929|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
150005702|NCT00576472|541154930|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
150005703|NCT00576472|541154931|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
150005704|NCT00576472|541154932|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
150005705|NCT00576472|541154933|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
150005706|NCT00576472|541154934|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
150005707|NCT00576472|541154935|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
150005708|NCT00576472|541154921|FG000|MPH Cross Over Phase|Physician Decision|0|||
150005709|NCT00576472|541154922|FG001|MPH Cross Over Phase|Physician Decision|0|||
150005710|NCT00576472|541154923|FG002|MPH Cross Over Phase|Physician Decision|0|||
150005711|NCT00576472|541154924|FG003|MPH Cross Over Phase|Physician Decision|0|||
150005712|NCT00576472|541154925|FG004|MPH Cross Over Phase|Physician Decision|0|||
150005713|NCT00576472|541154926|FG005|MPH Cross Over Phase|Physician Decision|0|||
150005714|NCT00576472|541154927|FG006|MPH Cross Over Phase|Physician Decision|4|||
150005715|NCT00576472|541154928|FG007|MPH Cross Over Phase|Physician Decision|0|||
150005716|NCT00576472|541154929|FG008|MPH Cross Over Phase|Physician Decision|0|||
150005717|NCT00576472|541154930|FG009|MPH Cross Over Phase|Physician Decision|0|||
150005718|NCT00576472|541154931|FG010|MPH Cross Over Phase|Physician Decision|0|||
150005719|NCT00576472|541154932|FG011|MPH Cross Over Phase|Physician Decision|0|||
150005720|NCT00576472|541154933|FG012|MPH Cross Over Phase|Physician Decision|0|||
150005721|NCT00576472|541154934|FG013|MPH Cross Over Phase|Physician Decision|0|||
150005722|NCT00576472|541154935|FG014|MPH Cross Over Phase|Physician Decision|0|||
150005723|NCT00576472|541154921|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005724|NCT00576472|541154922|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005725|NCT00576472|541154923|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005726|NCT00576472|541154924|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005727|NCT00576472|541154925|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005728|NCT00576472|541154926|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005729|NCT00576472|541154927|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005730|NCT00576472|541154928|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005731|NCT00576472|541154929|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
150055654|NCT00393510|541344234|FG001|Overall Study|Physician Decision|9|||
150055655|NCT01534182|541344237|FG000|Overall Study|Administrative problems|1|||
150055656|NCT01534182|541344238|FG001|Overall Study|Administrative problems|0|||
150055657|NCT01534182|541344237|FG000|Overall Study|Withdrawal by Subject|4|||
150055658|NCT01534182|541344238|FG001|Overall Study|Withdrawal by Subject|7|||
150005732|NCT00576472|541154930|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005733|NCT00576472|541154931|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
150005734|NCT00576472|541154932|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
150055659|NCT01534182|541344237|FG000|Overall Study|Adverse Event|7|||
150005735|NCT00576472|541154933|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005736|NCT00576472|541154934|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005737|NCT00576472|541154935|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
150005738|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005739|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150055660|NCT01534182|541344238|FG001|Overall Study|Adverse Event|3|||
150055661|NCT03077087|541344239|FG000|Overall Study|Physician Decision|2|||
150055662|NCT00770146|541344240|FG000|Treatment Period|Withdrawal by Subject|6|||
150055663|NCT00770146|541344241|FG001|Treatment Period|Withdrawal by Subject|13|||
150005740|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005741|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005742|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005743|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005744|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005745|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005746|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005747|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005748|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005749|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005750|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005751|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
150005752|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
150005753|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
150005754|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
150005755|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
150005756|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
150005757|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
150005758|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
150005759|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
150005760|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
150005761|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
150005762|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
150005763|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
150005764|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
150005765|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
150005766|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
150005767|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
150005768|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
150005769|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
150005770|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
150005771|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
150005772|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
150005773|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
150005774|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
150005775|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
150005776|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
150055664|NCT00770146|541344240|FG000|Treatment Period|Adverse Event|2|||
150055665|NCT00770146|541344241|FG001|Treatment Period|Adverse Event|26|||
150055666|NCT00770146|541344240|FG000|Treatment Period|Other|1|||
150005777|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
150005778|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
150005779|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
150005780|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
150005781|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
150005782|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
150055667|NCT00770146|541344241|FG001|Treatment Period|Other|5|||
150055668|NCT00770146|541344240|FG000|Treatment Period|Protocol non-compliance|0|||
150055669|NCT00770146|541344241|FG001|Treatment Period|Protocol non-compliance|1|||
150055670|NCT00770146|541344240|FG000|Follow-up Period|Withdrawal by Subject|7|||
150055671|NCT00770146|541344241|FG001|Follow-up Period|Withdrawal by Subject|13|||
150005783|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Side effects|0|||
150005784|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Side effects|0|||
150005785|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Side effects|0|||
150005786|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Side effects|0|||
150005787|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Side effects|0|||
150005788|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Side effects|0|||
150005789|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Side effects|0|||
150005790|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Side effects|0|||
150005791|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Side effects|0|||
150005792|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Side effects|0|||
150005793|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Side effects|0|||
150005794|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Side effects|0|||
150005795|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Side effects|0|||
150005796|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Side effects|0|||
150005797|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Side effects|8|||
150005798|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005799|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005800|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005801|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005802|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005803|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005804|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005805|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005806|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005807|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005808|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005809|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005810|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005811|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
150005812|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
150005813|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
150005814|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
150005815|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
150005816|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
150005817|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
150005818|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
150005819|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
150005820|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
150005821|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
150005822|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
150005823|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
150005824|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
150005825|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
150005826|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
150005827|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
150005828|NCT00576472|541154921|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005829|NCT00576472|541154922|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005830|NCT00576472|541154923|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005831|NCT00576472|541154924|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005832|NCT00576472|541154925|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005833|NCT00576472|541154926|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005834|NCT00576472|541154927|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005835|NCT00576472|541154928|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005836|NCT00576472|541154929|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005837|NCT00576472|541154930|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005838|NCT00576472|541154931|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005839|NCT00576472|541154932|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005840|NCT00576472|541154933|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005841|NCT00576472|541154934|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
150005842|NCT00576472|541154935|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
150179810|NCT03703336|541796842|FG000|Overall Study|Parent withdrew consent|29|||
150179811|NCT03703336|541796843|FG001|Overall Study|Parent withdrew consent|8|||
150179812|NCT03703336|541796842|FG000|Overall Study|Migration|3|||
150179813|NCT03703336|541796843|FG001|Overall Study|Migration|3|||
150179814|NCT03703336|541796842|FG000|Overall Study|Protocol Violation|3|||
150179815|NCT03703336|541796843|FG001|Overall Study|Protocol Violation|1|||
150179816|NCT03703336|541796842|FG000|Overall Study|Physician Decision|2|||
150179817|NCT03703336|541796843|FG001|Overall Study|Physician Decision|0|||
150179818|NCT03703336|541796842|FG000|Overall Study|Adverse Event|0|||
150179819|NCT03703336|541796843|FG001|Overall Study|Adverse Event|2|||
150179820|NCT03703336|541796842|FG000|Overall Study|Lost to Follow-up|1|||
150179821|NCT03703336|541796843|FG001|Overall Study|Lost to Follow-up|0|||
150179822|NCT00595413|541796844|FG000|Overall Study|Adverse Event|0|||
150179823|NCT00595413|541796845|FG001|Overall Study|Adverse Event|2|||
150179824|NCT00595413|541796846|FG002|Overall Study|Adverse Event|1|||
150179825|NCT00595413|541796847|FG003|Overall Study|Adverse Event|1|||
150179826|NCT00595413|541796844|FG000|Overall Study|Lost to Follow-up|2|||
150179827|NCT00595413|541796845|FG001|Overall Study|Lost to Follow-up|2|||
150179828|NCT00595413|541796846|FG002|Overall Study|Lost to Follow-up|1|||
150179829|NCT00595413|541796847|FG003|Overall Study|Lost to Follow-up|3|||
150179830|NCT00595413|541796844|FG000|Overall Study|Death|0|||
150179831|NCT00595413|541796845|FG001|Overall Study|Death|0|||
150179832|NCT00595413|541796846|FG002|Overall Study|Death|1|||
150179833|NCT00595413|541796847|FG003|Overall Study|Death|0|||
150179834|NCT00595413|541796844|FG000|Overall Study|Other|5|||
150179835|NCT00595413|541796845|FG001|Overall Study|Other|1|||
150179836|NCT00595413|541796846|FG002|Overall Study|Other|5|||
150179837|NCT00595413|541796847|FG003|Overall Study|Other|0|||
150179838|NCT04629950|541796850|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
150179839|NCT04629950|541796851|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
150179840|NCT04629950|541796852|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
150179841|NCT04629950|541796853|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
150179842|NCT04629950|541796850|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
150179843|NCT04629950|541796851|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
150179844|NCT04629950|541796852|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
150179845|NCT04629950|541796853|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
150179846|NCT04629950|541796850|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
150179847|NCT04629950|541796851|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
150179848|NCT04629950|541796852|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
150179849|NCT04629950|541796853|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
150179850|NCT04629950|541796850|FG000|Extension Study|Withdrawal by Subject|0|||
150179851|NCT04629950|541796851|FG001|Extension Study|Withdrawal by Subject|0|||
150179852|NCT04629950|541796852|FG002|Extension Study|Withdrawal by Subject|1|||
150179853|NCT04629950|541796853|FG003|Extension Study|Withdrawal by Subject|0|||
150179854|NCT04629950|541796850|FG000|Extension Study|Adverse Event|0|||
150179855|NCT04629950|541796851|FG001|Extension Study|Adverse Event|0|||
150179856|NCT04629950|541796852|FG002|Extension Study|Adverse Event|0|||
150179857|NCT04629950|541796853|FG003|Extension Study|Adverse Event|1|||
150179858|NCT01198145|541796854|FG000|Overall Study|Withdrawal by Subject|1|||
150179859|NCT01198145|541796855|FG001|Overall Study|Withdrawal by Subject|1|||
150179860|NCT03830866|541796856|FG000|Overall Study|Death|90|||
150179861|NCT03830866|541796857|FG001|Overall Study|Death|111|||
150179862|NCT03830866|541796856|FG000|Overall Study|Lost to Follow-up|7|||
150179863|NCT03830866|541796857|FG001|Overall Study|Lost to Follow-up|7|||
150179864|NCT03830866|541796856|FG000|Overall Study|Withdrawal by Subject|19|||
150179865|NCT03830866|541796857|FG001|Overall Study|Withdrawal by Subject|16|||
150179866|NCT03830866|541796856|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
150179867|NCT03830866|541796857|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
150179868|NCT03830866|541796856|FG000|Overall Study|Other|1|||
150179869|NCT03830866|541796857|FG001|Overall Study|Other|1|||
150005843|NCT00780273|541154936|FG000|Overall Study|Death|1|||
150179870|NCT02568683|541796858|FG000|Overall Study|Death|0|||
150179871|NCT02568683|541796859|FG001|Overall Study|Death|2|||
150179872|NCT02568683|541796858|FG000|Overall Study|Withdrew Consent|1|||
150179873|NCT02568683|541796859|FG001|Overall Study|Withdrew Consent|0|||
150179874|NCT02568683|541796858|FG000|Overall Study|Study Terminated By Sponsor|5|||
150179875|NCT02568683|541796859|FG001|Overall Study|Study Terminated By Sponsor|2|||
150179876|NCT00510887|541796860|FG000|Overall Study|Lost to Follow-up|1|||
150179877|NCT01248936|541796876|FG000|Overall Study|Sponsor Decision|259|||
150179878|NCT01248936|541796876|FG000|Overall Study|Progression of Disease|50|||
150005844|NCT00780273|541154936|FG000|Overall Study|Lost to Follow-up|1|||
150179879|NCT01248936|541796876|FG000|Overall Study|Death|26|||
150179880|NCT01248936|541796876|FG000|Overall Study|Withdrawal of Consent|20|||
150179881|NCT01248936|541796876|FG000|Overall Study|Adverse Event|8|||
150179882|NCT01248936|541796876|FG000|Overall Study|Lost to Follow-up|7|||
150179883|NCT01248936|541796876|FG000|Overall Study|Refused Treatment|1|||
150179884|NCT01248936|541796876|FG000|Overall Study|Other reason|3|||
150179885|NCT03485950|541796877|FG000|Overall Study|Adverse Event|1|||
150005845|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
150005846|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
150005847|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
150005848|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
150005849|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
150005850|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
150005851|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
150005852|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
150005853|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
150005854|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
150055672|NCT00770146|541344240|FG000|Follow-up Period|Adverse Event|0|||
150055673|NCT00770146|541344241|FG001|Follow-up Period|Adverse Event|2|||
150055674|NCT00770146|541344240|FG000|Follow-up Period|Other|4|||
150055675|NCT00770146|541344241|FG001|Follow-up Period|Other|5|||
150055676|NCT02412488|541344244|FG000|Overall Study|Lost to Follow-up|10|||
150055677|NCT02412488|541344244|FG000|Overall Study|Withdrawal by Subject|5|||
150055678|NCT02412488|541344244|FG000|Overall Study|Physician Decision|1|||
150055679|NCT02412488|541344244|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
150055680|NCT02412488|541344244|FG000|Overall Study|Reveal LINQ explant|1|||
150055681|NCT01989468|541344245|FG000|Overall Study|Adverse Event|10|||
150055682|NCT01989468|541344246|FG001|Overall Study|Adverse Event|15|||
150055683|NCT01989468|541344247|FG002|Overall Study|Adverse Event|4|||
150055684|NCT01989468|541344248|FG003|Overall Study|Adverse Event|5|||
150055685|NCT01989468|541344249|FG004|Overall Study|Adverse Event|4|||
150055686|NCT01989468|541344245|FG000|Overall Study|Lack of Efficacy|11|||
150055687|NCT01989468|541344246|FG001|Overall Study|Lack of Efficacy|11|||
150055688|NCT01989468|541344247|FG002|Overall Study|Lack of Efficacy|7|||
150055689|NCT01989468|541344248|FG003|Overall Study|Lack of Efficacy|4|||
150055690|NCT01989468|541344249|FG004|Overall Study|Lack of Efficacy|2|||
150055691|NCT01989468|541344245|FG000|Overall Study|Lost to Follow-up|5|||
150055692|NCT01989468|541344246|FG001|Overall Study|Lost to Follow-up|2|||
150055693|NCT01989468|541344247|FG002|Overall Study|Lost to Follow-up|0|||
150055694|NCT01989468|541344248|FG003|Overall Study|Lost to Follow-up|1|||
150055695|NCT01989468|541344249|FG004|Overall Study|Lost to Follow-up|1|||
150055696|NCT01989468|541344245|FG000|Overall Study|Physician Decision|4|||
150055697|NCT01989468|541344246|FG001|Overall Study|Physician Decision|1|||
150055698|NCT01989468|541344247|FG002|Overall Study|Physician Decision|0|||
150055699|NCT01989468|541344248|FG003|Overall Study|Physician Decision|1|||
150055700|NCT01989468|541344249|FG004|Overall Study|Physician Decision|0|||
150055701|NCT01989468|541344245|FG000|Overall Study|Pregnancy|0|||
150055702|NCT01989468|541344246|FG001|Overall Study|Pregnancy|1|||
150055703|NCT01989468|541344247|FG002|Overall Study|Pregnancy|0|||
150055704|NCT01989468|541344248|FG003|Overall Study|Pregnancy|0|||
150055705|NCT01989468|541344249|FG004|Overall Study|Pregnancy|0|||
150055706|NCT01989468|541344245|FG000|Overall Study|Technical Problems|3|||
150055707|NCT01989468|541344246|FG001|Overall Study|Technical Problems|1|||
150055708|NCT01989468|541344247|FG002|Overall Study|Technical Problems|3|||
150055709|NCT01989468|541344248|FG003|Overall Study|Technical Problems|1|||
150055710|NCT01989468|541344249|FG004|Overall Study|Technical Problems|0|||
150055711|NCT01989468|541344245|FG000|Overall Study|Subject Guardian Decision|11|||
150055712|NCT01989468|541344246|FG001|Overall Study|Subject Guardian Decision|6|||
150055713|NCT01989468|541344247|FG002|Overall Study|Subject Guardian Decision|4|||
150055714|NCT01989468|541344248|FG003|Overall Study|Subject Guardian Decision|4|||
150055715|NCT01989468|541344249|FG004|Overall Study|Subject Guardian Decision|1|||
150055716|NCT01989468|541344245|FG000|Overall Study|Death|3|||
150055717|NCT01989468|541344246|FG001|Overall Study|Death|0|||
150055718|NCT01989468|541344247|FG002|Overall Study|Death|1|||
150055719|NCT01989468|541344248|FG003|Overall Study|Death|0|||
150055720|NCT01989468|541344249|FG004|Overall Study|Death|0|||
150055721|NCT03222492|541344253|FG000|Overall Study|Withdrawal by Subject|0|||
150179886|NCT03485950|541796878|FG001|Overall Study|Adverse Event|0|||
150005855|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
150005856|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
150055722|NCT03222492|541344254|FG001|Overall Study|Withdrawal by Subject|0|||
150055723|NCT03222492|541344255|FG002|Overall Study|Withdrawal by Subject|1|||
150055724|NCT03222492|541344256|FG003|Overall Study|Withdrawal by Subject|0|||
150055725|NCT03222492|541344253|FG000|Overall Study|COVID-19 related|0|||
150055726|NCT03222492|541344254|FG001|Overall Study|COVID-19 related|0|||
150005857|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
150005858|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
150055727|NCT03222492|541344255|FG002|Overall Study|COVID-19 related|1|||
150055728|NCT03222492|541344256|FG003|Overall Study|COVID-19 related|0|||
150055729|NCT00674154|541344257|FG000|Overall Study|Withdrawal by Subject|3|||
150055730|NCT00674154|541344258|FG001|Overall Study|Withdrawal by Subject|1|||
150055731|NCT00674154|541344257|FG000|Overall Study|Did not want parathyroidectomy|0|||
150055732|NCT00674154|541344258|FG001|Overall Study|Did not want parathyroidectomy|2|||
150055733|NCT00816023|541344259|FG000|Overall Study|Lost to Follow-up|1|||
150005859|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
150005860|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
150005861|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
150005862|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
150005863|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
150005864|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
150005865|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
150005866|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
150005867|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
150055734|NCT00816023|541344260|FG001|Overall Study|Lost to Follow-up|1|||
150055735|NCT00816023|541344261|FG002|Overall Study|Lost to Follow-up|0|||
150055736|NCT00816023|541344262|FG003|Overall Study|Lost to Follow-up|0|||
150055737|NCT00816023|541344259|FG000|Overall Study|Withdrawal by Subject|1|||
150055738|NCT00816023|541344260|FG001|Overall Study|Withdrawal by Subject|0|||
150055739|NCT00816023|541344261|FG002|Overall Study|Withdrawal by Subject|0|||
150055740|NCT00816023|541344262|FG003|Overall Study|Withdrawal by Subject|0|||
150055741|NCT00816023|541344259|FG000|Overall Study|Physician Decision|0|||
150055742|NCT00816023|541344260|FG001|Overall Study|Physician Decision|0|||
150055743|NCT00816023|541344261|FG002|Overall Study|Physician Decision|1|||
150055744|NCT00816023|541344262|FG003|Overall Study|Physician Decision|0|||
150055745|NCT00816023|541344259|FG000|Overall Study|assessments complete prior to window|1|||
150055746|NCT00816023|541344260|FG001|Overall Study|assessments complete prior to window|1|||
150055747|NCT00816023|541344261|FG002|Overall Study|assessments complete prior to window|2|||
150055748|NCT00816023|541344262|FG003|Overall Study|assessments complete prior to window|1|||
150055749|NCT00816023|541344259|FG000|Overall Study|Randomized Not Treated|6|||
150055750|NCT00816023|541344260|FG001|Overall Study|Randomized Not Treated|4|||
150005868|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
150055751|NCT00816023|541344261|FG002|Overall Study|Randomized Not Treated|6|||
150005869|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
150005870|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
150055752|NCT00816023|541344262|FG003|Overall Study|Randomized Not Treated|11|||
150055753|NCT01525901|541344263|FG000|Period 2: 12 Weeks|Adverse Event|0|||
150055754|NCT01525901|541344264|FG001|Period 2: 12 Weeks|Adverse Event|1|||
150055755|NCT01525901|541344265|FG002|Period 2: 12 Weeks|Adverse Event|0|||
150055756|NCT01525901|541344266|FG003|Period 2: 12 Weeks|Adverse Event|0|||
150055757|NCT04449029|541344270|FG000|Overall Study|Adverse Event|0|||
150055758|NCT04449029|541344271|FG001|Overall Study|Adverse Event|1|||
150055759|NCT04449029|541344272|FG002|Overall Study|Adverse Event|1|||
150005871|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
150005872|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
150005873|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
150005874|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
150005875|NCT00121641|541154937|FG000|24-week Short-term Treatment Period|Other Reason|1|||
150005876|NCT00121641|541154938|FG001|24-week Short-term Treatment Period|Other Reason|0|||
150005877|NCT00121641|541154939|FG002|24-week Short-term Treatment Period|Other Reason|0|||
150005878|NCT00121641|541154940|FG003|24-week Short-term Treatment Period|Other Reason|0|||
150005879|NCT00121641|541154941|FG004|24-week Short-term Treatment Period|Other Reason|0|||
150005880|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
150005881|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
150005882|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
150005883|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
150005884|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
150005885|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
150005886|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
150005887|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
150005888|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
150005889|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
150005890|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
150005891|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
150005892|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
150005893|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
150005894|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
150005895|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
150005896|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
150005897|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
150005898|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
150005899|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
150005900|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
150005901|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
150005902|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
150005903|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
150005904|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
150005905|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
150005906|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
150005907|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
150005908|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
150005909|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
150005910|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
150005911|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
150005912|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
150005913|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
150005914|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
150005915|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
150005916|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
150005917|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
150005918|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
150005919|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
150005920|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Death|0|||
150005921|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Death|0|||
150005922|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Death|0|||
150005923|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Death|1|||
150005924|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Death|0|||
150005925|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Missing|0|||
150005926|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Missing|0|||
150005927|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Missing|1|||
150005928|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Missing|0|||
150005929|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Missing|0|||
150005930|NCT00121641|541154937|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
150005931|NCT00121641|541154938|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
150005932|NCT00121641|541154939|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
150005933|NCT00121641|541154940|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
150005934|NCT00121641|541154941|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
150005935|NCT00094107|541154946|FG000|Overall Study|Lack of Efficacy|23|||
150005936|NCT00094107|541154946|FG000|Overall Study|Death|5|||
150005937|NCT00094107|541154946|FG000|Overall Study|Adverse Event|3|||
150005938|NCT00094107|541154946|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
150005939|NCT00424190|541154953|FG000|Overall Study|Withdrew consent|3|||
150005940|NCT00424190|541154954|FG001|Overall Study|Withdrew consent|4|||
150005941|NCT00424190|541154953|FG000|Overall Study|Death|3|||
150005942|NCT00424190|541154954|FG001|Overall Study|Death|0|||
150005943|NCT00424190|541154953|FG000|Overall Study|Noncompliance|1|||
150005944|NCT00424190|541154954|FG001|Overall Study|Noncompliance|2|||
150005945|NCT00424190|541154953|FG000|Overall Study|Request of sponsor or investigator|0|||
150005946|NCT00424190|541154954|FG001|Overall Study|Request of sponsor or investigator|2|||
150005947|NCT00424190|541154953|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
150005948|NCT00424190|541154954|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
150005949|NCT00424190|541154953|FG000|Overall Study|Other|15|||
150005950|NCT00424190|541154954|FG001|Overall Study|Other|21|||
150005951|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
150005952|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
150005953|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
150005954|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
150005955|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
150005956|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
150005957|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
150005958|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
150005959|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
150005960|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
150005961|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
150005962|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
150005963|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
150005964|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
150005965|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
150005966|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
150005967|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
150005968|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
150005969|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
150005970|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
150005971|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
150005972|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
150005973|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
150005974|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
150005975|NCT01672866|541154955|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
150005976|NCT01672866|541154956|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
150005977|NCT01672866|541154957|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
150005978|NCT01672866|541154955|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
150005979|NCT01672866|541154956|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
150005980|NCT01672866|541154957|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
150005981|NCT01672866|541154955|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
150005982|NCT01672866|541154956|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
150005983|NCT01672866|541154957|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
150005984|NCT01672866|541154955|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
150005985|NCT01672866|541154956|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
150005986|NCT01672866|541154957|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
150005987|NCT01672866|541154955|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
150005988|NCT01672866|541154956|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
150005989|NCT01672866|541154957|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
150005990|NCT00358436|541156187|FG000|Overall Study|Adverse Event|29|||
150005991|NCT00358436|541156188|FG001|Overall Study|Adverse Event|13|||
150005992|NCT00358436|541156187|FG000|Overall Study|Lack of Efficacy|34|||
150179887|NCT03485950|541796877|FG000|Overall Study|Death|3|||
150005993|NCT00358436|541156188|FG001|Overall Study|Lack of Efficacy|36|||
150005994|NCT00358436|541156187|FG000|Overall Study|Lost to Follow-up|11|||
150005995|NCT00358436|541156188|FG001|Overall Study|Lost to Follow-up|6|||
150005996|NCT00358436|541156187|FG000|Overall Study|Protocol Violation|8|||
150005997|NCT00358436|541156188|FG001|Overall Study|Protocol Violation|3|||
150005998|NCT00358436|541156187|FG000|Overall Study|Withdrawal by Subject|40|||
150005999|NCT00358436|541156188|FG001|Overall Study|Withdrawal by Subject|17|||
150006000|NCT00358436|541156187|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
150006001|NCT00358436|541156188|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
150006002|NCT00358436|541156187|FG000|Overall Study|COPD exacerbation|22|||
150006003|NCT00358436|541156188|FG001|Overall Study|COPD exacerbation|10|||
150006004|NCT00358436|541156187|FG000|Overall Study|Other|6|||
150006005|NCT00358436|541156188|FG001|Overall Study|Other|1|||
150006006|NCT04327024|541156189|FG000|Overall Study|Death|1|||
150006007|NCT04327024|541156190|FG001|Overall Study|Death|2|||
150006008|NCT04327024|541156191|FG002|Overall Study|Death|1|||
150006009|NCT04327024|541156189|FG000|Overall Study|Non-compliance with study drug|0|||
150006010|NCT04327024|541156190|FG001|Overall Study|Non-compliance with study drug|1|||
150006011|NCT04327024|541156191|FG002|Overall Study|Non-compliance with study drug|0|||
150006012|NCT04327024|541156189|FG000|Overall Study|Withdrawal by Subject|1|||
150006013|NCT04327024|541156190|FG001|Overall Study|Withdrawal by Subject|1|||
150006014|NCT04327024|541156191|FG002|Overall Study|Withdrawal by Subject|2|||
150006015|NCT03938324|541156193|FG000|Overall Study|Lost to Follow-up|42|||
150006016|NCT03938324|541156194|FG001|Overall Study|Lost to Follow-up|21|||
150006017|NCT03938324|541156193|FG000|Overall Study|Withdrawal by Subject|6|||
150006018|NCT03938324|541156194|FG001|Overall Study|Withdrawal by Subject|1|||
150006019|NCT01266590|541156195|FG000|Overall Study|Adverse Event|3|||
150006020|NCT01266590|541156195|FG000|Overall Study|Lost to Follow-up|1|||
150006021|NCT01266590|541156195|FG000|Overall Study|Withdrawal by Subject|1|||
150006022|NCT01266590|541156195|FG000|Overall Study|Physician Decision|1|||
150006023|NCT02008773|541156198|FG000|Overall Study|Adverse Event|3|||
150006024|NCT02008773|541156199|FG001|Overall Study|Adverse Event|3|||
150006025|NCT02008773|541156200|FG002|Overall Study|Adverse Event|1|||
150006026|NCT02008773|541156201|FG003|Overall Study|Adverse Event|2|||
150006027|NCT02008773|541156198|FG000|Overall Study|Medication Non-compliance|2|||
150006028|NCT02008773|541156199|FG001|Overall Study|Medication Non-compliance|1|||
150006029|NCT02008773|541156200|FG002|Overall Study|Medication Non-compliance|3|||
150006030|NCT02008773|541156201|FG003|Overall Study|Medication Non-compliance|2|||
150006031|NCT02008773|541156198|FG000|Overall Study|Withdrawal by Subject|8|||
150006032|NCT02008773|541156199|FG001|Overall Study|Withdrawal by Subject|4|||
150006033|NCT02008773|541156200|FG002|Overall Study|Withdrawal by Subject|7|||
150006034|NCT02008773|541156201|FG003|Overall Study|Withdrawal by Subject|6|||
150006035|NCT02008773|541156198|FG000|Overall Study|Lost to Follow-up|0|||
150006036|NCT02008773|541156199|FG001|Overall Study|Lost to Follow-up|1|||
150006037|NCT02008773|541156200|FG002|Overall Study|Lost to Follow-up|3|||
150006038|NCT02008773|541156201|FG003|Overall Study|Lost to Follow-up|2|||
150006039|NCT04732949|541156202|FG000|Overall Study|Withdrawal by Subject|23|||
150006040|NCT04732949|541156203|FG001|Overall Study|Withdrawal by Subject|27|||
150006041|NCT04732949|541156202|FG000|Overall Study|Protocol Violation|0|||
150006042|NCT04732949|541156203|FG001|Overall Study|Protocol Violation|1|||
150006043|NCT04732949|541156202|FG000|Overall Study|Non-compliance|0|||
150006044|NCT04732949|541156203|FG001|Overall Study|Non-compliance|2|||
150006045|NCT04732949|541156202|FG000|Overall Study|Physician Decision|2|||
150006046|NCT04732949|541156203|FG001|Overall Study|Physician Decision|1|||
150006047|NCT04732949|541156202|FG000|Overall Study|Serious adverse event (Fatal)|16|||
150006048|NCT04732949|541156203|FG001|Overall Study|Serious adverse event (Fatal)|18|||
150006049|NCT04732949|541156202|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
150006050|NCT04732949|541156203|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
150006051|NCT04732949|541156202|FG000|Overall Study|Non-serious adverse event|1|||
150055760|NCT04449029|541344273|FG003|Overall Study|Adverse Event|0|||
150055761|NCT04449029|541344274|FG004|Overall Study|Adverse Event|1|||
150055762|NCT04449029|541344275|FG005|Overall Study|Adverse Event|0|||
150055763|NCT04449029|541344276|FG006|Overall Study|Adverse Event|1|||
150055764|NCT04449029|541344277|FG007|Overall Study|Adverse Event|0|||
150055765|NCT04449029|541344270|FG000|Overall Study|Lost to Follow-up|0|||
150055766|NCT04449029|541344271|FG001|Overall Study|Lost to Follow-up|1|||
150055767|NCT04449029|541344272|FG002|Overall Study|Lost to Follow-up|0|||
150006052|NCT04732949|541156203|FG001|Overall Study|Non-serious adverse event|3|||
150006053|NCT04732949|541156202|FG000|Overall Study|Lost to Follow-up|26|||
150006054|NCT04732949|541156203|FG001|Overall Study|Lost to Follow-up|27|||
150006055|NCT04732949|541156202|FG000|Overall Study|Other|6|||
150006056|NCT04732949|541156203|FG001|Overall Study|Other|3|||
150055768|NCT04449029|541344273|FG003|Overall Study|Lost to Follow-up|0|||
150006057|NCT04256512|541156206|FG000|Overall Study|Withdrawal by Subject|1|||
150006058|NCT04435600|541156207|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006059|NCT04435600|541156208|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150055769|NCT04449029|541344274|FG004|Overall Study|Lost to Follow-up|0|||
150055770|NCT04449029|541344275|FG005|Overall Study|Lost to Follow-up|0|||
150006060|NCT04435600|541156209|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
150006061|NCT04435600|541156210|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006062|NCT04435600|541156211|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006063|NCT04435600|541156212|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150055771|NCT04449029|541344276|FG006|Overall Study|Lost to Follow-up|0|||
150006064|NCT04435600|541156213|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006065|NCT04435600|541156214|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006066|NCT04435600|541156215|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006067|NCT04435600|541156216|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
150006068|NCT04435600|541156207|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006069|NCT04435600|541156208|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006070|NCT04435600|541156209|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006071|NCT04435600|541156210|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006072|NCT04435600|541156211|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006073|NCT04435600|541156212|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006074|NCT04435600|541156213|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006075|NCT04435600|541156214|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006076|NCT04435600|541156215|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
150006077|NCT04435600|541156216|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
150055772|NCT04449029|541344277|FG007|Overall Study|Lost to Follow-up|0|||
150055773|NCT04449029|541344270|FG000|Overall Study|Protocol Violation|0|||
150055774|NCT04449029|541344271|FG001|Overall Study|Protocol Violation|1|||
150055775|NCT04449029|541344272|FG002|Overall Study|Protocol Violation|0|||
150055776|NCT04449029|541344273|FG003|Overall Study|Protocol Violation|0|||
150055777|NCT04449029|541344274|FG004|Overall Study|Protocol Violation|0|||
150055778|NCT04449029|541344275|FG005|Overall Study|Protocol Violation|0|||
150055779|NCT04449029|541344276|FG006|Overall Study|Protocol Violation|0|||
150055780|NCT04449029|541344277|FG007|Overall Study|Protocol Violation|0|||
150006078|NCT04435600|541156207|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006079|NCT04435600|541156208|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006080|NCT04435600|541156209|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006081|NCT04435600|541156210|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006082|NCT04435600|541156211|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006083|NCT04435600|541156212|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006084|NCT04435600|541156213|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006085|NCT04435600|541156214|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006086|NCT04435600|541156215|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
150006087|NCT04435600|541156216|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
150006088|NCT04435600|541156207|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006089|NCT04435600|541156208|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006090|NCT04435600|541156209|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006091|NCT04435600|541156210|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006092|NCT04435600|541156211|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006093|NCT04435600|541156212|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006094|NCT04435600|541156213|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006095|NCT04435600|541156214|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006096|NCT04435600|541156215|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
150006097|NCT04435600|541156216|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
150006098|NCT05824936|541156220|FG000|Overall Study|Lost to Follow-up|1|||
150006099|NCT02258529|541156223|FG000|Overall Study|Study Terminated by Sponsor|9|||
150006100|NCT02258529|541156223|FG000|Overall Study|Adverse Event|1|||
150006101|NCT01533922|541156224|FG000|Overall Study|Adverse Event|5|||
150006102|NCT01533922|541156225|FG001|Overall Study|Adverse Event|8|||
150006103|NCT01533922|541156226|FG002|Overall Study|Adverse Event|6|||
150006104|NCT01533922|541156227|FG003|Overall Study|Adverse Event|3|||
150006105|NCT01533922|541156228|FG004|Overall Study|Adverse Event|4|||
150006106|NCT01533922|541156224|FG000|Overall Study|Lack of Efficacy|0|||
150006107|NCT01533922|541156225|FG001|Overall Study|Lack of Efficacy|0|||
150006108|NCT01533922|541156226|FG002|Overall Study|Lack of Efficacy|1|||
150006109|NCT01533922|541156227|FG003|Overall Study|Lack of Efficacy|0|||
150055781|NCT04449029|541344270|FG000|Overall Study|Physician Decision|0|||
150179888|NCT03485950|541796878|FG001|Overall Study|Death|2|||
150179889|NCT03485950|541796877|FG000|Overall Study|Withdrawal by Subject|3|||
150179890|NCT03485950|541796878|FG001|Overall Study|Withdrawal by Subject|0|||
150179891|NCT00609336|541796879|FG000|Overall Study|Protocol Violation|3|||
150179892|NCT00609336|541796879|FG000|Overall Study|Death|1|||
150179893|NCT00609336|541796879|FG000|Overall Study|LA or Met at Surgery|9|||
150179894|NCT02477605|541796880|FG000|Overall Study|Discontinued prior to treatment|1|||
150179895|NCT02477605|541796881|FG001|Overall Study|Discontinued prior to treatment|0|||
150179896|NCT02477605|541796880|FG000|Overall Study|Lost to Follow-up|0|||
150179897|NCT02477605|541796881|FG001|Overall Study|Lost to Follow-up|2|||
150179898|NCT02477605|541796880|FG000|Overall Study|Withdrawal by Subject|0|||
150179899|NCT02477605|541796881|FG001|Overall Study|Withdrawal by Subject|1|||
150179900|NCT02477605|541796880|FG000|Overall Study|Administered gas during surgery|0|||
150179901|NCT02477605|541796881|FG001|Overall Study|Administered gas during surgery|1|||
150179902|NCT00567489|541796882|FG000|Overall Study|Adverse Event|6|||
150179903|NCT00567489|541796883|FG001|Overall Study|Adverse Event|14|||
150179904|NCT00567489|541796882|FG000|Overall Study|Physician Decision|0|||
150179905|NCT00567489|541796883|FG001|Overall Study|Physician Decision|4|||
150006110|NCT01533922|541156228|FG004|Overall Study|Lack of Efficacy|0|||
150006111|NCT01533922|541156224|FG000|Overall Study|Protocol Violation|0|||
150006112|NCT01533922|541156225|FG001|Overall Study|Protocol Violation|3|||
150006113|NCT01533922|541156226|FG002|Overall Study|Protocol Violation|0|||
150006114|NCT01533922|541156227|FG003|Overall Study|Protocol Violation|0|||
150006115|NCT01533922|541156228|FG004|Overall Study|Protocol Violation|1|||
150006116|NCT01533922|541156224|FG000|Overall Study|Withdrawal by Subject|3|||
150006117|NCT01533922|541156225|FG001|Overall Study|Withdrawal by Subject|1|||
150006118|NCT01533922|541156226|FG002|Overall Study|Withdrawal by Subject|2|||
150006119|NCT01533922|541156227|FG003|Overall Study|Withdrawal by Subject|2|||
150006120|NCT01533922|541156228|FG004|Overall Study|Withdrawal by Subject|1|||
150006121|NCT01533922|541156224|FG000|Overall Study|Other reason not defined above|2|||
150179906|NCT00567489|541796882|FG000|Overall Study|Withdrawal by Subject|0|||
150179907|NCT00567489|541796883|FG001|Overall Study|Withdrawal by Subject|2|||
150006122|NCT01533922|541156225|FG001|Overall Study|Other reason not defined above|0|||
150006123|NCT01533922|541156226|FG002|Overall Study|Other reason not defined above|1|||
150006124|NCT01533922|541156227|FG003|Overall Study|Other reason not defined above|0|||
150006125|NCT01533922|541156228|FG004|Overall Study|Other reason not defined above|0|||
150006126|NCT02648217|541156229|FG000|Overall Study|Adverse Event|0|||
150006127|NCT02648217|541156230|FG001|Overall Study|Adverse Event|1|||
150006128|NCT02648217|541156229|FG000|Overall Study|Lost to Follow-up|1|||
150179908|NCT00567489|541796882|FG000|Overall Study|Renal Transplantation|0|||
150179909|NCT00567489|541796883|FG001|Overall Study|Renal Transplantation|3|||
150179910|NCT00567489|541796882|FG000|Overall Study|Other|1|||
150179911|NCT00567489|541796883|FG001|Overall Study|Other|0|||
150179912|NCT00068601|541796885|FG000|Overall Study|Ineligible|11|||
150179913|NCT00068601|541796886|FG001|Overall Study|Ineligible|13|||
150179914|NCT00068601|541796885|FG000|Overall Study|Not evaluable: withdrew consent|5|||
150179915|NCT00068601|541796886|FG001|Overall Study|Not evaluable: withdrew consent|4|||
150179916|NCT00068601|541796885|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
150179917|NCT00068601|541796886|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
150179918|NCT00068601|541796885|FG000|Overall Study|Death|11|||
150179919|NCT00068601|541796886|FG001|Overall Study|Death|3|||
150179920|NCT00068601|541796885|FG000|Overall Study|Lost to Follow-up|3|||
150179921|NCT00068601|541796886|FG001|Overall Study|Lost to Follow-up|2|||
150179922|NCT00068601|541796885|FG000|Overall Study|Missing primary outcome data|30|||
150179923|NCT00068601|541796886|FG001|Overall Study|Missing primary outcome data|34|||
150179924|NCT01061671|541796887|FG000|Overall Study|Withdrawal by Subject|16|||
150179925|NCT01061671|541796888|FG001|Overall Study|Withdrawal by Subject|20|||
150179926|NCT01061671|541796887|FG000|Overall Study|Lost to Follow-up|3|||
150179927|NCT01061671|541796888|FG001|Overall Study|Lost to Follow-up|5|||
150179928|NCT01061671|541796887|FG000|Overall Study|Death|28|||
150179929|NCT01061671|541796888|FG001|Overall Study|Death|30|||
150179930|NCT04992390|541796891|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
150006129|NCT02648217|541156230|FG001|Overall Study|Lost to Follow-up|1|||
150006130|NCT02648217|541156229|FG000|Overall Study|Withdrawal by Subject|4|||
150179931|NCT04992390|541796892|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
150179932|NCT04992390|541796893|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
150179933|NCT04992390|541796891|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
150179934|NCT04992390|541796892|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
150179935|NCT04992390|541796893|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
150179936|NCT04992390|541796891|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
150179937|NCT04992390|541796892|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
150179938|NCT04992390|541796893|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
150179939|NCT04992390|541796891|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
150179940|NCT04992390|541796892|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
150006131|NCT02648217|541156230|FG001|Overall Study|Withdrawal by Subject|3|||
150179941|NCT04992390|541796893|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
150006132|NCT02648217|541156229|FG000|Overall Study|Unclassified|5|||
150006133|NCT02648217|541156230|FG001|Overall Study|Unclassified|0|||
150006134|NCT04135859|541156232|FG000|Overall Study|Withdrawal by Subject|1|||
150006135|NCT04135859|541156233|FG001|Overall Study|Withdrawal by Subject|0|||
150006136|NCT04135859|541156232|FG000|Overall Study|Withdrawal due to screening failure|1|||
150006137|NCT04135859|541156233|FG001|Overall Study|Withdrawal due to screening failure|2|||
150006138|NCT04135859|541156232|FG000|Overall Study|Did not complete stress test|3|||
150006139|NCT04135859|541156233|FG001|Overall Study|Did not complete stress test|3|||
150006140|NCT04135859|541156232|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
150006141|NCT04135859|541156233|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
150006142|NCT04047420|541156234|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
150006143|NCT04047420|541156234|FG000|Washout Period|Refused Participation|2|||
150006144|NCT03262116|541156236|FG000|Overall Study|Physician Decision|0|||
150006145|NCT03262116|541156237|FG001|Overall Study|Physician Decision|2|||
150006146|NCT03262116|541156238|FG002|Overall Study|Physician Decision|1|||
150006147|NCT03262116|541156239|FG003|Overall Study|Physician Decision|1|||
150006148|NCT03262116|541156240|FG004|Overall Study|Physician Decision|1|||
150006149|NCT03262116|541156241|FG005|Overall Study|Physician Decision|2|||
150006150|NCT02608450|541156245|FG000|Overall Study|Lost to Follow-up|39|||
150006151|NCT02608450|541156246|FG001|Overall Study|Lost to Follow-up|32|||
150006152|NCT02608450|541156245|FG000|Overall Study|Withdrawal by Subject|21|||
150006153|NCT02608450|541156246|FG001|Overall Study|Withdrawal by Subject|15|||
150006154|NCT02608450|541156245|FG000|Overall Study|Adverse Event|3|||
150006155|NCT02608450|541156246|FG001|Overall Study|Adverse Event|6|||
150006156|NCT02608450|541156245|FG000|Overall Study|Withdrawal by parent|2|||
150006157|NCT02608450|541156246|FG001|Overall Study|Withdrawal by parent|3|||
150006158|NCT02608450|541156245|FG000|Overall Study|Lack of Efficacy|0|||
150006159|NCT02608450|541156246|FG001|Overall Study|Lack of Efficacy|3|||
150006160|NCT02608450|541156245|FG000|Overall Study|Noncompliance with study drug|0|||
150006161|NCT02608450|541156246|FG001|Overall Study|Noncompliance with study drug|2|||
150006162|NCT02608450|541156245|FG000|Overall Study|Physician Decision|0|||
150006163|NCT02608450|541156246|FG001|Overall Study|Physician Decision|1|||
150006164|NCT02608450|541156245|FG000|Overall Study|Pregnancy|0|||
150006165|NCT02608450|541156246|FG001|Overall Study|Pregnancy|1|||
150006166|NCT02608450|541156245|FG000|Overall Study|Progressive disease|1|||
150006167|NCT02608450|541156246|FG001|Overall Study|Progressive disease|0|||
150006168|NCT02608450|541156245|FG000|Overall Study|Multiple reasons|0|||
150006169|NCT02608450|541156246|FG001|Overall Study|Multiple reasons|2|||
150006170|NCT00635089|541156247|FG000|Overall Study|Adverse Event|7|||
150006171|NCT00635089|541156247|FG000|Overall Study|Lack of Efficacy|28|||
150006172|NCT00635089|541156247|FG000|Overall Study|Protocol Deviation|4|||
150006173|NCT00635089|541156247|FG000|Overall Study|Lost to Follow-up|8|||
150006174|NCT00635089|541156247|FG000|Overall Study|Other|31|||
150006175|NCT01283542|541156251|FG000|Main Phase|Acute or progressive vision loss|1|||
150006176|NCT01283542|541156251|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
150006177|NCT01283542|541156251|FG000|Main Phase|abnormal laboratory values|5|||
150006178|NCT01283542|541156251|FG000|Extension Phase|Physician Decision|1|||
150006179|NCT01283542|541156251|FG000|Extension Phase|Adverse Event|1|||
150006180|NCT01283542|541156251|FG000|Extension Phase|Administrative problems|1|||
150006181|NCT02636946|541156252|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
150006182|NCT02636946|541156253|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
150006183|NCT02636946|541156252|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
150006184|NCT02636946|541156253|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
150006185|NCT02636946|541156252|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
150006186|NCT02636946|541156253|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
150006187|NCT02636946|541156252|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
150006188|NCT02636946|541156253|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
150006189|NCT02636946|541156252|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
150006190|NCT02636946|541156253|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
150006191|NCT02636946|541156252|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
150006192|NCT02636946|541156253|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
150006193|NCT05059977|541156254|FG000|Overall Study|Withdrawal by Subject|0|||
150006194|NCT05059977|541156255|FG001|Overall Study|Withdrawal by Subject|0|||
150006195|NCT05059977|541156256|FG002|Overall Study|Withdrawal by Subject|1|||
150006196|NCT04405245|541156260|FG000|Overall Study|Adverse Event|0|||
150006197|NCT04405245|541156261|FG001|Overall Study|Adverse Event|1|||
150006198|NCT04405245|541156262|FG002|Overall Study|Adverse Event|0|||
150006199|NCT03443427|541156263|FG000|Overall Study|Adverse Event|2|||
150006200|NCT03443427|541156264|FG001|Overall Study|Adverse Event|3|||
150055782|NCT04449029|541344271|FG001|Overall Study|Physician Decision|0|||
150055783|NCT04449029|541344272|FG002|Overall Study|Physician Decision|0|||
150055784|NCT04449029|541344273|FG003|Overall Study|Physician Decision|0|||
150055785|NCT04449029|541344274|FG004|Overall Study|Physician Decision|0|||
150055786|NCT04449029|541344275|FG005|Overall Study|Physician Decision|1|||
150055787|NCT04449029|541344276|FG006|Overall Study|Physician Decision|0|||
150055788|NCT04449029|541344277|FG007|Overall Study|Physician Decision|0|||
150055789|NCT04449029|541344270|FG000|Overall Study|Withdrawal by Subject|3|||
150055790|NCT04449029|541344271|FG001|Overall Study|Withdrawal by Subject|0|||
150055791|NCT04449029|541344272|FG002|Overall Study|Withdrawal by Subject|1|||
150055792|NCT04449029|541344273|FG003|Overall Study|Withdrawal by Subject|1|||
150055793|NCT04449029|541344274|FG004|Overall Study|Withdrawal by Subject|5|||
150055794|NCT04449029|541344275|FG005|Overall Study|Withdrawal by Subject|1|||
150055795|NCT04449029|541344276|FG006|Overall Study|Withdrawal by Subject|4|||
150055796|NCT04449029|541344277|FG007|Overall Study|Withdrawal by Subject|0|||
150055797|NCT02025556|541344285|FG000|Overall Study|Adverse Event|0|||
150055798|NCT02025556|541344286|FG001|Overall Study|Adverse Event|4|||
150055799|NCT02025556|541344287|FG002|Overall Study|Adverse Event|2|||
150055800|NCT02025556|541344285|FG000|Overall Study|Lack of Efficacy|2|||
150055801|NCT02025556|541344286|FG001|Overall Study|Lack of Efficacy|1|||
150055802|NCT02025556|541344287|FG002|Overall Study|Lack of Efficacy|0|||
150055803|NCT02025556|541344285|FG000|Overall Study|Protocol Violation|2|||
150055804|NCT02025556|541344286|FG001|Overall Study|Protocol Violation|1|||
150055805|NCT02025556|541344287|FG002|Overall Study|Protocol Violation|0|||
150055806|NCT02025556|541344285|FG000|Overall Study|Withdrawal by Subject|0|||
150055807|NCT02025556|541344286|FG001|Overall Study|Withdrawal by Subject|3|||
150055808|NCT02025556|541344287|FG002|Overall Study|Withdrawal by Subject|6|||
150055809|NCT02025556|541344285|FG000|Overall Study|Lost to Follow-up|2|||
150055810|NCT02025556|541344286|FG001|Overall Study|Lost to Follow-up|4|||
150055811|NCT02025556|541344287|FG002|Overall Study|Lost to Follow-up|0|||
150055812|NCT02025556|541344285|FG000|Overall Study|Reason not reported|0|||
150055813|NCT02025556|541344286|FG001|Overall Study|Reason not reported|0|||
150055814|NCT02025556|541344287|FG002|Overall Study|Reason not reported|1|||
150006201|NCT03443427|541156263|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
150055815|NCT02112045|541344290|FG000|Overall Study|Withdrawal by Subject|1|||
150055816|NCT02112045|541344291|FG001|Overall Study|Withdrawal by Subject|0|||
150055817|NCT00627445|541344292|FG000|Overall Study|Adverse Event|3|||
150055818|NCT00627445|541344293|FG001|Overall Study|Adverse Event|3|||
150006202|NCT03443427|541156264|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
150006203|NCT03443427|541156263|FG000|Overall Study|Other|4|||
150006204|NCT03443427|541156264|FG001|Overall Study|Other|6|||
150006205|NCT02576860|541156265|FG000|Overall Study|Adverse Event|6|||
150006206|NCT02576860|541156266|FG001|Overall Study|Adverse Event|6|||
150006207|NCT02576860|541156265|FG000|Overall Study|Lost to Follow-up|5|||
150006208|NCT02576860|541156266|FG001|Overall Study|Lost to Follow-up|7|||
150006209|NCT02576860|541156265|FG000|Overall Study|Physician Decision|0|||
150006210|NCT02576860|541156266|FG001|Overall Study|Physician Decision|1|||
150006211|NCT02576860|541156265|FG000|Overall Study|Protocol Violation|0|||
150006212|NCT02576860|541156266|FG001|Overall Study|Protocol Violation|2|||
150006213|NCT02576860|541156265|FG000|Overall Study|Withdrawal by Subject|13|||
150055819|NCT00627445|541344292|FG000|Overall Study|Lack of Efficacy|0|||
150055820|NCT00627445|541344293|FG001|Overall Study|Lack of Efficacy|1|||
150055821|NCT00627445|541344292|FG000|Overall Study|Other|6|||
150055822|NCT00627445|541344293|FG001|Overall Study|Other|8|||
150055823|NCT00247611|541344297|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
150055824|NCT00247611|541344298|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
150055825|NCT00247611|541344297|FG000|Baselined|Completed baseline only|9|||
150055826|NCT00247611|541344298|FG001|Baselined|Completed baseline only|8|||
150055827|NCT05395091|541344299|FG000|Baseline to Month 12|Adverse Event|7|||
150055828|NCT05395091|541344300|FG001|Baseline to Month 12|Adverse Event|2|||
150055829|NCT05395091|541344301|FG002|Baseline to Month 12|Adverse Event|0|||
150055830|NCT05395091|541344299|FG000|Baseline to Month 12|Death|3|||
150055831|NCT05395091|541344300|FG001|Baseline to Month 12|Death|1|||
150055832|NCT05395091|541344301|FG002|Baseline to Month 12|Death|0|||
150055833|NCT05395091|541344299|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
150179942|NCT04992390|541796891|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
150006214|NCT02576860|541156266|FG001|Overall Study|Withdrawal by Subject|8|||
150006215|NCT02576860|541156265|FG000|Overall Study|Disallowed medication|1|||
150006216|NCT02576860|541156266|FG001|Overall Study|Disallowed medication|0|||
150055834|NCT05395091|541344300|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
150055835|NCT05395091|541344301|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
150055836|NCT05395091|541344299|FG000|Baseline to Month 12|Protocol Violation|2|||
150055837|NCT05395091|541344300|FG001|Baseline to Month 12|Protocol Violation|3|||
150055838|NCT05395091|541344301|FG002|Baseline to Month 12|Protocol Violation|0|||
150055839|NCT05395091|541344299|FG000|Baseline to Month 12|Physician Decision|1|||
150055840|NCT05395091|541344300|FG001|Baseline to Month 12|Physician Decision|0|||
150055841|NCT05395091|541344301|FG002|Baseline to Month 12|Physician Decision|0|||
150055842|NCT05395091|541344299|FG000|Month 12 to Month 18|Death|1|||
150006217|NCT00477269|541156267|FG000|Core Study|Adverse Event|6|||
150006218|NCT00477269|541156268|FG001|Core Study|Adverse Event|4|||
150006219|NCT00477269|541156269|FG002|Core Study|Adverse Event|0|||
150006220|NCT00477269|541156267|FG000|Core Study|Death|3|||
150006221|NCT00477269|541156268|FG001|Core Study|Death|3|||
150006222|NCT00477269|541156269|FG002|Core Study|Death|0|||
150006223|NCT00477269|541156267|FG000|Core Study|Withdrawn Consent|0|||
150006224|NCT00477269|541156268|FG001|Core Study|Withdrawn Consent|1|||
150006225|NCT00477269|541156269|FG002|Core Study|Withdrawn Consent|0|||
150006226|NCT00477269|541156267|FG000|Open Label Extension|Adverse Event|0|||
150006227|NCT00477269|541156268|FG001|Open Label Extension|Adverse Event|0|||
150006228|NCT00477269|541156269|FG002|Open Label Extension|Adverse Event|4|||
150006229|NCT00477269|541156267|FG000|Open Label Extension|Abnormal laboratory values|0|||
150006230|NCT00477269|541156268|FG001|Open Label Extension|Abnormal laboratory values|0|||
150006231|NCT00477269|541156269|FG002|Open Label Extension|Abnormal laboratory values|1|||
150006232|NCT00477269|541156267|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
150006233|NCT00477269|541156268|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
150006234|NCT00477269|541156269|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
150006235|NCT00477269|541156267|FG000|Open Label Extension|Adminiatrative problems|0|||
150006236|NCT00477269|541156268|FG001|Open Label Extension|Adminiatrative problems|0|||
150006237|NCT00477269|541156269|FG002|Open Label Extension|Adminiatrative problems|2|||
150006238|NCT00477269|541156267|FG000|Open Label Extension|Death|0|||
150006239|NCT00477269|541156268|FG001|Open Label Extension|Death|0|||
150006240|NCT00477269|541156269|FG002|Open Label Extension|Death|4|||
150006241|NCT02391961|541156270|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
150006242|NCT02391961|541156271|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
150006243|NCT02391961|541156270|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
150006244|NCT02391961|541156271|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
150006245|NCT02391961|541156270|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
150006246|NCT02391961|541156271|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
150006247|NCT03263780|541156272|FG000|Overall Study|Withdrawal by Subject|3|||
150006248|NCT03263780|541156272|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
150006249|NCT01792518|541156273|FG000|Overall Study|Adverse Event|3|||
150006250|NCT01792518|541156274|FG001|Overall Study|Adverse Event|4|||
150006251|NCT01792518|541156273|FG000|Overall Study|Protocol Violation|0|||
150006252|NCT01792518|541156274|FG001|Overall Study|Protocol Violation|1|||
150006253|NCT01792518|541156273|FG000|Overall Study|Lost to Follow-up|3|||
150006254|NCT01792518|541156274|FG001|Overall Study|Lost to Follow-up|1|||
150006255|NCT01792518|541156273|FG000|Overall Study|Withdrawal by Subject|2|||
150006256|NCT01792518|541156274|FG001|Overall Study|Withdrawal by Subject|0|||
150006257|NCT01792518|541156273|FG000|Overall Study|Other Reason|0|||
150006258|NCT01792518|541156274|FG001|Overall Study|Other Reason|1|||
150006259|NCT00249613|541156279|FG000|12 Month Follow-up|Death|1|||
150006260|NCT00249613|541156280|FG001|12 Month Follow-up|Death|1|||
150006261|NCT00249613|541156279|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
150006262|NCT00249613|541156280|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
150006263|NCT00249613|541156279|FG000|12 Month Follow-up|Lost to Follow-up|10|||
150006264|NCT00249613|541156280|FG001|12 Month Follow-up|Lost to Follow-up|8|||
150006265|NCT00806442|541156281|FG000|Overall Study|Lost to Follow-up|3|||
150006266|NCT00806442|541156282|FG001|Overall Study|Lost to Follow-up|2|||
150006267|NCT00806442|541156281|FG000|Overall Study|Withdrawal by Subject|1|||
150006268|NCT00806442|541156282|FG001|Overall Study|Withdrawal by Subject|5|||
150006269|NCT01455220|541156295|FG000|Overall Study|screen fail|30|||
150006270|NCT00267150|541156296|FG000|Overall Study|Adverse Event|1|||
150006271|NCT04881747|541156298|FG000|Period 2 Washout|Adverse Event|1|||
150006272|NCT04881747|541156299|FG001|Period 2 Washout|Adverse Event|0|||
150006273|NCT04881747|541156300|FG002|Period 2 Washout|Adverse Event|0|||
150006274|NCT04881747|541156301|FG003|Period 2 Washout|Adverse Event|0|||
150006275|NCT04881747|541156302|FG004|Period 2 Washout|Adverse Event|1|||
150006276|NCT04881747|541156303|FG005|Period 2 Washout|Adverse Event|0|||
150006277|NCT04881747|541156298|FG000|Period 2 Washout|Withdrawal by Subject|1|||
150006278|NCT04881747|541156299|FG001|Period 2 Washout|Withdrawal by Subject|0|||
150006279|NCT04881747|541156300|FG002|Period 2 Washout|Withdrawal by Subject|0|||
150006280|NCT04881747|541156301|FG003|Period 2 Washout|Withdrawal by Subject|1|||
150006281|NCT04881747|541156302|FG004|Period 2 Washout|Withdrawal by Subject|0|||
150006282|NCT04881747|541156303|FG005|Period 2 Washout|Withdrawal by Subject|0|||
150006283|NCT00351273|541156307|FG000|Overall Study|Lost to Follow-up|1|||
150006284|NCT00351273|541156308|FG001|Overall Study|Lost to Follow-up|2|||
150006285|NCT00351273|541156309|FG002|Overall Study|Lost to Follow-up|5|||
150006286|NCT01378429|541156310|FG000|Overall Study|Noncompliance with study drug|1|||
150006287|NCT01378429|541156311|FG001|Overall Study|Noncompliance with study drug|0|||
150006288|NCT00619489|541156312|FG000|Overall Study|Adverse Event|0|||
150055843|NCT05395091|541344300|FG001|Month 12 to Month 18|Death|0|||
150055844|NCT05395091|541344301|FG002|Month 12 to Month 18|Death|0|||
150055845|NCT05395091|541344299|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
150055846|NCT05395091|541344300|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
150055847|NCT05395091|541344301|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
150055848|NCT05395091|541344299|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
150055849|NCT05395091|541344300|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
150055850|NCT05395091|541344301|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
150006289|NCT00619489|541156313|FG001|Overall Study|Adverse Event|7|||
150006290|NCT00619489|541156312|FG000|Overall Study|Withdrawal by Subject|1|||
150006291|NCT00619489|541156313|FG001|Overall Study|Withdrawal by Subject|1|||
150006292|NCT00619489|541156312|FG000|Overall Study|Lack of Efficacy|0|||
150006293|NCT00619489|541156313|FG001|Overall Study|Lack of Efficacy|11|||
150006294|NCT00619489|541156312|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
150006295|NCT00619489|541156313|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
150006296|NCT02356887|541156314|FG000|Overall Study|poor compliance|2|||
150006297|NCT02544373|541156315|FG000|Overall Study|Lost to Follow-up|5|||
150055851|NCT05395091|541344299|FG000|Month 12 to Month 18|Other reasons|0|||
150055852|NCT05395091|541344300|FG001|Month 12 to Month 18|Other reasons|0|||
150055853|NCT05395091|541344301|FG002|Month 12 to Month 18|Other reasons|1|||
150055854|NCT01433250|541344305|FG000|Overall Study|Protocol Violation|0|||
150055855|NCT01433250|541344306|FG001|Overall Study|Protocol Violation|1|||
150055856|NCT01433250|541344305|FG000|Overall Study|Withdrawal by Subject|3|||
150055857|NCT01433250|541344306|FG001|Overall Study|Withdrawal by Subject|2|||
150055858|NCT03148691|541344307|FG000|Overall Study|Protocol Violation|1|||
150055859|NCT03148691|541344308|FG001|Overall Study|Protocol Violation|2|||
150055860|NCT03148691|541344309|FG002|Overall Study|Protocol Violation|7|||
150055861|NCT03148691|541344307|FG000|Overall Study|Lost to Follow-up|0|||
150055862|NCT03148691|541344308|FG001|Overall Study|Lost to Follow-up|0|||
150055863|NCT03148691|541344309|FG002|Overall Study|Lost to Follow-up|1|||
150055864|NCT03148691|541344307|FG000|Overall Study|Other|1|||
150055865|NCT03148691|541344308|FG001|Overall Study|Other|0|||
150055866|NCT03148691|541344309|FG002|Overall Study|Other|0|||
150055867|NCT03148691|541344307|FG000|Overall Study|Withdrawal by Subject|1|||
150055868|NCT03148691|541344308|FG001|Overall Study|Withdrawal by Subject|0|||
150055869|NCT03148691|541344309|FG002|Overall Study|Withdrawal by Subject|0|||
150055870|NCT01509053|541346187|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
150055871|NCT01509053|541346187|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
150055872|NCT01509053|541346187|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
150055873|NCT01509053|541346187|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
150055874|NCT01509053|541346187|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
150055875|NCT01509053|541346187|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
150055876|NCT00796991|541346189|FG000|Overall Study|Adverse Event|0|||
150055877|NCT00796991|541346190|FG001|Overall Study|Adverse Event|0|||
150055878|NCT00796991|541346191|FG002|Overall Study|Adverse Event|1|||
150006298|NCT02544373|541156316|FG001|Overall Study|Lost to Follow-up|3|||
150006299|NCT02544373|541156315|FG000|Overall Study|Withdrawal by Subject|8|||
150006300|NCT02544373|541156316|FG001|Overall Study|Withdrawal by Subject|2|||
150006301|NCT02273960|541156317|FG000|Short Term Period|Lost to Follow-up|1|||
150006302|NCT02273960|541156318|FG001|Short Term Period|Lost to Follow-up|0|||
150006303|NCT02273960|541156319|FG002|Short Term Period|Lost to Follow-up|0|||
150006304|NCT02273960|541156320|FG003|Short Term Period|Lost to Follow-up|0|||
150006305|NCT02273960|541156317|FG000|Short Term Period|Lack of Efficacy|0|||
150006306|NCT02273960|541156318|FG001|Short Term Period|Lack of Efficacy|0|||
150006307|NCT02273960|541156319|FG002|Short Term Period|Lack of Efficacy|0|||
150006308|NCT02273960|541156320|FG003|Short Term Period|Lack of Efficacy|1|||
150055879|NCT00796991|541346189|FG000|Overall Study|Death|2|||
150055880|NCT00796991|541346190|FG001|Overall Study|Death|0|||
150055881|NCT00796991|541346191|FG002|Overall Study|Death|0|||
150055882|NCT00796991|541346189|FG000|Overall Study|Disease Progression|10|||
150055883|NCT00796991|541346190|FG001|Overall Study|Disease Progression|9|||
150055884|NCT00796991|541346191|FG002|Overall Study|Disease Progression|7|||
150055885|NCT00796991|541346189|FG000|Overall Study|Study Drug Toxicity|3|||
150055886|NCT00796991|541346190|FG001|Overall Study|Study Drug Toxicity|3|||
150006309|NCT02273960|541156317|FG000|Short Term Period|ST complete, not entering LTE|4|||
150006310|NCT02273960|541156318|FG001|Short Term Period|ST complete, not entering LTE|6|||
150055887|NCT00796991|541346191|FG002|Overall Study|Study Drug Toxicity|5|||
150006311|NCT02273960|541156319|FG002|Short Term Period|ST complete, not entering LTE|4|||
150055888|NCT00796991|541346189|FG000|Overall Study|Withdrawal by Subject|0|||
150055889|NCT00796991|541346190|FG001|Overall Study|Withdrawal by Subject|0|||
150055890|NCT00796991|541346191|FG002|Overall Study|Withdrawal by Subject|1|||
150055891|NCT00171834|541346192|FG000|Overall Study|Adverse Event|2|||
150006312|NCT02273960|541156320|FG003|Short Term Period|ST complete, not entering LTE|5|||
150006313|NCT02273960|541156317|FG000|Long Term Extension|Death|0|||
150006314|NCT02273960|541156318|FG001|Long Term Extension|Death|0|||
150006315|NCT02273960|541156319|FG002|Long Term Extension|Death|0|||
150006316|NCT02273960|541156320|FG003|Long Term Extension|Death|1|||
150006317|NCT01789606|541156321|FG000|Overall Study|Participant not Purchased the Product|0|||
150006318|NCT01789606|541156322|FG001|Overall Study|Participant not Purchased the Product|20|||
150006319|NCT01789606|541156321|FG000|Overall Study|Withdrawal by Subject|0|||
150006320|NCT01789606|541156322|FG001|Overall Study|Withdrawal by Subject|1|||
150006321|NCT01789606|541156321|FG000|Overall Study|Ineligible|6|||
150006322|NCT01789606|541156322|FG001|Overall Study|Ineligible|2|||
150006323|NCT01789606|541156321|FG000|Overall Study|Administrative Reasons|17|||
150006324|NCT01789606|541156322|FG001|Overall Study|Administrative Reasons|6|||
150006325|NCT01789606|541156321|FG000|Overall Study|No Study Medication Taken|0|||
150006326|NCT01789606|541156322|FG001|Overall Study|No Study Medication Taken|1|||
150006327|NCT01789606|541156321|FG000|Overall Study|Protocol Violation|0|||
150006328|NCT01789606|541156322|FG001|Overall Study|Protocol Violation|55|||
150006329|NCT01789606|541156321|FG000|Overall Study|Adverse Event|0|||
150006330|NCT01789606|541156322|FG001|Overall Study|Adverse Event|3|||
150006331|NCT01789606|541156321|FG000|Overall Study|Lost to Follow-up|0|||
150006332|NCT01789606|541156322|FG001|Overall Study|Lost to Follow-up|14|||
150006333|NCT01789606|541156321|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
150006334|NCT01789606|541156322|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
150006335|NCT01105377|541156325|FG000|Overall Study|Withdrawal by Subject|0|||
150006336|NCT01105377|541156326|FG001|Overall Study|Withdrawal by Subject|1|||
150006337|NCT05011513|541157820|FG000|Overall Study|Death|0|||
150006338|NCT05011513|541157821|FG001|Overall Study|Death|1|||
150006339|NCT05011513|541157820|FG000|Overall Study|Lost to Follow-up|4|||
150006340|NCT05011513|541157821|FG001|Overall Study|Lost to Follow-up|0|||
150006341|NCT05011513|541157820|FG000|Overall Study|Withdrawal by Subject|18|||
150006342|NCT05011513|541157821|FG001|Overall Study|Withdrawal by Subject|17|||
150006343|NCT05011513|541157820|FG000|Overall Study|Other|4|||
150006344|NCT05011513|541157821|FG001|Overall Study|Other|2|||
150006345|NCT03667690|541157822|FG000|Overall Study|Adverse Event|0|||
150006346|NCT03667690|541157823|FG001|Overall Study|Adverse Event|3|||
150006347|NCT03667690|541157822|FG000|Overall Study|Death|22|||
150006348|NCT03667690|541157823|FG001|Overall Study|Death|21|||
150006349|NCT03667690|541157822|FG000|Overall Study|Lost to Follow-up|4|||
150006350|NCT03667690|541157823|FG001|Overall Study|Lost to Follow-up|5|||
150006351|NCT03667690|541157822|FG000|Overall Study|Withdrawal by Subject|7|||
150006352|NCT03667690|541157823|FG001|Overall Study|Withdrawal by Subject|8|||
150006353|NCT03667690|541157822|FG000|Overall Study|Subject could not return for additional investigational product|1|||
150006354|NCT03667690|541157823|FG001|Overall Study|Subject could not return for additional investigational product|0|||
150006355|NCT03667690|541157822|FG000|Overall Study|Subject discharged to hospice care|2|||
150006356|NCT03667690|541157823|FG001|Overall Study|Subject discharged to hospice care|0|||
150006357|NCT03667690|541157822|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
150006358|NCT03667690|541157823|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
150006359|NCT03667690|541157822|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
150006360|NCT03667690|541157823|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
150006361|NCT03667690|541157822|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
150006362|NCT03667690|541157823|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
150006363|NCT03667690|541157822|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
150006364|NCT03667690|541157823|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
150006365|NCT03667690|541157822|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
150006366|NCT03667690|541157823|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
150006367|NCT00837759|541157826|FG000|Overall Study|Protocol Violation|3|||
150006368|NCT00837759|541157826|FG000|Overall Study|Lost to Follow-up|1|||
150006369|NCT01073930|541157827|FG000|Overall Study|Withdrawal by Subject|3|||
150006370|NCT01073930|541157828|FG001|Overall Study|Withdrawal by Subject|2|||
150006371|NCT01073930|541157827|FG000|Overall Study|Lost to Follow-up|0|||
150006372|NCT01073930|541157828|FG001|Overall Study|Lost to Follow-up|1|||
150006373|NCT01073930|541157827|FG000|Overall Study|Adverse Event|0|||
150006374|NCT01073930|541157828|FG001|Overall Study|Adverse Event|1|||
150006375|NCT01073930|541157827|FG000|Overall Study|Noncompliance with study drug|0|||
150006376|NCT01073930|541157828|FG001|Overall Study|Noncompliance with study drug|1|||
150006377|NCT01073930|541157827|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
150006378|NCT01073930|541157828|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
150006379|NCT01192568|541157829|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
150006380|NCT01192568|541157830|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
150006381|NCT01192568|541157831|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
150006382|NCT01192568|541157832|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
150006383|NCT01192568|541157829|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
150006384|NCT01192568|541157830|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
150006385|NCT01192568|541157831|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
150006386|NCT01192568|541157832|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
150006387|NCT03459365|541157833|FG000|Overall Study|Withdrawal by Subject|6|||
150006388|NCT03459365|541157833|FG000|Overall Study|Protocol Violation|8|||
150006389|NCT00599755|541157834|FG000|Overall Study|Adverse Event|11|||
150006390|NCT00599755|541157834|FG000|Overall Study|Withdrawal by Subject|2|||
150006391|NCT00599755|541157834|FG000|Overall Study|Progression of Disease|3|||
150006392|NCT00599755|541157834|FG000|Overall Study|Other Reason|2|||
150006393|NCT00599755|541157834|FG000|Overall Study|No data available|1|||
150006394|NCT04037254|541157835|FG000|Overall Study|Protocol Violation|1|||
150006395|NCT04037254|541157836|FG001|Overall Study|Protocol Violation|0|||
150006396|NCT04037254|541157837|FG002|Overall Study|Protocol Violation|0|||
150006397|NCT04037254|541157838|FG003|Overall Study|Protocol Violation|0|||
150006398|NCT04037254|541157839|FG004|Overall Study|Protocol Violation|0|||
150006399|NCT04037254|541157835|FG000|Overall Study|Withdrawal by Subject|0|||
150006400|NCT04037254|541157836|FG001|Overall Study|Withdrawal by Subject|0|||
150006401|NCT04037254|541157837|FG002|Overall Study|Withdrawal by Subject|1|||
150006402|NCT04037254|541157838|FG003|Overall Study|Withdrawal by Subject|0|||
150006403|NCT04037254|541157839|FG004|Overall Study|Withdrawal by Subject|0|||
150006404|NCT04037254|541157835|FG000|Overall Study|Delayed or incomplete treatment|0|||
150006405|NCT04037254|541157836|FG001|Overall Study|Delayed or incomplete treatment|2|||
150006406|NCT04037254|541157837|FG002|Overall Study|Delayed or incomplete treatment|1|||
150006407|NCT04037254|541157838|FG003|Overall Study|Delayed or incomplete treatment|0|||
150006408|NCT04037254|541157839|FG004|Overall Study|Delayed or incomplete treatment|0|||
150006409|NCT03320330|541157840|FG000|Overall Study|Lack of Efficacy|5|||
150006410|NCT03320330|541157841|FG001|Overall Study|Lack of Efficacy|5|||
150006411|NCT03320330|541157842|FG002|Overall Study|Lack of Efficacy|14|||
150006412|NCT03320330|541157840|FG000|Overall Study|Physician Decision|1|||
150006413|NCT03320330|541157841|FG001|Overall Study|Physician Decision|0|||
150006414|NCT03320330|541157842|FG002|Overall Study|Physician Decision|0|||
150006415|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
150006416|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
150006417|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
150006418|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
150006419|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
150006420|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
150006421|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
150006422|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
150006423|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
150006424|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
150006425|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
150006426|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
150006427|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
150006428|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
150006429|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
150006430|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
150006431|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
150006432|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
150055892|NCT00171834|541346193|FG001|Overall Study|Adverse Event|1|||
150055893|NCT00171834|541346194|FG002|Overall Study|Adverse Event|3|||
150055894|NCT00171834|541346195|FG003|Overall Study|Adverse Event|2|||
150055895|NCT00171834|541346196|FG004|Overall Study|Adverse Event|2|||
150055896|NCT00171834|541346197|FG005|Overall Study|Adverse Event|15|||
150055897|NCT00171834|541346198|FG006|Overall Study|Adverse Event|1|||
150055898|NCT00171834|541346192|FG000|Overall Study|Withdrawal by Subject|0|||
150055899|NCT00171834|541346193|FG001|Overall Study|Withdrawal by Subject|2|||
150055900|NCT00171834|541346194|FG002|Overall Study|Withdrawal by Subject|0|||
150055901|NCT00171834|541346195|FG003|Overall Study|Withdrawal by Subject|1|||
150055902|NCT00171834|541346196|FG004|Overall Study|Withdrawal by Subject|1|||
150055903|NCT00171834|541346197|FG005|Overall Study|Withdrawal by Subject|1|||
150055904|NCT00171834|541346198|FG006|Overall Study|Withdrawal by Subject|0|||
150055905|NCT00171834|541346192|FG000|Overall Study|Death from study indication|0|||
150055906|NCT00171834|541346193|FG001|Overall Study|Death from study indication|1|||
150006433|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
150006434|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
150006435|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
150006436|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
150006437|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
150006438|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
150006439|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
150006440|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
150006441|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
150006442|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
150006443|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
150006444|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
150006445|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
150006446|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
150006447|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
150006448|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
150006449|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
150006450|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
150006451|NCT02198794|541157843|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
150006452|NCT02198794|541157844|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
150006453|NCT02198794|541157845|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
150006454|NCT02198794|541157846|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
150006455|NCT02198794|541157843|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
150006456|NCT02198794|541157844|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
150006457|NCT02198794|541157845|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
150006458|NCT02198794|541157846|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
150006459|NCT02198794|541157843|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
150006460|NCT02198794|541157844|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
150006461|NCT02198794|541157845|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
150006462|NCT02198794|541157846|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
150006463|NCT02198794|541157843|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
150006464|NCT02198794|541157844|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
150006465|NCT02198794|541157845|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
150006466|NCT02198794|541157846|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
150006467|NCT02198794|541157843|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
150006468|NCT02198794|541157844|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
150006469|NCT02198794|541157845|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
150006470|NCT02198794|541157846|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
150006471|NCT02198794|541157843|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
150006472|NCT02198794|541157844|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
150006473|NCT02198794|541157845|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
150006474|NCT02198794|541157846|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
150006475|NCT01306656|541157848|FG000|Overall Study|Lost to Follow-up|1|||
150006476|NCT01306656|541157849|FG001|Overall Study|Lost to Follow-up|0|||
150006477|NCT00477152|541157852|FG000|Overall Study|Parent withdrew consent|2|||
150006478|NCT00477152|541157852|FG000|Overall Study|Adverse Event|1|||
150006479|NCT01023672|541157853|FG000|Overall Study|Worsening disease|2|||
150006480|NCT01023672|541157853|FG000|Overall Study|Death|1|||
150006481|NCT01918332|541157854|FG000|Overall Study|Adverse Event|0|||
150006482|NCT01918332|541157855|FG001|Overall Study|Adverse Event|0|||
150006483|NCT01918332|541157856|FG002|Overall Study|Adverse Event|0|||
150006484|NCT01918332|541157857|FG003|Overall Study|Adverse Event|1|||
150006485|NCT01918332|541157854|FG000|Overall Study|Withdrawal by Subject|2|||
150006486|NCT01918332|541157855|FG001|Overall Study|Withdrawal by Subject|3|||
150055907|NCT00171834|541346194|FG002|Overall Study|Death from study indication|0|||
150055908|NCT00171834|541346195|FG003|Overall Study|Death from study indication|0|||
150055909|NCT00171834|541346196|FG004|Overall Study|Death from study indication|1|||
150055910|NCT00171834|541346197|FG005|Overall Study|Death from study indication|0|||
150055911|NCT00171834|541346198|FG006|Overall Study|Death from study indication|0|||
150055912|NCT00171834|541346192|FG000|Overall Study|Disease Progression|4|||
150055913|NCT00171834|541346193|FG001|Overall Study|Disease Progression|8|||
150055914|NCT00171834|541346194|FG002|Overall Study|Disease Progression|8|||
150055915|NCT00171834|541346195|FG003|Overall Study|Disease Progression|9|||
150055916|NCT00171834|541346196|FG004|Overall Study|Disease Progression|2|||
150055917|NCT00171834|541346197|FG005|Overall Study|Disease Progression|18|||
150055918|NCT00171834|541346198|FG006|Overall Study|Disease Progression|3|||
150055919|NCT00171834|541346192|FG000|Overall Study|Treatment Duration Completed|0|||
150179943|NCT04992390|541796892|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
150179944|NCT04992390|541796893|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
150179945|NCT04992390|541796891|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
150006487|NCT01918332|541157856|FG002|Overall Study|Withdrawal by Subject|2|||
150055920|NCT00171834|541346193|FG001|Overall Study|Treatment Duration Completed|0|||
150055921|NCT00171834|541346194|FG002|Overall Study|Treatment Duration Completed|1|||
150055922|NCT00171834|541346195|FG003|Overall Study|Treatment Duration Completed|0|||
150055923|NCT00171834|541346196|FG004|Overall Study|Treatment Duration Completed|2|||
150055924|NCT00171834|541346197|FG005|Overall Study|Treatment Duration Completed|1|||
150055925|NCT00171834|541346198|FG006|Overall Study|Treatment Duration Completed|0|||
150055926|NCT00834080|541346199|FG000|Overall Study|Adverse Event|7|||
150006488|NCT01918332|541157857|FG003|Overall Study|Withdrawal by Subject|3|||
150006489|NCT01918332|541157854|FG000|Overall Study|Protocol Violation|6|||
150006490|NCT01918332|541157855|FG001|Overall Study|Protocol Violation|2|||
150006491|NCT01918332|541157856|FG002|Overall Study|Protocol Violation|6|||
150006492|NCT01918332|541157857|FG003|Overall Study|Protocol Violation|3|||
150006493|NCT01918332|541157854|FG000|Overall Study|lipid result by central lab did not meet|0|||
150006494|NCT01918332|541157855|FG001|Overall Study|lipid result by central lab did not meet|0|||
150006495|NCT01918332|541157856|FG002|Overall Study|lipid result by central lab did not meet|1|||
150006496|NCT01918332|541157857|FG003|Overall Study|lipid result by central lab did not meet|0|||
150006497|NCT02905006|541157858|FG000|Overall Study|Adverse Event|1|||
150006498|NCT02905006|541157859|FG001|Overall Study|Adverse Event|1|||
150006499|NCT02905006|541157860|FG002|Overall Study|Adverse Event|1|||
150006500|NCT02905006|541157861|FG003|Overall Study|Adverse Event|1|||
150006501|NCT02905006|541157862|FG004|Overall Study|Adverse Event|0|||
150006502|NCT02905006|541157863|FG005|Overall Study|Adverse Event|1|||
150006503|NCT02905006|541157858|FG000|Overall Study|Lack of Efficacy|1|||
150006504|NCT02905006|541157859|FG001|Overall Study|Lack of Efficacy|0|||
150179946|NCT04992390|541796892|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
150179947|NCT04992390|541796893|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
150006505|NCT02905006|541157860|FG002|Overall Study|Lack of Efficacy|0|||
150006506|NCT02905006|541157861|FG003|Overall Study|Lack of Efficacy|0|||
150006507|NCT02905006|541157862|FG004|Overall Study|Lack of Efficacy|0|||
150006508|NCT02905006|541157863|FG005|Overall Study|Lack of Efficacy|0|||
150006509|NCT02905006|541157858|FG000|Overall Study|Protocol Violation|2|||
150006510|NCT02905006|541157859|FG001|Overall Study|Protocol Violation|0|||
150006511|NCT02905006|541157860|FG002|Overall Study|Protocol Violation|0|||
150006512|NCT02905006|541157861|FG003|Overall Study|Protocol Violation|0|||
150006513|NCT02905006|541157862|FG004|Overall Study|Protocol Violation|0|||
150006514|NCT02905006|541157863|FG005|Overall Study|Protocol Violation|0|||
150006515|NCT02905006|541157858|FG000|Overall Study|Lost to Follow-up|0|||
150006516|NCT02905006|541157859|FG001|Overall Study|Lost to Follow-up|0|||
150006517|NCT02905006|541157860|FG002|Overall Study|Lost to Follow-up|0|||
150006518|NCT02905006|541157861|FG003|Overall Study|Lost to Follow-up|1|||
150006519|NCT02905006|541157862|FG004|Overall Study|Lost to Follow-up|1|||
150006520|NCT02905006|541157863|FG005|Overall Study|Lost to Follow-up|0|||
150006521|NCT02905006|541157858|FG000|Overall Study|Withdrawal by Subject|0|||
150006522|NCT02905006|541157859|FG001|Overall Study|Withdrawal by Subject|0|||
150006523|NCT02905006|541157860|FG002|Overall Study|Withdrawal by Subject|1|||
150006524|NCT02905006|541157861|FG003|Overall Study|Withdrawal by Subject|1|||
150006525|NCT02905006|541157862|FG004|Overall Study|Withdrawal by Subject|0|||
150006526|NCT02905006|541157863|FG005|Overall Study|Withdrawal by Subject|1|||
150006527|NCT02905006|541157858|FG000|Overall Study|Screening exclusion criteria met|1|||
150006528|NCT02905006|541157859|FG001|Overall Study|Screening exclusion criteria met|0|||
150006529|NCT02905006|541157860|FG002|Overall Study|Screening exclusion criteria met|0|||
150006530|NCT02905006|541157861|FG003|Overall Study|Screening exclusion criteria met|0|||
150006531|NCT02905006|541157862|FG004|Overall Study|Screening exclusion criteria met|0|||
150006532|NCT02905006|541157863|FG005|Overall Study|Screening exclusion criteria met|0|||
150006533|NCT02905006|541157858|FG000|Overall Study|Lab withdrawal criterion met|0|||
150006534|NCT02905006|541157859|FG001|Overall Study|Lab withdrawal criterion met|1|||
150006535|NCT02905006|541157860|FG002|Overall Study|Lab withdrawal criterion met|2|||
150006536|NCT02905006|541157861|FG003|Overall Study|Lab withdrawal criterion met|2|||
150006537|NCT02905006|541157862|FG004|Overall Study|Lab withdrawal criterion met|2|||
150006538|NCT02905006|541157863|FG005|Overall Study|Lab withdrawal criterion met|1|||
150006539|NCT02905006|541157858|FG000|Overall Study|Positive for Tuberculosis|0|||
150006540|NCT02905006|541157859|FG001|Overall Study|Positive for Tuberculosis|1|||
150006541|NCT02905006|541157860|FG002|Overall Study|Positive for Tuberculosis|0|||
150006542|NCT02905006|541157861|FG003|Overall Study|Positive for Tuberculosis|0|||
150006543|NCT02905006|541157862|FG004|Overall Study|Positive for Tuberculosis|0|||
150006544|NCT02905006|541157863|FG005|Overall Study|Positive for Tuberculosis|0|||
150006545|NCT02905006|541157858|FG000|Overall Study|Subject positive for Hep B|0|||
150006546|NCT02905006|541157859|FG001|Overall Study|Subject positive for Hep B|0|||
150006547|NCT02905006|541157860|FG002|Overall Study|Subject positive for Hep B|1|||
150006548|NCT02905006|541157861|FG003|Overall Study|Subject positive for Hep B|0|||
150006549|NCT02905006|541157862|FG004|Overall Study|Subject positive for Hep B|0|||
150006550|NCT02905006|541157863|FG005|Overall Study|Subject positive for Hep B|0|||
150006551|NCT02905006|541157858|FG000|Overall Study|Patient moved abroad|0|||
150006552|NCT02905006|541157859|FG001|Overall Study|Patient moved abroad|0|||
150006553|NCT02905006|541157860|FG002|Overall Study|Patient moved abroad|0|||
150006554|NCT02905006|541157861|FG003|Overall Study|Patient moved abroad|1|||
150006555|NCT02905006|541157862|FG004|Overall Study|Patient moved abroad|0|||
150006556|NCT02905006|541157863|FG005|Overall Study|Patient moved abroad|0|||
150006557|NCT02905006|541157858|FG000|Overall Study|Patient randomized by mistake|0|||
150006558|NCT02905006|541157859|FG001|Overall Study|Patient randomized by mistake|0|||
150006559|NCT02905006|541157860|FG002|Overall Study|Patient randomized by mistake|0|||
150006560|NCT02905006|541157861|FG003|Overall Study|Patient randomized by mistake|0|||
150006561|NCT02905006|541157862|FG004|Overall Study|Patient randomized by mistake|0|||
150006562|NCT02905006|541157863|FG005|Overall Study|Patient randomized by mistake|1|||
150006563|NCT05063539|541157864|FG000|Overall Study|Adverse Event|1|||
150006564|NCT05063539|541157865|FG001|Overall Study|Adverse Event|2|||
150006565|NCT05063539|541157866|FG002|Overall Study|Adverse Event|1|||
150006566|NCT05063539|541157864|FG000|Overall Study|Death|0|||
150006567|NCT05063539|541157865|FG001|Overall Study|Death|1|||
150006568|NCT05063539|541157866|FG002|Overall Study|Death|1|||
150006569|NCT05063539|541157864|FG000|Overall Study|Lost to Follow-up|0|||
150006570|NCT05063539|541157865|FG001|Overall Study|Lost to Follow-up|1|||
150006571|NCT05063539|541157866|FG002|Overall Study|Lost to Follow-up|0|||
150006572|NCT05063539|541157864|FG000|Overall Study|Physician Decision|4|||
150006573|NCT05063539|541157865|FG001|Overall Study|Physician Decision|3|||
150006574|NCT05063539|541157866|FG002|Overall Study|Physician Decision|1|||
150006575|NCT05063539|541157864|FG000|Overall Study|Progressive Disease|0|||
150006576|NCT05063539|541157865|FG001|Overall Study|Progressive Disease|2|||
150006577|NCT05063539|541157866|FG002|Overall Study|Progressive Disease|0|||
150006578|NCT05063539|541157864|FG000|Overall Study|Withdrawal by Subject|17|||
150006579|NCT05063539|541157865|FG001|Overall Study|Withdrawal by Subject|26|||
150006580|NCT05063539|541157866|FG002|Overall Study|Withdrawal by Subject|14|||
150006581|NCT05063539|541157864|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
150006582|NCT05063539|541157865|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
150006583|NCT05063539|541157866|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
150006584|NCT05063539|541157864|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
150006585|NCT05063539|541157865|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
150006586|NCT05063539|541157866|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
150055927|NCT00834080|541346199|FG000|Overall Study|Lost to Follow-up|7|||
150006587|NCT05063539|541157864|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
150006588|NCT05063539|541157865|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
150006589|NCT05063539|541157866|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
150006590|NCT05063539|541157864|FG000|Overall Study|Discontinued due to Common Close Design|0|||
150179948|NCT04992390|541796891|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
150179949|NCT04992390|541796892|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
150179950|NCT04992390|541796893|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
150179951|NCT04992390|541796891|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
150179952|NCT04992390|541796892|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
150179953|NCT04992390|541796893|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
150179954|NCT04992390|541796891|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
150179955|NCT04992390|541796892|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
150179956|NCT04992390|541796893|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
150006591|NCT05063539|541157865|FG001|Overall Study|Discontinued due to Common Close Design|1|||
150006592|NCT05063539|541157866|FG002|Overall Study|Discontinued due to Common Close Design|0|||
150006593|NCT05063539|541157864|FG000|Overall Study|Participant not co-operative|0|||
150006594|NCT05063539|541157865|FG001|Overall Study|Participant not co-operative|1|||
150006595|NCT05063539|541157866|FG002|Overall Study|Participant not co-operative|0|||
150006596|NCT05063539|541157864|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
150006597|NCT05063539|541157865|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
150006598|NCT05063539|541157866|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
150006599|NCT05063539|541157864|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
150179957|NCT04992390|541796891|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
150179958|NCT04992390|541796892|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
150179959|NCT04992390|541796893|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
150006600|NCT05063539|541157865|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
150006601|NCT05063539|541157866|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
150006602|NCT01751139|541157867|FG000|Overall Study|Other|135|||
150006603|NCT01751139|541157867|FG000|Overall Study|Sponsor study termination|1609|||
150006604|NCT01751139|541157867|FG000|Overall Study|Lost to Follow-up|240|||
150006605|NCT01751139|541157867|FG000|Overall Study|Withdrawal by Subject|251|||
150006606|NCT01751139|541157867|FG000|Overall Study|Adverse Event|1|||
150006607|NCT01751139|541157867|FG000|Overall Study|Death|31|||
150006608|NCT04736628|541157868|FG000|Overall Study|Not treated|0|||
150006609|NCT04736628|541157869|FG001|Overall Study|Not treated|0|||
150006610|NCT04736628|541157870|FG002|Overall Study|Not treated|0|||
150006611|NCT04736628|541157871|FG003|Overall Study|Not treated|2|||
150006612|NCT04736628|541157868|FG000|Overall Study|Other reason than listed|1|||
150006613|NCT04736628|541157869|FG001|Overall Study|Other reason than listed|2|||
150006614|NCT04736628|541157870|FG002|Overall Study|Other reason than listed|2|||
150006615|NCT04736628|541157871|FG003|Overall Study|Other reason than listed|3|||
150006616|NCT04736628|541157868|FG000|Overall Study|Protocol deviation|0|||
150006617|NCT04736628|541157869|FG001|Overall Study|Protocol deviation|0|||
150006618|NCT04736628|541157870|FG002|Overall Study|Protocol deviation|0|||
150006619|NCT04736628|541157871|FG003|Overall Study|Protocol deviation|1|||
150006620|NCT04736628|541157868|FG000|Overall Study|Burden of study procedures|1|||
150006621|NCT04736628|541157869|FG001|Overall Study|Burden of study procedures|0|||
150006622|NCT04736628|541157870|FG002|Overall Study|Burden of study procedures|0|||
150006623|NCT04736628|541157871|FG003|Overall Study|Burden of study procedures|1|||
150006624|NCT04736628|541157868|FG000|Overall Study|Change of residence|0|||
150006625|NCT04736628|541157869|FG001|Overall Study|Change of residence|1|||
150006626|NCT04736628|541157870|FG002|Overall Study|Change of residence|0|||
150006627|NCT04736628|541157871|FG003|Overall Study|Change of residence|0|||
150006628|NCT04736628|541157868|FG000|Overall Study|Perceived lack of efficacy|1|||
150006629|NCT04736628|541157869|FG001|Overall Study|Perceived lack of efficacy|0|||
150006630|NCT04736628|541157870|FG002|Overall Study|Perceived lack of efficacy|0|||
150006631|NCT04736628|541157871|FG003|Overall Study|Perceived lack of efficacy|1|||
150006632|NCT04736628|541157868|FG000|Overall Study|Adverse Event|3|||
150006633|NCT04736628|541157869|FG001|Overall Study|Adverse Event|2|||
150006634|NCT04736628|541157870|FG002|Overall Study|Adverse Event|4|||
150006635|NCT04736628|541157871|FG003|Overall Study|Adverse Event|3|||
150006636|NCT02428205|541157874|FG000|Overall Study|Lack of Efficacy|1|||
150006637|NCT02428205|541157875|FG001|Overall Study|Lack of Efficacy|0|||
150006638|NCT02428205|541157874|FG000|Overall Study|Lost to Follow-up|1|||
150006639|NCT02428205|541157875|FG001|Overall Study|Lost to Follow-up|1|||
150006640|NCT02428205|541157874|FG000|Overall Study|Worse behavior|0|||
150006641|NCT02428205|541157875|FG001|Overall Study|Worse behavior|1|||
150006642|NCT00527319|541157876|FG000|Overall Study|Withdrawal by Subject|5|||
150006643|NCT00527319|541157877|FG001|Overall Study|Withdrawal by Subject|0|||
150006644|NCT00527319|541157878|FG002|Overall Study|Withdrawal by Subject|1|||
150006645|NCT00527319|541157876|FG000|Overall Study|Lost to Follow-up|1|||
150006646|NCT00527319|541157877|FG001|Overall Study|Lost to Follow-up|0|||
150006647|NCT00527319|541157878|FG002|Overall Study|Lost to Follow-up|0|||
150006648|NCT00527319|541157876|FG000|Overall Study|Death|0|||
150006649|NCT00527319|541157877|FG001|Overall Study|Death|3|||
150006650|NCT00527319|541157878|FG002|Overall Study|Death|1|||
150006651|NCT00527319|541157876|FG000|Overall Study|Intercurrent Medical Illness|0|||
150006652|NCT00527319|541157877|FG001|Overall Study|Intercurrent Medical Illness|1|||
150006653|NCT00527319|541157878|FG002|Overall Study|Intercurrent Medical Illness|3|||
150006654|NCT00527319|541157876|FG000|Overall Study|Adverse Event|0|||
150006655|NCT00527319|541157877|FG001|Overall Study|Adverse Event|0|||
150006656|NCT00527319|541157878|FG002|Overall Study|Adverse Event|1|||
150006657|NCT00680368|541157880|FG000|Overall Study|not supervised, not eligible|15|||
150006658|NCT00483041|541157881|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
150006659|NCT00483041|541157882|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
150006660|NCT03779503|541157883|FG000|First Intervention|Adverse Event|0|||
150006661|NCT03779503|541157884|FG001|First Intervention|Adverse Event|1|||
150006662|NCT03779503|541157883|FG000|First Intervention|Withdrawal by Subject|1|||
150006663|NCT03779503|541157884|FG001|First Intervention|Withdrawal by Subject|0|||
150006664|NCT00864851|541157885|FG000|Overall Study|Withdrawal by Subject|0|||
150006665|NCT00864851|541157886|FG001|Overall Study|Withdrawal by Subject|1|||
150006666|NCT00864851|541157887|FG002|Overall Study|Withdrawal by Subject|0|||
150006667|NCT00864851|541157885|FG000|Overall Study|Physician Decision|1|||
150006668|NCT00864851|541157886|FG001|Overall Study|Physician Decision|0|||
150006669|NCT00864851|541157887|FG002|Overall Study|Physician Decision|0|||
150006670|NCT00864851|541157885|FG000|Overall Study|Death|1|||
150006671|NCT00864851|541157886|FG001|Overall Study|Death|0|||
150006672|NCT00864851|541157887|FG002|Overall Study|Death|0|||
150006673|NCT00864851|541157885|FG000|Overall Study|Patient uncooperative|1|||
150006674|NCT00864851|541157886|FG001|Overall Study|Patient uncooperative|0|||
150006675|NCT00864851|541157887|FG002|Overall Study|Patient uncooperative|0|||
150006676|NCT02066415|541157888|FG000|Overall Study|Decision by Sponsor|5|||
150006677|NCT02066415|541157889|FG001|Overall Study|Decision by Sponsor|4|||
150006678|NCT02066415|541157890|FG002|Overall Study|Decision by Sponsor|2|||
150006679|NCT02066415|541157888|FG000|Overall Study|Withdrawal by Subject|9|||
150006680|NCT02066415|541157889|FG001|Overall Study|Withdrawal by Subject|1|||
150006681|NCT02066415|541157890|FG002|Overall Study|Withdrawal by Subject|4|||
150006682|NCT02066415|541157888|FG000|Overall Study|Lost to Follow-up|7|||
150006683|NCT02066415|541157889|FG001|Overall Study|Lost to Follow-up|2|||
150006684|NCT02066415|541157890|FG002|Overall Study|Lost to Follow-up|2|||
150006685|NCT04094584|541157894|FG000|Overall Study|No interest in study|88|||
150006686|NCT04094584|541157894|FG000|Overall Study|Unwilling to undergo screening tests|36|||
150006687|NCT04094584|541157894|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
150006688|NCT04094584|541157894|FG000|Overall Study|Opioid use|7|||
150006689|NCT04094584|541157894|FG000|Overall Study|Need for major surgery in study period|4|||
150006690|NCT04094584|541157894|FG000|Overall Study|eligible but declined enrollment|4|||
150006691|NCT04094584|541157894|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
150006692|NCT04094584|541157894|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
150006693|NCT04094584|541157894|FG000|Overall Study|Lost to Follow-up|3|||
150006694|NCT04094584|541157894|FG000|Overall Study|Withdrawal by Subject|2|||
150006695|NCT02713867|541157903|FG000|Randomization|Other Reason|2|||
150006696|NCT02713867|541157904|FG001|Randomization|Other Reason|1|||
150006697|NCT02713867|541157903|FG000|Randomization|Participant Withdrew consent|0|||
150006698|NCT02713867|541157904|FG001|Randomization|Participant Withdrew consent|2|||
150006699|NCT02713867|541157903|FG000|Treatment Period|Other Reasons|22|||
150006700|NCT02713867|541157904|FG001|Treatment Period|Other Reasons|28|||
150006701|NCT02713867|541157903|FG000|Treatment Period|Administrative reason by sponsor|21|||
150006702|NCT02713867|541157904|FG001|Treatment Period|Administrative reason by sponsor|16|||
150006703|NCT02713867|541157903|FG000|Treatment Period|No longer meets study criteria|2|||
150006704|NCT02713867|541157904|FG001|Treatment Period|No longer meets study criteria|1|||
150006705|NCT02713867|541157903|FG000|Treatment Period|Poor/Non Compliance|1|||
150006706|NCT02713867|541157904|FG001|Treatment Period|Poor/Non Compliance|0|||
150006707|NCT02713867|541157903|FG000|Treatment Period|Maximum Clinical Benefit|5|||
150006708|NCT02713867|541157904|FG001|Treatment Period|Maximum Clinical Benefit|6|||
150006709|NCT02713867|541157903|FG000|Treatment Period|Withdrew consent|3|||
150006710|NCT02713867|541157904|FG001|Treatment Period|Withdrew consent|6|||
150006711|NCT02713867|541157903|FG000|Treatment Period|Requested to Discontinue|8|||
150006712|NCT02713867|541157904|FG001|Treatment Period|Requested to Discontinue|8|||
150006713|NCT02713867|541157903|FG000|Treatment Period|AE unrelated to Study Drug|11|||
150006714|NCT02713867|541157904|FG001|Treatment Period|AE unrelated to Study Drug|10|||
150006715|NCT02713867|541157903|FG000|Treatment Period|Death|7|||
150006716|NCT02713867|541157904|FG001|Treatment Period|Death|3|||
150006717|NCT02713867|541157903|FG000|Treatment Period|Study Drug Toxicity|16|||
150006718|NCT02713867|541157904|FG001|Treatment Period|Study Drug Toxicity|19|||
150006719|NCT02713867|541157903|FG000|Treatment Period|Disease Progression|82|||
150006720|NCT02713867|541157904|FG001|Treatment Period|Disease Progression|83|||
150006721|NCT01600053|541157905|FG000|Overall Study|Adverse Event|2|||
150006722|NCT01600053|541157905|FG000|Overall Study|trial will not meet the interim endpoint|9|||
150006723|NCT02715726|541157906|FG000|Overall Study|Adverse Event|2|||
150006724|NCT02715726|541157907|FG001|Overall Study|Adverse Event|6|||
150006725|NCT02715726|541157906|FG000|Overall Study|Protocol Violation|1|||
150006726|NCT02715726|541157907|FG001|Overall Study|Protocol Violation|0|||
150006727|NCT02715726|541157906|FG000|Overall Study|Death|2|||
150006728|NCT02715726|541157907|FG001|Overall Study|Death|1|||
150006729|NCT02715726|541157906|FG000|Overall Study|Participant moved|1|||
150006730|NCT02715726|541157907|FG001|Overall Study|Participant moved|3|||
150006731|NCT02715726|541157906|FG000|Overall Study|Other than specified above|11|||
150006732|NCT02715726|541157907|FG001|Overall Study|Other than specified above|15|||
150006733|NCT02715726|541157906|FG000|Overall Study|Randomized but not treated|1|||
150006734|NCT02715726|541157907|FG001|Overall Study|Randomized but not treated|2|||
150006735|NCT02445573|541157908|FG000|Overall Study|Withdrawal by Subject|1|||
150006736|NCT02445573|541157909|FG001|Overall Study|Withdrawal by Subject|1|||
150006737|NCT02445573|541157908|FG000|Overall Study|Lost to Follow-up|0|||
150006738|NCT02445573|541157909|FG001|Overall Study|Lost to Follow-up|1|||
150006739|NCT01565941|541157910|FG000|Overall Study|Withdrawn by parent/guardian|3|||
150006740|NCT01565941|541157911|FG001|Overall Study|Withdrawn by parent/guardian|2|||
150006741|NCT01565941|541157910|FG000|Overall Study|Randomized; did not receive intevention|8|||
150006742|NCT01565941|541157911|FG001|Overall Study|Randomized; did not receive intevention|2|||
150006743|NCT03230292|541157912|FG000|Overall Study|Adverse Event|1|||
150006744|NCT03230292|541157912|FG000|Overall Study|Protocol Violation|1|||
150006745|NCT03230292|541157912|FG000|Overall Study|Lost to Follow-up|1|||
150006746|NCT03230292|541157912|FG000|Overall Study|Withdrawal by Subject|3|||
150006747|NCT02855944|541157913|FG000|Period 1: Treatment|Ongoing|14|||
150006748|NCT02855944|541157914|FG001|Period 1: Treatment|Ongoing|0|||
150006749|NCT02855944|541157913|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
150006750|NCT02855944|541157914|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
150006751|NCT02855944|541157913|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
150006752|NCT02855944|541157914|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
150006753|NCT01639755|541157915|FG000|Overall Study|Study Ongoing|15|||
150006754|NCT01639755|541157915|FG000|Overall Study|Patient had device explantation|4|||
150006755|NCT03629912|541157918|FG000|Overall Study|Lost to Follow-up|19|||
150006756|NCT03629912|541157919|FG001|Overall Study|Lost to Follow-up|7|||
150006757|NCT03629912|541157920|FG002|Overall Study|Lost to Follow-up|5|||
150006758|NCT03629912|541157921|FG003|Overall Study|Lost to Follow-up|1|||
150006759|NCT03629912|541157918|FG000|Overall Study|Withdrawal by Subject|6|||
150006760|NCT03629912|541157919|FG001|Overall Study|Withdrawal by Subject|0|||
150006761|NCT03629912|541157920|FG002|Overall Study|Withdrawal by Subject|1|||
150006762|NCT03629912|541157921|FG003|Overall Study|Withdrawal by Subject|2|||
150006763|NCT03629912|541157918|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
150006764|NCT03629912|541157919|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
150006765|NCT03629912|541157920|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
150006766|NCT03629912|541157921|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
150006767|NCT03629912|541157918|FG000|Overall Study|Death|1|||
150006768|NCT03629912|541157919|FG001|Overall Study|Death|0|||
150006769|NCT03629912|541157920|FG002|Overall Study|Death|0|||
150006770|NCT03629912|541157921|FG003|Overall Study|Death|0|||
150006771|NCT02365285|541157924|FG000|Overall Study|Physician Decision|0|||
150006772|NCT02365285|541157925|FG001|Overall Study|Physician Decision|1|||
150006773|NCT02365285|541157926|FG002|Overall Study|Physician Decision|1|||
150006774|NCT02365285|541157927|FG003|Overall Study|Physician Decision|0|||
150006775|NCT02365285|541157924|FG000|Overall Study|Adverse Event|0|||
150006776|NCT02365285|541157925|FG001|Overall Study|Adverse Event|0|||
150006777|NCT02365285|541157926|FG002|Overall Study|Adverse Event|0|||
150006778|NCT02365285|541157927|FG003|Overall Study|Adverse Event|2|||
150006779|NCT02404649|541157928|FG000|Overall Study|Adverse Event|1|||
150006780|NCT02404649|541157929|FG001|Overall Study|Adverse Event|2|||
150006781|NCT04208087|541157930|FG000|Overall Study|Adverse Event|1|||
150006782|NCT04208087|541157931|FG001|Overall Study|Adverse Event|0|||
150006783|NCT04208087|541157932|FG002|Overall Study|Adverse Event|0|||
150006784|NCT04208087|541157933|FG003|Overall Study|Adverse Event|0|||
150006785|NCT04208087|541157934|FG004|Overall Study|Adverse Event|0|||
150006786|NCT04208087|541157930|FG000|Overall Study|Withdrawal by Subject|0|||
150006787|NCT04208087|541157931|FG001|Overall Study|Withdrawal by Subject|0|||
150006788|NCT04208087|541157932|FG002|Overall Study|Withdrawal by Subject|1|||
150006789|NCT04208087|541157933|FG003|Overall Study|Withdrawal by Subject|0|||
150055928|NCT00834080|541346199|FG000|Overall Study|Withdrawal by Subject|5|||
150055929|NCT00834080|541346199|FG000|Overall Study|Other - Pregnancy|1|||
150055930|NCT00834080|541346199|FG000|Overall Study|Other - False positive tests of the UDS|1|||
150055931|NCT00834080|541346199|FG000|Overall Study|Physician Decision|1|||
150055932|NCT00834080|541346199|FG000|Overall Study|Subject Relocated|1|||
150055933|NCT04345367|541346203|FG000|Overall Study|Other|3|||
150055934|NCT04345367|541346204|FG001|Overall Study|Other|4|||
150055935|NCT04345367|541346203|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
150055936|NCT04345367|541346204|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
150055937|NCT04345367|541346203|FG000|Overall Study|Withdrawal by Subject|11|||
150055938|NCT04345367|541346204|FG001|Overall Study|Withdrawal by Subject|11|||
150255143|NCT01290315|542070556|FG002|Overall Study|Withdrawal by Subject|0|||
150055939|NCT04345367|541346203|FG000|Overall Study|Protocol Violation|4|||
150055940|NCT04345367|541346204|FG001|Overall Study|Protocol Violation|3|||
150006790|NCT04208087|541157934|FG004|Overall Study|Withdrawal by Subject|0|||
150006791|NCT04208087|541157930|FG000|Overall Study|Other|0|||
150006792|NCT04208087|541157931|FG001|Overall Study|Other|0|||
150006793|NCT04208087|541157932|FG002|Overall Study|Other|0|||
150006794|NCT04208087|541157933|FG003|Overall Study|Other|0|||
150006795|NCT04208087|541157934|FG004|Overall Study|Other|1|||
150006796|NCT01012323|541157947|FG000|Overall Study|Investigator Judgment|1|||
150006797|NCT00558272|541157948|FG000|Overall Study|Adverse Event|10|||
150006798|NCT00558272|541157949|FG001|Overall Study|Adverse Event|0|||
150006799|NCT00558272|541157948|FG000|Overall Study|Death|1|||
150255144|NCT01290315|542070557|FG003|Overall Study|Withdrawal by Subject|0|||
150255145|NCT00423943|542070562|FG000|Overall Study|Withdrawal by Subject|3|||
150255146|NCT00423943|542070563|FG001|Overall Study|Withdrawal by Subject|1|||
150255147|NCT02134977|542070564|FG000|Overall Study|Protocol Deviation|102|||
150255148|NCT00901186|542070569|FG000|Overall Study|Lack of Efficacy|0|||
150255149|NCT00901186|542070570|FG001|Overall Study|Lack of Efficacy|1|||
150255150|NCT00901186|542070569|FG000|Overall Study|Abnormal laboratory values|0|||
150255151|NCT00901186|542070570|FG001|Overall Study|Abnormal laboratory values|1|||
150255152|NCT00901186|542070569|FG000|Overall Study|Lost to Follow-up|2|||
150255153|NCT00901186|542070570|FG001|Overall Study|Lost to Follow-up|0|||
150255154|NCT00901186|542070569|FG000|Overall Study|Adverse Event|2|||
150255155|NCT00901186|542070570|FG001|Overall Study|Adverse Event|4|||
150255156|NCT00901186|542070569|FG000|Overall Study|Administration problems|0|||
150255157|NCT00901186|542070570|FG001|Overall Study|Administration problems|1|||
150255158|NCT00901186|542070569|FG000|Overall Study|Protocol deviations|5|||
150255159|NCT00901186|542070570|FG001|Overall Study|Protocol deviations|4|||
150255160|NCT02383056|542070571|FG000|Overall Study|Adverse Event|1|||
150006800|NCT00558272|541157949|FG001|Overall Study|Death|0|||
150006801|NCT00558272|541157948|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
150006802|NCT00558272|541157949|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
150006803|NCT00558272|541157948|FG000|Overall Study|AZ study team decision|0|||
150179960|NCT04992390|541796891|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
150179961|NCT04992390|541796892|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
150179962|NCT04992390|541796893|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
150179963|NCT04992390|541796891|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
150179964|NCT04992390|541796892|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
150179965|NCT04992390|541796893|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
150179966|NCT04992390|541796891|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
150179967|NCT04992390|541796892|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
150179968|NCT04992390|541796893|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
150179969|NCT04992390|541796891|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
150179970|NCT04992390|541796892|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
150179971|NCT04992390|541796893|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
150179972|NCT04992390|541796891|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
150179973|NCT04992390|541796892|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
150179974|NCT04992390|541796893|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
150179975|NCT04992390|541796891|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
150179976|NCT04992390|541796892|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
150179977|NCT04992390|541796893|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
150179978|NCT04201834|541799342|FG000|Overall Study|Screen fail|1|||
150179979|NCT04104321|541799345|FG000|Overall Study|didn't take the study drug|3|||
150179980|NCT02980276|541799346|FG000|Overall Study|Withdrawal by Subject|4|||
150179981|NCT02980276|541799347|FG001|Overall Study|Withdrawal by Subject|4|||
150179982|NCT02980276|541799346|FG000|Overall Study|Physician Decision|0|||
150179983|NCT02980276|541799347|FG001|Overall Study|Physician Decision|1|||
150179984|NCT02980276|541799346|FG000|Overall Study|Lost to Follow-up|18|||
150179985|NCT02980276|541799347|FG001|Overall Study|Lost to Follow-up|18|||
150179986|NCT02980276|541799346|FG000|Overall Study|Death|1|||
150179987|NCT02980276|541799347|FG001|Overall Study|Death|0|||
150179988|NCT02980276|541799346|FG000|Overall Study|Miscellaneous other|10|||
150179989|NCT02980276|541799347|FG001|Overall Study|Miscellaneous other|4|||
150179990|NCT03554265|541799349|FG000|Overall Study|Withdrawal by Subject|2|||
150179991|NCT03554265|541799350|FG001|Overall Study|Withdrawal by Subject|2|||
150179992|NCT03554265|541799351|FG002|Overall Study|Withdrawal by Subject|3|||
150179993|NCT03554265|541799349|FG000|Overall Study|Physician Decision|0|||
150179994|NCT03554265|541799350|FG001|Overall Study|Physician Decision|0|||
150179995|NCT03554265|541799351|FG002|Overall Study|Physician Decision|1|||
150179996|NCT02652260|541799352|FG000|Base Study|Pregnancy|0|||
150006804|NCT00558272|541157949|FG001|Overall Study|AZ study team decision|1|||
150006805|NCT00558272|541157948|FG000|Overall Study|Incorrectly enrolled|1|||
150006806|NCT00558272|541157949|FG001|Overall Study|Incorrectly enrolled|0|||
150179997|NCT02652260|541799353|FG001|Base Study|Pregnancy|1|||
150179998|NCT02652260|541799352|FG000|Base Study|Withdrawal by Subject|0|||
150179999|NCT02652260|541799353|FG001|Base Study|Withdrawal by Subject|1|||
150180000|NCT02652260|541799352|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
150180001|NCT02652260|541799353|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
150055941|NCT04345367|541346203|FG000|Overall Study|Lost to Follow-up|2|||
150055942|NCT04345367|541346204|FG001|Overall Study|Lost to Follow-up|4|||
150055943|NCT04345367|541346203|FG000|Overall Study|Lack of Efficacy|2|||
150055944|NCT04345367|541346204|FG001|Overall Study|Lack of Efficacy|0|||
150055945|NCT04345367|541346203|FG000|Overall Study|Death|2|||
150055946|NCT04345367|541346204|FG001|Overall Study|Death|0|||
150055947|NCT04345367|541346203|FG000|Overall Study|Adverse Event|10|||
150055948|NCT04345367|541346204|FG001|Overall Study|Adverse Event|9|||
150055949|NCT00796523|541346205|FG000|Overall Study|Lost to Follow-up|9|||
150055950|NCT00796523|541346206|FG001|Overall Study|Lost to Follow-up|7|||
150055951|NCT02431260|541346211|FG000|Overall Study|Subject Decision|0|||
150055952|NCT02431260|541346212|FG001|Overall Study|Subject Decision|1|||
150055953|NCT02431260|541346213|FG002|Overall Study|Subject Decision|1|||
150055954|NCT02431260|541346214|FG003|Overall Study|Subject Decision|0|||
150055955|NCT02431260|541346215|FG004|Overall Study|Subject Decision|0|||
150055956|NCT02431260|541346216|FG005|Overall Study|Subject Decision|0|||
150055957|NCT02431260|541346217|FG006|Overall Study|Subject Decision|0|||
150055958|NCT02431260|541346218|FG007|Overall Study|Subject Decision|0|||
150055959|NCT02431260|541346219|FG008|Overall Study|Subject Decision|1|||
150055960|NCT02431260|541346220|FG009|Overall Study|Subject Decision|1|||
150055961|NCT02431260|541346221|FG010|Overall Study|Subject Decision|0|||
150055962|NCT02431260|541346222|FG011|Overall Study|Subject Decision|1|||
150055963|NCT02431260|541346223|FG012|Overall Study|Subject Decision|0|||
150055964|NCT02431260|541346224|FG013|Overall Study|Subject Decision|0|||
150055965|NCT02431260|541346211|FG000|Overall Study|Death|4|||
150055966|NCT02431260|541346212|FG001|Overall Study|Death|4|||
150055967|NCT02431260|541346213|FG002|Overall Study|Death|3|||
150055968|NCT02431260|541346214|FG003|Overall Study|Death|4|||
150055969|NCT02431260|541346215|FG004|Overall Study|Death|2|||
150055970|NCT02431260|541346216|FG005|Overall Study|Death|2|||
150055971|NCT02431260|541346217|FG006|Overall Study|Death|3|||
150055972|NCT02431260|541346218|FG007|Overall Study|Death|1|||
150055973|NCT02431260|541346219|FG008|Overall Study|Death|6|||
150055974|NCT02431260|541346220|FG009|Overall Study|Death|6|||
150055975|NCT02431260|541346221|FG010|Overall Study|Death|3|||
150055976|NCT02431260|541346222|FG011|Overall Study|Death|2|||
150055977|NCT02431260|541346223|FG012|Overall Study|Death|5|||
150055978|NCT02431260|541346224|FG013|Overall Study|Death|1|||
150055979|NCT02431260|541346211|FG000|Overall Study|Lost to Follow-up|0|||
150180002|NCT02652260|541799352|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
150055980|NCT02431260|541346212|FG001|Overall Study|Lost to Follow-up|0|||
150055981|NCT02431260|541346213|FG002|Overall Study|Lost to Follow-up|0|||
150055982|NCT02431260|541346214|FG003|Overall Study|Lost to Follow-up|0|||
150055983|NCT02431260|541346215|FG004|Overall Study|Lost to Follow-up|0|||
150055984|NCT02431260|541346216|FG005|Overall Study|Lost to Follow-up|1|||
150055985|NCT02431260|541346217|FG006|Overall Study|Lost to Follow-up|0|||
150055986|NCT02431260|541346218|FG007|Overall Study|Lost to Follow-up|0|||
150055987|NCT02431260|541346219|FG008|Overall Study|Lost to Follow-up|0|||
150055988|NCT02431260|541346220|FG009|Overall Study|Lost to Follow-up|0|||
150055989|NCT02431260|541346221|FG010|Overall Study|Lost to Follow-up|0|||
150055990|NCT02431260|541346222|FG011|Overall Study|Lost to Follow-up|0|||
150180003|NCT02652260|541799353|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
150055991|NCT02431260|541346223|FG012|Overall Study|Lost to Follow-up|0|||
150055992|NCT02431260|541346224|FG013|Overall Study|Lost to Follow-up|0|||
150055993|NCT02431260|541346211|FG000|Overall Study|Study Terminated by the Sponsor|0|||
150055994|NCT02431260|541346212|FG001|Overall Study|Study Terminated by the Sponsor|0|||
150055995|NCT02431260|541346213|FG002|Overall Study|Study Terminated by the Sponsor|2|||
150055996|NCT02431260|541346214|FG003|Overall Study|Study Terminated by the Sponsor|1|||
150055997|NCT02431260|541346215|FG004|Overall Study|Study Terminated by the Sponsor|1|||
150055998|NCT02431260|541346216|FG005|Overall Study|Study Terminated by the Sponsor|0|||
150055999|NCT02431260|541346217|FG006|Overall Study|Study Terminated by the Sponsor|1|||
150056000|NCT02431260|541346218|FG007|Overall Study|Study Terminated by the Sponsor|2|||
150056001|NCT02431260|541346219|FG008|Overall Study|Study Terminated by the Sponsor|1|||
150056002|NCT02431260|541346220|FG009|Overall Study|Study Terminated by the Sponsor|1|||
150056003|NCT02431260|541346221|FG010|Overall Study|Study Terminated by the Sponsor|1|||
150056004|NCT02431260|541346222|FG011|Overall Study|Study Terminated by the Sponsor|0|||
150056005|NCT02431260|541346223|FG012|Overall Study|Study Terminated by the Sponsor|4|||
150056006|NCT02431260|541346224|FG013|Overall Study|Study Terminated by the Sponsor|0|||
150056007|NCT02431260|541346211|FG000|Overall Study|Physician Decision|0|||
150056008|NCT02431260|541346212|FG001|Overall Study|Physician Decision|0|||
150056009|NCT02431260|541346213|FG002|Overall Study|Physician Decision|0|||
150056010|NCT02431260|541346214|FG003|Overall Study|Physician Decision|0|||
150056011|NCT02431260|541346215|FG004|Overall Study|Physician Decision|0|||
150056012|NCT02431260|541346216|FG005|Overall Study|Physician Decision|1|||
150056013|NCT02431260|541346217|FG006|Overall Study|Physician Decision|0|||
150056014|NCT02431260|541346218|FG007|Overall Study|Physician Decision|0|||
150056015|NCT02431260|541346219|FG008|Overall Study|Physician Decision|0|||
150056016|NCT02431260|541346220|FG009|Overall Study|Physician Decision|0|||
150056017|NCT02431260|541346221|FG010|Overall Study|Physician Decision|0|||
150056018|NCT02431260|541346222|FG011|Overall Study|Physician Decision|0|||
150056019|NCT02431260|541346223|FG012|Overall Study|Physician Decision|0|||
150056020|NCT02431260|541346224|FG013|Overall Study|Physician Decision|0|||
150056021|NCT02431260|541346211|FG000|Overall Study|Other Unspecified|0|||
150056022|NCT02431260|541346212|FG001|Overall Study|Other Unspecified|0|||
150056023|NCT02431260|541346213|FG002|Overall Study|Other Unspecified|0|||
150056024|NCT02431260|541346214|FG003|Overall Study|Other Unspecified|0|||
150056025|NCT02431260|541346215|FG004|Overall Study|Other Unspecified|0|||
150056026|NCT02431260|541346216|FG005|Overall Study|Other Unspecified|0|||
150056027|NCT02431260|541346217|FG006|Overall Study|Other Unspecified|0|||
150056028|NCT02431260|541346218|FG007|Overall Study|Other Unspecified|0|||
150056029|NCT02431260|541346219|FG008|Overall Study|Other Unspecified|0|||
150056030|NCT02431260|541346220|FG009|Overall Study|Other Unspecified|0|||
150056031|NCT02431260|541346221|FG010|Overall Study|Other Unspecified|0|||
150056032|NCT02431260|541346222|FG011|Overall Study|Other Unspecified|1|||
150056033|NCT02431260|541346223|FG012|Overall Study|Other Unspecified|1|||
150056034|NCT02431260|541346224|FG013|Overall Study|Other Unspecified|0|||
150056035|NCT00321646|541346225|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
150056036|NCT00321646|541346225|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
150056037|NCT00321646|541346225|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
150056038|NCT00781885|541346229|FG000|Overall Study|Physician Decision|1|||
150006807|NCT00558272|541157948|FG000|Overall Study|Withdrawal by Subject|0|||
150006808|NCT00558272|541157949|FG001|Overall Study|Withdrawal by Subject|1|||
150006809|NCT02920957|541157950|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
150006810|NCT02920957|541157951|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
150006811|NCT02920957|541157950|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
150006812|NCT02920957|541157951|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
150006813|NCT02920957|541157950|FG000|First Intervention : 1 Month|Adverse Event|1|||
150006814|NCT02920957|541157951|FG001|First Intervention : 1 Month|Adverse Event|0|||
150006815|NCT02920957|541157950|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
150006816|NCT02920957|541157951|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
150180004|NCT02652260|541799352|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
150006817|NCT01597635|541160128|FG000|Part A|Adverse Event|3|||
150006818|NCT01597635|541160129|FG001|Part A|Adverse Event|0|||
150006819|NCT01597635|541160130|FG002|Part A|Adverse Event|0|||
150006820|NCT01597635|541160128|FG000|Part B|Adverse Event|0|||
150006821|NCT01597635|541160129|FG001|Part B|Adverse Event|0|||
150006822|NCT01597635|541160130|FG002|Part B|Adverse Event|1|||
150006823|NCT01597635|541160128|FG000|Part B|Protocol Violation|0|||
150006824|NCT01597635|541160129|FG001|Part B|Protocol Violation|1|||
150006825|NCT01597635|541160130|FG002|Part B|Protocol Violation|0|||
150006826|NCT01597635|541160128|FG000|Part B|Protocol-defined stopping criteria|0|||
150006827|NCT01597635|541160129|FG001|Part B|Protocol-defined stopping criteria|4|||
150006828|NCT01597635|541160130|FG002|Part B|Protocol-defined stopping criteria|3|||
150006829|NCT01597635|541160128|FG000|Part B|Withdrawal by Subject|0|||
150006830|NCT01597635|541160129|FG001|Part B|Withdrawal by Subject|1|||
150006831|NCT01597635|541160130|FG002|Part B|Withdrawal by Subject|0|||
150006832|NCT00652951|541160132|FG000|Booster Phase|Adverse event, non-fatal|0|||
150006833|NCT00652951|541160133|FG001|Booster Phase|Adverse event, non-fatal|1|||
150006834|NCT00652951|541160134|FG002|Booster Phase|Adverse event, non-fatal|0|||
150006835|NCT00652951|541160132|FG000|Booster Phase|Other|1|||
150006836|NCT00652951|541160133|FG001|Booster Phase|Other|0|||
150006837|NCT00652951|541160134|FG002|Booster Phase|Other|0|||
150006838|NCT02593825|541160135|FG000|Intervention|Lost to Follow-up|10|||
150006839|NCT02593825|541160136|FG001|Intervention|Lost to Follow-up|12|||
150006840|NCT01022424|541160137|FG000|Overall Study|Adverse Event|1|||
150006841|NCT01022424|541160137|FG000|Overall Study|Physician Decision|1|||
150006842|NCT01022424|541160137|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
150006843|NCT06359080|541160138|FG000|Overall Study|Withdrawal by Subject|3|||
150006844|NCT00511134|541160139|FG000|Overall Study|Withdrawal by Subject|0|||
150006845|NCT00511134|541160140|FG001|Overall Study|Withdrawal by Subject|2|||
150006846|NCT01949090|541160141|FG000|Overall Study|Serious Adverse Event|0|||
150006847|NCT01949090|541160142|FG001|Overall Study|Serious Adverse Event|1|||
150006848|NCT01949090|541160143|FG002|Overall Study|Serious Adverse Event|2|||
150006849|NCT01949090|541160144|FG003|Overall Study|Serious Adverse Event|0|||
150006850|NCT01949090|541160145|FG004|Overall Study|Serious Adverse Event|1|||
150006851|NCT01949090|541160141|FG000|Overall Study|Withdrawal by Subject|2|||
150006852|NCT01949090|541160142|FG001|Overall Study|Withdrawal by Subject|0|||
150006853|NCT01949090|541160143|FG002|Overall Study|Withdrawal by Subject|0|||
150006854|NCT01949090|541160144|FG003|Overall Study|Withdrawal by Subject|0|||
150006855|NCT01949090|541160145|FG004|Overall Study|Withdrawal by Subject|1|||
150006856|NCT01949090|541160141|FG000|Overall Study|Protocol non-compliance|0|||
150006857|NCT01949090|541160142|FG001|Overall Study|Protocol non-compliance|0|||
150006858|NCT01949090|541160143|FG002|Overall Study|Protocol non-compliance|0|||
150006859|NCT01949090|541160144|FG003|Overall Study|Protocol non-compliance|0|||
150006860|NCT01949090|541160145|FG004|Overall Study|Protocol non-compliance|1|||
150006861|NCT01949090|541160141|FG000|Overall Study|Lost to Follow-up|2|||
150006862|NCT01949090|541160142|FG001|Overall Study|Lost to Follow-up|1|||
150006863|NCT01949090|541160143|FG002|Overall Study|Lost to Follow-up|0|||
150006864|NCT01949090|541160144|FG003|Overall Study|Lost to Follow-up|1|||
150006865|NCT01949090|541160145|FG004|Overall Study|Lost to Follow-up|1|||
150006866|NCT03242252|541160147|FG000|Overall Study|At the Participant's own Request|18|||
150006867|NCT03242252|541160148|FG001|Overall Study|At the Participant's own Request|10|||
150006868|NCT03242252|541160149|FG002|Overall Study|At the Participant's own Request|15|||
150006869|NCT03242252|541160147|FG000|Overall Study|Adverse Event|8|||
150006870|NCT03242252|541160148|FG001|Overall Study|Adverse Event|6|||
150006871|NCT03242252|541160149|FG002|Overall Study|Adverse Event|9|||
150006872|NCT03242252|541160147|FG000|Overall Study|Poor Compliance to Protocol|0|||
150006873|NCT03242252|541160148|FG001|Overall Study|Poor Compliance to Protocol|2|||
150006874|NCT03242252|541160149|FG002|Overall Study|Poor Compliance to Protocol|3|||
150006875|NCT03242252|541160147|FG000|Overall Study|Study Terminated by Sponsor|1|||
150006876|NCT03242252|541160148|FG001|Overall Study|Study Terminated by Sponsor|0|||
150006877|NCT03242252|541160149|FG002|Overall Study|Study Terminated by Sponsor|0|||
150006878|NCT03242252|541160147|FG000|Overall Study|Reason not Specified|4|||
150006879|NCT03242252|541160148|FG001|Overall Study|Reason not Specified|4|||
150006880|NCT03242252|541160149|FG002|Overall Study|Reason not Specified|1|||
150006881|NCT03242252|541160147|FG000|Overall Study|Lost to Follow-up|5|||
150006882|NCT03242252|541160148|FG001|Overall Study|Lost to Follow-up|1|||
150006883|NCT03242252|541160149|FG002|Overall Study|Lost to Follow-up|4|||
150006884|NCT01116427|541160150|FG000|Core Phase|Adverse Event|0|||
150006885|NCT01116427|541160151|FG001|Core Phase|Adverse Event|1|||
150006886|NCT01116427|541160150|FG000|Core Phase|Lost to Follow-up|1|||
150180005|NCT02652260|541799353|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
150006887|NCT01116427|541160151|FG001|Core Phase|Lost to Follow-up|0|||
150006888|NCT01116427|541160150|FG000|Core Phase|Withdrawal by Subject|3|||
150006889|NCT01116427|541160151|FG001|Core Phase|Withdrawal by Subject|0|||
150006890|NCT01116427|541160150|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
150006891|NCT01116427|541160151|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
150006892|NCT01116427|541160150|FG000|Extension Phase|Adverse Event|1|||
150006893|NCT01116427|541160151|FG001|Extension Phase|Adverse Event|1|||
150180006|NCT02652260|541799352|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
150006894|NCT01116427|541160150|FG000|Extension Phase|Lost to Follow-up|2|||
150006895|NCT01116427|541160151|FG001|Extension Phase|Lost to Follow-up|0|||
150006896|NCT01116427|541160150|FG000|Extension Phase|Withdrawal by Subject|5|||
150006897|NCT01116427|541160151|FG001|Extension Phase|Withdrawal by Subject|1|||
150006898|NCT01116427|541160150|FG000|Extension Phase|Not using appropriate birth control|1|||
150006899|NCT01116427|541160151|FG001|Extension Phase|Not using appropriate birth control|0|||
150006900|NCT01079936|541160152|FG000|Phase I: MTD|First Remission Status|2|||
150006901|NCT01079936|541160153|FG001|Phase I: MTD|First Remission Status|0|||
150006902|NCT01079936|541160154|FG002|Phase I: MTD|First Remission Status|0|||
150006903|NCT01079936|541160155|FG003|Phase I: MTD|First Remission Status|0|||
150006904|NCT01079936|541160156|FG004|Phase I: MTD|First Remission Status|0|||
150180007|NCT02652260|541799353|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
150006905|NCT01079936|541160152|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
150006906|NCT01079936|541160153|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
150006907|NCT01079936|541160154|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
150006908|NCT01079936|541160155|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
150006909|NCT01079936|541160156|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
150006910|NCT01079936|541160152|FG000|Phase II|Adverse Event|0|||
150006911|NCT01079936|541160153|FG001|Phase II|Adverse Event|0|||
150006912|NCT01079936|541160154|FG002|Phase II|Adverse Event|1|||
150006913|NCT01079936|541160155|FG003|Phase II|Adverse Event|0|||
150006914|NCT01079936|541160156|FG004|Phase II|Adverse Event|0|||
150006915|NCT01079936|541160152|FG000|Phase II|Insurance Issue|0|||
150006916|NCT01079936|541160153|FG001|Phase II|Insurance Issue|0|||
150006917|NCT01079936|541160154|FG002|Phase II|Insurance Issue|0|||
150006918|NCT01079936|541160155|FG003|Phase II|Insurance Issue|0|||
150006919|NCT01079936|541160156|FG004|Phase II|Insurance Issue|1|||
150006920|NCT03344640|541160157|FG000|Overall Study|Adverse Event|1|||
150006921|NCT03344640|541160158|FG001|Overall Study|Adverse Event|0|||
150006922|NCT03344640|541160157|FG000|Overall Study|Physician Decision|1|||
150006923|NCT03344640|541160158|FG001|Overall Study|Physician Decision|1|||
150006924|NCT03344640|541160157|FG000|Overall Study|Withdrawal by Subject|1|||
150006925|NCT03344640|541160158|FG001|Overall Study|Withdrawal by Subject|2|||
150006926|NCT03344640|541160157|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
150006927|NCT03344640|541160158|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
150006928|NCT00657371|541160159|FG000|Overall Study|Poor bowel preparation|15|||
150006929|NCT00657371|541160159|FG000|Overall Study|Unable to intubate the cecum|5|||
150006930|NCT00657371|541160159|FG000|Overall Study|Protocol Violation|2|||
150006931|NCT00657371|541160159|FG000|Overall Study|Device- related reasons|13|||
150006932|NCT00657371|541160159|FG000|Overall Study|Pre-existing medical condition|4|||
150006933|NCT00652899|541160160|FG000|Overall Study|Death|1|||
150006934|NCT00652899|541160160|FG000|Overall Study|Treating physician decision|1|||
150006935|NCT03426631|541160167|FG000|Overall Study|Lost to Follow-up|0|||
150006936|NCT03426631|541160168|FG001|Overall Study|Lost to Follow-up|1|||
150006937|NCT00654004|541160169|FG000|Overall Study|Lost to Follow-up|1|||
150006938|NCT00654004|541160170|FG001|Overall Study|Lost to Follow-up|0|||
150006939|NCT00444067|541160175|FG000|Overall Study|Lost to Follow-up|0|||
150006940|NCT00444067|541160176|FG001|Overall Study|Lost to Follow-up|1|||
150006941|NCT00710385|541160177|FG000|Overall Study|Did not qualify|1|||
150006942|NCT00710385|541160177|FG000|Overall Study|Withdrawal by Subject|1|||
150006943|NCT00710385|541160177|FG000|Overall Study|Undisclosed back pain|1|||
150006944|NCT00710385|541160177|FG000|Overall Study|Physician Decision|1|||
150006945|NCT00710385|541160177|FG000|Overall Study|Undisclosed excessive methadone use|1|||
150006946|NCT01264770|541160178|FG000|Overall Study|Not reported|0|||
150006947|NCT01264770|541160179|FG001|Overall Study|Not reported|0|||
150006948|NCT01264770|541160180|FG002|Overall Study|Not reported|1|||
150006949|NCT01264770|541160181|FG003|Overall Study|Not reported|0|||
150006950|NCT01264770|541160182|FG004|Overall Study|Not reported|0|||
150006951|NCT01264770|541160183|FG005|Overall Study|Not reported|0|||
150006952|NCT01264770|541160178|FG000|Overall Study|e.g., change in circumstances|8|||
150006953|NCT01264770|541160179|FG001|Overall Study|e.g., change in circumstances|3|||
150006954|NCT01264770|541160180|FG002|Overall Study|e.g., change in circumstances|3|||
150006955|NCT01264770|541160181|FG003|Overall Study|e.g., change in circumstances|3|||
150006956|NCT01264770|541160182|FG004|Overall Study|e.g., change in circumstances|4|||
150006957|NCT01264770|541160183|FG005|Overall Study|e.g., change in circumstances|4|||
150006958|NCT01264770|541160178|FG000|Overall Study|Severe non-compliance to protocol|0|||
150006959|NCT01264770|541160179|FG001|Overall Study|Severe non-compliance to protocol|0|||
150006960|NCT01264770|541160180|FG002|Overall Study|Severe non-compliance to protocol|1|||
150006961|NCT01264770|541160181|FG003|Overall Study|Severe non-compliance to protocol|1|||
150006962|NCT01264770|541160182|FG004|Overall Study|Severe non-compliance to protocol|0|||
150006963|NCT01264770|541160183|FG005|Overall Study|Severe non-compliance to protocol|0|||
150006964|NCT01264770|541160178|FG000|Overall Study|Lack of therapeutic response|1|||
150006965|NCT01264770|541160179|FG001|Overall Study|Lack of therapeutic response|0|||
150006966|NCT01264770|541160180|FG002|Overall Study|Lack of therapeutic response|2|||
150006967|NCT01264770|541160181|FG003|Overall Study|Lack of therapeutic response|1|||
150006968|NCT01264770|541160182|FG004|Overall Study|Lack of therapeutic response|1|||
150006969|NCT01264770|541160183|FG005|Overall Study|Lack of therapeutic response|0|||
150006970|NCT01264770|541160178|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
150006971|NCT01264770|541160179|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
150006972|NCT01264770|541160180|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
150006973|NCT01264770|541160181|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
150006974|NCT01264770|541160182|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
150006975|NCT01264770|541160183|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
150006976|NCT01264770|541160178|FG000|Overall Study|Lost to Follow-up|0|||
150006977|NCT01264770|541160179|FG001|Overall Study|Lost to Follow-up|0|||
150006978|NCT01264770|541160180|FG002|Overall Study|Lost to Follow-up|1|||
150006979|NCT01264770|541160181|FG003|Overall Study|Lost to Follow-up|1|||
150006980|NCT01264770|541160182|FG004|Overall Study|Lost to Follow-up|0|||
150006981|NCT01264770|541160183|FG005|Overall Study|Lost to Follow-up|0|||
150006982|NCT01264770|541160178|FG000|Overall Study|Adverse Event|7|||
150006983|NCT01264770|541160179|FG001|Overall Study|Adverse Event|7|||
150006984|NCT01264770|541160180|FG002|Overall Study|Adverse Event|8|||
150006985|NCT01264770|541160181|FG003|Overall Study|Adverse Event|0|||
150006986|NCT01264770|541160182|FG004|Overall Study|Adverse Event|2|||
150006987|NCT01264770|541160183|FG005|Overall Study|Adverse Event|1|||
150006988|NCT00521222|541160187|FG000|Overall Study|Lost to Follow-up|0|||
150006989|NCT00521222|541160188|FG001|Overall Study|Lost to Follow-up|0|||
150006990|NCT00521222|541160189|FG002|Overall Study|Lost to Follow-up|1|||
150006991|NCT00521222|541160190|FG003|Overall Study|Lost to Follow-up|1|||
150006992|NCT00521222|541160187|FG000|Overall Study|Withdrawal by Subject|0|||
150006993|NCT00521222|541160188|FG001|Overall Study|Withdrawal by Subject|0|||
150006994|NCT00521222|541160189|FG002|Overall Study|Withdrawal by Subject|2|||
150006995|NCT00521222|541160190|FG003|Overall Study|Withdrawal by Subject|0|||
150006996|NCT00521222|541160187|FG000|Overall Study|Physician Decision|0|||
150006997|NCT00521222|541160188|FG001|Overall Study|Physician Decision|1|||
150006998|NCT00521222|541160189|FG002|Overall Study|Physician Decision|0|||
150006999|NCT00521222|541160190|FG003|Overall Study|Physician Decision|1|||
150007000|NCT02241187|541160192|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
150007001|NCT00199888|541160193|FG000|Overall Study|Lost to Follow-up|1|||
150007002|NCT00162266|541160202|FG000|Double-Blind Period|Adverse Event|5|||
150007003|NCT00162266|541160203|FG001|Double-Blind Period|Adverse Event|9|||
150007004|NCT00162266|541160204|FG002|Double-Blind Period|Adverse Event|11|||
150007005|NCT00162266|541160205|FG003|Double-Blind Period|Adverse Event|0|||
150007006|NCT00162266|541160202|FG000|Double-Blind Period|Death|0|||
150007007|NCT00162266|541160203|FG001|Double-Blind Period|Death|1|||
150007008|NCT00162266|541160204|FG002|Double-Blind Period|Death|0|||
150007009|NCT00162266|541160205|FG003|Double-Blind Period|Death|0|||
150007010|NCT00162266|541160202|FG000|Double-Blind Period|Lost to Follow-up|1|||
150007011|NCT00162266|541160203|FG001|Double-Blind Period|Lost to Follow-up|2|||
150007012|NCT00162266|541160204|FG002|Double-Blind Period|Lost to Follow-up|0|||
150007013|NCT00162266|541160205|FG003|Double-Blind Period|Lost to Follow-up|0|||
150007014|NCT00162266|541160202|FG000|Double-Blind Period|Other Reason|1|||
150007015|NCT00162266|541160203|FG001|Double-Blind Period|Other Reason|0|||
150007016|NCT00162266|541160204|FG002|Double-Blind Period|Other Reason|1|||
150007017|NCT00162266|541160205|FG003|Double-Blind Period|Other Reason|0|||
150007018|NCT00162266|541160202|FG000|Double-Blind Period|Lack of Efficacy|13|||
150007019|NCT00162266|541160203|FG001|Double-Blind Period|Lack of Efficacy|17|||
150007020|NCT00162266|541160204|FG002|Double-Blind Period|Lack of Efficacy|30|||
150007021|NCT00162266|541160205|FG003|Double-Blind Period|Lack of Efficacy|0|||
150007022|NCT00162266|541160202|FG000|Double-Blind Period|Withdrawal by Subject|5|||
150007023|NCT00162266|541160203|FG001|Double-Blind Period|Withdrawal by Subject|2|||
150007024|NCT00162266|541160204|FG002|Double-Blind Period|Withdrawal by Subject|6|||
150007025|NCT00162266|541160205|FG003|Double-Blind Period|Withdrawal by Subject|0|||
150007026|NCT00162266|541160202|FG000|Open-Label Period|Death|0|||
150007027|NCT00162266|541160203|FG001|Open-Label Period|Death|0|||
150007028|NCT00162266|541160204|FG002|Open-Label Period|Death|0|||
150007029|NCT00162266|541160205|FG003|Open-Label Period|Death|7|||
150007030|NCT00162266|541160202|FG000|Open-Label Period|Adverse Event|0|||
150007031|NCT00162266|541160203|FG001|Open-Label Period|Adverse Event|0|||
150007032|NCT00162266|541160204|FG002|Open-Label Period|Adverse Event|0|||
150007033|NCT00162266|541160205|FG003|Open-Label Period|Adverse Event|46|||
150007034|NCT00162266|541160202|FG000|Open-Label Period|Lack of Efficacy|0|||
150007035|NCT00162266|541160203|FG001|Open-Label Period|Lack of Efficacy|0|||
150007036|NCT00162266|541160204|FG002|Open-Label Period|Lack of Efficacy|0|||
150007037|NCT00162266|541160205|FG003|Open-Label Period|Lack of Efficacy|26|||
150007038|NCT00162266|541160202|FG000|Open-Label Period|Lost to Follow-up|0|||
150007039|NCT00162266|541160203|FG001|Open-Label Period|Lost to Follow-up|0|||
150007040|NCT00162266|541160204|FG002|Open-Label Period|Lost to Follow-up|0|||
150007041|NCT00162266|541160205|FG003|Open-Label Period|Lost to Follow-up|3|||
150007042|NCT00162266|541160202|FG000|Open-Label Period|Withdrawal by Subject|0|||
150007043|NCT00162266|541160203|FG001|Open-Label Period|Withdrawal by Subject|0|||
150007044|NCT00162266|541160204|FG002|Open-Label Period|Withdrawal by Subject|0|||
150007045|NCT00162266|541160205|FG003|Open-Label Period|Withdrawal by Subject|31|||
150007046|NCT00162266|541160202|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
150007047|NCT00162266|541160203|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
150007048|NCT00162266|541160204|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
150007049|NCT00162266|541160205|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
150007050|NCT00162266|541160202|FG000|Open-Label Period|Other Reasons|0|||
150007051|NCT00162266|541160203|FG001|Open-Label Period|Other Reasons|0|||
150007052|NCT00162266|541160204|FG002|Open-Label Period|Other Reasons|0|||
150007053|NCT00162266|541160205|FG003|Open-Label Period|Other Reasons|15|||
150007054|NCT01839656|541160206|FG000|Overall Study|Withdrawal by Subject|1|||
150007055|NCT01839656|541160207|FG001|Overall Study|Withdrawal by Subject|1|||
150007056|NCT01839656|541160206|FG000|Overall Study|Adverse event, serious fatal|1|||
150007057|NCT01839656|541160207|FG001|Overall Study|Adverse event, serious fatal|4|||
150007058|NCT01839656|541160206|FG000|Overall Study|Early study closure|0|||
150007059|NCT01839656|541160207|FG001|Overall Study|Early study closure|11|||
150007060|NCT01839656|541160206|FG000|Overall Study|Adverse Event|1|||
150007061|NCT01839656|541160207|FG001|Overall Study|Adverse Event|0|||
150007062|NCT01595581|541160208|FG000|Overall Study|Withdrawal by Subject|1|||
150007063|NCT01595581|541160209|FG001|Overall Study|Withdrawal by Subject|0|||
150007064|NCT02621073|541160210|FG000|Overall Study|Lost to Follow-up|0|||
150007065|NCT02621073|541160211|FG001|Overall Study|Lost to Follow-up|1|||
150007066|NCT02621073|541160210|FG000|Overall Study|Physician Decision|3|||
150007067|NCT02621073|541160211|FG001|Overall Study|Physician Decision|2|||
150007068|NCT00495755|541160212|FG000|Overall Study|Adverse Event|3|||
150007069|NCT02265796|541160213|FG000|Overall Study|Death|1|||
150007070|NCT02265796|541160214|FG001|Overall Study|Death|0|||
150007071|NCT02265796|541160213|FG000|Overall Study|started on excluded medication|1|||
150007072|NCT02265796|541160214|FG001|Overall Study|started on excluded medication|0|||
150007073|NCT02265796|541160213|FG000|Overall Study|Withdrawal by Subject|1|||
150007074|NCT02265796|541160214|FG001|Overall Study|Withdrawal by Subject|1|||
150007075|NCT01291277|541160221|FG000|Overall Study|Death|2|||
150007076|NCT01291277|541160222|FG001|Overall Study|Death|2|||
150007077|NCT01291277|541160221|FG000|Overall Study|Lost to Follow-up|3|||
150007078|NCT01291277|541160222|FG001|Overall Study|Lost to Follow-up|1|||
150007079|NCT00849108|541160223|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
150007080|NCT00849108|541160224|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
150007081|NCT00849108|541160223|FG000|Cohort 2 Efficacy|Adverse Event|0|||
150007082|NCT00849108|541160224|FG001|Cohort 2 Efficacy|Adverse Event|1|||
150007083|NCT00849108|541160223|FG000|Cohort 2 Efficacy|Other|0|||
150007084|NCT00849108|541160224|FG001|Cohort 2 Efficacy|Other|9|||
150007085|NCT02963701|541160225|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
150007086|NCT02963701|541160226|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
150007087|NCT00637572|541160229|FG000|Overall Study|Adverse Event|1|||
150007088|NCT00637572|541160230|FG001|Overall Study|Adverse Event|2|||
150007089|NCT00637572|541160229|FG000|Overall Study|Death|0|||
150007090|NCT00637572|541160230|FG001|Overall Study|Death|1|||
150007091|NCT00637572|541160229|FG000|Overall Study|Lost to Follow-up|0|||
150007092|NCT00637572|541160230|FG001|Overall Study|Lost to Follow-up|1|||
150007093|NCT00637572|541160229|FG000|Overall Study|Physician Decision|1|||
150007094|NCT00637572|541160230|FG001|Overall Study|Physician Decision|1|||
150007095|NCT00637572|541160229|FG000|Overall Study|Withdrawal by Subject|0|||
150007096|NCT00637572|541160230|FG001|Overall Study|Withdrawal by Subject|2|||
150056039|NCT02576145|541346230|FG000|Overall Study|Adverse Event|1|||
150056040|NCT02576145|541346231|FG001|Overall Study|Adverse Event|0|||
150056041|NCT02576145|541346230|FG000|Overall Study|Withdrawal by Subject|1|||
150056042|NCT02576145|541346231|FG001|Overall Study|Withdrawal by Subject|0|||
150056043|NCT02576145|541346230|FG000|Overall Study|Acute rejection|1|||
150056044|NCT02576145|541346231|FG001|Overall Study|Acute rejection|0|||
150056045|NCT02576145|541346230|FG000|Overall Study|Tetanus Titers Decreased|0|||
150056046|NCT02576145|541346231|FG001|Overall Study|Tetanus Titers Decreased|1|||
150056047|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
150056048|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
150056049|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
150056050|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
150056051|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
150056052|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
150056053|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
150056054|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
150056055|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
150056056|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
150056057|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
150056058|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
150056059|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
150056060|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
150056061|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
150056062|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
150056063|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
150056064|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
150056065|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
150056066|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
150056067|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
150056068|NCT01227824|541346232|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
150056069|NCT01227824|541346233|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
150056070|NCT01227824|541346234|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
150056071|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
150056072|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
150056073|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
150056074|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
150056075|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
150056076|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
150056077|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
150056078|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
150056079|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
150056080|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
150056081|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
150056082|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
150056083|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
150056084|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
150056085|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
150056086|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
150056087|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
150056088|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
150056089|NCT01227824|541346232|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
150056090|NCT01227824|541346233|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
150056091|NCT01227824|541346234|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
150056092|NCT01755026|541346235|FG000|Overall Study|Adverse Event|1|||
150056093|NCT01755026|541346236|FG001|Overall Study|Adverse Event|0|||
150056094|NCT01755026|541346235|FG000|Overall Study|Withdrawal by Subject|1|||
150056095|NCT01755026|541346236|FG001|Overall Study|Withdrawal by Subject|1|||
150056096|NCT00392379|541346239|FG000|Overall Study|Withdrawal by Subject|17|||
150056097|NCT00392379|541346240|FG001|Overall Study|Withdrawal by Subject|28|||
150056098|NCT00392379|541346239|FG000|Overall Study|Lost to Follow-up|4|||
150056099|NCT00392379|541346240|FG001|Overall Study|Lost to Follow-up|9|||
150056100|NCT00392379|541346239|FG000|Overall Study|Adverse Event|1|||
150056101|NCT00392379|541346240|FG001|Overall Study|Adverse Event|1|||
150056102|NCT01700387|541346241|FG000|Overall Study|Withdrawal by Subject|1|||
150056103|NCT01700387|541346242|FG001|Overall Study|Withdrawal by Subject|2|||
150056104|NCT01700387|541346241|FG000|Overall Study|Adverse Event|1|||
150056105|NCT01700387|541346242|FG001|Overall Study|Adverse Event|1|||
150056106|NCT01700387|541346241|FG000|Overall Study|Lost to Follow-up|2|||
150056107|NCT01700387|541346242|FG001|Overall Study|Lost to Follow-up|1|||
150056108|NCT02730793|541346250|FG000|Overall Study|Physician Decision|0|||
150255161|NCT02383056|542070572|FG001|Overall Study|Adverse Event|0|||
150255162|NCT02383056|542070571|FG000|Overall Study|Lost to Follow-up|0|||
150255163|NCT02383056|542070572|FG001|Overall Study|Lost to Follow-up|2|||
150255164|NCT01658150|542070573|FG000|Overall Study|Withdrawal by Subject|1|||
150255165|NCT04187989|542070574|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
150255166|NCT04187989|542070575|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
150255167|NCT04187989|542070574|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
150255168|NCT04187989|542070575|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
150255169|NCT03602066|542070576|FG000|Overall Study|Withdrawal by Subject|2|||
150255170|NCT03602066|542070577|FG001|Overall Study|Withdrawal by Subject|0|||
150255171|NCT03602066|542070576|FG000|Overall Study|Physician Decision|1|||
150255172|NCT03602066|542070577|FG001|Overall Study|Physician Decision|0|||
150255173|NCT01239043|542070578|FG000|Overall Study|Protocol Violation|2|||
150255174|NCT01239043|542070579|FG001|Overall Study|Protocol Violation|1|||
150255175|NCT02929329|542070580|FG000|Overall Study|Withdrawal by Subject|24|||
150255176|NCT02929329|542070581|FG001|Overall Study|Withdrawal by Subject|21|||
150007097|NCT00637572|541160229|FG000|Overall Study|Illicit Drug Use|1|||
150007098|NCT00637572|541160230|FG001|Overall Study|Illicit Drug Use|0|||
150007099|NCT01345682|541160231|FG000|Overall Study|Progressive disease per RECIST|226|||
150056109|NCT02730793|541346251|FG001|Overall Study|Physician Decision|1|||
150056110|NCT02730793|541346250|FG000|Overall Study|Withdrawal by Subject|0|||
150056111|NCT02730793|541346251|FG001|Overall Study|Withdrawal by Subject|1|||
150056112|NCT02365233|541346252|FG000|Overall Study|IRB withheld the data|1|||
150056113|NCT02365233|541346253|FG001|Overall Study|IRB withheld the data|2|||
150056114|NCT02365233|541346254|FG002|Overall Study|IRB withheld the data|2|||
150056115|NCT00995566|541346255|FG000|Overall Study|Adverse Event|2|||
150056116|NCT00995566|541346255|FG000|Overall Study|Early study termination|52|||
150056117|NCT01375075|541346260|FG000|Overall Study|Adverse Event|0|||
150056118|NCT01375075|541346261|FG001|Overall Study|Adverse Event|0|||
150056119|NCT01375075|541346262|FG002|Overall Study|Adverse Event|3|||
150056120|NCT01375075|541346263|FG003|Overall Study|Adverse Event|1|||
150056121|NCT01375075|541346264|FG004|Overall Study|Adverse Event|0|||
150056122|NCT01375075|541346265|FG005|Overall Study|Adverse Event|1|||
150056123|NCT01375075|541346260|FG000|Overall Study|Entry Criterion Not Met|1|||
150056124|NCT01375075|541346261|FG001|Overall Study|Entry Criterion Not Met|0|||
150007100|NCT01345682|541160232|FG001|Overall Study|Progressive disease per RECIST|93|||
150007101|NCT01345682|541160231|FG000|Overall Study|Worsening of underlying cancer disease|23|||
150007102|NCT01345682|541160232|FG001|Overall Study|Worsening of underlying cancer disease|12|||
150007103|NCT01345682|541160231|FG000|Overall Study|Adverse Event|51|||
150180008|NCT02652260|541799352|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
150180009|NCT02652260|541799353|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
150180010|NCT02652260|541799352|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
150007104|NCT01345682|541160232|FG001|Overall Study|Adverse Event|41|||
150007105|NCT01345682|541160231|FG000|Overall Study|Non-compliance with protocol|0|||
150007106|NCT01345682|541160232|FG001|Overall Study|Non-compliance with protocol|1|||
150007107|NCT01345682|541160231|FG000|Overall Study|Lost to Follow-up|0|||
150007108|NCT01345682|541160232|FG001|Overall Study|Lost to Follow-up|1|||
150007109|NCT01345682|541160231|FG000|Overall Study|Refused to continue trial medication|16|||
150007110|NCT01345682|541160232|FG001|Overall Study|Refused to continue trial medication|9|||
150007111|NCT01345682|541160231|FG000|Overall Study|Not treated|2|||
150007112|NCT01345682|541160232|FG001|Overall Study|Not treated|1|||
150007113|NCT01345682|541160231|FG000|Overall Study|Reason other than those specified above|4|||
150007114|NCT01345682|541160232|FG001|Overall Study|Reason other than those specified above|3|||
150007115|NCT00896649|541160233|FG000|Overall Study|Physician Decision|1|||
150007116|NCT00896649|541160233|FG000|Overall Study|Pregnancy|1|||
150007117|NCT00896649|541160233|FG000|Overall Study|missing documentation|1|||
150007118|NCT00896649|541160233|FG000|Overall Study|technical difficulties|2|||
150007119|NCT03180307|541160236|FG000|Overall Study|Lost to Follow-up|2|||
150007120|NCT03180307|541160237|FG001|Overall Study|Lost to Follow-up|0|||
150007121|NCT03180307|541160236|FG000|Overall Study|Death|1|||
150007122|NCT03180307|541160237|FG001|Overall Study|Death|0|||
150007123|NCT03180307|541160236|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
150007124|NCT03180307|541160237|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
150007125|NCT01563172|541160243|FG000|Overall Study|Adverse Event|5|||
150007126|NCT01563172|541160243|FG000|Overall Study|Lost to Follow-up|2|||
150007127|NCT01563172|541160243|FG000|Overall Study|Other (Protocol deviation)|5|||
150007128|NCT01563172|541160243|FG000|Overall Study|Other (Not specified)|1|||
150007129|NCT01075984|541160244|FG000|Treatment Phase|Adverse Event|0|||
150007130|NCT01075984|541160245|FG001|Treatment Phase|Adverse Event|1|||
150007131|NCT01075984|541160246|FG002|Treatment Phase|Adverse Event|3|||
150007132|NCT01075984|541160247|FG003|Treatment Phase|Adverse Event|7|||
150007133|NCT01075984|541160248|FG004|Treatment Phase|Adverse Event|35|||
150007134|NCT01075984|541160244|FG000|Treatment Phase|Protocol Violation|0|||
150007135|NCT01075984|541160245|FG001|Treatment Phase|Protocol Violation|0|||
150007136|NCT01075984|541160246|FG002|Treatment Phase|Protocol Violation|1|||
150007137|NCT01075984|541160247|FG003|Treatment Phase|Protocol Violation|0|||
150007138|NCT01075984|541160248|FG004|Treatment Phase|Protocol Violation|3|||
150007139|NCT01075984|541160244|FG000|Treatment Phase|Withdrawal by Subject|0|||
150007140|NCT01075984|541160245|FG001|Treatment Phase|Withdrawal by Subject|0|||
150007141|NCT01075984|541160246|FG002|Treatment Phase|Withdrawal by Subject|2|||
150007142|NCT01075984|541160247|FG003|Treatment Phase|Withdrawal by Subject|0|||
150007143|NCT01075984|541160248|FG004|Treatment Phase|Withdrawal by Subject|15|||
150007144|NCT01075984|541160244|FG000|Treatment Phase|Treatment Failure|0|||
150007145|NCT01075984|541160245|FG001|Treatment Phase|Treatment Failure|0|||
150180011|NCT02652260|541799353|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
150180012|NCT02652260|541799352|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
150007146|NCT01075984|541160246|FG002|Treatment Phase|Treatment Failure|1|||
150007147|NCT01075984|541160247|FG003|Treatment Phase|Treatment Failure|0|||
150007148|NCT01075984|541160248|FG004|Treatment Phase|Treatment Failure|5|||
150007149|NCT01075984|541160244|FG000|Treatment Phase|Progression of disease|0|||
150007150|NCT01075984|541160245|FG001|Treatment Phase|Progression of disease|0|||
150180013|NCT02652260|541799353|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
150180014|NCT02652260|541799352|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
150180015|NCT02652260|541799353|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
150180016|NCT02652260|541799352|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
150180017|NCT02652260|541799353|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
150180018|NCT02652260|541799352|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
150180019|NCT02652260|541799353|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
150180020|NCT02652260|541799352|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
150180021|NCT02652260|541799353|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
150180022|NCT02652260|541799352|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
150007151|NCT01075984|541160246|FG002|Treatment Phase|Progression of disease|0|||
150007152|NCT01075984|541160247|FG003|Treatment Phase|Progression of disease|0|||
150007153|NCT01075984|541160248|FG004|Treatment Phase|Progression of disease|2|||
150007154|NCT01075984|541160244|FG000|Follow-up Phase|Protocol Violation|0|||
150007155|NCT01075984|541160245|FG001|Follow-up Phase|Protocol Violation|0|||
150007156|NCT01075984|541160246|FG002|Follow-up Phase|Protocol Violation|1|||
150007157|NCT01075984|541160247|FG003|Follow-up Phase|Protocol Violation|0|||
150007158|NCT01075984|541160248|FG004|Follow-up Phase|Protocol Violation|3|||
150007159|NCT01075984|541160244|FG000|Follow-up Phase|Adverse Event|0|||
150007160|NCT01075984|541160245|FG001|Follow-up Phase|Adverse Event|0|||
150007161|NCT01075984|541160246|FG002|Follow-up Phase|Adverse Event|0|||
150007162|NCT01075984|541160247|FG003|Follow-up Phase|Adverse Event|2|||
150007163|NCT01075984|541160248|FG004|Follow-up Phase|Adverse Event|27|||
150180023|NCT02652260|541799353|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
150180024|NCT02723955|541799354|FG000|Escalation Phase|Death|1|||
150180025|NCT02723955|541799355|FG001|Escalation Phase|Death|1|||
150180026|NCT02723955|541799356|FG002|Escalation Phase|Death|2|||
150180027|NCT02723955|541799357|FG003|Escalation Phase|Death|7|||
150180028|NCT02723955|541799358|FG004|Escalation Phase|Death|18|||
150007164|NCT01075984|541160244|FG000|Follow-up Phase|Administrative|0|||
150007165|NCT01075984|541160245|FG001|Follow-up Phase|Administrative|0|||
150007166|NCT01075984|541160246|FG002|Follow-up Phase|Administrative|0|||
150007167|NCT01075984|541160247|FG003|Follow-up Phase|Administrative|0|||
150007168|NCT01075984|541160248|FG004|Follow-up Phase|Administrative|1|||
150007169|NCT01075984|541160244|FG000|Follow-up Phase|Withdrawal by Subject|0|||
150007170|NCT01075984|541160245|FG001|Follow-up Phase|Withdrawal by Subject|0|||
150007171|NCT01075984|541160246|FG002|Follow-up Phase|Withdrawal by Subject|0|||
150007172|NCT01075984|541160247|FG003|Follow-up Phase|Withdrawal by Subject|0|||
150007173|NCT01075984|541160248|FG004|Follow-up Phase|Withdrawal by Subject|10|||
150007174|NCT01075984|541160244|FG000|Follow-up Phase|Progression of disease|0|||
150007175|NCT01075984|541160245|FG001|Follow-up Phase|Progression of disease|0|||
150007176|NCT01075984|541160246|FG002|Follow-up Phase|Progression of disease|0|||
150007177|NCT01075984|541160247|FG003|Follow-up Phase|Progression of disease|0|||
150007178|NCT01075984|541160248|FG004|Follow-up Phase|Progression of disease|2|||
150007179|NCT01075984|541160244|FG000|Follow-up Phase|Treatment failure|0|||
150007180|NCT01075984|541160245|FG001|Follow-up Phase|Treatment failure|0|||
150007181|NCT01075984|541160246|FG002|Follow-up Phase|Treatment failure|0|||
150007182|NCT01075984|541160247|FG003|Follow-up Phase|Treatment failure|0|||
150007183|NCT01075984|541160248|FG004|Follow-up Phase|Treatment failure|4|||
150007184|NCT03652675|541160250|FG000|Overall Study|Lost to Follow-up|4|||
150007185|NCT03652675|541160251|FG001|Overall Study|Lost to Follow-up|4|||
150007186|NCT01638559|541160252|FG000|Overall Study|Lost to Follow-up|1|||
150007187|NCT01638559|541160252|FG000|Overall Study|Withdrawal by Subject|1|||
150007188|NCT01638559|541160252|FG000|Overall Study|Subject declined to travel for biopsy|1|||
150007189|NCT00483002|541160258|FG000|Overall Study|Adverse Event|68|||
150007190|NCT00483002|541160258|FG000|Overall Study|Lack of Efficacy|555|||
150007191|NCT00483002|541160258|FG000|Overall Study|Lost to Follow-up|962|||
150007192|NCT00483002|541160258|FG000|Overall Study|Other|2|||
150007193|NCT00483002|541160258|FG000|Overall Study|Other|967|||
150007194|NCT02014584|541160259|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150007195|NCT02014584|541160260|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
150007196|NCT02014584|541160261|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150007197|NCT02014584|541160262|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150007198|NCT02014584|541160263|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150007199|NCT02014584|541160264|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150007200|NCT02014584|541160259|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
150007201|NCT02014584|541160260|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
150007202|NCT02014584|541160261|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150007203|NCT02014584|541160262|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150180029|NCT02723955|541799359|FG005|Escalation Phase|Death|17|||
150180030|NCT02723955|541799360|FG006|Escalation Phase|Death|11|||
150180031|NCT02723955|541799361|FG007|Escalation Phase|Death|21|||
150180032|NCT02723955|541799362|FG008|Escalation Phase|Death|3|||
150180033|NCT02723955|541799363|FG009|Escalation Phase|Death|0|||
150180034|NCT02723955|541799364|FG010|Escalation Phase|Death|0|||
150180035|NCT02723955|541799365|FG011|Escalation Phase|Death|0|||
150180036|NCT02723955|541799366|FG012|Escalation Phase|Death|2|||
150007204|NCT02014584|541160263|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150007205|NCT02014584|541160264|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150007206|NCT02014584|541160259|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
150007207|NCT02014584|541160260|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
150007208|NCT02014584|541160261|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
150007209|NCT02014584|541160262|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
150007210|NCT02014584|541160263|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
150007211|NCT02014584|541160264|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
150007212|NCT02014584|541160259|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
150007213|NCT02014584|541160260|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
150007214|NCT02014584|541160261|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
150007215|NCT02014584|541160262|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
150007216|NCT02014584|541160263|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
150007217|NCT02014584|541160264|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
150007218|NCT02014584|541160259|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
150007219|NCT02014584|541160260|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
150007220|NCT02014584|541160261|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
150007221|NCT02014584|541160262|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
150007222|NCT02014584|541160263|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
150007223|NCT02014584|541160264|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
150007224|NCT03442296|541160268|FG000|3 Month Follow-up|Death|3|||
150007225|NCT03442296|541160269|FG001|3 Month Follow-up|Death|1|||
150007226|NCT03442296|541160268|FG000|3 Month Follow-up|Lost to Follow-up|1|||
150007227|NCT03442296|541160269|FG001|3 Month Follow-up|Lost to Follow-up|1|||
150007228|NCT03442296|541160268|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
150007229|NCT03442296|541160269|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
150007230|NCT03442296|541160268|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
150056125|NCT01375075|541346262|FG002|Overall Study|Entry Criterion Not Met|0|||
150056126|NCT01375075|541346263|FG003|Overall Study|Entry Criterion Not Met|0|||
150056127|NCT01375075|541346264|FG004|Overall Study|Entry Criterion Not Met|0|||
150056128|NCT01375075|541346265|FG005|Overall Study|Entry Criterion Not Met|1|||
150056129|NCT01375075|541346260|FG000|Overall Study|Withdrawal by Subject|0|||
150056130|NCT01375075|541346261|FG001|Overall Study|Withdrawal by Subject|1|||
150007231|NCT03442296|541160269|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
150007232|NCT03442296|541160268|FG000|12 Month Follow-up|Incomplete measurement|1|||
150007233|NCT03442296|541160269|FG001|12 Month Follow-up|Incomplete measurement|1|||
150007234|NCT01555125|541160270|FG000|Induction Period|Lost to Follow-up|0|||
150007235|NCT01555125|541160271|FG001|Induction Period|Lost to Follow-up|2|||
150007236|NCT01555125|541160272|FG002|Induction Period|Lost to Follow-up|0|||
150056131|NCT01375075|541346262|FG002|Overall Study|Withdrawal by Subject|0|||
150056132|NCT01375075|541346263|FG003|Overall Study|Withdrawal by Subject|0|||
150056133|NCT01375075|541346264|FG004|Overall Study|Withdrawal by Subject|0|||
150056134|NCT01375075|541346265|FG005|Overall Study|Withdrawal by Subject|1|||
150056135|NCT00384111|541346266|FG000|Overall Study|Disease Progression|3|||
150056136|NCT00384111|541346266|FG000|Overall Study|Adverse Event|1|||
150056137|NCT00384111|541346266|FG000|Overall Study|Investigator Decision|3|||
150056138|NCT00384111|541346266|FG000|Overall Study|Study Terminated by the Sponsor|19|||
150056139|NCT00545129|541346267|FG000|Overall Study|Lack of Efficacy|2|||
150056140|NCT00545129|541346268|FG001|Overall Study|Lack of Efficacy|5|||
150056141|NCT00545129|541346267|FG000|Overall Study|Death|2|||
150056142|NCT00545129|541346268|FG001|Overall Study|Death|1|||
150056143|NCT00545129|541346267|FG000|Overall Study|Adverse Event|1|||
150056144|NCT00545129|541346268|FG001|Overall Study|Adverse Event|1|||
150056145|NCT00545129|541346267|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
150056146|NCT00545129|541346268|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
150056147|NCT00545129|541346267|FG000|Overall Study|Other|3|||
150056148|NCT00545129|541346268|FG001|Overall Study|Other|3|||
150056149|NCT00821509|541346269|FG000|Overall Study|Withdrawal by Subject|12|||
150056150|NCT00821509|541346270|FG001|Overall Study|Withdrawal by Subject|11|||
150056151|NCT00821509|541346271|FG002|Overall Study|Withdrawal by Subject|34|||
150056152|NCT03678870|541346272|FG000|Overall Study|prescribed non- protocol medications|10|||
150056153|NCT03678870|541346273|FG001|Overall Study|prescribed non- protocol medications|6|||
150056154|NCT03678870|541346272|FG000|Overall Study|Lost to Follow-up|3|||
150056155|NCT03678870|541346273|FG001|Overall Study|Lost to Follow-up|2|||
150056156|NCT03104816|541346275|FG000|Overall Study|Lack of Efficacy|0|||
150056157|NCT03104816|541346276|FG001|Overall Study|Lack of Efficacy|2|||
150056158|NCT03104816|541346277|FG002|Overall Study|Lack of Efficacy|0|||
150056159|NCT03104816|541346275|FG000|Overall Study|Protocol Violation|2|||
150056160|NCT03104816|541346276|FG001|Overall Study|Protocol Violation|0|||
150056161|NCT03104816|541346277|FG002|Overall Study|Protocol Violation|2|||
150056162|NCT01894568|541346278|FG000|Overall Study|Adverse Event|2|||
150056163|NCT01894568|541346279|FG001|Overall Study|Adverse Event|3|||
150056164|NCT01894568|541346278|FG000|Overall Study|Protocol required discontinuation|2|||
150056165|NCT01894568|541346279|FG001|Overall Study|Protocol required discontinuation|1|||
150056166|NCT01894568|541346278|FG000|Overall Study|Withdrawal by Subject|5|||
150056167|NCT01894568|541346279|FG001|Overall Study|Withdrawal by Subject|5|||
150056168|NCT01894568|541346278|FG000|Overall Study|Physician Decision|1|||
150056169|NCT01894568|541346279|FG001|Overall Study|Physician Decision|0|||
150056170|NCT01894568|541346278|FG000|Overall Study|Lost to Follow-up|0|||
150056171|NCT01894568|541346279|FG001|Overall Study|Lost to Follow-up|1|||
150056172|NCT00807573|541346280|FG000|Overall Study|Withdrawal by Subject|1|||
150056173|NCT00807573|541346280|FG000|Overall Study|Adverse Event|1|||
150056174|NCT01426789|541346281|FG000|Part 1|Protocol deviation|0|||
150056175|NCT01426789|541346282|FG001|Part 1|Protocol deviation|1|||
150056176|NCT01426789|541346283|FG002|Part 1|Protocol deviation|0|||
150056177|NCT01426789|541346284|FG003|Part 1|Protocol deviation|0|||
150056178|NCT01426789|541346285|FG004|Part 1|Protocol deviation|0|||
150056179|NCT01426789|541346286|FG005|Part 1|Protocol deviation|0|||
150056180|NCT01426789|541346281|FG000|Part 1|Lost to Follow-up|1|||
150056181|NCT01426789|541346282|FG001|Part 1|Lost to Follow-up|2|||
150056182|NCT01426789|541346283|FG002|Part 1|Lost to Follow-up|0|||
150056183|NCT01426789|541346284|FG003|Part 1|Lost to Follow-up|0|||
150056184|NCT01426789|541346285|FG004|Part 1|Lost to Follow-up|0|||
150056185|NCT01426789|541346286|FG005|Part 1|Lost to Follow-up|0|||
150056186|NCT01426789|541346281|FG000|Part 1|Lack of Efficacy|2|||
150056187|NCT01426789|541346282|FG001|Part 1|Lack of Efficacy|1|||
150056188|NCT01426789|541346283|FG002|Part 1|Lack of Efficacy|0|||
150056189|NCT01426789|541346284|FG003|Part 1|Lack of Efficacy|0|||
150056190|NCT01426789|541346285|FG004|Part 1|Lack of Efficacy|0|||
150056191|NCT01426789|541346286|FG005|Part 1|Lack of Efficacy|0|||
150056192|NCT01426789|541346281|FG000|Part 1|Adverse Event|3|||
150056193|NCT01426789|541346282|FG001|Part 1|Adverse Event|0|||
150056194|NCT01426789|541346283|FG002|Part 1|Adverse Event|0|||
150056195|NCT01426789|541346284|FG003|Part 1|Adverse Event|0|||
150056196|NCT01426789|541346285|FG004|Part 1|Adverse Event|0|||
150056197|NCT01426789|541346286|FG005|Part 1|Adverse Event|0|||
150056198|NCT01426789|541346281|FG000|Part 2|Protocol deviation|0|||
150056199|NCT01426789|541346282|FG001|Part 2|Protocol deviation|0|||
150056200|NCT01426789|541346283|FG002|Part 2|Protocol deviation|1|||
150056201|NCT01426789|541346284|FG003|Part 2|Protocol deviation|0|||
150056202|NCT01426789|541346285|FG004|Part 2|Protocol deviation|0|||
150056203|NCT01426789|541346286|FG005|Part 2|Protocol deviation|0|||
150056204|NCT01426789|541346281|FG000|Part 2|Death|0|||
150056205|NCT01426789|541346282|FG001|Part 2|Death|0|||
150056206|NCT01426789|541346283|FG002|Part 2|Death|1|||
150056207|NCT01426789|541346284|FG003|Part 2|Death|0|||
150056208|NCT01426789|541346285|FG004|Part 2|Death|1|||
150056209|NCT01426789|541346286|FG005|Part 2|Death|0|||
150056210|NCT01426789|541346281|FG000|Part 2|Administrative problems|0|||
150056211|NCT01426789|541346282|FG001|Part 2|Administrative problems|0|||
150056212|NCT01426789|541346283|FG002|Part 2|Administrative problems|2|||
150056213|NCT01426789|541346284|FG003|Part 2|Administrative problems|0|||
150007237|NCT01555125|541160273|FG003|Induction Period|Lost to Follow-up|0|||
150007238|NCT01555125|541160274|FG004|Induction Period|Lost to Follow-up|0|||
150007239|NCT01555125|541160270|FG000|Induction Period|Adverse Event|0|||
150007240|NCT01555125|541160271|FG001|Induction Period|Adverse Event|1|||
150007241|NCT01555125|541160272|FG002|Induction Period|Adverse Event|0|||
150007242|NCT01555125|541160273|FG003|Induction Period|Adverse Event|0|||
150007243|NCT01555125|541160274|FG004|Induction Period|Adverse Event|1|||
150007244|NCT01555125|541160270|FG000|Induction Period|Subject / guardian decision|0|||
150007245|NCT01555125|541160271|FG001|Induction Period|Subject / guardian decision|0|||
150007246|NCT01555125|541160272|FG002|Induction Period|Subject / guardian decision|0|||
150056214|NCT01426789|541346285|FG004|Part 2|Administrative problems|1|||
150056215|NCT01426789|541346286|FG005|Part 2|Administrative problems|0|||
150056216|NCT01426789|541346281|FG000|Part 2|Lost to Follow-up|0|||
150007247|NCT01555125|541160273|FG003|Induction Period|Subject / guardian decision|0|||
150007248|NCT01555125|541160274|FG004|Induction Period|Subject / guardian decision|2|||
150007249|NCT01555125|541160270|FG000|Induction Period|Death|1|||
150007250|NCT01555125|541160271|FG001|Induction Period|Death|0|||
150007251|NCT01555125|541160272|FG002|Induction Period|Death|0|||
150007252|NCT01555125|541160273|FG003|Induction Period|Death|0|||
150007253|NCT01555125|541160274|FG004|Induction Period|Death|0|||
150056217|NCT01426789|541346282|FG001|Part 2|Lost to Follow-up|0|||
150056218|NCT01426789|541346283|FG002|Part 2|Lost to Follow-up|4|||
150056219|NCT01426789|541346284|FG003|Part 2|Lost to Follow-up|0|||
150056220|NCT01426789|541346285|FG004|Part 2|Lost to Follow-up|1|||
150056221|NCT01426789|541346286|FG005|Part 2|Lost to Follow-up|0|||
150056222|NCT01426789|541346281|FG000|Part 2|Withdrawal by Subject|0|||
150056223|NCT01426789|541346282|FG001|Part 2|Withdrawal by Subject|0|||
150056224|NCT01426789|541346283|FG002|Part 2|Withdrawal by Subject|0|||
150056225|NCT01426789|541346284|FG003|Part 2|Withdrawal by Subject|1|||
150056226|NCT01426789|541346285|FG004|Part 2|Withdrawal by Subject|2|||
150056227|NCT01426789|541346286|FG005|Part 2|Withdrawal by Subject|0|||
150056228|NCT01426789|541346281|FG000|Part 2|Lack of Efficacy|0|||
150056229|NCT01426789|541346282|FG001|Part 2|Lack of Efficacy|0|||
150056230|NCT01426789|541346283|FG002|Part 2|Lack of Efficacy|5|||
150056231|NCT01426789|541346284|FG003|Part 2|Lack of Efficacy|0|||
150056232|NCT01426789|541346285|FG004|Part 2|Lack of Efficacy|2|||
150056233|NCT01426789|541346286|FG005|Part 2|Lack of Efficacy|0|||
150056234|NCT01426789|541346281|FG000|Part 2|Adverse Event|0|||
150056235|NCT01426789|541346282|FG001|Part 2|Adverse Event|0|||
150056236|NCT01426789|541346283|FG002|Part 2|Adverse Event|2|||
150056237|NCT01426789|541346284|FG003|Part 2|Adverse Event|0|||
150056238|NCT01426789|541346285|FG004|Part 2|Adverse Event|1|||
150056239|NCT01426789|541346286|FG005|Part 2|Adverse Event|0|||
150056240|NCT04054947|541346287|FG000|Overall Study|Withdrawal by Subject|1|||
150056241|NCT04054947|541346288|FG001|Overall Study|Withdrawal by Subject|0|||
150056242|NCT04054947|541346287|FG000|Overall Study|Lost to Follow-up|2|||
150056243|NCT04054947|541346288|FG001|Overall Study|Lost to Follow-up|5|||
150056244|NCT00311584|541346289|FG000|Overall Study|Death|1|||
150056245|NCT00311584|541346290|FG001|Overall Study|Death|0|||
150056246|NCT00311584|541346289|FG000|Overall Study|Lack of Efficacy|12|||
150056247|NCT00311584|541346290|FG001|Overall Study|Lack of Efficacy|15|||
150056248|NCT00311584|541346289|FG000|Overall Study|Physician Decision|4|||
150056249|NCT00311584|541346290|FG001|Overall Study|Physician Decision|5|||
150056250|NCT00311584|541346289|FG000|Overall Study|Withdrawal by Subject|1|||
150056251|NCT00311584|541346290|FG001|Overall Study|Withdrawal by Subject|1|||
150056252|NCT00311584|541346289|FG000|Overall Study|ineligible|2|||
150056253|NCT00311584|541346290|FG001|Overall Study|ineligible|2|||
150056254|NCT03720652|541346291|FG000|Overall Study|Withdrawal by Subject|2|||
150056255|NCT03720652|541346292|FG001|Overall Study|Withdrawal by Subject|7|||
150056256|NCT03720652|541346291|FG000|Overall Study|Lost to Follow-up|0|||
150056257|NCT03720652|541346292|FG001|Overall Study|Lost to Follow-up|4|||
150056258|NCT03073733|541346299|FG000|Overall Study|Lost to Follow-up|1|||
150056259|NCT03073733|541346300|FG001|Overall Study|Lost to Follow-up|0|||
150056260|NCT03073733|541346301|FG002|Overall Study|Lost to Follow-up|0|||
150056261|NCT03073733|541346299|FG000|Overall Study|Physician Decision|0|||
150007254|NCT01555125|541160270|FG000|Maintenance Period|Adverse Event|1|||
150007255|NCT01555125|541160271|FG001|Maintenance Period|Adverse Event|1|||
150007256|NCT01555125|541160272|FG002|Maintenance Period|Adverse Event|0|||
150007257|NCT01555125|541160273|FG003|Maintenance Period|Adverse Event|0|||
150007258|NCT01555125|541160274|FG004|Maintenance Period|Adverse Event|0|||
150007259|NCT01555125|541160270|FG000|Maintenance Period|Subject / guardian decision|1|||
150007260|NCT01555125|541160271|FG001|Maintenance Period|Subject / guardian decision|2|||
150007261|NCT01555125|541160272|FG002|Maintenance Period|Subject / guardian decision|0|||
150007262|NCT01555125|541160273|FG003|Maintenance Period|Subject / guardian decision|0|||
150007263|NCT01555125|541160274|FG004|Maintenance Period|Subject / guardian decision|0|||
150007264|NCT01555125|541160270|FG000|Maintenance Period|Lost to Follow-up|2|||
150007265|NCT01555125|541160271|FG001|Maintenance Period|Lost to Follow-up|0|||
150056262|NCT03073733|541346300|FG001|Overall Study|Physician Decision|1|||
150180037|NCT02723955|541799367|FG013|Escalation Phase|Death|4|||
150007266|NCT01555125|541160272|FG002|Maintenance Period|Lost to Follow-up|0|||
150056263|NCT03073733|541346301|FG002|Overall Study|Physician Decision|0|||
150056264|NCT03073733|541346299|FG000|Overall Study|Withdrawal by Subject|0|||
150056265|NCT03073733|541346300|FG001|Overall Study|Withdrawal by Subject|0|||
150056266|NCT03073733|541346301|FG002|Overall Study|Withdrawal by Subject|1|||
150056267|NCT01454778|541346302|FG000|Overall Study|Lost to Follow-up|2|||
150056268|NCT01454778|541346302|FG000|Overall Study|Death|1|||
150056269|NCT00835731|541346303|FG000|Overall Study|Withdrawal by Subject|1|||
150056270|NCT00835731|541346304|FG001|Overall Study|Withdrawal by Subject|0|||
150180038|NCT02723955|541799368|FG014|Escalation Phase|Death|5|||
150180039|NCT02723955|541799369|FG015|Escalation Phase|Death|6|||
150180040|NCT02723955|541799370|FG016|Escalation Phase|Death|6|||
150180041|NCT02723955|541799371|FG017|Escalation Phase|Death|7|||
150007267|NCT01555125|541160273|FG003|Maintenance Period|Lost to Follow-up|1|||
150007268|NCT01555125|541160274|FG004|Maintenance Period|Lost to Follow-up|0|||
150056271|NCT00835731|541346303|FG000|Overall Study|Physician Decision|1|||
150056272|NCT00835731|541346304|FG001|Overall Study|Physician Decision|1|||
150056273|NCT00348881|541346305|FG000|Overall Study|Lost to Follow-up|12|||
150180042|NCT02723955|541799372|FG018|Escalation Phase|Death|1|||
150056274|NCT00348881|541346306|FG001|Overall Study|Lost to Follow-up|6|||
150056275|NCT00348881|541346305|FG000|Overall Study|Withdrawal by Subject|3|||
150056276|NCT00348881|541346306|FG001|Overall Study|Withdrawal by Subject|4|||
150056277|NCT00348881|541346305|FG000|Overall Study|Adverse Event|2|||
150007269|NCT01555125|541160270|FG000|Maintenance Period|Lack of Efficacy|6|||
150007270|NCT01555125|541160271|FG001|Maintenance Period|Lack of Efficacy|1|||
150007271|NCT01555125|541160272|FG002|Maintenance Period|Lack of Efficacy|3|||
150007272|NCT01555125|541160273|FG003|Maintenance Period|Lack of Efficacy|0|||
150007273|NCT01555125|541160274|FG004|Maintenance Period|Lack of Efficacy|0|||
150007274|NCT01555125|541160270|FG000|Maintenance Period|Physician Decision|0|||
150007275|NCT01555125|541160271|FG001|Maintenance Period|Physician Decision|0|||
150007276|NCT01555125|541160272|FG002|Maintenance Period|Physician Decision|1|||
150007277|NCT01555125|541160273|FG003|Maintenance Period|Physician Decision|0|||
150007278|NCT01555125|541160274|FG004|Maintenance Period|Physician Decision|0|||
150007279|NCT01555125|541160270|FG000|Maintenance Period|Death|0|||
150007280|NCT01555125|541160271|FG001|Maintenance Period|Death|0|||
150007281|NCT01555125|541160272|FG002|Maintenance Period|Death|0|||
150007282|NCT01555125|541160273|FG003|Maintenance Period|Death|1|||
150007283|NCT01555125|541160274|FG004|Maintenance Period|Death|0|||
150007284|NCT01555125|541160270|FG000|Extension|Adverse Event|1|||
150007285|NCT01555125|541160271|FG001|Extension|Adverse Event|2|||
150007286|NCT01555125|541160272|FG002|Extension|Adverse Event|1|||
150007287|NCT01555125|541160273|FG003|Extension|Adverse Event|1|||
150007288|NCT01555125|541160274|FG004|Extension|Adverse Event|0|||
150007289|NCT01555125|541160270|FG000|Extension|Protocol deviation|1|||
150007290|NCT01555125|541160271|FG001|Extension|Protocol deviation|0|||
150007291|NCT01555125|541160272|FG002|Extension|Protocol deviation|0|||
150007292|NCT01555125|541160273|FG003|Extension|Protocol deviation|0|||
150007293|NCT01555125|541160274|FG004|Extension|Protocol deviation|0|||
150007294|NCT01555125|541160270|FG000|Extension|Lack of Efficacy|7|||
150007295|NCT01555125|541160271|FG001|Extension|Lack of Efficacy|6|||
150007296|NCT01555125|541160272|FG002|Extension|Lack of Efficacy|3|||
150007297|NCT01555125|541160273|FG003|Extension|Lack of Efficacy|0|||
150007298|NCT01555125|541160274|FG004|Extension|Lack of Efficacy|0|||
150007299|NCT01555125|541160270|FG000|Extension|Lost to Follow-up|2|||
150007300|NCT01555125|541160271|FG001|Extension|Lost to Follow-up|1|||
150007301|NCT01555125|541160272|FG002|Extension|Lost to Follow-up|2|||
150007302|NCT01555125|541160273|FG003|Extension|Lost to Follow-up|0|||
150007303|NCT01555125|541160274|FG004|Extension|Lost to Follow-up|0|||
150007304|NCT01555125|541160270|FG000|Extension|Study terminated by sponsor|32|||
150007305|NCT01555125|541160271|FG001|Extension|Study terminated by sponsor|33|||
150007306|NCT01555125|541160272|FG002|Extension|Study terminated by sponsor|16|||
150007307|NCT01555125|541160273|FG003|Extension|Study terminated by sponsor|20|||
150007308|NCT01555125|541160274|FG004|Extension|Study terminated by sponsor|0|||
150007309|NCT01555125|541160270|FG000|Extension|Subject/guardian decision|1|||
150007310|NCT01555125|541160271|FG001|Extension|Subject/guardian decision|9|||
150007311|NCT01555125|541160272|FG002|Extension|Subject/guardian decision|1|||
150007312|NCT01555125|541160273|FG003|Extension|Subject/guardian decision|0|||
150007313|NCT01555125|541160274|FG004|Extension|Subject/guardian decision|0|||
150007314|NCT01555125|541160270|FG000|Extension|Technical Problems|1|||
150007315|NCT01555125|541160271|FG001|Extension|Technical Problems|0|||
150007316|NCT01555125|541160272|FG002|Extension|Technical Problems|0|||
150007317|NCT01555125|541160273|FG003|Extension|Technical Problems|1|||
150007318|NCT01555125|541160274|FG004|Extension|Technical Problems|0|||
150007319|NCT01555125|541160270|FG000|Follow-Up Period|Lost to Follow-up|1|||
150007320|NCT01555125|541160271|FG001|Follow-Up Period|Lost to Follow-up|0|||
150007321|NCT01555125|541160272|FG002|Follow-Up Period|Lost to Follow-up|0|||
150007322|NCT01555125|541160273|FG003|Follow-Up Period|Lost to Follow-up|0|||
150007323|NCT01555125|541160274|FG004|Follow-Up Period|Lost to Follow-up|0|||
150007324|NCT01555125|541160270|FG000|Follow-Up Period|Subject / guardian decision|3|||
150007325|NCT01555125|541160271|FG001|Follow-Up Period|Subject / guardian decision|1|||
150056278|NCT00348881|541346306|FG001|Overall Study|Adverse Event|0|||
150056279|NCT00348881|541346305|FG000|Overall Study|Serious Adverse Event|0|||
150056280|NCT00348881|541346306|FG001|Overall Study|Serious Adverse Event|2|||
150056281|NCT01227629|541346308|FG000|Overall Study|Adverse Event|2|||
150056282|NCT01227629|541346309|FG001|Overall Study|Adverse Event|2|||
150056283|NCT01227629|541346310|FG002|Overall Study|Adverse Event|1|||
150056284|NCT01227629|541346311|FG003|Overall Study|Adverse Event|6|||
150007326|NCT01555125|541160272|FG002|Follow-Up Period|Subject / guardian decision|1|||
150007327|NCT01555125|541160273|FG003|Follow-Up Period|Subject / guardian decision|1|||
150007328|NCT01555125|541160274|FG004|Follow-Up Period|Subject / guardian decision|0|||
150056285|NCT01227629|541346312|FG004|Overall Study|Adverse Event|1|||
150056286|NCT01227629|541346313|FG005|Overall Study|Adverse Event|1|||
150056287|NCT01227629|541346314|FG006|Overall Study|Adverse Event|6|||
150056288|NCT01227629|541346315|FG007|Overall Study|Adverse Event|6|||
150007329|NCT02651220|541160275|FG000|Overall Study|Adverse Event|1|||
150007330|NCT02651220|541160276|FG001|Overall Study|Adverse Event|5|||
150056289|NCT01227629|541346316|FG008|Overall Study|Adverse Event|4|||
150007331|NCT02651220|541160277|FG002|Overall Study|Adverse Event|1|||
150007332|NCT02651220|541160275|FG000|Overall Study|Lost to Follow-up|8|||
150007333|NCT02651220|541160276|FG001|Overall Study|Lost to Follow-up|14|||
150007334|NCT02651220|541160277|FG002|Overall Study|Lost to Follow-up|14|||
150056290|NCT01227629|541346317|FG009|Overall Study|Adverse Event|0|||
150007335|NCT02651220|541160275|FG000|Overall Study|Non-Compliance with Study Drug|4|||
150007336|NCT02651220|541160276|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150007337|NCT02651220|541160277|FG002|Overall Study|Non-Compliance with Study Drug|1|||
150007338|NCT02651220|541160275|FG000|Overall Study|Pregnancy|1|||
150007339|NCT02651220|541160276|FG001|Overall Study|Pregnancy|0|||
150007340|NCT02651220|541160277|FG002|Overall Study|Pregnancy|1|||
150007341|NCT02651220|541160275|FG000|Overall Study|Protocol Violation|0|||
150007342|NCT02651220|541160276|FG001|Overall Study|Protocol Violation|0|||
150007343|NCT02651220|541160277|FG002|Overall Study|Protocol Violation|1|||
150007344|NCT02651220|541160275|FG000|Overall Study|Withdrawal by Subject|5|||
150007345|NCT02651220|541160276|FG001|Overall Study|Withdrawal by Subject|6|||
150007346|NCT02651220|541160277|FG002|Overall Study|Withdrawal by Subject|8|||
150007347|NCT02651220|541160275|FG000|Overall Study|Miscellaneous|4|||
150007348|NCT02651220|541160276|FG001|Overall Study|Miscellaneous|1|||
150007349|NCT02651220|541160277|FG002|Overall Study|Miscellaneous|2|||
150007350|NCT02651220|541160275|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150007351|NCT02651220|541160276|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150007352|NCT02651220|541160277|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
150007353|NCT00447122|541160278|FG000|Overall Study|worsening medical condition -came off|0|||
150007354|NCT00447122|541160279|FG001|Overall Study|worsening medical condition -came off|1|||
150007355|NCT00447122|541160280|FG002|Overall Study|worsening medical condition -came off|0|||
150007356|NCT00447122|541160281|FG003|Overall Study|worsening medical condition -came off|0|||
150007357|NCT01274429|541160283|FG000|Overall Study|Study closed do to lack of funding|5|||
150007358|NCT01439373|541160289|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
150007359|NCT01439373|541160290|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
150007360|NCT01439373|541160289|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
150007361|NCT01439373|541160290|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
150007362|NCT04046250|541160293|FG000|Overall Study|Death|0|||
150007363|NCT04046250|541160294|FG001|Overall Study|Death|1|||
150007364|NCT04046250|541160293|FG000|Overall Study|Withdrawal by Subject|3|||
150007365|NCT04046250|541160294|FG001|Overall Study|Withdrawal by Subject|3|||
150007366|NCT04576897|541160301|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
150007367|NCT03834220|541160302|FG000|Overall Study|Adverse Event|1|||
150007368|NCT03834220|541160303|FG001|Overall Study|Adverse Event|0|||
150007369|NCT03834220|541160304|FG002|Overall Study|Adverse Event|0|||
150056291|NCT01227629|541346308|FG000|Overall Study|Protocol Violation|0|||
150056292|NCT01227629|541346309|FG001|Overall Study|Protocol Violation|0|||
150056293|NCT01227629|541346310|FG002|Overall Study|Protocol Violation|0|||
150056294|NCT01227629|541346311|FG003|Overall Study|Protocol Violation|1|||
150007370|NCT03834220|541160302|FG000|Overall Study|Death|8|||
150007371|NCT03834220|541160303|FG001|Overall Study|Death|1|||
150007372|NCT03834220|541160304|FG002|Overall Study|Death|17|||
150007373|NCT03834220|541160302|FG000|Overall Study|Reason not Specified|9|||
150007374|NCT03834220|541160303|FG001|Overall Study|Reason not Specified|0|||
150007375|NCT03834220|541160304|FG002|Overall Study|Reason not Specified|6|||
150007376|NCT03834220|541160302|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
150007377|NCT03834220|541160303|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
150056295|NCT01227629|541346312|FG004|Overall Study|Protocol Violation|0|||
150007378|NCT03834220|541160304|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
150007379|NCT03834220|541160302|FG000|Overall Study|Withdrawal of Consent|2|||
150007380|NCT03834220|541160303|FG001|Overall Study|Withdrawal of Consent|2|||
150007381|NCT03834220|541160304|FG002|Overall Study|Withdrawal of Consent|2|||
150007382|NCT02593318|541160307|FG000|Overall Study|Withdrawal by Subject|1|||
150007383|NCT02593318|541160308|FG001|Overall Study|Withdrawal by Subject|1|||
150007384|NCT03684694|541160310|FG000|Phase 1|Withdrawal by Subject|1|||
150007385|NCT03684694|541160311|FG001|Phase 1|Withdrawal by Subject|0|||
150007386|NCT03684694|541160312|FG002|Phase 1|Withdrawal by Subject|0|||
150007387|NCT03684694|541160313|FG003|Phase 1|Withdrawal by Subject|0|||
150007388|NCT03684694|541160314|FG004|Phase 1|Withdrawal by Subject|0|||
150007389|NCT03684694|541160315|FG005|Phase 1|Withdrawal by Subject|0|||
150007390|NCT03684694|541160310|FG000|Phase 1|Investigator/Sponsor Decision|12|||
150007391|NCT03684694|541160311|FG001|Phase 1|Investigator/Sponsor Decision|2|||
150007392|NCT03684694|541160312|FG002|Phase 1|Investigator/Sponsor Decision|1|||
150007393|NCT03684694|541160313|FG003|Phase 1|Investigator/Sponsor Decision|0|||
150007394|NCT03684694|541160314|FG004|Phase 1|Investigator/Sponsor Decision|0|||
150007395|NCT03684694|541160315|FG005|Phase 1|Investigator/Sponsor Decision|0|||
150007396|NCT03684694|541160310|FG000|Phase 1|Death|24|||
150007397|NCT03684694|541160311|FG001|Phase 1|Death|0|||
150007398|NCT03684694|541160312|FG002|Phase 1|Death|3|||
150007399|NCT03684694|541160313|FG003|Phase 1|Death|0|||
150007400|NCT03684694|541160314|FG004|Phase 1|Death|0|||
150007401|NCT03684694|541160315|FG005|Phase 1|Death|0|||
150007402|NCT03684694|541160310|FG000|Phase 1|Lost to Follow-up|0|||
150007403|NCT03684694|541160311|FG001|Phase 1|Lost to Follow-up|0|||
150007404|NCT03684694|541160312|FG002|Phase 1|Lost to Follow-up|1|||
150007405|NCT03684694|541160313|FG003|Phase 1|Lost to Follow-up|0|||
150007406|NCT03684694|541160314|FG004|Phase 1|Lost to Follow-up|0|||
150007407|NCT03684694|541160315|FG005|Phase 1|Lost to Follow-up|0|||
150007408|NCT03684694|541160310|FG000|Phase 1|Miscellaneous|0|||
150007409|NCT03684694|541160311|FG001|Phase 1|Miscellaneous|1|||
150007410|NCT03684694|541160312|FG002|Phase 1|Miscellaneous|0|||
150056296|NCT01227629|541346313|FG005|Overall Study|Protocol Violation|0|||
150007411|NCT03684694|541160313|FG003|Phase 1|Miscellaneous|0|||
150007412|NCT03684694|541160314|FG004|Phase 1|Miscellaneous|0|||
150007413|NCT03684694|541160315|FG005|Phase 1|Miscellaneous|0|||
150007414|NCT03684694|541160310|FG000|Phase 2|Withdrawal by Subject|0|||
150056297|NCT01227629|541346314|FG006|Overall Study|Protocol Violation|0|||
150056298|NCT01227629|541346315|FG007|Overall Study|Protocol Violation|0|||
150007415|NCT03684694|541160311|FG001|Phase 2|Withdrawal by Subject|0|||
150007416|NCT03684694|541160312|FG002|Phase 2|Withdrawal by Subject|0|||
150007417|NCT03684694|541160313|FG003|Phase 2|Withdrawal by Subject|0|||
150007418|NCT03684694|541160314|FG004|Phase 2|Withdrawal by Subject|0|||
150007419|NCT03684694|541160315|FG005|Phase 2|Withdrawal by Subject|1|||
150007420|NCT03684694|541160310|FG000|Phase 2|Investigator/Sponsor Decision|0|||
150007421|NCT03684694|541160311|FG001|Phase 2|Investigator/Sponsor Decision|0|||
150007422|NCT03684694|541160312|FG002|Phase 2|Investigator/Sponsor Decision|0|||
150007423|NCT03684694|541160313|FG003|Phase 2|Investigator/Sponsor Decision|17|||
150007424|NCT03684694|541160314|FG004|Phase 2|Investigator/Sponsor Decision|16|||
150007425|NCT03684694|541160315|FG005|Phase 2|Investigator/Sponsor Decision|6|||
150007426|NCT03684694|541160310|FG000|Phase 2|Death|0|||
150007427|NCT03684694|541160311|FG001|Phase 2|Death|0|||
150007428|NCT03684694|541160312|FG002|Phase 2|Death|0|||
150007429|NCT03684694|541160313|FG003|Phase 2|Death|28|||
150007430|NCT03684694|541160314|FG004|Phase 2|Death|14|||
150007431|NCT03684694|541160315|FG005|Phase 2|Death|3|||
150007432|NCT03684694|541160310|FG000|Phase 2|Lost to Follow-up|0|||
150007433|NCT03684694|541160311|FG001|Phase 2|Lost to Follow-up|0|||
150007434|NCT03684694|541160312|FG002|Phase 2|Lost to Follow-up|0|||
150007435|NCT03684694|541160313|FG003|Phase 2|Lost to Follow-up|1|||
150007436|NCT03684694|541160314|FG004|Phase 2|Lost to Follow-up|0|||
150007437|NCT03684694|541160315|FG005|Phase 2|Lost to Follow-up|0|||
150007438|NCT03684694|541160310|FG000|Phase 2|Miscellaneous|0|||
150007439|NCT03684694|541160311|FG001|Phase 2|Miscellaneous|0|||
150007440|NCT03684694|541160312|FG002|Phase 2|Miscellaneous|0|||
150007441|NCT03684694|541160313|FG003|Phase 2|Miscellaneous|3|||
150007442|NCT03684694|541160314|FG004|Phase 2|Miscellaneous|0|||
150007443|NCT03684694|541160315|FG005|Phase 2|Miscellaneous|0|||
150007444|NCT03268941|541162003|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150007445|NCT03268941|541162004|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150180043|NCT02723955|541799373|FG019|Escalation Phase|Death|3|||
150180044|NCT02723955|541799374|FG020|Escalation Phase|Death|13|||
150180045|NCT02723955|541799375|FG021|Escalation Phase|Death|3|||
150180046|NCT02723955|541799376|FG022|Escalation Phase|Death|2|||
150180047|NCT02723955|541799377|FG023|Escalation Phase|Death|4|||
150180048|NCT02723955|541799378|FG024|Escalation Phase|Death|31|||
150180049|NCT02723955|541799379|FG025|Escalation Phase|Death|7|||
150180050|NCT02723955|541799380|FG026|Escalation Phase|Death|13|||
150180051|NCT02723955|541799381|FG027|Escalation Phase|Death|0|||
150180052|NCT02723955|541799382|FG028|Escalation Phase|Death|1|||
150180053|NCT02723955|541799383|FG029|Escalation Phase|Death|0|||
150180054|NCT02723955|541799384|FG030|Escalation Phase|Death|0|||
150007446|NCT03268941|541162005|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150180055|NCT02723955|541799385|FG031|Escalation Phase|Death|0|||
150180056|NCT02723955|541799386|FG032|Escalation Phase|Death|0|||
150180057|NCT02723955|541799387|FG033|Escalation Phase|Death|0|||
150180058|NCT02723955|541799388|FG034|Escalation Phase|Death|0|||
150180059|NCT02723955|541799389|FG035|Escalation Phase|Death|0|||
150180060|NCT02723955|541799390|FG036|Escalation Phase|Death|0|||
150180061|NCT02723955|541799391|FG037|Escalation Phase|Death|0|||
150180062|NCT02723955|541799392|FG038|Escalation Phase|Death|0|||
150180063|NCT02723955|541799393|FG039|Escalation Phase|Death|0|||
150180064|NCT02723955|541799394|FG040|Escalation Phase|Death|0|||
150180065|NCT02723955|541799395|FG041|Escalation Phase|Death|0|||
150180066|NCT02723955|541799396|FG042|Escalation Phase|Death|0|||
150180067|NCT02723955|541799354|FG000|Escalation Phase|Lost to Follow-up|0|||
150180068|NCT02723955|541799355|FG001|Escalation Phase|Lost to Follow-up|0|||
150180069|NCT02723955|541799356|FG002|Escalation Phase|Lost to Follow-up|0|||
150180070|NCT02723955|541799357|FG003|Escalation Phase|Lost to Follow-up|0|||
150180071|NCT02723955|541799358|FG004|Escalation Phase|Lost to Follow-up|0|||
150180072|NCT02723955|541799359|FG005|Escalation Phase|Lost to Follow-up|2|||
150180073|NCT02723955|541799360|FG006|Escalation Phase|Lost to Follow-up|1|||
150180074|NCT02723955|541799361|FG007|Escalation Phase|Lost to Follow-up|1|||
150180075|NCT02723955|541799362|FG008|Escalation Phase|Lost to Follow-up|1|||
150180076|NCT02723955|541799363|FG009|Escalation Phase|Lost to Follow-up|0|||
150007447|NCT03268941|541162006|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
150007448|NCT03268941|541162007|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150007449|NCT03268941|541162008|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150007450|NCT03268941|541162009|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
150007451|NCT03268941|541162003|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
150007452|NCT03268941|541162004|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
150180077|NCT02723955|541799364|FG010|Escalation Phase|Lost to Follow-up|0|||
150180078|NCT02723955|541799365|FG011|Escalation Phase|Lost to Follow-up|0|||
150007453|NCT03268941|541162005|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
150007454|NCT03268941|541162006|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
150007455|NCT03268941|541162007|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
150180079|NCT02723955|541799366|FG012|Escalation Phase|Lost to Follow-up|1|||
150180080|NCT02723955|541799367|FG013|Escalation Phase|Lost to Follow-up|0|||
150180081|NCT02723955|541799368|FG014|Escalation Phase|Lost to Follow-up|0|||
150180082|NCT02723955|541799369|FG015|Escalation Phase|Lost to Follow-up|0|||
150180083|NCT02723955|541799370|FG016|Escalation Phase|Lost to Follow-up|1|||
150007456|NCT03268941|541162008|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
150007457|NCT03268941|541162009|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
150007458|NCT03268941|541162003|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
150007459|NCT03268941|541162004|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007460|NCT03268941|541162005|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007461|NCT03268941|541162006|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007462|NCT03268941|541162007|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007463|NCT03268941|541162008|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007464|NCT03268941|541162009|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
150007465|NCT03268941|541162003|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
150007466|NCT03268941|541162004|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
150007467|NCT03268941|541162005|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
150007468|NCT03268941|541162006|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
150007469|NCT03268941|541162007|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
150007470|NCT03268941|541162008|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
150007471|NCT03268941|541162009|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
150007472|NCT03268941|541162003|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150007473|NCT03268941|541162004|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150007474|NCT03268941|541162005|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150007475|NCT03268941|541162006|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150007476|NCT03268941|541162007|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150056299|NCT01227629|541346316|FG008|Overall Study|Protocol Violation|0|||
150056300|NCT01227629|541346317|FG009|Overall Study|Protocol Violation|0|||
150056301|NCT01227629|541346308|FG000|Overall Study|Lost to Follow-up|0|||
150056302|NCT01227629|541346309|FG001|Overall Study|Lost to Follow-up|0|||
150056303|NCT01227629|541346310|FG002|Overall Study|Lost to Follow-up|0|||
150056304|NCT01227629|541346311|FG003|Overall Study|Lost to Follow-up|0|||
150056305|NCT01227629|541346312|FG004|Overall Study|Lost to Follow-up|1|||
150056306|NCT01227629|541346313|FG005|Overall Study|Lost to Follow-up|0|||
150007477|NCT03268941|541162008|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
150007478|NCT03268941|541162009|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
150007479|NCT01216683|541162010|FG000|Induction|Never started treatment|0|||
150007480|NCT01216683|541162011|FG001|Induction|Never started treatment|6|||
150007481|NCT01216683|541162012|FG002|Induction|Never started treatment|3|||
150007482|NCT01216683|541162010|FG000|Induction|Lack of Efficacy|4|||
150007483|NCT01216683|541162011|FG001|Induction|Lack of Efficacy|3|||
150007484|NCT01216683|541162012|FG002|Induction|Lack of Efficacy|7|||
150007485|NCT01216683|541162010|FG000|Induction|Adverse Event|0|||
150007486|NCT01216683|541162011|FG001|Induction|Adverse Event|5|||
150007487|NCT01216683|541162012|FG002|Induction|Adverse Event|5|||
150007488|NCT01216683|541162010|FG000|Induction|Death|0|||
150007489|NCT01216683|541162011|FG001|Induction|Death|0|||
150007490|NCT01216683|541162012|FG002|Induction|Death|2|||
150056307|NCT01227629|541346314|FG006|Overall Study|Lost to Follow-up|0|||
150056308|NCT01227629|541346315|FG007|Overall Study|Lost to Follow-up|0|||
150056309|NCT01227629|541346316|FG008|Overall Study|Lost to Follow-up|0|||
150056310|NCT01227629|541346317|FG009|Overall Study|Lost to Follow-up|0|||
150007491|NCT01216683|541162010|FG000|Induction|Withdrawal by Subject|0|||
150007492|NCT01216683|541162011|FG001|Induction|Withdrawal by Subject|4|||
150007493|NCT01216683|541162012|FG002|Induction|Withdrawal by Subject|2|||
150007494|NCT01216683|541162010|FG000|Induction|Other disease|0|||
150007495|NCT01216683|541162011|FG001|Induction|Other disease|1|||
150007496|NCT01216683|541162012|FG002|Induction|Other disease|2|||
150007497|NCT01216683|541162010|FG000|Continuation|Lack of Efficacy|3|||
150007498|NCT01216683|541162011|FG001|Continuation|Lack of Efficacy|2|||
150007499|NCT01216683|541162012|FG002|Continuation|Lack of Efficacy|7|||
150007500|NCT01216683|541162010|FG000|Continuation|Adverse Event|5|||
150007501|NCT01216683|541162011|FG001|Continuation|Adverse Event|3|||
150007502|NCT01216683|541162012|FG002|Continuation|Adverse Event|16|||
150007503|NCT01216683|541162010|FG000|Continuation|Death|1|||
150007504|NCT01216683|541162011|FG001|Continuation|Death|0|||
150007505|NCT01216683|541162012|FG002|Continuation|Death|2|||
150007506|NCT01216683|541162010|FG000|Continuation|Withdrawal by Subject|4|||
150007507|NCT01216683|541162011|FG001|Continuation|Withdrawal by Subject|5|||
150007508|NCT01216683|541162012|FG002|Continuation|Withdrawal by Subject|9|||
150007509|NCT01216683|541162010|FG000|Continuation|Other diseases|0|||
150007510|NCT01216683|541162011|FG001|Continuation|Other diseases|2|||
150007511|NCT01216683|541162012|FG002|Continuation|Other diseases|1|||
150007512|NCT01216683|541162010|FG000|Continuation|Physician Decision|1|||
150007513|NCT01216683|541162011|FG001|Continuation|Physician Decision|0|||
150007514|NCT01216683|541162012|FG002|Continuation|Physician Decision|1|||
150007515|NCT01216683|541162010|FG000|Continuation|Non-compliance|1|||
150007516|NCT01216683|541162011|FG001|Continuation|Non-compliance|0|||
150007517|NCT01216683|541162012|FG002|Continuation|Non-compliance|1|||
150007518|NCT01216683|541162010|FG000|Continuation|Insurance change|0|||
150007519|NCT01216683|541162011|FG001|Continuation|Insurance change|1|||
150007520|NCT01216683|541162012|FG002|Continuation|Insurance change|0|||
150007521|NCT01216683|541162010|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
150007522|NCT01216683|541162011|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
150007523|NCT01216683|541162012|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
150007524|NCT01216683|541162010|FG000|Continuation|Not reported|0|||
150007525|NCT01216683|541162011|FG001|Continuation|Not reported|0|||
150007526|NCT01216683|541162012|FG002|Continuation|Not reported|1|||
150007527|NCT01216683|541162010|FG000|Continuation|Never started treatment|0|||
150007528|NCT01216683|541162011|FG001|Continuation|Never started treatment|1|||
150180084|NCT02723955|541799371|FG017|Escalation Phase|Lost to Follow-up|2|||
150007529|NCT01216683|541162012|FG002|Continuation|Never started treatment|5|||
150007530|NCT02100969|541162013|FG000|Overall Study|Did not pass screening phase|1|||
150007531|NCT01629953|541162014|FG000|Overall Study|Death|3|||
150007532|NCT01629953|541162015|FG001|Overall Study|Death|1|||
150007533|NCT01629953|541162014|FG000|Overall Study|Lost to Follow-up|10|||
150007534|NCT01629953|541162015|FG001|Overall Study|Lost to Follow-up|14|||
150007535|NCT00720343|541162016|FG000|Overall Study|Lost to Follow-up|1|||
150007536|NCT00720343|541162017|FG001|Overall Study|Lost to Follow-up|0|||
150007537|NCT00720343|541162016|FG000|Overall Study|Protocol Violation|0|||
150007538|NCT00720343|541162017|FG001|Overall Study|Protocol Violation|2|||
150007539|NCT00707954|541162018|FG000|Overall Study|Physician Decision|0|||
150007540|NCT00707954|541162019|FG001|Overall Study|Physician Decision|0|||
150007541|NCT00707954|541162020|FG002|Overall Study|Physician Decision|0|||
150007542|NCT00707954|541162021|FG003|Overall Study|Physician Decision|0|||
150007543|NCT00707954|541162022|FG004|Overall Study|Physician Decision|1|||
150007544|NCT04279613|541162024|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
150180085|NCT02723955|541799372|FG018|Escalation Phase|Lost to Follow-up|0|||
150007545|NCT04279613|541162025|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
150007546|NCT04279613|541162026|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
150180086|NCT02723955|541799373|FG019|Escalation Phase|Lost to Follow-up|1|||
150180087|NCT02723955|541799374|FG020|Escalation Phase|Lost to Follow-up|2|||
150007547|NCT04279613|541162027|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
150007548|NCT04279613|541162028|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
150007549|NCT04279613|541162024|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
150007550|NCT04279613|541162025|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
150007551|NCT04279613|541162026|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
150007552|NCT04279613|541162027|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
150007553|NCT04279613|541162028|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
150007554|NCT04279613|541162024|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
150007555|NCT04279613|541162025|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
150007556|NCT04279613|541162026|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
150007557|NCT04279613|541162027|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
150007558|NCT04279613|541162028|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
150007559|NCT04279613|541162024|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
150007560|NCT04279613|541162025|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
150007561|NCT04279613|541162026|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
150007562|NCT04279613|541162027|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
150007563|NCT04279613|541162028|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
150007564|NCT04279613|541162024|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
150007565|NCT04279613|541162025|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
150180088|NCT02723955|541799375|FG021|Escalation Phase|Lost to Follow-up|1|||
150180089|NCT02723955|541799376|FG022|Escalation Phase|Lost to Follow-up|0|||
150007566|NCT04279613|541162026|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
150007567|NCT04279613|541162027|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
150007568|NCT04279613|541162028|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
150007569|NCT02478164|541162029|FG000|Overall Study|Lack of Efficacy|13|||
150007570|NCT02478164|541162029|FG000|Overall Study|Adverse Event|1|||
150007571|NCT02478164|541162029|FG000|Overall Study|Withdrawal by Subject|1|||
150007572|NCT02888743|541162030|FG000|Overall Study|Withdrawal by Subject|1|||
150007573|NCT02888743|541162031|FG001|Overall Study|Withdrawal by Subject|2|||
150007574|NCT02888743|541162032|FG002|Overall Study|Withdrawal by Subject|2|||
150007575|NCT02888743|541162033|FG003|Overall Study|Withdrawal by Subject|0|||
150007576|NCT02888743|541162034|FG004|Overall Study|Withdrawal by Subject|1|||
150007577|NCT02888743|541162030|FG000|Overall Study|Disease progression before treatment|2|||
150007578|NCT02888743|541162031|FG001|Overall Study|Disease progression before treatment|0|||
150007579|NCT02888743|541162032|FG002|Overall Study|Disease progression before treatment|2|||
150007580|NCT02888743|541162033|FG003|Overall Study|Disease progression before treatment|0|||
150056311|NCT01227629|541346308|FG000|Overall Study|Withdrawal by Subject|0|||
150056312|NCT01227629|541346309|FG001|Overall Study|Withdrawal by Subject|0|||
150056313|NCT01227629|541346310|FG002|Overall Study|Withdrawal by Subject|0|||
150056314|NCT01227629|541346311|FG003|Overall Study|Withdrawal by Subject|0|||
150007581|NCT02888743|541162034|FG004|Overall Study|Disease progression before treatment|0|||
150056315|NCT01227629|541346312|FG004|Overall Study|Withdrawal by Subject|0|||
150056316|NCT01227629|541346313|FG005|Overall Study|Withdrawal by Subject|0|||
150056317|NCT01227629|541346314|FG006|Overall Study|Withdrawal by Subject|2|||
150056318|NCT01227629|541346315|FG007|Overall Study|Withdrawal by Subject|0|||
150056319|NCT01227629|541346316|FG008|Overall Study|Withdrawal by Subject|0|||
150056320|NCT01227629|541346317|FG009|Overall Study|Withdrawal by Subject|1|||
150056321|NCT01227629|541346308|FG000|Overall Study|Other|0|||
150056322|NCT01227629|541346309|FG001|Overall Study|Other|0|||
150056323|NCT01227629|541346310|FG002|Overall Study|Other|0|||
150056324|NCT01227629|541346311|FG003|Overall Study|Other|1|||
150056325|NCT01227629|541346312|FG004|Overall Study|Other|0|||
150056326|NCT01227629|541346313|FG005|Overall Study|Other|0|||
150056327|NCT01227629|541346314|FG006|Overall Study|Other|0|||
150056328|NCT01227629|541346315|FG007|Overall Study|Other|0|||
150056329|NCT01227629|541346316|FG008|Overall Study|Other|2|||
150056330|NCT01227629|541346317|FG009|Overall Study|Other|1|||
150056331|NCT00881868|541346324|FG000|Overall Study|Adverse Event|0|||
150056332|NCT00881868|541346325|FG001|Overall Study|Adverse Event|1|||
150056333|NCT00881868|541346324|FG000|Overall Study|Lost to Follow-up|2|||
150056334|NCT00881868|541346325|FG001|Overall Study|Lost to Follow-up|1|||
150056335|NCT00881868|541346324|FG000|Overall Study|Physician Decision|4|||
150056336|NCT00881868|541346325|FG001|Overall Study|Physician Decision|0|||
150056337|NCT00881868|541346324|FG000|Overall Study|Protocol Violation|2|||
150056338|NCT00881868|541346325|FG001|Overall Study|Protocol Violation|0|||
150056339|NCT01981551|541346326|FG000|Overall Study|Refused further treatment|8|||
150007582|NCT02888743|541162030|FG000|Overall Study|Patient ineligible|1|||
150056340|NCT01981551|541346326|FG000|Overall Study|Adverse Event|1|||
150056341|NCT02880956|541346327|FG000|Overall Study|Adverse Event|3|||
150007583|NCT02888743|541162031|FG001|Overall Study|Patient ineligible|2|||
150007584|NCT02888743|541162032|FG002|Overall Study|Patient ineligible|0|||
150007585|NCT02888743|541162033|FG003|Overall Study|Patient ineligible|0|||
150007586|NCT02888743|541162034|FG004|Overall Study|Patient ineligible|0|||
150007587|NCT01424566|541162035|FG000|Single-blind Treatment|Adverse Event|71|||
150007588|NCT01424566|541162036|FG001|Single-blind Treatment|Adverse Event|0|||
150007589|NCT01424566|541162037|FG002|Single-blind Treatment|Adverse Event|0|||
150007590|NCT01424566|541162035|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
150007591|NCT01424566|541162036|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
150007592|NCT01424566|541162037|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
150007593|NCT01424566|541162035|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
150007594|NCT01424566|541162036|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
150007595|NCT01424566|541162037|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
150007596|NCT01424566|541162035|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
150007597|NCT01424566|541162036|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
150007598|NCT01424566|541162037|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
150007599|NCT01424566|541162035|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
150007600|NCT01424566|541162036|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
150007601|NCT01424566|541162037|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
150007602|NCT01424566|541162035|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
150007603|NCT01424566|541162036|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
150007604|NCT01424566|541162037|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
150007605|NCT01424566|541162035|FG000|Double-blind Treatment|Adverse Event|0|||
150007606|NCT01424566|541162036|FG001|Double-blind Treatment|Adverse Event|21|||
150007607|NCT01424566|541162037|FG002|Double-blind Treatment|Adverse Event|13|||
150007608|NCT01424566|541162035|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
150007609|NCT01424566|541162036|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
150007610|NCT01424566|541162037|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
150007611|NCT01424566|541162035|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
150007612|NCT01424566|541162036|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
150007613|NCT01424566|541162037|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
150007614|NCT01424566|541162035|FG000|Double-blind Treatment|Lack of Efficacy|0|||
150007615|NCT01424566|541162036|FG001|Double-blind Treatment|Lack of Efficacy|1|||
150007616|NCT01424566|541162037|FG002|Double-blind Treatment|Lack of Efficacy|1|||
150007617|NCT01100528|541162043|FG000|Overall Study|Death|1|||
150007618|NCT01100528|541162043|FG000|Overall Study|Withdrawal by Subject|2|||
150007619|NCT02211313|541162047|FG000|Overall Study|Treatment Failure|5|||
150007620|NCT02211313|541162048|FG001|Overall Study|Treatment Failure|2|||
150007621|NCT02211313|541162047|FG000|Overall Study|No Follow up Questionnaires|1|||
150007622|NCT02211313|541162048|FG001|Overall Study|No Follow up Questionnaires|1|||
150056342|NCT02880956|541346328|FG001|Overall Study|Adverse Event|6|||
150056343|NCT02880956|541346329|FG002|Overall Study|Adverse Event|5|||
150056344|NCT02880956|541346330|FG003|Overall Study|Adverse Event|4|||
150056345|NCT02880956|541346327|FG000|Overall Study|Withdrawal by Subject|9|||
150056346|NCT02880956|541346328|FG001|Overall Study|Withdrawal by Subject|4|||
150056347|NCT02880956|541346329|FG002|Overall Study|Withdrawal by Subject|6|||
150007623|NCT00551291|541162049|FG000|Overall Study|Physician Decision|1|||
150007624|NCT01943552|541162050|FG000|Overall Study|Adverse Event|3|||
150056348|NCT02880956|541346330|FG003|Overall Study|Withdrawal by Subject|11|||
150056349|NCT02880956|541346327|FG000|Overall Study|Lost to Follow-up|0|||
150007625|NCT01943552|541162051|FG001|Overall Study|Adverse Event|2|||
150007626|NCT01943552|541162050|FG000|Overall Study|Withdrawal by Subject|6|||
150007627|NCT01943552|541162051|FG001|Overall Study|Withdrawal by Subject|6|||
150007628|NCT01943552|541162050|FG000|Overall Study|Other Reasons|16|||
150007629|NCT01943552|541162051|FG001|Overall Study|Other Reasons|17|||
150007630|NCT01177969|541162052|FG000|Overall Study|Protocol Violation|2|||
150007631|NCT01177969|541162053|FG001|Overall Study|Protocol Violation|1|||
150007632|NCT01177969|541162052|FG000|Overall Study|Withdrawal by Subject|1|||
150007633|NCT01177969|541162053|FG001|Overall Study|Withdrawal by Subject|2|||
150007634|NCT01475162|541162057|FG000|Overall Study|Physician Decision|1|||
150007635|NCT01475162|541162057|FG000|Overall Study|Death|10|||
150007636|NCT01475162|541162057|FG000|Overall Study|Study closed for safety|3|||
150007637|NCT00490022|541162058|FG000|Overall Study|Adverse Event|0|||
150007638|NCT00490022|541162059|FG001|Overall Study|Adverse Event|2|||
150007639|NCT00490022|541162058|FG000|Overall Study|Withdrawal by Subject|1|||
150007640|NCT00490022|541162059|FG001|Overall Study|Withdrawal by Subject|0|||
150007641|NCT00490022|541162058|FG000|Overall Study|Subject failed to disclose concommitant|0|||
150007642|NCT00490022|541162059|FG001|Overall Study|Subject failed to disclose concommitant|1|||
150007643|NCT02358044|541162062|FG000|Overall Study|Adverse Event|0|||
150007644|NCT02358044|541162063|FG001|Overall Study|Adverse Event|1|||
150007645|NCT02358044|541162062|FG000|Overall Study|Lost to Follow-up|2|||
150007646|NCT02358044|541162063|FG001|Overall Study|Lost to Follow-up|1|||
150007647|NCT02358044|541162062|FG000|Overall Study|Physician Decision|0|||
150007648|NCT02358044|541162063|FG001|Overall Study|Physician Decision|1|||
150007649|NCT02358044|541162062|FG000|Overall Study|Withdrawal by Subject|0|||
150007650|NCT02358044|541162063|FG001|Overall Study|Withdrawal by Subject|4|||
150007651|NCT01504204|541162066|FG000|Overall Study|Lost to Follow-up|1|||
150007652|NCT01504204|541162067|FG001|Overall Study|Lost to Follow-up|1|||
150007653|NCT00903331|541162068|FG000|Overall Study|Death|4|||
150007654|NCT00903331|541162069|FG001|Overall Study|Death|8|||
150007655|NCT00903331|541162068|FG000|Overall Study|Withdrawal of consent|1|||
150007656|NCT00903331|541162069|FG001|Overall Study|Withdrawal of consent|8|||
150007657|NCT00903331|541162068|FG000|Overall Study|Lung transplant|0|||
150007658|NCT00903331|541162069|FG001|Overall Study|Lung transplant|2|||
150007659|NCT01571453|541162072|FG000|Overall Study|Adverse Event|14|||
150007660|NCT01571453|541162073|FG001|Overall Study|Adverse Event|32|||
150007661|NCT01571453|541162072|FG000|Overall Study|Lack of Efficacy|8|||
150007662|NCT01571453|541162073|FG001|Overall Study|Lack of Efficacy|3|||
150007663|NCT01571453|541162072|FG000|Overall Study|Non-compliance|2|||
150007664|NCT01571453|541162073|FG001|Overall Study|Non-compliance|4|||
150007665|NCT01571453|541162072|FG000|Overall Study|Protocol Violation|1|||
150007666|NCT01571453|541162073|FG001|Overall Study|Protocol Violation|5|||
150007667|NCT01571453|541162072|FG000|Overall Study|Withdrawal of consent|5|||
150007668|NCT01571453|541162073|FG001|Overall Study|Withdrawal of consent|13|||
150007669|NCT01571453|541162072|FG000|Overall Study|Lost to Follow-up|4|||
150007670|NCT01571453|541162073|FG001|Overall Study|Lost to Follow-up|2|||
150007671|NCT01571453|541162072|FG000|Overall Study|Administrative or other reason(s)|4|||
150007672|NCT01571453|541162073|FG001|Overall Study|Administrative or other reason(s)|3|||
150007673|NCT00129961|541162074|FG000|Overall Study|Adverse Event|1|||
150007674|NCT00129961|541162075|FG001|Overall Study|Adverse Event|0|||
150007675|NCT00129961|541162074|FG000|Overall Study|Death|1|||
150007676|NCT00129961|541162075|FG001|Overall Study|Death|1|||
150007677|NCT00129961|541162074|FG000|Overall Study|Withdrawal by Sponsor|14|||
150007678|NCT00129961|541162075|FG001|Overall Study|Withdrawal by Sponsor|20|||
150007679|NCT00129961|541162074|FG000|Overall Study|Physician Decision|1|||
150007680|NCT00129961|541162075|FG001|Overall Study|Physician Decision|0|||
150007681|NCT00129961|541162074|FG000|Overall Study|Withdrawal by Subject|2|||
150007682|NCT00129961|541162075|FG001|Overall Study|Withdrawal by Subject|1|||
150007683|NCT00129961|541162074|FG000|Overall Study|Missing Record|0|||
150007684|NCT00129961|541162075|FG001|Overall Study|Missing Record|1|||
150007685|NCT01985360|541162076|FG000|Overall Study|Withdrawal by Subject|4|||
150007686|NCT01985360|541162077|FG001|Overall Study|Withdrawal by Subject|0|||
150007687|NCT01985360|541162076|FG000|Overall Study|Lost to Follow-up|5|||
150007688|NCT01985360|541162077|FG001|Overall Study|Lost to Follow-up|3|||
150007689|NCT03691779|541162078|FG000|Part B (24 Weeks)|Adverse Event|0|||
150007690|NCT03691779|541162079|FG001|Part B (24 Weeks)|Adverse Event|1|||
150007691|NCT03691779|541162078|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
150007692|NCT03691779|541162079|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
150007693|NCT02528357|541162080|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007694|NCT02528357|541162081|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
150007695|NCT02528357|541162082|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007696|NCT02528357|541162083|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007697|NCT02528357|541162084|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007698|NCT02528357|541162085|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007699|NCT02528357|541162086|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007700|NCT02528357|541162087|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007701|NCT02528357|541162088|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007702|NCT02528357|541162089|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007703|NCT02528357|541162090|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007704|NCT02528357|541162091|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007705|NCT02528357|541162092|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007706|NCT02528357|541162093|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007707|NCT02528357|541162094|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007708|NCT02528357|541162095|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007709|NCT02528357|541162096|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007710|NCT02528357|541162097|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007711|NCT02528357|541162098|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
150007712|NCT02528357|541162080|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007713|NCT02528357|541162081|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007714|NCT02528357|541162082|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007715|NCT02528357|541162083|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
150007716|NCT02528357|541162084|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007717|NCT02528357|541162085|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
150007718|NCT02528357|541162086|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007719|NCT02528357|541162087|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
150007720|NCT02528357|541162088|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007721|NCT02528357|541162089|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007722|NCT02528357|541162090|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007723|NCT02528357|541162091|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007724|NCT02528357|541162092|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007725|NCT02528357|541162093|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007726|NCT02528357|541162094|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007727|NCT02528357|541162095|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007728|NCT02528357|541162096|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007729|NCT02528357|541162097|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007730|NCT02528357|541162098|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
150007731|NCT02528357|541162080|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007732|NCT02528357|541162081|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007733|NCT02528357|541162082|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
150007734|NCT02528357|541162083|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007735|NCT02528357|541162084|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
150007736|NCT02528357|541162085|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007737|NCT02528357|541162086|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
150007738|NCT02528357|541162087|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
150007739|NCT02528357|541162088|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007740|NCT02528357|541162089|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007741|NCT02528357|541162090|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007742|NCT02528357|541162091|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007743|NCT02528357|541162092|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007744|NCT02528357|541162093|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007745|NCT02528357|541162094|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007746|NCT02528357|541162095|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007747|NCT02528357|541162096|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007748|NCT02528357|541162097|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007749|NCT02528357|541162098|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
150007750|NCT02528357|541162080|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007751|NCT02528357|541162081|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007752|NCT02528357|541162082|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150056350|NCT02880956|541346328|FG001|Overall Study|Lost to Follow-up|1|||
150056351|NCT02880956|541346329|FG002|Overall Study|Lost to Follow-up|0|||
150056352|NCT02880956|541346330|FG003|Overall Study|Lost to Follow-up|0|||
150056353|NCT02880956|541346327|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
150056354|NCT02880956|541346328|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
150056355|NCT02880956|541346329|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
150056356|NCT02880956|541346330|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
150007753|NCT02528357|541162083|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007754|NCT02528357|541162084|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007755|NCT02528357|541162085|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007756|NCT02528357|541162086|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007757|NCT02528357|541162087|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007758|NCT02528357|541162088|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007759|NCT02528357|541162089|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007760|NCT02528357|541162090|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007761|NCT02528357|541162091|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007762|NCT02528357|541162092|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007763|NCT02528357|541162093|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007764|NCT02528357|541162094|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007765|NCT02528357|541162095|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007766|NCT02528357|541162096|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007767|NCT02528357|541162097|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007768|NCT02528357|541162098|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007769|NCT02528357|541162080|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007770|NCT02528357|541162081|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007771|NCT02528357|541162082|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007772|NCT02528357|541162083|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007773|NCT02528357|541162084|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007774|NCT02528357|541162085|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007775|NCT02528357|541162086|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007776|NCT02528357|541162087|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007777|NCT02528357|541162088|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007778|NCT02528357|541162089|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007779|NCT02528357|541162090|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007780|NCT02528357|541162091|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007781|NCT02528357|541162092|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007782|NCT02528357|541162093|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
150007783|NCT02528357|541162094|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
150007784|NCT02528357|541162095|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007785|NCT02528357|541162096|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007786|NCT02528357|541162097|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007787|NCT02528357|541162098|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
150007788|NCT02528357|541162080|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007789|NCT02528357|541162081|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007790|NCT02528357|541162082|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007791|NCT02528357|541162083|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007792|NCT02528357|541162084|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007793|NCT02528357|541162085|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007794|NCT02528357|541162086|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007795|NCT02528357|541162087|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007796|NCT02528357|541162088|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007797|NCT02528357|541162089|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007798|NCT02528357|541162090|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007799|NCT02528357|541162091|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150180090|NCT02723955|541799377|FG023|Escalation Phase|Lost to Follow-up|0|||
150180091|NCT02723955|541799378|FG024|Escalation Phase|Lost to Follow-up|1|||
150007800|NCT02528357|541162092|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007801|NCT02528357|541162093|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
150007802|NCT02528357|541162094|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007803|NCT02528357|541162095|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007804|NCT02528357|541162096|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007805|NCT02528357|541162097|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007806|NCT02528357|541162098|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
150007807|NCT02528357|541162080|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007808|NCT02528357|541162081|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007809|NCT02528357|541162082|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007810|NCT02528357|541162083|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007811|NCT02528357|541162084|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007812|NCT02528357|541162085|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007813|NCT02528357|541162086|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007814|NCT02528357|541162087|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007815|NCT02528357|541162088|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007816|NCT02528357|541162089|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007817|NCT02528357|541162090|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
150007818|NCT02528357|541162091|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007819|NCT02528357|541162092|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
150007820|NCT02528357|541162093|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
150007821|NCT02528357|541162094|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
150007822|NCT02528357|541162095|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007823|NCT02528357|541162096|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007824|NCT02528357|541162097|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007825|NCT02528357|541162098|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
150007826|NCT02528357|541162080|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007827|NCT02528357|541162081|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007828|NCT02528357|541162082|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007829|NCT02528357|541162083|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007830|NCT02528357|541162084|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007831|NCT02528357|541162085|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007832|NCT02528357|541162086|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007833|NCT02528357|541162087|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007834|NCT02528357|541162088|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007835|NCT02528357|541162089|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007836|NCT02528357|541162090|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007837|NCT02528357|541162091|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
150007838|NCT02528357|541162092|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
150007839|NCT02528357|541162093|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007840|NCT02528357|541162094|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007841|NCT02528357|541162095|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007842|NCT02528357|541162096|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007843|NCT02528357|541162097|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007844|NCT02528357|541162098|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007845|NCT02528357|541162080|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007846|NCT02528357|541162081|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007847|NCT02528357|541162082|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150056357|NCT02880956|541346327|FG000|Overall Study|Other, Not Specified|4|||
150056358|NCT02880956|541346328|FG001|Overall Study|Other, Not Specified|2|||
150007848|NCT02528357|541162083|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007849|NCT02528357|541162084|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007850|NCT02528357|541162085|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007851|NCT02528357|541162086|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007852|NCT02528357|541162087|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007853|NCT02528357|541162088|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007854|NCT02528357|541162089|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007855|NCT02528357|541162090|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007856|NCT02528357|541162091|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007857|NCT02528357|541162092|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007858|NCT02528357|541162093|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007859|NCT02528357|541162094|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007860|NCT02528357|541162095|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007861|NCT02528357|541162096|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
150007862|NCT02528357|541162097|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007863|NCT02528357|541162098|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
150007864|NCT02528357|541162080|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007865|NCT02528357|541162081|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007866|NCT02528357|541162082|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007867|NCT02528357|541162083|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007868|NCT02528357|541162084|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007869|NCT02528357|541162085|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007870|NCT02528357|541162086|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007871|NCT02528357|541162087|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007872|NCT02528357|541162088|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007873|NCT02528357|541162089|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007874|NCT02528357|541162090|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007875|NCT02528357|541162091|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007876|NCT02528357|541162092|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007877|NCT02528357|541162093|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007878|NCT02528357|541162094|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150007879|NCT02528357|541162095|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
150180092|NCT02723955|541799379|FG025|Escalation Phase|Lost to Follow-up|1|||
150180093|NCT02723955|541799380|FG026|Escalation Phase|Lost to Follow-up|3|||
150180094|NCT02723955|541799381|FG027|Escalation Phase|Lost to Follow-up|0|||
150007880|NCT02528357|541162096|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
150007881|NCT02528357|541162097|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
150007882|NCT02528357|541162098|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
150007883|NCT03869333|541162104|FG000|Overall Study|Lost to Follow-up|1|||
150007884|NCT03869333|541162105|FG001|Overall Study|Lost to Follow-up|0|||
150007885|NCT03869333|541162106|FG002|Overall Study|Lost to Follow-up|0|||
150007886|NCT03869333|541162107|FG003|Overall Study|Lost to Follow-up|0|||
150007887|NCT03869333|541162104|FG000|Overall Study|Pregnancy|1|||
150007888|NCT03869333|541162105|FG001|Overall Study|Pregnancy|0|||
150007889|NCT03869333|541162106|FG002|Overall Study|Pregnancy|0|||
150007890|NCT03869333|541162107|FG003|Overall Study|Pregnancy|0|||
150007891|NCT03869333|541162104|FG000|Overall Study|Physician Decision|0|||
150007892|NCT03869333|541162105|FG001|Overall Study|Physician Decision|1|||
150007893|NCT03869333|541162106|FG002|Overall Study|Physician Decision|0|||
150007894|NCT03869333|541162107|FG003|Overall Study|Physician Decision|0|||
150007895|NCT01927055|541162108|FG000|Open-label|Adverse Event|6|||
150007896|NCT01927055|541162109|FG001|Open-label|Adverse Event|0|||
150007897|NCT01927055|541162110|FG002|Open-label|Adverse Event|0|||
150007898|NCT01927055|541162108|FG000|Open-label|Withdrawal by Subject|1|||
150007899|NCT01927055|541162109|FG001|Open-label|Withdrawal by Subject|0|||
150007900|NCT01927055|541162110|FG002|Open-label|Withdrawal by Subject|0|||
150007901|NCT01927055|541162108|FG000|Open-label|Study Stopped|4|||
150007902|NCT01927055|541162109|FG001|Open-label|Study Stopped|0|||
150007903|NCT01927055|541162110|FG002|Open-label|Study Stopped|0|||
150007904|NCT01927055|541162108|FG000|Open-label|Supine Hypertension|4|||
150007905|NCT01927055|541162109|FG001|Open-label|Supine Hypertension|0|||
150007906|NCT01927055|541162110|FG002|Open-label|Supine Hypertension|0|||
150007907|NCT01927055|541162108|FG000|Open-label|Difficulty attending study visits|1|||
150007908|NCT01927055|541162109|FG001|Open-label|Difficulty attending study visits|0|||
150007909|NCT01927055|541162110|FG002|Open-label|Difficulty attending study visits|0|||
150007910|NCT01927055|541162108|FG000|Double-Blind|Adverse Event|0|||
150007911|NCT01927055|541162109|FG001|Double-Blind|Adverse Event|1|||
150007912|NCT01927055|541162110|FG002|Double-Blind|Adverse Event|1|||
150007913|NCT01927055|541162108|FG000|Double-Blind|Protocol Violation|0|||
150007914|NCT01927055|541162109|FG001|Double-Blind|Protocol Violation|0|||
150007915|NCT01927055|541162110|FG002|Double-Blind|Protocol Violation|1|||
150007916|NCT01927055|541162108|FG000|Double-Blind|Withdrawal by Subject|0|||
150007917|NCT01927055|541162109|FG001|Double-Blind|Withdrawal by Subject|2|||
150007918|NCT01927055|541162110|FG002|Double-Blind|Withdrawal by Subject|3|||
150007919|NCT01927055|541162108|FG000|Double-Blind|Study Stopped|0|||
150007920|NCT01927055|541162109|FG001|Double-Blind|Study Stopped|7|||
150007921|NCT01927055|541162110|FG002|Double-Blind|Study Stopped|7|||
150007922|NCT01927055|541162108|FG000|Double-Blind|Supine Hypertension|0|||
150007923|NCT01927055|541162109|FG001|Double-Blind|Supine Hypertension|0|||
150007924|NCT01927055|541162110|FG002|Double-Blind|Supine Hypertension|1|||
150007925|NCT01927055|541162108|FG000|Double-Blind|Extended Vacation|0|||
150007926|NCT01927055|541162109|FG001|Double-Blind|Extended Vacation|1|||
150007927|NCT01927055|541162110|FG002|Double-Blind|Extended Vacation|0|||
150007928|NCT02598128|541162111|FG000|Period A: Days -7 to -1|Adverse Event|1|||
150007929|NCT02598128|541162112|FG001|Period A: Days -7 to -1|Adverse Event|0|||
150007930|NCT02598128|541162113|FG002|Period A: Days -7 to -1|Adverse Event|0|||
150007931|NCT02598128|541162114|FG003|Period A: Days -7 to -1|Adverse Event|0|||
150007932|NCT05219669|541162118|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
150007933|NCT05219669|541162119|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
150007934|NCT05219669|541162120|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
150007935|NCT05219669|541162121|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
150007936|NCT05219669|541162122|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
150007937|NCT05219669|541162123|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
150007938|NCT03134183|541162124|FG000|Overall Study|Withdrawal by Subject|1|||
150056359|NCT02880956|541346329|FG002|Overall Study|Other, Not Specified|0|||
150056360|NCT02880956|541346330|FG003|Overall Study|Other, Not Specified|3|||
150056361|NCT02055365|541348265|FG000|Overall Study|Prematurely Withdrawn|1|||
150056362|NCT00002931|541348267|FG000|Overall Study|rapidly progressing disease during|2|||
150056363|NCT02907892|541348268|FG000|Overall Study|Lost to Follow-up|27|||
150056364|NCT02907892|541348269|FG001|Overall Study|Lost to Follow-up|40|||
150056365|NCT04531462|541348270|FG000|Overall Study|Withdrawal by Subject|3|||
150056366|NCT04531462|541348271|FG001|Overall Study|Withdrawal by Subject|1|||
150056367|NCT04531462|541348270|FG000|Overall Study|Adverse Event|3|||
150180095|NCT02723955|541799382|FG028|Escalation Phase|Lost to Follow-up|1|||
150180096|NCT02723955|541799383|FG029|Escalation Phase|Lost to Follow-up|0|||
150056368|NCT04531462|541348271|FG001|Overall Study|Adverse Event|3|||
150007939|NCT03134183|541162125|FG001|Overall Study|Withdrawal by Subject|1|||
150007940|NCT00845065|541162127|FG000|Overall Study|Adverse Event|3|||
150007941|NCT00845065|541162128|FG001|Overall Study|Adverse Event|23|||
150007942|NCT00845065|541162127|FG000|Overall Study|Lack of Efficacy|43|||
150007943|NCT00845065|541162128|FG001|Overall Study|Lack of Efficacy|21|||
150007944|NCT00845065|541162127|FG000|Overall Study|Non-Medical Reasons|1|||
150180097|NCT02723955|541799384|FG030|Escalation Phase|Lost to Follow-up|0|||
150180098|NCT02723955|541799385|FG031|Escalation Phase|Lost to Follow-up|0|||
150007945|NCT00845065|541162128|FG001|Overall Study|Non-Medical Reasons|11|||
150007946|NCT02299076|541162129|FG000|Overall Study|Fraudulent Entries|20|||
150007947|NCT02299076|541162130|FG001|Overall Study|Fraudulent Entries|14|||
150007948|NCT01198509|541162131|FG000|Overall Study|Withdrawal by Subject|1|||
150007949|NCT01198509|541162132|FG001|Overall Study|Withdrawal by Subject|0|||
150007950|NCT01198509|541162133|FG002|Overall Study|Withdrawal by Subject|0|||
150007951|NCT01198509|541162134|FG003|Overall Study|Withdrawal by Subject|0|||
150007952|NCT01198509|541162135|FG004|Overall Study|Withdrawal by Subject|0|||
150007953|NCT01198509|541162136|FG005|Overall Study|Withdrawal by Subject|0|||
150007954|NCT00330668|541162137|FG000|BID Dosing Period|Adverse Event|1|||
150007955|NCT00330668|541162137|FG000|BID Dosing Period|Lost to Follow-up|7|||
150007956|NCT00330668|541162137|FG000|BID Dosing Period|Non-Compliance|5|||
150007957|NCT00330668|541162137|FG000|BID Dosing Period|Withdrawal by Subject|19|||
150007958|NCT00330668|541162137|FG000|BID Dosing Period|Sponsor's decision|1|||
150007959|NCT00330668|541162137|FG000|BID Dosing Period|Other|3|||
150007960|NCT00330668|541162137|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
150007961|NCT00330668|541162137|FG000|QD Dosing Period|Other|1|||
150007962|NCT00330668|541162137|FG000|QD Dosing Period|Withdrawal by Subject|1|||
150007963|NCT00330668|541162137|FG000|QD Dosing Period|Lost to Follow-up|2|||
150007964|NCT00499746|541162146|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
150007965|NCT00499746|541162146|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
150007966|NCT00499746|541162146|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
150007967|NCT00499746|541162146|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
150007968|NCT02228096|541162147|FG000|Overall Study|Study terminated by Sponsor|24|||
150007969|NCT02228096|541162147|FG000|Overall Study|Lack of Efficacy|18|||
150007970|NCT02228096|541162147|FG000|Overall Study|Death|12|||
150007971|NCT02228096|541162147|FG000|Overall Study|Physician Decision|3|||
150007972|NCT02228096|541162147|FG000|Overall Study|Subject/guardian decision|2|||
150007973|NCT02228096|541162147|FG000|Overall Study|New therapy for study indication|1|||
150007974|NCT02228096|541162147|FG000|Overall Study|Enrolled, not infused|11|||
150007975|NCT01969721|541162148|FG000|Overall Study|Adverse Event|3|||
150007976|NCT01969721|541162149|FG001|Overall Study|Adverse Event|8|||
150007977|NCT01969721|541162150|FG002|Overall Study|Adverse Event|3|||
150007978|NCT01969721|541162151|FG003|Overall Study|Adverse Event|2|||
150007979|NCT01969721|541162148|FG000|Overall Study|Lack of Efficacy|0|||
150007980|NCT01969721|541162149|FG001|Overall Study|Lack of Efficacy|0|||
150007981|NCT01969721|541162150|FG002|Overall Study|Lack of Efficacy|1|||
150007982|NCT01969721|541162151|FG003|Overall Study|Lack of Efficacy|0|||
150007983|NCT01969721|541162148|FG000|Overall Study|Non compliant with protocol|1|||
150007984|NCT01969721|541162149|FG001|Overall Study|Non compliant with protocol|1|||
150007985|NCT01969721|541162150|FG002|Overall Study|Non compliant with protocol|0|||
150007986|NCT01969721|541162151|FG003|Overall Study|Non compliant with protocol|2|||
150007987|NCT01969721|541162148|FG000|Overall Study|Other not defined above|0|||
150007988|NCT01969721|541162149|FG001|Overall Study|Other not defined above|2|||
150007989|NCT01969721|541162150|FG002|Overall Study|Other not defined above|0|||
150007990|NCT01969721|541162151|FG003|Overall Study|Other not defined above|0|||
150007991|NCT01969721|541162148|FG000|Overall Study|Discontinued during washout periods.|0|||
150007992|NCT01969721|541162149|FG001|Overall Study|Discontinued during washout periods.|1|||
150007993|NCT01969721|541162150|FG002|Overall Study|Discontinued during washout periods.|1|||
150007994|NCT01969721|541162151|FG003|Overall Study|Discontinued during washout periods.|2|||
150007995|NCT04023682|541162155|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
150007996|NCT02745535|541162157|FG000|Overall Study|Death|1|||
150007997|NCT02745535|541162157|FG000|Overall Study|Adverse Event|3|||
150007998|NCT02745535|541162157|FG000|Overall Study|Lost to Follow-up|2|||
150007999|NCT03480009|541162168|FG000|Overall Study|Lost to Follow-up|4|||
150008000|NCT03480009|541162169|FG001|Overall Study|Lost to Follow-up|5|||
150008001|NCT03480009|541162170|FG002|Overall Study|Lost to Follow-up|4|||
150008002|NCT03480009|541162171|FG003|Overall Study|Lost to Follow-up|0|||
150008003|NCT04268745|541162174|FG000|Overall Study|Lost to Follow-up|2|||
150008004|NCT04268745|541162175|FG001|Overall Study|Lost to Follow-up|3|||
150008005|NCT04268745|541162174|FG000|Overall Study|Withdrawal by Subject|4|||
150008006|NCT04268745|541162175|FG001|Overall Study|Withdrawal by Subject|2|||
150008007|NCT04268745|541162174|FG000|Overall Study|Death in the family|1|||
150008008|NCT04268745|541162175|FG001|Overall Study|Death in the family|0|||
150008009|NCT01174173|541162177|FG000|Overall Study|drug-drug interaction|1|||
150008010|NCT00527332|541162178|FG000|Overall Study|Protocol Violation|4|||
150008011|NCT00527332|541162179|FG001|Overall Study|Protocol Violation|8|||
150008012|NCT00527332|541162178|FG000|Overall Study|Withdrew consent|5|||
150008013|NCT00527332|541162179|FG001|Overall Study|Withdrew consent|1|||
150008014|NCT00528801|541164026|FG000|Overall Study|Withdrawal by Subject|1|||
150008015|NCT00528801|541164027|FG001|Overall Study|Withdrawal by Subject|1|||
150008016|NCT00528801|541164026|FG000|Overall Study|Protocol Violation|11|||
150255177|NCT02929329|542070580|FG000|Overall Study|Lost to Follow-up|26|||
150008017|NCT00528801|541164027|FG001|Overall Study|Protocol Violation|5|||
150008018|NCT00528801|541164026|FG000|Overall Study|Lost to Follow-up|15|||
150008019|NCT00528801|541164027|FG001|Overall Study|Lost to Follow-up|4|||
150008020|NCT00528801|541164026|FG000|Overall Study|Administrative Reasons|0|||
150008021|NCT00528801|541164027|FG001|Overall Study|Administrative Reasons|1|||
150008022|NCT02504580|541164031|FG000|Overall Study|Other|1|||
150008023|NCT02504580|541164032|FG001|Overall Study|Other|0|||
150008024|NCT02504580|541164033|FG002|Overall Study|Other|0|||
150008025|NCT02504580|541164034|FG003|Overall Study|Other|2|||
150008026|NCT02504580|541164035|FG004|Overall Study|Other|1|||
150056369|NCT00348933|541348274|FG000|Overall Study|Withdrawal by Subject|10|||
150056370|NCT00348933|541348274|FG000|Overall Study|Lost to Follow-up|6|||
150056371|NCT00348933|541348274|FG000|Overall Study|Protocol Violation|2|||
150056372|NCT00348933|541348274|FG000|Overall Study|Adverse Event|7|||
150056373|NCT01264081|541348275|FG000|Participants Screened|Screening failures|30|||
150056374|NCT01264081|541348275|FG000|Started Treatment|Withdrawal by Subject|1|||
150056375|NCT01264081|541348275|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
150056376|NCT01489111|541348276|FG000|Overall Study|Withdrawal criterion|1|||
150056377|NCT02716896|541348277|FG000|Overall Study|Physician Decision|0|||
150056378|NCT02716896|541348278|FG001|Overall Study|Physician Decision|1|||
150056379|NCT01727700|541348279|FG000|Overall Study|Adverse Event|0|||
150056380|NCT01727700|541348280|FG001|Overall Study|Adverse Event|7|||
150056381|NCT01727700|541348281|FG002|Overall Study|Adverse Event|1|||
150056382|NCT01727700|541348279|FG000|Overall Study|Particpant withdrew consent|0|||
150056383|NCT01727700|541348280|FG001|Overall Study|Particpant withdrew consent|3|||
150056384|NCT01727700|541348281|FG002|Overall Study|Particpant withdrew consent|1|||
150056385|NCT01727700|541348279|FG000|Overall Study|Protocol Violation|2|||
150056386|NCT01727700|541348280|FG001|Overall Study|Protocol Violation|0|||
150056387|NCT01727700|541348281|FG002|Overall Study|Protocol Violation|0|||
150056388|NCT01757691|541348286|FG000|Overall Study|Administrative problems|2|||
150056389|NCT01757691|541348287|FG001|Overall Study|Administrative problems|0|||
150056390|NCT02054481|541348291|FG000|Overall Study|Adverse Event|1|||
150056391|NCT02054481|541348292|FG001|Overall Study|Adverse Event|1|||
150056392|NCT02054481|541348293|FG002|Overall Study|Adverse Event|0|||
150056393|NCT02054481|541348294|FG003|Overall Study|Adverse Event|1|||
150056394|NCT02054481|541348291|FG000|Overall Study|Lost to Follow-up|1|||
150056395|NCT02054481|541348292|FG001|Overall Study|Lost to Follow-up|0|||
150056396|NCT02054481|541348293|FG002|Overall Study|Lost to Follow-up|0|||
150056397|NCT02054481|541348294|FG003|Overall Study|Lost to Follow-up|0|||
150056398|NCT02054481|541348291|FG000|Overall Study|Other reason|2|||
150056399|NCT02054481|541348292|FG001|Overall Study|Other reason|1|||
150056400|NCT02054481|541348293|FG002|Overall Study|Other reason|2|||
150056401|NCT02054481|541348294|FG003|Overall Study|Other reason|0|||
150056402|NCT02320903|541348295|FG000|Overall Study|Withdrawal by Subject|0|||
150056403|NCT02320903|541348296|FG001|Overall Study|Withdrawal by Subject|9|||
150056404|NCT02320903|541348297|FG002|Overall Study|Withdrawal by Subject|9|||
150056405|NCT02320903|541348295|FG000|Overall Study|Exited therapy; no longer eligible|8|||
150056406|NCT02320903|541348296|FG001|Overall Study|Exited therapy; no longer eligible|2|||
150056407|NCT02320903|541348297|FG002|Overall Study|Exited therapy; no longer eligible|2|||
150056408|NCT02320903|541348295|FG000|Overall Study|Lost to Follow-up|0|||
150056409|NCT02320903|541348296|FG001|Overall Study|Lost to Follow-up|5|||
150008027|NCT02504580|541164036|FG005|Overall Study|Other|1|||
150056410|NCT02320903|541348297|FG002|Overall Study|Lost to Follow-up|5|||
150056411|NCT01011478|541348299|FG000|Overall Study|No follow up data|12|||
150056412|NCT01011478|541348300|FG001|Overall Study|No follow up data|7|||
150056413|NCT04575597|541348301|FG000|Overall Study|Death|0|||
150056414|NCT04575597|541348302|FG001|Overall Study|Death|0|||
150056415|NCT04575597|541348303|FG002|Overall Study|Death|0|||
150056416|NCT04575597|541348304|FG003|Overall Study|Death|1|||
150056417|NCT04575597|541348305|FG004|Overall Study|Death|3|||
150056418|NCT04575597|541348306|FG005|Overall Study|Death|14|||
150056419|NCT04575597|541348301|FG000|Overall Study|Lost to Follow-up|2|||
150056420|NCT04575597|541348302|FG001|Overall Study|Lost to Follow-up|1|||
150056421|NCT04575597|541348303|FG002|Overall Study|Lost to Follow-up|1|||
150056422|NCT04575597|541348304|FG003|Overall Study|Lost to Follow-up|2|||
150008028|NCT02504580|541164037|FG006|Overall Study|Other|1|||
150056423|NCT04575597|541348305|FG004|Overall Study|Lost to Follow-up|10|||
150056424|NCT04575597|541348306|FG005|Overall Study|Lost to Follow-up|8|||
150056425|NCT04575597|541348301|FG000|Overall Study|Withdrawal by Subject|2|||
150056426|NCT04575597|541348302|FG001|Overall Study|Withdrawal by Subject|2|||
150056427|NCT04575597|541348303|FG002|Overall Study|Withdrawal by Subject|4|||
150056428|NCT04575597|541348304|FG003|Overall Study|Withdrawal by Subject|2|||
150056429|NCT04575597|541348305|FG004|Overall Study|Withdrawal by Subject|25|||
150056430|NCT04575597|541348306|FG005|Overall Study|Withdrawal by Subject|28|||
150056431|NCT04575597|541348301|FG000|Overall Study|Not Recorded|0|||
150056432|NCT04575597|541348302|FG001|Overall Study|Not Recorded|0|||
150056433|NCT04575597|541348303|FG002|Overall Study|Not Recorded|0|||
150008029|NCT02504580|541164038|FG007|Overall Study|Other|2|||
150008030|NCT02504580|541164039|FG008|Overall Study|Other|0|||
150008031|NCT02504580|541164040|FG009|Overall Study|Other|0|||
150056434|NCT04575597|541348304|FG003|Overall Study|Not Recorded|0|||
150056435|NCT04575597|541348305|FG004|Overall Study|Not Recorded|0|||
150056436|NCT04575597|541348306|FG005|Overall Study|Not Recorded|2|||
150056437|NCT04575597|541348301|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150056438|NCT04575597|541348302|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150056439|NCT04575597|541348303|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150056440|NCT04575597|541348304|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150056441|NCT04575597|541348305|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
150056442|NCT04575597|541348306|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
150056443|NCT02108262|541348308|FG000|Overall Study|Non-compliance|0|||
150056444|NCT02108262|541348309|FG001|Overall Study|Non-compliance|2|||
150056445|NCT02108262|541348310|FG002|Overall Study|Non-compliance|1|||
150056446|NCT02108262|541348311|FG003|Overall Study|Non-compliance|1|||
150180099|NCT02723955|541799386|FG032|Escalation Phase|Lost to Follow-up|0|||
150180100|NCT02723955|541799387|FG033|Escalation Phase|Lost to Follow-up|0|||
150180101|NCT02723955|541799388|FG034|Escalation Phase|Lost to Follow-up|0|||
150180102|NCT02723955|541799389|FG035|Escalation Phase|Lost to Follow-up|0|||
150180103|NCT02723955|541799390|FG036|Escalation Phase|Lost to Follow-up|0|||
150180104|NCT02723955|541799391|FG037|Escalation Phase|Lost to Follow-up|0|||
150180105|NCT02723955|541799392|FG038|Escalation Phase|Lost to Follow-up|0|||
150180106|NCT02723955|541799393|FG039|Escalation Phase|Lost to Follow-up|0|||
150180107|NCT02723955|541799394|FG040|Escalation Phase|Lost to Follow-up|0|||
150180108|NCT02723955|541799395|FG041|Escalation Phase|Lost to Follow-up|0|||
150180109|NCT02723955|541799396|FG042|Escalation Phase|Lost to Follow-up|0|||
150180110|NCT02723955|541799354|FG000|Escalation Phase|Physician Decision|0|||
150180111|NCT02723955|541799355|FG001|Escalation Phase|Physician Decision|0|||
150180112|NCT02723955|541799356|FG002|Escalation Phase|Physician Decision|0|||
150180113|NCT02723955|541799357|FG003|Escalation Phase|Physician Decision|0|||
150008032|NCT02504580|541164041|FG010|Overall Study|Other|0|||
150056447|NCT02108262|541348308|FG000|Overall Study|Randomized by error/screen failure|0|||
150056448|NCT02108262|541348309|FG001|Overall Study|Randomized by error/screen failure|0|||
150056449|NCT02108262|541348310|FG002|Overall Study|Randomized by error/screen failure|1|||
150056450|NCT02108262|541348311|FG003|Overall Study|Randomized by error/screen failure|0|||
150056451|NCT02108262|541348308|FG000|Overall Study|Distance to center|0|||
150056452|NCT02108262|541348309|FG001|Overall Study|Distance to center|1|||
150056453|NCT02108262|541348310|FG002|Overall Study|Distance to center|1|||
150056454|NCT02108262|541348311|FG003|Overall Study|Distance to center|0|||
150056455|NCT02108262|541348308|FG000|Overall Study|Adverse Event|0|||
150056456|NCT02108262|541348309|FG001|Overall Study|Adverse Event|11|||
150056457|NCT02108262|541348310|FG002|Overall Study|Adverse Event|6|||
150056458|NCT02108262|541348311|FG003|Overall Study|Adverse Event|12|||
150056459|NCT02108262|541348308|FG000|Overall Study|Death|0|||
150056460|NCT02108262|541348309|FG001|Overall Study|Death|2|||
150056461|NCT02108262|541348310|FG002|Overall Study|Death|2|||
150056462|NCT02108262|541348311|FG003|Overall Study|Death|1|||
150056463|NCT02108262|541348308|FG000|Overall Study|Lost to Follow-up|0|||
150056464|NCT02108262|541348309|FG001|Overall Study|Lost to Follow-up|0|||
150008033|NCT02504580|541164042|FG011|Overall Study|Other|2|||
150008034|NCT02504580|541164031|FG000|Overall Study|Subject refusal to continue|0|||
150008035|NCT02504580|541164032|FG001|Overall Study|Subject refusal to continue|1|||
150008036|NCT02504580|541164033|FG002|Overall Study|Subject refusal to continue|0|||
150008037|NCT02504580|541164034|FG003|Overall Study|Subject refusal to continue|0|||
150008038|NCT02504580|541164035|FG004|Overall Study|Subject refusal to continue|0|||
150008039|NCT02504580|541164036|FG005|Overall Study|Subject refusal to continue|0|||
150008040|NCT02504580|541164037|FG006|Overall Study|Subject refusal to continue|0|||
150008041|NCT02504580|541164038|FG007|Overall Study|Subject refusal to continue|0|||
150008042|NCT02504580|541164039|FG008|Overall Study|Subject refusal to continue|0|||
150008043|NCT02504580|541164040|FG009|Overall Study|Subject refusal to continue|0|||
150008044|NCT02504580|541164041|FG010|Overall Study|Subject refusal to continue|0|||
150008045|NCT02504580|541164042|FG011|Overall Study|Subject refusal to continue|0|||
150008046|NCT02252965|541164048|FG000|Overall Study|Adverse Event|9|||
150056465|NCT02108262|541348310|FG002|Overall Study|Lost to Follow-up|1|||
150056466|NCT02108262|541348311|FG003|Overall Study|Lost to Follow-up|0|||
150056467|NCT02108262|541348308|FG000|Overall Study|Physician Decision|0|||
150056468|NCT02108262|541348309|FG001|Overall Study|Physician Decision|0|||
150056469|NCT02108262|541348310|FG002|Overall Study|Physician Decision|2|||
150056470|NCT02108262|541348311|FG003|Overall Study|Physician Decision|0|||
150056471|NCT02108262|541348308|FG000|Overall Study|Withdrawal by Subject|0|||
150056472|NCT02108262|541348309|FG001|Overall Study|Withdrawal by Subject|7|||
150056473|NCT02108262|541348310|FG002|Overall Study|Withdrawal by Subject|3|||
150180114|NCT02723955|541799358|FG004|Escalation Phase|Physician Decision|0|||
150008047|NCT02252965|541164049|FG001|Overall Study|Adverse Event|14|||
150008048|NCT02252965|541164048|FG000|Overall Study|Lost to Follow-up|16|||
150056474|NCT02108262|541348311|FG003|Overall Study|Withdrawal by Subject|4|||
150056475|NCT02108262|541348308|FG000|Overall Study|Due to key hepatic values|0|||
150180115|NCT02723955|541799359|FG005|Escalation Phase|Physician Decision|2|||
150180116|NCT02723955|541799360|FG006|Escalation Phase|Physician Decision|0|||
150180117|NCT02723955|541799361|FG007|Escalation Phase|Physician Decision|0|||
150008049|NCT02252965|541164049|FG001|Overall Study|Lost to Follow-up|8|||
150008050|NCT02252965|541164048|FG000|Overall Study|Protocol Violation|4|||
150008051|NCT02252965|541164049|FG001|Overall Study|Protocol Violation|5|||
150008052|NCT02252965|541164048|FG000|Overall Study|Lack of Efficacy|0|||
150008053|NCT02252965|541164049|FG001|Overall Study|Lack of Efficacy|2|||
150008054|NCT02252965|541164048|FG000|Overall Study|Withdrawal by Subject|7|||
150008055|NCT02252965|541164049|FG001|Overall Study|Withdrawal by Subject|9|||
150008056|NCT02252965|541164048|FG000|Overall Study|Other|4|||
150008057|NCT02252965|541164049|FG001|Overall Study|Other|5|||
150008058|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
150008059|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
150008060|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
150008061|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
150008062|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
150008063|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
150008064|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
150008065|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
150008066|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
150008067|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
150008068|NCT02429791|541164052|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
150008069|NCT02429791|541164053|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
150008070|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
150008071|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
150008072|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
150008073|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
150008074|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
150008075|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
150008076|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
150008077|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
150008078|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
150008079|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
150008080|NCT02429791|541164052|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
150008081|NCT02429791|541164053|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
150008082|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
150008083|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
150008084|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
150008085|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
150008086|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
150008087|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
150008088|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
150008089|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
150008090|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
150008091|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
150008092|NCT02429791|541164052|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
150008093|NCT02429791|541164053|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
150008094|NCT02615691|541164054|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
150008095|NCT02615691|541164054|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
150008096|NCT02615691|541164054|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
150008097|NCT02615691|541164054|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
150008098|NCT00881504|541164055|FG000|Overall Study|Withdrawal by Subject|1|||
150008099|NCT01276223|541164056|FG000|Overall Study|Adverse Event|7|||
150008100|NCT01276223|541164057|FG001|Overall Study|Adverse Event|4|||
150008101|NCT01276223|541164058|FG002|Overall Study|Adverse Event|1|||
150008102|NCT01276223|541164056|FG000|Overall Study|Lost to Follow-up|0|||
150008103|NCT01276223|541164057|FG001|Overall Study|Lost to Follow-up|0|||
150008104|NCT01276223|541164058|FG002|Overall Study|Lost to Follow-up|1|||
150008105|NCT01276223|541164056|FG000|Overall Study|Other|0|||
150008106|NCT01276223|541164057|FG001|Overall Study|Other|0|||
150008107|NCT01276223|541164058|FG002|Overall Study|Other|1|||
150008108|NCT01276223|541164056|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
150008109|NCT01276223|541164057|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
150008110|NCT01276223|541164058|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
150008111|NCT01276223|541164056|FG000|Overall Study|Protocol Violation|1|||
150008112|NCT01276223|541164057|FG001|Overall Study|Protocol Violation|0|||
150008113|NCT01276223|541164058|FG002|Overall Study|Protocol Violation|0|||
150008114|NCT02017522|541164059|FG000|Overall Study|Withdrawal by Subject|1|||
150008115|NCT05856227|541164060|FG000|Overall Study|Adverse Event|0|||
150008116|NCT05856227|541164061|FG001|Overall Study|Adverse Event|1|||
150008117|NCT05856227|541164060|FG000|Overall Study|Due to Investigator absence|1|||
150008118|NCT05856227|541164061|FG001|Overall Study|Due to Investigator absence|0|||
150008119|NCT05856227|541164060|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
150008120|NCT05856227|541164061|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
150008121|NCT02596230|541164062|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
150008122|NCT02596230|541164063|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
150008123|NCT02596230|541164064|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
150008124|NCT02596230|541164065|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
150008125|NCT02596230|541164066|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
150008126|NCT02596230|541164062|FG000|Objective 2, One Year|Lost to Follow-up|0|||
150008127|NCT02596230|541164063|FG001|Objective 2, One Year|Lost to Follow-up|41|||
150008128|NCT02596230|541164064|FG002|Objective 2, One Year|Lost to Follow-up|41|||
150008129|NCT02596230|541164065|FG003|Objective 2, One Year|Lost to Follow-up|32|||
150008130|NCT02596230|541164066|FG004|Objective 2, One Year|Lost to Follow-up|46|||
150008131|NCT02596230|541164062|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
150008132|NCT02596230|541164063|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
150008133|NCT02596230|541164064|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
150008134|NCT02596230|541164065|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
150056476|NCT02108262|541348309|FG001|Overall Study|Due to key hepatic values|1|||
150008135|NCT02596230|541164066|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
150008136|NCT02596230|541164062|FG000|Objective 2, One Year|Adverse drug reaction|0|||
150008137|NCT02596230|541164063|FG001|Objective 2, One Year|Adverse drug reaction|1|||
150008138|NCT02596230|541164064|FG002|Objective 2, One Year|Adverse drug reaction|0|||
150008139|NCT02596230|541164065|FG003|Objective 2, One Year|Adverse drug reaction|0|||
150008140|NCT02596230|541164066|FG004|Objective 2, One Year|Adverse drug reaction|0|||
150008141|NCT02596230|541164062|FG000|Objective 2, One Year|Death|0|||
150008142|NCT02596230|541164063|FG001|Objective 2, One Year|Death|12|||
150008143|NCT02596230|541164064|FG002|Objective 2, One Year|Death|41|||
150008144|NCT02596230|541164065|FG003|Objective 2, One Year|Death|21|||
150008145|NCT02596230|541164066|FG004|Objective 2, One Year|Death|30|||
150008146|NCT02596230|541164062|FG000|Objective 2, One Year|Other|0|||
150008147|NCT02596230|541164063|FG001|Objective 2, One Year|Other|3|||
150008148|NCT02596230|541164064|FG002|Objective 2, One Year|Other|2|||
150008149|NCT02596230|541164065|FG003|Objective 2, One Year|Other|0|||
150008150|NCT02596230|541164066|FG004|Objective 2, One Year|Other|0|||
150008151|NCT01571232|541164067|FG000|Overall Study|Lost to Follow-up|0|||
150008152|NCT01571232|541164068|FG001|Overall Study|Lost to Follow-up|1|||
150008153|NCT01571232|541164067|FG000|Overall Study|Withdrawal by Subject|1|||
150008154|NCT01571232|541164068|FG001|Overall Study|Withdrawal by Subject|0|||
150008155|NCT02704689|541164070|FG000|Overall Study|Physician Decision|1|||
150008156|NCT02704689|541164070|FG000|Overall Study|Study device not implanted|2|||
150008157|NCT00802893|541164071|FG000|Overall Study|study terminated|3|||
150008158|NCT04051827|541164074|FG000|Overall Study|Death|1|||
150008159|NCT04051827|541164074|FG000|Overall Study|Withdrawal by Subject|4|||
150008160|NCT04051827|541164074|FG000|Overall Study|Progressive disease|16|||
150008161|NCT04051827|541164074|FG000|Overall Study|Physician Decision|1|||
150008162|NCT04051827|541164074|FG000|Overall Study|Other|4|||
150008163|NCT01646203|541164079|FG000|Overall Study|Adverse Event|2|||
150008164|NCT01646203|541164080|FG001|Overall Study|Adverse Event|0|||
150008165|NCT01646203|541164081|FG002|Overall Study|Adverse Event|1|||
150008166|NCT01646203|541164079|FG000|Overall Study|Withdrawal by Subject|0|||
150008167|NCT01646203|541164080|FG001|Overall Study|Withdrawal by Subject|1|||
150008168|NCT01646203|541164081|FG002|Overall Study|Withdrawal by Subject|0|||
150008169|NCT01646203|541164079|FG000|Overall Study|Physician's Decision|0|||
150008170|NCT01646203|541164080|FG001|Overall Study|Physician's Decision|1|||
150008171|NCT01646203|541164081|FG002|Overall Study|Physician's Decision|0|||
150008172|NCT02717130|541164083|FG000|Overall Study|Withdrawal by Subject|1|||
150008173|NCT02717130|541164083|FG000|Overall Study|Adverse Event|1|||
150008174|NCT02717130|541164083|FG000|Overall Study|Physician Decision|1|||
150008175|NCT02717130|541164083|FG000|Overall Study|Study Closure|4|||
150008176|NCT02335424|541164084|FG000|Overall Study|Withdrawal by Subject|19|||
150008177|NCT02335424|541164084|FG000|Overall Study|Adverse Event|25|||
150008178|NCT02335424|541164084|FG000|Overall Study|Death|273|||
150008179|NCT02335424|541164084|FG000|Overall Study|Lost to Follow-up|3|||
150008180|NCT02335424|541164084|FG000|Overall Study|Physician Decision|13|||
150008181|NCT02335424|541164084|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
150008182|NCT02335424|541164084|FG000|Overall Study|Protocol Violation|1|||
150008183|NCT02335424|541164084|FG000|Overall Study|Screen failure|1|||
150008184|NCT00548717|541164085|FG000|Overall Study|Death|5|||
150008185|NCT00548717|541164086|FG001|Overall Study|Death|2|||
150008186|NCT00548717|541164085|FG000|Overall Study|Relapse|3|||
150008187|NCT00548717|541164086|FG001|Overall Study|Relapse|0|||
150008188|NCT00548717|541164085|FG000|Overall Study|Alternative treatment for GVHD|1|||
150008189|NCT00548717|541164086|FG001|Overall Study|Alternative treatment for GVHD|0|||
150008190|NCT02712424|541164087|FG000|Overall Study|Lost to Follow-up|34|||
150008191|NCT02712424|541164088|FG001|Overall Study|Lost to Follow-up|32|||
150008192|NCT02809053|541164089|FG000|Overall Study|Death|0|||
150008193|NCT02809053|541164090|FG001|Overall Study|Death|1|||
150008194|NCT02809053|541164089|FG000|Overall Study|Lost to Follow-up|3|||
150008195|NCT02809053|541164090|FG001|Overall Study|Lost to Follow-up|1|||
150008196|NCT02809053|541164089|FG000|Overall Study|Withdrawal by Subject|2|||
150008197|NCT02809053|541164090|FG001|Overall Study|Withdrawal by Subject|3|||
150008198|NCT02809053|541164089|FG000|Overall Study|Disease Progression|2|||
150008199|NCT02809053|541164090|FG001|Overall Study|Disease Progression|1|||
150008200|NCT00908037|541164093|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008201|NCT00908037|541164094|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008202|NCT00908037|541164095|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008203|NCT00908037|541164096|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008204|NCT00908037|541164097|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
150008205|NCT00908037|541164098|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008206|NCT00908037|541164099|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
150008207|NCT00908037|541164100|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008208|NCT00908037|541164101|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
150008209|NCT00908037|541164102|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008210|NCT00908037|541164103|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008211|NCT00908037|541164104|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
150008212|NCT00908037|541164093|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008213|NCT00908037|541164094|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008214|NCT00908037|541164095|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008215|NCT00908037|541164096|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008216|NCT00908037|541164097|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
150008217|NCT00908037|541164098|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008218|NCT00908037|541164099|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008219|NCT00908037|541164100|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008220|NCT00908037|541164101|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
150008221|NCT00908037|541164102|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008222|NCT00908037|541164103|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008223|NCT00908037|541164104|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
150008224|NCT00908037|541164093|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008225|NCT00908037|541164094|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008226|NCT00908037|541164095|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008227|NCT00908037|541164096|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
150008228|NCT00908037|541164097|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008229|NCT00908037|541164098|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008230|NCT00908037|541164099|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
150008231|NCT00908037|541164100|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008232|NCT00908037|541164101|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008233|NCT00908037|541164102|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008234|NCT00908037|541164103|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008235|NCT00908037|541164104|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
150008236|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008237|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008238|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008239|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008240|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008241|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008242|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008243|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008244|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008245|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008246|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
150008247|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
150008248|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008249|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008250|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008251|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008252|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008253|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008254|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008255|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008256|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008257|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
150008258|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
150008259|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
150008260|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150180118|NCT02723955|541799362|FG008|Escalation Phase|Physician Decision|0|||
150180119|NCT02723955|541799363|FG009|Escalation Phase|Physician Decision|0|||
150180120|NCT02723955|541799364|FG010|Escalation Phase|Physician Decision|0|||
150180121|NCT02723955|541799365|FG011|Escalation Phase|Physician Decision|0|||
150180122|NCT02723955|541799366|FG012|Escalation Phase|Physician Decision|0|||
150008261|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008262|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008263|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008264|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008265|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008266|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150255178|NCT02929329|542070581|FG001|Overall Study|Lost to Follow-up|20|||
150008267|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008268|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008269|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
150008270|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008271|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
150008272|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008273|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008274|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008275|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008276|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008277|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008278|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008279|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008280|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008281|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008282|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
150008283|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
150008284|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008285|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008286|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008287|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008288|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008289|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008290|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008291|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008292|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008293|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
150008294|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008295|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
150008296|NCT00908037|541164093|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008297|NCT00908037|541164094|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008298|NCT00908037|541164095|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008299|NCT00908037|541164096|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008300|NCT00908037|541164097|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008301|NCT00908037|541164098|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008302|NCT00908037|541164099|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008303|NCT00908037|541164100|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008304|NCT00908037|541164101|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008305|NCT00908037|541164102|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008306|NCT00908037|541164103|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
150008307|NCT00908037|541164104|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
150008308|NCT02565810|541164105|FG000|Overall Study|Withdrawal by Subject|1|||
150008309|NCT02723175|541164106|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
150008310|NCT02723175|541164107|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
150008311|NCT02723175|541164106|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
150008312|NCT02723175|541164107|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
150008313|NCT04109976|541164108|FG000|Overall Study|Withdrawal by Subject|1|||
150008314|NCT04109976|541164109|FG001|Overall Study|Withdrawal by Subject|0|||
150008315|NCT00491608|541164110|FG000|Overall Study|Death|2|||
150008316|NCT00491608|541164110|FG000|Overall Study|Withdrawal by Subject|1|||
150008317|NCT00025155|541164111|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
150008318|NCT00025155|541164111|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
150008319|NCT05086510|541164116|FG000|Overall Study|Lost to Follow-up|0|||
150056477|NCT02108262|541348310|FG002|Overall Study|Due to key hepatic values|0|||
150008320|NCT05086510|541164117|FG001|Overall Study|Lost to Follow-up|2|||
150008321|NCT05086510|541164116|FG000|Overall Study|Death|0|||
150008322|NCT05086510|541164117|FG001|Overall Study|Death|2|||
150008323|NCT00413374|541164118|FG000|Overall Study|Ineligible due to screening criteria.|3|||
150008324|NCT00413374|541164119|FG001|Overall Study|Ineligible due to screening criteria.|0|||
150008325|NCT00413374|541164118|FG000|Overall Study|Adverse Event|1|||
150008326|NCT00413374|541164119|FG001|Overall Study|Adverse Event|0|||
150008327|NCT00413374|541164118|FG000|Overall Study|Lost to Follow-up|1|||
150008328|NCT00413374|541164119|FG001|Overall Study|Lost to Follow-up|0|||
150008329|NCT00413374|541164118|FG000|Overall Study|Surgery|1|||
150008330|NCT00413374|541164119|FG001|Overall Study|Surgery|0|||
150008331|NCT00552760|541164120|FG000|Overall Study|Adverse Event|3|||
150008332|NCT00552760|541164121|FG001|Overall Study|Adverse Event|5|||
150008333|NCT00552760|541164120|FG000|Overall Study|Relapsed- Depressed Event|10|||
150008334|NCT00552760|541164121|FG001|Overall Study|Relapsed- Depressed Event|16|||
150008335|NCT00552760|541164120|FG000|Overall Study|Relapse- Manic Event|3|||
150008336|NCT00552760|541164121|FG001|Overall Study|Relapse- Manic Event|3|||
150008337|NCT00552760|541164120|FG000|Overall Study|Relapsed- Mixed Event|3|||
150008338|NCT00552760|541164121|FG001|Overall Study|Relapsed- Mixed Event|5|||
150008339|NCT00552760|541164120|FG000|Overall Study|Protocol Violation|0|||
150008340|NCT00552760|541164121|FG001|Overall Study|Protocol Violation|1|||
150008341|NCT00552760|541164120|FG000|Overall Study|Lost to Follow-up|1|||
150008342|NCT00552760|541164121|FG001|Overall Study|Lost to Follow-up|1|||
150008343|NCT00552760|541164120|FG000|Overall Study|Non-compliance|1|||
150008344|NCT00552760|541164121|FG001|Overall Study|Non-compliance|1|||
150008345|NCT00552760|541164120|FG000|Overall Study|Medical Condition|1|||
150008346|NCT00552760|541164121|FG001|Overall Study|Medical Condition|1|||
150008347|NCT00552760|541164120|FG000|Overall Study|Withdrawal by Subject|3|||
150008348|NCT00552760|541164121|FG001|Overall Study|Withdrawal by Subject|0|||
150008349|NCT00552760|541164120|FG000|Overall Study|Medication Change|1|||
150008350|NCT00552760|541164121|FG001|Overall Study|Medication Change|0|||
150008351|NCT03022981|541164122|FG000|Overall Study|Adverse Event|0|||
150008352|NCT03022981|541164123|FG001|Overall Study|Adverse Event|1|||
150008353|NCT03022981|541164124|FG002|Overall Study|Adverse Event|0|||
150008354|NCT03022981|541164122|FG000|Overall Study|Investigator's Discretion|0|||
150008355|NCT03022981|541164123|FG001|Overall Study|Investigator's Discretion|1|||
150008356|NCT03022981|541164124|FG002|Overall Study|Investigator's Discretion|2|||
150008357|NCT03022981|541164122|FG000|Overall Study|Lost to Follow-up|6|||
150008358|NCT03022981|541164123|FG001|Overall Study|Lost to Follow-up|2|||
150008359|NCT03022981|541164124|FG002|Overall Study|Lost to Follow-up|1|||
150008360|NCT03022981|541164122|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150008361|NCT03022981|541164123|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150008362|NCT03022981|541164124|FG002|Overall Study|Non-Compliance With Study Drug|2|||
150008363|NCT03022981|541164122|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
150008364|NCT03022981|541164123|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
150008365|NCT03022981|541164124|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
150008366|NCT03615066|541164126|FG000|Main Study|Withdrew Consent|0|||
150008367|NCT03615066|541164127|FG001|Main Study|Withdrew Consent|1|||
150008368|NCT03615066|541164128|FG002|Main Study|Withdrew Consent|1|||
150008369|NCT03615066|541164126|FG000|Main Study|Lost to Follow-up|0|||
150008370|NCT03615066|541164127|FG001|Main Study|Lost to Follow-up|0|||
150008371|NCT03615066|541164128|FG002|Main Study|Lost to Follow-up|1|||
150008372|NCT03615066|541164126|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
150008373|NCT03615066|541164127|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
150008374|NCT03615066|541164128|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
150008375|NCT03615066|541164126|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
150008376|NCT03615066|541164127|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
150008377|NCT03615066|541164128|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
150008378|NCT03615066|541164126|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
150008379|NCT03615066|541164127|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
150008380|NCT03615066|541164128|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
150008381|NCT00924404|541164131|FG000|Overall Study|Lost to Follow-up|6|||
150008382|NCT00924404|541164132|FG001|Overall Study|Lost to Follow-up|4|||
150008383|NCT01459913|541164141|FG000|Overall Study|Adverse Event|0|||
150008384|NCT01459913|541164142|FG001|Overall Study|Adverse Event|0|||
150008385|NCT01459913|541164143|FG002|Overall Study|Adverse Event|0|||
150008386|NCT01459913|541164144|FG003|Overall Study|Adverse Event|3|||
150008387|NCT01459913|541164141|FG000|Overall Study|Withdrawal by Subject|4|||
150008388|NCT01459913|541164142|FG001|Overall Study|Withdrawal by Subject|0|||
150008389|NCT01459913|541164143|FG002|Overall Study|Withdrawal by Subject|0|||
150008390|NCT01459913|541164144|FG003|Overall Study|Withdrawal by Subject|5|||
150008391|NCT01459913|541164141|FG000|Overall Study|Lost to Follow-up|7|||
150008392|NCT01459913|541164142|FG001|Overall Study|Lost to Follow-up|4|||
150008393|NCT01459913|541164143|FG002|Overall Study|Lost to Follow-up|1|||
150008394|NCT01459913|541164144|FG003|Overall Study|Lost to Follow-up|8|||
150008395|NCT01459913|541164141|FG000|Overall Study|Death|0|||
150008396|NCT01459913|541164142|FG001|Overall Study|Death|0|||
150008397|NCT01459913|541164143|FG002|Overall Study|Death|0|||
150008398|NCT01459913|541164144|FG003|Overall Study|Death|1|||
150008399|NCT01459913|541164141|FG000|Overall Study|Non- Compliance|0|||
150008400|NCT01459913|541164142|FG001|Overall Study|Non- Compliance|0|||
150008401|NCT01459913|541164143|FG002|Overall Study|Non- Compliance|0|||
150008402|NCT01459913|541164144|FG003|Overall Study|Non- Compliance|3|||
150008403|NCT01459913|541164141|FG000|Overall Study|Physician Decision|0|||
150008404|NCT01459913|541164142|FG001|Overall Study|Physician Decision|1|||
150008405|NCT01459913|541164143|FG002|Overall Study|Physician Decision|0|||
150008406|NCT01459913|541164144|FG003|Overall Study|Physician Decision|0|||
150008407|NCT01459913|541164141|FG000|Overall Study|Study Terminated by Sponsor|30|||
150008408|NCT01459913|541164142|FG001|Overall Study|Study Terminated by Sponsor|15|||
150008409|NCT01459913|541164143|FG002|Overall Study|Study Terminated by Sponsor|9|||
150008410|NCT01459913|541164144|FG003|Overall Study|Study Terminated by Sponsor|11|||
150008411|NCT01459913|541164141|FG000|Overall Study|Other|0|||
150008412|NCT01459913|541164142|FG001|Overall Study|Other|0|||
150008413|NCT01459913|541164143|FG002|Overall Study|Other|3|||
150008414|NCT01459913|541164144|FG003|Overall Study|Other|1|||
150008415|NCT01459913|541164141|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
150008416|NCT01459913|541164142|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
150008417|NCT01459913|541164143|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
150008418|NCT01459913|541164144|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
150008419|NCT01064687|541164145|FG000|Overall Study|Adverse Event|9|||
150008420|NCT01064687|541164146|FG001|Overall Study|Adverse Event|4|||
150008421|NCT01064687|541164147|FG002|Overall Study|Adverse Event|10|||
150008422|NCT01064687|541164148|FG003|Overall Study|Adverse Event|3|||
150008423|NCT01064687|541164145|FG000|Overall Study|Death|1|||
150008424|NCT01064687|541164146|FG001|Overall Study|Death|1|||
150008425|NCT01064687|541164147|FG002|Overall Study|Death|0|||
150008426|NCT01064687|541164148|FG003|Overall Study|Death|0|||
150008427|NCT01064687|541164145|FG000|Overall Study|Entry Criteria Not Met|3|||
150008428|NCT01064687|541164146|FG001|Overall Study|Entry Criteria Not Met|0|||
150008429|NCT01064687|541164147|FG002|Overall Study|Entry Criteria Not Met|0|||
150008430|NCT01064687|541164148|FG003|Overall Study|Entry Criteria Not Met|0|||
150008431|NCT01064687|541164145|FG000|Overall Study|Lack of Efficacy|1|||
150008432|NCT01064687|541164146|FG001|Overall Study|Lack of Efficacy|0|||
150008433|NCT01064687|541164147|FG002|Overall Study|Lack of Efficacy|2|||
150008434|NCT01064687|541164148|FG003|Overall Study|Lack of Efficacy|3|||
150008435|NCT01064687|541164145|FG000|Overall Study|Lost to Follow-up|7|||
150008436|NCT01064687|541164146|FG001|Overall Study|Lost to Follow-up|10|||
150008437|NCT01064687|541164147|FG002|Overall Study|Lost to Follow-up|13|||
150008438|NCT01064687|541164148|FG003|Overall Study|Lost to Follow-up|5|||
150008439|NCT01064687|541164145|FG000|Overall Study|Physician Decision|2|||
150008440|NCT01064687|541164146|FG001|Overall Study|Physician Decision|2|||
150008441|NCT01064687|541164147|FG002|Overall Study|Physician Decision|0|||
150008442|NCT01064687|541164148|FG003|Overall Study|Physician Decision|0|||
150008443|NCT01064687|541164145|FG000|Overall Study|Protocol Violation|1|||
150008444|NCT01064687|541164146|FG001|Overall Study|Protocol Violation|1|||
150008445|NCT01064687|541164147|FG002|Overall Study|Protocol Violation|0|||
150008446|NCT01064687|541164148|FG003|Overall Study|Protocol Violation|1|||
150008447|NCT01064687|541164145|FG000|Overall Study|Sponsor Decision|0|||
150008448|NCT01064687|541164146|FG001|Overall Study|Sponsor Decision|0|||
150008449|NCT01064687|541164147|FG002|Overall Study|Sponsor Decision|3|||
150008450|NCT01064687|541164148|FG003|Overall Study|Sponsor Decision|0|||
150008451|NCT01064687|541164145|FG000|Overall Study|Withdrawal by Subject|9|||
150008452|NCT01064687|541164146|FG001|Overall Study|Withdrawal by Subject|7|||
150008453|NCT01064687|541164147|FG002|Overall Study|Withdrawal by Subject|12|||
150008454|NCT01064687|541164148|FG003|Overall Study|Withdrawal by Subject|5|||
150008455|NCT01064687|541164145|FG000|Overall Study|Treatment Noncompliance|1|||
150008456|NCT01064687|541164146|FG001|Overall Study|Treatment Noncompliance|1|||
150008457|NCT01064687|541164147|FG002|Overall Study|Treatment Noncompliance|1|||
150008458|NCT01064687|541164148|FG003|Overall Study|Treatment Noncompliance|0|||
150008459|NCT02966015|541164149|FG000|Inclusion Visit|did not answer questionnaire|8|||
150008460|NCT02966015|541164150|FG001|Inclusion Visit|did not answer questionnaire|3|||
150008461|NCT02177838|541164153|FG000|Overall Study|Withdrawal by Subject|1|||
150008462|NCT02177838|541164153|FG000|Overall Study|Physician Decision|1|||
150008463|NCT02177838|541164153|FG000|Overall Study|Death|1|||
150008464|NCT02383433|541164155|FG000|Overall Study|Disease progression|2|||
150008465|NCT02477553|541164158|FG000|Overall Study|Screening up-to-date|12|||
150008466|NCT02477553|541164159|FG001|Overall Study|Screening up-to-date|13|||
150008467|NCT02477553|541164158|FG000|Overall Study|No MD visit|1|||
150008468|NCT02477553|541164159|FG001|Overall Study|No MD visit|1|||
150008469|NCT02477553|541164158|FG000|Overall Study|Workup consistent w/CRC|1|||
150008470|NCT02477553|541164159|FG001|Overall Study|Workup consistent w/CRC|1|||
150180123|NCT02723955|541799367|FG013|Escalation Phase|Physician Decision|0|||
150180124|NCT02723955|541799368|FG014|Escalation Phase|Physician Decision|0|||
150008471|NCT02477553|541164158|FG000|Overall Study|Technical issues with intervention|2|||
150008472|NCT02477553|541164159|FG001|Overall Study|Technical issues with intervention|0|||
150008473|NCT02477553|541164158|FG000|Overall Study|Elevated risk for CRC|2|||
150008474|NCT02477553|541164159|FG001|Overall Study|Elevated risk for CRC|2|||
150008475|NCT02477553|541164158|FG000|Overall Study|MD advised against screening|1|||
150008476|NCT02477553|541164159|FG001|Overall Study|MD advised against screening|3|||
150008477|NCT02477553|541164158|FG000|Overall Study|patient deceased|1|||
150008478|NCT02477553|541164159|FG001|Overall Study|patient deceased|0|||
150008479|NCT04311463|541164160|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
150008480|NCT04311463|541164161|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
150008481|NCT04311463|541164160|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
150008482|NCT04311463|541164161|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
150008483|NCT04311463|541164160|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
150008484|NCT04311463|541164161|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
150008485|NCT00952614|541164162|FG000|Overall Study|Death|3|||
150008486|NCT00952614|541164162|FG000|Overall Study|Lost to Follow-up|3|||
150008487|NCT00952614|541164162|FG000|Overall Study|other reason|1|||
150008488|NCT00737633|541164163|FG000|Overall Study|Study terminated by sponsor|44|||
150008489|NCT00737633|541164164|FG001|Overall Study|Study terminated by sponsor|55|||
150008490|NCT00737633|541164163|FG000|Overall Study|Lost to Follow-up|0|||
150008491|NCT00737633|541164164|FG001|Overall Study|Lost to Follow-up|1|||
150008492|NCT00737633|541164163|FG000|Overall Study|protocol non-compliance|0|||
150008493|NCT00737633|541164164|FG001|Overall Study|protocol non-compliance|1|||
150008494|NCT00377364|541164165|FG000|Overall Study|Lost to Follow-up|1|||
150008495|NCT00377364|541164166|FG001|Overall Study|Lost to Follow-up|0|||
150008496|NCT00377364|541164165|FG000|Overall Study|Withdrawal by Subject|1|||
150008497|NCT00377364|541164166|FG001|Overall Study|Withdrawal by Subject|0|||
150008498|NCT02986854|541164167|FG000|Overall Study|Withdrawal by Subject|0|||
150008499|NCT02986854|541164168|FG001|Overall Study|Withdrawal by Subject|1|||
150008500|NCT02986854|541164169|FG002|Overall Study|Withdrawal by Subject|1|||
150008501|NCT02986854|541164167|FG000|Overall Study|Lost to Follow-up|3|||
150008502|NCT02986854|541164168|FG001|Overall Study|Lost to Follow-up|11|||
150008503|NCT02986854|541164169|FG002|Overall Study|Lost to Follow-up|2|||
150008504|NCT00695864|541164172|FG000|Placebo|Withdrawal by Subject|1|||
150008505|NCT00695864|541164172|FG000|Placebo|Physician Decision|4|||
150008506|NCT01403116|541164173|FG000|Overall Study|Adverse Event|7|||
150008507|NCT01403116|541164174|FG001|Overall Study|Adverse Event|4|||
150008508|NCT01403116|541164173|FG000|Overall Study|Lost to Follow-up|7|||
150008509|NCT01403116|541164174|FG001|Overall Study|Lost to Follow-up|5|||
150008510|NCT01403116|541164173|FG000|Overall Study|Withdrawal by Subject|12|||
150008511|NCT01403116|541164174|FG001|Overall Study|Withdrawal by Subject|15|||
150008512|NCT01403116|541164173|FG000|Overall Study|Non-compliance of study drug|3|||
150008513|NCT01403116|541164174|FG001|Overall Study|Non-compliance of study drug|0|||
150008514|NCT01403116|541164173|FG000|Overall Study|Protocol Violation|0|||
150008515|NCT01403116|541164174|FG001|Overall Study|Protocol Violation|1|||
150008516|NCT01403116|541164173|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
150008517|NCT01403116|541164174|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
150008518|NCT01403116|541164173|FG000|Overall Study|Hct >54%|2|||
150008519|NCT01403116|541164174|FG001|Overall Study|Hct >54%|0|||
150008520|NCT01403116|541164173|FG000|Overall Study|unable to keep appointments|0|||
150008521|NCT01403116|541164174|FG001|Overall Study|unable to keep appointments|2|||
150008522|NCT02409342|541164175|FG000|Overall Study|Death|211|||
150008523|NCT02409342|541164176|FG001|Overall Study|Death|201|||
150008524|NCT02409342|541164175|FG000|Overall Study|Withdrawal by Subject|24|||
150008525|NCT02409342|541164176|FG001|Overall Study|Withdrawal by Subject|17|||
150008526|NCT02409342|541164175|FG000|Overall Study|Study Terminated By Sponsor|48|||
150008527|NCT02409342|541164176|FG001|Overall Study|Study Terminated By Sponsor|59|||
150008528|NCT02409342|541164175|FG000|Overall Study|Lost to Follow-up|3|||
150008529|NCT02409342|541164176|FG001|Overall Study|Lost to Follow-up|5|||
150008530|NCT02409342|541164175|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
150008531|NCT02409342|541164176|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
150008532|NCT02409342|541164175|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
150008533|NCT02409342|541164176|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
150008534|NCT02409342|541164175|FG000|Overall Study|Sponsor Decision|1|||
150008535|NCT02409342|541164176|FG001|Overall Study|Sponsor Decision|0|||
150008536|NCT00279812|541164177|FG000|Overall Study|Protocol Violation|1|||
150180125|NCT02723955|541799369|FG015|Escalation Phase|Physician Decision|0|||
150008537|NCT00279812|541164178|FG001|Overall Study|Protocol Violation|1|||
150180126|NCT02723955|541799370|FG016|Escalation Phase|Physician Decision|0|||
150008538|NCT00279812|541164179|FG002|Overall Study|Protocol Violation|0|||
150008539|NCT00279812|541164180|FG003|Overall Study|Protocol Violation|0|||
150008540|NCT00279812|541164181|FG004|Overall Study|Protocol Violation|1|||
150008541|NCT00279812|541164182|FG005|Overall Study|Protocol Violation|0|||
150008542|NCT00279812|541164177|FG000|Overall Study|Withdrawal by Subject|0|||
150008543|NCT00279812|541164178|FG001|Overall Study|Withdrawal by Subject|4|||
150008544|NCT00279812|541164179|FG002|Overall Study|Withdrawal by Subject|2|||
150008545|NCT00279812|541164180|FG003|Overall Study|Withdrawal by Subject|0|||
150008546|NCT00279812|541164181|FG004|Overall Study|Withdrawal by Subject|0|||
150008547|NCT00279812|541164182|FG005|Overall Study|Withdrawal by Subject|0|||
150008548|NCT00279812|541164177|FG000|Overall Study|Adverse Event|0|||
150008549|NCT00279812|541164178|FG001|Overall Study|Adverse Event|1|||
150008550|NCT00279812|541164179|FG002|Overall Study|Adverse Event|1|||
150008551|NCT00279812|541164180|FG003|Overall Study|Adverse Event|0|||
150008552|NCT00279812|541164181|FG004|Overall Study|Adverse Event|2|||
150008553|NCT00279812|541164182|FG005|Overall Study|Adverse Event|1|||
150008554|NCT05327361|541164183|FG000|Overall Study|Lost to Follow-up|4|||
150008555|NCT02720692|541165811|FG000|Overall Study|Withdrawal by Subject|3|||
150008556|NCT02720692|541165812|FG001|Overall Study|Withdrawal by Subject|0|||
150008557|NCT02720692|541165811|FG000|Overall Study|Physician Decision|1|||
150008558|NCT02720692|541165812|FG001|Overall Study|Physician Decision|0|||
150008559|NCT02720692|541165811|FG000|Overall Study|Lost to Follow-up|8|||
150008560|NCT02720692|541165812|FG001|Overall Study|Lost to Follow-up|3|||
150008561|NCT02720692|541165811|FG000|Overall Study|Subject unable to return for visit|1|||
150008562|NCT02720692|541165812|FG001|Overall Study|Subject unable to return for visit|0|||
150008563|NCT02503501|541165813|FG000|Overall Study|Physician Decision|1|||
150008564|NCT02503501|541165814|FG001|Overall Study|Physician Decision|0|||
150008565|NCT02503501|541165813|FG000|Overall Study|Protocol Violation|0|||
150008566|NCT02503501|541165814|FG001|Overall Study|Protocol Violation|1|||
150008567|NCT02503501|541165813|FG000|Overall Study|Withdrawal by Subject|0|||
150008568|NCT02503501|541165814|FG001|Overall Study|Withdrawal by Subject|2|||
150008569|NCT01740401|541165815|FG000|Overall Study|Progression of disease|6|||
150008570|NCT01740401|541165815|FG000|Overall Study|Adverse Event|2|||
150008571|NCT01740401|541165815|FG000|Overall Study|Did not reach primary endpoint|2|||
150056478|NCT02108262|541348311|FG003|Overall Study|Due to key hepatic values|0|||
150056479|NCT02108262|541348308|FG000|Overall Study|Unable to contact patient|0|||
150056480|NCT02108262|541348309|FG001|Overall Study|Unable to contact patient|3|||
150056481|NCT02108262|541348310|FG002|Overall Study|Unable to contact patient|1|||
150056482|NCT02108262|541348311|FG003|Overall Study|Unable to contact patient|2|||
150056483|NCT02108262|541348308|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
150056484|NCT02108262|541348309|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
150056485|NCT02108262|541348310|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
150056486|NCT02108262|541348311|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
150056487|NCT02108262|541348308|FG000|Overall Study|Patient did not want another infusion|0|||
150056488|NCT02108262|541348309|FG001|Overall Study|Patient did not want another infusion|3|||
150056489|NCT02108262|541348310|FG002|Overall Study|Patient did not want another infusion|3|||
150056490|NCT02108262|541348311|FG003|Overall Study|Patient did not want another infusion|2|||
150056491|NCT02108262|541348308|FG000|Overall Study|Vacation|0|||
150056492|NCT02108262|541348309|FG001|Overall Study|Vacation|1|||
150056493|NCT02108262|541348310|FG002|Overall Study|Vacation|0|||
150056494|NCT02108262|541348311|FG003|Overall Study|Vacation|0|||
150056495|NCT02108262|541348308|FG000|Overall Study|Patient decision|0|||
150056496|NCT02108262|541348309|FG001|Overall Study|Patient decision|7|||
150056497|NCT02108262|541348310|FG002|Overall Study|Patient decision|9|||
150056498|NCT02108262|541348311|FG003|Overall Study|Patient decision|14|||
150056499|NCT02108262|541348308|FG000|Overall Study|Missed IV due to pharmacy error|0|||
150056500|NCT02108262|541348309|FG001|Overall Study|Missed IV due to pharmacy error|0|||
150056501|NCT02108262|541348310|FG002|Overall Study|Missed IV due to pharmacy error|1|||
150056502|NCT02108262|541348311|FG003|Overall Study|Missed IV due to pharmacy error|0|||
150056503|NCT05027971|541348312|FG000|Overall Study|Physician Decision|7|||
150056504|NCT05027971|541348313|FG001|Overall Study|Physician Decision|3|||
150056505|NCT05027971|541348312|FG000|Overall Study|Lost to Follow-up|1|||
150056506|NCT05027971|541348313|FG001|Overall Study|Lost to Follow-up|1|||
150056507|NCT05027971|541348312|FG000|Overall Study|Withdrawal by Subject|0|||
150056508|NCT05027971|541348313|FG001|Overall Study|Withdrawal by Subject|2|||
150008572|NCT03878758|541165816|FG000|Overall Study|Withdrawal by Subject|1|||
150056509|NCT05027971|541348312|FG000|Overall Study|Non-study fiber used.|0|||
150056510|NCT05027971|541348313|FG001|Overall Study|Non-study fiber used.|1|||
150056511|NCT05027971|541348312|FG000|Overall Study|Protocol Violation|0|||
150056512|NCT05027971|541348313|FG001|Overall Study|Protocol Violation|2|||
150056513|NCT02486627|541348314|FG000|Overall Study|Death|1|||
150056514|NCT02486627|541348315|FG001|Overall Study|Death|0|||
150056515|NCT02486627|541348314|FG000|Overall Study|Other Unspecified|0|||
150056516|NCT02486627|541348315|FG001|Overall Study|Other Unspecified|2|||
150255179|NCT02929329|542070580|FG000|Overall Study|Death|1054|||
150008573|NCT03878758|541165816|FG000|Overall Study|Protocol defined|2|||
150008574|NCT03878758|541165816|FG000|Overall Study|Improper consent documentation|1|||
150255180|NCT02929329|542070581|FG001|Overall Study|Death|1051|||
150008575|NCT01769196|541165817|FG000|Overall Study|Adverse Event|24|||
150008576|NCT01769196|541165818|FG001|Overall Study|Adverse Event|20|||
150056517|NCT02486627|541348314|FG000|Overall Study|Consent Withdrawn by Participant|4|||
150056518|NCT02486627|541348315|FG001|Overall Study|Consent Withdrawn by Participant|3|||
150056519|NCT02486627|541348314|FG000|Overall Study|Significant Participant Noncompliance|1|||
150056520|NCT02486627|541348315|FG001|Overall Study|Significant Participant Noncompliance|1|||
150056521|NCT02486627|541348314|FG000|Overall Study|Lost to Follow-up|1|||
150056522|NCT02486627|541348315|FG001|Overall Study|Lost to Follow-up|3|||
150056523|NCT01238588|541348316|FG000|Overall Study|Withdrawal by Subject|1|||
150056524|NCT01238588|541348316|FG000|Overall Study|Physician Decision|2|||
150056525|NCT01915303|541348319|FG000|Core Phase|Adverse Event|7|||
150056526|NCT01915303|541348319|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
150056527|NCT01915303|541348319|FG000|Core Phase|Death|2|||
150056528|NCT01915303|541348319|FG000|Core Phase|Protocol Violation|2|||
150056529|NCT01915303|541348319|FG000|Core Phase|Abnormal lab value|1|||
150056530|NCT01915303|541348319|FG000|Core Phase|Withdrawal by Subject|1|||
150056531|NCT01915303|541348319|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
150056532|NCT01915303|541348319|FG000|Extension Phase|Withdrawal by Subject|4|||
150056533|NCT01915303|541348319|FG000|Extension Phase|Adverse Event|3|||
150056534|NCT01915303|541348319|FG000|Extension Phase|Death|1|||
150056535|NCT01915303|541348319|FG000|Extension Phase|Protocol Violation|1|||
150056536|NCT00439738|541348324|FG000|Overall Study|Withdrawal by Subject|16|||
150056537|NCT00439738|541348325|FG001|Overall Study|Withdrawal by Subject|13|||
150056538|NCT00439738|541348324|FG000|Overall Study|Adverse Event|6|||
150056539|NCT00439738|541348325|FG001|Overall Study|Adverse Event|4|||
150056540|NCT00439738|541348324|FG000|Overall Study|Lost to Follow-up|5|||
150056541|NCT00439738|541348325|FG001|Overall Study|Lost to Follow-up|6|||
150056542|NCT00439738|541348324|FG000|Overall Study|Protocol Violation|6|||
150056543|NCT00439738|541348325|FG001|Overall Study|Protocol Violation|3|||
150056544|NCT00439738|541348324|FG000|Overall Study|Lack of Efficacy|2|||
150056545|NCT00439738|541348325|FG001|Overall Study|Lack of Efficacy|2|||
150056546|NCT00439738|541348324|FG000|Overall Study|Abnormal Lab Values|1|||
150056547|NCT00439738|541348325|FG001|Overall Study|Abnormal Lab Values|0|||
150056548|NCT01284491|541348327|FG000|Overall Study|Study termination|13|||
150056549|NCT01978938|541348328|FG000|Overall Study|Lost to Follow-up|12|||
150056550|NCT01978938|541348329|FG001|Overall Study|Lost to Follow-up|6|||
150056551|NCT01978938|541348328|FG000|Overall Study|Withdrawal by Subject|8|||
150056552|NCT01978938|541348329|FG001|Overall Study|Withdrawal by Subject|4|||
150056553|NCT01978938|541348328|FG000|Overall Study|Adverse Event, non-fatal|2|||
150056554|NCT01978938|541348329|FG001|Overall Study|Adverse Event, non-fatal|1|||
150056555|NCT01978938|541348328|FG000|Overall Study|Participant noncompliance|1|||
150056556|NCT01978938|541348329|FG001|Overall Study|Participant noncompliance|1|||
150056557|NCT01978938|541348328|FG000|Overall Study|Did not meet inclusion criteria|0|||
150056558|NCT01978938|541348329|FG001|Overall Study|Did not meet inclusion criteria|1|||
150056559|NCT01978938|541348328|FG000|Overall Study|Previously scheduled procedure|0|||
150056560|NCT01978938|541348329|FG001|Overall Study|Previously scheduled procedure|1|||
150056561|NCT02694757|541348330|FG000|Overall Study|Lack of Efficacy|3|||
150056562|NCT02395302|541348331|FG000|Overall Study|Screen Failure|3|||
150056563|NCT02395302|541348331|FG000|Overall Study|Run In Failure|7|||
150056564|NCT02395302|541348331|FG000|Overall Study|Withdrawal by Subject|2|||
150056565|NCT02395302|541348331|FG000|Overall Study|Physician Decision|2|||
150056566|NCT02650921|541348332|FG000|Overall Study|Withdrawal by Subject|4|||
150056567|NCT02650921|541348332|FG000|Overall Study|Lost to Follow-up|2|||
150056568|NCT02650921|541348332|FG000|Overall Study|Adverse Event|1|||
150056569|NCT02650921|541348332|FG000|Overall Study|Due to Medical Condition|1|||
150056570|NCT00783302|541348333|FG000|Overall Study|Lost to Follow-up|17|||
150056571|NCT00783302|541348333|FG000|Overall Study|Technical Problems|11|||
150056572|NCT00783302|541348333|FG000|Overall Study|Protocol Violation|3|||
150056573|NCT00783302|541348333|FG000|Overall Study|Physician Decision|1|||
150056574|NCT00783302|541348333|FG000|Overall Study|Withdrawal by Subject|3|||
150056575|NCT00160667|541348334|FG000|Overall Study|Adverse Event|3|||
150056576|NCT00160667|541348335|FG001|Overall Study|Adverse Event|1|||
150056577|NCT00160667|541348336|FG002|Overall Study|Adverse Event|4|||
150056578|NCT00160667|541348334|FG000|Overall Study|Withdrawal by Subject|2|||
150056579|NCT00160667|541348335|FG001|Overall Study|Withdrawal by Subject|0|||
150056580|NCT00160667|541348336|FG002|Overall Study|Withdrawal by Subject|1|||
150056581|NCT00160667|541348334|FG000|Overall Study|Lack of Efficacy|0|||
150056582|NCT00160667|541348335|FG001|Overall Study|Lack of Efficacy|1|||
150056583|NCT00160667|541348336|FG002|Overall Study|Lack of Efficacy|0|||
150056584|NCT00160667|541348334|FG000|Overall Study|Protocol Violation|0|||
150056585|NCT00160667|541348335|FG001|Overall Study|Protocol Violation|1|||
150056586|NCT00160667|541348336|FG002|Overall Study|Protocol Violation|0|||
150056587|NCT00160667|541348334|FG000|Overall Study|Patient decision|0|||
150056588|NCT00160667|541348335|FG001|Overall Study|Patient decision|0|||
150056589|NCT00160667|541348336|FG002|Overall Study|Patient decision|1|||
150008577|NCT01769196|541165817|FG000|Overall Study|Death|21|||
150008578|NCT01769196|541165818|FG001|Overall Study|Death|26|||
150008579|NCT01769196|541165817|FG000|Overall Study|Investigator Discretion|7|||
150008580|NCT01769196|541165818|FG001|Overall Study|Investigator Discretion|3|||
150008581|NCT01769196|541165817|FG000|Overall Study|Lack of Efficacy|3|||
150008582|NCT01769196|541165818|FG001|Overall Study|Lack of Efficacy|2|||
150008583|NCT01769196|541165817|FG000|Overall Study|Progressive disease|11|||
150008584|NCT01769196|541165818|FG001|Overall Study|Progressive disease|6|||
150008585|NCT01769196|541165817|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
150008586|NCT01769196|541165818|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
150008587|NCT01769196|541165817|FG000|Overall Study|Protocol Violation|0|||
150008588|NCT01769196|541165818|FG001|Overall Study|Protocol Violation|3|||
150008589|NCT01769196|541165817|FG000|Overall Study|Study terminated by sponsor|160|||
150008590|NCT01769196|541165818|FG001|Overall Study|Study terminated by sponsor|161|||
150008591|NCT01769196|541165817|FG000|Overall Study|Participant never dosed with study drug|1|||
150008592|NCT01769196|541165818|FG001|Overall Study|Participant never dosed with study drug|0|||
150008593|NCT01769196|541165817|FG000|Overall Study|Withdrew consent|36|||
150008594|NCT01769196|541165818|FG001|Overall Study|Withdrew consent|40|||
150008595|NCT00765063|541165819|FG000|Overall Study|Lack of Efficacy|5|||
150008596|NCT00765063|541165819|FG000|Overall Study|Withdrawal by Subject|1|||
150008597|NCT00765063|541165819|FG000|Overall Study|Other|16|||
150008598|NCT00765063|541165819|FG000|Overall Study|Protocol Violation|6|||
150008599|NCT00765063|541165819|FG000|Overall Study|Adverse Event|4|||
150008600|NCT03614325|541165820|FG000|Overall Study|Withdrawal by Subject|0|||
150008601|NCT03614325|541165821|FG001|Overall Study|Withdrawal by Subject|2|||
150008602|NCT03614325|541165820|FG000|Overall Study|Surgery Cancelled|2|||
150008603|NCT03614325|541165821|FG001|Overall Study|Surgery Cancelled|1|||
150008604|NCT03614325|541165820|FG000|Overall Study|Lost to Follow-up|2|||
150008605|NCT03614325|541165821|FG001|Overall Study|Lost to Follow-up|1|||
150008606|NCT03614325|541165820|FG000|Overall Study|Surgery never scheduled|1|||
150008607|NCT03614325|541165821|FG001|Overall Study|Surgery never scheduled|0|||
150008608|NCT00321464|541165822|FG000|Overall Study|Death|169|||
150008609|NCT00321464|541165823|FG001|Overall Study|Death|174|||
150008610|NCT00321464|541165822|FG000|Overall Study|Disease progression|124|||
150008611|NCT00321464|541165823|FG001|Overall Study|Disease progression|124|||
150008612|NCT00321464|541165822|FG000|Overall Study|Withdrawal by Subject|117|||
150008613|NCT00321464|541165823|FG001|Overall Study|Withdrawal by Subject|118|||
150008614|NCT00321464|541165822|FG000|Overall Study|Participant request|57|||
150008615|NCT00321464|541165823|FG001|Overall Study|Participant request|61|||
150008616|NCT00321464|541165822|FG000|Overall Study|Adverse Event|43|||
150008617|NCT00321464|541165823|FG001|Overall Study|Adverse Event|28|||
150008618|NCT00321464|541165822|FG000|Overall Study|Physician Decision|15|||
150008619|NCT00321464|541165823|FG001|Overall Study|Physician Decision|14|||
150008620|NCT00321464|541165822|FG000|Overall Study|Noncompliance|4|||
150008621|NCT00321464|541165823|FG001|Overall Study|Noncompliance|10|||
150008622|NCT00321464|541165822|FG000|Overall Study|Lost to Follow-up|7|||
150008623|NCT00321464|541165823|FG001|Overall Study|Lost to Follow-up|8|||
150008624|NCT00321464|541165822|FG000|Overall Study|Protocol deviation|0|||
150008625|NCT00321464|541165823|FG001|Overall Study|Protocol deviation|2|||
150008626|NCT00321464|541165822|FG000|Overall Study|Ineligibility determined|2|||
150008627|NCT00321464|541165823|FG001|Overall Study|Ineligibility determined|1|||
150056590|NCT01806662|541348340|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
150056591|NCT01806662|541348341|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
150008628|NCT00321464|541165822|FG000|Overall Study|Other|21|||
150008629|NCT00321464|541165823|FG001|Overall Study|Other|18|||
150008630|NCT01673620|541165829|FG000|Overall Study|Adverse Event|1|||
150008631|NCT01673620|541165830|FG001|Overall Study|Adverse Event|0|||
150008632|NCT01206582|541165831|FG000|Overall Study|Withdrew prior to study|1|||
150008633|NCT01206582|541165832|FG001|Overall Study|Withdrew prior to study|0|||
150008634|NCT01206582|541165831|FG000|Overall Study|Discontinued intervention before week 8|1|||
150180127|NCT02723955|541799371|FG017|Escalation Phase|Physician Decision|0|||
150180128|NCT02723955|541799372|FG018|Escalation Phase|Physician Decision|0|||
150180129|NCT02723955|541799373|FG019|Escalation Phase|Physician Decision|0|||
150180130|NCT02723955|541799374|FG020|Escalation Phase|Physician Decision|0|||
150180131|NCT02723955|541799375|FG021|Escalation Phase|Physician Decision|0|||
150180132|NCT02723955|541799376|FG022|Escalation Phase|Physician Decision|0|||
150180133|NCT02723955|541799377|FG023|Escalation Phase|Physician Decision|0|||
150180134|NCT02723955|541799378|FG024|Escalation Phase|Physician Decision|0|||
150180135|NCT02723955|541799379|FG025|Escalation Phase|Physician Decision|0|||
150180136|NCT02723955|541799380|FG026|Escalation Phase|Physician Decision|2|||
150180137|NCT02723955|541799381|FG027|Escalation Phase|Physician Decision|0|||
150180138|NCT02723955|541799382|FG028|Escalation Phase|Physician Decision|0|||
150008635|NCT01206582|541165832|FG001|Overall Study|Discontinued intervention before week 8|2|||
150008636|NCT02522325|541165833|FG000|Overall Study|Adverse Event|0|||
150008637|NCT02522325|541165834|FG001|Overall Study|Adverse Event|1|||
150008638|NCT02081599|541165837|FG000|Period 1：Double-blind Period|Adverse Event|3|||
150008639|NCT02081599|541165838|FG001|Period 1：Double-blind Period|Adverse Event|0|||
150008640|NCT02081599|541165837|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
150180139|NCT02723955|541799383|FG029|Escalation Phase|Physician Decision|0|||
150180140|NCT02723955|541799384|FG030|Escalation Phase|Physician Decision|0|||
150180141|NCT02723955|541799385|FG031|Escalation Phase|Physician Decision|0|||
150180142|NCT02723955|541799386|FG032|Escalation Phase|Physician Decision|0|||
150180143|NCT02723955|541799387|FG033|Escalation Phase|Physician Decision|0|||
150180144|NCT02723955|541799388|FG034|Escalation Phase|Physician Decision|0|||
150180145|NCT02723955|541799389|FG035|Escalation Phase|Physician Decision|0|||
150180146|NCT02723955|541799390|FG036|Escalation Phase|Physician Decision|0|||
150180147|NCT02723955|541799391|FG037|Escalation Phase|Physician Decision|0|||
150180148|NCT02723955|541799392|FG038|Escalation Phase|Physician Decision|0|||
150180149|NCT02723955|541799393|FG039|Escalation Phase|Physician Decision|0|||
150180150|NCT02723955|541799394|FG040|Escalation Phase|Physician Decision|0|||
150180151|NCT02723955|541799395|FG041|Escalation Phase|Physician Decision|0|||
150180152|NCT02723955|541799396|FG042|Escalation Phase|Physician Decision|0|||
150180153|NCT02723955|541799354|FG000|Escalation Phase|Withdrawal by Subject|0|||
150180154|NCT02723955|541799355|FG001|Escalation Phase|Withdrawal by Subject|0|||
150180155|NCT02723955|541799356|FG002|Escalation Phase|Withdrawal by Subject|0|||
150180156|NCT02723955|541799357|FG003|Escalation Phase|Withdrawal by Subject|0|||
150180157|NCT02723955|541799358|FG004|Escalation Phase|Withdrawal by Subject|1|||
150180158|NCT02723955|541799359|FG005|Escalation Phase|Withdrawal by Subject|1|||
150180159|NCT02723955|541799360|FG006|Escalation Phase|Withdrawal by Subject|1|||
150180160|NCT02723955|541799361|FG007|Escalation Phase|Withdrawal by Subject|1|||
150180161|NCT02723955|541799362|FG008|Escalation Phase|Withdrawal by Subject|0|||
150180162|NCT02723955|541799363|FG009|Escalation Phase|Withdrawal by Subject|0|||
150180163|NCT02723955|541799364|FG010|Escalation Phase|Withdrawal by Subject|0|||
150180164|NCT02723955|541799365|FG011|Escalation Phase|Withdrawal by Subject|0|||
150180165|NCT02723955|541799366|FG012|Escalation Phase|Withdrawal by Subject|1|||
150180166|NCT02723955|541799367|FG013|Escalation Phase|Withdrawal by Subject|0|||
150180167|NCT02723955|541799368|FG014|Escalation Phase|Withdrawal by Subject|0|||
150180168|NCT02723955|541799369|FG015|Escalation Phase|Withdrawal by Subject|0|||
150180169|NCT02723955|541799370|FG016|Escalation Phase|Withdrawal by Subject|1|||
150180170|NCT02723955|541799371|FG017|Escalation Phase|Withdrawal by Subject|0|||
150180171|NCT02723955|541799372|FG018|Escalation Phase|Withdrawal by Subject|0|||
150008641|NCT02081599|541165838|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
150008642|NCT02081599|541165837|FG000|Period 1：Double-blind Period|Physician Decision|1|||
150008643|NCT02081599|541165838|FG001|Period 1：Double-blind Period|Physician Decision|0|||
150008644|NCT02081599|541165837|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
150008645|NCT02081599|541165838|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
150008646|NCT02081599|541165837|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
150008647|NCT02081599|541165838|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
150008648|NCT02081599|541165837|FG000|Period 1：Double-blind Period|stopping criteria|1|||
150008649|NCT02081599|541165838|FG001|Period 1：Double-blind Period|stopping criteria|0|||
150008650|NCT02081599|541165837|FG000|Period 2：Open-label Period|Adverse Event|1|||
150008651|NCT02081599|541165838|FG001|Period 2：Open-label Period|Adverse Event|0|||
150008652|NCT02081599|541165837|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
150008653|NCT02081599|541165838|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
150008654|NCT02081599|541165837|FG000|Period 2：Open-label Period|Physician Decision|1|||
150008655|NCT02081599|541165838|FG001|Period 2：Open-label Period|Physician Decision|0|||
150008656|NCT02081599|541165837|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
150008657|NCT02081599|541165838|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
150008658|NCT00306527|541165844|FG000|Overall Study|Lost to Follow-up|3|||
150008659|NCT00306527|541165845|FG001|Overall Study|Lost to Follow-up|4|||
150008660|NCT00306527|541165846|FG002|Overall Study|Lost to Follow-up|3|||
150008661|NCT00306527|541165847|FG003|Overall Study|Lost to Follow-up|0|||
150008662|NCT00306527|541165844|FG000|Overall Study|Withdrawal by Subject|2|||
150008663|NCT00306527|541165845|FG001|Overall Study|Withdrawal by Subject|3|||
150008664|NCT00306527|541165846|FG002|Overall Study|Withdrawal by Subject|0|||
150008665|NCT00306527|541165847|FG003|Overall Study|Withdrawal by Subject|3|||
150008666|NCT00306527|541165844|FG000|Overall Study|Adverse Event|0|||
150008667|NCT00306527|541165845|FG001|Overall Study|Adverse Event|0|||
150008668|NCT00306527|541165846|FG002|Overall Study|Adverse Event|1|||
150008669|NCT00306527|541165847|FG003|Overall Study|Adverse Event|1|||
150008670|NCT00306527|541165844|FG000|Overall Study|Death|1|||
150008671|NCT00306527|541165845|FG001|Overall Study|Death|0|||
150008672|NCT00306527|541165846|FG002|Overall Study|Death|1|||
150008673|NCT00306527|541165847|FG003|Overall Study|Death|2|||
150008674|NCT00785980|541165848|FG000|7 Day Washout Period|Protocol Violation|3|||
150008675|NCT00344500|541165849|FG000|Overall Study|Adverse Event|6|||
150008676|NCT00344500|541165850|FG001|Overall Study|Adverse Event|2|||
150008677|NCT00344500|541165851|FG002|Overall Study|Adverse Event|0|||
150008678|NCT00344500|541165849|FG000|Overall Study|Lost to Follow-up|5|||
150008679|NCT00344500|541165850|FG001|Overall Study|Lost to Follow-up|13|||
150008680|NCT00344500|541165851|FG002|Overall Study|Lost to Follow-up|1|||
150008681|NCT00344500|541165849|FG000|Overall Study|Withdrawal by Subject|7|||
150008682|NCT00344500|541165850|FG001|Overall Study|Withdrawal by Subject|10|||
150008683|NCT00344500|541165851|FG002|Overall Study|Withdrawal by Subject|0|||
150008684|NCT00344500|541165849|FG000|Overall Study|Protocol Violation|4|||
150008685|NCT00344500|541165850|FG001|Overall Study|Protocol Violation|7|||
150008686|NCT00344500|541165851|FG002|Overall Study|Protocol Violation|1|||
150008687|NCT00344500|541165849|FG000|Overall Study|Not Noted|1|||
150008688|NCT00344500|541165850|FG001|Overall Study|Not Noted|3|||
150008689|NCT00344500|541165851|FG002|Overall Study|Not Noted|0|||
150008690|NCT02207491|541165852|FG000|Overall Study|Adverse Event|20|||
150008691|NCT02207491|541165853|FG001|Overall Study|Adverse Event|4|||
150056592|NCT01806662|541348340|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
150056593|NCT01806662|541348341|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
150056594|NCT01806662|541348340|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
150056595|NCT01806662|541348341|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
150056596|NCT01806662|541348340|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
150056597|NCT01806662|541348341|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
150008692|NCT02207491|541165852|FG000|Overall Study|Withdrawal by Subject|3|||
150008693|NCT02207491|541165853|FG001|Overall Study|Withdrawal by Subject|2|||
150008694|NCT02207491|541165852|FG000|Overall Study|Non-compliant|0|||
150008695|NCT02207491|541165853|FG001|Overall Study|Non-compliant|1|||
150008696|NCT02207491|541165852|FG000|Overall Study|Lost to Follow-up|0|||
150008697|NCT02207491|541165853|FG001|Overall Study|Lost to Follow-up|1|||
150008698|NCT02207491|541165852|FG000|Overall Study|Lack of Efficacy|3|||
150008699|NCT02207491|541165853|FG001|Overall Study|Lack of Efficacy|0|||
150008700|NCT02207491|541165852|FG000|Overall Study|Physician Decision|2|||
150008701|NCT02207491|541165853|FG001|Overall Study|Physician Decision|0|||
150008702|NCT02207491|541165852|FG000|Overall Study|Protocol Violation|3|||
150008703|NCT02207491|541165853|FG001|Overall Study|Protocol Violation|5|||
150008704|NCT00126776|541165854|FG000|Overall Study|follow up complete on all patients|0|||
150008705|NCT00126776|541165855|FG001|Overall Study|follow up complete on all patients|0|||
150008706|NCT00417963|541165856|FG000|Overall Study|Lost to Follow-up|3|||
150008707|NCT00417963|541165856|FG000|Overall Study|Withdrawal by Subject|18|||
150008708|NCT00417963|541165856|FG000|Overall Study|Death|17|||
150008709|NCT00417963|541165856|FG000|Overall Study|Study device could not be deployed|3|||
150008710|NCT00448747|541165868|FG000|Overall Study|collapsed veins|1|||
150008711|NCT00448747|541165869|FG001|Overall Study|collapsed veins|0|||
150008712|NCT00387725|541165870|FG000|Overall Study|Adverse Event|0|||
150008713|NCT00387725|541165871|FG001|Overall Study|Adverse Event|0|||
150008714|NCT00387725|541165872|FG002|Overall Study|Adverse Event|0|||
150008715|NCT00387725|541165873|FG003|Overall Study|Adverse Event|1|||
150008716|NCT00387725|541165870|FG000|Overall Study|Protocol Violation|0|||
150008717|NCT00387725|541165871|FG001|Overall Study|Protocol Violation|1|||
150008718|NCT00387725|541165872|FG002|Overall Study|Protocol Violation|0|||
150008719|NCT00387725|541165873|FG003|Overall Study|Protocol Violation|0|||
150008720|NCT00387725|541165870|FG000|Overall Study|Withdrawal by Subject|1|||
150008721|NCT00387725|541165871|FG001|Overall Study|Withdrawal by Subject|0|||
150008722|NCT00387725|541165872|FG002|Overall Study|Withdrawal by Subject|1|||
150008723|NCT00387725|541165873|FG003|Overall Study|Withdrawal by Subject|0|||
150008724|NCT00387725|541165870|FG000|Overall Study|Parent/legal guardian request|0|||
150008725|NCT00387725|541165871|FG001|Overall Study|Parent/legal guardian request|0|||
150008726|NCT00387725|541165872|FG002|Overall Study|Parent/legal guardian request|1|||
150008727|NCT00387725|541165873|FG003|Overall Study|Parent/legal guardian request|1|||
150008728|NCT04201093|541165875|FG000|Overall Study|Adverse Event|6|||
150008729|NCT04201093|541165876|FG001|Overall Study|Adverse Event|29|||
150008730|NCT04201093|541165877|FG002|Overall Study|Adverse Event|35|||
150008731|NCT04201093|541165875|FG000|Overall Study|Death|2|||
150008732|NCT04201093|541165876|FG001|Overall Study|Death|1|||
150008733|NCT04201093|541165877|FG002|Overall Study|Death|0|||
150008734|NCT04201093|541165875|FG000|Overall Study|Lack of Efficacy|5|||
150008735|NCT04201093|541165876|FG001|Overall Study|Lack of Efficacy|1|||
150008736|NCT04201093|541165877|FG002|Overall Study|Lack of Efficacy|2|||
150008737|NCT04201093|541165875|FG000|Overall Study|Lost to Follow-up|0|||
150008738|NCT04201093|541165876|FG001|Overall Study|Lost to Follow-up|0|||
150008739|NCT04201093|541165877|FG002|Overall Study|Lost to Follow-up|1|||
150008740|NCT04201093|541165875|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
150008741|NCT04201093|541165876|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
150008742|NCT04201093|541165877|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
150008743|NCT04201093|541165875|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
150008744|NCT04201093|541165876|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
150008745|NCT04201093|541165877|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
150008746|NCT04201093|541165875|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
150008747|NCT04201093|541165876|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
150008748|NCT04201093|541165877|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
150008749|NCT04201093|541165875|FG000|Overall Study|Physician Decision|1|||
150008750|NCT04201093|541165876|FG001|Overall Study|Physician Decision|0|||
150008751|NCT04201093|541165877|FG002|Overall Study|Physician Decision|0|||
150008752|NCT04201093|541165875|FG000|Overall Study|Protocol Deviation|1|||
150008753|NCT04201093|541165876|FG001|Overall Study|Protocol Deviation|0|||
150008754|NCT04201093|541165877|FG002|Overall Study|Protocol Deviation|0|||
150008755|NCT04201093|541165875|FG000|Overall Study|Site Terminated by Sponsor|5|||
150008756|NCT04201093|541165876|FG001|Overall Study|Site Terminated by Sponsor|3|||
150056598|NCT00043550|541348342|FG000|Overall Study|Withdrawal by Subject|22|||
150056599|NCT00043550|541348343|FG001|Overall Study|Withdrawal by Subject|12|||
150056600|NCT00043550|541348344|FG002|Overall Study|Withdrawal by Subject|20|||
150056601|NCT01917656|541348350|FG000|Overall Study|Adverse Event|11|||
150056602|NCT01917656|541348351|FG001|Overall Study|Adverse Event|0|||
150056603|NCT01917656|541348350|FG000|Overall Study|Withdrawal criteria|8|||
150056604|NCT01917656|541348351|FG001|Overall Study|Withdrawal criteria|14|||
150056605|NCT01917656|541348350|FG000|Overall Study|Unclassified|0|||
150056606|NCT01917656|541348351|FG001|Overall Study|Unclassified|3|||
150056607|NCT01917656|541348350|FG000|Overall Study|Withdrawal by Subject|4|||
150008757|NCT04201093|541165877|FG002|Overall Study|Site Terminated by Sponsor|1|||
150008758|NCT04201093|541165875|FG000|Overall Study|Withdrawal by Subject|7|||
150008759|NCT04201093|541165876|FG001|Overall Study|Withdrawal by Subject|8|||
150008760|NCT04201093|541165877|FG002|Overall Study|Withdrawal by Subject|15|||
150008761|NCT04201093|541165875|FG000|Overall Study|Other|0|||
150008762|NCT04201093|541165876|FG001|Overall Study|Other|1|||
150008763|NCT04201093|541165877|FG002|Overall Study|Other|2|||
150008764|NCT00007020|541165878|FG000|Overall Study|Death|16|||
150008765|NCT00007020|541165878|FG000|Overall Study|Lost to Follow-up|13|||
150008766|NCT00007020|541165878|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
150008767|NCT00007020|541165878|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
150008768|NCT00007020|541165878|FG000|Overall Study|Pt cared for by outside physician|4|||
150008769|NCT00007020|541165878|FG000|Overall Study|No evidence of treatment|6|||
150008770|NCT05011058|541165879|FG000|Overall Study|Sponsor Decision|2|||
150008771|NCT05011058|541165880|FG001|Overall Study|Sponsor Decision|0|||
150008772|NCT05011058|541165881|FG002|Overall Study|Sponsor Decision|14|||
150008773|NCT05011058|541165882|FG003|Overall Study|Sponsor Decision|0|||
150008774|NCT05011058|541165883|FG004|Overall Study|Sponsor Decision|0|||
150008775|NCT05011058|541165884|FG005|Overall Study|Sponsor Decision|1|||
150008776|NCT05011058|541165885|FG006|Overall Study|Sponsor Decision|0|||
150008777|NCT05011058|541165886|FG007|Overall Study|Sponsor Decision|5|||
150008778|NCT03908476|541165887|FG000|Overall Study|Death|3|||
150008779|NCT03908476|541165888|FG001|Overall Study|Death|0|||
150008780|NCT03908476|541165887|FG000|Overall Study|Lost to Follow-up|3|||
150008781|NCT03908476|541165888|FG001|Overall Study|Lost to Follow-up|1|||
150008782|NCT03908476|541165887|FG000|Overall Study|Withdrawal by Subject|7|||
150008783|NCT03908476|541165888|FG001|Overall Study|Withdrawal by Subject|1|||
150008784|NCT03908476|541165887|FG000|Overall Study|Physician Decision|2|||
150008785|NCT03908476|541165888|FG001|Overall Study|Physician Decision|0|||
150008786|NCT03908476|541165887|FG000|Overall Study|System Explanted and not Replaced|4|||
150008787|NCT03908476|541165888|FG001|Overall Study|System Explanted and not Replaced|0|||
150008788|NCT03908476|541165887|FG000|Overall Study|Intrathecal Pump|1|||
150008789|NCT03908476|541165888|FG001|Overall Study|Intrathecal Pump|0|||
150008790|NCT03908476|541165887|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
150056608|NCT01917656|541348351|FG001|Overall Study|Withdrawal by Subject|3|||
150008791|NCT03908476|541165888|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
150008792|NCT05194267|541165889|FG000|Overall Study|Withdrawal by Subject|2|||
150008793|NCT00320424|541165890|FG000|Overall Study|Adverse Event|3|||
150008794|NCT00320424|541165890|FG000|Overall Study|Other|3|||
150008795|NCT03270891|541165891|FG000|Overall Study|Lost to Follow-up|3|||
150008796|NCT03270891|541165892|FG001|Overall Study|Lost to Follow-up|6|||
150056609|NCT01917656|541348350|FG000|Overall Study|Lost to Follow-up|3|||
150056610|NCT01917656|541348351|FG001|Overall Study|Lost to Follow-up|4|||
150056611|NCT02285062|541348352|FG000|Pre-Treatment Period|Protocol Violation|0|||
150056612|NCT02285062|541348353|FG001|Pre-Treatment Period|Protocol Violation|2|||
150056613|NCT02285062|541348352|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
150056614|NCT02285062|541348353|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
150056615|NCT02015221|541348354|FG000|Overall Study|Withdrawal by Subject|8|||
150008797|NCT03270891|541165893|FG002|Overall Study|Lost to Follow-up|0|||
150008798|NCT03270891|541165891|FG000|Overall Study|Withdrawal by Subject|1|||
150008799|NCT03270891|541165892|FG001|Overall Study|Withdrawal by Subject|0|||
150008800|NCT03270891|541165893|FG002|Overall Study|Withdrawal by Subject|0|||
150008801|NCT03270891|541165891|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
150008802|NCT03270891|541165892|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
150008803|NCT03270891|541165893|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
150008804|NCT02540668|541165894|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
150008805|NCT02540668|541165895|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
150008806|NCT05779007|541165896|FG000|Overall Study|not meeting eligibility criteria|3517|||
150008807|NCT05779007|541165897|FG001|Overall Study|not meeting eligibility criteria|2009|||
150008808|NCT03194438|541165902|FG000|Overall Study|Withdrawal by Subject|2|||
150008809|NCT05147662|541165903|FG000|Overall Study|Withdrawal by parent/guardian|3|||
150008810|NCT05147662|541165903|FG000|Overall Study|Assigned to treatment but never treated|1|||
150008811|NCT00231413|541165906|FG000|Overall Study|Non-serious AE|0|||
150008812|NCT00231413|541165907|FG001|Overall Study|Non-serious AE|0|||
150008813|NCT00231413|541165908|FG002|Overall Study|Non-serious AE|1|||
150008814|NCT00231413|541165909|FG003|Overall Study|Non-serious AE|0|||
150008815|NCT00231413|541165910|FG004|Overall Study|Non-serious AE|0|||
150008816|NCT00231413|541165911|FG005|Overall Study|Non-serious AE|0|||
150008817|NCT00231413|541165912|FG006|Overall Study|Non-serious AE|1|||
150008818|NCT00231413|541165906|FG000|Overall Study|Withdrawal by Subject|3|||
150008819|NCT00231413|541165907|FG001|Overall Study|Withdrawal by Subject|1|||
150008820|NCT00231413|541165908|FG002|Overall Study|Withdrawal by Subject|4|||
150008821|NCT00231413|541165909|FG003|Overall Study|Withdrawal by Subject|2|||
150008822|NCT00231413|541165910|FG004|Overall Study|Withdrawal by Subject|2|||
150008823|NCT00231413|541165911|FG005|Overall Study|Withdrawal by Subject|0|||
150008824|NCT00231413|541165912|FG006|Overall Study|Withdrawal by Subject|3|||
150008825|NCT00231413|541165906|FG000|Overall Study|Migrated/moved from study area|0|||
150008826|NCT00231413|541165907|FG001|Overall Study|Migrated/moved from study area|0|||
150008827|NCT00231413|541165908|FG002|Overall Study|Migrated/moved from study area|1|||
150008828|NCT00231413|541165909|FG003|Overall Study|Migrated/moved from study area|0|||
150008829|NCT00231413|541165910|FG004|Overall Study|Migrated/moved from study area|0|||
150008830|NCT00231413|541165911|FG005|Overall Study|Migrated/moved from study area|1|||
150008831|NCT00231413|541165912|FG006|Overall Study|Migrated/moved from study area|0|||
150008832|NCT00231413|541165906|FG000|Overall Study|Lost to Follow-up|4|||
150008833|NCT00231413|541165907|FG001|Overall Study|Lost to Follow-up|4|||
150008834|NCT00231413|541165908|FG002|Overall Study|Lost to Follow-up|1|||
150008835|NCT00231413|541165909|FG003|Overall Study|Lost to Follow-up|1|||
150008836|NCT00231413|541165910|FG004|Overall Study|Lost to Follow-up|1|||
150008837|NCT00231413|541165911|FG005|Overall Study|Lost to Follow-up|4|||
150008838|NCT00231413|541165912|FG006|Overall Study|Lost to Follow-up|0|||
150008839|NCT00231413|541165906|FG000|Overall Study|Pregnancy|1|||
150008840|NCT00231413|541165907|FG001|Overall Study|Pregnancy|0|||
150008841|NCT00231413|541165908|FG002|Overall Study|Pregnancy|0|||
150008842|NCT00231413|541165909|FG003|Overall Study|Pregnancy|0|||
150008843|NCT00231413|541165910|FG004|Overall Study|Pregnancy|0|||
150008844|NCT00231413|541165911|FG005|Overall Study|Pregnancy|0|||
150008845|NCT00231413|541165912|FG006|Overall Study|Pregnancy|0|||
150008846|NCT02708485|541165913|FG000|Overall Study|Withdrawal by Subject|3|||
150008847|NCT02708485|541165914|FG001|Overall Study|Withdrawal by Subject|2|||
150008848|NCT01659255|541165915|FG000|Overall Study|Adverse Event|0|||
150008849|NCT01659255|541165916|FG001|Overall Study|Adverse Event|0|||
150008850|NCT01659255|541165917|FG002|Overall Study|Adverse Event|0|||
150008851|NCT01659255|541165918|FG003|Overall Study|Adverse Event|0|||
150008852|NCT01659255|541165919|FG004|Overall Study|Adverse Event|0|||
150008853|NCT01659255|541165920|FG005|Overall Study|Adverse Event|1|||
150008854|NCT01659255|541165921|FG006|Overall Study|Adverse Event|1|||
150008855|NCT01659255|541165922|FG007|Overall Study|Adverse Event|0|||
150008856|NCT01659255|541165923|FG008|Overall Study|Adverse Event|0|||
150008857|NCT01659255|541165924|FG009|Overall Study|Adverse Event|1|||
150008858|NCT01659255|541165925|FG010|Overall Study|Adverse Event|0|||
150008859|NCT01659255|541165926|FG011|Overall Study|Adverse Event|1|||
150008860|NCT01659255|541165927|FG012|Overall Study|Adverse Event|0|||
150008861|NCT01659255|541165928|FG013|Overall Study|Adverse Event|2|||
150008862|NCT01659255|541165929|FG014|Overall Study|Adverse Event|0|||
150008863|NCT01659255|541165930|FG015|Overall Study|Adverse Event|1|||
150008864|NCT01659255|541165931|FG016|Overall Study|Adverse Event|0|||
150008865|NCT01659255|541165915|FG000|Overall Study|Death|0|||
150008866|NCT01659255|541165916|FG001|Overall Study|Death|1|||
150008867|NCT01659255|541165917|FG002|Overall Study|Death|0|||
150008868|NCT01659255|541165918|FG003|Overall Study|Death|0|||
150008869|NCT01659255|541165919|FG004|Overall Study|Death|0|||
150008870|NCT01659255|541165920|FG005|Overall Study|Death|0|||
150008871|NCT01659255|541165921|FG006|Overall Study|Death|0|||
150008872|NCT01659255|541165922|FG007|Overall Study|Death|1|||
150008873|NCT01659255|541165923|FG008|Overall Study|Death|1|||
150008874|NCT01659255|541165924|FG009|Overall Study|Death|0|||
150008875|NCT01659255|541165925|FG010|Overall Study|Death|0|||
150008876|NCT01659255|541165926|FG011|Overall Study|Death|0|||
150008877|NCT01659255|541165927|FG012|Overall Study|Death|1|||
150008878|NCT01659255|541165928|FG013|Overall Study|Death|1|||
150008879|NCT01659255|541165929|FG014|Overall Study|Death|2|||
150008880|NCT01659255|541165930|FG015|Overall Study|Death|1|||
150008881|NCT01659255|541165931|FG016|Overall Study|Death|0|||
150008882|NCT01659255|541165915|FG000|Overall Study|Progressive Disease|2|||
150056616|NCT02015221|541348355|FG001|Overall Study|Withdrawal by Subject|6|||
150056617|NCT02015221|541348354|FG000|Overall Study|Lost to Follow-up|1|||
150056618|NCT02015221|541348355|FG001|Overall Study|Lost to Follow-up|0|||
150056619|NCT01306929|541348356|FG000|Overall Study|Withdrawal by Subject|23|||
150056620|NCT01306929|541348356|FG000|Overall Study|Adverse Event|21|||
150056621|NCT01306929|541348356|FG000|Overall Study|Physician Decision|13|||
150056622|NCT01306929|541348356|FG000|Overall Study|Death|8|||
150056623|NCT01306929|541348356|FG000|Overall Study|Withdrawal by parent/guardian|5|||
150056624|NCT01306929|541348356|FG000|Overall Study|Protocol Violation|3|||
150056625|NCT01306929|541348356|FG000|Overall Study|Non-compliance with study drug|2|||
150056626|NCT01306929|541348356|FG000|Overall Study|Lost to Follow-up|2|||
150056627|NCT01306929|541348356|FG000|Overall Study|Various|17|||
150056628|NCT03709576|541348362|FG000|Overall Study|progression prior to enrollment|1|||
150056629|NCT03041129|541348370|FG000|Overall Study|Withdrawal by Subject|2|||
150056630|NCT03041129|541348371|FG001|Overall Study|Withdrawal by Subject|0|||
150056631|NCT03041129|541348372|FG002|Overall Study|Withdrawal by Subject|0|||
150056632|NCT03041129|541348373|FG003|Overall Study|Withdrawal by Subject|0|||
150056633|NCT00510653|541348376|FG000|Overall Study|Withdrawal by Subject|8|||
150056634|NCT00510653|541348376|FG000|Overall Study|Monetary|3|||
150056635|NCT00483756|541348379|FG000|Overall Study|Death|2|||
150056636|NCT00483756|541348380|FG001|Overall Study|Death|0|||
150056637|NCT00483756|541348381|FG002|Overall Study|Death|1|||
150056638|NCT00483756|541348379|FG000|Overall Study|Adverse Event|19|||
150056639|NCT00483756|541348380|FG001|Overall Study|Adverse Event|38|||
150056640|NCT00483756|541348381|FG002|Overall Study|Adverse Event|40|||
150056641|NCT00483756|541348379|FG000|Overall Study|Lack of Efficacy|1|||
150056642|NCT00483756|541348380|FG001|Overall Study|Lack of Efficacy|0|||
150056643|NCT00483756|541348381|FG002|Overall Study|Lack of Efficacy|0|||
150056644|NCT00483756|541348379|FG000|Overall Study|Lost to Follow-up|3|||
150056645|NCT00483756|541348380|FG001|Overall Study|Lost to Follow-up|1|||
150056646|NCT00483756|541348381|FG002|Overall Study|Lost to Follow-up|0|||
150056647|NCT00483756|541348379|FG000|Overall Study|Withdrawal by Subject|5|||
150056648|NCT00483756|541348380|FG001|Overall Study|Withdrawal by Subject|3|||
150056649|NCT00483756|541348381|FG002|Overall Study|Withdrawal by Subject|4|||
150056650|NCT00483756|541348379|FG000|Overall Study|Other|2|||
150056651|NCT00483756|541348380|FG001|Overall Study|Other|4|||
150056652|NCT00483756|541348381|FG002|Overall Study|Other|3|||
150056653|NCT00483756|541348379|FG000|Overall Study|Randomized, Not Treated|1|||
150056654|NCT00483756|541348380|FG001|Overall Study|Randomized, Not Treated|4|||
150056655|NCT00483756|541348381|FG002|Overall Study|Randomized, Not Treated|4|||
150008883|NCT01659255|541165916|FG001|Overall Study|Progressive Disease|0|||
150008884|NCT01659255|541165917|FG002|Overall Study|Progressive Disease|0|||
150008885|NCT01659255|541165918|FG003|Overall Study|Progressive Disease|0|||
150008886|NCT01659255|541165919|FG004|Overall Study|Progressive Disease|0|||
150008887|NCT01659255|541165920|FG005|Overall Study|Progressive Disease|0|||
150008888|NCT01659255|541165921|FG006|Overall Study|Progressive Disease|0|||
150056656|NCT00710762|541348382|FG000|Overall Study|Progressive disease|27|||
150056657|NCT00710762|541348383|FG001|Overall Study|Progressive disease|30|||
150056658|NCT00710762|541348382|FG000|Overall Study|Adverse Event other disease worsening|2|||
150056659|NCT00710762|541348383|FG001|Overall Study|Adverse Event other disease worsening|1|||
150056660|NCT00710762|541348382|FG000|Overall Study|Other Adverse Event|7|||
150056661|NCT00710762|541348383|FG001|Overall Study|Other Adverse Event|7|||
150056662|NCT00710762|541348382|FG000|Overall Study|Lost to Follow-up|1|||
150008889|NCT01659255|541165922|FG007|Overall Study|Progressive Disease|1|||
150008890|NCT01659255|541165923|FG008|Overall Study|Progressive Disease|0|||
150180172|NCT02723955|541799373|FG019|Escalation Phase|Withdrawal by Subject|0|||
150180173|NCT02723955|541799374|FG020|Escalation Phase|Withdrawal by Subject|0|||
150180174|NCT02723955|541799375|FG021|Escalation Phase|Withdrawal by Subject|0|||
150180175|NCT02723955|541799376|FG022|Escalation Phase|Withdrawal by Subject|0|||
150180176|NCT02723955|541799377|FG023|Escalation Phase|Withdrawal by Subject|2|||
150180177|NCT02723955|541799378|FG024|Escalation Phase|Withdrawal by Subject|0|||
150180178|NCT02723955|541799379|FG025|Escalation Phase|Withdrawal by Subject|1|||
150180179|NCT02723955|541799380|FG026|Escalation Phase|Withdrawal by Subject|0|||
150180180|NCT02723955|541799381|FG027|Escalation Phase|Withdrawal by Subject|0|||
150180181|NCT02723955|541799382|FG028|Escalation Phase|Withdrawal by Subject|1|||
150180182|NCT02723955|541799383|FG029|Escalation Phase|Withdrawal by Subject|0|||
150180183|NCT02723955|541799384|FG030|Escalation Phase|Withdrawal by Subject|0|||
150180184|NCT02723955|541799385|FG031|Escalation Phase|Withdrawal by Subject|0|||
150180185|NCT02723955|541799386|FG032|Escalation Phase|Withdrawal by Subject|0|||
150180186|NCT02723955|541799387|FG033|Escalation Phase|Withdrawal by Subject|0|||
150180187|NCT02723955|541799388|FG034|Escalation Phase|Withdrawal by Subject|0|||
150180188|NCT02723955|541799389|FG035|Escalation Phase|Withdrawal by Subject|0|||
150180189|NCT02723955|541799390|FG036|Escalation Phase|Withdrawal by Subject|0|||
150180190|NCT02723955|541799391|FG037|Escalation Phase|Withdrawal by Subject|0|||
150180191|NCT02723955|541799392|FG038|Escalation Phase|Withdrawal by Subject|0|||
150180192|NCT02723955|541799393|FG039|Escalation Phase|Withdrawal by Subject|0|||
150180193|NCT02723955|541799394|FG040|Escalation Phase|Withdrawal by Subject|0|||
150180194|NCT02723955|541799395|FG041|Escalation Phase|Withdrawal by Subject|0|||
150180195|NCT02723955|541799396|FG042|Escalation Phase|Withdrawal by Subject|0|||
150180196|NCT02723955|541799354|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180197|NCT02723955|541799355|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180198|NCT02723955|541799356|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180199|NCT02723955|541799357|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180200|NCT02723955|541799358|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
150180201|NCT02723955|541799359|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
150180202|NCT02723955|541799360|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
150180203|NCT02723955|541799361|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
150180204|NCT02723955|541799362|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
150180205|NCT02723955|541799363|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180206|NCT02723955|541799364|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180207|NCT02723955|541799365|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180208|NCT02723955|541799366|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180209|NCT02723955|541799367|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180210|NCT02723955|541799368|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180211|NCT02723955|541799369|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180212|NCT02723955|541799370|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180213|NCT02723955|541799371|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180214|NCT02723955|541799372|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180215|NCT02723955|541799373|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180216|NCT02723955|541799374|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180217|NCT02723955|541799375|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180218|NCT02723955|541799376|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180219|NCT02723955|541799377|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180220|NCT02723955|541799378|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180221|NCT02723955|541799379|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180222|NCT02723955|541799380|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180223|NCT02723955|541799381|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180224|NCT02723955|541799382|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180225|NCT02723955|541799383|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180226|NCT02723955|541799384|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150056663|NCT00710762|541348383|FG001|Overall Study|Lost to Follow-up|0|||
150056664|NCT00710762|541348382|FG000|Overall Study|Reason other than listed above|2|||
150056665|NCT00710762|541348383|FG001|Overall Study|Reason other than listed above|2|||
150056666|NCT00436501|541348384|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
150056667|NCT00436501|541348385|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
150056668|NCT00436501|541348384|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
150056669|NCT00436501|541348385|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
150056670|NCT00495040|541348386|FG000|Overall Study|Withdrawal by Subject|3|||
150056671|NCT03011892|541348391|FG000|Double Blind (DB) Period|Adverse Event|0|||
150056672|NCT03011892|541348392|FG001|Double Blind (DB) Period|Adverse Event|1|||
150056673|NCT03011892|541348393|FG002|Double Blind (DB) Period|Adverse Event|1|||
150056674|NCT03011892|541348394|FG003|Double Blind (DB) Period|Adverse Event|0|||
150056675|NCT03011892|541348395|FG004|Double Blind (DB) Period|Adverse Event|0|||
150056676|NCT03011892|541348396|FG005|Double Blind (DB) Period|Adverse Event|0|||
150056677|NCT03011892|541348397|FG006|Double Blind (DB) Period|Adverse Event|0|||
150056678|NCT03011892|541348398|FG007|Double Blind (DB) Period|Adverse Event|0|||
150056679|NCT03011892|541348399|FG008|Double Blind (DB) Period|Adverse Event|0|||
150056680|NCT03011892|541348400|FG009|Double Blind (DB) Period|Adverse Event|0|||
150056681|NCT03011892|541348401|FG010|Double Blind (DB) Period|Adverse Event|0|||
150056682|NCT03011892|541348402|FG011|Double Blind (DB) Period|Adverse Event|0|||
150056683|NCT03011892|541348391|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
150056684|NCT03011892|541348392|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
150056685|NCT03011892|541348393|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
150056686|NCT03011892|541348394|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
150056687|NCT03011892|541348395|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
150056688|NCT03011892|541348396|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
150056689|NCT03011892|541348397|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
150056690|NCT03011892|541348398|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
150056691|NCT03011892|541348399|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
150056692|NCT03011892|541348400|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
150056693|NCT03011892|541348401|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
150056694|NCT03011892|541348402|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
150056695|NCT03011892|541348391|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
150056696|NCT03011892|541348392|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
150056697|NCT03011892|541348393|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
150056698|NCT03011892|541348394|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
150056699|NCT03011892|541348395|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
150056700|NCT03011892|541348396|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
150056701|NCT03011892|541348397|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
150056702|NCT03011892|541348398|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
150056703|NCT03011892|541348399|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
150056704|NCT03011892|541348400|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
150056705|NCT03011892|541348401|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
150056706|NCT03011892|541348402|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
150056707|NCT03011892|541348391|FG000|Double Blind (DB) Period|Other|1|||
150008891|NCT01659255|541165924|FG009|Overall Study|Progressive Disease|2|||
150008892|NCT01659255|541165925|FG010|Overall Study|Progressive Disease|2|||
150008893|NCT01659255|541165926|FG011|Overall Study|Progressive Disease|3|||
150008894|NCT01659255|541165927|FG012|Overall Study|Progressive Disease|5|||
150008895|NCT01659255|541165928|FG013|Overall Study|Progressive Disease|13|||
150008896|NCT01659255|541165929|FG014|Overall Study|Progressive Disease|6|||
150008897|NCT01659255|541165930|FG015|Overall Study|Progressive Disease|2|||
150008898|NCT01659255|541165931|FG016|Overall Study|Progressive Disease|3|||
150008899|NCT01659255|541165915|FG000|Overall Study|Withdrew Consent|0|||
150008900|NCT01659255|541165916|FG001|Overall Study|Withdrew Consent|0|||
150008901|NCT01659255|541165917|FG002|Overall Study|Withdrew Consent|0|||
150008902|NCT01659255|541165918|FG003|Overall Study|Withdrew Consent|0|||
150008903|NCT01659255|541165919|FG004|Overall Study|Withdrew Consent|0|||
150008904|NCT01659255|541165920|FG005|Overall Study|Withdrew Consent|0|||
150008905|NCT01659255|541165921|FG006|Overall Study|Withdrew Consent|0|||
150008906|NCT01659255|541165922|FG007|Overall Study|Withdrew Consent|0|||
150008907|NCT01659255|541165923|FG008|Overall Study|Withdrew Consent|0|||
150008908|NCT01659255|541165924|FG009|Overall Study|Withdrew Consent|0|||
150008909|NCT01659255|541165925|FG010|Overall Study|Withdrew Consent|1|||
150008910|NCT01659255|541165926|FG011|Overall Study|Withdrew Consent|0|||
150008911|NCT01659255|541165927|FG012|Overall Study|Withdrew Consent|0|||
150056708|NCT03011892|541348392|FG001|Double Blind (DB) Period|Other|1|||
150056709|NCT03011892|541348393|FG002|Double Blind (DB) Period|Other|1|||
150056710|NCT03011892|541348394|FG003|Double Blind (DB) Period|Other|0|||
150008912|NCT01659255|541165928|FG013|Overall Study|Withdrew Consent|1|||
150008913|NCT01659255|541165929|FG014|Overall Study|Withdrew Consent|0|||
150008914|NCT01659255|541165930|FG015|Overall Study|Withdrew Consent|0|||
150008915|NCT01659255|541165931|FG016|Overall Study|Withdrew Consent|0|||
150008916|NCT01659255|541165915|FG000|Overall Study|Investigator Decision|0|||
150056711|NCT03011892|541348395|FG004|Double Blind (DB) Period|Other|1|||
150056712|NCT03011892|541348396|FG005|Double Blind (DB) Period|Other|0|||
150056713|NCT03011892|541348397|FG006|Double Blind (DB) Period|Other|0|||
150056714|NCT03011892|541348398|FG007|Double Blind (DB) Period|Other|0|||
150056715|NCT03011892|541348399|FG008|Double Blind (DB) Period|Other|0|||
150056716|NCT03011892|541348400|FG009|Double Blind (DB) Period|Other|0|||
150056717|NCT03011892|541348401|FG010|Double Blind (DB) Period|Other|0|||
150056718|NCT03011892|541348402|FG011|Double Blind (DB) Period|Other|0|||
150056719|NCT03011892|541348391|FG000|Double Blind (DB) Period|Physician Decision|1|||
150056720|NCT03011892|541348392|FG001|Double Blind (DB) Period|Physician Decision|0|||
150056721|NCT03011892|541348393|FG002|Double Blind (DB) Period|Physician Decision|1|||
150056722|NCT03011892|541348394|FG003|Double Blind (DB) Period|Physician Decision|0|||
150056723|NCT03011892|541348395|FG004|Double Blind (DB) Period|Physician Decision|0|||
150056724|NCT03011892|541348396|FG005|Double Blind (DB) Period|Physician Decision|0|||
150056725|NCT03011892|541348397|FG006|Double Blind (DB) Period|Physician Decision|0|||
150056726|NCT03011892|541348398|FG007|Double Blind (DB) Period|Physician Decision|0|||
150056727|NCT03011892|541348399|FG008|Double Blind (DB) Period|Physician Decision|0|||
150056728|NCT03011892|541348400|FG009|Double Blind (DB) Period|Physician Decision|0|||
150056729|NCT03011892|541348401|FG010|Double Blind (DB) Period|Physician Decision|0|||
150056730|NCT03011892|541348402|FG011|Double Blind (DB) Period|Physician Decision|0|||
150056731|NCT03011892|541348391|FG000|Double Blind (DB) Period|Pregnancy|0|||
150056732|NCT03011892|541348392|FG001|Double Blind (DB) Period|Pregnancy|0|||
150056733|NCT03011892|541348393|FG002|Double Blind (DB) Period|Pregnancy|0|||
150056734|NCT03011892|541348394|FG003|Double Blind (DB) Period|Pregnancy|0|||
150056735|NCT03011892|541348395|FG004|Double Blind (DB) Period|Pregnancy|1|||
150056736|NCT03011892|541348396|FG005|Double Blind (DB) Period|Pregnancy|0|||
150056737|NCT03011892|541348397|FG006|Double Blind (DB) Period|Pregnancy|0|||
150056738|NCT03011892|541348398|FG007|Double Blind (DB) Period|Pregnancy|0|||
150056739|NCT03011892|541348399|FG008|Double Blind (DB) Period|Pregnancy|0|||
150056740|NCT03011892|541348400|FG009|Double Blind (DB) Period|Pregnancy|0|||
150056741|NCT03011892|541348401|FG010|Double Blind (DB) Period|Pregnancy|0|||
150056742|NCT03011892|541348402|FG011|Double Blind (DB) Period|Pregnancy|0|||
150056743|NCT03011892|541348391|FG000|Double Blind (DB) Period|Protocol Violation|1|||
150056744|NCT03011892|541348392|FG001|Double Blind (DB) Period|Protocol Violation|0|||
150056745|NCT03011892|541348393|FG002|Double Blind (DB) Period|Protocol Violation|0|||
150056746|NCT03011892|541348394|FG003|Double Blind (DB) Period|Protocol Violation|0|||
150056747|NCT03011892|541348395|FG004|Double Blind (DB) Period|Protocol Violation|0|||
150056748|NCT03011892|541348396|FG005|Double Blind (DB) Period|Protocol Violation|0|||
150056749|NCT03011892|541348397|FG006|Double Blind (DB) Period|Protocol Violation|0|||
150056750|NCT03011892|541348398|FG007|Double Blind (DB) Period|Protocol Violation|0|||
150056751|NCT03011892|541348399|FG008|Double Blind (DB) Period|Protocol Violation|0|||
150056752|NCT03011892|541348400|FG009|Double Blind (DB) Period|Protocol Violation|0|||
150056753|NCT03011892|541348401|FG010|Double Blind (DB) Period|Protocol Violation|0|||
150056754|NCT03011892|541348402|FG011|Double Blind (DB) Period|Protocol Violation|0|||
150056755|NCT03011892|541348391|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
150056756|NCT03011892|541348392|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
150056757|NCT03011892|541348393|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
150056758|NCT03011892|541348394|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
150056759|NCT03011892|541348395|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
150056760|NCT03011892|541348396|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
150180227|NCT02723955|541799385|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150056761|NCT03011892|541348397|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056762|NCT03011892|541348398|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056763|NCT03011892|541348399|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056764|NCT03011892|541348400|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056765|NCT03011892|541348401|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056766|NCT03011892|541348402|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
150056767|NCT03011892|541348391|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
150056768|NCT03011892|541348392|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
150056769|NCT03011892|541348393|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
150056770|NCT03011892|541348394|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
150056771|NCT03011892|541348395|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
150056772|NCT03011892|541348396|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
150056773|NCT03011892|541348397|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
150056774|NCT03011892|541348398|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
150056775|NCT03011892|541348399|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
150056776|NCT03011892|541348400|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
150056777|NCT03011892|541348401|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
150008917|NCT01659255|541165916|FG001|Overall Study|Investigator Decision|0|||
150008918|NCT01659255|541165917|FG002|Overall Study|Investigator Decision|0|||
150008919|NCT01659255|541165918|FG003|Overall Study|Investigator Decision|0|||
150008920|NCT01659255|541165919|FG004|Overall Study|Investigator Decision|0|||
150008921|NCT01659255|541165920|FG005|Overall Study|Investigator Decision|0|||
150008922|NCT01659255|541165921|FG006|Overall Study|Investigator Decision|0|||
150008923|NCT01659255|541165922|FG007|Overall Study|Investigator Decision|0|||
150008924|NCT01659255|541165923|FG008|Overall Study|Investigator Decision|0|||
150056778|NCT03011892|541348402|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
150056779|NCT03011892|541348391|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
150056780|NCT03011892|541348392|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
150056781|NCT03011892|541348393|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
150056782|NCT03011892|541348394|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
150056783|NCT03011892|541348395|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
150056784|NCT03011892|541348396|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
150056785|NCT03011892|541348397|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
150056786|NCT03011892|541348398|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
150056787|NCT03011892|541348399|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
150056788|NCT03011892|541348400|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
150056789|NCT03011892|541348401|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
150056790|NCT03011892|541348402|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
150056791|NCT03011892|541348391|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
150056792|NCT03011892|541348392|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
150056793|NCT03011892|541348393|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
150056794|NCT03011892|541348394|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
150056795|NCT03011892|541348395|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
150056796|NCT03011892|541348396|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
150056797|NCT03011892|541348397|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
150056798|NCT03011892|541348398|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
150056799|NCT03011892|541348399|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
150056800|NCT03011892|541348400|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
150056801|NCT03011892|541348401|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
150056802|NCT03011892|541348402|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
150056803|NCT03011892|541348391|FG000|Open Label (OL) Period|Reason not specified|0|||
150056804|NCT03011892|541348392|FG001|Open Label (OL) Period|Reason not specified|0|||
150056805|NCT03011892|541348393|FG002|Open Label (OL) Period|Reason not specified|0|||
150056806|NCT03011892|541348394|FG003|Open Label (OL) Period|Reason not specified|0|||
150056807|NCT03011892|541348395|FG004|Open Label (OL) Period|Reason not specified|0|||
150056808|NCT03011892|541348396|FG005|Open Label (OL) Period|Reason not specified|0|||
150056809|NCT03011892|541348397|FG006|Open Label (OL) Period|Reason not specified|0|||
150056810|NCT03011892|541348398|FG007|Open Label (OL) Period|Reason not specified|1|||
150056811|NCT03011892|541348399|FG008|Open Label (OL) Period|Reason not specified|0|||
150056812|NCT03011892|541348400|FG009|Open Label (OL) Period|Reason not specified|0|||
150056813|NCT03011892|541348401|FG010|Open Label (OL) Period|Reason not specified|0|||
150056814|NCT03011892|541348402|FG011|Open Label (OL) Period|Reason not specified|0|||
150056815|NCT02282293|541348403|FG000|Overall Study|Lost to Follow-up|2|||
150056816|NCT02282293|541348404|FG001|Overall Study|Lost to Follow-up|2|||
150056817|NCT02282293|541348403|FG000|Overall Study|Unable to comply with study procedures|1|||
150056818|NCT02282293|541348404|FG001|Overall Study|Unable to comply with study procedures|0|||
150056819|NCT02282293|541348403|FG000|Overall Study|Moved out of study area|0|||
150056820|NCT02282293|541348404|FG001|Overall Study|Moved out of study area|1|||
150056821|NCT01551420|541348413|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
150056822|NCT01551420|541348414|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
150056823|NCT01551420|541348413|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
150056824|NCT01551420|541348414|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
150056825|NCT01551420|541348413|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
150056826|NCT01551420|541348414|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
150056827|NCT01551420|541348413|FG000|Screened for Part B Eligibility|Declined participation|8|||
150056828|NCT01551420|541348414|FG001|Screened for Part B Eligibility|Declined participation|1|||
150056829|NCT01551420|541348413|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
150056830|NCT01551420|541348414|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
150056831|NCT01551420|541348413|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
150056832|NCT01551420|541348414|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
150056833|NCT01551420|541348413|FG000|Home Use (Part B)|Withdrawal by staff|0|||
150008925|NCT01659255|541165924|FG009|Overall Study|Investigator Decision|0|||
150008926|NCT01659255|541165925|FG010|Overall Study|Investigator Decision|0|||
150008927|NCT01659255|541165926|FG011|Overall Study|Investigator Decision|0|||
150008928|NCT01659255|541165927|FG012|Overall Study|Investigator Decision|1|||
150008929|NCT01659255|541165928|FG013|Overall Study|Investigator Decision|1|||
150008930|NCT01659255|541165929|FG014|Overall Study|Investigator Decision|0|||
150008931|NCT01659255|541165930|FG015|Overall Study|Investigator Decision|0|||
150008932|NCT01659255|541165931|FG016|Overall Study|Investigator Decision|0|||
150008933|NCT01659255|541165915|FG000|Overall Study|Sponsor's Decision|0|||
150008934|NCT01659255|541165916|FG001|Overall Study|Sponsor's Decision|0|||
150008935|NCT01659255|541165917|FG002|Overall Study|Sponsor's Decision|0|||
150056834|NCT01551420|541348414|FG001|Home Use (Part B)|Withdrawal by staff|1|||
150056835|NCT00169442|541348415|FG000|Overall Study|Withdrawal by Subject|0|||
150056836|NCT00169442|541348416|FG001|Overall Study|Withdrawal by Subject|0|||
150056837|NCT00169442|541348417|FG002|Overall Study|Withdrawal by Subject|1|||
150056838|NCT00169442|541348418|FG003|Overall Study|Withdrawal by Subject|0|||
150056839|NCT00169442|541348419|FG004|Overall Study|Withdrawal by Subject|0|||
150056840|NCT00169442|541348420|FG005|Overall Study|Withdrawal by Subject|0|||
150056841|NCT00169442|541348415|FG000|Overall Study|Migrated/moved from study area|0|||
150056842|NCT00169442|541348416|FG001|Overall Study|Migrated/moved from study area|0|||
150056843|NCT00169442|541348417|FG002|Overall Study|Migrated/moved from study area|0|||
150056844|NCT00169442|541348418|FG003|Overall Study|Migrated/moved from study area|0|||
150056845|NCT00169442|541348419|FG004|Overall Study|Migrated/moved from study area|0|||
150056846|NCT00169442|541348420|FG005|Overall Study|Migrated/moved from study area|2|||
150056847|NCT00169442|541348415|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150056848|NCT00169442|541348416|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150056849|NCT00169442|541348417|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150056850|NCT00169442|541348418|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150056851|NCT00169442|541348419|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
150056852|NCT00169442|541348420|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
150056853|NCT00169442|541348415|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
150056854|NCT00169442|541348416|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
150056855|NCT00169442|541348417|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
150056856|NCT00169442|541348418|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
150056857|NCT00169442|541348419|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
150056858|NCT00169442|541348420|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
150056859|NCT01155167|541348421|FG000|Overall Study|Insufficient ultrasound data|2|||
150056860|NCT01155167|541348422|FG001|Overall Study|Insufficient ultrasound data|0|||
150056861|NCT01155167|541348421|FG000|Overall Study|Access site changed to femoral artery|1|||
150056862|NCT01155167|541348422|FG001|Overall Study|Access site changed to femoral artery|0|||
150056863|NCT00336583|541350027|FG000|Overall Study|Lost to Follow-up|1|||
150056864|NCT00336583|541350027|FG000|Overall Study|Death|1|||
150056865|NCT01258998|541350030|FG000|Overall Study|Ineligible|1|||
150056866|NCT01143389|541350031|FG000|Overall Study|Lost to Follow-up|26|||
150056867|NCT01143389|541350032|FG001|Overall Study|Lost to Follow-up|25|||
150056868|NCT04966910|541350033|FG000|Baseline|Participant did not complete measure|0|||
150056869|NCT04966910|541350034|FG001|Baseline|Participant did not complete measure|0|||
150056870|NCT04966910|541350035|FG002|Baseline|Participant did not complete measure|1|||
150056871|NCT04966910|541350036|FG003|Baseline|Participant did not complete measure|0|||
150056872|NCT04966910|541350033|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
150056873|NCT04966910|541350034|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
150056874|NCT04966910|541350035|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
150056875|NCT04966910|541350036|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
150056876|NCT04966910|541350033|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
150056877|NCT04966910|541350034|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
150056878|NCT04966910|541350035|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
150056879|NCT04966910|541350036|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
150056880|NCT04966910|541350033|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
150056881|NCT04966910|541350034|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
150056882|NCT04966910|541350035|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
150056883|NCT04966910|541350036|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
150180228|NCT02723955|541799386|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150008936|NCT01659255|541165918|FG003|Overall Study|Sponsor's Decision|0|||
150008937|NCT01659255|541165919|FG004|Overall Study|Sponsor's Decision|0|||
150056884|NCT02276027|541350039|FG000|Overall Study|Death|1|||
150056885|NCT02276027|541350040|FG001|Overall Study|Death|0|||
150056886|NCT02276027|541350041|FG002|Overall Study|Death|0|||
150056887|NCT02276027|541350042|FG003|Overall Study|Death|2|||
150056888|NCT02276027|541350039|FG000|Overall Study|Physician Decision|0|||
150056889|NCT02276027|541350040|FG001|Overall Study|Physician Decision|0|||
150255181|NCT02121301|542070582|FG000|Overall Study|Protocol Violation|1|||
150008938|NCT01659255|541165920|FG005|Overall Study|Sponsor's Decision|0|||
150008939|NCT01659255|541165921|FG006|Overall Study|Sponsor's Decision|1|||
150056890|NCT02276027|541350041|FG002|Overall Study|Physician Decision|0|||
150056891|NCT02276027|541350042|FG003|Overall Study|Physician Decision|1|||
150056892|NCT02276027|541350039|FG000|Overall Study|Progressive disease|1|||
150056893|NCT02276027|541350040|FG001|Overall Study|Progressive disease|13|||
150056894|NCT02276027|541350041|FG002|Overall Study|Progressive disease|12|||
150056895|NCT02276027|541350042|FG003|Overall Study|Progressive disease|14|||
150056896|NCT02276027|541350039|FG000|Overall Study|Subject/guardian decision|0|||
150056897|NCT02276027|541350040|FG001|Overall Study|Subject/guardian decision|1|||
150056898|NCT02276027|541350041|FG002|Overall Study|Subject/guardian decision|0|||
150056899|NCT02276027|541350042|FG003|Overall Study|Subject/guardian decision|3|||
150056900|NCT02276027|541350039|FG000|Overall Study|Adverse Event|0|||
150056901|NCT02276027|541350040|FG001|Overall Study|Adverse Event|2|||
150056902|NCT02276027|541350041|FG002|Overall Study|Adverse Event|8|||
150056903|NCT02276027|541350042|FG003|Overall Study|Adverse Event|2|||
150056904|NCT03224598|541350043|FG000|Overall Study|Lost to Follow-up|0|||
150056905|NCT03224598|541350044|FG001|Overall Study|Lost to Follow-up|2|||
150056906|NCT03224598|541350045|FG002|Overall Study|Lost to Follow-up|0|||
150056907|NCT03224598|541350043|FG000|Overall Study|Other|0|||
150056908|NCT03224598|541350044|FG001|Overall Study|Other|1|||
150056909|NCT03224598|541350045|FG002|Overall Study|Other|0|||
150056910|NCT02446171|541350053|FG000|Overall Study|Withdrawal by Subject|0|||
150056911|NCT02446171|541350054|FG001|Overall Study|Withdrawal by Subject|0|||
150056912|NCT02446171|541350055|FG002|Overall Study|Withdrawal by Subject|2|||
150056913|NCT02446171|541350056|FG003|Overall Study|Withdrawal by Subject|0|||
150056914|NCT03328182|541350059|FG000|Overall Study|Withdrawal by Subject|1|||
150056915|NCT03328182|541350059|FG000|Overall Study|Protocol Violation|2|||
150056916|NCT03328182|541350059|FG000|Overall Study|No Product Evaluated|1|||
150056917|NCT00504582|541350060|FG000|Overall Study|Lost to Follow-up|1|||
150056918|NCT00504582|541350061|FG001|Overall Study|Lost to Follow-up|0|||
150056919|NCT00504582|541350062|FG002|Overall Study|Lost to Follow-up|0|||
150056920|NCT03384693|541350063|FG000|Overall Study|Adverse Event|3|||
150056921|NCT00883688|541350077|FG000|Overall Study|Ineligible|2|||
150056922|NCT00464490|541350079|FG000|Overall Study|Physician Decision|11|||
150056923|NCT00464490|541350080|FG001|Overall Study|Physician Decision|11|||
150056924|NCT03188042|541350081|FG000|Overall Study|Withdrawal by Subject|1|||
150056925|NCT03188042|541350082|FG001|Overall Study|Withdrawal by Subject|1|||
150056926|NCT00528970|541350085|FG000|Overall Study|Adverse Event|6|||
150056927|NCT00528970|541350086|FG001|Overall Study|Adverse Event|8|||
150056928|NCT00528970|541350087|FG002|Overall Study|Adverse Event|5|||
150056929|NCT00528970|541350085|FG000|Overall Study|Lost to Follow-up|0|||
150056930|NCT00528970|541350086|FG001|Overall Study|Lost to Follow-up|0|||
150056931|NCT00528970|541350087|FG002|Overall Study|Lost to Follow-up|1|||
150056932|NCT00528970|541350085|FG000|Overall Study|Other than specified|2|||
150056933|NCT00528970|541350086|FG001|Overall Study|Other than specified|3|||
150008940|NCT01659255|541165922|FG007|Overall Study|Sponsor's Decision|0|||
150008941|NCT01659255|541165923|FG008|Overall Study|Sponsor's Decision|0|||
150008942|NCT01659255|541165924|FG009|Overall Study|Sponsor's Decision|0|||
150008943|NCT01659255|541165925|FG010|Overall Study|Sponsor's Decision|0|||
150008944|NCT01659255|541165926|FG011|Overall Study|Sponsor's Decision|0|||
150008945|NCT01659255|541165927|FG012|Overall Study|Sponsor's Decision|0|||
150008946|NCT01659255|541165928|FG013|Overall Study|Sponsor's Decision|0|||
150008947|NCT01659255|541165929|FG014|Overall Study|Sponsor's Decision|0|||
150008948|NCT01659255|541165930|FG015|Overall Study|Sponsor's Decision|0|||
150008949|NCT01659255|541165931|FG016|Overall Study|Sponsor's Decision|0|||
150008950|NCT01659255|541165915|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008951|NCT01659255|541165916|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008952|NCT01659255|541165917|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150056934|NCT00528970|541350087|FG002|Overall Study|Other than specified|3|||
150056935|NCT00528970|541350085|FG000|Overall Study|Protocol Violation|2|||
150056936|NCT00528970|541350086|FG001|Overall Study|Protocol Violation|1|||
150008953|NCT01659255|541165918|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008954|NCT01659255|541165919|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150056937|NCT00528970|541350087|FG002|Overall Study|Protocol Violation|4|||
150056938|NCT00528970|541350085|FG000|Overall Study|Lack of Efficacy|0|||
150056939|NCT00528970|541350086|FG001|Overall Study|Lack of Efficacy|0|||
150056940|NCT00528970|541350087|FG002|Overall Study|Lack of Efficacy|1|||
150056941|NCT00528970|541350085|FG000|Overall Study|Withdrawal by Subject|4|||
150056942|NCT00528970|541350086|FG001|Overall Study|Withdrawal by Subject|3|||
150056943|NCT00528970|541350087|FG002|Overall Study|Withdrawal by Subject|5|||
150056944|NCT00528970|541350085|FG000|Overall Study|Randomized but not treated|0|||
150056945|NCT00528970|541350086|FG001|Overall Study|Randomized but not treated|0|||
150056946|NCT00528970|541350087|FG002|Overall Study|Randomized but not treated|1|||
150008955|NCT01659255|541165920|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008956|NCT01659255|541165921|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008957|NCT01659255|541165922|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150056947|NCT03860935|541350092|FG000|Overall Study|Withdrawal of Consent|15|||
150056948|NCT03860935|541350093|FG001|Overall Study|Withdrawal of Consent|6|||
150008958|NCT01659255|541165923|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008959|NCT01659255|541165924|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008960|NCT01659255|541165925|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008961|NCT01659255|541165926|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008962|NCT01659255|541165927|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150056949|NCT03860935|541350092|FG000|Overall Study|Death|75|||
150056950|NCT03860935|541350093|FG001|Overall Study|Death|51|||
150056951|NCT03086967|541350098|FG000|Overall Study|Screen Failure|2|||
150056952|NCT03086967|541350099|FG001|Overall Study|Screen Failure|2|||
150056953|NCT01475071|541350101|FG000|Overall Study|Physician Decision|1|||
150056954|NCT01475071|541350101|FG000|Overall Study|Withdrawal by Subject|6|||
150056955|NCT01475071|541350101|FG000|Overall Study|Lost to Follow-up|1|||
150056956|NCT01752036|541350102|FG000|Overall Study|Death|2|||
150056957|NCT02230527|541350103|FG000|Overall Study|Withdrawal by Subject|1|||
150056958|NCT02230527|541350104|FG001|Overall Study|Withdrawal by Subject|1|||
150056959|NCT02230527|541350103|FG000|Overall Study|Death|1|||
150056960|NCT02230527|541350104|FG001|Overall Study|Death|0|||
150056961|NCT02230527|541350103|FG000|Overall Study|Lost to Follow-up|2|||
150056962|NCT02230527|541350104|FG001|Overall Study|Lost to Follow-up|1|||
150056963|NCT02230527|541350103|FG000|Overall Study|Other|1|||
150056964|NCT02230527|541350104|FG001|Overall Study|Other|0|||
150056965|NCT04461600|541350105|FG000|Overall Study|Death|6|||
150056966|NCT04461600|541350106|FG001|Overall Study|Death|5|||
150056967|NCT04461600|541350105|FG000|Overall Study|Withdrawal by Subject|0|||
150056968|NCT04461600|541350106|FG001|Overall Study|Withdrawal by Subject|1|||
150056969|NCT02278471|541350111|FG000|Overall Study|Lost to Follow-up|6|||
150056970|NCT02278471|541350112|FG001|Overall Study|Lost to Follow-up|15|||
150056971|NCT02278471|541350111|FG000|Overall Study|Death|2|||
150056972|NCT02278471|541350112|FG001|Overall Study|Death|2|||
150056973|NCT02278471|541350111|FG000|Overall Study|Withdrawal by Subject|0|||
150056974|NCT02278471|541350112|FG001|Overall Study|Withdrawal by Subject|3|||
150056975|NCT01437995|541350113|FG000|Overall Study|Lost to Follow-up|11|||
150056976|NCT01437995|541350114|FG001|Overall Study|Lost to Follow-up|18|||
150056977|NCT01437995|541350115|FG002|Overall Study|Lost to Follow-up|20|||
150056978|NCT04618770|541350116|FG000|Overall Study|Censored from Analysis|12|||
150056979|NCT04618770|541350116|FG000|Overall Study|Early Termination|25|||
150056980|NCT04456673|541350117|FG000|Overall Study|Adverse Event|7|||
150056981|NCT04456673|541350118|FG001|Overall Study|Adverse Event|14|||
150056982|NCT04456673|541350117|FG000|Overall Study|Poor compliance to protocol|1|||
150056983|NCT04456673|541350118|FG001|Overall Study|Poor compliance to protocol|0|||
150056984|NCT04456673|541350117|FG000|Overall Study|Withdrawal by Subject|31|||
150056985|NCT04456673|541350118|FG001|Overall Study|Withdrawal by Subject|23|||
150056986|NCT04456673|541350117|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
150056987|NCT04456673|541350118|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
150056988|NCT04391049|541350119|FG000|Overall Study|Protocol Violation|1|||
150056989|NCT03874429|541350120|FG000|Overall Study|Adverse Event|2|||
150056990|NCT03874429|541350121|FG001|Overall Study|Adverse Event|2|||
150056991|NCT03874429|541350120|FG000|Overall Study|Lack of Efficacy|0|||
150056992|NCT03874429|541350121|FG001|Overall Study|Lack of Efficacy|1|||
150056993|NCT03874429|541350120|FG000|Overall Study|Covid-19 pandemic|4|||
150056994|NCT03874429|541350121|FG001|Overall Study|Covid-19 pandemic|2|||
150056995|NCT01101308|541350123|FG000|Period 1|Adverse Event|2|||
150056996|NCT01101308|541350124|FG001|Period 1|Adverse Event|1|||
150056997|NCT01101308|541350123|FG000|Period 1|Positive for cotinine|1|||
150056998|NCT01101308|541350124|FG001|Period 1|Positive for cotinine|0|||
150056999|NCT00711516|541350128|FG000|Overall Study|Adverse Event|1|||
150057000|NCT00711516|541350129|FG001|Overall Study|Adverse Event|1|||
150057001|NCT00711516|541350128|FG000|Overall Study|Withdrawal by Subject|0|||
150057002|NCT00711516|541350129|FG001|Overall Study|Withdrawal by Subject|1|||
150057003|NCT00711516|541350128|FG000|Overall Study|Protocol Violation|0|||
150057004|NCT00711516|541350129|FG001|Overall Study|Protocol Violation|1|||
150057005|NCT01895361|541350130|FG000|Overall Study|Adverse Event|1|||
150180229|NCT02723955|541799387|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180230|NCT02723955|541799388|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150057006|NCT01895361|541350131|FG001|Overall Study|Adverse Event|1|||
150057007|NCT01895361|541350132|FG002|Overall Study|Adverse Event|3|||
150057008|NCT01895361|541350130|FG000|Overall Study|Death|2|||
150057009|NCT01895361|541350131|FG001|Overall Study|Death|1|||
150057010|NCT01895361|541350132|FG002|Overall Study|Death|2|||
150057011|NCT01895361|541350130|FG000|Overall Study|Lost to Follow-up|4|||
150057012|NCT01895361|541350131|FG001|Overall Study|Lost to Follow-up|4|||
150057013|NCT01895361|541350132|FG002|Overall Study|Lost to Follow-up|6|||
150008963|NCT01659255|541165928|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008964|NCT01659255|541165929|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008965|NCT01659255|541165930|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
150057014|NCT01895361|541350130|FG000|Overall Study|Non-compliance with study|1|||
150057015|NCT01895361|541350131|FG001|Overall Study|Non-compliance with study|3|||
150180231|NCT02723955|541799389|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180232|NCT02723955|541799390|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180233|NCT02723955|541799391|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180234|NCT02723955|541799392|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180235|NCT02723955|541799393|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180236|NCT02723955|541799394|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180237|NCT02723955|541799395|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180238|NCT02723955|541799396|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
150180239|NCT02723955|541799354|FG000|Escalation Phase|Site Closed|0|||
150180240|NCT02723955|541799355|FG001|Escalation Phase|Site Closed|0|||
150180241|NCT02723955|541799356|FG002|Escalation Phase|Site Closed|0|||
150180242|NCT02723955|541799357|FG003|Escalation Phase|Site Closed|0|||
150180243|NCT02723955|541799358|FG004|Escalation Phase|Site Closed|0|||
150180244|NCT02723955|541799359|FG005|Escalation Phase|Site Closed|0|||
150180245|NCT02723955|541799360|FG006|Escalation Phase|Site Closed|0|||
150180246|NCT02723955|541799361|FG007|Escalation Phase|Site Closed|0|||
150180247|NCT02723955|541799362|FG008|Escalation Phase|Site Closed|0|||
150180248|NCT02723955|541799363|FG009|Escalation Phase|Site Closed|0|||
150180249|NCT02723955|541799364|FG010|Escalation Phase|Site Closed|0|||
150180250|NCT02723955|541799365|FG011|Escalation Phase|Site Closed|0|||
150180251|NCT02723955|541799366|FG012|Escalation Phase|Site Closed|0|||
150180252|NCT02723955|541799367|FG013|Escalation Phase|Site Closed|0|||
150180253|NCT02723955|541799368|FG014|Escalation Phase|Site Closed|0|||
150180254|NCT02723955|541799369|FG015|Escalation Phase|Site Closed|1|||
150180255|NCT02723955|541799370|FG016|Escalation Phase|Site Closed|0|||
150180256|NCT02723955|541799371|FG017|Escalation Phase|Site Closed|2|||
150180257|NCT02723955|541799372|FG018|Escalation Phase|Site Closed|0|||
150180258|NCT02723955|541799373|FG019|Escalation Phase|Site Closed|0|||
150180259|NCT02723955|541799374|FG020|Escalation Phase|Site Closed|1|||
150180260|NCT02723955|541799375|FG021|Escalation Phase|Site Closed|0|||
150180261|NCT02723955|541799376|FG022|Escalation Phase|Site Closed|0|||
150180262|NCT02723955|541799377|FG023|Escalation Phase|Site Closed|0|||
150180263|NCT02723955|541799378|FG024|Escalation Phase|Site Closed|3|||
150180264|NCT02723955|541799379|FG025|Escalation Phase|Site Closed|1|||
150180265|NCT02723955|541799380|FG026|Escalation Phase|Site Closed|3|||
150180266|NCT02723955|541799381|FG027|Escalation Phase|Site Closed|1|||
150180267|NCT02723955|541799382|FG028|Escalation Phase|Site Closed|1|||
150180268|NCT02723955|541799383|FG029|Escalation Phase|Site Closed|0|||
150180269|NCT02723955|541799384|FG030|Escalation Phase|Site Closed|0|||
150180270|NCT02723955|541799385|FG031|Escalation Phase|Site Closed|0|||
150180271|NCT02723955|541799386|FG032|Escalation Phase|Site Closed|0|||
150180272|NCT02723955|541799387|FG033|Escalation Phase|Site Closed|0|||
150180273|NCT02723955|541799388|FG034|Escalation Phase|Site Closed|0|||
150180274|NCT02723955|541799389|FG035|Escalation Phase|Site Closed|0|||
150180275|NCT02723955|541799390|FG036|Escalation Phase|Site Closed|0|||
150180276|NCT02723955|541799391|FG037|Escalation Phase|Site Closed|0|||
150180277|NCT02723955|541799392|FG038|Escalation Phase|Site Closed|0|||
150180278|NCT02723955|541799393|FG039|Escalation Phase|Site Closed|0|||
150180279|NCT02723955|541799394|FG040|Escalation Phase|Site Closed|0|||
150180280|NCT02723955|541799395|FG041|Escalation Phase|Site Closed|0|||
150180281|NCT02723955|541799396|FG042|Escalation Phase|Site Closed|0|||
150180282|NCT02723955|541799354|FG000|Expansion Phase|Death|0|||
150180283|NCT02723955|541799355|FG001|Expansion Phase|Death|0|||
150180284|NCT02723955|541799356|FG002|Expansion Phase|Death|0|||
150180285|NCT02723955|541799357|FG003|Expansion Phase|Death|0|||
150180286|NCT02723955|541799358|FG004|Expansion Phase|Death|0|||
150180287|NCT02723955|541799359|FG005|Expansion Phase|Death|0|||
150180288|NCT02723955|541799360|FG006|Expansion Phase|Death|0|||
150180289|NCT02723955|541799361|FG007|Expansion Phase|Death|0|||
150180290|NCT02723955|541799362|FG008|Expansion Phase|Death|0|||
150180291|NCT02723955|541799363|FG009|Expansion Phase|Death|25|||
150180292|NCT02723955|541799364|FG010|Expansion Phase|Death|69|||
150180293|NCT02723955|541799365|FG011|Expansion Phase|Death|48|||
150180294|NCT02723955|541799366|FG012|Expansion Phase|Death|0|||
150180295|NCT02723955|541799367|FG013|Expansion Phase|Death|0|||
150180296|NCT02723955|541799368|FG014|Expansion Phase|Death|0|||
150180297|NCT02723955|541799369|FG015|Expansion Phase|Death|0|||
150180298|NCT02723955|541799370|FG016|Expansion Phase|Death|0|||
150180299|NCT02723955|541799371|FG017|Expansion Phase|Death|0|||
150180300|NCT02723955|541799372|FG018|Expansion Phase|Death|0|||
150180301|NCT02723955|541799373|FG019|Expansion Phase|Death|0|||
150180302|NCT02723955|541799374|FG020|Expansion Phase|Death|0|||
150180303|NCT02723955|541799375|FG021|Expansion Phase|Death|0|||
150180304|NCT02723955|541799376|FG022|Expansion Phase|Death|0|||
150180305|NCT02723955|541799377|FG023|Expansion Phase|Death|0|||
150180306|NCT02723955|541799378|FG024|Expansion Phase|Death|0|||
150008966|NCT01659255|541165931|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
150008967|NCT01659255|541165915|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
150008968|NCT01659255|541165916|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
150008969|NCT01659255|541165917|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
150008970|NCT01659255|541165918|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
150008971|NCT01659255|541165919|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
150008972|NCT01659255|541165920|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
150008973|NCT01659255|541165921|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
150008974|NCT01659255|541165922|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
150008975|NCT01659255|541165923|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
150008976|NCT01659255|541165924|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
150008977|NCT01659255|541165925|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
150008978|NCT01659255|541165926|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
150008979|NCT01659255|541165927|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
150008980|NCT01659255|541165928|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
150008981|NCT01659255|541165929|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
150008982|NCT01659255|541165930|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
150008983|NCT01659255|541165931|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
150008984|NCT03316950|541165932|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
150008985|NCT03316950|541165933|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
150008986|NCT03316950|541165934|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
150008987|NCT03316950|541165935|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
150008988|NCT03316950|541165932|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
150008989|NCT03316950|541165933|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
150008990|NCT03316950|541165934|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
150008991|NCT03316950|541165935|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
150008992|NCT03316950|541165932|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
150008993|NCT03316950|541165933|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
150008994|NCT03316950|541165934|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
150008995|NCT03316950|541165935|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
150008996|NCT00549770|541165936|FG000|Overall Study|Protocol deviation|1|||
150008997|NCT00549770|541165937|FG001|Overall Study|Protocol deviation|1|||
150008998|NCT00549770|541165938|FG002|Overall Study|Protocol deviation|1|||
150008999|NCT00549770|541165939|FG003|Overall Study|Protocol deviation|2|||
150009000|NCT00549770|541165940|FG004|Overall Study|Protocol deviation|2|||
150009001|NCT00549770|541165941|FG005|Overall Study|Protocol deviation|2|||
150009002|NCT00549770|541165942|FG006|Overall Study|Protocol deviation|1|||
150009003|NCT00549770|541165943|FG007|Overall Study|Protocol deviation|2|||
150009004|NCT00549770|541165936|FG000|Overall Study|Administrative problems|0|||
150009005|NCT00549770|541165937|FG001|Overall Study|Administrative problems|1|||
150009006|NCT00549770|541165938|FG002|Overall Study|Administrative problems|0|||
150009007|NCT00549770|541165939|FG003|Overall Study|Administrative problems|0|||
150009008|NCT00549770|541165940|FG004|Overall Study|Administrative problems|0|||
150009009|NCT00549770|541165941|FG005|Overall Study|Administrative problems|0|||
150009010|NCT00549770|541165942|FG006|Overall Study|Administrative problems|0|||
150009011|NCT00549770|541165943|FG007|Overall Study|Administrative problems|1|||
150009012|NCT00549770|541165936|FG000|Overall Study|Lost to Follow-up|0|||
150009013|NCT00549770|541165937|FG001|Overall Study|Lost to Follow-up|0|||
150009014|NCT00549770|541165938|FG002|Overall Study|Lost to Follow-up|2|||
150009015|NCT00549770|541165939|FG003|Overall Study|Lost to Follow-up|2|||
150009016|NCT00549770|541165940|FG004|Overall Study|Lost to Follow-up|3|||
150009017|NCT00549770|541165941|FG005|Overall Study|Lost to Follow-up|2|||
150009018|NCT00549770|541165942|FG006|Overall Study|Lost to Follow-up|0|||
150009019|NCT00549770|541165943|FG007|Overall Study|Lost to Follow-up|0|||
150009020|NCT00549770|541165936|FG000|Overall Study|Withdrawal by Subject|4|||
150009021|NCT00549770|541165937|FG001|Overall Study|Withdrawal by Subject|6|||
150009022|NCT00549770|541165938|FG002|Overall Study|Withdrawal by Subject|4|||
150009023|NCT00549770|541165939|FG003|Overall Study|Withdrawal by Subject|5|||
150009024|NCT00549770|541165940|FG004|Overall Study|Withdrawal by Subject|6|||
150009025|NCT00549770|541165941|FG005|Overall Study|Withdrawal by Subject|6|||
150057016|NCT01895361|541350132|FG002|Overall Study|Non-compliance with study|1|||
150057017|NCT01895361|541350130|FG000|Overall Study|Physician Decision|2|||
150009026|NCT00549770|541165942|FG006|Overall Study|Withdrawal by Subject|4|||
150009027|NCT00549770|541165943|FG007|Overall Study|Withdrawal by Subject|9|||
150009028|NCT00549770|541165936|FG000|Overall Study|Lack of Efficacy|1|||
150009029|NCT00549770|541165937|FG001|Overall Study|Lack of Efficacy|0|||
150009030|NCT00549770|541165938|FG002|Overall Study|Lack of Efficacy|2|||
150009031|NCT00549770|541165939|FG003|Overall Study|Lack of Efficacy|3|||
150009032|NCT00549770|541165940|FG004|Overall Study|Lack of Efficacy|5|||
150009033|NCT00549770|541165941|FG005|Overall Study|Lack of Efficacy|1|||
150009034|NCT00549770|541165942|FG006|Overall Study|Lack of Efficacy|3|||
150009035|NCT00549770|541165943|FG007|Overall Study|Lack of Efficacy|8|||
150009036|NCT00549770|541165936|FG000|Overall Study|Abnormal test procedure results|0|||
150009037|NCT00549770|541165937|FG001|Overall Study|Abnormal test procedure results|0|||
150009038|NCT00549770|541165938|FG002|Overall Study|Abnormal test procedure results|0|||
150009039|NCT00549770|541165939|FG003|Overall Study|Abnormal test procedure results|2|||
150009040|NCT00549770|541165940|FG004|Overall Study|Abnormal test procedure results|0|||
150009041|NCT00549770|541165941|FG005|Overall Study|Abnormal test procedure results|1|||
150009042|NCT00549770|541165942|FG006|Overall Study|Abnormal test procedure results|1|||
150009043|NCT00549770|541165943|FG007|Overall Study|Abnormal test procedure results|1|||
150009044|NCT00549770|541165936|FG000|Overall Study|Abnormal laboratory values|0|||
150009045|NCT00549770|541165937|FG001|Overall Study|Abnormal laboratory values|0|||
150009046|NCT00549770|541165938|FG002|Overall Study|Abnormal laboratory values|0|||
150009047|NCT00549770|541165939|FG003|Overall Study|Abnormal laboratory values|0|||
150009048|NCT00549770|541165940|FG004|Overall Study|Abnormal laboratory values|0|||
150009049|NCT00549770|541165941|FG005|Overall Study|Abnormal laboratory values|1|||
150009050|NCT00549770|541165942|FG006|Overall Study|Abnormal laboratory values|0|||
150009051|NCT00549770|541165943|FG007|Overall Study|Abnormal laboratory values|0|||
150009052|NCT00549770|541165936|FG000|Overall Study|Adverse Event|1|||
150009053|NCT00549770|541165937|FG001|Overall Study|Adverse Event|3|||
150009054|NCT00549770|541165938|FG002|Overall Study|Adverse Event|1|||
150009055|NCT00549770|541165939|FG003|Overall Study|Adverse Event|2|||
150009056|NCT00549770|541165940|FG004|Overall Study|Adverse Event|1|||
150009057|NCT00549770|541165941|FG005|Overall Study|Adverse Event|0|||
150009058|NCT00549770|541165942|FG006|Overall Study|Adverse Event|5|||
150009059|NCT00549770|541165943|FG007|Overall Study|Adverse Event|4|||
150009060|NCT02049138|541165952|FG000|Overall Study|Adverse Event|46|||
150009061|NCT02049138|541165953|FG001|Overall Study|Adverse Event|25|||
150009062|NCT02049138|541165954|FG002|Overall Study|Adverse Event|1|||
150009063|NCT02049138|541165952|FG000|Overall Study|Withdrawal by Subject|57|||
150009064|NCT02049138|541165953|FG001|Overall Study|Withdrawal by Subject|21|||
150009065|NCT02049138|541165954|FG002|Overall Study|Withdrawal by Subject|5|||
150009066|NCT02049138|541165952|FG000|Overall Study|Lost to Follow-up|18|||
150009067|NCT02049138|541165953|FG001|Overall Study|Lost to Follow-up|5|||
150009068|NCT02049138|541165954|FG002|Overall Study|Lost to Follow-up|1|||
150009069|NCT02049138|541165952|FG000|Overall Study|Lack of Efficacy|10|||
150009070|NCT02049138|541165953|FG001|Overall Study|Lack of Efficacy|26|||
150009071|NCT02049138|541165954|FG002|Overall Study|Lack of Efficacy|1|||
150009072|NCT02049138|541165952|FG000|Overall Study|Non-Compliance|15|||
150009073|NCT02049138|541165953|FG001|Overall Study|Non-Compliance|6|||
150009074|NCT02049138|541165954|FG002|Overall Study|Non-Compliance|0|||
150009075|NCT02049138|541165952|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
150009076|NCT02049138|541165953|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
150009077|NCT02049138|541165954|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
150009078|NCT02049138|541165952|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
150009079|NCT02049138|541165953|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
150009080|NCT02049138|541165954|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
150009081|NCT02049138|541165952|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
150009082|NCT02049138|541165953|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
150009083|NCT02049138|541165954|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
150009084|NCT02049138|541165952|FG000|Overall Study|Other|15|||
150009085|NCT02049138|541165953|FG001|Overall Study|Other|13|||
150009086|NCT02049138|541165954|FG002|Overall Study|Other|0|||
150009087|NCT02049138|541165952|FG000|Overall Study|Missing|0|||
150009088|NCT02049138|541165953|FG001|Overall Study|Missing|1|||
150009089|NCT02049138|541165954|FG002|Overall Study|Missing|0|||
150009090|NCT00257660|541165955|FG000|Overall Study|Lack of Efficacy|5|||
150009091|NCT00257660|541165956|FG001|Overall Study|Lack of Efficacy|23|||
150009092|NCT00257660|541165955|FG000|Overall Study|Withdrawal by Subject|2|||
150009093|NCT00257660|541165956|FG001|Overall Study|Withdrawal by Subject|0|||
150009094|NCT00257660|541165955|FG000|Overall Study|Lost to Follow-up|1|||
150009095|NCT00257660|541165956|FG001|Overall Study|Lost to Follow-up|0|||
150009096|NCT00257660|541165955|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
150009097|NCT00257660|541165956|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
150009098|NCT00257660|541165955|FG000|Overall Study|No longer wanted to do blood draws|1|||
150057018|NCT01895361|541350131|FG001|Overall Study|Physician Decision|2|||
150057019|NCT01895361|541350132|FG002|Overall Study|Physician Decision|2|||
150009099|NCT00257660|541165956|FG001|Overall Study|No longer wanted to do blood draws|0|||
150009100|NCT02437084|541165957|FG000|Overall Study|Withdrawal by Subject|2|||
150009101|NCT02437084|541165957|FG000|Overall Study|Physician Decision|1|||
150009102|NCT03332160|541165962|FG000|Overall Study|Withdrawal by Subject|1|||
150009103|NCT03332160|541165963|FG001|Overall Study|Withdrawal by Subject|1|||
150009104|NCT03332160|541165962|FG000|Overall Study|Adverse Event|0|||
150009105|NCT03332160|541165963|FG001|Overall Study|Adverse Event|1|||
150009106|NCT03332160|541165962|FG000|Overall Study|Developed Exclusion Criteria|0|||
150009107|NCT03332160|541165963|FG001|Overall Study|Developed Exclusion Criteria|1|||
150009108|NCT03332160|541165962|FG000|Overall Study|Non-adherence to treatment|0|||
150180307|NCT02723955|541799379|FG025|Expansion Phase|Death|0|||
150180308|NCT02723955|541799380|FG026|Expansion Phase|Death|0|||
150180309|NCT02723955|541799381|FG027|Expansion Phase|Death|0|||
150009109|NCT03332160|541165963|FG001|Overall Study|Non-adherence to treatment|2|||
150009110|NCT04598269|541165964|FG000|Overall Study|Adverse Event|0|||
150009111|NCT04598269|541165965|FG001|Overall Study|Adverse Event|3|||
150009112|NCT04598269|541165964|FG000|Overall Study|Withdrawal by Subject|1|||
150009113|NCT04598269|541165965|FG001|Overall Study|Withdrawal by Subject|4|||
150180310|NCT02723955|541799382|FG028|Expansion Phase|Death|0|||
150180311|NCT02723955|541799383|FG029|Expansion Phase|Death|12|||
150180312|NCT02723955|541799384|FG030|Expansion Phase|Death|202|||
150180313|NCT02723955|541799385|FG031|Expansion Phase|Death|31|||
150180314|NCT02723955|541799386|FG032|Expansion Phase|Death|17|||
150180315|NCT02723955|541799387|FG033|Expansion Phase|Death|2|||
150180316|NCT02723955|541799388|FG034|Expansion Phase|Death|3|||
150180317|NCT02723955|541799389|FG035|Expansion Phase|Death|3|||
150180318|NCT02723955|541799390|FG036|Expansion Phase|Death|1|||
150180319|NCT02723955|541799391|FG037|Expansion Phase|Death|0|||
150180320|NCT02723955|541799392|FG038|Expansion Phase|Death|0|||
150180321|NCT02723955|541799393|FG039|Expansion Phase|Death|0|||
150180322|NCT02723955|541799394|FG040|Expansion Phase|Death|0|||
150180323|NCT02723955|541799395|FG041|Expansion Phase|Death|0|||
150180324|NCT02723955|541799396|FG042|Expansion Phase|Death|0|||
150180325|NCT02723955|541799354|FG000|Expansion Phase|Lost to Follow-up|0|||
150180326|NCT02723955|541799355|FG001|Expansion Phase|Lost to Follow-up|0|||
150180327|NCT02723955|541799356|FG002|Expansion Phase|Lost to Follow-up|0|||
150180328|NCT02723955|541799357|FG003|Expansion Phase|Lost to Follow-up|0|||
150180329|NCT02723955|541799358|FG004|Expansion Phase|Lost to Follow-up|0|||
150180330|NCT02723955|541799359|FG005|Expansion Phase|Lost to Follow-up|0|||
150180331|NCT02723955|541799360|FG006|Expansion Phase|Lost to Follow-up|0|||
150180332|NCT02723955|541799361|FG007|Expansion Phase|Lost to Follow-up|0|||
150180333|NCT02723955|541799362|FG008|Expansion Phase|Lost to Follow-up|0|||
150180334|NCT02723955|541799363|FG009|Expansion Phase|Lost to Follow-up|0|||
150180335|NCT02723955|541799364|FG010|Expansion Phase|Lost to Follow-up|4|||
150180336|NCT02723955|541799365|FG011|Expansion Phase|Lost to Follow-up|1|||
150180337|NCT02723955|541799366|FG012|Expansion Phase|Lost to Follow-up|0|||
150180338|NCT02723955|541799367|FG013|Expansion Phase|Lost to Follow-up|0|||
150180339|NCT02723955|541799368|FG014|Expansion Phase|Lost to Follow-up|0|||
150180340|NCT02723955|541799369|FG015|Expansion Phase|Lost to Follow-up|0|||
150180341|NCT02723955|541799370|FG016|Expansion Phase|Lost to Follow-up|0|||
150180342|NCT02723955|541799371|FG017|Expansion Phase|Lost to Follow-up|0|||
150180343|NCT02723955|541799372|FG018|Expansion Phase|Lost to Follow-up|0|||
150180344|NCT02723955|541799373|FG019|Expansion Phase|Lost to Follow-up|0|||
150180345|NCT02723955|541799374|FG020|Expansion Phase|Lost to Follow-up|0|||
150180346|NCT02723955|541799375|FG021|Expansion Phase|Lost to Follow-up|0|||
150180347|NCT02723955|541799376|FG022|Expansion Phase|Lost to Follow-up|0|||
150180348|NCT02723955|541799377|FG023|Expansion Phase|Lost to Follow-up|0|||
150180349|NCT02723955|541799378|FG024|Expansion Phase|Lost to Follow-up|0|||
150180350|NCT02723955|541799379|FG025|Expansion Phase|Lost to Follow-up|0|||
150180351|NCT02723955|541799380|FG026|Expansion Phase|Lost to Follow-up|0|||
150180352|NCT02723955|541799381|FG027|Expansion Phase|Lost to Follow-up|0|||
150180353|NCT02723955|541799382|FG028|Expansion Phase|Lost to Follow-up|0|||
150180354|NCT02723955|541799383|FG029|Expansion Phase|Lost to Follow-up|1|||
150180355|NCT02723955|541799384|FG030|Expansion Phase|Lost to Follow-up|19|||
150180356|NCT02723955|541799385|FG031|Expansion Phase|Lost to Follow-up|2|||
150180357|NCT02723955|541799386|FG032|Expansion Phase|Lost to Follow-up|1|||
150180358|NCT02723955|541799387|FG033|Expansion Phase|Lost to Follow-up|0|||
150180359|NCT02723955|541799388|FG034|Expansion Phase|Lost to Follow-up|0|||
150180360|NCT02723955|541799389|FG035|Expansion Phase|Lost to Follow-up|0|||
150180361|NCT02723955|541799390|FG036|Expansion Phase|Lost to Follow-up|0|||
150180362|NCT02723955|541799391|FG037|Expansion Phase|Lost to Follow-up|0|||
150180363|NCT02723955|541799392|FG038|Expansion Phase|Lost to Follow-up|0|||
150180364|NCT02723955|541799393|FG039|Expansion Phase|Lost to Follow-up|0|||
150009114|NCT04598269|541165964|FG000|Overall Study|Lost to Follow-up|1|||
150009115|NCT04598269|541165965|FG001|Overall Study|Lost to Follow-up|0|||
150180365|NCT02723955|541799394|FG040|Expansion Phase|Lost to Follow-up|0|||
150180366|NCT02723955|541799395|FG041|Expansion Phase|Lost to Follow-up|0|||
150180367|NCT02723955|541799396|FG042|Expansion Phase|Lost to Follow-up|0|||
150180368|NCT02723955|541799354|FG000|Expansion Phase|Physician Decision|0|||
150180369|NCT02723955|541799355|FG001|Expansion Phase|Physician Decision|0|||
150180370|NCT02723955|541799356|FG002|Expansion Phase|Physician Decision|0|||
150180371|NCT02723955|541799357|FG003|Expansion Phase|Physician Decision|0|||
150180372|NCT02723955|541799358|FG004|Expansion Phase|Physician Decision|0|||
150180373|NCT02723955|541799359|FG005|Expansion Phase|Physician Decision|0|||
150180374|NCT02723955|541799360|FG006|Expansion Phase|Physician Decision|0|||
150180375|NCT02723955|541799361|FG007|Expansion Phase|Physician Decision|0|||
150180376|NCT02723955|541799362|FG008|Expansion Phase|Physician Decision|0|||
150180377|NCT02723955|541799363|FG009|Expansion Phase|Physician Decision|0|||
150180378|NCT02723955|541799364|FG010|Expansion Phase|Physician Decision|0|||
150180379|NCT02723955|541799365|FG011|Expansion Phase|Physician Decision|0|||
150180380|NCT02723955|541799366|FG012|Expansion Phase|Physician Decision|0|||
150009116|NCT04598269|541165964|FG000|Overall Study|Not Treated|2|||
150009117|NCT04598269|541165965|FG001|Overall Study|Not Treated|0|||
150009118|NCT03101085|541165966|FG000|Overall Study|Lost to Follow-up|0|||
150009119|NCT03101085|541165967|FG001|Overall Study|Lost to Follow-up|1|||
150009120|NCT00718770|541165969|FG000|Overall Study|Adverse Event|1|||
150009121|NCT00718770|541165969|FG000|Overall Study|Lack of Efficacy|1|||
150009122|NCT00718770|541165969|FG000|Overall Study|Lack of Efficacy|1|||
150057020|NCT01895361|541350130|FG000|Overall Study|Withdrawal by Subject|7|||
150057021|NCT01895361|541350131|FG001|Overall Study|Withdrawal by Subject|6|||
150057022|NCT01895361|541350132|FG002|Overall Study|Withdrawal by Subject|6|||
150057023|NCT01895361|541350130|FG000|Overall Study|Lack of Efficacy|0|||
150057024|NCT01895361|541350131|FG001|Overall Study|Lack of Efficacy|1|||
150057025|NCT01895361|541350132|FG002|Overall Study|Lack of Efficacy|0|||
150057026|NCT01895361|541350130|FG000|Overall Study|Reasons different from categories above|7|||
150009123|NCT00718770|541165969|FG000|Overall Study|Adverse Event|1|||
150057027|NCT01895361|541350131|FG001|Overall Study|Reasons different from categories above|3|||
150057028|NCT01895361|541350132|FG002|Overall Study|Reasons different from categories above|4|||
150057029|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
150057030|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
150057031|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
150057032|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
150057033|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
150057034|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
150057035|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
150057036|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
150057037|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
150057038|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
150057039|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
150057040|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
150057041|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
150057042|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
150057043|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
150057044|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
150057045|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
150057046|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
150057047|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
150057048|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
150057049|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
150057050|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
150009124|NCT00718770|541165969|FG000|Overall Study|Lack of Efficacy|1|||
150009125|NCT00718770|541165969|FG000|Overall Study|Adverse Event|1|||
150009126|NCT00718770|541165969|FG000|Overall Study|Lack of Efficacy|1|||
150057051|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
150057052|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
150057053|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
150009127|NCT00718770|541165969|FG000|Overall Study|Adverse Event|1|||
150009128|NCT00772109|541165973|FG000|Overall Study|Serious adverse event|1|||
150009129|NCT00772109|541165974|FG001|Overall Study|Serious adverse event|0|||
150009130|NCT00772109|541165975|FG002|Overall Study|Serious adverse event|1|||
150009131|NCT00772109|541165976|FG003|Overall Study|Serious adverse event|0|||
150009132|NCT00772109|541165973|FG000|Overall Study|Protocol Violation|5|||
150009133|NCT00772109|541165974|FG001|Overall Study|Protocol Violation|8|||
150009134|NCT00772109|541165975|FG002|Overall Study|Protocol Violation|7|||
150009135|NCT00772109|541165976|FG003|Overall Study|Protocol Violation|6|||
150009136|NCT00772109|541165973|FG000|Overall Study|Lost to Follow-up|7|||
150009137|NCT00772109|541165974|FG001|Overall Study|Lost to Follow-up|3|||
150009138|NCT00772109|541165975|FG002|Overall Study|Lost to Follow-up|5|||
150009139|NCT00772109|541165976|FG003|Overall Study|Lost to Follow-up|9|||
150009140|NCT00772109|541165973|FG000|Overall Study|Withdrawal by Subject|8|||
150009141|NCT00772109|541165974|FG001|Overall Study|Withdrawal by Subject|8|||
150009142|NCT00772109|541165975|FG002|Overall Study|Withdrawal by Subject|6|||
150009143|NCT00772109|541165976|FG003|Overall Study|Withdrawal by Subject|16|||
150009144|NCT01624090|541165977|FG000|Overall Study|DLT, taken off therapy|0|||
150009145|NCT01624090|541165978|FG001|Overall Study|DLT, taken off therapy|1|||
150009146|NCT01624090|541165979|FG002|Overall Study|DLT, taken off therapy|0|||
150009147|NCT01624090|541165980|FG003|Overall Study|DLT, taken off therapy|0|||
150009148|NCT01624090|541165977|FG000|Overall Study|Withdrew prior to treatment|0|||
150009149|NCT01624090|541165978|FG001|Overall Study|Withdrew prior to treatment|1|||
150009150|NCT01624090|541165979|FG002|Overall Study|Withdrew prior to treatment|0|||
150009151|NCT01624090|541165980|FG003|Overall Study|Withdrew prior to treatment|0|||
150009152|NCT01624090|541165977|FG000|Overall Study|Died on study|0|||
150009153|NCT01624090|541165978|FG001|Overall Study|Died on study|0|||
150009154|NCT01624090|541165979|FG002|Overall Study|Died on study|2|||
150009155|NCT01624090|541165980|FG003|Overall Study|Died on study|0|||
150009156|NCT01624090|541165977|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
150009157|NCT01624090|541165978|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
150009158|NCT01624090|541165979|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
150009159|NCT01624090|541165980|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
150009160|NCT01624090|541165977|FG000|Overall Study|Dose escalated|0|||
150009161|NCT01624090|541165978|FG001|Overall Study|Dose escalated|0|||
150009162|NCT01624090|541165979|FG002|Overall Study|Dose escalated|3|||
150009163|NCT01624090|541165980|FG003|Overall Study|Dose escalated|0|||
150009164|NCT01895309|541165981|FG000|Overall Study|Adverse Event|13|||
150009165|NCT01895309|541165982|FG001|Overall Study|Adverse Event|17|||
150009166|NCT01895309|541165981|FG000|Overall Study|Protocol Violation|1|||
150009167|NCT01895309|541165982|FG001|Overall Study|Protocol Violation|0|||
150009168|NCT01895309|541165981|FG000|Overall Study|Lack of Efficacy|1|||
150009169|NCT01895309|541165982|FG001|Overall Study|Lack of Efficacy|3|||
150009170|NCT01895309|541165981|FG000|Overall Study|Lost to Follow-up|1|||
150009171|NCT01895309|541165982|FG001|Overall Study|Lost to Follow-up|3|||
150009172|NCT01895309|541165981|FG000|Overall Study|Physician Decision|15|||
150009173|NCT01895309|541165982|FG001|Overall Study|Physician Decision|10|||
150009174|NCT01895309|541165981|FG000|Overall Study|Withdrawal by Subject|9|||
150009175|NCT01895309|541165982|FG001|Overall Study|Withdrawal by Subject|18|||
150009176|NCT04232215|541165983|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
150009177|NCT04232215|541165984|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
150009178|NCT00626405|541165987|FG000|Overall Study|Deemed Ineligible|1|||
150009179|NCT00626405|541165988|FG001|Overall Study|Deemed Ineligible|0|||
150009180|NCT00626405|541165987|FG000|Overall Study|Withdrawal by Subject|0|||
150009181|NCT00626405|541165988|FG001|Overall Study|Withdrawal by Subject|1|||
150009182|NCT02666105|541165989|FG000|Overall Study|Death|1|||
150009183|NCT01264419|541165991|FG000|Overall Study|Lost to Follow-up|3|||
150009184|NCT02100475|541168148|FG000|Overall Study|Unclassified|1|||
150009185|NCT02100475|541168149|FG001|Overall Study|Unclassified|2|||
150009186|NCT02100475|541168148|FG000|Overall Study|Withdrawal criteria|1|||
150009187|NCT02100475|541168149|FG001|Overall Study|Withdrawal criteria|0|||
150057054|NCT00095147|541350137|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
150009188|NCT03109184|541168150|FG000|Overall Study|Lost to Follow-up|6|||
150009189|NCT03109184|541168151|FG001|Overall Study|Lost to Follow-up|6|||
150009190|NCT03109184|541168150|FG000|Overall Study|Withdrawal by Subject|1|||
150009191|NCT03109184|541168151|FG001|Overall Study|Withdrawal by Subject|1|||
150057055|NCT00095147|541350138|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
150009192|NCT02806960|541168154|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
150009193|NCT02806960|541168155|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
150009194|NCT02806960|541168156|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
150009195|NCT02806960|541168157|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
150009196|NCT01041287|541168158|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
150009197|NCT01041287|541168159|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
150009198|NCT01041287|541168158|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
150009199|NCT01041287|541168159|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
150009200|NCT01209078|541168160|FG000|Overall Study|Adverse Event|5|||
150009201|NCT01209078|541168161|FG001|Overall Study|Adverse Event|0|||
150009202|NCT01209078|541168160|FG000|Overall Study|Lost to Follow-up|4|||
150009203|NCT01209078|541168161|FG001|Overall Study|Lost to Follow-up|0|||
150009204|NCT01209078|541168160|FG000|Overall Study|Physician Decision|5|||
150009205|NCT01209078|541168161|FG001|Overall Study|Physician Decision|2|||
150009206|NCT01209078|541168160|FG000|Overall Study|Withdrawal by Subject|2|||
150009207|NCT01209078|541168161|FG001|Overall Study|Withdrawal by Subject|1|||
150009208|NCT00924508|541168162|FG000|Overall Study|Withdrawal by Subject|3|||
150009209|NCT00372697|541168163|FG000|Overall Study|Protocol Violation|1|||
150009210|NCT00372697|541168164|FG001|Overall Study|Protocol Violation|1|||
150009211|NCT03221842|541168166|FG000|Period 1 (Open-label)|Adverse Event|4|||
150057056|NCT00095147|541350139|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
150057057|NCT00095147|541350140|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
150057058|NCT00095147|541350141|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
150057059|NCT00095147|541350137|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
150057060|NCT00095147|541350138|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
150057061|NCT00095147|541350139|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
150057062|NCT00095147|541350140|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
150057063|NCT00095147|541350141|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
150057064|NCT00095147|541350137|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
150057065|NCT00095147|541350138|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
150057066|NCT00095147|541350139|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
150057067|NCT00095147|541350140|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
150057068|NCT00095147|541350141|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
150057069|NCT00095147|541350137|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
150180381|NCT02723955|541799367|FG013|Expansion Phase|Physician Decision|0|||
150180382|NCT02723955|541799368|FG014|Expansion Phase|Physician Decision|0|||
150180383|NCT02723955|541799369|FG015|Expansion Phase|Physician Decision|0|||
150180384|NCT02723955|541799370|FG016|Expansion Phase|Physician Decision|0|||
150180385|NCT02723955|541799371|FG017|Expansion Phase|Physician Decision|0|||
150180386|NCT02723955|541799372|FG018|Expansion Phase|Physician Decision|0|||
150180387|NCT02723955|541799373|FG019|Expansion Phase|Physician Decision|0|||
150180388|NCT02723955|541799374|FG020|Expansion Phase|Physician Decision|0|||
150180389|NCT02723955|541799375|FG021|Expansion Phase|Physician Decision|0|||
150180390|NCT02723955|541799376|FG022|Expansion Phase|Physician Decision|0|||
150180391|NCT02723955|541799377|FG023|Expansion Phase|Physician Decision|0|||
150180392|NCT02723955|541799378|FG024|Expansion Phase|Physician Decision|0|||
150180393|NCT02723955|541799379|FG025|Expansion Phase|Physician Decision|0|||
150180394|NCT02723955|541799380|FG026|Expansion Phase|Physician Decision|0|||
150180395|NCT02723955|541799381|FG027|Expansion Phase|Physician Decision|0|||
150180396|NCT02723955|541799382|FG028|Expansion Phase|Physician Decision|0|||
150180397|NCT02723955|541799383|FG029|Expansion Phase|Physician Decision|0|||
150180398|NCT02723955|541799384|FG030|Expansion Phase|Physician Decision|1|||
150180399|NCT02723955|541799385|FG031|Expansion Phase|Physician Decision|1|||
150180400|NCT02723955|541799386|FG032|Expansion Phase|Physician Decision|0|||
150180401|NCT02723955|541799387|FG033|Expansion Phase|Physician Decision|0|||
150180402|NCT02723955|541799388|FG034|Expansion Phase|Physician Decision|0|||
150180403|NCT02723955|541799389|FG035|Expansion Phase|Physician Decision|0|||
150180404|NCT02723955|541799390|FG036|Expansion Phase|Physician Decision|0|||
150180405|NCT02723955|541799391|FG037|Expansion Phase|Physician Decision|0|||
150180406|NCT02723955|541799392|FG038|Expansion Phase|Physician Decision|0|||
150180407|NCT02723955|541799393|FG039|Expansion Phase|Physician Decision|0|||
150180408|NCT02723955|541799394|FG040|Expansion Phase|Physician Decision|0|||
150180409|NCT02723955|541799395|FG041|Expansion Phase|Physician Decision|0|||
150180410|NCT02723955|541799396|FG042|Expansion Phase|Physician Decision|0|||
150180411|NCT02723955|541799354|FG000|Expansion Phase|Withdrawal by Subject|0|||
150180412|NCT02723955|541799355|FG001|Expansion Phase|Withdrawal by Subject|0|||
150180413|NCT02723955|541799356|FG002|Expansion Phase|Withdrawal by Subject|0|||
150180414|NCT02723955|541799357|FG003|Expansion Phase|Withdrawal by Subject|0|||
150180415|NCT02723955|541799358|FG004|Expansion Phase|Withdrawal by Subject|0|||
150180416|NCT02723955|541799359|FG005|Expansion Phase|Withdrawal by Subject|0|||
150180417|NCT02723955|541799360|FG006|Expansion Phase|Withdrawal by Subject|0|||
150180418|NCT02723955|541799361|FG007|Expansion Phase|Withdrawal by Subject|0|||
150180419|NCT02723955|541799362|FG008|Expansion Phase|Withdrawal by Subject|0|||
150180420|NCT02723955|541799363|FG009|Expansion Phase|Withdrawal by Subject|2|||
150180421|NCT02723955|541799364|FG010|Expansion Phase|Withdrawal by Subject|1|||
150180422|NCT02723955|541799365|FG011|Expansion Phase|Withdrawal by Subject|0|||
150180423|NCT02723955|541799366|FG012|Expansion Phase|Withdrawal by Subject|0|||
150180424|NCT02723955|541799367|FG013|Expansion Phase|Withdrawal by Subject|0|||
150180425|NCT02723955|541799368|FG014|Expansion Phase|Withdrawal by Subject|0|||
150180426|NCT02723955|541799369|FG015|Expansion Phase|Withdrawal by Subject|0|||
150180427|NCT02723955|541799370|FG016|Expansion Phase|Withdrawal by Subject|0|||
150180428|NCT02723955|541799371|FG017|Expansion Phase|Withdrawal by Subject|0|||
150180429|NCT02723955|541799372|FG018|Expansion Phase|Withdrawal by Subject|0|||
150180430|NCT02723955|541799373|FG019|Expansion Phase|Withdrawal by Subject|0|||
150180431|NCT02723955|541799374|FG020|Expansion Phase|Withdrawal by Subject|0|||
150009212|NCT03221842|541168167|FG001|Period 1 (Open-label)|Adverse Event|0|||
150009213|NCT03221842|541168166|FG000|Period 1 (Open-label)|Physician Decision|2|||
150009214|NCT03221842|541168167|FG001|Period 1 (Open-label)|Physician Decision|0|||
150009215|NCT03221842|541168166|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
150009216|NCT03221842|541168167|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
150009217|NCT03221842|541168166|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
150009218|NCT03221842|541168167|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
150009219|NCT03221842|541168166|FG000|Period 1 (Open-label)|Other|2|||
150009220|NCT03221842|541168167|FG001|Period 1 (Open-label)|Other|0|||
150009221|NCT03221842|541168166|FG000|Period 2 (Randomized, Blinded)|Death|0|||
150009222|NCT03221842|541168167|FG001|Period 2 (Randomized, Blinded)|Death|1|||
150009223|NCT03221842|541168166|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
150009224|NCT03221842|541168167|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
150009225|NCT00704288|541168168|FG000|Overall Treatment Period|Adverse Event|11|||
150009226|NCT00704288|541168169|FG001|Overall Treatment Period|Adverse Event|8|||
150009227|NCT00704288|541168170|FG002|Overall Treatment Period|Adverse Event|22|||
150009228|NCT00704288|541168168|FG000|Overall Treatment Period|Death|0|||
150009229|NCT00704288|541168169|FG001|Overall Treatment Period|Death|0|||
150009230|NCT00704288|541168170|FG002|Overall Treatment Period|Death|1|||
150009231|NCT00704288|541168168|FG000|Overall Treatment Period|Physician Decision|0|||
150009232|NCT00704288|541168169|FG001|Overall Treatment Period|Physician Decision|2|||
150009233|NCT00704288|541168170|FG002|Overall Treatment Period|Physician Decision|0|||
150009234|NCT00704288|541168168|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
150009235|NCT00704288|541168169|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
150009236|NCT00704288|541168170|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
150009237|NCT00704288|541168168|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
150009238|NCT00704288|541168169|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
150009239|NCT00704288|541168170|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
150009240|NCT00704288|541168168|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
150009241|NCT00704288|541168169|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
150009242|NCT00704288|541168170|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
150009243|NCT00704288|541168168|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
150009244|NCT00704288|541168169|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
150057070|NCT00095147|541350138|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
150057071|NCT00095147|541350139|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
150057072|NCT00095147|541350140|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
150057073|NCT00095147|541350141|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
150057074|NCT00095147|541350137|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
150057075|NCT00095147|541350138|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
150057076|NCT00095147|541350139|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
150057077|NCT00095147|541350140|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
150057078|NCT00095147|541350141|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
150057079|NCT00095147|541350137|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
150057080|NCT00095147|541350138|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
150057081|NCT00095147|541350139|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
150057082|NCT00095147|541350140|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
150057083|NCT00095147|541350141|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
150057084|NCT00095147|541350137|FG000|Long-term Extension Period|Death|0|||
150057085|NCT00095147|541350138|FG001|Long-term Extension Period|Death|0|||
150057086|NCT00095147|541350139|FG002|Long-term Extension Period|Death|0|||
150057087|NCT00095147|541350140|FG003|Long-term Extension Period|Death|0|||
150057088|NCT00095147|541350141|FG004|Long-term Extension Period|Death|3|||
150057089|NCT00095147|541350137|FG000|Long-term Extension Period|Adverse Event|0|||
150057090|NCT00095147|541350138|FG001|Long-term Extension Period|Adverse Event|0|||
150057091|NCT00095147|541350139|FG002|Long-term Extension Period|Adverse Event|0|||
150057092|NCT00095147|541350140|FG003|Long-term Extension Period|Adverse Event|0|||
150057093|NCT00095147|541350141|FG004|Long-term Extension Period|Adverse Event|11|||
150057094|NCT00095147|541350137|FG000|Long-term Extension Period|Lack of Efficacy|0|||
150057095|NCT00095147|541350138|FG001|Long-term Extension Period|Lack of Efficacy|0|||
150057096|NCT00095147|541350139|FG002|Long-term Extension Period|Lack of Efficacy|0|||
150180432|NCT02723955|541799375|FG021|Expansion Phase|Withdrawal by Subject|0|||
150180433|NCT02723955|541799376|FG022|Expansion Phase|Withdrawal by Subject|0|||
150057097|NCT00095147|541350140|FG003|Long-term Extension Period|Lack of Efficacy|0|||
150057098|NCT00095147|541350141|FG004|Long-term Extension Period|Lack of Efficacy|9|||
150180434|NCT02723955|541799377|FG023|Expansion Phase|Withdrawal by Subject|0|||
150180435|NCT02723955|541799378|FG024|Expansion Phase|Withdrawal by Subject|0|||
150009245|NCT00704288|541168170|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
150009246|NCT00704288|541168168|FG000|Overall Treatment Period|Roll-over to another study|1|||
150009247|NCT00704288|541168169|FG001|Overall Treatment Period|Roll-over to another study|0|||
150180436|NCT02723955|541799379|FG025|Expansion Phase|Withdrawal by Subject|0|||
150180437|NCT02723955|541799380|FG026|Expansion Phase|Withdrawal by Subject|0|||
150180438|NCT02723955|541799381|FG027|Expansion Phase|Withdrawal by Subject|0|||
150180439|NCT02723955|541799382|FG028|Expansion Phase|Withdrawal by Subject|0|||
150180440|NCT02723955|541799383|FG029|Expansion Phase|Withdrawal by Subject|0|||
150180441|NCT02723955|541799384|FG030|Expansion Phase|Withdrawal by Subject|8|||
150180442|NCT02723955|541799385|FG031|Expansion Phase|Withdrawal by Subject|4|||
150180443|NCT02723955|541799386|FG032|Expansion Phase|Withdrawal by Subject|0|||
150180444|NCT02723955|541799387|FG033|Expansion Phase|Withdrawal by Subject|0|||
150180445|NCT02723955|541799388|FG034|Expansion Phase|Withdrawal by Subject|0|||
150180446|NCT02723955|541799389|FG035|Expansion Phase|Withdrawal by Subject|1|||
150180447|NCT02723955|541799390|FG036|Expansion Phase|Withdrawal by Subject|0|||
150180448|NCT02723955|541799391|FG037|Expansion Phase|Withdrawal by Subject|0|||
150180449|NCT02723955|541799392|FG038|Expansion Phase|Withdrawal by Subject|0|||
150180450|NCT02723955|541799393|FG039|Expansion Phase|Withdrawal by Subject|0|||
150180451|NCT02723955|541799394|FG040|Expansion Phase|Withdrawal by Subject|0|||
150180452|NCT02723955|541799395|FG041|Expansion Phase|Withdrawal by Subject|0|||
150180453|NCT02723955|541799396|FG042|Expansion Phase|Withdrawal by Subject|0|||
150180454|NCT02723955|541799354|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180455|NCT02723955|541799355|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180456|NCT02723955|541799356|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180457|NCT02723955|541799357|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180458|NCT02723955|541799358|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180459|NCT02723955|541799359|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180460|NCT02723955|541799360|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180461|NCT02723955|541799361|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180462|NCT02723955|541799362|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180463|NCT02723955|541799363|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
150180464|NCT02723955|541799364|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
150180465|NCT02723955|541799365|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
150180466|NCT02723955|541799366|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180467|NCT02723955|541799367|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180468|NCT02723955|541799368|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180469|NCT02723955|541799369|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180470|NCT02723955|541799370|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180471|NCT02723955|541799371|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180472|NCT02723955|541799372|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180473|NCT02723955|541799373|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180474|NCT02723955|541799374|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180475|NCT02723955|541799375|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180476|NCT02723955|541799376|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180477|NCT02723955|541799377|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180478|NCT02723955|541799378|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180479|NCT02723955|541799379|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180480|NCT02723955|541799380|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180481|NCT02723955|541799381|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180482|NCT02723955|541799382|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180483|NCT02723955|541799383|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180484|NCT02723955|541799384|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
150180485|NCT02723955|541799385|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180486|NCT02723955|541799386|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180487|NCT02723955|541799387|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180488|NCT02723955|541799388|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180489|NCT02723955|541799389|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180490|NCT02723955|541799390|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180491|NCT02723955|541799391|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180492|NCT02723955|541799392|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180493|NCT02723955|541799393|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180494|NCT02723955|541799394|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180495|NCT02723955|541799395|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180496|NCT02723955|541799396|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
150180497|NCT02723955|541799354|FG000|Expansion Phase|Site Closed|0|||
150180498|NCT02723955|541799355|FG001|Expansion Phase|Site Closed|0|||
150180499|NCT02723955|541799356|FG002|Expansion Phase|Site Closed|0|||
150180500|NCT02723955|541799357|FG003|Expansion Phase|Site Closed|0|||
150180501|NCT02723955|541799358|FG004|Expansion Phase|Site Closed|0|||
150180502|NCT02723955|541799359|FG005|Expansion Phase|Site Closed|0|||
150180503|NCT02723955|541799360|FG006|Expansion Phase|Site Closed|0|||
150180504|NCT02723955|541799361|FG007|Expansion Phase|Site Closed|0|||
150180505|NCT02723955|541799362|FG008|Expansion Phase|Site Closed|0|||
150180506|NCT02723955|541799363|FG009|Expansion Phase|Site Closed|1|||
150180507|NCT02723955|541799364|FG010|Expansion Phase|Site Closed|2|||
150180508|NCT02723955|541799365|FG011|Expansion Phase|Site Closed|6|||
150180509|NCT02723955|541799366|FG012|Expansion Phase|Site Closed|0|||
150180510|NCT02723955|541799367|FG013|Expansion Phase|Site Closed|0|||
150180511|NCT02723955|541799368|FG014|Expansion Phase|Site Closed|0|||
150180512|NCT02723955|541799369|FG015|Expansion Phase|Site Closed|0|||
150180513|NCT02723955|541799370|FG016|Expansion Phase|Site Closed|0|||
150180514|NCT02723955|541799371|FG017|Expansion Phase|Site Closed|0|||
150180515|NCT02723955|541799372|FG018|Expansion Phase|Site Closed|0|||
150180516|NCT02723955|541799373|FG019|Expansion Phase|Site Closed|0|||
150180517|NCT02723955|541799374|FG020|Expansion Phase|Site Closed|0|||
150180518|NCT02723955|541799375|FG021|Expansion Phase|Site Closed|0|||
150180519|NCT02723955|541799376|FG022|Expansion Phase|Site Closed|0|||
150180520|NCT02723955|541799377|FG023|Expansion Phase|Site Closed|0|||
150180521|NCT02723955|541799378|FG024|Expansion Phase|Site Closed|0|||
150180522|NCT02723955|541799379|FG025|Expansion Phase|Site Closed|0|||
150180523|NCT02723955|541799380|FG026|Expansion Phase|Site Closed|0|||
150180524|NCT02723955|541799381|FG027|Expansion Phase|Site Closed|0|||
150180525|NCT02723955|541799382|FG028|Expansion Phase|Site Closed|0|||
150180526|NCT02723955|541799383|FG029|Expansion Phase|Site Closed|0|||
150180527|NCT02723955|541799384|FG030|Expansion Phase|Site Closed|8|||
150180528|NCT02723955|541799385|FG031|Expansion Phase|Site Closed|4|||
150180529|NCT02723955|541799386|FG032|Expansion Phase|Site Closed|2|||
150180530|NCT02723955|541799387|FG033|Expansion Phase|Site Closed|2|||
150180531|NCT02723955|541799388|FG034|Expansion Phase|Site Closed|0|||
150180532|NCT02723955|541799389|FG035|Expansion Phase|Site Closed|0|||
150180533|NCT02723955|541799390|FG036|Expansion Phase|Site Closed|0|||
150180534|NCT02723955|541799391|FG037|Expansion Phase|Site Closed|0|||
150180535|NCT02723955|541799392|FG038|Expansion Phase|Site Closed|0|||
150180536|NCT02723955|541799393|FG039|Expansion Phase|Site Closed|0|||
150180537|NCT02723955|541799394|FG040|Expansion Phase|Site Closed|0|||
150180538|NCT02723955|541799395|FG041|Expansion Phase|Site Closed|0|||
150180539|NCT02723955|541799396|FG042|Expansion Phase|Site Closed|0|||
150180540|NCT02723955|541799354|FG000|Crossover/ Re-treatment Phase|Death|0|||
150180541|NCT02723955|541799355|FG001|Crossover/ Re-treatment Phase|Death|0|||
150180542|NCT02723955|541799356|FG002|Crossover/ Re-treatment Phase|Death|0|||
150180543|NCT02723955|541799357|FG003|Crossover/ Re-treatment Phase|Death|0|||
150180544|NCT02723955|541799358|FG004|Crossover/ Re-treatment Phase|Death|0|||
150180545|NCT02723955|541799359|FG005|Crossover/ Re-treatment Phase|Death|0|||
150180546|NCT02723955|541799360|FG006|Crossover/ Re-treatment Phase|Death|0|||
150180547|NCT02723955|541799361|FG007|Crossover/ Re-treatment Phase|Death|0|||
150180548|NCT02723955|541799362|FG008|Crossover/ Re-treatment Phase|Death|0|||
150180549|NCT02723955|541799363|FG009|Crossover/ Re-treatment Phase|Death|0|||
150180550|NCT02723955|541799364|FG010|Crossover/ Re-treatment Phase|Death|0|||
150180551|NCT02723955|541799365|FG011|Crossover/ Re-treatment Phase|Death|0|||
150180552|NCT02723955|541799366|FG012|Crossover/ Re-treatment Phase|Death|0|||
150180553|NCT02723955|541799367|FG013|Crossover/ Re-treatment Phase|Death|0|||
150180554|NCT02723955|541799368|FG014|Crossover/ Re-treatment Phase|Death|0|||
150180555|NCT02723955|541799369|FG015|Crossover/ Re-treatment Phase|Death|0|||
150180556|NCT02723955|541799370|FG016|Crossover/ Re-treatment Phase|Death|0|||
150180557|NCT02723955|541799371|FG017|Crossover/ Re-treatment Phase|Death|0|||
150180558|NCT02723955|541799372|FG018|Crossover/ Re-treatment Phase|Death|0|||
150180559|NCT02723955|541799373|FG019|Crossover/ Re-treatment Phase|Death|0|||
150180560|NCT02723955|541799374|FG020|Crossover/ Re-treatment Phase|Death|0|||
150180561|NCT02723955|541799375|FG021|Crossover/ Re-treatment Phase|Death|0|||
150180562|NCT02723955|541799376|FG022|Crossover/ Re-treatment Phase|Death|0|||
150180563|NCT02723955|541799377|FG023|Crossover/ Re-treatment Phase|Death|0|||
150180564|NCT02723955|541799378|FG024|Crossover/ Re-treatment Phase|Death|0|||
150180565|NCT02723955|541799379|FG025|Crossover/ Re-treatment Phase|Death|0|||
150180566|NCT02723955|541799380|FG026|Crossover/ Re-treatment Phase|Death|0|||
150180567|NCT02723955|541799381|FG027|Crossover/ Re-treatment Phase|Death|0|||
150009248|NCT00704288|541168170|FG002|Overall Treatment Period|Roll-over to another study|4|||
150009249|NCT00704288|541168168|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
150009250|NCT00704288|541168169|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
150009251|NCT00704288|541168170|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
150009252|NCT00704288|541168168|FG000|Extended Post Treatment Follow Up Period|Death|41|||
150009253|NCT00704288|541168169|FG001|Extended Post Treatment Follow Up Period|Death|50|||
150009254|NCT00704288|541168170|FG002|Extended Post Treatment Follow Up Period|Death|93|||
150009255|NCT00704288|541168168|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
150009256|NCT00704288|541168169|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
150009257|NCT00704288|541168170|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
150009258|NCT00704288|541168168|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
150009259|NCT00704288|541168169|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
150009260|NCT00704288|541168170|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
150009261|NCT00704288|541168168|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
150009262|NCT00704288|541168169|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
150057099|NCT00095147|541350137|FG000|Long-term Extension Period|Lost to Follow-up|0|||
150057100|NCT00095147|541350138|FG001|Long-term Extension Period|Lost to Follow-up|0|||
150057101|NCT00095147|541350139|FG002|Long-term Extension Period|Lost to Follow-up|0|||
150057102|NCT00095147|541350140|FG003|Long-term Extension Period|Lost to Follow-up|0|||
150057103|NCT00095147|541350141|FG004|Long-term Extension Period|Lost to Follow-up|6|||
150057104|NCT00095147|541350137|FG000|Long-term Extension Period|Withdrawal of consent|0|||
150057105|NCT00095147|541350138|FG001|Long-term Extension Period|Withdrawal of consent|0|||
150057106|NCT00095147|541350139|FG002|Long-term Extension Period|Withdrawal of consent|0|||
150057107|NCT00095147|541350140|FG003|Long-term Extension Period|Withdrawal of consent|0|||
150057108|NCT00095147|541350141|FG004|Long-term Extension Period|Withdrawal of consent|12|||
150057109|NCT00095147|541350137|FG000|Long-term Extension Period|Pregnancy|0|||
150057110|NCT00095147|541350138|FG001|Long-term Extension Period|Pregnancy|0|||
150057111|NCT00095147|541350139|FG002|Long-term Extension Period|Pregnancy|0|||
150057112|NCT00095147|541350140|FG003|Long-term Extension Period|Pregnancy|0|||
150057113|NCT00095147|541350141|FG004|Long-term Extension Period|Pregnancy|1|||
150057114|NCT00095147|541350137|FG000|Long-term Extension Period|No longer meets study criteria|0|||
150057115|NCT00095147|541350138|FG001|Long-term Extension Period|No longer meets study criteria|0|||
150057116|NCT00095147|541350139|FG002|Long-term Extension Period|No longer meets study criteria|0|||
150057117|NCT00095147|541350140|FG003|Long-term Extension Period|No longer meets study criteria|0|||
150057118|NCT00095147|541350141|FG004|Long-term Extension Period|No longer meets study criteria|1|||
150057119|NCT00095147|541350137|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
150057120|NCT00095147|541350138|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
150057121|NCT00095147|541350139|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
150057122|NCT00095147|541350140|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
150057123|NCT00095147|541350141|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
150057124|NCT00095147|541350137|FG000|Long-term Extension Period|Leaving country|0|||
150057125|NCT00095147|541350138|FG001|Long-term Extension Period|Leaving country|0|||
150057126|NCT00095147|541350139|FG002|Long-term Extension Period|Leaving country|0|||
150057127|NCT00095147|541350140|FG003|Long-term Extension Period|Leaving country|0|||
150057128|NCT00095147|541350141|FG004|Long-term Extension Period|Leaving country|1|||
150057129|NCT00906971|541350144|FG000|Overall Study|Withdrawal by Subject|8|||
150057130|NCT00906971|541350145|FG001|Overall Study|Withdrawal by Subject|2|||
150057131|NCT00906971|541350144|FG000|Overall Study|Lost to Follow-up|0|||
150057132|NCT00906971|541350145|FG001|Overall Study|Lost to Follow-up|1|||
150057133|NCT04463069|541350148|FG000|Overall Study|Withdrawal by Subject|2|||
150057134|NCT04463069|541350149|FG001|Overall Study|Withdrawal by Subject|10|||
150057135|NCT04463069|541350148|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
150057136|NCT04463069|541350149|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
150057137|NCT03976648|541350150|FG000|Overall Study|Adverse Event|0|||
150057138|NCT03976648|541350151|FG001|Overall Study|Adverse Event|2|||
150057139|NCT03976648|541350150|FG000|Overall Study|Study terminated by sponsor|21|||
150057140|NCT03976648|541350151|FG001|Overall Study|Study terminated by sponsor|8|||
150057141|NCT00960570|541350152|FG000|21 Day Washout Period|Adverse Event|1|||
150009263|NCT00704288|541168170|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
150009264|NCT01055314|541168171|FG000|Overall Study|Adverse Event|7|||
150009265|NCT01055314|541168172|FG001|Overall Study|Adverse Event|4|||
150057142|NCT00960570|541350152|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
150057143|NCT00960570|541350152|FG000|1 Day Period Between Dosing|Adverse Event|2|||
150057144|NCT00960570|541350152|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
150057145|NCT01451437|541350153|FG000|Overall Study|Adverse Event|0|||
150057146|NCT01451437|541350154|FG001|Overall Study|Adverse Event|0|||
150057147|NCT01451437|541350155|FG002|Overall Study|Adverse Event|0|||
150009266|NCT01055314|541168171|FG000|Overall Study|Death|2|||
150057148|NCT01451437|541350156|FG003|Overall Study|Adverse Event|0|||
150180568|NCT02723955|541799382|FG028|Crossover/ Re-treatment Phase|Death|0|||
150009267|NCT01055314|541168172|FG001|Overall Study|Death|1|||
150009268|NCT01055314|541168171|FG000|Overall Study|Lack of Efficacy|11|||
150009269|NCT01055314|541168172|FG001|Overall Study|Lack of Efficacy|19|||
150009270|NCT01055314|541168171|FG000|Overall Study|Physician Decision|10|||
150009271|NCT01055314|541168172|FG001|Overall Study|Physician Decision|5|||
150009272|NCT01055314|541168171|FG000|Overall Study|Withdrawal by Subject|1|||
150009273|NCT01055314|541168172|FG001|Overall Study|Withdrawal by Subject|0|||
150009274|NCT01055314|541168171|FG000|Overall Study|Ineligible|3|||
150009275|NCT01055314|541168172|FG001|Overall Study|Ineligible|5|||
150009276|NCT01055314|541168171|FG000|Overall Study|Refusal of further protocol therapy|10|||
150009277|NCT01055314|541168172|FG001|Overall Study|Refusal of further protocol therapy|4|||
150057149|NCT01451437|541350157|FG004|Overall Study|Adverse Event|0|||
150057150|NCT01451437|541350158|FG005|Overall Study|Adverse Event|1|||
150057151|NCT01451437|541350159|FG006|Overall Study|Adverse Event|1|||
150057152|NCT01451437|541350160|FG007|Overall Study|Adverse Event|2|||
150057153|NCT01451437|541350161|FG008|Overall Study|Adverse Event|1|||
150057154|NCT01451437|541350153|FG000|Overall Study|Physician Decision|1|||
150057155|NCT01451437|541350154|FG001|Overall Study|Physician Decision|1|||
150057156|NCT01451437|541350155|FG002|Overall Study|Physician Decision|2|||
150057157|NCT01451437|541350156|FG003|Overall Study|Physician Decision|0|||
150057158|NCT01451437|541350157|FG004|Overall Study|Physician Decision|0|||
150057159|NCT01451437|541350158|FG005|Overall Study|Physician Decision|0|||
150057160|NCT01451437|541350159|FG006|Overall Study|Physician Decision|0|||
150057161|NCT01451437|541350160|FG007|Overall Study|Physician Decision|0|||
150057162|NCT01451437|541350161|FG008|Overall Study|Physician Decision|0|||
150057163|NCT01451437|541350153|FG000|Overall Study|Disease Progression|0|||
150057164|NCT01451437|541350154|FG001|Overall Study|Disease Progression|0|||
150057165|NCT01451437|541350155|FG002|Overall Study|Disease Progression|1|||
150057166|NCT01451437|541350156|FG003|Overall Study|Disease Progression|1|||
150057167|NCT01451437|541350157|FG004|Overall Study|Disease Progression|3|||
150057168|NCT01451437|541350158|FG005|Overall Study|Disease Progression|2|||
150057169|NCT01451437|541350159|FG006|Overall Study|Disease Progression|3|||
150057170|NCT01451437|541350160|FG007|Overall Study|Disease Progression|1|||
150057171|NCT01451437|541350161|FG008|Overall Study|Disease Progression|3|||
150057172|NCT01451437|541350153|FG000|Overall Study|Protocol Violation|0|||
150057173|NCT01451437|541350154|FG001|Overall Study|Protocol Violation|0|||
150057174|NCT01451437|541350155|FG002|Overall Study|Protocol Violation|0|||
150057175|NCT01451437|541350156|FG003|Overall Study|Protocol Violation|0|||
150057176|NCT01451437|541350157|FG004|Overall Study|Protocol Violation|0|||
150057177|NCT01451437|541350158|FG005|Overall Study|Protocol Violation|0|||
150057178|NCT01451437|541350159|FG006|Overall Study|Protocol Violation|1|||
150057179|NCT01451437|541350160|FG007|Overall Study|Protocol Violation|0|||
150057180|NCT01451437|541350161|FG008|Overall Study|Protocol Violation|0|||
150057181|NCT01451437|541350153|FG000|Overall Study|Withdrawal by Subject|0|||
150057182|NCT01451437|541350154|FG001|Overall Study|Withdrawal by Subject|0|||
150057183|NCT01451437|541350155|FG002|Overall Study|Withdrawal by Subject|0|||
150057184|NCT01451437|541350156|FG003|Overall Study|Withdrawal by Subject|0|||
150057185|NCT01451437|541350157|FG004|Overall Study|Withdrawal by Subject|1|||
150057186|NCT01451437|541350158|FG005|Overall Study|Withdrawal by Subject|0|||
150057187|NCT01451437|541350159|FG006|Overall Study|Withdrawal by Subject|1|||
150057188|NCT01451437|541350160|FG007|Overall Study|Withdrawal by Subject|0|||
150057189|NCT01451437|541350161|FG008|Overall Study|Withdrawal by Subject|0|||
150057190|NCT03603509|541351361|FG000|Overall Study|Lost to Follow-up|3|||
150057191|NCT03603509|541351362|FG001|Overall Study|Lost to Follow-up|4|||
150057192|NCT00773383|541351364|FG000|Overall Study|Adverse Event|4|||
150057193|NCT00773383|541351364|FG000|Overall Study|Death|1|||
150057194|NCT00773383|541351364|FG000|Overall Study|Progression of Disease|23|||
150057195|NCT00773383|541351364|FG000|Overall Study|Other|2|||
150057196|NCT00773383|541351364|FG000|Overall Study|No study dose received|1|||
150057197|NCT03811093|541351369|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
150057198|NCT03811093|541351370|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
150057199|NCT03811093|541351369|FG000|Overall Study|Unable to measure body fat percentage|2|||
150180569|NCT02723955|541799383|FG029|Crossover/ Re-treatment Phase|Death|0|||
150009278|NCT01055314|541168171|FG000|Overall Study|No treatment|1|||
150009279|NCT01055314|541168172|FG001|Overall Study|No treatment|0|||
150009280|NCT00527982|541168173|FG000|Overall Study|Physician Decision|1|||
150057200|NCT03811093|541351370|FG001|Overall Study|Unable to measure body fat percentage|0|||
150057201|NCT01095094|541351371|FG000|Overall Study|Withdrawal by Subject|1|||
150057202|NCT01095094|541351371|FG000|Overall Study|Death|1|||
150057203|NCT01095094|541351371|FG000|Overall Study|Physician Decision|1|||
150057204|NCT03699475|541351373|FG000|Overall Study|Death|1|||
150057205|NCT00137839|541351374|FG000|Overall Study|Adverse Event|7|||
150057206|NCT00137839|541351374|FG000|Overall Study|Physician Decision|7|||
150057207|NCT00137839|541351374|FG000|Overall Study|Death|8|||
150057208|NCT00137839|541351374|FG000|Overall Study|Disease Progression|60|||
150057209|NCT00137839|541351374|FG000|Overall Study|Not Start Treatment|1|||
150009281|NCT00527982|541168174|FG001|Overall Study|Physician Decision|0|||
150009282|NCT01939366|541168175|FG000|Overall Study|Adverse Event|8|||
150009283|NCT01939366|541168176|FG001|Overall Study|Adverse Event|17|||
150009284|NCT01939366|541168177|FG002|Overall Study|Adverse Event|30|||
150009285|NCT01939366|541168178|FG003|Overall Study|Adverse Event|8|||
150009286|NCT01939366|541168179|FG004|Overall Study|Adverse Event|5|||
150009287|NCT01939366|541168175|FG000|Overall Study|Lack of Efficacy|2|||
150009288|NCT01939366|541168176|FG001|Overall Study|Lack of Efficacy|1|||
150009289|NCT01939366|541168177|FG002|Overall Study|Lack of Efficacy|1|||
150009290|NCT01939366|541168178|FG003|Overall Study|Lack of Efficacy|1|||
150009291|NCT01939366|541168179|FG004|Overall Study|Lack of Efficacy|3|||
150009292|NCT01939366|541168175|FG000|Overall Study|Lost to Follow-up|1|||
150009293|NCT01939366|541168176|FG001|Overall Study|Lost to Follow-up|1|||
150009294|NCT01939366|541168177|FG002|Overall Study|Lost to Follow-up|0|||
150009295|NCT01939366|541168178|FG003|Overall Study|Lost to Follow-up|0|||
150009296|NCT01939366|541168179|FG004|Overall Study|Lost to Follow-up|0|||
150009297|NCT01939366|541168175|FG000|Overall Study|Withdrawal by Subject|1|||
150009298|NCT01939366|541168176|FG001|Overall Study|Withdrawal by Subject|0|||
150009299|NCT01939366|541168177|FG002|Overall Study|Withdrawal by Subject|2|||
150009300|NCT01939366|541168178|FG003|Overall Study|Withdrawal by Subject|2|||
150009301|NCT01939366|541168179|FG004|Overall Study|Withdrawal by Subject|3|||
150009302|NCT01939366|541168175|FG000|Overall Study|Inclusion criteria not met|0|||
150009303|NCT01939366|541168176|FG001|Overall Study|Inclusion criteria not met|1|||
150009304|NCT01939366|541168177|FG002|Overall Study|Inclusion criteria not met|1|||
150009305|NCT01939366|541168178|FG003|Overall Study|Inclusion criteria not met|0|||
150009306|NCT01939366|541168179|FG004|Overall Study|Inclusion criteria not met|1|||
150009307|NCT01939366|541168175|FG000|Overall Study|Other|0|||
150009308|NCT01939366|541168176|FG001|Overall Study|Other|0|||
150009309|NCT01939366|541168177|FG002|Overall Study|Other|2|||
150009310|NCT01939366|541168178|FG003|Overall Study|Other|2|||
150009311|NCT01939366|541168179|FG004|Overall Study|Other|1|||
150009312|NCT01939366|541168175|FG000|Overall Study|Protocol Violation|0|||
150009313|NCT01939366|541168176|FG001|Overall Study|Protocol Violation|0|||
150009314|NCT01939366|541168177|FG002|Overall Study|Protocol Violation|0|||
150009315|NCT01939366|541168178|FG003|Overall Study|Protocol Violation|1|||
150009316|NCT01939366|541168179|FG004|Overall Study|Protocol Violation|0|||
150009317|NCT01939366|541168175|FG000|Overall Study|Sponsor decision|0|||
150009318|NCT01939366|541168176|FG001|Overall Study|Sponsor decision|0|||
150009319|NCT01939366|541168177|FG002|Overall Study|Sponsor decision|0|||
150009320|NCT01939366|541168178|FG003|Overall Study|Sponsor decision|0|||
150009321|NCT01939366|541168179|FG004|Overall Study|Sponsor decision|2|||
150009322|NCT01939366|541168175|FG000|Overall Study|GCP non-compliance at site|2|||
150009323|NCT01939366|541168176|FG001|Overall Study|GCP non-compliance at site|3|||
150009324|NCT01939366|541168177|FG002|Overall Study|GCP non-compliance at site|2|||
150009325|NCT01939366|541168178|FG003|Overall Study|GCP non-compliance at site|3|||
150009326|NCT01939366|541168179|FG004|Overall Study|GCP non-compliance at site|3|||
150009327|NCT01272869|541168189|FG000|Period 2 (14 Days)|Adverse Event|1|||
150009328|NCT01272869|541168190|FG001|Period 2 (14 Days)|Adverse Event|0|||
150009329|NCT00771615|541168191|FG000|Overall Study|Withdrawal by Subject|0|||
150009330|NCT00771615|541168192|FG001|Overall Study|Withdrawal by Subject|1|||
150009331|NCT00771615|541168193|FG002|Overall Study|Withdrawal by Subject|0|||
150009332|NCT00771615|541168194|FG003|Overall Study|Withdrawal by Subject|0|||
150009333|NCT00771615|541168195|FG004|Overall Study|Withdrawal by Subject|0|||
150009334|NCT00771615|541168196|FG005|Overall Study|Withdrawal by Subject|0|||
150009335|NCT00771615|541168197|FG006|Overall Study|Withdrawal by Subject|0|||
150009336|NCT00771615|541168198|FG007|Overall Study|Withdrawal by Subject|1|||
150009337|NCT00771615|541168199|FG008|Overall Study|Withdrawal by Subject|0|||
150009338|NCT00771615|541168191|FG000|Overall Study|Lost to Follow-up|1|||
150009339|NCT00771615|541168192|FG001|Overall Study|Lost to Follow-up|1|||
150009340|NCT00771615|541168193|FG002|Overall Study|Lost to Follow-up|1|||
150009341|NCT00771615|541168194|FG003|Overall Study|Lost to Follow-up|1|||
150009342|NCT00771615|541168195|FG004|Overall Study|Lost to Follow-up|0|||
150009343|NCT00771615|541168196|FG005|Overall Study|Lost to Follow-up|1|||
150009344|NCT00771615|541168197|FG006|Overall Study|Lost to Follow-up|1|||
150009345|NCT00771615|541168198|FG007|Overall Study|Lost to Follow-up|0|||
150009346|NCT00771615|541168199|FG008|Overall Study|Lost to Follow-up|0|||
150009347|NCT02455076|541168200|FG000|Inpatient|Withdrawal by Subject|1|||
150009348|NCT02455076|541168201|FG001|Inpatient|Withdrawal by Subject|0|||
150009349|NCT02455076|541168202|FG002|Inpatient|Withdrawal by Subject|0|||
150009350|NCT02455076|541168203|FG003|Inpatient|Withdrawal by Subject|0|||
150009351|NCT02455076|541168204|FG004|Inpatient|Withdrawal by Subject|0|||
150009352|NCT02455076|541168200|FG000|Inpatient|Discharged <24 h after admission|0|||
150009353|NCT02455076|541168201|FG001|Inpatient|Discharged <24 h after admission|1|||
150009354|NCT02455076|541168202|FG002|Inpatient|Discharged <24 h after admission|0|||
150057210|NCT00137839|541351374|FG000|Overall Study|Prolonged Treatment Delay|1|||
150009355|NCT02455076|541168203|FG003|Inpatient|Discharged <24 h after admission|0|||
150009356|NCT02455076|541168204|FG004|Inpatient|Discharged <24 h after admission|0|||
150009357|NCT02455076|541168200|FG000|Inpatient|Adverse Event|3|||
150009358|NCT02455076|541168201|FG001|Inpatient|Adverse Event|0|||
150009359|NCT02455076|541168202|FG002|Inpatient|Adverse Event|0|||
150009360|NCT02455076|541168203|FG003|Inpatient|Adverse Event|0|||
150009361|NCT02455076|541168204|FG004|Inpatient|Adverse Event|0|||
150009362|NCT02455076|541168200|FG000|Outpatient|Adverse Event|0|||
150009363|NCT02455076|541168201|FG001|Outpatient|Adverse Event|0|||
150009364|NCT02455076|541168202|FG002|Outpatient|Adverse Event|0|||
150009365|NCT02455076|541168203|FG003|Outpatient|Adverse Event|5|||
150009366|NCT02455076|541168204|FG004|Outpatient|Adverse Event|0|||
150009367|NCT02455076|541168200|FG000|Outpatient|Lost to Follow-up|0|||
150009368|NCT02455076|541168201|FG001|Outpatient|Lost to Follow-up|0|||
150009369|NCT02455076|541168202|FG002|Outpatient|Lost to Follow-up|0|||
150009370|NCT02455076|541168203|FG003|Outpatient|Lost to Follow-up|1|||
150009371|NCT02455076|541168204|FG004|Outpatient|Lost to Follow-up|12|||
150009372|NCT01192412|541168205|FG000|Overall Study|Lost to Follow-up|2|||
150009373|NCT01192412|541168206|FG001|Overall Study|Lost to Follow-up|1|||
150009374|NCT01192412|541168205|FG000|Overall Study|Withdrawal by Subject|2|||
150009375|NCT01192412|541168206|FG001|Overall Study|Withdrawal by Subject|1|||
150009376|NCT00859937|541168207|FG000|Overall Study|Protocol Violation|1|||
150009377|NCT00859937|541168208|FG001|Overall Study|Protocol Violation|0|||
150009378|NCT00151476|541168209|FG000|FAP Identified Subjects|Protocol Violation|0|||
150009379|NCT00151476|541168210|FG001|FAP Identified Subjects|Protocol Violation|1|||
150009380|NCT00151476|541168209|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
150009381|NCT00151476|541168210|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
150009382|NCT00151476|541168209|FG000|FAP Analyzed Subjects|Other study participation|0|||
150009383|NCT00151476|541168210|FG001|FAP Analyzed Subjects|Other study participation|1|||
150009384|NCT04099511|541168215|FG000|Overall Study|Lost to Follow-up|2|||
150009385|NCT04099511|541168216|FG001|Overall Study|Lost to Follow-up|2|||
150009386|NCT04099511|541168215|FG000|Overall Study|Withdrawal by Subject|8|||
150009387|NCT04099511|541168216|FG001|Overall Study|Withdrawal by Subject|4|||
150009388|NCT02868229|541168217|FG000|Overall Study|Adverse Event|1|||
150009389|NCT02868229|541168218|FG001|Overall Study|Adverse Event|0|||
150009390|NCT02868229|541168219|FG002|Overall Study|Adverse Event|0|||
150009391|NCT02868229|541168220|FG003|Overall Study|Adverse Event|1|||
150009392|NCT02868229|541168217|FG000|Overall Study|Death|0|||
150009393|NCT02868229|541168218|FG001|Overall Study|Death|0|||
150009394|NCT02868229|541168219|FG002|Overall Study|Death|1|||
150009395|NCT02868229|541168220|FG003|Overall Study|Death|1|||
150057211|NCT01122394|541351375|FG000|Overall Study|Withdrawal by Subject|1|||
150057212|NCT01122394|541351376|FG001|Overall Study|Withdrawal by Subject|1|||
150057213|NCT01122394|541351375|FG000|Overall Study|Lost to Follow-up|2|||
150057214|NCT01122394|541351376|FG001|Overall Study|Lost to Follow-up|2|||
150057215|NCT01122394|541351375|FG000|Overall Study|Adverse Event|0|||
150057216|NCT01122394|541351376|FG001|Overall Study|Adverse Event|1|||
150057217|NCT00775203|541351377|FG000|Overall Study|Adverse Event|25|||
150057218|NCT00775203|541351378|FG001|Overall Study|Adverse Event|6|||
150057219|NCT00775203|541351377|FG000|Overall Study|Lack of Efficacy|8|||
150057220|NCT00775203|541351378|FG001|Overall Study|Lack of Efficacy|9|||
150057221|NCT00775203|541351377|FG000|Overall Study|Withdrawal by Subject|11|||
150057222|NCT00775203|541351378|FG001|Overall Study|Withdrawal by Subject|9|||
150057223|NCT00775203|541351377|FG000|Overall Study|Lost to Follow-up|11|||
150057224|NCT00775203|541351378|FG001|Overall Study|Lost to Follow-up|15|||
150057225|NCT00775203|541351377|FG000|Overall Study|Administrative reason|2|||
150057226|NCT00775203|541351378|FG001|Overall Study|Administrative reason|0|||
150057227|NCT00775203|541351377|FG000|Overall Study|Noncompliance|4|||
150057228|NCT00775203|541351378|FG001|Overall Study|Noncompliance|2|||
150057229|NCT00775203|541351377|FG000|Overall Study|Protocol Violation|0|||
150057230|NCT00775203|541351378|FG001|Overall Study|Protocol Violation|1|||
150057231|NCT00775203|541351377|FG000|Overall Study|Entered other study|1|||
150057232|NCT00775203|541351378|FG001|Overall Study|Entered other study|0|||
150057233|NCT00775203|541351377|FG000|Overall Study|Physician Decision|0|||
150057234|NCT00775203|541351378|FG001|Overall Study|Physician Decision|1|||
150057235|NCT04896229|541351379|FG000|Overall Study|Lost to Follow-up|113|||
150057236|NCT04896229|541351380|FG001|Overall Study|Lost to Follow-up|113|||
150057237|NCT00045942|541351381|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
150180570|NCT02723955|541799384|FG030|Crossover/ Re-treatment Phase|Death|0|||
150009396|NCT02868229|541168217|FG000|Overall Study|Missed dose|0|||
150009397|NCT02868229|541168218|FG001|Overall Study|Missed dose|0|||
150009398|NCT02868229|541168219|FG002|Overall Study|Missed dose|0|||
150009399|NCT02868229|541168220|FG003|Overall Study|Missed dose|3|||
150009400|NCT06151288|541168221|FG000|Overall Study|Lost to Follow-up|4|||
150009401|NCT06151288|541168222|FG001|Overall Study|Lost to Follow-up|2|||
150009402|NCT06151288|541168223|FG002|Overall Study|Lost to Follow-up|4|||
150009403|NCT06151288|541168224|FG003|Overall Study|Lost to Follow-up|3|||
150009404|NCT06151288|541168221|FG000|Overall Study|Withdrawal by Subject|4|||
150009405|NCT06151288|541168222|FG001|Overall Study|Withdrawal by Subject|5|||
150057238|NCT00045942|541351382|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150009406|NCT06151288|541168223|FG002|Overall Study|Withdrawal by Subject|1|||
150009407|NCT06151288|541168224|FG003|Overall Study|Withdrawal by Subject|1|||
150009408|NCT03157583|541168228|FG000|Overall Study|Other (did not meet study criteria)|1|||
150009409|NCT01581619|541168233|FG000|Overall Study|Withdrawal by Subject|1|||
150009410|NCT01581619|541168233|FG000|Overall Study|Lost to Follow-up|1|||
150009411|NCT00290498|541168234|FG000|Overall Study|Death|2|||
150009412|NCT00290498|541168235|FG001|Overall Study|Death|0|||
150009413|NCT00290498|541168234|FG000|Overall Study|Physician Decision|1|||
150009414|NCT00290498|541168235|FG001|Overall Study|Physician Decision|0|||
150009415|NCT00290498|541168234|FG000|Overall Study|Withdrawal by Subject|1|||
150009416|NCT00290498|541168235|FG001|Overall Study|Withdrawal by Subject|0|||
150009417|NCT00290498|541168234|FG000|Overall Study|Ineligible|3|||
150009418|NCT00290498|541168235|FG001|Overall Study|Ineligible|0|||
150009419|NCT00290498|541168234|FG000|Overall Study|Non-Compliance|1|||
150009420|NCT00290498|541168235|FG001|Overall Study|Non-Compliance|0|||
150009421|NCT04268173|541168238|FG000|Overall Study|Lost to Follow-up|75|||
150009422|NCT04268173|541168239|FG001|Overall Study|Lost to Follow-up|108|||
150009423|NCT00869401|541168240|FG000|Overall Study|Withdrawal by Subject|0|||
150009424|NCT00869401|541168241|FG001|Overall Study|Withdrawal by Subject|0|||
150009425|NCT00869401|541168242|FG002|Overall Study|Withdrawal by Subject|0|||
150009426|NCT00869401|541168243|FG003|Overall Study|Withdrawal by Subject|5|||
150009427|NCT00869401|541168244|FG004|Overall Study|Withdrawal by Subject|3|||
150009428|NCT03233438|541168245|FG000|Overall Study|Lost to Follow-up|4|||
150009429|NCT03233438|541168246|FG001|Overall Study|Lost to Follow-up|9|||
150009430|NCT03233438|541168245|FG000|Overall Study|Withdrawal by Subject|2|||
150009431|NCT03233438|541168246|FG001|Overall Study|Withdrawal by Subject|1|||
150009432|NCT03233438|541168245|FG000|Overall Study|No recording of dalbavancin|0|||
150057239|NCT00045942|541351383|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057240|NCT00045942|541351384|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057241|NCT00045942|541351385|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057242|NCT00045942|541351386|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057243|NCT00045942|541351387|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057244|NCT00045942|541351388|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057245|NCT00045942|541351389|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
150057246|NCT00045942|541351381|FG000|PKC412A2104 (Core)|Adverse Event|5|||
150057247|NCT00045942|541351382|FG001|PKC412A2104 (Core)|Adverse Event|0|||
150057248|NCT00045942|541351383|FG002|PKC412A2104 (Core)|Adverse Event|0|||
150057249|NCT00045942|541351384|FG003|PKC412A2104 (Core)|Adverse Event|0|||
150057250|NCT00045942|541351385|FG004|PKC412A2104 (Core)|Adverse Event|0|||
150057251|NCT00045942|541351386|FG005|PKC412A2104 (Core)|Adverse Event|0|||
150057252|NCT00045942|541351387|FG006|PKC412A2104 (Core)|Adverse Event|0|||
150057253|NCT00045942|541351388|FG007|PKC412A2104 (Core)|Adverse Event|0|||
150057254|NCT00045942|541351389|FG008|PKC412A2104 (Core)|Adverse Event|0|||
150057255|NCT00045942|541351381|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
150057256|NCT00045942|541351382|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057257|NCT00045942|541351383|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057258|NCT00045942|541351384|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057259|NCT00045942|541351385|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
150180571|NCT02723955|541799385|FG031|Crossover/ Re-treatment Phase|Death|0|||
150009433|NCT03233438|541168246|FG001|Overall Study|No recording of dalbavancin|1|||
150009434|NCT02925741|541168248|FG000|Overall Study|Withdrawal by Subject|11|||
150009435|NCT02925741|541168249|FG001|Overall Study|Withdrawal by Subject|0|||
150009436|NCT00494507|541168252|FG000|Double-Blind Phase|Adverse Event|2|||
150009437|NCT00494507|541168253|FG001|Double-Blind Phase|Adverse Event|0|||
150057260|NCT00045942|541351386|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057261|NCT00045942|541351387|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057262|NCT00045942|541351388|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
150009438|NCT00494507|541168254|FG002|Double-Blind Phase|Adverse Event|1|||
150009439|NCT00494507|541168255|FG003|Double-Blind Phase|Adverse Event|0|||
150009440|NCT00494507|541168252|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
150009441|NCT00494507|541168253|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
150009442|NCT00494507|541168254|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
150057263|NCT00045942|541351389|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
150057264|NCT00045942|541351381|FG000|PKC412A2104 (Core)|Death|1|||
150180572|NCT02723955|541799386|FG032|Crossover/ Re-treatment Phase|Death|0|||
150180573|NCT02723955|541799387|FG033|Crossover/ Re-treatment Phase|Death|0|||
150180574|NCT02723955|541799388|FG034|Crossover/ Re-treatment Phase|Death|0|||
150180575|NCT02723955|541799389|FG035|Crossover/ Re-treatment Phase|Death|0|||
150180576|NCT02723955|541799390|FG036|Crossover/ Re-treatment Phase|Death|0|||
150180577|NCT02723955|541799391|FG037|Crossover/ Re-treatment Phase|Death|1|||
150180578|NCT02723955|541799392|FG038|Crossover/ Re-treatment Phase|Death|14|||
150180579|NCT02723955|541799393|FG039|Crossover/ Re-treatment Phase|Death|32|||
150180580|NCT02723955|541799394|FG040|Crossover/ Re-treatment Phase|Death|2|||
150180581|NCT02723955|541799395|FG041|Crossover/ Re-treatment Phase|Death|1|||
150180582|NCT02723955|541799396|FG042|Crossover/ Re-treatment Phase|Death|0|||
150180583|NCT02723955|541799354|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180584|NCT02723955|541799355|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009443|NCT00494507|541168255|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
150009444|NCT00494507|541168252|FG000|Double-Blind Phase|Subject Non-compliance|0|||
150009445|NCT00494507|541168253|FG001|Double-Blind Phase|Subject Non-compliance|0|||
150009446|NCT00494507|541168254|FG002|Double-Blind Phase|Subject Non-compliance|1|||
150009447|NCT00494507|541168255|FG003|Double-Blind Phase|Subject Non-compliance|0|||
150009448|NCT00494507|541168252|FG000|Double-Blind Phase|Negative DNA test|0|||
150009449|NCT00494507|541168253|FG001|Double-Blind Phase|Negative DNA test|0|||
150009450|NCT00494507|541168254|FG002|Double-Blind Phase|Negative DNA test|0|||
150009451|NCT00494507|541168255|FG003|Double-Blind Phase|Negative DNA test|1|||
150009452|NCT00494507|541168252|FG000|Open-Label Phase|Adverse Event|0|||
150009453|NCT00494507|541168253|FG001|Open-Label Phase|Adverse Event|1|||
150009454|NCT00494507|541168254|FG002|Open-Label Phase|Adverse Event|5|||
150009455|NCT00494507|541168255|FG003|Open-Label Phase|Adverse Event|3|||
150009456|NCT00494507|541168252|FG000|Open-Label Phase|Worsening Disease|0|||
150009457|NCT00494507|541168253|FG001|Open-Label Phase|Worsening Disease|0|||
150009458|NCT00494507|541168254|FG002|Open-Label Phase|Worsening Disease|0|||
150009459|NCT00494507|541168255|FG003|Open-Label Phase|Worsening Disease|2|||
150009460|NCT03831945|541168256|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
150009461|NCT03831945|541168257|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
150009462|NCT03831945|541168256|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
150009463|NCT03831945|541168257|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
150009464|NCT03831945|541168256|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
150009465|NCT03831945|541168257|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
150009466|NCT00109577|541168258|FG000|Overall Study|Withdrawal by Subject|3|||
150009467|NCT00109577|541168259|FG001|Overall Study|Withdrawal by Subject|3|||
150009468|NCT00587847|541168260|FG000|Overall Study|Lack of Efficacy|5|||
150009469|NCT00587847|541168260|FG000|Overall Study|Adverse Event|2|||
150009470|NCT02613169|541168261|FG000|Overall Study|Withdrawal by Subject|4|||
150009471|NCT02613169|541168262|FG001|Overall Study|Withdrawal by Subject|1|||
150009472|NCT02613169|541168261|FG000|Overall Study|Lost to Follow-up|0|||
150009473|NCT02613169|541168262|FG001|Overall Study|Lost to Follow-up|5|||
150009474|NCT02613169|541168261|FG000|Overall Study|HIV|0|||
150009475|NCT02613169|541168262|FG001|Overall Study|HIV|2|||
150009476|NCT02613169|541168261|FG000|Overall Study|No TB infection endpoint|14|||
150009477|NCT02613169|541168262|FG001|Overall Study|No TB infection endpoint|9|||
150009478|NCT00343382|541168263|FG000|Overall Study|Adverse Event|2|||
150009479|NCT00343382|541168264|FG001|Overall Study|Adverse Event|10|||
150009480|NCT00343382|541168265|FG002|Overall Study|Adverse Event|7|||
150009481|NCT00343382|541168263|FG000|Overall Study|Withdrawal by Subject|1|||
150009482|NCT00343382|541168264|FG001|Overall Study|Withdrawal by Subject|2|||
150009483|NCT00343382|541168265|FG002|Overall Study|Withdrawal by Subject|6|||
150009484|NCT00343382|541168263|FG000|Overall Study|Other Reason Not Specified|1|||
150009485|NCT00343382|541168264|FG001|Overall Study|Other Reason Not Specified|2|||
150009486|NCT00343382|541168265|FG002|Overall Study|Other Reason Not Specified|4|||
150009487|NCT04032080|541168266|FG000|Overall Study|Death|6|||
150180585|NCT02723955|541799356|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180586|NCT02723955|541799357|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180587|NCT02723955|541799358|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180588|NCT02723955|541799359|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009488|NCT02337725|541168267|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
150009489|NCT02337725|541168268|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
150009490|NCT02337725|541168267|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
150009491|NCT02337725|541168268|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
150009492|NCT02337725|541168267|FG000|Overall Study|Major Protocol Deviation|0|||
150057265|NCT00045942|541351382|FG001|PKC412A2104 (Core)|Death|0|||
150057266|NCT00045942|541351383|FG002|PKC412A2104 (Core)|Death|0|||
150057267|NCT00045942|541351384|FG003|PKC412A2104 (Core)|Death|0|||
150057268|NCT00045942|541351385|FG004|PKC412A2104 (Core)|Death|0|||
150057269|NCT00045942|541351386|FG005|PKC412A2104 (Core)|Death|0|||
150057270|NCT00045942|541351387|FG006|PKC412A2104 (Core)|Death|0|||
150057271|NCT00045942|541351388|FG007|PKC412A2104 (Core)|Death|0|||
150057272|NCT00045942|541351389|FG008|PKC412A2104 (Core)|Death|0|||
150057273|NCT00045942|541351381|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
150057274|NCT00045942|541351382|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
150057275|NCT00045942|541351383|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
150057276|NCT00045942|541351384|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
150057277|NCT00045942|541351385|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
150057278|NCT00045942|541351386|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
150057279|NCT00045942|541351387|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
150057280|NCT00045942|541351388|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
150057281|NCT00045942|541351389|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
150057282|NCT00045942|541351381|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
150057283|NCT00045942|541351382|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
150057284|NCT00045942|541351383|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
150057285|NCT00045942|541351384|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
150057286|NCT00045942|541351385|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
150057287|NCT00045942|541351386|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
150057288|NCT00045942|541351387|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
150057289|NCT00045942|541351388|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
150057290|NCT00045942|541351389|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
150057291|NCT00045942|541351381|FG000|PKC412A2104E1|Lack of Efficacy|0|||
150057292|NCT00045942|541351382|FG001|PKC412A2104E1|Lack of Efficacy|11|||
150057293|NCT00045942|541351383|FG002|PKC412A2104E1|Lack of Efficacy|11|||
150057294|NCT00045942|541351384|FG003|PKC412A2104E1|Lack of Efficacy|23|||
150057295|NCT00045942|541351385|FG004|PKC412A2104E1|Lack of Efficacy|17|||
150057296|NCT00045942|541351386|FG005|PKC412A2104E1|Lack of Efficacy|0|||
150057297|NCT00045942|541351387|FG006|PKC412A2104E1|Lack of Efficacy|0|||
150057298|NCT00045942|541351388|FG007|PKC412A2104E1|Lack of Efficacy|0|||
150057299|NCT00045942|541351389|FG008|PKC412A2104E1|Lack of Efficacy|0|||
150180589|NCT02723955|541799360|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009493|NCT02337725|541168268|FG001|Overall Study|Major Protocol Deviation|1|||
150009494|NCT02337725|541168267|FG000|Overall Study|Voluntary Withdrawal|14|||
150009495|NCT02337725|541168268|FG001|Overall Study|Voluntary Withdrawal|3|||
150009496|NCT02337725|541168267|FG000|Overall Study|Lack of Efficacy|4|||
150009497|NCT02337725|541168268|FG001|Overall Study|Lack of Efficacy|0|||
150009498|NCT00084487|541168271|FG000|Overall Study|Death|1|||
150009499|NCT01561963|541168272|FG000|Overall Study|Adverse Event|1|||
150009500|NCT03040986|541168276|FG000|Overall Study|Hospice|1|||
150009501|NCT03040986|541168277|FG001|Overall Study|Hospice|0|||
150009502|NCT03040986|541168276|FG000|Overall Study|Adverse Event|2|||
150009503|NCT03040986|541168277|FG001|Overall Study|Adverse Event|1|||
150009504|NCT03040986|541168276|FG000|Overall Study|Disease progression on study|3|||
150009505|NCT03040986|541168277|FG001|Overall Study|Disease progression on study|1|||
150009506|NCT02925728|541168282|FG000|Overall Study|Death|3|||
150009507|NCT02925728|541168283|FG001|Overall Study|Death|5|||
150009508|NCT02925728|541168282|FG000|Overall Study|Physician Decision|1|||
150009509|NCT02925728|541168283|FG001|Overall Study|Physician Decision|0|||
150009510|NCT02925728|541168282|FG000|Overall Study|Withdrawal by Subject|1|||
150009511|NCT02925728|541168283|FG001|Overall Study|Withdrawal by Subject|0|||
150009512|NCT00752726|541168284|FG000|Overall Study|Lost to Follow-up|2|||
150009513|NCT00752726|541168285|FG001|Overall Study|Lost to Follow-up|1|||
150009514|NCT00752726|541168284|FG000|Overall Study|Adverse Event|3|||
150009515|NCT00752726|541168285|FG001|Overall Study|Adverse Event|0|||
150009516|NCT00752726|541168284|FG000|Overall Study|Withdrawal by Subject|5|||
150009517|NCT00752726|541168285|FG001|Overall Study|Withdrawal by Subject|10|||
150057300|NCT00045942|541351381|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
150057301|NCT00045942|541351382|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
150057302|NCT00045942|541351383|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
150057303|NCT00045942|541351384|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
150057304|NCT00045942|541351385|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
150009518|NCT00752726|541168284|FG000|Overall Study|Other Reason|1|||
150009519|NCT00752726|541168285|FG001|Overall Study|Other Reason|2|||
150009520|NCT00042666|541168286|FG000|Overall Study|Adverse Event|2|||
150057305|NCT00045942|541351386|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
150057306|NCT00045942|541351387|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
150057307|NCT00045942|541351388|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
150057308|NCT00045942|541351389|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
150009521|NCT00042666|541168286|FG000|Overall Study|Death|4|||
150009522|NCT00042666|541168286|FG000|Overall Study|Protocol Violation|1|||
150009523|NCT00042666|541168286|FG000|Overall Study|Participant/Physician Perception|1|||
150057309|NCT00045942|541351381|FG000|PKC412A2104E1|Adverse Event|0|||
150057310|NCT00045942|541351382|FG001|PKC412A2104E1|Adverse Event|1|||
150057311|NCT00045942|541351383|FG002|PKC412A2104E1|Adverse Event|1|||
150057312|NCT00045942|541351384|FG003|PKC412A2104E1|Adverse Event|3|||
150057313|NCT00045942|541351385|FG004|PKC412A2104E1|Adverse Event|6|||
150057314|NCT00045942|541351386|FG005|PKC412A2104E1|Adverse Event|0|||
150057315|NCT00045942|541351387|FG006|PKC412A2104E1|Adverse Event|0|||
150057316|NCT00045942|541351388|FG007|PKC412A2104E1|Adverse Event|0|||
150057317|NCT00045942|541351389|FG008|PKC412A2104E1|Adverse Event|0|||
150057318|NCT00045942|541351381|FG000|PKC412A2104E1|Death|0|||
150057319|NCT00045942|541351382|FG001|PKC412A2104E1|Death|4|||
150057320|NCT00045942|541351383|FG002|PKC412A2104E1|Death|1|||
150057321|NCT00045942|541351384|FG003|PKC412A2104E1|Death|1|||
150057322|NCT00045942|541351385|FG004|PKC412A2104E1|Death|1|||
150057323|NCT00045942|541351386|FG005|PKC412A2104E1|Death|0|||
150057324|NCT00045942|541351387|FG006|PKC412A2104E1|Death|0|||
150057325|NCT00045942|541351388|FG007|PKC412A2104E1|Death|0|||
150057326|NCT00045942|541351389|FG008|PKC412A2104E1|Death|0|||
150057327|NCT00045942|541351381|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057328|NCT00045942|541351382|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057329|NCT00045942|541351383|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
150057330|NCT00045942|541351384|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
150057331|NCT00045942|541351385|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057332|NCT00045942|541351386|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057333|NCT00045942|541351387|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057334|NCT00045942|541351388|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057335|NCT00045942|541351389|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
150057336|NCT00045942|541351381|FG000|PKC412A2104E2|Lost to Follow-up|0|||
150057337|NCT00045942|541351382|FG001|PKC412A2104E2|Lost to Follow-up|0|||
150057338|NCT00045942|541351383|FG002|PKC412A2104E2|Lost to Follow-up|0|||
150057339|NCT00045942|541351384|FG003|PKC412A2104E2|Lost to Follow-up|0|||
150057340|NCT00045942|541351385|FG004|PKC412A2104E2|Lost to Follow-up|0|||
150057341|NCT00045942|541351386|FG005|PKC412A2104E2|Lost to Follow-up|0|||
150057342|NCT00045942|541351387|FG006|PKC412A2104E2|Lost to Follow-up|0|||
150057343|NCT00045942|541351388|FG007|PKC412A2104E2|Lost to Follow-up|3|||
150057344|NCT00045942|541351389|FG008|PKC412A2104E2|Lost to Follow-up|0|||
150057345|NCT00045942|541351381|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
150057346|NCT00045942|541351382|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
150057347|NCT00045942|541351383|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
150057348|NCT00045942|541351384|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
150057349|NCT00045942|541351385|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
150057350|NCT00045942|541351386|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
150057351|NCT00045942|541351387|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
150057352|NCT00045942|541351388|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
150057353|NCT00045942|541351389|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
150057354|NCT00045942|541351381|FG000|PKC412A2104E2|Lack of Efficacy|0|||
150057355|NCT00045942|541351382|FG001|PKC412A2104E2|Lack of Efficacy|0|||
150057356|NCT00045942|541351383|FG002|PKC412A2104E2|Lack of Efficacy|0|||
150057357|NCT00045942|541351384|FG003|PKC412A2104E2|Lack of Efficacy|0|||
150057358|NCT00045942|541351385|FG004|PKC412A2104E2|Lack of Efficacy|0|||
150057359|NCT00045942|541351386|FG005|PKC412A2104E2|Lack of Efficacy|3|||
150057360|NCT00045942|541351387|FG006|PKC412A2104E2|Lack of Efficacy|2|||
150057361|NCT00045942|541351388|FG007|PKC412A2104E2|Lack of Efficacy|2|||
150057362|NCT00045942|541351389|FG008|PKC412A2104E2|Lack of Efficacy|6|||
150057363|NCT00045942|541351381|FG000|PKC412A2104E2|Adverse Event|0|||
150057364|NCT00045942|541351382|FG001|PKC412A2104E2|Adverse Event|0|||
150057365|NCT00045942|541351383|FG002|PKC412A2104E2|Adverse Event|0|||
150057366|NCT00045942|541351384|FG003|PKC412A2104E2|Adverse Event|0|||
150057367|NCT00045942|541351385|FG004|PKC412A2104E2|Adverse Event|0|||
150057368|NCT00045942|541351386|FG005|PKC412A2104E2|Adverse Event|4|||
150057369|NCT00045942|541351387|FG006|PKC412A2104E2|Adverse Event|3|||
150057370|NCT00045942|541351388|FG007|PKC412A2104E2|Adverse Event|1|||
150057371|NCT00045942|541351389|FG008|PKC412A2104E2|Adverse Event|0|||
150057372|NCT00045942|541351381|FG000|PKC412A2104E2|Death|0|||
150057373|NCT00045942|541351382|FG001|PKC412A2104E2|Death|0|||
150057374|NCT00045942|541351383|FG002|PKC412A2104E2|Death|0|||
150057375|NCT00045942|541351384|FG003|PKC412A2104E2|Death|0|||
150057376|NCT00045942|541351385|FG004|PKC412A2104E2|Death|0|||
150057377|NCT00045942|541351386|FG005|PKC412A2104E2|Death|1|||
150057378|NCT00045942|541351387|FG006|PKC412A2104E2|Death|2|||
150057379|NCT00045942|541351388|FG007|PKC412A2104E2|Death|0|||
150057380|NCT00045942|541351389|FG008|PKC412A2104E2|Death|0|||
150057381|NCT02692651|541351394|FG000|Study Treatment|Death|7|||
150057382|NCT02692651|541351395|FG001|Study Treatment|Death|3|||
150057383|NCT02692651|541351394|FG000|Study Treatment|comfort care|1|||
150057384|NCT02692651|541351395|FG001|Study Treatment|comfort care|1|||
150057385|NCT02692651|541351394|FG000|Study Treatment|Protocol violation per treating team preference|8|||
150057386|NCT02692651|541351395|FG001|Study Treatment|Protocol violation per treating team preference|6|||
150057387|NCT02692651|541351394|FG000|Post Study Treatment Follow-up|Death|4|||
150057388|NCT02692651|541351395|FG001|Post Study Treatment Follow-up|Death|4|||
150057389|NCT03490981|541351396|FG000|Overall Study|Lost to Follow-up|1|||
150009524|NCT00042666|541168286|FG000|Overall Study|Progressive Disease|41|||
150009525|NCT00042666|541168286|FG000|Overall Study|Other|1|||
150009526|NCT00042666|541168286|FG000|Overall Study|Other|4|||
150009527|NCT02039856|541168287|FG000|Overall Study|Death|5|||
150009528|NCT02039856|541168288|FG001|Overall Study|Death|3|||
150009529|NCT02039856|541168287|FG000|Overall Study|Partial survey completion|61|||
150009530|NCT02039856|541168288|FG001|Overall Study|Partial survey completion|26|||
150009531|NCT02039856|541168287|FG000|Overall Study|Lost to Follow-up|388|||
150009532|NCT02039856|541168288|FG001|Overall Study|Lost to Follow-up|206|||
150009533|NCT02039856|541168287|FG000|Overall Study|Withdrawal by Subject|1573|||
150009534|NCT02039856|541168288|FG001|Overall Study|Withdrawal by Subject|618|||
150009535|NCT02540291|541168289|FG000|Overall Study|Death|7|||
150009536|NCT02540291|541168290|FG001|Overall Study|Death|7|||
150009537|NCT02540291|541168291|FG002|Overall Study|Death|5|||
150009538|NCT02540291|541168292|FG003|Overall Study|Death|7|||
150009539|NCT02540291|541168289|FG000|Overall Study|Lost to Follow-up|0|||
150009540|NCT02540291|541168290|FG001|Overall Study|Lost to Follow-up|0|||
150009541|NCT02540291|541168291|FG002|Overall Study|Lost to Follow-up|1|||
150009542|NCT02540291|541168292|FG003|Overall Study|Lost to Follow-up|0|||
150009543|NCT02540291|541168289|FG000|Overall Study|Withdrawal Of Consent|0|||
150009544|NCT02540291|541168290|FG001|Overall Study|Withdrawal Of Consent|1|||
150009545|NCT02540291|541168291|FG002|Overall Study|Withdrawal Of Consent|0|||
150009546|NCT02540291|541168292|FG003|Overall Study|Withdrawal Of Consent|0|||
150009547|NCT02540291|541168289|FG000|Overall Study|Study Terminated By Sponsor|1|||
150009548|NCT02540291|541168290|FG001|Overall Study|Study Terminated By Sponsor|0|||
150009549|NCT02540291|541168291|FG002|Overall Study|Study Terminated By Sponsor|0|||
150009550|NCT02540291|541168292|FG003|Overall Study|Study Terminated By Sponsor|0|||
150009551|NCT02540291|541168289|FG000|Overall Study|Other|0|||
150009552|NCT02540291|541168290|FG001|Overall Study|Other|0|||
150009553|NCT02540291|541168291|FG002|Overall Study|Other|1|||
150009554|NCT02540291|541168292|FG003|Overall Study|Other|0|||
150009555|NCT01879072|541168308|FG000|Overall Study|Withdrawal by Subject|121|||
150009556|NCT01879072|541168308|FG000|Overall Study|Not Transplanted|30|||
150009557|NCT00602420|541170254|FG000|Overall Study|Death|1|||
150009558|NCT00602420|541170255|FG001|Overall Study|Death|4|||
150009559|NCT00602420|541170254|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
150009560|NCT00602420|541170255|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
150009561|NCT00602420|541170254|FG000|Overall Study|Withdrawal by Subject|18|||
150009562|NCT00602420|541170255|FG001|Overall Study|Withdrawal by Subject|17|||
150009563|NCT00602420|541170254|FG000|Overall Study|Adverse Event|1|||
150009564|NCT00602420|541170255|FG001|Overall Study|Adverse Event|0|||
150009565|NCT00767806|541170258|FG000|Overall Study|Adverse Event|30|||
150009566|NCT00767806|541170259|FG001|Overall Study|Adverse Event|11|||
150009567|NCT00767806|541170258|FG000|Overall Study|Withdrawal by Subject|8|||
150009568|NCT00767806|541170259|FG001|Overall Study|Withdrawal by Subject|13|||
150009569|NCT00767806|541170258|FG000|Overall Study|Protocol Violation|6|||
150009570|NCT00767806|541170259|FG001|Overall Study|Protocol Violation|5|||
150009571|NCT00767806|541170258|FG000|Overall Study|Lack of Efficacy|1|||
150009572|NCT00767806|541170259|FG001|Overall Study|Lack of Efficacy|9|||
150009573|NCT00767806|541170258|FG000|Overall Study|Physician Decision|4|||
150009574|NCT00767806|541170259|FG001|Overall Study|Physician Decision|3|||
150009575|NCT00767806|541170258|FG000|Overall Study|Lost to Follow-up|1|||
150009576|NCT00767806|541170259|FG001|Overall Study|Lost to Follow-up|4|||
150009577|NCT00767806|541170258|FG000|Overall Study|Entry Criteria Not Met|1|||
150009578|NCT00767806|541170259|FG001|Overall Study|Entry Criteria Not Met|1|||
150009579|NCT00767806|541170258|FG000|Overall Study|Sponsor Decision|0|||
150009580|NCT00767806|541170259|FG001|Overall Study|Sponsor Decision|1|||
150009581|NCT01815840|541170260|FG000|Overall Study|Missing|1|||
150009582|NCT01815840|541170261|FG001|Overall Study|Missing|0|||
150009583|NCT01815840|541170260|FG000|Overall Study|Withdrew Consent|31|||
150009584|NCT01815840|541170261|FG001|Overall Study|Withdrew Consent|30|||
150009585|NCT01815840|541170260|FG000|Overall Study|Administrative/Other|1|||
150009586|NCT01815840|541170261|FG001|Overall Study|Administrative/Other|3|||
150009587|NCT01815840|541170260|FG000|Overall Study|Adverse Event|10|||
150009588|NCT01815840|541170261|FG001|Overall Study|Adverse Event|16|||
150009589|NCT01815840|541170260|FG000|Overall Study|Death|2|||
150009590|NCT01815840|541170261|FG001|Overall Study|Death|2|||
150057390|NCT03490981|541351397|FG001|Overall Study|Lost to Follow-up|2|||
150057391|NCT02480712|541351404|FG000|Overall Study|Enrolled but Never Treated|1|||
150009591|NCT01815840|541170260|FG000|Overall Study|Disease progression|3|||
150009592|NCT01815840|541170261|FG001|Overall Study|Disease progression|2|||
150009593|NCT01815840|541170260|FG000|Overall Study|Investigators Decision|2|||
150009594|NCT01815840|541170261|FG001|Overall Study|Investigators Decision|3|||
150009595|NCT01815840|541170260|FG000|Overall Study|Lost to Follow-up|3|||
150009596|NCT01815840|541170261|FG001|Overall Study|Lost to Follow-up|6|||
150009597|NCT01815840|541170260|FG000|Overall Study|Refused Treatment|5|||
150009598|NCT01815840|541170261|FG001|Overall Study|Refused Treatment|1|||
150009599|NCT01815840|541170260|FG000|Overall Study|Sponsor Termination Treatment|1|||
150180590|NCT02723955|541799361|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180591|NCT02723955|541799362|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180592|NCT02723955|541799363|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180593|NCT02723955|541799364|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180594|NCT02723955|541799365|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180595|NCT02723955|541799366|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180596|NCT02723955|541799367|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180597|NCT02723955|541799368|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180598|NCT02723955|541799369|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180599|NCT02723955|541799370|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180600|NCT02723955|541799371|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180601|NCT02723955|541799372|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180602|NCT02723955|541799373|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180603|NCT02723955|541799374|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180604|NCT02723955|541799375|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150057392|NCT02480712|541351404|FG000|Overall Study|Lost to Follow-up|5|||
150057393|NCT02480712|541351404|FG000|Overall Study|Withdrew Consent|3|||
150057394|NCT02480712|541351404|FG000|Overall Study|Death|1|||
150057395|NCT02480712|541351404|FG000|Overall Study|Lack of Efficacy|1|||
150057396|NCT01860846|541351405|FG000|Overall Study|Lost to Follow-up|33|||
150057397|NCT05463198|541351406|FG000|Overall Study|Withdrawal by Subject|19|||
150057398|NCT05463198|541351406|FG000|Overall Study|Procedure Notes Missing|18|||
150057399|NCT02239120|541351409|FG000|Overall Study|Death|56|||
150057400|NCT02239120|541351410|FG001|Overall Study|Death|58|||
150057401|NCT02239120|541351409|FG000|Overall Study|Lost to Follow-up|19|||
150057402|NCT02239120|541351410|FG001|Overall Study|Lost to Follow-up|14|||
150057403|NCT00466687|541351411|FG000|Overall Study|Adverse Event|1|||
150057404|NCT00466687|541351411|FG000|Overall Study|Other complicating illness|3|||
150057405|NCT00466687|541351411|FG000|Overall Study|Withdrawal by Subject|1|||
150057406|NCT00466687|541351411|FG000|Overall Study|Disease progression|29|||
150057407|NCT02158364|541351415|FG000|Overall Study|Case report forms uncollected|10|||
150057408|NCT02158364|541351415|FG000|Overall Study|Protocol Deviation|50|||
150057409|NCT01944839|541351416|FG000|Overall Study|Physician Decision|2|||
150057410|NCT01944839|541351417|FG001|Overall Study|Physician Decision|2|||
150057411|NCT01944839|541351416|FG000|Overall Study|Protocol Violation|0|||
150057412|NCT01944839|541351417|FG001|Overall Study|Protocol Violation|1|||
150057413|NCT01944839|541351416|FG000|Overall Study|Adverse Event|10|||
150057414|NCT01944839|541351417|FG001|Overall Study|Adverse Event|5|||
150057415|NCT01944839|541351416|FG000|Overall Study|Withdrawal by Subject|9|||
150057416|NCT01944839|541351417|FG001|Overall Study|Withdrawal by Subject|17|||
150180605|NCT02723955|541799376|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180606|NCT02723955|541799377|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180607|NCT02723955|541799378|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180608|NCT02723955|541799379|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180609|NCT02723955|541799380|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009600|NCT01815840|541170261|FG001|Overall Study|Sponsor Termination Treatment|0|||
150009601|NCT00568126|541170262|FG000|Overall Study|Adverse Event|3|||
150009602|NCT00568126|541170263|FG001|Overall Study|Adverse Event|0|||
150009603|NCT00568126|541170262|FG000|Overall Study|Withdrawal by Subject|2|||
150009604|NCT00568126|541170263|FG001|Overall Study|Withdrawal by Subject|3|||
150009605|NCT00568126|541170262|FG000|Overall Study|Lost to Follow-up|4|||
150009606|NCT00568126|541170263|FG001|Overall Study|Lost to Follow-up|3|||
150009607|NCT00568126|541170262|FG000|Overall Study|Lack of Efficacy|0|||
150009608|NCT00568126|541170263|FG001|Overall Study|Lack of Efficacy|1|||
150009609|NCT00568126|541170262|FG000|Overall Study|Physician Decision|2|||
150009610|NCT00568126|541170263|FG001|Overall Study|Physician Decision|2|||
150009611|NCT04395690|541170264|FG000|Overall Study|Lost to Follow-up|1|||
150009612|NCT04395690|541170265|FG001|Overall Study|Lost to Follow-up|1|||
150009613|NCT03909152|541170266|FG000|Overall Study|Adverse Event|14|||
150009614|NCT03909152|541170267|FG001|Overall Study|Adverse Event|5|||
150009615|NCT03909152|541170268|FG002|Overall Study|Adverse Event|1|||
150009616|NCT03909152|541170269|FG003|Overall Study|Adverse Event|14|||
150057417|NCT01944839|541351416|FG000|Overall Study|Lost to Follow-up|1|||
150057418|NCT01944839|541351417|FG001|Overall Study|Lost to Follow-up|0|||
150009617|NCT04541628|541170272|FG000|Overall Study|Study Terminated|1|||
150057419|NCT01944839|541351416|FG000|Overall Study|Subject non-compliance|0|||
150057420|NCT01944839|541351417|FG001|Overall Study|Subject non-compliance|3|||
150057421|NCT00609362|541351418|FG000|Overall Study|Withdrawal by Subject|2|||
150180610|NCT02723955|541799381|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180611|NCT02723955|541799382|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180612|NCT02723955|541799383|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150255182|NCT02121301|542070583|FG001|Overall Study|Protocol Violation|4|||
150255183|NCT02121301|542070584|FG002|Overall Study|Protocol Violation|1|||
150255184|NCT00037830|542070587|FG000|Overall Study|Adverse Event|2|||
150255185|NCT00037830|542070588|FG001|Overall Study|Adverse Event|0|||
150255186|NCT00037830|542070589|FG002|Overall Study|Adverse Event|0|||
150009618|NCT04541628|541170273|FG001|Overall Study|Study Terminated|1|||
150009619|NCT04541628|541170274|FG002|Overall Study|Study Terminated|1|||
150009620|NCT00308074|541170276|FG000|Overall Study|Withdrawal by Subject|1|||
150009621|NCT03002311|541170277|FG000|Overall Study|Lost to Follow-up|13|||
150009622|NCT03002311|541170278|FG001|Overall Study|Lost to Follow-up|26|||
150009623|NCT03002311|541170277|FG000|Overall Study|Referral provider called to schedule app|3|||
150009624|NCT03002311|541170278|FG001|Overall Study|Referral provider called to schedule app|3|||
150009625|NCT03002311|541170277|FG000|Overall Study|Physician Decision|3|||
150009626|NCT03002311|541170278|FG001|Overall Study|Physician Decision|1|||
150009627|NCT03722524|541170279|FG000|Overall Study|Protocol Violation|86|||
150009628|NCT03722524|541170279|FG000|Overall Study|Adverse Event|7|||
150009629|NCT03722524|541170279|FG000|Overall Study|Lost to Follow-up|1|||
150009630|NCT03722524|541170279|FG000|Overall Study|Reason is not stated|1|||
150009631|NCT03722524|541170279|FG000|Overall Study|Physician Decision|1|||
150009632|NCT03722524|541170279|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
150009633|NCT04369950|541170281|FG000|Overall Study|Protocol Violation|2|||
150009634|NCT04369950|541170282|FG001|Overall Study|Protocol Violation|2|||
150180613|NCT02723955|541799384|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180614|NCT02723955|541799385|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009635|NCT01240200|541170289|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
150009636|NCT01240200|541170290|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
150009637|NCT01529034|541170293|FG000|Overall Study|Discontinued prior to study treatment|14|||
150009638|NCT01529034|541170293|FG000|Overall Study|Site closure|62|||
150009639|NCT01529034|541170293|FG000|Overall Study|Study termination|29|||
150009640|NCT01529034|541170293|FG000|Overall Study|Withdrawal by Subject|25|||
150009641|NCT01529034|541170293|FG000|Overall Study|No treated SCs within protocol window|13|||
150009642|NCT01529034|541170293|FG000|Overall Study|Noncompliance|8|||
150009643|NCT01529034|541170293|FG000|Overall Study|Caregiver no longer available|7|||
150009644|NCT01529034|541170293|FG000|Overall Study|Adverse Event|4|||
150009645|NCT01529034|541170293|FG000|Overall Study|Protocol Violation|4|||
150009646|NCT01529034|541170293|FG000|Overall Study|Lack of Efficacy|4|||
150009647|NCT01529034|541170293|FG000|Overall Study|Investigator no longer available|2|||
150009648|NCT01529034|541170293|FG000|Overall Study|Study drug not available|2|||
150009649|NCT04676867|541170294|FG000|Overall Study|Screen failure|0|||
150009650|NCT04676867|541170295|FG001|Overall Study|Screen failure|0|||
150009651|NCT04676867|541170296|FG002|Overall Study|Screen failure|6|||
150009652|NCT04676867|541170297|FG003|Overall Study|Screen failure|2|||
150009653|NCT04676867|541170294|FG000|Overall Study|Death|0|||
150009654|NCT04676867|541170295|FG001|Overall Study|Death|0|||
150009655|NCT04676867|541170296|FG002|Overall Study|Death|1|||
150009656|NCT04676867|541170297|FG003|Overall Study|Death|0|||
150009657|NCT04676867|541170294|FG000|Overall Study|Withdrawal by Subject|2|||
150009658|NCT04676867|541170295|FG001|Overall Study|Withdrawal by Subject|2|||
150009659|NCT04676867|541170296|FG002|Overall Study|Withdrawal by Subject|4|||
150009660|NCT04676867|541170297|FG003|Overall Study|Withdrawal by Subject|4|||
150009661|NCT04676867|541170294|FG000|Overall Study|Lost to Follow-up|1|||
150009662|NCT04676867|541170295|FG001|Overall Study|Lost to Follow-up|0|||
150009663|NCT04676867|541170296|FG002|Overall Study|Lost to Follow-up|0|||
150009664|NCT04676867|541170297|FG003|Overall Study|Lost to Follow-up|0|||
150009665|NCT01554514|541170302|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
150009666|NCT01554514|541170302|FG000|Overall Study|Physician Decision|1|||
150009667|NCT01423916|541170303|FG000|Overall Study|Adverse Event|5|||
150009668|NCT01423916|541170304|FG001|Overall Study|Adverse Event|9|||
150009669|NCT01423916|541170305|FG002|Overall Study|Adverse Event|2|||
150009670|NCT01423916|541170303|FG000|Overall Study|Met Withdrawal Criteria|1|||
150009671|NCT01423916|541170304|FG001|Overall Study|Met Withdrawal Criteria|1|||
150009672|NCT01423916|541170305|FG002|Overall Study|Met Withdrawal Criteria|1|||
150009673|NCT01423916|541170303|FG000|Overall Study|Physician Decision|1|||
150009674|NCT01423916|541170304|FG001|Overall Study|Physician Decision|0|||
150009675|NCT01423916|541170305|FG002|Overall Study|Physician Decision|1|||
150009676|NCT01423916|541170303|FG000|Overall Study|Withdrawal by Subject|3|||
150009677|NCT01423916|541170304|FG001|Overall Study|Withdrawal by Subject|10|||
150009678|NCT01423916|541170305|FG002|Overall Study|Withdrawal by Subject|3|||
150009679|NCT01423916|541170303|FG000|Overall Study|Protocol Deviation|1|||
150009680|NCT01423916|541170304|FG001|Overall Study|Protocol Deviation|0|||
150009681|NCT01423916|541170305|FG002|Overall Study|Protocol Deviation|0|||
150009682|NCT02294734|541170308|FG000|Overall Study|Adverse Event|5|||
150009683|NCT02294734|541170309|FG001|Overall Study|Adverse Event|5|||
150009684|NCT02294734|541170308|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
150009685|NCT02294734|541170309|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
150009686|NCT02294734|541170308|FG000|Overall Study|Lost to Follow-up|2|||
150009687|NCT02294734|541170309|FG001|Overall Study|Lost to Follow-up|0|||
150009688|NCT02294734|541170308|FG000|Overall Study|Physician Decision|2|||
150009689|NCT02294734|541170309|FG001|Overall Study|Physician Decision|1|||
150009690|NCT02294734|541170308|FG000|Overall Study|Withdrawal by Subject|4|||
150009691|NCT02294734|541170309|FG001|Overall Study|Withdrawal by Subject|2|||
150009692|NCT01141478|541170310|FG000|Overall Study|Withdrawal by Subject|1|||
150009693|NCT01141478|541170311|FG001|Overall Study|Withdrawal by Subject|1|||
150009694|NCT02250664|541170312|FG000|Overall Study|Lost to Follow-up|18|||
150009695|NCT02250664|541170313|FG001|Overall Study|Lost to Follow-up|28|||
150009696|NCT02250664|541170314|FG002|Overall Study|Lost to Follow-up|33|||
150009697|NCT02250664|541170312|FG000|Overall Study|Personal Reasons|7|||
150009698|NCT02250664|541170313|FG001|Overall Study|Personal Reasons|8|||
150009699|NCT02250664|541170314|FG002|Overall Study|Personal Reasons|14|||
150009700|NCT02250664|541170312|FG000|Overall Study|Adverse Event|6|||
150009701|NCT02250664|541170313|FG001|Overall Study|Adverse Event|3|||
150009702|NCT02250664|541170314|FG002|Overall Study|Adverse Event|8|||
150009703|NCT02250664|541170312|FG000|Overall Study|Incarcerated|2|||
150009704|NCT02250664|541170313|FG001|Overall Study|Incarcerated|1|||
150009705|NCT02250664|541170314|FG002|Overall Study|Incarcerated|2|||
150009706|NCT02250664|541170312|FG000|Overall Study|Withdrawal by Subject|0|||
150009707|NCT02250664|541170313|FG001|Overall Study|Withdrawal by Subject|1|||
150009708|NCT02250664|541170314|FG002|Overall Study|Withdrawal by Subject|2|||
150009709|NCT02250664|541170312|FG000|Overall Study|Death|0|||
150009710|NCT02250664|541170313|FG001|Overall Study|Death|1|||
150009711|NCT02250664|541170314|FG002|Overall Study|Death|1|||
150009712|NCT02250664|541170312|FG000|Overall Study|Physician Decision|1|||
150009713|NCT02250664|541170313|FG001|Overall Study|Physician Decision|3|||
150009714|NCT02250664|541170314|FG002|Overall Study|Physician Decision|1|||
150009715|NCT02250664|541170312|FG000|Overall Study|Protocol Violation|1|||
150009716|NCT02250664|541170313|FG001|Overall Study|Protocol Violation|0|||
150009717|NCT02250664|541170314|FG002|Overall Study|Protocol Violation|1|||
150009718|NCT02250664|541170312|FG000|Overall Study|Reason unknown|1|||
150009719|NCT02250664|541170313|FG001|Overall Study|Reason unknown|0|||
150009720|NCT02250664|541170314|FG002|Overall Study|Reason unknown|0|||
150009721|NCT03847909|541170316|FG000|Overall Study|Withdrawal by Subject|1|||
150009722|NCT03847909|541170317|FG001|Overall Study|Withdrawal by Subject|1|||
150009723|NCT00975143|541170318|FG000|Overall Study|Adverse Event|19|||
150009724|NCT00975143|541170319|FG001|Overall Study|Adverse Event|15|||
150009725|NCT00975143|541170318|FG000|Overall Study|Withdrawal by Subject|15|||
150009726|NCT00975143|541170319|FG001|Overall Study|Withdrawal by Subject|15|||
150009727|NCT00975143|541170318|FG000|Overall Study|Lost to Follow-up|20|||
150009728|NCT00975143|541170319|FG001|Overall Study|Lost to Follow-up|16|||
150009729|NCT00975143|541170318|FG000|Overall Study|Non-compliance|5|||
150009730|NCT00975143|541170319|FG001|Overall Study|Non-compliance|8|||
150009731|NCT00975143|541170318|FG000|Overall Study|Physician Decision|1|||
150009732|NCT00975143|541170319|FG001|Overall Study|Physician Decision|2|||
150009733|NCT00975143|541170318|FG000|Overall Study|Details not available|10|||
150009734|NCT00975143|541170319|FG001|Overall Study|Details not available|4|||
150009735|NCT01147900|541170320|FG000|At Year 10|Lost to Follow-up|0|||
150009736|NCT01147900|541170321|FG001|At Year 10|Lost to Follow-up|1|||
150009737|NCT01147900|541170322|FG002|At Year 10|Lost to Follow-up|0|||
150009738|NCT01375608|541170323|FG000|Overall Study|Withdrawal by Subject|2|||
150009739|NCT03129360|541170324|FG000|Overall Study|Did not meet entry criteria|0|||
150009740|NCT03129360|541170325|FG001|Overall Study|Did not meet entry criteria|2|||
150009741|NCT03129360|541170326|FG002|Overall Study|Did not meet entry criteria|1|||
150009742|NCT03129360|541170324|FG000|Overall Study|Excluded due to motion in scanner|1|||
150009743|NCT03129360|541170325|FG001|Overall Study|Excluded due to motion in scanner|0|||
150009744|NCT03129360|541170326|FG002|Overall Study|Excluded due to motion in scanner|0|||
150009745|NCT00545103|541170327|FG000|Overall Study|Lack of Efficacy|48|||
150009746|NCT00545103|541170328|FG001|Overall Study|Lack of Efficacy|45|||
150009747|NCT00545103|541170329|FG002|Overall Study|Lack of Efficacy|31|||
150009748|NCT00545103|541170330|FG003|Overall Study|Lack of Efficacy|27|||
150009749|NCT00545103|541170327|FG000|Overall Study|Withdrawal by Subject|6|||
150009750|NCT00545103|541170328|FG001|Overall Study|Withdrawal by Subject|10|||
150009751|NCT00545103|541170329|FG002|Overall Study|Withdrawal by Subject|18|||
150009752|NCT00545103|541170330|FG003|Overall Study|Withdrawal by Subject|22|||
150009753|NCT00545103|541170327|FG000|Overall Study|Adverse Event|11|||
150009754|NCT00545103|541170328|FG001|Overall Study|Adverse Event|12|||
150009755|NCT00545103|541170329|FG002|Overall Study|Adverse Event|17|||
150009756|NCT00545103|541170330|FG003|Overall Study|Adverse Event|10|||
150009757|NCT00545103|541170327|FG000|Overall Study|Lost to Follow-up|4|||
150009758|NCT00545103|541170328|FG001|Overall Study|Lost to Follow-up|6|||
150009759|NCT00545103|541170329|FG002|Overall Study|Lost to Follow-up|3|||
150009760|NCT00545103|541170330|FG003|Overall Study|Lost to Follow-up|4|||
150009761|NCT00545103|541170327|FG000|Overall Study|Protocol Violation|1|||
150009762|NCT00545103|541170328|FG001|Overall Study|Protocol Violation|2|||
150009763|NCT00545103|541170329|FG002|Overall Study|Protocol Violation|3|||
150009764|NCT00545103|541170330|FG003|Overall Study|Protocol Violation|0|||
150009765|NCT00545103|541170327|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
150009766|NCT00545103|541170328|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
150009767|NCT00545103|541170329|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
150009768|NCT00545103|541170330|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
150009769|NCT00545103|541170327|FG000|Overall Study|Difficult to open package|0|||
150057422|NCT00609362|541351419|FG001|Overall Study|Withdrawal by Subject|1|||
150057423|NCT00609362|541351418|FG000|Overall Study|Adverse Event|1|||
150057424|NCT00609362|541351419|FG001|Overall Study|Adverse Event|0|||
150057425|NCT05093790|541351420|FG000|Overall Study|Failure to meet continuation criteria|0|||
150057426|NCT05093790|541351421|FG001|Overall Study|Failure to meet continuation criteria|0|||
150009770|NCT00545103|541170328|FG001|Overall Study|Difficult to open package|0|||
150009771|NCT00545103|541170329|FG002|Overall Study|Difficult to open package|0|||
150057427|NCT05093790|541351422|FG002|Overall Study|Failure to meet continuation criteria|1|||
150057428|NCT05093790|541351423|FG003|Overall Study|Failure to meet continuation criteria|0|||
150057429|NCT05093790|541351420|FG000|Overall Study|Adverse Event|1|||
150057430|NCT05093790|541351421|FG001|Overall Study|Adverse Event|0|||
150057431|NCT05093790|541351422|FG002|Overall Study|Adverse Event|0|||
150057432|NCT05093790|541351423|FG003|Overall Study|Adverse Event|0|||
150009772|NCT00545103|541170330|FG003|Overall Study|Difficult to open package|1|||
150009773|NCT00545103|541170327|FG000|Overall Study|Investigational product not taken|1|||
150009774|NCT00545103|541170328|FG001|Overall Study|Investigational product not taken|0|||
150009775|NCT00545103|541170329|FG002|Overall Study|Investigational product not taken|0|||
150009776|NCT00545103|541170330|FG003|Overall Study|Investigational product not taken|1|||
150009777|NCT00545103|541170327|FG000|Overall Study|Wish to start a family|0|||
150009778|NCT00545103|541170328|FG001|Overall Study|Wish to start a family|0|||
150009779|NCT00545103|541170329|FG002|Overall Study|Wish to start a family|0|||
150009780|NCT00545103|541170330|FG003|Overall Study|Wish to start a family|1|||
150009781|NCT00545103|541170327|FG000|Overall Study|Diverticulitis crisis|0|||
150009782|NCT00545103|541170328|FG001|Overall Study|Diverticulitis crisis|0|||
150009783|NCT00545103|541170329|FG002|Overall Study|Diverticulitis crisis|0|||
150009784|NCT00545103|541170330|FG003|Overall Study|Diverticulitis crisis|1|||
150009785|NCT00545103|541170327|FG000|Overall Study|Personal reasons|1|||
150009786|NCT00545103|541170328|FG001|Overall Study|Personal reasons|0|||
150009787|NCT00545103|541170329|FG002|Overall Study|Personal reasons|0|||
150009788|NCT00545103|541170330|FG003|Overall Study|Personal reasons|0|||
150009789|NCT00545103|541170327|FG000|Overall Study|Subject's decision|1|||
150009790|NCT00545103|541170328|FG001|Overall Study|Subject's decision|0|||
150009791|NCT00545103|541170329|FG002|Overall Study|Subject's decision|0|||
150009792|NCT00545103|541170330|FG003|Overall Study|Subject's decision|0|||
150009793|NCT00545103|541170327|FG000|Overall Study|Noncompliance|0|||
150009794|NCT00545103|541170328|FG001|Overall Study|Noncompliance|1|||
150009795|NCT00545103|541170329|FG002|Overall Study|Noncompliance|0|||
150009796|NCT00545103|541170330|FG003|Overall Study|Noncompliance|0|||
150009797|NCT00545103|541170327|FG000|Overall Study|Investigator decision|0|||
150009798|NCT00545103|541170328|FG001|Overall Study|Investigator decision|0|||
150009799|NCT00545103|541170329|FG002|Overall Study|Investigator decision|1|||
150009800|NCT00545103|541170330|FG003|Overall Study|Investigator decision|0|||
150009801|NCT00545103|541170327|FG000|Overall Study|Subject moved|0|||
150009802|NCT00545103|541170328|FG001|Overall Study|Subject moved|1|||
150009803|NCT00545103|541170329|FG002|Overall Study|Subject moved|0|||
150009804|NCT00545103|541170330|FG003|Overall Study|Subject moved|0|||
150009805|NCT00545103|541170327|FG000|Overall Study|Use of prohibited medication|0|||
150009806|NCT00545103|541170328|FG001|Overall Study|Use of prohibited medication|0|||
150009807|NCT00545103|541170329|FG002|Overall Study|Use of prohibited medication|1|||
150009808|NCT00545103|541170330|FG003|Overall Study|Use of prohibited medication|0|||
150009809|NCT00545103|541170327|FG000|Overall Study|Does not want to take study drug anymore|1|||
150009810|NCT00545103|541170328|FG001|Overall Study|Does not want to take study drug anymore|0|||
150009811|NCT00545103|541170329|FG002|Overall Study|Does not want to take study drug anymore|1|||
150009812|NCT00545103|541170330|FG003|Overall Study|Does not want to take study drug anymore|0|||
150009813|NCT00545103|541170327|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
150009814|NCT00545103|541170328|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
150009815|NCT00545103|541170329|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
150057433|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
150057434|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
150057435|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
150057436|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
150057437|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
150057438|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
150057439|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
150180615|NCT02723955|541799386|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150009816|NCT00545103|541170330|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
150009817|NCT00545103|541170327|FG000|Overall Study|Death|0|||
150009818|NCT00545103|541170328|FG001|Overall Study|Death|1|||
150009819|NCT00545103|541170329|FG002|Overall Study|Death|0|||
150009820|NCT00545103|541170330|FG003|Overall Study|Death|0|||
150009821|NCT01953913|541170331|FG000|Overall Study|Disease Progression|349|||
150009822|NCT01953913|541170331|FG000|Overall Study|Worsening of underlying cancer|22|||
150057440|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
150057441|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
150009823|NCT01953913|541170331|FG000|Overall Study|Adverse Event|20|||
150009824|NCT01953913|541170331|FG000|Overall Study|Protocol Violation|6|||
150009825|NCT01953913|541170331|FG000|Overall Study|Lost to Follow-up|4|||
150009826|NCT01953913|541170331|FG000|Overall Study|Withdrawal by Subject|32|||
150009827|NCT01953913|541170331|FG000|Overall Study|Other than listed|108|||
150009828|NCT01953913|541170331|FG000|Overall Study|Not Treated|1|||
150009829|NCT05026853|541170332|FG000|Overall Study|Cancelled appointment|1|||
150009830|NCT05026853|541170333|FG001|Overall Study|Cancelled appointment|0|||
150009831|NCT05026853|541170332|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
150009832|NCT05026853|541170333|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
150009833|NCT05026853|541170332|FG000|Overall Study|Did not complete 12-week survey|16|||
150009834|NCT05026853|541170333|FG001|Overall Study|Did not complete 12-week survey|16|||
150009835|NCT03836677|541170334|FG000|Period 1|Adverse Event|0|||
150009836|NCT03836677|541170335|FG001|Period 1|Adverse Event|1|||
150009837|NCT03836677|541170334|FG000|Period 2|Severe non-compliance to protocol|1|||
150009838|NCT03836677|541170335|FG001|Period 2|Severe non-compliance to protocol|0|||
150009839|NCT01353911|541170336|FG000|Overall Study|Lost to Follow-up|2|||
150009840|NCT01353911|541170337|FG001|Overall Study|Lost to Follow-up|6|||
150009841|NCT01353911|541170338|FG002|Overall Study|Lost to Follow-up|4|||
150009842|NCT01353911|541170339|FG003|Overall Study|Lost to Follow-up|0|||
150009843|NCT01353911|541170340|FG004|Overall Study|Lost to Follow-up|4|||
150009844|NCT01353911|541170341|FG005|Overall Study|Lost to Follow-up|4|||
150009845|NCT01353911|541170342|FG006|Overall Study|Lost to Follow-up|3|||
150009846|NCT01353911|541170343|FG007|Overall Study|Lost to Follow-up|6|||
150009847|NCT01353911|541170336|FG000|Overall Study|Withdrawal by Subject|2|||
150009848|NCT01353911|541170337|FG001|Overall Study|Withdrawal by Subject|3|||
150009849|NCT01353911|541170338|FG002|Overall Study|Withdrawal by Subject|4|||
150009850|NCT01353911|541170339|FG003|Overall Study|Withdrawal by Subject|2|||
150009851|NCT01353911|541170340|FG004|Overall Study|Withdrawal by Subject|2|||
150009852|NCT01353911|541170341|FG005|Overall Study|Withdrawal by Subject|3|||
150009853|NCT01353911|541170342|FG006|Overall Study|Withdrawal by Subject|3|||
150009854|NCT01353911|541170343|FG007|Overall Study|Withdrawal by Subject|9|||
150009855|NCT01353911|541170336|FG000|Overall Study|Status Not Recorded|4|||
150009856|NCT01353911|541170337|FG001|Overall Study|Status Not Recorded|0|||
150009857|NCT01353911|541170338|FG002|Overall Study|Status Not Recorded|1|||
150009858|NCT01353911|541170339|FG003|Overall Study|Status Not Recorded|0|||
150009859|NCT01353911|541170340|FG004|Overall Study|Status Not Recorded|0|||
150009860|NCT01353911|541170341|FG005|Overall Study|Status Not Recorded|0|||
150009861|NCT01353911|541170342|FG006|Overall Study|Status Not Recorded|0|||
150009862|NCT01353911|541170343|FG007|Overall Study|Status Not Recorded|0|||
150009863|NCT01732913|541170344|FG000|Overall Study|Study Terminated by Sponsor|105|||
150009864|NCT01732913|541170345|FG001|Overall Study|Study Terminated by Sponsor|55|||
150009865|NCT01732913|541170344|FG000|Overall Study|Withdrawal by Subject|27|||
150009866|NCT01732913|541170345|FG001|Overall Study|Withdrawal by Subject|4|||
150009867|NCT01732913|541170344|FG000|Overall Study|Physician Decision|14|||
150009868|NCT01732913|541170345|FG001|Overall Study|Physician Decision|7|||
150009869|NCT01732913|541170344|FG000|Overall Study|Other|7|||
150009870|NCT01732913|541170345|FG001|Overall Study|Other|1|||
150009871|NCT01732913|541170344|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
150009872|NCT01732913|541170345|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
150009873|NCT00295932|541170347|FG000|Overall Study|Not Treated|0|||
150009874|NCT00295932|541170348|FG001|Overall Study|Not Treated|0|||
150009875|NCT00295932|541170349|FG002|Overall Study|Not Treated|0|||
150009876|NCT00295932|541170350|FG003|Overall Study|Not Treated|0|||
150009877|NCT00295932|541170351|FG004|Overall Study|Not Treated|0|||
150009878|NCT00295932|541170352|FG005|Overall Study|Not Treated|0|||
150009879|NCT00295932|541170353|FG006|Overall Study|Not Treated|0|||
150009880|NCT00295932|541170354|FG007|Overall Study|Not Treated|0|||
150009881|NCT00295932|541170355|FG008|Overall Study|Not Treated|0|||
150009882|NCT00295932|541170356|FG009|Overall Study|Not Treated|0|||
150009883|NCT00295932|541170357|FG010|Overall Study|Not Treated|1|||
150009884|NCT00884832|541170358|FG000|Overall Study|Withdrawal by Subject|0|||
150009885|NCT00884832|541170359|FG001|Overall Study|Withdrawal by Subject|1|||
150009886|NCT04891107|541170360|FG000|Overall Study|Physician Decision|1|||
150009887|NCT04891107|541170360|FG000|Overall Study|Withdrawal by Subject|1|||
150009888|NCT04891107|541170360|FG000|Overall Study|Screen failure after consent|1|||
150009889|NCT00500760|541170367|FG000|Overall Study|Death|32|||
150009890|NCT00500760|541170368|FG001|Overall Study|Death|15|||
150009891|NCT00500760|541170367|FG000|Overall Study|Withdrawal by Subject|5|||
150009892|NCT00500760|541170368|FG001|Overall Study|Withdrawal by Subject|7|||
150009893|NCT00500760|541170367|FG000|Overall Study|Administrative decision|2|||
150009894|NCT00500760|541170368|FG001|Overall Study|Administrative decision|0|||
150009895|NCT00500760|541170367|FG000|Overall Study|Lost to Follow-up|3|||
150009896|NCT00500760|541170368|FG001|Overall Study|Lost to Follow-up|0|||
150009897|NCT00500760|541170367|FG000|Overall Study|Other|1|||
150009898|NCT00500760|541170368|FG001|Overall Study|Other|2|||
150009899|NCT01600092|541170369|FG000|Overall Study|Adverse Event|2|||
150009900|NCT01600092|541170370|FG001|Overall Study|Adverse Event|0|||
150180616|NCT02723955|541799387|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180617|NCT02723955|541799388|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180618|NCT02723955|541799389|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180619|NCT02723955|541799390|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180620|NCT02723955|541799391|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180621|NCT02723955|541799392|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180622|NCT02723955|541799393|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
150180623|NCT02723955|541799394|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180624|NCT02723955|541799395|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180625|NCT02723955|541799396|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
150180626|NCT02723955|541799354|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180627|NCT02723955|541799355|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180628|NCT02723955|541799356|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180629|NCT02723955|541799357|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180630|NCT02723955|541799358|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180631|NCT02723955|541799359|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180632|NCT02723955|541799360|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180633|NCT02723955|541799361|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180634|NCT02723955|541799362|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
150009901|NCT01600092|541170369|FG000|Overall Study|Lost to Follow-up|4|||
150009902|NCT01600092|541170370|FG001|Overall Study|Lost to Follow-up|6|||
150009903|NCT01600092|541170369|FG000|Overall Study|Withdrawal by parent/guardian|8|||
150009904|NCT01600092|541170370|FG001|Overall Study|Withdrawal by parent/guardian|6|||
150009905|NCT01600092|541170369|FG000|Overall Study|Physician Decision|1|||
150009906|NCT01600092|541170370|FG001|Overall Study|Physician Decision|1|||
150009907|NCT01600092|541170369|FG000|Overall Study|Randomized but not vaccinated|3|||
150009908|NCT01600092|541170370|FG001|Overall Study|Randomized but not vaccinated|3|||
150009909|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
150009910|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
150009911|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
150009912|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
150009913|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
150009914|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
150009915|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
150009916|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
150009917|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
150009918|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
150009919|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
150009920|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
150009921|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
150009922|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
150009923|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009924|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
150009925|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
150009926|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009927|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009928|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009929|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009930|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
150009931|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009932|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
150009933|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
150009934|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
150009935|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
150009936|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
150009937|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009938|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009939|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009940|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009941|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
150009942|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
150009943|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
150009944|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
150009945|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009946|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
150180635|NCT02723955|541799363|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180636|NCT02723955|541799364|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180637|NCT02723955|541799365|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180638|NCT02723955|541799366|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
150009947|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
150009948|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009949|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009950|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009951|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009952|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
150009953|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009954|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009955|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
150009956|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009957|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009958|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
150009959|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009960|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009961|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009962|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009963|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
150009964|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
150009965|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009966|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009967|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009968|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009969|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009970|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009971|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009972|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009973|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009974|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
150009975|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009976|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009977|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
150009978|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009979|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009980|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009981|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009982|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009983|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009984|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009985|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
150009986|NCT02914561|541170372|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
150009987|NCT02914561|541170373|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009988|NCT02914561|541170374|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
150009989|NCT02914561|541170375|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
150009990|NCT02914561|541170376|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
150009991|NCT02914561|541170377|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
150009992|NCT02914561|541170378|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009993|NCT02914561|541170379|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009994|NCT02914561|541170380|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009995|NCT02914561|541170381|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009996|NCT02914561|541170382|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
150009997|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150009998|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150009999|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150010000|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150010001|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150010002|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
150010003|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
150057442|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
150057443|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
150010004|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
150010005|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
150010006|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
150010007|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
150057444|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
150010008|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010009|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010010|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010011|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010012|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010013|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
150010014|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
150010015|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
150010016|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
150010017|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
150010018|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
150010019|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010020|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010021|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010022|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010023|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010024|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
150010025|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
150010026|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
150010027|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
150010028|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
150010029|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
150010030|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010031|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010032|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010033|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010034|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010035|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010036|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
150010037|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010038|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
150010039|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
150010040|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
150010041|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010042|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010043|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010044|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010045|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010046|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010047|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
150010048|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
150010049|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
150010050|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
150010051|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
150010052|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010053|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010054|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010055|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010056|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010057|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010058|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
150010059|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010060|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
150010061|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010062|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
150010063|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010064|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010065|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010066|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010067|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010068|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010069|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150057445|NCT01087788|541351424|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
150057446|NCT01087788|541351425|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
150180639|NCT02723955|541799367|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
150010070|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010071|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
150010072|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010073|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
150010074|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010075|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010076|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010077|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010078|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010079|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010080|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
150010081|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010082|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010083|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010084|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
150010085|NCT02914561|541170372|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010086|NCT02914561|541170373|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010087|NCT02914561|541170374|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010088|NCT02914561|541170375|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010089|NCT02914561|541170376|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150057447|NCT01087788|541351426|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
150057448|NCT01087788|541351424|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
150057449|NCT01087788|541351425|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
150057450|NCT01087788|541351426|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
150057451|NCT01087788|541351424|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
150057452|NCT01087788|541351425|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
150057453|NCT01087788|541351426|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
150057454|NCT01087788|541351424|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
150057455|NCT01087788|541351425|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
150057456|NCT01087788|541351426|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
150057457|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
150057458|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
150057459|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
150057460|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
150057461|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
150057462|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
150057463|NCT01087788|541351424|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
150057464|NCT01087788|541351425|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
150057465|NCT01087788|541351426|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
150057466|NCT01087788|541351424|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
150057467|NCT01087788|541351425|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
150057468|NCT01087788|541351426|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
150057469|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
150057470|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
150057471|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
150057472|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
150057473|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
150057474|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
150057475|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
150057476|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
150057477|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
150057478|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
150057479|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
150057480|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
150057481|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
150057482|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
150057483|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
150057484|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
150057485|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
150010090|NCT02914561|541170377|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150180640|NCT02723955|541799368|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180641|NCT02723955|541799369|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180642|NCT02723955|541799370|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180643|NCT02723955|541799371|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180644|NCT02723955|541799372|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180645|NCT02723955|541799373|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180646|NCT02723955|541799374|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180647|NCT02723955|541799375|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180648|NCT02723955|541799376|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180649|NCT02723955|541799377|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180650|NCT02723955|541799378|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180651|NCT02723955|541799379|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180652|NCT02723955|541799380|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180653|NCT02723955|541799381|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180654|NCT02723955|541799382|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180655|NCT02723955|541799383|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180656|NCT02723955|541799384|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180657|NCT02723955|541799385|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180658|NCT02723955|541799386|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180659|NCT02723955|541799387|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180660|NCT02723955|541799388|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180661|NCT02723955|541799389|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180662|NCT02723955|541799390|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180663|NCT02723955|541799391|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180664|NCT02723955|541799392|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
150180665|NCT02723955|541799393|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
150180666|NCT02723955|541799394|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180667|NCT02723955|541799395|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
150180668|NCT02723955|541799396|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
150180669|NCT02723955|541799354|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
150180670|NCT02723955|541799355|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
150180671|NCT02723955|541799356|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
150180672|NCT02723955|541799357|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
150180673|NCT02723955|541799358|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
150180674|NCT02723955|541799359|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
150180675|NCT02723955|541799360|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
150180676|NCT02723955|541799361|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
150180677|NCT02723955|541799362|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
150180678|NCT02723955|541799363|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
150180679|NCT02723955|541799364|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
150180680|NCT02723955|541799365|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
150180681|NCT02723955|541799366|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
150180682|NCT02723955|541799367|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
150180683|NCT02723955|541799368|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
150180684|NCT02723955|541799369|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
150180685|NCT02723955|541799370|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
150180686|NCT02723955|541799371|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
150180687|NCT02723955|541799372|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
150180688|NCT02723955|541799373|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
150180689|NCT02723955|541799374|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
150180690|NCT02723955|541799375|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
150180691|NCT02723955|541799376|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
150180692|NCT02723955|541799377|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
150180693|NCT02723955|541799378|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
150180694|NCT02723955|541799379|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
150180695|NCT02723955|541799380|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
150180696|NCT02723955|541799381|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
150180697|NCT02723955|541799382|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
150180698|NCT02723955|541799383|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
150180699|NCT02723955|541799384|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
150180700|NCT02723955|541799385|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
150180701|NCT02723955|541799386|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
150180702|NCT02723955|541799387|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
150180703|NCT02723955|541799388|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
150180704|NCT02723955|541799389|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
150180705|NCT02723955|541799390|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
150180706|NCT02723955|541799391|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
150180707|NCT02723955|541799392|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
150180708|NCT02723955|541799393|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
150180709|NCT02723955|541799394|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
150180710|NCT02723955|541799395|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
150180711|NCT02723955|541799396|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
150180712|NCT04999085|541799399|FG000|Overall Study|Death|1|||
150010091|NCT02914561|541170378|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010092|NCT02914561|541170379|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
150010093|NCT02914561|541170380|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
150010094|NCT02914561|541170381|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
150010095|NCT02914561|541170382|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
150010096|NCT01300455|541170383|FG000|Washout|Withdrawal by Subject|1|||
150010097|NCT01300455|541170384|FG001|Washout|Withdrawal by Subject|0|||
150010098|NCT00565136|541170385|FG000|Overall Study|Lost to Follow-up|1|||
150010099|NCT00565136|541170385|FG000|Overall Study|Withdrawal by Subject|1|||
150010100|NCT00565136|541170385|FG000|Overall Study|Protocol Violation|1|||
150010101|NCT02438813|541170388|FG000|Overall Study|Patient Decision|59|||
150010102|NCT02438813|541170388|FG000|Overall Study|Patient Lost to Follow-Up|137|||
150010103|NCT02438813|541170388|FG000|Overall Study|Study Ended by Sponsor|80|||
150010104|NCT02438813|541170388|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
150010105|NCT00694304|541170389|FG000|Overall Study|Adverse Event|42|||
150010106|NCT00694304|541170389|FG000|Overall Study|Lack of Efficacy|35|||
150010107|NCT00694304|541170389|FG000|Overall Study|Non-compliance With Study Product|16|||
150010108|NCT00694304|541170389|FG000|Overall Study|Protocol Violation|6|||
150010109|NCT00694304|541170389|FG000|Overall Study|Withdrawal of Consent|61|||
150010110|NCT00694304|541170389|FG000|Overall Study|Lost to Follow-up|15|||
150010111|NCT00694304|541170389|FG000|Overall Study|Administrative or Other Reasons|32|||
150010112|NCT03135210|541170390|FG000|Overall Study|Death|0|||
150010113|NCT03135210|541170391|FG001|Overall Study|Death|1|||
150010114|NCT01805037|541170401|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
150010115|NCT01805037|541170402|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
150010116|NCT01805037|541170401|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
150010117|NCT01805037|541170402|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
150010118|NCT01805037|541170401|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
150010119|NCT01805037|541170402|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
150010120|NCT01805037|541170401|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
150010121|NCT01805037|541170402|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
150010122|NCT01805037|541170401|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
150010123|NCT01805037|541170402|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
150010124|NCT01805037|541170401|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
150010125|NCT01805037|541170402|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
150010126|NCT01805037|541170401|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
150010127|NCT01805037|541170402|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
150010128|NCT01805037|541170401|FG000|Follow Up (up to 3 Years)|Death|0|||
150010129|NCT01805037|541170402|FG001|Follow Up (up to 3 Years)|Death|2|||
150010130|NCT01805037|541170401|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
150010131|NCT01805037|541170402|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
150010132|NCT01805037|541170401|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
150010133|NCT01805037|541170402|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
150010134|NCT01270256|541170403|FG000|Overall Study|Withdrawal by Subject|1|||
150010135|NCT01270256|541170404|FG001|Overall Study|Withdrawal by Subject|0|||
150010136|NCT02879578|541170405|FG000|Overall Study|Adverse Event|1|||
150010137|NCT02879578|541170406|FG001|Overall Study|Adverse Event|2|||
150010138|NCT02879578|541170407|FG002|Overall Study|Adverse Event|14|||
150010139|NCT02879578|541170405|FG000|Overall Study|Protocol Violation|0|||
150010140|NCT02879578|541170406|FG001|Overall Study|Protocol Violation|1|||
150010141|NCT02879578|541170407|FG002|Overall Study|Protocol Violation|1|||
150010142|NCT02879578|541170405|FG000|Overall Study|Withdrawal by Subject|8|||
150010143|NCT02879578|541170406|FG001|Overall Study|Withdrawal by Subject|6|||
150010144|NCT02879578|541170407|FG002|Overall Study|Withdrawal by Subject|9|||
150010145|NCT02879578|541170405|FG000|Overall Study|Lost to Follow-up|1|||
150010146|NCT02879578|541170406|FG001|Overall Study|Lost to Follow-up|0|||
150010147|NCT02879578|541170407|FG002|Overall Study|Lost to Follow-up|4|||
150010148|NCT02879578|541170405|FG000|Overall Study|Physician Decision|0|||
150010149|NCT02879578|541170406|FG001|Overall Study|Physician Decision|0|||
150010150|NCT02879578|541170407|FG002|Overall Study|Physician Decision|4|||
150010151|NCT03517566|541170410|FG000|Overall Study|Adverse Event|5|||
150010152|NCT03517566|541170411|FG001|Overall Study|Adverse Event|2|||
150010153|NCT03517566|541170412|FG002|Overall Study|Adverse Event|2|||
150010154|NCT03517566|541170413|FG003|Overall Study|Adverse Event|8|||
150010155|NCT03517566|541170414|FG004|Overall Study|Adverse Event|7|||
150010156|NCT03517566|541170410|FG000|Overall Study|Lack of Efficacy|3|||
150010157|NCT03517566|541170411|FG001|Overall Study|Lack of Efficacy|2|||
150010158|NCT03517566|541170412|FG002|Overall Study|Lack of Efficacy|1|||
150057486|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
150057487|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
150180713|NCT03990649|541799412|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
150010159|NCT03517566|541170413|FG003|Overall Study|Lack of Efficacy|1|||
150010160|NCT03517566|541170414|FG004|Overall Study|Lack of Efficacy|4|||
150010161|NCT03517566|541170410|FG000|Overall Study|Lost to Follow-up|3|||
150180714|NCT03990649|541799413|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
150180715|NCT03990649|541799414|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
150180716|NCT03990649|541799412|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
150180717|NCT03990649|541799413|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
150180718|NCT03990649|541799414|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
150180719|NCT03990649|541799412|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
150180720|NCT03990649|541799413|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
150180721|NCT03990649|541799414|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
150180722|NCT03990649|541799412|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
150180723|NCT03990649|541799413|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
150180724|NCT03990649|541799414|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
150180725|NCT03990649|541799412|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
150180726|NCT03990649|541799413|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
150180727|NCT03990649|541799414|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
150180728|NCT03990649|541799412|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
150180729|NCT03990649|541799413|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
150180730|NCT03990649|541799414|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
150180731|NCT03990649|541799412|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
150180732|NCT03990649|541799413|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
150180733|NCT03990649|541799414|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
150180734|NCT05773313|541799415|FG000|Overall Study|Lost to Follow-up|3|||
150180735|NCT03050814|541799416|FG000|Overall Study|Screen failures|0|||
150180736|NCT03050814|541799417|FG001|Overall Study|Screen failures|0|||
150180737|NCT03050814|541799418|FG002|Overall Study|Screen failures|4|||
150180738|NCT01443845|541799419|FG000|Overall Study|Protocol Violation|43|||
150180739|NCT01443845|541799420|FG001|Overall Study|Protocol Violation|45|||
150180740|NCT01443845|541799419|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
150057488|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
150057489|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
150057490|NCT01087788|541351424|FG000|24-weeks Dose-blind Period|Patient moved|0|||
150057491|NCT01087788|541351425|FG001|24-weeks Dose-blind Period|Patient moved|0|||
150057492|NCT01087788|541351426|FG002|24-weeks Dose-blind Period|Patient moved|1|||
150057493|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
150057494|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
150057495|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
150057496|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
150057497|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
150057498|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
150057499|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
150180741|NCT01443845|541799420|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
150180742|NCT01443845|541799419|FG000|Overall Study|Deterioration in pulmonary function|1|||
150180743|NCT01443845|541799420|FG001|Overall Study|Deterioration in pulmonary function|4|||
150180744|NCT01443845|541799419|FG000|Overall Study|Lack of Efficacy|10|||
150180745|NCT01443845|541799420|FG001|Overall Study|Lack of Efficacy|5|||
150180746|NCT01443845|541799419|FG000|Overall Study|Adverse Event|64|||
150180747|NCT01443845|541799420|FG001|Overall Study|Adverse Event|138|||
150180748|NCT01443845|541799419|FG000|Overall Study|Withdrawal by Subject|63|||
150180749|NCT01443845|541799420|FG001|Overall Study|Withdrawal by Subject|67|||
150180750|NCT01443845|541799419|FG000|Overall Study|Military Conflict - Site Terminated|20|||
150180751|NCT01443845|541799420|FG001|Overall Study|Military Conflict - Site Terminated|21|||
150180752|NCT01443845|541799419|FG000|Overall Study|Lost to Follow-up|9|||
150180753|NCT01443845|541799420|FG001|Overall Study|Lost to Follow-up|13|||
150180754|NCT01471691|541799421|FG000|Overall Study|Lack of Efficacy|0|||
150180755|NCT01471691|541799422|FG001|Overall Study|Lack of Efficacy|1|||
150180756|NCT01854385|541799423|FG000|Pre-Treatment|Withdrawal by Subject|4|||
150180757|NCT01854385|541799423|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
150180758|NCT01854385|541799423|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
150180759|NCT01854385|541799423|FG000|Pre-Treatment|Unable to come for study visits|1|||
150180760|NCT01854385|541799423|FG000|Treatment|Lost to Follow-up|1|||
150180761|NCT02386553|541799424|FG000|Overall Study|Reason Not Specified|1|||
150180762|NCT02386553|541799425|FG001|Overall Study|Reason Not Specified|1|||
150180763|NCT02386553|541799424|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
150180764|NCT02386553|541799425|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
150180765|NCT01610297|541799426|FG000|Overall Study|Lost to Follow-up|1|||
150180766|NCT01561989|541799430|FG000|Overall Study|accural target not met.|5|||
150180767|NCT01561989|541799431|FG001|Overall Study|accural target not met.|6|||
150180768|NCT03930420|541799435|FG000|Overall Study|Withdrawal by Subject|7|||
150180769|NCT03930420|541799436|FG001|Overall Study|Withdrawal by Subject|9|||
150180770|NCT02372253|541799460|FG000|Overall Study|Non Compliance|2|||
150180771|NCT02372253|541799461|FG001|Overall Study|Non Compliance|0|||
150180772|NCT01803555|541799462|FG000|Overall Study|Adverse Event|3|||
150180773|NCT01803555|541799463|FG001|Overall Study|Adverse Event|2|||
150180774|NCT01803555|541799462|FG000|Overall Study|Withdrawal by Subject|3|||
150180775|NCT01803555|541799463|FG001|Overall Study|Withdrawal by Subject|3|||
150180776|NCT01803555|541799462|FG000|Overall Study|Non-compliance|1|||
150180777|NCT01803555|541799463|FG001|Overall Study|Non-compliance|1|||
150180778|NCT01803555|541799462|FG000|Overall Study|Protocol Violation|3|||
150180779|NCT01803555|541799463|FG001|Overall Study|Protocol Violation|5|||
150180780|NCT01803555|541799462|FG000|Overall Study|Lost to Follow-up|0|||
150180781|NCT01803555|541799463|FG001|Overall Study|Lost to Follow-up|2|||
150180782|NCT01803555|541799462|FG000|Overall Study|Other than specified|3|||
150180783|NCT01803555|541799463|FG001|Overall Study|Other than specified|5|||
150180784|NCT01551355|541799470|FG000|Overall Study|Lost to Follow-up|51|||
150180785|NCT01551355|541799471|FG001|Overall Study|Lost to Follow-up|49|||
150180786|NCT01551355|541799472|FG002|Overall Study|Lost to Follow-up|34|||
150180787|NCT01551355|541799473|FG003|Overall Study|Lost to Follow-up|24|||
150180788|NCT01551355|541799474|FG004|Overall Study|Lost to Follow-up|9|||
150180789|NCT01551355|541799475|FG005|Overall Study|Lost to Follow-up|6|||
150180790|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
150180791|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
150180792|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
150180793|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
150180794|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
150180795|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
150180796|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
150180797|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
150180798|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
150180799|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
150180800|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
150180801|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
150180802|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
150180803|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
150180804|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
150180805|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
150180806|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
150180807|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
150180808|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
150180809|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
150180810|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
150180811|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
150180812|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
150180813|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
150180814|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
150180815|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
150180816|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
150180817|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
150180818|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
150180819|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
150180820|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
150180821|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
150180822|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
150180823|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
150180824|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
150180825|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
150180826|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
150180827|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
150180828|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
150180829|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
150180830|NCT02409667|541799476|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
150180831|NCT02409667|541799477|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
150180832|NCT02409667|541799478|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
150180833|NCT02409667|541799479|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
150180834|NCT02409667|541799480|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
150180835|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
150180836|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
150180837|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
150180838|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
150180839|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
150180840|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
150180841|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
150180842|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
150180843|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
150180844|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
150180845|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
150180846|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
150180847|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
150180848|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
150180849|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
150180850|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
150180851|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
150180852|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
150180853|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
150180854|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
150180855|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
150180856|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
150180857|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
150180858|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
150180859|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
150180860|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
150180861|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
150180862|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
150180863|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
150010162|NCT03517566|541170411|FG001|Overall Study|Lost to Follow-up|1|||
150180864|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
150180865|NCT02409667|541799476|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
150010163|NCT03517566|541170412|FG002|Overall Study|Lost to Follow-up|1|||
150010164|NCT03517566|541170413|FG003|Overall Study|Lost to Follow-up|1|||
150010165|NCT03517566|541170414|FG004|Overall Study|Lost to Follow-up|0|||
150010166|NCT03517566|541170410|FG000|Overall Study|Physician Decision|1|||
150010167|NCT03517566|541170411|FG001|Overall Study|Physician Decision|1|||
150010168|NCT03517566|541170412|FG002|Overall Study|Physician Decision|0|||
150010169|NCT03517566|541170413|FG003|Overall Study|Physician Decision|1|||
150010170|NCT03517566|541170414|FG004|Overall Study|Physician Decision|0|||
150010171|NCT03517566|541170410|FG000|Overall Study|Pregnancy|0|||
150010172|NCT03517566|541170411|FG001|Overall Study|Pregnancy|1|||
150010173|NCT03517566|541170412|FG002|Overall Study|Pregnancy|0|||
150010174|NCT03517566|541170413|FG003|Overall Study|Pregnancy|0|||
150010175|NCT03517566|541170414|FG004|Overall Study|Pregnancy|0|||
150010176|NCT03517566|541170410|FG000|Overall Study|Protocol Deviation|0|||
150010177|NCT03517566|541170411|FG001|Overall Study|Protocol Deviation|1|||
150010178|NCT03517566|541170412|FG002|Overall Study|Protocol Deviation|0|||
150010179|NCT03517566|541170413|FG003|Overall Study|Protocol Deviation|1|||
150010180|NCT03517566|541170414|FG004|Overall Study|Protocol Deviation|1|||
150010181|NCT03517566|541170410|FG000|Overall Study|Study terminated by Sponsor|11|||
150010182|NCT03517566|541170411|FG001|Overall Study|Study terminated by Sponsor|5|||
150010183|NCT03517566|541170412|FG002|Overall Study|Study terminated by Sponsor|6|||
150010184|NCT03517566|541170413|FG003|Overall Study|Study terminated by Sponsor|14|||
150010185|NCT03517566|541170414|FG004|Overall Study|Study terminated by Sponsor|12|||
150010186|NCT03517566|541170410|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
150010187|NCT03517566|541170411|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
150010188|NCT03517566|541170412|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
150010189|NCT03517566|541170413|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
150010190|NCT03517566|541170414|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
150010191|NCT04566692|541170415|FG000|Overall Study|Adverse Event|2|||
150010192|NCT04566692|541170416|FG001|Overall Study|Adverse Event|0|||
150010193|NCT04566692|541170415|FG000|Overall Study|Withdrawal by Subject|1|||
150010194|NCT04566692|541170416|FG001|Overall Study|Withdrawal by Subject|1|||
150010195|NCT01183468|541170417|FG000|Overall Study|Lost to Follow-up|2|||
150010196|NCT01183468|541170418|FG001|Overall Study|Lost to Follow-up|1|||
150010197|NCT01183468|541170419|FG002|Overall Study|Lost to Follow-up|0|||
150010198|NCT01183468|541170420|FG003|Overall Study|Lost to Follow-up|0|||
150010199|NCT01183468|541170417|FG000|Overall Study|Physician Decision|1|||
150010200|NCT01183468|541170418|FG001|Overall Study|Physician Decision|0|||
150010201|NCT01183468|541170419|FG002|Overall Study|Physician Decision|0|||
150010202|NCT01183468|541170420|FG003|Overall Study|Physician Decision|0|||
150010203|NCT01183468|541170417|FG000|Overall Study|Withdrawal by Subject|0|||
150010204|NCT01183468|541170418|FG001|Overall Study|Withdrawal by Subject|1|||
150010205|NCT01183468|541170419|FG002|Overall Study|Withdrawal by Subject|0|||
150010206|NCT01183468|541170420|FG003|Overall Study|Withdrawal by Subject|0|||
150010207|NCT00454649|541170422|FG000|Overall Study|Lack of Efficacy|2|||
150010208|NCT00454649|541170423|FG001|Overall Study|Lack of Efficacy|2|||
150010209|NCT00454649|541170424|FG002|Overall Study|Lack of Efficacy|10|||
150010210|NCT00454649|541170425|FG003|Overall Study|Lack of Efficacy|3|||
150010211|NCT00454649|541170426|FG004|Overall Study|Lack of Efficacy|0|||
150010212|NCT00454649|541170427|FG005|Overall Study|Lack of Efficacy|4|||
150010213|NCT00454649|541170428|FG006|Overall Study|Lack of Efficacy|5|||
150010214|NCT00454649|541170429|FG007|Overall Study|Lack of Efficacy|13|||
150010215|NCT00454649|541170430|FG008|Overall Study|Lack of Efficacy|10|||
150010216|NCT00454649|541170431|FG009|Overall Study|Lack of Efficacy|2|||
150010217|NCT00454649|541170422|FG000|Overall Study|Adverse Event|0|||
150010218|NCT00454649|541170423|FG001|Overall Study|Adverse Event|1|||
150010219|NCT00454649|541170424|FG002|Overall Study|Adverse Event|3|||
150010220|NCT00454649|541170425|FG003|Overall Study|Adverse Event|0|||
150010221|NCT00454649|541170426|FG004|Overall Study|Adverse Event|1|||
150010222|NCT00454649|541170427|FG005|Overall Study|Adverse Event|2|||
150010223|NCT00454649|541170428|FG006|Overall Study|Adverse Event|3|||
150010224|NCT00454649|541170429|FG007|Overall Study|Adverse Event|4|||
150010225|NCT00454649|541170430|FG008|Overall Study|Adverse Event|6|||
150010226|NCT00454649|541170431|FG009|Overall Study|Adverse Event|2|||
150010227|NCT00454649|541170422|FG000|Overall Study|Lost to Follow-up|0|||
150010228|NCT00454649|541170423|FG001|Overall Study|Lost to Follow-up|0|||
150010229|NCT00454649|541170424|FG002|Overall Study|Lost to Follow-up|1|||
150010230|NCT00454649|541170425|FG003|Overall Study|Lost to Follow-up|0|||
150010231|NCT00454649|541170426|FG004|Overall Study|Lost to Follow-up|0|||
150010232|NCT00454649|541170427|FG005|Overall Study|Lost to Follow-up|0|||
150010233|NCT00454649|541170428|FG006|Overall Study|Lost to Follow-up|1|||
150010234|NCT00454649|541170429|FG007|Overall Study|Lost to Follow-up|0|||
150010235|NCT00454649|541170430|FG008|Overall Study|Lost to Follow-up|0|||
150010236|NCT00454649|541170431|FG009|Overall Study|Lost to Follow-up|0|||
150010237|NCT00454649|541170422|FG000|Overall Study|Other|1|||
150010238|NCT00454649|541170423|FG001|Overall Study|Other|1|||
150010239|NCT00454649|541170424|FG002|Overall Study|Other|5|||
150010240|NCT00454649|541170425|FG003|Overall Study|Other|3|||
150010241|NCT00454649|541170426|FG004|Overall Study|Other|0|||
150010242|NCT00454649|541170427|FG005|Overall Study|Other|0|||
150057500|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
150057501|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
150057502|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
150057503|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
150057504|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
150057505|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
150057506|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
150057507|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
150057508|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
150057509|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
150057510|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
150057511|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
150057512|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
150010243|NCT00454649|541170428|FG006|Overall Study|Other|0|||
150010244|NCT00454649|541170429|FG007|Overall Study|Other|0|||
150010245|NCT00454649|541170430|FG008|Overall Study|Other|3|||
150010246|NCT00454649|541170431|FG009|Overall Study|Other|1|||
150010247|NCT00454649|541170422|FG000|Overall Study|Withdrawal by Subject|0|||
150010248|NCT00454649|541170423|FG001|Overall Study|Withdrawal by Subject|0|||
150010249|NCT00454649|541170424|FG002|Overall Study|Withdrawal by Subject|0|||
150010250|NCT00454649|541170425|FG003|Overall Study|Withdrawal by Subject|0|||
150010251|NCT00454649|541170426|FG004|Overall Study|Withdrawal by Subject|0|||
150010252|NCT00454649|541170427|FG005|Overall Study|Withdrawal by Subject|1|||
150010253|NCT00454649|541170428|FG006|Overall Study|Withdrawal by Subject|0|||
150010254|NCT00454649|541170429|FG007|Overall Study|Withdrawal by Subject|2|||
150010255|NCT00454649|541170430|FG008|Overall Study|Withdrawal by Subject|1|||
150010256|NCT00454649|541170431|FG009|Overall Study|Withdrawal by Subject|0|||
150057513|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
150057514|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
150057515|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
150057516|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
150057517|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
150057518|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
150057519|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
150057520|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
150057521|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
150057522|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
150057523|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
150057524|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
150057525|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
150057526|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
150057527|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
150057528|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
150057529|NCT01087788|541351424|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
150057530|NCT01087788|541351425|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
150057531|NCT01087788|541351426|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
150057532|NCT00927940|541351427|FG000|Overall Study|Death|1|||
150057533|NCT03007888|541351428|FG000|First Intervention (14 Days)|Adverse Event|1|||
150057534|NCT03007888|541351429|FG001|First Intervention (14 Days)|Adverse Event|0|||
150057535|NCT00827931|541351431|FG000|Overall Study|Death|3|||
150057536|NCT00827931|541351432|FG001|Overall Study|Death|5|||
150057537|NCT00827931|541351431|FG000|Overall Study|Adverse Event|1|||
150057538|NCT00827931|541351432|FG001|Overall Study|Adverse Event|0|||
150057539|NCT00827931|541351431|FG000|Overall Study|Lost to Follow-up|1|||
150057540|NCT00827931|541351432|FG001|Overall Study|Lost to Follow-up|0|||
150057541|NCT00827931|541351431|FG000|Overall Study|Withdrawal by Subject|0|||
150057542|NCT00827931|541351432|FG001|Overall Study|Withdrawal by Subject|1|||
150057543|NCT00827931|541351431|FG000|Overall Study|Other|1|||
150057544|NCT00827931|541351432|FG001|Overall Study|Other|0|||
150010257|NCT02102399|541170435|FG000|Overall Study|Withdrawal by Subject|6|||
150010258|NCT02102399|541170436|FG001|Overall Study|Withdrawal by Subject|4|||
150010259|NCT00086411|541170444|FG000|Overall Study|Lost to Follow-up|11|||
150010260|NCT00086411|541170445|FG001|Overall Study|Lost to Follow-up|11|||
150010261|NCT00086411|541170446|FG002|Overall Study|Lost to Follow-up|13|||
150010262|NCT00086411|541170447|FG003|Overall Study|Lost to Follow-up|12|||
150010263|NCT00410605|541170450|FG000|Overall Study|Adverse Event|12|||
150057545|NCT01870076|541351433|FG000|Overall Study|Withdrawal by Subject|1|||
150057546|NCT01870076|541351434|FG001|Overall Study|Withdrawal by Subject|0|||
150057547|NCT01870076|541351435|FG002|Overall Study|Withdrawal by Subject|1|||
150010264|NCT00410605|541170450|FG000|Overall Study|Physician Decision|3|||
150010265|NCT00410605|541170450|FG000|Overall Study|Withdrawal by Subject|5|||
150057548|NCT01870076|541351436|FG003|Overall Study|Withdrawal by Subject|0|||
150057549|NCT00492063|541351437|FG000|Overall Study|Death|0|||
150057550|NCT00492063|541351438|FG001|Overall Study|Death|0|||
150057551|NCT00492063|541351439|FG002|Overall Study|Death|1|||
150057552|NCT00492063|541351440|FG003|Overall Study|Death|2|||
150057553|NCT00492063|541351437|FG000|Overall Study|Withdrawal by Subject|4|||
150057554|NCT00492063|541351438|FG001|Overall Study|Withdrawal by Subject|3|||
150057555|NCT00492063|541351439|FG002|Overall Study|Withdrawal by Subject|5|||
150057556|NCT00492063|541351440|FG003|Overall Study|Withdrawal by Subject|4|||
150057557|NCT00492063|541351437|FG000|Overall Study|Lost to Follow-up|6|||
150057558|NCT00492063|541351438|FG001|Overall Study|Lost to Follow-up|11|||
150057559|NCT00492063|541351439|FG002|Overall Study|Lost to Follow-up|5|||
150057560|NCT00492063|541351440|FG003|Overall Study|Lost to Follow-up|3|||
150057561|NCT00492063|541351437|FG000|Overall Study|Protocol Violation|0|||
150057562|NCT00492063|541351438|FG001|Overall Study|Protocol Violation|0|||
150057563|NCT00492063|541351439|FG002|Overall Study|Protocol Violation|0|||
150057564|NCT00492063|541351440|FG003|Overall Study|Protocol Violation|1|||
150057565|NCT00890045|541351443|FG000|Overall Study|Death|0|||
150057566|NCT00890045|541351444|FG001|Overall Study|Death|1|||
150057567|NCT00890045|541351443|FG000|Overall Study|Did not receive HeRO Graft|0|||
150057568|NCT00890045|541351444|FG001|Overall Study|Did not receive HeRO Graft|2|||
150057569|NCT00890045|541351443|FG000|Overall Study|Lost to Follow-up|5|||
150057570|NCT00890045|541351444|FG001|Overall Study|Lost to Follow-up|7|||
150057571|NCT01947855|541351445|FG000|Overall Study|Withdrawal by Subject|1|||
150057572|NCT01947855|541351446|FG001|Overall Study|Withdrawal by Subject|0|||
150057573|NCT01947855|541351447|FG002|Overall Study|Withdrawal by Subject|0|||
150057574|NCT00621621|541351450|FG000|Overall Study|Subjects were exited at EP study|30|||
150057575|NCT00621621|541351451|FG001|Overall Study|Subjects were exited at EP study|0|||
150057576|NCT00608569|541351452|FG000|Overall Study|Death|4|||
150057577|NCT00608569|541351453|FG001|Overall Study|Death|3|||
150057578|NCT00608569|541351452|FG000|Overall Study|Lost to Follow-up|4|||
150057579|NCT00608569|541351453|FG001|Overall Study|Lost to Follow-up|5|||
150057580|NCT00608569|541351452|FG000|Overall Study|Withdrawal by Subject|1|||
150057581|NCT00608569|541351453|FG001|Overall Study|Withdrawal by Subject|0|||
150057582|NCT00608569|541351452|FG000|Overall Study|Adverse Event|1|||
150057583|NCT00608569|541351453|FG001|Overall Study|Adverse Event|0|||
150057584|NCT00608569|541351452|FG000|Overall Study|Unable to adhere with study requirements|0|||
150057585|NCT00608569|541351453|FG001|Overall Study|Unable to adhere with study requirements|1|||
150057586|NCT02312687|541351458|FG000|Overall Study|Other, Not Specified|1|||
150057587|NCT03985878|541351459|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
150057588|NCT03985878|541351459|FG000|Overall Study|Study Terminated by Sponsor|12|||
150057589|NCT03985878|541351459|FG000|Overall Study|Withdrawal by Subject|1|||
150057590|NCT01514370|541351464|FG000|Overall Study|Protocol Violation|2|||
150057591|NCT01514370|541351465|FG001|Overall Study|Protocol Violation|3|||
150057592|NCT01514370|541351464|FG000|Overall Study|Lost to Follow-up|0|||
150057593|NCT01514370|541351465|FG001|Overall Study|Lost to Follow-up|2|||
150057594|NCT01514370|541351464|FG000|Overall Study|Withdrawal by Subject|2|||
150057595|NCT01514370|541351465|FG001|Overall Study|Withdrawal by Subject|1|||
150057596|NCT01514370|541351464|FG000|Overall Study|Adverse Event|1|||
150057597|NCT01514370|541351465|FG001|Overall Study|Adverse Event|3|||
150057598|NCT01514370|541351464|FG000|Overall Study|Other|6|||
150057599|NCT01514370|541351465|FG001|Overall Study|Other|7|||
150057600|NCT00129311|541351472|FG000|Overall Study|Withdrawal by Subject|12|||
150057601|NCT00129311|541351473|FG001|Overall Study|Withdrawal by Subject|19|||
150057602|NCT00534599|541351474|FG000|Overall Study|Adverse Event|25|||
150057603|NCT00534599|541351475|FG001|Overall Study|Adverse Event|4|||
150057604|NCT00534599|541351474|FG000|Overall Study|Incorrect enrollment|2|||
150057605|NCT00534599|541351475|FG001|Overall Study|Incorrect enrollment|1|||
150057606|NCT00534599|541351474|FG000|Overall Study|Mis-randomization|2|||
150057607|NCT00534599|541351475|FG001|Overall Study|Mis-randomization|2|||
150057608|NCT00534599|541351474|FG000|Overall Study|Developed study-specific d/c criteria|5|||
150057609|NCT00534599|541351475|FG001|Overall Study|Developed study-specific d/c criteria|0|||
150057610|NCT00534599|541351474|FG000|Overall Study|Lack of Efficacy|0|||
150057611|NCT00534599|541351475|FG001|Overall Study|Lack of Efficacy|1|||
150057612|NCT00534599|541351474|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
150057613|NCT00534599|541351475|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
150057614|NCT00534599|541351474|FG000|Overall Study|Protocol Violation|1|||
150057615|NCT00534599|541351475|FG001|Overall Study|Protocol Violation|3|||
150057616|NCT00534599|541351474|FG000|Overall Study|Lost to Follow-up|11|||
150057617|NCT00534599|541351475|FG001|Overall Study|Lost to Follow-up|14|||
150057618|NCT00534599|541351474|FG000|Overall Study|Withdrawal by Subject|4|||
150057619|NCT00534599|541351475|FG001|Overall Study|Withdrawal by Subject|6|||
150057620|NCT00534599|541351474|FG000|Overall Study|Other|7|||
150057621|NCT00534599|541351475|FG001|Overall Study|Other|0|||
150057622|NCT03645434|541351480|FG000|Period 1|Adverse Event|0|||
150057623|NCT03645434|541351481|FG001|Period 1|Adverse Event|0|||
150057624|NCT03645434|541351482|FG002|Period 1|Adverse Event|0|||
150057625|NCT03645434|541351483|FG003|Period 1|Adverse Event|1|||
150057626|NCT03645434|541351484|FG004|Period 1|Adverse Event|0|||
150180866|NCT02409667|541799477|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
150180867|NCT02409667|541799478|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
150180868|NCT02409667|541799479|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
150180869|NCT02409667|541799480|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
150180870|NCT01094184|541799481|FG000|Overall Study|Death|35|||
150180871|NCT01094184|541799482|FG001|Overall Study|Death|11|||
150180872|NCT01925339|541799483|FG000|Overall Study|Adverse Event|2|||
150180873|NCT01925339|541799484|FG001|Overall Study|Adverse Event|0|||
150180874|NCT01205048|541799487|FG000|Overall Study|Withdrawal by Subject|14|||
150180875|NCT01205048|541799487|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
150180876|NCT01205048|541799487|FG000|Overall Study|Lost to Follow-up|4|||
150180877|NCT01205048|541799487|FG000|Overall Study|Other|2|||
150180878|NCT01255670|541799488|FG000|Overall Study|Adverse Event|10|||
150180879|NCT01255670|541799489|FG001|Overall Study|Adverse Event|10|||
150180880|NCT01255670|541799488|FG000|Overall Study|Lost to Follow-up|16|||
150180881|NCT01255670|541799489|FG001|Overall Study|Lost to Follow-up|10|||
150180882|NCT03664960|541799490|FG000|Overall Study|Adverse Event|0|||
150180883|NCT03664960|541799491|FG001|Overall Study|Adverse Event|3|||
150180884|NCT03664960|541799490|FG000|Overall Study|Lost to Follow-up|3|||
150180885|NCT03664960|541799491|FG001|Overall Study|Lost to Follow-up|2|||
150180886|NCT03664960|541799490|FG000|Overall Study|Physician Decision|1|||
150180887|NCT03664960|541799491|FG001|Overall Study|Physician Decision|0|||
150180888|NCT03664960|541799490|FG000|Overall Study|Withdrawal by Subject|3|||
150180889|NCT03664960|541799491|FG001|Overall Study|Withdrawal by Subject|14|||
150180890|NCT03664960|541799490|FG000|Overall Study|Sponsor Decision|1|||
150180891|NCT03664960|541799491|FG001|Overall Study|Sponsor Decision|1|||
150180892|NCT03664960|541799490|FG000|Overall Study|Other|1|||
150180893|NCT03664960|541799491|FG001|Overall Study|Other|2|||
150180894|NCT00823472|541799492|FG000|Overall Study|Physician Decision|24|||
150180895|NCT00823472|541799493|FG001|Overall Study|Physician Decision|28|||
150180896|NCT04019444|541799494|FG000|Overall Study|Withdrawal by Subject|0|||
150180897|NCT04019444|541799495|FG001|Overall Study|Withdrawal by Subject|1|||
150180898|NCT04019444|541799496|FG002|Overall Study|Withdrawal by Subject|0|||
150180899|NCT04019444|541799497|FG003|Overall Study|Withdrawal by Subject|1|||
150010266|NCT00410605|541170450|FG000|Overall Study|Started Non-Protocol Therapy|3|||
150010267|NCT00410605|541170450|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
150010268|NCT00410605|541170450|FG000|Overall Study|Transferred to another Institution|1|||
150180900|NCT04019444|541799494|FG000|Overall Study|Solicited Event|0|||
150180901|NCT04019444|541799495|FG001|Overall Study|Solicited Event|0|||
150180902|NCT04019444|541799496|FG002|Overall Study|Solicited Event|2|||
150180903|NCT04019444|541799497|FG003|Overall Study|Solicited Event|0|||
150180904|NCT03997916|541799509|FG000|Overall Study|Protocol Violation|35|||
150180905|NCT03807778|541799514|FG000|Overall Study|Adverse Event|0|||
150180906|NCT03807778|541799515|FG001|Overall Study|Adverse Event|0|||
150180907|NCT03807778|541799516|FG002|Overall Study|Adverse Event|3|||
150180908|NCT03807778|541799517|FG003|Overall Study|Adverse Event|5|||
150180909|NCT03807778|541799514|FG000|Overall Study|Progressive Disease|4|||
150180910|NCT03807778|541799515|FG001|Overall Study|Progressive Disease|2|||
150180911|NCT03807778|541799516|FG002|Overall Study|Progressive Disease|8|||
150180912|NCT03807778|541799517|FG003|Overall Study|Progressive Disease|15|||
150180913|NCT03807778|541799514|FG000|Overall Study|Symptomatic Deterioration|0|||
150180914|NCT03807778|541799515|FG001|Overall Study|Symptomatic Deterioration|1|||
150180915|NCT03807778|541799516|FG002|Overall Study|Symptomatic Deterioration|0|||
150180916|NCT03807778|541799517|FG003|Overall Study|Symptomatic Deterioration|1|||
150180917|NCT03807778|541799514|FG000|Overall Study|Withdrawal by Subject|0|||
150180918|NCT03807778|541799515|FG001|Overall Study|Withdrawal by Subject|1|||
150180919|NCT03807778|541799516|FG002|Overall Study|Withdrawal by Subject|0|||
150180920|NCT03807778|541799517|FG003|Overall Study|Withdrawal by Subject|1|||
150010269|NCT01887353|541170457|FG000|Overall Study|Study stopped early|4|||
150010270|NCT01887353|541170458|FG001|Overall Study|Study stopped early|3|||
150180921|NCT03807778|541799514|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
150180922|NCT03807778|541799515|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
150180923|NCT03807778|541799516|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
150180924|NCT03807778|541799517|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
150180925|NCT01207492|541799518|FG000|Overall Study|Still on study|1|||
150010271|NCT01078168|541170465|FG000|Overall Study|Physician Decision|0|||
150010272|NCT01078168|541170466|FG001|Overall Study|Physician Decision|1|||
150180926|NCT01207492|541799518|FG000|Overall Study|Withdrawal by Subject|9|||
150180927|NCT01207492|541799518|FG000|Overall Study|Physician Decision|1|||
150180928|NCT01207492|541799518|FG000|Overall Study|Progressive disease|3|||
150180929|NCT01207492|541799518|FG000|Overall Study|Toxicity|1|||
150180930|NCT02769858|541799519|FG000|Overall Study|Withdrawal by Subject|2|||
150010273|NCT00649428|541172188|FG000|Overall Study|Adverse Event|2|||
150010274|NCT00649428|541172189|FG001|Overall Study|Adverse Event|2|||
150010275|NCT00649428|541172188|FG000|Overall Study|Withdrawal by Subject|6|||
150010276|NCT00649428|541172189|FG001|Overall Study|Withdrawal by Subject|6|||
150010277|NCT00649428|541172188|FG000|Overall Study|Lost to Follow-up|1|||
150010278|NCT00649428|541172189|FG001|Overall Study|Lost to Follow-up|3|||
150010279|NCT00649428|541172188|FG000|Overall Study|Insufficient manufacturing yield|5|||
150010280|NCT00649428|541172189|FG001|Overall Study|Insufficient manufacturing yield|1|||
150010281|NCT00649428|541172188|FG000|Overall Study|Protocol Violation|6|||
150010282|NCT00649428|541172189|FG001|Overall Study|Protocol Violation|2|||
150010283|NCT00649428|541172188|FG000|Overall Study|Physician Decision|0|||
150010284|NCT00649428|541172189|FG001|Overall Study|Physician Decision|1|||
150010285|NCT02315560|541172190|FG000|Overall Study|noncompliance by subjects|3|||
150010286|NCT02008227|541172191|FG000|Overall Study|Lost to Follow-up|7|||
150010287|NCT02008227|541172192|FG001|Overall Study|Lost to Follow-up|9|||
150010288|NCT02008227|541172191|FG000|Overall Study|Death|494|||
150010289|NCT02008227|541172192|FG001|Overall Study|Death|485|||
150010290|NCT02008227|541172191|FG000|Overall Study|Withdrawal by Subject|67|||
150010291|NCT02008227|541172192|FG001|Overall Study|Withdrawal by Subject|36|||
150010292|NCT02008227|541172191|FG000|Overall Study|Study Terminated By Sponsor|44|||
150010293|NCT02008227|541172192|FG001|Overall Study|Study Terminated By Sponsor|83|||
150010294|NCT02702180|541172193|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
150010295|NCT02702180|541172194|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
150010296|NCT02702180|541172195|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
150010297|NCT02702180|541172193|FG000|Double-blind Treatment Period|Adverse Event|0|||
150010298|NCT02702180|541172194|FG001|Double-blind Treatment Period|Adverse Event|0|||
150010299|NCT02702180|541172195|FG002|Double-blind Treatment Period|Adverse Event|1|||
150010300|NCT02702180|541172193|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
150010301|NCT02702180|541172194|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
150010302|NCT02702180|541172195|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
150010303|NCT02702180|541172193|FG000|Double-blind Treatment Period|Protocol Violation|0|||
150010304|NCT02702180|541172194|FG001|Double-blind Treatment Period|Protocol Violation|0|||
150010305|NCT02702180|541172195|FG002|Double-blind Treatment Period|Protocol Violation|2|||
150010306|NCT02702180|541172193|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
150010307|NCT02702180|541172194|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
150010308|NCT02702180|541172195|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
150010309|NCT02702180|541172193|FG000|Open-label Treatment Period|Withdrawn in error|0|||
150010310|NCT02702180|541172194|FG001|Open-label Treatment Period|Withdrawn in error|0|||
150010311|NCT02702180|541172195|FG002|Open-label Treatment Period|Withdrawn in error|1|||
150010312|NCT02241343|541172197|FG000|Overall Study|Adverse Event|1|||
150010313|NCT04680975|541172198|FG000|Overall Study|Adverse Event|3|||
150010314|NCT04680975|541172198|FG000|Overall Study|Death|1|||
150010315|NCT04680975|541172198|FG000|Overall Study|Progressive Disease|1|||
150010316|NCT04680975|541172198|FG000|Overall Study|Withdrawal by Subject|1|||
150010317|NCT00753454|541172199|FG000|Overall Study|Adverse Event|4|||
150010318|NCT00753454|541172199|FG000|Overall Study|Lack of Efficacy|1|||
150010319|NCT00753454|541172199|FG000|Overall Study|Lost to Follow-up|3|||
150010320|NCT00753454|541172199|FG000|Overall Study|Withdrawal by Subject|5|||
150010321|NCT00753454|541172199|FG000|Overall Study|Investigator Decision|1|||
150010322|NCT02702414|541172200|FG000|Overall Study|Death|96|||
150010323|NCT02702414|541172201|FG001|Overall Study|Death|42|||
150010324|NCT02702414|541172200|FG000|Overall Study|Lost to Follow-up|0|||
150057627|NCT03645434|541351485|FG005|Period 1|Adverse Event|0|||
150057628|NCT03645434|541351480|FG000|Period 1|COPD exacerbation|0|||
150057629|NCT03645434|541351481|FG001|Period 1|COPD exacerbation|0|||
150010325|NCT02702414|541172201|FG001|Overall Study|Lost to Follow-up|1|||
150010326|NCT02702414|541172200|FG000|Overall Study|Withdrawal by Subject|0|||
150010327|NCT02702414|541172201|FG001|Overall Study|Withdrawal by Subject|1|||
150010328|NCT02702414|541172200|FG000|Overall Study|Protocol Violation|1|||
150010329|NCT02702414|541172201|FG001|Overall Study|Protocol Violation|0|||
150010330|NCT02702414|541172200|FG000|Overall Study|Sponsor Decision|8|||
150010331|NCT02702414|541172201|FG001|Overall Study|Sponsor Decision|7|||
150010332|NCT00615030|541172202|FG000|Period I|Administrative problem|0|||
150010333|NCT00615030|541172203|FG001|Period I|Administrative problem|0|||
150010334|NCT00615030|541172204|FG002|Period I|Administrative problem|0|||
150010335|NCT00615030|541172205|FG003|Period I|Administrative problem|0|||
150010336|NCT00615030|541172206|FG004|Period I|Administrative problem|1|||
150010337|NCT00615030|541172207|FG005|Period I|Administrative problem|0|||
150010338|NCT00615030|541172208|FG006|Period I|Administrative problem|0|||
150010339|NCT00615030|541172209|FG007|Period I|Administrative problem|0|||
150010340|NCT00615030|541172210|FG008|Period I|Administrative problem|0|||
150010341|NCT00615030|541172211|FG009|Period I|Administrative problem|0|||
150180931|NCT04939246|541799521|FG000|After Treatment|Death|4|||
150180932|NCT04939246|541799521|FG000|After Treatment|Lost to Follow-up|1|||
150180933|NCT04939246|541799521|FG000|After Treatment|Discharged to hospice|2|||
150180934|NCT01216176|541800947|FG000|Overall Study|Adverse Event|0|||
150180935|NCT01216176|541800948|FG001|Overall Study|Adverse Event|8|||
150180936|NCT01216176|541800949|FG002|Overall Study|Adverse Event|0|||
150180937|NCT01216176|541800947|FG000|Overall Study|Physician Decision|0|||
150010342|NCT00615030|541172212|FG010|Period I|Administrative problem|0|||
150010343|NCT00615030|541172213|FG011|Period I|Administrative problem|0|||
150180938|NCT01216176|541800948|FG001|Overall Study|Physician Decision|0|||
150180939|NCT01216176|541800949|FG002|Overall Study|Physician Decision|1|||
150180940|NCT05056246|541800952|FG000|Overall Study|Adverse Event|0|||
150180941|NCT05056246|541800953|FG001|Overall Study|Adverse Event|0|||
150180942|NCT05056246|541800954|FG002|Overall Study|Adverse Event|0|||
150180943|NCT05056246|541800955|FG003|Overall Study|Adverse Event|0|||
150180944|NCT05056246|541800956|FG004|Overall Study|Adverse Event|1|||
150180945|NCT05056246|541800952|FG000|Overall Study|Lost to Follow-up|0|||
150180946|NCT05056246|541800953|FG001|Overall Study|Lost to Follow-up|0|||
150180947|NCT05056246|541800954|FG002|Overall Study|Lost to Follow-up|0|||
150180948|NCT05056246|541800955|FG003|Overall Study|Lost to Follow-up|2|||
150180949|NCT05056246|541800956|FG004|Overall Study|Lost to Follow-up|0|||
150180950|NCT05056246|541800952|FG000|Overall Study|Withdrawal by Subject|0|||
150180951|NCT05056246|541800953|FG001|Overall Study|Withdrawal by Subject|1|||
150180952|NCT05056246|541800954|FG002|Overall Study|Withdrawal by Subject|0|||
150180953|NCT05056246|541800955|FG003|Overall Study|Withdrawal by Subject|0|||
150180954|NCT05056246|541800956|FG004|Overall Study|Withdrawal by Subject|0|||
150180955|NCT05096819|541800961|FG000|Overall Study|Withdrawal by Subject|3|||
150180956|NCT05096819|541800962|FG001|Overall Study|Withdrawal by Subject|0|||
150180957|NCT03324984|541800963|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
150180958|NCT03324984|541800964|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
150180959|NCT02152137|541800966|FG000|Overall Study|Withdrawal by Subject|1|||
150180960|NCT02152137|541800966|FG000|Overall Study|Originally assigned to Arm B|3|||
150180961|NCT04878354|541800967|FG000|Overall Study|Adverse Event|4|||
150180962|NCT04878354|541800968|FG001|Overall Study|Adverse Event|13|||
150180963|NCT04878354|541800967|FG000|Overall Study|Withdrawal by Subject|14|||
150180964|NCT04878354|541800968|FG001|Overall Study|Withdrawal by Subject|12|||
150180965|NCT04878354|541800967|FG000|Overall Study|Lost to Follow-up|4|||
150180966|NCT04878354|541800968|FG001|Overall Study|Lost to Follow-up|1|||
150180967|NCT04878354|541800967|FG000|Overall Study|Lack of Efficacy|1|||
150180968|NCT04878354|541800968|FG001|Overall Study|Lack of Efficacy|0|||
150180969|NCT04878354|541800967|FG000|Overall Study|Protocol Violation|0|||
150180970|NCT04878354|541800968|FG001|Overall Study|Protocol Violation|1|||
150180971|NCT04878354|541800967|FG000|Overall Study|"Reason stated as other in CRF"|2|||
150180972|NCT04878354|541800968|FG001|Overall Study|"Reason stated as other in CRF"|3|||
150180973|NCT03358875|541800969|FG000|Overall Study|Death|409|||
150180974|NCT03358875|541800970|FG001|Overall Study|Death|223|||
150180975|NCT03358875|541800969|FG000|Overall Study|Study Closed by Sponsor|66|||
150180976|NCT03358875|541800970|FG001|Overall Study|Study Closed by Sponsor|29|||
150180977|NCT03358875|541800969|FG000|Overall Study|Withdrawal by Subject|13|||
150180978|NCT03358875|541800970|FG001|Overall Study|Withdrawal by Subject|16|||
150180979|NCT03358875|541800969|FG000|Overall Study|Lost to Follow-up|13|||
150180980|NCT03358875|541800970|FG001|Overall Study|Lost to Follow-up|2|||
150180981|NCT03358875|541800969|FG000|Overall Study|Miscellaneous|33|||
150180982|NCT03358875|541800970|FG001|Overall Study|Miscellaneous|0|||
150180983|NCT03358875|541800969|FG000|Overall Study|Remained on Study|1|||
150180984|NCT03358875|541800970|FG001|Overall Study|Remained on Study|0|||
150010344|NCT00615030|541172202|FG000|Period I|Protocol deviation|1|||
150010345|NCT00615030|541172203|FG001|Period I|Protocol deviation|0|||
150010346|NCT00615030|541172204|FG002|Period I|Protocol deviation|0|||
150010347|NCT00615030|541172205|FG003|Period I|Protocol deviation|0|||
150010348|NCT00615030|541172206|FG004|Period I|Protocol deviation|0|||
150010349|NCT00615030|541172207|FG005|Period I|Protocol deviation|0|||
150180985|NCT06194214|541800983|FG000|Overall Study|Adverse Event|1|||
150010350|NCT00615030|541172208|FG006|Period I|Protocol deviation|0|||
150010351|NCT00615030|541172209|FG007|Period I|Protocol deviation|0|||
150010352|NCT00615030|541172210|FG008|Period I|Protocol deviation|0|||
150180986|NCT05687903|541800984|FG000|Overall Study|Protocol Deviation|1|||
150180987|NCT05687903|541800985|FG001|Overall Study|Protocol Deviation|1|||
150010353|NCT00615030|541172211|FG009|Period I|Protocol deviation|0|||
150180988|NCT05687903|541800986|FG002|Overall Study|Protocol Deviation|0|||
150180989|NCT05687903|541800987|FG003|Overall Study|Protocol Deviation|1|||
150180990|NCT05687903|541800988|FG004|Overall Study|Protocol Deviation|0|||
150180991|NCT04847999|541800989|FG000|Overall Study|Lost to Follow-up|0|||
150010354|NCT00615030|541172212|FG010|Period I|Protocol deviation|0|||
150010355|NCT00615030|541172213|FG011|Period I|Protocol deviation|0|||
150010356|NCT00615030|541172202|FG000|Period I|Subject withdrew consent|0|||
150010357|NCT00615030|541172203|FG001|Period I|Subject withdrew consent|0|||
150010358|NCT00615030|541172204|FG002|Period I|Subject withdrew consent|0|||
150010359|NCT00615030|541172205|FG003|Period I|Subject withdrew consent|0|||
150010360|NCT00615030|541172206|FG004|Period I|Subject withdrew consent|0|||
150010361|NCT00615030|541172207|FG005|Period I|Subject withdrew consent|0|||
150010362|NCT00615030|541172208|FG006|Period I|Subject withdrew consent|0|||
150010363|NCT00615030|541172209|FG007|Period I|Subject withdrew consent|0|||
150010364|NCT00615030|541172210|FG008|Period I|Subject withdrew consent|1|||
150010365|NCT00615030|541172211|FG009|Period I|Subject withdrew consent|0|||
150010366|NCT00615030|541172212|FG010|Period I|Subject withdrew consent|1|||
150010367|NCT00615030|541172213|FG011|Period I|Subject withdrew consent|1|||
150010368|NCT00615030|541172202|FG000|Period I|Abnormal laboratory value(s)|0|||
150010369|NCT00615030|541172203|FG001|Period I|Abnormal laboratory value(s)|0|||
150010370|NCT00615030|541172204|FG002|Period I|Abnormal laboratory value(s)|0|||
150010371|NCT00615030|541172205|FG003|Period I|Abnormal laboratory value(s)|0|||
150010372|NCT00615030|541172206|FG004|Period I|Abnormal laboratory value(s)|0|||
150010373|NCT00615030|541172207|FG005|Period I|Abnormal laboratory value(s)|1|||
150010374|NCT00615030|541172208|FG006|Period I|Abnormal laboratory value(s)|0|||
150010375|NCT00615030|541172209|FG007|Period I|Abnormal laboratory value(s)|0|||
150010376|NCT00615030|541172210|FG008|Period I|Abnormal laboratory value(s)|0|||
150010377|NCT00615030|541172211|FG009|Period I|Abnormal laboratory value(s)|0|||
150010378|NCT00615030|541172212|FG010|Period I|Abnormal laboratory value(s)|0|||
150010379|NCT00615030|541172213|FG011|Period I|Abnormal laboratory value(s)|0|||
150010380|NCT00615030|541172202|FG000|Period II|Adverse Event|0|||
150010381|NCT00615030|541172203|FG001|Period II|Adverse Event|0|||
150010382|NCT00615030|541172204|FG002|Period II|Adverse Event|1|||
150010383|NCT00615030|541172205|FG003|Period II|Adverse Event|0|||
150010384|NCT00615030|541172206|FG004|Period II|Adverse Event|0|||
150010385|NCT00615030|541172207|FG005|Period II|Adverse Event|0|||
150010386|NCT00615030|541172208|FG006|Period II|Adverse Event|0|||
150010387|NCT00615030|541172209|FG007|Period II|Adverse Event|0|||
150010388|NCT00615030|541172210|FG008|Period II|Adverse Event|1|||
150010389|NCT00615030|541172211|FG009|Period II|Adverse Event|0|||
150010390|NCT00615030|541172212|FG010|Period II|Adverse Event|0|||
150010391|NCT00615030|541172213|FG011|Period II|Adverse Event|0|||
150010392|NCT00615030|541172202|FG000|Period II|Subject withdrew consent|0|||
150010393|NCT00615030|541172203|FG001|Period II|Subject withdrew consent|0|||
150010394|NCT00615030|541172204|FG002|Period II|Subject withdrew consent|0|||
150010395|NCT00615030|541172205|FG003|Period II|Subject withdrew consent|1|||
150010396|NCT00615030|541172206|FG004|Period II|Subject withdrew consent|0|||
150010397|NCT00615030|541172207|FG005|Period II|Subject withdrew consent|0|||
150010398|NCT00615030|541172208|FG006|Period II|Subject withdrew consent|1|||
150010399|NCT00615030|541172209|FG007|Period II|Subject withdrew consent|0|||
150010400|NCT00615030|541172210|FG008|Period II|Subject withdrew consent|0|||
150010401|NCT00615030|541172211|FG009|Period II|Subject withdrew consent|0|||
150010402|NCT00615030|541172212|FG010|Period II|Subject withdrew consent|0|||
150010403|NCT00615030|541172213|FG011|Period II|Subject withdrew consent|0|||
150010404|NCT00615030|541172202|FG000|Period III|Administrative problems|1|||
150010405|NCT00615030|541172203|FG001|Period III|Administrative problems|0|||
150010406|NCT00615030|541172204|FG002|Period III|Administrative problems|0|||
150010407|NCT00615030|541172205|FG003|Period III|Administrative problems|1|||
150010408|NCT00615030|541172206|FG004|Period III|Administrative problems|0|||
150010409|NCT00615030|541172207|FG005|Period III|Administrative problems|0|||
150010410|NCT00615030|541172208|FG006|Period III|Administrative problems|0|||
150010411|NCT00615030|541172209|FG007|Period III|Administrative problems|0|||
150010412|NCT00615030|541172210|FG008|Period III|Administrative problems|0|||
150010413|NCT00615030|541172211|FG009|Period III|Administrative problems|0|||
150010414|NCT00615030|541172212|FG010|Period III|Administrative problems|0|||
150010415|NCT00615030|541172213|FG011|Period III|Administrative problems|0|||
150010416|NCT03446456|541172214|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
150010417|NCT03446456|541172215|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
150010418|NCT03446456|541172214|FG000|Overall Study|Lost to Follow-up|1|||
150010419|NCT03446456|541172215|FG001|Overall Study|Lost to Follow-up|3|||
150057630|NCT03645434|541351482|FG002|Period 1|COPD exacerbation|0|||
150057631|NCT03645434|541351483|FG003|Period 1|COPD exacerbation|0|||
150057632|NCT03645434|541351484|FG004|Period 1|COPD exacerbation|1|||
150010420|NCT03446456|541172214|FG000|Overall Study|Participant failed the toxicology test|1|||
150010421|NCT03446456|541172215|FG001|Overall Study|Participant failed the toxicology test|0|||
150010422|NCT03446456|541172214|FG000|Overall Study|Break down of the experimental equipment|1|||
150010423|NCT03446456|541172215|FG001|Overall Study|Break down of the experimental equipment|0|||
150010424|NCT00989963|541172218|FG000|Overall Study|Adverse Event|1|||
150010425|NCT00989963|541172219|FG001|Overall Study|Adverse Event|1|||
150010426|NCT00989963|541172220|FG002|Overall Study|Adverse Event|1|||
150010427|NCT04588389|541172221|FG000|Overall Study|Issues with anesthesia during surgery|2|||
150010428|NCT04588389|541172222|FG001|Overall Study|Issues with anesthesia during surgery|0|||
150010429|NCT04588389|541172223|FG002|Overall Study|Issues with anesthesia during surgery|0|||
150010430|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
150010431|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
150010432|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
150010433|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
150010434|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
150010435|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
150010436|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Death|1|||
150180992|NCT04847999|541800990|FG001|Overall Study|Lost to Follow-up|1|||
150180993|NCT02879448|541800991|FG000|Overall Study|Death|251|||
150180994|NCT02879448|541800992|FG001|Overall Study|Death|263|||
150180995|NCT02879448|541800991|FG000|Overall Study|Lost to Follow-up|23|||
150180996|NCT02879448|541800992|FG001|Overall Study|Lost to Follow-up|28|||
150180997|NCT02879448|541800991|FG000|Overall Study|Withdrawal by Subject|42|||
150180998|NCT02879448|541800992|FG001|Overall Study|Withdrawal by Subject|79|||
150180999|NCT02879448|541800991|FG000|Overall Study|Other Reasons|8|||
150181000|NCT02879448|541800992|FG001|Overall Study|Other Reasons|12|||
150181001|NCT04300231|541800993|FG000|Overall Study|Protocol Violation|4|||
150181002|NCT04300231|541800994|FG001|Overall Study|Protocol Violation|3|||
150181003|NCT04300231|541800995|FG002|Overall Study|Protocol Violation|0|||
150181004|NCT04300231|541800996|FG003|Overall Study|Protocol Violation|2|||
150181005|NCT00998881|541801000|FG000|Overall Study|Adverse Event|2|||
150181006|NCT00998881|541801001|FG001|Overall Study|Adverse Event|2|||
150181007|NCT00998881|541801000|FG000|Overall Study|Lack of Efficacy|1|||
150181008|NCT00998881|541801001|FG001|Overall Study|Lack of Efficacy|0|||
150181009|NCT00998881|541801000|FG000|Overall Study|Physician Decision|3|||
150181010|NCT00998881|541801001|FG001|Overall Study|Physician Decision|0|||
150181011|NCT00998881|541801000|FG000|Overall Study|Withdrawal by Subject|1|||
150181012|NCT00998881|541801001|FG001|Overall Study|Withdrawal by Subject|0|||
150181013|NCT00998881|541801000|FG000|Overall Study|Personal matter|1|||
150181014|NCT00998881|541801001|FG001|Overall Study|Personal matter|0|||
150181015|NCT01121991|541801002|FG000|Overall Study|Lack of Ovarian Response|2|||
150181016|NCT01121991|541801002|FG000|Overall Study|No Oocytes Retrieved|3|||
150181017|NCT01121991|541801002|FG000|Overall Study|No Fertilization|1|||
150181018|NCT02590432|541801006|FG000|Open-label Treatment Period|Adverse Event|97|||
150181019|NCT02590432|541801007|FG001|Open-label Treatment Period|Adverse Event|79|||
150181020|NCT02590432|541801008|FG002|Open-label Treatment Period|Adverse Event|0|||
150181021|NCT02590432|541801009|FG003|Open-label Treatment Period|Adverse Event|0|||
150181022|NCT02590432|541801010|FG004|Open-label Treatment Period|Adverse Event|0|||
150181023|NCT02590432|541801011|FG005|Open-label Treatment Period|Adverse Event|0|||
150181024|NCT02590432|541801012|FG006|Open-label Treatment Period|Adverse Event|0|||
150181025|NCT02590432|541801013|FG007|Open-label Treatment Period|Adverse Event|0|||
150181026|NCT02590432|541801014|FG008|Open-label Treatment Period|Adverse Event|0|||
150181027|NCT02590432|541801006|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
150181028|NCT02590432|541801007|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
150181029|NCT02590432|541801008|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
150181030|NCT02590432|541801009|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
150181031|NCT02590432|541801010|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
150181032|NCT02590432|541801011|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
150181033|NCT02590432|541801012|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
150181034|NCT02590432|541801013|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
150181035|NCT02590432|541801014|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
150181036|NCT02590432|541801006|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
150181037|NCT02590432|541801007|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
150181038|NCT02590432|541801008|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
150181039|NCT02590432|541801009|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
150181040|NCT02590432|541801010|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
150181041|NCT02590432|541801011|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
150181042|NCT02590432|541801012|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
150181043|NCT02590432|541801013|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
150181044|NCT02590432|541801014|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
150181045|NCT02590432|541801006|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
150181046|NCT02590432|541801007|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
150181047|NCT02590432|541801008|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
150181048|NCT02590432|541801009|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
150181049|NCT02590432|541801010|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
150181050|NCT02590432|541801011|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
150181051|NCT02590432|541801012|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
150181052|NCT02590432|541801013|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
150181053|NCT02590432|541801014|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
150181054|NCT02590432|541801006|FG000|Open-label Treatment Period|Protocol Violation|10|||
150010437|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Death|4|||
150181055|NCT02590432|541801007|FG001|Open-label Treatment Period|Protocol Violation|4|||
150181056|NCT02590432|541801008|FG002|Open-label Treatment Period|Protocol Violation|0|||
150181057|NCT02590432|541801009|FG003|Open-label Treatment Period|Protocol Violation|0|||
150057633|NCT03645434|541351485|FG005|Period 1|COPD exacerbation|0|||
150057634|NCT00167778|541351486|FG000|Overall Study|Withdrawal by Subject|1|||
150057635|NCT02654717|541351487|FG000|Overall Study|Adverse Event|2|||
150057636|NCT02654717|541351488|FG001|Overall Study|Adverse Event|2|||
150057637|NCT02654717|541351487|FG000|Overall Study|Protocol Violation|1|||
150057638|NCT02654717|541351488|FG001|Overall Study|Protocol Violation|2|||
150057639|NCT02654717|541351487|FG000|Overall Study|Withdrawal by Subject|0|||
150057640|NCT02654717|541351488|FG001|Overall Study|Withdrawal by Subject|1|||
150057641|NCT02654717|541351487|FG000|Overall Study|Non-permitted medication|3|||
150057642|NCT02654717|541351488|FG001|Overall Study|Non-permitted medication|0|||
150057643|NCT02081859|541351490|FG000|Overall Study|No fertilization|2|||
150057644|NCT02081859|541351491|FG001|Overall Study|No fertilization|2|||
150057645|NCT02081859|541351490|FG000|Overall Study|No sperm|1|||
150057646|NCT02081859|541351491|FG001|Overall Study|No sperm|0|||
150057647|NCT02081859|541351490|FG000|Overall Study|Unanticipated freeze all cycle|2|||
150057648|NCT02081859|541351491|FG001|Overall Study|Unanticipated freeze all cycle|6|||
150057649|NCT02081859|541351490|FG000|Overall Study|< 4 embryos|27|||
150057650|NCT02081859|541351491|FG001|Overall Study|< 4 embryos|23|||
150057651|NCT02081859|541351490|FG000|Overall Study|Other reasons|2|||
150057652|NCT02081859|541351491|FG001|Overall Study|Other reasons|0|||
150057653|NCT00003830|541353496|FG000|Overall Study|No follow up data|3|||
150057654|NCT00003830|541353497|FG001|Overall Study|No follow up data|0|||
150057655|NCT00003830|541353496|FG000|Overall Study|Sentinel node positive patients|829|||
150057656|NCT00003830|541353497|FG001|Overall Study|Sentinel node positive patients|793|||
150057657|NCT05347147|541353498|FG000|Overall Study|Lost to Follow-up|0|||
150057658|NCT05347147|541353499|FG001|Overall Study|Lost to Follow-up|1|||
150057659|NCT05347147|541353498|FG000|Overall Study|Sponsor request|3|||
150181058|NCT02590432|541801010|FG004|Open-label Treatment Period|Protocol Violation|0|||
150181059|NCT02590432|541801011|FG005|Open-label Treatment Period|Protocol Violation|0|||
150181060|NCT02590432|541801012|FG006|Open-label Treatment Period|Protocol Violation|0|||
150057660|NCT05347147|541353499|FG001|Overall Study|Sponsor request|3|||
150057661|NCT05347147|541353498|FG000|Overall Study|Study termination|2|||
150057662|NCT05347147|541353499|FG001|Overall Study|Study termination|1|||
150057663|NCT03739242|541353503|FG000|Overall Study|Withdrawal by Subject|1|||
150057664|NCT03739242|541353504|FG001|Overall Study|Withdrawal by Subject|1|||
150057665|NCT03739242|541353503|FG000|Overall Study|Protocol Violation|0|||
150057666|NCT03739242|541353504|FG001|Overall Study|Protocol Violation|1|||
150057667|NCT00039871|541353505|FG000|Overall Study|Adverse Event|165|||
150057668|NCT00039871|541353505|FG000|Overall Study|Lost to Follow-up|18|||
150057669|NCT00039871|541353505|FG000|Overall Study|Protocol Violation|24|||
150057670|NCT00039871|541353505|FG000|Overall Study|Withdrawal by Subject|97|||
150181061|NCT02590432|541801013|FG007|Open-label Treatment Period|Protocol Violation|0|||
150181062|NCT02590432|541801014|FG008|Open-label Treatment Period|Protocol Violation|0|||
150181063|NCT02590432|541801006|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
150181064|NCT02590432|541801007|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
150181065|NCT02590432|541801008|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181066|NCT02590432|541801009|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181067|NCT02590432|541801010|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181068|NCT02590432|541801011|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181069|NCT02590432|541801012|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181070|NCT02590432|541801013|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181071|NCT02590432|541801014|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
150181072|NCT02590432|541801006|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
150181073|NCT02590432|541801007|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
150181074|NCT02590432|541801008|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150057671|NCT00039871|541353505|FG000|Overall Study|Did not meet eligibility criteria|11|||
150057672|NCT00039871|541353505|FG000|Overall Study|Administrative|1|||
150057673|NCT00039871|541353505|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
150057674|NCT00039871|541353505|FG000|Overall Study|Never entered follow-up|7|||
150057675|NCT02446743|541353506|FG000|Overall Study|Withdrawal by Subject|1|||
150057676|NCT02446743|541353507|FG001|Overall Study|Withdrawal by Subject|1|||
150057677|NCT02446743|541353506|FG000|Overall Study|Lost to Follow-up|1|||
150057678|NCT02446743|541353507|FG001|Overall Study|Lost to Follow-up|0|||
150057679|NCT02446743|541353506|FG000|Overall Study|Adverse Event|1|||
150057680|NCT02446743|541353507|FG001|Overall Study|Adverse Event|1|||
150057681|NCT02446743|541353506|FG000|Overall Study|Other|2|||
150181075|NCT02590432|541801009|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150181076|NCT02590432|541801010|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150057682|NCT02446743|541353507|FG001|Overall Study|Other|3|||
150057683|NCT03361176|541353508|FG000|Overall Study|Lost to Follow-up|1|||
150057684|NCT03361176|541353509|FG001|Overall Study|Lost to Follow-up|2|||
150057685|NCT03361176|541353508|FG000|Overall Study|Adverse Event|0|||
150057686|NCT03361176|541353509|FG001|Overall Study|Adverse Event|2|||
150057687|NCT03361176|541353508|FG000|Overall Study|Withdrawal by Subject|0|||
150057688|NCT03361176|541353509|FG001|Overall Study|Withdrawal by Subject|1|||
150010438|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
150010439|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
150010440|NCT00658814|541172224|FG000|Remission Induction Chemotherapy|Not eligible|1|||
150010441|NCT00658814|541172225|FG001|Remission Induction Chemotherapy|Not eligible|2|||
150010442|NCT00658814|541172224|FG000|Consolidation Therapy|Not protocol specified|0|||
150010443|NCT00658814|541172225|FG001|Consolidation Therapy|Not protocol specified|1|||
150010444|NCT00658814|541172224|FG000|Consolidation Therapy|Not eligible|2|||
150010445|NCT00658814|541172225|FG001|Consolidation Therapy|Not eligible|2|||
150010446|NCT00658814|541172224|FG000|Maintenance Therapy|Adverse Event|1|||
150010447|NCT00658814|541172225|FG001|Maintenance Therapy|Adverse Event|1|||
150010448|NCT00658814|541172224|FG000|Maintenance Therapy|Not protocol specified|1|||
150010449|NCT00658814|541172225|FG001|Maintenance Therapy|Not protocol specified|0|||
150010450|NCT00658814|541172224|FG000|Maintenance Therapy|Not eligible|1|||
150010451|NCT00658814|541172225|FG001|Maintenance Therapy|Not eligible|0|||
150010452|NCT02911142|541172226|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
150010453|NCT02911142|541172226|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
150010454|NCT02911142|541172226|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
150010455|NCT02911142|541172226|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
150010456|NCT01178099|541172227|FG000|Overall Study|Physician Decision|0|||
150010457|NCT01178099|541172228|FG001|Overall Study|Physician Decision|1|||
150010458|NCT02473367|541172231|FG000|Wait 1|Withdrawal by Subject|1|||
150010459|NCT02473367|541172231|FG000|Period 4|Lost to Follow-up|1|||
150010460|NCT04816721|541172232|FG000|Overall Study|Withdrawal by Subject|0|||
150010461|NCT04816721|541172233|FG001|Overall Study|Withdrawal by Subject|2|||
150010462|NCT04816721|541172234|FG002|Overall Study|Withdrawal by Subject|0|||
150010463|NCT04816721|541172235|FG003|Overall Study|Withdrawal by Subject|1|||
150010464|NCT04816721|541172236|FG004|Overall Study|Withdrawal by Subject|1|||
150010465|NCT04816721|541172237|FG005|Overall Study|Withdrawal by Subject|0|||
150010466|NCT04816721|541172238|FG006|Overall Study|Withdrawal by Subject|0|||
150010467|NCT04816721|541172239|FG007|Overall Study|Withdrawal by Subject|0|||
150010468|NCT04816721|541172232|FG000|Overall Study|Miscellaneous|0|||
150010469|NCT04816721|541172233|FG001|Overall Study|Miscellaneous|0|||
150010470|NCT04816721|541172234|FG002|Overall Study|Miscellaneous|0|||
150010471|NCT04816721|541172235|FG003|Overall Study|Miscellaneous|0|||
150010472|NCT04816721|541172236|FG004|Overall Study|Miscellaneous|0|||
150010473|NCT04816721|541172237|FG005|Overall Study|Miscellaneous|1|||
150010474|NCT04816721|541172238|FG006|Overall Study|Miscellaneous|0|||
150010475|NCT04816721|541172239|FG007|Overall Study|Miscellaneous|0|||
150010476|NCT04816721|541172232|FG000|Overall Study|Lost to Follow-up|0|||
150010477|NCT04816721|541172233|FG001|Overall Study|Lost to Follow-up|0|||
150010478|NCT04816721|541172234|FG002|Overall Study|Lost to Follow-up|0|||
150010479|NCT04816721|541172235|FG003|Overall Study|Lost to Follow-up|1|||
150010480|NCT04816721|541172236|FG004|Overall Study|Lost to Follow-up|0|||
150010481|NCT04816721|541172237|FG005|Overall Study|Lost to Follow-up|0|||
150010482|NCT04816721|541172238|FG006|Overall Study|Lost to Follow-up|0|||
150010483|NCT04816721|541172239|FG007|Overall Study|Lost to Follow-up|0|||
150010484|NCT01286740|541172244|FG000|Overall Study|Enrolled but not treated|1|||
150010485|NCT01286740|541172244|FG000|Overall Study|Protocol Violation|1|||
150010486|NCT00847015|541172247|FG000|Overall Study|Withdrawal by Subject|1|||
150010487|NCT00847015|541172247|FG000|Overall Study|declined any surgery|1|||
150010488|NCT00847015|541172247|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
150010489|NCT01641822|541172248|FG000|Run-in Phase|Noncompliance with study drug|1|||
150010490|NCT01641822|541172249|FG001|Run-in Phase|Noncompliance with study drug|0|||
150010491|NCT01641822|541172250|FG002|Run-in Phase|Noncompliance with study drug|0|||
150010492|NCT01641822|541172248|FG000|Run-in Phase|Adverse Event|3|||
150010493|NCT01641822|541172249|FG001|Run-in Phase|Adverse Event|0|||
150010494|NCT01641822|541172250|FG002|Run-in Phase|Adverse Event|0|||
150010495|NCT01641822|541172248|FG000|Run-in Phase|Withdrew consent|1|||
150010496|NCT01641822|541172249|FG001|Run-in Phase|Withdrew consent|0|||
150010497|NCT01641822|541172250|FG002|Run-in Phase|Withdrew consent|0|||
150010498|NCT01641822|541172248|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
150010499|NCT01641822|541172249|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
150010500|NCT01641822|541172250|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
150010501|NCT01641822|541172248|FG000|Comparative Phase|Noncompliance with study drug|0|||
150010502|NCT01641822|541172249|FG001|Comparative Phase|Noncompliance with study drug|1|||
150010503|NCT01641822|541172250|FG002|Comparative Phase|Noncompliance with study drug|0|||
150010504|NCT01641822|541172248|FG000|Comparative Phase|Investigator's discretion|0|||
150010505|NCT01641822|541172249|FG001|Comparative Phase|Investigator's discretion|0|||
150010506|NCT01641822|541172250|FG002|Comparative Phase|Investigator's discretion|1|||
150010507|NCT01641822|541172248|FG000|Comparative Phase|Pregnancy|0|||
150010508|NCT01641822|541172249|FG001|Comparative Phase|Pregnancy|0|||
150010509|NCT01641822|541172250|FG002|Comparative Phase|Pregnancy|1|||
150010510|NCT01641822|541172248|FG000|Comparative Phase|Adverse event, serious fatal|0|||
150010511|NCT01641822|541172249|FG001|Comparative Phase|Adverse event, serious fatal|1|||
150010512|NCT01641822|541172250|FG002|Comparative Phase|Adverse event, serious fatal|0|||
150010513|NCT01641822|541172248|FG000|Comparative Phase|Withdrew consent|0|||
150010514|NCT01641822|541172249|FG001|Comparative Phase|Withdrew consent|3|||
150010515|NCT01641822|541172250|FG002|Comparative Phase|Withdrew consent|7|||
150010516|NCT01641822|541172248|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
150010517|NCT01641822|541172249|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
150010518|NCT01641822|541172250|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
150010519|NCT00082381|541172257|FG000|Overall Study|Adverse Event|27|||
150010520|NCT00082381|541172258|FG001|Overall Study|Adverse Event|2|||
150057689|NCT02478398|541353510|FG000|Overall Study|Adverse Event|20|||
150057690|NCT02478398|541353511|FG001|Overall Study|Adverse Event|5|||
150057691|NCT02478398|541353510|FG000|Overall Study|Lost to Follow-up|5|||
150057692|NCT02478398|541353511|FG001|Overall Study|Lost to Follow-up|4|||
150010521|NCT00082381|541172257|FG000|Overall Study|Lost to Follow-up|5|||
150010522|NCT00082381|541172258|FG001|Overall Study|Lost to Follow-up|7|||
150010523|NCT00082381|541172257|FG000|Overall Study|Patient Decision|8|||
150010524|NCT00082381|541172258|FG001|Overall Study|Patient Decision|4|||
150010525|NCT00082381|541172257|FG000|Overall Study|Physician Decision|1|||
150010526|NCT00082381|541172258|FG001|Overall Study|Physician Decision|2|||
150010527|NCT00082381|541172257|FG000|Overall Study|Protocol Violation|10|||
150010528|NCT00082381|541172258|FG001|Overall Study|Protocol Violation|11|||
150010529|NCT00082381|541172257|FG000|Overall Study|Loss of Glucose Control|4|||
150010530|NCT00082381|541172258|FG001|Overall Study|Loss of Glucose Control|0|||
150010531|NCT02345330|541172259|FG000|Overall Study|Death|1|||
150010532|NCT02345330|541172259|FG000|Overall Study|Progressive Disease|2|||
150010533|NCT00454181|541172261|FG000|Overall Study|Adverse Event|1|||
150010534|NCT00454181|541172262|FG001|Overall Study|Adverse Event|1|||
150010535|NCT00454181|541172261|FG000|Overall Study|Lost to Follow-up|11|||
150010536|NCT00454181|541172262|FG001|Overall Study|Lost to Follow-up|1|||
150010537|NCT00454181|541172261|FG000|Overall Study|Protocol Violation|1|||
150010538|NCT00454181|541172262|FG001|Overall Study|Protocol Violation|1|||
150010539|NCT00454181|541172261|FG000|Overall Study|Withdrawal by Subject|2|||
150010540|NCT00454181|541172262|FG001|Overall Study|Withdrawal by Subject|0|||
150010541|NCT03729245|541172263|FG000|Overall Study|Lost to Follow-up|5|||
150010542|NCT03729245|541172264|FG001|Overall Study|Lost to Follow-up|6|||
150010543|NCT03729245|541172263|FG000|Overall Study|Withdrawal by Subject|16|||
150010544|NCT03729245|541172264|FG001|Overall Study|Withdrawal by Subject|19|||
150010545|NCT03729245|541172263|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
150057693|NCT02478398|541353510|FG000|Overall Study|Non-Compliance With Study Drug|5|||
150057694|NCT02478398|541353511|FG001|Overall Study|Non-Compliance With Study Drug|1|||
150057695|NCT02478398|541353510|FG000|Overall Study|Protocol Violation|3|||
150057696|NCT02478398|541353511|FG001|Overall Study|Protocol Violation|1|||
150057697|NCT02478398|541353510|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
150057698|NCT02478398|541353511|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
150057699|NCT02478398|541353510|FG000|Overall Study|Withdrawal By Participant|10|||
150057700|NCT02478398|541353511|FG001|Overall Study|Withdrawal By Participant|4|||
150057701|NCT00923364|541353518|FG000|Overall Study|Death|3|||
150057702|NCT00923364|541353519|FG001|Overall Study|Death|0|||
150057703|NCT00923364|541353518|FG000|Overall Study|Did not go to transplant|1|||
150057704|NCT00923364|541353519|FG001|Overall Study|Did not go to transplant|0|||
150057705|NCT03023046|541353521|FG000|Overall Study|Withdrawal by Subject|1|||
150057706|NCT01205581|541353522|FG000|Overall Study|Withdrawal by Subject|1|||
150057707|NCT01205581|541353523|FG001|Overall Study|Withdrawal by Subject|0|||
150057708|NCT01205581|541353524|FG002|Overall Study|Withdrawal by Subject|0|||
150057709|NCT01205581|541353525|FG003|Overall Study|Withdrawal by Subject|0|||
150057710|NCT01205581|541353526|FG004|Overall Study|Withdrawal by Subject|0|||
150010546|NCT03729245|541172264|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
150010547|NCT03322423|541172265|FG000|Period 1|Subject no longer eligible|0|||
150010548|NCT03322423|541172266|FG001|Period 1|Subject no longer eligible|1|||
150010549|NCT03322423|541172265|FG000|Period 1|Withdrawal by Subject|0|||
150057711|NCT01205581|541353527|FG005|Overall Study|Withdrawal by Subject|0|||
150057712|NCT00640835|541353528|FG000|Overall Study|Adverse Event|5|||
150057713|NCT00640835|541353529|FG001|Overall Study|Adverse Event|3|||
150010550|NCT03322423|541172266|FG001|Period 1|Withdrawal by Subject|1|||
150010551|NCT03322423|541172265|FG000|Period 1|Incorrect Lens Dispensed|1|||
150010552|NCT03322423|541172266|FG001|Period 1|Incorrect Lens Dispensed|0|||
150010553|NCT03322423|541172265|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
150010554|NCT03322423|541172266|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
150010555|NCT03322423|541172265|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
150010556|NCT03322423|541172266|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
150010557|NCT03322423|541172265|FG000|Period 2|Protocol Violation|1|||
150010558|NCT03322423|541172266|FG001|Period 2|Protocol Violation|0|||
150010559|NCT03322423|541172265|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
150010560|NCT03322423|541172266|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
150057714|NCT00640835|541353528|FG000|Overall Study|Withdrawal by Subject|12|||
150057715|NCT00640835|541353529|FG001|Overall Study|Withdrawal by Subject|14|||
150057716|NCT00640835|541353528|FG000|Overall Study|Physician Decision|10|||
150057717|NCT00640835|541353529|FG001|Overall Study|Physician Decision|14|||
150057718|NCT00640835|541353528|FG000|Overall Study|Sponsor's Decision|11|||
150057719|NCT00640835|541353529|FG001|Overall Study|Sponsor's Decision|7|||
150057720|NCT00640835|541353528|FG000|Overall Study|Protocol Violation|2|||
150057721|NCT00640835|541353529|FG001|Overall Study|Protocol Violation|2|||
150057722|NCT00640835|541353528|FG000|Overall Study|Lost to Follow-up|17|||
150057723|NCT00640835|541353529|FG001|Overall Study|Lost to Follow-up|13|||
150057724|NCT00640835|541353528|FG000|Overall Study|Other Reason|19|||
150057725|NCT00640835|541353529|FG001|Overall Study|Other Reason|4|||
150057726|NCT00704522|541353530|FG000|Overall Study|Lack of Efficacy|65|||
150057727|NCT00704522|541353531|FG001|Overall Study|Lack of Efficacy|17|||
150057728|NCT00704522|541353530|FG000|Overall Study|Failure to appear again at hospital|56|||
150010561|NCT02096263|541172267|FG000|Overall Study|Adverse Event|1|||
150010562|NCT02096263|541172268|FG001|Overall Study|Adverse Event|0|||
150010563|NCT02096263|541172269|FG002|Overall Study|Adverse Event|1|||
150010564|NCT02096263|541172267|FG000|Overall Study|Lost to Follow-up|14|||
150010565|NCT02096263|541172268|FG001|Overall Study|Lost to Follow-up|18|||
150010566|NCT02096263|541172269|FG002|Overall Study|Lost to Follow-up|15|||
150010567|NCT02096263|541172267|FG000|Overall Study|Other|7|||
150010568|NCT02096263|541172268|FG001|Overall Study|Other|9|||
150010569|NCT02096263|541172269|FG002|Overall Study|Other|6|||
150010570|NCT02096263|541172267|FG000|Overall Study|Sponsor study termination|0|||
150010571|NCT02096263|541172268|FG001|Overall Study|Sponsor study termination|0|||
150010572|NCT02096263|541172269|FG002|Overall Study|Sponsor study termination|1|||
150010573|NCT02096263|541172267|FG000|Overall Study|Protocol Violation|7|||
150010574|NCT02096263|541172268|FG001|Overall Study|Protocol Violation|2|||
150010575|NCT02096263|541172269|FG002|Overall Study|Protocol Violation|8|||
150010576|NCT02096263|541172267|FG000|Overall Study|Withdrawal by Subject|5|||
150010577|NCT02096263|541172268|FG001|Overall Study|Withdrawal by Subject|7|||
150010578|NCT02096263|541172269|FG002|Overall Study|Withdrawal by Subject|8|||
150010579|NCT03178669|541172273|FG000|Overall Study|Adverse Event|4|||
150010580|NCT03178669|541172274|FG001|Overall Study|Adverse Event|1|||
150010581|NCT03178669|541172275|FG002|Overall Study|Adverse Event|4|||
150010582|NCT03178669|541172276|FG003|Overall Study|Adverse Event|2|||
150010583|NCT03178669|541172277|FG004|Overall Study|Adverse Event|2|||
150010584|NCT03178669|541172273|FG000|Overall Study|Lack of Efficacy|0|||
150010585|NCT03178669|541172274|FG001|Overall Study|Lack of Efficacy|0|||
150010586|NCT03178669|541172275|FG002|Overall Study|Lack of Efficacy|2|||
150010587|NCT03178669|541172276|FG003|Overall Study|Lack of Efficacy|0|||
150010588|NCT03178669|541172277|FG004|Overall Study|Lack of Efficacy|1|||
150010589|NCT03178669|541172273|FG000|Overall Study|Physician Decision|0|||
150010590|NCT03178669|541172274|FG001|Overall Study|Physician Decision|0|||
150010591|NCT03178669|541172275|FG002|Overall Study|Physician Decision|0|||
150010592|NCT03178669|541172276|FG003|Overall Study|Physician Decision|0|||
150010593|NCT03178669|541172277|FG004|Overall Study|Physician Decision|1|||
150010594|NCT03178669|541172273|FG000|Overall Study|Withdrawal by Subject|1|||
150010595|NCT03178669|541172274|FG001|Overall Study|Withdrawal by Subject|0|||
150010596|NCT03178669|541172275|FG002|Overall Study|Withdrawal by Subject|1|||
150010597|NCT03178669|541172276|FG003|Overall Study|Withdrawal by Subject|1|||
150010598|NCT03178669|541172277|FG004|Overall Study|Withdrawal by Subject|0|||
150010599|NCT03178669|541172273|FG000|Overall Study|Lost to Follow-up|0|||
150010600|NCT03178669|541172274|FG001|Overall Study|Lost to Follow-up|0|||
150010601|NCT03178669|541172275|FG002|Overall Study|Lost to Follow-up|0|||
150010602|NCT03178669|541172276|FG003|Overall Study|Lost to Follow-up|1|||
150010603|NCT03178669|541172277|FG004|Overall Study|Lost to Follow-up|0|||
150010604|NCT02976103|541172278|FG000|Overall Study|Withdrawal by Subject|1|||
150010605|NCT02976103|541172279|FG001|Overall Study|Withdrawal by Subject|0|||
150010606|NCT02976103|541172278|FG000|Overall Study|Lost to Follow-up|12|||
150010607|NCT02976103|541172279|FG001|Overall Study|Lost to Follow-up|8|||
150010608|NCT00079677|541172280|FG000|Overall Study|Adverse Event|5|||
150010609|NCT00079677|541172281|FG001|Overall Study|Adverse Event|6|||
150010610|NCT00079677|541172280|FG000|Overall Study|Lack of Efficacy|1|||
150010611|NCT00079677|541172281|FG001|Overall Study|Lack of Efficacy|0|||
150010612|NCT00079677|541172280|FG000|Overall Study|Lost to Follow-up|2|||
150010613|NCT00079677|541172281|FG001|Overall Study|Lost to Follow-up|2|||
150010614|NCT00079677|541172280|FG000|Overall Study|Physician Decision|3|||
150010615|NCT00079677|541172281|FG001|Overall Study|Physician Decision|0|||
150010616|NCT00079677|541172280|FG000|Overall Study|Protocol Violation|2|||
150010617|NCT00079677|541172281|FG001|Overall Study|Protocol Violation|3|||
150010618|NCT00079677|541172280|FG000|Overall Study|Withdrawal by Subject|5|||
150010619|NCT00079677|541172281|FG001|Overall Study|Withdrawal by Subject|3|||
150010620|NCT00079677|541172280|FG000|Overall Study|Miscellaneous|2|||
150010621|NCT00079677|541172281|FG001|Overall Study|Miscellaneous|0|||
150010622|NCT00576576|541172290|FG000|Overall Study|Lost to Follow-up|6|||
150010623|NCT00576576|541172290|FG000|Overall Study|Protocol Violation|1|||
150010624|NCT00671437|541172291|FG000|Overall Study|Progressive disease before C1 week 8|8|||
150010625|NCT00671437|541172291|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
150010626|NCT00671437|541172291|FG000|Overall Study|Adverse Event|3|||
150010627|NCT00671437|541172291|FG000|Overall Study|Ineligible post-hoc|1|||
150010628|NCT03927404|541172292|FG000|Overall Study|Withdrawal by Subject|1|||
150010629|NCT01229449|541172293|FG000|Overall Study|Withdrawal by Subject|0|||
150010630|NCT01229449|541172294|FG001|Overall Study|Withdrawal by Subject|3|||
150010631|NCT01229449|541172295|FG002|Overall Study|Withdrawal by Subject|0|||
150010632|NCT01229449|541172296|FG003|Overall Study|Withdrawal by Subject|1|||
150010633|NCT01229449|541172297|FG004|Overall Study|Withdrawal by Subject|1|||
150010634|NCT01229449|541172293|FG000|Overall Study|Lost to Follow-up|1|||
150010635|NCT01229449|541172294|FG001|Overall Study|Lost to Follow-up|1|||
150010636|NCT01229449|541172295|FG002|Overall Study|Lost to Follow-up|1|||
150010637|NCT01229449|541172296|FG003|Overall Study|Lost to Follow-up|0|||
150010638|NCT01229449|541172297|FG004|Overall Study|Lost to Follow-up|0|||
150010639|NCT01229449|541172293|FG000|Overall Study|Physician Decision|0|||
150010640|NCT01229449|541172294|FG001|Overall Study|Physician Decision|0|||
150010641|NCT01229449|541172295|FG002|Overall Study|Physician Decision|1|||
150010642|NCT01229449|541172296|FG003|Overall Study|Physician Decision|0|||
150010643|NCT01229449|541172297|FG004|Overall Study|Physician Decision|0|||
150010644|NCT03203291|541172298|FG000|Overall Study|Withdrawal by Subject|1|||
150010645|NCT05098509|541172299|FG000|Overall Study|Withdrawal by Subject|0|||
150010646|NCT05098509|541172300|FG001|Overall Study|Withdrawal by Subject|0|||
150010647|NCT05098509|541172301|FG002|Overall Study|Withdrawal by Subject|1|||
150010648|NCT05098509|541172302|FG003|Overall Study|Withdrawal by Subject|0|||
150010649|NCT05098509|541172299|FG000|Overall Study|Early study termination|1|||
150010650|NCT05098509|541172300|FG001|Overall Study|Early study termination|1|||
150010651|NCT05098509|541172301|FG002|Overall Study|Early study termination|1|||
150010652|NCT05098509|541172302|FG003|Overall Study|Early study termination|0|||
150010653|NCT04033068|541172303|FG000|Overall Study|Withdrawal by Subject|0|||
150010654|NCT04033068|541172304|FG001|Overall Study|Withdrawal by Subject|0|||
150010655|NCT04033068|541172305|FG002|Overall Study|Withdrawal by Subject|1|||
150010656|NCT04033068|541172306|FG003|Overall Study|Withdrawal by Subject|0|||
150010657|NCT04033068|541172303|FG000|Overall Study|Lost to Follow-up|0|||
150010658|NCT04033068|541172304|FG001|Overall Study|Lost to Follow-up|1|||
150010659|NCT04033068|541172305|FG002|Overall Study|Lost to Follow-up|0|||
150010660|NCT04033068|541172306|FG003|Overall Study|Lost to Follow-up|0|||
150010661|NCT04033068|541172303|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
150010662|NCT04033068|541172304|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
150010663|NCT04033068|541172305|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
150010664|NCT04033068|541172306|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
150010665|NCT02540265|541172307|FG000|Overall Study|Lost to Follow-up|0|||
150010666|NCT02540265|541172308|FG001|Overall Study|Lost to Follow-up|0|||
150010667|NCT02540265|541172309|FG002|Overall Study|Lost to Follow-up|1|||
150010668|NCT03157037|541172310|FG000|Overall Study|Death|1|||
150010669|NCT00324233|541172311|FG000|First Period|unable to insert catheter|1|||
150010670|NCT00324233|541172312|FG001|First Period|unable to insert catheter|0|||
150010671|NCT00324233|541172311|FG000|Second Period|unable to insert catheter|1|||
150010672|NCT00324233|541172312|FG001|Second Period|unable to insert catheter|1|||
150010673|NCT00324233|541172311|FG000|Second Period|Protocol Violation|4|||
150010674|NCT00324233|541172312|FG001|Second Period|Protocol Violation|6|||
150010675|NCT01972789|541172313|FG000|Overall Study|Adverse Event|11|||
150010676|NCT01972789|541172314|FG001|Overall Study|Adverse Event|4|||
150010677|NCT01972789|541172313|FG000|Overall Study|Subject withdrew consent|14|||
150010678|NCT01972789|541172314|FG001|Overall Study|Subject withdrew consent|12|||
150010679|NCT01972789|541172313|FG000|Overall Study|Lost to Follow-up|4|||
150010680|NCT01972789|541172314|FG001|Overall Study|Lost to Follow-up|7|||
150010681|NCT01972789|541172313|FG000|Overall Study|Death|7|||
150010682|NCT01972789|541172314|FG001|Overall Study|Death|5|||
150010683|NCT01972789|541172313|FG000|Overall Study|Protocol deviation|1|||
150010684|NCT01972789|541172314|FG001|Overall Study|Protocol deviation|0|||
150010685|NCT01972789|541172313|FG000|Overall Study|Physician Decision|3|||
150010686|NCT01972789|541172314|FG001|Overall Study|Physician Decision|2|||
150010687|NCT01704456|541172317|FG000|Overall Study|Lost to Follow-up|8|||
150010688|NCT01704456|541172318|FG001|Overall Study|Lost to Follow-up|14|||
150010689|NCT04667104|541172324|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
150010690|NCT04667104|541172325|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
150010691|NCT04667104|541172326|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
150010692|NCT02126839|541172328|FG000|Overall Study|Adverse Event|0|||
150010693|NCT02126839|541172329|FG001|Overall Study|Adverse Event|1|||
150010694|NCT02126839|541172328|FG000|Overall Study|Withdrawal by Subject|1|||
150010695|NCT02126839|541172329|FG001|Overall Study|Withdrawal by Subject|0|||
150010696|NCT02126839|541172328|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150010697|NCT02126839|541172329|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150010698|NCT02126839|541172328|FG000|Overall Study|Protocol Violation|2|||
150010699|NCT02126839|541172329|FG001|Overall Study|Protocol Violation|3|||
150010700|NCT02126839|541172328|FG000|Overall Study|Sponsor request|0|||
150010701|NCT02126839|541172329|FG001|Overall Study|Sponsor request|1|||
150010702|NCT02126839|541172328|FG000|Overall Study|Lost to Follow-up|1|||
150010703|NCT02126839|541172329|FG001|Overall Study|Lost to Follow-up|4|||
150010704|NCT02126839|541172328|FG000|Overall Study|Other|5|||
150010705|NCT02126839|541172329|FG001|Overall Study|Other|5|||
150010706|NCT00422383|541172330|FG000|Overall Study|Adverse Event|5|||
150010707|NCT00422383|541172331|FG001|Overall Study|Adverse Event|3|||
150010708|NCT00422383|541172332|FG002|Overall Study|Adverse Event|1|||
150010709|NCT00422383|541172333|FG003|Overall Study|Adverse Event|1|||
150010710|NCT00422383|541172334|FG004|Overall Study|Adverse Event|0|||
150010711|NCT00422383|541172330|FG000|Overall Study|Lack of Efficacy|4|||
150010712|NCT00422383|541172331|FG001|Overall Study|Lack of Efficacy|4|||
150010713|NCT00422383|541172332|FG002|Overall Study|Lack of Efficacy|2|||
150010714|NCT00422383|541172333|FG003|Overall Study|Lack of Efficacy|1|||
150010715|NCT00422383|541172334|FG004|Overall Study|Lack of Efficacy|1|||
150010716|NCT00422383|541172330|FG000|Overall Study|Lost to Follow-up|0|||
150010717|NCT00422383|541172331|FG001|Overall Study|Lost to Follow-up|1|||
150010718|NCT00422383|541172332|FG002|Overall Study|Lost to Follow-up|0|||
150010719|NCT00422383|541172333|FG003|Overall Study|Lost to Follow-up|0|||
150010720|NCT00422383|541172334|FG004|Overall Study|Lost to Follow-up|1|||
150010721|NCT00422383|541172330|FG000|Overall Study|Protocol Violation|1|||
150010722|NCT00422383|541172331|FG001|Overall Study|Protocol Violation|1|||
150010723|NCT00422383|541172332|FG002|Overall Study|Protocol Violation|1|||
150010724|NCT00422383|541172333|FG003|Overall Study|Protocol Violation|0|||
150010725|NCT00422383|541172334|FG004|Overall Study|Protocol Violation|0|||
150010726|NCT00422383|541172330|FG000|Overall Study|Withdrawal by Subject|5|||
150010727|NCT00422383|541172331|FG001|Overall Study|Withdrawal by Subject|5|||
150010728|NCT00422383|541172332|FG002|Overall Study|Withdrawal by Subject|0|||
150010729|NCT00422383|541172333|FG003|Overall Study|Withdrawal by Subject|0|||
150010730|NCT00422383|541172334|FG004|Overall Study|Withdrawal by Subject|1|||
150010731|NCT00411632|541172335|FG000|Overall Study|Death|1|||
150010732|NCT00761527|541172338|FG000|Overall Study|Adverse Event|3|||
150010733|NCT00761527|541172338|FG000|Overall Study|Poor Compliance|8|||
150010734|NCT00761527|541172338|FG000|Overall Study|Lost to Follow-up|9|||
150010735|NCT00761527|541172338|FG000|Overall Study|Unknown reason|2|||
150010736|NCT04599465|541174041|FG000|Overall Study|Physician Decision|1|||
150010737|NCT04599465|541174041|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
150010738|NCT00742417|541174042|FG000|Randomized|Withdrawal by legal representative|0|||
150010739|NCT00742417|541174043|FG001|Randomized|Withdrawal by legal representative|1|||
150010740|NCT00742417|541174042|FG000|Randomized|Withdrawal by Subject|1|||
150010741|NCT00742417|541174043|FG001|Randomized|Withdrawal by Subject|0|||
150010742|NCT00742417|541174042|FG000|Randomized|Physician Decision|1|||
150010743|NCT00742417|541174043|FG001|Randomized|Physician Decision|0|||
150057729|NCT00704522|541353531|FG001|Overall Study|Failure to appear again at hospital|10|||
150057730|NCT00704522|541353530|FG000|Overall Study|Withdrawal by Subject|17|||
150057731|NCT00704522|541353531|FG001|Overall Study|Withdrawal by Subject|8|||
150057732|NCT00704522|541353530|FG000|Overall Study|Adverse Event|9|||
150057733|NCT00704522|541353531|FG001|Overall Study|Adverse Event|1|||
150010744|NCT00742417|541174042|FG000|Intensive Period|Withdrawal by Subject|1|||
150010745|NCT00742417|541174043|FG001|Intensive Period|Withdrawal by Subject|1|||
150010746|NCT00742417|541174042|FG000|Intensive Period|Adverse Event|2|||
150010747|NCT00742417|541174043|FG001|Intensive Period|Adverse Event|0|||
150010748|NCT00965575|541174048|FG000|Overall Study|subject unwillingness to swallow study c|1|||
150010749|NCT00965575|541174049|FG001|Overall Study|subject unwillingness to swallow study c|0|||
150010750|NCT03775512|541174052|FG000|Overall Study|Death|1|||
150010751|NCT03775512|541174053|FG001|Overall Study|Death|1|||
150010752|NCT03775512|541174052|FG000|Overall Study|Withdrawal by Subject|7|||
150010753|NCT03775512|541174053|FG001|Overall Study|Withdrawal by Subject|4|||
150010754|NCT03775512|541174052|FG000|Overall Study|Lost to Follow-up|5|||
150010755|NCT03775512|541174053|FG001|Overall Study|Lost to Follow-up|5|||
150010756|NCT03775512|541174052|FG000|Overall Study|Excluded before Catheter insertion|14|||
150010757|NCT03775512|541174053|FG001|Overall Study|Excluded before Catheter insertion|5|||
150010758|NCT03775512|541174052|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
150010759|NCT03775512|541174053|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
150010760|NCT03775512|541174052|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
150010761|NCT03775512|541174053|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
150057734|NCT00704522|541353530|FG000|Overall Study|Undefined causes|9|||
150010762|NCT00495625|541174054|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
150010763|NCT02629822|541174055|FG000|Base Study|Lost to Follow-up|2|||
150010764|NCT02629822|541174055|FG000|Base Study|Non-Compliance With Study Drug|1|||
150010765|NCT02629822|541174055|FG000|Extension Study|Adverse Event|1|||
150010766|NCT02629822|541174055|FG000|Extension Study|Lost to Follow-up|1|||
150010767|NCT01912339|541174056|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
150010768|NCT01912339|541174057|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
150010769|NCT01912339|541174058|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
150010770|NCT01912339|541174056|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
150010771|NCT01912339|541174057|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
150010772|NCT01912339|541174058|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
150010773|NCT01912339|541174056|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
150010774|NCT01912339|541174057|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
150010775|NCT01912339|541174058|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
150010776|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
150010777|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
150010778|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
150010779|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
150010780|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
150010781|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
150010782|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
150010783|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
150010784|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
150010785|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
150010786|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
150010787|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
150010788|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
150010789|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
150010790|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
150010791|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
150010792|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
150010793|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
150010794|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
150010795|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
150010796|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
150010797|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
150010798|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
150010799|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
150010800|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
150010801|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
150010802|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
150010803|NCT01912339|541174056|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
150010804|NCT01912339|541174057|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
150010805|NCT01912339|541174058|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
150010806|NCT03464019|541174060|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
150010807|NCT03464019|541174061|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
150010808|NCT03464019|541174062|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
150010809|NCT03464019|541174060|FG000|NODE-301 Part 1|Ablation|0|||
150010810|NCT03464019|541174061|FG001|NODE-301 Part 1|Ablation|0|||
150010811|NCT03464019|541174062|FG002|NODE-301 Part 1|Ablation|16|||
150010812|NCT03464019|541174060|FG000|NODE-301 Part 1|Test Dose Failure|0|||
150010813|NCT03464019|541174061|FG001|NODE-301 Part 1|Test Dose Failure|0|||
150010814|NCT03464019|541174062|FG002|NODE-301 Part 1|Test Dose Failure|8|||
150010815|NCT03464019|541174060|FG000|NODE-301 Part 1|Adverse Event|0|||
150010816|NCT03464019|541174061|FG001|NODE-301 Part 1|Adverse Event|0|||
150010817|NCT03464019|541174062|FG002|NODE-301 Part 1|Adverse Event|5|||
150010818|NCT03464019|541174060|FG000|NODE-301 Part 1|Physician Decision|0|||
150010819|NCT03464019|541174061|FG001|NODE-301 Part 1|Physician Decision|0|||
150010820|NCT03464019|541174062|FG002|NODE-301 Part 1|Physician Decision|4|||
150010821|NCT03464019|541174060|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
150010822|NCT03464019|541174061|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
150010823|NCT03464019|541174062|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
150010824|NCT03464019|541174060|FG000|NODE-301 Part 1|Protocol Violation|0|||
150057735|NCT00704522|541353531|FG001|Overall Study|Undefined causes|7|||
150057736|NCT00704522|541353530|FG000|Overall Study|No information on therapy end|27|||
150057737|NCT00704522|541353531|FG001|Overall Study|No information on therapy end|2|||
150057738|NCT04395001|541353532|FG000|Overall Study|Lost to Follow-up|8|||
150057739|NCT04395001|541353533|FG001|Overall Study|Lost to Follow-up|9|||
150010825|NCT03464019|541174061|FG001|NODE-301 Part 1|Protocol Violation|0|||
150010826|NCT03464019|541174062|FG002|NODE-301 Part 1|Protocol Violation|2|||
150010827|NCT03464019|541174060|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
150010828|NCT03464019|541174061|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
150010829|NCT03464019|541174062|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
150010830|NCT03464019|541174060|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
150010831|NCT03464019|541174061|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
150010832|NCT03464019|541174062|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
150010833|NCT03464019|541174060|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
150010834|NCT03464019|541174061|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
150010835|NCT03464019|541174062|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
150010836|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
150010837|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
150010838|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
150010839|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
150010840|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
150010841|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
150010842|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
150010843|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
150010844|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
150010845|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
150010846|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
150010847|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
150010848|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
150010849|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
150010850|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
150010851|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
150010852|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
150010853|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
150010854|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
150010855|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
150010856|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
150010857|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
150010858|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
150010859|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
150010860|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
150010861|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
150010862|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
150010863|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
150010864|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
150010865|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
150010866|NCT03464019|541174060|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
150010867|NCT03464019|541174061|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
150010868|NCT03464019|541174062|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
150010869|NCT01754493|541174063|FG000|Overall Study|Adverse Event|1|||
150010870|NCT01754493|541174063|FG000|Overall Study|Lost to Follow-up|3|||
150010871|NCT01754493|541174063|FG000|Overall Study|Withdrawal by Subject|1|||
150010872|NCT01754493|541174063|FG000|Overall Study|Moved out of town|1|||
150010873|NCT01754493|541174063|FG000|Overall Study|Scheduling conflict|1|||
150010874|NCT02489942|541174064|FG000|Overall Study|Request by patient|602|||
150010875|NCT02489942|541174064|FG000|Overall Study|Improvement/remission|157|||
150010876|NCT02489942|541174064|FG000|Overall Study|No change/Progressive disease|263|||
150010877|NCT02489942|541174064|FG000|Overall Study|Adverse Event|522|||
150010878|NCT02489942|541174064|FG000|Overall Study|Other personal reasons|1218|||
150010879|NCT02489942|541174064|FG000|Overall Study|Lost to Follow-up|456|||
150010880|NCT02489942|541174064|FG000|Overall Study|Not continuously investigated|7|||
150010881|NCT02489942|541174064|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
150010882|NCT02489942|541174064|FG000|Overall Study|Multiple registration|1|||
150010883|NCT02489942|541174064|FG000|Overall Study|No patient visit after entry|100|||
150010884|NCT02489942|541174064|FG000|Overall Study|No treatment with Jardiance|2|||
150010885|NCT02489942|541174064|FG000|Overall Study|Patient received Jardiance before registration|1|||
150010886|NCT02489942|541174064|FG000|Overall Study|No CRF collected|86|||
150010887|NCT00858208|541174065|FG000|Overall Study|Adverse Event|3|||
150010888|NCT00858208|541174065|FG000|Overall Study|Lost to Follow-up|26|||
150010889|NCT00858208|541174065|FG000|Overall Study|Participant refused|40|||
150057740|NCT04395001|541353534|FG002|Overall Study|Lost to Follow-up|5|||
150057741|NCT04395001|541353532|FG000|Overall Study|Withdrawal by Subject|3|||
150010890|NCT00858208|541174065|FG000|Overall Study|Other|10|||
150057742|NCT04395001|541353533|FG001|Overall Study|Withdrawal by Subject|1|||
150057743|NCT04395001|541353534|FG002|Overall Study|Withdrawal by Subject|3|||
150057744|NCT04395001|541353532|FG000|Overall Study|missed appointment|7|||
150057745|NCT04395001|541353533|FG001|Overall Study|missed appointment|4|||
150057746|NCT04395001|541353534|FG002|Overall Study|missed appointment|1|||
150057747|NCT04418661|541353535|FG000|Overall Study|Adverse Event|0|||
150057748|NCT04418661|541353536|FG001|Overall Study|Adverse Event|1|||
150057749|NCT04418661|541353537|FG002|Overall Study|Adverse Event|5|||
150057750|NCT04418661|541353538|FG003|Overall Study|Adverse Event|3|||
150057751|NCT04418661|541353539|FG004|Overall Study|Adverse Event|0|||
150057752|NCT04418661|541353540|FG005|Overall Study|Adverse Event|2|||
150057753|NCT04418661|541353535|FG000|Overall Study|Progressive disease|4|||
150057754|NCT04418661|541353536|FG001|Overall Study|Progressive disease|11|||
150181077|NCT02590432|541801011|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150010891|NCT01272635|541174066|FG000|Overall Study|Lost to Follow-up|31|||
150010892|NCT01272635|541174067|FG001|Overall Study|Lost to Follow-up|20|||
150010893|NCT01272635|541174068|FG002|Overall Study|Lost to Follow-up|31|||
150010894|NCT01272635|541174069|FG003|Overall Study|Lost to Follow-up|23|||
150010895|NCT01543776|541174072|FG000|Overall Study|Withdrawal by Subject|2|||
150010896|NCT01543776|541174073|FG001|Overall Study|Withdrawal by Subject|2|||
150010897|NCT02397057|541174074|FG000|Overall Study|Withdrawal by Subject|6|||
150010898|NCT02397057|541174075|FG001|Overall Study|Withdrawal by Subject|7|||
150010899|NCT02397057|541174074|FG000|Overall Study|Lost to Follow-up|4|||
150010900|NCT02397057|541174075|FG001|Overall Study|Lost to Follow-up|3|||
150010901|NCT02397057|541174074|FG000|Overall Study|Death|1|||
150010902|NCT02397057|541174075|FG001|Overall Study|Death|0|||
150010903|NCT02397057|541174074|FG000|Overall Study|Adverse Event|0|||
150010904|NCT02397057|541174075|FG001|Overall Study|Adverse Event|1|||
150010905|NCT02397057|541174074|FG000|Overall Study|Physician Decision|0|||
150010906|NCT02397057|541174075|FG001|Overall Study|Physician Decision|1|||
150010907|NCT02397057|541174074|FG000|Overall Study|Subject did not receive study drug|0|||
150010908|NCT02397057|541174075|FG001|Overall Study|Subject did not receive study drug|1|||
150010909|NCT00679172|541174078|FG000|Overall Study|Non-compliance|1|||
150010910|NCT00679172|541174079|FG001|Overall Study|Non-compliance|1|||
150010911|NCT00679172|541174080|FG002|Overall Study|Non-compliance|0|||
150010912|NCT00679172|541174081|FG003|Overall Study|Non-compliance|1|||
150010913|NCT00679172|541174082|FG004|Overall Study|Non-compliance|0|||
150010914|NCT00679172|541174078|FG000|Overall Study|Other not specified|0|||
150010915|NCT00679172|541174079|FG001|Overall Study|Other not specified|0|||
150010916|NCT00679172|541174080|FG002|Overall Study|Other not specified|1|||
150010917|NCT00679172|541174081|FG003|Overall Study|Other not specified|0|||
150010918|NCT00679172|541174082|FG004|Overall Study|Other not specified|0|||
150010919|NCT00434642|541174084|FG000|Blinded Treatment Phase|Adverse Event|12|||
150057755|NCT04418661|541353537|FG002|Overall Study|Progressive disease|6|||
150057756|NCT04418661|541353538|FG003|Overall Study|Progressive disease|11|||
150057757|NCT04418661|541353539|FG004|Overall Study|Progressive disease|1|||
150057758|NCT04418661|541353540|FG005|Overall Study|Progressive disease|12|||
150181078|NCT02590432|541801012|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150181079|NCT02590432|541801013|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150181080|NCT02590432|541801014|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
150181081|NCT02590432|541801006|FG000|Double-blind Treatment Period|Adverse Event|0|||
150181082|NCT02590432|541801007|FG001|Double-blind Treatment Period|Adverse Event|0|||
150181083|NCT02590432|541801008|FG002|Double-blind Treatment Period|Adverse Event|14|||
150181084|NCT02590432|541801009|FG003|Double-blind Treatment Period|Adverse Event|12|||
150181085|NCT02590432|541801010|FG004|Double-blind Treatment Period|Adverse Event|6|||
150181086|NCT02590432|541801011|FG005|Double-blind Treatment Period|Adverse Event|22|||
150181087|NCT02590432|541801012|FG006|Double-blind Treatment Period|Adverse Event|20|||
150181088|NCT02590432|541801013|FG007|Double-blind Treatment Period|Adverse Event|0|||
150181089|NCT02590432|541801014|FG008|Double-blind Treatment Period|Adverse Event|0|||
150057759|NCT04418661|541353535|FG000|Overall Study|Withdrawal by Subject|0|||
150057760|NCT04418661|541353536|FG001|Overall Study|Withdrawal by Subject|1|||
150057761|NCT04418661|541353537|FG002|Overall Study|Withdrawal by Subject|0|||
150181090|NCT02590432|541801006|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
150010920|NCT00434642|541174085|FG001|Blinded Treatment Phase|Adverse Event|58|||
150010921|NCT00434642|541174084|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
150010922|NCT00434642|541174085|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
150010923|NCT00434642|541174084|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
150057762|NCT04418661|541353538|FG003|Overall Study|Withdrawal by Subject|1|||
150057763|NCT04418661|541353539|FG004|Overall Study|Withdrawal by Subject|0|||
150010924|NCT00434642|541174085|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
150010925|NCT00434642|541174084|FG000|Blinded Treatment Phase|Physician Decision|19|||
150010926|NCT00434642|541174085|FG001|Blinded Treatment Phase|Physician Decision|27|||
150057764|NCT04418661|541353540|FG005|Overall Study|Withdrawal by Subject|0|||
150010927|NCT00434642|541174084|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
150010928|NCT00434642|541174085|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
150010929|NCT00434642|541174084|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
150010930|NCT00434642|541174085|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
150010931|NCT00434642|541174084|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
150010932|NCT00434642|541174085|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
150010933|NCT00434642|541174084|FG000|Open-label Treatment Phase|Adverse Event|0|||
150010934|NCT00434642|541174085|FG001|Open-label Treatment Phase|Adverse Event|5|||
150010935|NCT00434642|541174084|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
150010936|NCT00434642|541174085|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
150010937|NCT04512976|541174086|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
150010938|NCT04512976|541174087|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
150010939|NCT04512976|541174088|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
150010940|NCT04512976|541174089|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
150010941|NCT04512976|541174090|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
150010942|NCT04512976|541174091|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
150010943|NCT05249569|541174096|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
150010944|NCT03927144|541174097|FG000|Core Phase|Adverse Event|9|||
150010945|NCT03927144|541174098|FG001|Core Phase|Adverse Event|5|||
150010946|NCT03927144|541174097|FG000|Core Phase|Lost to Follow-up|3|||
150010947|NCT03927144|541174098|FG001|Core Phase|Lost to Follow-up|2|||
150010948|NCT03927144|541174097|FG000|Core Phase|New Therapy for Study Indication|0|||
150010949|NCT03927144|541174098|FG001|Core Phase|New Therapy for Study Indication|1|||
150010950|NCT03927144|541174097|FG000|Core Phase|No Longer Clinically Benefiting|4|||
150010951|NCT03927144|541174098|FG001|Core Phase|No Longer Clinically Benefiting|4|||
150010952|NCT03927144|541174097|FG000|Core Phase|Physician Decision|2|||
150010953|NCT03927144|541174098|FG001|Core Phase|Physician Decision|8|||
150010954|NCT03927144|541174097|FG000|Core Phase|Protocol Violation|2|||
150010955|NCT03927144|541174098|FG001|Core Phase|Protocol Violation|2|||
150010956|NCT03927144|541174097|FG000|Core Phase|Withdrawal by Subject|16|||
150010957|NCT03927144|541174098|FG001|Core Phase|Withdrawal by Subject|40|||
150057765|NCT04418661|541353535|FG000|Overall Study|Other|0|||
150057766|NCT04418661|541353536|FG001|Overall Study|Other|0|||
150057767|NCT04418661|541353537|FG002|Overall Study|Other|1|||
150057768|NCT04418661|541353538|FG003|Overall Study|Other|3|||
150057769|NCT04418661|541353539|FG004|Overall Study|Other|0|||
150057770|NCT04418661|541353540|FG005|Overall Study|Other|1|||
150057771|NCT00992589|541353543|FG000|Open-Label Phase|Adverse Event|4|||
150057772|NCT00992589|541353544|FG001|Open-Label Phase|Adverse Event|0|||
150057773|NCT00992589|541353545|FG002|Open-Label Phase|Adverse Event|0|||
150057774|NCT00992589|541353546|FG003|Open-Label Phase|Adverse Event|0|||
150057775|NCT00992589|541353543|FG000|Open-Label Phase|Withdrawal by Subject|20|||
150057776|NCT00992589|541353544|FG001|Open-Label Phase|Withdrawal by Subject|0|||
150057777|NCT00992589|541353545|FG002|Open-Label Phase|Withdrawal by Subject|0|||
150057778|NCT00992589|541353546|FG003|Open-Label Phase|Withdrawal by Subject|0|||
150057779|NCT00992589|541353543|FG000|Open-Label Phase|Lost to Follow-up|1|||
150057780|NCT00992589|541353544|FG001|Open-Label Phase|Lost to Follow-up|0|||
150057781|NCT00992589|541353545|FG002|Open-Label Phase|Lost to Follow-up|0|||
150057782|NCT00992589|541353546|FG003|Open-Label Phase|Lost to Follow-up|0|||
150057783|NCT00992589|541353543|FG000|Open-Label Phase|Protocol Violation|3|||
150181091|NCT02590432|541801007|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
150181092|NCT02590432|541801008|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
150181093|NCT02590432|541801009|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
150181094|NCT02590432|541801010|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
150181095|NCT02590432|541801011|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
150181096|NCT02590432|541801012|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
150181097|NCT02590432|541801013|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
150181098|NCT02590432|541801014|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
150181099|NCT02590432|541801006|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
150181100|NCT02590432|541801007|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
150010958|NCT03927144|541174097|FG000|Extension Phase|Adverse Event|2|||
150010959|NCT03927144|541174098|FG001|Extension Phase|Adverse Event|1|||
150010960|NCT03927144|541174097|FG000|Extension Phase|No longer clinically benefiting|4|||
150010961|NCT03927144|541174098|FG001|Extension Phase|No longer clinically benefiting|5|||
150010962|NCT03927144|541174097|FG000|Extension Phase|Pregnancy|1|||
150057784|NCT00992589|541353544|FG001|Open-Label Phase|Protocol Violation|0|||
150057785|NCT00992589|541353545|FG002|Open-Label Phase|Protocol Violation|0|||
150057786|NCT00992589|541353546|FG003|Open-Label Phase|Protocol Violation|0|||
150057787|NCT00992589|541353543|FG000|Open-Label Phase|Physician Decision|4|||
150057788|NCT00992589|541353544|FG001|Open-Label Phase|Physician Decision|0|||
150057789|NCT00992589|541353545|FG002|Open-Label Phase|Physician Decision|0|||
150010963|NCT03927144|541174098|FG001|Extension Phase|Pregnancy|0|||
150010964|NCT03927144|541174097|FG000|Extension Phase|Protocol Violation|0|||
150010965|NCT03927144|541174098|FG001|Extension Phase|Protocol Violation|1|||
150010966|NCT03927144|541174097|FG000|Extension Phase|Withdrawal by Subject|8|||
150010967|NCT03927144|541174098|FG001|Extension Phase|Withdrawal by Subject|3|||
150010968|NCT02271945|541174101|FG000|Overall Study|Death|3|||
150010969|NCT02271945|541174102|FG001|Overall Study|Death|3|||
150010970|NCT02271945|541174101|FG000|Overall Study|Withdrawal by Subject|1|||
150010971|NCT02271945|541174102|FG001|Overall Study|Withdrawal by Subject|1|||
150010972|NCT02271945|541174101|FG000|Overall Study|Other|1|||
150010973|NCT02271945|541174102|FG001|Overall Study|Other|1|||
150010974|NCT00719680|541174107|FG000|Overall Study|Adverse Event|1|||
150010975|NCT00719680|541174107|FG000|Overall Study|Lost to Follow-up|1|||
150010976|NCT00719680|541174107|FG000|Overall Study|Withdrawal by Subject|3|||
150010977|NCT04071158|541174108|FG000|Overall Study|Lost to Follow-up|1|||
150010978|NCT04071158|541174109|FG001|Overall Study|Lost to Follow-up|2|||
150010979|NCT04071158|541174110|FG002|Overall Study|Lost to Follow-up|3|||
150010980|NCT04071158|541174111|FG003|Overall Study|Lost to Follow-up|3|||
150010981|NCT04071158|541174112|FG004|Overall Study|Lost to Follow-up|5|||
150010982|NCT04071158|541174108|FG000|Overall Study|Randomized but not treated|2|||
150010983|NCT04071158|541174109|FG001|Overall Study|Randomized but not treated|2|||
150010984|NCT04071158|541174110|FG002|Overall Study|Randomized but not treated|0|||
150010985|NCT04071158|541174111|FG003|Overall Study|Randomized but not treated|0|||
150010986|NCT04071158|541174112|FG004|Overall Study|Randomized but not treated|0|||
150010987|NCT02678923|541174123|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
150010988|NCT02678923|541174124|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
150010989|NCT02678923|541174123|FG000|Overall Study|Withdrawal by Subject|3|||
150010990|NCT02678923|541174124|FG001|Overall Study|Withdrawal by Subject|2|||
150010991|NCT02678923|541174123|FG000|Overall Study|Lost to Follow-up|1|||
150010992|NCT02678923|541174124|FG001|Overall Study|Lost to Follow-up|0|||
150010993|NCT02678923|541174123|FG000|Overall Study|Did Not Return for Study Visits|1|||
150057790|NCT00992589|541353546|FG003|Open-Label Phase|Physician Decision|0|||
150057791|NCT00992589|541353543|FG000|Open-Label Phase|Other|45|||
150057792|NCT00992589|541353544|FG001|Open-Label Phase|Other|0|||
150057793|NCT00992589|541353545|FG002|Open-Label Phase|Other|0|||
150057794|NCT00992589|541353546|FG003|Open-Label Phase|Other|0|||
150057795|NCT00992589|541353543|FG000|Double-Blind Phase|Adverse Event|0|||
150057796|NCT00992589|541353544|FG001|Double-Blind Phase|Adverse Event|6|||
150057797|NCT00992589|541353545|FG002|Double-Blind Phase|Adverse Event|2|||
150057798|NCT00992589|541353546|FG003|Double-Blind Phase|Adverse Event|3|||
150057799|NCT00992589|541353543|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
150057800|NCT00992589|541353544|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
150057801|NCT00992589|541353545|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
150057802|NCT00992589|541353546|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
150057803|NCT00992589|541353543|FG000|Double-Blind Phase|Lost to Follow-up|0|||
150057804|NCT00992589|541353544|FG001|Double-Blind Phase|Lost to Follow-up|0|||
150057805|NCT00992589|541353545|FG002|Double-Blind Phase|Lost to Follow-up|0|||
150057806|NCT00992589|541353546|FG003|Double-Blind Phase|Lost to Follow-up|2|||
150057807|NCT00992589|541353543|FG000|Double-Blind Phase|Other|0|||
150057808|NCT00992589|541353544|FG001|Double-Blind Phase|Other|1|||
150057809|NCT00992589|541353545|FG002|Double-Blind Phase|Other|6|||
150057810|NCT00992589|541353546|FG003|Double-Blind Phase|Other|3|||
150057811|NCT05508074|541353547|FG000|Overall Study|Death|2|||
150057812|NCT05508074|541353548|FG001|Overall Study|Death|5|||
150057813|NCT05508074|541353547|FG000|Overall Study|Withdrawal by Subject|1|||
150057814|NCT05508074|541353548|FG001|Overall Study|Withdrawal by Subject|2|||
150057815|NCT05508074|541353547|FG000|Overall Study|Adverse Event|0|||
150057816|NCT05508074|541353548|FG001|Overall Study|Adverse Event|1|||
150057817|NCT05508074|541353547|FG000|Overall Study|Physician Decision|0|||
150057818|NCT05508074|541353548|FG001|Overall Study|Physician Decision|1|||
150057819|NCT05508074|541353547|FG000|Overall Study|wrongly randomized|0|||
150057820|NCT05508074|541353548|FG001|Overall Study|wrongly randomized|1|||
150057821|NCT05508074|541353547|FG000|Overall Study|non-compliance|0|||
150010994|NCT02678923|541174124|FG001|Overall Study|Did Not Return for Study Visits|0|||
150010995|NCT00455143|541174125|FG000|Overall Study|Physician Decision|1|||
150057822|NCT05508074|541353548|FG001|Overall Study|non-compliance|1|||
150057823|NCT02142387|541353549|FG000|Overall Study|<19 years old|49|||
150057824|NCT02142387|541353550|FG001|Overall Study|<19 years old|326|||
150010996|NCT00455143|541174125|FG000|Overall Study|Withdrawal by Subject|1|||
150010997|NCT00455143|541174125|FG000|Overall Study|Staff was not avail to follow patient|2|||
150010998|NCT00455143|541174125|FG000|Overall Study|No longer met Inclusion Criteria|1|||
150010999|NCT00455143|541174125|FG000|Overall Study|Surgical time, staff not available|1|||
150057825|NCT02142387|541353549|FG000|Overall Study|non-cardiac etiology|504|||
150057826|NCT02142387|541353550|FG001|Overall Study|non-cardiac etiology|3431|||
150057827|NCT02142387|541353549|FG000|Overall Study|CPR not performed|74|||
150011000|NCT03266172|541174126|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
150011001|NCT03266172|541174127|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
150011002|NCT03266172|541174128|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
150011003|NCT03266172|541174126|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
150011004|NCT03266172|541174127|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
150011005|NCT03266172|541174128|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
150011006|NCT03266172|541174126|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
150011007|NCT03266172|541174127|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
150011008|NCT03266172|541174128|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
150011009|NCT03266172|541174126|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
150011010|NCT03266172|541174127|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
150011011|NCT03266172|541174128|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
150011012|NCT03266172|541174126|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
150011013|NCT03266172|541174127|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
150011014|NCT03266172|541174128|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
150011015|NCT03266172|541174126|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
150011016|NCT03266172|541174127|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
150011017|NCT03266172|541174128|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
150011018|NCT05222555|541174132|FG000|Overall Study|Ongoing|2|||
150011019|NCT05222555|541174133|FG001|Overall Study|Ongoing|18|||
150011020|NCT05222555|541174132|FG000|Overall Study|Adverse Event|1|||
150011021|NCT05222555|541174133|FG001|Overall Study|Adverse Event|1|||
150011022|NCT05222555|541174132|FG000|Overall Study|Death|0|||
150011023|NCT05222555|541174133|FG001|Overall Study|Death|6|||
150011024|NCT05222555|541174132|FG000|Overall Study|Withdrawal by Subject|0|||
150011025|NCT05222555|541174133|FG001|Overall Study|Withdrawal by Subject|11|||
150011026|NCT00300365|541174134|FG000|Overall Study|Lost to Follow-up|1|||
150011027|NCT00300365|541174135|FG001|Overall Study|Lost to Follow-up|0|||
150011028|NCT00300365|541174134|FG000|Overall Study|Physician Decision|2|||
150011029|NCT00300365|541174135|FG001|Overall Study|Physician Decision|0|||
150011030|NCT00300365|541174134|FG000|Overall Study|Withdrawal by Subject|1|||
150011031|NCT00300365|541174135|FG001|Overall Study|Withdrawal by Subject|0|||
150011032|NCT00300365|541174134|FG000|Overall Study|Adverse Event|0|||
150011033|NCT00300365|541174135|FG001|Overall Study|Adverse Event|2|||
150011034|NCT01966445|541174138|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
150011035|NCT01966445|541174139|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
150011036|NCT01966445|541174140|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
150011037|NCT01966445|541174141|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
150011038|NCT01966445|541174142|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
150011039|NCT01966445|541174143|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
150011040|NCT01966445|541174144|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
150011041|NCT01966445|541174138|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
150011042|NCT01966445|541174139|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
150057828|NCT02142387|541353550|FG001|Overall Study|CPR not performed|473|||
150057829|NCT02142387|541353549|FG000|Overall Study|witnessed by paramedic|139|||
150057830|NCT02142387|541353550|FG001|Overall Study|witnessed by paramedic|917|||
150057831|NCT02142387|541353549|FG000|Overall Study|incomplete data|1|||
150057832|NCT02142387|541353550|FG001|Overall Study|incomplete data|9|||
150057833|NCT02142387|541353549|FG000|Overall Study|occurred not at home|298|||
150011043|NCT01966445|541174140|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
150057834|NCT02142387|541353550|FG001|Overall Study|occurred not at home|2474|||
150057835|NCT02984943|541353551|FG000|Overall Study|Withdrawal by Subject|3|||
150057836|NCT02984943|541353551|FG000|Overall Study|Physician Decision|1|||
150057837|NCT01268579|541353554|FG000|Overall Study|Adverse Event|1|||
150057838|NCT01268579|541353554|FG000|Overall Study|Withdrawal by Subject|2|||
150057839|NCT01209832|541353555|FG000|Period 1|Sponsor Decision and was not dosed|1|||
150057840|NCT01209832|541353555|FG000|Period 2|Sponsor Decision|1|||
150057841|NCT00046891|541353556|FG000|Overall Study|Cancels|5|||
150057842|NCT00046891|541353557|FG001|Overall Study|Cancels|9|||
150057843|NCT00046891|541353556|FG000|Overall Study|Ineligible|1|||
150057844|NCT00046891|541353557|FG001|Overall Study|Ineligible|1|||
150057845|NCT00046891|541353556|FG000|Overall Study|Withdrawal by Subject|18|||
150057846|NCT00046891|541353557|FG001|Overall Study|Withdrawal by Subject|15|||
150057847|NCT00046891|541353556|FG000|Overall Study|Adverse Event|5|||
150057848|NCT00046891|541353557|FG001|Overall Study|Adverse Event|5|||
150057849|NCT00420641|541353560|FG000|Overall Study|Adverse Event|3|||
150057850|NCT00420641|541353561|FG001|Overall Study|Adverse Event|25|||
150011044|NCT01966445|541174141|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
150181101|NCT02590432|541801008|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
150011045|NCT01966445|541174142|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
150011046|NCT01966445|541174143|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
150011047|NCT01966445|541174144|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
150011048|NCT01966445|541174138|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
150011049|NCT01966445|541174139|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
150011050|NCT01966445|541174140|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
150011051|NCT01966445|541174141|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
150011052|NCT01966445|541174142|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
150011053|NCT01966445|541174143|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
150011054|NCT01966445|541174144|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
150011055|NCT01966445|541174138|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011056|NCT01966445|541174139|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011057|NCT01966445|541174140|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011058|NCT01966445|541174141|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011059|NCT01966445|541174142|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011060|NCT01966445|541174143|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
150011061|NCT01966445|541174144|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
150011062|NCT01966445|541174138|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011063|NCT01966445|541174139|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011064|NCT01966445|541174140|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011065|NCT01966445|541174141|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011066|NCT01966445|541174142|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011067|NCT01966445|541174143|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
150011068|NCT01966445|541174144|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
150011069|NCT01374178|541174145|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
150011070|NCT01374178|541174146|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
150011071|NCT01374178|541174145|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
150011072|NCT01374178|541174146|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
150011073|NCT04856904|541174149|FG000|Overall Study|Physician Decision|1|||
150011074|NCT04856904|541174150|FG001|Overall Study|Physician Decision|1|||
150011075|NCT04856904|541174149|FG000|Overall Study|Withdrawal by Subject|13|||
150011076|NCT04856904|541174150|FG001|Overall Study|Withdrawal by Subject|13|||
150011077|NCT04856904|541174149|FG000|Overall Study|Adverse Event|1|||
150011078|NCT04856904|541174150|FG001|Overall Study|Adverse Event|1|||
150011079|NCT04856904|541174149|FG000|Overall Study|Non-compliance with study drug|1|||
150011080|NCT04856904|541174150|FG001|Overall Study|Non-compliance with study drug|1|||
150011081|NCT04856904|541174149|FG000|Overall Study|Lost to Follow-up|4|||
150011082|NCT04856904|541174150|FG001|Overall Study|Lost to Follow-up|4|||
150011083|NCT04856904|541174149|FG000|Overall Study|Withdrawal by Subject|1|||
150011084|NCT04856904|541174150|FG001|Overall Study|Withdrawal by Subject|1|||
150011085|NCT04856904|541174149|FG000|Overall Study|Protocol Violation|1|||
150011086|NCT04856904|541174150|FG001|Overall Study|Protocol Violation|1|||
150011087|NCT01422824|541174151|FG000|Overall Study|Case record form not evaluated|1|||
150011088|NCT01422824|541174151|FG000|Overall Study|Lost to Follow-up|37|||
150011089|NCT00902174|541174152|FG000|Overall Study|Adverse Event|27|||
150011090|NCT00902174|541174153|FG001|Overall Study|Adverse Event|7|||
150011091|NCT00902174|541174152|FG000|Overall Study|Lack of Efficacy|1|||
150011092|NCT00902174|541174153|FG001|Overall Study|Lack of Efficacy|5|||
150011093|NCT00902174|541174152|FG000|Overall Study|Death|2|||
150011094|NCT00902174|541174153|FG001|Overall Study|Death|2|||
150011095|NCT00902174|541174152|FG000|Overall Study|Withdrawal by Subject|2|||
150011096|NCT00902174|541174153|FG001|Overall Study|Withdrawal by Subject|1|||
150011097|NCT00902174|541174152|FG000|Overall Study|Abnormal labs|1|||
150011098|NCT00902174|541174153|FG001|Overall Study|Abnormal labs|1|||
150011099|NCT00902174|541174152|FG000|Overall Study|Protocol Violation|1|||
150011100|NCT00902174|541174153|FG001|Overall Study|Protocol Violation|1|||
150011101|NCT00902174|541174152|FG000|Overall Study|Administration problem|0|||
150011102|NCT00902174|541174153|FG001|Overall Study|Administration problem|1|||
150011103|NCT00454584|541174154|FG000|Controlled Period|Adverse Event|5|||
150011104|NCT00454584|541174155|FG001|Controlled Period|Adverse Event|2|||
150011105|NCT00454584|541174156|FG002|Controlled Period|Adverse Event|1|||
150011106|NCT00454584|541174157|FG003|Controlled Period|Adverse Event|0|||
150011107|NCT00454584|541174158|FG004|Controlled Period|Adverse Event|0|||
150011108|NCT00454584|541174159|FG005|Controlled Period|Adverse Event|0|||
150011109|NCT00454584|541174154|FG000|Controlled Period|Lost to Follow-up|1|||
150057851|NCT00420641|541353562|FG002|Overall Study|Adverse Event|10|||
150057852|NCT00420641|541353560|FG000|Overall Study|Lost to Follow-up|2|||
150011110|NCT00454584|541174155|FG001|Controlled Period|Lost to Follow-up|2|||
150011111|NCT00454584|541174156|FG002|Controlled Period|Lost to Follow-up|2|||
150011112|NCT00454584|541174157|FG003|Controlled Period|Lost to Follow-up|0|||
150011113|NCT00454584|541174158|FG004|Controlled Period|Lost to Follow-up|0|||
150011114|NCT00454584|541174159|FG005|Controlled Period|Lost to Follow-up|0|||
150011115|NCT00454584|541174154|FG000|Controlled Period|Other|5|||
150011116|NCT00454584|541174155|FG001|Controlled Period|Other|4|||
150011117|NCT00454584|541174156|FG002|Controlled Period|Other|2|||
150011118|NCT00454584|541174157|FG003|Controlled Period|Other|0|||
150057853|NCT00420641|541353561|FG001|Overall Study|Lost to Follow-up|4|||
150011119|NCT00454584|541174158|FG004|Controlled Period|Other|0|||
150011120|NCT00454584|541174159|FG005|Controlled Period|Other|0|||
150011121|NCT00454584|541174154|FG000|After Controlled Period|Adverse Event|0|||
150011122|NCT00454584|541174155|FG001|After Controlled Period|Adverse Event|0|||
150011123|NCT00454584|541174156|FG002|After Controlled Period|Adverse Event|0|||
150011124|NCT00454584|541174157|FG003|After Controlled Period|Adverse Event|9|||
150011125|NCT00454584|541174158|FG004|After Controlled Period|Adverse Event|3|||
150011126|NCT00454584|541174159|FG005|After Controlled Period|Adverse Event|9|||
150011127|NCT00454584|541174154|FG000|After Controlled Period|Lack of Efficacy|0|||
150011128|NCT00454584|541174155|FG001|After Controlled Period|Lack of Efficacy|0|||
150011129|NCT00454584|541174156|FG002|After Controlled Period|Lack of Efficacy|0|||
150011130|NCT00454584|541174157|FG003|After Controlled Period|Lack of Efficacy|1|||
150011131|NCT00454584|541174158|FG004|After Controlled Period|Lack of Efficacy|0|||
150011132|NCT00454584|541174159|FG005|After Controlled Period|Lack of Efficacy|0|||
150011133|NCT00454584|541174154|FG000|After Controlled Period|Lost to Follow-up|0|||
150011134|NCT00454584|541174155|FG001|After Controlled Period|Lost to Follow-up|0|||
150011135|NCT00454584|541174156|FG002|After Controlled Period|Lost to Follow-up|0|||
150011136|NCT00454584|541174157|FG003|After Controlled Period|Lost to Follow-up|2|||
150011137|NCT00454584|541174158|FG004|After Controlled Period|Lost to Follow-up|4|||
150011138|NCT00454584|541174159|FG005|After Controlled Period|Lost to Follow-up|6|||
150011139|NCT00454584|541174154|FG000|After Controlled Period|Other|0|||
150011140|NCT00454584|541174155|FG001|After Controlled Period|Other|0|||
150011141|NCT00454584|541174156|FG002|After Controlled Period|Other|0|||
150011142|NCT00454584|541174157|FG003|After Controlled Period|Other|1|||
150011143|NCT00454584|541174158|FG004|After Controlled Period|Other|0|||
150011144|NCT00454584|541174159|FG005|After Controlled Period|Other|0|||
150011145|NCT00454584|541174154|FG000|After Controlled Period|Other|0|||
150011146|NCT00454584|541174155|FG001|After Controlled Period|Other|0|||
150011147|NCT00454584|541174156|FG002|After Controlled Period|Other|0|||
150011148|NCT00454584|541174157|FG003|After Controlled Period|Other|13|||
150011149|NCT00454584|541174158|FG004|After Controlled Period|Other|5|||
150011150|NCT00454584|541174159|FG005|After Controlled Period|Other|17|||
150011151|NCT02760810|541174160|FG000|Overall Study|Protocol Violation|1|||
150011152|NCT02421601|541174161|FG000|Overall Study|Adverse Event|4|||
150011153|NCT02421601|541174161|FG000|Overall Study|Lack of Efficacy|5|||
150011154|NCT02421601|541174161|FG000|Overall Study|Physician Decision|1|||
150011155|NCT02421601|541174161|FG000|Overall Study|Withdrawal by Subject|31|||
150011156|NCT02421601|541174161|FG000|Overall Study|Others|41|||
150011157|NCT01716104|541174162|FG000|Overall Study|Do not meet inclusion criteria|6|||
150011158|NCT01716104|541174163|FG001|Overall Study|Do not meet inclusion criteria|7|||
150011159|NCT00117793|541174164|FG000|Overall Study|Withdrawal by Subject|12|||
150011160|NCT00581360|541174165|FG000|Overall Study|Withdrawal by Subject|1|||
150011161|NCT02895945|541174166|FG000|Overall Study|Physician Decision|2|||
150011162|NCT02895945|541174167|FG001|Overall Study|Physician Decision|1|||
150011163|NCT03429543|541174172|FG000|Overall Study|Adverse Event|1|||
150011164|NCT03429543|541174173|FG001|Overall Study|Adverse Event|1|||
150011165|NCT03429543|541174174|FG002|Overall Study|Adverse Event|0|||
150011166|NCT03429543|541174175|FG003|Overall Study|Adverse Event|0|||
150011167|NCT03429543|541174176|FG004|Overall Study|Adverse Event|0|||
150011168|NCT03429543|541174177|FG005|Overall Study|Adverse Event|2|||
150011169|NCT03429543|541174178|FG006|Overall Study|Adverse Event|0|||
150011170|NCT03429543|541174172|FG000|Overall Study|Lost to Follow-up|1|||
150011171|NCT03429543|541174173|FG001|Overall Study|Lost to Follow-up|0|||
150011172|NCT03429543|541174174|FG002|Overall Study|Lost to Follow-up|0|||
150011173|NCT03429543|541174175|FG003|Overall Study|Lost to Follow-up|0|||
150011174|NCT03429543|541174176|FG004|Overall Study|Lost to Follow-up|1|||
150011175|NCT03429543|541174177|FG005|Overall Study|Lost to Follow-up|0|||
150011176|NCT03429543|541174178|FG006|Overall Study|Lost to Follow-up|0|||
150011177|NCT03429543|541174172|FG000|Overall Study|Withdrawal by Subject|5|||
150057854|NCT00420641|541353562|FG002|Overall Study|Lost to Follow-up|2|||
150011178|NCT03429543|541174173|FG001|Overall Study|Withdrawal by Subject|0|||
150011179|NCT03429543|541174174|FG002|Overall Study|Withdrawal by Subject|1|||
150011180|NCT03429543|541174175|FG003|Overall Study|Withdrawal by Subject|2|||
150011181|NCT03429543|541174176|FG004|Overall Study|Withdrawal by Subject|6|||
150011182|NCT03429543|541174177|FG005|Overall Study|Withdrawal by Subject|3|||
150011183|NCT03429543|541174178|FG006|Overall Study|Withdrawal by Subject|1|||
150011184|NCT03429543|541174172|FG000|Overall Study|Other reason than listed|0|||
150011185|NCT03429543|541174173|FG001|Overall Study|Other reason than listed|1|||
150011186|NCT03429543|541174174|FG002|Overall Study|Other reason than listed|0|||
150011187|NCT03429543|541174175|FG003|Overall Study|Other reason than listed|0|||
150011188|NCT03429543|541174176|FG004|Overall Study|Other reason than listed|4|||
150011189|NCT03429543|541174177|FG005|Overall Study|Other reason than listed|4|||
150011190|NCT03429543|541174178|FG006|Overall Study|Other reason than listed|0|||
150011191|NCT03429543|541174172|FG000|Overall Study|Not treated|0|||
150011192|NCT03429543|541174173|FG001|Overall Study|Not treated|0|||
150011193|NCT03429543|541174174|FG002|Overall Study|Not treated|0|||
150011194|NCT03429543|541174175|FG003|Overall Study|Not treated|0|||
150011195|NCT03429543|541174176|FG004|Overall Study|Not treated|1|||
150011196|NCT03429543|541174177|FG005|Overall Study|Not treated|0|||
150011197|NCT03429543|541174178|FG006|Overall Study|Not treated|0|||
150011198|NCT01818492|541174179|FG000|Overall Study|Adverse Event|2|||
150011199|NCT01818492|541174179|FG000|Overall Study|Death|3|||
150011200|NCT01818492|541174179|FG000|Overall Study|Withdrawal by Subject|1|||
150011201|NCT01818492|541174179|FG000|Overall Study|Additional therapy when not allowed PP|4|||
150011202|NCT00989781|541174182|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
150011203|NCT00989781|541174183|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
150011204|NCT01026220|541174184|FG000|Induction|Death|1|||
150011205|NCT01026220|541174185|FG001|Induction|Death|0|||
150011206|NCT01026220|541174186|FG002|Induction|Death|0|||
150011207|NCT01026220|541174184|FG000|Induction|Lack of Efficacy|2|||
150011208|NCT01026220|541174185|FG001|Induction|Lack of Efficacy|0|||
150011209|NCT01026220|541174186|FG002|Induction|Lack of Efficacy|0|||
150011210|NCT01026220|541174184|FG000|Induction|Physician Decision|12|||
150011211|NCT01026220|541174185|FG001|Induction|Physician Decision|0|||
150011212|NCT01026220|541174186|FG002|Induction|Physician Decision|0|||
150011213|NCT01026220|541174184|FG000|Induction|Withdrawal by Subject|9|||
150011214|NCT01026220|541174185|FG001|Induction|Withdrawal by Subject|0|||
150011215|NCT01026220|541174186|FG002|Induction|Withdrawal by Subject|0|||
150011216|NCT01026220|541174184|FG000|Induction|Ineligible|1|||
150011217|NCT01026220|541174185|FG001|Induction|Ineligible|0|||
150011218|NCT01026220|541174186|FG002|Induction|Ineligible|0|||
150011219|NCT01026220|541174184|FG000|Consolidation Maintenance|Death|0|||
150011220|NCT01026220|541174185|FG001|Consolidation Maintenance|Death|1|||
150011221|NCT01026220|541174186|FG002|Consolidation Maintenance|Death|0|||
150011222|NCT01026220|541174184|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
150011223|NCT01026220|541174185|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
150011224|NCT01026220|541174186|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
150011225|NCT01026220|541174184|FG000|Consolidation Maintenance|Physician Decision|0|||
150011226|NCT01026220|541174185|FG001|Consolidation Maintenance|Physician Decision|2|||
150011227|NCT01026220|541174186|FG002|Consolidation Maintenance|Physician Decision|7|||
150011228|NCT01026220|541174184|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
150011229|NCT01026220|541174185|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
150011230|NCT01026220|541174186|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
150011231|NCT00409344|541174189|FG000|Overall Study|no enrollment|0|||
150011232|NCT00409344|541174190|FG001|Overall Study|no enrollment|0|||
150011233|NCT05096312|541174191|FG000|Overall Study|Lost to Follow-up|2|||
150011234|NCT05096312|541174192|FG001|Overall Study|Lost to Follow-up|4|||
150011235|NCT05096312|541174191|FG000|Overall Study|Adverse Event|1|||
150011236|NCT05096312|541174192|FG001|Overall Study|Adverse Event|0|||
150011237|NCT00498355|541174197|FG000|Overall Study|Lost to Follow-up|1|||
150011238|NCT02814175|541176338|FG000|Part 1|Adverse Event|2|||
150011239|NCT02814175|541176339|FG001|Part 1|Adverse Event|3|||
150011240|NCT02814175|541176340|FG002|Part 1|Adverse Event|0|||
150011241|NCT02814175|541176341|FG003|Part 1|Adverse Event|0|||
150011242|NCT02814175|541176342|FG004|Part 1|Adverse Event|0|||
150011243|NCT02814175|541176343|FG005|Part 1|Adverse Event|0|||
150057855|NCT00420641|541353560|FG000|Overall Study|Protocol Violation|8|||
150057856|NCT00420641|541353561|FG001|Overall Study|Protocol Violation|8|||
150057857|NCT00420641|541353562|FG002|Overall Study|Protocol Violation|7|||
150057858|NCT00420641|541353560|FG000|Overall Study|Withdrawal by Subject|15|||
150057859|NCT00420641|541353561|FG001|Overall Study|Withdrawal by Subject|21|||
150057860|NCT00420641|541353562|FG002|Overall Study|Withdrawal by Subject|14|||
150057861|NCT00420641|541353560|FG000|Overall Study|Lack of Efficacy|6|||
150057862|NCT00420641|541353561|FG001|Overall Study|Lack of Efficacy|5|||
150057863|NCT00420641|541353562|FG002|Overall Study|Lack of Efficacy|4|||
150181102|NCT02590432|541801009|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
150011244|NCT02814175|541176338|FG000|Part 1|Withdrawal Consent|8|||
150057864|NCT00420641|541353560|FG000|Overall Study|Non-compliance|7|||
150011245|NCT02814175|541176339|FG001|Part 1|Withdrawal Consent|1|||
150057865|NCT00420641|541353561|FG001|Overall Study|Non-compliance|5|||
150181103|NCT02590432|541801010|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
150181104|NCT02590432|541801011|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
150011246|NCT02814175|541176340|FG002|Part 1|Withdrawal Consent|0|||
150011247|NCT02814175|541176341|FG003|Part 1|Withdrawal Consent|0|||
150057866|NCT00420641|541353562|FG002|Overall Study|Non-compliance|4|||
150011248|NCT02814175|541176342|FG004|Part 1|Withdrawal Consent|0|||
150011249|NCT02814175|541176343|FG005|Part 1|Withdrawal Consent|0|||
150011250|NCT02814175|541176338|FG000|Part 1|Lost to Follow-up|1|||
150011251|NCT02814175|541176339|FG001|Part 1|Lost to Follow-up|0|||
150011252|NCT02814175|541176340|FG002|Part 1|Lost to Follow-up|0|||
150011253|NCT02814175|541176341|FG003|Part 1|Lost to Follow-up|0|||
150011254|NCT02814175|541176342|FG004|Part 1|Lost to Follow-up|0|||
150011255|NCT02814175|541176343|FG005|Part 1|Lost to Follow-up|0|||
150011256|NCT02814175|541176338|FG000|Part 1|Lack of Efficacy|1|||
150011257|NCT02814175|541176339|FG001|Part 1|Lack of Efficacy|2|||
150011258|NCT02814175|541176340|FG002|Part 1|Lack of Efficacy|0|||
150011259|NCT02814175|541176341|FG003|Part 1|Lack of Efficacy|0|||
150011260|NCT02814175|541176342|FG004|Part 1|Lack of Efficacy|0|||
150011261|NCT02814175|541176343|FG005|Part 1|Lack of Efficacy|0|||
150011262|NCT02814175|541176338|FG000|Part 2|Adverse Event|0|||
150011263|NCT02814175|541176339|FG001|Part 2|Adverse Event|0|||
150011264|NCT02814175|541176340|FG002|Part 2|Adverse Event|0|||
150011265|NCT02814175|541176341|FG003|Part 2|Adverse Event|1|||
150011266|NCT02814175|541176342|FG004|Part 2|Adverse Event|1|||
150011267|NCT02814175|541176343|FG005|Part 2|Adverse Event|2|||
150011268|NCT02814175|541176338|FG000|Part 2|Withdrawal Consent|0|||
150011269|NCT02814175|541176339|FG001|Part 2|Withdrawal Consent|0|||
150011270|NCT02814175|541176340|FG002|Part 2|Withdrawal Consent|0|||
150011271|NCT02814175|541176341|FG003|Part 2|Withdrawal Consent|2|||
150011272|NCT02814175|541176342|FG004|Part 2|Withdrawal Consent|1|||
150011273|NCT02814175|541176343|FG005|Part 2|Withdrawal Consent|1|||
150011274|NCT02814175|541176338|FG000|Part 2|Lost to Follow-up|0|||
150011275|NCT02814175|541176339|FG001|Part 2|Lost to Follow-up|0|||
150011276|NCT02814175|541176340|FG002|Part 2|Lost to Follow-up|0|||
150011277|NCT02814175|541176341|FG003|Part 2|Lost to Follow-up|1|||
150011278|NCT02814175|541176342|FG004|Part 2|Lost to Follow-up|0|||
150011279|NCT02814175|541176343|FG005|Part 2|Lost to Follow-up|0|||
150011280|NCT02814175|541176338|FG000|Part 2|Lack of Efficacy|0|||
150011281|NCT02814175|541176339|FG001|Part 2|Lack of Efficacy|0|||
150011282|NCT02814175|541176340|FG002|Part 2|Lack of Efficacy|0|||
150011283|NCT02814175|541176341|FG003|Part 2|Lack of Efficacy|0|||
150011284|NCT02814175|541176342|FG004|Part 2|Lack of Efficacy|0|||
150011285|NCT02814175|541176343|FG005|Part 2|Lack of Efficacy|3|||
150011286|NCT01971008|541176344|FG000|Overall Study|Protocol Violation|2|||
150011287|NCT01971008|541176345|FG001|Overall Study|Protocol Violation|1|||
150011288|NCT03679624|541176349|FG000|Overall Study|Adverse Event|1|||
150011289|NCT03679624|541176350|FG001|Overall Study|Adverse Event|0|||
150011290|NCT01329939|541176365|FG000|Overall Study|Lost to Follow-up|3|||
150011291|NCT01329939|541176366|FG001|Overall Study|Lost to Follow-up|0|||
150011292|NCT01329939|541176367|FG002|Overall Study|Lost to Follow-up|1|||
150011293|NCT01329939|541176368|FG003|Overall Study|Lost to Follow-up|2|||
150011294|NCT01329939|541176365|FG000|Overall Study|Withdrawal by Subject|0|||
150011295|NCT01329939|541176366|FG001|Overall Study|Withdrawal by Subject|1|||
150011296|NCT01329939|541176367|FG002|Overall Study|Withdrawal by Subject|0|||
150011297|NCT01329939|541176368|FG003|Overall Study|Withdrawal by Subject|0|||
150011298|NCT01329939|541176365|FG000|Overall Study|Adverse Event|0|||
150011299|NCT01329939|541176366|FG001|Overall Study|Adverse Event|0|||
150011300|NCT01329939|541176367|FG002|Overall Study|Adverse Event|0|||
150011301|NCT01329939|541176368|FG003|Overall Study|Adverse Event|3|||
150011302|NCT01753401|541176371|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
150011303|NCT01753401|541176372|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
150011304|NCT01753401|541176373|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
150011305|NCT01753401|541176374|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
150011306|NCT01753401|541176371|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
150011307|NCT01753401|541176372|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
150011308|NCT01753401|541176373|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
150011309|NCT01753401|541176374|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
150057867|NCT00420641|541353560|FG000|Overall Study|Other|4|||
150057868|NCT00420641|541353561|FG001|Overall Study|Other|4|||
150057869|NCT00420641|541353562|FG002|Overall Study|Other|3|||
150057870|NCT03459690|541353568|FG000|Overall Study|Lost to Follow-up|0|||
150057871|NCT03459690|541353569|FG001|Overall Study|Lost to Follow-up|1|||
150057872|NCT03459690|541353568|FG000|Overall Study|Withdrawal by Subject|1|||
150057873|NCT03459690|541353569|FG001|Overall Study|Withdrawal by Subject|1|||
150057874|NCT02586506|541353570|FG000|Overall Study|Protocol Violation|6|||
150057875|NCT02586506|541353570|FG000|Overall Study|Lost to Follow-up|1|||
150057876|NCT02586506|541353570|FG000|Overall Study|Other Reason|2|||
150057877|NCT02536404|541353576|FG000|Overall Study|Adverse Event|5|||
150057878|NCT02536404|541353577|FG001|Overall Study|Adverse Event|0|||
150057879|NCT02536404|541353576|FG000|Overall Study|Withdrawal by Subject|4|||
150057880|NCT02536404|541353577|FG001|Overall Study|Withdrawal by Subject|1|||
150011310|NCT01753401|541176371|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
150011311|NCT01753401|541176372|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
150011312|NCT01753401|541176373|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
150011313|NCT01753401|541176374|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
150011314|NCT01753401|541176371|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
150011315|NCT01753401|541176372|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
150011316|NCT01753401|541176373|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
150011317|NCT01753401|541176374|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
150011318|NCT01753401|541176371|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
150011319|NCT01753401|541176372|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
150011320|NCT01753401|541176373|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
150011321|NCT01753401|541176374|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
150057881|NCT02536404|541353576|FG000|Overall Study|Physician Decision|10|||
150011322|NCT01753401|541176371|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
150011323|NCT01753401|541176372|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
150011324|NCT01753401|541176373|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
150011325|NCT01753401|541176374|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
150011326|NCT01753401|541176371|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
150181105|NCT02590432|541801012|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
150011327|NCT01753401|541176372|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
150011328|NCT01753401|541176373|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
150011329|NCT01753401|541176374|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
150011330|NCT00470418|541176375|FG000|Overall Study|Withdrawal by Subject|1|||
150011331|NCT00470418|541176376|FG001|Overall Study|Withdrawal by Subject|0|||
150011332|NCT00599638|541176377|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
150011333|NCT00599638|541176378|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
150011334|NCT00599638|541176379|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
150011335|NCT00599638|541176380|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
150011336|NCT00599638|541176377|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
150011337|NCT00599638|541176378|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
150011338|NCT00599638|541176379|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
150011339|NCT00599638|541176380|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
150011340|NCT00599638|541176377|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
150011341|NCT00599638|541176378|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
150011342|NCT00599638|541176379|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
150011343|NCT00599638|541176380|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
150011344|NCT00599638|541176377|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
150011345|NCT00599638|541176378|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
150011346|NCT00599638|541176379|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
150011347|NCT00599638|541176380|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
150011348|NCT00599638|541176377|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
150011349|NCT00599638|541176378|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
150011350|NCT00599638|541176379|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
150011351|NCT00599638|541176380|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
150011352|NCT00599638|541176377|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
150011353|NCT00599638|541176378|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
150011354|NCT00599638|541176379|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
150011355|NCT00599638|541176380|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
150011356|NCT00599638|541176377|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
150181106|NCT02590432|541801013|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
150181107|NCT02590432|541801014|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
150181108|NCT02590432|541801006|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
150181109|NCT02590432|541801007|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
150011357|NCT00599638|541176378|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
150011358|NCT00599638|541176379|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
150011359|NCT00599638|541176380|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
150011360|NCT00599638|541176377|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
150011361|NCT00599638|541176378|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
150011362|NCT00599638|541176379|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
150011363|NCT00599638|541176380|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
150011364|NCT00599638|541176377|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
150011365|NCT00599638|541176378|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
150011366|NCT00599638|541176379|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
150011367|NCT00599638|541176380|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
150011368|NCT03006887|541176384|FG000|Overall Study|Adverse Event|1|||
150011369|NCT00462748|541176385|FG000|Overall Study|Adverse Event|7|||
150011370|NCT00462748|541176386|FG001|Overall Study|Adverse Event|5|||
150011371|NCT00462748|541176387|FG002|Overall Study|Adverse Event|9|||
150011372|NCT00462748|541176385|FG000|Overall Study|Protocol Violation|0|||
150011373|NCT00462748|541176386|FG001|Overall Study|Protocol Violation|2|||
150011374|NCT00462748|541176387|FG002|Overall Study|Protocol Violation|1|||
150011375|NCT00462748|541176385|FG000|Overall Study|Withdrew consent|3|||
150011376|NCT00462748|541176386|FG001|Overall Study|Withdrew consent|3|||
150011377|NCT00462748|541176387|FG002|Overall Study|Withdrew consent|0|||
150011378|NCT00462748|541176385|FG000|Overall Study|Lost to Follow-up|1|||
150011379|NCT00462748|541176386|FG001|Overall Study|Lost to Follow-up|1|||
150011380|NCT00462748|541176387|FG002|Overall Study|Lost to Follow-up|1|||
150011381|NCT00462748|541176385|FG000|Overall Study|Discontinued after 41 days Rx|1|||
150011382|NCT00462748|541176386|FG001|Overall Study|Discontinued after 41 days Rx|0|||
150057882|NCT02536404|541353577|FG001|Overall Study|Physician Decision|0|||
150057883|NCT02536404|541353576|FG000|Overall Study|Sponsor decision|1|||
150057884|NCT02536404|541353577|FG001|Overall Study|Sponsor decision|0|||
150057885|NCT01381562|541353580|FG000|Overall Study|Adverse Event|0|||
150057886|NCT01381562|541353581|FG001|Overall Study|Adverse Event|1|||
150057887|NCT01381562|541353582|FG002|Overall Study|Adverse Event|0|||
150057888|NCT00308581|541353586|FG000|Induction Phase|Adverse Event|0|||
150057889|NCT00308581|541353587|FG001|Induction Phase|Adverse Event|0|||
150057890|NCT00308581|541353588|FG002|Induction Phase|Adverse Event|37|||
150057891|NCT00308581|541353586|FG000|Induction Phase|Lack of Efficacy|0|||
150011383|NCT00462748|541176387|FG002|Overall Study|Discontinued after 41 days Rx|0|||
150011384|NCT01729208|541176388|FG000|Baseline|Physician Decision|5|||
150011385|NCT01729208|541176389|FG001|Baseline|Physician Decision|4|||
150011386|NCT01729208|541176388|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
150011387|NCT01729208|541176389|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
150011388|NCT01729208|541176388|FG000|12 Months Follow-up|Lost to Follow-up|3|||
150011389|NCT01729208|541176389|FG001|12 Months Follow-up|Lost to Follow-up|3|||
150011390|NCT01729208|541176388|FG000|24 Months Follow-up|Lost to Follow-up|3|||
150011391|NCT01729208|541176389|FG001|24 Months Follow-up|Lost to Follow-up|0|||
150011392|NCT01729208|541176388|FG000|36 Months Follow-up|Physician Decision|1|||
150011393|NCT01729208|541176389|FG001|36 Months Follow-up|Physician Decision|0|||
150011394|NCT01729208|541176388|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
150011395|NCT01729208|541176389|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
150011396|NCT02428413|541176390|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
150011397|NCT02428413|541176391|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
150011398|NCT02428413|541176390|FG000|Overall Study|Protocol Violation|1|||
150011399|NCT02428413|541176391|FG001|Overall Study|Protocol Violation|2|||
150011400|NCT02428413|541176390|FG000|Overall Study|Case Cancelled|2|||
150011401|NCT02428413|541176391|FG001|Overall Study|Case Cancelled|0|||
150011402|NCT02428413|541176390|FG000|Overall Study|Missed Cases|1|||
150011403|NCT02428413|541176391|FG001|Overall Study|Missed Cases|2|||
150011404|NCT02428413|541176390|FG000|Overall Study|Nurse Refusal|1|||
150011405|NCT02428413|541176391|FG001|Overall Study|Nurse Refusal|0|||
150011406|NCT03688100|541176393|FG000|Overall Study|Lost to Follow-up|21|||
150011407|NCT03688100|541176394|FG001|Overall Study|Lost to Follow-up|15|||
150011408|NCT03688100|541176395|FG002|Overall Study|Lost to Follow-up|15|||
150011409|NCT03688100|541176396|FG003|Overall Study|Lost to Follow-up|18|||
150011410|NCT03688100|541176393|FG000|Overall Study|Withdrawal by Subject|19|||
150011411|NCT03688100|541176394|FG001|Overall Study|Withdrawal by Subject|16|||
150011412|NCT03688100|541176395|FG002|Overall Study|Withdrawal by Subject|0|||
150011413|NCT03688100|541176396|FG003|Overall Study|Withdrawal by Subject|0|||
150011414|NCT03688100|541176393|FG000|Overall Study|Death|36|||
150011415|NCT03688100|541176394|FG001|Overall Study|Death|27|||
150011416|NCT03688100|541176395|FG002|Overall Study|Death|0|||
150011417|NCT03688100|541176396|FG003|Overall Study|Death|0|||
150011418|NCT02453555|541176406|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
150011419|NCT02453555|541176407|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
150011420|NCT02453555|541176408|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
150011421|NCT02453555|541176409|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
150011422|NCT02453555|541176410|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
150011423|NCT02453555|541176411|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
150011424|NCT02453555|541176406|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
150011425|NCT02453555|541176407|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
150011426|NCT02453555|541176408|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
150011427|NCT02453555|541176409|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
150011428|NCT02453555|541176410|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
150011429|NCT02453555|541176411|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
150057892|NCT00308581|541353587|FG001|Induction Phase|Lack of Efficacy|0|||
150057893|NCT00308581|541353588|FG002|Induction Phase|Lack of Efficacy|121|||
150057894|NCT00308581|541353586|FG000|Induction Phase|Withdrawal by Subject|0|||
150057895|NCT00308581|541353587|FG001|Induction Phase|Withdrawal by Subject|0|||
150011430|NCT02453555|541176406|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
150057896|NCT00308581|541353588|FG002|Induction Phase|Withdrawal by Subject|5|||
150011431|NCT02453555|541176407|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
150011432|NCT02453555|541176408|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
150011433|NCT02453555|541176409|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
150011434|NCT02453555|541176410|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
150011435|NCT02453555|541176411|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
150011436|NCT02453555|541176406|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
150011437|NCT02453555|541176407|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
150011438|NCT02453555|541176408|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
150011439|NCT02453555|541176409|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
150011440|NCT02453555|541176410|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
150011441|NCT02453555|541176411|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
150011442|NCT02453555|541176406|FG000|Extension Period|Adverse Event|0|||
150011443|NCT02453555|541176407|FG001|Extension Period|Adverse Event|0|||
150011444|NCT02453555|541176408|FG002|Extension Period|Adverse Event|1|||
150011445|NCT02453555|541176409|FG003|Extension Period|Adverse Event|2|||
150011446|NCT02453555|541176410|FG004|Extension Period|Adverse Event|1|||
150011447|NCT02453555|541176411|FG005|Extension Period|Adverse Event|1|||
150011448|NCT02453555|541176406|FG000|Extension Period|Protocol Violation|0|||
150011449|NCT02453555|541176407|FG001|Extension Period|Protocol Violation|0|||
150011450|NCT02453555|541176408|FG002|Extension Period|Protocol Violation|1|||
150011451|NCT02453555|541176409|FG003|Extension Period|Protocol Violation|0|||
150011452|NCT02453555|541176410|FG004|Extension Period|Protocol Violation|0|||
150011453|NCT02453555|541176411|FG005|Extension Period|Protocol Violation|0|||
150011454|NCT02453555|541176406|FG000|Extension Period|Withdrawal by Subject|0|||
150011455|NCT02453555|541176407|FG001|Extension Period|Withdrawal by Subject|0|||
150011456|NCT02453555|541176408|FG002|Extension Period|Withdrawal by Subject|1|||
150011457|NCT02453555|541176409|FG003|Extension Period|Withdrawal by Subject|0|||
150011458|NCT02453555|541176410|FG004|Extension Period|Withdrawal by Subject|0|||
150011459|NCT02453555|541176411|FG005|Extension Period|Withdrawal by Subject|0|||
150011460|NCT03689855|541176416|FG000|Overall Study|Adverse Event|3|||
150011461|NCT03689855|541176416|FG000|Overall Study|Withdrawal by Subject|1|||
150011462|NCT02409719|541176417|FG000|Overall Study|Lost to Follow-up|3|||
150011463|NCT02409719|541176418|FG001|Overall Study|Lost to Follow-up|3|||
150011464|NCT02479139|541176419|FG000|Overall Study|Lost to Follow-up|2|||
150011465|NCT02479139|541176420|FG001|Overall Study|Lost to Follow-up|4|||
150011466|NCT02479139|541176421|FG002|Overall Study|Lost to Follow-up|4|||
150011467|NCT02479139|541176422|FG003|Overall Study|Lost to Follow-up|2|||
150011468|NCT02479139|541176423|FG004|Overall Study|Lost to Follow-up|3|||
150011469|NCT02479139|541176424|FG005|Overall Study|Lost to Follow-up|5|||
150011470|NCT02479139|541176419|FG000|Overall Study|Withdrew Consent|5|||
150011471|NCT02479139|541176420|FG001|Overall Study|Withdrew Consent|6|||
150011472|NCT02479139|541176421|FG002|Overall Study|Withdrew Consent|1|||
150011473|NCT02479139|541176422|FG003|Overall Study|Withdrew Consent|4|||
150011474|NCT02479139|541176423|FG004|Overall Study|Withdrew Consent|1|||
150011475|NCT02479139|541176424|FG005|Overall Study|Withdrew Consent|1|||
150011476|NCT02479139|541176419|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
150011477|NCT02479139|541176420|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
150011478|NCT02479139|541176421|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
150011479|NCT02479139|541176422|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
150011480|NCT02479139|541176423|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
150011481|NCT02479139|541176424|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
150011482|NCT02479139|541176419|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150011483|NCT02479139|541176420|FG001|Overall Study|Other Miscellaneous Reasons|0|||
150011484|NCT02479139|541176421|FG002|Overall Study|Other Miscellaneous Reasons|1|||
150011485|NCT02479139|541176422|FG003|Overall Study|Other Miscellaneous Reasons|1|||
150011486|NCT02479139|541176423|FG004|Overall Study|Other Miscellaneous Reasons|1|||
150011487|NCT02479139|541176424|FG005|Overall Study|Other Miscellaneous Reasons|0|||
150011488|NCT00764673|541176425|FG000|Overall Study|Death|1|||
150011489|NCT00764673|541176425|FG000|Overall Study|Lost to Follow-up|3|||
150011490|NCT00764673|541176425|FG000|Overall Study|Withdrawal by Subject|6|||
150011491|NCT00764673|541176425|FG000|Overall Study|Revision of Device|2|||
150011492|NCT01438177|541176426|FG000|Overall Study|Withdrawal by Subject|1|||
150011493|NCT01438177|541176426|FG000|Overall Study|Initiation of new therapy|1|||
150011494|NCT01727336|541176427|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
150011495|NCT01727336|541176428|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
150011496|NCT01727336|541176429|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
150011497|NCT01727336|541176430|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
150011498|NCT01727336|541176431|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
150011499|NCT01727336|541176432|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
150011500|NCT01727336|541176427|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
150011501|NCT01727336|541176428|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
150011502|NCT01727336|541176429|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
150011503|NCT01727336|541176430|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
150011504|NCT01727336|541176431|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
150011505|NCT01727336|541176432|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
150011506|NCT01727336|541176427|FG000|Part 2 Blinded|Death|0|||
150011507|NCT01727336|541176428|FG001|Part 2 Blinded|Death|0|||
150011508|NCT01727336|541176429|FG002|Part 2 Blinded|Death|0|||
150011509|NCT01727336|541176430|FG003|Part 2 Blinded|Death|0|||
150011510|NCT01727336|541176431|FG004|Part 2 Blinded|Death|20|||
150011511|NCT01727336|541176432|FG005|Part 2 Blinded|Death|16|||
150011512|NCT01727336|541176427|FG000|Part 2 Blinded|Lack of Efficacy|0|||
150011513|NCT01727336|541176428|FG001|Part 2 Blinded|Lack of Efficacy|0|||
150011514|NCT01727336|541176429|FG002|Part 2 Blinded|Lack of Efficacy|0|||
150011515|NCT01727336|541176430|FG003|Part 2 Blinded|Lack of Efficacy|0|||
150011516|NCT01727336|541176431|FG004|Part 2 Blinded|Lack of Efficacy|42|||
150011517|NCT01727336|541176432|FG005|Part 2 Blinded|Lack of Efficacy|44|||
150011518|NCT01727336|541176427|FG000|Part 2 Blinded|Lost to Follow-up|0|||
150011519|NCT01727336|541176428|FG001|Part 2 Blinded|Lost to Follow-up|0|||
150011520|NCT01727336|541176429|FG002|Part 2 Blinded|Lost to Follow-up|0|||
150011521|NCT01727336|541176430|FG003|Part 2 Blinded|Lost to Follow-up|0|||
150011522|NCT01727336|541176431|FG004|Part 2 Blinded|Lost to Follow-up|0|||
150011523|NCT01727336|541176432|FG005|Part 2 Blinded|Lost to Follow-up|1|||
150011524|NCT01727336|541176427|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
150011525|NCT01727336|541176428|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
150011526|NCT01727336|541176429|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
150011527|NCT01727336|541176430|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
150011528|NCT01727336|541176431|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
150011529|NCT01727336|541176432|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
150011530|NCT01727336|541176427|FG000|Part 2 Blinded|use of prohibited medications|0|||
150011531|NCT01727336|541176428|FG001|Part 2 Blinded|use of prohibited medications|0|||
150011532|NCT01727336|541176429|FG002|Part 2 Blinded|use of prohibited medications|0|||
150011533|NCT01727336|541176430|FG003|Part 2 Blinded|use of prohibited medications|0|||
150011534|NCT01727336|541176431|FG004|Part 2 Blinded|use of prohibited medications|1|||
150011535|NCT01727336|541176432|FG005|Part 2 Blinded|use of prohibited medications|3|||
150011536|NCT00619099|541176435|FG000|Overall Study|Progressive Disease|7|||
150011537|NCT00619099|541176436|FG001|Overall Study|Progressive Disease|5|||
150011538|NCT00619099|541176435|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
150011539|NCT00619099|541176436|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
150011540|NCT00619099|541176435|FG000|Overall Study|Adverse Event|4|||
150011541|NCT00619099|541176436|FG001|Overall Study|Adverse Event|3|||
150011542|NCT00619099|541176435|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
150011543|NCT00619099|541176436|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
150011544|NCT00619099|541176435|FG000|Overall Study|Withdrawal by Subject|10|||
150011545|NCT00619099|541176436|FG001|Overall Study|Withdrawal by Subject|2|||
150011546|NCT00619099|541176435|FG000|Overall Study|Physician Decision|9|||
150011547|NCT00619099|541176436|FG001|Overall Study|Physician Decision|6|||
150011548|NCT00885482|541176437|FG000|Overall Study|Pregnancy|1|||
150011549|NCT00885482|541176437|FG000|Overall Study|Lack of Efficacy|1|||
150011550|NCT00885482|541176437|FG000|Overall Study|Death|1|||
150011551|NCT00885482|541176437|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
150011552|NCT00084656|541176438|FG000|Overall Study|Other reasons|0|||
150011553|NCT00084656|541176439|FG001|Overall Study|Other reasons|12|||
150011554|NCT00084656|541176440|FG002|Overall Study|Other reasons|11|||
150011555|NCT00084656|541176438|FG000|Overall Study|Withdrawal by Subject|15|||
150011556|NCT00084656|541176439|FG001|Overall Study|Withdrawal by Subject|4|||
150011557|NCT00084656|541176440|FG002|Overall Study|Withdrawal by Subject|4|||
150011558|NCT00084656|541176438|FG000|Overall Study|Disease relapse|0|||
150011559|NCT00084656|541176439|FG001|Overall Study|Disease relapse|9|||
150011560|NCT00084656|541176440|FG002|Overall Study|Disease relapse|10|||
150011561|NCT00084656|541176438|FG000|Overall Study|Disease progression|9|||
150011562|NCT00084656|541176439|FG001|Overall Study|Disease progression|0|||
150011563|NCT00084656|541176440|FG002|Overall Study|Disease progression|0|||
150011564|NCT00084656|541176438|FG000|Overall Study|Lost to Follow-up|1|||
150011565|NCT00084656|541176439|FG001|Overall Study|Lost to Follow-up|0|||
150011566|NCT00084656|541176440|FG002|Overall Study|Lost to Follow-up|1|||
150011567|NCT02772978|541176441|FG000|Overall Study|Withdrawal by Subject|1|||
150011568|NCT02772978|541176442|FG001|Overall Study|Withdrawal by Subject|1|||
150181110|NCT02590432|541801008|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
150011569|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
150011570|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
150011571|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
150011572|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
150011573|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
150011574|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
150011575|NCT01389323|541176449|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
150011576|NCT01389323|541176449|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
150011577|NCT01389323|541176449|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
150011578|NCT01389323|541176449|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
150011579|NCT01389323|541176449|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
150011580|NCT04349033|541176454|FG000|Overall Study|Lost to Follow-up|3|||
150011581|NCT04349033|541176455|FG001|Overall Study|Lost to Follow-up|1|||
150011582|NCT04349033|541176456|FG002|Overall Study|Lost to Follow-up|1|||
150011583|NCT03596450|541176466|FG000|Overall Study|Death|9|||
150011584|NCT03596450|541176467|FG001|Overall Study|Death|9|||
150011585|NCT03596450|541176466|FG000|Overall Study|Protocol Violation|18|||
150011586|NCT03596450|541176467|FG001|Overall Study|Protocol Violation|26|||
150011587|NCT03596450|541176466|FG000|Overall Study|Lost to Follow-up|50|||
150011588|NCT03596450|541176467|FG001|Overall Study|Lost to Follow-up|56|||
150011589|NCT03596450|541176466|FG000|Overall Study|Adverse Event|14|||
150011590|NCT03596450|541176467|FG001|Overall Study|Adverse Event|7|||
150011591|NCT03596450|541176466|FG000|Overall Study|Withdrawal by Subject|38|||
150011592|NCT03596450|541176467|FG001|Overall Study|Withdrawal by Subject|36|||
150011593|NCT03596450|541176466|FG000|Overall Study|Accidentally Randomized|2|||
150011594|NCT03596450|541176467|FG001|Overall Study|Accidentally Randomized|0|||
150011595|NCT03596450|541176466|FG000|Overall Study|Other reasons|48|||
150011596|NCT03596450|541176467|FG001|Overall Study|Other reasons|53|||
150011597|NCT03596450|541176466|FG000|Overall Study|Pregnancy|2|||
150011598|NCT03596450|541176467|FG001|Overall Study|Pregnancy|0|||
150011599|NCT04583956|541176468|FG000|Overall Study|Death|9|||
150011600|NCT04583956|541176469|FG001|Overall Study|Death|11|||
150011601|NCT04583956|541176468|FG000|Overall Study|Lost to Follow-up|7|||
150011602|NCT04583956|541176469|FG001|Overall Study|Lost to Follow-up|9|||
150011603|NCT04583956|541176468|FG000|Overall Study|Protocol Violation|2|||
150011604|NCT04583956|541176469|FG001|Overall Study|Protocol Violation|0|||
150011605|NCT04583956|541176468|FG000|Overall Study|Withdrawal by Subject|0|||
150011606|NCT04583956|541176469|FG001|Overall Study|Withdrawal by Subject|2|||
150011607|NCT04583956|541176468|FG000|Overall Study|Randomized but not dosed|2|||
150011608|NCT04583956|541176469|FG001|Overall Study|Randomized but not dosed|3|||
150011609|NCT04583956|541176468|FG000|Overall Study|Withdrawal of consent before product administration|1|||
150011610|NCT04583956|541176469|FG001|Overall Study|Withdrawal of consent before product administration|0|||
150011611|NCT01069705|541176470|FG000|Overall Study|Adverse Event|1|||
150011612|NCT01069705|541176470|FG000|Overall Study|Withdrawal by Subject|2|||
150011613|NCT00915551|541176471|FG000|Overall Study|Withdrawal by Subject|0|||
150011614|NCT00915551|541176472|FG001|Overall Study|Withdrawal by Subject|1|||
150011615|NCT04390841|541176473|FG000|Overall Study|Withdrawal by Subject|2|||
150011616|NCT02999633|541176474|FG000|Overall Study|Adverse Event|2|||
150011617|NCT02999633|541176474|FG000|Overall Study|Progressive disease|12|||
150011618|NCT02607228|541176475|FG000|Overall Study|Progressive Disease|4|||
150011619|NCT02607228|541176476|FG001|Overall Study|Progressive Disease|3|||
150011620|NCT02607228|541176477|FG002|Overall Study|Progressive Disease|1|||
150011621|NCT02607228|541176478|FG003|Overall Study|Progressive Disease|5|||
150011622|NCT02607228|541176479|FG004|Overall Study|Progressive Disease|4|||
150011623|NCT02607228|541176480|FG005|Overall Study|Progressive Disease|3|||
150011624|NCT02607228|541176481|FG006|Overall Study|Progressive Disease|1|||
150011625|NCT02607228|541176475|FG000|Overall Study|Adverse Event|1|||
150011626|NCT02607228|541176476|FG001|Overall Study|Adverse Event|0|||
150011627|NCT02607228|541176477|FG002|Overall Study|Adverse Event|1|||
150011628|NCT02607228|541176478|FG003|Overall Study|Adverse Event|0|||
150011629|NCT02607228|541176479|FG004|Overall Study|Adverse Event|1|||
150011630|NCT02607228|541176480|FG005|Overall Study|Adverse Event|1|||
150011631|NCT02607228|541176481|FG006|Overall Study|Adverse Event|1|||
150011632|NCT02607228|541176475|FG000|Overall Study|Investigator's Discretion|0|||
150011633|NCT02607228|541176476|FG001|Overall Study|Investigator's Discretion|0|||
150011634|NCT02607228|541176477|FG002|Overall Study|Investigator's Discretion|1|||
150011635|NCT02607228|541176478|FG003|Overall Study|Investigator's Discretion|0|||
150011636|NCT02607228|541176479|FG004|Overall Study|Investigator's Discretion|0|||
150011637|NCT02607228|541176480|FG005|Overall Study|Investigator's Discretion|1|||
150011638|NCT02607228|541176481|FG006|Overall Study|Investigator's Discretion|0|||
150011639|NCT02607228|541176475|FG000|Overall Study|Withdrew Consent|0|||
150011640|NCT02607228|541176476|FG001|Overall Study|Withdrew Consent|1|||
150011641|NCT02607228|541176477|FG002|Overall Study|Withdrew Consent|0|||
150011642|NCT02607228|541176478|FG003|Overall Study|Withdrew Consent|0|||
150057897|NCT00308581|541353586|FG000|Induction Phase|Unknown reason|0|||
150011643|NCT02607228|541176479|FG004|Overall Study|Withdrew Consent|0|||
150011644|NCT02607228|541176480|FG005|Overall Study|Withdrew Consent|1|||
150011645|NCT02607228|541176481|FG006|Overall Study|Withdrew Consent|0|||
150011646|NCT02607228|541176475|FG000|Overall Study|Study Terminated by Sponsor|0|||
150011647|NCT02607228|541176476|FG001|Overall Study|Study Terminated by Sponsor|0|||
150011648|NCT02607228|541176477|FG002|Overall Study|Study Terminated by Sponsor|0|||
150011649|NCT02607228|541176478|FG003|Overall Study|Study Terminated by Sponsor|1|||
150011650|NCT02607228|541176479|FG004|Overall Study|Study Terminated by Sponsor|0|||
150011651|NCT02607228|541176480|FG005|Overall Study|Study Terminated by Sponsor|0|||
150011652|NCT02607228|541176481|FG006|Overall Study|Study Terminated by Sponsor|0|||
150011653|NCT01196416|541176487|FG000|Overall Study|Withdrawal by Subject|2|||
150011654|NCT03908970|541176488|FG000|Overall Study|Adverse Event|7|||
150011655|NCT03908970|541176489|FG001|Overall Study|Adverse Event|21|||
150011656|NCT03908970|541176488|FG000|Overall Study|Physician Decision|1|||
150011657|NCT03908970|541176489|FG001|Overall Study|Physician Decision|4|||
150011658|NCT03908970|541176488|FG000|Overall Study|Withdrawal by Subject|9|||
150011659|NCT03908970|541176489|FG001|Overall Study|Withdrawal by Subject|22|||
150011660|NCT04407234|541176490|FG000|Overall Study|Adverse Event|3|||
150011661|NCT04407234|541176491|FG001|Overall Study|Adverse Event|3|||
150011662|NCT00727558|541176497|FG000|Overall Study|Lens issue|0|||
150011663|NCT00727558|541176498|FG001|Overall Study|Lens issue|1|||
150011664|NCT00727558|541176497|FG000|Overall Study|Adverse Event|0|||
150011665|NCT00727558|541176498|FG001|Overall Study|Adverse Event|1|||
150011666|NCT00727558|541176497|FG000|Overall Study|Subject unable to return for follow-up|1|||
150011667|NCT00727558|541176498|FG001|Overall Study|Subject unable to return for follow-up|1|||
150011668|NCT00727558|541176497|FG000|Overall Study|Lost to Follow-up|1|||
150011669|NCT00727558|541176498|FG001|Overall Study|Lost to Follow-up|0|||
150011670|NCT01717326|541176499|FG000|Overall Study|Death|0|||
150011671|NCT01717326|541176500|FG001|Overall Study|Death|0|||
150011672|NCT01717326|541176501|FG002|Overall Study|Death|0|||
150011673|NCT01717326|541176502|FG003|Overall Study|Death|0|||
150011674|NCT01717326|541176503|FG004|Overall Study|Death|0|||
150011675|NCT01717326|541176504|FG005|Overall Study|Death|0|||
150011676|NCT01717326|541176505|FG006|Overall Study|Death|0|||
150011677|NCT01717326|541176506|FG007|Overall Study|Death|0|||
150011678|NCT01717326|541176507|FG008|Overall Study|Death|0|||
150011679|NCT01717326|541176508|FG009|Overall Study|Death|0|||
150011680|NCT01717326|541176509|FG010|Overall Study|Death|1|||
150011681|NCT01717326|541176510|FG011|Overall Study|Death|0|||
150011682|NCT01717326|541176511|FG012|Overall Study|Death|0|||
150011683|NCT01717326|541176512|FG013|Overall Study|Death|0|||
150011684|NCT01717326|541176513|FG014|Overall Study|Death|0|||
150011685|NCT01717326|541176514|FG015|Overall Study|Death|0|||
150011686|NCT01717326|541176515|FG016|Overall Study|Death|0|||
150011687|NCT01717326|541176516|FG017|Overall Study|Death|0|||
150011688|NCT01717326|541176517|FG018|Overall Study|Death|0|||
150011689|NCT01717326|541176518|FG019|Overall Study|Death|0|||
150011690|NCT01717326|541176499|FG000|Overall Study|Lost to Follow-up|3|||
150011691|NCT01717326|541176500|FG001|Overall Study|Lost to Follow-up|0|||
150011692|NCT01717326|541176501|FG002|Overall Study|Lost to Follow-up|0|||
150011693|NCT01717326|541176502|FG003|Overall Study|Lost to Follow-up|2|||
150011694|NCT01717326|541176503|FG004|Overall Study|Lost to Follow-up|1|||
150011695|NCT01717326|541176504|FG005|Overall Study|Lost to Follow-up|0|||
150011696|NCT01717326|541176505|FG006|Overall Study|Lost to Follow-up|1|||
150011697|NCT01717326|541176506|FG007|Overall Study|Lost to Follow-up|0|||
150011698|NCT01717326|541176507|FG008|Overall Study|Lost to Follow-up|0|||
150057898|NCT00308581|541353587|FG001|Induction Phase|Unknown reason|0|||
150057899|NCT00308581|541353588|FG002|Induction Phase|Unknown reason|3|||
150057900|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Adverse Event|10|||
150011699|NCT01717326|541176508|FG009|Overall Study|Lost to Follow-up|0|||
150011700|NCT01717326|541176509|FG010|Overall Study|Lost to Follow-up|1|||
150011701|NCT01717326|541176510|FG011|Overall Study|Lost to Follow-up|0|||
150011702|NCT01717326|541176511|FG012|Overall Study|Lost to Follow-up|0|||
150011703|NCT01717326|541176512|FG013|Overall Study|Lost to Follow-up|0|||
150011704|NCT01717326|541176513|FG014|Overall Study|Lost to Follow-up|0|||
150011705|NCT01717326|541176514|FG015|Overall Study|Lost to Follow-up|2|||
150057901|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Adverse Event|17|||
150057902|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Adverse Event|0|||
150057903|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
150011706|NCT01717326|541176515|FG016|Overall Study|Lost to Follow-up|1|||
150011707|NCT01717326|541176516|FG017|Overall Study|Lost to Follow-up|0|||
150011708|NCT01717326|541176517|FG018|Overall Study|Lost to Follow-up|2|||
150057904|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
150057905|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
150057906|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
150011709|NCT01717326|541176518|FG019|Overall Study|Lost to Follow-up|3|||
150011710|NCT01717326|541176499|FG000|Overall Study|Physician Decision|0|||
150011711|NCT01717326|541176500|FG001|Overall Study|Physician Decision|0|||
150011712|NCT01717326|541176501|FG002|Overall Study|Physician Decision|0|||
150011713|NCT01717326|541176502|FG003|Overall Study|Physician Decision|0|||
150011714|NCT01717326|541176503|FG004|Overall Study|Physician Decision|0|||
150011715|NCT01717326|541176504|FG005|Overall Study|Physician Decision|0|||
150011716|NCT01717326|541176505|FG006|Overall Study|Physician Decision|0|||
150011717|NCT01717326|541176506|FG007|Overall Study|Physician Decision|0|||
150011718|NCT01717326|541176507|FG008|Overall Study|Physician Decision|0|||
150011719|NCT01717326|541176508|FG009|Overall Study|Physician Decision|1|||
150011720|NCT01717326|541176509|FG010|Overall Study|Physician Decision|0|||
150011721|NCT01717326|541176510|FG011|Overall Study|Physician Decision|0|||
150011722|NCT01717326|541176511|FG012|Overall Study|Physician Decision|0|||
150011723|NCT01717326|541176512|FG013|Overall Study|Physician Decision|0|||
150011724|NCT01717326|541176513|FG014|Overall Study|Physician Decision|0|||
150011725|NCT01717326|541176514|FG015|Overall Study|Physician Decision|0|||
150011726|NCT01717326|541176515|FG016|Overall Study|Physician Decision|0|||
150011727|NCT01717326|541176516|FG017|Overall Study|Physician Decision|0|||
150011728|NCT01717326|541176517|FG018|Overall Study|Physician Decision|0|||
150011729|NCT01717326|541176518|FG019|Overall Study|Physician Decision|0|||
150011730|NCT01717326|541176499|FG000|Overall Study|Protocol Violation|0|||
150011731|NCT01717326|541176500|FG001|Overall Study|Protocol Violation|0|||
150011732|NCT01717326|541176501|FG002|Overall Study|Protocol Violation|0|||
150011733|NCT01717326|541176502|FG003|Overall Study|Protocol Violation|0|||
150011734|NCT01717326|541176503|FG004|Overall Study|Protocol Violation|1|||
150011735|NCT01717326|541176504|FG005|Overall Study|Protocol Violation|0|||
150011736|NCT01717326|541176505|FG006|Overall Study|Protocol Violation|0|||
150011737|NCT01717326|541176506|FG007|Overall Study|Protocol Violation|0|||
150011738|NCT01717326|541176507|FG008|Overall Study|Protocol Violation|0|||
150011739|NCT01717326|541176508|FG009|Overall Study|Protocol Violation|0|||
150011740|NCT01717326|541176509|FG010|Overall Study|Protocol Violation|0|||
150011741|NCT01717326|541176510|FG011|Overall Study|Protocol Violation|0|||
150011742|NCT01717326|541176511|FG012|Overall Study|Protocol Violation|0|||
150011743|NCT01717326|541176512|FG013|Overall Study|Protocol Violation|0|||
150011744|NCT01717326|541176513|FG014|Overall Study|Protocol Violation|0|||
150011745|NCT01717326|541176514|FG015|Overall Study|Protocol Violation|0|||
150011746|NCT01717326|541176515|FG016|Overall Study|Protocol Violation|0|||
150011747|NCT01717326|541176516|FG017|Overall Study|Protocol Violation|0|||
150011748|NCT01717326|541176517|FG018|Overall Study|Protocol Violation|0|||
150011749|NCT01717326|541176518|FG019|Overall Study|Protocol Violation|0|||
150011750|NCT01717326|541176499|FG000|Overall Study|Withdrawal by Subject|0|||
150011751|NCT01717326|541176500|FG001|Overall Study|Withdrawal by Subject|1|||
150011752|NCT01717326|541176501|FG002|Overall Study|Withdrawal by Subject|0|||
150011753|NCT01717326|541176502|FG003|Overall Study|Withdrawal by Subject|0|||
150011754|NCT01717326|541176503|FG004|Overall Study|Withdrawal by Subject|0|||
150011755|NCT01717326|541176504|FG005|Overall Study|Withdrawal by Subject|0|||
150057907|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
150057908|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
150057909|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
150057910|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
150057911|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
150057912|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
150057913|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
150057914|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
150057915|NCT00308581|541353586|FG000|Randomized Maintenance Phase|Unknown reason|3|||
150057916|NCT00308581|541353587|FG001|Randomized Maintenance Phase|Unknown reason|0|||
150057917|NCT00308581|541353588|FG002|Randomized Maintenance Phase|Unknown reason|0|||
150057918|NCT00952380|541353589|FG000|Overall Study|Other|0|||
150057919|NCT00952380|541353590|FG001|Overall Study|Other|0|||
150057920|NCT00952380|541353591|FG002|Overall Study|Other|0|||
150057921|NCT00952380|541353592|FG003|Overall Study|Other|0|||
150057922|NCT00952380|541353593|FG004|Overall Study|Other|1|||
150057923|NCT00952380|541353589|FG000|Overall Study|Withdrawal by Subject|0|||
150057924|NCT00952380|541353590|FG001|Overall Study|Withdrawal by Subject|0|||
150057925|NCT00952380|541353591|FG002|Overall Study|Withdrawal by Subject|1|||
150057926|NCT00952380|541353592|FG003|Overall Study|Withdrawal by Subject|0|||
150057927|NCT00952380|541353593|FG004|Overall Study|Withdrawal by Subject|2|||
150011756|NCT01717326|541176505|FG006|Overall Study|Withdrawal by Subject|0|||
150011757|NCT01717326|541176506|FG007|Overall Study|Withdrawal by Subject|0|||
150057928|NCT00952380|541353589|FG000|Overall Study|Adverse Event|0|||
150057929|NCT00952380|541353590|FG001|Overall Study|Adverse Event|1|||
150057930|NCT00952380|541353591|FG002|Overall Study|Adverse Event|0|||
150057931|NCT00952380|541353592|FG003|Overall Study|Adverse Event|0|||
150057932|NCT00952380|541353593|FG004|Overall Study|Adverse Event|3|||
150057933|NCT00952380|541353589|FG000|Overall Study|Physician Decision|0|||
150057934|NCT00952380|541353590|FG001|Overall Study|Physician Decision|0|||
150011758|NCT01717326|541176507|FG008|Overall Study|Withdrawal by Subject|0|||
150011759|NCT01717326|541176508|FG009|Overall Study|Withdrawal by Subject|1|||
150011760|NCT01717326|541176509|FG010|Overall Study|Withdrawal by Subject|0|||
150011761|NCT01717326|541176510|FG011|Overall Study|Withdrawal by Subject|0|||
150011762|NCT01717326|541176511|FG012|Overall Study|Withdrawal by Subject|1|||
150011763|NCT01717326|541176512|FG013|Overall Study|Withdrawal by Subject|0|||
150011764|NCT01717326|541176513|FG014|Overall Study|Withdrawal by Subject|0|||
150011765|NCT01717326|541176514|FG015|Overall Study|Withdrawal by Subject|1|||
150057935|NCT00952380|541353591|FG002|Overall Study|Physician Decision|1|||
150057936|NCT00952380|541353592|FG003|Overall Study|Physician Decision|2|||
150057937|NCT00952380|541353593|FG004|Overall Study|Physician Decision|0|||
150057938|NCT00952380|541353589|FG000|Overall Study|Non-compliant to protocol|0|||
150057939|NCT00952380|541353590|FG001|Overall Study|Non-compliant to protocol|0|||
150057940|NCT00952380|541353591|FG002|Overall Study|Non-compliant to protocol|0|||
150057941|NCT00952380|541353592|FG003|Overall Study|Non-compliant to protocol|1|||
150057942|NCT00952380|541353593|FG004|Overall Study|Non-compliant to protocol|0|||
150057943|NCT03400956|541353594|FG000|Treatment Period 1|Adverse Event|0|||
150057944|NCT03400956|541353595|FG001|Treatment Period 1|Adverse Event|1|||
150057945|NCT03400956|541353596|FG002|Treatment Period 1|Adverse Event|0|||
150057946|NCT03400956|541353594|FG000|Treatment Period 1|Lost to Follow-up|0|||
150057947|NCT03400956|541353595|FG001|Treatment Period 1|Lost to Follow-up|0|||
150057948|NCT03400956|541353596|FG002|Treatment Period 1|Lost to Follow-up|1|||
150057949|NCT03400956|541353594|FG000|Treatment Period 1|Protocol Violation|0|||
150057950|NCT03400956|541353595|FG001|Treatment Period 1|Protocol Violation|2|||
150057951|NCT03400956|541353596|FG002|Treatment Period 1|Protocol Violation|0|||
150057952|NCT03400956|541353594|FG000|Treatment Period 1|Study terminated by sponsor|3|||
150057953|NCT03400956|541353595|FG001|Treatment Period 1|Study terminated by sponsor|1|||
150057954|NCT03400956|541353596|FG002|Treatment Period 1|Study terminated by sponsor|1|||
150057955|NCT03400956|541353594|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150057956|NCT03400956|541353595|FG001|Treatment Period 1|Withdrawal by Subject|2|||
150057957|NCT03400956|541353596|FG002|Treatment Period 1|Withdrawal by Subject|4|||
150057958|NCT03400956|541353594|FG000|Treatment Period 1|Other|1|||
150057959|NCT03400956|541353595|FG001|Treatment Period 1|Other|2|||
150057960|NCT03400956|541353596|FG002|Treatment Period 1|Other|3|||
150057961|NCT03400956|541353594|FG000|Post-treatment Period 1|Adverse Event|0|||
150057962|NCT03400956|541353595|FG001|Post-treatment Period 1|Adverse Event|0|||
150057963|NCT03400956|541353596|FG002|Post-treatment Period 1|Adverse Event|1|||
150057964|NCT03400956|541353594|FG000|Post-treatment Period 1|Physician Decision|2|||
150057965|NCT03400956|541353595|FG001|Post-treatment Period 1|Physician Decision|3|||
150057966|NCT03400956|541353596|FG002|Post-treatment Period 1|Physician Decision|0|||
150057967|NCT03400956|541353594|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
150057968|NCT03400956|541353595|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
150057969|NCT03400956|541353596|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
150011766|NCT01717326|541176515|FG016|Overall Study|Withdrawal by Subject|0|||
150011767|NCT01717326|541176516|FG017|Overall Study|Withdrawal by Subject|0|||
150011768|NCT01717326|541176517|FG018|Overall Study|Withdrawal by Subject|2|||
150011769|NCT01717326|541176518|FG019|Overall Study|Withdrawal by Subject|3|||
150011770|NCT01123707|541176521|FG000|Overall Study|Lost to Follow-up|3|||
150011771|NCT01123707|541176522|FG001|Overall Study|Lost to Follow-up|1|||
150011772|NCT01123707|541176523|FG002|Overall Study|Lost to Follow-up|3|||
150011773|NCT01123707|541176524|FG003|Overall Study|Lost to Follow-up|2|||
150011774|NCT01123707|541176521|FG000|Overall Study|Adverse Event|5|||
150011775|NCT01123707|541176522|FG001|Overall Study|Adverse Event|7|||
150011776|NCT01123707|541176523|FG002|Overall Study|Adverse Event|5|||
150011777|NCT01123707|541176524|FG003|Overall Study|Adverse Event|3|||
150011778|NCT01123707|541176521|FG000|Overall Study|Sponsor Discontinued Study|30|||
150011779|NCT01123707|541176522|FG001|Overall Study|Sponsor Discontinued Study|24|||
150011780|NCT01123707|541176523|FG002|Overall Study|Sponsor Discontinued Study|25|||
150011781|NCT01123707|541176524|FG003|Overall Study|Sponsor Discontinued Study|40|||
150011782|NCT01123707|541176521|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
150057970|NCT03400956|541353594|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
150011783|NCT01123707|541176522|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
150011784|NCT01123707|541176523|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
150011785|NCT01123707|541176524|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
150011786|NCT01123707|541176521|FG000|Overall Study|Investigator Withdrew Participant|0|||
150011787|NCT01123707|541176522|FG001|Overall Study|Investigator Withdrew Participant|1|||
150011788|NCT01123707|541176523|FG002|Overall Study|Investigator Withdrew Participant|1|||
150011789|NCT01123707|541176524|FG003|Overall Study|Investigator Withdrew Participant|1|||
150011790|NCT01123707|541176521|FG000|Overall Study|Subject Withdrew Consent|4|||
150011791|NCT01123707|541176522|FG001|Overall Study|Subject Withdrew Consent|5|||
150011792|NCT01123707|541176523|FG002|Overall Study|Subject Withdrew Consent|1|||
150011793|NCT01123707|541176524|FG003|Overall Study|Subject Withdrew Consent|2|||
150011794|NCT01123707|541176521|FG000|Overall Study|Lack of Efficacy|1|||
150011795|NCT01123707|541176522|FG001|Overall Study|Lack of Efficacy|2|||
150011796|NCT01123707|541176523|FG002|Overall Study|Lack of Efficacy|1|||
150011797|NCT01123707|541176524|FG003|Overall Study|Lack of Efficacy|0|||
150057971|NCT03400956|541353595|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
150057972|NCT03400956|541353596|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
150057973|NCT03400956|541353594|FG000|Post-treatment Period 1|Other|4|||
150057974|NCT03400956|541353595|FG001|Post-treatment Period 1|Other|3|||
150057975|NCT03400956|541353596|FG002|Post-treatment Period 1|Other|4|||
150057976|NCT03400956|541353594|FG000|Treatment Period 2|Adverse Event|2|||
150057977|NCT03400956|541353595|FG001|Treatment Period 2|Adverse Event|1|||
150011798|NCT01123707|541176521|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
150011799|NCT01123707|541176522|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
150011800|NCT01123707|541176523|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
150011801|NCT01123707|541176524|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
150011802|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
150011803|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
150011804|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
150011805|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
150011806|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
150011807|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
150011808|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
150011809|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
150011810|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Death|0|||
150011811|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Death|1|||
150011812|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
150011813|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
150011814|NCT03281304|541176529|FG000|Treatment Phase (up to 42 Months)|Other|0|||
150011815|NCT03281304|541176530|FG001|Treatment Phase (up to 42 Months)|Other|2|||
150011816|NCT03281304|541176529|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
150011817|NCT03281304|541176530|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
150011818|NCT00428844|541176531|FG000|Completed Study Drug Treatment|Adverse Event|2|||
150011819|NCT00428844|541176532|FG001|Completed Study Drug Treatment|Adverse Event|4|||
150011820|NCT00428844|541176533|FG002|Completed Study Drug Treatment|Adverse Event|4|||
150011821|NCT00428844|541176531|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
150011822|NCT00428844|541176532|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
150011823|NCT00428844|541176533|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
150011824|NCT00428844|541176531|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
150011825|NCT00428844|541176532|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
150011826|NCT00428844|541176533|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
150011827|NCT00428844|541176531|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
150011828|NCT00428844|541176532|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
150011829|NCT00428844|541176533|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
150011830|NCT00428844|541176531|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
150011831|NCT00428844|541176532|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
150011832|NCT00428844|541176533|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
150011833|NCT00428844|541176531|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
150011834|NCT00428844|541176532|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
150011835|NCT00428844|541176533|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
150011836|NCT00428844|541176531|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
150011837|NCT00428844|541176532|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
150011838|NCT00428844|541176533|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
150011839|NCT00428844|541176531|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
150011840|NCT00428844|541176532|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
150011841|NCT00428844|541176533|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
150011842|NCT00428844|541176531|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
150011843|NCT00428844|541176532|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
150011844|NCT00428844|541176533|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
150011845|NCT00488826|541176536|FG000|Overall Study|Withdrawal by Subject|40|||
150011846|NCT00488826|541176537|FG001|Overall Study|Withdrawal by Subject|35|||
150011847|NCT00488826|541176538|FG002|Overall Study|Withdrawal by Subject|19|||
150011848|NCT00488826|541176536|FG000|Overall Study|Protocol Violation|0|||
150011849|NCT00488826|541176537|FG001|Overall Study|Protocol Violation|0|||
150011850|NCT00488826|541176538|FG002|Overall Study|Protocol Violation|2|||
150011851|NCT00488826|541176536|FG000|Overall Study|Adverse Event|9|||
150011852|NCT00488826|541176537|FG001|Overall Study|Adverse Event|15|||
150011853|NCT00488826|541176538|FG002|Overall Study|Adverse Event|4|||
150011854|NCT00488826|541176536|FG000|Overall Study|Lost to Follow-up|5|||
150011855|NCT00488826|541176537|FG001|Overall Study|Lost to Follow-up|1|||
150011856|NCT00488826|541176538|FG002|Overall Study|Lost to Follow-up|0|||
150011857|NCT00488826|541176536|FG000|Overall Study|Protocol Deviations|2|||
150011858|NCT00488826|541176537|FG001|Overall Study|Protocol Deviations|1|||
150011859|NCT00488826|541176538|FG002|Overall Study|Protocol Deviations|1|||
150011860|NCT03208088|541176544|FG000|Period 2|Withdrawal by Subject|0|||
150011861|NCT03208088|541176545|FG001|Period 2|Withdrawal by Subject|0|||
150011862|NCT03208088|541176546|FG002|Period 2|Withdrawal by Subject|0|||
150011863|NCT03208088|541176547|FG003|Period 2|Withdrawal by Subject|0|||
150011864|NCT03208088|541176548|FG004|Period 2|Withdrawal by Subject|0|||
150011865|NCT03208088|541176549|FG005|Period 2|Withdrawal by Subject|0|||
150011866|NCT03208088|541176550|FG006|Period 2|Withdrawal by Subject|0|||
150181111|NCT02590432|541801009|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
150011867|NCT03208088|541176551|FG007|Period 2|Withdrawal by Subject|0|||
150011868|NCT03208088|541176552|FG008|Period 2|Withdrawal by Subject|1|||
150011869|NCT03208088|541176553|FG009|Period 2|Withdrawal by Subject|0|||
150011870|NCT03208088|541176544|FG000|Period 3|Unsatisfactory Test Article|0|||
150011871|NCT03208088|541176545|FG001|Period 3|Unsatisfactory Test Article|0|||
150011872|NCT03208088|541176546|FG002|Period 3|Unsatisfactory Test Article|0|||
150011873|NCT03208088|541176547|FG003|Period 3|Unsatisfactory Test Article|1|||
150011874|NCT03208088|541176548|FG004|Period 3|Unsatisfactory Test Article|0|||
150011875|NCT03208088|541176549|FG005|Period 3|Unsatisfactory Test Article|0|||
150011876|NCT03208088|541176550|FG006|Period 3|Unsatisfactory Test Article|0|||
150011877|NCT03208088|541176551|FG007|Period 3|Unsatisfactory Test Article|0|||
150011878|NCT03208088|541176552|FG008|Period 3|Unsatisfactory Test Article|0|||
150011879|NCT03208088|541176553|FG009|Period 3|Unsatisfactory Test Article|0|||
150011880|NCT03208088|541176544|FG000|Period 4|Unsatisfactory Test Article|0|||
150011881|NCT03208088|541176545|FG001|Period 4|Unsatisfactory Test Article|0|||
150011882|NCT03208088|541176546|FG002|Period 4|Unsatisfactory Test Article|0|||
150011883|NCT03208088|541176547|FG003|Period 4|Unsatisfactory Test Article|1|||
150011884|NCT03208088|541176548|FG004|Period 4|Unsatisfactory Test Article|0|||
150011885|NCT03208088|541176549|FG005|Period 4|Unsatisfactory Test Article|0|||
150011886|NCT03208088|541176550|FG006|Period 4|Unsatisfactory Test Article|0|||
150011887|NCT03208088|541176551|FG007|Period 4|Unsatisfactory Test Article|0|||
150011888|NCT03208088|541176552|FG008|Period 4|Unsatisfactory Test Article|0|||
150011889|NCT03208088|541176553|FG009|Period 4|Unsatisfactory Test Article|0|||
150011890|NCT00605345|541176554|FG000|Overall Study|Withdrawal by Subject|1|||
150011891|NCT00605345|541176555|FG001|Overall Study|Withdrawal by Subject|0|||
150011892|NCT00605345|541176554|FG000|Overall Study|Adverse Event|0|||
150011893|NCT00605345|541176555|FG001|Overall Study|Adverse Event|1|||
150011894|NCT00605345|541176554|FG000|Overall Study|Protocol Violation|0|||
150011895|NCT00605345|541176555|FG001|Overall Study|Protocol Violation|2|||
150011896|NCT01108523|541176556|FG000|Overall Study|Protocol Violation|4|||
150011897|NCT03210961|541178680|FG000|Overall Study|Adverse Event|0|||
150011898|NCT03210961|541178681|FG001|Overall Study|Adverse Event|0|||
150011899|NCT03210961|541178682|FG002|Overall Study|Adverse Event|0|||
150011900|NCT03210961|541178683|FG003|Overall Study|Adverse Event|0|||
150011901|NCT03210961|541178684|FG004|Overall Study|Adverse Event|0|||
150011902|NCT03210961|541178685|FG005|Overall Study|Adverse Event|0|||
150011903|NCT03210961|541178686|FG006|Overall Study|Adverse Event|0|||
150011904|NCT03210961|541178687|FG007|Overall Study|Adverse Event|0|||
150011905|NCT03210961|541178688|FG008|Overall Study|Adverse Event|0|||
150181112|NCT02590432|541801010|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
150181113|NCT02590432|541801011|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
150181114|NCT02590432|541801012|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
150181115|NCT02590432|541801013|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
150181116|NCT02590432|541801014|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
150011906|NCT03210961|541178689|FG009|Overall Study|Adverse Event|0|||
150011907|NCT03210961|541178690|FG010|Overall Study|Adverse Event|0|||
150181117|NCT02590432|541801006|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150011908|NCT03210961|541178691|FG011|Overall Study|Adverse Event|0|||
150011909|NCT03210961|541178692|FG012|Overall Study|Adverse Event|0|||
150011910|NCT03210961|541178693|FG013|Overall Study|Adverse Event|1|||
150011911|NCT03210961|541178694|FG014|Overall Study|Adverse Event|0|||
150011912|NCT03210961|541178680|FG000|Overall Study|Lost to Follow-up|0|||
150011913|NCT03210961|541178681|FG001|Overall Study|Lost to Follow-up|0|||
150011914|NCT03210961|541178682|FG002|Overall Study|Lost to Follow-up|0|||
150011915|NCT03210961|541178683|FG003|Overall Study|Lost to Follow-up|0|||
150011916|NCT03210961|541178684|FG004|Overall Study|Lost to Follow-up|0|||
150011917|NCT03210961|541178685|FG005|Overall Study|Lost to Follow-up|0|||
150181118|NCT02590432|541801007|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150011918|NCT03210961|541178686|FG006|Overall Study|Lost to Follow-up|0|||
150011919|NCT03210961|541178687|FG007|Overall Study|Lost to Follow-up|0|||
150181119|NCT02590432|541801008|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150181120|NCT02590432|541801009|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150181121|NCT02590432|541801010|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150011920|NCT03210961|541178688|FG008|Overall Study|Lost to Follow-up|0|||
150011921|NCT03210961|541178689|FG009|Overall Study|Lost to Follow-up|0|||
150011922|NCT03210961|541178690|FG010|Overall Study|Lost to Follow-up|0|||
150011923|NCT03210961|541178691|FG011|Overall Study|Lost to Follow-up|0|||
150011924|NCT03210961|541178692|FG012|Overall Study|Lost to Follow-up|0|||
150011925|NCT03210961|541178693|FG013|Overall Study|Lost to Follow-up|0|||
150011926|NCT03210961|541178694|FG014|Overall Study|Lost to Follow-up|1|||
150011927|NCT03210961|541178680|FG000|Overall Study|Withdrawal by Subject|0|||
150011928|NCT03210961|541178681|FG001|Overall Study|Withdrawal by Subject|0|||
150011929|NCT03210961|541178682|FG002|Overall Study|Withdrawal by Subject|0|||
150011930|NCT03210961|541178683|FG003|Overall Study|Withdrawal by Subject|0|||
150011931|NCT03210961|541178684|FG004|Overall Study|Withdrawal by Subject|0|||
150011932|NCT03210961|541178685|FG005|Overall Study|Withdrawal by Subject|0|||
150011933|NCT03210961|541178686|FG006|Overall Study|Withdrawal by Subject|0|||
150011934|NCT03210961|541178687|FG007|Overall Study|Withdrawal by Subject|0|||
150011935|NCT03210961|541178688|FG008|Overall Study|Withdrawal by Subject|0|||
150011936|NCT03210961|541178689|FG009|Overall Study|Withdrawal by Subject|0|||
150011937|NCT03210961|541178690|FG010|Overall Study|Withdrawal by Subject|0|||
150011938|NCT03210961|541178691|FG011|Overall Study|Withdrawal by Subject|0|||
150011939|NCT03210961|541178692|FG012|Overall Study|Withdrawal by Subject|0|||
150011940|NCT03210961|541178693|FG013|Overall Study|Withdrawal by Subject|0|||
150011941|NCT03210961|541178694|FG014|Overall Study|Withdrawal by Subject|1|||
150011942|NCT03210961|541178680|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011943|NCT03210961|541178681|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011944|NCT03210961|541178682|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011945|NCT03210961|541178683|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011946|NCT03210961|541178684|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011947|NCT03210961|541178685|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011948|NCT03210961|541178686|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011949|NCT03210961|541178687|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011950|NCT03210961|541178688|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011951|NCT03210961|541178689|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011952|NCT03210961|541178690|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011953|NCT03210961|541178691|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011954|NCT03210961|541178692|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011955|NCT03210961|541178693|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
150011956|NCT03210961|541178694|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
150011957|NCT03210961|541178680|FG000|Overall Study|Other|0|||
150011958|NCT03210961|541178681|FG001|Overall Study|Other|0|||
150011959|NCT03210961|541178682|FG002|Overall Study|Other|0|||
150011960|NCT03210961|541178683|FG003|Overall Study|Other|1|||
150011961|NCT03210961|541178684|FG004|Overall Study|Other|0|||
150011962|NCT03210961|541178685|FG005|Overall Study|Other|0|||
150011963|NCT03210961|541178686|FG006|Overall Study|Other|1|||
150011964|NCT03210961|541178687|FG007|Overall Study|Other|0|||
150011965|NCT03210961|541178688|FG008|Overall Study|Other|0|||
150011966|NCT03210961|541178689|FG009|Overall Study|Other|0|||
150011967|NCT03210961|541178690|FG010|Overall Study|Other|1|||
150011968|NCT03210961|541178691|FG011|Overall Study|Other|0|||
150011969|NCT03210961|541178692|FG012|Overall Study|Other|2|||
150011970|NCT03210961|541178693|FG013|Overall Study|Other|2|||
150011971|NCT03210961|541178694|FG014|Overall Study|Other|0|||
150011972|NCT03831100|541178696|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
150011973|NCT03831100|541178697|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
150011974|NCT04566601|541178698|FG000|Overall Study|Other than listed|13|||
150011975|NCT04566601|541178699|FG001|Overall Study|Other than listed|4|||
150011976|NCT04566601|541178700|FG002|Overall Study|Other than listed|2|||
150011977|NCT04566601|541178701|FG003|Overall Study|Other than listed|1|||
150011978|NCT04566601|541178702|FG004|Overall Study|Other than listed|4|||
150011979|NCT04566601|541178698|FG000|Overall Study|Protocol deviation|3|||
150011980|NCT04566601|541178699|FG001|Overall Study|Protocol deviation|0|||
150011981|NCT04566601|541178700|FG002|Overall Study|Protocol deviation|1|||
150011982|NCT04566601|541178701|FG003|Overall Study|Protocol deviation|1|||
150011983|NCT04566601|541178702|FG004|Overall Study|Protocol deviation|1|||
150011984|NCT04566601|541178698|FG000|Overall Study|Technical problems|0|||
150011985|NCT04566601|541178699|FG001|Overall Study|Technical problems|0|||
150011986|NCT04566601|541178700|FG002|Overall Study|Technical problems|1|||
150011987|NCT04566601|541178701|FG003|Overall Study|Technical problems|0|||
150011988|NCT04566601|541178702|FG004|Overall Study|Technical problems|0|||
150011989|NCT04566601|541178698|FG000|Overall Study|No reason available|3|||
150011990|NCT04566601|541178699|FG001|Overall Study|No reason available|2|||
150011991|NCT04566601|541178700|FG002|Overall Study|No reason available|7|||
150011992|NCT04566601|541178701|FG003|Overall Study|No reason available|1|||
150011993|NCT04566601|541178702|FG004|Overall Study|No reason available|5|||
150011994|NCT04566601|541178698|FG000|Overall Study|Burden of study procedures|3|||
150011995|NCT04566601|541178699|FG001|Overall Study|Burden of study procedures|0|||
150011996|NCT04566601|541178700|FG002|Overall Study|Burden of study procedures|0|||
150011997|NCT04566601|541178701|FG003|Overall Study|Burden of study procedures|3|||
150011998|NCT04566601|541178702|FG004|Overall Study|Burden of study procedures|1|||
150011999|NCT04566601|541178698|FG000|Overall Study|Change of residence|2|||
150012000|NCT04566601|541178699|FG001|Overall Study|Change of residence|2|||
150012001|NCT04566601|541178700|FG002|Overall Study|Change of residence|0|||
150012002|NCT04566601|541178701|FG003|Overall Study|Change of residence|1|||
150012003|NCT04566601|541178702|FG004|Overall Study|Change of residence|2|||
150012004|NCT04566601|541178698|FG000|Overall Study|Perceived lack of efficacy|2|||
150012005|NCT04566601|541178699|FG001|Overall Study|Perceived lack of efficacy|0|||
150012006|NCT04566601|541178700|FG002|Overall Study|Perceived lack of efficacy|1|||
150012007|NCT04566601|541178701|FG003|Overall Study|Perceived lack of efficacy|1|||
150012008|NCT04566601|541178702|FG004|Overall Study|Perceived lack of efficacy|2|||
150012009|NCT04566601|541178698|FG000|Overall Study|Adverse Event|7|||
150012010|NCT04566601|541178699|FG001|Overall Study|Adverse Event|4|||
150012011|NCT04566601|541178700|FG002|Overall Study|Adverse Event|6|||
150012012|NCT04566601|541178701|FG003|Overall Study|Adverse Event|5|||
150012013|NCT04566601|541178702|FG004|Overall Study|Adverse Event|12|||
150012014|NCT03047031|541178705|FG000|Overall Study|Other than listed|1|||
150012015|NCT03047031|541178706|FG001|Overall Study|Other than listed|0|||
150012016|NCT03047031|541178707|FG002|Overall Study|Other than listed|0|||
150012017|NCT03047031|541178705|FG000|Overall Study|Lost to Follow-up|4|||
150012018|NCT03047031|541178706|FG001|Overall Study|Lost to Follow-up|0|||
150012019|NCT03047031|541178707|FG002|Overall Study|Lost to Follow-up|0|||
150012020|NCT03047031|541178705|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
150012021|NCT03047031|541178706|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
150012022|NCT03047031|541178707|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
150012023|NCT03047031|541178705|FG000|Overall Study|Adverse Event|1|||
150012024|NCT03047031|541178706|FG001|Overall Study|Adverse Event|0|||
150012025|NCT03047031|541178707|FG002|Overall Study|Adverse Event|0|||
150012026|NCT03047031|541178705|FG000|Overall Study|Withdrawal by Subject|2|||
150012027|NCT03047031|541178706|FG001|Overall Study|Withdrawal by Subject|0|||
150012028|NCT03047031|541178707|FG002|Overall Study|Withdrawal by Subject|0|||
150012029|NCT03047031|541178705|FG000|Overall Study|Change to other medication|2|||
150012030|NCT03047031|541178706|FG001|Overall Study|Change to other medication|0|||
150012031|NCT03047031|541178707|FG002|Overall Study|Change to other medication|0|||
150012032|NCT03047031|541178705|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
150012033|NCT03047031|541178706|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
150012034|NCT03047031|541178707|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
150012035|NCT00666224|541178711|FG000|Double-Blind|Adverse Event|15|||
150012036|NCT00666224|541178712|FG001|Double-Blind|Adverse Event|5|||
150012037|NCT00666224|541178711|FG000|Double-Blind|Lost to Follow-up|2|||
150012038|NCT00666224|541178712|FG001|Double-Blind|Lost to Follow-up|2|||
150012039|NCT00666224|541178711|FG000|Double-Blind|Withdrawal by Subject|18|||
150012040|NCT00666224|541178712|FG001|Double-Blind|Withdrawal by Subject|14|||
150012041|NCT00666224|541178711|FG000|Double-Blind|Physician Decision|0|||
150012042|NCT00666224|541178712|FG001|Double-Blind|Physician Decision|3|||
150012043|NCT00666224|541178711|FG000|Double-Blind|Sponsor decision|1|||
150012044|NCT00666224|541178712|FG001|Double-Blind|Sponsor decision|0|||
150012045|NCT00666224|541178711|FG000|Double-Blind|Pregnancy|3|||
150012046|NCT00666224|541178712|FG001|Double-Blind|Pregnancy|2|||
150012047|NCT00666224|541178711|FG000|Double-Blind|Noncompliance|1|||
150012048|NCT00666224|541178712|FG001|Double-Blind|Noncompliance|0|||
150012049|NCT00666224|541178711|FG000|Double-Blind|Death|1|||
150012050|NCT00666224|541178712|FG001|Double-Blind|Death|0|||
150012051|NCT00666224|541178711|FG000|Double-Blind|Undefined/Unknown|4|||
150012052|NCT00666224|541178712|FG001|Double-Blind|Undefined/Unknown|1|||
150012053|NCT00666224|541178711|FG000|Open-Label|Adverse Event|8|||
150012054|NCT00666224|541178712|FG001|Open-Label|Adverse Event|43|||
150012055|NCT00666224|541178711|FG000|Open-Label|Lost to Follow-up|4|||
150012056|NCT00666224|541178712|FG001|Open-Label|Lost to Follow-up|5|||
150012057|NCT00666224|541178711|FG000|Open-Label|Withdrawal by Subject|12|||
150012058|NCT00666224|541178712|FG001|Open-Label|Withdrawal by Subject|25|||
150012059|NCT00666224|541178711|FG000|Open-Label|Physician Decision|7|||
150012060|NCT00666224|541178712|FG001|Open-Label|Physician Decision|5|||
150012061|NCT00666224|541178711|FG000|Open-Label|Pregnancy|1|||
150012062|NCT00666224|541178712|FG001|Open-Label|Pregnancy|5|||
150012063|NCT00666224|541178711|FG000|Open-Label|Noncompliance|2|||
150012064|NCT00666224|541178712|FG001|Open-Label|Noncompliance|1|||
150012065|NCT00666224|541178711|FG000|Open-Label|Undefined/Unknown|1|||
150012066|NCT00666224|541178712|FG001|Open-Label|Undefined/Unknown|1|||
150012067|NCT01450098|541178713|FG000|Period 3|Protocol Violation|0|||
150012068|NCT01450098|541178714|FG001|Period 3|Protocol Violation|1|||
150012069|NCT01450098|541178713|FG000|Period 3|Withdrawal by Subject|0|||
150012070|NCT01450098|541178714|FG001|Period 3|Withdrawal by Subject|2|||
150012071|NCT03828617|541178725|FG000|Overall Study|Lost to Follow-up|22|||
150012072|NCT03828617|541178726|FG001|Overall Study|Lost to Follow-up|12|||
150012073|NCT03828617|541178727|FG002|Overall Study|Lost to Follow-up|23|||
150012074|NCT03828617|541178728|FG003|Overall Study|Lost to Follow-up|7|||
150012075|NCT03828617|541178725|FG000|Overall Study|No longer met eligibility criteria|0|||
150012076|NCT03828617|541178726|FG001|Overall Study|No longer met eligibility criteria|1|||
150012077|NCT03828617|541178727|FG002|Overall Study|No longer met eligibility criteria|1|||
150012078|NCT03828617|541178728|FG003|Overall Study|No longer met eligibility criteria|3|||
150012079|NCT03828617|541178725|FG000|Overall Study|Protocol Violation|0|||
150012080|NCT03828617|541178726|FG001|Overall Study|Protocol Violation|2|||
150012081|NCT03828617|541178727|FG002|Overall Study|Protocol Violation|0|||
150012082|NCT03828617|541178728|FG003|Overall Study|Protocol Violation|0|||
150012083|NCT03828617|541178725|FG000|Overall Study|Withdrawal by Subject|2|||
150012084|NCT03828617|541178726|FG001|Overall Study|Withdrawal by Subject|0|||
150012085|NCT03828617|541178727|FG002|Overall Study|Withdrawal by Subject|2|||
150012086|NCT03828617|541178728|FG003|Overall Study|Withdrawal by Subject|0|||
150012087|NCT03354273|541178730|FG000|Overall Study|Adverse Event|5|||
150012088|NCT03354273|541178730|FG000|Overall Study|Screen Failure|21|||
150012089|NCT03354273|541178730|FG000|Overall Study|Withdrawal by Subject|34|||
150012090|NCT03354273|541178730|FG000|Overall Study|Technical Problems|30|||
150012091|NCT03354273|541178730|FG000|Overall Study|Lost to Follow-up|4|||
150012092|NCT03354273|541178730|FG000|Overall Study|Investigator Decision|3|||
150012093|NCT03354273|541178730|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
150012094|NCT03354273|541178730|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
150012095|NCT03354273|541178730|FG000|Overall Study|COVID-19 Restrictions|9|||
150012096|NCT03354273|541178730|FG000|Overall Study|Other|5|||
150012097|NCT03229109|541178734|FG000|Overall Study|Withdrawal by Subject|0|||
150012098|NCT03229109|541178735|FG001|Overall Study|Withdrawal by Subject|0|||
150012099|NCT03229109|541178736|FG002|Overall Study|Withdrawal by Subject|0|||
150012100|NCT03229109|541178737|FG003|Overall Study|Withdrawal by Subject|1|||
150012101|NCT04207749|541178740|FG000|Overall Study|Lost to Follow-up|0|||
150012102|NCT04207749|541178741|FG001|Overall Study|Lost to Follow-up|2|||
150012103|NCT04207749|541178740|FG000|Overall Study|Protocol Violation|0|||
150012104|NCT04207749|541178741|FG001|Overall Study|Protocol Violation|1|||
150012105|NCT04207749|541178740|FG000|Overall Study|Withdrawal by Subject|3|||
150012106|NCT04207749|541178741|FG001|Overall Study|Withdrawal by Subject|0|||
150012107|NCT04207749|541178740|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
150012108|NCT04207749|541178741|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
150012109|NCT00655629|541178742|FG000|Overall Study|Adverse Event|4|||
150012110|NCT00655629|541178743|FG001|Overall Study|Adverse Event|1|||
150012111|NCT00655629|541178742|FG000|Overall Study|Lack of Efficacy|2|||
150012112|NCT00655629|541178743|FG001|Overall Study|Lack of Efficacy|12|||
150012113|NCT00655629|541178742|FG000|Overall Study|Lost to Follow-up|4|||
150012114|NCT00655629|541178743|FG001|Overall Study|Lost to Follow-up|3|||
150012115|NCT00655629|541178742|FG000|Overall Study|Protocol Violation|5|||
150012116|NCT00655629|541178743|FG001|Overall Study|Protocol Violation|3|||
150012117|NCT00655629|541178742|FG000|Overall Study|consent withdrawn|6|||
150012118|NCT00655629|541178743|FG001|Overall Study|consent withdrawn|4|||
150012119|NCT03416127|541178746|FG000|Overall Study|Withdrawal by Subject|0|||
150012120|NCT03416127|541178747|FG001|Overall Study|Withdrawal by Subject|1|||
150012121|NCT03416127|541178748|FG002|Overall Study|Withdrawal by Subject|1|||
150012122|NCT00705367|541178751|FG000|Long-term Extension Period|Adverse Event|2|||
150012123|NCT00705367|541178752|FG001|Long-term Extension Period|Adverse Event|0|||
150012124|NCT00705367|541178751|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
150012125|NCT00705367|541178752|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
150012126|NCT00705367|541178751|FG000|Long-term Extension Period|Lack of Efficacy|1|||
150012127|NCT00705367|541178752|FG001|Long-term Extension Period|Lack of Efficacy|0|||
150012128|NCT00705367|541178751|FG000|Long-term Extension Period|No longer met study criteria|1|||
150012129|NCT00705367|541178752|FG001|Long-term Extension Period|No longer met study criteria|0|||
150012130|NCT00705367|541178751|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
150012131|NCT00705367|541178752|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
150012132|NCT01959139|541178753|FG000|Phase II|Disease progression|0|||
150012133|NCT01959139|541178754|FG001|Phase II|Disease progression|0|||
150012134|NCT01959139|541178755|FG002|Phase II|Disease progression|26|||
150012135|NCT01959139|541178756|FG003|Phase II|Disease progression|34|||
150012136|NCT01959139|541178753|FG000|Phase II|Adverse Event|0|||
150012137|NCT01959139|541178754|FG001|Phase II|Adverse Event|0|||
150012138|NCT01959139|541178755|FG002|Phase II|Adverse Event|10|||
150012139|NCT01959139|541178756|FG003|Phase II|Adverse Event|11|||
150012140|NCT01959139|541178753|FG000|Phase II|Patient Refusal|0|||
150012141|NCT01959139|541178754|FG001|Phase II|Patient Refusal|0|||
150012142|NCT01959139|541178755|FG002|Phase II|Patient Refusal|5|||
150012143|NCT01959139|541178756|FG003|Phase II|Patient Refusal|4|||
150012144|NCT01959139|541178753|FG000|Phase II|Death|0|||
150012145|NCT01959139|541178754|FG001|Phase II|Death|0|||
150012146|NCT01959139|541178755|FG002|Phase II|Death|3|||
150012147|NCT01959139|541178756|FG003|Phase II|Death|1|||
150012148|NCT01959139|541178753|FG000|Phase II|Other/Unknown|0|||
150012149|NCT01959139|541178754|FG001|Phase II|Other/Unknown|0|||
150012150|NCT01959139|541178755|FG002|Phase II|Other/Unknown|8|||
150012151|NCT01959139|541178756|FG003|Phase II|Other/Unknown|5|||
150012152|NCT01959139|541178753|FG000|Phase II|On treatment|0|||
150012153|NCT01959139|541178754|FG001|Phase II|On treatment|0|||
150012154|NCT01959139|541178755|FG002|Phase II|On treatment|4|||
150057978|NCT03400956|541353596|FG002|Treatment Period 2|Adverse Event|1|||
150057979|NCT03400956|541353594|FG000|Treatment Period 2|Lost to Follow-up|1|||
150057980|NCT03400956|541353595|FG001|Treatment Period 2|Lost to Follow-up|1|||
150012155|NCT01959139|541178756|FG003|Phase II|On treatment|0|||
150012156|NCT01610336|541178757|FG000|Overall Study|Progressive Disease|4|||
150057981|NCT03400956|541353596|FG002|Treatment Period 2|Lost to Follow-up|0|||
150012157|NCT01610336|541178758|FG001|Overall Study|Progressive Disease|6|||
150012158|NCT01610336|541178759|FG002|Overall Study|Progressive Disease|6|||
150012159|NCT01610336|541178760|FG003|Overall Study|Progressive Disease|5|||
150012160|NCT01610336|541178761|FG004|Overall Study|Progressive Disease|3|||
150012161|NCT01610336|541178762|FG005|Overall Study|Progressive Disease|10|||
150012162|NCT01610336|541178763|FG006|Overall Study|Progressive Disease|1|||
150012163|NCT01610336|541178764|FG007|Overall Study|Progressive Disease|6|||
150012164|NCT01610336|541178765|FG008|Overall Study|Progressive Disease|6|||
150012165|NCT01610336|541178766|FG009|Overall Study|Progressive Disease|40|||
150012166|NCT01610336|541178767|FG010|Overall Study|Progressive Disease|36|||
150012167|NCT01610336|541178757|FG000|Overall Study|Adverse Event|0|||
150012168|NCT01610336|541178758|FG001|Overall Study|Adverse Event|0|||
150012169|NCT01610336|541178759|FG002|Overall Study|Adverse Event|0|||
150012170|NCT01610336|541178760|FG003|Overall Study|Adverse Event|1|||
150012171|NCT01610336|541178761|FG004|Overall Study|Adverse Event|1|||
150012172|NCT01610336|541178762|FG005|Overall Study|Adverse Event|1|||
150012173|NCT01610336|541178763|FG006|Overall Study|Adverse Event|0|||
150012174|NCT01610336|541178764|FG007|Overall Study|Adverse Event|0|||
150012175|NCT01610336|541178765|FG008|Overall Study|Adverse Event|2|||
150012176|NCT01610336|541178766|FG009|Overall Study|Adverse Event|8|||
150012177|NCT01610336|541178767|FG010|Overall Study|Adverse Event|6|||
150012178|NCT01610336|541178757|FG000|Overall Study|Subject/Guardian decision|1|||
150012179|NCT01610336|541178758|FG001|Overall Study|Subject/Guardian decision|1|||
150012180|NCT01610336|541178759|FG002|Overall Study|Subject/Guardian decision|0|||
150012181|NCT01610336|541178760|FG003|Overall Study|Subject/Guardian decision|1|||
150012182|NCT01610336|541178761|FG004|Overall Study|Subject/Guardian decision|0|||
150012183|NCT01610336|541178762|FG005|Overall Study|Subject/Guardian decision|0|||
150012184|NCT01610336|541178763|FG006|Overall Study|Subject/Guardian decision|0|||
150012185|NCT01610336|541178764|FG007|Overall Study|Subject/Guardian decision|1|||
150012186|NCT01610336|541178765|FG008|Overall Study|Subject/Guardian decision|0|||
150012187|NCT01610336|541178766|FG009|Overall Study|Subject/Guardian decision|2|||
150012188|NCT01610336|541178767|FG010|Overall Study|Subject/Guardian decision|2|||
150012189|NCT01610336|541178757|FG000|Overall Study|Death|0|||
150012190|NCT01610336|541178758|FG001|Overall Study|Death|0|||
150012191|NCT01610336|541178759|FG002|Overall Study|Death|0|||
150012192|NCT01610336|541178760|FG003|Overall Study|Death|0|||
150012193|NCT01610336|541178761|FG004|Overall Study|Death|0|||
150012194|NCT01610336|541178762|FG005|Overall Study|Death|1|||
150012195|NCT01610336|541178763|FG006|Overall Study|Death|3|||
150012196|NCT01610336|541178764|FG007|Overall Study|Death|0|||
150012197|NCT01610336|541178765|FG008|Overall Study|Death|0|||
150012198|NCT01610336|541178766|FG009|Overall Study|Death|1|||
150012199|NCT01610336|541178767|FG010|Overall Study|Death|2|||
150012200|NCT01610336|541178757|FG000|Overall Study|Non-Compliance with study treatment|0|||
150012201|NCT01610336|541178758|FG001|Overall Study|Non-Compliance with study treatment|0|||
150012202|NCT01610336|541178759|FG002|Overall Study|Non-Compliance with study treatment|0|||
150012203|NCT01610336|541178760|FG003|Overall Study|Non-Compliance with study treatment|0|||
150012204|NCT01610336|541178761|FG004|Overall Study|Non-Compliance with study treatment|0|||
150012205|NCT01610336|541178762|FG005|Overall Study|Non-Compliance with study treatment|0|||
150012206|NCT01610336|541178763|FG006|Overall Study|Non-Compliance with study treatment|0|||
150012207|NCT01610336|541178764|FG007|Overall Study|Non-Compliance with study treatment|0|||
150012208|NCT01610336|541178765|FG008|Overall Study|Non-Compliance with study treatment|0|||
150012209|NCT01610336|541178766|FG009|Overall Study|Non-Compliance with study treatment|1|||
150012210|NCT01610336|541178767|FG010|Overall Study|Non-Compliance with study treatment|0|||
150012211|NCT01610336|541178757|FG000|Overall Study|Physician Decision|0|||
150012212|NCT01610336|541178758|FG001|Overall Study|Physician Decision|0|||
150012213|NCT01610336|541178759|FG002|Overall Study|Physician Decision|0|||
150012214|NCT01610336|541178760|FG003|Overall Study|Physician Decision|0|||
150012215|NCT01610336|541178761|FG004|Overall Study|Physician Decision|0|||
150012216|NCT01610336|541178762|FG005|Overall Study|Physician Decision|0|||
150012217|NCT01610336|541178763|FG006|Overall Study|Physician Decision|1|||
150012218|NCT01610336|541178764|FG007|Overall Study|Physician Decision|0|||
150012219|NCT01610336|541178765|FG008|Overall Study|Physician Decision|0|||
150012220|NCT01610336|541178766|FG009|Overall Study|Physician Decision|0|||
150012221|NCT01610336|541178767|FG010|Overall Study|Physician Decision|0|||
150012222|NCT01610336|541178757|FG000|Overall Study|Protocol Deviation|0|||
150012223|NCT01610336|541178758|FG001|Overall Study|Protocol Deviation|0|||
150012224|NCT01610336|541178759|FG002|Overall Study|Protocol Deviation|0|||
150012225|NCT01610336|541178760|FG003|Overall Study|Protocol Deviation|0|||
150012226|NCT01610336|541178761|FG004|Overall Study|Protocol Deviation|0|||
150012227|NCT01610336|541178762|FG005|Overall Study|Protocol Deviation|0|||
150012228|NCT01610336|541178763|FG006|Overall Study|Protocol Deviation|0|||
150012229|NCT01610336|541178764|FG007|Overall Study|Protocol Deviation|0|||
150012230|NCT01610336|541178765|FG008|Overall Study|Protocol Deviation|0|||
150012231|NCT01610336|541178766|FG009|Overall Study|Protocol Deviation|1|||
150012232|NCT01610336|541178767|FG010|Overall Study|Protocol Deviation|0|||
150012233|NCT01610336|541178757|FG000|Overall Study|Transfer to another trial|0|||
150012234|NCT01610336|541178758|FG001|Overall Study|Transfer to another trial|0|||
150012235|NCT01610336|541178759|FG002|Overall Study|Transfer to another trial|0|||
150012236|NCT01610336|541178760|FG003|Overall Study|Transfer to another trial|0|||
150012237|NCT01610336|541178761|FG004|Overall Study|Transfer to another trial|0|||
150012238|NCT01610336|541178762|FG005|Overall Study|Transfer to another trial|0|||
150012239|NCT01610336|541178763|FG006|Overall Study|Transfer to another trial|0|||
150012240|NCT01610336|541178764|FG007|Overall Study|Transfer to another trial|0|||
150012241|NCT01610336|541178765|FG008|Overall Study|Transfer to another trial|0|||
150012242|NCT01610336|541178766|FG009|Overall Study|Transfer to another trial|0|||
150012243|NCT01610336|541178767|FG010|Overall Study|Transfer to another trial|1|||
150012244|NCT00741013|541178768|FG000|Overall Study|Adverse Event|1|||
150012245|NCT00741013|541178769|FG001|Overall Study|Adverse Event|0|||
150012246|NCT00741013|541178770|FG002|Overall Study|Adverse Event|0|||
150012247|NCT00741013|541178768|FG000|Overall Study|Withdrawal by Subject|0|||
150012248|NCT00741013|541178769|FG001|Overall Study|Withdrawal by Subject|0|||
150012249|NCT00741013|541178770|FG002|Overall Study|Withdrawal by Subject|1|||
150012250|NCT00741013|541178768|FG000|Overall Study|Discovered failed screen after enrolled|0|||
150012251|NCT00741013|541178769|FG001|Overall Study|Discovered failed screen after enrolled|2|||
150012252|NCT00741013|541178770|FG002|Overall Study|Discovered failed screen after enrolled|0|||
150012253|NCT01559675|541178771|FG000|Overall Study|Protocol Violation|1|||
150012254|NCT01559675|541178772|FG001|Overall Study|Protocol Violation|2|||
150012255|NCT01559675|541178771|FG000|Overall Study|2nd operation on same patient excluded|14|||
150012256|NCT01559675|541178772|FG001|Overall Study|2nd operation on same patient excluded|12|||
150012257|NCT00082407|541178773|FG000|Overall Study|Adverse Event|20|||
150012258|NCT00082407|541178774|FG001|Overall Study|Adverse Event|0|||
150012259|NCT00082407|541178773|FG000|Overall Study|Protocol Violation|14|||
150012260|NCT00082407|541178774|FG001|Overall Study|Protocol Violation|12|||
150012261|NCT00082407|541178773|FG000|Overall Study|Patient Decision|13|||
150012262|NCT00082407|541178774|FG001|Overall Study|Patient Decision|6|||
150012263|NCT00082407|541178773|FG000|Overall Study|Physician Decision|5|||
150012264|NCT00082407|541178774|FG001|Overall Study|Physician Decision|3|||
150012265|NCT00082407|541178773|FG000|Overall Study|Loss of Glucose Control|2|||
150012266|NCT00082407|541178774|FG001|Overall Study|Loss of Glucose Control|2|||
150012267|NCT00082407|541178773|FG000|Overall Study|Death|2|||
150012268|NCT00082407|541178774|FG001|Overall Study|Death|1|||
150012269|NCT00082407|541178773|FG000|Overall Study|Lost to Follow-up|0|||
150012270|NCT00082407|541178774|FG001|Overall Study|Lost to Follow-up|3|||
150012271|NCT00567359|541178775|FG000|Overall Study|Withdrawal by Subject|1|||
150012272|NCT02352753|541178776|FG000|6-Month Dosing Period|Decision by sponsor|2|||
150012273|NCT02352753|541178776|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
150012274|NCT02352753|541178776|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
150012275|NCT02352753|541178776|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
150012276|NCT02352753|541178776|FG000|3-Month Dosing Period|Decision by sponsor|14|||
150012277|NCT02352753|541178776|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
150012278|NCT00539305|541178777|FG000|Overall Study|Adverse Event|1|||
150012279|NCT00539305|541178778|FG001|Overall Study|Adverse Event|0|||
150012280|NCT00539305|541178777|FG000|Overall Study|Substance Use|0|||
150012281|NCT00539305|541178778|FG001|Overall Study|Substance Use|1|||
150012282|NCT00539305|541178777|FG000|Overall Study|Withdrawal by Subject|0|||
150012283|NCT00539305|541178778|FG001|Overall Study|Withdrawal by Subject|1|||
150012284|NCT03626545|541178781|FG000|Overall Study|Progressive disease|3|||
150012285|NCT03626545|541178782|FG001|Overall Study|Progressive disease|82|||
150057982|NCT03400956|541353594|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150057983|NCT03400956|541353595|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150057984|NCT03400956|541353596|FG002|Treatment Period 2|Withdrawal by Subject|3|||
150057985|NCT03400956|541353594|FG000|Treatment Period 2|Other|1|||
150057986|NCT03400956|541353595|FG001|Treatment Period 2|Other|1|||
150057987|NCT03400956|541353596|FG002|Treatment Period 2|Other|0|||
150057988|NCT03400956|541353594|FG000|Follow-up Period|Withdrawal by Subject|0|||
150057989|NCT03400956|541353595|FG001|Follow-up Period|Withdrawal by Subject|0|||
150057990|NCT03400956|541353596|FG002|Follow-up Period|Withdrawal by Subject|1|||
150057991|NCT03400956|541353594|FG000|Follow-up Period|Other|0|||
150181122|NCT02590432|541801011|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
150181123|NCT02590432|541801012|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150012286|NCT03626545|541178783|FG002|Overall Study|Progressive disease|85|||
150012287|NCT03626545|541178781|FG000|Overall Study|Adverse Event|3|||
150012288|NCT03626545|541178782|FG001|Overall Study|Adverse Event|13|||
150012289|NCT03626545|541178783|FG002|Overall Study|Adverse Event|10|||
150012290|NCT03626545|541178781|FG000|Overall Study|Physician Decision|1|||
150057992|NCT03400956|541353595|FG001|Follow-up Period|Other|0|||
150012291|NCT03626545|541178782|FG001|Overall Study|Physician Decision|18|||
150012292|NCT03626545|541178783|FG002|Overall Study|Physician Decision|14|||
150012293|NCT03626545|541178781|FG000|Overall Study|Subject Decision|0|||
150012294|NCT03626545|541178782|FG001|Overall Study|Subject Decision|5|||
150012295|NCT03626545|541178783|FG002|Overall Study|Subject Decision|5|||
150012296|NCT03626545|541178781|FG000|Overall Study|Death|1|||
150012297|NCT03626545|541178782|FG001|Overall Study|Death|1|||
150012298|NCT03626545|541178783|FG002|Overall Study|Death|1|||
150012299|NCT03626545|541178781|FG000|Overall Study|Protocol Deviation|0|||
150012300|NCT03626545|541178782|FG001|Overall Study|Protocol Deviation|1|||
150012301|NCT03626545|541178783|FG002|Overall Study|Protocol Deviation|1|||
150012302|NCT03626545|541178781|FG000|Overall Study|Guardian Decision|0|||
150012303|NCT03626545|541178782|FG001|Overall Study|Guardian Decision|0|||
150012304|NCT03626545|541178783|FG002|Overall Study|Guardian Decision|1|||
150012305|NCT00793325|541178785|FG000|Overall Study|Protocol Violation|18|||
150012306|NCT00793325|541178785|FG000|Overall Study|Lost to Follow-up|1|||
150012307|NCT01440816|541178786|FG000|Overall Study|Disease Progression|0|||
150012308|NCT01440816|541178787|FG001|Overall Study|Disease Progression|9|||
150012309|NCT01440816|541178786|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
150012310|NCT01440816|541178787|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
150012311|NCT03387020|541178788|FG000|Overall Study|Adverse Event|0|||
150012312|NCT03387020|541178789|FG001|Overall Study|Adverse Event|2|||
150012313|NCT03387020|541178790|FG002|Overall Study|Adverse Event|0|||
150012314|NCT03387020|541178788|FG000|Overall Study|Withdrawal by Subject|2|||
150012315|NCT03387020|541178789|FG001|Overall Study|Withdrawal by Subject|0|||
150012316|NCT03387020|541178790|FG002|Overall Study|Withdrawal by Subject|0|||
150012317|NCT01452919|541178791|FG000|Open-Label Treatment|Adverse Event|5|||
150012318|NCT01452919|541178792|FG001|Open-Label Treatment|Adverse Event|0|||
150012319|NCT01452919|541178793|FG002|Open-Label Treatment|Adverse Event|0|||
150012320|NCT01452919|541178791|FG000|Open-Label Treatment|Lost to Follow-up|4|||
150012321|NCT01452919|541178792|FG001|Open-Label Treatment|Lost to Follow-up|0|||
150012322|NCT01452919|541178793|FG002|Open-Label Treatment|Lost to Follow-up|0|||
150012323|NCT01452919|541178791|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
150012324|NCT01452919|541178792|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
150012325|NCT01452919|541178793|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
150012326|NCT01452919|541178791|FG000|Open-Label Treatment|Protocol Violation|4|||
150012327|NCT01452919|541178792|FG001|Open-Label Treatment|Protocol Violation|0|||
150012328|NCT01452919|541178793|FG002|Open-Label Treatment|Protocol Violation|0|||
150012329|NCT01452919|541178791|FG000|Open-Label Treatment|Sponsor Decision|1|||
150012330|NCT01452919|541178792|FG001|Open-Label Treatment|Sponsor Decision|0|||
150012331|NCT01452919|541178793|FG002|Open-Label Treatment|Sponsor Decision|0|||
150012332|NCT01452919|541178791|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
150012333|NCT01452919|541178792|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
150012334|NCT01452919|541178793|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
150012335|NCT01452919|541178791|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
150012336|NCT01452919|541178792|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
150012337|NCT01452919|541178793|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
150012338|NCT01452919|541178791|FG000|Randomization Treatment|Adverse Event|0|||
150012339|NCT01452919|541178792|FG001|Randomization Treatment|Adverse Event|0|||
150012340|NCT01452919|541178793|FG002|Randomization Treatment|Adverse Event|2|||
150012341|NCT01452919|541178791|FG000|Randomization Treatment|Sponsor Decision|0|||
150012342|NCT01452919|541178792|FG001|Randomization Treatment|Sponsor Decision|1|||
150012343|NCT01452919|541178793|FG002|Randomization Treatment|Sponsor Decision|0|||
150012344|NCT01452919|541178791|FG000|Randomization Treatment|Withdrawal by Subject|0|||
150012345|NCT01452919|541178792|FG001|Randomization Treatment|Withdrawal by Subject|1|||
150012346|NCT01452919|541178793|FG002|Randomization Treatment|Withdrawal by Subject|0|||
150012347|NCT01452919|541178791|FG000|Randomization Treatment|Subject is moving or has moved|0|||
150012348|NCT01452919|541178792|FG001|Randomization Treatment|Subject is moving or has moved|1|||
150012349|NCT01452919|541178793|FG002|Randomization Treatment|Subject is moving or has moved|0|||
150012350|NCT02421588|541178794|FG000|Overall Study|Non-treatment-related AE|8|||
150012351|NCT02421588|541178795|FG001|Overall Study|Non-treatment-related AE|8|||
150012352|NCT02421588|541178794|FG000|Overall Study|Progressive disease|152|||
150012353|NCT02421588|541178795|FG001|Overall Study|Progressive disease|135|||
150012354|NCT02421588|541178794|FG000|Overall Study|Death|11|||
150012355|NCT02421588|541178795|FG001|Overall Study|Death|3|||
150012356|NCT02421588|541178794|FG000|Overall Study|Physician Decision|8|||
150012357|NCT02421588|541178795|FG001|Overall Study|Physician Decision|17|||
150012358|NCT02421588|541178794|FG000|Overall Study|Other reason not specified|3|||
150012359|NCT02421588|541178795|FG001|Overall Study|Other reason not specified|1|||
150012360|NCT02421588|541178794|FG000|Overall Study|Symptomatic deterioration|13|||
150012361|NCT02421588|541178795|FG001|Overall Study|Symptomatic deterioration|19|||
150012362|NCT02421588|541178794|FG000|Overall Study|Treatment-related AE|10|||
150012363|NCT02421588|541178795|FG001|Overall Study|Treatment-related AE|14|||
150012364|NCT02421588|541178794|FG000|Overall Study|Withdrawal by Subject|14|||
150012365|NCT02421588|541178795|FG001|Overall Study|Withdrawal by Subject|16|||
150012366|NCT02421588|541178794|FG000|Overall Study|Not treated|2|||
150012367|NCT02421588|541178795|FG001|Overall Study|Not treated|8|||
150012368|NCT01359943|541178796|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
150012369|NCT01359943|541178797|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
150012370|NCT01359943|541178798|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
150012371|NCT01359943|541178796|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
150012372|NCT01359943|541178797|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
150012373|NCT01359943|541178798|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
150012374|NCT01359943|541178796|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
150012375|NCT01359943|541178797|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
150012376|NCT01359943|541178798|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
150012377|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
150012378|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
150012379|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
150012380|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
150012381|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
150012382|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
150012383|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
150012384|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
150012385|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
150012386|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
150012387|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
150012388|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
150012389|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
150012390|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
150012391|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
150012392|NCT01359943|541178796|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
150012393|NCT01359943|541178797|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
150012394|NCT01359943|541178798|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
150012395|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
150012396|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
150012397|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
150012398|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
150012399|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
150012400|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
150012401|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
150012402|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
150012403|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
150012404|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
150012405|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
150012406|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
150012407|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
150012408|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
150012409|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
150012410|NCT01359943|541178796|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
150012411|NCT01359943|541178797|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
150012412|NCT01359943|541178798|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
150012413|NCT02516592|541178799|FG000|Overall Study|Patient withdrew consent|5|||
150012414|NCT02516592|541178800|FG001|Overall Study|Patient withdrew consent|2|||
150012415|NCT02516592|541178799|FG000|Overall Study|Protocol deviation|4|||
150012416|NCT02516592|541178800|FG001|Overall Study|Protocol deviation|4|||
150012417|NCT02516592|541178799|FG000|Overall Study|Lost to Follow-up|2|||
150012418|NCT02516592|541178800|FG001|Overall Study|Lost to Follow-up|3|||
150012419|NCT02516592|541178799|FG000|Overall Study|Patient/guardian decision|2|||
150012420|NCT02516592|541178800|FG001|Overall Study|Patient/guardian decision|1|||
150012421|NCT02516592|541178799|FG000|Overall Study|Adverse Event|1|||
150012422|NCT02516592|541178800|FG001|Overall Study|Adverse Event|2|||
150012423|NCT02516592|541178799|FG000|Overall Study|Abnormal test procedure result|1|||
150012424|NCT02516592|541178800|FG001|Overall Study|Abnormal test procedure result|0|||
150012425|NCT02516592|541178799|FG000|Overall Study|Death|1|||
150012426|NCT02516592|541178800|FG001|Overall Study|Death|1|||
150012427|NCT01110382|541178802|FG000|Overall Study|Withdrawal by Subject|0|||
150012428|NCT01110382|541178803|FG001|Overall Study|Withdrawal by Subject|1|||
150012429|NCT01110382|541178802|FG000|Overall Study|Protocol Violation|0|||
150057993|NCT03400956|541353596|FG002|Follow-up Period|Other|1|||
150057994|NCT02048241|541353598|FG000|Overall Study|Withdrawal by Subject|0|||
150012430|NCT01110382|541178803|FG001|Overall Study|Protocol Violation|1|||
150012431|NCT00098306|541178804|FG000|Double Blind|Randomized, not treated|9|||
150012432|NCT00098306|541178805|FG001|Double Blind|Randomized, not treated|5|||
150012433|NCT00098306|541178806|FG002|Double Blind|Randomized, not treated|2|||
150012434|NCT00098306|541178807|FG003|Double Blind|Randomized, not treated|0|||
150012435|NCT00098306|541178808|FG004|Double Blind|Randomized, not treated|0|||
150012436|NCT00098306|541178809|FG005|Double Blind|Randomized, not treated|0|||
150012437|NCT00098306|541178810|FG006|Double Blind|Randomized, not treated|0|||
150057995|NCT02048241|541353599|FG001|Overall Study|Withdrawal by Subject|1|||
150012438|NCT00098306|541178804|FG000|Double Blind|Ongoing at cut-off date|151|||
150012439|NCT00098306|541178805|FG001|Double Blind|Ongoing at cut-off date|166|||
150012440|NCT00098306|541178806|FG002|Double Blind|Ongoing at cut-off date|72|||
150012441|NCT00098306|541178807|FG003|Double Blind|Ongoing at cut-off date|0|||
150012442|NCT00098306|541178808|FG004|Double Blind|Ongoing at cut-off date|0|||
150012443|NCT00098306|541178809|FG005|Double Blind|Ongoing at cut-off date|0|||
150012444|NCT00098306|541178810|FG006|Double Blind|Ongoing at cut-off date|0|||
150012445|NCT00098306|541178804|FG000|Double Blind|Adverse Event|11|||
150012446|NCT00098306|541178805|FG001|Double Blind|Adverse Event|10|||
150012447|NCT00098306|541178806|FG002|Double Blind|Adverse Event|6|||
150012448|NCT00098306|541178807|FG003|Double Blind|Adverse Event|0|||
150012449|NCT00098306|541178808|FG004|Double Blind|Adverse Event|0|||
150012450|NCT00098306|541178809|FG005|Double Blind|Adverse Event|0|||
150012451|NCT00098306|541178810|FG006|Double Blind|Adverse Event|0|||
150012452|NCT00098306|541178804|FG000|Double Blind|Lack of Efficacy|43|||
150012453|NCT00098306|541178805|FG001|Double Blind|Lack of Efficacy|34|||
150012454|NCT00098306|541178806|FG002|Double Blind|Lack of Efficacy|17|||
150012455|NCT00098306|541178807|FG003|Double Blind|Lack of Efficacy|0|||
150012456|NCT00098306|541178808|FG004|Double Blind|Lack of Efficacy|0|||
150012457|NCT00098306|541178809|FG005|Double Blind|Lack of Efficacy|0|||
150012458|NCT00098306|541178810|FG006|Double Blind|Lack of Efficacy|0|||
150012459|NCT00098306|541178804|FG000|Double Blind|Death|1|||
150012460|NCT00098306|541178805|FG001|Double Blind|Death|4|||
150012461|NCT00098306|541178806|FG002|Double Blind|Death|1|||
150012462|NCT00098306|541178807|FG003|Double Blind|Death|0|||
150012463|NCT00098306|541178808|FG004|Double Blind|Death|0|||
150012464|NCT00098306|541178809|FG005|Double Blind|Death|0|||
150012465|NCT00098306|541178810|FG006|Double Blind|Death|0|||
150012466|NCT00098306|541178804|FG000|Double Blind|Participant defaulted|19|||
150012467|NCT00098306|541178805|FG001|Double Blind|Participant defaulted|18|||
150012468|NCT00098306|541178806|FG002|Double Blind|Participant defaulted|11|||
150012469|NCT00098306|541178807|FG003|Double Blind|Participant defaulted|0|||
150012470|NCT00098306|541178808|FG004|Double Blind|Participant defaulted|0|||
150012471|NCT00098306|541178809|FG005|Double Blind|Participant defaulted|0|||
150012472|NCT00098306|541178810|FG006|Double Blind|Participant defaulted|0|||
150012473|NCT00098306|541178804|FG000|Double Blind|Un-specified|7|||
150012474|NCT00098306|541178805|FG001|Double Blind|Un-specified|3|||
150012475|NCT00098306|541178806|FG002|Double Blind|Un-specified|11|||
150012476|NCT00098306|541178807|FG003|Double Blind|Un-specified|0|||
150012477|NCT00098306|541178808|FG004|Double Blind|Un-specified|0|||
150012478|NCT00098306|541178809|FG005|Double Blind|Un-specified|0|||
150012479|NCT00098306|541178810|FG006|Double Blind|Un-specified|0|||
150012480|NCT00098306|541178804|FG000|Open Label|Lack of Efficacy|0|||
150012481|NCT00098306|541178805|FG001|Open Label|Lack of Efficacy|0|||
150012482|NCT00098306|541178806|FG002|Open Label|Lack of Efficacy|0|||
150012483|NCT00098306|541178807|FG003|Open Label|Lack of Efficacy|13|||
150012484|NCT00098306|541178808|FG004|Open Label|Lack of Efficacy|0|||
150012485|NCT00098306|541178809|FG005|Open Label|Lack of Efficacy|0|||
150012486|NCT00098306|541178810|FG006|Open Label|Lack of Efficacy|0|||
150012487|NCT00098306|541178804|FG000|Open Label|Adverse Event|0|||
150012488|NCT00098306|541178805|FG001|Open Label|Adverse Event|0|||
150012489|NCT00098306|541178806|FG002|Open Label|Adverse Event|0|||
150012490|NCT00098306|541178807|FG003|Open Label|Adverse Event|2|||
150012491|NCT00098306|541178808|FG004|Open Label|Adverse Event|0|||
150012492|NCT00098306|541178809|FG005|Open Label|Adverse Event|0|||
150012493|NCT00098306|541178810|FG006|Open Label|Adverse Event|0|||
150012494|NCT00098306|541178804|FG000|Open Label|Death|0|||
150012495|NCT00098306|541178805|FG001|Open Label|Death|0|||
150012496|NCT00098306|541178806|FG002|Open Label|Death|0|||
150012497|NCT00098306|541178807|FG003|Open Label|Death|4|||
150012498|NCT00098306|541178808|FG004|Open Label|Death|0|||
150057996|NCT00534313|541353600|FG000|Short-term Period|Adverse Event|1|||
150057997|NCT00534313|541353601|FG001|Short-term Period|Adverse Event|2|||
150012499|NCT00098306|541178809|FG005|Open Label|Death|0|||
150012500|NCT00098306|541178810|FG006|Open Label|Death|0|||
150012501|NCT00098306|541178804|FG000|Open Label|Participant defaulted|0|||
150012502|NCT00098306|541178805|FG001|Open Label|Participant defaulted|0|||
150012503|NCT00098306|541178806|FG002|Open Label|Participant defaulted|0|||
150012504|NCT00098306|541178807|FG003|Open Label|Participant defaulted|24|||
150012505|NCT00098306|541178808|FG004|Open Label|Participant defaulted|0|||
150057998|NCT00534313|541353602|FG002|Short-term Period|Adverse Event|1|||
150012506|NCT00098306|541178809|FG005|Open Label|Participant defaulted|0|||
150012507|NCT00098306|541178810|FG006|Open Label|Participant defaulted|0|||
150012508|NCT00098306|541178804|FG000|Open Label|Un-specified|0|||
150012509|NCT00098306|541178805|FG001|Open Label|Un-specified|0|||
150012510|NCT00098306|541178806|FG002|Open Label|Un-specified|0|||
150012511|NCT00098306|541178807|FG003|Open Label|Un-specified|15|||
150012512|NCT00098306|541178808|FG004|Open Label|Un-specified|0|||
150012513|NCT00098306|541178809|FG005|Open Label|Un-specified|0|||
150012514|NCT00098306|541178810|FG006|Open Label|Un-specified|0|||
150012515|NCT00098306|541178804|FG000|Open Label|Ongoing at cut-off date|0|||
150012516|NCT00098306|541178805|FG001|Open Label|Ongoing at cut-off date|0|||
150012517|NCT00098306|541178806|FG002|Open Label|Ongoing at cut-off date|0|||
150012518|NCT00098306|541178807|FG003|Open Label|Ongoing at cut-off date|269|||
150012519|NCT00098306|541178808|FG004|Open Label|Ongoing at cut-off date|62|||
150012520|NCT00098306|541178809|FG005|Open Label|Ongoing at cut-off date|0|||
150012521|NCT00098306|541178810|FG006|Open Label|Ongoing at cut-off date|0|||
150012522|NCT00098306|541178804|FG000|Observational Phase|Death|0|||
150012523|NCT00098306|541178805|FG001|Observational Phase|Death|0|||
150012524|NCT00098306|541178806|FG002|Observational Phase|Death|0|||
150012525|NCT00098306|541178807|FG003|Observational Phase|Death|0|||
150012526|NCT00098306|541178808|FG004|Observational Phase|Death|0|||
150012527|NCT00098306|541178809|FG005|Observational Phase|Death|5|||
150012528|NCT00098306|541178810|FG006|Observational Phase|Death|4|||
150012529|NCT00098306|541178804|FG000|Observational Phase|Participant defaulted|0|||
150012530|NCT00098306|541178805|FG001|Observational Phase|Participant defaulted|0|||
150012531|NCT00098306|541178806|FG002|Observational Phase|Participant defaulted|0|||
150012532|NCT00098306|541178807|FG003|Observational Phase|Participant defaulted|0|||
150012533|NCT00098306|541178808|FG004|Observational Phase|Participant defaulted|0|||
150012534|NCT00098306|541178809|FG005|Observational Phase|Participant defaulted|34|||
150012535|NCT00098306|541178810|FG006|Observational Phase|Participant defaulted|18|||
150012536|NCT00098306|541178804|FG000|Observational Phase|Un-specified|0|||
150012537|NCT00098306|541178805|FG001|Observational Phase|Un-specified|0|||
150012538|NCT00098306|541178806|FG002|Observational Phase|Un-specified|0|||
150012539|NCT00098306|541178807|FG003|Observational Phase|Un-specified|0|||
150012540|NCT00098306|541178808|FG004|Observational Phase|Un-specified|0|||
150012541|NCT00098306|541178809|FG005|Observational Phase|Un-specified|7|||
150012542|NCT00098306|541178810|FG006|Observational Phase|Un-specified|4|||
150012543|NCT00360568|541178811|FG000|Overall Study|Adverse Event|1|||
150012544|NCT00360568|541178812|FG001|Overall Study|Adverse Event|2|||
150012545|NCT00360568|541178811|FG000|Overall Study|Lack of Efficacy|1|||
150012546|NCT00360568|541178812|FG001|Overall Study|Lack of Efficacy|0|||
150012547|NCT00360568|541178811|FG000|Overall Study|Withdrawal by Subject|0|||
150012548|NCT00360568|541178812|FG001|Overall Study|Withdrawal by Subject|3|||
150012549|NCT01114438|541178815|FG000|Overall Study|Adverse Event|10|||
150012550|NCT01114438|541178815|FG000|Overall Study|concomitant medication|1|||
150012551|NCT01114438|541178815|FG000|Overall Study|Physician Decision|1|||
150012552|NCT01114438|541178815|FG000|Overall Study|Withdrawal by Subject|2|||
150012553|NCT02292706|541178818|FG000|Overall Study|Lost to Follow-up|20|||
150012554|NCT02292706|541178819|FG001|Overall Study|Lost to Follow-up|44|||
150012555|NCT02292706|541178820|FG002|Overall Study|Lost to Follow-up|24|||
150012556|NCT02292706|541178821|FG003|Overall Study|Lost to Follow-up|61|||
150012557|NCT02292706|541178822|FG004|Overall Study|Lost to Follow-up|21|||
150012558|NCT02292706|541178823|FG005|Overall Study|Lost to Follow-up|52|||
150012559|NCT02292706|541178824|FG006|Overall Study|Lost to Follow-up|25|||
150012560|NCT02292706|541178825|FG007|Overall Study|Lost to Follow-up|0|||
150012561|NCT02292706|541178818|FG000|Overall Study|Withdrew consent|15|||
150012562|NCT02292706|541178819|FG001|Overall Study|Withdrew consent|56|||
150012563|NCT02292706|541178820|FG002|Overall Study|Withdrew consent|43|||
150012564|NCT02292706|541178821|FG003|Overall Study|Withdrew consent|36|||
150012565|NCT02292706|541178822|FG004|Overall Study|Withdrew consent|13|||
150012566|NCT02292706|541178823|FG005|Overall Study|Withdrew consent|51|||
150012567|NCT02292706|541178824|FG006|Overall Study|Withdrew consent|20|||
150012568|NCT02292706|541178825|FG007|Overall Study|Withdrew consent|0|||
150012569|NCT02292706|541178818|FG000|Overall Study|Death|3|||
150012570|NCT02292706|541178819|FG001|Overall Study|Death|11|||
150012571|NCT02292706|541178820|FG002|Overall Study|Death|16|||
150012572|NCT02292706|541178821|FG003|Overall Study|Death|22|||
150012573|NCT02292706|541178822|FG004|Overall Study|Death|8|||
150012574|NCT02292706|541178823|FG005|Overall Study|Death|17|||
150012575|NCT02292706|541178824|FG006|Overall Study|Death|3|||
150012576|NCT02292706|541178825|FG007|Overall Study|Death|0|||
150012577|NCT02292706|541178818|FG000|Overall Study|Study terminated by sponsor|0|||
150012578|NCT02292706|541178819|FG001|Overall Study|Study terminated by sponsor|9|||
150181124|NCT02590432|541801013|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150181125|NCT02590432|541801014|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
150012579|NCT02292706|541178820|FG002|Overall Study|Study terminated by sponsor|4|||
150012580|NCT02292706|541178821|FG003|Overall Study|Study terminated by sponsor|21|||
150012581|NCT02292706|541178822|FG004|Overall Study|Study terminated by sponsor|11|||
150012582|NCT02292706|541178823|FG005|Overall Study|Study terminated by sponsor|13|||
150012583|NCT02292706|541178824|FG006|Overall Study|Study terminated by sponsor|3|||
150012584|NCT02292706|541178825|FG007|Overall Study|Study terminated by sponsor|0|||
150012585|NCT02292706|541178818|FG000|Overall Study|Investigator's discretion|4|||
150012586|NCT02292706|541178819|FG001|Overall Study|Investigator's discretion|9|||
150012587|NCT02292706|541178820|FG002|Overall Study|Investigator's discretion|7|||
150012588|NCT02292706|541178821|FG003|Overall Study|Investigator's discretion|11|||
150012589|NCT02292706|541178822|FG004|Overall Study|Investigator's discretion|4|||
150012590|NCT02292706|541178823|FG005|Overall Study|Investigator's discretion|10|||
150012591|NCT02292706|541178824|FG006|Overall Study|Investigator's discretion|1|||
150012592|NCT02292706|541178825|FG007|Overall Study|Investigator's discretion|0|||
150012593|NCT02292706|541178818|FG000|Overall Study|Liver transplant|1|||
150012594|NCT02292706|541178819|FG001|Overall Study|Liver transplant|1|||
150012595|NCT02292706|541178820|FG002|Overall Study|Liver transplant|11|||
150012596|NCT02292706|541178821|FG003|Overall Study|Liver transplant|16|||
150012597|NCT02292706|541178822|FG004|Overall Study|Liver transplant|5|||
150012598|NCT02292706|541178823|FG005|Overall Study|Liver transplant|6|||
150012599|NCT02292706|541178824|FG006|Overall Study|Liver transplant|5|||
150012600|NCT02292706|541178825|FG007|Overall Study|Liver transplant|0|||
150012601|NCT02292706|541178818|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
150012602|NCT02292706|541178819|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
150012603|NCT02292706|541178820|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
150012604|NCT02292706|541178821|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
150012605|NCT02292706|541178822|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
150012606|NCT02292706|541178823|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
150012607|NCT02292706|541178824|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
150012608|NCT02292706|541178825|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
150012609|NCT02292706|541178818|FG000|Overall Study|Subject terminated by sponsor|1|||
150012610|NCT02292706|541178819|FG001|Overall Study|Subject terminated by sponsor|0|||
150012611|NCT02292706|541178820|FG002|Overall Study|Subject terminated by sponsor|0|||
150012612|NCT02292706|541178821|FG003|Overall Study|Subject terminated by sponsor|2|||
150012613|NCT02292706|541178822|FG004|Overall Study|Subject terminated by sponsor|1|||
150012614|NCT02292706|541178823|FG005|Overall Study|Subject terminated by sponsor|0|||
150012615|NCT02292706|541178824|FG006|Overall Study|Subject terminated by sponsor|0|||
150012616|NCT02292706|541178825|FG007|Overall Study|Subject terminated by sponsor|0|||
150012617|NCT02292706|541178818|FG000|Overall Study|Missing|0|||
150012618|NCT02292706|541178819|FG001|Overall Study|Missing|0|||
150012619|NCT02292706|541178820|FG002|Overall Study|Missing|1|||
150012620|NCT02292706|541178821|FG003|Overall Study|Missing|1|||
150012621|NCT02292706|541178822|FG004|Overall Study|Missing|0|||
150012622|NCT02292706|541178823|FG005|Overall Study|Missing|1|||
150012623|NCT02292706|541178824|FG006|Overall Study|Missing|0|||
150012624|NCT02292706|541178825|FG007|Overall Study|Missing|0|||
150012625|NCT02292706|541178818|FG000|Overall Study|Virologic relapse or reinfection|1|||
150012626|NCT02292706|541178819|FG001|Overall Study|Virologic relapse or reinfection|0|||
150012627|NCT02292706|541178820|FG002|Overall Study|Virologic relapse or reinfection|0|||
150012628|NCT02292706|541178821|FG003|Overall Study|Virologic relapse or reinfection|1|||
150012629|NCT02292706|541178822|FG004|Overall Study|Virologic relapse or reinfection|0|||
150012630|NCT02292706|541178823|FG005|Overall Study|Virologic relapse or reinfection|1|||
150012631|NCT02292706|541178824|FG006|Overall Study|Virologic relapse or reinfection|0|||
150012632|NCT02292706|541178825|FG007|Overall Study|Virologic relapse or reinfection|0|||
150012633|NCT02725866|541178828|FG000|Overall Study|Failure to return|6|||
150012634|NCT02725866|541178828|FG000|Overall Study|Withdrew consent|3|||
150012635|NCT02725866|541178828|FG000|Overall Study|Insufficient virological response|1|||
150012636|NCT02725866|541178828|FG000|Overall Study|Other, not specified|4|||
150012637|NCT01990612|541178829|FG000|Overall Study|Lost to Follow-up|2|||
150012638|NCT01990612|541178830|FG001|Overall Study|Lost to Follow-up|1|||
150012639|NCT01990612|541178829|FG000|Overall Study|Withdrawal by Subject|5|||
150012640|NCT01990612|541178830|FG001|Overall Study|Withdrawal by Subject|2|||
150012641|NCT02188849|541178833|FG000|Overall Study|Lost to Follow-up|3|||
150012642|NCT02188849|541178834|FG001|Overall Study|Lost to Follow-up|8|||
150012643|NCT02577016|541178840|FG000|Overall Study|Adverse Event|2|||
150012644|NCT02577016|541178841|FG001|Overall Study|Adverse Event|1|||
150012645|NCT02577016|541178840|FG000|Overall Study|Physician Decision|0|||
150012646|NCT02577016|541178841|FG001|Overall Study|Physician Decision|1|||
150012647|NCT00812565|541178842|FG000|Overall Study|Did Not Receive Study Medication|1|||
150012648|NCT00812565|541178843|FG001|Overall Study|Did Not Receive Study Medication|1|||
150012649|NCT00812565|541178844|FG002|Overall Study|Did Not Receive Study Medication|0|||
150012650|NCT00812565|541178845|FG003|Overall Study|Did Not Receive Study Medication|0|||
150057999|NCT00534313|541353603|FG003|Short-term Period|Adverse Event|3|||
150058000|NCT00534313|541353600|FG000|Short-term Period|Lack of Efficacy|3|||
150058001|NCT00534313|541353601|FG001|Short-term Period|Lack of Efficacy|4|||
150058002|NCT00534313|541353602|FG002|Short-term Period|Lack of Efficacy|0|||
150058003|NCT00534313|541353603|FG003|Short-term Period|Lack of Efficacy|3|||
150058004|NCT00534313|541353600|FG000|Short-term Period|Participant not meeting study criteria|0|||
150012651|NCT00812565|541178846|FG004|Overall Study|Did Not Receive Study Medication|0|||
150058005|NCT00534313|541353601|FG001|Short-term Period|Participant not meeting study criteria|0|||
150058006|NCT00534313|541353602|FG002|Short-term Period|Participant not meeting study criteria|0|||
150058007|NCT00534313|541353603|FG003|Short-term Period|Participant not meeting study criteria|1|||
150012652|NCT00812565|541178847|FG005|Overall Study|Did Not Receive Study Medication|0|||
150012653|NCT00812565|541178848|FG006|Overall Study|Did Not Receive Study Medication|0|||
150012654|NCT00812565|541178849|FG007|Overall Study|Did Not Receive Study Medication|0|||
150012655|NCT00812565|541178842|FG000|Overall Study|Adverse Event|0|||
150012656|NCT00812565|541178843|FG001|Overall Study|Adverse Event|0|||
150058008|NCT00534313|541353600|FG000|Short-term Period|Participant withdrew consent|2|||
150058009|NCT00534313|541353601|FG001|Short-term Period|Participant withdrew consent|0|||
150012657|NCT00812565|541178844|FG002|Overall Study|Adverse Event|0|||
150012658|NCT00812565|541178845|FG003|Overall Study|Adverse Event|2|||
150012659|NCT00812565|541178846|FG004|Overall Study|Adverse Event|0|||
150012660|NCT00812565|541178847|FG005|Overall Study|Adverse Event|0|||
150012661|NCT00812565|541178848|FG006|Overall Study|Adverse Event|0|||
150012662|NCT00812565|541178849|FG007|Overall Study|Adverse Event|1|||
150012663|NCT00812565|541178842|FG000|Overall Study|Did Not Come to Study Visit|1|||
150012664|NCT00812565|541178843|FG001|Overall Study|Did Not Come to Study Visit|0|||
150012665|NCT00812565|541178844|FG002|Overall Study|Did Not Come to Study Visit|0|||
150012666|NCT00812565|541178845|FG003|Overall Study|Did Not Come to Study Visit|0|||
150012667|NCT00812565|541178846|FG004|Overall Study|Did Not Come to Study Visit|0|||
150012668|NCT00812565|541178847|FG005|Overall Study|Did Not Come to Study Visit|0|||
150012669|NCT00812565|541178848|FG006|Overall Study|Did Not Come to Study Visit|0|||
150012670|NCT00812565|541178849|FG007|Overall Study|Did Not Come to Study Visit|0|||
150012671|NCT00812565|541178842|FG000|Overall Study|Withdrawal of Consent|1|||
150012672|NCT00812565|541178843|FG001|Overall Study|Withdrawal of Consent|0|||
150012673|NCT00812565|541178844|FG002|Overall Study|Withdrawal of Consent|0|||
150012674|NCT00812565|541178845|FG003|Overall Study|Withdrawal of Consent|0|||
150012675|NCT00812565|541178846|FG004|Overall Study|Withdrawal of Consent|1|||
150012676|NCT00812565|541178847|FG005|Overall Study|Withdrawal of Consent|0|||
150012677|NCT00812565|541178848|FG006|Overall Study|Withdrawal of Consent|0|||
150012678|NCT00812565|541178849|FG007|Overall Study|Withdrawal of Consent|0|||
150012679|NCT00812565|541178842|FG000|Overall Study|Reason Not Specified|0|||
150012680|NCT00812565|541178843|FG001|Overall Study|Reason Not Specified|0|||
150012681|NCT00812565|541178844|FG002|Overall Study|Reason Not Specified|0|||
150012682|NCT00812565|541178845|FG003|Overall Study|Reason Not Specified|0|||
150012683|NCT00812565|541178846|FG004|Overall Study|Reason Not Specified|0|||
150012684|NCT00812565|541178847|FG005|Overall Study|Reason Not Specified|1|||
150012685|NCT00812565|541178848|FG006|Overall Study|Reason Not Specified|0|||
150012686|NCT00812565|541178849|FG007|Overall Study|Reason Not Specified|0|||
150012687|NCT00566254|541178852|FG000|Overall Study|Adverse Event|3|||
150012688|NCT00566254|541178853|FG001|Overall Study|Adverse Event|1|||
150012689|NCT00566254|541178852|FG000|Overall Study|Protocol Violation|1|||
150012690|NCT00566254|541178853|FG001|Overall Study|Protocol Violation|3|||
150012691|NCT00566254|541178852|FG000|Overall Study|Withdrawal by Subject|1|||
150012692|NCT00566254|541178853|FG001|Overall Study|Withdrawal by Subject|2|||
150012693|NCT00566254|541178852|FG000|Overall Study|Lack of Efficacy|5|||
150012694|NCT00566254|541178853|FG001|Overall Study|Lack of Efficacy|6|||
150012695|NCT00566254|541178852|FG000|Overall Study|Other|0|||
150012696|NCT00566254|541178853|FG001|Overall Study|Other|2|||
150012697|NCT01793883|541178854|FG000|Overall Study|Withdrawal by Subject|3|||
150012698|NCT01793883|541178855|FG001|Overall Study|Withdrawal by Subject|7|||
150012699|NCT01793883|541178856|FG002|Overall Study|Withdrawal by Subject|3|||
150012700|NCT01793883|541178854|FG000|Overall Study|Subject noncompliance|0|||
150012701|NCT01793883|541178855|FG001|Overall Study|Subject noncompliance|1|||
150012702|NCT01793883|541178856|FG002|Overall Study|Subject noncompliance|1|||
150012703|NCT01793883|541178854|FG000|Overall Study|Lost to Follow-up|5|||
150012704|NCT01793883|541178855|FG001|Overall Study|Lost to Follow-up|1|||
150012705|NCT01793883|541178856|FG002|Overall Study|Lost to Follow-up|3|||
150012706|NCT01793883|541178854|FG000|Overall Study|Randomized in error|1|||
150012707|NCT01793883|541178855|FG001|Overall Study|Randomized in error|0|||
150012708|NCT01793883|541178856|FG002|Overall Study|Randomized in error|0|||
150012709|NCT01793883|541178854|FG000|Overall Study|Unable to complete spriometry|1|||
150012710|NCT01793883|541178855|FG001|Overall Study|Unable to complete spriometry|0|||
150012711|NCT01793883|541178856|FG002|Overall Study|Unable to complete spriometry|0|||
150012712|NCT01793883|541178854|FG000|Overall Study|Unable to complete measurements|1|||
150012713|NCT01793883|541178855|FG001|Overall Study|Unable to complete measurements|0|||
150012714|NCT01793883|541178856|FG002|Overall Study|Unable to complete measurements|0|||
150012715|NCT01793883|541178854|FG000|Overall Study|Met exclusion criteria|1|||
150012716|NCT01793883|541178855|FG001|Overall Study|Met exclusion criteria|0|||
150012717|NCT01793883|541178856|FG002|Overall Study|Met exclusion criteria|0|||
150012718|NCT01793883|541178854|FG000|Overall Study|Dosing error|0|||
150012719|NCT01793883|541178855|FG001|Overall Study|Dosing error|1|||
150012720|NCT01793883|541178856|FG002|Overall Study|Dosing error|0|||
150012721|NCT01793883|541178854|FG000|Overall Study|Respiratory distress during spirometry|0|||
150012722|NCT01793883|541178855|FG001|Overall Study|Respiratory distress during spirometry|0|||
150012723|NCT01793883|541178856|FG002|Overall Study|Respiratory distress during spirometry|1|||
150012724|NCT00687531|541178857|FG000|Overall Study|Did not meet protocol eligibility|104|||
150012725|NCT00687531|541178857|FG000|Overall Study|Adverse Event|5|||
150012726|NCT00687531|541178857|FG000|Overall Study|Lost to Follow-up|26|||
150012727|NCT02353728|541178858|FG000|Overall Study|Subject non-compliance|1|||
150012728|NCT02301624|541178859|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
150012729|NCT02301624|541178860|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
150012730|NCT02301624|541178859|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
150012731|NCT02301624|541178860|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
150012732|NCT02301624|541178859|FG000|Open-label Maintenance Phase|Adverse Event|2|||
150012733|NCT02301624|541178860|FG001|Open-label Maintenance Phase|Adverse Event|5|||
150012734|NCT02301624|541178859|FG000|Open-label Maintenance Phase|Physician Decision|3|||
150012735|NCT02301624|541178860|FG001|Open-label Maintenance Phase|Physician Decision|3|||
150012736|NCT02301624|541178859|FG000|Open-label Maintenance Phase|Death|2|||
150012737|NCT02301624|541178860|FG001|Open-label Maintenance Phase|Death|1|||
150012738|NCT02301624|541178859|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
150012739|NCT02301624|541178860|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
150012740|NCT00895310|541178861|FG000|Overall Study|Withdrawal by Subject|1|||
150012741|NCT00659230|541178862|FG000|Overall Study|Lost to Follow-up|2|||
150012742|NCT00659230|541178863|FG001|Overall Study|Lost to Follow-up|5|||
150012743|NCT00659230|541178862|FG000|Overall Study|Lost source documentation|5|||
150012744|NCT00659230|541178863|FG001|Overall Study|Lost source documentation|4|||
150012745|NCT00659230|541178862|FG000|Overall Study|Did not return post-randomization|2|||
150012746|NCT00659230|541178863|FG001|Overall Study|Did not return post-randomization|3|||
150012747|NCT05066165|541180696|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
150012748|NCT05066165|541180697|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
150012749|NCT05066165|541180696|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
150012750|NCT05066165|541180697|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
150012751|NCT02467582|541180698|FG000|Allocation|Withdrawal by Subject|1|||
150012752|NCT02467582|541180699|FG001|Allocation|Withdrawal by Subject|0|||
150012753|NCT02467582|541180698|FG000|Follow-up|Death|5|||
150012754|NCT02467582|541180699|FG001|Follow-up|Death|4|||
150012755|NCT02467582|541180698|FG000|Follow-up|Lost to Follow-up|6|||
150012756|NCT02467582|541180699|FG001|Follow-up|Lost to Follow-up|5|||
150012757|NCT01370265|541180700|FG000|First Intervention|Adverse Event|1|||
150012758|NCT01370265|541180701|FG001|First Intervention|Adverse Event|1|||
150012759|NCT03343626|541180702|FG000|Overall Study|Lost to Follow-up|4|||
150012760|NCT03343626|541180703|FG001|Overall Study|Lost to Follow-up|3|||
150012761|NCT03343626|541180704|FG002|Overall Study|Lost to Follow-up|2|||
150012762|NCT03343626|541180705|FG003|Overall Study|Lost to Follow-up|5|||
150012763|NCT03343626|541180706|FG004|Overall Study|Lost to Follow-up|4|||
150012764|NCT03343626|541180707|FG005|Overall Study|Lost to Follow-up|4|||
150012765|NCT03343626|541180708|FG006|Overall Study|Lost to Follow-up|4|||
150012766|NCT03343626|541180709|FG007|Overall Study|Lost to Follow-up|7|||
150012767|NCT03343626|541180702|FG000|Overall Study|Withdrawal of Consent|2|||
150012768|NCT03343626|541180703|FG001|Overall Study|Withdrawal of Consent|1|||
150012769|NCT03343626|541180704|FG002|Overall Study|Withdrawal of Consent|0|||
150012770|NCT03343626|541180705|FG003|Overall Study|Withdrawal of Consent|3|||
150012771|NCT03343626|541180706|FG004|Overall Study|Withdrawal of Consent|3|||
150012772|NCT03343626|541180707|FG005|Overall Study|Withdrawal of Consent|1|||
150012773|NCT03343626|541180708|FG006|Overall Study|Withdrawal of Consent|1|||
150012774|NCT03343626|541180709|FG007|Overall Study|Withdrawal of Consent|2|||
150012775|NCT03343626|541180702|FG000|Overall Study|Reason not Specified|0|||
150012776|NCT03343626|541180703|FG001|Overall Study|Reason not Specified|1|||
150012777|NCT03343626|541180704|FG002|Overall Study|Reason not Specified|0|||
150012778|NCT03343626|541180705|FG003|Overall Study|Reason not Specified|0|||
150012779|NCT03343626|541180706|FG004|Overall Study|Reason not Specified|0|||
150012780|NCT03343626|541180707|FG005|Overall Study|Reason not Specified|0|||
150012781|NCT03343626|541180708|FG006|Overall Study|Reason not Specified|0|||
150012782|NCT03343626|541180709|FG007|Overall Study|Reason not Specified|1|||
150012783|NCT03343626|541180702|FG000|Overall Study|Data Entry Error|0|||
150012784|NCT03343626|541180703|FG001|Overall Study|Data Entry Error|0|||
150012785|NCT03343626|541180704|FG002|Overall Study|Data Entry Error|0|||
150012786|NCT03343626|541180705|FG003|Overall Study|Data Entry Error|0|||
150012787|NCT03343626|541180706|FG004|Overall Study|Data Entry Error|0|||
150012788|NCT03343626|541180707|FG005|Overall Study|Data Entry Error|0|||
150012789|NCT03343626|541180708|FG006|Overall Study|Data Entry Error|0|||
150012790|NCT03343626|541180709|FG007|Overall Study|Data Entry Error|1|||
150012791|NCT00703924|541180710|FG000|Overall Study|Withdrawal by Subject|1|||
150012792|NCT00703924|541180711|FG001|Overall Study|Withdrawal by Subject|1|||
150012793|NCT01031979|541180714|FG000|Overall Study|Lost to Follow-up|5|||
150012794|NCT01031979|541180715|FG001|Overall Study|Lost to Follow-up|4|||
150012795|NCT03592368|541180716|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
150012796|NCT03592368|541180717|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
150012797|NCT03592368|541180718|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
150012798|NCT03592368|541180719|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
150012799|NCT03592368|541180716|FG000|Overall Study|Adverse Event|0|||
150012800|NCT03592368|541180717|FG001|Overall Study|Adverse Event|0|||
150012801|NCT03592368|541180718|FG002|Overall Study|Adverse Event|0|||
150012802|NCT03592368|541180719|FG003|Overall Study|Adverse Event|1|||
150012803|NCT03592368|541180716|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
150012804|NCT03592368|541180717|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
150012805|NCT03592368|541180718|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
150012806|NCT03592368|541180719|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
150012807|NCT02454478|541180726|FG000|Overall Study|Incomplete DLT Evaluation|1|||
150012808|NCT01732770|541180731|FG000|Overall Study|Lost to Follow-up|2|||
150012809|NCT01732770|541180732|FG001|Overall Study|Lost to Follow-up|3|||
150012810|NCT01732770|541180731|FG000|Overall Study|Withdrawal by Subject|5|||
150012811|NCT01732770|541180732|FG001|Overall Study|Withdrawal by Subject|3|||
150012812|NCT01732770|541180731|FG000|Overall Study|Decision by Sponsor|2|||
150012813|NCT01732770|541180732|FG001|Overall Study|Decision by Sponsor|2|||
150012814|NCT01732770|541180731|FG000|Overall Study|Death|1|||
150012815|NCT01732770|541180732|FG001|Overall Study|Death|0|||
150012816|NCT01959841|541180735|FG000|Overall Study|Adverse Event|1|||
150012817|NCT01959841|541180736|FG001|Overall Study|Adverse Event|3|||
150012818|NCT01959841|541180737|FG002|Overall Study|Adverse Event|2|||
150012819|NCT01959841|541180735|FG000|Overall Study|Lack of Efficacy|5|||
150012820|NCT01959841|541180736|FG001|Overall Study|Lack of Efficacy|0|||
150012821|NCT01959841|541180737|FG002|Overall Study|Lack of Efficacy|0|||
150012822|NCT01959841|541180735|FG000|Overall Study|Lost to Follow-up|1|||
150012823|NCT01959841|541180736|FG001|Overall Study|Lost to Follow-up|1|||
150012824|NCT01959841|541180737|FG002|Overall Study|Lost to Follow-up|0|||
150012825|NCT01959841|541180735|FG000|Overall Study|Physician Decision|0|||
150012826|NCT01959841|541180736|FG001|Overall Study|Physician Decision|2|||
150012827|NCT01959841|541180737|FG002|Overall Study|Physician Decision|3|||
150012828|NCT01959841|541180735|FG000|Overall Study|Protocol Violation|16|||
150012829|NCT01959841|541180736|FG001|Overall Study|Protocol Violation|23|||
150012830|NCT01959841|541180737|FG002|Overall Study|Protocol Violation|16|||
150012831|NCT01959841|541180735|FG000|Overall Study|Withdrawal by Subject|7|||
150012832|NCT01959841|541180736|FG001|Overall Study|Withdrawal by Subject|7|||
150012833|NCT01959841|541180737|FG002|Overall Study|Withdrawal by Subject|5|||
150012834|NCT01959841|541180735|FG000|Overall Study|Clinical laboratory value|2|||
150012835|NCT01959841|541180736|FG001|Overall Study|Clinical laboratory value|6|||
150012836|NCT01959841|541180737|FG002|Overall Study|Clinical laboratory value|6|||
150012837|NCT01959841|541180735|FG000|Overall Study|Platelet count below on day1 or 4|11|||
150012838|NCT01959841|541180736|FG001|Overall Study|Platelet count below on day1 or 4|15|||
150012839|NCT01959841|541180737|FG002|Overall Study|Platelet count below on day1 or 4|11|||
150012840|NCT00780416|541180738|FG000|Overall Study|Physician Decision|3|||
150012841|NCT00780416|541180739|FG001|Overall Study|Physician Decision|3|||
150012842|NCT00780416|541180738|FG000|Overall Study|Protocol Violation|1|||
150012843|NCT00780416|541180739|FG001|Overall Study|Protocol Violation|0|||
150012844|NCT00780416|541180738|FG000|Overall Study|Withdrawal by Subject|8|||
150012845|NCT00780416|541180739|FG001|Overall Study|Withdrawal by Subject|6|||
150012846|NCT03521141|541180746|FG000|Overall Study|Death|1|||
150012847|NCT03521141|541180747|FG001|Overall Study|Death|0|||
150012848|NCT03521141|541180748|FG002|Overall Study|Death|1|||
150012849|NCT01496469|541180755|FG000|Overall Study|Adverse Event|1|||
150012850|NCT01496469|541180756|FG001|Overall Study|Adverse Event|0|||
150012851|NCT01496469|541180755|FG000|Overall Study|Protocol Violation|2|||
150012852|NCT01496469|541180756|FG001|Overall Study|Protocol Violation|0|||
150012853|NCT01496469|541180755|FG000|Overall Study|Lost to Follow-up|1|||
150012854|NCT01496469|541180756|FG001|Overall Study|Lost to Follow-up|1|||
150012855|NCT01496469|541180755|FG000|Overall Study|Withdrawal by Subject|4|||
150012856|NCT01496469|541180756|FG001|Overall Study|Withdrawal by Subject|4|||
150012857|NCT01496469|541180755|FG000|Overall Study|BP exceeds protocol limits|1|||
150012858|NCT01496469|541180756|FG001|Overall Study|BP exceeds protocol limits|2|||
150012859|NCT01496469|541180755|FG000|Overall Study|Other|1|||
150012860|NCT01496469|541180756|FG001|Overall Study|Other|1|||
150012861|NCT00077649|541180757|FG000|Overall Study|Adverse Event|5|||
150012862|NCT00077649|541180758|FG001|Overall Study|Adverse Event|1|||
150012863|NCT00077649|541180759|FG002|Overall Study|Adverse Event|7|||
150012864|NCT00077649|541180760|FG003|Overall Study|Adverse Event|9|||
150012865|NCT00077649|541180757|FG000|Overall Study|Lack of Efficacy|5|||
150012866|NCT00077649|541180758|FG001|Overall Study|Lack of Efficacy|3|||
150012867|NCT00077649|541180759|FG002|Overall Study|Lack of Efficacy|3|||
150012868|NCT00077649|541180760|FG003|Overall Study|Lack of Efficacy|2|||
150012869|NCT00077649|541180757|FG000|Overall Study|Withdrawal by Subject|0|||
150012870|NCT00077649|541180758|FG001|Overall Study|Withdrawal by Subject|1|||
150012871|NCT00077649|541180759|FG002|Overall Study|Withdrawal by Subject|1|||
150012872|NCT00077649|541180760|FG003|Overall Study|Withdrawal by Subject|2|||
150012873|NCT00077649|541180757|FG000|Overall Study|Lost to Follow-up|2|||
150012874|NCT00077649|541180758|FG001|Overall Study|Lost to Follow-up|2|||
150012875|NCT00077649|541180759|FG002|Overall Study|Lost to Follow-up|3|||
150012876|NCT00077649|541180760|FG003|Overall Study|Lost to Follow-up|2|||
150012877|NCT00077649|541180757|FG000|Overall Study|Abnormality of Laboratory Test|1|||
150012878|NCT00077649|541180758|FG001|Overall Study|Abnormality of Laboratory Test|2|||
150012879|NCT00077649|541180759|FG002|Overall Study|Abnormality of Laboratory Test|1|||
150012880|NCT00077649|541180760|FG003|Overall Study|Abnormality of Laboratory Test|2|||
150012881|NCT00077649|541180757|FG000|Overall Study|Randomized but never dosed|1|||
150012882|NCT00077649|541180758|FG001|Overall Study|Randomized but never dosed|0|||
150012883|NCT00077649|541180759|FG002|Overall Study|Randomized but never dosed|0|||
150012884|NCT00077649|541180760|FG003|Overall Study|Randomized but never dosed|0|||
150012885|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
150012886|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
150012887|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
150058010|NCT00534313|541353602|FG002|Short-term Period|Participant withdrew consent|0|||
150058011|NCT00534313|541353603|FG003|Short-term Period|Participant withdrew consent|2|||
150058012|NCT00534313|541353600|FG000|Short-term Period|Pregnancy|0|||
150058013|NCT00534313|541353601|FG001|Short-term Period|Pregnancy|0|||
150058014|NCT00534313|541353602|FG002|Short-term Period|Pregnancy|1|||
150058015|NCT00534313|541353603|FG003|Short-term Period|Pregnancy|0|||
150058016|NCT00534313|541353600|FG000|Long-term Period|Adverse Event|2|||
150058017|NCT00534313|541353601|FG001|Long-term Period|Adverse Event|1|||
150058018|NCT00534313|541353602|FG002|Long-term Period|Adverse Event|0|||
150058019|NCT00534313|541353603|FG003|Long-term Period|Adverse Event|1|||
150012888|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
150012889|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
150012890|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
150012891|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
150012892|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
150012893|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
150012894|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
150012895|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
150012896|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
150012897|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
150012898|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
150012899|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
150012900|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
150181126|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150181127|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150181128|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150181129|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150181130|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150012901|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
150012902|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
150012903|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
150012904|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
150012905|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
150012906|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
150012907|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
150012908|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
150012909|NCT01532869|541180761|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
150012910|NCT01532869|541180762|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
150012911|NCT01532869|541180761|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
150012912|NCT01532869|541180762|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
150012913|NCT01532869|541180761|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
150012914|NCT01532869|541180762|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
150012915|NCT01532869|541180761|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
150012916|NCT01532869|541180762|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
150012917|NCT01532869|541180761|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
150012918|NCT01532869|541180762|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
150012919|NCT01331291|541180763|FG000|Overall Study|Lack of Efficacy|2|||
150012920|NCT01331291|541180764|FG001|Overall Study|Lack of Efficacy|8|||
150012921|NCT01331291|541180763|FG000|Overall Study|Death|0|||
150058020|NCT00534313|541353600|FG000|Long-term Period|Lack of Efficacy|14|||
150058021|NCT00534313|541353601|FG001|Long-term Period|Lack of Efficacy|10|||
150058022|NCT00534313|541353602|FG002|Long-term Period|Lack of Efficacy|14|||
150012922|NCT01331291|541180764|FG001|Overall Study|Death|1|||
150058023|NCT00534313|541353603|FG003|Long-term Period|Lack of Efficacy|12|||
150181131|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150012923|NCT00778895|541180765|FG000|Active Phase|Adverse Event|3|||
150058024|NCT00534313|541353600|FG000|Long-term Period|Lost to Follow-up|1|||
150058025|NCT00534313|541353601|FG001|Long-term Period|Lost to Follow-up|2|||
150058026|NCT00534313|541353602|FG002|Long-term Period|Lost to Follow-up|0|||
150058027|NCT00534313|541353603|FG003|Long-term Period|Lost to Follow-up|0|||
150012924|NCT00778895|541180766|FG001|Active Phase|Adverse Event|1|||
150012925|NCT00778895|541180767|FG002|Active Phase|Adverse Event|0|||
150012926|NCT00778895|541180765|FG000|Active Phase|Withdrawal by Subject|1|||
150012927|NCT00778895|541180766|FG001|Active Phase|Withdrawal by Subject|4|||
150012928|NCT00778895|541180767|FG002|Active Phase|Withdrawal by Subject|0|||
150012929|NCT00778895|541180765|FG000|Active Phase|Lost to Follow-up|1|||
150012930|NCT00778895|541180766|FG001|Active Phase|Lost to Follow-up|1|||
150012931|NCT00778895|541180767|FG002|Active Phase|Lost to Follow-up|0|||
150012932|NCT00778895|541180765|FG000|Active Phase|Other|2|||
150012933|NCT00778895|541180766|FG001|Active Phase|Other|0|||
150012934|NCT00778895|541180767|FG002|Active Phase|Other|0|||
150012935|NCT00778895|541180765|FG000|ESFU Phase|Adverse Event|2|||
150012936|NCT00778895|541180766|FG001|ESFU Phase|Adverse Event|1|||
150012937|NCT00778895|541180767|FG002|ESFU Phase|Adverse Event|0|||
150012938|NCT00778895|541180765|FG000|ESFU Phase|Withdrawal by Subject|1|||
150012939|NCT00778895|541180766|FG001|ESFU Phase|Withdrawal by Subject|4|||
150012940|NCT00778895|541180767|FG002|ESFU Phase|Withdrawal by Subject|0|||
150012941|NCT00778895|541180765|FG000|ESFU Phase|Lost to Follow-up|6|||
150012942|NCT00778895|541180766|FG001|ESFU Phase|Lost to Follow-up|7|||
150012943|NCT00778895|541180767|FG002|ESFU Phase|Lost to Follow-up|2|||
150012944|NCT00778895|541180765|FG000|ESFU Phase|Other|2|||
150012945|NCT00778895|541180766|FG001|ESFU Phase|Other|0|||
150012946|NCT00778895|541180767|FG002|ESFU Phase|Other|0|||
150012947|NCT00820222|541180771|FG000|Overall Study|Lost to Follow-up|10|||
150012948|NCT00820222|541180772|FG001|Overall Study|Lost to Follow-up|9|||
150012949|NCT00820222|541180771|FG000|Overall Study|Withdrawal by Subject|19|||
150012950|NCT00820222|541180772|FG001|Overall Study|Withdrawal by Subject|21|||
150012951|NCT00820222|541180771|FG000|Overall Study|Physician Decision|93|||
150012952|NCT00820222|541180772|FG001|Overall Study|Physician Decision|88|||
150012953|NCT00820222|541180771|FG000|Overall Study|Sponsor Terminated Study|43|||
150012954|NCT00820222|541180772|FG001|Overall Study|Sponsor Terminated Study|65|||
150181132|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
150181133|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
150181134|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
150012955|NCT00820222|541180771|FG000|Overall Study|Unkown|11|||
150012956|NCT00820222|541180772|FG001|Overall Study|Unkown|7|||
150012957|NCT00590577|541180773|FG000|Overall Study|Lack of Efficacy|31|||
150012958|NCT00590577|541180774|FG001|Overall Study|Lack of Efficacy|28|||
150012959|NCT00590577|541180775|FG002|Overall Study|Lack of Efficacy|23|||
150012960|NCT00590577|541180776|FG003|Overall Study|Lack of Efficacy|45|||
150012961|NCT00590577|541180773|FG000|Overall Study|Withdrawal by Subject|23|||
150012962|NCT00590577|541180774|FG001|Overall Study|Withdrawal by Subject|28|||
150012963|NCT00590577|541180775|FG002|Overall Study|Withdrawal by Subject|30|||
150012964|NCT00590577|541180776|FG003|Overall Study|Withdrawal by Subject|26|||
150012965|NCT00590577|541180773|FG000|Overall Study|Adverse Event|10|||
150012966|NCT00590577|541180774|FG001|Overall Study|Adverse Event|10|||
150012967|NCT00590577|541180775|FG002|Overall Study|Adverse Event|13|||
150012968|NCT00590577|541180776|FG003|Overall Study|Adverse Event|11|||
150012969|NCT00590577|541180773|FG000|Overall Study|Lost to Follow-up|12|||
150012970|NCT00590577|541180774|FG001|Overall Study|Lost to Follow-up|6|||
150012971|NCT00590577|541180775|FG002|Overall Study|Lost to Follow-up|6|||
150012972|NCT00590577|541180776|FG003|Overall Study|Lost to Follow-up|9|||
150181135|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150012973|NCT00590577|541180773|FG000|Overall Study|Pregnancy|0|||
150012974|NCT00590577|541180774|FG001|Overall Study|Pregnancy|1|||
150012975|NCT00590577|541180775|FG002|Overall Study|Pregnancy|0|||
150012976|NCT00590577|541180776|FG003|Overall Study|Pregnancy|0|||
150012977|NCT00590577|541180773|FG000|Overall Study|Various reasons|1|||
150012978|NCT00590577|541180774|FG001|Overall Study|Various reasons|3|||
150012979|NCT00590577|541180775|FG002|Overall Study|Various reasons|1|||
150181136|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181137|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150012980|NCT00590577|541180776|FG003|Overall Study|Various reasons|2|||
150012981|NCT02690714|541180777|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
150012982|NCT02690714|541180777|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
150012983|NCT01300260|541180778|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
150012984|NCT01300260|541180779|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
150012985|NCT01300260|541180778|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
150012986|NCT01300260|541180779|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
150012987|NCT01300260|541180778|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
150012988|NCT01300260|541180779|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
150012989|NCT00293020|541180783|FG000|Overall Study|Withdrawal by Subject|34|||
150012990|NCT00293020|541180783|FG000|Overall Study|Adverse Event|30|||
150012991|NCT00293020|541180783|FG000|Overall Study|Death|32|||
150012992|NCT00293020|541180783|FG000|Overall Study|Lack of Efficacy|12|||
150012993|NCT00293020|541180783|FG000|Overall Study|Lost to Follow-up|4|||
150012994|NCT00293020|541180783|FG000|Overall Study|Protocol Violation|6|||
150012995|NCT00293020|541180783|FG000|Overall Study|Physician Decision|21|||
150012996|NCT00293020|541180783|FG000|Overall Study|Other Reason|22|||
150012997|NCT00293020|541180783|FG000|Overall Study|No dose taken|1|||
150012998|NCT01147848|541180784|FG000|Run-in Period|Screen Failure|623|||
150012999|NCT01147848|541180785|FG001|Run-in Period|Screen Failure|0|||
150013000|NCT01147848|541180786|FG002|Run-in Period|Screen Failure|0|||
150013001|NCT01147848|541180784|FG000|Run-in Period|Run-in Failure|135|||
150013002|NCT01147848|541180785|FG001|Run-in Period|Run-in Failure|0|||
150013003|NCT01147848|541180786|FG002|Run-in Period|Run-in Failure|0|||
150013004|NCT01147848|541180784|FG000|Randomized Phase|Adverse Event|0|||
150013005|NCT01147848|541180785|FG001|Randomized Phase|Adverse Event|6|||
150013006|NCT01147848|541180786|FG002|Randomized Phase|Adverse Event|8|||
150013007|NCT01147848|541180784|FG000|Randomized Phase|Lack of Efficacy|0|||
150013008|NCT01147848|541180785|FG001|Randomized Phase|Lack of Efficacy|20|||
150013009|NCT01147848|541180786|FG002|Randomized Phase|Lack of Efficacy|11|||
150013010|NCT01147848|541180784|FG000|Randomized Phase|Protocol Violation|0|||
150013011|NCT01147848|541180785|FG001|Randomized Phase|Protocol Violation|7|||
150013012|NCT01147848|541180786|FG002|Randomized Phase|Protocol Violation|10|||
150013013|NCT01147848|541180784|FG000|Randomized Phase|Lost to Follow-up|0|||
150013014|NCT01147848|541180785|FG001|Randomized Phase|Lost to Follow-up|5|||
150013015|NCT01147848|541180786|FG002|Randomized Phase|Lost to Follow-up|7|||
150013016|NCT01147848|541180784|FG000|Randomized Phase|Physician Decision|0|||
150013017|NCT01147848|541180785|FG001|Randomized Phase|Physician Decision|0|||
150013018|NCT01147848|541180786|FG002|Randomized Phase|Physician Decision|1|||
150013019|NCT01147848|541180784|FG000|Randomized Phase|Withdrawal by Subject|0|||
150013020|NCT01147848|541180785|FG001|Randomized Phase|Withdrawal by Subject|7|||
150013021|NCT01147848|541180786|FG002|Randomized Phase|Withdrawal by Subject|9|||
150013022|NCT01894022|541180794|FG000|Overall Study|Death|1|||
150013023|NCT01894022|541180795|FG001|Overall Study|Death|0|||
150013024|NCT01894022|541180794|FG000|Overall Study|Adverse Event, non-fatal|1|||
150013025|NCT01894022|541180795|FG001|Overall Study|Adverse Event, non-fatal|0|||
150013026|NCT01894022|541180794|FG000|Overall Study|Study Closed/terminated|7|||
150013027|NCT01894022|541180795|FG001|Overall Study|Study Closed/terminated|10|||
150013028|NCT04058886|541180802|FG000|Overall Study|Withdrawal by Subject|4|||
150013029|NCT04058886|541180802|FG000|Overall Study|Inadequate deafness interpreter service|1|||
150013030|NCT03624127|541180803|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
150013031|NCT03624127|541180804|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
150013032|NCT03624127|541180805|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
150013033|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
150013034|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
150013035|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
150013036|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Death|0|||
150013037|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Death|1|||
150013038|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Death|0|||
150013039|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
150013040|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
150013041|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
150013042|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
150013043|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
150013044|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
150013045|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
150013046|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
150013047|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
150013048|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
150013049|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
150013050|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
150058028|NCT00534313|541353600|FG000|Long-term Period|Withdrawal by Subject|2|||
150058029|NCT00534313|541353601|FG001|Long-term Period|Withdrawal by Subject|2|||
150013051|NCT03624127|541180803|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
150013052|NCT03624127|541180804|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
150013053|NCT03624127|541180805|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
150013054|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
150013055|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
150013056|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
150013057|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
150013058|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
150013059|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
150013060|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
150013061|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
150013062|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
150013063|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
150013064|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
150013065|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
150013066|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
150013067|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
150013068|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
150013069|NCT03624127|541180803|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
150013070|NCT03624127|541180804|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
150013071|NCT03624127|541180805|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
150013072|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
150013073|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
150013074|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
150013075|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
150013076|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
150013077|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
150013078|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
150013079|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
150013080|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
150013081|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
150013082|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
150013083|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
150013084|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
150013085|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
150013086|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
150013087|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
150013088|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
150013089|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
150013090|NCT03624127|541180803|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
150013091|NCT03624127|541180804|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
150013092|NCT03624127|541180805|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
150058030|NCT00534313|541353602|FG002|Long-term Period|Withdrawal by Subject|0|||
150058031|NCT00534313|541353603|FG003|Long-term Period|Withdrawal by Subject|0|||
150058032|NCT00534313|541353600|FG000|Long-term Period|No longer meets study criteria|0|||
150058033|NCT00534313|541353601|FG001|Long-term Period|No longer meets study criteria|1|||
150058034|NCT00534313|541353602|FG002|Long-term Period|No longer meets study criteria|0|||
150013093|NCT01545050|541180808|FG000|Overall Study|Lack of Efficacy|0|||
150058035|NCT00534313|541353603|FG003|Long-term Period|No longer meets study criteria|0|||
150013094|NCT01545050|541180809|FG001|Overall Study|Lack of Efficacy|0|||
150013095|NCT01545050|541180810|FG002|Overall Study|Lack of Efficacy|0|||
150013096|NCT01545050|541180811|FG003|Overall Study|Lack of Efficacy|3|||
150058036|NCT00534313|541353600|FG000|Long-term Period|Poor compliance/noncompliance|0|||
150058037|NCT00534313|541353601|FG001|Long-term Period|Poor compliance/noncompliance|1|||
150013097|NCT01545050|541180812|FG004|Overall Study|Lack of Efficacy|2|||
150013098|NCT01545050|541180808|FG000|Overall Study|Adverse Event|1|||
150013099|NCT01545050|541180809|FG001|Overall Study|Adverse Event|1|||
150013100|NCT01545050|541180810|FG002|Overall Study|Adverse Event|2|||
150013101|NCT01545050|541180811|FG003|Overall Study|Adverse Event|2|||
150013102|NCT01545050|541180812|FG004|Overall Study|Adverse Event|0|||
150013103|NCT01545050|541180808|FG000|Overall Study|Discontinued study treatment|1|||
150013104|NCT01545050|541180809|FG001|Overall Study|Discontinued study treatment|0|||
150013105|NCT01545050|541180810|FG002|Overall Study|Discontinued study treatment|0|||
150013106|NCT01545050|541180811|FG003|Overall Study|Discontinued study treatment|0|||
150013107|NCT01545050|541180812|FG004|Overall Study|Discontinued study treatment|0|||
150013108|NCT01545050|541180808|FG000|Overall Study|Withdrawal by Subject|1|||
150013109|NCT01545050|541180809|FG001|Overall Study|Withdrawal by Subject|0|||
150013110|NCT01545050|541180810|FG002|Overall Study|Withdrawal by Subject|0|||
150013111|NCT01545050|541180811|FG003|Overall Study|Withdrawal by Subject|2|||
150013112|NCT01545050|541180812|FG004|Overall Study|Withdrawal by Subject|1|||
150013113|NCT01545050|541180808|FG000|Overall Study|Participant no longer meets study criteria|0|||
150013114|NCT01545050|541180809|FG001|Overall Study|Participant no longer meets study criteria|2|||
150013115|NCT01545050|541180810|FG002|Overall Study|Participant no longer meets study criteria|0|||
150013116|NCT01545050|541180811|FG003|Overall Study|Participant no longer meets study criteria|0|||
150013117|NCT01545050|541180812|FG004|Overall Study|Participant no longer meets study criteria|1|||
150013118|NCT01545050|541180808|FG000|Overall Study|Administrative reason by sponsor|4|||
150013119|NCT01545050|541180809|FG001|Overall Study|Administrative reason by sponsor|2|||
150013120|NCT01545050|541180810|FG002|Overall Study|Administrative reason by sponsor|3|||
150013121|NCT01545050|541180811|FG003|Overall Study|Administrative reason by sponsor|5|||
150013122|NCT01545050|541180812|FG004|Overall Study|Administrative reason by sponsor|5|||
150013123|NCT03262441|541180813|FG000|Overall Study|Withdrawal by Subject|1|||
150013124|NCT03235089|541180814|FG000|Overall Study|Lost to Follow-up|1|||
150013125|NCT03235089|541180815|FG001|Overall Study|Lost to Follow-up|1|||
150013126|NCT03235089|541180814|FG000|Overall Study|Physician Decision|2|||
150013127|NCT03235089|541180815|FG001|Overall Study|Physician Decision|2|||
150013128|NCT03238924|541180822|FG000|Overall Study|Withdrawal by Subject|2|||
150013129|NCT03238924|541180823|FG001|Overall Study|Withdrawal by Subject|2|||
150013130|NCT00559988|541180824|FG000|Overall Study|Death|147|||
150013131|NCT00559988|541180825|FG001|Overall Study|Death|140|||
150013132|NCT00559988|541180824|FG000|Overall Study|Withdrawal by Subject|152|||
150013133|NCT00559988|541180825|FG001|Overall Study|Withdrawal by Subject|139|||
150013134|NCT00559988|541180824|FG000|Overall Study|Lost to Follow-up|42|||
150013135|NCT00559988|541180825|FG001|Overall Study|Lost to Follow-up|56|||
150013136|NCT00559988|541180824|FG000|Overall Study|ICD device explanted|10|||
150013137|NCT00559988|541180825|FG001|Overall Study|ICD device explanted|17|||
150013138|NCT02891382|541180826|FG000|Overall Study|Lost to Follow-up|3|||
150013139|NCT02891382|541180827|FG001|Overall Study|Lost to Follow-up|4|||
150013140|NCT02891382|541180828|FG002|Overall Study|Lost to Follow-up|5|||
150013141|NCT02891382|541180829|FG003|Overall Study|Lost to Follow-up|3|||
150058038|NCT00534313|541353602|FG002|Long-term Period|Poor compliance/noncompliance|1|||
150058039|NCT00534313|541353603|FG003|Long-term Period|Poor compliance/noncompliance|0|||
150058040|NCT00534313|541353600|FG000|Long-term Period|Administrative reason by sponsor|17|||
150058041|NCT00534313|541353601|FG001|Long-term Period|Administrative reason by sponsor|15|||
150058042|NCT00534313|541353602|FG002|Long-term Period|Administrative reason by sponsor|26|||
150058043|NCT00534313|541353603|FG003|Long-term Period|Administrative reason by sponsor|18|||
150058044|NCT00534313|541353600|FG000|Long-term Period|Other|1|||
150058045|NCT00534313|541353601|FG001|Long-term Period|Other|2|||
150058046|NCT00534313|541353602|FG002|Long-term Period|Other|2|||
150058047|NCT00534313|541353603|FG003|Long-term Period|Other|2|||
150013142|NCT02891382|541180830|FG004|Overall Study|Lost to Follow-up|4|||
150013143|NCT01455194|541180831|FG000|Overall Study|Screen Failure|20|||
150013144|NCT01455194|541180832|FG001|Overall Study|Screen Failure|0|||
150013145|NCT01455194|541180833|FG002|Overall Study|Screen Failure|0|||
150013146|NCT01455194|541180834|FG003|Overall Study|Screen Failure|0|||
150013147|NCT01455194|541180831|FG000|Overall Study|Randomisation Failure|90|||
150013148|NCT01455194|541180832|FG001|Overall Study|Randomisation Failure|0|||
150013149|NCT01455194|541180833|FG002|Overall Study|Randomisation Failure|0|||
150058048|NCT03044574|541353604|FG000|Overall Study|Lost to Follow-up|37|||
150013150|NCT01455194|541180834|FG003|Overall Study|Randomisation Failure|0|||
150013151|NCT01455194|541180831|FG000|Overall Study|Deterioration in asthma|12|||
150013152|NCT01455194|541180832|FG001|Overall Study|Deterioration in asthma|6|||
150013153|NCT01455194|541180833|FG002|Overall Study|Deterioration in asthma|14|||
150013154|NCT01455194|541180834|FG003|Overall Study|Deterioration in asthma|9|||
150013155|NCT01455194|541180831|FG000|Overall Study|Adverse Event|1|||
150013156|NCT01455194|541180832|FG001|Overall Study|Adverse Event|1|||
150013157|NCT01455194|541180833|FG002|Overall Study|Adverse Event|1|||
150013158|NCT01455194|541180834|FG003|Overall Study|Adverse Event|3|||
150013159|NCT01455194|541180831|FG000|Overall Study|Withdrawal by Subject|21|||
150013160|NCT01455194|541180832|FG001|Overall Study|Withdrawal by Subject|16|||
150013161|NCT01455194|541180833|FG002|Overall Study|Withdrawal by Subject|12|||
150013162|NCT01455194|541180834|FG003|Overall Study|Withdrawal by Subject|9|||
150013163|NCT01455194|541180831|FG000|Overall Study|Lost to Follow-up|2|||
150013164|NCT01455194|541180832|FG001|Overall Study|Lost to Follow-up|0|||
150013165|NCT01455194|541180833|FG002|Overall Study|Lost to Follow-up|1|||
150013166|NCT01455194|541180834|FG003|Overall Study|Lost to Follow-up|1|||
150013167|NCT01455194|541180831|FG000|Overall Study|Pregnancy|0|||
150013168|NCT01455194|541180832|FG001|Overall Study|Pregnancy|1|||
150013169|NCT01455194|541180833|FG002|Overall Study|Pregnancy|1|||
150013170|NCT01455194|541180834|FG003|Overall Study|Pregnancy|0|||
150013171|NCT01455194|541180831|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
150013172|NCT01455194|541180832|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
150013173|NCT01455194|541180833|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
150013174|NCT01455194|541180834|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
150013175|NCT01455194|541180831|FG000|Overall Study|Miscellaneous|4|||
150013176|NCT01455194|541180832|FG001|Overall Study|Miscellaneous|5|||
150013177|NCT01455194|541180833|FG002|Overall Study|Miscellaneous|1|||
150013178|NCT01455194|541180834|FG003|Overall Study|Miscellaneous|4|||
150013179|NCT02516228|541180835|FG000|Overall Study|Lost to Follow-up|1|||
150013180|NCT02516228|541180835|FG000|Overall Study|Withdrawal by Subject|1|||
150013181|NCT02516228|541180835|FG000|Overall Study|Physician Decision|1|||
150013182|NCT03916484|541180836|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
150013183|NCT03916484|541180837|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
150013184|NCT03916484|541180838|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
150013185|NCT03916484|541180839|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
150013186|NCT03916484|541180836|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
150013187|NCT03916484|541180837|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
150013188|NCT03916484|541180838|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
150013189|NCT03916484|541180839|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
150013190|NCT05090852|541180840|FG000|Overall Study|Physician Decision|5|||
150013191|NCT00504894|541180841|FG000|Overall Study|fMRI technical problems|1|||
150013192|NCT00504894|541180842|FG001|Overall Study|fMRI technical problems|1|||
150013193|NCT00504894|541180843|FG002|Overall Study|fMRI technical problems|0|||
150013194|NCT00504894|541180841|FG000|Overall Study|Withdrawal by Subject|0|||
150013195|NCT00504894|541180842|FG001|Overall Study|Withdrawal by Subject|1|||
150013196|NCT00504894|541180843|FG002|Overall Study|Withdrawal by Subject|0|||
150013197|NCT00504894|541180841|FG000|Overall Study|Infusion technical problems|0|||
150013198|NCT00504894|541180842|FG001|Overall Study|Infusion technical problems|1|||
150013199|NCT00504894|541180843|FG002|Overall Study|Infusion technical problems|0|||
150013200|NCT00504894|541180841|FG000|Overall Study|poor subject data|2|||
150013201|NCT00504894|541180842|FG001|Overall Study|poor subject data|0|||
150013202|NCT00504894|541180843|FG002|Overall Study|poor subject data|0|||
150013203|NCT04356040|541180846|FG000|Overall Study|Death|2|||
150013204|NCT04356040|541180847|FG001|Overall Study|Death|0|||
150013205|NCT04356040|541180846|FG000|Overall Study|Lost to Follow-up|1|||
150013206|NCT04356040|541180847|FG001|Overall Study|Lost to Follow-up|0|||
150013207|NCT04356040|541180846|FG000|Overall Study|Physician Decision|0|||
150013208|NCT04356040|541180847|FG001|Overall Study|Physician Decision|1|||
150013209|NCT04356040|541180846|FG000|Overall Study|Withdrawal by Subject|13|||
150013210|NCT04356040|541180847|FG001|Overall Study|Withdrawal by Subject|1|||
150013211|NCT04356040|541180846|FG000|Overall Study|Enrollment Pause|10|||
150013212|NCT04356040|541180847|FG001|Overall Study|Enrollment Pause|0|||
150013213|NCT04356040|541180846|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
150013214|NCT04356040|541180847|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
150013215|NCT04356040|541180846|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
150013216|NCT04356040|541180847|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
150013217|NCT04356040|541180846|FG000|Overall Study|PI left institution|3|||
150013218|NCT04356040|541180847|FG001|Overall Study|PI left institution|0|||
150181138|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181139|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181140|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181141|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181142|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
150181143|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
150181144|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181145|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181146|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181147|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181148|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181149|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181150|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
150181151|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
150181152|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
150181153|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181154|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150013219|NCT00788710|541180848|FG000|Overall Study|Adverse Event|1|||
150013220|NCT00788710|541180849|FG001|Overall Study|Adverse Event|3|||
150013221|NCT00788710|541180850|FG002|Overall Study|Adverse Event|4|||
150013222|NCT00788710|541180848|FG000|Overall Study|Lack of Efficacy|0|||
150013223|NCT00788710|541180849|FG001|Overall Study|Lack of Efficacy|0|||
150013224|NCT00788710|541180850|FG002|Overall Study|Lack of Efficacy|1|||
150013225|NCT00788710|541180848|FG000|Overall Study|Lost to Follow-up|0|||
150013226|NCT00788710|541180849|FG001|Overall Study|Lost to Follow-up|1|||
150013227|NCT00788710|541180850|FG002|Overall Study|Lost to Follow-up|0|||
150013228|NCT00788710|541180848|FG000|Overall Study|Physician Decision|2|||
150013229|NCT00788710|541180849|FG001|Overall Study|Physician Decision|1|||
150013230|NCT00788710|541180850|FG002|Overall Study|Physician Decision|0|||
150013231|NCT00788710|541180848|FG000|Overall Study|Protocol Violation|0|||
150013232|NCT00788710|541180849|FG001|Overall Study|Protocol Violation|1|||
150013233|NCT00788710|541180850|FG002|Overall Study|Protocol Violation|1|||
150013234|NCT00788710|541180848|FG000|Overall Study|Withdrawal by Subject|2|||
150013235|NCT00788710|541180849|FG001|Overall Study|Withdrawal by Subject|2|||
150013236|NCT00788710|541180850|FG002|Overall Study|Withdrawal by Subject|0|||
150013237|NCT01008904|541180851|FG000|Overall Study|Lost to Follow-up|1|||
150013238|NCT01008904|541180851|FG000|Overall Study|Adverse Event|2|||
150013239|NCT01008904|541180851|FG000|Overall Study|unexpected unrelated surgery|1|||
150013240|NCT01008449|541180854|FG000|Overall Study|Lost to Follow-up|29|||
150013241|NCT01008449|541180855|FG001|Overall Study|Lost to Follow-up|19|||
150013242|NCT01220180|541180856|FG000|Overall Study|Lost to Follow-up|76|||
150013243|NCT01220180|541180856|FG000|Overall Study|Other|72|||
150013244|NCT01220180|541180856|FG000|Overall Study|Adverse Event|35|||
150013245|NCT01220180|541180856|FG000|Overall Study|Lack of Efficacy|22|||
150013246|NCT01220180|541180856|FG000|Overall Study|Death|1|||
150013247|NCT01220180|541180856|FG000|Overall Study|Randomized but not treated|1|||
150013248|NCT01990859|541180857|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
150013249|NCT01990859|541180857|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
150013250|NCT02262754|541180858|FG000|Overall Study|Adverse Event|3|||
150013251|NCT02262754|541180859|FG001|Overall Study|Adverse Event|4|||
150013252|NCT02262754|541180860|FG002|Overall Study|Adverse Event|0|||
150013253|NCT02262754|541180858|FG000|Overall Study|Lack of Efficacy|2|||
150013254|NCT02262754|541180859|FG001|Overall Study|Lack of Efficacy|0|||
150013255|NCT02262754|541180860|FG002|Overall Study|Lack of Efficacy|1|||
150013256|NCT02262754|541180858|FG000|Overall Study|Lost to Follow-up|0|||
150013257|NCT02262754|541180859|FG001|Overall Study|Lost to Follow-up|0|||
150013258|NCT02262754|541180860|FG002|Overall Study|Lost to Follow-up|1|||
150013259|NCT02262754|541180858|FG000|Overall Study|No longer meets eligibility criteria|0|||
150181155|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181156|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181157|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181158|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150013260|NCT02262754|541180859|FG001|Overall Study|No longer meets eligibility criteria|1|||
150013261|NCT02262754|541180860|FG002|Overall Study|No longer meets eligibility criteria|0|||
150013262|NCT02262754|541180858|FG000|Overall Study|Study terminated by sponsor|5|||
150013263|NCT02262754|541180859|FG001|Overall Study|Study terminated by sponsor|4|||
150013264|NCT02262754|541180860|FG002|Overall Study|Study terminated by sponsor|4|||
150013265|NCT02262754|541180858|FG000|Overall Study|Protocol Violation|1|||
150013266|NCT02262754|541180859|FG001|Overall Study|Protocol Violation|0|||
150013267|NCT02262754|541180860|FG002|Overall Study|Protocol Violation|0|||
150013268|NCT02262754|541180858|FG000|Overall Study|Withdrawal by Subject|1|||
150013269|NCT02262754|541180859|FG001|Overall Study|Withdrawal by Subject|0|||
150013270|NCT02262754|541180860|FG002|Overall Study|Withdrawal by Subject|1|||
150013271|NCT02262754|541180858|FG000|Overall Study|Other|4|||
150013272|NCT02262754|541180859|FG001|Overall Study|Other|0|||
150013273|NCT02262754|541180860|FG002|Overall Study|Other|2|||
150013274|NCT01067469|541180861|FG000|Overall Study|Withdrawal by Subject|0|||
150013275|NCT01067469|541180862|FG001|Overall Study|Withdrawal by Subject|1|||
150013276|NCT01067469|541180861|FG000|Overall Study|Disease Progression|0|||
150013277|NCT01067469|541180862|FG001|Overall Study|Disease Progression|1|||
150013278|NCT04079114|541180866|FG000|Overall Study|Study prematuely terminated.|166|||
150013279|NCT01364389|541180868|FG000|Overall Study|Withdrawal by Subject|0|||
150013280|NCT01364389|541180869|FG001|Overall Study|Withdrawal by Subject|1|||
150013281|NCT01364389|541180870|FG002|Overall Study|Withdrawal by Subject|0|||
150013282|NCT01364389|541180868|FG000|Overall Study|Protocol deviation|0|||
150013283|NCT01364389|541180869|FG001|Overall Study|Protocol deviation|0|||
150013284|NCT01364389|541180870|FG002|Overall Study|Protocol deviation|1|||
150013285|NCT01364389|541180868|FG000|Overall Study|Administrative problems|1|||
150013286|NCT01364389|541180869|FG001|Overall Study|Administrative problems|0|||
150013287|NCT01364389|541180870|FG002|Overall Study|Administrative problems|0|||
150013288|NCT01364389|541180868|FG000|Overall Study|Adverse Event|1|||
150013289|NCT01364389|541180869|FG001|Overall Study|Adverse Event|0|||
150013290|NCT01364389|541180870|FG002|Overall Study|Adverse Event|0|||
150013291|NCT00629798|541180873|FG000|Overall Study|Not Treated|4|||
150013292|NCT02554981|541180874|FG000|Overall Study|Adverse Event|1|||
150013293|NCT02554981|541180874|FG000|Overall Study|Administrative Reasons|1|||
150013294|NCT02554981|541180874|FG000|Overall Study|Other Miscellaneous Reasons|3|||
150013295|NCT01959243|541180879|FG000|Overall Study|Investigator Decision|3|||
150013296|NCT01959243|541180880|FG001|Overall Study|Investigator Decision|0|||
150013297|NCT01959243|541180879|FG000|Overall Study|Adverse Event|5|||
150013298|NCT01959243|541180880|FG001|Overall Study|Adverse Event|2|||
150013299|NCT01959243|541180879|FG000|Overall Study|Administrative reasons|2|||
150013300|NCT01959243|541180880|FG001|Overall Study|Administrative reasons|1|||
150013301|NCT01959243|541180879|FG000|Overall Study|Lost to Follow-up|3|||
150013302|NCT01959243|541180880|FG001|Overall Study|Lost to Follow-up|1|||
150013303|NCT01345669|541180881|FG000|Overall Study|Primary tumour recurrence|53|||
150013304|NCT01345669|541180882|FG001|Overall Study|Primary tumour recurrence|32|||
150013305|NCT01345669|541180881|FG000|Overall Study|Second primary tumour|4|||
150013306|NCT01345669|541180882|FG001|Overall Study|Second primary tumour|3|||
150013307|NCT01345669|541180881|FG000|Overall Study|Adverse Event|63|||
150013308|NCT01345669|541180882|FG001|Overall Study|Adverse Event|9|||
150013309|NCT01345669|541180881|FG000|Overall Study|Protocol Violation|3|||
150013310|NCT01345669|541180882|FG001|Overall Study|Protocol Violation|1|||
150013311|NCT01345669|541180881|FG000|Overall Study|Lost to Follow-up|1|||
150013312|NCT01345669|541180882|FG001|Overall Study|Lost to Follow-up|1|||
150013313|NCT01345669|541180881|FG000|Overall Study|Withdrawal by Subject|52|||
150013314|NCT01345669|541180882|FG001|Overall Study|Withdrawal by Subject|13|||
150013315|NCT01345669|541180881|FG000|Overall Study|Other Reasons|111|||
150013316|NCT01345669|541180882|FG001|Overall Study|Other Reasons|60|||
150013317|NCT00547521|541180888|FG000|Short Term Study (4 Months)|Adverse Event|1|||
150013318|NCT00547521|541180889|FG001|Short Term Study (4 Months)|Adverse Event|0|||
150013319|NCT00547521|541180888|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
150013320|NCT00547521|541180889|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
150013321|NCT00547521|541180888|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
150013322|NCT00547521|541180889|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
150013323|NCT00547521|541180888|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
150013324|NCT00547521|541180889|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
150013325|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
150013326|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
150013327|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
150013328|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
150058049|NCT03044574|541353605|FG001|Overall Study|Lost to Follow-up|45|||
150058050|NCT00592774|541353609|FG000|Overall Study|Adverse Event|5|||
150013329|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
150058051|NCT00592774|541353610|FG001|Overall Study|Adverse Event|19|||
150013330|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
150013331|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
150181159|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181160|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
150181161|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
150181162|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181163|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181164|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181165|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181166|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181167|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181168|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181169|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
150181170|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
150181171|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181172|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181173|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181174|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181175|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181176|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181177|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150181178|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
150181179|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
150013332|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
150181180|NCT02590432|541801006|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181181|NCT02590432|541801007|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181182|NCT02590432|541801008|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181183|NCT02590432|541801009|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181184|NCT02590432|541801010|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181185|NCT02590432|541801011|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181186|NCT02590432|541801012|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181187|NCT02590432|541801013|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
150181188|NCT02590432|541801014|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
150181189|NCT02006758|541801015|FG000|Overall Study|Protocol Violation|1|||
150181190|NCT02006758|541801015|FG000|Overall Study|Death|1|||
150013333|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Other|0|||
150013334|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Other|2|||
150013335|NCT00547521|541180888|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
150013336|NCT00547521|541180889|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
150013337|NCT01487265|541182692|FG000|Overall Study|Adverse Event|8|||
150013338|NCT01487265|541182692|FG000|Overall Study|Withdrawal by Subject|5|||
150013339|NCT01487265|541182692|FG000|Overall Study|Disease Progression|21|||
150013340|NCT01487265|541182692|FG000|Overall Study|Death|2|||
150013341|NCT01487265|541182692|FG000|Overall Study|Still on Treatment|1|||
150013342|NCT02291419|541182693|FG000|Overall Study|Early study termination|1|||
150013343|NCT02291419|541182694|FG001|Overall Study|Early study termination|5|||
150013344|NCT01271725|541182702|FG000|Part A|Progressive disease according to RECIST|8|||
150013345|NCT01271725|541182703|FG001|Part A|Progressive disease according to RECIST|0|||
150013346|NCT01271725|541182702|FG000|Part A|Clinical signs/symptoms of progression|2|||
150013347|NCT01271725|541182703|FG001|Part A|Clinical signs/symptoms of progression|0|||
150013348|NCT01271725|541182702|FG000|Part A|Other Adverse Event|8|||
150013349|NCT01271725|541182703|FG001|Part A|Other Adverse Event|0|||
150013350|NCT01271725|541182702|FG000|Part A|Lost to Follow-up|1|||
150013351|NCT01271725|541182703|FG001|Part A|Lost to Follow-up|0|||
150013352|NCT01271725|541182702|FG000|Part A|Withdrawal by Subject|12|||
150013353|NCT01271725|541182703|FG001|Part A|Withdrawal by Subject|0|||
150013354|NCT01271725|541182702|FG000|Part A|Other than specified|3|||
150013355|NCT01271725|541182703|FG001|Part A|Other than specified|0|||
150013356|NCT01271725|541182702|FG000|Part A|Protocol Violation|1|||
150013357|NCT01271725|541182703|FG001|Part A|Protocol Violation|0|||
150013358|NCT01271725|541182702|FG000|Part B|Other than specified|0|||
150013359|NCT01271725|541182703|FG001|Part B|Other than specified|2|||
150013360|NCT01271725|541182702|FG000|Part B|Clinical signs/symptoms of progression|0|||
150013361|NCT01271725|541182703|FG001|Part B|Clinical signs/symptoms of progression|2|||
150181191|NCT02006758|541801015|FG000|Overall Study|Lost to Follow-up|4|||
150181192|NCT02006758|541801015|FG000|Overall Study|Withdrawal by Subject|4|||
150181193|NCT02006758|541801015|FG000|Overall Study|Procedurally excluded|1|||
150181194|NCT02006758|541801015|FG000|Overall Study|Other|2|||
150181195|NCT02740231|541801016|FG000|Overall Study|Withdrawal by Subject|1|||
150013362|NCT01271725|541182702|FG000|Part B|Other Adverse Event|0|||
150013363|NCT01271725|541182703|FG001|Part B|Other Adverse Event|1|||
150013364|NCT01271725|541182702|FG000|Part B|Protocol Violation|0|||
150013365|NCT01271725|541182703|FG001|Part B|Protocol Violation|1|||
150013366|NCT01271725|541182702|FG000|Part B|Withdrawal by Subject|0|||
150013367|NCT01271725|541182703|FG001|Part B|Withdrawal by Subject|6|||
150013368|NCT00303485|541182707|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
150013369|NCT00303485|541182708|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
150013370|NCT00303485|541182707|FG000|Overall Study|Failure to return|0|||
150013371|NCT00303485|541182708|FG001|Overall Study|Failure to return|1|||
150013372|NCT00303485|541182707|FG000|Overall Study|Withdrawal by Subject|1|||
150013373|NCT00303485|541182708|FG001|Overall Study|Withdrawal by Subject|0|||
150013374|NCT01378325|541182712|FG000|Overall Study|Protocol Violation|0|||
150013375|NCT01378325|541182713|FG001|Overall Study|Protocol Violation|1|||
150013376|NCT00193180|541182717|FG000|Overall Study|Lack of Efficacy|1|||
150013377|NCT00193180|541182717|FG000|Overall Study|Adverse Event|8|||
150013378|NCT00193180|541182717|FG000|Overall Study|Protocol Violation|1|||
150013379|NCT00891228|541182719|FG000|Overall Study|Adverse Event|0|||
150013380|NCT00891228|541182720|FG001|Overall Study|Adverse Event|2|||
150013381|NCT00891228|541182721|FG002|Overall Study|Adverse Event|3|||
150181196|NCT02740231|541801017|FG001|Overall Study|Withdrawal by Subject|1|||
150181197|NCT02740231|541801018|FG002|Overall Study|Withdrawal by Subject|1|||
150013382|NCT00891228|541182719|FG000|Overall Study|Withdrawal by Subject|2|||
150013383|NCT00891228|541182720|FG001|Overall Study|Withdrawal by Subject|4|||
150013384|NCT00891228|541182721|FG002|Overall Study|Withdrawal by Subject|5|||
150013385|NCT00891228|541182719|FG000|Overall Study|Protocol Violation|3|||
150013386|NCT00891228|541182720|FG001|Overall Study|Protocol Violation|1|||
150013387|NCT00891228|541182721|FG002|Overall Study|Protocol Violation|2|||
150181198|NCT02740231|541801019|FG003|Overall Study|Withdrawal by Subject|0|||
150013388|NCT00891228|541182719|FG000|Overall Study|Physician Decision|2|||
150013389|NCT00891228|541182720|FG001|Overall Study|Physician Decision|1|||
150181199|NCT02740231|541801016|FG000|Overall Study|Lack of Efficacy|0|||
150181200|NCT02740231|541801017|FG001|Overall Study|Lack of Efficacy|1|||
150181201|NCT02740231|541801018|FG002|Overall Study|Lack of Efficacy|0|||
150013390|NCT00891228|541182721|FG002|Overall Study|Physician Decision|0|||
150013391|NCT00891228|541182719|FG000|Overall Study|Lost to Follow-up|4|||
150013392|NCT00891228|541182720|FG001|Overall Study|Lost to Follow-up|4|||
150013393|NCT00891228|541182721|FG002|Overall Study|Lost to Follow-up|5|||
150013394|NCT00891228|541182719|FG000|Overall Study|Pregnancy|0|||
150013395|NCT00891228|541182720|FG001|Overall Study|Pregnancy|1|||
150013396|NCT00891228|541182721|FG002|Overall Study|Pregnancy|0|||
150013397|NCT02688985|541182730|FG000|Overall Study|Adverse Event|1|||
150013398|NCT02688985|541182731|FG001|Overall Study|Adverse Event|2|||
150013399|NCT02688985|541182732|FG002|Overall Study|Adverse Event|2|||
150013400|NCT02688985|541182733|FG003|Overall Study|Adverse Event|0|||
150013401|NCT02688985|541182734|FG004|Overall Study|Adverse Event|0|||
150013402|NCT02688985|541182730|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
150013403|NCT02688985|541182731|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
150013404|NCT02688985|541182732|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
150013405|NCT02688985|541182733|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
150013406|NCT02688985|541182734|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
150013407|NCT02688985|541182730|FG000|Overall Study|Death|0|||
150013408|NCT02688985|541182731|FG001|Overall Study|Death|0|||
150013409|NCT02688985|541182732|FG002|Overall Study|Death|0|||
150013410|NCT02688985|541182733|FG003|Overall Study|Death|0|||
150013411|NCT02688985|541182734|FG004|Overall Study|Death|1|||
150013412|NCT02688985|541182730|FG000|Overall Study|Lack of Efficacy|0|||
150013413|NCT02688985|541182731|FG001|Overall Study|Lack of Efficacy|0|||
150013414|NCT02688985|541182732|FG002|Overall Study|Lack of Efficacy|0|||
150013415|NCT02688985|541182733|FG003|Overall Study|Lack of Efficacy|0|||
150013416|NCT02688985|541182734|FG004|Overall Study|Lack of Efficacy|1|||
150013417|NCT02688985|541182730|FG000|Overall Study|Lost to Follow-up|2|||
150013418|NCT02688985|541182731|FG001|Overall Study|Lost to Follow-up|0|||
150013419|NCT02688985|541182732|FG002|Overall Study|Lost to Follow-up|1|||
150058052|NCT00592774|541353611|FG002|Overall Study|Adverse Event|2|||
150058053|NCT00592774|541353612|FG003|Overall Study|Adverse Event|14|||
150058054|NCT00592774|541353613|FG004|Overall Study|Adverse Event|8|||
150058055|NCT00592774|541353609|FG000|Overall Study|Protocol Violation|0|||
150058056|NCT00592774|541353610|FG001|Overall Study|Protocol Violation|1|||
150058057|NCT00592774|541353611|FG002|Overall Study|Protocol Violation|0|||
150058058|NCT00592774|541353612|FG003|Overall Study|Protocol Violation|0|||
150058059|NCT00592774|541353613|FG004|Overall Study|Protocol Violation|1|||
150058060|NCT00592774|541353609|FG000|Overall Study|Withdrawal by Subject|3|||
150058061|NCT00592774|541353610|FG001|Overall Study|Withdrawal by Subject|7|||
150058062|NCT00592774|541353611|FG002|Overall Study|Withdrawal by Subject|0|||
150058063|NCT00592774|541353612|FG003|Overall Study|Withdrawal by Subject|0|||
150058064|NCT00592774|541353613|FG004|Overall Study|Withdrawal by Subject|0|||
150058065|NCT00592774|541353609|FG000|Overall Study|Lack of Efficacy|3|||
150058066|NCT00592774|541353610|FG001|Overall Study|Lack of Efficacy|3|||
150058067|NCT00592774|541353611|FG002|Overall Study|Lack of Efficacy|0|||
150058068|NCT00592774|541353612|FG003|Overall Study|Lack of Efficacy|0|||
150058069|NCT00592774|541353613|FG004|Overall Study|Lack of Efficacy|2|||
150058070|NCT00592774|541353609|FG000|Overall Study|Physician Decision|0|||
150058071|NCT00592774|541353610|FG001|Overall Study|Physician Decision|1|||
150058072|NCT00592774|541353611|FG002|Overall Study|Physician Decision|1|||
150058073|NCT00592774|541353612|FG003|Overall Study|Physician Decision|0|||
150058074|NCT00592774|541353613|FG004|Overall Study|Physician Decision|1|||
150058075|NCT00592774|541353609|FG000|Overall Study|Other|0|||
150058076|NCT00592774|541353610|FG001|Overall Study|Other|1|||
150058077|NCT00592774|541353611|FG002|Overall Study|Other|1|||
150058078|NCT00592774|541353612|FG003|Overall Study|Other|0|||
150058079|NCT00592774|541353613|FG004|Overall Study|Other|2|||
150058080|NCT01892384|541353614|FG000|Overall Study|Withdrawal by Subject|1|||
150058081|NCT01892384|541353615|FG001|Overall Study|Withdrawal by Subject|1|||
150013420|NCT02688985|541182733|FG003|Overall Study|Lost to Follow-up|1|||
150013421|NCT02688985|541182734|FG004|Overall Study|Lost to Follow-up|1|||
150058082|NCT01892384|541353616|FG002|Overall Study|Withdrawal by Subject|0|||
150058083|NCT01892384|541353617|FG003|Overall Study|Withdrawal by Subject|0|||
150181202|NCT02740231|541801019|FG003|Overall Study|Lack of Efficacy|4|||
150013422|NCT02688985|541182730|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150013423|NCT02688985|541182731|FG001|Overall Study|Non-Compliance With Study Drug|3|||
150013424|NCT02688985|541182732|FG002|Overall Study|Non-Compliance With Study Drug|1|||
150013425|NCT02688985|541182733|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150013426|NCT02688985|541182734|FG004|Overall Study|Non-Compliance With Study Drug|1|||
150013427|NCT02688985|541182730|FG000|Overall Study|Other|3|||
150058084|NCT01700439|541353618|FG000|Overall Study|Lost to Follow-up|47|||
150058085|NCT01700439|541353618|FG000|Overall Study|Withdrawal by Subject|183|||
150058086|NCT01700439|541353618|FG000|Overall Study|Death|186|||
150058087|NCT01829243|541353625|FG000|First Intervention|Screen Failure|4|||
150058088|NCT01829243|541353626|FG001|First Intervention|Screen Failure|2|||
150058089|NCT00266877|541353632|FG000|Overall Study|Death|1|||
150013428|NCT02688985|541182731|FG001|Overall Study|Other|4|||
150013429|NCT02688985|541182732|FG002|Overall Study|Other|1|||
150013430|NCT02688985|541182733|FG003|Overall Study|Other|0|||
150013431|NCT02688985|541182734|FG004|Overall Study|Other|0|||
150013432|NCT02688985|541182730|FG000|Overall Study|Physician Decision|2|||
150013433|NCT02688985|541182731|FG001|Overall Study|Physician Decision|2|||
150013434|NCT02688985|541182732|FG002|Overall Study|Physician Decision|0|||
150013435|NCT02688985|541182733|FG003|Overall Study|Physician Decision|0|||
150013436|NCT02688985|541182734|FG004|Overall Study|Physician Decision|1|||
150013437|NCT02688985|541182730|FG000|Overall Study|Pregnancy|0|||
150013438|NCT02688985|541182731|FG001|Overall Study|Pregnancy|0|||
150013439|NCT02688985|541182732|FG002|Overall Study|Pregnancy|2|||
150013440|NCT02688985|541182733|FG003|Overall Study|Pregnancy|1|||
150013441|NCT02688985|541182734|FG004|Overall Study|Pregnancy|0|||
150013442|NCT02688985|541182730|FG000|Overall Study|Study Terminated By Sponsor|0|||
150013443|NCT02688985|541182731|FG001|Overall Study|Study Terminated By Sponsor|0|||
150013444|NCT02688985|541182732|FG002|Overall Study|Study Terminated By Sponsor|0|||
150013445|NCT02688985|541182733|FG003|Overall Study|Study Terminated By Sponsor|1|||
150013446|NCT02688985|541182734|FG004|Overall Study|Study Terminated By Sponsor|0|||
150013447|NCT02688985|541182730|FG000|Overall Study|Withdrawal by Subject|2|||
150013448|NCT02688985|541182731|FG001|Overall Study|Withdrawal by Subject|8|||
150013449|NCT02688985|541182732|FG002|Overall Study|Withdrawal by Subject|7|||
150013450|NCT02688985|541182733|FG003|Overall Study|Withdrawal by Subject|1|||
150013451|NCT02688985|541182734|FG004|Overall Study|Withdrawal by Subject|4|||
150013452|NCT00930553|541182737|FG000|Overall Study|Adverse Event|1|||
150013453|NCT00930553|541182737|FG000|Overall Study|Lack of Efficacy|7|||
150013454|NCT00930553|541182737|FG000|Overall Study|Physician Decision|39|||
150013455|NCT00930553|541182737|FG000|Overall Study|Protocol Violation|1|||
150013456|NCT00930553|541182737|FG000|Overall Study|Pregnancy|1|||
150013457|NCT00930553|541182737|FG000|Overall Study|Withdrawal by Subject|88|||
150013458|NCT00930553|541182737|FG000|Overall Study|Lost to Follow-up|25|||
150013459|NCT00930553|541182737|FG000|Overall Study|Death|9|||
150013460|NCT00930553|541182737|FG000|Overall Study|Study terminated by sponsor|24|||
150013461|NCT00930553|541182737|FG000|Overall Study|Other than specified above|28|||
150013462|NCT01964963|541182738|FG000|Overall Study|Case Report Forms Uncollected|888|||
150013463|NCT01964963|541182738|FG000|Overall Study|Protocol Deviation|50|||
150013464|NCT01964963|541182738|FG000|Overall Study|Data Reliability was not Assured|5|||
150013465|NCT01726582|541182739|FG000|Overall Study|Physician Decision|99|||
150013466|NCT01726582|541182739|FG000|Overall Study|Death|85|||
150013467|NCT01235234|541182740|FG000|Overall Study|Adverse Event|2|||
150013468|NCT01235234|541182741|FG001|Overall Study|Adverse Event|2|||
150013469|NCT01235234|541182742|FG002|Overall Study|Adverse Event|1|||
150013470|NCT02630472|541182743|FG000|Overall Study|Physician Decision|10|||
150013471|NCT02630472|541182744|FG001|Overall Study|Physician Decision|0|||
150013472|NCT01393639|541182749|FG000|Overall Study|Protocol Violation|0|||
150013473|NCT01393639|541182750|FG001|Overall Study|Protocol Violation|0|||
150013474|NCT01393639|541182751|FG002|Overall Study|Protocol Violation|0|||
150013475|NCT01393639|541182752|FG003|Overall Study|Protocol Violation|1|||
150013476|NCT01393639|541182753|FG004|Overall Study|Protocol Violation|0|||
150013477|NCT01393639|541182754|FG005|Overall Study|Protocol Violation|0|||
150013478|NCT01393639|541182755|FG006|Overall Study|Protocol Violation|0|||
150013479|NCT01393639|541182749|FG000|Overall Study|Other|0|||
150013480|NCT01393639|541182750|FG001|Overall Study|Other|2|||
150013481|NCT01393639|541182751|FG002|Overall Study|Other|0|||
150013482|NCT01393639|541182752|FG003|Overall Study|Other|2|||
150013483|NCT01393639|541182753|FG004|Overall Study|Other|1|||
150013484|NCT01393639|541182754|FG005|Overall Study|Other|0|||
150013485|NCT01393639|541182755|FG006|Overall Study|Other|1|||
150013486|NCT01393639|541182749|FG000|Overall Study|Withdrawal by Subject|1|||
150013487|NCT01393639|541182750|FG001|Overall Study|Withdrawal by Subject|1|||
150013488|NCT01393639|541182751|FG002|Overall Study|Withdrawal by Subject|0|||
150013489|NCT01393639|541182752|FG003|Overall Study|Withdrawal by Subject|0|||
150013490|NCT01393639|541182753|FG004|Overall Study|Withdrawal by Subject|0|||
150013491|NCT01393639|541182754|FG005|Overall Study|Withdrawal by Subject|0|||
150013492|NCT01393639|541182755|FG006|Overall Study|Withdrawal by Subject|1|||
150013493|NCT01393639|541182749|FG000|Overall Study|Medication error without associated AE|0|||
150181203|NCT02740231|541801016|FG000|Overall Study|Lost to Follow-up|1|||
150181204|NCT02740231|541801017|FG001|Overall Study|Lost to Follow-up|3|||
150181205|NCT02740231|541801018|FG002|Overall Study|Lost to Follow-up|0|||
150181206|NCT02740231|541801019|FG003|Overall Study|Lost to Follow-up|3|||
150181207|NCT02740231|541801016|FG000|Overall Study|Adverse Event|0|||
150013494|NCT01393639|541182750|FG001|Overall Study|Medication error without associated AE|0|||
150013495|NCT01393639|541182751|FG002|Overall Study|Medication error without associated AE|0|||
150013496|NCT01393639|541182752|FG003|Overall Study|Medication error without associated AE|0|||
150013497|NCT01393639|541182753|FG004|Overall Study|Medication error without associated AE|0|||
150013498|NCT01393639|541182754|FG005|Overall Study|Medication error without associated AE|0|||
150013499|NCT01393639|541182755|FG006|Overall Study|Medication error without associated AE|1|||
150013500|NCT01393639|541182749|FG000|Overall Study|Lost to Follow-up|0|||
150013501|NCT01393639|541182750|FG001|Overall Study|Lost to Follow-up|1|||
150181208|NCT02740231|541801017|FG001|Overall Study|Adverse Event|1|||
150181209|NCT02740231|541801018|FG002|Overall Study|Adverse Event|0|||
150181210|NCT02740231|541801019|FG003|Overall Study|Adverse Event|1|||
150181211|NCT05052996|541801022|FG000|Overall Study|Still on study|0|||
150181212|NCT05052996|541801023|FG001|Overall Study|Still on study|0|||
150181213|NCT05052996|541801024|FG002|Overall Study|Still on study|47|||
150013502|NCT01393639|541182751|FG002|Overall Study|Lost to Follow-up|0|||
150013503|NCT01393639|541182752|FG003|Overall Study|Lost to Follow-up|0|||
150013504|NCT01393639|541182753|FG004|Overall Study|Lost to Follow-up|0|||
150013505|NCT01393639|541182754|FG005|Overall Study|Lost to Follow-up|0|||
150013506|NCT01393639|541182755|FG006|Overall Study|Lost to Follow-up|1|||
150013507|NCT01393639|541182749|FG000|Overall Study|Lack of Efficacy|0|||
150013508|NCT01393639|541182750|FG001|Overall Study|Lack of Efficacy|0|||
150013509|NCT01393639|541182751|FG002|Overall Study|Lack of Efficacy|0|||
150013510|NCT01393639|541182752|FG003|Overall Study|Lack of Efficacy|0|||
150013511|NCT01393639|541182753|FG004|Overall Study|Lack of Efficacy|0|||
150013512|NCT01393639|541182754|FG005|Overall Study|Lack of Efficacy|0|||
150013513|NCT01393639|541182755|FG006|Overall Study|Lack of Efficacy|1|||
150013514|NCT01393639|541182749|FG000|Overall Study|Adverse Event|2|||
150013515|NCT01393639|541182750|FG001|Overall Study|Adverse Event|3|||
150013516|NCT01393639|541182751|FG002|Overall Study|Adverse Event|1|||
150013517|NCT01393639|541182752|FG003|Overall Study|Adverse Event|2|||
150013518|NCT01393639|541182753|FG004|Overall Study|Adverse Event|0|||
150013519|NCT01393639|541182754|FG005|Overall Study|Adverse Event|2|||
150013520|NCT01393639|541182755|FG006|Overall Study|Adverse Event|3|||
150013521|NCT01832155|541182756|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
150013522|NCT01832155|541182757|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
150013523|NCT01832155|541182756|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
150013524|NCT01832155|541182757|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
150013525|NCT01279616|541182758|FG000|Overall Study|donor could not be located|5|||
150013526|NCT01279616|541182758|FG000|Overall Study|no signs of sickle cell disease|2|||
150013527|NCT00183625|541182761|FG000|Overall Study|Withdrawal by Subject|18|||
150013528|NCT00183625|541182762|FG001|Overall Study|Withdrawal by Subject|18|||
150013529|NCT00183625|541182763|FG002|Overall Study|Withdrawal by Subject|19|||
150013530|NCT00183625|541182764|FG003|Overall Study|Withdrawal by Subject|14|||
150013531|NCT01369641|541182767|FG000|Overall Study|Withdrawal by Subject|1|||
150013532|NCT00842543|541182768|FG000|Overall Study|Withdrawal by Subject|2|||
150013533|NCT00842543|541182769|FG001|Overall Study|Withdrawal by Subject|0|||
150013534|NCT00842543|541182770|FG002|Overall Study|Withdrawal by Subject|3|||
150013535|NCT00842543|541182771|FG003|Overall Study|Withdrawal by Subject|4|||
150013536|NCT01483183|541182776|FG000|Overall Study|Physician Decision|0|||
150013537|NCT01483183|541182777|FG001|Overall Study|Physician Decision|0|||
150013538|NCT01483183|541182778|FG002|Overall Study|Physician Decision|0|||
150013539|NCT01483183|541182779|FG003|Overall Study|Physician Decision|0|||
150013540|NCT01483183|541182780|FG004|Overall Study|Physician Decision|0|||
150013541|NCT01483183|541182781|FG005|Overall Study|Physician Decision|0|||
150013542|NCT01483183|541182782|FG006|Overall Study|Physician Decision|2|||
150013543|NCT01483183|541182783|FG007|Overall Study|Physician Decision|0|||
150013544|NCT01483183|541182784|FG008|Overall Study|Physician Decision|0|||
150013545|NCT01483183|541182785|FG009|Overall Study|Physician Decision|0|||
150013546|NCT01483183|541182776|FG000|Overall Study|Withdrawal by Subject|0|||
150013547|NCT01483183|541182777|FG001|Overall Study|Withdrawal by Subject|0|||
150013548|NCT01483183|541182778|FG002|Overall Study|Withdrawal by Subject|0|||
150013549|NCT01483183|541182779|FG003|Overall Study|Withdrawal by Subject|0|||
150013550|NCT01483183|541182780|FG004|Overall Study|Withdrawal by Subject|0|||
150013551|NCT01483183|541182781|FG005|Overall Study|Withdrawal by Subject|0|||
150013552|NCT01483183|541182782|FG006|Overall Study|Withdrawal by Subject|0|||
150013553|NCT01483183|541182783|FG007|Overall Study|Withdrawal by Subject|0|||
150013554|NCT01483183|541182784|FG008|Overall Study|Withdrawal by Subject|0|||
150013555|NCT01483183|541182785|FG009|Overall Study|Withdrawal by Subject|1|||
150013556|NCT00239928|541182786|FG000|Overall Study|Lack of Efficacy|1|||
150013557|NCT00239928|541182786|FG000|Overall Study|Adverse Event|4|||
150013558|NCT00239928|541182786|FG000|Overall Study|Not need to continue study|3|||
150013559|NCT00239928|541182786|FG000|Overall Study|Withdrawal by Subject|2|||
150013560|NCT02718716|541182788|FG000|Overall Study|Lack of Efficacy|1|||
150013561|NCT02718716|541182789|FG001|Overall Study|Lack of Efficacy|0|||
150013562|NCT02718716|541182790|FG002|Overall Study|Lack of Efficacy|0|||
150013563|NCT02718716|541182791|FG003|Overall Study|Lack of Efficacy|0|||
150013564|NCT02718716|541182792|FG004|Overall Study|Lack of Efficacy|0|||
150013565|NCT02942485|541182793|FG000|Overall Study|Lost to Follow-up|1|||
150181214|NCT05052996|541801025|FG003|Overall Study|Still on study|44|||
150181215|NCT05052996|541801022|FG000|Overall Study|Cohort terminated by sponsor|21|||
150013566|NCT02942485|541182794|FG001|Overall Study|Lost to Follow-up|0|||
150013567|NCT04869358|541182803|FG000|Overall Study|Wish to have children.|1|||
150013568|NCT04869358|541182804|FG001|Overall Study|Wish to have children.|0|||
150181216|NCT05052996|541801023|FG001|Overall Study|Cohort terminated by sponsor|12|||
150013569|NCT04869358|541182805|FG002|Overall Study|Wish to have children.|0|||
150013570|NCT04869358|541182806|FG003|Overall Study|Wish to have children.|0|||
150013571|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
150013572|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
150013573|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
150013574|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
150013575|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Death|2|||
150013576|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Death|2|||
150013577|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Death|0|||
150013578|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Death|0|||
150013579|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
150013580|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
150013581|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
150013582|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
150013583|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
150013584|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
150013585|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
150013586|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
150013587|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
150013588|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
150013589|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
150013590|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
150013591|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
150013592|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
150013593|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
150013594|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
150013595|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
150013596|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
150013597|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
150013598|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
150013599|NCT03068754|541182809|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
150013600|NCT03068754|541182810|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
150013601|NCT03068754|541182811|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
150013602|NCT03068754|541182812|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
150013603|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
150013604|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
150013605|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
150013606|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
150013607|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Death|0|||
150013608|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Death|0|||
150013609|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Death|0|||
150013610|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Death|1|||
150013611|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
150013612|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
150013613|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
150013614|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
150013615|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
150013616|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
150013617|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
150013618|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
150013619|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
150013620|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
150013621|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
150013622|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
150013623|NCT03068754|541182809|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
150013624|NCT03068754|541182810|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
150013625|NCT03068754|541182811|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
150013626|NCT03068754|541182812|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
150013627|NCT00129467|541182813|FG000|Received Intervention|Death|1|||
150013628|NCT00129467|541182814|FG001|Received Intervention|Death|1|||
150013629|NCT00129467|541182813|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
150013630|NCT00129467|541182814|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
150013631|NCT00129467|541182813|FG000|Received Intervention|Delirium|2|||
150013632|NCT00129467|541182814|FG001|Received Intervention|Delirium|0|||
150013633|NCT00129467|541182813|FG000|Received Intervention|Withdrawal by Subject|1|||
150058090|NCT00266877|541353633|FG001|Overall Study|Death|1|||
150181217|NCT05052996|541801024|FG002|Overall Study|Cohort terminated by sponsor|0|||
150013634|NCT00129467|541182814|FG001|Received Intervention|Withdrawal by Subject|0|||
150013635|NCT00129467|541182813|FG000|Received Intervention|Nausea|1|||
150013636|NCT00129467|541182814|FG001|Received Intervention|Nausea|0|||
150013637|NCT00129467|541182813|FG000|Received Intervention|Intolerance to citalopram|0|||
150013638|NCT00129467|541182814|FG001|Received Intervention|Intolerance to citalopram|1|||
150013639|NCT00129467|541182813|FG000|Received Intervention|Dizzyness, fatigue|0|||
150013640|NCT00129467|541182814|FG001|Received Intervention|Dizzyness, fatigue|1|||
150013641|NCT00129467|541182813|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
150013642|NCT00129467|541182814|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
150013643|NCT00129467|541182813|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
150013644|NCT00129467|541182814|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
150013645|NCT01009086|541182815|FG000|Overall Study|Lack of Efficacy|16|||
150013646|NCT01009086|541182816|FG001|Overall Study|Lack of Efficacy|15|||
150013647|NCT01009086|541182817|FG002|Overall Study|Lack of Efficacy|9|||
150013648|NCT01009086|541182815|FG000|Overall Study|Lost to Follow-up|4|||
150013649|NCT01009086|541182816|FG001|Overall Study|Lost to Follow-up|5|||
150013650|NCT01009086|541182817|FG002|Overall Study|Lost to Follow-up|3|||
150013651|NCT01009086|541182815|FG000|Overall Study|Adverse Event|12|||
150013652|NCT01009086|541182816|FG001|Overall Study|Adverse Event|11|||
150013653|NCT01009086|541182817|FG002|Overall Study|Adverse Event|8|||
150013654|NCT01009086|541182815|FG000|Overall Study|Withdrawal by Subject|9|||
150013655|NCT01009086|541182816|FG001|Overall Study|Withdrawal by Subject|11|||
150013656|NCT01009086|541182817|FG002|Overall Study|Withdrawal by Subject|13|||
150013657|NCT01009086|541182815|FG000|Overall Study|Other|3|||
150013658|NCT01009086|541182816|FG001|Overall Study|Other|5|||
150013659|NCT01009086|541182817|FG002|Overall Study|Other|1|||
150013660|NCT01424228|541182818|FG000|Overall Study|Withdrawal by Subject|27|||
150013661|NCT01424228|541182819|FG001|Overall Study|Withdrawal by Subject|11|||
150013662|NCT01424228|541182818|FG000|Overall Study|Adverse Event|10|||
150013663|NCT01424228|541182819|FG001|Overall Study|Adverse Event|14|||
150013664|NCT01424228|541182818|FG000|Overall Study|Sponsor's decision|9|||
150013665|NCT01424228|541182819|FG001|Overall Study|Sponsor's decision|12|||
150013666|NCT01424228|541182818|FG000|Overall Study|Lack of Efficacy|5|||
150013667|NCT01424228|541182819|FG001|Overall Study|Lack of Efficacy|7|||
150013668|NCT01424228|541182818|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
150013669|NCT01424228|541182819|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
150013670|NCT01424228|541182818|FG000|Overall Study|Non-compliance|2|||
150013671|NCT01424228|541182819|FG001|Overall Study|Non-compliance|0|||
150013672|NCT01424228|541182818|FG000|Overall Study|Worsening of symptoms|1|||
150013673|NCT01424228|541182819|FG001|Overall Study|Worsening of symptoms|0|||
150013674|NCT01424228|541182818|FG000|Overall Study|Unplanned journey|0|||
150013675|NCT01424228|541182819|FG001|Overall Study|Unplanned journey|1|||
150013676|NCT04496453|541182827|FG000|Overall Study|Lost to Follow-up|6|||
150013677|NCT05392803|541182830|FG000|Overall Study|Lost to Follow-up|0|||
150013678|NCT05392803|541182831|FG001|Overall Study|Lost to Follow-up|2|||
150013679|NCT00235716|541182832|FG000|Overall Study|Death|26|||
150013680|NCT00235716|541182833|FG001|Overall Study|Death|39|||
150013681|NCT00235716|541182834|FG002|Overall Study|Death|32|||
150013682|NCT00235716|541182835|FG003|Overall Study|Death|31|||
150013683|NCT00235716|541182832|FG000|Overall Study|Withdrawal by Subject|23|||
150013684|NCT00235716|541182833|FG001|Overall Study|Withdrawal by Subject|19|||
150013685|NCT00235716|541182834|FG002|Overall Study|Withdrawal by Subject|17|||
150013686|NCT00235716|541182835|FG003|Overall Study|Withdrawal by Subject|18|||
150013687|NCT00235716|541182832|FG000|Overall Study|Lost to Follow-up|12|||
150013688|NCT00235716|541182833|FG001|Overall Study|Lost to Follow-up|7|||
150013689|NCT00235716|541182834|FG002|Overall Study|Lost to Follow-up|14|||
150013690|NCT00235716|541182835|FG003|Overall Study|Lost to Follow-up|10|||
150013691|NCT00235716|541182832|FG000|Overall Study|Adverse Event|1|||
150013692|NCT00235716|541182833|FG001|Overall Study|Adverse Event|1|||
150013693|NCT00235716|541182834|FG002|Overall Study|Adverse Event|1|||
150013694|NCT00235716|541182835|FG003|Overall Study|Adverse Event|0|||
150013695|NCT00235716|541182832|FG000|Overall Study|Physician Decision|0|||
150013696|NCT00235716|541182833|FG001|Overall Study|Physician Decision|1|||
150013697|NCT00235716|541182834|FG002|Overall Study|Physician Decision|1|||
150013698|NCT00235716|541182835|FG003|Overall Study|Physician Decision|3|||
150013699|NCT03576716|541182836|FG000|Overall Study|Withdrawal by Subject|0|||
150013700|NCT03576716|541182837|FG001|Overall Study|Withdrawal by Subject|1|||
150013701|NCT02249182|541182838|FG000|Treatment Phase|Lost to Follow-up|4|||
150013702|NCT02249182|541182839|FG001|Treatment Phase|Lost to Follow-up|0|||
150013703|NCT02249182|541182840|FG002|Treatment Phase|Lost to Follow-up|0|||
150013704|NCT02249182|541182841|FG003|Treatment Phase|Lost to Follow-up|0|||
150013705|NCT02249182|541182842|FG004|Treatment Phase|Lost to Follow-up|0|||
150013706|NCT00148941|541182843|FG000|Overall Study|Lost to Follow-up|17|||
150013707|NCT00148941|541182844|FG001|Overall Study|Lost to Follow-up|24|||
150013708|NCT00148941|541182845|FG002|Overall Study|Lost to Follow-up|18|||
150013709|NCT00148941|541182846|FG003|Overall Study|Lost to Follow-up|22|||
150013710|NCT00148941|541182843|FG000|Overall Study|Withdrawal by Subject|1|||
150013711|NCT00148941|541182844|FG001|Overall Study|Withdrawal by Subject|0|||
150013712|NCT00148941|541182845|FG002|Overall Study|Withdrawal by Subject|1|||
150013713|NCT00148941|541182846|FG003|Overall Study|Withdrawal by Subject|0|||
150013714|NCT00148941|541182843|FG000|Overall Study|Other|0|||
150013715|NCT00148941|541182844|FG001|Overall Study|Other|0|||
150013716|NCT00148941|541182845|FG002|Overall Study|Other|1|||
150013717|NCT00148941|541182846|FG003|Overall Study|Other|2|||
150013718|NCT03244826|541182847|FG000|Overall Study|Withdrawal by Subject|2|||
150013719|NCT03244826|541182848|FG001|Overall Study|Withdrawal by Subject|0|||
150013720|NCT03244826|541182847|FG000|Overall Study|Transplant delayed or withdrawn|12|||
150013721|NCT03244826|541182848|FG001|Overall Study|Transplant delayed or withdrawn|10|||
150013722|NCT02673684|541182849|FG000|Overall Study|Study not completed d/t loss of funding|9|||
150013723|NCT02673684|541182850|FG001|Overall Study|Study not completed d/t loss of funding|8|||
150013724|NCT01092663|541182851|FG000|Overall Study|Withdrawal by Subject|3|||
150013725|NCT01092663|541182852|FG001|Overall Study|Withdrawal by Subject|2|||
150013726|NCT01092663|541182851|FG000|Overall Study|Glucose >300mg/dL|1|||
150013727|NCT01092663|541182852|FG001|Overall Study|Glucose >300mg/dL|0|||
150013728|NCT01092663|541182851|FG000|Overall Study|High fasting triglyceride|2|||
150013729|NCT01092663|541182852|FG001|Overall Study|High fasting triglyceride|0|||
150013730|NCT01092663|541182851|FG000|Overall Study|Adverse Event|1|||
150013731|NCT01092663|541182852|FG001|Overall Study|Adverse Event|1|||
150013732|NCT01092663|541182851|FG000|Overall Study|Protocol Violation|0|||
150013733|NCT01092663|541182852|FG001|Overall Study|Protocol Violation|1|||
150013734|NCT01534195|541182856|FG000|Overall Study|Withdrawal by Subject|1|||
150013735|NCT01534195|541182857|FG001|Overall Study|Withdrawal by Subject|1|||
150013736|NCT02974842|541182858|FG000|Overall Study|Withdrawal by Subject|4|||
150013737|NCT02974842|541182858|FG000|Overall Study|Screen failures|4|||
150013738|NCT01368081|541182861|FG000|Overall Study|Adverse Event|4|||
150013739|NCT01368081|541182862|FG001|Overall Study|Adverse Event|4|||
150013740|NCT01368081|541182863|FG002|Overall Study|Adverse Event|3|||
150013741|NCT01368081|541182864|FG003|Overall Study|Adverse Event|2|||
150013742|NCT01368081|541182865|FG004|Overall Study|Adverse Event|2|||
150013743|NCT01368081|541182866|FG005|Overall Study|Adverse Event|5|||
150013744|NCT01368081|541182867|FG006|Overall Study|Adverse Event|6|||
150013745|NCT01368081|541182868|FG007|Overall Study|Adverse Event|2|||
150013746|NCT01368081|541182869|FG008|Overall Study|Adverse Event|3|||
150013747|NCT01368081|541182870|FG009|Overall Study|Adverse Event|5|||
150013748|NCT01368081|541182871|FG010|Overall Study|Adverse Event|6|||
150013749|NCT01368081|541182872|FG011|Overall Study|Adverse Event|1|||
150013750|NCT01368081|541182873|FG012|Overall Study|Adverse Event|3|||
150013751|NCT01368081|541182861|FG000|Overall Study|Lack of Efficacy|0|||
150013752|NCT01368081|541182862|FG001|Overall Study|Lack of Efficacy|1|||
150013753|NCT01368081|541182863|FG002|Overall Study|Lack of Efficacy|0|||
150013754|NCT01368081|541182864|FG003|Overall Study|Lack of Efficacy|1|||
150013755|NCT01368081|541182865|FG004|Overall Study|Lack of Efficacy|0|||
150013756|NCT01368081|541182866|FG005|Overall Study|Lack of Efficacy|0|||
150013757|NCT01368081|541182867|FG006|Overall Study|Lack of Efficacy|0|||
150013758|NCT01368081|541182868|FG007|Overall Study|Lack of Efficacy|2|||
150013759|NCT01368081|541182869|FG008|Overall Study|Lack of Efficacy|0|||
150013760|NCT01368081|541182870|FG009|Overall Study|Lack of Efficacy|0|||
150013761|NCT01368081|541182871|FG010|Overall Study|Lack of Efficacy|0|||
150013762|NCT01368081|541182872|FG011|Overall Study|Lack of Efficacy|0|||
150013763|NCT01368081|541182873|FG012|Overall Study|Lack of Efficacy|0|||
150058091|NCT00266877|541353634|FG002|Overall Study|Death|1|||
150058092|NCT00266877|541353632|FG000|Overall Study|Adverse Event|6|||
150058093|NCT00266877|541353633|FG001|Overall Study|Adverse Event|4|||
150058094|NCT00266877|541353634|FG002|Overall Study|Adverse Event|1|||
150058095|NCT00266877|541353632|FG000|Overall Study|Physician Decision|2|||
150058096|NCT00266877|541353633|FG001|Overall Study|Physician Decision|1|||
150058097|NCT00266877|541353634|FG002|Overall Study|Physician Decision|1|||
150058098|NCT00266877|541353632|FG000|Overall Study|Withdrawal by Subject|3|||
150058099|NCT00266877|541353633|FG001|Overall Study|Withdrawal by Subject|1|||
150058100|NCT00266877|541353634|FG002|Overall Study|Withdrawal by Subject|1|||
150058101|NCT00266877|541353632|FG000|Overall Study|Disease Progression|72|||
150013764|NCT01368081|541182861|FG000|Overall Study|Protocol Violation|0|||
150058102|NCT00266877|541353633|FG001|Overall Study|Disease Progression|37|||
150013765|NCT01368081|541182862|FG001|Overall Study|Protocol Violation|0|||
150013766|NCT01368081|541182863|FG002|Overall Study|Protocol Violation|0|||
150013767|NCT01368081|541182864|FG003|Overall Study|Protocol Violation|0|||
150058103|NCT00266877|541353634|FG002|Overall Study|Disease Progression|23|||
150058104|NCT00266877|541353632|FG000|Overall Study|Symptomatic Deterioration|6|||
150013768|NCT01368081|541182865|FG004|Overall Study|Protocol Violation|0|||
150013769|NCT01368081|541182866|FG005|Overall Study|Protocol Violation|1|||
150013770|NCT01368081|541182867|FG006|Overall Study|Protocol Violation|0|||
150013771|NCT01368081|541182868|FG007|Overall Study|Protocol Violation|1|||
150013772|NCT01368081|541182869|FG008|Overall Study|Protocol Violation|0|||
150013773|NCT01368081|541182870|FG009|Overall Study|Protocol Violation|0|||
150013774|NCT01368081|541182871|FG010|Overall Study|Protocol Violation|0|||
150013775|NCT01368081|541182872|FG011|Overall Study|Protocol Violation|0|||
150013776|NCT01368081|541182873|FG012|Overall Study|Protocol Violation|0|||
150058105|NCT00266877|541353633|FG001|Overall Study|Symptomatic Deterioration|3|||
150058106|NCT00266877|541353634|FG002|Overall Study|Symptomatic Deterioration|1|||
150013777|NCT01368081|541182861|FG000|Overall Study|Lost to Follow-up|0|||
150013778|NCT01368081|541182862|FG001|Overall Study|Lost to Follow-up|0|||
150013779|NCT01368081|541182863|FG002|Overall Study|Lost to Follow-up|0|||
150013780|NCT01368081|541182864|FG003|Overall Study|Lost to Follow-up|0|||
150013781|NCT01368081|541182865|FG004|Overall Study|Lost to Follow-up|0|||
150013782|NCT01368081|541182866|FG005|Overall Study|Lost to Follow-up|0|||
150013783|NCT01368081|541182867|FG006|Overall Study|Lost to Follow-up|0|||
150013784|NCT01368081|541182868|FG007|Overall Study|Lost to Follow-up|0|||
150013785|NCT01368081|541182869|FG008|Overall Study|Lost to Follow-up|0|||
150013786|NCT01368081|541182870|FG009|Overall Study|Lost to Follow-up|0|||
150013787|NCT01368081|541182871|FG010|Overall Study|Lost to Follow-up|0|||
150013788|NCT01368081|541182872|FG011|Overall Study|Lost to Follow-up|0|||
150013789|NCT01368081|541182873|FG012|Overall Study|Lost to Follow-up|1|||
150013790|NCT01368081|541182861|FG000|Overall Study|Withdrawal by Subject|4|||
150013791|NCT01368081|541182862|FG001|Overall Study|Withdrawal by Subject|4|||
150013792|NCT01368081|541182863|FG002|Overall Study|Withdrawal by Subject|1|||
150013793|NCT01368081|541182864|FG003|Overall Study|Withdrawal by Subject|1|||
150013794|NCT01368081|541182865|FG004|Overall Study|Withdrawal by Subject|0|||
150013795|NCT01368081|541182866|FG005|Overall Study|Withdrawal by Subject|3|||
150013796|NCT01368081|541182867|FG006|Overall Study|Withdrawal by Subject|4|||
150013797|NCT01368081|541182868|FG007|Overall Study|Withdrawal by Subject|2|||
150013798|NCT01368081|541182869|FG008|Overall Study|Withdrawal by Subject|5|||
150013799|NCT01368081|541182870|FG009|Overall Study|Withdrawal by Subject|4|||
150013800|NCT01368081|541182871|FG010|Overall Study|Withdrawal by Subject|3|||
150013801|NCT01368081|541182872|FG011|Overall Study|Withdrawal by Subject|2|||
150013802|NCT01368081|541182873|FG012|Overall Study|Withdrawal by Subject|0|||
150013803|NCT01368081|541182861|FG000|Overall Study|Other reason not defined above|2|||
150013804|NCT01368081|541182862|FG001|Overall Study|Other reason not defined above|0|||
150013805|NCT01368081|541182863|FG002|Overall Study|Other reason not defined above|0|||
150013806|NCT01368081|541182864|FG003|Overall Study|Other reason not defined above|1|||
150013807|NCT01368081|541182865|FG004|Overall Study|Other reason not defined above|0|||
150013808|NCT01368081|541182866|FG005|Overall Study|Other reason not defined above|1|||
150013809|NCT01368081|541182867|FG006|Overall Study|Other reason not defined above|2|||
150013810|NCT01368081|541182868|FG007|Overall Study|Other reason not defined above|0|||
150013811|NCT01368081|541182869|FG008|Overall Study|Other reason not defined above|0|||
150013812|NCT01368081|541182870|FG009|Overall Study|Other reason not defined above|1|||
150013813|NCT01368081|541182871|FG010|Overall Study|Other reason not defined above|0|||
150013814|NCT01368081|541182872|FG011|Overall Study|Other reason not defined above|0|||
150013815|NCT01368081|541182873|FG012|Overall Study|Other reason not defined above|3|||
150013816|NCT00061633|541182874|FG000|Overall Study|Adverse Event|1|||
150013817|NCT00061633|541182875|FG001|Overall Study|Adverse Event|2|||
150013818|NCT00061633|541182874|FG000|Overall Study|Withdrawal by Subject|2|||
150013819|NCT00061633|541182875|FG001|Overall Study|Withdrawal by Subject|2|||
150013820|NCT00061633|541182874|FG000|Overall Study|Lost to Follow-up|1|||
150013821|NCT00061633|541182875|FG001|Overall Study|Lost to Follow-up|4|||
150013822|NCT00061633|541182874|FG000|Overall Study|Other|1|||
150013823|NCT00061633|541182875|FG001|Overall Study|Other|1|||
150013824|NCT00061633|541182874|FG000|Overall Study|Never received study treatment|0|||
150013825|NCT00061633|541182875|FG001|Overall Study|Never received study treatment|2|||
150013826|NCT02611817|541184259|FG000|Open-label Induction Phase|Reason not Specified|9|||
150013827|NCT02611817|541184260|FG001|Open-label Induction Phase|Reason not Specified|0|||
150013828|NCT02611817|541184261|FG002|Open-label Induction Phase|Reason not Specified|0|||
150013829|NCT02611817|541184259|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
150013830|NCT02611817|541184260|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
150013831|NCT02611817|541184261|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
150013832|NCT02611817|541184259|FG000|Open-label Induction Phase|Pregnancy|1|||
150013833|NCT02611817|541184260|FG001|Open-label Induction Phase|Pregnancy|0|||
150013834|NCT02611817|541184261|FG002|Open-label Induction Phase|Pregnancy|0|||
150013835|NCT02611817|541184259|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
150013836|NCT02611817|541184260|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
150013837|NCT02611817|541184261|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
150013838|NCT02611817|541184259|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
150013839|NCT02611817|541184260|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
150013840|NCT02611817|541184261|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
150013841|NCT02611817|541184259|FG000|Open-label Induction Phase|Protocol Violation|5|||
150013842|NCT02611817|541184260|FG001|Open-label Induction Phase|Protocol Violation|0|||
150013843|NCT02611817|541184261|FG002|Open-label Induction Phase|Protocol Violation|0|||
150013844|NCT02611817|541184259|FG000|Open-label Induction Phase|Adverse Event|16|||
150013845|NCT02611817|541184260|FG001|Open-label Induction Phase|Adverse Event|0|||
150013846|NCT02611817|541184261|FG002|Open-label Induction Phase|Adverse Event|0|||
150013847|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
150013848|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
150013849|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
150013850|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
150013851|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
150013852|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
150013853|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
150013854|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
150013855|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
150013856|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
150013857|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
150013858|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
150013859|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
150013860|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
150013861|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
150013862|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
150013863|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
150013864|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
150013865|NCT02611817|541184259|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
150013866|NCT02611817|541184260|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
150013867|NCT02611817|541184261|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
150013868|NCT02950480|541184262|FG000|Overall Study|Withdrawal by Subject|1|||
150013869|NCT02950480|541184263|FG001|Overall Study|Withdrawal by Subject|0|||
150013870|NCT01363661|541184264|FG000|Overall Study|Adverse Event|9|||
150013871|NCT01363661|541184265|FG001|Overall Study|Adverse Event|2|||
150013872|NCT01363661|541184264|FG000|Overall Study|Withdrawal by Subject|1|||
150013873|NCT01363661|541184265|FG001|Overall Study|Withdrawal by Subject|1|||
150013874|NCT01363661|541184264|FG000|Overall Study|Protocol Violation|1|||
150013875|NCT01363661|541184265|FG001|Overall Study|Protocol Violation|0|||
150013876|NCT01363661|541184264|FG000|Overall Study|Lost to Follow-up|3|||
150013877|NCT01363661|541184265|FG001|Overall Study|Lost to Follow-up|1|||
150013878|NCT01835223|541184266|FG000|Overall Study|Adverse Event|1|||
150013879|NCT01835223|541184267|FG001|Overall Study|Adverse Event|0|||
150013880|NCT01835223|541184266|FG000|Overall Study|Withdrawal by Subject|2|||
150013881|NCT01835223|541184267|FG001|Overall Study|Withdrawal by Subject|0|||
150013882|NCT01835223|541184266|FG000|Overall Study|Disease progression|2|||
150013883|NCT01835223|541184267|FG001|Overall Study|Disease progression|1|||
150013884|NCT01835223|541184266|FG000|Overall Study|Became Inelligible|4|||
150013885|NCT01835223|541184267|FG001|Overall Study|Became Inelligible|0|||
150013886|NCT03149055|541184268|FG000|Overall Study|Not treated|4|||
150013887|NCT00630344|541184269|FG000|Overall Study|Adverse Event|5|||
150013888|NCT00630344|541184269|FG000|Overall Study|Progressive Disease|19|||
150013889|NCT00630344|541184269|FG000|Overall Study|Physician Decision|9|||
150013890|NCT00630344|541184269|FG000|Overall Study|Withdrawal by Subject|1|||
150013891|NCT00630344|541184269|FG000|Overall Study|Intercurrent Illness|1|||
150013892|NCT00630344|541184269|FG000|Overall Study|Other|1|||
150013893|NCT00413036|541184270|FG000|Overall Study|Adverse Event|44|||
150013894|NCT00413036|541184270|FG000|Overall Study|Lack of Efficacy|129|||
150013895|NCT00413036|541184270|FG000|Overall Study|Withdrawal by Subject|7|||
150013896|NCT00413036|541184270|FG000|Overall Study|Death|9|||
150013897|NCT00413036|541184270|FG000|Overall Study|Other|26|||
150013898|NCT00413036|541184270|FG000|Overall Study|Missing|2|||
150013899|NCT03250182|541184271|FG000|Overall Study|Withdrawal by Subject|1|||
150013900|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013901|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013902|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
150013903|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
150013904|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
150013905|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013906|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
150013907|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
150013908|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
150013909|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013910|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013911|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013912|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
150013913|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
150013914|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
150013915|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
150013916|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
150013917|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
150013918|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
150013919|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
150013920|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
150013921|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
150013922|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
150013923|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
150058107|NCT00266877|541353632|FG000|Overall Study|Hospitalization|1|||
150058108|NCT00266877|541353633|FG001|Overall Study|Hospitalization|0|||
150058109|NCT00266877|541353634|FG002|Overall Study|Hospitalization|0|||
150058110|NCT00266877|541353632|FG000|Overall Study|Concomitant Radiotherapy|0|||
150013924|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
150013925|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
150013926|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013927|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
150013928|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
150013929|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013930|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013931|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
150013932|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
150013933|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013934|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013935|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013936|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013937|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013938|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
150013939|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013940|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
150013941|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
150013942|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013943|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013944|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013945|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
150013946|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013947|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
150013948|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013949|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013950|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013951|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
150013952|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013953|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013954|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013955|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
150013956|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013957|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013958|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013959|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
150013960|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013961|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013962|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013963|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013964|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
150013965|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013966|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013967|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013968|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
150058111|NCT00266877|541353633|FG001|Overall Study|Concomitant Radiotherapy|1|||
150058112|NCT00266877|541353634|FG002|Overall Study|Concomitant Radiotherapy|0|||
150013969|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013970|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013971|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
150013972|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013973|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013974|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013975|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013976|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013977|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
150013978|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013979|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
150013980|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013981|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013982|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150058113|NCT01077375|541353641|FG000|Overall Study|Adverse Event|2|||
150058114|NCT01077375|541353642|FG001|Overall Study|Adverse Event|15|||
150013983|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013984|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013985|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013986|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013987|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013988|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013989|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013990|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
150013991|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
150013992|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013993|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013994|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013995|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013996|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013997|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013998|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150013999|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150014000|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150014001|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150014002|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150014003|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
150014004|NCT03100058|541184275|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014005|NCT03100058|541184276|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014006|NCT03100058|541184277|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014007|NCT03100058|541184278|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014008|NCT03100058|541184279|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014009|NCT03100058|541184280|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014010|NCT03100058|541184281|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
150014011|NCT03100058|541184282|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014012|NCT03100058|541184283|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014013|NCT03100058|541184284|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014014|NCT03100058|541184285|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014015|NCT03100058|541184286|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014016|NCT03100058|541184287|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
150014017|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014018|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014019|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014020|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014021|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014022|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014023|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014024|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014025|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014026|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
150014027|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
150014028|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
150014029|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
150014030|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014031|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014032|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014033|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014034|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014035|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014036|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014037|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014038|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014039|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014040|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
150014041|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
150014042|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
150014043|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014044|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014045|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014046|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014047|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014048|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014049|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014050|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014051|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014052|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
150014053|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
150014054|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
150014055|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
150014056|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014057|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014058|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014059|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014060|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014061|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014062|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014063|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014064|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014065|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014066|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
150014067|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014068|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
150014069|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014070|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014071|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014072|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014073|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014074|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014075|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014076|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014077|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014078|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014079|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014080|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
150014081|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
150014082|NCT03100058|541184275|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014083|NCT03100058|541184276|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014084|NCT03100058|541184277|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014085|NCT03100058|541184278|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014086|NCT03100058|541184279|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014087|NCT03100058|541184280|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014088|NCT03100058|541184281|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014089|NCT03100058|541184282|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014090|NCT03100058|541184283|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014091|NCT03100058|541184284|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
150014092|NCT03100058|541184285|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150058115|NCT01077375|541353641|FG000|Overall Study|Lack of Efficacy|6|||
150058116|NCT01077375|541353642|FG001|Overall Study|Lack of Efficacy|8|||
150014093|NCT03100058|541184286|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014094|NCT03100058|541184287|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
150014095|NCT03194646|541184288|FG000|Overall Study|Adverse Event|24|||
150014096|NCT03194646|541184289|FG001|Overall Study|Adverse Event|25|||
150014097|NCT03194646|541184290|FG002|Overall Study|Adverse Event|14|||
150014098|NCT03194646|541184291|FG003|Overall Study|Adverse Event|17|||
150014099|NCT03194646|541184288|FG000|Overall Study|Lack of Efficacy|4|||
150014100|NCT03194646|541184289|FG001|Overall Study|Lack of Efficacy|2|||
150014101|NCT03194646|541184290|FG002|Overall Study|Lack of Efficacy|2|||
150058117|NCT01077375|541353641|FG000|Overall Study|Withdrawal by Subject|0|||
150058118|NCT01077375|541353642|FG001|Overall Study|Withdrawal by Subject|6|||
150058119|NCT01077375|541353641|FG000|Overall Study|Lost to Follow-up|2|||
150058120|NCT01077375|541353642|FG001|Overall Study|Lost to Follow-up|5|||
150014102|NCT03194646|541184291|FG003|Overall Study|Lack of Efficacy|12|||
150058121|NCT01077375|541353641|FG000|Overall Study|Other Reason|0|||
150058122|NCT01077375|541353642|FG001|Overall Study|Other Reason|1|||
150058123|NCT01924429|541353643|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
150058124|NCT01924429|541353644|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
150014103|NCT03194646|541184288|FG000|Overall Study|Lost to Follow-up|30|||
150014104|NCT03194646|541184289|FG001|Overall Study|Lost to Follow-up|22|||
150014105|NCT03194646|541184290|FG002|Overall Study|Lost to Follow-up|12|||
150014106|NCT03194646|541184291|FG003|Overall Study|Lost to Follow-up|35|||
150014107|NCT03194646|541184288|FG000|Overall Study|Non-compliance with study drug|4|||
150014108|NCT03194646|541184289|FG001|Overall Study|Non-compliance with study drug|0|||
150014109|NCT03194646|541184290|FG002|Overall Study|Non-compliance with study drug|1|||
150014110|NCT03194646|541184291|FG003|Overall Study|Non-compliance with study drug|1|||
150014111|NCT03194646|541184288|FG000|Overall Study|Other|89|||
150014112|NCT03194646|541184289|FG001|Overall Study|Other|68|||
150014113|NCT03194646|541184290|FG002|Overall Study|Other|34|||
150014114|NCT03194646|541184291|FG003|Overall Study|Other|31|||
150014115|NCT03194646|541184288|FG000|Overall Study|Physician Decision|7|||
150014116|NCT03194646|541184289|FG001|Overall Study|Physician Decision|9|||
150014117|NCT03194646|541184290|FG002|Overall Study|Physician Decision|5|||
150014118|NCT03194646|541184291|FG003|Overall Study|Physician Decision|4|||
150014119|NCT03194646|541184288|FG000|Overall Study|Pregnancy|4|||
150014120|NCT03194646|541184289|FG001|Overall Study|Pregnancy|5|||
150014121|NCT03194646|541184290|FG002|Overall Study|Pregnancy|1|||
150014122|NCT03194646|541184291|FG003|Overall Study|Pregnancy|2|||
150014123|NCT03194646|541184288|FG000|Overall Study|Protocol Violation|4|||
150014124|NCT03194646|541184289|FG001|Overall Study|Protocol Violation|2|||
150014125|NCT03194646|541184290|FG002|Overall Study|Protocol Violation|1|||
150014126|NCT03194646|541184291|FG003|Overall Study|Protocol Violation|1|||
150014127|NCT03194646|541184288|FG000|Overall Study|Site terminated by sponsor|0|||
150014128|NCT03194646|541184289|FG001|Overall Study|Site terminated by sponsor|0|||
150014129|NCT03194646|541184290|FG002|Overall Study|Site terminated by sponsor|2|||
150014130|NCT03194646|541184291|FG003|Overall Study|Site terminated by sponsor|0|||
150014131|NCT03194646|541184288|FG000|Overall Study|Study terminated by sponsor|62|||
150014132|NCT03194646|541184289|FG001|Overall Study|Study terminated by sponsor|61|||
150014133|NCT03194646|541184290|FG002|Overall Study|Study terminated by sponsor|30|||
150014134|NCT03194646|541184291|FG003|Overall Study|Study terminated by sponsor|34|||
150014135|NCT03194646|541184288|FG000|Overall Study|Withdrawal by Subject|75|||
150014136|NCT03194646|541184289|FG001|Overall Study|Withdrawal by Subject|74|||
150014137|NCT03194646|541184290|FG002|Overall Study|Withdrawal by Subject|36|||
150014138|NCT03194646|541184291|FG003|Overall Study|Withdrawal by Subject|131|||
150014139|NCT03194646|541184288|FG000|Overall Study|Missing|1|||
150014140|NCT03194646|541184289|FG001|Overall Study|Missing|0|||
150014141|NCT03194646|541184290|FG002|Overall Study|Missing|1|||
150014142|NCT03194646|541184291|FG003|Overall Study|Missing|12|||
150014143|NCT02141360|541184292|FG000|Overall Study|Withdrawal by Subject|6|||
150014144|NCT02141360|541184293|FG001|Overall Study|Withdrawal by Subject|0|||
150014145|NCT02141360|541184294|FG002|Overall Study|Withdrawal by Subject|0|||
150014146|NCT02141360|541184292|FG000|Overall Study|Study Terminated before Visit|1|||
150014147|NCT02141360|541184293|FG001|Overall Study|Study Terminated before Visit|0|||
150014148|NCT02141360|541184294|FG002|Overall Study|Study Terminated before Visit|0|||
150014149|NCT04302545|541184295|FG000|Overall Study|Lost to Follow-up|3|||
150014150|NCT04302545|541184296|FG001|Overall Study|Lost to Follow-up|4|||
150014151|NCT03550404|541184297|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
150014152|NCT03550404|541184298|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
150014153|NCT03550404|541184299|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
150014154|NCT03550404|541184297|FG000|Phase 2|Vacated position|1|||
150014155|NCT03550404|541184298|FG001|Phase 2|Vacated position|0|||
150014156|NCT03550404|541184299|FG002|Phase 2|Vacated position|0|||
150014157|NCT00932165|541184300|FG000|Overall Study|Lost to Follow-up|1|||
150014158|NCT01336023|541184301|FG000|Week 0 to Week 26|Adverse Event|8|||
150014159|NCT01336023|541184302|FG001|Week 0 to Week 26|Adverse Event|10|||
150014160|NCT01336023|541184303|FG002|Week 0 to Week 26|Adverse Event|24|||
150014161|NCT01336023|541184301|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
150014162|NCT01336023|541184302|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
150014163|NCT01336023|541184303|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
150014164|NCT01336023|541184301|FG000|Week 0 to Week 26|Protocol Violation|1|||
150014165|NCT01336023|541184302|FG001|Week 0 to Week 26|Protocol Violation|2|||
150014166|NCT01336023|541184303|FG002|Week 0 to Week 26|Protocol Violation|0|||
150014167|NCT01336023|541184301|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
150014168|NCT01336023|541184302|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
150014169|NCT01336023|541184303|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
150014170|NCT01336023|541184301|FG000|Week 0 to Week 26|Unclassified|5|||
150014171|NCT01336023|541184302|FG001|Week 0 to Week 26|Unclassified|16|||
150014172|NCT01336023|541184303|FG002|Week 0 to Week 26|Unclassified|9|||
150014173|NCT01336023|541184301|FG000|Week 27 to 52|Adverse Event|1|||
150014174|NCT01336023|541184302|FG001|Week 27 to 52|Adverse Event|5|||
150014175|NCT01336023|541184303|FG002|Week 27 to 52|Adverse Event|2|||
150014176|NCT01336023|541184301|FG000|Week 27 to 52|Protocol Violation|0|||
150014177|NCT01336023|541184302|FG001|Week 27 to 52|Protocol Violation|2|||
150014178|NCT01336023|541184303|FG002|Week 27 to 52|Protocol Violation|1|||
150014179|NCT01336023|541184301|FG000|Week 27 to 52|Withdrawal Criteria|14|||
150014180|NCT01336023|541184302|FG001|Week 27 to 52|Withdrawal Criteria|19|||
150014181|NCT01336023|541184303|FG002|Week 27 to 52|Withdrawal Criteria|16|||
150014182|NCT01336023|541184301|FG000|Week 27 to 52|Unclassified|13|||
150014183|NCT01336023|541184302|FG001|Week 27 to 52|Unclassified|18|||
150014184|NCT01336023|541184303|FG002|Week 27 to 52|Unclassified|9|||
150014185|NCT00666965|541184304|FG000|Overall Study|Adverse Event|0|||
150014186|NCT00666965|541184305|FG001|Overall Study|Adverse Event|2|||
150014187|NCT00666965|541184306|FG002|Overall Study|Adverse Event|1|||
150014188|NCT00666965|541184307|FG003|Overall Study|Adverse Event|9|||
150014189|NCT00666965|541184304|FG000|Overall Study|Lack of Efficacy|1|||
150014190|NCT00666965|541184305|FG001|Overall Study|Lack of Efficacy|1|||
150014191|NCT00666965|541184306|FG002|Overall Study|Lack of Efficacy|0|||
150014192|NCT00666965|541184307|FG003|Overall Study|Lack of Efficacy|0|||
150014193|NCT00666965|541184304|FG000|Overall Study|Protocol Violation|0|||
150014194|NCT00666965|541184305|FG001|Overall Study|Protocol Violation|0|||
150014195|NCT00666965|541184306|FG002|Overall Study|Protocol Violation|0|||
150014196|NCT00666965|541184307|FG003|Overall Study|Protocol Violation|2|||
150014197|NCT00666965|541184304|FG000|Overall Study|Discontinuation criteria|2|||
150014198|NCT00666965|541184305|FG001|Overall Study|Discontinuation criteria|1|||
150014199|NCT00666965|541184306|FG002|Overall Study|Discontinuation criteria|1|||
150014200|NCT00666965|541184307|FG003|Overall Study|Discontinuation criteria|2|||
150014201|NCT00666965|541184304|FG000|Overall Study|Withdrawal by Subject|0|||
150014202|NCT00666965|541184305|FG001|Overall Study|Withdrawal by Subject|0|||
150014203|NCT00666965|541184306|FG002|Overall Study|Withdrawal by Subject|0|||
150014204|NCT00666965|541184307|FG003|Overall Study|Withdrawal by Subject|2|||
150014205|NCT01361178|541184311|FG000|Overall Study|Death|13|||
150014206|NCT01361178|541184312|FG001|Overall Study|Death|0|||
150014207|NCT04294147|541184313|FG000|Overall Study|Protocol Violation|2|||
150014208|NCT04294147|541184314|FG001|Overall Study|Protocol Violation|0|||
150014209|NCT02726022|541184317|FG000|Overall Study|Adverse Event|14|||
150014210|NCT02726022|541184317|FG000|Overall Study|Treatment Failure|8|||
150014211|NCT02726022|541184317|FG000|Overall Study|Poor Compliance|13|||
150014212|NCT02726022|541184317|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
150014213|NCT02456857|541184324|FG000|Overall Study|Disease Progression|4|||
150014214|NCT00781859|541184325|FG000|Overall Study|Adverse Event|2|||
150014215|NCT00781859|541184326|FG001|Overall Study|Adverse Event|2|||
150014216|NCT00781859|541184325|FG000|Overall Study|Withdrawal by Subject|8|||
150014217|NCT00781859|541184326|FG001|Overall Study|Withdrawal by Subject|4|||
150014218|NCT00781859|541184325|FG000|Overall Study|Lost to Follow-up|6|||
150014219|NCT00781859|541184326|FG001|Overall Study|Lost to Follow-up|3|||
150014220|NCT00781859|541184325|FG000|Overall Study|Death|3|||
150014221|NCT00781859|541184326|FG001|Overall Study|Death|0|||
150014222|NCT01983774|541184330|FG000|Overall Study|Lung Transplant|0|||
150014223|NCT01983774|541184331|FG001|Overall Study|Lung Transplant|1|||
150014224|NCT01983774|541184330|FG000|Overall Study|Lost to Follow-up|1|||
150014225|NCT01983774|541184331|FG001|Overall Study|Lost to Follow-up|0|||
150014226|NCT01339897|541184332|FG000|Overall Study|Adverse Event|1|||
150014227|NCT01339897|541184333|FG001|Overall Study|Adverse Event|0|||
150014228|NCT01339897|541184334|FG002|Overall Study|Adverse Event|0|||
150014229|NCT01339897|541184335|FG003|Overall Study|Adverse Event|1|||
150014230|NCT01138501|541184336|FG000|Overall Study|Protocol Violation|2|||
150014231|NCT01138501|541184336|FG000|Overall Study|Withdrawal by Subject|3|||
150014232|NCT03657095|541184341|FG000|Overall Study|Withdrawal by Subject|1|||
150014233|NCT03657095|541184342|FG001|Overall Study|Withdrawal by Subject|1|||
150014234|NCT03657095|541184341|FG000|Overall Study|Adverse Event|0|||
150014235|NCT03657095|541184342|FG001|Overall Study|Adverse Event|3|||
150014236|NCT03657095|541184341|FG000|Overall Study|Study Terminated by Sponsor|58|||
150014237|NCT03657095|541184342|FG001|Overall Study|Study Terminated by Sponsor|49|||
150058125|NCT01089361|541353648|FG000|Overall Study|Death|1|||
150058126|NCT01089361|541353649|FG001|Overall Study|Death|0|||
150058127|NCT01606878|541353650|FG000|Overall Study|Adverse Event|1|||
150058128|NCT01606878|541353651|FG001|Overall Study|Adverse Event|1|||
150058129|NCT01606878|541353652|FG002|Overall Study|Adverse Event|0|||
150014238|NCT00348309|541184345|FG000|Overall Study|Adverse Event|56|||
150014239|NCT00348309|541184346|FG001|Overall Study|Adverse Event|28|||
150014240|NCT00348309|541184347|FG002|Overall Study|Adverse Event|63|||
150014241|NCT00348309|541184345|FG000|Overall Study|Lost to Follow-up|6|||
150014242|NCT00348309|541184346|FG001|Overall Study|Lost to Follow-up|7|||
150014243|NCT00348309|541184347|FG002|Overall Study|Lost to Follow-up|4|||
150014244|NCT00348309|541184345|FG000|Overall Study|Protocol Violation|7|||
150014245|NCT00348309|541184346|FG001|Overall Study|Protocol Violation|12|||
150014246|NCT00348309|541184347|FG002|Overall Study|Protocol Violation|7|||
150014247|NCT00348309|541184345|FG000|Overall Study|Withdrawal by Subject|33|||
150058130|NCT01606878|541353653|FG003|Overall Study|Adverse Event|0|||
150014248|NCT00348309|541184346|FG001|Overall Study|Withdrawal by Subject|37|||
150014249|NCT00348309|541184347|FG002|Overall Study|Withdrawal by Subject|40|||
150014250|NCT00348309|541184345|FG000|Overall Study|Non-compliance|8|||
150014251|NCT00348309|541184346|FG001|Overall Study|Non-compliance|6|||
150014252|NCT00348309|541184347|FG002|Overall Study|Non-compliance|8|||
150058131|NCT01606878|541353654|FG004|Overall Study|Adverse Event|0|||
150014253|NCT00348309|541184345|FG000|Overall Study|Death of caregiver|1|||
150014254|NCT00348309|541184346|FG001|Overall Study|Death of caregiver|0|||
150014255|NCT00348309|541184347|FG002|Overall Study|Death of caregiver|1|||
150014256|NCT00348309|541184345|FG000|Overall Study|Lack of insight, dementia|1|||
150014257|NCT00348309|541184346|FG001|Overall Study|Lack of insight, dementia|0|||
150014258|NCT00348309|541184347|FG002|Overall Study|Lack of insight, dementia|0|||
150014259|NCT00348309|541184345|FG000|Overall Study|Wrong bottle allocated|1|||
150014260|NCT00348309|541184346|FG001|Overall Study|Wrong bottle allocated|0|||
150014261|NCT00348309|541184347|FG002|Overall Study|Wrong bottle allocated|0|||
150014262|NCT00348309|541184345|FG000|Overall Study|Caregiver sick|1|||
150014263|NCT00348309|541184346|FG001|Overall Study|Caregiver sick|0|||
150014264|NCT00348309|541184347|FG002|Overall Study|Caregiver sick|0|||
150014265|NCT00348309|541184345|FG000|Overall Study|Use of prohibited medication|5|||
150014266|NCT00348309|541184346|FG001|Overall Study|Use of prohibited medication|2|||
150014267|NCT00348309|541184347|FG002|Overall Study|Use of prohibited medication|2|||
150014268|NCT00348309|541184345|FG000|Overall Study|Caregiver withdrawal|3|||
150014269|NCT00348309|541184346|FG001|Overall Study|Caregiver withdrawal|0|||
150014270|NCT00348309|541184347|FG002|Overall Study|Caregiver withdrawal|7|||
150014271|NCT00348309|541184345|FG000|Overall Study|Unable to complete ET visit|1|||
150014272|NCT00348309|541184346|FG001|Overall Study|Unable to complete ET visit|0|||
150014273|NCT00348309|541184347|FG002|Overall Study|Unable to complete ET visit|0|||
150014274|NCT00348309|541184345|FG000|Overall Study|PI closing medical practice|1|||
150014275|NCT00348309|541184346|FG001|Overall Study|PI closing medical practice|0|||
150014276|NCT00348309|541184347|FG002|Overall Study|PI closing medical practice|0|||
150014277|NCT00348309|541184345|FG000|Overall Study|Principal investigator's decision|1|||
150014278|NCT00348309|541184346|FG001|Overall Study|Principal investigator's decision|0|||
150014279|NCT00348309|541184347|FG002|Overall Study|Principal investigator's decision|0|||
150014280|NCT00348309|541184345|FG000|Overall Study|No disponibility of medication|1|||
150014281|NCT00348309|541184346|FG001|Overall Study|No disponibility of medication|0|||
150014282|NCT00348309|541184347|FG002|Overall Study|No disponibility of medication|0|||
150058132|NCT01606878|541353655|FG005|Overall Study|Adverse Event|0|||
150058133|NCT01606878|541353656|FG006|Overall Study|Adverse Event|1|||
150058134|NCT01606878|541353657|FG007|Overall Study|Adverse Event|0|||
150058135|NCT01606878|541353658|FG008|Overall Study|Adverse Event|1|||
150058136|NCT01606878|541353659|FG009|Overall Study|Adverse Event|3|||
150058137|NCT01606878|541353660|FG010|Overall Study|Adverse Event|0|||
150058138|NCT01606878|541353650|FG000|Overall Study|Lack of Efficacy|1|||
150058139|NCT01606878|541353651|FG001|Overall Study|Lack of Efficacy|1|||
150058140|NCT01606878|541353652|FG002|Overall Study|Lack of Efficacy|1|||
150058141|NCT01606878|541353653|FG003|Overall Study|Lack of Efficacy|2|||
150058142|NCT01606878|541353654|FG004|Overall Study|Lack of Efficacy|1|||
150058143|NCT01606878|541353655|FG005|Overall Study|Lack of Efficacy|2|||
150058144|NCT01606878|541353656|FG006|Overall Study|Lack of Efficacy|1|||
150058145|NCT01606878|541353657|FG007|Overall Study|Lack of Efficacy|2|||
150058146|NCT01606878|541353658|FG008|Overall Study|Lack of Efficacy|2|||
150058147|NCT01606878|541353659|FG009|Overall Study|Lack of Efficacy|0|||
150058148|NCT01606878|541353660|FG010|Overall Study|Lack of Efficacy|1|||
150058149|NCT01606878|541353650|FG000|Overall Study|Physician Decision|1|||
150058150|NCT01606878|541353651|FG001|Overall Study|Physician Decision|0|||
150058151|NCT01606878|541353652|FG002|Overall Study|Physician Decision|2|||
150058152|NCT01606878|541353653|FG003|Overall Study|Physician Decision|1|||
150058153|NCT01606878|541353654|FG004|Overall Study|Physician Decision|1|||
150058154|NCT01606878|541353655|FG005|Overall Study|Physician Decision|1|||
150058155|NCT01606878|541353656|FG006|Overall Study|Physician Decision|2|||
150058156|NCT01606878|541353657|FG007|Overall Study|Physician Decision|0|||
150058157|NCT01606878|541353658|FG008|Overall Study|Physician Decision|1|||
150058158|NCT01606878|541353659|FG009|Overall Study|Physician Decision|0|||
150058159|NCT01606878|541353660|FG010|Overall Study|Physician Decision|0|||
150014283|NCT00348309|541184345|FG000|Overall Study|Worsened neurodegenerative disease|1|||
150014284|NCT00348309|541184346|FG001|Overall Study|Worsened neurodegenerative disease|0|||
150014285|NCT00348309|541184347|FG002|Overall Study|Worsened neurodegenerative disease|0|||
150014286|NCT00348309|541184345|FG000|Overall Study|Cognitive and behaviour worsening|2|||
150014287|NCT00348309|541184346|FG001|Overall Study|Cognitive and behaviour worsening|0|||
150014288|NCT00348309|541184347|FG002|Overall Study|Cognitive and behaviour worsening|0|||
150014289|NCT00348309|541184345|FG000|Overall Study|Worsening of alzheimer|1|||
150058160|NCT01606878|541353650|FG000|Overall Study|Withdrawal by Subject|3|||
150058161|NCT01606878|541353651|FG001|Overall Study|Withdrawal by Subject|2|||
150058162|NCT01606878|541353652|FG002|Overall Study|Withdrawal by Subject|2|||
150058163|NCT01606878|541353653|FG003|Overall Study|Withdrawal by Subject|0|||
150058164|NCT01606878|541353654|FG004|Overall Study|Withdrawal by Subject|1|||
150058165|NCT01606878|541353655|FG005|Overall Study|Withdrawal by Subject|1|||
150058166|NCT01606878|541353656|FG006|Overall Study|Withdrawal by Subject|2|||
150058167|NCT01606878|541353657|FG007|Overall Study|Withdrawal by Subject|1|||
150014290|NCT00348309|541184346|FG001|Overall Study|Worsening of alzheimer|0|||
150014291|NCT00348309|541184347|FG002|Overall Study|Worsening of alzheimer|1|||
150014292|NCT00348309|541184345|FG000|Overall Study|Did not appear in time for Visit 3|1|||
150014293|NCT00348309|541184346|FG001|Overall Study|Did not appear in time for Visit 3|0|||
150014294|NCT00348309|541184347|FG002|Overall Study|Did not appear in time for Visit 3|0|||
150014295|NCT00348309|541184345|FG000|Overall Study|Participant died|2|||
150014296|NCT00348309|541184346|FG001|Overall Study|Participant died|1|||
150014297|NCT00348309|541184347|FG002|Overall Study|Participant died|1|||
150014298|NCT00348309|541184345|FG000|Overall Study|Decision of sponsor|1|||
150014299|NCT00348309|541184346|FG001|Overall Study|Decision of sponsor|0|||
150014300|NCT00348309|541184347|FG002|Overall Study|Decision of sponsor|0|||
150014301|NCT00348309|541184345|FG000|Overall Study|Ineffectiveness of treatment|0|||
150014302|NCT00348309|541184346|FG001|Overall Study|Ineffectiveness of treatment|1|||
150014303|NCT00348309|541184347|FG002|Overall Study|Ineffectiveness of treatment|0|||
150014304|NCT00348309|541184345|FG000|Overall Study|A foul of exclusion criteria|0|||
150014305|NCT00348309|541184346|FG001|Overall Study|A foul of exclusion criteria|1|||
150014306|NCT00348309|541184347|FG002|Overall Study|A foul of exclusion criteria|0|||
150014307|NCT00348309|541184345|FG000|Overall Study|Participant was hospitalized|0|||
150014308|NCT00348309|541184346|FG001|Overall Study|Participant was hospitalized|1|||
150014309|NCT00348309|541184347|FG002|Overall Study|Participant was hospitalized|0|||
150014310|NCT00348309|541184345|FG000|Overall Study|Sponsor refuseal|0|||
150014311|NCT00348309|541184346|FG001|Overall Study|Sponsor refuseal|1|||
150014312|NCT00348309|541184347|FG002|Overall Study|Sponsor refuseal|1|||
150014313|NCT00348309|541184345|FG000|Overall Study|Forgot often medication|0|||
150014314|NCT00348309|541184346|FG001|Overall Study|Forgot often medication|1|||
150014315|NCT00348309|541184347|FG002|Overall Study|Forgot often medication|0|||
150014316|NCT00348309|541184345|FG000|Overall Study|Medical Monitor decision|0|||
150014317|NCT00348309|541184346|FG001|Overall Study|Medical Monitor decision|0|||
150014318|NCT00348309|541184347|FG002|Overall Study|Medical Monitor decision|1|||
150014319|NCT00348309|541184345|FG000|Overall Study|Increased dose of Aricept|0|||
150014320|NCT00348309|541184346|FG001|Overall Study|Increased dose of Aricept|0|||
150014321|NCT00348309|541184347|FG002|Overall Study|Increased dose of Aricept|1|||
150014322|NCT00348309|541184345|FG000|Overall Study|Site closure|0|||
150014323|NCT00348309|541184346|FG001|Overall Study|Site closure|0|||
150014324|NCT00348309|541184347|FG002|Overall Study|Site closure|1|||
150014325|NCT00348309|541184345|FG000|Overall Study|Adverse event not attended|0|||
150014326|NCT00348309|541184346|FG001|Overall Study|Adverse event not attended|0|||
150014327|NCT00348309|541184347|FG002|Overall Study|Adverse event not attended|1|||
150014328|NCT00348309|541184345|FG000|Overall Study|ECG abnormal|0|||
150014329|NCT00348309|541184346|FG001|Overall Study|ECG abnormal|0|||
150014330|NCT00348309|541184347|FG002|Overall Study|ECG abnormal|2|||
150014331|NCT00348309|541184345|FG000|Overall Study|Cardiologist recommendations|0|||
150014332|NCT00348309|541184346|FG001|Overall Study|Cardiologist recommendations|0|||
150014333|NCT00348309|541184347|FG002|Overall Study|Cardiologist recommendations|1|||
150014334|NCT00348309|541184345|FG000|Overall Study|HCV career|0|||
150014335|NCT00348309|541184346|FG001|Overall Study|HCV career|0|||
150014336|NCT00348309|541184347|FG002|Overall Study|HCV career|1|||
150014337|NCT00622388|541184348|FG000|Overall Study|Disease Progression|47|||
150014338|NCT00622388|541184348|FG000|Overall Study|Adverse Event|6|||
150014339|NCT00622388|541184348|FG000|Overall Study|Protocol Violation|3|||
150014340|NCT00622388|541184348|FG000|Overall Study|Participant Refusal|1|||
150014341|NCT00622388|541184348|FG000|Overall Study|Death|3|||
150014342|NCT00622388|541184348|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
150014343|NCT00622388|541184348|FG000|Overall Study|Took Prohibited Medication|2|||
150014344|NCT00622388|541184348|FG000|Overall Study|Withdrew Consent|1|||
150014345|NCT00622388|541184348|FG000|Overall Study|Insurance Expired|1|||
150014346|NCT01894243|541184349|FG000|Overall Study|Adverse Event|0|||
150014347|NCT01894243|541184350|FG001|Overall Study|Adverse Event|1|||
150014348|NCT01894243|541184351|FG002|Overall Study|Adverse Event|2|||
150014349|NCT01894243|541184349|FG000|Overall Study|Death|0|||
150014350|NCT01894243|541184350|FG001|Overall Study|Death|0|||
150014351|NCT01894243|541184351|FG002|Overall Study|Death|3|||
150014352|NCT01894243|541184349|FG000|Overall Study|Lack of Efficacy|3|||
150014353|NCT01894243|541184350|FG001|Overall Study|Lack of Efficacy|3|||
150014354|NCT01894243|541184351|FG002|Overall Study|Lack of Efficacy|1|||
150014355|NCT01894243|541184349|FG000|Overall Study|Condition under investigation worsened|8|||
150014356|NCT01894243|541184350|FG001|Overall Study|Condition under investigation worsened|6|||
150014357|NCT01894243|541184351|FG002|Overall Study|Condition under investigation worsened|2|||
150014358|NCT01894243|541184349|FG000|Overall Study|Subject decision|1|||
150014359|NCT01894243|541184350|FG001|Overall Study|Subject decision|0|||
150014360|NCT01894243|541184351|FG002|Overall Study|Subject decision|0|||
150014361|NCT01894243|541184349|FG000|Overall Study|Other|1|||
150014362|NCT01894243|541184350|FG001|Overall Study|Other|0|||
150014363|NCT01894243|541184351|FG002|Overall Study|Other|0|||
150014364|NCT01743040|541184352|FG000|Overall Study|Death|1|||
150014365|NCT01743040|541184352|FG000|Overall Study|Lost to Follow-up|66|||
150014366|NCT01743040|541184352|FG000|Overall Study|Physician Decision|40|||
150014367|NCT01743040|541184352|FG000|Overall Study|Protocol Violation|1|||
150014368|NCT01743040|541184352|FG000|Overall Study|Withdrawal by Subject|121|||
150014369|NCT00828750|541184355|FG000|Overall Study|Lack of Efficacy|3|||
150014370|NCT00828750|541184355|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
150014371|NCT04006392|541184356|FG000|Overall Study|Lost to Follow-up|0|||
150014372|NCT04006392|541184357|FG001|Overall Study|Lost to Follow-up|1|||
150014373|NCT01299116|541184358|FG000|Overall Study|Lost to Follow-up|65|||
150014374|NCT01299116|541184359|FG001|Overall Study|Lost to Follow-up|9|||
150014375|NCT01299116|541184360|FG002|Overall Study|Lost to Follow-up|11|||
150014376|NCT03043651|541184363|FG000|Overall Study|Death|1|||
150014377|NCT03043651|541184363|FG000|Overall Study|Progressive Disease|2|||
150014378|NCT03043651|541184363|FG000|Overall Study|Adverse Event|2|||
150014379|NCT03043651|541184363|FG000|Overall Study|Withdrawal by Subject|4|||
150014380|NCT03043651|541184363|FG000|Overall Study|Study Terminated by Sponsor|39|||
150014381|NCT01630889|541184364|FG000|Overall Study|Death|2|||
150014382|NCT01630889|541184364|FG000|Overall Study|Withdrawal by Subject|1|||
150014383|NCT01630889|541184364|FG000|Overall Study|Other than Specified|2|||
150014384|NCT01630889|541184364|FG000|Overall Study|Lost to Follow-up|4|||
150014385|NCT01630889|541184364|FG000|Overall Study|Other|1|||
150014386|NCT02980133|541184365|FG000|Overall Study|Other than specified|1|||
150014387|NCT02980133|541184366|FG001|Overall Study|Other than specified|1|||
150014388|NCT02980133|541184367|FG002|Overall Study|Other than specified|2|||
150014389|NCT02980133|541184368|FG003|Overall Study|Other than specified|2|||
150014390|NCT02980133|541184365|FG000|Overall Study|Lost to Follow-up|0|||
150014391|NCT02980133|541184366|FG001|Overall Study|Lost to Follow-up|0|||
150014392|NCT02980133|541184367|FG002|Overall Study|Lost to Follow-up|1|||
150014393|NCT02980133|541184368|FG003|Overall Study|Lost to Follow-up|3|||
150014394|NCT02980133|541184365|FG000|Overall Study|Protocol Violation|0|||
150014395|NCT02980133|541184366|FG001|Overall Study|Protocol Violation|1|||
150014396|NCT02980133|541184367|FG002|Overall Study|Protocol Violation|0|||
150014397|NCT02980133|541184368|FG003|Overall Study|Protocol Violation|0|||
150014398|NCT02980133|541184365|FG000|Overall Study|Withdrawal by parent/guardian|6|||
150014399|NCT02980133|541184366|FG001|Overall Study|Withdrawal by parent/guardian|3|||
150014400|NCT02980133|541184367|FG002|Overall Study|Withdrawal by parent/guardian|3|||
150014401|NCT02980133|541184368|FG003|Overall Study|Withdrawal by parent/guardian|1|||
150014402|NCT02980133|541184365|FG000|Overall Study|Withdrawal by Subject|0|||
150014403|NCT02980133|541184366|FG001|Overall Study|Withdrawal by Subject|0|||
150014404|NCT02980133|541184367|FG002|Overall Study|Withdrawal by Subject|1|||
150014405|NCT02980133|541184368|FG003|Overall Study|Withdrawal by Subject|0|||
150014406|NCT01068158|541184374|FG000|Overall Study|Withdrawal by Subject|1|||
150014407|NCT01068158|541184375|FG001|Overall Study|Withdrawal by Subject|2|||
150014408|NCT01068158|541184374|FG000|Overall Study|Lost to Follow-up|7|||
150014409|NCT01068158|541184375|FG001|Overall Study|Lost to Follow-up|0|||
150014410|NCT01068158|541184374|FG000|Overall Study|Protocol Violation|0|||
150014411|NCT01068158|541184375|FG001|Overall Study|Protocol Violation|2|||
150014412|NCT02596945|541184382|FG000|Overall Study|No documentation of study drug dosing|3|||
150014413|NCT02596945|541184382|FG000|Overall Study|Other|32|||
150014414|NCT02596945|541184382|FG000|Overall Study|Change to hemodialysis|15|||
150014415|NCT02596945|541184382|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
150014416|NCT02596945|541184382|FG000|Overall Study|Withdrawal by Subject|1|||
150014417|NCT02596945|541184382|FG000|Overall Study|Missing|1|||
150014418|NCT00238238|541184388|FG000|Overall Study|Withdrawal by Subject|0|||
150014419|NCT00238238|541184389|FG001|Overall Study|Withdrawal by Subject|3|||
150014420|NCT00238238|541184390|FG002|Overall Study|Withdrawal by Subject|0|||
150014421|NCT01007838|541184391|FG000|Overall Study|Withdrawal by Subject|1|||
150014422|NCT01007838|541184392|FG001|Overall Study|Withdrawal by Subject|0|||
150058168|NCT01606878|541353658|FG008|Overall Study|Withdrawal by Subject|2|||
150058169|NCT01606878|541353659|FG009|Overall Study|Withdrawal by Subject|0|||
150058170|NCT01606878|541353660|FG010|Overall Study|Withdrawal by Subject|2|||
150058171|NCT01159431|541353661|FG000|Overall Study|Adverse Event|1|||
150014423|NCT01007838|541184393|FG002|Overall Study|Withdrawal by Subject|0|||
150014424|NCT01007838|541184394|FG003|Overall Study|Withdrawal by Subject|0|||
150058172|NCT01159431|541353662|FG001|Overall Study|Adverse Event|2|||
150014425|NCT01007838|541184391|FG000|Overall Study|Physician Decision|1|||
150014426|NCT01007838|541184392|FG001|Overall Study|Physician Decision|0|||
150014427|NCT01007838|541184393|FG002|Overall Study|Physician Decision|0|||
150014428|NCT01007838|541184394|FG003|Overall Study|Physician Decision|0|||
150014429|NCT01007838|541184391|FG000|Overall Study|Started home haemodialysis|1|||
150014430|NCT01007838|541184392|FG001|Overall Study|Started home haemodialysis|0|||
150014431|NCT01007838|541184393|FG002|Overall Study|Started home haemodialysis|0|||
150014432|NCT01007838|541184394|FG003|Overall Study|Started home haemodialysis|0|||
150014433|NCT02277119|541184398|FG000|Overall Study|Lack of Efficacy|1|||
150014434|NCT02277119|541184399|FG001|Overall Study|Lack of Efficacy|1|||
150014435|NCT02277119|541184400|FG002|Overall Study|Lack of Efficacy|1|||
150014436|NCT02277119|541184398|FG000|Overall Study|Protocol Violation|2|||
150014437|NCT02277119|541184399|FG001|Overall Study|Protocol Violation|3|||
150014438|NCT02277119|541184400|FG002|Overall Study|Protocol Violation|7|||
150014439|NCT04699461|541184401|FG000|Overall Study|Withdrawal by Subject|1|||
150014440|NCT04699461|541184402|FG001|Overall Study|Withdrawal by Subject|0|||
150014441|NCT04699461|541184401|FG000|Overall Study|Study termination by sponsor|2|||
150014442|NCT04699461|541184402|FG001|Overall Study|Study termination by sponsor|1|||
150014443|NCT04699461|541184401|FG000|Overall Study|Death|1|||
150014444|NCT04699461|541184402|FG001|Overall Study|Death|0|||
150014445|NCT04699461|541184401|FG000|Overall Study|Radiographic progression|0|||
150014446|NCT04699461|541184402|FG001|Overall Study|Radiographic progression|1|||
150014447|NCT02478255|541184403|FG000|Overall Study|Physician Decision|6|||
150014448|NCT02478255|541184404|FG001|Overall Study|Physician Decision|0|||
150014449|NCT02478255|541184403|FG000|Overall Study|Withdrawal by Subject|2|||
150014450|NCT02478255|541184404|FG001|Overall Study|Withdrawal by Subject|0|||
150014451|NCT03068767|541184410|FG000|Overall Study|Lost to Follow-up|7|||
150014452|NCT03068767|541184411|FG001|Overall Study|Lost to Follow-up|3|||
150014453|NCT03068767|541184410|FG000|Overall Study|Protocol Violation|3|||
150014454|NCT03068767|541184411|FG001|Overall Study|Protocol Violation|0|||
150014455|NCT01730586|541184412|FG000|Overall Study|Progressive Disease|2|||
150014456|NCT01730586|541184412|FG000|Overall Study|Inadequate Trial|8|||
150014457|NCT01730586|541184412|FG000|Overall Study|Adverse Event|2|||
150014458|NCT01730586|541184412|FG000|Overall Study|Hospice|1|||
150014459|NCT01431963|541184413|FG000|Overall Study|Adverse Event|18|||
150014460|NCT01431963|541184413|FG000|Overall Study|Lack of Efficacy|7|||
150014461|NCT01431963|541184413|FG000|Overall Study|Protocol Violation|1|||
150014462|NCT01431963|541184413|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
150014463|NCT01431963|541184413|FG000|Overall Study|Physician Decision|4|||
150014464|NCT01431963|541184413|FG000|Overall Study|Withdrawal by Subject|3|||
150014465|NCT03077919|541186875|FG000|Overall Study|Lost to Follow-up|4|||
150014466|NCT03077919|541186876|FG001|Overall Study|Lost to Follow-up|1|||
150014467|NCT03738618|541186877|FG000|Overall Study|Protocol deviation|23|||
150014468|NCT03738618|541186878|FG001|Overall Study|Protocol deviation|0|||
150014469|NCT03738618|541186877|FG000|Overall Study|Adverse Event|4|||
150014470|NCT03738618|541186878|FG001|Overall Study|Adverse Event|0|||
150014471|NCT03738618|541186877|FG000|Overall Study|Lost to Follow-up|2|||
150014472|NCT03738618|541186878|FG001|Overall Study|Lost to Follow-up|0|||
150014473|NCT03738618|541186877|FG000|Overall Study|Randomization failure|1|||
150014474|NCT03738618|541186878|FG001|Overall Study|Randomization failure|0|||
150014475|NCT03738618|541186877|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
150014476|NCT03738618|541186878|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
150014477|NCT03738618|541186877|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
150014478|NCT03738618|541186878|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
150014479|NCT00826618|541186879|FG000|Overall Study|Withdrawal by Subject|1|||
150014480|NCT03499314|541186882|FG000|Overall Study|Time Commitment|1|||
150014481|NCT03499314|541186883|FG001|Overall Study|Time Commitment|2|||
150014482|NCT03499314|541186882|FG000|Overall Study|Medical issue unrelated to research study|1|||
150014483|NCT03499314|541186883|FG001|Overall Study|Medical issue unrelated to research study|1|||
150014484|NCT01618695|541186884|FG000|Core Phase|Adverse Event|4|||
150014485|NCT01618695|541186885|FG001|Core Phase|Adverse Event|5|||
150014486|NCT01618695|541186886|FG002|Core Phase|Adverse Event|15|||
150014487|NCT01618695|541186887|FG003|Core Phase|Adverse Event|20|||
150014488|NCT01618695|541186884|FG000|Core Phase|Lost to Follow-up|0|||
150014489|NCT01618695|541186885|FG001|Core Phase|Lost to Follow-up|0|||
150014490|NCT01618695|541186886|FG002|Core Phase|Lost to Follow-up|1|||
150014491|NCT01618695|541186887|FG003|Core Phase|Lost to Follow-up|0|||
150014492|NCT01618695|541186884|FG000|Core Phase|Withdrawal by Subject|16|||
150014493|NCT01618695|541186885|FG001|Core Phase|Withdrawal by Subject|11|||
150058173|NCT01159431|541353661|FG000|Overall Study|non-compliance|1|||
150058174|NCT01159431|541353662|FG001|Overall Study|non-compliance|1|||
150058175|NCT01159431|541353661|FG000|Overall Study|Lack of Efficacy|0|||
150058176|NCT01159431|541353662|FG001|Overall Study|Lack of Efficacy|3|||
150058177|NCT03353740|541353663|FG000|Overall Study|Images for these participants not viable|52|||
150014494|NCT01618695|541186886|FG002|Core Phase|Withdrawal by Subject|9|||
150014495|NCT01618695|541186887|FG003|Core Phase|Withdrawal by Subject|13|||
150014496|NCT01618695|541186884|FG000|Core Phase|Pregnancy|2|||
150014497|NCT01618695|541186885|FG001|Core Phase|Pregnancy|0|||
150014498|NCT01618695|541186886|FG002|Core Phase|Pregnancy|0|||
150014499|NCT01618695|541186887|FG003|Core Phase|Pregnancy|0|||
150014500|NCT01618695|541186884|FG000|Core Phase|Lack of Efficacy|1|||
150014501|NCT01618695|541186885|FG001|Core Phase|Lack of Efficacy|2|||
150014502|NCT01618695|541186886|FG002|Core Phase|Lack of Efficacy|1|||
150014503|NCT01618695|541186887|FG003|Core Phase|Lack of Efficacy|1|||
150014504|NCT01618695|541186884|FG000|Core Phase|Other than specified|1|||
150014505|NCT01618695|541186885|FG001|Core Phase|Other than specified|2|||
150014506|NCT01618695|541186886|FG002|Core Phase|Other than specified|2|||
150014507|NCT01618695|541186887|FG003|Core Phase|Other than specified|2|||
150014508|NCT01618695|541186884|FG000|Core Phase|Not treated|1|||
150014509|NCT01618695|541186885|FG001|Core Phase|Not treated|0|||
150014510|NCT01618695|541186886|FG002|Core Phase|Not treated|2|||
150014511|NCT01618695|541186887|FG003|Core Phase|Not treated|0|||
150014512|NCT01618695|541186884|FG000|Extension Phase|Lack of Efficacy|17|||
150014513|NCT01618695|541186885|FG001|Extension Phase|Lack of Efficacy|33|||
150014514|NCT01618695|541186886|FG002|Extension Phase|Lack of Efficacy|26|||
150014515|NCT01618695|541186887|FG003|Extension Phase|Lack of Efficacy|24|||
150014516|NCT01618695|541186884|FG000|Extension Phase|Pregnancy|2|||
150014517|NCT01618695|541186885|FG001|Extension Phase|Pregnancy|0|||
150014518|NCT01618695|541186886|FG002|Extension Phase|Pregnancy|1|||
150014519|NCT01618695|541186887|FG003|Extension Phase|Pregnancy|1|||
150014520|NCT01618695|541186884|FG000|Extension Phase|Withdrawal by Subject|43|||
150014521|NCT01618695|541186885|FG001|Extension Phase|Withdrawal by Subject|48|||
150014522|NCT01618695|541186886|FG002|Extension Phase|Withdrawal by Subject|42|||
150014523|NCT01618695|541186887|FG003|Extension Phase|Withdrawal by Subject|33|||
150014524|NCT01618695|541186884|FG000|Extension Phase|Adverse Event|18|||
150014525|NCT01618695|541186885|FG001|Extension Phase|Adverse Event|16|||
150014526|NCT01618695|541186886|FG002|Extension Phase|Adverse Event|9|||
150014527|NCT01618695|541186887|FG003|Extension Phase|Adverse Event|20|||
150014528|NCT01618695|541186884|FG000|Extension Phase|Lost to Follow-up|2|||
150014529|NCT01618695|541186885|FG001|Extension Phase|Lost to Follow-up|1|||
150014530|NCT01618695|541186886|FG002|Extension Phase|Lost to Follow-up|1|||
150014531|NCT01618695|541186887|FG003|Extension Phase|Lost to Follow-up|1|||
150014532|NCT01618695|541186884|FG000|Extension Phase|Other than specified|13|||
150014533|NCT01618695|541186885|FG001|Extension Phase|Other than specified|18|||
150014534|NCT01618695|541186886|FG002|Extension Phase|Other than specified|13|||
150014535|NCT01618695|541186887|FG003|Extension Phase|Other than specified|18|||
150014536|NCT00931606|541186891|FG000|Overall Study|Death|1|||
150014537|NCT00931606|541186892|FG001|Overall Study|Death|3|||
150014538|NCT00931606|541186893|FG002|Overall Study|Death|2|||
150014539|NCT00931606|541186894|FG003|Overall Study|Death|0|||
150014540|NCT00931606|541186891|FG000|Overall Study|Lost to Follow-up|0|||
150014541|NCT00931606|541186892|FG001|Overall Study|Lost to Follow-up|1|||
150014542|NCT00931606|541186893|FG002|Overall Study|Lost to Follow-up|0|||
150014543|NCT00931606|541186894|FG003|Overall Study|Lost to Follow-up|0|||
150014544|NCT00931606|541186891|FG000|Overall Study|Physician Decision|0|||
150014545|NCT00931606|541186892|FG001|Overall Study|Physician Decision|0|||
150014546|NCT00931606|541186893|FG002|Overall Study|Physician Decision|3|||
150014547|NCT00931606|541186894|FG003|Overall Study|Physician Decision|0|||
150014548|NCT00931606|541186891|FG000|Overall Study|Sponsor Decision|1|||
150014549|NCT00931606|541186892|FG001|Overall Study|Sponsor Decision|4|||
150014550|NCT00931606|541186893|FG002|Overall Study|Sponsor Decision|0|||
150014551|NCT00931606|541186894|FG003|Overall Study|Sponsor Decision|2|||
150014552|NCT00931606|541186891|FG000|Overall Study|Withdrawal by Subject|3|||
150014553|NCT00931606|541186892|FG001|Overall Study|Withdrawal by Subject|1|||
150014554|NCT00931606|541186893|FG002|Overall Study|Withdrawal by Subject|1|||
150014555|NCT00931606|541186894|FG003|Overall Study|Withdrawal by Subject|1|||
150014556|NCT00871338|541186895|FG000|Prior to Booster|Withdrawal by Subject|1|||
150014557|NCT00871338|541186896|FG001|Prior to Booster|Withdrawal by Subject|3|||
150014558|NCT00871338|541186895|FG000|Prior to Booster|Lost to Follow-up|1|||
150014559|NCT00871338|541186896|FG001|Prior to Booster|Lost to Follow-up|0|||
150014560|NCT01016600|541186897|FG000|Overall Study|Did not start treatment|1|||
150014561|NCT01016600|541186898|FG001|Overall Study|Did not start treatment|0|||
150014562|NCT01016600|541186899|FG002|Overall Study|Did not start treatment|0|||
150014563|NCT01016600|541186900|FG003|Overall Study|Did not start treatment|0|||
150014564|NCT00872599|541186901|FG000|Second Washout Period|Adverse Event|1|||
150014565|NCT00872599|541186902|FG001|Second Washout Period|Adverse Event|1|||
150014566|NCT04794270|541186903|FG000|Period 1|Non Compliance|1|||
150014567|NCT04794270|541186904|FG001|Period 1|Non Compliance|0|||
150014568|NCT04794270|541186903|FG000|Period 1|Adverse Event|1|||
150014569|NCT04794270|541186904|FG001|Period 1|Adverse Event|0|||
150014570|NCT04794270|541186903|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
150014571|NCT04794270|541186904|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
150014572|NCT00801229|541186907|FG000|Signed Consent|Withdrawal by Subject|2|||
150014573|NCT00801229|541186908|FG001|Signed Consent|Withdrawal by Subject|2|||
150014574|NCT00801229|541186907|FG000|Signed Consent|Found Ineligible|1|||
150014575|NCT00801229|541186908|FG001|Signed Consent|Found Ineligible|1|||
150058178|NCT00604214|541353665|FG000|Baseline to Day 28|Death|223|||
150014576|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
150014577|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
150014578|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
150014579|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
150014580|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
150014581|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
150014582|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
150014583|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
150014584|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
150014585|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
150014586|NCT00801229|541186907|FG000|Received Study Drug/Placebo|Adverse Event|1|||
150014587|NCT00801229|541186908|FG001|Received Study Drug/Placebo|Adverse Event|1|||
150014588|NCT03826186|541186909|FG000|Overall Study|Protocol Violation|2|||
150014589|NCT03826186|541186910|FG001|Overall Study|Protocol Violation|0|||
150014590|NCT03826186|541186909|FG000|Overall Study|Withdrawal by Subject|1|||
150014591|NCT03826186|541186910|FG001|Overall Study|Withdrawal by Subject|0|||
150014592|NCT02510001|541186913|FG000|Overall Study|Early disease progression|0|||
150014593|NCT02510001|541186914|FG001|Overall Study|Early disease progression|0|||
150058179|NCT00604214|541353666|FG001|Baseline to Day 28|Death|202|||
150058180|NCT00604214|541353665|FG000|Baseline to Day 28|Lost to Follow-up|2|||
150058181|NCT00604214|541353666|FG001|Baseline to Day 28|Lost to Follow-up|4|||
150058182|NCT00604214|541353665|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
150058183|NCT00604214|541353666|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
150058184|NCT00604214|541353665|FG000|Day 29 to Day 90|Death|64|||
150058185|NCT00604214|541353666|FG001|Day 29 to Day 90|Death|67|||
150181218|NCT05052996|541801025|FG003|Overall Study|Cohort terminated by sponsor|0|||
150181219|NCT05052996|541801022|FG000|Overall Study|Withdrew consent|1|||
150181220|NCT05052996|541801023|FG001|Overall Study|Withdrew consent|0|||
150181221|NCT05052996|541801024|FG002|Overall Study|Withdrew consent|1|||
150181222|NCT05052996|541801025|FG003|Overall Study|Withdrew consent|2|||
150181223|NCT05052996|541801022|FG000|Overall Study|Lost to Follow-up|1|||
150181224|NCT05052996|541801023|FG001|Overall Study|Lost to Follow-up|0|||
150181225|NCT05052996|541801024|FG002|Overall Study|Lost to Follow-up|0|||
150181226|NCT05052996|541801025|FG003|Overall Study|Lost to Follow-up|2|||
150181227|NCT05052996|541801022|FG000|Overall Study|Adverse Event|0|||
150181228|NCT05052996|541801023|FG001|Overall Study|Adverse Event|0|||
150181229|NCT05052996|541801024|FG002|Overall Study|Adverse Event|2|||
150181230|NCT05052996|541801025|FG003|Overall Study|Adverse Event|0|||
150181231|NCT05052996|541801022|FG000|Overall Study|Randomized but never treated|0|||
150181232|NCT05052996|541801023|FG001|Overall Study|Randomized but never treated|0|||
150181233|NCT05052996|541801024|FG002|Overall Study|Randomized but never treated|1|||
150181234|NCT05052996|541801025|FG003|Overall Study|Randomized but never treated|1|||
150181235|NCT05052996|541801022|FG000|Overall Study|Protocol Violation|1|||
150181236|NCT05052996|541801023|FG001|Overall Study|Protocol Violation|0|||
150181237|NCT05052996|541801024|FG002|Overall Study|Protocol Violation|0|||
150181238|NCT05052996|541801025|FG003|Overall Study|Protocol Violation|0|||
150181239|NCT04149002|541801026|FG000|Overall Study|Lost to Follow-up|1|||
150181240|NCT04149002|541801027|FG001|Overall Study|Lost to Follow-up|0|||
150181241|NCT04149002|541801026|FG000|Overall Study|Withdrawal by Subject|1|||
150181242|NCT04149002|541801027|FG001|Overall Study|Withdrawal by Subject|0|||
150181243|NCT04704284|541801028|FG000|Overall Study|Withdrawal by Subject|1|||
150181244|NCT01736215|541801031|FG000|Overall Study|Early termination of erythropoietin use|1|||
150181245|NCT01736215|541801031|FG000|Overall Study|Adverse Event|4|||
150181246|NCT01736215|541801031|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
150181247|NCT01736215|541801031|FG000|Overall Study|Insufficient data to perform analysis|8|||
150181248|NCT03447249|541801033|FG000|Overall Study|Adverse Event|1|||
150181249|NCT03447249|541801034|FG001|Overall Study|Adverse Event|0|||
150181250|NCT03447249|541801033|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
150181251|NCT03447249|541801034|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
150181252|NCT03447249|541801033|FG000|Overall Study|Other|3|||
150181253|NCT03447249|541801034|FG001|Overall Study|Other|0|||
150181254|NCT00988858|541801035|FG000|Overall Study|Adverse Event|7|||
150181255|NCT00988858|541801035|FG000|Overall Study|Death|1|||
150058186|NCT00604214|541353665|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
150058187|NCT00604214|541353666|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
150058188|NCT00604214|541353665|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
150058189|NCT00604214|541353666|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
150058190|NCT00604214|541353665|FG000|Day 91 to Day 180|Death|19|||
150058191|NCT00604214|541353666|FG001|Day 91 to Day 180|Death|23|||
150058192|NCT00604214|541353665|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
150181256|NCT00988858|541801035|FG000|Overall Study|Physician Decision|1|||
150181257|NCT00988858|541801035|FG000|Overall Study|Sponsor Decision|1|||
150181258|NCT02238483|541801036|FG000|Overall Study|Withdrawal by Subject|2|||
150014594|NCT02510001|541186915|FG002|Overall Study|Early disease progression|0|||
150014595|NCT02510001|541186916|FG003|Overall Study|Early disease progression|1|||
150058193|NCT00604214|541353666|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
150058194|NCT00604214|541353665|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
150181259|NCT02238483|541801037|FG001|Overall Study|Withdrawal by Subject|7|||
150181260|NCT02238483|541801036|FG000|Overall Study|Lost to Follow-up|1|||
150181261|NCT02238483|541801037|FG001|Overall Study|Lost to Follow-up|1|||
150181262|NCT02238483|541801036|FG000|Overall Study|Protocol Violation|1|||
150014596|NCT02510001|541186917|FG004|Overall Study|Early disease progression|1|||
150014597|NCT02510001|541186918|FG005|Overall Study|Early disease progression|1|||
150014598|NCT02510001|541186919|FG006|Overall Study|Early disease progression|0|||
150014599|NCT02510001|541186920|FG007|Overall Study|Early disease progression|0|||
150014600|NCT02510001|541186913|FG000|Overall Study|Adverse Event|0|||
150014601|NCT02510001|541186914|FG001|Overall Study|Adverse Event|0|||
150014602|NCT02510001|541186915|FG002|Overall Study|Adverse Event|0|||
150014603|NCT02510001|541186916|FG003|Overall Study|Adverse Event|1|||
150014604|NCT02510001|541186917|FG004|Overall Study|Adverse Event|2|||
150014605|NCT02510001|541186918|FG005|Overall Study|Adverse Event|1|||
150014606|NCT02510001|541186919|FG006|Overall Study|Adverse Event|2|||
150014607|NCT02510001|541186920|FG007|Overall Study|Adverse Event|5|||
150014608|NCT02510001|541186913|FG000|Overall Study|Physician Decision|0|||
150014609|NCT02510001|541186914|FG001|Overall Study|Physician Decision|0|||
150014610|NCT02510001|541186915|FG002|Overall Study|Physician Decision|0|||
150014611|NCT02510001|541186916|FG003|Overall Study|Physician Decision|0|||
150014612|NCT02510001|541186917|FG004|Overall Study|Physician Decision|1|||
150014613|NCT02510001|541186918|FG005|Overall Study|Physician Decision|0|||
150014614|NCT02510001|541186919|FG006|Overall Study|Physician Decision|0|||
150014615|NCT02510001|541186920|FG007|Overall Study|Physician Decision|0|||
150014616|NCT02510001|541186913|FG000|Overall Study|Withdrawal by Subject|0|||
150014617|NCT02510001|541186914|FG001|Overall Study|Withdrawal by Subject|0|||
150014618|NCT02510001|541186915|FG002|Overall Study|Withdrawal by Subject|0|||
150014619|NCT02510001|541186916|FG003|Overall Study|Withdrawal by Subject|0|||
150014620|NCT02510001|541186917|FG004|Overall Study|Withdrawal by Subject|0|||
150014621|NCT02510001|541186918|FG005|Overall Study|Withdrawal by Subject|0|||
150014622|NCT02510001|541186919|FG006|Overall Study|Withdrawal by Subject|0|||
150014623|NCT02510001|541186920|FG007|Overall Study|Withdrawal by Subject|2|||
150014624|NCT01357551|541186939|FG000|Overall Study|Withdrawal by Subject|6|||
150014625|NCT01357551|541186940|FG001|Overall Study|Withdrawal by Subject|4|||
150014626|NCT01357551|541186939|FG000|Overall Study|Death|0|||
150014627|NCT01357551|541186940|FG001|Overall Study|Death|1|||
150014628|NCT01357551|541186939|FG000|Overall Study|Lost to Follow-up|16|||
150014629|NCT01357551|541186940|FG001|Overall Study|Lost to Follow-up|6|||
150181263|NCT02238483|541801037|FG001|Overall Study|Protocol Violation|2|||
150181264|NCT02238483|541801036|FG000|Overall Study|Death|1|||
150181265|NCT02238483|541801037|FG001|Overall Study|Death|0|||
150181266|NCT02238483|541801036|FG000|Overall Study|Adverse Event|7|||
150181267|NCT02238483|541801037|FG001|Overall Study|Adverse Event|3|||
150181268|NCT02238483|541801036|FG000|Overall Study|Withdrawn due to physician decision|1|||
150181269|NCT02238483|541801037|FG001|Overall Study|Withdrawn due to physician decision|0|||
150181270|NCT02238483|541801036|FG000|Overall Study|Completion status not recorded|1|||
150181271|NCT02238483|541801037|FG001|Overall Study|Completion status not recorded|1|||
150014630|NCT02219334|541186942|FG000|Overall Study|Withdrawal by Subject|1|||
150014631|NCT02219334|541186943|FG001|Overall Study|Withdrawal by Subject|0|||
150058195|NCT00604214|541353666|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
150058196|NCT00853970|541353673|FG000|Overall Study|Withdrawal by Subject|2|||
150058197|NCT00853970|541353674|FG001|Overall Study|Withdrawal by Subject|1|||
150058198|NCT00853970|541353673|FG000|Overall Study|Cancelled surgery|4|||
150058199|NCT00853970|541353674|FG001|Overall Study|Cancelled surgery|2|||
150181272|NCT02238483|541801036|FG000|Overall Study|Illness in family member|1|||
150181273|NCT02238483|541801037|FG001|Overall Study|Illness in family member|0|||
150181274|NCT00390299|541801038|FG000|Overall Study|Cancellation|1|||
150181275|NCT00390299|541801039|FG001|Overall Study|Cancellation|0|||
150181276|NCT00390299|541801040|FG002|Overall Study|Cancellation|0|||
150181277|NCT00390299|541801041|FG003|Overall Study|Cancellation|0|||
150181278|NCT00390299|541801042|FG004|Overall Study|Cancellation|0|||
150181279|NCT00331136|541801046|FG000|Overall Study|Adverse Event|3|||
150181280|NCT00331136|541801047|FG001|Overall Study|Adverse Event|5|||
150181281|NCT00331136|541801048|FG002|Overall Study|Adverse Event|0|||
150181282|NCT00331136|541801049|FG003|Overall Study|Adverse Event|1|||
150014632|NCT02219334|541186942|FG000|Overall Study|Protocol Violation|7|||
150181283|NCT00331136|541801046|FG000|Overall Study|Withdrawal by Subject|0|||
150181284|NCT00331136|541801047|FG001|Overall Study|Withdrawal by Subject|1|||
150181285|NCT00331136|541801048|FG002|Overall Study|Withdrawal by Subject|0|||
150014633|NCT02219334|541186943|FG001|Overall Study|Protocol Violation|3|||
150014634|NCT05362058|541186944|FG000|Treatment Period|Adverse Event|3|||
150181286|NCT00331136|541801049|FG003|Overall Study|Withdrawal by Subject|0|||
150014635|NCT05362058|541186945|FG001|Treatment Period|Adverse Event|3|||
150014636|NCT05362058|541186944|FG000|Treatment Period|Assigned treatment by mistake|3|||
150014637|NCT05362058|541186945|FG001|Treatment Period|Assigned treatment by mistake|4|||
150014638|NCT05362058|541186944|FG000|Treatment Period|Death|1|||
150014639|NCT05362058|541186945|FG001|Treatment Period|Death|1|||
150014640|NCT05362058|541186944|FG000|Treatment Period|Lost to Follow-up|6|||
150181287|NCT00331136|541801046|FG000|Overall Study|Lost to Follow-up|0|||
150181288|NCT00331136|541801047|FG001|Overall Study|Lost to Follow-up|1|||
150181289|NCT00331136|541801048|FG002|Overall Study|Lost to Follow-up|0|||
150181290|NCT00331136|541801049|FG003|Overall Study|Lost to Follow-up|0|||
150181291|NCT00331136|541801046|FG000|Overall Study|Protocol Violation|1|||
150181292|NCT00331136|541801047|FG001|Overall Study|Protocol Violation|0|||
150181293|NCT00331136|541801048|FG002|Overall Study|Protocol Violation|0|||
150181294|NCT00331136|541801049|FG003|Overall Study|Protocol Violation|0|||
150181295|NCT00331136|541801046|FG000|Overall Study|Not treated|1|||
150181296|NCT00331136|541801047|FG001|Overall Study|Not treated|0|||
150181297|NCT00331136|541801048|FG002|Overall Study|Not treated|0|||
150014641|NCT05362058|541186945|FG001|Treatment Period|Lost to Follow-up|3|||
150014642|NCT05362058|541186944|FG000|Treatment Period|Non-compliance with study drug|0|||
150014643|NCT05362058|541186945|FG001|Treatment Period|Non-compliance with study drug|1|||
150014644|NCT05362058|541186944|FG000|Treatment Period|Physician Decision|1|||
150014645|NCT05362058|541186945|FG001|Treatment Period|Physician Decision|0|||
150014646|NCT05362058|541186944|FG000|Treatment Period|Protocol deviation|1|||
150014647|NCT05362058|541186945|FG001|Treatment Period|Protocol deviation|0|||
150014648|NCT05362058|541186944|FG000|Treatment Period|Withdrawal by Subject|10|||
150014649|NCT05362058|541186945|FG001|Treatment Period|Withdrawal by Subject|11|||
150014650|NCT05362058|541186944|FG000|Follow-Up Period|Death|1|||
150014651|NCT05362058|541186945|FG001|Follow-Up Period|Death|0|||
150014652|NCT05362058|541186944|FG000|Follow-Up Period|Lost to Follow-up|2|||
150014653|NCT05362058|541186945|FG001|Follow-Up Period|Lost to Follow-up|1|||
150014654|NCT05362058|541186944|FG000|Follow-Up Period|Protocol deviation|1|||
150014655|NCT05362058|541186945|FG001|Follow-Up Period|Protocol deviation|1|||
150014656|NCT05362058|541186944|FG000|Follow-Up Period|Withdrawal by Subject|0|||
150014657|NCT05362058|541186945|FG001|Follow-Up Period|Withdrawal by Subject|3|||
150014658|NCT00711971|541186947|FG000|Overall Study|Lost to Follow-up|3|||
150014659|NCT00711971|541186948|FG001|Overall Study|Lost to Follow-up|4|||
150014660|NCT00711971|541186949|FG002|Overall Study|Lost to Follow-up|1|||
150014661|NCT03704688|541186952|FG000|Overall Study|Adverse Event|0|||
150014662|NCT03704688|541186953|FG001|Overall Study|Adverse Event|0|||
150014663|NCT03704688|541186954|FG002|Overall Study|Adverse Event|0|||
150014664|NCT03704688|541186955|FG003|Overall Study|Adverse Event|4|||
150014665|NCT03704688|541186956|FG004|Overall Study|Adverse Event|1|||
150014666|NCT03704688|541186957|FG005|Overall Study|Adverse Event|0|||
150014667|NCT03704688|541186952|FG000|Overall Study|Disease Progression|0|||
150014668|NCT03704688|541186953|FG001|Overall Study|Disease Progression|0|||
150014669|NCT03704688|541186954|FG002|Overall Study|Disease Progression|0|||
150014670|NCT03704688|541186955|FG003|Overall Study|Disease Progression|3|||
150014671|NCT03704688|541186956|FG004|Overall Study|Disease Progression|1|||
150014672|NCT03704688|541186957|FG005|Overall Study|Disease Progression|0|||
150014673|NCT03704688|541186952|FG000|Overall Study|Death|0|||
150014674|NCT03704688|541186953|FG001|Overall Study|Death|0|||
150014675|NCT03704688|541186954|FG002|Overall Study|Death|0|||
150014676|NCT03704688|541186955|FG003|Overall Study|Death|0|||
150014677|NCT03704688|541186956|FG004|Overall Study|Death|3|||
150014678|NCT03704688|541186957|FG005|Overall Study|Death|0|||
150014679|NCT04774926|541186959|FG000|Overall Study|Adverse Event|15|||
150014680|NCT04774926|541186959|FG000|Overall Study|Lost to Follow-up|3|||
150014681|NCT04774926|541186959|FG000|Overall Study|Physician Decision|6|||
150014682|NCT04774926|541186959|FG000|Overall Study|Withdrawal by Subject|3|||
150014683|NCT04774926|541186959|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
150014684|NCT00787189|541186960|FG000|Overall Study|Lost to Follow-up|2|||
150014685|NCT00787189|541186961|FG001|Overall Study|Lost to Follow-up|2|||
150014686|NCT01068769|541186964|FG000|Overall Study|Ineligible|1|||
150014687|NCT02524158|541186969|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
150014688|NCT02524158|541186970|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
150014689|NCT02524158|541186969|FG000|12-weeks Assessment|Lost to Follow-up|18|||
150014690|NCT02524158|541186970|FG001|12-weeks Assessment|Lost to Follow-up|12|||
150014691|NCT02524158|541186969|FG000|6-month Assessment|Withdrawal by Subject|1|||
150014692|NCT02524158|541186970|FG001|6-month Assessment|Withdrawal by Subject|1|||
150014693|NCT02524158|541186969|FG000|6-month Assessment|Lost to Follow-up|21|||
150014694|NCT02524158|541186970|FG001|6-month Assessment|Lost to Follow-up|20|||
150014695|NCT03671304|541186971|FG000|Overall Study|study terminated|7|||
150014696|NCT00596830|541186972|FG000|Overall Study|Death|258|||
150014697|NCT00596830|541186973|FG001|Overall Study|Death|247|||
150014698|NCT00596830|541186972|FG000|Overall Study|Lost to Follow-up|7|||
150014699|NCT00596830|541186973|FG001|Overall Study|Lost to Follow-up|11|||
150181298|NCT00331136|541801049|FG003|Overall Study|Not treated|0|||
150181299|NCT02692417|541801050|FG000|Overall Study|Withdrawal by Subject|5|||
150181300|NCT02692417|541801051|FG001|Overall Study|Withdrawal by Subject|1|||
150014700|NCT00596830|541186972|FG000|Overall Study|Withdrawal by Subject|22|||
150014701|NCT00596830|541186973|FG001|Overall Study|Withdrawal by Subject|12|||
150014702|NCT00596830|541186972|FG000|Overall Study|Study terminated by sponsor|51|||
150181301|NCT02692417|541801050|FG000|Overall Study|Adverse Event|1|||
150014703|NCT00596830|541186973|FG001|Overall Study|Study terminated by sponsor|62|||
150014704|NCT00596830|541186972|FG000|Overall Study|Follow-up was discontinued|1|||
150014705|NCT00596830|541186973|FG001|Overall Study|Follow-up was discontinued|0|||
150014706|NCT00596830|541186972|FG000|Overall Study|Randomized but not treated|3|||
150181302|NCT02692417|541801051|FG001|Overall Study|Adverse Event|0|||
150181303|NCT00393484|541801055|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
150181304|NCT00393484|541801056|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
150014707|NCT00596830|541186973|FG001|Overall Study|Randomized but not treated|7|||
150014708|NCT00887926|541186976|FG000|Overall Study|Withdrawal by Subject|0|||
150014709|NCT00887926|541186977|FG001|Overall Study|Withdrawal by Subject|1|||
150014710|NCT00887926|541186978|FG002|Overall Study|Withdrawal by Subject|0|||
150014711|NCT00887926|541186979|FG003|Overall Study|Withdrawal by Subject|0|||
150014712|NCT02097030|541186980|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
150014713|NCT02097030|541186981|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
150014714|NCT02097030|541186980|FG000|First Intervention (3 Days)|Visual Acuity|0|||
150014715|NCT02097030|541186981|FG001|First Intervention (3 Days)|Visual Acuity|1|||
150014716|NCT00844558|541186986|FG000|Overall Study|Withdrawal by Subject|9|||
150014717|NCT00844558|541186987|FG001|Overall Study|Withdrawal by Subject|2|||
150014718|NCT00844558|541186986|FG000|Overall Study|Death|1|||
150014719|NCT00844558|541186987|FG001|Overall Study|Death|0|||
150014720|NCT00844558|541186986|FG000|Overall Study|Protocol Violation|1|||
150014721|NCT00844558|541186987|FG001|Overall Study|Protocol Violation|1|||
150014722|NCT00844558|541186986|FG000|Overall Study|Lost to Follow-up|0|||
150058200|NCT01397825|541355334|FG000|Overall Study|Progressive Disease|10|||
150058201|NCT01397825|541355335|FG001|Overall Study|Progressive Disease|3|||
150058202|NCT01397825|541355336|FG002|Overall Study|Progressive Disease|11|||
150058203|NCT01397825|541355337|FG003|Overall Study|Progressive Disease|1|||
150014723|NCT00844558|541186987|FG001|Overall Study|Lost to Follow-up|1|||
150014724|NCT00844558|541186986|FG000|Overall Study|Physician Decision|1|||
150014725|NCT00844558|541186987|FG001|Overall Study|Physician Decision|0|||
150014726|NCT00588094|541186988|FG000|Overall Study|Adverse Event|3|||
150058204|NCT01397825|541355338|FG004|Overall Study|Progressive Disease|0|||
150058205|NCT01397825|541355334|FG000|Overall Study|Symptomatic Deterioration|2|||
150058206|NCT01397825|541355335|FG001|Overall Study|Symptomatic Deterioration|0|||
150058207|NCT01397825|541355336|FG002|Overall Study|Symptomatic Deterioration|4|||
150058208|NCT01397825|541355337|FG003|Overall Study|Symptomatic Deterioration|0|||
150058209|NCT01397825|541355338|FG004|Overall Study|Symptomatic Deterioration|0|||
150058210|NCT01397825|541355334|FG000|Overall Study|Adverse Event|0|||
150058211|NCT01397825|541355335|FG001|Overall Study|Adverse Event|1|||
150058212|NCT01397825|541355336|FG002|Overall Study|Adverse Event|5|||
150058213|NCT01397825|541355337|FG003|Overall Study|Adverse Event|1|||
150058214|NCT01397825|541355338|FG004|Overall Study|Adverse Event|0|||
150058215|NCT01397825|541355334|FG000|Overall Study|Withdrawal by Subject|1|||
150058216|NCT01397825|541355335|FG001|Overall Study|Withdrawal by Subject|0|||
150058217|NCT01397825|541355336|FG002|Overall Study|Withdrawal by Subject|5|||
150058218|NCT01397825|541355337|FG003|Overall Study|Withdrawal by Subject|1|||
150058219|NCT01397825|541355338|FG004|Overall Study|Withdrawal by Subject|0|||
150058220|NCT01931670|541355339|FG000|Treatment Period|Exclusionary Medication Received|1|||
150058221|NCT01931670|541355340|FG001|Treatment Period|Exclusionary Medication Received|1|||
150058222|NCT01931670|541355341|FG002|Treatment Period|Exclusionary Medication Received|1|||
150058223|NCT01931670|541355339|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
150058224|NCT01931670|541355340|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
150058225|NCT01931670|541355341|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
150058226|NCT01931670|541355339|FG000|Treatment Period|Subject Noncompliant|4|||
150058227|NCT01931670|541355340|FG001|Treatment Period|Subject Noncompliant|9|||
150058228|NCT01931670|541355341|FG002|Treatment Period|Subject Noncompliant|5|||
150058229|NCT01931670|541355339|FG000|Treatment Period|Adverse Event|19|||
150058230|NCT01931670|541355340|FG001|Treatment Period|Adverse Event|8|||
150058231|NCT01931670|541355341|FG002|Treatment Period|Adverse Event|21|||
150058232|NCT01931670|541355339|FG000|Treatment Period|Lack of Efficacy|11|||
150058233|NCT01931670|541355340|FG001|Treatment Period|Lack of Efficacy|2|||
150058234|NCT01931670|541355341|FG002|Treatment Period|Lack of Efficacy|2|||
150058235|NCT01931670|541355339|FG000|Treatment Period|Pregnancy|7|||
150058236|NCT01931670|541355340|FG001|Treatment Period|Pregnancy|2|||
150014727|NCT00588094|541186988|FG000|Overall Study|Progression of Disease|2|||
150014728|NCT02951429|541186995|FG000|Overall Study|Adverse Event|3|||
150058237|NCT01931670|541355341|FG002|Treatment Period|Pregnancy|0|||
150058238|NCT01931670|541355339|FG000|Treatment Period|Other|8|||
150058239|NCT01931670|541355340|FG001|Treatment Period|Other|7|||
150058240|NCT01931670|541355341|FG002|Treatment Period|Other|2|||
150014729|NCT02951429|541186996|FG001|Overall Study|Adverse Event|7|||
150014730|NCT02951429|541186995|FG000|Overall Study|Death|28|||
150014731|NCT02951429|541186996|FG001|Overall Study|Death|36|||
150014732|NCT02951429|541186995|FG000|Overall Study|Lack of Efficacy|0|||
150014733|NCT02951429|541186996|FG001|Overall Study|Lack of Efficacy|1|||
150014734|NCT02951429|541186995|FG000|Overall Study|Lost to Follow-up|0|||
150014735|NCT02951429|541186996|FG001|Overall Study|Lost to Follow-up|1|||
150014736|NCT02951429|541186995|FG000|Overall Study|Lung Transplantation|9|||
150014737|NCT02951429|541186996|FG001|Overall Study|Lung Transplantation|6|||
150014738|NCT02951429|541186995|FG000|Overall Study|Other|1|||
150014739|NCT02951429|541186996|FG001|Overall Study|Other|3|||
150014740|NCT02951429|541186995|FG000|Overall Study|Progressive Disease|1|||
150014741|NCT02951429|541186996|FG001|Overall Study|Progressive Disease|1|||
150014742|NCT02951429|541186995|FG000|Overall Study|Withdrawal by Subject|7|||
150014743|NCT02951429|541186996|FG001|Overall Study|Withdrawal by Subject|11|||
150014744|NCT02951429|541186995|FG000|Overall Study|Participant ongoing in the study|23|||
150014745|NCT02951429|541186996|FG001|Overall Study|Participant ongoing in the study|17|||
150014746|NCT01457846|541187004|FG000|Overall Study|Death before treatment|1|||
150014747|NCT01457846|541187005|FG001|Overall Study|Death before treatment|2|||
150014748|NCT01457846|541187004|FG000|Overall Study|Did not receive treatment|0|||
150014749|NCT01457846|541187005|FG001|Overall Study|Did not receive treatment|1|||
150014750|NCT01457846|541187004|FG000|Overall Study|Death|27|||
150014751|NCT01457846|541187005|FG001|Overall Study|Death|16|||
150014752|NCT01457846|541187004|FG000|Overall Study|Unclassified reason for not completed|11|||
150014753|NCT01457846|541187005|FG001|Overall Study|Unclassified reason for not completed|10|||
150014754|NCT01457846|541187004|FG000|Overall Study|Withdrawal by Subject|1|||
150014755|NCT01457846|541187005|FG001|Overall Study|Withdrawal by Subject|1|||
150014756|NCT01457846|541187004|FG000|Overall Study|Lost to Follow-up|1|||
150014757|NCT01457846|541187005|FG001|Overall Study|Lost to Follow-up|0|||
150014758|NCT01846741|541187006|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
150014759|NCT01853878|541187007|FG000|Overall Study|Recurrence|2|||
150014760|NCT01853878|541187008|FG001|Overall Study|Recurrence|0|||
150014761|NCT01853878|541187007|FG000|Overall Study|Adverse Event|2|||
150014762|NCT01853878|541187008|FG001|Overall Study|Adverse Event|0|||
150014763|NCT01853878|541187007|FG000|Overall Study|Withdrawal by Subject|3|||
150014764|NCT01853878|541187008|FG001|Overall Study|Withdrawal by Subject|1|||
150014765|NCT01853878|541187007|FG000|Overall Study|Migrated/moved from the study area|1|||
150014766|NCT01853878|541187008|FG001|Overall Study|Migrated/moved from the study area|0|||
150014767|NCT01853878|541187007|FG000|Overall Study|Other|55|||
150014768|NCT01853878|541187008|FG001|Overall Study|Other|43|||
150014769|NCT00383162|541187009|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
150014770|NCT00383162|541187010|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
150014771|NCT00383162|541187009|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
150014772|NCT00383162|541187010|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
150014773|NCT00383162|541187009|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
150014774|NCT00383162|541187010|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
150014775|NCT00383162|541187009|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
150014776|NCT00383162|541187010|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
150014777|NCT00383162|541187009|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
150014778|NCT00383162|541187010|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
150014779|NCT00383162|541187009|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
150014780|NCT00383162|541187010|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
150014781|NCT00383162|541187009|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
150014782|NCT00383162|541187010|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
150014783|NCT00383162|541187009|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
150014784|NCT00383162|541187010|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
150014785|NCT00383162|541187009|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
150014786|NCT00383162|541187010|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
150014787|NCT00465647|541187015|FG000|Overall Study|Administrative|2|||
150014788|NCT00465647|541187016|FG001|Overall Study|Administrative|2|||
150014789|NCT00465647|541187017|FG002|Overall Study|Administrative|3|||
150014790|NCT00465647|541187018|FG003|Overall Study|Administrative|2|||
150014791|NCT00465647|541187015|FG000|Overall Study|Adverse Event|2|||
150014792|NCT00465647|541187016|FG001|Overall Study|Adverse Event|0|||
150014793|NCT00465647|541187017|FG002|Overall Study|Adverse Event|3|||
150014794|NCT00465647|541187018|FG003|Overall Study|Adverse Event|2|||
150014795|NCT00465647|541187015|FG000|Overall Study|Withdrawal by Subject|1|||
150014796|NCT00465647|541187016|FG001|Overall Study|Withdrawal by Subject|2|||
150014797|NCT00465647|541187017|FG002|Overall Study|Withdrawal by Subject|2|||
150014798|NCT00465647|541187018|FG003|Overall Study|Withdrawal by Subject|7|||
150014799|NCT00465647|541187015|FG000|Overall Study|"The other reasons included loss of IV"|8|||
150014800|NCT00465647|541187016|FG001|Overall Study|"The other reasons included loss of IV"|4|||
150014801|NCT00465647|541187017|FG002|Overall Study|"The other reasons included loss of IV"|3|||
150014802|NCT00465647|541187018|FG003|Overall Study|"The other reasons included loss of IV"|2|||
150014803|NCT03916081|541187019|FG000|Overall Study|Adverse Event|1|||
150014804|NCT03916081|541187020|FG001|Overall Study|Adverse Event|0|||
150014805|NCT03916081|541187021|FG002|Overall Study|Adverse Event|0|||
150014806|NCT03916081|541187019|FG000|Overall Study|Physician Decision|0|||
150014807|NCT03916081|541187020|FG001|Overall Study|Physician Decision|0|||
150014808|NCT03916081|541187021|FG002|Overall Study|Physician Decision|1|||
150014809|NCT03916081|541187019|FG000|Overall Study|Lost to Follow-up|0|||
150014810|NCT03916081|541187020|FG001|Overall Study|Lost to Follow-up|1|||
150014811|NCT03916081|541187021|FG002|Overall Study|Lost to Follow-up|0|||
150014812|NCT03916081|541187019|FG000|Overall Study|Withdrawal by Subject|3|||
150014813|NCT03916081|541187020|FG001|Overall Study|Withdrawal by Subject|0|||
150014814|NCT03916081|541187021|FG002|Overall Study|Withdrawal by Subject|1|||
150014815|NCT03916081|541187019|FG000|Overall Study|Worsening of AD|0|||
150014816|NCT03916081|541187020|FG001|Overall Study|Worsening of AD|0|||
150014817|NCT03916081|541187021|FG002|Overall Study|Worsening of AD|1|||
150014818|NCT01240135|541187022|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
150014819|NCT01240135|541187023|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
150014820|NCT01240135|541187022|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
150014821|NCT01240135|541187023|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
150014822|NCT04038567|541187024|FG000|Overall Study|Lost to Follow-up|6|||
150014823|NCT04038567|541187025|FG001|Overall Study|Lost to Follow-up|4|||
150014824|NCT04038567|541187026|FG002|Overall Study|Lost to Follow-up|5|||
150014825|NCT04038567|541187027|FG003|Overall Study|Lost to Follow-up|4|||
150014826|NCT04038567|541187028|FG004|Overall Study|Lost to Follow-up|6|||
150014827|NCT04038567|541187029|FG005|Overall Study|Lost to Follow-up|4|||
150014828|NCT04038567|541187030|FG006|Overall Study|Lost to Follow-up|4|||
150014829|NCT04038567|541187031|FG007|Overall Study|Lost to Follow-up|1|||
150014830|NCT04038567|541187024|FG000|Overall Study|Withdrawal by Subject|2|||
150014831|NCT04038567|541187025|FG001|Overall Study|Withdrawal by Subject|1|||
150014832|NCT04038567|541187026|FG002|Overall Study|Withdrawal by Subject|1|||
150014833|NCT04038567|541187027|FG003|Overall Study|Withdrawal by Subject|1|||
150014834|NCT04038567|541187028|FG004|Overall Study|Withdrawal by Subject|4|||
150014835|NCT04038567|541187029|FG005|Overall Study|Withdrawal by Subject|1|||
150014836|NCT04038567|541187030|FG006|Overall Study|Withdrawal by Subject|1|||
150014837|NCT04038567|541187031|FG007|Overall Study|Withdrawal by Subject|1|||
150014838|NCT04038567|541187024|FG000|Overall Study|missed survey window|1|||
150014839|NCT04038567|541187025|FG001|Overall Study|missed survey window|2|||
150014840|NCT04038567|541187026|FG002|Overall Study|missed survey window|0|||
150014841|NCT04038567|541187027|FG003|Overall Study|missed survey window|0|||
150014842|NCT04038567|541187028|FG004|Overall Study|missed survey window|1|||
150014843|NCT04038567|541187029|FG005|Overall Study|missed survey window|1|||
150014844|NCT04038567|541187030|FG006|Overall Study|missed survey window|2|||
150014845|NCT04038567|541187031|FG007|Overall Study|missed survey window|2|||
150014846|NCT04038567|541187024|FG000|Overall Study|technical issues|0|||
150014847|NCT04038567|541187025|FG001|Overall Study|technical issues|0|||
150058241|NCT01931670|541355339|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
150058242|NCT01931670|541355340|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
150058243|NCT01931670|541355341|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
150058244|NCT01931670|541355339|FG000|Treatment Period|Lost to Follow-up|19|||
150058245|NCT01931670|541355340|FG001|Treatment Period|Lost to Follow-up|5|||
150058246|NCT01931670|541355341|FG002|Treatment Period|Lost to Follow-up|7|||
150058247|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
150058248|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
150058249|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
150058250|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
150058251|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
150058252|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
150058253|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
150058254|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
150058255|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
150058256|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
150058257|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
150058258|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
150058259|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
150014848|NCT04038567|541187026|FG002|Overall Study|technical issues|0|||
150014849|NCT04038567|541187027|FG003|Overall Study|technical issues|0|||
150014850|NCT04038567|541187028|FG004|Overall Study|technical issues|0|||
150014851|NCT04038567|541187029|FG005|Overall Study|technical issues|0|||
150014852|NCT04038567|541187030|FG006|Overall Study|technical issues|1|||
150014853|NCT04038567|541187031|FG007|Overall Study|technical issues|0|||
150014854|NCT04038567|541187024|FG000|Overall Study|Medical issues (i.e., illness)|0|||
150014855|NCT04038567|541187025|FG001|Overall Study|Medical issues (i.e., illness)|1|||
150181305|NCT00393484|541801055|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
150014856|NCT04038567|541187026|FG002|Overall Study|Medical issues (i.e., illness)|2|||
150014857|NCT04038567|541187027|FG003|Overall Study|Medical issues (i.e., illness)|1|||
150014858|NCT04038567|541187028|FG004|Overall Study|Medical issues (i.e., illness)|1|||
150014859|NCT04038567|541187029|FG005|Overall Study|Medical issues (i.e., illness)|1|||
150014860|NCT04038567|541187030|FG006|Overall Study|Medical issues (i.e., illness)|0|||
150014861|NCT04038567|541187031|FG007|Overall Study|Medical issues (i.e., illness)|0|||
150014862|NCT04038567|541187024|FG000|Overall Study|Death|0|||
150014863|NCT04038567|541187025|FG001|Overall Study|Death|0|||
150014864|NCT04038567|541187026|FG002|Overall Study|Death|0|||
150014865|NCT04038567|541187027|FG003|Overall Study|Death|1|||
150014866|NCT04038567|541187028|FG004|Overall Study|Death|1|||
150014867|NCT04038567|541187029|FG005|Overall Study|Death|0|||
150014868|NCT04038567|541187030|FG006|Overall Study|Death|0|||
150014869|NCT04038567|541187031|FG007|Overall Study|Death|1|||
150014870|NCT02828020|541187046|FG000|Treatment Period|Adverse Event|3|||
150014871|NCT02828020|541187047|FG001|Treatment Period|Adverse Event|1|||
150014872|NCT02828020|541187048|FG002|Treatment Period|Adverse Event|1|||
150014873|NCT02828020|541187046|FG000|Treatment Period|Withdrawal of Consent|10|||
150014874|NCT02828020|541187047|FG001|Treatment Period|Withdrawal of Consent|14|||
150014875|NCT02828020|541187048|FG002|Treatment Period|Withdrawal of Consent|9|||
150014876|NCT02828020|541187046|FG000|Treatment Period|Lost to Follow-up|21|||
150014877|NCT02828020|541187047|FG001|Treatment Period|Lost to Follow-up|24|||
150014878|NCT02828020|541187048|FG002|Treatment Period|Lost to Follow-up|18|||
150014879|NCT02828020|541187046|FG000|Treatment Period|Lack of Qualifying Event|44|||
150014880|NCT02828020|541187047|FG001|Treatment Period|Lack of Qualifying Event|53|||
150014881|NCT02828020|541187048|FG002|Treatment Period|Lack of Qualifying Event|43|||
150058260|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
150058261|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
150058262|NCT01931670|541355339|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
150014882|NCT02828020|541187046|FG000|Treatment Period|Pregnancy|0|||
150014883|NCT02828020|541187047|FG001|Treatment Period|Pregnancy|2|||
150014884|NCT02828020|541187048|FG002|Treatment Period|Pregnancy|0|||
150014885|NCT02828020|541187046|FG000|Treatment Period|Protocol Violation|2|||
150014886|NCT02828020|541187047|FG001|Treatment Period|Protocol Violation|4|||
150014887|NCT02828020|541187048|FG002|Treatment Period|Protocol Violation|7|||
150014888|NCT02828020|541187046|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
150014889|NCT02828020|541187047|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
150014890|NCT02828020|541187048|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
150014891|NCT02828020|541187046|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
150014892|NCT02828020|541187047|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
150014893|NCT02828020|541187048|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
150014894|NCT02828020|541187046|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
150014895|NCT02828020|541187047|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
150014896|NCT02828020|541187048|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
150014897|NCT02828020|541187046|FG000|Safety Follow-up Period|Protocol Violation|0|||
150014898|NCT02828020|541187047|FG001|Safety Follow-up Period|Protocol Violation|2|||
150014899|NCT02828020|541187048|FG002|Safety Follow-up Period|Protocol Violation|1|||
150014900|NCT02828020|541187046|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
150014901|NCT02828020|541187047|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
150014902|NCT02828020|541187048|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
150014903|NCT03688620|541187049|FG000|Overall Study|Other|0|||
150014904|NCT03688620|541187050|FG001|Overall Study|Other|0|||
150014905|NCT03688620|541187051|FG002|Overall Study|Other|1|||
150014906|NCT03688620|541187049|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
150058263|NCT01931670|541355340|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
150058264|NCT01931670|541355341|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
150058265|NCT04352127|541355342|FG000|Overall Study|Unable to obtain readings|4|||
150058266|NCT04352127|541355343|FG001|Overall Study|Unable to obtain readings|1|||
150058267|NCT01992159|541355344|FG000|Overall Study|Withdrawal by Subject|4|||
150058268|NCT01992159|541355345|FG001|Overall Study|Withdrawal by Subject|7|||
150058269|NCT01992159|541355346|FG002|Overall Study|Withdrawal by Subject|0|||
150058270|NCT01992159|541355347|FG003|Overall Study|Withdrawal by Subject|3|||
150058271|NCT01992159|541355344|FG000|Overall Study|Adverse Event|0|||
150181306|NCT00393484|541801056|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
150181307|NCT00393484|541801055|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
150014907|NCT03688620|541187050|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
150014908|NCT03688620|541187051|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
150014909|NCT03688620|541187049|FG000|Overall Study|Lost to Follow-up|16|||
150014910|NCT03688620|541187050|FG001|Overall Study|Lost to Follow-up|0|||
150014911|NCT03688620|541187051|FG002|Overall Study|Lost to Follow-up|1|||
150014912|NCT03688620|541187049|FG000|Overall Study|Withdrawal by Subject|0|||
150058272|NCT01992159|541355345|FG001|Overall Study|Adverse Event|1|||
150058273|NCT01992159|541355346|FG002|Overall Study|Adverse Event|0|||
150058274|NCT01992159|541355347|FG003|Overall Study|Adverse Event|1|||
150181308|NCT00393484|541801056|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
150181309|NCT00393484|541801055|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
150181310|NCT00393484|541801056|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
150181311|NCT00393484|541801055|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
150181312|NCT00393484|541801056|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
150181313|NCT00393484|541801055|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
150181314|NCT00393484|541801056|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
150181315|NCT00393484|541801055|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
150014913|NCT03688620|541187050|FG001|Overall Study|Withdrawal by Subject|0|||
150014914|NCT03688620|541187051|FG002|Overall Study|Withdrawal by Subject|6|||
150014915|NCT04356352|541187052|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
150014916|NCT04356352|541187053|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
150014917|NCT04356352|541187054|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
150014918|NCT04356352|541187052|FG000|Overall Study|Protocol Violation|0|||
150014919|NCT04356352|541187053|FG001|Overall Study|Protocol Violation|3|||
150014920|NCT04356352|541187054|FG002|Overall Study|Protocol Violation|1|||
150014921|NCT01183065|541187056|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
150014922|NCT00416455|541187057|FG000|Overall Study|PET / CT not done|3|||
150014923|NCT00416455|541187058|FG001|Overall Study|PET / CT not done|5|||
150014924|NCT00416455|541187057|FG000|Overall Study|PET / CT poor quality|2|||
150014925|NCT00416455|541187058|FG001|Overall Study|PET / CT poor quality|1|||
150014926|NCT00416455|541187057|FG000|Overall Study|Inadequate pathology|11|||
150014927|NCT00416455|541187058|FG001|Overall Study|Inadequate pathology|2|||
150014928|NCT02475278|541191058|FG000|Overall Study|Lost to Follow-up|1|||
150014929|NCT02475278|541191058|FG000|Overall Study|Reason Not Specified|1|||
150014930|NCT02391363|541191059|FG000|Overall Study|Lost to Follow-up|5|||
150014931|NCT02391363|541191060|FG001|Overall Study|Lost to Follow-up|5|||
150014932|NCT02391363|541191059|FG000|Overall Study|Withdrawal by Subject|6|||
150014933|NCT02391363|541191060|FG001|Overall Study|Withdrawal by Subject|3|||
150014934|NCT00265317|541191064|FG000|Lead-In|Objective progression or relapse|6|||
150014935|NCT00265317|541191065|FG001|Lead-In|Objective progression or relapse|11|||
150014936|NCT00265317|541191066|FG002|Lead-In|Objective progression or relapse|0|||
150014937|NCT00265317|541191067|FG003|Lead-In|Objective progression or relapse|0|||
150014938|NCT00265317|541191064|FG000|Lead-In|Adverse Event|2|||
150014939|NCT00265317|541191065|FG001|Lead-In|Adverse Event|1|||
150014940|NCT00265317|541191066|FG002|Lead-In|Adverse Event|0|||
150014941|NCT00265317|541191067|FG003|Lead-In|Adverse Event|0|||
150014942|NCT00265317|541191064|FG000|Lead-In|Death|3|||
150014943|NCT00265317|541191065|FG001|Lead-In|Death|5|||
150014944|NCT00265317|541191066|FG002|Lead-In|Death|0|||
150014945|NCT00265317|541191067|FG003|Lead-In|Death|0|||
150014946|NCT00265317|541191064|FG000|Lead-In|Withdrawal/other than adverse event|1|||
150014947|NCT00265317|541191065|FG001|Lead-In|Withdrawal/other than adverse event|0|||
150014948|NCT00265317|541191066|FG002|Lead-In|Withdrawal/other than adverse event|0|||
150014949|NCT00265317|541191067|FG003|Lead-In|Withdrawal/other than adverse event|0|||
150014950|NCT00265317|541191064|FG000|Phase 2|Objective progression or relapse|0|||
150014951|NCT00265317|541191065|FG001|Phase 2|Objective progression or relapse|0|||
150014952|NCT00265317|541191066|FG002|Phase 2|Objective progression or relapse|37|||
150014953|NCT00265317|541191067|FG003|Phase 2|Objective progression or relapse|38|||
150014954|NCT00265317|541191064|FG000|Phase 2|Global deterioration of health status|0|||
150014955|NCT00265317|541191065|FG001|Phase 2|Global deterioration of health status|0|||
150058275|NCT01992159|541355344|FG000|Overall Study|Death|0|||
150058276|NCT01992159|541355345|FG001|Overall Study|Death|0|||
150058277|NCT01992159|541355346|FG002|Overall Study|Death|1|||
150058278|NCT01992159|541355347|FG003|Overall Study|Death|0|||
150058279|NCT02160002|541355348|FG000|Overall Study|Withdrawal by Subject|2|||
150058280|NCT02160002|541355349|FG001|Overall Study|Withdrawal by Subject|1|||
150058281|NCT00635024|541355350|FG000|Overall Study|Adverse Event|1|||
150058282|NCT00713310|541355352|FG000|Overall Study|Adverse Event|5|||
150058283|NCT00713310|541355353|FG001|Overall Study|Adverse Event|2|||
150181316|NCT00393484|541801056|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
150181317|NCT00393484|541801055|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
150181318|NCT00393484|541801056|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
150058284|NCT00713310|541355352|FG000|Overall Study|Lack of Efficacy|0|||
150181319|NCT00393484|541801055|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
150014956|NCT00265317|541191066|FG002|Phase 2|Global deterioration of health status|3|||
150014957|NCT00265317|541191067|FG003|Phase 2|Global deterioration of health status|0|||
150014958|NCT00265317|541191064|FG000|Phase 2|Adverse Event|0|||
150014959|NCT00265317|541191065|FG001|Phase 2|Adverse Event|0|||
150014960|NCT00265317|541191066|FG002|Phase 2|Adverse Event|7|||
150014961|NCT00265317|541191067|FG003|Phase 2|Adverse Event|5|||
150014962|NCT00265317|541191064|FG000|Phase 2|Death|0|||
150058285|NCT00713310|541355353|FG001|Overall Study|Lack of Efficacy|2|||
150058286|NCT00713310|541355352|FG000|Overall Study|Withdrawal by Subject|0|||
150058287|NCT00713310|541355353|FG001|Overall Study|Withdrawal by Subject|2|||
150014963|NCT00265317|541191065|FG001|Phase 2|Death|0|||
150014964|NCT00265317|541191066|FG002|Phase 2|Death|12|||
150014965|NCT00265317|541191067|FG003|Phase 2|Death|15|||
150014966|NCT00265317|541191064|FG000|Phase 2|Protocol Violation|0|||
150014967|NCT00265317|541191065|FG001|Phase 2|Protocol Violation|0|||
150014968|NCT00265317|541191066|FG002|Phase 2|Protocol Violation|1|||
150014969|NCT00265317|541191067|FG003|Phase 2|Protocol Violation|4|||
150181320|NCT00393484|541801056|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
150181321|NCT00393484|541801055|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
150181322|NCT00393484|541801056|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
150181323|NCT03750968|541801059|FG000|Overall Study|Adverse Event|2|||
150181324|NCT03750968|541801060|FG001|Overall Study|Adverse Event|0|||
150181325|NCT03750968|541801059|FG000|Overall Study|Lost to Follow-up|1|||
150181326|NCT03750968|541801060|FG001|Overall Study|Lost to Follow-up|3|||
150181327|NCT02178098|541801069|FG000|Overall Study|Withdrawal by Subject|0|||
150181328|NCT02178098|541801070|FG001|Overall Study|Withdrawal by Subject|6|||
150181329|NCT02178098|541801069|FG000|Overall Study|Adverse Event|1|||
150181330|NCT02178098|541801070|FG001|Overall Study|Adverse Event|2|||
150181331|NCT02178098|541801069|FG000|Overall Study|Protocol Violation|1|||
150181332|NCT02178098|541801070|FG001|Overall Study|Protocol Violation|1|||
150181333|NCT02178098|541801069|FG000|Overall Study|Lost to Follow-up|0|||
150181334|NCT02178098|541801070|FG001|Overall Study|Lost to Follow-up|1|||
150181335|NCT02178098|541801069|FG000|Overall Study|Sponsor Request|1|||
150181336|NCT02178098|541801070|FG001|Overall Study|Sponsor Request|0|||
150181337|NCT02178098|541801069|FG000|Overall Study|Other|2|||
150014970|NCT00265317|541191064|FG000|Phase 2|Lost to Follow-up|0|||
150014971|NCT00265317|541191065|FG001|Phase 2|Lost to Follow-up|0|||
150181338|NCT02178098|541801070|FG001|Overall Study|Other|2|||
150014972|NCT00265317|541191066|FG002|Phase 2|Lost to Follow-up|0|||
150014973|NCT00265317|541191067|FG003|Phase 2|Lost to Follow-up|1|||
150014974|NCT00265317|541191064|FG000|Phase 2|Withdrawal/other than adverse event|0|||
150014975|NCT00265317|541191065|FG001|Phase 2|Withdrawal/other than adverse event|0|||
150014976|NCT00265317|541191066|FG002|Phase 2|Withdrawal/other than adverse event|2|||
150014977|NCT00265317|541191067|FG003|Phase 2|Withdrawal/other than adverse event|1|||
150014978|NCT00265317|541191064|FG000|Phase 2|Study terminated by sponsor|0|||
150014979|NCT00265317|541191065|FG001|Phase 2|Study terminated by sponsor|0|||
150014980|NCT00265317|541191066|FG002|Phase 2|Study terminated by sponsor|1|||
150014981|NCT00265317|541191067|FG003|Phase 2|Study terminated by sponsor|0|||
150014982|NCT00265317|541191064|FG000|Phase 2|Other|0|||
150014983|NCT00265317|541191065|FG001|Phase 2|Other|0|||
150014984|NCT00265317|541191066|FG002|Phase 2|Other|1|||
150014985|NCT00265317|541191067|FG003|Phase 2|Other|1|||
150014986|NCT02300259|541191068|FG000|Period 1|Adverse Event|0|||
150014987|NCT02300259|541191069|FG001|Period 1|Adverse Event|0|||
150014988|NCT02300259|541191070|FG002|Period 1|Adverse Event|1|||
150014989|NCT02300259|541191068|FG000|Period 1|Withdrawal by Subject|0|||
150014990|NCT02300259|541191069|FG001|Period 1|Withdrawal by Subject|0|||
150014991|NCT02300259|541191070|FG002|Period 1|Withdrawal by Subject|1|||
150014992|NCT02300259|541191068|FG000|Period 2|Adverse Event|1|||
150014993|NCT02300259|541191069|FG001|Period 2|Adverse Event|0|||
150014994|NCT02300259|541191070|FG002|Period 2|Adverse Event|0|||
150014995|NCT02300259|541191068|FG000|Period 2|Withdrawal by Subject|0|||
150014996|NCT02300259|541191069|FG001|Period 2|Withdrawal by Subject|0|||
150014997|NCT02300259|541191070|FG002|Period 2|Withdrawal by Subject|1|||
150014998|NCT02737475|541191071|FG000|Overall Study|Other reasons|0|||
150014999|NCT02737475|541191072|FG001|Overall Study|Other reasons|0|||
150015000|NCT02737475|541191073|FG002|Overall Study|Other reasons|0|||
150015001|NCT02737475|541191074|FG003|Overall Study|Other reasons|0|||
150015002|NCT02737475|541191075|FG004|Overall Study|Other reasons|1|||
150181339|NCT02318134|541801075|FG000|Overall Study|Withdrawal by Subject|2|||
150181340|NCT02318134|541801076|FG001|Overall Study|Withdrawal by Subject|1|||
150015003|NCT02737475|541191076|FG005|Overall Study|Other reasons|1|||
150015004|NCT02737475|541191077|FG006|Overall Study|Other reasons|0|||
150015005|NCT02737475|541191078|FG007|Overall Study|Other reasons|0|||
150015006|NCT02737475|541191079|FG008|Overall Study|Other reasons|1|||
150015007|NCT02737475|541191080|FG009|Overall Study|Other reasons|0|||
150015008|NCT02737475|541191081|FG010|Overall Study|Other reasons|1|||
150015009|NCT02737475|541191082|FG011|Overall Study|Other reasons|0|||
150015010|NCT02737475|541191083|FG012|Overall Study|Other reasons|0|||
150015011|NCT02737475|541191084|FG013|Overall Study|Other reasons|0|||
150015012|NCT02737475|541191085|FG014|Overall Study|Other reasons|0|||
150015013|NCT02737475|541191086|FG015|Overall Study|Other reasons|0|||
150015014|NCT02737475|541191087|FG016|Overall Study|Other reasons|0|||
150015015|NCT02737475|541191088|FG017|Overall Study|Other reasons|0|||
150181341|NCT00031694|541801077|FG000|Overall Study|Adverse Event|12|||
150181342|NCT00031694|541801077|FG000|Overall Study|Death|2|||
150181343|NCT00031694|541801077|FG000|Overall Study|Withdrawal by Subject|5|||
150015016|NCT02737475|541191089|FG018|Overall Study|Other reasons|0|||
150015017|NCT02737475|541191090|FG019|Overall Study|Other reasons|0|||
150015018|NCT02737475|541191091|FG020|Overall Study|Other reasons|0|||
150015019|NCT02737475|541191092|FG021|Overall Study|Other reasons|1|||
150015020|NCT02737475|541191093|FG022|Overall Study|Other reasons|0|||
150015021|NCT02737475|541191094|FG023|Overall Study|Other reasons|1|||
150015022|NCT02737475|541191095|FG024|Overall Study|Other reasons|1|||
150015023|NCT02737475|541191096|FG025|Overall Study|Other reasons|1|||
150015024|NCT02737475|541191097|FG026|Overall Study|Other reasons|0|||
150015025|NCT02737475|541191071|FG000|Overall Study|Death|1|||
150015026|NCT02737475|541191072|FG001|Overall Study|Death|0|||
150015027|NCT02737475|541191073|FG002|Overall Study|Death|0|||
150015028|NCT02737475|541191074|FG003|Overall Study|Death|1|||
150015029|NCT02737475|541191075|FG004|Overall Study|Death|0|||
150015030|NCT02737475|541191076|FG005|Overall Study|Death|0|||
150015031|NCT02737475|541191077|FG006|Overall Study|Death|0|||
150015032|NCT02737475|541191078|FG007|Overall Study|Death|2|||
150015033|NCT02737475|541191079|FG008|Overall Study|Death|0|||
150015034|NCT02737475|541191080|FG009|Overall Study|Death|0|||
150015035|NCT02737475|541191081|FG010|Overall Study|Death|0|||
150015036|NCT02737475|541191082|FG011|Overall Study|Death|4|||
150015037|NCT02737475|541191083|FG012|Overall Study|Death|2|||
150015038|NCT02737475|541191084|FG013|Overall Study|Death|2|||
150015039|NCT02737475|541191085|FG014|Overall Study|Death|0|||
150015040|NCT02737475|541191086|FG015|Overall Study|Death|2|||
150015041|NCT02737475|541191087|FG016|Overall Study|Death|2|||
150015042|NCT02737475|541191088|FG017|Overall Study|Death|2|||
150015043|NCT02737475|541191089|FG018|Overall Study|Death|1|||
150015044|NCT02737475|541191090|FG019|Overall Study|Death|0|||
150015045|NCT02737475|541191091|FG020|Overall Study|Death|0|||
150015046|NCT02737475|541191092|FG021|Overall Study|Death|0|||
150015047|NCT02737475|541191093|FG022|Overall Study|Death|0|||
150015048|NCT02737475|541191094|FG023|Overall Study|Death|0|||
150015049|NCT02737475|541191095|FG024|Overall Study|Death|0|||
150015050|NCT02737475|541191096|FG025|Overall Study|Death|0|||
150015051|NCT02737475|541191097|FG026|Overall Study|Death|0|||
150015052|NCT02737475|541191071|FG000|Overall Study|Participant withdrew consent|0|||
150015053|NCT02737475|541191072|FG001|Overall Study|Participant withdrew consent|0|||
150015054|NCT02737475|541191073|FG002|Overall Study|Participant withdrew consent|0|||
150015055|NCT02737475|541191074|FG003|Overall Study|Participant withdrew consent|0|||
150015056|NCT02737475|541191075|FG004|Overall Study|Participant withdrew consent|0|||
150015057|NCT02737475|541191076|FG005|Overall Study|Participant withdrew consent|2|||
150015058|NCT02737475|541191077|FG006|Overall Study|Participant withdrew consent|0|||
150015059|NCT02737475|541191078|FG007|Overall Study|Participant withdrew consent|0|||
150015060|NCT02737475|541191079|FG008|Overall Study|Participant withdrew consent|0|||
150015061|NCT02737475|541191080|FG009|Overall Study|Participant withdrew consent|0|||
150015062|NCT02737475|541191081|FG010|Overall Study|Participant withdrew consent|0|||
150015063|NCT02737475|541191082|FG011|Overall Study|Participant withdrew consent|0|||
150015064|NCT02737475|541191083|FG012|Overall Study|Participant withdrew consent|0|||
150015065|NCT02737475|541191084|FG013|Overall Study|Participant withdrew consent|0|||
150015066|NCT02737475|541191085|FG014|Overall Study|Participant withdrew consent|1|||
150015067|NCT02737475|541191086|FG015|Overall Study|Participant withdrew consent|0|||
150015068|NCT02737475|541191087|FG016|Overall Study|Participant withdrew consent|0|||
150015069|NCT02737475|541191088|FG017|Overall Study|Participant withdrew consent|2|||
150015070|NCT02737475|541191089|FG018|Overall Study|Participant withdrew consent|1|||
150015071|NCT02737475|541191090|FG019|Overall Study|Participant withdrew consent|0|||
150015072|NCT02737475|541191091|FG020|Overall Study|Participant withdrew consent|2|||
150015073|NCT02737475|541191092|FG021|Overall Study|Participant withdrew consent|0|||
150015074|NCT02737475|541191093|FG022|Overall Study|Participant withdrew consent|0|||
150015075|NCT02737475|541191094|FG023|Overall Study|Participant withdrew consent|0|||
150015076|NCT02737475|541191095|FG024|Overall Study|Participant withdrew consent|0|||
150015077|NCT02737475|541191096|FG025|Overall Study|Participant withdrew consent|0|||
150015078|NCT02737475|541191097|FG026|Overall Study|Participant withdrew consent|0|||
150015079|NCT02737475|541191071|FG000|Overall Study|Lost to Follow-up|0|||
150015080|NCT02737475|541191072|FG001|Overall Study|Lost to Follow-up|0|||
150015081|NCT02737475|541191073|FG002|Overall Study|Lost to Follow-up|0|||
150015082|NCT02737475|541191074|FG003|Overall Study|Lost to Follow-up|0|||
150015083|NCT02737475|541191075|FG004|Overall Study|Lost to Follow-up|0|||
150015084|NCT02737475|541191076|FG005|Overall Study|Lost to Follow-up|0|||
150015085|NCT02737475|541191077|FG006|Overall Study|Lost to Follow-up|0|||
150015086|NCT02737475|541191078|FG007|Overall Study|Lost to Follow-up|0|||
150015087|NCT02737475|541191079|FG008|Overall Study|Lost to Follow-up|0|||
150015088|NCT02737475|541191080|FG009|Overall Study|Lost to Follow-up|0|||
150015089|NCT02737475|541191081|FG010|Overall Study|Lost to Follow-up|0|||
150015090|NCT02737475|541191082|FG011|Overall Study|Lost to Follow-up|0|||
150015091|NCT02737475|541191083|FG012|Overall Study|Lost to Follow-up|0|||
150015092|NCT02737475|541191084|FG013|Overall Study|Lost to Follow-up|0|||
150015093|NCT02737475|541191085|FG014|Overall Study|Lost to Follow-up|0|||
150015094|NCT02737475|541191086|FG015|Overall Study|Lost to Follow-up|1|||
150015095|NCT02737475|541191087|FG016|Overall Study|Lost to Follow-up|0|||
150015096|NCT02737475|541191088|FG017|Overall Study|Lost to Follow-up|0|||
150015097|NCT02737475|541191089|FG018|Overall Study|Lost to Follow-up|0|||
150015098|NCT02737475|541191090|FG019|Overall Study|Lost to Follow-up|0|||
150015099|NCT02737475|541191091|FG020|Overall Study|Lost to Follow-up|0|||
150015100|NCT02737475|541191092|FG021|Overall Study|Lost to Follow-up|0|||
150015101|NCT02737475|541191093|FG022|Overall Study|Lost to Follow-up|0|||
150015102|NCT02737475|541191094|FG023|Overall Study|Lost to Follow-up|0|||
150015103|NCT02737475|541191095|FG024|Overall Study|Lost to Follow-up|0|||
150015104|NCT02737475|541191096|FG025|Overall Study|Lost to Follow-up|0|||
150015105|NCT02737475|541191097|FG026|Overall Study|Lost to Follow-up|0|||
150015106|NCT02737475|541191071|FG000|Overall Study|Disease Progression|0|||
150015107|NCT02737475|541191072|FG001|Overall Study|Disease Progression|0|||
150015108|NCT02737475|541191073|FG002|Overall Study|Disease Progression|0|||
150015109|NCT02737475|541191074|FG003|Overall Study|Disease Progression|0|||
150015110|NCT02737475|541191075|FG004|Overall Study|Disease Progression|0|||
150015111|NCT02737475|541191076|FG005|Overall Study|Disease Progression|0|||
150015112|NCT02737475|541191077|FG006|Overall Study|Disease Progression|0|||
150015113|NCT02737475|541191078|FG007|Overall Study|Disease Progression|0|||
150015114|NCT02737475|541191079|FG008|Overall Study|Disease Progression|0|||
150015115|NCT02737475|541191080|FG009|Overall Study|Disease Progression|0|||
150015116|NCT02737475|541191081|FG010|Overall Study|Disease Progression|0|||
150015117|NCT02737475|541191082|FG011|Overall Study|Disease Progression|0|||
150015118|NCT02737475|541191083|FG012|Overall Study|Disease Progression|0|||
150015119|NCT02737475|541191084|FG013|Overall Study|Disease Progression|0|||
150015120|NCT02737475|541191085|FG014|Overall Study|Disease Progression|0|||
150015121|NCT02737475|541191086|FG015|Overall Study|Disease Progression|0|||
150015122|NCT02737475|541191087|FG016|Overall Study|Disease Progression|0|||
150015123|NCT02737475|541191088|FG017|Overall Study|Disease Progression|0|||
150015124|NCT02737475|541191089|FG018|Overall Study|Disease Progression|0|||
150015125|NCT02737475|541191090|FG019|Overall Study|Disease Progression|0|||
150015126|NCT02737475|541191091|FG020|Overall Study|Disease Progression|0|||
150015127|NCT02737475|541191092|FG021|Overall Study|Disease Progression|0|||
150015128|NCT02737475|541191093|FG022|Overall Study|Disease Progression|0|||
150015129|NCT02737475|541191094|FG023|Overall Study|Disease Progression|0|||
150015130|NCT02737475|541191095|FG024|Overall Study|Disease Progression|0|||
150015131|NCT02737475|541191096|FG025|Overall Study|Disease Progression|0|||
150015132|NCT02737475|541191097|FG026|Overall Study|Disease Progression|1|||
150015133|NCT01504841|541191103|FG000|Overall Study|Withdrawal by Subject|1|||
150015134|NCT01504841|541191104|FG001|Overall Study|Withdrawal by Subject|1|||
150015135|NCT01504841|541191105|FG002|Overall Study|Withdrawal by Subject|0|||
150015136|NCT04440813|541191108|FG000|Overall Study|Lost to Follow-up|5|||
150015137|NCT04440813|541191109|FG001|Overall Study|Lost to Follow-up|5|||
150015138|NCT02255461|541191110|FG000|Overall Study|Adverse Event|0|||
150015139|NCT02255461|541191111|FG001|Overall Study|Adverse Event|1|||
150015140|NCT02255461|541191112|FG002|Overall Study|Adverse Event|0|||
150015141|NCT02255461|541191113|FG003|Overall Study|Adverse Event|0|||
150015142|NCT02255461|541191114|FG004|Overall Study|Adverse Event|1|||
150015143|NCT02255461|541191110|FG000|Overall Study|Withdrawal by Subject|0|||
150015144|NCT02255461|541191111|FG001|Overall Study|Withdrawal by Subject|0|||
150015145|NCT02255461|541191112|FG002|Overall Study|Withdrawal by Subject|1|||
150015146|NCT02255461|541191113|FG003|Overall Study|Withdrawal by Subject|0|||
150015147|NCT02255461|541191114|FG004|Overall Study|Withdrawal by Subject|1|||
150015148|NCT02255461|541191110|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
150015149|NCT02255461|541191111|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
150015150|NCT02255461|541191112|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
150015151|NCT02255461|541191113|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
150015152|NCT02255461|541191114|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
150015153|NCT00291018|541191117|FG000|Overall Study|Not Consented or Declined PAS|12|||
150015154|NCT00291018|541191118|FG001|Overall Study|Not Consented or Declined PAS|15|||
150015155|NCT00291018|541191119|FG002|Overall Study|Not Consented or Declined PAS|15|||
150015156|NCT00291018|541191117|FG000|Overall Study|Death|3|||
150015157|NCT00291018|541191118|FG001|Overall Study|Death|3|||
150015158|NCT00291018|541191119|FG002|Overall Study|Death|4|||
150015159|NCT00291018|541191117|FG000|Overall Study|Withdrawal by Subject|2|||
150015160|NCT00291018|541191118|FG001|Overall Study|Withdrawal by Subject|8|||
150015161|NCT00291018|541191119|FG002|Overall Study|Withdrawal by Subject|1|||
150015162|NCT00291018|541191117|FG000|Overall Study|Failures|5|||
150015163|NCT00291018|541191118|FG001|Overall Study|Failures|12|||
150015164|NCT00291018|541191119|FG002|Overall Study|Failures|5|||
150015165|NCT00291018|541191117|FG000|Overall Study|Lost to Follow-up|3|||
150015166|NCT00291018|541191118|FG001|Overall Study|Lost to Follow-up|4|||
150015167|NCT00291018|541191119|FG002|Overall Study|Lost to Follow-up|18|||
150015168|NCT00847886|541191130|FG000|Overall Study|Adverse Event|0|||
150015169|NCT00847886|541191131|FG001|Overall Study|Adverse Event|1|||
150015170|NCT02462720|541191132|FG000|Part 2|Withdrawal by Subject|1|||
150015171|NCT02462720|541191133|FG001|Part 2|Withdrawal by Subject|0|||
150015172|NCT02462720|541191132|FG000|Part 2|Protocol Violation|0|||
150015173|NCT02462720|541191133|FG001|Part 2|Protocol Violation|1|||
150015174|NCT03668613|541191135|FG000|Overall Study|Adverse Event|1|||
150015175|NCT03668613|541191136|FG001|Overall Study|Adverse Event|2|||
150015176|NCT03668613|541191135|FG000|Overall Study|Lack of Efficacy|5|||
150015177|NCT03668613|541191136|FG001|Overall Study|Lack of Efficacy|1|||
150015178|NCT03668613|541191135|FG000|Overall Study|Pregnancy|0|||
150015179|NCT03668613|541191136|FG001|Overall Study|Pregnancy|2|||
150015180|NCT03668613|541191135|FG000|Overall Study|Protocol Violation|1|||
150015181|NCT03668613|541191136|FG001|Overall Study|Protocol Violation|0|||
150015182|NCT03668613|541191135|FG000|Overall Study|Physician Decision|1|||
150015183|NCT03668613|541191136|FG001|Overall Study|Physician Decision|0|||
150015184|NCT03668613|541191135|FG000|Overall Study|Withdrawal by Subject|2|||
150015185|NCT03668613|541191136|FG001|Overall Study|Withdrawal by Subject|1|||
150015186|NCT03668613|541191135|FG000|Overall Study|Guardian decision|1|||
150015187|NCT03668613|541191136|FG001|Overall Study|Guardian decision|0|||
150015188|NCT01858740|541191139|FG000|Overall Study|Death|4|||
150015189|NCT03386487|541191140|FG000|Overall Study|Lost to Follow-up|5|||
150015190|NCT03386487|541191141|FG001|Overall Study|Lost to Follow-up|6|||
150015191|NCT03386487|541191140|FG000|Overall Study|Withdrawal by Subject|11|||
150015192|NCT03386487|541191141|FG001|Overall Study|Withdrawal by Subject|7|||
150015193|NCT03386487|541191140|FG000|Overall Study|Physician Decision|11|||
150015194|NCT03386487|541191141|FG001|Overall Study|Physician Decision|8|||
150015195|NCT00286494|541191148|FG000|Overall Study|Hyperglycemic rescue|12|||
150015196|NCT00286494|541191149|FG001|Overall Study|Hyperglycemic rescue|19|||
150015197|NCT00286494|541191150|FG002|Overall Study|Hyperglycemic rescue|18|||
150015198|NCT00286494|541191148|FG000|Overall Study|Withdrawal by Subject|2|||
150015199|NCT00286494|541191149|FG001|Overall Study|Withdrawal by Subject|10|||
150015200|NCT00286494|541191150|FG002|Overall Study|Withdrawal by Subject|9|||
150015201|NCT00286494|541191148|FG000|Overall Study|Adverse Event|3|||
150015202|NCT00286494|541191149|FG001|Overall Study|Adverse Event|8|||
150015203|NCT00286494|541191150|FG002|Overall Study|Adverse Event|6|||
150015204|NCT00286494|541191148|FG000|Overall Study|Physician Decision|5|||
150015205|NCT00286494|541191149|FG001|Overall Study|Physician Decision|5|||
150015206|NCT00286494|541191150|FG002|Overall Study|Physician Decision|1|||
150015207|NCT00286494|541191148|FG000|Overall Study|Lost to Follow-up|3|||
150015208|NCT00286494|541191149|FG001|Overall Study|Lost to Follow-up|1|||
150015209|NCT00286494|541191150|FG002|Overall Study|Lost to Follow-up|3|||
150015210|NCT00286494|541191148|FG000|Overall Study|Protocol Violation|1|||
150015211|NCT00286494|541191149|FG001|Overall Study|Protocol Violation|1|||
150015212|NCT00286494|541191150|FG002|Overall Study|Protocol Violation|2|||
150015213|NCT04776317|541191151|FG000|Overall Study|Physician Decision|0|||
150015214|NCT04776317|541191152|FG001|Overall Study|Physician Decision|1|||
150015215|NCT04776317|541191153|FG002|Overall Study|Physician Decision|0|||
150015216|NCT04776317|541191154|FG003|Overall Study|Physician Decision|0|||
150015217|NCT04776317|541191155|FG004|Overall Study|Physician Decision|0|||
150015218|NCT04776317|541191156|FG005|Overall Study|Physician Decision|0|||
150015219|NCT04776317|541191157|FG006|Overall Study|Physician Decision|0|||
150015220|NCT04776317|541191158|FG007|Overall Study|Physician Decision|0|||
150015221|NCT04776317|541191159|FG008|Overall Study|Physician Decision|0|||
150015222|NCT04776317|541191160|FG009|Overall Study|Physician Decision|0|||
150015223|NCT04776317|541191161|FG010|Overall Study|Physician Decision|0|||
150015224|NCT04776317|541191162|FG011|Overall Study|Physician Decision|0|||
150015225|NCT04776317|541191163|FG012|Overall Study|Physician Decision|0|||
150015226|NCT04776317|541191164|FG013|Overall Study|Physician Decision|0|||
150015227|NCT04776317|541191165|FG014|Overall Study|Physician Decision|0|||
150015228|NCT04776317|541191151|FG000|Overall Study|Protocol Violation|0|||
150015229|NCT04776317|541191152|FG001|Overall Study|Protocol Violation|0|||
150015230|NCT04776317|541191153|FG002|Overall Study|Protocol Violation|1|||
150015231|NCT04776317|541191154|FG003|Overall Study|Protocol Violation|0|||
150015232|NCT04776317|541191155|FG004|Overall Study|Protocol Violation|0|||
150015233|NCT04776317|541191156|FG005|Overall Study|Protocol Violation|0|||
150015234|NCT04776317|541191157|FG006|Overall Study|Protocol Violation|0|||
150015235|NCT04776317|541191158|FG007|Overall Study|Protocol Violation|0|||
150015236|NCT04776317|541191159|FG008|Overall Study|Protocol Violation|0|||
150015237|NCT04776317|541191160|FG009|Overall Study|Protocol Violation|0|||
150015238|NCT04776317|541191161|FG010|Overall Study|Protocol Violation|0|||
150015239|NCT04776317|541191162|FG011|Overall Study|Protocol Violation|0|||
150015240|NCT04776317|541191163|FG012|Overall Study|Protocol Violation|0|||
150015241|NCT04776317|541191164|FG013|Overall Study|Protocol Violation|0|||
150015242|NCT04776317|541191165|FG014|Overall Study|Protocol Violation|0|||
150015243|NCT04776317|541191151|FG000|Overall Study|Withdrawal by Subject|0|||
150015244|NCT04776317|541191152|FG001|Overall Study|Withdrawal by Subject|0|||
150015245|NCT04776317|541191153|FG002|Overall Study|Withdrawal by Subject|0|||
150015246|NCT04776317|541191154|FG003|Overall Study|Withdrawal by Subject|0|||
150015247|NCT04776317|541191155|FG004|Overall Study|Withdrawal by Subject|1|||
150015248|NCT04776317|541191156|FG005|Overall Study|Withdrawal by Subject|0|||
150015249|NCT04776317|541191157|FG006|Overall Study|Withdrawal by Subject|0|||
150015250|NCT04776317|541191158|FG007|Overall Study|Withdrawal by Subject|0|||
150015251|NCT04776317|541191159|FG008|Overall Study|Withdrawal by Subject|0|||
150015252|NCT04776317|541191160|FG009|Overall Study|Withdrawal by Subject|0|||
150015253|NCT04776317|541191161|FG010|Overall Study|Withdrawal by Subject|0|||
150015254|NCT04776317|541191162|FG011|Overall Study|Withdrawal by Subject|0|||
150015255|NCT04776317|541191163|FG012|Overall Study|Withdrawal by Subject|0|||
150015256|NCT04776317|541191164|FG013|Overall Study|Withdrawal by Subject|0|||
150058288|NCT00329901|541355354|FG000|Overall Study|Withdrawal by Subject|4|||
150058289|NCT00329901|541355355|FG001|Overall Study|Withdrawal by Subject|3|||
150058290|NCT00329901|541355356|FG002|Overall Study|Withdrawal by Subject|2|||
150058291|NCT00329901|541355354|FG000|Overall Study|Lost to Follow-up|2|||
150058292|NCT00329901|541355355|FG001|Overall Study|Lost to Follow-up|0|||
150058293|NCT00329901|541355356|FG002|Overall Study|Lost to Follow-up|1|||
150058294|NCT00329901|541355354|FG000|Overall Study|Protocol Violation|1|||
150058295|NCT00329901|541355355|FG001|Overall Study|Protocol Violation|0|||
150058296|NCT00329901|541355356|FG002|Overall Study|Protocol Violation|1|||
150015257|NCT04776317|541191165|FG014|Overall Study|Withdrawal by Subject|0|||
150015258|NCT04207060|541191166|FG000|Overall Study|Lost to Follow-up|2|||
150015259|NCT04207060|541191167|FG001|Overall Study|Lost to Follow-up|0|||
150015260|NCT05438576|541191168|FG000|Overall Study|Death|1|||
150015261|NCT05438576|541191169|FG001|Overall Study|Death|1|||
150015262|NCT05438576|541191168|FG000|Overall Study|Withdrawal by Subject|4|||
150015263|NCT05438576|541191169|FG001|Overall Study|Withdrawal by Subject|2|||
150015264|NCT05438576|541191168|FG000|Overall Study|Not Eligible|2|||
150015265|NCT05438576|541191169|FG001|Overall Study|Not Eligible|1|||
150015266|NCT05438576|541191168|FG000|Overall Study|Did not complete baseline testing|22|||
150015267|NCT05438576|541191169|FG001|Overall Study|Did not complete baseline testing|4|||
150015268|NCT01067144|541191170|FG000|Treatment|Did not receive allocated intervention|4|||
150015269|NCT01067144|541191171|FG001|Treatment|Did not receive allocated intervention|7|||
150015270|NCT01067144|541191170|FG000|Follow-up|Lost to Follow-up|22|||
150015271|NCT01067144|541191171|FG001|Follow-up|Lost to Follow-up|12|||
150015272|NCT01067144|541191170|FG000|Follow-up|Censored owing to second surgery|19|||
150015273|NCT01067144|541191171|FG001|Follow-up|Censored owing to second surgery|28|||
150015274|NCT01067144|541191170|FG000|Follow-up|Withdrawal by Subject|18|||
150015275|NCT01067144|541191171|FG001|Follow-up|Withdrawal by Subject|14|||
150015276|NCT01067144|541191170|FG000|Follow-up|Surgery cancelled|0|||
150015277|NCT01067144|541191171|FG001|Follow-up|Surgery cancelled|1|||
150015278|NCT01067144|541191170|FG000|Follow-up|Death|0|||
150015279|NCT01067144|541191171|FG001|Follow-up|Death|1|||
150015280|NCT01835158|541191173|FG000|Overall Study|Withdrawal by Subject|1|||
150015281|NCT01835158|541191174|FG001|Overall Study|Withdrawal by Subject|6|||
150015282|NCT00296140|541191175|FG000|Overall Study|Lost to Follow-up|1|||
150015283|NCT00296140|541191176|FG001|Overall Study|Lost to Follow-up|0|||
150015284|NCT00296140|541191175|FG000|Overall Study|Withdrawal by Subject|1|||
150015285|NCT00296140|541191176|FG001|Overall Study|Withdrawal by Subject|0|||
150015286|NCT00296140|541191175|FG000|Overall Study|Discharge to Nursing Home|1|||
150015287|NCT00296140|541191176|FG001|Overall Study|Discharge to Nursing Home|0|||
150015288|NCT01856582|541191177|FG000|Overall Study|Died prior to Boost infusion|1|||
150015289|NCT00880191|541191181|FG000|Overall Study|Refused further treatment|4|||
150015290|NCT00880191|541191182|FG001|Overall Study|Refused further treatment|1|||
150015291|NCT00880191|541191181|FG000|Overall Study|Adverse Event|8|||
150015292|NCT00880191|541191182|FG001|Overall Study|Adverse Event|6|||
150015293|NCT00880191|541191181|FG000|Overall Study|Hospitalization/efficacy|1|||
150015294|NCT00880191|541191182|FG001|Overall Study|Hospitalization/efficacy|1|||
150015295|NCT00774800|541191186|FG000|Intervention 4|Withdrawal by Subject|1|||
150015296|NCT01919801|541191187|FG000|Overall Study|Withdrawal by Subject|1|||
150015297|NCT01919801|541191188|FG001|Overall Study|Withdrawal by Subject|0|||
150015298|NCT01919801|541191187|FG000|Overall Study|Physician Decision|0|||
150015299|NCT01919801|541191188|FG001|Overall Study|Physician Decision|1|||
150015300|NCT01919801|541191187|FG000|Overall Study|Lost to Follow-up|0|||
150015301|NCT01919801|541191188|FG001|Overall Study|Lost to Follow-up|1|||
150015302|NCT01919801|541191187|FG000|Overall Study|Other|0|||
150015303|NCT01919801|541191188|FG001|Overall Study|Other|1|||
150015304|NCT01843062|541191189|FG000|Overall Study|Protocol Violation|1|||
150015305|NCT01843062|541191190|FG001|Overall Study|Protocol Violation|0|||
150015306|NCT01843062|541191189|FG000|Overall Study|New treatment following progression|2|||
150015307|NCT01843062|541191190|FG001|Overall Study|New treatment following progression|0|||
150015308|NCT01843062|541191189|FG000|Overall Study|Pregnancy|1|||
150015309|NCT01843062|541191190|FG001|Overall Study|Pregnancy|0|||
150015310|NCT01843062|541191189|FG000|Overall Study|Adverse Event|2|||
150015311|NCT01843062|541191190|FG001|Overall Study|Adverse Event|0|||
150015312|NCT01843062|541191189|FG000|Overall Study|Incorrect randomisation|1|||
150015313|NCT01843062|541191190|FG001|Overall Study|Incorrect randomisation|0|||
150015314|NCT01843062|541191189|FG000|Overall Study|Withdrawal by Subject|12|||
150058297|NCT00329901|541355354|FG000|Overall Study|Unable to classify|2|||
150015315|NCT01843062|541191190|FG001|Overall Study|Withdrawal by Subject|3|||
150015316|NCT01843062|541191189|FG000|Overall Study|Death|1|||
150015317|NCT01843062|541191190|FG001|Overall Study|Death|2|||
150015318|NCT01843062|541191189|FG000|Overall Study|Lost to Follow-up|2|||
150015319|NCT01843062|541191190|FG001|Overall Study|Lost to Follow-up|4|||
150015320|NCT01677858|541191195|FG000|Overall Study|Adverse Event|0|||
150015321|NCT01677858|541191196|FG001|Overall Study|Adverse Event|0|||
150015322|NCT01677858|541191197|FG002|Overall Study|Adverse Event|2|||
150058298|NCT00329901|541355355|FG001|Overall Study|Unable to classify|2|||
150058299|NCT00329901|541355356|FG002|Overall Study|Unable to classify|0|||
150058300|NCT05028361|541355357|FG000|Overall Study|Withdrawal by Subject|1|||
150015323|NCT01677858|541191198|FG003|Overall Study|Adverse Event|3|||
150015324|NCT01677858|541191199|FG004|Overall Study|Adverse Event|13|||
150015325|NCT01677858|541191195|FG000|Overall Study|Death|0|||
150015326|NCT01677858|541191196|FG001|Overall Study|Death|0|||
150015327|NCT01677858|541191197|FG002|Overall Study|Death|0|||
150015328|NCT01677858|541191198|FG003|Overall Study|Death|0|||
150015329|NCT01677858|541191199|FG004|Overall Study|Death|1|||
150015330|NCT01677858|541191195|FG000|Overall Study|Physician Decision|1|||
150015331|NCT01677858|541191196|FG001|Overall Study|Physician Decision|0|||
150015332|NCT01677858|541191197|FG002|Overall Study|Physician Decision|2|||
150015333|NCT01677858|541191198|FG003|Overall Study|Physician Decision|0|||
150015334|NCT01677858|541191199|FG004|Overall Study|Physician Decision|12|||
150015335|NCT01677858|541191195|FG000|Overall Study|Progressive Disease|2|||
150015336|NCT01677858|541191196|FG001|Overall Study|Progressive Disease|1|||
150015337|NCT01677858|541191197|FG002|Overall Study|Progressive Disease|9|||
150015338|NCT01677858|541191198|FG003|Overall Study|Progressive Disease|3|||
150015339|NCT01677858|541191199|FG004|Overall Study|Progressive Disease|43|||
150015340|NCT01677858|541191195|FG000|Overall Study|Withdrawal by Subject|0|||
150015341|NCT01677858|541191196|FG001|Overall Study|Withdrawal by Subject|1|||
150015342|NCT01677858|541191197|FG002|Overall Study|Withdrawal by Subject|1|||
150015343|NCT01677858|541191198|FG003|Overall Study|Withdrawal by Subject|0|||
150015344|NCT01677858|541191199|FG004|Overall Study|Withdrawal by Subject|15|||
150015345|NCT01677858|541191195|FG000|Overall Study|Lost to Follow-up|0|||
150015346|NCT01677858|541191196|FG001|Overall Study|Lost to Follow-up|0|||
150058301|NCT05028361|541355358|FG001|Overall Study|Withdrawal by Subject|0|||
150058302|NCT00779259|541355359|FG000|Quinine Alone|Adverse Event|2|||
150058303|NCT00282464|541355362|FG000|Overall Study|Adverse Event|26|||
150058304|NCT00282464|541355363|FG001|Overall Study|Adverse Event|20|||
150058305|NCT00282464|541355362|FG000|Overall Study|Lack of Efficacy|8|||
150058306|NCT00282464|541355363|FG001|Overall Study|Lack of Efficacy|8|||
150058307|NCT00282464|541355362|FG000|Overall Study|Lost to Follow-up|10|||
150058308|NCT00282464|541355363|FG001|Overall Study|Lost to Follow-up|10|||
150058309|NCT00282464|541355362|FG000|Overall Study|Withdrawal by Subject|24|||
150058310|NCT00282464|541355363|FG001|Overall Study|Withdrawal by Subject|10|||
150058311|NCT00282464|541355362|FG000|Overall Study|laboratory abnormality|1|||
150058312|NCT00282464|541355363|FG001|Overall Study|laboratory abnormality|2|||
150058313|NCT00282464|541355362|FG000|Overall Study|Protocol Violation|0|||
150058314|NCT00282464|541355363|FG001|Overall Study|Protocol Violation|7|||
150058315|NCT00282464|541355362|FG000|Overall Study|Patient moved|1|||
150058316|NCT00282464|541355363|FG001|Overall Study|Patient moved|0|||
150058317|NCT00282464|541355362|FG000|Overall Study|patient non-compliant|3|||
150058318|NCT00282464|541355363|FG001|Overall Study|patient non-compliant|0|||
150058319|NCT00282464|541355362|FG000|Overall Study|patient no show|0|||
150058320|NCT00282464|541355363|FG001|Overall Study|patient no show|1|||
150058321|NCT00282464|541355362|FG000|Overall Study|patient incarcerated|0|||
150058322|NCT00282464|541355363|FG001|Overall Study|patient incarcerated|1|||
150058323|NCT00282464|541355362|FG000|Overall Study|family crisis|0|||
150058324|NCT00282464|541355363|FG001|Overall Study|family crisis|1|||
150058325|NCT00282464|541355362|FG000|Overall Study|dispensed wrong kit|0|||
150058326|NCT00282464|541355363|FG001|Overall Study|dispensed wrong kit|1|||
150058327|NCT00282464|541355362|FG000|Overall Study|dropped due to missed visits|0|||
150058328|NCT00282464|541355363|FG001|Overall Study|dropped due to missed visits|1|||
150058329|NCT01214174|541355364|FG000|Overall Study|Withdrawal by Subject|0|||
150058330|NCT01214174|541355365|FG001|Overall Study|Withdrawal by Subject|0|||
150058331|NCT01214174|541355366|FG002|Overall Study|Withdrawal by Subject|1|||
150058332|NCT02963831|541355369|FG000|Overall Study|Progressive Disease|3|||
150058333|NCT02963831|541355370|FG001|Overall Study|Progressive Disease|3|||
150058334|NCT02963831|541355371|FG002|Overall Study|Progressive Disease|16|||
150058335|NCT02963831|541355372|FG003|Overall Study|Progressive Disease|27|||
150015347|NCT01677858|541191197|FG002|Overall Study|Lost to Follow-up|0|||
150015348|NCT01677858|541191198|FG003|Overall Study|Lost to Follow-up|0|||
150015349|NCT01677858|541191199|FG004|Overall Study|Lost to Follow-up|1|||
150015350|NCT01331109|541191200|FG000|Overall Study|Adverse Event|6|||
150015351|NCT01331109|541191200|FG000|Overall Study|Lack of Efficacy|2|||
150015352|NCT01331109|541191200|FG000|Overall Study|Protocol Violation|3|||
150015353|NCT01331109|541191200|FG000|Overall Study|Withdrawal by Subject|7|||
150015354|NCT01331109|541191200|FG000|Overall Study|Lost to Follow-up|1|||
150015355|NCT01331109|541191200|FG000|Overall Study|Study Terminated by Sponsor|38|||
150058336|NCT02963831|541355369|FG000|Overall Study|Withdrawal by Subject|1|||
150058337|NCT02963831|541355370|FG001|Overall Study|Withdrawal by Subject|0|||
150058338|NCT02963831|541355371|FG002|Overall Study|Withdrawal by Subject|2|||
150058339|NCT02963831|541355372|FG003|Overall Study|Withdrawal by Subject|4|||
150058340|NCT02963831|541355369|FG000|Overall Study|Adverse Event|0|||
150058341|NCT02963831|541355370|FG001|Overall Study|Adverse Event|1|||
150058342|NCT02963831|541355371|FG002|Overall Study|Adverse Event|1|||
150058343|NCT02963831|541355372|FG003|Overall Study|Adverse Event|2|||
150058344|NCT02963831|541355369|FG000|Overall Study|Death|0|||
150058345|NCT02963831|541355370|FG001|Overall Study|Death|0|||
150058346|NCT02963831|541355371|FG002|Overall Study|Death|0|||
150015356|NCT00988091|541191204|FG000|Double-blind Period|Withdrawal by Subject|15|||
150015357|NCT00988091|541191205|FG001|Double-blind Period|Withdrawal by Subject|13|||
150015358|NCT00988091|541191204|FG000|Double-blind Period|Lost to Follow-up|12|||
150015359|NCT00988091|541191205|FG001|Double-blind Period|Lost to Follow-up|14|||
150015360|NCT00988091|541191204|FG000|Double-blind Period|Other|8|||
150015361|NCT00988091|541191205|FG001|Double-blind Period|Other|8|||
150015362|NCT00988091|541191204|FG000|Double-blind Period|Adverse Event|6|||
150015363|NCT00988091|541191205|FG001|Double-blind Period|Adverse Event|9|||
150015364|NCT00988091|541191204|FG000|Double-blind Period|Use of exclusionary medication|2|||
150015365|NCT00988091|541191205|FG001|Double-blind Period|Use of exclusionary medication|3|||
150015366|NCT00988091|541191204|FG000|Open-label Period|Adverse Event|4|||
150015367|NCT00988091|541191205|FG001|Open-label Period|Adverse Event|7|||
150015368|NCT00988091|541191204|FG000|Open-label Period|Use of exclusionary medication|1|||
150015369|NCT00988091|541191205|FG001|Open-label Period|Use of exclusionary medication|1|||
150015370|NCT00988091|541191204|FG000|Open-label Period|Protocol Violation|1|||
150015371|NCT00988091|541191205|FG001|Open-label Period|Protocol Violation|1|||
150015372|NCT00988091|541191204|FG000|Open-label Period|Withdrawal by Subject|10|||
150015373|NCT00988091|541191205|FG001|Open-label Period|Withdrawal by Subject|16|||
150015374|NCT00988091|541191204|FG000|Open-label Period|Lost to Follow-up|3|||
150015375|NCT00988091|541191205|FG001|Open-label Period|Lost to Follow-up|5|||
150015376|NCT00988091|541191204|FG000|Open-label Period|Other|2|||
150015377|NCT00988091|541191205|FG001|Open-label Period|Other|3|||
150015378|NCT00773747|541191206|FG000|Overall Study|Lack of Efficacy|112|||
150015379|NCT00773747|541191207|FG001|Overall Study|Lack of Efficacy|144|||
150015380|NCT00773747|541191206|FG000|Overall Study|Physician Decision|26|||
150015381|NCT00773747|541191207|FG001|Overall Study|Physician Decision|18|||
150015382|NCT00773747|541191206|FG000|Overall Study|Lost to Follow-up|0|||
150015383|NCT00773747|541191207|FG001|Overall Study|Lost to Follow-up|1|||
150015384|NCT00773747|541191206|FG000|Overall Study|Protocol Violation|2|||
150015385|NCT00773747|541191207|FG001|Overall Study|Protocol Violation|2|||
150015386|NCT00773747|541191206|FG000|Overall Study|Withdrawal by Subject|89|||
150015387|NCT00773747|541191207|FG001|Overall Study|Withdrawal by Subject|61|||
150015388|NCT00773747|541191206|FG000|Overall Study|Adverse Event|61|||
150015389|NCT00773747|541191207|FG001|Overall Study|Adverse Event|62|||
150058347|NCT02963831|541355372|FG003|Overall Study|Death|2|||
150058348|NCT01966432|541355373|FG000|Overall Study|Lost to Follow-up|3|||
150058349|NCT01966432|541355374|FG001|Overall Study|Lost to Follow-up|2|||
150058350|NCT01966432|541355375|FG002|Overall Study|Lost to Follow-up|5|||
150058351|NCT01966432|541355373|FG000|Overall Study|Withdrawal by Subject|1|||
150058352|NCT01966432|541355374|FG001|Overall Study|Withdrawal by Subject|3|||
150058353|NCT01966432|541355375|FG002|Overall Study|Withdrawal by Subject|0|||
150058354|NCT01966432|541355373|FG000|Overall Study|Subject Incarcerated|0|||
150058355|NCT01966432|541355374|FG001|Overall Study|Subject Incarcerated|0|||
150058356|NCT01966432|541355375|FG002|Overall Study|Subject Incarcerated|1|||
150058357|NCT01966432|541355373|FG000|Overall Study|SBIRT program ended|1|||
150058358|NCT01966432|541355374|FG001|Overall Study|SBIRT program ended|8|||
150058359|NCT01966432|541355375|FG002|Overall Study|SBIRT program ended|20|||
150058360|NCT02815280|541355377|FG000|Double-Blind Phase|Adverse Event|1|||
150058361|NCT02815280|541355378|FG001|Double-Blind Phase|Adverse Event|1|||
150058362|NCT02815280|541355377|FG000|Double-Blind Phase|Lost to Follow-up|10|||
150058363|NCT02815280|541355378|FG001|Double-Blind Phase|Lost to Follow-up|9|||
150058364|NCT02815280|541355377|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
150058365|NCT02815280|541355378|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
150058366|NCT02815280|541355377|FG000|Double-Blind Phase|Protocol Violation|2|||
150058367|NCT02815280|541355378|FG001|Double-Blind Phase|Protocol Violation|2|||
150058368|NCT02815280|541355377|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
150181344|NCT04766034|541801078|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
150181345|NCT04766034|541801079|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
150181346|NCT04766034|541801080|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
150181347|NCT04766034|541801081|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
150181348|NCT04766034|541801082|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
150181349|NCT04766034|541801078|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
150015390|NCT00773747|541191206|FG000|Overall Study|Death|5|||
150015391|NCT00773747|541191207|FG001|Overall Study|Death|8|||
150015392|NCT00773747|541191206|FG000|Overall Study|Not Treated|2|||
150015393|NCT00773747|541191207|FG001|Overall Study|Not Treated|0|||
150015394|NCT02669212|541191208|FG000|Overall Study|Lost to Follow-up|1|||
150015395|NCT02669212|541191209|FG001|Overall Study|Lost to Follow-up|0|||
150015396|NCT02669212|541191208|FG000|Overall Study|Medical Condition|3|||
150058369|NCT02815280|541355378|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
150058370|NCT02815280|541355377|FG000|Open-Label Phase|Adverse Event|2|||
150058371|NCT02815280|541355378|FG001|Open-Label Phase|Adverse Event|3|||
150015397|NCT02669212|541191209|FG001|Overall Study|Medical Condition|4|||
150015398|NCT02669212|541191208|FG000|Overall Study|Withdrawal by Subject|0|||
150015399|NCT02669212|541191209|FG001|Overall Study|Withdrawal by Subject|2|||
150015400|NCT02669212|541191208|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
150015401|NCT02669212|541191209|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
150015402|NCT03549104|541191210|FG000|Overall Study|Withdrawal by Subject|5|||
150015403|NCT03549104|541191211|FG001|Overall Study|Withdrawal by Subject|2|||
150015404|NCT03549104|541191210|FG000|Overall Study|Covid shelter in place|1|||
150015405|NCT03549104|541191211|FG001|Overall Study|Covid shelter in place|2|||
150015406|NCT01973998|541191212|FG000|Overall Study|Death|2|||
150015407|NCT01973998|541191213|FG001|Overall Study|Death|2|||
150015408|NCT00646399|541191214|FG000|Overall Study|Death|63|||
150015409|NCT00646399|541191215|FG001|Overall Study|Death|53|||
150015410|NCT00646399|541191214|FG000|Overall Study|Withdrawal by Subject|9|||
150015411|NCT00646399|541191215|FG001|Overall Study|Withdrawal by Subject|10|||
150015412|NCT00646399|541191214|FG000|Overall Study|Other Reason|11|||
150015413|NCT00646399|541191215|FG001|Overall Study|Other Reason|11|||
150015414|NCT04929249|541191219|FG000|Overall Study|Adverse Event|2|||
150015415|NCT04929249|541191220|FG001|Overall Study|Adverse Event|1|||
150015416|NCT04929249|541191219|FG000|Overall Study|Death|2|||
150015417|NCT04929249|541191220|FG001|Overall Study|Death|1|||
150015418|NCT04929249|541191219|FG000|Overall Study|Lost to Follow-up|3|||
150015419|NCT04929249|541191220|FG001|Overall Study|Lost to Follow-up|11|||
150015420|NCT04929249|541191219|FG000|Overall Study|Technical problems|0|||
150015421|NCT04929249|541191220|FG001|Overall Study|Technical problems|1|||
150015422|NCT04929249|541191219|FG000|Overall Study|Subject decision|6|||
150015423|NCT04929249|541191220|FG001|Overall Study|Subject decision|8|||
150015424|NCT04929249|541191219|FG000|Overall Study|Withdrew consent|0|||
150015425|NCT04929249|541191220|FG001|Overall Study|Withdrew consent|8|||
150015426|NCT02540993|541191221|FG000|Overall Study|Lost to Follow-up|5|||
150015427|NCT02540993|541191222|FG001|Overall Study|Lost to Follow-up|3|||
150015428|NCT02540993|541191221|FG000|Overall Study|Withdrawal by Subject|4|||
150015429|NCT02540993|541191222|FG001|Overall Study|Withdrawal by Subject|6|||
150015430|NCT02540993|541191221|FG000|Overall Study|GCP violations|33|||
150015431|NCT02540993|541191222|FG001|Overall Study|GCP violations|27|||
150015432|NCT01620528|541191223|FG000|Treatment Period|Did Not Receive Study Drug|0|||
150015433|NCT01620528|541191224|FG001|Treatment Period|Did Not Receive Study Drug|0|||
150015434|NCT01620528|541191225|FG002|Treatment Period|Did Not Receive Study Drug|1|||
150015435|NCT01620528|541191223|FG000|Treatment Period|Withdrawal by Subject|35|||
150015436|NCT01620528|541191224|FG001|Treatment Period|Withdrawal by Subject|21|||
150015437|NCT01620528|541191225|FG002|Treatment Period|Withdrawal by Subject|16|||
150015438|NCT01620528|541191223|FG000|Treatment Period|Adverse Event|17|||
150015439|NCT01620528|541191224|FG001|Treatment Period|Adverse Event|13|||
150015440|NCT01620528|541191225|FG002|Treatment Period|Adverse Event|21|||
150015441|NCT01620528|541191223|FG000|Treatment Period|Lost to Follow-up|16|||
150015442|NCT01620528|541191224|FG001|Treatment Period|Lost to Follow-up|8|||
150015443|NCT01620528|541191225|FG002|Treatment Period|Lost to Follow-up|14|||
150015444|NCT01620528|541191223|FG000|Treatment Period|Other|9|||
150015445|NCT01620528|541191224|FG001|Treatment Period|Other|5|||
150015446|NCT01620528|541191225|FG002|Treatment Period|Other|7|||
150015447|NCT01620528|541191223|FG000|Treatment Period|Subject Noncompliant|11|||
150015448|NCT01620528|541191224|FG001|Treatment Period|Subject Noncompliant|2|||
150015449|NCT01620528|541191225|FG002|Treatment Period|Subject Noncompliant|2|||
150015450|NCT01620528|541191223|FG000|Treatment Period|Pregnancy|7|||
150015451|NCT01620528|541191224|FG001|Treatment Period|Pregnancy|2|||
150015452|NCT01620528|541191225|FG002|Treatment Period|Pregnancy|2|||
150015453|NCT01620528|541191223|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
150015454|NCT01620528|541191224|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
150015455|NCT01620528|541191225|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
150015456|NCT01620528|541191223|FG000|Treatment Period|Exclusionary Medication Received|0|||
150015457|NCT01620528|541191224|FG001|Treatment Period|Exclusionary Medication Received|1|||
150015458|NCT01620528|541191225|FG002|Treatment Period|Exclusionary Medication Received|0|||
150015459|NCT01620528|541191223|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
150015460|NCT01620528|541191224|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
150015461|NCT01620528|541191225|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
150015462|NCT01620528|541191223|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
150015463|NCT01620528|541191224|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
150015464|NCT01620528|541191225|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
150015465|NCT01620528|541191223|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
150015466|NCT01620528|541191224|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
150015467|NCT01620528|541191225|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
150015468|NCT01620528|541191223|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
150015469|NCT01620528|541191224|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
150015470|NCT01620528|541191225|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
150015471|NCT01620528|541191223|FG000|Post-Treatment Follow-Up Period|Other|6|||
150015472|NCT01620528|541191224|FG001|Post-Treatment Follow-Up Period|Other|4|||
150015473|NCT01620528|541191225|FG002|Post-Treatment Follow-Up Period|Other|2|||
150015474|NCT02202538|541191226|FG000|Overall Study|Withdrawal by Subject|5|||
150015475|NCT02202538|541191226|FG000|Overall Study|Did not meet all inclusion criteria|2|||
150015476|NCT02202538|541191226|FG000|Overall Study|Investigator Decision|1|||
150015477|NCT03997825|541191227|FG000|Overall Study|Death|3|||
150015478|NCT03997825|541191227|FG000|Overall Study|Lost to Follow-up|10|||
150015479|NCT03997825|541191227|FG000|Overall Study|Withdrawal by Subject|3|||
150015480|NCT03997825|541191227|FG000|Overall Study|Refused participation|1|||
150015481|NCT00767819|541191228|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
150015482|NCT00767819|541191229|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
150015483|NCT00767819|541191230|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
150015484|NCT00767819|541191228|FG000|Overall Study|Withdrawal by Subject|1|||
150015485|NCT00767819|541191229|FG001|Overall Study|Withdrawal by Subject|1|||
150015486|NCT00767819|541191230|FG002|Overall Study|Withdrawal by Subject|0|||
150015487|NCT00767819|541191228|FG000|Overall Study|Administrative problems|0|||
150015488|NCT00767819|541191229|FG001|Overall Study|Administrative problems|1|||
150015489|NCT00767819|541191230|FG002|Overall Study|Administrative problems|0|||
150015490|NCT00767819|541191228|FG000|Overall Study|Death|2|||
150015491|NCT00767819|541191229|FG001|Overall Study|Death|3|||
150015492|NCT00767819|541191230|FG002|Overall Study|Death|0|||
150015493|NCT00767819|541191228|FG000|Overall Study|Adverse Event|2|||
150015494|NCT00767819|541191229|FG001|Overall Study|Adverse Event|0|||
150015495|NCT00767819|541191230|FG002|Overall Study|Adverse Event|0|||
150015496|NCT00767819|541191228|FG000|Overall Study|Abnormal lab values|1|||
150015497|NCT00767819|541191229|FG001|Overall Study|Abnormal lab values|0|||
150015498|NCT00767819|541191230|FG002|Overall Study|Abnormal lab values|0|||
150015499|NCT00767819|541191228|FG000|Overall Study|Lost to Follow-up|1|||
150015500|NCT00767819|541191229|FG001|Overall Study|Lost to Follow-up|0|||
150015501|NCT00767819|541191230|FG002|Overall Study|Lost to Follow-up|0|||
150058372|NCT02815280|541355377|FG000|Open-Label Phase|Lost to Follow-up|18|||
150015502|NCT01153698|541191231|FG000|Overall Study|Adverse Event|12|||
150015503|NCT01153698|541191231|FG000|Overall Study|Lost to Follow-up|4|||
150015504|NCT01153698|541191231|FG000|Overall Study|Withdrawal by Subject|2|||
150015505|NCT01153698|541191231|FG000|Overall Study|Switch to other anticoagulants|4|||
150015506|NCT01153698|541191231|FG000|Overall Study|Other|2|||
150015507|NCT01153698|541191231|FG000|Overall Study|Not treated with Pradaxa|5|||
150015508|NCT02332291|541191235|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
150015509|NCT02332291|541191236|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
150015510|NCT02332291|541191235|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
150015511|NCT02332291|541191236|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
150015512|NCT02332291|541191235|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
150015513|NCT02332291|541191236|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
150015514|NCT02332291|541191235|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
150015515|NCT02332291|541191236|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
150015516|NCT02332291|541191235|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
150015517|NCT02332291|541191236|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
150015518|NCT02332291|541191235|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
150015519|NCT02332291|541191236|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
150015520|NCT00699335|541191237|FG000|Overall Study|Combination of multiple reasons|176|||
150015521|NCT00699335|541191237|FG000|Overall Study|Missing data|52|||
150015522|NCT01371305|541191242|FG000|Overall Study|Adverse Event|0|||
150015523|NCT01371305|541191243|FG001|Overall Study|Adverse Event|0|||
150015524|NCT01371305|541191244|FG002|Overall Study|Adverse Event|0|||
150015525|NCT01371305|541191245|FG003|Overall Study|Adverse Event|2|||
150015526|NCT01371305|541191246|FG004|Overall Study|Adverse Event|1|||
150015527|NCT01371305|541191247|FG005|Overall Study|Adverse Event|0|||
150015528|NCT01371305|541191242|FG000|Overall Study|Study terminated by sponsor|0|||
150015529|NCT01371305|541191243|FG001|Overall Study|Study terminated by sponsor|0|||
150015530|NCT01371305|541191244|FG002|Overall Study|Study terminated by sponsor|0|||
150015531|NCT01371305|541191245|FG003|Overall Study|Study terminated by sponsor|0|||
150015532|NCT01371305|541191246|FG004|Overall Study|Study terminated by sponsor|3|||
150015533|NCT01371305|541191247|FG005|Overall Study|Study terminated by sponsor|1|||
150015534|NCT01371305|541191242|FG000|Overall Study|Subject request|0|||
150015535|NCT01371305|541191243|FG001|Overall Study|Subject request|0|||
150015536|NCT01371305|541191244|FG002|Overall Study|Subject request|0|||
150015537|NCT01371305|541191245|FG003|Overall Study|Subject request|0|||
150015538|NCT01371305|541191246|FG004|Overall Study|Subject request|0|||
150015539|NCT01371305|541191247|FG005|Overall Study|Subject request|1|||
150015540|NCT02220712|541191248|FG000|Overall Study|Adverse Event|1|||
150015541|NCT02220712|541191248|FG000|Overall Study|Withdrawal by Subject|2|||
150015542|NCT02220712|541191248|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
150015543|NCT00760838|541191252|FG000|Overall Study|Adverse Event|1|||
150015544|NCT00760838|541191253|FG001|Overall Study|Adverse Event|1|||
150015545|NCT00760838|541191252|FG000|Overall Study|Lack of Efficacy|1|||
150015546|NCT00760838|541191253|FG001|Overall Study|Lack of Efficacy|0|||
150015547|NCT00760838|541191252|FG000|Overall Study|Lost to Follow-up|2|||
150015548|NCT00760838|541191253|FG001|Overall Study|Lost to Follow-up|0|||
150015549|NCT00760838|541191252|FG000|Overall Study|Withdrawal by Subject|1|||
150015550|NCT00760838|541191253|FG001|Overall Study|Withdrawal by Subject|1|||
150015551|NCT01817959|541191254|FG000|Overall Study|Graft loss|1|||
150015552|NCT01817959|541191255|FG001|Overall Study|Graft loss|1|||
150015553|NCT01817959|541191254|FG000|Overall Study|forbidden medication|1|||
150015554|NCT01817959|541191255|FG001|Overall Study|forbidden medication|1|||
150015555|NCT01817959|541191254|FG000|Overall Study|Adverse Event|1|||
150015556|NCT01817959|541191255|FG001|Overall Study|Adverse Event|0|||
150015557|NCT01817959|541191254|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
150015558|NCT01817959|541191255|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
150015559|NCT01628965|541191262|FG000|Overall Study|Adverse Event|30|||
150015560|NCT01628965|541191262|FG000|Overall Study|Lack of Efficacy|7|||
150015561|NCT01628965|541191262|FG000|Overall Study|Withdrawal by Subject|3|||
150015562|NCT01628965|541191262|FG000|Overall Study|Lost to Follow-up|1|||
150015563|NCT01628965|541191262|FG000|Overall Study|Discontinuation criteria|8|||
150015564|NCT00330681|541191263|FG000|Overall Study|Adverse Event|3|||
150015565|NCT00330681|541191264|FG001|Overall Study|Adverse Event|6|||
150015566|NCT00330681|541191263|FG000|Overall Study|Protocol Violation|0|||
150015567|NCT00330681|541191264|FG001|Overall Study|Protocol Violation|1|||
150015568|NCT00330681|541191263|FG000|Overall Study|Withdrawal by Subject|5|||
150015569|NCT00330681|541191264|FG001|Overall Study|Withdrawal by Subject|5|||
150015570|NCT00330681|541191263|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
150015571|NCT00330681|541191264|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
150015572|NCT03597061|541191265|FG000|Overall Study|Lost to Follow-up|1|||
150015573|NCT03597061|541191266|FG001|Overall Study|Lost to Follow-up|0|||
150015574|NCT03597061|541191265|FG000|Overall Study|Protocol Violation|0|||
150015575|NCT03597061|541191266|FG001|Overall Study|Protocol Violation|1|||
150015576|NCT02160145|541191267|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
150015577|NCT02160145|541191268|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
150015578|NCT02160145|541191269|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
150015579|NCT02160145|541191267|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
150015580|NCT02160145|541191268|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
150015581|NCT02160145|541191269|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
150015582|NCT02160145|541191267|FG000|Randomized Double-blind Period|Subject decision|0|||
150015583|NCT02160145|541191268|FG001|Randomized Double-blind Period|Subject decision|21|||
150015584|NCT02160145|541191269|FG002|Randomized Double-blind Period|Subject decision|20|||
150015585|NCT02160145|541191267|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
150015586|NCT02160145|541191268|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
150015587|NCT02160145|541191269|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
150015588|NCT02160145|541191267|FG000|Randomized Double-blind Period|Physician Decision|0|||
150015589|NCT02160145|541191268|FG001|Randomized Double-blind Period|Physician Decision|7|||
150015590|NCT02160145|541191269|FG002|Randomized Double-blind Period|Physician Decision|5|||
150015591|NCT02006979|541191270|FG000|Overall Study|Withdrawal by Subject|1|||
150015592|NCT02006979|541191271|FG001|Overall Study|Withdrawal by Subject|1|||
150015593|NCT02006979|541191270|FG000|Overall Study|Protocol Violation|0|||
150015594|NCT02006979|541191271|FG001|Overall Study|Protocol Violation|1|||
150015595|NCT03170193|541191272|FG000|Overall Study|Withdrawal by Subject|0|||
150015596|NCT03170193|541191273|FG001|Overall Study|Withdrawal by Subject|0|||
150015597|NCT03170193|541191274|FG002|Overall Study|Withdrawal by Subject|0|||
150015598|NCT03170193|541191275|FG003|Overall Study|Withdrawal by Subject|1|||
150015599|NCT03170193|541191276|FG004|Overall Study|Withdrawal by Subject|0|||
150015600|NCT03170193|541191277|FG005|Overall Study|Withdrawal by Subject|0|||
150015601|NCT03170193|541191278|FG006|Overall Study|Withdrawal by Subject|0|||
150015602|NCT03170193|541191272|FG000|Overall Study|Lost to Follow-up|1|||
150015603|NCT03170193|541191273|FG001|Overall Study|Lost to Follow-up|1|||
150015604|NCT03170193|541191274|FG002|Overall Study|Lost to Follow-up|0|||
150015605|NCT03170193|541191275|FG003|Overall Study|Lost to Follow-up|0|||
150015606|NCT03170193|541191276|FG004|Overall Study|Lost to Follow-up|0|||
150015607|NCT03170193|541191277|FG005|Overall Study|Lost to Follow-up|0|||
150015608|NCT03170193|541191278|FG006|Overall Study|Lost to Follow-up|0|||
150015609|NCT00375518|541191279|FG000|Overall Study|Withdrawal by Subject|2|||
150015610|NCT00375518|541191280|FG001|Overall Study|Withdrawal by Subject|10|||
150015611|NCT00375518|541191279|FG000|Overall Study|Patient Not Treated|6|||
150015612|NCT00375518|541191280|FG001|Overall Study|Patient Not Treated|6|||
150015613|NCT00375518|541191279|FG000|Overall Study|Death|0|||
150015614|NCT00375518|541191280|FG001|Overall Study|Death|1|||
150015615|NCT00894361|541192673|FG000|Overall Study|deaths and less than 2 years followup|24|||
150015616|NCT00894361|541192674|FG001|Overall Study|deaths and less than 2 years followup|64|||
150015617|NCT02881762|541192675|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
150015618|NCT02881762|541192676|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
150015619|NCT00994422|541192686|FG000|Overall Study|Lost to Follow-up|7|||
150015620|NCT00994422|541192687|FG001|Overall Study|Lost to Follow-up|1|||
150015621|NCT03078855|541192691|FG000|Overall Study|Lack of Efficacy|62|||
150015622|NCT03078855|541192692|FG001|Overall Study|Lack of Efficacy|31|||
150015623|NCT03078855|541192691|FG000|Overall Study|Death|1|||
150015624|NCT03078855|541192692|FG001|Overall Study|Death|0|||
150015625|NCT03078855|541192691|FG000|Overall Study|Withdrawal by Subject|12|||
150015626|NCT03078855|541192692|FG001|Overall Study|Withdrawal by Subject|6|||
150015627|NCT03078855|541192691|FG000|Overall Study|Physician Decision|3|||
150015628|NCT03078855|541192692|FG001|Overall Study|Physician Decision|2|||
150015629|NCT03078855|541192691|FG000|Overall Study|Second Malignancy|4|||
150015630|NCT03078855|541192692|FG001|Overall Study|Second Malignancy|0|||
150015631|NCT03078855|541192691|FG000|Overall Study|Ineligible|2|||
150015632|NCT03078855|541192692|FG001|Overall Study|Ineligible|0|||
150015633|NCT03078855|541192691|FG000|Overall Study|Withdrew before day 1 treatment|2|||
150015634|NCT03078855|541192692|FG001|Overall Study|Withdrew before day 1 treatment|1|||
150015635|NCT00391027|541192693|FG000|Overall Study|Adverse Event|8|||
150015636|NCT00391027|541192694|FG001|Overall Study|Adverse Event|8|||
150015637|NCT00391027|541192693|FG000|Overall Study|Lack of Efficacy|3|||
150015638|NCT00391027|541192694|FG001|Overall Study|Lack of Efficacy|0|||
150015639|NCT00391027|541192693|FG000|Overall Study|Withdrawal by Subject|10|||
150015640|NCT00391027|541192694|FG001|Overall Study|Withdrawal by Subject|1|||
150015641|NCT00391027|541192693|FG000|Overall Study|Other|4|||
150015642|NCT00391027|541192694|FG001|Overall Study|Other|3|||
150015643|NCT03422536|541192695|FG000|Randomized|Physician Decision|1|||
150015644|NCT03422536|541192696|FG001|Randomized|Physician Decision|1|||
150015645|NCT03422536|541192695|FG000|Allocation - Received Intervention|Disease progression|19|||
150015646|NCT03422536|541192696|FG001|Allocation - Received Intervention|Disease progression|25|||
150015647|NCT03422536|541192695|FG000|Allocation - Received Intervention|Death|1|||
150015648|NCT03422536|541192696|FG001|Allocation - Received Intervention|Death|3|||
150015649|NCT03422536|541192695|FG000|Allocation - Received Intervention|Adverse Event|1|||
150015650|NCT03422536|541192696|FG001|Allocation - Received Intervention|Adverse Event|0|||
150015651|NCT03422536|541192695|FG000|Allocation - Received Intervention|Physician Decision|1|||
150015652|NCT03422536|541192696|FG001|Allocation - Received Intervention|Physician Decision|1|||
150015653|NCT03422536|541192695|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
150015654|NCT03422536|541192696|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
150015655|NCT03422536|541192695|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
150015656|NCT03422536|541192696|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
150015657|NCT00532298|541192697|FG000|Overall Study|Adverse Event|1|||
150015658|NCT00532298|541192698|FG001|Overall Study|Adverse Event|0|||
150015659|NCT00532298|541192699|FG002|Overall Study|Adverse Event|0|||
150015660|NCT00532298|541192700|FG003|Overall Study|Adverse Event|0|||
150015661|NCT00532298|541192701|FG004|Overall Study|Adverse Event|1|||
150015662|NCT00532298|541192702|FG005|Overall Study|Adverse Event|1|||
150015663|NCT00532298|541192697|FG000|Overall Study|Lost to Follow-up|1|||
150015664|NCT00532298|541192698|FG001|Overall Study|Lost to Follow-up|1|||
150015665|NCT00532298|541192699|FG002|Overall Study|Lost to Follow-up|1|||
150015666|NCT00532298|541192700|FG003|Overall Study|Lost to Follow-up|0|||
150015667|NCT00532298|541192701|FG004|Overall Study|Lost to Follow-up|0|||
150015668|NCT00532298|541192702|FG005|Overall Study|Lost to Follow-up|1|||
150015669|NCT00479856|541192703|FG000|Overall Study|Adverse Event|1|||
150015670|NCT00479856|541192703|FG000|Overall Study|Withdrawal by Subject|1|||
150015671|NCT00479856|541192703|FG000|Overall Study|Physician Decision|1|||
150015672|NCT04164732|541192710|FG000|Treatment run-in Period|Adverse Event|4|||
150015673|NCT04164732|541192711|FG001|Treatment run-in Period|Adverse Event|0|||
150015674|NCT04164732|541192712|FG002|Treatment run-in Period|Adverse Event|0|||
150015675|NCT04164732|541192710|FG000|Treatment run-in Period|Physician Decision|1|||
150015676|NCT04164732|541192711|FG001|Treatment run-in Period|Physician Decision|0|||
150015677|NCT04164732|541192712|FG002|Treatment run-in Period|Physician Decision|0|||
150015678|NCT04164732|541192710|FG000|Treatment run-in Period|Screen Failure|1|||
150015679|NCT04164732|541192711|FG001|Treatment run-in Period|Screen Failure|0|||
150015680|NCT04164732|541192712|FG002|Treatment run-in Period|Screen Failure|0|||
150015681|NCT04164732|541192710|FG000|Randomized Treatment Period|Adverse Event|0|||
150015682|NCT04164732|541192711|FG001|Randomized Treatment Period|Adverse Event|1|||
150015683|NCT04164732|541192712|FG002|Randomized Treatment Period|Adverse Event|0|||
150015684|NCT04164732|541192710|FG000|Randomized Treatment Period|Protocol Deviation|0|||
150015685|NCT04164732|541192711|FG001|Randomized Treatment Period|Protocol Deviation|1|||
150015686|NCT04164732|541192712|FG002|Randomized Treatment Period|Protocol Deviation|1|||
150015687|NCT04164732|541192710|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
150015688|NCT04164732|541192711|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
150015689|NCT04164732|541192712|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
150015690|NCT00661622|541192713|FG000|Overall Study|Protocol Violation|1|||
150015691|NCT00661622|541192714|FG001|Overall Study|Protocol Violation|0|||
150015692|NCT04765202|541192717|FG000|Overall Study|Lost to Follow-up|1|||
150015693|NCT04765202|541192718|FG001|Overall Study|Lost to Follow-up|1|||
150015694|NCT04765202|541192719|FG002|Overall Study|Lost to Follow-up|2|||
150015695|NCT04765202|541192720|FG003|Overall Study|Lost to Follow-up|2|||
150015696|NCT04765202|541192717|FG000|Overall Study|Physician Decision|0|||
150015697|NCT04765202|541192718|FG001|Overall Study|Physician Decision|0|||
150015698|NCT04765202|541192719|FG002|Overall Study|Physician Decision|1|||
150015699|NCT04765202|541192720|FG003|Overall Study|Physician Decision|1|||
150015700|NCT01636986|541192723|FG000|Overall Study|Withdrawal by Subject|0|||
150015701|NCT01636986|541192724|FG001|Overall Study|Withdrawal by Subject|1|||
150015702|NCT01636986|541192723|FG000|Overall Study|Corneal Staining|0|||
150015703|NCT01636986|541192724|FG001|Overall Study|Corneal Staining|1|||
150015704|NCT00395850|541192726|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
150015705|NCT00395850|541192727|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
150015706|NCT00395850|541192728|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
150015707|NCT00395850|541192729|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
150015708|NCT00395850|541192726|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
150015709|NCT00395850|541192727|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
150015710|NCT00395850|541192728|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
150015711|NCT00395850|541192729|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
150015712|NCT00395850|541192726|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
150015713|NCT00395850|541192727|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
150015714|NCT00395850|541192728|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
150015715|NCT00395850|541192729|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
150015716|NCT00395850|541192726|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
150015717|NCT00395850|541192727|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
150015718|NCT00395850|541192728|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
150015719|NCT00395850|541192729|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
150015720|NCT00395850|541192726|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
150015721|NCT00395850|541192727|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
150015722|NCT00395850|541192728|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
150015723|NCT00395850|541192729|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
150015724|NCT00395850|541192726|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
150015725|NCT00395850|541192727|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
150015726|NCT00395850|541192728|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
150058373|NCT02815280|541355378|FG001|Open-Label Phase|Lost to Follow-up|9|||
150015727|NCT00395850|541192729|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
150015728|NCT00395850|541192726|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
150015729|NCT00395850|541192727|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
150015730|NCT00395850|541192728|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
150015731|NCT00395850|541192729|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
150015732|NCT01620762|541192736|FG000|Overall Study|Protocol Violation|1|||
150058374|NCT02815280|541355377|FG000|Open-Label Phase|Withdrawal by Subject|33|||
150058375|NCT02815280|541355378|FG001|Open-Label Phase|Withdrawal by Subject|18|||
150058376|NCT02815280|541355377|FG000|Open-Label Phase|Protocol Violation|3|||
150058377|NCT02815280|541355378|FG001|Open-Label Phase|Protocol Violation|0|||
150058378|NCT02815280|541355377|FG000|Open-Label Phase|Administrative|26|||
150058379|NCT02815280|541355378|FG001|Open-Label Phase|Administrative|12|||
150058380|NCT02815280|541355377|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
150015733|NCT01620762|541192737|FG001|Overall Study|Protocol Violation|1|||
150058381|NCT02815280|541355378|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
150058382|NCT02514473|541355386|FG000|Overall Study|Adverse Event|0|||
150058383|NCT02514473|541355387|FG001|Overall Study|Adverse Event|2|||
150058384|NCT02514473|541355386|FG000|Overall Study|Withdrawal by Subject|2|||
150058385|NCT02514473|541355387|FG001|Overall Study|Withdrawal by Subject|1|||
150058386|NCT02514473|541355386|FG000|Overall Study|Lost to Follow-up|0|||
150015734|NCT01620762|541192738|FG002|Overall Study|Protocol Violation|1|||
150015735|NCT01620762|541192736|FG000|Overall Study|Adverse Event|9|||
150015736|NCT01620762|541192737|FG001|Overall Study|Adverse Event|5|||
150015737|NCT01620762|541192738|FG002|Overall Study|Adverse Event|2|||
150015738|NCT01620762|541192736|FG000|Overall Study|Withdrawal by Subject|23|||
150015739|NCT01620762|541192737|FG001|Overall Study|Withdrawal by Subject|26|||
150015740|NCT01620762|541192738|FG002|Overall Study|Withdrawal by Subject|27|||
150015741|NCT01620762|541192736|FG000|Overall Study|Lost to Follow-up|11|||
150015742|NCT01620762|541192737|FG001|Overall Study|Lost to Follow-up|17|||
150015743|NCT01620762|541192738|FG002|Overall Study|Lost to Follow-up|10|||
150015744|NCT01620762|541192736|FG000|Overall Study|Protocol deviation|1|||
150015745|NCT01620762|541192737|FG001|Overall Study|Protocol deviation|1|||
150015746|NCT01620762|541192738|FG002|Overall Study|Protocol deviation|6|||
150015747|NCT01620762|541192736|FG000|Overall Study|Subject deterioration|0|||
150015748|NCT01620762|541192737|FG001|Overall Study|Subject deterioration|1|||
150015749|NCT01620762|541192738|FG002|Overall Study|Subject deterioration|1|||
150015750|NCT01620762|541192736|FG000|Overall Study|Non-specified|3|||
150015751|NCT01620762|541192737|FG001|Overall Study|Non-specified|6|||
150015752|NCT01620762|541192738|FG002|Overall Study|Non-specified|5|||
150015753|NCT01620762|541192736|FG000|Overall Study|Use of prohibted therapies|0|||
150015754|NCT01620762|541192737|FG001|Overall Study|Use of prohibted therapies|1|||
150015755|NCT01620762|541192738|FG002|Overall Study|Use of prohibted therapies|1|||
150015756|NCT00705146|541192739|FG000|Overall Study|Lost to Follow-up|1|||
150015757|NCT00705146|541192740|FG001|Overall Study|Lost to Follow-up|1|||
150015758|NCT00095173|541192741|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
150015759|NCT00095173|541192742|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
150015760|NCT00095173|541192743|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
150015761|NCT00095173|541192744|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
150015762|NCT00095173|541192745|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
150015763|NCT00095173|541192746|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
150015764|NCT00095173|541192741|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
150015765|NCT00095173|541192742|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
150015766|NCT00095173|541192743|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
150015767|NCT00095173|541192744|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
150015768|NCT00095173|541192745|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
150015769|NCT00095173|541192746|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
150015770|NCT00095173|541192741|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
150015771|NCT00095173|541192742|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
150015772|NCT00095173|541192743|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
150015773|NCT00095173|541192744|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
150015774|NCT00095173|541192745|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
150015775|NCT00095173|541192746|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
150015776|NCT00095173|541192741|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
150015777|NCT00095173|541192742|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
150015778|NCT00095173|541192743|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
150015779|NCT00095173|541192744|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
150015780|NCT00095173|541192745|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
150015781|NCT00095173|541192746|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
150015782|NCT00095173|541192741|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
150015783|NCT00095173|541192742|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
150015784|NCT00095173|541192743|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
150015785|NCT00095173|541192744|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
150015786|NCT00095173|541192745|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
150015787|NCT00095173|541192746|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
150015788|NCT00095173|541192741|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
150015789|NCT00095173|541192742|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
150015790|NCT00095173|541192743|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
150015791|NCT00095173|541192744|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
150015792|NCT00095173|541192745|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
150015793|NCT00095173|541192746|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
150015794|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Death|0|||
150058387|NCT02514473|541355387|FG001|Overall Study|Lost to Follow-up|1|||
150058388|NCT02514473|541355386|FG000|Overall Study|Other|1|||
150058389|NCT02514473|541355387|FG001|Overall Study|Other|1|||
150058390|NCT04381988|541355390|FG000|Overall Study|The study was terminated|4|||
150058391|NCT04381988|541355391|FG001|Overall Study|The study was terminated|0|||
150058392|NCT03915860|541355392|FG000|Overall Study|Adverse Event|3|||
150058393|NCT03915860|541355392|FG000|Overall Study|Withdrawal by Subject|6|||
150058394|NCT03915860|541355392|FG000|Overall Study|Lost to Follow-up|2|||
150058395|NCT03915860|541355392|FG000|Overall Study|Other than specified|3|||
150058396|NCT01107379|541355396|FG000|Overall Study|Withdrawal by Subject|18|||
150058397|NCT01107379|541355396|FG000|Overall Study|Lost to Follow-up|3|||
150058398|NCT04559529|541355397|FG000|First Intervention (1 Day)|Adverse Event|0|||
150058399|NCT04559529|541355398|FG001|First Intervention (1 Day)|Adverse Event|0|||
150058400|NCT04559529|541355399|FG002|First Intervention (1 Day)|Adverse Event|0|||
150058401|NCT04559529|541355400|FG003|First Intervention (1 Day)|Adverse Event|1|||
150058402|NCT04559529|541355397|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
150058403|NCT04559529|541355398|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
150058404|NCT04559529|541355399|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
150058405|NCT04559529|541355400|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
150058406|NCT04559529|541355397|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
150058407|NCT04559529|541355398|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
150058408|NCT04559529|541355399|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
150058409|NCT04559529|541355400|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
150015795|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Death|0|||
150015796|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Death|0|||
150015797|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Death|0|||
150015798|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Death|0|||
150015799|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Death|1|||
150015800|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
150015801|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
150015802|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
150015803|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
150015804|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
150015805|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
150015806|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
150015807|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
150015808|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
150015809|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
150015810|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
150015811|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
150015812|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
150015813|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
150015814|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
150015815|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
150015816|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
150015817|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
150015818|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
150015819|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
150015820|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
150015821|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
150015822|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
150015823|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
150015824|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
150015825|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
150015826|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
150015827|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
150015828|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
150015829|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
150015830|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
150015831|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
150015832|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
150015833|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
150015834|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
150015835|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
150015836|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
150015837|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
150015838|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
150015839|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
150015840|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
150015841|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
150015842|NCT00095173|541192741|FG000|Open-Label Extension Phase (Period C)|Other|0|||
150015843|NCT00095173|541192742|FG001|Open-Label Extension Phase (Period C)|Other|0|||
150015844|NCT00095173|541192743|FG002|Open-Label Extension Phase (Period C)|Other|0|||
150015845|NCT00095173|541192744|FG003|Open-Label Extension Phase (Period C)|Other|4|||
150015846|NCT00095173|541192745|FG004|Open-Label Extension Phase (Period C)|Other|6|||
150015847|NCT00095173|541192746|FG005|Open-Label Extension Phase (Period C)|Other|8|||
150015848|NCT02161757|541192751|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
150015849|NCT02161757|541192752|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
150015850|NCT02161757|541192753|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
150015851|NCT02161757|541192751|FG000|Treatment Through Study Completion|Adverse Event|1|||
150015852|NCT02161757|541192752|FG001|Treatment Through Study Completion|Adverse Event|1|||
150058410|NCT01009281|541355401|FG000|Overall Study|Administrative problems|7|||
150058411|NCT00548405|541355402|FG000|Overall Study|Adverse Event|6|||
150058412|NCT00548405|541355403|FG001|Overall Study|Adverse Event|2|||
150058413|NCT00548405|541355404|FG002|Overall Study|Adverse Event|0|||
150058414|NCT00548405|541355402|FG000|Overall Study|Lack of Efficacy|6|||
150058415|NCT00548405|541355403|FG001|Overall Study|Lack of Efficacy|0|||
150015853|NCT02161757|541192753|FG002|Treatment Through Study Completion|Adverse Event|0|||
150015854|NCT02161757|541192751|FG000|Treatment Through Study Completion|Protocol Violation|0|||
150015855|NCT02161757|541192752|FG001|Treatment Through Study Completion|Protocol Violation|1|||
150015856|NCT02161757|541192753|FG002|Treatment Through Study Completion|Protocol Violation|2|||
150015857|NCT02161757|541192751|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
150015858|NCT02161757|541192752|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
150015859|NCT02161757|541192753|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
150015860|NCT02161757|541192751|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
150015861|NCT02161757|541192752|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
150015862|NCT02161757|541192753|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
150015863|NCT02161757|541192751|FG000|Treatment Through Study Completion|Other|20|||
150015864|NCT02161757|541192752|FG001|Treatment Through Study Completion|Other|19|||
150015865|NCT02161757|541192753|FG002|Treatment Through Study Completion|Other|12|||
150015866|NCT02161757|541192751|FG000|Treatment Through Study Completion|Death|2|||
150015867|NCT02161757|541192752|FG001|Treatment Through Study Completion|Death|1|||
150015868|NCT02161757|541192753|FG002|Treatment Through Study Completion|Death|1|||
150015869|NCT00391625|541192754|FG000|Month 14|Withdrawal by Subject|1|||
150015870|NCT00391625|541192754|FG000|Month 50|Physician Decision|1|||
150015871|NCT03664765|541192755|FG000|Overall Study|Withdrawal by Subject|4|||
150015872|NCT03664765|541192756|FG001|Overall Study|Withdrawal by Subject|1|||
150058416|NCT00548405|541355404|FG002|Overall Study|Lack of Efficacy|0|||
150058417|NCT00548405|541355402|FG000|Overall Study|Physician Decision|3|||
150058418|NCT00548405|541355403|FG001|Overall Study|Physician Decision|4|||
150058419|NCT00548405|541355404|FG002|Overall Study|Physician Decision|1|||
150058420|NCT00548405|541355402|FG000|Overall Study|Pregnancy|1|||
150058421|NCT00548405|541355403|FG001|Overall Study|Pregnancy|0|||
150058422|NCT00548405|541355404|FG002|Overall Study|Pregnancy|0|||
150058423|NCT00548405|541355402|FG000|Overall Study|Protocol Violation|1|||
150058424|NCT00548405|541355403|FG001|Overall Study|Protocol Violation|0|||
150058425|NCT00548405|541355404|FG002|Overall Study|Protocol Violation|0|||
150058426|NCT00548405|541355402|FG000|Overall Study|Withdrawal by Subject|36|||
150058427|NCT00548405|541355403|FG001|Overall Study|Withdrawal by Subject|12|||
150058428|NCT00548405|541355404|FG002|Overall Study|Withdrawal by Subject|5|||
150058429|NCT00548405|541355402|FG000|Overall Study|Lost to Follow-up|1|||
150058430|NCT00548405|541355403|FG001|Overall Study|Lost to Follow-up|1|||
150058431|NCT00548405|541355404|FG002|Overall Study|Lost to Follow-up|2|||
150058432|NCT00548405|541355402|FG000|Overall Study|Death|0|||
150058433|NCT00548405|541355403|FG001|Overall Study|Death|1|||
150058434|NCT00548405|541355404|FG002|Overall Study|Death|1|||
150058435|NCT00548405|541355402|FG000|Overall Study|Sponsor decision|1|||
150058436|NCT00548405|541355403|FG001|Overall Study|Sponsor decision|0|||
150058437|NCT00548405|541355404|FG002|Overall Study|Sponsor decision|0|||
150058438|NCT00548405|541355402|FG000|Overall Study|Randomized but not treated|1|||
150058439|NCT00548405|541355403|FG001|Overall Study|Randomized but not treated|0|||
150058440|NCT00548405|541355404|FG002|Overall Study|Randomized but not treated|0|||
150058441|NCT00924170|541355405|FG000|Overall Study|Refused further treatment|0|||
150058442|NCT00924170|541355406|FG001|Overall Study|Refused further treatment|1|||
150058443|NCT00924170|541355405|FG000|Overall Study|Physician Decision|0|||
150058444|NCT00924170|541355406|FG001|Overall Study|Physician Decision|1|||
150058445|NCT00924170|541355405|FG000|Overall Study|Progressive disease|3|||
150058446|NCT00924170|541355406|FG001|Overall Study|Progressive disease|6|||
150058447|NCT00924170|541355405|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
150058448|NCT00924170|541355406|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
150058449|NCT00924170|541355405|FG000|Overall Study|Death|1|||
150058450|NCT00924170|541355406|FG001|Overall Study|Death|0|||
150058451|NCT01624870|541355409|FG000|Overall Study|Death|19|||
150058452|NCT01624870|541355409|FG000|Overall Study|Withdrawal by Subject|1|||
150058453|NCT01624870|541355409|FG000|Overall Study|CoreValve not implanted|6|||
150058454|NCT01624870|541355409|FG000|Overall Study|Lost to follow up|1|||
150058455|NCT03901456|541355410|FG000|Overall Study|Withdrawal by Subject|0|||
150015873|NCT03664765|541192755|FG000|Overall Study|Lost to Follow-up|0|||
150015874|NCT03664765|541192756|FG001|Overall Study|Lost to Follow-up|1|||
150015875|NCT01496846|541192757|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
150058456|NCT03901456|541355411|FG001|Overall Study|Withdrawal by Subject|0|||
150058457|NCT03901456|541355412|FG002|Overall Study|Withdrawal by Subject|1|||
150058458|NCT03901456|541355410|FG000|Overall Study|Lost to Follow-up|0|||
150058459|NCT03901456|541355411|FG001|Overall Study|Lost to Follow-up|1|||
150058460|NCT03901456|541355412|FG002|Overall Study|Lost to Follow-up|0|||
150058461|NCT04098224|541355414|FG000|Overall Study|Adverse Event|1|||
150015876|NCT01496846|541192758|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
150015877|NCT01496846|541192759|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
150015878|NCT01496846|541192760|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
150015879|NCT01496846|541192761|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
150015880|NCT01496846|541192762|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
150015881|NCT01772576|541192763|FG000|Overall Study|Death|15|||
150015882|NCT01772576|541192763|FG000|Overall Study|Protocol Violation|1|||
150015883|NCT01772576|541192763|FG000|Overall Study|Lost to Follow-up|3|||
150015884|NCT01772576|541192763|FG000|Overall Study|Study device not used|3|||
150015885|NCT01772576|541192763|FG000|Overall Study|Adverse Event|6|||
150015886|NCT01772576|541192763|FG000|Overall Study|Withdrawal by Subject|6|||
150015887|NCT00923845|541192764|FG000|Induction Therapy|Poor performance status|0|||
150015888|NCT00923845|541192765|FG001|Induction Therapy|Poor performance status|2|||
150015889|NCT00379912|541192766|FG000|Overall Study|Lack of Efficacy|1|||
150015890|NCT00379912|541192767|FG001|Overall Study|Lack of Efficacy|0|||
150015891|NCT02578186|541192768|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
150015892|NCT02578186|541192769|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
150015893|NCT02578186|541192768|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
150015894|NCT02578186|541192769|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
150015895|NCT02873338|541192770|FG000|Overall Study|Adverse Event|0|||
150015896|NCT02873338|541192771|FG001|Overall Study|Adverse Event|2|||
150015897|NCT02873338|541192772|FG002|Overall Study|Adverse Event|1|||
150015898|NCT02873338|541192770|FG000|Overall Study|Death|2|||
150015899|NCT02873338|541192771|FG001|Overall Study|Death|1|||
150181350|NCT04766034|541801079|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
150181351|NCT04766034|541801080|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
150181352|NCT04766034|541801081|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
150181353|NCT04766034|541801082|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
150181354|NCT04766034|541801078|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
150181355|NCT04766034|541801079|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
150181356|NCT04766034|541801080|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
150181357|NCT04766034|541801081|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
150181358|NCT04766034|541801082|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
150181359|NCT04766034|541801078|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
150181360|NCT04766034|541801079|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
150181361|NCT04766034|541801080|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
150181362|NCT04766034|541801081|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
150181363|NCT04766034|541801082|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
150181364|NCT03892564|541801083|FG000|Overall Study|Withdrawal by Subject|2|||
150015900|NCT02873338|541192772|FG002|Overall Study|Death|1|||
150015901|NCT02873338|541192770|FG000|Overall Study|Withdrawal by Subject|2|||
150015902|NCT02873338|541192771|FG001|Overall Study|Withdrawal by Subject|1|||
150058462|NCT04098224|541355415|FG001|Overall Study|Adverse Event|0|||
150015903|NCT02873338|541192772|FG002|Overall Study|Withdrawal by Subject|3|||
150015904|NCT02873338|541192770|FG000|Overall Study|Lack of Efficacy|0|||
150015905|NCT02873338|541192771|FG001|Overall Study|Lack of Efficacy|2|||
150015906|NCT02873338|541192772|FG002|Overall Study|Lack of Efficacy|0|||
150015907|NCT02873338|541192770|FG000|Overall Study|Other or Missing|14|||
150015908|NCT02873338|541192771|FG001|Overall Study|Other or Missing|15|||
150015909|NCT02873338|541192772|FG002|Overall Study|Other or Missing|13|||
150015910|NCT00847197|541192773|FG000|Overall Study|Adverse Event|21|||
150015911|NCT00847197|541192774|FG001|Overall Study|Adverse Event|3|||
150015912|NCT00847197|541192773|FG000|Overall Study|Protocol Violation|0|||
150015913|NCT00847197|541192774|FG001|Overall Study|Protocol Violation|1|||
150015914|NCT00847197|541192773|FG000|Overall Study|Withdrawal by Subject|3|||
150058463|NCT04098224|541355414|FG000|Overall Study|Physician Decision|1|||
150058464|NCT04098224|541355415|FG001|Overall Study|Physician Decision|0|||
150058465|NCT04098224|541355414|FG000|Overall Study|Patient not required enteral feeding|1|||
150058466|NCT04098224|541355415|FG001|Overall Study|Patient not required enteral feeding|0|||
150181365|NCT05094141|541801086|FG000|Overall Study|Death|0|||
150181366|NCT05094141|541801087|FG001|Overall Study|Death|0|||
150015915|NCT00847197|541192774|FG001|Overall Study|Withdrawal by Subject|1|||
150015916|NCT01620944|541192775|FG000|Overall Study|Early termination of Study|2|||
150058467|NCT04098224|541355414|FG000|Overall Study|Patient failure nasogastric tube|1|||
150058468|NCT04098224|541355415|FG001|Overall Study|Patient failure nasogastric tube|0|||
150058469|NCT04098224|541355414|FG000|Overall Study|Patient early extubation|1|||
150058470|NCT04098224|541355415|FG001|Overall Study|Patient early extubation|3|||
150058471|NCT01587898|541355421|FG000|Overall Study|Adverse Event|1|||
150058472|NCT01587898|541355422|FG001|Overall Study|Adverse Event|1|||
150058473|NCT01587898|541355423|FG002|Overall Study|Adverse Event|0|||
150058474|NCT01587898|541355424|FG003|Overall Study|Adverse Event|0|||
150058475|NCT01587898|541355421|FG000|Overall Study|Protocol Violation|0|||
150015917|NCT01620944|541192776|FG001|Overall Study|Early termination of Study|1|||
150015918|NCT04378114|541192777|FG000|Overall Study|Withdrawal by Subject|5|||
150015919|NCT00830180|541192778|FG000|Overall Study|Adverse Event|6|||
150015920|NCT00830180|541192778|FG000|Overall Study|Death|11|||
150015921|NCT00830180|541192778|FG000|Overall Study|Insufficient clinical response|1|||
150015922|NCT00830180|541192778|FG000|Overall Study|Withdrawal by Subject|5|||
150015923|NCT00830180|541192778|FG000|Overall Study|Progressive disease|2|||
150015924|NCT00830180|541192778|FG000|Overall Study|Other - Unspecified|1|||
150015925|NCT01832532|541192780|FG000|Overall Study|Withdrawal by Subject|5|||
150015926|NCT01832532|541192781|FG001|Overall Study|Withdrawal by Subject|2|||
150015927|NCT00392990|541192782|FG000|Treatment on Study|Adverse Event|3|||
150015928|NCT00392990|541192783|FG001|Treatment on Study|Adverse Event|1|||
150058476|NCT01587898|541355422|FG001|Overall Study|Protocol Violation|2|||
150058477|NCT01587898|541355423|FG002|Overall Study|Protocol Violation|1|||
150058478|NCT01587898|541355424|FG003|Overall Study|Protocol Violation|1|||
150058479|NCT01587898|541355421|FG000|Overall Study|Lost to Follow-up|0|||
150058480|NCT01587898|541355422|FG001|Overall Study|Lost to Follow-up|0|||
150058481|NCT01587898|541355423|FG002|Overall Study|Lost to Follow-up|0|||
150058482|NCT01587898|541355424|FG003|Overall Study|Lost to Follow-up|1|||
150058483|NCT01587898|541355421|FG000|Overall Study|Withdrawal by Subject|2|||
150058484|NCT01587898|541355422|FG001|Overall Study|Withdrawal by Subject|1|||
150181367|NCT05094141|541801088|FG002|Overall Study|Death|1|||
150015929|NCT00392990|541192782|FG000|Follow up for 2 Years|Death|4|||
150015930|NCT00392990|541192783|FG001|Follow up for 2 Years|Death|0|||
150015931|NCT00825812|541192787|FG000|Overall Study|Never entered follow up|0|||
150015932|NCT00825812|541192788|FG001|Overall Study|Never entered follow up|0|||
150015933|NCT00825812|541192789|FG002|Overall Study|Never entered follow up|0|||
150015934|NCT00825812|541192790|FG003|Overall Study|Never entered follow up|1|||
150015935|NCT00825812|541192787|FG000|Overall Study|Adverse Event|0|||
150015936|NCT00825812|541192788|FG001|Overall Study|Adverse Event|0|||
150015937|NCT00825812|541192789|FG002|Overall Study|Adverse Event|0|||
150015938|NCT00825812|541192790|FG003|Overall Study|Adverse Event|1|||
150015939|NCT00825812|541192787|FG000|Overall Study|Subject withdrew consent|0|||
150015940|NCT00825812|541192788|FG001|Overall Study|Subject withdrew consent|0|||
150015941|NCT00825812|541192789|FG002|Overall Study|Subject withdrew consent|3|||
150015942|NCT00825812|541192790|FG003|Overall Study|Subject withdrew consent|2|||
150015943|NCT00825812|541192787|FG000|Overall Study|Non-compliance with protocol|0|||
150015944|NCT00825812|541192788|FG001|Overall Study|Non-compliance with protocol|0|||
150015945|NCT00825812|541192789|FG002|Overall Study|Non-compliance with protocol|0|||
150015946|NCT00825812|541192790|FG003|Overall Study|Non-compliance with protocol|1|||
150015947|NCT00825812|541192787|FG000|Overall Study|Administrative|0|||
150015948|NCT00825812|541192788|FG001|Overall Study|Administrative|1|||
150015949|NCT00825812|541192789|FG002|Overall Study|Administrative|3|||
150015950|NCT00825812|541192790|FG003|Overall Study|Administrative|5|||
150015951|NCT00991406|541192792|FG000|Overall Study|One participant did not respond to FES.|1|||
150015952|NCT03824587|541192793|FG000|Run-in Period|Screen Failure|0|||
150015953|NCT03824587|541192794|FG001|Run-in Period|Screen Failure|275|||
150015954|NCT03824587|541192793|FG000|Treatment Period|Adverse Event|4|||
150015955|NCT03824587|541192794|FG001|Treatment Period|Adverse Event|1|||
150015956|NCT03824587|541192793|FG000|Treatment Period|Withdrawal by Subject|0|||
150015957|NCT03824587|541192794|FG001|Treatment Period|Withdrawal by Subject|1|||
150015958|NCT03824587|541192793|FG000|Treatment Period|Kidney Transplant|1|||
150015959|NCT03824587|541192794|FG001|Treatment Period|Kidney Transplant|1|||
150015960|NCT01300572|541192795|FG000|Overall Study|HAMA + post dosimetry|1|||
150015961|NCT00986362|541192796|FG000|Overall Study|Death|2|||
150015962|NCT00986362|541192797|FG001|Overall Study|Death|0|||
150015963|NCT00986362|541192796|FG000|Overall Study|Lost to Follow-up|0|||
150015964|NCT00986362|541192797|FG001|Overall Study|Lost to Follow-up|1|||
150015965|NCT03052816|541192800|FG000|Overall Study|Withdrawal by Subject|1|||
150015966|NCT03052816|541192801|FG001|Overall Study|Withdrawal by Subject|0|||
150015967|NCT03052816|541192800|FG000|Overall Study|Desired opioids|2|||
150015968|NCT03052816|541192801|FG001|Overall Study|Desired opioids|0|||
150015969|NCT03755661|541192804|FG000|Overall Study|Lost to Follow-up|1|||
150015970|NCT03755661|541192805|FG001|Overall Study|Lost to Follow-up|0|||
150015971|NCT00895453|541192806|FG000|Overall Study|Lost to Follow-up|25|||
150015972|NCT00895453|541192807|FG001|Overall Study|Lost to Follow-up|25|||
150058485|NCT01587898|541355423|FG002|Overall Study|Withdrawal by Subject|0|||
150058486|NCT01587898|541355424|FG003|Overall Study|Withdrawal by Subject|0|||
150058487|NCT01587898|541355421|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
150058488|NCT01587898|541355422|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
150058489|NCT01587898|541355423|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
150058490|NCT01587898|541355424|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
150058491|NCT01738477|541355425|FG000|Overall Study|Lost to Follow-up|1|||
150058492|NCT01738477|541355426|FG001|Overall Study|Lost to Follow-up|4|||
150058493|NCT00502203|541355427|FG000|Overall Study|Inevaluable|1|||
150058494|NCT01302834|541355428|FG000|Overall Study|Protocol Violation|17|||
150058495|NCT01302834|541355429|FG001|Overall Study|Protocol Violation|23|||
150058496|NCT01302834|541355428|FG000|Overall Study|HIV positive|1|||
150058497|NCT01302834|541355429|FG001|Overall Study|HIV positive|3|||
150058498|NCT00899392|541355430|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
150058499|NCT00899392|541355431|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
150058500|NCT02437110|541355432|FG000|Screening|Lost to Follow-up|3|||
150058501|NCT02437110|541355432|FG000|Screening|Physician Decision|1|||
150058502|NCT02437110|541355432|FG000|ART|Adverse Event|3|||
150181368|NCT05094141|541801086|FG000|Overall Study|Withdrawal by Subject|0|||
150058503|NCT02437110|541355432|FG000|ART|Protocol Violation|3|||
150181369|NCT05094141|541801087|FG001|Overall Study|Withdrawal by Subject|0|||
150181370|NCT05094141|541801088|FG002|Overall Study|Withdrawal by Subject|1|||
150015973|NCT00895453|541192808|FG002|Overall Study|Lost to Follow-up|23|||
150015974|NCT01736618|541192809|FG000|Overall Study|Death|294|||
150015975|NCT01736618|541192809|FG000|Overall Study|Lost to Follow-up|193|||
150015976|NCT01736618|541192809|FG000|Overall Study|Withdrawal by Subject|54|||
150015977|NCT01736618|541192809|FG000|Overall Study|Subject unable to be followed at study location|223|||
150015978|NCT01736618|541192809|FG000|Overall Study|Physician Decision|33|||
150015979|NCT01736618|541192809|FG000|Overall Study|Transplant or removal of target organ|19|||
150015980|NCT01736618|541192809|FG000|Overall Study|Change in indication or condition|78|||
150015981|NCT01736618|541192809|FG000|Overall Study|Study device explant|103|||
150058504|NCT02437110|541355432|FG000|ART|Withdrawal by Subject|4|||
150058505|NCT02437110|541355432|FG000|ART|Lost to follow-up prior to start of intervention|1|||
150058506|NCT02437110|541355432|FG000|ART|Physician decision prior to start of intervention|2|||
150015982|NCT01736618|541192809|FG000|Overall Study|Unable to complete implant|2|||
150015983|NCT04167137|541192810|FG000|Overall Study|Disease progression|1|||
150015984|NCT04167137|541192811|FG001|Overall Study|Disease progression|1|||
150015985|NCT04167137|541192812|FG002|Overall Study|Disease progression|3|||
150015986|NCT04167137|541192813|FG003|Overall Study|Disease progression|3|||
150015987|NCT04167137|541192814|FG004|Overall Study|Disease progression|2|||
150015988|NCT04167137|541192815|FG005|Overall Study|Disease progression|3|||
150015989|NCT04167137|541192816|FG006|Overall Study|Disease progression|2|||
150015990|NCT04167137|541192817|FG007|Overall Study|Disease progression|2|||
150015991|NCT04167137|541192810|FG000|Overall Study|Withdrawal by Subject|1|||
150015992|NCT04167137|541192811|FG001|Overall Study|Withdrawal by Subject|0|||
150015993|NCT04167137|541192812|FG002|Overall Study|Withdrawal by Subject|0|||
150015994|NCT04167137|541192813|FG003|Overall Study|Withdrawal by Subject|1|||
150015995|NCT04167137|541192814|FG004|Overall Study|Withdrawal by Subject|0|||
150015996|NCT04167137|541192815|FG005|Overall Study|Withdrawal by Subject|2|||
150015997|NCT04167137|541192816|FG006|Overall Study|Withdrawal by Subject|1|||
150015998|NCT04167137|541192817|FG007|Overall Study|Withdrawal by Subject|0|||
150015999|NCT04167137|541192810|FG000|Overall Study|Adverse Event|0|||
150058507|NCT02437110|541355432|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
150058508|NCT02437110|541355432|FG000|Post-ART|Lost to Follow-up|3|||
150058509|NCT02437110|541355432|FG000|Post-ART|Protocol Violation|4|||
150181371|NCT05094141|541801086|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
150016000|NCT04167137|541192811|FG001|Overall Study|Adverse Event|0|||
150016001|NCT04167137|541192812|FG002|Overall Study|Adverse Event|0|||
150016002|NCT04167137|541192813|FG003|Overall Study|Adverse Event|0|||
150016003|NCT04167137|541192814|FG004|Overall Study|Adverse Event|0|||
150016004|NCT04167137|541192815|FG005|Overall Study|Adverse Event|1|||
150016005|NCT04167137|541192816|FG006|Overall Study|Adverse Event|0|||
150016006|NCT04167137|541192817|FG007|Overall Study|Adverse Event|1|||
150016007|NCT04167137|541192810|FG000|Overall Study|Physician Decision|0|||
150016008|NCT04167137|541192811|FG001|Overall Study|Physician Decision|0|||
150016009|NCT04167137|541192812|FG002|Overall Study|Physician Decision|0|||
150016010|NCT04167137|541192813|FG003|Overall Study|Physician Decision|1|||
150016011|NCT04167137|541192814|FG004|Overall Study|Physician Decision|0|||
150016012|NCT04167137|541192815|FG005|Overall Study|Physician Decision|0|||
150016013|NCT04167137|541192816|FG006|Overall Study|Physician Decision|1|||
150016014|NCT04167137|541192817|FG007|Overall Study|Physician Decision|0|||
150016015|NCT04167137|541192810|FG000|Overall Study|Death|0|||
150016016|NCT04167137|541192811|FG001|Overall Study|Death|1|||
150016017|NCT04167137|541192812|FG002|Overall Study|Death|0|||
150016018|NCT04167137|541192813|FG003|Overall Study|Death|0|||
150016019|NCT04167137|541192814|FG004|Overall Study|Death|0|||
150016020|NCT04167137|541192815|FG005|Overall Study|Death|0|||
150016021|NCT04167137|541192816|FG006|Overall Study|Death|0|||
150016022|NCT04167137|541192817|FG007|Overall Study|Death|0|||
150016023|NCT04167137|541192810|FG000|Overall Study|Study terminated by Sponsor|0|||
150016024|NCT04167137|541192811|FG001|Overall Study|Study terminated by Sponsor|0|||
150016025|NCT04167137|541192812|FG002|Overall Study|Study terminated by Sponsor|0|||
150016026|NCT04167137|541192813|FG003|Overall Study|Study terminated by Sponsor|0|||
150016027|NCT04167137|541192814|FG004|Overall Study|Study terminated by Sponsor|0|||
150016028|NCT04167137|541192815|FG005|Overall Study|Study terminated by Sponsor|0|||
150016029|NCT04167137|541192816|FG006|Overall Study|Study terminated by Sponsor|0|||
150016030|NCT04167137|541192817|FG007|Overall Study|Study terminated by Sponsor|1|||
150016031|NCT01748825|541192819|FG000|Dose Escalation|Refused further treatment|2|||
150016032|NCT01748825|541192820|FG001|Dose Escalation|Refused further treatment|2|||
150016033|NCT01748825|541192821|FG002|Dose Escalation|Refused further treatment|0|||
150016034|NCT01748825|541192822|FG003|Dose Escalation|Refused further treatment|0|||
150016035|NCT01748825|541192823|FG004|Dose Escalation|Refused further treatment|1|||
150016036|NCT01748825|541192824|FG005|Dose Escalation|Refused further treatment|2|||
150016037|NCT01748825|541192825|FG006|Dose Escalation|Refused further treatment|0|||
150016038|NCT01748825|541192826|FG007|Dose Escalation|Refused further treatment|0|||
150016039|NCT01748825|541192827|FG008|Dose Escalation|Refused further treatment|0|||
150016040|NCT01748825|541192828|FG009|Dose Escalation|Refused further treatment|0|||
150016041|NCT01748825|541192819|FG000|Dose Escalation|Switched to alternative treatment|0|||
150016042|NCT01748825|541192820|FG001|Dose Escalation|Switched to alternative treatment|0|||
150016043|NCT01748825|541192821|FG002|Dose Escalation|Switched to alternative treatment|0|||
150016044|NCT01748825|541192822|FG003|Dose Escalation|Switched to alternative treatment|1|||
150016045|NCT01748825|541192823|FG004|Dose Escalation|Switched to alternative treatment|0|||
150016046|NCT01748825|541192824|FG005|Dose Escalation|Switched to alternative treatment|0|||
150016047|NCT01748825|541192825|FG006|Dose Escalation|Switched to alternative treatment|0|||
150016048|NCT01748825|541192826|FG007|Dose Escalation|Switched to alternative treatment|0|||
150016049|NCT01748825|541192827|FG008|Dose Escalation|Switched to alternative treatment|0|||
150016050|NCT01748825|541192828|FG009|Dose Escalation|Switched to alternative treatment|0|||
150016051|NCT01748825|541192819|FG000|Dose Escalation|Adverse Event|0|||
150016052|NCT01748825|541192820|FG001|Dose Escalation|Adverse Event|0|||
150016053|NCT01748825|541192821|FG002|Dose Escalation|Adverse Event|0|||
150016054|NCT01748825|541192822|FG003|Dose Escalation|Adverse Event|0|||
150016055|NCT01748825|541192823|FG004|Dose Escalation|Adverse Event|0|||
150016056|NCT01748825|541192824|FG005|Dose Escalation|Adverse Event|0|||
150016057|NCT01748825|541192825|FG006|Dose Escalation|Adverse Event|1|||
150016058|NCT01748825|541192826|FG007|Dose Escalation|Adverse Event|0|||
150016059|NCT01748825|541192827|FG008|Dose Escalation|Adverse Event|0|||
150016060|NCT01748825|541192828|FG009|Dose Escalation|Adverse Event|0|||
150016061|NCT01748825|541192819|FG000|Dose Expansion|Refused further treatment|0|||
150016062|NCT01748825|541192820|FG001|Dose Expansion|Refused further treatment|0|||
150016063|NCT01748825|541192821|FG002|Dose Expansion|Refused further treatment|0|||
150016064|NCT01748825|541192822|FG003|Dose Expansion|Refused further treatment|0|||
150016065|NCT01748825|541192823|FG004|Dose Expansion|Refused further treatment|0|||
150016066|NCT01748825|541192824|FG005|Dose Expansion|Refused further treatment|0|||
150016067|NCT01748825|541192825|FG006|Dose Expansion|Refused further treatment|0|||
150016068|NCT01748825|541192826|FG007|Dose Expansion|Refused further treatment|0|||
150016069|NCT01748825|541192827|FG008|Dose Expansion|Refused further treatment|1|||
150016070|NCT01748825|541192828|FG009|Dose Expansion|Refused further treatment|1|||
150016071|NCT01748825|541192819|FG000|Dose Expansion|Switched to alternative treatment|0|||
150016072|NCT01748825|541192820|FG001|Dose Expansion|Switched to alternative treatment|0|||
150016073|NCT01748825|541192821|FG002|Dose Expansion|Switched to alternative treatment|0|||
150016074|NCT01748825|541192822|FG003|Dose Expansion|Switched to alternative treatment|0|||
150016075|NCT01748825|541192823|FG004|Dose Expansion|Switched to alternative treatment|0|||
150016076|NCT01748825|541192824|FG005|Dose Expansion|Switched to alternative treatment|0|||
150016077|NCT01748825|541192825|FG006|Dose Expansion|Switched to alternative treatment|0|||
150016078|NCT01748825|541192826|FG007|Dose Expansion|Switched to alternative treatment|0|||
150016079|NCT01748825|541192827|FG008|Dose Expansion|Switched to alternative treatment|0|||
150016080|NCT01748825|541192828|FG009|Dose Expansion|Switched to alternative treatment|1|||
150016081|NCT01748825|541192819|FG000|Dose Expansion|Adverse Event|0|||
150016082|NCT01748825|541192820|FG001|Dose Expansion|Adverse Event|0|||
150016083|NCT01748825|541192821|FG002|Dose Expansion|Adverse Event|0|||
150016084|NCT01748825|541192822|FG003|Dose Expansion|Adverse Event|0|||
150016085|NCT01748825|541192823|FG004|Dose Expansion|Adverse Event|0|||
150016086|NCT01748825|541192824|FG005|Dose Expansion|Adverse Event|0|||
150016087|NCT01748825|541192825|FG006|Dose Expansion|Adverse Event|0|||
150016088|NCT01748825|541192826|FG007|Dose Expansion|Adverse Event|0|||
150016089|NCT01748825|541192827|FG008|Dose Expansion|Adverse Event|0|||
150016090|NCT01748825|541192828|FG009|Dose Expansion|Adverse Event|3|||
150016091|NCT01748825|541192819|FG000|Dose Expansion|Physician Decision|0|||
150016092|NCT01748825|541192820|FG001|Dose Expansion|Physician Decision|0|||
150016093|NCT01748825|541192821|FG002|Dose Expansion|Physician Decision|0|||
150016094|NCT01748825|541192822|FG003|Dose Expansion|Physician Decision|0|||
150016095|NCT01748825|541192823|FG004|Dose Expansion|Physician Decision|0|||
150016096|NCT01748825|541192824|FG005|Dose Expansion|Physician Decision|0|||
150016097|NCT01748825|541192825|FG006|Dose Expansion|Physician Decision|0|||
150016098|NCT01748825|541192826|FG007|Dose Expansion|Physician Decision|0|||
150016099|NCT01748825|541192827|FG008|Dose Expansion|Physician Decision|1|||
150016100|NCT01748825|541192828|FG009|Dose Expansion|Physician Decision|0|||
150016101|NCT02461745|541192832|FG000|Overall Study|Lack of Efficacy|9|||
150016102|NCT02461745|541192833|FG001|Overall Study|Lack of Efficacy|1|||
150016103|NCT02461745|541192832|FG000|Overall Study|Lost to Follow-up|2|||
150016104|NCT02461745|541192833|FG001|Overall Study|Lost to Follow-up|2|||
150016105|NCT02461745|541192832|FG000|Overall Study|Withdrawal by Subject|3|||
150016106|NCT02461745|541192833|FG001|Overall Study|Withdrawal by Subject|1|||
150016107|NCT00211887|541192834|FG000|Overall Study|Adverse Event|8|||
150016108|NCT00211887|541192835|FG001|Overall Study|Adverse Event|4|||
150016109|NCT00211887|541192836|FG002|Overall Study|Adverse Event|6|||
150016110|NCT00211887|541192834|FG000|Overall Study|Death|1|||
150016111|NCT00211887|541192835|FG001|Overall Study|Death|1|||
150016112|NCT00211887|541192836|FG002|Overall Study|Death|1|||
150016113|NCT00211887|541192834|FG000|Overall Study|Lost to Follow-up|28|||
150016114|NCT00211887|541192835|FG001|Overall Study|Lost to Follow-up|13|||
150016115|NCT00211887|541192836|FG002|Overall Study|Lost to Follow-up|9|||
150016116|NCT00211887|541192834|FG000|Overall Study|Non-medical reason|31|||
150016117|NCT00211887|541192835|FG001|Overall Study|Non-medical reason|14|||
150016118|NCT00211887|541192836|FG002|Overall Study|Non-medical reason|8|||
150016119|NCT00211887|541192834|FG000|Overall Study|Other medical reason|15|||
150016120|NCT00211887|541192835|FG001|Overall Study|Other medical reason|11|||
150016121|NCT00211887|541192836|FG002|Overall Study|Other medical reason|7|||
150016122|NCT00211887|541192834|FG000|Overall Study|Side effects|19|||
150016123|NCT00211887|541192835|FG001|Overall Study|Side effects|13|||
150016124|NCT00211887|541192836|FG002|Overall Study|Side effects|5|||
150016125|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Adverse Event|33|||
150016126|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
150016127|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
150016128|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
150058510|NCT02437110|541355432|FG000|Post-ART|Withdrawal by Subject|3|||
150058511|NCT01431638|541355433|FG000|Overall Study|Adverse Event|1|||
150058512|NCT01431638|541355434|FG001|Overall Study|Adverse Event|3|||
150058513|NCT01431638|541355435|FG002|Overall Study|Adverse Event|1|||
150058514|NCT01431638|541355433|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150016129|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Physician Decision|6|||
150016130|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
150016131|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
150058515|NCT01431638|541355434|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150058516|NCT01431638|541355435|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
150058517|NCT01431638|541355433|FG000|Overall Study|Participants condition no longer requires study drug|0|||
150058518|NCT01431638|541355434|FG001|Overall Study|Participants condition no longer requires study drug|1|||
150058519|NCT01431638|541355435|FG002|Overall Study|Participants condition no longer requires study drug|0|||
150058520|NCT01431638|541355433|FG000|Overall Study|Participant withdrew consent|14|||
150058521|NCT01431638|541355434|FG001|Overall Study|Participant withdrew consent|5|||
150058522|NCT01431638|541355435|FG002|Overall Study|Participant withdrew consent|8|||
150058523|NCT01431638|541355433|FG000|Overall Study|Lost to Follow-up|7|||
150058524|NCT01431638|541355434|FG001|Overall Study|Lost to Follow-up|9|||
150058525|NCT01431638|541355435|FG002|Overall Study|Lost to Follow-up|7|||
150058526|NCT01431638|541355433|FG000|Overall Study|Administrative problems|1|||
150058527|NCT01431638|541355434|FG001|Overall Study|Administrative problems|4|||
150058528|NCT01431638|541355435|FG002|Overall Study|Administrative problems|6|||
150058529|NCT01431638|541355433|FG000|Overall Study|Death|1|||
150058530|NCT01431638|541355434|FG001|Overall Study|Death|0|||
150058531|NCT01431638|541355435|FG002|Overall Study|Death|0|||
150058532|NCT01431638|541355433|FG000|Overall Study|Protocol deviation|1|||
150058533|NCT01431638|541355434|FG001|Overall Study|Protocol deviation|1|||
150058534|NCT01431638|541355435|FG002|Overall Study|Protocol deviation|4|||
150058535|NCT01431638|541355433|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
150058536|NCT01431638|541355434|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
150058537|NCT01431638|541355435|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
150058538|NCT01261780|541355436|FG000|Overall Study|Withdrawal by Subject|1|||
150058539|NCT01261780|541355437|FG001|Overall Study|Withdrawal by Subject|0|||
150058540|NCT01261780|541355436|FG000|Overall Study|Event not related to subject|1|||
150058541|NCT01261780|541355437|FG001|Overall Study|Event not related to subject|2|||
150058542|NCT01239732|541355438|FG000|Overall Study|Termination of study per protocol|667|||
150058543|NCT01239732|541355438|FG000|Overall Study|Death|226|||
150058544|NCT01239732|541355438|FG000|Overall Study|Withdrawal by Subject|87|||
150058545|NCT01239732|541355438|FG000|Overall Study|Adverse Event|6|||
150058546|NCT01239732|541355438|FG000|Overall Study|Protocol Violation|3|||
150058547|NCT01239732|541355438|FG000|Overall Study|Participant non compliance|5|||
150058548|NCT01239732|541355438|FG000|Overall Study|Study termination by sponsor|2|||
150058549|NCT01239732|541355438|FG000|Overall Study|Investigator's decision|4|||
150058550|NCT01239732|541355438|FG000|Overall Study|Treatment failure|2|||
150058551|NCT01239732|541355438|FG000|Overall Study|Other|19|||
150058552|NCT03836001|541355439|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
150058553|NCT03836001|541355440|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
150016132|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
150016133|NCT00965419|541192837|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
150016134|NCT00965419|541192837|FG000|Follow-up Phase|Adverse Event|9|||
150016135|NCT00965419|541192837|FG000|Follow-up Phase|Protocol Violation|4|||
150016136|NCT00965419|541192837|FG000|Follow-up Phase|Withdrawal by Subject|8|||
150016137|NCT00965419|541192837|FG000|Follow-up Phase|Physician Decision|4|||
150016138|NCT00965419|541192837|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
150016139|NCT00965419|541192837|FG000|Follow-up Phase|Lack of Efficacy|28|||
150016140|NCT01946152|541194336|FG000|Overall Study|Adverse Event|1|||
150016141|NCT01946152|541194337|FG001|Overall Study|Adverse Event|0|||
150016142|NCT01946152|541194338|FG002|Overall Study|Adverse Event|0|||
150016143|NCT01946152|541194339|FG003|Overall Study|Adverse Event|0|||
150016144|NCT01946152|541194336|FG000|Overall Study|Withdrawal by Subject|0|||
150016145|NCT01946152|541194337|FG001|Overall Study|Withdrawal by Subject|2|||
150016146|NCT01946152|541194338|FG002|Overall Study|Withdrawal by Subject|0|||
150016147|NCT01946152|541194339|FG003|Overall Study|Withdrawal by Subject|0|||
150016148|NCT01946152|541194336|FG000|Overall Study|Progression|0|||
150016149|NCT01946152|541194337|FG001|Overall Study|Progression|1|||
150016150|NCT01946152|541194338|FG002|Overall Study|Progression|4|||
150016151|NCT01946152|541194339|FG003|Overall Study|Progression|7|||
150016152|NCT01946152|541194336|FG000|Overall Study|Physician Decision|0|||
150016153|NCT01946152|541194337|FG001|Overall Study|Physician Decision|0|||
150016154|NCT01946152|541194338|FG002|Overall Study|Physician Decision|1|||
150016155|NCT01946152|541194339|FG003|Overall Study|Physician Decision|0|||
150016156|NCT01946152|541194336|FG000|Overall Study|Second malignancy|0|||
150016157|NCT01946152|541194337|FG001|Overall Study|Second malignancy|0|||
150016158|NCT01946152|541194338|FG002|Overall Study|Second malignancy|1|||
150016159|NCT01946152|541194339|FG003|Overall Study|Second malignancy|0|||
150181372|NCT05094141|541801087|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
150181373|NCT05094141|541801088|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
150181374|NCT05094141|541801086|FG000|Overall Study|Did not participate in randomization|0|||
150181375|NCT05094141|541801087|FG001|Overall Study|Did not participate in randomization|0|||
150181376|NCT05094141|541801088|FG002|Overall Study|Did not participate in randomization|33|||
150181377|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
150181378|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
150181379|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
150181380|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
150181381|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
150181382|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
150181383|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
150181384|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
150181385|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
150181386|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
150181387|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
150181388|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
150181389|NCT01600014|541802711|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
150181390|NCT01600014|541802712|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
150181391|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
150181392|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
150181393|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
150181394|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
150181395|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
150181396|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
150181397|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
150181398|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
150181399|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
150181400|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
150181401|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
150181402|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
150016160|NCT01946152|541194336|FG000|Overall Study|Adverse Event|0|||
150016161|NCT01946152|541194337|FG001|Overall Study|Adverse Event|0|||
150016162|NCT01946152|541194338|FG002|Overall Study|Adverse Event|0|||
150016163|NCT01946152|541194339|FG003|Overall Study|Adverse Event|1|||
150016164|NCT03712787|541194340|FG000|Overall Study|Adverse Event|2|||
150016165|NCT03712787|541194341|FG001|Overall Study|Adverse Event|3|||
150016166|NCT03712787|541194342|FG002|Overall Study|Adverse Event|0|||
150016167|NCT03712787|541194343|FG003|Overall Study|Adverse Event|4|||
150016168|NCT03712787|541194340|FG000|Overall Study|Withdrawal by Subject|4|||
150016169|NCT03712787|541194341|FG001|Overall Study|Withdrawal by Subject|14|||
150016170|NCT03712787|541194342|FG002|Overall Study|Withdrawal by Subject|12|||
150016171|NCT03712787|541194343|FG003|Overall Study|Withdrawal by Subject|8|||
150016172|NCT03712787|541194340|FG000|Overall Study|Lost to Follow-up|1|||
150016173|NCT03712787|541194341|FG001|Overall Study|Lost to Follow-up|1|||
150016174|NCT03712787|541194342|FG002|Overall Study|Lost to Follow-up|2|||
150016175|NCT03712787|541194343|FG003|Overall Study|Lost to Follow-up|1|||
150016176|NCT03712787|541194340|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
150016177|NCT03712787|541194341|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
150016178|NCT03712787|541194342|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
150016179|NCT03712787|541194343|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
150016180|NCT03712787|541194340|FG000|Overall Study|COVID-19 Infection|0|||
150016181|NCT03712787|541194341|FG001|Overall Study|COVID-19 Infection|1|||
150016182|NCT03712787|541194342|FG002|Overall Study|COVID-19 Infection|0|||
150016183|NCT03712787|541194343|FG003|Overall Study|COVID-19 Infection|0|||
150016184|NCT03712787|541194340|FG000|Overall Study|Other, Not Specified|79|||
150016185|NCT03712787|541194341|FG001|Overall Study|Other, Not Specified|77|||
150016186|NCT03712787|541194342|FG002|Overall Study|Other, Not Specified|74|||
150016187|NCT03712787|541194343|FG003|Overall Study|Other, Not Specified|78|||
150016188|NCT01865448|541194344|FG000|Overall Study|Adverse Event|1|||
150016189|NCT01865448|541194345|FG001|Overall Study|Adverse Event|1|||
150016190|NCT01865448|541194344|FG000|Overall Study|Pregnancy|0|||
150016191|NCT01865448|541194345|FG001|Overall Study|Pregnancy|1|||
150016192|NCT01865448|541194344|FG000|Overall Study|dropout unrelated to study|1|||
150016193|NCT01865448|541194345|FG001|Overall Study|dropout unrelated to study|1|||
150016194|NCT05111249|541194350|FG000|Overall Study|Lost to Follow-up|0|||
150016195|NCT05111249|541194351|FG001|Overall Study|Lost to Follow-up|2|||
150016196|NCT05111249|541194350|FG000|Overall Study|Physician Decision|0|||
150016197|NCT05111249|541194351|FG001|Overall Study|Physician Decision|1|||
150181403|NCT01600014|541802711|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
150181404|NCT01600014|541802712|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
150181405|NCT01600014|541802711|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
150181406|NCT01600014|541802712|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
150181407|NCT01600014|541802711|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
150181408|NCT01600014|541802712|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
150181409|NCT01600014|541802711|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
150181410|NCT01600014|541802712|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
150016198|NCT05111249|541194350|FG000|Overall Study|Participant decision|1|||
150016199|NCT05111249|541194351|FG001|Overall Study|Participant decision|5|||
150016200|NCT05128578|541194352|FG000|Overall Study|Withdrawal by Subject|9|||
150016201|NCT05128578|541194352|FG000|Overall Study|Lost to Follow-up|5|||
150016202|NCT00799266|541194357|FG000|Overall Study|Adverse Event|0|||
150016203|NCT00799266|541194358|FG001|Overall Study|Adverse Event|1|||
150016204|NCT00799266|541194357|FG000|Overall Study|Subject withdrew consent|3|||
150016205|NCT00799266|541194358|FG001|Overall Study|Subject withdrew consent|0|||
150016206|NCT01702025|541194359|FG000|Overall Study|Equipment failure|1|||
150016207|NCT01702025|541194360|FG001|Overall Study|Equipment failure|0|||
150016208|NCT01702025|541194361|FG002|Overall Study|Equipment failure|0|||
150016209|NCT01702025|541194362|FG003|Overall Study|Equipment failure|0|||
150016210|NCT01702025|541194359|FG000|Overall Study|Adverse Event|1|||
150016211|NCT01702025|541194360|FG001|Overall Study|Adverse Event|1|||
150016212|NCT01702025|541194361|FG002|Overall Study|Adverse Event|1|||
150016213|NCT01702025|541194362|FG003|Overall Study|Adverse Event|0|||
150016214|NCT02679755|541194363|FG000|Overall Study|Death|0|||
150016215|NCT02679755|541194364|FG001|Overall Study|Death|3|||
150016216|NCT02679755|541194363|FG000|Overall Study|Global deterioration of health status|1|||
150016217|NCT02679755|541194364|FG001|Overall Study|Global deterioration of health status|8|||
150016218|NCT02679755|541194363|FG000|Overall Study|Lost to Follow-up|1|||
150016219|NCT02679755|541194364|FG001|Overall Study|Lost to Follow-up|0|||
150016220|NCT02679755|541194363|FG000|Overall Study|Objective progression or relapse|24|||
150016221|NCT02679755|541194364|FG001|Overall Study|Objective progression or relapse|83|||
150016222|NCT02679755|541194363|FG000|Overall Study|Not defined|0|||
150016223|NCT02679755|541194364|FG001|Overall Study|Not defined|2|||
150016224|NCT02679755|541194363|FG000|Overall Study|Withdrawal by participant|6|||
150016225|NCT02679755|541194364|FG001|Overall Study|Withdrawal by participant|3|||
150016226|NCT02679755|541194363|FG000|Overall Study|Adverse Event|1|||
150016227|NCT02679755|541194364|FG001|Overall Study|Adverse Event|4|||
150016228|NCT02679755|541194363|FG000|Overall Study|Adverse events not related to study drug|1|||
150016229|NCT02679755|541194364|FG001|Overall Study|Adverse events not related to study drug|2|||
150016230|NCT01061359|541194365|FG000|Overall Study|Death|32|||
150016231|NCT01061359|541194365|FG000|Overall Study|Lost to Follow-up|1072|||
150016232|NCT01061359|541194365|FG000|Overall Study|Relapse|187|||
150016233|NCT01061359|541194365|FG000|Overall Study|Secondary neoplasm|11|||
150016234|NCT02610777|541194368|FG000|Overall Study|Lost to Follow-up|1|||
150016235|NCT02610777|541194369|FG001|Overall Study|Lost to Follow-up|0|||
150016236|NCT02610777|541194368|FG000|Overall Study|Site Terminated by Sponsor|9|||
150016237|NCT02610777|541194369|FG001|Overall Study|Site Terminated by Sponsor|8|||
150016238|NCT02610777|541194368|FG000|Overall Study|Withdrawal by Subject|2|||
150016239|NCT02610777|541194369|FG001|Overall Study|Withdrawal by Subject|2|||
150016240|NCT02610777|541194368|FG000|Overall Study|Reason not Specified|0|||
150016241|NCT02610777|541194369|FG001|Overall Study|Reason not Specified|1|||
150016242|NCT02610777|541194368|FG000|Overall Study|Death|50|||
150016243|NCT02610777|541194369|FG001|Overall Study|Death|47|||
150016244|NCT00732875|541194370|FG000|Overall Study|Adverse Event|16|||
150181411|NCT03954184|541802713|FG000|Overall Study|Lost to Follow-up|500|||
150016245|NCT00732875|541194370|FG000|Overall Study|Withdrawal by Subject|6|||
150016246|NCT00732875|541194370|FG000|Overall Study|Lack of Efficacy|13|||
150016247|NCT03688074|541194373|FG000|Overall Study|Adverse Event|0|||
150016248|NCT03688074|541194374|FG001|Overall Study|Adverse Event|1|||
150016249|NCT03688074|541194373|FG000|Overall Study|Other|1|||
150016250|NCT03688074|541194374|FG001|Overall Study|Other|0|||
150016251|NCT00660179|541194377|FG000|Overall Study|Death|44|||
150016252|NCT00660179|541194378|FG001|Overall Study|Death|47|||
150016253|NCT00660179|541194379|FG002|Overall Study|Death|34|||
150016254|NCT00660179|541194377|FG000|Overall Study|Withdrawal of consent|4|||
150016255|NCT00660179|541194378|FG001|Overall Study|Withdrawal of consent|6|||
150016256|NCT00660179|541194379|FG002|Overall Study|Withdrawal of consent|4|||
150016257|NCT00660179|541194377|FG000|Overall Study|Lost to Follow-up|7|||
150016258|NCT00660179|541194378|FG001|Overall Study|Lost to Follow-up|5|||
150016259|NCT00660179|541194379|FG002|Overall Study|Lost to Follow-up|2|||
150016260|NCT00660179|541194377|FG000|Overall Study|Administrative reason|0|||
150016261|NCT00660179|541194378|FG001|Overall Study|Administrative reason|0|||
150016262|NCT00660179|541194379|FG002|Overall Study|Administrative reason|1|||
150016263|NCT00660179|541194377|FG000|Overall Study|Incorrect randomization|1|||
150016264|NCT00660179|541194378|FG001|Overall Study|Incorrect randomization|0|||
150016265|NCT00660179|541194379|FG002|Overall Study|Incorrect randomization|0|||
150016266|NCT03056339|541194382|FG000|Overall Study|Failed Requirements|0|||
150016267|NCT03056339|541194383|FG001|Overall Study|Failed Requirements|2|||
150016268|NCT03056339|541194384|FG002|Overall Study|Failed Requirements|7|||
150016269|NCT03056339|541194385|FG003|Overall Study|Failed Requirements|1|||
150016270|NCT04171219|541194388|FG000|Overall Study|Adverse Event|1|||
150016271|NCT04171219|541194389|FG001|Overall Study|Adverse Event|0|||
150016272|NCT04171219|541194388|FG000|Overall Study|Death|0|||
150016273|NCT04171219|541194389|FG001|Overall Study|Death|1|||
150016274|NCT04171219|541194388|FG000|Overall Study|Lack of Efficacy|9|||
150016275|NCT04171219|541194389|FG001|Overall Study|Lack of Efficacy|13|||
150016276|NCT04171219|541194388|FG000|Overall Study|Withdrawal by Subject|1|||
150016277|NCT04171219|541194389|FG001|Overall Study|Withdrawal by Subject|2|||
150016278|NCT04171219|541194388|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
150016279|NCT04171219|541194389|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
150016280|NCT04171219|541194388|FG000|Overall Study|Clinical PD/Patient choice|1|||
150016281|NCT04171219|541194389|FG001|Overall Study|Clinical PD/Patient choice|0|||
150016282|NCT04171219|541194388|FG000|Overall Study|Toxicity/ Patient choice|1|||
150016283|NCT04171219|541194389|FG001|Overall Study|Toxicity/ Patient choice|0|||
150016284|NCT02974257|541194392|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
150016285|NCT02974257|541194393|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
150016286|NCT02974257|541194392|FG000|Overall Study|Clinical indication for thiamine|1|||
150016287|NCT02974257|541194393|FG001|Overall Study|Clinical indication for thiamine|0|||
150016288|NCT02974257|541194392|FG000|Overall Study|Already on thiamine|1|||
150016289|NCT02974257|541194393|FG001|Overall Study|Already on thiamine|0|||
150016290|NCT02974257|541194392|FG000|Overall Study|Extubated prior to study drug|0|||
150016291|NCT02974257|541194393|FG001|Overall Study|Extubated prior to study drug|1|||
150016292|NCT02974257|541194392|FG000|Overall Study|Death|0|||
150016293|NCT02974257|541194393|FG001|Overall Study|Death|1|||
150016294|NCT00398567|541194394|FG000|Overall Study|Disease Progression|3|||
150016295|NCT00398567|541194395|FG001|Overall Study|Disease Progression|4|||
150016296|NCT00398567|541194396|FG002|Overall Study|Disease Progression|27|||
150016297|NCT00398567|541194394|FG000|Overall Study|Withdrawal by Subject|1|||
150016298|NCT00398567|541194395|FG001|Overall Study|Withdrawal by Subject|0|||
150016299|NCT00398567|541194396|FG002|Overall Study|Withdrawal by Subject|4|||
150016300|NCT00398567|541194394|FG000|Overall Study|Adverse Event|0|||
150016301|NCT00398567|541194395|FG001|Overall Study|Adverse Event|0|||
150016302|NCT00398567|541194396|FG002|Overall Study|Adverse Event|2|||
150016303|NCT00398567|541194394|FG000|Overall Study|Protocol Violation|0|||
150016304|NCT00398567|541194395|FG001|Overall Study|Protocol Violation|0|||
150016305|NCT00398567|541194396|FG002|Overall Study|Protocol Violation|1|||
150016306|NCT01363908|541194397|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
150016307|NCT01363908|541194398|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
150016308|NCT01363908|541194397|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
150016309|NCT01363908|541194398|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
150016310|NCT01363908|541194397|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
150016311|NCT01363908|541194398|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
150016312|NCT01363908|541194397|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
150016313|NCT01363908|541194398|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
150016314|NCT04878211|541194403|FG000|Overall Study|Lost to Follow-up|0|||
150016315|NCT04878211|541194404|FG001|Overall Study|Lost to Follow-up|0|||
150016316|NCT04878211|541194405|FG002|Overall Study|Lost to Follow-up|0|||
150016317|NCT04878211|541194406|FG003|Overall Study|Lost to Follow-up|1|||
150016318|NCT04878211|541194407|FG004|Overall Study|Lost to Follow-up|0|||
150016319|NCT04878211|541194408|FG005|Overall Study|Lost to Follow-up|1|||
150016320|NCT04878211|541194403|FG000|Overall Study|Protocol deviation|1|||
150016321|NCT04878211|541194404|FG001|Overall Study|Protocol deviation|0|||
150016322|NCT04878211|541194405|FG002|Overall Study|Protocol deviation|0|||
150016323|NCT04878211|541194406|FG003|Overall Study|Protocol deviation|0|||
150016324|NCT04878211|541194407|FG004|Overall Study|Protocol deviation|0|||
150016325|NCT04878211|541194408|FG005|Overall Study|Protocol deviation|0|||
150016326|NCT04878211|541194403|FG000|Overall Study|Study terminated by sponsor|0|||
150016327|NCT04878211|541194404|FG001|Overall Study|Study terminated by sponsor|0|||
150016328|NCT04878211|541194405|FG002|Overall Study|Study terminated by sponsor|0|||
150016329|NCT04878211|541194406|FG003|Overall Study|Study terminated by sponsor|0|||
150016330|NCT04878211|541194407|FG004|Overall Study|Study terminated by sponsor|9|||
150016331|NCT04878211|541194408|FG005|Overall Study|Study terminated by sponsor|4|||
150016332|NCT04878211|541194403|FG000|Overall Study|Subject decision|0|||
150058554|NCT03836001|541355441|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
150058555|NCT03836001|541355439|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
150058556|NCT03836001|541355440|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
150058557|NCT03836001|541355441|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
150058558|NCT03836001|541355439|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
150058559|NCT03836001|541355440|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
150058560|NCT03836001|541355441|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
150058561|NCT03836001|541355439|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
150058562|NCT03836001|541355440|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
150058563|NCT03836001|541355441|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
150058564|NCT02660138|541355443|FG000|Overall Study|Adverse Event|0|||
150058565|NCT02660138|541355444|FG001|Overall Study|Adverse Event|3|||
150058566|NCT02660138|541355445|FG002|Overall Study|Adverse Event|2|||
150058567|NCT02660138|541355443|FG000|Overall Study|Lack of Efficacy|1|||
150058568|NCT02660138|541355444|FG001|Overall Study|Lack of Efficacy|2|||
150058569|NCT02660138|541355445|FG002|Overall Study|Lack of Efficacy|1|||
150058570|NCT02660138|541355443|FG000|Overall Study|Withdrawal by Subject|7|||
150058571|NCT02660138|541355444|FG001|Overall Study|Withdrawal by Subject|6|||
150058572|NCT02660138|541355445|FG002|Overall Study|Withdrawal by Subject|6|||
150058573|NCT02660138|541355443|FG000|Overall Study|Lost to Follow-up|4|||
150058574|NCT02660138|541355444|FG001|Overall Study|Lost to Follow-up|4|||
150058575|NCT02660138|541355445|FG002|Overall Study|Lost to Follow-up|1|||
150058576|NCT02660138|541355443|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
150058577|NCT02660138|541355444|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
150058578|NCT02660138|541355445|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
150058579|NCT02660138|541355443|FG000|Overall Study|Other|1|||
150058580|NCT02660138|541355444|FG001|Overall Study|Other|1|||
150058581|NCT02660138|541355445|FG002|Overall Study|Other|0|||
150058582|NCT02660138|541355443|FG000|Overall Study|Not treated|0|||
150058583|NCT02660138|541355444|FG001|Overall Study|Not treated|1|||
150058584|NCT02660138|541355445|FG002|Overall Study|Not treated|0|||
150058585|NCT01642732|541355446|FG000|Overall Study|Withdrawal by Subject|1|||
150058586|NCT00899353|541355449|FG000|Overall Study|Adverse Event|2|||
150058587|NCT00899353|541355449|FG000|Overall Study|Lost to Follow-up|1|||
150058588|NCT00899353|541355449|FG000|Overall Study|Withdrawal by Subject|2|||
150058589|NCT04604132|541355458|FG000|Overall Study|Adverse Event|2|||
150058590|NCT04604132|541355459|FG001|Overall Study|Adverse Event|0|||
150058591|NCT04604132|541355460|FG002|Overall Study|Adverse Event|0|||
150058592|NCT04604132|541355461|FG003|Overall Study|Adverse Event|1|||
150058593|NCT04604132|541355462|FG004|Overall Study|Adverse Event|2|||
150058594|NCT04604132|541355458|FG000|Overall Study|Study terminated by sponsor|0|||
150058595|NCT04604132|541355459|FG001|Overall Study|Study terminated by sponsor|0|||
150058596|NCT04604132|541355460|FG002|Overall Study|Study terminated by sponsor|0|||
150058597|NCT04604132|541355461|FG003|Overall Study|Study terminated by sponsor|0|||
150058598|NCT04604132|541355462|FG004|Overall Study|Study terminated by sponsor|1|||
150058599|NCT04604132|541355458|FG000|Overall Study|Progressive disease: Clinical progression|0|||
150181412|NCT03954184|541802714|FG001|Overall Study|Lost to Follow-up|0|||
150181413|NCT04842500|541802715|FG000|Overall Study|Withdrawal by Subject|4|||
150181414|NCT04842500|541802716|FG001|Overall Study|Withdrawal by Subject|1|||
150181415|NCT04842500|541802717|FG002|Overall Study|Withdrawal by Subject|2|||
150181416|NCT04842500|541802718|FG003|Overall Study|Withdrawal by Subject|3|||
150181417|NCT04842500|541802715|FG000|Overall Study|Protocol Violation|1|||
150016333|NCT04878211|541194404|FG001|Overall Study|Subject decision|0|||
150016334|NCT04878211|541194405|FG002|Overall Study|Subject decision|0|||
150058600|NCT04604132|541355459|FG001|Overall Study|Progressive disease: Clinical progression|0|||
150058601|NCT04604132|541355460|FG002|Overall Study|Progressive disease: Clinical progression|1|||
150058602|NCT04604132|541355461|FG003|Overall Study|Progressive disease: Clinical progression|0|||
150058603|NCT04604132|541355462|FG004|Overall Study|Progressive disease: Clinical progression|0|||
150058604|NCT04604132|541355458|FG000|Overall Study|Progressive disease: Radiological progression|8|||
150058605|NCT04604132|541355459|FG001|Overall Study|Progressive disease: Radiological progression|7|||
150058606|NCT04604132|541355460|FG002|Overall Study|Progressive disease: Radiological progression|10|||
150181418|NCT04842500|541802716|FG001|Overall Study|Protocol Violation|0|||
150016335|NCT04878211|541194406|FG003|Overall Study|Subject decision|0|||
150016336|NCT04878211|541194407|FG004|Overall Study|Subject decision|1|||
150016337|NCT04878211|541194408|FG005|Overall Study|Subject decision|0|||
150016338|NCT04273893|541194409|FG000|Overall Study|Withdrawal by Subject|0|||
150016339|NCT04273893|541194410|FG001|Overall Study|Withdrawal by Subject|2|||
150016340|NCT04273893|541194409|FG000|Overall Study|Treatment of Disease Progression|0|||
150016341|NCT04273893|541194410|FG001|Overall Study|Treatment of Disease Progression|2|||
150016342|NCT04273893|541194409|FG000|Overall Study|Death|1|||
150016343|NCT04273893|541194410|FG001|Overall Study|Death|2|||
150016344|NCT04273893|541194409|FG000|Overall Study|Lost to Follow-up|0|||
150016345|NCT04273893|541194410|FG001|Overall Study|Lost to Follow-up|2|||
150016346|NCT04273893|541194409|FG000|Overall Study|Physician Decision|1|||
150016347|NCT04273893|541194410|FG001|Overall Study|Physician Decision|0|||
150016348|NCT00856544|541194423|FG000|Overall Study|Randomized but not treated|3|||
150016349|NCT00856544|541194424|FG001|Overall Study|Randomized but not treated|0|||
150016350|NCT00856544|541194425|FG002|Overall Study|Randomized but not treated|0|||
150016351|NCT00856544|541194426|FG003|Overall Study|Randomized but not treated|0|||
150016352|NCT00856544|541194423|FG000|Overall Study|Death|0|||
150016353|NCT00856544|541194424|FG001|Overall Study|Death|2|||
150016354|NCT00856544|541194425|FG002|Overall Study|Death|0|||
150016355|NCT00856544|541194426|FG003|Overall Study|Death|0|||
150016356|NCT00856544|541194423|FG000|Overall Study|Adverse Event|20|||
150016357|NCT00856544|541194424|FG001|Overall Study|Adverse Event|29|||
150016358|NCT00856544|541194425|FG002|Overall Study|Adverse Event|2|||
150016359|NCT00856544|541194426|FG003|Overall Study|Adverse Event|3|||
150016360|NCT00856544|541194423|FG000|Overall Study|Lack of Efficacy|16|||
150016361|NCT00856544|541194424|FG001|Overall Study|Lack of Efficacy|12|||
150016362|NCT00856544|541194425|FG002|Overall Study|Lack of Efficacy|3|||
150016363|NCT00856544|541194426|FG003|Overall Study|Lack of Efficacy|3|||
150016364|NCT00856544|541194423|FG000|Overall Study|Other|9|||
150016365|NCT00856544|541194424|FG001|Overall Study|Other|16|||
150016366|NCT00856544|541194425|FG002|Overall Study|Other|1|||
150016367|NCT00856544|541194426|FG003|Overall Study|Other|6|||
150016368|NCT00856544|541194423|FG000|Overall Study|Lost to Follow-up|1|||
150016369|NCT00856544|541194424|FG001|Overall Study|Lost to Follow-up|2|||
150016370|NCT00856544|541194425|FG002|Overall Study|Lost to Follow-up|2|||
150016371|NCT00856544|541194426|FG003|Overall Study|Lost to Follow-up|0|||
150016372|NCT00856544|541194423|FG000|Overall Study|Withdrawal by Subject|8|||
150016373|NCT00856544|541194424|FG001|Overall Study|Withdrawal by Subject|5|||
150016374|NCT00856544|541194425|FG002|Overall Study|Withdrawal by Subject|0|||
150016375|NCT00856544|541194426|FG003|Overall Study|Withdrawal by Subject|1|||
150016376|NCT01036321|541194427|FG000|Overall Study|Ineligible after randomization|0|||
150016377|NCT01036321|541194428|FG001|Overall Study|Ineligible after randomization|1|||
150016378|NCT01036321|541194427|FG000|Overall Study|Withdrawal by Subject|3|||
150016379|NCT01036321|541194428|FG001|Overall Study|Withdrawal by Subject|2|||
150016380|NCT01036321|541194427|FG000|Overall Study|Adverse Event|2|||
150016381|NCT01036321|541194428|FG001|Overall Study|Adverse Event|1|||
150016382|NCT01687101|541194429|FG000|Overall Study|Lost to Follow-up|7|||
150016383|NCT05274269|541194430|FG000|Overall Study|Adverse Event|0|||
150016384|NCT05274269|541194431|FG001|Overall Study|Adverse Event|3|||
150016385|NCT05274269|541194430|FG000|Overall Study|Death|0|||
150016386|NCT05274269|541194431|FG001|Overall Study|Death|1|||
150016387|NCT05274269|541194430|FG000|Overall Study|Other|0|||
150016388|NCT05274269|541194431|FG001|Overall Study|Other|2|||
150016389|NCT05274269|541194430|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
150016390|NCT05274269|541194431|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
150016391|NCT02206035|541194432|FG000|Overall Study|Physician Decision|10|||
150016392|NCT02206035|541194433|FG001|Overall Study|Physician Decision|0|||
150016393|NCT02206035|541194434|FG002|Overall Study|Physician Decision|175|||
150016394|NCT02936843|541194435|FG000|Overall Study|Lost to Follow-up|3|||
150016395|NCT02936843|541194436|FG001|Overall Study|Lost to Follow-up|1|||
150016396|NCT02936843|541194435|FG000|Overall Study|Withdrawal by Subject|1|||
150058607|NCT04604132|541355461|FG003|Overall Study|Progressive disease: Radiological progression|4|||
150058608|NCT04604132|541355462|FG004|Overall Study|Progressive disease: Radiological progression|3|||
150058609|NCT04604132|541355458|FG000|Overall Study|Death|3|||
150058610|NCT04604132|541355459|FG001|Overall Study|Death|1|||
150016397|NCT02936843|541194436|FG001|Overall Study|Withdrawal by Subject|1|||
150016398|NCT01824355|541194440|FG000|Overall Study|Adverse Event|2|||
150016399|NCT01824355|541194440|FG000|Overall Study|unevaluable reference method results per|1|||
150016400|NCT04124705|541194441|FG000|Titration Period|Adverse Event|9|||
150016401|NCT04124705|541194442|FG001|Titration Period|Adverse Event|5|||
150016402|NCT04124705|541194441|FG000|Titration Period|Withdrawal by Subject|6|||
150058611|NCT04604132|541355460|FG002|Overall Study|Death|2|||
150016403|NCT04124705|541194442|FG001|Titration Period|Withdrawal by Subject|3|||
150016404|NCT04124705|541194441|FG000|Titration Period|Lost to Follow-up|0|||
150016405|NCT04124705|541194442|FG001|Titration Period|Lost to Follow-up|1|||
150016406|NCT04124705|541194441|FG000|Titration Period|Death|1|||
150016407|NCT04124705|541194442|FG001|Titration Period|Death|1|||
150016408|NCT04124705|541194441|FG000|Titration Period|Lack of Efficacy|2|||
150016409|NCT04124705|541194442|FG001|Titration Period|Lack of Efficacy|0|||
150016410|NCT04124705|541194441|FG000|Titration Period|Physician Decision|2|||
150016411|NCT04124705|541194442|FG001|Titration Period|Physician Decision|0|||
150016412|NCT04124705|541194441|FG000|Titration Period|Non-compliance with Study Drug|2|||
150016413|NCT04124705|541194442|FG001|Titration Period|Non-compliance with Study Drug|0|||
150016414|NCT04124705|541194441|FG000|Titration Period|Other|4|||
150016415|NCT04124705|541194442|FG001|Titration Period|Other|9|||
150016416|NCT04124705|541194441|FG000|Stabilization Period|Adverse Event|4|||
150016417|NCT04124705|541194442|FG001|Stabilization Period|Adverse Event|2|||
150016418|NCT04124705|541194441|FG000|Stabilization Period|Withdrawal by Subject|1|||
150016419|NCT04124705|541194442|FG001|Stabilization Period|Withdrawal by Subject|1|||
150016420|NCT04124705|541194441|FG000|Stabilization Period|Lost to Follow-up|0|||
150016421|NCT04124705|541194442|FG001|Stabilization Period|Lost to Follow-up|1|||
150016422|NCT04124705|541194441|FG000|Stabilization Period|Lack of Efficacy|4|||
150016423|NCT04124705|541194442|FG001|Stabilization Period|Lack of Efficacy|2|||
150016424|NCT04124705|541194441|FG000|Stabilization Period|Protocol Deviation|0|||
150016425|NCT04124705|541194442|FG001|Stabilization Period|Protocol Deviation|2|||
150016426|NCT04124705|541194441|FG000|Stabilization Period|Other|2|||
150016427|NCT04124705|541194442|FG001|Stabilization Period|Other|2|||
150016428|NCT02106403|541194460|FG000|Follow-Up Visit 3|Other Reason|0|||
150016429|NCT02106403|541194461|FG001|Follow-Up Visit 3|Other Reason|0|||
150016430|NCT02106403|541194462|FG002|Follow-Up Visit 3|Other Reason|0|||
150016431|NCT02106403|541194463|FG003|Follow-Up Visit 3|Other Reason|0|||
150016432|NCT02106403|541194464|FG004|Follow-Up Visit 3|Other Reason|0|||
150016433|NCT02106403|541194465|FG005|Follow-Up Visit 3|Other Reason|1|||
150016434|NCT02038075|541194468|FG000|Overall Study|Withdrawal by Subject|3|||
150016435|NCT02038075|541194469|FG001|Overall Study|Withdrawal by Subject|0|||
150016436|NCT04000581|541194470|FG000|Overall Study|Withdrawal by Subject|0|||
150016437|NCT04000581|541194471|FG001|Overall Study|Withdrawal by Subject|1|||
150016438|NCT03477838|541194472|FG000|Overall Study|Lost to Follow-up|14|||
150016439|NCT02519595|541194474|FG000|Overall Study|Protocol Violation|8|||
150016440|NCT02519595|541194475|FG001|Overall Study|Protocol Violation|22|||
150016441|NCT02519595|541194476|FG002|Overall Study|Protocol Violation|16|||
150016442|NCT00850538|541194479|FG000|Overall Study|unable/unwilling to complete MRI|13|||
150016443|NCT00850538|541194479|FG000|Overall Study|specimen missed due to scheduling error|14|||
150016444|NCT00850538|541194479|FG000|Overall Study|specimen unusable|7|||
150016445|NCT00850538|541194479|FG000|Overall Study|Withdrawal by Subject|3|||
150016446|NCT00850538|541194479|FG000|Overall Study|radiology error|2|||
150016447|NCT00850538|541194479|FG000|Overall Study|Protocol Violation|2|||
150016448|NCT03188510|541194485|FG000|Overall Study|Inappropriate behavior with site staff|0|||
150016449|NCT03188510|541194486|FG001|Overall Study|Inappropriate behavior with site staff|1|||
150016450|NCT03188510|541194487|FG002|Overall Study|Inappropriate behavior with site staff|0|||
150016451|NCT01088399|541194493|FG000|Overall Study|Adverse Event|211|||
150016452|NCT01088399|541194494|FG001|Overall Study|Adverse Event|16|||
150016453|NCT01088399|541194495|FG002|Overall Study|Adverse Event|0|||
150016454|NCT01088399|541194493|FG000|Overall Study|Death|204|||
150016455|NCT01088399|541194494|FG001|Overall Study|Death|45|||
150016456|NCT01088399|541194495|FG002|Overall Study|Death|0|||
150016457|NCT01088399|541194493|FG000|Overall Study|Lack of Efficacy|298|||
150016458|NCT01088399|541194494|FG001|Overall Study|Lack of Efficacy|7|||
150016459|NCT01088399|541194495|FG002|Overall Study|Lack of Efficacy|5|||
150016460|NCT01088399|541194493|FG000|Overall Study|Lost to Follow-up|1070|||
150016461|NCT01088399|541194494|FG001|Overall Study|Lost to Follow-up|278|||
150016462|NCT01088399|541194495|FG002|Overall Study|Lost to Follow-up|58|||
150016463|NCT01088399|541194493|FG000|Overall Study|Physician Decision|531|||
150016464|NCT01088399|541194494|FG001|Overall Study|Physician Decision|88|||
150016465|NCT01088399|541194495|FG002|Overall Study|Physician Decision|16|||
150016466|NCT01088399|541194493|FG000|Overall Study|Withdrawal by Subject|544|||
150016467|NCT01088399|541194494|FG001|Overall Study|Withdrawal by Subject|195|||
150181419|NCT04842500|541802717|FG002|Overall Study|Protocol Violation|0|||
150181420|NCT04842500|541802718|FG003|Overall Study|Protocol Violation|1|||
150016468|NCT01088399|541194495|FG002|Overall Study|Withdrawal by Subject|33|||
150016469|NCT01088399|541194493|FG000|Overall Study|Change to or start of somatropin therapy|234|||
150016470|NCT01088399|541194494|FG001|Overall Study|Change to or start of somatropin therapy|17|||
150016471|NCT01088399|541194495|FG002|Overall Study|Change to or start of somatropin therapy|12|||
150016472|NCT01088399|541194493|FG000|Overall Study|Sponsor decision|1573|||
150016473|NCT01088399|541194494|FG001|Overall Study|Sponsor decision|298|||
150016474|NCT01088399|541194495|FG002|Overall Study|Sponsor decision|7|||
150016475|NCT01088399|541194493|FG000|Overall Study|Protocol Violation|10|||
150016476|NCT01088399|541194494|FG001|Overall Study|Protocol Violation|1|||
150016477|NCT01088399|541194495|FG002|Overall Study|Protocol Violation|0|||
150181421|NCT03397108|541802719|FG000|Overall Study|Lost to Follow-up|15|||
150181422|NCT03397108|541802720|FG001|Overall Study|Lost to Follow-up|0|||
150016478|NCT01088399|541194493|FG000|Overall Study|Enrollment criteria not met|48|||
150058612|NCT04604132|541355461|FG003|Overall Study|Death|1|||
150016479|NCT01088399|541194494|FG001|Overall Study|Enrollment criteria not met|119|||
150016480|NCT01088399|541194495|FG002|Overall Study|Enrollment criteria not met|70|||
150016481|NCT01088399|541194493|FG000|Overall Study|Study summary visit not completed|2398|||
150058613|NCT04604132|541355462|FG004|Overall Study|Death|0|||
150058614|NCT00402233|541355463|FG000|Overall Study|Adverse Event|1|||
150058615|NCT00402233|541355464|FG001|Overall Study|Adverse Event|7|||
150058616|NCT00402233|541355465|FG002|Overall Study|Adverse Event|9|||
150058617|NCT00402233|541355466|FG003|Overall Study|Adverse Event|9|||
150058618|NCT00402233|541355463|FG000|Overall Study|Protocol Violation|0|||
150058619|NCT00402233|541355464|FG001|Overall Study|Protocol Violation|1|||
150058620|NCT00402233|541355465|FG002|Overall Study|Protocol Violation|0|||
150058621|NCT00402233|541355466|FG003|Overall Study|Protocol Violation|0|||
150058622|NCT00402233|541355463|FG000|Overall Study|Withdrawal by Subject|2|||
150058623|NCT00402233|541355464|FG001|Overall Study|Withdrawal by Subject|1|||
150058624|NCT00402233|541355465|FG002|Overall Study|Withdrawal by Subject|2|||
150058625|NCT00402233|541355466|FG003|Overall Study|Withdrawal by Subject|2|||
150058626|NCT00402233|541355463|FG000|Overall Study|Worsening of disease under study|2|||
150058627|NCT00402233|541355464|FG001|Overall Study|Worsening of disease under study|0|||
150058628|NCT00402233|541355465|FG002|Overall Study|Worsening of disease under study|0|||
150058629|NCT00402233|541355466|FG003|Overall Study|Worsening of disease under study|0|||
150058630|NCT00402233|541355463|FG000|Overall Study|Worsening of other pre-existing disease|0|||
150058631|NCT00402233|541355464|FG001|Overall Study|Worsening of other pre-existing disease|1|||
150058632|NCT00402233|541355465|FG002|Overall Study|Worsening of other pre-existing disease|0|||
150058633|NCT00402233|541355466|FG003|Overall Study|Worsening of other pre-existing disease|0|||
150058634|NCT00053898|541355472|FG000|Overall Study|No follow-up data from any source|9|||
150058635|NCT00053898|541355473|FG001|Overall Study|No follow-up data from any source|12|||
150058636|NCT00053898|541355472|FG000|Overall Study|Follow-up from telephone contact only|5|||
150058637|NCT00053898|541355473|FG001|Overall Study|Follow-up from telephone contact only|1|||
150058638|NCT01007253|541355476|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
150058639|NCT01007253|541355477|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
150058640|NCT01007253|541355478|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
150058641|NCT01007253|541355479|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
150058642|NCT02232880|541355480|FG000|Overall Study|study stopped prior to randomization|1|||
150058643|NCT04085367|541356778|FG000|Overall Study|Adverse Event|1|||
150058644|NCT04085367|541356779|FG001|Overall Study|Adverse Event|1|||
150058645|NCT04085367|541356778|FG000|Overall Study|Withdrawal by Subject|13|||
150058646|NCT04085367|541356779|FG001|Overall Study|Withdrawal by Subject|4|||
150058647|NCT04085367|541356778|FG000|Overall Study|Lost to Follow-up|3|||
150058648|NCT04085367|541356779|FG001|Overall Study|Lost to Follow-up|1|||
150181423|NCT03397108|541802719|FG000|Overall Study|Insufficient milk production|3|||
150181424|NCT03397108|541802720|FG001|Overall Study|Insufficient milk production|2|||
150181425|NCT03397108|541802719|FG000|Overall Study|Withdrawal by Subject|2|||
150181426|NCT03397108|541802720|FG001|Overall Study|Withdrawal by Subject|0|||
150181427|NCT04337372|541802722|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
150181428|NCT04337372|541802723|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
150181429|NCT04337372|541802724|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
150181430|NCT04337372|541802725|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
150181431|NCT04337372|541802722|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
150181432|NCT04337372|541802723|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
150016482|NCT01088399|541194494|FG001|Overall Study|Study summary visit not completed|283|||
150016483|NCT01088399|541194495|FG002|Overall Study|Study summary visit not completed|80|||
150016484|NCT00400569|541194499|FG000|Overall Study|Death|1|||
150016485|NCT02921087|541194500|FG000|Overall Study|Withdrawal by Subject|0|||
150016486|NCT02921087|541194501|FG001|Overall Study|Withdrawal by Subject|1|||
150016487|NCT00852241|541194502|FG000|Overall Study|Physician Decision|18|||
150016488|NCT03848949|541194503|FG000|Overall Study|Lost to Follow-up|5|||
150016489|NCT03848949|541194504|FG001|Overall Study|Lost to Follow-up|7|||
150016490|NCT00619307|541194506|FG000|Overall Study|Adverse Event|0|||
150016491|NCT00619307|541194507|FG001|Overall Study|Adverse Event|1|||
150181433|NCT04337372|541802724|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
150016492|NCT00619307|541194506|FG000|Overall Study|Lost to Follow-up|0|||
150181434|NCT04337372|541802725|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
150181435|NCT04337372|541802722|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
150181436|NCT04337372|541802723|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
150016493|NCT00619307|541194507|FG001|Overall Study|Lost to Follow-up|1|||
150016494|NCT00619307|541194506|FG000|Overall Study|Protocol Violation|3|||
150016495|NCT00619307|541194507|FG001|Overall Study|Protocol Violation|0|||
150058649|NCT04085367|541356778|FG000|Overall Study|Other unspecified|2|||
150058650|NCT04085367|541356779|FG001|Overall Study|Other unspecified|1|||
150058651|NCT04085367|541356778|FG000|Overall Study|Status Unknown|1|||
150058652|NCT04085367|541356779|FG001|Overall Study|Status Unknown|1|||
150058653|NCT00130442|541356782|FG000|Overall Study|Withdrawal by Subject|0|||
150058654|NCT00130442|541356783|FG001|Overall Study|Withdrawal by Subject|1|||
150058655|NCT00130442|541356782|FG000|Overall Study|did not meet criteria|1|||
150016496|NCT00619307|541194506|FG000|Overall Study|Withdrew consent|1|||
150016497|NCT00619307|541194507|FG001|Overall Study|Withdrew consent|0|||
150016498|NCT00619307|541194506|FG000|Overall Study|Severe migraine|0|||
150016499|NCT00619307|541194507|FG001|Overall Study|Severe migraine|1|||
150016500|NCT00619307|541194506|FG000|Overall Study|MS attack plus steroids|0|||
150016501|NCT00619307|541194507|FG001|Overall Study|MS attack plus steroids|1|||
150016502|NCT00118430|541194510|FG000|Overall Study|Withdrawal by Subject|6|||
150016503|NCT00118430|541194511|FG001|Overall Study|Withdrawal by Subject|2|||
150016504|NCT00118430|541194512|FG002|Overall Study|Withdrawal by Subject|0|||
150016505|NCT00118430|541194510|FG000|Overall Study|Lost to Follow-up|15|||
150016506|NCT00118430|541194511|FG001|Overall Study|Lost to Follow-up|22|||
150016507|NCT00118430|541194512|FG002|Overall Study|Lost to Follow-up|28|||
150016508|NCT02147288|541194513|FG000|Overall Study|post-operative hematoma|1|||
150016509|NCT02147288|541194514|FG001|Overall Study|post-operative hematoma|1|||
150016510|NCT02147288|541194515|FG002|Overall Study|post-operative hematoma|0|||
150016511|NCT02147288|541194516|FG003|Overall Study|post-operative hematoma|0|||
150016512|NCT02147288|541194517|FG004|Overall Study|post-operative hematoma|0|||
150016513|NCT02147288|541194518|FG005|Overall Study|post-operative hematoma|0|||
150016514|NCT02147288|541194519|FG006|Overall Study|post-operative hematoma|0|||
150016515|NCT02147288|541194520|FG007|Overall Study|post-operative hematoma|0|||
150016516|NCT02147288|541194521|FG008|Overall Study|post-operative hematoma|0|||
150016517|NCT02147288|541194522|FG009|Overall Study|post-operative hematoma|0|||
150016518|NCT02147288|541194513|FG000|Overall Study|complications from concurrent hernia rep|0|||
150016519|NCT02147288|541194514|FG001|Overall Study|complications from concurrent hernia rep|1|||
150016520|NCT02147288|541194515|FG002|Overall Study|complications from concurrent hernia rep|0|||
150016521|NCT02147288|541194516|FG003|Overall Study|complications from concurrent hernia rep|0|||
150016522|NCT02147288|541194517|FG004|Overall Study|complications from concurrent hernia rep|0|||
150016523|NCT02147288|541194518|FG005|Overall Study|complications from concurrent hernia rep|0|||
150016524|NCT02147288|541194519|FG006|Overall Study|complications from concurrent hernia rep|0|||
150016525|NCT02147288|541194520|FG007|Overall Study|complications from concurrent hernia rep|0|||
150016526|NCT02147288|541194521|FG008|Overall Study|complications from concurrent hernia rep|0|||
150016527|NCT02147288|541194522|FG009|Overall Study|complications from concurrent hernia rep|0|||
150016528|NCT01362608|541196136|FG000|Overall Study|Protocol Violation|0|||
150016529|NCT01362608|541196137|FG001|Overall Study|Protocol Violation|1|||
150016530|NCT01362608|541196136|FG000|Overall Study|Lost to Follow-up|3|||
150016531|NCT01362608|541196137|FG001|Overall Study|Lost to Follow-up|1|||
150016532|NCT01362608|541196136|FG000|Overall Study|Withdrawal by Subject|1|||
150016533|NCT01362608|541196137|FG001|Overall Study|Withdrawal by Subject|2|||
150016534|NCT01362608|541196136|FG000|Overall Study|Lack of Efficacy|0|||
150016535|NCT01362608|541196137|FG001|Overall Study|Lack of Efficacy|2|||
150016536|NCT01362608|541196136|FG000|Overall Study|Adverse Event|0|||
150016537|NCT01362608|541196137|FG001|Overall Study|Adverse Event|2|||
150016538|NCT01504412|541196139|FG000|Overall Study|Adverse Event|1|||
150016539|NCT01504412|541196140|FG001|Overall Study|Adverse Event|8|||
150016540|NCT01504412|541196141|FG002|Overall Study|Adverse Event|1|||
150016541|NCT01504412|541196142|FG003|Overall Study|Adverse Event|7|||
150016542|NCT01504412|541196143|FG004|Overall Study|Adverse Event|10|||
150016543|NCT01504412|541196139|FG000|Overall Study|Withdrawal by Subject|2|||
150016544|NCT01504412|541196140|FG001|Overall Study|Withdrawal by Subject|1|||
150016545|NCT01504412|541196141|FG002|Overall Study|Withdrawal by Subject|1|||
150016546|NCT01504412|541196142|FG003|Overall Study|Withdrawal by Subject|5|||
150016547|NCT01504412|541196143|FG004|Overall Study|Withdrawal by Subject|1|||
150016548|NCT01504412|541196139|FG000|Overall Study|Other|2|||
150016549|NCT01504412|541196140|FG001|Overall Study|Other|1|||
150016550|NCT01504412|541196141|FG002|Overall Study|Other|1|||
150016551|NCT01504412|541196142|FG003|Overall Study|Other|6|||
150016552|NCT01504412|541196143|FG004|Overall Study|Other|1|||
150016553|NCT01504412|541196139|FG000|Overall Study|Lost to Follow-up|0|||
150016554|NCT01504412|541196140|FG001|Overall Study|Lost to Follow-up|2|||
150016555|NCT01504412|541196141|FG002|Overall Study|Lost to Follow-up|0|||
150016556|NCT01504412|541196142|FG003|Overall Study|Lost to Follow-up|0|||
150016557|NCT01504412|541196143|FG004|Overall Study|Lost to Follow-up|0|||
150016558|NCT01504412|541196139|FG000|Overall Study|Lack of Efficacy|0|||
150016559|NCT01504412|541196140|FG001|Overall Study|Lack of Efficacy|0|||
150016560|NCT01504412|541196141|FG002|Overall Study|Lack of Efficacy|1|||
150016561|NCT01504412|541196142|FG003|Overall Study|Lack of Efficacy|0|||
150016562|NCT01504412|541196143|FG004|Overall Study|Lack of Efficacy|1|||
150016563|NCT01504412|541196139|FG000|Overall Study|Death|0|||
150016564|NCT01504412|541196140|FG001|Overall Study|Death|0|||
150016565|NCT01504412|541196141|FG002|Overall Study|Death|0|||
150016566|NCT01504412|541196142|FG003|Overall Study|Death|1|||
150016567|NCT01504412|541196143|FG004|Overall Study|Death|0|||
150016568|NCT03437577|541196144|FG000|Pre-Randomization|Withdrawal by Subject|0|||
150016569|NCT03437577|541196145|FG001|Pre-Randomization|Withdrawal by Subject|0|||
150016570|NCT03437577|541196146|FG002|Pre-Randomization|Withdrawal by Subject|10|||
150016571|NCT03437577|541196144|FG000|Post-Randomization|Physician Decision|0|||
150016572|NCT03437577|541196145|FG001|Post-Randomization|Physician Decision|2|||
150016573|NCT03437577|541196146|FG002|Post-Randomization|Physician Decision|0|||
150016574|NCT00536471|541196147|FG000|Overall Study|Lost to Follow-up|48|||
150016575|NCT00536471|541196148|FG001|Overall Study|Lost to Follow-up|23|||
150016576|NCT00536471|541196149|FG002|Overall Study|Lost to Follow-up|48|||
150016577|NCT00536471|541196150|FG003|Overall Study|Lost to Follow-up|22|||
150016578|NCT00536471|541196147|FG000|Overall Study|Adverse Event|32|||
150016579|NCT00536471|541196148|FG001|Overall Study|Adverse Event|16|||
150016580|NCT00536471|541196149|FG002|Overall Study|Adverse Event|28|||
150016581|NCT00536471|541196150|FG003|Overall Study|Adverse Event|13|||
150016582|NCT00536471|541196147|FG000|Overall Study|Withdrawal by Subject|40|||
150016583|NCT00536471|541196148|FG001|Overall Study|Withdrawal by Subject|24|||
150016584|NCT00536471|541196149|FG002|Overall Study|Withdrawal by Subject|43|||
150016585|NCT00536471|541196150|FG003|Overall Study|Withdrawal by Subject|21|||
150016586|NCT00536471|541196147|FG000|Overall Study|Lack of Efficacy|17|||
150016587|NCT00536471|541196148|FG001|Overall Study|Lack of Efficacy|18|||
150016588|NCT00536471|541196149|FG002|Overall Study|Lack of Efficacy|11|||
150016589|NCT00536471|541196150|FG003|Overall Study|Lack of Efficacy|9|||
150016590|NCT00536471|541196147|FG000|Overall Study|Protocol Violation|8|||
150016591|NCT00536471|541196148|FG001|Overall Study|Protocol Violation|1|||
150016592|NCT00536471|541196149|FG002|Overall Study|Protocol Violation|2|||
150016593|NCT00536471|541196150|FG003|Overall Study|Protocol Violation|3|||
150016594|NCT00536471|541196147|FG000|Overall Study|Physician Decision|11|||
150016595|NCT00536471|541196148|FG001|Overall Study|Physician Decision|1|||
150016596|NCT00536471|541196149|FG002|Overall Study|Physician Decision|3|||
150016597|NCT00536471|541196150|FG003|Overall Study|Physician Decision|2|||
150016598|NCT00536471|541196147|FG000|Overall Study|Death|0|||
150016599|NCT00536471|541196148|FG001|Overall Study|Death|0|||
150016600|NCT00536471|541196149|FG002|Overall Study|Death|1|||
150016601|NCT00536471|541196150|FG003|Overall Study|Death|2|||
150016602|NCT00536471|541196147|FG000|Overall Study|Sponsor Decision|0|||
150016603|NCT00536471|541196148|FG001|Overall Study|Sponsor Decision|1|||
150016604|NCT00536471|541196149|FG002|Overall Study|Sponsor Decision|3|||
150016605|NCT00536471|541196150|FG003|Overall Study|Sponsor Decision|2|||
150016606|NCT00381693|541196151|FG000|Overall Study|Death|1|||
150016607|NCT00381693|541196151|FG000|Overall Study|Adverse Event|4|||
150016608|NCT00381693|541196151|FG000|Overall Study|Patient Choice|1|||
150016609|NCT00381693|541196151|FG000|Overall Study|Progression|2|||
150016610|NCT02003534|541196162|FG000|Overall Study|Lost to Follow-up|47|||
150016611|NCT03920254|541196164|FG000|Overall Study|Adverse Event|1|||
150016612|NCT03920254|541196165|FG001|Overall Study|Adverse Event|0|||
150016613|NCT03920254|541196166|FG002|Overall Study|Adverse Event|0|||
150016614|NCT03920254|541196164|FG000|Overall Study|Physician Decision|0|||
150016615|NCT03920254|541196165|FG001|Overall Study|Physician Decision|1|||
150016616|NCT03920254|541196166|FG002|Overall Study|Physician Decision|2|||
150016617|NCT03920254|541196164|FG000|Overall Study|Study Terminated By Sponsor|12|||
150016618|NCT03920254|541196165|FG001|Overall Study|Study Terminated By Sponsor|17|||
150016619|NCT03920254|541196166|FG002|Overall Study|Study Terminated By Sponsor|12|||
150016620|NCT03920254|541196164|FG000|Overall Study|Withdrawal by Subject|0|||
150016621|NCT03920254|541196165|FG001|Overall Study|Withdrawal by Subject|0|||
150016622|NCT03920254|541196166|FG002|Overall Study|Withdrawal by Subject|1|||
150016623|NCT03040674|541196167|FG000|Overall Study|Lost to Follow-up|225|||
150016624|NCT03040674|541196167|FG000|Overall Study|Death|23|||
150016625|NCT01934010|541196168|FG000|Overall Study|Adverse Event|1|||
150016626|NCT01934010|541196169|FG001|Overall Study|Adverse Event|1|||
150016627|NCT01934010|541196170|FG002|Overall Study|Adverse Event|0|||
150016628|NCT01934010|541196168|FG000|Overall Study|Withdrawal by Subject|15|||
150016629|NCT01934010|541196169|FG001|Overall Study|Withdrawal by Subject|6|||
150016630|NCT01934010|541196170|FG002|Overall Study|Withdrawal by Subject|2|||
150016631|NCT01934010|541196168|FG000|Overall Study|Lost to Follow-up|7|||
150016632|NCT01934010|541196169|FG001|Overall Study|Lost to Follow-up|4|||
150016633|NCT01934010|541196170|FG002|Overall Study|Lost to Follow-up|0|||
150016634|NCT01393821|541196171|FG000|Overall Study|Cancel|1|||
150016635|NCT01393821|541196172|FG001|Overall Study|Cancel|1|||
150016636|NCT01393821|541196171|FG000|Overall Study|not evaluable for primary endpoint|4|||
150016637|NCT01393821|541196172|FG001|Overall Study|not evaluable for primary endpoint|2|||
150016638|NCT00377858|541196183|FG000|Overall Study|Withdrawal by Subject|12|||
150016639|NCT00377858|541196184|FG001|Overall Study|Withdrawal by Subject|11|||
150016640|NCT00377858|541196183|FG000|Overall Study|Lost to Follow-up|6|||
150016641|NCT00377858|541196184|FG001|Overall Study|Lost to Follow-up|1|||
150016642|NCT00377858|541196183|FG000|Overall Study|Physician Decision|5|||
150016643|NCT00377858|541196184|FG001|Overall Study|Physician Decision|5|||
150016644|NCT00377858|541196183|FG000|Overall Study|Protocol Violation|3|||
150016645|NCT00377858|541196184|FG001|Overall Study|Protocol Violation|4|||
150016646|NCT00377858|541196183|FG000|Overall Study|Adverse Event|2|||
150016647|NCT00377858|541196184|FG001|Overall Study|Adverse Event|1|||
150016648|NCT00377858|541196183|FG000|Overall Study|Entry Criteria Not Met|2|||
150016649|NCT00377858|541196184|FG001|Overall Study|Entry Criteria Not Met|0|||
150016650|NCT00377858|541196183|FG000|Overall Study|Sponsor Decision|1|||
150016651|NCT00377858|541196184|FG001|Overall Study|Sponsor Decision|2|||
150016652|NCT00377858|541196183|FG000|Overall Study|Death|0|||
150016653|NCT00377858|541196184|FG001|Overall Study|Death|3|||
150016654|NCT03534141|541196185|FG000|Overall Study|Enrolled in other clinical trial|1|||
150016655|NCT03534141|541196186|FG001|Overall Study|Enrolled in other clinical trial|0|||
150016656|NCT03534141|541196185|FG000|Overall Study|Liver transplant aborted after randomization|0|||
150016657|NCT03534141|541196186|FG001|Overall Study|Liver transplant aborted after randomization|2|||
150016658|NCT03534141|541196185|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
150016659|NCT03534141|541196186|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
150016660|NCT00517361|541196187|FG000|Overall Study|Death|6|||
150016661|NCT00517361|541196187|FG000|Overall Study|The study was terminated|5|||
150016662|NCT00709618|541196188|FG000|Overall Study|Withdrawal by Subject|4|||
150016663|NCT00709618|541196188|FG000|Overall Study|Lost to Follow-up|1|||
150016664|NCT00709618|541196188|FG000|Overall Study|Study Closed/Terminated|25|||
150016665|NCT04042909|541196190|FG000|Overall Study|Withdrawal by Subject|1|||
150016666|NCT04042909|541196191|FG001|Overall Study|Withdrawal by Subject|0|||
150016667|NCT04042909|541196192|FG002|Overall Study|Withdrawal by Subject|0|||
150016668|NCT04042909|541196190|FG000|Overall Study|duplicate cases|2|||
150016669|NCT04042909|541196191|FG001|Overall Study|duplicate cases|0|||
150016670|NCT04042909|541196192|FG002|Overall Study|duplicate cases|0|||
150016671|NCT04042909|541196190|FG000|Overall Study|technical problem|0|||
150016672|NCT04042909|541196191|FG001|Overall Study|technical problem|1|||
150016673|NCT04042909|541196192|FG002|Overall Study|technical problem|0|||
150016674|NCT04303572|541196193|FG000|Overall Study|Study closed due to poor enrollment|1|||
150016675|NCT06312592|541196194|FG000|Overall Study|Lost to Follow-up|29|||
150016676|NCT06312592|541196195|FG001|Overall Study|Lost to Follow-up|13|||
150016677|NCT03785405|541196198|FG000|Overall Study|Adverse Event|16|||
150016678|NCT03785405|541196199|FG001|Overall Study|Adverse Event|1|||
150016679|NCT03785405|541196198|FG000|Overall Study|Death|6|||
150016680|NCT03785405|541196199|FG001|Overall Study|Death|4|||
150016681|NCT03785405|541196198|FG000|Overall Study|Guardian decision|4|||
150016682|NCT03785405|541196199|FG001|Overall Study|Guardian decision|1|||
150016683|NCT03785405|541196198|FG000|Overall Study|Lost to Follow-up|1|||
150016684|NCT03785405|541196199|FG001|Overall Study|Lost to Follow-up|0|||
150016685|NCT03785405|541196198|FG000|Overall Study|Physician Decision|8|||
150016686|NCT03785405|541196199|FG001|Overall Study|Physician Decision|5|||
150016687|NCT03785405|541196198|FG000|Overall Study|Participant decision|2|||
150016688|NCT03785405|541196199|FG001|Overall Study|Participant decision|0|||
150016689|NCT03785405|541196198|FG000|Overall Study|Other|1|||
150016690|NCT03785405|541196199|FG001|Overall Study|Other|0|||
150016691|NCT03785405|541196198|FG000|Overall Study|No treatment was received|0|||
150016692|NCT03785405|541196199|FG001|Overall Study|No treatment was received|1|||
150016693|NCT01948063|541196200|FG000|Overall Study|Boston MCI halted research protocol|0|||
150016694|NCT01948063|541196201|FG001|Overall Study|Boston MCI halted research protocol|1|||
150016695|NCT01948063|541196200|FG000|Overall Study|Discovered an enrollment in other study|0|||
150016696|NCT01948063|541196201|FG001|Overall Study|Discovered an enrollment in other study|1|||
150016697|NCT01948063|541196200|FG000|Overall Study|Blood samples were accidentally thawed|1|||
150016698|NCT01948063|541196201|FG001|Overall Study|Blood samples were accidentally thawed|0|||
150016699|NCT01858766|541196202|FG000|Overall Study|Randomized but Never Treated|0|||
150016700|NCT01858766|541196203|FG001|Overall Study|Randomized but Never Treated|0|||
150016701|NCT01858766|541196204|FG002|Overall Study|Randomized but Never Treated|0|||
150016702|NCT01858766|541196205|FG003|Overall Study|Randomized but Never Treated|0|||
150016703|NCT01858766|541196206|FG004|Overall Study|Randomized but Never Treated|0|||
150016704|NCT01858766|541196207|FG005|Overall Study|Randomized but Never Treated|1|||
150016705|NCT01858766|541196208|FG006|Overall Study|Randomized but Never Treated|0|||
150016706|NCT01858766|541196209|FG007|Overall Study|Randomized but Never Treated|0|||
150016707|NCT01858766|541196210|FG008|Overall Study|Randomized but Never Treated|0|||
150016708|NCT01858766|541196211|FG009|Overall Study|Randomized but Never Treated|0|||
150016709|NCT01858766|541196212|FG010|Overall Study|Randomized but Never Treated|0|||
150016710|NCT01858766|541196213|FG011|Overall Study|Randomized but Never Treated|0|||
150016711|NCT01858766|541196214|FG012|Overall Study|Randomized but Never Treated|0|||
150016712|NCT01858766|541196215|FG013|Overall Study|Randomized but Never Treated|0|||
150016713|NCT01858766|541196216|FG014|Overall Study|Randomized but Never Treated|0|||
150016714|NCT01858766|541196217|FG015|Overall Study|Randomized but Never Treated|0|||
150016715|NCT01858766|541196218|FG016|Overall Study|Randomized but Never Treated|0|||
150016716|NCT01858766|541196219|FG017|Overall Study|Randomized but Never Treated|1|||
150016717|NCT01858766|541196220|FG018|Overall Study|Randomized but Never Treated|0|||
150016718|NCT01858766|541196202|FG000|Overall Study|Death|0|||
150016719|NCT01858766|541196203|FG001|Overall Study|Death|0|||
150016720|NCT01858766|541196204|FG002|Overall Study|Death|1|||
150016721|NCT01858766|541196205|FG003|Overall Study|Death|0|||
150016722|NCT01858766|541196206|FG004|Overall Study|Death|0|||
150016723|NCT01858766|541196207|FG005|Overall Study|Death|0|||
150016724|NCT01858766|541196208|FG006|Overall Study|Death|0|||
150016725|NCT01858766|541196209|FG007|Overall Study|Death|0|||
150016726|NCT01858766|541196210|FG008|Overall Study|Death|0|||
150016727|NCT01858766|541196211|FG009|Overall Study|Death|0|||
150016728|NCT01858766|541196212|FG010|Overall Study|Death|0|||
150016729|NCT01858766|541196213|FG011|Overall Study|Death|0|||
150016730|NCT01858766|541196214|FG012|Overall Study|Death|0|||
150016731|NCT01858766|541196215|FG013|Overall Study|Death|0|||
150016732|NCT01858766|541196216|FG014|Overall Study|Death|0|||
150016733|NCT01858766|541196217|FG015|Overall Study|Death|0|||
150016734|NCT01858766|541196218|FG016|Overall Study|Death|0|||
150016735|NCT01858766|541196219|FG017|Overall Study|Death|0|||
150016736|NCT01858766|541196220|FG018|Overall Study|Death|0|||
150016737|NCT01858766|541196202|FG000|Overall Study|Lack of Efficacy|1|||
150016738|NCT01858766|541196203|FG001|Overall Study|Lack of Efficacy|0|||
150016739|NCT01858766|541196204|FG002|Overall Study|Lack of Efficacy|0|||
150016740|NCT01858766|541196205|FG003|Overall Study|Lack of Efficacy|0|||
150016741|NCT01858766|541196206|FG004|Overall Study|Lack of Efficacy|1|||
150016742|NCT01858766|541196207|FG005|Overall Study|Lack of Efficacy|2|||
150016743|NCT01858766|541196208|FG006|Overall Study|Lack of Efficacy|0|||
150016744|NCT01858766|541196209|FG007|Overall Study|Lack of Efficacy|0|||
150016745|NCT01858766|541196210|FG008|Overall Study|Lack of Efficacy|0|||
150016746|NCT01858766|541196211|FG009|Overall Study|Lack of Efficacy|0|||
150016747|NCT01858766|541196212|FG010|Overall Study|Lack of Efficacy|0|||
150016748|NCT01858766|541196213|FG011|Overall Study|Lack of Efficacy|3|||
150016749|NCT01858766|541196214|FG012|Overall Study|Lack of Efficacy|5|||
150016750|NCT01858766|541196215|FG013|Overall Study|Lack of Efficacy|3|||
150016751|NCT01858766|541196216|FG014|Overall Study|Lack of Efficacy|5|||
150016752|NCT01858766|541196217|FG015|Overall Study|Lack of Efficacy|5|||
150016753|NCT01858766|541196218|FG016|Overall Study|Lack of Efficacy|2|||
150016754|NCT01858766|541196219|FG017|Overall Study|Lack of Efficacy|3|||
150016755|NCT01858766|541196220|FG018|Overall Study|Lack of Efficacy|3|||
150016756|NCT01858766|541196202|FG000|Overall Study|Lost to Follow-up|0|||
150016757|NCT01858766|541196203|FG001|Overall Study|Lost to Follow-up|0|||
150016758|NCT01858766|541196204|FG002|Overall Study|Lost to Follow-up|0|||
150016759|NCT01858766|541196205|FG003|Overall Study|Lost to Follow-up|0|||
150016760|NCT01858766|541196206|FG004|Overall Study|Lost to Follow-up|0|||
150016761|NCT01858766|541196207|FG005|Overall Study|Lost to Follow-up|1|||
150016762|NCT01858766|541196208|FG006|Overall Study|Lost to Follow-up|0|||
150016763|NCT01858766|541196209|FG007|Overall Study|Lost to Follow-up|2|||
150016764|NCT01858766|541196210|FG008|Overall Study|Lost to Follow-up|0|||
150016765|NCT01858766|541196211|FG009|Overall Study|Lost to Follow-up|0|||
150016766|NCT01858766|541196212|FG010|Overall Study|Lost to Follow-up|0|||
150016767|NCT01858766|541196213|FG011|Overall Study|Lost to Follow-up|1|||
150016768|NCT01858766|541196214|FG012|Overall Study|Lost to Follow-up|0|||
150016769|NCT01858766|541196215|FG013|Overall Study|Lost to Follow-up|0|||
150016770|NCT01858766|541196216|FG014|Overall Study|Lost to Follow-up|3|||
150016771|NCT01858766|541196217|FG015|Overall Study|Lost to Follow-up|1|||
150016772|NCT01858766|541196218|FG016|Overall Study|Lost to Follow-up|1|||
150016773|NCT01858766|541196219|FG017|Overall Study|Lost to Follow-up|0|||
150016774|NCT01858766|541196220|FG018|Overall Study|Lost to Follow-up|1|||
150016775|NCT01858766|541196202|FG000|Overall Study|Withdrew Consent|0|||
150016776|NCT01858766|541196203|FG001|Overall Study|Withdrew Consent|0|||
150016777|NCT01858766|541196204|FG002|Overall Study|Withdrew Consent|0|||
150016778|NCT01858766|541196205|FG003|Overall Study|Withdrew Consent|0|||
150016779|NCT01858766|541196206|FG004|Overall Study|Withdrew Consent|0|||
150016780|NCT01858766|541196207|FG005|Overall Study|Withdrew Consent|0|||
150016781|NCT01858766|541196208|FG006|Overall Study|Withdrew Consent|0|||
150016782|NCT01858766|541196209|FG007|Overall Study|Withdrew Consent|0|||
150016783|NCT01858766|541196210|FG008|Overall Study|Withdrew Consent|0|||
150016784|NCT01858766|541196211|FG009|Overall Study|Withdrew Consent|0|||
150016785|NCT01858766|541196212|FG010|Overall Study|Withdrew Consent|0|||
150016786|NCT01858766|541196213|FG011|Overall Study|Withdrew Consent|1|||
150016787|NCT01858766|541196214|FG012|Overall Study|Withdrew Consent|0|||
150016788|NCT01858766|541196215|FG013|Overall Study|Withdrew Consent|0|||
150016789|NCT01858766|541196216|FG014|Overall Study|Withdrew Consent|0|||
150016790|NCT01858766|541196217|FG015|Overall Study|Withdrew Consent|0|||
150016791|NCT01858766|541196218|FG016|Overall Study|Withdrew Consent|0|||
150016792|NCT01858766|541196219|FG017|Overall Study|Withdrew Consent|0|||
150016793|NCT01858766|541196220|FG018|Overall Study|Withdrew Consent|0|||
150058656|NCT00130442|541356783|FG001|Overall Study|did not meet criteria|1|||
150058657|NCT00814333|541356784|FG000|Enrollment|Lost to Follow-up|1|||
150016794|NCT03517228|541196223|FG000|Overall Study|Withdrawal by Subject|2|||
150016795|NCT03517228|541196223|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
150016796|NCT03517228|541196223|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
150016797|NCT03517228|541196223|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
150016798|NCT03517228|541196223|FG000|Overall Study|Canceled due to device being updated|1|||
150016799|NCT03517228|541196223|FG000|Overall Study|No V Cares in stock|1|||
150016800|NCT03517228|541196223|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
150016801|NCT03781414|541196230|FG000|Overall Study|Study terminated by sponsor|39|||
150016802|NCT03781414|541196231|FG001|Overall Study|Study terminated by sponsor|34|||
150016803|NCT03781414|541196232|FG002|Overall Study|Study terminated by sponsor|25|||
150016804|NCT03781414|541196230|FG000|Overall Study|Adverse Event|3|||
150058658|NCT00814333|541356785|FG001|Enrollment|Lost to Follow-up|0|||
150016805|NCT03781414|541196231|FG001|Overall Study|Adverse Event|6|||
150016806|NCT03781414|541196232|FG002|Overall Study|Adverse Event|3|||
150016807|NCT03781414|541196230|FG000|Overall Study|Physician Decision|2|||
150016808|NCT03781414|541196231|FG001|Overall Study|Physician Decision|0|||
150016809|NCT03781414|541196232|FG002|Overall Study|Physician Decision|1|||
150016810|NCT03781414|541196230|FG000|Overall Study|Withdrawal by Subject|2|||
150016811|NCT03781414|541196231|FG001|Overall Study|Withdrawal by Subject|3|||
150016812|NCT03781414|541196232|FG002|Overall Study|Withdrawal by Subject|3|||
150016813|NCT03781414|541196230|FG000|Overall Study|Death|1|||
150016814|NCT03781414|541196231|FG001|Overall Study|Death|4|||
150016815|NCT03781414|541196232|FG002|Overall Study|Death|0|||
150016816|NCT03781414|541196230|FG000|Overall Study|Lost to Follow-up|1|||
150016817|NCT03781414|541196231|FG001|Overall Study|Lost to Follow-up|1|||
150016818|NCT03781414|541196232|FG002|Overall Study|Lost to Follow-up|0|||
150016819|NCT00245037|541196237|FG000|Overall Study|Death|17|||
150016820|NCT04752358|541196238|FG000|Overall Study|Death|2|||
150016821|NCT04752358|541196239|FG001|Overall Study|Death|1|||
150016822|NCT00555672|541196240|FG000|Overall Study|Death|0|||
150016823|NCT00555672|541196241|FG001|Overall Study|Death|2|||
150016824|NCT00555672|541196240|FG000|Overall Study|Adverse Event|8|||
150016825|NCT00555672|541196241|FG001|Overall Study|Adverse Event|2|||
150016826|NCT00555672|541196240|FG000|Overall Study|Objective progression or relapse|11|||
150016827|NCT00555672|541196241|FG001|Overall Study|Objective progression or relapse|5|||
150016828|NCT00555672|541196240|FG000|Overall Study|Other|3|||
150016829|NCT00555672|541196241|FG001|Overall Study|Other|1|||
150016830|NCT00555672|541196240|FG000|Overall Study|Participant refused|2|||
150016831|NCT00555672|541196241|FG001|Overall Study|Participant refused|0|||
150016832|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
150016833|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150016834|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150016835|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150016836|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150016837|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
150016838|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
150016839|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150016840|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150016841|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150016842|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150016843|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
150016844|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
150016845|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150016846|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150016847|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150016848|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150016849|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
150016850|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
150016851|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
150016852|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
150016853|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
150016854|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
150016855|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
150016856|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
150016857|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
150016858|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
150016859|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
150016860|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
150016861|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
150016862|NCT01053988|541196242|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
150016863|NCT01053988|541196243|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150016864|NCT01053988|541196244|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150016865|NCT01053988|541196245|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150016866|NCT01053988|541196246|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150016867|NCT01053988|541196247|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
150016868|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
150016869|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
150016870|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
150016871|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
150016872|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
150016873|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
150016874|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150016875|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
150016876|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
150016877|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
150016878|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
150016879|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
150016880|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
150016881|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
150016882|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
150016883|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
150016884|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
150016885|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
150016886|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
150016887|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
150016888|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
150016889|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
150016890|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
150016891|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
150016892|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
150016893|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
150016894|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
150016895|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
150016896|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
150016897|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
150016898|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150016899|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
150016900|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
150016901|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
150016902|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
150016903|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
150016904|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
150016905|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
150016906|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
150016907|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
150016908|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
150016909|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
150016910|NCT01053988|541196242|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
150016911|NCT01053988|541196243|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
150016912|NCT01053988|541196244|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
150016913|NCT01053988|541196245|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
150016914|NCT01053988|541196246|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
150016915|NCT01053988|541196247|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
150016916|NCT01922271|541196248|FG000|WASHOUT Period|Withdrawal by Subject|1|||
150016917|NCT01922271|541196249|FG001|WASHOUT Period|Withdrawal by Subject|0|||
150016918|NCT00719355|541196250|FG000|Overall Study|Death|0|||
150016919|NCT00719355|541196251|FG001|Overall Study|Death|1|||
150016920|NCT00719355|541196250|FG000|Overall Study|Medical|14|||
150016921|NCT00719355|541196251|FG001|Overall Study|Medical|5|||
150016922|NCT00719355|541196250|FG000|Overall Study|Compliance|4|||
150016923|NCT00719355|541196251|FG001|Overall Study|Compliance|6|||
150016924|NCT00719355|541196250|FG000|Overall Study|Moved|0|||
150016925|NCT00719355|541196251|FG001|Overall Study|Moved|1|||
150016926|NCT01415401|541196252|FG000|Overall Study|Adverse Event|5|||
150016927|NCT01415401|541196252|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
150016928|NCT01415401|541196252|FG000|Overall Study|Terminated by Sponsor|1|||
150016929|NCT00836186|541196255|FG000|Overall Study|Blood could not be drawn|1|||
150016930|NCT04427072|541196262|FG000|Randomized Treatment Phase|Progressive disease|9|||
150016931|NCT04427072|541196263|FG001|Randomized Treatment Phase|Progressive disease|4|||
150016932|NCT04427072|541196262|FG000|Randomized Treatment Phase|Adverse Event|3|||
150016933|NCT04427072|541196263|FG001|Randomized Treatment Phase|Adverse Event|1|||
150058659|NCT01527357|541356788|FG000|Overall Study|Death|8|||
150058660|NCT01527357|541356789|FG001|Overall Study|Death|2|||
150016934|NCT04427072|541196262|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
150016935|NCT04427072|541196263|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
150016936|NCT04427072|541196262|FG000|Randomized Treatment Phase|Death|0|||
150058661|NCT01527357|541356788|FG000|Overall Study|Lost to Follow-up|6|||
150016937|NCT04427072|541196263|FG001|Randomized Treatment Phase|Death|1|||
150016938|NCT04427072|541196262|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
150016939|NCT04427072|541196263|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
150016940|NCT04427072|541196262|FG000|Extension Treatment Phase|Progressive disease|0|||
150016941|NCT04427072|541196263|FG001|Extension Treatment Phase|Progressive disease|5|||
150016942|NCT05232864|541196264|FG000|Overall Study|Adverse Event|0|||
150016943|NCT05232864|541196265|FG001|Overall Study|Adverse Event|1|||
150016944|NCT05232864|541196264|FG000|Overall Study|Study terminated by sponsor|16|||
150016945|NCT05232864|541196265|FG001|Overall Study|Study terminated by sponsor|14|||
150016946|NCT02023996|541196266|FG000|Overall Study|Protocol Violation|6|||
150016947|NCT01844778|541196267|FG000|Overall Study|Protocol deviation|0|||
150016948|NCT01844778|541196268|FG001|Overall Study|Protocol deviation|1|||
150016949|NCT01844778|541196269|FG002|Overall Study|Protocol deviation|2|||
150016950|NCT01844778|541196267|FG000|Overall Study|Withdrawal by Subject|2|||
150016951|NCT01844778|541196268|FG001|Overall Study|Withdrawal by Subject|0|||
150016952|NCT01844778|541196269|FG002|Overall Study|Withdrawal by Subject|0|||
150016953|NCT01844778|541196267|FG000|Overall Study|Adverse Event|0|||
150016954|NCT01844778|541196268|FG001|Overall Study|Adverse Event|2|||
150016955|NCT01844778|541196269|FG002|Overall Study|Adverse Event|2|||
150016956|NCT01128946|541196282|FG000|Period I|Protocol Violation|0|||
150016957|NCT01128946|541196283|FG001|Period I|Protocol Violation|1|||
150016958|NCT01128946|541196284|FG002|Period I|Protocol Violation|0|||
150016959|NCT01128946|541196285|FG003|Period I|Protocol Violation|0|||
150016960|NCT01128946|541196282|FG000|Period I|Withdrawal by Subject|0|||
150016961|NCT01128946|541196283|FG001|Period I|Withdrawal by Subject|0|||
150016962|NCT01128946|541196284|FG002|Period I|Withdrawal by Subject|1|||
150016963|NCT01128946|541196285|FG003|Period I|Withdrawal by Subject|1|||
150016964|NCT01128946|541196282|FG000|Period II|Protocol Violation|0|||
150016965|NCT01128946|541196283|FG001|Period II|Protocol Violation|1|||
150016966|NCT01128946|541196284|FG002|Period II|Protocol Violation|0|||
150016967|NCT01128946|541196285|FG003|Period II|Protocol Violation|0|||
150016968|NCT01128946|541196282|FG000|Period II|Withdrawal by Subject|0|||
150016969|NCT01128946|541196283|FG001|Period II|Withdrawal by Subject|0|||
150016970|NCT01128946|541196284|FG002|Period II|Withdrawal by Subject|0|||
150016971|NCT01128946|541196285|FG003|Period II|Withdrawal by Subject|1|||
150016972|NCT01128946|541196282|FG000|Period III|Protocol Violation|1|||
150016973|NCT01128946|541196283|FG001|Period III|Protocol Violation|0|||
150016974|NCT01128946|541196284|FG002|Period III|Protocol Violation|0|||
150016975|NCT01128946|541196285|FG003|Period III|Protocol Violation|0|||
150016976|NCT00145574|541196286|FG000|Double Blind|Adverse Event|0|||
150016977|NCT00145574|541196287|FG001|Double Blind|Adverse Event|3|||
150016978|NCT00145574|541196288|FG002|Double Blind|Adverse Event|1|||
150016979|NCT00145574|541196286|FG000|Double Blind|Withdrawal by Subject|1|||
150016980|NCT00145574|541196287|FG001|Double Blind|Withdrawal by Subject|1|||
150016981|NCT00145574|541196288|FG002|Double Blind|Withdrawal by Subject|1|||
150016982|NCT00145574|541196286|FG000|Double Blind|required restricted medicine|0|||
150016983|NCT00145574|541196287|FG001|Double Blind|required restricted medicine|1|||
150016984|NCT00145574|541196288|FG002|Double Blind|required restricted medicine|0|||
150016985|NCT00145574|541196286|FG000|Open Label Long-term Extension|Adverse Event|0|||
150016986|NCT00145574|541196287|FG001|Open Label Long-term Extension|Adverse Event|0|||
150016987|NCT00145574|541196288|FG002|Open Label Long-term Extension|Adverse Event|5|||
150016988|NCT00145574|541196286|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
150016989|NCT00145574|541196287|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
150016990|NCT00145574|541196288|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
150016991|NCT00145574|541196286|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
150058662|NCT01527357|541356789|FG001|Overall Study|Lost to Follow-up|4|||
150058663|NCT01527357|541356788|FG000|Overall Study|Withdrew Consent|1|||
150058664|NCT01527357|541356789|FG001|Overall Study|Withdrew Consent|1|||
150058665|NCT01527357|541356788|FG000|Overall Study|Non-compliance|0|||
150058666|NCT01527357|541356789|FG001|Overall Study|Non-compliance|1|||
150058667|NCT01527357|541356788|FG000|Overall Study|No Day 29 Visit|0|||
150181437|NCT04337372|541802724|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
150016992|NCT00145574|541196287|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
150016993|NCT00145574|541196288|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
150016994|NCT00145574|541196286|FG000|Open Label Long-term Extension|required restricted medicine|0|||
150016995|NCT00145574|541196287|FG001|Open Label Long-term Extension|required restricted medicine|0|||
150016996|NCT00145574|541196288|FG002|Open Label Long-term Extension|required restricted medicine|1|||
150016997|NCT00621140|541196289|FG000|Overall Study|Adverse Event|4|||
150016998|NCT00621140|541196290|FG001|Overall Study|Adverse Event|5|||
150016999|NCT00621140|541196289|FG000|Overall Study|Lost to Follow-up|1|||
150017000|NCT00621140|541196290|FG001|Overall Study|Lost to Follow-up|2|||
150058668|NCT01527357|541356789|FG001|Overall Study|No Day 29 Visit|1|||
150058669|NCT01527357|541356788|FG000|Overall Study|Did Not Receive Treatment|2|||
150017001|NCT00621140|541196289|FG000|Overall Study|Withdrawal by Subject|4|||
150017002|NCT00621140|541196290|FG001|Overall Study|Withdrawal by Subject|6|||
150017003|NCT00621140|541196289|FG000|Overall Study|Other incl. lack of efficacy|6|||
150017004|NCT00621140|541196290|FG001|Overall Study|Other incl. lack of efficacy|5|||
150017005|NCT00527904|541196291|FG000|Overall Study|Adverse Event|45|||
150017006|NCT00527904|541196291|FG000|Overall Study|Withdrawal by Subject|21|||
150017007|NCT00527904|541196291|FG000|Overall Study|Lost to Follow-up|8|||
150017008|NCT00527904|541196291|FG000|Overall Study|misc|22|||
150017009|NCT02669121|541196293|FG000|Overall Study|Adverse Event|4|||
150017010|NCT02669121|541196294|FG001|Overall Study|Adverse Event|5|||
150017011|NCT02669121|541196293|FG000|Overall Study|Lost to Follow-up|15|||
150017012|NCT02669121|541196294|FG001|Overall Study|Lost to Follow-up|27|||
150017013|NCT02669121|541196293|FG000|Overall Study|Withdrawal by Subject|132|||
150017014|NCT02669121|541196294|FG001|Overall Study|Withdrawal by Subject|140|||
150017015|NCT02669121|541196293|FG000|Overall Study|Pregnancy|0|||
150017016|NCT02669121|541196294|FG001|Overall Study|Pregnancy|1|||
150017017|NCT02669121|541196293|FG000|Overall Study|Discharged from US Military Active Service|117|||
150017018|NCT02669121|541196294|FG001|Overall Study|Discharged from US Military Active Service|91|||
150017019|NCT02669121|541196293|FG000|Overall Study|Reason not Specified|22|||
150017020|NCT02669121|541196294|FG001|Overall Study|Reason not Specified|18|||
150017021|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
150017022|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
150017023|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
150017024|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017025|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017026|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017027|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017028|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017029|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
150017030|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Physician Decision|1|||
150017031|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Physician Decision|2|||
150017032|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Physician Decision|0|||
150017033|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Physician Decision|0|||
150017034|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Physician Decision|0|||
150017035|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Physician Decision|0|||
150017036|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Physician Decision|0|||
150017037|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Physician Decision|0|||
150017038|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Physician Decision|0|||
150017039|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
150017040|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
150017041|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
150017042|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
150017043|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
150017044|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
150017045|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
150017046|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
150017047|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
150017048|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
150017049|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017050|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017051|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017052|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017053|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017054|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017055|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017056|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
150017057|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
150017058|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
150017059|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150058670|NCT01527357|541356789|FG001|Overall Study|Did Not Receive Treatment|0|||
150058671|NCT02233946|541356790|FG000|Baseline|Withdrawal by Subject|2|||
150058672|NCT02233946|541356791|FG001|Baseline|Withdrawal by Subject|0|||
150058673|NCT02233946|541356790|FG000|3-months Follow-up|Lost to Follow-up|53|||
150058674|NCT02233946|541356791|FG001|3-months Follow-up|Lost to Follow-up|29|||
150017060|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150017061|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150017062|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150017063|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150058675|NCT02233946|541356790|FG000|6-months Follow-up|Lost to Follow-up|21|||
150058676|NCT02233946|541356791|FG001|6-months Follow-up|Lost to Follow-up|2|||
150017064|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150181438|NCT04337372|541802725|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
150181439|NCT04337372|541802722|FG000|Day 2: EEG Measures|Protocol Violation|6|||
150181440|NCT04337372|541802723|FG001|Day 2: EEG Measures|Protocol Violation|6|||
150181441|NCT04337372|541802724|FG002|Day 2: EEG Measures|Protocol Violation|5|||
150181442|NCT04337372|541802725|FG003|Day 2: EEG Measures|Protocol Violation|17|||
150181443|NCT05307783|541802726|FG000|Overall Study|Death|7|||
150181444|NCT05307783|541802726|FG000|Overall Study|Lost to Follow-up|4|||
150181445|NCT04883645|541802727|FG000|Overall Study|Death|1|||
150181446|NCT03460236|541802731|FG000|Overall Study|failed radiographic screening|16|||
150181447|NCT03460236|541802731|FG000|Overall Study|Withdrawal by Subject|11|||
150181448|NCT05613205|541802732|FG000|Overall Study|Lost to Follow-up|0|||
150181449|NCT05613205|541802733|FG001|Overall Study|Lost to Follow-up|0|||
150181450|NCT05613205|541802734|FG002|Overall Study|Lost to Follow-up|1|||
150181451|NCT05613205|541802735|FG003|Overall Study|Lost to Follow-up|1|||
150181452|NCT05613205|541802736|FG004|Overall Study|Lost to Follow-up|0|||
150181453|NCT05613205|541802732|FG000|Overall Study|Withdrawal by Subject|0|||
150181454|NCT05613205|541802733|FG001|Overall Study|Withdrawal by Subject|0|||
150181455|NCT05613205|541802734|FG002|Overall Study|Withdrawal by Subject|1|||
150181456|NCT05613205|541802735|FG003|Overall Study|Withdrawal by Subject|1|||
150181457|NCT05613205|541802736|FG004|Overall Study|Withdrawal by Subject|0|||
150181458|NCT04869982|541802743|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
150181459|NCT04869982|541802744|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
150181460|NCT04869982|541802743|FG000|Overall Study|Migrated / moved from the study area|1|||
150181461|NCT04869982|541802744|FG001|Overall Study|Migrated / moved from the study area|1|||
150181462|NCT04869982|541802743|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
150181463|NCT04869982|541802744|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
150181464|NCT04869982|541802743|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
150181465|NCT04869982|541802744|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
150181466|NCT04869982|541802743|FG000|Overall Study|Solicited adverse event|2|||
150181467|NCT04869982|541802744|FG001|Overall Study|Solicited adverse event|1|||
150181468|NCT04608045|541802745|FG000|Overall Study|Physician Decision|1|||
150181469|NCT02473250|541802747|FG000|Overall Study|Lost to Follow-up|10|||
150181470|NCT02473250|541802747|FG000|Overall Study|Physician Decision|5|||
150181471|NCT02473250|541802747|FG000|Overall Study|Did not tolerate medication washout|3|||
150181472|NCT02473250|541802747|FG000|Overall Study|Antidepressant effect of divalproex|2|||
150181473|NCT03103321|541802748|FG000|Overall Study|Protocol Violation|1|||
150181474|NCT03103321|541802749|FG001|Overall Study|Protocol Violation|1|||
150181475|NCT03103321|541802750|FG002|Overall Study|Protocol Violation|1|||
150181476|NCT03103321|541802751|FG003|Overall Study|Protocol Violation|0|||
150181477|NCT01704079|541802752|FG000|Overall Study|Withdrawal by Subject|5|||
150181478|NCT01704079|541802753|FG001|Overall Study|Withdrawal by Subject|7|||
150181479|NCT01704079|541802752|FG000|Overall Study|Lost to Follow-up|2|||
150181480|NCT01704079|541802753|FG001|Overall Study|Lost to Follow-up|5|||
150181481|NCT01704079|541802752|FG000|Overall Study|Adverse Event|4|||
150181482|NCT01704079|541802753|FG001|Overall Study|Adverse Event|7|||
150017065|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
150017066|NCT04405076|541196295|FG000|Part A (Blinded Phase)|Other than Specified|0|||
150017067|NCT04405076|541196296|FG001|Part A (Blinded Phase)|Other than Specified|0|||
150017068|NCT04405076|541196297|FG002|Part A (Blinded Phase)|Other than Specified|3|||
150017069|NCT04405076|541196298|FG003|Part A (Blinded Phase)|Other than Specified|0|||
150017070|NCT04405076|541196299|FG004|Part A (Blinded Phase)|Other than Specified|0|||
150017071|NCT04405076|541196300|FG005|Part A (Blinded Phase)|Other than Specified|0|||
150017072|NCT04405076|541196301|FG006|Part A (Blinded Phase)|Other than Specified|0|||
150017073|NCT04405076|541196302|FG007|Part A (Blinded Phase)|Other than Specified|0|||
150017074|NCT04405076|541196303|FG008|Part A (Blinded Phase)|Other than Specified|0|||
150017075|NCT04405076|541196295|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150017076|NCT04405076|541196296|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150181483|NCT01704079|541802752|FG000|Overall Study|Protocol Violation|1|||
150181484|NCT01704079|541802753|FG001|Overall Study|Protocol Violation|0|||
150181485|NCT01704079|541802752|FG000|Overall Study|Subject noncompliance|2|||
150017077|NCT04405076|541196297|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150017078|NCT04405076|541196298|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
150017079|NCT04405076|541196299|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
150181486|NCT01704079|541802753|FG001|Overall Study|Subject noncompliance|3|||
150181487|NCT01704079|541802752|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
150181488|NCT01704079|541802753|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
150181489|NCT06023082|541802754|FG000|Overall Study|Withdrawal by Subject|2|||
150181490|NCT06023082|541802754|FG000|Overall Study|Lost to Follow-up|15|||
150181491|NCT06023082|541802754|FG000|Overall Study|Side effects|5|||
150181492|NCT03584516|541802755|FG000|Part 1|Death|2|||
150017080|NCT04405076|541196300|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
150017081|NCT04405076|541196301|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150017082|NCT04405076|541196302|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150017083|NCT04405076|541196303|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
150017084|NCT04405076|541196295|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017085|NCT04405076|541196296|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017086|NCT04405076|541196297|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017087|NCT04405076|541196298|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017088|NCT04405076|541196299|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
150017089|NCT04405076|541196300|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017090|NCT04405076|541196301|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017091|NCT04405076|541196302|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017092|NCT04405076|541196303|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
150017093|NCT04405076|541196295|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017094|NCT04405076|541196296|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017095|NCT04405076|541196297|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017096|NCT04405076|541196298|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
150017097|NCT04405076|541196299|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
150017098|NCT04405076|541196300|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
150017099|NCT04405076|541196301|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017100|NCT04405076|541196302|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017101|NCT04405076|541196303|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
150017102|NCT04405076|541196295|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017103|NCT04405076|541196296|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017104|NCT04405076|541196297|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017105|NCT04405076|541196298|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017106|NCT04405076|541196299|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017107|NCT04405076|541196300|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017108|NCT04405076|541196301|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
150017109|NCT04405076|541196302|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
150017110|NCT04405076|541196303|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
150017111|NCT04405076|541196295|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017112|NCT04405076|541196296|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017113|NCT04405076|541196297|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017114|NCT04405076|541196298|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017115|NCT04405076|541196299|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017116|NCT04405076|541196300|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017117|NCT04405076|541196301|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
150017118|NCT04405076|541196302|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017119|NCT04405076|541196303|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
150017120|NCT04310566|541196304|FG000|Period 1|Study Termination due to COVID-19|15|||
150017121|NCT04310566|541196305|FG001|Period 1|Study Termination due to COVID-19|17|||
150017122|NCT04310566|541196304|FG000|Period 1|Protocol Violation|0|||
150017123|NCT04310566|541196305|FG001|Period 1|Protocol Violation|1|||
150017124|NCT04310566|541196304|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
150017125|NCT04310566|541196305|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
150017126|NCT04310566|541196304|FG000|Period 1|Lost to Follow-up|1|||
150017127|NCT04310566|541196305|FG001|Period 1|Lost to Follow-up|0|||
150017128|NCT04310566|541196304|FG000|Period 1|Withdrawal by Subject|0|||
150017129|NCT04310566|541196305|FG001|Period 1|Withdrawal by Subject|1|||
150017130|NCT04310566|541196304|FG000|Period 2|Study Termination|7|||
150017131|NCT04310566|541196305|FG001|Period 2|Study Termination|5|||
150017132|NCT00620113|541196309|FG000|Overall Study|Adverse Event|3|||
150017133|NCT00620113|541196310|FG001|Overall Study|Adverse Event|2|||
150017134|NCT00620113|541196311|FG002|Overall Study|Adverse Event|2|||
150017135|NCT00620113|541196312|FG003|Overall Study|Adverse Event|1|||
150017136|NCT00620113|541196309|FG000|Overall Study|Lack of Efficacy|2|||
150017137|NCT00620113|541196310|FG001|Overall Study|Lack of Efficacy|3|||
150017138|NCT00620113|541196311|FG002|Overall Study|Lack of Efficacy|0|||
150017139|NCT00620113|541196312|FG003|Overall Study|Lack of Efficacy|2|||
150017140|NCT00620113|541196309|FG000|Overall Study|Physician Decision|1|||
150017141|NCT00620113|541196310|FG001|Overall Study|Physician Decision|0|||
150017142|NCT00620113|541196311|FG002|Overall Study|Physician Decision|0|||
150017143|NCT00620113|541196312|FG003|Overall Study|Physician Decision|2|||
150017144|NCT00620113|541196309|FG000|Overall Study|Protocol Violation|2|||
150017145|NCT00620113|541196310|FG001|Overall Study|Protocol Violation|1|||
150017146|NCT00620113|541196311|FG002|Overall Study|Protocol Violation|0|||
150017147|NCT00620113|541196312|FG003|Overall Study|Protocol Violation|0|||
150017148|NCT00620113|541196309|FG000|Overall Study|Withdrawal by Subject|5|||
150017149|NCT00620113|541196310|FG001|Overall Study|Withdrawal by Subject|1|||
150017150|NCT00620113|541196311|FG002|Overall Study|Withdrawal by Subject|3|||
150017151|NCT00620113|541196312|FG003|Overall Study|Withdrawal by Subject|5|||
150017152|NCT04412707|541196313|FG000|Cycle 1|Death|0|||
150017153|NCT04412707|541196314|FG001|Cycle 1|Death|3|||
150017154|NCT04412707|541196313|FG000|Cycle 1|Disease progression|1|||
150017155|NCT04412707|541196314|FG001|Cycle 1|Disease progression|2|||
150017156|NCT04412707|541196313|FG000|Cycle 2|Death|0|||
150017157|NCT04412707|541196314|FG001|Cycle 2|Death|1|||
150017158|NCT04412707|541196313|FG000|Cycle 2|Disease progression|3|||
150017159|NCT04412707|541196314|FG001|Cycle 2|Disease progression|0|||
150017160|NCT04412707|541196313|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
150017161|NCT04412707|541196314|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
150017162|NCT04412707|541196313|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
150017163|NCT04412707|541196314|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
150017164|NCT04412707|541196313|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
150017165|NCT04412707|541196314|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
150017166|NCT04412707|541196313|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
150017167|NCT04412707|541196314|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
150017168|NCT02813889|541197501|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
150017169|NCT02813889|541197502|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
150017170|NCT04014062|541197506|FG000|Period I: Dosing|Medical Grounds|4|||
150017171|NCT04014062|541197507|FG001|Period I: Dosing|Medical Grounds|5|||
150017172|NCT04014062|541197506|FG000|Period I: Dosing|Withdrawal by Subject|3|||
150017173|NCT04014062|541197507|FG001|Period I: Dosing|Withdrawal by Subject|1|||
150017174|NCT00546000|541197508|FG000|Overall Study|Adverse Event|1|||
150017175|NCT00546000|541197508|FG000|Overall Study|Lost to Follow-up|1|||
150017176|NCT00546000|541197508|FG000|Overall Study|Baseline HPA Axis Supression|2|||
150017177|NCT04809285|541197520|FG000|Phase 1|Lost to Follow-up|6|||
150017178|NCT04809285|541197520|FG000|Phase 1|Protocol Violation|2|||
150017179|NCT04809285|541197520|FG000|Phase 1|Physician Decision|3|||
150017180|NCT04809285|541197520|FG000|Phase 1|Withdrawal by Subject|29|||
150017181|NCT04809285|541197520|FG000|Phase 2|Protocol Violation|3|||
150017182|NCT04809285|541197520|FG000|Phase 2|Withdrawal by Subject|4|||
150017183|NCT02837029|541197521|FG000|Screening|Failed to meet screening requirements.|7|||
150017184|NCT02837029|541197522|FG001|Screening|Failed to meet screening requirements.|3|||
150017185|NCT02837029|541197523|FG002|Screening|Failed to meet screening requirements.|0|||
150017186|NCT02837029|541197521|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
150017187|NCT02837029|541197522|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
150017188|NCT02837029|541197523|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
150017189|NCT02837029|541197521|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
150017190|NCT02837029|541197522|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
150017191|NCT02837029|541197523|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
150017192|NCT02837029|541197521|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
150017193|NCT02837029|541197522|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
150017194|NCT02837029|541197523|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
150017195|NCT02837029|541197521|FG000|Cycle 2 and Beyond|Adverse Event|1|||
150017196|NCT02837029|541197522|FG001|Cycle 2 and Beyond|Adverse Event|0|||
150017197|NCT02837029|541197523|FG002|Cycle 2 and Beyond|Adverse Event|0|||
150017198|NCT02837029|541197521|FG000|2 Year Follow-up|Death|6|||
150017199|NCT02837029|541197522|FG001|2 Year Follow-up|Death|7|||
150017200|NCT02837029|541197523|FG002|2 Year Follow-up|Death|0|||
150017201|NCT02644343|541197524|FG000|Overall Study|Withdrawal by Subject|1|||
150181493|NCT03584516|541802756|FG001|Part 1|Death|3|||
150181494|NCT03584516|541802757|FG002|Part 1|Death|0|||
150181495|NCT03584516|541802758|FG003|Part 1|Death|0|||
150181496|NCT03584516|541802759|FG004|Part 1|Death|0|||
150181497|NCT03584516|541802760|FG005|Part 1|Death|0|||
150017202|NCT02034877|541197527|FG000|Overall Study|Lost to Follow-up|0|||
150017203|NCT02034877|541197528|FG001|Overall Study|Lost to Follow-up|3|||
150017204|NCT02034877|541197527|FG000|Overall Study|No Longer Willing to Participate|0|||
150017205|NCT02034877|541197528|FG001|Overall Study|No Longer Willing to Participate|3|||
150017206|NCT02783599|541197536|FG000|Overall Study|Progressive disease|23|||
150017207|NCT02783599|541197536|FG000|Overall Study|Surgical Resection|10|||
150017208|NCT02783599|541197536|FG000|Overall Study|Adverse Event|4|||
150017209|NCT02783599|541197536|FG000|Overall Study|Physician Decision|2|||
150017210|NCT02783599|541197536|FG000|Overall Study|Death|1|||
150017211|NCT01564732|541197541|FG000|Overall Study|Early termination by the study sponsor|6|||
150017212|NCT01564732|541197542|FG001|Overall Study|Early termination by the study sponsor|5|||
150017213|NCT02598297|541197547|FG000|Overall Study|Study terminated by Sponsor|21|||
150017214|NCT02598297|541197548|FG001|Overall Study|Study terminated by Sponsor|23|||
150017215|NCT02598297|541197547|FG000|Overall Study|Adverse Event|1|||
150017216|NCT02598297|541197548|FG001|Overall Study|Adverse Event|1|||
150017217|NCT02598297|541197547|FG000|Overall Study|Physician Decision|1|||
150017218|NCT02598297|541197548|FG001|Overall Study|Physician Decision|0|||
150181498|NCT03584516|541802755|FG000|Part 1|Withdrawal by Subject|2|||
150181499|NCT03584516|541802756|FG001|Part 1|Withdrawal by Subject|0|||
150017219|NCT02598297|541197547|FG000|Overall Study|Subject/guardian decision|1|||
150017220|NCT02598297|541197548|FG001|Overall Study|Subject/guardian decision|0|||
150017221|NCT02598297|541197547|FG000|Overall Study|Followed for survival|1|||
150017222|NCT02598297|541197548|FG001|Overall Study|Followed for survival|0|||
150017223|NCT00394706|541197552|FG000|Overall Study|Withdrawal by Subject|2|||
150017224|NCT00394706|541197553|FG001|Overall Study|Withdrawal by Subject|0|||
150017225|NCT00394706|541197554|FG002|Overall Study|Withdrawal by Subject|1|||
150017226|NCT00394706|541197555|FG003|Overall Study|Withdrawal by Subject|0|||
150017227|NCT00394706|541197556|FG004|Overall Study|Withdrawal by Subject|0|||
150017228|NCT00394706|541197557|FG005|Overall Study|Withdrawal by Subject|2|||
150017229|NCT00394706|541197558|FG006|Overall Study|Withdrawal by Subject|1|||
150017230|NCT00394706|541197559|FG007|Overall Study|Withdrawal by Subject|0|||
150017231|NCT00394706|541197552|FG000|Overall Study|Lost to Follow-up|2|||
150017232|NCT00394706|541197553|FG001|Overall Study|Lost to Follow-up|2|||
150017233|NCT00394706|541197554|FG002|Overall Study|Lost to Follow-up|8|||
150017234|NCT00394706|541197555|FG003|Overall Study|Lost to Follow-up|1|||
150017235|NCT00394706|541197556|FG004|Overall Study|Lost to Follow-up|2|||
150017236|NCT00394706|541197557|FG005|Overall Study|Lost to Follow-up|5|||
150017237|NCT00394706|541197558|FG006|Overall Study|Lost to Follow-up|2|||
150017238|NCT00394706|541197559|FG007|Overall Study|Lost to Follow-up|0|||
150017239|NCT00887549|541197563|FG000|Induction Therapy|Adverse Event|8|||
150017240|NCT00887549|541197563|FG000|Induction Therapy|Physician Decision|1|||
150017241|NCT00887549|541197563|FG000|Induction Therapy|Progressive Disease|13|||
150017242|NCT00887549|541197563|FG000|Induction Therapy|Death due to Study Disease|4|||
150017243|NCT00887549|541197563|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
150017244|NCT00887549|541197563|FG000|Maintenance Therapy|Adverse Event|16|||
150017245|NCT00887549|541197563|FG000|Maintenance Therapy|Physician Decision|1|||
150017246|NCT00887549|541197563|FG000|Maintenance Therapy|Progressive Disease|25|||
150017247|NCT00887549|541197563|FG000|Maintenance Therapy|Death due to adverse event|1|||
150017248|NCT04112303|541197564|FG000|Overall Study|Death|1|||
150017249|NCT05173012|541197565|FG000|Overall Study|Adverse Event|2|||
150017250|NCT05173012|541197566|FG001|Overall Study|Adverse Event|3|||
150017251|NCT05173012|541197567|FG002|Overall Study|Adverse Event|4|||
150017252|NCT05173012|541197568|FG003|Overall Study|Adverse Event|13|||
150017253|NCT05173012|541197569|FG004|Overall Study|Adverse Event|0|||
150017254|NCT05173012|541197570|FG005|Overall Study|Adverse Event|0|||
150017255|NCT05173012|541197571|FG006|Overall Study|Adverse Event|2|||
150017256|NCT05173012|541197572|FG007|Overall Study|Adverse Event|4|||
150017257|NCT05173012|541197565|FG000|Overall Study|Lost to Follow-up|0|||
150017258|NCT05173012|541197566|FG001|Overall Study|Lost to Follow-up|0|||
150017259|NCT05173012|541197567|FG002|Overall Study|Lost to Follow-up|0|||
150017260|NCT05173012|541197568|FG003|Overall Study|Lost to Follow-up|1|||
150017261|NCT05173012|541197569|FG004|Overall Study|Lost to Follow-up|0|||
150017262|NCT05173012|541197570|FG005|Overall Study|Lost to Follow-up|0|||
150017263|NCT05173012|541197571|FG006|Overall Study|Lost to Follow-up|0|||
150017264|NCT05173012|541197572|FG007|Overall Study|Lost to Follow-up|0|||
150017265|NCT05173012|541197565|FG000|Overall Study|Withdrawal by Subject|1|||
150017266|NCT05173012|541197566|FG001|Overall Study|Withdrawal by Subject|0|||
150017267|NCT05173012|541197567|FG002|Overall Study|Withdrawal by Subject|1|||
150017268|NCT05173012|541197568|FG003|Overall Study|Withdrawal by Subject|3|||
150017269|NCT05173012|541197569|FG004|Overall Study|Withdrawal by Subject|1|||
150017270|NCT05173012|541197570|FG005|Overall Study|Withdrawal by Subject|0|||
150017271|NCT05173012|541197571|FG006|Overall Study|Withdrawal by Subject|1|||
150017272|NCT05173012|541197572|FG007|Overall Study|Withdrawal by Subject|0|||
150017273|NCT05173012|541197565|FG000|Overall Study|Protocol Deviation|0|||
150017274|NCT05173012|541197566|FG001|Overall Study|Protocol Deviation|0|||
150017275|NCT05173012|541197567|FG002|Overall Study|Protocol Deviation|0|||
150017276|NCT05173012|541197568|FG003|Overall Study|Protocol Deviation|1|||
150017277|NCT05173012|541197569|FG004|Overall Study|Protocol Deviation|0|||
150017278|NCT05173012|541197570|FG005|Overall Study|Protocol Deviation|0|||
150017279|NCT05173012|541197571|FG006|Overall Study|Protocol Deviation|0|||
150017280|NCT05173012|541197572|FG007|Overall Study|Protocol Deviation|0|||
150017281|NCT05173012|541197565|FG000|Overall Study|Other|0|||
150017282|NCT05173012|541197566|FG001|Overall Study|Other|0|||
150017283|NCT05173012|541197567|FG002|Overall Study|Other|0|||
150017284|NCT05173012|541197568|FG003|Overall Study|Other|2|||
150181500|NCT03584516|541802757|FG002|Part 1|Withdrawal by Subject|0|||
150017285|NCT05173012|541197569|FG004|Overall Study|Other|0|||
150017286|NCT05173012|541197570|FG005|Overall Study|Other|0|||
150017287|NCT05173012|541197571|FG006|Overall Study|Other|0|||
150017288|NCT05173012|541197572|FG007|Overall Study|Other|0|||
150017289|NCT00100789|541197573|FG000|Overall Study|Adverse Event|10|||
150017290|NCT00100789|541197573|FG000|Overall Study|Withdrawal by Subject|1|||
150017291|NCT00100789|541197573|FG000|Overall Study|Progression/relapse|42|||
150017292|NCT00100789|541197573|FG000|Overall Study|Death|2|||
150017293|NCT00100789|541197573|FG000|Overall Study|Not protocol specified|5|||
150017294|NCT00100789|541197573|FG000|Overall Study|Ineligible|3|||
150017295|NCT00100789|541197573|FG000|Overall Study|Never received treatment|1|||
150017296|NCT03472950|541197574|FG000|Overall Study|Lost to Follow-up|0|||
150017297|NCT03472950|541197575|FG001|Overall Study|Lost to Follow-up|1|||
150017298|NCT03472950|541197574|FG000|Overall Study|Adverse Event|0|||
150017299|NCT03472950|541197575|FG001|Overall Study|Adverse Event|3|||
150017300|NCT02506192|541197579|FG000|Overall Study|Withdrawal by Subject|1|||
150017301|NCT02506192|541197580|FG001|Overall Study|Withdrawal by Subject|1|||
150017302|NCT01685697|541197581|FG000|Overall Study|Protocol Violation|3|||
150017303|NCT01685697|541197582|FG001|Overall Study|Protocol Violation|3|||
150017304|NCT02703324|541197583|FG000|Period Two|Withdrawal by Subject|0|||
150017305|NCT02703324|541197584|FG001|Period Two|Withdrawal by Subject|0|||
150017306|NCT02703324|541197585|FG002|Period Two|Withdrawal by Subject|1|||
150017307|NCT02703324|541197586|FG003|Period Two|Withdrawal by Subject|0|||
150017308|NCT02703324|541197587|FG004|Period Two|Withdrawal by Subject|0|||
150017309|NCT02703324|541197588|FG005|Period Two|Withdrawal by Subject|0|||
150017310|NCT03705559|541197590|FG000|Overall Study|COVID Shut down|1|||
150017311|NCT00195091|541197591|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
150017312|NCT01979952|541197601|FG000|Overall Study|Adverse Event|4|||
150017313|NCT01979952|541197602|FG001|Overall Study|Adverse Event|5|||
150017314|NCT01979952|541197601|FG000|Overall Study|Protocol Violation|1|||
150017315|NCT01979952|541197602|FG001|Overall Study|Protocol Violation|0|||
150017316|NCT01979952|541197601|FG000|Overall Study|Withdrawal by Subject|2|||
150017317|NCT01979952|541197602|FG001|Overall Study|Withdrawal by Subject|1|||
150017318|NCT01979952|541197601|FG000|Overall Study|Other than specified above|1|||
150017319|NCT01979952|541197602|FG001|Overall Study|Other than specified above|0|||
150017320|NCT00203424|541197607|FG000|Treatment Period|Withdrawal by Subject|4|||
150017321|NCT00203424|541197607|FG000|Treatment Period|Adverse Event|5|||
150017322|NCT00203424|541197607|FG000|Treatment Period|progressive disease|2|||
150017323|NCT00203424|541197607|FG000|Follow-up Period|Withdrawal by Subject|1|||
150017324|NCT00203424|541197607|FG000|Follow-up Period|progressive disease|4|||
150017325|NCT00203424|541197607|FG000|Follow-up Period|Lost to Follow-up|1|||
150017326|NCT00475709|541197608|FG000|Overall Study|Did not meet eligibility criteria|8|||
150017327|NCT00475709|541197608|FG000|Overall Study|Death|41|||
150017328|NCT00475709|541197608|FG000|Overall Study|Device Explant|6|||
150017329|NCT00475709|541197608|FG000|Overall Study|Lost to Follow-up|21|||
150017330|NCT03364738|541197619|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
150017331|NCT03364738|541197619|FG000|Overall Study|Withdrawal by Subject|1|||
150017332|NCT03364738|541197619|FG000|Overall Study|Adverse Event|1|||
150017333|NCT03245398|541197620|FG000|Overall Study|Travelled to another island|1|||
150017334|NCT03245398|541197621|FG001|Overall Study|Travelled to another island|0|||
150017335|NCT04079816|541197623|FG000|Overall Study|Request of Subject|2|||
150017336|NCT04079816|541197623|FG000|Overall Study|Unable to draw samples|1|||
150017337|NCT01702246|541197624|FG000|Overall Study|Lost to Follow-up|2|||
150017338|NCT01702246|541197624|FG000|Overall Study|Withdrawal by Subject|2|||
150017339|NCT01702246|541197624|FG000|Overall Study|Physician Decision|1|||
150017340|NCT02687581|541197625|FG000|Overall Study|Withdrawal by Subject|1|||
150017341|NCT02687581|541197626|FG001|Overall Study|Withdrawal by Subject|0|||
150017342|NCT02687581|541197627|FG002|Overall Study|Withdrawal by Subject|0|||
150017343|NCT02687581|541197628|FG003|Overall Study|Withdrawal by Subject|1|||
150017344|NCT02687581|541197625|FG000|Overall Study|Lost to Follow-up|2|||
150017345|NCT02687581|541197626|FG001|Overall Study|Lost to Follow-up|2|||
150017346|NCT02687581|541197627|FG002|Overall Study|Lost to Follow-up|0|||
150017347|NCT02687581|541197628|FG003|Overall Study|Lost to Follow-up|0|||
150017348|NCT02687581|541197625|FG000|Overall Study|the device is too small for the patient.|1|||
150017349|NCT02687581|541197626|FG001|Overall Study|the device is too small for the patient.|0|||
150017350|NCT02687581|541197627|FG002|Overall Study|the device is too small for the patient.|0|||
150017351|NCT02687581|541197628|FG003|Overall Study|the device is too small for the patient.|0|||
150017352|NCT00835341|541197629|FG000|Overall Study|Lost to Follow-up|3|||
150017353|NCT00835341|541197630|FG001|Overall Study|Lost to Follow-up|12|||
150017354|NCT02560012|541197639|FG000|Overall Study|Study Terminated|2|||
150017355|NCT02218008|541197642|FG000|Stage 1 (S1)|Adverse Event|6|||
150017356|NCT02218008|541197643|FG001|Stage 1 (S1)|Adverse Event|5|||
150017357|NCT02218008|541197644|FG002|Stage 1 (S1)|Adverse Event|11|||
150058677|NCT02233946|541356790|FG000|9-month Follow-up|Lost to Follow-up|20|||
150058678|NCT02233946|541356791|FG001|9-month Follow-up|Lost to Follow-up|11|||
150017358|NCT02218008|541197645|FG003|Stage 1 (S1)|Adverse Event|0|||
150017359|NCT02218008|541197646|FG004|Stage 1 (S1)|Adverse Event|0|||
150017360|NCT02218008|541197647|FG005|Stage 1 (S1)|Adverse Event|0|||
150017361|NCT02218008|541197642|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
150017362|NCT02218008|541197643|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
150017363|NCT02218008|541197644|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
150017364|NCT02218008|541197645|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
150017365|NCT02218008|541197646|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
150017366|NCT02218008|541197647|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
150017367|NCT02218008|541197642|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
150017368|NCT02218008|541197643|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
150017369|NCT02218008|541197644|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
150017370|NCT02218008|541197645|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
150017371|NCT02218008|541197646|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
150181501|NCT03584516|541802758|FG003|Part 1|Withdrawal by Subject|0|||
150181502|NCT03584516|541802759|FG004|Part 1|Withdrawal by Subject|0|||
150181503|NCT03584516|541802760|FG005|Part 1|Withdrawal by Subject|0|||
150181504|NCT03584516|541802755|FG000|Part 1|Lost to Follow-up|1|||
150181505|NCT03584516|541802756|FG001|Part 1|Lost to Follow-up|0|||
150017372|NCT02218008|541197647|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
150017373|NCT02218008|541197642|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
150017374|NCT02218008|541197643|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
150017375|NCT02218008|541197644|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
150017376|NCT02218008|541197645|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
150017377|NCT02218008|541197646|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
150017378|NCT02218008|541197647|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
150017379|NCT02218008|541197642|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
150017380|NCT02218008|541197643|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
150017381|NCT02218008|541197644|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
150017382|NCT02218008|541197645|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
150017383|NCT02218008|541197646|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
150017384|NCT02218008|541197647|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
150017385|NCT02218008|541197642|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
150017386|NCT02218008|541197643|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
150017387|NCT02218008|541197644|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
150017388|NCT02218008|541197645|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
150017389|NCT02218008|541197646|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
150017390|NCT02218008|541197647|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
150017391|NCT02218008|541197642|FG000|Stage 1 (S1)|Pregnancy|0|||
150017392|NCT02218008|541197643|FG001|Stage 1 (S1)|Pregnancy|0|||
150017393|NCT02218008|541197644|FG002|Stage 1 (S1)|Pregnancy|1|||
150017394|NCT02218008|541197645|FG003|Stage 1 (S1)|Pregnancy|0|||
150017395|NCT02218008|541197646|FG004|Stage 1 (S1)|Pregnancy|0|||
150017396|NCT02218008|541197647|FG005|Stage 1 (S1)|Pregnancy|0|||
150017397|NCT02218008|541197642|FG000|Stage 1 (S1)|Protocol Violation|0|||
150017398|NCT02218008|541197643|FG001|Stage 1 (S1)|Protocol Violation|0|||
150017399|NCT02218008|541197644|FG002|Stage 1 (S1)|Protocol Violation|1|||
150017400|NCT02218008|541197645|FG003|Stage 1 (S1)|Protocol Violation|0|||
150017401|NCT02218008|541197646|FG004|Stage 1 (S1)|Protocol Violation|0|||
150017402|NCT02218008|541197647|FG005|Stage 1 (S1)|Protocol Violation|0|||
150017403|NCT02218008|541197642|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
150017404|NCT02218008|541197643|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
150017405|NCT02218008|541197644|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
150017406|NCT02218008|541197645|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
150017407|NCT02218008|541197646|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
150017408|NCT02218008|541197647|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
150017409|NCT02218008|541197642|FG000|Stage 2 (S2)|Adverse Event|0|||
150017410|NCT02218008|541197643|FG001|Stage 2 (S2)|Adverse Event|0|||
150017411|NCT02218008|541197644|FG002|Stage 2 (S2)|Adverse Event|0|||
150017412|NCT02218008|541197645|FG003|Stage 2 (S2)|Adverse Event|2|||
150017413|NCT02218008|541197646|FG004|Stage 2 (S2)|Adverse Event|3|||
150017414|NCT02218008|541197647|FG005|Stage 2 (S2)|Adverse Event|3|||
150017415|NCT02218008|541197642|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
150017416|NCT02218008|541197643|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
150017417|NCT02218008|541197644|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
150017418|NCT02218008|541197645|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
150017419|NCT02218008|541197646|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
150017420|NCT02218008|541197647|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
150017421|NCT02218008|541197642|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
150017422|NCT02218008|541197643|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
150017423|NCT02218008|541197644|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
150017424|NCT02218008|541197645|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
150181506|NCT03584516|541802757|FG002|Part 1|Lost to Follow-up|0|||
150181507|NCT03584516|541802758|FG003|Part 1|Lost to Follow-up|0|||
150181508|NCT03584516|541802759|FG004|Part 1|Lost to Follow-up|0|||
150181509|NCT03584516|541802760|FG005|Part 1|Lost to Follow-up|0|||
150017425|NCT02218008|541197646|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
150017426|NCT02218008|541197647|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
150017427|NCT02218008|541197642|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
150181510|NCT03584516|541802755|FG000|Part 1|Study Terminated by Sponsor|0|||
150017428|NCT02218008|541197643|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
150017429|NCT02218008|541197644|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
150017430|NCT02218008|541197645|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
150017431|NCT02218008|541197646|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
150017432|NCT02218008|541197647|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
150017433|NCT02218008|541197642|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
150017434|NCT02218008|541197643|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
150017435|NCT02218008|541197644|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
150017436|NCT02218008|541197645|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
150017437|NCT02218008|541197646|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
150181511|NCT03584516|541802756|FG001|Part 1|Study Terminated by Sponsor|2|||
150181512|NCT03584516|541802757|FG002|Part 1|Study Terminated by Sponsor|0|||
150017438|NCT02218008|541197647|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
150017439|NCT01278797|541197648|FG000|Period 1|Adverse Event|0|||
150017440|NCT01278797|541197649|FG001|Period 1|Adverse Event|1|||
150017441|NCT01278797|541197648|FG000|Period 1|Protocol Violation|1|||
150017442|NCT01278797|541197649|FG001|Period 1|Protocol Violation|0|||
150017443|NCT02069392|541197650|FG000|Overall Study|Withdrawal by Subject|4|||
150017444|NCT02069392|541197651|FG001|Overall Study|Withdrawal by Subject|2|||
150017445|NCT00269633|541197652|FG000|Overall Study|Withdrawal by Subject|1|||
150017446|NCT00269633|541197653|FG001|Overall Study|Withdrawal by Subject|0|||
150017447|NCT03058692|541200056|FG000|Overall Study|Lost to Follow-up|2|||
150017448|NCT03058692|541200057|FG001|Overall Study|Lost to Follow-up|1|||
150017449|NCT03058692|541200056|FG000|Overall Study|Withdrawal by Subject|1|||
150017450|NCT03058692|541200057|FG001|Overall Study|Withdrawal by Subject|1|||
150017451|NCT03038126|541200059|FG000|Overall Study|Death|1|||
150017452|NCT03038126|541200060|FG001|Overall Study|Death|1|||
150017453|NCT03038126|541200059|FG000|Overall Study|Withdrawal by Subject|5|||
150017454|NCT03038126|541200060|FG001|Overall Study|Withdrawal by Subject|0|||
150017455|NCT03038126|541200059|FG000|Overall Study|Lost to Follow-up|0|||
150017456|NCT03038126|541200060|FG001|Overall Study|Lost to Follow-up|1|||
150017457|NCT03038126|541200059|FG000|Overall Study|Long Term Hospitalization|2|||
150017458|NCT03038126|541200060|FG001|Overall Study|Long Term Hospitalization|0|||
150017459|NCT03038126|541200059|FG000|Overall Study|Too Ill to Participate|1|||
150017460|NCT03038126|541200060|FG001|Overall Study|Too Ill to Participate|2|||
150017461|NCT02451917|541200061|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
150017462|NCT02451917|541200062|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
150017463|NCT02451917|541200061|FG000|First Intervention (24 Weeks)|Death|0|||
150017464|NCT02451917|541200062|FG001|First Intervention (24 Weeks)|Death|1|||
150017465|NCT02451917|541200061|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
150017466|NCT02451917|541200062|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
150017467|NCT01724866|541200063|FG000|Overall Study|Adverse Event|0|||
150017468|NCT01724866|541200064|FG001|Overall Study|Adverse Event|0|||
150017469|NCT01724866|541200065|FG002|Overall Study|Adverse Event|1|||
150017470|NCT01724866|541200066|FG003|Overall Study|Adverse Event|1|||
150017471|NCT01724866|541200063|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
150017472|NCT01724866|541200064|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
150017473|NCT01724866|541200065|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
150017474|NCT01724866|541200066|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
150017475|NCT01724866|541200063|FG000|Overall Study|Investigator's Discretion|0|||
150017476|NCT01724866|541200064|FG001|Overall Study|Investigator's Discretion|1|||
150017477|NCT01724866|541200065|FG002|Overall Study|Investigator's Discretion|1|||
150017478|NCT01724866|541200066|FG003|Overall Study|Investigator's Discretion|0|||
150017479|NCT01724866|541200063|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
150017480|NCT01724866|541200064|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
150017481|NCT01724866|541200065|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
150017482|NCT01724866|541200066|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
150017483|NCT01724866|541200063|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
150017484|NCT01724866|541200064|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
150017485|NCT01724866|541200065|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
150017486|NCT01724866|541200066|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
150017487|NCT00411671|541200069|FG000|Overall Study|Adverse Event|15|||
150017488|NCT00411671|541200069|FG000|Overall Study|Death|2|||
150017489|NCT00411671|541200069|FG000|Overall Study|Lost to Follow-up|3|||
150017490|NCT01424501|541200070|FG000|Overall Study|Withdrawal by Subject|1|||
150017491|NCT01424501|541200071|FG001|Overall Study|Withdrawal by Subject|0|||
150017492|NCT01424501|541200072|FG002|Overall Study|Withdrawal by Subject|1|||
150017493|NCT01424501|541200073|FG003|Overall Study|Withdrawal by Subject|0|||
150017494|NCT01424501|541200074|FG004|Overall Study|Withdrawal by Subject|0|||
150017495|NCT01424501|541200075|FG005|Overall Study|Withdrawal by Subject|0|||
150017496|NCT01424501|541200070|FG000|Overall Study|Lost to Follow-up|0|||
150017497|NCT01424501|541200071|FG001|Overall Study|Lost to Follow-up|1|||
150017498|NCT01424501|541200072|FG002|Overall Study|Lost to Follow-up|1|||
150017499|NCT01424501|541200073|FG003|Overall Study|Lost to Follow-up|0|||
150017500|NCT01424501|541200074|FG004|Overall Study|Lost to Follow-up|0|||
150017501|NCT01424501|541200075|FG005|Overall Study|Lost to Follow-up|0|||
150017502|NCT01980095|541200076|FG000|Overall Study|Lost to Follow-up|6|||
150017503|NCT01980095|541200077|FG001|Overall Study|Lost to Follow-up|7|||
150017504|NCT01980095|541200076|FG000|Overall Study|Withdrawal by Subject|2|||
150017505|NCT01980095|541200077|FG001|Overall Study|Withdrawal by Subject|3|||
150017506|NCT01980095|541200076|FG000|Overall Study|Poor compliance|5|||
150017507|NCT01980095|541200077|FG001|Overall Study|Poor compliance|0|||
150181513|NCT03584516|541802758|FG003|Part 1|Study Terminated by Sponsor|0|||
150017508|NCT01980095|541200076|FG000|Overall Study|Safety issue|0|||
150017509|NCT01980095|541200077|FG001|Overall Study|Safety issue|1|||
150017510|NCT01980095|541200076|FG000|Overall Study|Study drug discontinued|1|||
150017511|NCT01980095|541200077|FG001|Overall Study|Study drug discontinued|0|||
150017512|NCT01980095|541200076|FG000|Overall Study|Randomized by mistake|1|||
150017513|NCT01980095|541200077|FG001|Overall Study|Randomized by mistake|0|||
150017514|NCT04737278|541200078|FG000|Overall Study|Lost to Follow-up|1|||
150017515|NCT04737278|541200079|FG001|Overall Study|Lost to Follow-up|1|||
150017516|NCT04737278|541200078|FG000|Overall Study|Withdrawal by Subject|1|||
150017517|NCT04737278|541200079|FG001|Overall Study|Withdrawal by Subject|0|||
150017518|NCT04737278|541200078|FG000|Overall Study|Protocol Violation|1|||
150017519|NCT04737278|541200079|FG001|Overall Study|Protocol Violation|1|||
150017520|NCT04737278|541200078|FG000|Overall Study|failure to complete questionnaire|1|||
150017521|NCT04737278|541200079|FG001|Overall Study|failure to complete questionnaire|1|||
150017522|NCT01128244|541200086|FG000|Overall Study|Adverse Event|1|||
150017523|NCT01128244|541200086|FG000|Overall Study|Scheduling conflict|2|||
150017524|NCT04506502|541200091|FG000|Overall Study|Withdrawal by Subject|1|||
150017525|NCT04506502|541200091|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
150017526|NCT01449006|541200092|FG000|Overall Study|Lost to Follow-up|1|||
150017527|NCT01449006|541200093|FG001|Overall Study|Lost to Follow-up|0|||
150017528|NCT01449006|541200092|FG000|Overall Study|Withdrawal by Subject|1|||
150017529|NCT01449006|541200093|FG001|Overall Study|Withdrawal by Subject|0|||
150017530|NCT01449006|541200092|FG000|Overall Study|Protocol Violation|1|||
150058679|NCT02233946|541356790|FG000|12-month Follow-up|Lost to Follow-up|28|||
150058680|NCT02233946|541356791|FG001|12-month Follow-up|Lost to Follow-up|11|||
150058681|NCT00910247|541356792|FG000|Overall Study|Adverse Event|15|||
150058682|NCT00910247|541356792|FG000|Overall Study|Death|2|||
150058683|NCT00910247|541356792|FG000|Overall Study|Lost to Follow-up|10|||
150058684|NCT00910247|541356792|FG000|Overall Study|Physician Decision|3|||
150058685|NCT00910247|541356792|FG000|Overall Study|Protocol Violation|10|||
150058686|NCT00910247|541356792|FG000|Overall Study|Withdrawal by Subject|25|||
150058687|NCT00910247|541356792|FG000|Overall Study|Not collected|4|||
150058688|NCT01879579|541356793|FG000|Overall Study|Phone incompatible with texting platform|3|||
150058689|NCT01879579|541356794|FG001|Overall Study|Phone incompatible with texting platform|0|||
150058690|NCT01879579|541356793|FG000|Overall Study|Did not enroll in texting platform|1|||
150058691|NCT01879579|541356794|FG001|Overall Study|Did not enroll in texting platform|0|||
150058692|NCT01879579|541356793|FG000|Overall Study|Did not initiate insulin treatment|1|||
150058693|NCT01879579|541356794|FG001|Overall Study|Did not initiate insulin treatment|0|||
150058694|NCT01879579|541356793|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
150058695|NCT01879579|541356794|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
150058696|NCT01879579|541356793|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
150058697|NCT01879579|541356794|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
150058698|NCT02927067|541356795|FG000|Overall Study|Withdrawn Consent|20|||
150058699|NCT02927067|541356796|FG001|Overall Study|Withdrawn Consent|12|||
150058700|NCT02927067|541356795|FG000|Overall Study|Death|18|||
150058701|NCT02927067|541356796|FG001|Overall Study|Death|31|||
150058702|NCT02927067|541356795|FG000|Overall Study|Adverse Event|13|||
150058703|NCT02927067|541356796|FG001|Overall Study|Adverse Event|10|||
150058704|NCT02927067|541356795|FG000|Overall Study|Noncompliance|5|||
150058705|NCT02927067|541356796|FG001|Overall Study|Noncompliance|2|||
150058706|NCT02927067|541356795|FG000|Overall Study|Reason not Specified|4|||
150058707|NCT02927067|541356796|FG001|Overall Study|Reason not Specified|6|||
150058708|NCT02292784|541356799|FG000|Overall Study|Lost to Follow-up|1|||
150058709|NCT02292784|541356800|FG001|Overall Study|Lost to Follow-up|17|||
150058710|NCT02292784|541356801|FG002|Overall Study|Lost to Follow-up|18|||
150058711|NCT02292784|541356799|FG000|Overall Study|Withdrawal by Subject|0|||
150058712|NCT02292784|541356800|FG001|Overall Study|Withdrawal by Subject|3|||
150058713|NCT02292784|541356801|FG002|Overall Study|Withdrawal by Subject|3|||
150058714|NCT00134784|541356802|FG000|Overall Study|Withdrawal by Subject|2|||
150058715|NCT00134784|541356803|FG001|Overall Study|Withdrawal by Subject|2|||
150058716|NCT00134784|541356804|FG002|Overall Study|Withdrawal by Subject|2|||
150058717|NCT00134784|541356805|FG003|Overall Study|Withdrawal by Subject|1|||
150017531|NCT01449006|541200093|FG001|Overall Study|Protocol Violation|0|||
150058718|NCT02519855|541356806|FG000|Overall Study|Adverse Event|0|||
150058719|NCT02519855|541356807|FG001|Overall Study|Adverse Event|1|||
150058720|NCT02519855|541356806|FG000|Overall Study|Lost to Follow-up|3|||
150017532|NCT03350815|541200094|FG000|Period 1|Adverse Event|10|||
150017533|NCT03350815|541200095|FG001|Period 1|Adverse Event|0|||
150017534|NCT03350815|541200096|FG002|Period 1|Adverse Event|0|||
150017535|NCT03350815|541200097|FG003|Period 1|Adverse Event|0|||
150017536|NCT03350815|541200094|FG000|Period 1|Technical problems|1|||
150017537|NCT03350815|541200095|FG001|Period 1|Technical problems|0|||
150017538|NCT03350815|541200096|FG002|Period 1|Technical problems|0|||
150017539|NCT03350815|541200097|FG003|Period 1|Technical problems|0|||
150017540|NCT03350815|541200094|FG000|Period 1|Lost to Follow-up|3|||
150017541|NCT03350815|541200095|FG001|Period 1|Lost to Follow-up|0|||
150017542|NCT03350815|541200096|FG002|Period 1|Lost to Follow-up|0|||
150017543|NCT03350815|541200097|FG003|Period 1|Lost to Follow-up|0|||
150017544|NCT03350815|541200094|FG000|Period 1|Physician Decision|1|||
150017545|NCT03350815|541200095|FG001|Period 1|Physician Decision|0|||
150017546|NCT03350815|541200096|FG002|Period 1|Physician Decision|0|||
150017547|NCT03350815|541200097|FG003|Period 1|Physician Decision|0|||
150017548|NCT03350815|541200094|FG000|Period 1|Withdrawal by Subject|8|||
150017549|NCT03350815|541200095|FG001|Period 1|Withdrawal by Subject|0|||
150017550|NCT03350815|541200096|FG002|Period 1|Withdrawal by Subject|0|||
150017551|NCT03350815|541200097|FG003|Period 1|Withdrawal by Subject|0|||
150017552|NCT03350815|541200094|FG000|Period 1|Lack of Efficacy|15|||
150017553|NCT03350815|541200095|FG001|Period 1|Lack of Efficacy|0|||
150017554|NCT03350815|541200096|FG002|Period 1|Lack of Efficacy|0|||
150017555|NCT03350815|541200097|FG003|Period 1|Lack of Efficacy|0|||
150017556|NCT03350815|541200094|FG000|Period 1|Non-compliance with study treatment|2|||
150017557|NCT03350815|541200095|FG001|Period 1|Non-compliance with study treatment|0|||
150017558|NCT03350815|541200096|FG002|Period 1|Non-compliance with study treatment|0|||
150017559|NCT03350815|541200097|FG003|Period 1|Non-compliance with study treatment|0|||
150017560|NCT03350815|541200094|FG000|Period 1|Protocol Violation|3|||
150017561|NCT03350815|541200095|FG001|Period 1|Protocol Violation|0|||
150017562|NCT03350815|541200096|FG002|Period 1|Protocol Violation|0|||
150017563|NCT03350815|541200097|FG003|Period 1|Protocol Violation|0|||
150017564|NCT03350815|541200094|FG000|Period 2|Adverse Event|0|||
150017565|NCT03350815|541200095|FG001|Period 2|Adverse Event|3|||
150017566|NCT03350815|541200096|FG002|Period 2|Adverse Event|5|||
150017567|NCT03350815|541200097|FG003|Period 2|Adverse Event|0|||
150017568|NCT03350815|541200094|FG000|Period 2|Technical problem|0|||
150017569|NCT03350815|541200095|FG001|Period 2|Technical problem|1|||
150017570|NCT03350815|541200096|FG002|Period 2|Technical problem|0|||
150017571|NCT03350815|541200097|FG003|Period 2|Technical problem|0|||
150017572|NCT03350815|541200094|FG000|Period 2|Lost to Follow-up|0|||
150017573|NCT03350815|541200095|FG001|Period 2|Lost to Follow-up|3|||
150017574|NCT03350815|541200096|FG002|Period 2|Lost to Follow-up|3|||
150017575|NCT03350815|541200097|FG003|Period 2|Lost to Follow-up|0|||
150017576|NCT03350815|541200094|FG000|Period 2|Physician Decision|0|||
150017577|NCT03350815|541200095|FG001|Period 2|Physician Decision|0|||
150017578|NCT03350815|541200096|FG002|Period 2|Physician Decision|1|||
150017579|NCT03350815|541200097|FG003|Period 2|Physician Decision|0|||
150017580|NCT03350815|541200094|FG000|Period 2|Withdrawal by Subject|0|||
150017581|NCT03350815|541200095|FG001|Period 2|Withdrawal by Subject|3|||
150017582|NCT03350815|541200096|FG002|Period 2|Withdrawal by Subject|4|||
150017583|NCT03350815|541200097|FG003|Period 2|Withdrawal by Subject|0|||
150017584|NCT03350815|541200094|FG000|Period 2|Lack of Efficacy|0|||
150017585|NCT03350815|541200095|FG001|Period 2|Lack of Efficacy|6|||
150017586|NCT03350815|541200096|FG002|Period 2|Lack of Efficacy|2|||
150017587|NCT03350815|541200097|FG003|Period 2|Lack of Efficacy|0|||
150017588|NCT03350815|541200094|FG000|Period 2|Protocol Violation|0|||
150017589|NCT03350815|541200095|FG001|Period 2|Protocol Violation|0|||
150017590|NCT03350815|541200096|FG002|Period 2|Protocol Violation|1|||
150017591|NCT03350815|541200097|FG003|Period 2|Protocol Violation|0|||
150017592|NCT03350815|541200094|FG000|Period 2|New therapy for study indication|0|||
150017593|NCT03350815|541200095|FG001|Period 2|New therapy for study indication|0|||
150017594|NCT03350815|541200096|FG002|Period 2|New therapy for study indication|1|||
150017595|NCT03350815|541200097|FG003|Period 2|New therapy for study indication|0|||
150017596|NCT03526146|541200098|FG000|Overall Study|Lost to Follow-up|5|||
150017597|NCT03526146|541200098|FG000|Overall Study|Withdrawal by Subject|6|||
150017598|NCT03526146|541200098|FG000|Overall Study|class canceled due to COVID-19|4|||
150017599|NCT03724890|541200105|FG000|Overall Study|Death|2|||
150017600|NCT03724890|541200106|FG001|Overall Study|Death|6|||
150017601|NCT03724890|541200107|FG002|Overall Study|Death|3|||
150017602|NCT03724890|541200108|FG003|Overall Study|Death|5|||
150181514|NCT03584516|541802759|FG004|Part 1|Study Terminated by Sponsor|0|||
150017603|NCT03724890|541200109|FG004|Overall Study|Death|2|||
150017604|NCT03724890|541200110|FG005|Overall Study|Death|0|||
150017605|NCT03724890|541200111|FG006|Overall Study|Death|2|||
150017606|NCT03724890|541200112|FG007|Overall Study|Death|3|||
150017607|NCT03724890|541200113|FG008|Overall Study|Death|4|||
150181515|NCT03584516|541802760|FG005|Part 1|Study Terminated by Sponsor|0|||
150017608|NCT03724890|541200114|FG009|Overall Study|Death|2|||
150017609|NCT03724890|541200115|FG010|Overall Study|Death|2|||
150017610|NCT03724890|541200105|FG000|Overall Study|Lost to Follow-up|0|||
150017611|NCT03724890|541200106|FG001|Overall Study|Lost to Follow-up|3|||
150017612|NCT03724890|541200107|FG002|Overall Study|Lost to Follow-up|0|||
150017613|NCT03724890|541200108|FG003|Overall Study|Lost to Follow-up|1|||
150017614|NCT03724890|541200109|FG004|Overall Study|Lost to Follow-up|2|||
150017615|NCT03724890|541200110|FG005|Overall Study|Lost to Follow-up|2|||
150017616|NCT03724890|541200111|FG006|Overall Study|Lost to Follow-up|1|||
150017617|NCT03724890|541200112|FG007|Overall Study|Lost to Follow-up|0|||
150017618|NCT03724890|541200113|FG008|Overall Study|Lost to Follow-up|2|||
150017619|NCT03724890|541200114|FG009|Overall Study|Lost to Follow-up|0|||
150017620|NCT03724890|541200115|FG010|Overall Study|Lost to Follow-up|0|||
150017621|NCT03724890|541200105|FG000|Overall Study|Withdrawal by Subject|1|||
150017622|NCT03724890|541200106|FG001|Overall Study|Withdrawal by Subject|2|||
150017623|NCT03724890|541200107|FG002|Overall Study|Withdrawal by Subject|1|||
150017624|NCT03724890|541200108|FG003|Overall Study|Withdrawal by Subject|0|||
150017625|NCT03724890|541200109|FG004|Overall Study|Withdrawal by Subject|0|||
150017626|NCT03724890|541200110|FG005|Overall Study|Withdrawal by Subject|1|||
150017627|NCT03724890|541200111|FG006|Overall Study|Withdrawal by Subject|0|||
150017628|NCT03724890|541200112|FG007|Overall Study|Withdrawal by Subject|0|||
150017629|NCT03724890|541200113|FG008|Overall Study|Withdrawal by Subject|2|||
150017630|NCT03724890|541200114|FG009|Overall Study|Withdrawal by Subject|2|||
150017631|NCT03724890|541200115|FG010|Overall Study|Withdrawal by Subject|1|||
150017632|NCT03724890|541200105|FG000|Overall Study|Other|1|||
150017633|NCT03724890|541200106|FG001|Overall Study|Other|0|||
150017634|NCT03724890|541200107|FG002|Overall Study|Other|0|||
150017635|NCT03724890|541200108|FG003|Overall Study|Other|0|||
150017636|NCT03724890|541200109|FG004|Overall Study|Other|0|||
150017637|NCT03724890|541200110|FG005|Overall Study|Other|0|||
150017638|NCT03724890|541200111|FG006|Overall Study|Other|0|||
150017639|NCT03724890|541200112|FG007|Overall Study|Other|1|||
150017640|NCT03724890|541200113|FG008|Overall Study|Other|1|||
150017641|NCT03724890|541200114|FG009|Overall Study|Other|0|||
150017642|NCT03724890|541200115|FG010|Overall Study|Other|2|||
150017643|NCT02123823|541200116|FG000|Overall Study|Lack of Efficacy|0|||
150017644|NCT02123823|541200117|FG001|Overall Study|Lack of Efficacy|2|||
150017645|NCT02123823|541200118|FG002|Overall Study|Lack of Efficacy|8|||
150017646|NCT02123823|541200119|FG003|Overall Study|Lack of Efficacy|10|||
150017647|NCT02123823|541200116|FG000|Overall Study|Progressive disease|3|||
150017648|NCT02123823|541200117|FG001|Overall Study|Progressive disease|19|||
150017649|NCT02123823|541200118|FG002|Overall Study|Progressive disease|52|||
150017650|NCT02123823|541200119|FG003|Overall Study|Progressive disease|53|||
150017651|NCT02123823|541200116|FG000|Overall Study|Withdrawal by Subject|0|||
150017652|NCT02123823|541200117|FG001|Overall Study|Withdrawal by Subject|0|||
150017653|NCT02123823|541200118|FG002|Overall Study|Withdrawal by Subject|7|||
150017654|NCT02123823|541200119|FG003|Overall Study|Withdrawal by Subject|2|||
150017655|NCT02123823|541200116|FG000|Overall Study|Adverse Event|0|||
150017656|NCT02123823|541200117|FG001|Overall Study|Adverse Event|0|||
150017657|NCT02123823|541200118|FG002|Overall Study|Adverse Event|3|||
150017658|NCT02123823|541200119|FG003|Overall Study|Adverse Event|5|||
150017659|NCT02104947|541200167|FG000|Overall Study|Withdrawal by Subject|10|||
150017660|NCT02104947|541200168|FG001|Overall Study|Withdrawal by Subject|3|||
150017661|NCT02104947|541200167|FG000|Overall Study|Lost to Follow-up|4|||
150017662|NCT02104947|541200168|FG001|Overall Study|Lost to Follow-up|4|||
150017663|NCT02104947|541200167|FG000|Overall Study|Protocol Violation|6|||
150017664|NCT02104947|541200168|FG001|Overall Study|Protocol Violation|8|||
150017665|NCT02104947|541200167|FG000|Overall Study|Adverse Event|57|||
150017666|NCT02104947|541200168|FG001|Overall Study|Adverse Event|38|||
150017667|NCT02104947|541200167|FG000|Overall Study|Other than stated above|2|||
150017668|NCT02104947|541200168|FG001|Overall Study|Other than stated above|3|||
150017669|NCT01090063|541200169|FG000|Screen|Screen Failed|4|||
150017670|NCT01090063|541200169|FG000|Treatment|Withdrawal by Subject|4|||
150017671|NCT04698993|541200175|FG000|Overall Study|PCR results not accessible|2|||
150017672|NCT04698993|541200176|FG001|Overall Study|PCR results not accessible|7|||
150017673|NCT04698993|541200175|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
150017674|NCT04698993|541200176|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
150017675|NCT01298765|541200177|FG000|Titration Period|Adverse Event|26|||
150017676|NCT01298765|541200177|FG000|Titration Period|Death|1|||
150017677|NCT01298765|541200177|FG000|Titration Period|Lack of Efficacy|21|||
150017678|NCT01298765|541200177|FG000|Titration Period|Lost to Follow-up|9|||
150017679|NCT01298765|541200177|FG000|Titration Period|Physician Decision|1|||
150017680|NCT01298765|541200177|FG000|Titration Period|Withdrawal by Subject|10|||
150017681|NCT01298765|541200177|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
150017682|NCT01298765|541200177|FG000|Long-Term Treatment Period|Adverse Event|19|||
150017683|NCT01298765|541200177|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
150017684|NCT01298765|541200177|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
150017685|NCT01298765|541200177|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
150017686|NCT01298765|541200177|FG000|Long-Term Treatment Period|Physician Decision|1|||
150058721|NCT02519855|541356807|FG001|Overall Study|Lost to Follow-up|3|||
150017687|NCT01298765|541200177|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
150017688|NCT03216746|541200181|FG000|Overall Study|Lost to Follow-up|6|||
150017689|NCT03216746|541200182|FG001|Overall Study|Lost to Follow-up|8|||
150017690|NCT03216746|541200183|FG002|Overall Study|Lost to Follow-up|5|||
150017691|NCT03216746|541200184|FG003|Overall Study|Lost to Follow-up|6|||
150017692|NCT00635882|541200185|FG000|Overall Study|Protocol Violation|1|||
150017693|NCT00635882|541200186|FG001|Overall Study|Protocol Violation|0|||
150017694|NCT00635882|541200187|FG002|Overall Study|Protocol Violation|0|||
150017695|NCT00635882|541200188|FG003|Overall Study|Protocol Violation|0|||
150017696|NCT00635882|541200189|FG004|Overall Study|Protocol Violation|0|||
150017697|NCT00635882|541200190|FG005|Overall Study|Protocol Violation|0|||
150017698|NCT01320202|541200191|FG000|Overall Study|Adverse Event|5|||
150017699|NCT01320202|541200192|FG001|Overall Study|Adverse Event|5|||
150017700|NCT01320202|541200191|FG000|Overall Study|Death|5|||
150017701|NCT01320202|541200192|FG001|Overall Study|Death|3|||
150017702|NCT01320202|541200191|FG000|Overall Study|Lost to Follow-up|1|||
150017703|NCT01320202|541200192|FG001|Overall Study|Lost to Follow-up|0|||
150017704|NCT01320202|541200191|FG000|Overall Study|Physician Decision|3|||
150017705|NCT01320202|541200192|FG001|Overall Study|Physician Decision|1|||
150017706|NCT01320202|541200191|FG000|Overall Study|Protocol Violation|2|||
150017707|NCT01320202|541200192|FG001|Overall Study|Protocol Violation|1|||
150017708|NCT01320202|541200191|FG000|Overall Study|Withdrawal by Subject|10|||
150017709|NCT01320202|541200192|FG001|Overall Study|Withdrawal by Subject|3|||
150017710|NCT01320202|541200191|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
150017711|NCT01320202|541200192|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
150017712|NCT01320202|541200191|FG000|Overall Study|kidney transplant|1|||
150017713|NCT01320202|541200192|FG001|Overall Study|kidney transplant|2|||
150017714|NCT01320202|541200191|FG000|Overall Study|blood transfusion|1|||
150017715|NCT01320202|541200192|FG001|Overall Study|blood transfusion|7|||
150017716|NCT01320202|541200191|FG000|Overall Study|moved/changed dialysis|5|||
150017717|NCT01320202|541200192|FG001|Overall Study|moved/changed dialysis|2|||
150017718|NCT01320202|541200191|FG000|Overall Study|sponsor request|2|||
150017719|NCT01320202|541200192|FG001|Overall Study|sponsor request|0|||
150017720|NCT01320202|541200191|FG000|Overall Study|ineligible|3|||
150017721|NCT01320202|541200192|FG001|Overall Study|ineligible|0|||
150017722|NCT01320202|541200191|FG000|Overall Study|regained renal function|1|||
150017723|NCT01320202|541200192|FG001|Overall Study|regained renal function|0|||
150017724|NCT04090242|541200193|FG000|Overall Study|Withdrawal by Subject|1|||
150017725|NCT04090242|541200194|FG001|Overall Study|Withdrawal by Subject|0|||
150017726|NCT02305238|541200195|FG000|Overall Study|Death|2|||
150017727|NCT02305238|541200196|FG001|Overall Study|Death|1|||
150017728|NCT02305238|541200197|FG002|Overall Study|Death|0|||
150017729|NCT02305238|541200195|FG000|Overall Study|Progressive disease|4|||
150017730|NCT02305238|541200196|FG001|Overall Study|Progressive disease|4|||
150017731|NCT02305238|541200197|FG002|Overall Study|Progressive disease|0|||
150017732|NCT02305238|541200195|FG000|Overall Study|Logistical difficulties|1|||
150017733|NCT02305238|541200196|FG001|Overall Study|Logistical difficulties|3|||
150017734|NCT02305238|541200197|FG002|Overall Study|Logistical difficulties|0|||
150017735|NCT02305238|541200195|FG000|Overall Study|Protocol Violation|0|||
150017736|NCT02305238|541200196|FG001|Overall Study|Protocol Violation|3|||
150017737|NCT02305238|541200197|FG002|Overall Study|Protocol Violation|0|||
150017738|NCT02305238|541200195|FG000|Overall Study|Physician Decision|2|||
150017739|NCT02305238|541200196|FG001|Overall Study|Physician Decision|1|||
150017740|NCT02305238|541200197|FG002|Overall Study|Physician Decision|0|||
150017741|NCT02305238|541200195|FG000|Overall Study|Adverse Event|4|||
150017742|NCT02305238|541200196|FG001|Overall Study|Adverse Event|2|||
150017743|NCT02305238|541200197|FG002|Overall Study|Adverse Event|0|||
150017744|NCT02305238|541200195|FG000|Overall Study|Withdrawal by Subject|3|||
150017745|NCT02305238|541200196|FG001|Overall Study|Withdrawal by Subject|4|||
150017746|NCT02305238|541200197|FG002|Overall Study|Withdrawal by Subject|0|||
150017747|NCT02305238|541200195|FG000|Overall Study|Randomized failure|0|||
150017748|NCT02305238|541200196|FG001|Overall Study|Randomized failure|0|||
150017749|NCT02305238|541200197|FG002|Overall Study|Randomized failure|8|||
150017750|NCT02305238|541200195|FG000|Overall Study|Required procedure failed|0|||
150017751|NCT02305238|541200196|FG001|Overall Study|Required procedure failed|1|||
150017752|NCT02305238|541200197|FG002|Overall Study|Required procedure failed|0|||
150017753|NCT02513472|541200198|FG000|Overall Study|Radiological Disease Progression|45|||
150017754|NCT02513472|541200199|FG001|Overall Study|Radiological Disease Progression|57|||
150017755|NCT02513472|541200198|FG000|Overall Study|Clinical Disease Progression|5|||
150017756|NCT02513472|541200199|FG001|Overall Study|Clinical Disease Progression|13|||
150017757|NCT02513472|541200198|FG000|Overall Study|Adverse Event|8|||
150017758|NCT02513472|541200199|FG001|Overall Study|Adverse Event|11|||
150017759|NCT02513472|541200198|FG000|Overall Study|Withdrawal by Subject|0|||
150017760|NCT02513472|541200199|FG001|Overall Study|Withdrawal by Subject|4|||
150017761|NCT02513472|541200198|FG000|Overall Study|Subject Choice|2|||
150017762|NCT02513472|541200199|FG001|Overall Study|Subject Choice|7|||
150017763|NCT02513472|541200198|FG000|Overall Study|Treatment Completed as per Protocol|3|||
150017764|NCT02513472|541200199|FG001|Overall Study|Treatment Completed as per Protocol|3|||
150017765|NCT02513472|541200198|FG000|Overall Study|Other|3|||
150017766|NCT02513472|541200199|FG001|Overall Study|Other|6|||
150017767|NCT01019369|541200200|FG000|Overall Study|Lost to Follow-up|10|||
150017768|NCT01019369|541200201|FG001|Overall Study|Lost to Follow-up|6|||
150017769|NCT01019369|541200200|FG000|Overall Study|Withdrawal by Subject|0|||
150017770|NCT01019369|541200201|FG001|Overall Study|Withdrawal by Subject|1|||
150017771|NCT01711645|541200204|FG000|Overall Study|Withdrawal by Subject|8|||
150017772|NCT01711645|541200204|FG000|Overall Study|Lost to Follow-up|6|||
150017773|NCT01711645|541200204|FG000|Overall Study|Physician Decision|5|||
150017774|NCT00384332|541200207|FG000|Overall Study|Lost to Follow-up|4|||
150017775|NCT00384332|541200208|FG001|Overall Study|Lost to Follow-up|0|||
150017776|NCT00408434|541200209|FG000|Overall Study|Adverse Event|0|||
150017777|NCT00408434|541200210|FG001|Overall Study|Adverse Event|0|||
150017778|NCT00408434|541200211|FG002|Overall Study|Adverse Event|1|||
150017779|NCT00408434|541200212|FG003|Overall Study|Adverse Event|0|||
150017780|NCT00408434|541200213|FG004|Overall Study|Adverse Event|0|||
150017781|NCT00408434|541200214|FG005|Overall Study|Adverse Event|0|||
150017782|NCT00408434|541200215|FG006|Overall Study|Adverse Event|0|||
150017783|NCT00408434|541200209|FG000|Overall Study|Progressive disease|6|||
150017784|NCT00408434|541200210|FG001|Overall Study|Progressive disease|3|||
150017785|NCT00408434|541200211|FG002|Overall Study|Progressive disease|4|||
150017786|NCT00408434|541200212|FG003|Overall Study|Progressive disease|3|||
150017787|NCT00408434|541200213|FG004|Overall Study|Progressive disease|3|||
150017788|NCT00408434|541200214|FG005|Overall Study|Progressive disease|1|||
150017789|NCT00408434|541200215|FG006|Overall Study|Progressive disease|4|||
150017790|NCT00408434|541200209|FG000|Overall Study|Other|0|||
150017791|NCT00408434|541200210|FG001|Overall Study|Other|0|||
150017792|NCT00408434|541200211|FG002|Overall Study|Other|1|||
150017793|NCT00408434|541200212|FG003|Overall Study|Other|0|||
150017794|NCT00408434|541200213|FG004|Overall Study|Other|2|||
150017795|NCT00408434|541200214|FG005|Overall Study|Other|1|||
150017796|NCT00408434|541200215|FG006|Overall Study|Other|0|||
150017797|NCT00408434|541200209|FG000|Overall Study|Terminated by Investigator|0|||
150017798|NCT00408434|541200210|FG001|Overall Study|Terminated by Investigator|0|||
150017799|NCT00408434|541200211|FG002|Overall Study|Terminated by Investigator|0|||
150017800|NCT00408434|541200212|FG003|Overall Study|Terminated by Investigator|0|||
150017801|NCT00408434|541200213|FG004|Overall Study|Terminated by Investigator|1|||
150017802|NCT00408434|541200214|FG005|Overall Study|Terminated by Investigator|1|||
150017803|NCT00408434|541200215|FG006|Overall Study|Terminated by Investigator|0|||
150017804|NCT00588354|541200216|FG000|Baseline to 2 Weeks|Adverse Event|1|||
150017805|NCT00588354|541200217|FG001|Baseline to 2 Weeks|Adverse Event|0|||
150017806|NCT00588354|541200216|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
150017807|NCT00588354|541200217|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
150017808|NCT00588354|541200216|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
150017809|NCT00588354|541200217|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
150017810|NCT01811186|541200218|FG000|Overall Study|Adverse Event|54|||
150017811|NCT01811186|541200219|FG001|Overall Study|Adverse Event|38|||
150017812|NCT01811186|541200218|FG000|Overall Study|Protocol Violation|5|||
150017813|NCT01811186|541200219|FG001|Overall Study|Protocol Violation|6|||
150017814|NCT01811186|541200218|FG000|Overall Study|Withdrawal by Subject|5|||
150017815|NCT01811186|541200219|FG001|Overall Study|Withdrawal by Subject|10|||
150017816|NCT01811186|541200218|FG000|Overall Study|Lack of Efficacy|3|||
150017817|NCT01811186|541200219|FG001|Overall Study|Lack of Efficacy|6|||
150017818|NCT01811186|541200218|FG000|Overall Study|Lost to Follow-up|4|||
150017819|NCT01811186|541200219|FG001|Overall Study|Lost to Follow-up|2|||
150017820|NCT04230213|541200228|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
150017821|NCT04230213|541200229|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
150017822|NCT04230213|541200230|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
150017823|NCT04230213|541200228|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
150017824|NCT04230213|541200229|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
150017825|NCT04230213|541200230|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
150017826|NCT04230213|541200228|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
150017827|NCT04230213|541200229|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
150017828|NCT04230213|541200230|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
150017829|NCT04230213|541200228|FG000|TP2: Week 10 to Week 16|Other|0|||
150017830|NCT04230213|541200229|FG001|TP2: Week 10 to Week 16|Other|2|||
150017831|NCT04230213|541200230|FG002|TP2: Week 10 to Week 16|Other|1|||
150017832|NCT04230213|541200228|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
150017833|NCT04230213|541200229|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
150017834|NCT04230213|541200230|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
150017835|NCT04230213|541200228|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
150017836|NCT04230213|541200229|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
150017837|NCT04230213|541200230|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
150017838|NCT04230213|541200228|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
150017839|NCT04230213|541200229|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
150017840|NCT04230213|541200230|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
150017841|NCT04230213|541200228|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
150017842|NCT04230213|541200229|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
150017843|NCT04230213|541200230|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
150017844|NCT04230213|541200228|FG000|TP3: Week 16 to Week 22|Other|0|||
150181516|NCT03584516|541802755|FG000|Part 1 Expansion|Death|0|||
150181517|NCT03584516|541802756|FG001|Part 1 Expansion|Death|0|||
150181518|NCT03584516|541802757|FG002|Part 1 Expansion|Death|9|||
150181519|NCT03584516|541802758|FG003|Part 1 Expansion|Death|8|||
150181520|NCT03584516|541802759|FG004|Part 1 Expansion|Death|4|||
150181521|NCT03584516|541802760|FG005|Part 1 Expansion|Death|5|||
150181522|NCT03584516|541802755|FG000|Part 1 Expansion|Lost to Follow-up|0|||
150181523|NCT03584516|541802756|FG001|Part 1 Expansion|Lost to Follow-up|0|||
150017845|NCT04230213|541200229|FG001|TP3: Week 16 to Week 22|Other|1|||
150017846|NCT04230213|541200230|FG002|TP3: Week 16 to Week 22|Other|3|||
150017847|NCT04230213|541200228|FG000|TP4: Week 22 to Week 32|Other|0|||
150017848|NCT04230213|541200229|FG001|TP4: Week 22 to Week 32|Other|5|||
150017849|NCT04230213|541200230|FG002|TP4: Week 22 to Week 32|Other|5|||
150017850|NCT04230213|541200228|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
150017851|NCT04230213|541200229|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
150017852|NCT04230213|541200230|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
150017853|NCT04230213|541200228|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
150017854|NCT04230213|541200229|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
150017855|NCT04230213|541200230|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
150017856|NCT04230213|541200228|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
150017857|NCT04230213|541200229|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
150017858|NCT04230213|541200230|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
150017859|NCT04230213|541200228|FG000|Follow up: Week 32 to Week 36|Other|0|||
150017860|NCT04230213|541200229|FG001|Follow up: Week 32 to Week 36|Other|1|||
150017861|NCT04230213|541200230|FG002|Follow up: Week 32 to Week 36|Other|1|||
150017862|NCT00534976|541200250|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
150017863|NCT00534976|541200251|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
150017864|NCT00534976|541200250|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
150017865|NCT00534976|541200251|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
150017866|NCT00534976|541200250|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
150017867|NCT00534976|541200251|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
150017868|NCT00861471|541200252|FG000|Overall Study|Withdrawal by Subject|1|||
150017869|NCT00861471|541200252|FG000|Overall Study|Adverse Event|2|||
150017870|NCT00861471|541200252|FG000|Overall Study|Lack of Efficacy|3|||
150017871|NCT00861471|541200252|FG000|Overall Study|treatment for lumbar laminectomy|1|||
150017872|NCT00861471|541200252|FG000|Overall Study|Physician Decision|2|||
150017873|NCT02092025|541200253|FG000|Overall Study|Case Report Forms Uncollected|44|||
150017874|NCT02092025|541200253|FG000|Overall Study|Protocol Deviation|24|||
150017875|NCT02927938|541200254|FG000|Overall Study|Death|0|||
150017876|NCT02927938|541200255|FG001|Overall Study|Death|1|||
150058722|NCT03621475|541356808|FG000|Overall Study|No longer required restraints at initiation|0|||
150058723|NCT03621475|541356809|FG001|Overall Study|No longer required restraints at initiation|1|||
150058724|NCT01842633|541356810|FG000|Overall Study|Screen Failure|1|||
150058725|NCT01842633|541356811|FG001|Overall Study|Screen Failure|0|||
150058726|NCT01842633|541356812|FG002|Overall Study|Screen Failure|0|||
150058727|NCT01842633|541356810|FG000|Overall Study|Adverse Event|1|||
150058728|NCT01842633|541356811|FG001|Overall Study|Adverse Event|1|||
150058729|NCT01842633|541356812|FG002|Overall Study|Adverse Event|0|||
150058730|NCT01842633|541356810|FG000|Overall Study|Withdrawal by Subject|0|||
150058731|NCT01842633|541356811|FG001|Overall Study|Withdrawal by Subject|1|||
150058732|NCT01842633|541356812|FG002|Overall Study|Withdrawal by Subject|0|||
150058733|NCT01842633|541356810|FG000|Overall Study|Technical issues|1|||
150058734|NCT01842633|541356811|FG001|Overall Study|Technical issues|0|||
150058735|NCT01842633|541356812|FG002|Overall Study|Technical issues|0|||
150181524|NCT03584516|541802757|FG002|Part 1 Expansion|Lost to Follow-up|0|||
150181525|NCT03584516|541802758|FG003|Part 1 Expansion|Lost to Follow-up|1|||
150017877|NCT02927938|541200256|FG002|Overall Study|Death|0|||
150017878|NCT02927938|541200257|FG003|Overall Study|Death|4|||
150017879|NCT02927938|541200254|FG000|Overall Study|Early Study Termination|1|||
150181526|NCT03584516|541802759|FG004|Part 1 Expansion|Lost to Follow-up|0|||
150181527|NCT03584516|541802760|FG005|Part 1 Expansion|Lost to Follow-up|0|||
150181528|NCT03584516|541802755|FG000|Part 1 Expansion|Physician Decision|0|||
150181529|NCT03584516|541802756|FG001|Part 1 Expansion|Physician Decision|0|||
150181530|NCT03584516|541802757|FG002|Part 1 Expansion|Physician Decision|4|||
150181531|NCT03584516|541802758|FG003|Part 1 Expansion|Physician Decision|3|||
150181532|NCT03584516|541802759|FG004|Part 1 Expansion|Physician Decision|2|||
150181533|NCT03584516|541802760|FG005|Part 1 Expansion|Physician Decision|3|||
150181534|NCT03584516|541802755|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
150181535|NCT03584516|541802756|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
150181536|NCT03584516|541802757|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
150181537|NCT03584516|541802758|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
150181538|NCT03584516|541802759|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
150017880|NCT02927938|541200255|FG001|Overall Study|Early Study Termination|5|||
150058736|NCT03565367|541356813|FG000|Overall Study|No scan due to technical issues|4|||
150058737|NCT03565367|541356814|FG001|Overall Study|No scan due to technical issues|0|||
150058738|NCT00920907|541356819|FG000|Induction Period|Adverse Event|0|||
150017881|NCT02927938|541200256|FG002|Overall Study|Early Study Termination|4|||
150017882|NCT02927938|541200257|FG003|Overall Study|Early Study Termination|3|||
150017883|NCT00264537|541200258|FG000|Overall Study|Death|0|||
150017884|NCT00264537|541200259|FG001|Overall Study|Death|3|||
150017885|NCT00264537|541200260|FG002|Overall Study|Death|3|||
150017886|NCT00264537|541200261|FG003|Overall Study|Death|2|||
150017887|NCT00264537|541200258|FG000|Overall Study|Lost to Follow-up|3|||
150017888|NCT00264537|541200259|FG001|Overall Study|Lost to Follow-up|4|||
150017889|NCT00264537|541200260|FG002|Overall Study|Lost to Follow-up|7|||
150017890|NCT00264537|541200261|FG003|Overall Study|Lost to Follow-up|6|||
150017891|NCT00264537|541200258|FG000|Overall Study|Adverse Event|21|||
150017892|NCT00264537|541200259|FG001|Overall Study|Adverse Event|32|||
150017893|NCT00264537|541200260|FG002|Overall Study|Adverse Event|24|||
150017894|NCT00264537|541200261|FG003|Overall Study|Adverse Event|34|||
150017895|NCT00264537|541200258|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
150017896|NCT00264537|541200259|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
150017897|NCT00264537|541200260|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
150017898|NCT00264537|541200261|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
150017899|NCT00264537|541200258|FG000|Overall Study|Other|21|||
150017900|NCT00264537|541200259|FG001|Overall Study|Other|11|||
150017901|NCT00264537|541200260|FG002|Overall Study|Other|10|||
150017902|NCT00264537|541200261|FG003|Overall Study|Other|11|||
150017903|NCT00264537|541200258|FG000|Overall Study|Not treated|0|||
150017904|NCT00264537|541200259|FG001|Overall Study|Not treated|2|||
150017905|NCT00264537|541200260|FG002|Overall Study|Not treated|1|||
150017906|NCT00264537|541200261|FG003|Overall Study|Not treated|0|||
150017907|NCT02476006|541200262|FG000|Overall Study|Death|4|||
150017908|NCT02476006|541200262|FG000|Overall Study|Lack of treatment efficacy|2|||
150017909|NCT02476006|541200262|FG000|Overall Study|Pregnancy|1|||
150017910|NCT02476006|541200262|FG000|Overall Study|Participant did not wish to continue|39|||
150017911|NCT02476006|541200262|FG000|Overall Study|Adverse Event|41|||
150017912|NCT02476006|541200262|FG000|Overall Study|Poor compliance to study protocol|3|||
150017913|NCT02476006|541200262|FG000|Overall Study|Sponsor decision|6|||
150017914|NCT02476006|541200262|FG000|Overall Study|Lost to Follow-up|5|||
150017915|NCT02476006|541200262|FG000|Overall Study|Physician Decision|5|||
150017916|NCT02476006|541200262|FG000|Overall Study|Study ended treatment not available|4|||
150017917|NCT02476006|541200262|FG000|Overall Study|Switched to commercial drug|4|||
150017918|NCT02476006|541200262|FG000|Overall Study|Excluded from study|1|||
150017919|NCT02476006|541200262|FG000|Overall Study|Protocol Violation|1|||
150017920|NCT02476006|541200262|FG000|Overall Study|Enrolled but not treated|4|||
150017921|NCT00615017|541201879|FG000|Overall Study|Adverse Event|0|||
150017922|NCT00615017|541201880|FG001|Overall Study|Adverse Event|1|||
150017923|NCT00615017|541201881|FG002|Overall Study|Adverse Event|2|||
150017924|NCT00615017|541201882|FG003|Overall Study|Adverse Event|0|||
150017925|NCT00615017|541201883|FG004|Overall Study|Adverse Event|0|||
150017926|NCT00615017|541201884|FG005|Overall Study|Adverse Event|1|||
150017927|NCT00615017|541201879|FG000|Overall Study|Death|0|||
150017928|NCT00615017|541201880|FG001|Overall Study|Death|0|||
150017929|NCT00615017|541201881|FG002|Overall Study|Death|2|||
150017930|NCT00615017|541201882|FG003|Overall Study|Death|0|||
150058739|NCT00920907|541356820|FG001|Induction Period|Adverse Event|2|||
150058740|NCT00920907|541356819|FG000|Induction Period|Death|1|||
150058741|NCT00920907|541356820|FG001|Induction Period|Death|1|||
150058742|NCT00920907|541356819|FG000|Induction Period|Disease Progression|12|||
150058743|NCT00920907|541356820|FG001|Induction Period|Disease Progression|11|||
150058744|NCT00920907|541356819|FG000|Induction Period|Study Drug Toxicity|8|||
150058745|NCT00920907|541356820|FG001|Induction Period|Study Drug Toxicity|6|||
150058746|NCT00920907|541356819|FG000|Induction Period|No longer meets study criteria|0|||
150058747|NCT00920907|541356820|FG001|Induction Period|No longer meets study criteria|1|||
150058748|NCT00920907|541356819|FG000|Induction Period|Withdrawal by Subject|1|||
150017931|NCT00615017|541201883|FG004|Overall Study|Death|1|||
150017932|NCT00615017|541201884|FG005|Overall Study|Death|1|||
150017933|NCT00615017|541201879|FG000|Overall Study|Sepsis resolved|0|||
150017934|NCT00615017|541201880|FG001|Overall Study|Sepsis resolved|0|||
150058749|NCT00920907|541356820|FG001|Induction Period|Withdrawal by Subject|1|||
150058750|NCT00920907|541356819|FG000|Maintenance Period|Disease Progression|3|||
150017935|NCT00615017|541201881|FG002|Overall Study|Sepsis resolved|1|||
150017936|NCT00615017|541201882|FG003|Overall Study|Sepsis resolved|0|||
150017937|NCT00615017|541201883|FG004|Overall Study|Sepsis resolved|0|||
150017938|NCT00615017|541201884|FG005|Overall Study|Sepsis resolved|0|||
150017939|NCT00615017|541201879|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
150017940|NCT00615017|541201880|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
150017941|NCT00615017|541201881|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
150017942|NCT00615017|541201882|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
150017943|NCT00615017|541201883|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
150181539|NCT03584516|541802760|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
150181540|NCT03584516|541802755|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
150181541|NCT03584516|541802756|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
150181542|NCT03584516|541802757|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
150181543|NCT03584516|541802758|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
150181544|NCT03584516|541802759|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
150181545|NCT03584516|541802760|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
150181546|NCT03584516|541802755|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
150181547|NCT03584516|541802756|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
150181548|NCT03584516|541802757|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
150017944|NCT00615017|541201884|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
150017945|NCT00615017|541201879|FG000|Overall Study|Physician discontinued drug|0|||
150017946|NCT00615017|541201880|FG001|Overall Study|Physician discontinued drug|0|||
150017947|NCT00615017|541201881|FG002|Overall Study|Physician discontinued drug|0|||
150017948|NCT00615017|541201882|FG003|Overall Study|Physician discontinued drug|0|||
150017949|NCT00615017|541201883|FG004|Overall Study|Physician discontinued drug|0|||
150017950|NCT00615017|541201884|FG005|Overall Study|Physician discontinued drug|1|||
150017951|NCT00806988|541201885|FG000|Overall Study|Death|15|||
150017952|NCT00806988|541201886|FG001|Overall Study|Death|16|||
150017953|NCT00806988|541201885|FG000|Overall Study|Withdrawal by Subject|8|||
150017954|NCT00806988|541201886|FG001|Overall Study|Withdrawal by Subject|8|||
150017955|NCT00806988|541201885|FG000|Overall Study|Lost to Follow-up|4|||
150017956|NCT00806988|541201886|FG001|Overall Study|Lost to Follow-up|19|||
150017957|NCT04775953|541201888|FG000|Overall Study|Lost to Follow-up|6|||
150017958|NCT04775953|541201889|FG001|Overall Study|Lost to Follow-up|11|||
150017959|NCT04775953|541201888|FG000|Overall Study|Death|5|||
150017960|NCT04775953|541201889|FG001|Overall Study|Death|4|||
150017961|NCT04775953|541201888|FG000|Overall Study|Withdrawal by Subject|3|||
150017962|NCT04775953|541201889|FG001|Overall Study|Withdrawal by Subject|3|||
150017963|NCT04775953|541201888|FG000|Overall Study|Protocol Violation|2|||
150017964|NCT04775953|541201889|FG001|Overall Study|Protocol Violation|0|||
150017965|NCT04775953|541201888|FG000|Overall Study|Participant non-compliance|0|||
150017966|NCT04775953|541201889|FG001|Overall Study|Participant non-compliance|1|||
150017967|NCT01698814|541201890|FG000|Overall Study|Adverse Event|0|||
150017968|NCT01698814|541201891|FG001|Overall Study|Adverse Event|2|||
150017969|NCT01698814|541201890|FG000|Overall Study|Lost to Follow-up|0|||
150017970|NCT01698814|541201891|FG001|Overall Study|Lost to Follow-up|1|||
150017971|NCT01698814|541201890|FG000|Overall Study|Pregnancy|1|||
150017972|NCT01698814|541201891|FG001|Overall Study|Pregnancy|0|||
150017973|NCT01698814|541201890|FG000|Overall Study|Randomized in error|1|||
150017974|NCT01698814|541201891|FG001|Overall Study|Randomized in error|0|||
150017975|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
150017976|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
150017977|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
150017978|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
150017979|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
150017980|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
150017981|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
150017982|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
150017983|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
150017984|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
150017985|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
150017986|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
150017987|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
150017988|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
150017989|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
150017990|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
150181549|NCT03584516|541802758|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
150181550|NCT03584516|541802759|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
150181551|NCT03584516|541802760|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
150181552|NCT03584516|541802755|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
150017991|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
150017992|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
150017993|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
150017994|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
150017995|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
150017996|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
150017997|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
150017998|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
150017999|NCT03777059|541201892|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
150018000|NCT03777059|541201893|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
150018001|NCT03777059|541201894|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
150018002|NCT03777059|541201895|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
150018003|NCT03777059|541201892|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
150018004|NCT03777059|541201893|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
150018005|NCT03777059|541201894|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
150018006|NCT03777059|541201895|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
150018007|NCT03777059|541201892|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
150018008|NCT03777059|541201893|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
150018009|NCT03777059|541201894|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
150018010|NCT03777059|541201895|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
150018011|NCT03777059|541201892|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
150018012|NCT03777059|541201893|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
150018013|NCT03777059|541201894|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
150018014|NCT03777059|541201895|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
150018015|NCT03777059|541201892|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
150018016|NCT03777059|541201893|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
150018017|NCT03777059|541201894|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
150018018|NCT03777059|541201895|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
150018019|NCT00855959|541201896|FG000|Overall Study|Adverse Event|2|||
150018020|NCT00855959|541201896|FG000|Overall Study|Lost to Follow-up|2|||
150018021|NCT00855959|541201896|FG000|Overall Study|Withdrawal by Subject|3|||
150018022|NCT00855959|541201896|FG000|Overall Study|Pregnancy|1|||
150018023|NCT00855959|541201896|FG000|Overall Study|Incorrect enrolment|1|||
150018024|NCT00368641|541201900|FG000|Overall Study|Adverse Event|2|||
150018025|NCT00368641|541201901|FG001|Overall Study|Adverse Event|1|||
150018026|NCT00368641|541201900|FG000|Overall Study|Death|1|||
150058751|NCT00920907|541356820|FG001|Maintenance Period|Disease Progression|7|||
150018027|NCT00368641|541201901|FG001|Overall Study|Death|0|||
150018028|NCT00368641|541201900|FG000|Overall Study|Withdrawal by Subject|1|||
150058752|NCT00920907|541356819|FG000|Maintenance Period|Administrative (study closure)|7|||
150058753|NCT00920907|541356820|FG001|Maintenance Period|Administrative (study closure)|2|||
150018029|NCT00368641|541201901|FG001|Overall Study|Withdrawal by Subject|0|||
150018030|NCT00368641|541201900|FG000|Overall Study|Sponsor decision to terminate study|2|||
150018031|NCT00368641|541201901|FG001|Overall Study|Sponsor decision to terminate study|5|||
150018032|NCT02517541|541201904|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
150018033|NCT02517541|541201904|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
150018034|NCT02517541|541201904|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
150018035|NCT02517541|541201904|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
150018036|NCT02517541|541201904|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
150018037|NCT02517541|541201904|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
150018038|NCT00699608|541201905|FG000|First Intervention|Withdrawal by Subject|0|||
150018039|NCT00699608|541201906|FG001|First Intervention|Withdrawal by Subject|0|||
150018040|NCT00699608|541201907|FG002|First Intervention|Withdrawal by Subject|1|||
150018041|NCT00699608|541201908|FG003|First Intervention|Withdrawal by Subject|0|||
150018042|NCT00699608|541201909|FG004|First Intervention|Withdrawal by Subject|0|||
150018043|NCT00699608|541201910|FG005|First Intervention|Withdrawal by Subject|0|||
150018044|NCT00699608|541201905|FG000|First Intervention|Protocol Violation|0|||
150018045|NCT00699608|541201906|FG001|First Intervention|Protocol Violation|0|||
150018046|NCT00699608|541201907|FG002|First Intervention|Protocol Violation|0|||
150018047|NCT00699608|541201908|FG003|First Intervention|Protocol Violation|0|||
150018048|NCT00699608|541201909|FG004|First Intervention|Protocol Violation|1|||
150018049|NCT00699608|541201910|FG005|First Intervention|Protocol Violation|0|||
150018050|NCT00699608|541201905|FG000|Second Intervention|Adverse Event|0|||
150018051|NCT00699608|541201906|FG001|Second Intervention|Adverse Event|0|||
150018052|NCT00699608|541201907|FG002|Second Intervention|Adverse Event|1|||
150018053|NCT00699608|541201908|FG003|Second Intervention|Adverse Event|0|||
150018054|NCT00699608|541201909|FG004|Second Intervention|Adverse Event|0|||
150018055|NCT00699608|541201910|FG005|Second Intervention|Adverse Event|0|||
150018056|NCT00699608|541201905|FG000|Second Intervention|Withdrawal by Subject|0|||
150018057|NCT00699608|541201906|FG001|Second Intervention|Withdrawal by Subject|0|||
150018058|NCT00699608|541201907|FG002|Second Intervention|Withdrawal by Subject|0|||
150018059|NCT00699608|541201908|FG003|Second Intervention|Withdrawal by Subject|1|||
150018060|NCT00699608|541201909|FG004|Second Intervention|Withdrawal by Subject|0|||
150018061|NCT00699608|541201910|FG005|Second Intervention|Withdrawal by Subject|0|||
150018062|NCT01136408|541201911|FG000|Overall Study|Adverse Event|4|||
150018063|NCT01136408|541201912|FG001|Overall Study|Adverse Event|8|||
150018064|NCT01136408|541201913|FG002|Overall Study|Adverse Event|4|||
150018065|NCT01136408|541201911|FG000|Overall Study|Protocol Violation|1|||
150018066|NCT01136408|541201912|FG001|Overall Study|Protocol Violation|1|||
150018067|NCT01136408|541201913|FG002|Overall Study|Protocol Violation|1|||
150018068|NCT02828436|541201914|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
150058754|NCT00920907|541356819|FG000|Maintenance Period|Study Drug Toxicity|0|||
150058755|NCT00920907|541356820|FG001|Maintenance Period|Study Drug Toxicity|2|||
150058756|NCT00920907|541356819|FG000|Maintenance Period|Death|1|||
150058757|NCT00920907|541356820|FG001|Maintenance Period|Death|1|||
150018069|NCT02828436|541201915|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
150018070|NCT02828436|541201914|FG000|Period 1|Lost to Follow-up|0|||
150018071|NCT02828436|541201915|FG001|Period 1|Lost to Follow-up|1|||
150018072|NCT02828436|541201914|FG000|Period 2|Withdrawal by Subject|4|||
150018073|NCT02828436|541201915|FG001|Period 2|Withdrawal by Subject|0|||
150018074|NCT02828436|541201914|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
150018075|NCT02828436|541201915|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
150018076|NCT02828436|541201914|FG000|Period 2|Lost to Follow-up|1|||
150018077|NCT02828436|541201915|FG001|Period 2|Lost to Follow-up|0|||
150018078|NCT03078556|541201920|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
150018079|NCT03078556|541201921|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
150018080|NCT03078556|541201922|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
150018081|NCT03078556|541201923|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
150018082|NCT03078556|541201920|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
150018083|NCT03078556|541201921|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
150018084|NCT03078556|541201922|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
150018085|NCT03078556|541201923|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
150018086|NCT03078556|541201920|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
150018087|NCT03078556|541201921|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
150018088|NCT03078556|541201922|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
150018089|NCT03078556|541201923|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
150018090|NCT03078556|541201920|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
150018091|NCT03078556|541201921|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
150018092|NCT03078556|541201922|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
150018093|NCT03078556|541201923|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
150018094|NCT04421482|541201925|FG000|Overall Study|Physician Decision|1|||
150018095|NCT03010319|541201926|FG000|Overall Study|Adverse Event|15|||
150018096|NCT03010319|541201927|FG001|Overall Study|Adverse Event|9|||
150018097|NCT03010319|541201926|FG000|Overall Study|Withdrawal by Subject|1|||
150018098|NCT03010319|541201927|FG001|Overall Study|Withdrawal by Subject|6|||
150018099|NCT03010319|541201926|FG000|Overall Study|Physician Decision|2|||
150018100|NCT03010319|541201927|FG001|Overall Study|Physician Decision|4|||
150018101|NCT03010319|541201926|FG000|Overall Study|Sponsor requested withdrawal|2|||
150018102|NCT03010319|541201927|FG001|Overall Study|Sponsor requested withdrawal|2|||
150018103|NCT03010319|541201926|FG000|Overall Study|Death|1|||
150018104|NCT03010319|541201927|FG001|Overall Study|Death|0|||
150018105|NCT03010319|541201926|FG000|Overall Study|Lost to Follow-up|0|||
150018106|NCT03010319|541201927|FG001|Overall Study|Lost to Follow-up|1|||
150018107|NCT03010319|541201926|FG000|Overall Study|Other Reason|5|||
150018108|NCT03010319|541201927|FG001|Overall Study|Other Reason|7|||
150018109|NCT02128724|541201928|FG000|Overall Study|Death|1|||
150018110|NCT02128724|541201929|FG001|Overall Study|Death|0|||
150018111|NCT02128724|541201930|FG002|Overall Study|Death|0|||
150018112|NCT02128724|541201931|FG003|Overall Study|Death|0|||
150018113|NCT02128724|541201928|FG000|Overall Study|Adverse Event|0|||
150018114|NCT02128724|541201929|FG001|Overall Study|Adverse Event|1|||
150058758|NCT00920907|541356819|FG000|Maintenance Period|Withdrawal by Subject|1|||
150058759|NCT00920907|541356820|FG001|Maintenance Period|Withdrawal by Subject|0|||
150058760|NCT00920907|541356819|FG000|Maintenance Period|Adverse Event|0|||
150058761|NCT00920907|541356820|FG001|Maintenance Period|Adverse Event|1|||
150181553|NCT03584516|541802756|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
150181554|NCT03584516|541802757|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
150181555|NCT03584516|541802758|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
150181556|NCT03584516|541802759|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
150181557|NCT03584516|541802760|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
150181558|NCT05986565|541802761|FG000|Overall Study|Lost to Follow-up|8|||
150181559|NCT05986565|541802762|FG001|Overall Study|Lost to Follow-up|3|||
150181560|NCT05986565|541802761|FG000|Overall Study|Withdrawal by Subject|0|||
150181561|NCT05986565|541802762|FG001|Overall Study|Withdrawal by Subject|1|||
150181562|NCT05846646|541802764|FG000|Overall Study|Physician Decision|1|||
150181563|NCT05846646|541802765|FG001|Overall Study|Physician Decision|0|||
150181564|NCT05846646|541802766|FG002|Overall Study|Physician Decision|0|||
150181565|NCT05846646|541802764|FG000|Overall Study|Lack of Efficacy|1|||
150181566|NCT05846646|541802765|FG001|Overall Study|Lack of Efficacy|1|||
150181567|NCT05846646|541802766|FG002|Overall Study|Lack of Efficacy|0|||
150181568|NCT05846646|541802764|FG000|Overall Study|Early Study Termination|1|||
150181569|NCT05846646|541802765|FG001|Overall Study|Early Study Termination|2|||
150181570|NCT05846646|541802766|FG002|Overall Study|Early Study Termination|0|||
150181571|NCT00670046|541802767|FG000|Overall Study|Lost to Follow-up|1|||
150181572|NCT00670046|541802768|FG001|Overall Study|Lost to Follow-up|1|||
150181573|NCT00670046|541802767|FG000|Overall Study|Withdrawal by Subject|0|||
150181574|NCT00670046|541802768|FG001|Overall Study|Withdrawal by Subject|1|||
150181575|NCT03655262|541802774|FG000|Overall Study|Withdrawal by Subject|0|||
150181576|NCT03655262|541802775|FG001|Overall Study|Withdrawal by Subject|0|||
150181577|NCT03655262|541802776|FG002|Overall Study|Withdrawal by Subject|1|||
150181578|NCT02554786|541802777|FG000|Overall Study|Subject/guardian decision|29|||
150181579|NCT02554786|541802778|FG001|Overall Study|Subject/guardian decision|17|||
150181580|NCT02554786|541802779|FG002|Overall Study|Subject/guardian decision|18|||
150181581|NCT02554786|541802780|FG003|Overall Study|Subject/guardian decision|30|||
150181582|NCT02554786|541802781|FG004|Overall Study|Subject/guardian decision|20|||
150181583|NCT02554786|541802777|FG000|Overall Study|Lost to Follow-up|4|||
150181584|NCT02554786|541802778|FG001|Overall Study|Lost to Follow-up|3|||
150181585|NCT02554786|541802779|FG002|Overall Study|Lost to Follow-up|4|||
150181586|NCT02554786|541802780|FG003|Overall Study|Lost to Follow-up|2|||
150181587|NCT02554786|541802781|FG004|Overall Study|Lost to Follow-up|2|||
150181588|NCT02554786|541802777|FG000|Overall Study|Protocol deviation|1|||
150181589|NCT02554786|541802778|FG001|Overall Study|Protocol deviation|3|||
150181590|NCT02554786|541802779|FG002|Overall Study|Protocol deviation|3|||
150181591|NCT02554786|541802780|FG003|Overall Study|Protocol deviation|4|||
150181592|NCT02554786|541802781|FG004|Overall Study|Protocol deviation|2|||
150181593|NCT02554786|541802777|FG000|Overall Study|Technical problems|1|||
150018115|NCT02128724|541201930|FG002|Overall Study|Adverse Event|0|||
150018116|NCT02128724|541201931|FG003|Overall Study|Adverse Event|0|||
150018117|NCT02128724|541201928|FG000|Overall Study|Physician Decision|0|||
150018118|NCT02128724|541201929|FG001|Overall Study|Physician Decision|0|||
150018119|NCT02128724|541201930|FG002|Overall Study|Physician Decision|0|||
150018120|NCT02128724|541201931|FG003|Overall Study|Physician Decision|2|||
150018121|NCT02128724|541201928|FG000|Overall Study|Withdrawal by Subject|0|||
150018122|NCT02128724|541201929|FG001|Overall Study|Withdrawal by Subject|0|||
150018123|NCT02128724|541201930|FG002|Overall Study|Withdrawal by Subject|0|||
150018124|NCT02128724|541201931|FG003|Overall Study|Withdrawal by Subject|1|||
150018125|NCT01442714|541201932|FG000|Overall Study|Death|11|||
150018126|NCT01442714|541201932|FG000|Overall Study|Withdrawal by Subject|1|||
150018127|NCT04306510|541201933|FG000|Overall Study|Voluntarily withdrawal|1|||
150018128|NCT04306510|541201933|FG000|Overall Study|Enrolled but Not Treated|1|||
150018129|NCT04720417|541201936|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
150018130|NCT03329092|541201937|FG000|Overall Study|Other|2|||
150018131|NCT03329092|541201938|FG001|Overall Study|Other|2|||
150018132|NCT03329092|541201937|FG000|Overall Study|Withdrawal by Subject|16|||
150018133|NCT03329092|541201938|FG001|Overall Study|Withdrawal by Subject|3|||
150018134|NCT03329092|541201937|FG000|Overall Study|Physician Decision|1|||
150018135|NCT03329092|541201938|FG001|Overall Study|Physician Decision|0|||
150018136|NCT03329092|541201937|FG000|Overall Study|Death|17|||
150018137|NCT03329092|541201938|FG001|Overall Study|Death|11|||
150018138|NCT03329092|541201937|FG000|Overall Study|Adverse Event|3|||
150018139|NCT03329092|541201938|FG001|Overall Study|Adverse Event|1|||
150018140|NCT03329092|541201937|FG000|Overall Study|Lost to Follow-up|1|||
150018141|NCT03329092|541201938|FG001|Overall Study|Lost to Follow-up|1|||
150018142|NCT03314987|541201939|FG000|Overall Study|Lost to Follow-up|13|||
150018143|NCT03314987|541201940|FG001|Overall Study|Lost to Follow-up|13|||
150018144|NCT03574779|541201941|FG000|Overall Study|Screening failure|13|||
150018145|NCT03574779|541201942|FG001|Overall Study|Screening failure|83|||
150018146|NCT02751580|541201943|FG000|Overall Study|Lost to Follow-up|4|||
150018147|NCT02751580|541201943|FG000|Overall Study|Death|2|||
150018148|NCT02588261|541201944|FG000|Overall Study|Study Terminated by Sponsor|157|||
150018149|NCT02588261|541201945|FG001|Overall Study|Study Terminated by Sponsor|142|||
150018150|NCT02588261|541201944|FG000|Overall Study|Protocol Deviation|1|||
150018151|NCT02588261|541201945|FG001|Overall Study|Protocol Deviation|0|||
150018152|NCT02588261|541201944|FG000|Overall Study|Death|1|||
150018153|NCT02588261|541201945|FG001|Overall Study|Death|2|||
150018154|NCT02588261|541201944|FG000|Overall Study|Withdrawal by Subject|12|||
150018155|NCT02588261|541201945|FG001|Overall Study|Withdrawal by Subject|8|||
150018156|NCT02588261|541201944|FG000|Overall Study|Noncompliance with Study Drug|0|||
150018157|NCT02588261|541201945|FG001|Overall Study|Noncompliance with Study Drug|1|||
150018158|NCT02588261|541201944|FG000|Overall Study|Miscellaneous|5|||
150018159|NCT02588261|541201945|FG001|Overall Study|Miscellaneous|4|||
150018160|NCT02588261|541201944|FG000|Overall Study|Progressive Disease|61|||
150018161|NCT02588261|541201945|FG001|Overall Study|Progressive Disease|82|||
150018162|NCT02588261|541201944|FG000|Overall Study|Adverse Event|29|||
150018163|NCT02588261|541201945|FG001|Overall Study|Adverse Event|24|||
150018164|NCT02588261|541201944|FG000|Overall Study|Lost to Follow-up|1|||
150018165|NCT02588261|541201945|FG001|Overall Study|Lost to Follow-up|0|||
150018166|NCT03755882|541201950|FG000|Period 1|Protocol Violation|1|||
150018167|NCT03755882|541201951|FG001|Period 1|Protocol Violation|0|||
150018168|NCT03755882|541201950|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
150018169|NCT03755882|541201951|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
150018170|NCT01746368|541201955|FG000|Overall Study|Lost to Follow-up|2|||
150018171|NCT01746368|541201956|FG001|Overall Study|Lost to Follow-up|0|||
150018172|NCT01746368|541201955|FG000|Overall Study|Withdrawal by Subject|0|||
150018173|NCT01746368|541201956|FG001|Overall Study|Withdrawal by Subject|1|||
150018174|NCT05636852|541201957|FG000|Overall Study|Withdrawal by Subject|1|||
150018175|NCT05636852|541201957|FG000|Overall Study|Other than specified|1|||
150018176|NCT01076036|541201960|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
150018177|NCT02221674|541201961|FG000|Overall Study|Lost to Follow-up|1|||
150018178|NCT02221674|541201962|FG001|Overall Study|Lost to Follow-up|0|||
150018179|NCT02221674|541201963|FG002|Overall Study|Lost to Follow-up|0|||
150018180|NCT05292131|541201964|FG000|Overall Study|Lost to Follow-up|1|||
150018181|NCT05292131|541201965|FG001|Overall Study|Lost to Follow-up|1|||
150018182|NCT05292131|541201964|FG000|Overall Study|Withdrawal by Subject|0|||
150018183|NCT05292131|541201965|FG001|Overall Study|Withdrawal by Subject|1|||
150018184|NCT02557542|541201966|FG000|Overall Study|Poor recruitment|3|||
150018185|NCT02557542|541201967|FG001|Overall Study|Poor recruitment|0|||
150018186|NCT04390880|541201968|FG000|Overall Study|Withdrawal by Subject|1|||
150018187|NCT01345188|541201969|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
150018188|NCT01345188|541201969|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
150018189|NCT06041919|541201972|FG000|Overall Study|Lost to Follow-up|1|||
150058762|NCT01275339|541356821|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
150058763|NCT01275339|541356822|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
150058764|NCT01275339|541356823|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
150058765|NCT01275339|541356824|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
150058766|NCT01275339|541356821|FG000|Overall Study|Withdrawal by Subject|0|||
150058767|NCT01275339|541356822|FG001|Overall Study|Withdrawal by Subject|0|||
150058768|NCT01275339|541356823|FG002|Overall Study|Withdrawal by Subject|1|||
150058769|NCT01275339|541356824|FG003|Overall Study|Withdrawal by Subject|0|||
150058770|NCT04389970|541356825|FG000|Overall Study|Lost to Follow-up|1|||
150058771|NCT00718081|541356828|FG000|Overall Study|Adverse Event|0|||
150058772|NCT00718081|541356829|FG001|Overall Study|Adverse Event|1|||
150058773|NCT00718081|541356830|FG002|Overall Study|Adverse Event|0|||
150058774|NCT00718081|541356828|FG000|Overall Study|Lack of Efficacy|7|||
150058775|NCT00718081|541356829|FG001|Overall Study|Lack of Efficacy|3|||
150058776|NCT00718081|541356830|FG002|Overall Study|Lack of Efficacy|21|||
150058777|NCT00815516|541356831|FG000|Overall Study|Death|3|||
150058778|NCT00815516|541356832|FG001|Overall Study|Death|1|||
150058779|NCT00815516|541356831|FG000|Overall Study|Physician Decision|1|||
150058780|NCT00815516|541356832|FG001|Overall Study|Physician Decision|0|||
150058781|NCT00976508|541356834|FG000|Overall Study|Death|7|||
150058782|NCT00976508|541356835|FG001|Overall Study|Death|1|||
150058783|NCT00976508|541356834|FG000|Overall Study|Lost to Follow-up|1|||
150058784|NCT00976508|541356835|FG001|Overall Study|Lost to Follow-up|0|||
150058785|NCT00976508|541356834|FG000|Overall Study|Withdrawal by Subject|1|||
150058786|NCT00976508|541356835|FG001|Overall Study|Withdrawal by Subject|0|||
150058787|NCT00976508|541356834|FG000|Overall Study|Disease Progression|4|||
150058788|NCT00976508|541356835|FG001|Overall Study|Disease Progression|4|||
150058789|NCT00976508|541356834|FG000|Overall Study|Subject Enrolled in Hospice|1|||
150058790|NCT00976508|541356835|FG001|Overall Study|Subject Enrolled in Hospice|0|||
150058791|NCT00976508|541356834|FG000|Overall Study|Terminated by the Sponsor|0|||
150058792|NCT00976508|541356835|FG001|Overall Study|Terminated by the Sponsor|1|||
150058793|NCT01993836|541356843|FG000|Overall Study|Surgery Cancelled|3|||
150058794|NCT01993836|541356844|FG001|Overall Study|Surgery Cancelled|0|||
150058795|NCT01993836|541356845|FG002|Overall Study|Surgery Cancelled|0|||
150058796|NCT01993836|541356843|FG000|Overall Study|Physician Decision|2|||
150058797|NCT01993836|541356844|FG001|Overall Study|Physician Decision|1|||
150058798|NCT01993836|541356845|FG002|Overall Study|Physician Decision|0|||
150058799|NCT01993836|541356843|FG000|Overall Study|Death|0|||
150058800|NCT01993836|541356844|FG001|Overall Study|Death|2|||
150058801|NCT01993836|541356845|FG002|Overall Study|Death|0|||
150058802|NCT01993836|541356843|FG000|Overall Study|Withdrawal by Subject|12|||
150058803|NCT01993836|541356844|FG001|Overall Study|Withdrawal by Subject|10|||
150058804|NCT01993836|541356845|FG002|Overall Study|Withdrawal by Subject|5|||
150058805|NCT02195687|541356846|FG000|Overall Study|Personal Reasons|1|||
150058806|NCT02195687|541356847|FG001|Overall Study|Personal Reasons|1|||
150058807|NCT02195687|541356846|FG000|Overall Study|Lost to Follow-up|4|||
150058808|NCT02195687|541356847|FG001|Overall Study|Lost to Follow-up|1|||
150058809|NCT00686634|541356848|FG000|Overall Study|Protocol Violation|6|||
150058810|NCT02296138|541356851|FG000|Overall Study|Adverse Event|348|||
150058811|NCT02296138|541356852|FG001|Overall Study|Adverse Event|259|||
150058812|NCT02296138|541356851|FG000|Overall Study|Lack of Efficacy|59|||
150058813|NCT02296138|541356852|FG001|Overall Study|Lack of Efficacy|37|||
150058814|NCT02296138|541356851|FG000|Overall Study|Protocol Violation|35|||
150058815|NCT02296138|541356852|FG001|Overall Study|Protocol Violation|36|||
150058816|NCT02296138|541356851|FG000|Overall Study|Lost to Follow-up|9|||
150058817|NCT02296138|541356852|FG001|Overall Study|Lost to Follow-up|12|||
150058818|NCT02296138|541356851|FG000|Overall Study|Withdrawal by Subject|184|||
150058819|NCT02296138|541356852|FG001|Overall Study|Withdrawal by Subject|131|||
150058820|NCT02296138|541356851|FG000|Overall Study|Not Treated|1|||
150058821|NCT02296138|541356852|FG001|Overall Study|Not Treated|1|||
150058822|NCT02296138|541356851|FG000|Overall Study|Patients with data irregularities|10|||
150058823|NCT02296138|541356852|FG001|Overall Study|Patients with data irregularities|11|||
150058824|NCT02296138|541356851|FG000|Overall Study|Other than specified|15|||
150058825|NCT02296138|541356852|FG001|Overall Study|Other than specified|13|||
150058826|NCT04369924|541356853|FG000|Overall Study|Lost to Follow-up|302|||
150058827|NCT04369924|541356854|FG001|Overall Study|Lost to Follow-up|339|||
150058828|NCT01653132|541356855|FG000|First Intervention|Protocol Violation|1|||
150058829|NCT01653132|541356856|FG001|First Intervention|Protocol Violation|0|||
150058830|NCT03312751|541356857|FG000|Overall Study|Death|7|||
150058831|NCT03312751|541356858|FG001|Overall Study|Death|9|||
150058832|NCT03312751|541356857|FG000|Overall Study|Study discontinuation due to other reason|0|||
150058833|NCT03312751|541356858|FG001|Overall Study|Study discontinuation due to other reason|1|||
150058834|NCT00475423|541356859|FG000|Overall Study|Protocol Violation|5|||
150058835|NCT00475423|541356859|FG000|Overall Study|Adverse Event|4|||
150058836|NCT00475423|541356859|FG000|Overall Study|Withdrawal by Subject|6|||
150058837|NCT00475423|541356859|FG000|Overall Study|Lack of Efficacy|8|||
150058838|NCT00475423|541356859|FG000|Overall Study|Death|1|||
150058839|NCT00475423|541356859|FG000|Overall Study|Reason not specified|1|||
150058840|NCT00475423|541356859|FG000|Overall Study|Lost to Follow-up|7|||
150018190|NCT06041919|541201973|FG001|Overall Study|Lost to Follow-up|0|||
150018191|NCT06041919|541201974|FG002|Overall Study|Lost to Follow-up|0|||
150018192|NCT06041919|541201975|FG003|Overall Study|Lost to Follow-up|0|||
150018193|NCT06041919|541201976|FG004|Overall Study|Lost to Follow-up|0|||
150018194|NCT06041919|541201972|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
150018195|NCT06041919|541201973|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
150018196|NCT06041919|541201974|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
150018197|NCT06041919|541201975|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
150018198|NCT06041919|541201976|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
150018199|NCT04526145|541201977|FG000|Overall Study|Withdrawal by Subject|5|||
150018200|NCT00577824|541201979|FG000|Overall Study|Adverse Event|6|||
150018201|NCT00577824|541201980|FG001|Overall Study|Adverse Event|18|||
150018202|NCT00577824|541201981|FG002|Overall Study|Adverse Event|1|||
150018203|NCT00577824|541201979|FG000|Overall Study|Patient decision|0|||
150018204|NCT00577824|541201980|FG001|Overall Study|Patient decision|1|||
150018205|NCT00577824|541201981|FG002|Overall Study|Patient decision|1|||
150018206|NCT00577824|541201979|FG000|Overall Study|Protocol Violation|1|||
150018207|NCT00577824|541201980|FG001|Overall Study|Protocol Violation|1|||
150018208|NCT00577824|541201981|FG002|Overall Study|Protocol Violation|0|||
150018209|NCT04531241|541201982|FG000|Period 1|Withdrawal by Subject|2|||
150018210|NCT04531241|541201983|FG001|Period 1|Withdrawal by Subject|0|||
150018211|NCT04531241|541201982|FG000|Period 1|Dispesed incorrect lens power|1|||
150018212|NCT04531241|541201983|FG001|Period 1|Dispesed incorrect lens power|0|||
150018213|NCT04531241|541201982|FG000|Period 1|Protocol Violation|1|||
150018214|NCT04531241|541201983|FG001|Period 1|Protocol Violation|0|||
150058841|NCT02217527|541356861|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
150058842|NCT02217527|541356862|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
150058843|NCT02217527|541356861|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
150058844|NCT02217527|541356862|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
150058845|NCT01203852|541356866|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
150058846|NCT01203852|541356866|FG000|Washout 2 Weeks|Physician Decision|46|||
150058847|NCT02582684|541356869|FG000|Overall Study|Unable to contact subject/parent|4|||
150058848|NCT02582684|541356869|FG000|Overall Study|Subject not able to get to clinic|10|||
150058849|NCT02582684|541356869|FG000|Overall Study|Subject withdrew consent|1|||
150058850|NCT02582684|541356869|FG000|Overall Study|Found to be ineligible after enrollment|2|||
150058851|NCT01878149|541356870|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
150058852|NCT01878149|541356871|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
150058853|NCT04672252|541356872|FG000|Overall Study|Protocol Violation|1|||
150058854|NCT04672252|541356873|FG001|Overall Study|Protocol Violation|0|||
150058855|NCT06390839|541356877|FG000|Overall Study|Ineligible|2|||
150058856|NCT06390839|541356877|FG000|Overall Study|Never start protocol therapy|3|||
150058857|NCT06390839|541356877|FG000|Overall Study|Adverse Event|1|||
150058858|NCT06390839|541356877|FG000|Overall Study|Alternative therapy|2|||
150058859|NCT06390839|541356877|FG000|Overall Study|Death|3|||
150058860|NCT06390839|541356877|FG000|Overall Study|Disease progression|28|||
150058861|NCT06390839|541356877|FG000|Overall Study|Withdrawal by Subject|2|||
150058862|NCT06390839|541356877|FG000|Overall Study|Complicating disease|1|||
150058863|NCT06390839|541356877|FG000|Overall Study|Noncompliance|1|||
150058864|NCT02720094|541356880|FG000|Overall Study|Ongoing|2210|||
150058865|NCT02720094|541356881|FG001|Overall Study|Ongoing|2203|||
150058866|NCT02720094|541356880|FG000|Overall Study|Scheduled exit visit/end of study|2|||
150058867|NCT02720094|541356881|FG001|Overall Study|Scheduled exit visit/end of study|1|||
150058868|NCT02720094|541356880|FG000|Overall Study|Death|4|||
150058869|NCT02720094|541356881|FG001|Overall Study|Death|7|||
150058870|NCT02720094|541356880|FG000|Overall Study|Withdrawal by Subject|55|||
150058871|NCT02720094|541356881|FG001|Overall Study|Withdrawal by Subject|56|||
150058872|NCT02720094|541356880|FG000|Overall Study|Lost to Follow-up|2|||
150058873|NCT02720094|541356881|FG001|Overall Study|Lost to Follow-up|7|||
150058874|NCT02720094|541356880|FG000|Overall Study|Physician Decision|1|||
150058875|NCT02720094|541356881|FG001|Overall Study|Physician Decision|3|||
150058876|NCT02720094|541356880|FG000|Overall Study|Inappropriate enrollment|1|||
150058877|NCT02720094|541356881|FG001|Overall Study|Inappropriate enrollment|3|||
150058878|NCT02720094|541356880|FG000|Overall Study|Relocation|1|||
150058879|NCT02720094|541356881|FG001|Overall Study|Relocation|1|||
150058880|NCT01903252|541356884|FG000|Double-Blind Induction|Adverse Event|20|||
150058881|NCT01903252|541356885|FG001|Double-Blind Induction|Adverse Event|18|||
150018215|NCT04531241|541201982|FG000|Period 1|No longer eligible|0|||
150018216|NCT04531241|541201983|FG001|Period 1|No longer eligible|1|||
150018217|NCT04531241|541201982|FG000|Period 1|Lens Discomfort|0|||
150058882|NCT01903252|541356886|FG002|Double-Blind Induction|Adverse Event|0|||
150058883|NCT01903252|541356887|FG003|Double-Blind Induction|Adverse Event|0|||
150058884|NCT01903252|541356888|FG004|Double-Blind Induction|Adverse Event|0|||
150058885|NCT01903252|541356889|FG005|Double-Blind Induction|Adverse Event|0|||
150058886|NCT01903252|541356884|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
150058887|NCT01903252|541356885|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
150058888|NCT01903252|541356886|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
150058889|NCT01903252|541356887|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
150058890|NCT01903252|541356888|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
150058891|NCT01903252|541356889|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
150058892|NCT01903252|541356884|FG000|Double-Blind Induction|Physician Decision|2|||
150058893|NCT01903252|541356885|FG001|Double-Blind Induction|Physician Decision|3|||
150058894|NCT01903252|541356886|FG002|Double-Blind Induction|Physician Decision|0|||
150058895|NCT01903252|541356887|FG003|Double-Blind Induction|Physician Decision|0|||
150018218|NCT04531241|541201983|FG001|Period 1|Lens Discomfort|1|||
150018219|NCT04531241|541201982|FG000|Period 2|Covid-19 Related|1|||
150018220|NCT04531241|541201983|FG001|Period 2|Covid-19 Related|1|||
150058896|NCT01903252|541356888|FG004|Double-Blind Induction|Physician Decision|0|||
150058897|NCT01903252|541356889|FG005|Double-Blind Induction|Physician Decision|0|||
150058898|NCT01903252|541356884|FG000|Double-Blind Induction|non-compliance,|7|||
150058899|NCT01903252|541356885|FG001|Double-Blind Induction|non-compliance,|7|||
150058900|NCT01903252|541356886|FG002|Double-Blind Induction|non-compliance,|0|||
150058901|NCT01903252|541356887|FG003|Double-Blind Induction|non-compliance,|0|||
150058902|NCT01903252|541356888|FG004|Double-Blind Induction|non-compliance,|0|||
150058903|NCT01903252|541356889|FG005|Double-Blind Induction|non-compliance,|0|||
150058904|NCT01903252|541356884|FG000|Extended Induction, Open-Label|Adverse Event|0|||
150058905|NCT01903252|541356885|FG001|Extended Induction, Open-Label|Adverse Event|0|||
150058906|NCT01903252|541356886|FG002|Extended Induction, Open-Label|Adverse Event|17|||
150058907|NCT01903252|541356887|FG003|Extended Induction, Open-Label|Adverse Event|0|||
150058908|NCT01903252|541356888|FG004|Extended Induction, Open-Label|Adverse Event|0|||
150058909|NCT01903252|541356889|FG005|Extended Induction, Open-Label|Adverse Event|0|||
150058910|NCT01903252|541356884|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
150058911|NCT01903252|541356885|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
150058912|NCT01903252|541356886|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
150058913|NCT01903252|541356887|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
150058914|NCT01903252|541356888|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
150058915|NCT01903252|541356889|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
150058916|NCT01903252|541356884|FG000|Extended Induction, Open-Label|Physician Decision|0|||
150058917|NCT01903252|541356885|FG001|Extended Induction, Open-Label|Physician Decision|0|||
150058918|NCT01903252|541356886|FG002|Extended Induction, Open-Label|Physician Decision|1|||
150058919|NCT01903252|541356887|FG003|Extended Induction, Open-Label|Physician Decision|0|||
150058920|NCT01903252|541356888|FG004|Extended Induction, Open-Label|Physician Decision|0|||
150058921|NCT01903252|541356889|FG005|Extended Induction, Open-Label|Physician Decision|0|||
150058922|NCT01903252|541356884|FG000|Maintenance, Open-Label|Adverse Event|0|||
150058923|NCT01903252|541356885|FG001|Maintenance, Open-Label|Adverse Event|0|||
150058924|NCT01903252|541356886|FG002|Maintenance, Open-Label|Adverse Event|0|||
150058925|NCT01903252|541356887|FG003|Maintenance, Open-Label|Adverse Event|3|||
150058926|NCT01903252|541356888|FG004|Maintenance, Open-Label|Adverse Event|9|||
150058927|NCT01903252|541356889|FG005|Maintenance, Open-Label|Adverse Event|14|||
150058928|NCT01903252|541356884|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
150058929|NCT01903252|541356885|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
150058930|NCT01903252|541356886|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
150058931|NCT01903252|541356887|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
150058932|NCT01903252|541356888|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
150058933|NCT01903252|541356889|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
150058934|NCT01903252|541356884|FG000|Maintenance, Open-Label|Other|0|||
150058935|NCT01903252|541356885|FG001|Maintenance, Open-Label|Other|0|||
150058936|NCT01903252|541356886|FG002|Maintenance, Open-Label|Other|0|||
150058937|NCT01903252|541356887|FG003|Maintenance, Open-Label|Other|2|||
150058938|NCT01903252|541356888|FG004|Maintenance, Open-Label|Other|6|||
150058939|NCT01903252|541356889|FG005|Maintenance, Open-Label|Other|2|||
150058940|NCT03735238|541356890|FG000|Overall Study|Did not want to participate in research|3|||
150058941|NCT03735238|541356890|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
150058942|NCT03562767|541356893|FG000|Overall Study|Physician Decision|2|||
150058943|NCT03562767|541356894|FG001|Overall Study|Physician Decision|0|||
150058944|NCT03562767|541356895|FG002|Overall Study|Physician Decision|0|||
150058945|NCT03562767|541356893|FG000|Overall Study|Logistic Reason|1|||
150058946|NCT03562767|541356894|FG001|Overall Study|Logistic Reason|3|||
150058947|NCT03562767|541356895|FG002|Overall Study|Logistic Reason|0|||
150058948|NCT04658940|541356903|FG000|Overall Study|Withdrawal by Subject|1|||
150058949|NCT00821327|541356904|FG000|Overall Study|Adverse Event|13|||
150058950|NCT00821327|541356904|FG000|Overall Study|Patient Request|1|||
150058951|NCT00821327|541356904|FG000|Overall Study|Investigator Request|2|||
150058952|NCT00821327|541356904|FG000|Overall Study|Sponsor Request|1|||
150058953|NCT00821327|541356904|FG000|Overall Study|Disease Progression|13|||
150058954|NCT00821327|541356904|FG000|Overall Study|Other/Unknown|5|||
150058955|NCT02119676|541356905|FG000|Overall Study|Adverse Event|9|||
150058956|NCT02119676|541356906|FG001|Overall Study|Adverse Event|17|||
150058957|NCT02119676|541356907|FG002|Overall Study|Adverse Event|10|||
150058958|NCT02119676|541356908|FG003|Overall Study|Adverse Event|10|||
150058959|NCT02119676|541356905|FG000|Overall Study|Disease progression|53|||
150018221|NCT02576795|541201984|FG000|Overall Study|Lost to Follow-up|0|||
150018222|NCT02576795|541201985|FG001|Overall Study|Lost to Follow-up|0|||
150018223|NCT02576795|541201986|FG002|Overall Study|Lost to Follow-up|1|||
150018224|NCT02576795|541201987|FG003|Overall Study|Lost to Follow-up|0|||
150018225|NCT01635855|541201988|FG000|Overall Study|Withdrawal by Subject|4|||
150018226|NCT03400176|541201991|FG000|Dose Escalation|Progressive disease|1|||
150018227|NCT03400176|541201992|FG001|Dose Escalation|Progressive disease|1|||
150018228|NCT03400176|541201993|FG002|Dose Escalation|Progressive disease|0|||
150018229|NCT03400176|541201994|FG003|Dose Escalation|Progressive disease|0|||
150058960|NCT02119676|541356906|FG001|Overall Study|Disease progression|55|||
150058961|NCT02119676|541356907|FG002|Overall Study|Disease progression|68|||
150058962|NCT02119676|541356908|FG003|Overall Study|Disease progression|73|||
150058963|NCT02119676|541356905|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
150058964|NCT02119676|541356906|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
150058965|NCT02119676|541356907|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
150058966|NCT02119676|541356908|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
150058967|NCT02119676|541356905|FG000|Overall Study|Physician Decision|4|||
150018230|NCT03400176|541201995|FG004|Dose Escalation|Progressive disease|1|||
150018231|NCT03400176|541201991|FG000|Dose Escalation|Patient decision|0|||
150058968|NCT02119676|541356906|FG001|Overall Study|Physician Decision|2|||
150058969|NCT02119676|541356907|FG002|Overall Study|Physician Decision|3|||
150058970|NCT02119676|541356908|FG003|Overall Study|Physician Decision|2|||
150058971|NCT02119676|541356905|FG000|Overall Study|Death|9|||
150058972|NCT02119676|541356906|FG001|Overall Study|Death|3|||
150058973|NCT02119676|541356907|FG002|Overall Study|Death|2|||
150058974|NCT02119676|541356908|FG003|Overall Study|Death|1|||
150058975|NCT02119676|541356905|FG000|Overall Study|Noncompliance|0|||
150058976|NCT02119676|541356906|FG001|Overall Study|Noncompliance|1|||
150058977|NCT02119676|541356907|FG002|Overall Study|Noncompliance|0|||
150058978|NCT02119676|541356908|FG003|Overall Study|Noncompliance|0|||
150058979|NCT02119676|541356905|FG000|Overall Study|Lost to Follow-up|0|||
150058980|NCT02119676|541356906|FG001|Overall Study|Lost to Follow-up|0|||
150058981|NCT02119676|541356907|FG002|Overall Study|Lost to Follow-up|1|||
150058982|NCT02119676|541356908|FG003|Overall Study|Lost to Follow-up|0|||
150058983|NCT02119676|541356905|FG000|Overall Study|Protocol deviation|0|||
150058984|NCT02119676|541356906|FG001|Overall Study|Protocol deviation|0|||
150058985|NCT02119676|541356907|FG002|Overall Study|Protocol deviation|1|||
150058986|NCT02119676|541356908|FG003|Overall Study|Protocol deviation|0|||
150058987|NCT02119676|541356905|FG000|Overall Study|Other, unspecified|2|||
150058988|NCT02119676|541356906|FG001|Overall Study|Other, unspecified|1|||
150058989|NCT02119676|541356907|FG002|Overall Study|Other, unspecified|3|||
150058990|NCT02119676|541356908|FG003|Overall Study|Other, unspecified|4|||
150058991|NCT02119676|541356905|FG000|Overall Study|Did not receive study med|2|||
150058992|NCT02119676|541356906|FG001|Overall Study|Did not receive study med|2|||
150058993|NCT02119676|541356907|FG002|Overall Study|Did not receive study med|4|||
150058994|NCT02119676|541356908|FG003|Overall Study|Did not receive study med|5|||
150058995|NCT04268823|541356909|FG000|Overall Study|Adverse Event|1|||
150058996|NCT04268823|541356910|FG001|Overall Study|Adverse Event|0|||
150058997|NCT04268823|541356909|FG000|Overall Study|Participant Decision|1|||
150058998|NCT04268823|541356910|FG001|Overall Study|Participant Decision|0|||
150058999|NCT02919969|541358443|FG000|Overall Study|Lack of Efficacy|22|||
150059000|NCT02919969|541358443|FG000|Overall Study|Death|4|||
150059001|NCT02919969|541358443|FG000|Overall Study|Physician Decision|3|||
150059002|NCT02919969|541358443|FG000|Overall Study|Withdrawal by Subject|2|||
150059003|NCT02093351|541358444|FG000|Part A|Adverse Event|0|||
150059004|NCT02093351|541358445|FG001|Part A|Adverse Event|1|||
150059005|NCT02093351|541358446|FG002|Part A|Adverse Event|1|||
150059006|NCT02093351|541358447|FG003|Part A|Adverse Event|0|||
150059007|NCT02093351|541358444|FG000|Part A|Condition under investigation worsened|2|||
150059008|NCT02093351|541358445|FG001|Part A|Condition under investigation worsened|0|||
150059009|NCT02093351|541358446|FG002|Part A|Condition under investigation worsened|2|||
150059010|NCT02093351|541358447|FG003|Part A|Condition under investigation worsened|0|||
150059011|NCT02093351|541358444|FG000|Part A|Death|0|||
150059012|NCT02093351|541358445|FG001|Part A|Death|1|||
150059013|NCT02093351|541358446|FG002|Part A|Death|0|||
150059014|NCT02093351|541358447|FG003|Part A|Death|0|||
150059015|NCT02093351|541358444|FG000|Part B|Patient decision|0|||
150059016|NCT02093351|541358445|FG001|Part B|Patient decision|0|||
150059017|NCT02093351|541358446|FG002|Part B|Patient decision|0|||
150059018|NCT02093351|541358447|FG003|Part B|Patient decision|3|||
150059019|NCT02093351|541358444|FG000|Part B|Disease progression|0|||
150059020|NCT02093351|541358445|FG001|Part B|Disease progression|0|||
150059021|NCT02093351|541358446|FG002|Part B|Disease progression|0|||
150059022|NCT02093351|541358447|FG003|Part B|Disease progression|4|||
150059023|NCT02093351|541358444|FG000|Part B|Complete response|0|||
150059024|NCT02093351|541358445|FG001|Part B|Complete response|0|||
150059025|NCT02093351|541358446|FG002|Part B|Complete response|0|||
150059026|NCT02093351|541358447|FG003|Part B|Complete response|1|||
150059027|NCT02093351|541358444|FG000|Part B|Adverse event + disease progression|0|||
150059028|NCT02093351|541358445|FG001|Part B|Adverse event + disease progression|0|||
150059029|NCT02093351|541358446|FG002|Part B|Adverse event + disease progression|0|||
150059030|NCT02093351|541358447|FG003|Part B|Adverse event + disease progression|1|||
150059031|NCT02093351|541358444|FG000|Part B|Lack of therapeutic response|0|||
150059032|NCT02093351|541358445|FG001|Part B|Lack of therapeutic response|0|||
150059033|NCT02093351|541358446|FG002|Part B|Lack of therapeutic response|0|||
150059034|NCT02093351|541358447|FG003|Part B|Lack of therapeutic response|12|||
150059035|NCT02093351|541358444|FG000|Part B|Condition under investigation worsened|0|||
150059036|NCT02093351|541358445|FG001|Part B|Condition under investigation worsened|0|||
150059037|NCT02093351|541358446|FG002|Part B|Condition under investigation worsened|0|||
150059038|NCT02093351|541358447|FG003|Part B|Condition under investigation worsened|39|||
150018232|NCT03400176|541201992|FG001|Dose Escalation|Patient decision|0|||
150018233|NCT03400176|541201993|FG002|Dose Escalation|Patient decision|0|||
150018234|NCT03400176|541201994|FG003|Dose Escalation|Patient decision|0|||
150018235|NCT03400176|541201995|FG004|Dose Escalation|Patient decision|1|||
150018236|NCT03400176|541201991|FG000|Dose Expansion|Patient decision|0|||
150181594|NCT02554786|541802778|FG001|Overall Study|Technical problems|1|||
150018237|NCT03400176|541201992|FG001|Dose Expansion|Patient decision|0|||
150018238|NCT03400176|541201993|FG002|Dose Expansion|Patient decision|0|||
150018239|NCT03400176|541201994|FG003|Dose Expansion|Patient decision|1|||
150018240|NCT03400176|541201995|FG004|Dose Expansion|Patient decision|0|||
150018241|NCT03400176|541201991|FG000|Dose Expansion|Adverse Event|0|||
150018242|NCT03400176|541201992|FG001|Dose Expansion|Adverse Event|0|||
150018243|NCT03400176|541201993|FG002|Dose Expansion|Adverse Event|0|||
150018244|NCT03400176|541201994|FG003|Dose Expansion|Adverse Event|1|||
150018245|NCT03400176|541201995|FG004|Dose Expansion|Adverse Event|0|||
150018246|NCT03400176|541201991|FG000|Dose Expansion|Physician Decision|0|||
150018247|NCT03400176|541201992|FG001|Dose Expansion|Physician Decision|0|||
150018248|NCT03400176|541201993|FG002|Dose Expansion|Physician Decision|0|||
150018249|NCT03400176|541201994|FG003|Dose Expansion|Physician Decision|1|||
150018250|NCT03400176|541201995|FG004|Dose Expansion|Physician Decision|0|||
150018251|NCT03400176|541201991|FG000|Dose Expansion|Progressive disease|0|||
150018252|NCT03400176|541201992|FG001|Dose Expansion|Progressive disease|0|||
150018253|NCT03400176|541201993|FG002|Dose Expansion|Progressive disease|1|||
150018254|NCT03400176|541201994|FG003|Dose Expansion|Progressive disease|1|||
150018255|NCT03400176|541201995|FG004|Dose Expansion|Progressive disease|0|||
150018256|NCT01371734|541201998|FG000|Overall Study|Other|2|||
150018257|NCT01371734|541201999|FG001|Overall Study|Other|1|||
150018258|NCT01371734|541202000|FG002|Overall Study|Other|2|||
150018259|NCT01371734|541201998|FG000|Overall Study|Withdrawal by Subject|3|||
150018260|NCT01371734|541201999|FG001|Overall Study|Withdrawal by Subject|4|||
150018261|NCT01371734|541202000|FG002|Overall Study|Withdrawal by Subject|9|||
150018262|NCT01371734|541201998|FG000|Overall Study|Lost to Follow-up|5|||
150018263|NCT01371734|541201999|FG001|Overall Study|Lost to Follow-up|3|||
150181595|NCT02554786|541802779|FG002|Overall Study|Technical problems|0|||
150181596|NCT02554786|541802780|FG003|Overall Study|Technical problems|2|||
150018264|NCT01371734|541202000|FG002|Overall Study|Lost to Follow-up|1|||
150059039|NCT02093351|541358444|FG000|Part B|Adverse Event|0|||
150181597|NCT02554786|541802781|FG004|Overall Study|Technical problems|1|||
150018265|NCT01371734|541201998|FG000|Overall Study|Protocol Violation|3|||
150018266|NCT01371734|541201999|FG001|Overall Study|Protocol Violation|1|||
150018267|NCT01371734|541202000|FG002|Overall Study|Protocol Violation|2|||
150018268|NCT01371734|541201998|FG000|Overall Study|Adverse Event|8|||
150018269|NCT01371734|541201999|FG001|Overall Study|Adverse Event|8|||
150018270|NCT01371734|541202000|FG002|Overall Study|Adverse Event|3|||
150018271|NCT01371734|541201998|FG000|Overall Study|Lack of Efficacy|2|||
150018272|NCT01371734|541201999|FG001|Overall Study|Lack of Efficacy|2|||
150018273|NCT01371734|541202000|FG002|Overall Study|Lack of Efficacy|0|||
150018274|NCT00206440|541202001|FG000|Overall Study|Protocol Violation|1|||
150018275|NCT00206440|541202002|FG001|Overall Study|Protocol Violation|2|||
150181598|NCT02554786|541802777|FG000|Overall Study|Adverse Event|0|||
150018276|NCT00206440|541202001|FG000|Overall Study|Adverse Event|4|||
150018277|NCT00206440|541202002|FG001|Overall Study|Adverse Event|2|||
150018278|NCT00958165|541202003|FG000|Overall Study|Lost to Follow-up|5|||
150018279|NCT00958165|541202003|FG000|Overall Study|Not eligible|9|||
150181599|NCT02554786|541802778|FG001|Overall Study|Adverse Event|0|||
150018280|NCT03565237|541202004|FG000|Overall Study|Non-compliance of Investigational Product|1|||
150018281|NCT03565237|541202004|FG000|Overall Study|Physician Decision|1|||
150018282|NCT01140061|541202007|FG000|Part I|Adverse Event|1|||
150018283|NCT01140061|541202008|FG001|Part I|Adverse Event|0|||
150018284|NCT01140061|541202009|FG002|Part I|Adverse Event|0|||
150018285|NCT01140061|541202010|FG003|Part I|Adverse Event|0|||
150018286|NCT01140061|541202011|FG004|Part I|Adverse Event|0|||
150018287|NCT01140061|541202012|FG005|Part I|Adverse Event|0|||
150018288|NCT01140061|541202013|FG006|Part I|Adverse Event|0|||
150018289|NCT01140061|541202014|FG007|Part I|Adverse Event|0|||
150018290|NCT01140061|541202015|FG008|Part I|Adverse Event|0|||
150018291|NCT01140061|541202016|FG009|Part I|Adverse Event|0|||
150018292|NCT01140061|541202007|FG000|Extension|Laboratory Adverse Event|0|||
150018293|NCT01140061|541202008|FG001|Extension|Laboratory Adverse Event|0|||
150018294|NCT01140061|541202009|FG002|Extension|Laboratory Adverse Event|0|||
150018295|NCT01140061|541202010|FG003|Extension|Laboratory Adverse Event|0|||
150018296|NCT01140061|541202011|FG004|Extension|Laboratory Adverse Event|0|||
150018297|NCT01140061|541202012|FG005|Extension|Laboratory Adverse Event|0|||
150018298|NCT01140061|541202013|FG006|Extension|Laboratory Adverse Event|0|||
150018299|NCT01140061|541202014|FG007|Extension|Laboratory Adverse Event|0|||
150018300|NCT01140061|541202015|FG008|Extension|Laboratory Adverse Event|0|||
150018301|NCT01140061|541202016|FG009|Extension|Laboratory Adverse Event|1|||
150018302|NCT00428389|541202018|FG000|Core Phase|Adverse Event|6|||
150018303|NCT00428389|541202019|FG001|Core Phase|Adverse Event|4|||
150018304|NCT00428389|541202018|FG000|Core Phase|Lack of Efficacy|2|||
150018305|NCT00428389|541202019|FG001|Core Phase|Lack of Efficacy|0|||
150018306|NCT00428389|541202018|FG000|Core Phase|Abnormal test procedure result(s)|0|||
150018307|NCT00428389|541202019|FG001|Core Phase|Abnormal test procedure result(s)|1|||
150018308|NCT00428389|541202018|FG000|Core Phase|Withdrawal by Subject|3|||
150018309|NCT00428389|541202019|FG001|Core Phase|Withdrawal by Subject|4|||
150018310|NCT00428389|541202018|FG000|Core Phase|Protocol deviation|0|||
150018311|NCT00428389|541202019|FG001|Core Phase|Protocol deviation|2|||
150018312|NCT00428389|541202018|FG000|Extension Phase|Adverse Event|17|||
150059040|NCT02093351|541358445|FG001|Part B|Adverse Event|0|||
150018313|NCT00428389|541202019|FG001|Extension Phase|Adverse Event|11|||
150018314|NCT00428389|541202018|FG000|Extension Phase|Lack of Efficacy|4|||
150018315|NCT00428389|541202019|FG001|Extension Phase|Lack of Efficacy|3|||
150181600|NCT02554786|541802779|FG002|Overall Study|Adverse Event|0|||
150181601|NCT02554786|541802780|FG003|Overall Study|Adverse Event|0|||
150181602|NCT02554786|541802781|FG004|Overall Study|Adverse Event|2|||
150018316|NCT00428389|541202018|FG000|Extension Phase|Withdrawal by Subject|6|||
150018317|NCT00428389|541202019|FG001|Extension Phase|Withdrawal by Subject|6|||
150018318|NCT00428389|541202018|FG000|Extension Phase|Lost to Follow-up|0|||
150018319|NCT00428389|541202019|FG001|Extension Phase|Lost to Follow-up|3|||
150018320|NCT00428389|541202018|FG000|Extension Phase|Death|1|||
150018321|NCT00428389|541202019|FG001|Extension Phase|Death|0|||
150018322|NCT00428389|541202018|FG000|Extension Phase|Protocol Violation|3|||
150018323|NCT00428389|541202019|FG001|Extension Phase|Protocol Violation|2|||
150018324|NCT00428389|541202018|FG000|Extension Phase|Administrative problems|1|||
150181603|NCT02554786|541802777|FG000|Overall Study|Death|0|||
150181604|NCT02554786|541802778|FG001|Overall Study|Death|0|||
150181605|NCT02554786|541802779|FG002|Overall Study|Death|0|||
150181606|NCT02554786|541802780|FG003|Overall Study|Death|1|||
150181607|NCT02554786|541802781|FG004|Overall Study|Death|0|||
150181608|NCT02554786|541802777|FG000|Overall Study|Non-compliance with study treatment|0|||
150181609|NCT02554786|541802778|FG001|Overall Study|Non-compliance with study treatment|1|||
150018325|NCT00428389|541202019|FG001|Extension Phase|Administrative problems|1|||
150018326|NCT00766051|541202020|FG000|Overall Study|Withdrawal by Subject|2|||
150018327|NCT00766051|541202021|FG001|Overall Study|Withdrawal by Subject|0|||
150018328|NCT02708355|541202022|FG000|Overall Study|Adverse Event|1|||
150018329|NCT02708355|541202023|FG001|Overall Study|Adverse Event|0|||
150018330|NCT02708355|541202024|FG002|Overall Study|Adverse Event|0|||
150018331|NCT01098305|541202025|FG000|Overall Study|Lost to Follow-up|31|||
150018332|NCT01098305|541202026|FG001|Overall Study|Lost to Follow-up|33|||
150018333|NCT01746173|541202028|FG000|Overall Study|Disease Progression|2|||
150018334|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
150018335|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150018336|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150018337|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150018338|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150018339|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
150018340|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150018341|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150018342|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150018343|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150018344|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
150018345|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150018346|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150018347|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150018348|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150018349|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
150018350|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150018351|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150018352|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150018353|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150018354|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
150018355|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150018356|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150018357|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150018358|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150018359|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
150018360|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150018361|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150018362|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150018363|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150018364|NCT01173601|541203510|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
150018365|NCT01173601|541203511|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150018366|NCT01173601|541203512|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150018367|NCT01173601|541203513|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150018368|NCT01173601|541203514|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150018369|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
150018370|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
150018371|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
150018372|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
150018373|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
150018374|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
150018375|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
150018376|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
150018377|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
150059041|NCT02093351|541358446|FG002|Part B|Adverse Event|0|||
150181610|NCT02554786|541802779|FG002|Overall Study|Non-compliance with study treatment|1|||
150018378|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
150018379|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
150018380|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
150018381|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
150018382|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
150018383|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
150018384|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150018385|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
150018386|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150018387|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
150018388|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
150018389|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
150018390|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
150018391|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
150018392|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
150018393|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
150018394|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
150018395|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
150018396|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
150018397|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
150018398|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
150018399|NCT01173601|541203510|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150018400|NCT01173601|541203511|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150018401|NCT01173601|541203512|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150018402|NCT01173601|541203513|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
150018403|NCT01173601|541203514|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
150018404|NCT05258149|541203515|FG000|Period 1|Protocol Deviation|1|||
150018405|NCT05258149|541203516|FG001|Period 1|Protocol Deviation|0|||
150018406|NCT05258149|541203515|FG000|Period 1|Adverse Event|0|||
150018407|NCT05258149|541203516|FG001|Period 1|Adverse Event|1|||
150018408|NCT05258149|541203515|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
150018409|NCT05258149|541203516|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
150018410|NCT05258149|541203515|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
150018411|NCT05258149|541203516|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
150018412|NCT05258149|541203515|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
150018413|NCT05258149|541203516|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
150018414|NCT00108862|541203525|FG000|Overall Study|Death|31|||
150018415|NCT00108862|541203526|FG001|Overall Study|Death|37|||
150018416|NCT00108862|541203525|FG000|Overall Study|Withdrawal by Subject|10|||
150018417|NCT00108862|541203526|FG001|Overall Study|Withdrawal by Subject|6|||
150018418|NCT00108862|541203525|FG000|Overall Study|Lost to Follow-up|27|||
150018419|NCT00108862|541203526|FG001|Overall Study|Lost to Follow-up|19|||
150018420|NCT01625000|541203528|FG000|Overall Study|Physician Decision|15|||
150018421|NCT01625000|541203529|FG001|Overall Study|Physician Decision|7|||
150018422|NCT01625000|541203530|FG002|Overall Study|Physician Decision|7|||
150018423|NCT01625000|541203531|FG003|Overall Study|Physician Decision|2|||
150018424|NCT01625000|541203532|FG004|Overall Study|Physician Decision|15|||
150018425|NCT01625000|541203528|FG000|Overall Study|Protocol Violation|3|||
150018426|NCT01625000|541203529|FG001|Overall Study|Protocol Violation|10|||
150018427|NCT01625000|541203530|FG002|Overall Study|Protocol Violation|4|||
150018428|NCT01625000|541203531|FG003|Overall Study|Protocol Violation|1|||
150018429|NCT01625000|541203532|FG004|Overall Study|Protocol Violation|2|||
150018430|NCT01625000|541203528|FG000|Overall Study|Withdrawal by Subject|19|||
150018431|NCT01625000|541203529|FG001|Overall Study|Withdrawal by Subject|16|||
150018432|NCT01625000|541203530|FG002|Overall Study|Withdrawal by Subject|11|||
150018433|NCT01625000|541203531|FG003|Overall Study|Withdrawal by Subject|9|||
150018434|NCT01625000|541203532|FG004|Overall Study|Withdrawal by Subject|17|||
150018435|NCT01625000|541203528|FG000|Overall Study|Adverse Event (including Death)|15|||
150018436|NCT01625000|541203529|FG001|Overall Study|Adverse Event (including Death)|19|||
150018437|NCT01625000|541203530|FG002|Overall Study|Adverse Event (including Death)|11|||
150018438|NCT01625000|541203531|FG003|Overall Study|Adverse Event (including Death)|7|||
150018439|NCT01625000|541203532|FG004|Overall Study|Adverse Event (including Death)|21|||
150018440|NCT00566852|541203533|FG000|Overall Study|Protocol Violation|22|||
150018441|NCT00566852|541203534|FG001|Overall Study|Protocol Violation|24|||
150018442|NCT00566852|541203533|FG000|Overall Study|Death|95|||
150018443|NCT00566852|541203534|FG001|Overall Study|Death|78|||
150018444|NCT00566852|541203533|FG000|Overall Study|Withdrawal by Subject|30|||
150018445|NCT00566852|541203534|FG001|Overall Study|Withdrawal by Subject|25|||
150018446|NCT00566852|541203533|FG000|Overall Study|Patient refusal|37|||
150018447|NCT00566852|541203534|FG001|Overall Study|Patient refusal|37|||
150018448|NCT00566852|541203533|FG000|Overall Study|Not tested due to disability|6|||
150018449|NCT00566852|541203534|FG001|Overall Study|Not tested due to disability|12|||
150018450|NCT00566852|541203533|FG000|Overall Study|Missing reason not specified|1|||
150018451|NCT00566852|541203534|FG001|Overall Study|Missing reason not specified|2|||
150018452|NCT00566852|541203533|FG000|Overall Study|Missing reason not reported|16|||
150018453|NCT00566852|541203534|FG001|Overall Study|Missing reason not reported|20|||
150018454|NCT01147055|541203535|FG000|First Intervention Period|Lost to Follow-up|1|||
150018455|NCT01147055|541203536|FG001|First Intervention Period|Lost to Follow-up|0|||
150018456|NCT01518374|541203537|FG000|Overall Study|Withdrawal by Subject|2|||
150018457|NCT01518374|541203537|FG000|Overall Study|Protocol Violation|3|||
150018458|NCT01518374|541203537|FG000|Overall Study|Lost to Follow-up|2|||
150018459|NCT00465452|541203538|FG000|Overall Study|Adverse Event|1|||
150018460|NCT03828019|541203539|FG000|Overall Study|Withdrawal by Subject|3|||
150018461|NCT03828019|541203540|FG001|Overall Study|Withdrawal by Subject|8|||
150018462|NCT03828019|541203539|FG000|Overall Study|Lost to Follow-up|1|||
150018463|NCT03828019|541203540|FG001|Overall Study|Lost to Follow-up|6|||
150018464|NCT03828019|541203539|FG000|Overall Study|Incarcerated|1|||
150018465|NCT03828019|541203540|FG001|Overall Study|Incarcerated|0|||
150018466|NCT03828019|541203539|FG000|Overall Study|Adverse Event|0|||
150018467|NCT03828019|541203540|FG001|Overall Study|Adverse Event|1|||
150018468|NCT05715242|541203541|FG000|Overall Study|Lost to Follow-up|0|||
150018469|NCT05715242|541203542|FG001|Overall Study|Lost to Follow-up|0|||
150018470|NCT05715242|541203543|FG002|Overall Study|Lost to Follow-up|1|||
150018471|NCT05715242|541203544|FG003|Overall Study|Lost to Follow-up|0|||
150018472|NCT05715242|541203545|FG004|Overall Study|Lost to Follow-up|0|||
150018473|NCT05715242|541203546|FG005|Overall Study|Lost to Follow-up|1|||
150018474|NCT05715242|541203547|FG006|Overall Study|Lost to Follow-up|0|||
150018475|NCT05715242|541203548|FG007|Overall Study|Lost to Follow-up|0|||
150018476|NCT05715242|541203549|FG008|Overall Study|Lost to Follow-up|0|||
150018477|NCT05715242|541203550|FG009|Overall Study|Lost to Follow-up|0|||
150018478|NCT05715242|541203551|FG010|Overall Study|Lost to Follow-up|0|||
150018479|NCT05715242|541203552|FG011|Overall Study|Lost to Follow-up|0|||
150018480|NCT05715242|541203553|FG012|Overall Study|Lost to Follow-up|0|||
150018481|NCT05715242|541203554|FG013|Overall Study|Lost to Follow-up|0|||
150018482|NCT05715242|541203555|FG014|Overall Study|Lost to Follow-up|0|||
150018483|NCT05715242|541203556|FG015|Overall Study|Lost to Follow-up|0|||
150018484|NCT02343406|541203557|FG000|Overall Study|Progressive disease|72|||
150018485|NCT02343406|541203558|FG001|Overall Study|Progressive disease|70|||
150018486|NCT02343406|541203559|FG002|Overall Study|Progressive disease|43|||
150018487|NCT02343406|541203560|FG003|Overall Study|Progressive disease|15|||
150018488|NCT02343406|541203561|FG004|Overall Study|Progressive disease|5|||
150018489|NCT02343406|541203557|FG000|Overall Study|Adverse Event|6|||
150018490|NCT02343406|541203558|FG001|Overall Study|Adverse Event|8|||
150018491|NCT02343406|541203559|FG002|Overall Study|Adverse Event|6|||
150018492|NCT02343406|541203560|FG003|Overall Study|Adverse Event|3|||
150018493|NCT02343406|541203561|FG004|Overall Study|Adverse Event|0|||
150018494|NCT02343406|541203557|FG000|Overall Study|Withdrawal by Subject|6|||
150018495|NCT02343406|541203558|FG001|Overall Study|Withdrawal by Subject|4|||
150018496|NCT02343406|541203559|FG002|Overall Study|Withdrawal by Subject|8|||
150018497|NCT02343406|541203560|FG003|Overall Study|Withdrawal by Subject|3|||
150181611|NCT02554786|541802780|FG003|Overall Study|Non-compliance with study treatment|0|||
150181612|NCT02554786|541802781|FG004|Overall Study|Non-compliance with study treatment|1|||
150181613|NCT02554786|541802777|FG000|Overall Study|Physician Decision|0|||
150181614|NCT02554786|541802778|FG001|Overall Study|Physician Decision|1|||
150181615|NCT02554786|541802779|FG002|Overall Study|Physician Decision|4|||
150181616|NCT02554786|541802780|FG003|Overall Study|Physician Decision|1|||
150181617|NCT02554786|541802781|FG004|Overall Study|Physician Decision|1|||
150181618|NCT02554786|541802777|FG000|Overall Study|Pregnancy|0|||
150181619|NCT02554786|541802778|FG001|Overall Study|Pregnancy|0|||
150181620|NCT02554786|541802779|FG002|Overall Study|Pregnancy|0|||
150181621|NCT02554786|541802780|FG003|Overall Study|Pregnancy|1|||
150181622|NCT02554786|541802781|FG004|Overall Study|Pregnancy|1|||
150181623|NCT01695954|541802782|FG000|Overall Study|Withdrawal by Subject|4|||
150181624|NCT01695954|541802783|FG001|Overall Study|Withdrawal by Subject|0|||
150181625|NCT01695954|541802782|FG000|Overall Study|Adverse Event|0|||
150018498|NCT02343406|541203561|FG004|Overall Study|Withdrawal by Subject|0|||
150018499|NCT02343406|541203557|FG000|Overall Study|Death|2|||
150018500|NCT02343406|541203558|FG001|Overall Study|Death|1|||
150059042|NCT02093351|541358447|FG003|Part B|Adverse Event|2|||
150018501|NCT02343406|541203559|FG002|Overall Study|Death|0|||
150018502|NCT02343406|541203560|FG003|Overall Study|Death|0|||
150018503|NCT02343406|541203561|FG004|Overall Study|Death|0|||
150018504|NCT02343406|541203557|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
150018505|NCT02343406|541203558|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
150018506|NCT02343406|541203559|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
150059043|NCT02093351|541358444|FG000|Part B|Death|0|||
150181626|NCT01695954|541802783|FG001|Overall Study|Adverse Event|2|||
150181627|NCT04328727|541802785|FG000|Overall Study|Guardian Decision|1|||
150181628|NCT04328727|541802785|FG000|Overall Study|Participant decision|4|||
150018507|NCT02343406|541203560|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
150018508|NCT02343406|541203561|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
150018509|NCT02343406|541203557|FG000|Overall Study|Other primary malignancy|0|||
150018510|NCT02343406|541203558|FG001|Overall Study|Other primary malignancy|1|||
150018511|NCT02343406|541203559|FG002|Overall Study|Other primary malignancy|0|||
150018512|NCT02343406|541203560|FG003|Overall Study|Other primary malignancy|0|||
150018513|NCT02343406|541203561|FG004|Overall Study|Other primary malignancy|0|||
150018514|NCT02343406|541203557|FG000|Overall Study|Other, not specified|2|||
150018515|NCT02343406|541203558|FG001|Overall Study|Other, not specified|1|||
150059044|NCT02093351|541358445|FG001|Part B|Death|0|||
150059045|NCT02093351|541358446|FG002|Part B|Death|0|||
150059046|NCT02093351|541358447|FG003|Part B|Death|1|||
150059047|NCT01099709|541358448|FG000|Period 1|Withdrawal by Subject|0|||
150059048|NCT01099709|541358449|FG001|Period 1|Withdrawal by Subject|1|||
150059049|NCT01099709|541358448|FG000|Period 1|Positive cotinine test|0|||
150059050|NCT01099709|541358449|FG001|Period 1|Positive cotinine test|1|||
150059051|NCT01099709|541358448|FG000|Period 1|Adverse Event|1|||
150018516|NCT02343406|541203559|FG002|Overall Study|Other, not specified|1|||
150059052|NCT01099709|541358449|FG001|Period 1|Adverse Event|0|||
150181629|NCT04328727|541802785|FG000|Overall Study|Death|3|||
150181630|NCT04583423|541802798|FG000|Overall Study|Lost to Follow-up|0|||
150181631|NCT04583423|541802799|FG001|Overall Study|Lost to Follow-up|1|||
150181632|NCT04583423|541802800|FG002|Overall Study|Lost to Follow-up|0|||
150181633|NCT04583423|541802801|FG003|Overall Study|Lost to Follow-up|2|||
150181634|NCT04583423|541802798|FG000|Overall Study|Study Terminated by Sponsor|32|||
150181635|NCT04583423|541802799|FG001|Overall Study|Study Terminated by Sponsor|35|||
150018517|NCT02343406|541203560|FG003|Overall Study|Other, not specified|4|||
150018518|NCT02343406|541203561|FG004|Overall Study|Other, not specified|0|||
150018519|NCT04384523|541203562|FG000|Overall Study|Lost to Follow-up|0|||
150018520|NCT04384523|541203563|FG001|Overall Study|Lost to Follow-up|0|||
150018521|NCT04384523|541203564|FG002|Overall Study|Lost to Follow-up|0|||
150018522|NCT04384523|541203565|FG003|Overall Study|Lost to Follow-up|0|||
150018523|NCT04384523|541203566|FG004|Overall Study|Lost to Follow-up|0|||
150018524|NCT04384523|541203567|FG005|Overall Study|Lost to Follow-up|1|||
150018525|NCT04384523|541203562|FG000|Overall Study|Protocol Violation|0|||
150018526|NCT04384523|541203563|FG001|Overall Study|Protocol Violation|1|||
150018527|NCT04384523|541203564|FG002|Overall Study|Protocol Violation|0|||
150018528|NCT04384523|541203565|FG003|Overall Study|Protocol Violation|0|||
150181636|NCT04583423|541802800|FG002|Overall Study|Study Terminated by Sponsor|36|||
150181637|NCT04583423|541802801|FG003|Overall Study|Study Terminated by Sponsor|33|||
150181638|NCT04583423|541802798|FG000|Overall Study|Withdrawal by Subject|3|||
150181639|NCT04583423|541802799|FG001|Overall Study|Withdrawal by Subject|1|||
150181640|NCT04583423|541802800|FG002|Overall Study|Withdrawal by Subject|2|||
150181641|NCT04583423|541802801|FG003|Overall Study|Withdrawal by Subject|1|||
150018529|NCT04384523|541203566|FG004|Overall Study|Protocol Violation|0|||
150018530|NCT04384523|541203567|FG005|Overall Study|Protocol Violation|0|||
150018531|NCT04384523|541203562|FG000|Overall Study|Withdrawal by Subject|1|||
150018532|NCT04384523|541203563|FG001|Overall Study|Withdrawal by Subject|0|||
150018533|NCT04384523|541203564|FG002|Overall Study|Withdrawal by Subject|0|||
150181642|NCT03330795|541802808|FG000|Overall Study|Death|3|||
150018534|NCT04384523|541203565|FG003|Overall Study|Withdrawal by Subject|0|||
150059053|NCT00706849|541358450|FG000|Treatment Period|Adverse Event|0|||
150059054|NCT00706849|541358451|FG001|Treatment Period|Adverse Event|9|||
150018535|NCT04384523|541203566|FG004|Overall Study|Withdrawal by Subject|0|||
150018536|NCT04384523|541203567|FG005|Overall Study|Withdrawal by Subject|0|||
150018537|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
150018538|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
150018539|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
150181643|NCT03330795|541802808|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
150018540|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Death|0|||
150018541|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Death|2|||
150018542|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Death|0|||
150018543|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
150018544|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
150018545|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
150018546|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
150018547|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
150018548|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
150018549|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
150018550|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
150018551|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
150018552|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
150018553|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
150018554|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
150018555|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
150018556|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
150018557|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
150018558|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Recovery|1|||
150018559|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Recovery|0|||
150018560|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Recovery|1|||
150018561|NCT00195663|541203568|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
150018562|NCT00195663|541203569|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
150018563|NCT00195663|541203570|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
150018564|NCT00195663|541203568|FG000|Open-Label Extension Period|Adverse Event|21|||
150018565|NCT00195663|541203569|FG001|Open-Label Extension Period|Adverse Event|32|||
150018566|NCT00195663|541203570|FG002|Open-Label Extension Period|Adverse Event|36|||
150018567|NCT00195663|541203568|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
150018568|NCT00195663|541203569|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
150018569|NCT00195663|541203570|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
150018570|NCT00195663|541203568|FG000|Open-Label Extension Period|Recovery|0|||
150018571|NCT00195663|541203569|FG001|Open-Label Extension Period|Recovery|2|||
150018572|NCT00195663|541203570|FG002|Open-Label Extension Period|Recovery|2|||
150018573|NCT00195663|541203568|FG000|Open-Label Extension Period|Protocol Violation|3|||
150018574|NCT00195663|541203569|FG001|Open-Label Extension Period|Protocol Violation|4|||
150018575|NCT00195663|541203570|FG002|Open-Label Extension Period|Protocol Violation|4|||
150018576|NCT00195663|541203568|FG000|Open-Label Extension Period|Death|2|||
150018577|NCT00195663|541203569|FG001|Open-Label Extension Period|Death|2|||
150018578|NCT00195663|541203570|FG002|Open-Label Extension Period|Death|2|||
150018579|NCT00195663|541203568|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
150018580|NCT00195663|541203569|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
150018581|NCT00195663|541203570|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
150018582|NCT00195663|541203568|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
150018583|NCT00195663|541203569|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
150018584|NCT00195663|541203570|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
150018585|NCT00195663|541203568|FG000|Open-Label Extension Period|Administrative reasons|11|||
150018586|NCT00195663|541203569|FG001|Open-Label Extension Period|Administrative reasons|11|||
150018587|NCT00195663|541203570|FG002|Open-Label Extension Period|Administrative reasons|13|||
150018588|NCT03214406|541203571|FG000|Overall Study|did not meet enrollment criteria|9|||
150018589|NCT03214406|541203572|FG001|Overall Study|did not meet enrollment criteria|13|||
150018590|NCT03214406|541203571|FG000|Overall Study|Withdrawal by Subject|1|||
150018591|NCT03214406|541203572|FG001|Overall Study|Withdrawal by Subject|0|||
150018592|NCT03214406|541203571|FG000|Overall Study|Lost to Follow-up|0|||
150018593|NCT03214406|541203572|FG001|Overall Study|Lost to Follow-up|2|||
150018594|NCT04565951|541203578|FG000|Overall Study|Lost to Follow-up|66|||
150018595|NCT04565951|541203579|FG001|Overall Study|Lost to Follow-up|38|||
150018596|NCT04565951|541203578|FG000|Overall Study|Withdrawal by Subject|14|||
150018597|NCT04565951|541203579|FG001|Overall Study|Withdrawal by Subject|7|||
150181644|NCT05782231|541802809|FG000|Overall Study|Withdrawal by Subject|1|||
150181645|NCT01070069|541802811|FG000|Overall Study|Death|1|||
150181646|NCT01070069|541802812|FG001|Overall Study|Death|0|||
150181647|NCT01070069|541802813|FG002|Overall Study|Death|2|||
150181648|NCT01070069|541802814|FG003|Overall Study|Death|0|||
150181649|NCT01070069|541802815|FG004|Overall Study|Death|1|||
150181650|NCT01070069|541802811|FG000|Overall Study|Withdrawal by Subject|1|||
150181651|NCT01070069|541802812|FG001|Overall Study|Withdrawal by Subject|1|||
150181652|NCT01070069|541802813|FG002|Overall Study|Withdrawal by Subject|4|||
150181653|NCT01070069|541802814|FG003|Overall Study|Withdrawal by Subject|0|||
150181654|NCT01070069|541802815|FG004|Overall Study|Withdrawal by Subject|0|||
150181655|NCT01070069|541802811|FG000|Overall Study|Lost to Follow-up|4|||
150181656|NCT01070069|541802812|FG001|Overall Study|Lost to Follow-up|1|||
150181657|NCT01070069|541802813|FG002|Overall Study|Lost to Follow-up|0|||
150181658|NCT01070069|541802814|FG003|Overall Study|Lost to Follow-up|0|||
150181659|NCT01070069|541802815|FG004|Overall Study|Lost to Follow-up|3|||
150018598|NCT04565951|541203578|FG000|Overall Study|Death|0|||
150018599|NCT04565951|541203579|FG001|Overall Study|Death|1|||
150018600|NCT03182907|541203581|FG000|Overall Study|Death|3|||
150018601|NCT03182907|541203582|FG001|Overall Study|Death|0|||
150018602|NCT03182907|541203581|FG000|Overall Study|Protocol Violation|4|||
150018603|NCT03182907|541203582|FG001|Overall Study|Protocol Violation|0|||
150018604|NCT03182907|541203581|FG000|Overall Study|Lost to Follow-up|1|||
150018605|NCT03182907|541203582|FG001|Overall Study|Lost to Follow-up|0|||
150018606|NCT03182907|541203581|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150018607|NCT03182907|541203582|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
150018608|NCT00429169|541203583|FG000|Overall Study|Lost to Follow-up|0|||
150018609|NCT00429169|541203584|FG001|Overall Study|Lost to Follow-up|1|||
150018610|NCT00429169|541203583|FG000|Overall Study|Ineligibility discovered after entry|2|||
150018611|NCT00429169|541203584|FG001|Overall Study|Ineligibility discovered after entry|1|||
150018612|NCT00172042|541203591|FG000|Overall Study|Adverse Event|27|||
150018613|NCT00172042|541203592|FG001|Overall Study|Adverse Event|13|||
150018614|NCT00172042|541203591|FG000|Overall Study|Abnormal laboratory value(s)|5|||
150018615|NCT00172042|541203592|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150018616|NCT00172042|541203591|FG000|Overall Study|Abnormal test procedure(s)|0|||
150018617|NCT00172042|541203592|FG001|Overall Study|Abnormal test procedure(s)|3|||
150018618|NCT00172042|541203591|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
150059055|NCT00706849|541358450|FG000|Treatment Period|Other|0|||
150059056|NCT00706849|541358451|FG001|Treatment Period|Other|1|||
150059057|NCT00706849|541358450|FG000|Follow-up Period|Withdrawal by Subject|0|||
150059058|NCT00706849|541358451|FG001|Follow-up Period|Withdrawal by Subject|2|||
150059059|NCT00706849|541358450|FG000|Follow-up Period|Protocol non-compliance|0|||
150059060|NCT00706849|541358451|FG001|Follow-up Period|Protocol non-compliance|1|||
150059061|NCT01611454|541358452|FG000|Overall Study|Lack of Efficacy|18|||
150059062|NCT01611454|541358453|FG001|Overall Study|Lack of Efficacy|10|||
150059063|NCT02616601|541358454|FG000|Overall Study|Withdrawal by Subject|4|||
150059064|NCT02616601|541358455|FG001|Overall Study|Withdrawal by Subject|4|||
150059065|NCT02616601|541358456|FG002|Overall Study|Withdrawal by Subject|3|||
150059066|NCT02616601|541358454|FG000|Overall Study|Adverse Event|2|||
150059067|NCT02616601|541358455|FG001|Overall Study|Adverse Event|0|||
150059068|NCT02616601|541358456|FG002|Overall Study|Adverse Event|2|||
150059069|NCT02616601|541358454|FG000|Overall Study|Death|1|||
150059070|NCT02616601|541358455|FG001|Overall Study|Death|0|||
150059071|NCT02616601|541358456|FG002|Overall Study|Death|0|||
150059072|NCT02616601|541358454|FG000|Overall Study|Lost to Follow-up|1|||
150059073|NCT02616601|541358455|FG001|Overall Study|Lost to Follow-up|0|||
150059074|NCT02616601|541358456|FG002|Overall Study|Lost to Follow-up|1|||
150059075|NCT02616601|541358454|FG000|Overall Study|Non-Compliance with Test Article|1|||
150059076|NCT02616601|541358455|FG001|Overall Study|Non-Compliance with Test Article|0|||
150059077|NCT02616601|541358456|FG002|Overall Study|Non-Compliance with Test Article|1|||
150059078|NCT03718299|541358457|FG000|Overall Study|Adverse Event|1|||
150059079|NCT03718299|541358457|FG000|Overall Study|Withdrawal by Subject|6|||
150059080|NCT03718299|541358457|FG000|Overall Study|Physician Decision|2|||
150059081|NCT03718299|541358457|FG000|Overall Study|Lost to Follow-up|1|||
150059082|NCT01343823|541358458|FG000|Overall Study|Study Terminated|1|||
150059083|NCT01343823|541358459|FG001|Overall Study|Study Terminated|0|||
150059084|NCT01343823|541358460|FG002|Overall Study|Study Terminated|0|||
150059085|NCT01343823|541358461|FG003|Overall Study|Study Terminated|1|||
150059086|NCT01343823|541358458|FG000|Overall Study|Withdrawal by Subject|1|||
150059087|NCT01343823|541358459|FG001|Overall Study|Withdrawal by Subject|0|||
150059088|NCT01343823|541358460|FG002|Overall Study|Withdrawal by Subject|0|||
150059089|NCT01343823|541358461|FG003|Overall Study|Withdrawal by Subject|0|||
150059090|NCT01236118|541358472|FG000|Overall Study|Adverse Event|2|||
150059091|NCT01236118|541358473|FG001|Overall Study|Adverse Event|0|||
150059092|NCT01236118|541358474|FG002|Overall Study|Adverse Event|2|||
150059093|NCT01236118|541358472|FG000|Overall Study|Physician Decision|0|||
150059094|NCT01236118|541358473|FG001|Overall Study|Physician Decision|1|||
150059095|NCT01236118|541358474|FG002|Overall Study|Physician Decision|0|||
150059096|NCT01236118|541358472|FG000|Overall Study|Withdrawal by Subject|0|||
150181660|NCT02538341|541802818|FG000|Overall Study|Lost to Follow-up|51|||
150059097|NCT01236118|541358473|FG001|Overall Study|Withdrawal by Subject|0|||
150059098|NCT01236118|541358474|FG002|Overall Study|Withdrawal by Subject|1|||
150018619|NCT00172042|541203592|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
150018620|NCT00172042|541203591|FG000|Overall Study|Patient no longer requires study drug|10|||
150018621|NCT00172042|541203592|FG001|Overall Study|Patient no longer requires study drug|8|||
150059099|NCT04535167|541358475|FG000|Treatment|Adverse Event|0|||
150059100|NCT04535167|541358476|FG001|Treatment|Adverse Event|0|||
150059101|NCT04535167|541358477|FG002|Treatment|Adverse Event|0|||
150059102|NCT04535167|541358478|FG003|Treatment|Adverse Event|0|||
150018622|NCT00172042|541203591|FG000|Overall Study|Protocol Violation|8|||
150018623|NCT00172042|541203592|FG001|Overall Study|Protocol Violation|7|||
150018624|NCT00172042|541203591|FG000|Overall Study|Withdrawal by Subject|37|||
150018625|NCT00172042|541203592|FG001|Overall Study|Withdrawal by Subject|25|||
150018626|NCT00172042|541203591|FG000|Overall Study|Lost to Follow-up|3|||
150018627|NCT00172042|541203592|FG001|Overall Study|Lost to Follow-up|5|||
150018628|NCT00172042|541203591|FG000|Overall Study|Administrative problems|13|||
150018629|NCT00172042|541203592|FG001|Overall Study|Administrative problems|10|||
150018630|NCT00172042|541203591|FG000|Overall Study|Death|42|||
150018631|NCT00172042|541203592|FG001|Overall Study|Death|42|||
150018632|NCT01771250|541203593|FG000|Period 1|Met exclusion criteria|1|||
150018633|NCT01771250|541203594|FG001|Period 1|Met exclusion criteria|0|||
150018634|NCT02058563|541203595|FG000|Overall Study|Lost to Follow-up|26|||
150018635|NCT02058563|541203596|FG001|Overall Study|Lost to Follow-up|22|||
150018636|NCT02058563|541203595|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
150018637|NCT02058563|541203596|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
150018638|NCT02058563|541203595|FG000|Overall Study|Consent Withdrawal|1|||
150018639|NCT02058563|541203596|FG001|Overall Study|Consent Withdrawal|1|||
150018640|NCT02058563|541203595|FG000|Overall Study|Other (patient incarcerated)|0|||
150018641|NCT02058563|541203596|FG001|Overall Study|Other (patient incarcerated)|1|||
150018642|NCT01180296|541203597|FG000|Overall Study|Protocol Violation|1|||
150018643|NCT01180296|541203598|FG001|Overall Study|Protocol Violation|2|||
150018644|NCT00166439|541203599|FG000|Overall Study|Ineligible|5|||
150018645|NCT00483938|541203600|FG000|Overall Study|Protocol Violation|0|||
150018646|NCT00483938|541203601|FG001|Overall Study|Protocol Violation|0|||
150059103|NCT04535167|541358479|FG004|Treatment|Adverse Event|0|||
150059104|NCT04535167|541358480|FG005|Treatment|Adverse Event|0|||
150059105|NCT04535167|541358481|FG006|Treatment|Adverse Event|1|||
150059106|NCT04535167|541358475|FG000|Follow-Up|Death|0|||
150059107|NCT04535167|541358476|FG001|Follow-Up|Death|0|||
150059108|NCT04535167|541358477|FG002|Follow-Up|Death|0|||
150059109|NCT04535167|541358478|FG003|Follow-Up|Death|0|||
150059110|NCT04535167|541358479|FG004|Follow-Up|Death|0|||
150059111|NCT04535167|541358480|FG005|Follow-Up|Death|0|||
150059112|NCT04535167|541358481|FG006|Follow-Up|Death|1|||
150059113|NCT04535167|541358475|FG000|Follow-Up|Lost to Follow-up|0|||
150059114|NCT04535167|541358476|FG001|Follow-Up|Lost to Follow-up|0|||
150059115|NCT04535167|541358477|FG002|Follow-Up|Lost to Follow-up|0|||
150059116|NCT04535167|541358478|FG003|Follow-Up|Lost to Follow-up|1|||
150059117|NCT04535167|541358479|FG004|Follow-Up|Lost to Follow-up|0|||
150059118|NCT04535167|541358480|FG005|Follow-Up|Lost to Follow-up|0|||
150059119|NCT04535167|541358481|FG006|Follow-Up|Lost to Follow-up|0|||
150059120|NCT03404960|541358482|FG000|Overall Study|Adverse Event|0|||
150059121|NCT03404960|541358483|FG001|Overall Study|Adverse Event|2|||
150059122|NCT03404960|541358482|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
150059123|NCT03404960|541358483|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
150059124|NCT03404960|541358482|FG000|Overall Study|Bowel obstruction|0|||
150018647|NCT00483938|541203602|FG002|Overall Study|Protocol Violation|0|||
150018648|NCT00483938|541203603|FG003|Overall Study|Protocol Violation|0|||
150059125|NCT03404960|541358483|FG001|Overall Study|Bowel obstruction|1|||
150059126|NCT03404960|541358482|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
150059127|NCT03404960|541358483|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
150059128|NCT00075270|541358484|FG000|Overall Study|Withdrawal by Subject|28|||
150059129|NCT00075270|541358485|FG001|Overall Study|Withdrawal by Subject|21|||
150059130|NCT00075270|541358484|FG000|Overall Study|Lost to Follow-up|25|||
150059131|NCT00075270|541358485|FG001|Overall Study|Lost to Follow-up|28|||
150059132|NCT00075270|541358484|FG000|Overall Study|Protocol Violation|0|||
150059133|NCT00075270|541358485|FG001|Overall Study|Protocol Violation|2|||
150059134|NCT00075270|541358484|FG000|Overall Study|Death|198|||
150059135|NCT00075270|541358485|FG001|Overall Study|Death|215|||
150059136|NCT00075270|541358484|FG000|Overall Study|Other/Unknown|9|||
150059137|NCT00075270|541358485|FG001|Overall Study|Other/Unknown|5|||
150059138|NCT00075270|541358484|FG000|Overall Study|Missing|26|||
150018649|NCT00483938|541203604|FG004|Overall Study|Protocol Violation|0|||
150018650|NCT00483938|541203605|FG005|Overall Study|Protocol Violation|0|||
150018651|NCT00483938|541203606|FG006|Overall Study|Protocol Violation|3|||
150059139|NCT00075270|541358485|FG001|Overall Study|Missing|13|||
150059140|NCT00246571|541358486|FG000|Overall Study|Adverse Event|7|||
150059141|NCT00246571|541358487|FG001|Overall Study|Adverse Event|0|||
150059142|NCT00246571|541358486|FG000|Overall Study|Protocol Violation|0|||
150018652|NCT00483938|541203600|FG000|Overall Study|Withdrawal by Subject|1|||
150018653|NCT00483938|541203601|FG001|Overall Study|Withdrawal by Subject|6|||
150018654|NCT00483938|541203602|FG002|Overall Study|Withdrawal by Subject|0|||
150018655|NCT00483938|541203603|FG003|Overall Study|Withdrawal by Subject|0|||
150018656|NCT00483938|541203604|FG004|Overall Study|Withdrawal by Subject|1|||
150018657|NCT00483938|541203605|FG005|Overall Study|Withdrawal by Subject|3|||
150018658|NCT00483938|541203606|FG006|Overall Study|Withdrawal by Subject|2|||
150018659|NCT00483938|541203600|FG000|Overall Study|Lost to Follow-up|1|||
150018660|NCT00483938|541203601|FG001|Overall Study|Lost to Follow-up|2|||
150018661|NCT00483938|541203602|FG002|Overall Study|Lost to Follow-up|0|||
150018662|NCT00483938|541203603|FG003|Overall Study|Lost to Follow-up|2|||
150018663|NCT00483938|541203604|FG004|Overall Study|Lost to Follow-up|1|||
150018664|NCT00483938|541203605|FG005|Overall Study|Lost to Follow-up|1|||
150018665|NCT00483938|541203606|FG006|Overall Study|Lost to Follow-up|3|||
150018666|NCT00483938|541203600|FG000|Overall Study|Death|0|||
150018667|NCT00483938|541203601|FG001|Overall Study|Death|2|||
150018668|NCT00483938|541203602|FG002|Overall Study|Death|0|||
150018669|NCT00483938|541203603|FG003|Overall Study|Death|0|||
150018670|NCT00483938|541203604|FG004|Overall Study|Death|0|||
150018671|NCT00483938|541203605|FG005|Overall Study|Death|0|||
150018672|NCT00483938|541203606|FG006|Overall Study|Death|0|||
150018673|NCT00483938|541203600|FG000|Overall Study|Other|3|||
150018674|NCT00483938|541203601|FG001|Overall Study|Other|9|||
150018675|NCT00483938|541203602|FG002|Overall Study|Other|0|||
150018676|NCT00483938|541203603|FG003|Overall Study|Other|4|||
150018677|NCT00483938|541203604|FG004|Overall Study|Other|0|||
150018678|NCT00483938|541203605|FG005|Overall Study|Other|4|||
150018679|NCT00483938|541203606|FG006|Overall Study|Other|32|||
150018680|NCT00106353|541203611|FG000|Part 1|Disease progression|3|||
150018681|NCT00106353|541203612|FG001|Part 1|Disease progression|4|||
150018682|NCT00106353|541203613|FG002|Part 1|Disease progression|1|||
150018683|NCT00106353|541203614|FG003|Part 1|Disease progression|3|||
150018684|NCT00106353|541203615|FG004|Part 1|Disease progression|0|||
150018685|NCT00106353|541203616|FG005|Part 1|Disease progression|0|||
150018686|NCT00106353|541203617|FG006|Part 1|Disease progression|0|||
150018687|NCT00106353|541203611|FG000|Part 1|Withdrawal by Subject|0|||
150018688|NCT00106353|541203612|FG001|Part 1|Withdrawal by Subject|0|||
150018689|NCT00106353|541203613|FG002|Part 1|Withdrawal by Subject|1|||
150018690|NCT00106353|541203614|FG003|Part 1|Withdrawal by Subject|2|||
150018691|NCT00106353|541203615|FG004|Part 1|Withdrawal by Subject|0|||
150018692|NCT00106353|541203616|FG005|Part 1|Withdrawal by Subject|0|||
150018693|NCT00106353|541203617|FG006|Part 1|Withdrawal by Subject|0|||
150018694|NCT00106353|541203611|FG000|Part 1|Symptomatic deterioration|0|||
150018695|NCT00106353|541203612|FG001|Part 1|Symptomatic deterioration|0|||
150018696|NCT00106353|541203613|FG002|Part 1|Symptomatic deterioration|1|||
150018697|NCT00106353|541203614|FG003|Part 1|Symptomatic deterioration|0|||
150018698|NCT00106353|541203615|FG004|Part 1|Symptomatic deterioration|0|||
150018699|NCT00106353|541203616|FG005|Part 1|Symptomatic deterioration|0|||
150018700|NCT00106353|541203617|FG006|Part 1|Symptomatic deterioration|0|||
150018701|NCT00106353|541203611|FG000|Part 1|Entered follow-up phase|1|||
150018702|NCT00106353|541203612|FG001|Part 1|Entered follow-up phase|1|||
150018703|NCT00106353|541203613|FG002|Part 1|Entered follow-up phase|0|||
150018704|NCT00106353|541203614|FG003|Part 1|Entered follow-up phase|1|||
150018705|NCT00106353|541203615|FG004|Part 1|Entered follow-up phase|0|||
150018706|NCT00106353|541203616|FG005|Part 1|Entered follow-up phase|0|||
150018707|NCT00106353|541203617|FG006|Part 1|Entered follow-up phase|0|||
150018708|NCT00106353|541203611|FG000|Part 1|Adverse Event|0|||
150018709|NCT00106353|541203612|FG001|Part 1|Adverse Event|0|||
150018710|NCT00106353|541203613|FG002|Part 1|Adverse Event|0|||
150018711|NCT00106353|541203614|FG003|Part 1|Adverse Event|1|||
150018712|NCT00106353|541203615|FG004|Part 1|Adverse Event|0|||
150018713|NCT00106353|541203616|FG005|Part 1|Adverse Event|0|||
150018714|NCT00106353|541203617|FG006|Part 1|Adverse Event|0|||
150018715|NCT00106353|541203611|FG000|Part 2|Disease progression|0|||
150018716|NCT00106353|541203612|FG001|Part 2|Disease progression|0|||
150059143|NCT00246571|541358487|FG001|Overall Study|Protocol Violation|1|||
150018717|NCT00106353|541203613|FG002|Part 2|Disease progression|0|||
150018718|NCT00106353|541203614|FG003|Part 2|Disease progression|0|||
150018719|NCT00106353|541203615|FG004|Part 2|Disease progression|8|||
150018720|NCT00106353|541203616|FG005|Part 2|Disease progression|14|||
150059144|NCT00246571|541358486|FG000|Overall Study|Withdrawal by Subject|2|||
150018721|NCT00106353|541203617|FG006|Part 2|Disease progression|13|||
150018722|NCT00106353|541203611|FG000|Part 2|Death|0|||
150018723|NCT00106353|541203612|FG001|Part 2|Death|0|||
150018724|NCT00106353|541203613|FG002|Part 2|Death|0|||
150018725|NCT00106353|541203614|FG003|Part 2|Death|0|||
150018726|NCT00106353|541203615|FG004|Part 2|Death|3|||
150018727|NCT00106353|541203616|FG005|Part 2|Death|0|||
150018728|NCT00106353|541203617|FG006|Part 2|Death|1|||
150018729|NCT00106353|541203611|FG000|Part 2|Symptomatic deterioration|0|||
150018730|NCT00106353|541203612|FG001|Part 2|Symptomatic deterioration|0|||
150018731|NCT00106353|541203613|FG002|Part 2|Symptomatic deterioration|0|||
150018732|NCT00106353|541203614|FG003|Part 2|Symptomatic deterioration|0|||
150018733|NCT00106353|541203615|FG004|Part 2|Symptomatic deterioration|3|||
150018734|NCT00106353|541203616|FG005|Part 2|Symptomatic deterioration|0|||
150018735|NCT00106353|541203617|FG006|Part 2|Symptomatic deterioration|0|||
150018736|NCT00106353|541203611|FG000|Part 2|Adverse Event|0|||
150018737|NCT00106353|541203612|FG001|Part 2|Adverse Event|0|||
150018738|NCT00106353|541203613|FG002|Part 2|Adverse Event|0|||
150018739|NCT00106353|541203614|FG003|Part 2|Adverse Event|0|||
150018740|NCT00106353|541203615|FG004|Part 2|Adverse Event|0|||
150018741|NCT00106353|541203616|FG005|Part 2|Adverse Event|2|||
150018742|NCT00106353|541203617|FG006|Part 2|Adverse Event|1|||
150018743|NCT00106353|541203611|FG000|Part 2|Other|0|||
150018744|NCT00106353|541203612|FG001|Part 2|Other|0|||
150018745|NCT00106353|541203613|FG002|Part 2|Other|0|||
150018746|NCT00106353|541203614|FG003|Part 2|Other|0|||
150018747|NCT00106353|541203615|FG004|Part 2|Other|1|||
150018748|NCT00106353|541203616|FG005|Part 2|Other|1|||
150018749|NCT00106353|541203617|FG006|Part 2|Other|1|||
150018750|NCT00106353|541203611|FG000|Part 2|Withdrawal by Subject|0|||
150018751|NCT00106353|541203612|FG001|Part 2|Withdrawal by Subject|0|||
150018752|NCT00106353|541203613|FG002|Part 2|Withdrawal by Subject|0|||
150018753|NCT00106353|541203614|FG003|Part 2|Withdrawal by Subject|0|||
150018754|NCT00106353|541203615|FG004|Part 2|Withdrawal by Subject|1|||
150018755|NCT00106353|541203616|FG005|Part 2|Withdrawal by Subject|0|||
150018756|NCT00106353|541203617|FG006|Part 2|Withdrawal by Subject|0|||
150018757|NCT00106353|541203611|FG000|Part 2|Physician Decision|0|||
150018758|NCT00106353|541203612|FG001|Part 2|Physician Decision|0|||
150018759|NCT00106353|541203613|FG002|Part 2|Physician Decision|0|||
150018760|NCT00106353|541203614|FG003|Part 2|Physician Decision|0|||
150018761|NCT00106353|541203615|FG004|Part 2|Physician Decision|0|||
150018762|NCT00106353|541203616|FG005|Part 2|Physician Decision|1|||
150018763|NCT00106353|541203617|FG006|Part 2|Physician Decision|0|||
150018764|NCT04039217|541203618|FG000|Overall Study|Lost to Follow-up|1|||
150018765|NCT01371552|541203619|FG000|Part 1, First 3 Days|Inconvenience|0|||
150018766|NCT01371552|541203620|FG001|Part 1, First 3 Days|Inconvenience|0|||
150018767|NCT01371552|541203621|FG002|Part 1, First 3 Days|Inconvenience|1|||
150018768|NCT01371552|541203622|FG003|Part 1, First 3 Days|Inconvenience|0|||
150018769|NCT01371552|541203623|FG004|Part 1, First 3 Days|Inconvenience|0|||
150018770|NCT01371552|541203624|FG005|Part 1, First 3 Days|Inconvenience|0|||
150018771|NCT03364309|541203625|FG000|Induction Period|Adverse Event|4|||
150018772|NCT03364309|541203626|FG001|Induction Period|Adverse Event|0|||
150018773|NCT03364309|541203627|FG002|Induction Period|Adverse Event|1|||
150059145|NCT00246571|541358487|FG001|Overall Study|Withdrawal by Subject|3|||
150059146|NCT00246571|541358486|FG000|Overall Study|Lack of Efficacy|84|||
150059147|NCT00246571|541358487|FG001|Overall Study|Lack of Efficacy|21|||
150059148|NCT00246571|541358486|FG000|Overall Study|Death|17|||
150059149|NCT00246571|541358487|FG001|Overall Study|Death|3|||
150059150|NCT00246571|541358486|FG000|Overall Study|Sponsor|0|||
150059151|NCT00246571|541358487|FG001|Overall Study|Sponsor|1|||
150059152|NCT00246571|541358486|FG000|Overall Study|Did not meet entrance criteria|2|||
150059153|NCT00246571|541358487|FG001|Overall Study|Did not meet entrance criteria|1|||
150059154|NCT00246571|541358486|FG000|Overall Study|Laboratory abnormalities|1|||
150059155|NCT00246571|541358487|FG001|Overall Study|Laboratory abnormalities|0|||
150059156|NCT00246571|541358486|FG000|Overall Study|Crossover participants|0|||
150059157|NCT00246571|541358487|FG001|Overall Study|Crossover participants|74|||
150059158|NCT03422627|541358488|FG000|Overall Study|Protocol-specified Criteria|1|||
150059159|NCT03422627|541358489|FG001|Overall Study|Protocol-specified Criteria|1|||
150018774|NCT03364309|541203628|FG003|Induction Period|Adverse Event|0|||
150018775|NCT03364309|541203629|FG004|Induction Period|Adverse Event|0|||
150018776|NCT03364309|541203630|FG005|Induction Period|Adverse Event|0|||
150018777|NCT03364309|541203631|FG006|Induction Period|Adverse Event|0|||
150018778|NCT03364309|541203632|FG007|Induction Period|Adverse Event|0|||
150018779|NCT03364309|541203633|FG008|Induction Period|Adverse Event|0|||
150018780|NCT03364309|541203634|FG009|Induction Period|Adverse Event|0|||
150018781|NCT03364309|541203635|FG010|Induction Period|Adverse Event|0|||
150018782|NCT03364309|541203636|FG011|Induction Period|Adverse Event|0|||
150018783|NCT03364309|541203637|FG012|Induction Period|Adverse Event|0|||
150018784|NCT03364309|541203638|FG013|Induction Period|Adverse Event|0|||
150018785|NCT03364309|541203639|FG014|Induction Period|Adverse Event|0|||
150018786|NCT03364309|541203640|FG015|Induction Period|Adverse Event|0|||
150059160|NCT03422627|541358490|FG002|Overall Study|Protocol-specified Criteria|0|||
150059161|NCT03422627|541358491|FG003|Overall Study|Protocol-specified Criteria|0|||
150059162|NCT03422627|541358492|FG004|Overall Study|Protocol-specified Criteria|2|||
150018787|NCT03364309|541203641|FG016|Induction Period|Adverse Event|0|||
150018788|NCT03364309|541203642|FG017|Induction Period|Adverse Event|0|||
150018789|NCT03364309|541203643|FG018|Induction Period|Adverse Event|0|||
150018790|NCT03364309|541203625|FG000|Induction Period|Withdrawal by Subject|1|||
150018791|NCT03364309|541203626|FG001|Induction Period|Withdrawal by Subject|3|||
150018792|NCT03364309|541203627|FG002|Induction Period|Withdrawal by Subject|0|||
150018793|NCT03364309|541203628|FG003|Induction Period|Withdrawal by Subject|0|||
150018794|NCT03364309|541203629|FG004|Induction Period|Withdrawal by Subject|0|||
150018795|NCT03364309|541203630|FG005|Induction Period|Withdrawal by Subject|0|||
150018796|NCT03364309|541203631|FG006|Induction Period|Withdrawal by Subject|0|||
150018797|NCT03364309|541203632|FG007|Induction Period|Withdrawal by Subject|0|||
150018798|NCT03364309|541203633|FG008|Induction Period|Withdrawal by Subject|0|||
150018799|NCT03364309|541203634|FG009|Induction Period|Withdrawal by Subject|0|||
150018800|NCT03364309|541203635|FG010|Induction Period|Withdrawal by Subject|0|||
150018801|NCT03364309|541203636|FG011|Induction Period|Withdrawal by Subject|0|||
150018802|NCT03364309|541203637|FG012|Induction Period|Withdrawal by Subject|0|||
150018803|NCT03364309|541203638|FG013|Induction Period|Withdrawal by Subject|0|||
150018804|NCT03364309|541203639|FG014|Induction Period|Withdrawal by Subject|0|||
150018805|NCT03364309|541203640|FG015|Induction Period|Withdrawal by Subject|0|||
150018806|NCT03364309|541203641|FG016|Induction Period|Withdrawal by Subject|0|||
150018807|NCT03364309|541203642|FG017|Induction Period|Withdrawal by Subject|0|||
150018808|NCT03364309|541203643|FG018|Induction Period|Withdrawal by Subject|0|||
150018809|NCT03364309|541203625|FG000|Induction Period|Lost to Follow-up|1|||
150018810|NCT03364309|541203626|FG001|Induction Period|Lost to Follow-up|0|||
150018811|NCT03364309|541203627|FG002|Induction Period|Lost to Follow-up|0|||
150018812|NCT03364309|541203628|FG003|Induction Period|Lost to Follow-up|0|||
150018813|NCT03364309|541203629|FG004|Induction Period|Lost to Follow-up|0|||
150018814|NCT03364309|541203630|FG005|Induction Period|Lost to Follow-up|0|||
150018815|NCT03364309|541203631|FG006|Induction Period|Lost to Follow-up|0|||
150018816|NCT03364309|541203632|FG007|Induction Period|Lost to Follow-up|0|||
150018817|NCT03364309|541203633|FG008|Induction Period|Lost to Follow-up|0|||
150018818|NCT03364309|541203634|FG009|Induction Period|Lost to Follow-up|0|||
150018819|NCT03364309|541203635|FG010|Induction Period|Lost to Follow-up|0|||
150018820|NCT03364309|541203636|FG011|Induction Period|Lost to Follow-up|0|||
150018821|NCT03364309|541203637|FG012|Induction Period|Lost to Follow-up|0|||
150018822|NCT03364309|541203638|FG013|Induction Period|Lost to Follow-up|0|||
150018823|NCT03364309|541203639|FG014|Induction Period|Lost to Follow-up|0|||
150018824|NCT03364309|541203640|FG015|Induction Period|Lost to Follow-up|0|||
150018825|NCT03364309|541203641|FG016|Induction Period|Lost to Follow-up|0|||
150018826|NCT03364309|541203642|FG017|Induction Period|Lost to Follow-up|0|||
150018827|NCT03364309|541203643|FG018|Induction Period|Lost to Follow-up|0|||
150018828|NCT03364309|541203625|FG000|Induction Period|Physician Decision|0|||
150018829|NCT03364309|541203626|FG001|Induction Period|Physician Decision|1|||
150018830|NCT03364309|541203627|FG002|Induction Period|Physician Decision|0|||
150059163|NCT03422627|541358488|FG000|Overall Study|Requirement for Alternative Therapy|1|||
150059164|NCT03422627|541358489|FG001|Overall Study|Requirement for Alternative Therapy|1|||
150059165|NCT03422627|541358490|FG002|Overall Study|Requirement for Alternative Therapy|2|||
150018831|NCT03364309|541203628|FG003|Induction Period|Physician Decision|0|||
150018832|NCT03364309|541203629|FG004|Induction Period|Physician Decision|0|||
150018833|NCT03364309|541203630|FG005|Induction Period|Physician Decision|0|||
150059166|NCT03422627|541358491|FG003|Overall Study|Requirement for Alternative Therapy|0|||
150059167|NCT03422627|541358492|FG004|Overall Study|Requirement for Alternative Therapy|0|||
150059168|NCT03422627|541358488|FG000|Overall Study|Disease Progression|1|||
150059169|NCT03422627|541358489|FG001|Overall Study|Disease Progression|0|||
150018834|NCT03364309|541203631|FG006|Induction Period|Physician Decision|0|||
150018835|NCT03364309|541203632|FG007|Induction Period|Physician Decision|0|||
150018836|NCT03364309|541203633|FG008|Induction Period|Physician Decision|0|||
150059170|NCT03422627|541358490|FG002|Overall Study|Disease Progression|1|||
150059171|NCT03422627|541358491|FG003|Overall Study|Disease Progression|2|||
150018837|NCT03364309|541203634|FG009|Induction Period|Physician Decision|0|||
150018838|NCT03364309|541203635|FG010|Induction Period|Physician Decision|0|||
150018839|NCT03364309|541203636|FG011|Induction Period|Physician Decision|0|||
150018840|NCT03364309|541203637|FG012|Induction Period|Physician Decision|0|||
150018841|NCT03364309|541203638|FG013|Induction Period|Physician Decision|0|||
150018842|NCT03364309|541203639|FG014|Induction Period|Physician Decision|0|||
150018843|NCT03364309|541203640|FG015|Induction Period|Physician Decision|0|||
150018844|NCT03364309|541203641|FG016|Induction Period|Physician Decision|0|||
150018845|NCT03364309|541203642|FG017|Induction Period|Physician Decision|0|||
150018846|NCT03364309|541203643|FG018|Induction Period|Physician Decision|0|||
150018847|NCT03364309|541203625|FG000|Maintenance Period|Withdrawal by Subject|0|||
150018848|NCT03364309|541203626|FG001|Maintenance Period|Withdrawal by Subject|0|||
150018849|NCT03364309|541203627|FG002|Maintenance Period|Withdrawal by Subject|0|||
150018850|NCT03364309|541203628|FG003|Maintenance Period|Withdrawal by Subject|1|||
150018851|NCT03364309|541203629|FG004|Maintenance Period|Withdrawal by Subject|3|||
150018852|NCT03364309|541203630|FG005|Maintenance Period|Withdrawal by Subject|1|||
150018853|NCT03364309|541203631|FG006|Maintenance Period|Withdrawal by Subject|3|||
150018854|NCT03364309|541203632|FG007|Maintenance Period|Withdrawal by Subject|0|||
150018855|NCT03364309|541203633|FG008|Maintenance Period|Withdrawal by Subject|1|||
150018856|NCT03364309|541203634|FG009|Maintenance Period|Withdrawal by Subject|1|||
150018857|NCT03364309|541203635|FG010|Maintenance Period|Withdrawal by Subject|2|||
150018858|NCT03364309|541203636|FG011|Maintenance Period|Withdrawal by Subject|0|||
150018859|NCT03364309|541203637|FG012|Maintenance Period|Withdrawal by Subject|0|||
150018860|NCT03364309|541203638|FG013|Maintenance Period|Withdrawal by Subject|0|||
150018861|NCT03364309|541203639|FG014|Maintenance Period|Withdrawal by Subject|0|||
150018862|NCT03364309|541203640|FG015|Maintenance Period|Withdrawal by Subject|0|||
150018863|NCT03364309|541203641|FG016|Maintenance Period|Withdrawal by Subject|0|||
150018864|NCT03364309|541203642|FG017|Maintenance Period|Withdrawal by Subject|0|||
150018865|NCT03364309|541203643|FG018|Maintenance Period|Withdrawal by Subject|0|||
150018866|NCT03364309|541203625|FG000|Maintenance Period|Adverse Event|0|||
150018867|NCT03364309|541203626|FG001|Maintenance Period|Adverse Event|0|||
150018868|NCT03364309|541203627|FG002|Maintenance Period|Adverse Event|0|||
150018869|NCT03364309|541203628|FG003|Maintenance Period|Adverse Event|0|||
150018870|NCT03364309|541203629|FG004|Maintenance Period|Adverse Event|2|||
150018871|NCT03364309|541203630|FG005|Maintenance Period|Adverse Event|0|||
150018872|NCT03364309|541203631|FG006|Maintenance Period|Adverse Event|3|||
150018873|NCT03364309|541203632|FG007|Maintenance Period|Adverse Event|0|||
150018874|NCT03364309|541203633|FG008|Maintenance Period|Adverse Event|1|||
150018875|NCT03364309|541203634|FG009|Maintenance Period|Adverse Event|0|||
150018876|NCT03364309|541203635|FG010|Maintenance Period|Adverse Event|2|||
150018877|NCT03364309|541203636|FG011|Maintenance Period|Adverse Event|0|||
150018878|NCT03364309|541203637|FG012|Maintenance Period|Adverse Event|0|||
150018879|NCT03364309|541203638|FG013|Maintenance Period|Adverse Event|0|||
150018880|NCT03364309|541203639|FG014|Maintenance Period|Adverse Event|0|||
150018881|NCT03364309|541203640|FG015|Maintenance Period|Adverse Event|0|||
150018882|NCT03364309|541203641|FG016|Maintenance Period|Adverse Event|0|||
150018883|NCT03364309|541203642|FG017|Maintenance Period|Adverse Event|0|||
150018884|NCT03364309|541203643|FG018|Maintenance Period|Adverse Event|0|||
150018885|NCT03364309|541203625|FG000|Maintenance Period|Relapsed|0|||
150018886|NCT03364309|541203626|FG001|Maintenance Period|Relapsed|0|||
150018887|NCT03364309|541203627|FG002|Maintenance Period|Relapsed|0|||
150018888|NCT03364309|541203628|FG003|Maintenance Period|Relapsed|43|||
150018889|NCT03364309|541203629|FG004|Maintenance Period|Relapsed|7|||
150018890|NCT03364309|541203630|FG005|Maintenance Period|Relapsed|45|||
150018891|NCT03364309|541203631|FG006|Maintenance Period|Relapsed|10|||
150018892|NCT03364309|541203632|FG007|Maintenance Period|Relapsed|2|||
150018893|NCT03364309|541203633|FG008|Maintenance Period|Relapsed|0|||
150018894|NCT03364309|541203634|FG009|Maintenance Period|Relapsed|0|||
150018895|NCT03364309|541203635|FG010|Maintenance Period|Relapsed|0|||
150018896|NCT03364309|541203636|FG011|Maintenance Period|Relapsed|0|||
150018897|NCT03364309|541203637|FG012|Maintenance Period|Relapsed|0|||
150018898|NCT03364309|541203638|FG013|Maintenance Period|Relapsed|0|||
150018899|NCT03364309|541203639|FG014|Maintenance Period|Relapsed|0|||
150018900|NCT03364309|541203640|FG015|Maintenance Period|Relapsed|0|||
150018901|NCT03364309|541203641|FG016|Maintenance Period|Relapsed|0|||
150018902|NCT03364309|541203642|FG017|Maintenance Period|Relapsed|0|||
150018903|NCT03364309|541203643|FG018|Maintenance Period|Relapsed|0|||
150018904|NCT03364309|541203625|FG000|Maintenance Period|Lack of Efficacy|0|||
150018905|NCT03364309|541203626|FG001|Maintenance Period|Lack of Efficacy|0|||
150059172|NCT03422627|541358492|FG004|Overall Study|Disease Progression|0|||
150059173|NCT03422627|541358488|FG000|Overall Study|Adverse Event|2|||
150059174|NCT03422627|541358489|FG001|Overall Study|Adverse Event|1|||
150059175|NCT03422627|541358490|FG002|Overall Study|Adverse Event|0|||
150059176|NCT03422627|541358491|FG003|Overall Study|Adverse Event|0|||
150059177|NCT03422627|541358492|FG004|Overall Study|Adverse Event|2|||
150059178|NCT03422627|541358488|FG000|Overall Study|Ineligibility Determined|0|||
150059179|NCT03422627|541358489|FG001|Overall Study|Ineligibility Determined|1|||
150059180|NCT03422627|541358490|FG002|Overall Study|Ineligibility Determined|0|||
150059181|NCT03422627|541358491|FG003|Overall Study|Ineligibility Determined|0|||
150059182|NCT03422627|541358492|FG004|Overall Study|Ineligibility Determined|0|||
150059183|NCT03422627|541358488|FG000|Overall Study|Death|0|||
150059184|NCT03422627|541358489|FG001|Overall Study|Death|1|||
150059185|NCT03422627|541358490|FG002|Overall Study|Death|1|||
150059186|NCT03422627|541358491|FG003|Overall Study|Death|0|||
150059187|NCT03422627|541358492|FG004|Overall Study|Death|0|||
150059188|NCT03422627|541358488|FG000|Overall Study|Withdrawal by Subject|0|||
150059189|NCT03422627|541358489|FG001|Overall Study|Withdrawal by Subject|0|||
150059190|NCT03422627|541358490|FG002|Overall Study|Withdrawal by Subject|0|||
150059191|NCT03422627|541358491|FG003|Overall Study|Withdrawal by Subject|1|||
150018906|NCT03364309|541203627|FG002|Maintenance Period|Lack of Efficacy|0|||
150018907|NCT03364309|541203628|FG003|Maintenance Period|Lack of Efficacy|0|||
150018908|NCT03364309|541203629|FG004|Maintenance Period|Lack of Efficacy|0|||
150018909|NCT03364309|541203630|FG005|Maintenance Period|Lack of Efficacy|0|||
150018910|NCT03364309|541203631|FG006|Maintenance Period|Lack of Efficacy|0|||
150018911|NCT03364309|541203632|FG007|Maintenance Period|Lack of Efficacy|0|||
150018912|NCT03364309|541203633|FG008|Maintenance Period|Lack of Efficacy|1|||
150018913|NCT03364309|541203634|FG009|Maintenance Period|Lack of Efficacy|3|||
150018914|NCT03364309|541203635|FG010|Maintenance Period|Lack of Efficacy|2|||
150018915|NCT03364309|541203636|FG011|Maintenance Period|Lack of Efficacy|0|||
150018916|NCT03364309|541203637|FG012|Maintenance Period|Lack of Efficacy|0|||
150018917|NCT03364309|541203638|FG013|Maintenance Period|Lack of Efficacy|0|||
150018918|NCT03364309|541203639|FG014|Maintenance Period|Lack of Efficacy|0|||
150018919|NCT03364309|541203640|FG015|Maintenance Period|Lack of Efficacy|0|||
150018920|NCT03364309|541203641|FG016|Maintenance Period|Lack of Efficacy|0|||
150018921|NCT03364309|541203642|FG017|Maintenance Period|Lack of Efficacy|0|||
150018922|NCT03364309|541203643|FG018|Maintenance Period|Lack of Efficacy|0|||
150018923|NCT03364309|541203625|FG000|Maintenance Period|Death|0|||
150018924|NCT03364309|541203626|FG001|Maintenance Period|Death|0|||
150018925|NCT03364309|541203627|FG002|Maintenance Period|Death|0|||
150059192|NCT03422627|541358492|FG004|Overall Study|Withdrawal by Subject|0|||
150059193|NCT02455557|541358493|FG000|Overall Study|Withdrawal by Subject|2|||
150059194|NCT03828370|541358503|FG000|3 Month Follow-up|Lost to Follow-up|4|||
150059195|NCT03828370|541358504|FG001|3 Month Follow-up|Lost to Follow-up|12|||
150018926|NCT03364309|541203628|FG003|Maintenance Period|Death|0|||
150018927|NCT03364309|541203629|FG004|Maintenance Period|Death|0|||
150018928|NCT03364309|541203630|FG005|Maintenance Period|Death|0|||
150018929|NCT03364309|541203631|FG006|Maintenance Period|Death|0|||
150018930|NCT03364309|541203632|FG007|Maintenance Period|Death|0|||
150059196|NCT03828370|541358503|FG000|9 Month Follow up|Lost to Follow-up|12|||
150059197|NCT03828370|541358504|FG001|9 Month Follow up|Lost to Follow-up|20|||
150059198|NCT02677324|541358505|FG000|Overall Study|Disease Progression|6|||
150059199|NCT02677324|541358505|FG000|Overall Study|Inability to Swallow pills|1|||
150059200|NCT02677324|541358505|FG000|Overall Study|Non-compliance|1|||
150059201|NCT02677324|541358505|FG000|Overall Study|Lack of Efficacy|1|||
150059202|NCT02677324|541358505|FG000|Overall Study|Medical insurance coverage|1|||
150059203|NCT02677324|541358505|FG000|Overall Study|Adverse Event|1|||
150059204|NCT02677324|541358505|FG000|Overall Study|IgM Myeloma diagnosis|1|||
150059205|NCT00761150|541358508|FG000|Open-label Period|Adverse Event|36|||
150181661|NCT02538341|541802819|FG001|Overall Study|Lost to Follow-up|46|||
150181662|NCT02538341|541802818|FG000|Overall Study|Withdrawal by Subject|3|||
150018931|NCT03364309|541203633|FG008|Maintenance Period|Death|1|||
150018932|NCT03364309|541203634|FG009|Maintenance Period|Death|0|||
150018933|NCT03364309|541203635|FG010|Maintenance Period|Death|0|||
150018934|NCT03364309|541203636|FG011|Maintenance Period|Death|0|||
150018935|NCT03364309|541203637|FG012|Maintenance Period|Death|0|||
150018936|NCT03364309|541203638|FG013|Maintenance Period|Death|0|||
150018937|NCT03364309|541203639|FG014|Maintenance Period|Death|0|||
150018938|NCT03364309|541203640|FG015|Maintenance Period|Death|0|||
150018939|NCT03364309|541203641|FG016|Maintenance Period|Death|0|||
150018940|NCT03364309|541203642|FG017|Maintenance Period|Death|0|||
150018941|NCT03364309|541203643|FG018|Maintenance Period|Death|0|||
150018942|NCT03364309|541203625|FG000|Maintenance Period|Lost to Follow-up|0|||
150018943|NCT03364309|541203626|FG001|Maintenance Period|Lost to Follow-up|0|||
150018944|NCT03364309|541203627|FG002|Maintenance Period|Lost to Follow-up|0|||
150018945|NCT03364309|541203628|FG003|Maintenance Period|Lost to Follow-up|0|||
150018946|NCT03364309|541203629|FG004|Maintenance Period|Lost to Follow-up|0|||
150018947|NCT03364309|541203630|FG005|Maintenance Period|Lost to Follow-up|0|||
150018948|NCT03364309|541203631|FG006|Maintenance Period|Lost to Follow-up|0|||
150018949|NCT03364309|541203632|FG007|Maintenance Period|Lost to Follow-up|0|||
150018950|NCT03364309|541203633|FG008|Maintenance Period|Lost to Follow-up|1|||
150018951|NCT03364309|541203634|FG009|Maintenance Period|Lost to Follow-up|0|||
150018952|NCT03364309|541203635|FG010|Maintenance Period|Lost to Follow-up|0|||
150018953|NCT03364309|541203636|FG011|Maintenance Period|Lost to Follow-up|0|||
150018954|NCT03364309|541203637|FG012|Maintenance Period|Lost to Follow-up|0|||
150018955|NCT03364309|541203638|FG013|Maintenance Period|Lost to Follow-up|0|||
150018956|NCT03364309|541203639|FG014|Maintenance Period|Lost to Follow-up|0|||
150018957|NCT03364309|541203640|FG015|Maintenance Period|Lost to Follow-up|0|||
150018958|NCT03364309|541203641|FG016|Maintenance Period|Lost to Follow-up|0|||
150018959|NCT03364309|541203642|FG017|Maintenance Period|Lost to Follow-up|0|||
150018960|NCT03364309|541203643|FG018|Maintenance Period|Lost to Follow-up|0|||
150018961|NCT03364309|541203625|FG000|Maintenance Period|Miscellaneous|0|||
150018962|NCT03364309|541203626|FG001|Maintenance Period|Miscellaneous|0|||
150018963|NCT03364309|541203627|FG002|Maintenance Period|Miscellaneous|0|||
150018964|NCT03364309|541203628|FG003|Maintenance Period|Miscellaneous|0|||
150018965|NCT03364309|541203629|FG004|Maintenance Period|Miscellaneous|0|||
150018966|NCT03364309|541203630|FG005|Maintenance Period|Miscellaneous|0|||
150018967|NCT03364309|541203631|FG006|Maintenance Period|Miscellaneous|0|||
150018968|NCT03364309|541203632|FG007|Maintenance Period|Miscellaneous|0|||
150018969|NCT03364309|541203633|FG008|Maintenance Period|Miscellaneous|1|||
150018970|NCT03364309|541203634|FG009|Maintenance Period|Miscellaneous|0|||
150018971|NCT03364309|541203635|FG010|Maintenance Period|Miscellaneous|0|||
150018972|NCT03364309|541203636|FG011|Maintenance Period|Miscellaneous|0|||
150018973|NCT03364309|541203637|FG012|Maintenance Period|Miscellaneous|0|||
150018974|NCT03364309|541203638|FG013|Maintenance Period|Miscellaneous|0|||
150018975|NCT03364309|541203639|FG014|Maintenance Period|Miscellaneous|0|||
150018976|NCT03364309|541203640|FG015|Maintenance Period|Miscellaneous|0|||
150018977|NCT03364309|541203641|FG016|Maintenance Period|Miscellaneous|0|||
150018978|NCT03364309|541203642|FG017|Maintenance Period|Miscellaneous|0|||
150018979|NCT03364309|541203643|FG018|Maintenance Period|Miscellaneous|0|||
150018980|NCT03364309|541203625|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018981|NCT03364309|541203626|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018982|NCT03364309|541203627|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018983|NCT03364309|541203628|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150059206|NCT00761150|541358509|FG001|Open-label Period|Adverse Event|0|||
150059207|NCT00761150|541358510|FG002|Open-label Period|Adverse Event|0|||
150059208|NCT00761150|541358508|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
150018984|NCT03364309|541203629|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018985|NCT03364309|541203630|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018986|NCT03364309|541203631|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018987|NCT03364309|541203632|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018988|NCT03364309|541203633|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150059209|NCT00761150|541358509|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
150018989|NCT03364309|541203634|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018990|NCT03364309|541203635|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018991|NCT03364309|541203636|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018992|NCT03364309|541203637|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018993|NCT03364309|541203638|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
150018994|NCT03364309|541203639|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
150018995|NCT03364309|541203640|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
150018996|NCT03364309|541203641|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018997|NCT03364309|541203642|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018998|NCT03364309|541203643|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
150018999|NCT03364309|541203625|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019000|NCT03364309|541203626|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019001|NCT03364309|541203627|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019002|NCT03364309|541203628|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019003|NCT03364309|541203629|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019004|NCT03364309|541203630|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019005|NCT03364309|541203631|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019006|NCT03364309|541203632|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019007|NCT03364309|541203633|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019008|NCT03364309|541203634|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019009|NCT03364309|541203635|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019010|NCT03364309|541203636|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019011|NCT03364309|541203637|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019012|NCT03364309|541203638|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019013|NCT03364309|541203639|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
150019014|NCT03364309|541203640|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019015|NCT03364309|541203641|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019016|NCT03364309|541203642|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019017|NCT03364309|541203643|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
150019018|NCT03364309|541203625|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
150019019|NCT03364309|541203626|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
150019020|NCT03364309|541203627|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
150019021|NCT03364309|541203628|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
150019022|NCT03364309|541203629|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
150019023|NCT03364309|541203630|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
150019024|NCT03364309|541203631|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
150019025|NCT03364309|541203632|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
150019026|NCT03364309|541203633|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
150019027|NCT03364309|541203634|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
150019028|NCT03364309|541203635|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
150019029|NCT03364309|541203636|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
150019030|NCT03364309|541203637|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
150019031|NCT03364309|541203638|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
150019032|NCT03364309|541203639|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
150019033|NCT03364309|541203640|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
150019034|NCT03364309|541203641|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
150019035|NCT03364309|541203642|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
150019036|NCT03364309|541203643|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
150019037|NCT03364309|541203625|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019038|NCT03364309|541203626|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019039|NCT03364309|541203627|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019040|NCT03364309|541203628|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019041|NCT03364309|541203629|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019042|NCT03364309|541203630|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019043|NCT03364309|541203631|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019044|NCT03364309|541203632|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019045|NCT03364309|541203633|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019046|NCT03364309|541203634|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019047|NCT03364309|541203635|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019048|NCT03364309|541203636|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019049|NCT03364309|541203637|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019050|NCT03364309|541203638|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019051|NCT03364309|541203639|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019052|NCT03364309|541203640|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
150019053|NCT03364309|541203641|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
150019054|NCT03364309|541203642|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
150019055|NCT03364309|541203643|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
150019056|NCT03364309|541203625|FG000|Post-Treatment Followup Period|Adverse Event|0|||
150019057|NCT03364309|541203626|FG001|Post-Treatment Followup Period|Adverse Event|0|||
150019058|NCT03364309|541203627|FG002|Post-Treatment Followup Period|Adverse Event|0|||
150019059|NCT03364309|541203628|FG003|Post-Treatment Followup Period|Adverse Event|0|||
150019060|NCT03364309|541203629|FG004|Post-Treatment Followup Period|Adverse Event|0|||
150019061|NCT03364309|541203630|FG005|Post-Treatment Followup Period|Adverse Event|0|||
150019062|NCT03364309|541203631|FG006|Post-Treatment Followup Period|Adverse Event|0|||
150019063|NCT03364309|541203632|FG007|Post-Treatment Followup Period|Adverse Event|0|||
150019064|NCT03364309|541203633|FG008|Post-Treatment Followup Period|Adverse Event|0|||
150059210|NCT00761150|541358510|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
150059211|NCT00761150|541358508|FG000|Open-label Period|Lost to Follow-up|7|||
150059212|NCT00761150|541358509|FG001|Open-label Period|Lost to Follow-up|0|||
150059213|NCT00761150|541358510|FG002|Open-label Period|Lost to Follow-up|0|||
150059214|NCT00761150|541358508|FG000|Open-label Period|Lack of Efficacy|4|||
150059215|NCT00761150|541358509|FG001|Open-label Period|Lack of Efficacy|0|||
150059216|NCT00761150|541358510|FG002|Open-label Period|Lack of Efficacy|0|||
150059217|NCT00761150|541358508|FG000|Open-label Period|Withdrawal by Subject|5|||
150059218|NCT00761150|541358509|FG001|Open-label Period|Withdrawal by Subject|0|||
150059219|NCT00761150|541358510|FG002|Open-label Period|Withdrawal by Subject|0|||
150181663|NCT02538341|541802819|FG001|Overall Study|Withdrawal by Subject|1|||
150181664|NCT02538341|541802818|FG000|Overall Study|Death|2|||
150181665|NCT02538341|541802819|FG001|Overall Study|Death|0|||
150181666|NCT02321514|541802820|FG000|Overall Study|Death|15|||
150181667|NCT02321514|541802820|FG000|Overall Study|Missed Visit|7|||
150181668|NCT02321514|541802820|FG000|Overall Study|Study Exit|3|||
150181669|NCT04732338|541802824|FG000|Overall Study|Lost to Follow-up|3|||
150181670|NCT04732338|541802825|FG001|Overall Study|Lost to Follow-up|3|||
150059220|NCT00761150|541358508|FG000|Open-label Period|Noncompliance|2|||
150059221|NCT00761150|541358509|FG001|Open-label Period|Noncompliance|0|||
150059222|NCT00761150|541358510|FG002|Open-label Period|Noncompliance|0|||
150059223|NCT00761150|541358508|FG000|Open-label Period|Other|5|||
150059224|NCT00761150|541358509|FG001|Open-label Period|Other|0|||
150059225|NCT00761150|541358510|FG002|Open-label Period|Other|0|||
150059226|NCT00761150|541358508|FG000|Double-blind Period|Lack of Efficacy|0|||
150059227|NCT00761150|541358509|FG001|Double-blind Period|Lack of Efficacy|2|||
150059228|NCT00761150|541358510|FG002|Double-blind Period|Lack of Efficacy|19|||
150059229|NCT00761150|541358508|FG000|Double-blind Period|Adverse Event|0|||
150059230|NCT00761150|541358509|FG001|Double-blind Period|Adverse Event|3|||
150059231|NCT00761150|541358510|FG002|Double-blind Period|Adverse Event|3|||
150059232|NCT00761150|541358508|FG000|Double-blind Period|Withdrawal by Subject|0|||
150059233|NCT00761150|541358509|FG001|Double-blind Period|Withdrawal by Subject|3|||
150059234|NCT00761150|541358510|FG002|Double-blind Period|Withdrawal by Subject|2|||
150059235|NCT00761150|541358508|FG000|Double-blind Period|Lost to Follow-up|0|||
150059236|NCT00761150|541358509|FG001|Double-blind Period|Lost to Follow-up|2|||
150059237|NCT00761150|541358510|FG002|Double-blind Period|Lost to Follow-up|1|||
150059238|NCT00761150|541358508|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
150059239|NCT00761150|541358509|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
150059240|NCT00761150|541358510|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
150059241|NCT00761150|541358508|FG000|Double-blind Period|Noncompliance|0|||
150059242|NCT00761150|541358509|FG001|Double-blind Period|Noncompliance|1|||
150059243|NCT00761150|541358510|FG002|Double-blind Period|Noncompliance|0|||
150059244|NCT00761150|541358508|FG000|Double-blind Period|Other|0|||
150059245|NCT00761150|541358509|FG001|Double-blind Period|Other|3|||
150059246|NCT00761150|541358510|FG002|Double-blind Period|Other|3|||
150059247|NCT00290407|541358511|FG000|Overall Study|Physician Decision|2|||
150059248|NCT01925989|541358520|FG000|Period 1|Sponsor Decision|1|||
150059249|NCT01925989|541358521|FG001|Period 1|Sponsor Decision|1|||
150059250|NCT01925989|541358522|FG002|Period 1|Sponsor Decision|0|||
150059251|NCT01925989|541358520|FG000|Period 1|Withdrawal by Subject|0|||
150059252|NCT01925989|541358521|FG001|Period 1|Withdrawal by Subject|1|||
150059253|NCT01925989|541358522|FG002|Period 1|Withdrawal by Subject|0|||
150059254|NCT00868517|541358523|FG000|Overall Study|Withdrawal by Subject|3|||
150059255|NCT00868517|541358524|FG001|Overall Study|Withdrawal by Subject|3|||
150059256|NCT00868517|541358525|FG002|Overall Study|Withdrawal by Subject|2|||
150059257|NCT00868517|541358523|FG000|Overall Study|Protocol Violation|1|||
150059258|NCT00868517|541358524|FG001|Overall Study|Protocol Violation|1|||
150059259|NCT00868517|541358525|FG002|Overall Study|Protocol Violation|0|||
150059260|NCT02496676|541358526|FG000|Phase 1 - Period 1|Adverse Event|0|||
150059261|NCT02496676|541358527|FG001|Phase 1 - Period 1|Adverse Event|1|||
150059262|NCT02496676|541358526|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
150059263|NCT02496676|541358527|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
150059264|NCT05442775|541358528|FG000|Overall Study|Trial terminated|61|||
150059265|NCT05442775|541358528|FG000|Overall Study|Lack of Efficacy|4|||
150181671|NCT00088413|541802829|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
150181672|NCT00088413|541802830|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
150059266|NCT05442775|541358528|FG000|Overall Study|Withdrawal by Subject|4|||
150059267|NCT05442775|541358528|FG000|Overall Study|Death|1|||
150059268|NCT05442775|541358528|FG000|Overall Study|Participant removed at Sponsor request|1|||
150059269|NCT02106923|541358539|FG000|Overall Study|Protocol Violation|0|||
150059270|NCT02106923|541358540|FG001|Overall Study|Protocol Violation|0|||
150059271|NCT02106923|541358541|FG002|Overall Study|Protocol Violation|0|||
150059272|NCT02106923|541358542|FG003|Overall Study|Protocol Violation|0|||
150059273|NCT02106923|541358543|FG004|Overall Study|Protocol Violation|0|||
150059274|NCT02106923|541358544|FG005|Overall Study|Protocol Violation|1|||
150059275|NCT03579602|541358547|FG000|Overall Study|Subject unable to receive study drug|0|||
150059276|NCT03579602|541358548|FG001|Overall Study|Subject unable to receive study drug|2|||
150059277|NCT03579602|541358547|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
150059278|NCT03579602|541358548|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
150059279|NCT02889562|541358552|FG000|Overall Study|Physician Decision|0|||
150019065|NCT03364309|541203634|FG009|Post-Treatment Followup Period|Adverse Event|0|||
150019066|NCT03364309|541203635|FG010|Post-Treatment Followup Period|Adverse Event|0|||
150019067|NCT03364309|541203636|FG011|Post-Treatment Followup Period|Adverse Event|0|||
150019068|NCT03364309|541203637|FG012|Post-Treatment Followup Period|Adverse Event|0|||
150019069|NCT03364309|541203638|FG013|Post-Treatment Followup Period|Adverse Event|0|||
150019070|NCT03364309|541203639|FG014|Post-Treatment Followup Period|Adverse Event|0|||
150019071|NCT03364309|541203640|FG015|Post-Treatment Followup Period|Adverse Event|0|||
150019072|NCT03364309|541203641|FG016|Post-Treatment Followup Period|Adverse Event|2|||
150019073|NCT03364309|541203642|FG017|Post-Treatment Followup Period|Adverse Event|6|||
150019074|NCT03364309|541203643|FG018|Post-Treatment Followup Period|Adverse Event|1|||
150019075|NCT03364309|541203625|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019076|NCT03364309|541203626|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019077|NCT03364309|541203627|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019078|NCT03364309|541203628|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
150059280|NCT02889562|541358553|FG001|Overall Study|Physician Decision|1|||
150019079|NCT03364309|541203629|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019080|NCT03364309|541203630|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019081|NCT03364309|541203631|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019082|NCT03364309|541203632|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019083|NCT03364309|541203633|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019084|NCT03364309|541203634|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019085|NCT03364309|541203635|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
150059281|NCT02889562|541358552|FG000|Overall Study|Withdrawal by Subject|0|||
150019086|NCT03364309|541203636|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019087|NCT03364309|541203637|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019088|NCT03364309|541203638|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019089|NCT03364309|541203639|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019090|NCT03364309|541203640|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019091|NCT03364309|541203641|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019092|NCT03364309|541203642|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
150059282|NCT02889562|541358553|FG001|Overall Study|Withdrawal by Subject|1|||
150059283|NCT01470989|541358556|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
150059284|NCT01470989|541358557|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
150059285|NCT01470989|541358556|FG000|Overall Study|Adverse Event|2|||
150059286|NCT01470989|541358557|FG001|Overall Study|Adverse Event|5|||
150059287|NCT01470989|541358556|FG000|Overall Study|Abnormal laboratory value|1|||
150059288|NCT01470989|541358557|FG001|Overall Study|Abnormal laboratory value|1|||
150059289|NCT01470989|541358556|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150059290|NCT01470989|541358557|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
150059291|NCT01470989|541358556|FG000|Overall Study|Withdrawal by Subject|19|||
150059292|NCT01470989|541358557|FG001|Overall Study|Withdrawal by Subject|17|||
150059293|NCT01470989|541358556|FG000|Overall Study|Lost to Follow-up|18|||
150059294|NCT01470989|541358557|FG001|Overall Study|Lost to Follow-up|13|||
150059295|NCT01470989|541358556|FG000|Overall Study|Administrative problems|2|||
150181673|NCT00088413|541802831|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
150181674|NCT00088413|541802832|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
150059296|NCT01470989|541358557|FG001|Overall Study|Administrative problems|4|||
150059297|NCT01470989|541358556|FG000|Overall Study|Death|2|||
150059298|NCT01470989|541358557|FG001|Overall Study|Death|2|||
150019093|NCT03364309|541203643|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
150019094|NCT03364309|541203625|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
150019095|NCT03364309|541203626|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
150019096|NCT03364309|541203627|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
150019097|NCT03364309|541203628|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
150019098|NCT03364309|541203629|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
150019099|NCT03364309|541203630|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
150019100|NCT03364309|541203631|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
150019101|NCT03364309|541203632|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
150019102|NCT03364309|541203633|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
150019103|NCT03364309|541203634|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
150019104|NCT03364309|541203635|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
150019105|NCT03364309|541203636|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
150019106|NCT03364309|541203637|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
150019107|NCT03364309|541203638|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
150019108|NCT03364309|541203639|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
150019109|NCT03364309|541203640|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
150019110|NCT03364309|541203641|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
150019111|NCT03364309|541203642|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
150019112|NCT03364309|541203643|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
150019113|NCT00615992|541203644|FG000|Overall Study|Protocol Violation|67|||
150019114|NCT02328027|541203645|FG000|Overall Study|Withdrawal by Subject|0|||
150019115|NCT02328027|541203646|FG001|Overall Study|Withdrawal by Subject|1|||
150019116|NCT03319212|541203647|FG000|Overall Study|Discontinued as moving out of local area|0|||
150019117|NCT03319212|541203648|FG001|Overall Study|Discontinued as moving out of local area|1|||
150019118|NCT03319212|541203647|FG000|Overall Study|Adverse Event|2|||
150019119|NCT03319212|541203648|FG001|Overall Study|Adverse Event|2|||
150019120|NCT03319212|541203647|FG000|Overall Study|Withdrawal by Subject|0|||
150019121|NCT03319212|541203648|FG001|Overall Study|Withdrawal by Subject|1|||
150019122|NCT03319212|541203647|FG000|Overall Study|Lost to Follow-up|0|||
150019123|NCT03319212|541203648|FG001|Overall Study|Lost to Follow-up|1|||
150019124|NCT03319212|541203647|FG000|Overall Study|Physician Decision|1|||
150019125|NCT03319212|541203648|FG001|Overall Study|Physician Decision|0|||
150019126|NCT02465203|541203650|FG000|Overall Study|Protocol Violation|1|||
150019127|NCT02465203|541203651|FG001|Overall Study|Protocol Violation|1|||
150019128|NCT02465203|541203652|FG002|Overall Study|Protocol Violation|1|||
150019129|NCT02465203|541203650|FG000|Overall Study|Study terminated by sponsor|50|||
150019130|NCT02465203|541203651|FG001|Overall Study|Study terminated by sponsor|34|||
150019131|NCT02465203|541203652|FG002|Overall Study|Study terminated by sponsor|11|||
150059299|NCT01470989|541358556|FG000|Overall Study|Protocol deviation|1|||
150059300|NCT01470989|541358557|FG001|Overall Study|Protocol deviation|2|||
150059301|NCT00969280|541358558|FG000|Overall Study|Protocol Violation|2|||
150059302|NCT00969280|541358559|FG001|Overall Study|Protocol Violation|1|||
150059303|NCT00969280|541358558|FG000|Overall Study|Withdrawal by Subject|0|||
150059304|NCT00969280|541358559|FG001|Overall Study|Withdrawal by Subject|1|||
150059305|NCT00969280|541358558|FG000|Overall Study|infection of influenza A(H1N1)|0|||
150059306|NCT00969280|541358559|FG001|Overall Study|infection of influenza A(H1N1)|1|||
150059307|NCT00217464|541358560|FG000|Overall Study|Progression|15|||
150181675|NCT00088413|541802829|FG000|Overall Study|Adverse Events/Side Effects|0|||
150019132|NCT02465203|541203650|FG000|Overall Study|New therapy for study indication|4|||
150019133|NCT02465203|541203651|FG001|Overall Study|New therapy for study indication|0|||
150019134|NCT02465203|541203652|FG002|Overall Study|New therapy for study indication|0|||
150019135|NCT02465203|541203650|FG000|Overall Study|Patient/guardian decision|1|||
150019136|NCT02465203|541203651|FG001|Overall Study|Patient/guardian decision|1|||
150019137|NCT02465203|541203652|FG002|Overall Study|Patient/guardian decision|1|||
150019138|NCT04072887|541203657|FG000|Overall Study|Withdrawal by Subject|3|||
150059308|NCT00217464|541358560|FG000|Overall Study|Other|2|||
150059309|NCT00459979|541358561|FG000|Overall Study|Withdrawal by Subject|1|||
150019139|NCT04072887|541203658|FG001|Overall Study|Withdrawal by Subject|8|||
150019140|NCT04072887|541203659|FG002|Overall Study|Withdrawal by Subject|1|||
150019141|NCT04072887|541203660|FG003|Overall Study|Withdrawal by Subject|3|||
150019142|NCT04072887|541203661|FG004|Overall Study|Withdrawal by Subject|3|||
150059310|NCT00459979|541358561|FG000|Overall Study|Protocol Violation|1|||
150019143|NCT04072887|541203662|FG005|Overall Study|Withdrawal by Subject|13|||
150059311|NCT00989573|541358562|FG000|Overall Study|Adverse Event|8|||
150019144|NCT04072887|541203657|FG000|Overall Study|Adverse Event|2|||
150019145|NCT04072887|541203658|FG001|Overall Study|Adverse Event|4|||
150019146|NCT04072887|541203659|FG002|Overall Study|Adverse Event|1|||
150019147|NCT04072887|541203660|FG003|Overall Study|Adverse Event|4|||
150019148|NCT04072887|541203661|FG004|Overall Study|Adverse Event|0|||
150019149|NCT04072887|541203662|FG005|Overall Study|Adverse Event|1|||
150019150|NCT04072887|541203657|FG000|Overall Study|Physician Decision|2|||
150019151|NCT04072887|541203658|FG001|Overall Study|Physician Decision|0|||
150019152|NCT04072887|541203659|FG002|Overall Study|Physician Decision|0|||
150019153|NCT04072887|541203660|FG003|Overall Study|Physician Decision|0|||
150019154|NCT04072887|541203661|FG004|Overall Study|Physician Decision|0|||
150019155|NCT04072887|541203662|FG005|Overall Study|Physician Decision|1|||
150019156|NCT04072887|541203657|FG000|Overall Study|Lost to Follow-up|1|||
150019157|NCT04072887|541203658|FG001|Overall Study|Lost to Follow-up|3|||
150019158|NCT04072887|541203659|FG002|Overall Study|Lost to Follow-up|0|||
150019159|NCT04072887|541203660|FG003|Overall Study|Lost to Follow-up|0|||
150019160|NCT04072887|541203661|FG004|Overall Study|Lost to Follow-up|0|||
150019161|NCT04072887|541203662|FG005|Overall Study|Lost to Follow-up|0|||
150019162|NCT04072887|541203657|FG000|Overall Study|Death|0|||
150019163|NCT04072887|541203658|FG001|Overall Study|Death|2|||
150019164|NCT04072887|541203659|FG002|Overall Study|Death|0|||
150019165|NCT04072887|541203660|FG003|Overall Study|Death|2|||
150019166|NCT04072887|541203661|FG004|Overall Study|Death|3|||
150019167|NCT04072887|541203662|FG005|Overall Study|Death|0|||
150019168|NCT03193736|541203663|FG000|Overall Study|Death|2|||
150019169|NCT03193736|541203663|FG000|Overall Study|Withdrawal by Subject|1|||
150019170|NCT03193736|541203663|FG000|Overall Study|Lost to Follow-up|1|||
150019171|NCT03193736|541203663|FG000|Overall Study|implant not received|1|||
150019172|NCT00856297|541203664|FG000|Overall Study|Unable to classify|2|||
150019173|NCT00856297|541203665|FG001|Overall Study|Unable to classify|0|||
150019174|NCT00856297|541203666|FG002|Overall Study|Unable to classify|0|||
150019175|NCT00856297|541203667|FG003|Overall Study|Unable to classify|0|||
150019176|NCT00856297|541203668|FG004|Overall Study|Unable to classify|0|||
150019177|NCT03369236|541203669|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
150019178|NCT03369236|541203670|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
150019179|NCT03369236|541203669|FG000|Open-label Extension Period|Lack of Efficacy|2|||
150019180|NCT03369236|541203670|FG001|Open-label Extension Period|Lack of Efficacy|1|||
150019181|NCT03369236|541203669|FG000|Open-label Extension Period|Adverse Event|0|||
150019182|NCT03369236|541203670|FG001|Open-label Extension Period|Adverse Event|1|||
150019183|NCT03369236|541203669|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
150019184|NCT03369236|541203670|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
150019185|NCT00423449|541203673|FG000|Overall Study|Clinical Adverse Event|1|||
150019186|NCT00423449|541203674|FG001|Overall Study|Clinical Adverse Event|0|||
150019187|NCT00423449|541203675|FG002|Overall Study|Clinical Adverse Event|1|||
150019188|NCT00423449|541203676|FG003|Overall Study|Clinical Adverse Event|8|||
150019189|NCT00423449|541203677|FG004|Overall Study|Clinical Adverse Event|2|||
150019190|NCT00423449|541203673|FG000|Overall Study|Death|1|||
150019191|NCT00423449|541203674|FG001|Overall Study|Death|0|||
150019192|NCT00423449|541203675|FG002|Overall Study|Death|2|||
150019193|NCT00423449|541203676|FG003|Overall Study|Death|1|||
150019194|NCT00423449|541203677|FG004|Overall Study|Death|1|||
150019195|NCT00423449|541203673|FG000|Overall Study|Progressive Disease|1|||
150019196|NCT00423449|541203674|FG001|Overall Study|Progressive Disease|3|||
150019197|NCT00423449|541203675|FG002|Overall Study|Progressive Disease|8|||
150019198|NCT00423449|541203676|FG003|Overall Study|Progressive Disease|11|||
150019199|NCT00423449|541203677|FG004|Overall Study|Progressive Disease|4|||
150019200|NCT00423449|541203673|FG000|Overall Study|Laboratory Adverse Event|0|||
150019201|NCT00423449|541203674|FG001|Overall Study|Laboratory Adverse Event|1|||
150019202|NCT00423449|541203675|FG002|Overall Study|Laboratory Adverse Event|2|||
150019203|NCT00423449|541203676|FG003|Overall Study|Laboratory Adverse Event|0|||
150019204|NCT00423449|541203677|FG004|Overall Study|Laboratory Adverse Event|0|||
150019205|NCT00423449|541203673|FG000|Overall Study|Other|0|||
150019206|NCT00423449|541203674|FG001|Overall Study|Other|0|||
150019207|NCT00423449|541203675|FG002|Overall Study|Other|0|||
150019208|NCT00423449|541203676|FG003|Overall Study|Other|1|||
150019209|NCT00423449|541203677|FG004|Overall Study|Other|0|||
150019210|NCT00423449|541203673|FG000|Overall Study|Protocol Violation|0|||
150019211|NCT00423449|541203674|FG001|Overall Study|Protocol Violation|0|||
150019212|NCT00423449|541203675|FG002|Overall Study|Protocol Violation|2|||
150019213|NCT00423449|541203676|FG003|Overall Study|Protocol Violation|1|||
150019214|NCT00423449|541203677|FG004|Overall Study|Protocol Violation|0|||
150019215|NCT01153724|541203684|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150019216|NCT01153724|541203684|FG000|Treatment Period 2|Adverse Event|1|||
150019217|NCT01153724|541203684|FG000|Treatment Period 2|Other reason not defined above|1|||
150019218|NCT02697435|541203685|FG000|Overall Study|Withdrawal by Subject|1|||
150019219|NCT02697435|541203686|FG001|Overall Study|Withdrawal by Subject|0|||
150019220|NCT02697435|541203685|FG000|Overall Study|Physician Decision|0|||
150019221|NCT02697435|541203686|FG001|Overall Study|Physician Decision|4|||
150019222|NCT02508428|541203690|FG000|Overall Study|Death|32|||
150019223|NCT02508428|541203691|FG001|Overall Study|Death|33|||
150019224|NCT02508428|541203690|FG000|Overall Study|Liner revised|3|||
150019225|NCT02508428|541203691|FG001|Overall Study|Liner revised|19|||
150019226|NCT02508428|541203690|FG000|Overall Study|Incomplete follow-up|17|||
150019227|NCT02508428|541203691|FG001|Overall Study|Incomplete follow-up|15|||
150019228|NCT04371666|541203694|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
150019229|NCT04371666|541203695|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
150019230|NCT04371666|541203694|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
150019231|NCT04371666|541203695|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
150019232|NCT04371666|541203694|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
150019233|NCT04371666|541203695|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
150019234|NCT04371666|541203694|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
150019235|NCT04371666|541203695|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
150019236|NCT04371666|541203694|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
150019237|NCT04371666|541203695|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
150019238|NCT04371666|541203694|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
150019239|NCT04371666|541203695|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
150019240|NCT03228212|541203696|FG000|Period 1|Adverse Event|1|||
150019241|NCT03228212|541203697|FG001|Period 1|Adverse Event|0|||
150019242|NCT03228212|541203696|FG000|Period 1|no longer meets eligibility criteria|0|||
150019243|NCT03228212|541203697|FG001|Period 1|no longer meets eligibility criteria|1|||
150019244|NCT03228212|541203696|FG000|Period 2|Lost to Follow-up|1|||
150019245|NCT03228212|541203697|FG001|Period 2|Lost to Follow-up|0|||
150019246|NCT00999544|541205328|FG000|Overall Study|Withdrawal by Subject|1|||
150019247|NCT01392547|541205329|FG000|Overall Study|Adverse Event|2|||
150019248|NCT01392547|541205329|FG000|Overall Study|Non-compliance|2|||
150019249|NCT01392547|541205329|FG000|Overall Study|Withdrawal criteria|3|||
150019250|NCT01392547|541205329|FG000|Overall Study|Unclassified|1|||
150019251|NCT02936635|541205330|FG000|Overall Study|Adverse Event|43|||
150019252|NCT02936635|541205331|FG001|Overall Study|Adverse Event|25|||
150019253|NCT02936635|541205330|FG000|Overall Study|Progressive Disease|10|||
150019254|NCT02936635|541205331|FG001|Overall Study|Progressive Disease|18|||
150019255|NCT02936635|541205330|FG000|Overall Study|Sponsor Discretion|10|||
150019256|NCT02936635|541205331|FG001|Overall Study|Sponsor Discretion|16|||
150019257|NCT02936635|541205330|FG000|Overall Study|Death|9|||
150019258|NCT02936635|541205331|FG001|Overall Study|Death|15|||
150019259|NCT02936635|541205330|FG000|Overall Study|Withdrawal by Subject|8|||
150019260|NCT02936635|541205331|FG001|Overall Study|Withdrawal by Subject|15|||
150019261|NCT02936635|541205330|FG000|Overall Study|Physician Decision|2|||
150019262|NCT02936635|541205331|FG001|Overall Study|Physician Decision|9|||
150019263|NCT02936635|541205330|FG000|Overall Study|Lost to Follow-up|1|||
150019264|NCT02936635|541205331|FG001|Overall Study|Lost to Follow-up|2|||
150019265|NCT02936635|541205330|FG000|Overall Study|Protocol Violation|1|||
150019266|NCT02936635|541205331|FG001|Overall Study|Protocol Violation|0|||
150019267|NCT02936635|541205330|FG000|Overall Study|Lack of effect/Entry into other study|31|||
150019268|NCT02936635|541205331|FG001|Overall Study|Lack of effect/Entry into other study|65|||
150019269|NCT00447226|541205332|FG000|12-Week Open-label Phase|Adverse Event|0|||
150019270|NCT00447226|541205333|FG001|12-Week Open-label Phase|Adverse Event|3|||
150019271|NCT00447226|541205332|FG000|12-Week Open-label Phase|Protocol Violation|0|||
150019272|NCT00447226|541205333|FG001|12-Week Open-label Phase|Protocol Violation|1|||
150019273|NCT00447226|541205332|FG000|12-Week Open-label Phase|Disease Progression|0|||
150019274|NCT00447226|541205333|FG001|12-Week Open-label Phase|Disease Progression|20|||
150019275|NCT00447226|541205332|FG000|12-Week Open-label Phase|Physician Decision|0|||
150019276|NCT00447226|541205333|FG001|12-Week Open-label Phase|Physician Decision|1|||
150019277|NCT00447226|541205332|FG000|Double-blind Phase|Disease Progression|4|||
150019278|NCT00447226|541205333|FG001|Double-blind Phase|Disease Progression|3|||
150019279|NCT00584012|541205341|FG000|Overall Study|Withdrawal by Subject|1|||
150019280|NCT04404556|541205342|FG000|Intervention|Withdrawal by Subject|15|||
150019281|NCT04404556|541205343|FG001|Intervention|Withdrawal by Subject|3|||
150019282|NCT04404556|541205342|FG000|Intervention|Did not complete all intervention sessions|2|||
150019283|NCT04404556|541205343|FG001|Intervention|Did not complete all intervention sessions|1|||
150019284|NCT04404556|541205342|FG000|Post-Intervention|Missing Data|1|||
150019285|NCT04404556|541205343|FG001|Post-Intervention|Missing Data|2|||
150181676|NCT00088413|541802830|FG001|Overall Study|Adverse Events/Side Effects|1|||
150019286|NCT04404556|541205342|FG000|Follow-up 1|Withdrawal by Subject|5|||
150019287|NCT04404556|541205343|FG001|Follow-up 1|Withdrawal by Subject|1|||
150019288|NCT04404556|541205342|FG000|Follow-up 1|Missing Data|4|||
150019289|NCT04404556|541205343|FG001|Follow-up 1|Missing Data|7|||
150019290|NCT04404556|541205342|FG000|Follow-up 2|Withdrawal by Subject|1|||
150019291|NCT04404556|541205343|FG001|Follow-up 2|Withdrawal by Subject|1|||
150019292|NCT04404556|541205342|FG000|Follow-up 2|Missing Data|6|||
150019293|NCT04404556|541205343|FG001|Follow-up 2|Missing Data|5|||
150181677|NCT00088413|541802831|FG002|Overall Study|Adverse Events/Side Effects|1|||
150181678|NCT00088413|541802832|FG003|Overall Study|Adverse Events/Side Effects|0|||
150019294|NCT02871635|541205344|FG000|Overall Study|Primary lack of efficacy|4|||
150019295|NCT02871635|541205345|FG001|Overall Study|Primary lack of efficacy|4|||
150019296|NCT02871635|541205344|FG000|Overall Study|Protocol Violation|3|||
150019297|NCT02871635|541205345|FG001|Overall Study|Protocol Violation|1|||
150019298|NCT02871635|541205344|FG000|Overall Study|Lost to Follow-up|1|||
150019299|NCT02871635|541205345|FG001|Overall Study|Lost to Follow-up|2|||
150019300|NCT02871635|541205344|FG000|Overall Study|Pregnancy|0|||
150019301|NCT02871635|541205345|FG001|Overall Study|Pregnancy|2|||
150019302|NCT02871635|541205344|FG000|Overall Study|Physician Decision|1|||
150019303|NCT02871635|541205345|FG001|Overall Study|Physician Decision|1|||
150019304|NCT02871635|541205344|FG000|Overall Study|Withdrawal by Subject|3|||
150019305|NCT02871635|541205345|FG001|Overall Study|Withdrawal by Subject|4|||
150019306|NCT02871635|541205344|FG000|Overall Study|Adverse Event|4|||
150019307|NCT02871635|541205345|FG001|Overall Study|Adverse Event|4|||
150019308|NCT02871635|541205344|FG000|Overall Study|Secondary lack of efficacy|2|||
150019309|NCT02871635|541205345|FG001|Overall Study|Secondary lack of efficacy|1|||
150019310|NCT00502671|541205346|FG000|Overall Study|Disease Progression|13|||
150019311|NCT00502671|541205346|FG000|Overall Study|Personal Reasons|22|||
150019312|NCT00502671|541205346|FG000|Overall Study|Lost to Follow-up|7|||
150019313|NCT00502671|541205346|FG000|Overall Study|Protocol Violation|16|||
150019314|NCT00502671|541205346|FG000|Overall Study|Adverse Event|19|||
150019315|NCT00681629|541205347|FG000|Overall Study|Study termination|4|||
150019316|NCT00681629|541205348|FG001|Overall Study|Study termination|2|||
150019317|NCT00681629|541205347|FG000|Overall Study|Adverse Event|1|||
150019318|NCT00681629|541205348|FG001|Overall Study|Adverse Event|0|||
150019319|NCT01510158|541205350|FG000|Overall Study|Adverse Event|7|||
150019320|NCT01510158|541205351|FG001|Overall Study|Adverse Event|8|||
150019321|NCT01510158|541205352|FG002|Overall Study|Adverse Event|5|||
150019322|NCT01510158|541205350|FG000|Overall Study|Gout flare|1|||
150019323|NCT01510158|541205351|FG001|Overall Study|Gout flare|0|||
150019324|NCT01510158|541205352|FG002|Overall Study|Gout flare|0|||
150019325|NCT01510158|541205350|FG000|Overall Study|Protocol Violation|17|||
150019326|NCT01510158|541205351|FG001|Overall Study|Protocol Violation|16|||
150019327|NCT01510158|541205352|FG002|Overall Study|Protocol Violation|24|||
150019328|NCT01510158|541205350|FG000|Overall Study|Sponsor terminated study.|2|||
150019329|NCT01510158|541205351|FG001|Overall Study|Sponsor terminated study.|0|||
150019330|NCT01510158|541205352|FG002|Overall Study|Sponsor terminated study.|2|||
150019331|NCT01510158|541205350|FG000|Overall Study|Lost to Follow-up|13|||
150019332|NCT01510158|541205351|FG001|Overall Study|Lost to Follow-up|16|||
150019333|NCT01510158|541205352|FG002|Overall Study|Lost to Follow-up|9|||
150019334|NCT01510158|541205350|FG000|Overall Study|Withdrawal by Subject|10|||
150019335|NCT01510158|541205351|FG001|Overall Study|Withdrawal by Subject|13|||
150019336|NCT01510158|541205352|FG002|Overall Study|Withdrawal by Subject|10|||
150019337|NCT01510158|541205350|FG000|Overall Study|Death|1|||
150019338|NCT01510158|541205351|FG001|Overall Study|Death|0|||
150019339|NCT01510158|541205352|FG002|Overall Study|Death|0|||
150019340|NCT00832416|541205353|FG000|Overall Study|Lack of Efficacy|17|||
150019341|NCT00832416|541205354|FG001|Overall Study|Lack of Efficacy|15|||
150019342|NCT00832416|541205355|FG002|Overall Study|Lack of Efficacy|13|||
150019343|NCT00832416|541205356|FG003|Overall Study|Lack of Efficacy|52|||
150181679|NCT00088413|541802829|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
150059312|NCT00989573|541358563|FG001|Overall Study|Adverse Event|12|||
150019344|NCT00832416|541205353|FG000|Overall Study|Withdrawal by Subject|5|||
150019345|NCT00832416|541205354|FG001|Overall Study|Withdrawal by Subject|7|||
150019346|NCT00832416|541205355|FG002|Overall Study|Withdrawal by Subject|2|||
150019347|NCT00832416|541205356|FG003|Overall Study|Withdrawal by Subject|10|||
150019348|NCT00832416|541205353|FG000|Overall Study|Physician Decision|2|||
150019349|NCT00832416|541205354|FG001|Overall Study|Physician Decision|12|||
150019350|NCT00832416|541205355|FG002|Overall Study|Physician Decision|5|||
150019351|NCT00832416|541205356|FG003|Overall Study|Physician Decision|10|||
150019352|NCT00832416|541205353|FG000|Overall Study|Administrative|0|||
150019353|NCT00832416|541205354|FG001|Overall Study|Administrative|0|||
150019354|NCT00832416|541205355|FG002|Overall Study|Administrative|0|||
150019355|NCT00832416|541205356|FG003|Overall Study|Administrative|1|||
150019356|NCT00832416|541205353|FG000|Overall Study|Adverse Event|21|||
150019357|NCT00832416|541205354|FG001|Overall Study|Adverse Event|19|||
150019358|NCT00832416|541205355|FG002|Overall Study|Adverse Event|41|||
150019359|NCT00832416|541205356|FG003|Overall Study|Adverse Event|10|||
150019360|NCT00832416|541205353|FG000|Overall Study|Death|1|||
150019361|NCT00832416|541205354|FG001|Overall Study|Death|0|||
150019362|NCT00832416|541205355|FG002|Overall Study|Death|0|||
150019363|NCT00832416|541205356|FG003|Overall Study|Death|0|||
150019364|NCT02114606|541205357|FG000|Overall Study|Unable to swallow Cytosponge|6|||
150019365|NCT05786508|541205358|FG000|Overall Study|Withdrawal by Subject|2|||
150019366|NCT05786508|541205359|FG001|Overall Study|Withdrawal by Subject|0|||
150019367|NCT04426318|541205360|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
150019368|NCT04426318|541205361|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
150019369|NCT04829916|541205362|FG000|Overall Study|Withdrawal by Subject|1|||
150019370|NCT04829916|541205363|FG001|Overall Study|Withdrawal by Subject|0|||
150019371|NCT03781778|541205365|FG000|Overall Study|Withdrawal by Subject|2|||
150019372|NCT03781778|541205366|FG001|Overall Study|Withdrawal by Subject|2|||
150019373|NCT02287467|541205367|FG000|Overall Study|Protocol Violation|12|||
150019374|NCT02287467|541205368|FG001|Overall Study|Protocol Violation|9|||
150019375|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Technical problems|0|||
150019376|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Technical problems|0|||
150019377|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Technical problems|0|||
150019378|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Technical problems|1|||
150019379|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
150019380|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
150019381|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
150019382|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
150019383|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
150019384|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
150019385|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
150019386|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
150019387|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
150019388|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
150019389|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
150019390|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
150019391|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Death|0|||
150019392|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Death|3|||
150019393|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Death|1|||
150019394|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Death|0|||
150019395|NCT02152761|541205372|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
150019396|NCT02152761|541205373|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
150019397|NCT02152761|541205374|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
150019398|NCT02152761|541205375|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
150019399|NCT02152761|541205372|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
150019400|NCT02152761|541205373|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
150019401|NCT02152761|541205374|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
150019402|NCT02152761|541205375|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
150019403|NCT02152761|541205372|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
150019404|NCT02152761|541205373|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
150019405|NCT02152761|541205374|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
150019406|NCT02152761|541205375|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
150019407|NCT02152761|541205372|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
150019408|NCT02152761|541205373|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
150019409|NCT02152761|541205374|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
150019410|NCT02152761|541205375|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
150019411|NCT02152761|541205372|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
150019412|NCT02152761|541205373|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
150019413|NCT02152761|541205374|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
150019414|NCT02152761|541205375|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
150019415|NCT04343755|541205376|FG000|Overall Study|Death|11|||
150019416|NCT04343755|541205376|FG000|Overall Study|Screen Failure|1|||
150019417|NCT01290757|541205381|FG000|Overall Study|Adverse Event|1|||
150019418|NCT01290757|541205382|FG001|Overall Study|Adverse Event|0|||
150019419|NCT01290757|541205381|FG000|Overall Study|Protocol Violation|1|||
150019420|NCT01290757|541205382|FG001|Overall Study|Protocol Violation|1|||
150019421|NCT01290757|541205381|FG000|Overall Study|Other|0|||
150019422|NCT01290757|541205382|FG001|Overall Study|Other|1|||
150019423|NCT02021643|541205384|FG000|Overall Study|Enrolled but Never Treated|1|||
150019424|NCT02021643|541205385|FG001|Overall Study|Enrolled but Never Treated|0|||
150019425|NCT02021643|541205386|FG002|Overall Study|Enrolled but Never Treated|0|||
150019426|NCT02021643|541205387|FG003|Overall Study|Enrolled but Never Treated|0|||
150019427|NCT02021643|541205384|FG000|Overall Study|Adverse Event|0|||
150019428|NCT02021643|541205385|FG001|Overall Study|Adverse Event|1|||
150019429|NCT02021643|541205386|FG002|Overall Study|Adverse Event|0|||
150019430|NCT02021643|541205387|FG003|Overall Study|Adverse Event|0|||
150019431|NCT02021643|541205384|FG000|Overall Study|Death|0|||
150019432|NCT02021643|541205385|FG001|Overall Study|Death|1|||
150019433|NCT02021643|541205386|FG002|Overall Study|Death|0|||
150019434|NCT02021643|541205387|FG003|Overall Study|Death|0|||
150019435|NCT02021643|541205384|FG000|Overall Study|Investigator's Discretion|1|||
150019436|NCT02021643|541205385|FG001|Overall Study|Investigator's Discretion|0|||
150019437|NCT02021643|541205386|FG002|Overall Study|Investigator's Discretion|0|||
150019438|NCT02021643|541205387|FG003|Overall Study|Investigator's Discretion|0|||
150019439|NCT02021643|541205384|FG000|Overall Study|Lack of Efficacy|7|||
150019440|NCT02021643|541205385|FG001|Overall Study|Lack of Efficacy|6|||
150019441|NCT02021643|541205386|FG002|Overall Study|Lack of Efficacy|0|||
150019442|NCT02021643|541205387|FG003|Overall Study|Lack of Efficacy|12|||
150019443|NCT02021643|541205384|FG000|Overall Study|Lost to Follow-up|0|||
150019444|NCT02021643|541205385|FG001|Overall Study|Lost to Follow-up|1|||
150019445|NCT02021643|541205386|FG002|Overall Study|Lost to Follow-up|0|||
150019446|NCT02021643|541205387|FG003|Overall Study|Lost to Follow-up|0|||
150019447|NCT02021643|541205384|FG000|Overall Study|Withdrew Consent|0|||
150019448|NCT02021643|541205385|FG001|Overall Study|Withdrew Consent|1|||
150019449|NCT02021643|541205386|FG002|Overall Study|Withdrew Consent|0|||
150019450|NCT02021643|541205387|FG003|Overall Study|Withdrew Consent|0|||
150019451|NCT05280717|541205390|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
150019452|NCT05280717|541205391|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
150019453|NCT05280717|541205392|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
150019454|NCT05280717|541205393|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
150019455|NCT05280717|541205394|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
150019456|NCT05280717|541205395|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
150019457|NCT05280717|541205396|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
150019458|NCT05280717|541205390|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
150019459|NCT05280717|541205391|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019460|NCT05280717|541205392|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019461|NCT05280717|541205393|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019462|NCT05280717|541205394|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019463|NCT05280717|541205395|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019464|NCT05280717|541205396|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
150019465|NCT05280717|541205390|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019466|NCT05280717|541205391|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
150019467|NCT05280717|541205392|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019468|NCT05280717|541205393|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019469|NCT05280717|541205394|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019470|NCT05280717|541205395|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019471|NCT05280717|541205396|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
150019472|NCT05280717|541205390|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019473|NCT05280717|541205391|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019474|NCT05280717|541205392|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
150019475|NCT05280717|541205393|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019476|NCT05280717|541205394|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019477|NCT05280717|541205395|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019478|NCT05280717|541205396|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
150019479|NCT05280717|541205390|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019480|NCT05280717|541205391|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019481|NCT05280717|541205392|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019482|NCT05280717|541205393|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019483|NCT05280717|541205394|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019484|NCT05280717|541205395|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
150019485|NCT05280717|541205396|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
150019486|NCT05280717|541205390|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150019487|NCT05280717|541205391|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150059313|NCT00989573|541358564|FG002|Overall Study|Adverse Event|4|||
150019488|NCT05280717|541205392|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150019489|NCT05280717|541205393|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150019490|NCT05280717|541205394|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150019491|NCT05280717|541205395|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
150019492|NCT05280717|541205396|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
150019493|NCT05888181|541205399|FG000|Overall Study|Lost to Follow-up|1|||
150019494|NCT05888181|541205400|FG001|Overall Study|Lost to Follow-up|1|||
150019495|NCT05888181|541205401|FG002|Overall Study|Lost to Follow-up|0|||
150019496|NCT04300309|541205405|FG000|Overall Study|Lost to Follow-up|1|||
150019497|NCT04300309|541205406|FG001|Overall Study|Lost to Follow-up|0|||
150019498|NCT04607837|541205412|FG000|Overall Study|Adverse Event|8|||
150019499|NCT04607837|541205413|FG001|Overall Study|Adverse Event|2|||
150019500|NCT04607837|541205412|FG000|Overall Study|Withdrawal by Subject|8|||
150019501|NCT04607837|541205413|FG001|Overall Study|Withdrawal by Subject|7|||
150019502|NCT04607837|541205412|FG000|Overall Study|Physician Decision|2|||
150019503|NCT04607837|541205413|FG001|Overall Study|Physician Decision|0|||
150019504|NCT04607837|541205412|FG000|Overall Study|Lack of Efficacy|2|||
150019505|NCT04607837|541205413|FG001|Overall Study|Lack of Efficacy|0|||
150019506|NCT04607837|541205412|FG000|Overall Study|Participant terminated by sponsor|1|||
150019507|NCT04607837|541205413|FG001|Overall Study|Participant terminated by sponsor|0|||
150019508|NCT04607837|541205412|FG000|Overall Study|Disease worsening|36|||
150019509|NCT04607837|541205413|FG001|Overall Study|Disease worsening|36|||
150019510|NCT04607837|541205412|FG000|Overall Study|Other|1|||
150019511|NCT04607837|541205413|FG001|Overall Study|Other|0|||
150019512|NCT02362464|541205414|FG000|Overall Study|Switched to alternative therapy|1|||
150019513|NCT02362464|541205414|FG000|Overall Study|Refused further treatment|1|||
150019514|NCT02362464|541205414|FG000|Overall Study|Physician Decision|4|||
150019515|NCT04209205|541205422|FG000|Overall Study|Adverse Event|2|||
150019516|NCT04209205|541205423|FG001|Overall Study|Adverse Event|3|||
150019517|NCT04209205|541205422|FG000|Overall Study|Lost to Follow-up|3|||
150019518|NCT04209205|541205423|FG001|Overall Study|Lost to Follow-up|1|||
150019519|NCT04209205|541205422|FG000|Overall Study|Physician Decision|1|||
150019520|NCT04209205|541205423|FG001|Overall Study|Physician Decision|1|||
150019521|NCT04209205|541205422|FG000|Overall Study|Subject decision|10|||
150019522|NCT04209205|541205423|FG001|Overall Study|Subject decision|10|||
150019523|NCT04209205|541205422|FG000|Overall Study|Progressive disease|1|||
150059314|NCT00989573|541358562|FG000|Overall Study|Physician Decision|0|||
150059315|NCT00989573|541358563|FG001|Overall Study|Physician Decision|2|||
150059316|NCT00989573|541358564|FG002|Overall Study|Physician Decision|0|||
150059317|NCT00989573|541358562|FG000|Overall Study|Protocol Violation|1|||
150059318|NCT00989573|541358563|FG001|Overall Study|Protocol Violation|1|||
150059319|NCT00989573|541358564|FG002|Overall Study|Protocol Violation|1|||
150059320|NCT00989573|541358562|FG000|Overall Study|Withdrawal by Subject|4|||
150059321|NCT00989573|541358563|FG001|Overall Study|Withdrawal by Subject|7|||
150019524|NCT04209205|541205423|FG001|Overall Study|Progressive disease|0|||
150019525|NCT04209205|541205422|FG000|Overall Study|Protocol deviation|0|||
150019526|NCT04209205|541205423|FG001|Overall Study|Protocol deviation|1|||
150019527|NCT04209205|541205422|FG000|Overall Study|New therapy for study indication|1|||
150059322|NCT00989573|541358564|FG002|Overall Study|Withdrawal by Subject|3|||
150059323|NCT00278915|541358567|FG000|Overall Study|Disease progression|1|||
150059324|NCT05214573|541358568|FG000|Overall Study|Physician Decision|5924|||
150059325|NCT05214573|541358569|FG001|Overall Study|Physician Decision|0|||
150059326|NCT00814801|541358570|FG000|Overall Study|Adverse Event|15|||
150059327|NCT00814801|541358571|FG001|Overall Study|Adverse Event|16|||
150059328|NCT00814801|541358572|FG002|Overall Study|Adverse Event|19|||
150059329|NCT00814801|541358570|FG000|Overall Study|Withdrawal by Subject|9|||
150059330|NCT00814801|541358571|FG001|Overall Study|Withdrawal by Subject|11|||
150059331|NCT00814801|541358572|FG002|Overall Study|Withdrawal by Subject|14|||
150059332|NCT00814801|541358570|FG000|Overall Study|Inappropriate as a subject|1|||
150059333|NCT00814801|541358571|FG001|Overall Study|Inappropriate as a subject|1|||
150059334|NCT00814801|541358572|FG002|Overall Study|Inappropriate as a subject|1|||
150059335|NCT00814801|541358570|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
150059336|NCT00814801|541358571|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
150059337|NCT00814801|541358572|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
150059338|NCT00814801|541358570|FG000|Overall Study|Missing or change of caregiver|6|||
150019528|NCT04209205|541205423|FG001|Overall Study|New therapy for study indication|0|||
150019529|NCT04209205|541205422|FG000|Overall Study|Adverse event - placebo not switched|0|||
150059339|NCT00814801|541358571|FG001|Overall Study|Missing or change of caregiver|2|||
150059340|NCT00814801|541358572|FG002|Overall Study|Missing or change of caregiver|4|||
150059341|NCT00814801|541358570|FG000|Overall Study|Non-compliance|0|||
150059342|NCT00814801|541358571|FG001|Overall Study|Non-compliance|1|||
150059343|NCT00814801|541358572|FG002|Overall Study|Non-compliance|1|||
150019530|NCT04209205|541205423|FG001|Overall Study|Adverse event - placebo not switched|1|||
150059344|NCT00814801|541358570|FG000|Overall Study|Other|2|||
150059345|NCT00814801|541358571|FG001|Overall Study|Other|6|||
150019531|NCT04209205|541205422|FG000|Overall Study|Subject decision - placebo not switched|0|||
150019532|NCT04209205|541205423|FG001|Overall Study|Subject decision - placebo not switched|5|||
150019533|NCT04209205|541205422|FG000|Overall Study|Death - placebo not switched|0|||
150019534|NCT04209205|541205423|FG001|Overall Study|Death - placebo not switched|1|||
150019535|NCT00048347|541205431|FG000|Overall Study|Screen failure|2|||
150019536|NCT00548145|541205432|FG000|Overall Study|Death|0|||
150019537|NCT00548145|541205433|FG001|Overall Study|Death|1|||
150019538|NCT00548145|541205432|FG000|Overall Study|Withdrawal by Subject|0|||
150019539|NCT00548145|541205433|FG001|Overall Study|Withdrawal by Subject|2|||
150019540|NCT00548145|541205432|FG000|Overall Study|Physician Decision|1|||
150019541|NCT00548145|541205433|FG001|Overall Study|Physician Decision|1|||
150019542|NCT00874848|541205434|FG000|Overall Study|Adverse Event|13|||
150019543|NCT00874848|541205435|FG001|Overall Study|Adverse Event|2|||
150019544|NCT00874848|541205434|FG000|Overall Study|Progressive neoplastic disease|38|||
150019545|NCT00874848|541205435|FG001|Overall Study|Progressive neoplastic disease|18|||
150019546|NCT00874848|541205434|FG000|Overall Study|Withdrawal by Subject|7|||
150019547|NCT00874848|541205435|FG001|Overall Study|Withdrawal by Subject|4|||
150019548|NCT00874848|541205434|FG000|Overall Study|Noncompliance|1|||
150019549|NCT00874848|541205435|FG001|Overall Study|Noncompliance|1|||
150019550|NCT00874848|541205434|FG000|Overall Study|Failure to comply with protocol|0|||
150019551|NCT00874848|541205435|FG001|Overall Study|Failure to comply with protocol|1|||
150019552|NCT00874848|541205434|FG000|Overall Study|Physician Decision|0|||
150019553|NCT00874848|541205435|FG001|Overall Study|Physician Decision|2|||
150019554|NCT00858637|541205440|FG000|Active Comparison Phase|Adverse Event|14|||
150019555|NCT00858637|541205441|FG001|Active Comparison Phase|Adverse Event|0|||
150019556|NCT00858637|541205442|FG002|Active Comparison Phase|Adverse Event|0|||
150019557|NCT00858637|541205443|FG003|Active Comparison Phase|Adverse Event|9|||
150019558|NCT00858637|541205444|FG004|Active Comparison Phase|Adverse Event|0|||
150019559|NCT00858637|541205445|FG005|Active Comparison Phase|Adverse Event|0|||
150019560|NCT00858637|541205440|FG000|Active Comparison Phase|Death|1|||
150019561|NCT00858637|541205441|FG001|Active Comparison Phase|Death|0|||
150019562|NCT00858637|541205442|FG002|Active Comparison Phase|Death|0|||
150019563|NCT00858637|541205443|FG003|Active Comparison Phase|Death|1|||
150019564|NCT00858637|541205444|FG004|Active Comparison Phase|Death|0|||
150019565|NCT00858637|541205445|FG005|Active Comparison Phase|Death|0|||
150019566|NCT00858637|541205440|FG000|Active Comparison Phase|Physician Decision|1|||
150019567|NCT00858637|541205441|FG001|Active Comparison Phase|Physician Decision|0|||
150019568|NCT00858637|541205442|FG002|Active Comparison Phase|Physician Decision|0|||
150019569|NCT00858637|541205443|FG003|Active Comparison Phase|Physician Decision|1|||
150019570|NCT00858637|541205444|FG004|Active Comparison Phase|Physician Decision|0|||
150019571|NCT00858637|541205445|FG005|Active Comparison Phase|Physician Decision|0|||
150019572|NCT00858637|541205440|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
150019573|NCT00858637|541205441|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
150019574|NCT00858637|541205442|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
150019575|NCT00858637|541205443|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
150019576|NCT00858637|541205444|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
150019577|NCT00858637|541205445|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
150019578|NCT00858637|541205440|FG000|Active Comparison Phase|Other Reasons|1|||
150019579|NCT00858637|541205441|FG001|Active Comparison Phase|Other Reasons|0|||
150019580|NCT00858637|541205442|FG002|Active Comparison Phase|Other Reasons|0|||
150019581|NCT00858637|541205443|FG003|Active Comparison Phase|Other Reasons|1|||
150019582|NCT00858637|541205444|FG004|Active Comparison Phase|Other Reasons|0|||
150019583|NCT00858637|541205445|FG005|Active Comparison Phase|Other Reasons|0|||
150019584|NCT00858637|541205440|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
150019585|NCT00858637|541205441|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
150019586|NCT00858637|541205442|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
150019587|NCT00858637|541205443|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
150019588|NCT00858637|541205444|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
150019589|NCT00858637|541205445|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
150019590|NCT00858637|541205440|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
150019591|NCT00858637|541205441|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
150019592|NCT00858637|541205442|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
150019593|NCT00858637|541205443|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
150019594|NCT00858637|541205444|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
150019595|NCT00858637|541205445|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
150059346|NCT00814801|541358572|FG002|Overall Study|Other|4|||
150019596|NCT01380834|541205446|FG000|Overall Study|Physician Decision|1|||
150019597|NCT01380834|541205447|FG001|Overall Study|Physician Decision|0|||
150019598|NCT00604695|541205448|FG000|Overall Study|Did not receive first bolus.|0|||
150019599|NCT00604695|541205449|FG001|Overall Study|Did not receive first bolus.|4|||
150019600|NCT04677504|541205454|FG000|Overall Study|Death|51|||
150019601|NCT04677504|541205455|FG001|Overall Study|Death|49|||
150019602|NCT04677504|541205454|FG000|Overall Study|Progressive Disease|1|||
150019603|NCT04677504|541205455|FG001|Overall Study|Progressive Disease|0|||
150019604|NCT04677504|541205454|FG000|Overall Study|Symptomatic Deterioration|1|||
150019605|NCT04677504|541205455|FG001|Overall Study|Symptomatic Deterioration|0|||
150019606|NCT04677504|541205454|FG000|Overall Study|Withdrawal by Subject|2|||
150019607|NCT04677504|541205455|FG001|Overall Study|Withdrawal by Subject|5|||
150019608|NCT04677504|541205454|FG000|Overall Study|Study Terminated By Sponsor|28|||
150019609|NCT04677504|541205455|FG001|Overall Study|Study Terminated By Sponsor|24|||
150019610|NCT04677504|541205454|FG000|Overall Study|Adverse Event|0|||
150019611|NCT04677504|541205455|FG001|Overall Study|Adverse Event|1|||
150019612|NCT00167310|541205458|FG000|Overall Study|Protocol Violation|5|||
150019613|NCT00167310|541205459|FG001|Overall Study|Protocol Violation|3|||
150019614|NCT00167310|541205458|FG000|Overall Study|Withdrawal by Subject|3|||
150019615|NCT00167310|541205459|FG001|Overall Study|Withdrawal by Subject|7|||
150019616|NCT04522141|541205460|FG000|Overall Study|Withdrawal by Subject|1|||
150019617|NCT04522141|541205461|FG001|Overall Study|Withdrawal by Subject|0|||
150019618|NCT03052049|541205462|FG000|Overall Study|Withdrawal by Subject|2|||
150019619|NCT03304873|541205463|FG000|Overall Study|Lost to Follow-up|1|||
150019620|NCT03304873|541205464|FG001|Overall Study|Lost to Follow-up|8|||
150019621|NCT01868477|541205466|FG000|Overall Study|Adverse Event|2|||
150019622|NCT01868477|541205467|FG001|Overall Study|Adverse Event|4|||
150019623|NCT01868477|541205466|FG000|Overall Study|Disease progression|1|||
150019624|NCT01868477|541205467|FG001|Overall Study|Disease progression|1|||
150019625|NCT01868477|541205466|FG000|Overall Study|Withdrawal by Subject|1|||
150019626|NCT01868477|541205467|FG001|Overall Study|Withdrawal by Subject|0|||
150019627|NCT00042991|541205468|FG000|Overall Study|Adverse Event|1|||
150019628|NCT00042991|541205469|FG001|Overall Study|Adverse Event|4|||
150019629|NCT00042991|541205470|FG002|Overall Study|Adverse Event|2|||
150019630|NCT00042991|541205471|FG003|Overall Study|Adverse Event|0|||
150019631|NCT00042991|541205472|FG004|Overall Study|Adverse Event|0|||
150019632|NCT00042991|541205473|FG005|Overall Study|Adverse Event|1|||
150019633|NCT00042991|541205474|FG006|Overall Study|Adverse Event|0|||
150019634|NCT00042991|541205468|FG000|Overall Study|Withdrawal by Subject|0|||
150019635|NCT00042991|541205469|FG001|Overall Study|Withdrawal by Subject|7|||
150019636|NCT00042991|541205470|FG002|Overall Study|Withdrawal by Subject|2|||
150019637|NCT00042991|541205471|FG003|Overall Study|Withdrawal by Subject|0|||
150019638|NCT00042991|541205472|FG004|Overall Study|Withdrawal by Subject|1|||
150019639|NCT00042991|541205473|FG005|Overall Study|Withdrawal by Subject|0|||
150019640|NCT00042991|541205474|FG006|Overall Study|Withdrawal by Subject|0|||
150019641|NCT00042991|541205468|FG000|Overall Study|Disease Progression|5|||
150019642|NCT00042991|541205469|FG001|Overall Study|Disease Progression|29|||
150019643|NCT00042991|541205470|FG002|Overall Study|Disease Progression|2|||
150019644|NCT00042991|541205471|FG003|Overall Study|Disease Progression|2|||
150019645|NCT00042991|541205472|FG004|Overall Study|Disease Progression|1|||
150019646|NCT00042991|541205473|FG005|Overall Study|Disease Progression|4|||
150019647|NCT00042991|541205474|FG006|Overall Study|Disease Progression|2|||
150019648|NCT00042991|541205468|FG000|Overall Study|Alternative Therapy|0|||
150019649|NCT00042991|541205469|FG001|Overall Study|Alternative Therapy|0|||
150019650|NCT00042991|541205470|FG002|Overall Study|Alternative Therapy|0|||
150019651|NCT00042991|541205471|FG003|Overall Study|Alternative Therapy|0|||
150019652|NCT00042991|541205472|FG004|Overall Study|Alternative Therapy|1|||
150019653|NCT00042991|541205473|FG005|Overall Study|Alternative Therapy|0|||
150019654|NCT00042991|541205474|FG006|Overall Study|Alternative Therapy|0|||
150019655|NCT00367835|541205477|FG000|Overall Study|Adverse Event|14|||
150019656|NCT00367835|541205478|FG001|Overall Study|Adverse Event|1|||
150019657|NCT00367835|541205477|FG000|Overall Study|Protocol Violation|1|||
150019658|NCT00367835|541205478|FG001|Overall Study|Protocol Violation|7|||
150019659|NCT00367835|541205477|FG000|Overall Study|Withdrawal by Subject|7|||
150019660|NCT00367835|541205478|FG001|Overall Study|Withdrawal by Subject|6|||
150019661|NCT00367835|541205477|FG000|Overall Study|Lost to Follow-up|1|||
150019662|NCT00367835|541205478|FG001|Overall Study|Lost to Follow-up|4|||
150019663|NCT00367835|541205477|FG000|Overall Study|Lack of Efficacy|3|||
150019664|NCT00367835|541205478|FG001|Overall Study|Lack of Efficacy|12|||
150019665|NCT00367835|541205477|FG000|Overall Study|Subject in juvenile detention center|1|||
150019666|NCT00367835|541205478|FG001|Overall Study|Subject in juvenile detention center|0|||
150019667|NCT00367835|541205477|FG000|Overall Study|refused blood collection|1|||
150019668|NCT00367835|541205478|FG001|Overall Study|refused blood collection|0|||
150019669|NCT00367835|541205477|FG000|Overall Study|Did not respond to calls|1|||
150059347|NCT02486718|541358575|FG000|Enrollment Phase|Death|19|||
150019670|NCT00367835|541205478|FG001|Overall Study|Did not respond to calls|0|||
150019671|NCT00367835|541205477|FG000|Overall Study|History of lead poisoning|0|||
150019672|NCT00367835|541205478|FG001|Overall Study|History of lead poisoning|1|||
150019673|NCT01574651|541205479|FG000|Overall Study|Lost to Follow-up|2|||
150019674|NCT01574651|541205480|FG001|Overall Study|Lost to Follow-up|4|||
150019675|NCT01574651|541205479|FG000|Overall Study|Administrative problems|0|||
150019676|NCT01574651|541205480|FG001|Overall Study|Administrative problems|1|||
150019677|NCT01574651|541205479|FG000|Overall Study|Death|3|||
150019678|NCT01574651|541205480|FG001|Overall Study|Death|3|||
150019679|NCT01574651|541205479|FG000|Overall Study|Patient's inability to use the device|0|||
150019680|NCT01574651|541205480|FG001|Overall Study|Patient's inability to use the device|1|||
150019681|NCT01574651|541205479|FG000|Overall Study|Adverse Event|36|||
150019682|NCT01574651|541205480|FG001|Overall Study|Adverse Event|27|||
150019683|NCT01574651|541205479|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150019684|NCT01574651|541205480|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150019685|NCT01574651|541205479|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150019686|NCT01574651|541205480|FG001|Overall Study|Abnormal test procedure result(s)|1|||
150019687|NCT01574651|541205479|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
150019688|NCT01574651|541205480|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150019689|NCT01574651|541205479|FG000|Overall Study|Protocol Violation|3|||
150019690|NCT01574651|541205480|FG001|Overall Study|Protocol Violation|5|||
150019691|NCT01574651|541205479|FG000|Overall Study|Withdrawal by Subject|9|||
150019692|NCT01574651|541205480|FG001|Overall Study|Withdrawal by Subject|10|||
150019693|NCT03887221|541205481|FG000|Overall Study|Protocol Violation|1|||
150019694|NCT03887221|541205482|FG001|Overall Study|Protocol Violation|0|||
150019695|NCT00445770|541205483|FG000|Overall Study|Adverse Event|9|||
150019696|NCT00445770|541205484|FG001|Overall Study|Adverse Event|15|||
150019697|NCT00445770|541205485|FG002|Overall Study|Adverse Event|19|||
150019698|NCT00445770|541205483|FG000|Overall Study|Lack of Efficacy|38|||
150019699|NCT00445770|541205484|FG001|Overall Study|Lack of Efficacy|13|||
150019700|NCT00445770|541205485|FG002|Overall Study|Lack of Efficacy|6|||
150019701|NCT00445770|541205483|FG000|Overall Study|Lost to Follow-up|0|||
150019702|NCT00445770|541205484|FG001|Overall Study|Lost to Follow-up|2|||
150019703|NCT00445770|541205485|FG002|Overall Study|Lost to Follow-up|0|||
150019704|NCT00445770|541205483|FG000|Overall Study|Other|6|||
150019705|NCT00445770|541205484|FG001|Overall Study|Other|5|||
150019706|NCT00445770|541205485|FG002|Overall Study|Other|6|||
150019707|NCT00947115|541205486|FG000|Overall Study|Missed reporting interval|3|||
150019708|NCT00947115|541205487|FG001|Overall Study|Missed reporting interval|4|||
150019709|NCT00947115|541205488|FG002|Overall Study|Missed reporting interval|2|||
150019710|NCT00947115|541205486|FG000|Overall Study|Physician Decision|0|||
150019711|NCT00947115|541205487|FG001|Overall Study|Physician Decision|2|||
150019712|NCT00947115|541205488|FG002|Overall Study|Physician Decision|0|||
150019713|NCT00947115|541205486|FG000|Overall Study|Death|0|||
150019714|NCT00947115|541205487|FG001|Overall Study|Death|1|||
150019715|NCT00947115|541205488|FG002|Overall Study|Death|1|||
150019716|NCT00947115|541205486|FG000|Overall Study|Migrated from study area|2|||
150019717|NCT00947115|541205487|FG001|Overall Study|Migrated from study area|0|||
150019718|NCT00947115|541205488|FG002|Overall Study|Migrated from study area|0|||
150019719|NCT00947115|541205486|FG000|Overall Study|Withdrawal by Subject|1|||
150019720|NCT00947115|541205487|FG001|Overall Study|Withdrawal by Subject|3|||
150019721|NCT00947115|541205488|FG002|Overall Study|Withdrawal by Subject|4|||
150019722|NCT00947115|541205486|FG000|Overall Study|Lost to Follow-up|11|||
150019723|NCT00947115|541205487|FG001|Overall Study|Lost to Follow-up|12|||
150019724|NCT00947115|541205488|FG002|Overall Study|Lost to Follow-up|8|||
150019725|NCT02123576|541205491|FG000|Overall Study|Adverse Event|1|||
150019726|NCT02123576|541205492|FG001|Overall Study|Adverse Event|0|||
150019727|NCT00934128|541205494|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
150019728|NCT00934128|541205495|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
150019729|NCT00934128|541205494|FG000|First Intervention (2 Hours)|Adverse Event|4|||
150019730|NCT00934128|541205495|FG001|First Intervention (2 Hours)|Adverse Event|1|||
150059348|NCT02486718|541358576|FG001|Enrollment Phase|Death|0|||
150059349|NCT02486718|541358577|FG002|Enrollment Phase|Death|0|||
150019731|NCT00934128|541205494|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
150019732|NCT00934128|541205495|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
150019733|NCT00934128|541205494|FG000|Washout Period (1 Hour)|Patient preference|1|||
150019734|NCT00934128|541205495|FG001|Washout Period (1 Hour)|Patient preference|3|||
150019735|NCT00934128|541205494|FG000|Washout Period (1 Hour)|Pain|1|||
150019736|NCT00934128|541205495|FG001|Washout Period (1 Hour)|Pain|0|||
150059350|NCT02486718|541358575|FG000|Enrollment Phase|Symptomatic deterioration|1|||
150019737|NCT00934128|541205494|FG000|Washout Period (1 Hour)|Too tired|1|||
150019738|NCT00934128|541205495|FG001|Washout Period (1 Hour)|Too tired|0|||
150019739|NCT00934128|541205494|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
150019740|NCT00934128|541205495|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
150019741|NCT00934128|541205494|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
150059351|NCT02486718|541358576|FG001|Enrollment Phase|Symptomatic deterioration|0|||
150019742|NCT00934128|541205495|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
150019743|NCT02834247|541205499|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
150019744|NCT02834247|541205500|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
150019745|NCT02834247|541205501|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
150019746|NCT02834247|541205502|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
150019747|NCT02834247|541205499|FG000|Dose Escalation Phase|Death|5|||
150019748|NCT02834247|541205500|FG001|Dose Escalation Phase|Death|6|||
150019749|NCT02834247|541205501|FG002|Dose Escalation Phase|Death|5|||
150019750|NCT02834247|541205502|FG003|Dose Escalation Phase|Death|0|||
150019751|NCT02834247|541205499|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
150019752|NCT02834247|541205500|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
150019753|NCT02834247|541205501|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
150019754|NCT02834247|541205502|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
150019755|NCT02834247|541205499|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
150019756|NCT02834247|541205500|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
150019757|NCT02834247|541205501|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
150019758|NCT02834247|541205502|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
150019759|NCT02834247|541205499|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
150019760|NCT02834247|541205500|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
150019761|NCT02834247|541205501|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
150019762|NCT02834247|541205502|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
150019763|NCT02834247|541205499|FG000|Dose Expansion Phase|Death|0|||
150019764|NCT02834247|541205500|FG001|Dose Expansion Phase|Death|0|||
150019765|NCT02834247|541205501|FG002|Dose Expansion Phase|Death|0|||
150019766|NCT02834247|541205502|FG003|Dose Expansion Phase|Death|8|||
150019767|NCT02834247|541205499|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
150019768|NCT02834247|541205500|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
150019769|NCT02834247|541205501|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
150019770|NCT02834247|541205502|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
150019771|NCT02834247|541205499|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
150019772|NCT02834247|541205500|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
150019773|NCT02834247|541205501|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
150019774|NCT02834247|541205502|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
150019775|NCT01807299|541205503|FG000|Overall Study|Protocol Violation|3|||
150019776|NCT01807299|541205504|FG001|Overall Study|Protocol Violation|1|||
150019777|NCT01807299|541205505|FG002|Overall Study|Protocol Violation|0|||
150019778|NCT01807299|541205506|FG003|Overall Study|Protocol Violation|2|||
150019779|NCT00811174|541205507|FG000|Overall Study|Protocol Violation|2|||
150019780|NCT00811174|541205507|FG000|Overall Study|Sponsors Decision|1|||
150019781|NCT00763386|541207394|FG000|Overall Study|Adverse Event|43|||
150019782|NCT00763386|541207395|FG001|Overall Study|Adverse Event|33|||
150019783|NCT00763386|541207394|FG000|Overall Study|Death|1|||
150019784|NCT00763386|541207395|FG001|Overall Study|Death|2|||
150019785|NCT00763386|541207394|FG000|Overall Study|Lost to Follow-up|3|||
150019786|NCT00763386|541207395|FG001|Overall Study|Lost to Follow-up|3|||
150019787|NCT00763386|541207394|FG000|Overall Study|Withdrawal by Subject|0|||
150019788|NCT00763386|541207395|FG001|Overall Study|Withdrawal by Subject|1|||
150019789|NCT00763386|541207394|FG000|Overall Study|CRF missing|0|||
150019790|NCT00763386|541207395|FG001|Overall Study|CRF missing|1|||
150019791|NCT00763386|541207394|FG000|Overall Study|Study Prosthesis Removed|1|||
150019792|NCT00763386|541207395|FG001|Overall Study|Study Prosthesis Removed|0|||
150019793|NCT01402817|541207396|FG000|Overall Study|Withdrawal by Subject|3|||
150019794|NCT01402817|541207396|FG000|Overall Study|Study Suspended by FDA|8|||
150019795|NCT00412893|541207397|FG000|Overall Study|Adverse Event|31|||
150019796|NCT00412893|541207398|FG001|Overall Study|Adverse Event|53|||
150019797|NCT00412893|541207397|FG000|Overall Study|Death|17|||
150019798|NCT00412893|541207398|FG001|Overall Study|Death|21|||
150019799|NCT00412893|541207397|FG000|Overall Study|Insufficient Therapeutic Response|39|||
150019800|NCT00412893|541207398|FG001|Overall Study|Insufficient Therapeutic Response|23|||
150019801|NCT00412893|541207397|FG000|Overall Study|Lost to Follow-up|2|||
150019802|NCT00412893|541207398|FG001|Overall Study|Lost to Follow-up|1|||
150019803|NCT00412893|541207397|FG000|Overall Study|Violation of Selection at Entry|17|||
150019804|NCT00412893|541207398|FG001|Overall Study|Violation of Selection at Entry|10|||
150059352|NCT02486718|541358577|FG002|Enrollment Phase|Symptomatic deterioration|0|||
150059353|NCT02486718|541358575|FG000|Enrollment Phase|Withdrawal by Subject|86|||
150019805|NCT00412893|541207397|FG000|Overall Study|Other Protocol Violation|10|||
150019806|NCT00412893|541207398|FG001|Overall Study|Other Protocol Violation|6|||
150019807|NCT00412893|541207397|FG000|Overall Study|Did Not Cooperate|12|||
150019808|NCT00412893|541207398|FG001|Overall Study|Did Not Cooperate|9|||
150019809|NCT00412893|541207397|FG000|Overall Study|Administrative Reason|12|||
150019810|NCT00412893|541207398|FG001|Overall Study|Administrative Reason|15|||
150019811|NCT00412893|541207397|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
150019812|NCT00412893|541207398|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
150019813|NCT00853151|541207399|FG000|Overall Study|Adverse Event|1|||
150019814|NCT00853151|541207400|FG001|Overall Study|Adverse Event|4|||
150019815|NCT00853151|541207401|FG002|Overall Study|Adverse Event|2|||
150019816|NCT00853151|541207402|FG003|Overall Study|Adverse Event|0|||
150019817|NCT00853151|541207399|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
150019818|NCT00853151|541207400|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150019819|NCT00853151|541207401|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150019820|NCT00853151|541207402|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150019821|NCT00853151|541207399|FG000|Overall Study|Lost to Follow-up|2|||
150019822|NCT00853151|541207400|FG001|Overall Study|Lost to Follow-up|0|||
150019823|NCT00853151|541207401|FG002|Overall Study|Lost to Follow-up|3|||
150019824|NCT00853151|541207402|FG003|Overall Study|Lost to Follow-up|0|||
150019825|NCT00853151|541207399|FG000|Overall Study|Death|1|||
150019826|NCT00853151|541207400|FG001|Overall Study|Death|0|||
150019827|NCT00853151|541207401|FG002|Overall Study|Death|0|||
150019828|NCT00853151|541207402|FG003|Overall Study|Death|1|||
150019829|NCT00853151|541207399|FG000|Overall Study|Protocol Violation|0|||
150019830|NCT00853151|541207400|FG001|Overall Study|Protocol Violation|0|||
150019831|NCT00853151|541207401|FG002|Overall Study|Protocol Violation|0|||
150019832|NCT00853151|541207402|FG003|Overall Study|Protocol Violation|1|||
150019833|NCT00853151|541207399|FG000|Overall Study|Withdrawal by Subject|5|||
150019834|NCT00853151|541207400|FG001|Overall Study|Withdrawal by Subject|4|||
150019835|NCT00853151|541207401|FG002|Overall Study|Withdrawal by Subject|2|||
150019836|NCT00853151|541207402|FG003|Overall Study|Withdrawal by Subject|1|||
150019837|NCT00853151|541207399|FG000|Overall Study|Physician Decision|0|||
150019838|NCT00853151|541207400|FG001|Overall Study|Physician Decision|2|||
150019839|NCT00853151|541207401|FG002|Overall Study|Physician Decision|1|||
150019840|NCT00853151|541207402|FG003|Overall Study|Physician Decision|0|||
150019841|NCT00853151|541207399|FG000|Overall Study|Sponsor Decision|0|||
150019842|NCT00853151|541207400|FG001|Overall Study|Sponsor Decision|3|||
150019843|NCT00853151|541207401|FG002|Overall Study|Sponsor Decision|0|||
150019844|NCT00853151|541207402|FG003|Overall Study|Sponsor Decision|0|||
150019845|NCT01751984|541207403|FG000|Overall Study|Adverse Event|5|||
150019846|NCT01751984|541207404|FG001|Overall Study|Adverse Event|3|||
150019847|NCT01751984|541207403|FG000|Overall Study|Withdrawal by Subject|0|||
150019848|NCT01751984|541207404|FG001|Overall Study|Withdrawal by Subject|1|||
150019849|NCT01751984|541207403|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
150019850|NCT01751984|541207404|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
150019851|NCT02274792|541207405|FG000|Overall Study|Withdrawal by Subject|13|||
150019852|NCT02274792|541207405|FG000|Overall Study|Lost to Follow-up|8|||
150019853|NCT02274792|541207405|FG000|Overall Study|Protocol Specified Criteria|2|||
150019854|NCT02274792|541207405|FG000|Overall Study|Sponsor Decision|2|||
150019855|NCT01957202|541207415|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019856|NCT01957202|541207416|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
150019857|NCT01957202|541207417|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019858|NCT01957202|541207418|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019859|NCT01957202|541207419|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019860|NCT01957202|541207420|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019861|NCT01957202|541207421|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019862|NCT01957202|541207422|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019863|NCT01957202|541207423|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019864|NCT01957202|541207424|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019865|NCT01957202|541207425|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019866|NCT01957202|541207426|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019867|NCT01957202|541207427|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019868|NCT01957202|541207428|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019869|NCT01957202|541207429|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019870|NCT01957202|541207430|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019871|NCT01957202|541207431|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
150019872|NCT01957202|541207432|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
150019873|NCT01957202|541207415|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019874|NCT01957202|541207416|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019875|NCT01957202|541207417|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019876|NCT01957202|541207418|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019877|NCT01957202|541207419|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019878|NCT01957202|541207420|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019879|NCT01957202|541207421|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019880|NCT01957202|541207422|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019881|NCT01957202|541207423|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019882|NCT01957202|541207424|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
150059354|NCT02486718|541358576|FG001|Enrollment Phase|Withdrawal by Subject|0|||
150019883|NCT01957202|541207425|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019884|NCT01957202|541207426|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019885|NCT01957202|541207427|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019886|NCT01957202|541207428|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019887|NCT01957202|541207429|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019888|NCT01957202|541207430|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019889|NCT01957202|541207431|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
150019890|NCT01957202|541207432|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
150019891|NCT01456169|541207433|FG000|Overall Study|Adverse Event|1|||
150019892|NCT01456169|541207434|FG001|Overall Study|Adverse Event|2|||
150019893|NCT01456169|541207435|FG002|Overall Study|Adverse Event|7|||
150019894|NCT01456169|541207433|FG000|Overall Study|Major Protocol Deviation|3|||
150019895|NCT01456169|541207434|FG001|Overall Study|Major Protocol Deviation|2|||
150019896|NCT01456169|541207435|FG002|Overall Study|Major Protocol Deviation|3|||
150019897|NCT01456169|541207433|FG000|Overall Study|Voluntary Withdrawal|3|||
150019898|NCT01456169|541207434|FG001|Overall Study|Voluntary Withdrawal|0|||
150019899|NCT01456169|541207435|FG002|Overall Study|Voluntary Withdrawal|2|||
150019900|NCT01456169|541207433|FG000|Overall Study|Lack of Efficacy|2|||
150019901|NCT01456169|541207434|FG001|Overall Study|Lack of Efficacy|0|||
150019902|NCT01456169|541207435|FG002|Overall Study|Lack of Efficacy|0|||
150019903|NCT01456169|541207433|FG000|Overall Study|Other|1|||
150019904|NCT01456169|541207434|FG001|Overall Study|Other|1|||
150019905|NCT01456169|541207435|FG002|Overall Study|Other|0|||
150019906|NCT02292446|541207436|FG000|Overall Study|Adverse Event|12|||
150019907|NCT02292446|541207436|FG000|Overall Study|Death|1|||
150019908|NCT02292446|541207436|FG000|Overall Study|Disease progression|2|||
150019909|NCT02292446|541207436|FG000|Overall Study|Subject/guardian decision|2|||
150019910|NCT02292446|541207436|FG000|Overall Study|Withdrawal by Subject|3|||
150019911|NCT02652156|541207440|FG000|Overall Study|Physician Decision|1|||
150019912|NCT02652156|541207441|FG001|Overall Study|Physician Decision|0|||
150019913|NCT02652156|541207442|FG002|Overall Study|Physician Decision|0|||
150019914|NCT00496080|541207447|FG000|Overall Study|Lost to Follow-up|9|||
150019915|NCT00496080|541207447|FG000|Overall Study|Surgical re-intervention|7|||
150019916|NCT00496080|541207447|FG000|Overall Study|Withdrawal by Subject|5|||
150019917|NCT00496080|541207447|FG000|Overall Study|Physician Decision|6|||
150019918|NCT04098809|541207448|FG000|Overall Study|Withdrawal by Subject|1|||
150019919|NCT04098809|541207449|FG001|Overall Study|Withdrawal by Subject|3|||
150019920|NCT04098809|541207448|FG000|Overall Study|Physician Decision|2|||
150019921|NCT04098809|541207449|FG001|Overall Study|Physician Decision|1|||
150019922|NCT01200368|541207450|FG000|Infant Series|Adverse Event|2|||
150019923|NCT01200368|541207451|FG001|Infant Series|Adverse Event|2|||
150019924|NCT01200368|541207452|FG002|Infant Series|Adverse Event|3|||
150019925|NCT01200368|541207450|FG000|Infant Series|Withdrawal by Subject|0|||
150019926|NCT01200368|541207451|FG001|Infant Series|Withdrawal by Subject|2|||
150059355|NCT02486718|541358577|FG002|Enrollment Phase|Withdrawal by Subject|0|||
150059356|NCT02486718|541358575|FG000|Enrollment Phase|Protocol Violation|18|||
150059357|NCT02486718|541358576|FG001|Enrollment Phase|Protocol Violation|0|||
150059358|NCT02486718|541358577|FG002|Enrollment Phase|Protocol Violation|0|||
150059359|NCT02486718|541358575|FG000|Enrollment Phase|Physician Decision|18|||
150059360|NCT02486718|541358576|FG001|Enrollment Phase|Physician Decision|0|||
150059361|NCT02486718|541358577|FG002|Enrollment Phase|Physician Decision|0|||
150059362|NCT02486718|541358575|FG000|Enrollment Phase|Reason not provided|41|||
150059363|NCT02486718|541358576|FG001|Enrollment Phase|Reason not provided|0|||
150059364|NCT02486718|541358577|FG002|Enrollment Phase|Reason not provided|0|||
150059365|NCT02486718|541358575|FG000|Enrollment Phase|Disease relapse|54|||
150059366|NCT02486718|541358576|FG001|Enrollment Phase|Disease relapse|0|||
150181680|NCT00088413|541802830|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
150181681|NCT00088413|541802831|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
150181682|NCT00088413|541802832|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
150181683|NCT00088413|541802829|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
150181684|NCT00088413|541802830|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
150019927|NCT01200368|541207452|FG002|Infant Series|Withdrawal by Subject|2|||
150019928|NCT01200368|541207450|FG000|Infant Series|Did not meet entrance criteria|0|||
150019929|NCT01200368|541207451|FG001|Infant Series|Did not meet entrance criteria|1|||
150019930|NCT01200368|541207452|FG002|Infant Series|Did not meet entrance criteria|0|||
150019931|NCT01200368|541207450|FG000|Infant Series|Randomized, not vaccinated|0|||
150019932|NCT01200368|541207451|FG001|Infant Series|Randomized, not vaccinated|1|||
150019933|NCT01200368|541207452|FG002|Infant Series|Randomized, not vaccinated|1|||
150019934|NCT01200368|541207450|FG000|Infant Series|Other|1|||
150019935|NCT01200368|541207451|FG001|Infant Series|Other|0|||
150019936|NCT01200368|541207452|FG002|Infant Series|Other|0|||
150059367|NCT02486718|541358577|FG002|Enrollment Phase|Disease relapse|0|||
150059368|NCT02486718|541358575|FG000|Enrollment Phase|Lost to Follow-up|4|||
150181685|NCT00088413|541802831|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
150181686|NCT00088413|541802832|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
150019937|NCT01200368|541207450|FG000|After Infant Series|Adverse Event|6|||
150019938|NCT01200368|541207451|FG001|After Infant Series|Adverse Event|6|||
150019939|NCT01200368|541207452|FG002|After Infant Series|Adverse Event|3|||
150019940|NCT01200368|541207450|FG000|After Infant Series|Withdrawal by Subject|10|||
150019941|NCT01200368|541207451|FG001|After Infant Series|Withdrawal by Subject|8|||
150019942|NCT01200368|541207452|FG002|After Infant Series|Withdrawal by Subject|4|||
150019943|NCT01200368|541207450|FG000|After Infant Series|Lost to Follow-up|1|||
150019944|NCT01200368|541207451|FG001|After Infant Series|Lost to Follow-up|0|||
150019945|NCT01200368|541207452|FG002|After Infant Series|Lost to Follow-up|0|||
150019946|NCT01200368|541207450|FG000|After Infant Series|Other|1|||
150019947|NCT01200368|541207451|FG001|After Infant Series|Other|2|||
150019948|NCT01200368|541207452|FG002|After Infant Series|Other|2|||
150019949|NCT01200368|541207450|FG000|Toddler Dose|Adverse Event|0|||
150019950|NCT01200368|541207451|FG001|Toddler Dose|Adverse Event|3|||
150019951|NCT01200368|541207452|FG002|Toddler Dose|Adverse Event|1|||
150019952|NCT00570310|541207453|FG000|Overall Study|Adverse Event|1|||
150019953|NCT00570310|541207454|FG001|Overall Study|Adverse Event|2|||
150019954|NCT00570310|541207453|FG000|Overall Study|Lack of Efficacy|1|||
150019955|NCT00570310|541207454|FG001|Overall Study|Lack of Efficacy|4|||
150019956|NCT00479336|541207456|FG000|Overall Study|Adverse Event|1|||
150019957|NCT00479336|541207457|FG001|Overall Study|Adverse Event|1|||
150019958|NCT00479336|541207458|FG002|Overall Study|Adverse Event|1|||
150019959|NCT00479336|541207459|FG003|Overall Study|Adverse Event|3|||
150019960|NCT00479336|541207456|FG000|Overall Study|Lack of Efficacy|1|||
150019961|NCT00479336|541207457|FG001|Overall Study|Lack of Efficacy|0|||
150019962|NCT00479336|541207458|FG002|Overall Study|Lack of Efficacy|0|||
150019963|NCT00479336|541207459|FG003|Overall Study|Lack of Efficacy|0|||
150019964|NCT00479336|541207456|FG000|Overall Study|Protocol Violation|0|||
150019965|NCT00479336|541207457|FG001|Overall Study|Protocol Violation|1|||
150019966|NCT00479336|541207458|FG002|Overall Study|Protocol Violation|0|||
150019967|NCT00479336|541207459|FG003|Overall Study|Protocol Violation|0|||
150019968|NCT00479336|541207456|FG000|Overall Study|Withdrawal by Subject|1|||
150019969|NCT00479336|541207457|FG001|Overall Study|Withdrawal by Subject|2|||
150019970|NCT00479336|541207458|FG002|Overall Study|Withdrawal by Subject|0|||
150019971|NCT00479336|541207459|FG003|Overall Study|Withdrawal by Subject|0|||
150019972|NCT00479336|541207456|FG000|Overall Study|Physician Decision|0|||
150019973|NCT00479336|541207457|FG001|Overall Study|Physician Decision|1|||
150019974|NCT00479336|541207458|FG002|Overall Study|Physician Decision|0|||
150019975|NCT00479336|541207459|FG003|Overall Study|Physician Decision|2|||
150019976|NCT00479336|541207456|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
150019977|NCT00479336|541207457|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
150019978|NCT00479336|541207458|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
150019979|NCT00479336|541207459|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
150181687|NCT00088413|541802829|FG000|Overall Study|Death|0|||
150181688|NCT00088413|541802830|FG001|Overall Study|Death|1|||
150181689|NCT00088413|541802831|FG002|Overall Study|Death|0|||
150019980|NCT02741596|541207460|FG000|Overall Study|Adverse Event|1|||
150181690|NCT00088413|541802832|FG003|Overall Study|Death|0|||
150181691|NCT00088413|541802829|FG000|Overall Study|Progressive disease|9|||
150019981|NCT02741596|541207461|FG001|Overall Study|Adverse Event|5|||
150019982|NCT02741596|541207460|FG000|Overall Study|Lost to Follow-up|1|||
150019983|NCT02741596|541207461|FG001|Overall Study|Lost to Follow-up|1|||
150019984|NCT02741596|541207460|FG000|Overall Study|Physician Decision|2|||
150019985|NCT02741596|541207461|FG001|Overall Study|Physician Decision|1|||
150019986|NCT02741596|541207460|FG000|Overall Study|Pregnancy|3|||
150019987|NCT02741596|541207461|FG001|Overall Study|Pregnancy|1|||
150019988|NCT02741596|541207460|FG000|Overall Study|Other (Unspecified)|0|||
150019989|NCT02741596|541207461|FG001|Overall Study|Other (Unspecified)|3|||
150019990|NCT02741596|541207460|FG000|Overall Study|Subject withdrawn-Other|17|||
150181692|NCT00088413|541802830|FG001|Overall Study|Progressive disease|11|||
150019991|NCT02741596|541207461|FG001|Overall Study|Subject withdrawn-Other|4|||
150019992|NCT02741596|541207460|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
150019993|NCT02741596|541207461|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
150019994|NCT03329846|541207462|FG000|Overall Study|Disease progression|4|||
150019995|NCT03329846|541207463|FG001|Overall Study|Disease progression|6|||
150019996|NCT03329846|541207462|FG000|Overall Study|Study drug toxicity|1|||
150019997|NCT03329846|541207463|FG001|Overall Study|Study drug toxicity|0|||
150019998|NCT03329846|541207462|FG000|Overall Study|Participant request to discontinue treatment|0|||
150019999|NCT03329846|541207463|FG001|Overall Study|Participant request to discontinue treatment|1|||
150020000|NCT03329846|541207462|FG000|Overall Study|Participant withdrew consent|1|||
150020001|NCT03329846|541207463|FG001|Overall Study|Participant withdrew consent|0|||
150020002|NCT03329846|541207462|FG000|Overall Study|Other reasons|2|||
150020003|NCT03329846|541207463|FG001|Overall Study|Other reasons|2|||
150020004|NCT03066193|541207464|FG000|Overall Study|Withdrawal by Subject|1|||
150020005|NCT02631551|541207465|FG000|Overall Study|Adverse Event|1|||
150020006|NCT02631551|541207466|FG001|Overall Study|Adverse Event|2|||
150020007|NCT02631551|541207467|FG002|Overall Study|Adverse Event|4|||
150020008|NCT02631551|541207468|FG003|Overall Study|Adverse Event|0|||
150020009|NCT02631551|541207465|FG000|Overall Study|Lack of Efficacy|0|||
150020010|NCT02631551|541207466|FG001|Overall Study|Lack of Efficacy|0|||
150020011|NCT02631551|541207467|FG002|Overall Study|Lack of Efficacy|1|||
150020012|NCT02631551|541207468|FG003|Overall Study|Lack of Efficacy|0|||
150020013|NCT02631551|541207465|FG000|Overall Study|Lost to Follow-up|1|||
150020014|NCT02631551|541207466|FG001|Overall Study|Lost to Follow-up|2|||
150020015|NCT02631551|541207467|FG002|Overall Study|Lost to Follow-up|0|||
150020016|NCT02631551|541207468|FG003|Overall Study|Lost to Follow-up|3|||
150020017|NCT02631551|541207465|FG000|Overall Study|Withdrawal by Subject|2|||
150020018|NCT02631551|541207466|FG001|Overall Study|Withdrawal by Subject|2|||
150020019|NCT02631551|541207467|FG002|Overall Study|Withdrawal by Subject|0|||
150020020|NCT02631551|541207468|FG003|Overall Study|Withdrawal by Subject|5|||
150020021|NCT02631551|541207465|FG000|Overall Study|Protocol deviation|3|||
150020022|NCT02631551|541207466|FG001|Overall Study|Protocol deviation|6|||
150020023|NCT02631551|541207467|FG002|Overall Study|Protocol deviation|3|||
150020024|NCT02631551|541207468|FG003|Overall Study|Protocol deviation|0|||
150020025|NCT02631551|541207465|FG000|Overall Study|Non-compliance with study procedures|0|||
150020026|NCT02631551|541207466|FG001|Overall Study|Non-compliance with study procedures|0|||
150020027|NCT02631551|541207467|FG002|Overall Study|Non-compliance with study procedures|1|||
150020028|NCT02631551|541207468|FG003|Overall Study|Non-compliance with study procedures|1|||
150020029|NCT02631551|541207465|FG000|Overall Study|Non-compliance with study drug|1|||
150020030|NCT02631551|541207466|FG001|Overall Study|Non-compliance with study drug|0|||
150020031|NCT02631551|541207467|FG002|Overall Study|Non-compliance with study drug|0|||
150020032|NCT02631551|541207468|FG003|Overall Study|Non-compliance with study drug|0|||
150020033|NCT02631551|541207465|FG000|Overall Study|Other, specific reasons not collected|5|||
150020034|NCT02631551|541207466|FG001|Overall Study|Other, specific reasons not collected|7|||
150020035|NCT02631551|541207467|FG002|Overall Study|Other, specific reasons not collected|2|||
150020036|NCT02631551|541207468|FG003|Overall Study|Other, specific reasons not collected|2|||
150020037|NCT02859246|541207469|FG000|Overall Study|Screen fails|3|||
150020038|NCT02859246|541207469|FG000|Overall Study|Adverse Event|1|||
150020039|NCT02859246|541207469|FG000|Overall Study|Withdrawal by Subject|1|||
150020040|NCT00080301|541207470|FG000|Overall Study|Randomized but Never Treated|5|||
150020041|NCT00080301|541207471|FG001|Overall Study|Randomized but Never Treated|10|||
150020042|NCT00080301|541207470|FG000|Overall Study|Still on Treatment as of CSR date|0|||
150020043|NCT00080301|541207471|FG001|Overall Study|Still on Treatment as of CSR date|1|||
150020044|NCT01196026|541207472|FG000|Overall Study|Withdrawal by Subject|1|||
150020045|NCT01196026|541207473|FG001|Overall Study|Withdrawal by Subject|4|||
150020046|NCT01196026|541207474|FG002|Overall Study|Withdrawal by Subject|0|||
150020047|NCT01196026|541207475|FG003|Overall Study|Withdrawal by Subject|0|||
150020048|NCT01196026|541207476|FG004|Overall Study|Withdrawal by Subject|0|||
150020049|NCT01196026|541207477|FG005|Overall Study|Withdrawal by Subject|0|||
150020050|NCT01196026|541207472|FG000|Overall Study|Lost to Follow-up|0|||
150020051|NCT01196026|541207473|FG001|Overall Study|Lost to Follow-up|3|||
150020052|NCT01196026|541207474|FG002|Overall Study|Lost to Follow-up|0|||
150020053|NCT01196026|541207475|FG003|Overall Study|Lost to Follow-up|0|||
150020054|NCT01196026|541207476|FG004|Overall Study|Lost to Follow-up|1|||
150020055|NCT01196026|541207477|FG005|Overall Study|Lost to Follow-up|0|||
150020056|NCT01196026|541207472|FG000|Overall Study|Other|0|||
150020057|NCT01196026|541207473|FG001|Overall Study|Other|1|||
150020058|NCT01196026|541207474|FG002|Overall Study|Other|0|||
150020059|NCT01196026|541207475|FG003|Overall Study|Other|0|||
150020060|NCT01196026|541207476|FG004|Overall Study|Other|0|||
150020061|NCT01196026|541207477|FG005|Overall Study|Other|0|||
150020062|NCT04034004|541207478|FG000|Overall Study|Withdrawal by Subject|1|||
150020063|NCT04034004|541207479|FG001|Overall Study|Withdrawal by Subject|2|||
150020064|NCT04034004|541207480|FG002|Overall Study|Withdrawal by Subject|2|||
150020065|NCT04034004|541207481|FG003|Overall Study|Withdrawal by Subject|3|||
150020066|NCT04034004|541207478|FG000|Overall Study|could not find vein to administer IV|2|||
150020067|NCT04034004|541207479|FG001|Overall Study|could not find vein to administer IV|1|||
150020068|NCT04034004|541207480|FG002|Overall Study|could not find vein to administer IV|0|||
150020069|NCT04034004|541207481|FG003|Overall Study|could not find vein to administer IV|0|||
150020070|NCT04034004|541207478|FG000|Overall Study|nurse accidentally unblinded subject|0|||
150020071|NCT04034004|541207479|FG001|Overall Study|nurse accidentally unblinded subject|0|||
150020072|NCT04034004|541207480|FG002|Overall Study|nurse accidentally unblinded subject|0|||
150020073|NCT04034004|541207481|FG003|Overall Study|nurse accidentally unblinded subject|1|||
150020074|NCT04317040|541207483|FG000|Overall Study|Lost to Follow-up|2|||
150020075|NCT04317040|541207484|FG001|Overall Study|Lost to Follow-up|0|||
150020076|NCT04317040|541207483|FG000|Overall Study|Death|16|||
150020077|NCT04317040|541207484|FG001|Overall Study|Death|18|||
150020078|NCT04317040|541207483|FG000|Overall Study|Withdrawal by Subject|0|||
150020079|NCT04317040|541207484|FG001|Overall Study|Withdrawal by Subject|1|||
150020080|NCT04317040|541207483|FG000|Overall Study|Incomplete assessments|0|||
150020081|NCT04317040|541207484|FG001|Overall Study|Incomplete assessments|1|||
150020082|NCT03672292|541207485|FG000|Overall Study|Adverse Event|3|||
150020083|NCT03672292|541207486|FG001|Overall Study|Adverse Event|1|||
150020084|NCT03672292|541207485|FG000|Overall Study|Physician Decision|0|||
150020085|NCT03672292|541207486|FG001|Overall Study|Physician Decision|1|||
150020086|NCT03672292|541207485|FG000|Overall Study|Withdrawal by Subject|1|||
150020087|NCT03672292|541207486|FG001|Overall Study|Withdrawal by Subject|2|||
150020088|NCT00799903|541207487|FG000|Overall Study|Investigator Site Closed|25|||
150020089|NCT00799903|541207488|FG001|Overall Study|Investigator Site Closed|23|||
150020090|NCT00799903|541207487|FG000|Overall Study|Withdrawal by Subject|179|||
150020091|NCT00799903|541207488|FG001|Overall Study|Withdrawal by Subject|175|||
150020092|NCT00799903|541207487|FG000|Overall Study|Lost to Follow-up|69|||
150020093|NCT00799903|541207488|FG001|Overall Study|Lost to Follow-up|80|||
150020094|NCT02518971|541207489|FG000|Overall Study|Lost to Follow-up|0|||
150020095|NCT02518971|541207490|FG001|Overall Study|Lost to Follow-up|1|||
150020096|NCT02518971|541207489|FG000|Overall Study|Physician Decision|6|||
150020097|NCT02518971|541207490|FG001|Overall Study|Physician Decision|6|||
150020098|NCT02518971|541207489|FG000|Overall Study|Protocol Violation|6|||
150020099|NCT02518971|541207490|FG001|Overall Study|Protocol Violation|4|||
150020100|NCT02518971|541207489|FG000|Overall Study|Withdrawal by Subject|4|||
150020101|NCT02518971|541207490|FG001|Overall Study|Withdrawal by Subject|5|||
150020102|NCT02518971|541207489|FG000|Overall Study|Side effects|1|||
150020103|NCT02518971|541207490|FG001|Overall Study|Side effects|0|||
150020104|NCT02518971|541207489|FG000|Overall Study|medication lost in mail|0|||
150020105|NCT02518971|541207490|FG001|Overall Study|medication lost in mail|1|||
150020106|NCT02518971|541207489|FG000|Overall Study|eligibility criteria no longer met|6|||
150020107|NCT02518971|541207490|FG001|Overall Study|eligibility criteria no longer met|3|||
150020108|NCT03088917|541207491|FG000|Overall Study|In care/cured elsewhere|15|||
150059369|NCT02486718|541358576|FG001|Enrollment Phase|Lost to Follow-up|0|||
150059370|NCT02486718|541358577|FG002|Enrollment Phase|Lost to Follow-up|0|||
150059371|NCT02486718|541358575|FG000|Enrollment Phase|Adverse Event|34|||
150059372|NCT02486718|541358576|FG001|Enrollment Phase|Adverse Event|0|||
150020109|NCT03088917|541207491|FG000|Overall Study|Refuse re-evaluation|13|||
150020110|NCT03088917|541207491|FG000|Overall Study|Contact not established|13|||
150020111|NCT03088917|541207491|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
150020112|NCT03088917|541207491|FG000|Overall Study|Moved outside study region|50|||
150059373|NCT02486718|541358577|FG002|Enrollment Phase|Adverse Event|0|||
150020113|NCT00757237|541207492|FG000|Overall Study|Lost to Follow-up|0|||
150020114|NCT00757237|541207493|FG001|Overall Study|Lost to Follow-up|1|||
150020115|NCT00757237|541207492|FG000|Overall Study|Protocol Violation|0|||
150020116|NCT00757237|541207493|FG001|Overall Study|Protocol Violation|2|||
150020117|NCT00757237|541207492|FG000|Overall Study|Physician Decision|2|||
150020118|NCT00757237|541207493|FG001|Overall Study|Physician Decision|3|||
150020119|NCT00757237|541207492|FG000|Overall Study|Withdrawal by Subject|8|||
150020120|NCT00757237|541207493|FG001|Overall Study|Withdrawal by Subject|12|||
150020121|NCT00757237|541207492|FG000|Overall Study|Safety or Tolerability|3|||
150020122|NCT00757237|541207493|FG001|Overall Study|Safety or Tolerability|5|||
150020123|NCT00757237|541207492|FG000|Overall Study|Other|0|||
150020124|NCT00757237|541207493|FG001|Overall Study|Other|2|||
150020125|NCT05150990|541207500|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
150020126|NCT05150990|541207501|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
150020127|NCT05150990|541207500|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
150020128|NCT05150990|541207501|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
150020129|NCT05150990|541207500|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
150020130|NCT05150990|541207501|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
150020131|NCT05150990|541207500|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
150020132|NCT05150990|541207501|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
150020133|NCT05150990|541207500|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
150020134|NCT05150990|541207501|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
150020135|NCT05150990|541207500|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
150020136|NCT05150990|541207501|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
150020137|NCT05150990|541207500|FG000|Overall Study|Death (unrelated to the intervention)|1|||
150020138|NCT05150990|541207501|FG001|Overall Study|Death (unrelated to the intervention)|2|||
150020139|NCT00779025|541207502|FG000|Overall Study|Withdrawal by Subject|1|||
150020140|NCT01397461|541207504|FG000|Overall Study|Withdrawal by Subject|2|||
150020141|NCT01397461|541207505|FG001|Overall Study|Withdrawal by Subject|1|||
150020142|NCT01397461|541207506|FG002|Overall Study|Withdrawal by Subject|0|||
150020143|NCT01397461|541207504|FG000|Overall Study|Lost to Follow-up|0|||
150020144|NCT01397461|541207505|FG001|Overall Study|Lost to Follow-up|2|||
150020145|NCT01397461|541207506|FG002|Overall Study|Lost to Follow-up|1|||
150020146|NCT01397461|541207504|FG000|Overall Study|Lack of Efficacy|0|||
150020147|NCT01397461|541207505|FG001|Overall Study|Lack of Efficacy|3|||
150020148|NCT01397461|541207506|FG002|Overall Study|Lack of Efficacy|0|||
150020149|NCT01397461|541207504|FG000|Overall Study|Not treated|0|||
150020150|NCT01397461|541207505|FG001|Overall Study|Not treated|0|||
150020151|NCT01397461|541207506|FG002|Overall Study|Not treated|1|||
150020152|NCT05729568|541207523|FG000|Overall Study|Still on Study|52|||
150020153|NCT05729568|541207524|FG001|Overall Study|Still on Study|26|||
150020154|NCT05729568|541207523|FG000|Overall Study|Randomized but Never Treated|3|||
150020155|NCT05729568|541207524|FG001|Overall Study|Randomized but Never Treated|0|||
150020156|NCT05729568|541207523|FG000|Overall Study|Adverse Event|0|||
150020157|NCT05729568|541207524|FG001|Overall Study|Adverse Event|1|||
150020158|NCT05729568|541207523|FG000|Overall Study|Investigator's Discretion|1|||
150020159|NCT05729568|541207524|FG001|Overall Study|Investigator's Discretion|0|||
150020160|NCT04181762|541207525|FG000|Overall Study|Adverse Event|1|||
150020161|NCT04181762|541207526|FG001|Overall Study|Adverse Event|3|||
150020162|NCT04181762|541207525|FG000|Overall Study|Lost to Follow-up|1|||
150020163|NCT04181762|541207526|FG001|Overall Study|Lost to Follow-up|1|||
150020164|NCT04181762|541207525|FG000|Overall Study|Physician Decision|1|||
150020165|NCT04181762|541207526|FG001|Overall Study|Physician Decision|3|||
150020166|NCT04181762|541207525|FG000|Overall Study|Pregnancy|0|||
150020167|NCT04181762|541207526|FG001|Overall Study|Pregnancy|1|||
150020168|NCT04181762|541207525|FG000|Overall Study|Lack of Efficacy|2|||
150020169|NCT04181762|541207526|FG001|Overall Study|Lack of Efficacy|2|||
150020170|NCT04181762|541207525|FG000|Overall Study|Study terminated by sponsor|95|||
150020171|NCT04181762|541207526|FG001|Overall Study|Study terminated by sponsor|97|||
150020172|NCT04181762|541207525|FG000|Overall Study|Subject decision|11|||
150059374|NCT02486718|541358575|FG000|Randomized Phase|Withdrawal by Subject|0|||
150059375|NCT02486718|541358576|FG001|Randomized Phase|Withdrawal by Subject|44|||
150020173|NCT04181762|541207526|FG001|Overall Study|Subject decision|4|||
150020174|NCT04181762|541207525|FG000|Overall Study|Death|1|||
150020175|NCT04181762|541207526|FG001|Overall Study|Death|1|||
150020176|NCT04181762|541207525|FG000|Overall Study|Protocol deviation|1|||
150059376|NCT02486718|541358577|FG002|Randomized Phase|Withdrawal by Subject|47|||
150059377|NCT02486718|541358575|FG000|Randomized Phase|Protocol Violation|0|||
150181693|NCT00088413|541802831|FG002|Overall Study|Progressive disease|8|||
150181694|NCT00088413|541802832|FG003|Overall Study|Progressive disease|14|||
150181695|NCT00088413|541802829|FG000|Overall Study|Other|0|||
150181696|NCT00088413|541802830|FG001|Overall Study|Other|1|||
150181697|NCT00088413|541802831|FG002|Overall Study|Other|0|||
150181698|NCT00088413|541802832|FG003|Overall Study|Other|0|||
150181699|NCT00088413|541802829|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
150181700|NCT00088413|541802830|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
150181701|NCT00088413|541802831|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
150181702|NCT00088413|541802832|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
150181703|NCT02539225|541802833|FG000|Part A|Adverse Event|13|||
150020177|NCT04181762|541207526|FG001|Overall Study|Protocol deviation|0|||
150020178|NCT04181762|541207525|FG000|Overall Study|Withdrawal of informed consent|1|||
150020179|NCT04181762|541207526|FG001|Overall Study|Withdrawal of informed consent|3|||
150020180|NCT01221350|541207538|FG000|Overall Study|Discontinued intervention (GERD)|1|||
150020181|NCT01221350|541207539|FG001|Overall Study|Discontinued intervention (GERD)|0|||
150020182|NCT01221350|541207538|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
150020183|NCT01221350|541207539|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
150020184|NCT01221350|541207538|FG000|Overall Study|Withdrawal by Subject|4|||
150020185|NCT01221350|541207539|FG001|Overall Study|Withdrawal by Subject|2|||
150020186|NCT01514201|541207540|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
150020187|NCT01514201|541207541|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020188|NCT01514201|541207542|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020189|NCT01514201|541207543|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020190|NCT01514201|541207540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
150020191|NCT01514201|541207541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
150020192|NCT01514201|541207542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
150020193|NCT01514201|541207543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
150020194|NCT01514201|541207540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
150020195|NCT01514201|541207541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
150020196|NCT01514201|541207542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
150020197|NCT01514201|541207543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
150020198|NCT01514201|541207540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
150020199|NCT01514201|541207541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
150020200|NCT01514201|541207542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
150020201|NCT01514201|541207543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
150020202|NCT01514201|541207540|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
150020203|NCT01514201|541207541|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
150020204|NCT01514201|541207542|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
150020205|NCT01514201|541207543|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
150020206|NCT01514201|541207540|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
150020207|NCT01514201|541207541|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
150020208|NCT01514201|541207542|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
150020209|NCT01514201|541207543|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
150020210|NCT01514201|541207540|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
150020211|NCT01514201|541207541|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
150020212|NCT01514201|541207542|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
150020213|NCT01514201|541207543|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
150020214|NCT01514201|541207540|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020215|NCT01514201|541207541|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020216|NCT01514201|541207542|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
150020217|NCT01514201|541207543|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
150020218|NCT01514201|541207540|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
150020219|NCT01514201|541207541|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
150020220|NCT01514201|541207542|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
150020221|NCT01514201|541207543|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
150020222|NCT01514201|541207540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
150020223|NCT01514201|541207541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
150020224|NCT01514201|541207542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
150020225|NCT01514201|541207543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
150059378|NCT02486718|541358576|FG001|Randomized Phase|Protocol Violation|2|||
150059379|NCT02486718|541358577|FG002|Randomized Phase|Protocol Violation|0|||
150059380|NCT02486718|541358575|FG000|Randomized Phase|Physician Decision|0|||
150059381|NCT02486718|541358576|FG001|Randomized Phase|Physician Decision|0|||
150059382|NCT02486718|541358577|FG002|Randomized Phase|Physician Decision|3|||
150059383|NCT02486718|541358575|FG000|Randomized Phase|Lost to Follow-up|0|||
150059384|NCT02486718|541358576|FG001|Randomized Phase|Lost to Follow-up|5|||
150020226|NCT01514201|541207540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
150020227|NCT01514201|541207541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
150020228|NCT01514201|541207542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
150020229|NCT01514201|541207543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
150020230|NCT01514201|541207540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
150059385|NCT02486718|541358577|FG002|Randomized Phase|Lost to Follow-up|11|||
150059386|NCT02486718|541358575|FG000|Randomized Phase|Disease Relapse|0|||
150059387|NCT02486718|541358576|FG001|Randomized Phase|Disease Relapse|1|||
150059388|NCT02486718|541358577|FG002|Randomized Phase|Disease Relapse|0|||
150059389|NCT02486718|541358575|FG000|Randomized Phase|Death|0|||
150059390|NCT02486718|541358576|FG001|Randomized Phase|Death|154|||
150059391|NCT02486718|541358577|FG002|Randomized Phase|Death|155|||
150020231|NCT01514201|541207541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
150020232|NCT01514201|541207542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
150020233|NCT01514201|541207543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
150020234|NCT02735343|541207548|FG000|Overall Study|screen fail|0|||
150020235|NCT02735343|541207549|FG001|Overall Study|screen fail|2|||
150020236|NCT00637416|541207552|FG000|Overall Study|Lost to Follow-up|1|||
150020237|NCT00637416|541207553|FG001|Overall Study|Lost to Follow-up|1|||
150020238|NCT00637416|541207552|FG000|Overall Study|Unable to take study drug|0|||
150020239|NCT00637416|541207553|FG001|Overall Study|Unable to take study drug|1|||
150020240|NCT02534909|541207561|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
150020241|NCT00132808|541207564|FG000|Stratum I|Adverse Event|2|||
150020242|NCT00132808|541207565|FG001|Stratum I|Adverse Event|1|||
150020243|NCT00132808|541207566|FG002|Stratum I|Adverse Event|0|||
150020244|NCT00132808|541207564|FG000|Stratum I|Lost to Follow-up|3|||
150020245|NCT00132808|541207565|FG001|Stratum I|Lost to Follow-up|4|||
150020246|NCT00132808|541207566|FG002|Stratum I|Lost to Follow-up|1|||
150020247|NCT00132808|541207564|FG000|Stratum I|Withdrawal by Subject|4|||
150020248|NCT00132808|541207565|FG001|Stratum I|Withdrawal by Subject|7|||
150020249|NCT00132808|541207566|FG002|Stratum I|Withdrawal by Subject|3|||
150059392|NCT02486718|541358575|FG000|Randomized Phase|Ongoing|0|||
150059393|NCT02486718|541358576|FG001|Randomized Phase|Ongoing|301|||
150059394|NCT02486718|541358577|FG002|Randomized Phase|Ongoing|282|||
150059395|NCT02520089|541358578|FG000|Overall Study|Lost to Follow-up|3|||
150059396|NCT02520089|541358579|FG001|Overall Study|Lost to Follow-up|4|||
150059397|NCT01037088|541358582|FG000|Overall Study|Withdrawal by Subject|3|||
150059398|NCT02216812|541358585|FG000|Overall Study|Lost to Follow-up|10|||
150059399|NCT02216812|541358586|FG001|Overall Study|Lost to Follow-up|5|||
150059400|NCT00527488|541358591|FG000|Overall Study|Withdrawn prior to dosing|0|||
150059401|NCT00527488|541358592|FG001|Overall Study|Withdrawn prior to dosing|1|||
150059402|NCT00527488|541358593|FG002|Overall Study|Withdrawn prior to dosing|1|||
150059403|NCT00527488|541358594|FG003|Overall Study|Withdrawn prior to dosing|0|||
150059404|NCT01958827|541358595|FG000|Overall Study|Adverse Event|3|||
150059405|NCT01958827|541358595|FG000|Overall Study|Lack of Efficacy|6|||
150059406|NCT01958827|541358595|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
150059407|NCT03036800|541358596|FG000|Overall Study|Protocol Violation|1|||
150059408|NCT03036800|541358597|FG001|Overall Study|Protocol Violation|0|||
150059409|NCT03036800|541358596|FG000|Overall Study|Non-compliance|1|||
150059410|NCT03036800|541358597|FG001|Overall Study|Non-compliance|0|||
150059411|NCT03036800|541358596|FG000|Overall Study|Lost to Follow-up|1|||
150059412|NCT03036800|541358597|FG001|Overall Study|Lost to Follow-up|0|||
150059413|NCT03036800|541358596|FG000|Overall Study|Death|1|||
150059414|NCT03036800|541358597|FG001|Overall Study|Death|0|||
150059415|NCT03036800|541358596|FG000|Overall Study|Tolerance|5|||
150059416|NCT03036800|541358597|FG001|Overall Study|Tolerance|0|||
150059417|NCT03036800|541358596|FG000|Overall Study|Unknown/no reason given|50|||
150059418|NCT03036800|541358597|FG001|Overall Study|Unknown/no reason given|39|||
150059419|NCT02829944|541358605|FG000|Overall Study|Physician Decision|0|||
150059420|NCT02829944|541358606|FG001|Overall Study|Physician Decision|1|||
150059421|NCT02829944|541358605|FG000|Overall Study|Screen Failure|2|||
150059422|NCT02829944|541358606|FG001|Overall Study|Screen Failure|2|||
150059423|NCT02829944|541358605|FG000|Overall Study|Inadequate Neuraxial Block|1|||
150059424|NCT02829944|541358606|FG001|Overall Study|Inadequate Neuraxial Block|1|||
150059425|NCT02829944|541358605|FG000|Overall Study|Withdrawal by Subject|2|||
150059426|NCT02829944|541358606|FG001|Overall Study|Withdrawal by Subject|1|||
150059427|NCT02829944|541358605|FG000|Overall Study|Catheter Displacement|1|||
150059428|NCT02829944|541358606|FG001|Overall Study|Catheter Displacement|0|||
150059429|NCT02829944|541358605|FG000|Overall Study|Catheter broke|0|||
150059430|NCT02829944|541358606|FG001|Overall Study|Catheter broke|1|||
150059431|NCT02829944|541358605|FG000|Overall Study|Staff unavailable|0|||
150059432|NCT02829944|541358606|FG001|Overall Study|Staff unavailable|1|||
150059433|NCT01730937|541358608|FG000|Overall Study|Protocol Violation|5|||
150059434|NCT01730937|541358609|FG001|Overall Study|Protocol Violation|11|||
150059435|NCT03875235|541358610|FG000|Overall Study|Ongoing study treatment|63|||
150059436|NCT03875235|541358611|FG001|Overall Study|Ongoing study treatment|20|||
150059437|NCT03875235|541358610|FG000|Overall Study|Off treatment|77|||
150059438|NCT03875235|541358611|FG001|Overall Study|Off treatment|91|||
150059439|NCT03875235|541358610|FG000|Overall Study|Withdrawal by Subject|3|||
150059440|NCT03875235|541358611|FG001|Overall Study|Withdrawal by Subject|10|||
150059441|NCT03875235|541358610|FG000|Overall Study|Death|198|||
150059442|NCT03875235|541358611|FG001|Overall Study|Death|223|||
150059443|NCT01395784|541358614|FG000|Overall Study|Lost to Follow-up|7|||
150059444|NCT01395784|541358614|FG000|Overall Study|Withdrawal by Subject|3|||
150059445|NCT01395784|541358614|FG000|Overall Study|Physician Decision|5|||
150059446|NCT00622739|541360283|FG000|Overall Study|Physician Decision|1|||
150020250|NCT00132808|541207564|FG000|Stratum I|Abnormal test procedure result (s)|0|||
150020251|NCT00132808|541207565|FG001|Stratum I|Abnormal test procedure result (s)|0|||
150020252|NCT00132808|541207566|FG002|Stratum I|Abnormal test procedure result (s)|1|||
150020253|NCT00132808|541207564|FG000|Stratum II|Adverse Event|1|||
150020254|NCT00132808|541207565|FG001|Stratum II|Adverse Event|2|||
150020255|NCT00132808|541207566|FG002|Stratum II|Adverse Event|1|||
150020256|NCT00132808|541207564|FG000|Stratum II|Death|1|||
150020257|NCT00132808|541207565|FG001|Stratum II|Death|0|||
150020258|NCT00132808|541207566|FG002|Stratum II|Death|0|||
150020259|NCT00132808|541207564|FG000|Stratum II|Lost to Follow-up|2|||
150020260|NCT00132808|541207565|FG001|Stratum II|Lost to Follow-up|2|||
150020261|NCT00132808|541207566|FG002|Stratum II|Lost to Follow-up|1|||
150020262|NCT00132808|541207564|FG000|Stratum II|Protocol Violation|0|||
150020263|NCT00132808|541207565|FG001|Stratum II|Protocol Violation|2|||
150020264|NCT00132808|541207566|FG002|Stratum II|Protocol Violation|1|||
150020265|NCT00132808|541207564|FG000|Stratum II|Withdrawal by Subject|4|||
150020266|NCT00132808|541207565|FG001|Stratum II|Withdrawal by Subject|9|||
150020267|NCT00132808|541207566|FG002|Stratum II|Withdrawal by Subject|6|||
150020268|NCT02715609|541207573|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
150020269|NCT02715609|541207574|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
150020270|NCT02715609|541207575|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
150020271|NCT02715609|541207573|FG000|Overall Study|Withdrawal by Subject|0|||
150020272|NCT02715609|541207574|FG001|Overall Study|Withdrawal by Subject|0|||
150020273|NCT02715609|541207575|FG002|Overall Study|Withdrawal by Subject|1|||
150020274|NCT00362648|541207576|FG000|Overall Study|Adverse Event|12|||
150020275|NCT00362648|541207577|FG001|Overall Study|Adverse Event|21|||
150020276|NCT00362648|541207578|FG002|Overall Study|Adverse Event|1|||
150020277|NCT00362648|541207579|FG003|Overall Study|Adverse Event|0|||
150020278|NCT00362648|541207576|FG000|Overall Study|Lost to Follow-up|62|||
150020279|NCT00362648|541207577|FG001|Overall Study|Lost to Follow-up|69|||
150020280|NCT00362648|541207578|FG002|Overall Study|Lost to Follow-up|4|||
150020281|NCT00362648|541207579|FG003|Overall Study|Lost to Follow-up|3|||
150020282|NCT00362648|541207576|FG000|Overall Study|Protocol Violation|4|||
150020283|NCT00362648|541207577|FG001|Overall Study|Protocol Violation|2|||
150020284|NCT00362648|541207578|FG002|Overall Study|Protocol Violation|2|||
150020285|NCT00362648|541207579|FG003|Overall Study|Protocol Violation|2|||
150020286|NCT00362648|541207576|FG000|Overall Study|Withdrawal by Subject|48|||
150020287|NCT00362648|541207577|FG001|Overall Study|Withdrawal by Subject|42|||
150020288|NCT00362648|541207578|FG002|Overall Study|Withdrawal by Subject|2|||
150020289|NCT00362648|541207579|FG003|Overall Study|Withdrawal by Subject|6|||
150020290|NCT02204072|541207580|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
150020291|NCT02204072|541207581|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
150020292|NCT02204072|541207582|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
150020293|NCT02204072|541207583|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
150020294|NCT02204072|541207584|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
150020295|NCT02204072|541207580|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
150020296|NCT02204072|541207581|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
150020297|NCT02204072|541207582|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
150020298|NCT02204072|541207583|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
150020299|NCT02204072|541207584|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
150020300|NCT02204072|541207580|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
150020301|NCT02204072|541207581|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
150020302|NCT02204072|541207582|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
150020303|NCT02204072|541207583|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
150020304|NCT02204072|541207584|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
150020305|NCT02204072|541207580|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
150020306|NCT02204072|541207581|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
150020307|NCT02204072|541207582|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
150020308|NCT02204072|541207583|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
150020309|NCT02204072|541207584|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
150020310|NCT03983304|541207585|FG000|Overall Study|Withdrawal by Subject|5|||
150020311|NCT03983304|541207585|FG000|Overall Study|Lost to Follow-up|2|||
150020312|NCT00310817|541207586|FG000|Overall Study|AE or Death|3|||
150020313|NCT00310817|541207587|FG001|Overall Study|AE or Death|1|||
150020314|NCT00310817|541207588|FG002|Overall Study|AE or Death|0|||
150020315|NCT00310817|541207589|FG003|Overall Study|AE or Death|0|||
150020316|NCT00310817|541207586|FG000|Overall Study|Withdrawal by Subject|1|||
150020317|NCT00310817|541207587|FG001|Overall Study|Withdrawal by Subject|4|||
150020318|NCT00310817|541207588|FG002|Overall Study|Withdrawal by Subject|6|||
150059447|NCT00622739|541360284|FG001|Overall Study|Physician Decision|0|||
150059448|NCT00622739|541360283|FG000|Overall Study|Adverse Event|1|||
150059449|NCT00622739|541360284|FG001|Overall Study|Adverse Event|2|||
150059450|NCT00622739|541360283|FG000|Overall Study|Lack of Efficacy|0|||
150059451|NCT00622739|541360284|FG001|Overall Study|Lack of Efficacy|2|||
150059452|NCT00622739|541360283|FG000|Overall Study|Withdrawal by Subject|0|||
150059453|NCT00622739|541360284|FG001|Overall Study|Withdrawal by Subject|1|||
150059454|NCT00622739|541360283|FG000|Overall Study|Lost to Follow-up|0|||
150059455|NCT00622739|541360284|FG001|Overall Study|Lost to Follow-up|1|||
150020319|NCT00310817|541207589|FG003|Overall Study|Withdrawal by Subject|7|||
150020320|NCT00310817|541207586|FG000|Overall Study|Lost to Follow-up|2|||
150020321|NCT00310817|541207587|FG001|Overall Study|Lost to Follow-up|1|||
150020322|NCT00310817|541207588|FG002|Overall Study|Lost to Follow-up|0|||
150020323|NCT00310817|541207589|FG003|Overall Study|Lost to Follow-up|0|||
150020324|NCT00310817|541207586|FG000|Overall Study|Inappropriate Enrollment|1|||
150020325|NCT00310817|541207587|FG001|Overall Study|Inappropriate Enrollment|0|||
150020326|NCT00310817|541207588|FG002|Overall Study|Inappropriate Enrollment|1|||
150020327|NCT00310817|541207589|FG003|Overall Study|Inappropriate Enrollment|0|||
150020328|NCT00310817|541207586|FG000|Overall Study|Protocol Violation|1|||
150020329|NCT00310817|541207587|FG001|Overall Study|Protocol Violation|1|||
150020330|NCT00310817|541207588|FG002|Overall Study|Protocol Violation|1|||
150020331|NCT00310817|541207589|FG003|Overall Study|Protocol Violation|1|||
150020332|NCT00310817|541207586|FG000|Overall Study|Unable to classify|3|||
150020333|NCT00310817|541207587|FG001|Overall Study|Unable to classify|1|||
150020334|NCT00310817|541207588|FG002|Overall Study|Unable to classify|0|||
150020335|NCT00310817|541207589|FG003|Overall Study|Unable to classify|0|||
150020336|NCT01587040|541207595|FG000|Overall Study|Protocol Violation|0|||
150020337|NCT01587040|541207596|FG001|Overall Study|Protocol Violation|0|||
150020338|NCT01587040|541207597|FG002|Overall Study|Protocol Violation|1|||
150020339|NCT01587040|541207598|FG003|Overall Study|Protocol Violation|0|||
150020340|NCT01587040|541207595|FG000|Overall Study|Adverse Event|0|||
150020341|NCT01587040|541207596|FG001|Overall Study|Adverse Event|1|||
150059456|NCT03123185|541360295|FG000|Overall Study|Withdrawal by Subject|0|||
150059457|NCT03123185|541360296|FG001|Overall Study|Withdrawal by Subject|0|||
150059458|NCT03123185|541360297|FG002|Overall Study|Withdrawal by Subject|0|||
150059459|NCT03123185|541360298|FG003|Overall Study|Withdrawal by Subject|0|||
150059460|NCT03123185|541360299|FG004|Overall Study|Withdrawal by Subject|0|||
150059461|NCT03123185|541360300|FG005|Overall Study|Withdrawal by Subject|0|||
150059462|NCT03123185|541360301|FG006|Overall Study|Withdrawal by Subject|0|||
150059463|NCT03123185|541360302|FG007|Overall Study|Withdrawal by Subject|0|||
150059464|NCT03123185|541360303|FG008|Overall Study|Withdrawal by Subject|0|||
150059465|NCT03123185|541360304|FG009|Overall Study|Withdrawal by Subject|0|||
150059466|NCT03123185|541360305|FG010|Overall Study|Withdrawal by Subject|0|||
150059467|NCT03123185|541360306|FG011|Overall Study|Withdrawal by Subject|0|||
150059468|NCT03123185|541360307|FG012|Overall Study|Withdrawal by Subject|1|||
150059469|NCT03123185|541360308|FG013|Overall Study|Withdrawal by Subject|0|||
150059470|NCT03468543|541360312|FG000|Overall Study|Protocol stopping rules met|3|||
150059471|NCT00470158|541360313|FG000|Overall Study|Death|0|||
150059472|NCT00470158|541360314|FG001|Overall Study|Death|0|||
150059473|NCT00470158|541360315|FG002|Overall Study|Death|0|||
150059474|NCT00470158|541360316|FG003|Overall Study|Death|0|||
150059475|NCT00470158|541360317|FG004|Overall Study|Death|2|||
150059476|NCT00470158|541360313|FG000|Overall Study|Lost to Follow-up|7|||
150059477|NCT00470158|541360314|FG001|Overall Study|Lost to Follow-up|8|||
150059478|NCT00470158|541360315|FG002|Overall Study|Lost to Follow-up|8|||
150059479|NCT00470158|541360316|FG003|Overall Study|Lost to Follow-up|5|||
150059480|NCT00470158|541360317|FG004|Overall Study|Lost to Follow-up|4|||
150059481|NCT00470158|541360313|FG000|Overall Study|Protocol Violation|1|||
150059482|NCT00470158|541360314|FG001|Overall Study|Protocol Violation|0|||
150059483|NCT00470158|541360315|FG002|Overall Study|Protocol Violation|0|||
150059484|NCT00470158|541360316|FG003|Overall Study|Protocol Violation|0|||
150059485|NCT00470158|541360317|FG004|Overall Study|Protocol Violation|0|||
150059486|NCT01249118|541360318|FG000|First Washout Period|Physician Decision|0|||
150059487|NCT01249118|541360319|FG001|First Washout Period|Physician Decision|1|||
150059488|NCT01249118|541360320|FG002|First Washout Period|Physician Decision|0|||
150059489|NCT00880685|541360321|FG000|Memantine 10mg|Lost to Follow-up|2|||
150059490|NCT00880685|541360321|FG000|Memantine 20mg|Withdrawal by Subject|1|||
150059491|NCT04179890|541360322|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
150059492|NCT04179890|541360323|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
150059493|NCT04179890|541360322|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
150059494|NCT04179890|541360323|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
150020342|NCT01587040|541207597|FG002|Overall Study|Adverse Event|10|||
150020343|NCT01587040|541207598|FG003|Overall Study|Adverse Event|0|||
150020344|NCT01587040|541207595|FG000|Overall Study|Disease progression|12|||
150020345|NCT01587040|541207596|FG001|Overall Study|Disease progression|1|||
150059495|NCT04179890|541360322|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
150059496|NCT04179890|541360323|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
150059497|NCT04179890|541360322|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
150059498|NCT04179890|541360323|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
150059499|NCT04179890|541360322|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
150181704|NCT02539225|541802834|FG001|Part A|Adverse Event|4|||
150020346|NCT01587040|541207597|FG002|Overall Study|Disease progression|15|||
150020347|NCT01587040|541207598|FG003|Overall Study|Disease progression|3|||
150020348|NCT01587040|541207595|FG000|Overall Study|Other than specified|5|||
150020349|NCT01587040|541207596|FG001|Overall Study|Other than specified|1|||
150020350|NCT01587040|541207597|FG002|Overall Study|Other than specified|11|||
150020351|NCT01587040|541207598|FG003|Overall Study|Other than specified|1|||
150020352|NCT04346654|541207601|FG000|Overall Study|Adverse Event|2|||
150020353|NCT04346654|541207602|FG001|Overall Study|Adverse Event|0|||
150020354|NCT04346654|541207601|FG000|Overall Study|Non-response|1|||
150020355|NCT04346654|541207602|FG001|Overall Study|Non-response|1|||
150020356|NCT04346654|541207601|FG000|Overall Study|Withdrawal by Subject|2|||
150020357|NCT04346654|541207602|FG001|Overall Study|Withdrawal by Subject|0|||
150020358|NCT04346654|541207601|FG000|Overall Study|Lost to Follow-up|0|||
150020359|NCT04346654|541207602|FG001|Overall Study|Lost to Follow-up|1|||
150020360|NCT04346654|541207601|FG000|Overall Study|Pregnancy|0|||
150020361|NCT04346654|541207602|FG001|Overall Study|Pregnancy|1|||
150020362|NCT05870865|541207603|FG000|Randomized|Did not receive study treatment|2|||
150020363|NCT05870865|541207604|FG001|Randomized|Did not receive study treatment|4|||
150020364|NCT05870865|541207605|FG002|Randomized|Did not receive study treatment|4|||
150059500|NCT04179890|541360323|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
150059501|NCT04179890|541360322|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
150059502|NCT04179890|541360323|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
150059503|NCT04179890|541360322|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
150059504|NCT04179890|541360323|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
150059505|NCT04179890|541360322|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
150059506|NCT04179890|541360323|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
150059507|NCT04179890|541360322|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
150059508|NCT04179890|541360323|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
150059509|NCT00978432|541360325|FG000|Overall Study|Withdrawal by Subject|0|||
150059510|NCT00978432|541360326|FG001|Overall Study|Withdrawal by Subject|0|||
150059511|NCT00978432|541360327|FG002|Overall Study|Withdrawal by Subject|1|||
150059512|NCT00978432|541360325|FG000|Overall Study|Lack of Efficacy|1|||
150059513|NCT00978432|541360326|FG001|Overall Study|Lack of Efficacy|1|||
150059514|NCT00978432|541360327|FG002|Overall Study|Lack of Efficacy|3|||
150059515|NCT00978432|541360325|FG000|Overall Study|Adverse Event|2|||
150059516|NCT00978432|541360326|FG001|Overall Study|Adverse Event|0|||
150059517|NCT00978432|541360327|FG002|Overall Study|Adverse Event|1|||
150059518|NCT02579928|541360328|FG000|Overall Study|Withdrawal by Subject|1|||
150059519|NCT02579928|541360329|FG001|Overall Study|Withdrawal by Subject|0|||
150059520|NCT04972630|541360330|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
150059521|NCT04972630|541360331|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
150059522|NCT04972630|541360332|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
150059523|NCT05247398|541360338|FG000|Overall Study|Withdrawal by Subject|1|||
150059524|NCT04251156|541360339|FG000|Overall Study|Lost to Follow-up|1|||
150059525|NCT04251156|541360340|FG001|Overall Study|Lost to Follow-up|1|||
150059526|NCT04251156|541360339|FG000|Overall Study|Withdrawal by Subject|4|||
150059527|NCT04251156|541360340|FG001|Overall Study|Withdrawal by Subject|4|||
150059528|NCT04656275|541360341|FG000|Overall Study|Study terminated by sponsor|2|||
150059529|NCT04656275|541360342|FG001|Overall Study|Study terminated by sponsor|4|||
150059530|NCT05954143|541360344|FG000|Overall Study|Progressive Disease|1|||
150059531|NCT05954143|541360345|FG001|Overall Study|Progressive Disease|0|||
150059532|NCT05954143|541360344|FG000|Overall Study|Physician Decision|1|||
150059533|NCT05954143|541360345|FG001|Overall Study|Physician Decision|0|||
150059534|NCT05954143|541360344|FG000|Overall Study|Study Terminated by Sponsor|2|||
150059535|NCT05954143|541360345|FG001|Overall Study|Study Terminated by Sponsor|4|||
150059536|NCT05954143|541360344|FG000|Overall Study|Death|1|||
150059537|NCT05954143|541360345|FG001|Overall Study|Death|0|||
150059538|NCT05954143|541360344|FG000|Overall Study|Withdrawal by Subject|0|||
150059539|NCT05954143|541360345|FG001|Overall Study|Withdrawal by Subject|1|||
150059540|NCT05954143|541360344|FG000|Overall Study|Other|1|||
150059541|NCT05954143|541360345|FG001|Overall Study|Other|0|||
150059542|NCT01129024|541360346|FG000|Overall Study|Physician Decision|5|||
150059543|NCT01129024|541360346|FG000|Overall Study|Study Terminated by Sponsor|8|||
150059544|NCT01129024|541360346|FG000|Overall Study|Withdrawal by Subject|2|||
150059545|NCT01129024|541360346|FG000|Overall Study|Lack of Efficacy|3|||
150059546|NCT01129024|541360346|FG000|Overall Study|Needed a Platelet Transfusion|1|||
150059547|NCT00934648|541360349|FG000|Overall Study|Failure to return|8|||
150059548|NCT00934648|541360349|FG000|Overall Study|Withdrawal by Subject|1|||
150059549|NCT02361580|541360350|FG000|Overall Study|Lost to Follow-up|6|||
150059550|NCT02361580|541360351|FG001|Overall Study|Lost to Follow-up|3|||
150020365|NCT05870865|541207606|FG003|Randomized|Did not receive study treatment|3|||
150020366|NCT05870865|541207603|FG000|Treatment Period|Adverse Event|1|||
150020367|NCT05870865|541207604|FG001|Treatment Period|Adverse Event|1|||
150020368|NCT05870865|541207605|FG002|Treatment Period|Adverse Event|1|||
150020369|NCT05870865|541207606|FG003|Treatment Period|Adverse Event|1|||
150020370|NCT05870865|541207603|FG000|Treatment Period|Lost to Follow-up|0|||
150020371|NCT05870865|541207604|FG001|Treatment Period|Lost to Follow-up|1|||
150020372|NCT05870865|541207605|FG002|Treatment Period|Lost to Follow-up|2|||
150020373|NCT05870865|541207606|FG003|Treatment Period|Lost to Follow-up|0|||
150020374|NCT05870865|541207603|FG000|Treatment Period|Protocol Violation|0|||
150020375|NCT05870865|541207604|FG001|Treatment Period|Protocol Violation|0|||
150020376|NCT05870865|541207605|FG002|Treatment Period|Protocol Violation|0|||
150020377|NCT05870865|541207606|FG003|Treatment Period|Protocol Violation|1|||
150020378|NCT05870865|541207603|FG000|Treatment Period|Withdrawal by Subject|0|||
150020379|NCT05870865|541207604|FG001|Treatment Period|Withdrawal by Subject|1|||
150020380|NCT05870865|541207605|FG002|Treatment Period|Withdrawal by Subject|1|||
150020381|NCT05870865|541207606|FG003|Treatment Period|Withdrawal by Subject|1|||
150020382|NCT01594931|541209234|FG000|Overall Study|Adverse Event|3|||
150020383|NCT01594931|541209235|FG001|Overall Study|Adverse Event|1|||
150020384|NCT01594931|541209236|FG002|Overall Study|Adverse Event|1|||
150020385|NCT01594931|541209234|FG000|Overall Study|Withdrawal by Subject|2|||
150020386|NCT01594931|541209235|FG001|Overall Study|Withdrawal by Subject|1|||
150020387|NCT01594931|541209236|FG002|Overall Study|Withdrawal by Subject|1|||
150020388|NCT01594931|541209234|FG000|Overall Study|Lack of Efficacy|7|||
150020389|NCT01594931|541209235|FG001|Overall Study|Lack of Efficacy|2|||
150020390|NCT01594931|541209236|FG002|Overall Study|Lack of Efficacy|2|||
150020391|NCT01594931|541209234|FG000|Overall Study|Lost to Follow-up|4|||
150020392|NCT01594931|541209235|FG001|Overall Study|Lost to Follow-up|3|||
150020393|NCT01594931|541209236|FG002|Overall Study|Lost to Follow-up|3|||
150020394|NCT01594931|541209234|FG000|Overall Study|Protocol Violation|2|||
150020395|NCT01594931|541209235|FG001|Overall Study|Protocol Violation|1|||
150020396|NCT01594931|541209236|FG002|Overall Study|Protocol Violation|0|||
150020397|NCT01594931|541209234|FG000|Overall Study|No defiined|11|||
150020398|NCT01594931|541209235|FG001|Overall Study|No defiined|4|||
150020399|NCT01594931|541209236|FG002|Overall Study|No defiined|7|||
150020400|NCT02407223|541209238|FG000|Overall Study|Adverse Event|1|||
150020401|NCT02407223|541209239|FG001|Overall Study|Adverse Event|0|||
150020402|NCT02407223|541209240|FG002|Overall Study|Adverse Event|1|||
150020403|NCT02407223|541209238|FG000|Overall Study|Lack of Efficacy|6|||
150020404|NCT02407223|541209239|FG001|Overall Study|Lack of Efficacy|6|||
150020405|NCT02407223|541209240|FG002|Overall Study|Lack of Efficacy|4|||
150020406|NCT02407223|541209238|FG000|Overall Study|Lost to Follow-up|1|||
150020407|NCT02407223|541209239|FG001|Overall Study|Lost to Follow-up|0|||
150020408|NCT02407223|541209240|FG002|Overall Study|Lost to Follow-up|2|||
150020409|NCT02407223|541209238|FG000|Overall Study|Withdrawal by Subject|2|||
150020410|NCT02407223|541209239|FG001|Overall Study|Withdrawal by Subject|4|||
150020411|NCT02407223|541209240|FG002|Overall Study|Withdrawal by Subject|4|||
150020412|NCT02407223|541209238|FG000|Overall Study|Study Terminated by Sponsor|77|||
150020413|NCT02407223|541209239|FG001|Overall Study|Study Terminated by Sponsor|80|||
150020414|NCT02407223|541209240|FG002|Overall Study|Study Terminated by Sponsor|86|||
150020415|NCT02407223|541209238|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
150020416|NCT02407223|541209239|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
150020417|NCT02407223|541209240|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
150020418|NCT02407223|541209238|FG000|Overall Study|Other|29|||
150020419|NCT02407223|541209239|FG001|Overall Study|Other|27|||
150020420|NCT02407223|541209240|FG002|Overall Study|Other|25|||
150020421|NCT04864639|541209242|FG000|Overall Study|Death|1|||
150059551|NCT02047318|541360352|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
150059552|NCT02047318|541360352|FG000|Core Study Period|Adverse Event|1|||
150059553|NCT02047318|541360352|FG000|Core Study Period|Withdrawal by caregiver|3|||
150059554|NCT02047318|541360352|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
150059555|NCT01857310|541360353|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
150181705|NCT02539225|541802833|FG000|Part A|Withdrawal by Subject|2|||
150020422|NCT04864639|541209242|FG000|Overall Study|Lost to Follow-up|1|||
150020423|NCT03449758|541209243|FG000|Overall Study|Major protocol deviation|1|||
150020424|NCT03449758|541209243|FG000|Overall Study|Treatment inefficacy|5|||
150020425|NCT03449758|541209243|FG000|Overall Study|Adverse Event|9|||
150020426|NCT03449758|541209243|FG000|Overall Study|Consent withdrawal|1|||
150020427|NCT03449758|541209243|FG000|Overall Study|Other unspecified reason|3|||
150020428|NCT01478971|541209252|FG000|Standard of Care Period|Adverse Event|1|||
150020429|NCT01478971|541209252|FG000|Standard of Care Period|Withdrawal by Subject|3|||
150020430|NCT01478971|541209252|FG000|Standard of Care Period|Death|8|||
150020431|NCT01478971|541209252|FG000|Standard of Care Period|Lost to Follow-up|9|||
150020432|NCT01478971|541209252|FG000|Standard of Care Period|Other|4|||
150020433|NCT01478971|541209252|FG000|Peginesatide Treatment Period|Adverse Event|1|||
150020434|NCT01478971|541209252|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
150020435|NCT01478971|541209252|FG000|Peginesatide Treatment Period|Death|4|||
150020436|NCT01478971|541209252|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
150020437|NCT01478971|541209252|FG000|Peginesatide Treatment Period|Other|4|||
150020438|NCT03937713|541209256|FG000|Overall Study|Withdrawal by Subject|3|||
150020439|NCT03937713|541209257|FG001|Overall Study|Withdrawal by Subject|6|||
150020440|NCT03937713|541209256|FG000|Overall Study|Lost to Follow-up|1|||
150020441|NCT03937713|541209257|FG001|Overall Study|Lost to Follow-up|0|||
150020442|NCT01101035|541209262|FG000|Overall Study|Adverse Event|191|||
150020443|NCT01101035|541209263|FG001|Overall Study|Adverse Event|172|||
150020444|NCT01101035|541209262|FG000|Overall Study|Major Protocol Deviation|52|||
150020445|NCT01101035|541209263|FG001|Overall Study|Major Protocol Deviation|46|||
150020446|NCT01101035|541209262|FG000|Overall Study|Lost to Follow-up|226|||
150020447|NCT01101035|541209263|FG001|Overall Study|Lost to Follow-up|223|||
150020448|NCT01101035|541209262|FG000|Overall Study|Voluntary Withdrawal|595|||
150020449|NCT01101035|541209263|FG001|Overall Study|Voluntary Withdrawal|587|||
150020450|NCT01101035|541209262|FG000|Overall Study|Reason not Specified|333|||
150020451|NCT01101035|541209263|FG001|Overall Study|Reason not Specified|363|||
150020452|NCT00922623|541209264|FG000|Overall Study|Other|4|||
150020453|NCT00922623|541209264|FG000|Overall Study|Lost to Follow-up|1|||
150020454|NCT00950846|541209269|FG000|Overall Study|Death|6|||
150020455|NCT00950846|541209269|FG000|Overall Study|Lost to Follow-up|3|||
150020456|NCT00950846|541209269|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
150020457|NCT01799226|541209272|FG000|Overall Study|Withdrawal by Subject|1|||
150020458|NCT01799226|541209273|FG001|Overall Study|Withdrawal by Subject|0|||
150020459|NCT01799226|541209272|FG000|Overall Study|Disqualified at Day 14|1|||
150020460|NCT01799226|541209273|FG001|Overall Study|Disqualified at Day 14|0|||
150059556|NCT01857310|541360354|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
150059557|NCT00998764|541360355|FG000|Overall Study|Lack of Efficacy|3|||
150059558|NCT00998764|541360356|FG001|Overall Study|Lack of Efficacy|6|||
150059559|NCT00998764|541360355|FG000|Overall Study|Adverse Event|17|||
150059560|NCT00998764|541360356|FG001|Overall Study|Adverse Event|12|||
150059561|NCT00998764|541360355|FG000|Overall Study|Withdrawal by Subject|19|||
150059562|NCT00998764|541360356|FG001|Overall Study|Withdrawal by Subject|25|||
150059563|NCT00998764|541360355|FG000|Overall Study|Physician Decision|3|||
150059564|NCT00998764|541360356|FG001|Overall Study|Physician Decision|3|||
150059565|NCT00998764|541360355|FG000|Overall Study|Death|3|||
150059566|NCT00998764|541360356|FG001|Overall Study|Death|1|||
150059567|NCT00998764|541360355|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
150059568|NCT00998764|541360356|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
150020461|NCT02178995|541209274|FG000|Double Blind|Adverse Event|0|||
150020462|NCT02178995|541209275|FG001|Double Blind|Adverse Event|0|||
150020463|NCT02178995|541209276|FG002|Double Blind|Adverse Event|0|||
150020464|NCT02178995|541209277|FG003|Double Blind|Adverse Event|0|||
150020465|NCT02178995|541209278|FG004|Double Blind|Adverse Event|0|||
150020466|NCT02178995|541209279|FG005|Double Blind|Adverse Event|1|||
150020467|NCT02178995|541209280|FG006|Double Blind|Adverse Event|0|||
150020468|NCT02178995|541209281|FG007|Double Blind|Adverse Event|1|||
150020469|NCT02178995|541209282|FG008|Double Blind|Adverse Event|1|||
150020470|NCT02178995|541209274|FG000|Double Blind|Lost to Follow-up|0|||
150020471|NCT02178995|541209275|FG001|Double Blind|Lost to Follow-up|1|||
150020472|NCT02178995|541209276|FG002|Double Blind|Lost to Follow-up|0|||
150020473|NCT02178995|541209277|FG003|Double Blind|Lost to Follow-up|0|||
150020474|NCT02178995|541209278|FG004|Double Blind|Lost to Follow-up|0|||
150059569|NCT00998764|541360355|FG000|Overall Study|Protocol Violation|0|||
150020475|NCT02178995|541209279|FG005|Double Blind|Lost to Follow-up|0|||
150059570|NCT00998764|541360356|FG001|Overall Study|Protocol Violation|1|||
150059571|NCT00998764|541360355|FG000|Overall Study|Failed to Return|1|||
150059572|NCT00998764|541360356|FG001|Overall Study|Failed to Return|1|||
150059573|NCT00998764|541360355|FG000|Overall Study|Lost to Follow-up|1|||
150059574|NCT00998764|541360356|FG001|Overall Study|Lost to Follow-up|1|||
150059575|NCT00998764|541360355|FG000|Overall Study|Loss of Caregiver|0|||
150059576|NCT00998764|541360356|FG001|Overall Study|Loss of Caregiver|3|||
150059577|NCT00998764|541360355|FG000|Overall Study|Other|4|||
150059578|NCT00998764|541360356|FG001|Overall Study|Other|4|||
150059579|NCT00998764|541360355|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
150181706|NCT02539225|541802834|FG001|Part A|Withdrawal by Subject|4|||
150059580|NCT00998764|541360356|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
150059581|NCT04761627|541360357|FG000|Run-in Period|Death|1|||
150059582|NCT04761627|541360358|FG001|Run-in Period|Death|0|||
150020476|NCT02178995|541209280|FG006|Double Blind|Lost to Follow-up|0|||
150020477|NCT02178995|541209281|FG007|Double Blind|Lost to Follow-up|1|||
150020478|NCT02178995|541209282|FG008|Double Blind|Lost to Follow-up|0|||
150020479|NCT02178995|541209274|FG000|Open Label|Adverse Event|2|||
150020480|NCT02178995|541209275|FG001|Open Label|Adverse Event|0|||
150020481|NCT02178995|541209276|FG002|Open Label|Adverse Event|0|||
150020482|NCT02178995|541209277|FG003|Open Label|Adverse Event|0|||
150059583|NCT04761627|541360359|FG002|Run-in Period|Death|0|||
150020483|NCT02178995|541209278|FG004|Open Label|Adverse Event|0|||
150059584|NCT04761627|541360357|FG000|Run-in Period|Required alternative therapy|2|||
150181707|NCT02539225|541802833|FG000|Part A|Physician Decision|4|||
150020484|NCT02178995|541209279|FG005|Open Label|Adverse Event|0|||
150020485|NCT02178995|541209280|FG006|Open Label|Adverse Event|0|||
150020486|NCT02178995|541209281|FG007|Open Label|Adverse Event|0|||
150020487|NCT02178995|541209282|FG008|Open Label|Adverse Event|0|||
150020488|NCT00587158|541209283|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
150020489|NCT00587158|541209284|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
150020490|NCT00587158|541209283|FG000|Overall Study|Physician Decision|0|||
150020491|NCT00587158|541209284|FG001|Overall Study|Physician Decision|1|||
150020492|NCT00587158|541209283|FG000|Overall Study|Lost to Follow-up|1|||
150020493|NCT00587158|541209284|FG001|Overall Study|Lost to Follow-up|2|||
150020494|NCT00587158|541209283|FG000|Overall Study|Death|0|||
150020495|NCT00587158|541209284|FG001|Overall Study|Death|1|||
150020496|NCT00587158|541209283|FG000|Overall Study|Subject did not want to take study med|0|||
150020497|NCT00587158|541209284|FG001|Overall Study|Subject did not want to take study med|1|||
150020498|NCT00981461|541209285|FG000|Overall Study|Lost to Follow-up|5|||
150020499|NCT00981461|541209286|FG001|Overall Study|Lost to Follow-up|2|||
150020500|NCT00483405|541209287|FG000|Overall Study|Adverse Event|8|||
150020501|NCT00483405|541209287|FG000|Overall Study|Lack of Efficacy|14|||
150020502|NCT00483405|541209287|FG000|Overall Study|Death|3|||
150020503|NCT00483405|541209287|FG000|Overall Study|Withdrawal by Subject|2|||
150020504|NCT00483405|541209287|FG000|Overall Study|Other complicating disease|1|||
150020505|NCT00571038|541209288|FG000|Overall Study|Lost to Follow-up|1|||
150020506|NCT00571038|541209289|FG001|Overall Study|Lost to Follow-up|4|||
150020507|NCT00571038|541209288|FG000|Overall Study|Death|7|||
150020508|NCT00571038|541209289|FG001|Overall Study|Death|5|||
150020509|NCT00571038|541209288|FG000|Overall Study|Withdrawal by Subject|1|||
150020510|NCT00571038|541209289|FG001|Overall Study|Withdrawal by Subject|3|||
150020511|NCT00571038|541209288|FG000|Overall Study|Moved out of state|2|||
150020512|NCT00571038|541209289|FG001|Overall Study|Moved out of state|2|||
150020513|NCT01797263|541209290|FG000|Overall Study|Withdrawal by Subject|21|||
150020514|NCT01797263|541209291|FG001|Overall Study|Withdrawal by Subject|25|||
150020515|NCT01797263|541209290|FG000|Overall Study|Death|1|||
150020516|NCT01797263|541209291|FG001|Overall Study|Death|0|||
150020517|NCT01797263|541209290|FG000|Overall Study|Lost to Follow-up|15|||
150020518|NCT01797263|541209291|FG001|Overall Study|Lost to Follow-up|15|||
150020519|NCT02342223|541209292|FG000|Overall Study|Lost to Follow-up|1|||
150020520|NCT04854551|541209295|FG000|Overall Study|Withdrawal by Subject|1|||
150020521|NCT04854551|541209296|FG001|Overall Study|Withdrawal by Subject|1|||
150020522|NCT00181766|541209300|FG000|Overall Study|Lost to Follow-up|6|||
150020523|NCT00181766|541209300|FG000|Overall Study|Adverse Event|4|||
150020524|NCT00181766|541209300|FG000|Overall Study|non-compliance|2|||
150020525|NCT00687804|541209301|FG000|Core Study|Adverse Event|5|||
150020526|NCT00687804|541209302|FG001|Core Study|Adverse Event|3|||
150020527|NCT00687804|541209303|FG002|Core Study|Adverse Event|3|||
150020528|NCT00687804|541209301|FG000|Core Study|Abnormal laboratory value(s)|1|||
150020529|NCT00687804|541209302|FG001|Core Study|Abnormal laboratory value(s)|0|||
150020530|NCT00687804|541209303|FG002|Core Study|Abnormal laboratory value(s)|0|||
150020531|NCT00687804|541209301|FG000|Core Study|Lack of Efficacy|1|||
150020532|NCT00687804|541209302|FG001|Core Study|Lack of Efficacy|1|||
150020533|NCT00687804|541209303|FG002|Core Study|Lack of Efficacy|1|||
150020534|NCT00687804|541209301|FG000|Core Study|Withdrawal by Subject|4|||
150020535|NCT00687804|541209302|FG001|Core Study|Withdrawal by Subject|7|||
150020536|NCT00687804|541209303|FG002|Core Study|Withdrawal by Subject|7|||
150020537|NCT00687804|541209301|FG000|Core Study|Lost to Follow-up|0|||
150020538|NCT00687804|541209302|FG001|Core Study|Lost to Follow-up|1|||
150020539|NCT00687804|541209303|FG002|Core Study|Lost to Follow-up|0|||
150020540|NCT00687804|541209301|FG000|Core Study|Death|2|||
150020541|NCT00687804|541209302|FG001|Core Study|Death|2|||
150020542|NCT00687804|541209303|FG002|Core Study|Death|2|||
150020543|NCT00687804|541209301|FG000|Core Study|Protocol Violation|1|||
150020544|NCT00687804|541209302|FG001|Core Study|Protocol Violation|1|||
150020545|NCT00687804|541209303|FG002|Core Study|Protocol Violation|0|||
150020546|NCT00687804|541209301|FG000|Open-Label Extension Study|Adverse Event|2|||
150020547|NCT00687804|541209302|FG001|Open-Label Extension Study|Adverse Event|2|||
150020548|NCT00687804|541209303|FG002|Open-Label Extension Study|Adverse Event|2|||
150020549|NCT00687804|541209301|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
150020550|NCT00687804|541209302|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
150020551|NCT00687804|541209303|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
150020552|NCT00687804|541209301|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
150020553|NCT00687804|541209302|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
150020554|NCT00687804|541209303|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
150020555|NCT00687804|541209301|FG000|Open-Label Extension Study|Administrative problems|1|||
150020556|NCT00687804|541209302|FG001|Open-Label Extension Study|Administrative problems|1|||
150020557|NCT00687804|541209303|FG002|Open-Label Extension Study|Administrative problems|0|||
150020558|NCT00687804|541209301|FG000|Open-Label Extension Study|Death|2|||
150020559|NCT00687804|541209302|FG001|Open-Label Extension Study|Death|3|||
150020560|NCT00687804|541209303|FG002|Open-Label Extension Study|Death|3|||
150020561|NCT04390243|541209304|FG000|Overall Study|Death|1|||
150020562|NCT04390243|541209304|FG000|Overall Study|Disease Progression|4|||
150020563|NCT04390243|541209304|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
150020564|NCT02915978|541209307|FG000|Overall Study|Adverse Event|2|||
150059585|NCT04761627|541360358|FG001|Run-in Period|Required alternative therapy|0|||
150059586|NCT04761627|541360359|FG002|Run-in Period|Required alternative therapy|0|||
150059587|NCT04761627|541360357|FG000|Run-in Period|Lost to Follow-up|2|||
150059588|NCT04761627|541360358|FG001|Run-in Period|Lost to Follow-up|0|||
150020565|NCT02915978|541209308|FG001|Overall Study|Adverse Event|1|||
150020566|NCT02915978|541209309|FG002|Overall Study|Adverse Event|0|||
150020567|NCT02451124|541209313|FG000|Overall Study|Withdrawal by Subject|1|||
150020568|NCT03301350|541209314|FG000|Overall Study|Withdrawal by Subject|4|||
150020569|NCT03301350|541209314|FG000|Overall Study|Adverse Event|1|||
150020570|NCT03301350|541209314|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
150020571|NCT03301350|541209314|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
150020572|NCT03301350|541209314|FG000|Overall Study|no detail provided|1|||
150020573|NCT01248949|541209315|FG000|Overall Study|Lost to Follow-up|2|||
150020574|NCT01248949|541209316|FG001|Overall Study|Lost to Follow-up|2|||
150020575|NCT01248949|541209317|FG002|Overall Study|Lost to Follow-up|2|||
150020576|NCT01248949|541209318|FG003|Overall Study|Lost to Follow-up|1|||
150020577|NCT01248949|541209319|FG004|Overall Study|Lost to Follow-up|0|||
150020578|NCT01248949|541209315|FG000|Overall Study|Withdrawal by Subject|5|||
150020579|NCT01248949|541209316|FG001|Overall Study|Withdrawal by Subject|3|||
150020580|NCT01248949|541209317|FG002|Overall Study|Withdrawal by Subject|11|||
150020581|NCT01248949|541209318|FG003|Overall Study|Withdrawal by Subject|3|||
150020582|NCT01248949|541209319|FG004|Overall Study|Withdrawal by Subject|1|||
150020583|NCT01248949|541209315|FG000|Overall Study|Death|22|||
150020584|NCT01248949|541209316|FG001|Overall Study|Death|7|||
150020585|NCT01248949|541209317|FG002|Overall Study|Death|21|||
150020586|NCT01248949|541209318|FG003|Overall Study|Death|6|||
150020587|NCT01248949|541209319|FG004|Overall Study|Death|2|||
150020588|NCT01248949|541209315|FG000|Overall Study|Alternative Therapy|1|||
150020589|NCT01248949|541209316|FG001|Overall Study|Alternative Therapy|0|||
150020590|NCT01248949|541209317|FG002|Overall Study|Alternative Therapy|0|||
150020591|NCT01248949|541209318|FG003|Overall Study|Alternative Therapy|0|||
150020592|NCT01248949|541209319|FG004|Overall Study|Alternative Therapy|0|||
150020593|NCT01248949|541209315|FG000|Overall Study|Alternative Therapy.|1|||
150020594|NCT01248949|541209316|FG001|Overall Study|Alternative Therapy.|0|||
150020595|NCT01248949|541209317|FG002|Overall Study|Alternative Therapy.|0|||
150020596|NCT01248949|541209318|FG003|Overall Study|Alternative Therapy.|0|||
150020597|NCT01248949|541209319|FG004|Overall Study|Alternative Therapy.|0|||
150020598|NCT01248949|541209315|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
150020599|NCT01248949|541209316|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
150020600|NCT01248949|541209317|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
150020601|NCT01248949|541209318|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
150020602|NCT01248949|541209319|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
150020603|NCT01248949|541209315|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
150020604|NCT01248949|541209316|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
150020605|NCT01248949|541209317|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
150020606|NCT01248949|541209318|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
150020607|NCT01248949|541209319|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
150020608|NCT01248949|541209315|FG000|Overall Study|Participant Went To Hospice|0|||
150020609|NCT01248949|541209316|FG001|Overall Study|Participant Went To Hospice|0|||
150020610|NCT01248949|541209317|FG002|Overall Study|Participant Went To Hospice|1|||
150020611|NCT01248949|541209318|FG003|Overall Study|Participant Went To Hospice|0|||
150059589|NCT04761627|541360359|FG002|Run-in Period|Lost to Follow-up|0|||
150059590|NCT04761627|541360357|FG000|Run-in Period|Protocol Violation|3|||
150059591|NCT04761627|541360358|FG001|Run-in Period|Protocol Violation|0|||
150059592|NCT04761627|541360359|FG002|Run-in Period|Protocol Violation|0|||
150020612|NCT01248949|541209319|FG004|Overall Study|Participant Went To Hospice|0|||
150020613|NCT01248949|541209315|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
150020614|NCT01248949|541209316|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
150020615|NCT01248949|541209317|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
150020616|NCT01248949|541209318|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
150020617|NCT01248949|541209319|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
150020618|NCT01248949|541209315|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
150020619|NCT01248949|541209316|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
150020620|NCT01248949|541209317|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
150059593|NCT04761627|541360357|FG000|Run-in Period|Abnormal liver function|1|||
150059594|NCT04761627|541360358|FG001|Run-in Period|Abnormal liver function|0|||
150059595|NCT04761627|541360359|FG002|Run-in Period|Abnormal liver function|0|||
150020621|NCT01248949|541209318|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
150020622|NCT01248949|541209319|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
150059596|NCT04761627|541360357|FG000|Run-in Period|Adverse Event|6|||
150020623|NCT01248949|541209315|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
150020624|NCT01248949|541209316|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
150020625|NCT01248949|541209317|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
150020626|NCT01248949|541209318|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
150020627|NCT01248949|541209319|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
150020628|NCT01248949|541209315|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
150020629|NCT01248949|541209316|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
150020630|NCT01248949|541209317|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
150020631|NCT01248949|541209318|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
150020632|NCT01248949|541209319|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
150020633|NCT00286429|541209320|FG000|Overall Study|Adverse Event|4|||
150020634|NCT00286429|541209321|FG001|Overall Study|Adverse Event|1|||
150020635|NCT00286429|541209322|FG002|Overall Study|Adverse Event|6|||
150020636|NCT00286429|541209320|FG000|Overall Study|Lack of Efficacy|52|||
150020637|NCT00286429|541209321|FG001|Overall Study|Lack of Efficacy|27|||
150020638|NCT00286429|541209322|FG002|Overall Study|Lack of Efficacy|25|||
150020639|NCT00286429|541209320|FG000|Overall Study|Lost to Follow-up|2|||
150020640|NCT00286429|541209321|FG001|Overall Study|Lost to Follow-up|4|||
150020641|NCT00286429|541209322|FG002|Overall Study|Lost to Follow-up|3|||
150020642|NCT00286429|541209320|FG000|Overall Study|Physician Decision|10|||
150020643|NCT00286429|541209321|FG001|Overall Study|Physician Decision|7|||
150020644|NCT00286429|541209322|FG002|Overall Study|Physician Decision|7|||
150020645|NCT00286429|541209320|FG000|Overall Study|Protocol Violation|3|||
150020646|NCT00286429|541209321|FG001|Overall Study|Protocol Violation|5|||
150020647|NCT00286429|541209322|FG002|Overall Study|Protocol Violation|4|||
150020648|NCT00286429|541209320|FG000|Overall Study|Withdrawal by Subject|3|||
150020649|NCT00286429|541209321|FG001|Overall Study|Withdrawal by Subject|2|||
150020650|NCT00286429|541209322|FG002|Overall Study|Withdrawal by Subject|6|||
150020651|NCT00286429|541209320|FG000|Overall Study|Administrative Error|1|||
150020652|NCT00286429|541209321|FG001|Overall Study|Administrative Error|1|||
150020653|NCT00286429|541209322|FG002|Overall Study|Administrative Error|1|||
150020654|NCT00286429|541209320|FG000|Overall Study|Administrative Decision|0|||
150020655|NCT00286429|541209321|FG001|Overall Study|Administrative Decision|1|||
150020656|NCT00286429|541209322|FG002|Overall Study|Administrative Decision|0|||
150020657|NCT01746225|541209325|FG000|Overall Study|Death|1|||
150020658|NCT01746225|541209326|FG001|Overall Study|Death|0|||
150020659|NCT01746225|541209327|FG002|Overall Study|Death|1|||
150020660|NCT01746225|541209325|FG000|Overall Study|Withdrawal by Subject|5|||
150020661|NCT01746225|541209326|FG001|Overall Study|Withdrawal by Subject|15|||
150020662|NCT01746225|541209327|FG002|Overall Study|Withdrawal by Subject|19|||
150020663|NCT01746225|541209325|FG000|Overall Study|Physician Decision|14|||
150020664|NCT01746225|541209326|FG001|Overall Study|Physician Decision|11|||
150020665|NCT01746225|541209327|FG002|Overall Study|Physician Decision|3|||
150020666|NCT01746225|541209325|FG000|Overall Study|Adverse Event|15|||
150020667|NCT01746225|541209326|FG001|Overall Study|Adverse Event|12|||
150020668|NCT01746225|541209327|FG002|Overall Study|Adverse Event|17|||
150020669|NCT01746225|541209325|FG000|Overall Study|Continuing Treatment|5|||
150020670|NCT01746225|541209326|FG001|Overall Study|Continuing Treatment|8|||
150020671|NCT01746225|541209327|FG002|Overall Study|Continuing Treatment|3|||
150020672|NCT03508609|541209328|FG000|Overall Study|Withdrawal by Subject|1|||
150020673|NCT00999518|541209329|FG000|Overall Study|Adverse Event|1|||
150020674|NCT00999518|541209330|FG001|Overall Study|Adverse Event|6|||
150020675|NCT00999518|541209331|FG002|Overall Study|Adverse Event|3|||
150020676|NCT00999518|541209332|FG003|Overall Study|Adverse Event|1|||
150020677|NCT00999518|541209333|FG004|Overall Study|Adverse Event|2|||
150020678|NCT00999518|541209329|FG000|Overall Study|Lack of Efficacy|2|||
150020679|NCT00999518|541209330|FG001|Overall Study|Lack of Efficacy|0|||
150020680|NCT00999518|541209331|FG002|Overall Study|Lack of Efficacy|0|||
150020681|NCT00999518|541209332|FG003|Overall Study|Lack of Efficacy|2|||
150020682|NCT00999518|541209333|FG004|Overall Study|Lack of Efficacy|2|||
150020683|NCT00999518|541209329|FG000|Overall Study|Lost to Follow-up|0|||
150020684|NCT00999518|541209330|FG001|Overall Study|Lost to Follow-up|0|||
150020685|NCT00999518|541209331|FG002|Overall Study|Lost to Follow-up|0|||
150020686|NCT00999518|541209332|FG003|Overall Study|Lost to Follow-up|4|||
150020687|NCT00999518|541209333|FG004|Overall Study|Lost to Follow-up|1|||
150020688|NCT00999518|541209329|FG000|Overall Study|Did not meet entrance criteria|0|||
150020689|NCT00999518|541209330|FG001|Overall Study|Did not meet entrance criteria|0|||
150020690|NCT00999518|541209331|FG002|Overall Study|Did not meet entrance criteria|0|||
150020691|NCT00999518|541209332|FG003|Overall Study|Did not meet entrance criteria|0|||
150020692|NCT00999518|541209333|FG004|Overall Study|Did not meet entrance criteria|1|||
150020693|NCT00999518|541209329|FG000|Overall Study|Study terminated by sponsor|10|||
150020694|NCT00999518|541209330|FG001|Overall Study|Study terminated by sponsor|6|||
150020695|NCT00999518|541209331|FG002|Overall Study|Study terminated by sponsor|5|||
150020696|NCT00999518|541209332|FG003|Overall Study|Study terminated by sponsor|5|||
150020697|NCT00999518|541209333|FG004|Overall Study|Study terminated by sponsor|9|||
150020698|NCT00999518|541209329|FG000|Overall Study|Pregnancy|0|||
150020699|NCT00999518|541209330|FG001|Overall Study|Pregnancy|0|||
150020700|NCT00999518|541209331|FG002|Overall Study|Pregnancy|1|||
150020701|NCT00999518|541209332|FG003|Overall Study|Pregnancy|0|||
150020702|NCT00999518|541209333|FG004|Overall Study|Pregnancy|0|||
150020703|NCT00999518|541209329|FG000|Overall Study|Protocol Violation|0|||
150020704|NCT00999518|541209330|FG001|Overall Study|Protocol Violation|1|||
150020705|NCT00999518|541209331|FG002|Overall Study|Protocol Violation|0|||
150020706|NCT00999518|541209332|FG003|Overall Study|Protocol Violation|0|||
150020707|NCT00999518|541209333|FG004|Overall Study|Protocol Violation|2|||
150020708|NCT00999518|541209329|FG000|Overall Study|Withdrawal by Subject|5|||
150020709|NCT00999518|541209330|FG001|Overall Study|Withdrawal by Subject|4|||
150020710|NCT00999518|541209331|FG002|Overall Study|Withdrawal by Subject|10|||
150020711|NCT00999518|541209332|FG003|Overall Study|Withdrawal by Subject|6|||
150020712|NCT00999518|541209333|FG004|Overall Study|Withdrawal by Subject|1|||
150020713|NCT00999518|541209329|FG000|Overall Study|Other|5|||
150020714|NCT00999518|541209330|FG001|Overall Study|Other|7|||
150020715|NCT00999518|541209331|FG002|Overall Study|Other|1|||
150020716|NCT00999518|541209332|FG003|Overall Study|Other|4|||
150020717|NCT00999518|541209333|FG004|Overall Study|Other|5|||
150020718|NCT00999518|541209329|FG000|Overall Study|Randomized but not Treated|1|||
150020719|NCT00999518|541209330|FG001|Overall Study|Randomized but not Treated|1|||
150020720|NCT00999518|541209331|FG002|Overall Study|Randomized but not Treated|2|||
150020721|NCT00999518|541209332|FG003|Overall Study|Randomized but not Treated|0|||
150020722|NCT00999518|541209333|FG004|Overall Study|Randomized but not Treated|1|||
150020723|NCT00250276|541209337|FG000|Overall Study|Serious Adverse Event|0|||
150020724|NCT00250276|541209338|FG001|Overall Study|Serious Adverse Event|0|||
150020725|NCT00250276|541209339|FG002|Overall Study|Serious Adverse Event|1|||
150020726|NCT00250276|541209340|FG003|Overall Study|Serious Adverse Event|0|||
150020727|NCT00250276|541209337|FG000|Overall Study|Non-serious Adverse Event|2|||
150020728|NCT00250276|541209338|FG001|Overall Study|Non-serious Adverse Event|0|||
150020729|NCT00250276|541209339|FG002|Overall Study|Non-serious Adverse Event|0|||
150059597|NCT04761627|541360358|FG001|Run-in Period|Adverse Event|0|||
150059598|NCT04761627|541360359|FG002|Run-in Period|Adverse Event|0|||
150059599|NCT04761627|541360357|FG000|Run-in Period|Withdrawal by Subject|7|||
150059600|NCT04761627|541360358|FG001|Run-in Period|Withdrawal by Subject|0|||
150059601|NCT04761627|541360359|FG002|Run-in Period|Withdrawal by Subject|0|||
150059602|NCT04761627|541360357|FG000|Run-in Period|Did not meet PASI 50|15|||
150059603|NCT04761627|541360358|FG001|Run-in Period|Did not meet PASI 50|0|||
150059604|NCT04761627|541360359|FG002|Run-in Period|Did not meet PASI 50|0|||
150059605|NCT04761627|541360357|FG000|Run-in Period|Study site closure|2|||
150059606|NCT04761627|541360358|FG001|Run-in Period|Study site closure|0|||
150020730|NCT00250276|541209340|FG003|Overall Study|Non-serious Adverse Event|2|||
150020731|NCT00250276|541209337|FG000|Overall Study|Protocol Violation|0|||
150020732|NCT00250276|541209338|FG001|Overall Study|Protocol Violation|1|||
150020733|NCT00250276|541209339|FG002|Overall Study|Protocol Violation|0|||
150020734|NCT00250276|541209340|FG003|Overall Study|Protocol Violation|0|||
150020735|NCT00250276|541209337|FG000|Overall Study|Withdrawal by Subject|1|||
150020736|NCT00250276|541209338|FG001|Overall Study|Withdrawal by Subject|2|||
150020737|NCT00250276|541209339|FG002|Overall Study|Withdrawal by Subject|3|||
150020738|NCT00250276|541209340|FG003|Overall Study|Withdrawal by Subject|2|||
150020739|NCT00250276|541209337|FG000|Overall Study|Migrated/moved from study area|3|||
150020740|NCT00250276|541209338|FG001|Overall Study|Migrated/moved from study area|0|||
150020741|NCT00250276|541209339|FG002|Overall Study|Migrated/moved from study area|2|||
150020742|NCT00250276|541209340|FG003|Overall Study|Migrated/moved from study area|7|||
150020743|NCT00250276|541209337|FG000|Overall Study|Lost to Follow-up|11|||
150020744|NCT00250276|541209338|FG001|Overall Study|Lost to Follow-up|18|||
150020745|NCT00250276|541209339|FG002|Overall Study|Lost to Follow-up|13|||
150020746|NCT00250276|541209340|FG003|Overall Study|Lost to Follow-up|8|||
150020747|NCT01546688|541209341|FG000|Overall Study|Adverse Event|0|||
150020748|NCT01546688|541209342|FG001|Overall Study|Adverse Event|4|||
150020749|NCT01546688|541209341|FG000|Overall Study|Withdrawal by Subject|2|||
150020750|NCT01546688|541209342|FG001|Overall Study|Withdrawal by Subject|1|||
150020751|NCT01546688|541209341|FG000|Overall Study|Lack of Efficacy|1|||
150020752|NCT01546688|541209342|FG001|Overall Study|Lack of Efficacy|0|||
150020753|NCT00782483|541209345|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
150020754|NCT03543137|541209346|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
150020755|NCT03543137|541209347|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
150020756|NCT03543137|541209346|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
150020757|NCT03543137|541209347|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
150020758|NCT03543137|541209346|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
150020759|NCT03543137|541209347|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
150020760|NCT01052077|541209349|FG000|Phase A|Lost to Follow-up|22|||
150020761|NCT01052077|541209350|FG001|Phase A|Lost to Follow-up|0|||
150020762|NCT01052077|541209351|FG002|Phase A|Lost to Follow-up|0|||
150020763|NCT01052077|541209352|FG003|Phase A|Lost to Follow-up|0|||
150020764|NCT01052077|541209349|FG000|Phase A|Adverse Event|32|||
150020765|NCT01052077|541209350|FG001|Phase A|Adverse Event|0|||
150020766|NCT01052077|541209351|FG002|Phase A|Adverse Event|0|||
150020767|NCT01052077|541209352|FG003|Phase A|Adverse Event|0|||
150020768|NCT01052077|541209349|FG000|Phase A|Met Withdrawal Criteria|26|||
150020769|NCT01052077|541209350|FG001|Phase A|Met Withdrawal Criteria|0|||
150020770|NCT01052077|541209351|FG002|Phase A|Met Withdrawal Criteria|0|||
150020771|NCT01052077|541209352|FG003|Phase A|Met Withdrawal Criteria|0|||
150020772|NCT01052077|541209349|FG000|Phase A|Physician Decision|10|||
150020773|NCT01052077|541209350|FG001|Phase A|Physician Decision|0|||
150020774|NCT01052077|541209351|FG002|Phase A|Physician Decision|0|||
150020775|NCT01052077|541209352|FG003|Phase A|Physician Decision|0|||
150020776|NCT01052077|541209349|FG000|Phase A|Withdrawal by Subject|29|||
150020777|NCT01052077|541209350|FG001|Phase A|Withdrawal by Subject|0|||
150020778|NCT01052077|541209351|FG002|Phase A|Withdrawal by Subject|0|||
150020779|NCT01052077|541209352|FG003|Phase A|Withdrawal by Subject|0|||
150020780|NCT01052077|541209349|FG000|Phase A|Protocol Deviation|27|||
150020781|NCT01052077|541209350|FG001|Phase A|Protocol Deviation|0|||
150020782|NCT01052077|541209351|FG002|Phase A|Protocol Deviation|0|||
150020783|NCT01052077|541209352|FG003|Phase A|Protocol Deviation|0|||
150020784|NCT01052077|541209349|FG000|Phase B|Lost to Follow-up|0|||
150020785|NCT01052077|541209350|FG001|Phase B|Lost to Follow-up|2|||
150020786|NCT01052077|541209351|FG002|Phase B|Lost to Follow-up|3|||
150020787|NCT01052077|541209352|FG003|Phase B|Lost to Follow-up|0|||
150020788|NCT01052077|541209349|FG000|Phase B|Adverse Event|0|||
150020789|NCT01052077|541209350|FG001|Phase B|Adverse Event|9|||
150020790|NCT01052077|541209351|FG002|Phase B|Adverse Event|2|||
150020791|NCT01052077|541209352|FG003|Phase B|Adverse Event|0|||
150020792|NCT01052077|541209349|FG000|Phase B|Met Withdrawal Criteria|0|||
150020793|NCT01052077|541209350|FG001|Phase B|Met Withdrawal Criteria|2|||
150020794|NCT01052077|541209351|FG002|Phase B|Met Withdrawal Criteria|1|||
150020795|NCT01052077|541209352|FG003|Phase B|Met Withdrawal Criteria|0|||
150020796|NCT01052077|541209349|FG000|Phase B|Physician Decision|0|||
150020797|NCT01052077|541209350|FG001|Phase B|Physician Decision|1|||
150020798|NCT01052077|541209351|FG002|Phase B|Physician Decision|1|||
150020799|NCT01052077|541209352|FG003|Phase B|Physician Decision|0|||
150020800|NCT01052077|541209349|FG000|Phase B|Withdrawal by Subject|0|||
150020801|NCT01052077|541209350|FG001|Phase B|Withdrawal by Subject|0|||
150020802|NCT01052077|541209351|FG002|Phase B|Withdrawal by Subject|5|||
150020803|NCT01052077|541209352|FG003|Phase B|Withdrawal by Subject|0|||
150020804|NCT01052077|541209349|FG000|Phase B|Protocol Deviation|0|||
150020805|NCT01052077|541209350|FG001|Phase B|Protocol Deviation|3|||
150020806|NCT01052077|541209351|FG002|Phase B|Protocol Deviation|4|||
150020807|NCT01052077|541209352|FG003|Phase B|Protocol Deviation|0|||
150020808|NCT01052077|541209349|FG000|Phase B|Lack of Efficacy|0|||
150020809|NCT01052077|541209350|FG001|Phase B|Lack of Efficacy|1|||
150020810|NCT01052077|541209351|FG002|Phase B|Lack of Efficacy|0|||
150059607|NCT04761627|541360359|FG002|Run-in Period|Study site closure|0|||
150059608|NCT04761627|541360357|FG000|Run-in Period|Pregnancy|2|||
150059609|NCT04761627|541360358|FG001|Run-in Period|Pregnancy|0|||
150020811|NCT01052077|541209352|FG003|Phase B|Lack of Efficacy|0|||
150020812|NCT01052077|541209349|FG000|Phase A+|Lost to Follow-up|0|||
150020813|NCT01052077|541209350|FG001|Phase A+|Lost to Follow-up|0|||
150020814|NCT01052077|541209351|FG002|Phase A+|Lost to Follow-up|0|||
150020815|NCT01052077|541209352|FG003|Phase A+|Lost to Follow-up|8|||
150020816|NCT01052077|541209349|FG000|Phase A+|Adverse Event|0|||
150020817|NCT01052077|541209350|FG001|Phase A+|Adverse Event|0|||
150020818|NCT01052077|541209351|FG002|Phase A+|Adverse Event|0|||
150059610|NCT04761627|541360359|FG002|Run-in Period|Pregnancy|0|||
150020819|NCT01052077|541209352|FG003|Phase A+|Adverse Event|4|||
150020820|NCT01052077|541209349|FG000|Phase A+|Met Withdrawal Criteria|0|||
150020821|NCT01052077|541209350|FG001|Phase A+|Met Withdrawal Criteria|0|||
150020822|NCT01052077|541209351|FG002|Phase A+|Met Withdrawal Criteria|0|||
150181708|NCT02539225|541802834|FG001|Part A|Physician Decision|7|||
150020823|NCT01052077|541209352|FG003|Phase A+|Met Withdrawal Criteria|2|||
150020824|NCT01052077|541209349|FG000|Phase A+|Withdrawal by Subject|0|||
150181709|NCT02539225|541802833|FG000|Part A|Did Not Receive study Drug|1|||
150020825|NCT01052077|541209350|FG001|Phase A+|Withdrawal by Subject|0|||
150020826|NCT01052077|541209351|FG002|Phase A+|Withdrawal by Subject|0|||
150020827|NCT01052077|541209352|FG003|Phase A+|Withdrawal by Subject|7|||
150020828|NCT01445080|541209353|FG000|Overall Study|Adverse Event|5|||
150020829|NCT01445080|541209354|FG001|Overall Study|Adverse Event|3|||
150020830|NCT01445080|541209355|FG002|Overall Study|Adverse Event|11|||
150020831|NCT01445080|541209356|FG003|Overall Study|Adverse Event|6|||
150020832|NCT01445080|541209357|FG004|Overall Study|Adverse Event|2|||
150020833|NCT01445080|541209358|FG005|Overall Study|Adverse Event|3|||
150020834|NCT01445080|541209359|FG006|Overall Study|Adverse Event|0|||
150020835|NCT01445080|541209360|FG007|Overall Study|Adverse Event|3|||
150020836|NCT01445080|541209361|FG008|Overall Study|Adverse Event|10|||
150020837|NCT01445080|541209353|FG000|Overall Study|Physician Decision|0|||
150020838|NCT01445080|541209354|FG001|Overall Study|Physician Decision|0|||
150020839|NCT01445080|541209355|FG002|Overall Study|Physician Decision|1|||
150020840|NCT01445080|541209356|FG003|Overall Study|Physician Decision|0|||
150020841|NCT01445080|541209357|FG004|Overall Study|Physician Decision|0|||
150020842|NCT01445080|541209358|FG005|Overall Study|Physician Decision|3|||
150020843|NCT01445080|541209359|FG006|Overall Study|Physician Decision|2|||
150020844|NCT01445080|541209360|FG007|Overall Study|Physician Decision|2|||
150020845|NCT01445080|541209361|FG008|Overall Study|Physician Decision|0|||
150020846|NCT01445080|541209353|FG000|Overall Study|Withdrawal by Subject|1|||
150020847|NCT01445080|541209354|FG001|Overall Study|Withdrawal by Subject|0|||
150020848|NCT01445080|541209355|FG002|Overall Study|Withdrawal by Subject|0|||
150020849|NCT01445080|541209356|FG003|Overall Study|Withdrawal by Subject|1|||
150020850|NCT01445080|541209357|FG004|Overall Study|Withdrawal by Subject|0|||
150020851|NCT01445080|541209358|FG005|Overall Study|Withdrawal by Subject|0|||
150020852|NCT01445080|541209359|FG006|Overall Study|Withdrawal by Subject|0|||
150020853|NCT01445080|541209360|FG007|Overall Study|Withdrawal by Subject|0|||
150020854|NCT01445080|541209361|FG008|Overall Study|Withdrawal by Subject|2|||
150020855|NCT01445080|541209353|FG000|Overall Study|Ineligible/Inevaluable|1|||
150020856|NCT01445080|541209354|FG001|Overall Study|Ineligible/Inevaluable|2|||
150020857|NCT01445080|541209355|FG002|Overall Study|Ineligible/Inevaluable|0|||
150020858|NCT01445080|541209356|FG003|Overall Study|Ineligible/Inevaluable|1|||
150020859|NCT01445080|541209357|FG004|Overall Study|Ineligible/Inevaluable|2|||
150020860|NCT01445080|541209358|FG005|Overall Study|Ineligible/Inevaluable|3|||
150020861|NCT01445080|541209359|FG006|Overall Study|Ineligible/Inevaluable|0|||
150020862|NCT01445080|541209360|FG007|Overall Study|Ineligible/Inevaluable|0|||
150020863|NCT01445080|541209361|FG008|Overall Study|Ineligible/Inevaluable|6|||
150020864|NCT02487030|541209362|FG000|Overall Study|Lack of Efficacy|2|||
150020865|NCT02487030|541209363|FG001|Overall Study|Lack of Efficacy|4|||
150059611|NCT04761627|541360357|FG000|Post-randomization Period|Military service|0|||
150059612|NCT04761627|541360358|FG001|Post-randomization Period|Military service|1|||
150059613|NCT04761627|541360359|FG002|Post-randomization Period|Military service|0|||
150059614|NCT04761627|541360357|FG000|Post-randomization Period|Adverse Event|0|||
150059615|NCT04761627|541360358|FG001|Post-randomization Period|Adverse Event|4|||
150059616|NCT04761627|541360359|FG002|Post-randomization Period|Adverse Event|2|||
150059617|NCT04761627|541360357|FG000|Post-randomization Period|Lost to Follow-up|0|||
150059618|NCT04761627|541360358|FG001|Post-randomization Period|Lost to Follow-up|6|||
150059619|NCT04761627|541360359|FG002|Post-randomization Period|Lost to Follow-up|6|||
150059620|NCT04761627|541360357|FG000|Post-randomization Period|Withdrawal by Subject|0|||
150059621|NCT04761627|541360358|FG001|Post-randomization Period|Withdrawal by Subject|7|||
150059622|NCT04761627|541360359|FG002|Post-randomization Period|Withdrawal by Subject|6|||
150181710|NCT02539225|541802834|FG001|Part A|Did Not Receive study Drug|1|||
150181711|NCT02539225|541802833|FG000|Pre Treatment for Part B|Progressive disease|1|||
150020866|NCT02487030|541209364|FG002|Overall Study|Lack of Efficacy|1|||
150020867|NCT02487030|541209365|FG003|Overall Study|Lack of Efficacy|0|||
150020868|NCT02487030|541209366|FG004|Overall Study|Lack of Efficacy|1|||
150020869|NCT02487030|541209367|FG005|Overall Study|Lack of Efficacy|0|||
150020870|NCT02487030|541209368|FG006|Overall Study|Lack of Efficacy|0|||
150020871|NCT02487030|541209362|FG000|Overall Study|Lost to Follow-up|0|||
150020872|NCT02487030|541209363|FG001|Overall Study|Lost to Follow-up|0|||
150020873|NCT02487030|541209364|FG002|Overall Study|Lost to Follow-up|1|||
150020874|NCT02487030|541209365|FG003|Overall Study|Lost to Follow-up|1|||
150059623|NCT04761627|541360357|FG000|Post-randomization Period|Pregnancy|0|||
150059624|NCT04761627|541360358|FG001|Post-randomization Period|Pregnancy|0|||
150059625|NCT04761627|541360359|FG002|Post-randomization Period|Pregnancy|1|||
150059626|NCT04761627|541360357|FG000|Post-randomization Period|Study site closure|0|||
150181712|NCT02539225|541802834|FG001|Pre Treatment for Part B|Progressive disease|1|||
150181713|NCT02539225|541802833|FG000|Pre Treatment for Part B|Adverse Event|1|||
150181714|NCT02539225|541802834|FG001|Pre Treatment for Part B|Adverse Event|1|||
150181715|NCT02539225|541802833|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
150181716|NCT02539225|541802834|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
150020875|NCT02487030|541209366|FG004|Overall Study|Lost to Follow-up|0|||
150020876|NCT02487030|541209367|FG005|Overall Study|Lost to Follow-up|1|||
150020877|NCT02487030|541209368|FG006|Overall Study|Lost to Follow-up|0|||
150020878|NCT02487030|541209362|FG000|Overall Study|Adverse Event|0|||
150020879|NCT02487030|541209363|FG001|Overall Study|Adverse Event|0|||
150020880|NCT02487030|541209364|FG002|Overall Study|Adverse Event|0|||
150020881|NCT02487030|541209365|FG003|Overall Study|Adverse Event|1|||
150020882|NCT02487030|541209366|FG004|Overall Study|Adverse Event|0|||
150020883|NCT02487030|541209367|FG005|Overall Study|Adverse Event|0|||
150020884|NCT02487030|541209368|FG006|Overall Study|Adverse Event|0|||
150020885|NCT02487030|541209362|FG000|Overall Study|Death|0|||
150020886|NCT02487030|541209363|FG001|Overall Study|Death|0|||
150020887|NCT02487030|541209364|FG002|Overall Study|Death|0|||
150020888|NCT02487030|541209365|FG003|Overall Study|Death|0|||
150020889|NCT02487030|541209366|FG004|Overall Study|Death|1|||
150020890|NCT02487030|541209367|FG005|Overall Study|Death|0|||
150020891|NCT02487030|541209368|FG006|Overall Study|Death|0|||
150020892|NCT03857542|541209369|FG000|Overall Study|Adverse Event|1|||
150020893|NCT03857542|541209370|FG001|Overall Study|Adverse Event|3|||
150020894|NCT03857542|541209369|FG000|Overall Study|Withdrawal by Subject|2|||
150020895|NCT03857542|541209370|FG001|Overall Study|Withdrawal by Subject|1|||
150020896|NCT03857542|541209369|FG000|Overall Study|Lost to Follow-up|2|||
150020897|NCT03857542|541209370|FG001|Overall Study|Lost to Follow-up|1|||
150020898|NCT03857542|541209369|FG000|Overall Study|Reason not Specified|1|||
150020899|NCT03857542|541209370|FG001|Overall Study|Reason not Specified|0|||
150020900|NCT01525615|541210918|FG000|Overall Study|Adverse Event|11|||
150020901|NCT01525615|541210919|FG001|Overall Study|Adverse Event|7|||
150020902|NCT01525615|541210920|FG002|Overall Study|Adverse Event|5|||
150020903|NCT01525615|541210918|FG000|Overall Study|Lost to Follow-up|1|||
150020904|NCT01525615|541210919|FG001|Overall Study|Lost to Follow-up|0|||
150020905|NCT01525615|541210920|FG002|Overall Study|Lost to Follow-up|0|||
150020906|NCT01525615|541210918|FG000|Overall Study|Withdrawal by Subject|1|||
150020907|NCT01525615|541210919|FG001|Overall Study|Withdrawal by Subject|0|||
150020908|NCT01525615|541210920|FG002|Overall Study|Withdrawal by Subject|0|||
150020909|NCT01525615|541210918|FG000|Overall Study|Other reason not described above|1|||
150020910|NCT01525615|541210919|FG001|Overall Study|Other reason not described above|0|||
150020911|NCT01525615|541210920|FG002|Overall Study|Other reason not described above|1|||
150020912|NCT04050618|541210921|FG000|First Intervention|Withdrawal by Subject|2|||
150020913|NCT04050618|541210922|FG001|First Intervention|Withdrawal by Subject|0|||
150020914|NCT04050618|541210921|FG000|Second Intervention|Withdrawal by Subject|1|||
150020915|NCT04050618|541210922|FG001|Second Intervention|Withdrawal by Subject|0|||
150020916|NCT02451943|541210929|FG000|Overall Study|Withdrawal by Subject|13|||
150020917|NCT02451943|541210930|FG001|Overall Study|Withdrawal by Subject|16|||
150020918|NCT02451943|541210929|FG000|Overall Study|Lost to Follow-up|3|||
150020919|NCT02451943|541210930|FG001|Overall Study|Lost to Follow-up|4|||
150020920|NCT02451943|541210929|FG000|Overall Study|Sponsor Decision|0|||
150020921|NCT02451943|541210930|FG001|Overall Study|Sponsor Decision|4|||
150020922|NCT00859547|541210932|FG000|Overall Study|Lost to Follow-up|1|||
150020923|NCT00859547|541210932|FG000|Overall Study|Parent withdrew consent|1|||
150020924|NCT01473732|541210933|FG000|Overall Study|Adverse Event|1|||
150020925|NCT01473732|541210934|FG001|Overall Study|Adverse Event|0|||
150020926|NCT01473732|541210933|FG000|Overall Study|Death|1|||
150020927|NCT01473732|541210934|FG001|Overall Study|Death|0|||
150020928|NCT00786799|541210938|FG000|Overall Study|Lost to Follow-up|1|||
150020929|NCT00786799|541210939|FG001|Overall Study|Lost to Follow-up|1|||
150020930|NCT01641601|541210940|FG000|Overall Study|Study discontinued.|3|||
150020931|NCT01641601|541210941|FG001|Overall Study|Study discontinued.|5|||
150020932|NCT03361293|541210944|FG000|Overall Study|Lost to Follow-up|0|||
150020933|NCT03361293|541210945|FG001|Overall Study|Lost to Follow-up|2|||
150020934|NCT03361293|541210944|FG000|Overall Study|Withdrawal by Subject|1|||
150020935|NCT03361293|541210945|FG001|Overall Study|Withdrawal by Subject|3|||
150020936|NCT01426958|541210946|FG000|Overall Study|Adverse Event|2|||
150020937|NCT01521507|541210968|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
150020938|NCT01521507|541210969|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
150020939|NCT01521507|541210968|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
150020940|NCT01521507|541210969|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
150020941|NCT01521507|541210968|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
150020942|NCT01521507|541210969|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
150020943|NCT01521507|541210968|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
150020944|NCT01521507|541210969|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
150181717|NCT02539225|541802833|FG000|Pre Treatment for Part B|Physician Decision|2|||
150181718|NCT02539225|541802834|FG001|Pre Treatment for Part B|Physician Decision|0|||
150020945|NCT01521507|541210968|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
150020946|NCT01521507|541210969|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
150020947|NCT01521507|541210968|FG000|Stage 2: Observational Design|Physician Decision|1|||
150020948|NCT01521507|541210969|FG001|Stage 2: Observational Design|Physician Decision|0|||
150020949|NCT03188432|541210970|FG000|Overall Study|Death|3|||
150020950|NCT03188432|541210970|FG000|Overall Study|Withdrawal by Subject|15|||
150020951|NCT03188432|541210970|FG000|Overall Study|Did not complete protocol treatment|9|||
150020952|NCT00413218|541210974|FG000|Overall Study|Randomized but didn't receive study drug|2|||
150020953|NCT00413218|541210975|FG001|Overall Study|Randomized but didn't receive study drug|8|||
150020954|NCT00413218|541210974|FG000|Overall Study|Death|57|||
150020955|NCT00413218|541210975|FG001|Overall Study|Death|56|||
150020956|NCT00413218|541210974|FG000|Overall Study|Lost to Follow-up|14|||
150020957|NCT00413218|541210975|FG001|Overall Study|Lost to Follow-up|17|||
150020958|NCT00413218|541210974|FG000|Overall Study|Admin|20|||
150020959|NCT00413218|541210975|FG001|Overall Study|Admin|14|||
150020960|NCT00413218|541210974|FG000|Overall Study|Missing|1|||
150020961|NCT00413218|541210975|FG001|Overall Study|Missing|0|||
150020962|NCT00413218|541210974|FG000|Overall Study|Withdrawal by Subject|9|||
150020963|NCT00413218|541210975|FG001|Overall Study|Withdrawal by Subject|1|||
150020964|NCT01843023|541210978|FG000|Overall Study|Death|1|||
150020965|NCT01843023|541210979|FG001|Overall Study|Death|0|||
150020966|NCT01843023|541210978|FG000|Overall Study|Lost to Follow-up|24|||
150020967|NCT01843023|541210979|FG001|Overall Study|Lost to Follow-up|29|||
150020968|NCT01843023|541210978|FG000|Overall Study|Withdrawal by Subject|8|||
150020969|NCT01843023|541210979|FG001|Overall Study|Withdrawal by Subject|6|||
150020970|NCT00466921|541210980|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
150020971|NCT00466921|541210980|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
150020972|NCT00466921|541210980|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
150020973|NCT00466921|541210980|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
150020974|NCT00466921|541210980|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
150020975|NCT00466921|541210980|FG000|Follow up for a Minimum of 1 Year|Death|6|||
150020976|NCT02741635|541210986|FG000|Overall Study|Withdrawal by Subject|1|||
150020977|NCT01427933|541210990|FG000|Overall Study|Withdrawal by Subject|5|||
150020978|NCT01427933|541210991|FG001|Overall Study|Withdrawal by Subject|8|||
150020979|NCT01427933|541210990|FG000|Overall Study|Lost to Follow-up|1|||
150020980|NCT01427933|541210991|FG001|Overall Study|Lost to Follow-up|5|||
150020981|NCT01427933|541210990|FG000|Overall Study|Other|1|||
150020982|NCT01427933|541210991|FG001|Overall Study|Other|0|||
150020983|NCT01427933|541210990|FG000|Overall Study|Investigator's Decision|1|||
150020984|NCT01427933|541210991|FG001|Overall Study|Investigator's Decision|0|||
150020985|NCT01633541|541210994|FG000|Overall Study|Death|1|||
150020986|NCT01633541|541210995|FG001|Overall Study|Death|0|||
150020987|NCT03472326|541210996|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
150020988|NCT03472326|541210997|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
150020989|NCT03472326|541210998|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
150020990|NCT03472326|541210999|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
150020991|NCT03472326|541210996|FG000|Part 2: Combination Therapy|Pregnancy|0|||
150020992|NCT03472326|541210997|FG001|Part 2: Combination Therapy|Pregnancy|0|||
150020993|NCT03472326|541210998|FG002|Part 2: Combination Therapy|Pregnancy|0|||
150020994|NCT03472326|541210999|FG003|Part 2: Combination Therapy|Pregnancy|1|||
150059627|NCT04761627|541360358|FG001|Post-randomization Period|Study site closure|0|||
150059628|NCT04761627|541360359|FG002|Post-randomization Period|Study site closure|1|||
150059629|NCT04761627|541360357|FG000|Post-randomization Period|Family planning|0|||
150059630|NCT04761627|541360358|FG001|Post-randomization Period|Family planning|1|||
150059631|NCT04761627|541360359|FG002|Post-randomization Period|Family planning|0|||
150059632|NCT01933789|541360360|FG000|Overall Study|Death|0|||
150059633|NCT01933789|541360361|FG001|Overall Study|Death|0|||
150059634|NCT01933789|541360362|FG002|Overall Study|Death|0|||
150020995|NCT05447663|541211000|FG000|Overall Study|Study terminated by Sponsor|5|||
150020996|NCT05447663|541211000|FG000|Overall Study|Death|2|||
150020997|NCT05447663|541211000|FG000|Overall Study|Withdrawal by Subject|1|||
150020998|NCT01100320|541211003|FG000|Period 1|Withdrawal by Subject|2|||
150059635|NCT01933789|541360363|FG003|Overall Study|Death|0|||
150059636|NCT01933789|541360364|FG004|Overall Study|Death|21|||
150059637|NCT01933789|541360365|FG005|Overall Study|Death|32|||
150020999|NCT01100320|541211004|FG001|Period 1|Withdrawal by Subject|4|||
150021000|NCT01100320|541211003|FG000|Period 1|Positive Drug Screen|1|||
150021001|NCT01100320|541211004|FG001|Period 1|Positive Drug Screen|1|||
150021002|NCT01100320|541211003|FG000|Period 1|Adverse Event|2|||
150021003|NCT01100320|541211004|FG001|Period 1|Adverse Event|2|||
150021004|NCT01100320|541211003|FG000|Period 2|Withdrawal by Subject|1|||
150021005|NCT01100320|541211004|FG001|Period 2|Withdrawal by Subject|1|||
150059638|NCT01933789|541360366|FG006|Overall Study|Death|0|||
150059639|NCT01933789|541360367|FG007|Overall Study|Death|0|||
150059640|NCT01933789|541360368|FG008|Overall Study|Death|0|||
150021006|NCT04980612|541211005|FG000|Overall Study|Withdrawal by Subject|7|||
150021007|NCT04980612|541211006|FG001|Overall Study|Withdrawal by Subject|5|||
150021008|NCT01502228|541211009|FG000|Overall Study|Death|1|||
150059641|NCT01933789|541360360|FG000|Overall Study|Lost to Follow-up|0|||
150021009|NCT05730387|541211010|FG000|Overall Study|Stillbirth|0|||
150021010|NCT05730387|541211011|FG001|Overall Study|Stillbirth|262|||
150021011|NCT05730387|541211010|FG000|Overall Study|Died during or after delivery|2|||
150021012|NCT05730387|541211011|FG001|Overall Study|Died during or after delivery|85|||
150021013|NCT05730387|541211010|FG000|Overall Study|Died after being admitted|0|||
150021014|NCT05730387|541211011|FG001|Overall Study|Died after being admitted|44|||
150021015|NCT05730387|541211010|FG000|Overall Study|Lost to Follow-up|69|||
150059642|NCT01933789|541360361|FG001|Overall Study|Lost to Follow-up|0|||
150059643|NCT01933789|541360362|FG002|Overall Study|Lost to Follow-up|0|||
150059644|NCT01933789|541360363|FG003|Overall Study|Lost to Follow-up|1|||
150059645|NCT01933789|541360364|FG004|Overall Study|Lost to Follow-up|8|||
150059646|NCT01933789|541360365|FG005|Overall Study|Lost to Follow-up|9|||
150059647|NCT01933789|541360366|FG006|Overall Study|Lost to Follow-up|1|||
150059648|NCT01933789|541360367|FG007|Overall Study|Lost to Follow-up|4|||
150059649|NCT01933789|541360368|FG008|Overall Study|Lost to Follow-up|0|||
150059650|NCT01933789|541360360|FG000|Overall Study|Withdrawal by Subject|2|||
150059651|NCT01933789|541360361|FG001|Overall Study|Withdrawal by Subject|1|||
150059652|NCT01933789|541360362|FG002|Overall Study|Withdrawal by Subject|0|||
150021016|NCT05730387|541211011|FG001|Overall Study|Lost to Follow-up|77|||
150021017|NCT02728089|541211012|FG000|Overall Study|Physician Decision|2|||
150021018|NCT02728089|541211012|FG000|Overall Study|Withdrawal by Subject|1|||
150059653|NCT01933789|541360363|FG003|Overall Study|Withdrawal by Subject|0|||
150059654|NCT01933789|541360364|FG004|Overall Study|Withdrawal by Subject|17|||
150059655|NCT01933789|541360365|FG005|Overall Study|Withdrawal by Subject|16|||
150059656|NCT01933789|541360366|FG006|Overall Study|Withdrawal by Subject|1|||
150059657|NCT01933789|541360367|FG007|Overall Study|Withdrawal by Subject|4|||
150059658|NCT01933789|541360368|FG008|Overall Study|Withdrawal by Subject|0|||
150059659|NCT01933789|541360360|FG000|Overall Study|Became Ineligible|4|||
150059660|NCT01933789|541360361|FG001|Overall Study|Became Ineligible|0|||
150059661|NCT01933789|541360362|FG002|Overall Study|Became Ineligible|0|||
150059662|NCT01933789|541360363|FG003|Overall Study|Became Ineligible|0|||
150059663|NCT01933789|541360364|FG004|Overall Study|Became Ineligible|13|||
150059664|NCT01933789|541360365|FG005|Overall Study|Became Ineligible|10|||
150059665|NCT01933789|541360366|FG006|Overall Study|Became Ineligible|13|||
150059666|NCT01933789|541360367|FG007|Overall Study|Became Ineligible|6|||
150059667|NCT01933789|541360368|FG008|Overall Study|Became Ineligible|0|||
150059668|NCT00723203|541360369|FG000|Overall Study|Withdrawal by Subject|3|||
150059669|NCT01323920|541360373|FG000|Overall Study|Death|5|||
150059670|NCT01323920|541360373|FG000|Overall Study|Withdrawal by Subject|1|||
150059671|NCT06400251|541360376|FG000|Overall Study|Never Start Protocol Therapy|1|||
150059672|NCT06400251|541360376|FG000|Overall Study|Ineligible|2|||
150059673|NCT06400251|541360376|FG000|Overall Study|Mutation Status Not Confirmed|3|||
150059674|NCT06400251|541360376|FG000|Overall Study|Disease Progression|25|||
150059675|NCT06400251|541360376|FG000|Overall Study|Adverse Event|1|||
150059676|NCT06400251|541360376|FG000|Overall Study|Complicating Disease|1|||
150059677|NCT06400251|541360376|FG000|Overall Study|Physician Decision|2|||
150059678|NCT00732940|541360386|FG000|Overall Study|Withdrawal by Subject|1|||
150059679|NCT00732940|541360387|FG001|Overall Study|Withdrawal by Subject|2|||
150059680|NCT00732940|541360386|FG000|Overall Study|Adverse Event|0|||
150059681|NCT00732940|541360387|FG001|Overall Study|Adverse Event|1|||
150059682|NCT00732940|541360386|FG000|Overall Study|Lost to Follow-up|1|||
150059683|NCT00732940|541360387|FG001|Overall Study|Lost to Follow-up|0|||
150059684|NCT00938886|541360388|FG000|Overall Study|Death|0|||
150059685|NCT00938886|541360389|FG001|Overall Study|Death|1|||
150059686|NCT00938886|541360388|FG000|Overall Study|Withdrawal by Subject|4|||
150059687|NCT00938886|541360389|FG001|Overall Study|Withdrawal by Subject|7|||
150059688|NCT00938886|541360388|FG000|Overall Study|Lost to Follow-up|3|||
150059689|NCT00938886|541360389|FG001|Overall Study|Lost to Follow-up|2|||
150059690|NCT02518464|541360391|FG000|Overall Study|Adverse Event|2|||
150059691|NCT01120067|541360394|FG000|Overall Study|Lost to Follow-up|3|||
150059692|NCT01120067|541360395|FG001|Overall Study|Lost to Follow-up|1|||
150059693|NCT01120067|541360394|FG000|Overall Study|fail to engage >3 sessions|2|||
150059694|NCT01120067|541360395|FG001|Overall Study|fail to engage >3 sessions|0|||
150059695|NCT01150474|541360399|FG000|Overall Study|Withdrawal by Subject|5|||
150059696|NCT01150474|541360400|FG001|Overall Study|Withdrawal by Subject|2|||
150059697|NCT01150474|541360399|FG000|Overall Study|Cancer found|1|||
150059698|NCT01150474|541360400|FG001|Overall Study|Cancer found|0|||
150181719|NCT02539225|541802833|FG000|Part B|Adverse Event|4|||
150021019|NCT04669301|541211013|FG000|Overall Study|Lost to Follow-up|0|||
150059699|NCT01150474|541360399|FG000|Overall Study|Multiple Studies|0|||
150059700|NCT01150474|541360400|FG001|Overall Study|Multiple Studies|1|||
150059701|NCT01150474|541360399|FG000|Overall Study|Rectotomy|1|||
150059702|NCT01150474|541360400|FG001|Overall Study|Rectotomy|0|||
150059703|NCT01150474|541360399|FG000|Overall Study|Drug did not arrive in time|1|||
150059704|NCT01150474|541360400|FG001|Overall Study|Drug did not arrive in time|0|||
150059705|NCT01150474|541360399|FG000|Overall Study|Drug not administered|1|||
150181720|NCT02539225|541802834|FG001|Part B|Adverse Event|4|||
150021020|NCT04669301|541211014|FG001|Overall Study|Lost to Follow-up|1|||
150021021|NCT04669301|541211015|FG002|Overall Study|Lost to Follow-up|0|||
150021022|NCT04669301|541211013|FG000|Overall Study|Withdrawal by Subject|3|||
150021023|NCT04669301|541211014|FG001|Overall Study|Withdrawal by Subject|2|||
150021024|NCT04669301|541211015|FG002|Overall Study|Withdrawal by Subject|0|||
150021025|NCT04137731|541211017|FG000|Overall Study|Surgery Cancellation|1|||
150021026|NCT04137731|541211018|FG001|Overall Study|Surgery Cancellation|2|||
150021027|NCT04137731|541211017|FG000|Overall Study|Withdrawal by Subject|2|||
150021028|NCT04137731|541211018|FG001|Overall Study|Withdrawal by Subject|0|||
150021029|NCT04137731|541211017|FG000|Overall Study|Protocol Violation|0|||
150021030|NCT04137731|541211018|FG001|Overall Study|Protocol Violation|1|||
150021031|NCT05236257|541211022|FG000|Overall Study|Ongoing with study treatment|29|||
150021032|NCT05236257|541211023|FG001|Overall Study|Ongoing with study treatment|1|||
150021033|NCT05236257|541211022|FG000|Overall Study|Discontinued study treatment|22|||
150021034|NCT05236257|541211023|FG001|Overall Study|Discontinued study treatment|41|||
150021035|NCT04752332|541211024|FG000|Overall Study|Adverse Event|3|||
150021036|NCT04752332|541211025|FG001|Overall Study|Adverse Event|1|||
150021037|NCT04752332|541211024|FG000|Overall Study|Disease Relapse|1|||
150021038|NCT04752332|541211025|FG001|Overall Study|Disease Relapse|0|||
150021039|NCT04752332|541211024|FG000|Overall Study|Non-compliance With Study Drug|2|||
150021040|NCT04752332|541211025|FG001|Overall Study|Non-compliance With Study Drug|0|||
150021041|NCT04752332|541211024|FG000|Overall Study|Physician Decision|2|||
150021042|NCT04752332|541211025|FG001|Overall Study|Physician Decision|1|||
150021043|NCT04752332|541211024|FG000|Overall Study|Protocol Violation|1|||
150021044|NCT04752332|541211025|FG001|Overall Study|Protocol Violation|1|||
150021045|NCT04752332|541211024|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
150021046|NCT04752332|541211025|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
150021047|NCT04752332|541211024|FG000|Overall Study|Study Terminated by Sponsor|10|||
150021048|NCT04752332|541211025|FG001|Overall Study|Study Terminated by Sponsor|48|||
150021049|NCT04752332|541211024|FG000|Overall Study|Withdrawal by Subject|11|||
150021050|NCT04752332|541211025|FG001|Overall Study|Withdrawal by Subject|3|||
150021051|NCT00924443|541211028|FG000|Overall Study|Physician Decision|2|||
150021052|NCT00924443|541211028|FG000|Overall Study|Protocol Violation|1|||
150021053|NCT02863328|541211029|FG000|Overall Study|Lost to Follow-up|4|||
150021054|NCT02863328|541211030|FG001|Overall Study|Lost to Follow-up|10|||
150021055|NCT02863328|541211029|FG000|Overall Study|Withdrawal by Subject|7|||
150021056|NCT02863328|541211030|FG001|Overall Study|Withdrawal by Subject|12|||
150021057|NCT02863328|541211029|FG000|Overall Study|Died|0|||
150021058|NCT02863328|541211030|FG001|Overall Study|Died|1|||
150021059|NCT00595478|541211033|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
150021060|NCT00595478|541211034|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
150021061|NCT00595478|541211033|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
150021062|NCT00595478|541211034|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
150021063|NCT03245775|541211035|FG000|Overall Study|Lost to Follow-up|25|||
150021064|NCT03245775|541211036|FG001|Overall Study|Lost to Follow-up|26|||
150021065|NCT03245775|541211037|FG002|Overall Study|Lost to Follow-up|16|||
150021066|NCT03245775|541211038|FG003|Overall Study|Lost to Follow-up|16|||
150021067|NCT02713828|541211041|FG000|Overall Study|Death|2|||
150021068|NCT02713828|541211042|FG001|Overall Study|Death|0|||
150021069|NCT02713828|541211041|FG000|Overall Study|Withdrawal by Subject|1|||
150021070|NCT02713828|541211042|FG001|Overall Study|Withdrawal by Subject|0|||
150021071|NCT02713828|541211041|FG000|Overall Study|study terminated but patient allowed to|2|||
150021072|NCT02713828|541211042|FG001|Overall Study|study terminated but patient allowed to|0|||
150021073|NCT03302247|541211046|FG000|Overall Study|the study has closed prematurely|2|||
150021074|NCT03302247|541211046|FG000|Overall Study|Death|1|||
150021075|NCT03197376|541211047|FG000|Primary and Booster Phase|Adverse Event|0|||
150021076|NCT03197376|541211048|FG001|Primary and Booster Phase|Adverse Event|0|||
150021077|NCT03197376|541211049|FG002|Primary and Booster Phase|Adverse Event|0|||
150021078|NCT03197376|541211050|FG003|Primary and Booster Phase|Adverse Event|1|||
150021079|NCT03197376|541211047|FG000|Primary and Booster Phase|Death|1|||
150021080|NCT03197376|541211048|FG001|Primary and Booster Phase|Death|0|||
150021081|NCT03197376|541211049|FG002|Primary and Booster Phase|Death|0|||
150021082|NCT03197376|541211050|FG003|Primary and Booster Phase|Death|2|||
150021083|NCT03197376|541211047|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
150181721|NCT02539225|541802833|FG000|Part B|Withdrawal by Subject|0|||
150021084|NCT03197376|541211048|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
150021085|NCT03197376|541211049|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
150021086|NCT03197376|541211050|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
150021087|NCT03197376|541211047|FG000|Primary and Booster Phase|Physician Decision|1|||
150021088|NCT03197376|541211048|FG001|Primary and Booster Phase|Physician Decision|0|||
150021089|NCT03197376|541211049|FG002|Primary and Booster Phase|Physician Decision|1|||
150021090|NCT03197376|541211050|FG003|Primary and Booster Phase|Physician Decision|3|||
150021091|NCT03197376|541211047|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
150021092|NCT03197376|541211048|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
150181722|NCT02539225|541802834|FG001|Part B|Withdrawal by Subject|3|||
150021093|NCT03197376|541211049|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
150181723|NCT02539225|541802833|FG000|Part B|Physician Decision|0|||
150021094|NCT03197376|541211050|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
150021095|NCT03197376|541211047|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
150021096|NCT03197376|541211048|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
150021097|NCT03197376|541211049|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
150021098|NCT03197376|541211050|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
150021099|NCT03197376|541211047|FG000|Primary and Booster Phase|Not vaccine related|1|||
150021100|NCT03197376|541211048|FG001|Primary and Booster Phase|Not vaccine related|2|||
150021101|NCT03197376|541211049|FG002|Primary and Booster Phase|Not vaccine related|0|||
150021102|NCT03197376|541211050|FG003|Primary and Booster Phase|Not vaccine related|6|||
150021103|NCT03197376|541211047|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
150021104|NCT03197376|541211048|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
150021105|NCT03197376|541211049|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
150021106|NCT03197376|541211050|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
150021107|NCT03197376|541211047|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
150021108|NCT03197376|541211048|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
150021109|NCT03197376|541211049|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
150021110|NCT03197376|541211050|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
150021111|NCT03197376|541211047|FG000|Immune Persistence Phase|Not vaccine related|1|||
150021112|NCT03197376|541211048|FG001|Immune Persistence Phase|Not vaccine related|0|||
150021113|NCT03197376|541211049|FG002|Immune Persistence Phase|Not vaccine related|1|||
150021114|NCT03197376|541211050|FG003|Immune Persistence Phase|Not vaccine related|1|||
150021115|NCT02978833|541211054|FG000|Overall Study|Study terminated|1|||
150021116|NCT02978833|541211055|FG001|Overall Study|Study terminated|1|||
150021117|NCT01123395|541211056|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
150021118|NCT01123395|541211057|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
150021119|NCT00186901|541211058|FG000|Overall Study|Pregnancy|6|||
150021120|NCT00186901|541211059|FG001|Overall Study|Pregnancy|3|||
150021121|NCT00186901|541211060|FG002|Overall Study|Pregnancy|0|||
150021122|NCT00186901|541211058|FG000|Overall Study|Lost to Follow-up|6|||
150021123|NCT00186901|541211059|FG001|Overall Study|Lost to Follow-up|3|||
150021124|NCT00186901|541211060|FG002|Overall Study|Lost to Follow-up|0|||
150021125|NCT00186901|541211058|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
150021126|NCT00186901|541211059|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
150021127|NCT00186901|541211060|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
150021128|NCT00186901|541211058|FG000|Overall Study|ALL relapse or second malignancy|1|||
150021129|NCT00186901|541211059|FG001|Overall Study|ALL relapse or second malignancy|2|||
150021130|NCT00186901|541211060|FG002|Overall Study|ALL relapse or second malignancy|0|||
150021131|NCT00186901|541211058|FG000|Overall Study|Withdrawal by Subject|4|||
150021132|NCT00186901|541211059|FG001|Overall Study|Withdrawal by Subject|5|||
150021133|NCT00186901|541211060|FG002|Overall Study|Withdrawal by Subject|0|||
150021134|NCT00186901|541211058|FG000|Overall Study|Open label|3|||
150021135|NCT00186901|541211059|FG001|Overall Study|Open label|2|||
150021136|NCT00186901|541211060|FG002|Overall Study|Open label|0|||
150021137|NCT00186901|541211058|FG000|Overall Study|Limited adherence to study requirements|20|||
150021138|NCT00186901|541211059|FG001|Overall Study|Limited adherence to study requirements|23|||
150021139|NCT00186901|541211060|FG002|Overall Study|Limited adherence to study requirements|0|||
150021140|NCT00186901|541211058|FG000|Overall Study|Bone Mineral Density > 0|0|||
150021141|NCT00186901|541211059|FG001|Overall Study|Bone Mineral Density > 0|0|||
150021142|NCT00186901|541211060|FG002|Overall Study|Bone Mineral Density > 0|149|||
150021143|NCT02420379|541212693|FG000|Overall Study|Withdrawal by Subject|0|||
150021144|NCT02420379|541212694|FG001|Overall Study|Withdrawal by Subject|3|||
150021145|NCT02420379|541212693|FG000|Overall Study|Unable to complete due to schooling|0|||
150021146|NCT02420379|541212694|FG001|Overall Study|Unable to complete due to schooling|1|||
150021147|NCT02420379|541212693|FG000|Overall Study|Transitioned to commercial drug|1|||
150021148|NCT02420379|541212694|FG001|Overall Study|Transitioned to commercial drug|0|||
150021149|NCT01410890|541212702|FG000|Overall Study|Withdrawal by Subject|0|||
150021150|NCT01410890|541212703|FG001|Overall Study|Withdrawal by Subject|1|||
150021151|NCT00217425|541212704|FG000|Overall Study|Never started treatment|2|||
150021152|NCT00217425|541212704|FG000|Overall Study|Patient ineligible|5|||
150021153|NCT00217425|541212704|FG000|Overall Study|Lack of Efficacy|13|||
150021154|NCT00217425|541212704|FG000|Overall Study|Adverse Event|8|||
150021155|NCT00217425|541212704|FG000|Overall Study|Withdrawal by Subject|4|||
150021156|NCT00217425|541212704|FG000|Overall Study|Other complicating disease|1|||
150021157|NCT00217425|541212704|FG000|Overall Study|Other|4|||
150021158|NCT03951077|541212705|FG000|Overall Study|Adverse Event|1|||
150021159|NCT03951077|541212706|FG001|Overall Study|Adverse Event|0|||
150021160|NCT03951077|541212707|FG002|Overall Study|Adverse Event|0|||
150021161|NCT03951077|541212708|FG003|Overall Study|Adverse Event|0|||
150021162|NCT03951077|541212709|FG004|Overall Study|Adverse Event|0|||
150021163|NCT03951077|541212710|FG005|Overall Study|Adverse Event|0|||
150021164|NCT03951077|541212705|FG000|Overall Study|Withdrawal by Subject|3|||
150021165|NCT03951077|541212706|FG001|Overall Study|Withdrawal by Subject|3|||
150021166|NCT03951077|541212707|FG002|Overall Study|Withdrawal by Subject|0|||
150021167|NCT03951077|541212708|FG003|Overall Study|Withdrawal by Subject|3|||
150021168|NCT03951077|541212709|FG004|Overall Study|Withdrawal by Subject|3|||
150021169|NCT03951077|541212710|FG005|Overall Study|Withdrawal by Subject|2|||
150021170|NCT03951077|541212705|FG000|Overall Study|Lost to Follow-up|1|||
150021171|NCT03951077|541212706|FG001|Overall Study|Lost to Follow-up|1|||
150021172|NCT03951077|541212707|FG002|Overall Study|Lost to Follow-up|2|||
150021173|NCT03951077|541212708|FG003|Overall Study|Lost to Follow-up|3|||
150021174|NCT03951077|541212709|FG004|Overall Study|Lost to Follow-up|2|||
150021175|NCT03951077|541212710|FG005|Overall Study|Lost to Follow-up|3|||
150021176|NCT03951077|541212705|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
150021177|NCT03951077|541212706|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
150021178|NCT03951077|541212707|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
150021179|NCT03951077|541212708|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
150021180|NCT03951077|541212709|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
150021181|NCT03951077|541212710|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
150021182|NCT03951077|541212705|FG000|Overall Study|Other, Not Specified|12|||
150021183|NCT03951077|541212706|FG001|Overall Study|Other, Not Specified|10|||
150021184|NCT03951077|541212707|FG002|Overall Study|Other, Not Specified|10|||
150021185|NCT03951077|541212708|FG003|Overall Study|Other, Not Specified|5|||
150021186|NCT03951077|541212709|FG004|Overall Study|Other, Not Specified|9|||
150021187|NCT03951077|541212710|FG005|Overall Study|Other, Not Specified|6|||
150021188|NCT03951077|541212705|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
150021189|NCT03951077|541212706|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
150021190|NCT03951077|541212707|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
150021191|NCT03951077|541212708|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
150021192|NCT03951077|541212709|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
150021193|NCT03951077|541212710|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
150021194|NCT00086047|541212712|FG000|Overall Study|Lost to Follow-up|7|||
150021195|NCT00086047|541212713|FG001|Overall Study|Lost to Follow-up|6|||
150021196|NCT00086047|541212712|FG000|Overall Study|Physician Decision|0|||
150021197|NCT00086047|541212713|FG001|Overall Study|Physician Decision|1|||
150021198|NCT01395901|541212714|FG000|Overall Study|Lost to Follow-up|4|||
150021199|NCT01395901|541212715|FG001|Overall Study|Lost to Follow-up|0|||
150021200|NCT01395901|541212714|FG000|Overall Study|Randomized but not received study drug|5|||
150021201|NCT01395901|541212715|FG001|Overall Study|Randomized but not received study drug|4|||
150021202|NCT01395901|541212714|FG000|Overall Study|Adverse Event|0|||
150021203|NCT01395901|541212715|FG001|Overall Study|Adverse Event|1|||
150021204|NCT01395901|541212714|FG000|Overall Study|Withdrawal of consent|1|||
150021205|NCT01395901|541212715|FG001|Overall Study|Withdrawal of consent|0|||
150021206|NCT01217944|541212724|FG000|Overall Study|Protocol Violation|1|||
150021207|NCT01217944|541212725|FG001|Overall Study|Protocol Violation|1|||
150021208|NCT01217944|541212726|FG002|Overall Study|Protocol Violation|0|||
150021209|NCT01217944|541212724|FG000|Overall Study|Lost to Follow-up|3|||
150021210|NCT01217944|541212725|FG001|Overall Study|Lost to Follow-up|1|||
150021211|NCT01217944|541212726|FG002|Overall Study|Lost to Follow-up|0|||
150021212|NCT01217944|541212724|FG000|Overall Study|Withdrawal by Subject|1|||
150021213|NCT01217944|541212725|FG001|Overall Study|Withdrawal by Subject|2|||
150021214|NCT01217944|541212726|FG002|Overall Study|Withdrawal by Subject|0|||
150021215|NCT01217944|541212724|FG000|Overall Study|Lack of Efficacy|1|||
150021216|NCT01217944|541212725|FG001|Overall Study|Lack of Efficacy|0|||
150021217|NCT01217944|541212726|FG002|Overall Study|Lack of Efficacy|0|||
150021218|NCT03579940|541212727|FG000|Period 2|Withdrawal by Subject|0|||
150021219|NCT03579940|541212728|FG001|Period 2|Withdrawal by Subject|0|||
150021220|NCT03579940|541212729|FG002|Period 2|Withdrawal by Subject|1|||
150021221|NCT03579940|541212730|FG003|Period 2|Withdrawal by Subject|0|||
150021222|NCT03579940|541212731|FG004|Period 2|Withdrawal by Subject|0|||
150021223|NCT03579940|541212732|FG005|Period 2|Withdrawal by Subject|0|||
150021224|NCT03579940|541212733|FG006|Period 2|Withdrawal by Subject|0|||
150021225|NCT03579940|541212734|FG007|Period 2|Withdrawal by Subject|0|||
150021226|NCT03579940|541212735|FG008|Period 2|Withdrawal by Subject|0|||
150021227|NCT03579940|541212736|FG009|Period 2|Withdrawal by Subject|0|||
150021228|NCT03579940|541212737|FG010|Period 2|Withdrawal by Subject|0|||
150021229|NCT00671034|541212738|FG000|Overall Study|Adverse Event|5|||
150021230|NCT00671034|541212739|FG001|Overall Study|Adverse Event|7|||
150021231|NCT00671034|541212740|FG002|Overall Study|Adverse Event|1|||
150021232|NCT00671034|541212738|FG000|Overall Study|Death|3|||
150021233|NCT00671034|541212739|FG001|Overall Study|Death|2|||
150021234|NCT00671034|541212740|FG002|Overall Study|Death|1|||
150021235|NCT00671034|541212738|FG000|Overall Study|Physician Decision|12|||
150021236|NCT00671034|541212739|FG001|Overall Study|Physician Decision|4|||
150021237|NCT00671034|541212740|FG002|Overall Study|Physician Decision|5|||
150021238|NCT00671034|541212738|FG000|Overall Study|VHR ALL feature|8|||
150021239|NCT00671034|541212739|FG001|Overall Study|VHR ALL feature|3|||
150021240|NCT00671034|541212740|FG002|Overall Study|VHR ALL feature|5|||
150021241|NCT00671034|541212738|FG000|Overall Study|Refusal|5|||
150021242|NCT00671034|541212739|FG001|Overall Study|Refusal|3|||
150021243|NCT00671034|541212740|FG002|Overall Study|Refusal|5|||
150021244|NCT00671034|541212738|FG000|Overall Study|includes Alternative therapy, etc.|6|||
150181724|NCT02539225|541802834|FG001|Part B|Physician Decision|9|||
150021245|NCT00671034|541212739|FG001|Overall Study|includes Alternative therapy, etc.|1|||
150021246|NCT00671034|541212740|FG002|Overall Study|includes Alternative therapy, etc.|7|||
150021247|NCT00997035|541212741|FG000|3-week Followup Visit|Lost to Follow-up|9|||
150021248|NCT00997035|541212742|FG001|3-week Followup Visit|Lost to Follow-up|6|||
150021249|NCT00997035|541212741|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
150021250|NCT00997035|541212742|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
150021251|NCT00713544|541212745|FG000|Overall Study|Adverse Event|5|||
150021252|NCT00713544|541212746|FG001|Overall Study|Adverse Event|3|||
150021253|NCT00713544|541212747|FG002|Overall Study|Adverse Event|7|||
150021254|NCT00713544|541212748|FG003|Overall Study|Adverse Event|7|||
150021255|NCT00713544|541212749|FG004|Overall Study|Adverse Event|3|||
150021256|NCT00713544|541212750|FG005|Overall Study|Adverse Event|5|||
150021257|NCT00713544|541212745|FG000|Overall Study|Withdrawal by Subject|2|||
150021258|NCT00713544|541212746|FG001|Overall Study|Withdrawal by Subject|0|||
150021259|NCT00713544|541212747|FG002|Overall Study|Withdrawal by Subject|3|||
150021260|NCT00713544|541212748|FG003|Overall Study|Withdrawal by Subject|2|||
150021261|NCT00713544|541212749|FG004|Overall Study|Withdrawal by Subject|3|||
150021262|NCT00713544|541212750|FG005|Overall Study|Withdrawal by Subject|1|||
150021263|NCT00713544|541212745|FG000|Overall Study|Protocol Violation|0|||
150021264|NCT00713544|541212746|FG001|Overall Study|Protocol Violation|0|||
150021265|NCT00713544|541212747|FG002|Overall Study|Protocol Violation|0|||
150021266|NCT00713544|541212748|FG003|Overall Study|Protocol Violation|0|||
150021267|NCT00713544|541212749|FG004|Overall Study|Protocol Violation|0|||
150021268|NCT00713544|541212750|FG005|Overall Study|Protocol Violation|1|||
150021269|NCT00713544|541212745|FG000|Overall Study|Physician Decision|0|||
150021270|NCT00713544|541212746|FG001|Overall Study|Physician Decision|0|||
150021271|NCT00713544|541212747|FG002|Overall Study|Physician Decision|0|||
150021272|NCT00713544|541212748|FG003|Overall Study|Physician Decision|0|||
150021273|NCT00713544|541212749|FG004|Overall Study|Physician Decision|0|||
150021274|NCT00713544|541212750|FG005|Overall Study|Physician Decision|2|||
150021275|NCT00713544|541212745|FG000|Overall Study|Lack of Efficacy|0|||
150021276|NCT00713544|541212746|FG001|Overall Study|Lack of Efficacy|1|||
150021277|NCT00713544|541212747|FG002|Overall Study|Lack of Efficacy|0|||
150021278|NCT00713544|541212748|FG003|Overall Study|Lack of Efficacy|1|||
150021279|NCT00713544|541212749|FG004|Overall Study|Lack of Efficacy|1|||
150021280|NCT00713544|541212750|FG005|Overall Study|Lack of Efficacy|0|||
150021281|NCT00713544|541212745|FG000|Overall Study|Lost to Follow-up|0|||
150021282|NCT00713544|541212746|FG001|Overall Study|Lost to Follow-up|0|||
150021283|NCT00713544|541212747|FG002|Overall Study|Lost to Follow-up|1|||
150021284|NCT00713544|541212748|FG003|Overall Study|Lost to Follow-up|0|||
150021285|NCT00713544|541212749|FG004|Overall Study|Lost to Follow-up|0|||
150021286|NCT00713544|541212750|FG005|Overall Study|Lost to Follow-up|0|||
150021287|NCT00713544|541212745|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
150021288|NCT00713544|541212746|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
150021289|NCT00713544|541212747|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
150021290|NCT00713544|541212748|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
150021291|NCT00713544|541212749|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
150021292|NCT00713544|541212750|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
150021293|NCT00713544|541212745|FG000|Overall Study|Incorrect enrollment|0|||
150021294|NCT00713544|541212746|FG001|Overall Study|Incorrect enrollment|1|||
150021295|NCT00713544|541212747|FG002|Overall Study|Incorrect enrollment|0|||
150021296|NCT00713544|541212748|FG003|Overall Study|Incorrect enrollment|0|||
150021297|NCT00713544|541212749|FG004|Overall Study|Incorrect enrollment|0|||
150021298|NCT00713544|541212750|FG005|Overall Study|Incorrect enrollment|0|||
150021299|NCT00713544|541212745|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
150021300|NCT00713544|541212746|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
150021301|NCT00713544|541212747|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
150021302|NCT00713544|541212748|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
150021303|NCT00713544|541212749|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
150021304|NCT00713544|541212750|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
150021305|NCT00269919|541212751|FG000|Overall Study|Other|26|||
150021306|NCT00269919|541212751|FG000|Overall Study|Started but not treated|1|||
150021307|NCT02471014|541212754|FG000|Overall Study|Lost to Follow-up|2|||
150021308|NCT02471014|541212755|FG001|Overall Study|Lost to Follow-up|2|||
150021309|NCT02544503|541212756|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
150021310|NCT02544503|541212757|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
150021311|NCT02544503|541212756|FG000|Overall Study|Lost to Follow-up|9|||
150021312|NCT02544503|541212757|FG001|Overall Study|Lost to Follow-up|0|||
150021313|NCT02544503|541212756|FG000|Overall Study|Withdrawal by Subject|1|||
150021314|NCT02544503|541212757|FG001|Overall Study|Withdrawal by Subject|0|||
150021315|NCT02380287|541212758|FG000|Overall Study|Adverse Event|0|||
150021316|NCT02380287|541212759|FG001|Overall Study|Adverse Event|0|||
150021317|NCT02380287|541212760|FG002|Overall Study|Adverse Event|1|||
150021318|NCT02380287|541212761|FG003|Overall Study|Adverse Event|0|||
150021319|NCT02380287|541212762|FG004|Overall Study|Adverse Event|0|||
150059706|NCT01150474|541360400|FG001|Overall Study|Drug not administered|0|||
150021320|NCT02380287|541212763|FG005|Overall Study|Adverse Event|0|||
150021321|NCT02380287|541212764|FG006|Overall Study|Adverse Event|0|||
150021322|NCT02380287|541212765|FG007|Overall Study|Adverse Event|0|||
150021323|NCT04473963|541212766|FG000|Overall Study|Withdrawal by Subject|1|||
150021324|NCT04473963|541212767|FG001|Overall Study|Withdrawal by Subject|1|||
150021325|NCT04473963|541212768|FG002|Overall Study|Withdrawal by Subject|0|||
150021326|NCT04473963|541212766|FG000|Overall Study|Not inducible in AF|0|||
150021327|NCT04473963|541212767|FG001|Overall Study|Not inducible in AF|0|||
150021328|NCT04473963|541212768|FG002|Overall Study|Not inducible in AF|2|||
150021329|NCT04640311|541212769|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
150021330|NCT04640311|541212770|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021331|NCT04640311|541212771|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021332|NCT04640311|541212772|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021333|NCT04640311|541212773|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021334|NCT04640311|541212774|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021335|NCT04640311|541212775|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021336|NCT04640311|541212776|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021337|NCT04640311|541212777|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021338|NCT04640311|541212778|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021339|NCT04640311|541212779|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021340|NCT04640311|541212780|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021341|NCT04640311|541212781|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021342|NCT04640311|541212769|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021343|NCT04640311|541212770|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
150021344|NCT04640311|541212771|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021345|NCT04640311|541212772|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021346|NCT04640311|541212773|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021347|NCT04640311|541212774|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021348|NCT04640311|541212775|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021349|NCT04640311|541212776|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021350|NCT04640311|541212777|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021351|NCT04640311|541212778|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021352|NCT04640311|541212779|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021353|NCT04640311|541212780|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021354|NCT04640311|541212781|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
150021355|NCT04640311|541212769|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021356|NCT04640311|541212770|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
150021357|NCT04640311|541212771|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021358|NCT04640311|541212772|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021359|NCT04640311|541212773|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021360|NCT04640311|541212774|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021361|NCT04640311|541212775|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021362|NCT04640311|541212776|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021363|NCT04640311|541212777|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021364|NCT04640311|541212778|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021365|NCT04640311|541212779|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021366|NCT04640311|541212780|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021367|NCT04640311|541212781|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021368|NCT04640311|541212769|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
150021369|NCT04640311|541212770|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
150021370|NCT04640311|541212771|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
150021371|NCT04640311|541212772|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021372|NCT04640311|541212773|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150059707|NCT01150474|541360399|FG000|Overall Study|Surgery Changed|1|||
150059708|NCT01150474|541360400|FG001|Overall Study|Surgery Changed|0|||
150059709|NCT03021564|541360401|FG000|Overall Study|Death|84|||
150059710|NCT03021564|541360402|FG001|Overall Study|Death|466|||
150059711|NCT03021564|541360401|FG000|Overall Study|Lost to Follow-up|0|||
150059712|NCT03021564|541360402|FG001|Overall Study|Lost to Follow-up|2|||
150059713|NCT01077154|541360407|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
150059714|NCT01077154|541360408|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
150059715|NCT01077154|541360407|FG000|Overall Study|Withdrawal by Subject|369|||
150059716|NCT01077154|541360408|FG001|Overall Study|Withdrawal by Subject|385|||
150059717|NCT01077154|541360407|FG000|Overall Study|Death|215|||
150021373|NCT04640311|541212774|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021374|NCT04640311|541212775|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021375|NCT04640311|541212776|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021376|NCT04640311|541212777|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021377|NCT04640311|541212778|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021378|NCT04640311|541212779|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021379|NCT04640311|541212780|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021380|NCT04640311|541212781|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
150021381|NCT04640311|541212769|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021382|NCT04640311|541212770|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021383|NCT04640311|541212771|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
150021384|NCT04640311|541212772|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021385|NCT04640311|541212773|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021386|NCT04640311|541212774|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021387|NCT04640311|541212775|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021388|NCT04640311|541212776|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021389|NCT04640311|541212777|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021390|NCT04640311|541212778|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021391|NCT04640311|541212779|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021392|NCT04640311|541212780|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150021393|NCT04640311|541212781|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
150059718|NCT01077154|541360408|FG001|Overall Study|Death|214|||
150059719|NCT01077154|541360407|FG000|Overall Study|Lost to Follow-up|43|||
150059720|NCT01077154|541360408|FG001|Overall Study|Lost to Follow-up|35|||
150059721|NCT01077154|541360407|FG000|Overall Study|Noncompliance|22|||
150059722|NCT01077154|541360408|FG001|Overall Study|Noncompliance|20|||
150059723|NCT01077154|541360407|FG000|Overall Study|Disease Progression|18|||
150059724|NCT01077154|541360408|FG001|Overall Study|Disease Progression|20|||
150059725|NCT01077154|541360407|FG000|Overall Study|Ineligibility Determined|10|||
150059726|NCT01077154|541360408|FG001|Overall Study|Ineligibility Determined|14|||
150059727|NCT01077154|541360407|FG000|Overall Study|Other|14|||
150059728|NCT01077154|541360408|FG001|Overall Study|Other|11|||
150059729|NCT01077154|541360407|FG000|Overall Study|Adverse Event|9|||
150059730|NCT01077154|541360408|FG001|Overall Study|Adverse Event|9|||
150059731|NCT01077154|541360407|FG000|Overall Study|Administrative Decision|1|||
150059732|NCT01077154|541360408|FG001|Overall Study|Administrative Decision|6|||
150059733|NCT01077154|541360407|FG000|Overall Study|Protocol Deviation|1|||
150059734|NCT01077154|541360408|FG001|Overall Study|Protocol Deviation|0|||
150059735|NCT02207946|541360409|FG000|Overall Study|Lost to Follow-up|1|||
150059736|NCT02207946|541360410|FG001|Overall Study|Lost to Follow-up|0|||
150059737|NCT02207946|541360409|FG000|Overall Study|Adverse Event|0|||
150059738|NCT02207946|541360410|FG001|Overall Study|Adverse Event|1|||
150059739|NCT02545543|541360411|FG000|Overall Study|Lost to Follow-up|67|||
150059740|NCT02545543|541360412|FG001|Overall Study|Lost to Follow-up|25|||
150059741|NCT02545543|541360411|FG000|Overall Study|Physician Decision|3|||
150059742|NCT02545543|541360412|FG001|Overall Study|Physician Decision|0|||
150059743|NCT02545543|541360411|FG000|Overall Study|Withdrawal by Subject|9|||
150059744|NCT02545543|541360412|FG001|Overall Study|Withdrawal by Subject|8|||
150059745|NCT02545543|541360411|FG000|Overall Study|Noncomplaince|1|||
150059746|NCT02545543|541360412|FG001|Overall Study|Noncomplaince|0|||
150059747|NCT02545543|541360411|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
150021394|NCT04640311|541212769|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021395|NCT04640311|541212770|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150059748|NCT02545543|541360412|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
150059749|NCT04675151|541360415|FG000|Overall Study|Protocol Violation|1|||
150059750|NCT04675151|541360416|FG001|Overall Study|Protocol Violation|0|||
150059751|NCT04675151|541360417|FG002|Overall Study|Protocol Violation|0|||
150059752|NCT04675151|541360418|FG003|Overall Study|Protocol Violation|1|||
150181725|NCT01044303|541802835|FG000|Overall Study|Lost to Follow-up|2|||
150181726|NCT01109524|541802840|FG000|Overall Study|Disease Progression|29|||
150021396|NCT04640311|541212771|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021397|NCT04640311|541212772|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
150021398|NCT04640311|541212773|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021399|NCT04640311|541212774|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021400|NCT04640311|541212775|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
150021401|NCT04640311|541212776|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021402|NCT04640311|541212777|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021403|NCT04640311|541212778|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021404|NCT04640311|541212779|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021405|NCT04640311|541212780|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021406|NCT04640311|541212781|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
150021407|NCT04640311|541212769|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021408|NCT04640311|541212770|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021409|NCT04640311|541212771|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021410|NCT04640311|541212772|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021411|NCT04640311|541212773|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021412|NCT04640311|541212774|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
150021413|NCT04640311|541212775|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021414|NCT04640311|541212776|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021415|NCT04640311|541212777|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
150021416|NCT04640311|541212778|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021417|NCT04640311|541212779|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021418|NCT04640311|541212780|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021419|NCT04640311|541212781|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
150021420|NCT04640311|541212769|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021421|NCT04640311|541212770|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021422|NCT04640311|541212771|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021423|NCT04640311|541212772|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021424|NCT04640311|541212773|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021425|NCT04640311|541212774|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021426|NCT04640311|541212775|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
150021427|NCT04640311|541212776|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021428|NCT04640311|541212777|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021429|NCT04640311|541212778|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021430|NCT04640311|541212779|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
150021431|NCT04640311|541212780|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021432|NCT04640311|541212781|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
150021433|NCT04640311|541212769|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021434|NCT04640311|541212770|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021435|NCT04640311|541212771|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021436|NCT04640311|541212772|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021437|NCT04640311|541212773|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021438|NCT04640311|541212774|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021439|NCT04640311|541212775|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021440|NCT04640311|541212776|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021441|NCT04640311|541212777|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021442|NCT04640311|541212778|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021443|NCT04640311|541212779|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021444|NCT04640311|541212780|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
150021445|NCT04640311|541212781|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
150021446|NCT00991939|541212786|FG000|Overall Study|Lost to Follow-up|0|||
150021447|NCT00991939|541212787|FG001|Overall Study|Lost to Follow-up|1|||
150021448|NCT00991939|541212786|FG000|Overall Study|Withdrawal by Subject|1|||
150021449|NCT00991939|541212787|FG001|Overall Study|Withdrawal by Subject|0|||
150021450|NCT00991939|541212786|FG000|Overall Study|Entire study terminated|4|||
150021451|NCT00991939|541212787|FG001|Overall Study|Entire study terminated|1|||
150021452|NCT01461707|541212788|FG000|Overall Study|Withdrawal by Subject|1|||
150021453|NCT01461707|541212789|FG001|Overall Study|Withdrawal by Subject|0|||
150021454|NCT01450761|541212790|FG000|Randomization|Subject no longer meets study criteria|1|||
150021455|NCT01450761|541212791|FG001|Randomization|Subject no longer meets study criteria|2|||
150021456|NCT01450761|541212790|FG000|Randomization|Withdrawal by Subject|2|||
150021457|NCT01450761|541212791|FG001|Randomization|Withdrawal by Subject|0|||
150021458|NCT01450761|541212790|FG000|Randomization|Disease progression|0|||
150021459|NCT01450761|541212791|FG001|Randomization|Disease progression|2|||
150021460|NCT01450761|541212790|FG000|Randomization|Adverse Event unrelated to study drug|1|||
150021461|NCT01450761|541212791|FG001|Randomization|Adverse Event unrelated to study drug|0|||
150021462|NCT01450761|541212790|FG000|Randomization|Other|0|||
150021463|NCT01450761|541212791|FG001|Randomization|Other|1|||
150021464|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Disease progression|33|||
150021465|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Disease progression|32|||
150021466|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
150021467|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
150021468|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
150021469|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
150021470|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
150021471|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
150021472|NCT01450761|541212790|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
150021473|NCT01450761|541212791|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
150021474|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Death|3|||
150021475|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Death|3|||
150021476|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Other|2|||
150021477|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Other|2|||
150021478|NCT01450761|541212790|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
150021479|NCT01450761|541212791|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
150021480|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
150021481|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
150021482|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
150021483|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
150021484|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
150021485|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
150021486|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
150021487|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
150021488|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
150021489|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
150021490|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Death|5|||
150021491|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Death|6|||
150021492|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
150021493|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
150021494|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
150021495|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
150021496|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
150021497|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
150021498|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
150021499|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
150021500|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
150021501|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
150021502|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
150021503|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
150021504|NCT01450761|541212790|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
150021505|NCT01450761|541212791|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
150021506|NCT02073682|541212804|FG000|Overall Study|Low Creatinine Clearance|1|||
150021507|NCT02073682|541212805|FG001|Overall Study|Low Creatinine Clearance|2|||
150021508|NCT02073682|541212804|FG000|Overall Study|Death|86|||
150021509|NCT02073682|541212805|FG001|Overall Study|Death|100|||
150021510|NCT02073682|541212804|FG000|Overall Study|Cancer Cured|10|||
150021511|NCT02073682|541212805|FG001|Overall Study|Cancer Cured|15|||
150021512|NCT02073682|541212804|FG000|Overall Study|ID: Patient Noncompliance|1|||
150021513|NCT02073682|541212805|FG001|Overall Study|ID: Patient Noncompliance|2|||
150021514|NCT02073682|541212804|FG000|Overall Study|ID: Palliative Treatment Only|10|||
150021515|NCT02073682|541212805|FG001|Overall Study|ID: Palliative Treatment Only|7|||
150021516|NCT02073682|541212804|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
150021517|NCT02073682|541212805|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
150021518|NCT02073682|541212804|FG000|Overall Study|Platelet Count <50,000/mL|1|||
150021519|NCT02073682|541212805|FG001|Overall Study|Platelet Count <50,000/mL|2|||
150021520|NCT02073682|541212804|FG000|Overall Study|Surgery/Medical Procedure|3|||
150021521|NCT02073682|541212805|FG001|Overall Study|Surgery/Medical Procedure|1|||
150021522|NCT02073682|541212804|FG000|Overall Study|Withdrawal by Subject|6|||
150021523|NCT02073682|541212805|FG001|Overall Study|Withdrawal by Subject|8|||
150021524|NCT02073682|541212804|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
150021525|NCT02073682|541212805|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
150021526|NCT02073682|541212804|FG000|Overall Study|Cancer Progression|53|||
150021527|NCT02073682|541212805|FG001|Overall Study|Cancer Progression|33|||
150021528|NCT02073682|541212804|FG000|Overall Study|Protocol Violation|1|||
150021529|NCT02073682|541212805|FG001|Overall Study|Protocol Violation|0|||
150021530|NCT02073682|541212804|FG000|Overall Study|Adverse Event|79|||
150021531|NCT02073682|541212805|FG001|Overall Study|Adverse Event|62|||
150021532|NCT02073682|541212804|FG000|Overall Study|No reason provided|11|||
150021533|NCT02073682|541212805|FG001|Overall Study|No reason provided|9|||
150021534|NCT02073682|541212804|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
150021535|NCT02073682|541212805|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
150021536|NCT02073682|541212804|FG000|Overall Study|Lost to Follow-up|1|||
150021537|NCT02073682|541212805|FG001|Overall Study|Lost to Follow-up|1|||
150021538|NCT02073682|541212804|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
150021539|NCT02073682|541212805|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
150021540|NCT03801174|541212806|FG000|Overall Study|Withdrawal by Subject|14|||
150021541|NCT03801174|541212807|FG001|Overall Study|Withdrawal by Subject|15|||
150021542|NCT03801174|541212806|FG000|Overall Study|Death|1|||
150021543|NCT03801174|541212807|FG001|Overall Study|Death|0|||
150021544|NCT03801174|541212806|FG000|Overall Study|Pregnancy|2|||
150021545|NCT03801174|541212807|FG001|Overall Study|Pregnancy|2|||
150021546|NCT03801174|541212806|FG000|Overall Study|Lost to Follow-up|19|||
150021547|NCT03801174|541212807|FG001|Overall Study|Lost to Follow-up|10|||
150021548|NCT03801174|541212806|FG000|Overall Study|Other|4|||
150021549|NCT03801174|541212807|FG001|Overall Study|Other|3|||
150021550|NCT03801174|541212806|FG000|Overall Study|Lack of Efficacy|4|||
150021551|NCT03801174|541212807|FG001|Overall Study|Lack of Efficacy|0|||
150021552|NCT03801174|541212806|FG000|Overall Study|Unwilling to complete activities|5|||
150021553|NCT03801174|541212807|FG001|Overall Study|Unwilling to complete activities|6|||
150021554|NCT03801174|541212806|FG000|Overall Study|Moved out of area|3|||
150021555|NCT03801174|541212807|FG001|Overall Study|Moved out of area|0|||
150021556|NCT00855816|541212808|FG000|Overall Study|Withdrawal by Subject|22|||
150021557|NCT00855816|541212809|FG001|Overall Study|Withdrawal by Subject|15|||
150021558|NCT00855816|541212808|FG000|Overall Study|Lost to Follow-up|3|||
150021559|NCT00855816|541212809|FG001|Overall Study|Lost to Follow-up|5|||
150021560|NCT00855816|541212808|FG000|Overall Study|Death|1|||
150021561|NCT00855816|541212809|FG001|Overall Study|Death|0|||
150021562|NCT00855816|541212808|FG000|Overall Study|Became ineligible|0|||
150021563|NCT00855816|541212809|FG001|Overall Study|Became ineligible|1|||
150021564|NCT01965704|541212810|FG000|Overall Study|Withdrawal by Subject|2|||
150021565|NCT01965704|541212811|FG001|Overall Study|Withdrawal by Subject|2|||
150021566|NCT01965704|541212812|FG002|Overall Study|Withdrawal by Subject|1|||
150021567|NCT01965704|541212813|FG003|Overall Study|Withdrawal by Subject|1|||
150021568|NCT01965704|541212810|FG000|Overall Study|Delivered at home|1|||
150021569|NCT01965704|541212811|FG001|Overall Study|Delivered at home|1|||
150021570|NCT01965704|541212812|FG002|Overall Study|Delivered at home|0|||
150021571|NCT01965704|541212813|FG003|Overall Study|Delivered at home|0|||
150021572|NCT01965704|541212810|FG000|Overall Study|Experienced complications|0|||
150021573|NCT01965704|541212811|FG001|Overall Study|Experienced complications|0|||
150021574|NCT01965704|541212812|FG002|Overall Study|Experienced complications|2|||
150021575|NCT01965704|541212813|FG003|Overall Study|Experienced complications|2|||
150021576|NCT01965704|541212810|FG000|Overall Study|Adverse Event|0|||
150021577|NCT01965704|541212811|FG001|Overall Study|Adverse Event|0|||
150021578|NCT01965704|541212812|FG002|Overall Study|Adverse Event|1|||
150021579|NCT01965704|541212813|FG003|Overall Study|Adverse Event|1|||
150021580|NCT01965704|541212810|FG000|Overall Study|Did not meet inclusion criteria|0|||
150021581|NCT01965704|541212811|FG001|Overall Study|Did not meet inclusion criteria|0|||
150021582|NCT01965704|541212812|FG002|Overall Study|Did not meet inclusion criteria|1|||
150021583|NCT01965704|541212813|FG003|Overall Study|Did not meet inclusion criteria|1|||
150021584|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
150021585|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
150021586|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
150021587|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
150021588|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
150021589|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
150021590|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
150021591|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
150021592|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
150021593|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
150021594|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
150021595|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
150021596|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
150021597|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
150021598|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
150021599|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
150021600|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
150021601|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
150021602|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
150021603|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
150021604|NCT03573323|541212814|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
150021605|NCT03573323|541212815|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
150021606|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
150021607|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
150021608|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
150021609|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
150021610|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
150021611|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
150021612|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
150021613|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
150021614|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
150021615|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
150021616|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
150021617|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
150021618|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
150021619|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
150021620|NCT03573323|541212814|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
150021621|NCT03573323|541212815|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
150021622|NCT01687296|541212818|FG000|Overall Study|Lack of Efficacy|1|||
150021623|NCT01687296|541212819|FG001|Overall Study|Lack of Efficacy|1|||
150021624|NCT01687296|541212818|FG000|Overall Study|Protocol Violation|0|||
150021625|NCT01687296|541212819|FG001|Overall Study|Protocol Violation|1|||
150021626|NCT01687296|541212818|FG000|Overall Study|Withdrawal by Subject|6|||
150021627|NCT01687296|541212819|FG001|Overall Study|Withdrawal by Subject|3|||
150021628|NCT01479868|541212824|FG000|Overall Study|Adverse Event|1|||
150021629|NCT01479868|541212824|FG000|Overall Study|Lost to Follow-up|4|||
150021630|NCT01479868|541212824|FG000|Overall Study|Protocol Violation|1|||
150021631|NCT01479868|541212824|FG000|Overall Study|Withdrawal by Subject|1|||
150021632|NCT01479868|541212824|FG000|Overall Study|Sponsor's Decision|1|||
150021633|NCT01479868|541212824|FG000|Overall Study|Initiation of new HCV Therapy|1|||
150021634|NCT01177007|541212825|FG000|Overall Study|Lost to Follow-up|2|||
150021635|NCT01177007|541212825|FG000|Overall Study|Death|4|||
150021636|NCT01177007|541212825|FG000|Overall Study|Entered hospice care|5|||
150021637|NCT01177007|541212825|FG000|Overall Study|Required additional Y90 treatment|6|||
150021638|NCT01177007|541212825|FG000|Overall Study|Change in treatment modality|21|||
150021639|NCT02336230|541212828|FG000|Overall Study|Adverse Event|1|||
150021640|NCT02336230|541212828|FG000|Overall Study|Withdrawal of consent|1|||
150021641|NCT02336230|541212828|FG000|Overall Study|Death|9|||
150021642|NCT02336230|541212828|FG000|Overall Study|Dose not received due to shipping delay|1|||
150021643|NCT02336230|541212828|FG000|Overall Study|Discontinuation of MSC infusion|1|||
150021644|NCT02524171|541212829|FG000|6-month Follow-up|Lost to Follow-up|53|||
150021645|NCT02524171|541212830|FG001|6-month Follow-up|Lost to Follow-up|45|||
150021646|NCT02524171|541212829|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
150021647|NCT02524171|541212830|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
150021648|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Progressive disease|50|||
150021649|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Progressive disease|110|||
150021650|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Progressive disease|0|||
150021651|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Progressive disease|0|||
150021652|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
150021653|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
150021654|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150021655|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150021656|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Adverse Event|7|||
150021657|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Adverse Event|7|||
150021658|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Adverse Event|0|||
150021659|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Adverse Event|0|||
150021660|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Other|1|||
150021661|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Other|3|||
150021662|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Other|0|||
150021663|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Other|0|||
150181727|NCT01109524|541802840|FG000|Overall Study|Study Drug toxicity|6|||
150181728|NCT01109524|541802840|FG000|Overall Study|Adverse Event|4|||
150181729|NCT01109524|541802840|FG000|Overall Study|Withdrawal by Subject|2|||
150021664|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Physician Decision|6|||
150021665|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Physician Decision|3|||
150021666|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Physician Decision|0|||
150021667|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Physician Decision|0|||
150021668|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Death|1|||
150021669|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Death|1|||
150021670|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Death|0|||
150021671|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Death|0|||
150021672|NCT01695135|541212837|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
150021673|NCT01695135|541212838|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
150021674|NCT01695135|541212839|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
150021675|NCT01695135|541212840|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
150021676|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
150021677|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
150021678|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
150021679|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
150021680|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
150021681|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
150021682|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
150021683|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
150021684|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
150021685|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
150021686|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
150021687|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
150021688|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Other|0|||
150021689|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Other|0|||
150021690|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Other|4|||
150021691|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Other|7|||
150021692|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
150021693|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
150021694|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
150021695|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
150021696|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Death|0|||
150021697|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Death|0|||
150021698|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Death|2|||
150021699|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Death|7|||
150021700|NCT01695135|541212837|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
150021701|NCT01695135|541212838|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
150021702|NCT01695135|541212839|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
150021703|NCT01695135|541212840|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
150021704|NCT02753946|541212843|FG000|Overall Study|Adverse Event|7|||
150021705|NCT02753946|541212844|FG001|Overall Study|Adverse Event|6|||
150021706|NCT02753946|541212843|FG000|Overall Study|Withdrawal by Subject|6|||
150021707|NCT02753946|541212844|FG001|Overall Study|Withdrawal by Subject|1|||
150021708|NCT02753946|541212843|FG000|Overall Study|Lack of Efficacy|1|||
150021709|NCT02753946|541212844|FG001|Overall Study|Lack of Efficacy|0|||
150021710|NCT02753946|541212843|FG000|Overall Study|Physician Decision|0|||
150021711|NCT02753946|541212844|FG001|Overall Study|Physician Decision|2|||
150021712|NCT00216671|541212845|FG000|Overall Study|Adverse Event|4|||
150021713|NCT00216671|541212846|FG001|Overall Study|Adverse Event|9|||
150021714|NCT00216671|541212845|FG000|Overall Study|Pregnancy|0|||
150021715|NCT00216671|541212846|FG001|Overall Study|Pregnancy|1|||
150021716|NCT00216671|541212845|FG000|Overall Study|Withdrawal by Subject|4|||
150021717|NCT00216671|541212846|FG001|Overall Study|Withdrawal by Subject|2|||
150021718|NCT00216671|541212845|FG000|Overall Study|Refused Injections|3|||
150021719|NCT00216671|541212846|FG001|Overall Study|Refused Injections|13|||
150021720|NCT00216671|541212845|FG000|Overall Study|No Need to Continue Medication|1|||
150021721|NCT00216671|541212846|FG001|Overall Study|No Need to Continue Medication|1|||
150021722|NCT00216671|541212845|FG000|Overall Study|Insufficient Response|9|||
150021723|NCT00216671|541212846|FG001|Overall Study|Insufficient Response|4|||
150021724|NCT00216671|541212845|FG000|Overall Study|Lost to Follow-up|3|||
150059753|NCT04035486|541360419|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
150059754|NCT04035486|541360420|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
150059755|NCT04035486|541360421|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
150059756|NCT04035486|541360422|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
150059757|NCT04035486|541360419|FG000|Overall Study|Death|6|||
150059758|NCT04035486|541360420|FG001|Overall Study|Death|3|||
150021725|NCT00216671|541212846|FG001|Overall Study|Lost to Follow-up|5|||
150021726|NCT00216671|541212845|FG000|Overall Study|Non compliant|2|||
150021727|NCT00216671|541212846|FG001|Overall Study|Non compliant|2|||
150021728|NCT00216671|541212845|FG000|Overall Study|Ineligible|0|||
150021729|NCT00216671|541212846|FG001|Overall Study|Ineligible|2|||
150021730|NCT00216671|541212845|FG000|Overall Study|Physician Decision|1|||
150021731|NCT00216671|541212846|FG001|Overall Study|Physician Decision|1|||
150021732|NCT00216671|541212845|FG000|Overall Study|Protocol Violation|3|||
150021733|NCT00216671|541212846|FG001|Overall Study|Protocol Violation|5|||
150021734|NCT00216671|541212845|FG000|Overall Study|Relapse|1|||
150021735|NCT00216671|541212846|FG001|Overall Study|Relapse|0|||
150021736|NCT00216671|541212845|FG000|Overall Study|Investigator Illness|0|||
150021737|NCT00216671|541212846|FG001|Overall Study|Investigator Illness|1|||
150021738|NCT00216671|541212845|FG000|Overall Study|Patient Moved|0|||
150021739|NCT00216671|541212846|FG001|Overall Study|Patient Moved|1|||
150021740|NCT00216671|541212845|FG000|Overall Study|Ineligible, no efficacy data|2|||
150021741|NCT00216671|541212846|FG001|Overall Study|Ineligible, no efficacy data|2|||
150021742|NCT00216671|541212845|FG000|Overall Study|Insufficient Response Adverse Event|2|||
150021743|NCT00216671|541212846|FG001|Overall Study|Insufficient Response Adverse Event|1|||
150021744|NCT02714569|541212847|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
150021745|NCT02714569|541212848|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
150021746|NCT02714569|541212849|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
150021747|NCT02714569|541212850|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
150021748|NCT02714569|541212851|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
150021749|NCT02714569|541212852|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
150021750|NCT02714569|541212853|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
150021751|NCT02714569|541212854|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
150021752|NCT02714569|541212855|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
150021753|NCT02714569|541212856|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
150021754|NCT02714569|541212857|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
150021755|NCT02714569|541212847|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021756|NCT02714569|541212848|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021757|NCT02714569|541212849|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021758|NCT02714569|541212850|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
150021759|NCT02714569|541212851|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021760|NCT02714569|541212852|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021761|NCT02714569|541212853|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021762|NCT02714569|541212854|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021763|NCT02714569|541212855|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021764|NCT02714569|541212856|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021765|NCT02714569|541212857|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
150021766|NCT02714569|541212847|FG000|Part A Third Intervention|Adverse Event|0|||
150021767|NCT02714569|541212848|FG001|Part A Third Intervention|Adverse Event|0|||
150021768|NCT02714569|541212849|FG002|Part A Third Intervention|Adverse Event|1|||
150021769|NCT02714569|541212850|FG003|Part A Third Intervention|Adverse Event|0|||
150021770|NCT02714569|541212851|FG004|Part A Third Intervention|Adverse Event|0|||
150021771|NCT02714569|541212852|FG005|Part A Third Intervention|Adverse Event|0|||
150021772|NCT02714569|541212853|FG006|Part A Third Intervention|Adverse Event|0|||
150021773|NCT02714569|541212854|FG007|Part A Third Intervention|Adverse Event|0|||
150021774|NCT02714569|541212855|FG008|Part A Third Intervention|Adverse Event|0|||
150021775|NCT02714569|541212856|FG009|Part A Third Intervention|Adverse Event|0|||
150021776|NCT02714569|541212857|FG010|Part A Third Intervention|Adverse Event|0|||
150021777|NCT02714569|541212847|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
150021778|NCT02714569|541212848|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021779|NCT02714569|541212849|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021780|NCT02714569|541212850|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021781|NCT02714569|541212851|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021782|NCT02714569|541212852|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
150021783|NCT02714569|541212853|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021784|NCT02714569|541212854|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021785|NCT02714569|541212855|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150059759|NCT04035486|541360421|FG002|Overall Study|Death|70|||
150059760|NCT04035486|541360422|FG003|Overall Study|Death|77|||
150059761|NCT04035486|541360419|FG000|Overall Study|Screen Failure|0|||
150059762|NCT04035486|541360420|FG001|Overall Study|Screen Failure|0|||
150059763|NCT04035486|541360421|FG002|Overall Study|Screen Failure|1|||
150059764|NCT04035486|541360422|FG003|Overall Study|Screen Failure|1|||
150021786|NCT02714569|541212856|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150021787|NCT02714569|541212857|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
150059765|NCT04035486|541360419|FG000|Overall Study|Withdrawal by Subject|1|||
150059766|NCT04035486|541360420|FG001|Overall Study|Withdrawal by Subject|1|||
150059767|NCT04035486|541360421|FG002|Overall Study|Withdrawal by Subject|11|||
150021788|NCT02714569|541212847|FG000|Part B (Overall)|Lost to Follow-up|0|||
150021789|NCT02714569|541212848|FG001|Part B (Overall)|Lost to Follow-up|0|||
150021790|NCT02714569|541212849|FG002|Part B (Overall)|Lost to Follow-up|0|||
150021791|NCT02714569|541212850|FG003|Part B (Overall)|Lost to Follow-up|0|||
150021792|NCT02714569|541212851|FG004|Part B (Overall)|Lost to Follow-up|0|||
150021793|NCT02714569|541212852|FG005|Part B (Overall)|Lost to Follow-up|0|||
150021794|NCT02714569|541212853|FG006|Part B (Overall)|Lost to Follow-up|1|||
150021795|NCT02714569|541212854|FG007|Part B (Overall)|Lost to Follow-up|0|||
150021796|NCT02714569|541212855|FG008|Part B (Overall)|Lost to Follow-up|0|||
150021797|NCT02714569|541212856|FG009|Part B (Overall)|Lost to Follow-up|0|||
150021798|NCT02714569|541212857|FG010|Part B (Overall)|Lost to Follow-up|0|||
150021799|NCT02714569|541212847|FG000|Part B (Overall)|Withdrawal by Subject|0|||
150021800|NCT02714569|541212848|FG001|Part B (Overall)|Withdrawal by Subject|0|||
150021801|NCT02714569|541212849|FG002|Part B (Overall)|Withdrawal by Subject|0|||
150021802|NCT02714569|541212850|FG003|Part B (Overall)|Withdrawal by Subject|0|||
150021803|NCT02714569|541212851|FG004|Part B (Overall)|Withdrawal by Subject|0|||
150021804|NCT02714569|541212852|FG005|Part B (Overall)|Withdrawal by Subject|0|||
150021805|NCT02714569|541212853|FG006|Part B (Overall)|Withdrawal by Subject|0|||
150021806|NCT02714569|541212854|FG007|Part B (Overall)|Withdrawal by Subject|1|||
150021807|NCT02714569|541212855|FG008|Part B (Overall)|Withdrawal by Subject|0|||
150021808|NCT02714569|541212856|FG009|Part B (Overall)|Withdrawal by Subject|1|||
150021809|NCT02714569|541212857|FG010|Part B (Overall)|Withdrawal by Subject|0|||
150021810|NCT02714569|541212847|FG000|Part B (Overall)|Adverse Event|0|||
150021811|NCT02714569|541212848|FG001|Part B (Overall)|Adverse Event|0|||
150021812|NCT02714569|541212849|FG002|Part B (Overall)|Adverse Event|0|||
150021813|NCT02714569|541212850|FG003|Part B (Overall)|Adverse Event|0|||
150021814|NCT02714569|541212851|FG004|Part B (Overall)|Adverse Event|0|||
150021815|NCT02714569|541212852|FG005|Part B (Overall)|Adverse Event|0|||
150021816|NCT02714569|541212853|FG006|Part B (Overall)|Adverse Event|0|||
150021817|NCT02714569|541212854|FG007|Part B (Overall)|Adverse Event|0|||
150021818|NCT02714569|541212855|FG008|Part B (Overall)|Adverse Event|0|||
150021819|NCT02714569|541212856|FG009|Part B (Overall)|Adverse Event|1|||
150021820|NCT02714569|541212857|FG010|Part B (Overall)|Adverse Event|0|||
150021821|NCT01219985|541212858|FG000|Overall Study|Physician Decision|20|||
150021822|NCT00596752|541212859|FG000|Overall Study|Other Reason|44|||
150021823|NCT00596752|541212860|FG001|Overall Study|Other Reason|49|||
150021824|NCT00596752|541212859|FG000|Overall Study|Adverse Event|34|||
150021825|NCT00596752|541212860|FG001|Overall Study|Adverse Event|34|||
150021826|NCT00596752|541212859|FG000|Overall Study|Lost to Follow-up|22|||
150021827|NCT00596752|541212860|FG001|Overall Study|Lost to Follow-up|38|||
150021828|NCT00596752|541212859|FG000|Overall Study|Withdrawal by Subject|12|||
150021829|NCT00596752|541212860|FG001|Overall Study|Withdrawal by Subject|9|||
150021830|NCT00596752|541212859|FG000|Overall Study|Unsatisfactory Compliance|9|||
150021831|NCT00596752|541212860|FG001|Overall Study|Unsatisfactory Compliance|6|||
150021832|NCT00596752|541212859|FG000|Overall Study|Lack of Efficacy|4|||
150021833|NCT00596752|541212860|FG001|Overall Study|Lack of Efficacy|7|||
150021834|NCT00596752|541212859|FG000|Overall Study|Protocol Violation|1|||
150021835|NCT00596752|541212860|FG001|Overall Study|Protocol Violation|0|||
150021836|NCT01870726|541212861|FG000|Overall Study|Withdrawal of informed consent|0|||
150021837|NCT01870726|541212862|FG001|Overall Study|Withdrawal of informed consent|0|||
150021838|NCT01870726|541212863|FG002|Overall Study|Withdrawal of informed consent|0|||
150021839|NCT01870726|541212864|FG003|Overall Study|Withdrawal of informed consent|1|||
150021840|NCT01870726|541212865|FG004|Overall Study|Withdrawal of informed consent|0|||
150021841|NCT01870726|541212866|FG005|Overall Study|Withdrawal of informed consent|0|||
150021842|NCT01870726|541212867|FG006|Overall Study|Withdrawal of informed consent|0|||
150021843|NCT01870726|541212861|FG000|Overall Study|Withdrawal by Subject|0|||
150021844|NCT01870726|541212862|FG001|Overall Study|Withdrawal by Subject|1|||
150021845|NCT01870726|541212863|FG002|Overall Study|Withdrawal by Subject|0|||
150021846|NCT01870726|541212864|FG003|Overall Study|Withdrawal by Subject|0|||
150021847|NCT01870726|541212865|FG004|Overall Study|Withdrawal by Subject|0|||
150021848|NCT01870726|541212866|FG005|Overall Study|Withdrawal by Subject|0|||
150021849|NCT01870726|541212867|FG006|Overall Study|Withdrawal by Subject|0|||
150021850|NCT01870726|541212861|FG000|Overall Study|Adverse Event|0|||
150021851|NCT01870726|541212862|FG001|Overall Study|Adverse Event|0|||
150021852|NCT01870726|541212863|FG002|Overall Study|Adverse Event|0|||
150021853|NCT01870726|541212864|FG003|Overall Study|Adverse Event|0|||
150021854|NCT01870726|541212865|FG004|Overall Study|Adverse Event|1|||
150021855|NCT01870726|541212866|FG005|Overall Study|Adverse Event|1|||
150021856|NCT01870726|541212867|FG006|Overall Study|Adverse Event|0|||
150021857|NCT01870726|541212861|FG000|Overall Study|Progressive disease|5|||
150021858|NCT01870726|541212862|FG001|Overall Study|Progressive disease|5|||
150021859|NCT01870726|541212863|FG002|Overall Study|Progressive disease|4|||
150021860|NCT01870726|541212864|FG003|Overall Study|Progressive disease|5|||
150021861|NCT01870726|541212865|FG004|Overall Study|Progressive disease|6|||
150021862|NCT01870726|541212866|FG005|Overall Study|Progressive disease|4|||
150021863|NCT01870726|541212867|FG006|Overall Study|Progressive disease|10|||
150021864|NCT03691571|541212868|FG000|Overall Study|Withdrawal by Subject|9|||
150021865|NCT03691571|541212869|FG001|Overall Study|Withdrawal by Subject|2|||
150021866|NCT00555217|541212871|FG000|Overall Study|Withdrawal by Subject|35|||
150021867|NCT00555217|541212872|FG001|Overall Study|Withdrawal by Subject|31|||
150021868|NCT00555217|541212871|FG000|Overall Study|Lost to Follow-up|19|||
150021869|NCT00555217|541212872|FG001|Overall Study|Lost to Follow-up|20|||
150021870|NCT00555217|541212871|FG000|Overall Study|close out sites|21|||
150021871|NCT00555217|541212872|FG001|Overall Study|close out sites|17|||
150021872|NCT00983385|541212873|FG000|Observation Period|Not eligible to be dosed|20|||
150021873|NCT00983385|541212873|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
150021874|NCT00900029|541212874|FG000|Overall Study|Lost to Follow-up|0|||
150021875|NCT00900029|541212875|FG001|Overall Study|Lost to Follow-up|2|||
150021876|NCT00900029|541212876|FG002|Overall Study|Lost to Follow-up|1|||
150021877|NCT00900029|541212877|FG003|Overall Study|Lost to Follow-up|4|||
150021878|NCT00900029|541212878|FG004|Overall Study|Lost to Follow-up|4|||
150021879|NCT00900029|541212874|FG000|Overall Study|Withdrawal by Subject|2|||
150021880|NCT00900029|541212875|FG001|Overall Study|Withdrawal by Subject|2|||
150021881|NCT00900029|541212876|FG002|Overall Study|Withdrawal by Subject|1|||
150021882|NCT00900029|541212877|FG003|Overall Study|Withdrawal by Subject|1|||
150021883|NCT00900029|541212878|FG004|Overall Study|Withdrawal by Subject|1|||
150021884|NCT00900029|541212874|FG000|Overall Study|Adverse Event|0|||
150021885|NCT00900029|541212875|FG001|Overall Study|Adverse Event|0|||
150021886|NCT00900029|541212876|FG002|Overall Study|Adverse Event|1|||
150021887|NCT00900029|541212877|FG003|Overall Study|Adverse Event|1|||
150021888|NCT00900029|541212878|FG004|Overall Study|Adverse Event|1|||
150021889|NCT00900029|541212874|FG000|Overall Study|Death|1|||
150021890|NCT00900029|541212875|FG001|Overall Study|Death|0|||
150021891|NCT00900029|541212876|FG002|Overall Study|Death|0|||
150021892|NCT00900029|541212877|FG003|Overall Study|Death|1|||
150021893|NCT00900029|541212878|FG004|Overall Study|Death|0|||
150021894|NCT02709330|541212879|FG000|Overall Study|Death|5|||
150021895|NCT02709330|541212880|FG001|Overall Study|Death|0|||
150021896|NCT02709330|541212879|FG000|Overall Study|Lost to Follow-up|2|||
150021897|NCT02709330|541212880|FG001|Overall Study|Lost to Follow-up|0|||
150021898|NCT02709330|541212879|FG000|Overall Study|Physician Decision|2|||
150021899|NCT02709330|541212880|FG001|Overall Study|Physician Decision|0|||
150021900|NCT02709330|541212879|FG000|Overall Study|Withdrawal by Subject|4|||
150021901|NCT02709330|541212880|FG001|Overall Study|Withdrawal by Subject|0|||
150021902|NCT02587819|541212881|FG000|Overall Study|Adverse Event|1|||
150021903|NCT02587819|541212881|FG000|Overall Study|Lost to Follow-up|1|||
150021904|NCT00511238|541212882|FG000|Overall Study|Adverse Event|13|||
150021905|NCT00511238|541212883|FG001|Overall Study|Adverse Event|33|||
150021906|NCT00511238|541212882|FG000|Overall Study|Withdrawal by Subject|2|||
150021907|NCT00511238|541212883|FG001|Overall Study|Withdrawal by Subject|22|||
150021908|NCT00511238|541212882|FG000|Overall Study|Progressive Disease|23|||
150021909|NCT00511238|541212883|FG001|Overall Study|Progressive Disease|157|||
150021910|NCT00511238|541212882|FG000|Overall Study|various reasons|4|||
150021911|NCT00511238|541212883|FG001|Overall Study|various reasons|14|||
150021912|NCT00330759|541216047|FG000|Overall Study|Death|316|||
150021913|NCT00330759|541216048|FG001|Overall Study|Death|310|||
150021914|NCT00330759|541216047|FG000|Overall Study|Disease progression|104|||
150021915|NCT00330759|541216048|FG001|Overall Study|Disease progression|126|||
150021916|NCT00330759|541216047|FG000|Overall Study|Withdrawal by Subject|143|||
150021917|NCT00330759|541216048|FG001|Overall Study|Withdrawal by Subject|124|||
150021918|NCT00330759|541216047|FG000|Overall Study|Adverse Event|48|||
150021919|NCT00330759|541216048|FG001|Overall Study|Adverse Event|36|||
150021920|NCT00330759|541216047|FG000|Overall Study|Participant request|31|||
150021921|NCT00330759|541216048|FG001|Overall Study|Participant request|22|||
150021922|NCT00330759|541216047|FG000|Overall Study|Lost to Follow-up|16|||
150021923|NCT00330759|541216048|FG001|Overall Study|Lost to Follow-up|22|||
150021924|NCT00330759|541216047|FG000|Overall Study|Noncompliance|15|||
150021925|NCT00330759|541216048|FG001|Overall Study|Noncompliance|17|||
150021926|NCT00330759|541216047|FG000|Overall Study|Physician Decision|1|||
150021927|NCT00330759|541216048|FG001|Overall Study|Physician Decision|2|||
150021928|NCT00330759|541216047|FG000|Overall Study|Protocol deviation|0|||
150021929|NCT00330759|541216048|FG001|Overall Study|Protocol deviation|2|||
150021930|NCT00330759|541216047|FG000|Overall Study|Ineligibility determined|2|||
150021931|NCT00330759|541216048|FG001|Overall Study|Ineligibility determined|1|||
150021932|NCT00330759|541216047|FG000|Overall Study|Other|36|||
150021933|NCT00330759|541216048|FG001|Overall Study|Other|44|||
150021934|NCT04070989|541216052|FG000|Overall Study|Death|1|||
150021935|NCT04070989|541216053|FG001|Overall Study|Death|0|||
150021936|NCT04070989|541216054|FG002|Overall Study|Death|0|||
150021937|NCT04070989|541216052|FG000|Overall Study|Study Terminated by Sponsor|7|||
150059768|NCT04035486|541360422|FG003|Overall Study|Withdrawal by Subject|9|||
150021938|NCT04070989|541216053|FG001|Overall Study|Study Terminated by Sponsor|8|||
150021939|NCT04070989|541216054|FG002|Overall Study|Study Terminated by Sponsor|23|||
150021940|NCT04070989|541216052|FG000|Overall Study|Withdrawal by Subject|0|||
150021941|NCT04070989|541216053|FG001|Overall Study|Withdrawal by Subject|1|||
150021942|NCT04070989|541216054|FG002|Overall Study|Withdrawal by Subject|0|||
150021943|NCT04070989|541216052|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
150021944|NCT04070989|541216053|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
150021945|NCT04070989|541216054|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
150021946|NCT04070989|541216052|FG000|Overall Study|Other|1|||
150021947|NCT04070989|541216053|FG001|Overall Study|Other|1|||
150021948|NCT04070989|541216054|FG002|Overall Study|Other|0|||
150021949|NCT04685798|541216071|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
150021950|NCT00592904|541216076|FG000|Overall Study|Adverse Event|15|||
150021951|NCT00592904|541216077|FG001|Overall Study|Adverse Event|25|||
150021952|NCT00592904|541216078|FG002|Overall Study|Adverse Event|13|||
150021953|NCT00592904|541216079|FG003|Overall Study|Adverse Event|5|||
150021954|NCT00592904|541216076|FG000|Overall Study|Protocol Violation|1|||
150021955|NCT00592904|541216077|FG001|Overall Study|Protocol Violation|1|||
150021956|NCT00592904|541216078|FG002|Overall Study|Protocol Violation|0|||
150021957|NCT00592904|541216079|FG003|Overall Study|Protocol Violation|1|||
150021958|NCT00592904|541216076|FG000|Overall Study|Withdrawal by Subject|4|||
150021959|NCT00592904|541216077|FG001|Overall Study|Withdrawal by Subject|16|||
150021960|NCT00592904|541216078|FG002|Overall Study|Withdrawal by Subject|1|||
150021961|NCT00592904|541216079|FG003|Overall Study|Withdrawal by Subject|2|||
150021962|NCT00592904|541216076|FG000|Overall Study|Lack of Efficacy|2|||
150021963|NCT00592904|541216077|FG001|Overall Study|Lack of Efficacy|7|||
150021964|NCT00592904|541216078|FG002|Overall Study|Lack of Efficacy|2|||
150021965|NCT00592904|541216079|FG003|Overall Study|Lack of Efficacy|3|||
150021966|NCT00592904|541216076|FG000|Overall Study|Physician Decision|0|||
150021967|NCT00592904|541216077|FG001|Overall Study|Physician Decision|3|||
150021968|NCT00592904|541216078|FG002|Overall Study|Physician Decision|1|||
150021969|NCT00592904|541216079|FG003|Overall Study|Physician Decision|0|||
150021970|NCT00592904|541216076|FG000|Overall Study|Other|3|||
150021971|NCT00592904|541216077|FG001|Overall Study|Other|3|||
150021972|NCT00592904|541216078|FG002|Overall Study|Other|0|||
150021973|NCT00592904|541216079|FG003|Overall Study|Other|0|||
150021974|NCT01388907|541216080|FG000|Overall Study|Adverse Event|2|||
150021975|NCT01388907|541216081|FG001|Overall Study|Adverse Event|0|||
150021976|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
150021977|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
150021978|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
150021979|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
150021980|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
150021981|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
150021982|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
150021983|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
150021984|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
150021985|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
150021986|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
150021987|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
150021988|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
150021989|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
150021990|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
150021991|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
150021992|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
150021993|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
150021994|NCT01910402|541216082|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
150021995|NCT01910402|541216083|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
150021996|NCT01910402|541216084|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
150021997|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
150021998|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
150021999|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
150022000|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
150022001|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
150022002|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
150022003|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
150022004|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
150022005|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
150022006|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
150022007|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
150022008|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
150022009|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
150022010|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
150022011|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
150059769|NCT03947684|541360423|FG000|Overall Study|Lost to Follow-up|13|||
150022012|NCT01910402|541216082|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
150022013|NCT01910402|541216083|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
150022014|NCT01910402|541216084|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
150022015|NCT00824473|541216085|FG000|Overall Study|Adverse Event|4|||
150022016|NCT00824473|541216086|FG001|Overall Study|Adverse Event|5|||
150022017|NCT00824473|541216085|FG000|Overall Study|Lack of Efficacy|2|||
150022018|NCT00824473|541216086|FG001|Overall Study|Lack of Efficacy|2|||
150022019|NCT00824473|541216085|FG000|Overall Study|Protocol Violation|2|||
150022020|NCT00824473|541216086|FG001|Overall Study|Protocol Violation|0|||
150022021|NCT00824473|541216085|FG000|Overall Study|Non-Compliance|4|||
150022022|NCT00824473|541216086|FG001|Overall Study|Non-Compliance|2|||
150022023|NCT00824473|541216085|FG000|Overall Study|Withdrawal by Subject|2|||
150022024|NCT00824473|541216086|FG001|Overall Study|Withdrawal by Subject|3|||
150022025|NCT00824473|541216085|FG000|Overall Study|Other|1|||
150022026|NCT00824473|541216086|FG001|Overall Study|Other|1|||
150022027|NCT01359904|541216087|FG000|Overall Study|Withdrawal by Subject|1|||
150022028|NCT01359904|541216088|FG001|Overall Study|Withdrawal by Subject|0|||
150022029|NCT03594773|541216090|FG000|Overall Study|Withdrawal by Subject|3|||
150022030|NCT03594773|541216091|FG001|Overall Study|Withdrawal by Subject|2|||
150022031|NCT03594773|541216090|FG000|Overall Study|Lost to Follow-up|3|||
150022032|NCT03594773|541216091|FG001|Overall Study|Lost to Follow-up|4|||
150022033|NCT03191630|541216092|FG000|Overall Study|Lost to Follow-up|7|||
150022034|NCT03191630|541216093|FG001|Overall Study|Lost to Follow-up|7|||
150022035|NCT01550757|541216094|FG000|Overall Study|Lost to Follow-up|21|||
150022036|NCT01550757|541216095|FG001|Overall Study|Lost to Follow-up|14|||
150022037|NCT01550757|541216096|FG002|Overall Study|Lost to Follow-up|42|||
150022038|NCT01550757|541216097|FG003|Overall Study|Lost to Follow-up|53|||
150022039|NCT01550757|541216094|FG000|Overall Study|Withdrawal by Subject|2|||
150022040|NCT01550757|541216095|FG001|Overall Study|Withdrawal by Subject|0|||
150022041|NCT01550757|541216096|FG002|Overall Study|Withdrawal by Subject|3|||
150059770|NCT03947684|541360424|FG001|Overall Study|Lost to Follow-up|5|||
150059771|NCT03947684|541360425|FG002|Overall Study|Lost to Follow-up|1|||
150059772|NCT03947684|541360423|FG000|Overall Study|Withdrawal by Subject|11|||
150059773|NCT03947684|541360424|FG001|Overall Study|Withdrawal by Subject|4|||
150059774|NCT03947684|541360425|FG002|Overall Study|Withdrawal by Subject|0|||
150059775|NCT03947684|541360423|FG000|Overall Study|Physician Decision|1|||
150059776|NCT03947684|541360424|FG001|Overall Study|Physician Decision|0|||
150059777|NCT03947684|541360425|FG002|Overall Study|Physician Decision|0|||
150059778|NCT03947684|541360423|FG000|Overall Study|Lack of adherence to study protocol|2|||
150059779|NCT03947684|541360424|FG001|Overall Study|Lack of adherence to study protocol|0|||
150059780|NCT03947684|541360425|FG002|Overall Study|Lack of adherence to study protocol|0|||
150059781|NCT05772702|541360433|FG000|Overall Study|Adverse Event|1|||
150059782|NCT00884377|541361315|FG000|Overall Study|Withdrawal by Subject|1|||
150059783|NCT00884377|541361316|FG001|Overall Study|Withdrawal by Subject|0|||
150059784|NCT00884377|541361315|FG000|Overall Study|Could not confirm diagnosis|1|||
150059785|NCT00884377|541361316|FG001|Overall Study|Could not confirm diagnosis|0|||
150059786|NCT00884377|541361315|FG000|Overall Study|Physician Decision|0|||
150059787|NCT00884377|541361316|FG001|Overall Study|Physician Decision|1|||
150059788|NCT04300751|541361319|FG000|Overall Study|Withdrawal by Subject|1|||
150059789|NCT02311582|541361322|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
150059790|NCT02311582|541361323|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
150059791|NCT02311582|541361324|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
150059792|NCT02311582|541361325|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
150059793|NCT02311582|541361326|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
150059794|NCT04214288|541361329|FG000|Overall Study|Ongoing in the study|41|||
150022042|NCT01550757|541216097|FG003|Overall Study|Withdrawal by Subject|1|||
150022043|NCT00193206|541216100|FG000|Preoperative Therapy|Lack of Efficacy|2|||
150022044|NCT00193206|541216100|FG000|Preoperative Therapy|Adverse Event|2|||
150022045|NCT00193206|541216100|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
150022046|NCT00193206|541216100|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
150022047|NCT00193206|541216100|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
150022048|NCT00193206|541216100|FG000|Postoperative Therapy|Physician Decision|3|||
150022049|NCT00193206|541216100|FG000|Postoperative Therapy|Intercurrent Illness|2|||
150022050|NCT00193206|541216100|FG000|Postoperative Therapy|Lack of Efficacy|1|||
150022051|NCT00193206|541216100|FG000|Postoperative Therapy|Protocol Violation|1|||
150022052|NCT00714415|541216107|FG000|Overall Study|Lack of Efficacy|1|||
150022053|NCT00714415|541216108|FG001|Overall Study|Lack of Efficacy|0|||
150059795|NCT04214288|541361330|FG001|Overall Study|Ongoing in the study|51|||
150059796|NCT04214288|541361331|FG002|Overall Study|Ongoing in the study|12|||
150059797|NCT04214288|541361332|FG003|Overall Study|Ongoing in the study|39|||
150181730|NCT01109524|541802840|FG000|Overall Study|Maximum clinical benefit|3|||
150022054|NCT00714415|541216107|FG000|Overall Study|Death|1|||
150022055|NCT00714415|541216108|FG001|Overall Study|Death|0|||
150022056|NCT00740584|541216111|FG000|Overall Study|Withdrawal by Subject|1|||
150022057|NCT00337207|541216120|FG000|Overall Study|Withdrawal by Subject|3|||
150059798|NCT04214288|541361329|FG000|Overall Study|Adverse Event|1|||
150059799|NCT04214288|541361330|FG001|Overall Study|Adverse Event|0|||
150022058|NCT01618669|541216122|FG000|Overall Study|Lost to Follow-up|1|||
150022059|NCT01618669|541216123|FG001|Overall Study|Lost to Follow-up|1|||
150022060|NCT01618669|541216122|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
150022061|NCT01618669|541216123|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
150022062|NCT01618669|541216122|FG000|Overall Study|Adverse Event|16|||
150022063|NCT01618669|541216123|FG001|Overall Study|Adverse Event|7|||
150022064|NCT01618669|541216122|FG000|Overall Study|Protocol Violation|5|||
150022065|NCT01618669|541216123|FG001|Overall Study|Protocol Violation|3|||
150022066|NCT01618669|541216122|FG000|Overall Study|Withdrawal by Subject|9|||
150022067|NCT01618669|541216123|FG001|Overall Study|Withdrawal by Subject|9|||
150022068|NCT01618669|541216122|FG000|Overall Study|Miscellaneous Reason|0|||
150022069|NCT01618669|541216123|FG001|Overall Study|Miscellaneous Reason|1|||
150022070|NCT03259087|541216124|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
150022071|NCT03259087|541216125|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
150022072|NCT03259087|541216126|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
150022073|NCT03259087|541216127|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
150022074|NCT03259087|541216128|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
150022075|NCT03259087|541216124|FG000|Period 2 of Part 2|Adverse Event|0|||
150022076|NCT03259087|541216125|FG001|Period 2 of Part 2|Adverse Event|0|||
150022077|NCT03259087|541216126|FG002|Period 2 of Part 2|Adverse Event|0|||
150022078|NCT03259087|541216127|FG003|Period 2 of Part 2|Adverse Event|0|||
150022079|NCT03259087|541216128|FG004|Period 2 of Part 2|Adverse Event|1|||
150022080|NCT05202418|541216129|FG000|Overall Study|Withdrawal by Subject|2|||
150022081|NCT05202418|541216130|FG001|Overall Study|Withdrawal by Subject|1|||
150022082|NCT05202418|541216129|FG000|Overall Study|Lost to Follow-up|1|||
150022083|NCT05202418|541216130|FG001|Overall Study|Lost to Follow-up|1|||
150022084|NCT02562716|541216131|FG000|Overall Study|Adverse Event|7|||
150022085|NCT02562716|541216132|FG001|Overall Study|Adverse Event|14|||
150022086|NCT02562716|541216131|FG000|Overall Study|Withdrawal unrelated to AE|7|||
150022087|NCT02562716|541216132|FG001|Overall Study|Withdrawal unrelated to AE|1|||
150022088|NCT02562716|541216131|FG000|Overall Study|Progression|8|||
150022089|NCT02562716|541216132|FG001|Overall Study|Progression|10|||
150022090|NCT02562716|541216131|FG000|Overall Study|Death|2|||
150022091|NCT02562716|541216132|FG001|Overall Study|Death|1|||
150022092|NCT02562716|541216131|FG000|Overall Study|Not protocol specified|4|||
150022093|NCT02562716|541216132|FG001|Overall Study|Not protocol specified|2|||
150022094|NCT00684996|541216133|FG000|Overall Study|Adverse Event|1|||
150022095|NCT00684996|541216133|FG000|Overall Study|Refusal unrelated to adverse event|1|||
150022096|NCT00684996|541216133|FG000|Overall Study|Progression/relapse|2|||
150022097|NCT00684996|541216133|FG000|Overall Study|Other reasons not protocol specified|1|||
150022098|NCT02519439|541216134|FG000|Overall Study|Study Termination|19|||
150022099|NCT02519439|541216134|FG000|Overall Study|Withdrawal by Subject|1|||
150022100|NCT02519439|541216134|FG000|Overall Study|Adverse Event|1|||
150022101|NCT01078441|541216139|FG000|Overall Study|Withdrawal by Subject|1|||
150022102|NCT02868554|541216140|FG000|Overall Study|Lost to Follow-up|3|||
150022103|NCT02868554|541216141|FG001|Overall Study|Lost to Follow-up|0|||
150022104|NCT02868554|541216142|FG002|Overall Study|Lost to Follow-up|1|||
150022105|NCT04915729|541216143|FG000|Overall Study|Lost to Follow-up|20|||
150022106|NCT04915729|541216144|FG001|Overall Study|Lost to Follow-up|10|||
150022107|NCT04915729|541216143|FG000|Overall Study|Withdrawal by Subject|12|||
150022108|NCT04915729|541216144|FG001|Overall Study|Withdrawal by Subject|5|||
150059800|NCT04214288|541361331|FG002|Overall Study|Adverse Event|0|||
150059801|NCT04214288|541361332|FG003|Overall Study|Adverse Event|0|||
150059802|NCT04214288|541361329|FG000|Overall Study|Death|22|||
150059803|NCT04214288|541361330|FG001|Overall Study|Death|13|||
150059804|NCT04214288|541361331|FG002|Overall Study|Death|7|||
150059805|NCT04214288|541361332|FG003|Overall Study|Death|19|||
150059806|NCT04214288|541361329|FG000|Overall Study|Lost to Follow-up|1|||
150059807|NCT04214288|541361330|FG001|Overall Study|Lost to Follow-up|2|||
150022109|NCT04915729|541216143|FG000|Overall Study|Death|34|||
150059808|NCT04214288|541361331|FG002|Overall Study|Lost to Follow-up|1|||
150059809|NCT04214288|541361332|FG003|Overall Study|Lost to Follow-up|0|||
150059810|NCT04214288|541361329|FG000|Overall Study|Other|1|||
150059811|NCT04214288|541361330|FG001|Overall Study|Other|2|||
150059812|NCT04214288|541361331|FG002|Overall Study|Other|0|||
150022110|NCT04915729|541216144|FG001|Overall Study|Death|44|||
150022111|NCT04915729|541216143|FG000|Overall Study|not treated|3|||
150022112|NCT04915729|541216144|FG001|Overall Study|not treated|6|||
150022113|NCT04915729|541216143|FG000|Overall Study|Investigator removed subject|1|||
150022114|NCT04915729|541216144|FG001|Overall Study|Investigator removed subject|2|||
150022115|NCT04915729|541216143|FG000|Overall Study|questionnaire result not evaluated|1|||
150022116|NCT04915729|541216144|FG001|Overall Study|questionnaire result not evaluated|0|||
150022117|NCT04915729|541216143|FG000|Overall Study|refuse of hospital visit|1|||
150022118|NCT04915729|541216144|FG001|Overall Study|refuse of hospital visit|3|||
150059813|NCT04214288|541361332|FG003|Overall Study|Other|6|||
150059814|NCT04214288|541361329|FG000|Overall Study|Protocol Violation|0|||
150022119|NCT04915729|541216143|FG000|Overall Study|Subject withdrew|1|||
150022120|NCT04915729|541216144|FG001|Overall Study|Subject withdrew|0|||
150022121|NCT04961541|541216145|FG000|Overall Study|Adverse Event|0|||
150022122|NCT04961541|541216146|FG001|Overall Study|Adverse Event|0|||
150022123|NCT04961541|541216147|FG002|Overall Study|Adverse Event|0|||
150022124|NCT04961541|541216148|FG003|Overall Study|Adverse Event|0|||
150022125|NCT04961541|541216149|FG004|Overall Study|Adverse Event|0|||
150022126|NCT04961541|541216150|FG005|Overall Study|Adverse Event|1|||
150022127|NCT04961541|541216151|FG006|Overall Study|Adverse Event|0|||
150022128|NCT04961541|541216152|FG007|Overall Study|Adverse Event|0|||
150022129|NCT04961541|541216153|FG008|Overall Study|Adverse Event|0|||
150022130|NCT04961541|541216154|FG009|Overall Study|Adverse Event|0|||
150022131|NCT04961541|541216155|FG010|Overall Study|Adverse Event|0|||
150022132|NCT04961541|541216156|FG011|Overall Study|Adverse Event|0|||
150022133|NCT04961541|541216157|FG012|Overall Study|Adverse Event|0|||
150022134|NCT04961541|541216158|FG013|Overall Study|Adverse Event|0|||
150022135|NCT04961541|541216145|FG000|Overall Study|Lost to Follow-up|0|||
150022136|NCT04961541|541216146|FG001|Overall Study|Lost to Follow-up|0|||
150022137|NCT04961541|541216147|FG002|Overall Study|Lost to Follow-up|3|||
150022138|NCT04961541|541216148|FG003|Overall Study|Lost to Follow-up|0|||
150022139|NCT04961541|541216149|FG004|Overall Study|Lost to Follow-up|0|||
150022140|NCT04961541|541216150|FG005|Overall Study|Lost to Follow-up|0|||
150022141|NCT04961541|541216151|FG006|Overall Study|Lost to Follow-up|1|||
150022142|NCT04961541|541216152|FG007|Overall Study|Lost to Follow-up|1|||
150022143|NCT04961541|541216153|FG008|Overall Study|Lost to Follow-up|0|||
150022144|NCT04961541|541216154|FG009|Overall Study|Lost to Follow-up|1|||
150022145|NCT04961541|541216155|FG010|Overall Study|Lost to Follow-up|0|||
150022146|NCT04961541|541216156|FG011|Overall Study|Lost to Follow-up|0|||
150022147|NCT04961541|541216157|FG012|Overall Study|Lost to Follow-up|1|||
150022148|NCT04961541|541216158|FG013|Overall Study|Lost to Follow-up|0|||
150022149|NCT04961541|541216145|FG000|Overall Study|Withdrawal by Subject|0|||
150022150|NCT04961541|541216146|FG001|Overall Study|Withdrawal by Subject|0|||
150022151|NCT04961541|541216147|FG002|Overall Study|Withdrawal by Subject|1|||
150022152|NCT04961541|541216148|FG003|Overall Study|Withdrawal by Subject|1|||
150022153|NCT04961541|541216149|FG004|Overall Study|Withdrawal by Subject|0|||
150022154|NCT04961541|541216150|FG005|Overall Study|Withdrawal by Subject|0|||
150022155|NCT04961541|541216151|FG006|Overall Study|Withdrawal by Subject|0|||
150022156|NCT04961541|541216152|FG007|Overall Study|Withdrawal by Subject|0|||
150022157|NCT04961541|541216153|FG008|Overall Study|Withdrawal by Subject|0|||
150022158|NCT04961541|541216154|FG009|Overall Study|Withdrawal by Subject|1|||
150022159|NCT04961541|541216155|FG010|Overall Study|Withdrawal by Subject|0|||
150022160|NCT04961541|541216156|FG011|Overall Study|Withdrawal by Subject|0|||
150022161|NCT04961541|541216157|FG012|Overall Study|Withdrawal by Subject|0|||
150022162|NCT04961541|541216158|FG013|Overall Study|Withdrawal by Subject|0|||
150022163|NCT01684202|541216159|FG000|Dose-escalation Period|Adverse Event|0|||
150022164|NCT01684202|541216160|FG001|Dose-escalation Period|Adverse Event|1|||
150022165|NCT01684202|541216161|FG002|Dose-escalation Period|Adverse Event|0|||
150022166|NCT01684202|541216162|FG003|Dose-escalation Period|Adverse Event|0|||
150022167|NCT01684202|541216159|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
150022168|NCT01684202|541216160|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
150022169|NCT01684202|541216161|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
150022170|NCT01684202|541216162|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
150022171|NCT01684202|541216159|FG000|Maintenance Period|Adverse Event|1|||
150022172|NCT01684202|541216160|FG001|Maintenance Period|Adverse Event|1|||
150022173|NCT01684202|541216161|FG002|Maintenance Period|Adverse Event|1|||
150022174|NCT01684202|541216162|FG003|Maintenance Period|Adverse Event|1|||
150022175|NCT01684202|541216159|FG000|Maintenance Period|Physician Decision|0|||
150022176|NCT01684202|541216160|FG001|Maintenance Period|Physician Decision|1|||
150022177|NCT01684202|541216161|FG002|Maintenance Period|Physician Decision|0|||
150181731|NCT01109524|541802840|FG000|Overall Study|Death|2|||
150181732|NCT01109524|541802840|FG000|Overall Study|No longer meets criteria|2|||
150181733|NCT01109524|541802840|FG000|Overall Study|Participant requested to end treatment|4|||
150181734|NCT01109524|541802840|FG000|Overall Study|Other|5|||
150181735|NCT03101371|541802841|FG000|Overall Study|Physician Decision|0|||
150022178|NCT01684202|541216162|FG003|Maintenance Period|Physician Decision|0|||
150022179|NCT01684202|541216159|FG000|Maintenance Period|Withdrawal by Subject|0|||
150181736|NCT03101371|541802842|FG001|Overall Study|Physician Decision|1|||
150181737|NCT03101371|541802841|FG000|Overall Study|Lost to Follow-up|1|||
150181738|NCT03101371|541802842|FG001|Overall Study|Lost to Follow-up|4|||
150181739|NCT03101371|541802841|FG000|Overall Study|Did not meet eligibility criteria|2|||
150022180|NCT01684202|541216160|FG001|Maintenance Period|Withdrawal by Subject|1|||
150022181|NCT01684202|541216161|FG002|Maintenance Period|Withdrawal by Subject|0|||
150022182|NCT01684202|541216162|FG003|Maintenance Period|Withdrawal by Subject|0|||
150022183|NCT00191308|541216163|FG000|Overall Study|Adverse Event|1|||
150022184|NCT03305770|541216165|FG000|Overall Study|Physician Decision - prior to dispense|0|||
150022185|NCT03305770|541216166|FG001|Overall Study|Physician Decision - prior to dispense|1|||
150022186|NCT03305770|541216165|FG000|Overall Study|Subject moved|1|||
150022187|NCT03305770|541216166|FG001|Overall Study|Subject moved|0|||
150022188|NCT03539601|541216167|FG000|Overall Study|Withdraw by parent/guardian|1|||
150022189|NCT03539601|541216168|FG001|Overall Study|Withdraw by parent/guardian|0|||
150022190|NCT03539601|541216169|FG002|Overall Study|Withdraw by parent/guardian|1|||
150022191|NCT03539601|541216170|FG003|Overall Study|Withdraw by parent/guardian|0|||
150022192|NCT03539601|541216167|FG000|Overall Study|Adverse Event|0|||
150022193|NCT03539601|541216168|FG001|Overall Study|Adverse Event|2|||
150022194|NCT03539601|541216169|FG002|Overall Study|Adverse Event|0|||
150022195|NCT03539601|541216170|FG003|Overall Study|Adverse Event|0|||
150022196|NCT03539601|541216167|FG000|Overall Study|Lost to Follow-up|2|||
150022197|NCT03539601|541216168|FG001|Overall Study|Lost to Follow-up|4|||
150022198|NCT03539601|541216169|FG002|Overall Study|Lost to Follow-up|5|||
150022199|NCT03539601|541216170|FG003|Overall Study|Lost to Follow-up|0|||
150022200|NCT03539601|541216167|FG000|Overall Study|Withdrawal by Subject|2|||
150022201|NCT03539601|541216168|FG001|Overall Study|Withdrawal by Subject|0|||
150022202|NCT03539601|541216169|FG002|Overall Study|Withdrawal by Subject|0|||
150022203|NCT03539601|541216170|FG003|Overall Study|Withdrawal by Subject|1|||
150022204|NCT03539601|541216167|FG000|Overall Study|Randomized but not treated|1|||
150022205|NCT03539601|541216168|FG001|Overall Study|Randomized but not treated|1|||
150022206|NCT03539601|541216169|FG002|Overall Study|Randomized but not treated|0|||
150022207|NCT03539601|541216170|FG003|Overall Study|Randomized but not treated|0|||
150022208|NCT03710642|541216171|FG000|Overall Study|Adverse Event|5|||
150022209|NCT03710642|541216172|FG001|Overall Study|Adverse Event|1|||
150022210|NCT03710642|541216171|FG000|Overall Study|non-site physician recommendation|1|||
150022211|NCT03710642|541216172|FG001|Overall Study|non-site physician recommendation|0|||
150022212|NCT03710642|541216171|FG000|Overall Study|Participant unwilling or unable to participate|1|||
150022213|NCT03710642|541216172|FG001|Overall Study|Participant unwilling or unable to participate|1|||
150022214|NCT03710642|541216171|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
150022215|NCT03710642|541216172|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
150022216|NCT03710642|541216171|FG000|Overall Study|NA-no code provided|1|||
150022217|NCT03710642|541216172|FG001|Overall Study|NA-no code provided|0|||
150022218|NCT03710642|541216171|FG000|Overall Study|Withdrawal by Subject|1|||
150022219|NCT03710642|541216172|FG001|Overall Study|Withdrawal by Subject|0|||
150022220|NCT01970306|541216173|FG000|Overall Study|Not eligible|3|||
150022221|NCT01970306|541216173|FG000|Overall Study|Not able to be treated|9|||
150022222|NCT00226811|541216174|FG000|Overall Study|Death|8|||
150022223|NCT00226811|541216174|FG000|Overall Study|Adverse Event|11|||
150022224|NCT00226811|541216174|FG000|Overall Study|Lack of Efficacy|55|||
150022225|NCT00226811|541216174|FG000|Overall Study|Withdrawal by Subject|2|||
150022226|NCT01010971|541216175|FG000|Overall Study|Adverse Event|2|||
150022227|NCT01010971|541216176|FG001|Overall Study|Adverse Event|4|||
150022228|NCT01010971|541216177|FG002|Overall Study|Adverse Event|3|||
150022229|NCT01010971|541216175|FG000|Overall Study|Withdrawal by Subject|0|||
150022230|NCT01010971|541216176|FG001|Overall Study|Withdrawal by Subject|2|||
150022231|NCT01010971|541216177|FG002|Overall Study|Withdrawal by Subject|5|||
150022232|NCT01010971|541216175|FG000|Overall Study|Lost to Follow-up|0|||
150022233|NCT01010971|541216176|FG001|Overall Study|Lost to Follow-up|2|||
150022234|NCT01010971|541216177|FG002|Overall Study|Lost to Follow-up|3|||
150022235|NCT01010971|541216175|FG000|Overall Study|Other|1|||
150022236|NCT01010971|541216176|FG001|Overall Study|Other|0|||
150022237|NCT01010971|541216177|FG002|Overall Study|Other|2|||
150022238|NCT03386721|541216178|FG000|Overall Study|Death|12|||
150022239|NCT03386721|541216179|FG001|Overall Study|Death|21|||
150022240|NCT03386721|541216180|FG002|Overall Study|Death|2|||
150022241|NCT03386721|541216181|FG003|Overall Study|Death|5|||
150022242|NCT03386721|541216182|FG004|Overall Study|Death|1|||
150022243|NCT03386721|541216183|FG005|Overall Study|Death|12|||
150022244|NCT03386721|541216184|FG006|Overall Study|Death|1|||
150022245|NCT03386721|541216185|FG007|Overall Study|Death|1|||
150022246|NCT03386721|541216186|FG008|Overall Study|Death|12|||
150022247|NCT03386721|541216187|FG009|Overall Study|Death|20|||
150022248|NCT03386721|541216188|FG010|Overall Study|Death|21|||
150022249|NCT03386721|541216189|FG011|Overall Study|Death|21|||
150022250|NCT03386721|541216190|FG012|Overall Study|Death|14|||
150022251|NCT03386721|541216191|FG013|Overall Study|Death|2|||
150022252|NCT03386721|541216192|FG014|Overall Study|Death|1|||
150022253|NCT03386721|541216178|FG000|Overall Study|Lost to Follow-up|1|||
150022254|NCT03386721|541216179|FG001|Overall Study|Lost to Follow-up|3|||
150022255|NCT03386721|541216180|FG002|Overall Study|Lost to Follow-up|0|||
150022256|NCT03386721|541216181|FG003|Overall Study|Lost to Follow-up|0|||
150022257|NCT03386721|541216182|FG004|Overall Study|Lost to Follow-up|0|||
150022258|NCT03386721|541216183|FG005|Overall Study|Lost to Follow-up|2|||
150022259|NCT03386721|541216184|FG006|Overall Study|Lost to Follow-up|1|||
150022260|NCT03386721|541216185|FG007|Overall Study|Lost to Follow-up|0|||
150022261|NCT03386721|541216186|FG008|Overall Study|Lost to Follow-up|1|||
150022262|NCT03386721|541216187|FG009|Overall Study|Lost to Follow-up|2|||
150022263|NCT03386721|541216188|FG010|Overall Study|Lost to Follow-up|1|||
150022264|NCT03386721|541216189|FG011|Overall Study|Lost to Follow-up|0|||
150022265|NCT03386721|541216190|FG012|Overall Study|Lost to Follow-up|0|||
150022266|NCT03386721|541216191|FG013|Overall Study|Lost to Follow-up|0|||
150022267|NCT03386721|541216192|FG014|Overall Study|Lost to Follow-up|0|||
150022268|NCT03386721|541216178|FG000|Overall Study|Reason not specified|3|||
150022269|NCT03386721|541216179|FG001|Overall Study|Reason not specified|0|||
150022270|NCT03386721|541216180|FG002|Overall Study|Reason not specified|0|||
150022271|NCT03386721|541216181|FG003|Overall Study|Reason not specified|0|||
150022272|NCT03386721|541216182|FG004|Overall Study|Reason not specified|0|||
150022273|NCT03386721|541216183|FG005|Overall Study|Reason not specified|3|||
150022274|NCT03386721|541216184|FG006|Overall Study|Reason not specified|1|||
150022275|NCT03386721|541216185|FG007|Overall Study|Reason not specified|0|||
150022276|NCT03386721|541216186|FG008|Overall Study|Reason not specified|0|||
150022277|NCT03386721|541216187|FG009|Overall Study|Reason not specified|1|||
150022278|NCT03386721|541216188|FG010|Overall Study|Reason not specified|2|||
150022279|NCT03386721|541216189|FG011|Overall Study|Reason not specified|6|||
150022280|NCT03386721|541216190|FG012|Overall Study|Reason not specified|1|||
150022281|NCT03386721|541216191|FG013|Overall Study|Reason not specified|0|||
150022282|NCT03386721|541216192|FG014|Overall Study|Reason not specified|0|||
150022283|NCT03386721|541216178|FG000|Overall Study|Progressive Disease|0|||
150022284|NCT03386721|541216179|FG001|Overall Study|Progressive Disease|0|||
150022285|NCT03386721|541216180|FG002|Overall Study|Progressive Disease|1|||
150022286|NCT03386721|541216181|FG003|Overall Study|Progressive Disease|0|||
150022287|NCT03386721|541216182|FG004|Overall Study|Progressive Disease|0|||
150022288|NCT03386721|541216183|FG005|Overall Study|Progressive Disease|1|||
150022289|NCT03386721|541216184|FG006|Overall Study|Progressive Disease|0|||
150022290|NCT03386721|541216185|FG007|Overall Study|Progressive Disease|0|||
150022291|NCT03386721|541216186|FG008|Overall Study|Progressive Disease|2|||
150022292|NCT03386721|541216187|FG009|Overall Study|Progressive Disease|1|||
150022293|NCT03386721|541216188|FG010|Overall Study|Progressive Disease|1|||
150022294|NCT03386721|541216189|FG011|Overall Study|Progressive Disease|0|||
150022295|NCT03386721|541216190|FG012|Overall Study|Progressive Disease|1|||
150022296|NCT03386721|541216191|FG013|Overall Study|Progressive Disease|0|||
150022297|NCT03386721|541216192|FG014|Overall Study|Progressive Disease|0|||
150022298|NCT03386721|541216178|FG000|Overall Study|Site Terminated by Sponsor|5|||
150022299|NCT03386721|541216179|FG001|Overall Study|Site Terminated by Sponsor|5|||
150022300|NCT03386721|541216180|FG002|Overall Study|Site Terminated by Sponsor|0|||
150022301|NCT03386721|541216181|FG003|Overall Study|Site Terminated by Sponsor|0|||
150022302|NCT03386721|541216182|FG004|Overall Study|Site Terminated by Sponsor|1|||
150022303|NCT03386721|541216183|FG005|Overall Study|Site Terminated by Sponsor|3|||
150022304|NCT03386721|541216184|FG006|Overall Study|Site Terminated by Sponsor|0|||
150022305|NCT03386721|541216185|FG007|Overall Study|Site Terminated by Sponsor|1|||
150022306|NCT03386721|541216186|FG008|Overall Study|Site Terminated by Sponsor|4|||
150022307|NCT03386721|541216187|FG009|Overall Study|Site Terminated by Sponsor|5|||
150022308|NCT03386721|541216188|FG010|Overall Study|Site Terminated by Sponsor|3|||
150022309|NCT03386721|541216189|FG011|Overall Study|Site Terminated by Sponsor|11|||
150022310|NCT03386721|541216190|FG012|Overall Study|Site Terminated by Sponsor|6|||
150022311|NCT03386721|541216191|FG013|Overall Study|Site Terminated by Sponsor|0|||
150022312|NCT03386721|541216192|FG014|Overall Study|Site Terminated by Sponsor|0|||
150022313|NCT03386721|541216178|FG000|Overall Study|Symptomatic Deterioration|0|||
150022314|NCT03386721|541216179|FG001|Overall Study|Symptomatic Deterioration|0|||
150022315|NCT03386721|541216180|FG002|Overall Study|Symptomatic Deterioration|0|||
150022316|NCT03386721|541216181|FG003|Overall Study|Symptomatic Deterioration|0|||
150022317|NCT03386721|541216182|FG004|Overall Study|Symptomatic Deterioration|0|||
150022318|NCT03386721|541216183|FG005|Overall Study|Symptomatic Deterioration|0|||
150022319|NCT03386721|541216184|FG006|Overall Study|Symptomatic Deterioration|0|||
150022320|NCT03386721|541216185|FG007|Overall Study|Symptomatic Deterioration|0|||
150022321|NCT03386721|541216186|FG008|Overall Study|Symptomatic Deterioration|1|||
150022322|NCT03386721|541216187|FG009|Overall Study|Symptomatic Deterioration|0|||
150022323|NCT03386721|541216188|FG010|Overall Study|Symptomatic Deterioration|0|||
150022324|NCT03386721|541216189|FG011|Overall Study|Symptomatic Deterioration|1|||
150022325|NCT03386721|541216190|FG012|Overall Study|Symptomatic Deterioration|0|||
150022326|NCT03386721|541216191|FG013|Overall Study|Symptomatic Deterioration|0|||
150022327|NCT03386721|541216192|FG014|Overall Study|Symptomatic Deterioration|0|||
150022328|NCT03386721|541216178|FG000|Overall Study|Withdrawal by Subject|1|||
150022329|NCT03386721|541216179|FG001|Overall Study|Withdrawal by Subject|2|||
150022330|NCT03386721|541216180|FG002|Overall Study|Withdrawal by Subject|0|||
150022331|NCT03386721|541216181|FG003|Overall Study|Withdrawal by Subject|0|||
150022332|NCT03386721|541216182|FG004|Overall Study|Withdrawal by Subject|0|||
150022333|NCT03386721|541216183|FG005|Overall Study|Withdrawal by Subject|0|||
150022334|NCT03386721|541216184|FG006|Overall Study|Withdrawal by Subject|0|||
150022335|NCT03386721|541216185|FG007|Overall Study|Withdrawal by Subject|0|||
150022336|NCT03386721|541216186|FG008|Overall Study|Withdrawal by Subject|2|||
150022337|NCT03386721|541216187|FG009|Overall Study|Withdrawal by Subject|1|||
150022338|NCT03386721|541216188|FG010|Overall Study|Withdrawal by Subject|3|||
150022339|NCT03386721|541216189|FG011|Overall Study|Withdrawal by Subject|2|||
150022340|NCT03386721|541216190|FG012|Overall Study|Withdrawal by Subject|3|||
150022341|NCT03386721|541216191|FG013|Overall Study|Withdrawal by Subject|0|||
150022342|NCT03386721|541216192|FG014|Overall Study|Withdrawal by Subject|0|||
150022343|NCT00700713|541216194|FG000|Overall Study|Protocol Violation|1|||
150022344|NCT00700713|541216195|FG001|Overall Study|Protocol Violation|0|||
150022345|NCT00700713|541216196|FG002|Overall Study|Protocol Violation|1|||
150022346|NCT00700713|541216194|FG000|Overall Study|Withdrawal by Subject|0|||
150022347|NCT00700713|541216195|FG001|Overall Study|Withdrawal by Subject|0|||
150022348|NCT00700713|541216196|FG002|Overall Study|Withdrawal by Subject|1|||
150022349|NCT00550953|541216197|FG000|Overall Study|Adverse Event|4|||
150022350|NCT00550953|541216198|FG001|Overall Study|Adverse Event|3|||
150022351|NCT00550953|541216197|FG000|Overall Study|Not able to visit the site|2|||
150022352|NCT00550953|541216198|FG001|Overall Study|Not able to visit the site|3|||
150022353|NCT03797586|541216199|FG000|Overall Study|Lost to Follow-up|3|||
150022354|NCT03797586|541216200|FG001|Overall Study|Lost to Follow-up|6|||
150022355|NCT03797586|541216199|FG000|Overall Study|Death|1|||
150022356|NCT03797586|541216200|FG001|Overall Study|Death|1|||
150022357|NCT03797586|541216199|FG000|Overall Study|Adverse Event|0|||
150022358|NCT03797586|541216200|FG001|Overall Study|Adverse Event|2|||
150022359|NCT01369784|541216201|FG000|Overall Study|Protocol Violation|12|||
150022360|NCT02680665|541216202|FG000|Overall Study|No visit after the first prescription|5|||
150022361|NCT02905266|541216203|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
150022362|NCT02905266|541216204|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
150022363|NCT02905266|541216203|FG000|Treatment Phase Part 1|Disease Progression|6|||
150022364|NCT02905266|541216204|FG001|Treatment Phase Part 1|Disease Progression|7|||
150022365|NCT02905266|541216203|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
150022366|NCT02905266|541216204|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
150022367|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
150022368|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
150022369|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
150022370|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
150022371|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
150022372|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
150022373|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Death|0|||
150022374|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Death|1|||
150022375|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
150022376|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
150022377|NCT02905266|541216203|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
150022378|NCT02905266|541216204|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
150022379|NCT02905266|541216203|FG000|Maintenance Phase Part 2|Disease Progression|9|||
150022380|NCT02905266|541216204|FG001|Maintenance Phase Part 2|Disease Progression|2|||
150022381|NCT02905266|541216203|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
150022382|NCT02905266|541216204|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
150022383|NCT02905266|541216203|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
150022384|NCT02905266|541216204|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
150022385|NCT04797780|541216205|FG000|Overall Study|Lost to Follow-up|1|||
150022386|NCT04797780|541216206|FG001|Overall Study|Lost to Follow-up|1|||
150022387|NCT04797780|541216205|FG000|Overall Study|Withdrawal by Subject|14|||
150022388|NCT04797780|541216206|FG001|Overall Study|Withdrawal by Subject|9|||
150022389|NCT04797780|541216205|FG000|Overall Study|Death|49|||
150022390|NCT04797780|541216206|FG001|Overall Study|Death|20|||
150022391|NCT01099397|541216211|FG000|Overall Study|Lost to Follow-up|4|||
150022392|NCT01099397|541216211|FG000|Overall Study|Protocol Violation|4|||
150022393|NCT01099397|541216211|FG000|Overall Study|Withdrawal by Subject|5|||
150022394|NCT02363959|541216212|FG000|Overall Study|Medical instability|1|||
150022395|NCT02363959|541216213|FG001|Overall Study|Medical instability|0|||
150022396|NCT00950248|541216215|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
150022397|NCT00950248|541216216|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
150022398|NCT00950248|541216217|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
150022399|NCT00950248|541216215|FG000|Year 1: Baseline|worsening of symptoms|2|||
150022400|NCT00950248|541216216|FG001|Year 1: Baseline|worsening of symptoms|0|||
150022401|NCT00950248|541216217|FG002|Year 1: Baseline|worsening of symptoms|0|||
150022402|NCT00950248|541216215|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
150022403|NCT00950248|541216216|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
150022404|NCT00950248|541216217|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
150022405|NCT00950248|541216215|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
150022406|NCT00950248|541216216|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
150022407|NCT00950248|541216217|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
150022408|NCT00950248|541216215|FG000|Year 2&3 Treatment Randomization|Death|0|||
150022409|NCT00950248|541216216|FG001|Year 2&3 Treatment Randomization|Death|0|||
150022410|NCT00950248|541216217|FG002|Year 2&3 Treatment Randomization|Death|1|||
150022411|NCT00950248|541216215|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
150022412|NCT00950248|541216216|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
150022413|NCT00950248|541216217|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
150022414|NCT00003199|541216218|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
150022415|NCT00003199|541216218|FG000|Overall Study|Lack of insurance clearance|2|||
150022416|NCT00003199|541216218|FG000|Overall Study|Screen fail|15|||
150022417|NCT00940498|541216219|FG000|Overall Study|Death|2|||
150022418|NCT00940498|541216220|FG001|Overall Study|Death|0|||
150022419|NCT00940498|541216221|FG002|Overall Study|Death|0|||
150022420|NCT00940498|541216222|FG003|Overall Study|Death|1|||
150022421|NCT00940498|541216223|FG004|Overall Study|Death|5|||
150022422|NCT00940498|541216224|FG005|Overall Study|Death|0|||
150022423|NCT00940498|541216225|FG006|Overall Study|Death|1|||
150022424|NCT00940498|541216226|FG007|Overall Study|Death|0|||
150022425|NCT00940498|541216219|FG000|Overall Study|Lost to Follow-up|1|||
150022426|NCT00940498|541216220|FG001|Overall Study|Lost to Follow-up|1|||
150022427|NCT00940498|541216221|FG002|Overall Study|Lost to Follow-up|2|||
150022428|NCT00940498|541216222|FG003|Overall Study|Lost to Follow-up|0|||
150022429|NCT00940498|541216223|FG004|Overall Study|Lost to Follow-up|1|||
150022430|NCT00940498|541216224|FG005|Overall Study|Lost to Follow-up|0|||
150022431|NCT00940498|541216225|FG006|Overall Study|Lost to Follow-up|0|||
150022432|NCT00940498|541216226|FG007|Overall Study|Lost to Follow-up|1|||
150022433|NCT00940498|541216219|FG000|Overall Study|Disease Progression|0|||
150022434|NCT00940498|541216220|FG001|Overall Study|Disease Progression|0|||
150022435|NCT00940498|541216221|FG002|Overall Study|Disease Progression|1|||
150022436|NCT00940498|541216222|FG003|Overall Study|Disease Progression|1|||
150022437|NCT00940498|541216223|FG004|Overall Study|Disease Progression|0|||
150022438|NCT00940498|541216224|FG005|Overall Study|Disease Progression|1|||
150022439|NCT00940498|541216225|FG006|Overall Study|Disease Progression|0|||
150022440|NCT00940498|541216226|FG007|Overall Study|Disease Progression|0|||
150022441|NCT00940498|541216219|FG000|Overall Study|Physician Decision|0|||
150022442|NCT00940498|541216220|FG001|Overall Study|Physician Decision|0|||
150022443|NCT00940498|541216221|FG002|Overall Study|Physician Decision|0|||
150022444|NCT00940498|541216222|FG003|Overall Study|Physician Decision|0|||
150022445|NCT00940498|541216223|FG004|Overall Study|Physician Decision|2|||
150022446|NCT00940498|541216224|FG005|Overall Study|Physician Decision|0|||
150022447|NCT00940498|541216225|FG006|Overall Study|Physician Decision|0|||
150022448|NCT00940498|541216226|FG007|Overall Study|Physician Decision|0|||
150022449|NCT00940498|541216219|FG000|Overall Study|Not treated due to disease related pain|0|||
150022450|NCT00940498|541216220|FG001|Overall Study|Not treated due to disease related pain|0|||
150022451|NCT00940498|541216221|FG002|Overall Study|Not treated due to disease related pain|0|||
150022452|NCT00940498|541216222|FG003|Overall Study|Not treated due to disease related pain|0|||
150022453|NCT00940498|541216223|FG004|Overall Study|Not treated due to disease related pain|1|||
150059815|NCT04214288|541361330|FG001|Overall Study|Protocol Violation|1|||
150059816|NCT04214288|541361331|FG002|Overall Study|Protocol Violation|0|||
150059817|NCT04214288|541361332|FG003|Overall Study|Protocol Violation|0|||
150059818|NCT04214288|541361329|FG000|Overall Study|Withdrawal by Subject|8|||
150059819|NCT04214288|541361330|FG001|Overall Study|Withdrawal by Subject|4|||
150059820|NCT04214288|541361331|FG002|Overall Study|Withdrawal by Subject|0|||
150059821|NCT04214288|541361332|FG003|Overall Study|Withdrawal by Subject|9|||
150059822|NCT00807027|541361333|FG000|Overall Study|Withdrawal by Subject|13|||
150059823|NCT00807027|541361334|FG001|Overall Study|Withdrawal by Subject|14|||
150022454|NCT00940498|541216224|FG005|Overall Study|Not treated due to disease related pain|0|||
150022455|NCT00940498|541216225|FG006|Overall Study|Not treated due to disease related pain|0|||
150022456|NCT00940498|541216226|FG007|Overall Study|Not treated due to disease related pain|0|||
150022457|NCT00650845|541216227|FG000|Overall Study|Withdrawal by Subject|5|||
150022458|NCT00650845|541216228|FG001|Overall Study|Withdrawal by Subject|0|||
150022459|NCT00650845|541216227|FG000|Overall Study|Protocol Violation|0|||
150022460|NCT00650845|541216228|FG001|Overall Study|Protocol Violation|13|||
150181740|NCT03101371|541802842|FG001|Overall Study|Did not meet eligibility criteria|1|||
150022461|NCT03761810|541216229|FG000|Overall Study|Adverse Event|12|||
150022462|NCT03761810|541216230|FG001|Overall Study|Adverse Event|0|||
150022463|NCT03761810|541216229|FG000|Overall Study|Lost to Follow-up|15|||
150022464|NCT03761810|541216230|FG001|Overall Study|Lost to Follow-up|7|||
150022465|NCT03761810|541216229|FG000|Overall Study|Pregnancy|1|||
150022466|NCT03761810|541216230|FG001|Overall Study|Pregnancy|0|||
150022467|NCT03761810|541216229|FG000|Overall Study|Withdrawal by Subject|14|||
150022468|NCT03761810|541216230|FG001|Overall Study|Withdrawal by Subject|5|||
150022469|NCT03761810|541216229|FG000|Overall Study|Physician Decision|1|||
150022470|NCT03761810|541216230|FG001|Overall Study|Physician Decision|0|||
150022471|NCT03761810|541216229|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
150022472|NCT03761810|541216230|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150022473|NCT03761810|541216229|FG000|Overall Study|Other Than Specified|1|||
150022474|NCT03761810|541216230|FG001|Overall Study|Other Than Specified|0|||
150022475|NCT00869518|541216231|FG000|Overall Study|Lost to Follow-up|1|||
150022476|NCT00869518|541216232|FG001|Overall Study|Lost to Follow-up|1|||
150022477|NCT04178720|541216233|FG000|Overall Study|Withdrawal by Subject|2|||
150022478|NCT04178720|541216234|FG001|Overall Study|Withdrawal by Subject|0|||
150022479|NCT04178720|541216233|FG000|Overall Study|Relocation|0|||
150022480|NCT04178720|541216234|FG001|Overall Study|Relocation|1|||
150022481|NCT02663622|541216235|FG000|Overall Study|Death|3|||
150022482|NCT02663622|541216236|FG001|Overall Study|Death|1|||
150022483|NCT02663622|541216237|FG002|Overall Study|Death|1|||
150022484|NCT02663622|541216238|FG003|Overall Study|Death|8|||
150022485|NCT02663622|541216235|FG000|Overall Study|Protocol Violation|0|||
150022486|NCT02663622|541216236|FG001|Overall Study|Protocol Violation|0|||
150022487|NCT02663622|541216237|FG002|Overall Study|Protocol Violation|0|||
150022488|NCT02663622|541216238|FG003|Overall Study|Protocol Violation|1|||
150022489|NCT00930930|541216241|FG000|Overall Study|Death|1|||
150022490|NCT00930930|541216242|FG001|Overall Study|Death|0|||
150022491|NCT00930930|541216241|FG000|Overall Study|Physician Decision|1|||
150022492|NCT00930930|541216242|FG001|Overall Study|Physician Decision|0|||
150022493|NCT00930930|541216241|FG000|Overall Study|Adverse Event|13|||
150022494|NCT00930930|541216242|FG001|Overall Study|Adverse Event|3|||
150022495|NCT00930930|541216241|FG000|Overall Study|Withdrawal by Subject|3|||
150022496|NCT00930930|541216242|FG001|Overall Study|Withdrawal by Subject|1|||
150022497|NCT00930930|541216241|FG000|Overall Study|Disease progression|2|||
150022498|NCT00930930|541216242|FG001|Overall Study|Disease progression|3|||
150022499|NCT00930930|541216241|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
150022500|NCT00930930|541216242|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
150022501|NCT00930930|541216241|FG000|Overall Study|patients not compliant|1|||
150022502|NCT00930930|541216242|FG001|Overall Study|patients not compliant|1|||
150022503|NCT04618744|541216243|FG000|Overall Study|Adverse Event|0|||
150022504|NCT04618744|541216244|FG001|Overall Study|Adverse Event|1|||
150022505|NCT04618744|541216243|FG000|Overall Study|Withdrawal by Subject|0|||
150022506|NCT04618744|541216244|FG001|Overall Study|Withdrawal by Subject|1|||
150022507|NCT01633788|541218325|FG000|Overall Study|Adverse Event|1|||
150022508|NCT01633788|541218326|FG001|Overall Study|Adverse Event|3|||
150022509|NCT01633788|541218327|FG002|Overall Study|Adverse Event|3|||
150022510|NCT01633788|541218328|FG003|Overall Study|Adverse Event|3|||
150022511|NCT01633788|541218325|FG000|Overall Study|Lost to Follow-up|2|||
150022512|NCT01633788|541218326|FG001|Overall Study|Lost to Follow-up|2|||
150022513|NCT01633788|541218327|FG002|Overall Study|Lost to Follow-up|2|||
150022514|NCT01633788|541218328|FG003|Overall Study|Lost to Follow-up|0|||
150022515|NCT01633788|541218325|FG000|Overall Study|Personal Reasons|3|||
150022516|NCT01633788|541218326|FG001|Overall Study|Personal Reasons|1|||
150022517|NCT01633788|541218327|FG002|Overall Study|Personal Reasons|1|||
150022518|NCT01633788|541218328|FG003|Overall Study|Personal Reasons|3|||
150022519|NCT01633788|541218325|FG000|Overall Study|Protocol Violation|1|||
150022520|NCT01633788|541218326|FG001|Overall Study|Protocol Violation|0|||
150022521|NCT01633788|541218327|FG002|Overall Study|Protocol Violation|1|||
150022522|NCT01633788|541218328|FG003|Overall Study|Protocol Violation|0|||
150022523|NCT01633788|541218325|FG000|Overall Study|Other Reasons|0|||
150022524|NCT01633788|541218326|FG001|Overall Study|Other Reasons|2|||
150022525|NCT01633788|541218327|FG002|Overall Study|Other Reasons|3|||
150022526|NCT01633788|541218328|FG003|Overall Study|Other Reasons|7|||
150022527|NCT01929226|541218329|FG000|Overall Study|Lost to Follow-up|4|||
150022528|NCT01929226|541218330|FG001|Overall Study|Lost to Follow-up|0|||
150181741|NCT05028582|541802850|FG000|Overall Study|Lost to Follow-up|11|||
150022529|NCT01929226|541218329|FG000|Overall Study|Withdrawal by Subject|1|||
150022530|NCT01929226|541218330|FG001|Overall Study|Withdrawal by Subject|1|||
150022531|NCT03310723|541218331|FG000|Overall Study|Withdrawal by Subject|0|||
150181742|NCT05028582|541802851|FG001|Overall Study|Lost to Follow-up|9|||
150022532|NCT03310723|541218332|FG001|Overall Study|Withdrawal by Subject|1|||
150022533|NCT03310723|541218331|FG000|Overall Study|Protocol Violation|0|||
150022534|NCT03310723|541218332|FG001|Overall Study|Protocol Violation|2|||
150022535|NCT02098746|541218333|FG000|Overall Study|Changes of Investigator|2|||
150022536|NCT02098746|541218333|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150022537|NCT02098746|541218333|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
150022538|NCT02098746|541218333|FG000|Overall Study|Data Not Available After Treatment|1|||
150022539|NCT02640547|541218336|FG000|Overall Study|Failure to Return|1|||
150022540|NCT02640547|541218336|FG000|Overall Study|Withdrawal by Subject|1|||
150022541|NCT02640547|541218336|FG000|Overall Study|Death|6|||
150022542|NCT02640547|541218336|FG000|Overall Study|Miscellaneous|3|||
150022543|NCT03018691|541218337|FG000|Overall Study|Adverse Event|1|||
150022544|NCT03018691|541218338|FG001|Overall Study|Adverse Event|1|||
150022545|NCT03018691|541218339|FG002|Overall Study|Adverse Event|4|||
150022546|NCT03018691|541218337|FG000|Overall Study|Lack of Efficacy|0|||
150022547|NCT03018691|541218338|FG001|Overall Study|Lack of Efficacy|0|||
150022548|NCT03018691|541218339|FG002|Overall Study|Lack of Efficacy|1|||
150022549|NCT03018691|541218337|FG000|Overall Study|Withdrawal by Subject|0|||
150022550|NCT03018691|541218338|FG001|Overall Study|Withdrawal by Subject|0|||
150022551|NCT03018691|541218339|FG002|Overall Study|Withdrawal by Subject|1|||
150022552|NCT03018691|541218337|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150022553|NCT03018691|541218338|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150022554|NCT03018691|541218339|FG002|Overall Study|Withdrawal by parent/guardian|1|||
150022555|NCT01172535|541218340|FG000|Overall Study|Death|3|||
150022556|NCT01172535|541218340|FG000|Overall Study|Withdrawal by Subject|2|||
150022557|NCT01172535|541218340|FG000|Overall Study|Lost to Follow-up|1|||
150022558|NCT01172535|541218340|FG000|Overall Study|Ineligible at study entry|1|||
150022559|NCT01172535|541218340|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
150022560|NCT03461146|541218341|FG000|Overall Study|Adverse Event|2|||
150022561|NCT03461146|541218341|FG000|Overall Study|Physician Decision|1|||
150022562|NCT02915263|541218348|FG000|Overall Study|Covid|3|||
150022563|NCT02915263|541218349|FG001|Overall Study|Covid|2|||
150022564|NCT02478463|541218350|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
150022565|NCT02478463|541218350|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
150022566|NCT02478463|541218350|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
150022567|NCT01879683|541218351|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
150022568|NCT01508169|541218355|FG000|Overall Study|Adverse Event|1|||
150022569|NCT01508169|541218356|FG001|Overall Study|Adverse Event|0|||
150022570|NCT01508169|541218355|FG000|Overall Study|Withdrawal by Subject|1|||
150022571|NCT01508169|541218356|FG001|Overall Study|Withdrawal by Subject|0|||
150022572|NCT01508169|541218355|FG000|Overall Study|Lost to Follow-up|1|||
150022573|NCT01508169|541218356|FG001|Overall Study|Lost to Follow-up|2|||
150022574|NCT03600740|541218362|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
150022575|NCT01702558|541218363|FG000|Overall Study|Withdrawal by Subject|0|||
150022576|NCT01702558|541218364|FG001|Overall Study|Withdrawal by Subject|0|||
150022577|NCT01702558|541218365|FG002|Overall Study|Withdrawal by Subject|0|||
150022578|NCT01702558|541218366|FG003|Overall Study|Withdrawal by Subject|12|||
150022579|NCT01702558|541218367|FG004|Overall Study|Withdrawal by Subject|4|||
150022580|NCT01702558|541218363|FG000|Overall Study|Lost to Follow-up|0|||
150022581|NCT01702558|541218364|FG001|Overall Study|Lost to Follow-up|0|||
150022582|NCT01702558|541218365|FG002|Overall Study|Lost to Follow-up|0|||
150022583|NCT01702558|541218366|FG003|Overall Study|Lost to Follow-up|3|||
150022584|NCT01702558|541218367|FG004|Overall Study|Lost to Follow-up|0|||
150022585|NCT01702558|541218363|FG000|Overall Study|Death|4|||
150022586|NCT01702558|541218364|FG001|Overall Study|Death|3|||
150022587|NCT01702558|541218365|FG002|Overall Study|Death|3|||
150022588|NCT01702558|541218366|FG003|Overall Study|Death|16|||
150022589|NCT01702558|541218367|FG004|Overall Study|Death|20|||
150022590|NCT01702558|541218363|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
150022591|NCT01702558|541218364|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
150022592|NCT01702558|541218365|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
150022593|NCT01702558|541218366|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
150022594|NCT01702558|541218367|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
150022595|NCT01702558|541218363|FG000|Overall Study|Study Terminated by Sponsor|0|||
150022596|NCT01702558|541218364|FG001|Overall Study|Study Terminated by Sponsor|1|||
150022597|NCT01702558|541218365|FG002|Overall Study|Study Terminated by Sponsor|0|||
150022598|NCT01702558|541218366|FG003|Overall Study|Study Terminated by Sponsor|0|||
150022599|NCT01702558|541218367|FG004|Overall Study|Study Terminated by Sponsor|1|||
150022600|NCT01702558|541218363|FG000|Overall Study|Other|0|||
150022601|NCT01702558|541218364|FG001|Overall Study|Other|0|||
150022602|NCT01702558|541218365|FG002|Overall Study|Other|0|||
150022603|NCT01702558|541218366|FG003|Overall Study|Other|16|||
150022604|NCT01702558|541218367|FG004|Overall Study|Other|17|||
150022605|NCT02396212|541218370|FG000|Overall Study|Adverse Event|1|||
150022606|NCT02396212|541218370|FG000|Overall Study|Lack of Efficacy|2|||
150022607|NCT01623115|541218371|FG000|Overall Study|Randomized but not treated|0|||
150022608|NCT01623115|541218372|FG001|Overall Study|Randomized but not treated|1|||
150022609|NCT01623115|541218371|FG000|Overall Study|Physician Decision|1|||
150022610|NCT01623115|541218372|FG001|Overall Study|Physician Decision|0|||
150022611|NCT01623115|541218371|FG000|Overall Study|Participants moved|1|||
150022612|NCT01623115|541218372|FG001|Overall Study|Participants moved|5|||
150022613|NCT01623115|541218371|FG000|Overall Study|Adverse Event|10|||
150022614|NCT01623115|541218372|FG001|Overall Study|Adverse Event|13|||
150022615|NCT01623115|541218371|FG000|Overall Study|Poor compliance to protocol|4|||
150022616|NCT01623115|541218372|FG001|Overall Study|Poor compliance to protocol|10|||
150022617|NCT01623115|541218371|FG000|Overall Study|Consent withdrawn by participant|2|||
150022618|NCT01623115|541218372|FG001|Overall Study|Consent withdrawn by participant|6|||
150022619|NCT01623115|541218371|FG000|Overall Study|Related to study drug administration|0|||
150022620|NCT01623115|541218372|FG001|Overall Study|Related to study drug administration|2|||
150022621|NCT01623115|541218371|FG000|Overall Study|Last visit outside protocol visit window|14|||
150022622|NCT01623115|541218372|FG001|Overall Study|Last visit outside protocol visit window|26|||
150022623|NCT01623115|541218371|FG000|Overall Study|Site closure|1|||
150022624|NCT01623115|541218372|FG001|Overall Study|Site closure|7|||
150022625|NCT01623115|541218371|FG000|Overall Study|Death|0|||
150022626|NCT01623115|541218372|FG001|Overall Study|Death|4|||
150022627|NCT01623115|541218371|FG000|Overall Study|Other than specified above|0|||
150022628|NCT01623115|541218372|FG001|Overall Study|Other than specified above|3|||
150022629|NCT04950465|541218373|FG000|Overall Study|Lost to Follow-up|1|||
150022630|NCT04950465|541218374|FG001|Overall Study|Lost to Follow-up|0|||
150022631|NCT04950465|541218375|FG002|Overall Study|Lost to Follow-up|0|||
150022632|NCT01338818|541218386|FG000|Overall Study|Adverse Event|8|||
150022633|NCT01338818|541218386|FG000|Overall Study|Lack of Efficacy|5|||
150022634|NCT01338818|541218386|FG000|Overall Study|no longer require study drug|1|||
150022635|NCT01338818|541218386|FG000|Overall Study|Withdrawal by Subject|11|||
150022636|NCT01338818|541218386|FG000|Overall Study|Lost to Follow-up|4|||
150022637|NCT01338818|541218386|FG000|Overall Study|Administrative problems|3|||
150022638|NCT01338818|541218386|FG000|Overall Study|Protocol Deviation|4|||
150022639|NCT01620086|541218387|FG000|Overall Study|Withdrawal by Subject|3|||
150022640|NCT01620086|541218388|FG001|Overall Study|Withdrawal by Subject|3|||
150022641|NCT01620086|541218389|FG002|Overall Study|Withdrawal by Subject|0|||
150022642|NCT01620086|541218387|FG000|Overall Study|failed study criteria|1|||
150022643|NCT01620086|541218388|FG001|Overall Study|failed study criteria|4|||
150022644|NCT01620086|541218389|FG002|Overall Study|failed study criteria|0|||
150022645|NCT01620086|541218387|FG000|Overall Study|Physician Decision|1|||
150022646|NCT01620086|541218388|FG001|Overall Study|Physician Decision|0|||
150022647|NCT01620086|541218389|FG002|Overall Study|Physician Decision|0|||
150022648|NCT00580723|541218395|FG000|Overall Study|Did not want to participate in extension|3|||
150022649|NCT00580723|541218395|FG000|Overall Study|Lost to Follow-up|5|||
150022650|NCT00556998|541218396|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
150022651|NCT00556998|541218396|FG000|Voriconazole Intravenous (IV)|Other|4|||
150022652|NCT00556998|541218396|FG000|Voriconazole Oral|Adverse Event|1|||
150022653|NCT00556998|541218396|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
150022654|NCT01425801|541218399|FG000|Period 1|Withdrawal by Subject|0|||
150022655|NCT01425801|541218400|FG001|Period 1|Withdrawal by Subject|0|||
150022656|NCT01425801|541218401|FG002|Period 1|Withdrawal by Subject|0|||
150022657|NCT01425801|541218402|FG003|Period 1|Withdrawal by Subject|0|||
150022658|NCT01425801|541218403|FG004|Period 1|Withdrawal by Subject|1|||
150022659|NCT01425801|541218404|FG005|Period 1|Withdrawal by Subject|0|||
150022660|NCT01425801|541218399|FG000|Period 2|Withdrawal by Subject|0|||
150022661|NCT01425801|541218400|FG001|Period 2|Withdrawal by Subject|0|||
150022662|NCT01425801|541218401|FG002|Period 2|Withdrawal by Subject|0|||
150022663|NCT01425801|541218402|FG003|Period 2|Withdrawal by Subject|0|||
150022664|NCT01425801|541218403|FG004|Period 2|Withdrawal by Subject|1|||
150022665|NCT01425801|541218404|FG005|Period 2|Withdrawal by Subject|0|||
150022666|NCT01425801|541218399|FG000|Period 3|Stability criteria not fullfilled|0|||
150022667|NCT01425801|541218400|FG001|Period 3|Stability criteria not fullfilled|0|||
150022668|NCT01425801|541218401|FG002|Period 3|Stability criteria not fullfilled|1|||
150022669|NCT01425801|541218402|FG003|Period 3|Stability criteria not fullfilled|0|||
150022670|NCT01425801|541218403|FG004|Period 3|Stability criteria not fullfilled|0|||
150022671|NCT01425801|541218404|FG005|Period 3|Stability criteria not fullfilled|0|||
150022672|NCT01425801|541218399|FG000|Period 4|Not able to maintain visit schedule|0|||
150022673|NCT01425801|541218400|FG001|Period 4|Not able to maintain visit schedule|0|||
150022674|NCT01425801|541218401|FG002|Period 4|Not able to maintain visit schedule|1|||
150022675|NCT01425801|541218402|FG003|Period 4|Not able to maintain visit schedule|0|||
150022676|NCT01425801|541218403|FG004|Period 4|Not able to maintain visit schedule|0|||
150022677|NCT01425801|541218404|FG005|Period 4|Not able to maintain visit schedule|0|||
150022678|NCT03066596|541218405|FG000|Overall Study|Withdrawal by Subject|4|||
150022679|NCT03066596|541218406|FG001|Overall Study|Withdrawal by Subject|2|||
150022680|NCT03066596|541218405|FG000|Overall Study|Lost to Follow-up|14|||
150022681|NCT03066596|541218406|FG001|Overall Study|Lost to Follow-up|10|||
150022682|NCT02330055|541218407|FG000|Overall Study|technical issues|2|||
150022683|NCT02330055|541218408|FG001|Overall Study|technical issues|0|||
150022684|NCT02330055|541218407|FG000|Overall Study|participant forgot to wear device|5|||
150022685|NCT02330055|541218408|FG001|Overall Study|participant forgot to wear device|5|||
150022686|NCT02330055|541218407|FG000|Overall Study|data for less than 60 minutes|3|||
150022687|NCT02330055|541218408|FG001|Overall Study|data for less than 60 minutes|3|||
150059824|NCT00807027|541361333|FG000|Overall Study|Protocol Violation|1|||
150022688|NCT02330055|541218407|FG000|Overall Study|participant did not sleep|0|||
150022689|NCT02330055|541218408|FG001|Overall Study|participant did not sleep|1|||
150022690|NCT02959437|541218409|FG000|Overall Study|Death|33|||
150022691|NCT02959437|541218410|FG001|Overall Study|Death|3|||
150022692|NCT02959437|541218411|FG002|Overall Study|Death|0|||
150059825|NCT00807027|541361334|FG001|Overall Study|Protocol Violation|1|||
150059826|NCT00807027|541361333|FG000|Overall Study|Adverse Event|2|||
150059827|NCT00807027|541361334|FG001|Overall Study|Adverse Event|2|||
150059828|NCT03997383|541361335|FG000|Double-blind Treatment Period|Adverse Event|4|||
150059829|NCT03997383|541361336|FG001|Double-blind Treatment Period|Adverse Event|3|||
150022693|NCT02959437|541218412|FG003|Overall Study|Death|0|||
150022694|NCT02959437|541218409|FG000|Overall Study|Lost to Follow-up|3|||
150022695|NCT02959437|541218410|FG001|Overall Study|Lost to Follow-up|1|||
150022696|NCT02959437|541218411|FG002|Overall Study|Lost to Follow-up|0|||
150022697|NCT02959437|541218412|FG003|Overall Study|Lost to Follow-up|0|||
150022698|NCT02959437|541218409|FG000|Overall Study|Withdrawal by Subject|11|||
150022699|NCT02959437|541218410|FG001|Overall Study|Withdrawal by Subject|3|||
150022700|NCT02959437|541218411|FG002|Overall Study|Withdrawal by Subject|0|||
150022701|NCT02959437|541218412|FG003|Overall Study|Withdrawal by Subject|0|||
150022702|NCT02959437|541218409|FG000|Overall Study|Progressive Disease|9|||
150022703|NCT02959437|541218410|FG001|Overall Study|Progressive Disease|1|||
150022704|NCT02959437|541218411|FG002|Overall Study|Progressive Disease|0|||
150022705|NCT02959437|541218412|FG003|Overall Study|Progressive Disease|0|||
150022706|NCT02959437|541218409|FG000|Overall Study|Study Terminated by Sponsor|4|||
150022707|NCT02959437|541218410|FG001|Overall Study|Study Terminated by Sponsor|0|||
150022708|NCT02959437|541218411|FG002|Overall Study|Study Terminated by Sponsor|0|||
150022709|NCT02959437|541218412|FG003|Overall Study|Study Terminated by Sponsor|0|||
150022710|NCT02959437|541218409|FG000|Overall Study|Other Unspecified|2|||
150022711|NCT02959437|541218410|FG001|Overall Study|Other Unspecified|0|||
150022712|NCT02959437|541218411|FG002|Overall Study|Other Unspecified|0|||
150022713|NCT02959437|541218412|FG003|Overall Study|Other Unspecified|0|||
150022714|NCT02864901|541218413|FG000|Overall Study|Withdrawal by Subject|1|||
150022715|NCT02864901|541218414|FG001|Overall Study|Withdrawal by Subject|0|||
150022716|NCT00782717|541218417|FG000|Overall Study|Adverse Event|2|||
150022717|NCT00782717|541218418|FG001|Overall Study|Adverse Event|5|||
150022718|NCT00782717|541218417|FG000|Overall Study|Patient decision unrelated to AE|6|||
150022719|NCT00782717|541218418|FG001|Overall Study|Patient decision unrelated to AE|3|||
150022720|NCT00782717|541218417|FG000|Overall Study|Noncompliance|2|||
150022721|NCT00782717|541218418|FG001|Overall Study|Noncompliance|1|||
150022722|NCT00782717|541218417|FG000|Overall Study|Treatment failure|3|||
150022723|NCT00782717|541218418|FG001|Overall Study|Treatment failure|14|||
150022724|NCT00782717|541218417|FG000|Overall Study|Enrollment close prior to surgery|1|||
150022725|NCT00782717|541218418|FG001|Overall Study|Enrollment close prior to surgery|0|||
150022726|NCT00782717|541218417|FG000|Overall Study|Did not meet entrance criteria|1|||
150022727|NCT00782717|541218418|FG001|Overall Study|Did not meet entrance criteria|3|||
150022728|NCT00782717|541218417|FG000|Overall Study|Exited in error|0|||
150059830|NCT03997383|541361335|FG000|Double-blind Treatment Period|Death|4|||
150059831|NCT03997383|541361336|FG001|Double-blind Treatment Period|Death|4|||
150059832|NCT03997383|541361335|FG000|Double-blind Treatment Period|Physician Decision|2|||
150059833|NCT03997383|541361336|FG001|Double-blind Treatment Period|Physician Decision|0|||
150059834|NCT03997383|541361335|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
150059835|NCT03997383|541361336|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
150059836|NCT03997383|541361335|FG000|Open-label Extension Period|Ongoing|148|||
150059837|NCT03997383|541361336|FG001|Open-label Extension Period|Ongoing|151|||
150059838|NCT03997383|541361335|FG000|Open-label Extension Period|Adverse Event|4|||
150059839|NCT03997383|541361336|FG001|Open-label Extension Period|Adverse Event|1|||
150059840|NCT03997383|541361335|FG000|Open-label Extension Period|Death|8|||
150059841|NCT03997383|541361336|FG001|Open-label Extension Period|Death|9|||
150059842|NCT03997383|541361335|FG000|Open-label Extension Period|Physician Decision|1|||
150059843|NCT03997383|541361336|FG001|Open-label Extension Period|Physician Decision|1|||
150059844|NCT03997383|541361335|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
150059845|NCT03997383|541361336|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
150059846|NCT03997383|541361335|FG000|Open-label Extension Period|Reason Not Specified|2|||
150181743|NCT05028582|541802850|FG000|Overall Study|Withdrawal by Subject|9|||
150181744|NCT05028582|541802851|FG001|Overall Study|Withdrawal by Subject|10|||
150022729|NCT00782717|541218418|FG001|Overall Study|Exited in error|2|||
150022730|NCT02446717|541218419|FG000|Overall Study|Adverse Event|0|||
150022731|NCT02446717|541218420|FG001|Overall Study|Adverse Event|0|||
150059847|NCT03997383|541361336|FG001|Open-label Extension Period|Reason Not Specified|0|||
150059848|NCT00924781|541361337|FG000|Overall Study|Study terminated by sponsor|12|||
150059849|NCT00924781|541361338|FG001|Overall Study|Study terminated by sponsor|10|||
150059850|NCT00708201|541361339|FG000|Overall Study|Adverse Event|4|||
150059851|NCT00708201|541361340|FG001|Overall Study|Adverse Event|4|||
150022732|NCT02446717|541218421|FG002|Overall Study|Adverse Event|1|||
150022733|NCT02446717|541218422|FG003|Overall Study|Adverse Event|0|||
150022734|NCT02446717|541218423|FG004|Overall Study|Adverse Event|0|||
150022735|NCT02446717|541218419|FG000|Overall Study|Lost to Follow-up|0|||
150022736|NCT02446717|541218420|FG001|Overall Study|Lost to Follow-up|1|||
150022737|NCT02446717|541218421|FG002|Overall Study|Lost to Follow-up|1|||
150022738|NCT02446717|541218422|FG003|Overall Study|Lost to Follow-up|0|||
150022739|NCT02446717|541218423|FG004|Overall Study|Lost to Follow-up|1|||
150022740|NCT02446717|541218419|FG000|Overall Study|Withdrew consent|0|||
150022741|NCT02446717|541218420|FG001|Overall Study|Withdrew consent|0|||
150022742|NCT02446717|541218421|FG002|Overall Study|Withdrew consent|0|||
150022743|NCT02446717|541218422|FG003|Overall Study|Withdrew consent|1|||
150022744|NCT02446717|541218423|FG004|Overall Study|Withdrew consent|0|||
150022745|NCT02292719|541218429|FG000|Overall Study|Withdrawal by Subject|0|||
150022746|NCT02292719|541218430|FG001|Overall Study|Withdrawal by Subject|0|||
150022747|NCT02292719|541218431|FG002|Overall Study|Withdrawal by Subject|0|||
150022748|NCT02292719|541218432|FG003|Overall Study|Withdrawal by Subject|1|||
150022749|NCT02292719|541218433|FG004|Overall Study|Withdrawal by Subject|1|||
150022750|NCT02292719|541218434|FG005|Overall Study|Withdrawal by Subject|0|||
150022751|NCT02292719|541218429|FG000|Overall Study|Subject enrolled in new study.|0|||
150022752|NCT02292719|541218430|FG001|Overall Study|Subject enrolled in new study.|0|||
150022753|NCT02292719|541218431|FG002|Overall Study|Subject enrolled in new study.|1|||
150022754|NCT02292719|541218432|FG003|Overall Study|Subject enrolled in new study.|0|||
150022755|NCT02292719|541218433|FG004|Overall Study|Subject enrolled in new study.|0|||
150022756|NCT02292719|541218434|FG005|Overall Study|Subject enrolled in new study.|0|||
150022757|NCT02940496|541218437|FG000|Overall Study|Adverse Event|1|||
150022758|NCT02940496|541218438|FG001|Overall Study|Adverse Event|0|||
150022759|NCT02940496|541218437|FG000|Overall Study|Death|2|||
150022760|NCT02940496|541218438|FG001|Overall Study|Death|0|||
150022761|NCT02940496|541218437|FG000|Overall Study|Hospice Care|1|||
150022762|NCT02940496|541218438|FG001|Overall Study|Hospice Care|0|||
150022763|NCT02940496|541218437|FG000|Overall Study|No MRE Done|1|||
150022764|NCT02940496|541218438|FG001|Overall Study|No MRE Done|0|||
150022765|NCT02940496|541218437|FG000|Overall Study|MRE Failure|1|||
150022766|NCT02940496|541218438|FG001|Overall Study|MRE Failure|0|||
150022767|NCT02586727|541218439|FG000|Overall Study|Lost to Follow-up|1|||
150022768|NCT02586727|541218440|FG001|Overall Study|Lost to Follow-up|0|||
150022769|NCT05973006|541218441|FG000|Overall Study|Early termination|3|||
150022770|NCT05973006|541218442|FG001|Overall Study|Early termination|9|||
150022771|NCT05167825|541218443|FG000|Overall Study|Ongoing|3|||
150022772|NCT02326597|541218452|FG000|Overall Study|Lost to Follow-up|42|||
150022773|NCT02326597|541218453|FG001|Overall Study|Lost to Follow-up|32|||
150022774|NCT04089761|541218456|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
150022775|NCT04089761|541218456|FG000|"Run In Phase"|Lost to Follow-up|1|||
150022776|NCT04089761|541218456|FG000|"Treatment Phase"|No evaluable data|5|||
150022777|NCT04089761|541218456|FG000|"Treatment Phase"|Lost to Follow-up|1|||
150022778|NCT00770601|541218457|FG000|Overall Study|Withdrawal by Subject|1|||
150022779|NCT00428948|541218459|FG000|Overall Study|Lost to Follow-up|15|||
150022780|NCT00428948|541218460|FG001|Overall Study|Lost to Follow-up|8|||
150022781|NCT00428948|541218459|FG000|Overall Study|Adverse Event|148|||
150022782|NCT00428948|541218460|FG001|Overall Study|Adverse Event|24|||
150022783|NCT00428948|541218459|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
150022784|NCT00428948|541218460|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
150022785|NCT00428948|541218459|FG000|Overall Study|Investigator Withdrew Subject|3|||
150022786|NCT00428948|541218460|FG001|Overall Study|Investigator Withdrew Subject|4|||
150022787|NCT00428948|541218459|FG000|Overall Study|Subject Withdrew Consent|50|||
150022788|NCT00428948|541218460|FG001|Overall Study|Subject Withdrew Consent|30|||
150022789|NCT00428948|541218459|FG000|Overall Study|Protocol Deviation|1|||
150022790|NCT00428948|541218460|FG001|Overall Study|Protocol Deviation|1|||
150022791|NCT03201419|541218463|FG000|Overall Study|Adverse Event|3|||
150022792|NCT03201419|541218464|FG001|Overall Study|Adverse Event|1|||
150022793|NCT03201419|541218465|FG002|Overall Study|Adverse Event|0|||
150022794|NCT03201419|541218466|FG003|Overall Study|Adverse Event|0|||
150022795|NCT03201419|541218467|FG004|Overall Study|Adverse Event|1|||
150022796|NCT03201419|541218468|FG005|Overall Study|Adverse Event|1|||
150022797|NCT03201419|541218469|FG006|Overall Study|Adverse Event|5|||
150022798|NCT03201419|541218470|FG007|Overall Study|Adverse Event|0|||
150022799|NCT03201419|541218471|FG008|Overall Study|Adverse Event|0|||
150022800|NCT03201419|541218463|FG000|Overall Study|Lost to Follow-up|1|||
150022801|NCT03201419|541218464|FG001|Overall Study|Lost to Follow-up|0|||
150181745|NCT05028582|541802850|FG000|Overall Study|Adverse Event|5|||
150181746|NCT05028582|541802851|FG001|Overall Study|Adverse Event|2|||
150022802|NCT03201419|541218465|FG002|Overall Study|Lost to Follow-up|0|||
150022803|NCT03201419|541218466|FG003|Overall Study|Lost to Follow-up|0|||
150022804|NCT03201419|541218467|FG004|Overall Study|Lost to Follow-up|0|||
150022805|NCT03201419|541218468|FG005|Overall Study|Lost to Follow-up|0|||
150022806|NCT03201419|541218469|FG006|Overall Study|Lost to Follow-up|0|||
150022807|NCT03201419|541218470|FG007|Overall Study|Lost to Follow-up|0|||
150022808|NCT03201419|541218471|FG008|Overall Study|Lost to Follow-up|0|||
150022809|NCT03201419|541218463|FG000|Overall Study|Protocol Deviation|0|||
150022810|NCT03201419|541218464|FG001|Overall Study|Protocol Deviation|0|||
150022811|NCT03201419|541218465|FG002|Overall Study|Protocol Deviation|0|||
150181747|NCT05028582|541802850|FG000|Overall Study|Miscellaneous|3|||
150181748|NCT05028582|541802851|FG001|Overall Study|Miscellaneous|2|||
150181749|NCT05028582|541802850|FG000|Overall Study|Lack of Efficacy|3|||
150181750|NCT05028582|541802851|FG001|Overall Study|Lack of Efficacy|1|||
150181751|NCT05028582|541802850|FG000|Overall Study|Physician Decision|0|||
150181752|NCT05028582|541802851|FG001|Overall Study|Physician Decision|1|||
150181753|NCT02576509|541804590|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
150181754|NCT02576509|541804591|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
150181755|NCT02576509|541804590|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
150181756|NCT02576509|541804591|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
150181757|NCT02576509|541804590|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
150181758|NCT02576509|541804591|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
150181759|NCT02576509|541804590|FG000|Treatment Period|Disease progression|263|||
150181760|NCT02576509|541804591|FG001|Treatment Period|Disease progression|244|||
150181761|NCT02576509|541804590|FG000|Treatment Period|Study drug toxicity|37|||
150181762|NCT02576509|541804591|FG001|Treatment Period|Study drug toxicity|41|||
150181763|NCT02576509|541804590|FG000|Treatment Period|Death|1|||
150181764|NCT02576509|541804591|FG001|Treatment Period|Death|1|||
150181765|NCT02576509|541804590|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
150181766|NCT02576509|541804591|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
150181767|NCT02576509|541804590|FG000|Treatment Period|Participant request to stop treatment|8|||
150181768|NCT02576509|541804591|FG001|Treatment Period|Participant request to stop treatment|18|||
150181769|NCT02576509|541804590|FG000|Treatment Period|Participant withdrew consent|3|||
150181770|NCT02576509|541804591|FG001|Treatment Period|Participant withdrew consent|7|||
150181771|NCT02576509|541804590|FG000|Treatment Period|Lost to Follow-up|0|||
150181772|NCT02576509|541804591|FG001|Treatment Period|Lost to Follow-up|1|||
150181773|NCT02576509|541804590|FG000|Treatment Period|Maximum clinical benefit|1|||
150181774|NCT02576509|541804591|FG001|Treatment Period|Maximum clinical benefit|0|||
150181775|NCT02576509|541804590|FG000|Treatment Period|Poor/non-compliance|1|||
150181776|NCT02576509|541804591|FG001|Treatment Period|Poor/non-compliance|1|||
150181777|NCT02576509|541804590|FG000|Treatment Period|Participant no longer meets criteria|1|||
150181778|NCT02576509|541804591|FG001|Treatment Period|Participant no longer meets criteria|0|||
150181779|NCT02576509|541804590|FG000|Treatment Period|Other reason|12|||
150181780|NCT02576509|541804591|FG001|Treatment Period|Other reason|8|||
150181781|NCT02576509|541804590|FG000|Treatment Period|NOT REPORTED|1|||
150181782|NCT02576509|541804591|FG001|Treatment Period|NOT REPORTED|0|||
150022812|NCT03201419|541218466|FG003|Overall Study|Protocol Deviation|0|||
150022813|NCT03201419|541218467|FG004|Overall Study|Protocol Deviation|0|||
150022814|NCT03201419|541218468|FG005|Overall Study|Protocol Deviation|0|||
150022815|NCT03201419|541218469|FG006|Overall Study|Protocol Deviation|1|||
150022816|NCT03201419|541218470|FG007|Overall Study|Protocol Deviation|0|||
150022817|NCT03201419|541218471|FG008|Overall Study|Protocol Deviation|0|||
150022818|NCT03201419|541218463|FG000|Overall Study|Withdrawal by Subject|4|||
150022819|NCT03201419|541218464|FG001|Overall Study|Withdrawal by Subject|2|||
150022820|NCT03201419|541218465|FG002|Overall Study|Withdrawal by Subject|1|||
150022821|NCT03201419|541218466|FG003|Overall Study|Withdrawal by Subject|0|||
150022822|NCT03201419|541218467|FG004|Overall Study|Withdrawal by Subject|0|||
150022823|NCT03201419|541218468|FG005|Overall Study|Withdrawal by Subject|0|||
150022824|NCT03201419|541218469|FG006|Overall Study|Withdrawal by Subject|0|||
150022825|NCT03201419|541218470|FG007|Overall Study|Withdrawal by Subject|1|||
150022826|NCT03201419|541218471|FG008|Overall Study|Withdrawal by Subject|2|||
150022827|NCT03201419|541218463|FG000|Overall Study|Other|0|||
150022828|NCT03201419|541218464|FG001|Overall Study|Other|0|||
150022829|NCT03201419|541218465|FG002|Overall Study|Other|1|||
150022830|NCT03201419|541218466|FG003|Overall Study|Other|0|||
150022831|NCT03201419|541218467|FG004|Overall Study|Other|0|||
150022832|NCT03201419|541218468|FG005|Overall Study|Other|0|||
150022833|NCT03201419|541218469|FG006|Overall Study|Other|0|||
150022834|NCT03201419|541218470|FG007|Overall Study|Other|0|||
150022835|NCT03201419|541218471|FG008|Overall Study|Other|0|||
150022836|NCT05907395|541218472|FG000|Period 1|No longer met eligibility criteria|0|||
150022837|NCT05907395|541218473|FG001|Period 1|No longer met eligibility criteria|1|||
150022838|NCT05907395|541218474|FG002|Period 1|No longer met eligibility criteria|0|||
150022839|NCT05907395|541218475|FG003|Period 1|No longer met eligibility criteria|0|||
150022840|NCT05907395|541218476|FG004|Period 1|No longer met eligibility criteria|0|||
150022841|NCT05907395|541218477|FG005|Period 1|No longer met eligibility criteria|1|||
150022842|NCT05907395|541218478|FG006|Period 1|No longer met eligibility criteria|1|||
150022843|NCT05907395|541218479|FG007|Period 1|No longer met eligibility criteria|0|||
150022844|NCT05907395|541218480|FG008|Period 1|No longer met eligibility criteria|0|||
150022845|NCT05907395|541218481|FG009|Period 1|No longer met eligibility criteria|0|||
150022846|NCT05907395|541218482|FG010|Period 1|No longer met eligibility criteria|0|||
150022847|NCT05907395|541218483|FG011|Period 1|No longer met eligibility criteria|0|||
150022848|NCT05907395|541218472|FG000|Period 2|Adverse Event|0|||
150022849|NCT05907395|541218473|FG001|Period 2|Adverse Event|0|||
150022850|NCT05907395|541218474|FG002|Period 2|Adverse Event|0|||
150022851|NCT05907395|541218475|FG003|Period 2|Adverse Event|1|||
150022852|NCT05907395|541218476|FG004|Period 2|Adverse Event|0|||
150022853|NCT05907395|541218477|FG005|Period 2|Adverse Event|0|||
150022854|NCT05907395|541218478|FG006|Period 2|Adverse Event|0|||
150022855|NCT05907395|541218479|FG007|Period 2|Adverse Event|1|||
150022856|NCT05907395|541218480|FG008|Period 2|Adverse Event|0|||
150022857|NCT05907395|541218481|FG009|Period 2|Adverse Event|0|||
150022858|NCT05907395|541218482|FG010|Period 2|Adverse Event|0|||
150022859|NCT05907395|541218483|FG011|Period 2|Adverse Event|0|||
150022860|NCT05907395|541218472|FG000|Period 2|Personal reason|0|||
150022861|NCT05907395|541218473|FG001|Period 2|Personal reason|0|||
150022862|NCT05907395|541218474|FG002|Period 2|Personal reason|0|||
150022863|NCT05907395|541218475|FG003|Period 2|Personal reason|0|||
150022864|NCT05907395|541218476|FG004|Period 2|Personal reason|0|||
150022865|NCT05907395|541218477|FG005|Period 2|Personal reason|0|||
150022866|NCT05907395|541218478|FG006|Period 2|Personal reason|0|||
150022867|NCT05907395|541218479|FG007|Period 2|Personal reason|0|||
150022868|NCT05907395|541218480|FG008|Period 2|Personal reason|0|||
150022869|NCT05907395|541218481|FG009|Period 2|Personal reason|1|||
150022870|NCT05907395|541218482|FG010|Period 2|Personal reason|0|||
150022871|NCT05907395|541218483|FG011|Period 2|Personal reason|0|||
150022872|NCT05907395|541218472|FG000|Period 3|Adverse Event|0|||
150022873|NCT05907395|541218473|FG001|Period 3|Adverse Event|0|||
150022874|NCT05907395|541218474|FG002|Period 3|Adverse Event|0|||
150022875|NCT05907395|541218475|FG003|Period 3|Adverse Event|0|||
150022876|NCT05907395|541218476|FG004|Period 3|Adverse Event|1|||
150022877|NCT05907395|541218477|FG005|Period 3|Adverse Event|0|||
150022878|NCT05907395|541218478|FG006|Period 3|Adverse Event|0|||
150022879|NCT05907395|541218479|FG007|Period 3|Adverse Event|0|||
150022880|NCT05907395|541218480|FG008|Period 3|Adverse Event|0|||
150022881|NCT05907395|541218481|FG009|Period 3|Adverse Event|0|||
150022882|NCT05907395|541218482|FG010|Period 3|Adverse Event|0|||
150022883|NCT05907395|541218483|FG011|Period 3|Adverse Event|0|||
150022884|NCT04544956|541218484|FG000|Overall Study|Withdrawal by Subject|1|||
150022885|NCT02119663|541218485|FG000|Overall Study|Disease progression|26|||
150022886|NCT02119663|541218486|FG001|Overall Study|Disease progression|27|||
150022887|NCT02119663|541218485|FG000|Overall Study|Adverse Event|5|||
150022888|NCT02119663|541218486|FG001|Overall Study|Adverse Event|5|||
150022889|NCT02119663|541218485|FG000|Overall Study|Death|3|||
150022890|NCT02119663|541218486|FG001|Overall Study|Death|2|||
150022891|NCT02119663|541218485|FG000|Overall Study|Physician Decision|1|||
150022892|NCT02119663|541218486|FG001|Overall Study|Physician Decision|2|||
150022893|NCT02119663|541218485|FG000|Overall Study|Other unspecified|2|||
150022894|NCT02119663|541218486|FG001|Overall Study|Other unspecified|0|||
150022895|NCT02119663|541218485|FG000|Overall Study|Subject decision|0|||
150022896|NCT02119663|541218486|FG001|Overall Study|Subject decision|1|||
150022897|NCT02119663|541218485|FG000|Overall Study|Study Terminated by the Sponsor|3|||
150022898|NCT02119663|541218486|FG001|Overall Study|Study Terminated by the Sponsor|4|||
150022899|NCT00892775|541218487|FG000|Overall Study|Protocol Violation|1|||
150022900|NCT00892775|541218488|FG001|Overall Study|Protocol Violation|0|||
150022901|NCT00892775|541218487|FG000|Overall Study|Subject difficulties with blood drawing|1|||
150022902|NCT00892775|541218488|FG001|Overall Study|Subject difficulties with blood drawing|0|||
150022903|NCT00892775|541218487|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
150181783|NCT02576509|541804590|FG000|Treatment Period|Administrative reason by sponsor|0|||
150181784|NCT02576509|541804591|FG001|Treatment Period|Administrative reason by sponsor|1|||
150022904|NCT00892775|541218488|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
150022905|NCT00892775|541218487|FG000|Overall Study|Migrated/ moved from study area|1|||
150022906|NCT00892775|541218488|FG001|Overall Study|Migrated/ moved from study area|0|||
150022907|NCT00892775|541218487|FG000|Overall Study|Withdrawal by Subject|0|||
150022908|NCT00892775|541218488|FG001|Overall Study|Withdrawal by Subject|1|||
150022909|NCT00892775|541218487|FG000|Overall Study|Lost to Follow-up|1|||
150022910|NCT00892775|541218488|FG001|Overall Study|Lost to Follow-up|0|||
150022911|NCT00699660|541218489|FG000|Overall Study|Lost to Follow-up|4|||
150022912|NCT00699660|541218490|FG001|Overall Study|Lost to Follow-up|2|||
150022913|NCT00699660|541218489|FG000|Overall Study|missing reports and recording failures|10|||
150022914|NCT00699660|541218490|FG001|Overall Study|missing reports and recording failures|6|||
150022915|NCT00103740|541218491|FG000|Period 1 - Core|Adverse Event|1|||
150181785|NCT03481660|541804594|FG000|Overall Study|Adverse Event|5|||
150022916|NCT00103740|541218492|FG001|Period 1 - Core|Adverse Event|0|||
150022917|NCT00103740|541218491|FG000|Period 1 - Core|Protocol Violation|3|||
150022918|NCT00103740|541218492|FG001|Period 1 - Core|Protocol Violation|2|||
150022919|NCT00103740|541218491|FG000|Period 1 - Core|Patient withdrew consent|3|||
150022920|NCT00103740|541218492|FG001|Period 1 - Core|Patient withdrew consent|2|||
150022921|NCT00103740|541218491|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
150022922|NCT00103740|541218492|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
150022923|NCT00103740|541218491|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
150022924|NCT00103740|541218492|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
150022925|NCT00103740|541218491|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
150022926|NCT00103740|541218492|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
150022927|NCT00103740|541218491|FG000|Period 2 - Extended Observation Period|Death|6|||
150022928|NCT00103740|541218492|FG001|Period 2 - Extended Observation Period|Death|2|||
150022929|NCT00103740|541218491|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
150022930|NCT00103740|541218492|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
150022931|NCT01223183|541218496|FG000|Imaging Day 1|Physician Decision|0|||
150022932|NCT01223183|541218497|FG001|Imaging Day 1|Physician Decision|1|||
150022933|NCT01223183|541218496|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
150022934|NCT01223183|541218497|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
150022935|NCT01223183|541218496|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
150022936|NCT01223183|541218497|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
150022937|NCT00163020|541218498|FG000|Overall Study|Lost to Follow-up|0|||
150022938|NCT00163020|541218499|FG001|Overall Study|Lost to Follow-up|2|||
150022939|NCT03553758|541220263|FG000|Overall Study|Lost to Follow-up|1|||
150022940|NCT01467505|541220268|FG000|Overall Study|Adverse Event|1|||
150022941|NCT01467505|541220269|FG001|Overall Study|Adverse Event|0|||
150022942|NCT01467505|541220268|FG000|Overall Study|Withdrawal by Subject|4|||
150022943|NCT01467505|541220269|FG001|Overall Study|Withdrawal by Subject|0|||
150022944|NCT01467505|541220268|FG000|Overall Study|Study Terminated by Sponsor|28|||
150022945|NCT01467505|541220269|FG001|Overall Study|Study Terminated by Sponsor|3|||
150022946|NCT02807623|541220270|FG000|Overall Study|Lost to Follow-up|23|||
150022947|NCT02807623|541220271|FG001|Overall Study|Lost to Follow-up|18|||
150022948|NCT02807623|541220272|FG002|Overall Study|Lost to Follow-up|22|||
150022949|NCT02807623|541220270|FG000|Overall Study|Drug intolerance|0|||
150022950|NCT02807623|541220271|FG001|Overall Study|Drug intolerance|1|||
150022951|NCT02807623|541220272|FG002|Overall Study|Drug intolerance|0|||
150022952|NCT02807623|541220270|FG000|Overall Study|incomplete blood draw|0|||
150022953|NCT02807623|541220271|FG001|Overall Study|incomplete blood draw|2|||
150022954|NCT02807623|541220272|FG002|Overall Study|incomplete blood draw|1|||
150022955|NCT03811340|541220273|FG000|Overall Study|subjects did not complete the survey.|90|||
150022956|NCT05104450|541220274|FG000|Overall Study|Death|1|||
150022957|NCT05104450|541220275|FG001|Overall Study|Death|2|||
150022958|NCT05104450|541220274|FG000|Overall Study|Withdrawal by Subject|3|||
150022959|NCT05104450|541220275|FG001|Overall Study|Withdrawal by Subject|1|||
150022960|NCT01080807|541220284|FG000|Overall Study|Adverse Event|9|||
150022961|NCT01080807|541220285|FG001|Overall Study|Adverse Event|1|||
150022962|NCT01080807|541220284|FG000|Overall Study|Lack of Efficacy|0|||
150022963|NCT01080807|541220285|FG001|Overall Study|Lack of Efficacy|1|||
150022964|NCT01080807|541220284|FG000|Overall Study|Withdrawal by Subject|7|||
150022965|NCT01080807|541220285|FG001|Overall Study|Withdrawal by Subject|2|||
150022966|NCT01080807|541220284|FG000|Overall Study|Protocol Violation|7|||
150022967|NCT01080807|541220285|FG001|Overall Study|Protocol Violation|6|||
150022968|NCT01080807|541220284|FG000|Overall Study|Lost to Follow-up|6|||
150022969|NCT01080807|541220285|FG001|Overall Study|Lost to Follow-up|4|||
150022970|NCT01080807|541220284|FG000|Overall Study|Noncompliance with drug administration|1|||
150022971|NCT01080807|541220285|FG001|Overall Study|Noncompliance with drug administration|1|||
150022972|NCT01080807|541220284|FG000|Overall Study|Noncompliance to study procedures|1|||
150022973|NCT01080807|541220285|FG001|Overall Study|Noncompliance to study procedures|1|||
150022974|NCT01080807|541220284|FG000|Overall Study|Began working day shift|0|||
150022975|NCT01080807|541220285|FG001|Overall Study|Began working day shift|2|||
150022976|NCT01080807|541220284|FG000|Overall Study|Laid off or terminated from job|1|||
150022977|NCT01080807|541220285|FG001|Overall Study|Laid off or terminated from job|2|||
150022978|NCT01080807|541220284|FG000|Overall Study|Stopped working consistent night shifts|0|||
150022979|NCT01080807|541220285|FG001|Overall Study|Stopped working consistent night shifts|1|||
150022980|NCT01080807|541220284|FG000|Overall Study|Work schedule changing|1|||
150022981|NCT01080807|541220285|FG001|Overall Study|Work schedule changing|1|||
150022982|NCT01080807|541220284|FG000|Overall Study|Work schedule and travel|0|||
150022983|NCT01080807|541220285|FG001|Overall Study|Work schedule and travel|1|||
150022984|NCT01080807|541220284|FG000|Overall Study|Switched to first shift|1|||
150022985|NCT01080807|541220285|FG001|Overall Study|Switched to first shift|0|||
150022986|NCT01080807|541220284|FG000|Overall Study|Moved away without notifying center|1|||
150022987|NCT01080807|541220285|FG001|Overall Study|Moved away without notifying center|0|||
150022988|NCT02045095|541220294|FG000|Overall Study|Other|0|||
150022989|NCT02045095|541220295|FG001|Overall Study|Other|0|||
150022990|NCT02045095|541220296|FG002|Overall Study|Other|1|||
150022991|NCT02045095|541220297|FG003|Overall Study|Other|0|||
150022992|NCT02045095|541220298|FG004|Overall Study|Other|0|||
150059852|NCT00708201|541361339|FG000|Overall Study|Withdrawal by Subject|1|||
150059853|NCT00708201|541361340|FG001|Overall Study|Withdrawal by Subject|1|||
150059854|NCT00708201|541361339|FG000|Overall Study|Lost to Follow-up|2|||
150059855|NCT00708201|541361340|FG001|Overall Study|Lost to Follow-up|0|||
150059856|NCT00708201|541361339|FG000|Overall Study|Protocol Violation|0|||
150059857|NCT00708201|541361340|FG001|Overall Study|Protocol Violation|1|||
150059858|NCT00761748|541361341|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
150059859|NCT00761748|541361342|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
150022993|NCT02045095|541220299|FG005|Overall Study|Other|2|||
150059860|NCT00761748|541361341|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
150022994|NCT02045095|541220300|FG006|Overall Study|Other|0|||
150022995|NCT02045095|541220294|FG000|Overall Study|Progressive Disease|3|||
150022996|NCT02045095|541220295|FG001|Overall Study|Progressive Disease|3|||
150022997|NCT02045095|541220296|FG002|Overall Study|Progressive Disease|2|||
150022998|NCT02045095|541220297|FG003|Overall Study|Progressive Disease|4|||
150022999|NCT02045095|541220298|FG004|Overall Study|Progressive Disease|2|||
150023000|NCT02045095|541220299|FG005|Overall Study|Progressive Disease|4|||
150023001|NCT02045095|541220300|FG006|Overall Study|Progressive Disease|1|||
150023002|NCT02045095|541220294|FG000|Overall Study|Withdrawal by Subject|0|||
150023003|NCT02045095|541220295|FG001|Overall Study|Withdrawal by Subject|0|||
150023004|NCT02045095|541220296|FG002|Overall Study|Withdrawal by Subject|0|||
150023005|NCT02045095|541220297|FG003|Overall Study|Withdrawal by Subject|0|||
150023006|NCT02045095|541220298|FG004|Overall Study|Withdrawal by Subject|3|||
150023007|NCT02045095|541220299|FG005|Overall Study|Withdrawal by Subject|0|||
150023008|NCT02045095|541220300|FG006|Overall Study|Withdrawal by Subject|0|||
150023009|NCT02045095|541220294|FG000|Overall Study|Adverse Event|0|||
150023010|NCT02045095|541220295|FG001|Overall Study|Adverse Event|1|||
150023011|NCT02045095|541220296|FG002|Overall Study|Adverse Event|1|||
150023012|NCT02045095|541220297|FG003|Overall Study|Adverse Event|0|||
150023013|NCT02045095|541220298|FG004|Overall Study|Adverse Event|0|||
150023014|NCT02045095|541220299|FG005|Overall Study|Adverse Event|2|||
150023015|NCT02045095|541220300|FG006|Overall Study|Adverse Event|0|||
150023016|NCT02525588|541220301|FG000|Overall Study|Death|3|||
150023017|NCT02525588|541220302|FG001|Overall Study|Death|1|||
150023018|NCT02525588|541220301|FG000|Overall Study|Lost to Follow-up|2|||
150023019|NCT02525588|541220302|FG001|Overall Study|Lost to Follow-up|0|||
150023020|NCT02525588|541220301|FG000|Overall Study|Withdrawal by Subject|1|||
150023021|NCT02525588|541220302|FG001|Overall Study|Withdrawal by Subject|1|||
150023022|NCT02525588|541220301|FG000|Overall Study|Adverse Event|0|||
150023023|NCT02525588|541220302|FG001|Overall Study|Adverse Event|1|||
150023024|NCT03369418|541220305|FG000|Overall Study|Withdrawal by Subject|3|||
150023025|NCT03369418|541220306|FG001|Overall Study|Withdrawal by Subject|3|||
150023026|NCT01485094|541220307|FG000|Overall Study|Adverse Event|1|||
150023027|NCT01485094|541220308|FG001|Overall Study|Adverse Event|1|||
150023028|NCT01485094|541220309|FG002|Overall Study|Adverse Event|1|||
150023029|NCT01485094|541220307|FG000|Overall Study|Lost to Follow-up|1|||
150023030|NCT01485094|541220308|FG001|Overall Study|Lost to Follow-up|0|||
150023031|NCT01485094|541220309|FG002|Overall Study|Lost to Follow-up|0|||
150023032|NCT01485094|541220307|FG000|Overall Study|Withdrawal by Subject|1|||
150023033|NCT01485094|541220308|FG001|Overall Study|Withdrawal by Subject|1|||
150059861|NCT00761748|541361342|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
150059862|NCT02554279|541361343|FG000|Overall Study|Adverse Event|2|||
150059863|NCT02554279|541361344|FG001|Overall Study|Adverse Event|5|||
150059864|NCT02554279|541361343|FG000|Overall Study|Lost to Follow-up|3|||
150059865|NCT02554279|541361344|FG001|Overall Study|Lost to Follow-up|2|||
150059866|NCT02554279|541361343|FG000|Overall Study|Withdrawal by Subject|6|||
150059867|NCT02554279|541361344|FG001|Overall Study|Withdrawal by Subject|4|||
150181786|NCT03481660|541804595|FG001|Overall Study|Adverse Event|4|||
150181787|NCT03481660|541804594|FG000|Overall Study|Death|13|||
150023034|NCT01485094|541220309|FG002|Overall Study|Withdrawal by Subject|0|||
150059868|NCT02554279|541361343|FG000|Overall Study|Protocol Violation|2|||
150059869|NCT02554279|541361344|FG001|Overall Study|Protocol Violation|1|||
150059870|NCT02554279|541361343|FG000|Overall Study|Other reason|19|||
150059871|NCT02554279|541361344|FG001|Overall Study|Other reason|6|||
150059872|NCT00812487|541361345|FG000|Overall Study|Lost to Follow-up|2|||
150059873|NCT00812487|541361346|FG001|Overall Study|Lost to Follow-up|0|||
150023035|NCT01818596|541220317|FG000|Overall Study|Enrolled but Not Treated|4|||
150023036|NCT01818596|541220318|FG001|Overall Study|Enrolled but Not Treated|0|||
150023037|NCT01818596|541220317|FG000|Overall Study|Adverse Event|7|||
150059874|NCT00812487|541361345|FG000|Overall Study|Withdrawal by Subject|3|||
150059875|NCT00812487|541361346|FG001|Overall Study|Withdrawal by Subject|2|||
150023038|NCT01818596|541220318|FG001|Overall Study|Adverse Event|0|||
150023039|NCT01818596|541220317|FG000|Overall Study|Death|3|||
150023040|NCT01818596|541220318|FG001|Overall Study|Death|0|||
150023041|NCT01818596|541220317|FG000|Overall Study|Investigator's Discretion|4|||
150023042|NCT01818596|541220318|FG001|Overall Study|Investigator's Discretion|0|||
150181788|NCT03481660|541804595|FG001|Overall Study|Death|9|||
150023043|NCT01818596|541220317|FG000|Overall Study|Protocol Violation|1|||
150023044|NCT01818596|541220318|FG001|Overall Study|Protocol Violation|0|||
150023045|NCT01818596|541220317|FG000|Overall Study|Withdrew Consent|5|||
150023046|NCT01818596|541220318|FG001|Overall Study|Withdrew Consent|0|||
150023047|NCT01818596|541220317|FG000|Overall Study|Lost to Follow-up|7|||
150023048|NCT01818596|541220318|FG001|Overall Study|Lost to Follow-up|0|||
150023049|NCT04435366|541220326|FG000|Year 1 (12 Months)|Adverse Event|3|||
150023050|NCT04435366|541220327|FG001|Year 1 (12 Months)|Adverse Event|0|||
150023051|NCT04435366|541220328|FG002|Year 1 (12 Months)|Adverse Event|2|||
150023052|NCT04435366|541220326|FG000|Year 1 (12 Months)|Death|2|||
150023053|NCT04435366|541220327|FG001|Year 1 (12 Months)|Death|0|||
150023054|NCT04435366|541220328|FG002|Year 1 (12 Months)|Death|1|||
150023055|NCT04435366|541220326|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
150023056|NCT04435366|541220327|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
150023057|NCT04435366|541220328|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
150023058|NCT04435366|541220326|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
150023059|NCT04435366|541220327|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
150023060|NCT04435366|541220328|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
150023061|NCT04435366|541220326|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
150023062|NCT04435366|541220327|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
150023063|NCT04435366|541220328|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
150023064|NCT04435366|541220326|FG000|Year 1 (12 Months)|Not treated|0|||
150023065|NCT04435366|541220327|FG001|Year 1 (12 Months)|Not treated|0|||
150023066|NCT04435366|541220328|FG002|Year 1 (12 Months)|Not treated|1|||
150023067|NCT04435366|541220326|FG000|Year 2 (12 Months)|Death|1|||
150023068|NCT04435366|541220327|FG001|Year 2 (12 Months)|Death|4|||
150023069|NCT04435366|541220328|FG002|Year 2 (12 Months)|Death|6|||
150023070|NCT04435366|541220326|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
150023071|NCT04435366|541220327|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
150023072|NCT04435366|541220328|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
150023073|NCT04435366|541220326|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
150023074|NCT04435366|541220327|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
150023075|NCT04435366|541220328|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
150023076|NCT04435366|541220326|FG000|Year 2 (12 Months)|Adverse Event|2|||
150023077|NCT04435366|541220327|FG001|Year 2 (12 Months)|Adverse Event|1|||
150023078|NCT04435366|541220328|FG002|Year 2 (12 Months)|Adverse Event|6|||
150023079|NCT04112810|541220330|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
150023080|NCT00837213|541220331|FG000|Overall Study|Lost to Follow-up|3|||
150023081|NCT00837213|541220332|FG001|Overall Study|Lost to Follow-up|2|||
150023082|NCT00837213|541220331|FG000|Overall Study|Withdrawal by Subject|2|||
150023083|NCT00837213|541220332|FG001|Overall Study|Withdrawal by Subject|2|||
150023084|NCT00837213|541220331|FG000|Overall Study|not stated|1|||
150023085|NCT00837213|541220332|FG001|Overall Study|not stated|1|||
150023086|NCT04497116|541220334|FG000|Overall Study|Lost to Follow-up|1|||
150023087|NCT04497116|541220335|FG001|Overall Study|Lost to Follow-up|0|||
150023088|NCT04497116|541220336|FG002|Overall Study|Lost to Follow-up|0|||
150059876|NCT00812487|541361345|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
150059877|NCT00812487|541361346|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
150059878|NCT00812487|541361345|FG000|Overall Study|Protocol Violation|0|||
150059879|NCT00812487|541361346|FG001|Overall Study|Protocol Violation|1|||
150059880|NCT01117792|541361353|FG000|Overall Study|Death|1|||
150059881|NCT01117792|541361353|FG000|Overall Study|Adverse Event|3|||
150059882|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
150023089|NCT04497116|541220337|FG003|Overall Study|Lost to Follow-up|0|||
150023090|NCT04497116|541220338|FG004|Overall Study|Lost to Follow-up|0|||
150023091|NCT04497116|541220339|FG005|Overall Study|Lost to Follow-up|0|||
150023092|NCT04497116|541220340|FG006|Overall Study|Lost to Follow-up|0|||
150023093|NCT04497116|541220341|FG007|Overall Study|Lost to Follow-up|3|||
150059883|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
150059884|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
150023094|NCT04497116|541220342|FG008|Overall Study|Lost to Follow-up|3|||
150023095|NCT04497116|541220343|FG009|Overall Study|Lost to Follow-up|0|||
150023096|NCT04497116|541220344|FG010|Overall Study|Lost to Follow-up|0|||
150023097|NCT04497116|541220345|FG011|Overall Study|Lost to Follow-up|0|||
150023098|NCT04497116|541220346|FG012|Overall Study|Lost to Follow-up|0|||
150023099|NCT04497116|541220347|FG013|Overall Study|Lost to Follow-up|0|||
150023100|NCT04497116|541220348|FG014|Overall Study|Lost to Follow-up|0|||
150023101|NCT04497116|541220349|FG015|Overall Study|Lost to Follow-up|0|||
150023102|NCT04497116|541220350|FG016|Overall Study|Lost to Follow-up|0|||
150023103|NCT04497116|541220351|FG017|Overall Study|Lost to Follow-up|0|||
150023104|NCT04497116|541220352|FG018|Overall Study|Lost to Follow-up|0|||
150059885|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
150023105|NCT04497116|541220353|FG019|Overall Study|Lost to Follow-up|0|||
150023106|NCT04497116|541220354|FG020|Overall Study|Lost to Follow-up|0|||
150023107|NCT04497116|541220355|FG021|Overall Study|Lost to Follow-up|0|||
150023108|NCT04497116|541220356|FG022|Overall Study|Lost to Follow-up|1|||
150023109|NCT04497116|541220357|FG023|Overall Study|Lost to Follow-up|0|||
150023110|NCT04497116|541220358|FG024|Overall Study|Lost to Follow-up|0|||
150023111|NCT04497116|541220334|FG000|Overall Study|Sponsor decision to terminate study|0|||
150023112|NCT04497116|541220335|FG001|Overall Study|Sponsor decision to terminate study|0|||
150023113|NCT04497116|541220336|FG002|Overall Study|Sponsor decision to terminate study|0|||
150023114|NCT04497116|541220337|FG003|Overall Study|Sponsor decision to terminate study|0|||
150023115|NCT04497116|541220338|FG004|Overall Study|Sponsor decision to terminate study|0|||
150023116|NCT04497116|541220339|FG005|Overall Study|Sponsor decision to terminate study|0|||
150023117|NCT04497116|541220340|FG006|Overall Study|Sponsor decision to terminate study|1|||
150023118|NCT04497116|541220341|FG007|Overall Study|Sponsor decision to terminate study|0|||
150023119|NCT04497116|541220342|FG008|Overall Study|Sponsor decision to terminate study|0|||
150023120|NCT04497116|541220343|FG009|Overall Study|Sponsor decision to terminate study|1|||
150023121|NCT04497116|541220344|FG010|Overall Study|Sponsor decision to terminate study|0|||
150023122|NCT04497116|541220345|FG011|Overall Study|Sponsor decision to terminate study|0|||
150023123|NCT04497116|541220346|FG012|Overall Study|Sponsor decision to terminate study|0|||
150023124|NCT04497116|541220347|FG013|Overall Study|Sponsor decision to terminate study|0|||
150023125|NCT04497116|541220348|FG014|Overall Study|Sponsor decision to terminate study|0|||
150023126|NCT04497116|541220349|FG015|Overall Study|Sponsor decision to terminate study|0|||
150023127|NCT04497116|541220350|FG016|Overall Study|Sponsor decision to terminate study|0|||
150023128|NCT04497116|541220351|FG017|Overall Study|Sponsor decision to terminate study|0|||
150023129|NCT04497116|541220352|FG018|Overall Study|Sponsor decision to terminate study|0|||
150023130|NCT04497116|541220353|FG019|Overall Study|Sponsor decision to terminate study|1|||
150023131|NCT04497116|541220354|FG020|Overall Study|Sponsor decision to terminate study|0|||
150023132|NCT04497116|541220355|FG021|Overall Study|Sponsor decision to terminate study|0|||
150023133|NCT04497116|541220356|FG022|Overall Study|Sponsor decision to terminate study|0|||
150023134|NCT04497116|541220357|FG023|Overall Study|Sponsor decision to terminate study|0|||
150023135|NCT04497116|541220358|FG024|Overall Study|Sponsor decision to terminate study|0|||
150023136|NCT04497116|541220334|FG000|Overall Study|Death|4|||
150023137|NCT04497116|541220335|FG001|Overall Study|Death|5|||
150023138|NCT04497116|541220336|FG002|Overall Study|Death|2|||
150023139|NCT04497116|541220337|FG003|Overall Study|Death|2|||
150023140|NCT04497116|541220338|FG004|Overall Study|Death|1|||
150023141|NCT04497116|541220339|FG005|Overall Study|Death|1|||
150023142|NCT04497116|541220340|FG006|Overall Study|Death|3|||
150023143|NCT04497116|541220341|FG007|Overall Study|Death|10|||
150023144|NCT04497116|541220342|FG008|Overall Study|Death|37|||
150023145|NCT04497116|541220343|FG009|Overall Study|Death|17|||
150023146|NCT04497116|541220344|FG010|Overall Study|Death|2|||
150023147|NCT04497116|541220345|FG011|Overall Study|Death|1|||
150023148|NCT04497116|541220346|FG012|Overall Study|Death|1|||
150023149|NCT04497116|541220347|FG013|Overall Study|Death|3|||
150023150|NCT04497116|541220348|FG014|Overall Study|Death|18|||
150023151|NCT04497116|541220349|FG015|Overall Study|Death|3|||
150023152|NCT04497116|541220350|FG016|Overall Study|Death|2|||
150023153|NCT04497116|541220351|FG017|Overall Study|Death|1|||
150023154|NCT04497116|541220352|FG018|Overall Study|Death|4|||
150023155|NCT04497116|541220353|FG019|Overall Study|Death|17|||
150023156|NCT04497116|541220354|FG020|Overall Study|Death|1|||
150023157|NCT04497116|541220355|FG021|Overall Study|Death|0|||
150023158|NCT04497116|541220356|FG022|Overall Study|Death|3|||
150023159|NCT04497116|541220357|FG023|Overall Study|Death|5|||
150023160|NCT04497116|541220358|FG024|Overall Study|Death|4|||
150023161|NCT04497116|541220334|FG000|Overall Study|Withdrawal by Subject|1|||
150023162|NCT04497116|541220335|FG001|Overall Study|Withdrawal by Subject|0|||
150023163|NCT04497116|541220336|FG002|Overall Study|Withdrawal by Subject|1|||
150023164|NCT04497116|541220337|FG003|Overall Study|Withdrawal by Subject|0|||
150023165|NCT04497116|541220338|FG004|Overall Study|Withdrawal by Subject|0|||
150023166|NCT04497116|541220339|FG005|Overall Study|Withdrawal by Subject|0|||
150023167|NCT04497116|541220340|FG006|Overall Study|Withdrawal by Subject|0|||
150023168|NCT04497116|541220341|FG007|Overall Study|Withdrawal by Subject|7|||
150023169|NCT04497116|541220342|FG008|Overall Study|Withdrawal by Subject|14|||
150023170|NCT04497116|541220343|FG009|Overall Study|Withdrawal by Subject|3|||
150023171|NCT04497116|541220344|FG010|Overall Study|Withdrawal by Subject|3|||
150023172|NCT04497116|541220345|FG011|Overall Study|Withdrawal by Subject|0|||
150023173|NCT04497116|541220346|FG012|Overall Study|Withdrawal by Subject|1|||
150023174|NCT04497116|541220347|FG013|Overall Study|Withdrawal by Subject|0|||
150023175|NCT04497116|541220348|FG014|Overall Study|Withdrawal by Subject|7|||
150023176|NCT04497116|541220349|FG015|Overall Study|Withdrawal by Subject|1|||
150023177|NCT04497116|541220350|FG016|Overall Study|Withdrawal by Subject|3|||
150023178|NCT04497116|541220351|FG017|Overall Study|Withdrawal by Subject|1|||
150023179|NCT04497116|541220352|FG018|Overall Study|Withdrawal by Subject|1|||
150023180|NCT04497116|541220353|FG019|Overall Study|Withdrawal by Subject|5|||
150023181|NCT04497116|541220354|FG020|Overall Study|Withdrawal by Subject|2|||
150023182|NCT04497116|541220355|FG021|Overall Study|Withdrawal by Subject|2|||
150023183|NCT04497116|541220356|FG022|Overall Study|Withdrawal by Subject|2|||
150023184|NCT04497116|541220357|FG023|Overall Study|Withdrawal by Subject|4|||
150023185|NCT04497116|541220358|FG024|Overall Study|Withdrawal by Subject|3|||
150023186|NCT04497116|541220334|FG000|Overall Study|Physician Decision|0|||
150023187|NCT04497116|541220335|FG001|Overall Study|Physician Decision|0|||
150023188|NCT04497116|541220336|FG002|Overall Study|Physician Decision|0|||
150023189|NCT04497116|541220337|FG003|Overall Study|Physician Decision|0|||
150023190|NCT04497116|541220338|FG004|Overall Study|Physician Decision|0|||
150023191|NCT04497116|541220339|FG005|Overall Study|Physician Decision|0|||
150023192|NCT04497116|541220340|FG006|Overall Study|Physician Decision|0|||
150023193|NCT04497116|541220341|FG007|Overall Study|Physician Decision|0|||
150023194|NCT04497116|541220342|FG008|Overall Study|Physician Decision|0|||
150023195|NCT04497116|541220343|FG009|Overall Study|Physician Decision|0|||
150023196|NCT04497116|541220344|FG010|Overall Study|Physician Decision|0|||
150023197|NCT04497116|541220345|FG011|Overall Study|Physician Decision|0|||
150023198|NCT04497116|541220346|FG012|Overall Study|Physician Decision|0|||
150023199|NCT04497116|541220347|FG013|Overall Study|Physician Decision|0|||
150023200|NCT04497116|541220348|FG014|Overall Study|Physician Decision|0|||
150023201|NCT04497116|541220349|FG015|Overall Study|Physician Decision|0|||
150023202|NCT04497116|541220350|FG016|Overall Study|Physician Decision|0|||
150023203|NCT04497116|541220351|FG017|Overall Study|Physician Decision|0|||
150023204|NCT04497116|541220352|FG018|Overall Study|Physician Decision|0|||
150023205|NCT04497116|541220353|FG019|Overall Study|Physician Decision|0|||
150023206|NCT04497116|541220354|FG020|Overall Study|Physician Decision|0|||
150023207|NCT04497116|541220355|FG021|Overall Study|Physician Decision|0|||
150023208|NCT04497116|541220356|FG022|Overall Study|Physician Decision|0|||
150023209|NCT04497116|541220357|FG023|Overall Study|Physician Decision|1|||
150023210|NCT04497116|541220358|FG024|Overall Study|Physician Decision|0|||
150023211|NCT04497116|541220334|FG000|Overall Study|Clinical Progression Related|0|||
150023212|NCT04497116|541220335|FG001|Overall Study|Clinical Progression Related|0|||
150023213|NCT04497116|541220336|FG002|Overall Study|Clinical Progression Related|0|||
150023214|NCT04497116|541220337|FG003|Overall Study|Clinical Progression Related|0|||
150023215|NCT04497116|541220338|FG004|Overall Study|Clinical Progression Related|0|||
150023216|NCT04497116|541220339|FG005|Overall Study|Clinical Progression Related|0|||
150023217|NCT04497116|541220340|FG006|Overall Study|Clinical Progression Related|0|||
150023218|NCT04497116|541220341|FG007|Overall Study|Clinical Progression Related|0|||
150023219|NCT04497116|541220342|FG008|Overall Study|Clinical Progression Related|0|||
150023220|NCT04497116|541220343|FG009|Overall Study|Clinical Progression Related|1|||
150023221|NCT04497116|541220344|FG010|Overall Study|Clinical Progression Related|0|||
150023222|NCT04497116|541220345|FG011|Overall Study|Clinical Progression Related|0|||
150023223|NCT04497116|541220346|FG012|Overall Study|Clinical Progression Related|0|||
150023224|NCT04497116|541220347|FG013|Overall Study|Clinical Progression Related|0|||
150023225|NCT04497116|541220348|FG014|Overall Study|Clinical Progression Related|0|||
150023226|NCT04497116|541220349|FG015|Overall Study|Clinical Progression Related|0|||
150023227|NCT04497116|541220350|FG016|Overall Study|Clinical Progression Related|0|||
150023228|NCT04497116|541220351|FG017|Overall Study|Clinical Progression Related|0|||
150023229|NCT04497116|541220352|FG018|Overall Study|Clinical Progression Related|0|||
150023230|NCT04497116|541220353|FG019|Overall Study|Clinical Progression Related|0|||
150023231|NCT04497116|541220354|FG020|Overall Study|Clinical Progression Related|0|||
150023232|NCT04497116|541220355|FG021|Overall Study|Clinical Progression Related|0|||
150023233|NCT04497116|541220356|FG022|Overall Study|Clinical Progression Related|0|||
150023234|NCT04497116|541220357|FG023|Overall Study|Clinical Progression Related|0|||
150023235|NCT04497116|541220358|FG024|Overall Study|Clinical Progression Related|0|||
150023236|NCT02698826|541220359|FG000|Overall Study|Death|13|||
150023237|NCT02698826|541220359|FG000|Overall Study|Adverse Event|1|||
150023238|NCT04524858|541220362|FG000|Overall Study|Adverse Event|1|||
150023239|NCT01788566|541220364|FG000|Overall Study|Death|4|||
150023240|NCT01788566|541220364|FG000|Overall Study|Adverse Event|1|||
150023241|NCT01788566|541220364|FG000|Overall Study|Clinical Progressive Disease|3|||
150023242|NCT04739436|541220367|FG000|Overall Study|Lost to Follow-up|21|||
150023243|NCT04739436|541220368|FG001|Overall Study|Lost to Follow-up|23|||
150023244|NCT04739436|541220367|FG000|Overall Study|Withdrawal by Subject|4|||
150023245|NCT04739436|541220368|FG001|Overall Study|Withdrawal by Subject|6|||
150023246|NCT04739436|541220367|FG000|Overall Study|not randomized properly|1|||
150023247|NCT04739436|541220368|FG001|Overall Study|not randomized properly|0|||
150023248|NCT03622814|541220369|FG000|Overall Study|Lost to Follow-up|8|||
150023249|NCT03622814|541220370|FG001|Overall Study|Lost to Follow-up|14|||
150023250|NCT03269994|541220371|FG000|Overall Study|Withdrawal by Subject|4|||
150023251|NCT03269994|541220372|FG001|Overall Study|Withdrawal by Subject|5|||
150023252|NCT03269994|541220371|FG000|Overall Study|Unresectable at surgery|39|||
150023253|NCT03269994|541220372|FG001|Overall Study|Unresectable at surgery|58|||
150023254|NCT03269994|541220371|FG000|Overall Study|Patient canceled surgery|5|||
150023255|NCT03269994|541220372|FG001|Overall Study|Patient canceled surgery|14|||
150023256|NCT03269994|541220371|FG000|Overall Study|Preoperative progression|14|||
150023257|NCT03269994|541220372|FG001|Overall Study|Preoperative progression|9|||
150023258|NCT03269994|541220371|FG000|Overall Study|Preoperative infection|10|||
150023259|NCT03269994|541220372|FG001|Overall Study|Preoperative infection|4|||
150023260|NCT03269994|541220371|FG000|Overall Study|Kidney insufficiency|1|||
150023261|NCT03269994|541220372|FG001|Overall Study|Kidney insufficiency|0|||
150023262|NCT03269994|541220371|FG000|Overall Study|Drug allergy|0|||
150023263|NCT03269994|541220372|FG001|Overall Study|Drug allergy|2|||
150023264|NCT03269994|541220371|FG000|Overall Study|Operation changed to different resection|9|||
150023265|NCT03269994|541220372|FG001|Overall Study|Operation changed to different resection|0|||
150023266|NCT03269994|541220371|FG000|Overall Study|Preoperative steroid|0|||
150023267|NCT03269994|541220372|FG001|Overall Study|Preoperative steroid|3|||
150023268|NCT03269994|541220371|FG000|Overall Study|Accrual Closed|2|||
150023269|NCT03269994|541220372|FG001|Overall Study|Accrual Closed|0|||
150023270|NCT03269994|541220371|FG000|Overall Study|Operation changed to different resection|0|||
150023271|NCT03269994|541220372|FG001|Overall Study|Operation changed to different resection|10|||
150023272|NCT04417361|541220373|FG000|Overall Study|Withdrawal by Subject|1|||
150023273|NCT04417361|541220374|FG001|Overall Study|Withdrawal by Subject|0|||
150023274|NCT04417361|541220373|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
150023275|NCT04417361|541220374|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
150023276|NCT04661150|541220377|FG000|Overall Study|Ongoing in study|19|||
150023277|NCT04661150|541220378|FG001|Overall Study|Ongoing in study|20|||
150023278|NCT04661150|541220377|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
150023279|NCT04661150|541220378|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
150023280|NCT04661150|541220377|FG000|Overall Study|Death|2|||
150023281|NCT04661150|541220378|FG001|Overall Study|Death|0|||
150023282|NCT02701283|541220379|FG000|Overall Study|Death|25|||
150023283|NCT02701283|541220380|FG001|Overall Study|Death|29|||
150023284|NCT02701283|541220381|FG002|Overall Study|Death|19|||
150023285|NCT02701283|541220379|FG000|Overall Study|Lost to Follow-up|3|||
150023286|NCT02701283|541220380|FG001|Overall Study|Lost to Follow-up|8|||
150023287|NCT02701283|541220381|FG002|Overall Study|Lost to Follow-up|1|||
150023288|NCT02701283|541220379|FG000|Overall Study|Withdrawal by Subject|12|||
150023289|NCT02701283|541220380|FG001|Overall Study|Withdrawal by Subject|41|||
150023290|NCT02701283|541220381|FG002|Overall Study|Withdrawal by Subject|1|||
150023291|NCT02701283|541220379|FG000|Overall Study|Missed 2-year visit|22|||
150023292|NCT02701283|541220380|FG001|Overall Study|Missed 2-year visit|27|||
150023293|NCT02701283|541220381|FG002|Overall Study|Missed 2-year visit|0|||
150023294|NCT02701283|541220379|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
150023295|NCT02701283|541220380|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
150023296|NCT02701283|541220381|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
150023297|NCT02777827|541220382|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
150023298|NCT02777827|541220383|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
150023299|NCT02777827|541220384|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
150023300|NCT02777827|541220385|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
150023301|NCT02777827|541220386|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
150023302|NCT02777827|541220387|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
150023303|NCT00398320|541220388|FG000|Overall Study|Death|1|||
150023304|NCT00398320|541220388|FG000|Overall Study|Adverse Event|4|||
150059886|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
150059887|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
150059888|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
150059889|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
150059890|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
150023305|NCT00398320|541220388|FG000|Overall Study|Physician Decision|1|||
150023306|NCT00064792|541220389|FG000|Overall Study|Withdrawal by Subject|2|||
150023307|NCT00064792|541220390|FG001|Overall Study|Withdrawal by Subject|0|||
150023308|NCT00064792|541220389|FG000|Overall Study|Adverse Event|3|||
150023309|NCT00064792|541220390|FG001|Overall Study|Adverse Event|0|||
150023310|NCT03160898|541220393|FG000|Overall Study|Adverse Event|4|||
150023311|NCT03160898|541220394|FG001|Overall Study|Adverse Event|8|||
150023312|NCT03160898|541220395|FG002|Overall Study|Adverse Event|7|||
150023313|NCT03160898|541220396|FG003|Overall Study|Adverse Event|10|||
150023314|NCT03160898|541220393|FG000|Overall Study|Death|1|||
150059891|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
150181789|NCT03481660|541804594|FG000|Overall Study|Lost to Follow-up|2|||
150023315|NCT03160898|541220394|FG001|Overall Study|Death|0|||
150023316|NCT03160898|541220395|FG002|Overall Study|Death|0|||
150023317|NCT03160898|541220396|FG003|Overall Study|Death|1|||
150023318|NCT03160898|541220393|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
150023319|NCT03160898|541220394|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
150023320|NCT03160898|541220395|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
150023321|NCT03160898|541220396|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
150023322|NCT03160898|541220393|FG000|Overall Study|Lost to Follow-up|1|||
150023323|NCT03160898|541220394|FG001|Overall Study|Lost to Follow-up|1|||
150023324|NCT03160898|541220395|FG002|Overall Study|Lost to Follow-up|1|||
150023325|NCT03160898|541220396|FG003|Overall Study|Lost to Follow-up|2|||
150023326|NCT03160898|541220393|FG000|Overall Study|Physician Decision|1|||
150023327|NCT03160898|541220394|FG001|Overall Study|Physician Decision|0|||
150023328|NCT03160898|541220395|FG002|Overall Study|Physician Decision|0|||
150023329|NCT03160898|541220396|FG003|Overall Study|Physician Decision|1|||
150023330|NCT03160898|541220393|FG000|Overall Study|Progressive Disease|4|||
150023331|NCT03160898|541220394|FG001|Overall Study|Progressive Disease|1|||
150023332|NCT03160898|541220395|FG002|Overall Study|Progressive Disease|2|||
150023333|NCT03160898|541220396|FG003|Overall Study|Progressive Disease|1|||
150023334|NCT03160898|541220393|FG000|Overall Study|Protocol Violation|1|||
150059892|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
150023335|NCT03160898|541220394|FG001|Overall Study|Protocol Violation|0|||
150023336|NCT03160898|541220395|FG002|Overall Study|Protocol Violation|2|||
150023337|NCT03160898|541220396|FG003|Overall Study|Protocol Violation|0|||
150023338|NCT03160898|541220393|FG000|Overall Study|Sponsor Discretion|2|||
150023339|NCT03160898|541220394|FG001|Overall Study|Sponsor Discretion|0|||
150023340|NCT03160898|541220395|FG002|Overall Study|Sponsor Discretion|0|||
150023341|NCT03160898|541220396|FG003|Overall Study|Sponsor Discretion|0|||
150023342|NCT03160898|541220393|FG000|Overall Study|Withdrawal by Subject|1|||
150023343|NCT03160898|541220394|FG001|Overall Study|Withdrawal by Subject|3|||
150023344|NCT03160898|541220395|FG002|Overall Study|Withdrawal by Subject|2|||
150023345|NCT03160898|541220396|FG003|Overall Study|Withdrawal by Subject|1|||
150023346|NCT03160898|541220393|FG000|Overall Study|Other|2|||
150023347|NCT03160898|541220394|FG001|Overall Study|Other|0|||
150023348|NCT03160898|541220395|FG002|Overall Study|Other|2|||
150023349|NCT03160898|541220396|FG003|Overall Study|Other|2|||
150023350|NCT03405818|541220399|FG000|Overall Study|Withdrawal by Subject|4|||
150023351|NCT03405818|541220399|FG000|Overall Study|Lost to Follow-up|4|||
150023352|NCT00291486|541220405|FG000|Overall Study|Adverse Event|0|||
150023353|NCT00291486|541220406|FG001|Overall Study|Adverse Event|3|||
150023354|NCT00291486|541220407|FG002|Overall Study|Adverse Event|0|||
150023355|NCT00291486|541220408|FG003|Overall Study|Adverse Event|1|||
150023356|NCT00291486|541220409|FG004|Overall Study|Adverse Event|0|||
150023357|NCT00291486|541220405|FG000|Overall Study|Withdrawal by Subject|0|||
150023358|NCT00291486|541220406|FG001|Overall Study|Withdrawal by Subject|0|||
150023359|NCT00291486|541220407|FG002|Overall Study|Withdrawal by Subject|0|||
150023360|NCT00291486|541220408|FG003|Overall Study|Withdrawal by Subject|0|||
150023361|NCT00291486|541220409|FG004|Overall Study|Withdrawal by Subject|1|||
150023362|NCT00291486|541220405|FG000|Overall Study|Disease progression|1|||
150023363|NCT00291486|541220406|FG001|Overall Study|Disease progression|0|||
150023364|NCT00291486|541220407|FG002|Overall Study|Disease progression|1|||
150023365|NCT00291486|541220408|FG003|Overall Study|Disease progression|0|||
150059893|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
150023366|NCT00291486|541220409|FG004|Overall Study|Disease progression|0|||
150023367|NCT01657292|541220419|FG000|Overall Study|Adverse Event|6|||
150023368|NCT01657292|541220419|FG000|Overall Study|Withdrawal by Subject|2|||
150181790|NCT03481660|541804595|FG001|Overall Study|Lost to Follow-up|2|||
150023369|NCT01657292|541220419|FG000|Overall Study|Violation of eligibility criteria|1|||
150023370|NCT01657292|541220419|FG000|Overall Study|Change of therapy|1|||
150023371|NCT01900652|541220421|FG000|Overall Study|Progressive Disease|1|||
150023372|NCT01900652|541220422|FG001|Overall Study|Progressive Disease|0|||
150023373|NCT01900652|541220421|FG000|Overall Study|Consent withdrawn by subject|1|||
150023374|NCT01900652|541220422|FG001|Overall Study|Consent withdrawn by subject|1|||
150023375|NCT01900652|541220421|FG000|Overall Study|Death|3|||
150023376|NCT01900652|541220422|FG001|Overall Study|Death|0|||
150023377|NCT01900652|541220421|FG000|Overall Study|Adverse Event|2|||
150023378|NCT01900652|541220422|FG001|Overall Study|Adverse Event|1|||
150059894|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
150059895|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
150059896|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
150059897|NCT00274924|541361354|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
150059898|NCT00274924|541361355|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
150059899|NCT00274924|541361356|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
150059900|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
150059901|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
150059902|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
150059903|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
150059904|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
150059905|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
150059906|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
150059907|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
150059908|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
150059909|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
150059910|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
150059911|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
150059912|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
150023379|NCT01900652|541220421|FG000|Overall Study|Physician Decision|1|||
150023380|NCT01900652|541220422|FG001|Overall Study|Physician Decision|1|||
150023381|NCT03932760|541220425|FG000|Overall Study|Became Ineligible|2|||
150023382|NCT03932760|541220426|FG001|Overall Study|Became Ineligible|5|||
150023383|NCT03932760|541220425|FG000|Overall Study|Withdrawal by Subject|6|||
150023384|NCT03932760|541220426|FG001|Overall Study|Withdrawal by Subject|6|||
150023385|NCT03922620|541220429|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
150023386|NCT03922620|541220430|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
150023387|NCT03566082|541220431|FG000|Overall Study|Death|7|||
150023388|NCT03566082|541220431|FG000|Overall Study|Failures (revision required)|2|||
150023389|NCT03566082|541220431|FG000|Overall Study|Lost to Follow-up|8|||
150023390|NCT04725500|541220432|FG000|Screening|Screen Failure|26|||
150023391|NCT04725500|541220432|FG000|Screening|Withdrawal by Subject|1|||
150023392|NCT04725500|541220432|FG000|2 Week Take Home|Screen Fail|5|||
150023393|NCT03772665|541220434|FG000|Overall Study|Protocol Violation|1|||
150023394|NCT03772665|541220435|FG001|Overall Study|Protocol Violation|0|||
150023395|NCT01389882|541222196|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
150023396|NCT01389882|541222197|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
150023397|NCT01389882|541222196|FG000|Overall Study|Withdrawal by Subject|0|||
150023398|NCT01389882|541222197|FG001|Overall Study|Withdrawal by Subject|1|||
150023399|NCT03790111|541222198|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
150023400|NCT00280917|541222201|FG000|Overall Study|Adverse Event|1|||
150023401|NCT00280917|541222202|FG001|Overall Study|Adverse Event|1|||
150023402|NCT00280917|541222203|FG002|Overall Study|Adverse Event|4|||
150023403|NCT00280917|541222204|FG003|Overall Study|Adverse Event|1|||
150023404|NCT00280917|541222201|FG000|Overall Study|Change Therapy|1|||
150023405|NCT00280917|541222202|FG001|Overall Study|Change Therapy|2|||
150023406|NCT00280917|541222203|FG002|Overall Study|Change Therapy|0|||
150023407|NCT00280917|541222204|FG003|Overall Study|Change Therapy|0|||
150023408|NCT00280917|541222201|FG000|Overall Study|Withdrawal by Subject|0|||
150023409|NCT00280917|541222202|FG001|Overall Study|Withdrawal by Subject|2|||
150023410|NCT00280917|541222203|FG002|Overall Study|Withdrawal by Subject|0|||
150023411|NCT00280917|541222204|FG003|Overall Study|Withdrawal by Subject|1|||
150023412|NCT00280917|541222201|FG000|Overall Study|Noncompliance|0|||
150023413|NCT00280917|541222202|FG001|Overall Study|Noncompliance|1|||
150023414|NCT00280917|541222203|FG002|Overall Study|Noncompliance|2|||
150023415|NCT00280917|541222204|FG003|Overall Study|Noncompliance|0|||
150023416|NCT03529110|541222205|FG000|Overall Study|Progressive Disease|66|||
150023417|NCT03529110|541222206|FG001|Overall Study|Progressive Disease|158|||
150059913|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
150059914|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
150059915|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
150059916|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
150059917|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
150059918|NCT00274924|541361354|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
150059919|NCT00274924|541361355|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
150023418|NCT03529110|541222205|FG000|Overall Study|Clinical Progression|4|||
150023419|NCT03529110|541222206|FG001|Overall Study|Clinical Progression|12|||
150023420|NCT03529110|541222205|FG000|Overall Study|Adverse Event|35|||
150023421|NCT03529110|541222206|FG001|Overall Study|Adverse Event|17|||
150023422|NCT03529110|541222205|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
150023423|NCT03529110|541222206|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
150181791|NCT03481660|541804594|FG000|Overall Study|Physician Decision|2|||
150181792|NCT03481660|541804595|FG001|Overall Study|Physician Decision|3|||
150181793|NCT03481660|541804594|FG000|Overall Study|Withdrawal by Subject|14|||
150181794|NCT03481660|541804595|FG001|Overall Study|Withdrawal by Subject|7|||
150023424|NCT03529110|541222205|FG000|Overall Study|Lack of Efficacy|3|||
150023425|NCT03529110|541222206|FG001|Overall Study|Lack of Efficacy|3|||
150023426|NCT03529110|541222205|FG000|Overall Study|Physician Decision|2|||
150023427|NCT03529110|541222206|FG001|Overall Study|Physician Decision|8|||
150023428|NCT03529110|541222205|FG000|Overall Study|Miscellaneous|2|||
150023429|NCT03529110|541222206|FG001|Overall Study|Miscellaneous|5|||
150023430|NCT01584232|541222207|FG000|Overall Study|Adverse Event|3|||
150023431|NCT01584232|541222208|FG001|Overall Study|Adverse Event|1|||
150023432|NCT01584232|541222207|FG000|Overall Study|Withdrawal by Subject|2|||
150023433|NCT01584232|541222208|FG001|Overall Study|Withdrawal by Subject|1|||
150023434|NCT01584232|541222207|FG000|Overall Study|Physician Decision|2|||
150023435|NCT01584232|541222208|FG001|Overall Study|Physician Decision|1|||
150023436|NCT01584232|541222207|FG000|Overall Study|Lost to Follow-up|1|||
150023437|NCT01584232|541222208|FG001|Overall Study|Lost to Follow-up|0|||
150023438|NCT01380769|541222210|FG000|Overall Study|Withdrawal by Subject|7|||
150023439|NCT01380769|541222211|FG001|Overall Study|Withdrawal by Subject|11|||
150023440|NCT01380769|541222210|FG000|Overall Study|Physician Decision|1|||
150023441|NCT01380769|541222211|FG001|Overall Study|Physician Decision|1|||
150023442|NCT01380769|541222210|FG000|Overall Study|Adverse Event|1|||
150023443|NCT01380769|541222211|FG001|Overall Study|Adverse Event|1|||
150023444|NCT01380769|541222210|FG000|Overall Study|Protocol Violation|0|||
150023445|NCT01380769|541222211|FG001|Overall Study|Protocol Violation|1|||
150023446|NCT00742183|541222212|FG000|Overall Study|Adverse Event|2|||
150023447|NCT00742183|541222213|FG001|Overall Study|Adverse Event|2|||
150023448|NCT00742183|541222212|FG000|Overall Study|Death|1|||
150023449|NCT00742183|541222213|FG001|Overall Study|Death|0|||
150023450|NCT00742183|541222212|FG000|Overall Study|Physician Decision|0|||
150023451|NCT00742183|541222213|FG001|Overall Study|Physician Decision|2|||
150023452|NCT00742183|541222212|FG000|Overall Study|Lost to Follow-up|4|||
150023453|NCT00742183|541222213|FG001|Overall Study|Lost to Follow-up|4|||
150023454|NCT00742183|541222212|FG000|Overall Study|Required skin-graft|1|||
150023455|NCT00742183|541222213|FG001|Overall Study|Required skin-graft|1|||
150023456|NCT00742183|541222212|FG000|Overall Study|Withdrawal by Subject|1|||
150023457|NCT00742183|541222213|FG001|Overall Study|Withdrawal by Subject|0|||
150023458|NCT00742183|541222212|FG000|Overall Study|Lack of Efficacy|0|||
150023459|NCT00742183|541222213|FG001|Overall Study|Lack of Efficacy|3|||
150181795|NCT03398148|541804596|FG000|Substudy 1 Period 1|Adverse Event|5|||
150023460|NCT00764699|541222217|FG000|Overall Study|PI left and study terminated|3|||
150023461|NCT02107703|541222218|FG000|Overall Study|Withdrawal by Subject|46|||
150023462|NCT02107703|541222219|FG001|Overall Study|Withdrawal by Subject|21|||
150023463|NCT02107703|541222218|FG000|Overall Study|Lost to Follow-up|20|||
150023464|NCT02107703|541222219|FG001|Overall Study|Lost to Follow-up|9|||
150023465|NCT02107703|541222218|FG000|Overall Study|On study treatment/follow up|48|||
150023466|NCT02107703|541222219|FG001|Overall Study|On study treatment/follow up|5|||
150023467|NCT03906071|541222220|FG000|Overall Study|Death|180|||
150023468|NCT03906071|541222221|FG001|Overall Study|Death|185|||
150023469|NCT03906071|541222220|FG000|Overall Study|Lost to Follow-up|3|||
150023470|NCT03906071|541222221|FG001|Overall Study|Lost to Follow-up|3|||
150023471|NCT03906071|541222220|FG000|Overall Study|Withdrawal by Subject|15|||
150023472|NCT03906071|541222221|FG001|Overall Study|Withdrawal by Subject|27|||
150023473|NCT03906071|541222220|FG000|Overall Study|Other|2|||
150023474|NCT03906071|541222221|FG001|Overall Study|Other|1|||
150023475|NCT05963022|541222226|FG000|Overall Study|Adverse Event|0|||
150023476|NCT05963022|541222227|FG001|Overall Study|Adverse Event|1|||
150023477|NCT05963022|541222228|FG002|Overall Study|Adverse Event|1|||
150023478|NCT05963022|541222229|FG003|Overall Study|Adverse Event|0|||
150023479|NCT05963022|541222226|FG000|Overall Study|Protocol Violation|0|||
150181796|NCT03398148|541804597|FG001|Substudy 1 Period 1|Adverse Event|2|||
150181797|NCT03398148|541804598|FG002|Substudy 1 Period 1|Adverse Event|2|||
150181798|NCT03398148|541804599|FG003|Substudy 1 Period 1|Adverse Event|0|||
150023480|NCT05963022|541222227|FG001|Overall Study|Protocol Violation|3|||
150181799|NCT03398148|541804600|FG004|Substudy 1 Period 1|Adverse Event|8|||
150023481|NCT05963022|541222228|FG002|Overall Study|Protocol Violation|0|||
150023482|NCT05963022|541222229|FG003|Overall Study|Protocol Violation|0|||
150023483|NCT05963022|541222226|FG000|Overall Study|Pregnancy|0|||
150181800|NCT03398148|541804601|FG005|Substudy 1 Period 1|Adverse Event|0|||
150181801|NCT03398148|541804602|FG006|Substudy 1 Period 1|Adverse Event|0|||
150023484|NCT05963022|541222227|FG001|Overall Study|Pregnancy|1|||
150023485|NCT05963022|541222228|FG002|Overall Study|Pregnancy|1|||
150023486|NCT05963022|541222229|FG003|Overall Study|Pregnancy|1|||
150023487|NCT05963022|541222226|FG000|Overall Study|Withdrawal by Subject|0|||
150023488|NCT05963022|541222227|FG001|Overall Study|Withdrawal by Subject|0|||
150023489|NCT05963022|541222228|FG002|Overall Study|Withdrawal by Subject|2|||
150023490|NCT05963022|541222229|FG003|Overall Study|Withdrawal by Subject|1|||
150181802|NCT03398148|541804603|FG007|Substudy 1 Period 1|Adverse Event|0|||
150181803|NCT03398148|541804604|FG008|Substudy 1 Period 1|Adverse Event|0|||
150023491|NCT05963022|541222226|FG000|Overall Study|Lost to Follow-up|0|||
150023492|NCT05963022|541222227|FG001|Overall Study|Lost to Follow-up|0|||
150023493|NCT05963022|541222228|FG002|Overall Study|Lost to Follow-up|0|||
150023494|NCT05963022|541222229|FG003|Overall Study|Lost to Follow-up|1|||
150023495|NCT05963022|541222226|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
150023496|NCT05963022|541222227|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
150023497|NCT05963022|541222228|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
150023498|NCT05963022|541222229|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
150023499|NCT03030417|541222235|FG000|Dose Expansion|Disease progression before treatment|0|||
150023500|NCT03030417|541222236|FG001|Dose Expansion|Disease progression before treatment|0|||
150023501|NCT03030417|541222237|FG002|Dose Expansion|Disease progression before treatment|0|||
150023502|NCT03030417|541222238|FG003|Dose Expansion|Disease progression before treatment|0|||
150023503|NCT03030417|541222239|FG004|Dose Expansion|Disease progression before treatment|0|||
150023504|NCT03030417|541222240|FG005|Dose Expansion|Disease progression before treatment|0|||
150023505|NCT03030417|541222241|FG006|Dose Expansion|Disease progression before treatment|0|||
150023506|NCT03030417|541222242|FG007|Dose Expansion|Disease progression before treatment|0|||
150023507|NCT03030417|541222243|FG008|Dose Expansion|Disease progression before treatment|0|||
150023508|NCT03030417|541222244|FG009|Dose Expansion|Disease progression before treatment|0|||
150023509|NCT03030417|541222245|FG010|Dose Expansion|Disease progression before treatment|0|||
150023510|NCT03030417|541222246|FG011|Dose Expansion|Disease progression before treatment|0|||
150023511|NCT03030417|541222247|FG012|Dose Expansion|Disease progression before treatment|1|||
150023512|NCT01539759|541222248|FG000|Overall Study|Lost to Follow-up|6|||
150023513|NCT01539759|541222249|FG001|Overall Study|Lost to Follow-up|8|||
150023514|NCT02175017|541222250|FG000|Overall Study|Did not receive the investigational product|1|||
150023515|NCT02175017|541222251|FG001|Overall Study|Did not receive the investigational product|2|||
150023516|NCT02175017|541222250|FG000|Overall Study|Withdrawal by Subject|6|||
150023517|NCT02175017|541222251|FG001|Overall Study|Withdrawal by Subject|3|||
150023518|NCT02175017|541222250|FG000|Overall Study|Met an exclusion criteria|0|||
150023519|NCT02175017|541222251|FG001|Overall Study|Met an exclusion criteria|1|||
150023520|NCT02175017|541222250|FG000|Overall Study|Adverse Event|3|||
150023521|NCT02175017|541222251|FG001|Overall Study|Adverse Event|10|||
150023522|NCT02175017|541222250|FG000|Overall Study|Disease progression|20|||
150023523|NCT02175017|541222251|FG001|Overall Study|Disease progression|27|||
150023524|NCT02175017|541222250|FG000|Overall Study|Other than above reasons|3|||
150023525|NCT02175017|541222251|FG001|Overall Study|Other than above reasons|0|||
150023526|NCT02491983|541222252|FG000|Overall Study|Physician Decision|1|||
150023527|NCT02491983|541222253|FG001|Overall Study|Physician Decision|0|||
150023528|NCT02491983|541222252|FG000|Overall Study|Not meet selection criteria|1|||
150023529|NCT02491983|541222253|FG001|Overall Study|Not meet selection criteria|0|||
150023530|NCT02491983|541222252|FG000|Overall Study|Withdrawal by Subject|0|||
150023531|NCT02491983|541222253|FG001|Overall Study|Withdrawal by Subject|1|||
150023532|NCT03575403|541222254|FG000|Overall Study|Adverse Event|1|||
150023533|NCT03575403|541222255|FG001|Overall Study|Adverse Event|0|||
150023534|NCT03575403|541222256|FG002|Overall Study|Adverse Event|0|||
150023535|NCT03575403|541222254|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
150023536|NCT03575403|541222255|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
150023537|NCT03575403|541222256|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
150023538|NCT00773513|541222257|FG000|Overall Study|Renal Transplant|254|||
150023539|NCT00773513|541222258|FG001|Overall Study|Renal Transplant|263|||
150023540|NCT00773513|541222257|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
150023541|NCT00773513|541222258|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
150023542|NCT00773513|541222257|FG000|Overall Study|Withdrew Consent|68|||
150023543|NCT00773513|541222258|FG001|Overall Study|Withdrew Consent|69|||
150023544|NCT00773513|541222257|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
150023545|NCT00773513|541222258|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
150023546|NCT00773513|541222257|FG000|Overall Study|Failure to Return|22|||
150059920|NCT00274924|541361356|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
150059921|NCT01055496|541361357|FG000|Overall Study|Withdrawal by Subject|2|||
150059922|NCT01055496|541361358|FG001|Overall Study|Withdrawal by Subject|4|||
150059923|NCT01055496|541361357|FG000|Overall Study|Death|13|||
150023547|NCT00773513|541222258|FG001|Overall Study|Failure to Return|8|||
150023548|NCT00773513|541222257|FG000|Overall Study|Insufficient Therapeutic Response|1|||
150059924|NCT01055496|541361358|FG001|Overall Study|Death|23|||
150059925|NCT01055496|541361357|FG000|Overall Study|Lost to Follow-up|0|||
150059926|NCT01055496|541361358|FG001|Overall Study|Lost to Follow-up|2|||
150059927|NCT01055496|541361357|FG000|Overall Study|Other - Unspecified|0|||
150059928|NCT01055496|541361358|FG001|Overall Study|Other - Unspecified|1|||
150059929|NCT00584740|541361359|FG000|Overall Study|Adverse Event|1|||
150059930|NCT00584740|541361360|FG001|Overall Study|Adverse Event|1|||
150059931|NCT00584740|541361359|FG000|Overall Study|Lack of Efficacy|8|||
150059932|NCT00584740|541361360|FG001|Overall Study|Lack of Efficacy|2|||
150023549|NCT00773513|541222258|FG001|Overall Study|Insufficient Therapeutic Response|18|||
150023550|NCT00773513|541222257|FG000|Overall Study|Reason Not Specified|159|||
150023551|NCT00773513|541222258|FG001|Overall Study|Reason Not Specified|126|||
150023552|NCT00773513|541222257|FG000|Overall Study|Death|531|||
150023553|NCT00773513|541222258|FG001|Overall Study|Death|545|||
150023554|NCT03359174|541222262|FG000|Overall Study|Adverse Event|1|||
150023555|NCT01332994|541222266|FG000|Overall Study|Adverse Event|34|||
150023556|NCT01332994|541222266|FG000|Overall Study|Death|1|||
150023557|NCT01332994|541222266|FG000|Overall Study|Lack of Efficacy|1|||
150023558|NCT01332994|541222266|FG000|Overall Study|Lost to Follow-up|4|||
150023559|NCT01332994|541222266|FG000|Overall Study|Protocol Violation|6|||
150023560|NCT01332994|541222266|FG000|Overall Study|Withdrawal by Subject|15|||
150023561|NCT01332994|541222266|FG000|Overall Study|Administrative Problem|2|||
150023562|NCT01332994|541222266|FG000|Overall Study|Other|8|||
150023563|NCT04170543|541222267|FG000|Overall Study|Death|1|||
150023564|NCT04170543|541222268|FG001|Overall Study|Death|1|||
150023565|NCT04170543|541222269|FG002|Overall Study|Death|1|||
150023566|NCT04170543|541222270|FG003|Overall Study|Death|1|||
150023567|NCT04170543|541222271|FG004|Overall Study|Death|1|||
150023568|NCT04170543|541222267|FG000|Overall Study|Lost to Follow-up|3|||
150023569|NCT04170543|541222268|FG001|Overall Study|Lost to Follow-up|3|||
150023570|NCT04170543|541222269|FG002|Overall Study|Lost to Follow-up|0|||
150023571|NCT04170543|541222270|FG003|Overall Study|Lost to Follow-up|3|||
150023572|NCT04170543|541222271|FG004|Overall Study|Lost to Follow-up|1|||
150023573|NCT04170543|541222267|FG000|Overall Study|Withdrawal by Subject|13|||
150023574|NCT04170543|541222268|FG001|Overall Study|Withdrawal by Subject|6|||
150023575|NCT04170543|541222269|FG002|Overall Study|Withdrawal by Subject|5|||
150023576|NCT04170543|541222270|FG003|Overall Study|Withdrawal by Subject|4|||
150023577|NCT04170543|541222271|FG004|Overall Study|Withdrawal by Subject|9|||
150023578|NCT04170543|541222267|FG000|Overall Study|Not able to transition to phase 2b|8|||
150023579|NCT04170543|541222268|FG001|Overall Study|Not able to transition to phase 2b|0|||
150023580|NCT04170543|541222269|FG002|Overall Study|Not able to transition to phase 2b|10|||
150023581|NCT04170543|541222270|FG003|Overall Study|Not able to transition to phase 2b|0|||
150023582|NCT04170543|541222271|FG004|Overall Study|Not able to transition to phase 2b|6|||
150023583|NCT04170543|541222267|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
150023584|NCT04170543|541222268|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
150023585|NCT04170543|541222269|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
150023586|NCT04170543|541222270|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
150023587|NCT04170543|541222271|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
150023588|NCT04170543|541222267|FG000|Overall Study|Not Treated|0|||
150023589|NCT04170543|541222268|FG001|Overall Study|Not Treated|0|||
150023590|NCT04170543|541222269|FG002|Overall Study|Not Treated|0|||
150023591|NCT04170543|541222270|FG003|Overall Study|Not Treated|0|||
150023592|NCT04170543|541222271|FG004|Overall Study|Not Treated|2|||
150023593|NCT04170543|541222267|FG000|Overall Study|(CRF)|16|||
150023594|NCT04170543|541222268|FG001|Overall Study|(CRF)|15|||
150023595|NCT04170543|541222269|FG002|Overall Study|(CRF)|12|||
150023596|NCT04170543|541222270|FG003|Overall Study|(CRF)|17|||
150023597|NCT04170543|541222271|FG004|Overall Study|(CRF)|17|||
150023598|NCT04170543|541222267|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
150023599|NCT04170543|541222268|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
150023600|NCT04170543|541222269|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
150023601|NCT04170543|541222270|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
150023602|NCT04170543|541222271|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
150023603|NCT04628780|541222272|FG000|Overall Study|Death|0|||
150023604|NCT04628780|541222273|FG001|Overall Study|Death|1|||
150023605|NCT04628780|541222274|FG002|Overall Study|Death|0|||
150023606|NCT04628780|541222275|FG003|Overall Study|Death|0|||
150023607|NCT04628780|541222276|FG004|Overall Study|Death|1|||
150023608|NCT04628780|541222277|FG005|Overall Study|Death|0|||
150023609|NCT04628780|541222272|FG000|Overall Study|Physician Decision|2|||
150023610|NCT04628780|541222273|FG001|Overall Study|Physician Decision|0|||
150023611|NCT04628780|541222274|FG002|Overall Study|Physician Decision|0|||
150023612|NCT04628780|541222275|FG003|Overall Study|Physician Decision|0|||
150059933|NCT00584740|541361359|FG000|Overall Study|Withdrawal by Subject|3|||
150059934|NCT00584740|541361360|FG001|Overall Study|Withdrawal by Subject|2|||
150023613|NCT04628780|541222276|FG004|Overall Study|Physician Decision|2|||
150023614|NCT04628780|541222277|FG005|Overall Study|Physician Decision|0|||
150023615|NCT04628780|541222272|FG000|Overall Study|Progressive disease|2|||
150023616|NCT04628780|541222273|FG001|Overall Study|Progressive disease|2|||
150023617|NCT04628780|541222274|FG002|Overall Study|Progressive disease|2|||
150023618|NCT04628780|541222275|FG003|Overall Study|Progressive disease|3|||
150023619|NCT04628780|541222276|FG004|Overall Study|Progressive disease|9|||
150023620|NCT04628780|541222277|FG005|Overall Study|Progressive disease|4|||
150023621|NCT04628780|541222272|FG000|Overall Study|Withdrawal by Subject|0|||
150023622|NCT04628780|541222273|FG001|Overall Study|Withdrawal by Subject|1|||
150023623|NCT04628780|541222274|FG002|Overall Study|Withdrawal by Subject|2|||
150023624|NCT04628780|541222275|FG003|Overall Study|Withdrawal by Subject|0|||
150023625|NCT04628780|541222276|FG004|Overall Study|Withdrawal by Subject|3|||
150023626|NCT04628780|541222277|FG005|Overall Study|Withdrawal by Subject|1|||
150023627|NCT04628780|541222272|FG000|Overall Study|Global deterioration of health status|0|||
150023628|NCT04628780|541222273|FG001|Overall Study|Global deterioration of health status|0|||
150023629|NCT04628780|541222274|FG002|Overall Study|Global deterioration of health status|0|||
150023630|NCT04628780|541222275|FG003|Overall Study|Global deterioration of health status|0|||
150023631|NCT04628780|541222276|FG004|Overall Study|Global deterioration of health status|1|||
150023632|NCT04628780|541222277|FG005|Overall Study|Global deterioration of health status|1|||
150023633|NCT04303559|541222279|FG000|Overall Study|Study closed due to poor enrollment.|1|||
150023634|NCT01987102|541222282|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
150023635|NCT01987102|541222283|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
150023636|NCT01987102|541222282|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
150023637|NCT01987102|541222283|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
150023638|NCT01987102|541222282|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
150023639|NCT01987102|541222283|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
150023640|NCT01987102|541222282|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
150023641|NCT01987102|541222283|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
150023642|NCT01987102|541222282|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
150023643|NCT01987102|541222283|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
150023644|NCT01987102|541222282|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
150023645|NCT01987102|541222283|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
150023646|NCT04378270|541222284|FG000|Overall Study|Lack of Efficacy|1|||
150023647|NCT04378270|541222284|FG000|Overall Study|Withdrawal by Subject|1|||
150023648|NCT04378270|541222284|FG000|Overall Study|Screen Failure|1|||
150023649|NCT04378270|541222284|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
150023650|NCT01327599|541222285|FG000|Overall Study|Adverse Event|1|||
150023651|NCT01327599|541222285|FG000|Overall Study|Could Not Attend Visit|1|||
150023652|NCT01327599|541222285|FG000|Overall Study|Withdrawal of Consent|1|||
150023653|NCT01132313|541222286|FG000|Overall Study|Lack of Efficacy|1|||
150023654|NCT01132313|541222287|FG001|Overall Study|Lack of Efficacy|0|||
150023655|NCT01132313|541222288|FG002|Overall Study|Lack of Efficacy|0|||
150023656|NCT01132313|541222289|FG003|Overall Study|Lack of Efficacy|0|||
150023657|NCT01132313|541222290|FG004|Overall Study|Lack of Efficacy|0|||
150023658|NCT01132313|541222291|FG005|Overall Study|Lack of Efficacy|0|||
150023659|NCT01132313|541222292|FG006|Overall Study|Lack of Efficacy|0|||
150023660|NCT01132313|541222293|FG007|Overall Study|Lack of Efficacy|3|||
150023661|NCT01132313|541222294|FG008|Overall Study|Lack of Efficacy|14|||
150023662|NCT01132313|541222295|FG009|Overall Study|Lack of Efficacy|16|||
150023663|NCT01132313|541222296|FG010|Overall Study|Lack of Efficacy|0|||
150023664|NCT01132313|541222297|FG011|Overall Study|Lack of Efficacy|0|||
150023665|NCT01132313|541222286|FG000|Overall Study|Not treated|2|||
150023666|NCT01132313|541222287|FG001|Overall Study|Not treated|0|||
150023667|NCT01132313|541222288|FG002|Overall Study|Not treated|0|||
150023668|NCT01132313|541222289|FG003|Overall Study|Not treated|0|||
150023669|NCT01132313|541222290|FG004|Overall Study|Not treated|2|||
150023670|NCT01132313|541222291|FG005|Overall Study|Not treated|1|||
150023671|NCT01132313|541222292|FG006|Overall Study|Not treated|3|||
150023672|NCT01132313|541222293|FG007|Overall Study|Not treated|0|||
150023673|NCT01132313|541222294|FG008|Overall Study|Not treated|0|||
150023674|NCT01132313|541222295|FG009|Overall Study|Not treated|0|||
150023675|NCT01132313|541222296|FG010|Overall Study|Not treated|0|||
150023676|NCT01132313|541222297|FG011|Overall Study|Not treated|0|||
150023677|NCT01132313|541222286|FG000|Overall Study|Adverse Event|0|||
150023678|NCT01132313|541222287|FG001|Overall Study|Adverse Event|0|||
150023679|NCT01132313|541222288|FG002|Overall Study|Adverse Event|4|||
150023680|NCT01132313|541222289|FG003|Overall Study|Adverse Event|10|||
150023681|NCT01132313|541222290|FG004|Overall Study|Adverse Event|19|||
150023682|NCT01132313|541222291|FG005|Overall Study|Adverse Event|6|||
150023683|NCT01132313|541222292|FG006|Overall Study|Adverse Event|5|||
150023684|NCT01132313|541222293|FG007|Overall Study|Adverse Event|3|||
150023685|NCT01132313|541222294|FG008|Overall Study|Adverse Event|7|||
150023686|NCT01132313|541222295|FG009|Overall Study|Adverse Event|2|||
150023687|NCT01132313|541222296|FG010|Overall Study|Adverse Event|0|||
150023688|NCT01132313|541222297|FG011|Overall Study|Adverse Event|0|||
150023689|NCT01132313|541222286|FG000|Overall Study|Protocol Violation|0|||
150023690|NCT01132313|541222287|FG001|Overall Study|Protocol Violation|0|||
150023691|NCT01132313|541222288|FG002|Overall Study|Protocol Violation|0|||
150023692|NCT01132313|541222289|FG003|Overall Study|Protocol Violation|1|||
150023693|NCT01132313|541222290|FG004|Overall Study|Protocol Violation|0|||
150023694|NCT01132313|541222291|FG005|Overall Study|Protocol Violation|0|||
150023695|NCT01132313|541222292|FG006|Overall Study|Protocol Violation|0|||
150023696|NCT01132313|541222293|FG007|Overall Study|Protocol Violation|0|||
150023697|NCT01132313|541222294|FG008|Overall Study|Protocol Violation|0|||
150023698|NCT01132313|541222295|FG009|Overall Study|Protocol Violation|0|||
150023699|NCT01132313|541222296|FG010|Overall Study|Protocol Violation|0|||
150023700|NCT01132313|541222297|FG011|Overall Study|Protocol Violation|0|||
150023701|NCT01132313|541222286|FG000|Overall Study|Lost to Follow-up|0|||
150023702|NCT01132313|541222287|FG001|Overall Study|Lost to Follow-up|0|||
150023703|NCT01132313|541222288|FG002|Overall Study|Lost to Follow-up|1|||
150059935|NCT00584740|541361359|FG000|Overall Study|Lost to Follow-up|0|||
150059936|NCT00584740|541361360|FG001|Overall Study|Lost to Follow-up|1|||
150059937|NCT01673282|541361362|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
150059938|NCT01673282|541361363|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
150059939|NCT01673282|541361362|FG000|Overall Study|Lack of Efficacy|9|||
150059940|NCT01673282|541361363|FG001|Overall Study|Lack of Efficacy|2|||
150059941|NCT01673282|541361362|FG000|Overall Study|Lost to Follow-up|11|||
150059942|NCT01673282|541361363|FG001|Overall Study|Lost to Follow-up|10|||
150059943|NCT01673282|541361362|FG000|Overall Study|Withdrawal by Subject|3|||
150059944|NCT01673282|541361363|FG001|Overall Study|Withdrawal by Subject|3|||
150059945|NCT01673282|541361362|FG000|Overall Study|Other|1|||
150059946|NCT01673282|541361363|FG001|Overall Study|Other|6|||
150059947|NCT03485495|541361364|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
150059948|NCT03485495|541361365|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
150059949|NCT02915874|541361366|FG000|Overall Study|Lost to Follow-up|5|||
150059950|NCT02915874|541361367|FG001|Overall Study|Lost to Follow-up|4|||
150059951|NCT02915874|541361366|FG000|Overall Study|Withdrawal by Subject|1|||
150059952|NCT02915874|541361367|FG001|Overall Study|Withdrawal by Subject|1|||
150059953|NCT02915874|541361366|FG000|Overall Study|Started New Anxiety Medication|0|||
150059954|NCT02915874|541361367|FG001|Overall Study|Started New Anxiety Medication|1|||
150059955|NCT05318183|541361369|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
150059956|NCT05318183|541361370|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
150059957|NCT05318183|541361369|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
150059958|NCT05318183|541361370|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
150059959|NCT05318183|541361369|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
150059960|NCT05318183|541361370|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
150059961|NCT05318183|541361369|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
150059962|NCT05318183|541361370|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
150023704|NCT01132313|541222289|FG003|Overall Study|Lost to Follow-up|0|||
150023705|NCT01132313|541222290|FG004|Overall Study|Lost to Follow-up|0|||
150023706|NCT01132313|541222291|FG005|Overall Study|Lost to Follow-up|0|||
150023707|NCT01132313|541222292|FG006|Overall Study|Lost to Follow-up|0|||
150023708|NCT01132313|541222293|FG007|Overall Study|Lost to Follow-up|1|||
150023709|NCT01132313|541222294|FG008|Overall Study|Lost to Follow-up|0|||
150023710|NCT01132313|541222295|FG009|Overall Study|Lost to Follow-up|0|||
150023711|NCT01132313|541222296|FG010|Overall Study|Lost to Follow-up|0|||
150023712|NCT01132313|541222297|FG011|Overall Study|Lost to Follow-up|0|||
150023713|NCT01132313|541222286|FG000|Overall Study|Withdrawal by Subject|0|||
150023714|NCT01132313|541222287|FG001|Overall Study|Withdrawal by Subject|0|||
150023715|NCT01132313|541222288|FG002|Overall Study|Withdrawal by Subject|3|||
150023716|NCT01132313|541222289|FG003|Overall Study|Withdrawal by Subject|3|||
150023717|NCT01132313|541222290|FG004|Overall Study|Withdrawal by Subject|6|||
150023718|NCT01132313|541222291|FG005|Overall Study|Withdrawal by Subject|0|||
150023719|NCT01132313|541222292|FG006|Overall Study|Withdrawal by Subject|1|||
150023720|NCT01132313|541222293|FG007|Overall Study|Withdrawal by Subject|0|||
150023721|NCT01132313|541222294|FG008|Overall Study|Withdrawal by Subject|0|||
150023722|NCT01132313|541222295|FG009|Overall Study|Withdrawal by Subject|2|||
150023723|NCT01132313|541222296|FG010|Overall Study|Withdrawal by Subject|0|||
150023724|NCT01132313|541222297|FG011|Overall Study|Withdrawal by Subject|0|||
150023725|NCT01132313|541222286|FG000|Overall Study|Lack of antiviral response|0|||
150023726|NCT01132313|541222287|FG001|Overall Study|Lack of antiviral response|0|||
150023727|NCT01132313|541222288|FG002|Overall Study|Lack of antiviral response|12|||
150023728|NCT01132313|541222289|FG003|Overall Study|Lack of antiviral response|18|||
150023729|NCT01132313|541222290|FG004|Overall Study|Lack of antiviral response|18|||
150023730|NCT01132313|541222291|FG005|Overall Study|Lack of antiviral response|18|||
150023731|NCT01132313|541222292|FG006|Overall Study|Lack of antiviral response|21|||
150023732|NCT01132313|541222293|FG007|Overall Study|Lack of antiviral response|0|||
150023733|NCT01132313|541222294|FG008|Overall Study|Lack of antiviral response|0|||
150023734|NCT01132313|541222295|FG009|Overall Study|Lack of antiviral response|0|||
150023735|NCT01132313|541222296|FG010|Overall Study|Lack of antiviral response|1|||
150023736|NCT01132313|541222297|FG011|Overall Study|Lack of antiviral response|0|||
150023737|NCT01132313|541222286|FG000|Overall Study|Other reason not defined above|0|||
150059963|NCT02751931|541361372|FG000|Overall Study|Adverse Event|3|||
150059964|NCT02751931|541361373|FG001|Overall Study|Adverse Event|0|||
150059965|NCT02751931|541361372|FG000|Overall Study|Other: Miscelleneous|10|||
150059966|NCT02751931|541361373|FG001|Overall Study|Other: Miscelleneous|8|||
150059967|NCT03473548|541361375|FG000|Overall Study|Did not attempt HST testing|3|||
150059968|NCT03473548|541361376|FG001|Overall Study|Did not attempt HST testing|0|||
150059969|NCT01986933|541361383|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
150059970|NCT01986933|541361384|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
150059971|NCT01986933|541361385|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
150059972|NCT01986933|541361386|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
150059973|NCT01986933|541361387|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
150023738|NCT01132313|541222287|FG001|Overall Study|Other reason not defined above|0|||
150023739|NCT01132313|541222288|FG002|Overall Study|Other reason not defined above|0|||
150181804|NCT03398148|541804605|FG009|Substudy 1 Period 1|Adverse Event|0|||
150181805|NCT03398148|541804606|FG010|Substudy 1 Period 1|Adverse Event|0|||
150181806|NCT03398148|541804607|FG011|Substudy 1 Period 1|Adverse Event|0|||
150181807|NCT03398148|541804608|FG012|Substudy 1 Period 1|Adverse Event|0|||
150181808|NCT03398148|541804609|FG013|Substudy 1 Period 1|Adverse Event|0|||
150181809|NCT03398148|541804610|FG014|Substudy 1 Period 1|Adverse Event|0|||
150023740|NCT01132313|541222289|FG003|Overall Study|Other reason not defined above|0|||
150023741|NCT01132313|541222290|FG004|Overall Study|Other reason not defined above|0|||
150023742|NCT01132313|541222291|FG005|Overall Study|Other reason not defined above|0|||
150023743|NCT01132313|541222292|FG006|Overall Study|Other reason not defined above|0|||
150023744|NCT01132313|541222293|FG007|Overall Study|Other reason not defined above|1|||
150023745|NCT01132313|541222294|FG008|Overall Study|Other reason not defined above|0|||
150023746|NCT01132313|541222295|FG009|Overall Study|Other reason not defined above|0|||
150023747|NCT01132313|541222296|FG010|Overall Study|Other reason not defined above|0|||
150023748|NCT01132313|541222297|FG011|Overall Study|Other reason not defined above|0|||
150023749|NCT01156714|541222298|FG000|Overall Study|Withdrawal by Subject|9|||
150023750|NCT01156714|541222299|FG001|Overall Study|Withdrawal by Subject|4|||
150023751|NCT01156714|541222300|FG002|Overall Study|Withdrawal by Subject|3|||
150023752|NCT01236521|541222301|FG000|Overall Study|Withdrawal by Subject|12|||
150023753|NCT01236521|541222302|FG001|Overall Study|Withdrawal by Subject|17|||
150023754|NCT01236521|541222301|FG000|Overall Study|Death|2|||
150023755|NCT01236521|541222302|FG001|Overall Study|Death|1|||
150023756|NCT01236521|541222301|FG000|Overall Study|Lost to Follow-up|9|||
150023757|NCT01236521|541222302|FG001|Overall Study|Lost to Follow-up|7|||
150023758|NCT00165672|541222307|FG000|Overall Study|Adverse Event|0|||
150023759|NCT00165672|541222308|FG001|Overall Study|Adverse Event|1|||
150023760|NCT04965688|541222316|FG000|Overall Study|Withdrawal by Subject|2|||
150023761|NCT04266795|541222317|FG000|Overall Study|Adverse Event|10|||
150023762|NCT04266795|541222318|FG001|Overall Study|Adverse Event|19|||
150023763|NCT04266795|541222317|FG000|Overall Study|Death|7|||
150023764|NCT04266795|541222318|FG001|Overall Study|Death|8|||
150023765|NCT04266795|541222317|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
150023766|NCT04266795|541222318|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
150023767|NCT04266795|541222317|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
150023768|NCT04266795|541222318|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
150023769|NCT04266795|541222317|FG000|Overall Study|Progressive Disease|12|||
150023770|NCT04266795|541222318|FG001|Overall Study|Progressive Disease|9|||
150023771|NCT04266795|541222317|FG000|Overall Study|Withdrawal by Patient|5|||
150023772|NCT04266795|541222318|FG001|Overall Study|Withdrawal by Patient|6|||
150023773|NCT04266795|541222317|FG000|Overall Study|Disease Relapse|3|||
150023774|NCT04266795|541222318|FG001|Overall Study|Disease Relapse|6|||
150023775|NCT04266795|541222317|FG000|Overall Study|Reason not Specified|12|||
150023776|NCT04266795|541222318|FG001|Overall Study|Reason not Specified|10|||
150023777|NCT04266795|541222317|FG000|Overall Study|Participants Ongoing on Treatment|25|||
150023778|NCT04266795|541222318|FG001|Overall Study|Participants Ongoing on Treatment|23|||
150023779|NCT03043872|541222319|FG000|Overall Study|Withdrawal by Subject|6|||
150023780|NCT03043872|541222320|FG001|Overall Study|Withdrawal by Subject|6|||
150023781|NCT03043872|541222321|FG002|Overall Study|Withdrawal by Subject|15|||
150023782|NCT03043872|541222319|FG000|Overall Study|Lost to Follow-up|2|||
150023783|NCT03043872|541222320|FG001|Overall Study|Lost to Follow-up|1|||
150023784|NCT03043872|541222321|FG002|Overall Study|Lost to Follow-up|1|||
150023785|NCT03043872|541222319|FG000|Overall Study|Death|270|||
150023786|NCT03043872|541222320|FG001|Overall Study|Death|269|||
150023787|NCT03043872|541222321|FG002|Overall Study|Death|296|||
150023788|NCT03868943|541222322|FG000|Overall Study|Adverse Event|1|||
150023789|NCT04551066|541222323|FG000|Overall Study|Death|5|||
150023790|NCT04551066|541222324|FG001|Overall Study|Death|3|||
150023791|NCT04551066|541222323|FG000|Overall Study|Lost to Follow-up|1|||
150181810|NCT03398148|541804596|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
150023792|NCT04551066|541222324|FG001|Overall Study|Lost to Follow-up|0|||
150023793|NCT04551066|541222323|FG000|Overall Study|Sponsor Decision|104|||
150023794|NCT04551066|541222324|FG001|Overall Study|Sponsor Decision|117|||
150023795|NCT04551066|541222323|FG000|Overall Study|Withdrawal by Subject|8|||
150023796|NCT04551066|541222324|FG001|Overall Study|Withdrawal by Subject|2|||
150023797|NCT04551066|541222323|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
150023798|NCT04551066|541222324|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
150023799|NCT04551066|541222323|FG000|Overall Study|Adverse Event|2|||
150023800|NCT04551066|541222324|FG001|Overall Study|Adverse Event|0|||
150181811|NCT03398148|541804597|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
150059974|NCT01986933|541361383|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
150059975|NCT01986933|541361384|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
150059976|NCT01986933|541361385|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
150059977|NCT01986933|541361386|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
150059978|NCT01986933|541361387|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
150059979|NCT01986933|541361383|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
150059980|NCT01986933|541361384|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
150059981|NCT01986933|541361385|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
150059982|NCT01986933|541361386|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
150059983|NCT01986933|541361387|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
150059984|NCT01986933|541361383|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
150023801|NCT04551066|541222323|FG000|Overall Study|Physician Decision|2|||
150023802|NCT04551066|541222324|FG001|Overall Study|Physician Decision|0|||
150023803|NCT04551066|541222323|FG000|Overall Study|Protocol Violation|1|||
150023804|NCT04551066|541222324|FG001|Overall Study|Protocol Violation|0|||
150023805|NCT04551066|541222323|FG000|Overall Study|Lack of Efficacy|0|||
150023806|NCT04551066|541222324|FG001|Overall Study|Lack of Efficacy|1|||
150023807|NCT04551066|541222323|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
150023808|NCT04551066|541222324|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
150023809|NCT00369577|541222325|FG000|Overall Study|Withdrawal by Subject|0|||
150023810|NCT00369577|541222326|FG001|Overall Study|Withdrawal by Subject|0|||
150023811|NCT00369577|541222327|FG002|Overall Study|Withdrawal by Subject|1|||
150023812|NCT03915470|541222328|FG000|Overall Study|Death|3|||
150023813|NCT03915470|541222329|FG001|Overall Study|Death|1|||
150023814|NCT03915470|541222328|FG000|Overall Study|Adverse Event|1|||
150023815|NCT03915470|541222329|FG001|Overall Study|Adverse Event|0|||
150023816|NCT03915470|541222328|FG000|Overall Study|Physician Decision|1|||
150023817|NCT03915470|541222329|FG001|Overall Study|Physician Decision|0|||
150023818|NCT03915470|541222328|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
150023819|NCT03915470|541222329|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
150023820|NCT00434109|541222330|FG000|Overall Study|Physician Decision|9|||
150023821|NCT00434109|541222330|FG000|Overall Study|Adverse Event|5|||
150023822|NCT00434109|541222330|FG000|Overall Study|Protocol Violation|1|||
150023823|NCT00434109|541222330|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
150023824|NCT01463306|541222333|FG000|Overall Study|Adverse Event|6|||
150023825|NCT01463306|541222334|FG001|Overall Study|Adverse Event|9|||
150023826|NCT01463306|541222335|FG002|Overall Study|Adverse Event|3|||
150023827|NCT01463306|541222333|FG000|Overall Study|Death|3|||
150023828|NCT01463306|541222334|FG001|Overall Study|Death|3|||
150023829|NCT01463306|541222335|FG002|Overall Study|Death|0|||
150023830|NCT01463306|541222333|FG000|Overall Study|Lack of Efficacy|22|||
150023831|NCT01463306|541222334|FG001|Overall Study|Lack of Efficacy|16|||
150023832|NCT01463306|541222335|FG002|Overall Study|Lack of Efficacy|1|||
150023833|NCT01463306|541222333|FG000|Overall Study|Lost to Follow-up|5|||
150023834|NCT01463306|541222334|FG001|Overall Study|Lost to Follow-up|2|||
150023835|NCT01463306|541222335|FG002|Overall Study|Lost to Follow-up|0|||
150023836|NCT01463306|541222333|FG000|Overall Study|Protocol Violation|4|||
150023837|NCT01463306|541222334|FG001|Overall Study|Protocol Violation|0|||
150059985|NCT01986933|541361384|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
150059986|NCT01986933|541361385|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
150059987|NCT01986933|541361386|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
150059988|NCT01986933|541361387|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
150059989|NCT01986933|541361383|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
150059990|NCT01986933|541361384|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
150059991|NCT01986933|541361385|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
150059992|NCT01986933|541361386|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
150059993|NCT01986933|541361387|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
150059994|NCT01986933|541361383|FG000|Active-to-active (Part B)|Adverse Event|0|||
150059995|NCT01986933|541361384|FG001|Active-to-active (Part B)|Adverse Event|2|||
150059996|NCT01986933|541361385|FG002|Active-to-active (Part B)|Adverse Event|0|||
150059997|NCT01986933|541361386|FG003|Active-to-active (Part B)|Adverse Event|1|||
150059998|NCT01986933|541361387|FG004|Active-to-active (Part B)|Adverse Event|3|||
150059999|NCT01986933|541361383|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
150060000|NCT01986933|541361384|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
150023838|NCT01463306|541222335|FG002|Overall Study|Protocol Violation|0|||
150023839|NCT01463306|541222333|FG000|Overall Study|Withdrawal by Subject|19|||
150023840|NCT01463306|541222334|FG001|Overall Study|Withdrawal by Subject|9|||
150023841|NCT01463306|541222335|FG002|Overall Study|Withdrawal by Subject|1|||
150023842|NCT01463306|541222333|FG000|Overall Study|Other|26|||
150023843|NCT01463306|541222334|FG001|Overall Study|Other|13|||
150023844|NCT01463306|541222335|FG002|Overall Study|Other|0|||
150023845|NCT01463306|541222333|FG000|Overall Study|Approval expiry at site|1|||
150023846|NCT01463306|541222334|FG001|Overall Study|Approval expiry at site|0|||
150023847|NCT01463306|541222335|FG002|Overall Study|Approval expiry at site|0|||
150023848|NCT03790917|541222336|FG000|Overall Study|Death|1|||
150023849|NCT04186871|541222337|FG000|Overall Study|Lack of Efficacy|0|||
150023850|NCT04186871|541222338|FG001|Overall Study|Lack of Efficacy|1|||
150023851|NCT04186871|541222339|FG002|Overall Study|Lack of Efficacy|0|||
150023852|NCT04186871|541222340|FG003|Overall Study|Lack of Efficacy|0|||
150023853|NCT04186871|541222341|FG004|Overall Study|Lack of Efficacy|1|||
150023854|NCT04186871|541222342|FG005|Overall Study|Lack of Efficacy|1|||
150023855|NCT04186871|541222337|FG000|Overall Study|Adverse Event|1|||
150023856|NCT04186871|541222338|FG001|Overall Study|Adverse Event|1|||
150023857|NCT04186871|541222339|FG002|Overall Study|Adverse Event|0|||
150023858|NCT04186871|541222340|FG003|Overall Study|Adverse Event|0|||
150023859|NCT04186871|541222341|FG004|Overall Study|Adverse Event|0|||
150023860|NCT04186871|541222342|FG005|Overall Study|Adverse Event|2|||
150023861|NCT04186871|541222337|FG000|Overall Study|Study terminated by sponsor|1|||
150023862|NCT04186871|541222338|FG001|Overall Study|Study terminated by sponsor|2|||
150023863|NCT04186871|541222339|FG002|Overall Study|Study terminated by sponsor|0|||
150023864|NCT04186871|541222340|FG003|Overall Study|Study terminated by sponsor|1|||
150023865|NCT04186871|541222341|FG004|Overall Study|Study terminated by sponsor|0|||
150023866|NCT04186871|541222342|FG005|Overall Study|Study terminated by sponsor|0|||
150023867|NCT04186871|541222337|FG000|Overall Study|Other reasons|0|||
150023868|NCT04186871|541222338|FG001|Overall Study|Other reasons|0|||
150023869|NCT04186871|541222339|FG002|Overall Study|Other reasons|0|||
150023870|NCT04186871|541222340|FG003|Overall Study|Other reasons|0|||
150023871|NCT04186871|541222341|FG004|Overall Study|Other reasons|0|||
150023872|NCT04186871|541222342|FG005|Overall Study|Other reasons|1|||
150023873|NCT04186871|541222337|FG000|Overall Study|Withdrawal by Subject|0|||
150023874|NCT04186871|541222338|FG001|Overall Study|Withdrawal by Subject|0|||
150023875|NCT04186871|541222339|FG002|Overall Study|Withdrawal by Subject|0|||
150023876|NCT04186871|541222340|FG003|Overall Study|Withdrawal by Subject|0|||
150023877|NCT04186871|541222341|FG004|Overall Study|Withdrawal by Subject|0|||
150023878|NCT04186871|541222342|FG005|Overall Study|Withdrawal by Subject|1|||
150023879|NCT04186871|541222337|FG000|Overall Study|Lost to Follow-up|0|||
150023880|NCT04186871|541222338|FG001|Overall Study|Lost to Follow-up|0|||
150023881|NCT04186871|541222339|FG002|Overall Study|Lost to Follow-up|0|||
150023882|NCT04186871|541222340|FG003|Overall Study|Lost to Follow-up|0|||
150023883|NCT04186871|541222341|FG004|Overall Study|Lost to Follow-up|0|||
150023884|NCT04186871|541222342|FG005|Overall Study|Lost to Follow-up|1|||
150023885|NCT01045694|541222347|FG000|Overall Study|Withdrawal by Subject|2|||
150023886|NCT01408459|541222351|FG000|Overall Study|Withdrawal by Subject|1|||
150023887|NCT01408459|541222352|FG001|Overall Study|Withdrawal by Subject|1|||
150023888|NCT00992459|541222353|FG000|Overall Study|Withdrawal by Subject|0|||
150023889|NCT00992459|541222354|FG001|Overall Study|Withdrawal by Subject|1|||
150023890|NCT00992459|541222353|FG000|Overall Study|Adverse Event|1|||
150023891|NCT00992459|541222354|FG001|Overall Study|Adverse Event|0|||
150023892|NCT00543387|541222361|FG000|Panel 1 + Panel 2|Adverse Event|0|||
150023893|NCT00543387|541222362|FG001|Panel 1 + Panel 2|Adverse Event|1|||
150023894|NCT00543387|541222363|FG002|Panel 1 + Panel 2|Adverse Event|0|||
150023895|NCT00543387|541222364|FG003|Panel 1 + Panel 2|Adverse Event|0|||
150023896|NCT00543387|541222365|FG004|Panel 1 + Panel 2|Adverse Event|0|||
150023897|NCT00543387|541222366|FG005|Panel 1 + Panel 2|Adverse Event|0|||
150023898|NCT00543387|541222367|FG006|Panel 1 + Panel 2|Adverse Event|0|||
150023899|NCT00543387|541222368|FG007|Panel 1 + Panel 2|Adverse Event|1|||
150023900|NCT00543387|541222369|FG008|Panel 1 + Panel 2|Adverse Event|1|||
150023901|NCT00543387|541222370|FG009|Panel 1 + Panel 2|Adverse Event|0|||
150023902|NCT00543387|541222371|FG010|Panel 1 + Panel 2|Adverse Event|0|||
150023903|NCT00543387|541222361|FG000|Panel 1 + Panel 2|Physician Decision|0|||
150023904|NCT00543387|541222362|FG001|Panel 1 + Panel 2|Physician Decision|0|||
150023905|NCT00543387|541222363|FG002|Panel 1 + Panel 2|Physician Decision|1|||
150023906|NCT00543387|541222364|FG003|Panel 1 + Panel 2|Physician Decision|0|||
150023907|NCT00543387|541222365|FG004|Panel 1 + Panel 2|Physician Decision|0|||
150023908|NCT00543387|541222366|FG005|Panel 1 + Panel 2|Physician Decision|0|||
150023909|NCT00543387|541222367|FG006|Panel 1 + Panel 2|Physician Decision|0|||
150023910|NCT00543387|541222368|FG007|Panel 1 + Panel 2|Physician Decision|1|||
150023911|NCT00543387|541222369|FG008|Panel 1 + Panel 2|Physician Decision|0|||
150023912|NCT00543387|541222370|FG009|Panel 1 + Panel 2|Physician Decision|0|||
150023913|NCT00543387|541222371|FG010|Panel 1 + Panel 2|Physician Decision|0|||
150023914|NCT00543387|541222361|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
150023915|NCT00543387|541222362|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
150023916|NCT00543387|541222363|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
150023917|NCT00543387|541222364|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
150023918|NCT00543387|541222365|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
150023919|NCT00543387|541222366|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
150023920|NCT00543387|541222367|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
150060001|NCT01986933|541361385|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
150060002|NCT01986933|541361386|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
150060003|NCT01986933|541361387|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
150060004|NCT01986933|541361383|FG000|Active-to-active (Part B)|Pregnancy|0|||
150060005|NCT01986933|541361384|FG001|Active-to-active (Part B)|Pregnancy|0|||
150060006|NCT01986933|541361385|FG002|Active-to-active (Part B)|Pregnancy|0|||
150060007|NCT01986933|541361386|FG003|Active-to-active (Part B)|Pregnancy|0|||
150060008|NCT01986933|541361387|FG004|Active-to-active (Part B)|Pregnancy|1|||
150060009|NCT01986933|541361383|FG000|Active-to-active (Part B)|Physician Decision|0|||
150060010|NCT01986933|541361384|FG001|Active-to-active (Part B)|Physician Decision|0|||
150060011|NCT01986933|541361385|FG002|Active-to-active (Part B)|Physician Decision|1|||
150060012|NCT01986933|541361386|FG003|Active-to-active (Part B)|Physician Decision|1|||
150060013|NCT01986933|541361387|FG004|Active-to-active (Part B)|Physician Decision|0|||
150060014|NCT01986933|541361383|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
150060015|NCT01986933|541361384|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
150060016|NCT01986933|541361385|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
150060017|NCT01986933|541361386|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
150023921|NCT00543387|541222368|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
150023922|NCT00543387|541222369|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
150023923|NCT00543387|541222370|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
150023924|NCT00543387|541222371|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
150023925|NCT00543387|541222361|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023926|NCT00543387|541222362|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023927|NCT00543387|541222363|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023928|NCT00543387|541222364|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023929|NCT00543387|541222365|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023930|NCT00543387|541222366|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023931|NCT00543387|541222367|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
150023932|NCT00543387|541222368|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023933|NCT00543387|541222369|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023934|NCT00543387|541222370|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023935|NCT00543387|541222371|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
150023936|NCT00543387|541222361|FG000|Crossover Participants|Progressive Disease|0|||
150023937|NCT00543387|541222362|FG001|Crossover Participants|Progressive Disease|0|||
150023938|NCT00543387|541222363|FG002|Crossover Participants|Progressive Disease|0|||
150023939|NCT00543387|541222364|FG003|Crossover Participants|Progressive Disease|0|||
150023940|NCT00543387|541222365|FG004|Crossover Participants|Progressive Disease|0|||
150023941|NCT00543387|541222366|FG005|Crossover Participants|Progressive Disease|0|||
150023942|NCT00543387|541222367|FG006|Crossover Participants|Progressive Disease|0|||
150023943|NCT00543387|541222368|FG007|Crossover Participants|Progressive Disease|0|||
150023944|NCT00543387|541222369|FG008|Crossover Participants|Progressive Disease|0|||
150023945|NCT00543387|541222370|FG009|Crossover Participants|Progressive Disease|1|||
150023946|NCT00543387|541222371|FG010|Crossover Participants|Progressive Disease|2|||
150023947|NCT00543387|541222361|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
150023948|NCT00543387|541222362|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
150023949|NCT00543387|541222363|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
150023950|NCT00543387|541222364|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
150023951|NCT00543387|541222365|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
150023952|NCT00543387|541222366|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
150023953|NCT00543387|541222367|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
150023954|NCT00543387|541222368|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
150023955|NCT00543387|541222369|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
150023956|NCT00543387|541222370|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
150023957|NCT00543387|541222371|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
150023958|NCT00549445|541222372|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
150023959|NCT00549445|541222373|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
150023960|NCT02614729|541223649|FG000|Overall Study|Withdrawal by Subject|1|||
150023961|NCT02614729|541223650|FG001|Overall Study|Withdrawal by Subject|0|||
150023962|NCT02796677|541223653|FG000|Overall Study|Adverse Event|11|||
150060018|NCT01986933|541361387|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
150060019|NCT01986933|541361383|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
150060020|NCT01986933|541361384|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
150023963|NCT02796677|541223654|FG001|Overall Study|Adverse Event|22|||
150023964|NCT02796677|541223655|FG002|Overall Study|Adverse Event|14|||
150023965|NCT02796677|541223656|FG003|Overall Study|Adverse Event|14|||
150023966|NCT02796677|541223653|FG000|Overall Study|Protocol Violation|7|||
150023967|NCT02796677|541223654|FG001|Overall Study|Protocol Violation|5|||
150023968|NCT02796677|541223655|FG002|Overall Study|Protocol Violation|4|||
150060021|NCT01986933|541361385|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
150060022|NCT01986933|541361386|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
150060023|NCT01986933|541361387|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
150060024|NCT01986933|541361383|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
150060025|NCT01986933|541361384|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
150060026|NCT01986933|541361385|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
150060027|NCT01986933|541361386|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
150060028|NCT01986933|541361387|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
150060029|NCT01986933|541361383|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
150060030|NCT01986933|541361384|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
150060031|NCT01986933|541361385|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
150060032|NCT01986933|541361386|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
150060033|NCT01986933|541361387|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
150060034|NCT01986933|541361383|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
150060035|NCT01986933|541361384|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
150060036|NCT01986933|541361385|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
150060037|NCT01986933|541361386|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
150060038|NCT01986933|541361387|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
150060039|NCT01986933|541361383|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
150060040|NCT01986933|541361384|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
150060041|NCT01986933|541361385|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
150060042|NCT01986933|541361386|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
150060043|NCT01986933|541361387|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
150060044|NCT01986933|541361383|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
150060045|NCT01986933|541361384|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
150060046|NCT01986933|541361385|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
150060047|NCT01986933|541361386|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
150060048|NCT01986933|541361387|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
150060049|NCT01986933|541361383|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
150060050|NCT01986933|541361384|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
150060051|NCT01986933|541361385|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
150060052|NCT01986933|541361386|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
150060053|NCT01986933|541361387|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
150060054|NCT00811642|541361388|FG000|Overall Study|Adverse Event|3|||
150060055|NCT00811642|541361388|FG000|Overall Study|Protocol Violation|1|||
150060056|NCT00811642|541361388|FG000|Overall Study|Death|2|||
150060057|NCT00811642|541361388|FG000|Overall Study|Withdrawal by Subject|7|||
150060058|NCT00811642|541361388|FG000|Overall Study|Cumulative use of antifungal agent|2|||
150060059|NCT01006603|541361390|FG000|Overall Study|Withdrawal by Subject|17|||
150060060|NCT01006603|541361391|FG001|Overall Study|Withdrawal by Subject|19|||
150060061|NCT01006603|541361390|FG000|Overall Study|Lost to Follow-up|0|||
150060062|NCT01006603|541361391|FG001|Overall Study|Lost to Follow-up|1|||
150060063|NCT01006603|541361390|FG000|Overall Study|Safety reason|1|||
150060064|NCT01006603|541361391|FG001|Overall Study|Safety reason|1|||
150060065|NCT01006603|541361390|FG000|Overall Study|Protocol Violation|1|||
150060066|NCT01006603|541361391|FG001|Overall Study|Protocol Violation|3|||
150060067|NCT01006603|541361390|FG000|Overall Study|Incorrect enrolment|0|||
150060068|NCT01006603|541361391|FG001|Overall Study|Incorrect enrolment|2|||
150060069|NCT01006603|541361390|FG000|Overall Study|Adverse Event|15|||
150060070|NCT01006603|541361391|FG001|Overall Study|Adverse Event|7|||
150060071|NCT01006603|541361390|FG000|Overall Study|Death|1|||
150023969|NCT02796677|541223656|FG003|Overall Study|Protocol Violation|8|||
150023970|NCT02796677|541223653|FG000|Overall Study|Lost to Follow-up|1|||
150023971|NCT02796677|541223654|FG001|Overall Study|Lost to Follow-up|5|||
150023972|NCT02796677|541223655|FG002|Overall Study|Lost to Follow-up|2|||
150023973|NCT02796677|541223656|FG003|Overall Study|Lost to Follow-up|2|||
150023974|NCT02796677|541223653|FG000|Overall Study|Lack of Efficacy|7|||
150023975|NCT02796677|541223654|FG001|Overall Study|Lack of Efficacy|9|||
150023976|NCT02796677|541223655|FG002|Overall Study|Lack of Efficacy|14|||
150023977|NCT02796677|541223656|FG003|Overall Study|Lack of Efficacy|20|||
150023978|NCT02796677|541223653|FG000|Overall Study|Withdrawal by Subject|4|||
150023979|NCT02796677|541223654|FG001|Overall Study|Withdrawal by Subject|14|||
150023980|NCT02796677|541223655|FG002|Overall Study|Withdrawal by Subject|6|||
150023981|NCT02796677|541223656|FG003|Overall Study|Withdrawal by Subject|7|||
150023982|NCT02796677|541223653|FG000|Overall Study|Progressive disease|6|||
150023983|NCT02796677|541223654|FG001|Overall Study|Progressive disease|15|||
150023984|NCT02796677|541223655|FG002|Overall Study|Progressive disease|13|||
150023985|NCT02796677|541223656|FG003|Overall Study|Progressive disease|18|||
150023986|NCT02796677|541223653|FG000|Overall Study|Reason not mentioned|2|||
150023987|NCT02796677|541223654|FG001|Overall Study|Reason not mentioned|3|||
150023988|NCT02796677|541223655|FG002|Overall Study|Reason not mentioned|0|||
150023989|NCT02796677|541223656|FG003|Overall Study|Reason not mentioned|5|||
150023990|NCT03798717|541223657|FG000|Overall Study|Failed Screening|0|||
150023991|NCT03798717|541223658|FG001|Overall Study|Failed Screening|0|||
150023992|NCT03798717|541223659|FG002|Overall Study|Failed Screening|0|||
150023993|NCT03798717|541223660|FG003|Overall Study|Failed Screening|0|||
150023994|NCT03798717|541223661|FG004|Overall Study|Failed Screening|0|||
150023995|NCT03798717|541223662|FG005|Overall Study|Failed Screening|1|||
150023996|NCT03798717|541223657|FG000|Overall Study|Physician Decision|1|||
150023997|NCT03798717|541223658|FG001|Overall Study|Physician Decision|0|||
150023998|NCT03798717|541223659|FG002|Overall Study|Physician Decision|1|||
150023999|NCT03798717|541223660|FG003|Overall Study|Physician Decision|0|||
150024000|NCT03798717|541223661|FG004|Overall Study|Physician Decision|0|||
150024001|NCT03798717|541223662|FG005|Overall Study|Physician Decision|0|||
150024002|NCT03798717|541223657|FG000|Overall Study|Withdrawal by Subject|0|||
150024003|NCT03798717|541223658|FG001|Overall Study|Withdrawal by Subject|0|||
150024004|NCT03798717|541223659|FG002|Overall Study|Withdrawal by Subject|0|||
150024005|NCT03798717|541223660|FG003|Overall Study|Withdrawal by Subject|1|||
150024006|NCT03798717|541223661|FG004|Overall Study|Withdrawal by Subject|0|||
150024007|NCT03798717|541223662|FG005|Overall Study|Withdrawal by Subject|0|||
150024008|NCT03798717|541223657|FG000|Overall Study|Lost to Follow-up|1|||
150024009|NCT03798717|541223658|FG001|Overall Study|Lost to Follow-up|0|||
150024010|NCT03798717|541223659|FG002|Overall Study|Lost to Follow-up|0|||
150024011|NCT03798717|541223660|FG003|Overall Study|Lost to Follow-up|1|||
150024012|NCT03798717|541223661|FG004|Overall Study|Lost to Follow-up|0|||
150024013|NCT03798717|541223662|FG005|Overall Study|Lost to Follow-up|0|||
150024014|NCT03798717|541223657|FG000|Overall Study|Adverse Event|0|||
150024015|NCT03798717|541223658|FG001|Overall Study|Adverse Event|1|||
150024016|NCT03798717|541223659|FG002|Overall Study|Adverse Event|0|||
150024017|NCT03798717|541223660|FG003|Overall Study|Adverse Event|0|||
150024018|NCT03798717|541223661|FG004|Overall Study|Adverse Event|0|||
150024019|NCT03798717|541223662|FG005|Overall Study|Adverse Event|0|||
150024020|NCT03798717|541223657|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
150024021|NCT03798717|541223658|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
150024022|NCT03798717|541223659|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
150024023|NCT03798717|541223660|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
150024024|NCT03798717|541223661|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
150024025|NCT03798717|541223662|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
150024026|NCT04002960|541223664|FG000|Overall Study|Withdrawn prior to Completion|2|||
150024027|NCT00961181|541223665|FG000|Overall Study|Death|2|||
150024028|NCT00961181|541223665|FG000|Overall Study|Withdrawal by Subject|2|||
150024029|NCT00961181|541223665|FG000|Overall Study|Lost to Follow-up|1|||
150024030|NCT01045967|541223666|FG000|Second Intervention|Protocol Violation|0|||
150024031|NCT01045967|541223667|FG001|Second Intervention|Protocol Violation|1|||
150024032|NCT01777308|541223668|FG000|Overall Study|Withdrawal by Subject|5|||
150024033|NCT01777308|541223669|FG001|Overall Study|Withdrawal by Subject|1|||
150024034|NCT01777308|541223668|FG000|Overall Study|Migrated/moved from study area|1|||
150024035|NCT01777308|541223669|FG001|Overall Study|Migrated/moved from study area|0|||
150024036|NCT01777308|541223668|FG000|Overall Study|Lost to Follow-up|7|||
150024037|NCT01777308|541223669|FG001|Overall Study|Lost to Follow-up|2|||
150024038|NCT01777308|541223668|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
150024039|NCT01777308|541223669|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
150024040|NCT03212326|541223671|FG000|Overall Study|Physician Decision|4|||
150024041|NCT03057496|541223681|FG000|Overall Study|Withdrawal by Subject|8|||
150024042|NCT03057496|541223681|FG000|Overall Study|Lost to Follow-up|5|||
150024043|NCT03057496|541223681|FG000|Overall Study|Did not use device during home trial|3|||
150024044|NCT03057496|541223681|FG000|Overall Study|Device failure|2|||
150024045|NCT01790594|541223686|FG000|Overall Study|Death|1|||
150024046|NCT01790594|541223687|FG001|Overall Study|Death|0|||
150024047|NCT01790594|541223688|FG002|Overall Study|Death|0|||
150024048|NCT01790594|541223686|FG000|Overall Study|Physician Decision|2|||
150024049|NCT01790594|541223687|FG001|Overall Study|Physician Decision|1|||
150024050|NCT01790594|541223688|FG002|Overall Study|Physician Decision|0|||
150024051|NCT01790594|541223686|FG000|Overall Study|Withdrawal by Subject|2|||
150024052|NCT01790594|541223687|FG001|Overall Study|Withdrawal by Subject|0|||
150024053|NCT01790594|541223688|FG002|Overall Study|Withdrawal by Subject|0|||
150024054|NCT01790594|541223686|FG000|Overall Study|Transplant was not done|0|||
150024055|NCT01790594|541223687|FG001|Overall Study|Transplant was not done|0|||
150024056|NCT01790594|541223688|FG002|Overall Study|Transplant was not done|3|||
150024057|NCT01790594|541223686|FG000|Overall Study|Terminated prior to week 76|0|||
150024058|NCT01790594|541223687|FG001|Overall Study|Terminated prior to week 76|2|||
150024059|NCT01790594|541223688|FG002|Overall Study|Terminated prior to week 76|0|||
150024060|NCT00404651|541223691|FG000|Overall Study|Serious Adverse Event|0|||
150024061|NCT00404651|541223692|FG001|Overall Study|Serious Adverse Event|0|||
150024062|NCT00404651|541223693|FG002|Overall Study|Serious Adverse Event|2|||
150024063|NCT00404651|541223694|FG003|Overall Study|Serious Adverse Event|0|||
150024064|NCT00404651|541223691|FG000|Overall Study|Protocol Violation|10|||
150024065|NCT00404651|541223692|FG001|Overall Study|Protocol Violation|5|||
150024066|NCT00404651|541223693|FG002|Overall Study|Protocol Violation|14|||
150024067|NCT00404651|541223694|FG003|Overall Study|Protocol Violation|5|||
150024068|NCT00404651|541223691|FG000|Overall Study|Lost to Follow-up|15|||
150024069|NCT00404651|541223692|FG001|Overall Study|Lost to Follow-up|11|||
150024070|NCT00404651|541223693|FG002|Overall Study|Lost to Follow-up|13|||
150024071|NCT00404651|541223694|FG003|Overall Study|Lost to Follow-up|10|||
150024072|NCT00404651|541223691|FG000|Overall Study|Withdrawal by Subject|14|||
150060072|NCT01006603|541361391|FG001|Overall Study|Death|1|||
150060073|NCT01006603|541361390|FG000|Overall Study|Study specific discontinuation criteria|33|||
150060074|NCT01006603|541361391|FG001|Overall Study|Study specific discontinuation criteria|34|||
150060075|NCT01006603|541361390|FG000|Overall Study|Other|3|||
150060076|NCT01006603|541361391|FG001|Overall Study|Other|7|||
150060077|NCT01892722|541361394|FG000|Overall Study|Protocol deviation|0|||
150060078|NCT01892722|541361395|FG001|Overall Study|Protocol deviation|1|||
150060079|NCT01892722|541361394|FG000|Overall Study|Administrative problems|0|||
150060080|NCT01892722|541361395|FG001|Overall Study|Administrative problems|1|||
150060081|NCT01892722|541361394|FG000|Overall Study|Patient/guardian decision|0|||
150060082|NCT01892722|541361395|FG001|Overall Study|Patient/guardian decision|2|||
150060083|NCT01892722|541361394|FG000|Overall Study|Physician Decision|1|||
150060084|NCT01892722|541361395|FG001|Overall Study|Physician Decision|2|||
150060085|NCT01892722|541361394|FG000|Overall Study|Adverse Event|3|||
150060086|NCT01892722|541361395|FG001|Overall Study|Adverse Event|2|||
150060087|NCT01892722|541361394|FG000|Overall Study|Lack of Efficacy|0|||
150060088|NCT01892722|541361395|FG001|Overall Study|Lack of Efficacy|7|||
150060089|NCT01892722|541361394|FG000|Overall Study|Withdrawal by Subject|3|||
150060090|NCT01892722|541361395|FG001|Overall Study|Withdrawal by Subject|5|||
150060091|NCT04153149|541361396|FG000|Double Blind Period|Death|63|||
150060092|NCT04153149|541361397|FG001|Double Blind Period|Death|49|||
150060093|NCT04153149|541361398|FG002|Double Blind Period|Death|0|||
150060094|NCT04153149|541361399|FG003|Double Blind Period|Death|0|||
150060095|NCT04153149|541361396|FG000|Double Blind Period|Withdrawal by Subject|16|||
150060096|NCT04153149|541361397|FG001|Double Blind Period|Withdrawal by Subject|11|||
150060097|NCT04153149|541361398|FG002|Double Blind Period|Withdrawal by Subject|0|||
150060098|NCT04153149|541361399|FG003|Double Blind Period|Withdrawal by Subject|0|||
150060099|NCT04153149|541361396|FG000|Double Blind Period|Adverse Event|6|||
150060100|NCT04153149|541361397|FG001|Double Blind Period|Adverse Event|2|||
150060101|NCT04153149|541361398|FG002|Double Blind Period|Adverse Event|0|||
150060102|NCT04153149|541361399|FG003|Double Blind Period|Adverse Event|0|||
150060103|NCT04153149|541361396|FG000|Double Blind Period|Lost to Follow-up|2|||
150060104|NCT04153149|541361397|FG001|Double Blind Period|Lost to Follow-up|1|||
150060105|NCT04153149|541361398|FG002|Double Blind Period|Lost to Follow-up|0|||
150060106|NCT04153149|541361399|FG003|Double Blind Period|Lost to Follow-up|0|||
150060107|NCT04153149|541361396|FG000|Double Blind Period|Withdrawal by guardian|0|||
150060108|NCT04153149|541361397|FG001|Double Blind Period|Withdrawal by guardian|2|||
150060109|NCT04153149|541361398|FG002|Double Blind Period|Withdrawal by guardian|0|||
150024073|NCT00404651|541223692|FG001|Overall Study|Withdrawal by Subject|12|||
150024074|NCT00404651|541223693|FG002|Overall Study|Withdrawal by Subject|16|||
150024075|NCT00404651|541223694|FG003|Overall Study|Withdrawal by Subject|6|||
150024076|NCT01132807|541223711|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
150024077|NCT01132807|541223712|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
150024078|NCT01132807|541223713|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
150024079|NCT01132807|541223711|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
150024080|NCT01132807|541223712|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
150024081|NCT01132807|541223713|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
150024082|NCT05030350|541223716|FG000|Overall Study|Adverse Event|13|||
150024083|NCT05030350|541223716|FG000|Overall Study|Lack of Efficacy|8|||
150024084|NCT05030350|541223716|FG000|Overall Study|Lost to Follow-up|35|||
150024085|NCT05030350|541223716|FG000|Overall Study|Pregnancy|2|||
150024086|NCT05030350|541223716|FG000|Overall Study|Protocol Violation|2|||
150024087|NCT05030350|541223716|FG000|Overall Study|Withdrawal by Subject|60|||
150024088|NCT05030350|541223716|FG000|Overall Study|Study terminated by sponsor|349|||
150024089|NCT05030350|541223716|FG000|Overall Study|Positive Drug Screen|4|||
150024090|NCT05030350|541223716|FG000|Overall Study|Other|8|||
150024091|NCT03654690|541223718|FG000|Overall Study|Withdrawal by Subject|1|||
150024092|NCT03654690|541223719|FG001|Overall Study|Withdrawal by Subject|0|||
150024093|NCT03654690|541223720|FG002|Overall Study|Withdrawal by Subject|0|||
150024094|NCT02711137|541223721|FG000|Overall Study|Death|1|||
150024095|NCT02711137|541223722|FG001|Overall Study|Death|4|||
150024096|NCT02711137|541223723|FG002|Overall Study|Death|5|||
150024097|NCT02711137|541223724|FG003|Overall Study|Death|5|||
150024098|NCT02711137|541223725|FG004|Overall Study|Death|3|||
150024099|NCT02711137|541223726|FG005|Overall Study|Death|1|||
150024100|NCT02711137|541223727|FG006|Overall Study|Death|61|||
150024101|NCT02711137|541223728|FG007|Overall Study|Death|3|||
150024102|NCT02711137|541223729|FG008|Overall Study|Death|0|||
150024103|NCT02711137|541223730|FG009|Overall Study|Death|1|||
150024104|NCT02711137|541223731|FG010|Overall Study|Death|1|||
150024105|NCT02711137|541223732|FG011|Overall Study|Death|1|||
150060110|NCT04153149|541361399|FG003|Double Blind Period|Withdrawal by guardian|0|||
150181812|NCT03398148|541804598|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150060111|NCT04153149|541361396|FG000|Double Blind Period|Reason Not Specified|5|||
150060112|NCT04153149|541361397|FG001|Double Blind Period|Reason Not Specified|4|||
150060113|NCT04153149|541361398|FG002|Double Blind Period|Reason Not Specified|0|||
150060114|NCT04153149|541361399|FG003|Double Blind Period|Reason Not Specified|0|||
150060115|NCT04153149|541361396|FG000|Double Blind Period|Physician Decision|2|||
150060116|NCT04153149|541361397|FG001|Double Blind Period|Physician Decision|0|||
150060117|NCT04153149|541361398|FG002|Double Blind Period|Physician Decision|0|||
150060118|NCT04153149|541361399|FG003|Double Blind Period|Physician Decision|0|||
150060119|NCT04153149|541361396|FG000|Open Label Extension Period|Death|0|||
150060120|NCT04153149|541361397|FG001|Open Label Extension Period|Death|0|||
150060121|NCT04153149|541361398|FG002|Open Label Extension Period|Death|7|||
150060122|NCT04153149|541361399|FG003|Open Label Extension Period|Death|3|||
150060123|NCT04153149|541361396|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
150060124|NCT04153149|541361397|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
150060125|NCT04153149|541361398|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
150060126|NCT04153149|541361399|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
150060127|NCT04153149|541361396|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
150060128|NCT04153149|541361397|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
150060129|NCT04153149|541361398|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
150060130|NCT04153149|541361399|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
150060131|NCT04153149|541361396|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
150060132|NCT04153149|541361397|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
150060133|NCT04153149|541361398|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
150060134|NCT04153149|541361399|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
150060135|NCT02003365|541361852|FG000|Overall Study|Lost to Follow-up|0|||
150060136|NCT02003365|541361853|FG001|Overall Study|Lost to Follow-up|0|||
150060137|NCT02003365|541361854|FG002|Overall Study|Lost to Follow-up|1|||
150060138|NCT00625742|541361855|FG000|Overall Study|Disease Progression|2|||
150060139|NCT00625742|541361855|FG000|Overall Study|Withdrawal by Subject|1|||
150060140|NCT00625742|541361855|FG000|Overall Study|Adverse Event|4|||
150060141|NCT00625742|541361855|FG000|Overall Study|Lost to Follow-up|4|||
150060142|NCT00625742|541361855|FG000|Overall Study|Ineligible|1|||
150060143|NCT02316548|541361856|FG000|Overall Study|Protocol Violation|0|||
150060144|NCT02316548|541361857|FG001|Overall Study|Protocol Violation|1|||
150060145|NCT00371761|541361858|FG000|Overall Study|Adverse Event|1|||
150060146|NCT00371761|541361859|FG001|Overall Study|Adverse Event|1|||
150060147|NCT00371761|541361858|FG000|Overall Study|Withdrawal by Subject|1|||
150060148|NCT00371761|541361859|FG001|Overall Study|Withdrawal by Subject|3|||
150060149|NCT00371761|541361858|FG000|Overall Study|Investigator Judgment|2|||
150060150|NCT00371761|541361859|FG001|Overall Study|Investigator Judgment|3|||
150060151|NCT00371761|541361858|FG000|Overall Study|Study termination|4|||
150060152|NCT00371761|541361859|FG001|Overall Study|Study termination|3|||
150060153|NCT05171816|541361863|FG000|Overall Study|Death|18|||
150060154|NCT05171816|541361864|FG001|Overall Study|Death|16|||
150060155|NCT02937571|541361865|FG000|Overall Study|Adverse Event|0|||
150060156|NCT02937571|541361866|FG001|Overall Study|Adverse Event|0|||
150060157|NCT02937571|541361867|FG002|Overall Study|Adverse Event|4|||
150060158|NCT02937571|541361865|FG000|Overall Study|Withdrawal by Subject|0|||
150060159|NCT02937571|541361866|FG001|Overall Study|Withdrawal by Subject|0|||
150060160|NCT02937571|541361867|FG002|Overall Study|Withdrawal by Subject|3|||
150060161|NCT03675321|541361868|FG000|Overall Study|Lack of Efficacy|2|||
150060162|NCT03675321|541361869|FG001|Overall Study|Lack of Efficacy|2|||
150060163|NCT03675321|541361868|FG000|Overall Study|Withdrawal by Subject|1|||
150060164|NCT03675321|541361869|FG001|Overall Study|Withdrawal by Subject|3|||
150060165|NCT04391569|541361870|FG000|Overall Study|Death|15|||
150060166|NCT04391569|541361871|FG001|Overall Study|Death|10|||
150060167|NCT04391569|541361870|FG000|Overall Study|Withdrawal by Subject|1|||
150060168|NCT04391569|541361871|FG001|Overall Study|Withdrawal by Subject|0|||
150060169|NCT04391569|541361870|FG000|Overall Study|Lost to Follow-up|3|||
150060170|NCT04391569|541361871|FG001|Overall Study|Lost to Follow-up|2|||
150060171|NCT04391569|541361870|FG000|Overall Study|Lack of Efficacy|0|||
150060172|NCT04391569|541361871|FG001|Overall Study|Lack of Efficacy|1|||
150060173|NCT04391569|541361870|FG000|Overall Study|Participant discharged to hospice facility|0|||
150060174|NCT04391569|541361871|FG001|Overall Study|Participant discharged to hospice facility|1|||
150181813|NCT03398148|541804599|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
150181814|NCT03398148|541804600|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
150060175|NCT04391569|541361870|FG000|Overall Study|Participant family decision|1|||
150060176|NCT04391569|541361871|FG001|Overall Study|Participant family decision|0|||
150060177|NCT04391569|541361870|FG000|Overall Study|Participant discharged prematurely|1|||
150060178|NCT04391569|541361871|FG001|Overall Study|Participant discharged prematurely|0|||
150060179|NCT00219544|541361892|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
150060180|NCT00219544|541361893|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
150060181|NCT00219544|541361892|FG000|Single Blind Treatment Period|Adverse Event|9|||
150060182|NCT00219544|541361893|FG001|Single Blind Treatment Period|Adverse Event|0|||
150060183|NCT00219544|541361892|FG000|Single Blind Treatment Period|Protocol Violation|4|||
150060184|NCT00219544|541361893|FG001|Single Blind Treatment Period|Protocol Violation|0|||
150060185|NCT00219544|541361892|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
150060186|NCT00219544|541361893|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
150060187|NCT00219544|541361892|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
150181815|NCT03398148|541804601|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150024106|NCT02711137|541223733|FG012|Overall Study|Death|0|||
150024107|NCT02711137|541223734|FG013|Overall Study|Death|0|||
150024108|NCT02711137|541223735|FG014|Overall Study|Death|0|||
150024109|NCT02711137|541223721|FG000|Overall Study|Study Terminated by Sponsor|0|||
150024110|NCT02711137|541223722|FG001|Overall Study|Study Terminated by Sponsor|0|||
150024111|NCT02711137|541223723|FG002|Overall Study|Study Terminated by Sponsor|1|||
150024112|NCT02711137|541223724|FG003|Overall Study|Study Terminated by Sponsor|0|||
150024113|NCT02711137|541223725|FG004|Overall Study|Study Terminated by Sponsor|0|||
150024114|NCT02711137|541223726|FG005|Overall Study|Study Terminated by Sponsor|0|||
150024115|NCT02711137|541223727|FG006|Overall Study|Study Terminated by Sponsor|1|||
150024116|NCT02711137|541223728|FG007|Overall Study|Study Terminated by Sponsor|0|||
150024117|NCT02711137|541223729|FG008|Overall Study|Study Terminated by Sponsor|0|||
150024118|NCT02711137|541223730|FG009|Overall Study|Study Terminated by Sponsor|0|||
150024119|NCT02711137|541223731|FG010|Overall Study|Study Terminated by Sponsor|0|||
150024120|NCT02711137|541223732|FG011|Overall Study|Study Terminated by Sponsor|0|||
150024121|NCT02711137|541223733|FG012|Overall Study|Study Terminated by Sponsor|0|||
150024122|NCT02711137|541223734|FG013|Overall Study|Study Terminated by Sponsor|0|||
150024123|NCT02711137|541223735|FG014|Overall Study|Study Terminated by Sponsor|0|||
150024124|NCT02711137|541223721|FG000|Overall Study|Physician Decision|1|||
150024125|NCT02711137|541223722|FG001|Overall Study|Physician Decision|0|||
150024126|NCT02711137|541223723|FG002|Overall Study|Physician Decision|2|||
150024127|NCT02711137|541223724|FG003|Overall Study|Physician Decision|1|||
150024128|NCT02711137|541223725|FG004|Overall Study|Physician Decision|1|||
150024129|NCT02711137|541223726|FG005|Overall Study|Physician Decision|0|||
150024130|NCT02711137|541223727|FG006|Overall Study|Physician Decision|12|||
150024131|NCT02711137|541223728|FG007|Overall Study|Physician Decision|2|||
150024132|NCT02711137|541223729|FG008|Overall Study|Physician Decision|1|||
150024133|NCT02711137|541223730|FG009|Overall Study|Physician Decision|1|||
150024134|NCT02711137|541223731|FG010|Overall Study|Physician Decision|3|||
150024135|NCT02711137|541223732|FG011|Overall Study|Physician Decision|2|||
150024136|NCT02711137|541223733|FG012|Overall Study|Physician Decision|1|||
150024137|NCT02711137|541223734|FG013|Overall Study|Physician Decision|1|||
150024138|NCT02711137|541223735|FG014|Overall Study|Physician Decision|2|||
150024139|NCT02711137|541223721|FG000|Overall Study|Other|0|||
150024140|NCT02711137|541223722|FG001|Overall Study|Other|1|||
150024141|NCT02711137|541223723|FG002|Overall Study|Other|0|||
150024142|NCT02711137|541223724|FG003|Overall Study|Other|0|||
150024143|NCT02711137|541223725|FG004|Overall Study|Other|0|||
150024144|NCT02711137|541223726|FG005|Overall Study|Other|0|||
150024145|NCT02711137|541223727|FG006|Overall Study|Other|3|||
150024146|NCT02711137|541223728|FG007|Overall Study|Other|0|||
150024147|NCT02711137|541223729|FG008|Overall Study|Other|0|||
150024148|NCT02711137|541223730|FG009|Overall Study|Other|0|||
150024149|NCT02711137|541223731|FG010|Overall Study|Other|0|||
150024150|NCT02711137|541223732|FG011|Overall Study|Other|0|||
150024151|NCT02711137|541223733|FG012|Overall Study|Other|0|||
150024152|NCT02711137|541223734|FG013|Overall Study|Other|0|||
150024153|NCT02711137|541223735|FG014|Overall Study|Other|1|||
150024154|NCT02711137|541223721|FG000|Overall Study|Withdrawal by Subject|1|||
150024155|NCT02711137|541223722|FG001|Overall Study|Withdrawal by Subject|0|||
150024156|NCT02711137|541223723|FG002|Overall Study|Withdrawal by Subject|0|||
150024157|NCT02711137|541223724|FG003|Overall Study|Withdrawal by Subject|1|||
150024158|NCT02711137|541223725|FG004|Overall Study|Withdrawal by Subject|1|||
150024159|NCT02711137|541223726|FG005|Overall Study|Withdrawal by Subject|0|||
150024160|NCT02711137|541223727|FG006|Overall Study|Withdrawal by Subject|7|||
150060188|NCT00219544|541361893|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
150181816|NCT03398148|541804602|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150024161|NCT02711137|541223728|FG007|Overall Study|Withdrawal by Subject|0|||
150024162|NCT02711137|541223729|FG008|Overall Study|Withdrawal by Subject|0|||
150024163|NCT02711137|541223730|FG009|Overall Study|Withdrawal by Subject|0|||
150024164|NCT02711137|541223731|FG010|Overall Study|Withdrawal by Subject|0|||
150024165|NCT02711137|541223732|FG011|Overall Study|Withdrawal by Subject|0|||
150024166|NCT02711137|541223733|FG012|Overall Study|Withdrawal by Subject|0|||
150024167|NCT02711137|541223734|FG013|Overall Study|Withdrawal by Subject|1|||
150024168|NCT02711137|541223735|FG014|Overall Study|Withdrawal by Subject|0|||
150024169|NCT02711137|541223721|FG000|Overall Study|Lost to Follow-up|1|||
150024170|NCT02711137|541223722|FG001|Overall Study|Lost to Follow-up|0|||
150024171|NCT02711137|541223723|FG002|Overall Study|Lost to Follow-up|0|||
150024172|NCT02711137|541223724|FG003|Overall Study|Lost to Follow-up|0|||
150024173|NCT02711137|541223725|FG004|Overall Study|Lost to Follow-up|0|||
150024174|NCT02711137|541223726|FG005|Overall Study|Lost to Follow-up|0|||
150024175|NCT02711137|541223727|FG006|Overall Study|Lost to Follow-up|2|||
150024176|NCT02711137|541223728|FG007|Overall Study|Lost to Follow-up|0|||
150024177|NCT02711137|541223729|FG008|Overall Study|Lost to Follow-up|0|||
150024178|NCT02711137|541223730|FG009|Overall Study|Lost to Follow-up|0|||
150024179|NCT02711137|541223731|FG010|Overall Study|Lost to Follow-up|0|||
150024180|NCT02711137|541223732|FG011|Overall Study|Lost to Follow-up|0|||
150024181|NCT02711137|541223733|FG012|Overall Study|Lost to Follow-up|0|||
150024182|NCT02711137|541223734|FG013|Overall Study|Lost to Follow-up|0|||
150024183|NCT02711137|541223735|FG014|Overall Study|Lost to Follow-up|0|||
150024184|NCT03922581|541223742|FG000|Overall Study|Lost to Follow-up|20|||
150024185|NCT03922581|541223743|FG001|Overall Study|Lost to Follow-up|9|||
150024186|NCT03922581|541223742|FG000|Overall Study|Physician Decision|1|||
150024187|NCT03922581|541223743|FG001|Overall Study|Physician Decision|1|||
150024188|NCT03922581|541223742|FG000|Overall Study|Withdrawal by Subject|1|||
150024189|NCT03922581|541223743|FG001|Overall Study|Withdrawal by Subject|0|||
150024190|NCT01508312|541223749|FG000|Overall Study|Lost to Follow-up|1|||
150024191|NCT01508312|541223750|FG001|Overall Study|Lost to Follow-up|0|||
150024192|NCT01508312|541223751|FG002|Overall Study|Lost to Follow-up|0|||
150024193|NCT01508312|541223752|FG003|Overall Study|Lost to Follow-up|0|||
150024194|NCT01508312|541223749|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
150024195|NCT01508312|541223750|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
150024196|NCT01508312|541223751|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
150024197|NCT01508312|541223752|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
150024198|NCT01508312|541223749|FG000|Overall Study|Adverse Event|0|||
150024199|NCT01508312|541223750|FG001|Overall Study|Adverse Event|0|||
150024200|NCT01508312|541223751|FG002|Overall Study|Adverse Event|2|||
150024201|NCT01508312|541223752|FG003|Overall Study|Adverse Event|0|||
150024202|NCT01508312|541223749|FG000|Overall Study|Lack of Efficacy|0|||
150024203|NCT01508312|541223750|FG001|Overall Study|Lack of Efficacy|0|||
150024204|NCT01508312|541223751|FG002|Overall Study|Lack of Efficacy|1|||
150024205|NCT01508312|541223752|FG003|Overall Study|Lack of Efficacy|0|||
150024206|NCT01508312|541223749|FG000|Overall Study|Withdrawal by Subject|0|||
150024207|NCT01508312|541223750|FG001|Overall Study|Withdrawal by Subject|0|||
150024208|NCT01508312|541223751|FG002|Overall Study|Withdrawal by Subject|1|||
150024209|NCT01508312|541223752|FG003|Overall Study|Withdrawal by Subject|0|||
150024210|NCT02223715|541223753|FG000|Overall Study|Death|31|||
150024211|NCT02223715|541223753|FG000|Overall Study|Lost to Follow-up|73|||
150024212|NCT02222558|541223754|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
150024213|NCT02222558|541223755|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
150024214|NCT02222558|541223756|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
150024215|NCT02222558|541223757|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
150024216|NCT02222558|541223758|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
150024217|NCT02222558|541223759|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
150024218|NCT02222558|541223754|FG000|Period 3|Withdrawal by Subject|0|||
150024219|NCT02222558|541223755|FG001|Period 3|Withdrawal by Subject|0|||
150024220|NCT02222558|541223756|FG002|Period 3|Withdrawal by Subject|0|||
150024221|NCT02222558|541223757|FG003|Period 3|Withdrawal by Subject|0|||
150024222|NCT02222558|541223758|FG004|Period 3|Withdrawal by Subject|0|||
150024223|NCT02222558|541223759|FG005|Period 3|Withdrawal by Subject|1|||
150024224|NCT01745367|541223760|FG000|Overall Study|Death|1|||
150024225|NCT01745367|541223761|FG001|Overall Study|Death|0|||
150024226|NCT01745367|541223760|FG000|Overall Study|Withdrawal by Subject|1|||
150024227|NCT01745367|541223761|FG001|Overall Study|Withdrawal by Subject|2|||
150024228|NCT01745367|541223760|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
150024229|NCT01745367|541223761|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
150024230|NCT01745367|541223760|FG000|Overall Study|Other Reasons Unspecified|0|||
150024231|NCT01745367|541223761|FG001|Overall Study|Other Reasons Unspecified|2|||
150024232|NCT02322281|541223764|FG000|Overall Study|Progressive Disease|42|||
150024233|NCT02322281|541223765|FG001|Overall Study|Progressive Disease|14|||
150024234|NCT02322281|541223766|FG002|Overall Study|Progressive Disease|49|||
150024235|NCT02322281|541223764|FG000|Overall Study|Adverse Event|3|||
150024236|NCT02322281|541223765|FG001|Overall Study|Adverse Event|4|||
150024237|NCT02322281|541223766|FG002|Overall Study|Adverse Event|6|||
150024238|NCT02322281|541223764|FG000|Overall Study|Death|3|||
150024239|NCT02322281|541223765|FG001|Overall Study|Death|3|||
150024240|NCT02322281|541223766|FG002|Overall Study|Death|3|||
150024241|NCT02322281|541223764|FG000|Overall Study|Withdrawal by Subject|1|||
150024242|NCT02322281|541223765|FG001|Overall Study|Withdrawal by Subject|1|||
150024243|NCT02322281|541223766|FG002|Overall Study|Withdrawal by Subject|6|||
150024244|NCT02322281|541223764|FG000|Overall Study|Physician Decision|2|||
150024245|NCT02322281|541223765|FG001|Overall Study|Physician Decision|0|||
150024246|NCT02322281|541223766|FG002|Overall Study|Physician Decision|5|||
150024247|NCT02322281|541223764|FG000|Overall Study|Study Terminated by Sponsor|2|||
150024248|NCT02322281|541223765|FG001|Overall Study|Study Terminated by Sponsor|0|||
150024249|NCT02322281|541223766|FG002|Overall Study|Study Terminated by Sponsor|0|||
150024250|NCT02322281|541223764|FG000|Overall Study|Missing|0|||
150024251|NCT02322281|541223765|FG001|Overall Study|Missing|0|||
150024252|NCT02322281|541223766|FG002|Overall Study|Missing|1|||
150024253|NCT02322281|541223764|FG000|Overall Study|Miscellaneous|0|||
150024254|NCT02322281|541223765|FG001|Overall Study|Miscellaneous|0|||
150024255|NCT02322281|541223766|FG002|Overall Study|Miscellaneous|4|||
150024256|NCT00936702|541223773|FG000|Overall Study|Disease progression|34|||
150024257|NCT00936702|541223773|FG000|Overall Study|Adverse Event|8|||
150024258|NCT00936702|541223773|FG000|Overall Study|Withdrawal by Subject|2|||
150024259|NCT00936702|541223773|FG000|Overall Study|Alternative Treatment|1|||
150024260|NCT00936702|541223773|FG000|Overall Study|Other|1|||
150024261|NCT00354679|541223778|FG000|Overall Study|Patient Not Treated|1|||
150024262|NCT03456076|541223779|FG000|Overall Study|Withdrawal by Subject|5|||
150024263|NCT03456076|541223780|FG001|Overall Study|Withdrawal by Subject|9|||
150024264|NCT03456076|541223779|FG000|Overall Study|Protocol deviation|0|||
150024265|NCT03456076|541223780|FG001|Overall Study|Protocol deviation|1|||
150024266|NCT03456076|541223779|FG000|Overall Study|Lost to Follow-up|0|||
150024267|NCT03456076|541223780|FG001|Overall Study|Lost to Follow-up|1|||
150024268|NCT03456076|541223779|FG000|Overall Study|Death|2|||
150024269|NCT03456076|541223780|FG001|Overall Study|Death|5|||
150024270|NCT03456076|541223779|FG000|Overall Study|Study ongoing|123|||
150024271|NCT03456076|541223780|FG001|Overall Study|Study ongoing|111|||
150024272|NCT00466440|541223781|FG000|Overall Study|Adverse Event|0|||
150024273|NCT00466440|541223782|FG001|Overall Study|Adverse Event|3|||
150024274|NCT00466440|541223783|FG002|Overall Study|Adverse Event|1|||
150024275|NCT00466440|541223781|FG000|Overall Study|Death|1|||
150024276|NCT00466440|541223782|FG001|Overall Study|Death|1|||
150024277|NCT00466440|541223783|FG002|Overall Study|Death|0|||
150024278|NCT00466440|541223781|FG000|Overall Study|Progressive disease|13|||
150024279|NCT00466440|541223782|FG001|Overall Study|Progressive disease|5|||
150024280|NCT00466440|541223783|FG002|Overall Study|Progressive disease|4|||
150024281|NCT00466440|541223781|FG000|Overall Study|Lost to Follow-up|0|||
150024282|NCT00466440|541223782|FG001|Overall Study|Lost to Follow-up|1|||
150060189|NCT00219544|541361892|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
150060190|NCT00219544|541361893|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
150060191|NCT01163032|541361894|FG000|Randomization Phase|Withdrawal by Subject|2|||
150060192|NCT01163032|541361895|FG001|Randomization Phase|Withdrawal by Subject|3|||
150060193|NCT01163032|541361896|FG002|Randomization Phase|Withdrawal by Subject|0|||
150060194|NCT01163032|541361894|FG000|Randomization Phase|Adverse Event|3|||
150060195|NCT01163032|541361895|FG001|Randomization Phase|Adverse Event|3|||
150060196|NCT01163032|541361896|FG002|Randomization Phase|Adverse Event|0|||
150060197|NCT01163032|541361894|FG000|Randomization Phase|Protocol Violation|0|||
150060198|NCT01163032|541361895|FG001|Randomization Phase|Protocol Violation|1|||
150060199|NCT01163032|541361896|FG002|Randomization Phase|Protocol Violation|0|||
150060200|NCT01163032|541361894|FG000|Randomization Phase|Various*|5|||
150060201|NCT01163032|541361895|FG001|Randomization Phase|Various*|4|||
150060202|NCT01163032|541361896|FG002|Randomization Phase|Various*|0|||
150060203|NCT01163032|541361894|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
150060204|NCT01163032|541361895|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
150060205|NCT01163032|541361896|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
150060206|NCT01163032|541361894|FG000|Open Label Extension Phase|Adverse Event|0|||
150060207|NCT01163032|541361895|FG001|Open Label Extension Phase|Adverse Event|0|||
150060208|NCT01163032|541361896|FG002|Open Label Extension Phase|Adverse Event|3|||
150060209|NCT01163032|541361894|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
150060210|NCT01163032|541361895|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
150060211|NCT01163032|541361896|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
150060212|NCT01163032|541361894|FG000|Open Label Extension Phase|Protocol Violation|0|||
150060213|NCT01163032|541361895|FG001|Open Label Extension Phase|Protocol Violation|0|||
150060214|NCT01163032|541361896|FG002|Open Label Extension Phase|Protocol Violation|1|||
150060215|NCT01163032|541361894|FG000|Open Label Extension Phase|Study Termination|0|||
150060216|NCT01163032|541361895|FG001|Open Label Extension Phase|Study Termination|0|||
150060217|NCT01163032|541361896|FG002|Open Label Extension Phase|Study Termination|7|||
150060218|NCT01163032|541361894|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
150060219|NCT01163032|541361895|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
150060220|NCT01163032|541361896|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
150060221|NCT04030026|541361903|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
150060222|NCT04030026|541361904|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
150060223|NCT04030026|541361903|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
150060224|NCT04030026|541361904|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
150060225|NCT04030026|541361903|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
150060226|NCT04030026|541361904|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
150060227|NCT04030026|541361903|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
150060228|NCT04030026|541361904|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
150060229|NCT04030026|541361903|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
150060230|NCT04030026|541361904|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
150060231|NCT04030026|541361903|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
150060232|NCT04030026|541361904|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
150060233|NCT04030026|541361903|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
150060234|NCT04030026|541361904|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
150060235|NCT03764033|541361906|FG000|Treatment Phase|Withdrawal by Subject|8|||
150060236|NCT03764033|541361907|FG001|Treatment Phase|Withdrawal by Subject|3|||
150060237|NCT03764033|541361906|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
150060238|NCT03764033|541361907|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
150060239|NCT03764033|541361906|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
150060240|NCT03764033|541361907|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
150060241|NCT05856760|541361908|FG000|Overall Study|Adverse Event|2|||
150060242|NCT05856760|541361908|FG000|Overall Study|Physician Decision|1|||
150060243|NCT05856760|541361908|FG000|Overall Study|Protocol Violation|1|||
150060244|NCT05856760|541361908|FG000|Overall Study|Withdrawal by Subject|3|||
150060245|NCT02477696|541361911|FG000|Overall Study|Death|89|||
150060246|NCT02477696|541361912|FG001|Overall Study|Death|106|||
150060247|NCT02477696|541361911|FG000|Overall Study|Lost to Follow-up|7|||
150060248|NCT02477696|541361912|FG001|Overall Study|Lost to Follow-up|5|||
150060249|NCT02477696|541361911|FG000|Overall Study|Withdrawal by Subject|37|||
150060250|NCT02477696|541361912|FG001|Overall Study|Withdrawal by Subject|34|||
150060251|NCT02477696|541361911|FG000|Overall Study|Physician Decision|7|||
150060252|NCT02477696|541361912|FG001|Overall Study|Physician Decision|9|||
150060253|NCT02477696|541361911|FG000|Overall Study|Study terminated by sponsor|103|||
150060254|NCT02477696|541361912|FG001|Overall Study|Study terminated by sponsor|99|||
150060255|NCT02477696|541361911|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
150060256|NCT02477696|541361912|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
150060257|NCT02477696|541361911|FG000|Overall Study|Missing/Unknown|2|||
150060258|NCT02477696|541361912|FG001|Overall Study|Missing/Unknown|0|||
150060259|NCT02278341|541363131|FG000|Overall Study|Randomized but never received study drug|1|||
150024283|NCT00466440|541223783|FG002|Overall Study|Lost to Follow-up|0|||
150024284|NCT00466440|541223781|FG000|Overall Study|Physician Decision|0|||
150024285|NCT00466440|541223782|FG001|Overall Study|Physician Decision|1|||
150024286|NCT00466440|541223783|FG002|Overall Study|Physician Decision|2|||
150024287|NCT00466440|541223781|FG000|Overall Study|Protocol entry criteria not met|0|||
150024288|NCT00466440|541223782|FG001|Overall Study|Protocol entry criteria not met|0|||
150024289|NCT00466440|541223783|FG002|Overall Study|Protocol entry criteria not met|4|||
150024290|NCT00466440|541223781|FG000|Overall Study|Withdrawal by Subject|0|||
150024291|NCT00466440|541223782|FG001|Overall Study|Withdrawal by Subject|1|||
150024292|NCT00466440|541223783|FG002|Overall Study|Withdrawal by Subject|0|||
150024293|NCT00466440|541223781|FG000|Overall Study|Sponsor decision|0|||
150024294|NCT00466440|541223782|FG001|Overall Study|Sponsor decision|0|||
150024295|NCT00466440|541223783|FG002|Overall Study|Sponsor decision|1|||
150024296|NCT03187132|541223786|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
150024297|NCT03187132|541223787|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
150024298|NCT03187132|541223786|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
150024299|NCT03187132|541223787|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
150024300|NCT03187132|541223786|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
150024301|NCT03187132|541223787|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
150024302|NCT03187132|541223786|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
150024303|NCT03187132|541223787|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
150024304|NCT03187132|541223786|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
150024305|NCT03187132|541223787|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
150024306|NCT03187132|541223786|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
150024307|NCT03187132|541223787|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
150024308|NCT03187132|541223786|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
150024309|NCT03187132|541223787|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
150024310|NCT03187132|541223786|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
150024311|NCT03187132|541223787|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
150024312|NCT03187132|541223786|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
150024313|NCT03187132|541223787|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
150024314|NCT03187132|541223786|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
150024315|NCT03187132|541223787|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
150024316|NCT03187132|541223786|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
150024317|NCT03187132|541223787|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
150024318|NCT01020786|541223792|FG000|Induction Period|Entry Criteria Not Met|2|||
150024319|NCT01020786|541223792|FG000|Induction Period|Adverse Event|10|||
150024320|NCT01020786|541223792|FG000|Induction Period|Progressive Disease|31|||
150024321|NCT01020786|541223792|FG000|Induction Period|Investigator Decision|3|||
150024322|NCT01020786|541223792|FG000|Induction Period|Withdrawal by Subject|3|||
150024323|NCT01020786|541223792|FG000|Maintenance Period|Adverse Event|8|||
150024324|NCT01020786|541223792|FG000|Maintenance Period|Progressive Disease|43|||
150024325|NCT01020786|541223792|FG000|Maintenance Period|Withdrawal by Subject|8|||
150024326|NCT01020786|541223792|FG000|Maintenance Period|Sponsor Decision|1|||
150024327|NCT01358825|541223803|FG000|Overall Study|Blood sample not drawn|0|||
150024328|NCT01358825|541223804|FG001|Overall Study|Blood sample not drawn|1|||
150024329|NCT00113841|541223805|FG000|Overall Study|Disease progression|0|||
150024330|NCT00113841|541223806|FG001|Overall Study|Disease progression|2|||
150024331|NCT00113841|541223805|FG000|Overall Study|Non-compliant|1|||
150024332|NCT00113841|541223806|FG001|Overall Study|Non-compliant|0|||
150024333|NCT02366195|541223807|FG000|Overall Study|Protocol-specified criteria|3|||
150024334|NCT02366195|541223807|FG000|Overall Study|Withdrawal by Subject|9|||
150024335|NCT02366195|541223807|FG000|Overall Study|Lost to Follow-up|1|||
150024336|NCT02366195|541223807|FG000|Overall Study|Death|41|||
150024337|NCT01076959|541223808|FG000|Overall Study|Adverse Event|767|||
150024338|NCT01076959|541223808|FG000|Overall Study|Lack of Efficacy|849|||
150024339|NCT01076959|541223808|FG000|Overall Study|Non-compliance|274|||
150024340|NCT01076959|541223808|FG000|Overall Study|Lost to Follow-up|241|||
150024341|NCT01076959|541223808|FG000|Overall Study|Other|119|||
150024342|NCT02452424|541223809|FG000|Overall Study|Death|2|||
150024343|NCT02452424|541223810|FG001|Overall Study|Death|2|||
150024344|NCT02452424|541223811|FG002|Overall Study|Death|2|||
150024345|NCT02452424|541223812|FG003|Overall Study|Death|6|||
150024346|NCT02452424|541223813|FG004|Overall Study|Death|2|||
150024347|NCT02452424|541223814|FG005|Overall Study|Death|0|||
150024348|NCT02452424|541223815|FG006|Overall Study|Death|5|||
150024349|NCT02452424|541223816|FG007|Overall Study|Death|1|||
150024350|NCT02452424|541223817|FG008|Overall Study|Death|3|||
150024351|NCT02452424|541223818|FG009|Overall Study|Death|1|||
150024352|NCT02452424|541223819|FG010|Overall Study|Death|0|||
150024353|NCT02452424|541223809|FG000|Overall Study|Lost to Follow-up|0|||
150024354|NCT02452424|541223810|FG001|Overall Study|Lost to Follow-up|1|||
150024355|NCT02452424|541223811|FG002|Overall Study|Lost to Follow-up|1|||
150024356|NCT02452424|541223812|FG003|Overall Study|Lost to Follow-up|0|||
150024357|NCT02452424|541223813|FG004|Overall Study|Lost to Follow-up|0|||
150060260|NCT02278341|541363132|FG001|Overall Study|Randomized but never received study drug|1|||
150060261|NCT02278341|541363131|FG000|Overall Study|Adverse Event|3|||
150060262|NCT02278341|541363132|FG001|Overall Study|Adverse Event|0|||
150060263|NCT02278341|541363131|FG000|Overall Study|Death|68|||
150060264|NCT02278341|541363132|FG001|Overall Study|Death|56|||
150060265|NCT02278341|541363131|FG000|Overall Study|Withdrawal by Subject|30|||
150060266|NCT02278341|541363132|FG001|Overall Study|Withdrawal by Subject|19|||
150060267|NCT02278341|541363131|FG000|Overall Study|Lost to Follow-up|0|||
150060268|NCT02278341|541363132|FG001|Overall Study|Lost to Follow-up|1|||
150060269|NCT02278341|541363131|FG000|Overall Study|Physician Decision|1|||
150060270|NCT02278341|541363132|FG001|Overall Study|Physician Decision|1|||
150060271|NCT02278341|541363131|FG000|Overall Study|Miscellaneous|15|||
150060272|NCT02278341|541363132|FG001|Overall Study|Miscellaneous|14|||
150060273|NCT04902326|541363133|FG000|Overall Study|Withdrawal by Subject|1|||
150060274|NCT04902326|541363134|FG001|Overall Study|Withdrawal by Subject|3|||
150060275|NCT04902326|541363135|FG002|Overall Study|Withdrawal by Subject|0|||
150060276|NCT04902326|541363136|FG003|Overall Study|Withdrawal by Subject|1|||
150060277|NCT04902326|541363133|FG000|Overall Study|Lost to Follow-up|14|||
150060278|NCT04902326|541363134|FG001|Overall Study|Lost to Follow-up|14|||
150060279|NCT04902326|541363135|FG002|Overall Study|Lost to Follow-up|14|||
150060280|NCT04902326|541363136|FG003|Overall Study|Lost to Follow-up|6|||
150060281|NCT01487577|541363138|FG000|Overall Study|Became ineligible after signing consent|1|||
150060282|NCT01479985|541363142|FG000|Overall Study|Tablet malfunction, no data saved|1|||
150060283|NCT01479985|541363143|FG001|Overall Study|Tablet malfunction, no data saved|1|||
150060284|NCT01479985|541363142|FG000|Overall Study|No decisional conflict scale responses|0|||
150060285|NCT01479985|541363143|FG001|Overall Study|No decisional conflict scale responses|2|||
150060286|NCT01479985|541363142|FG000|Overall Study|No post-visit survey|5|||
150060287|NCT01479985|541363143|FG001|Overall Study|No post-visit survey|3|||
150060288|NCT01653782|541363144|FG000|Overall Study|Withdrawal by Subject|9|||
150060289|NCT01653782|541363145|FG001|Overall Study|Withdrawal by Subject|15|||
150060290|NCT01653782|541363146|FG002|Overall Study|Withdrawal by Subject|4|||
150060291|NCT01653782|541363144|FG000|Overall Study|Lost to Follow-up|7|||
150060292|NCT01653782|541363145|FG001|Overall Study|Lost to Follow-up|3|||
150060293|NCT01653782|541363146|FG002|Overall Study|Lost to Follow-up|2|||
150060294|NCT01155479|541363152|FG000|Part I|Adverse Event|13|||
150060295|NCT01155479|541363153|FG001|Part I|Adverse Event|8|||
150060296|NCT01155479|541363154|FG002|Part I|Adverse Event|18|||
150060297|NCT01155479|541363155|FG003|Part I|Adverse Event|7|||
150060298|NCT01155479|541363156|FG004|Part I|Adverse Event|6|||
150060299|NCT01155479|541363152|FG000|Part I|Administrative|2|||
150060300|NCT01155479|541363153|FG001|Part I|Administrative|2|||
150060301|NCT01155479|541363154|FG002|Part I|Administrative|2|||
150060302|NCT01155479|541363155|FG003|Part I|Administrative|0|||
150060303|NCT01155479|541363156|FG004|Part I|Administrative|0|||
150060304|NCT01155479|541363152|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
150060305|NCT01155479|541363153|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
150060306|NCT01155479|541363154|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
150060307|NCT01155479|541363155|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
150060308|NCT01155479|541363156|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
150060309|NCT01155479|541363152|FG000|Part I|Withdrawal by Subject|11|||
150060310|NCT01155479|541363153|FG001|Part I|Withdrawal by Subject|13|||
150060311|NCT01155479|541363154|FG002|Part I|Withdrawal by Subject|8|||
150060312|NCT01155479|541363155|FG003|Part I|Withdrawal by Subject|8|||
150060313|NCT01155479|541363156|FG004|Part I|Withdrawal by Subject|9|||
150060314|NCT01155479|541363152|FG000|Part I|Lost to Follow-up|0|||
150060315|NCT01155479|541363153|FG001|Part I|Lost to Follow-up|0|||
150060316|NCT01155479|541363154|FG002|Part I|Lost to Follow-up|1|||
150060317|NCT01155479|541363155|FG003|Part I|Lost to Follow-up|1|||
150060318|NCT01155479|541363156|FG004|Part I|Lost to Follow-up|0|||
150060319|NCT01155479|541363152|FG000|Part I|Treatment Failure|3|||
150060320|NCT01155479|541363153|FG001|Part I|Treatment Failure|0|||
150060321|NCT01155479|541363154|FG002|Part I|Treatment Failure|3|||
150060322|NCT01155479|541363155|FG003|Part I|Treatment Failure|1|||
150060323|NCT01155479|541363156|FG004|Part I|Treatment Failure|2|||
150060324|NCT01155479|541363152|FG000|Part I|Did Not Receive Treatment|4|||
150060325|NCT01155479|541363153|FG001|Part I|Did Not Receive Treatment|2|||
150060326|NCT01155479|541363154|FG002|Part I|Did Not Receive Treatment|2|||
150060327|NCT01155479|541363155|FG003|Part I|Did Not Receive Treatment|6|||
150060328|NCT01155479|541363156|FG004|Part I|Did Not Receive Treatment|1|||
150060329|NCT01155479|541363152|FG000|Part I|Non-Compliance with Protocol|2|||
150060330|NCT01155479|541363153|FG001|Part I|Non-Compliance with Protocol|1|||
150060331|NCT01155479|541363154|FG002|Part I|Non-Compliance with Protocol|3|||
150060332|NCT01155479|541363155|FG003|Part I|Non-Compliance with Protocol|3|||
150060333|NCT01155479|541363156|FG004|Part I|Non-Compliance with Protocol|2|||
150060334|NCT01155479|541363152|FG000|Part II|Adverse Event|7|||
150060335|NCT01155479|541363153|FG001|Part II|Adverse Event|6|||
150060336|NCT01155479|541363154|FG002|Part II|Adverse Event|8|||
150060337|NCT01155479|541363155|FG003|Part II|Adverse Event|3|||
150060338|NCT01155479|541363156|FG004|Part II|Adverse Event|4|||
150060339|NCT01155479|541363152|FG000|Part II|Administrative|43|||
150060340|NCT01155479|541363153|FG001|Part II|Administrative|49|||
150060341|NCT01155479|541363154|FG002|Part II|Administrative|36|||
150060342|NCT01155479|541363155|FG003|Part II|Administrative|38|||
150060343|NCT01155479|541363156|FG004|Part II|Administrative|46|||
150060344|NCT01155479|541363152|FG000|Part II|Withdrawal by Subject|8|||
150060345|NCT01155479|541363153|FG001|Part II|Withdrawal by Subject|4|||
150060346|NCT01155479|541363154|FG002|Part II|Withdrawal by Subject|12|||
150060347|NCT01155479|541363155|FG003|Part II|Withdrawal by Subject|7|||
150060348|NCT01155479|541363156|FG004|Part II|Withdrawal by Subject|3|||
150060349|NCT01155479|541363152|FG000|Part II|Lost to Follow-up|1|||
150060350|NCT01155479|541363153|FG001|Part II|Lost to Follow-up|0|||
150060351|NCT01155479|541363154|FG002|Part II|Lost to Follow-up|0|||
150060352|NCT01155479|541363155|FG003|Part II|Lost to Follow-up|0|||
150060353|NCT01155479|541363156|FG004|Part II|Lost to Follow-up|1|||
150060354|NCT01155479|541363152|FG000|Part II|Treatment Failure|0|||
150060355|NCT01155479|541363153|FG001|Part II|Treatment Failure|1|||
150060356|NCT01155479|541363154|FG002|Part II|Treatment Failure|2|||
150060357|NCT01155479|541363155|FG003|Part II|Treatment Failure|0|||
150060358|NCT01155479|541363156|FG004|Part II|Treatment Failure|1|||
150060359|NCT01155479|541363152|FG000|Part II|Non-Compliance with Protocol|0|||
150060360|NCT01155479|541363153|FG001|Part II|Non-Compliance with Protocol|1|||
150060361|NCT01155479|541363154|FG002|Part II|Non-Compliance with Protocol|0|||
150060362|NCT01155479|541363155|FG003|Part II|Non-Compliance with Protocol|2|||
150060363|NCT01155479|541363156|FG004|Part II|Non-Compliance with Protocol|0|||
150060364|NCT02360605|541363157|FG000|Overall Study|Withdrawal by Subject|4|||
150060365|NCT02360605|541363158|FG001|Overall Study|Withdrawal by Subject|9|||
150060366|NCT02360605|541363157|FG000|Overall Study|Lost to Follow-up|7|||
150060367|NCT02360605|541363158|FG001|Overall Study|Lost to Follow-up|8|||
150060368|NCT02360605|541363157|FG000|Overall Study|Death|0|||
150060369|NCT02360605|541363158|FG001|Overall Study|Death|1|||
150060370|NCT05867342|541363161|FG000|Overall Study|Investigator Decision|3|||
150060371|NCT05867342|541363162|FG001|Overall Study|Investigator Decision|3|||
150060372|NCT01721577|541363163|FG000|Overall Study|Lack of Efficacy|1|||
150060373|NCT01721577|541363164|FG001|Overall Study|Lack of Efficacy|0|||
150060374|NCT01721577|541363163|FG000|Overall Study|Death|1|||
150060375|NCT01721577|541363164|FG001|Overall Study|Death|0|||
150060376|NCT01721577|541363163|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
150060377|NCT01721577|541363164|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
150060378|NCT01721577|541363163|FG000|Overall Study|Adverse Event|0|||
150060379|NCT01721577|541363164|FG001|Overall Study|Adverse Event|2|||
150060380|NCT02497976|541363165|FG000|Overall Study|Withdrawal by Subject|2|||
150060381|NCT02497976|541363166|FG001|Overall Study|Withdrawal by Subject|0|||
150060382|NCT02497976|541363165|FG000|Overall Study|Moved out of area|0|||
150060383|NCT02497976|541363166|FG001|Overall Study|Moved out of area|1|||
150060384|NCT01903525|541363170|FG000|Overall Study|Lost to Follow-up|5|||
150060385|NCT01903525|541363171|FG001|Overall Study|Lost to Follow-up|9|||
150060386|NCT01903525|541363170|FG000|Overall Study|Adverse Event|0|||
150060387|NCT01903525|541363171|FG001|Overall Study|Adverse Event|1|||
150060388|NCT03977454|541363172|FG000|Overall Study|immediate postoperative revision|2|||
150060389|NCT03977454|541363173|FG001|Overall Study|immediate postoperative revision|2|||
150060390|NCT04365257|541363174|FG000|Overall Study|Physician Decision|1|||
150060391|NCT04365257|541363175|FG001|Overall Study|Physician Decision|0|||
150060392|NCT04365257|541363174|FG000|Overall Study|Patient Noncompliance|1|||
150060393|NCT04365257|541363175|FG001|Overall Study|Patient Noncompliance|0|||
150060394|NCT04365257|541363174|FG000|Overall Study|Withdrawal by Subject|0|||
150060395|NCT04365257|541363175|FG001|Overall Study|Withdrawal by Subject|1|||
150060396|NCT02129777|541363176|FG000|Double-Blind Period|Adverse Event|0|||
150060397|NCT02129777|541363177|FG001|Double-Blind Period|Adverse Event|0|||
150060398|NCT02129777|541363178|FG002|Double-Blind Period|Adverse Event|0|||
150060399|NCT02129777|541363179|FG003|Double-Blind Period|Adverse Event|0|||
150060400|NCT02129777|541363180|FG004|Double-Blind Period|Adverse Event|1|||
150060401|NCT02129777|541363181|FG005|Double-Blind Period|Adverse Event|0|||
150060402|NCT02129777|541363182|FG006|Double-Blind Period|Adverse Event|0|||
150060403|NCT02129777|541363176|FG000|Double-Blind Period|Lost to Follow-up|1|||
150060404|NCT02129777|541363177|FG001|Double-Blind Period|Lost to Follow-up|1|||
150060405|NCT02129777|541363178|FG002|Double-Blind Period|Lost to Follow-up|1|||
150060406|NCT02129777|541363179|FG003|Double-Blind Period|Lost to Follow-up|2|||
150060407|NCT02129777|541363180|FG004|Double-Blind Period|Lost to Follow-up|0|||
150060408|NCT02129777|541363181|FG005|Double-Blind Period|Lost to Follow-up|0|||
150060409|NCT02129777|541363182|FG006|Double-Blind Period|Lost to Follow-up|0|||
150060410|NCT02129777|541363176|FG000|Double-Blind Period|Withdrawal by Subject|2|||
150060411|NCT02129777|541363177|FG001|Double-Blind Period|Withdrawal by Subject|4|||
150060412|NCT02129777|541363178|FG002|Double-Blind Period|Withdrawal by Subject|3|||
150060413|NCT02129777|541363179|FG003|Double-Blind Period|Withdrawal by Subject|2|||
150060414|NCT02129777|541363180|FG004|Double-Blind Period|Withdrawal by Subject|3|||
150060415|NCT02129777|541363181|FG005|Double-Blind Period|Withdrawal by Subject|0|||
150060416|NCT02129777|541363182|FG006|Double-Blind Period|Withdrawal by Subject|0|||
150060417|NCT02129777|541363176|FG000|Double-Blind Period|Pregnancy|0|||
150060418|NCT02129777|541363177|FG001|Double-Blind Period|Pregnancy|0|||
150060419|NCT02129777|541363178|FG002|Double-Blind Period|Pregnancy|0|||
150060420|NCT02129777|541363179|FG003|Double-Blind Period|Pregnancy|0|||
150060421|NCT02129777|541363180|FG004|Double-Blind Period|Pregnancy|1|||
150060422|NCT02129777|541363181|FG005|Double-Blind Period|Pregnancy|0|||
150060423|NCT02129777|541363182|FG006|Double-Blind Period|Pregnancy|0|||
150060424|NCT02129777|541363176|FG000|Double-Blind Period|Lack of Efficacy|3|||
150060425|NCT02129777|541363177|FG001|Double-Blind Period|Lack of Efficacy|1|||
150060426|NCT02129777|541363178|FG002|Double-Blind Period|Lack of Efficacy|0|||
150060427|NCT02129777|541363179|FG003|Double-Blind Period|Lack of Efficacy|3|||
150060428|NCT02129777|541363180|FG004|Double-Blind Period|Lack of Efficacy|2|||
150060429|NCT02129777|541363181|FG005|Double-Blind Period|Lack of Efficacy|0|||
150060430|NCT02129777|541363182|FG006|Double-Blind Period|Lack of Efficacy|0|||
150060431|NCT02129777|541363176|FG000|Double-Blind Period|Other|1|||
150060432|NCT02129777|541363177|FG001|Double-Blind Period|Other|2|||
150060433|NCT02129777|541363178|FG002|Double-Blind Period|Other|0|||
150060434|NCT02129777|541363179|FG003|Double-Blind Period|Other|0|||
150060435|NCT02129777|541363180|FG004|Double-Blind Period|Other|0|||
150060436|NCT02129777|541363181|FG005|Double-Blind Period|Other|0|||
150060437|NCT02129777|541363182|FG006|Double-Blind Period|Other|0|||
150060438|NCT02129777|541363176|FG000|Open-Label Period|Lack of Efficacy|0|||
150060439|NCT02129777|541363177|FG001|Open-Label Period|Lack of Efficacy|0|||
150060440|NCT02129777|541363178|FG002|Open-Label Period|Lack of Efficacy|0|||
150060441|NCT02129777|541363179|FG003|Open-Label Period|Lack of Efficacy|0|||
150060442|NCT02129777|541363180|FG004|Open-Label Period|Lack of Efficacy|0|||
150060443|NCT02129777|541363181|FG005|Open-Label Period|Lack of Efficacy|0|||
150060444|NCT02129777|541363182|FG006|Open-Label Period|Lack of Efficacy|5|||
150060445|NCT02129777|541363176|FG000|Open-Label Period|Lost to Follow-up|0|||
150060446|NCT02129777|541363177|FG001|Open-Label Period|Lost to Follow-up|0|||
150060447|NCT02129777|541363178|FG002|Open-Label Period|Lost to Follow-up|0|||
150060448|NCT02129777|541363179|FG003|Open-Label Period|Lost to Follow-up|0|||
150060449|NCT02129777|541363180|FG004|Open-Label Period|Lost to Follow-up|0|||
150060450|NCT02129777|541363181|FG005|Open-Label Period|Lost to Follow-up|1|||
150060451|NCT02129777|541363182|FG006|Open-Label Period|Lost to Follow-up|1|||
150060452|NCT02129777|541363176|FG000|Open-Label Period|Withdrawal by Subject|0|||
150060453|NCT02129777|541363177|FG001|Open-Label Period|Withdrawal by Subject|0|||
150060454|NCT02129777|541363178|FG002|Open-Label Period|Withdrawal by Subject|0|||
150060455|NCT02129777|541363179|FG003|Open-Label Period|Withdrawal by Subject|0|||
150060456|NCT02129777|541363180|FG004|Open-Label Period|Withdrawal by Subject|0|||
150060457|NCT02129777|541363181|FG005|Open-Label Period|Withdrawal by Subject|1|||
150060458|NCT02129777|541363182|FG006|Open-Label Period|Withdrawal by Subject|3|||
150060459|NCT02129777|541363176|FG000|Open-Label Period|Study Termination|0|||
150060460|NCT02129777|541363177|FG001|Open-Label Period|Study Termination|0|||
150060461|NCT02129777|541363178|FG002|Open-Label Period|Study Termination|0|||
150060462|NCT02129777|541363179|FG003|Open-Label Period|Study Termination|0|||
150060463|NCT02129777|541363180|FG004|Open-Label Period|Study Termination|0|||
150060464|NCT02129777|541363181|FG005|Open-Label Period|Study Termination|10|||
150060465|NCT02129777|541363182|FG006|Open-Label Period|Study Termination|39|||
150060466|NCT01609478|541363187|FG000|Overall Study|Adverse Event|3|||
150060467|NCT01609478|541363188|FG001|Overall Study|Adverse Event|1|||
150060468|NCT01609478|541363189|FG002|Overall Study|Adverse Event|5|||
150060469|NCT01609478|541363187|FG000|Overall Study|Protocol Deviation|0|||
150060470|NCT01609478|541363188|FG001|Overall Study|Protocol Deviation|1|||
150060471|NCT01609478|541363189|FG002|Overall Study|Protocol Deviation|1|||
150060472|NCT01609478|541363187|FG000|Overall Study|Non-Compliance with study treatment|1|||
150060473|NCT01609478|541363188|FG001|Overall Study|Non-Compliance with study treatment|0|||
150060474|NCT01609478|541363189|FG002|Overall Study|Non-Compliance with study treatment|0|||
150181817|NCT03398148|541804603|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150181818|NCT03398148|541804604|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150024358|NCT02452424|541223814|FG005|Overall Study|Lost to Follow-up|0|||
150024359|NCT02452424|541223815|FG006|Overall Study|Lost to Follow-up|0|||
150024360|NCT02452424|541223816|FG007|Overall Study|Lost to Follow-up|0|||
150024361|NCT02452424|541223817|FG008|Overall Study|Lost to Follow-up|0|||
150024362|NCT02452424|541223818|FG009|Overall Study|Lost to Follow-up|0|||
150024363|NCT02452424|541223819|FG010|Overall Study|Lost to Follow-up|0|||
150024364|NCT02452424|541223809|FG000|Overall Study|Withdrawal by Subject|0|||
150024365|NCT02452424|541223810|FG001|Overall Study|Withdrawal by Subject|0|||
150024366|NCT02452424|541223811|FG002|Overall Study|Withdrawal by Subject|3|||
150024367|NCT02452424|541223812|FG003|Overall Study|Withdrawal by Subject|2|||
150024368|NCT02452424|541223813|FG004|Overall Study|Withdrawal by Subject|0|||
150024369|NCT02452424|541223814|FG005|Overall Study|Withdrawal by Subject|0|||
150024370|NCT02452424|541223815|FG006|Overall Study|Withdrawal by Subject|1|||
150024371|NCT02452424|541223816|FG007|Overall Study|Withdrawal by Subject|0|||
150024372|NCT02452424|541223817|FG008|Overall Study|Withdrawal by Subject|1|||
150024373|NCT02452424|541223818|FG009|Overall Study|Withdrawal by Subject|1|||
150024374|NCT02452424|541223819|FG010|Overall Study|Withdrawal by Subject|0|||
150024375|NCT02452424|541223809|FG000|Overall Study|Other|0|||
150024376|NCT02452424|541223810|FG001|Overall Study|Other|0|||
150024377|NCT02452424|541223811|FG002|Overall Study|Other|1|||
150024378|NCT02452424|541223812|FG003|Overall Study|Other|0|||
150024379|NCT02452424|541223813|FG004|Overall Study|Other|0|||
150024380|NCT02452424|541223814|FG005|Overall Study|Other|1|||
150024381|NCT02452424|541223815|FG006|Overall Study|Other|4|||
150024382|NCT02452424|541223816|FG007|Overall Study|Other|3|||
150024383|NCT02452424|541223817|FG008|Overall Study|Other|0|||
150024384|NCT02452424|541223818|FG009|Overall Study|Other|0|||
150024385|NCT02452424|541223819|FG010|Overall Study|Other|1|||
150024386|NCT02452424|541223809|FG000|Overall Study|Progressive disease (per RECIST)|0|||
150024387|NCT02452424|541223810|FG001|Overall Study|Progressive disease (per RECIST)|0|||
150024388|NCT02452424|541223811|FG002|Overall Study|Progressive disease (per RECIST)|0|||
150024389|NCT02452424|541223812|FG003|Overall Study|Progressive disease (per RECIST)|0|||
150024390|NCT02452424|541223813|FG004|Overall Study|Progressive disease (per RECIST)|0|||
150024391|NCT02452424|541223814|FG005|Overall Study|Progressive disease (per RECIST)|0|||
150024392|NCT02452424|541223815|FG006|Overall Study|Progressive disease (per RECIST)|0|||
150024393|NCT02452424|541223816|FG007|Overall Study|Progressive disease (per RECIST)|0|||
150024394|NCT02452424|541223817|FG008|Overall Study|Progressive disease (per RECIST)|2|||
150024395|NCT02452424|541223818|FG009|Overall Study|Progressive disease (per RECIST)|0|||
150024396|NCT02452424|541223819|FG010|Overall Study|Progressive disease (per RECIST)|0|||
150024397|NCT02452424|541223809|FG000|Overall Study|Adverse Event|0|||
150024398|NCT02452424|541223810|FG001|Overall Study|Adverse Event|0|||
150024399|NCT02452424|541223811|FG002|Overall Study|Adverse Event|0|||
150024400|NCT02452424|541223812|FG003|Overall Study|Adverse Event|0|||
150024401|NCT02452424|541223813|FG004|Overall Study|Adverse Event|0|||
150024402|NCT02452424|541223814|FG005|Overall Study|Adverse Event|0|||
150024403|NCT02452424|541223815|FG006|Overall Study|Adverse Event|0|||
150024404|NCT02452424|541223816|FG007|Overall Study|Adverse Event|0|||
150024405|NCT02452424|541223817|FG008|Overall Study|Adverse Event|0|||
150024406|NCT02452424|541223818|FG009|Overall Study|Adverse Event|0|||
150024407|NCT02452424|541223819|FG010|Overall Study|Adverse Event|1|||
150024408|NCT01059318|541223822|FG000|Core Study (26 Week)|Adverse Event|3|||
150024409|NCT01059318|541223822|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
150024410|NCT01059318|541223822|FG000|Extension (36 Week)|Adverse Event|3|||
150024411|NCT00176462|541223829|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
150024412|NCT00176462|541223830|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
150024413|NCT00176462|541223829|FG000|Induction (4 Weeks)|Death|1|||
150024414|NCT00176462|541223830|FG001|Induction (4 Weeks)|Death|2|||
150024415|NCT00176462|541223829|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
150024416|NCT00176462|541223830|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
150024417|NCT00176462|541223829|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
150024418|NCT00176462|541223830|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
150024419|NCT00176462|541223829|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
150060475|NCT01609478|541363187|FG000|Overall Study|Physician Decision|1|||
150060476|NCT01609478|541363188|FG001|Overall Study|Physician Decision|0|||
150060477|NCT01609478|541363189|FG002|Overall Study|Physician Decision|1|||
150060478|NCT01609478|541363187|FG000|Overall Study|Withdrawal by Subject|2|||
150060479|NCT01609478|541363188|FG001|Overall Study|Withdrawal by Subject|0|||
150060480|NCT01609478|541363189|FG002|Overall Study|Withdrawal by Subject|2|||
150060481|NCT05040971|541363190|FG000|Overall Study|Withdrawal by Subject|0|||
150060482|NCT05040971|541363191|FG001|Overall Study|Withdrawal by Subject|2|||
150060483|NCT05040971|541363190|FG000|Overall Study|Lost to Follow-up|8|||
150060484|NCT05040971|541363191|FG001|Overall Study|Lost to Follow-up|3|||
150060485|NCT05040971|541363190|FG000|Overall Study|Death|2|||
150060486|NCT05040971|541363191|FG001|Overall Study|Death|0|||
150060487|NCT01589770|541363197|FG000|Overall Study|EGFR <60ml/min|6|||
150060488|NCT01589770|541363198|FG001|Overall Study|EGFR <60ml/min|4|||
150060489|NCT01589770|541363197|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
150060490|NCT01589770|541363198|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
150060491|NCT02283177|541363199|FG000|Overall Study|Withdrawal by Subject|1|||
150060492|NCT02283177|541363200|FG001|Overall Study|Withdrawal by Subject|1|||
150060493|NCT01101191|541363201|FG000|Period 1|Withdrawal by Subject|1|||
150060494|NCT01101191|541363202|FG001|Period 1|Withdrawal by Subject|0|||
150060495|NCT01101191|541363201|FG000|Period 1|Adverse Event|1|||
150060496|NCT01101191|541363202|FG001|Period 1|Adverse Event|2|||
150060497|NCT03761797|541363203|FG000|Overall Study|Changing hospital|11|||
150060498|NCT03761797|541363203|FG000|Overall Study|Improvement/remission|6|||
150060499|NCT03761797|541363203|FG000|Overall Study|Withdrawal by Subject|19|||
150060500|NCT03761797|541363203|FG000|Overall Study|Lost to Follow-up|33|||
150060501|NCT03761797|541363203|FG000|Overall Study|Adverse Event|37|||
150060502|NCT03761797|541363203|FG000|Overall Study|Case report form (CRF) not collected|5|||
150060503|NCT03761797|541363203|FG000|Overall Study|No patient visit after entry|13|||
150060504|NCT03761797|541363203|FG000|Overall Study|Switch to other diabetes medication|10|||
150060505|NCT03761797|541363203|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
150060506|NCT03761797|541363203|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
150060507|NCT03761797|541363203|FG000|Overall Study|Insufficient effectives|2|||
150060508|NCT03761797|541363203|FG000|Overall Study|Excessive alcohol intake|1|||
150060509|NCT00879879|541363210|FG000|Overall Study|Death|1|||
150060510|NCT00879879|541363210|FG000|Overall Study|Withdrawal by Subject|1|||
150060511|NCT00879879|541363210|FG000|Overall Study|Physician Decision|1|||
150060512|NCT00645788|541363211|FG000|Overall Study|Did not receive study drug|1|||
150060513|NCT00645788|541363212|FG001|Overall Study|Did not receive study drug|1|||
150060514|NCT00645788|541363213|FG002|Overall Study|Did not receive study drug|0|||
150060515|NCT00645788|541363214|FG003|Overall Study|Did not receive study drug|0|||
150060516|NCT00645788|541363211|FG000|Overall Study|Adverse Event|4|||
150060517|NCT00645788|541363212|FG001|Overall Study|Adverse Event|9|||
150060518|NCT00645788|541363213|FG002|Overall Study|Adverse Event|5|||
150060519|NCT00645788|541363214|FG003|Overall Study|Adverse Event|3|||
150060520|NCT00645788|541363211|FG000|Overall Study|Lost to Follow-up|1|||
150060521|NCT00645788|541363212|FG001|Overall Study|Lost to Follow-up|0|||
150060522|NCT00645788|541363213|FG002|Overall Study|Lost to Follow-up|0|||
150060523|NCT00645788|541363214|FG003|Overall Study|Lost to Follow-up|0|||
150060524|NCT00645788|541363211|FG000|Overall Study|Protocol Violation|1|||
150060525|NCT00645788|541363212|FG001|Overall Study|Protocol Violation|0|||
150060526|NCT00645788|541363213|FG002|Overall Study|Protocol Violation|2|||
150060527|NCT00645788|541363214|FG003|Overall Study|Protocol Violation|0|||
150060528|NCT00645788|541363211|FG000|Overall Study|Withdrawal by Subject|0|||
150060529|NCT00645788|541363212|FG001|Overall Study|Withdrawal by Subject|1|||
150060530|NCT00645788|541363213|FG002|Overall Study|Withdrawal by Subject|0|||
150060531|NCT00645788|541363214|FG003|Overall Study|Withdrawal by Subject|2|||
150060532|NCT00645788|541363211|FG000|Overall Study|Pulmonary exacerbation|13|||
150060533|NCT00645788|541363212|FG001|Overall Study|Pulmonary exacerbation|16|||
150060534|NCT00645788|541363213|FG002|Overall Study|Pulmonary exacerbation|11|||
150181819|NCT03398148|541804605|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150181820|NCT03398148|541804606|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150181821|NCT03398148|541804607|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150060535|NCT00645788|541363214|FG003|Overall Study|Pulmonary exacerbation|9|||
150181822|NCT03398148|541804608|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150060536|NCT00327470|541363216|FG000|Overall Study|Randomized, but not treated|0|||
150060537|NCT00327470|541363217|FG001|Overall Study|Randomized, but not treated|2|||
150060538|NCT00327470|541363216|FG000|Overall Study|Adverse Event|9|||
150060539|NCT00327470|541363217|FG001|Overall Study|Adverse Event|14|||
150060540|NCT00327470|541363216|FG000|Overall Study|Lack of Efficacy|7|||
150060541|NCT00327470|541363217|FG001|Overall Study|Lack of Efficacy|19|||
150060542|NCT00327470|541363216|FG000|Overall Study|Other|5|||
150060543|NCT00327470|541363217|FG001|Overall Study|Other|9|||
150060544|NCT00327470|541363216|FG000|Overall Study|Lost to Follow-up|1|||
150060545|NCT00327470|541363217|FG001|Overall Study|Lost to Follow-up|3|||
150060546|NCT00327470|541363216|FG000|Overall Study|Withdrawal by Subject|6|||
150060547|NCT00327470|541363217|FG001|Overall Study|Withdrawal by Subject|12|||
150060548|NCT00327470|541363216|FG000|Overall Study|Death|1|||
150060549|NCT00327470|541363217|FG001|Overall Study|Death|4|||
150060550|NCT02290431|541363218|FG000|Overall Study|Adverse Event|20|||
150060551|NCT02290431|541363218|FG000|Overall Study|Progressive disease|4|||
150060552|NCT02290431|541363218|FG000|Overall Study|Study terminated by Sponsor|1|||
150060553|NCT02290431|541363218|FG000|Overall Study|Physician Decision|2|||
150060554|NCT02197234|541363219|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
150060555|NCT02197234|541363219|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
150060556|NCT02197234|541363219|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
150060557|NCT02197234|541363219|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
150060558|NCT02197234|541363219|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
150060559|NCT02197234|541363219|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
150060560|NCT03783702|541363220|FG000|Overall Study|Lost to Follow-up|6|||
150060561|NCT03783702|541363221|FG001|Overall Study|Lost to Follow-up|8|||
150060562|NCT03783702|541363220|FG000|Overall Study|Protocol Violation|1|||
150060563|NCT03783702|541363221|FG001|Overall Study|Protocol Violation|3|||
150060564|NCT02274038|541363222|FG000|Overall Study|Death|1|||
150060565|NCT02361346|541363223|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060566|NCT02361346|541363224|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060567|NCT02361346|541363225|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060568|NCT02361346|541363226|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
150060569|NCT02361346|541363227|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060570|NCT02361346|541363228|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060571|NCT02361346|541363229|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060572|NCT02361346|541363230|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060573|NCT02361346|541363231|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
150060574|NCT02361346|541363223|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060575|NCT02361346|541363224|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060576|NCT02361346|541363225|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060577|NCT02361346|541363226|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060578|NCT02361346|541363227|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
150060579|NCT02361346|541363228|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060580|NCT02361346|541363229|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060581|NCT02361346|541363230|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060582|NCT02361346|541363231|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
150060583|NCT02361346|541363223|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
150060584|NCT02361346|541363224|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
150024420|NCT00176462|541223830|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
150024421|NCT00176462|541223829|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
150024422|NCT00176462|541223830|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
150024423|NCT00176462|541223829|FG000|Consolidation (12 Weeks)|Not documented|0|||
150024424|NCT00176462|541223830|FG001|Consolidation (12 Weeks)|Not documented|1|||
150024425|NCT00176462|541223829|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
150024426|NCT00176462|541223830|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
150024427|NCT00176462|541223829|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
150024428|NCT00176462|541223830|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
150024429|NCT01150097|541223832|FG000|Months 24 to 36 Post-transplantation|Death|2|||
150024430|NCT01150097|541223833|FG001|Months 24 to 36 Post-transplantation|Death|0|||
150024431|NCT01150097|541223834|FG002|Months 24 to 36 Post-transplantation|Death|0|||
150024432|NCT01150097|541223832|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
150024433|NCT01150097|541223833|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
150024434|NCT01150097|541223834|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
150024435|NCT01150097|541223832|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
150060585|NCT02361346|541363225|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
150060586|NCT02361346|541363226|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
150060587|NCT02361346|541363227|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
150060588|NCT02361346|541363228|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
150060589|NCT02361346|541363229|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
150060590|NCT02361346|541363230|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
150060591|NCT02361346|541363231|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
150060592|NCT02361346|541363223|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060593|NCT02361346|541363224|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060594|NCT02361346|541363225|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060595|NCT02361346|541363226|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060596|NCT02361346|541363227|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060597|NCT02361346|541363228|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060598|NCT02361346|541363229|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060599|NCT02361346|541363230|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
150060600|NCT02361346|541363231|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
150060601|NCT02361346|541363223|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060602|NCT02361346|541363224|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060603|NCT02361346|541363225|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060604|NCT02361346|541363226|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060605|NCT02361346|541363227|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060606|NCT02361346|541363228|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060607|NCT02361346|541363229|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060608|NCT02361346|541363230|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
150060609|NCT02361346|541363231|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
150060610|NCT02361346|541363223|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060611|NCT02361346|541363224|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060612|NCT02361346|541363225|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060613|NCT02361346|541363226|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060614|NCT02361346|541363227|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060615|NCT02361346|541363228|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060616|NCT02361346|541363229|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060617|NCT02361346|541363230|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
150060618|NCT02361346|541363231|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
150060619|NCT01163318|541363232|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
150060620|NCT01163318|541363232|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
150060621|NCT01163318|541363232|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
150060622|NCT01163318|541363232|FG000|Overall Study|Participants Without Case Report Form|7|||
150060623|NCT01163318|541363232|FG000|Overall Study|Multiple Reasons Per Participant|224|||
150060624|NCT03587727|541363237|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
150060625|NCT03587727|541363237|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
150060626|NCT00562627|541364651|FG000|Overall Study|Protocol Violation|1|||
150060627|NCT00562627|541364652|FG001|Overall Study|Protocol Violation|1|||
150060628|NCT00562627|541364653|FG002|Overall Study|Protocol Violation|1|||
150060629|NCT00997438|541364654|FG000|Overall Study|Blood draw difficulty|2|||
150060630|NCT00997438|541364655|FG001|Overall Study|Blood draw difficulty|0|||
150060631|NCT00997438|541364656|FG002|Overall Study|Blood draw difficulty|1|||
150060632|NCT00997438|541364654|FG000|Overall Study|Withdrawal by Subject|1|||
150060633|NCT00997438|541364655|FG001|Overall Study|Withdrawal by Subject|1|||
150060634|NCT00997438|541364656|FG002|Overall Study|Withdrawal by Subject|0|||
150060635|NCT00997438|541364654|FG000|Overall Study|Exclusion criteria at visit 1|2|||
150060636|NCT00997438|541364655|FG001|Overall Study|Exclusion criteria at visit 1|2|||
150060637|NCT00997438|541364656|FG002|Overall Study|Exclusion criteria at visit 1|3|||
150060638|NCT04393298|541364657|FG000|Overall Study|Adverse Event|0|||
150060639|NCT04393298|541364658|FG001|Overall Study|Adverse Event|0|||
150060640|NCT04393298|541364659|FG002|Overall Study|Adverse Event|0|||
150060641|NCT04393298|541364660|FG003|Overall Study|Adverse Event|0|||
150060642|NCT04393298|541364661|FG004|Overall Study|Adverse Event|1|||
150060643|NCT04393298|541364662|FG005|Overall Study|Adverse Event|0|||
150060644|NCT04393298|541364663|FG006|Overall Study|Adverse Event|0|||
150060645|NCT04393298|541364664|FG007|Overall Study|Adverse Event|0|||
150060646|NCT04393298|541364665|FG008|Overall Study|Adverse Event|2|||
150060647|NCT04393298|541364666|FG009|Overall Study|Adverse Event|0|||
150060648|NCT04393298|541364667|FG010|Overall Study|Adverse Event|0|||
150060649|NCT04393298|541364668|FG011|Overall Study|Adverse Event|0|||
150060650|NCT04393298|541364669|FG012|Overall Study|Adverse Event|1|||
150060651|NCT04393298|541364670|FG013|Overall Study|Adverse Event|1|||
150060652|NCT04393298|541364671|FG014|Overall Study|Adverse Event|0|||
150060653|NCT04393298|541364657|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060654|NCT04393298|541364658|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060655|NCT04393298|541364659|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
150060656|NCT04393298|541364660|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060657|NCT04393298|541364661|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060658|NCT04393298|541364662|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060659|NCT04393298|541364663|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060660|NCT04393298|541364664|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060661|NCT04393298|541364665|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060662|NCT04393298|541364666|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060663|NCT04393298|541364667|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060664|NCT04393298|541364668|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060665|NCT04393298|541364669|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060666|NCT04393298|541364670|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
150060667|NCT04393298|541364671|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
150060668|NCT04393298|541364657|FG000|Overall Study|Lack of Efficacy|0|||
150060669|NCT04393298|541364658|FG001|Overall Study|Lack of Efficacy|0|||
150060670|NCT04393298|541364659|FG002|Overall Study|Lack of Efficacy|0|||
150060671|NCT04393298|541364660|FG003|Overall Study|Lack of Efficacy|0|||
150060672|NCT04393298|541364661|FG004|Overall Study|Lack of Efficacy|0|||
150060673|NCT04393298|541364662|FG005|Overall Study|Lack of Efficacy|0|||
150060674|NCT04393298|541364663|FG006|Overall Study|Lack of Efficacy|0|||
150060675|NCT04393298|541364664|FG007|Overall Study|Lack of Efficacy|0|||
150060676|NCT04393298|541364665|FG008|Overall Study|Lack of Efficacy|0|||
150060677|NCT04393298|541364666|FG009|Overall Study|Lack of Efficacy|0|||
150060678|NCT04393298|541364667|FG010|Overall Study|Lack of Efficacy|0|||
150060679|NCT04393298|541364668|FG011|Overall Study|Lack of Efficacy|0|||
150060680|NCT04393298|541364669|FG012|Overall Study|Lack of Efficacy|0|||
150060681|NCT04393298|541364670|FG013|Overall Study|Lack of Efficacy|0|||
150060682|NCT04393298|541364671|FG014|Overall Study|Lack of Efficacy|1|||
150060683|NCT04393298|541364657|FG000|Overall Study|Progression|1|||
150060684|NCT04393298|541364658|FG001|Overall Study|Progression|0|||
150060685|NCT04393298|541364659|FG002|Overall Study|Progression|0|||
150060686|NCT04393298|541364660|FG003|Overall Study|Progression|0|||
150060687|NCT04393298|541364661|FG004|Overall Study|Progression|0|||
150060688|NCT04393298|541364662|FG005|Overall Study|Progression|0|||
150060689|NCT04393298|541364663|FG006|Overall Study|Progression|0|||
150060690|NCT04393298|541364664|FG007|Overall Study|Progression|0|||
150060691|NCT04393298|541364665|FG008|Overall Study|Progression|0|||
150060692|NCT04393298|541364666|FG009|Overall Study|Progression|0|||
150060693|NCT04393298|541364667|FG010|Overall Study|Progression|1|||
150060694|NCT04393298|541364668|FG011|Overall Study|Progression|1|||
150060695|NCT04393298|541364669|FG012|Overall Study|Progression|0|||
150060696|NCT04393298|541364670|FG013|Overall Study|Progression|0|||
150060697|NCT04393298|541364671|FG014|Overall Study|Progression|0|||
150060698|NCT04393298|541364657|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
150060699|NCT04393298|541364658|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060700|NCT04393298|541364659|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060701|NCT04393298|541364660|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060702|NCT04393298|541364661|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060703|NCT04393298|541364662|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060704|NCT04393298|541364663|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060705|NCT04393298|541364664|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060706|NCT04393298|541364665|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060707|NCT04393298|541364666|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060708|NCT04393298|541364667|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
150181823|NCT03398148|541804609|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150181824|NCT03398148|541804610|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
150181825|NCT03398148|541804596|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
150181826|NCT03398148|541804597|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
150060709|NCT04393298|541364668|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060710|NCT04393298|541364669|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060711|NCT04393298|541364670|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060712|NCT04393298|541364671|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
150060713|NCT04393298|541364657|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060714|NCT04393298|541364658|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
150060715|NCT04393298|541364659|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060716|NCT04393298|541364660|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060717|NCT04393298|541364661|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060718|NCT04393298|541364662|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060719|NCT04393298|541364663|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060720|NCT04393298|541364664|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060721|NCT04393298|541364665|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150024436|NCT01150097|541223833|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
150024437|NCT01150097|541223834|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
150024438|NCT01150097|541223832|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
150024439|NCT01150097|541223833|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
150024440|NCT01150097|541223834|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
150024441|NCT01150097|541223832|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
150024442|NCT01150097|541223833|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
150024443|NCT01150097|541223834|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
150024444|NCT01150097|541223832|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
150024445|NCT01150097|541223833|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
150024446|NCT01150097|541223834|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
150024447|NCT01150097|541223832|FG000|Months 24 to 48 Post-transplantation|Death|2|||
150024448|NCT01150097|541223833|FG001|Months 24 to 48 Post-transplantation|Death|0|||
150024449|NCT01150097|541223834|FG002|Months 24 to 48 Post-transplantation|Death|0|||
150024450|NCT01301833|541223835|FG000|Overall Study|Adverse Event|7|||
150024451|NCT01301833|541223836|FG001|Overall Study|Adverse Event|5|||
150024452|NCT01301833|541223837|FG002|Overall Study|Adverse Event|5|||
150024453|NCT01301833|541223838|FG003|Overall Study|Adverse Event|5|||
150024454|NCT01301833|541223835|FG000|Overall Study|Lack of Efficacy|1|||
150024455|NCT01301833|541223836|FG001|Overall Study|Lack of Efficacy|1|||
150024456|NCT01301833|541223837|FG002|Overall Study|Lack of Efficacy|0|||
150024457|NCT01301833|541223838|FG003|Overall Study|Lack of Efficacy|0|||
150024458|NCT01301833|541223835|FG000|Overall Study|Physician Decision|3|||
150024459|NCT01301833|541223836|FG001|Overall Study|Physician Decision|1|||
150024460|NCT01301833|541223837|FG002|Overall Study|Physician Decision|1|||
150024461|NCT01301833|541223838|FG003|Overall Study|Physician Decision|0|||
150024462|NCT01301833|541223835|FG000|Overall Study|Withdrawal by Subject|3|||
150024463|NCT01301833|541223836|FG001|Overall Study|Withdrawal by Subject|1|||
150024464|NCT01301833|541223837|FG002|Overall Study|Withdrawal by Subject|1|||
150024465|NCT01301833|541223838|FG003|Overall Study|Withdrawal by Subject|2|||
150024466|NCT01301833|541223835|FG000|Overall Study|Personal matter|1|||
150024467|NCT01301833|541223836|FG001|Overall Study|Personal matter|0|||
150024468|NCT01301833|541223837|FG002|Overall Study|Personal matter|0|||
150024469|NCT01301833|541223838|FG003|Overall Study|Personal matter|0|||
150024470|NCT01792115|541223839|FG000|Overall Study|Lost to Follow-up|0|||
150024471|NCT01792115|541223840|FG001|Overall Study|Lost to Follow-up|1|||
150024472|NCT01792115|541223841|FG002|Overall Study|Lost to Follow-up|0|||
150024473|NCT02719171|541225947|FG000|Overall Study|Adverse Event|1|||
150024474|NCT02719171|541225948|FG001|Overall Study|Adverse Event|2|||
150024475|NCT02719171|541225949|FG002|Overall Study|Adverse Event|0|||
150024476|NCT02719171|541225950|FG003|Overall Study|Adverse Event|0|||
150024477|NCT02719171|541225951|FG004|Overall Study|Adverse Event|2|||
150024478|NCT02719171|541225947|FG000|Overall Study|Lost to Follow-up|0|||
150024479|NCT02719171|541225948|FG001|Overall Study|Lost to Follow-up|0|||
150024480|NCT02719171|541225949|FG002|Overall Study|Lost to Follow-up|1|||
150024481|NCT02719171|541225950|FG003|Overall Study|Lost to Follow-up|0|||
150024482|NCT02719171|541225951|FG004|Overall Study|Lost to Follow-up|0|||
150024483|NCT02719171|541225947|FG000|Overall Study|Subject Withdrawal|0|||
150024484|NCT02719171|541225948|FG001|Overall Study|Subject Withdrawal|2|||
150024485|NCT02719171|541225949|FG002|Overall Study|Subject Withdrawal|2|||
150024486|NCT02719171|541225950|FG003|Overall Study|Subject Withdrawal|1|||
150024487|NCT02719171|541225951|FG004|Overall Study|Subject Withdrawal|0|||
150024488|NCT02719171|541225947|FG000|Overall Study|Other|0|||
150024489|NCT02719171|541225948|FG001|Overall Study|Other|0|||
150024490|NCT02719171|541225949|FG002|Overall Study|Other|0|||
150024491|NCT02719171|541225950|FG003|Overall Study|Other|1|||
150024492|NCT02719171|541225951|FG004|Overall Study|Other|0|||
150024493|NCT00227721|541225952|FG000|Overall Study|On study, but never treated.|1|||
150024494|NCT02539797|541225962|FG000|Overall Study|Lost to Follow-up|0|||
150024495|NCT02539797|541225963|FG001|Overall Study|Lost to Follow-up|1|||
150024496|NCT02539797|541225964|FG002|Overall Study|Lost to Follow-up|0|||
150024497|NCT00383786|541225974|FG000|Overall Study|Protocol Violation|2|||
150024498|NCT00383786|541225975|FG001|Overall Study|Protocol Violation|6|||
150024499|NCT00383786|541225974|FG000|Overall Study|Withdrawal by Subject|2|||
150024500|NCT00383786|541225975|FG001|Overall Study|Withdrawal by Subject|5|||
150024501|NCT00383786|541225974|FG000|Overall Study|Physician Decision|0|||
150024502|NCT00383786|541225975|FG001|Overall Study|Physician Decision|1|||
150024503|NCT00531284|541225976|FG000|Overall Study|Progressive Disease|1|||
150024504|NCT00531284|541225977|FG001|Overall Study|Progressive Disease|3|||
150024505|NCT00531284|541225978|FG002|Overall Study|Progressive Disease|5|||
150181827|NCT03398148|541804598|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
150181828|NCT03398148|541804599|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
150181829|NCT03398148|541804600|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
150181830|NCT03398148|541804601|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
150060722|NCT04393298|541364666|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060723|NCT04393298|541364667|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060724|NCT04393298|541364668|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060725|NCT04393298|541364669|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060726|NCT04393298|541364670|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060727|NCT04393298|541364671|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
150060728|NCT04393298|541364657|FG000|Overall Study|Clinical Progression|0|||
150060729|NCT04393298|541364658|FG001|Overall Study|Clinical Progression|2|||
150060730|NCT04393298|541364659|FG002|Overall Study|Clinical Progression|0|||
150060731|NCT04393298|541364660|FG003|Overall Study|Clinical Progression|0|||
150060732|NCT04393298|541364661|FG004|Overall Study|Clinical Progression|0|||
150060733|NCT04393298|541364662|FG005|Overall Study|Clinical Progression|0|||
150060734|NCT04393298|541364663|FG006|Overall Study|Clinical Progression|0|||
150060735|NCT04393298|541364664|FG007|Overall Study|Clinical Progression|0|||
150060736|NCT04393298|541364665|FG008|Overall Study|Clinical Progression|0|||
150060737|NCT04393298|541364666|FG009|Overall Study|Clinical Progression|0|||
150060738|NCT04393298|541364667|FG010|Overall Study|Clinical Progression|0|||
150060739|NCT04393298|541364668|FG011|Overall Study|Clinical Progression|0|||
150060740|NCT04393298|541364669|FG012|Overall Study|Clinical Progression|0|||
150060741|NCT04393298|541364670|FG013|Overall Study|Clinical Progression|0|||
150060742|NCT04393298|541364671|FG014|Overall Study|Clinical Progression|0|||
150060743|NCT04393298|541364657|FG000|Overall Study|Disease Progression|0|||
150060744|NCT04393298|541364658|FG001|Overall Study|Disease Progression|1|||
150060745|NCT04393298|541364659|FG002|Overall Study|Disease Progression|0|||
150060746|NCT04393298|541364660|FG003|Overall Study|Disease Progression|0|||
150060747|NCT04393298|541364661|FG004|Overall Study|Disease Progression|0|||
150060748|NCT04393298|541364662|FG005|Overall Study|Disease Progression|3|||
150060749|NCT04393298|541364663|FG006|Overall Study|Disease Progression|2|||
150060750|NCT04393298|541364664|FG007|Overall Study|Disease Progression|1|||
150060751|NCT04393298|541364665|FG008|Overall Study|Disease Progression|2|||
150060752|NCT04393298|541364666|FG009|Overall Study|Disease Progression|1|||
150060753|NCT04393298|541364667|FG010|Overall Study|Disease Progression|0|||
150060754|NCT04393298|541364668|FG011|Overall Study|Disease Progression|3|||
150060755|NCT04393298|541364669|FG012|Overall Study|Disease Progression|0|||
150060756|NCT04393298|541364670|FG013|Overall Study|Disease Progression|0|||
150060757|NCT04393298|541364671|FG014|Overall Study|Disease Progression|1|||
150060758|NCT04393298|541364657|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060759|NCT04393298|541364658|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060760|NCT04393298|541364659|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
150060761|NCT04393298|541364660|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060762|NCT04393298|541364661|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060763|NCT04393298|541364662|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060764|NCT04393298|541364663|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060765|NCT04393298|541364664|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060766|NCT04393298|541364665|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060767|NCT04393298|541364666|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060768|NCT04393298|541364667|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060769|NCT04393298|541364668|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060770|NCT04393298|541364669|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060771|NCT04393298|541364670|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060772|NCT04393298|541364671|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
150060773|NCT04393298|541364657|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060774|NCT04393298|541364658|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060775|NCT04393298|541364659|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
150060776|NCT04393298|541364660|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060777|NCT04393298|541364661|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060778|NCT04393298|541364662|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060779|NCT04393298|541364663|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060780|NCT04393298|541364664|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060781|NCT04393298|541364665|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060782|NCT04393298|541364666|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060783|NCT04393298|541364667|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060784|NCT04393298|541364668|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060785|NCT04393298|541364669|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060786|NCT04393298|541364670|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060787|NCT04393298|541364671|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
150060788|NCT04393298|541364657|FG000|Overall Study|Progressive Disease (PD)|0|||
150060789|NCT04393298|541364658|FG001|Overall Study|Progressive Disease (PD)|0|||
150060790|NCT04393298|541364659|FG002|Overall Study|Progressive Disease (PD)|0|||
150060791|NCT04393298|541364660|FG003|Overall Study|Progressive Disease (PD)|3|||
150060792|NCT04393298|541364661|FG004|Overall Study|Progressive Disease (PD)|0|||
150060793|NCT04393298|541364662|FG005|Overall Study|Progressive Disease (PD)|0|||
150060794|NCT04393298|541364663|FG006|Overall Study|Progressive Disease (PD)|0|||
150060795|NCT04393298|541364664|FG007|Overall Study|Progressive Disease (PD)|0|||
150060796|NCT04393298|541364665|FG008|Overall Study|Progressive Disease (PD)|0|||
150060797|NCT04393298|541364666|FG009|Overall Study|Progressive Disease (PD)|0|||
150060798|NCT04393298|541364667|FG010|Overall Study|Progressive Disease (PD)|0|||
150060799|NCT04393298|541364668|FG011|Overall Study|Progressive Disease (PD)|0|||
150060800|NCT04393298|541364669|FG012|Overall Study|Progressive Disease (PD)|0|||
150060801|NCT04393298|541364670|FG013|Overall Study|Progressive Disease (PD)|0|||
150060802|NCT04393298|541364671|FG014|Overall Study|Progressive Disease (PD)|0|||
150060803|NCT04393298|541364657|FG000|Overall Study|Started a New Cancer Treatment|0|||
150060804|NCT04393298|541364658|FG001|Overall Study|Started a New Cancer Treatment|0|||
150060805|NCT04393298|541364659|FG002|Overall Study|Started a New Cancer Treatment|0|||
150060806|NCT04393298|541364660|FG003|Overall Study|Started a New Cancer Treatment|0|||
150060807|NCT04393298|541364661|FG004|Overall Study|Started a New Cancer Treatment|1|||
150060808|NCT04393298|541364662|FG005|Overall Study|Started a New Cancer Treatment|0|||
150060809|NCT04393298|541364663|FG006|Overall Study|Started a New Cancer Treatment|0|||
150060810|NCT04393298|541364664|FG007|Overall Study|Started a New Cancer Treatment|0|||
150060811|NCT04393298|541364665|FG008|Overall Study|Started a New Cancer Treatment|0|||
150060812|NCT04393298|541364666|FG009|Overall Study|Started a New Cancer Treatment|0|||
150060813|NCT04393298|541364667|FG010|Overall Study|Started a New Cancer Treatment|0|||
150060814|NCT04393298|541364668|FG011|Overall Study|Started a New Cancer Treatment|0|||
150060815|NCT04393298|541364669|FG012|Overall Study|Started a New Cancer Treatment|0|||
150060816|NCT04393298|541364670|FG013|Overall Study|Started a New Cancer Treatment|0|||
150181831|NCT03398148|541804602|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
150181832|NCT03398148|541804603|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
150181833|NCT03398148|541804604|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
150060817|NCT04393298|541364671|FG014|Overall Study|Started a New Cancer Treatment|0|||
150060818|NCT04393298|541364657|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060819|NCT04393298|541364658|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060820|NCT04393298|541364659|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060821|NCT04393298|541364660|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060822|NCT04393298|541364661|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
150060823|NCT04393298|541364662|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060824|NCT04393298|541364663|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060825|NCT04393298|541364664|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060826|NCT04393298|541364665|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060827|NCT04393298|541364666|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060828|NCT04393298|541364667|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060829|NCT04393298|541364668|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060830|NCT04393298|541364669|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060831|NCT04393298|541364670|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060832|NCT04393298|541364671|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
150060833|NCT04393298|541364657|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060834|NCT04393298|541364658|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060835|NCT04393298|541364659|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060836|NCT04393298|541364660|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060837|NCT04393298|541364661|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060838|NCT04393298|541364662|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
150181834|NCT03398148|541804605|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
150181835|NCT03398148|541804606|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
150181836|NCT03398148|541804607|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
150060839|NCT04393298|541364663|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060840|NCT04393298|541364664|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060841|NCT04393298|541364665|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060842|NCT04393298|541364666|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060843|NCT04393298|541364667|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150181837|NCT03398148|541804608|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
150024506|NCT00531284|541225979|FG003|Overall Study|Progressive Disease|42|||
150024507|NCT00531284|541225980|FG004|Overall Study|Progressive Disease|4|||
150024508|NCT00531284|541225981|FG005|Overall Study|Progressive Disease|4|||
150024509|NCT00531284|541225982|FG006|Overall Study|Progressive Disease|3|||
150024510|NCT00531284|541225983|FG007|Overall Study|Progressive Disease|8|||
150024511|NCT00531284|541225984|FG008|Overall Study|Progressive Disease|6|||
150024512|NCT00531284|541225985|FG009|Overall Study|Progressive Disease|3|||
150024513|NCT00531284|541225986|FG010|Overall Study|Progressive Disease|3|||
150024514|NCT00531284|541225987|FG011|Overall Study|Progressive Disease|14|||
150024515|NCT00531284|541225988|FG012|Overall Study|Progressive Disease|2|||
150024516|NCT00531284|541225989|FG013|Overall Study|Progressive Disease|1|||
150024517|NCT00531284|541225990|FG014|Overall Study|Progressive Disease|2|||
150024518|NCT00531284|541225991|FG015|Overall Study|Progressive Disease|11|||
150024519|NCT00531284|541225992|FG016|Overall Study|Progressive Disease|5|||
150024520|NCT00531284|541225976|FG000|Overall Study|Adverse Event|0|||
150024521|NCT00531284|541225977|FG001|Overall Study|Adverse Event|1|||
150024522|NCT00531284|541225978|FG002|Overall Study|Adverse Event|1|||
150024523|NCT00531284|541225979|FG003|Overall Study|Adverse Event|7|||
150024524|NCT00531284|541225980|FG004|Overall Study|Adverse Event|0|||
150024525|NCT00531284|541225981|FG005|Overall Study|Adverse Event|2|||
150024526|NCT00531284|541225982|FG006|Overall Study|Adverse Event|3|||
150024527|NCT00531284|541225983|FG007|Overall Study|Adverse Event|2|||
150024528|NCT00531284|541225984|FG008|Overall Study|Adverse Event|3|||
150024529|NCT00531284|541225985|FG009|Overall Study|Adverse Event|0|||
150024530|NCT00531284|541225986|FG010|Overall Study|Adverse Event|0|||
150024531|NCT00531284|541225987|FG011|Overall Study|Adverse Event|5|||
150024532|NCT00531284|541225988|FG012|Overall Study|Adverse Event|0|||
150024533|NCT00531284|541225989|FG013|Overall Study|Adverse Event|1|||
150024534|NCT00531284|541225990|FG014|Overall Study|Adverse Event|1|||
150024535|NCT00531284|541225991|FG015|Overall Study|Adverse Event|0|||
150024536|NCT00531284|541225992|FG016|Overall Study|Adverse Event|2|||
150024537|NCT00531284|541225976|FG000|Overall Study|Withdrawal by Subject|1|||
150024538|NCT00531284|541225977|FG001|Overall Study|Withdrawal by Subject|0|||
150024539|NCT00531284|541225978|FG002|Overall Study|Withdrawal by Subject|0|||
150024540|NCT00531284|541225979|FG003|Overall Study|Withdrawal by Subject|4|||
150024541|NCT00531284|541225980|FG004|Overall Study|Withdrawal by Subject|0|||
150024542|NCT00531284|541225981|FG005|Overall Study|Withdrawal by Subject|0|||
150024543|NCT00531284|541225982|FG006|Overall Study|Withdrawal by Subject|0|||
150024544|NCT00531284|541225983|FG007|Overall Study|Withdrawal by Subject|0|||
150024545|NCT00531284|541225984|FG008|Overall Study|Withdrawal by Subject|0|||
150024546|NCT00531284|541225985|FG009|Overall Study|Withdrawal by Subject|0|||
150024547|NCT00531284|541225986|FG010|Overall Study|Withdrawal by Subject|0|||
150024548|NCT00531284|541225987|FG011|Overall Study|Withdrawal by Subject|3|||
150024549|NCT00531284|541225988|FG012|Overall Study|Withdrawal by Subject|0|||
150024550|NCT00531284|541225989|FG013|Overall Study|Withdrawal by Subject|1|||
150024551|NCT00531284|541225990|FG014|Overall Study|Withdrawal by Subject|0|||
150024552|NCT00531284|541225991|FG015|Overall Study|Withdrawal by Subject|1|||
150024553|NCT00531284|541225992|FG016|Overall Study|Withdrawal by Subject|1|||
150024554|NCT00531284|541225976|FG000|Overall Study|Other|1|||
150024555|NCT00531284|541225977|FG001|Overall Study|Other|0|||
150024556|NCT00531284|541225978|FG002|Overall Study|Other|0|||
150024557|NCT00531284|541225979|FG003|Overall Study|Other|10|||
150024558|NCT00531284|541225980|FG004|Overall Study|Other|2|||
150024559|NCT00531284|541225981|FG005|Overall Study|Other|1|||
150024560|NCT00531284|541225982|FG006|Overall Study|Other|0|||
150024561|NCT00531284|541225983|FG007|Overall Study|Other|0|||
150024562|NCT00531284|541225984|FG008|Overall Study|Other|2|||
150024563|NCT00531284|541225985|FG009|Overall Study|Other|1|||
150024564|NCT00531284|541225986|FG010|Overall Study|Other|0|||
150024565|NCT00531284|541225987|FG011|Overall Study|Other|2|||
150024566|NCT00531284|541225988|FG012|Overall Study|Other|0|||
150024567|NCT00531284|541225989|FG013|Overall Study|Other|0|||
150024568|NCT00531284|541225990|FG014|Overall Study|Other|1|||
150024569|NCT00531284|541225991|FG015|Overall Study|Other|0|||
150024570|NCT00531284|541225992|FG016|Overall Study|Other|0|||
150024571|NCT02219464|541225994|FG000|Overall Study|Withdrawal by Subject|1|||
150024572|NCT02219464|541225995|FG001|Overall Study|Withdrawal by Subject|0|||
150024573|NCT02219464|541225994|FG000|Overall Study|case cancelled|1|||
150024574|NCT02219464|541225995|FG001|Overall Study|case cancelled|0|||
150024575|NCT02219464|541225994|FG000|Overall Study|catheter malfunction|1|||
150024576|NCT02219464|541225995|FG001|Overall Study|catheter malfunction|0|||
150024577|NCT02544321|541226000|FG000|Overall Study|Withdrawal by Subject|1|||
150024578|NCT02544321|541226001|FG001|Overall Study|Withdrawal by Subject|2|||
150024579|NCT02544321|541226000|FG000|Overall Study|Adverse Event|1|||
150024580|NCT02544321|541226001|FG001|Overall Study|Adverse Event|1|||
150060844|NCT04393298|541364668|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060845|NCT04393298|541364669|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060846|NCT04393298|541364670|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060847|NCT04393298|541364671|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
150060848|NCT04393298|541364657|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060849|NCT04393298|541364658|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060850|NCT04393298|541364659|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060851|NCT04393298|541364660|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060852|NCT04393298|541364661|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060853|NCT04393298|541364662|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
150060854|NCT04393298|541364663|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060855|NCT04393298|541364664|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060856|NCT04393298|541364665|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060857|NCT04393298|541364666|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060858|NCT04393298|541364667|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060859|NCT04393298|541364668|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060860|NCT04393298|541364669|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060861|NCT04393298|541364670|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
150060862|NCT04393298|541364671|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
150060863|NCT04393298|541364657|FG000|Overall Study|Death|0|||
150060864|NCT04393298|541364658|FG001|Overall Study|Death|0|||
150060865|NCT04393298|541364659|FG002|Overall Study|Death|0|||
150060866|NCT04393298|541364660|FG003|Overall Study|Death|0|||
150060867|NCT04393298|541364661|FG004|Overall Study|Death|0|||
150060868|NCT04393298|541364662|FG005|Overall Study|Death|1|||
150060869|NCT04393298|541364663|FG006|Overall Study|Death|1|||
150060870|NCT04393298|541364664|FG007|Overall Study|Death|0|||
150060871|NCT04393298|541364665|FG008|Overall Study|Death|1|||
150060872|NCT04393298|541364666|FG009|Overall Study|Death|1|||
150060873|NCT04393298|541364667|FG010|Overall Study|Death|0|||
150060874|NCT04393298|541364668|FG011|Overall Study|Death|1|||
150060875|NCT04393298|541364669|FG012|Overall Study|Death|1|||
150060876|NCT04393298|541364670|FG013|Overall Study|Death|0|||
150060877|NCT04393298|541364671|FG014|Overall Study|Death|1|||
150060878|NCT04393298|541364657|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060879|NCT04393298|541364658|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060880|NCT04393298|541364659|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060881|NCT04393298|541364660|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060882|NCT04393298|541364661|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060883|NCT04393298|541364662|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
150060884|NCT04393298|541364663|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060885|NCT04393298|541364664|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060886|NCT04393298|541364665|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060887|NCT04393298|541364666|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060888|NCT04393298|541364667|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060889|NCT04393298|541364668|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060890|NCT04393298|541364669|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060891|NCT04393298|541364670|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060892|NCT04393298|541364671|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
150060893|NCT04393298|541364657|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
150060894|NCT04393298|541364658|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
150060895|NCT04393298|541364659|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
150060896|NCT04393298|541364660|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
150060897|NCT04393298|541364661|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
150060898|NCT04393298|541364662|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
150060899|NCT04393298|541364663|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
150060900|NCT04393298|541364664|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
150060901|NCT04393298|541364665|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
150060902|NCT04393298|541364666|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
150060903|NCT04393298|541364667|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
150060904|NCT04393298|541364668|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
150060905|NCT04393298|541364669|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
150060906|NCT04393298|541364670|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
150181838|NCT03398148|541804609|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
150060907|NCT04393298|541364671|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
150060908|NCT04393298|541364657|FG000|Overall Study|Patient Passed Away|0|||
150060909|NCT04393298|541364658|FG001|Overall Study|Patient Passed Away|0|||
150060910|NCT04393298|541364659|FG002|Overall Study|Patient Passed Away|0|||
150060911|NCT04393298|541364660|FG003|Overall Study|Patient Passed Away|0|||
150060912|NCT04393298|541364661|FG004|Overall Study|Patient Passed Away|0|||
150060913|NCT04393298|541364662|FG005|Overall Study|Patient Passed Away|0|||
150060914|NCT04393298|541364663|FG006|Overall Study|Patient Passed Away|0|||
150060915|NCT04393298|541364664|FG007|Overall Study|Patient Passed Away|1|||
150060916|NCT04393298|541364665|FG008|Overall Study|Patient Passed Away|0|||
150060917|NCT04393298|541364666|FG009|Overall Study|Patient Passed Away|0|||
150060918|NCT04393298|541364667|FG010|Overall Study|Patient Passed Away|0|||
150060919|NCT04393298|541364668|FG011|Overall Study|Patient Passed Away|0|||
150060920|NCT04393298|541364669|FG012|Overall Study|Patient Passed Away|0|||
150060921|NCT04393298|541364670|FG013|Overall Study|Patient Passed Away|0|||
150060922|NCT04393298|541364671|FG014|Overall Study|Patient Passed Away|0|||
150060923|NCT04393298|541364657|FG000|Overall Study|Patient Deceased|0|||
150060924|NCT04393298|541364658|FG001|Overall Study|Patient Deceased|0|||
150060925|NCT04393298|541364659|FG002|Overall Study|Patient Deceased|0|||
150060926|NCT04393298|541364660|FG003|Overall Study|Patient Deceased|0|||
150060927|NCT04393298|541364661|FG004|Overall Study|Patient Deceased|0|||
150060928|NCT04393298|541364662|FG005|Overall Study|Patient Deceased|0|||
150060929|NCT04393298|541364663|FG006|Overall Study|Patient Deceased|0|||
150060930|NCT04393298|541364664|FG007|Overall Study|Patient Deceased|1|||
150060931|NCT04393298|541364665|FG008|Overall Study|Patient Deceased|0|||
150060932|NCT04393298|541364666|FG009|Overall Study|Patient Deceased|0|||
150060933|NCT04393298|541364667|FG010|Overall Study|Patient Deceased|0|||
150060934|NCT04393298|541364668|FG011|Overall Study|Patient Deceased|0|||
150060935|NCT04393298|541364669|FG012|Overall Study|Patient Deceased|0|||
150060936|NCT04393298|541364670|FG013|Overall Study|Patient Deceased|0|||
150060937|NCT04393298|541364671|FG014|Overall Study|Patient Deceased|0|||
150060938|NCT04393298|541364657|FG000|Overall Study|Patient Discharged to Hospice|0|||
150060939|NCT04393298|541364658|FG001|Overall Study|Patient Discharged to Hospice|0|||
150060940|NCT04393298|541364659|FG002|Overall Study|Patient Discharged to Hospice|0|||
150060941|NCT04393298|541364660|FG003|Overall Study|Patient Discharged to Hospice|0|||
150060942|NCT04393298|541364661|FG004|Overall Study|Patient Discharged to Hospice|0|||
150060943|NCT04393298|541364662|FG005|Overall Study|Patient Discharged to Hospice|0|||
150060944|NCT04393298|541364663|FG006|Overall Study|Patient Discharged to Hospice|0|||
150060945|NCT04393298|541364664|FG007|Overall Study|Patient Discharged to Hospice|0|||
150060946|NCT04393298|541364665|FG008|Overall Study|Patient Discharged to Hospice|1|||
150060947|NCT04393298|541364666|FG009|Overall Study|Patient Discharged to Hospice|0|||
150060948|NCT04393298|541364667|FG010|Overall Study|Patient Discharged to Hospice|0|||
150060949|NCT04393298|541364668|FG011|Overall Study|Patient Discharged to Hospice|0|||
150060950|NCT04393298|541364669|FG012|Overall Study|Patient Discharged to Hospice|0|||
150060951|NCT04393298|541364670|FG013|Overall Study|Patient Discharged to Hospice|0|||
150060952|NCT04393298|541364671|FG014|Overall Study|Patient Discharged to Hospice|0|||
150060953|NCT04393298|541364657|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060954|NCT04393298|541364658|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060955|NCT04393298|541364659|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060956|NCT04393298|541364660|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060957|NCT04393298|541364661|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060958|NCT04393298|541364662|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060959|NCT04393298|541364663|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060960|NCT04393298|541364664|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060961|NCT04393298|541364665|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060962|NCT04393298|541364666|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
150060963|NCT04393298|541364667|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060964|NCT04393298|541364668|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060965|NCT04393298|541364669|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060966|NCT04393298|541364670|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060967|NCT04393298|541364671|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
150060968|NCT04393298|541364657|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
150060969|NCT04393298|541364658|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
150060970|NCT04393298|541364659|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
150060971|NCT04393298|541364660|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
150060972|NCT04393298|541364661|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
150060973|NCT04393298|541364662|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
150060974|NCT04393298|541364663|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
150060975|NCT04393298|541364664|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
150060976|NCT04393298|541364665|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
150060977|NCT04393298|541364666|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
150060978|NCT04393298|541364667|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
150181839|NCT03398148|541804610|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
150181840|NCT03398148|541804596|FG000|Substudy 1 Period 1|Other|0|||
150181841|NCT03398148|541804597|FG001|Substudy 1 Period 1|Other|1|||
150181842|NCT03398148|541804598|FG002|Substudy 1 Period 1|Other|0|||
150024581|NCT02544321|541226000|FG000|Overall Study|Protocol Violation|0|||
150024582|NCT02544321|541226001|FG001|Overall Study|Protocol Violation|1|||
150024583|NCT03493945|541226002|FG000|Phase I Dose Escalation|Ineligible|0|||
150024584|NCT03493945|541226003|FG001|Phase I Dose Escalation|Ineligible|0|||
150024585|NCT03493945|541226004|FG002|Phase I Dose Escalation|Ineligible|1|||
150024586|NCT03493945|541226005|FG003|Phase I Dose Escalation|Ineligible|0|||
150024587|NCT03493945|541226006|FG004|Phase I Dose Escalation|Ineligible|0|||
150024588|NCT03493945|541226007|FG005|Phase I Dose Escalation|Ineligible|0|||
150024589|NCT03493945|541226008|FG006|Phase I Dose Escalation|Ineligible|0|||
150024590|NCT03493945|541226002|FG000|Phase I Dose Escalation|New therapy|0|||
150024591|NCT03493945|541226003|FG001|Phase I Dose Escalation|New therapy|1|||
150024592|NCT03493945|541226004|FG002|Phase I Dose Escalation|New therapy|0|||
150024593|NCT03493945|541226005|FG003|Phase I Dose Escalation|New therapy|0|||
150024594|NCT03493945|541226006|FG004|Phase I Dose Escalation|New therapy|0|||
150024595|NCT03493945|541226007|FG005|Phase I Dose Escalation|New therapy|0|||
150024596|NCT03493945|541226008|FG006|Phase I Dose Escalation|New therapy|0|||
150024597|NCT03493945|541226002|FG000|Phase II Dose Expansion|Refused further treatment|0|||
150024598|NCT03493945|541226003|FG001|Phase II Dose Expansion|Refused further treatment|0|||
150024599|NCT03493945|541226004|FG002|Phase II Dose Expansion|Refused further treatment|0|||
150024600|NCT03493945|541226005|FG003|Phase II Dose Expansion|Refused further treatment|0|||
150024601|NCT03493945|541226006|FG004|Phase II Dose Expansion|Refused further treatment|1|||
150024602|NCT03493945|541226007|FG005|Phase II Dose Expansion|Refused further treatment|1|||
150024603|NCT03493945|541226008|FG006|Phase II Dose Expansion|Refused further treatment|0|||
150024604|NCT03493945|541226002|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024605|NCT03493945|541226003|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024606|NCT03493945|541226004|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024607|NCT03493945|541226005|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
150024608|NCT03493945|541226006|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024609|NCT03493945|541226007|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024610|NCT03493945|541226008|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
150024611|NCT01517750|541226009|FG000|Overall Study|Lost to Follow-up|1|||
150024612|NCT01517750|541226010|FG001|Overall Study|Lost to Follow-up|2|||
150024613|NCT01517750|541226011|FG002|Overall Study|Lost to Follow-up|4|||
150024614|NCT01517750|541226012|FG003|Overall Study|Lost to Follow-up|1|||
150024615|NCT01307319|541226013|FG000|Overall Study|Adverse Event|2|||
150024616|NCT01307319|541226014|FG001|Overall Study|Adverse Event|2|||
150024617|NCT01307319|541226015|FG002|Overall Study|Adverse Event|1|||
150024618|NCT01307319|541226013|FG000|Overall Study|Lost to Follow-up|1|||
150024619|NCT01307319|541226014|FG001|Overall Study|Lost to Follow-up|0|||
150024620|NCT01307319|541226015|FG002|Overall Study|Lost to Follow-up|1|||
150024621|NCT01307319|541226013|FG000|Overall Study|Protocol Violation|1|||
150024622|NCT01307319|541226014|FG001|Overall Study|Protocol Violation|1|||
150024623|NCT01307319|541226015|FG002|Overall Study|Protocol Violation|0|||
150024624|NCT01307319|541226013|FG000|Overall Study|Withdrawal by Subject|0|||
150024625|NCT01307319|541226014|FG001|Overall Study|Withdrawal by Subject|1|||
150024626|NCT01307319|541226015|FG002|Overall Study|Withdrawal by Subject|2|||
150024627|NCT01307319|541226013|FG000|Overall Study|Other|0|||
150024628|NCT01307319|541226014|FG001|Overall Study|Other|4|||
150024629|NCT01307319|541226015|FG002|Overall Study|Other|3|||
150024630|NCT02735239|541226016|FG000|Overall Study|Adverse Event|0|||
150024631|NCT02735239|541226017|FG001|Overall Study|Adverse Event|0|||
150024632|NCT02735239|541226018|FG002|Overall Study|Adverse Event|4|||
150024633|NCT02735239|541226019|FG003|Overall Study|Adverse Event|0|||
150024634|NCT02735239|541226020|FG004|Overall Study|Adverse Event|0|||
150024635|NCT02735239|541226021|FG005|Overall Study|Adverse Event|0|||
150024636|NCT02735239|541226016|FG000|Overall Study|Death|1|||
150024637|NCT02735239|541226017|FG001|Overall Study|Death|1|||
150024638|NCT02735239|541226018|FG002|Overall Study|Death|0|||
150181843|NCT03398148|541804599|FG003|Substudy 1 Period 1|Other|0|||
150181844|NCT03398148|541804600|FG004|Substudy 1 Period 1|Other|3|||
150024639|NCT02735239|541226019|FG003|Overall Study|Death|0|||
150024640|NCT02735239|541226020|FG004|Overall Study|Death|0|||
150024641|NCT02735239|541226021|FG005|Overall Study|Death|0|||
150024642|NCT02735239|541226016|FG000|Overall Study|Physician Decision|0|||
150024643|NCT02735239|541226017|FG001|Overall Study|Physician Decision|0|||
150024644|NCT02735239|541226018|FG002|Overall Study|Physician Decision|1|||
150024645|NCT02735239|541226019|FG003|Overall Study|Physician Decision|0|||
150024646|NCT02735239|541226020|FG004|Overall Study|Physician Decision|0|||
150024647|NCT02735239|541226021|FG005|Overall Study|Physician Decision|0|||
150024648|NCT02735239|541226016|FG000|Overall Study|Progressive disease|3|||
150024649|NCT02735239|541226017|FG001|Overall Study|Progressive disease|1|||
150181845|NCT03398148|541804601|FG005|Substudy 1 Period 1|Other|0|||
150181846|NCT03398148|541804602|FG006|Substudy 1 Period 1|Other|0|||
150060979|NCT04393298|541364668|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
150060980|NCT04393298|541364669|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
150060981|NCT04393298|541364670|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
150060982|NCT04393298|541364671|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
150060983|NCT03754972|541364674|FG000|Overall Study|Protocol Violation|25|||
150060984|NCT05128929|541364676|FG000|Overall Study|Adverse Event|0|||
150060985|NCT05128929|541364677|FG001|Overall Study|Adverse Event|1|||
150060986|NCT04704154|541364682|FG000|Overall Study|Adverse Event|3|||
150060987|NCT04704154|541364683|FG001|Overall Study|Adverse Event|2|||
150060988|NCT04704154|541364684|FG002|Overall Study|Adverse Event|4|||
150060989|NCT04704154|541364685|FG003|Overall Study|Adverse Event|2|||
150060990|NCT04704154|541364686|FG004|Overall Study|Adverse Event|3|||
150060991|NCT04704154|541364687|FG005|Overall Study|Adverse Event|0|||
150060992|NCT04704154|541364682|FG000|Overall Study|Death|3|||
150060993|NCT04704154|541364683|FG001|Overall Study|Death|0|||
150060994|NCT04704154|541364684|FG002|Overall Study|Death|0|||
150060995|NCT04704154|541364685|FG003|Overall Study|Death|0|||
150060996|NCT04704154|541364686|FG004|Overall Study|Death|3|||
150060997|NCT04704154|541364687|FG005|Overall Study|Death|0|||
150060998|NCT04704154|541364682|FG000|Overall Study|Physician Decision|1|||
150060999|NCT04704154|541364683|FG001|Overall Study|Physician Decision|0|||
150061000|NCT04704154|541364684|FG002|Overall Study|Physician Decision|1|||
150061001|NCT04704154|541364685|FG003|Overall Study|Physician Decision|0|||
150061002|NCT04704154|541364686|FG004|Overall Study|Physician Decision|2|||
150061003|NCT04704154|541364687|FG005|Overall Study|Physician Decision|0|||
150061004|NCT04704154|541364682|FG000|Overall Study|Participant Decision|1|||
150061005|NCT04704154|541364683|FG001|Overall Study|Participant Decision|1|||
150061006|NCT04704154|541364684|FG002|Overall Study|Participant Decision|0|||
150061007|NCT04704154|541364685|FG003|Overall Study|Participant Decision|0|||
150061008|NCT04704154|541364686|FG004|Overall Study|Participant Decision|0|||
150061009|NCT04704154|541364687|FG005|Overall Study|Participant Decision|0|||
150061010|NCT04704154|541364682|FG000|Overall Study|Progressive Disease|19|||
150061011|NCT04704154|541364683|FG001|Overall Study|Progressive Disease|17|||
150061012|NCT04704154|541364684|FG002|Overall Study|Progressive Disease|20|||
150061013|NCT04704154|541364685|FG003|Overall Study|Progressive Disease|18|||
150061014|NCT04704154|541364686|FG004|Overall Study|Progressive Disease|36|||
150061015|NCT04704154|541364687|FG005|Overall Study|Progressive Disease|30|||
150061016|NCT04704154|541364682|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
150061017|NCT04704154|541364683|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
150061018|NCT04704154|541364684|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
150061019|NCT04704154|541364685|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
150061020|NCT04704154|541364686|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
150061021|NCT04704154|541364687|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
150061022|NCT04704154|541364682|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
150061023|NCT04704154|541364683|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
150061024|NCT04704154|541364684|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
150061025|NCT04704154|541364685|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
150061026|NCT04704154|541364686|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
150061027|NCT04704154|541364687|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
150061028|NCT02604017|541364689|FG000|Overall Study|Withdrew Consent|0|||
150061029|NCT02604017|541364690|FG001|Overall Study|Withdrew Consent|2|||
150061030|NCT02604017|541364689|FG000|Overall Study|Lost to Follow-up|5|||
150061031|NCT02604017|541364690|FG001|Overall Study|Lost to Follow-up|6|||
150061032|NCT02604017|541364689|FG000|Overall Study|Other|1|||
150061033|NCT02604017|541364690|FG001|Overall Study|Other|0|||
150061034|NCT01634178|541364691|FG000|Treatment Period 1|Adverse Event|0|||
150061035|NCT01634178|541364692|FG001|Treatment Period 1|Adverse Event|1|||
150061036|NCT01634178|541364691|FG000|Treatment Period 2|Adverse Event|1|||
150061037|NCT01634178|541364692|FG001|Treatment Period 2|Adverse Event|0|||
150061038|NCT00058539|541364697|FG000|Overall Study|Disease progression|24|||
150061039|NCT00058539|541364697|FG000|Overall Study|Adverse Event|3|||
150061040|NCT00058539|541364697|FG000|Overall Study|Withdrawal by Subject|5|||
150061041|NCT00058539|541364697|FG000|Overall Study|Physician Decision|9|||
150061042|NCT00058539|541364697|FG000|Overall Study|Death|1|||
150061043|NCT02483533|541364702|FG000|Overall Study|Lack of Efficacy|50|||
150061044|NCT02483533|541364703|FG001|Overall Study|Lack of Efficacy|50|||
150061045|NCT03116347|541364708|FG000|Overall Study|Withdrawal by Subject|1|||
150061046|NCT03116347|541364709|FG001|Overall Study|Withdrawal by Subject|2|||
150061047|NCT01255787|541364710|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
150061048|NCT01255787|541364711|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
150061049|NCT01255787|541364712|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
150061050|NCT01255787|541364713|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
150061051|NCT01255787|541364710|FG000|Overall Study|Major Protocol Deviation|1|||
150061052|NCT01255787|541364711|FG001|Overall Study|Major Protocol Deviation|1|||
150061053|NCT01255787|541364712|FG002|Overall Study|Major Protocol Deviation|0|||
150061054|NCT01255787|541364713|FG003|Overall Study|Major Protocol Deviation|4|||
150061055|NCT01255787|541364710|FG000|Overall Study|Lost to Follow-up|1|||
150061056|NCT01255787|541364711|FG001|Overall Study|Lost to Follow-up|2|||
150061057|NCT01255787|541364712|FG002|Overall Study|Lost to Follow-up|4|||
150061058|NCT01255787|541364713|FG003|Overall Study|Lost to Follow-up|2|||
150061059|NCT01255787|541364710|FG000|Overall Study|Withdrawal of Consent|3|||
150061060|NCT01255787|541364711|FG001|Overall Study|Withdrawal of Consent|9|||
150061061|NCT01255787|541364712|FG002|Overall Study|Withdrawal of Consent|3|||
150061062|NCT01255787|541364713|FG003|Overall Study|Withdrawal of Consent|4|||
150061063|NCT01255787|541364710|FG000|Overall Study|Pregnancy|0|||
150061064|NCT01255787|541364711|FG001|Overall Study|Pregnancy|0|||
150061065|NCT01255787|541364712|FG002|Overall Study|Pregnancy|0|||
150061066|NCT01255787|541364713|FG003|Overall Study|Pregnancy|1|||
150061067|NCT01255787|541364710|FG000|Overall Study|Lack of Efficacy|2|||
150061068|NCT01255787|541364711|FG001|Overall Study|Lack of Efficacy|2|||
150061069|NCT01255787|541364712|FG002|Overall Study|Lack of Efficacy|2|||
150061070|NCT01255787|541364713|FG003|Overall Study|Lack of Efficacy|2|||
150061071|NCT01255787|541364710|FG000|Overall Study|Noncompliance with Study Drug|3|||
150061072|NCT01255787|541364711|FG001|Overall Study|Noncompliance with Study Drug|1|||
150061073|NCT01255787|541364712|FG002|Overall Study|Noncompliance with Study Drug|0|||
150061074|NCT01255787|541364713|FG003|Overall Study|Noncompliance with Study Drug|0|||
150061075|NCT00476047|541364714|FG000|Overall Study|Lost to Follow-up|1|||
150061076|NCT04966741|541364715|FG000|Overall Study|Lost to Follow-up|1|||
150061077|NCT04966741|541364716|FG001|Overall Study|Lost to Follow-up|0|||
150061078|NCT02241889|541364723|FG000|Overall Study|device issues|0|||
150061079|NCT02241889|541364724|FG001|Overall Study|device issues|0|||
150061080|NCT02241889|541364725|FG002|Overall Study|device issues|1|||
150061081|NCT02241889|541364726|FG003|Overall Study|device issues|0|||
150061082|NCT02241889|541364727|FG004|Overall Study|device issues|0|||
150061083|NCT02241889|541364728|FG005|Overall Study|device issues|0|||
150061084|NCT02241889|541364723|FG000|Overall Study|Withdrawal by Subject|0|||
150061085|NCT02241889|541364724|FG001|Overall Study|Withdrawal by Subject|0|||
150061086|NCT02241889|541364725|FG002|Overall Study|Withdrawal by Subject|0|||
150061087|NCT02241889|541364726|FG003|Overall Study|Withdrawal by Subject|0|||
150061088|NCT02241889|541364727|FG004|Overall Study|Withdrawal by Subject|0|||
150061089|NCT02241889|541364728|FG005|Overall Study|Withdrawal by Subject|1|||
150061090|NCT00773838|541364729|FG000|Overall Study|Adverse Event|29|||
150061091|NCT00773838|541364729|FG000|Overall Study|Lost to Follow-up|1|||
150061092|NCT00773838|541364729|FG000|Overall Study|Physician Decision|8|||
150061093|NCT00773838|541364729|FG000|Overall Study|Progressive Disease|82|||
150061094|NCT00773838|541364729|FG000|Overall Study|Protocol Violation|2|||
150061095|NCT00773838|541364729|FG000|Overall Study|Withdrawal by Subject|21|||
150061096|NCT00509262|541364731|FG000|Overall Study|Adverse Event|16|||
150061097|NCT00509262|541364732|FG001|Overall Study|Adverse Event|18|||
150061098|NCT00509262|541364731|FG000|Overall Study|Other|2|||
150061099|NCT00509262|541364732|FG001|Overall Study|Other|2|||
150061100|NCT00509262|541364731|FG000|Overall Study|Lack of Efficacy|1|||
150061101|NCT00509262|541364732|FG001|Overall Study|Lack of Efficacy|0|||
150061102|NCT00509262|541364731|FG000|Overall Study|Lost to Follow-up|1|||
150061103|NCT00509262|541364732|FG001|Overall Study|Lost to Follow-up|6|||
150061104|NCT00509262|541364731|FG000|Overall Study|Physician Decision|1|||
150061105|NCT00509262|541364732|FG001|Overall Study|Physician Decision|3|||
150061106|NCT00509262|541364731|FG000|Overall Study|Protocol Violation|2|||
150061107|NCT00509262|541364732|FG001|Overall Study|Protocol Violation|2|||
150061108|NCT00509262|541364731|FG000|Overall Study|Withdrawal by Subject|24|||
150061109|NCT00509262|541364732|FG001|Overall Study|Withdrawal by Subject|11|||
150061110|NCT01853618|541364733|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
150061111|NCT01853618|541364734|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
150061112|NCT01853618|541364735|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
150061113|NCT01853618|541364736|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
150181847|NCT03398148|541804603|FG007|Substudy 1 Period 1|Other|0|||
150061114|NCT01853618|541364737|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
150061115|NCT01853618|541364733|FG000|Overall Study|Progressive disease|1|||
150061116|NCT01853618|541364734|FG001|Overall Study|Progressive disease|1|||
150061117|NCT01853618|541364735|FG002|Overall Study|Progressive disease|1|||
150061118|NCT01853618|541364736|FG003|Overall Study|Progressive disease|1|||
150061119|NCT01853618|541364737|FG004|Overall Study|Progressive disease|2|||
150061120|NCT01853618|541364733|FG000|Overall Study|Physician Decision|0|||
150061121|NCT01853618|541364734|FG001|Overall Study|Physician Decision|1|||
150061122|NCT01853618|541364735|FG002|Overall Study|Physician Decision|1|||
150061123|NCT01853618|541364736|FG003|Overall Study|Physician Decision|0|||
150061124|NCT01853618|541364737|FG004|Overall Study|Physician Decision|0|||
150061125|NCT01853618|541364733|FG000|Overall Study|Refused further treatment|0|||
150061126|NCT01853618|541364734|FG001|Overall Study|Refused further treatment|0|||
150061127|NCT01853618|541364735|FG002|Overall Study|Refused further treatment|0|||
150024650|NCT02735239|541226018|FG002|Overall Study|Progressive disease|3|||
150024651|NCT02735239|541226019|FG003|Overall Study|Progressive disease|0|||
150024652|NCT02735239|541226020|FG004|Overall Study|Progressive disease|0|||
150024653|NCT02735239|541226021|FG005|Overall Study|Progressive disease|2|||
150024654|NCT02735239|541226016|FG000|Overall Study|Withdrawal by Subject|0|||
150024655|NCT02735239|541226017|FG001|Overall Study|Withdrawal by Subject|1|||
150024656|NCT02735239|541226018|FG002|Overall Study|Withdrawal by Subject|0|||
150024657|NCT02735239|541226019|FG003|Overall Study|Withdrawal by Subject|0|||
150024658|NCT02735239|541226020|FG004|Overall Study|Withdrawal by Subject|0|||
150024659|NCT02735239|541226021|FG005|Overall Study|Withdrawal by Subject|0|||
150024660|NCT02152631|541226023|FG000|Overall Study|Adverse Event|32|||
150024661|NCT02152631|541226024|FG001|Overall Study|Adverse Event|4|||
150024662|NCT02152631|541226023|FG000|Overall Study|Withdrawal by Subject|13|||
150024663|NCT02152631|541226024|FG001|Overall Study|Withdrawal by Subject|16|||
150024664|NCT02152631|541226023|FG000|Overall Study|Noncompliance with study drug|1|||
150024665|NCT02152631|541226024|FG001|Overall Study|Noncompliance with study drug|0|||
150024666|NCT02152631|541226023|FG000|Overall Study|Physician Decision|1|||
150024667|NCT02152631|541226024|FG001|Overall Study|Physician Decision|2|||
150024668|NCT02152631|541226023|FG000|Overall Study|Lost to Follow-up|0|||
150024669|NCT02152631|541226024|FG001|Overall Study|Lost to Follow-up|1|||
150024670|NCT02152631|541226023|FG000|Overall Study|On Treatment|19|||
150024671|NCT02152631|541226024|FG001|Overall Study|On Treatment|3|||
150024672|NCT02038153|541226025|FG000|Overall Study|Withdrawal by Subject|1|||
150024673|NCT02647281|541226026|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024674|NCT02647281|541226027|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024675|NCT02647281|541226028|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024676|NCT02647281|541226029|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024677|NCT02647281|541226030|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024678|NCT02647281|541226031|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024679|NCT02647281|541226032|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024680|NCT02647281|541226033|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
150024681|NCT02647281|541226034|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
150024682|NCT03347123|541226036|FG000|Overall Study|Death|1|||
150024683|NCT03347123|541226037|FG001|Overall Study|Death|2|||
150024684|NCT03347123|541226038|FG002|Overall Study|Death|0|||
150024685|NCT03347123|541226039|FG003|Overall Study|Death|0|||
150024686|NCT03347123|541226040|FG004|Overall Study|Death|0|||
150024687|NCT03347123|541226041|FG005|Overall Study|Death|0|||
150024688|NCT03347123|541226042|FG006|Overall Study|Death|0|||
150024689|NCT03347123|541226036|FG000|Overall Study|Withdrawal by Subject|1|||
150024690|NCT03347123|541226037|FG001|Overall Study|Withdrawal by Subject|0|||
150024691|NCT03347123|541226038|FG002|Overall Study|Withdrawal by Subject|0|||
150024692|NCT03347123|541226039|FG003|Overall Study|Withdrawal by Subject|0|||
150024693|NCT03347123|541226040|FG004|Overall Study|Withdrawal by Subject|0|||
150024694|NCT03347123|541226041|FG005|Overall Study|Withdrawal by Subject|0|||
150061128|NCT01853618|541364736|FG003|Overall Study|Refused further treatment|0|||
150061129|NCT01853618|541364737|FG004|Overall Study|Refused further treatment|1|||
150024695|NCT03347123|541226042|FG006|Overall Study|Withdrawal by Subject|0|||
150024696|NCT03347123|541226036|FG000|Overall Study|Reason not Specified|3|||
150024697|NCT03347123|541226037|FG001|Overall Study|Reason not Specified|4|||
150024698|NCT03347123|541226038|FG002|Overall Study|Reason not Specified|0|||
150024699|NCT03347123|541226039|FG003|Overall Study|Reason not Specified|0|||
150024700|NCT03347123|541226040|FG004|Overall Study|Reason not Specified|0|||
150024701|NCT03347123|541226041|FG005|Overall Study|Reason not Specified|0|||
150061130|NCT02398227|541364742|FG000|Overall Study|Lost to Follow-up|21|||
150061131|NCT02398227|541364743|FG001|Overall Study|Lost to Follow-up|12|||
150061132|NCT02398227|541364742|FG000|Overall Study|Withdrawal by Subject|5|||
150061133|NCT02398227|541364743|FG001|Overall Study|Withdrawal by Subject|6|||
150061134|NCT02398227|541364742|FG000|Overall Study|Removed from treatment and dropped out|1|||
150061135|NCT02398227|541364743|FG001|Overall Study|Removed from treatment and dropped out|0|||
150061136|NCT01715129|541364744|FG000|Overall Study|Adverse Event, fatal|1|||
150061137|NCT01715129|541364744|FG000|Overall Study|Lack of Efficacy|3|||
150061138|NCT01715129|541364744|FG000|Overall Study|Protocol Violation|1|||
150061139|NCT01715129|541364744|FG000|Overall Study|Consent Withdrawn|2|||
150061140|NCT01715129|541364744|FG000|Overall Study|Lost to Follow-up|1|||
150061141|NCT01715129|541364744|FG000|Overall Study|Other|1|||
150061142|NCT02009384|541364745|FG000|Overall Study|Death|2|||
150061143|NCT01146860|541364746|FG000|Overall Study|Withdrawal by Subject|0|||
150061144|NCT01146860|541364747|FG001|Overall Study|Withdrawal by Subject|1|||
150061145|NCT01092832|541364748|FG000|Overall Study|Other|1|||
150061146|NCT01092832|541364749|FG001|Overall Study|Other|0|||
150061147|NCT02674854|541364750|FG000|Overall Study|Adverse Event|17|||
150061148|NCT02674854|541364751|FG001|Overall Study|Adverse Event|15|||
150061149|NCT02674854|541364752|FG002|Overall Study|Adverse Event|5|||
150061150|NCT02674854|541364750|FG000|Overall Study|Withdrawal by Subject|1|||
150061151|NCT02674854|541364751|FG001|Overall Study|Withdrawal by Subject|5|||
150061152|NCT02674854|541364752|FG002|Overall Study|Withdrawal by Subject|4|||
150024702|NCT03347123|541226042|FG006|Overall Study|Reason not Specified|0|||
150024703|NCT03985761|541226045|FG000|Overall Study|Withdrawal by Subject|2|||
150024704|NCT03985761|541226046|FG001|Overall Study|Withdrawal by Subject|3|||
150024705|NCT02532465|541226047|FG000|Overall Study|Protocol Violation|1|||
150024706|NCT02532465|541226048|FG001|Overall Study|Protocol Violation|0|||
150024707|NCT02532465|541226047|FG000|Overall Study|Lack of Efficacy|0|||
150024708|NCT02532465|541226048|FG001|Overall Study|Lack of Efficacy|1|||
150024709|NCT02420093|541226052|FG000|Overall Study|Withdrawal by Subject|1|||
150024710|NCT02420093|541226053|FG001|Overall Study|Withdrawal by Subject|1|||
150024711|NCT03001557|541226055|FG000|Core Phase|Randomized but not treated|0|||
150024712|NCT03001557|541226056|FG001|Core Phase|Randomized but not treated|0|||
150024713|NCT03001557|541226057|FG002|Core Phase|Randomized but not treated|1|||
150024714|NCT03001557|541226058|FG003|Core Phase|Randomized but not treated|0|||
150024715|NCT03001557|541226059|FG004|Core Phase|Randomized but not treated|0|||
150024716|NCT03001557|541226060|FG005|Core Phase|Randomized but not treated|0|||
150024717|NCT03001557|541226061|FG006|Core Phase|Randomized but not treated|0|||
150024718|NCT03001557|541226062|FG007|Core Phase|Randomized but not treated|0|||
150024719|NCT03001557|541226055|FG000|Extension Phase|Adverse Event|0|||
150024720|NCT03001557|541226056|FG001|Extension Phase|Adverse Event|0|||
150024721|NCT03001557|541226057|FG002|Extension Phase|Adverse Event|0|||
150024722|NCT03001557|541226058|FG003|Extension Phase|Adverse Event|0|||
150024723|NCT03001557|541226059|FG004|Extension Phase|Adverse Event|0|||
150024724|NCT03001557|541226060|FG005|Extension Phase|Adverse Event|2|||
150024725|NCT03001557|541226061|FG006|Extension Phase|Adverse Event|0|||
150024726|NCT03001557|541226062|FG007|Extension Phase|Adverse Event|0|||
150024727|NCT03001557|541226055|FG000|Extension Phase|Withdrawal by Subject|0|||
150024728|NCT03001557|541226056|FG001|Extension Phase|Withdrawal by Subject|0|||
150024729|NCT03001557|541226057|FG002|Extension Phase|Withdrawal by Subject|0|||
150024730|NCT03001557|541226058|FG003|Extension Phase|Withdrawal by Subject|0|||
150024731|NCT03001557|541226059|FG004|Extension Phase|Withdrawal by Subject|0|||
150024732|NCT03001557|541226060|FG005|Extension Phase|Withdrawal by Subject|1|||
150024733|NCT03001557|541226061|FG006|Extension Phase|Withdrawal by Subject|5|||
150024734|NCT03001557|541226062|FG007|Extension Phase|Withdrawal by Subject|2|||
150024735|NCT03001557|541226055|FG000|Extension Phase|Lost to Follow-up|0|||
150024736|NCT03001557|541226056|FG001|Extension Phase|Lost to Follow-up|0|||
150024737|NCT03001557|541226057|FG002|Extension Phase|Lost to Follow-up|0|||
150024738|NCT03001557|541226058|FG003|Extension Phase|Lost to Follow-up|0|||
150024739|NCT03001557|541226059|FG004|Extension Phase|Lost to Follow-up|0|||
150024740|NCT03001557|541226060|FG005|Extension Phase|Lost to Follow-up|0|||
150024741|NCT03001557|541226061|FG006|Extension Phase|Lost to Follow-up|2|||
150024742|NCT03001557|541226062|FG007|Extension Phase|Lost to Follow-up|1|||
150024743|NCT03001557|541226055|FG000|Extension Phase|Administrative Reason|0|||
150024744|NCT03001557|541226056|FG001|Extension Phase|Administrative Reason|0|||
150024745|NCT03001557|541226057|FG002|Extension Phase|Administrative Reason|0|||
150024746|NCT03001557|541226058|FG003|Extension Phase|Administrative Reason|0|||
150024747|NCT03001557|541226059|FG004|Extension Phase|Administrative Reason|0|||
150024748|NCT03001557|541226060|FG005|Extension Phase|Administrative Reason|1|||
150024749|NCT03001557|541226061|FG006|Extension Phase|Administrative Reason|3|||
150024750|NCT03001557|541226062|FG007|Extension Phase|Administrative Reason|3|||
150061153|NCT02674854|541364750|FG000|Overall Study|No-compliant subject|1|||
150061154|NCT02674854|541364751|FG001|Overall Study|No-compliant subject|0|||
150061155|NCT02674854|541364752|FG002|Overall Study|No-compliant subject|1|||
150061156|NCT02674854|541364750|FG000|Overall Study|Lost to Follow-up|1|||
150061157|NCT02674854|541364751|FG001|Overall Study|Lost to Follow-up|0|||
150061158|NCT02674854|541364752|FG002|Overall Study|Lost to Follow-up|2|||
150061159|NCT02674854|541364750|FG000|Overall Study|Lack of Efficacy|0|||
150061160|NCT02674854|541364751|FG001|Overall Study|Lack of Efficacy|3|||
150061161|NCT02674854|541364752|FG002|Overall Study|Lack of Efficacy|0|||
150061162|NCT02674854|541364750|FG000|Overall Study|Disallowed Concurrent Medication|2|||
150061163|NCT02674854|541364751|FG001|Overall Study|Disallowed Concurrent Medication|2|||
150061164|NCT02674854|541364752|FG002|Overall Study|Disallowed Concurrent Medication|0|||
150061165|NCT02674854|541364750|FG000|Overall Study|Protocol Violation|1|||
150061166|NCT02674854|541364751|FG001|Overall Study|Protocol Violation|1|||
150061167|NCT02674854|541364752|FG002|Overall Study|Protocol Violation|2|||
150061168|NCT02674854|541364750|FG000|Overall Study|Death|0|||
150061169|NCT02674854|541364751|FG001|Overall Study|Death|1|||
150061170|NCT02674854|541364752|FG002|Overall Study|Death|0|||
150061171|NCT02674854|541364750|FG000|Overall Study|Subject missed V6.2|1|||
150061172|NCT02674854|541364751|FG001|Overall Study|Subject missed V6.2|0|||
150061173|NCT02674854|541364752|FG002|Overall Study|Subject missed V6.2|0|||
150061174|NCT03149848|541364753|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
150061175|NCT03149848|541364753|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
150061176|NCT00400153|541364754|FG000|Overall Study|AE due to study disease worsening|14|||
150061177|NCT00400153|541364755|FG001|Overall Study|AE due to study disease worsening|19|||
150061178|NCT00400153|541364756|FG002|Overall Study|AE due to study disease worsening|20|||
150061179|NCT00400153|541364754|FG000|Overall Study|AE due to other disease worsening|2|||
150061180|NCT00400153|541364755|FG001|Overall Study|AE due to other disease worsening|1|||
150061181|NCT00400153|541364756|FG002|Overall Study|AE due to other disease worsening|0|||
150061182|NCT00400153|541364754|FG000|Overall Study|AE due to other condition|3|||
150061183|NCT00400153|541364755|FG001|Overall Study|AE due to other condition|14|||
150061184|NCT00400153|541364756|FG002|Overall Study|AE due to other condition|15|||
150061185|NCT00400153|541364754|FG000|Overall Study|Protocol Violation|7|||
150061186|NCT00400153|541364755|FG001|Overall Study|Protocol Violation|4|||
150061187|NCT00400153|541364756|FG002|Overall Study|Protocol Violation|9|||
150061188|NCT00400153|541364754|FG000|Overall Study|Lost to Follow-up|2|||
150061189|NCT00400153|541364755|FG001|Overall Study|Lost to Follow-up|1|||
150061190|NCT00400153|541364756|FG002|Overall Study|Lost to Follow-up|4|||
150061191|NCT00400153|541364754|FG000|Overall Study|Withdrawal by Subject|12|||
150061192|NCT00400153|541364755|FG001|Overall Study|Withdrawal by Subject|11|||
150061193|NCT00400153|541364756|FG002|Overall Study|Withdrawal by Subject|10|||
150061194|NCT00400153|541364754|FG000|Overall Study|Other reasons - not mentioned above|8|||
150061195|NCT00400153|541364755|FG001|Overall Study|Other reasons - not mentioned above|5|||
150061196|NCT00400153|541364756|FG002|Overall Study|Other reasons - not mentioned above|3|||
150061197|NCT04738318|541364759|FG000|Overall Study|Protocol Violation|1|||
150061198|NCT04738318|541364760|FG001|Overall Study|Protocol Violation|0|||
150061199|NCT01226121|541364761|FG000|Overall Study|Lost to Follow-up|2|||
150061200|NCT01226121|541364762|FG001|Overall Study|Lost to Follow-up|0|||
150061201|NCT01226121|541364763|FG002|Overall Study|Lost to Follow-up|1|||
150061202|NCT04231981|541364764|FG000|Overall Study|Adverse Event|1|||
150061203|NCT04231981|541364764|FG000|Overall Study|Death|16|||
150061204|NCT04231981|541364764|FG000|Overall Study|Lost to Follow-up|1|||
150061205|NCT00378079|541364765|FG000|Overall Study|Lost to Follow-up|6|||
150061206|NCT00378079|541364766|FG001|Overall Study|Lost to Follow-up|1|||
150061207|NCT00378079|541364767|FG002|Overall Study|Lost to Follow-up|0|||
150061208|NCT02581943|541364768|FG000|Overall Study|Death|5|||
150061209|NCT02581943|541364769|FG001|Overall Study|Death|2|||
150061210|NCT02581943|541364768|FG000|Overall Study|Disease Progression|12|||
150061211|NCT02581943|541364769|FG001|Overall Study|Disease Progression|15|||
150061212|NCT02581943|541364768|FG000|Overall Study|Withdrawal by Subject|1|||
150061213|NCT02581943|541364769|FG001|Overall Study|Withdrawal by Subject|2|||
150061214|NCT01233687|541364770|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
150061215|NCT01233687|541364770|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
150061216|NCT01233687|541364770|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
150061217|NCT04473482|541364775|FG000|Overall Study|Death|0|||
150061218|NCT04473482|541364776|FG001|Overall Study|Death|3|||
150061219|NCT04473482|541364775|FG000|Overall Study|Lost to Follow-up|9|||
150061220|NCT04473482|541364776|FG001|Overall Study|Lost to Follow-up|7|||
150061221|NCT04473482|541364775|FG000|Overall Study|Withdrawal by Subject|2|||
150061222|NCT04473482|541364776|FG001|Overall Study|Withdrawal by Subject|1|||
150061223|NCT00745615|541364783|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
150061224|NCT00745615|541364784|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
150061225|NCT00745615|541364785|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
150061226|NCT00745615|541364786|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
150061227|NCT00745615|541364787|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
150024751|NCT03001557|541226055|FG000|Extension Phase|Loss of caregiver|0|||
150024752|NCT03001557|541226056|FG001|Extension Phase|Loss of caregiver|0|||
150024753|NCT03001557|541226057|FG002|Extension Phase|Loss of caregiver|0|||
150024754|NCT03001557|541226058|FG003|Extension Phase|Loss of caregiver|0|||
150024755|NCT03001557|541226059|FG004|Extension Phase|Loss of caregiver|0|||
150024756|NCT03001557|541226060|FG005|Extension Phase|Loss of caregiver|0|||
150024757|NCT03001557|541226061|FG006|Extension Phase|Loss of caregiver|1|||
150024758|NCT03001557|541226062|FG007|Extension Phase|Loss of caregiver|0|||
150024759|NCT03001557|541226055|FG000|Extension Phase|Others|0|||
150024760|NCT03001557|541226056|FG001|Extension Phase|Others|0|||
150024761|NCT03001557|541226057|FG002|Extension Phase|Others|0|||
150024762|NCT03001557|541226058|FG003|Extension Phase|Others|0|||
150024763|NCT03001557|541226059|FG004|Extension Phase|Others|0|||
150024764|NCT03001557|541226060|FG005|Extension Phase|Others|1|||
150024765|NCT03001557|541226061|FG006|Extension Phase|Others|3|||
150024766|NCT03001557|541226062|FG007|Extension Phase|Others|0|||
150024767|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
150024768|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
150024769|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Death|1|||
150024770|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Death|2|||
150024771|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
150024772|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
150024773|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
150024774|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
150024775|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
150024776|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
150024777|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
150024778|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
150024779|NCT01794000|541226063|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
150024780|NCT01794000|541226064|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
150024781|NCT01794000|541226063|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
150024782|NCT01794000|541226064|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
150024783|NCT00965081|541226065|FG000|Overall Study|Adverse Event|14|||
150024784|NCT00965081|541226066|FG001|Overall Study|Adverse Event|9|||
150024785|NCT00965081|541226065|FG000|Overall Study|Lack of Efficacy|2|||
150024786|NCT00965081|541226066|FG001|Overall Study|Lack of Efficacy|5|||
150024787|NCT00965081|541226065|FG000|Overall Study|Lost to Follow-up|4|||
150024788|NCT00965081|541226066|FG001|Overall Study|Lost to Follow-up|5|||
150024789|NCT00965081|541226065|FG000|Overall Study|Physician Decision|2|||
150024790|NCT00965081|541226066|FG001|Overall Study|Physician Decision|0|||
150024791|NCT00965081|541226065|FG000|Overall Study|Protocol Violation|2|||
150024792|NCT00965081|541226066|FG001|Overall Study|Protocol Violation|5|||
150024793|NCT00965081|541226065|FG000|Overall Study|Sponsor Decision|1|||
150024794|NCT00965081|541226066|FG001|Overall Study|Sponsor Decision|0|||
150024795|NCT00965081|541226065|FG000|Overall Study|Withdrawal by Subject|4|||
150024796|NCT00965081|541226066|FG001|Overall Study|Withdrawal by Subject|7|||
150024797|NCT00965081|541226065|FG000|Overall Study|Switched to Rescue Arm|5|||
150024798|NCT00965081|541226066|FG001|Overall Study|Switched to Rescue Arm|12|||
150024799|NCT01367834|541226069|FG000|Overall Study|Withdrawal by Subject|2|||
150024800|NCT01367834|541226070|FG001|Overall Study|Withdrawal by Subject|2|||
150024801|NCT01367834|541226069|FG000|Overall Study|Study was ended.|0|||
150024802|NCT01367834|541226070|FG001|Overall Study|Study was ended.|1|||
150024803|NCT00255190|541226071|FG000|Overall Study|Adverse Event|17|||
150024804|NCT00255190|541226072|FG001|Overall Study|Adverse Event|36|||
150024805|NCT00255190|541226071|FG000|Overall Study|Protocol Violation|2|||
150024806|NCT00255190|541226072|FG001|Overall Study|Protocol Violation|2|||
150061228|NCT00745615|541364788|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
150061229|NCT00745615|541364783|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
150061230|NCT00745615|541364784|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
150061231|NCT00745615|541364785|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
150061232|NCT00745615|541364786|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
150181848|NCT03398148|541804604|FG008|Substudy 1 Period 1|Other|0|||
150181849|NCT03398148|541804605|FG009|Substudy 1 Period 1|Other|0|||
150181850|NCT03398148|541804606|FG010|Substudy 1 Period 1|Other|0|||
150181851|NCT03398148|541804607|FG011|Substudy 1 Period 1|Other|0|||
150181852|NCT03398148|541804608|FG012|Substudy 1 Period 1|Other|0|||
150181853|NCT03398148|541804609|FG013|Substudy 1 Period 1|Other|0|||
150181854|NCT03398148|541804610|FG014|Substudy 1 Period 1|Other|0|||
150181855|NCT03398148|541804596|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181856|NCT03398148|541804597|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181857|NCT03398148|541804598|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181858|NCT03398148|541804599|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181859|NCT03398148|541804600|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
150181860|NCT03398148|541804601|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181861|NCT03398148|541804602|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181862|NCT03398148|541804603|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181863|NCT03398148|541804604|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181864|NCT03398148|541804605|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181865|NCT03398148|541804606|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181866|NCT03398148|541804607|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181867|NCT03398148|541804608|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181868|NCT03398148|541804609|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181869|NCT03398148|541804610|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
150181870|NCT03398148|541804596|FG000|Substudy 1 Period 2|Adverse Event|0|||
150181871|NCT03398148|541804597|FG001|Substudy 1 Period 2|Adverse Event|0|||
150181872|NCT03398148|541804598|FG002|Substudy 1 Period 2|Adverse Event|0|||
150181873|NCT03398148|541804599|FG003|Substudy 1 Period 2|Adverse Event|0|||
150181874|NCT03398148|541804600|FG004|Substudy 1 Period 2|Adverse Event|0|||
150181875|NCT03398148|541804601|FG005|Substudy 1 Period 2|Adverse Event|2|||
150181876|NCT03398148|541804602|FG006|Substudy 1 Period 2|Adverse Event|4|||
150061233|NCT00745615|541364787|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
150061234|NCT00745615|541364788|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
150061235|NCT00745615|541364783|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
150061236|NCT00745615|541364784|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
150061237|NCT00745615|541364785|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
150061238|NCT00745615|541364786|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
150061239|NCT00745615|541364787|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
150061240|NCT00745615|541364788|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
150061241|NCT00745615|541364783|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
150061242|NCT00745615|541364784|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
150061243|NCT00745615|541364785|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
150061244|NCT00745615|541364786|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
150061245|NCT00745615|541364787|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
150061246|NCT00745615|541364788|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
150061247|NCT00745615|541364783|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
150061248|NCT00745615|541364784|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
150061249|NCT00745615|541364785|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
150061250|NCT00745615|541364786|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
150061251|NCT00745615|541364787|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
150061252|NCT00745615|541364788|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
150061253|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
150061254|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
150181877|NCT03398148|541804603|FG007|Substudy 1 Period 2|Adverse Event|0|||
150181878|NCT03398148|541804604|FG008|Substudy 1 Period 2|Adverse Event|0|||
150181879|NCT03398148|541804605|FG009|Substudy 1 Period 2|Adverse Event|0|||
150181880|NCT03398148|541804606|FG010|Substudy 1 Period 2|Adverse Event|0|||
150181881|NCT03398148|541804607|FG011|Substudy 1 Period 2|Adverse Event|0|||
150181882|NCT03398148|541804608|FG012|Substudy 1 Period 2|Adverse Event|0|||
150181883|NCT03398148|541804609|FG013|Substudy 1 Period 2|Adverse Event|0|||
150181884|NCT03398148|541804610|FG014|Substudy 1 Period 2|Adverse Event|0|||
150061255|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
150061256|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
150061257|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
150061258|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
150061259|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
150061260|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
150061261|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
150061262|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
150061263|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
150061264|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
150061265|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
150061266|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
150061267|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
150061268|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
150061269|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
150061270|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
150061271|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
150061272|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
150061273|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
150061274|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
150061275|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
150061276|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
150061277|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
150061278|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
150061279|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
150061280|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
150061281|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
150061282|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
150061283|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
150061284|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
150061285|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
150061286|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
150061287|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
150061288|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
150061289|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
150061290|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
150061291|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
150061292|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
150061293|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
150061294|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
150061295|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
150061296|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
150061297|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
150061298|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
150061299|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
150061300|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
150061301|NCT00745615|541364783|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
150061302|NCT00745615|541364784|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
150061303|NCT00745615|541364785|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
150061304|NCT00745615|541364786|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
150061305|NCT00745615|541364787|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
150061306|NCT00745615|541364788|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
150061307|NCT00570232|541364789|FG000|Overall Study|Adverse Event|10|||
150061308|NCT00570232|541364789|FG000|Overall Study|discontinued due to medical condition|3|||
150061309|NCT00570232|541364789|FG000|Overall Study|discontinued due to recurrence|8|||
150181885|NCT03398148|541804596|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181886|NCT03398148|541804597|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181887|NCT03398148|541804598|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181888|NCT03398148|541804599|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181889|NCT03398148|541804600|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150061310|NCT00570232|541364789|FG000|Overall Study|discontinued due to noncompliance|2|||
150181890|NCT03398148|541804601|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181891|NCT03398148|541804602|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
150181892|NCT03398148|541804603|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
150181893|NCT03398148|541804604|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150061311|NCT01076075|541364790|FG000|Overall Study|Adverse Event|3|||
150061312|NCT01076075|541364791|FG001|Overall Study|Adverse Event|9|||
150061313|NCT01076075|541364790|FG000|Overall Study|Lack of Efficacy|5|||
150061314|NCT01076075|541364791|FG001|Overall Study|Lack of Efficacy|4|||
150061315|NCT01076075|541364790|FG000|Overall Study|Lost to Follow-up|6|||
150061316|NCT01076075|541364791|FG001|Overall Study|Lost to Follow-up|5|||
150061317|NCT01076075|541364790|FG000|Overall Study|other|19|||
150061318|NCT01076075|541364791|FG001|Overall Study|other|9|||
150061319|NCT01076075|541364790|FG000|Overall Study|Protocol Violation|0|||
150061320|NCT01076075|541364791|FG001|Overall Study|Protocol Violation|1|||
150061321|NCT01076075|541364790|FG000|Overall Study|Withdrawal by Subject|8|||
150061322|NCT01076075|541364791|FG001|Overall Study|Withdrawal by Subject|19|||
150061323|NCT01445886|541364797|FG000|Overall Study|Lost to Follow-up|2|||
150061324|NCT01445886|541364797|FG000|Overall Study|Protocol Violation|3|||
150061325|NCT01602666|541364798|FG000|Induction Chemotherapy|Death|2|||
150061326|NCT01602666|541364799|FG001|Induction Chemotherapy|Death|1|||
150061327|NCT01602666|541364798|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
150061328|NCT01602666|541364799|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
150061329|NCT01602666|541364798|FG000|Induction Chemotherapy|Physician Decision|12|||
150061330|NCT01602666|541364799|FG001|Induction Chemotherapy|Physician Decision|5|||
150061331|NCT01602666|541364798|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
150061332|NCT01602666|541364799|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
150061333|NCT01602666|541364798|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
150061334|NCT01602666|541364799|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
150061335|NCT01602666|541364798|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
150061336|NCT01602666|541364799|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
150061337|NCT01602666|541364798|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
150061338|NCT01602666|541364799|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
150061339|NCT01602666|541364798|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
150061340|NCT01602666|541364799|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
150061341|NCT01602666|541364798|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
150061342|NCT01602666|541364799|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
150061343|NCT01602666|541364798|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
150061344|NCT01602666|541364799|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
150061345|NCT01602666|541364798|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
150061346|NCT01602666|541364799|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
150061347|NCT03576274|541364800|FG000|Overall Study|Lost to Follow-up|3|||
150061348|NCT03576274|541364801|FG001|Overall Study|Lost to Follow-up|2|||
150061349|NCT03576274|541364802|FG002|Overall Study|Lost to Follow-up|3|||
150061350|NCT03576274|541364803|FG003|Overall Study|Lost to Follow-up|1|||
150061351|NCT03576274|541364804|FG004|Overall Study|Lost to Follow-up|3|||
150061352|NCT03576274|541364800|FG000|Overall Study|Withdrawal by Subject|5|||
150061353|NCT03576274|541364801|FG001|Overall Study|Withdrawal by Subject|3|||
150061354|NCT03576274|541364802|FG002|Overall Study|Withdrawal by Subject|2|||
150061355|NCT03576274|541364803|FG003|Overall Study|Withdrawal by Subject|8|||
150061356|NCT03576274|541364804|FG004|Overall Study|Withdrawal by Subject|6|||
150061357|NCT03387150|541366143|FG000|Overall Study|Withdrawal by Subject|3|||
150061358|NCT03387150|541366144|FG001|Overall Study|Withdrawal by Subject|0|||
150061359|NCT03387150|541366145|FG002|Overall Study|Withdrawal by Subject|3|||
150061360|NCT03387150|541366146|FG003|Overall Study|Withdrawal by Subject|4|||
150061361|NCT03387150|541366147|FG004|Overall Study|Withdrawal by Subject|1|||
150061362|NCT03387150|541366148|FG005|Overall Study|Withdrawal by Subject|2|||
150061363|NCT03387150|541366149|FG006|Overall Study|Withdrawal by Subject|0|||
150061364|NCT03387150|541366143|FG000|Overall Study|Lost to Follow-up|3|||
150061365|NCT03387150|541366144|FG001|Overall Study|Lost to Follow-up|2|||
150061366|NCT03387150|541366145|FG002|Overall Study|Lost to Follow-up|2|||
150061367|NCT03387150|541366146|FG003|Overall Study|Lost to Follow-up|3|||
150061368|NCT03387150|541366147|FG004|Overall Study|Lost to Follow-up|3|||
150061369|NCT03387150|541366148|FG005|Overall Study|Lost to Follow-up|3|||
150061370|NCT03387150|541366149|FG006|Overall Study|Lost to Follow-up|0|||
150061371|NCT03387150|541366143|FG000|Overall Study|Participant unable to adhere to visit|0|||
150061372|NCT03387150|541366144|FG001|Overall Study|Participant unable to adhere to visit|1|||
150061373|NCT03387150|541366145|FG002|Overall Study|Participant unable to adhere to visit|0|||
150061374|NCT03387150|541366146|FG003|Overall Study|Participant unable to adhere to visit|0|||
150061375|NCT03387150|541366147|FG004|Overall Study|Participant unable to adhere to visit|2|||
150061376|NCT03387150|541366148|FG005|Overall Study|Participant unable to adhere to visit|2|||
150181894|NCT03398148|541804605|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181895|NCT03398148|541804606|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150061377|NCT03387150|541366149|FG006|Overall Study|Participant unable to adhere to visit|0|||
150061378|NCT04078178|541366150|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
150061379|NCT04078178|541366151|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
150061380|NCT04078178|541366150|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
150061381|NCT04078178|541366151|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
150061382|NCT04078178|541366150|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
150061383|NCT04078178|541366151|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
150061384|NCT04078178|541366150|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
150061385|NCT04078178|541366151|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
150061386|NCT04078178|541366150|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
150061387|NCT04078178|541366151|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
150061388|NCT04006119|541366152|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
150061389|NCT04006119|541366152|FG000|End of Treatment Veledimex|Adverse Event|2|||
150061390|NCT04006119|541366152|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
150061391|NCT04006119|541366152|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
150061392|NCT04006119|541366152|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
150061393|NCT04006119|541366152|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
150061394|NCT04617795|541366153|FG000|Main Study|Lost to Follow-up|1|||
150061395|NCT04617795|541366154|FG001|Main Study|Lost to Follow-up|0|||
150061396|NCT00472459|541366155|FG000|Overall Study|Adverse Event|13|||
150061397|NCT00472459|541366156|FG001|Overall Study|Adverse Event|13|||
150061398|NCT00472459|541366155|FG000|Overall Study|Withdrawal by Subject|5|||
150061399|NCT00472459|541366156|FG001|Overall Study|Withdrawal by Subject|5|||
150061400|NCT00472459|541366155|FG000|Overall Study|Protocol Violation|3|||
150061401|NCT00472459|541366156|FG001|Overall Study|Protocol Violation|3|||
150061402|NCT00472459|541366155|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
150061403|NCT00472459|541366156|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
150061404|NCT00472459|541366155|FG000|Overall Study|Lost to Follow-up|1|||
150061405|NCT00472459|541366156|FG001|Overall Study|Lost to Follow-up|1|||
150061406|NCT04850313|541366157|FG000|Overall Study|Withdrawal by Subject|0|||
150061407|NCT04850313|541366158|FG001|Overall Study|Withdrawal by Subject|1|||
150061408|NCT03269552|541366161|FG000|Overall Study|Adverse Event|2|||
150061409|NCT02186301|541366162|FG000|Overall Study|Progressive Disease|7|||
150061410|NCT02186301|541366163|FG001|Overall Study|Progressive Disease|22|||
150061411|NCT02186301|541366164|FG002|Overall Study|Progressive Disease|27|||
150061412|NCT02186301|541366162|FG000|Overall Study|Adverse Event|5|||
150061413|NCT02186301|541366163|FG001|Overall Study|Adverse Event|5|||
150061414|NCT02186301|541366164|FG002|Overall Study|Adverse Event|5|||
150061415|NCT02186301|541366162|FG000|Overall Study|Death|1|||
150061416|NCT02186301|541366163|FG001|Overall Study|Death|0|||
150061417|NCT02186301|541366164|FG002|Overall Study|Death|0|||
150061418|NCT02186301|541366162|FG000|Overall Study|Withdrawal by Subject|5|||
150061419|NCT02186301|541366163|FG001|Overall Study|Withdrawal by Subject|1|||
150061420|NCT02186301|541366164|FG002|Overall Study|Withdrawal by Subject|3|||
150061421|NCT02186301|541366162|FG000|Overall Study|Physician Decision|1|||
150061422|NCT02186301|541366163|FG001|Overall Study|Physician Decision|0|||
150061423|NCT02186301|541366164|FG002|Overall Study|Physician Decision|1|||
150061424|NCT02186301|541366162|FG000|Overall Study|Study Terminated by Sponsor|1|||
150061425|NCT02186301|541366163|FG001|Overall Study|Study Terminated by Sponsor|0|||
150061426|NCT02186301|541366164|FG002|Overall Study|Study Terminated by Sponsor|11|||
150061427|NCT02186301|541366162|FG000|Overall Study|Protocol Deviation|0|||
150061428|NCT02186301|541366163|FG001|Overall Study|Protocol Deviation|2|||
150061429|NCT02186301|541366164|FG002|Overall Study|Protocol Deviation|0|||
150061430|NCT02186301|541366162|FG000|Overall Study|Missing|0|||
150061431|NCT02186301|541366163|FG001|Overall Study|Missing|0|||
150061432|NCT02186301|541366164|FG002|Overall Study|Missing|2|||
150061433|NCT02186301|541366162|FG000|Overall Study|Other|0|||
150061434|NCT02186301|541366163|FG001|Overall Study|Other|0|||
150061435|NCT02186301|541366164|FG002|Overall Study|Other|1|||
150061436|NCT00095238|541366167|FG000|Overall Study|Lack of Efficacy|9|||
150061437|NCT00095238|541366168|FG001|Overall Study|Lack of Efficacy|9|||
150061438|NCT00095238|541366167|FG000|Overall Study|Adverse Event|331|||
150061439|NCT00095238|541366168|FG001|Overall Study|Adverse Event|287|||
150061440|NCT00095238|541366167|FG000|Overall Study|Subject Withdrew Consent|208|||
150061441|NCT00095238|541366168|FG001|Overall Study|Subject Withdrew Consent|223|||
150061442|NCT00095238|541366167|FG000|Overall Study|Death|154|||
150061443|NCT00095238|541366168|FG001|Overall Study|Death|170|||
150061444|NCT00095238|541366167|FG000|Overall Study|Lost to Follow-up|19|||
150061445|NCT00095238|541366168|FG001|Overall Study|Lost to Follow-up|24|||
150061446|NCT00095238|541366167|FG000|Overall Study|Noncompliance|44|||
150061447|NCT00095238|541366168|FG001|Overall Study|Noncompliance|45|||
150061448|NCT00095238|541366167|FG000|Overall Study|No longer met study criteria|4|||
150061449|NCT00095238|541366168|FG001|Overall Study|No longer met study criteria|5|||
150061450|NCT00095238|541366167|FG000|Overall Study|Study terminated by sponsor|0|||
150061451|NCT00095238|541366168|FG001|Overall Study|Study terminated by sponsor|1|||
150061452|NCT00095238|541366167|FG000|Overall Study|Missing|1|||
150061453|NCT00095238|541366168|FG001|Overall Study|Missing|0|||
150061454|NCT00095238|541366167|FG000|Overall Study|Other Reasons|87|||
150061455|NCT00095238|541366168|FG001|Overall Study|Other Reasons|88|||
150061456|NCT03505671|541366169|FG000|Overall Study|Withdrawal by Subject|2|||
150061457|NCT03505671|541366170|FG001|Overall Study|Withdrawal by Subject|1|||
150061458|NCT03505671|541366169|FG000|Overall Study|Lost to Follow-up|1|||
150024807|NCT00255190|541226071|FG000|Overall Study|Lost to Follow-up|10|||
150024808|NCT00255190|541226072|FG001|Overall Study|Lost to Follow-up|27|||
150024809|NCT00255190|541226071|FG000|Overall Study|Withdrew Consent|17|||
150024810|NCT00255190|541226072|FG001|Overall Study|Withdrew Consent|48|||
150024811|NCT00255190|541226071|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
150024812|NCT00255190|541226072|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
150024813|NCT00255190|541226071|FG000|Overall Study|Erosive esophagitis not healed|0|||
150024814|NCT00255190|541226072|FG001|Overall Study|Erosive esophagitis not healed|20|||
150024815|NCT00255190|541226071|FG000|Overall Study|Various|4|||
150024816|NCT00255190|541226072|FG001|Overall Study|Various|23|||
150024817|NCT04537793|541226078|FG000|Part B (24 Weeks)|Adverse Event|0|||
150024818|NCT04537793|541226079|FG001|Part B (24 Weeks)|Adverse Event|1|||
150024819|NCT00988598|541226080|FG000|Overall Study|Withdrawal by Subject|2|||
150024820|NCT00988598|541226081|FG001|Overall Study|Withdrawal by Subject|0|||
150024821|NCT00256724|541226084|FG000|Overall Study|Physician Decision|2|||
150024822|NCT00256724|541226085|FG001|Overall Study|Physician Decision|5|||
150024823|NCT00256724|541226084|FG000|Overall Study|Protocol Violation|3|||
150024824|NCT00256724|541226085|FG001|Overall Study|Protocol Violation|3|||
150024825|NCT01217463|541226086|FG000|Overall Study|Adverse Event|8|||
150024826|NCT01217463|541226087|FG001|Overall Study|Adverse Event|5|||
150024827|NCT01217463|541226086|FG000|Overall Study|Physician Decision|0|||
150024828|NCT01217463|541226087|FG001|Overall Study|Physician Decision|1|||
150024829|NCT01217463|541226086|FG000|Overall Study|Withdrawal by Subject|3|||
150024830|NCT01217463|541226087|FG001|Overall Study|Withdrawal by Subject|0|||
150024831|NCT01217463|541226086|FG000|Overall Study|Surgery on the Target Limb|0|||
150024832|NCT01217463|541226087|FG001|Overall Study|Surgery on the Target Limb|1|||
150024833|NCT01217463|541226086|FG000|Overall Study|Patient Non-compliant|1|||
150024834|NCT01217463|541226087|FG001|Overall Study|Patient Non-compliant|0|||
150024835|NCT01217463|541226086|FG000|Overall Study|Other|1|||
150024836|NCT01217463|541226087|FG001|Overall Study|Other|1|||
150024837|NCT01569841|541226090|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
150024838|NCT01569841|541226091|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
150024839|NCT01141712|541226101|FG000|Overall Study|Disease progression|3|||
150024840|NCT01012258|541226102|FG000|Overall Study|Death|14|||
150024841|NCT01012258|541226102|FG000|Overall Study|Lost to Follow-up|1|||
150024842|NCT01012258|541226102|FG000|Overall Study|Adverse Event|1|||
150024843|NCT01012258|541226102|FG000|Overall Study|Progressive Disease (PD)|18|||
150024844|NCT01012258|541226102|FG000|Overall Study|Symptomatic Deterioration|1|||
150024845|NCT01012258|541226102|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
150024846|NCT01012258|541226102|FG000|Overall Study|Another Tumor Discovered|1|||
150024847|NCT01012258|541226102|FG000|Overall Study|Ongoing|29|||
150024848|NCT01814527|541226103|FG000|Overall Study|RTP greater than 30 days|6|||
150024849|NCT01814527|541226104|FG001|Overall Study|RTP greater than 30 days|1|||
150024850|NCT03571204|541226107|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
150024851|NCT03571204|541226108|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
150024852|NCT03571204|541226109|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
150024853|NCT03571204|541226107|FG000|Overall Study|Physician Decision|0|||
150024854|NCT03571204|541226108|FG001|Overall Study|Physician Decision|1|||
150024855|NCT03571204|541226109|FG002|Overall Study|Physician Decision|0|||
150024856|NCT00857285|541226110|FG000|Overall Study|Adverse Event|4|||
150024857|NCT00857285|541226111|FG001|Overall Study|Adverse Event|2|||
150024858|NCT00857285|541226110|FG000|Overall Study|Lack of Efficacy|0|||
150024859|NCT00857285|541226111|FG001|Overall Study|Lack of Efficacy|2|||
150024860|NCT00857285|541226110|FG000|Overall Study|Protocol Violation|3|||
150024861|NCT00857285|541226111|FG001|Overall Study|Protocol Violation|1|||
150024862|NCT00857285|541226110|FG000|Overall Study|Withdrawal by Subject|4|||
150024863|NCT00857285|541226111|FG001|Overall Study|Withdrawal by Subject|0|||
150024864|NCT00857285|541226110|FG000|Overall Study|Randomization criteria not met|1|||
150024865|NCT00857285|541226111|FG001|Overall Study|Randomization criteria not met|1|||
150024866|NCT03081884|541226114|FG000|Overall Study|deferred prostate cancer treatment|1|||
150024867|NCT03081884|541226114|FG000|Overall Study|metastasis managed with systemic therapy|3|||
150024868|NCT03948334|541226115|FG000|Overall Study|Adverse Event|1|||
150024869|NCT03948334|541226116|FG001|Overall Study|Adverse Event|4|||
150024870|NCT03948334|541226115|FG000|Overall Study|Lack of Efficacy|2|||
150024871|NCT03948334|541226116|FG001|Overall Study|Lack of Efficacy|0|||
150024872|NCT03948334|541226115|FG000|Overall Study|Lost to Follow-up|1|||
150024873|NCT03948334|541226116|FG001|Overall Study|Lost to Follow-up|0|||
150024874|NCT03948334|541226115|FG000|Overall Study|Physician Decision|1|||
150024875|NCT03948334|541226116|FG001|Overall Study|Physician Decision|0|||
150024876|NCT03948334|541226115|FG000|Overall Study|Pregnancy|0|||
150024877|NCT03948334|541226116|FG001|Overall Study|Pregnancy|1|||
150024878|NCT03948334|541226115|FG000|Overall Study|Protocol Deviation|1|||
150024879|NCT03948334|541226116|FG001|Overall Study|Protocol Deviation|0|||
150024880|NCT03948334|541226115|FG000|Overall Study|Study terminated by Sponsor|50|||
150024881|NCT03948334|541226116|FG001|Overall Study|Study terminated by Sponsor|51|||
150024882|NCT03948334|541226115|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
150024883|NCT03948334|541226116|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
150024884|NCT05114473|541226117|FG000|Overall Study|Lost to Follow-up|2|||
150024885|NCT05114473|541226118|FG001|Overall Study|Lost to Follow-up|2|||
150024886|NCT05114473|541226119|FG002|Overall Study|Lost to Follow-up|0|||
150024887|NCT00279916|541226120|FG000|Overall Study|Withdrawal by Subject|4|||
150024888|NCT00279916|541226121|FG001|Overall Study|Withdrawal by Subject|3|||
150024889|NCT00279916|541226120|FG000|Overall Study|Lost to Follow-up|3|||
150024890|NCT00279916|541226121|FG001|Overall Study|Lost to Follow-up|2|||
150024891|NCT01807598|541226122|FG000|Overall Study|Withdrawal by Subject|4|||
150024892|NCT01807598|541226122|FG000|Overall Study|Adverse Event|1|||
150024893|NCT01807598|541226122|FG000|Overall Study|Other Physician Decision|1|||
150024894|NCT00731679|541226123|FG000|Overall Study|Adverse Event|7|||
150024895|NCT00731679|541226124|FG001|Overall Study|Adverse Event|8|||
150024896|NCT00731679|541226123|FG000|Overall Study|Withdrawal by Subject|8|||
150024897|NCT00731679|541226124|FG001|Overall Study|Withdrawal by Subject|8|||
150024898|NCT00731679|541226123|FG000|Overall Study|Lost to Follow-up|7|||
150024899|NCT00731679|541226124|FG001|Overall Study|Lost to Follow-up|8|||
150024900|NCT00731679|541226123|FG000|Overall Study|Noncompliance|0|||
150024901|NCT00731679|541226124|FG001|Overall Study|Noncompliance|1|||
150024902|NCT00731679|541226123|FG000|Overall Study|Pregnancy|0|||
150024903|NCT00731679|541226124|FG001|Overall Study|Pregnancy|1|||
150024904|NCT03384940|541226125|FG000|Overall Study|Progressive disease|36|||
150024905|NCT03384940|541226126|FG001|Overall Study|Progressive disease|11|||
150024906|NCT03384940|541226127|FG002|Overall Study|Progressive disease|13|||
150024907|NCT03384940|541226125|FG000|Overall Study|Clinical progression|4|||
150024908|NCT03384940|541226126|FG001|Overall Study|Clinical progression|0|||
150024909|NCT03384940|541226127|FG002|Overall Study|Clinical progression|3|||
150024910|NCT03384940|541226125|FG000|Overall Study|Adverse Event|7|||
150024911|NCT03384940|541226126|FG001|Overall Study|Adverse Event|1|||
150024912|NCT03384940|541226127|FG002|Overall Study|Adverse Event|1|||
150024913|NCT03384940|541226125|FG000|Overall Study|Withdrawal by Subject|3|||
150024914|NCT03384940|541226126|FG001|Overall Study|Withdrawal by Subject|1|||
150024915|NCT03384940|541226127|FG002|Overall Study|Withdrawal by Subject|0|||
150024916|NCT03384940|541226125|FG000|Overall Study|Physician Decision|1|||
150024917|NCT03384940|541226126|FG001|Overall Study|Physician Decision|1|||
150024918|NCT03384940|541226127|FG002|Overall Study|Physician Decision|0|||
150024919|NCT03384940|541226125|FG000|Overall Study|Death|2|||
150024920|NCT03384940|541226126|FG001|Overall Study|Death|1|||
150024921|NCT03384940|541226127|FG002|Overall Study|Death|0|||
150024922|NCT03384940|541226125|FG000|Overall Study|Other|0|||
150024923|NCT03384940|541226126|FG001|Overall Study|Other|0|||
150024924|NCT03384940|541226127|FG002|Overall Study|Other|1|||
150024925|NCT03089580|541226133|FG000|Overall Study|Lost to Follow-up|2|||
150024926|NCT03087513|541226134|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
150024927|NCT01288989|541226135|FG000|Overall Study|Death|0|||
150024928|NCT01288989|541226136|FG001|Overall Study|Death|0|||
150024929|NCT01288989|541226137|FG002|Overall Study|Death|0|||
150024930|NCT01288989|541226138|FG003|Overall Study|Death|1|||
150024931|NCT01288989|541226139|FG004|Overall Study|Death|0|||
150024932|NCT01288989|541226135|FG000|Overall Study|Dose limiting toxicity|1|||
150024933|NCT01288989|541226136|FG001|Overall Study|Dose limiting toxicity|0|||
150024934|NCT01288989|541226137|FG002|Overall Study|Dose limiting toxicity|0|||
150024935|NCT01288989|541226138|FG003|Overall Study|Dose limiting toxicity|0|||
150024936|NCT01288989|541226139|FG004|Overall Study|Dose limiting toxicity|0|||
150024937|NCT01288989|541226135|FG000|Overall Study|Adverse Event|0|||
150024938|NCT01288989|541226136|FG001|Overall Study|Adverse Event|0|||
150024939|NCT01288989|541226137|FG002|Overall Study|Adverse Event|0|||
150024940|NCT01288989|541226138|FG003|Overall Study|Adverse Event|0|||
150024941|NCT01288989|541226139|FG004|Overall Study|Adverse Event|2|||
150024942|NCT01288989|541226135|FG000|Overall Study|Physician Decision|0|||
150024943|NCT01288989|541226136|FG001|Overall Study|Physician Decision|0|||
150024944|NCT01288989|541226137|FG002|Overall Study|Physician Decision|0|||
150024945|NCT01288989|541226138|FG003|Overall Study|Physician Decision|0|||
150024946|NCT01288989|541226139|FG004|Overall Study|Physician Decision|1|||
150024947|NCT01288989|541226135|FG000|Overall Study|Withdrawal by Subject|0|||
150024948|NCT01288989|541226136|FG001|Overall Study|Withdrawal by Subject|0|||
150024949|NCT01288989|541226137|FG002|Overall Study|Withdrawal by Subject|0|||
150024950|NCT01288989|541226138|FG003|Overall Study|Withdrawal by Subject|0|||
150024951|NCT01288989|541226139|FG004|Overall Study|Withdrawal by Subject|3|||
150024952|NCT04896593|541226144|FG000|Overall Study|Withdrawal by Subject|2|||
150024953|NCT04896593|541226144|FG000|Overall Study|Lost to Follow-up|1|||
150024954|NCT04896593|541226144|FG000|Overall Study|Did not complete onboarding|2|||
150024955|NCT00452790|541226145|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
150061459|NCT03505671|541366170|FG001|Overall Study|Lost to Follow-up|0|||
150024956|NCT00452790|541226146|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
150024957|NCT00452790|541226145|FG000|Infant Series|Parent/legal guardian request|8|||
150024958|NCT00452790|541226146|FG001|Infant Series|Parent/legal guardian request|6|||
150024959|NCT00452790|541226145|FG000|Infant Series|Failed to return|4|||
150024960|NCT00452790|541226146|FG001|Infant Series|Failed to return|1|||
150024961|NCT00452790|541226145|FG000|Infant Series|Protocol Violation|1|||
150024962|NCT00452790|541226146|FG001|Infant Series|Protocol Violation|3|||
150024963|NCT00452790|541226145|FG000|Infant Series|Lost to Follow-up|2|||
150024964|NCT00452790|541226146|FG001|Infant Series|Lost to Follow-up|2|||
150024965|NCT00452790|541226145|FG000|Infant Series|Adverse Event|1|||
150024966|NCT00452790|541226146|FG001|Infant Series|Adverse Event|2|||
150024967|NCT00452790|541226145|FG000|Infant Series|Other reasons|1|||
150024968|NCT00452790|541226146|FG001|Infant Series|Other reasons|2|||
150024969|NCT00452790|541226145|FG000|Infant Series|Investigator request|0|||
150024970|NCT00452790|541226146|FG001|Infant Series|Investigator request|1|||
150024971|NCT00452790|541226145|FG000|Infant Series|Death|0|||
150024972|NCT00452790|541226146|FG001|Infant Series|Death|1|||
150024973|NCT00452790|541226145|FG000|After Infant Series|Investigator request|10|||
150024974|NCT00452790|541226146|FG001|After Infant Series|Investigator request|10|||
150024975|NCT00452790|541226145|FG000|After Infant Series|Adverse Event|4|||
150024976|NCT00452790|541226146|FG001|After Infant Series|Adverse Event|1|||
150024977|NCT00452790|541226145|FG000|After Infant Series|Parent/legal guardian request|1|||
150024978|NCT00452790|541226146|FG001|After Infant Series|Parent/legal guardian request|3|||
150024979|NCT00452790|541226145|FG000|After Infant Series|Lost to Follow-up|4|||
150024980|NCT00452790|541226146|FG001|After Infant Series|Lost to Follow-up|0|||
150024981|NCT00452790|541226145|FG000|After Infant Series|Failed to return|1|||
150024982|NCT00452790|541226146|FG001|After Infant Series|Failed to return|0|||
150024983|NCT00452790|541226145|FG000|After Infant Series|Other reasons|1|||
150024984|NCT00452790|541226146|FG001|After Infant Series|Other reasons|0|||
150024985|NCT00452790|541226145|FG000|Toddler Dose|Failed to return|0|||
150024986|NCT00452790|541226146|FG001|Toddler Dose|Failed to return|1|||
150024987|NCT00452790|541226145|FG000|Toddler Dose|Parent/legal guardian request|0|||
150024988|NCT00452790|541226146|FG001|Toddler Dose|Parent/legal guardian request|1|||
150024989|NCT00985673|541228404|FG000|Overall Study|Lost to Follow-up|6|||
150024990|NCT00985673|541228405|FG001|Overall Study|Lost to Follow-up|7|||
150024991|NCT00985673|541228406|FG002|Overall Study|Lost to Follow-up|6|||
150024992|NCT00985673|541228407|FG003|Overall Study|Lost to Follow-up|10|||
150024993|NCT00985673|541228408|FG004|Overall Study|Lost to Follow-up|5|||
150024994|NCT00985673|541228409|FG005|Overall Study|Lost to Follow-up|3|||
150024995|NCT00985673|541228404|FG000|Overall Study|Withdrawal by Subject|0|||
150024996|NCT00985673|541228405|FG001|Overall Study|Withdrawal by Subject|4|||
150024997|NCT00985673|541228406|FG002|Overall Study|Withdrawal by Subject|5|||
150024998|NCT00985673|541228407|FG003|Overall Study|Withdrawal by Subject|2|||
150024999|NCT00985673|541228408|FG004|Overall Study|Withdrawal by Subject|2|||
150025000|NCT00985673|541228409|FG005|Overall Study|Withdrawal by Subject|3|||
150025001|NCT00985673|541228404|FG000|Overall Study|Other|1|||
150025002|NCT00985673|541228405|FG001|Overall Study|Other|0|||
150025003|NCT00985673|541228406|FG002|Overall Study|Other|1|||
150025004|NCT00985673|541228407|FG003|Overall Study|Other|0|||
150025005|NCT00985673|541228408|FG004|Overall Study|Other|1|||
150025006|NCT00985673|541228409|FG005|Overall Study|Other|0|||
150025007|NCT02252146|541228410|FG000|Overall Study|Lack of Efficacy|4|||
150025008|NCT02252146|541228410|FG000|Overall Study|Entered hospice care|1|||
150025009|NCT02252146|541228410|FG000|Overall Study|Inability to travel to study site|1|||
150025010|NCT00984256|541228413|FG000|Overall Study|Withdrawal by Subject|0|||
150025011|NCT00984256|541228414|FG001|Overall Study|Withdrawal by Subject|1|||
150025012|NCT01131507|541228417|FG000|Overall Study|Adverse Event|1|||
150025013|NCT01131507|541228417|FG000|Overall Study|Lost to Follow-up|1|||
150025014|NCT01131507|541228417|FG000|Overall Study|Withdrawal by Subject|1|||
150025015|NCT04388111|541228418|FG000|Overall Study|Lost to Follow-up|5|||
150025016|NCT04388111|541228419|FG001|Overall Study|Lost to Follow-up|3|||
150025017|NCT04388111|541228418|FG000|Overall Study|Adverse Event|1|||
150025018|NCT04388111|541228419|FG001|Overall Study|Adverse Event|1|||
150025019|NCT04388111|541228418|FG000|Overall Study|Protocol Violation|2|||
150025020|NCT04388111|541228419|FG001|Overall Study|Protocol Violation|4|||
150025021|NCT04388111|541228418|FG000|Overall Study|Withdrawal by Subject|1|||
150025022|NCT04388111|541228419|FG001|Overall Study|Withdrawal by Subject|0|||
150061460|NCT02038829|541366173|FG000|Washout Period 1|Death|0|||
150025023|NCT00527735|541228422|FG000|Overall Study|Disease progression|47|||
150025024|NCT00527735|541228423|FG001|Overall Study|Disease progression|61|||
150025025|NCT00527735|541228424|FG002|Overall Study|Disease progression|53|||
150025026|NCT00527735|541228422|FG000|Overall Study|Death|23|||
150025027|NCT00527735|541228423|FG001|Overall Study|Death|13|||
150025028|NCT00527735|541228424|FG002|Overall Study|Death|15|||
150025029|NCT00527735|541228422|FG000|Overall Study|Completed treatment in treatment phase|14|||
150061461|NCT02038829|541366174|FG001|Washout Period 1|Death|0|||
150061462|NCT02038829|541366175|FG002|Washout Period 1|Death|0|||
150061463|NCT02038829|541366176|FG003|Washout Period 1|Death|0|||
150061464|NCT02038829|541366177|FG004|Washout Period 1|Death|1|||
150061465|NCT02038829|541366178|FG005|Washout Period 1|Death|0|||
150061466|NCT02038829|541366179|FG006|Washout Period 1|Death|0|||
150061467|NCT02038829|541366180|FG007|Washout Period 1|Death|0|||
150061468|NCT02038829|541366181|FG008|Washout Period 1|Death|0|||
150061469|NCT02038829|541366182|FG009|Washout Period 1|Death|0|||
150061470|NCT02038829|541366183|FG010|Washout Period 1|Death|0|||
150061471|NCT02038829|541366184|FG011|Washout Period 1|Death|0|||
150061472|NCT02038829|541366173|FG000|Treatment Period 2|Adverse Event|0|||
150061473|NCT02038829|541366174|FG001|Treatment Period 2|Adverse Event|0|||
150061474|NCT02038829|541366175|FG002|Treatment Period 2|Adverse Event|0|||
150061475|NCT02038829|541366176|FG003|Treatment Period 2|Adverse Event|0|||
150061476|NCT02038829|541366177|FG004|Treatment Period 2|Adverse Event|0|||
150061477|NCT02038829|541366178|FG005|Treatment Period 2|Adverse Event|0|||
150061478|NCT02038829|541366179|FG006|Treatment Period 2|Adverse Event|0|||
150061479|NCT02038829|541366180|FG007|Treatment Period 2|Adverse Event|0|||
150061480|NCT02038829|541366181|FG008|Treatment Period 2|Adverse Event|0|||
150061481|NCT02038829|541366182|FG009|Treatment Period 2|Adverse Event|0|||
150061482|NCT02038829|541366183|FG010|Treatment Period 2|Adverse Event|1|||
150061483|NCT02038829|541366184|FG011|Treatment Period 2|Adverse Event|0|||
150061484|NCT02038829|541366173|FG000|Treatment Period 2|Withdrawal by Subject|1|||
150061485|NCT02038829|541366174|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150061486|NCT02038829|541366175|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150061487|NCT02038829|541366176|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150061488|NCT02038829|541366177|FG004|Treatment Period 2|Withdrawal by Subject|0|||
150061489|NCT02038829|541366178|FG005|Treatment Period 2|Withdrawal by Subject|0|||
150061490|NCT02038829|541366179|FG006|Treatment Period 2|Withdrawal by Subject|0|||
150061491|NCT02038829|541366180|FG007|Treatment Period 2|Withdrawal by Subject|0|||
150061492|NCT02038829|541366181|FG008|Treatment Period 2|Withdrawal by Subject|0|||
150061493|NCT02038829|541366182|FG009|Treatment Period 2|Withdrawal by Subject|0|||
150061494|NCT02038829|541366183|FG010|Treatment Period 2|Withdrawal by Subject|0|||
150061495|NCT02038829|541366184|FG011|Treatment Period 2|Withdrawal by Subject|0|||
150061496|NCT02038829|541366173|FG000|Washout Period 2|Adverse Event|0|||
150061497|NCT02038829|541366174|FG001|Washout Period 2|Adverse Event|0|||
150061498|NCT02038829|541366175|FG002|Washout Period 2|Adverse Event|0|||
150061499|NCT02038829|541366176|FG003|Washout Period 2|Adverse Event|0|||
150061500|NCT02038829|541366177|FG004|Washout Period 2|Adverse Event|0|||
150061501|NCT02038829|541366178|FG005|Washout Period 2|Adverse Event|0|||
150061502|NCT02038829|541366179|FG006|Washout Period 2|Adverse Event|0|||
150061503|NCT02038829|541366180|FG007|Washout Period 2|Adverse Event|0|||
150061504|NCT02038829|541366181|FG008|Washout Period 2|Adverse Event|1|||
150061505|NCT02038829|541366182|FG009|Washout Period 2|Adverse Event|0|||
150061506|NCT02038829|541366183|FG010|Washout Period 2|Adverse Event|0|||
150061507|NCT02038829|541366184|FG011|Washout Period 2|Adverse Event|0|||
150061508|NCT02038829|541366173|FG000|Washout Period 2|Withdrawal by Subject|0|||
150061509|NCT02038829|541366174|FG001|Washout Period 2|Withdrawal by Subject|0|||
150061510|NCT02038829|541366175|FG002|Washout Period 2|Withdrawal by Subject|0|||
150061511|NCT02038829|541366176|FG003|Washout Period 2|Withdrawal by Subject|0|||
150061512|NCT02038829|541366177|FG004|Washout Period 2|Withdrawal by Subject|0|||
150061513|NCT02038829|541366178|FG005|Washout Period 2|Withdrawal by Subject|1|||
150061514|NCT02038829|541366179|FG006|Washout Period 2|Withdrawal by Subject|0|||
150061515|NCT02038829|541366180|FG007|Washout Period 2|Withdrawal by Subject|0|||
150061516|NCT02038829|541366181|FG008|Washout Period 2|Withdrawal by Subject|0|||
150061517|NCT02038829|541366182|FG009|Washout Period 2|Withdrawal by Subject|0|||
150061518|NCT02038829|541366183|FG010|Washout Period 2|Withdrawal by Subject|0|||
150061519|NCT02038829|541366184|FG011|Washout Period 2|Withdrawal by Subject|0|||
150061520|NCT02038829|541366173|FG000|Treatment Period 4|Adverse Event|0|||
150061521|NCT02038829|541366174|FG001|Treatment Period 4|Adverse Event|1|||
150061522|NCT02038829|541366175|FG002|Treatment Period 4|Adverse Event|0|||
150061523|NCT02038829|541366176|FG003|Treatment Period 4|Adverse Event|0|||
150061524|NCT02038829|541366177|FG004|Treatment Period 4|Adverse Event|0|||
150061525|NCT02038829|541366178|FG005|Treatment Period 4|Adverse Event|0|||
150061526|NCT02038829|541366179|FG006|Treatment Period 4|Adverse Event|0|||
150061527|NCT02038829|541366180|FG007|Treatment Period 4|Adverse Event|0|||
150061528|NCT02038829|541366181|FG008|Treatment Period 4|Adverse Event|0|||
150061529|NCT02038829|541366182|FG009|Treatment Period 4|Adverse Event|0|||
150061530|NCT02038829|541366183|FG010|Treatment Period 4|Adverse Event|0|||
150061531|NCT02038829|541366184|FG011|Treatment Period 4|Adverse Event|0|||
150061532|NCT02038829|541366173|FG000|Washout Period 4|Adverse Event|0|||
150061533|NCT02038829|541366174|FG001|Washout Period 4|Adverse Event|0|||
150061534|NCT02038829|541366175|FG002|Washout Period 4|Adverse Event|0|||
150061535|NCT02038829|541366176|FG003|Washout Period 4|Adverse Event|0|||
150061536|NCT02038829|541366177|FG004|Washout Period 4|Adverse Event|0|||
150061537|NCT02038829|541366178|FG005|Washout Period 4|Adverse Event|0|||
150061538|NCT02038829|541366179|FG006|Washout Period 4|Adverse Event|1|||
150061539|NCT02038829|541366180|FG007|Washout Period 4|Adverse Event|0|||
150061540|NCT02038829|541366181|FG008|Washout Period 4|Adverse Event|0|||
150061541|NCT02038829|541366182|FG009|Washout Period 4|Adverse Event|0|||
150061542|NCT02038829|541366183|FG010|Washout Period 4|Adverse Event|0|||
150061543|NCT02038829|541366184|FG011|Washout Period 4|Adverse Event|0|||
150061544|NCT02038829|541366173|FG000|Treatment Period 6|Adverse Event|0|||
150061545|NCT02038829|541366174|FG001|Treatment Period 6|Adverse Event|0|||
150061546|NCT02038829|541366175|FG002|Treatment Period 6|Adverse Event|1|||
150061547|NCT02038829|541366176|FG003|Treatment Period 6|Adverse Event|0|||
150061548|NCT02038829|541366177|FG004|Treatment Period 6|Adverse Event|0|||
150061549|NCT02038829|541366178|FG005|Treatment Period 6|Adverse Event|0|||
150061550|NCT02038829|541366179|FG006|Treatment Period 6|Adverse Event|0|||
150061551|NCT02038829|541366180|FG007|Treatment Period 6|Adverse Event|0|||
150061552|NCT02038829|541366181|FG008|Treatment Period 6|Adverse Event|0|||
150061553|NCT02038829|541366182|FG009|Treatment Period 6|Adverse Event|0|||
150061554|NCT02038829|541366183|FG010|Treatment Period 6|Adverse Event|0|||
150061555|NCT02038829|541366184|FG011|Treatment Period 6|Adverse Event|0|||
150061556|NCT00749580|541366185|FG000|Overall Study|Lost to Follow-up|4|||
150061557|NCT00749580|541366186|FG001|Overall Study|Lost to Follow-up|8|||
150061558|NCT00749580|541366185|FG000|Overall Study|Adverse Event|0|||
150061559|NCT00749580|541366186|FG001|Overall Study|Adverse Event|1|||
150061560|NCT06460493|541366192|FG000|Overall Study|Withdrawal by Subject|2|||
150061561|NCT02987660|541366193|FG000|Overall Study|Study terminated by sponsor|10|||
150061562|NCT02987660|541366194|FG001|Overall Study|Study terminated by sponsor|10|||
150061563|NCT03707184|541366195|FG000|Overall Study|Withdrawal by Subject|2|||
150061564|NCT04950608|541366196|FG000|Overall Study|Withdrawal by Subject|2|||
150061565|NCT04950608|541366196|FG000|Overall Study|Physician Decision|3|||
150061566|NCT05007717|541366197|FG000|Overall Study|Death|3|||
150061567|NCT05007717|541366198|FG001|Overall Study|Death|2|||
150061568|NCT03553836|541366199|FG000|Overall Study|Ongoing in Study|460|||
150061569|NCT03553836|541366200|FG001|Overall Study|Ongoing in Study|459|||
150061570|NCT03553836|541366199|FG000|Overall Study|Withdrawal by Subject|9|||
150061571|NCT03553836|541366200|FG001|Overall Study|Withdrawal by Subject|10|||
150061572|NCT03553836|541366199|FG000|Overall Study|Lost to Follow-up|1|||
150061573|NCT03553836|541366200|FG001|Overall Study|Lost to Follow-up|3|||
150061574|NCT03553836|541366199|FG000|Overall Study|Death|17|||
150061575|NCT03553836|541366200|FG001|Overall Study|Death|17|||
150061576|NCT03220438|541366201|FG000|Overall Study|Lost to Follow-up|0|||
150061577|NCT03220438|541366202|FG001|Overall Study|Lost to Follow-up|0|||
150061578|NCT03220438|541366203|FG002|Overall Study|Lost to Follow-up|1|||
150061579|NCT03220438|541366204|FG003|Overall Study|Lost to Follow-up|0|||
150061580|NCT04062123|541366205|FG000|Overall Study|Withdrawal by Subject|0|||
150061581|NCT04062123|541366206|FG001|Overall Study|Withdrawal by Subject|1|||
150061582|NCT04062123|541366207|FG002|Overall Study|Withdrawal by Subject|0|||
150061583|NCT04626310|541366213|FG000|Overall Study|4-miss from treatment|6|||
150061584|NCT04626310|541366214|FG001|Overall Study|4-miss from treatment|5|||
150061585|NCT04626310|541366215|FG002|Overall Study|4-miss from treatment|5|||
150061586|NCT04626310|541366213|FG000|Overall Study|Withdrawal by Subject|1|||
150061587|NCT04626310|541366214|FG001|Overall Study|Withdrawal by Subject|0|||
150061588|NCT04626310|541366215|FG002|Overall Study|Withdrawal by Subject|3|||
150061589|NCT01850602|541366216|FG000|Overall Study|Adverse Event|7|||
150061590|NCT01850602|541366217|FG001|Overall Study|Adverse Event|10|||
150061591|NCT01850602|541366216|FG000|Overall Study|Physician Decision|2|||
150061592|NCT01850602|541366217|FG001|Overall Study|Physician Decision|1|||
150061593|NCT01850602|541366216|FG000|Overall Study|Withdrawal by Subject|2|||
150061594|NCT01850602|541366217|FG001|Overall Study|Withdrawal by Subject|4|||
150061595|NCT01850602|541366216|FG000|Overall Study|Decrease in serum calcium|2|||
150061596|NCT01850602|541366217|FG001|Overall Study|Decrease in serum calcium|3|||
150061597|NCT01850602|541366216|FG000|Overall Study|Increase in serum ferritin|1|||
150061598|NCT01850602|541366217|FG001|Overall Study|Increase in serum ferritin|0|||
150061599|NCT00367770|541366218|FG000|Overall Study|Adverse Event|1|||
150061600|NCT00367770|541366218|FG000|Overall Study|Withdrawal by Subject|1|||
150061601|NCT01315236|541366219|FG000|Double-blind Phase|Death|1|||
150061602|NCT01315236|541366220|FG001|Double-blind Phase|Death|0|||
150061603|NCT01315236|541366219|FG000|Double-blind Phase|Adverse Event|1|||
150061604|NCT01315236|541366220|FG001|Double-blind Phase|Adverse Event|0|||
150061605|NCT01315236|541366219|FG000|Double-blind Phase|Withdrawal of Consent|1|||
150061606|NCT01315236|541366220|FG001|Double-blind Phase|Withdrawal of Consent|0|||
150061607|NCT01315236|541366219|FG000|Double-blind Phase|Lost to Follow-up|1|||
150061608|NCT01315236|541366220|FG001|Double-blind Phase|Lost to Follow-up|0|||
150061609|NCT01315236|541366219|FG000|Open-label Phase|Death|1|||
150061610|NCT01315236|541366220|FG001|Open-label Phase|Death|0|||
150061611|NCT01315236|541366219|FG000|Open-label Phase|Adverse Event|0|||
150061612|NCT01315236|541366220|FG001|Open-label Phase|Adverse Event|1|||
150061613|NCT01315236|541366219|FG000|Open-label Phase|Other|0|||
150061614|NCT01315236|541366220|FG001|Open-label Phase|Other|1|||
150061615|NCT01315236|541366219|FG000|12-Month Follow-up Period|Death|0|||
150061616|NCT01315236|541366220|FG001|12-Month Follow-up Period|Death|1|||
150061617|NCT01315236|541366219|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
150061618|NCT01315236|541366220|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
150061619|NCT00287079|541366221|FG000|Overall Study|Qualifying relapse|12|||
150061620|NCT00287079|541366222|FG001|Overall Study|Qualifying relapse|1|||
150061621|NCT00287079|541366221|FG000|Overall Study|Non-qualifying relapse|1|||
150061622|NCT00287079|541366222|FG001|Overall Study|Non-qualifying relapse|0|||
150061623|NCT00287079|541366221|FG000|Overall Study|Adverse Event|5|||
150061624|NCT00287079|541366222|FG001|Overall Study|Adverse Event|0|||
150061625|NCT00287079|541366221|FG000|Overall Study|Protocol Violation|1|||
150061626|NCT00287079|541366222|FG001|Overall Study|Protocol Violation|0|||
150061627|NCT00287079|541366221|FG000|Overall Study|Other|3|||
150061628|NCT00287079|541366222|FG001|Overall Study|Other|0|||
150061629|NCT01282203|541366225|FG000|Overall Study|Adverse Event|1|||
150061630|NCT03282565|541366226|FG000|Overall Study|COVID-19 Research Shutdown|0|||
150061631|NCT03282565|541366227|FG001|Overall Study|COVID-19 Research Shutdown|2|||
150061632|NCT03282565|541366228|FG002|Overall Study|COVID-19 Research Shutdown|2|||
150061633|NCT00740051|541366229|FG000|Overall Study|Lack of Efficacy|2|||
150061634|NCT00740051|541366230|FG001|Overall Study|Lack of Efficacy|5|||
150061635|NCT00740051|541366229|FG000|Overall Study|Adverse Event|1|||
150061636|NCT00740051|541366230|FG001|Overall Study|Adverse Event|4|||
150061637|NCT00740051|541366229|FG000|Overall Study|Protocol Violation|2|||
150061638|NCT00740051|541366230|FG001|Overall Study|Protocol Violation|6|||
150061639|NCT00740051|541366229|FG000|Overall Study|Lost to Follow-up|3|||
150061640|NCT00740051|541366230|FG001|Overall Study|Lost to Follow-up|8|||
150061641|NCT00740051|541366229|FG000|Overall Study|Withdrawal by Subject|6|||
150061642|NCT00740051|541366230|FG001|Overall Study|Withdrawal by Subject|8|||
150061643|NCT00740051|541366229|FG000|Overall Study|Other reason (not specified)|4|||
150061644|NCT00740051|541366230|FG001|Overall Study|Other reason (not specified)|1|||
150061645|NCT02011893|541366231|FG000|Enrollment to Randomization|Adverse Event|2|||
150061646|NCT02011893|541366232|FG001|Enrollment to Randomization|Adverse Event|0|||
150061647|NCT02011893|541366233|FG002|Enrollment to Randomization|Adverse Event|0|||
150061648|NCT02011893|541366231|FG000|Enrollment to Randomization|Physician Decision|10|||
150061649|NCT02011893|541366232|FG001|Enrollment to Randomization|Physician Decision|0|||
150061650|NCT02011893|541366233|FG002|Enrollment to Randomization|Physician Decision|0|||
150061651|NCT02011893|541366231|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
150061652|NCT02011893|541366232|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
150061653|NCT02011893|541366233|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
150061654|NCT02011893|541366231|FG000|Enrollment to Randomization|Screening Failure|29|||
150061655|NCT02011893|541366232|FG001|Enrollment to Randomization|Screening Failure|0|||
150061656|NCT02011893|541366233|FG002|Enrollment to Randomization|Screening Failure|0|||
150061657|NCT02011893|541366231|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
150061658|NCT02011893|541366232|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
150061659|NCT02011893|541366233|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
150061660|NCT02011893|541366231|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
150061661|NCT02011893|541366232|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
150061662|NCT02011893|541366233|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
150061663|NCT02011893|541366231|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
150061664|NCT02011893|541366232|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
150061665|NCT02011893|541366233|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
150061666|NCT02011893|541366231|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
150061667|NCT02011893|541366232|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
150061668|NCT02011893|541366233|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
150061669|NCT02011893|541366231|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
150061670|NCT02011893|541366232|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
150061671|NCT02011893|541366233|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
150061672|NCT00930982|541366234|FG000|Overall Study|Adverse Event|19|||
150061673|NCT00930982|541366235|FG001|Overall Study|Adverse Event|23|||
150061674|NCT00930982|541366234|FG000|Overall Study|Protocol Violation|1|||
150061675|NCT00930982|541366235|FG001|Overall Study|Protocol Violation|5|||
150061676|NCT00930982|541366234|FG000|Overall Study|Withdrawal by Subject|1|||
150061677|NCT00930982|541366235|FG001|Overall Study|Withdrawal by Subject|1|||
150061678|NCT00991952|541366236|FG000|Overall Study|Adverse Event|0|||
150061679|NCT00991952|541366237|FG001|Overall Study|Adverse Event|1|||
150061680|NCT00518973|541366238|FG000|Overall Study|Withdrawal by Subject|3|||
150061681|NCT00518973|541366239|FG001|Overall Study|Withdrawal by Subject|2|||
150061682|NCT03452527|541366240|FG000|Overall Study|Withdrawal by Subject|1|||
150061683|NCT03452527|541366241|FG001|Overall Study|Withdrawal by Subject|1|||
150061684|NCT03452527|541366240|FG000|Overall Study|Study Terminated|2|||
150061685|NCT03452527|541366241|FG001|Overall Study|Study Terminated|3|||
150061686|NCT00582816|541366242|FG000|Overall Study|Engraftment Failure|3|||
150061687|NCT01565499|541366246|FG000|Overall Study|Physician Decision|1|||
150061688|NCT01565499|541366246|FG000|Overall Study|Adverse Event|5|||
150061689|NCT01565499|541366246|FG000|Overall Study|Withdrawal by Subject|2|||
150061690|NCT03170232|541366247|FG000|Overall Study|Adverse Event|0|||
150061691|NCT03170232|541366248|FG001|Overall Study|Adverse Event|1|||
150061692|NCT03170232|541366247|FG000|Overall Study|Protocol Violation|0|||
150061693|NCT03170232|541366248|FG001|Overall Study|Protocol Violation|1|||
150061694|NCT03170232|541366247|FG000|Overall Study|Lack of Efficacy|0|||
150061695|NCT03170232|541366248|FG001|Overall Study|Lack of Efficacy|1|||
150061696|NCT03170232|541366247|FG000|Overall Study|Study closed/terminated|26|||
150061697|NCT03170232|541366248|FG001|Overall Study|Study closed/terminated|23|||
150061698|NCT03170232|541366247|FG000|Overall Study|Lost to Follow-up|1|||
150061699|NCT03170232|541366248|FG001|Overall Study|Lost to Follow-up|0|||
150061700|NCT03170232|541366247|FG000|Overall Study|Withdrawal by Subject|0|||
150061701|NCT03170232|541366248|FG001|Overall Study|Withdrawal by Subject|1|||
150061702|NCT01658813|541366249|FG000|Overall Study|Disease progression|3|||
150061703|NCT00722371|541366251|FG000|Overall Study|Adverse Event|6|||
150061704|NCT00722371|541366252|FG001|Overall Study|Adverse Event|13|||
150061705|NCT00722371|541366253|FG002|Overall Study|Adverse Event|9|||
150061706|NCT00722371|541366254|FG003|Overall Study|Adverse Event|10|||
150061707|NCT00722371|541366255|FG004|Overall Study|Adverse Event|6|||
150061708|NCT00722371|541366256|FG005|Overall Study|Adverse Event|8|||
150061709|NCT00722371|541366257|FG006|Overall Study|Adverse Event|4|||
150061710|NCT00722371|541366251|FG000|Overall Study|Contraindication|0|||
150061711|NCT00722371|541366252|FG001|Overall Study|Contraindication|0|||
150061712|NCT00722371|541366253|FG002|Overall Study|Contraindication|1|||
150061713|NCT00722371|541366254|FG003|Overall Study|Contraindication|0|||
150061714|NCT00722371|541366255|FG004|Overall Study|Contraindication|0|||
150061715|NCT00722371|541366256|FG005|Overall Study|Contraindication|0|||
150061716|NCT00722371|541366257|FG006|Overall Study|Contraindication|0|||
150061717|NCT00722371|541366251|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
150061718|NCT00722371|541366252|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
150061719|NCT00722371|541366253|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
150061720|NCT00722371|541366254|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
150061721|NCT00722371|541366255|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
150061722|NCT00722371|541366256|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
150061723|NCT00722371|541366257|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
150061724|NCT00722371|541366251|FG000|Overall Study|Excluded medication|0|||
150061725|NCT00722371|541366252|FG001|Overall Study|Excluded medication|1|||
150061726|NCT00722371|541366253|FG002|Overall Study|Excluded medication|1|||
150061727|NCT00722371|541366254|FG003|Overall Study|Excluded medication|0|||
150061728|NCT00722371|541366255|FG004|Overall Study|Excluded medication|0|||
150061729|NCT00722371|541366256|FG005|Overall Study|Excluded medication|0|||
150061730|NCT00722371|541366257|FG006|Overall Study|Excluded medication|1|||
150061731|NCT00722371|541366251|FG000|Overall Study|Hyperglycemia|2|||
150061732|NCT00722371|541366252|FG001|Overall Study|Hyperglycemia|6|||
150061733|NCT00722371|541366253|FG002|Overall Study|Hyperglycemia|4|||
150061734|NCT00722371|541366254|FG003|Overall Study|Hyperglycemia|2|||
150061735|NCT00722371|541366255|FG004|Overall Study|Hyperglycemia|5|||
150061736|NCT00722371|541366256|FG005|Overall Study|Hyperglycemia|1|||
150061737|NCT00722371|541366257|FG006|Overall Study|Hyperglycemia|1|||
150061738|NCT00722371|541366251|FG000|Overall Study|Hypoglycemia|1|||
150061739|NCT00722371|541366252|FG001|Overall Study|Hypoglycemia|0|||
150061740|NCT00722371|541366253|FG002|Overall Study|Hypoglycemia|0|||
150061741|NCT00722371|541366254|FG003|Overall Study|Hypoglycemia|0|||
150061742|NCT00722371|541366255|FG004|Overall Study|Hypoglycemia|0|||
150061743|NCT00722371|541366256|FG005|Overall Study|Hypoglycemia|0|||
150061744|NCT00722371|541366257|FG006|Overall Study|Hypoglycemia|0|||
150061745|NCT00722371|541366251|FG000|Overall Study|Lack of Efficacy|4|||
150061746|NCT00722371|541366252|FG001|Overall Study|Lack of Efficacy|6|||
150061747|NCT00722371|541366253|FG002|Overall Study|Lack of Efficacy|6|||
150061748|NCT00722371|541366254|FG003|Overall Study|Lack of Efficacy|6|||
150061749|NCT00722371|541366255|FG004|Overall Study|Lack of Efficacy|2|||
150061750|NCT00722371|541366256|FG005|Overall Study|Lack of Efficacy|3|||
150061751|NCT00722371|541366257|FG006|Overall Study|Lack of Efficacy|0|||
150061752|NCT00722371|541366251|FG000|Overall Study|Lost to Follow-up|11|||
150061753|NCT00722371|541366252|FG001|Overall Study|Lost to Follow-up|14|||
150061754|NCT00722371|541366253|FG002|Overall Study|Lost to Follow-up|21|||
150061755|NCT00722371|541366254|FG003|Overall Study|Lost to Follow-up|13|||
150181896|NCT03398148|541804607|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181897|NCT03398148|541804608|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150181898|NCT03398148|541804609|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150061756|NCT00722371|541366255|FG004|Overall Study|Lost to Follow-up|8|||
150061757|NCT00722371|541366256|FG005|Overall Study|Lost to Follow-up|16|||
150061758|NCT00722371|541366257|FG006|Overall Study|Lost to Follow-up|13|||
150061759|NCT00722371|541366251|FG000|Overall Study|Physician Decision|5|||
150061760|NCT00722371|541366252|FG001|Overall Study|Physician Decision|2|||
150061761|NCT00722371|541366253|FG002|Overall Study|Physician Decision|2|||
150061762|NCT00722371|541366254|FG003|Overall Study|Physician Decision|5|||
150061763|NCT00722371|541366255|FG004|Overall Study|Physician Decision|2|||
150061764|NCT00722371|541366256|FG005|Overall Study|Physician Decision|3|||
150061765|NCT00722371|541366257|FG006|Overall Study|Physician Decision|4|||
150061766|NCT00722371|541366251|FG000|Overall Study|Pregnancy|1|||
150061767|NCT00722371|541366252|FG001|Overall Study|Pregnancy|1|||
150061768|NCT00722371|541366253|FG002|Overall Study|Pregnancy|0|||
150061769|NCT00722371|541366254|FG003|Overall Study|Pregnancy|0|||
150061770|NCT00722371|541366255|FG004|Overall Study|Pregnancy|0|||
150061771|NCT00722371|541366256|FG005|Overall Study|Pregnancy|1|||
150061772|NCT00722371|541366257|FG006|Overall Study|Pregnancy|0|||
150061773|NCT00722371|541366251|FG000|Overall Study|Protocol Violation|6|||
150061774|NCT00722371|541366252|FG001|Overall Study|Protocol Violation|1|||
150061775|NCT00722371|541366253|FG002|Overall Study|Protocol Violation|0|||
150061776|NCT00722371|541366254|FG003|Overall Study|Protocol Violation|1|||
150061777|NCT00722371|541366255|FG004|Overall Study|Protocol Violation|4|||
150061778|NCT00722371|541366256|FG005|Overall Study|Protocol Violation|2|||
150061779|NCT00722371|541366257|FG006|Overall Study|Protocol Violation|1|||
150061780|NCT00722371|541366251|FG000|Overall Study|Withdrawal by Subject|18|||
150061781|NCT00722371|541366252|FG001|Overall Study|Withdrawal by Subject|27|||
150061782|NCT00722371|541366253|FG002|Overall Study|Withdrawal by Subject|19|||
150061783|NCT00722371|541366254|FG003|Overall Study|Withdrawal by Subject|23|||
150061784|NCT00722371|541366255|FG004|Overall Study|Withdrawal by Subject|19|||
150061785|NCT00722371|541366256|FG005|Overall Study|Withdrawal by Subject|18|||
150061786|NCT00722371|541366257|FG006|Overall Study|Withdrawal by Subject|26|||
150061787|NCT01075191|541366258|FG000|Overall Study|Death|1|||
150061788|NCT01075191|541366258|FG000|Overall Study|Intensification|3|||
150061789|NCT01075191|541366258|FG000|Overall Study|Co-morbidities|1|||
150061790|NCT01075191|541366258|FG000|Overall Study|Adverse Event|4|||
150061791|NCT01075191|541366258|FG000|Overall Study|Noncompliance|3|||
150061792|NCT01075191|541366258|FG000|Overall Study|Therapy Break|3|||
150061793|NCT01075191|541366258|FG000|Overall Study|Patient's Wish|2|||
150061794|NCT01075191|541366258|FG000|Overall Study|Unknown Reasons|1|||
150061795|NCT00718237|541366263|FG000|Overall Study|Adverse Event|1|||
150061796|NCT00718237|541366264|FG001|Overall Study|Adverse Event|3|||
150061797|NCT00718237|541366263|FG000|Overall Study|Lost to Follow-up|2|||
150061798|NCT00718237|541366264|FG001|Overall Study|Lost to Follow-up|2|||
150061799|NCT00718237|541366263|FG000|Overall Study|Physician Decision|1|||
150061800|NCT00718237|541366264|FG001|Overall Study|Physician Decision|0|||
150061801|NCT00718237|541366263|FG000|Overall Study|Withdrawal by Subject|9|||
150061802|NCT00718237|541366264|FG001|Overall Study|Withdrawal by Subject|10|||
150061803|NCT02635646|541366266|FG000|Overall Study|Lost to Follow-up|24|||
150061804|NCT02635646|541366267|FG001|Overall Study|Lost to Follow-up|25|||
150061805|NCT02635646|541366266|FG000|Overall Study|Pregnancy|1|||
150061806|NCT02635646|541366267|FG001|Overall Study|Pregnancy|1|||
150061807|NCT00913692|541366268|FG000|Screening (4 Months)|Physician Decision|3|||
150061808|NCT00913692|541366268|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
150061809|NCT00913692|541366268|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
150061810|NCT01423604|541366274|FG000|Safety Run-In|Adverse Event|3|||
150061811|NCT01423604|541366275|FG001|Safety Run-In|Adverse Event|0|||
150061812|NCT01423604|541366274|FG000|Safety Run-In|Death|1|||
150061813|NCT01423604|541366275|FG001|Safety Run-In|Death|0|||
150061814|NCT01423604|541366274|FG000|Safety Run-In|Physician Decision|1|||
150061815|NCT01423604|541366275|FG001|Safety Run-In|Physician Decision|0|||
150061816|NCT01423604|541366274|FG000|Safety Run-In|Disease progression|3|||
150061817|NCT01423604|541366275|FG001|Safety Run-In|Disease progression|0|||
150061818|NCT01423604|541366274|FG000|Safety Run-In|Patient decision|1|||
150061819|NCT01423604|541366275|FG001|Safety Run-In|Patient decision|0|||
150061820|NCT01423604|541366274|FG000|Randomized|Adverse Event|4|||
150061821|NCT01423604|541366275|FG001|Randomized|Adverse Event|10|||
150061822|NCT01423604|541366274|FG000|Randomized|Death|1|||
150061823|NCT01423604|541366275|FG001|Randomized|Death|0|||
150061824|NCT01423604|541366274|FG000|Randomized|Physician Decision|16|||
150061825|NCT01423604|541366275|FG001|Randomized|Physician Decision|13|||
150061826|NCT01423604|541366274|FG000|Randomized|Other - unspecified|37|||
150061827|NCT01423604|541366275|FG001|Randomized|Other - unspecified|31|||
150061828|NCT01423604|541366274|FG000|Randomized|Patient decision|5|||
150061829|NCT01423604|541366275|FG001|Randomized|Patient decision|9|||
150061830|NCT03324581|541366276|FG000|Overall Study|Adverse Event|18|||
150061831|NCT03324581|541366277|FG001|Overall Study|Adverse Event|11|||
150061832|NCT03324581|541366278|FG002|Overall Study|Adverse Event|7|||
150061833|NCT03324581|541366276|FG000|Overall Study|Lack of Efficacy|0|||
150061834|NCT03324581|541366277|FG001|Overall Study|Lack of Efficacy|1|||
150061835|NCT03324581|541366278|FG002|Overall Study|Lack of Efficacy|0|||
150061836|NCT03324581|541366276|FG000|Overall Study|Lost to Follow-up|5|||
150061837|NCT03324581|541366277|FG001|Overall Study|Lost to Follow-up|3|||
150061838|NCT03324581|541366278|FG002|Overall Study|Lost to Follow-up|6|||
150061839|NCT03324581|541366276|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
150061840|NCT03324581|541366277|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
150061841|NCT03324581|541366278|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
150061842|NCT03324581|541366276|FG000|Overall Study|Physician Decision|0|||
150061843|NCT03324581|541366277|FG001|Overall Study|Physician Decision|1|||
150061844|NCT03324581|541366278|FG002|Overall Study|Physician Decision|2|||
150061845|NCT03324581|541366276|FG000|Overall Study|Protocol Deviation|8|||
150061846|NCT03324581|541366277|FG001|Overall Study|Protocol Deviation|9|||
150061847|NCT03324581|541366278|FG002|Overall Study|Protocol Deviation|4|||
150061848|NCT03324581|541366276|FG000|Overall Study|Withdrawal by Subject|6|||
150061849|NCT03324581|541366277|FG001|Overall Study|Withdrawal by Subject|8|||
150061850|NCT03324581|541366278|FG002|Overall Study|Withdrawal by Subject|6|||
150061851|NCT03324581|541366276|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
150061852|NCT03324581|541366277|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
150061853|NCT03324581|541366278|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
150061854|NCT00586664|541366280|FG000|Overall Study|Withdrawal by Subject|3|||
150061855|NCT00586664|541366281|FG001|Overall Study|Withdrawal by Subject|7|||
150061856|NCT00586664|541366282|FG002|Overall Study|Withdrawal by Subject|1|||
150061857|NCT00586664|541366280|FG000|Overall Study|Exclusion criteria met|2|||
150061858|NCT00586664|541366281|FG001|Overall Study|Exclusion criteria met|0|||
150061859|NCT00586664|541366282|FG002|Overall Study|Exclusion criteria met|0|||
150061860|NCT04285580|541367742|FG000|Overall Study|Protocol Violation|0|||
150061861|NCT04285580|541367743|FG001|Overall Study|Protocol Violation|1|||
150061862|NCT02582255|541367744|FG000|Overall Study|Protocol Violation|0|||
150061863|NCT02582255|541367745|FG001|Overall Study|Protocol Violation|3|||
150061864|NCT04854642|541367746|FG000|Overall Study|Adverse Event|1|||
150061865|NCT04854642|541367747|FG001|Overall Study|Adverse Event|2|||
150061866|NCT04854642|541367746|FG000|Overall Study|Withdrawal by Subject|0|||
150061867|NCT04854642|541367747|FG001|Overall Study|Withdrawal by Subject|1|||
150061868|NCT01709578|541367750|FG000|Overall Study|Rescued and entered in long term safety|63|||
150061869|NCT01709578|541367751|FG001|Overall Study|Rescued and entered in long term safety|25|||
150061870|NCT01709578|541367752|FG002|Overall Study|Rescued and entered in long term safety|26|||
150061871|NCT01709578|541367750|FG000|Overall Study|Adverse Event|9|||
150061872|NCT01709578|541367751|FG001|Overall Study|Adverse Event|18|||
150061873|NCT01709578|541367752|FG002|Overall Study|Adverse Event|17|||
150061874|NCT01709578|541367750|FG000|Overall Study|Lack of Efficacy|5|||
150061875|NCT01709578|541367751|FG001|Overall Study|Lack of Efficacy|4|||
150061876|NCT01709578|541367752|FG002|Overall Study|Lack of Efficacy|2|||
150061877|NCT01709578|541367750|FG000|Overall Study|Poor compliance to protocol|1|||
150061878|NCT01709578|541367751|FG001|Overall Study|Poor compliance to protocol|2|||
150061879|NCT01709578|541367752|FG002|Overall Study|Poor compliance to protocol|1|||
150061880|NCT01709578|541367750|FG000|Overall Study|Other, not related to safety or efficacy|2|||
150061881|NCT01709578|541367751|FG001|Overall Study|Other, not related to safety or efficacy|7|||
150061882|NCT01709578|541367752|FG002|Overall Study|Other, not related to safety or efficacy|5|||
150061883|NCT04050371|541367753|FG000|Overall Study|Withdrawal by Subject|1|||
150061884|NCT04050371|541367754|FG001|Overall Study|Withdrawal by Subject|0|||
150061885|NCT00597701|541367755|FG000|Overall Study|Withdrawal by Subject|5|||
150061886|NCT00597701|541367756|FG001|Overall Study|Withdrawal by Subject|5|||
150061887|NCT00597701|541367755|FG000|Overall Study|Death|0|||
150061888|NCT00597701|541367756|FG001|Overall Study|Death|1|||
150061889|NCT00597701|541367755|FG000|Overall Study|Physician Decision|2|||
150061890|NCT00597701|541367756|FG001|Overall Study|Physician Decision|0|||
150061891|NCT00597701|541367755|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
150061892|NCT00597701|541367756|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
150061893|NCT01107418|541367757|FG000|Overall Study|Disease Progression|45|||
150061894|NCT01107418|541367757|FG000|Overall Study|Adverse Event|3|||
150061895|NCT01107418|541367757|FG000|Overall Study|Withdrawal by Subject|1|||
150061896|NCT01107418|541367757|FG000|Overall Study|Study Closing|1|||
150061897|NCT01107418|541367757|FG000|Overall Study|Started Other Therapy|1|||
150061898|NCT01107418|541367757|FG000|Overall Study|Entered Extension Study|1|||
150061899|NCT01155219|541367761|FG000|Overall Study|Adverse Event|3|||
150061900|NCT01155219|541367762|FG001|Overall Study|Adverse Event|1|||
150061901|NCT01155219|541367761|FG000|Overall Study|non-medical reason|1|||
150061902|NCT01155219|541367762|FG001|Overall Study|non-medical reason|2|||
150061903|NCT01314911|541367764|FG000|Overall Study|Lost to Follow-up|3|||
150061904|NCT01314911|541367765|FG001|Overall Study|Lost to Follow-up|2|||
150061905|NCT01314911|541367764|FG000|Overall Study|Withdrawal by Subject|1|||
150061906|NCT01314911|541367765|FG001|Overall Study|Withdrawal by Subject|3|||
150061907|NCT01314911|541367764|FG000|Overall Study|Received Non-randomized Study Drug|0|||
150061908|NCT01314911|541367765|FG001|Overall Study|Received Non-randomized Study Drug|1|||
150061909|NCT01314911|541367764|FG000|Overall Study|Never Started Treatment|1|||
150061910|NCT01314911|541367765|FG001|Overall Study|Never Started Treatment|0|||
150061911|NCT00814879|541367769|FG000|By Week 24|Cancer Diagnosis|1|||
150061912|NCT00814879|541367770|FG001|By Week 24|Cancer Diagnosis|0|||
150061913|NCT00814879|541367769|FG000|By Week 24|Incarceration|0|||
150061914|NCT00814879|541367770|FG001|By Week 24|Incarceration|1|||
150061915|NCT00814879|541367769|FG000|By Week 48|Lost to Follow-up|2|||
150061916|NCT00814879|541367770|FG001|By Week 48|Lost to Follow-up|2|||
150061917|NCT00814879|541367769|FG000|By Week 48|Death|0|||
150061918|NCT00814879|541367770|FG001|By Week 48|Death|1|||
150061919|NCT01277042|541367771|FG000|Overall Study|Adverse Event|4|||
150061920|NCT01277042|541367772|FG001|Overall Study|Adverse Event|3|||
150061921|NCT01277042|541367771|FG000|Overall Study|Lost to Follow-up|2|||
150061922|NCT01277042|541367772|FG001|Overall Study|Lost to Follow-up|2|||
150061923|NCT01277042|541367771|FG000|Overall Study|Withdrawal by Subject|2|||
150061924|NCT01277042|541367772|FG001|Overall Study|Withdrawal by Subject|0|||
150061925|NCT03560739|541367774|FG000|Overall Study|Adverse Event|0|||
150061926|NCT03560739|541367775|FG001|Overall Study|Adverse Event|1|||
150061927|NCT03560739|541367776|FG002|Overall Study|Adverse Event|0|||
150061928|NCT03560739|541367777|FG003|Overall Study|Adverse Event|0|||
150061929|NCT01362595|541367778|FG000|Overall Study|Screen failure|10|||
150061930|NCT01362595|541367778|FG000|Overall Study|Withdrawal by Subject|2|||
150061931|NCT00959374|541367779|FG000|Overall Study|Withdrawal by Subject|2|||
150061932|NCT00959374|541367779|FG000|Overall Study|Lost to Follow-up|14|||
150061933|NCT00959374|541367779|FG000|Overall Study|Death|1|||
150061934|NCT00959374|541367779|FG000|Overall Study|Protocol Violation|1|||
150061935|NCT00959374|541367779|FG000|Overall Study|Implant Removed/Not Replaced|4|||
150061936|NCT00959374|541367779|FG000|Overall Study|Physician Decision|1|||
150061937|NCT02448680|541367780|FG000|Overall Study|Physician Decision|1|||
150061938|NCT02448680|541367781|FG001|Overall Study|Physician Decision|1|||
150061939|NCT02448680|541367780|FG000|Overall Study|Withdrawal by Subject|0|||
150061940|NCT02448680|541367781|FG001|Overall Study|Withdrawal by Subject|2|||
150061941|NCT01741012|541367783|FG000|Overall Study|Lost to Follow-up|1|||
150061942|NCT01741012|541367783|FG000|Overall Study|Withdrawal by Subject|2|||
150061943|NCT04123665|541367784|FG000|Overall Study|Withdrawal by Subject|7|||
150061944|NCT04123665|541367785|FG001|Overall Study|Withdrawal by Subject|0|||
150061945|NCT04123665|541367784|FG000|Overall Study|Lost to Follow-up|1|||
150061946|NCT04123665|541367785|FG001|Overall Study|Lost to Follow-up|0|||
150061947|NCT01711879|541367787|FG000|Overall Study|Death|1|||
150061948|NCT01711879|541367788|FG001|Overall Study|Death|0|||
150061949|NCT00958789|541367789|FG000|Overall Study|Death|5|||
150061950|NCT00958789|541367789|FG000|Overall Study|Lost to Follow-up|14|||
150061951|NCT00958789|541367789|FG000|Overall Study|Withdrawal by Subject|17|||
150061952|NCT00958789|541367789|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
150061953|NCT00958789|541367789|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
150061954|NCT00958789|541367789|FG000|Overall Study|Subject terminated|2|||
150061955|NCT00958789|541367789|FG000|Overall Study|Revision|7|||
150061956|NCT00478881|541367792|FG000|Overall Study|Adverse Event|31|||
150061957|NCT00478881|541367793|FG001|Overall Study|Adverse Event|12|||
150061958|NCT00478881|541367792|FG000|Overall Study|Lack of Efficacy|0|||
150061959|NCT00478881|541367793|FG001|Overall Study|Lack of Efficacy|3|||
150061960|NCT00478881|541367792|FG000|Overall Study|Lost to Follow-up|0|||
150061961|NCT00478881|541367793|FG001|Overall Study|Lost to Follow-up|1|||
150061962|NCT00478881|541367792|FG000|Overall Study|Protocol Violation|2|||
150061963|NCT00478881|541367793|FG001|Overall Study|Protocol Violation|2|||
150061964|NCT00478881|541367792|FG000|Overall Study|Withdrawal by Subject|6|||
150061965|NCT00478881|541367793|FG001|Overall Study|Withdrawal by Subject|2|||
150061966|NCT00478881|541367792|FG000|Overall Study|Non-Compliance with Study Medication|0|||
150061967|NCT00478881|541367793|FG001|Overall Study|Non-Compliance with Study Medication|2|||
150061968|NCT01466179|541367794|FG000|Overall Study|Ongoing in core study|2|||
150061969|NCT01466179|541367794|FG000|Overall Study|Physician Decision|46|||
150061970|NCT01466179|541367794|FG000|Overall Study|Progressive disease|43|||
150061971|NCT01466179|541367794|FG000|Overall Study|Adverse Event|32|||
150061972|NCT01466179|541367794|FG000|Overall Study|Disease relapse|23|||
150061973|NCT01466179|541367794|FG000|Overall Study|Lack of Efficacy|14|||
150061974|NCT01466179|541367794|FG000|Overall Study|Death|7|||
150061975|NCT01466179|541367794|FG000|Overall Study|Withdrawal by Subject|7|||
150061976|NCT01466179|541367794|FG000|Overall Study|Protocol Violation|2|||
150061977|NCT01466179|541367794|FG000|Overall Study|Other|3|||
150061978|NCT01083173|541367797|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
150061979|NCT01083173|541367798|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
150061980|NCT01083173|541367797|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
150061981|NCT01083173|541367798|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
150061982|NCT01083173|541367797|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
150061983|NCT01083173|541367798|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
150061984|NCT01083173|541367797|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
150061985|NCT01083173|541367798|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
150061986|NCT01083173|541367797|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
150061987|NCT01083173|541367798|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
150061988|NCT01083173|541367797|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
150061989|NCT01083173|541367798|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
150061990|NCT01083173|541367797|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
150061991|NCT01083173|541367798|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
150061992|NCT01083173|541367797|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
150061993|NCT01083173|541367798|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
150061994|NCT01083173|541367797|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
150061995|NCT01083173|541367798|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
150061996|NCT01083173|541367797|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
150061997|NCT01083173|541367798|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
150061998|NCT01083173|541367797|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
150061999|NCT01083173|541367798|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
150062000|NCT03410823|541367799|FG000|Overall Study|Death|1|||
150062001|NCT03410823|541367799|FG000|Overall Study|Withdrawal by Subject|2|||
150062002|NCT03410823|541367799|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
150062003|NCT04565236|541367801|FG000|Overall Study|Patient/Guardian Decision|0|||
150062004|NCT04565236|541367802|FG001|Overall Study|Patient/Guardian Decision|0|||
150062005|NCT04565236|541367803|FG002|Overall Study|Patient/Guardian Decision|1|||
150062006|NCT04565236|541367804|FG003|Overall Study|Patient/Guardian Decision|0|||
150062007|NCT01041495|541367805|FG000|Overall Study|Withdrawal by Subject|2|||
150062008|NCT01041495|541367806|FG001|Overall Study|Withdrawal by Subject|5|||
150062009|NCT01041495|541367805|FG000|Overall Study|Adverse Event|2|||
150062010|NCT01041495|541367806|FG001|Overall Study|Adverse Event|1|||
150062011|NCT01041495|541367805|FG000|Overall Study|Lost to Follow-up|0|||
150062012|NCT01041495|541367806|FG001|Overall Study|Lost to Follow-up|1|||
150062013|NCT03584373|541367807|FG000|Overall Study|Lost to Follow-up|7|||
150062014|NCT03584373|541367808|FG001|Overall Study|Lost to Follow-up|8|||
150062015|NCT03780400|541367809|FG000|Overall Study|Lost to Follow-up|5|||
150062016|NCT03780400|541367809|FG000|Overall Study|Withdrawal by Subject|2|||
150062017|NCT00470184|541367814|FG000|Overall Study|Not Treated(became ineligible)|4|||
150062018|NCT00470184|541367814|FG000|Overall Study|Not treated (other)|1|||
150062019|NCT00470184|541367814|FG000|Overall Study|disease Progression|4|||
150062020|NCT00470184|541367814|FG000|Overall Study|Adverse Event|3|||
150062021|NCT00470184|541367814|FG000|Overall Study|Withdrawal by Subject|4|||
150062022|NCT00470184|541367814|FG000|Overall Study|other|5|||
150062023|NCT00470184|541367814|FG000|Overall Study|recurrence|1|||
150062024|NCT01923168|541367817|FG000|Overall Study|Protocol Violation|1|||
150062025|NCT01923168|541367818|FG001|Overall Study|Protocol Violation|1|||
150062026|NCT01923168|541367819|FG002|Overall Study|Protocol Violation|0|||
150062027|NCT01923168|541367817|FG000|Overall Study|Subject/guardian decision|14|||
150062028|NCT01923168|541367818|FG001|Overall Study|Subject/guardian decision|14|||
150062029|NCT01923168|541367819|FG002|Overall Study|Subject/guardian decision|4|||
150062030|NCT01923168|541367817|FG000|Overall Study|Adverse Event|12|||
150062031|NCT01923168|541367818|FG001|Overall Study|Adverse Event|12|||
150062032|NCT01923168|541367819|FG002|Overall Study|Adverse Event|0|||
150062033|NCT01923168|541367817|FG000|Overall Study|Physician Decision|6|||
150062034|NCT01923168|541367818|FG001|Overall Study|Physician Decision|9|||
150062035|NCT01923168|541367819|FG002|Overall Study|Physician Decision|5|||
150062036|NCT01923168|541367817|FG000|Overall Study|Progressive disease|4|||
150062037|NCT01923168|541367818|FG001|Overall Study|Progressive disease|3|||
150062038|NCT01923168|541367819|FG002|Overall Study|Progressive disease|7|||
150062039|NCT01923168|541367817|FG000|Overall Study|Death|0|||
150062040|NCT01923168|541367818|FG001|Overall Study|Death|0|||
150062041|NCT01923168|541367819|FG002|Overall Study|Death|1|||
150062042|NCT00768469|541367820|FG000|Overall Study|Adverse Event|0|||
150062043|NCT00768469|541367821|FG001|Overall Study|Adverse Event|2|||
150062044|NCT00768469|541367820|FG000|Overall Study|Disease Progression|3|||
150062045|NCT00768469|541367821|FG001|Overall Study|Disease Progression|4|||
150062046|NCT00768469|541367820|FG000|Overall Study|Withdrawal by Subject|0|||
150062047|NCT00768469|541367821|FG001|Overall Study|Withdrawal by Subject|1|||
150062048|NCT00459056|541367826|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
150062049|NCT00459056|541367827|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
150062050|NCT02522871|541367828|FG000|Overall Study|Protocol Violation|1|||
150062051|NCT02522871|541367829|FG001|Overall Study|Protocol Violation|4|||
150062052|NCT02522871|541367828|FG000|Overall Study|Treated without randomization|1|||
150062053|NCT02522871|541367829|FG001|Overall Study|Treated without randomization|0|||
150181899|NCT03398148|541804610|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
150062054|NCT02522871|541367828|FG000|Overall Study|Death|9|||
150062055|NCT02522871|541367829|FG001|Overall Study|Death|9|||
150062056|NCT02522871|541367828|FG000|Overall Study|Died in operating room prior to transplant|0|||
150062057|NCT02522871|541367829|FG001|Overall Study|Died in operating room prior to transplant|1|||
150062058|NCT01222403|541367832|FG000|Overall Study|Inappropriate enrollment|0|||
150062059|NCT01222403|541367833|FG001|Overall Study|Inappropriate enrollment|2|||
150062060|NCT00725842|541367834|FG000|Overall Study|Lost to Follow-up|19|||
150062061|NCT00725842|541367834|FG000|Overall Study|Death|1|||
150062062|NCT00725842|541367834|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
150062063|NCT00725842|541367834|FG000|Overall Study|Consent date prior to study start date|5|||
150062064|NCT00725842|541367834|FG000|Overall Study|Inclusion criterion not met|1|||
150062065|NCT00725842|541367834|FG000|Overall Study|No Visit 1 data|1|||
150062066|NCT02793622|541367837|FG000|Overall Study|Lost to Follow-up|31|||
150062067|NCT02793622|541367838|FG001|Overall Study|Lost to Follow-up|19|||
150062068|NCT02793622|541367837|FG000|Overall Study|Withdrawal by Subject|21|||
150062069|NCT02793622|541367838|FG001|Overall Study|Withdrawal by Subject|17|||
150062070|NCT02793622|541367837|FG000|Overall Study|Adverse Event|0|||
150062071|NCT02793622|541367838|FG001|Overall Study|Adverse Event|1|||
150062072|NCT02793622|541367837|FG000|Overall Study|Protocol Violation|1|||
150062073|NCT02793622|541367838|FG001|Overall Study|Protocol Violation|5|||
150062074|NCT02068768|541367840|FG000|Overall Study|Lost to Follow-up|5|||
150062075|NCT02068768|541367840|FG000|Overall Study|Early Termination by Sponsor|2|||
150062076|NCT01262352|541367841|FG000|Period 1|Illness after randomization|1|||
150062077|NCT01262352|541367842|FG001|Period 1|Illness after randomization|0|||
150062078|NCT01262352|541367841|FG000|Washout|Adverse Event|1|||
150062079|NCT01262352|541367842|FG001|Washout|Adverse Event|1|||
150062080|NCT01262352|541367841|FG000|Washout|Extended Washout|0|||
150062081|NCT01262352|541367842|FG001|Washout|Extended Washout|1|||
150062082|NCT01185834|541367843|FG000|Overall Study|Lost to Follow-up|2|||
150062083|NCT01185834|541367843|FG000|Overall Study|Discomfort|4|||
150062084|NCT01185834|541367843|FG000|Overall Study|Biomicroscopy|4|||
150062085|NCT01185834|541367843|FG000|Overall Study|Time/Job Conflict|2|||
150062086|NCT01185834|541367843|FG000|Overall Study|Early exit - Site error|2|||
150062087|NCT03189381|541367844|FG000|Overall Study|Death|1|||
150062088|NCT03189381|541367845|FG001|Overall Study|Death|0|||
150062089|NCT01401959|541367846|FG000|Enrolled|Withdrawal by Subject|1|||
150062090|NCT01401959|541367847|FG001|Enrolled|Withdrawal by Subject|0|||
150062091|NCT01401959|541367848|FG002|Enrolled|Withdrawal by Subject|0|||
150062092|NCT01401959|541367846|FG000|Treated|Disease Progression|2|||
150062093|NCT01401959|541367847|FG001|Treated|Disease Progression|2|||
150062094|NCT01401959|541367848|FG002|Treated|Disease Progression|1|||
150062095|NCT01401959|541367846|FG000|Treated|Adverse Event|4|||
150062096|NCT01401959|541367847|FG001|Treated|Adverse Event|3|||
150062097|NCT01401959|541367848|FG002|Treated|Adverse Event|2|||
150062098|NCT01401959|541367846|FG000|Treated|Withdrawal by Subject|1|||
150062099|NCT01401959|541367847|FG001|Treated|Withdrawal by Subject|2|||
150062100|NCT01401959|541367848|FG002|Treated|Withdrawal by Subject|2|||
150062101|NCT01401959|541367846|FG000|Treated|Protocol Violation|0|||
150062102|NCT01401959|541367847|FG001|Treated|Protocol Violation|1|||
150062103|NCT01401959|541367848|FG002|Treated|Protocol Violation|0|||
150062104|NCT02925793|541367849|FG000|Overall Study|Adverse Event|3|||
150062105|NCT02925793|541367850|FG001|Overall Study|Adverse Event|3|||
150062106|NCT02925793|541367851|FG002|Overall Study|Adverse Event|6|||
150062107|NCT02925793|541367849|FG000|Overall Study|Withdrawal by Subject|16|||
150062108|NCT02925793|541367850|FG001|Overall Study|Withdrawal by Subject|15|||
150062109|NCT02925793|541367851|FG002|Overall Study|Withdrawal by Subject|13|||
150062110|NCT02925793|541367849|FG000|Overall Study|Investigator Discretion|0|||
150062111|NCT02925793|541367850|FG001|Overall Study|Investigator Discretion|1|||
150062112|NCT02925793|541367851|FG002|Overall Study|Investigator Discretion|1|||
150062113|NCT02925793|541367849|FG000|Overall Study|Lost to Follow-up|2|||
150062114|NCT02925793|541367850|FG001|Overall Study|Lost to Follow-up|3|||
150062115|NCT02925793|541367851|FG002|Overall Study|Lost to Follow-up|1|||
150062116|NCT02925793|541367849|FG000|Overall Study|Lack of Efficacy|2|||
150062117|NCT02925793|541367850|FG001|Overall Study|Lack of Efficacy|6|||
150062118|NCT02925793|541367851|FG002|Overall Study|Lack of Efficacy|4|||
150062119|NCT02925793|541367849|FG000|Overall Study|Other:|2|||
150062120|NCT02925793|541367850|FG001|Overall Study|Other:|1|||
150062121|NCT02925793|541367851|FG002|Overall Study|Other:|3|||
150062122|NCT01244490|541367852|FG000|Overall Study|Lack of Efficacy|14|||
150062123|NCT01244490|541367853|FG001|Overall Study|Lack of Efficacy|5|||
150062124|NCT01244490|541367854|FG002|Overall Study|Lack of Efficacy|5|||
150062125|NCT01244490|541367852|FG000|Overall Study|Withdrawal by Subject|4|||
150062126|NCT01244490|541367853|FG001|Overall Study|Withdrawal by Subject|4|||
150062127|NCT01244490|541367854|FG002|Overall Study|Withdrawal by Subject|9|||
150062128|NCT01244490|541367852|FG000|Overall Study|Adverse Event|1|||
150062129|NCT01244490|541367853|FG001|Overall Study|Adverse Event|9|||
150062130|NCT01244490|541367854|FG002|Overall Study|Adverse Event|5|||
150062131|NCT01244490|541367852|FG000|Overall Study|Lost to Follow-up|0|||
150062132|NCT01244490|541367853|FG001|Overall Study|Lost to Follow-up|6|||
150062133|NCT01244490|541367854|FG002|Overall Study|Lost to Follow-up|3|||
150062134|NCT01244490|541367852|FG000|Overall Study|Other|0|||
150062135|NCT01244490|541367853|FG001|Overall Study|Other|0|||
150062136|NCT01244490|541367854|FG002|Overall Study|Other|1|||
150062137|NCT00321893|541367857|FG000|Overall Study|Non-Compliance/Refusal|16|||
150062138|NCT00321893|541367858|FG001|Overall Study|Non-Compliance/Refusal|10|||
150062139|NCT00321893|541367857|FG000|Overall Study|Lost to Follow-up|2|||
150062140|NCT00321893|541367858|FG001|Overall Study|Lost to Follow-up|1|||
150062141|NCT00321893|541367857|FG000|Overall Study|Adverse Event|6|||
150062142|NCT00321893|541367858|FG001|Overall Study|Adverse Event|3|||
150062143|NCT03455764|541367859|FG000|Overall Study|Adverse Event|1|||
150062144|NCT03455764|541367860|FG001|Overall Study|Adverse Event|0|||
150062145|NCT03455764|541367861|FG002|Overall Study|Adverse Event|0|||
150062146|NCT03455764|541367862|FG003|Overall Study|Adverse Event|0|||
150062147|NCT03455764|541367863|FG004|Overall Study|Adverse Event|0|||
150062148|NCT03455764|541367859|FG000|Overall Study|Disease Progression|4|||
150062149|NCT03455764|541367860|FG001|Overall Study|Disease Progression|0|||
150062150|NCT03455764|541367861|FG002|Overall Study|Disease Progression|0|||
150062151|NCT03455764|541367862|FG003|Overall Study|Disease Progression|0|||
150062152|NCT03455764|541367863|FG004|Overall Study|Disease Progression|0|||
150062153|NCT03455764|541367859|FG000|Overall Study|On Treatment|1|||
150062154|NCT03455764|541367860|FG001|Overall Study|On Treatment|0|||
150062155|NCT03455764|541367861|FG002|Overall Study|On Treatment|0|||
150062156|NCT03455764|541367862|FG003|Overall Study|On Treatment|0|||
150062157|NCT03455764|541367863|FG004|Overall Study|On Treatment|0|||
150062158|NCT01585584|541367864|FG000|Overall Study|Lack of Efficacy|1|||
150062159|NCT01585584|541367864|FG000|Overall Study|Withdrawal by Subject|1|||
150062160|NCT01585584|541367864|FG000|Overall Study|Physician Decision|2|||
150062161|NCT00686998|541367865|FG000|Overall Study|Adverse Event|3|||
150062162|NCT00686998|541367866|FG001|Overall Study|Adverse Event|2|||
150062163|NCT00686998|541367867|FG002|Overall Study|Adverse Event|1|||
150062164|NCT00686998|541367865|FG000|Overall Study|Withdrawal by Subject|2|||
150062165|NCT00686998|541367866|FG001|Overall Study|Withdrawal by Subject|1|||
150062166|NCT00686998|541367867|FG002|Overall Study|Withdrawal by Subject|2|||
150062167|NCT00686998|541367865|FG000|Overall Study|Lack of Efficacy|7|||
150062168|NCT00686998|541367866|FG001|Overall Study|Lack of Efficacy|5|||
150181900|NCT03398148|541804596|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
150062169|NCT00686998|541367867|FG002|Overall Study|Lack of Efficacy|0|||
150062170|NCT00686998|541367865|FG000|Overall Study|Other|0|||
150062171|NCT00686998|541367866|FG001|Overall Study|Other|0|||
150062172|NCT00686998|541367867|FG002|Overall Study|Other|1|||
150062173|NCT00686998|541367865|FG000|Overall Study|Safety Reasons|1|||
150062174|NCT00686998|541367866|FG001|Overall Study|Safety Reasons|0|||
150062175|NCT00686998|541367867|FG002|Overall Study|Safety Reasons|0|||
150062176|NCT05985980|541367868|FG000|Overall Study|Withdrawal by Subject|1|||
150062177|NCT05985980|541367868|FG000|Overall Study|Withdrawal by Subject|1|||
150062178|NCT05985980|541367868|FG000|Overall Study|Withdrawal by Subject|1|||
150062179|NCT05985980|541367868|FG000|Overall Study|Withdrawal by Subject|1|||
150062180|NCT01394718|541369281|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
150062181|NCT01394718|541369282|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
150062182|NCT04478123|541369283|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
150062183|NCT04478123|541369283|FG000|Overall Study|NE|1|||
150062184|NCT02395016|541369284|FG000|Overall Study|Adverse Event|4|||
150062185|NCT02395016|541369285|FG001|Overall Study|Adverse Event|3|||
150062186|NCT02395016|541369284|FG000|Overall Study|Withdrawal by Subject|9|||
150062187|NCT02395016|541369285|FG001|Overall Study|Withdrawal by Subject|6|||
150062188|NCT02395016|541369284|FG000|Overall Study|Protocol Violation|2|||
150062189|NCT02395016|541369285|FG001|Overall Study|Protocol Violation|3|||
150062190|NCT04444895|541369286|FG000|Overall Study|Adverse Event|2|||
150062191|NCT04444895|541369286|FG000|Overall Study|Lost to Follow-up|2|||
150062192|NCT04444895|541369286|FG000|Overall Study|Withdrawal by Subject|5|||
150062193|NCT01547780|541369287|FG000|Baseline PET Scan|Physician Decision|1|||
150062194|NCT01547780|541369288|FG001|Baseline PET Scan|Physician Decision|0|||
150062195|NCT01547780|541369289|FG002|Baseline PET Scan|Physician Decision|1|||
150062196|NCT01547780|541369290|FG003|Baseline PET Scan|Physician Decision|0|||
150062197|NCT01547780|541369287|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
150062198|NCT01547780|541369288|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
150062199|NCT01547780|541369289|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
150062200|NCT01547780|541369290|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
150062201|NCT00719264|541369291|FG000|Overall Study|Adverse Event|41|||
150062202|NCT00719264|541369292|FG001|Overall Study|Adverse Event|49|||
150062203|NCT00719264|541369291|FG000|Overall Study|Death|13|||
150062204|NCT00719264|541369292|FG001|Overall Study|Death|10|||
150062205|NCT00719264|541369291|FG000|Overall Study|Administrative Problems|6|||
150062206|NCT00719264|541369292|FG001|Overall Study|Administrative Problems|4|||
150062207|NCT00719264|541369291|FG000|Overall Study|Lost to Follow-up|1|||
150062208|NCT00719264|541369292|FG001|Overall Study|Lost to Follow-up|1|||
150062209|NCT00719264|541369291|FG000|Overall Study|Withdrawal by Subject|12|||
150062210|NCT00719264|541369292|FG001|Overall Study|Withdrawal by Subject|7|||
150062211|NCT00719264|541369291|FG000|Overall Study|Protocol Deviation|1|||
150062212|NCT00719264|541369292|FG001|Overall Study|Protocol Deviation|3|||
150062213|NCT00719264|541369291|FG000|Overall Study|New Cancer Therapy|4|||
150062214|NCT00719264|541369292|FG001|Overall Study|New Cancer Therapy|2|||
150062215|NCT00719264|541369291|FG000|Overall Study|Disease Progression|104|||
150062216|NCT00719264|541369292|FG001|Overall Study|Disease Progression|107|||
150062217|NCT00588952|541369294|FG000|Overall Study|Adverse Event|0|||
150062218|NCT00588952|541369295|FG001|Overall Study|Adverse Event|2|||
150062219|NCT00588952|541369294|FG000|Overall Study|Withdrawal by Subject|3|||
150062220|NCT00588952|541369295|FG001|Overall Study|Withdrawal by Subject|5|||
150062221|NCT01461057|541369296|FG000|Overall Study|Death|10|||
150062222|NCT01461057|541369297|FG001|Overall Study|Death|9|||
150062223|NCT01461057|541369296|FG000|Overall Study|Withdrawal by Subject|2|||
150062224|NCT01461057|541369297|FG001|Overall Study|Withdrawal by Subject|3|||
150062225|NCT01461057|541369296|FG000|Overall Study|Physician Decision|0|||
150062226|NCT01461057|541369297|FG001|Overall Study|Physician Decision|2|||
150062227|NCT01461057|541369296|FG000|Overall Study|Adverse Event|0|||
150062228|NCT01461057|541369297|FG001|Overall Study|Adverse Event|1|||
150062229|NCT01461057|541369296|FG000|Overall Study|Progression of Disease|1|||
150062230|NCT01461057|541369297|FG001|Overall Study|Progression of Disease|0|||
150062231|NCT01461057|541369296|FG000|Overall Study|Study Terminated by Sponsor|2|||
150062232|NCT01461057|541369297|FG001|Overall Study|Study Terminated by Sponsor|0|||
150062233|NCT01288976|541369298|FG000|Overall Study|Withdrawal by Subject|58|||
150062234|NCT01288976|541369299|FG001|Overall Study|Withdrawal by Subject|12|||
150062235|NCT01288976|541369300|FG002|Overall Study|Withdrawal by Subject|9|||
150062236|NCT01288976|541369298|FG000|Overall Study|Death|98|||
150062237|NCT01288976|541369299|FG001|Overall Study|Death|6|||
150062238|NCT01288976|541369300|FG002|Overall Study|Death|4|||
150062239|NCT01288976|541369298|FG000|Overall Study|Data unavailable|22|||
150062240|NCT01288976|541369299|FG001|Overall Study|Data unavailable|9|||
150062241|NCT01288976|541369300|FG002|Overall Study|Data unavailable|7|||
150062242|NCT00642473|541369309|FG000|Overall Study|Withdrawal by Subject|0|||
150062243|NCT00642473|541369310|FG001|Overall Study|Withdrawal by Subject|5|||
150062244|NCT00642473|541369309|FG000|Overall Study|Progression or death|2|||
150062245|NCT00642473|541369310|FG001|Overall Study|Progression or death|4|||
150062246|NCT00642473|541369309|FG000|Overall Study|Other|2|||
150062247|NCT00642473|541369310|FG001|Overall Study|Other|2|||
150062248|NCT00740246|541369314|FG000|Overall Study|Received Blood Transfusion|0|||
150062249|NCT00740246|541369315|FG001|Overall Study|Received Blood Transfusion|1|||
150062250|NCT00740246|541369314|FG000|Overall Study|Adverse Event|1|||
150062251|NCT00740246|541369315|FG001|Overall Study|Adverse Event|2|||
150062252|NCT00740246|541369314|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
150062253|NCT00740246|541369315|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
150062254|NCT00740246|541369314|FG000|Overall Study|Lost to Follow-up|2|||
150062255|NCT00740246|541369315|FG001|Overall Study|Lost to Follow-up|2|||
150062256|NCT00740246|541369314|FG000|Overall Study|Withdrawal by Subject|4|||
150062257|NCT00740246|541369315|FG001|Overall Study|Withdrawal by Subject|3|||
150062258|NCT00740246|541369314|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
150062259|NCT00740246|541369315|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
150062260|NCT00740246|541369314|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
150062261|NCT00740246|541369315|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
150062262|NCT00740246|541369314|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
150062263|NCT00740246|541369315|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
150062264|NCT00740246|541369314|FG000|Overall Study|Unable To Comply With Study Visits|2|||
150062265|NCT00740246|541369315|FG001|Overall Study|Unable To Comply With Study Visits|0|||
150062266|NCT00740246|541369314|FG000|Overall Study|Unable to Access Vein|0|||
150062267|NCT00740246|541369315|FG001|Overall Study|Unable to Access Vein|2|||
150062268|NCT00740246|541369314|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
150062269|NCT00740246|541369315|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
150062270|NCT00662532|541369317|FG000|Overall Study|Adverse Event|0|||
150062271|NCT00662532|541369318|FG001|Overall Study|Adverse Event|1|||
150062272|NCT00662532|541369317|FG000|Overall Study|Lost to Follow-up|0|||
150062273|NCT00662532|541369318|FG001|Overall Study|Lost to Follow-up|1|||
150062274|NCT00366340|541369319|FG000|Infant Series|Protocol Violation|3|||
150062275|NCT00366340|541369320|FG001|Infant Series|Protocol Violation|4|||
150062276|NCT00366340|541369319|FG000|Infant Series|Withdrawal by Subject|3|||
150062277|NCT00366340|541369320|FG001|Infant Series|Withdrawal by Subject|3|||
150062278|NCT00366340|541369319|FG000|Infant Series|Adverse Event|0|||
150062279|NCT00366340|541369320|FG001|Infant Series|Adverse Event|2|||
150062280|NCT00366340|541369319|FG000|Infant Series|Lost to Follow-up|1|||
150062281|NCT00366340|541369320|FG001|Infant Series|Lost to Follow-up|1|||
150062282|NCT00366340|541369319|FG000|Infant Series|Failure to return|1|||
150062283|NCT00366340|541369320|FG001|Infant Series|Failure to return|0|||
150062284|NCT00366340|541369319|FG000|After the Infant Series|Parent/legal guardian request|1|||
150062285|NCT00366340|541369320|FG001|After the Infant Series|Parent/legal guardian request|1|||
150062286|NCT00366340|541369319|FG000|After the Infant Series|Failed to return|0|||
150062287|NCT00366340|541369320|FG001|After the Infant Series|Failed to return|1|||
150062288|NCT00366340|541369319|FG000|After the Infant Series|Protocol Violation|2|||
150062289|NCT00366340|541369320|FG001|After the Infant Series|Protocol Violation|2|||
150062290|NCT00366340|541369319|FG000|After the Infant Series|Adverse Event|0|||
150062291|NCT00366340|541369320|FG001|After the Infant Series|Adverse Event|1|||
150062292|NCT00366340|541369319|FG000|After the Infant Series|Lost to Follow-up|0|||
150062293|NCT00366340|541369320|FG001|After the Infant Series|Lost to Follow-up|1|||
150062294|NCT00366340|541369319|FG000|Toddler Dose|Failed to return|1|||
150062295|NCT00366340|541369320|FG001|Toddler Dose|Failed to return|0|||
150062296|NCT00366340|541369319|FG000|Toddler Dose|Parent/legal guardian request|0|||
150062297|NCT00366340|541369320|FG001|Toddler Dose|Parent/legal guardian request|1|||
150062298|NCT00442468|541369321|FG000|Overall Study|Adverse Event|4|||
150062299|NCT00442468|541369321|FG000|Overall Study|Withdrawal by Subject|91|||
150062300|NCT00442468|541369321|FG000|Overall Study|Did not complete all study procedures|88|||
150062301|NCT00589784|541369322|FG000|Overall Study|Withdrawal by Subject|0|||
150062302|NCT00589784|541369323|FG001|Overall Study|Withdrawal by Subject|6|||
150062303|NCT00589784|541369322|FG000|Overall Study|Patient inevaluable|1|||
150062304|NCT00589784|541369323|FG001|Overall Study|Patient inevaluable|0|||
150062305|NCT00589784|541369322|FG000|Overall Study|Adverse Event|0|||
150062306|NCT00589784|541369323|FG001|Overall Study|Adverse Event|4|||
150062307|NCT03823378|541369324|FG000|Overall Study|Adverse Event|2|||
150062308|NCT03823378|541369325|FG001|Overall Study|Adverse Event|2|||
150062309|NCT03823378|541369326|FG002|Overall Study|Adverse Event|0|||
150062310|NCT03823378|541369327|FG003|Overall Study|Adverse Event|0|||
150062311|NCT03823378|541369328|FG004|Overall Study|Adverse Event|0|||
150062312|NCT03823378|541369329|FG005|Overall Study|Adverse Event|0|||
150062313|NCT03823378|541369324|FG000|Overall Study|Lost to Follow-up|0|||
150062314|NCT03823378|541369325|FG001|Overall Study|Lost to Follow-up|1|||
150062315|NCT03823378|541369326|FG002|Overall Study|Lost to Follow-up|0|||
150062316|NCT03823378|541369327|FG003|Overall Study|Lost to Follow-up|0|||
150062317|NCT03823378|541369328|FG004|Overall Study|Lost to Follow-up|1|||
150062318|NCT03823378|541369329|FG005|Overall Study|Lost to Follow-up|0|||
150062319|NCT03823378|541369324|FG000|Overall Study|Withdrawal by Subject|0|||
150062320|NCT03823378|541369325|FG001|Overall Study|Withdrawal by Subject|1|||
150062321|NCT03823378|541369326|FG002|Overall Study|Withdrawal by Subject|4|||
150062322|NCT03823378|541369327|FG003|Overall Study|Withdrawal by Subject|2|||
150062323|NCT03823378|541369328|FG004|Overall Study|Withdrawal by Subject|0|||
150062324|NCT03823378|541369329|FG005|Overall Study|Withdrawal by Subject|1|||
150062325|NCT03823378|541369324|FG000|Overall Study|Other, not specified|19|||
150062326|NCT03823378|541369325|FG001|Overall Study|Other, not specified|12|||
150062327|NCT03823378|541369326|FG002|Overall Study|Other, not specified|6|||
150062328|NCT03823378|541369327|FG003|Overall Study|Other, not specified|8|||
150062329|NCT03823378|541369328|FG004|Overall Study|Other, not specified|17|||
150062330|NCT03823378|541369329|FG005|Overall Study|Other, not specified|7|||
150062331|NCT01606254|541369330|FG000|Overall Study|Withdrawal by Subject|1|||
150062332|NCT01606254|541369331|FG001|Overall Study|Withdrawal by Subject|3|||
150062333|NCT01606254|541369332|FG002|Overall Study|Withdrawal by Subject|0|||
150062334|NCT01606254|541369333|FG003|Overall Study|Withdrawal by Subject|2|||
150062335|NCT01606254|541369330|FG000|Overall Study|Adverse Event|1|||
150062336|NCT01606254|541369331|FG001|Overall Study|Adverse Event|1|||
150062337|NCT01606254|541369332|FG002|Overall Study|Adverse Event|0|||
150062338|NCT01606254|541369333|FG003|Overall Study|Adverse Event|1|||
150062339|NCT01001299|541369334|FG000|Overall Study|Insufficient Therapeutic Response|20|||
150062340|NCT01001299|541369334|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
150062341|NCT01001299|541369334|FG000|Overall Study|Death|1|||
150062342|NCT01001299|541369334|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
150062343|NCT01001299|541369334|FG000|Overall Study|Withdrew Consent|1|||
150062344|NCT02195011|541369336|FG000|Overall Study|Adverse Event|4|||
150062345|NCT02195011|541369337|FG001|Overall Study|Adverse Event|0|||
150062346|NCT02195011|541369336|FG000|Overall Study|Progressive Disease|18|||
150062347|NCT02195011|541369337|FG001|Overall Study|Progressive Disease|1|||
150062348|NCT02195011|541369336|FG000|Overall Study|Withdrawal by Subject|3|||
150062349|NCT02195011|541369337|FG001|Overall Study|Withdrawal by Subject|0|||
150062350|NCT00174291|541369338|FG000|Overall Study|Lost to Follow-up|1|||
150062351|NCT00174291|541369339|FG001|Overall Study|Lost to Follow-up|1|||
150062352|NCT00174291|541369338|FG000|Overall Study|Protocol Violation|0|||
150062353|NCT00174291|541369339|FG001|Overall Study|Protocol Violation|2|||
150062354|NCT00174291|541369338|FG000|Overall Study|Study terminated by sponsor|1|||
150062355|NCT00174291|541369339|FG001|Overall Study|Study terminated by sponsor|0|||
150062356|NCT00174291|541369338|FG000|Overall Study|Withdrawal by Subject|3|||
150062357|NCT00174291|541369339|FG001|Overall Study|Withdrawal by Subject|3|||
150062358|NCT00450112|541369340|FG000|Overall Study|Other Treatment Required|5|||
150062359|NCT00450112|541369341|FG001|Overall Study|Other Treatment Required|1|||
150062360|NCT00450112|541369340|FG000|Overall Study|Withdrawal by Subject|4|||
150062361|NCT00450112|541369341|FG001|Overall Study|Withdrawal by Subject|1|||
150062362|NCT00450112|541369340|FG000|Overall Study|Lost to Follow-up|2|||
150062363|NCT00450112|541369341|FG001|Overall Study|Lost to Follow-up|1|||
150062364|NCT00450112|541369340|FG000|Overall Study|Others|2|||
150062365|NCT00450112|541369341|FG001|Overall Study|Others|3|||
150062366|NCT03418571|541369342|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
150062367|NCT03418571|541369343|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
150062368|NCT03882008|541369344|FG000|Overall Study|Withdrawal by Subject|1|||
150062369|NCT03882008|541369344|FG000|Overall Study|Lost to Follow-up|1|||
150062370|NCT01582854|541369345|FG000|Overall Study|Death|8|||
150062371|NCT01582854|541369346|FG001|Overall Study|Death|5|||
150062372|NCT01582854|541369345|FG000|Overall Study|Adverse Event|2|||
150062373|NCT01582854|541369346|FG001|Overall Study|Adverse Event|3|||
150062374|NCT01582854|541369345|FG000|Overall Study|Withdrawal by Participant|8|||
150062375|NCT01582854|541369346|FG001|Overall Study|Withdrawal by Participant|11|||
150062376|NCT01582854|541369345|FG000|Overall Study|Lost to Follow-up|1|||
150062377|NCT01582854|541369346|FG001|Overall Study|Lost to Follow-up|2|||
150062378|NCT01582854|541369345|FG000|Overall Study|Physician Decision|0|||
150062379|NCT01582854|541369346|FG001|Overall Study|Physician Decision|1|||
150062380|NCT01582854|541369345|FG000|Overall Study|Recurrent Stroke|13|||
150062381|NCT01582854|541369346|FG001|Overall Study|Recurrent Stroke|8|||
150062382|NCT01582854|541369345|FG000|Overall Study|Disallowed Concomitant Medication|3|||
150062383|NCT01582854|541369346|FG001|Overall Study|Disallowed Concomitant Medication|2|||
150062384|NCT01582854|541369345|FG000|Overall Study|Carotid or Neurosurgery|0|||
150062385|NCT01582854|541369346|FG001|Overall Study|Carotid or Neurosurgery|1|||
150062386|NCT01582854|541369345|FG000|Overall Study|General Anaesthesia|0|||
150062387|NCT01582854|541369346|FG001|Overall Study|General Anaesthesia|1|||
150062388|NCT01582854|541369345|FG000|Overall Study|Other Miscellaneous Reason|1|||
150062389|NCT01582854|541369346|FG001|Overall Study|Other Miscellaneous Reason|0|||
150062390|NCT04068896|541369347|FG000|Overall Study|Adverse Event|2|||
150062391|NCT04068896|541369348|FG001|Overall Study|Adverse Event|0|||
150062392|NCT04068896|541369349|FG002|Overall Study|Adverse Event|1|||
150062393|NCT04068896|541369350|FG003|Overall Study|Adverse Event|0|||
150062394|NCT04068896|541369351|FG004|Overall Study|Adverse Event|0|||
150062395|NCT04068896|541369352|FG005|Overall Study|Adverse Event|0|||
150062396|NCT04068896|541369347|FG000|Overall Study|Death|3|||
150062397|NCT04068896|541369348|FG001|Overall Study|Death|1|||
150062398|NCT04068896|541369349|FG002|Overall Study|Death|3|||
150062399|NCT04068896|541369350|FG003|Overall Study|Death|19|||
150062400|NCT04068896|541369351|FG004|Overall Study|Death|17|||
150062401|NCT04068896|541369352|FG005|Overall Study|Death|0|||
150062402|NCT04068896|541369347|FG000|Overall Study|Physician Decision|0|||
150062403|NCT04068896|541369348|FG001|Overall Study|Physician Decision|0|||
150062404|NCT04068896|541369349|FG002|Overall Study|Physician Decision|0|||
150062405|NCT04068896|541369350|FG003|Overall Study|Physician Decision|1|||
150062406|NCT04068896|541369351|FG004|Overall Study|Physician Decision|0|||
150062407|NCT04068896|541369352|FG005|Overall Study|Physician Decision|0|||
150062408|NCT04068896|541369347|FG000|Overall Study|progressive disease|3|||
150062409|NCT04068896|541369348|FG001|Overall Study|progressive disease|5|||
150062410|NCT04068896|541369349|FG002|Overall Study|progressive disease|3|||
150062411|NCT04068896|541369350|FG003|Overall Study|progressive disease|2|||
150062412|NCT04068896|541369351|FG004|Overall Study|progressive disease|1|||
150062413|NCT04068896|541369352|FG005|Overall Study|progressive disease|2|||
150062414|NCT04068896|541369347|FG000|Overall Study|Study terminated by sponsor|0|||
150062415|NCT04068896|541369348|FG001|Overall Study|Study terminated by sponsor|0|||
150062416|NCT04068896|541369349|FG002|Overall Study|Study terminated by sponsor|1|||
150062417|NCT04068896|541369350|FG003|Overall Study|Study terminated by sponsor|2|||
150062418|NCT04068896|541369351|FG004|Overall Study|Study terminated by sponsor|1|||
150062419|NCT04068896|541369352|FG005|Overall Study|Study terminated by sponsor|4|||
150062420|NCT04068896|541369347|FG000|Overall Study|Protocol Violation|0|||
150062421|NCT04068896|541369348|FG001|Overall Study|Protocol Violation|0|||
150062422|NCT04068896|541369349|FG002|Overall Study|Protocol Violation|0|||
150062423|NCT04068896|541369350|FG003|Overall Study|Protocol Violation|1|||
150062424|NCT04068896|541369351|FG004|Overall Study|Protocol Violation|0|||
150062425|NCT04068896|541369352|FG005|Overall Study|Protocol Violation|0|||
150062426|NCT04068896|541369347|FG000|Overall Study|Withdrawal by Subject|0|||
150062427|NCT04068896|541369348|FG001|Overall Study|Withdrawal by Subject|3|||
150062428|NCT04068896|541369349|FG002|Overall Study|Withdrawal by Subject|0|||
150062429|NCT04068896|541369350|FG003|Overall Study|Withdrawal by Subject|2|||
150062430|NCT04068896|541369351|FG004|Overall Study|Withdrawal by Subject|1|||
150062431|NCT04068896|541369352|FG005|Overall Study|Withdrawal by Subject|0|||
150062432|NCT04068896|541369347|FG000|Overall Study|Symptomatic deterioration|2|||
150062433|NCT04068896|541369348|FG001|Overall Study|Symptomatic deterioration|0|||
150062434|NCT04068896|541369349|FG002|Overall Study|Symptomatic deterioration|0|||
150062435|NCT04068896|541369350|FG003|Overall Study|Symptomatic deterioration|0|||
150062436|NCT04068896|541369351|FG004|Overall Study|Symptomatic deterioration|0|||
150062437|NCT04068896|541369352|FG005|Overall Study|Symptomatic deterioration|0|||
150062438|NCT02953509|541369353|FG000|Overall Study|Death|1|||
150062439|NCT02953509|541369354|FG001|Overall Study|Death|3|||
150062440|NCT02953509|541369355|FG002|Overall Study|Death|3|||
150062441|NCT02953509|541369356|FG003|Overall Study|Death|4|||
150062442|NCT02953509|541369357|FG004|Overall Study|Death|12|||
150062443|NCT02953509|541369358|FG005|Overall Study|Death|3|||
150062444|NCT02953509|541369359|FG006|Overall Study|Death|25|||
150062445|NCT02953509|541369360|FG007|Overall Study|Death|10|||
150062446|NCT02953509|541369361|FG008|Overall Study|Death|21|||
150062447|NCT02953509|541369362|FG009|Overall Study|Death|20|||
150062448|NCT02953509|541369353|FG000|Overall Study|Reason Not Specified|0|||
150062449|NCT02953509|541369354|FG001|Overall Study|Reason Not Specified|2|||
150062450|NCT02953509|541369355|FG002|Overall Study|Reason Not Specified|8|||
150062451|NCT02953509|541369356|FG003|Overall Study|Reason Not Specified|2|||
150062452|NCT02953509|541369357|FG004|Overall Study|Reason Not Specified|11|||
150062453|NCT02953509|541369358|FG005|Overall Study|Reason Not Specified|4|||
150062454|NCT02953509|541369359|FG006|Overall Study|Reason Not Specified|12|||
150062455|NCT02953509|541369360|FG007|Overall Study|Reason Not Specified|2|||
150062456|NCT02953509|541369361|FG008|Overall Study|Reason Not Specified|7|||
150062457|NCT02953509|541369362|FG009|Overall Study|Reason Not Specified|2|||
150062458|NCT02953509|541369353|FG000|Overall Study|Consent Withdrawn|1|||
150062459|NCT02953509|541369354|FG001|Overall Study|Consent Withdrawn|1|||
150062460|NCT02953509|541369355|FG002|Overall Study|Consent Withdrawn|2|||
150062461|NCT02953509|541369356|FG003|Overall Study|Consent Withdrawn|1|||
150062462|NCT02953509|541369357|FG004|Overall Study|Consent Withdrawn|3|||
150062463|NCT02953509|541369358|FG005|Overall Study|Consent Withdrawn|0|||
150062464|NCT02953509|541369359|FG006|Overall Study|Consent Withdrawn|4|||
150062465|NCT02953509|541369360|FG007|Overall Study|Consent Withdrawn|1|||
150062466|NCT02953509|541369361|FG008|Overall Study|Consent Withdrawn|1|||
150062467|NCT02953509|541369362|FG009|Overall Study|Consent Withdrawn|4|||
150062468|NCT02953509|541369353|FG000|Overall Study|Lost to Follow-up|0|||
150062469|NCT02953509|541369354|FG001|Overall Study|Lost to Follow-up|0|||
150062470|NCT02953509|541369355|FG002|Overall Study|Lost to Follow-up|0|||
150062471|NCT02953509|541369356|FG003|Overall Study|Lost to Follow-up|0|||
150062472|NCT02953509|541369357|FG004|Overall Study|Lost to Follow-up|0|||
150062473|NCT02953509|541369358|FG005|Overall Study|Lost to Follow-up|0|||
150062474|NCT02953509|541369359|FG006|Overall Study|Lost to Follow-up|1|||
150062475|NCT02953509|541369360|FG007|Overall Study|Lost to Follow-up|1|||
150062476|NCT02953509|541369361|FG008|Overall Study|Lost to Follow-up|1|||
150062477|NCT02953509|541369362|FG009|Overall Study|Lost to Follow-up|1|||
150062478|NCT02953509|541369353|FG000|Overall Study|Study terminated by sponsor|1|||
150062479|NCT02953509|541369354|FG001|Overall Study|Study terminated by sponsor|0|||
150062480|NCT02953509|541369355|FG002|Overall Study|Study terminated by sponsor|0|||
150062481|NCT02953509|541369356|FG003|Overall Study|Study terminated by sponsor|0|||
150062482|NCT02953509|541369357|FG004|Overall Study|Study terminated by sponsor|0|||
150062483|NCT02953509|541369358|FG005|Overall Study|Study terminated by sponsor|0|||
150062484|NCT02953509|541369359|FG006|Overall Study|Study terminated by sponsor|1|||
150181901|NCT03398148|541804597|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
150062485|NCT02953509|541369360|FG007|Overall Study|Study terminated by sponsor|0|||
150062486|NCT02953509|541369361|FG008|Overall Study|Study terminated by sponsor|1|||
150062487|NCT02953509|541369362|FG009|Overall Study|Study terminated by sponsor|1|||
150062488|NCT00484185|541369363|FG000|Overall Study|Lost to Follow-up|44|||
150062489|NCT00484185|541369363|FG000|Overall Study|Other|20|||
150062490|NCT00484185|541369363|FG000|Overall Study|Randomized but not treated|5|||
150062491|NCT00484185|541369363|FG000|Overall Study|Death|2|||
150062492|NCT00251004|541369364|FG000|Overall Study|Withdrawal by Subject|23|||
150062493|NCT00251004|541369365|FG001|Overall Study|Withdrawal by Subject|16|||
150062494|NCT00251004|541369366|FG002|Overall Study|Withdrawal by Subject|14|||
150062495|NCT00251004|541369364|FG000|Overall Study|Death|9|||
150062496|NCT00251004|541369365|FG001|Overall Study|Death|10|||
150062497|NCT00251004|541369366|FG002|Overall Study|Death|8|||
150062498|NCT00251004|541369364|FG000|Overall Study|Lost to Follow-up|1|||
150062499|NCT00251004|541369365|FG001|Overall Study|Lost to Follow-up|2|||
150062500|NCT00251004|541369366|FG002|Overall Study|Lost to Follow-up|1|||
150062501|NCT00251004|541369364|FG000|Overall Study|Graft Loss|12|||
150062502|NCT00251004|541369365|FG001|Overall Study|Graft Loss|13|||
150062503|NCT00251004|541369366|FG002|Overall Study|Graft Loss|8|||
150062504|NCT02694718|541369371|FG000|Overall Study|Death|1|||
150062505|NCT02694718|541369371|FG000|Overall Study|Withdrawal by Subject|1|||
150062506|NCT02045303|541369375|FG000|Overall Study|Protocol Violation|2|||
150062507|NCT02045303|541369376|FG001|Overall Study|Protocol Violation|1|||
150062508|NCT02045303|541369377|FG002|Overall Study|Protocol Violation|0|||
150062509|NCT02045303|541369375|FG000|Overall Study|Withdrawal by Subject|0|||
150062510|NCT02045303|541369376|FG001|Overall Study|Withdrawal by Subject|2|||
150062511|NCT02045303|541369377|FG002|Overall Study|Withdrawal by Subject|0|||
150062512|NCT00256282|541369378|FG000|Overall Study|Disease progression, relapse during acti|12|||
150062513|NCT00256282|541369378|FG000|Overall Study|Adverse Event|3|||
150062514|NCT00256282|541369378|FG000|Overall Study|Physician Decision|1|||
150062515|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
150062516|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
150062517|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Other|2|||
150062518|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Other|2|||
150062519|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Personal reasons|2|||
150062520|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Personal reasons|2|||
150062521|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
150062522|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
150062523|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
150062524|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
150062525|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
150062526|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
150062527|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
150062528|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
150062529|NCT00667446|541369379|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
150062530|NCT00667446|541369380|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
150062531|NCT00667446|541369379|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
150062532|NCT00667446|541369380|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
150062533|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
150062534|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
150062535|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
150062536|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
150062537|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
150062538|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
150062539|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
150062540|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
150062541|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
150062542|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
150062543|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
150062544|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
150062545|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
150062546|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
150062547|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
150062548|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
150062549|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
150062550|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
150062551|NCT00591578|541369383|FG000|Double-Blind Treatment Phase|Other|4|||
150062552|NCT00591578|541369384|FG001|Double-Blind Treatment Phase|Other|9|||
150062553|NCT00591578|541369385|FG002|Double-Blind Treatment Phase|Other|4|||
150062554|NCT00591578|541369383|FG000|Open-Label Extension Phase|Adverse Event|3|||
150062555|NCT00591578|541369384|FG001|Open-Label Extension Phase|Adverse Event|5|||
150062556|NCT00591578|541369385|FG002|Open-Label Extension Phase|Adverse Event|0|||
150062557|NCT00591578|541369383|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
150062558|NCT00591578|541369384|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
150062559|NCT00591578|541369385|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
150062560|NCT00591578|541369383|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
150062561|NCT00591578|541369384|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
150062562|NCT00591578|541369385|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
150062563|NCT00591578|541369383|FG000|Open-Label Extension Phase|Other|1|||
150062564|NCT00591578|541369384|FG001|Open-Label Extension Phase|Other|0|||
150062565|NCT00591578|541369385|FG002|Open-Label Extension Phase|Other|0|||
150062566|NCT02380690|541369389|FG000|Overall Study|Lost to Follow-up|14|||
150062567|NCT02380690|541369390|FG001|Overall Study|Lost to Follow-up|4|||
150062568|NCT02380690|541369389|FG000|Overall Study|Withdrawal by Subject|20|||
150062569|NCT02380690|541369390|FG001|Overall Study|Withdrawal by Subject|8|||
150062570|NCT00727532|541369391|FG000|Overall Study|Adverse Event|1|||
150062571|NCT00727532|541369391|FG000|Overall Study|Withdrawal by Subject|1|||
150062572|NCT00829933|541369392|FG000|Overall Study|Adverse Event|2|||
150062573|NCT00829933|541369393|FG001|Overall Study|Adverse Event|3|||
150062574|NCT00829933|541369394|FG002|Overall Study|Adverse Event|2|||
150062575|NCT00829933|541369395|FG003|Overall Study|Adverse Event|1|||
150062576|NCT00829933|541369392|FG000|Overall Study|Death|0|||
150062577|NCT00829933|541369393|FG001|Overall Study|Death|0|||
150062578|NCT00829933|541369394|FG002|Overall Study|Death|1|||
150062579|NCT00829933|541369395|FG003|Overall Study|Death|1|||
150062580|NCT00829933|541369392|FG000|Overall Study|Lack of Efficacy|0|||
150062581|NCT00829933|541369393|FG001|Overall Study|Lack of Efficacy|1|||
150062582|NCT00829933|541369394|FG002|Overall Study|Lack of Efficacy|0|||
150062583|NCT00829933|541369395|FG003|Overall Study|Lack of Efficacy|0|||
150062584|NCT00829933|541369392|FG000|Overall Study|Physician Decision|5|||
150062585|NCT00829933|541369393|FG001|Overall Study|Physician Decision|7|||
150062586|NCT00829933|541369394|FG002|Overall Study|Physician Decision|8|||
150062587|NCT00829933|541369395|FG003|Overall Study|Physician Decision|1|||
150062588|NCT00829933|541369392|FG000|Overall Study|Pregnancy|0|||
150062589|NCT00829933|541369393|FG001|Overall Study|Pregnancy|0|||
150062590|NCT00829933|541369394|FG002|Overall Study|Pregnancy|0|||
150062591|NCT00829933|541369395|FG003|Overall Study|Pregnancy|2|||
150062592|NCT00829933|541369392|FG000|Overall Study|Protocol Violation|2|||
150062593|NCT00829933|541369393|FG001|Overall Study|Protocol Violation|1|||
150062594|NCT00829933|541369394|FG002|Overall Study|Protocol Violation|0|||
150062595|NCT00829933|541369395|FG003|Overall Study|Protocol Violation|0|||
150062596|NCT00829933|541369392|FG000|Overall Study|withdrew before treatment started|5|||
150062597|NCT00829933|541369393|FG001|Overall Study|withdrew before treatment started|1|||
150062598|NCT00829933|541369394|FG002|Overall Study|withdrew before treatment started|2|||
150062599|NCT00829933|541369395|FG003|Overall Study|withdrew before treatment started|9|||
150062600|NCT03687970|541369396|FG000|Overall Study|visit scheduling conflicts|2|||
150062601|NCT03687970|541369397|FG001|Overall Study|visit scheduling conflicts|0|||
150062602|NCT00523367|541369404|FG000|Overall Study|19 screen failures|19|||
150062603|NCT00523367|541369404|FG000|Overall Study|4 Withdrawn by PI|4|||
150062604|NCT00356122|541369408|FG000|TREATMENT|Lack of Efficacy|26|||
150062605|NCT00356122|541369408|FG000|TREATMENT|Adverse Event|10|||
150062606|NCT00356122|541369408|FG000|TREATMENT|Subject's request|4|||
150062607|NCT00356122|541369408|FG000|TREATMENT|Other|4|||
150062608|NCT00356122|541369408|FG000|TREATMENT|Did not receive study medication|1|||
150062609|NCT00356122|541369408|FG000|FOLLOW-UP|Death|37|||
150062610|NCT00356122|541369408|FG000|FOLLOW-UP|Lost to Follow-up|2|||
150062611|NCT00356122|541369408|FG000|FOLLOW-UP|Other|2|||
150062612|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
150062613|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
150062614|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
150062615|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
150062616|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
150062617|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
150062618|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
150062619|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
150062620|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
150062621|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
150062622|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
150062623|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
150062624|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
150062625|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
150062626|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
150062627|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
150062628|NCT00491556|541369409|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
150062629|NCT00491556|541369410|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
150062630|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
150062631|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
150062632|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
150062633|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
150062634|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
150062635|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
150062636|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
150062637|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
150062638|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
150181902|NCT03398148|541804598|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
150062639|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
150062640|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
150062641|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
150062642|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
150062643|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
150062644|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
150062645|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
150062646|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
150062647|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
150062648|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
150062649|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
150062650|NCT00491556|541369409|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
150062651|NCT00491556|541369410|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
150062652|NCT00782795|541369411|FG000|Overall Study|Withdrawal by Subject|1|||
150062653|NCT00782795|541369412|FG001|Overall Study|Withdrawal by Subject|2|||
150062654|NCT04480424|541369413|FG000|Overall Study|Withdrawal by Subject|0|||
150062655|NCT04480424|541369414|FG001|Overall Study|Withdrawal by Subject|2|||
150062656|NCT04480424|541369413|FG000|Overall Study|Lost to Follow-up|3|||
150062657|NCT04480424|541369414|FG001|Overall Study|Lost to Follow-up|3|||
150062658|NCT04480424|541369413|FG000|Overall Study|Death|14|||
150062659|NCT04480424|541369414|FG001|Overall Study|Death|16|||
150062660|NCT04480424|541369413|FG000|Overall Study|Reason not Specified|5|||
150062661|NCT04480424|541369414|FG001|Overall Study|Reason not Specified|5|||
150062662|NCT01683019|541371337|FG000|Overall Study|Withdrawal by Subject|2|||
150062663|NCT01683019|541371338|FG001|Overall Study|Withdrawal by Subject|1|||
150062664|NCT01683019|541371339|FG002|Overall Study|Withdrawal by Subject|4|||
150062665|NCT00543855|541371340|FG000|Overall Study|Adverse Event|3|||
150062666|NCT00543855|541371341|FG001|Overall Study|Adverse Event|1|||
150062667|NCT00543855|541371342|FG002|Overall Study|Adverse Event|3|||
150062668|NCT00543855|541371343|FG003|Overall Study|Adverse Event|4|||
150062669|NCT00543855|541371340|FG000|Overall Study|Lost to Follow-up|0|||
150062670|NCT00543855|541371341|FG001|Overall Study|Lost to Follow-up|0|||
150062671|NCT00543855|541371342|FG002|Overall Study|Lost to Follow-up|1|||
150062672|NCT00543855|541371343|FG003|Overall Study|Lost to Follow-up|0|||
150062673|NCT00543855|541371340|FG000|Overall Study|Withdrawal by Subject|0|||
150062674|NCT00543855|541371341|FG001|Overall Study|Withdrawal by Subject|1|||
150062675|NCT00543855|541371342|FG002|Overall Study|Withdrawal by Subject|2|||
150062676|NCT00543855|541371343|FG003|Overall Study|Withdrawal by Subject|0|||
150062677|NCT00543855|541371340|FG000|Overall Study|Protocol Violation|1|||
150062678|NCT00543855|541371341|FG001|Overall Study|Protocol Violation|0|||
150062679|NCT00543855|541371342|FG002|Overall Study|Protocol Violation|0|||
150062680|NCT00543855|541371343|FG003|Overall Study|Protocol Violation|0|||
150062681|NCT00076024|541371344|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
150062682|NCT00076024|541371345|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
150062683|NCT00076024|541371346|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
150062684|NCT00076024|541371347|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
150062685|NCT00076024|541371344|FG000|Phase 1, Lead-in|Adverse Event|1|||
150062686|NCT00076024|541371345|FG001|Phase 1, Lead-in|Adverse Event|0|||
150062687|NCT00076024|541371346|FG002|Phase 1, Lead-in|Adverse Event|0|||
150062688|NCT00076024|541371347|FG003|Phase 1, Lead-in|Adverse Event|0|||
150062689|NCT00076024|541371344|FG000|Phase 1, Lead-in|Clinical progression|1|||
150062690|NCT00076024|541371345|FG001|Phase 1, Lead-in|Clinical progression|0|||
150062691|NCT00076024|541371346|FG002|Phase 1, Lead-in|Clinical progression|0|||
150062692|NCT00076024|541371347|FG003|Phase 1, Lead-in|Clinical progression|0|||
150062693|NCT00076024|541371344|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
150062694|NCT00076024|541371345|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
150062695|NCT00076024|541371346|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
150062696|NCT00076024|541371347|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
150062697|NCT00076024|541371344|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
150062698|NCT00076024|541371345|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
150062699|NCT00076024|541371346|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
150062700|NCT00076024|541371347|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
150062701|NCT00076024|541371344|FG000|Phase 2, Double-blind|Adverse Event|0|||
150062702|NCT00076024|541371345|FG001|Phase 2, Double-blind|Adverse Event|25|||
150062703|NCT00076024|541371346|FG002|Phase 2, Double-blind|Adverse Event|6|||
150062704|NCT00076024|541371347|FG003|Phase 2, Double-blind|Adverse Event|0|||
150062705|NCT00076024|541371344|FG000|Phase 2, Double-blind|Un-specified|0|||
150062706|NCT00076024|541371345|FG001|Phase 2, Double-blind|Un-specified|14|||
150062707|NCT00076024|541371346|FG002|Phase 2, Double-blind|Un-specified|6|||
150062708|NCT00076024|541371347|FG003|Phase 2, Double-blind|Un-specified|0|||
150062709|NCT00076024|541371344|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
150062710|NCT00076024|541371345|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
150062711|NCT00076024|541371346|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
150062712|NCT00076024|541371347|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
150062713|NCT00076024|541371344|FG000|Phase 2, Open-label|Adverse Event|0|||
150062714|NCT00076024|541371345|FG001|Phase 2, Open-label|Adverse Event|0|||
150062715|NCT00076024|541371346|FG002|Phase 2, Open-label|Adverse Event|0|||
150062716|NCT00076024|541371347|FG003|Phase 2, Open-label|Adverse Event|2|||
150062717|NCT00076024|541371344|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
150062718|NCT00076024|541371345|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
150062719|NCT00076024|541371346|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
150062720|NCT00076024|541371347|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
150062721|NCT00076024|541371344|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
150062722|NCT00076024|541371345|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
150062723|NCT00076024|541371346|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
150062724|NCT00076024|541371347|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
150062725|NCT00076024|541371344|FG000|Phase 2, Open-label|Other|0|||
150062726|NCT00076024|541371345|FG001|Phase 2, Open-label|Other|0|||
150062727|NCT00076024|541371346|FG002|Phase 2, Open-label|Other|0|||
150062728|NCT00076024|541371347|FG003|Phase 2, Open-label|Other|2|||
150062729|NCT00301821|541371354|FG000|Overall Study|Ineligible|25|||
150062730|NCT00301821|541371354|FG000|Overall Study|Cancel|1|||
150062731|NCT02294773|541371355|FG000|Overall Study|Withdrawal by Subject|0|||
150062732|NCT02294773|541371356|FG001|Overall Study|Withdrawal by Subject|2|||
150062733|NCT03052764|541371357|FG000|Double-Blind Treatment Period|Adverse Event|2|||
150062734|NCT03052764|541371358|FG001|Double-Blind Treatment Period|Adverse Event|0|||
150062735|NCT03052764|541371357|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
150062736|NCT03052764|541371358|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
150062737|NCT03052764|541371357|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
150062738|NCT03052764|541371358|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
150062739|NCT03052764|541371357|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
150062740|NCT03052764|541371358|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
150062741|NCT03052764|541371357|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
150062742|NCT03052764|541371358|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
150062743|NCT03150485|541371359|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
150062744|NCT03150485|541371360|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
150062745|NCT03150485|541371361|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
150062746|NCT03150485|541371362|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
150062747|NCT03150485|541371363|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
150062748|NCT03150485|541371364|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
150062749|NCT05828095|541371366|FG000|Overall Study|Lost to Follow-up|1|||
150062750|NCT05828095|541371367|FG001|Overall Study|Lost to Follow-up|0|||
150062751|NCT05828095|541371366|FG000|Overall Study|Reactogenicity symptom|0|||
150062752|NCT05828095|541371367|FG001|Overall Study|Reactogenicity symptom|1|||
150062753|NCT03206073|541371370|FG000|Overall Study|Participant Noncompliance|0|||
150062754|NCT03206073|541371371|FG001|Overall Study|Participant Noncompliance|1|||
150062755|NCT03206073|541371372|FG002|Overall Study|Participant Noncompliance|0|||
150062756|NCT03206073|541371373|FG003|Overall Study|Participant Noncompliance|0|||
150062757|NCT03206073|541371370|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
150062758|NCT03206073|541371371|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
150062759|NCT03206073|541371372|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
150062760|NCT03206073|541371373|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
150062761|NCT03206073|541371370|FG000|Overall Study|Death|0|||
150062762|NCT03206073|541371371|FG001|Overall Study|Death|0|||
150062763|NCT03206073|541371372|FG002|Overall Study|Death|1|||
150062764|NCT03206073|541371373|FG003|Overall Study|Death|0|||
150062765|NCT03206073|541371370|FG000|Overall Study|Taken off active treatment|0|||
150062766|NCT03206073|541371371|FG001|Overall Study|Taken off active treatment|0|||
150062767|NCT03206073|541371372|FG002|Overall Study|Taken off active treatment|3|||
150062768|NCT03206073|541371373|FG003|Overall Study|Taken off active treatment|0|||
150062769|NCT00096954|541371376|FG000|Overall Study|Adverse Event|3|||
150062770|NCT00096954|541371377|FG001|Overall Study|Adverse Event|1|||
150062771|NCT00096954|541371376|FG000|Overall Study|Withdrawal by Subject|9|||
150062772|NCT00096954|541371377|FG001|Overall Study|Withdrawal by Subject|8|||
150062773|NCT00096954|541371376|FG000|Overall Study|Physician Decision|1|||
150062774|NCT00096954|541371377|FG001|Overall Study|Physician Decision|1|||
150062775|NCT00096954|541371376|FG000|Overall Study|Sponsors Decision|1|||
150062776|NCT00096954|541371377|FG001|Overall Study|Sponsors Decision|1|||
150062777|NCT00096954|541371376|FG000|Overall Study|Pregnancy|1|||
150062778|NCT00096954|541371377|FG001|Overall Study|Pregnancy|1|||
150062779|NCT00096954|541371376|FG000|Overall Study|Initiation of immunotherapy|1|||
150062780|NCT00096954|541371377|FG001|Overall Study|Initiation of immunotherapy|0|||
150062781|NCT00096954|541371376|FG000|Overall Study|Non-compliance|0|||
150062782|NCT00096954|541371377|FG001|Overall Study|Non-compliance|3|||
150062783|NCT00096954|541371376|FG000|Overall Study|Lost to Follow-up|8|||
150062784|NCT00096954|541371377|FG001|Overall Study|Lost to Follow-up|5|||
150062785|NCT03034200|541371378|FG000|Overall Study|Disease progression|8|||
150062786|NCT03034200|541371379|FG001|Overall Study|Disease progression|10|||
150025030|NCT00527735|541228423|FG001|Overall Study|Completed treatment in treatment phase|13|||
150025031|NCT00527735|541228424|FG002|Overall Study|Completed treatment in treatment phase|18|||
150025032|NCT00527735|541228422|FG000|Overall Study|Adverse Event|10|||
150025033|NCT00527735|541228423|FG001|Overall Study|Adverse Event|6|||
150025034|NCT00527735|541228424|FG002|Overall Study|Adverse Event|7|||
150025035|NCT00527735|541228422|FG000|Overall Study|Not identified|5|||
150025036|NCT00527735|541228423|FG001|Overall Study|Not identified|5|||
150025037|NCT00527735|541228424|FG002|Overall Study|Not identified|5|||
150025038|NCT00527735|541228422|FG000|Overall Study|Withdrawal by Subject|5|||
150025039|NCT00527735|541228423|FG001|Overall Study|Withdrawal by Subject|4|||
150025040|NCT00527735|541228424|FG002|Overall Study|Withdrawal by Subject|3|||
150025041|NCT00527735|541228422|FG000|Overall Study|No longer met study criteria|2|||
150025042|NCT00527735|541228423|FG001|Overall Study|No longer met study criteria|2|||
150025043|NCT00527735|541228424|FG002|Overall Study|No longer met study criteria|1|||
150025044|NCT00527735|541228422|FG000|Overall Study|Lost to Follow-up|0|||
150025045|NCT00527735|541228423|FG001|Overall Study|Lost to Follow-up|0|||
150025046|NCT00527735|541228424|FG002|Overall Study|Lost to Follow-up|3|||
150025047|NCT00527735|541228422|FG000|Overall Study|Poor compliance or noncompliance|0|||
150025048|NCT00527735|541228423|FG001|Overall Study|Poor compliance or noncompliance|1|||
150025049|NCT00527735|541228424|FG002|Overall Study|Poor compliance or noncompliance|1|||
150025050|NCT00527735|541228422|FG000|Overall Study|Completed treatment during maintenance|2|||
150025051|NCT00527735|541228423|FG001|Overall Study|Completed treatment during maintenance|2|||
150025052|NCT00527735|541228424|FG002|Overall Study|Completed treatment during maintenance|1|||
150025053|NCT01855412|541228425|FG000|Overall Study|Death|77|||
150025054|NCT01855412|541228426|FG001|Overall Study|Death|123|||
150025055|NCT01855412|541228427|FG002|Overall Study|Death|30|||
150025056|NCT01855412|541228425|FG000|Overall Study|Lost to Follow-up|28|||
150025057|NCT01855412|541228426|FG001|Overall Study|Lost to Follow-up|46|||
150025058|NCT01855412|541228427|FG002|Overall Study|Lost to Follow-up|15|||
150025059|NCT01855412|541228425|FG000|Overall Study|Withdrawal by Subject|77|||
150025060|NCT01855412|541228426|FG001|Overall Study|Withdrawal by Subject|123|||
150025061|NCT01855412|541228427|FG002|Overall Study|Withdrawal by Subject|24|||
150025062|NCT01855412|541228425|FG000|Overall Study|Physician Decision|25|||
150025063|NCT01855412|541228426|FG001|Overall Study|Physician Decision|31|||
150025064|NCT01855412|541228427|FG002|Overall Study|Physician Decision|3|||
150025065|NCT01855412|541228425|FG000|Overall Study|Site Closure|4|||
150025066|NCT01855412|541228426|FG001|Overall Study|Site Closure|18|||
150025067|NCT01855412|541228427|FG002|Overall Study|Site Closure|1|||
150025068|NCT01855412|541228425|FG000|Overall Study|Reason not Specified|1|||
150025069|NCT01855412|541228426|FG001|Overall Study|Reason not Specified|2|||
150025070|NCT01855412|541228427|FG002|Overall Study|Reason not Specified|3|||
150025071|NCT01121146|541228436|FG000|Overall Study|Death|17|||
150025072|NCT01121146|541228437|FG001|Overall Study|Death|15|||
150025073|NCT01121146|541228436|FG000|Overall Study|Adverse Event|2|||
150025074|NCT01121146|541228437|FG001|Overall Study|Adverse Event|11|||
150025075|NCT01121146|541228436|FG000|Overall Study|Lost to Follow-up|7|||
150025076|NCT01121146|541228437|FG001|Overall Study|Lost to Follow-up|16|||
150025077|NCT00346216|541228438|FG000|Overall Study|Other|181|||
150025078|NCT00346216|541228439|FG001|Overall Study|Other|231|||
150025079|NCT00346216|541228440|FG002|Overall Study|Other|205|||
150025080|NCT00346216|541228438|FG000|Overall Study|No longer willing to participate|600|||
150025081|NCT00346216|541228439|FG001|Overall Study|No longer willing to participate|606|||
150025082|NCT00346216|541228440|FG002|Overall Study|No longer willing to participate|585|||
150025083|NCT00346216|541228438|FG000|Overall Study|Withdrawal by Subject|661|||
150025084|NCT00346216|541228439|FG001|Overall Study|Withdrawal by Subject|692|||
150025085|NCT00346216|541228440|FG002|Overall Study|Withdrawal by Subject|651|||
150025086|NCT00346216|541228438|FG000|Overall Study|Lost to Follow-up|611|||
150025087|NCT00346216|541228439|FG001|Overall Study|Lost to Follow-up|588|||
150025088|NCT00346216|541228440|FG002|Overall Study|Lost to Follow-up|542|||
150025089|NCT00346216|541228438|FG000|Overall Study|Physician Decision|80|||
150025090|NCT00346216|541228439|FG001|Overall Study|Physician Decision|76|||
150025091|NCT00346216|541228440|FG002|Overall Study|Physician Decision|59|||
150025092|NCT00346216|541228438|FG000|Overall Study|Does not meet entrance criteria|13|||
150025093|NCT00346216|541228439|FG001|Overall Study|Does not meet entrance criteria|10|||
150025094|NCT00346216|541228440|FG002|Overall Study|Does not meet entrance criteria|8|||
150025095|NCT00346216|541228438|FG000|Overall Study|Death|189|||
150025096|NCT00346216|541228439|FG001|Overall Study|Death|192|||
150025097|NCT00346216|541228440|FG002|Overall Study|Death|228|||
150025098|NCT00346216|541228438|FG000|Overall Study|Study terminated by sponsor|11|||
150025099|NCT00346216|541228439|FG001|Overall Study|Study terminated by sponsor|4|||
150025100|NCT00346216|541228440|FG002|Overall Study|Study terminated by sponsor|8|||
150025101|NCT00346216|541228438|FG000|Overall Study|Missing Subject Summary Status|62|||
150025102|NCT00346216|541228439|FG001|Overall Study|Missing Subject Summary Status|61|||
150062787|NCT03034200|541371380|FG002|Overall Study|Disease progression|4|||
150062788|NCT03034200|541371378|FG000|Overall Study|Physician Decision|2|||
150062789|NCT03034200|541371379|FG001|Overall Study|Physician Decision|0|||
150062790|NCT03034200|541371380|FG002|Overall Study|Physician Decision|3|||
150062791|NCT03034200|541371378|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
150062792|NCT03034200|541371379|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
150062793|NCT03034200|541371380|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
150062794|NCT03034200|541371378|FG000|Overall Study|Adjuvant Therapy|0|||
150062795|NCT03034200|541371379|FG001|Overall Study|Adjuvant Therapy|0|||
150062796|NCT03034200|541371380|FG002|Overall Study|Adjuvant Therapy|1|||
150062797|NCT01739400|541371381|FG000|Overall Study|Physician Decision|3|||
150062798|NCT01739400|541371382|FG001|Overall Study|Physician Decision|0|||
150062799|NCT01739400|541371381|FG000|Overall Study|Lost to Follow-up|2|||
150062800|NCT01739400|541371382|FG001|Overall Study|Lost to Follow-up|0|||
150062801|NCT01739400|541371381|FG000|Overall Study|Death|5|||
150062802|NCT01739400|541371382|FG001|Overall Study|Death|2|||
150062803|NCT01739400|541371381|FG000|Overall Study|Withdrawal by Subject|7|||
150062804|NCT01739400|541371382|FG001|Overall Study|Withdrawal by Subject|7|||
150062805|NCT01736657|541371383|FG000|Overall Study|insufficient vascular access|1|||
150062806|NCT03350984|541371384|FG000|Overall Study|Death|1|||
150062807|NCT03350984|541371385|FG001|Overall Study|Death|0|||
150062808|NCT03350984|541371384|FG000|Overall Study|Lost to Follow-up|5|||
150062809|NCT03350984|541371385|FG001|Overall Study|Lost to Follow-up|6|||
150062810|NCT03350984|541371384|FG000|Overall Study|Protocol Violation|1|||
150062811|NCT03350984|541371385|FG001|Overall Study|Protocol Violation|2|||
150062812|NCT03350984|541371384|FG000|Overall Study|Physician Decision|1|||
150062813|NCT03350984|541371385|FG001|Overall Study|Physician Decision|0|||
150062814|NCT01347307|541371386|FG000|Overall Study|Death|0|||
150062815|NCT01347307|541371387|FG001|Overall Study|Death|4|||
150062816|NCT01347307|541371386|FG000|Overall Study|Physician Decision|0|||
150062817|NCT01347307|541371387|FG001|Overall Study|Physician Decision|1|||
150062818|NCT00920829|541371389|FG000|Allocation|No post randomization data|3|||
150062819|NCT00920829|541371390|FG001|Allocation|No post randomization data|1|||
150062820|NCT00920829|541371391|FG002|Allocation|No post randomization data|0|||
150062821|NCT00920829|541371392|FG003|Allocation|No post randomization data|2|||
150062822|NCT00920829|541371389|FG000|Available for Analysis|Withdrawal by Subject|6|||
150062823|NCT00920829|541371390|FG001|Available for Analysis|Withdrawal by Subject|6|||
150062824|NCT00920829|541371391|FG002|Available for Analysis|Withdrawal by Subject|6|||
150062825|NCT00920829|541371392|FG003|Available for Analysis|Withdrawal by Subject|10|||
150062826|NCT00920829|541371389|FG000|Available for Analysis|Required Medical Treatment|0|||
150062827|NCT00920829|541371390|FG001|Available for Analysis|Required Medical Treatment|1|||
150062828|NCT00920829|541371391|FG002|Available for Analysis|Required Medical Treatment|2|||
150062829|NCT00920829|541371392|FG003|Available for Analysis|Required Medical Treatment|0|||
150062830|NCT00920829|541371389|FG000|Available for Analysis|Adverse Event|1|||
150062831|NCT00920829|541371390|FG001|Available for Analysis|Adverse Event|2|||
150062832|NCT00920829|541371391|FG002|Available for Analysis|Adverse Event|1|||
150062833|NCT00920829|541371392|FG003|Available for Analysis|Adverse Event|0|||
150062834|NCT00920829|541371389|FG000|Available for Analysis|Death|1|||
150062835|NCT00920829|541371390|FG001|Available for Analysis|Death|0|||
150062836|NCT00920829|541371391|FG002|Available for Analysis|Death|0|||
150062837|NCT00920829|541371392|FG003|Available for Analysis|Death|0|||
150062838|NCT00920829|541371389|FG000|Available for Analysis|Protocol Violation|0|||
150062839|NCT00920829|541371390|FG001|Available for Analysis|Protocol Violation|0|||
150062840|NCT00920829|541371391|FG002|Available for Analysis|Protocol Violation|1|||
150062841|NCT00920829|541371392|FG003|Available for Analysis|Protocol Violation|0|||
150062842|NCT00920829|541371389|FG000|Available for Analysis|Required more treatment|0|||
150062843|NCT00920829|541371390|FG001|Available for Analysis|Required more treatment|2|||
150062844|NCT00920829|541371391|FG002|Available for Analysis|Required more treatment|0|||
150062845|NCT00920829|541371392|FG003|Available for Analysis|Required more treatment|1|||
150062846|NCT04533880|541371393|FG000|Overall Study|Lost to Follow-up|0|||
150062847|NCT04533880|541371394|FG001|Overall Study|Lost to Follow-up|1|||
150062848|NCT04533880|541371395|FG002|Overall Study|Lost to Follow-up|1|||
150062849|NCT02284178|541371396|FG000|Overall Study|Met exclusion criteria|49|||
150062850|NCT02284178|541371397|FG001|Overall Study|Met exclusion criteria|54|||
150062851|NCT03954041|541371404|FG000|Overall Study|Lost to Follow-up|3|||
150062852|NCT03954041|541371405|FG001|Overall Study|Lost to Follow-up|3|||
150062853|NCT03954041|541371406|FG002|Overall Study|Lost to Follow-up|6|||
150062854|NCT03954041|541371404|FG000|Overall Study|Death|4|||
150062855|NCT03954041|541371405|FG001|Overall Study|Death|0|||
150062856|NCT03954041|541371406|FG002|Overall Study|Death|1|||
150062857|NCT03954041|541371404|FG000|Overall Study|Death by neurologic criteria|0|||
150062858|NCT03954041|541371405|FG001|Overall Study|Death by neurologic criteria|0|||
150062859|NCT03954041|541371406|FG002|Overall Study|Death by neurologic criteria|1|||
150062860|NCT03954041|541371404|FG000|Overall Study|Reason not specified|7|||
150062861|NCT03954041|541371405|FG001|Overall Study|Reason not specified|4|||
150062862|NCT03954041|541371406|FG002|Overall Study|Reason not specified|2|||
150062863|NCT03954041|541371404|FG000|Overall Study|Withdrew prior to dosing|4|||
150062864|NCT03954041|541371405|FG001|Overall Study|Withdrew prior to dosing|2|||
150062865|NCT03954041|541371406|FG002|Overall Study|Withdrew prior to dosing|0|||
150062866|NCT03868124|541371409|FG000|Overall Study|Withdrawal by Subject|4|||
150062867|NCT03868124|541371410|FG001|Overall Study|Withdrawal by Subject|0|||
150062868|NCT03868124|541371411|FG002|Overall Study|Withdrawal by Subject|1|||
150062869|NCT03868124|541371409|FG000|Overall Study|Physician Decision|1|||
150062870|NCT03868124|541371410|FG001|Overall Study|Physician Decision|0|||
150062871|NCT03868124|541371411|FG002|Overall Study|Physician Decision|1|||
150062872|NCT03868124|541371409|FG000|Overall Study|Lost to Follow-up|1|||
150062873|NCT03868124|541371410|FG001|Overall Study|Lost to Follow-up|1|||
150062874|NCT03868124|541371411|FG002|Overall Study|Lost to Follow-up|2|||
150062875|NCT03868124|541371409|FG000|Overall Study|Death|1|||
150062876|NCT03868124|541371410|FG001|Overall Study|Death|1|||
150062877|NCT03868124|541371411|FG002|Overall Study|Death|2|||
150062878|NCT03868124|541371409|FG000|Overall Study|Adverse Event|0|||
150062879|NCT03868124|541371410|FG001|Overall Study|Adverse Event|0|||
150062880|NCT03868124|541371411|FG002|Overall Study|Adverse Event|3|||
150062881|NCT03868124|541371409|FG000|Overall Study|Explanted|2|||
150062882|NCT03868124|541371410|FG001|Overall Study|Explanted|1|||
150062883|NCT03868124|541371411|FG002|Overall Study|Explanted|0|||
150062884|NCT03868124|541371409|FG000|Overall Study|Ongoing in study|176|||
150062885|NCT03868124|541371410|FG001|Overall Study|Ongoing in study|180|||
150062886|NCT03868124|541371411|FG002|Overall Study|Ongoing in study|183|||
150062887|NCT04177355|541371412|FG000|Overall Study|Lost to Follow-up|0|||
150062888|NCT04177355|541371413|FG001|Overall Study|Lost to Follow-up|2|||
150062889|NCT04177355|541371414|FG002|Overall Study|Lost to Follow-up|0|||
150062890|NCT04177355|541371415|FG003|Overall Study|Lost to Follow-up|1|||
150062891|NCT04177355|541371416|FG004|Overall Study|Lost to Follow-up|2|||
150062892|NCT04177355|541371417|FG005|Overall Study|Lost to Follow-up|0|||
150062893|NCT04177355|541371418|FG006|Overall Study|Lost to Follow-up|1|||
150062894|NCT04177355|541371419|FG007|Overall Study|Lost to Follow-up|0|||
150062895|NCT04177355|541371420|FG008|Overall Study|Lost to Follow-up|0|||
150062896|NCT04177355|541371421|FG009|Overall Study|Lost to Follow-up|0|||
150062897|NCT04177355|541371422|FG010|Overall Study|Lost to Follow-up|0|||
150062898|NCT04177355|541371412|FG000|Overall Study|Withdrawal by Subject|0|||
150062899|NCT04177355|541371413|FG001|Overall Study|Withdrawal by Subject|0|||
150062900|NCT04177355|541371414|FG002|Overall Study|Withdrawal by Subject|0|||
150062901|NCT04177355|541371415|FG003|Overall Study|Withdrawal by Subject|1|||
150062902|NCT04177355|541371416|FG004|Overall Study|Withdrawal by Subject|1|||
150062903|NCT04177355|541371417|FG005|Overall Study|Withdrawal by Subject|0|||
150062904|NCT04177355|541371418|FG006|Overall Study|Withdrawal by Subject|0|||
150062905|NCT04177355|541371419|FG007|Overall Study|Withdrawal by Subject|0|||
150062906|NCT04177355|541371420|FG008|Overall Study|Withdrawal by Subject|1|||
150062907|NCT04177355|541371421|FG009|Overall Study|Withdrawal by Subject|0|||
150062908|NCT04177355|541371422|FG010|Overall Study|Withdrawal by Subject|0|||
150062909|NCT03981822|541371423|FG000|Overall Study|Lost to Follow-up|0|||
150062910|NCT03981822|541371424|FG001|Overall Study|Lost to Follow-up|1|||
150062911|NCT03981822|541371425|FG002|Overall Study|Lost to Follow-up|1|||
150062912|NCT03981822|541371426|FG003|Overall Study|Lost to Follow-up|0|||
150062913|NCT03981822|541371427|FG004|Overall Study|Lost to Follow-up|6|||
150062914|NCT03981822|541371428|FG005|Overall Study|Lost to Follow-up|4|||
150062915|NCT03981822|541371429|FG006|Overall Study|Lost to Follow-up|4|||
150062916|NCT03981822|541371430|FG007|Overall Study|Lost to Follow-up|2|||
150062917|NCT03981822|541371423|FG000|Overall Study|Withdrawal by Subject|0|||
150062918|NCT03981822|541371424|FG001|Overall Study|Withdrawal by Subject|1|||
150062919|NCT03981822|541371425|FG002|Overall Study|Withdrawal by Subject|0|||
150062920|NCT03981822|541371426|FG003|Overall Study|Withdrawal by Subject|0|||
150062921|NCT03981822|541371427|FG004|Overall Study|Withdrawal by Subject|0|||
150062922|NCT03981822|541371428|FG005|Overall Study|Withdrawal by Subject|1|||
150062923|NCT03981822|541371429|FG006|Overall Study|Withdrawal by Subject|0|||
150062924|NCT03981822|541371430|FG007|Overall Study|Withdrawal by Subject|2|||
150062925|NCT03981822|541371423|FG000|Overall Study|COVID-19 Related|0|||
150062926|NCT03981822|541371424|FG001|Overall Study|COVID-19 Related|0|||
150062927|NCT03981822|541371425|FG002|Overall Study|COVID-19 Related|0|||
150062928|NCT03981822|541371426|FG003|Overall Study|COVID-19 Related|0|||
150062929|NCT03981822|541371427|FG004|Overall Study|COVID-19 Related|2|||
150062930|NCT03981822|541371428|FG005|Overall Study|COVID-19 Related|1|||
150062931|NCT03981822|541371429|FG006|Overall Study|COVID-19 Related|2|||
150062932|NCT03981822|541371430|FG007|Overall Study|COVID-19 Related|1|||
150062933|NCT02742246|541371431|FG000|Overall Study|Never initiated treatment|5|||
150062934|NCT02742246|541371432|FG001|Overall Study|Never initiated treatment|3|||
150062935|NCT02742246|541371433|FG002|Overall Study|Never initiated treatment|1|||
150062936|NCT02742246|541371431|FG000|Overall Study|dropped out during treatment|7|||
150062937|NCT02742246|541371432|FG001|Overall Study|dropped out during treatment|13|||
150062938|NCT02742246|541371433|FG002|Overall Study|dropped out during treatment|10|||
150062939|NCT02742246|541371431|FG000|Overall Study|Death|1|||
150062940|NCT02742246|541371432|FG001|Overall Study|Death|0|||
150062941|NCT02742246|541371433|FG002|Overall Study|Death|0|||
150062942|NCT03489551|541371434|FG000|Overall Study|Withdrawal by Subject|2|||
150062943|NCT00054717|541371436|FG000|Overall Study|Randomized but not treated|2|||
150062944|NCT00054717|541371437|FG001|Overall Study|Randomized but not treated|8|||
150062945|NCT00054717|541371436|FG000|Overall Study|Adverse Event|70|||
150062946|NCT00054717|541371437|FG001|Overall Study|Adverse Event|22|||
150062947|NCT00054717|541371436|FG000|Overall Study|Protocol Violation|18|||
150062948|NCT00054717|541371437|FG001|Overall Study|Protocol Violation|19|||
150062949|NCT00054717|541371436|FG000|Overall Study|Lost to Follow-up|23|||
150062950|NCT00054717|541371437|FG001|Overall Study|Lost to Follow-up|13|||
150062951|NCT00054717|541371436|FG000|Overall Study|Withdrawal by Subject|32|||
150062952|NCT00054717|541371437|FG001|Overall Study|Withdrawal by Subject|20|||
150062953|NCT00054717|541371436|FG000|Overall Study|Other reason not defined above|117|||
150062954|NCT00054717|541371437|FG001|Overall Study|Other reason not defined above|217|||
150062955|NCT03139604|541371440|FG000|Overall Study|Other|7|||
150062956|NCT03139604|541371441|FG001|Overall Study|Other|3|||
150062957|NCT03139604|541371440|FG000|Overall Study|Withdrawal by Subject|16|||
150062958|NCT03139604|541371441|FG001|Overall Study|Withdrawal by Subject|17|||
150062959|NCT03139604|541371440|FG000|Overall Study|Physician Decision|1|||
150062960|NCT03139604|541371441|FG001|Overall Study|Physician Decision|2|||
150062961|NCT03139604|541371440|FG000|Overall Study|Lost to Follow-up|3|||
150062962|NCT03139604|541371441|FG001|Overall Study|Lost to Follow-up|1|||
150062963|NCT03139604|541371440|FG000|Overall Study|Death|65|||
150062964|NCT03139604|541371441|FG001|Overall Study|Death|67|||
150062965|NCT03139604|541371440|FG000|Overall Study|Study Terminated by Sponsor|122|||
150062966|NCT03139604|541371441|FG001|Overall Study|Study Terminated by Sponsor|127|||
150062967|NCT03139604|541371440|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
150062968|NCT03139604|541371441|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
150062969|NCT01117051|541371447|FG000|Overall Study|Withdrawal by Subject|5|||
150062970|NCT01117051|541371448|FG001|Overall Study|Withdrawal by Subject|3|||
150062971|NCT01117051|541371447|FG000|Overall Study|Adverse Event|4|||
150062972|NCT01117051|541371448|FG001|Overall Study|Adverse Event|3|||
150062973|NCT01117051|541371447|FG000|Overall Study|Lost to Follow-up|0|||
150062974|NCT01117051|541371448|FG001|Overall Study|Lost to Follow-up|1|||
150062975|NCT01117051|541371447|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
150062976|NCT01117051|541371448|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
150062977|NCT01117051|541371447|FG000|Overall Study|Sponsor's decision|3|||
150062978|NCT01117051|541371448|FG001|Overall Study|Sponsor's decision|1|||
150062979|NCT01117051|541371447|FG000|Overall Study|Surgical procedure|0|||
150062980|NCT01117051|541371448|FG001|Overall Study|Surgical procedure|1|||
150062981|NCT01117051|541371447|FG000|Overall Study|Randomized by mistake|0|||
150062982|NCT01117051|541371448|FG001|Overall Study|Randomized by mistake|1|||
150062983|NCT01117051|541371447|FG000|Overall Study|Convenience issue|1|||
150062984|NCT01117051|541371448|FG001|Overall Study|Convenience issue|0|||
150062985|NCT03190369|541371449|FG000|Overall Study|Poor compliance to protocol|0|||
150062986|NCT03190369|541371450|FG001|Overall Study|Poor compliance to protocol|1|||
150062987|NCT03190369|541371449|FG000|Overall Study|Withdraw before treatment|1|||
150062988|NCT03190369|541371450|FG001|Overall Study|Withdraw before treatment|5|||
150062989|NCT03190369|541371449|FG000|Overall Study|Randomized but not treated|0|||
150062990|NCT03190369|541371450|FG001|Overall Study|Randomized but not treated|2|||
150062991|NCT04543409|541371451|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
150062992|NCT04543409|541371452|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
150062993|NCT04543409|541371451|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
150062994|NCT04543409|541371452|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
150062995|NCT04543409|541371451|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
150062996|NCT04543409|541371452|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
150062997|NCT04543409|541371451|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
150062998|NCT04543409|541371452|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
150062999|NCT04543409|541371451|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
150063000|NCT04543409|541371452|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
150063001|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
150063002|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
150063003|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
150063004|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
150063005|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
150063006|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
150063007|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
150063008|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
150063009|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
150063010|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
150063011|NCT04543409|541371451|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
150063012|NCT04543409|541371452|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
150063013|NCT02093026|541371453|FG000|Overall Study|Adverse Event|26|||
150063014|NCT02093026|541371453|FG000|Overall Study|Death|10|||
150063015|NCT02093026|541371453|FG000|Overall Study|Other|157|||
150063016|NCT01056380|541371456|FG000|Overall Study|Lost to Follow-up|2|||
150063017|NCT01056380|541371457|FG001|Overall Study|Lost to Follow-up|3|||
150063018|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
150063019|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
150063020|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
150063021|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
150063022|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
150063023|NCT00586326|541371458|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
150063024|NCT00586326|541371458|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
150063025|NCT00586326|541371458|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
150063026|NCT00586326|541371458|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
150063027|NCT00586326|541371458|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
150063028|NCT00586326|541371458|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
150063029|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
150063030|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
150063031|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
150063032|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
150063033|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
150063034|NCT00586326|541371458|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
150063035|NCT03595774|541371459|FG000|Overall Study|Adverse Event|1|||
150063036|NCT03595774|541371460|FG001|Overall Study|Adverse Event|0|||
150063037|NCT03595774|541371461|FG002|Overall Study|Adverse Event|1|||
150063038|NCT03595774|541371462|FG003|Overall Study|Adverse Event|0|||
150063039|NCT03595774|541371459|FG000|Overall Study|screen failure|0|||
150063040|NCT03595774|541371460|FG001|Overall Study|screen failure|1|||
150063041|NCT03595774|541371461|FG002|Overall Study|screen failure|0|||
150063042|NCT03595774|541371462|FG003|Overall Study|screen failure|1|||
150063043|NCT03519386|541371464|FG000|Overall Study|Withdrawal by Subject|4|||
150063044|NCT03519386|541371465|FG001|Overall Study|Withdrawal by Subject|1|||
150063045|NCT03519386|541371466|FG002|Overall Study|Withdrawal by Subject|2|||
150063046|NCT03519386|541371464|FG000|Overall Study|Physician Decision|1|||
150063047|NCT03519386|541371465|FG001|Overall Study|Physician Decision|1|||
150063048|NCT03519386|541371466|FG002|Overall Study|Physician Decision|1|||
150063049|NCT03519386|541371464|FG000|Overall Study|Lost to Follow-up|0|||
150063050|NCT03519386|541371465|FG001|Overall Study|Lost to Follow-up|1|||
150063051|NCT03519386|541371466|FG002|Overall Study|Lost to Follow-up|1|||
150063052|NCT03519386|541371464|FG000|Overall Study|Death|1|||
150063053|NCT03519386|541371465|FG001|Overall Study|Death|0|||
150063054|NCT03519386|541371466|FG002|Overall Study|Death|4|||
150063055|NCT03519386|541371464|FG000|Overall Study|Adverse Event|2|||
150063056|NCT03519386|541371465|FG001|Overall Study|Adverse Event|1|||
150063057|NCT03519386|541371466|FG002|Overall Study|Adverse Event|2|||
150063058|NCT03519386|541371464|FG000|Overall Study|Explanted|2|||
150063059|NCT03519386|541371465|FG001|Overall Study|Explanted|1|||
150063060|NCT03519386|541371466|FG002|Overall Study|Explanted|0|||
150063061|NCT03519386|541371464|FG000|Overall Study|Ongoing in study|190|||
150063062|NCT03519386|541371465|FG001|Overall Study|Ongoing in study|192|||
150063063|NCT03519386|541371466|FG002|Overall Study|Ongoing in study|183|||
150063064|NCT03101267|541371468|FG000|Primary Study Period|Withdrawal by Subject|1|||
150063065|NCT03101267|541371469|FG001|Primary Study Period|Withdrawal by Subject|2|||
150063066|NCT03101267|541371470|FG002|Primary Study Period|Withdrawal by Subject|3|||
150063067|NCT03101267|541371468|FG000|Primary Study Period|Miscellaneous|2|||
150063068|NCT03101267|541371469|FG001|Primary Study Period|Miscellaneous|0|||
150063069|NCT03101267|541371470|FG002|Primary Study Period|Miscellaneous|0|||
150063070|NCT00555425|541371471|FG000|Overall Study|Missed Medication > 1 wk|34|||
150063071|NCT00555425|541371472|FG001|Overall Study|Missed Medication > 1 wk|15|||
150063072|NCT00555425|541371471|FG000|Overall Study|Missed 3 physician management visits|1|||
150063073|NCT00555425|541371472|FG001|Overall Study|Missed 3 physician management visits|0|||
150063074|NCT00555425|541371471|FG000|Overall Study|Met criteria for protective transfer|16|||
150063075|NCT00555425|541371472|FG001|Overall Study|Met criteria for protective transfer|3|||
150063076|NCT00555425|541371471|FG000|Overall Study|Became pregnant and transferred care|0|||
150063077|NCT00555425|541371472|FG001|Overall Study|Became pregnant and transferred care|1|||
150063078|NCT00393042|541371473|FG000|First Intervention|Withdrawal by Subject|1|||
150063079|NCT00393042|541371474|FG001|First Intervention|Withdrawal by Subject|2|||
150063080|NCT00393042|541371473|FG000|First Intervention|Lost to Follow-up|3|||
150063081|NCT00393042|541371474|FG001|First Intervention|Lost to Follow-up|3|||
150063082|NCT00393042|541371473|FG000|First Intervention|Protocol Violation|1|||
150063083|NCT00393042|541371474|FG001|First Intervention|Protocol Violation|0|||
150063084|NCT00393042|541371473|FG000|First Intervention|Adverse Event|0|||
150063085|NCT00393042|541371474|FG001|First Intervention|Adverse Event|1|||
150063086|NCT00393042|541371473|FG000|Second Intervetion|Adverse Event|0|||
150063087|NCT00393042|541371474|FG001|Second Intervetion|Adverse Event|3|||
150063088|NCT00393042|541371473|FG000|Second Intervetion|Withdrawal by Subject|0|||
150063089|NCT00393042|541371474|FG001|Second Intervetion|Withdrawal by Subject|2|||
150063090|NCT00393042|541371473|FG000|Second Intervetion|Lack of Efficacy|1|||
150063091|NCT00393042|541371474|FG001|Second Intervetion|Lack of Efficacy|0|||
150063092|NCT00393042|541371473|FG000|Second Intervetion|Lost to Follow-up|0|||
150063093|NCT00393042|541371474|FG001|Second Intervetion|Lost to Follow-up|2|||
150063094|NCT00393042|541371473|FG000|Second Intervetion|Protocol Violation|1|||
150063095|NCT00393042|541371474|FG001|Second Intervetion|Protocol Violation|1|||
150063096|NCT00829283|541371475|FG000|Overall Study|Lost to Follow-up|7|||
150063097|NCT00829283|541371476|FG001|Overall Study|Lost to Follow-up|25|||
150063098|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
150063099|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
150063100|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
150063101|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
150063102|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
150063103|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
150063104|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
150063105|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
150063106|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
150063107|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
150025103|NCT00346216|541228440|FG002|Overall Study|Missing Subject Summary Status|62|||
150025104|NCT01276639|541228441|FG000|Week 0 to 16|Death|1|||
150025105|NCT01276639|541228442|FG001|Week 0 to 16|Death|0|||
150025106|NCT01276639|541228443|FG002|Week 0 to 16|Death|0|||
150025107|NCT01276639|541228444|FG003|Week 0 to 16|Death|0|||
150025108|NCT01276639|541228445|FG004|Week 0 to 16|Death|0|||
150025109|NCT01276639|541228441|FG000|Week 0 to 16|Adverse Event|11|||
150025110|NCT01276639|541228442|FG001|Week 0 to 16|Adverse Event|8|||
150025111|NCT01276639|541228443|FG002|Week 0 to 16|Adverse Event|11|||
150025112|NCT01276639|541228444|FG003|Week 0 to 16|Adverse Event|0|||
150025113|NCT01276639|541228445|FG004|Week 0 to 16|Adverse Event|0|||
150025114|NCT01276639|541228441|FG000|Week 0 to 16|Lack of Efficacy|20|||
150025115|NCT01276639|541228442|FG001|Week 0 to 16|Lack of Efficacy|15|||
150025116|NCT01276639|541228443|FG002|Week 0 to 16|Lack of Efficacy|25|||
150025117|NCT01276639|541228444|FG003|Week 0 to 16|Lack of Efficacy|0|||
150025118|NCT01276639|541228445|FG004|Week 0 to 16|Lack of Efficacy|0|||
150025119|NCT01276639|541228441|FG000|Week 0 to 16|Lost to Follow-up|3|||
150025120|NCT01276639|541228442|FG001|Week 0 to 16|Lost to Follow-up|5|||
150025121|NCT01276639|541228443|FG002|Week 0 to 16|Lost to Follow-up|3|||
150025122|NCT01276639|541228444|FG003|Week 0 to 16|Lost to Follow-up|0|||
150025123|NCT01276639|541228445|FG004|Week 0 to 16|Lost to Follow-up|0|||
150025124|NCT01276639|541228441|FG000|Week 0 to 16|Withdrawal by Subject|8|||
150025125|NCT01276639|541228442|FG001|Week 0 to 16|Withdrawal by Subject|5|||
150025126|NCT01276639|541228443|FG002|Week 0 to 16|Withdrawal by Subject|4|||
150025127|NCT01276639|541228444|FG003|Week 0 to 16|Withdrawal by Subject|0|||
150025128|NCT01276639|541228445|FG004|Week 0 to 16|Withdrawal by Subject|0|||
150025129|NCT01276639|541228441|FG000|Week 0 to 16|Other|7|||
150025130|NCT01276639|541228442|FG001|Week 0 to 16|Other|7|||
150025131|NCT01276639|541228443|FG002|Week 0 to 16|Other|2|||
150025132|NCT01276639|541228444|FG003|Week 0 to 16|Other|0|||
150025133|NCT01276639|541228445|FG004|Week 0 to 16|Other|0|||
150025134|NCT01276639|541228441|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
150025135|NCT01276639|541228442|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
150025136|NCT01276639|541228443|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
150025137|NCT01276639|541228444|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
150025138|NCT01276639|541228445|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
150025139|NCT01276639|541228441|FG000|Week 16 to 52|Death|1|||
150025140|NCT01276639|541228442|FG001|Week 16 to 52|Death|0|||
150025141|NCT01276639|541228443|FG002|Week 16 to 52|Death|0|||
150025142|NCT01276639|541228444|FG003|Week 16 to 52|Death|0|||
150063108|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
150063109|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
150063110|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
150025143|NCT01276639|541228445|FG004|Week 16 to 52|Death|0|||
150025144|NCT01276639|541228441|FG000|Week 16 to 52|Adverse Event|10|||
150025145|NCT01276639|541228442|FG001|Week 16 to 52|Adverse Event|13|||
150025146|NCT01276639|541228443|FG002|Week 16 to 52|Adverse Event|0|||
150063111|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
150063112|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
150063113|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
150063114|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
150063115|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
150063116|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
150063117|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
150063118|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
150063119|NCT02431247|541371477|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
150063120|NCT02431247|541371478|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
150063121|NCT02431247|541371479|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
150063122|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
150063123|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
150063124|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
150063125|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
150063126|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
150063127|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
150063128|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
150063129|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
150063130|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
150063131|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
150063132|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
150063133|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
150063134|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
150063135|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
150063136|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
150063137|NCT02431247|541371477|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
150063138|NCT02431247|541371478|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
150063139|NCT02431247|541371479|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
150063140|NCT00322153|541371480|FG000|Overall Study|Adverse Event|21|||
150063141|NCT00322153|541371481|FG001|Overall Study|Adverse Event|34|||
150063142|NCT00322153|541371480|FG000|Overall Study|Protocol Violation|6|||
150063143|NCT00322153|541371481|FG001|Overall Study|Protocol Violation|14|||
150063144|NCT00322153|541371480|FG000|Overall Study|Withdrawal by Subject|18|||
150063145|NCT00322153|541371481|FG001|Overall Study|Withdrawal by Subject|10|||
150063146|NCT00322153|541371480|FG000|Overall Study|Lack of Efficacy|8|||
150063147|NCT00322153|541371481|FG001|Overall Study|Lack of Efficacy|3|||
150063148|NCT00322153|541371480|FG000|Overall Study|Lost to Follow-up|5|||
150063149|NCT00322153|541371481|FG001|Overall Study|Lost to Follow-up|4|||
150063150|NCT00322153|541371480|FG000|Overall Study|Withdrawn for other reasons|5|||
150063151|NCT00322153|541371481|FG001|Overall Study|Withdrawn for other reasons|4|||
150063152|NCT02414139|541371482|FG000|Treatment Period|Adverse Event|11|||
150063153|NCT02414139|541371483|FG001|Treatment Period|Adverse Event|6|||
150063154|NCT02414139|541371484|FG002|Treatment Period|Adverse Event|8|||
150063155|NCT02414139|541371485|FG003|Treatment Period|Adverse Event|5|||
150063156|NCT02414139|541371486|FG004|Treatment Period|Adverse Event|14|||
150063157|NCT02414139|541371487|FG005|Treatment Period|Adverse Event|3|||
150063158|NCT02414139|541371488|FG006|Treatment Period|Adverse Event|6|||
150063159|NCT02414139|541371489|FG007|Treatment Period|Adverse Event|1|||
150063160|NCT02414139|541371490|FG008|Treatment Period|Adverse Event|6|||
150063161|NCT02414139|541371491|FG009|Treatment Period|Adverse Event|8|||
150063162|NCT02414139|541371482|FG000|Treatment Period|Death|0|||
150063163|NCT02414139|541371483|FG001|Treatment Period|Death|0|||
150063164|NCT02414139|541371484|FG002|Treatment Period|Death|1|||
150063165|NCT02414139|541371485|FG003|Treatment Period|Death|1|||
150063166|NCT02414139|541371486|FG004|Treatment Period|Death|0|||
150063167|NCT02414139|541371487|FG005|Treatment Period|Death|0|||
150063168|NCT02414139|541371488|FG006|Treatment Period|Death|0|||
150063169|NCT02414139|541371489|FG007|Treatment Period|Death|0|||
150063170|NCT02414139|541371490|FG008|Treatment Period|Death|0|||
150063171|NCT02414139|541371491|FG009|Treatment Period|Death|1|||
150063172|NCT02414139|541371482|FG000|Treatment Period|Physician Decision|5|||
150063173|NCT02414139|541371483|FG001|Treatment Period|Physician Decision|4|||
150063174|NCT02414139|541371484|FG002|Treatment Period|Physician Decision|6|||
150063175|NCT02414139|541371485|FG003|Treatment Period|Physician Decision|1|||
150063176|NCT02414139|541371486|FG004|Treatment Period|Physician Decision|4|||
150063177|NCT02414139|541371487|FG005|Treatment Period|Physician Decision|0|||
150063178|NCT02414139|541371488|FG006|Treatment Period|Physician Decision|2|||
150063179|NCT02414139|541371489|FG007|Treatment Period|Physician Decision|0|||
150063180|NCT02414139|541371490|FG008|Treatment Period|Physician Decision|1|||
150063181|NCT02414139|541371491|FG009|Treatment Period|Physician Decision|4|||
150063182|NCT02414139|541371482|FG000|Treatment Period|Progressive disease|48|||
150063183|NCT02414139|541371483|FG001|Treatment Period|Progressive disease|31|||
150063184|NCT02414139|541371484|FG002|Treatment Period|Progressive disease|37|||
150063185|NCT02414139|541371485|FG003|Treatment Period|Progressive disease|21|||
150063186|NCT02414139|541371486|FG004|Treatment Period|Progressive disease|43|||
150063187|NCT02414139|541371487|FG005|Treatment Period|Progressive disease|12|||
150063188|NCT02414139|541371488|FG006|Treatment Period|Progressive disease|16|||
150063189|NCT02414139|541371489|FG007|Treatment Period|Progressive disease|2|||
150063190|NCT02414139|541371490|FG008|Treatment Period|Progressive disease|20|||
150063191|NCT02414139|541371491|FG009|Treatment Period|Progressive disease|14|||
150063192|NCT02414139|541371482|FG000|Treatment Period|Protocol deviation|0|||
150063193|NCT02414139|541371483|FG001|Treatment Period|Protocol deviation|0|||
150063194|NCT02414139|541371484|FG002|Treatment Period|Protocol deviation|1|||
150063195|NCT02414139|541371485|FG003|Treatment Period|Protocol deviation|0|||
150063196|NCT02414139|541371486|FG004|Treatment Period|Protocol deviation|0|||
150063197|NCT02414139|541371487|FG005|Treatment Period|Protocol deviation|0|||
150063198|NCT02414139|541371488|FG006|Treatment Period|Protocol deviation|0|||
150063199|NCT02414139|541371489|FG007|Treatment Period|Protocol deviation|0|||
150063200|NCT02414139|541371490|FG008|Treatment Period|Protocol deviation|0|||
150063201|NCT02414139|541371491|FG009|Treatment Period|Protocol deviation|0|||
150063202|NCT02414139|541371482|FG000|Treatment Period|Subject/Guardian decision|5|||
150063203|NCT02414139|541371483|FG001|Treatment Period|Subject/Guardian decision|1|||
150063204|NCT02414139|541371484|FG002|Treatment Period|Subject/Guardian decision|1|||
150063205|NCT02414139|541371485|FG003|Treatment Period|Subject/Guardian decision|2|||
150063206|NCT02414139|541371486|FG004|Treatment Period|Subject/Guardian decision|5|||
150063207|NCT02414139|541371487|FG005|Treatment Period|Subject/Guardian decision|0|||
150063208|NCT02414139|541371488|FG006|Treatment Period|Subject/Guardian decision|2|||
150063209|NCT02414139|541371489|FG007|Treatment Period|Subject/Guardian decision|0|||
150063210|NCT02414139|541371490|FG008|Treatment Period|Subject/Guardian decision|1|||
150063211|NCT02414139|541371491|FG009|Treatment Period|Subject/Guardian decision|1|||
150063212|NCT02414139|541371482|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063213|NCT02414139|541371483|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063214|NCT02414139|541371484|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063215|NCT02414139|541371485|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063216|NCT02414139|541371486|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
150063217|NCT02414139|541371487|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063218|NCT02414139|541371488|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
150063219|NCT02414139|541371489|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
150063220|NCT02414139|541371490|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
150063221|NCT02414139|541371491|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
150063222|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
150063223|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063224|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063225|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063226|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
150063227|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063228|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063229|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063230|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063231|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150063232|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Death|0|||
150063233|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Death|1|||
150063234|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Death|0|||
150063235|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Death|0|||
150063236|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Death|1|||
150063237|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Death|0|||
150063238|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Death|0|||
150063239|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Death|0|||
150063240|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Death|0|||
150063241|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Death|1|||
150063242|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
150063243|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063244|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063245|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063246|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063247|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063248|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063249|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063250|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063251|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150063252|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
150063253|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
150063254|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
150063255|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
150063256|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
150063257|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
150063258|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
150063259|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
150063260|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
150063261|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
150063262|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
150063263|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
150063264|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
150063265|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
150063266|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
150063267|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
150063268|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
150063269|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
150063270|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
150063271|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
150063272|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063273|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
150063274|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063275|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063276|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063277|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063278|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063279|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063280|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
150063281|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
150063282|NCT02414139|541371482|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
150063283|NCT02414139|541371483|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
150063284|NCT02414139|541371484|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
150063285|NCT02414139|541371485|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
150063286|NCT02414139|541371486|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
150063287|NCT02414139|541371487|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
150063288|NCT02414139|541371488|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
150063289|NCT02414139|541371489|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
150063290|NCT02414139|541371490|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
150063291|NCT02414139|541371491|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
150063292|NCT03523000|541371492|FG000|Overall Study|Withdrawal by Subject|3|||
150063293|NCT03523000|541371493|FG001|Overall Study|Withdrawal by Subject|0|||
150063294|NCT03523000|541371492|FG000|Overall Study|Unsuccessful trial|2|||
150063295|NCT03523000|541371493|FG001|Overall Study|Unsuccessful trial|0|||
150063296|NCT00772070|541371494|FG000|Overall Study|Lost to Follow-up|0|||
150063297|NCT00772070|541371495|FG001|Overall Study|Lost to Follow-up|8|||
150063298|NCT00772070|541371494|FG000|Overall Study|Withdrawal by Subject|0|||
150063299|NCT00772070|541371495|FG001|Overall Study|Withdrawal by Subject|2|||
150063300|NCT00772070|541371494|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
150063301|NCT00772070|541371495|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
150063302|NCT01309308|541371496|FG000|Overall Study|Lost to Follow-up|6|||
150063303|NCT01309308|541371497|FG001|Overall Study|Lost to Follow-up|4|||
150063304|NCT00495131|541371498|FG000|Overall Study|Adverse Event|6|||
150063305|NCT00495131|541371499|FG001|Overall Study|Adverse Event|2|||
150063306|NCT00495131|541371498|FG000|Overall Study|Lack of Efficacy|0|||
150063307|NCT00495131|541371499|FG001|Overall Study|Lack of Efficacy|2|||
150063308|NCT00495131|541371498|FG000|Overall Study|Lost to Follow-up|0|||
150063309|NCT00495131|541371499|FG001|Overall Study|Lost to Follow-up|2|||
150063310|NCT00495131|541371498|FG000|Overall Study|Withdrawal by Subject|1|||
150063311|NCT00495131|541371499|FG001|Overall Study|Withdrawal by Subject|0|||
150063312|NCT01307020|541371501|FG000|Overall Study|Lost to Follow-up|0|||
150063313|NCT01307020|541371502|FG001|Overall Study|Lost to Follow-up|0|||
150063314|NCT01307020|541371503|FG002|Overall Study|Lost to Follow-up|1|||
150063315|NCT01307020|541371504|FG003|Overall Study|Lost to Follow-up|1|||
150063316|NCT01307020|541371505|FG004|Overall Study|Lost to Follow-up|0|||
150063317|NCT01307020|541371506|FG005|Overall Study|Lost to Follow-up|0|||
150181903|NCT03398148|541804599|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
150063318|NCT01307020|541371507|FG006|Overall Study|Lost to Follow-up|1|||
150063319|NCT01307020|541371508|FG007|Overall Study|Lost to Follow-up|0|||
150063320|NCT01307020|541371509|FG008|Overall Study|Lost to Follow-up|0|||
150063321|NCT01307020|541371510|FG009|Overall Study|Lost to Follow-up|0|||
150063322|NCT01307020|541371501|FG000|Overall Study|Electronic data capture failure|0|||
150063323|NCT01307020|541371502|FG001|Overall Study|Electronic data capture failure|1|||
150063324|NCT01307020|541371503|FG002|Overall Study|Electronic data capture failure|0|||
150063325|NCT01307020|541371504|FG003|Overall Study|Electronic data capture failure|0|||
150063326|NCT01307020|541371505|FG004|Overall Study|Electronic data capture failure|0|||
150063327|NCT01307020|541371506|FG005|Overall Study|Electronic data capture failure|0|||
150063328|NCT01307020|541371507|FG006|Overall Study|Electronic data capture failure|0|||
150063329|NCT01307020|541371508|FG007|Overall Study|Electronic data capture failure|0|||
150063330|NCT01307020|541371509|FG008|Overall Study|Electronic data capture failure|0|||
150063331|NCT01307020|541371510|FG009|Overall Study|Electronic data capture failure|0|||
150063332|NCT00266864|541371511|FG000|Overall Study|Lost to Follow-up|4|||
150063333|NCT00266864|541371512|FG001|Overall Study|Lost to Follow-up|1|||
150063334|NCT00266864|541371511|FG000|Overall Study|Withdrawal by Subject|1|||
150063335|NCT00266864|541371512|FG001|Overall Study|Withdrawal by Subject|1|||
150063336|NCT01909453|541371523|FG000|Overall Study|Ongoing|118|||
150063337|NCT01909453|541371524|FG001|Overall Study|Ongoing|103|||
150063338|NCT01909453|541371525|FG002|Overall Study|Ongoing|83|||
150063339|NCT01909453|541371526|FG003|Overall Study|Ongoing|164|||
150063340|NCT01909453|541371527|FG004|Overall Study|Ongoing|50|||
150063341|NCT01909453|541371523|FG000|Overall Study|Death|69|||
150063342|NCT01909453|541371524|FG001|Overall Study|Death|74|||
150063343|NCT01909453|541371525|FG002|Overall Study|Death|88|||
150063344|NCT01909453|541371526|FG003|Overall Study|Death|86|||
150063345|NCT01909453|541371527|FG004|Overall Study|Death|29|||
150063346|NCT01909453|541371523|FG000|Overall Study|Lost to Follow-up|3|||
150063347|NCT01909453|541371524|FG001|Overall Study|Lost to Follow-up|4|||
150063348|NCT01909453|541371525|FG002|Overall Study|Lost to Follow-up|4|||
150063349|NCT01909453|541371526|FG003|Overall Study|Lost to Follow-up|3|||
150063350|NCT01909453|541371527|FG004|Overall Study|Lost to Follow-up|3|||
150063351|NCT01909453|541371523|FG000|Overall Study|Withdrawal by Subject|2|||
150063352|NCT01909453|541371524|FG001|Overall Study|Withdrawal by Subject|13|||
150063353|NCT01909453|541371525|FG002|Overall Study|Withdrawal by Subject|16|||
150063354|NCT01909453|541371526|FG003|Overall Study|Withdrawal by Subject|5|||
150063355|NCT01909453|541371527|FG004|Overall Study|Withdrawal by Subject|4|||
150063356|NCT01994590|541373483|FG000|Overall Study|Adverse Event|1|||
150063357|NCT01994590|541373483|FG000|Overall Study|Trial Terminated|1|||
150063358|NCT03332771|541373485|FG000|Overall Study|Adverse Event|6|||
150063359|NCT03332771|541373486|FG001|Overall Study|Adverse Event|4|||
150063360|NCT03332771|541373487|FG002|Overall Study|Adverse Event|1|||
150063361|NCT03332771|541373488|FG003|Overall Study|Adverse Event|3|||
150063362|NCT03332771|541373485|FG000|Overall Study|Poor Compliance to Protocol|0|||
150063363|NCT03332771|541373486|FG001|Overall Study|Poor Compliance to Protocol|1|||
150063364|NCT03332771|541373487|FG002|Overall Study|Poor Compliance to Protocol|0|||
150063365|NCT03332771|541373488|FG003|Overall Study|Poor Compliance to Protocol|1|||
150063366|NCT03332771|541373485|FG000|Overall Study|Lost to Follow-up|2|||
150063367|NCT03332771|541373486|FG001|Overall Study|Lost to Follow-up|2|||
150063368|NCT03332771|541373487|FG002|Overall Study|Lost to Follow-up|1|||
150063369|NCT03332771|541373488|FG003|Overall Study|Lost to Follow-up|2|||
150063370|NCT03332771|541373485|FG000|Overall Study|At the Participant's own request|20|||
150063371|NCT03332771|541373486|FG001|Overall Study|At the Participant's own request|26|||
150063372|NCT03332771|541373487|FG002|Overall Study|At the Participant's own request|14|||
150063373|NCT03332771|541373488|FG003|Overall Study|At the Participant's own request|23|||
150063374|NCT03332771|541373485|FG000|Overall Study|Reason Not Specified|6|||
150063375|NCT03332771|541373486|FG001|Overall Study|Reason Not Specified|18|||
150063376|NCT03332771|541373487|FG002|Overall Study|Reason Not Specified|16|||
150063377|NCT03332771|541373488|FG003|Overall Study|Reason Not Specified|19|||
150063378|NCT03442764|541373489|FG000|Overall Study|Adverse Event|1|||
150063379|NCT03442764|541373490|FG001|Overall Study|Adverse Event|0|||
150063380|NCT03442764|541373491|FG002|Overall Study|Adverse Event|0|||
150063381|NCT05523323|541373498|FG000|Overall Study|Death|26|||
150063382|NCT05523323|541373499|FG001|Overall Study|Death|21|||
150063383|NCT05523323|541373498|FG000|Overall Study|Ongoing participants|35|||
150063384|NCT05523323|541373499|FG001|Overall Study|Ongoing participants|30|||
150063385|NCT02469038|541373500|FG000|Overall Study|Physician Decision|4|||
150063386|NCT02469038|541373501|FG001|Overall Study|Physician Decision|5|||
150063387|NCT03435640|541373502|FG000|Overall Study|Withdrawal by Subject|0|||
150063388|NCT03435640|541373503|FG001|Overall Study|Withdrawal by Subject|1|||
150063389|NCT03435640|541373504|FG002|Overall Study|Withdrawal by Subject|0|||
150063390|NCT03435640|541373505|FG003|Overall Study|Withdrawal by Subject|2|||
150063391|NCT03435640|541373506|FG004|Overall Study|Withdrawal by Subject|0|||
150063392|NCT03435640|541373507|FG005|Overall Study|Withdrawal by Subject|0|||
150063393|NCT03435640|541373508|FG006|Overall Study|Withdrawal by Subject|3|||
150063394|NCT03435640|541373509|FG007|Overall Study|Withdrawal by Subject|0|||
150063395|NCT03435640|541373510|FG008|Overall Study|Withdrawal by Subject|0|||
150063396|NCT03435640|541373511|FG009|Overall Study|Withdrawal by Subject|2|||
150063397|NCT03435640|541373512|FG010|Overall Study|Withdrawal by Subject|3|||
150063398|NCT03435640|541373502|FG000|Overall Study|Lost to Follow-up|0|||
150063399|NCT03435640|541373503|FG001|Overall Study|Lost to Follow-up|0|||
150063400|NCT03435640|541373504|FG002|Overall Study|Lost to Follow-up|1|||
150063401|NCT03435640|541373505|FG003|Overall Study|Lost to Follow-up|0|||
150063402|NCT03435640|541373506|FG004|Overall Study|Lost to Follow-up|0|||
150063403|NCT03435640|541373507|FG005|Overall Study|Lost to Follow-up|0|||
150063404|NCT03435640|541373508|FG006|Overall Study|Lost to Follow-up|0|||
150063405|NCT03435640|541373509|FG007|Overall Study|Lost to Follow-up|0|||
150063406|NCT03435640|541373510|FG008|Overall Study|Lost to Follow-up|0|||
150063407|NCT03435640|541373511|FG009|Overall Study|Lost to Follow-up|0|||
150063408|NCT03435640|541373512|FG010|Overall Study|Lost to Follow-up|0|||
150063409|NCT00636987|541373513|FG000|Overall Study|Death|44|||
150063410|NCT00636987|541373513|FG000|Overall Study|Explanted|13|||
150063411|NCT00636987|541373513|FG000|Overall Study|Lost to Follow-up|63|||
150063412|NCT00636987|541373513|FG000|Overall Study|5 year visit window not complete|69|||
150063413|NCT01251146|541373514|FG000|Overall Study|Lost to Follow-up|3|||
150063414|NCT01251146|541373515|FG001|Overall Study|Lost to Follow-up|10|||
150063415|NCT00053365|541373520|FG000|Overall Study|Incorrect cell type|1|||
150063416|NCT00053365|541373520|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
150063417|NCT00053365|541373520|FG000|Overall Study|Never treated|4|||
150063418|NCT01483690|541373521|FG000|Overall Study|Adverse Event|1|||
150063419|NCT01483690|541373522|FG001|Overall Study|Adverse Event|2|||
150063420|NCT01483690|541373521|FG000|Overall Study|clinical deterioration|1|||
150063421|NCT01483690|541373522|FG001|Overall Study|clinical deterioration|0|||
150063422|NCT01483690|541373521|FG000|Overall Study|Physician Decision|0|||
150063423|NCT01483690|541373522|FG001|Overall Study|Physician Decision|2|||
150063424|NCT01483690|541373521|FG000|Overall Study|exclusionary procedure|0|||
150063425|NCT01483690|541373522|FG001|Overall Study|exclusionary procedure|1|||
150063426|NCT02239224|541373528|FG000|Overall Study|Administrative|0|||
150063427|NCT02239224|541373529|FG001|Overall Study|Administrative|0|||
150063428|NCT02239224|541373530|FG002|Overall Study|Administrative|3|||
150063429|NCT02239224|541373531|FG003|Overall Study|Administrative|1|||
150063430|NCT03183778|541373534|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
150063431|NCT00737464|541373535|FG000|Overall Study|Adverse Event|1|||
150063432|NCT00737464|541373535|FG000|Overall Study|Death|6|||
150063433|NCT00737464|541373535|FG000|Overall Study|Other - Failure to Return|1|||
150063434|NCT00737464|541373535|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
150063435|NCT00737464|541373535|FG000|Overall Study|Other reasons|4|||
150063436|NCT03228420|541373549|FG000|Overall Study|Lost to Follow-up|5|||
150063437|NCT03228420|541373550|FG001|Overall Study|Lost to Follow-up|3|||
150063438|NCT03228420|541373549|FG000|Overall Study|Withdrawal by Subject|10|||
150063439|NCT03228420|541373550|FG001|Overall Study|Withdrawal by Subject|0|||
150063440|NCT03228420|541373549|FG000|Overall Study|Adverse Event|5|||
150063441|NCT03228420|541373550|FG001|Overall Study|Adverse Event|2|||
150063442|NCT00206076|541373552|FG000|Overall Study|Physician Decision|2|||
150063443|NCT00206076|541373553|FG001|Overall Study|Physician Decision|0|||
150063444|NCT00206076|541373552|FG000|Overall Study|Withdrawal by Subject|1|||
150063445|NCT00206076|541373553|FG001|Overall Study|Withdrawal by Subject|1|||
150063446|NCT00427960|541373555|FG000|Overall Study|Adverse Event|2|||
150063447|NCT00427960|541373556|FG001|Overall Study|Adverse Event|0|||
150063448|NCT00427960|541373555|FG000|Overall Study|Withdrawal by Subject|0|||
150063449|NCT00427960|541373556|FG001|Overall Study|Withdrawal by Subject|3|||
150063450|NCT00427960|541373555|FG000|Overall Study|Other|0|||
150063451|NCT00427960|541373556|FG001|Overall Study|Other|1|||
150063452|NCT01142128|541373557|FG000|Overall Study|Physician Decision|1|||
150063453|NCT01142128|541373557|FG000|Overall Study|Lost to Follow-up|1|||
150063454|NCT01142128|541373557|FG000|Overall Study|Withdrawal by Subject|2|||
150063455|NCT03355664|541373558|FG000|Overall Study|Adverse Event|1|||
150063456|NCT03355664|541373559|FG001|Overall Study|Adverse Event|2|||
150063457|NCT03355664|541373558|FG000|Overall Study|Lost to Follow-up|11|||
150063458|NCT03355664|541373559|FG001|Overall Study|Lost to Follow-up|7|||
150063459|NCT03355664|541373558|FG000|Overall Study|Protocol Violation|1|||
150063460|NCT03355664|541373559|FG001|Overall Study|Protocol Violation|2|||
150063461|NCT03355664|541373558|FG000|Overall Study|Withdrawal by Subject|2|||
150063462|NCT03355664|541373559|FG001|Overall Study|Withdrawal by Subject|1|||
150181904|NCT03398148|541804600|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
150063463|NCT04163718|541373565|FG000|Overall Study|Study terminated|12|||
150063464|NCT01289782|541373566|FG000|Overall Study|Lost to Follow-up|14|||
150063465|NCT01289782|541373567|FG001|Overall Study|Lost to Follow-up|7|||
150063466|NCT01289782|541373566|FG000|Overall Study|Protocol Violation|1|||
150063467|NCT01289782|541373567|FG001|Overall Study|Protocol Violation|1|||
150063468|NCT01289782|541373566|FG000|Overall Study|Withdrawal by Subject|8|||
150063469|NCT01289782|541373567|FG001|Overall Study|Withdrawal by Subject|2|||
150063470|NCT01289782|541373566|FG000|Overall Study|Sponsor's Decision|1|||
150063471|NCT01289782|541373567|FG001|Overall Study|Sponsor's Decision|0|||
150063472|NCT01289782|541373566|FG000|Overall Study|Reason not specified|1|||
150063473|NCT01289782|541373567|FG001|Overall Study|Reason not specified|2|||
150063474|NCT02131532|541373568|FG000|Overall Study|Withdrawal by Subject|1|||
150063475|NCT02131532|541373568|FG000|Overall Study|Physician Decision|1|||
150063476|NCT02131532|541373568|FG000|Overall Study|Other health conditions|2|||
150063477|NCT01569464|541373588|FG000|Overall Study|Adverse Event|4|||
150063478|NCT01569464|541373589|FG001|Overall Study|Adverse Event|0|||
150063479|NCT01569464|541373588|FG000|Overall Study|Lack of Efficacy|1|||
150063480|NCT01569464|541373589|FG001|Overall Study|Lack of Efficacy|0|||
150063481|NCT01569464|541373588|FG000|Overall Study|Protocol Violation|1|||
150063482|NCT01569464|541373589|FG001|Overall Study|Protocol Violation|0|||
150063483|NCT01569464|541373588|FG000|Overall Study|Lost to Follow-up|2|||
150063484|NCT01569464|541373589|FG001|Overall Study|Lost to Follow-up|3|||
150063485|NCT01569464|541373588|FG000|Overall Study|Withdrawal by Subject|1|||
150063486|NCT01569464|541373589|FG001|Overall Study|Withdrawal by Subject|1|||
150063487|NCT01569464|541373588|FG000|Overall Study|Other|1|||
150063488|NCT01569464|541373589|FG001|Overall Study|Other|1|||
150063489|NCT01642407|541373595|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
150063490|NCT01642407|541373595|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
150063491|NCT01642407|541373595|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
150063492|NCT03063203|541373596|FG000|Overall Study|Chose alternative therapy|3|||
150063493|NCT03063203|541373596|FG000|Overall Study|Death|2|||
150063494|NCT03063203|541373596|FG000|Overall Study|Disease progression|4|||
150063495|NCT03063203|541373596|FG000|Overall Study|Physician Decision|5|||
150063496|NCT01856023|541373597|FG000|Overall Study|Death|1|||
150063497|NCT01856023|541373598|FG001|Overall Study|Death|2|||
150063498|NCT01856023|541373597|FG000|Overall Study|Adverse Event|2|||
150063499|NCT01856023|541373598|FG001|Overall Study|Adverse Event|1|||
150063500|NCT01856023|541373597|FG000|Overall Study|Lack of Efficacy|5|||
150063501|NCT01856023|541373598|FG001|Overall Study|Lack of Efficacy|5|||
150063502|NCT01856023|541373597|FG000|Overall Study|non compliance, study closure|1|||
150063503|NCT01856023|541373598|FG001|Overall Study|non compliance, study closure|3|||
150063504|NCT01856023|541373597|FG000|Overall Study|Withdrawal by Subject|1|||
150063505|NCT01856023|541373598|FG001|Overall Study|Withdrawal by Subject|1|||
150063506|NCT00424255|541373599|FG000|Overall Study|Death|115|||
150063507|NCT00424255|541373600|FG001|Overall Study|Death|111|||
150063508|NCT00424255|541373599|FG000|Overall Study|Lost to Follow-up|26|||
150063509|NCT00424255|541373600|FG001|Overall Study|Lost to Follow-up|20|||
150063510|NCT00424255|541373599|FG000|Overall Study|Protocol Violation|0|||
150063511|NCT00424255|541373600|FG001|Overall Study|Protocol Violation|1|||
150063512|NCT00424255|541373599|FG000|Overall Study|Withdrawal by Subject|34|||
150063513|NCT00424255|541373600|FG001|Overall Study|Withdrawal by Subject|38|||
150063514|NCT00424255|541373599|FG000|Overall Study|Physician Decision|3|||
150063515|NCT00424255|541373600|FG001|Overall Study|Physician Decision|7|||
150063516|NCT00424255|541373599|FG000|Overall Study|Cognitive Disturbance|1|||
150063517|NCT00424255|541373600|FG001|Overall Study|Cognitive Disturbance|0|||
150063518|NCT00424255|541373599|FG000|Overall Study|Non-compliance by Participants|1|||
150063519|NCT00424255|541373600|FG001|Overall Study|Non-compliance by Participants|0|||
150063520|NCT00424255|541373599|FG000|Overall Study|Fatigue|1|||
150063521|NCT00424255|541373600|FG001|Overall Study|Fatigue|0|||
150063522|NCT00424255|541373599|FG000|Overall Study|Disease Progression|0|||
150063523|NCT00424255|541373600|FG001|Overall Study|Disease Progression|2|||
150063524|NCT00424255|541373599|FG000|Overall Study|Sponsor Terminated Study|161|||
150063525|NCT00424255|541373600|FG001|Overall Study|Sponsor Terminated Study|167|||
150063526|NCT02632838|541373602|FG000|Overall Study|Withdrawal by Subject|3|||
150063527|NCT02632838|541373603|FG001|Overall Study|Withdrawal by Subject|0|||
150063528|NCT02632838|541373602|FG000|Overall Study|Lost to Follow-up|0|||
150063529|NCT02632838|541373603|FG001|Overall Study|Lost to Follow-up|2|||
150063530|NCT03631355|541373604|FG000|Overall Study|Lost to Follow-up|1|||
150063531|NCT03631355|541373605|FG001|Overall Study|Lost to Follow-up|2|||
150063532|NCT02810340|541373606|FG000|Overall Study|Withdrawal by Subject|1|||
150063533|NCT02810340|541373607|FG001|Overall Study|Withdrawal by Subject|0|||
150063534|NCT02810340|541373608|FG002|Overall Study|Withdrawal by Subject|0|||
150063535|NCT02810340|541373606|FG000|Overall Study|Incarceration|0|||
150063536|NCT02810340|541373607|FG001|Overall Study|Incarceration|1|||
150063537|NCT02810340|541373608|FG002|Overall Study|Incarceration|0|||
150063538|NCT02810340|541373606|FG000|Overall Study|Lost to Follow-up|0|||
150063539|NCT02810340|541373607|FG001|Overall Study|Lost to Follow-up|0|||
150063540|NCT02810340|541373608|FG002|Overall Study|Lost to Follow-up|1|||
150063541|NCT03945175|541373611|FG000|Overall Study|Did not meet inclusion criteria|31|||
150063542|NCT03945175|541373611|FG000|Overall Study|Withdrew consent|2|||
150063543|NCT03945175|541373611|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
150063544|NCT03945175|541373611|FG000|Overall Study|Early termination during Mydayis treatment|1|||
150063545|NCT00870233|541373615|FG000|Overall Study|Withdrawal by Subject|18|||
150063546|NCT00870233|541373615|FG000|Overall Study|Did not undergo laparotomy|3|||
150063547|NCT00870233|541373615|FG000|Overall Study|Incompatible internet browser|2|||
150063548|NCT00870233|541373615|FG000|Overall Study|Death|1|||
150063549|NCT00769483|541373617|FG000|Overall Study|Withdrawal by Subject|0|||
150063550|NCT00769483|541373618|FG001|Overall Study|Withdrawal by Subject|1|||
150025147|NCT01276639|541228444|FG003|Week 16 to 52|Adverse Event|1|||
150025148|NCT01276639|541228445|FG004|Week 16 to 52|Adverse Event|3|||
150025149|NCT01276639|541228441|FG000|Week 16 to 52|Lack of Efficacy|99|||
150025150|NCT01276639|541228442|FG001|Week 16 to 52|Lack of Efficacy|71|||
150025151|NCT01276639|541228443|FG002|Week 16 to 52|Lack of Efficacy|0|||
150025152|NCT01276639|541228444|FG003|Week 16 to 52|Lack of Efficacy|14|||
150025153|NCT01276639|541228445|FG004|Week 16 to 52|Lack of Efficacy|13|||
150025154|NCT01276639|541228441|FG000|Week 16 to 52|Lost to Follow-up|3|||
150025155|NCT01276639|541228442|FG001|Week 16 to 52|Lost to Follow-up|1|||
150025156|NCT01276639|541228443|FG002|Week 16 to 52|Lost to Follow-up|0|||
150025157|NCT01276639|541228444|FG003|Week 16 to 52|Lost to Follow-up|0|||
150025158|NCT01276639|541228445|FG004|Week 16 to 52|Lost to Follow-up|1|||
150025159|NCT01276639|541228441|FG000|Week 16 to 52|Withdrawal by Subject|4|||
150025160|NCT01276639|541228442|FG001|Week 16 to 52|Withdrawal by Subject|4|||
150025161|NCT01276639|541228443|FG002|Week 16 to 52|Withdrawal by Subject|0|||
150025162|NCT01276639|541228444|FG003|Week 16 to 52|Withdrawal by Subject|0|||
150025163|NCT01276639|541228445|FG004|Week 16 to 52|Withdrawal by Subject|1|||
150025164|NCT01276639|541228441|FG000|Week 16 to 52|Other|10|||
150025165|NCT01276639|541228442|FG001|Week 16 to 52|Other|12|||
150025166|NCT01276639|541228443|FG002|Week 16 to 52|Other|0|||
150025167|NCT01276639|541228444|FG003|Week 16 to 52|Other|1|||
150025168|NCT01276639|541228445|FG004|Week 16 to 52|Other|3|||
150025169|NCT03431441|541228446|FG000|Overall Study|Withdrawal by Subject|2|||
150025170|NCT03431441|541228446|FG000|Overall Study|Adverse Event|2|||
150025171|NCT03431441|541228446|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
150025172|NCT03400852|541228448|FG000|Blinded Treatment Period|Physician Decision|0|||
150025173|NCT03400852|541228449|FG001|Blinded Treatment Period|Physician Decision|1|||
150025174|NCT03400852|541228450|FG002|Blinded Treatment Period|Physician Decision|0|||
150025175|NCT03400852|541228448|FG000|Blinded Treatment Period|Adverse Event|1|||
150025176|NCT03400852|541228449|FG001|Blinded Treatment Period|Adverse Event|1|||
150025177|NCT03400852|541228450|FG002|Blinded Treatment Period|Adverse Event|0|||
150025178|NCT03400852|541228448|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
150025179|NCT03400852|541228449|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
150025180|NCT03400852|541228450|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
150025181|NCT03400852|541228448|FG000|Open Label Period|Physician Decision|0|||
150025182|NCT03400852|541228449|FG001|Open Label Period|Physician Decision|0|||
150025183|NCT03400852|541228450|FG002|Open Label Period|Physician Decision|1|||
150025184|NCT03400852|541228448|FG000|Open Label Period|Study terminated by sponsor|0|||
150025185|NCT03400852|541228449|FG001|Open Label Period|Study terminated by sponsor|0|||
150025186|NCT03400852|541228450|FG002|Open Label Period|Study terminated by sponsor|21|||
150025187|NCT01285401|541228451|FG000|Overall Study|Prematurely withdrawn from the study|17|||
150025188|NCT01285401|541228452|FG001|Overall Study|Prematurely withdrawn from the study|29|||
150025189|NCT02366312|541228453|FG000|Overall Study|Lost to Follow-up|0|||
150025190|NCT02366312|541228454|FG001|Overall Study|Lost to Follow-up|1|||
150025191|NCT03719131|541228456|FG000|Overall Study|Death|1|||
150025192|NCT03719131|541228457|FG001|Overall Study|Death|2|||
150025193|NCT01544920|541228458|FG000|Overall Study|Adverse Event|0|||
150025194|NCT01544920|541228459|FG001|Overall Study|Adverse Event|3|||
150025195|NCT01544920|541228458|FG000|Overall Study|Death|0|||
150025196|NCT01544920|541228459|FG001|Overall Study|Death|1|||
150025197|NCT01544920|541228458|FG000|Overall Study|Lost to Follow-up|11|||
150025198|NCT01544920|541228459|FG001|Overall Study|Lost to Follow-up|12|||
150025199|NCT01544920|541228458|FG000|Overall Study|Protocol Violation|0|||
150025200|NCT01544920|541228459|FG001|Overall Study|Protocol Violation|2|||
150025201|NCT01544920|541228458|FG000|Overall Study|Physician Decision|4|||
150025202|NCT01544920|541228459|FG001|Overall Study|Physician Decision|1|||
150025203|NCT01544920|541228458|FG000|Overall Study|Withdrawal by Subject|4|||
150025204|NCT01544920|541228459|FG001|Overall Study|Withdrawal by Subject|4|||
150025205|NCT03244917|541228465|FG000|Overall Study|Lost to Follow-up|2|||
150025206|NCT03244917|541228466|FG001|Overall Study|Lost to Follow-up|2|||
150025207|NCT01272232|541228467|FG000|Weeks 0-56|Adverse Event|39|||
150025208|NCT01272232|541228468|FG001|Weeks 0-56|Adverse Event|18|||
150025209|NCT01272232|541228469|FG002|Weeks 0-56|Adverse Event|7|||
150025210|NCT01272232|541228467|FG000|Weeks 0-56|Lack of Efficacy|0|||
150025211|NCT01272232|541228468|FG001|Weeks 0-56|Lack of Efficacy|0|||
150025212|NCT01272232|541228469|FG002|Weeks 0-56|Lack of Efficacy|3|||
150025213|NCT01272232|541228467|FG000|Weeks 0-56|Protocol Violation|12|||
150025214|NCT01272232|541228468|FG001|Weeks 0-56|Protocol Violation|8|||
150025215|NCT01272232|541228469|FG002|Weeks 0-56|Protocol Violation|13|||
150025216|NCT01272232|541228467|FG000|Weeks 0-56|Withdrawal criteria|32|||
150181905|NCT03398148|541804601|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
150025217|NCT01272232|541228468|FG001|Weeks 0-56|Withdrawal criteria|14|||
150025218|NCT01272232|541228469|FG002|Weeks 0-56|Withdrawal criteria|37|||
150025219|NCT01272232|541228467|FG000|Weeks 0-56|Unclassified|16|||
150025220|NCT01272232|541228468|FG001|Weeks 0-56|Unclassified|7|||
150025221|NCT01272232|541228469|FG002|Weeks 0-56|Unclassified|12|||
150025222|NCT01272232|541228467|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
150025223|NCT01272232|541228468|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
150025224|NCT01272232|541228469|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
150025225|NCT01272232|541228467|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
150025226|NCT01272232|541228468|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
150025227|NCT01272232|541228469|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
150025228|NCT01272232|541228467|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
150025229|NCT01272232|541228468|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
150025230|NCT01272232|541228469|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
150025231|NCT01272232|541228467|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
150025232|NCT01272232|541228468|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
150025233|NCT01272232|541228469|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
150025234|NCT01272232|541228467|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
150025235|NCT01272232|541228468|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
150025236|NCT01272232|541228469|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
150025237|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
150025238|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
150025239|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
150025240|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025241|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025242|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025243|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025244|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025245|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025246|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025247|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025248|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025249|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
150025250|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025251|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
150025252|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025253|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
150025254|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025255|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025256|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
150025257|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
150025258|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
150025259|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
150025260|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025261|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
150025262|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025263|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025264|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
150025265|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
150025266|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
150025267|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
150025268|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
150025269|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
150025270|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
150025271|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
150025272|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
150025273|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
150025274|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
150025275|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
150025276|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
150025277|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
150025278|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
150025279|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
150025280|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
150025281|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
150025282|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
150025283|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025284|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150063551|NCT00769483|541373619|FG002|Overall Study|Withdrawal by Subject|0|||
150063552|NCT00769483|541373620|FG003|Overall Study|Withdrawal by Subject|0|||
150063553|NCT00769483|541373621|FG004|Overall Study|Withdrawal by Subject|1|||
150063554|NCT00769483|541373622|FG005|Overall Study|Withdrawal by Subject|0|||
150063555|NCT01306877|541373623|FG000|Overall Study|Lost to Follow-up|3|||
150063556|NCT01306877|541373624|FG001|Overall Study|Lost to Follow-up|3|||
150063557|NCT01306877|541373623|FG000|Overall Study|Physician Decision|0|||
150063558|NCT01306877|541373624|FG001|Overall Study|Physician Decision|1|||
150063559|NCT00999921|541373631|FG000|Overall Study|Lost to Follow-up|10|||
150063560|NCT00999921|541373632|FG001|Overall Study|Lost to Follow-up|19|||
150063561|NCT00704808|541373635|FG000|Overall Study|Discontinued prior to starting treatment|14|||
150063562|NCT00704808|541373635|FG000|Overall Study|Death|7|||
150063563|NCT00704808|541373635|FG000|Overall Study|Tumor progression|80|||
150063564|NCT00704808|541373635|FG000|Overall Study|Patient's decision|11|||
150063565|NCT00704808|541373635|FG000|Overall Study|Early therapy discontinuation|16|||
150063566|NCT00704808|541373635|FG000|Overall Study|Adverse Event|1|||
150063567|NCT00704808|541373635|FG000|Overall Study|Lost to Follow-up|1|||
150063568|NCT00704808|541373635|FG000|Overall Study|Treatment change|1|||
150063569|NCT00473746|541373639|FG000|Period 1 (Phase 1)|Adverse Event|1|||
150063570|NCT00473746|541373640|FG001|Period 1 (Phase 1)|Adverse Event|0|||
150063571|NCT00473746|541373641|FG002|Period 1 (Phase 1)|Adverse Event|0|||
150063572|NCT00473746|541373642|FG003|Period 1 (Phase 1)|Adverse Event|0|||
150063573|NCT00473746|541373643|FG004|Period 1 (Phase 1)|Adverse Event|0|||
150063574|NCT00473746|541373639|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
150063575|NCT00473746|541373640|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
150063576|NCT00473746|541373641|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
150063577|NCT00473746|541373642|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
150063578|NCT00473746|541373643|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
150063579|NCT00473746|541373639|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
150063580|NCT00473746|541373640|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
150063581|NCT00473746|541373641|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
150063582|NCT00473746|541373642|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
150063583|NCT00473746|541373643|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
150063584|NCT00473746|541373639|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
150063585|NCT00473746|541373640|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
150063586|NCT00473746|541373641|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
150063587|NCT00473746|541373642|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
150063588|NCT00473746|541373643|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
150063589|NCT00473746|541373639|FG000|Period 1 (Phase 1)|Reason not specified|0|||
150063590|NCT00473746|541373640|FG001|Period 1 (Phase 1)|Reason not specified|1|||
150063591|NCT00473746|541373641|FG002|Period 1 (Phase 1)|Reason not specified|0|||
150063592|NCT00473746|541373642|FG003|Period 1 (Phase 1)|Reason not specified|0|||
150063593|NCT00473746|541373643|FG004|Period 1 (Phase 1)|Reason not specified|0|||
150063594|NCT00473746|541373639|FG000|Period 2 (Phase 2)|Adverse Event|0|||
150063595|NCT00473746|541373640|FG001|Period 2 (Phase 2)|Adverse Event|0|||
150063596|NCT00473746|541373641|FG002|Period 2 (Phase 2)|Adverse Event|0|||
150063597|NCT00473746|541373642|FG003|Period 2 (Phase 2)|Adverse Event|0|||
150063598|NCT00473746|541373643|FG004|Period 2 (Phase 2)|Adverse Event|3|||
150063599|NCT00473746|541373639|FG000|Period 2 (Phase 2)|Death|0|||
150063600|NCT00473746|541373640|FG001|Period 2 (Phase 2)|Death|0|||
150063601|NCT00473746|541373641|FG002|Period 2 (Phase 2)|Death|0|||
150063602|NCT00473746|541373642|FG003|Period 2 (Phase 2)|Death|0|||
150063603|NCT00473746|541373643|FG004|Period 2 (Phase 2)|Death|1|||
150063604|NCT00473746|541373639|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
150063605|NCT00473746|541373640|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
150063606|NCT00473746|541373641|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
150063607|NCT00473746|541373642|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
150063608|NCT00473746|541373643|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
150063609|NCT00473746|541373639|FG000|Period 2 (Phase 2)|Reason not specified|0|||
150181906|NCT03398148|541804602|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
150063610|NCT00473746|541373640|FG001|Period 2 (Phase 2)|Reason not specified|0|||
150063611|NCT00473746|541373641|FG002|Period 2 (Phase 2)|Reason not specified|0|||
150181907|NCT03398148|541804603|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
150063612|NCT00473746|541373642|FG003|Period 2 (Phase 2)|Reason not specified|0|||
150181908|NCT03398148|541804604|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
150063613|NCT00473746|541373643|FG004|Period 2 (Phase 2)|Reason not specified|3|||
150063614|NCT01962922|541373644|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
150063615|NCT01962922|541373645|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
150063616|NCT01962922|541373644|FG000|PK Portion Day 7|non-compliance|1|||
150063617|NCT01962922|541373645|FG001|PK Portion Day 7|non-compliance|0|||
150063618|NCT01962922|541373644|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
150063619|NCT01962922|541373645|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
150063620|NCT01962922|541373644|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
150063621|NCT01962922|541373645|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
150063622|NCT00744471|541373646|FG000|Overall Study|Randomized but not treated|1|||
150063623|NCT00744471|541373647|FG001|Overall Study|Randomized but not treated|1|||
150063624|NCT00744471|541373648|FG002|Overall Study|Randomized but not treated|4|||
150063625|NCT00744471|541373649|FG003|Overall Study|Randomized but not treated|0|||
150063626|NCT00744471|541373646|FG000|Overall Study|Death|0|||
150063627|NCT00744471|541373647|FG001|Overall Study|Death|0|||
150063628|NCT00744471|541373648|FG002|Overall Study|Death|0|||
150063629|NCT00744471|541373649|FG003|Overall Study|Death|1|||
150063630|NCT00744471|541373646|FG000|Overall Study|Adverse Event|6|||
150063631|NCT00744471|541373647|FG001|Overall Study|Adverse Event|7|||
150063632|NCT00744471|541373648|FG002|Overall Study|Adverse Event|5|||
150063633|NCT00744471|541373649|FG003|Overall Study|Adverse Event|9|||
150063634|NCT00744471|541373646|FG000|Overall Study|Withdrawal by Subject|9|||
150063635|NCT00744471|541373647|FG001|Overall Study|Withdrawal by Subject|9|||
150063636|NCT00744471|541373648|FG002|Overall Study|Withdrawal by Subject|15|||
150063637|NCT00744471|541373649|FG003|Overall Study|Withdrawal by Subject|12|||
150063638|NCT00744471|541373646|FG000|Overall Study|Protocol Violation|1|||
150063639|NCT00744471|541373647|FG001|Overall Study|Protocol Violation|4|||
150063640|NCT00744471|541373648|FG002|Overall Study|Protocol Violation|1|||
150063641|NCT00744471|541373649|FG003|Overall Study|Protocol Violation|2|||
150063642|NCT00744471|541373646|FG000|Overall Study|Entered extension study|41|||
150063643|NCT00744471|541373647|FG001|Overall Study|Entered extension study|84|||
150063644|NCT00744471|541373648|FG002|Overall Study|Entered extension study|100|||
150063645|NCT00744471|541373649|FG003|Overall Study|Entered extension study|91|||
150063646|NCT00744471|541373646|FG000|Overall Study|Other|2|||
150063647|NCT00744471|541373647|FG001|Overall Study|Other|3|||
150063648|NCT00744471|541373648|FG002|Overall Study|Other|6|||
150063649|NCT00744471|541373649|FG003|Overall Study|Other|2|||
150063650|NCT00744471|541373646|FG000|Overall Study|Lack of Efficacy|83|||
150063651|NCT00744471|541373647|FG001|Overall Study|Lack of Efficacy|37|||
150063652|NCT00744471|541373648|FG002|Overall Study|Lack of Efficacy|19|||
150063653|NCT00744471|541373649|FG003|Overall Study|Lack of Efficacy|31|||
150063654|NCT00744471|541373646|FG000|Overall Study|Lost to Follow-up|0|||
150063655|NCT00744471|541373647|FG001|Overall Study|Lost to Follow-up|0|||
150063656|NCT00744471|541373648|FG002|Overall Study|Lost to Follow-up|2|||
150063657|NCT00744471|541373649|FG003|Overall Study|Lost to Follow-up|0|||
150063658|NCT03224546|541373650|FG000|Overall Study|Lost to Follow-up|9|||
150063659|NCT03224546|541373651|FG001|Overall Study|Lost to Follow-up|8|||
150063660|NCT03224546|541373652|FG002|Overall Study|Lost to Follow-up|3|||
150063661|NCT03224546|541373650|FG000|Overall Study|Withdrawal by Subject|7|||
150063662|NCT03224546|541373651|FG001|Overall Study|Withdrawal by Subject|14|||
150063663|NCT03224546|541373652|FG002|Overall Study|Withdrawal by Subject|12|||
150063664|NCT04706416|541373653|FG000|Overall Study|Lost to Follow-up|2|||
150063665|NCT04706416|541373654|FG001|Overall Study|Lost to Follow-up|0|||
150063666|NCT00976573|541373662|FG000|Overall Study|Ineligible|0|||
150063667|NCT00976573|541373663|FG001|Overall Study|Ineligible|1|||
150063668|NCT00976573|541373662|FG000|Overall Study|Cancel prior to receiving treatment|4|||
150063669|NCT00976573|541373663|FG001|Overall Study|Cancel prior to receiving treatment|2|||
150063670|NCT02117427|541373664|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
150063671|NCT02117427|541373665|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
150063672|NCT02117427|541373666|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
150063673|NCT02117427|541373664|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
150063674|NCT02117427|541373665|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
150063675|NCT02117427|541373666|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
150063676|NCT02117427|541373664|FG000|Overall Study|Physician Decision|0|||
150063677|NCT02117427|541373665|FG001|Overall Study|Physician Decision|2|||
150063678|NCT02117427|541373666|FG002|Overall Study|Physician Decision|0|||
150063679|NCT02117427|541373664|FG000|Overall Study|No longer meets inclusion criteria|0|||
150063680|NCT02117427|541373665|FG001|Overall Study|No longer meets inclusion criteria|1|||
150063681|NCT02117427|541373666|FG002|Overall Study|No longer meets inclusion criteria|0|||
150063682|NCT02117427|541373664|FG000|Overall Study|Death|0|||
150063683|NCT02117427|541373665|FG001|Overall Study|Death|1|||
150063684|NCT02117427|541373666|FG002|Overall Study|Death|0|||
150063685|NCT02730208|541373667|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
150063686|NCT02730208|541373668|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
150063687|NCT00055471|541373669|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
150063688|NCT00055471|541373670|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
150063689|NCT00055471|541373671|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
150063690|NCT00055471|541373669|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
150063691|NCT00055471|541373670|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
150063692|NCT00055471|541373671|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
150063693|NCT00055471|541373669|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
150063694|NCT00055471|541373670|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
150063695|NCT00055471|541373671|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
150063696|NCT03437512|541375273|FG000|Randomized|Withdrawal by Subject|0|||
150063697|NCT03437512|541375274|FG001|Randomized|Withdrawal by Subject|2|||
150063698|NCT03437512|541375273|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
150063699|NCT03437512|541375274|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
150063700|NCT01897714|541375275|FG000|Phase I (Dose Escalation)|Disease progression|3|||
150063701|NCT01897714|541375276|FG001|Phase I (Dose Escalation)|Disease progression|5|||
150063702|NCT01897714|541375277|FG002|Phase I (Dose Escalation)|Disease progression|1|||
150063703|NCT01897714|541375278|FG003|Phase I (Dose Escalation)|Disease progression|3|||
150063704|NCT01897714|541375279|FG004|Phase I (Dose Escalation)|Disease progression|0|||
150063705|NCT01897714|541375280|FG005|Phase I (Dose Escalation)|Disease progression|0|||
150063706|NCT01897714|541375275|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
150063707|NCT01897714|541375276|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
150063708|NCT01897714|541375277|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
150063709|NCT01897714|541375278|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
150063710|NCT01897714|541375279|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
150063711|NCT01897714|541375280|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
150063712|NCT01897714|541375275|FG000|Phase I (Dose Escalation)|Other|0|||
150063713|NCT01897714|541375276|FG001|Phase I (Dose Escalation)|Other|1|||
150063714|NCT01897714|541375277|FG002|Phase I (Dose Escalation)|Other|0|||
150063715|NCT01897714|541375278|FG003|Phase I (Dose Escalation)|Other|0|||
150063716|NCT01897714|541375279|FG004|Phase I (Dose Escalation)|Other|0|||
150063717|NCT01897714|541375280|FG005|Phase I (Dose Escalation)|Other|0|||
150063718|NCT01897714|541375275|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
150063719|NCT01897714|541375276|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
150063720|NCT01897714|541375277|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
150063721|NCT01897714|541375278|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
150063722|NCT01897714|541375279|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
150063723|NCT01897714|541375280|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
150063724|NCT01897714|541375275|FG000|Phase II (MTD)|Lost to Follow-up|0|||
150063725|NCT01897714|541375276|FG001|Phase II (MTD)|Lost to Follow-up|0|||
150063726|NCT01897714|541375277|FG002|Phase II (MTD)|Lost to Follow-up|0|||
150063727|NCT01897714|541375278|FG003|Phase II (MTD)|Lost to Follow-up|0|||
150063728|NCT01897714|541375279|FG004|Phase II (MTD)|Lost to Follow-up|1|||
150063729|NCT01897714|541375280|FG005|Phase II (MTD)|Lost to Follow-up|0|||
150063730|NCT01897714|541375275|FG000|Phase II (MTD)|Death|0|||
150063731|NCT01897714|541375276|FG001|Phase II (MTD)|Death|0|||
150063732|NCT01897714|541375277|FG002|Phase II (MTD)|Death|0|||
150063733|NCT01897714|541375278|FG003|Phase II (MTD)|Death|0|||
150063734|NCT01897714|541375279|FG004|Phase II (MTD)|Death|25|||
150063735|NCT01897714|541375280|FG005|Phase II (MTD)|Death|10|||
150063736|NCT01897714|541375275|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
150063737|NCT01897714|541375276|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
150063738|NCT01897714|541375277|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
150063739|NCT01897714|541375278|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
150063740|NCT01897714|541375279|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
150063741|NCT01897714|541375280|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
150063742|NCT01897714|541375275|FG000|Phase II (MTD)|Other|0|||
150063743|NCT01897714|541375276|FG001|Phase II (MTD)|Other|0|||
150063744|NCT01897714|541375277|FG002|Phase II (MTD)|Other|0|||
150063745|NCT01897714|541375278|FG003|Phase II (MTD)|Other|0|||
150063746|NCT01897714|541375279|FG004|Phase II (MTD)|Other|3|||
150063747|NCT01897714|541375280|FG005|Phase II (MTD)|Other|0|||
150063748|NCT01801072|541375281|FG000|Overall Study|Lost to Follow-up|17|||
150063749|NCT01801072|541375282|FG001|Overall Study|Lost to Follow-up|14|||
150063750|NCT01801072|541375281|FG000|Overall Study|Physician Decision|2|||
150063751|NCT01801072|541375282|FG001|Overall Study|Physician Decision|3|||
150063752|NCT01801072|541375281|FG000|Overall Study|Withdrawal by Subject|1|||
150063753|NCT01801072|541375282|FG001|Overall Study|Withdrawal by Subject|0|||
150063754|NCT01801072|541375281|FG000|Overall Study|Protocol Violation|2|||
150063755|NCT01801072|541375282|FG001|Overall Study|Protocol Violation|0|||
150063756|NCT01801072|541375281|FG000|Overall Study|Death|7|||
150063757|NCT01801072|541375282|FG001|Overall Study|Death|8|||
150063758|NCT03693170|541375283|FG000|Overall Study|Disease Progression|48|||
150063759|NCT03693170|541375283|FG000|Overall Study|Adverse Event|16|||
150063760|NCT03693170|541375283|FG000|Overall Study|Physician Decision|6|||
150063761|NCT03693170|541375283|FG000|Overall Study|Protocol Violation|2|||
150063762|NCT03693170|541375283|FG000|Overall Study|Death|1|||
150063763|NCT03693170|541375283|FG000|Overall Study|Non compliance with study drug|1|||
150063764|NCT03693170|541375283|FG000|Overall Study|Withdrawal by Subject|1|||
150063765|NCT03581786|541375284|FG000|Overall Study|Death|67|||
150063766|NCT03581786|541375285|FG001|Overall Study|Death|47|||
150063767|NCT03581786|541375284|FG000|Overall Study|Withdrawal by Subject|2|||
150063768|NCT03581786|541375285|FG001|Overall Study|Withdrawal by Subject|5|||
150063769|NCT03581786|541375284|FG000|Overall Study|Lost to Follow-up|7|||
150063770|NCT03581786|541375285|FG001|Overall Study|Lost to Follow-up|4|||
150063771|NCT03581786|541375284|FG000|Overall Study|reason other than specified above|0|||
150063772|NCT03581786|541375285|FG001|Overall Study|reason other than specified above|1|||
150063773|NCT00510874|541375286|FG000|Overall Study|Withdrawal by Subject|1|||
150063774|NCT00510874|541375287|FG001|Overall Study|Withdrawal by Subject|1|||
150063775|NCT00510874|541375288|FG002|Overall Study|Withdrawal by Subject|0|||
150063776|NCT00510874|541375289|FG003|Overall Study|Withdrawal by Subject|0|||
150063777|NCT00510874|541375290|FG004|Overall Study|Withdrawal by Subject|3|||
150063778|NCT00510874|541375291|FG005|Overall Study|Withdrawal by Subject|0|||
150063779|NCT00510874|541375292|FG006|Overall Study|Withdrawal by Subject|0|||
150063780|NCT00510874|541375286|FG000|Overall Study|Lost to Follow-up|2|||
150063781|NCT00510874|541375287|FG001|Overall Study|Lost to Follow-up|3|||
150063782|NCT00510874|541375288|FG002|Overall Study|Lost to Follow-up|1|||
150063783|NCT00510874|541375289|FG003|Overall Study|Lost to Follow-up|3|||
150063784|NCT00510874|541375290|FG004|Overall Study|Lost to Follow-up|4|||
150063785|NCT00510874|541375291|FG005|Overall Study|Lost to Follow-up|0|||
150063786|NCT00510874|541375292|FG006|Overall Study|Lost to Follow-up|1|||
150063787|NCT00721123|541375298|FG000|Overall Study|Adverse Event|96|||
150063788|NCT00721123|541375298|FG000|Overall Study|Death|10|||
150063789|NCT00721123|541375298|FG000|Overall Study|Insufficient Therapeutic Response|21|||
150063790|NCT00721123|541375298|FG000|Overall Study|Protocol Violation|1|||
150063791|NCT00721123|541375298|FG000|Overall Study|Refused Treatment|41|||
150063792|NCT00721123|541375298|FG000|Overall Study|Failure to Return|9|||
150063793|NCT00721123|541375298|FG000|Overall Study|Withdrawal by Subject|5|||
150063794|NCT00397943|541375299|FG000|Overall Study|Unspecified reasons|12|||
150063795|NCT00397943|541375300|FG001|Overall Study|Unspecified reasons|9|||
150063796|NCT00397943|541375301|FG002|Overall Study|Unspecified reasons|0|||
150063797|NCT00397943|541375302|FG003|Overall Study|Unspecified reasons|0|||
150063798|NCT00397943|541375303|FG004|Overall Study|Unspecified reasons|0|||
150063799|NCT02806973|541375306|FG000|Period 1|Withdrawal by Subject|0|||
150063800|NCT02806973|541375307|FG001|Period 1|Withdrawal by Subject|2|||
150063801|NCT02806973|541375308|FG002|Period 1|Withdrawal by Subject|1|||
150063802|NCT02806973|541375309|FG003|Period 1|Withdrawal by Subject|1|||
150063803|NCT02806973|541375306|FG000|Period 1|Adverse Event|0|||
150063804|NCT02806973|541375307|FG001|Period 1|Adverse Event|0|||
150063805|NCT02806973|541375308|FG002|Period 1|Adverse Event|0|||
150063806|NCT02806973|541375309|FG003|Period 1|Adverse Event|1|||
150063807|NCT02806973|541375306|FG000|Period 3|Withdrawal by Subject|0|||
150063808|NCT02806973|541375307|FG001|Period 3|Withdrawal by Subject|0|||
150063809|NCT02806973|541375308|FG002|Period 3|Withdrawal by Subject|0|||
150063810|NCT02806973|541375309|FG003|Period 3|Withdrawal by Subject|3|||
150063811|NCT02806973|541375306|FG000|Period 3|Adverse Event|0|||
150063812|NCT02806973|541375307|FG001|Period 3|Adverse Event|0|||
150063813|NCT02806973|541375308|FG002|Period 3|Adverse Event|1|||
150063814|NCT02806973|541375309|FG003|Period 3|Adverse Event|0|||
150063815|NCT04209426|541375312|FG000|Overall Study|Lost to Follow-up|3|||
150063816|NCT04209426|541375313|FG001|Overall Study|Lost to Follow-up|2|||
150063817|NCT00423670|541375317|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
150063818|NCT00423670|541375318|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063819|NCT00423670|541375319|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063820|NCT00423670|541375320|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063821|NCT00423670|541375321|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063822|NCT00423670|541375322|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063823|NCT00423670|541375323|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063824|NCT00423670|541375324|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
150063825|NCT00423670|541375317|FG000|Treatment Period|Adverse Event|8|||
150063826|NCT00423670|541375318|FG001|Treatment Period|Adverse Event|12|||
150063827|NCT00423670|541375319|FG002|Treatment Period|Adverse Event|15|||
150063828|NCT00423670|541375320|FG003|Treatment Period|Adverse Event|20|||
150063829|NCT00423670|541375321|FG004|Treatment Period|Adverse Event|9|||
150063830|NCT00423670|541375322|FG005|Treatment Period|Adverse Event|4|||
150063831|NCT00423670|541375323|FG006|Treatment Period|Adverse Event|7|||
150063832|NCT00423670|541375324|FG007|Treatment Period|Adverse Event|2|||
150063833|NCT00423670|541375317|FG000|Treatment Period|Protocol-defined clinical event|0|||
150063834|NCT00423670|541375318|FG001|Treatment Period|Protocol-defined clinical event|7|||
150063835|NCT00423670|541375319|FG002|Treatment Period|Protocol-defined clinical event|4|||
150063836|NCT00423670|541375320|FG003|Treatment Period|Protocol-defined clinical event|12|||
150063837|NCT00423670|541375321|FG004|Treatment Period|Protocol-defined clinical event|5|||
150063838|NCT00423670|541375322|FG005|Treatment Period|Protocol-defined clinical event|4|||
150063839|NCT00423670|541375323|FG006|Treatment Period|Protocol-defined clinical event|16|||
150063840|NCT00423670|541375324|FG007|Treatment Period|Protocol-defined clinical event|15|||
150063841|NCT00423670|541375317|FG000|Treatment Period|Lost to Follow-up|2|||
150063842|NCT00423670|541375318|FG001|Treatment Period|Lost to Follow-up|1|||
150063843|NCT00423670|541375319|FG002|Treatment Period|Lost to Follow-up|3|||
150063844|NCT00423670|541375320|FG003|Treatment Period|Lost to Follow-up|1|||
150063845|NCT00423670|541375321|FG004|Treatment Period|Lost to Follow-up|6|||
150063846|NCT00423670|541375322|FG005|Treatment Period|Lost to Follow-up|0|||
150063847|NCT00423670|541375323|FG006|Treatment Period|Lost to Follow-up|3|||
150063848|NCT00423670|541375324|FG007|Treatment Period|Lost to Follow-up|1|||
150063849|NCT00423670|541375317|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
150063850|NCT00423670|541375318|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
150063851|NCT00423670|541375319|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
150063852|NCT00423670|541375320|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
150063853|NCT00423670|541375321|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
150063854|NCT00423670|541375322|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
150063855|NCT00423670|541375323|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
150063856|NCT00423670|541375324|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
150063857|NCT00423670|541375317|FG000|Treatment Period|Investigator decision|0|||
150063858|NCT00423670|541375318|FG001|Treatment Period|Investigator decision|0|||
150063859|NCT00423670|541375319|FG002|Treatment Period|Investigator decision|0|||
150063860|NCT00423670|541375320|FG003|Treatment Period|Investigator decision|0|||
150063861|NCT00423670|541375321|FG004|Treatment Period|Investigator decision|0|||
150063862|NCT00423670|541375322|FG005|Treatment Period|Investigator decision|0|||
150063863|NCT00423670|541375323|FG006|Treatment Period|Investigator decision|0|||
150063864|NCT00423670|541375324|FG007|Treatment Period|Investigator decision|1|||
150063865|NCT00423670|541375317|FG000|Treatment Period|Non-compliance with protocol|3|||
150063866|NCT00423670|541375318|FG001|Treatment Period|Non-compliance with protocol|1|||
150063867|NCT00423670|541375319|FG002|Treatment Period|Non-compliance with protocol|1|||
150063868|NCT00423670|541375320|FG003|Treatment Period|Non-compliance with protocol|3|||
150063869|NCT00423670|541375321|FG004|Treatment Period|Non-compliance with protocol|2|||
150063870|NCT00423670|541375322|FG005|Treatment Period|Non-compliance with protocol|0|||
150063871|NCT00423670|541375323|FG006|Treatment Period|Non-compliance with protocol|2|||
150063872|NCT00423670|541375324|FG007|Treatment Period|Non-compliance with protocol|2|||
150063873|NCT00423670|541375317|FG000|Follow-up Period|Lost to Follow-up|0|||
150063874|NCT00423670|541375318|FG001|Follow-up Period|Lost to Follow-up|12|||
150063875|NCT00423670|541375319|FG002|Follow-up Period|Lost to Follow-up|8|||
150063876|NCT00423670|541375320|FG003|Follow-up Period|Lost to Follow-up|3|||
150063877|NCT00423670|541375321|FG004|Follow-up Period|Lost to Follow-up|1|||
150063878|NCT00423670|541375322|FG005|Follow-up Period|Lost to Follow-up|0|||
150063879|NCT00423670|541375323|FG006|Follow-up Period|Lost to Follow-up|5|||
150063880|NCT00423670|541375324|FG007|Follow-up Period|Lost to Follow-up|0|||
150063881|NCT00423670|541375317|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
150063882|NCT00423670|541375318|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
150063883|NCT00423670|541375319|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
150063884|NCT00423670|541375320|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
150063885|NCT00423670|541375321|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
150063886|NCT00423670|541375322|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
150063887|NCT00423670|541375323|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
150063888|NCT00423670|541375324|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
150063889|NCT00423670|541375317|FG000|Follow-up Period|Non-compliance with protocol|2|||
150063890|NCT00423670|541375318|FG001|Follow-up Period|Non-compliance with protocol|0|||
150063891|NCT00423670|541375319|FG002|Follow-up Period|Non-compliance with protocol|1|||
150063892|NCT00423670|541375320|FG003|Follow-up Period|Non-compliance with protocol|1|||
150063893|NCT00423670|541375321|FG004|Follow-up Period|Non-compliance with protocol|0|||
150063894|NCT00423670|541375322|FG005|Follow-up Period|Non-compliance with protocol|0|||
150063895|NCT00423670|541375323|FG006|Follow-up Period|Non-compliance with protocol|3|||
150063896|NCT00423670|541375324|FG007|Follow-up Period|Non-compliance with protocol|2|||
150025285|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
150025286|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025287|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025288|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025289|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025290|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025291|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025292|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
150025293|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025294|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025295|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025296|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
150025297|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025298|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025299|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025300|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025301|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025302|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025303|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025304|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025305|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025306|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025307|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025308|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025309|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025310|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
150025311|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
150025312|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025313|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025314|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025315|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
150025316|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025317|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025318|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025319|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025320|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025321|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025322|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
150025323|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025324|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025325|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025326|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
150025327|NCT01147666|541228470|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025328|NCT01147666|541228471|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025329|NCT01147666|541228472|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025330|NCT01147666|541228473|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025331|NCT01147666|541228474|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025332|NCT01147666|541228475|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025333|NCT01147666|541228476|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025334|NCT01147666|541228477|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025335|NCT01147666|541228478|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025336|NCT01147666|541228479|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025337|NCT01147666|541228480|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025338|NCT01147666|541228481|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
150025339|NCT01147666|541228482|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
150025340|NCT01147666|541228483|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
150025341|NCT01147666|541228484|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
150063897|NCT00900601|541375325|FG000|Overall Study|Physician Decision|1|||
150063898|NCT01052844|541375330|FG000|Overall Study|Adverse Event|0|||
150063899|NCT01052844|541375331|FG001|Overall Study|Adverse Event|1|||
150063900|NCT01241240|541375332|FG000|Overall Study|Adverse Event|5|||
150063901|NCT01241240|541375333|FG001|Overall Study|Adverse Event|4|||
150063902|NCT01241240|541375332|FG000|Overall Study|Lost to Follow-up|2|||
150063903|NCT01241240|541375333|FG001|Overall Study|Lost to Follow-up|4|||
150063904|NCT01241240|541375332|FG000|Overall Study|Personal Reasons|1|||
150063905|NCT01241240|541375333|FG001|Overall Study|Personal Reasons|1|||
150063906|NCT01466595|541375334|FG000|Overall Study|Withdrawal by Subject|0|||
150063907|NCT01466595|541375335|FG001|Overall Study|Withdrawal by Subject|1|||
150063908|NCT02376829|541375338|FG000|Overall Study|Withdrawal by Subject|27|||
150063909|NCT02376829|541375339|FG001|Overall Study|Withdrawal by Subject|44|||
150063910|NCT01439347|541375340|FG000|Overall Study|Death|10|||
150063911|NCT01439347|541375341|FG001|Overall Study|Death|9|||
150063912|NCT01439347|541375340|FG000|Overall Study|Withdrawal by Subject|0|||
150063913|NCT01439347|541375341|FG001|Overall Study|Withdrawal by Subject|1|||
150063914|NCT01439347|541375340|FG000|Overall Study|Physician Decision|1|||
150063915|NCT01439347|541375341|FG001|Overall Study|Physician Decision|0|||
150063916|NCT01439347|541375340|FG000|Overall Study|Sponsor Terminated Study|2|||
150063917|NCT01439347|541375341|FG001|Overall Study|Sponsor Terminated Study|3|||
150063918|NCT02325791|541375345|FG000|Overall Study|Adverse Event|0|||
150063919|NCT02325791|541375346|FG001|Overall Study|Adverse Event|1|||
150063920|NCT02325791|541375347|FG002|Overall Study|Adverse Event|1|||
150063921|NCT02325791|541375348|FG003|Overall Study|Adverse Event|0|||
150063922|NCT02325791|541375345|FG000|Overall Study|Death|0|||
150063923|NCT02325791|541375346|FG001|Overall Study|Death|3|||
150063924|NCT02325791|541375347|FG002|Overall Study|Death|0|||
150181909|NCT03398148|541804605|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
150181910|NCT03398148|541804606|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
150181911|NCT03398148|541804607|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
150181912|NCT03398148|541804608|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
150181913|NCT03398148|541804609|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
150181914|NCT03398148|541804610|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
150181915|NCT03398148|541804596|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181916|NCT03398148|541804597|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181917|NCT03398148|541804598|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181918|NCT03398148|541804599|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181919|NCT03398148|541804600|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181920|NCT03398148|541804601|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181921|NCT03398148|541804602|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
150181922|NCT03398148|541804603|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181923|NCT03398148|541804604|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181924|NCT03398148|541804605|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181925|NCT03398148|541804606|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181926|NCT03398148|541804607|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181927|NCT03398148|541804608|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181928|NCT03398148|541804609|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181929|NCT03398148|541804610|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150181930|NCT03398148|541804596|FG000|Substudy 1 Period 2|Other|0|||
150181931|NCT03398148|541804597|FG001|Substudy 1 Period 2|Other|0|||
150181932|NCT03398148|541804598|FG002|Substudy 1 Period 2|Other|0|||
150181933|NCT03398148|541804599|FG003|Substudy 1 Period 2|Other|0|||
150181934|NCT03398148|541804600|FG004|Substudy 1 Period 2|Other|0|||
150181935|NCT03398148|541804601|FG005|Substudy 1 Period 2|Other|0|||
150181936|NCT03398148|541804602|FG006|Substudy 1 Period 2|Other|1|||
150181937|NCT03398148|541804603|FG007|Substudy 1 Period 2|Other|0|||
150181938|NCT03398148|541804604|FG008|Substudy 1 Period 2|Other|0|||
150181939|NCT03398148|541804605|FG009|Substudy 1 Period 2|Other|0|||
150181940|NCT03398148|541804606|FG010|Substudy 1 Period 2|Other|0|||
150181941|NCT03398148|541804607|FG011|Substudy 1 Period 2|Other|0|||
150181942|NCT03398148|541804608|FG012|Substudy 1 Period 2|Other|0|||
150181943|NCT03398148|541804609|FG013|Substudy 1 Period 2|Other|0|||
150181944|NCT03398148|541804610|FG014|Substudy 1 Period 2|Other|0|||
150181945|NCT03398148|541804596|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181946|NCT03398148|541804597|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181947|NCT03398148|541804598|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181948|NCT03398148|541804599|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181949|NCT03398148|541804600|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
150063925|NCT02325791|541375348|FG003|Overall Study|Death|1|||
150063926|NCT02325791|541375345|FG000|Overall Study|Lost to Follow-up|0|||
150063927|NCT02325791|541375346|FG001|Overall Study|Lost to Follow-up|15|||
150063928|NCT02325791|541375347|FG002|Overall Study|Lost to Follow-up|14|||
150063929|NCT02325791|541375348|FG003|Overall Study|Lost to Follow-up|9|||
150063930|NCT02325791|541375345|FG000|Overall Study|Physician Decision|0|||
150063931|NCT02325791|541375346|FG001|Overall Study|Physician Decision|1|||
150063932|NCT02325791|541375347|FG002|Overall Study|Physician Decision|1|||
150181950|NCT03398148|541804601|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181951|NCT03398148|541804602|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
150181952|NCT03398148|541804603|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181953|NCT03398148|541804604|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181954|NCT03398148|541804605|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
150025342|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
150063933|NCT02325791|541375348|FG003|Overall Study|Physician Decision|0|||
150063934|NCT02325791|541375345|FG000|Overall Study|Protocol Violation|0|||
150063935|NCT02325791|541375346|FG001|Overall Study|Protocol Violation|0|||
150063936|NCT02325791|541375347|FG002|Overall Study|Protocol Violation|1|||
150063937|NCT02325791|541375348|FG003|Overall Study|Protocol Violation|0|||
150063938|NCT02325791|541375345|FG000|Overall Study|Withdrawal by Subject|0|||
150063939|NCT02325791|541375346|FG001|Overall Study|Withdrawal by Subject|5|||
150063940|NCT02325791|541375347|FG002|Overall Study|Withdrawal by Subject|8|||
150063941|NCT02325791|541375348|FG003|Overall Study|Withdrawal by Subject|16|||
150063942|NCT01298193|541375349|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
150063943|NCT01298193|541375349|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
150063944|NCT01298193|541375349|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
150063945|NCT01298193|541375349|FG000|Efficacy Phase (Second Cycle)|Death|1|||
150063946|NCT00107952|541375350|FG000|Overall Study|Death|75|||
150063947|NCT00107952|541375351|FG001|Overall Study|Death|61|||
150063948|NCT00107952|541375350|FG000|Overall Study|Lost to Follow-up|0|||
150063949|NCT00107952|541375351|FG001|Overall Study|Lost to Follow-up|3|||
150063950|NCT00107952|541375350|FG000|Overall Study|Withdrawal by Subject|9|||
150063951|NCT00107952|541375351|FG001|Overall Study|Withdrawal by Subject|6|||
150063952|NCT00107952|541375350|FG000|Overall Study|Other|2|||
150063953|NCT00107952|541375351|FG001|Overall Study|Other|5|||
150063954|NCT00107952|541375350|FG000|Overall Study|Never received study treatment|9|||
150063955|NCT00107952|541375351|FG001|Overall Study|Never received study treatment|6|||
150063956|NCT01975831|541375352|FG000|Overall Study|Adverse Event|1|||
150063957|NCT01975831|541375353|FG001|Overall Study|Adverse Event|2|||
150063958|NCT01975831|541375354|FG002|Overall Study|Adverse Event|2|||
150063959|NCT01975831|541375355|FG003|Overall Study|Adverse Event|0|||
150063960|NCT01975831|541375356|FG004|Overall Study|Adverse Event|1|||
150063961|NCT01975831|541375357|FG005|Overall Study|Adverse Event|1|||
150063962|NCT01975831|541375358|FG006|Overall Study|Adverse Event|3|||
150063963|NCT01975831|541375359|FG007|Overall Study|Adverse Event|4|||
150063964|NCT01975831|541375360|FG008|Overall Study|Adverse Event|1|||
150063965|NCT01975831|541375352|FG000|Overall Study|Death|1|||
150063966|NCT01975831|541375353|FG001|Overall Study|Death|1|||
150063967|NCT01975831|541375354|FG002|Overall Study|Death|0|||
150063968|NCT01975831|541375355|FG003|Overall Study|Death|0|||
150063969|NCT01975831|541375356|FG004|Overall Study|Death|1|||
150063970|NCT01975831|541375357|FG005|Overall Study|Death|0|||
150063971|NCT01975831|541375358|FG006|Overall Study|Death|1|||
150063972|NCT01975831|541375359|FG007|Overall Study|Death|0|||
150063973|NCT01975831|541375360|FG008|Overall Study|Death|0|||
150063974|NCT01975831|541375352|FG000|Overall Study|Progressive Disease|1|||
150063975|NCT01975831|541375353|FG001|Overall Study|Progressive Disease|3|||
150063976|NCT01975831|541375354|FG002|Overall Study|Progressive Disease|2|||
150063977|NCT01975831|541375355|FG003|Overall Study|Progressive Disease|4|||
150063978|NCT01975831|541375356|FG004|Overall Study|Progressive Disease|13|||
150025343|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
150025344|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
150025345|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
150025346|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
150025347|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
150025348|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
150025349|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
150025350|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
150025351|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
150025352|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
150025353|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
150025354|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
150025355|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
150063979|NCT01975831|541375357|FG005|Overall Study|Progressive Disease|9|||
150063980|NCT01975831|541375358|FG006|Overall Study|Progressive Disease|10|||
150063981|NCT01975831|541375359|FG007|Overall Study|Progressive Disease|8|||
150063982|NCT01975831|541375360|FG008|Overall Study|Progressive Disease|10|||
150063983|NCT01975831|541375352|FG000|Overall Study|Withdrawal by Subject|0|||
150063984|NCT01975831|541375353|FG001|Overall Study|Withdrawal by Subject|3|||
150063985|NCT01975831|541375354|FG002|Overall Study|Withdrawal by Subject|0|||
150063986|NCT01975831|541375355|FG003|Overall Study|Withdrawal by Subject|0|||
150063987|NCT01975831|541375356|FG004|Overall Study|Withdrawal by Subject|3|||
150063988|NCT01975831|541375357|FG005|Overall Study|Withdrawal by Subject|1|||
150063989|NCT01975831|541375358|FG006|Overall Study|Withdrawal by Subject|1|||
150063990|NCT01975831|541375359|FG007|Overall Study|Withdrawal by Subject|0|||
150063991|NCT01975831|541375360|FG008|Overall Study|Withdrawal by Subject|0|||
150063992|NCT01975831|541375352|FG000|Overall Study|Physician Decision|0|||
150063993|NCT01975831|541375353|FG001|Overall Study|Physician Decision|0|||
150063994|NCT01975831|541375354|FG002|Overall Study|Physician Decision|0|||
150063995|NCT01975831|541375355|FG003|Overall Study|Physician Decision|0|||
150063996|NCT01975831|541375356|FG004|Overall Study|Physician Decision|0|||
150063997|NCT01975831|541375357|FG005|Overall Study|Physician Decision|1|||
150063998|NCT01975831|541375358|FG006|Overall Study|Physician Decision|0|||
150063999|NCT01975831|541375359|FG007|Overall Study|Physician Decision|1|||
150064000|NCT01975831|541375360|FG008|Overall Study|Physician Decision|0|||
150064001|NCT01975831|541375352|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
150064002|NCT01975831|541375353|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
150064003|NCT01975831|541375354|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
150064004|NCT01975831|541375355|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
150064005|NCT01975831|541375356|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
150064006|NCT01975831|541375357|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
150064007|NCT01975831|541375358|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
150064008|NCT01975831|541375359|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
150064009|NCT01975831|541375360|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
150064010|NCT01975831|541375352|FG000|Overall Study|Entered Hospice|0|||
150064011|NCT01975831|541375353|FG001|Overall Study|Entered Hospice|0|||
150064012|NCT01975831|541375354|FG002|Overall Study|Entered Hospice|0|||
150064013|NCT01975831|541375355|FG003|Overall Study|Entered Hospice|0|||
150064014|NCT01975831|541375356|FG004|Overall Study|Entered Hospice|0|||
150064015|NCT01975831|541375357|FG005|Overall Study|Entered Hospice|1|||
150064016|NCT01975831|541375358|FG006|Overall Study|Entered Hospice|0|||
150064017|NCT01975831|541375359|FG007|Overall Study|Entered Hospice|0|||
150064018|NCT01975831|541375360|FG008|Overall Study|Entered Hospice|0|||
150064019|NCT01975831|541375352|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064020|NCT01975831|541375353|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064021|NCT01975831|541375354|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064022|NCT01975831|541375355|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064023|NCT01975831|541375356|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064024|NCT01975831|541375357|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064025|NCT01975831|541375358|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
150064026|NCT01975831|541375359|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
150064027|NCT01975831|541375360|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
150064028|NCT03475875|541375361|FG000|Period 1|Lost to Follow-up|1|||
150064029|NCT03475875|541375362|FG001|Period 1|Lost to Follow-up|0|||
150064030|NCT03475875|541375361|FG000|Period 1|Adverse Event|2|||
150064031|NCT03475875|541375362|FG001|Period 1|Adverse Event|1|||
150064032|NCT03475875|541375361|FG000|Period 2|Adverse Event|3|||
150064033|NCT03475875|541375362|FG001|Period 2|Adverse Event|0|||
150064034|NCT03475875|541375361|FG000|Period 2|Protocol Violation|0|||
150064035|NCT03475875|541375362|FG001|Period 2|Protocol Violation|1|||
150064036|NCT04025710|541375363|FG000|Overall Study|Death|3|||
150064037|NCT04025710|541375363|FG000|Overall Study|Lost to Follow-up|5|||
150064038|NCT04025710|541375363|FG000|Overall Study|Withdrawal by Subject|1|||
150064039|NCT04025710|541375363|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
150064040|NCT04025710|541375363|FG000|Overall Study|Drop-out according to protocol|34|||
150064041|NCT00006389|541375364|FG000|Overall Study|Adverse Event|1|||
150064042|NCT00596362|541375399|FG000|Overall Study|Progressive Disease|1|||
150064043|NCT00817479|541375400|FG000|Overall Study|Physician Decision|1|||
150064044|NCT00817479|541375401|FG001|Overall Study|Physician Decision|1|||
150064045|NCT02793128|541375402|FG000|Overall Study|Death|4|||
150064046|NCT02793128|541375402|FG000|Overall Study|Withdrawal by Subject|2|||
150064047|NCT02793128|541375402|FG000|Overall Study|Physician Decision|1|||
150064048|NCT02793128|541375402|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
150064049|NCT02793128|541375402|FG000|Overall Study|Patient elected nephroureterectomy|1|||
150064050|NCT02359851|541375406|FG000|Overall Study|Death|1|||
150064051|NCT02359851|541375406|FG000|Overall Study|Disease progression|1|||
150064052|NCT01854944|541375407|FG000|Overall Study|Withdrawal by Subject|0|||
150064053|NCT01854944|541375408|FG001|Overall Study|Withdrawal by Subject|0|||
150064054|NCT01854944|541375409|FG002|Overall Study|Withdrawal by Subject|1|||
150064055|NCT00282347|541375412|FG000|Treatment Period|Death|2|||
150064056|NCT00282347|541375413|FG001|Treatment Period|Death|0|||
150064057|NCT00282347|541375412|FG000|Treatment Period|Lost to Follow-up|2|||
150064058|NCT00282347|541375413|FG001|Treatment Period|Lost to Follow-up|5|||
150064059|NCT00282347|541375412|FG000|Treatment Period|Withdrawal by Subject|1|||
150064060|NCT00282347|541375413|FG001|Treatment Period|Withdrawal by Subject|3|||
150064061|NCT00282347|541375412|FG000|Treatment Period|Physician Decision|0|||
150064062|NCT00282347|541375413|FG001|Treatment Period|Physician Decision|1|||
150064063|NCT00282347|541375412|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
150064064|NCT00282347|541375413|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
150064065|NCT00282347|541375412|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
150064066|NCT00282347|541375413|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
150064067|NCT00282347|541375412|FG000|Safety Follow-up Period|Physician Decision|1|||
150064068|NCT00282347|541375413|FG001|Safety Follow-up Period|Physician Decision|1|||
150064069|NCT00282347|541375412|FG000|Safety Follow-up Period|Protocol Deviation|0|||
150064070|NCT00282347|541375413|FG001|Safety Follow-up Period|Protocol Deviation|2|||
150064071|NCT00282347|541375412|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
150064072|NCT00282347|541375413|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
150064073|NCT00282347|541375412|FG000|B Cell Follow-up Period|Physician Decision|1|||
150064074|NCT00282347|541375413|FG001|B Cell Follow-up Period|Physician Decision|0|||
150064075|NCT00282347|541375412|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
150064076|NCT00282347|541375413|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
150064077|NCT02101112|541375414|FG000|Overall Study|Adverse Event|0|||
150064078|NCT02101112|541375415|FG001|Overall Study|Adverse Event|0|||
150064079|NCT02101112|541375416|FG002|Overall Study|Adverse Event|1|||
150064080|NCT02101112|541375417|FG003|Overall Study|Adverse Event|0|||
150064081|NCT02101112|541375418|FG004|Overall Study|Adverse Event|0|||
150064082|NCT02101112|541375419|FG005|Overall Study|Adverse Event|0|||
150064083|NCT02101112|541375414|FG000|Overall Study|Withdrawal by Subject|0|||
150064084|NCT02101112|541375415|FG001|Overall Study|Withdrawal by Subject|0|||
150064085|NCT02101112|541375416|FG002|Overall Study|Withdrawal by Subject|0|||
150064086|NCT02101112|541375417|FG003|Overall Study|Withdrawal by Subject|0|||
150064087|NCT02101112|541375418|FG004|Overall Study|Withdrawal by Subject|1|||
150064088|NCT02101112|541375419|FG005|Overall Study|Withdrawal by Subject|0|||
150064089|NCT02782923|541375420|FG000|Overall Study|Lost to Follow-up|15|||
150064090|NCT02418156|541375421|FG000|Overall Study|Lost to Follow-up|12|||
150064091|NCT02418156|541375421|FG000|Overall Study|Death|2|||
150064092|NCT02418156|541375421|FG000|Overall Study|Physician Decision|1|||
150064093|NCT02418156|541375421|FG000|Overall Study|Withdrawal by Subject|1|||
150064094|NCT02418156|541375421|FG000|Overall Study|Subject refused to return|1|||
150064095|NCT00993044|541375424|FG000|Irinotecan 50 mg|Physician Decision|1|||
150064096|NCT00734747|541375426|FG000|SRS Procedure|No staples placed|3|||
150064097|NCT00734747|541375426|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
150064098|NCT05063318|541375429|FG000|Overall Study|Progressive disease|2|||
150064099|NCT05063318|541375430|FG001|Overall Study|Progressive disease|0|||
150064100|NCT05063318|541375431|FG002|Overall Study|Progressive disease|3|||
150064101|NCT05063318|541375429|FG000|Overall Study|Compassionate use|1|||
150064102|NCT05063318|541375430|FG001|Overall Study|Compassionate use|3|||
150064103|NCT05063318|541375431|FG002|Overall Study|Compassionate use|3|||
150064104|NCT05063318|541375429|FG000|Overall Study|Adverse Event|0|||
150064105|NCT05063318|541375430|FG001|Overall Study|Adverse Event|1|||
150064106|NCT05063318|541375431|FG002|Overall Study|Adverse Event|0|||
150064107|NCT05063318|541375429|FG000|Overall Study|Withdrawal by Subject|0|||
150064108|NCT05063318|541375430|FG001|Overall Study|Withdrawal by Subject|1|||
150064109|NCT05063318|541375431|FG002|Overall Study|Withdrawal by Subject|0|||
150064110|NCT03287635|541375432|FG000|Overall Study|Lost to Follow-up|5|||
150064111|NCT03287635|541375432|FG000|Overall Study|Withdrawal by Subject|1|||
150064112|NCT03287635|541375432|FG000|Overall Study|Physician Decision|1|||
150064113|NCT00323869|541375433|FG000|Overall Study|Death|1|||
150064114|NCT01865084|541377214|FG000|Double Blind Period (DB)|Adverse Event|2|||
150064115|NCT01865084|541377215|FG001|Double Blind Period (DB)|Adverse Event|2|||
150064116|NCT01865084|541377216|FG002|Double Blind Period (DB)|Adverse Event|1|||
150064117|NCT01865084|541377214|FG000|Double Blind Period (DB)|Protocol Violation|0|||
150064118|NCT01865084|541377215|FG001|Double Blind Period (DB)|Protocol Violation|0|||
150064119|NCT01865084|541377216|FG002|Double Blind Period (DB)|Protocol Violation|1|||
150064120|NCT01865084|541377214|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
150064121|NCT01865084|541377215|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
150064122|NCT01865084|541377216|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
150064123|NCT01865084|541377214|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
150064124|NCT01865084|541377215|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
150064125|NCT01865084|541377216|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
150064126|NCT01865084|541377214|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
150064127|NCT01865084|541377215|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
150064128|NCT01865084|541377216|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
150064129|NCT01865084|541377214|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
150064130|NCT01865084|541377215|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
150064131|NCT01865084|541377216|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
150064132|NCT01865084|541377214|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
150064133|NCT01865084|541377215|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
150064134|NCT01865084|541377216|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
150064135|NCT01865084|541377214|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
150064136|NCT01865084|541377215|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
150064137|NCT01865084|541377216|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
150064138|NCT01865084|541377214|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
150064139|NCT01865084|541377215|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
150064140|NCT01865084|541377216|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
150064141|NCT01751802|541377222|FG000|Overall Study|Adverse Event|4|||
150064142|NCT01751802|541377223|FG001|Overall Study|Adverse Event|2|||
150064143|NCT00521001|541377224|FG000|Overall Study|Ineligible|1|||
150064144|NCT02821910|541377225|FG000|Overall Study|Withdrawal by Subject|0|||
150064145|NCT02821910|541377226|FG001|Overall Study|Withdrawal by Subject|0|||
150064146|NCT02821910|541377227|FG002|Overall Study|Withdrawal by Subject|1|||
150064147|NCT02821910|541377228|FG003|Overall Study|Withdrawal by Subject|0|||
150064148|NCT02821910|541377229|FG004|Overall Study|Withdrawal by Subject|0|||
150064149|NCT02821910|541377230|FG005|Overall Study|Withdrawal by Subject|1|||
150064150|NCT02821910|541377225|FG000|Overall Study|Other than specified|1|||
150064151|NCT02821910|541377226|FG001|Overall Study|Other than specified|0|||
150064152|NCT02821910|541377227|FG002|Overall Study|Other than specified|1|||
150064153|NCT02821910|541377228|FG003|Overall Study|Other than specified|0|||
150064154|NCT02821910|541377229|FG004|Overall Study|Other than specified|0|||
150064155|NCT02821910|541377230|FG005|Overall Study|Other than specified|0|||
150064156|NCT01082640|541377231|FG000|Overall Study|Adverse Event|9|||
150064157|NCT01082640|541377232|FG001|Overall Study|Adverse Event|5|||
150064158|NCT01082640|541377233|FG002|Overall Study|Adverse Event|3|||
150064159|NCT01082640|541377231|FG000|Overall Study|Withdrawal by Subject|3|||
150064160|NCT01082640|541377232|FG001|Overall Study|Withdrawal by Subject|3|||
150064161|NCT01082640|541377233|FG002|Overall Study|Withdrawal by Subject|2|||
150064162|NCT01082640|541377231|FG000|Overall Study|Major protocol deviation|3|||
150064163|NCT01082640|541377232|FG001|Overall Study|Major protocol deviation|3|||
150064164|NCT01082640|541377233|FG002|Overall Study|Major protocol deviation|0|||
150064165|NCT01082640|541377231|FG000|Overall Study|Lost to Follow-up|0|||
150064166|NCT01082640|541377232|FG001|Overall Study|Lost to Follow-up|3|||
150064167|NCT01082640|541377233|FG002|Overall Study|Lost to Follow-up|0|||
150064168|NCT01082640|541377231|FG000|Overall Study|Other|2|||
150064169|NCT01082640|541377232|FG001|Overall Study|Other|1|||
150064170|NCT01082640|541377233|FG002|Overall Study|Other|3|||
150064171|NCT01025154|541377242|FG000|Overall Study|Lost to Follow-up|1|||
150064172|NCT01025154|541377242|FG000|Overall Study|Withdrawal by Subject|1|||
150064173|NCT01810432|541377243|FG000|Washout|Protocol Violation|0|||
150064174|NCT01810432|541377244|FG001|Washout|Protocol Violation|1|||
150064175|NCT01810432|541377243|FG000|Washout|Adverse Event|1|||
150064176|NCT01810432|541377244|FG001|Washout|Adverse Event|0|||
150064177|NCT01810432|541377243|FG000|Period 2|Withdrawal by Subject|2|||
150064178|NCT01810432|541377244|FG001|Period 2|Withdrawal by Subject|1|||
150064179|NCT01810432|541377243|FG000|Period 2|Physician Decision|1|||
150064180|NCT01810432|541377244|FG001|Period 2|Physician Decision|0|||
150064181|NCT01810432|541377243|FG000|Period 2|Lost to Follow-up|1|||
150064182|NCT01810432|541377244|FG001|Period 2|Lost to Follow-up|1|||
150064183|NCT00057954|541377245|FG000|Overall Study|Death|1|||
150064184|NCT00057954|541377245|FG000|Overall Study|Disease progression|1|||
150064185|NCT00559754|541377246|FG000|Overall Study|Disease progression|1|||
150064186|NCT00559754|541377246|FG000|Overall Study|Adverse Event|5|||
150064187|NCT00559754|541377246|FG000|Overall Study|Protocol Violation|1|||
150064188|NCT00559754|541377246|FG000|Overall Study|Investigator criteria|2|||
150064189|NCT00559754|541377246|FG000|Overall Study|Withdrawal by Subject|2|||
150064190|NCT01264016|541377247|FG000|Overall Study|Withdrawal by Subject|1|||
150064191|NCT01264016|541377247|FG000|Overall Study|Felt faint at sight of blood|1|||
150064192|NCT02117414|541377248|FG000|Overall Study|Death|5|||
150064193|NCT02117414|541377249|FG001|Overall Study|Death|2|||
150064194|NCT02117414|541377248|FG000|Overall Study|Withdrawal by Subject|10|||
150064195|NCT02117414|541377249|FG001|Overall Study|Withdrawal by Subject|4|||
150064196|NCT01629706|541377250|FG000|Phase 1 PureVision|Screen Failure|4|||
150064197|NCT01629706|541377250|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
150064198|NCT01629706|541377250|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
150064199|NCT01629706|541377250|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
150064200|NCT01629706|541377250|FG000|Phase 2 Habitual|Screen Failure|6|||
150064201|NCT01629706|541377250|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
150064202|NCT01629706|541377250|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
150064203|NCT01629706|541377250|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
150064204|NCT01629706|541377250|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
150064205|NCT02537574|541377252|FG000|Overall Study|Adverse Event|1|||
150064206|NCT02537574|541377253|FG001|Overall Study|Adverse Event|3|||
150064207|NCT02537574|541377254|FG002|Overall Study|Adverse Event|2|||
150064208|NCT02537574|541377252|FG000|Overall Study|Lost to Follow-up|40|||
150064209|NCT02537574|541377253|FG001|Overall Study|Lost to Follow-up|51|||
150064210|NCT02537574|541377254|FG002|Overall Study|Lost to Follow-up|55|||
150064211|NCT02537574|541377252|FG000|Overall Study|Noncompliance with study drug|0|||
150064212|NCT02537574|541377253|FG001|Overall Study|Noncompliance with study drug|1|||
150064213|NCT02537574|541377254|FG002|Overall Study|Noncompliance with study drug|1|||
150064214|NCT02537574|541377252|FG000|Overall Study|Physician Decision|2|||
150064215|NCT02537574|541377253|FG001|Overall Study|Physician Decision|0|||
150064216|NCT02537574|541377254|FG002|Overall Study|Physician Decision|0|||
150064217|NCT02537574|541377252|FG000|Overall Study|Protocol Violation|4|||
150064218|NCT02537574|541377253|FG001|Overall Study|Protocol Violation|2|||
150064219|NCT02537574|541377254|FG002|Overall Study|Protocol Violation|3|||
150064220|NCT02537574|541377252|FG000|Overall Study|Withdrawal by Subject|37|||
150064221|NCT02537574|541377253|FG001|Overall Study|Withdrawal by Subject|27|||
150064222|NCT02537574|541377254|FG002|Overall Study|Withdrawal by Subject|29|||
150064223|NCT02537574|541377252|FG000|Overall Study|Lack of Efficacy|14|||
150064224|NCT02537574|541377253|FG001|Overall Study|Lack of Efficacy|16|||
150064225|NCT02537574|541377254|FG002|Overall Study|Lack of Efficacy|15|||
150064226|NCT02537574|541377252|FG000|Overall Study|Duplicate Patient|1|||
150064227|NCT02537574|541377253|FG001|Overall Study|Duplicate Patient|0|||
150064228|NCT02537574|541377254|FG002|Overall Study|Duplicate Patient|0|||
150064229|NCT02537574|541377252|FG000|Overall Study|Patient not Stable|0|||
150064230|NCT02537574|541377253|FG001|Overall Study|Patient not Stable|1|||
150064231|NCT02537574|541377254|FG002|Overall Study|Patient not Stable|0|||
150064232|NCT02537574|541377252|FG000|Overall Study|Incarceration|0|||
150064233|NCT02537574|541377253|FG001|Overall Study|Incarceration|1|||
150064234|NCT02537574|541377254|FG002|Overall Study|Incarceration|0|||
150064235|NCT02537574|541377252|FG000|Overall Study|Failed Naloxone Challenge|0|||
150064236|NCT02537574|541377253|FG001|Overall Study|Failed Naloxone Challenge|1|||
150064237|NCT02537574|541377254|FG002|Overall Study|Failed Naloxone Challenge|0|||
150064238|NCT02537574|541377252|FG000|Overall Study|Transportation Issues|0|||
150064239|NCT02537574|541377253|FG001|Overall Study|Transportation Issues|0|||
150064240|NCT02537574|541377254|FG002|Overall Study|Transportation Issues|1|||
150064241|NCT02537574|541377252|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
150064242|NCT02537574|541377253|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
150064243|NCT02537574|541377254|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
150064244|NCT02537574|541377252|FG000|Overall Study|Noncompliance with Protocol|0|||
150064245|NCT02537574|541377253|FG001|Overall Study|Noncompliance with Protocol|0|||
150064246|NCT02537574|541377254|FG002|Overall Study|Noncompliance with Protocol|1|||
150064247|NCT02663687|541377255|FG000|Overall Study|Adverse Event|1|||
150064248|NCT02663687|541377256|FG001|Overall Study|Adverse Event|0|||
150064249|NCT02663687|541377257|FG002|Overall Study|Adverse Event|0|||
150064250|NCT02663687|541377258|FG003|Overall Study|Adverse Event|0|||
150064251|NCT02663687|541377259|FG004|Overall Study|Adverse Event|0|||
150064252|NCT02663687|541377255|FG000|Overall Study|Other|1|||
150064253|NCT02663687|541377256|FG001|Overall Study|Other|0|||
150064254|NCT02663687|541377257|FG002|Overall Study|Other|1|||
150064255|NCT02663687|541377258|FG003|Overall Study|Other|0|||
150064256|NCT02663687|541377259|FG004|Overall Study|Other|0|||
150064257|NCT01151098|541377260|FG000|Overall Study|Adverse Event|82|||
150064258|NCT01151098|541377260|FG000|Overall Study|Lost to Follow-up|6|||
150064259|NCT01151098|541377260|FG000|Overall Study|Lack of Efficacy|15|||
150064260|NCT01151098|541377260|FG000|Overall Study|Protocol Violation|1|||
150064261|NCT01151098|541377260|FG000|Overall Study|Miscellaneous|13|||
150064262|NCT03343067|541377263|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
150064263|NCT03343067|541377264|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
150064264|NCT03343067|541377265|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
150064265|NCT00542451|541377266|FG000|Overall Study|Adverse Event|31|||
150064266|NCT00542451|541377266|FG000|Overall Study|Withdrawal by Subject|30|||
150064267|NCT00542451|541377266|FG000|Overall Study|Physician Decision|4|||
150064268|NCT00542451|541377266|FG000|Overall Study|Recurrent disease|1|||
150064269|NCT00542451|541377266|FG000|Overall Study|unknown reason|1|||
150064270|NCT00542451|541377266|FG000|Overall Study|Death|2|||
150064271|NCT00542451|541377266|FG000|Overall Study|Lost to Follow-up|10|||
150064272|NCT00116168|541377267|FG000|Overall Study|Lost to Follow-up|6|||
150064273|NCT00116168|541377268|FG001|Overall Study|Lost to Follow-up|5|||
150064274|NCT00116168|541377269|FG002|Overall Study|Lost to Follow-up|0|||
150064275|NCT00116168|541377270|FG003|Overall Study|Lost to Follow-up|0|||
150064276|NCT05153473|541377271|FG000|Overall Study|Death|46|||
150064277|NCT05153473|541377271|FG000|Overall Study|Lost to Follow-up|3|||
150064278|NCT02788474|541377272|FG000|Double Blind Treatment Period|Not treated|1|||
150064279|NCT02788474|541377273|FG001|Double Blind Treatment Period|Not treated|0|||
150064280|NCT02788474|541377272|FG000|Double Blind Treatment Period|Patient's refusal|3|||
150064281|NCT02788474|541377273|FG001|Double Blind Treatment Period|Patient's refusal|0|||
150064282|NCT02788474|541377272|FG000|Double Blind Treatment Period|Adverse Event|6|||
150064283|NCT02788474|541377273|FG001|Double Blind Treatment Period|Adverse Event|4|||
150064284|NCT02788474|541377272|FG000|Open Label Treatment Period|Adverse Event|29|||
150064285|NCT02788474|541377273|FG001|Open Label Treatment Period|Adverse Event|9|||
150064286|NCT02788474|541377272|FG000|Open Label Treatment Period|Other than reason specified|1|||
150064287|NCT02788474|541377273|FG001|Open Label Treatment Period|Other than reason specified|0|||
150064288|NCT02788474|541377272|FG000|Open Label Treatment Period|Patient's refusal|1|||
150064289|NCT02788474|541377273|FG001|Open Label Treatment Period|Patient's refusal|3|||
150064290|NCT02788474|541377272|FG000|Open Label Treatment Period|Non-compliance|1|||
150064291|NCT02788474|541377273|FG001|Open Label Treatment Period|Non-compliance|0|||
150064292|NCT00245583|541377276|FG000|Overall Study|Lost to Follow-up|1|||
150064293|NCT00245583|541377277|FG001|Overall Study|Lost to Follow-up|5|||
150064294|NCT00245583|541377276|FG000|Overall Study|Adverse Event|2|||
150064295|NCT00245583|541377277|FG001|Overall Study|Adverse Event|1|||
150064296|NCT00245583|541377276|FG000|Overall Study|Lack of Efficacy|1|||
150064297|NCT00245583|541377277|FG001|Overall Study|Lack of Efficacy|0|||
150064298|NCT00245583|541377276|FG000|Overall Study|Withdrawal by Subject|2|||
150064299|NCT00245583|541377277|FG001|Overall Study|Withdrawal by Subject|3|||
150064300|NCT04718103|541377278|FG000|Overall Study|Adverse Event|1|||
150064301|NCT04718103|541377279|FG001|Overall Study|Adverse Event|1|||
150064302|NCT04718103|541377278|FG000|Overall Study|Lack of Efficacy|4|||
150064303|NCT04718103|541377279|FG001|Overall Study|Lack of Efficacy|1|||
150064304|NCT04718103|541377278|FG000|Overall Study|Lost to Follow-up|2|||
150064305|NCT04718103|541377279|FG001|Overall Study|Lost to Follow-up|2|||
150064306|NCT04718103|541377278|FG000|Overall Study|Physician Decision|2|||
150064307|NCT04718103|541377279|FG001|Overall Study|Physician Decision|0|||
150064308|NCT04718103|541377278|FG000|Overall Study|Pregnancy|0|||
150064309|NCT04718103|541377279|FG001|Overall Study|Pregnancy|1|||
150064310|NCT04718103|541377278|FG000|Overall Study|Withdrawal by Subject|10|||
150064311|NCT04718103|541377279|FG001|Overall Study|Withdrawal by Subject|6|||
150064312|NCT04718103|541377278|FG000|Overall Study|Randomized, not treated|4|||
150064313|NCT04718103|541377279|FG001|Overall Study|Randomized, not treated|1|||
150064314|NCT04718103|541377278|FG000|Overall Study|GCP violations|7|||
150064315|NCT04718103|541377279|FG001|Overall Study|GCP violations|5|||
150064316|NCT01343901|541377280|FG000|Overall Study|Death|85|||
150064317|NCT01343901|541377280|FG000|Overall Study|Physician Decision|4|||
150064318|NCT01343901|541377280|FG000|Overall Study|Lost to Follow-up|12|||
150064319|NCT01343901|541377280|FG000|Overall Study|Management by another medical team|11|||
150064320|NCT01343901|541377280|FG000|Overall Study|Participant decision|1|||
150064321|NCT01369485|541377281|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
150064322|NCT01369485|541377282|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
150064323|NCT01369485|541377281|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
150064324|NCT01369485|541377282|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
150064325|NCT01369485|541377281|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
150064326|NCT01369485|541377282|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
150064327|NCT01369485|541377281|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
150064328|NCT01369485|541377282|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
150064329|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
150064330|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
150064331|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
150064332|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
150064333|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
150064334|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
150064335|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
150064336|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
150064337|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
150064338|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
150064339|NCT01369485|541377281|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
150064340|NCT01369485|541377282|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
150064341|NCT02764190|541377284|FG000|Overall Study|Lost to Follow-up|17|||
150064342|NCT02764190|541377285|FG001|Overall Study|Lost to Follow-up|13|||
150064343|NCT01484938|541377286|FG000|Overall Study|Adverse Event|2|||
150064344|NCT01484938|541377286|FG000|Overall Study|Lost to Follow-up|1|||
150064345|NCT01484938|541377286|FG000|Overall Study|Noncompliance|1|||
150064346|NCT02140775|541377288|FG000|Overall Study|Withdrawal by Subject|30|||
150064347|NCT02140775|541377289|FG001|Overall Study|Withdrawal by Subject|7|||
150064348|NCT02942576|541377291|FG000|Overall Study|Adverse Event|28|||
150064349|NCT02942576|541377292|FG001|Overall Study|Adverse Event|6|||
150064350|NCT02942576|541377291|FG000|Overall Study|Withdrawal by Subject|7|||
150064351|NCT02942576|541377292|FG001|Overall Study|Withdrawal by Subject|5|||
150064352|NCT02942576|541377291|FG000|Overall Study|Physician Decision|1|||
150064353|NCT02942576|541377292|FG001|Overall Study|Physician Decision|4|||
150064354|NCT02942576|541377291|FG000|Overall Study|Other|10|||
150064355|NCT02942576|541377292|FG001|Overall Study|Other|8|||
150064356|NCT00938964|541377295|FG000|Overall Study|Death|3|||
150064357|NCT00938964|541377296|FG001|Overall Study|Death|3|||
150064358|NCT00938964|541377295|FG000|Overall Study|Lost to Follow-up|2|||
150064359|NCT00938964|541377296|FG001|Overall Study|Lost to Follow-up|3|||
150064360|NCT00938964|541377295|FG000|Overall Study|Withdrawal by Subject|22|||
150064361|NCT00938964|541377296|FG001|Overall Study|Withdrawal by Subject|18|||
150064362|NCT00938964|541377295|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
150064363|NCT00938964|541377296|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
150064364|NCT01227564|541377298|FG000|Overall Study|No Longer Willing to Participate|4|||
150064365|NCT01227564|541377299|FG001|Overall Study|No Longer Willing to Participate|2|||
150064366|NCT01227564|541377300|FG002|Overall Study|No Longer Willing to Participate|5|||
150064367|NCT01227564|541377298|FG000|Overall Study|Participant moved to another town|0|||
150064368|NCT01227564|541377299|FG001|Overall Study|Participant moved to another town|0|||
150064369|NCT01227564|541377300|FG002|Overall Study|Participant moved to another town|1|||
150064370|NCT04650854|541377301|FG000|Overall Study|Adverse Event|1|||
150064371|NCT04650854|541377302|FG001|Overall Study|Adverse Event|12|||
150064372|NCT04650854|541377303|FG002|Overall Study|Adverse Event|14|||
150064373|NCT04650854|541377301|FG000|Overall Study|Lack of Efficacy|1|||
150064374|NCT04650854|541377302|FG001|Overall Study|Lack of Efficacy|3|||
150064375|NCT04650854|541377303|FG002|Overall Study|Lack of Efficacy|6|||
150064376|NCT04650854|541377301|FG000|Overall Study|Lost to Follow-up|1|||
150064377|NCT04650854|541377302|FG001|Overall Study|Lost to Follow-up|1|||
150064378|NCT04650854|541377303|FG002|Overall Study|Lost to Follow-up|0|||
150064379|NCT04650854|541377301|FG000|Overall Study|Withdrawal by Subject|2|||
150064380|NCT04650854|541377302|FG001|Overall Study|Withdrawal by Subject|17|||
150064381|NCT04650854|541377303|FG002|Overall Study|Withdrawal by Subject|9|||
150064382|NCT04650854|541377301|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
150064383|NCT04650854|541377302|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
150064384|NCT04650854|541377303|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
150064385|NCT04650854|541377301|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
150064386|NCT04650854|541377302|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
150064387|NCT04650854|541377303|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
150064388|NCT04650854|541377301|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
150064389|NCT04650854|541377302|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
150064390|NCT04650854|541377303|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
150064391|NCT04650854|541377301|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
150064392|NCT04650854|541377302|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
150064393|NCT04650854|541377303|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
150064394|NCT04650854|541377301|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
150064395|NCT04650854|541377302|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
150064396|NCT04650854|541377303|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
150064397|NCT04650854|541377301|FG000|Overall Study|Use of Rescue Medication|0|||
150064398|NCT04650854|541377302|FG001|Overall Study|Use of Rescue Medication|0|||
150064399|NCT04650854|541377303|FG002|Overall Study|Use of Rescue Medication|1|||
150064400|NCT04650854|541377301|FG000|Overall Study|Last Treatment Per Sponsor|0|||
150064401|NCT04650854|541377302|FG001|Overall Study|Last Treatment Per Sponsor|0|||
150064402|NCT04650854|541377303|FG002|Overall Study|Last Treatment Per Sponsor|2|||
150064403|NCT04650854|541377301|FG000|Overall Study|Rescue Medication|0|||
150064404|NCT04650854|541377302|FG001|Overall Study|Rescue Medication|0|||
150064405|NCT04650854|541377303|FG002|Overall Study|Rescue Medication|1|||
150064406|NCT04650854|541377301|FG000|Overall Study|Participant Want to Start a Family|0|||
150064407|NCT04650854|541377302|FG001|Overall Study|Participant Want to Start a Family|0|||
150064408|NCT04650854|541377303|FG002|Overall Study|Participant Want to Start a Family|1|||
150064409|NCT04650854|541377301|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
150064410|NCT04650854|541377302|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
150064411|NCT04650854|541377303|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
150064412|NCT04650854|541377301|FG000|Overall Study|Participant Screened For MG0020|0|||
150064413|NCT04650854|541377302|FG001|Overall Study|Participant Screened For MG0020|2|||
150064414|NCT04650854|541377303|FG002|Overall Study|Participant Screened For MG0020|3|||
150064415|NCT04650854|541377301|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
150064416|NCT04650854|541377302|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
150064417|NCT04650854|541377303|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
150064418|NCT04650854|541377301|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
150064419|NCT04650854|541377302|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
150064420|NCT04650854|541377303|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
150064421|NCT04650854|541377301|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
150064422|NCT04650854|541377302|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
150064423|NCT04650854|541377303|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
150064424|NCT04650854|541377301|FG000|Overall Study|End Of Study|0|||
150064425|NCT04650854|541377302|FG001|Overall Study|End Of Study|2|||
150064426|NCT04650854|541377303|FG002|Overall Study|End Of Study|1|||
150064427|NCT04650854|541377301|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
150064428|NCT04650854|541377302|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
150064429|NCT04650854|541377303|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
150064430|NCT04650854|541377301|FG000|Overall Study|Participant Received Rescue Medication|0|||
150064431|NCT04650854|541377302|FG001|Overall Study|Participant Received Rescue Medication|1|||
150064432|NCT04650854|541377303|FG002|Overall Study|Participant Received Rescue Medication|0|||
150064433|NCT04650854|541377301|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
150064434|NCT04650854|541377302|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
150064435|NCT04650854|541377303|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
150064436|NCT04650854|541377301|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
150064437|NCT04650854|541377302|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
150064438|NCT04650854|541377303|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
150064439|NCT04650854|541377301|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
150064440|NCT04650854|541377302|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
150064441|NCT04650854|541377303|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
150064442|NCT04650854|541377301|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
150064443|NCT04650854|541377302|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
150064444|NCT04650854|541377303|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
150064445|NCT04650854|541377301|FG000|Overall Study|Enrollment Cup|0|||
150064446|NCT04650854|541377302|FG001|Overall Study|Enrollment Cup|0|||
150064447|NCT04650854|541377303|FG002|Overall Study|Enrollment Cup|1|||
150064448|NCT00194675|541377304|FG000|Overall Study|Lost to Follow-up|1|||
150064449|NCT00194675|541377305|FG001|Overall Study|Lost to Follow-up|1|||
150064450|NCT00194675|541377304|FG000|Overall Study|lack of interest|1|||
150064451|NCT00194675|541377305|FG001|Overall Study|lack of interest|1|||
150064452|NCT00194675|541377304|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
150064453|NCT00194675|541377305|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
150064454|NCT00194675|541377304|FG000|Overall Study|Protocol Violation|1|||
150064455|NCT00194675|541377305|FG001|Overall Study|Protocol Violation|0|||
150064456|NCT00194675|541377304|FG000|Overall Study|Death|1|||
150064457|NCT00194675|541377305|FG001|Overall Study|Death|0|||
150064458|NCT05308290|541377306|FG000|Overall Study|Death|1|||
150064459|NCT05308290|541377307|FG001|Overall Study|Death|0|||
150064460|NCT05308290|541377306|FG000|Overall Study|Lost to Follow-up|2|||
150064461|NCT05308290|541377307|FG001|Overall Study|Lost to Follow-up|1|||
150064462|NCT05308290|541377306|FG000|Overall Study|still in study followup|0|||
150064463|NCT05308290|541377307|FG001|Overall Study|still in study followup|1|||
150064464|NCT01285960|541377308|FG000|Overall Study|Withdrawal by Subject|2|||
150064465|NCT01285960|541377308|FG000|Overall Study|Lost to Follow-up|2|||
150064466|NCT01285960|541377308|FG000|Overall Study|2 subjects received less 10 sonications|2|||
150064467|NCT00667420|541377309|FG000|Overall Study|Adverse Event|2|||
150064468|NCT00667420|541377309|FG000|Overall Study|Lack of Efficacy|5|||
150064469|NCT00667420|541377309|FG000|Overall Study|Physician Decision|1|||
150064470|NCT00667420|541377309|FG000|Overall Study|Withdrawal by Subject|2|||
150064471|NCT00995865|541377321|FG000|Overall Study|Protocol Violation|2|||
150064472|NCT00995865|541377322|FG001|Overall Study|Protocol Violation|0|||
150064473|NCT00995865|541377323|FG002|Overall Study|Protocol Violation|0|||
150064474|NCT00995865|541377321|FG000|Overall Study|Lost to Follow-up|0|||
150064475|NCT00995865|541377322|FG001|Overall Study|Lost to Follow-up|0|||
150064476|NCT00995865|541377323|FG002|Overall Study|Lost to Follow-up|1|||
150064477|NCT00410202|541377324|FG000|On-Treatment|Continuing treatment|69|||
150064478|NCT00410202|541377325|FG001|On-Treatment|Continuing treatment|71|||
150064479|NCT00410202|541377326|FG002|On-Treatment|Continuing treatment|66|||
150064480|NCT00410202|541377324|FG000|On-Treatment|Adverse Event|1|||
150064481|NCT00410202|541377325|FG001|On-Treatment|Adverse Event|3|||
150064482|NCT00410202|541377326|FG002|On-Treatment|Adverse Event|2|||
150064483|NCT00410202|541377324|FG000|On-Treatment|Death|1|||
150064484|NCT00410202|541377325|FG001|On-Treatment|Death|0|||
150064485|NCT00410202|541377326|FG002|On-Treatment|Death|0|||
150064486|NCT00410202|541377324|FG000|On-Treatment|Lost to Follow-up|1|||
150064487|NCT00410202|541377325|FG001|On-Treatment|Lost to Follow-up|0|||
150064488|NCT00410202|541377326|FG002|On-Treatment|Lost to Follow-up|1|||
150064489|NCT00410202|541377324|FG000|On-Treatment|Lack of Efficacy|1|||
150064490|NCT00410202|541377325|FG001|On-Treatment|Lack of Efficacy|4|||
150064491|NCT00410202|541377326|FG002|On-Treatment|Lack of Efficacy|0|||
150064492|NCT00410202|541377324|FG000|On-Treatment|Withdrawal by Subject|2|||
150064493|NCT00410202|541377325|FG001|On-Treatment|Withdrawal by Subject|1|||
150064494|NCT00410202|541377326|FG002|On-Treatment|Withdrawal by Subject|1|||
150064495|NCT00410202|541377324|FG000|On-Treatment|Other Reason|0|||
150064496|NCT00410202|541377325|FG001|On-Treatment|Other Reason|0|||
150064497|NCT00410202|541377326|FG002|On-Treatment|Other Reason|1|||
150064498|NCT00410202|541377324|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
150064499|NCT00410202|541377325|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
150064500|NCT00410202|541377326|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
150064501|NCT00410202|541377324|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
150064502|NCT00410202|541377325|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
150064503|NCT00410202|541377326|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
150064504|NCT00410202|541377324|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
150064505|NCT00410202|541377325|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
150064506|NCT00410202|541377326|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
150064507|NCT00144027|541377327|FG000|Overall Study|Lost to Follow-up|1|||
150064508|NCT00144027|541377328|FG001|Overall Study|Lost to Follow-up|3|||
150064509|NCT00144027|541377327|FG000|Overall Study|Withdrawal by Subject|2|||
150064510|NCT00144027|541377328|FG001|Overall Study|Withdrawal by Subject|2|||
150064511|NCT00144027|541377327|FG000|Overall Study|did not complete baseline assessment|0|||
150064512|NCT00144027|541377328|FG001|Overall Study|did not complete baseline assessment|6|||
150064513|NCT05080660|541377329|FG000|Overall Study|Adverse Event|4|||
150064514|NCT05080660|541377330|FG001|Overall Study|Adverse Event|0|||
150064515|NCT05080660|541377329|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
150064516|NCT05080660|541377330|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
150064517|NCT05080660|541377329|FG000|Overall Study|Physician Decision|1|||
150064518|NCT05080660|541377330|FG001|Overall Study|Physician Decision|0|||
150064519|NCT05080660|541377329|FG000|Overall Study|Protocol Deviation|2|||
150064520|NCT05080660|541377330|FG001|Overall Study|Protocol Deviation|0|||
150064521|NCT05080660|541377329|FG000|Overall Study|Withdrawal by Subject|5|||
150064522|NCT05080660|541377330|FG001|Overall Study|Withdrawal by Subject|2|||
150064523|NCT04221230|541377335|FG000|Overall Study|Lost to Follow-up|12|||
150064524|NCT04221230|541377336|FG001|Overall Study|Lost to Follow-up|12|||
150064525|NCT04221230|541377335|FG000|Overall Study|Protocol Violation|2|||
150064526|NCT04221230|541377336|FG001|Overall Study|Protocol Violation|2|||
150064527|NCT04221230|541377335|FG000|Overall Study|Adverse Event|0|||
150064528|NCT04221230|541377336|FG001|Overall Study|Adverse Event|8|||
150064529|NCT04221230|541377335|FG000|Overall Study|Physician Decision|1|||
150064530|NCT04221230|541377336|FG001|Overall Study|Physician Decision|0|||
150064531|NCT04221230|541377335|FG000|Overall Study|Withdrawal by Subject|13|||
150064532|NCT04221230|541377336|FG001|Overall Study|Withdrawal by Subject|11|||
150064533|NCT04221230|541377335|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150064534|NCT04221230|541377336|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150064535|NCT04221230|541377335|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150064536|NCT04221230|541377336|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
150064537|NCT04221230|541377335|FG000|Overall Study|Pregnancy|0|||
150064538|NCT04221230|541377336|FG001|Overall Study|Pregnancy|1|||
150064539|NCT04221230|541377335|FG000|Overall Study|Other|1|||
150064540|NCT04221230|541377336|FG001|Overall Study|Other|2|||
150064541|NCT03119701|541377338|FG000|6-day Dosing|Death|4|||
150064542|NCT03119701|541377339|FG001|6-day Dosing|Death|1|||
150025356|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
150025357|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025358|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025359|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025360|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025361|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
150025362|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
150025363|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
150025364|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
150025365|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025366|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
150025367|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025368|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025369|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
150025370|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
150025371|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
150025372|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025373|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025374|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025375|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
150025376|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025377|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025378|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025379|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025380|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025381|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025382|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025383|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025384|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025385|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025386|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
150025387|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025388|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025389|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025390|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025391|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
150025392|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
150025393|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025394|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
150025395|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025396|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
150025397|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025398|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025399|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025400|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
150025401|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
150025402|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150064543|NCT03119701|541377338|FG000|6-day Dosing|Adverse Event|3|||
150064544|NCT03119701|541377339|FG001|6-day Dosing|Adverse Event|0|||
150064545|NCT03119701|541377338|FG000|6-day Dosing|Physician Decision|0|||
150064546|NCT03119701|541377339|FG001|6-day Dosing|Physician Decision|1|||
150064547|NCT03119701|541377338|FG000|6-day Dosing|Withdrawal by Subject|0|||
150064548|NCT03119701|541377339|FG001|6-day Dosing|Withdrawal by Subject|1|||
150064549|NCT03119701|541377338|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
150064550|NCT03119701|541377339|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
150064551|NCT02125604|541377342|FG000|Overall Study|Other|4|||
150064552|NCT02125604|541377342|FG000|Overall Study|Investigator Decision|1|||
150064553|NCT02125604|541377342|FG000|Overall Study|Lost to Follow-up|2|||
150064554|NCT02125604|541377342|FG000|Overall Study|Consent Withdrawn|4|||
150064555|NCT02125604|541377342|FG000|Overall Study|Adverse Event|20|||
150064556|NCT04340063|541377343|FG000|Overall Study|Withdrawal by Subject|1|||
150064557|NCT04340063|541377344|FG001|Overall Study|Withdrawal by Subject|2|||
150064558|NCT04340063|541377343|FG000|Overall Study|Lost to Follow-up|3|||
150064559|NCT04340063|541377344|FG001|Overall Study|Lost to Follow-up|1|||
150064560|NCT04340063|541377343|FG000|Overall Study|Protocol Violation|0|||
150064561|NCT04340063|541377344|FG001|Overall Study|Protocol Violation|1|||
150064562|NCT03670836|541377350|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
150064563|NCT03670836|541377351|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
150064564|NCT03670836|541377350|FG000|Per Protocol Population (PP)|Physician Decision|9|||
150064565|NCT03670836|541377351|FG001|Per Protocol Population (PP)|Physician Decision|10|||
150064566|NCT03670836|541377350|FG000|Per Protocol Population (PP)|Physician Decision|4|||
150064567|NCT03670836|541377351|FG001|Per Protocol Population (PP)|Physician Decision|6|||
150064568|NCT03670836|541377350|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
150064569|NCT03670836|541377351|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
150064570|NCT03875118|541378641|FG000|Overall Study|Withdrawal by Subject|4|||
150064571|NCT03875118|541378642|FG001|Overall Study|Withdrawal by Subject|4|||
150064572|NCT02237911|541378643|FG000|Overall Study|Withdrawal by Subject|4|||
150064573|NCT02237911|541378644|FG001|Overall Study|Withdrawal by Subject|7|||
150064574|NCT02237911|541378645|FG002|Overall Study|Withdrawal by Subject|2|||
150064575|NCT02237911|541378643|FG000|Overall Study|Lost to Follow-up|3|||
150064576|NCT02237911|541378644|FG001|Overall Study|Lost to Follow-up|1|||
150064577|NCT02237911|541378645|FG002|Overall Study|Lost to Follow-up|1|||
150064578|NCT02423109|541378646|FG000|Lens 1|Adverse Event|1|||
150064579|NCT02423109|541378647|FG001|Lens 1|Adverse Event|0|||
150064580|NCT02428608|541378648|FG000|Overall Study|Pregnancy|2|||
150064581|NCT02428608|541378648|FG000|Overall Study|Lost to Follow-up|37|||
150064582|NCT02428608|541378648|FG000|Overall Study|Withdrawal by Subject|2|||
150064583|NCT02428608|541378648|FG000|Overall Study|scheduling conflicts|15|||
150064584|NCT02428608|541378648|FG000|Overall Study|moved away|10|||
150064585|NCT02428608|541378648|FG000|Overall Study|Death|1|||
150064586|NCT02428608|541378648|FG000|Overall Study|various|16|||
150064587|NCT04521777|541378649|FG000|Overall Study|Death|2|||
150064588|NCT04521777|541378649|FG000|Overall Study|Withdrawal by Subject|2|||
150064589|NCT04060862|541378650|FG000|Overall Study|Symptomatic Deterioration|1|||
150064590|NCT04060862|541378650|FG000|Overall Study|Un-specified|6|||
150064591|NCT04060862|541378650|FG000|Overall Study|Progressive disease|12|||
150064592|NCT04060862|541378650|FG000|Overall Study|Physician Decision|1|||
150064593|NCT01143207|541378653|FG000|Overall Study|Lost to Follow-up|2|||
150064594|NCT00048061|541378656|FG000|Overall Study|Adverse Event|41|||
150064595|NCT00048061|541378657|FG001|Overall Study|Adverse Event|32|||
150064596|NCT00048061|541378658|FG002|Overall Study|Adverse Event|44|||
150064597|NCT00048061|541378659|FG003|Overall Study|Adverse Event|37|||
150064598|NCT00048061|541378656|FG000|Overall Study|Lost to Follow-up|3|||
150064599|NCT00048061|541378657|FG001|Overall Study|Lost to Follow-up|2|||
150064600|NCT00048061|541378658|FG002|Overall Study|Lost to Follow-up|4|||
150064601|NCT00048061|541378659|FG003|Overall Study|Lost to Follow-up|5|||
150064602|NCT00048061|541378656|FG000|Overall Study|Withdrawal by Subject|20|||
150064603|NCT00048061|541378657|FG001|Overall Study|Withdrawal by Subject|29|||
150064604|NCT00048061|541378658|FG002|Overall Study|Withdrawal by Subject|29|||
150064605|NCT00048061|541378659|FG003|Overall Study|Withdrawal by Subject|32|||
150064606|NCT00048061|541378656|FG000|Overall Study|Did not follow-up|5|||
150064607|NCT00048061|541378657|FG001|Overall Study|Did not follow-up|5|||
150064608|NCT00048061|541378658|FG002|Overall Study|Did not follow-up|4|||
150064609|NCT00048061|541378659|FG003|Overall Study|Did not follow-up|5|||
150064610|NCT00048061|541378656|FG000|Overall Study|Early improvement|6|||
150064611|NCT00048061|541378657|FG001|Overall Study|Early improvement|5|||
150064612|NCT00048061|541378658|FG002|Overall Study|Early improvement|3|||
150064613|NCT00048061|541378659|FG003|Overall Study|Early improvement|0|||
150064614|NCT03555435|541378660|FG000|Overall Study|Lost to Follow-up|17|||
150064615|NCT03555435|541378661|FG001|Overall Study|Lost to Follow-up|19|||
150064616|NCT03555435|541378662|FG002|Overall Study|Lost to Follow-up|8|||
150064617|NCT02169284|541378669|FG000|Overall Study|Physician Decision|0|||
150064618|NCT02169284|541378670|FG001|Overall Study|Physician Decision|1|||
150064619|NCT04341662|541378671|FG000|Overall Study|Did not have source-verified blood loss data|423|||
150064620|NCT04341662|541378672|FG001|Overall Study|Did not have source-verified blood loss data|514|||
150064621|NCT02273739|541378676|FG000|Overall Study|Progression of Disease|3|||
150064622|NCT02273739|541378677|FG001|Overall Study|Progression of Disease|4|||
150064623|NCT02273739|541378678|FG002|Overall Study|Progression of Disease|5|||
150064624|NCT02273739|541378679|FG003|Overall Study|Progression of Disease|2|||
150064625|NCT02273739|541378676|FG000|Overall Study|Death|0|||
150064626|NCT02273739|541378677|FG001|Overall Study|Death|0|||
150064627|NCT02273739|541378678|FG002|Overall Study|Death|0|||
150064628|NCT02273739|541378679|FG003|Overall Study|Death|2|||
150064629|NCT02273739|541378676|FG000|Overall Study|Adverse Event|0|||
150064630|NCT02273739|541378677|FG001|Overall Study|Adverse Event|0|||
150064631|NCT02273739|541378678|FG002|Overall Study|Adverse Event|0|||
150064632|NCT02273739|541378679|FG003|Overall Study|Adverse Event|1|||
150064633|NCT02273739|541378676|FG000|Overall Study|Withdrawal by Subject|0|||
150064634|NCT02273739|541378677|FG001|Overall Study|Withdrawal by Subject|0|||
150064635|NCT02273739|541378678|FG002|Overall Study|Withdrawal by Subject|2|||
150064636|NCT02273739|541378679|FG003|Overall Study|Withdrawal by Subject|1|||
150064637|NCT02273739|541378676|FG000|Overall Study|Physician Decision|0|||
150064638|NCT02273739|541378677|FG001|Overall Study|Physician Decision|0|||
150064639|NCT02273739|541378678|FG002|Overall Study|Physician Decision|0|||
150064640|NCT02273739|541378679|FG003|Overall Study|Physician Decision|1|||
150064641|NCT01309893|541378680|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
150064642|NCT01309893|541378681|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
150064643|NCT01309893|541378680|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
150064644|NCT01309893|541378681|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
150064645|NCT03370289|541378683|FG000|Overall Study|Screen Failure|1|||
150064646|NCT03370289|541378683|FG000|Overall Study|Sample Size Sufficient|4|||
150064647|NCT00873860|541378685|FG000|Overall Study|Lost to Follow-up|1|||
150064648|NCT00873860|541378686|FG001|Overall Study|Lost to Follow-up|0|||
150064649|NCT00873860|541378687|FG002|Overall Study|Lost to Follow-up|0|||
150064650|NCT00873860|541378688|FG003|Overall Study|Lost to Follow-up|1|||
150064651|NCT00873860|541378685|FG000|Overall Study|Withdrawal by Subject|1|||
150064652|NCT00873860|541378686|FG001|Overall Study|Withdrawal by Subject|0|||
150064653|NCT00873860|541378687|FG002|Overall Study|Withdrawal by Subject|2|||
150064654|NCT00873860|541378688|FG003|Overall Study|Withdrawal by Subject|0|||
150064655|NCT00873860|541378685|FG000|Overall Study|Death|1|||
150064656|NCT00873860|541378686|FG001|Overall Study|Death|0|||
150064657|NCT00873860|541378687|FG002|Overall Study|Death|0|||
150064658|NCT00873860|541378688|FG003|Overall Study|Death|0|||
150064659|NCT00873860|541378685|FG000|Overall Study|Other|1|||
150064660|NCT00873860|541378686|FG001|Overall Study|Other|0|||
150064661|NCT00873860|541378687|FG002|Overall Study|Other|1|||
150064662|NCT00873860|541378688|FG003|Overall Study|Other|0|||
150064663|NCT01858636|541378693|FG000|Overall Study|No Device Deployment Attempted|24|||
150064664|NCT01858636|541378693|FG000|Overall Study|Physician Decision|1|||
150064665|NCT01858636|541378693|FG000|Overall Study|Death|1|||
150064666|NCT01858636|541378693|FG000|Overall Study|Lost to Follow-up|1|||
150064667|NCT01858636|541378693|FG000|Overall Study|Withdrawal by Subject|1|||
150064668|NCT02862600|541378696|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
150064669|NCT02862600|541378696|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
150064670|NCT02862600|541378696|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
150064671|NCT02862600|541378696|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
150064672|NCT01017575|541378705|FG000|Overall Study|Lack of Efficacy|0|||
150064673|NCT01017575|541378706|FG001|Overall Study|Lack of Efficacy|1|||
150064674|NCT01017575|541378707|FG002|Overall Study|Lack of Efficacy|0|||
150064675|NCT01017575|541378708|FG003|Overall Study|Lack of Efficacy|1|||
150064676|NCT01017575|541378709|FG004|Overall Study|Lack of Efficacy|1|||
150064677|NCT01017575|541378705|FG000|Overall Study|Adverse Event|0|||
150064678|NCT01017575|541378706|FG001|Overall Study|Adverse Event|1|||
150064679|NCT01017575|541378707|FG002|Overall Study|Adverse Event|0|||
150064680|NCT01017575|541378708|FG003|Overall Study|Adverse Event|0|||
150064681|NCT01017575|541378709|FG004|Overall Study|Adverse Event|2|||
150064682|NCT01017575|541378705|FG000|Overall Study|Withdrawal by Subject|1|||
150064683|NCT01017575|541378706|FG001|Overall Study|Withdrawal by Subject|0|||
150064684|NCT01017575|541378707|FG002|Overall Study|Withdrawal by Subject|0|||
150064685|NCT01017575|541378708|FG003|Overall Study|Withdrawal by Subject|0|||
150064686|NCT01017575|541378709|FG004|Overall Study|Withdrawal by Subject|0|||
150064687|NCT04437368|541378710|FG000|Overall Study|Death|3|||
150064688|NCT04437368|541378711|FG001|Overall Study|Death|0|||
150064689|NCT04437368|541378712|FG002|Overall Study|Death|2|||
150064690|NCT04437368|541378710|FG000|Overall Study|Study terminated by sponsor|16|||
150064691|NCT04437368|541378711|FG001|Overall Study|Study terminated by sponsor|1|||
150064692|NCT04437368|541378712|FG002|Overall Study|Study terminated by sponsor|25|||
150064693|NCT04437368|541378710|FG000|Overall Study|Withdrawal by Subject|4|||
150064694|NCT04437368|541378711|FG001|Overall Study|Withdrawal by Subject|0|||
150064695|NCT04437368|541378712|FG002|Overall Study|Withdrawal by Subject|3|||
150064696|NCT04437368|541378710|FG000|Overall Study|Sponsor instructions|23|||
150064697|NCT04437368|541378711|FG001|Overall Study|Sponsor instructions|0|||
150064698|NCT04437368|541378712|FG002|Overall Study|Sponsor instructions|0|||
150064699|NCT03500679|541378713|FG000|Overall Study|Lost to Follow-up|6|||
150064700|NCT03500679|541378714|FG001|Overall Study|Lost to Follow-up|3|||
150064701|NCT03500679|541378713|FG000|Overall Study|Withdrawal by Subject|3|||
150064702|NCT03500679|541378714|FG001|Overall Study|Withdrawal by Subject|0|||
150064703|NCT00095628|541378716|FG000|Overall Study|Disease progression prior to treatment|1|||
150064704|NCT04271280|541378717|FG000|Overall Study|Lost to Follow-up|300|||
150064705|NCT04271280|541378717|FG000|Overall Study|Death|153|||
150064706|NCT04271280|541378717|FG000|Overall Study|Withdrawal of consent by patient|59|||
150064707|NCT04271280|541378717|FG000|Overall Study|Other|51|||
150064708|NCT04271280|541378717|FG000|Overall Study|No end of study information|42|||
150064709|NCT02280473|541378718|FG000|Overall Study|Adverse Event|1|||
150064710|NCT02280473|541378719|FG001|Overall Study|Adverse Event|1|||
150064711|NCT02280473|541378718|FG000|Overall Study|Lack of Efficacy|0|||
150064712|NCT02280473|541378719|FG001|Overall Study|Lack of Efficacy|1|||
150064713|NCT02280473|541378718|FG000|Overall Study|Lost to Follow-up|0|||
150064714|NCT02280473|541378719|FG001|Overall Study|Lost to Follow-up|1|||
150064715|NCT01280955|541378725|FG000|Overall Study|Death|2|||
150064716|NCT01280955|541378725|FG000|Overall Study|Withdrawal by Subject|1|||
150064717|NCT01484054|541378728|FG000|Period 1|Withdrawal by Subject|0|||
150064718|NCT01484054|541378729|FG001|Period 1|Withdrawal by Subject|1|||
150064719|NCT01539317|541378730|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
150064720|NCT01539317|541378731|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
150064721|NCT04223232|541378732|FG000|Overall Study|Withdrawal by Subject|1|||
150064722|NCT00364130|541378733|FG000|Intervention Period|Lost to Follow-up|4|||
150064723|NCT00364130|541378734|FG001|Intervention Period|Lost to Follow-up|3|||
150064724|NCT00364130|541378733|FG000|Intervention Period|Pregnancy|1|||
150064725|NCT00364130|541378734|FG001|Intervention Period|Pregnancy|0|||
150064726|NCT00364130|541378733|FG000|Intervention Period|Withdrawal by Subject|4|||
150064727|NCT00364130|541378734|FG001|Intervention Period|Withdrawal by Subject|5|||
150064728|NCT00364130|541378733|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
150064729|NCT00364130|541378734|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
150064730|NCT05281601|541378735|FG000|Overall Study|Physician Decision|2|||
150064731|NCT05281601|541378736|FG001|Overall Study|Physician Decision|0|||
150064732|NCT05281601|541378735|FG000|Overall Study|Lost to Follow-up|2|||
150064733|NCT05281601|541378736|FG001|Overall Study|Lost to Follow-up|0|||
150064734|NCT05281601|541378735|FG000|Overall Study|Death|1|||
150064735|NCT05281601|541378736|FG001|Overall Study|Death|0|||
150064736|NCT05281601|541378735|FG000|Overall Study|Withdrawal by parent/guardian|2|||
150064737|NCT05281601|541378736|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150064738|NCT00901927|541378737|FG000|Overall Study|Lack of Efficacy|1|||
150064739|NCT00901927|541378737|FG000|Overall Study|Protocol Violation|3|||
150064740|NCT00901927|541378737|FG000|Overall Study|Withdrawal by Subject|2|||
150064741|NCT01178073|541378743|FG000|Overall Study|Adverse Event|34|||
150064742|NCT01178073|541378744|FG001|Overall Study|Adverse Event|27|||
150064743|NCT01178073|541378745|FG002|Overall Study|Adverse Event|24|||
150064744|NCT01178073|541378743|FG000|Overall Study|Protocol Violation|1|||
150064745|NCT01178073|541378744|FG001|Overall Study|Protocol Violation|1|||
150064746|NCT01178073|541378745|FG002|Overall Study|Protocol Violation|1|||
150064747|NCT01178073|541378743|FG000|Overall Study|Lost to Follow-up|2|||
150064748|NCT01178073|541378744|FG001|Overall Study|Lost to Follow-up|0|||
150064749|NCT01178073|541378745|FG002|Overall Study|Lost to Follow-up|3|||
150064750|NCT01178073|541378743|FG000|Overall Study|Physician Decision|14|||
150064751|NCT01178073|541378744|FG001|Overall Study|Physician Decision|10|||
150064752|NCT01178073|541378745|FG002|Overall Study|Physician Decision|10|||
150064753|NCT01178073|541378743|FG000|Overall Study|Withdrawal by Subject|10|||
150064754|NCT01178073|541378744|FG001|Overall Study|Withdrawal by Subject|6|||
150064755|NCT01178073|541378745|FG002|Overall Study|Withdrawal by Subject|8|||
150064756|NCT01178073|541378743|FG000|Overall Study|Missing Completion Status|1|||
150064757|NCT01178073|541378744|FG001|Overall Study|Missing Completion Status|0|||
150064758|NCT01178073|541378745|FG002|Overall Study|Missing Completion Status|0|||
150064759|NCT01674634|541378746|FG000|Overall Study|Withdrawal by Subject|3|||
150064760|NCT01674634|541378746|FG000|Overall Study|Lost to Follow-up|3|||
150064761|NCT00937391|541378747|FG000|Stage 2|Withdrawal by Subject|1|||
150064762|NCT02021656|541378767|FG000|Overall Study|Adverse Event|1|||
150064763|NCT02021656|541378767|FG000|Overall Study|Lack of Efficacy|2|||
150064764|NCT02021656|541378767|FG000|Overall Study|Lost to Follow-up|1|||
150064765|NCT02021656|541378767|FG000|Overall Study|Withdrew Consent|2|||
150064766|NCT00510952|541378768|FG000|Overall Study|Adverse Event|1|||
150064767|NCT00510952|541378769|FG001|Overall Study|Adverse Event|0|||
150064768|NCT00510952|541378768|FG000|Overall Study|Entry Criteria Not Met|3|||
150064769|NCT00510952|541378769|FG001|Overall Study|Entry Criteria Not Met|1|||
150064770|NCT00510952|541378768|FG000|Overall Study|Lost to Follow-up|5|||
150064771|NCT00510952|541378769|FG001|Overall Study|Lost to Follow-up|3|||
150064772|NCT00510952|541378768|FG000|Overall Study|Physician Decision|1|||
150064773|NCT00510952|541378769|FG001|Overall Study|Physician Decision|1|||
150064774|NCT00510952|541378768|FG000|Overall Study|Protocol Violation|7|||
150064775|NCT00510952|541378769|FG001|Overall Study|Protocol Violation|4|||
150064776|NCT00510952|541378768|FG000|Overall Study|Sponsor Decision|1|||
150064777|NCT00510952|541378769|FG001|Overall Study|Sponsor Decision|0|||
150064778|NCT00510952|541378768|FG000|Overall Study|Withdrawal by Subject|6|||
150064779|NCT00510952|541378769|FG001|Overall Study|Withdrawal by Subject|7|||
150064780|NCT00510952|541378768|FG000|Overall Study|Did Not Receive Study Drug|2|||
150064781|NCT00510952|541378769|FG001|Overall Study|Did Not Receive Study Drug|0|||
150064782|NCT03172910|541380488|FG000|Overall Study|Adverse Event|0|||
150064783|NCT03172910|541380489|FG001|Overall Study|Adverse Event|0|||
150064784|NCT03172910|541380490|FG002|Overall Study|Adverse Event|0|||
150064785|NCT03172910|541380491|FG003|Overall Study|Adverse Event|0|||
150064786|NCT03172910|541380492|FG004|Overall Study|Adverse Event|1|||
150064787|NCT01659658|541380494|FG000|Overall Study|Withdrawal by Patient|18|||
150064788|NCT01659658|541380495|FG001|Overall Study|Withdrawal by Patient|4|||
150064789|NCT01659658|541380496|FG002|Overall Study|Withdrawal by Patient|2|||
150064790|NCT01659658|541380497|FG003|Overall Study|Withdrawal by Patient|0|||
150064791|NCT01659658|541380498|FG004|Overall Study|Withdrawal by Patient|11|||
150064792|NCT01659658|541380494|FG000|Overall Study|Study Terminated by Sponsor|9|||
150064793|NCT01659658|541380495|FG001|Overall Study|Study Terminated by Sponsor|7|||
150064794|NCT01659658|541380496|FG002|Overall Study|Study Terminated by Sponsor|0|||
150064795|NCT01659658|541380497|FG003|Overall Study|Study Terminated by Sponsor|1|||
150064796|NCT01659658|541380498|FG004|Overall Study|Study Terminated by Sponsor|4|||
150064797|NCT01659658|541380494|FG000|Overall Study|Reason not Specified|61|||
150064798|NCT01659658|541380495|FG001|Overall Study|Reason not Specified|15|||
150064799|NCT01659658|541380496|FG002|Overall Study|Reason not Specified|8|||
150064800|NCT01659658|541380497|FG003|Overall Study|Reason not Specified|1|||
150064801|NCT01659658|541380498|FG004|Overall Study|Reason not Specified|34|||
150064802|NCT01659658|541380494|FG000|Overall Study|Lost to Follow-up|2|||
150064803|NCT01659658|541380495|FG001|Overall Study|Lost to Follow-up|0|||
150064804|NCT01659658|541380496|FG002|Overall Study|Lost to Follow-up|0|||
150064805|NCT01659658|541380497|FG003|Overall Study|Lost to Follow-up|0|||
150064806|NCT01659658|541380498|FG004|Overall Study|Lost to Follow-up|0|||
150064807|NCT02247531|541380506|FG000|Overall Study|Adverse Event|3|||
150064808|NCT02247531|541380507|FG001|Overall Study|Adverse Event|4|||
150064809|NCT02247531|541380508|FG002|Overall Study|Adverse Event|9|||
150064810|NCT02247531|541380506|FG000|Overall Study|Death|8|||
150064811|NCT02247531|541380507|FG001|Overall Study|Death|9|||
150064812|NCT02247531|541380508|FG002|Overall Study|Death|5|||
150064813|NCT02247531|541380506|FG000|Overall Study|Lost to Follow-up|1|||
150064814|NCT02247531|541380507|FG001|Overall Study|Lost to Follow-up|8|||
150064815|NCT02247531|541380508|FG002|Overall Study|Lost to Follow-up|3|||
150064816|NCT02247531|541380506|FG000|Overall Study|Non-compliance|2|||
150064817|NCT02247531|541380507|FG001|Overall Study|Non-compliance|2|||
150064818|NCT02247531|541380508|FG002|Overall Study|Non-compliance|0|||
150064819|NCT02247531|541380506|FG000|Overall Study|Withdrawal by Subject|26|||
150064820|NCT02247531|541380507|FG001|Overall Study|Withdrawal by Subject|31|||
150064821|NCT02247531|541380508|FG002|Overall Study|Withdrawal by Subject|25|||
150064822|NCT02247531|541380506|FG000|Overall Study|Study Terminated by Sponsor|64|||
150064823|NCT02247531|541380507|FG001|Overall Study|Study Terminated by Sponsor|66|||
150064824|NCT02247531|541380508|FG002|Overall Study|Study Terminated by Sponsor|62|||
150064825|NCT02247531|541380506|FG000|Overall Study|Physician Decision|0|||
150064826|NCT02247531|541380507|FG001|Overall Study|Physician Decision|2|||
150064827|NCT02247531|541380508|FG002|Overall Study|Physician Decision|2|||
150064828|NCT02247531|541380506|FG000|Overall Study|Unspecified Reason|2|||
150064829|NCT02247531|541380507|FG001|Overall Study|Unspecified Reason|3|||
150064830|NCT02247531|541380508|FG002|Overall Study|Unspecified Reason|4|||
150064831|NCT03347188|541380509|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
150064832|NCT03347188|541380510|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
150064833|NCT03347188|541380509|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
150064834|NCT03347188|541380510|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
150064835|NCT03347188|541380509|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
150064836|NCT03347188|541380510|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
150064837|NCT03347188|541380509|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
150064838|NCT03347188|541380510|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
150064839|NCT03347188|541380509|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
150064840|NCT03347188|541380510|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
150064841|NCT03347188|541380509|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
150064842|NCT03347188|541380510|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
150064843|NCT03347188|541380509|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
150064844|NCT03347188|541380510|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
150064845|NCT03347188|541380509|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
150064846|NCT03347188|541380510|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
150064847|NCT03468985|541380511|FG000|Overall Study|Adverse Event|0|||
150064848|NCT03468985|541380512|FG001|Overall Study|Adverse Event|2|||
150064849|NCT03468985|541380513|FG002|Overall Study|Adverse Event|0|||
150064850|NCT03468985|541380514|FG003|Overall Study|Adverse Event|0|||
150064851|NCT03468985|541380511|FG000|Overall Study|Withdrawal by Subject|0|||
150064852|NCT03468985|541380512|FG001|Overall Study|Withdrawal by Subject|0|||
150064853|NCT03468985|541380513|FG002|Overall Study|Withdrawal by Subject|0|||
150064854|NCT03468985|541380514|FG003|Overall Study|Withdrawal by Subject|1|||
150064855|NCT01869725|541380517|FG000|Overall Study|ineligible after registration|1|||
150064856|NCT01869725|541380517|FG000|Overall Study|Death|1|||
150064857|NCT01869725|541380517|FG000|Overall Study|Lost to Follow-up|2|||
150064858|NCT03416374|541380524|FG000|Between Treatment Period I and II|Other|0|||
150064859|NCT03416374|541380525|FG001|Between Treatment Period I and II|Other|9|||
150064860|NCT03416374|541380524|FG000|Treatment Period II|Lack of Efficacy|3|||
150064861|NCT03416374|541380525|FG001|Treatment Period II|Lack of Efficacy|11|||
150064862|NCT03416374|541380524|FG000|Treatment Period II|Adverse Event|1|||
150064863|NCT03416374|541380525|FG001|Treatment Period II|Adverse Event|4|||
150064864|NCT03416374|541380524|FG000|Treatment Period II|Death|0|||
150064865|NCT03416374|541380525|FG001|Treatment Period II|Death|1|||
150064866|NCT03416374|541380524|FG000|Treatment Period II|Other|0|||
150064867|NCT03416374|541380525|FG001|Treatment Period II|Other|2|||
150064868|NCT03463031|541380526|FG000|Overall Study|Withdrawal by Subject|4|||
150064869|NCT03463031|541380527|FG001|Overall Study|Withdrawal by Subject|2|||
150064870|NCT03463031|541380526|FG000|Overall Study|Investigator/Sponsor Decision|0|||
150064871|NCT03463031|541380527|FG001|Overall Study|Investigator/Sponsor Decision|1|||
150064872|NCT03463031|541380526|FG000|Overall Study|Lost to Follow-up|1|||
150064873|NCT03463031|541380527|FG001|Overall Study|Lost to Follow-up|1|||
150064874|NCT03463031|541380526|FG000|Overall Study|Adverse Event|4|||
150064875|NCT03463031|541380527|FG001|Overall Study|Adverse Event|1|||
150064876|NCT03463031|541380526|FG000|Overall Study|Use of prohibited medication by subject|1|||
150064877|NCT03463031|541380527|FG001|Overall Study|Use of prohibited medication by subject|0|||
150064878|NCT01068652|541380528|FG000|Overall Study|Adverse Event|4|||
150064879|NCT01068652|541380529|FG001|Overall Study|Adverse Event|0|||
150064880|NCT01068652|541380528|FG000|Overall Study|Lack of Efficacy|0|||
150064881|NCT01068652|541380529|FG001|Overall Study|Lack of Efficacy|2|||
150064882|NCT01068652|541380528|FG000|Overall Study|Lost to Follow-up|2|||
150064883|NCT01068652|541380529|FG001|Overall Study|Lost to Follow-up|1|||
150064884|NCT01068652|541380528|FG000|Overall Study|Protocol Violation|3|||
150064885|NCT01068652|541380529|FG001|Overall Study|Protocol Violation|6|||
150064886|NCT01068652|541380528|FG000|Overall Study|Withdrawal criteria|1|||
150064887|NCT01068652|541380529|FG001|Overall Study|Withdrawal criteria|2|||
150064888|NCT01068652|541380528|FG000|Overall Study|Patient was not eligible|1|||
150064889|NCT01068652|541380529|FG001|Overall Study|Patient was not eligible|0|||
150064890|NCT01068652|541380528|FG000|Overall Study|Unclassified|7|||
150064891|NCT01068652|541380529|FG001|Overall Study|Unclassified|4|||
150064892|NCT00417482|541380530|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
150064893|NCT00417482|541380531|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
150064894|NCT00417482|541380532|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
150064895|NCT00417482|541380530|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
150064896|NCT00417482|541380531|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
150064897|NCT00417482|541380532|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
150064898|NCT00417482|541380530|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
150064899|NCT00417482|541380531|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
150064900|NCT00417482|541380532|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
150064901|NCT00417482|541380530|FG000|Phase B 1st 16 Weeks|Death|1|||
150064902|NCT00417482|541380531|FG001|Phase B 1st 16 Weeks|Death|0|||
150064903|NCT00417482|541380532|FG002|Phase B 1st 16 Weeks|Death|0|||
150064904|NCT00417482|541380530|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
150064905|NCT00417482|541380531|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
150064906|NCT00417482|541380532|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
150064907|NCT00417482|541380530|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
150064908|NCT00417482|541380531|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
150064909|NCT00417482|541380532|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
150064910|NCT00417482|541380530|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
150064911|NCT00417482|541380531|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
150064912|NCT00417482|541380532|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
150064913|NCT00417482|541380530|FG000|Phase B 2nd 16 Weeks|Death|1|||
150064914|NCT00417482|541380531|FG001|Phase B 2nd 16 Weeks|Death|1|||
150064915|NCT00417482|541380532|FG002|Phase B 2nd 16 Weeks|Death|0|||
150064916|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
150064917|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
150064918|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
150064919|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
150064920|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
150064921|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
150064922|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
150064923|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
150064924|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
150064925|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
150064926|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
150064927|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
150064928|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
150064929|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
150064930|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
150064931|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
150064932|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Program Termination|3|||
150064933|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Program Termination|0|||
150064934|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Program Termination|1|||
150064935|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Program Termination|1|||
150064936|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
150064937|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
150064938|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
150064939|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
150064940|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
150064941|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
150064942|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
150064943|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
150064944|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
150064945|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
150064946|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
150064947|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
150064948|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
150064949|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
150064950|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
150064951|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
150064952|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
150064953|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
150064954|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
150064955|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
150064956|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
150064957|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
150064958|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
150064959|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
150064960|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
150064961|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
150064962|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
150064963|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
150064964|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
150064965|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
150064966|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
150064967|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
150064968|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
150064969|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
150064970|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
150064971|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
150064972|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
150064973|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
150064974|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
150064975|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
150064976|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
150064977|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
150064978|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
150064979|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
150064980|NCT03739840|541380533|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
150064981|NCT03739840|541380534|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
150064982|NCT03739840|541380535|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
150064983|NCT03739840|541380536|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
150064984|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
150064985|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
150064986|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
150064987|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
150064988|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
150064989|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
150064990|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
150064991|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
150064992|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
150064993|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
150064994|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
150064995|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
150064996|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
150064997|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
150064998|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
150064999|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
150065000|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
150065001|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
150065002|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
150065003|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
150065004|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
150065005|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
150065006|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
150065007|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
150065008|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
150065009|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
150065010|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
150065011|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
150065012|NCT03739840|541380533|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
150065013|NCT03739840|541380534|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
150065014|NCT03739840|541380535|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
150065015|NCT03739840|541380536|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
150065016|NCT01323946|541380537|FG000|Overall Study|Lost to Follow-up|0|||
150065017|NCT01323946|541380538|FG001|Overall Study|Lost to Follow-up|1|||
150065018|NCT01323946|541380539|FG002|Overall Study|Lost to Follow-up|0|||
150065019|NCT01323946|541380537|FG000|Overall Study|Parents refused the last blood draw|1|||
150065020|NCT01323946|541380538|FG001|Overall Study|Parents refused the last blood draw|0|||
150065021|NCT01323946|541380539|FG002|Overall Study|Parents refused the last blood draw|0|||
150065022|NCT01323946|541380537|FG000|Overall Study|Withdrawal by Subject|2|||
150065023|NCT01323946|541380538|FG001|Overall Study|Withdrawal by Subject|2|||
150065024|NCT01323946|541380539|FG002|Overall Study|Withdrawal by Subject|0|||
150065025|NCT01058265|541380540|FG000|Overall Study|Lost to Follow-up|11|||
150065026|NCT01058265|541380541|FG001|Overall Study|Lost to Follow-up|12|||
150065027|NCT01243671|541380542|FG000|Overall Study|Adverse Event|3|||
150065028|NCT01243671|541380542|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
150065029|NCT01243671|541380542|FG000|Overall Study|Other|1|||
150065030|NCT02869438|541380543|FG000|Overall Study|Lost to Follow-up|1|||
150065031|NCT02869438|541380544|FG001|Overall Study|Lost to Follow-up|0|||
150065032|NCT02869438|541380543|FG000|Overall Study|Adverse Event|1|||
150065033|NCT02869438|541380544|FG001|Overall Study|Adverse Event|0|||
150065034|NCT02869438|541380543|FG000|Overall Study|Withdrawal by Subject|1|||
150065035|NCT02869438|541380544|FG001|Overall Study|Withdrawal by Subject|2|||
150065036|NCT02962765|541380545|FG000|Overall Study|Protocol Violation|9|||
150065037|NCT02962765|541380545|FG000|Overall Study|Withdrawal by Subject|3|||
150065038|NCT02962765|541380545|FG000|Overall Study|Lost to Follow-up|1|||
150065039|NCT02962765|541380545|FG000|Overall Study|Death|1|||
150065040|NCT02962765|541380545|FG000|Overall Study|Limited access to study medication|3|||
150065041|NCT03583073|541380546|FG000|Overall Study|Lost to Follow-up|8|||
150065042|NCT03583073|541380547|FG001|Overall Study|Lost to Follow-up|12|||
150065043|NCT02964507|541380548|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065044|NCT02964507|541380549|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
150065045|NCT02964507|541380550|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065046|NCT02964507|541380551|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065047|NCT02964507|541380552|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
150065048|NCT02964507|541380553|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065049|NCT02964507|541380554|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065050|NCT02964507|541380555|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
150065051|NCT02964507|541380548|FG000|Overall Study|Study terminated by Sponsor|9|||
150065052|NCT02964507|541380549|FG001|Overall Study|Study terminated by Sponsor|1|||
150065053|NCT02964507|541380550|FG002|Overall Study|Study terminated by Sponsor|9|||
150065054|NCT02964507|541380551|FG003|Overall Study|Study terminated by Sponsor|3|||
150065055|NCT02964507|541380552|FG004|Overall Study|Study terminated by Sponsor|3|||
150065056|NCT02964507|541380553|FG005|Overall Study|Study terminated by Sponsor|2|||
150065057|NCT02964507|541380554|FG006|Overall Study|Study terminated by Sponsor|0|||
150065058|NCT02964507|541380555|FG007|Overall Study|Study terminated by Sponsor|0|||
150025403|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150065059|NCT02964507|541380548|FG000|Overall Study|Other|3|||
150065060|NCT02964507|541380549|FG001|Overall Study|Other|0|||
150065061|NCT02964507|541380550|FG002|Overall Study|Other|0|||
150065062|NCT02964507|541380551|FG003|Overall Study|Other|0|||
150065063|NCT02964507|541380552|FG004|Overall Study|Other|1|||
150025404|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025405|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
150025406|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025407|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025408|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025409|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025410|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025411|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025412|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
150025413|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025414|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025415|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025416|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
150025417|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025418|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025419|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025420|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025421|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025422|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025423|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025424|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025425|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025426|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025427|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025428|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025429|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
150025430|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025431|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
150025432|NCT01147666|541228470|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025433|NCT01147666|541228471|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025434|NCT01147666|541228472|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025435|NCT01147666|541228473|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025436|NCT01147666|541228474|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025437|NCT01147666|541228475|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025438|NCT01147666|541228476|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025439|NCT01147666|541228477|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025440|NCT01147666|541228478|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025441|NCT01147666|541228479|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025442|NCT01147666|541228480|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025443|NCT01147666|541228481|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025444|NCT01147666|541228482|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
150025445|NCT01147666|541228483|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
150025446|NCT01147666|541228484|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
150025447|NCT00796666|541228485|FG000|Overall Study|Death|2|||
150065064|NCT02964507|541380553|FG005|Overall Study|Other|0|||
150065065|NCT02964507|541380554|FG006|Overall Study|Other|0|||
150065066|NCT02964507|541380555|FG007|Overall Study|Other|0|||
150065067|NCT02964507|541380548|FG000|Overall Study|Death|11|||
150065068|NCT02964507|541380549|FG001|Overall Study|Death|9|||
150065069|NCT02964507|541380550|FG002|Overall Study|Death|12|||
150065070|NCT02964507|541380551|FG003|Overall Study|Death|2|||
150065071|NCT02964507|541380552|FG004|Overall Study|Death|10|||
150065072|NCT02964507|541380553|FG005|Overall Study|Death|5|||
150065073|NCT02964507|541380554|FG006|Overall Study|Death|0|||
150065074|NCT02964507|541380555|FG007|Overall Study|Death|0|||
150065075|NCT02964507|541380548|FG000|Overall Study|Withdrawal by Subject|1|||
150065076|NCT02964507|541380549|FG001|Overall Study|Withdrawal by Subject|0|||
150065077|NCT02964507|541380550|FG002|Overall Study|Withdrawal by Subject|1|||
150065078|NCT02964507|541380551|FG003|Overall Study|Withdrawal by Subject|1|||
150065079|NCT02964507|541380552|FG004|Overall Study|Withdrawal by Subject|0|||
150065080|NCT02964507|541380553|FG005|Overall Study|Withdrawal by Subject|1|||
150065081|NCT02964507|541380554|FG006|Overall Study|Withdrawal by Subject|0|||
150065082|NCT02964507|541380555|FG007|Overall Study|Withdrawal by Subject|0|||
150065083|NCT02964507|541380548|FG000|Overall Study|Physician Decision|2|||
150065084|NCT02964507|541380549|FG001|Overall Study|Physician Decision|0|||
150065085|NCT02964507|541380550|FG002|Overall Study|Physician Decision|3|||
150065086|NCT02964507|541380551|FG003|Overall Study|Physician Decision|0|||
150065087|NCT02964507|541380552|FG004|Overall Study|Physician Decision|1|||
150065088|NCT02964507|541380553|FG005|Overall Study|Physician Decision|0|||
150065089|NCT02964507|541380554|FG006|Overall Study|Physician Decision|0|||
150065090|NCT02964507|541380555|FG007|Overall Study|Physician Decision|0|||
150065091|NCT05323656|541380557|FG000|Overall Study|Still On-Treatment|6|||
150065092|NCT05323656|541380558|FG001|Overall Study|Still On-Treatment|6|||
150065093|NCT05323656|541380557|FG000|Overall Study|Progressive Disease|15|||
150065094|NCT05323656|541380558|FG001|Overall Study|Progressive Disease|14|||
150065095|NCT05323656|541380557|FG000|Overall Study|Adverse Event|2|||
150065096|NCT05323656|541380558|FG001|Overall Study|Adverse Event|3|||
150065097|NCT05323656|541380557|FG000|Overall Study|Death|1|||
150065098|NCT05323656|541380558|FG001|Overall Study|Death|2|||
150065099|NCT05323656|541380557|FG000|Overall Study|Withdrawal by Subject|1|||
150065100|NCT05323656|541380558|FG001|Overall Study|Withdrawal by Subject|0|||
150065101|NCT05323656|541380557|FG000|Overall Study|Clinical disease progression|0|||
150065102|NCT05323656|541380558|FG001|Overall Study|Clinical disease progression|1|||
150065103|NCT05323656|541380557|FG000|Overall Study|Patient and Investigator decision|1|||
150065104|NCT05323656|541380558|FG001|Overall Study|Patient and Investigator decision|0|||
150065105|NCT05323656|541380557|FG000|Overall Study|Physician Decision|0|||
150065106|NCT05323656|541380558|FG001|Overall Study|Physician Decision|1|||
150065107|NCT02495233|541380559|FG000|Overall Study|Miscellaneous|0|||
150065108|NCT02495233|541380560|FG001|Overall Study|Miscellaneous|1|||
150065109|NCT03880461|541380561|FG000|Overall Study|Determined ineligible after enrollment|45|||
150065110|NCT03880461|541380562|FG001|Overall Study|Determined ineligible after enrollment|44|||
150065111|NCT03880461|541380561|FG000|Overall Study|No weight measurement after enrollment|24|||
150065112|NCT03880461|541380562|FG001|Overall Study|No weight measurement after enrollment|17|||
150065113|NCT01028378|541380565|FG000|Overall Study|Lost to Follow-up|12|||
150065114|NCT01028378|541380565|FG000|Overall Study|Withdrawal by Subject|1|||
150065115|NCT01028378|541380565|FG000|Overall Study|Adminstrative Reasons|4|||
150065116|NCT01115803|541380569|FG000|Overall Study|Withdrawal by Subject|0|||
150065117|NCT01115803|541380570|FG001|Overall Study|Withdrawal by Subject|0|||
150065118|NCT01115803|541380571|FG002|Overall Study|Withdrawal by Subject|0|||
150065119|NCT01115803|541380572|FG003|Overall Study|Withdrawal by Subject|0|||
150065120|NCT01115803|541380573|FG004|Overall Study|Withdrawal by Subject|0|||
150065121|NCT01115803|541380574|FG005|Overall Study|Withdrawal by Subject|0|||
150065122|NCT01115803|541380575|FG006|Overall Study|Withdrawal by Subject|1|||
150065123|NCT01115803|541380569|FG000|Overall Study|Lost to Follow-up|0|||
150065124|NCT01115803|541380570|FG001|Overall Study|Lost to Follow-up|0|||
150065125|NCT01115803|541380571|FG002|Overall Study|Lost to Follow-up|1|||
150065126|NCT01115803|541380572|FG003|Overall Study|Lost to Follow-up|0|||
150065127|NCT01115803|541380573|FG004|Overall Study|Lost to Follow-up|0|||
150065128|NCT01115803|541380574|FG005|Overall Study|Lost to Follow-up|0|||
150065129|NCT01115803|541380575|FG006|Overall Study|Lost to Follow-up|0|||
150065130|NCT01115803|541380569|FG000|Overall Study|Progressive Disease during Cycle1|0|||
150065131|NCT01115803|541380570|FG001|Overall Study|Progressive Disease during Cycle1|0|||
150065132|NCT01115803|541380571|FG002|Overall Study|Progressive Disease during Cycle1|0|||
150065133|NCT01115803|541380572|FG003|Overall Study|Progressive Disease during Cycle1|0|||
150065134|NCT01115803|541380573|FG004|Overall Study|Progressive Disease during Cycle1|0|||
150065135|NCT01115803|541380574|FG005|Overall Study|Progressive Disease during Cycle1|0|||
150065136|NCT01115803|541380575|FG006|Overall Study|Progressive Disease during Cycle1|1|||
150065137|NCT00064298|541380576|FG000|Overall Study|Withdrawal by Subject|2|||
150065138|NCT00064298|541380577|FG001|Overall Study|Withdrawal by Subject|1|||
150065139|NCT00064298|541380576|FG000|Overall Study|Lost to Follow-up|2|||
150065140|NCT00064298|541380577|FG001|Overall Study|Lost to Follow-up|2|||
150065141|NCT00064298|541380576|FG000|Overall Study|Death|0|||
150065142|NCT00064298|541380577|FG001|Overall Study|Death|1|||
150065143|NCT00064298|541380576|FG000|Overall Study|Disease Progression|2|||
150065144|NCT00064298|541380577|FG001|Overall Study|Disease Progression|1|||
150065145|NCT03614975|541380578|FG000|Overall Study|Physician Decision|7|||
150065146|NCT03614975|541380579|FG001|Overall Study|Physician Decision|5|||
150065147|NCT03614975|541380578|FG000|Overall Study|Withdrawal by Subject|2|||
150065148|NCT03614975|541380579|FG001|Overall Study|Withdrawal by Subject|2|||
150065149|NCT03614975|541380578|FG000|Overall Study|Specimens not in lab batch shipment|1|||
150065150|NCT03614975|541380579|FG001|Overall Study|Specimens not in lab batch shipment|1|||
150065151|NCT00450385|541380580|FG000|Overall Study|Death|3|||
150065152|NCT00450385|541380580|FG000|Overall Study|Protocol Violation|1|||
150065153|NCT00450385|541380580|FG000|Overall Study|Withdrawal by Subject|2|||
150065154|NCT00450385|541380580|FG000|Overall Study|Lack of Efficacy|2|||
150065155|NCT00450385|541380580|FG000|Overall Study|Adverse Event|1|||
150065156|NCT00450385|541380580|FG000|Overall Study|Physician Decision|1|||
150065157|NCT00450385|541380580|FG000|Overall Study|Other|3|||
150065158|NCT01390220|541380581|FG000|Test Dose Phase|Adverse Event|17|||
150065159|NCT01390220|541380582|FG001|Test Dose Phase|Adverse Event|0|||
150065160|NCT01390220|541380583|FG002|Test Dose Phase|Adverse Event|0|||
150065161|NCT01390220|541380581|FG000|Test Dose Phase|Withdrawal by Subject|8|||
150065162|NCT01390220|541380582|FG001|Test Dose Phase|Withdrawal by Subject|0|||
150065163|NCT01390220|541380583|FG002|Test Dose Phase|Withdrawal by Subject|0|||
150065164|NCT01390220|541380581|FG000|Test Dose Phase|Lost to Follow-up|2|||
150065165|NCT01390220|541380582|FG001|Test Dose Phase|Lost to Follow-up|0|||
150065166|NCT01390220|541380583|FG002|Test Dose Phase|Lost to Follow-up|0|||
150065167|NCT01390220|541380581|FG000|Test Dose Phase|Protocol Violation|8|||
150065168|NCT01390220|541380582|FG001|Test Dose Phase|Protocol Violation|0|||
150065169|NCT01390220|541380583|FG002|Test Dose Phase|Protocol Violation|0|||
150065170|NCT01390220|541380581|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
150065171|NCT01390220|541380582|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
150065172|NCT01390220|541380583|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
150065173|NCT01390220|541380581|FG000|Test Dose Phase|Study/Site closure|6|||
150065174|NCT01390220|541380582|FG001|Test Dose Phase|Study/Site closure|0|||
150065175|NCT01390220|541380583|FG002|Test Dose Phase|Study/Site closure|0|||
150065176|NCT01390220|541380581|FG000|Test Dose Phase|Caregiver no longer available|5|||
150065177|NCT01390220|541380582|FG001|Test Dose Phase|Caregiver no longer available|0|||
150065178|NCT01390220|541380583|FG002|Test Dose Phase|Caregiver no longer available|0|||
150065179|NCT01390220|541380581|FG000|Test Dose Phase|Noncompliance|2|||
150065180|NCT01390220|541380582|FG001|Test Dose Phase|Noncompliance|0|||
150065181|NCT01390220|541380583|FG002|Test Dose Phase|Noncompliance|0|||
150065182|NCT01390220|541380581|FG000|Test Dose Phase|Logistical|6|||
150065183|NCT01390220|541380582|FG001|Test Dose Phase|Logistical|0|||
150065184|NCT01390220|541380583|FG002|Test Dose Phase|Logistical|0|||
150065185|NCT01390220|541380581|FG000|Comparative Phase|Withdrawal by Subject|0|||
150065186|NCT01390220|541380582|FG001|Comparative Phase|Withdrawal by Subject|1|||
150065187|NCT01390220|541380583|FG002|Comparative Phase|Withdrawal by Subject|0|||
150065188|NCT03533686|541380584|FG000|Overall Study|Withdrawal by Subject|1|||
150065189|NCT03533686|541380585|FG001|Overall Study|Withdrawal by Subject|0|||
150065190|NCT03533686|541380586|FG002|Overall Study|Withdrawal by Subject|0|||
150065191|NCT03533686|541380587|FG003|Overall Study|Withdrawal by Subject|3|||
150065192|NCT03533686|541380588|FG004|Overall Study|Withdrawal by Subject|5|||
150065193|NCT03533686|541380589|FG005|Overall Study|Withdrawal by Subject|1|||
150065194|NCT03533686|541380584|FG000|Overall Study|Lost to Follow-up|0|||
150065195|NCT03533686|541380585|FG001|Overall Study|Lost to Follow-up|1|||
150065196|NCT03533686|541380586|FG002|Overall Study|Lost to Follow-up|0|||
150065197|NCT03533686|541380587|FG003|Overall Study|Lost to Follow-up|0|||
150065198|NCT03533686|541380588|FG004|Overall Study|Lost to Follow-up|2|||
150065199|NCT03533686|541380589|FG005|Overall Study|Lost to Follow-up|0|||
150065200|NCT03533686|541380584|FG000|Overall Study|Screen Failure|0|||
150065201|NCT03533686|541380585|FG001|Overall Study|Screen Failure|0|||
150065202|NCT03533686|541380586|FG002|Overall Study|Screen Failure|0|||
150065203|NCT03533686|541380587|FG003|Overall Study|Screen Failure|2|||
150065204|NCT03533686|541380588|FG004|Overall Study|Screen Failure|0|||
150065205|NCT03533686|541380589|FG005|Overall Study|Screen Failure|0|||
150065206|NCT00136604|541380590|FG000|Overall Study|Lost to Follow-up|1|||
150065207|NCT00136604|541380591|FG001|Overall Study|Lost to Follow-up|0|||
150065208|NCT00136604|541380592|FG002|Overall Study|Lost to Follow-up|0|||
150065209|NCT00136604|541380593|FG003|Overall Study|Lost to Follow-up|0|||
150065210|NCT00136604|541380594|FG004|Overall Study|Lost to Follow-up|1|||
150065211|NCT00136604|541380590|FG000|Overall Study|Migrated/moved from study area|0|||
150065212|NCT00136604|541380591|FG001|Overall Study|Migrated/moved from study area|1|||
150065213|NCT00136604|541380592|FG002|Overall Study|Migrated/moved from study area|0|||
150065214|NCT00136604|541380593|FG003|Overall Study|Migrated/moved from study area|0|||
150065215|NCT00136604|541380594|FG004|Overall Study|Migrated/moved from study area|0|||
150065216|NCT02017171|541380595|FG000|Overall Study|Death|10|||
150065217|NCT02017171|541380596|FG001|Overall Study|Death|4|||
150065218|NCT02017171|541380595|FG000|Overall Study|Withdrawal by Subject|23|||
150065219|NCT02017171|541380596|FG001|Overall Study|Withdrawal by Subject|17|||
150065220|NCT02017171|541380595|FG000|Overall Study|Lost to Follow-up|21|||
150065221|NCT02017171|541380596|FG001|Overall Study|Lost to Follow-up|20|||
150065222|NCT02017171|541380595|FG000|Overall Study|ESKD|6|||
150065223|NCT02017171|541380596|FG001|Overall Study|ESKD|2|||
150065224|NCT02017171|541380595|FG000|Overall Study|Miscellaneous|2|||
150065225|NCT02017171|541380596|FG001|Overall Study|Miscellaneous|3|||
150065226|NCT01562873|541380597|FG000|Overall Study|Disease Progression per RECIST|10|||
150065227|NCT01562873|541380598|FG001|Overall Study|Disease Progression per RECIST|0|||
150065228|NCT01562873|541380597|FG000|Overall Study|Adverse Event|1|||
150065229|NCT01562873|541380598|FG001|Overall Study|Adverse Event|0|||
150065230|NCT01562873|541380597|FG000|Overall Study|Clinical Disease Progression|9|||
150065231|NCT01562873|541380598|FG001|Overall Study|Clinical Disease Progression|0|||
150065232|NCT01562873|541380597|FG000|Overall Study|Clinical PD and adverse event|1|||
150065233|NCT01562873|541380598|FG001|Overall Study|Clinical PD and adverse event|0|||
150065234|NCT02536833|541380601|FG000|Overall Study|Discontinued Before Treatment|0|||
150065235|NCT02536833|541380602|FG001|Overall Study|Discontinued Before Treatment|0|||
150065236|NCT02536833|541380603|FG002|Overall Study|Discontinued Before Treatment|1|||
150065237|NCT02536833|541380604|FG003|Overall Study|Discontinued Before Treatment|2|||
150065238|NCT02536833|541380601|FG000|Overall Study|Adverse Event|1|||
150065239|NCT02536833|541380602|FG001|Overall Study|Adverse Event|3|||
150065240|NCT02536833|541380603|FG002|Overall Study|Adverse Event|4|||
150065241|NCT02536833|541380604|FG003|Overall Study|Adverse Event|1|||
150065242|NCT02536833|541380601|FG000|Overall Study|Lost to Follow-up|2|||
150065243|NCT02536833|541380602|FG001|Overall Study|Lost to Follow-up|1|||
150065244|NCT02536833|541380603|FG002|Overall Study|Lost to Follow-up|2|||
150065245|NCT02536833|541380604|FG003|Overall Study|Lost to Follow-up|2|||
150065246|NCT02536833|541380601|FG000|Overall Study|Physician Decision|0|||
150065247|NCT02536833|541380602|FG001|Overall Study|Physician Decision|0|||
150065248|NCT02536833|541380603|FG002|Overall Study|Physician Decision|0|||
150065249|NCT02536833|541380604|FG003|Overall Study|Physician Decision|1|||
150065250|NCT02536833|541380601|FG000|Overall Study|Site Terminated by Sponsor|2|||
150065251|NCT02536833|541380602|FG001|Overall Study|Site Terminated by Sponsor|2|||
150065252|NCT02536833|541380603|FG002|Overall Study|Site Terminated by Sponsor|2|||
150065253|NCT02536833|541380604|FG003|Overall Study|Site Terminated by Sponsor|2|||
150065254|NCT02536833|541380601|FG000|Overall Study|Subject Non-Compliance|0|||
150065255|NCT02536833|541380602|FG001|Overall Study|Subject Non-Compliance|1|||
150065256|NCT02536833|541380603|FG002|Overall Study|Subject Non-Compliance|1|||
150065257|NCT02536833|541380604|FG003|Overall Study|Subject Non-Compliance|0|||
150065258|NCT02536833|541380601|FG000|Overall Study|Withdrawal by Subject|4|||
150065259|NCT02536833|541380602|FG001|Overall Study|Withdrawal by Subject|3|||
150065260|NCT02536833|541380603|FG002|Overall Study|Withdrawal by Subject|5|||
150065261|NCT02536833|541380604|FG003|Overall Study|Withdrawal by Subject|11|||
150065262|NCT02220998|541380605|FG000|Overall Study|Randomized but Never Treated|1|||
150065263|NCT02220998|541380606|FG001|Overall Study|Randomized but Never Treated|2|||
150065264|NCT02220998|541380605|FG000|Overall Study|Death|2|||
150065265|NCT02220998|541380606|FG001|Overall Study|Death|0|||
150065266|NCT02220998|541380605|FG000|Overall Study|Lack of Efficacy|0|||
150065267|NCT02220998|541380606|FG001|Overall Study|Lack of Efficacy|5|||
150065268|NCT02220998|541380605|FG000|Overall Study|Lost to Follow-up|4|||
150065269|NCT02220998|541380606|FG001|Overall Study|Lost to Follow-up|4|||
150065270|NCT01172275|541380607|FG000|Overall Study|Lost to Follow-up|1|||
150065271|NCT01172275|541380608|FG001|Overall Study|Lost to Follow-up|0|||
150065272|NCT01172275|541380607|FG000|Overall Study|Protocol Violation|1|||
150065273|NCT01172275|541380608|FG001|Overall Study|Protocol Violation|0|||
150065274|NCT01977937|541380618|FG000|Overall Study|Withdrawal by Subject|2|||
150065275|NCT01977937|541380619|FG001|Overall Study|Withdrawal by Subject|1|||
150065276|NCT01977937|541380618|FG000|Overall Study|Adverse Event|1|||
150065277|NCT01977937|541380619|FG001|Overall Study|Adverse Event|0|||
150065278|NCT01977937|541380618|FG000|Overall Study|Physician Decision|0|||
150065279|NCT01977937|541380619|FG001|Overall Study|Physician Decision|1|||
150065280|NCT03004443|541380623|FG000|Overall Study|Pregnancy|0|||
150065281|NCT03004443|541380624|FG001|Overall Study|Pregnancy|1|||
150065282|NCT00828854|541380625|FG000|Overall Study|Disease Progression|17|||
150065283|NCT00828854|541380625|FG000|Overall Study|Adverse Event|9|||
150065284|NCT00828854|541380625|FG000|Overall Study|Reason not Specified|1|||
150065285|NCT00915356|541380626|FG000|Overall Study|Withdrawal by Subject|1|||
150065286|NCT00915356|541380627|FG001|Overall Study|Withdrawal by Subject|0|||
150065287|NCT00915356|541380628|FG002|Overall Study|Withdrawal by Subject|0|||
150065288|NCT00915356|541380629|FG003|Overall Study|Withdrawal by Subject|0|||
150065289|NCT00915356|541380630|FG004|Overall Study|Withdrawal by Subject|0|||
150065290|NCT00191646|541380633|FG000|Overall Study|Toxicity|26|||
150065291|NCT00191646|541380634|FG001|Overall Study|Toxicity|37|||
150065292|NCT00191646|541380633|FG000|Overall Study|Disease Progression|5|||
150065293|NCT00191646|541380634|FG001|Overall Study|Disease Progression|6|||
150065294|NCT00191646|541380633|FG000|Overall Study|Physician Decision|20|||
150065295|NCT00191646|541380634|FG001|Overall Study|Physician Decision|11|||
150065296|NCT00191646|541380633|FG000|Overall Study|Withdrawal by Subject|58|||
150065297|NCT00191646|541380634|FG001|Overall Study|Withdrawal by Subject|39|||
150065298|NCT00191646|541380633|FG000|Overall Study|Protocol Violation|5|||
150065299|NCT00191646|541380634|FG001|Overall Study|Protocol Violation|7|||
150065300|NCT00191646|541380633|FG000|Overall Study|Death|6|||
150065301|NCT00191646|541380634|FG001|Overall Study|Death|8|||
150065302|NCT00191646|541380633|FG000|Overall Study|Other|33|||
150065303|NCT00191646|541380634|FG001|Overall Study|Other|34|||
150065304|NCT00191646|541380633|FG000|Overall Study|Missing Data|18|||
150065305|NCT00191646|541380634|FG001|Overall Study|Missing Data|11|||
150065306|NCT03194490|541380636|FG000|Overall Study|Lost to Follow-up|1|||
150065307|NCT03194490|541380637|FG001|Overall Study|Lost to Follow-up|3|||
150065308|NCT03194490|541380636|FG000|Overall Study|participant developed specific neck pain|1|||
150065309|NCT03194490|541380637|FG001|Overall Study|participant developed specific neck pain|0|||
150065310|NCT01505647|541380638|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
150065311|NCT01505647|541380639|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
150065312|NCT01505647|541380638|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
150065313|NCT01505647|541380639|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
150065314|NCT01505647|541380638|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
150065315|NCT01505647|541380639|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
150065316|NCT01505647|541380638|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
150065317|NCT01505647|541380639|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
150065318|NCT01505647|541380638|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
150065319|NCT01505647|541380639|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
150065320|NCT01574079|541380640|FG000|Overall Study|Physician Decision|0|||
150065321|NCT01574079|541380641|FG001|Overall Study|Physician Decision|2|||
150065322|NCT01574079|541380640|FG000|Overall Study|Lost to Follow-up|1|||
150065323|NCT01574079|541380641|FG001|Overall Study|Lost to Follow-up|0|||
150065324|NCT00406718|541380642|FG000|Overall Study|Withdrawal by Subject|2|||
150065325|NCT00406718|541380643|FG001|Overall Study|Withdrawal by Subject|9|||
150065326|NCT00406718|541380644|FG002|Overall Study|Withdrawal by Subject|4|||
150065327|NCT00406718|541380642|FG000|Overall Study|Lost to Follow-up|2|||
150065328|NCT00406718|541380643|FG001|Overall Study|Lost to Follow-up|5|||
150065329|NCT00406718|541380644|FG002|Overall Study|Lost to Follow-up|4|||
150065330|NCT01927341|541382541|FG000|Phase 1b|Lost to Follow-up|1|||
150065331|NCT01927341|541382542|FG001|Phase 1b|Lost to Follow-up|0|||
150065332|NCT01927341|541382543|FG002|Phase 1b|Lost to Follow-up|0|||
150065333|NCT01927341|541382544|FG003|Phase 1b|Lost to Follow-up|0|||
150065334|NCT01927341|541382545|FG004|Phase 1b|Lost to Follow-up|0|||
150065335|NCT01927341|541382541|FG000|Phase 1b|Death|2|||
150065336|NCT01927341|541382542|FG001|Phase 1b|Death|0|||
150065337|NCT01927341|541382543|FG002|Phase 1b|Death|0|||
150065338|NCT01927341|541382544|FG003|Phase 1b|Death|0|||
150065339|NCT01927341|541382545|FG004|Phase 1b|Death|0|||
150065340|NCT01927341|541382541|FG000|Phase 1b|Follow-up completed|7|||
150065341|NCT01927341|541382542|FG001|Phase 1b|Follow-up completed|0|||
150065342|NCT01927341|541382543|FG002|Phase 1b|Follow-up completed|0|||
150065343|NCT01927341|541382544|FG003|Phase 1b|Follow-up completed|0|||
150065344|NCT01927341|541382545|FG004|Phase 1b|Follow-up completed|0|||
150065345|NCT01927341|541382541|FG000|Phase 2|Lost to Follow-up|0|||
150065346|NCT01927341|541382542|FG001|Phase 2|Lost to Follow-up|1|||
150065347|NCT01927341|541382543|FG002|Phase 2|Lost to Follow-up|0|||
150065348|NCT01927341|541382544|FG003|Phase 2|Lost to Follow-up|0|||
150065349|NCT01927341|541382545|FG004|Phase 2|Lost to Follow-up|0|||
150065350|NCT01927341|541382541|FG000|Phase 2|Participant withdrew consent|0|||
150065351|NCT01927341|541382542|FG001|Phase 2|Participant withdrew consent|2|||
150065352|NCT01927341|541382543|FG002|Phase 2|Participant withdrew consent|1|||
150065353|NCT01927341|541382544|FG003|Phase 2|Participant withdrew consent|2|||
150065354|NCT01927341|541382545|FG004|Phase 2|Participant withdrew consent|3|||
150065355|NCT01927341|541382541|FG000|Phase 2|Death|0|||
150065356|NCT01927341|541382542|FG001|Phase 2|Death|4|||
150065357|NCT01927341|541382543|FG002|Phase 2|Death|0|||
150065358|NCT01927341|541382544|FG003|Phase 2|Death|3|||
150065359|NCT01927341|541382545|FG004|Phase 2|Death|2|||
150065360|NCT01927341|541382541|FG000|Phase 2|New cancer therapy|0|||
150065361|NCT01927341|541382542|FG001|Phase 2|New cancer therapy|1|||
150065362|NCT01927341|541382543|FG002|Phase 2|New cancer therapy|0|||
150065363|NCT01927341|541382544|FG003|Phase 2|New cancer therapy|4|||
150065364|NCT01927341|541382545|FG004|Phase 2|New cancer therapy|1|||
150065365|NCT01927341|541382541|FG000|Phase 2|Disease progression|0|||
150065366|NCT01927341|541382542|FG001|Phase 2|Disease progression|1|||
150065367|NCT01927341|541382543|FG002|Phase 2|Disease progression|1|||
150065368|NCT01927341|541382544|FG003|Phase 2|Disease progression|1|||
150065369|NCT01927341|541382545|FG004|Phase 2|Disease progression|0|||
150065370|NCT01927341|541382541|FG000|Phase 2|Follow-up completed|0|||
150065371|NCT01927341|541382542|FG001|Phase 2|Follow-up completed|6|||
150065372|NCT01927341|541382543|FG002|Phase 2|Follow-up completed|3|||
150065373|NCT01927341|541382544|FG003|Phase 2|Follow-up completed|5|||
150065374|NCT01927341|541382545|FG004|Phase 2|Follow-up completed|2|||
150065375|NCT01397201|541382546|FG000|Overall Study|Not treated|0|||
150065376|NCT01397201|541382547|FG001|Overall Study|Not treated|0|||
150065377|NCT01397201|541382548|FG002|Overall Study|Not treated|1|||
150065378|NCT01397201|541382549|FG003|Overall Study|Not treated|0|||
150065379|NCT01397201|541382550|FG004|Overall Study|Not treated|0|||
150065380|NCT01397201|541382546|FG000|Overall Study|Not yet defined|3|||
150065381|NCT01397201|541382547|FG001|Overall Study|Not yet defined|6|||
150065382|NCT01397201|541382548|FG002|Overall Study|Not yet defined|5|||
150065383|NCT01397201|541382549|FG003|Overall Study|Not yet defined|5|||
150065384|NCT01397201|541382550|FG004|Overall Study|Not yet defined|4|||
150065385|NCT01397201|541382546|FG000|Overall Study|Adverse Event|2|||
150065386|NCT01397201|541382547|FG001|Overall Study|Adverse Event|0|||
150065387|NCT01397201|541382548|FG002|Overall Study|Adverse Event|0|||
150065388|NCT01397201|541382549|FG003|Overall Study|Adverse Event|0|||
150065389|NCT01397201|541382550|FG004|Overall Study|Adverse Event|0|||
150065390|NCT00451451|541382553|FG000|Overall Study|Adverse Event|11|||
150065391|NCT00451451|541382554|FG001|Overall Study|Adverse Event|21|||
150065392|NCT00451451|541382555|FG002|Overall Study|Adverse Event|26|||
150065393|NCT00451451|541382556|FG003|Overall Study|Adverse Event|10|||
150065394|NCT00451451|541382553|FG000|Overall Study|Lost to Follow-up|11|||
150065395|NCT00451451|541382554|FG001|Overall Study|Lost to Follow-up|9|||
150065396|NCT00451451|541382555|FG002|Overall Study|Lost to Follow-up|8|||
150065397|NCT00451451|541382556|FG003|Overall Study|Lost to Follow-up|11|||
150065398|NCT00451451|541382553|FG000|Overall Study|Consent Withdrawn|14|||
150065399|NCT00451451|541382554|FG001|Overall Study|Consent Withdrawn|9|||
150065400|NCT00451451|541382555|FG002|Overall Study|Consent Withdrawn|17|||
150065401|NCT00451451|541382556|FG003|Overall Study|Consent Withdrawn|17|||
150065402|NCT00451451|541382553|FG000|Overall Study|Investigator Decision|6|||
150065403|NCT00451451|541382554|FG001|Overall Study|Investigator Decision|2|||
150065404|NCT00451451|541382555|FG002|Overall Study|Investigator Decision|1|||
150065405|NCT00451451|541382556|FG003|Overall Study|Investigator Decision|2|||
150065406|NCT00451451|541382553|FG000|Overall Study|Subject Non-Compliance|8|||
150065407|NCT00451451|541382554|FG001|Overall Study|Subject Non-Compliance|4|||
150065408|NCT00451451|541382555|FG002|Overall Study|Subject Non-Compliance|3|||
150065409|NCT00451451|541382556|FG003|Overall Study|Subject Non-Compliance|3|||
150065410|NCT00451451|541382553|FG000|Overall Study|Death|1|||
150065411|NCT00451451|541382554|FG001|Overall Study|Death|0|||
150065412|NCT00451451|541382555|FG002|Overall Study|Death|0|||
150065413|NCT00451451|541382556|FG003|Overall Study|Death|1|||
150065414|NCT00451451|541382553|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
150065415|NCT00451451|541382554|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
150065416|NCT00451451|541382555|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
150065417|NCT00451451|541382556|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
150065418|NCT00122278|541382557|FG000|Overall Study|Lost to Follow-up|2|||
150065419|NCT00122278|541382558|FG001|Overall Study|Lost to Follow-up|0|||
150065420|NCT01002482|541382559|FG000|Overall Study|Withdrawal by Subject|14|||
150065421|NCT01002482|541382560|FG001|Overall Study|Withdrawal by Subject|21|||
150065422|NCT01002482|541382559|FG000|Overall Study|Included twice|1|||
150065423|NCT01002482|541382560|FG001|Overall Study|Included twice|0|||
150065424|NCT01442038|541382572|FG000|Overall Study|Death|35|||
150065425|NCT01442038|541382573|FG001|Overall Study|Death|29|||
150065426|NCT01442038|541382572|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
150065427|NCT01442038|541382573|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
150065428|NCT01442038|541382572|FG000|Overall Study|Participant Withdrew Consent|137|||
150065429|NCT01442038|541382573|FG001|Overall Study|Participant Withdrew Consent|102|||
150065430|NCT01442038|541382572|FG000|Overall Study|Lost to Follow-up|37|||
150065431|NCT01442038|541382573|FG001|Overall Study|Lost to Follow-up|51|||
150065432|NCT01442038|541382572|FG000|Overall Study|Adverse Event|26|||
150065433|NCT01442038|541382573|FG001|Overall Study|Adverse Event|15|||
150065434|NCT01442038|541382572|FG000|Overall Study|Protocol Deviation|9|||
150065435|NCT01442038|541382573|FG001|Overall Study|Protocol Deviation|20|||
150065436|NCT01442038|541382572|FG000|Overall Study|Investigator's Discretion|13|||
150065437|NCT01442038|541382573|FG001|Overall Study|Investigator's Discretion|16|||
150181955|NCT03398148|541804606|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181956|NCT03398148|541804607|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
150065438|NCT01442038|541382572|FG000|Overall Study|Study Terminated By Sponsor|2|||
150065439|NCT01442038|541382573|FG001|Overall Study|Study Terminated By Sponsor|3|||
150065440|NCT00089284|541382574|FG000|Overall Study|Adverse event before starting treatment|0|||
150065441|NCT00089284|541382575|FG001|Overall Study|Adverse event before starting treatment|0|||
150065442|NCT00089284|541382576|FG002|Overall Study|Adverse event before starting treatment|0|||
150065443|NCT00089284|541382577|FG003|Overall Study|Adverse event before starting treatment|0|||
150065444|NCT00089284|541382578|FG004|Overall Study|Adverse event before starting treatment|0|||
150065445|NCT00089284|541382579|FG005|Overall Study|Adverse event before starting treatment|0|||
150065446|NCT00089284|541382580|FG006|Overall Study|Adverse event before starting treatment|1|||
150065447|NCT03956056|541382581|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
150065448|NCT03956056|541382581|FG000|Overall Study|Lack of Efficacy|1|||
150065449|NCT01298531|541382585|FG000|Overall Study|Lack of Efficacy|0|||
150065450|NCT01298531|541382586|FG001|Overall Study|Lack of Efficacy|1|||
150065451|NCT01298531|541382585|FG000|Overall Study|Lost to Follow-up|2|||
150065452|NCT01298531|541382586|FG001|Overall Study|Lost to Follow-up|0|||
150065453|NCT01298531|541382585|FG000|Overall Study|Protocol Violation|1|||
150065454|NCT01298531|541382586|FG001|Overall Study|Protocol Violation|1|||
150065455|NCT01298531|541382585|FG000|Overall Study|Adverse Event|4|||
150065456|NCT01298531|541382586|FG001|Overall Study|Adverse Event|3|||
150065457|NCT01298531|541382585|FG000|Overall Study|Does not meet entrance criteria|0|||
150065458|NCT01298531|541382586|FG001|Overall Study|Does not meet entrance criteria|1|||
150065459|NCT01298531|541382585|FG000|Overall Study|Other|2|||
150065460|NCT01298531|541382586|FG001|Overall Study|Other|1|||
150065461|NCT01229397|541382587|FG000|Overall Study|Withdrawal by Subject|3|||
150065462|NCT01229397|541382588|FG001|Overall Study|Withdrawal by Subject|3|||
150065463|NCT01229397|541382587|FG000|Overall Study|Lost to Follow-up|7|||
150065464|NCT01229397|541382588|FG001|Overall Study|Lost to Follow-up|6|||
150065465|NCT01229397|541382587|FG000|Overall Study|Migrated/moved from study area|1|||
150065466|NCT01229397|541382588|FG001|Overall Study|Migrated/moved from study area|0|||
150065467|NCT00608543|541382589|FG000|Overall Study|Adverse Event|4|||
150065468|NCT01251744|541382594|FG000|Overall Study|Lost to Follow-up|1|||
150065469|NCT01251744|541382595|FG001|Overall Study|Lost to Follow-up|0|||
150065470|NCT00214500|541382596|FG000|Treatment Period|Adverse Event|1|||
150065471|NCT00214500|541382596|FG000|Extension Period|Withdrawal by Subject|2|||
150065472|NCT02147184|541382597|FG000|Overall Study|Lost to Follow-up|28|||
150065473|NCT02147184|541382598|FG001|Overall Study|Lost to Follow-up|15|||
150065474|NCT02147184|541382597|FG000|Overall Study|Study Burden|11|||
150065475|NCT02147184|541382598|FG001|Overall Study|Study Burden|7|||
150065476|NCT02147184|541382597|FG000|Overall Study|Pregnancy|6|||
150065477|NCT02147184|541382598|FG001|Overall Study|Pregnancy|0|||
150065478|NCT02147184|541382597|FG000|Overall Study|Moved out of state|3|||
150065479|NCT02147184|541382598|FG001|Overall Study|Moved out of state|3|||
150065480|NCT02147184|541382597|FG000|Overall Study|Physician Decision|0|||
150065481|NCT02147184|541382598|FG001|Overall Study|Physician Decision|2|||
150065482|NCT02147184|541382597|FG000|Overall Study|Other|1|||
150065483|NCT02147184|541382598|FG001|Overall Study|Other|0|||
150065484|NCT06400979|541382603|FG000|Overall Study|Lost to Follow-up|29|||
150065485|NCT06400979|541382603|FG000|Overall Study|Withdrawal by Subject|1|||
150065486|NCT00117286|541382606|FG000|Overall Study|Adverse Event|12|||
150065487|NCT00117286|541382607|FG001|Overall Study|Adverse Event|6|||
150065488|NCT00117286|541382606|FG000|Overall Study|Lost to Follow-up|2|||
150065489|NCT00117286|541382607|FG001|Overall Study|Lost to Follow-up|0|||
150065490|NCT00117286|541382606|FG000|Overall Study|Protocol Violation|3|||
150065491|NCT00117286|541382607|FG001|Overall Study|Protocol Violation|3|||
150065492|NCT00117286|541382606|FG000|Overall Study|Withdrawal by Subject|6|||
150065493|NCT00117286|541382607|FG001|Overall Study|Withdrawal by Subject|2|||
150065494|NCT00117286|541382606|FG000|Overall Study|Physician Decision|3|||
150065495|NCT00117286|541382607|FG001|Overall Study|Physician Decision|7|||
150065496|NCT00117286|541382606|FG000|Overall Study|Lack of Efficacy|2|||
150065497|NCT00117286|541382607|FG001|Overall Study|Lack of Efficacy|1|||
150065498|NCT00117286|541382606|FG000|Overall Study|Research site closing|0|||
150065499|NCT00117286|541382607|FG001|Overall Study|Research site closing|2|||
150065500|NCT00750880|541382613|FG000|Overall Study|Adverse Event|76|||
150065501|NCT00750880|541382613|FG000|Overall Study|Death|4|||
150065502|NCT00750880|541382613|FG000|Overall Study|Lack of Efficacy|46|||
150065503|NCT00750880|541382613|FG000|Overall Study|Lost to Follow-up|10|||
150065504|NCT00750880|541382613|FG000|Overall Study|Protocol Violation|15|||
150065505|NCT00750880|541382613|FG000|Overall Study|Withdrawal by Subject|33|||
150065506|NCT00750880|541382613|FG000|Overall Study|Physician Decision|20|||
150181957|NCT03398148|541804608|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181958|NCT03398148|541804609|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
150065507|NCT00750880|541382613|FG000|Overall Study|Administrative|11|||
150065508|NCT02675231|541382616|FG000|Overall Study|Withdrawal by Subject|2|||
150065509|NCT02675231|541382617|FG001|Overall Study|Withdrawal by Subject|4|||
150065510|NCT02675231|541382618|FG002|Overall Study|Withdrawal by Subject|2|||
150065511|NCT02675231|541382616|FG000|Overall Study|Lost to Follow-up|3|||
150065512|NCT02675231|541382617|FG001|Overall Study|Lost to Follow-up|4|||
150065513|NCT02675231|541382618|FG002|Overall Study|Lost to Follow-up|3|||
150065514|NCT02961218|541382621|FG000|Overall Study|Lost to Follow-up|0|||
150065515|NCT02961218|541382622|FG001|Overall Study|Lost to Follow-up|2|||
150065516|NCT02961218|541382621|FG000|Overall Study|Physician Decision|0|||
150065517|NCT02961218|541382622|FG001|Overall Study|Physician Decision|2|||
150065518|NCT02961218|541382621|FG000|Overall Study|Subject/Guardian Decision|3|||
150065519|NCT02961218|541382622|FG001|Overall Study|Subject/Guardian Decision|1|||
150065520|NCT01462227|541382628|FG000|Second Assignment|Lost to Follow-up|1|||
150065521|NCT01462227|541382629|FG001|Second Assignment|Lost to Follow-up|0|||
150065522|NCT01462227|541382630|FG002|Second Assignment|Lost to Follow-up|0|||
150065523|NCT01462227|541382631|FG003|Second Assignment|Lost to Follow-up|0|||
150065524|NCT01462227|541382628|FG000|Second Assignment|Protocol Violation|0|||
150065525|NCT01462227|541382629|FG001|Second Assignment|Protocol Violation|1|||
150065526|NCT01462227|541382630|FG002|Second Assignment|Protocol Violation|1|||
150065527|NCT01462227|541382631|FG003|Second Assignment|Protocol Violation|0|||
150065528|NCT00591266|541382632|FG000|Overall Study|Adverse Event|2|||
150065529|NCT00591266|541382633|FG001|Overall Study|Adverse Event|2|||
150065530|NCT00591266|541382634|FG002|Overall Study|Adverse Event|3|||
150065531|NCT00591266|541382632|FG000|Overall Study|Lost to Follow-up|0|||
150065532|NCT00591266|541382633|FG001|Overall Study|Lost to Follow-up|1|||
150065533|NCT00591266|541382634|FG002|Overall Study|Lost to Follow-up|0|||
150065534|NCT00591266|541382632|FG000|Overall Study|Protocol Violation|0|||
150065535|NCT00591266|541382633|FG001|Overall Study|Protocol Violation|0|||
150065536|NCT00591266|541382634|FG002|Overall Study|Protocol Violation|1|||
150065537|NCT00591266|541382632|FG000|Overall Study|Withdrawal by Subject|6|||
150065538|NCT00591266|541382633|FG001|Overall Study|Withdrawal by Subject|2|||
150065539|NCT00591266|541382634|FG002|Overall Study|Withdrawal by Subject|5|||
150065540|NCT00591266|541382632|FG000|Overall Study|Lack of Efficacy|0|||
150065541|NCT00591266|541382633|FG001|Overall Study|Lack of Efficacy|2|||
150065542|NCT00591266|541382634|FG002|Overall Study|Lack of Efficacy|0|||
150065543|NCT00591266|541382632|FG000|Overall Study|Other|1|||
150065544|NCT00591266|541382633|FG001|Overall Study|Other|4|||
150065545|NCT00591266|541382634|FG002|Overall Study|Other|5|||
150065546|NCT00586846|541382637|FG000|Overall Study|Physician Decision|1|||
150065547|NCT00586846|541382637|FG000|Overall Study|Death|1|||
150065548|NCT00586846|541382637|FG000|Overall Study|Evaluable for Toxicity Only|4|||
150065549|NCT05298306|541382641|FG000|Overall Study|Physician Decision|0|||
150065550|NCT05298306|541382642|FG001|Overall Study|Physician Decision|0|||
150065551|NCT05298306|541382643|FG002|Overall Study|Physician Decision|0|||
150065552|NCT05298306|541382644|FG003|Overall Study|Physician Decision|1|||
150065553|NCT05298306|541382645|FG004|Overall Study|Physician Decision|0|||
150065554|NCT05298306|541382646|FG005|Overall Study|Physician Decision|0|||
150065555|NCT03497676|541382648|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
150065556|NCT03497676|541382649|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
150065557|NCT03497676|541382650|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
150065558|NCT03497676|541382651|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
150065559|NCT03497676|541382648|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
150065560|NCT03497676|541382649|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
150065561|NCT03497676|541382650|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
150065562|NCT03497676|541382651|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
150065563|NCT03497676|541382648|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
150065564|NCT03497676|541382649|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
150065565|NCT03497676|541382650|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
150065566|NCT03497676|541382651|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
150065567|NCT03497676|541382648|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
150065568|NCT03497676|541382649|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
150065569|NCT03497676|541382650|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
150065570|NCT03497676|541382651|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
150065571|NCT03497676|541382648|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
150065572|NCT03497676|541382649|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
150065573|NCT03497676|541382650|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
150065574|NCT03497676|541382651|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
150065575|NCT03497676|541382648|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
150065576|NCT03497676|541382649|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
150065577|NCT03497676|541382650|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
150065578|NCT03497676|541382651|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
150065579|NCT03497676|541382648|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
150065580|NCT03497676|541382649|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
150065581|NCT03497676|541382650|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
150065582|NCT03497676|541382651|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
150065583|NCT03497676|541382648|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
150065584|NCT03497676|541382649|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
150065585|NCT03497676|541382650|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
150065586|NCT03497676|541382651|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
150065587|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
150065588|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
150065589|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
150065590|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
150065591|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
150065592|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
150065593|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
150065594|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
150065595|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
150065596|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
150065597|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
150065598|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
150065599|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
150065600|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
150065601|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
150065602|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
150065603|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
150065604|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
150065605|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
150065606|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
150065607|NCT01226043|541382661|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
150065608|NCT01226043|541382662|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
150065609|NCT01226043|541382663|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
150065610|NCT01226043|541382664|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
150065611|NCT01226043|541382661|FG000|6-week Re-randomization Phase|Adverse Event|0|||
150065612|NCT01226043|541382662|FG001|6-week Re-randomization Phase|Adverse Event|0|||
150065613|NCT01226043|541382663|FG002|6-week Re-randomization Phase|Adverse Event|1|||
150065614|NCT01226043|541382664|FG003|6-week Re-randomization Phase|Adverse Event|1|||
150065615|NCT01226043|541382661|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
150065616|NCT01226043|541382662|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
150065617|NCT01226043|541382663|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
150065618|NCT01226043|541382664|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
150065619|NCT01226043|541382661|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
150065620|NCT01226043|541382662|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
150065621|NCT01226043|541382663|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
150065622|NCT01226043|541382664|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
150065623|NCT01226043|541382661|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
150065624|NCT01226043|541382662|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
150065625|NCT01226043|541382663|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
150065626|NCT01226043|541382664|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
150065627|NCT01226043|541382661|FG000|6-week Re-randomization Phase|Physician Decision|0|||
150065628|NCT01226043|541382662|FG001|6-week Re-randomization Phase|Physician Decision|0|||
150065629|NCT01226043|541382663|FG002|6-week Re-randomization Phase|Physician Decision|3|||
150065630|NCT01226043|541382664|FG003|6-week Re-randomization Phase|Physician Decision|2|||
150065631|NCT01226043|541382661|FG000|6-week Re-randomization Phase|completed in error|0|||
150065632|NCT01226043|541382662|FG001|6-week Re-randomization Phase|completed in error|0|||
150065633|NCT01226043|541382663|FG002|6-week Re-randomization Phase|completed in error|0|||
150065634|NCT01226043|541382664|FG003|6-week Re-randomization Phase|completed in error|1|||
150065635|NCT01226043|541382661|FG000|30-week Observational Phase|Adverse Event|0|||
150065636|NCT01226043|541382662|FG001|30-week Observational Phase|Adverse Event|0|||
150065637|NCT01226043|541382663|FG002|30-week Observational Phase|Adverse Event|1|||
150065638|NCT01226043|541382664|FG003|30-week Observational Phase|Adverse Event|1|||
150065639|NCT01226043|541382661|FG000|30-week Observational Phase|Protocol Violation|0|||
150065640|NCT01226043|541382662|FG001|30-week Observational Phase|Protocol Violation|0|||
150065641|NCT01226043|541382663|FG002|30-week Observational Phase|Protocol Violation|0|||
150065642|NCT01226043|541382664|FG003|30-week Observational Phase|Protocol Violation|1|||
150065643|NCT01226043|541382661|FG000|30-week Observational Phase|Lost to Follow-up|0|||
150065644|NCT01226043|541382662|FG001|30-week Observational Phase|Lost to Follow-up|0|||
150065645|NCT01226043|541382663|FG002|30-week Observational Phase|Lost to Follow-up|2|||
150065646|NCT01226043|541382664|FG003|30-week Observational Phase|Lost to Follow-up|2|||
150065647|NCT01226043|541382661|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
150065648|NCT01226043|541382662|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
150065649|NCT01226043|541382663|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
150065650|NCT01226043|541382664|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
150065651|NCT01226043|541382661|FG000|30-week Observational Phase|Physician Decision|0|||
150065652|NCT01226043|541382662|FG001|30-week Observational Phase|Physician Decision|0|||
150065653|NCT01226043|541382663|FG002|30-week Observational Phase|Physician Decision|2|||
150065654|NCT01226043|541382664|FG003|30-week Observational Phase|Physician Decision|2|||
150065655|NCT02204007|541382665|FG000|Overall Study|Surgery Canceled|1|||
150065656|NCT02204007|541382666|FG001|Overall Study|Surgery Canceled|1|||
150065657|NCT01702571|541382667|FG000|Overall Study|Death|1067|||
150065658|NCT01702571|541382668|FG001|Overall Study|Death|76|||
150065659|NCT01702571|541382667|FG000|Overall Study|Lost to Follow-up|144|||
150065660|NCT01702571|541382668|FG001|Overall Study|Lost to Follow-up|10|||
150065661|NCT01702571|541382667|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
150065662|NCT01702571|541382668|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
150065663|NCT01702571|541382667|FG000|Overall Study|Investigator Decision|5|||
150065664|NCT01702571|541382668|FG001|Overall Study|Investigator Decision|0|||
150065665|NCT01702571|541382667|FG000|Overall Study|Not Classifiable|1|||
150065666|NCT01702571|541382668|FG001|Overall Study|Not Classifiable|0|||
150065667|NCT01702571|541382667|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
150065668|NCT01702571|541382668|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
150065669|NCT01702571|541382667|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
150065670|NCT01702571|541382668|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
150065671|NCT01702571|541382667|FG000|Overall Study|Progressive Disease|3|||
150065672|NCT01702571|541382668|FG001|Overall Study|Progressive Disease|0|||
150065673|NCT01702571|541382667|FG000|Overall Study|Protocol Violation|2|||
150065674|NCT01702571|541382668|FG001|Overall Study|Protocol Violation|0|||
150065675|NCT01702571|541382667|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
150065676|NCT01702571|541382668|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
150065677|NCT01702571|541382667|FG000|Overall Study|Termination By Sponsor|4|||
150065678|NCT01702571|541382668|FG001|Overall Study|Termination By Sponsor|0|||
150065679|NCT01702571|541382667|FG000|Overall Study|Withdrawal by Subject|177|||
150065680|NCT01702571|541382668|FG001|Overall Study|Withdrawal by Subject|29|||
150065681|NCT00910988|541382669|FG000|Overall Study|Lost to Follow-up|2|||
150065682|NCT00910988|541382670|FG001|Overall Study|Lost to Follow-up|4|||
150065683|NCT00910988|541382671|FG002|Overall Study|Lost to Follow-up|3|||
150065684|NCT00910988|541382672|FG003|Overall Study|Lost to Follow-up|0|||
150065685|NCT05211284|541382680|FG000|Overall Study|Study Terminated|3|||
150065686|NCT05211284|541382681|FG001|Overall Study|Study Terminated|1|||
150065687|NCT03911843|541382682|FG000|Overall Study|Adverse Event|2|||
150065688|NCT03911843|541382683|FG001|Overall Study|Adverse Event|0|||
150065689|NCT03911843|541382682|FG000|Overall Study|Protocol Violation|2|||
150065690|NCT03911843|541382683|FG001|Overall Study|Protocol Violation|0|||
150065691|NCT03911843|541382682|FG000|Overall Study|Lost to Follow-up|0|||
150065692|NCT03911843|541382683|FG001|Overall Study|Lost to Follow-up|1|||
150065693|NCT01907100|541382684|FG000|Overall Study|PD based on modified RECIST criteria|31|||
150065694|NCT01907100|541382685|FG001|Overall Study|PD based on modified RECIST criteria|32|||
150065695|NCT01907100|541382686|FG002|Overall Study|PD based on modified RECIST criteria|95|||
150065696|NCT01907100|541382687|FG003|Overall Study|PD based on modified RECIST criteria|92|||
150065697|NCT01907100|541382684|FG000|Overall Study|Withdrawal by Subject|2|||
150065698|NCT01907100|541382685|FG001|Overall Study|Withdrawal by Subject|5|||
150065699|NCT01907100|541382686|FG002|Overall Study|Withdrawal by Subject|10|||
150065700|NCT01907100|541382687|FG003|Overall Study|Withdrawal by Subject|13|||
150065701|NCT01907100|541382684|FG000|Overall Study|Protocol Violation|0|||
150065702|NCT01907100|541382685|FG001|Overall Study|Protocol Violation|0|||
150065703|NCT01907100|541382686|FG002|Overall Study|Protocol Violation|1|||
150065704|NCT01907100|541382687|FG003|Overall Study|Protocol Violation|1|||
150065705|NCT01907100|541382684|FG000|Overall Study|Lost to Follow-up|0|||
150065706|NCT01907100|541382685|FG001|Overall Study|Lost to Follow-up|0|||
150065707|NCT01907100|541382686|FG002|Overall Study|Lost to Follow-up|0|||
150065708|NCT01907100|541382687|FG003|Overall Study|Lost to Follow-up|1|||
150065709|NCT01907100|541382684|FG000|Overall Study|Not treated|2|||
150065710|NCT01907100|541382685|FG001|Overall Study|Not treated|0|||
150065711|NCT01907100|541382686|FG002|Overall Study|Not treated|1|||
150065712|NCT01907100|541382687|FG003|Overall Study|Not treated|2|||
150065713|NCT01907100|541382684|FG000|Overall Study|Other than reasons specified|1|||
150065714|NCT01907100|541382685|FG001|Overall Study|Other than reasons specified|0|||
150065715|NCT01907100|541382686|FG002|Overall Study|Other than reasons specified|10|||
150065716|NCT01907100|541382687|FG003|Overall Study|Other than reasons specified|6|||
150065717|NCT01907100|541382684|FG000|Overall Study|Adverse event (AE)|6|||
150065718|NCT01907100|541382685|FG001|Overall Study|Adverse event (AE)|3|||
150065719|NCT01907100|541382686|FG002|Overall Study|Adverse event (AE)|22|||
150065720|NCT01907100|541382687|FG003|Overall Study|Adverse event (AE)|23|||
150065721|NCT01907100|541382684|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
150065722|NCT01907100|541382685|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
150065723|NCT01907100|541382686|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
150065724|NCT01907100|541382687|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
150065725|NCT00667602|541382690|FG000|Overall Study|Withdrawal by Subject|4|||
150065726|NCT00667602|541382691|FG001|Overall Study|Withdrawal by Subject|9|||
150065727|NCT00667602|541382692|FG002|Overall Study|Withdrawal by Subject|10|||
150065728|NCT00667602|541382690|FG000|Overall Study|Lost to Follow-up|4|||
150065729|NCT00667602|541382691|FG001|Overall Study|Lost to Follow-up|5|||
150065730|NCT00667602|541382692|FG002|Overall Study|Lost to Follow-up|6|||
150065731|NCT00667602|541382690|FG000|Overall Study|Administrative reason|0|||
150065732|NCT00667602|541382691|FG001|Overall Study|Administrative reason|0|||
150065733|NCT00667602|541382692|FG002|Overall Study|Administrative reason|2|||
150065734|NCT00667602|541382690|FG000|Overall Study|Protocol Violation|0|||
150065735|NCT00667602|541382691|FG001|Overall Study|Protocol Violation|1|||
150065736|NCT00667602|541382692|FG002|Overall Study|Protocol Violation|0|||
150065737|NCT03640559|541382697|FG000|Overall Study|Physician Decision|1|||
150065738|NCT03640559|541382698|FG001|Overall Study|Physician Decision|1|||
150065739|NCT03640559|541382697|FG000|Overall Study|Withdrawal by Subject|1|||
150065740|NCT03640559|541382698|FG001|Overall Study|Withdrawal by Subject|0|||
150065741|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
150065742|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
150065743|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
150065744|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
150065745|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
150065746|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
150065747|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
150065748|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
150065749|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
150065750|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
150065751|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
150065752|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
150065753|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
150065754|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
150065755|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
150065756|NCT01436162|541382699|FG000|Single-blind Lead-in Phase|Other|107|||
150065757|NCT01436162|541382700|FG001|Single-blind Lead-in Phase|Other|0|||
150065758|NCT01436162|541382701|FG002|Single-blind Lead-in Phase|Other|0|||
150065759|NCT01436162|541382699|FG000|Randomized Phase|Adverse Event|1|||
150065760|NCT01436162|541382700|FG001|Randomized Phase|Adverse Event|5|||
150065761|NCT01436162|541382701|FG002|Randomized Phase|Adverse Event|6|||
150065762|NCT01436162|541382699|FG000|Randomized Phase|Protocol Violation|4|||
150065763|NCT01436162|541382700|FG001|Randomized Phase|Protocol Violation|4|||
150065764|NCT01436162|541382701|FG002|Randomized Phase|Protocol Violation|2|||
150065765|NCT01436162|541382699|FG000|Randomized Phase|Withdrawal by Subject|16|||
150065766|NCT01436162|541382700|FG001|Randomized Phase|Withdrawal by Subject|9|||
150065767|NCT01436162|541382701|FG002|Randomized Phase|Withdrawal by Subject|8|||
150065768|NCT01436162|541382699|FG000|Randomized Phase|Lost to Follow-up|17|||
150065769|NCT01436162|541382700|FG001|Randomized Phase|Lost to Follow-up|5|||
150065770|NCT01436162|541382701|FG002|Randomized Phase|Lost to Follow-up|4|||
150065771|NCT01436162|541382699|FG000|Randomized Phase|Lack of Efficacy|0|||
150065772|NCT01436162|541382700|FG001|Randomized Phase|Lack of Efficacy|1|||
150065773|NCT01436162|541382701|FG002|Randomized Phase|Lack of Efficacy|1|||
150065774|NCT01436162|541382699|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
150065775|NCT01436162|541382700|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
150065776|NCT01436162|541382701|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
150065777|NCT01436162|541382699|FG000|Randomized Phase|Other|2|||
150065778|NCT01436162|541382700|FG001|Randomized Phase|Other|5|||
150065779|NCT01436162|541382701|FG002|Randomized Phase|Other|4|||
150065780|NCT01888003|541382702|FG000|Overall Study|Study Terminated|5|||
150065781|NCT01888003|541382703|FG001|Overall Study|Study Terminated|6|||
150065782|NCT01888003|541382704|FG002|Overall Study|Study Terminated|40|||
150065783|NCT03187756|541382705|FG000|Overall Study|Termination of study|4|||
150065784|NCT01931202|541382707|FG000|Overall Study|Withdrawal by Subject|0|||
150065785|NCT01931202|541382708|FG001|Overall Study|Withdrawal by Subject|0|||
150065786|NCT01931202|541382709|FG002|Overall Study|Withdrawal by Subject|2|||
150065787|NCT01931202|541382707|FG000|Overall Study|Lost to Follow-up|0|||
150065788|NCT01931202|541382708|FG001|Overall Study|Lost to Follow-up|5|||
150065789|NCT01931202|541382709|FG002|Overall Study|Lost to Follow-up|2|||
150065790|NCT04597918|541382710|FG000|Overall Study|Withdrawal by Subject|6|||
150065791|NCT04597918|541382710|FG000|Overall Study|Lost to Follow-up|3|||
150065792|NCT04597918|541382710|FG000|Overall Study|Death|1|||
150065793|NCT00395538|541382711|FG000|Overall Study|Did not re-consent to revised protocol|1|||
150065794|NCT00395538|541382712|FG001|Overall Study|Did not re-consent to revised protocol|10|||
150065795|NCT00395538|541382713|FG002|Overall Study|Did not re-consent to revised protocol|0|||
150065796|NCT00395538|541382711|FG000|Overall Study|FDA partial hold on PTH|0|||
150065797|NCT00395538|541382712|FG001|Overall Study|FDA partial hold on PTH|0|||
150065798|NCT00395538|541382713|FG002|Overall Study|FDA partial hold on PTH|11|||
150065799|NCT00395538|541382711|FG000|Overall Study|Failed screening|0|||
150065800|NCT00395538|541382712|FG001|Overall Study|Failed screening|0|||
150065801|NCT00395538|541382713|FG002|Overall Study|Failed screening|4|||
150181959|NCT03398148|541804610|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
150181960|NCT03398148|541804596|FG000|Substudy 2 Period 1|Adverse Event|0|||
150181961|NCT03398148|541804597|FG001|Substudy 2 Period 1|Adverse Event|0|||
150181962|NCT03398148|541804598|FG002|Substudy 2 Period 1|Adverse Event|0|||
150065802|NCT00395538|541382711|FG000|Overall Study|Switch to Natpara|0|||
150065803|NCT00395538|541382712|FG001|Overall Study|Switch to Natpara|0|||
150065804|NCT00395538|541382713|FG002|Overall Study|Switch to Natpara|3|||
150065805|NCT00395538|541382711|FG000|Overall Study|Adverse Event|1|||
150065806|NCT00395538|541382712|FG001|Overall Study|Adverse Event|0|||
150065807|NCT00395538|541382713|FG002|Overall Study|Adverse Event|2|||
150065808|NCT00395538|541382711|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
150065809|NCT00395538|541382712|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
150065810|NCT00395538|541382713|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
150065811|NCT00395538|541382711|FG000|Overall Study|Non-compliance with study protocol|0|||
150065812|NCT00395538|541382712|FG001|Overall Study|Non-compliance with study protocol|1|||
150065813|NCT00395538|541382713|FG002|Overall Study|Non-compliance with study protocol|0|||
150065814|NCT00395538|541382711|FG000|Overall Study|PTH resistance|0|||
150065815|NCT00395538|541382712|FG001|Overall Study|PTH resistance|0|||
150065816|NCT00395538|541382713|FG002|Overall Study|PTH resistance|1|||
150065817|NCT00395538|541382711|FG000|Overall Study|Pregnancy|1|||
150065818|NCT00395538|541382712|FG001|Overall Study|Pregnancy|0|||
150065819|NCT00395538|541382713|FG002|Overall Study|Pregnancy|0|||
150065820|NCT00395538|541382711|FG000|Overall Study|Partial recovery of parathyroid function|0|||
150065821|NCT00395538|541382712|FG001|Overall Study|Partial recovery of parathyroid function|0|||
150065822|NCT00395538|541382713|FG002|Overall Study|Partial recovery of parathyroid function|1|||
150065823|NCT00395538|541382711|FG000|Overall Study|Participant elected to discontinue|0|||
150065824|NCT00395538|541382712|FG001|Overall Study|Participant elected to discontinue|0|||
150065825|NCT00395538|541382713|FG002|Overall Study|Participant elected to discontinue|1|||
150065826|NCT01876810|541382714|FG000|Overall Study|Physician Decision|0|||
150065827|NCT01876810|541382715|FG001|Overall Study|Physician Decision|1|||
150065828|NCT01857583|541382718|FG000|Overall Study|Adverse Event|0|||
150065829|NCT01857583|541382719|FG001|Overall Study|Adverse Event|0|||
150065830|NCT01857583|541382720|FG002|Overall Study|Adverse Event|1|||
150065831|NCT01857583|541382721|FG003|Overall Study|Adverse Event|1|||
150065832|NCT01857583|541382718|FG000|Overall Study|Death|0|||
150065833|NCT01857583|541382719|FG001|Overall Study|Death|1|||
150065834|NCT01857583|541382720|FG002|Overall Study|Death|1|||
150181963|NCT03398148|541804599|FG003|Substudy 2 Period 1|Adverse Event|0|||
150181964|NCT03398148|541804600|FG004|Substudy 2 Period 1|Adverse Event|0|||
150181965|NCT03398148|541804601|FG005|Substudy 2 Period 1|Adverse Event|0|||
150181966|NCT03398148|541804602|FG006|Substudy 2 Period 1|Adverse Event|0|||
150181967|NCT03398148|541804603|FG007|Substudy 2 Period 1|Adverse Event|0|||
150181968|NCT03398148|541804604|FG008|Substudy 2 Period 1|Adverse Event|0|||
150181969|NCT03398148|541804605|FG009|Substudy 2 Period 1|Adverse Event|12|||
150065835|NCT01857583|541382721|FG003|Overall Study|Death|0|||
150181970|NCT03398148|541804606|FG010|Substudy 2 Period 1|Adverse Event|2|||
150181971|NCT03398148|541804607|FG011|Substudy 2 Period 1|Adverse Event|0|||
150181972|NCT03398148|541804608|FG012|Substudy 2 Period 1|Adverse Event|0|||
150181973|NCT03398148|541804609|FG013|Substudy 2 Period 1|Adverse Event|0|||
150065836|NCT01857583|541382718|FG000|Overall Study|Physician Decision|0|||
150065837|NCT01857583|541382719|FG001|Overall Study|Physician Decision|0|||
150065838|NCT01857583|541382720|FG002|Overall Study|Physician Decision|0|||
150065839|NCT01857583|541382721|FG003|Overall Study|Physician Decision|1|||
150065840|NCT01857583|541382718|FG000|Overall Study|Withdrawal by Subject|1|||
150065841|NCT01857583|541382719|FG001|Overall Study|Withdrawal by Subject|0|||
150181974|NCT03398148|541804610|FG014|Substudy 2 Period 1|Adverse Event|0|||
150065842|NCT01857583|541382720|FG002|Overall Study|Withdrawal by Subject|1|||
150065843|NCT01857583|541382721|FG003|Overall Study|Withdrawal by Subject|2|||
150181975|NCT03398148|541804596|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150065844|NCT03120624|541382722|FG000|Overall Study|Withdrawal by Subject|0|||
150065845|NCT03120624|541382723|FG001|Overall Study|Withdrawal by Subject|1|||
150065846|NCT03120624|541382724|FG002|Overall Study|Withdrawal by Subject|0|||
150065847|NCT03120624|541382725|FG003|Overall Study|Withdrawal by Subject|0|||
150065848|NCT03120624|541382726|FG004|Overall Study|Withdrawal by Subject|0|||
150065849|NCT03120624|541382727|FG005|Overall Study|Withdrawal by Subject|0|||
150065850|NCT03120624|541382728|FG006|Overall Study|Withdrawal by Subject|0|||
150065851|NCT03120624|541382729|FG007|Overall Study|Withdrawal by Subject|0|||
150065852|NCT04571515|541382730|FG000|Overall Study|Physician Decision|0|||
150065853|NCT04571515|541382731|FG001|Overall Study|Physician Decision|0|||
150065854|NCT04571515|541382732|FG002|Overall Study|Physician Decision|0|||
150065855|NCT04571515|541382733|FG003|Overall Study|Physician Decision|0|||
150065856|NCT04571515|541382734|FG004|Overall Study|Physician Decision|1|||
150065857|NCT04571515|541382730|FG000|Overall Study|Withdrawal by Subject|0|||
150065858|NCT04571515|541382731|FG001|Overall Study|Withdrawal by Subject|0|||
150065859|NCT04571515|541382732|FG002|Overall Study|Withdrawal by Subject|0|||
150065860|NCT04571515|541382733|FG003|Overall Study|Withdrawal by Subject|0|||
150065861|NCT04571515|541382734|FG004|Overall Study|Withdrawal by Subject|1|||
150065862|NCT04571515|541382730|FG000|Overall Study|insufficient pain|1|||
150065863|NCT04571515|541382731|FG001|Overall Study|insufficient pain|0|||
150065864|NCT04571515|541382732|FG002|Overall Study|insufficient pain|0|||
150065865|NCT04571515|541382733|FG003|Overall Study|insufficient pain|0|||
150065866|NCT04571515|541382734|FG004|Overall Study|insufficient pain|1|||
150065867|NCT05140382|541382735|FG000|Overall Study|Death|3|||
150065868|NCT05140382|541382736|FG001|Overall Study|Death|0|||
150065869|NCT05140382|541382737|FG002|Overall Study|Death|0|||
150065870|NCT05140382|541382735|FG000|Overall Study|Investigator decision|1|||
150065871|NCT05140382|541382736|FG001|Overall Study|Investigator decision|0|||
150065872|NCT05140382|541382737|FG002|Overall Study|Investigator decision|0|||
150065873|NCT05140382|541382735|FG000|Overall Study|Other|4|||
150065874|NCT05140382|541382736|FG001|Overall Study|Other|0|||
150065875|NCT05140382|541382737|FG002|Overall Study|Other|1|||
150065876|NCT05140382|541382735|FG000|Overall Study|Progressive disease|20|||
150065877|NCT05140382|541382736|FG001|Overall Study|Progressive disease|1|||
150065878|NCT05140382|541382737|FG002|Overall Study|Progressive disease|12|||
150065879|NCT05140382|541382735|FG000|Overall Study|Subjective disease progression|2|||
150065880|NCT05140382|541382736|FG001|Overall Study|Subjective disease progression|1|||
150065881|NCT05140382|541382737|FG002|Overall Study|Subjective disease progression|0|||
150065882|NCT05140382|541382735|FG000|Overall Study|Unknown at data cut-off|0|||
150065883|NCT05140382|541382736|FG001|Overall Study|Unknown at data cut-off|0|||
150065884|NCT05140382|541382737|FG002|Overall Study|Unknown at data cut-off|1|||
150065885|NCT05140382|541382735|FG000|Overall Study|Withdrawal by Subject|1|||
150065886|NCT05140382|541382736|FG001|Overall Study|Withdrawal by Subject|0|||
150065887|NCT05140382|541382737|FG002|Overall Study|Withdrawal by Subject|4|||
150065888|NCT05140382|541382735|FG000|Overall Study|Withdrawal of consent|0|||
150065889|NCT05140382|541382736|FG001|Overall Study|Withdrawal of consent|0|||
150065890|NCT05140382|541382737|FG002|Overall Study|Withdrawal of consent|1|||
150065891|NCT00401531|541384103|FG000|Overall Study|Adverse Event|2|||
150065892|NCT00401531|541384104|FG001|Overall Study|Adverse Event|0|||
150065893|NCT00401531|541384103|FG000|Overall Study|Protocol Violation|3|||
150065894|NCT00401531|541384104|FG001|Overall Study|Protocol Violation|7|||
150065895|NCT00401531|541384103|FG000|Overall Study|Lost to Follow-up|1|||
150065896|NCT00401531|541384104|FG001|Overall Study|Lost to Follow-up|1|||
150065897|NCT00401531|541384103|FG000|Overall Study|Withdrawal by Subject|3|||
150065898|NCT00401531|541384104|FG001|Overall Study|Withdrawal by Subject|2|||
150065899|NCT02437513|541384105|FG000|Overall Study|Withdrawal by Subject|2|||
150065900|NCT03403374|541384108|FG000|Overall Study|Lost to Follow-up|1|||
150065901|NCT04879225|541384109|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
150065902|NCT04879225|541384109|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
150065903|NCT00736957|541384112|FG000|Overall Study|Adverse Event|43|||
150065904|NCT00736957|541384112|FG000|Overall Study|Withdrawal by Subject|49|||
150065905|NCT00736957|541384112|FG000|Overall Study|violation of eligibility criteria|2|||
150065906|NCT00736957|541384112|FG000|Overall Study|did not attend hospital appointments|1|||
150065907|NCT00736957|541384112|FG000|Overall Study|not eligible for Treatment Period I|22|||
150065908|NCT00736957|541384112|FG000|Overall Study|Physician Decision|5|||
150065909|NCT01092507|541384113|FG000|Overall Study|Withdrawal by Subject|2|||
150065910|NCT01092507|541384114|FG001|Overall Study|Withdrawal by Subject|0|||
150065911|NCT03646643|541384115|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
150065912|NCT03646643|541384116|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
150065913|NCT03646643|541384115|FG000|Overall Study|Lost to Follow-up|0|||
150065914|NCT03646643|541384116|FG001|Overall Study|Lost to Follow-up|1|||
150065915|NCT05314478|541384119|FG000|Overall Study|Physician Decision|1|||
150065916|NCT04629508|541384120|FG000|Overall Study|Adverse Event|1|||
150065917|NCT04629508|541384120|FG000|Overall Study|Death|2|||
150065918|NCT04629508|541384120|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
150065919|NCT04073368|541384125|FG000|Overall Study|Adverse Event|2|||
150065920|NCT04073368|541384126|FG001|Overall Study|Adverse Event|0|||
150065921|NCT04073368|541384127|FG002|Overall Study|Adverse Event|1|||
150065922|NCT04073368|541384128|FG003|Overall Study|Adverse Event|1|||
150065923|NCT04073368|541384125|FG000|Overall Study|Withdrawal by Subject|2|||
150065924|NCT04073368|541384126|FG001|Overall Study|Withdrawal by Subject|2|||
150065925|NCT04073368|541384127|FG002|Overall Study|Withdrawal by Subject|1|||
150065926|NCT04073368|541384128|FG003|Overall Study|Withdrawal by Subject|1|||
150065927|NCT04073368|541384125|FG000|Overall Study|Lost to Follow-up|1|||
150065928|NCT04073368|541384126|FG001|Overall Study|Lost to Follow-up|1|||
150065929|NCT04073368|541384127|FG002|Overall Study|Lost to Follow-up|1|||
150065930|NCT04073368|541384128|FG003|Overall Study|Lost to Follow-up|0|||
150065931|NCT04073368|541384125|FG000|Overall Study|Protocol Violation|0|||
150065932|NCT04073368|541384126|FG001|Overall Study|Protocol Violation|1|||
150065933|NCT04073368|541384127|FG002|Overall Study|Protocol Violation|0|||
150065934|NCT04073368|541384128|FG003|Overall Study|Protocol Violation|0|||
150065935|NCT04073368|541384125|FG000|Overall Study|Subject noncompliance|7|||
150065936|NCT04073368|541384126|FG001|Overall Study|Subject noncompliance|4|||
150065937|NCT04073368|541384127|FG002|Overall Study|Subject noncompliance|0|||
150065938|NCT04073368|541384128|FG003|Overall Study|Subject noncompliance|0|||
150065939|NCT00145600|541384129|FG000|Overall Study|Death|1|||
150065940|NCT00145600|541384130|FG001|Overall Study|Death|2|||
150065941|NCT00145600|541384131|FG002|Overall Study|Death|2|||
150065942|NCT00145600|541384132|FG003|Overall Study|Death|6|||
150065943|NCT00145600|541384129|FG000|Overall Study|Ineligible|3|||
150065944|NCT00145600|541384130|FG001|Overall Study|Ineligible|0|||
150065945|NCT00145600|541384131|FG002|Overall Study|Ineligible|1|||
150065946|NCT00145600|541384132|FG003|Overall Study|Ineligible|5|||
150065947|NCT00145600|541384129|FG000|Overall Study|Lost to Follow-up|2|||
150065948|NCT00145600|541384130|FG001|Overall Study|Lost to Follow-up|6|||
150065949|NCT00145600|541384131|FG002|Overall Study|Lost to Follow-up|2|||
150065950|NCT00145600|541384132|FG003|Overall Study|Lost to Follow-up|4|||
150065951|NCT00145600|541384129|FG000|Overall Study|Noncompliance|1|||
150065952|NCT00145600|541384130|FG001|Overall Study|Noncompliance|0|||
150065953|NCT00145600|541384131|FG002|Overall Study|Noncompliance|0|||
150065954|NCT00145600|541384132|FG003|Overall Study|Noncompliance|0|||
150065955|NCT00145600|541384129|FG000|Overall Study|Withdrawal by Subject|1|||
150065956|NCT00145600|541384130|FG001|Overall Study|Withdrawal by Subject|2|||
150065957|NCT00145600|541384131|FG002|Overall Study|Withdrawal by Subject|0|||
150065958|NCT00145600|541384132|FG003|Overall Study|Withdrawal by Subject|1|||
150065959|NCT00147251|541384135|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
150065960|NCT00147251|541384136|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
150065961|NCT02694523|541384141|FG000|Part A|Adverse Event|7|||
150065962|NCT02694523|541384142|FG001|Part A|Adverse Event|3|||
150065963|NCT02694523|541384143|FG002|Part A|Adverse Event|0|||
150065964|NCT02694523|541384144|FG003|Part A|Adverse Event|0|||
150065965|NCT02694523|541384145|FG004|Part A|Adverse Event|0|||
150065966|NCT02694523|541384146|FG005|Part A|Adverse Event|0|||
150065967|NCT02694523|541384147|FG006|Part A|Adverse Event|0|||
150065968|NCT02694523|541384141|FG000|Part A|Protocol Violation|1|||
150065969|NCT02694523|541384142|FG001|Part A|Protocol Violation|0|||
150065970|NCT02694523|541384143|FG002|Part A|Protocol Violation|0|||
150065971|NCT02694523|541384144|FG003|Part A|Protocol Violation|0|||
150065972|NCT02694523|541384145|FG004|Part A|Protocol Violation|0|||
150065973|NCT02694523|541384146|FG005|Part A|Protocol Violation|0|||
150065974|NCT02694523|541384147|FG006|Part A|Protocol Violation|0|||
150065975|NCT02694523|541384141|FG000|Part A|Lost to Follow-up|1|||
150065976|NCT02694523|541384142|FG001|Part A|Lost to Follow-up|2|||
150065977|NCT02694523|541384143|FG002|Part A|Lost to Follow-up|0|||
150065978|NCT02694523|541384144|FG003|Part A|Lost to Follow-up|0|||
150065979|NCT02694523|541384145|FG004|Part A|Lost to Follow-up|0|||
150065980|NCT02694523|541384146|FG005|Part A|Lost to Follow-up|0|||
150065981|NCT02694523|541384147|FG006|Part A|Lost to Follow-up|0|||
150065982|NCT02694523|541384141|FG000|Part A|Withdrawal by Subject|3|||
150065983|NCT02694523|541384142|FG001|Part A|Withdrawal by Subject|1|||
150065984|NCT02694523|541384143|FG002|Part A|Withdrawal by Subject|0|||
150065985|NCT02694523|541384144|FG003|Part A|Withdrawal by Subject|0|||
150065986|NCT02694523|541384145|FG004|Part A|Withdrawal by Subject|0|||
150065987|NCT02694523|541384146|FG005|Part A|Withdrawal by Subject|0|||
150065988|NCT02694523|541384147|FG006|Part A|Withdrawal by Subject|0|||
150065989|NCT02694523|541384141|FG000|Part A|Other|1|||
150065990|NCT02694523|541384142|FG001|Part A|Other|1|||
150065991|NCT02694523|541384143|FG002|Part A|Other|0|||
150065992|NCT02694523|541384144|FG003|Part A|Other|0|||
150065993|NCT02694523|541384145|FG004|Part A|Other|0|||
150065994|NCT02694523|541384146|FG005|Part A|Other|0|||
150065995|NCT02694523|541384147|FG006|Part A|Other|0|||
150065996|NCT02694523|541384141|FG000|Part B|Adverse Event|0|||
150065997|NCT02694523|541384142|FG001|Part B|Adverse Event|0|||
150065998|NCT02694523|541384143|FG002|Part B|Adverse Event|7|||
150065999|NCT02694523|541384144|FG003|Part B|Adverse Event|1|||
150066000|NCT02694523|541384145|FG004|Part B|Adverse Event|1|||
150066001|NCT02694523|541384146|FG005|Part B|Adverse Event|2|||
150066002|NCT02694523|541384147|FG006|Part B|Adverse Event|0|||
150066003|NCT02694523|541384141|FG000|Part B|Protocol Violation|0|||
150066004|NCT02694523|541384142|FG001|Part B|Protocol Violation|0|||
150025448|NCT00796666|541228486|FG001|Overall Study|Death|4|||
150025449|NCT00796666|541228485|FG000|Overall Study|Withdrawal by Subject|2|||
150025450|NCT00796666|541228486|FG001|Overall Study|Withdrawal by Subject|0|||
150025451|NCT00796666|541228485|FG000|Overall Study|Adverse Event|7|||
150025452|NCT00796666|541228486|FG001|Overall Study|Adverse Event|5|||
150025453|NCT00796666|541228485|FG000|Overall Study|Protocol Violation|1|||
150025454|NCT00796666|541228486|FG001|Overall Study|Protocol Violation|0|||
150025455|NCT00796666|541228485|FG000|Overall Study|Other|1|||
150025456|NCT00796666|541228486|FG001|Overall Study|Other|0|||
150025457|NCT00796666|541228485|FG000|Overall Study|Terminated by sponsor|53|||
150025458|NCT00796666|541228486|FG001|Overall Study|Terminated by sponsor|55|||
150025459|NCT00796666|541228485|FG000|Overall Study|Randomized and not treated|1|||
150025460|NCT00796666|541228486|FG001|Overall Study|Randomized and not treated|0|||
150025461|NCT02159066|541228487|FG000|Part I|Adverse Event|7|||
150025462|NCT02159066|541228488|FG001|Part I|Adverse Event|5|||
150025463|NCT02159066|541228489|FG002|Part I|Adverse Event|0|||
150025464|NCT02159066|541228490|FG003|Part I|Adverse Event|0|||
150025465|NCT02159066|541228491|FG004|Part I|Adverse Event|0|||
150025466|NCT02159066|541228492|FG005|Part I|Adverse Event|0|||
150025467|NCT02159066|541228487|FG000|Part I|Death|11|||
150025468|NCT02159066|541228488|FG001|Part I|Death|9|||
150025469|NCT02159066|541228489|FG002|Part I|Death|0|||
150025470|NCT02159066|541228490|FG003|Part I|Death|0|||
150025471|NCT02159066|541228491|FG004|Part I|Death|0|||
150025472|NCT02159066|541228492|FG005|Part I|Death|0|||
150025473|NCT02159066|541228487|FG000|Part I|Progressive Disease|37|||
150025474|NCT02159066|541228488|FG001|Part I|Progressive Disease|46|||
150025475|NCT02159066|541228489|FG002|Part I|Progressive Disease|0|||
150025476|NCT02159066|541228490|FG003|Part I|Progressive Disease|0|||
150025477|NCT02159066|541228491|FG004|Part I|Progressive Disease|0|||
150025478|NCT02159066|541228492|FG005|Part I|Progressive Disease|0|||
150025479|NCT02159066|541228487|FG000|Part I|New Therapy for Study Indication|5|||
150025480|NCT02159066|541228488|FG001|Part I|New Therapy for Study Indication|4|||
150025481|NCT02159066|541228489|FG002|Part I|New Therapy for Study Indication|0|||
150025482|NCT02159066|541228490|FG003|Part I|New Therapy for Study Indication|0|||
150025483|NCT02159066|541228491|FG004|Part I|New Therapy for Study Indication|0|||
150025484|NCT02159066|541228492|FG005|Part I|New Therapy for Study Indication|0|||
150025485|NCT02159066|541228487|FG000|Part I|Termination of participants from the study|3|||
150025486|NCT02159066|541228488|FG001|Part I|Termination of participants from the study|3|||
150025487|NCT02159066|541228489|FG002|Part I|Termination of participants from the study|0|||
150025488|NCT02159066|541228490|FG003|Part I|Termination of participants from the study|0|||
150025489|NCT02159066|541228491|FG004|Part I|Termination of participants from the study|0|||
150025490|NCT02159066|541228492|FG005|Part I|Termination of participants from the study|0|||
150025491|NCT02159066|541228487|FG000|Part I|Physician Decision|2|||
150025492|NCT02159066|541228488|FG001|Part I|Physician Decision|9|||
150025493|NCT02159066|541228489|FG002|Part I|Physician Decision|0|||
150025494|NCT02159066|541228490|FG003|Part I|Physician Decision|0|||
150025495|NCT02159066|541228491|FG004|Part I|Physician Decision|0|||
150025496|NCT02159066|541228492|FG005|Part I|Physician Decision|0|||
150025497|NCT02159066|541228487|FG000|Part I|Participant/Guardian Decision|9|||
150025498|NCT02159066|541228488|FG001|Part I|Participant/Guardian Decision|3|||
150025499|NCT02159066|541228489|FG002|Part I|Participant/Guardian Decision|0|||
150025500|NCT02159066|541228490|FG003|Part I|Participant/Guardian Decision|0|||
150025501|NCT02159066|541228491|FG004|Part I|Participant/Guardian Decision|0|||
150025502|NCT02159066|541228492|FG005|Part I|Participant/Guardian Decision|0|||
150025503|NCT02159066|541228487|FG000|Part I|Missing Data|1|||
150025504|NCT02159066|541228488|FG001|Part I|Missing Data|0|||
150025505|NCT02159066|541228489|FG002|Part I|Missing Data|0|||
150025506|NCT02159066|541228490|FG003|Part I|Missing Data|0|||
150025507|NCT02159066|541228491|FG004|Part I|Missing Data|0|||
150025508|NCT02159066|541228492|FG005|Part I|Missing Data|0|||
150025509|NCT02159066|541228487|FG000|Part II|Adverse Event|0|||
150025510|NCT02159066|541228488|FG001|Part II|Adverse Event|0|||
150025511|NCT02159066|541228489|FG002|Part II|Adverse Event|1|||
150025512|NCT02159066|541228490|FG003|Part II|Adverse Event|0|||
150025513|NCT02159066|541228491|FG004|Part II|Adverse Event|1|||
150025514|NCT02159066|541228492|FG005|Part II|Adverse Event|1|||
150025515|NCT02159066|541228487|FG000|Part II|Death|0|||
150025516|NCT02159066|541228488|FG001|Part II|Death|0|||
150025517|NCT02159066|541228489|FG002|Part II|Death|1|||
150025518|NCT02159066|541228490|FG003|Part II|Death|0|||
150025519|NCT02159066|541228491|FG004|Part II|Death|2|||
150025520|NCT02159066|541228492|FG005|Part II|Death|1|||
150025521|NCT02159066|541228487|FG000|Part II|Progressive Disease|0|||
150025522|NCT02159066|541228488|FG001|Part II|Progressive Disease|0|||
150025523|NCT02159066|541228489|FG002|Part II|Progressive Disease|35|||
150025524|NCT02159066|541228490|FG003|Part II|Progressive Disease|1|||
150025525|NCT02159066|541228491|FG004|Part II|Progressive Disease|7|||
150025526|NCT02159066|541228492|FG005|Part II|Progressive Disease|4|||
150025527|NCT02159066|541228487|FG000|Part II|New Therapy for Study Indication|0|||
150025528|NCT02159066|541228488|FG001|Part II|New Therapy for Study Indication|0|||
150025529|NCT02159066|541228489|FG002|Part II|New Therapy for Study Indication|0|||
150066005|NCT02694523|541384143|FG002|Part B|Protocol Violation|1|||
150066006|NCT02694523|541384144|FG003|Part B|Protocol Violation|0|||
150066007|NCT02694523|541384145|FG004|Part B|Protocol Violation|0|||
150066008|NCT02694523|541384146|FG005|Part B|Protocol Violation|0|||
150066009|NCT02694523|541384147|FG006|Part B|Protocol Violation|0|||
150066010|NCT02694523|541384141|FG000|Part B|Lost to Follow-up|0|||
150066011|NCT02694523|541384142|FG001|Part B|Lost to Follow-up|0|||
150066012|NCT02694523|541384143|FG002|Part B|Lost to Follow-up|2|||
150066013|NCT02694523|541384144|FG003|Part B|Lost to Follow-up|3|||
150066014|NCT02694523|541384145|FG004|Part B|Lost to Follow-up|2|||
150066015|NCT02694523|541384146|FG005|Part B|Lost to Follow-up|0|||
150066016|NCT02694523|541384147|FG006|Part B|Lost to Follow-up|1|||
150066017|NCT02694523|541384141|FG000|Part B|Withdrawal by Subject|0|||
150066018|NCT02694523|541384142|FG001|Part B|Withdrawal by Subject|0|||
150066019|NCT02694523|541384143|FG002|Part B|Withdrawal by Subject|9|||
150066020|NCT02694523|541384144|FG003|Part B|Withdrawal by Subject|0|||
150066021|NCT02694523|541384145|FG004|Part B|Withdrawal by Subject|1|||
150066022|NCT02694523|541384146|FG005|Part B|Withdrawal by Subject|3|||
150066023|NCT02694523|541384147|FG006|Part B|Withdrawal by Subject|0|||
150066024|NCT02694523|541384141|FG000|Part B|Other|0|||
150066025|NCT02694523|541384142|FG001|Part B|Other|0|||
150066026|NCT02694523|541384143|FG002|Part B|Other|1|||
150066027|NCT02694523|541384144|FG003|Part B|Other|0|||
150066028|NCT02694523|541384145|FG004|Part B|Other|0|||
150066029|NCT02694523|541384146|FG005|Part B|Other|0|||
150066030|NCT02694523|541384147|FG006|Part B|Other|1|||
150066031|NCT01086423|541384148|FG000|Overall Study|Protocol Violation|0|||
150066032|NCT01086423|541384149|FG001|Overall Study|Protocol Violation|0|||
150066033|NCT01086423|541384150|FG002|Overall Study|Protocol Violation|1|||
150066034|NCT01086423|541384148|FG000|Overall Study|Migrated/moved from study area|2|||
150066035|NCT01086423|541384149|FG001|Overall Study|Migrated/moved from study area|0|||
150066036|NCT01086423|541384150|FG002|Overall Study|Migrated/moved from study area|4|||
150066037|NCT01086423|541384148|FG000|Overall Study|Adverse event, fatal|1|||
150066038|NCT01086423|541384149|FG001|Overall Study|Adverse event, fatal|1|||
150066039|NCT01086423|541384150|FG002|Overall Study|Adverse event, fatal|0|||
150066040|NCT01086423|541384148|FG000|Overall Study|Adverse event, non-fatal|2|||
150066041|NCT01086423|541384149|FG001|Overall Study|Adverse event, non-fatal|1|||
150066042|NCT01086423|541384150|FG002|Overall Study|Adverse event, non-fatal|0|||
150066043|NCT01086423|541384148|FG000|Overall Study|Withdrawal by Subject|5|||
150066044|NCT01086423|541384149|FG001|Overall Study|Withdrawal by Subject|1|||
150066045|NCT01086423|541384150|FG002|Overall Study|Withdrawal by Subject|3|||
150066046|NCT01086423|541384148|FG000|Overall Study|Lost to Follow-up|0|||
150066047|NCT01086423|541384149|FG001|Overall Study|Lost to Follow-up|0|||
150066048|NCT01086423|541384150|FG002|Overall Study|Lost to Follow-up|1|||
150066049|NCT04505540|541384151|FG000|Baseline|Protocol Violation|10|||
150066050|NCT04505540|541384151|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
150066051|NCT04505540|541384151|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
150066052|NCT04505540|541384151|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
150066053|NCT04505540|541384151|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
150066054|NCT04505540|541384151|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
150066055|NCT04505540|541384151|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
150066056|NCT04505540|541384151|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
150066057|NCT04505540|541384151|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
150066058|NCT04505540|541384151|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
150066059|NCT04505540|541384151|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
150066060|NCT04505540|541384151|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
150066061|NCT04505540|541384151|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
150066062|NCT01367119|541384152|FG000|Overall Study|Adverse Event|1|||
150066063|NCT01367119|541384153|FG001|Overall Study|Adverse Event|0|||
150066064|NCT01367119|541384152|FG000|Overall Study|Withdrawal by Subject|1|||
150066065|NCT01367119|541384153|FG001|Overall Study|Withdrawal by Subject|1|||
150066066|NCT05342532|541384154|FG000|Overall Study|Adverse Event|5|||
150066067|NCT05342532|541384155|FG001|Overall Study|Adverse Event|20|||
150066068|NCT05342532|541384154|FG000|Overall Study|Lost to Follow-up|10|||
150066069|NCT05342532|541384155|FG001|Overall Study|Lost to Follow-up|15|||
150066070|NCT02057393|541384158|FG000|Overall Study|Withdrawal by Subject|1|||
150066071|NCT02057393|541384158|FG000|Overall Study|Patient did not meet criteria|1|||
150066072|NCT03180684|541384159|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
150066073|NCT03180684|541384160|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
150066074|NCT03180684|541384159|FG000|Overall Study|Physician Decision|1|||
150066075|NCT03180684|541384160|FG001|Overall Study|Physician Decision|0|||
150066076|NCT03180684|541384159|FG000|Overall Study|Lost to Follow-up|1|||
150066077|NCT03180684|541384160|FG001|Overall Study|Lost to Follow-up|0|||
150066078|NCT03180684|541384159|FG000|Overall Study|Progressive Disease|1|||
150066079|NCT03180684|541384160|FG001|Overall Study|Progressive Disease|0|||
150066080|NCT02652767|541384162|FG000|Overall Study|Death|2|||
150066081|NCT02652767|541384162|FG000|Overall Study|Lost to Follow-up|1|||
150066082|NCT02652767|541384162|FG000|Overall Study|Withdrawal by Subject|1|||
150066083|NCT03953183|541384163|FG000|Overall Study|Physician Decision|0|||
150066084|NCT03953183|541384164|FG001|Overall Study|Physician Decision|1|||
150066085|NCT03953183|541384163|FG000|Overall Study|Withdrawal by Subject|0|||
150066086|NCT03953183|541384164|FG001|Overall Study|Withdrawal by Subject|1|||
150066087|NCT01130103|541384165|FG000|Randomized Treatment|Adverse Event|1|||
150066088|NCT01130103|541384166|FG001|Randomized Treatment|Adverse Event|1|||
150066089|NCT01130103|541384165|FG000|Randomized Treatment|Lost to Follow-up|1|||
150066090|NCT01130103|541384166|FG001|Randomized Treatment|Lost to Follow-up|0|||
150066091|NCT01130103|541384165|FG000|Randomized Treatment|Protocol Violation|3|||
150066092|NCT01130103|541384166|FG001|Randomized Treatment|Protocol Violation|2|||
150066093|NCT01130103|541384165|FG000|Randomized Treatment|Withdrawal by Subject|1|||
150066094|NCT01130103|541384166|FG001|Randomized Treatment|Withdrawal by Subject|2|||
150066095|NCT01130103|541384165|FG000|Maintenance Treatment|Lack of Efficacy|0|||
150066096|NCT01130103|541384166|FG001|Maintenance Treatment|Lack of Efficacy|1|||
150066097|NCT01130103|541384165|FG000|Maintenance Treatment|Lost to Follow-up|1|||
150066098|NCT01130103|541384166|FG001|Maintenance Treatment|Lost to Follow-up|1|||
150066099|NCT01130103|541384165|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
150066100|NCT01130103|541384166|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
150066101|NCT00887744|541384177|FG000|Overall Study|Adverse Event|3|||
150066102|NCT00887744|541384177|FG000|Overall Study|Death|1|||
150066103|NCT00887744|541384177|FG000|Overall Study|Lost to Follow-up|3|||
150066104|NCT00887744|541384177|FG000|Overall Study|Withdrawal by Subject|18|||
150066105|NCT00887744|541384177|FG000|Overall Study|Various reasons|9|||
150066106|NCT03091777|541384178|FG000|Overall Study|Pregnancy|2|||
150066107|NCT03091777|541384179|FG001|Overall Study|Pregnancy|1|||
150066108|NCT03091777|541384180|FG002|Overall Study|Pregnancy|0|||
150066109|NCT03091777|541384178|FG000|Overall Study|Adverse Event|2|||
150066110|NCT03091777|541384179|FG001|Overall Study|Adverse Event|1|||
150066111|NCT03091777|541384180|FG002|Overall Study|Adverse Event|4|||
150066112|NCT03091777|541384178|FG000|Overall Study|Withdrawal by Subject|4|||
150066113|NCT03091777|541384179|FG001|Overall Study|Withdrawal by Subject|2|||
150066114|NCT03091777|541384180|FG002|Overall Study|Withdrawal by Subject|6|||
150066115|NCT03091777|541384178|FG000|Overall Study|Protocol Violation|2|||
150066116|NCT03091777|541384179|FG001|Overall Study|Protocol Violation|1|||
150066117|NCT03091777|541384180|FG002|Overall Study|Protocol Violation|1|||
150066118|NCT03091777|541384178|FG000|Overall Study|Lost to Follow-up|12|||
150066119|NCT03091777|541384179|FG001|Overall Study|Lost to Follow-up|14|||
150066120|NCT03091777|541384180|FG002|Overall Study|Lost to Follow-up|7|||
150066121|NCT03091777|541384178|FG000|Overall Study|Lack of Efficacy|0|||
150066122|NCT03091777|541384179|FG001|Overall Study|Lack of Efficacy|0|||
150066123|NCT03091777|541384180|FG002|Overall Study|Lack of Efficacy|5|||
150066124|NCT03091777|541384178|FG000|Overall Study|Noncompliance with study drug|2|||
150066125|NCT03091777|541384179|FG001|Overall Study|Noncompliance with study drug|3|||
150066126|NCT03091777|541384180|FG002|Overall Study|Noncompliance with study drug|1|||
150066127|NCT03091777|541384178|FG000|Overall Study|Physician Decision|1|||
150066128|NCT03091777|541384179|FG001|Overall Study|Physician Decision|0|||
150066129|NCT03091777|541384180|FG002|Overall Study|Physician Decision|1|||
150066130|NCT03091777|541384178|FG000|Overall Study|Abnormal Laboratory Value|7|||
150066131|NCT03091777|541384179|FG001|Overall Study|Abnormal Laboratory Value|11|||
150066132|NCT03091777|541384180|FG002|Overall Study|Abnormal Laboratory Value|12|||
150066133|NCT02314143|541384181|FG000|Overall Study|Adverse Event|0|||
150066134|NCT02314143|541384182|FG001|Overall Study|Adverse Event|6|||
150066135|NCT02314143|541384183|FG002|Overall Study|Adverse Event|4|||
150066136|NCT02314143|541384181|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
150066137|NCT02314143|541384182|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
150066138|NCT02314143|541384183|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
150066139|NCT02314143|541384181|FG000|Overall Study|Physician Decision|2|||
150066140|NCT02314143|541384182|FG001|Overall Study|Physician Decision|1|||
150066141|NCT02314143|541384183|FG002|Overall Study|Physician Decision|0|||
150066142|NCT02314143|541384181|FG000|Overall Study|Withdrawal by Subject|1|||
150066143|NCT02314143|541384182|FG001|Overall Study|Withdrawal by Subject|0|||
150066144|NCT02314143|541384183|FG002|Overall Study|Withdrawal by Subject|1|||
150066145|NCT00089674|541384185|FG000|Overall Study|Physician Decision|4|||
150066146|NCT00089674|541384186|FG001|Overall Study|Physician Decision|2|||
150066147|NCT00089674|541384185|FG000|Overall Study|Adverse Event|23|||
150066148|NCT00089674|541384186|FG001|Overall Study|Adverse Event|29|||
150066149|NCT00089674|541384185|FG000|Overall Study|Withdrawal by Subject|143|||
150181976|NCT03398148|541804597|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181977|NCT03398148|541804598|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181978|NCT03398148|541804599|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181979|NCT03398148|541804600|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181980|NCT03398148|541804601|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150066150|NCT00089674|541384186|FG001|Overall Study|Withdrawal by Subject|127|||
150066151|NCT00089674|541384185|FG000|Overall Study|Death|43|||
150066152|NCT00089674|541384186|FG001|Overall Study|Death|43|||
150066153|NCT00089674|541384185|FG000|Overall Study|Disease progression|21|||
150181981|NCT03398148|541804602|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181982|NCT03398148|541804603|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181983|NCT03398148|541804604|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181984|NCT03398148|541804605|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
150181985|NCT03398148|541804606|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
150181986|NCT03398148|541804607|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181987|NCT03398148|541804608|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181988|NCT03398148|541804609|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181989|NCT03398148|541804610|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
150181990|NCT03398148|541804596|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
150181991|NCT03398148|541804597|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
150181992|NCT03398148|541804598|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
150181993|NCT03398148|541804599|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
150181994|NCT03398148|541804600|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
150181995|NCT03398148|541804601|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
150181996|NCT03398148|541804602|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
150181997|NCT03398148|541804603|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
150181998|NCT03398148|541804604|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
150181999|NCT03398148|541804605|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
150182000|NCT03398148|541804606|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
150182001|NCT03398148|541804607|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
150182002|NCT03398148|541804608|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
150182003|NCT03398148|541804609|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
150182004|NCT03398148|541804610|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
150182005|NCT03398148|541804596|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182006|NCT03398148|541804597|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182007|NCT03398148|541804598|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150066154|NCT00089674|541384186|FG001|Overall Study|Disease progression|23|||
150066155|NCT00089674|541384185|FG000|Overall Study|Ineligibility determined|8|||
150066156|NCT00089674|541384186|FG001|Overall Study|Ineligibility determined|10|||
150066157|NCT00089674|541384185|FG000|Overall Study|Lost to Follow-up|21|||
150066158|NCT00089674|541384186|FG001|Overall Study|Lost to Follow-up|17|||
150066159|NCT00089674|541384185|FG000|Overall Study|Noncompliance|7|||
150066160|NCT00089674|541384186|FG001|Overall Study|Noncompliance|3|||
150066161|NCT00089674|541384185|FG000|Overall Study|Other|5|||
150066162|NCT00089674|541384186|FG001|Overall Study|Other|9|||
150066163|NCT00089674|541384185|FG000|Overall Study|Requirement for alternative therapy|14|||
150066164|NCT00089674|541384186|FG001|Overall Study|Requirement for alternative therapy|4|||
150182008|NCT03398148|541804599|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182009|NCT03398148|541804600|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182010|NCT03398148|541804601|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182011|NCT03398148|541804602|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182012|NCT03398148|541804603|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182013|NCT03398148|541804604|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182014|NCT03398148|541804605|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182015|NCT03398148|541804606|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
150182016|NCT03398148|541804607|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182017|NCT03398148|541804608|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150182018|NCT03398148|541804609|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150066165|NCT03963401|541384187|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
150066166|NCT03963401|541384188|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
150066167|NCT03963401|541384189|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
150066168|NCT03963401|541384190|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
150066169|NCT03963401|541384191|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
150066170|NCT03963401|541384192|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
150066171|NCT03963401|541384187|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
150066172|NCT03963401|541384188|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
150066173|NCT03963401|541384189|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
150066174|NCT03963401|541384190|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
150066175|NCT03963401|541384191|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
150066176|NCT03963401|541384192|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
150066177|NCT03963401|541384187|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
150066178|NCT03963401|541384188|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
150066179|NCT03963401|541384189|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
150066180|NCT03963401|541384190|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
150066181|NCT03963401|541384191|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
150066182|NCT03963401|541384192|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
150066183|NCT03963401|541384187|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
150066184|NCT03963401|541384188|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
150066185|NCT03963401|541384189|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
150066186|NCT03963401|541384190|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
150066187|NCT03963401|541384191|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
150066188|NCT03963401|541384192|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
150066189|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
150066190|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
150066191|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
150066192|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
150066193|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
150066194|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
150066195|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
150066196|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
150066197|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
150066198|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
150066199|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
150066200|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
150066201|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
150066202|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
150066203|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
150066204|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
150066205|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
150066206|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
150066207|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
150066208|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
150066209|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
150066210|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
150066211|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
150066212|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
150066213|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
150066214|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
150066215|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
150066216|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
150066217|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
150066218|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
150066219|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
150066220|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
150066221|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
150066222|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
150066223|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
150066224|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
150066225|NCT03963401|541384187|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
150066226|NCT03963401|541384188|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
150066227|NCT03963401|541384189|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
150066228|NCT03963401|541384190|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
150066229|NCT03963401|541384191|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
150066230|NCT03963401|541384192|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
150066231|NCT01528215|541384197|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
150066232|NCT01528215|541384198|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
150066233|NCT01528215|541384197|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
150066234|NCT01528215|541384198|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
150066235|NCT01528215|541384197|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
150066236|NCT01528215|541384198|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
150066237|NCT01528215|541384197|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
150066238|NCT01528215|541384198|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
150066239|NCT01476644|541384199|FG000|Overall Study|Death|5|||
150066240|NCT01476644|541384199|FG000|Overall Study|moved to another state|2|||
150066241|NCT01476644|541384199|FG000|Overall Study|Lost to Follow-up|19|||
150066242|NCT01476644|541384199|FG000|Overall Study|Withdrawal by Subject|13|||
150066243|NCT01610271|541384200|FG000|Overall Study|Surgery not complete|0|||
150066244|NCT01610271|541384201|FG001|Overall Study|Surgery not complete|1|||
150066245|NCT01610271|541384200|FG000|Overall Study|Prosthesis not implanted|2|||
150066246|NCT01610271|541384201|FG001|Overall Study|Prosthesis not implanted|3|||
150066247|NCT02393690|541384202|FG000|Overall Study|Ineligible|0|||
150066248|NCT02393690|541384203|FG001|Overall Study|Ineligible|1|||
150066249|NCT03488927|541384204|FG000|Overall Study|Withdrawal by Subject|44|||
150066250|NCT03488927|541384205|FG001|Overall Study|Withdrawal by Subject|118|||
150066251|NCT03488927|541384206|FG002|Overall Study|Withdrawal by Subject|217|||
150066252|NCT00237185|541384207|FG000|Core|Adverse Event|3|||
150066253|NCT00237185|541384208|FG001|Core|Adverse Event|4|||
150066254|NCT00237185|541384207|FG000|Core|Abnormal laboratory value|0|||
150066255|NCT00237185|541384208|FG001|Core|Abnormal laboratory value|4|||
150066256|NCT00237185|541384207|FG000|Core|Abnormal test procedure results|1|||
150066257|NCT00237185|541384208|FG001|Core|Abnormal test procedure results|0|||
150066258|NCT00237185|541384207|FG000|Core|Lack of Efficacy|30|||
150066259|NCT00237185|541384208|FG001|Core|Lack of Efficacy|23|||
150066260|NCT00237185|541384207|FG000|Core|Protocol Violation|1|||
150066261|NCT00237185|541384208|FG001|Core|Protocol Violation|1|||
150066262|NCT00237185|541384207|FG000|Core|Withdrawal by Subject|4|||
150066263|NCT00237185|541384208|FG001|Core|Withdrawal by Subject|4|||
150066264|NCT00237185|541384207|FG000|Core|Administrative problems|0|||
150066265|NCT00237185|541384208|FG001|Core|Administrative problems|1|||
150066266|NCT00237185|541384207|FG000|Core|Death|4|||
150066267|NCT00237185|541384208|FG001|Core|Death|0|||
150066268|NCT00237185|541384207|FG000|Core|Determined ineligible post randomization|1|||
150066269|NCT00237185|541384208|FG001|Core|Determined ineligible post randomization|0|||
150066270|NCT00237185|541384207|FG000|Extension|Adverse Event|1|||
150066271|NCT00237185|541384208|FG001|Extension|Adverse Event|0|||
150066272|NCT00237185|541384207|FG000|Extension|Abnormal laboratory value|0|||
150066273|NCT00237185|541384208|FG001|Extension|Abnormal laboratory value|1|||
150066274|NCT00237185|541384207|FG000|Extension|Lack of Efficacy|9|||
150066275|NCT00237185|541384208|FG001|Extension|Lack of Efficacy|14|||
150066276|NCT00237185|541384207|FG000|Extension|Condition no longer required study drug|0|||
150066277|NCT00237185|541384208|FG001|Extension|Condition no longer required study drug|1|||
150066278|NCT00237185|541384207|FG000|Extension|Withdrawal by Subject|3|||
150066279|NCT00237185|541384208|FG001|Extension|Withdrawal by Subject|2|||
150066280|NCT00237185|541384207|FG000|Extension|Lost to Follow-up|1|||
150066281|NCT00237185|541384208|FG001|Extension|Lost to Follow-up|0|||
150066282|NCT00237185|541384207|FG000|Extension|Administrative problems|1|||
150066283|NCT00237185|541384208|FG001|Extension|Administrative problems|0|||
150066284|NCT00237185|541384207|FG000|Extension|Death|1|||
150066285|NCT00237185|541384208|FG001|Extension|Death|1|||
150066286|NCT02819518|541384214|FG000|Overall Study|Death|9|||
150066287|NCT02819518|541384215|FG001|Overall Study|Death|12|||
150066288|NCT02819518|541384216|FG002|Overall Study|Death|9|||
150066289|NCT02819518|541384217|FG003|Overall Study|Death|475|||
150066290|NCT02819518|541384218|FG004|Overall Study|Death|244|||
150066291|NCT02819518|541384214|FG000|Overall Study|Withdrawal by Subject|0|||
150066292|NCT02819518|541384215|FG001|Overall Study|Withdrawal by Subject|0|||
150066293|NCT02819518|541384216|FG002|Overall Study|Withdrawal by Subject|0|||
150066294|NCT02819518|541384217|FG003|Overall Study|Withdrawal by Subject|25|||
150066295|NCT02819518|541384218|FG004|Overall Study|Withdrawal by Subject|8|||
150066296|NCT02819518|541384214|FG000|Overall Study|Lost to Follow-up|0|||
150066297|NCT02819518|541384215|FG001|Overall Study|Lost to Follow-up|0|||
150066298|NCT02819518|541384216|FG002|Overall Study|Lost to Follow-up|0|||
150066299|NCT02819518|541384217|FG003|Overall Study|Lost to Follow-up|0|||
150066300|NCT02819518|541384218|FG004|Overall Study|Lost to Follow-up|1|||
150066301|NCT02819518|541384214|FG000|Overall Study|Sponsor Decision|1|||
150066302|NCT02819518|541384215|FG001|Overall Study|Sponsor Decision|1|||
150066303|NCT02819518|541384216|FG002|Overall Study|Sponsor Decision|0|||
150066304|NCT02819518|541384217|FG003|Overall Study|Sponsor Decision|34|||
150066305|NCT02819518|541384218|FG004|Overall Study|Sponsor Decision|17|||
150066306|NCT02819518|541384214|FG000|Overall Study|Transferred to extension study|1|||
150066307|NCT02819518|541384215|FG001|Overall Study|Transferred to extension study|1|||
150066308|NCT02819518|541384216|FG002|Overall Study|Transferred to extension study|1|||
150066309|NCT02819518|541384217|FG003|Overall Study|Transferred to extension study|32|||
150066310|NCT02819518|541384218|FG004|Overall Study|Transferred to extension study|11|||
150066311|NCT00880165|541384219|FG000|Overall Study|Withdrawal by Subject|27|||
150066312|NCT00880165|541384220|FG001|Overall Study|Withdrawal by Subject|23|||
150066313|NCT00880165|541384219|FG000|Overall Study|Not diagnosed with OSA|14|||
150066314|NCT00880165|541384220|FG001|Overall Study|Not diagnosed with OSA|8|||
150066315|NCT00880165|541384219|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
150066316|NCT00880165|541384220|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
150066317|NCT00880165|541384219|FG000|Overall Study|Lost to follow|9|||
150066318|NCT00880165|541384220|FG001|Overall Study|Lost to follow|15|||
150066319|NCT01758289|541384221|FG000|Overall Study|Premature Study Termination|44|||
150066320|NCT01758289|541384221|FG000|Overall Study|Adverse Event|9|||
150066321|NCT03552965|541384223|FG000|Overall Study|Death|1|||
150066322|NCT03552965|541384224|FG001|Overall Study|Death|1|||
150066323|NCT03552965|541384223|FG000|Overall Study|Lost to Follow-up|1|||
150066324|NCT03552965|541384224|FG001|Overall Study|Lost to Follow-up|1|||
150066325|NCT03552965|541384223|FG000|Overall Study|Physician Decision|1|||
150066326|NCT03552965|541384224|FG001|Overall Study|Physician Decision|1|||
150066327|NCT03552965|541384223|FG000|Overall Study|Withdrawal by Subject|0|||
150066328|NCT03552965|541384224|FG001|Overall Study|Withdrawal by Subject|2|||
150066329|NCT03552965|541384223|FG000|Overall Study|Continuation not in patient best interest|1|||
150066330|NCT03552965|541384224|FG001|Overall Study|Continuation not in patient best interest|0|||
150066331|NCT03552965|541384223|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
150066332|NCT03552965|541384224|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
150066333|NCT01104701|541385923|FG000|Overall Study|Withdrawal by Subject|0|||
150066334|NCT01104701|541385924|FG001|Overall Study|Withdrawal by Subject|1|||
150066335|NCT01104701|541385925|FG002|Overall Study|Withdrawal by Subject|2|||
150066336|NCT01104701|541385926|FG003|Overall Study|Withdrawal by Subject|1|||
150066337|NCT01104701|541385923|FG000|Overall Study|Adverse Event|0|||
150066338|NCT01104701|541385924|FG001|Overall Study|Adverse Event|0|||
150066339|NCT01104701|541385925|FG002|Overall Study|Adverse Event|0|||
150066340|NCT01104701|541385926|FG003|Overall Study|Adverse Event|1|||
150066341|NCT01104701|541385923|FG000|Overall Study|Physician Decision|0|||
150066342|NCT01104701|541385924|FG001|Overall Study|Physician Decision|2|||
150066343|NCT01104701|541385925|FG002|Overall Study|Physician Decision|0|||
150066344|NCT01104701|541385926|FG003|Overall Study|Physician Decision|0|||
150066345|NCT02171065|541385929|FG000|Overall Study|Withdrawal by Subject|1|||
150066346|NCT02171065|541385930|FG001|Overall Study|Withdrawal by Subject|0|||
150066347|NCT02171065|541385931|FG002|Overall Study|Withdrawal by Subject|0|||
150066348|NCT02171065|541385929|FG000|Overall Study|Lost to Follow-up|0|||
150066349|NCT02171065|541385930|FG001|Overall Study|Lost to Follow-up|0|||
150066350|NCT02171065|541385931|FG002|Overall Study|Lost to Follow-up|1|||
150066351|NCT00518687|541385932|FG000|Overall Study|Adverse Event|201|||
150066352|NCT00518687|541385933|FG001|Overall Study|Adverse Event|177|||
150066353|NCT00518687|541385932|FG000|Overall Study|Lost to Follow-up|144|||
150066354|NCT00518687|541385933|FG001|Overall Study|Lost to Follow-up|155|||
150066355|NCT00518687|541385932|FG000|Overall Study|Physician Decision|42|||
150066356|NCT00518687|541385933|FG001|Overall Study|Physician Decision|48|||
150066357|NCT00518687|541385932|FG000|Overall Study|Progressive disease|2|||
150066358|NCT00518687|541385933|FG001|Overall Study|Progressive disease|2|||
150066359|NCT00518687|541385932|FG000|Overall Study|Protocol Violation|8|||
150066360|NCT00518687|541385933|FG001|Overall Study|Protocol Violation|10|||
150066361|NCT00518687|541385932|FG000|Overall Study|Study terminated by sponsor|930|||
150066362|NCT00518687|541385933|FG001|Overall Study|Study terminated by sponsor|918|||
150066363|NCT00518687|541385932|FG000|Overall Study|Withdrawal by Subject|110|||
150066364|NCT00518687|541385933|FG001|Overall Study|Withdrawal by Subject|110|||
150066365|NCT02598960|541385934|FG000|Treatment Period|Disease Progression|4|||
150066366|NCT02598960|541385935|FG001|Treatment Period|Disease Progression|4|||
150066367|NCT02598960|541385936|FG002|Treatment Period|Disease Progression|4|||
150066368|NCT02598960|541385937|FG003|Treatment Period|Disease Progression|6|||
150066369|NCT02598960|541385938|FG004|Treatment Period|Disease Progression|8|||
150066370|NCT02598960|541385939|FG005|Treatment Period|Disease Progression|2|||
150066371|NCT02598960|541385940|FG006|Treatment Period|Disease Progression|2|||
150066372|NCT02598960|541385941|FG007|Treatment Period|Disease Progression|3|||
150066373|NCT02598960|541385942|FG008|Treatment Period|Disease Progression|7|||
150066374|NCT02598960|541385943|FG009|Treatment Period|Disease Progression|9|||
150066375|NCT02598960|541385944|FG010|Treatment Period|Disease Progression|7|||
150066376|NCT02598960|541385945|FG011|Treatment Period|Disease Progression|143|||
150066377|NCT02598960|541385946|FG012|Treatment Period|Disease Progression|23|||
150066378|NCT02598960|541385934|FG000|Treatment Period|Study drug toxicity|0|||
150066379|NCT02598960|541385935|FG001|Treatment Period|Study drug toxicity|0|||
150066380|NCT02598960|541385936|FG002|Treatment Period|Study drug toxicity|0|||
150066381|NCT02598960|541385937|FG003|Treatment Period|Study drug toxicity|0|||
150066382|NCT02598960|541385938|FG004|Treatment Period|Study drug toxicity|0|||
150066383|NCT02598960|541385939|FG005|Treatment Period|Study drug toxicity|0|||
150066384|NCT02598960|541385940|FG006|Treatment Period|Study drug toxicity|0|||
150066385|NCT02598960|541385941|FG007|Treatment Period|Study drug toxicity|0|||
150066386|NCT02598960|541385942|FG008|Treatment Period|Study drug toxicity|0|||
150066387|NCT02598960|541385943|FG009|Treatment Period|Study drug toxicity|1|||
150066388|NCT02598960|541385944|FG010|Treatment Period|Study drug toxicity|0|||
150066389|NCT02598960|541385945|FG011|Treatment Period|Study drug toxicity|3|||
150066390|NCT02598960|541385946|FG012|Treatment Period|Study drug toxicity|0|||
150066391|NCT02598960|541385934|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
150066392|NCT02598960|541385935|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
150066393|NCT02598960|541385936|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
150066394|NCT02598960|541385937|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
150066395|NCT02598960|541385938|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
150066396|NCT02598960|541385939|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
150066397|NCT02598960|541385940|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
150066398|NCT02598960|541385941|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
150066399|NCT02598960|541385942|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
150066400|NCT02598960|541385943|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
150066401|NCT02598960|541385944|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
150066402|NCT02598960|541385945|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
150066403|NCT02598960|541385946|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
150066404|NCT02598960|541385934|FG000|Treatment Period|participant request to discontinue|0|||
150066405|NCT02598960|541385935|FG001|Treatment Period|participant request to discontinue|1|||
150066406|NCT02598960|541385936|FG002|Treatment Period|participant request to discontinue|0|||
150066407|NCT02598960|541385937|FG003|Treatment Period|participant request to discontinue|0|||
150066408|NCT02598960|541385938|FG004|Treatment Period|participant request to discontinue|1|||
150066409|NCT02598960|541385939|FG005|Treatment Period|participant request to discontinue|0|||
150066410|NCT02598960|541385940|FG006|Treatment Period|participant request to discontinue|0|||
150066411|NCT02598960|541385941|FG007|Treatment Period|participant request to discontinue|0|||
150066412|NCT02598960|541385942|FG008|Treatment Period|participant request to discontinue|0|||
150066413|NCT02598960|541385943|FG009|Treatment Period|participant request to discontinue|0|||
150066414|NCT02598960|541385944|FG010|Treatment Period|participant request to discontinue|1|||
150066415|NCT02598960|541385945|FG011|Treatment Period|participant request to discontinue|4|||
150066416|NCT02598960|541385946|FG012|Treatment Period|participant request to discontinue|0|||
150066417|NCT02598960|541385934|FG000|Treatment Period|participant withdrew consent|0|||
150066418|NCT02598960|541385935|FG001|Treatment Period|participant withdrew consent|0|||
150066419|NCT02598960|541385936|FG002|Treatment Period|participant withdrew consent|0|||
150066420|NCT02598960|541385937|FG003|Treatment Period|participant withdrew consent|0|||
150066421|NCT02598960|541385938|FG004|Treatment Period|participant withdrew consent|0|||
150066422|NCT02598960|541385939|FG005|Treatment Period|participant withdrew consent|0|||
150066423|NCT02598960|541385940|FG006|Treatment Period|participant withdrew consent|0|||
150066424|NCT02598960|541385941|FG007|Treatment Period|participant withdrew consent|0|||
150066425|NCT02598960|541385942|FG008|Treatment Period|participant withdrew consent|0|||
150066426|NCT02598960|541385943|FG009|Treatment Period|participant withdrew consent|0|||
150066427|NCT02598960|541385944|FG010|Treatment Period|participant withdrew consent|0|||
150066428|NCT02598960|541385945|FG011|Treatment Period|participant withdrew consent|3|||
150066429|NCT02598960|541385946|FG012|Treatment Period|participant withdrew consent|0|||
150066430|NCT02598960|541385934|FG000|Treatment Period|No longer meets study criteria|0|||
150066431|NCT02598960|541385935|FG001|Treatment Period|No longer meets study criteria|0|||
150066432|NCT02598960|541385936|FG002|Treatment Period|No longer meets study criteria|0|||
150066433|NCT02598960|541385937|FG003|Treatment Period|No longer meets study criteria|0|||
150066434|NCT02598960|541385938|FG004|Treatment Period|No longer meets study criteria|0|||
150066435|NCT02598960|541385939|FG005|Treatment Period|No longer meets study criteria|0|||
150066436|NCT02598960|541385940|FG006|Treatment Period|No longer meets study criteria|0|||
150066437|NCT02598960|541385941|FG007|Treatment Period|No longer meets study criteria|0|||
150066438|NCT02598960|541385942|FG008|Treatment Period|No longer meets study criteria|0|||
150066439|NCT02598960|541385943|FG009|Treatment Period|No longer meets study criteria|0|||
150066440|NCT02598960|541385944|FG010|Treatment Period|No longer meets study criteria|0|||
150066441|NCT02598960|541385945|FG011|Treatment Period|No longer meets study criteria|1|||
150066442|NCT02598960|541385946|FG012|Treatment Period|No longer meets study criteria|0|||
150066443|NCT02598960|541385934|FG000|Treatment Period|Other Reasons|0|||
150066444|NCT02598960|541385935|FG001|Treatment Period|Other Reasons|0|||
150066445|NCT02598960|541385936|FG002|Treatment Period|Other Reasons|0|||
150066446|NCT02598960|541385937|FG003|Treatment Period|Other Reasons|0|||
150066447|NCT02598960|541385938|FG004|Treatment Period|Other Reasons|0|||
150066448|NCT02598960|541385939|FG005|Treatment Period|Other Reasons|0|||
150066449|NCT02598960|541385940|FG006|Treatment Period|Other Reasons|0|||
150066450|NCT02598960|541385941|FG007|Treatment Period|Other Reasons|0|||
150066451|NCT02598960|541385942|FG008|Treatment Period|Other Reasons|0|||
150025530|NCT02159066|541228490|FG003|Part II|New Therapy for Study Indication|0|||
150025531|NCT02159066|541228491|FG004|Part II|New Therapy for Study Indication|1|||
150025532|NCT02159066|541228492|FG005|Part II|New Therapy for Study Indication|0|||
150025533|NCT02159066|541228487|FG000|Part II|Physician Decision|0|||
150025534|NCT02159066|541228488|FG001|Part II|Physician Decision|0|||
150025535|NCT02159066|541228489|FG002|Part II|Physician Decision|1|||
150025536|NCT02159066|541228490|FG003|Part II|Physician Decision|0|||
150025537|NCT02159066|541228491|FG004|Part II|Physician Decision|0|||
150025538|NCT02159066|541228492|FG005|Part II|Physician Decision|0|||
150025539|NCT02159066|541228487|FG000|Part II|Participant/Guardian Decision|0|||
150025540|NCT02159066|541228488|FG001|Part II|Participant/Guardian Decision|0|||
150025541|NCT02159066|541228489|FG002|Part II|Participant/Guardian Decision|0|||
150025542|NCT02159066|541228490|FG003|Part II|Participant/Guardian Decision|0|||
150025543|NCT02159066|541228491|FG004|Part II|Participant/Guardian Decision|2|||
150025544|NCT02159066|541228492|FG005|Part II|Participant/Guardian Decision|0|||
150025545|NCT01135134|541228493|FG000|Overall Study|Adverse Event|1|||
150025546|NCT01135134|541228494|FG001|Overall Study|Adverse Event|1|||
150025547|NCT01135134|541228493|FG000|Overall Study|Did not meet protocol eligibility|1|||
150025548|NCT01135134|541228494|FG001|Overall Study|Did not meet protocol eligibility|0|||
150025549|NCT01156480|541228499|FG000|Overall Study|change in diagnosis|0|||
150025550|NCT01156480|541228500|FG001|Overall Study|change in diagnosis|1|||
150025551|NCT05470387|541228501|FG000|Overall Study|Protocol Violation|0|||
150025552|NCT05470387|541228502|FG001|Overall Study|Protocol Violation|3|||
150025553|NCT01255423|541228503|FG000|Overall Study|Abnormal Laboratory value|3|||
150025554|NCT01255423|541228504|FG001|Overall Study|Abnormal Laboratory value|2|||
150025555|NCT01255423|541228503|FG000|Overall Study|Use of prohibited medications|0|||
150025556|NCT01255423|541228504|FG001|Overall Study|Use of prohibited medications|1|||
150066452|NCT02598960|541385943|FG009|Treatment Period|Other Reasons|0|||
150066453|NCT02598960|541385944|FG010|Treatment Period|Other Reasons|0|||
150066454|NCT02598960|541385945|FG011|Treatment Period|Other Reasons|0|||
150066455|NCT02598960|541385946|FG012|Treatment Period|Other Reasons|1|||
150066456|NCT02598960|541385934|FG000|Participants Entering Follow Up Period|Death|1|||
150066457|NCT02598960|541385935|FG001|Participants Entering Follow Up Period|Death|0|||
150066458|NCT02598960|541385936|FG002|Participants Entering Follow Up Period|Death|0|||
150066459|NCT02598960|541385937|FG003|Participants Entering Follow Up Period|Death|0|||
150066460|NCT02598960|541385938|FG004|Participants Entering Follow Up Period|Death|0|||
150066461|NCT02598960|541385939|FG005|Participants Entering Follow Up Period|Death|0|||
150066462|NCT02598960|541385940|FG006|Participants Entering Follow Up Period|Death|0|||
150066463|NCT02598960|541385941|FG007|Participants Entering Follow Up Period|Death|0|||
150066464|NCT02598960|541385942|FG008|Participants Entering Follow Up Period|Death|0|||
150066465|NCT02598960|541385943|FG009|Participants Entering Follow Up Period|Death|1|||
150066466|NCT02598960|541385944|FG010|Participants Entering Follow Up Period|Death|0|||
150066467|NCT02598960|541385945|FG011|Participants Entering Follow Up Period|Death|11|||
150066468|NCT02598960|541385946|FG012|Participants Entering Follow Up Period|Death|2|||
150066469|NCT02598960|541385934|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066470|NCT02598960|541385935|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066471|NCT02598960|541385936|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066472|NCT02598960|541385937|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066473|NCT02598960|541385938|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066474|NCT02598960|541385939|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066475|NCT02598960|541385940|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066476|NCT02598960|541385941|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066477|NCT02598960|541385942|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066478|NCT02598960|541385943|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066479|NCT02598960|541385944|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066480|NCT02598960|541385945|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
150066481|NCT02598960|541385946|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
150066482|NCT02598960|541385934|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
150066483|NCT02598960|541385935|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
150066484|NCT02598960|541385936|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
150066485|NCT02598960|541385937|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
150066486|NCT02598960|541385938|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
150066487|NCT02598960|541385939|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
150066488|NCT02598960|541385940|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
150066489|NCT02598960|541385941|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
150066490|NCT02598960|541385942|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
150066491|NCT02598960|541385943|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
150066492|NCT02598960|541385944|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
150066493|NCT02598960|541385945|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
150066494|NCT02598960|541385946|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
150066495|NCT02598960|541385934|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066496|NCT02598960|541385935|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066497|NCT02598960|541385936|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066498|NCT02598960|541385937|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066499|NCT02598960|541385938|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066500|NCT02598960|541385939|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066501|NCT02598960|541385940|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066502|NCT02598960|541385941|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066503|NCT02598960|541385942|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066504|NCT02598960|541385943|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066505|NCT02598960|541385944|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066506|NCT02598960|541385945|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
150066507|NCT02598960|541385946|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
150066508|NCT02598960|541385934|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
150066509|NCT02598960|541385935|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
150066510|NCT02598960|541385936|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
150066511|NCT02598960|541385937|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
150066512|NCT02598960|541385938|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
150066513|NCT02598960|541385939|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
150066514|NCT02598960|541385940|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
150066515|NCT02598960|541385941|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
150066516|NCT02598960|541385942|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
150066517|NCT02598960|541385943|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
150066518|NCT02598960|541385944|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
150066519|NCT02598960|541385945|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
150066520|NCT02598960|541385946|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
150066521|NCT01614600|541385947|FG000|Overall Study|Unacceptable fit|1|||
150066522|NCT01614600|541385947|FG000|Overall Study|Discomfort|1|||
150066523|NCT01614600|541385947|FG000|Overall Study|Unable to remove lens at the end of day|1|||
150066524|NCT01614600|541385947|FG000|Overall Study|Protocol deviation|1|||
150066525|NCT02231918|541385948|FG000|Overall Study|Withdrawal by Subject|0|||
150066526|NCT02231918|541385949|FG001|Overall Study|Withdrawal by Subject|1|||
150066527|NCT02231918|541385950|FG002|Overall Study|Withdrawal by Subject|0|||
150066528|NCT02231918|541385948|FG000|Overall Study|Adverse Event|0|||
150066529|NCT02231918|541385949|FG001|Overall Study|Adverse Event|0|||
150066530|NCT02231918|541385950|FG002|Overall Study|Adverse Event|1|||
150066531|NCT00137631|541385958|FG000|Overall Study|Lost to Follow-up|37|||
150066532|NCT00137631|541385959|FG001|Overall Study|Lost to Follow-up|41|||
150066533|NCT00085709|541385960|FG000|Overall Study|Adverse Event|8|||
150066534|NCT00085709|541385961|FG001|Overall Study|Adverse Event|0|||
150066535|NCT00085709|541385960|FG000|Overall Study|Death|8|||
150066536|NCT00085709|541385961|FG001|Overall Study|Death|2|||
150066537|NCT00085709|541385960|FG000|Overall Study|Refusal unrelated to adverse events|1|||
150066538|NCT00085709|541385961|FG001|Overall Study|Refusal unrelated to adverse events|2|||
150066539|NCT00085709|541385960|FG000|Overall Study|Progression|3|||
150066540|NCT00085709|541385961|FG001|Overall Study|Progression|4|||
150066541|NCT00085709|541385960|FG000|Overall Study|Not protocol specified|12|||
150066542|NCT00085709|541385961|FG001|Overall Study|Not protocol specified|22|||
150066543|NCT00085709|541385960|FG000|Overall Study|Not eligible|19|||
150066544|NCT00085709|541385961|FG001|Overall Study|Not eligible|19|||
150066545|NCT00085709|541385960|FG000|Overall Study|Withdrawal by Subject|2|||
150066546|NCT00085709|541385961|FG001|Overall Study|Withdrawal by Subject|1|||
150066547|NCT00293215|541385962|FG000|Overall Study|Progressive disease|3|||
150066548|NCT00293215|541385963|FG001|Overall Study|Progressive disease|1|||
150066549|NCT00293215|541385962|FG000|Overall Study|Adverse Event|2|||
150066550|NCT00293215|541385963|FG001|Overall Study|Adverse Event|2|||
150066551|NCT02213042|541385964|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
150066552|NCT02213042|541385965|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
150066553|NCT02213042|541385966|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
150066554|NCT02213042|541385964|FG000|Overall Study|Adverse Event|2|||
150066555|NCT02213042|541385965|FG001|Overall Study|Adverse Event|1|||
150066556|NCT02213042|541385966|FG002|Overall Study|Adverse Event|0|||
150066557|NCT02213042|541385964|FG000|Overall Study|Withdrawal by Subject|0|||
150066558|NCT02213042|541385965|FG001|Overall Study|Withdrawal by Subject|1|||
150066559|NCT02213042|541385966|FG002|Overall Study|Withdrawal by Subject|1|||
150066560|NCT02213042|541385964|FG000|Overall Study|Protocol Violation|1|||
150066561|NCT02213042|541385965|FG001|Overall Study|Protocol Violation|0|||
150066562|NCT02213042|541385966|FG002|Overall Study|Protocol Violation|0|||
150066563|NCT02213042|541385964|FG000|Overall Study|Investigator discretion|0|||
150066564|NCT02213042|541385965|FG001|Overall Study|Investigator discretion|0|||
150066565|NCT02213042|541385966|FG002|Overall Study|Investigator discretion|1|||
150066566|NCT04622735|541385967|FG000|Overall Study|Lost to Follow-up|1|||
150066567|NCT04622735|541385968|FG001|Overall Study|Lost to Follow-up|2|||
150066568|NCT04622735|541385969|FG002|Overall Study|Lost to Follow-up|1|||
150066569|NCT04622735|541385967|FG000|Overall Study|Adverse Event|0|||
150066570|NCT04622735|541385968|FG001|Overall Study|Adverse Event|0|||
150066571|NCT04622735|541385969|FG002|Overall Study|Adverse Event|1|||
150066572|NCT04622735|541385967|FG000|Overall Study|Protocol Violation|1|||
150066573|NCT04622735|541385968|FG001|Overall Study|Protocol Violation|0|||
150066574|NCT04622735|541385969|FG002|Overall Study|Protocol Violation|0|||
150066575|NCT02007512|541385970|FG000|Double Blind Treatment Period|Adverse Event|4|||
150066576|NCT02007512|541385971|FG001|Double Blind Treatment Period|Adverse Event|6|||
150066577|NCT02007512|541385972|FG002|Double Blind Treatment Period|Adverse Event|2|||
150066578|NCT02007512|541385973|FG003|Double Blind Treatment Period|Adverse Event|2|||
150066579|NCT02007512|541385970|FG000|Double Blind Treatment Period|Death|1|||
150066580|NCT02007512|541385971|FG001|Double Blind Treatment Period|Death|0|||
150066581|NCT02007512|541385972|FG002|Double Blind Treatment Period|Death|0|||
150066582|NCT02007512|541385973|FG003|Double Blind Treatment Period|Death|0|||
150066583|NCT02007512|541385970|FG000|Double Blind Treatment Period|Disease progression|51|||
150066584|NCT02007512|541385971|FG001|Double Blind Treatment Period|Disease progression|50|||
150066585|NCT02007512|541385972|FG002|Double Blind Treatment Period|Disease progression|57|||
150066586|NCT02007512|541385973|FG003|Double Blind Treatment Period|Disease progression|52|||
150066587|NCT02007512|541385970|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066588|NCT02007512|541385971|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066589|NCT02007512|541385972|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066590|NCT02007512|541385973|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066591|NCT02007512|541385970|FG000|Double Blind Treatment Period|Protocol Violation|1|||
150066592|NCT02007512|541385971|FG001|Double Blind Treatment Period|Protocol Violation|0|||
150066593|NCT02007512|541385972|FG002|Double Blind Treatment Period|Protocol Violation|0|||
150066594|NCT02007512|541385973|FG003|Double Blind Treatment Period|Protocol Violation|1|||
150066595|NCT02007512|541385970|FG000|Double Blind Treatment Period|Other|2|||
150066596|NCT02007512|541385971|FG001|Double Blind Treatment Period|Other|1|||
150066597|NCT02007512|541385972|FG002|Double Blind Treatment Period|Other|1|||
150066598|NCT02007512|541385973|FG003|Double Blind Treatment Period|Other|2|||
150066599|NCT02007512|541385970|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
150066600|NCT02007512|541385971|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
150066601|NCT02007512|541385972|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
150066602|NCT02007512|541385973|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
150066603|NCT02007512|541385970|FG000|Open Label Treatment Period|Adverse Event|1|||
150066604|NCT02007512|541385971|FG001|Open Label Treatment Period|Adverse Event|0|||
150066605|NCT02007512|541385972|FG002|Open Label Treatment Period|Adverse Event|0|||
150066606|NCT02007512|541385973|FG003|Open Label Treatment Period|Adverse Event|0|||
150066607|NCT02007512|541385970|FG000|Open Label Treatment Period|Other|1|||
150066608|NCT02007512|541385971|FG001|Open Label Treatment Period|Other|1|||
150066609|NCT02007512|541385972|FG002|Open Label Treatment Period|Other|0|||
150066610|NCT02007512|541385973|FG003|Open Label Treatment Period|Other|0|||
150066611|NCT02007512|541385970|FG000|Open Label Treatment Period|Disease progression|23|||
150066612|NCT02007512|541385971|FG001|Open Label Treatment Period|Disease progression|11|||
150066613|NCT02007512|541385972|FG002|Open Label Treatment Period|Disease progression|0|||
150066614|NCT02007512|541385973|FG003|Open Label Treatment Period|Disease progression|0|||
150066615|NCT04087213|541385974|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
150066616|NCT04087213|541385974|FG000|In-Facility Introduction|Adverse Event|1|||
150066617|NCT04087213|541385974|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
150066618|NCT04087213|541385974|FG000|Assisted Evaluable Period|Personal reasons|3|||
150066619|NCT04087213|541385974|FG000|Transition Period B|Renal Transplantation|1|||
150066620|NCT01134315|541385975|FG000|Overall Study|Adverse Event|1|||
150066621|NCT01134315|541385976|FG001|Overall Study|Adverse Event|2|||
150066622|NCT01134315|541385975|FG000|Overall Study|Other Reason|8|||
150066623|NCT01134315|541385976|FG001|Overall Study|Other Reason|17|||
150066624|NCT02545075|541385978|FG000|Randomization|Lost to Follow-up|0|||
150066625|NCT02545075|541385979|FG001|Randomization|Lost to Follow-up|1|||
150066626|NCT02545075|541385978|FG000|Randomization|Withdrawal by Subject|0|||
150066627|NCT02545075|541385979|FG001|Randomization|Withdrawal by Subject|6|||
150066628|NCT02545075|541385978|FG000|Treatment|Disease progression|71|||
150066629|NCT02545075|541385979|FG001|Treatment|Disease progression|32|||
150066630|NCT02545075|541385978|FG000|Treatment|Participant dicontinued study treatment|7|||
150066631|NCT02545075|541385979|FG001|Treatment|Participant dicontinued study treatment|9|||
150066632|NCT02545075|541385978|FG000|Treatment|Withdrawal by Subject|1|||
150066633|NCT02545075|541385979|FG001|Treatment|Withdrawal by Subject|0|||
150066634|NCT02545075|541385978|FG000|Treatment|Adverse event not related to study drug|1|||
150066635|NCT02545075|541385979|FG001|Treatment|Adverse event not related to study drug|0|||
150066636|NCT02545075|541385978|FG000|Treatment|Death|1|||
150066637|NCT02545075|541385979|FG001|Treatment|Death|0|||
150066638|NCT02545075|541385978|FG000|Treatment|Participant drug toxicity|1|||
150066639|NCT02545075|541385979|FG001|Treatment|Participant drug toxicity|0|||
150066640|NCT02545075|541385978|FG000|Treatment|Completed treatment|40|||
150066641|NCT02545075|541385979|FG001|Treatment|Completed treatment|12|||
150066642|NCT03923738|541385983|FG000|Period 1|Adverse Event|1|||
150066643|NCT03923738|541385983|FG000|Period 1|Withdrawal by Subject|1|||
150066644|NCT05246397|541385985|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
150066645|NCT03583164|541385988|FG000|Overall Study|Death in Main Phase|35|||
150066646|NCT03583164|541385988|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
150066647|NCT03583164|541385988|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
150066648|NCT03583164|541385988|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
150066649|NCT03583164|541385988|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
150066650|NCT03583164|541385988|FG000|Overall Study|Physician decision in Main Phase|1|||
150066651|NCT03583164|541385988|FG000|Overall Study|Physician decision in Extended Phase|2|||
150066652|NCT03583164|541385988|FG000|Overall Study|Death in Extended Phase|13|||
150066653|NCT03583164|541385988|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
150066654|NCT03583164|541385988|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
150066655|NCT03583164|541385988|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
150066656|NCT03583164|541385988|FG000|Overall Study|Treatment failure in Main Phase|2|||
150066657|NCT03583164|541385988|FG000|Overall Study|Treatment failure in Extended Phase|4|||
150066658|NCT03583164|541385988|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
150066659|NCT03583164|541385988|FG000|Overall Study|Other not specified reason in Main Phase|2|||
150066660|NCT01272661|541385992|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
150066661|NCT01272661|541385993|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
150066662|NCT01272661|541385994|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
150066663|NCT00984568|541385996|FG000|Overall Study|Withdrawal by Subject|1|||
150066664|NCT00984568|541385997|FG001|Overall Study|Withdrawal by Subject|2|||
150066665|NCT00984568|541385996|FG000|Overall Study|Lack of Efficacy|2|||
150066666|NCT00984568|541385997|FG001|Overall Study|Lack of Efficacy|0|||
150066667|NCT00984568|541385996|FG000|Overall Study|Adverse Event|2|||
150066668|NCT00984568|541385997|FG001|Overall Study|Adverse Event|0|||
150066669|NCT00984568|541385996|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
150066670|NCT00984568|541385997|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
150066671|NCT00984568|541385996|FG000|Overall Study|Lost to Follow-up|0|||
150066672|NCT00984568|541385997|FG001|Overall Study|Lost to Follow-up|1|||
150066673|NCT00984568|541385996|FG000|Overall Study|Opportunistic Infection|1|||
150066674|NCT00984568|541385997|FG001|Overall Study|Opportunistic Infection|0|||
150066675|NCT00984568|541385996|FG000|Overall Study|Unknown Reason|1|||
150066676|NCT00984568|541385997|FG001|Overall Study|Unknown Reason|3|||
150066677|NCT00573248|541385998|FG000|Overall Study|scheduling conflicts|15|||
150066678|NCT00573248|541385999|FG001|Overall Study|scheduling conflicts|11|||
150066679|NCT02791594|541386000|FG000|Overall Study|Physician Decision|2|||
150066680|NCT04508140|541386003|FG000|Overall Study|Adverse Event|2|||
150066681|NCT04508140|541386004|FG001|Overall Study|Adverse Event|2|||
150066682|NCT04508140|541386003|FG000|Overall Study|Withdrawal by Subject|0|||
150066683|NCT04508140|541386004|FG001|Overall Study|Withdrawal by Subject|2|||
150066684|NCT04508140|541386003|FG000|Overall Study|progressive disease|9|||
150066685|NCT04508140|541386004|FG001|Overall Study|progressive disease|3|||
150066686|NCT03059446|541386005|FG000|Overall Study|Adverse Event|11|||
150066687|NCT03059446|541386005|FG000|Overall Study|Withdrawal of Consent|16|||
150066688|NCT03059446|541386005|FG000|Overall Study|Lost to Follow-up|3|||
150066689|NCT03059446|541386005|FG000|Overall Study|Protocol Violation|1|||
150066690|NCT03059446|541386005|FG000|Overall Study|Study Terminated by Sponsor|131|||
150066691|NCT03059446|541386005|FG000|Overall Study|Reason not Specified|5|||
150066692|NCT01982331|541386006|FG000|Received Vaccination 2|Adverse Event|1|||
150066693|NCT01982331|541386007|FG001|Received Vaccination 2|Adverse Event|2|||
150066694|NCT01982331|541386006|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
150066695|NCT01982331|541386007|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
150066696|NCT01982331|541386006|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
150066697|NCT01982331|541386007|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
150066698|NCT00586066|541386009|FG000|Overall Study|Lost to Follow-up|6|||
150066699|NCT00586066|541386010|FG001|Overall Study|Lost to Follow-up|3|||
150066700|NCT00586066|541386009|FG000|Overall Study|Lack of Efficacy|5|||
150066701|NCT00586066|541386010|FG001|Overall Study|Lack of Efficacy|3|||
150066702|NCT00586066|541386009|FG000|Overall Study|Adverse Event|2|||
150066703|NCT00586066|541386010|FG001|Overall Study|Adverse Event|2|||
150066704|NCT00586066|541386009|FG000|Overall Study|Physician Decision|1|||
150182019|NCT03398148|541804610|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
150066705|NCT00586066|541386010|FG001|Overall Study|Physician Decision|0|||
150066706|NCT00586066|541386009|FG000|Overall Study|Withdrawal of consent|4|||
150066707|NCT00586066|541386010|FG001|Overall Study|Withdrawal of consent|2|||
150066708|NCT02676466|541386011|FG000|Overall Study|Death|0|||
150066709|NCT02676466|541386012|FG001|Overall Study|Death|2|||
150066710|NCT02676466|541386013|FG002|Overall Study|Death|1|||
150066711|NCT02676466|541386014|FG003|Overall Study|Death|0|||
150066712|NCT02676466|541386015|FG004|Overall Study|Death|0|||
150066713|NCT02676466|541386016|FG005|Overall Study|Death|0|||
150066714|NCT02676466|541386017|FG006|Overall Study|Death|0|||
150066715|NCT02676466|541386018|FG007|Overall Study|Death|0|||
150066716|NCT02676466|541386011|FG000|Overall Study|Withdrawal by Subject|4|||
150066717|NCT02676466|541386012|FG001|Overall Study|Withdrawal by Subject|3|||
150066718|NCT02676466|541386013|FG002|Overall Study|Withdrawal by Subject|1|||
150066719|NCT02676466|541386014|FG003|Overall Study|Withdrawal by Subject|0|||
150066720|NCT02676466|541386015|FG004|Overall Study|Withdrawal by Subject|3|||
150066721|NCT02676466|541386016|FG005|Overall Study|Withdrawal by Subject|1|||
150066722|NCT02676466|541386017|FG006|Overall Study|Withdrawal by Subject|1|||
150066723|NCT02676466|541386018|FG007|Overall Study|Withdrawal by Subject|1|||
150066724|NCT00908011|541386024|FG000|Overall Study|Withdrawal by Subject|2|||
150066725|NCT00908011|541386025|FG001|Overall Study|Withdrawal by Subject|2|||
150066726|NCT02301988|541386031|FG000|Overall Study|Withdrawal by Subject|2|||
150066727|NCT02301988|541386032|FG001|Overall Study|Withdrawal by Subject|1|||
150066728|NCT02301988|541386031|FG000|Overall Study|Physician Decision|2|||
150066729|NCT02301988|541386032|FG001|Overall Study|Physician Decision|2|||
150066730|NCT02301988|541386031|FG000|Overall Study|Unknown Reason|1|||
150066731|NCT02301988|541386032|FG001|Overall Study|Unknown Reason|3|||
150066732|NCT02301988|541386031|FG000|Overall Study|Lack of Efficacy|3|||
150066733|NCT02301988|541386032|FG001|Overall Study|Lack of Efficacy|2|||
150066734|NCT02301988|541386031|FG000|Overall Study|Death|1|||
150066735|NCT02301988|541386032|FG001|Overall Study|Death|0|||
150066736|NCT02301988|541386031|FG000|Overall Study|Adverse Event|1|||
150066737|NCT02301988|541386032|FG001|Overall Study|Adverse Event|1|||
150066738|NCT02891161|541386035|FG000|Study Treatment|Disease Progression|2|||
150066739|NCT02891161|541386036|FG001|Study Treatment|Disease Progression|4|||
150066740|NCT02891161|541386035|FG000|Study Treatment|AE/Side Effects/Complications|1|||
150066741|NCT02891161|541386036|FG001|Study Treatment|AE/Side Effects/Complications|5|||
150066742|NCT02891161|541386035|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
150066743|NCT02891161|541386036|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
150066744|NCT02891161|541386035|FG000|Follow up|Death|4|||
150066745|NCT02891161|541386036|FG001|Follow up|Death|8|||
150066746|NCT02891161|541386035|FG000|Follow up|Refused to Follow up|0|||
150066747|NCT02891161|541386036|FG001|Follow up|Refused to Follow up|2|||
150066748|NCT02891161|541386035|FG000|Follow up|Symptomatic deterioration|0|||
150066749|NCT02891161|541386036|FG001|Follow up|Symptomatic deterioration|1|||
150066750|NCT02891161|541386035|FG000|Follow up|Study terminated|0|||
150066751|NCT02891161|541386036|FG001|Follow up|Study terminated|6|||
150066752|NCT02750943|541386037|FG000|Overall Study|Lost to Follow-up|1|||
150066753|NCT02750943|541386038|FG001|Overall Study|Lost to Follow-up|2|||
150066754|NCT02750943|541386037|FG000|Overall Study|Withdrawal by Subject|5|||
150066755|NCT02750943|541386038|FG001|Overall Study|Withdrawal by Subject|7|||
150066756|NCT01074047|541386045|FG000|Treatment Phase|Adverse Event|89|||
150066757|NCT01074047|541386046|FG001|Treatment Phase|Adverse Event|66|||
150066758|NCT01074047|541386045|FG000|Treatment Phase|Disease Progression|16|||
150066759|NCT01074047|541386046|FG001|Treatment Phase|Disease Progression|21|||
150066760|NCT01074047|541386045|FG000|Treatment Phase|Withdrawal by Subject|27|||
150066761|NCT01074047|541386046|FG001|Treatment Phase|Withdrawal by Subject|48|||
150066762|NCT01074047|541386045|FG000|Treatment Phase|Death|53|||
150066763|NCT01074047|541386046|FG001|Treatment Phase|Death|58|||
150066764|NCT01074047|541386045|FG000|Treatment Phase|Lost to Follow-up|0|||
150066765|NCT01074047|541386046|FG001|Treatment Phase|Lost to Follow-up|1|||
150066766|NCT01074047|541386045|FG000|Treatment Phase|Protocol Violation|0|||
150066767|NCT01074047|541386046|FG001|Treatment Phase|Protocol Violation|1|||
150066768|NCT01074047|541386045|FG000|Treatment Phase|Miscellaneous|32|||
150066769|NCT01074047|541386046|FG001|Treatment Phase|Miscellaneous|39|||
150066770|NCT01074047|541386045|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
150066771|NCT01074047|541386046|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
150066772|NCT01074047|541386045|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
150066773|NCT01074047|541386046|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
150066774|NCT01074047|541386045|FG000|Survival Follow-Up Phase|Death|116|||
150066775|NCT01074047|541386046|FG001|Survival Follow-Up Phase|Death|124|||
150066776|NCT01074047|541386045|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
150066777|NCT01074047|541386046|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
150066778|NCT01074047|541386045|FG000|Extension Phase|Physician Decision|1|||
150066779|NCT01074047|541386046|FG001|Extension Phase|Physician Decision|0|||
150066780|NCT01074047|541386045|FG000|Extension Phase|Adverse Event|5|||
150066781|NCT01074047|541386046|FG001|Extension Phase|Adverse Event|0|||
150066782|NCT01074047|541386045|FG000|Extension Phase|Disease Progression|9|||
150066783|NCT01074047|541386046|FG001|Extension Phase|Disease Progression|0|||
150066784|NCT01074047|541386045|FG000|Extension Phase|Withdrawal by Subject|2|||
150066785|NCT01074047|541386046|FG001|Extension Phase|Withdrawal by Subject|0|||
150066786|NCT01074047|541386045|FG000|Extension Phase|Death|5|||
150066787|NCT01074047|541386046|FG001|Extension Phase|Death|0|||
150066788|NCT04669535|541386047|FG000|Overall Study|Death|1|||
150066789|NCT04669535|541386048|FG001|Overall Study|Death|1|||
150066790|NCT04669535|541386049|FG002|Overall Study|Death|0|||
150066791|NCT04669535|541386050|FG003|Overall Study|Death|0|||
150066792|NCT05169567|541386052|FG000|Overall Study|On study treatment|116|||
150066793|NCT05169567|541386053|FG001|Overall Study|On study treatment|128|||
150066794|NCT05169567|541386052|FG000|Overall Study|Lost to Follow-up|1|||
150066795|NCT05169567|541386053|FG001|Overall Study|Lost to Follow-up|0|||
150066796|NCT05169567|541386052|FG000|Overall Study|Withdrawal by Subject|25|||
150066797|NCT05169567|541386053|FG001|Overall Study|Withdrawal by Subject|21|||
150066798|NCT02211638|541386054|FG000|Overall Study|Case Report Forms Uncollected|291|||
150066799|NCT02211638|541386054|FG000|Overall Study|Protocol Violation|692|||
150066800|NCT04382755|541386055|FG000|Overall Study|Withdrawal by Subject|1|||
150066801|NCT04382755|541386056|FG001|Overall Study|Withdrawal by Subject|0|||
150066802|NCT04382755|541386055|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
150066803|NCT04382755|541386056|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
150066804|NCT04382755|541386055|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
150066805|NCT04382755|541386056|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
150066806|NCT02775903|541386061|FG000|Overall Study|Death|7|||
150066807|NCT02775903|541386062|FG001|Overall Study|Death|11|||
150066808|NCT02775903|541386063|FG002|Overall Study|Death|12|||
150066809|NCT02775903|541386064|FG003|Overall Study|Death|11|||
150066810|NCT02775903|541386061|FG000|Overall Study|Adverse Event|0|||
150066811|NCT02775903|541386062|FG001|Overall Study|Adverse Event|1|||
150066812|NCT02775903|541386063|FG002|Overall Study|Adverse Event|12|||
150066813|NCT02775903|541386064|FG003|Overall Study|Adverse Event|3|||
150066814|NCT02775903|541386061|FG000|Overall Study|Progressive disease|15|||
150066815|NCT02775903|541386062|FG001|Overall Study|Progressive disease|14|||
150066816|NCT02775903|541386063|FG002|Overall Study|Progressive disease|30|||
150066817|NCT02775903|541386064|FG003|Overall Study|Progressive disease|20|||
150066818|NCT02775903|541386061|FG000|Overall Study|Lack of Efficacy|2|||
150066819|NCT02775903|541386062|FG001|Overall Study|Lack of Efficacy|2|||
150066820|NCT02775903|541386063|FG002|Overall Study|Lack of Efficacy|2|||
150066821|NCT02775903|541386064|FG003|Overall Study|Lack of Efficacy|6|||
150066822|NCT02775903|541386061|FG000|Overall Study|Withdrawal by Subject|7|||
150066823|NCT02775903|541386062|FG001|Overall Study|Withdrawal by Subject|5|||
150066824|NCT02775903|541386063|FG002|Overall Study|Withdrawal by Subject|5|||
150066825|NCT02775903|541386064|FG003|Overall Study|Withdrawal by Subject|8|||
150066826|NCT02775903|541386061|FG000|Overall Study|Other reasons|7|||
150066827|NCT02775903|541386062|FG001|Overall Study|Other reasons|8|||
150066828|NCT02775903|541386063|FG002|Overall Study|Other reasons|2|||
150066829|NCT02775903|541386064|FG003|Overall Study|Other reasons|12|||
150066830|NCT04041700|541386065|FG000|Overall Study|Pregnancy|1|||
150066831|NCT04041700|541386065|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
150066832|NCT00458536|541386068|FG000|Overall Study|Disease progression prior to treatment|7|||
150066833|NCT00458536|541386068|FG000|Overall Study|Unable to make vaccine|3|||
150066834|NCT00458536|541386068|FG000|Overall Study|No measurable disease after surgery|2|||
150066835|NCT00458536|541386068|FG000|Overall Study|Did not have renal cell carcinoma|2|||
150066836|NCT00458536|541386068|FG000|Overall Study|Patient did not have surgery|1|||
150066837|NCT00458536|541386068|FG000|Overall Study|Ineligible due to toxicity|1|||
150066838|NCT00458536|541386068|FG000|Overall Study|Withdrawal by Subject|1|||
150066839|NCT00458536|541386068|FG000|Overall Study|Progressive disease during treatment|2|||
150066840|NCT00285207|541386071|FG000|Overall Study|Lost to Follow-up|3|||
150066841|NCT00285207|541386072|FG001|Overall Study|Lost to Follow-up|2|||
150066842|NCT00285207|541386071|FG000|Overall Study|Withdrawal by Subject|5|||
150066843|NCT00285207|541386072|FG001|Overall Study|Withdrawal by Subject|2|||
150066844|NCT00285207|541386071|FG000|Overall Study|Pregnancy|1|||
150066845|NCT00285207|541386072|FG001|Overall Study|Pregnancy|1|||
150066846|NCT00285207|541386071|FG000|Overall Study|non-compliance|0|||
150066847|NCT00285207|541386072|FG001|Overall Study|non-compliance|1|||
150066848|NCT05419908|541386075|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
150066849|NCT05419908|541386076|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
150066850|NCT05419908|541386075|FG000|Overall Study|Serious Adverse Event|0|||
150066851|NCT05419908|541386076|FG001|Overall Study|Serious Adverse Event|2|||
150066852|NCT05419908|541386075|FG000|Overall Study|Withdrawal by Subject|2|||
150066853|NCT05419908|541386076|FG001|Overall Study|Withdrawal by Subject|0|||
150066854|NCT05419908|541386075|FG000|Overall Study|Miscellaneous|1|||
150066855|NCT05419908|541386076|FG001|Overall Study|Miscellaneous|1|||
150066856|NCT05069259|541386080|FG000|Overall Study|Withdrawal by Subject|1|||
150182020|NCT03398148|541804596|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150066857|NCT05069259|541386080|FG000|Overall Study|Sponsor decision|1|||
150066858|NCT00084838|541387366|FG000|Overall Study|Death|1|||
150066859|NCT00084838|541387366|FG000|Overall Study|Adverse Event|2|||
150066860|NCT00084838|541387366|FG000|Overall Study|Withdrawal by Subject|1|||
150066861|NCT00084838|541387366|FG000|Overall Study|Progressive Disease|4|||
150066862|NCT00084838|541387366|FG000|Overall Study|Pt Non-Compliance|1|||
150066863|NCT00084838|541387366|FG000|Overall Study|Ineligible|4|||
150066864|NCT01846104|541387368|FG000|Overall Study|Withdrawal by Subject|1|||
150066865|NCT00851630|541387369|FG000|Overall Study|Death|2|||
150066866|NCT00851630|541387370|FG001|Overall Study|Death|1|||
150066867|NCT00851630|541387369|FG000|Overall Study|Clinical failure|0|||
150066868|NCT00851630|541387370|FG001|Overall Study|Clinical failure|1|||
150066869|NCT00398411|541387371|FG000|Overall Study|Death|0|||
150066870|NCT00398411|541387372|FG001|Overall Study|Death|1|||
150066871|NCT01397162|541387373|FG000|Overall Study|Adverse Event|4|||
150066872|NCT01397162|541387374|FG001|Overall Study|Adverse Event|0|||
150066873|NCT01397162|541387375|FG002|Overall Study|Adverse Event|0|||
150066874|NCT01397162|541387376|FG003|Overall Study|Adverse Event|0|||
150066875|NCT01397162|541387377|FG004|Overall Study|Adverse Event|0|||
150066876|NCT01397162|541387373|FG000|Overall Study|Not yet defined|3|||
150066877|NCT01397162|541387374|FG001|Overall Study|Not yet defined|4|||
150066878|NCT01397162|541387375|FG002|Overall Study|Not yet defined|3|||
150066879|NCT01397162|541387376|FG003|Overall Study|Not yet defined|5|||
150066880|NCT01397162|541387377|FG004|Overall Study|Not yet defined|3|||
150066881|NCT01409434|541387378|FG000|Overall Study|Protocol Violation|4|||
150066882|NCT03026088|541387382|FG000|Overall Study|Study termination|20|||
150066883|NCT00761579|541387383|FG000|Overall Study|Adverse Event|10|||
150066884|NCT00761579|541387383|FG000|Overall Study|Death|2|||
150066885|NCT00761579|541387383|FG000|Overall Study|Lack of Efficacy|21|||
150066886|NCT00761579|541387383|FG000|Overall Study|Lost to Follow-up|16|||
150066887|NCT00761579|541387383|FG000|Overall Study|Pregnancy|1|||
150066888|NCT00761579|541387383|FG000|Overall Study|Withdrawal by Subject|34|||
150066889|NCT00761579|541387383|FG000|Overall Study|Lack of compliance|2|||
150066890|NCT00761579|541387383|FG000|Overall Study|Protocol deviation|1|||
150066891|NCT00761579|541387383|FG000|Overall Study|Drug overdose|1|||
150066892|NCT00761579|541387383|FG000|Overall Study|Aggravation of depression|1|||
150066893|NCT00761579|541387383|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
150066894|NCT00761579|541387383|FG000|Overall Study|Lost survey form|1|||
150066895|NCT00761579|541387383|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
150066896|NCT03611010|541387384|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
150066897|NCT03611010|541387385|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
150066898|NCT03611010|541387386|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
150066899|NCT03611010|541387387|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
150066900|NCT00950911|541387389|FG000|Overall Study|Adverse Event|0|||
150066901|NCT00950911|541387390|FG001|Overall Study|Adverse Event|2|||
150066902|NCT00950911|541387389|FG000|Overall Study|Death|4|||
150066903|NCT00950911|541387390|FG001|Overall Study|Death|6|||
150066904|NCT00950911|541387389|FG000|Overall Study|Disease progression|2|||
150066905|NCT00950911|541387390|FG001|Overall Study|Disease progression|2|||
150066906|NCT00950911|541387389|FG000|Overall Study|Consent withdrawn|1|||
150066907|NCT00950911|541387390|FG001|Overall Study|Consent withdrawn|3|||
150066908|NCT00950911|541387389|FG000|Overall Study|Administrative decision|3|||
150066909|NCT00950911|541387390|FG001|Overall Study|Administrative decision|1|||
150066910|NCT00950911|541387389|FG000|Overall Study|Ineligibility determined|1|||
150066911|NCT00950911|541387390|FG001|Overall Study|Ineligibility determined|0|||
150066912|NCT00950911|541387389|FG000|Overall Study|Noncompliance|1|||
150066913|NCT00950911|541387390|FG001|Overall Study|Noncompliance|0|||
150066914|NCT00950911|541387389|FG000|Overall Study|Poor performance status|0|||
150066915|NCT00950911|541387390|FG001|Overall Study|Poor performance status|1|||
150066916|NCT02413372|541387395|FG000|Treatment|Lost to Follow-up|0|||
150066917|NCT02413372|541387396|FG001|Treatment|Lost to Follow-up|2|||
150066918|NCT02413372|541387397|FG002|Treatment|Lost to Follow-up|1|||
150066919|NCT02413372|541387395|FG000|Treatment|Withdrawal by Subject|1|||
150066920|NCT02413372|541387396|FG001|Treatment|Withdrawal by Subject|0|||
150066921|NCT02413372|541387397|FG002|Treatment|Withdrawal by Subject|0|||
150066922|NCT02413372|541387395|FG000|Follow-up|Lost to Follow-up|1|||
150066923|NCT02413372|541387396|FG001|Follow-up|Lost to Follow-up|1|||
150066924|NCT02413372|541387397|FG002|Follow-up|Lost to Follow-up|0|||
150066925|NCT02413372|541387395|FG000|Follow-up|Subject Withdrew Consent|1|||
150066926|NCT02413372|541387396|FG001|Follow-up|Subject Withdrew Consent|0|||
150066927|NCT02413372|541387397|FG002|Follow-up|Subject Withdrew Consent|1|||
150066928|NCT02413372|541387395|FG000|Follow-up|Subject unable to return for visit|0|||
150066929|NCT02413372|541387396|FG001|Follow-up|Subject unable to return for visit|0|||
150066930|NCT02413372|541387397|FG002|Follow-up|Subject unable to return for visit|1|||
150066931|NCT00760214|541387404|FG000|Overall Study|Adverse Event|8|||
150066932|NCT00760214|541387405|FG001|Overall Study|Adverse Event|9|||
150066933|NCT00760214|541387406|FG002|Overall Study|Adverse Event|12|||
150066934|NCT00760214|541387404|FG000|Overall Study|Protocol Violation|3|||
150066935|NCT00760214|541387405|FG001|Overall Study|Protocol Violation|0|||
150066936|NCT00760214|541387406|FG002|Overall Study|Protocol Violation|3|||
150066937|NCT00760214|541387404|FG000|Overall Study|Lost to Follow-up|0|||
150066938|NCT00760214|541387405|FG001|Overall Study|Lost to Follow-up|0|||
150066939|NCT00760214|541387406|FG002|Overall Study|Lost to Follow-up|1|||
150066940|NCT00760214|541387404|FG000|Overall Study|Withdrawal by Subject|12|||
150066941|NCT00760214|541387405|FG001|Overall Study|Withdrawal by Subject|14|||
150066942|NCT00760214|541387406|FG002|Overall Study|Withdrawal by Subject|13|||
150066943|NCT00760214|541387404|FG000|Overall Study|Lack of Efficacy|3|||
150066944|NCT00760214|541387405|FG001|Overall Study|Lack of Efficacy|2|||
150066945|NCT00760214|541387406|FG002|Overall Study|Lack of Efficacy|4|||
150066946|NCT00760214|541387404|FG000|Overall Study|Pregnancy|0|||
150066947|NCT00760214|541387405|FG001|Overall Study|Pregnancy|0|||
150066948|NCT00760214|541387406|FG002|Overall Study|Pregnancy|1|||
150066949|NCT00760214|541387404|FG000|Overall Study|Physician Decision|1|||
150066950|NCT00760214|541387405|FG001|Overall Study|Physician Decision|1|||
150066951|NCT00760214|541387406|FG002|Overall Study|Physician Decision|1|||
150066952|NCT00760214|541387404|FG000|Overall Study|Other|3|||
150066953|NCT00760214|541387405|FG001|Overall Study|Other|4|||
150066954|NCT00760214|541387406|FG002|Overall Study|Other|6|||
150066955|NCT03960554|541387412|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
150066956|NCT03960554|541387413|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
150066957|NCT04587271|541387414|FG000|Overall Study|Lost to Follow-up|2|||
150066958|NCT04587271|541387415|FG001|Overall Study|Lost to Follow-up|2|||
150066959|NCT04587271|541387416|FG002|Overall Study|Lost to Follow-up|0|||
150066960|NCT04587271|541387417|FG003|Overall Study|Lost to Follow-up|2|||
150066961|NCT04587271|541387418|FG004|Overall Study|Lost to Follow-up|2|||
150066962|NCT04587271|541387419|FG005|Overall Study|Lost to Follow-up|0|||
150066963|NCT04587271|541387414|FG000|Overall Study|Caregiver brought child to visits|0|||
150066964|NCT04587271|541387415|FG001|Overall Study|Caregiver brought child to visits|0|||
150066965|NCT04587271|541387416|FG002|Overall Study|Caregiver brought child to visits|0|||
150066966|NCT04587271|541387417|FG003|Overall Study|Caregiver brought child to visits|1|||
150066967|NCT04587271|541387418|FG004|Overall Study|Caregiver brought child to visits|0|||
150066968|NCT04587271|541387419|FG005|Overall Study|Caregiver brought child to visits|0|||
150066969|NCT00736879|541387420|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
150066970|NCT00736879|541387421|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
150066971|NCT00736879|541387422|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
150066972|NCT00736879|541387423|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
150066973|NCT00736879|541387420|FG000|Double Blind Treatment Period|Adverse Event|0|||
150066974|NCT00736879|541387421|FG001|Double Blind Treatment Period|Adverse Event|1|||
150066975|NCT00736879|541387422|FG002|Double Blind Treatment Period|Adverse Event|1|||
150066976|NCT00736879|541387423|FG003|Double Blind Treatment Period|Adverse Event|0|||
150066977|NCT00736879|541387420|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
150066978|NCT00736879|541387421|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
150066979|NCT00736879|541387422|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066980|NCT00736879|541387423|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
150066981|NCT00736879|541387420|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
150066982|NCT00736879|541387421|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
150066983|NCT00736879|541387422|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
150066984|NCT00736879|541387423|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
150066985|NCT00736879|541387420|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
150066986|NCT00736879|541387421|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
150066987|NCT00736879|541387422|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
150066988|NCT00736879|541387423|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
150066989|NCT00736879|541387420|FG000|Double Blind Treatment Period|No longer met criteria|0|||
150066990|NCT00736879|541387421|FG001|Double Blind Treatment Period|No longer met criteria|1|||
150066991|NCT00736879|541387422|FG002|Double Blind Treatment Period|No longer met criteria|0|||
150066992|NCT00736879|541387423|FG003|Double Blind Treatment Period|No longer met criteria|0|||
150066993|NCT00736879|541387420|FG000|Double Blind Treatment Period|non-specified|0|||
150066994|NCT00736879|541387421|FG001|Double Blind Treatment Period|non-specified|1|||
150066995|NCT00736879|541387422|FG002|Double Blind Treatment Period|non-specified|0|||
150066996|NCT00736879|541387423|FG003|Double Blind Treatment Period|non-specified|0|||
150066997|NCT00736879|541387420|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
150066998|NCT00736879|541387421|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
150066999|NCT00736879|541387422|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
150067000|NCT00736879|541387423|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
150067001|NCT00736879|541387420|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
150067002|NCT00736879|541387421|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
150067003|NCT00736879|541387422|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
150067004|NCT00736879|541387423|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
150067005|NCT02360111|541387424|FG000|Overall Study|Death|2|||
150067006|NCT00735254|541387427|FG000|Overall Study|Protocol Violation|1|||
150067007|NCT00735254|541387428|FG001|Overall Study|Protocol Violation|1|||
150067008|NCT00735254|541387429|FG002|Overall Study|Protocol Violation|1|||
150067009|NCT00735254|541387430|FG003|Overall Study|Protocol Violation|0|||
150067010|NCT01031381|541387435|FG000|Overall Study|Physician Decision|3|||
150067011|NCT01031381|541387435|FG000|Overall Study|Withdrawal by Subject|6|||
150067012|NCT00751621|541387436|FG000|Overall Study|Adverse Event|1|||
150067013|NCT00751621|541387436|FG000|Overall Study|Withdrawal by Subject|1|||
150182021|NCT03398148|541804597|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067014|NCT00751621|541387436|FG000|Overall Study|Subject moved to another country|1|||
150067015|NCT00751621|541387436|FG000|Overall Study|Poor adherence to asthma treatment|1|||
150067016|NCT01822678|541387450|FG000|Overall Study|Withdrawal by Subject|5|||
150067017|NCT01822678|541387451|FG001|Overall Study|Withdrawal by Subject|4|||
150067018|NCT01822678|541387452|FG002|Overall Study|Withdrawal by Subject|4|||
150067019|NCT01822678|541387450|FG000|Overall Study|Adverse Event|4|||
150067020|NCT01822678|541387451|FG001|Overall Study|Adverse Event|3|||
150067021|NCT01822678|541387452|FG002|Overall Study|Adverse Event|1|||
150067022|NCT01822678|541387450|FG000|Overall Study|Lack of Efficacy|3|||
150067023|NCT01822678|541387451|FG001|Overall Study|Lack of Efficacy|6|||
150067024|NCT01822678|541387452|FG002|Overall Study|Lack of Efficacy|5|||
150067025|NCT01822678|541387450|FG000|Overall Study|Lost to Follow-up|0|||
150067026|NCT01822678|541387451|FG001|Overall Study|Lost to Follow-up|2|||
150067027|NCT01822678|541387452|FG002|Overall Study|Lost to Follow-up|1|||
150067028|NCT00249288|541387458|FG000|Overall Study|Lost to Follow-up|3|||
150067029|NCT00249288|541387459|FG001|Overall Study|Lost to Follow-up|3|||
150067030|NCT00249288|541387458|FG000|Overall Study|Withdrawal by Subject|2|||
150067031|NCT00249288|541387459|FG001|Overall Study|Withdrawal by Subject|2|||
150067032|NCT03309046|541387460|FG000|Overall Study|Withdrawal by Subject|4|||
150067033|NCT03309046|541387461|FG001|Overall Study|Withdrawal by Subject|17|||
150067034|NCT01070043|541387462|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
150067035|NCT01070043|541387463|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
150067036|NCT01070043|541387464|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
150067037|NCT01070043|541387462|FG000|Double-Blind Treatment|Adverse Event|0|||
150067038|NCT01070043|541387463|FG001|Double-Blind Treatment|Adverse Event|0|||
150067039|NCT01070043|541387464|FG002|Double-Blind Treatment|Adverse Event|2|||
150067040|NCT01721070|541387465|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
150067041|NCT02047227|541387466|FG000|Overall Study|Adverse Event|2|||
150067042|NCT02047227|541387467|FG001|Overall Study|Adverse Event|4|||
150067043|NCT02047227|541387466|FG000|Overall Study|Lost to Follow-up|0|||
150067044|NCT02047227|541387467|FG001|Overall Study|Lost to Follow-up|3|||
150067045|NCT02047227|541387466|FG000|Overall Study|Protocol Violation|1|||
150067046|NCT02047227|541387467|FG001|Overall Study|Protocol Violation|0|||
150067047|NCT02047227|541387466|FG000|Overall Study|Spontaneous pregnancy|1|||
150067048|NCT02047227|541387467|FG001|Overall Study|Spontaneous pregnancy|0|||
150067049|NCT02047227|541387466|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
150067050|NCT02047227|541387467|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
150067051|NCT02047227|541387466|FG000|Overall Study|No oocytes retrieved|21|||
150067052|NCT02047227|541387467|FG001|Overall Study|No oocytes retrieved|20|||
150067053|NCT02047227|541387466|FG000|Overall Study|No fertilization|61|||
150067054|NCT02047227|541387467|FG001|Overall Study|No fertilization|51|||
150067055|NCT02047227|541387466|FG000|Overall Study|Intention to freeze all embryos|1|||
150067056|NCT02047227|541387467|FG001|Overall Study|Intention to freeze all embryos|0|||
150067057|NCT02047227|541387466|FG000|Overall Study|All embryos discarded|12|||
150067058|NCT02047227|541387467|FG001|Overall Study|All embryos discarded|11|||
150067059|NCT02047227|541387466|FG000|Overall Study|Other|10|||
150067060|NCT02047227|541387467|FG001|Overall Study|Other|9|||
150067061|NCT01090973|541387480|FG000|Overall Study|Disease progression|1|||
150067062|NCT00445978|541387481|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
150067063|NCT00445978|541387481|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
150067064|NCT00445978|541387481|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
150067065|NCT00445978|541387481|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
150067066|NCT00445978|541387481|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
150067067|NCT00445978|541387481|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
150067068|NCT00445978|541387481|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
150067069|NCT00445978|541387481|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
150067070|NCT00445978|541387481|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
150067071|NCT02766465|541387482|FG000|Overall Study|Withdrawal by Subject|0|||
150067072|NCT02766465|541387483|FG001|Overall Study|Withdrawal by Subject|10|||
150067073|NCT02435069|541387484|FG000|Dose Response - First Intervention|Adverse Event|0|||
150067074|NCT02435069|541387485|FG001|Dose Response - First Intervention|Adverse Event|1|||
150067075|NCT02435069|541387486|FG002|Dose Response - First Intervention|Adverse Event|1|||
150067076|NCT02435069|541387487|FG003|Dose Response - First Intervention|Adverse Event|0|||
150067077|NCT02435069|541387488|FG004|Dose Response - First Intervention|Adverse Event|0|||
150067078|NCT02435069|541387484|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
150182022|NCT03398148|541804598|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067079|NCT02435069|541387485|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
150067080|NCT02435069|541387486|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
150067081|NCT02435069|541387487|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
150067082|NCT02435069|541387488|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
150067083|NCT03112590|541387489|FG000|Overall Study|Adverse Event|0|||
150067084|NCT03112590|541387490|FG001|Overall Study|Adverse Event|1|||
150067085|NCT03112590|541387491|FG002|Overall Study|Adverse Event|0|||
150067086|NCT02059005|541387494|FG000|Overall Study|Death|1|||
150067087|NCT02059005|541387495|FG001|Overall Study|Death|3|||
150067088|NCT02059005|541387494|FG000|Overall Study|Lost to Follow-up|19|||
150067089|NCT02059005|541387495|FG001|Overall Study|Lost to Follow-up|19|||
150067090|NCT02059005|541387494|FG000|Overall Study|Incarceration|0|||
150067091|NCT02059005|541387495|FG001|Overall Study|Incarceration|1|||
150067092|NCT02059005|541387494|FG000|Overall Study|Inpatient|0|||
150067093|NCT02059005|541387495|FG001|Overall Study|Inpatient|1|||
150067094|NCT00739596|541387496|FG000|Overall Study|Adverse Event|12|||
150067095|NCT00739596|541387497|FG001|Overall Study|Adverse Event|6|||
150067096|NCT00739596|541387496|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
150067097|NCT00739596|541387497|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150067098|NCT00739596|541387496|FG000|Overall Study|Patient Withdrew Consent|8|||
150067099|NCT00739596|541387497|FG001|Overall Study|Patient Withdrew Consent|8|||
150067100|NCT00739596|541387496|FG000|Overall Study|Lost to Follow-up|0|||
150067101|NCT00739596|541387497|FG001|Overall Study|Lost to Follow-up|2|||
150067102|NCT00739596|541387496|FG000|Overall Study|Protocol Deviation|1|||
150067103|NCT00739596|541387497|FG001|Overall Study|Protocol Deviation|1|||
150067104|NCT02520661|541387498|FG000|Overall Study|Lost to Follow-up|7|||
150067105|NCT02520661|541387499|FG001|Overall Study|Lost to Follow-up|3|||
150067106|NCT02520661|541387498|FG000|Overall Study|Admitted from ED|49|||
150067107|NCT02520661|541387499|FG001|Overall Study|Admitted from ED|48|||
150067108|NCT02520661|541387498|FG000|Overall Study|ED greater than 24 hours|29|||
150067109|NCT02520661|541387499|FG001|Overall Study|ED greater than 24 hours|38|||
150067110|NCT02520661|541387498|FG000|Overall Study|other ineligibility|14|||
150067111|NCT02520661|541387499|FG001|Overall Study|other ineligibility|22|||
150067112|NCT02520661|541387498|FG000|Overall Study|Withdrawal by Subject|7|||
150067113|NCT02520661|541387499|FG001|Overall Study|Withdrawal by Subject|16|||
150067114|NCT00843726|541387500|FG000|Overall Study|Death|1|||
150067115|NCT00843726|541387501|FG001|Overall Study|Death|0|||
150067116|NCT00843726|541387500|FG000|Overall Study|Withdrawal by Subject|0|||
150067117|NCT00843726|541387501|FG001|Overall Study|Withdrawal by Subject|1|||
150067118|NCT00760084|541387507|FG000|Overall Study|Physician Decision|5|||
150067119|NCT00760084|541387507|FG000|Overall Study|Withdrawal by Subject|2|||
150067120|NCT00760084|541387507|FG000|Overall Study|Progressive Disease|3|||
150067121|NCT02567552|541387508|FG000|Overall Study|Adverse Event|0|||
150067122|NCT02567552|541387509|FG001|Overall Study|Adverse Event|1|||
150067123|NCT00171054|541387511|FG000|Overall Study|Protocol Violation|1|||
150067124|NCT00171054|541387512|FG001|Overall Study|Protocol Violation|2|||
150067125|NCT00171054|541387511|FG000|Overall Study|Patient withdrew consent|1|||
150067126|NCT00171054|541387512|FG001|Overall Study|Patient withdrew consent|0|||
150067127|NCT00171054|541387511|FG000|Overall Study|Lost to Follow-up|0|||
150067128|NCT00171054|541387512|FG001|Overall Study|Lost to Follow-up|1|||
150067129|NCT00171054|541387511|FG000|Overall Study|Adverse Event|8|||
150067130|NCT00171054|541387512|FG001|Overall Study|Adverse Event|8|||
150067131|NCT00171054|541387511|FG000|Overall Study|Condition no longer required study drug|0|||
150067132|NCT00171054|541387512|FG001|Overall Study|Condition no longer required study drug|1|||
150067133|NCT01828320|541387519|FG000|Overall Study|Lost to Follow-up|1|||
150067134|NCT01828320|541387520|FG001|Overall Study|Lost to Follow-up|3|||
150067135|NCT01828320|541387519|FG000|Overall Study|Withdrawal by Subject|7|||
150067136|NCT01828320|541387520|FG001|Overall Study|Withdrawal by Subject|2|||
150067137|NCT02160782|541388866|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
150067138|NCT02160782|541388867|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
150067139|NCT02160782|541388868|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
150067140|NCT02160782|541388869|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
150067141|NCT02160782|541388870|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
150067142|NCT02160782|541388866|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
150067143|NCT02160782|541388867|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
150067144|NCT02160782|541388868|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
150067145|NCT02160782|541388869|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
150067146|NCT02160782|541388870|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
150067147|NCT02160782|541388866|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
150067148|NCT02160782|541388867|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
150067149|NCT02160782|541388868|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
150067150|NCT02160782|541388869|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
150067151|NCT02160782|541388870|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
150067152|NCT02160782|541388866|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
150067153|NCT02160782|541388867|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
150067154|NCT02160782|541388868|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
150067155|NCT02160782|541388869|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
150067156|NCT02160782|541388870|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
150182023|NCT03398148|541804599|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067157|NCT02160782|541388866|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
150067158|NCT02160782|541388867|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
150067159|NCT02160782|541388868|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
150067160|NCT02160782|541388869|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
150067161|NCT02160782|541388870|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
150067162|NCT02160782|541388866|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
150067163|NCT02160782|541388867|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
150067164|NCT02160782|541388868|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
150067165|NCT02160782|541388869|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
150067166|NCT02160782|541388870|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
150067167|NCT02160782|541388866|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
150067168|NCT02160782|541388867|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
150067169|NCT02160782|541388868|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
150067170|NCT02160782|541388869|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
150067171|NCT02160782|541388870|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
150067172|NCT00891462|541388873|FG000|Overall Study|Withdrawal by Subject|9|||
150067173|NCT00891462|541388874|FG001|Overall Study|Withdrawal by Subject|6|||
150067174|NCT00891462|541388875|FG002|Overall Study|Withdrawal by Subject|7|||
150067175|NCT00891462|541388873|FG000|Overall Study|Adverse Event|7|||
150067176|NCT00891462|541388874|FG001|Overall Study|Adverse Event|8|||
150067177|NCT00891462|541388875|FG002|Overall Study|Adverse Event|7|||
150067178|NCT00891462|541388873|FG000|Overall Study|Lack of Efficacy|10|||
150067179|NCT00891462|541388874|FG001|Overall Study|Lack of Efficacy|5|||
150067180|NCT00891462|541388875|FG002|Overall Study|Lack of Efficacy|1|||
150067181|NCT00891462|541388873|FG000|Overall Study|COPD exacerbation|7|||
150067182|NCT00891462|541388874|FG001|Overall Study|COPD exacerbation|4|||
150067183|NCT00891462|541388875|FG002|Overall Study|COPD exacerbation|1|||
150067184|NCT00891462|541388873|FG000|Overall Study|Other Reason|2|||
150067185|NCT00891462|541388874|FG001|Overall Study|Other Reason|5|||
150067186|NCT00891462|541388875|FG002|Overall Study|Other Reason|3|||
150067187|NCT00891462|541388873|FG000|Overall Study|Protocol Violation|2|||
150067188|NCT00891462|541388874|FG001|Overall Study|Protocol Violation|1|||
150067189|NCT00891462|541388875|FG002|Overall Study|Protocol Violation|3|||
150067190|NCT00891462|541388873|FG000|Overall Study|Inclusion/exclusion criteria|0|||
150067191|NCT00891462|541388874|FG001|Overall Study|Inclusion/exclusion criteria|2|||
150067192|NCT00891462|541388875|FG002|Overall Study|Inclusion/exclusion criteria|2|||
150067193|NCT00891462|541388873|FG000|Overall Study|Lost to Follow-up|0|||
150067194|NCT00891462|541388874|FG001|Overall Study|Lost to Follow-up|2|||
150067195|NCT00891462|541388875|FG002|Overall Study|Lost to Follow-up|0|||
150067196|NCT00423722|541388879|FG000|Overall Study|Death|4|||
150067197|NCT00423722|541388880|FG001|Overall Study|Death|4|||
150067198|NCT00423722|541388879|FG000|Overall Study|Declined to participate|2|||
150067199|NCT00423722|541388880|FG001|Overall Study|Declined to participate|3|||
150067200|NCT00423722|541388879|FG000|Overall Study|Unable to complete questionnaires|4|||
150067201|NCT00423722|541388880|FG001|Overall Study|Unable to complete questionnaires|4|||
150067202|NCT00423722|541388879|FG000|Overall Study|Withdrawal by Subject|4|||
150067203|NCT00423722|541388880|FG001|Overall Study|Withdrawal by Subject|2|||
150067204|NCT00215683|541388881|FG000|Overall Study|Adverse Event|15|||
150067205|NCT00215683|541388882|FG001|Overall Study|Adverse Event|16|||
150067206|NCT00215683|541388883|FG002|Overall Study|Adverse Event|15|||
150067207|NCT00215683|541388881|FG000|Overall Study|Lack of Efficacy|5|||
150067208|NCT00215683|541388882|FG001|Overall Study|Lack of Efficacy|1|||
150067209|NCT00215683|541388883|FG002|Overall Study|Lack of Efficacy|2|||
150067210|NCT00215683|541388881|FG000|Overall Study|Lost to Follow-up|0|||
150067211|NCT00215683|541388882|FG001|Overall Study|Lost to Follow-up|2|||
150067212|NCT00215683|541388883|FG002|Overall Study|Lost to Follow-up|1|||
150067213|NCT00215683|541388881|FG000|Overall Study|Withdrawal by Subject|9|||
150067214|NCT00215683|541388882|FG001|Overall Study|Withdrawal by Subject|4|||
150067215|NCT00215683|541388883|FG002|Overall Study|Withdrawal by Subject|13|||
150067216|NCT00215683|541388881|FG000|Overall Study|Physician Decision|0|||
150067217|NCT00215683|541388882|FG001|Overall Study|Physician Decision|0|||
150067218|NCT00215683|541388883|FG002|Overall Study|Physician Decision|1|||
150067219|NCT00215683|541388881|FG000|Overall Study|Difficult to attend visits|0|||
150067220|NCT00215683|541388882|FG001|Overall Study|Difficult to attend visits|1|||
150067221|NCT00215683|541388883|FG002|Overall Study|Difficult to attend visits|0|||
150067222|NCT00215683|541388881|FG000|Overall Study|No study drug available|0|||
150067223|NCT00215683|541388882|FG001|Overall Study|No study drug available|1|||
150067224|NCT00215683|541388883|FG002|Overall Study|No study drug available|0|||
150067225|NCT00215683|541388881|FG000|Overall Study|Intermittent therapy required|0|||
150067226|NCT00215683|541388882|FG001|Overall Study|Intermittent therapy required|1|||
150067227|NCT00215683|541388883|FG002|Overall Study|Intermittent therapy required|0|||
150067228|NCT01083485|541388884|FG000|Overall Study|Adverse Event|0|||
150067229|NCT01083485|541388885|FG001|Overall Study|Adverse Event|1|||
150067230|NCT01083485|541388884|FG000|Overall Study|Protocol Violation|1|||
150067231|NCT01083485|541388885|FG001|Overall Study|Protocol Violation|0|||
150067232|NCT01083485|541388884|FG000|Overall Study|Withdrawal by Subject|5|||
150067233|NCT01083485|541388885|FG001|Overall Study|Withdrawal by Subject|2|||
150067234|NCT01083485|541388884|FG000|Overall Study|Other|1|||
150067235|NCT01083485|541388885|FG001|Overall Study|Other|0|||
150067236|NCT00674973|541388886|FG000|Overall Study|Insufficient Therapeutic Response|77|||
150067237|NCT00674973|541388887|FG001|Overall Study|Insufficient Therapeutic Response|72|||
150067238|NCT00674973|541388886|FG000|Overall Study|Refused Treatment|1|||
150067239|NCT00674973|541388887|FG001|Overall Study|Refused Treatment|5|||
150067240|NCT00674973|541388886|FG000|Overall Study|Failure to Return|1|||
150067241|NCT00674973|541388887|FG001|Overall Study|Failure to Return|0|||
150067242|NCT00674973|541388886|FG000|Overall Study|Adverse Event|2|||
150067243|NCT00674973|541388887|FG001|Overall Study|Adverse Event|9|||
150067244|NCT00674973|541388886|FG000|Overall Study|Death|19|||
150067245|NCT00674973|541388887|FG001|Overall Study|Death|15|||
150067246|NCT00674973|541388886|FG000|Overall Study|Protocol Violation|0|||
150067247|NCT00674973|541388887|FG001|Overall Study|Protocol Violation|1|||
150067248|NCT05108922|541388890|FG000|Overall Study|Adverse Event|2|||
150067249|NCT05108922|541388891|FG001|Overall Study|Adverse Event|3|||
150067250|NCT05108922|541388890|FG000|Overall Study|Lost to Follow-up|2|||
150067251|NCT05108922|541388891|FG001|Overall Study|Lost to Follow-up|1|||
150067252|NCT05108922|541388890|FG000|Overall Study|Inadvertent enrollment|0|||
150067253|NCT05108922|541388891|FG001|Overall Study|Inadvertent enrollment|1|||
150067254|NCT05108922|541388890|FG000|Overall Study|Physician Decision|2|||
150067255|NCT05108922|541388891|FG001|Overall Study|Physician Decision|3|||
150067256|NCT05108922|541388890|FG000|Overall Study|Protocol deviation|1|||
150067257|NCT05108922|541388891|FG001|Overall Study|Protocol deviation|0|||
150067258|NCT05108922|541388890|FG000|Overall Study|Screen failure|1|||
150067259|NCT05108922|541388891|FG001|Overall Study|Screen failure|0|||
150067260|NCT05108922|541388890|FG000|Overall Study|Withdrawal by Subject|11|||
150067261|NCT05108922|541388891|FG001|Overall Study|Withdrawal by Subject|8|||
150067262|NCT05036369|541388892|FG000|Overall Study|Run In non compliance|1|||
150067263|NCT05036369|541388893|FG001|Overall Study|Run In non compliance|2|||
150067264|NCT05036369|541388892|FG000|Overall Study|Change in eligibility criteria|0|||
150067265|NCT05036369|541388893|FG001|Overall Study|Change in eligibility criteria|1|||
150067266|NCT02349061|541388895|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
150067267|NCT02349061|541388896|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
150067268|NCT02349061|541388897|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
150067269|NCT02349061|541388895|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
150067270|NCT02349061|541388896|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
150067271|NCT02349061|541388897|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
150067272|NCT02349061|541388895|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
150067273|NCT02349061|541388896|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
150067274|NCT02349061|541388897|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
150067275|NCT02349061|541388895|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
150067276|NCT02349061|541388896|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
150067277|NCT02349061|541388897|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
150067278|NCT02349061|541388895|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
150067279|NCT02349061|541388896|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
150067280|NCT02349061|541388897|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
150067281|NCT02349061|541388895|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
150067282|NCT02349061|541388896|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
150067283|NCT02349061|541388897|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
150067284|NCT02349061|541388895|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
150067285|NCT02349061|541388896|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
150067286|NCT02349061|541388897|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
150067287|NCT02349061|541388895|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
150067288|NCT02349061|541388896|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
150067289|NCT02349061|541388897|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
150067290|NCT02349061|541388895|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
150067291|NCT02349061|541388896|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
150067292|NCT02349061|541388897|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
150067293|NCT02349061|541388895|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
150067294|NCT02349061|541388896|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
150067295|NCT02349061|541388897|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
150067296|NCT02349061|541388895|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
150067297|NCT02349061|541388896|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
150067298|NCT02349061|541388897|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
150067299|NCT02349061|541388895|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
150067300|NCT02349061|541388896|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
150067301|NCT02349061|541388897|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
150067302|NCT02349061|541388895|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
150067303|NCT02349061|541388896|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
150067304|NCT02349061|541388897|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
150067305|NCT02095223|541388900|FG000|Overall Study|Withdrawal by Subject|1|||
150067306|NCT02095223|541388901|FG001|Overall Study|Withdrawal by Subject|0|||
150067307|NCT01507298|541388904|FG000|Overall Study|Protocol Violation|0|||
150067308|NCT01507298|541388905|FG001|Overall Study|Protocol Violation|6|||
150067309|NCT03906461|541388906|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
150067310|NCT03906461|541388906|FG000|Completed 12-month Follow-up|Missed Visit|6|||
150067311|NCT00426231|541388909|FG000|Overall Study|Withdrawal by Subject|9|||
150067312|NCT00426231|541388910|FG001|Overall Study|Withdrawal by Subject|12|||
150067313|NCT01795638|541388911|FG000|Overall Study|Death|0|||
150067314|NCT01795638|541388912|FG001|Overall Study|Death|3|||
150067315|NCT01795638|541388911|FG000|Overall Study|transferred to quaternary hospital|2|||
150067316|NCT01795638|541388912|FG001|Overall Study|transferred to quaternary hospital|3|||
150067317|NCT01795638|541388911|FG000|Overall Study|Protocol Violation|3|||
150067318|NCT01795638|541388912|FG001|Overall Study|Protocol Violation|0|||
150067319|NCT01795638|541388911|FG000|Overall Study|discharged from hospital|7|||
150067320|NCT01795638|541388912|FG001|Overall Study|discharged from hospital|5|||
150067321|NCT01795638|541388911|FG000|Overall Study|Withdrawal by Subject|1|||
150067322|NCT01795638|541388912|FG001|Overall Study|Withdrawal by Subject|0|||
150067323|NCT03061097|541388913|FG000|Overall Study|Withdrawal by Subject|0|||
150067324|NCT03061097|541388914|FG001|Overall Study|Withdrawal by Subject|3|||
150067325|NCT00595465|541388921|FG000|Overall Study|Adverse Event|4|||
150067326|NCT00595465|541388922|FG001|Overall Study|Adverse Event|3|||
150067327|NCT00595465|541388923|FG002|Overall Study|Adverse Event|3|||
150067328|NCT00595465|541388921|FG000|Overall Study|Pregnancy|0|||
150067329|NCT00595465|541388922|FG001|Overall Study|Pregnancy|0|||
150067330|NCT00595465|541388923|FG002|Overall Study|Pregnancy|1|||
150067331|NCT00595465|541388921|FG000|Overall Study|Protocol Violation|2|||
150067332|NCT00595465|541388922|FG001|Overall Study|Protocol Violation|1|||
150067333|NCT00595465|541388923|FG002|Overall Study|Protocol Violation|0|||
150067334|NCT00595465|541388921|FG000|Overall Study|Lost to Follow-up|0|||
150067335|NCT00595465|541388922|FG001|Overall Study|Lost to Follow-up|0|||
150067336|NCT00595465|541388923|FG002|Overall Study|Lost to Follow-up|2|||
150067337|NCT00595465|541388921|FG000|Overall Study|administrative reason|0|||
150067338|NCT00595465|541388922|FG001|Overall Study|administrative reason|0|||
150067339|NCT00595465|541388923|FG002|Overall Study|administrative reason|1|||
150067340|NCT00107783|541388924|FG000|Overall Study|Adverse Event|0|||
150067341|NCT00107783|541388925|FG001|Overall Study|Adverse Event|2|||
150067342|NCT00107783|541388924|FG000|Overall Study|Death|0|||
150067343|NCT00107783|541388925|FG001|Overall Study|Death|1|||
150067344|NCT00107783|541388924|FG000|Overall Study|Withdrawal by Subject|2|||
150067345|NCT00107783|541388925|FG001|Overall Study|Withdrawal by Subject|0|||
150067346|NCT00107783|541388924|FG000|Overall Study|Second hip replacement|1|||
150067347|NCT00107783|541388925|FG001|Overall Study|Second hip replacement|1|||
150067348|NCT02360995|541388926|FG000|Overall Study|Lost to Follow-up|2|||
150067349|NCT02360995|541388927|FG001|Overall Study|Lost to Follow-up|0|||
150067350|NCT02360995|541388928|FG002|Overall Study|Lost to Follow-up|2|||
150067351|NCT02360995|541388926|FG000|Overall Study|Withdrawal by Subject|0|||
150067352|NCT02360995|541388927|FG001|Overall Study|Withdrawal by Subject|1|||
150067353|NCT02360995|541388928|FG002|Overall Study|Withdrawal by Subject|0|||
150067354|NCT00331864|541388929|FG000|Overall Study|Adverse Event|30|||
150067355|NCT00331864|541388930|FG001|Overall Study|Adverse Event|1|||
150067356|NCT00331864|541388929|FG000|Overall Study|Lack of Efficacy|4|||
150067357|NCT00331864|541388930|FG001|Overall Study|Lack of Efficacy|0|||
150067358|NCT00331864|541388929|FG000|Overall Study|Protocol Violation|3|||
150067359|NCT00331864|541388930|FG001|Overall Study|Protocol Violation|0|||
150067360|NCT00331864|541388929|FG000|Overall Study|Withdrawal by Subject|10|||
150067361|NCT00331864|541388930|FG001|Overall Study|Withdrawal by Subject|0|||
150067362|NCT00331864|541388929|FG000|Overall Study|Lost to Follow-up|4|||
150067363|NCT00331864|541388930|FG001|Overall Study|Lost to Follow-up|3|||
150067364|NCT00331864|541388929|FG000|Overall Study|Administrative Problems|1|||
150067365|NCT00331864|541388930|FG001|Overall Study|Administrative Problems|0|||
150067366|NCT00331864|541388929|FG000|Overall Study|Death|6|||
150182024|NCT03398148|541804600|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067367|NCT00331864|541388930|FG001|Overall Study|Death|0|||
150067368|NCT02611960|541388931|FG000|Overall Study|Adverse Event|7|||
150067369|NCT02611960|541388932|FG001|Overall Study|Adverse Event|8|||
150067370|NCT02611960|541388931|FG000|Overall Study|Death|98|||
150067371|NCT02611960|541388932|FG001|Overall Study|Death|92|||
150067372|NCT02611960|541388931|FG000|Overall Study|Withdrawal by Subject|1|||
150067373|NCT02611960|541388932|FG001|Overall Study|Withdrawal by Subject|5|||
150067374|NCT02611960|541388931|FG000|Overall Study|Sponsor Decision|11|||
150067375|NCT02611960|541388932|FG001|Overall Study|Sponsor Decision|11|||
150067376|NCT02395666|541388933|FG000|Overall Study|Physician Decision|3|||
150067377|NCT02395666|541388934|FG001|Overall Study|Physician Decision|0|||
150067378|NCT02395666|541388933|FG000|Overall Study|Lost to Follow-up|1|||
150067379|NCT02395666|541388934|FG001|Overall Study|Lost to Follow-up|0|||
150067380|NCT02395666|541388933|FG000|Overall Study|Withdrawal by Subject|2|||
150067381|NCT02395666|541388934|FG001|Overall Study|Withdrawal by Subject|1|||
150067382|NCT04131556|541388937|FG000|Overall Study|Adverse Event|1|||
150067383|NCT04131556|541388937|FG000|Overall Study|Withdrawal by Subject|1|||
150067384|NCT01229371|541388938|FG000|Overall Study|Withdrawal by Subject|0|||
150067385|NCT01229371|541388939|FG001|Overall Study|Withdrawal by Subject|1|||
150067386|NCT01229371|541388940|FG002|Overall Study|Withdrawal by Subject|0|||
150067387|NCT01229371|541388941|FG003|Overall Study|Withdrawal by Subject|0|||
150067388|NCT02106910|541388942|FG000|Overall Study|Lost to Follow-up|1|||
150067389|NCT02106910|541388943|FG001|Overall Study|Lost to Follow-up|1|||
150067390|NCT02476422|541388944|FG000|Overall Study|Subject/guardian decision|0|||
150067391|NCT02476422|541388945|FG001|Overall Study|Subject/guardian decision|1|||
150067392|NCT01859143|541388946|FG000|Overall Study|Lost to Follow-up|2|||
150067393|NCT01859143|541388947|FG001|Overall Study|Lost to Follow-up|0|||
150067394|NCT00700570|541388948|FG000|Overall Study|Adverse Event|2|||
150067395|NCT00700570|541388949|FG001|Overall Study|Adverse Event|6|||
150067396|NCT00700570|541388948|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
150067397|NCT00700570|541388949|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
150067398|NCT00700570|541388948|FG000|Overall Study|Disease Progression|8|||
150067399|NCT00700570|541388949|FG001|Overall Study|Disease Progression|11|||
150067400|NCT00700570|541388948|FG000|Overall Study|Withdrawal by Subject|1|||
150067401|NCT00700570|541388949|FG001|Overall Study|Withdrawal by Subject|6|||
150067402|NCT01933217|541388955|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
150067403|NCT01933217|541388956|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
150067404|NCT01933217|541388955|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
150067405|NCT01933217|541388956|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
150067406|NCT02180165|541388957|FG000|Overall Study|Not Treated|0|||
150067407|NCT02180165|541388958|FG001|Overall Study|Not Treated|0|||
150067408|NCT02180165|541388959|FG002|Overall Study|Not Treated|1|||
150067409|NCT02180165|541388960|FG003|Overall Study|Not Treated|0|||
150067410|NCT02180165|541388957|FG000|Overall Study|Adverse Event|7|||
150067411|NCT02180165|541388958|FG001|Overall Study|Adverse Event|0|||
150067412|NCT02180165|541388959|FG002|Overall Study|Adverse Event|18|||
150067413|NCT02180165|541388960|FG003|Overall Study|Adverse Event|3|||
150067414|NCT02180165|541388957|FG000|Overall Study|Lack of Efficacy|0|||
150067415|NCT02180165|541388958|FG001|Overall Study|Lack of Efficacy|1|||
150067416|NCT02180165|541388959|FG002|Overall Study|Lack of Efficacy|3|||
150067417|NCT02180165|541388960|FG003|Overall Study|Lack of Efficacy|2|||
150067418|NCT02180165|541388957|FG000|Overall Study|Physician Decision|1|||
150067419|NCT02180165|541388958|FG001|Overall Study|Physician Decision|0|||
150067420|NCT02180165|541388959|FG002|Overall Study|Physician Decision|5|||
150067421|NCT02180165|541388960|FG003|Overall Study|Physician Decision|0|||
150067422|NCT02180165|541388957|FG000|Overall Study|Withdrawal by Subject|3|||
150067423|NCT02180165|541388958|FG001|Overall Study|Withdrawal by Subject|0|||
150067424|NCT02180165|541388959|FG002|Overall Study|Withdrawal by Subject|2|||
150067425|NCT02180165|541388960|FG003|Overall Study|Withdrawal by Subject|1|||
150067426|NCT00267189|541388963|FG000|Overall Study|Patient withdrew consent|1|||
150067427|NCT00267189|541388964|FG001|Overall Study|Patient withdrew consent|1|||
150067428|NCT00267189|541388963|FG000|Overall Study|Death|1|||
150067429|NCT00267189|541388964|FG001|Overall Study|Death|0|||
150067430|NCT00267189|541388963|FG000|Overall Study|Missing|3|||
150067431|NCT00267189|541388964|FG001|Overall Study|Missing|0|||
150067432|NCT04137224|541388967|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
150067433|NCT04137224|541388968|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
150067434|NCT04137224|541388967|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
150067435|NCT04137224|541388968|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
150067436|NCT04137224|541388967|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
150067437|NCT04137224|541388968|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
150067438|NCT00925990|541388969|FG000|Overall Study|Adverse Event|1|||
150067439|NCT00925990|541388970|FG001|Overall Study|Adverse Event|3|||
150067440|NCT00925990|541388969|FG000|Overall Study|Withdrawal by Subject|2|||
150067441|NCT00925990|541388970|FG001|Overall Study|Withdrawal by Subject|2|||
150067442|NCT00925990|541388969|FG000|Overall Study|Lost to Follow-up|1|||
150067443|NCT00925990|541388970|FG001|Overall Study|Lost to Follow-up|3|||
150067444|NCT00925990|541388969|FG000|Overall Study|Physician Decision|1|||
150067445|NCT00925990|541388970|FG001|Overall Study|Physician Decision|1|||
150067446|NCT00925990|541388969|FG000|Overall Study|moved out of state, missed medication|0|||
150067447|NCT00925990|541388970|FG001|Overall Study|moved out of state, missed medication|2|||
150067448|NCT01368432|541388971|FG000|Overall Study|Lost to Follow-up|0|||
150067449|NCT01368432|541388972|FG001|Overall Study|Lost to Follow-up|1|||
150067450|NCT02310321|541388973|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
150067451|NCT02310321|541388974|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
150067452|NCT02310321|541388975|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
150067453|NCT02310321|541388973|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
150067454|NCT02310321|541388974|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
150067455|NCT02310321|541388975|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
150067456|NCT02310321|541388973|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
150067457|NCT02310321|541388974|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
150067458|NCT02310321|541388975|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
150067459|NCT02310321|541388973|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
150067460|NCT02310321|541388974|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
150067461|NCT02310321|541388975|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
150067462|NCT02310321|541388973|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
150067463|NCT02310321|541388974|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
150067464|NCT02310321|541388975|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
150067465|NCT02310321|541388973|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
150067466|NCT02310321|541388974|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
150067467|NCT02310321|541388975|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
150067468|NCT02310321|541388973|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
150067469|NCT02310321|541388974|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
150067470|NCT02310321|541388975|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
150067471|NCT02310321|541388973|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
150067472|NCT02310321|541388974|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
150067473|NCT02310321|541388975|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
150067474|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
150067475|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
150067476|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
150067477|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
150067478|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
150067479|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
150067480|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
150067481|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
150067482|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
150067483|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
150067484|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
150067485|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
150067486|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
150067487|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
150067488|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
150067489|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
150067490|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
150067491|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
150067492|NCT02310321|541388973|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
150067493|NCT02310321|541388974|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
150067494|NCT02310321|541388975|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
150067495|NCT02310321|541388973|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
150067496|NCT02310321|541388974|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
150067497|NCT02310321|541388975|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
150067498|NCT02310321|541388973|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
150067499|NCT02310321|541388974|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
150067500|NCT02310321|541388975|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
150067501|NCT02310321|541388973|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
150067502|NCT02310321|541388974|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
150067503|NCT02310321|541388975|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
150067504|NCT02310321|541388973|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
150067505|NCT02310321|541388974|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
150067506|NCT02310321|541388975|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
150067507|NCT02310321|541388973|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
150067508|NCT02310321|541388974|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
150067509|NCT02310321|541388975|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
150067510|NCT02310321|541388973|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
150067511|NCT02310321|541388974|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
150067512|NCT02310321|541388975|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
150067513|NCT02310321|541388973|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
150067514|NCT02310321|541388974|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
150067515|NCT02310321|541388975|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
150067516|NCT02310321|541388973|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
150067517|NCT02310321|541388974|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
150067518|NCT02310321|541388975|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
150067519|NCT04950166|541388976|FG000|Overall Study|Withdrawal by Subject|1|||
150067520|NCT01698905|541388977|FG000|Overall Study|Adverse Event|4|||
150067521|NCT01698905|541388977|FG000|Overall Study|Physician Decision|2|||
150067522|NCT01698905|541388977|FG000|Overall Study|Pregnancy|1|||
150067523|NCT01698905|541388977|FG000|Overall Study|Protocol Violation|1|||
150067524|NCT01698905|541388977|FG000|Overall Study|Subject/guardian decision|2|||
150067525|NCT01698905|541388977|FG000|Overall Study|Death|1|||
150067526|NCT05896748|541388978|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
150067527|NCT05896748|541388978|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
150067528|NCT05896748|541388978|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
150067529|NCT05896748|541388978|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
150067530|NCT05896748|541388978|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
150067531|NCT00857415|541388981|FG000|Overall Study|Image acquisition failure|2|||
150067532|NCT00857415|541388982|FG001|Overall Study|Image acquisition failure|0|||
150067533|NCT00857415|541388981|FG000|Overall Study|Invalid image or not imaged|3|||
150067534|NCT00857415|541388982|FG001|Overall Study|Invalid image or not imaged|0|||
150067535|NCT00857415|541388981|FG000|Overall Study|Subject still living at end of study|110|||
150067536|NCT00857415|541388982|FG001|Overall Study|Subject still living at end of study|0|||
150067537|NCT00857415|541388981|FG000|Overall Study|Deceased with no autopsy|2|||
150067538|NCT00857415|541388982|FG001|Overall Study|Deceased with no autopsy|0|||
150067539|NCT00764504|541388983|FG000|Overall Study|Death|12|||
150067540|NCT00764504|541388984|FG001|Overall Study|Death|6|||
150067541|NCT00764504|541388985|FG002|Overall Study|Death|13|||
150067542|NCT00764504|541388983|FG000|Overall Study|Revision of Device|12|||
150067543|NCT00764504|541388984|FG001|Overall Study|Revision of Device|23|||
150067544|NCT00764504|541388985|FG002|Overall Study|Revision of Device|14|||
150067545|NCT00764504|541388983|FG000|Overall Study|Physician Decision|1|||
150067546|NCT00764504|541388984|FG001|Overall Study|Physician Decision|0|||
150067547|NCT00764504|541388985|FG002|Overall Study|Physician Decision|0|||
150067548|NCT00764504|541388983|FG000|Overall Study|Withdrawal by Subject|1|||
150067549|NCT00764504|541388984|FG001|Overall Study|Withdrawal by Subject|7|||
150067550|NCT00764504|541388985|FG002|Overall Study|Withdrawal by Subject|4|||
150067551|NCT00764504|541388983|FG000|Overall Study|Lost to Follow-up|40|||
150067552|NCT00764504|541388984|FG001|Overall Study|Lost to Follow-up|34|||
150067553|NCT00764504|541388985|FG002|Overall Study|Lost to Follow-up|72|||
150067554|NCT04795622|541388986|FG000|Overall Study|Adverse Event|1|||
150067555|NCT04795622|541388987|FG001|Overall Study|Adverse Event|0|||
150067556|NCT04795622|541388986|FG000|Overall Study|Withdrawal by Subject|3|||
150067557|NCT04795622|541388987|FG001|Overall Study|Withdrawal by Subject|3|||
150067558|NCT04795622|541388986|FG000|Overall Study|Protocol Violation|0|||
150067559|NCT04795622|541388987|FG001|Overall Study|Protocol Violation|2|||
150067560|NCT04795622|541388986|FG000|Overall Study|Lost to Follow-up|2|||
150067561|NCT04795622|541388987|FG001|Overall Study|Lost to Follow-up|3|||
150067562|NCT04795622|541388986|FG000|Overall Study|Other|7|||
150067563|NCT04795622|541388987|FG001|Overall Study|Other|8|||
150067564|NCT01437878|541388990|FG000|Overall Study|Withdrawal by Subject|1|||
150067565|NCT01437878|541388991|FG001|Overall Study|Withdrawal by Subject|0|||
150067566|NCT01369615|541388992|FG000|Overall Study|Withdrawal by Subject|0|||
150067567|NCT01369615|541388993|FG001|Overall Study|Withdrawal by Subject|1|||
150067568|NCT01369615|541388992|FG000|Overall Study|Lost to Follow-up|0|||
150067569|NCT01369615|541388993|FG001|Overall Study|Lost to Follow-up|1|||
150067570|NCT04263454|541388994|FG000|Overall Study|Adverse Event|0|||
150067571|NCT04263454|541388995|FG001|Overall Study|Adverse Event|2|||
150067572|NCT04263454|541388994|FG000|Overall Study|Physician Decision|3|||
150067573|NCT04263454|541388995|FG001|Overall Study|Physician Decision|5|||
150067574|NCT04263454|541388994|FG000|Overall Study|Poor Data Quality|0|||
150067575|NCT04263454|541388995|FG001|Overall Study|Poor Data Quality|1|||
150067576|NCT00986479|541388996|FG000|Period 1|Improved mood|1|||
150067577|NCT00986479|541388997|FG001|Period 1|Improved mood|0|||
150067578|NCT00986479|541388996|FG000|Period 1|Administrative reasons|1|||
150067579|NCT00986479|541388997|FG001|Period 1|Administrative reasons|0|||
150067580|NCT02035475|541388998|FG000|Overall Study|Withdrawal by Subject|4|||
150067581|NCT02035475|541388998|FG000|Overall Study|Physician Decision|1|||
150067582|NCT02035475|541388998|FG000|Overall Study|Equipment Error|1|||
150067583|NCT01460368|541388999|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067584|NCT01460368|541389000|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067585|NCT01460368|541389001|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067586|NCT01460368|541389002|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067587|NCT01460368|541389003|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
150067588|NCT01460368|541389004|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067589|NCT01460368|541389005|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
150067590|NCT01460368|541388999|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
150067591|NCT01460368|541389000|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
150067592|NCT01460368|541389001|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
150067593|NCT01460368|541389002|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
150067594|NCT01460368|541389003|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
150067595|NCT01460368|541389004|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
150067596|NCT01460368|541389005|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
150067597|NCT01460368|541388999|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067598|NCT01460368|541389000|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
150067599|NCT01460368|541389001|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067600|NCT01460368|541389002|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067601|NCT01460368|541389003|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067602|NCT01460368|541389004|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067603|NCT01460368|541389005|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
150067604|NCT01460368|541388999|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067605|NCT01460368|541389000|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067606|NCT01460368|541389001|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
150067607|NCT01460368|541389002|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067608|NCT01460368|541389003|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067609|NCT01460368|541389004|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067610|NCT01460368|541389005|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
150067611|NCT01460368|541388999|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
150067612|NCT01460368|541389000|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
150067613|NCT01460368|541389001|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
150067614|NCT01460368|541389002|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
150067615|NCT01460368|541389003|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
150067616|NCT01460368|541389004|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
150067617|NCT01460368|541389005|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
150067618|NCT02322021|541389006|FG000|Core Phase|Adverse Event|1|||
150067619|NCT02322021|541389007|FG001|Core Phase|Adverse Event|3|||
150067620|NCT02322021|541389008|FG002|Core Phase|Adverse Event|4|||
150067621|NCT02322021|541389009|FG003|Core Phase|Adverse Event|2|||
150067622|NCT02322021|541389010|FG004|Core Phase|Adverse Event|0|||
150067623|NCT02322021|541389006|FG000|Core Phase|Participant Choice|4|||
150067624|NCT02322021|541389007|FG001|Core Phase|Participant Choice|5|||
150067625|NCT02322021|541389008|FG002|Core Phase|Participant Choice|4|||
150067626|NCT02322021|541389009|FG003|Core Phase|Participant Choice|2|||
150067627|NCT02322021|541389010|FG004|Core Phase|Participant Choice|0|||
150067628|NCT02322021|541389006|FG000|Core Phase|Lost to Follow-up|0|||
150067629|NCT02322021|541389007|FG001|Core Phase|Lost to Follow-up|0|||
150067630|NCT02322021|541389008|FG002|Core Phase|Lost to Follow-up|0|||
150067631|NCT02322021|541389009|FG003|Core Phase|Lost to Follow-up|1|||
150067632|NCT02322021|541389010|FG004|Core Phase|Lost to Follow-up|0|||
150067633|NCT02322021|541389006|FG000|Core Phase|Other|0|||
150067634|NCT02322021|541389007|FG001|Core Phase|Other|0|||
150067635|NCT02322021|541389008|FG002|Core Phase|Other|1|||
150067636|NCT02322021|541389009|FG003|Core Phase|Other|0|||
150067637|NCT02322021|541389010|FG004|Core Phase|Other|0|||
150067638|NCT02322021|541389006|FG000|Extension Phase|Adverse Event|0|||
150067639|NCT02322021|541389007|FG001|Extension Phase|Adverse Event|0|||
150067640|NCT02322021|541389008|FG002|Extension Phase|Adverse Event|0|||
150067641|NCT02322021|541389009|FG003|Extension Phase|Adverse Event|0|||
150067642|NCT02322021|541389010|FG004|Extension Phase|Adverse Event|3|||
150067643|NCT02322021|541389006|FG000|Extension Phase|Participant Choice|0|||
150067644|NCT02322021|541389007|FG001|Extension Phase|Participant Choice|0|||
150067645|NCT02322021|541389008|FG002|Extension Phase|Participant Choice|0|||
150067646|NCT02322021|541389009|FG003|Extension Phase|Participant Choice|0|||
150067647|NCT02322021|541389010|FG004|Extension Phase|Participant Choice|6|||
150067648|NCT02322021|541389006|FG000|Extension Phase|Other|0|||
150067649|NCT02322021|541389007|FG001|Extension Phase|Other|0|||
150067650|NCT02322021|541389008|FG002|Extension Phase|Other|0|||
150067651|NCT02322021|541389009|FG003|Extension Phase|Other|0|||
150067652|NCT02322021|541389010|FG004|Extension Phase|Other|3|||
150067653|NCT02322021|541389006|FG000|Extension Phase|Lost to Follow-up|0|||
150067654|NCT02322021|541389007|FG001|Extension Phase|Lost to Follow-up|0|||
150067655|NCT02322021|541389008|FG002|Extension Phase|Lost to Follow-up|0|||
150067656|NCT02322021|541389009|FG003|Extension Phase|Lost to Follow-up|0|||
150067657|NCT02322021|541389010|FG004|Extension Phase|Lost to Follow-up|1|||
150067658|NCT02322021|541389006|FG000|Extension Phase|Study terminated by sponsor|0|||
150067659|NCT02322021|541389007|FG001|Extension Phase|Study terminated by sponsor|0|||
150067660|NCT02322021|541389008|FG002|Extension Phase|Study terminated by sponsor|0|||
150067661|NCT02322021|541389009|FG003|Extension Phase|Study terminated by sponsor|0|||
150067662|NCT02322021|541389010|FG004|Extension Phase|Study terminated by sponsor|28|||
150067663|NCT04493333|541390311|FG000|Overall Study|Withdrawal by Subject|1|||
150067664|NCT04493333|541390312|FG001|Overall Study|Withdrawal by Subject|1|||
150067665|NCT04493333|541390311|FG000|Overall Study|Ineligible|0|||
150067666|NCT04493333|541390312|FG001|Overall Study|Ineligible|1|||
150067667|NCT04493333|541390311|FG000|Overall Study|Noncompliance|2|||
150067668|NCT04493333|541390312|FG001|Overall Study|Noncompliance|1|||
150067669|NCT01920555|541390321|FG000|Overall Study|Physician Decision|1|||
150067670|NCT01920555|541390322|FG001|Overall Study|Physician Decision|2|||
150067671|NCT01920555|541390323|FG002|Overall Study|Physician Decision|1|||
150067672|NCT01920555|541390324|FG003|Overall Study|Physician Decision|2|||
150067673|NCT01920555|541390325|FG004|Overall Study|Physician Decision|0|||
150067674|NCT01920555|541390321|FG000|Overall Study|Lack of Efficacy|2|||
150067675|NCT01920555|541390322|FG001|Overall Study|Lack of Efficacy|0|||
150067676|NCT01920555|541390323|FG002|Overall Study|Lack of Efficacy|0|||
150067677|NCT01920555|541390324|FG003|Overall Study|Lack of Efficacy|0|||
150067678|NCT01920555|541390325|FG004|Overall Study|Lack of Efficacy|0|||
150067679|NCT01920555|541390321|FG000|Overall Study|Travel Difficulties|1|||
150067680|NCT01920555|541390322|FG001|Overall Study|Travel Difficulties|1|||
150067681|NCT01920555|541390323|FG002|Overall Study|Travel Difficulties|0|||
150067682|NCT01920555|541390324|FG003|Overall Study|Travel Difficulties|0|||
150067683|NCT01920555|541390325|FG004|Overall Study|Travel Difficulties|1|||
150067684|NCT01920555|541390321|FG000|Overall Study|Lost to Follow-up|0|||
150067685|NCT01920555|541390322|FG001|Overall Study|Lost to Follow-up|1|||
150067686|NCT01920555|541390323|FG002|Overall Study|Lost to Follow-up|0|||
150067687|NCT01920555|541390324|FG003|Overall Study|Lost to Follow-up|1|||
150067688|NCT01920555|541390325|FG004|Overall Study|Lost to Follow-up|0|||
150067689|NCT00422097|541390326|FG000|Dose Level 2|Still on treatment|0|||
150067690|NCT00422097|541390327|FG001|Dose Level 2|Still on treatment|1|||
150067691|NCT00422097|541390328|FG002|Dose Level 2|Still on treatment|0|||
150067692|NCT00422097|541390329|FG003|Dose Level 2|Still on treatment|0|||
150067693|NCT00422097|541390330|FG004|Dose Level 2|Still on treatment|0|||
150067694|NCT00422097|541390331|FG005|Dose Level 2|Still on treatment|0|||
150067695|NCT00422097|541390332|FG006|Dose Level 2|Still on treatment|0|||
150067696|NCT00422097|541390333|FG007|Dose Level 2|Still on treatment|0|||
150067697|NCT02572388|541390334|FG000|Overall Study|Withdrawal by Subject|1|||
150067698|NCT02572388|541390335|FG001|Overall Study|Withdrawal by Subject|1|||
150067699|NCT02572388|541390336|FG002|Overall Study|Withdrawal by Subject|2|||
150067700|NCT02572388|541390337|FG003|Overall Study|Withdrawal by Subject|2|||
150067701|NCT01051466|541390338|FG000|Overall Study|Adverse Event|1|||
150067702|NCT01051466|541390339|FG001|Overall Study|Adverse Event|0|||
150067703|NCT01051466|541390338|FG000|Overall Study|Lost to Follow-up|1|||
150067704|NCT01051466|541390339|FG001|Overall Study|Lost to Follow-up|1|||
150067705|NCT01051466|541390338|FG000|Overall Study|Withdrawal by Subject|5|||
150067706|NCT01051466|541390339|FG001|Overall Study|Withdrawal by Subject|1|||
150067707|NCT01051466|541390338|FG000|Overall Study|Entry Criteria Not Met|0|||
150067708|NCT01051466|541390339|FG001|Overall Study|Entry Criteria Not Met|3|||
150067709|NCT01051466|541390338|FG000|Overall Study|Physician Decision|1|||
150067710|NCT01051466|541390339|FG001|Overall Study|Physician Decision|0|||
150067711|NCT00810108|541390340|FG000|Overall Study|Withdrawal by Subject|1|||
150067712|NCT00810108|541390341|FG001|Overall Study|Withdrawal by Subject|0|||
150067713|NCT01539642|541390358|FG000|Overall Study|Lack of Efficacy|20|||
150067714|NCT01539642|541390359|FG001|Overall Study|Lack of Efficacy|18|||
150067715|NCT01539642|541390358|FG000|Overall Study|Patient ready for early discharge|8|||
150067716|NCT01539642|541390359|FG001|Overall Study|Patient ready for early discharge|7|||
150067717|NCT01539642|541390358|FG000|Overall Study|Adverse Event|6|||
150067718|NCT01539642|541390359|FG001|Overall Study|Adverse Event|4|||
150067719|NCT01539642|541390358|FG000|Overall Study|Withdrawal by Subject|2|||
150067720|NCT01539642|541390359|FG001|Overall Study|Withdrawal by Subject|2|||
150067721|NCT02600351|541390360|FG000|Overall Study|Lack of Efficacy|3|||
150067722|NCT02600351|541390361|FG001|Overall Study|Lack of Efficacy|0|||
150067723|NCT02600351|541390362|FG002|Overall Study|Lack of Efficacy|5|||
150067724|NCT02600351|541390363|FG003|Overall Study|Lack of Efficacy|2|||
150067725|NCT02600351|541390360|FG000|Overall Study|Lost to Follow-up|1|||
150067726|NCT02600351|541390361|FG001|Overall Study|Lost to Follow-up|0|||
150067727|NCT02600351|541390362|FG002|Overall Study|Lost to Follow-up|0|||
150067728|NCT02600351|541390363|FG003|Overall Study|Lost to Follow-up|0|||
150067729|NCT02600351|541390360|FG000|Overall Study|Randomized but Not Treated|1|||
150067730|NCT02600351|541390361|FG001|Overall Study|Randomized but Not Treated|0|||
150067731|NCT02600351|541390362|FG002|Overall Study|Randomized but Not Treated|1|||
150067732|NCT02600351|541390363|FG003|Overall Study|Randomized but Not Treated|3|||
150067733|NCT00567593|541390366|FG000|Overall Study|Adverse Event|1|||
150067734|NCT00567593|541390366|FG000|Overall Study|Physician Decision|1|||
150067735|NCT02943460|541390370|FG000|Blinded Study Phase|Adverse Event|3|||
150067736|NCT02943460|541390371|FG001|Blinded Study Phase|Adverse Event|0|||
150067737|NCT02943460|541390372|FG002|Blinded Study Phase|Adverse Event|0|||
150067738|NCT02943460|541390370|FG000|Blinded Study Phase|Withdrew Consent|0|||
150067739|NCT02943460|541390371|FG001|Blinded Study Phase|Withdrew Consent|1|||
150067740|NCT02943460|541390372|FG002|Blinded Study Phase|Withdrew Consent|0|||
150067741|NCT02943460|541390370|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
150067742|NCT02943460|541390371|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
150067743|NCT02943460|541390372|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
150067744|NCT02943460|541390370|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
150067745|NCT02943460|541390371|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
150067746|NCT02943460|541390372|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
150067747|NCT02943460|541390370|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
150067748|NCT02943460|541390371|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
150067749|NCT02943460|541390372|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
150067750|NCT03875768|541390373|FG000|Overall Study|Lost to Follow-up|16|||
150067751|NCT03875768|541390374|FG001|Overall Study|Lost to Follow-up|13|||
150067752|NCT03875768|541390373|FG000|Overall Study|Withdrawal by Subject|10|||
150067753|NCT03875768|541390374|FG001|Overall Study|Withdrawal by Subject|21|||
150067754|NCT03875768|541390373|FG000|Overall Study|Did not complete assessment|21|||
150067755|NCT03875768|541390374|FG001|Overall Study|Did not complete assessment|12|||
150067756|NCT03875768|541390373|FG000|Overall Study|Became ineligible|1|||
150067757|NCT03875768|541390374|FG001|Overall Study|Became ineligible|0|||
150067758|NCT01925274|541390375|FG000|Overall Study|Death|1|||
150067759|NCT01925274|541390376|FG001|Overall Study|Death|0|||
150067760|NCT01925274|541390377|FG002|Overall Study|Death|0|||
150067761|NCT01925274|541390375|FG000|Overall Study|Lost to Follow-up|0|||
150067762|NCT01925274|541390376|FG001|Overall Study|Lost to Follow-up|1|||
150067763|NCT01925274|541390377|FG002|Overall Study|Lost to Follow-up|0|||
150067764|NCT01925274|541390375|FG000|Overall Study|Withdrawal by Subject|1|||
150067765|NCT01925274|541390376|FG001|Overall Study|Withdrawal by Subject|2|||
150067766|NCT01925274|541390377|FG002|Overall Study|Withdrawal by Subject|0|||
150067767|NCT01925274|541390375|FG000|Overall Study|Study terminated by sponsor|4|||
150067768|NCT01925274|541390376|FG001|Overall Study|Study terminated by sponsor|0|||
150067769|NCT01925274|541390377|FG002|Overall Study|Study terminated by sponsor|0|||
150067770|NCT01925274|541390375|FG000|Overall Study|Protocol amendment|1|||
150067771|NCT01925274|541390376|FG001|Overall Study|Protocol amendment|3|||
150067772|NCT01925274|541390377|FG002|Overall Study|Protocol amendment|6|||
150067773|NCT04327674|541390379|FG000|Overall Study|Protocol Violation|19|||
150067774|NCT00723398|541390380|FG000|Overall Study|Withdrawal by Subject|2|||
150067775|NCT00723398|541390381|FG001|Overall Study|Withdrawal by Subject|6|||
150067776|NCT00723398|541390382|FG002|Overall Study|Withdrawal by Subject|4|||
150067777|NCT00723398|541390383|FG003|Overall Study|Withdrawal by Subject|4|||
150067778|NCT00723398|541390384|FG004|Overall Study|Withdrawal by Subject|4|||
150067779|NCT00723398|541390380|FG000|Overall Study|Protocol Violation|2|||
150067780|NCT00723398|541390381|FG001|Overall Study|Protocol Violation|1|||
150067781|NCT00723398|541390382|FG002|Overall Study|Protocol Violation|5|||
150067782|NCT00723398|541390383|FG003|Overall Study|Protocol Violation|0|||
150067783|NCT00723398|541390384|FG004|Overall Study|Protocol Violation|0|||
150067784|NCT00723398|541390380|FG000|Overall Study|Physician Decision|2|||
150067785|NCT00723398|541390381|FG001|Overall Study|Physician Decision|2|||
150067786|NCT00723398|541390382|FG002|Overall Study|Physician Decision|5|||
150067787|NCT00723398|541390383|FG003|Overall Study|Physician Decision|0|||
150067788|NCT00723398|541390384|FG004|Overall Study|Physician Decision|1|||
150067789|NCT00723398|541390380|FG000|Overall Study|Adverse Event|0|||
150067790|NCT00723398|541390381|FG001|Overall Study|Adverse Event|5|||
150067791|NCT00723398|541390382|FG002|Overall Study|Adverse Event|3|||
150182025|NCT03398148|541804601|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067792|NCT00723398|541390383|FG003|Overall Study|Adverse Event|1|||
150067793|NCT00723398|541390384|FG004|Overall Study|Adverse Event|4|||
150067794|NCT00723398|541390380|FG000|Overall Study|Lost to Follow-up|0|||
150067795|NCT00723398|541390381|FG001|Overall Study|Lost to Follow-up|1|||
150067796|NCT00723398|541390382|FG002|Overall Study|Lost to Follow-up|0|||
150067797|NCT00723398|541390383|FG003|Overall Study|Lost to Follow-up|0|||
150067798|NCT00723398|541390384|FG004|Overall Study|Lost to Follow-up|0|||
150067799|NCT01225887|541390390|FG000|Overall Study|Ineligible:required test not done|2|||
150067800|NCT01225887|541390390|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
150067801|NCT01225887|541390390|FG000|Overall Study|Ineligible:inadequate pathology|2|||
150067802|NCT00566501|541390391|FG000|Overall Study|Adverse Event|68|||
150067803|NCT00566501|541390392|FG001|Overall Study|Adverse Event|59|||
150067804|NCT00566501|541390391|FG000|Overall Study|Medication Non-compliance|5|||
150067805|NCT00566501|541390392|FG001|Overall Study|Medication Non-compliance|0|||
150067806|NCT00566501|541390391|FG000|Overall Study|Protocol Violation|2|||
150067807|NCT00566501|541390392|FG001|Overall Study|Protocol Violation|2|||
150067808|NCT00566501|541390391|FG000|Overall Study|Request of Investigator or Sponsor|6|||
150067809|NCT00566501|541390392|FG001|Overall Study|Request of Investigator or Sponsor|7|||
150067810|NCT00566501|541390391|FG000|Overall Study|Withdrawal by Subject|33|||
150067811|NCT00566501|541390392|FG001|Overall Study|Withdrawal by Subject|30|||
150067812|NCT00566501|541390391|FG000|Overall Study|Lack of Efficacy|8|||
150067813|NCT00566501|541390392|FG001|Overall Study|Lack of Efficacy|3|||
150067814|NCT00566501|541390391|FG000|Overall Study|Other|25|||
150067815|NCT00566501|541390392|FG001|Overall Study|Other|21|||
150067816|NCT01400815|541390404|FG000|Overall Study|Adverse Event|3|||
150067817|NCT01400815|541390405|FG001|Overall Study|Adverse Event|0|||
150067818|NCT01400815|541390404|FG000|Overall Study|Death|0|||
150067819|NCT01400815|541390405|FG001|Overall Study|Death|1|||
150067820|NCT01400815|541390404|FG000|Overall Study|Lost to Follow-up|18|||
150067821|NCT01400815|541390405|FG001|Overall Study|Lost to Follow-up|11|||
150067822|NCT01400815|541390404|FG000|Overall Study|Protocol Violation|0|||
150067823|NCT01400815|541390405|FG001|Overall Study|Protocol Violation|1|||
150067824|NCT01400815|541390404|FG000|Overall Study|Physician Decision|1|||
150067825|NCT01400815|541390405|FG001|Overall Study|Physician Decision|0|||
150067826|NCT01400815|541390404|FG000|Overall Study|Withdrawal by Subject|15|||
150067827|NCT01400815|541390405|FG001|Overall Study|Withdrawal by Subject|8|||
150067828|NCT01400815|541390404|FG000|Overall Study|Subject in jail|1|||
150067829|NCT01400815|541390405|FG001|Overall Study|Subject in jail|0|||
150067830|NCT01123850|541390406|FG000|Overall Study|Slow enrollment|45|||
150067831|NCT02456103|541390408|FG000|Overall Study|Study Closure|207|||
150067832|NCT02456103|541390408|FG000|Overall Study|Physician Decision|1|||
150067833|NCT02456103|541390408|FG000|Overall Study|Required prohibited medications|5|||
150067834|NCT02456103|541390408|FG000|Overall Study|Protocol Violation|1|||
150067835|NCT02456103|541390408|FG000|Overall Study|Adverse Event|5|||
150067836|NCT02456103|541390408|FG000|Overall Study|Abnormal Laboratory Value|2|||
150067837|NCT02456103|541390408|FG000|Overall Study|Lost to Follow-up|1|||
150067838|NCT02456103|541390408|FG000|Overall Study|Withdrawal by Subject|24|||
150067839|NCT02448810|541390409|FG000|Overall Study|Adverse Event|0|||
150067840|NCT02448810|541390410|FG001|Overall Study|Adverse Event|0|||
150067841|NCT02448810|541390411|FG002|Overall Study|Adverse Event|1|||
150067842|NCT02448810|541390412|FG003|Overall Study|Adverse Event|0|||
150067843|NCT02448810|541390413|FG004|Overall Study|Adverse Event|0|||
150067844|NCT02448810|541390414|FG005|Overall Study|Adverse Event|0|||
150067845|NCT02448810|541390415|FG006|Overall Study|Adverse Event|0|||
150067846|NCT02448810|541390416|FG007|Overall Study|Adverse Event|0|||
150067847|NCT02448810|541390409|FG000|Overall Study|Withdrawal by Subject|0|||
150067848|NCT02448810|541390410|FG001|Overall Study|Withdrawal by Subject|0|||
150067849|NCT02448810|541390411|FG002|Overall Study|Withdrawal by Subject|1|||
150067850|NCT02448810|541390412|FG003|Overall Study|Withdrawal by Subject|0|||
150067851|NCT02448810|541390413|FG004|Overall Study|Withdrawal by Subject|3|||
150067852|NCT02448810|541390414|FG005|Overall Study|Withdrawal by Subject|5|||
150067853|NCT02448810|541390415|FG006|Overall Study|Withdrawal by Subject|0|||
150182026|NCT03398148|541804602|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067854|NCT02448810|541390416|FG007|Overall Study|Withdrawal by Subject|2|||
150067855|NCT02448810|541390409|FG000|Overall Study|Other (study terminated by sponsor)|0|||
150067856|NCT02448810|541390410|FG001|Overall Study|Other (study terminated by sponsor)|0|||
150067857|NCT02448810|541390411|FG002|Overall Study|Other (study terminated by sponsor)|0|||
150067858|NCT02448810|541390412|FG003|Overall Study|Other (study terminated by sponsor)|0|||
150067859|NCT02448810|541390413|FG004|Overall Study|Other (study terminated by sponsor)|4|||
150067860|NCT02448810|541390414|FG005|Overall Study|Other (study terminated by sponsor)|2|||
150067861|NCT02448810|541390415|FG006|Overall Study|Other (study terminated by sponsor)|2|||
150067862|NCT02448810|541390416|FG007|Overall Study|Other (study terminated by sponsor)|1|||
150067863|NCT02448810|541390409|FG000|Overall Study|Death|1|||
150067864|NCT02448810|541390410|FG001|Overall Study|Death|0|||
150067865|NCT02448810|541390411|FG002|Overall Study|Death|1|||
150067866|NCT02448810|541390412|FG003|Overall Study|Death|0|||
150182027|NCT03398148|541804603|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150067867|NCT02448810|541390413|FG004|Overall Study|Death|1|||
150067868|NCT02448810|541390414|FG005|Overall Study|Death|0|||
150067869|NCT02448810|541390415|FG006|Overall Study|Death|0|||
150067870|NCT02448810|541390416|FG007|Overall Study|Death|0|||
150067871|NCT02448810|541390409|FG000|Overall Study|Other (Progressive disease)|2|||
150067872|NCT02448810|541390410|FG001|Overall Study|Other (Progressive disease)|2|||
150067873|NCT02448810|541390411|FG002|Overall Study|Other (Progressive disease)|0|||
150067874|NCT02448810|541390412|FG003|Overall Study|Other (Progressive disease)|3|||
150067875|NCT02448810|541390413|FG004|Overall Study|Other (Progressive disease)|23|||
150067876|NCT02448810|541390414|FG005|Overall Study|Other (Progressive disease)|9|||
150067877|NCT02448810|541390415|FG006|Overall Study|Other (Progressive disease)|14|||
150067878|NCT02448810|541390416|FG007|Overall Study|Other (Progressive disease)|5|||
150067879|NCT02448810|541390409|FG000|Overall Study|Lost to Follow-up|0|||
150067880|NCT02448810|541390410|FG001|Overall Study|Lost to Follow-up|1|||
150067881|NCT02448810|541390411|FG002|Overall Study|Lost to Follow-up|0|||
150067882|NCT02448810|541390412|FG003|Overall Study|Lost to Follow-up|0|||
150067883|NCT02448810|541390413|FG004|Overall Study|Lost to Follow-up|0|||
150067884|NCT02448810|541390414|FG005|Overall Study|Lost to Follow-up|0|||
150067885|NCT02448810|541390415|FG006|Overall Study|Lost to Follow-up|0|||
150067886|NCT02448810|541390416|FG007|Overall Study|Lost to Follow-up|0|||
150067887|NCT02448810|541390409|FG000|Overall Study|Other (unspecified)|0|||
150067888|NCT02448810|541390410|FG001|Overall Study|Other (unspecified)|0|||
150067889|NCT02448810|541390411|FG002|Overall Study|Other (unspecified)|0|||
150067890|NCT02448810|541390412|FG003|Overall Study|Other (unspecified)|0|||
150067891|NCT02448810|541390413|FG004|Overall Study|Other (unspecified)|0|||
150067892|NCT02448810|541390414|FG005|Overall Study|Other (unspecified)|0|||
150067893|NCT02448810|541390415|FG006|Overall Study|Other (unspecified)|2|||
150067894|NCT02448810|541390416|FG007|Overall Study|Other (unspecified)|0|||
150067895|NCT00470847|541390419|FG000|Overall Study|Pt still receiving treatment|1|||
150067896|NCT00568685|541390424|FG000|Overall Study|Adverse Event|2|||
150067897|NCT00568685|541390425|FG001|Overall Study|Adverse Event|3|||
150067898|NCT00568685|541390426|FG002|Overall Study|Adverse Event|3|||
150067899|NCT00568685|541390424|FG000|Overall Study|Withdrawal by Subject|7|||
150067900|NCT00568685|541390425|FG001|Overall Study|Withdrawal by Subject|2|||
150067901|NCT00568685|541390426|FG002|Overall Study|Withdrawal by Subject|2|||
150067902|NCT00568685|541390424|FG000|Overall Study|Protocol Violation|1|||
150067903|NCT00568685|541390425|FG001|Overall Study|Protocol Violation|0|||
150067904|NCT00568685|541390426|FG002|Overall Study|Protocol Violation|0|||
150067905|NCT00467610|541390430|FG000|Overall Study|Withdrawal by Subject|1|||
150067906|NCT02001181|541390433|FG000|Overall Study|Adverse Event|0|||
150067907|NCT02001181|541390434|FG001|Overall Study|Adverse Event|2|||
150067908|NCT02001181|541390433|FG000|Overall Study|Lost to Follow-up|1|||
150067909|NCT02001181|541390434|FG001|Overall Study|Lost to Follow-up|0|||
150067910|NCT02001181|541390433|FG000|Overall Study|Withdrawal by Subject|0|||
150067911|NCT02001181|541390434|FG001|Overall Study|Withdrawal by Subject|1|||
150067912|NCT03643159|541390442|FG000|Overall Study|Adverse Event|1|||
150067913|NCT03643159|541390442|FG000|Overall Study|Withdrawal by Subject|1|||
150067914|NCT03438383|541390443|FG000|Overall Study|Protocol Violation|9|||
150067915|NCT03438383|541390444|FG001|Overall Study|Protocol Violation|3|||
150067916|NCT01528033|541390445|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
150067917|NCT01528033|541390446|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
150067918|NCT01528033|541390445|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
150067919|NCT01528033|541390446|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
150067920|NCT01528033|541390445|FG000|Primary Endpoint Assessment ITT|Death|2|||
150067921|NCT01528033|541390446|FG001|Primary Endpoint Assessment ITT|Death|2|||
150067922|NCT01528033|541390445|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
150067923|NCT01528033|541390446|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
150067924|NCT01528033|541390445|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
150067925|NCT01528033|541390446|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
150067926|NCT01528033|541390445|FG000|Follow Up|No data available|46|||
150067927|NCT01528033|541390446|FG001|Follow Up|No data available|44|||
150067928|NCT02898116|541390455|FG000|Overall Study|Adverse Event|1|||
150067929|NCT02898116|541390455|FG000|Overall Study|Progressive disease|1|||
150067930|NCT03635788|541390456|FG000|Step 1|Death|1|||
150067931|NCT03635788|541390457|FG001|Step 1|Death|0|||
150067932|NCT03635788|541390458|FG002|Step 1|Death|0|||
150067933|NCT03635788|541390456|FG000|Step 1|Lost to Follow-up|31|||
150067934|NCT03635788|541390457|FG001|Step 1|Lost to Follow-up|0|||
150067935|NCT03635788|541390458|FG002|Step 1|Lost to Follow-up|0|||
150067936|NCT03635788|541390456|FG000|Step 1|Pregnancy|1|||
150067937|NCT03635788|541390457|FG001|Step 1|Pregnancy|0|||
150067938|NCT03635788|541390458|FG002|Step 1|Pregnancy|0|||
150067939|NCT03635788|541390456|FG000|Step 1|Protocol Violation|8|||
150067940|NCT03635788|541390457|FG001|Step 1|Protocol Violation|0|||
150067941|NCT03635788|541390458|FG002|Step 1|Protocol Violation|0|||
150067942|NCT03635788|541390456|FG000|Step 1|Withdrawal by Subject|13|||
150067943|NCT03635788|541390457|FG001|Step 1|Withdrawal by Subject|0|||
150067944|NCT03635788|541390458|FG002|Step 1|Withdrawal by Subject|0|||
150067945|NCT03635788|541390456|FG000|Step 1|Other reasons|12|||
150067946|NCT03635788|541390457|FG001|Step 1|Other reasons|0|||
150067947|NCT03635788|541390458|FG002|Step 1|Other reasons|0|||
150067948|NCT03635788|541390456|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
150067949|NCT03635788|541390457|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
150067950|NCT03635788|541390458|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
150067951|NCT03635788|541390456|FG000|Step 2|Lost to Follow-up|0|||
150067952|NCT03635788|541390457|FG001|Step 2|Lost to Follow-up|8|||
150067953|NCT03635788|541390458|FG002|Step 2|Lost to Follow-up|15|||
150067954|NCT03635788|541390456|FG000|Step 2|Withdrawal by Subject|0|||
150067955|NCT03635788|541390457|FG001|Step 2|Withdrawal by Subject|6|||
150067956|NCT03635788|541390458|FG002|Step 2|Withdrawal by Subject|6|||
150067957|NCT03635788|541390456|FG000|Step 2|Death|0|||
150067958|NCT03635788|541390457|FG001|Step 2|Death|2|||
150067959|NCT03635788|541390458|FG002|Step 2|Death|0|||
150067960|NCT03635788|541390456|FG000|Step 2|Incarceration|0|||
150067961|NCT03635788|541390457|FG001|Step 2|Incarceration|2|||
150067962|NCT03635788|541390458|FG002|Step 2|Incarceration|0|||
150067963|NCT03635788|541390456|FG000|Step 2|Non-Compliance With Study Requirements|0|||
150067964|NCT03635788|541390457|FG001|Step 2|Non-Compliance With Study Requirements|1|||
150067965|NCT03635788|541390458|FG002|Step 2|Non-Compliance With Study Requirements|1|||
150067966|NCT03635788|541390456|FG000|Step 2|Confounding Medical Condition|0|||
150067967|NCT03635788|541390457|FG001|Step 2|Confounding Medical Condition|0|||
150067968|NCT03635788|541390458|FG002|Step 2|Confounding Medical Condition|1|||
150067969|NCT03635788|541390456|FG000|Step 2|Out Of State With No Plan To Return|0|||
150067970|NCT03635788|541390457|FG001|Step 2|Out Of State With No Plan To Return|1|||
150067971|NCT03635788|541390458|FG002|Step 2|Out Of State With No Plan To Return|0|||
150067972|NCT03635788|541390456|FG000|Step 2|Switched To Injectables|0|||
150067973|NCT03635788|541390457|FG001|Step 2|Switched To Injectables|0|||
150067974|NCT03635788|541390458|FG002|Step 2|Switched To Injectables|1|||
150067975|NCT03635788|541390456|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
150067976|NCT03635788|541390457|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
150067977|NCT03635788|541390458|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
150067978|NCT05521906|541390459|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
150067979|NCT05521906|541390460|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
150067980|NCT03803683|541390461|FG000|Overall Study|Lost to Follow-up|41|||
150067981|NCT03803683|541390462|FG001|Overall Study|Lost to Follow-up|18|||
150067982|NCT03803683|541390463|FG002|Overall Study|Lost to Follow-up|12|||
150067983|NCT03803683|541390461|FG000|Overall Study|Withdrawal by Subject|9|||
150067984|NCT03803683|541390462|FG001|Overall Study|Withdrawal by Subject|1|||
150067985|NCT03803683|541390463|FG002|Overall Study|Withdrawal by Subject|4|||
150067986|NCT00492050|541390464|FG000|Overall Study|Adverse Event|1|||
150067987|NCT00492050|541390464|FG000|Overall Study|Lack of Efficacy|1|||
150067988|NCT00492050|541390464|FG000|Overall Study|Withdrawal by Subject|3|||
150067989|NCT00492050|541390464|FG000|Overall Study|Unable to collect SCT|2|||
150067990|NCT00492050|541390464|FG000|Overall Study|Progressive Disease|2|||
150067991|NCT00282412|541392272|FG000|Overall Study|Death|2|||
150067992|NCT01854658|541392273|FG000|Overall Study|Protocol Violation|6|||
150067993|NCT01854658|541392274|FG001|Overall Study|Protocol Violation|2|||
150067994|NCT01854658|541392275|FG002|Overall Study|Protocol Violation|2|||
150067995|NCT01854658|541392276|FG003|Overall Study|Protocol Violation|1|||
150067996|NCT01854658|541392273|FG000|Overall Study|Physician Decision|7|||
150067997|NCT01854658|541392274|FG001|Overall Study|Physician Decision|5|||
150067998|NCT01854658|541392275|FG002|Overall Study|Physician Decision|2|||
150067999|NCT01854658|541392276|FG003|Overall Study|Physician Decision|4|||
150068000|NCT01854658|541392273|FG000|Overall Study|Lost to Follow-up|8|||
150068001|NCT01854658|541392274|FG001|Overall Study|Lost to Follow-up|9|||
150068002|NCT01854658|541392275|FG002|Overall Study|Lost to Follow-up|8|||
150068003|NCT01854658|541392276|FG003|Overall Study|Lost to Follow-up|4|||
150068004|NCT01854658|541392273|FG000|Overall Study|Withdrawal by Subject|28|||
150068005|NCT01854658|541392274|FG001|Overall Study|Withdrawal by Subject|21|||
150068006|NCT01854658|541392275|FG002|Overall Study|Withdrawal by Subject|29|||
150068007|NCT01854658|541392276|FG003|Overall Study|Withdrawal by Subject|15|||
150068008|NCT01854658|541392273|FG000|Overall Study|Protocol-specified criteria|15|||
150068009|NCT01854658|541392274|FG001|Overall Study|Protocol-specified criteria|15|||
150068010|NCT01854658|541392275|FG002|Overall Study|Protocol-specified criteria|10|||
150068011|NCT01854658|541392276|FG003|Overall Study|Protocol-specified criteria|7|||
150068012|NCT01854658|541392273|FG000|Overall Study|Lack of Efficacy|3|||
150068013|NCT01854658|541392274|FG001|Overall Study|Lack of Efficacy|8|||
150068014|NCT01854658|541392275|FG002|Overall Study|Lack of Efficacy|4|||
150068015|NCT01854658|541392276|FG003|Overall Study|Lack of Efficacy|7|||
150068016|NCT01854658|541392273|FG000|Overall Study|Adverse Event|21|||
150068017|NCT01854658|541392274|FG001|Overall Study|Adverse Event|14|||
150068018|NCT01854658|541392275|FG002|Overall Study|Adverse Event|23|||
150068019|NCT01854658|541392276|FG003|Overall Study|Adverse Event|19|||
150068020|NCT01854658|541392273|FG000|Overall Study|Administrative reasons|5|||
150068021|NCT01854658|541392274|FG001|Overall Study|Administrative reasons|1|||
150068022|NCT01854658|541392275|FG002|Overall Study|Administrative reasons|2|||
150068023|NCT01854658|541392276|FG003|Overall Study|Administrative reasons|2|||
150068024|NCT03911713|541392277|FG000|Overall Study|Lost to Follow-up|0|||
150068025|NCT03911713|541392278|FG001|Overall Study|Lost to Follow-up|2|||
150068026|NCT03911713|541392279|FG002|Overall Study|Lost to Follow-up|0|||
150068027|NCT03911713|541392280|FG003|Overall Study|Lost to Follow-up|0|||
150068028|NCT03911713|541392281|FG004|Overall Study|Lost to Follow-up|0|||
150068029|NCT03911713|541392277|FG000|Overall Study|Other|0|||
150068030|NCT03911713|541392278|FG001|Overall Study|Other|0|||
150068031|NCT03911713|541392279|FG002|Overall Study|Other|0|||
150068032|NCT03911713|541392280|FG003|Overall Study|Other|1|||
150068033|NCT03911713|541392281|FG004|Overall Study|Other|0|||
150068034|NCT03911713|541392277|FG000|Overall Study|Randomized, Never Dosed|1|||
150068035|NCT03911713|541392278|FG001|Overall Study|Randomized, Never Dosed|0|||
150068036|NCT03911713|541392279|FG002|Overall Study|Randomized, Never Dosed|0|||
150068037|NCT03911713|541392280|FG003|Overall Study|Randomized, Never Dosed|1|||
150068038|NCT03911713|541392281|FG004|Overall Study|Randomized, Never Dosed|0|||
150068039|NCT02203071|541392284|FG000|Overall Study|Lost to Follow-up|3|||
150068040|NCT02203071|541392285|FG001|Overall Study|Lost to Follow-up|1|||
150068041|NCT01845818|541392286|FG000|Overall Study|Withdrawal by Subject|0|||
150068042|NCT01845818|541392287|FG001|Overall Study|Withdrawal by Subject|1|||
150068043|NCT01845818|541392286|FG000|Overall Study|Lost to Follow-up|7|||
150068044|NCT01845818|541392287|FG001|Overall Study|Lost to Follow-up|5|||
150068045|NCT01845818|541392286|FG000|Overall Study|Administrative Reasons|3|||
150068046|NCT01845818|541392287|FG001|Overall Study|Administrative Reasons|1|||
150068047|NCT01845818|541392286|FG000|Overall Study|Serious Adverse Event|1|||
150068048|NCT01845818|541392287|FG001|Overall Study|Serious Adverse Event|1|||
150068049|NCT01845818|541392286|FG000|Overall Study|Other|25|||
150068050|NCT01845818|541392287|FG001|Overall Study|Other|8|||
150068051|NCT01845818|541392286|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
150068052|NCT01845818|541392287|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
150068053|NCT01845818|541392286|FG000|Overall Study|No Follow-Up Data Available|4|||
150068054|NCT01845818|541392287|FG001|Overall Study|No Follow-Up Data Available|1|||
150068055|NCT00195273|541392288|FG000|Overall Study|Adverse Event|9|||
150068056|NCT00195273|541392289|FG001|Overall Study|Adverse Event|9|||
150068057|NCT00195273|541392288|FG000|Overall Study|Protocol deviation|0|||
150068058|NCT00195273|541392289|FG001|Overall Study|Protocol deviation|1|||
150068059|NCT00195273|541392288|FG000|Overall Study|Lack of Efficacy|3|||
150068060|NCT00195273|541392289|FG001|Overall Study|Lack of Efficacy|1|||
150068061|NCT00195273|541392288|FG000|Overall Study|Procedural complications|9|||
150068062|NCT00195273|541392289|FG001|Overall Study|Procedural complications|3|||
150068063|NCT01680965|541392290|FG000|Overall Study|Death|0|||
150068064|NCT01680965|541392291|FG001|Overall Study|Death|0|||
150068065|NCT01680965|541392292|FG002|Overall Study|Death|0|||
150068066|NCT01680965|541392293|FG003|Overall Study|Death|6|||
150068067|NCT02595970|541392294|FG000|Overall Study|Withdrawal by Subject|2|||
150068068|NCT02595970|541392294|FG000|Overall Study|Physician Decision|2|||
150068069|NCT02595970|541392294|FG000|Overall Study|Protocol Violation|4|||
150068070|NCT02595970|541392294|FG000|Overall Study|Adverse Event|5|||
150068071|NCT02595970|541392294|FG000|Overall Study|Lack of Efficacy|7|||
150068072|NCT01886716|541392295|FG000|Week 1|Lost to Follow-up|0|||
150068073|NCT01886716|541392296|FG001|Week 1|Lost to Follow-up|0|||
150068074|NCT01886716|541392297|FG002|Week 1|Lost to Follow-up|2|||
150068075|NCT01886716|541392298|FG003|Week 1|Lost to Follow-up|2|||
150068076|NCT01886716|541392295|FG000|Week 2|Lost to Follow-up|3|||
150068077|NCT01886716|541392296|FG001|Week 2|Lost to Follow-up|2|||
150068078|NCT01886716|541392297|FG002|Week 2|Lost to Follow-up|1|||
150068079|NCT01886716|541392298|FG003|Week 2|Lost to Follow-up|3|||
150068080|NCT01886716|541392295|FG000|Week 3|Lost to Follow-up|1|||
150068081|NCT01886716|541392296|FG001|Week 3|Lost to Follow-up|1|||
150068082|NCT01886716|541392297|FG002|Week 3|Lost to Follow-up|0|||
150068083|NCT01886716|541392298|FG003|Week 3|Lost to Follow-up|1|||
150068084|NCT02367131|541392299|FG000|Overall Study|Adverse Event|64|||
150068085|NCT02367131|541392299|FG000|Overall Study|No visit since the first visit|3|||
150068086|NCT02367131|541392299|FG000|Overall Study|Request by patient|53|||
150068087|NCT02367131|541392299|FG000|Overall Study|Improvement/remission|2|||
150068088|NCT02367131|541392299|FG000|Overall Study|No change/progressive disease|78|||
150068089|NCT02367131|541392299|FG000|Overall Study|Other than stated above|20|||
150068090|NCT02367131|541392299|FG000|Overall Study|Not treated|2|||
150068091|NCT02570074|541392300|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
150068092|NCT02570074|541392301|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
150068093|NCT05061966|541392302|FG000|Overall Study|Lost to Follow-up|13|||
150068094|NCT05061966|541392303|FG001|Overall Study|Lost to Follow-up|13|||
150068095|NCT03793556|541392304|FG000|Overall Study|Withdrawal by Subject|12|||
150068096|NCT03793556|541392305|FG001|Overall Study|Withdrawal by Subject|1|||
150068097|NCT03793556|541392304|FG000|Overall Study|Lost to Follow-up|1|||
150068098|NCT03793556|541392305|FG001|Overall Study|Lost to Follow-up|1|||
150068099|NCT04416633|541392306|FG000|Overall Study|Death|1|||
150068100|NCT04416633|541392306|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
150068101|NCT04416633|541392306|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
150068102|NCT04416633|541392306|FG000|Overall Study|Adverse Event|6|||
150068103|NCT04416633|541392306|FG000|Overall Study|Withdrawal by Subject|6|||
150068104|NCT02923427|541392307|FG000|Overall Study|convert to laparatomy|2|||
150068105|NCT02923427|541392308|FG001|Overall Study|convert to laparatomy|2|||
150068106|NCT02923427|541392307|FG000|Overall Study|destaturation|1|||
150068107|NCT02923427|541392308|FG001|Overall Study|destaturation|0|||
150068108|NCT02923427|541392307|FG000|Overall Study|can not replace LMA|1|||
150068109|NCT02923427|541392308|FG001|Overall Study|can not replace LMA|0|||
150068110|NCT01325623|541392309|FG000|Overall Study|Withdrawal by Subject|3|||
150068111|NCT00598702|541392310|FG000|Overall Study|Other|0|||
150068112|NCT00598702|541392311|FG001|Overall Study|Other|2|||
150068113|NCT00598702|541392312|FG002|Overall Study|Other|0|||
150068114|NCT00598702|541392313|FG003|Overall Study|Other|0|||
150068115|NCT00598702|541392314|FG004|Overall Study|Other|0|||
150068116|NCT00598702|541392315|FG005|Overall Study|Other|1|||
150068117|NCT00598702|541392316|FG006|Overall Study|Other|0|||
150068118|NCT00598702|541392317|FG007|Overall Study|Other|0|||
150068119|NCT00598702|541392310|FG000|Overall Study|Early discharge from hospital|0|||
150068120|NCT00598702|541392311|FG001|Overall Study|Early discharge from hospital|0|||
150068121|NCT00598702|541392312|FG002|Overall Study|Early discharge from hospital|2|||
150068122|NCT00598702|541392313|FG003|Overall Study|Early discharge from hospital|5|||
150068123|NCT00598702|541392314|FG004|Overall Study|Early discharge from hospital|0|||
150068124|NCT00598702|541392315|FG005|Overall Study|Early discharge from hospital|10|||
150068125|NCT00598702|541392316|FG006|Overall Study|Early discharge from hospital|1|||
150068126|NCT00598702|541392317|FG007|Overall Study|Early discharge from hospital|0|||
150068127|NCT00598702|541392310|FG000|Overall Study|Adverse Event|0|||
150068128|NCT00598702|541392311|FG001|Overall Study|Adverse Event|0|||
150068129|NCT00598702|541392312|FG002|Overall Study|Adverse Event|0|||
150068130|NCT00598702|541392313|FG003|Overall Study|Adverse Event|1|||
150068131|NCT00598702|541392314|FG004|Overall Study|Adverse Event|0|||
150068132|NCT00598702|541392315|FG005|Overall Study|Adverse Event|0|||
150068133|NCT00598702|541392316|FG006|Overall Study|Adverse Event|0|||
150068134|NCT00598702|541392317|FG007|Overall Study|Adverse Event|0|||
150068135|NCT00598702|541392310|FG000|Overall Study|Withdrawal by Subject|0|||
150068136|NCT00598702|541392311|FG001|Overall Study|Withdrawal by Subject|0|||
150068137|NCT00598702|541392312|FG002|Overall Study|Withdrawal by Subject|0|||
150068138|NCT00598702|541392313|FG003|Overall Study|Withdrawal by Subject|1|||
150068139|NCT00598702|541392314|FG004|Overall Study|Withdrawal by Subject|1|||
150068140|NCT00598702|541392315|FG005|Overall Study|Withdrawal by Subject|0|||
150068141|NCT00598702|541392316|FG006|Overall Study|Withdrawal by Subject|0|||
150068142|NCT00598702|541392317|FG007|Overall Study|Withdrawal by Subject|0|||
150068143|NCT00598702|541392310|FG000|Overall Study|Physician Decision|0|||
150068144|NCT00598702|541392311|FG001|Overall Study|Physician Decision|0|||
150068145|NCT00598702|541392312|FG002|Overall Study|Physician Decision|0|||
150068146|NCT00598702|541392313|FG003|Overall Study|Physician Decision|0|||
150068147|NCT00598702|541392314|FG004|Overall Study|Physician Decision|1|||
150068148|NCT00598702|541392315|FG005|Overall Study|Physician Decision|0|||
150068149|NCT00598702|541392316|FG006|Overall Study|Physician Decision|0|||
150068150|NCT00598702|541392317|FG007|Overall Study|Physician Decision|0|||
150068151|NCT00598702|541392310|FG000|Overall Study|Dose limiting toxicity|0|||
150068152|NCT00598702|541392311|FG001|Overall Study|Dose limiting toxicity|0|||
150068153|NCT00598702|541392312|FG002|Overall Study|Dose limiting toxicity|0|||
150068154|NCT00598702|541392313|FG003|Overall Study|Dose limiting toxicity|1|||
150068155|NCT00598702|541392314|FG004|Overall Study|Dose limiting toxicity|1|||
150068156|NCT00598702|541392315|FG005|Overall Study|Dose limiting toxicity|1|||
150068157|NCT00598702|541392316|FG006|Overall Study|Dose limiting toxicity|0|||
150068158|NCT00598702|541392317|FG007|Overall Study|Dose limiting toxicity|0|||
150068159|NCT02063880|541392318|FG000|Overall Study|Death|21|||
150068160|NCT02063880|541392319|FG001|Overall Study|Death|18|||
150068161|NCT02063880|541392318|FG000|Overall Study|Lost to Follow-up|7|||
150068162|NCT02063880|541392319|FG001|Overall Study|Lost to Follow-up|7|||
150068163|NCT02063880|541392318|FG000|Overall Study|Ineligible|0|||
150068164|NCT02063880|541392319|FG001|Overall Study|Ineligible|2|||
150068165|NCT00611533|541392320|FG000|First Intervention (6 Weeks)|Never started study|0|||
150068166|NCT00611533|541392321|FG001|First Intervention (6 Weeks)|Never started study|1|||
150068167|NCT00611533|541392320|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
150068168|NCT00611533|541392321|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
150068169|NCT00611533|541392320|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
150068170|NCT00611533|541392321|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
150068171|NCT01461980|541392326|FG000|Overall Study|Other|9|||
150068172|NCT01461980|541392327|FG001|Overall Study|Other|8|||
150068173|NCT01461980|541392328|FG002|Overall Study|Other|6|||
150068174|NCT01461980|541392326|FG000|Overall Study|Medication error|7|||
150068175|NCT01461980|541392327|FG001|Overall Study|Medication error|5|||
150068176|NCT01461980|541392328|FG002|Overall Study|Medication error|6|||
150068177|NCT01461980|541392326|FG000|Overall Study|Adverse Event|12|||
150068178|NCT01461980|541392327|FG001|Overall Study|Adverse Event|5|||
150068179|NCT01461980|541392328|FG002|Overall Study|Adverse Event|6|||
150068180|NCT01461980|541392326|FG000|Overall Study|Protocol Violation|12|||
150068181|NCT01461980|541392327|FG001|Overall Study|Protocol Violation|19|||
150068182|NCT01461980|541392328|FG002|Overall Study|Protocol Violation|16|||
150068183|NCT01461980|541392326|FG000|Overall Study|No longer meets eligibility criteria|18|||
150068184|NCT01461980|541392327|FG001|Overall Study|No longer meets eligibility criteria|9|||
150068185|NCT01461980|541392328|FG002|Overall Study|No longer meets eligibility criteria|19|||
150068186|NCT01461980|541392326|FG000|Overall Study|Lost to Follow-up|52|||
150068187|NCT01461980|541392327|FG001|Overall Study|Lost to Follow-up|53|||
150068188|NCT01461980|541392328|FG002|Overall Study|Lost to Follow-up|51|||
150068189|NCT01461980|541392326|FG000|Overall Study|No longer willing to participate|52|||
150068190|NCT01461980|541392327|FG001|Overall Study|No longer willing to participate|38|||
150068191|NCT01461980|541392328|FG002|Overall Study|No longer willing to participate|54|||
150068192|NCT01461980|541392326|FG000|Overall Study|Randomized but not vaccinated|4|||
150068193|NCT01461980|541392327|FG001|Overall Study|Randomized but not vaccinated|8|||
150068194|NCT01461980|541392328|FG002|Overall Study|Randomized but not vaccinated|7|||
150068195|NCT04171765|541392329|FG000|Overall Study|Adverse Event|2|||
150068196|NCT04171765|541392330|FG001|Overall Study|Adverse Event|0|||
150068197|NCT04171765|541392331|FG002|Overall Study|Adverse Event|1|||
150068198|NCT04171765|541392332|FG003|Overall Study|Adverse Event|0|||
150068199|NCT04171765|541392329|FG000|Overall Study|Lost to Follow-up|0|||
150068200|NCT04171765|541392330|FG001|Overall Study|Lost to Follow-up|2|||
150068201|NCT04171765|541392331|FG002|Overall Study|Lost to Follow-up|2|||
150068202|NCT04171765|541392332|FG003|Overall Study|Lost to Follow-up|2|||
150068203|NCT04171765|541392329|FG000|Overall Study|Week 58 visit missed|0|||
150068204|NCT04171765|541392330|FG001|Overall Study|Week 58 visit missed|0|||
150068205|NCT04171765|541392331|FG002|Overall Study|Week 58 visit missed|1|||
150068206|NCT04171765|541392332|FG003|Overall Study|Week 58 visit missed|0|||
150068207|NCT04171765|541392329|FG000|Overall Study|Study terminated by sponsor|2|||
150068208|NCT04171765|541392330|FG001|Overall Study|Study terminated by sponsor|0|||
150068209|NCT04171765|541392331|FG002|Overall Study|Study terminated by sponsor|0|||
150068210|NCT04171765|541392332|FG003|Overall Study|Study terminated by sponsor|0|||
150068211|NCT04171765|541392329|FG000|Overall Study|Withdrawal by Subject|1|||
150068212|NCT04171765|541392330|FG001|Overall Study|Withdrawal by Subject|0|||
150068213|NCT04171765|541392331|FG002|Overall Study|Withdrawal by Subject|0|||
150068214|NCT04171765|541392332|FG003|Overall Study|Withdrawal by Subject|3|||
150068215|NCT00122109|541392333|FG000|Overall Study|Did not meet criteria|6|||
150068216|NCT00122109|541392334|FG001|Overall Study|Did not meet criteria|7|||
150068217|NCT00809354|541392338|FG000|Overall Study|Adverse Event|32|||
150068218|NCT00809354|541392339|FG001|Overall Study|Adverse Event|45|||
150068219|NCT00809354|541392340|FG002|Overall Study|Adverse Event|37|||
150068220|NCT00809354|541392341|FG003|Overall Study|Adverse Event|53|||
150068221|NCT00809354|541392342|FG004|Overall Study|Adverse Event|26|||
150068222|NCT00809354|541392343|FG005|Overall Study|Adverse Event|33|||
150068223|NCT00809354|541392344|FG006|Overall Study|Adverse Event|44|||
150068224|NCT00809354|541392345|FG007|Overall Study|Adverse Event|40|||
150068225|NCT00809354|541392346|FG008|Overall Study|Adverse Event|46|||
150068226|NCT00809354|541392347|FG009|Overall Study|Adverse Event|26|||
150068227|NCT00809354|541392338|FG000|Overall Study|Lack of Efficacy|23|||
150068228|NCT00809354|541392339|FG001|Overall Study|Lack of Efficacy|23|||
150068229|NCT00809354|541392340|FG002|Overall Study|Lack of Efficacy|22|||
150068230|NCT00809354|541392341|FG003|Overall Study|Lack of Efficacy|15|||
150068231|NCT00809354|541392342|FG004|Overall Study|Lack of Efficacy|40|||
150068232|NCT00809354|541392343|FG005|Overall Study|Lack of Efficacy|19|||
150068233|NCT00809354|541392344|FG006|Overall Study|Lack of Efficacy|21|||
150068234|NCT00809354|541392345|FG007|Overall Study|Lack of Efficacy|15|||
150068235|NCT00809354|541392346|FG008|Overall Study|Lack of Efficacy|18|||
150068236|NCT00809354|541392347|FG009|Overall Study|Lack of Efficacy|38|||
150068237|NCT00809354|541392338|FG000|Overall Study|Lost to Follow-up|10|||
150068238|NCT00809354|541392339|FG001|Overall Study|Lost to Follow-up|11|||
150068239|NCT00809354|541392340|FG002|Overall Study|Lost to Follow-up|8|||
150068240|NCT00809354|541392341|FG003|Overall Study|Lost to Follow-up|13|||
150068241|NCT00809354|541392342|FG004|Overall Study|Lost to Follow-up|6|||
150068242|NCT00809354|541392343|FG005|Overall Study|Lost to Follow-up|2|||
150068243|NCT00809354|541392344|FG006|Overall Study|Lost to Follow-up|0|||
150068244|NCT00809354|541392345|FG007|Overall Study|Lost to Follow-up|5|||
150068245|NCT00809354|541392346|FG008|Overall Study|Lost to Follow-up|4|||
150068246|NCT00809354|541392347|FG009|Overall Study|Lost to Follow-up|0|||
150068247|NCT00809354|541392338|FG000|Overall Study|Protocol Violation|7|||
150182028|NCT03398148|541804604|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150068248|NCT00809354|541392339|FG001|Overall Study|Protocol Violation|14|||
150068249|NCT00809354|541392340|FG002|Overall Study|Protocol Violation|14|||
150068250|NCT00809354|541392341|FG003|Overall Study|Protocol Violation|12|||
150068251|NCT00809354|541392342|FG004|Overall Study|Protocol Violation|14|||
150068252|NCT00809354|541392343|FG005|Overall Study|Protocol Violation|6|||
150068253|NCT00809354|541392344|FG006|Overall Study|Protocol Violation|4|||
150068254|NCT00809354|541392345|FG007|Overall Study|Protocol Violation|6|||
150068255|NCT00809354|541392346|FG008|Overall Study|Protocol Violation|9|||
150068256|NCT00809354|541392347|FG009|Overall Study|Protocol Violation|3|||
150068257|NCT00809354|541392338|FG000|Overall Study|Withdrawal by Subject|32|||
150068258|NCT00809354|541392339|FG001|Overall Study|Withdrawal by Subject|27|||
150068259|NCT00809354|541392340|FG002|Overall Study|Withdrawal by Subject|31|||
150068260|NCT00809354|541392341|FG003|Overall Study|Withdrawal by Subject|33|||
150068261|NCT00809354|541392342|FG004|Overall Study|Withdrawal by Subject|34|||
150068262|NCT00809354|541392343|FG005|Overall Study|Withdrawal by Subject|29|||
150068263|NCT00809354|541392344|FG006|Overall Study|Withdrawal by Subject|27|||
150068264|NCT00809354|541392345|FG007|Overall Study|Withdrawal by Subject|19|||
150068265|NCT00809354|541392346|FG008|Overall Study|Withdrawal by Subject|18|||
150068266|NCT00809354|541392347|FG009|Overall Study|Withdrawal by Subject|20|||
150068267|NCT00809354|541392338|FG000|Overall Study|Other|10|||
150068268|NCT00809354|541392339|FG001|Overall Study|Other|2|||
150068269|NCT00809354|541392340|FG002|Overall Study|Other|7|||
150068270|NCT00809354|541392341|FG003|Overall Study|Other|10|||
150068271|NCT00809354|541392342|FG004|Overall Study|Other|5|||
150068272|NCT00809354|541392343|FG005|Overall Study|Other|3|||
150068273|NCT00809354|541392344|FG006|Overall Study|Other|2|||
150068274|NCT00809354|541392345|FG007|Overall Study|Other|3|||
150068275|NCT00809354|541392346|FG008|Overall Study|Other|4|||
150068276|NCT00809354|541392347|FG009|Overall Study|Other|3|||
150068277|NCT00809354|541392338|FG000|Overall Study|Study terminated by sponsor|138|||
150068278|NCT00809354|541392339|FG001|Overall Study|Study terminated by sponsor|134|||
150068279|NCT00809354|541392340|FG002|Overall Study|Study terminated by sponsor|129|||
150068280|NCT00809354|541392341|FG003|Overall Study|Study terminated by sponsor|120|||
150068281|NCT00809354|541392342|FG004|Overall Study|Study terminated by sponsor|126|||
150068282|NCT00809354|541392343|FG005|Overall Study|Study terminated by sponsor|133|||
150068283|NCT00809354|541392344|FG006|Overall Study|Study terminated by sponsor|124|||
150068284|NCT00809354|541392345|FG007|Overall Study|Study terminated by sponsor|148|||
150068285|NCT00809354|541392346|FG008|Overall Study|Study terminated by sponsor|127|||
150068286|NCT00809354|541392347|FG009|Overall Study|Study terminated by sponsor|135|||
150068287|NCT00809354|541392338|FG000|Overall Study|Withdrawn due to pregnancy|0|||
150068288|NCT00809354|541392339|FG001|Overall Study|Withdrawn due to pregnancy|1|||
150068289|NCT00809354|541392340|FG002|Overall Study|Withdrawn due to pregnancy|0|||
150068290|NCT00809354|541392341|FG003|Overall Study|Withdrawn due to pregnancy|0|||
150068291|NCT00809354|541392342|FG004|Overall Study|Withdrawn due to pregnancy|0|||
150068292|NCT00809354|541392343|FG005|Overall Study|Withdrawn due to pregnancy|0|||
150068293|NCT00809354|541392344|FG006|Overall Study|Withdrawn due to pregnancy|0|||
150068294|NCT00809354|541392345|FG007|Overall Study|Withdrawn due to pregnancy|0|||
150068295|NCT00809354|541392346|FG008|Overall Study|Withdrawn due to pregnancy|0|||
150068296|NCT00809354|541392347|FG009|Overall Study|Withdrawn due to pregnancy|0|||
150068297|NCT00809354|541392338|FG000|Overall Study|Randomized but not Treated|3|||
150068298|NCT00809354|541392339|FG001|Overall Study|Randomized but not Treated|1|||
150068299|NCT00809354|541392340|FG002|Overall Study|Randomized but not Treated|6|||
150068300|NCT00809354|541392341|FG003|Overall Study|Randomized but not Treated|0|||
150068301|NCT00809354|541392342|FG004|Overall Study|Randomized but not Treated|5|||
150068302|NCT00809354|541392343|FG005|Overall Study|Randomized but not Treated|0|||
150068303|NCT00809354|541392344|FG006|Overall Study|Randomized but not Treated|1|||
150068304|NCT00809354|541392345|FG007|Overall Study|Randomized but not Treated|1|||
150068305|NCT00809354|541392346|FG008|Overall Study|Randomized but not Treated|2|||
150068306|NCT00809354|541392347|FG009|Overall Study|Randomized but not Treated|1|||
150068307|NCT00809354|541392338|FG000|Overall Study|Death|0|||
150068308|NCT00809354|541392339|FG001|Overall Study|Death|0|||
150068309|NCT00809354|541392340|FG002|Overall Study|Death|0|||
150068310|NCT00809354|541392341|FG003|Overall Study|Death|0|||
150068311|NCT00809354|541392342|FG004|Overall Study|Death|0|||
150068312|NCT00809354|541392343|FG005|Overall Study|Death|0|||
150068313|NCT00809354|541392344|FG006|Overall Study|Death|0|||
150068314|NCT00809354|541392345|FG007|Overall Study|Death|1|||
150068315|NCT00809354|541392346|FG008|Overall Study|Death|0|||
150068316|NCT00809354|541392347|FG009|Overall Study|Death|0|||
150068317|NCT01439568|541392355|FG000|Overall Study|Lost to Follow-up|1|||
150068318|NCT01439568|541392356|FG001|Overall Study|Lost to Follow-up|0|||
150068319|NCT01439568|541392355|FG000|Overall Study|Withdrawal by Subject|2|||
150068320|NCT01439568|541392356|FG001|Overall Study|Withdrawal by Subject|2|||
150068321|NCT01578330|541392357|FG000|Overall Study|Adverse Event|2|||
150068322|NCT01578330|541392357|FG000|Overall Study|Protocol Violation|5|||
150068323|NCT01134731|541392358|FG000|Overall Study|Adverse Event|3|||
150068324|NCT01134731|541392359|FG001|Overall Study|Adverse Event|2|||
150068325|NCT01134731|541392360|FG002|Overall Study|Adverse Event|1|||
150068326|NCT01134731|541392358|FG000|Overall Study|Physician Decision|2|||
150068327|NCT01134731|541392359|FG001|Overall Study|Physician Decision|2|||
150068328|NCT01134731|541392360|FG002|Overall Study|Physician Decision|2|||
150182029|NCT03398148|541804605|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150068329|NCT01134731|541392358|FG000|Overall Study|Lack of Efficacy|0|||
150068330|NCT01134731|541392359|FG001|Overall Study|Lack of Efficacy|0|||
150068331|NCT01134731|541392360|FG002|Overall Study|Lack of Efficacy|1|||
150068332|NCT01134731|541392358|FG000|Overall Study|Withdrawal by Subject|3|||
150068333|NCT01134731|541392359|FG001|Overall Study|Withdrawal by Subject|3|||
150068334|NCT01134731|541392360|FG002|Overall Study|Withdrawal by Subject|1|||
150068335|NCT01134731|541392358|FG000|Overall Study|Lost to Follow-up|5|||
150068336|NCT01134731|541392359|FG001|Overall Study|Lost to Follow-up|4|||
150182030|NCT03398148|541804606|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
150182031|NCT03398148|541804607|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150182032|NCT03398148|541804608|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150182033|NCT03398148|541804609|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150182034|NCT03398148|541804610|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
150068337|NCT01134731|541392360|FG002|Overall Study|Lost to Follow-up|3|||
150068338|NCT01669928|541392361|FG000|First Intervention|Withdrawal by Subject|3|||
150068339|NCT01669928|541392362|FG001|First Intervention|Withdrawal by Subject|5|||
150068340|NCT01954342|541392365|FG000|Overall Study|Missing data from 13-16week study visit|0|||
150068341|NCT01954342|541392366|FG001|Overall Study|Missing data from 13-16week study visit|0|||
150068342|NCT01954342|541392367|FG002|Overall Study|Missing data from 13-16week study visit|0|||
150068343|NCT01954342|541392368|FG003|Overall Study|Missing data from 13-16week study visit|1|||
150068344|NCT01954342|541392365|FG000|Overall Study|Miscarriage|0|||
150068345|NCT01954342|541392366|FG001|Overall Study|Miscarriage|0|||
150068346|NCT01954342|541392367|FG002|Overall Study|Miscarriage|0|||
150068347|NCT01954342|541392368|FG003|Overall Study|Miscarriage|3|||
150068348|NCT01954342|541392365|FG000|Overall Study|Lost to Follow-up|0|||
150068349|NCT01954342|541392366|FG001|Overall Study|Lost to Follow-up|0|||
150068350|NCT01954342|541392367|FG002|Overall Study|Lost to Follow-up|0|||
150068351|NCT01954342|541392368|FG003|Overall Study|Lost to Follow-up|5|||
150068352|NCT01954342|541392365|FG000|Overall Study|Preterm delivery|0|||
150068353|NCT01954342|541392366|FG001|Overall Study|Preterm delivery|0|||
150068354|NCT01954342|541392367|FG002|Overall Study|Preterm delivery|0|||
150068355|NCT01954342|541392368|FG003|Overall Study|Preterm delivery|3|||
150068356|NCT01954342|541392365|FG000|Overall Study|Pre-eclampsia|0|||
150068357|NCT01954342|541392366|FG001|Overall Study|Pre-eclampsia|0|||
150068358|NCT01954342|541392367|FG002|Overall Study|Pre-eclampsia|0|||
150068359|NCT01954342|541392368|FG003|Overall Study|Pre-eclampsia|4|||
150068360|NCT01954342|541392365|FG000|Overall Study|Unreliable Data|0|||
150068361|NCT01954342|541392366|FG001|Overall Study|Unreliable Data|0|||
150068362|NCT01954342|541392367|FG002|Overall Study|Unreliable Data|0|||
150068363|NCT01954342|541392368|FG003|Overall Study|Unreliable Data|2|||
150068364|NCT00437320|541392370|FG000|Overall Study|Participant request|2|||
150068365|NCT00437320|541392371|FG001|Overall Study|Participant request|1|||
150068366|NCT00437320|541392372|FG002|Overall Study|Participant request|4|||
150068367|NCT01199731|541392377|FG000|Overall Study|Adverse Event|0|||
150068368|NCT01199731|541392378|FG001|Overall Study|Adverse Event|1|||
150068369|NCT01199731|541392379|FG002|Overall Study|Adverse Event|0|||
150068370|NCT01199731|541392377|FG000|Overall Study|Study closed/terminated|7|||
150068371|NCT01199731|541392378|FG001|Overall Study|Study closed/terminated|9|||
150068372|NCT01199731|541392379|FG002|Overall Study|Study closed/terminated|7|||
150068373|NCT01199731|541392377|FG000|Overall Study|Lost to Follow-up|0|||
150068374|NCT01199731|541392378|FG001|Overall Study|Lost to Follow-up|0|||
150068375|NCT01199731|541392379|FG002|Overall Study|Lost to Follow-up|2|||
150068376|NCT01199731|541392377|FG000|Overall Study|Physician Decision|0|||
150068377|NCT01199731|541392378|FG001|Overall Study|Physician Decision|1|||
150068378|NCT01199731|541392379|FG002|Overall Study|Physician Decision|1|||
150068379|NCT01199731|541392377|FG000|Overall Study|Withdrawal by Subject|2|||
150068380|NCT01199731|541392378|FG001|Overall Study|Withdrawal by Subject|0|||
150068381|NCT01199731|541392379|FG002|Overall Study|Withdrawal by Subject|0|||
150068382|NCT01638819|541392388|FG000|Overall Study|Lost to Follow-up|1|||
150068383|NCT01638819|541392389|FG001|Overall Study|Lost to Follow-up|0|||
150068384|NCT00471146|541392392|FG000|Overall Study|Adverse Event|32|||
150068385|NCT00471146|541392393|FG001|Overall Study|Adverse Event|33|||
150068386|NCT00471146|541392392|FG000|Overall Study|Withdrawal by Subject|14|||
150068387|NCT00471146|541392393|FG001|Overall Study|Withdrawal by Subject|11|||
150068388|NCT00471146|541392392|FG000|Overall Study|Death|11|||
150068389|NCT00471146|541392393|FG001|Overall Study|Death|12|||
150068390|NCT00471146|541392392|FG000|Overall Study|Lost to Follow-up|4|||
150068391|NCT00471146|541392393|FG001|Overall Study|Lost to Follow-up|2|||
150068392|NCT00471146|541392392|FG000|Overall Study|Protocol Violation|2|||
150068393|NCT00471146|541392393|FG001|Overall Study|Protocol Violation|2|||
150068394|NCT00471146|541392392|FG000|Overall Study|Objective progression or relapse|84|||
150068395|NCT00471146|541392393|FG001|Overall Study|Objective progression or relapse|87|||
150068396|NCT00471146|541392392|FG000|Overall Study|Global deterioration of health status|12|||
150068397|NCT00471146|541392393|FG001|Overall Study|Global deterioration of health status|14|||
150068398|NCT00471146|541392392|FG000|Overall Study|Randomized but not treated|9|||
150068399|NCT00471146|541392393|FG001|Overall Study|Randomized but not treated|8|||
150068400|NCT00471146|541392392|FG000|Overall Study|Other|4|||
150068401|NCT00471146|541392393|FG001|Overall Study|Other|5|||
150068402|NCT03538431|541392394|FG000|Overall Study|Physician Decision|0|||
150068403|NCT03538431|541392395|FG001|Overall Study|Physician Decision|1|||
150182035|NCT03398148|541804596|FG000|Substudy 2 Period 1|Other|0|||
150182036|NCT03398148|541804597|FG001|Substudy 2 Period 1|Other|0|||
150068404|NCT03538431|541392394|FG000|Overall Study|Withdrawal by Subject|1|||
150068405|NCT03538431|541392395|FG001|Overall Study|Withdrawal by Subject|0|||
150068406|NCT01414608|541392409|FG000|Overall Study|Ineligible|5|||
150068407|NCT01414608|541392410|FG001|Overall Study|Ineligible|2|||
150068408|NCT05156073|541392411|FG000|Overall Study|Patient canceled appointment with PCP|1|||
150068409|NCT00973349|541392412|FG000|Overall Study|Adverse Event|0|||
150068410|NCT00973349|541392413|FG001|Overall Study|Adverse Event|0|||
150068411|NCT00973349|541392414|FG002|Overall Study|Adverse Event|0|||
150068412|NCT00973349|541392415|FG003|Overall Study|Adverse Event|0|||
150068413|NCT00973349|541392416|FG004|Overall Study|Adverse Event|1|||
150068414|NCT00973349|541392417|FG005|Overall Study|Adverse Event|0|||
150068415|NCT00973349|541392418|FG006|Overall Study|Adverse Event|0|||
150068416|NCT00973349|541392419|FG007|Overall Study|Adverse Event|0|||
150068417|NCT00973349|541392420|FG008|Overall Study|Adverse Event|1|||
150068418|NCT00973349|541392421|FG009|Overall Study|Adverse Event|0|||
150068419|NCT00973349|541392422|FG010|Overall Study|Adverse Event|0|||
150068420|NCT00973349|541392423|FG011|Overall Study|Adverse Event|0|||
150068421|NCT00973349|541392424|FG012|Overall Study|Adverse Event|0|||
150068422|NCT00973349|541392425|FG013|Overall Study|Adverse Event|0|||
150068423|NCT00973349|541392426|FG014|Overall Study|Adverse Event|1|||
150068424|NCT00973349|541392427|FG015|Overall Study|Adverse Event|0|||
150068425|NCT00973349|541392412|FG000|Overall Study|Withdrawal by Subject|1|||
150068426|NCT00973349|541392413|FG001|Overall Study|Withdrawal by Subject|2|||
150068427|NCT00973349|541392414|FG002|Overall Study|Withdrawal by Subject|2|||
150068428|NCT00973349|541392415|FG003|Overall Study|Withdrawal by Subject|3|||
150068429|NCT00973349|541392416|FG004|Overall Study|Withdrawal by Subject|2|||
150068430|NCT00973349|541392417|FG005|Overall Study|Withdrawal by Subject|0|||
150068431|NCT00973349|541392418|FG006|Overall Study|Withdrawal by Subject|2|||
150068432|NCT00973349|541392419|FG007|Overall Study|Withdrawal by Subject|2|||
150068433|NCT00973349|541392420|FG008|Overall Study|Withdrawal by Subject|0|||
150068434|NCT00973349|541392421|FG009|Overall Study|Withdrawal by Subject|2|||
150068435|NCT00973349|541392422|FG010|Overall Study|Withdrawal by Subject|0|||
150068436|NCT00973349|541392423|FG011|Overall Study|Withdrawal by Subject|1|||
150068437|NCT00973349|541392424|FG012|Overall Study|Withdrawal by Subject|0|||
150068438|NCT00973349|541392425|FG013|Overall Study|Withdrawal by Subject|0|||
150068439|NCT00973349|541392426|FG014|Overall Study|Withdrawal by Subject|0|||
150068440|NCT00973349|541392427|FG015|Overall Study|Withdrawal by Subject|0|||
150068441|NCT00973349|541392412|FG000|Overall Study|Lost to Follow-up|3|||
150068442|NCT00973349|541392413|FG001|Overall Study|Lost to Follow-up|1|||
150068443|NCT00973349|541392414|FG002|Overall Study|Lost to Follow-up|2|||
150068444|NCT00973349|541392415|FG003|Overall Study|Lost to Follow-up|2|||
150068445|NCT00973349|541392416|FG004|Overall Study|Lost to Follow-up|1|||
150068446|NCT00973349|541392417|FG005|Overall Study|Lost to Follow-up|3|||
150068447|NCT00973349|541392418|FG006|Overall Study|Lost to Follow-up|0|||
150068448|NCT00973349|541392419|FG007|Overall Study|Lost to Follow-up|1|||
150068449|NCT00973349|541392420|FG008|Overall Study|Lost to Follow-up|2|||
150068450|NCT00973349|541392421|FG009|Overall Study|Lost to Follow-up|1|||
150068451|NCT00973349|541392422|FG010|Overall Study|Lost to Follow-up|0|||
150068452|NCT00973349|541392423|FG011|Overall Study|Lost to Follow-up|1|||
150068453|NCT00973349|541392424|FG012|Overall Study|Lost to Follow-up|0|||
150068454|NCT00973349|541392425|FG013|Overall Study|Lost to Follow-up|0|||
150068455|NCT00973349|541392426|FG014|Overall Study|Lost to Follow-up|0|||
150068456|NCT00973349|541392427|FG015|Overall Study|Lost to Follow-up|1|||
150068457|NCT00973349|541392412|FG000|Overall Study|Inappropriate enrolment|0|||
150068458|NCT00973349|541392413|FG001|Overall Study|Inappropriate enrolment|0|||
150068459|NCT00973349|541392414|FG002|Overall Study|Inappropriate enrolment|1|||
150068460|NCT00973349|541392415|FG003|Overall Study|Inappropriate enrolment|0|||
150068461|NCT00973349|541392416|FG004|Overall Study|Inappropriate enrolment|0|||
150068462|NCT00973349|541392417|FG005|Overall Study|Inappropriate enrolment|0|||
150068463|NCT00973349|541392418|FG006|Overall Study|Inappropriate enrolment|0|||
150068464|NCT00973349|541392419|FG007|Overall Study|Inappropriate enrolment|0|||
150068465|NCT00973349|541392420|FG008|Overall Study|Inappropriate enrolment|0|||
150068466|NCT00973349|541392421|FG009|Overall Study|Inappropriate enrolment|2|||
150068467|NCT00973349|541392422|FG010|Overall Study|Inappropriate enrolment|0|||
150068468|NCT00973349|541392423|FG011|Overall Study|Inappropriate enrolment|0|||
150068469|NCT00973349|541392424|FG012|Overall Study|Inappropriate enrolment|1|||
150068470|NCT00973349|541392425|FG013|Overall Study|Inappropriate enrolment|0|||
150068471|NCT00973349|541392426|FG014|Overall Study|Inappropriate enrolment|1|||
150068472|NCT00973349|541392427|FG015|Overall Study|Inappropriate enrolment|1|||
150068473|NCT00973349|541392412|FG000|Overall Study|Protocol Violation|0|||
150068474|NCT00973349|541392413|FG001|Overall Study|Protocol Violation|0|||
150068475|NCT00973349|541392414|FG002|Overall Study|Protocol Violation|0|||
150068476|NCT00973349|541392415|FG003|Overall Study|Protocol Violation|0|||
150068477|NCT00973349|541392416|FG004|Overall Study|Protocol Violation|0|||
150068478|NCT00973349|541392417|FG005|Overall Study|Protocol Violation|0|||
150068479|NCT00973349|541392418|FG006|Overall Study|Protocol Violation|0|||
150068480|NCT00973349|541392419|FG007|Overall Study|Protocol Violation|0|||
150068481|NCT00973349|541392420|FG008|Overall Study|Protocol Violation|1|||
150068482|NCT00973349|541392421|FG009|Overall Study|Protocol Violation|0|||
150068483|NCT00973349|541392422|FG010|Overall Study|Protocol Violation|0|||
150068484|NCT00973349|541392423|FG011|Overall Study|Protocol Violation|0|||
150068485|NCT00973349|541392424|FG012|Overall Study|Protocol Violation|0|||
150068486|NCT00973349|541392425|FG013|Overall Study|Protocol Violation|0|||
150068487|NCT00973349|541392426|FG014|Overall Study|Protocol Violation|0|||
150068488|NCT00973349|541392427|FG015|Overall Study|Protocol Violation|0|||
150068489|NCT00973349|541392412|FG000|Overall Study|Unable to classify|0|||
150068490|NCT00973349|541392413|FG001|Overall Study|Unable to classify|0|||
150068491|NCT00973349|541392414|FG002|Overall Study|Unable to classify|0|||
150068492|NCT00973349|541392415|FG003|Overall Study|Unable to classify|0|||
150068493|NCT00973349|541392416|FG004|Overall Study|Unable to classify|1|||
150068494|NCT00973349|541392417|FG005|Overall Study|Unable to classify|1|||
150068495|NCT00973349|541392418|FG006|Overall Study|Unable to classify|0|||
150068496|NCT00973349|541392419|FG007|Overall Study|Unable to classify|0|||
150068497|NCT00973349|541392420|FG008|Overall Study|Unable to classify|0|||
150068498|NCT00973349|541392421|FG009|Overall Study|Unable to classify|1|||
150068499|NCT00973349|541392422|FG010|Overall Study|Unable to classify|0|||
150068500|NCT00973349|541392423|FG011|Overall Study|Unable to classify|0|||
150068501|NCT00973349|541392424|FG012|Overall Study|Unable to classify|0|||
150068502|NCT00973349|541392425|FG013|Overall Study|Unable to classify|0|||
150068503|NCT00973349|541392426|FG014|Overall Study|Unable to classify|0|||
150068504|NCT00973349|541392427|FG015|Overall Study|Unable to classify|0|||
150068505|NCT01015131|541392428|FG000|Overall Study|Physician Decision|1|||
150068506|NCT01015131|541392428|FG000|Overall Study|Protocol Violation|1|||
150068507|NCT01015131|541392428|FG000|Overall Study|Withdrawal by Subject|2|||
150068508|NCT01015131|541392428|FG000|Overall Study|Other Protocol Specified Criteria|4|||
150068509|NCT05430022|541392429|FG000|Overall Study|Withdrawal by Subject|4|||
150068510|NCT05430022|541392430|FG001|Overall Study|Withdrawal by Subject|4|||
150068511|NCT02452697|541392431|FG000|Overall Study|Physician Decision|4|||
150068512|NCT02452697|541392432|FG001|Overall Study|Physician Decision|4|||
150068513|NCT02452697|541392433|FG002|Overall Study|Physician Decision|3|||
150068514|NCT02452697|541392434|FG003|Overall Study|Physician Decision|2|||
150068515|NCT02452697|541392431|FG000|Overall Study|Withdrawal by Subject|1|||
150068516|NCT02452697|541392432|FG001|Overall Study|Withdrawal by Subject|0|||
150068517|NCT02452697|541392433|FG002|Overall Study|Withdrawal by Subject|0|||
150068518|NCT02452697|541392434|FG003|Overall Study|Withdrawal by Subject|0|||
150068519|NCT02452697|541392431|FG000|Overall Study|still in follow-up|2|||
150068520|NCT02452697|541392432|FG001|Overall Study|still in follow-up|2|||
150068521|NCT02452697|541392433|FG002|Overall Study|still in follow-up|1|||
150068522|NCT02452697|541392434|FG003|Overall Study|still in follow-up|3|||
150068523|NCT03148275|541392435|FG000|Overall Study|Death|6|||
150068524|NCT03148275|541392435|FG000|Overall Study|Adverse Event|3|||
150068525|NCT03148275|541392435|FG000|Overall Study|Liver transplant|2|||
150068526|NCT03148275|541392435|FG000|Overall Study|Patient decision|5|||
150068527|NCT03148275|541392435|FG000|Overall Study|transition to commercial drug|1|||
150068528|NCT03148275|541392435|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
150068529|NCT05098938|541392436|FG000|Overall Study|Adverse Event|4|||
150068530|NCT05098938|541392437|FG001|Overall Study|Adverse Event|3|||
150068531|NCT05098938|541392436|FG000|Overall Study|inclusion/exclusion criteria change|11|||
150068532|NCT05098938|541392437|FG001|Overall Study|inclusion/exclusion criteria change|5|||
150068533|NCT05098938|541392436|FG000|Overall Study|lack of compliance|26|||
150182037|NCT03398148|541804598|FG002|Substudy 2 Period 1|Other|0|||
150182038|NCT03398148|541804599|FG003|Substudy 2 Period 1|Other|0|||
150182039|NCT03398148|541804600|FG004|Substudy 2 Period 1|Other|0|||
150182040|NCT03398148|541804601|FG005|Substudy 2 Period 1|Other|0|||
150068534|NCT05098938|541392437|FG001|Overall Study|lack of compliance|19|||
150068535|NCT05098938|541392436|FG000|Overall Study|Lost to Follow-up|37|||
150068536|NCT05098938|541392437|FG001|Overall Study|Lost to Follow-up|40|||
150068537|NCT05098938|541392436|FG000|Overall Study|Lost in treatment period|17|||
150068538|NCT05098938|541392437|FG001|Overall Study|Lost in treatment period|13|||
150068539|NCT05098938|541392436|FG000|Overall Study|Met an exclusion criterion|0|||
150068540|NCT05098938|541392437|FG001|Overall Study|Met an exclusion criterion|3|||
150068541|NCT05098938|541392436|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
150068542|NCT05098938|541392437|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
150068543|NCT05098938|541392436|FG000|Overall Study|Physician Decision|25|||
150182041|NCT03398148|541804602|FG006|Substudy 2 Period 1|Other|0|||
150182042|NCT03398148|541804603|FG007|Substudy 2 Period 1|Other|0|||
150068544|NCT05098938|541392437|FG001|Overall Study|Physician Decision|32|||
150068545|NCT05098938|541392436|FG000|Overall Study|Run in failure in treatment phase|1|||
150068546|NCT05098938|541392437|FG001|Overall Study|Run in failure in treatment phase|1|||
150068547|NCT05098938|541392436|FG000|Overall Study|Withdrawal by Subject|0|||
150182043|NCT03398148|541804604|FG008|Substudy 2 Period 1|Other|0|||
150182044|NCT03398148|541804605|FG009|Substudy 2 Period 1|Other|4|||
150068548|NCT05098938|541392437|FG001|Overall Study|Withdrawal by Subject|3|||
150068549|NCT05098938|541392436|FG000|Overall Study|Run-in Failure in early study|505|||
150068550|NCT05098938|541392437|FG001|Overall Study|Run-in Failure in early study|514|||
150068551|NCT05098938|541392436|FG000|Overall Study|IMP delivery missed|1|||
150068552|NCT05098938|541392437|FG001|Overall Study|IMP delivery missed|5|||
150068553|NCT05098938|541392436|FG000|Overall Study|6 months visit was missed|2|||
150068554|NCT05098938|541392437|FG001|Overall Study|6 months visit was missed|0|||
150068555|NCT05098938|541392436|FG000|Overall Study|fit for use was not completed within window|3|||
150068556|NCT05098938|541392437|FG001|Overall Study|fit for use was not completed within window|0|||
150068557|NCT05098938|541392436|FG000|Overall Study|V2 visit was not completed within window|0|||
150068558|NCT05098938|541392437|FG001|Overall Study|V2 visit was not completed within window|1|||
150068559|NCT05098938|541392436|FG000|Overall Study|exclusionary medication use|1|||
150068560|NCT05098938|541392437|FG001|Overall Study|exclusionary medication use|2|||
150068561|NCT05098938|541392436|FG000|Overall Study|change in medication|1|||
150068562|NCT05098938|541392437|FG001|Overall Study|change in medication|0|||
150068563|NCT05098938|541392436|FG000|Overall Study|treatment failure|2|||
150068564|NCT05098938|541392437|FG001|Overall Study|treatment failure|1|||
150068565|NCT00866788|541394053|FG000|Overall Study|Adverse Event|0|||
150068566|NCT00866788|541394054|FG001|Overall Study|Adverse Event|2|||
150068567|NCT00866788|541394055|FG002|Overall Study|Adverse Event|0|||
150068568|NCT00866788|541394056|FG003|Overall Study|Adverse Event|1|||
150068569|NCT00866788|541394053|FG000|Overall Study|Lost to Follow-up|1|||
150068570|NCT00866788|541394054|FG001|Overall Study|Lost to Follow-up|1|||
150068571|NCT00866788|541394055|FG002|Overall Study|Lost to Follow-up|0|||
150068572|NCT00866788|541394056|FG003|Overall Study|Lost to Follow-up|2|||
150068573|NCT00866788|541394053|FG000|Overall Study|Withdrawal by Subject|2|||
150068574|NCT00866788|541394054|FG001|Overall Study|Withdrawal by Subject|1|||
150068575|NCT00866788|541394055|FG002|Overall Study|Withdrawal by Subject|0|||
150068576|NCT00866788|541394056|FG003|Overall Study|Withdrawal by Subject|1|||
150068577|NCT00866788|541394053|FG000|Overall Study|Pregnancy|0|||
150068578|NCT00866788|541394054|FG001|Overall Study|Pregnancy|1|||
150068579|NCT00866788|541394055|FG002|Overall Study|Pregnancy|0|||
150068580|NCT00866788|541394056|FG003|Overall Study|Pregnancy|0|||
150068581|NCT00866788|541394053|FG000|Overall Study|Disease progression|3|||
150068582|NCT00866788|541394054|FG001|Overall Study|Disease progression|1|||
150068583|NCT00866788|541394055|FG002|Overall Study|Disease progression|1|||
150068584|NCT00866788|541394056|FG003|Overall Study|Disease progression|0|||
150068585|NCT00866788|541394053|FG000|Overall Study|Physician Decision|0|||
150068586|NCT00866788|541394054|FG001|Overall Study|Physician Decision|0|||
150068587|NCT00866788|541394055|FG002|Overall Study|Physician Decision|1|||
150068588|NCT00866788|541394056|FG003|Overall Study|Physician Decision|1|||
150068589|NCT02339285|541394057|FG000|Overall Study|Withdrawal by Subject|0|||
150068590|NCT02339285|541394058|FG001|Overall Study|Withdrawal by Subject|1|||
150068591|NCT02339285|541394059|FG002|Overall Study|Withdrawal by Subject|1|||
150068592|NCT02339285|541394057|FG000|Overall Study|Lost to Follow-up|1|||
150068593|NCT02339285|541394058|FG001|Overall Study|Lost to Follow-up|1|||
150068594|NCT02339285|541394059|FG002|Overall Study|Lost to Follow-up|1|||
150068595|NCT02339285|541394057|FG000|Overall Study|Protocol Deviation|0|||
150068596|NCT02339285|541394058|FG001|Overall Study|Protocol Deviation|1|||
150068597|NCT02339285|541394059|FG002|Overall Study|Protocol Deviation|0|||
150068598|NCT00537238|541394062|FG000|Overall Study|Death|1|||
150068599|NCT00537238|541394063|FG001|Overall Study|Death|2|||
150068600|NCT00537238|541394062|FG000|Overall Study|Adverse Event|31|||
150068601|NCT00537238|541394063|FG001|Overall Study|Adverse Event|22|||
150068602|NCT00537238|541394062|FG000|Overall Study|Lack of Efficacy|20|||
150068603|NCT00537238|541394063|FG001|Overall Study|Lack of Efficacy|21|||
150068604|NCT00537238|541394062|FG000|Overall Study|Lost to Follow-up|12|||
150068605|NCT00537238|541394063|FG001|Overall Study|Lost to Follow-up|8|||
150068606|NCT00537238|541394062|FG000|Overall Study|Withdrawal by Subject|51|||
150068607|NCT00537238|541394063|FG001|Overall Study|Withdrawal by Subject|47|||
150068608|NCT00537238|541394062|FG000|Overall Study|Protocol Violation|15|||
150068609|NCT00537238|541394063|FG001|Overall Study|Protocol Violation|19|||
150068610|NCT00537238|541394062|FG000|Overall Study|Does not meet entrance criteria|0|||
150068611|NCT00537238|541394063|FG001|Overall Study|Does not meet entrance criteria|2|||
150068612|NCT00537238|541394062|FG000|Overall Study|Other|44|||
150068613|NCT00537238|541394063|FG001|Overall Study|Other|52|||
150068614|NCT01193660|541394066|FG000|Overall Study|Withdrawal by Subject|2|||
150068615|NCT01193660|541394067|FG001|Overall Study|Withdrawal by Subject|3|||
150068616|NCT01193660|541394068|FG002|Overall Study|Withdrawal by Subject|1|||
150068617|NCT01193660|541394066|FG000|Overall Study|Death|1|||
150068618|NCT01193660|541394067|FG001|Overall Study|Death|0|||
150068619|NCT01193660|541394068|FG002|Overall Study|Death|0|||
150068620|NCT01193660|541394066|FG000|Overall Study|Physician Decision|1|||
150068621|NCT01193660|541394067|FG001|Overall Study|Physician Decision|0|||
150068622|NCT01193660|541394068|FG002|Overall Study|Physician Decision|1|||
150068623|NCT02436304|541394070|FG000|Overall Study|Lost to Follow-up|0|||
150068624|NCT02436304|541394071|FG001|Overall Study|Lost to Follow-up|1|||
150068625|NCT02436304|541394072|FG002|Overall Study|Lost to Follow-up|0|||
150068626|NCT02436304|541394070|FG000|Overall Study|Withdrawal by Subject|0|||
150068627|NCT02436304|541394071|FG001|Overall Study|Withdrawal by Subject|1|||
150068628|NCT02436304|541394072|FG002|Overall Study|Withdrawal by Subject|0|||
150068629|NCT02436304|541394070|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
150068630|NCT02436304|541394071|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
150068631|NCT02436304|541394072|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
150068632|NCT00785928|541394075|FG000|Treatment Phase|Adverse Event|1|||
150068633|NCT00785928|541394076|FG001|Treatment Phase|Adverse Event|1|||
150068634|NCT00785928|541394077|FG002|Treatment Phase|Adverse Event|2|||
150068635|NCT00785928|541394078|FG003|Treatment Phase|Adverse Event|0|||
150068636|NCT00785928|541394079|FG004|Treatment Phase|Adverse Event|0|||
150068637|NCT00785928|541394080|FG005|Treatment Phase|Adverse Event|0|||
150068638|NCT00785928|541394081|FG006|Treatment Phase|Adverse Event|2|||
150068639|NCT00785928|541394075|FG000|Treatment Phase|Inadequate Response|0|||
150068640|NCT00785928|541394076|FG001|Treatment Phase|Inadequate Response|1|||
150068641|NCT00785928|541394077|FG002|Treatment Phase|Inadequate Response|0|||
150068642|NCT00785928|541394078|FG003|Treatment Phase|Inadequate Response|0|||
150068643|NCT00785928|541394079|FG004|Treatment Phase|Inadequate Response|0|||
150068644|NCT00785928|541394080|FG005|Treatment Phase|Inadequate Response|0|||
150068645|NCT00785928|541394081|FG006|Treatment Phase|Inadequate Response|0|||
150068646|NCT00785928|541394075|FG000|Treatment Phase|Lack of Efficacy|0|||
150068647|NCT00785928|541394076|FG001|Treatment Phase|Lack of Efficacy|1|||
150068648|NCT00785928|541394077|FG002|Treatment Phase|Lack of Efficacy|1|||
150068649|NCT00785928|541394078|FG003|Treatment Phase|Lack of Efficacy|0|||
150068650|NCT00785928|541394079|FG004|Treatment Phase|Lack of Efficacy|0|||
150068651|NCT00785928|541394080|FG005|Treatment Phase|Lack of Efficacy|0|||
150068652|NCT00785928|541394081|FG006|Treatment Phase|Lack of Efficacy|0|||
150068653|NCT00785928|541394075|FG000|Treatment Phase|Physician Decision|0|||
150068654|NCT00785928|541394076|FG001|Treatment Phase|Physician Decision|0|||
150068655|NCT00785928|541394077|FG002|Treatment Phase|Physician Decision|0|||
150068656|NCT00785928|541394078|FG003|Treatment Phase|Physician Decision|0|||
150068657|NCT00785928|541394079|FG004|Treatment Phase|Physician Decision|1|||
150068658|NCT00785928|541394080|FG005|Treatment Phase|Physician Decision|0|||
150068659|NCT00785928|541394081|FG006|Treatment Phase|Physician Decision|0|||
150068660|NCT00785928|541394075|FG000|Treatment Phase|Sponsor Decision|1|||
150068661|NCT00785928|541394076|FG001|Treatment Phase|Sponsor Decision|0|||
150068662|NCT00785928|541394077|FG002|Treatment Phase|Sponsor Decision|0|||
150068663|NCT00785928|541394078|FG003|Treatment Phase|Sponsor Decision|0|||
150068664|NCT00785928|541394079|FG004|Treatment Phase|Sponsor Decision|0|||
150068665|NCT00785928|541394080|FG005|Treatment Phase|Sponsor Decision|0|||
150068666|NCT00785928|541394081|FG006|Treatment Phase|Sponsor Decision|1|||
150068667|NCT00785928|541394075|FG000|Treatment Phase|Withdrawal by Subject|1|||
150068668|NCT00785928|541394076|FG001|Treatment Phase|Withdrawal by Subject|2|||
150068669|NCT00785928|541394077|FG002|Treatment Phase|Withdrawal by Subject|0|||
150068670|NCT00785928|541394078|FG003|Treatment Phase|Withdrawal by Subject|0|||
150068671|NCT00785928|541394079|FG004|Treatment Phase|Withdrawal by Subject|1|||
150068672|NCT00785928|541394080|FG005|Treatment Phase|Withdrawal by Subject|0|||
150068673|NCT00785928|541394081|FG006|Treatment Phase|Withdrawal by Subject|0|||
150068674|NCT01675427|541394084|FG000|Overall Study|Withdrawal by Subject|7|||
150068675|NCT01675427|541394084|FG000|Overall Study|Participant Refused Sample Collection|18|||
150068676|NCT01675427|541394084|FG000|Overall Study|Sample not Collected by Mistake|2|||
150068677|NCT01675427|541394084|FG000|Overall Study|Lost to Follow-up|5|||
150068678|NCT01675427|541394084|FG000|Overall Study|Other|2|||
150068679|NCT02556203|541394085|FG000|Overall Study|Withdrawal by Subject|21|||
150068680|NCT02556203|541394086|FG001|Overall Study|Withdrawal by Subject|21|||
150068681|NCT02556203|541394085|FG000|Overall Study|Lost to Follow-up|5|||
150068682|NCT02556203|541394086|FG001|Overall Study|Lost to Follow-up|5|||
150068683|NCT02556203|541394085|FG000|Overall Study|Adverse Event|1|||
150068684|NCT02556203|541394086|FG001|Overall Study|Adverse Event|0|||
150068685|NCT05021081|541394089|FG000|Phase 2|Subject enrolled in error|1|||
150068686|NCT05021081|541394090|FG001|Phase 2|Subject enrolled in error|1|||
150068687|NCT05021081|541394091|FG002|Phase 2|Subject enrolled in error|0|||
150068688|NCT00100178|541394094|FG000|Overall Study|Lost to Follow-up|0|||
150182045|NCT03398148|541804606|FG010|Substudy 2 Period 1|Other|4|||
150068689|NCT00100178|541394095|FG001|Overall Study|Lost to Follow-up|6|||
150068690|NCT00100178|541394096|FG002|Overall Study|Lost to Follow-up|5|||
150068691|NCT00100178|541394094|FG000|Overall Study|Adverse Event|2|||
150182046|NCT03398148|541804607|FG011|Substudy 2 Period 1|Other|0|||
150068692|NCT00100178|541394095|FG001|Overall Study|Adverse Event|2|||
150068693|NCT00100178|541394096|FG002|Overall Study|Adverse Event|1|||
150068694|NCT00100178|541394094|FG000|Overall Study|Withdrawal by Subject|1|||
150068695|NCT00100178|541394095|FG001|Overall Study|Withdrawal by Subject|1|||
150068696|NCT00100178|541394096|FG002|Overall Study|Withdrawal by Subject|1|||
150068697|NCT00100178|541394094|FG000|Overall Study|Physician Decision|6|||
150068698|NCT00100178|541394095|FG001|Overall Study|Physician Decision|1|||
150182047|NCT03398148|541804608|FG012|Substudy 2 Period 1|Other|0|||
150068699|NCT00100178|541394096|FG002|Overall Study|Physician Decision|3|||
150068700|NCT02477839|541394097|FG000|Overall Study|Adverse Event|0|||
150068701|NCT02477839|541394098|FG001|Overall Study|Adverse Event|1|||
150068702|NCT02477839|541394097|FG000|Overall Study|Protocol Violation|0|||
150068703|NCT02477839|541394098|FG001|Overall Study|Protocol Violation|2|||
150068704|NCT02477839|541394097|FG000|Overall Study|Withdrawal by Subject|3|||
150068705|NCT02477839|541394098|FG001|Overall Study|Withdrawal by Subject|3|||
150068706|NCT02477839|541394097|FG000|Overall Study|Participant had PGS during V6|0|||
150068707|NCT02477839|541394098|FG001|Overall Study|Participant had PGS during V6|1|||
150068708|NCT02477839|541394097|FG000|Overall Study|Parents decided to stop medication|0|||
150068709|NCT02477839|541394098|FG001|Overall Study|Parents decided to stop medication|1|||
150068710|NCT02477839|541394097|FG000|Overall Study|Lack of tolerability|0|||
150068711|NCT02477839|541394098|FG001|Overall Study|Lack of tolerability|1|||
150068712|NCT02477839|541394097|FG000|Overall Study|Exclusion criterion|0|||
150068713|NCT02477839|541394098|FG001|Overall Study|Exclusion criterion|1|||
150068714|NCT00631696|541394101|FG000|Overall Study|Entered, not randomized to treatment|1|||
150068715|NCT00631696|541394102|FG001|Overall Study|Entered, not randomized to treatment|1|||
150068716|NCT00631696|541394101|FG000|Overall Study|Discontinued after database release date|1|||
150068717|NCT00631696|541394102|FG001|Overall Study|Discontinued after database release date|0|||
150068718|NCT00631696|541394101|FG000|Overall Study|Follow up after database release date|1|||
150068719|NCT00631696|541394102|FG001|Overall Study|Follow up after database release date|0|||
150068720|NCT00631696|541394101|FG000|Overall Study|Lost to Follow-up|7|||
150068721|NCT00631696|541394102|FG001|Overall Study|Lost to Follow-up|10|||
150068722|NCT00631696|541394101|FG000|Overall Study|Withdrawal by Subject|2|||
150068723|NCT00631696|541394102|FG001|Overall Study|Withdrawal by Subject|9|||
150068724|NCT00631696|541394101|FG000|Overall Study|Other|8|||
150068725|NCT00631696|541394102|FG001|Overall Study|Other|8|||
150068726|NCT00631696|541394101|FG000|Overall Study|Protocol Violation|9|||
150068727|NCT00631696|541394102|FG001|Overall Study|Protocol Violation|9|||
150068728|NCT00631696|541394101|FG000|Overall Study|Study terminated by sponsor|3|||
150068729|NCT00631696|541394102|FG001|Overall Study|Study terminated by sponsor|3|||
150068730|NCT00631696|541394101|FG000|Overall Study|Adverse Event|5|||
150068731|NCT00631696|541394102|FG001|Overall Study|Adverse Event|0|||
150068732|NCT01050543|541394103|FG000|Overall Study|Withdrawal by Subject|0|||
150068733|NCT01050543|541394104|FG001|Overall Study|Withdrawal by Subject|2|||
150068734|NCT01050543|541394103|FG000|Overall Study|Protocol Violation|0|||
150068735|NCT01050543|541394104|FG001|Overall Study|Protocol Violation|1|||
150068736|NCT01050543|541394103|FG000|Overall Study|Administrative|4|||
150068737|NCT01050543|541394104|FG001|Overall Study|Administrative|1|||
150068738|NCT01465191|541394109|FG000|Overall Study|Protocol Violation|6|||
150068739|NCT01465191|541394110|FG001|Overall Study|Protocol Violation|3|||
150068740|NCT01465191|541394111|FG002|Overall Study|Protocol Violation|3|||
150068741|NCT01465191|541394109|FG000|Overall Study|Lost to Follow-up|3|||
150068742|NCT01465191|541394110|FG001|Overall Study|Lost to Follow-up|6|||
150068743|NCT01465191|541394111|FG002|Overall Study|Lost to Follow-up|4|||
150068744|NCT00943124|541394112|FG000|Period 1|Withdrawal by Subject|1|||
150068745|NCT00943124|541394113|FG001|Period 1|Withdrawal by Subject|1|||
150068746|NCT00943124|541394112|FG000|Period 1|Did Not Follow Study Procedures|1|||
150068747|NCT00943124|541394113|FG001|Period 1|Did Not Follow Study Procedures|0|||
150068748|NCT00943124|541394112|FG000|Period 1|Personal Reasons|0|||
150068749|NCT00943124|541394113|FG001|Period 1|Personal Reasons|1|||
150068750|NCT04010539|541394114|FG000|Overall Study|Withdrawal by Subject|4|||
150068751|NCT04010539|541394115|FG001|Overall Study|Withdrawal by Subject|1|||
150068752|NCT04010539|541394114|FG000|Overall Study|Physician Decision|0|||
150068753|NCT04010539|541394115|FG001|Overall Study|Physician Decision|2|||
150068754|NCT04010539|541394114|FG000|Overall Study|Lost to Follow-up|10|||
150068755|NCT04010539|541394115|FG001|Overall Study|Lost to Follow-up|14|||
150068756|NCT04010539|541394114|FG000|Overall Study|Adverse Event|3|||
150068757|NCT04010539|541394115|FG001|Overall Study|Adverse Event|0|||
150068758|NCT04010539|541394114|FG000|Overall Study|Participant Did Not Receive IP|0|||
150068759|NCT04010539|541394115|FG001|Overall Study|Participant Did Not Receive IP|1|||
150068760|NCT04010539|541394114|FG000|Overall Study|Protocol Deviation|0|||
150068761|NCT04010539|541394115|FG001|Overall Study|Protocol Deviation|1|||
150068762|NCT04010539|541394114|FG000|Overall Study|Randomized in Error/ Mistake|2|||
150068763|NCT04010539|541394115|FG001|Overall Study|Randomized in Error/ Mistake|0|||
150068764|NCT04010539|541394114|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
150068765|NCT04010539|541394115|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
150068766|NCT02992132|541394116|FG000|Overall Study|Adverse Event|4|||
150068767|NCT02992132|541394117|FG001|Overall Study|Adverse Event|1|||
150068768|NCT02992132|541394118|FG002|Overall Study|Adverse Event|3|||
150068769|NCT02992132|541394116|FG000|Overall Study|Lack of Efficacy|2|||
150068770|NCT02992132|541394117|FG001|Overall Study|Lack of Efficacy|0|||
150068771|NCT02992132|541394118|FG002|Overall Study|Lack of Efficacy|0|||
150068772|NCT02992132|541394116|FG000|Overall Study|Non-compliance with study drug|2|||
150068773|NCT02992132|541394117|FG001|Overall Study|Non-compliance with study drug|0|||
150068774|NCT02992132|541394118|FG002|Overall Study|Non-compliance with study drug|0|||
150068775|NCT02992132|541394116|FG000|Overall Study|Progressive disease|1|||
150068776|NCT02992132|541394117|FG001|Overall Study|Progressive disease|0|||
150068777|NCT02992132|541394118|FG002|Overall Study|Progressive disease|0|||
150068778|NCT02992132|541394116|FG000|Overall Study|Protocol Violation|2|||
150068779|NCT02992132|541394117|FG001|Overall Study|Protocol Violation|2|||
150068780|NCT02992132|541394118|FG002|Overall Study|Protocol Violation|0|||
150068781|NCT02992132|541394116|FG000|Overall Study|Caregiver withdrew consent|2|||
150068782|NCT02992132|541394117|FG001|Overall Study|Caregiver withdrew consent|3|||
150068783|NCT02992132|541394118|FG002|Overall Study|Caregiver withdrew consent|2|||
150068784|NCT02992132|541394116|FG000|Overall Study|Withdrawal by Subject|0|||
150068785|NCT02992132|541394117|FG001|Overall Study|Withdrawal by Subject|2|||
150068786|NCT02992132|541394118|FG002|Overall Study|Withdrawal by Subject|1|||
150068787|NCT02992132|541394116|FG000|Overall Study|Physician Decision|0|||
150068788|NCT02992132|541394117|FG001|Overall Study|Physician Decision|0|||
150068789|NCT02992132|541394118|FG002|Overall Study|Physician Decision|1|||
150068790|NCT00381381|541394124|FG000|Overall Study|Adverse Event|3|||
150068791|NCT00381381|541394124|FG000|Overall Study|Lost to Follow-up|52|||
150068792|NCT00381381|541394124|FG000|Overall Study|Withdrawal by Subject|9|||
150068793|NCT01916967|541394125|FG000|Overall Study|Adverse Event|0|||
150068794|NCT01916967|541394126|FG001|Overall Study|Adverse Event|0|||
150068795|NCT01916967|541394127|FG002|Overall Study|Adverse Event|2|||
150068796|NCT01916967|541394125|FG000|Overall Study|Lack of Efficacy|0|||
150068797|NCT01916967|541394126|FG001|Overall Study|Lack of Efficacy|0|||
150068798|NCT01916967|541394127|FG002|Overall Study|Lack of Efficacy|6|||
150068799|NCT01916967|541394125|FG000|Overall Study|Physician Decision|0|||
150068800|NCT01916967|541394126|FG001|Overall Study|Physician Decision|0|||
150068801|NCT01916967|541394127|FG002|Overall Study|Physician Decision|1|||
150068802|NCT01916967|541394125|FG000|Overall Study|Protocol Violation|0|||
150068803|NCT01916967|541394126|FG001|Overall Study|Protocol Violation|1|||
150068804|NCT01916967|541394127|FG002|Overall Study|Protocol Violation|0|||
150068805|NCT01104155|541394132|FG000|Overall Study|Adverse Event|15|||
150068806|NCT01104155|541394133|FG001|Overall Study|Adverse Event|8|||
150068807|NCT01104155|541394132|FG000|Overall Study|Participant choice|6|||
150068808|NCT01104155|541394133|FG001|Overall Study|Participant choice|5|||
150068809|NCT01104155|541394132|FG000|Overall Study|Withdrawal of consent|1|||
150068810|NCT01104155|541394133|FG001|Overall Study|Withdrawal of consent|1|||
150068811|NCT01104155|541394132|FG000|Overall Study|Other|3|||
150068812|NCT01104155|541394133|FG001|Overall Study|Other|4|||
150068813|NCT03799211|541394139|FG000|Overall Study|Lost to Follow-up|2|||
150068814|NCT03799211|541394140|FG001|Overall Study|Lost to Follow-up|13|||
150068815|NCT03799211|541394139|FG000|Overall Study|Withdrawal by Subject|2|||
150068816|NCT03799211|541394140|FG001|Overall Study|Withdrawal by Subject|0|||
150068817|NCT00764491|541394141|FG000|Overall Study|Lost to Follow-up|35|||
150068818|NCT00764491|541394142|FG001|Overall Study|Lost to Follow-up|17|||
150068819|NCT00923936|541394143|FG000|Overall Study|progressive disease on study|2|||
150068820|NCT00923936|541394144|FG001|Overall Study|progressive disease on study|1|||
150068821|NCT00923936|541394143|FG000|Overall Study|Adverse Event|2|||
150068822|NCT00923936|541394144|FG001|Overall Study|Adverse Event|1|||
150068823|NCT00923936|541394143|FG000|Overall Study|Lost to follow up|2|||
150068824|NCT00923936|541394144|FG001|Overall Study|Lost to follow up|0|||
150068825|NCT00923936|541394143|FG000|Overall Study|Continuing in follow up period|2|||
150068826|NCT00923936|541394144|FG001|Overall Study|Continuing in follow up period|1|||
150068827|NCT05394350|541394145|FG000|Overall Study|Death|2|||
150068828|NCT05394350|541394146|FG001|Overall Study|Death|2|||
150068829|NCT05394350|541394147|FG002|Overall Study|Death|4|||
150068830|NCT05394350|541394148|FG003|Overall Study|Death|0|||
150068831|NCT05394350|541394149|FG004|Overall Study|Death|1|||
150068832|NCT05394350|541394150|FG005|Overall Study|Death|0|||
150068833|NCT05394350|541394145|FG000|Overall Study|Study terminated by sponsor|1|||
150068834|NCT05394350|541394146|FG001|Overall Study|Study terminated by sponsor|1|||
150068835|NCT05394350|541394147|FG002|Overall Study|Study terminated by sponsor|7|||
150068836|NCT05394350|541394148|FG003|Overall Study|Study terminated by sponsor|3|||
150068837|NCT05394350|541394149|FG004|Overall Study|Study terminated by sponsor|2|||
150068838|NCT05394350|541394150|FG005|Overall Study|Study terminated by sponsor|4|||
150068839|NCT01385371|541394153|FG000|Overall Study|Adverse Event|54|||
150068840|NCT01385371|541394154|FG001|Overall Study|Adverse Event|19|||
150068841|NCT01385371|541394153|FG000|Overall Study|Lost to Follow-up|16|||
150068842|NCT01385371|541394154|FG001|Overall Study|Lost to Follow-up|16|||
150068843|NCT01385371|541394153|FG000|Overall Study|Withdrawal by Subject|52|||
150068844|NCT01385371|541394154|FG001|Overall Study|Withdrawal by Subject|39|||
150068845|NCT01385371|541394153|FG000|Overall Study|Protocol Violation|25|||
150068846|NCT01385371|541394154|FG001|Overall Study|Protocol Violation|21|||
150068847|NCT01385371|541394153|FG000|Overall Study|Administrative|2|||
150068848|NCT01385371|541394154|FG001|Overall Study|Administrative|2|||
150068849|NCT00292318|541394155|FG000|Overall Study|Study terminated by officials|2|||
150068850|NCT00292318|541394156|FG001|Overall Study|Study terminated by officials|1|||
150068851|NCT02027376|541394157|FG000|Overall Study|Death|1|||
150068852|NCT02027376|541394158|FG001|Overall Study|Death|0|||
150068853|NCT02027376|541394159|FG002|Overall Study|Death|0|||
150068854|NCT00304239|541394161|FG000|Overall Study|Protocol Deviations/Violations|15|||
150068855|NCT00304239|541394162|FG001|Overall Study|Protocol Deviations/Violations|0|||
150068856|NCT00304239|541394161|FG000|Overall Study|Adverse Event|2|||
150068857|NCT00304239|541394162|FG001|Overall Study|Adverse Event|0|||
150068858|NCT02979197|541394163|FG000|Overall Study|Adverse Event|4|||
150068859|NCT02979197|541394164|FG001|Overall Study|Adverse Event|2|||
150068860|NCT02979197|541394165|FG002|Overall Study|Adverse Event|0|||
150068861|NCT02979197|541394163|FG000|Overall Study|Protocol Violation|0|||
150068862|NCT02979197|541394164|FG001|Overall Study|Protocol Violation|1|||
150068863|NCT02979197|541394165|FG002|Overall Study|Protocol Violation|0|||
150068864|NCT02979197|541394163|FG000|Overall Study|Subject unable to commit to study dates|0|||
150068865|NCT02979197|541394164|FG001|Overall Study|Subject unable to commit to study dates|1|||
150068866|NCT02979197|541394165|FG002|Overall Study|Subject unable to commit to study dates|0|||
150068867|NCT02436681|541394166|FG000|Overall Study|Lost to Follow-up|10|||
150068868|NCT02436681|541394166|FG000|Overall Study|Withdrawal by Subject|2|||
150068869|NCT02436681|541394166|FG000|Overall Study|Death|2|||
150068870|NCT02030938|541394167|FG000|Overall Study|Lost to Follow-up|4|||
150068871|NCT02030938|541394167|FG000|Overall Study|Withdrawal by Subject|1|||
150068872|NCT03954132|541394169|FG000|Overall Study|Adverse Event|2|||
150068873|NCT03954132|541394170|FG001|Overall Study|Adverse Event|0|||
150068874|NCT03954132|541394169|FG000|Overall Study|Patient's wish|5|||
150068875|NCT03954132|541394170|FG001|Overall Study|Patient's wish|0|||
150068876|NCT03954132|541394169|FG000|Overall Study|Lost to Follow-up|10|||
150068877|NCT03954132|541394170|FG001|Overall Study|Lost to Follow-up|0|||
150068878|NCT03954132|541394169|FG000|Overall Study|Screening failure|0|||
150068879|NCT03954132|541394170|FG001|Overall Study|Screening failure|1|||
150068880|NCT03954132|541394169|FG000|Overall Study|No registration after Visit 1|5|||
150068881|NCT03954132|541394170|FG001|Overall Study|No registration after Visit 1|2|||
150068882|NCT03954132|541394169|FG000|Overall Study|Other reason than listed|2|||
150068883|NCT03954132|541394170|FG001|Overall Study|Other reason than listed|2|||
150068884|NCT03954132|541394169|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
150068885|NCT03954132|541394170|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
150068886|NCT03954132|541394169|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
150068887|NCT03954132|541394170|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
150068888|NCT02949700|541394171|FG000|Phase I|Withdrawal by Subject|1|||
150068889|NCT02949700|541394172|FG001|Phase I|Withdrawal by Subject|1|||
150068890|NCT02949700|541394173|FG002|Phase I|Withdrawal by Subject|0|||
150068891|NCT02949700|541394174|FG003|Phase I|Withdrawal by Subject|0|||
150068892|NCT02949700|541394171|FG000|Phase I|Protocol Violation|1|||
150068893|NCT02949700|541394172|FG001|Phase I|Protocol Violation|0|||
150068894|NCT02949700|541394173|FG002|Phase I|Protocol Violation|0|||
150068895|NCT02949700|541394174|FG003|Phase I|Protocol Violation|0|||
150068896|NCT02949700|541394171|FG000|Phase II|Withdrawal by Subject|0|||
150068897|NCT02949700|541394172|FG001|Phase II|Withdrawal by Subject|0|||
150068898|NCT02949700|541394173|FG002|Phase II|Withdrawal by Subject|0|||
150068899|NCT02949700|541394174|FG003|Phase II|Withdrawal by Subject|2|||
150068900|NCT02949700|541394171|FG000|Phase II|Protocol Violation|0|||
150068901|NCT02949700|541394172|FG001|Phase II|Protocol Violation|0|||
150068902|NCT02949700|541394173|FG002|Phase II|Protocol Violation|1|||
150068903|NCT02949700|541394174|FG003|Phase II|Protocol Violation|3|||
150068904|NCT05597020|541394178|FG000|Washout|Forbidden medication|2|||
150068905|NCT05597020|541394179|FG001|Washout|Forbidden medication|0|||
150068906|NCT05597020|541394178|FG000|Treatment Period II|Advice from primary care physician|1|||
150068907|NCT05597020|541394179|FG001|Treatment Period II|Advice from primary care physician|0|||
150068908|NCT05597020|541394178|FG000|Treatment Period II|Subject lost investigational product|1|||
150068909|NCT05597020|541394179|FG001|Treatment Period II|Subject lost investigational product|0|||
150068910|NCT05597020|541394178|FG000|Treatment Period II|Private reasons|0|||
150182048|NCT03398148|541804609|FG013|Substudy 2 Period 1|Other|0|||
150068911|NCT05597020|541394179|FG001|Treatment Period II|Private reasons|1|||
150068912|NCT00560885|541394186|FG000|Overall Study|Death|7|||
150068913|NCT00560885|541394186|FG000|Overall Study|Withdrawal by Subject|1|||
150068914|NCT02887859|541394194|FG000|Overall Study|Ongoing|6|||
150068915|NCT02887859|541394194|FG000|Overall Study|Adverse Event|7|||
150068916|NCT02887859|541394194|FG000|Overall Study|Death|1|||
150068917|NCT02887859|541394194|FG000|Overall Study|Physician Decision|1|||
150068918|NCT01554397|541394197|FG000|Overall Study|Withdrawal by Subject|1|||
150068919|NCT01554397|541394198|FG001|Overall Study|Withdrawal by Subject|0|||
150068920|NCT01554397|541394197|FG000|Overall Study|Ineligible|7|||
150068921|NCT01554397|541394198|FG001|Overall Study|Ineligible|0|||
150068922|NCT00257608|541396611|FG000|Chemotherapy Phase|Adverse Event|138|||
150068923|NCT00257608|541396612|FG001|Chemotherapy Phase|Adverse Event|0|||
150068924|NCT00257608|541396613|FG002|Chemotherapy Phase|Adverse Event|0|||
150068925|NCT00257608|541396611|FG000|Chemotherapy Phase|Disease progression|139|||
150068926|NCT00257608|541396612|FG001|Chemotherapy Phase|Disease progression|0|||
150068927|NCT00257608|541396613|FG002|Chemotherapy Phase|Disease progression|0|||
150068928|NCT00257608|541396611|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
150068929|NCT00257608|541396612|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
150068930|NCT00257608|541396613|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
150068931|NCT00257608|541396611|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
150068932|NCT00257608|541396612|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
150068933|NCT00257608|541396613|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
150068934|NCT00257608|541396611|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
150068935|NCT00257608|541396612|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
150068936|NCT00257608|541396613|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
150068937|NCT00257608|541396611|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
150068938|NCT00257608|541396612|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
150068939|NCT00257608|541396613|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
150068940|NCT00257608|541396611|FG000|Chemotherapy Phase|Physician Decision|28|||
150068941|NCT00257608|541396612|FG001|Chemotherapy Phase|Physician Decision|0|||
150068942|NCT00257608|541396613|FG002|Chemotherapy Phase|Physician Decision|0|||
150068943|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Adverse Event|0|||
150068944|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Adverse Event|34|||
150068945|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Adverse Event|38|||
150068946|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Disease progression|0|||
150068947|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Disease progression|204|||
150068948|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Disease progression|168|||
150068949|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
150068950|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
150068951|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
150068952|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
150068953|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
150068954|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
150068955|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
150068956|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
150068957|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
150068958|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
150068959|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
150068960|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
150068961|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
150068962|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
150068963|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
150068964|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Physician Decision|0|||
150068965|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Physician Decision|8|||
150068966|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Physician Decision|11|||
150068967|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
150068968|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
150068969|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
150068970|NCT00257608|541396611|FG000|Post Chemotherapy Phase|Not treated|0|||
150068971|NCT00257608|541396612|FG001|Post Chemotherapy Phase|Not treated|4|||
150068972|NCT00257608|541396613|FG002|Post Chemotherapy Phase|Not treated|7|||
150068973|NCT01896050|541396614|FG000|Overall Study|Adverse Event|37|||
150068974|NCT01896050|541396615|FG001|Overall Study|Adverse Event|2|||
150068975|NCT01896050|541396614|FG000|Overall Study|Death|1|||
150068976|NCT01896050|541396615|FG001|Overall Study|Death|0|||
150068977|NCT02206048|541396616|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
150068978|NCT02925923|541396617|FG000|Overall Study|blood samples hemolyzed|0|||
150068979|NCT02925923|541396618|FG001|Overall Study|blood samples hemolyzed|2|||
150068980|NCT03265665|541396619|FG000|24-week Data Collection|Withdrawal by Subject|2|||
150068981|NCT03265665|541396620|FG001|24-week Data Collection|Withdrawal by Subject|2|||
150068982|NCT03265665|541396619|FG000|24-week Data Collection|Lost to Follow-up|4|||
150068983|NCT03265665|541396620|FG001|24-week Data Collection|Lost to Follow-up|5|||
150068984|NCT03265665|541396619|FG000|36-week Data Collection|Lost to Follow-up|6|||
150068985|NCT03265665|541396620|FG001|36-week Data Collection|Lost to Follow-up|8|||
150068986|NCT01858376|541396621|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
150068987|NCT00108433|541396623|FG000|Overall Study|Lack of Efficacy|1|||
150068988|NCT00108433|541396624|FG001|Overall Study|Lack of Efficacy|2|||
150068989|NCT00108433|541396623|FG000|Overall Study|Death|3|||
150068990|NCT00108433|541396624|FG001|Overall Study|Death|0|||
150068991|NCT00108433|541396623|FG000|Overall Study|Adverse Event|3|||
150068992|NCT00108433|541396624|FG001|Overall Study|Adverse Event|1|||
150068993|NCT00108433|541396623|FG000|Overall Study|Other|14|||
150068994|NCT00108433|541396624|FG001|Overall Study|Other|14|||
150068995|NCT04806503|541396635|FG000|Overall Study|Lost to Follow-up|0|||
150068996|NCT04806503|541396636|FG001|Overall Study|Lost to Follow-up|0|||
150068997|NCT04806503|541396637|FG002|Overall Study|Lost to Follow-up|1|||
150068998|NCT04806503|541396638|FG003|Overall Study|Lost to Follow-up|0|||
150068999|NCT04806503|541396639|FG004|Overall Study|Lost to Follow-up|0|||
150069000|NCT04806503|541396635|FG000|Overall Study|Withdrawal by Subject|1|||
150069001|NCT04806503|541396636|FG001|Overall Study|Withdrawal by Subject|0|||
150069002|NCT04806503|541396637|FG002|Overall Study|Withdrawal by Subject|1|||
150069003|NCT04806503|541396638|FG003|Overall Study|Withdrawal by Subject|1|||
150069004|NCT04806503|541396639|FG004|Overall Study|Withdrawal by Subject|1|||
150069005|NCT04806503|541396635|FG000|Overall Study|Adverse Event|1|||
150069006|NCT04806503|541396636|FG001|Overall Study|Adverse Event|1|||
150069007|NCT04806503|541396637|FG002|Overall Study|Adverse Event|0|||
150069008|NCT04806503|541396638|FG003|Overall Study|Adverse Event|1|||
150069009|NCT04806503|541396639|FG004|Overall Study|Adverse Event|0|||
150069010|NCT03589469|541396640|FG000|Overall Study|Withdrawal by Subject|8|||
150069011|NCT03589469|541396640|FG000|Overall Study|Physician Decision|20|||
150069012|NCT03589469|541396640|FG000|Overall Study|Death|97|||
150069013|NCT03589469|541396640|FG000|Overall Study|Lost to Follow-up|8|||
150069014|NCT03589469|541396640|FG000|Overall Study|Miscellaneous|1|||
150069015|NCT01824342|541396649|FG000|Overall Study|Withdrawal by Subject|0|||
150069016|NCT01824342|541396650|FG001|Overall Study|Withdrawal by Subject|3|||
150069017|NCT01824342|541396649|FG000|Overall Study|Adverse Event|1|||
150069018|NCT01824342|541396650|FG001|Overall Study|Adverse Event|1|||
150069019|NCT01824342|541396649|FG000|Overall Study|Disease Progression|1|||
150069020|NCT01824342|541396650|FG001|Overall Study|Disease Progression|1|||
150069021|NCT01824342|541396649|FG000|Overall Study|Physician Decision|5|||
150069022|NCT01824342|541396650|FG001|Overall Study|Physician Decision|0|||
150069023|NCT01824342|541396649|FG000|Overall Study|Death|2|||
150069024|NCT01824342|541396650|FG001|Overall Study|Death|0|||
150069025|NCT01871142|541396651|FG000|Overall Study|Adverse Event|1|||
150069026|NCT00734474|541396661|FG000|Overall Study|Entry Criteria Not Met|0|||
150069027|NCT00734474|541396662|FG001|Overall Study|Entry Criteria Not Met|0|||
150069028|NCT00734474|541396663|FG002|Overall Study|Entry Criteria Not Met|5|||
150069029|NCT00734474|541396664|FG003|Overall Study|Entry Criteria Not Met|0|||
150069030|NCT00734474|541396665|FG004|Overall Study|Entry Criteria Not Met|3|||
150069031|NCT00734474|541396666|FG005|Overall Study|Entry Criteria Not Met|1|||
150069032|NCT00734474|541396667|FG006|Overall Study|Entry Criteria Not Met|0|||
150069033|NCT00734474|541396668|FG007|Overall Study|Entry Criteria Not Met|1|||
150069034|NCT00734474|541396669|FG008|Overall Study|Entry Criteria Not Met|1|||
150069035|NCT00734474|541396661|FG000|Overall Study|Lost to Follow-up|1|||
150069036|NCT00734474|541396662|FG001|Overall Study|Lost to Follow-up|0|||
150069037|NCT00734474|541396663|FG002|Overall Study|Lost to Follow-up|13|||
150069038|NCT00734474|541396664|FG003|Overall Study|Lost to Follow-up|0|||
150069039|NCT00734474|541396665|FG004|Overall Study|Lost to Follow-up|11|||
150069040|NCT00734474|541396666|FG005|Overall Study|Lost to Follow-up|1|||
150069041|NCT00734474|541396667|FG006|Overall Study|Lost to Follow-up|0|||
150069042|NCT00734474|541396668|FG007|Overall Study|Lost to Follow-up|9|||
150069043|NCT00734474|541396669|FG008|Overall Study|Lost to Follow-up|4|||
150069044|NCT00734474|541396661|FG000|Overall Study|Withdrawal by Subject|2|||
150069045|NCT00734474|541396662|FG001|Overall Study|Withdrawal by Subject|1|||
150069046|NCT00734474|541396663|FG002|Overall Study|Withdrawal by Subject|18|||
150069047|NCT00734474|541396664|FG003|Overall Study|Withdrawal by Subject|0|||
150069048|NCT00734474|541396665|FG004|Overall Study|Withdrawal by Subject|24|||
150069049|NCT00734474|541396666|FG005|Overall Study|Withdrawal by Subject|2|||
150069050|NCT00734474|541396667|FG006|Overall Study|Withdrawal by Subject|0|||
150069051|NCT00734474|541396668|FG007|Overall Study|Withdrawal by Subject|36|||
150069052|NCT00734474|541396669|FG008|Overall Study|Withdrawal by Subject|21|||
150069053|NCT00734474|541396661|FG000|Overall Study|Physician Decision|0|||
150069054|NCT00734474|541396662|FG001|Overall Study|Physician Decision|0|||
150069055|NCT00734474|541396663|FG002|Overall Study|Physician Decision|4|||
150069056|NCT00734474|541396664|FG003|Overall Study|Physician Decision|1|||
150069057|NCT00734474|541396665|FG004|Overall Study|Physician Decision|11|||
150069058|NCT00734474|541396666|FG005|Overall Study|Physician Decision|0|||
150069059|NCT00734474|541396667|FG006|Overall Study|Physician Decision|0|||
150069060|NCT00734474|541396668|FG007|Overall Study|Physician Decision|9|||
150069061|NCT00734474|541396669|FG008|Overall Study|Physician Decision|9|||
150069062|NCT00734474|541396661|FG000|Overall Study|Adverse Event|4|||
150069063|NCT00734474|541396662|FG001|Overall Study|Adverse Event|4|||
150069064|NCT00734474|541396663|FG002|Overall Study|Adverse Event|63|||
150069065|NCT00734474|541396664|FG003|Overall Study|Adverse Event|1|||
150069066|NCT00734474|541396665|FG004|Overall Study|Adverse Event|64|||
150069067|NCT00734474|541396666|FG005|Overall Study|Adverse Event|0|||
150069068|NCT00734474|541396667|FG006|Overall Study|Adverse Event|1|||
150069069|NCT00734474|541396668|FG007|Overall Study|Adverse Event|65|||
150069070|NCT00734474|541396669|FG008|Overall Study|Adverse Event|39|||
150069071|NCT00734474|541396661|FG000|Overall Study|Protocol Violation|0|||
150069072|NCT00734474|541396662|FG001|Overall Study|Protocol Violation|0|||
150069073|NCT00734474|541396663|FG002|Overall Study|Protocol Violation|4|||
150069074|NCT00734474|541396664|FG003|Overall Study|Protocol Violation|0|||
150069075|NCT00734474|541396665|FG004|Overall Study|Protocol Violation|3|||
150069076|NCT00734474|541396666|FG005|Overall Study|Protocol Violation|0|||
150069077|NCT00734474|541396667|FG006|Overall Study|Protocol Violation|0|||
150069078|NCT00734474|541396668|FG007|Overall Study|Protocol Violation|3|||
150069079|NCT00734474|541396669|FG008|Overall Study|Protocol Violation|1|||
150069080|NCT00734474|541396661|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
150069081|NCT00734474|541396662|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
150069082|NCT00734474|541396663|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
150069083|NCT00734474|541396664|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
150069084|NCT00734474|541396665|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
150069085|NCT00734474|541396666|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
150069086|NCT00734474|541396667|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
150069087|NCT00734474|541396668|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
150069088|NCT00734474|541396669|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
150069089|NCT00734474|541396661|FG000|Overall Study|Sponsor Decision|0|||
150069090|NCT00734474|541396662|FG001|Overall Study|Sponsor Decision|0|||
150069091|NCT00734474|541396663|FG002|Overall Study|Sponsor Decision|0|||
150069092|NCT00734474|541396664|FG003|Overall Study|Sponsor Decision|0|||
150069093|NCT00734474|541396665|FG004|Overall Study|Sponsor Decision|2|||
150069094|NCT00734474|541396666|FG005|Overall Study|Sponsor Decision|0|||
150069095|NCT00734474|541396667|FG006|Overall Study|Sponsor Decision|0|||
150069096|NCT00734474|541396668|FG007|Overall Study|Sponsor Decision|0|||
150069097|NCT00734474|541396669|FG008|Overall Study|Sponsor Decision|0|||
150069098|NCT00734474|541396661|FG000|Overall Study|Death|0|||
150069099|NCT00734474|541396662|FG001|Overall Study|Death|0|||
150069100|NCT00734474|541396663|FG002|Overall Study|Death|1|||
150069101|NCT00734474|541396664|FG003|Overall Study|Death|0|||
150069102|NCT00734474|541396665|FG004|Overall Study|Death|0|||
150069103|NCT00734474|541396666|FG005|Overall Study|Death|0|||
150069104|NCT00734474|541396667|FG006|Overall Study|Death|0|||
150069105|NCT00734474|541396668|FG007|Overall Study|Death|2|||
150069106|NCT00734474|541396669|FG008|Overall Study|Death|1|||
150069107|NCT00734474|541396661|FG000|Overall Study|Lack of Efficacy|0|||
150069108|NCT00734474|541396662|FG001|Overall Study|Lack of Efficacy|0|||
150069109|NCT00734474|541396663|FG002|Overall Study|Lack of Efficacy|4|||
150069110|NCT00734474|541396664|FG003|Overall Study|Lack of Efficacy|0|||
150069111|NCT00734474|541396665|FG004|Overall Study|Lack of Efficacy|0|||
150069112|NCT00734474|541396666|FG005|Overall Study|Lack of Efficacy|0|||
150069113|NCT00734474|541396667|FG006|Overall Study|Lack of Efficacy|0|||
150069114|NCT00734474|541396668|FG007|Overall Study|Lack of Efficacy|4|||
150069115|NCT00734474|541396669|FG008|Overall Study|Lack of Efficacy|6|||
150069116|NCT00231842|541396676|FG000|Overall Study|Withdrawal by Subject|3|||
150069117|NCT00231842|541396676|FG000|Overall Study|Did not complete the last 3 cycle|8|||
150069118|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
150069119|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
150069120|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
150069121|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
150069122|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
150069123|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
150069124|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
150069125|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
150069126|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
150069127|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
150069128|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
150069129|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
150069130|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
150069131|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
150069132|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
150069133|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
150069134|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
150069135|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
150069136|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
150069137|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
150069138|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
150069139|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
150069140|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
150069141|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
150069142|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
150069143|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
150069144|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
150069145|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
150069146|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
150069147|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
150069148|NCT00313300|541396677|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
150069149|NCT00313300|541396678|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
150069150|NCT00313300|541396679|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
150069151|NCT00313300|541396680|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
150069152|NCT00313300|541396681|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
150069153|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
150069154|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
150069155|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
150069156|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
150069157|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
150069158|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
150069159|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
150069160|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
150069161|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
150069162|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
150069163|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
150069164|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
150069165|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
150069166|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
150069167|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
150069168|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
150069169|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
150069170|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
150069171|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
150069172|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
150069173|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
150069174|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
150069175|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
150069176|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
150069177|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
150069178|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
150069179|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
150069180|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
150069181|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
150069182|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
150069183|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
150069184|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
150182049|NCT03398148|541804610|FG014|Substudy 2 Period 1|Other|0|||
150069185|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
150069186|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
150069187|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
150069188|NCT00313300|541396677|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
150069189|NCT00313300|541396678|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
150069190|NCT00313300|541396679|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
150069191|NCT00313300|541396680|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
150069192|NCT00313300|541396681|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
150069193|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
150069194|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
150069195|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
150069196|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
150069197|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
150069198|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
150069199|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
150069200|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
150069201|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
150069202|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
150069203|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
150069204|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
150069205|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
150069206|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
150069207|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
150069208|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
150069209|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
150069210|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
150069211|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
150069212|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
150069213|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
150069214|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
150069215|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
150069216|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
150069217|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
150069218|NCT00313300|541396677|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
150069219|NCT00313300|541396678|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
150069220|NCT00313300|541396679|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
150069221|NCT00313300|541396680|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
150069222|NCT00313300|541396681|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
150069223|NCT00639678|541396682|FG000|Overall Study|Withdrawal by Subject|3|||
150069224|NCT00639678|541396683|FG001|Overall Study|Withdrawal by Subject|0|||
150069225|NCT00639678|541396684|FG002|Overall Study|Withdrawal by Subject|4|||
150069226|NCT00639678|541396685|FG003|Overall Study|Withdrawal by Subject|0|||
150069227|NCT00639678|541396682|FG000|Overall Study|Lost to Follow-up|1|||
150069228|NCT00639678|541396683|FG001|Overall Study|Lost to Follow-up|0|||
150069229|NCT00639678|541396684|FG002|Overall Study|Lost to Follow-up|6|||
150069230|NCT00639678|541396685|FG003|Overall Study|Lost to Follow-up|0|||
150069231|NCT00639678|541396682|FG000|Overall Study|Adverse Event|0|||
150069232|NCT00639678|541396683|FG001|Overall Study|Adverse Event|1|||
150069233|NCT00639678|541396684|FG002|Overall Study|Adverse Event|0|||
150069234|NCT00639678|541396685|FG003|Overall Study|Adverse Event|0|||
150069235|NCT00639678|541396682|FG000|Overall Study|Lack of Compliance|0|||
150069236|NCT00639678|541396683|FG001|Overall Study|Lack of Compliance|0|||
150069237|NCT00639678|541396684|FG002|Overall Study|Lack of Compliance|1|||
150069238|NCT00639678|541396685|FG003|Overall Study|Lack of Compliance|0|||
150069239|NCT01973569|541396686|FG000|Overall Study|Adverse Event|9|||
150069240|NCT01973569|541396687|FG001|Overall Study|Adverse Event|2|||
150069241|NCT01973569|541396688|FG002|Overall Study|Adverse Event|4|||
150069242|NCT01973569|541396686|FG000|Overall Study|Protocol Violation|2|||
150069243|NCT01973569|541396687|FG001|Overall Study|Protocol Violation|1|||
150069244|NCT01973569|541396688|FG002|Overall Study|Protocol Violation|3|||
150069245|NCT01973569|541396686|FG000|Overall Study|Withdrawal by Subject|7|||
150069246|NCT01973569|541396687|FG001|Overall Study|Withdrawal by Subject|5|||
150069247|NCT01973569|541396688|FG002|Overall Study|Withdrawal by Subject|2|||
150069248|NCT01973569|541396686|FG000|Overall Study|Invasive dental treatment|3|||
150069249|NCT01973569|541396687|FG001|Overall Study|Invasive dental treatment|5|||
150069250|NCT01973569|541396688|FG002|Overall Study|Invasive dental treatment|6|||
150069251|NCT01973569|541396686|FG000|Overall Study|Prohibited concomitant d|1|||
150069252|NCT01973569|541396687|FG001|Overall Study|Prohibited concomitant d|5|||
150069253|NCT01973569|541396688|FG002|Overall Study|Prohibited concomitant d|0|||
150069254|NCT01973569|541396686|FG000|Overall Study|Disease progression|0|||
150069255|NCT01973569|541396687|FG001|Overall Study|Disease progression|3|||
150069256|NCT01973569|541396688|FG002|Overall Study|Disease progression|0|||
150069257|NCT01973569|541396686|FG000|Overall Study|Other|1|||
150069258|NCT01973569|541396687|FG001|Overall Study|Other|1|||
150069259|NCT01973569|541396688|FG002|Overall Study|Other|0|||
150069260|NCT01973569|541396686|FG000|Overall Study|Did not receive study drug|6|||
150069261|NCT01973569|541396687|FG001|Overall Study|Did not receive study drug|3|||
150069262|NCT01973569|541396688|FG002|Overall Study|Did not receive study drug|3|||
150069263|NCT02651467|541396702|FG000|Overall Study|Withdrawal by Subject|0|||
150069264|NCT02651467|541396703|FG001|Overall Study|Withdrawal by Subject|0|||
150069265|NCT02651467|541396704|FG002|Overall Study|Withdrawal by Subject|2|||
150069266|NCT02651467|541396702|FG000|Overall Study|Other (Not specified)|1|||
150069267|NCT02651467|541396703|FG001|Overall Study|Other (Not specified)|0|||
150069268|NCT02651467|541396704|FG002|Overall Study|Other (Not specified)|2|||
150069269|NCT00573937|541396705|FG000|Overall Study|Study Terminated|0|||
150069270|NCT00573937|541396706|FG001|Overall Study|Study Terminated|1|||
150069271|NCT00333801|541396707|FG000|Overall Study|Moved to another state|5|||
150069272|NCT00333801|541396708|FG001|Overall Study|Moved to another state|3|||
150069273|NCT00333801|541396707|FG000|Overall Study|Lost to Follow-up|2|||
150069274|NCT00333801|541396708|FG001|Overall Study|Lost to Follow-up|0|||
150069275|NCT00333801|541396707|FG000|Overall Study|Incarcerated|1|||
150069276|NCT00333801|541396708|FG001|Overall Study|Incarcerated|2|||
150069277|NCT00333801|541396707|FG000|Overall Study|Withdrawal by Subject|0|||
150069278|NCT00333801|541396708|FG001|Overall Study|Withdrawal by Subject|1|||
150069279|NCT03633617|541396709|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
150069280|NCT03633617|541396710|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
150069281|NCT03633617|541396711|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069282|NCT03633617|541396712|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069283|NCT03633617|541396713|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069284|NCT03633617|541396714|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069285|NCT03633617|541396715|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069286|NCT03633617|541396716|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069287|NCT03633617|541396717|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069288|NCT03633617|541396718|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069289|NCT03633617|541396719|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
150069290|NCT03633617|541396709|FG000|Part A|Unconfirmed early termination visit|1|||
150069291|NCT03633617|541396710|FG001|Part A|Unconfirmed early termination visit|0|||
150069292|NCT03633617|541396711|FG002|Part A|Unconfirmed early termination visit|0|||
150069293|NCT03633617|541396712|FG003|Part A|Unconfirmed early termination visit|0|||
150069294|NCT03633617|541396713|FG004|Part A|Unconfirmed early termination visit|0|||
150069295|NCT03633617|541396714|FG005|Part A|Unconfirmed early termination visit|0|||
150069296|NCT03633617|541396715|FG006|Part A|Unconfirmed early termination visit|0|||
150069297|NCT03633617|541396716|FG007|Part A|Unconfirmed early termination visit|0|||
150069298|NCT03633617|541396717|FG008|Part A|Unconfirmed early termination visit|0|||
150069299|NCT03633617|541396718|FG009|Part A|Unconfirmed early termination visit|0|||
150069300|NCT03633617|541396719|FG010|Part A|Unconfirmed early termination visit|0|||
150069301|NCT03633617|541396709|FG000|Part A|Adverse Event|0|||
150069302|NCT03633617|541396710|FG001|Part A|Adverse Event|1|||
150069303|NCT03633617|541396711|FG002|Part A|Adverse Event|0|||
150069304|NCT03633617|541396712|FG003|Part A|Adverse Event|0|||
150069305|NCT03633617|541396713|FG004|Part A|Adverse Event|0|||
150069306|NCT03633617|541396714|FG005|Part A|Adverse Event|0|||
150069307|NCT03633617|541396715|FG006|Part A|Adverse Event|0|||
150069308|NCT03633617|541396716|FG007|Part A|Adverse Event|0|||
150069309|NCT03633617|541396717|FG008|Part A|Adverse Event|0|||
150069310|NCT03633617|541396718|FG009|Part A|Adverse Event|0|||
150069311|NCT03633617|541396719|FG010|Part A|Adverse Event|0|||
150069312|NCT03633617|541396709|FG000|Part A|Pregnancy|1|||
150069313|NCT03633617|541396710|FG001|Part A|Pregnancy|0|||
150069314|NCT03633617|541396711|FG002|Part A|Pregnancy|0|||
150069315|NCT03633617|541396712|FG003|Part A|Pregnancy|0|||
150069316|NCT03633617|541396713|FG004|Part A|Pregnancy|0|||
150069317|NCT03633617|541396714|FG005|Part A|Pregnancy|0|||
150069318|NCT03633617|541396715|FG006|Part A|Pregnancy|0|||
150069319|NCT03633617|541396716|FG007|Part A|Pregnancy|0|||
150069320|NCT03633617|541396717|FG008|Part A|Pregnancy|0|||
150069321|NCT03633617|541396718|FG009|Part A|Pregnancy|0|||
150069322|NCT03633617|541396719|FG010|Part A|Pregnancy|0|||
150069323|NCT03633617|541396709|FG000|Part A|Withdrawal by Subject|0|||
150069324|NCT03633617|541396710|FG001|Part A|Withdrawal by Subject|1|||
150069325|NCT03633617|541396711|FG002|Part A|Withdrawal by Subject|0|||
150069326|NCT03633617|541396712|FG003|Part A|Withdrawal by Subject|0|||
150069327|NCT03633617|541396713|FG004|Part A|Withdrawal by Subject|0|||
150069328|NCT03633617|541396714|FG005|Part A|Withdrawal by Subject|0|||
150069329|NCT03633617|541396715|FG006|Part A|Withdrawal by Subject|0|||
150182050|NCT03398148|541804596|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
150069330|NCT03633617|541396716|FG007|Part A|Withdrawal by Subject|0|||
150182051|NCT03398148|541804597|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
150069331|NCT03633617|541396717|FG008|Part A|Withdrawal by Subject|0|||
150069332|NCT03633617|541396718|FG009|Part A|Withdrawal by Subject|0|||
150069333|NCT03633617|541396719|FG010|Part A|Withdrawal by Subject|0|||
150069334|NCT03633617|541396709|FG000|Part B|Adverse Event|0|||
150069335|NCT03633617|541396710|FG001|Part B|Adverse Event|0|||
150069336|NCT03633617|541396711|FG002|Part B|Adverse Event|2|||
150069337|NCT03633617|541396712|FG003|Part B|Adverse Event|2|||
150069338|NCT03633617|541396713|FG004|Part B|Adverse Event|1|||
150069339|NCT03633617|541396714|FG005|Part B|Adverse Event|0|||
150069340|NCT03633617|541396715|FG006|Part B|Adverse Event|0|||
150069341|NCT03633617|541396716|FG007|Part B|Adverse Event|0|||
150069342|NCT03633617|541396717|FG008|Part B|Adverse Event|0|||
150069343|NCT03633617|541396718|FG009|Part B|Adverse Event|0|||
150069344|NCT03633617|541396719|FG010|Part B|Adverse Event|0|||
150069345|NCT03633617|541396709|FG000|Part B|Withdrawal by Subject|0|||
150069346|NCT03633617|541396710|FG001|Part B|Withdrawal by Subject|0|||
150069347|NCT03633617|541396711|FG002|Part B|Withdrawal by Subject|1|||
150069348|NCT03633617|541396712|FG003|Part B|Withdrawal by Subject|0|||
150069349|NCT03633617|541396713|FG004|Part B|Withdrawal by Subject|2|||
150069350|NCT03633617|541396714|FG005|Part B|Withdrawal by Subject|0|||
150069351|NCT03633617|541396715|FG006|Part B|Withdrawal by Subject|0|||
150069352|NCT03633617|541396716|FG007|Part B|Withdrawal by Subject|0|||
150069353|NCT03633617|541396717|FG008|Part B|Withdrawal by Subject|0|||
150069354|NCT03633617|541396718|FG009|Part B|Withdrawal by Subject|0|||
150069355|NCT03633617|541396719|FG010|Part B|Withdrawal by Subject|0|||
150069356|NCT03633617|541396709|FG000|Part B|Lost to Follow-up|0|||
150069357|NCT03633617|541396710|FG001|Part B|Lost to Follow-up|0|||
150069358|NCT03633617|541396711|FG002|Part B|Lost to Follow-up|0|||
150069359|NCT03633617|541396712|FG003|Part B|Lost to Follow-up|0|||
150069360|NCT03633617|541396713|FG004|Part B|Lost to Follow-up|1|||
150069361|NCT03633617|541396714|FG005|Part B|Lost to Follow-up|0|||
150069362|NCT03633617|541396715|FG006|Part B|Lost to Follow-up|0|||
150069363|NCT03633617|541396716|FG007|Part B|Lost to Follow-up|0|||
150069364|NCT03633617|541396717|FG008|Part B|Lost to Follow-up|0|||
150069365|NCT03633617|541396718|FG009|Part B|Lost to Follow-up|0|||
150069366|NCT03633617|541396719|FG010|Part B|Lost to Follow-up|0|||
150069367|NCT03633617|541396709|FG000|Part B|Physician Decision|0|||
150069368|NCT03633617|541396710|FG001|Part B|Physician Decision|0|||
150069369|NCT03633617|541396711|FG002|Part B|Physician Decision|0|||
150069370|NCT03633617|541396712|FG003|Part B|Physician Decision|0|||
150069371|NCT03633617|541396713|FG004|Part B|Physician Decision|1|||
150069372|NCT03633617|541396714|FG005|Part B|Physician Decision|0|||
150069373|NCT03633617|541396715|FG006|Part B|Physician Decision|0|||
150069374|NCT03633617|541396716|FG007|Part B|Physician Decision|0|||
150069375|NCT03633617|541396717|FG008|Part B|Physician Decision|0|||
150069376|NCT03633617|541396718|FG009|Part B|Physician Decision|0|||
150069377|NCT03633617|541396719|FG010|Part B|Physician Decision|0|||
150069378|NCT03633617|541396709|FG000|Part B|COVID-19 Restrictions|0|||
150069379|NCT03633617|541396710|FG001|Part B|COVID-19 Restrictions|0|||
150069380|NCT03633617|541396711|FG002|Part B|COVID-19 Restrictions|1|||
150069381|NCT03633617|541396712|FG003|Part B|COVID-19 Restrictions|0|||
150069382|NCT03633617|541396713|FG004|Part B|COVID-19 Restrictions|0|||
150069383|NCT03633617|541396714|FG005|Part B|COVID-19 Restrictions|0|||
150069384|NCT03633617|541396715|FG006|Part B|COVID-19 Restrictions|0|||
150069385|NCT03633617|541396716|FG007|Part B|COVID-19 Restrictions|0|||
150069386|NCT03633617|541396717|FG008|Part B|COVID-19 Restrictions|0|||
150069387|NCT03633617|541396718|FG009|Part B|COVID-19 Restrictions|0|||
150069388|NCT03633617|541396719|FG010|Part B|COVID-19 Restrictions|0|||
150069389|NCT03633617|541396709|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069390|NCT03633617|541396710|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069391|NCT03633617|541396711|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
150069392|NCT03633617|541396712|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069393|NCT03633617|541396713|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069394|NCT03633617|541396714|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069395|NCT03633617|541396715|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069396|NCT03633617|541396716|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069397|NCT03633617|541396717|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069398|NCT03633617|541396718|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069399|NCT03633617|541396719|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
150069400|NCT03633617|541396709|FG000|Part C (& Follow-up)|Adverse Event|0|||
150069401|NCT03633617|541396710|FG001|Part C (& Follow-up)|Adverse Event|0|||
150069402|NCT03633617|541396711|FG002|Part C (& Follow-up)|Adverse Event|0|||
150069403|NCT03633617|541396712|FG003|Part C (& Follow-up)|Adverse Event|0|||
150069404|NCT03633617|541396713|FG004|Part C (& Follow-up)|Adverse Event|0|||
150069405|NCT03633617|541396714|FG005|Part C (& Follow-up)|Adverse Event|1|||
150069406|NCT03633617|541396715|FG006|Part C (& Follow-up)|Adverse Event|0|||
150069407|NCT03633617|541396716|FG007|Part C (& Follow-up)|Adverse Event|1|||
150069408|NCT03633617|541396717|FG008|Part C (& Follow-up)|Adverse Event|0|||
150069409|NCT03633617|541396718|FG009|Part C (& Follow-up)|Adverse Event|0|||
150069410|NCT03633617|541396719|FG010|Part C (& Follow-up)|Adverse Event|0|||
150069411|NCT03633617|541396709|FG000|Part C (& Follow-up)|Pregnancy|0|||
150069412|NCT03633617|541396710|FG001|Part C (& Follow-up)|Pregnancy|0|||
150069413|NCT03633617|541396711|FG002|Part C (& Follow-up)|Pregnancy|0|||
150069414|NCT03633617|541396712|FG003|Part C (& Follow-up)|Pregnancy|0|||
150069415|NCT03633617|541396713|FG004|Part C (& Follow-up)|Pregnancy|0|||
150069416|NCT03633617|541396714|FG005|Part C (& Follow-up)|Pregnancy|0|||
150069417|NCT03633617|541396715|FG006|Part C (& Follow-up)|Pregnancy|0|||
150069418|NCT03633617|541396716|FG007|Part C (& Follow-up)|Pregnancy|0|||
150069419|NCT03633617|541396717|FG008|Part C (& Follow-up)|Pregnancy|0|||
150069420|NCT03633617|541396718|FG009|Part C (& Follow-up)|Pregnancy|1|||
150069421|NCT03633617|541396719|FG010|Part C (& Follow-up)|Pregnancy|0|||
150069422|NCT03633617|541396709|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069423|NCT03633617|541396710|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069424|NCT03633617|541396711|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069425|NCT03633617|541396712|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069426|NCT03633617|541396713|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069427|NCT03633617|541396714|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
150069428|NCT03633617|541396715|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
150069429|NCT03633617|541396716|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
150069430|NCT03633617|541396717|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
150069431|NCT03633617|541396718|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
150069432|NCT03633617|541396719|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
150069433|NCT03633617|541396709|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
150069434|NCT03633617|541396710|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
150069435|NCT03633617|541396711|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
150069436|NCT03633617|541396712|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
150069437|NCT03633617|541396713|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
150069438|NCT03633617|541396714|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
150069439|NCT03633617|541396715|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
150069440|NCT03633617|541396716|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
150069441|NCT03633617|541396717|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
150069442|NCT03633617|541396718|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
150069443|NCT03633617|541396719|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
150069444|NCT03633617|541396709|FG000|Part C (& Follow-up)|Physician Decision|0|||
150069445|NCT03633617|541396710|FG001|Part C (& Follow-up)|Physician Decision|0|||
150069446|NCT03633617|541396711|FG002|Part C (& Follow-up)|Physician Decision|0|||
150069447|NCT03633617|541396712|FG003|Part C (& Follow-up)|Physician Decision|0|||
150069448|NCT03633617|541396713|FG004|Part C (& Follow-up)|Physician Decision|0|||
150069449|NCT03633617|541396714|FG005|Part C (& Follow-up)|Physician Decision|0|||
150069450|NCT03633617|541396715|FG006|Part C (& Follow-up)|Physician Decision|0|||
150069451|NCT03633617|541396716|FG007|Part C (& Follow-up)|Physician Decision|1|||
150069452|NCT03633617|541396717|FG008|Part C (& Follow-up)|Physician Decision|0|||
150069453|NCT03633617|541396718|FG009|Part C (& Follow-up)|Physician Decision|0|||
150069454|NCT03633617|541396719|FG010|Part C (& Follow-up)|Physician Decision|1|||
150069455|NCT03633617|541396709|FG000|Part C (& Follow-up)|COVID-19 related|0|||
150069456|NCT03633617|541396710|FG001|Part C (& Follow-up)|COVID-19 related|0|||
150069457|NCT03633617|541396711|FG002|Part C (& Follow-up)|COVID-19 related|0|||
150069458|NCT03633617|541396712|FG003|Part C (& Follow-up)|COVID-19 related|0|||
150069459|NCT03633617|541396713|FG004|Part C (& Follow-up)|COVID-19 related|0|||
150069460|NCT03633617|541396714|FG005|Part C (& Follow-up)|COVID-19 related|1|||
150069461|NCT03633617|541396715|FG006|Part C (& Follow-up)|COVID-19 related|0|||
150069462|NCT03633617|541396716|FG007|Part C (& Follow-up)|COVID-19 related|0|||
150069463|NCT03633617|541396717|FG008|Part C (& Follow-up)|COVID-19 related|0|||
150069464|NCT03633617|541396718|FG009|Part C (& Follow-up)|COVID-19 related|0|||
150069465|NCT03633617|541396719|FG010|Part C (& Follow-up)|COVID-19 related|0|||
150069466|NCT03633617|541396709|FG000|Part C (& Follow-up)|Protocol Violation|0|||
150069467|NCT03633617|541396710|FG001|Part C (& Follow-up)|Protocol Violation|0|||
150182052|NCT03398148|541804598|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182053|NCT03398148|541804599|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182054|NCT03398148|541804600|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182055|NCT03398148|541804601|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182056|NCT03398148|541804602|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182057|NCT03398148|541804603|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182058|NCT03398148|541804604|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182059|NCT03398148|541804605|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182060|NCT03398148|541804606|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
150182061|NCT03398148|541804607|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
150069468|NCT03633617|541396711|FG002|Part C (& Follow-up)|Protocol Violation|0|||
150069469|NCT03633617|541396712|FG003|Part C (& Follow-up)|Protocol Violation|0|||
150069470|NCT03633617|541396713|FG004|Part C (& Follow-up)|Protocol Violation|0|||
150069471|NCT03633617|541396714|FG005|Part C (& Follow-up)|Protocol Violation|0|||
150069472|NCT03633617|541396715|FG006|Part C (& Follow-up)|Protocol Violation|0|||
150069473|NCT03633617|541396716|FG007|Part C (& Follow-up)|Protocol Violation|0|||
150069474|NCT03633617|541396717|FG008|Part C (& Follow-up)|Protocol Violation|0|||
150069475|NCT03633617|541396718|FG009|Part C (& Follow-up)|Protocol Violation|3|||
150069476|NCT03633617|541396719|FG010|Part C (& Follow-up)|Protocol Violation|1|||
150069477|NCT03633617|541396709|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
150069478|NCT03633617|541396710|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
150069479|NCT03633617|541396711|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
150069480|NCT03633617|541396712|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
150069481|NCT03633617|541396713|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
150069482|NCT03633617|541396714|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
150069483|NCT03633617|541396715|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
150069484|NCT03633617|541396716|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
150069485|NCT03633617|541396717|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
150069486|NCT03633617|541396718|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
150069487|NCT03633617|541396719|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
150069488|NCT00580970|541396722|FG000|Pre-treatment|Non-compliance|1|||
150069489|NCT00580970|541396722|FG000|Treatment (Lovastatin)|Non-compliance|6|||
150069490|NCT00580970|541396722|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
150069491|NCT00580970|541396722|FG000|Treatment (Lovastatin)|Physician Decision|4|||
150069492|NCT00580970|541396722|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
150069493|NCT00580970|541396722|FG000|Treatment (Lovastatin)|Death|1|||
150069494|NCT03161093|541396723|FG000|Overall Study|Protocol Violation|11|||
150069495|NCT03161093|541396724|FG001|Overall Study|Protocol Violation|14|||
150069496|NCT03161093|541396725|FG002|Overall Study|Protocol Violation|6|||
150069497|NCT03161093|541396726|FG003|Overall Study|Protocol Violation|13|||
150069498|NCT03161093|541396727|FG004|Overall Study|Protocol Violation|1|||
150069499|NCT03161093|541396728|FG005|Overall Study|Protocol Violation|0|||
150069500|NCT03161093|541396723|FG000|Overall Study|Adverse Event|5|||
150069501|NCT03161093|541396724|FG001|Overall Study|Adverse Event|21|||
150069502|NCT03161093|541396725|FG002|Overall Study|Adverse Event|16|||
150069503|NCT03161093|541396726|FG003|Overall Study|Adverse Event|35|||
150069504|NCT03161093|541396727|FG004|Overall Study|Adverse Event|2|||
150069505|NCT03161093|541396728|FG005|Overall Study|Adverse Event|1|||
150069506|NCT03161093|541396723|FG000|Overall Study|Lack of Efficacy|9|||
150069507|NCT03161093|541396724|FG001|Overall Study|Lack of Efficacy|13|||
150069508|NCT03161093|541396725|FG002|Overall Study|Lack of Efficacy|9|||
150069509|NCT03161093|541396726|FG003|Overall Study|Lack of Efficacy|24|||
150069510|NCT03161093|541396727|FG004|Overall Study|Lack of Efficacy|4|||
150069511|NCT03161093|541396728|FG005|Overall Study|Lack of Efficacy|1|||
150069512|NCT03161093|541396723|FG000|Overall Study|Physician Decision|0|||
150069513|NCT03161093|541396724|FG001|Overall Study|Physician Decision|1|||
150069514|NCT03161093|541396725|FG002|Overall Study|Physician Decision|0|||
150069515|NCT03161093|541396726|FG003|Overall Study|Physician Decision|2|||
150069516|NCT03161093|541396727|FG004|Overall Study|Physician Decision|17|||
150069517|NCT03161093|541396728|FG005|Overall Study|Physician Decision|15|||
150069518|NCT03161093|541396723|FG000|Overall Study|Withdrawal by Subject|24|||
150069519|NCT03161093|541396724|FG001|Overall Study|Withdrawal by Subject|73|||
150069520|NCT03161093|541396725|FG002|Overall Study|Withdrawal by Subject|44|||
150069521|NCT03161093|541396726|FG003|Overall Study|Withdrawal by Subject|97|||
150069522|NCT03161093|541396727|FG004|Overall Study|Withdrawal by Subject|11|||
150069523|NCT03161093|541396728|FG005|Overall Study|Withdrawal by Subject|10|||
150069524|NCT03161093|541396723|FG000|Overall Study|Lost to Follow-up|3|||
150069525|NCT03161093|541396724|FG001|Overall Study|Lost to Follow-up|12|||
150069526|NCT03161093|541396725|FG002|Overall Study|Lost to Follow-up|4|||
150069527|NCT03161093|541396726|FG003|Overall Study|Lost to Follow-up|7|||
150069528|NCT03161093|541396727|FG004|Overall Study|Lost to Follow-up|8|||
150069529|NCT03161093|541396728|FG005|Overall Study|Lost to Follow-up|13|||
150069530|NCT03161093|541396723|FG000|Overall Study|Death|3|||
150069531|NCT03161093|541396724|FG001|Overall Study|Death|9|||
150069532|NCT03161093|541396725|FG002|Overall Study|Death|7|||
150069533|NCT03161093|541396726|FG003|Overall Study|Death|9|||
150069534|NCT03161093|541396727|FG004|Overall Study|Death|0|||
150069535|NCT03161093|541396728|FG005|Overall Study|Death|0|||
150069536|NCT03161093|541396723|FG000|Overall Study|Unknown - Not reported|0|||
150069537|NCT03161093|541396724|FG001|Overall Study|Unknown - Not reported|1|||
150069538|NCT03161093|541396725|FG002|Overall Study|Unknown - Not reported|0|||
150069539|NCT03161093|541396726|FG003|Overall Study|Unknown - Not reported|0|||
150069540|NCT03161093|541396727|FG004|Overall Study|Unknown - Not reported|0|||
150069541|NCT03161093|541396728|FG005|Overall Study|Unknown - Not reported|1|||
150069542|NCT00570765|541396729|FG000|DB Phase|Withdrawal by Subject|1|||
150069543|NCT00570765|541396730|FG001|DB Phase|Withdrawal by Subject|0|||
150069544|NCT00570765|541396731|FG002|DB Phase|Withdrawal by Subject|0|||
150069545|NCT00570765|541396732|FG003|DB Phase|Withdrawal by Subject|0|||
150069546|NCT00570765|541396729|FG000|DB Phase|Protocol Violation|0|||
150069547|NCT00570765|541396730|FG001|DB Phase|Protocol Violation|1|||
150069548|NCT00570765|541396731|FG002|DB Phase|Protocol Violation|0|||
150069549|NCT00570765|541396732|FG003|DB Phase|Protocol Violation|0|||
150069550|NCT00570765|541396729|FG000|DB Phase|Adverse Event|3|||
150069551|NCT00570765|541396730|FG001|DB Phase|Adverse Event|6|||
150069552|NCT00570765|541396731|FG002|DB Phase|Adverse Event|0|||
150069553|NCT00570765|541396732|FG003|DB Phase|Adverse Event|0|||
150069554|NCT00570765|541396729|FG000|DB Phase|Did Not Receive Study Drug|0|||
150069555|NCT00570765|541396730|FG001|DB Phase|Did Not Receive Study Drug|0|||
150069556|NCT00570765|541396731|FG002|DB Phase|Did Not Receive Study Drug|1|||
150069557|NCT00570765|541396732|FG003|DB Phase|Did Not Receive Study Drug|0|||
150069558|NCT00570765|541396729|FG000|LTSE Phase|Withdrawal by Subject|0|||
150069559|NCT00570765|541396730|FG001|LTSE Phase|Withdrawal by Subject|0|||
150069560|NCT00570765|541396731|FG002|LTSE Phase|Withdrawal by Subject|0|||
150069561|NCT00570765|541396732|FG003|LTSE Phase|Withdrawal by Subject|1|||
150069562|NCT00570765|541396729|FG000|LTSE Phase|Adverse Event|0|||
150069563|NCT00570765|541396730|FG001|LTSE Phase|Adverse Event|0|||
150069564|NCT00570765|541396731|FG002|LTSE Phase|Adverse Event|0|||
150069565|NCT00570765|541396732|FG003|LTSE Phase|Adverse Event|7|||
150069566|NCT00570765|541396729|FG000|LTSE Phase|Physician Decision|0|||
150069567|NCT00570765|541396730|FG001|LTSE Phase|Physician Decision|0|||
150069568|NCT00570765|541396731|FG002|LTSE Phase|Physician Decision|0|||
150069569|NCT00570765|541396732|FG003|LTSE Phase|Physician Decision|4|||
150069570|NCT01031706|541396733|FG000|Overall Study|Adverse Event|1|||
150069571|NCT01031706|541396734|FG001|Overall Study|Adverse Event|0|||
150069572|NCT01031706|541396733|FG000|Overall Study|Withdrawal by Subject|1|||
150069573|NCT01031706|541396734|FG001|Overall Study|Withdrawal by Subject|1|||
150069574|NCT03114488|541396735|FG000|Time Period 2|Withdrawal by Subject|1|||
150069575|NCT03114488|541396736|FG001|Time Period 2|Withdrawal by Subject|3|||
150069576|NCT03711266|541396737|FG000|Overall Study|Lost to Follow-up|10|||
150069577|NCT01646073|541396738|FG000|Period A (12 Weeks)|Adverse Event|0|||
150069578|NCT01646073|541396739|FG001|Period A (12 Weeks)|Adverse Event|2|||
150069579|NCT01646073|541396738|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
150069580|NCT01646073|541396739|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
150069581|NCT01646073|541396738|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
150069582|NCT01646073|541396739|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
150069583|NCT01646073|541396738|FG000|Period A (12 Weeks)|Protocol Violation|0|||
150069584|NCT01646073|541396739|FG001|Period A (12 Weeks)|Protocol Violation|1|||
150069585|NCT01646073|541396738|FG000|Period A (12 Weeks)|Other|0|||
150069586|NCT01646073|541396739|FG001|Period A (12 Weeks)|Other|1|||
150069587|NCT01646073|541396738|FG000|Period B (12 Weeks)|Adverse Event|0|||
150069588|NCT01646073|541396739|FG001|Period B (12 Weeks)|Adverse Event|7|||
150069589|NCT01646073|541396738|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
150069590|NCT01646073|541396739|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
150069591|NCT01646073|541396738|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
150069592|NCT01646073|541396739|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
150069593|NCT00057876|541396742|FG000|Overall Study|Adverse Event|8|||
150069594|NCT00057876|541396743|FG001|Overall Study|Adverse Event|8|||
150069595|NCT00057876|541396742|FG000|Overall Study|Death|2|||
150069596|NCT00057876|541396743|FG001|Overall Study|Death|1|||
150069597|NCT00057876|541396742|FG000|Overall Study|Withdrawal by Subject|5|||
150069598|NCT00057876|541396743|FG001|Overall Study|Withdrawal by Subject|6|||
150069599|NCT00057876|541396742|FG000|Overall Study|Lack of Efficacy|10|||
150069600|NCT00057876|541396743|FG001|Overall Study|Lack of Efficacy|8|||
150069601|NCT00057876|541396742|FG000|Overall Study|Ineligible|1|||
150069602|NCT00057876|541396743|FG001|Overall Study|Ineligible|2|||
150069603|NCT00057876|541396742|FG000|Overall Study|other reason|2|||
150069604|NCT00057876|541396743|FG001|Overall Study|other reason|2|||
150069605|NCT00057876|541396742|FG000|Overall Study|other complicating disease|1|||
150069606|NCT00057876|541396743|FG001|Overall Study|other complicating disease|0|||
150069607|NCT01393301|541396744|FG000|Overall Study|Lost to Follow-up|5|||
150069608|NCT01393301|541396745|FG001|Overall Study|Lost to Follow-up|3|||
150069609|NCT01393301|541396744|FG000|Overall Study|Withdrawal by Subject|2|||
150069610|NCT01393301|541396745|FG001|Overall Study|Withdrawal by Subject|0|||
150069611|NCT01393301|541396744|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
150069612|NCT01393301|541396745|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
150069613|NCT02758171|541396746|FG000|Wash-out|Withdrawal by Subject|1|||
150069614|NCT02758171|541396747|FG001|Wash-out|Withdrawal by Subject|0|||
150069615|NCT02758171|541396746|FG000|Wash-out|Other reason|1|||
150069616|NCT02758171|541396747|FG001|Wash-out|Other reason|0|||
150069617|NCT01999114|541396748|FG000|Overall Study|Adverse Event|8|||
150069618|NCT01999114|541396749|FG001|Overall Study|Adverse Event|7|||
150069619|NCT01999114|541396750|FG002|Overall Study|Adverse Event|2|||
150069620|NCT01999114|541396751|FG003|Overall Study|Adverse Event|2|||
150069621|NCT01999114|541396752|FG004|Overall Study|Adverse Event|1|||
150069622|NCT01999114|541396748|FG000|Overall Study|Withdrawal by Subject|0|||
150069623|NCT01999114|541396749|FG001|Overall Study|Withdrawal by Subject|0|||
150069624|NCT01999114|541396750|FG002|Overall Study|Withdrawal by Subject|1|||
150069625|NCT01999114|541396751|FG003|Overall Study|Withdrawal by Subject|0|||
150069626|NCT01999114|541396752|FG004|Overall Study|Withdrawal by Subject|1|||
150069627|NCT01999114|541396748|FG000|Overall Study|Lost to Follow-up|0|||
150069628|NCT01999114|541396749|FG001|Overall Study|Lost to Follow-up|0|||
150025557|NCT03367858|541228505|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
150025558|NCT03367858|541228506|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
150025559|NCT03367858|541228505|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
150025560|NCT03367858|541228506|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
150025561|NCT03367858|541228505|FG000|3 Month Follow Up|Lost to Follow-up|8|||
150025562|NCT03367858|541228506|FG001|3 Month Follow Up|Lost to Follow-up|3|||
150025563|NCT03367858|541228505|FG000|3 Month Follow Up|Moved out of study area|2|||
150025564|NCT03367858|541228506|FG001|3 Month Follow Up|Moved out of study area|6|||
150025565|NCT03367858|541228505|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
150025566|NCT03367858|541228506|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
150025567|NCT03367858|541228505|FG000|3 Month Follow Up|MRI contraindication|2|||
150025568|NCT03367858|541228506|FG001|3 Month Follow Up|MRI contraindication|1|||
150025569|NCT03367858|541228505|FG000|3 Month Follow Up|Incarcerated|0|||
150025570|NCT03367858|541228506|FG001|3 Month Follow Up|Incarcerated|1|||
150025571|NCT03367858|541228505|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
150025572|NCT03367858|541228506|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
150025573|NCT03367858|541228505|FG000|6 Month Follow Up|Lost to Follow-up|5|||
150025574|NCT03367858|541228506|FG001|6 Month Follow Up|Lost to Follow-up|2|||
150025575|NCT03367858|541228505|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
150025576|NCT03367858|541228506|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
150025577|NCT03367858|541228505|FG000|12 Month Follow Up|Lost to Follow-up|3|||
150025578|NCT03367858|541228506|FG001|12 Month Follow Up|Lost to Follow-up|3|||
150025579|NCT03367858|541228505|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
150025580|NCT03367858|541228506|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
150025581|NCT01176058|541228508|FG000|Overall Study|Adverse Event|1|||
150025582|NCT01176058|541228509|FG001|Overall Study|Adverse Event|0|||
150025583|NCT01176058|541228508|FG000|Overall Study|Insufficient clinical response|2|||
150025584|NCT01176058|541228509|FG001|Overall Study|Insufficient clinical response|2|||
150025585|NCT01176058|541228508|FG000|Overall Study|Insufficient mycological response|0|||
150025586|NCT01176058|541228509|FG001|Overall Study|Insufficient mycological response|1|||
150025587|NCT01176058|541228508|FG000|Overall Study|Withdrawal by Subject|1|||
150025588|NCT01176058|541228509|FG001|Overall Study|Withdrawal by Subject|0|||
150025589|NCT01858363|541228512|FG000|Overall Study|Death|35|||
150025590|NCT01858363|541228513|FG001|Overall Study|Death|9|||
150025591|NCT01858363|541228512|FG000|Overall Study|Withdrawal by Subject|28|||
150025592|NCT01858363|541228513|FG001|Overall Study|Withdrawal by Subject|14|||
150025593|NCT01858363|541228512|FG000|Overall Study|Lost to Follow-up|13|||
150025594|NCT01858363|541228513|FG001|Overall Study|Lost to Follow-up|3|||
150025595|NCT01859923|541228514|FG000|Overall Study|Adverse Event|0|||
150025596|NCT01859923|541228515|FG001|Overall Study|Adverse Event|0|||
150025597|NCT01859923|541228516|FG002|Overall Study|Adverse Event|1|||
150025598|NCT01859923|541228517|FG003|Overall Study|Adverse Event|1|||
150025599|NCT00057863|541228523|FG000|Overall Study|Death|1|||
150025600|NCT00057863|541228523|FG000|Overall Study|Withdrawal by Subject|2|||
150025601|NCT00764361|541228524|FG000|Overall Study|Withdrawal by Subject|2|||
150025602|NCT00764361|541228525|FG001|Overall Study|Withdrawal by Subject|3|||
150025603|NCT00764361|541228524|FG000|Overall Study|Adverse Event|0|||
150025604|NCT00764361|541228525|FG001|Overall Study|Adverse Event|1|||
150025605|NCT02090426|541228526|FG000|Overall Study|Lost to Follow-up|12|||
150025606|NCT02090426|541228527|FG001|Overall Study|Lost to Follow-up|6|||
150025607|NCT02079038|541228531|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
150025608|NCT02079038|541228532|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
150025609|NCT02079038|541228531|FG000|Modified Intent to Treat Population|Death|1|||
150025610|NCT02079038|541228532|FG001|Modified Intent to Treat Population|Death|0|||
150025611|NCT02079038|541228531|FG000|Completed 6 Months|Lost to Follow-up|2|||
150025612|NCT02079038|541228532|FG001|Completed 6 Months|Lost to Follow-up|1|||
150025613|NCT03480152|541228533|FG000|Phase I|Signed consent. Died before treatment.|1|||
150025614|NCT03480152|541228534|FG001|Phase I|Signed consent. Died before treatment.|0|||
150025615|NCT03480152|541228535|FG002|Phase I|Signed consent. Died before treatment.|0|||
150025616|NCT01308736|541228536|FG000|Overall Study|Did not attend a single session|6|||
150025617|NCT01308736|541228537|FG001|Overall Study|Did not attend a single session|5|||
150025618|NCT03634085|541228538|FG000|Overall Study|Adverse Event|1|||
150025619|NCT03634085|541228539|FG001|Overall Study|Adverse Event|0|||
150025620|NCT03634085|541228538|FG000|Overall Study|Withdrawal by Subject|0|||
150025621|NCT03634085|541228539|FG001|Overall Study|Withdrawal by Subject|2|||
150025622|NCT04276233|541228540|FG000|Overall Study|Adverse Event|1|||
150025623|NCT04276233|541228540|FG000|Overall Study|Lost to Follow-up|3|||
150025624|NCT04276233|541228540|FG000|Overall Study|Physician Decision|4|||
150025625|NCT04276233|541228540|FG000|Overall Study|Withdrawal by Subject|2|||
150025626|NCT01946139|541228543|FG000|Overall Study|Withdrawal by Subject|8|||
150025627|NCT01946139|541228543|FG000|Overall Study|ineligible|8|||
150025628|NCT01946139|541228543|FG000|Overall Study|Specimens not available|4|||
150025629|NCT03901144|541228555|FG000|Overall Study|Lost to Follow-up|1|||
150025630|NCT03901144|541228556|FG001|Overall Study|Lost to Follow-up|1|||
150025631|NCT03901144|541228557|FG002|Overall Study|Lost to Follow-up|1|||
150069629|NCT01999114|541396750|FG002|Overall Study|Lost to Follow-up|1|||
150069630|NCT01999114|541396751|FG003|Overall Study|Lost to Follow-up|0|||
150069631|NCT01999114|541396752|FG004|Overall Study|Lost to Follow-up|0|||
150069632|NCT01999114|541396748|FG000|Overall Study|Administrative|0|||
150069633|NCT01999114|541396749|FG001|Overall Study|Administrative|0|||
150069634|NCT01999114|541396750|FG002|Overall Study|Administrative|1|||
150069635|NCT01999114|541396751|FG003|Overall Study|Administrative|1|||
150069636|NCT01999114|541396752|FG004|Overall Study|Administrative|2|||
150069637|NCT03342963|541396755|FG000|Overall Study|Adverse Event|1|||
150069638|NCT03342963|541396756|FG001|Overall Study|Adverse Event|2|||
150069639|NCT03342963|541396757|FG002|Overall Study|Adverse Event|0|||
150069640|NCT03342963|541396758|FG003|Overall Study|Adverse Event|0|||
150069641|NCT03342963|541396755|FG000|Overall Study|Withdrawal by Subject|1|||
150069642|NCT03342963|541396756|FG001|Overall Study|Withdrawal by Subject|0|||
150069643|NCT03342963|541396757|FG002|Overall Study|Withdrawal by Subject|0|||
150069644|NCT03342963|541396758|FG003|Overall Study|Withdrawal by Subject|0|||
150069645|NCT01309165|541396759|FG000|Overall Study|Lost to Follow-up|4|||
150069646|NCT01309165|541396760|FG001|Overall Study|Lost to Follow-up|3|||
150069647|NCT01309165|541396759|FG000|Overall Study|Return to work|1|||
150069648|NCT01309165|541396760|FG001|Overall Study|Return to work|2|||
150069649|NCT01309165|541396759|FG000|Overall Study|Left country|0|||
150069650|NCT01309165|541396760|FG001|Overall Study|Left country|1|||
150069651|NCT01309165|541396759|FG000|Overall Study|No transportation|0|||
150069652|NCT01309165|541396760|FG001|Overall Study|No transportation|1|||
150069653|NCT01309165|541396759|FG000|Overall Study|Admitted to hospital for second stroke|1|||
150069654|NCT01309165|541396760|FG001|Overall Study|Admitted to hospital for second stroke|0|||
150069655|NCT01739309|541396763|FG000|Overall Study|Adverse Event|1|||
150069656|NCT01739309|541396763|FG000|Overall Study|Withdrawal by Subject|1|||
150069657|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Adverse Event|10|||
150069658|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Adverse Event|0|||
150069659|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
150069660|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
150069661|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
150069662|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
150069663|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
150069664|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
150069665|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
150069666|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
150069667|NCT02787551|541396767|FG000|Core Period: 26 Weeks|Other than specified|3|||
150069668|NCT02787551|541396768|FG001|Core Period: 26 Weeks|Other than specified|1|||
150069669|NCT02787551|541396767|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
150069670|NCT02787551|541396768|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
150069671|NCT02787551|541396767|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
150069672|NCT02787551|541396768|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
150069673|NCT02787551|541396767|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
150069674|NCT02787551|541396768|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
150069675|NCT00620464|541396769|FG000|Overall Study|Adverse Event|15|||
150069676|NCT00620464|541396770|FG001|Overall Study|Adverse Event|17|||
150069677|NCT00620464|541396769|FG000|Overall Study|Lost to Follow-up|1|||
150069678|NCT00620464|541396770|FG001|Overall Study|Lost to Follow-up|1|||
150069679|NCT00620464|541396769|FG000|Overall Study|Planning Pregnancy|1|||
150069680|NCT00620464|541396770|FG001|Overall Study|Planning Pregnancy|4|||
150069681|NCT00620464|541396769|FG000|Overall Study|Personal|2|||
150069682|NCT00620464|541396770|FG001|Overall Study|Personal|2|||
150069683|NCT00620464|541396769|FG000|Overall Study|Used prohibited medication|1|||
150069684|NCT00620464|541396770|FG001|Overall Study|Used prohibited medication|0|||
150069685|NCT02038452|541396771|FG000|Overall Study|Withdrawal by Subject|7|||
150069686|NCT02038452|541396772|FG001|Overall Study|Withdrawal by Subject|9|||
150069687|NCT02038452|541396771|FG000|Overall Study|Lost to Follow-up|31|||
150069688|NCT02038452|541396772|FG001|Overall Study|Lost to Follow-up|28|||
150069689|NCT03139279|541396773|FG000|Overall Study|Physician Decision|2|||
150069690|NCT03139279|541396774|FG001|Overall Study|Physician Decision|0|||
150069691|NCT03139279|541396773|FG000|Overall Study|Protocol Violation|5|||
150069692|NCT03139279|541396774|FG001|Overall Study|Protocol Violation|4|||
150069693|NCT03139279|541396773|FG000|Overall Study|Withdrawal by Subject|0|||
150182062|NCT03398148|541804608|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
150069694|NCT03139279|541396774|FG001|Overall Study|Withdrawal by Subject|2|||
150069695|NCT01336569|541396775|FG000|Overall Study|Lost to Follow-up|4|||
150069696|NCT02337738|541396776|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
150069697|NCT02337738|541396777|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
150069698|NCT02337738|541396778|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
150069699|NCT02337738|541396776|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
150069700|NCT02337738|541396777|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
150069701|NCT02337738|541396778|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
150069702|NCT02337738|541396776|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
150069703|NCT02337738|541396777|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
150069704|NCT02337738|541396778|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
150069705|NCT02337738|541396776|FG000|Overall Study|Voluntary Withdrawal|10|||
150069706|NCT02337738|541396777|FG001|Overall Study|Voluntary Withdrawal|5|||
150069707|NCT02337738|541396778|FG002|Overall Study|Voluntary Withdrawal|2|||
150069708|NCT02337738|541396776|FG000|Overall Study|Lack of Efficacy|2|||
150069709|NCT02337738|541396777|FG001|Overall Study|Lack of Efficacy|4|||
150069710|NCT02337738|541396778|FG002|Overall Study|Lack of Efficacy|0|||
150069711|NCT02337738|541396776|FG000|Overall Study|Investigator's Judgment|1|||
150069712|NCT02337738|541396777|FG001|Overall Study|Investigator's Judgment|1|||
150069713|NCT02337738|541396778|FG002|Overall Study|Investigator's Judgment|3|||
150069714|NCT03911154|541396779|FG000|Overall Study|Withdrawal by Subject|1|||
150069715|NCT00406354|541396780|FG000|All Randomized Patients|Protocol Violation|0|||
150069716|NCT00406354|541396781|FG001|All Randomized Patients|Protocol Violation|0|||
150069717|NCT00406354|541396782|FG002|All Randomized Patients|Protocol Violation|1|||
150069718|NCT00406354|541396780|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
150069719|NCT00406354|541396781|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
150069720|NCT00406354|541396782|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
150069721|NCT00406354|541396780|FG000|All Randomized and Treated Patients|Adverse Event|6|||
150069722|NCT00406354|541396781|FG001|All Randomized and Treated Patients|Adverse Event|2|||
150069723|NCT00406354|541396782|FG002|All Randomized and Treated Patients|Adverse Event|1|||
150069724|NCT00406354|541396780|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
150069725|NCT00406354|541396781|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
150069726|NCT00406354|541396782|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
150069727|NCT00406354|541396780|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
150069728|NCT00406354|541396781|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
150069729|NCT00406354|541396782|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
150069730|NCT00406354|541396780|FG000|All Randomized and Treated Patients|Physician Decision|0|||
150069731|NCT00406354|541396781|FG001|All Randomized and Treated Patients|Physician Decision|0|||
150069732|NCT00406354|541396782|FG002|All Randomized and Treated Patients|Physician Decision|1|||
150069733|NCT01231347|541396783|FG000|Overall Study|Full Consent withdrawn|19|||
150069734|NCT01231347|541396784|FG001|Overall Study|Full Consent withdrawn|19|||
150069735|NCT01231347|541396785|FG002|Overall Study|Full Consent withdrawn|11|||
150069736|NCT01231347|541396783|FG000|Overall Study|Lost to Follow-up|4|||
150069737|NCT01231347|541396784|FG001|Overall Study|Lost to Follow-up|2|||
150069738|NCT01231347|541396785|FG002|Overall Study|Lost to Follow-up|2|||
150069739|NCT01231347|541396783|FG000|Overall Study|Death|202|||
150069740|NCT01231347|541396784|FG001|Overall Study|Death|210|||
150069741|NCT01231347|541396785|FG002|Overall Study|Death|101|||
150069742|NCT01231347|541396783|FG000|Overall Study|other event|7|||
150069743|NCT01231347|541396784|FG001|Overall Study|other event|9|||
150069744|NCT01231347|541396785|FG002|Overall Study|other event|3|||
150069745|NCT01626495|541396790|FG000|Overall Study|Adverse Event|3|||
150069746|NCT01626495|541396790|FG000|Overall Study|Disease progression|27|||
150069747|NCT01626495|541396790|FG000|Overall Study|Withdrawal by Subject|1|||
150069748|NCT01626495|541396790|FG000|Overall Study|Administrative problem|1|||
150069749|NCT01626495|541396790|FG000|Overall Study|Death|2|||
150069750|NCT01626495|541396790|FG000|Overall Study|Physician Decision|1|||
150069751|NCT01626495|541396790|FG000|Overall Study|New cancer therapy|16|||
150069752|NCT01626495|541396790|FG000|Overall Study|Manufacturing failure|1|||
150069753|NCT01565642|541396791|FG000|Overall Study|Withdrawal by Subject|2|||
150069754|NCT01565642|541396792|FG001|Overall Study|Withdrawal by Subject|1|||
150069755|NCT01934972|541396793|FG000|Overall Study|Withdrawal by Subject|9|||
150069756|NCT01934972|541396794|FG001|Overall Study|Withdrawal by Subject|6|||
150069757|NCT01278160|541396795|FG000|Overall Study|Adverse Event|1|||
150069758|NCT01278160|541396796|FG001|Overall Study|Adverse Event|1|||
150069759|NCT01278160|541396795|FG000|Overall Study|Lost to Follow-up|0|||
150069760|NCT01278160|541396796|FG001|Overall Study|Lost to Follow-up|1|||
150069761|NCT01278160|541396795|FG000|Overall Study|Withdrawal by Subject|3|||
150069762|NCT01278160|541396796|FG001|Overall Study|Withdrawal by Subject|2|||
150069763|NCT01278160|541396795|FG000|Overall Study|Unclassified|1|||
150069764|NCT01278160|541396796|FG001|Overall Study|Unclassified|2|||
150069765|NCT01631812|541396797|FG000|Overall Study|Adverse Event|25|||
150069766|NCT01631812|541396797|FG000|Overall Study|Lack of Efficacy|5|||
150069767|NCT01631812|541396797|FG000|Overall Study|Withdrawal by Subject|4|||
150069768|NCT01631812|541396797|FG000|Overall Study|Physician Decision|3|||
150069769|NCT00932737|541396800|FG000|Overall Study|Not treated in second episode|1|||
150069770|NCT00932737|541396801|FG001|Overall Study|Not treated in second episode|0|||
150069771|NCT00932737|541396800|FG000|Overall Study|Adverse Event|0|||
150069772|NCT00932737|541396801|FG001|Overall Study|Adverse Event|1|||
150069773|NCT02718300|541396804|FG000|Overall Study|Death|4|||
150069774|NCT02718300|541396805|FG001|Overall Study|Death|5|||
150069775|NCT02718300|541396806|FG002|Overall Study|Death|17|||
150069776|NCT02718300|541396804|FG000|Overall Study|Lost to Follow-up|1|||
150069777|NCT02718300|541396805|FG001|Overall Study|Lost to Follow-up|0|||
150069778|NCT02718300|541396806|FG002|Overall Study|Lost to Follow-up|2|||
150069779|NCT02718300|541396804|FG000|Overall Study|Physician Decision|1|||
150069780|NCT02718300|541396805|FG001|Overall Study|Physician Decision|0|||
150069781|NCT02718300|541396806|FG002|Overall Study|Physician Decision|2|||
150069782|NCT02718300|541396804|FG000|Overall Study|Study Terminated by Sponsor|6|||
150069783|NCT02718300|541396805|FG001|Overall Study|Study Terminated by Sponsor|3|||
150069784|NCT02718300|541396806|FG002|Overall Study|Study Terminated by Sponsor|4|||
150069785|NCT02718300|541396804|FG000|Overall Study|Withdrawal by Subject|0|||
150069786|NCT02718300|541396805|FG001|Overall Study|Withdrawal by Subject|4|||
150069787|NCT02718300|541396806|FG002|Overall Study|Withdrawal by Subject|3|||
150069788|NCT02718300|541396804|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
150069789|NCT02718300|541396805|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
150069790|NCT02718300|541396806|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
150069791|NCT03673046|541398213|FG000|Overall Study|Adverse Event|1|||
150069792|NCT03673046|541398214|FG001|Overall Study|Adverse Event|1|||
150069793|NCT03673046|541398213|FG000|Overall Study|Withdrawal by Subject|8|||
150069794|NCT03673046|541398214|FG001|Overall Study|Withdrawal by Subject|2|||
150069795|NCT03817879|541398215|FG000|Overall Study|Drop out|5|||
150069796|NCT03817879|541398216|FG001|Overall Study|Drop out|12|||
150069797|NCT03817879|541398215|FG000|Overall Study|Withdrawal by Subject|0|||
150069798|NCT03817879|541398216|FG001|Overall Study|Withdrawal by Subject|1|||
150069799|NCT03693300|541398217|FG000|Overall Study|Withdrawal by Subject|6|||
150069800|NCT03693300|541398218|FG001|Overall Study|Withdrawal by Subject|0|||
150069801|NCT03693300|541398217|FG000|Overall Study|Death|50|||
150069802|NCT03693300|541398218|FG001|Overall Study|Death|2|||
150069803|NCT03693300|541398217|FG000|Overall Study|Lost to Follow-up|2|||
150069804|NCT03693300|541398218|FG001|Overall Study|Lost to Follow-up|0|||
150069805|NCT00697073|541398219|FG000|Overall Study|Withdrawal by Subject|2|||
150069806|NCT00697073|541398219|FG000|Overall Study|Pregnancy|1|||
150069807|NCT00697073|541398219|FG000|Overall Study|non compliance and other|6|||
150069808|NCT03894046|541398222|FG000|Overall Study|Protocol Violation|1|||
150069809|NCT03894046|541398223|FG001|Overall Study|Protocol Violation|0|||
150069810|NCT03894046|541398224|FG002|Overall Study|Protocol Violation|0|||
150069811|NCT03894046|541398222|FG000|Overall Study|Adverse Event|0|||
150069812|NCT03894046|541398223|FG001|Overall Study|Adverse Event|1|||
150069813|NCT03894046|541398224|FG002|Overall Study|Adverse Event|0|||
150069814|NCT03894046|541398222|FG000|Overall Study|Withdrawal by Subject|2|||
150069815|NCT03894046|541398223|FG001|Overall Study|Withdrawal by Subject|3|||
150069816|NCT03894046|541398224|FG002|Overall Study|Withdrawal by Subject|1|||
150069817|NCT03894046|541398222|FG000|Overall Study|Death|15|||
150069818|NCT03894046|541398223|FG001|Overall Study|Death|21|||
150069819|NCT03894046|541398224|FG002|Overall Study|Death|4|||
150069820|NCT03894046|541398222|FG000|Overall Study|No growth of ABC|2|||
150069821|NCT03894046|541398223|FG001|Overall Study|No growth of ABC|1|||
150069822|NCT03894046|541398224|FG002|Overall Study|No growth of ABC|0|||
150069823|NCT03894046|541398222|FG000|Overall Study|Physician Decision|1|||
150069824|NCT03894046|541398223|FG001|Overall Study|Physician Decision|1|||
150069825|NCT03894046|541398224|FG002|Overall Study|Physician Decision|1|||
150069826|NCT03894046|541398222|FG000|Overall Study|Prohibited concomitant medication|1|||
150069827|NCT03894046|541398223|FG001|Overall Study|Prohibited concomitant medication|0|||
150069828|NCT03894046|541398224|FG002|Overall Study|Prohibited concomitant medication|0|||
150069829|NCT03894046|541398222|FG000|Overall Study|Transferred to other arm/group|1|||
150069830|NCT03894046|541398223|FG001|Overall Study|Transferred to other arm/group|1|||
150069831|NCT03894046|541398224|FG002|Overall Study|Transferred to other arm/group|0|||
150069832|NCT02202837|541398227|FG000|Overall Study|Enbrel treatment discontinued|36|||
150069833|NCT02202837|541398228|FG001|Overall Study|Enbrel treatment discontinued|4|||
150069834|NCT02202837|541398227|FG000|Overall Study|Other|10|||
150069835|NCT02202837|541398228|FG001|Overall Study|Other|0|||
150069836|NCT02202837|541398227|FG000|Overall Study|Lost to Follow-up|7|||
150069837|NCT02202837|541398228|FG001|Overall Study|Lost to Follow-up|1|||
150069838|NCT04195906|541398231|FG000|Part 1|Adverse Event|3|||
150069839|NCT04195906|541398232|FG001|Part 1|Adverse Event|7|||
150069840|NCT04195906|541398231|FG000|Part 1|Withdrawal by Subject|0|||
150069841|NCT04195906|541398232|FG001|Part 1|Withdrawal by Subject|1|||
150069842|NCT04195906|541398231|FG000|Part 2|Adverse Event|1|||
150069843|NCT04195906|541398232|FG001|Part 2|Adverse Event|1|||
150069844|NCT04195906|541398231|FG000|Part 2|Withdrawal by Subject|0|||
150069845|NCT04195906|541398232|FG001|Part 2|Withdrawal by Subject|3|||
150069846|NCT04195906|541398231|FG000|Part 2|Other|1|||
150069847|NCT04195906|541398232|FG001|Part 2|Other|3|||
150069848|NCT02486302|541398233|FG000|Overall Study|Discontinued prematurely|410|||
150069849|NCT02486302|541398233|FG000|Overall Study|Documentation not completed|255|||
150069850|NCT02486302|541398233|FG000|Overall Study|Excluded due to legal reasons|8|||
150069851|NCT02486302|541398233|FG000|Overall Study|Not treated|3|||
150069852|NCT00385762|541398236|FG000|Overall Study|Adverse Event|1|||
150069853|NCT00385762|541398236|FG000|Overall Study|Lost to Follow-up|1|||
150069854|NCT02422303|541398237|FG000|Overall Study|Lost to Follow-up|1|||
150069855|NCT02422303|541398238|FG001|Overall Study|Lost to Follow-up|1|||
150069856|NCT00428792|541398240|FG000|Overall Study|Lack of Efficacy|1|||
150069857|NCT00428792|541398241|FG001|Overall Study|Lack of Efficacy|3|||
150069858|NCT00428792|541398240|FG000|Overall Study|Lost to Follow-up|0|||
150069859|NCT00428792|541398241|FG001|Overall Study|Lost to Follow-up|1|||
150069860|NCT00850343|541398242|FG000|Overall Study|Withdrawal by Subject|11|||
150069861|NCT00850343|541398243|FG001|Overall Study|Withdrawal by Subject|0|||
150069862|NCT00850343|541398244|FG002|Overall Study|Withdrawal by Subject|3|||
150069863|NCT00850343|541398245|FG003|Overall Study|Withdrawal by Subject|2|||
150069864|NCT00850343|541398242|FG000|Overall Study|Adverse Event|15|||
150069865|NCT00850343|541398243|FG001|Overall Study|Adverse Event|2|||
150069866|NCT00850343|541398244|FG002|Overall Study|Adverse Event|6|||
150069867|NCT00850343|541398245|FG003|Overall Study|Adverse Event|6|||
150069868|NCT00850343|541398242|FG000|Overall Study|Pregnancy|0|||
150069869|NCT00850343|541398243|FG001|Overall Study|Pregnancy|0|||
150069870|NCT00850343|541398244|FG002|Overall Study|Pregnancy|0|||
150069871|NCT00850343|541398245|FG003|Overall Study|Pregnancy|1|||
150069872|NCT00850343|541398242|FG000|Overall Study|Lack of Efficacy|17|||
150069873|NCT00850343|541398243|FG001|Overall Study|Lack of Efficacy|0|||
150069874|NCT00850343|541398244|FG002|Overall Study|Lack of Efficacy|3|||
150069875|NCT00850343|541398245|FG003|Overall Study|Lack of Efficacy|2|||
150069876|NCT00850343|541398242|FG000|Overall Study|Non-compliance with Study Procedures|1|||
150069877|NCT00850343|541398243|FG001|Overall Study|Non-compliance with Study Procedures|0|||
150069878|NCT00850343|541398244|FG002|Overall Study|Non-compliance with Study Procedures|1|||
150069879|NCT00850343|541398245|FG003|Overall Study|Non-compliance with Study Procedures|1|||
150069880|NCT00850343|541398242|FG000|Overall Study|Physician Decision|2|||
150069881|NCT00850343|541398243|FG001|Overall Study|Physician Decision|1|||
150069882|NCT00850343|541398244|FG002|Overall Study|Physician Decision|1|||
150069883|NCT00850343|541398245|FG003|Overall Study|Physician Decision|1|||
150069884|NCT00371826|541398246|FG000|Core Phase (12 Months)|Adverse Event|15|||
150069885|NCT00371826|541398247|FG001|Core Phase (12 Months)|Adverse Event|4|||
150069886|NCT00371826|541398248|FG002|Core Phase (12 Months)|Adverse Event|9|||
150069887|NCT00371826|541398246|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
150069888|NCT00371826|541398247|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
150182063|NCT03398148|541804609|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182064|NCT03398148|541804610|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
150182065|NCT03398148|541804596|FG000|Substudy 2 Period 2|Adverse Event|0|||
150182066|NCT03398148|541804597|FG001|Substudy 2 Period 2|Adverse Event|0|||
150182067|NCT03398148|541804598|FG002|Substudy 2 Period 2|Adverse Event|0|||
150182068|NCT03398148|541804599|FG003|Substudy 2 Period 2|Adverse Event|0|||
150182069|NCT03398148|541804600|FG004|Substudy 2 Period 2|Adverse Event|0|||
150182070|NCT03398148|541804601|FG005|Substudy 2 Period 2|Adverse Event|0|||
150182071|NCT03398148|541804602|FG006|Substudy 2 Period 2|Adverse Event|0|||
150182072|NCT03398148|541804603|FG007|Substudy 2 Period 2|Adverse Event|0|||
150182073|NCT03398148|541804604|FG008|Substudy 2 Period 2|Adverse Event|0|||
150069889|NCT00371826|541398248|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
150069890|NCT00371826|541398246|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
150069891|NCT00371826|541398247|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
150069892|NCT00371826|541398248|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
150069893|NCT00371826|541398246|FG000|Core Phase (12 Months)|Protocol Violation|1|||
150069894|NCT00371826|541398247|FG001|Core Phase (12 Months)|Protocol Violation|0|||
150069895|NCT00371826|541398248|FG002|Core Phase (12 Months)|Protocol Violation|1|||
150069896|NCT00371826|541398246|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
150069897|NCT00371826|541398247|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
150069898|NCT00371826|541398248|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
150069899|NCT00371826|541398246|FG000|Core Phase (12 Months)|Administrative problems|1|||
150025632|NCT03901144|541228558|FG003|Overall Study|Lost to Follow-up|1|||
150025633|NCT04445662|541228562|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
150025634|NCT04445662|541228563|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
150025635|NCT04445662|541228562|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
150025636|NCT04445662|541228563|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
150025637|NCT04445662|541228562|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
150025638|NCT04445662|541228563|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
150025639|NCT04445662|541228562|FG000|Post-treatment (12-24 weeks)|Death|1|||
150025640|NCT04445662|541228563|FG001|Post-treatment (12-24 weeks)|Death|0|||
150025641|NCT02488005|541228567|FG000|Overall Study|Lost to Follow-up|2|||
150025642|NCT05864586|541228568|FG000|Overall Study|Ineligible|4|||
150025643|NCT05864586|541228569|FG001|Overall Study|Ineligible|12|||
150025644|NCT05864586|541228568|FG000|Overall Study|Pregnancy|0|||
150025645|NCT05864586|541228569|FG001|Overall Study|Pregnancy|1|||
150025646|NCT05864586|541228568|FG000|Overall Study|Withdrawal by Subject|0|||
150025647|NCT05864586|541228569|FG001|Overall Study|Withdrawal by Subject|1|||
150025648|NCT03635424|541228570|FG000|Overall Study|Adverse Event|1|||
150025649|NCT03635424|541228570|FG000|Overall Study|Death|1|||
150025650|NCT03635424|541228570|FG000|Overall Study|Device not implanted|1|||
150025651|NCT05081219|541228571|FG000|Overall Study|Withdrawal by Subject|4|||
150025652|NCT05081219|541228572|FG001|Overall Study|Withdrawal by Subject|0|||
150025653|NCT05081219|541228573|FG002|Overall Study|Withdrawal by Subject|0|||
150025654|NCT05081219|541228574|FG003|Overall Study|Withdrawal by Subject|1|||
150025655|NCT01050634|541230361|FG000|Overall Study|Enrolled, but Not Treated|56|||
150025656|NCT01050634|541230361|FG000|Overall Study|Death|2|||
150025657|NCT01050634|541230361|FG000|Overall Study|Adverse Event|42|||
150025658|NCT01050634|541230361|FG000|Overall Study|Lost to Follow-up|2|||
150025659|NCT01050634|541230361|FG000|Overall Study|Other|21|||
150025660|NCT01050634|541230361|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
150025661|NCT01702844|541230362|FG000|Overall Study|Adverse Event|9|||
150025662|NCT01702844|541230362|FG000|Overall Study|Death|1|||
150025663|NCT01702844|541230362|FG000|Overall Study|Withdrawal by Subject|3|||
150025664|NCT01702844|541230362|FG000|Overall Study|Physician Decision|6|||
150025665|NCT03956550|541230363|FG000|Overall Study|Sponsor decision|65|||
150025666|NCT03956550|541230364|FG001|Overall Study|Sponsor decision|66|||
150025667|NCT03956550|541230365|FG002|Overall Study|Sponsor decision|64|||
150025668|NCT03956550|541230363|FG000|Overall Study|Adverse Event|0|||
150025669|NCT03956550|541230364|FG001|Overall Study|Adverse Event|1|||
150025670|NCT03956550|541230365|FG002|Overall Study|Adverse Event|0|||
150025671|NCT03956550|541230363|FG000|Overall Study|Withdrawal by Subject|5|||
150025672|NCT03956550|541230364|FG001|Overall Study|Withdrawal by Subject|5|||
150025673|NCT03956550|541230365|FG002|Overall Study|Withdrawal by Subject|6|||
150025674|NCT04154943|541230368|FG000|Overall Study|Study Ongoing|68|||
150025675|NCT04154943|541230368|FG000|Overall Study|Lost to Follow-up|1|||
150025676|NCT04154943|541230368|FG000|Overall Study|Decision by the Investigator|1|||
150025677|NCT04154943|541230368|FG000|Overall Study|Death|5|||
150025678|NCT04154943|541230368|FG000|Overall Study|Withdrawal by Subject|4|||
150025679|NCT00296816|541230369|FG000|Overall Study|Disease Progression|37|||
150025680|NCT00296816|541230369|FG000|Overall Study|Adverse Event|18|||
150025681|NCT00296816|541230369|FG000|Overall Study|Investigator/Participant request|5|||
150025682|NCT00296816|541230369|FG000|Overall Study|Non-compliance|1|||
150025683|NCT00296816|541230369|FG000|Overall Study|Missing for end of treatment|4|||
150025684|NCT00296816|541230369|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
150025685|NCT00296816|541230369|FG000|Overall Study|Poor performance status|1|||
150025686|NCT00296816|541230369|FG000|Overall Study|Relocation to Florida|1|||
150025687|NCT00296816|541230369|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
150025688|NCT00296816|541230369|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
150025689|NCT00296816|541230369|FG000|Overall Study|Neuropathy/patient preference|1|||
150025690|NCT00296816|541230369|FG000|Overall Study|Proteinuria|1|||
150025691|NCT00296816|541230369|FG000|Overall Study|ineligibility due to radiation treatment|1|||
150025692|NCT01363700|541230370|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
150025693|NCT01363700|541230371|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
150025694|NCT01363700|541230372|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
150025695|NCT01363700|541230373|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
150182074|NCT03398148|541804605|FG009|Substudy 2 Period 2|Adverse Event|0|||
150069900|NCT00371826|541398247|FG001|Core Phase (12 Months)|Administrative problems|0|||
150069901|NCT00371826|541398248|FG002|Core Phase (12 Months)|Administrative problems|8|||
150069902|NCT00371826|541398246|FG000|Core Phase (12 Months)|Graft Loss|0|||
150069903|NCT00371826|541398247|FG001|Core Phase (12 Months)|Graft Loss|1|||
150069904|NCT00371826|541398248|FG002|Core Phase (12 Months)|Graft Loss|0|||
150069905|NCT00371826|541398246|FG000|Extension Phase (24 Months)|Adverse Event|4|||
150069906|NCT00371826|541398247|FG001|Extension Phase (24 Months)|Adverse Event|5|||
150069907|NCT00371826|541398248|FG002|Extension Phase (24 Months)|Adverse Event|0|||
150069908|NCT00371826|541398246|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
150069909|NCT00371826|541398247|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
150069910|NCT00371826|541398248|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
150069911|NCT00371826|541398246|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
150069912|NCT00371826|541398247|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
150069913|NCT00371826|541398248|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
150069914|NCT00371826|541398246|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
150069915|NCT00371826|541398247|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
150069916|NCT00371826|541398248|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
150069917|NCT00371826|541398246|FG000|Extension Phase (24 Months)|Administrative problems|0|||
150069918|NCT00371826|541398247|FG001|Extension Phase (24 Months)|Administrative problems|0|||
150069919|NCT00371826|541398248|FG002|Extension Phase (24 Months)|Administrative problems|2|||
150069920|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Death|1|||
150069921|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Death|1|||
150069922|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Death|0|||
150069923|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Death|0|||
150069924|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
150069925|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
150069926|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
150069927|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
150069928|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
150069929|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
150069930|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
150069931|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
150069932|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
150069933|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
150069934|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
150069935|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
150069936|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
150069937|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
150069938|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
150069939|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
150069940|NCT04612790|541398252|FG000|DB Period (Up to 36 Weeks)|Other|1|||
150069941|NCT04612790|541398253|FG001|DB Period (Up to 36 Weeks)|Other|0|||
150069942|NCT04612790|541398254|FG002|DB Period (Up to 36 Weeks)|Other|0|||
150069943|NCT04612790|541398255|FG003|DB Period (Up to 36 Weeks)|Other|0|||
150069944|NCT04612790|541398252|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
150069945|NCT04612790|541398253|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
150069946|NCT04612790|541398254|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
150069947|NCT04612790|541398255|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
150069948|NCT04612790|541398252|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
150069949|NCT04612790|541398253|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
150069950|NCT04612790|541398254|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
150069951|NCT04612790|541398255|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
150069952|NCT04612790|541398252|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
150069953|NCT04612790|541398253|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
150069954|NCT04612790|541398254|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
150182075|NCT03398148|541804606|FG010|Substudy 2 Period 2|Adverse Event|0|||
150069955|NCT04612790|541398255|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
150069956|NCT04612790|541398252|FG000|OLE Period (Up to 1 Year)|Other|0|||
150069957|NCT04612790|541398253|FG001|OLE Period (Up to 1 Year)|Other|0|||
150069958|NCT04612790|541398254|FG002|OLE Period (Up to 1 Year)|Other|0|||
150069959|NCT04612790|541398255|FG003|OLE Period (Up to 1 Year)|Other|1|||
150069960|NCT03053271|541398256|FG000|Overall Study|Did not meet randomization criteria|3|||
150069961|NCT03053271|541398256|FG000|Overall Study|Withdrawal by Subject|1|||
150069962|NCT02124161|541398259|FG000|Overall Study|Other unspecified|0|||
150069963|NCT02124161|541398260|FG001|Overall Study|Other unspecified|1|||
150069964|NCT02124161|541398259|FG000|Overall Study|Death|1|||
150069965|NCT02124161|541398260|FG001|Overall Study|Death|0|||
150069966|NCT02124161|541398259|FG000|Overall Study|Protocol Violation|2|||
150069967|NCT02124161|541398260|FG001|Overall Study|Protocol Violation|1|||
150182076|NCT03398148|541804607|FG011|Substudy 2 Period 2|Adverse Event|0|||
150182077|NCT03398148|541804608|FG012|Substudy 2 Period 2|Adverse Event|0|||
150182078|NCT03398148|541804609|FG013|Substudy 2 Period 2|Adverse Event|1|||
150069968|NCT02124161|541398259|FG000|Overall Study|Withdrawal by Subject|1|||
150069969|NCT02124161|541398260|FG001|Overall Study|Withdrawal by Subject|2|||
150069970|NCT02124161|541398259|FG000|Overall Study|Adverse Event|2|||
150069971|NCT02124161|541398260|FG001|Overall Study|Adverse Event|0|||
150069972|NCT02124161|541398259|FG000|Overall Study|Does not meet entrance criteria|2|||
150069973|NCT02124161|541398260|FG001|Overall Study|Does not meet entrance criteria|3|||
150069974|NCT02124161|541398259|FG000|Overall Study|No longer meets eligibility criteria|5|||
150069975|NCT02124161|541398260|FG001|Overall Study|No longer meets eligibility criteria|4|||
150069976|NCT02124161|541398259|FG000|Overall Study|Lost to Follow-up|3|||
150069977|NCT02124161|541398260|FG001|Overall Study|Lost to Follow-up|4|||
150069978|NCT02517866|541398261|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
150069979|NCT02517866|541398262|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
150069980|NCT02517866|541398263|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
150069981|NCT02517866|541398261|FG000|Overall Study|Significant Protocol Deviation|4|||
150069982|NCT02517866|541398262|FG001|Overall Study|Significant Protocol Deviation|1|||
150069983|NCT02517866|541398263|FG002|Overall Study|Significant Protocol Deviation|0|||
150069984|NCT02517866|541398261|FG000|Overall Study|Lost to Follow-up|1|||
150069985|NCT02517866|541398262|FG001|Overall Study|Lost to Follow-up|0|||
150069986|NCT02517866|541398263|FG002|Overall Study|Lost to Follow-up|0|||
150069987|NCT02517866|541398261|FG000|Overall Study|Voluntary Withdrawal|2|||
150069988|NCT02517866|541398262|FG001|Overall Study|Voluntary Withdrawal|2|||
150069989|NCT02517866|541398263|FG002|Overall Study|Voluntary Withdrawal|0|||
150069990|NCT02517866|541398261|FG000|Overall Study|Investigator Decision|2|||
150069991|NCT02517866|541398262|FG001|Overall Study|Investigator Decision|1|||
150069992|NCT02517866|541398263|FG002|Overall Study|Investigator Decision|0|||
150069993|NCT02517866|541398261|FG000|Overall Study|Reason not specified|2|||
150069994|NCT02517866|541398262|FG001|Overall Study|Reason not specified|0|||
150069995|NCT02517866|541398263|FG002|Overall Study|Reason not specified|0|||
150069996|NCT05095454|541398265|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
150069997|NCT05095454|541398266|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
150069998|NCT00679055|541398267|FG000|Overall Study|Adverse Event|0|||
150069999|NCT00679055|541398268|FG001|Overall Study|Adverse Event|1|||
150070000|NCT00679055|541398267|FG000|Overall Study|Other|0|||
150070001|NCT00679055|541398268|FG001|Overall Study|Other|3|||
150070002|NCT00679055|541398267|FG000|Overall Study|Study Terminated|2|||
150070003|NCT00679055|541398268|FG001|Overall Study|Study Terminated|1|||
150070004|NCT00853073|541398269|FG000|Overall Study|Withdrawal by Subject|3|||
150070005|NCT00853073|541398270|FG001|Overall Study|Withdrawal by Subject|2|||
150070006|NCT01008150|541398271|FG000|Overall Study|did not receive study drug|1|||
150070007|NCT01008150|541398272|FG001|Overall Study|did not receive study drug|1|||
150070008|NCT01008150|541398273|FG002|Overall Study|did not receive study drug|1|||
150070009|NCT01008150|541398274|FG003|Overall Study|did not receive study drug|0|||
150070010|NCT01497275|541398275|FG000|Overall Study|Death|1|||
150070011|NCT01497275|541398275|FG000|Overall Study|Adverse Event|1|||
150070012|NCT01950169|541398276|FG000|Overall Study|Withdrawal by Subject|2|||
150070013|NCT01950169|541398277|FG001|Overall Study|Withdrawal by Subject|8|||
150070014|NCT01950169|541398278|FG002|Overall Study|Withdrawal by Subject|1|||
150070015|NCT01950169|541398276|FG000|Overall Study|Death|1|||
150070016|NCT01950169|541398277|FG001|Overall Study|Death|0|||
150070017|NCT01950169|541398278|FG002|Overall Study|Death|0|||
150070018|NCT01938573|541398279|FG000|Overall Study|Lack of Efficacy|1|||
150070019|NCT01938573|541398280|FG001|Overall Study|Lack of Efficacy|0|||
150070020|NCT01938573|541398279|FG000|Overall Study|Operation at other hospital|1|||
150070021|NCT01938573|541398280|FG001|Overall Study|Operation at other hospital|0|||
150070022|NCT00737438|541398285|FG000|Overall Study|Withdrawal by Subject|2|||
150070023|NCT00737438|541398285|FG000|Overall Study|Patient ineligible|1|||
150070024|NCT02410551|541398286|FG000|Overall Study|Adverse Event|1|||
150070025|NCT02410551|541398286|FG000|Overall Study|Withdrawal by Subject|1|||
150070026|NCT02410551|541398286|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
150070027|NCT05085730|541398289|FG000|Overall Study|Withdrawal by Subject|4|||
150070028|NCT05085730|541398289|FG000|Overall Study|Physician Decision|1|||
150070029|NCT05447897|541398290|FG000|Overall Study|Did not participate in survey|2|||
150070030|NCT04553679|541398291|FG000|Overall Study|Withdrawal by Subject|2|||
150070031|NCT04553679|541398292|FG001|Overall Study|Withdrawal by Subject|0|||
150070032|NCT04553679|541398291|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
150070033|NCT04553679|541398292|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
150070034|NCT01649804|541398293|FG000|Overall Study|Administrative/Other|8|||
150070035|NCT03719586|541398294|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
150070036|NCT03719586|541398295|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
150070037|NCT03719586|541398296|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
150070038|NCT03719586|541398297|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
150070039|NCT00178633|541398298|FG000|Overall Study|Lost to Follow-up|6|||
150070040|NCT03845543|541398299|FG000|Overall Study|Death|25|||
150070041|NCT03845543|541398299|FG000|Overall Study|Withdrawal by Subject|2|||
150070042|NCT03845543|541398299|FG000|Overall Study|Lost to Follow-up|12|||
150070043|NCT03845543|541398299|FG000|Overall Study|Adverse Event|17|||
150070044|NCT02028871|541398303|FG000|Overall Study|Positive urine drug screen|1|||
150070045|NCT02028871|541398304|FG001|Overall Study|Positive urine drug screen|1|||
150070046|NCT02028871|541398303|FG000|Overall Study|Withdrawal by Subject|1|||
150070047|NCT02028871|541398304|FG001|Overall Study|Withdrawal by Subject|2|||
150070048|NCT02028871|541398303|FG000|Overall Study|IV placement difficulty|1|||
150070049|NCT02028871|541398304|FG001|Overall Study|IV placement difficulty|0|||
150070050|NCT02028871|541398303|FG000|Overall Study|Current Illness|1|||
150070051|NCT02028871|541398304|FG001|Overall Study|Current Illness|0|||
150070052|NCT02633501|541398307|FG000|Overall Study|Adverse Event|0|||
150070053|NCT02633501|541398308|FG001|Overall Study|Adverse Event|0|||
150070054|NCT02633501|541398309|FG002|Overall Study|Adverse Event|1|||
150070055|NCT02633501|541398310|FG003|Overall Study|Adverse Event|0|||
150070056|NCT02633501|541398311|FG004|Overall Study|Adverse Event|1|||
150070057|NCT02633501|541398312|FG005|Overall Study|Adverse Event|1|||
150070058|NCT02633501|541398307|FG000|Overall Study|Withdrawal by Subject|2|||
150070059|NCT02633501|541398308|FG001|Overall Study|Withdrawal by Subject|1|||
150070060|NCT02633501|541398309|FG002|Overall Study|Withdrawal by Subject|2|||
150070061|NCT02633501|541398310|FG003|Overall Study|Withdrawal by Subject|2|||
150070062|NCT02633501|541398311|FG004|Overall Study|Withdrawal by Subject|1|||
150070063|NCT02633501|541398312|FG005|Overall Study|Withdrawal by Subject|3|||
150070064|NCT02633501|541398307|FG000|Overall Study|Various other reasons|0|||
150070065|NCT02633501|541398308|FG001|Overall Study|Various other reasons|2|||
150070066|NCT02633501|541398309|FG002|Overall Study|Various other reasons|4|||
150070067|NCT02633501|541398310|FG003|Overall Study|Various other reasons|1|||
150070068|NCT02633501|541398311|FG004|Overall Study|Various other reasons|7|||
150070069|NCT02633501|541398312|FG005|Overall Study|Various other reasons|11|||
150070070|NCT02633501|541398307|FG000|Overall Study|Lost to Follow-up|0|||
150070071|NCT02633501|541398308|FG001|Overall Study|Lost to Follow-up|0|||
150070072|NCT02633501|541398309|FG002|Overall Study|Lost to Follow-up|0|||
150070073|NCT02633501|541398310|FG003|Overall Study|Lost to Follow-up|1|||
150070074|NCT02633501|541398311|FG004|Overall Study|Lost to Follow-up|2|||
150070075|NCT02633501|541398312|FG005|Overall Study|Lost to Follow-up|0|||
150070076|NCT02963935|541398315|FG000|Overall Study|Adverse Event|12|||
150070077|NCT02963935|541398316|FG001|Overall Study|Adverse Event|6|||
150070078|NCT02963935|541398315|FG000|Overall Study|Protocol Violation|2|||
150070079|NCT02963935|541398316|FG001|Overall Study|Protocol Violation|1|||
150070080|NCT02963935|541398315|FG000|Overall Study|Lack of Efficacy|0|||
150070081|NCT02963935|541398316|FG001|Overall Study|Lack of Efficacy|2|||
150070082|NCT02963935|541398315|FG000|Overall Study|Lost to Follow-up|1|||
150070083|NCT02963935|541398316|FG001|Overall Study|Lost to Follow-up|6|||
150070084|NCT02963935|541398315|FG000|Overall Study|Unclassified|13|||
150070085|NCT02963935|541398316|FG001|Overall Study|Unclassified|22|||
150070086|NCT00771316|541398319|FG000|Overall Study|Adverse Event|0|||
150070087|NCT00771316|541398320|FG001|Overall Study|Adverse Event|1|||
150070088|NCT00771316|541398319|FG000|Overall Study|Patient withdrew consent|1|||
150070089|NCT00771316|541398320|FG001|Overall Study|Patient withdrew consent|0|||
150070090|NCT00771316|541398319|FG000|Overall Study|Discontinued due to early termination|1|||
150070091|NCT00771316|541398320|FG001|Overall Study|Discontinued due to early termination|0|||
150070092|NCT02955797|541398322|FG000|Overall Study|Protocol Violation|1|||
150070093|NCT02955797|541398323|FG001|Overall Study|Protocol Violation|0|||
150070094|NCT02955797|541398324|FG002|Overall Study|Protocol Violation|0|||
150070095|NCT02955797|541398325|FG003|Overall Study|Protocol Violation|1|||
150070096|NCT02955797|541398322|FG000|Overall Study|Withdrawal by Subject|2|||
150070097|NCT02955797|541398323|FG001|Overall Study|Withdrawal by Subject|2|||
150070098|NCT02955797|541398324|FG002|Overall Study|Withdrawal by Subject|0|||
150070099|NCT02955797|541398325|FG003|Overall Study|Withdrawal by Subject|1|||
150070100|NCT02955797|541398322|FG000|Overall Study|Lost to Follow-up|0|||
150070101|NCT02955797|541398323|FG001|Overall Study|Lost to Follow-up|1|||
150070102|NCT02955797|541398324|FG002|Overall Study|Lost to Follow-up|0|||
150070103|NCT02955797|541398325|FG003|Overall Study|Lost to Follow-up|0|||
150070104|NCT02906332|541398329|FG000|Overall Study|Withdrawal by Subject|1|||
150070105|NCT04176705|541398333|FG000|Overall Study|Withdrawal by Subject|4|||
150070106|NCT04176705|541398334|FG001|Overall Study|Withdrawal by Subject|4|||
150070107|NCT04176705|541398333|FG000|Overall Study|Death|1|||
150070108|NCT04176705|541398334|FG001|Overall Study|Death|1|||
150070109|NCT04176705|541398333|FG000|Overall Study|Lost to Follow-up|3|||
150070110|NCT04176705|541398334|FG001|Overall Study|Lost to Follow-up|3|||
150070111|NCT03805646|541398335|FG000|Overall Study|Death|40|||
150070112|NCT03805646|541398336|FG001|Overall Study|Death|49|||
150070113|NCT03805646|541398335|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
150070114|NCT03805646|541398336|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
150070115|NCT00392015|541399911|FG000|Overall Study|Lost to Follow-up|2|||
150070116|NCT00392015|541399912|FG001|Overall Study|Lost to Follow-up|0|||
150070117|NCT00392015|541399913|FG002|Overall Study|Lost to Follow-up|2|||
150025696|NCT01363700|541230374|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
150025697|NCT00148759|541230375|FG000|Overall Study|Withdrawal by Subject|1|||
150025698|NCT00148759|541230376|FG001|Overall Study|Withdrawal by Subject|1|||
150025699|NCT00148759|541230375|FG000|Overall Study|Lost to Follow-up|1|||
150025700|NCT00148759|541230376|FG001|Overall Study|Lost to Follow-up|0|||
150025701|NCT01454596|541230377|FG000|Overall Study|Death|0|||
150025702|NCT01454596|541230378|FG001|Overall Study|Death|0|||
150025703|NCT01454596|541230379|FG002|Overall Study|Death|0|||
150025704|NCT01454596|541230380|FG003|Overall Study|Death|0|||
150025705|NCT01454596|541230381|FG004|Overall Study|Death|0|||
150025706|NCT01454596|541230382|FG005|Overall Study|Death|0|||
150025707|NCT01454596|541230383|FG006|Overall Study|Death|0|||
150025708|NCT01454596|541230384|FG007|Overall Study|Death|0|||
150025709|NCT01454596|541230385|FG008|Overall Study|Death|0|||
150025710|NCT01454596|541230386|FG009|Overall Study|Death|1|||
150025711|NCT01454596|541230387|FG010|Overall Study|Death|1|||
150025712|NCT01454596|541230388|FG011|Overall Study|Death|0|||
150025713|NCT02721875|541230393|FG000|Overall Study|Progressive disease/relapse|1|||
150025714|NCT02721875|541230394|FG001|Overall Study|Progressive disease/relapse|0|||
150025715|NCT02888106|541230398|FG000|Overall Study|Withdrawal by Subject|1|||
150025716|NCT02888106|541230399|FG001|Overall Study|Withdrawal by Subject|2|||
150025717|NCT02888106|541230400|FG002|Overall Study|Withdrawal by Subject|0|||
150025718|NCT02888106|541230401|FG003|Overall Study|Withdrawal by Subject|1|||
150025719|NCT02888106|541230402|FG004|Overall Study|Withdrawal by Subject|0|||
150025720|NCT02888106|541230403|FG005|Overall Study|Withdrawal by Subject|0|||
150025721|NCT02888106|541230398|FG000|Overall Study|Lost to Follow-up|1|||
150025722|NCT02888106|541230399|FG001|Overall Study|Lost to Follow-up|0|||
150025723|NCT02888106|541230400|FG002|Overall Study|Lost to Follow-up|0|||
150025724|NCT02888106|541230401|FG003|Overall Study|Lost to Follow-up|1|||
150025725|NCT02888106|541230402|FG004|Overall Study|Lost to Follow-up|0|||
150025726|NCT02888106|541230403|FG005|Overall Study|Lost to Follow-up|1|||
150025727|NCT02888106|541230398|FG000|Overall Study|Adverse Event|2|||
150025728|NCT02888106|541230399|FG001|Overall Study|Adverse Event|0|||
150025729|NCT02888106|541230400|FG002|Overall Study|Adverse Event|0|||
150025730|NCT02888106|541230401|FG003|Overall Study|Adverse Event|0|||
150025731|NCT02888106|541230402|FG004|Overall Study|Adverse Event|0|||
150025732|NCT02888106|541230403|FG005|Overall Study|Adverse Event|0|||
150025733|NCT02888106|541230398|FG000|Overall Study|Withdrawal of consent|0|||
150025734|NCT02888106|541230399|FG001|Overall Study|Withdrawal of consent|0|||
150025735|NCT02888106|541230400|FG002|Overall Study|Withdrawal of consent|0|||
150025736|NCT02888106|541230401|FG003|Overall Study|Withdrawal of consent|0|||
150025737|NCT02888106|541230402|FG004|Overall Study|Withdrawal of consent|1|||
150025738|NCT02888106|541230403|FG005|Overall Study|Withdrawal of consent|0|||
150025739|NCT02888106|541230398|FG000|Overall Study|Pregnancy|1|||
150025740|NCT02888106|541230399|FG001|Overall Study|Pregnancy|0|||
150025741|NCT02888106|541230400|FG002|Overall Study|Pregnancy|0|||
150025742|NCT02888106|541230401|FG003|Overall Study|Pregnancy|0|||
150025743|NCT02888106|541230402|FG004|Overall Study|Pregnancy|0|||
150025744|NCT02888106|541230403|FG005|Overall Study|Pregnancy|0|||
150025745|NCT00430716|541230408|FG000|Double Blind Phase|Death|1|||
150025746|NCT00430716|541230409|FG001|Double Blind Phase|Death|0|||
150025747|NCT00430716|541230410|FG002|Double Blind Phase|Death|0|||
150025748|NCT00430716|541230408|FG000|Double Blind Phase|No longer willing to participate|2|||
150025749|NCT00430716|541230409|FG001|Double Blind Phase|No longer willing to participate|1|||
150025750|NCT00430716|541230410|FG002|Double Blind Phase|No longer willing to participate|1|||
150025751|NCT00430716|541230408|FG000|Double Blind Phase|Other|0|||
150025752|NCT00430716|541230409|FG001|Double Blind Phase|Other|2|||
150025753|NCT00430716|541230410|FG002|Double Blind Phase|Other|0|||
150025754|NCT00430716|541230408|FG000|Double Blind Phase|Study terminated by sponsor|1|||
150025755|NCT00430716|541230409|FG001|Double Blind Phase|Study terminated by sponsor|1|||
150025756|NCT00430716|541230410|FG002|Double Blind Phase|Study terminated by sponsor|2|||
150025757|NCT00430716|541230408|FG000|Double Blind Phase|Adverse Event|1|||
150025758|NCT00430716|541230409|FG001|Double Blind Phase|Adverse Event|1|||
150025759|NCT00430716|541230410|FG002|Double Blind Phase|Adverse Event|3|||
150025760|NCT00430716|541230408|FG000|Double Blind Phase|Not treated|1|||
150025761|NCT00430716|541230409|FG001|Double Blind Phase|Not treated|0|||
150025762|NCT00430716|541230410|FG002|Double Blind Phase|Not treated|0|||
150025763|NCT00430716|541230408|FG000|Open Label Phase|Lost to Follow-up|1|||
150025764|NCT00430716|541230409|FG001|Open Label Phase|Lost to Follow-up|0|||
150025765|NCT00430716|541230410|FG002|Open Label Phase|Lost to Follow-up|1|||
150025766|NCT00430716|541230408|FG000|Open Label Phase|No longer willing to participate|0|||
150070118|NCT00392015|541399914|FG003|Overall Study|Lost to Follow-up|1|||
150070119|NCT00392015|541399915|FG004|Overall Study|Lost to Follow-up|1|||
150070120|NCT00392015|541399916|FG005|Overall Study|Lost to Follow-up|0|||
150070121|NCT00392015|541399911|FG000|Overall Study|Withdrawal by Subject|0|||
150025767|NCT00430716|541230409|FG001|Open Label Phase|No longer willing to participate|1|||
150025768|NCT00430716|541230410|FG002|Open Label Phase|No longer willing to participate|1|||
150070122|NCT00392015|541399912|FG001|Overall Study|Withdrawal by Subject|0|||
150070123|NCT00392015|541399913|FG002|Overall Study|Withdrawal by Subject|2|||
150070124|NCT00392015|541399914|FG003|Overall Study|Withdrawal by Subject|0|||
150070125|NCT00392015|541399915|FG004|Overall Study|Withdrawal by Subject|0|||
150070126|NCT00392015|541399916|FG005|Overall Study|Withdrawal by Subject|0|||
150070127|NCT00392015|541399911|FG000|Overall Study|Adverse Event|0|||
150070128|NCT00392015|541399912|FG001|Overall Study|Adverse Event|0|||
150070129|NCT00392015|541399913|FG002|Overall Study|Adverse Event|0|||
150070130|NCT00392015|541399914|FG003|Overall Study|Adverse Event|0|||
150070131|NCT00392015|541399915|FG004|Overall Study|Adverse Event|1|||
150070132|NCT00392015|541399916|FG005|Overall Study|Adverse Event|0|||
150070133|NCT00392015|541399911|FG000|Overall Study|Previous trial recipient|0|||
150070134|NCT00392015|541399912|FG001|Overall Study|Previous trial recipient|0|||
150070135|NCT00392015|541399913|FG002|Overall Study|Previous trial recipient|0|||
150070136|NCT00392015|541399914|FG003|Overall Study|Previous trial recipient|0|||
150070137|NCT00392015|541399915|FG004|Overall Study|Previous trial recipient|1|||
150070138|NCT00392015|541399916|FG005|Overall Study|Previous trial recipient|0|||
150070139|NCT02742441|541399918|FG000|Overall Study|Lost to Follow-up|4|||
150070140|NCT02742441|541399919|FG001|Overall Study|Lost to Follow-up|4|||
150070141|NCT02742441|541399918|FG000|Overall Study|Withdrawal by Subject|2|||
150070142|NCT02742441|541399919|FG001|Overall Study|Withdrawal by Subject|2|||
150070143|NCT02742441|541399918|FG000|Overall Study|Adverse Event|0|||
150070144|NCT02742441|541399919|FG001|Overall Study|Adverse Event|2|||
150070145|NCT02281773|541399924|FG000|Overall Study|Adverse Event|6|||
150070146|NCT02281773|541399925|FG001|Overall Study|Adverse Event|1|||
150070147|NCT02281773|541399926|FG002|Overall Study|Adverse Event|4|||
150070148|NCT02281773|541399927|FG003|Overall Study|Adverse Event|8|||
150070149|NCT02281773|541399928|FG004|Overall Study|Adverse Event|9|||
150070150|NCT02281773|541399924|FG000|Overall Study|Protocol Violation|1|||
150070151|NCT02281773|541399925|FG001|Overall Study|Protocol Violation|0|||
150070152|NCT02281773|541399926|FG002|Overall Study|Protocol Violation|0|||
150070153|NCT02281773|541399927|FG003|Overall Study|Protocol Violation|2|||
150070154|NCT02281773|541399928|FG004|Overall Study|Protocol Violation|2|||
150070155|NCT02281773|541399924|FG000|Overall Study|Lost to Follow-up|2|||
150070156|NCT02281773|541399925|FG001|Overall Study|Lost to Follow-up|2|||
150070157|NCT02281773|541399926|FG002|Overall Study|Lost to Follow-up|6|||
150070158|NCT02281773|541399927|FG003|Overall Study|Lost to Follow-up|2|||
150070159|NCT02281773|541399928|FG004|Overall Study|Lost to Follow-up|10|||
150070160|NCT02281773|541399924|FG000|Overall Study|Withdrawal by Subject|2|||
150070161|NCT02281773|541399925|FG001|Overall Study|Withdrawal by Subject|8|||
150070162|NCT02281773|541399926|FG002|Overall Study|Withdrawal by Subject|6|||
150070163|NCT02281773|541399927|FG003|Overall Study|Withdrawal by Subject|6|||
150070164|NCT02281773|541399928|FG004|Overall Study|Withdrawal by Subject|8|||
150070165|NCT02281773|541399924|FG000|Overall Study|Other Reason|0|||
150070166|NCT02281773|541399925|FG001|Overall Study|Other Reason|4|||
150070167|NCT02281773|541399926|FG002|Overall Study|Other Reason|2|||
150070168|NCT02281773|541399927|FG003|Overall Study|Other Reason|3|||
150070169|NCT02281773|541399928|FG004|Overall Study|Other Reason|1|||
150070170|NCT02104752|541399929|FG000|Overall Study|Withdrawal by Subject|1|||
150070171|NCT02104752|541399930|FG001|Overall Study|Withdrawal by Subject|0|||
150070172|NCT02104752|541399929|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
150070173|NCT02104752|541399930|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
150070174|NCT02899299|541399933|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
150070175|NCT02899299|541399934|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
150070176|NCT02899299|541399933|FG000|Pre-treatment|Participant withdrew consent|1|||
150070177|NCT02899299|541399934|FG001|Pre-treatment|Participant withdrew consent|11|||
150070178|NCT02899299|541399933|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
150070179|NCT02899299|541399934|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
150070180|NCT02899299|541399933|FG000|Pre-treatment|Not reported|0|||
150070181|NCT02899299|541399934|FG001|Pre-treatment|Not reported|1|||
150070182|NCT02899299|541399933|FG000|Treatment|Disease Progression|182|||
150070183|NCT02899299|541399934|FG001|Treatment|Disease Progression|43|||
150070184|NCT02899299|541399933|FG000|Treatment|Study Drug Toxicity|60|||
150070185|NCT02899299|541399934|FG001|Treatment|Study Drug Toxicity|24|||
150070186|NCT02899299|541399933|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
150070187|NCT02899299|541399934|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
150070188|NCT02899299|541399933|FG000|Treatment|Participant request to discontinue Study treatment|4|||
150070189|NCT02899299|541399934|FG001|Treatment|Participant request to discontinue Study treatment|10|||
150070190|NCT02899299|541399933|FG000|Treatment|Participant withdrew consent|6|||
150070191|NCT02899299|541399934|FG001|Treatment|Participant withdrew consent|3|||
150070192|NCT02899299|541399933|FG000|Treatment|Lost to Follow-up|0|||
150070193|NCT02899299|541399934|FG001|Treatment|Lost to Follow-up|2|||
150070194|NCT02899299|541399933|FG000|Treatment|Maximum Clinical Benefit|11|||
150070195|NCT02899299|541399934|FG001|Treatment|Maximum Clinical Benefit|2|||
150070196|NCT02899299|541399933|FG000|Treatment|Poor/Non-compliance|1|||
150070197|NCT02899299|541399934|FG001|Treatment|Poor/Non-compliance|0|||
150070198|NCT02899299|541399933|FG000|Treatment|Participant no longer meets Study criteria|4|||
150070199|NCT02899299|541399934|FG001|Treatment|Participant no longer meets Study criteria|0|||
150070200|NCT02899299|541399933|FG000|Treatment|Administrative reason by Sponsor|2|||
150070201|NCT02899299|541399934|FG001|Treatment|Administrative reason by Sponsor|0|||
150070202|NCT02899299|541399933|FG000|Treatment|Other reasons|12|||
150070203|NCT02899299|541399934|FG001|Treatment|Other reasons|2|||
150070204|NCT02899299|541399933|FG000|Treatment|Not reported|7|||
150070205|NCT02899299|541399934|FG001|Treatment|Not reported|0|||
150070206|NCT02497612|541399937|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
150070207|NCT02497612|541399938|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
150070208|NCT02497612|541399939|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
150070209|NCT02497612|541399940|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
150070210|NCT02497612|541399937|FG000|Overall Study|Participant's request|2|||
150070211|NCT02497612|541399938|FG001|Overall Study|Participant's request|3|||
150070212|NCT02497612|541399939|FG002|Overall Study|Participant's request|4|||
150070213|NCT02497612|541399940|FG003|Overall Study|Participant's request|1|||
150070214|NCT02497612|541399937|FG000|Overall Study|Investigator's judgement|1|||
150070215|NCT02497612|541399938|FG001|Overall Study|Investigator's judgement|0|||
150070216|NCT02497612|541399939|FG002|Overall Study|Investigator's judgement|0|||
150070217|NCT02497612|541399940|FG003|Overall Study|Investigator's judgement|2|||
150070218|NCT02497612|541399937|FG000|Overall Study|Adverse Event|3|||
150070219|NCT02497612|541399938|FG001|Overall Study|Adverse Event|1|||
150070220|NCT02497612|541399939|FG002|Overall Study|Adverse Event|4|||
150070221|NCT02497612|541399940|FG003|Overall Study|Adverse Event|1|||
150070222|NCT02497612|541399937|FG000|Overall Study|Lost to Follow-up|1|||
150070223|NCT02497612|541399938|FG001|Overall Study|Lost to Follow-up|1|||
150070224|NCT02497612|541399939|FG002|Overall Study|Lost to Follow-up|0|||
150070225|NCT02497612|541399940|FG003|Overall Study|Lost to Follow-up|1|||
150070226|NCT02497612|541399937|FG000|Overall Study|Other unspecified|1|||
150070227|NCT02497612|541399938|FG001|Overall Study|Other unspecified|1|||
150070228|NCT02497612|541399939|FG002|Overall Study|Other unspecified|2|||
150070229|NCT02497612|541399940|FG003|Overall Study|Other unspecified|0|||
150070230|NCT02497612|541399937|FG000|Overall Study|Not eligible|1|||
150070231|NCT02497612|541399938|FG001|Overall Study|Not eligible|0|||
150070232|NCT02497612|541399939|FG002|Overall Study|Not eligible|0|||
150070233|NCT02497612|541399940|FG003|Overall Study|Not eligible|1|||
150070234|NCT00369122|541399943|FG000|Overall Study|Ineligible|10|||
150070235|NCT00369122|541399943|FG000|Overall Study|No protocol treatment|1|||
150070236|NCT00004635|541399944|FG000|Period One|refused|2|||
150070237|NCT00004635|541399945|FG001|Period One|refused|1|||
150070238|NCT00004635|541399944|FG000|Period One|Withdrawal by Subject|1|||
150070239|NCT00004635|541399945|FG001|Period One|Withdrawal by Subject|1|||
150070240|NCT00004635|541399944|FG000|Period One|Protocol Violation|1|||
150070241|NCT00004635|541399945|FG001|Period One|Protocol Violation|0|||
150070242|NCT00004635|541399944|FG000|Period One|PSA did not go <5 ng/mL|1|||
150070243|NCT00004635|541399945|FG001|Period One|PSA did not go <5 ng/mL|0|||
150070244|NCT00004635|541399944|FG000|Period One|second malignancy|1|||
150070245|NCT00004635|541399945|FG001|Period One|second malignancy|0|||
150070246|NCT00004635|541399944|FG000|Period One|progressed|0|||
150070247|NCT00004635|541399945|FG001|Period One|progressed|2|||
150070248|NCT00004635|541399944|FG000|Period One|health problem|0|||
150070249|NCT00004635|541399945|FG001|Period One|health problem|1|||
150070250|NCT00004635|541399944|FG000|Period One|discrepancy in data entry|0|||
150070251|NCT00004635|541399945|FG001|Period One|discrepancy in data entry|1|||
150070252|NCT00004635|541399944|FG000|Period Two|progression|2|||
150070253|NCT00004635|541399945|FG001|Period Two|progression|3|||
150070254|NCT00004635|541399944|FG000|Period Two|Adverse Event|1|||
150070255|NCT00004635|541399945|FG001|Period Two|Adverse Event|0|||
150070256|NCT00004635|541399944|FG000|Period Two|refused|0|||
150070257|NCT00004635|541399945|FG001|Period Two|refused|2|||
150070258|NCT00004635|541399944|FG000|Period Two|health problem|1|||
150070259|NCT00004635|541399945|FG001|Period Two|health problem|1|||
150070260|NCT00004635|541399944|FG000|Period Two|travel issues|0|||
150070261|NCT00004635|541399945|FG001|Period Two|travel issues|1|||
150070262|NCT00004635|541399944|FG000|Period Two|secondary malignancy|1|||
150070263|NCT00004635|541399945|FG001|Period Two|secondary malignancy|1|||
150070264|NCT00004635|541399944|FG000|Period Two|Lost to Follow-up|1|||
150070265|NCT00004635|541399945|FG001|Period Two|Lost to Follow-up|0|||
150070266|NCT00004635|541399944|FG000|Period Two|discrepancy in data entry|0|||
150070267|NCT00004635|541399945|FG001|Period Two|discrepancy in data entry|1|||
150070268|NCT00408629|541399946|FG000|Overall Study|Adverse Event|13|||
150070269|NCT00408629|541399947|FG001|Overall Study|Adverse Event|27|||
150070270|NCT00408629|541399946|FG000|Overall Study|Withdrawal by Subject|8|||
150070271|NCT00408629|541399947|FG001|Overall Study|Withdrawal by Subject|4|||
150070272|NCT00408629|541399946|FG000|Overall Study|Lost to Follow-up|1|||
150070273|NCT00408629|541399947|FG001|Overall Study|Lost to Follow-up|1|||
150070274|NCT00408629|541399946|FG000|Overall Study|Lack of Efficacy|63|||
150070275|NCT00408629|541399947|FG001|Overall Study|Lack of Efficacy|73|||
150070276|NCT00408629|541399946|FG000|Overall Study|Protocol Violation|1|||
150070277|NCT00408629|541399947|FG001|Overall Study|Protocol Violation|5|||
150070278|NCT00408629|541399946|FG000|Overall Study|Miscellaneous|11|||
150070279|NCT00408629|541399947|FG001|Overall Study|Miscellaneous|15|||
150070280|NCT00191906|541399948|FG000|Study Period II|Adverse Event|0|||
150070281|NCT00191906|541399949|FG001|Study Period II|Adverse Event|1|||
150070282|NCT00191906|541399950|FG002|Study Period II|Adverse Event|0|||
150070283|NCT00191906|541399951|FG003|Study Period II|Adverse Event|0|||
150070284|NCT00191906|541399948|FG000|Study Period II|Withdrawal by Subject|0|||
150070285|NCT00191906|541399949|FG001|Study Period II|Withdrawal by Subject|3|||
150070286|NCT00191906|541399950|FG002|Study Period II|Withdrawal by Subject|0|||
150070287|NCT00191906|541399951|FG003|Study Period II|Withdrawal by Subject|0|||
150070288|NCT00191906|541399948|FG000|Study Period II|Parent/Caregiver Decision|0|||
150070289|NCT00191906|541399949|FG001|Study Period II|Parent/Caregiver Decision|1|||
150070290|NCT00191906|541399950|FG002|Study Period II|Parent/Caregiver Decision|0|||
150070291|NCT00191906|541399951|FG003|Study Period II|Parent/Caregiver Decision|0|||
150070292|NCT00191906|541399948|FG000|Study Period II|Entry Criteria Exclusion|0|||
150070293|NCT00191906|541399949|FG001|Study Period II|Entry Criteria Exclusion|0|||
150070294|NCT00191906|541399950|FG002|Study Period II|Entry Criteria Exclusion|1|||
150070295|NCT00191906|541399951|FG003|Study Period II|Entry Criteria Exclusion|0|||
150070296|NCT00191906|541399948|FG000|Study Period III|Adverse Event|1|||
150070297|NCT00191906|541399949|FG001|Study Period III|Adverse Event|0|||
150070298|NCT00191906|541399950|FG002|Study Period III|Adverse Event|0|||
150070299|NCT00191906|541399951|FG003|Study Period III|Adverse Event|0|||
150070300|NCT00191906|541399948|FG000|Study Period III|Lost to Follow-up|0|||
150070301|NCT00191906|541399949|FG001|Study Period III|Lost to Follow-up|1|||
150070302|NCT00191906|541399950|FG002|Study Period III|Lost to Follow-up|0|||
150070303|NCT00191906|541399951|FG003|Study Period III|Lost to Follow-up|0|||
150070304|NCT00191906|541399948|FG000|Study Period III|Parent/Caregiver Decision|1|||
150070305|NCT00191906|541399949|FG001|Study Period III|Parent/Caregiver Decision|0|||
150182079|NCT03398148|541804610|FG014|Substudy 2 Period 2|Adverse Event|3|||
150182080|NCT03398148|541804596|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
150182081|NCT03398148|541804597|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
150182082|NCT03398148|541804598|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
150182083|NCT03398148|541804599|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
150182084|NCT03398148|541804600|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
150182085|NCT03398148|541804601|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
150070306|NCT00191906|541399950|FG002|Study Period III|Parent/Caregiver Decision|0|||
150070307|NCT00191906|541399951|FG003|Study Period III|Parent/Caregiver Decision|0|||
150070308|NCT00191906|541399948|FG000|Study Period III|Lack of Efficacy|3|||
150070309|NCT00191906|541399949|FG001|Study Period III|Lack of Efficacy|3|||
150070310|NCT00191906|541399950|FG002|Study Period III|Lack of Efficacy|0|||
150070311|NCT00191906|541399951|FG003|Study Period III|Lack of Efficacy|0|||
150070312|NCT01890746|541399952|FG000|Overall Study|Death|39|||
150070313|NCT01890746|541399953|FG001|Overall Study|Death|30|||
150182086|NCT03398148|541804602|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
150070314|NCT01890746|541399952|FG000|Overall Study|Adverse Event|1|||
150070315|NCT01890746|541399953|FG001|Overall Study|Adverse Event|0|||
150070316|NCT01890746|541399952|FG000|Overall Study|Lost to Follow-up|4|||
150070317|NCT01890746|541399953|FG001|Overall Study|Lost to Follow-up|1|||
150070318|NCT01890746|541399952|FG000|Overall Study|Physician Decision|3|||
150070319|NCT01890746|541399953|FG001|Overall Study|Physician Decision|2|||
150070320|NCT01890746|541399952|FG000|Overall Study|Withdrawal by Subject|5|||
150070321|NCT01890746|541399953|FG001|Overall Study|Withdrawal by Subject|8|||
150070322|NCT00777205|541399956|FG000|Overall Study|Lost to Follow-up|25|||
150070323|NCT00777205|541399957|FG001|Overall Study|Lost to Follow-up|9|||
150070324|NCT00777205|541399956|FG000|Overall Study|Withdrawal by Subject|6|||
150070325|NCT00777205|541399957|FG001|Overall Study|Withdrawal by Subject|4|||
150070326|NCT00777205|541399956|FG000|Overall Study|Death|0|||
150070327|NCT00777205|541399957|FG001|Overall Study|Death|2|||
150070328|NCT00777205|541399956|FG000|Overall Study|Protocol Violation|0|||
150070329|NCT00777205|541399957|FG001|Overall Study|Protocol Violation|56|||
150070330|NCT03257371|541399958|FG000|Overall Study|Lost to Follow-up|1|||
150070331|NCT03198078|541399964|FG000|Overall Study|Adverse Event|0|||
150070332|NCT03198078|541399965|FG001|Overall Study|Adverse Event|1|||
150070333|NCT03198078|541399966|FG002|Overall Study|Adverse Event|2|||
150070334|NCT03198078|541399964|FG000|Overall Study|Lack of Efficacy|0|||
150070335|NCT03198078|541399965|FG001|Overall Study|Lack of Efficacy|0|||
150070336|NCT03198078|541399966|FG002|Overall Study|Lack of Efficacy|3|||
150070337|NCT03198078|541399964|FG000|Overall Study|Lost to Follow-up|1|||
150070338|NCT03198078|541399965|FG001|Overall Study|Lost to Follow-up|0|||
150070339|NCT03198078|541399966|FG002|Overall Study|Lost to Follow-up|0|||
150070340|NCT03198078|541399964|FG000|Overall Study|Pregnancy|0|||
150070341|NCT03198078|541399965|FG001|Overall Study|Pregnancy|1|||
150070342|NCT03198078|541399966|FG002|Overall Study|Pregnancy|0|||
150070343|NCT03198078|541399964|FG000|Overall Study|Withdrawal by Subject|1|||
150070344|NCT03198078|541399965|FG001|Overall Study|Withdrawal by Subject|0|||
150070345|NCT03198078|541399966|FG002|Overall Study|Withdrawal by Subject|2|||
150070346|NCT03198078|541399964|FG000|Overall Study|Withdrawal by Caregiver|1|||
150070347|NCT03198078|541399965|FG001|Overall Study|Withdrawal by Caregiver|3|||
150070348|NCT03198078|541399966|FG002|Overall Study|Withdrawal by Caregiver|5|||
150070349|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
150070350|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
150070351|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
150070352|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
150070353|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
150070354|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
150070355|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
150070356|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
150070357|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
150070358|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
150070359|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
150070360|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
150070361|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
150070362|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
150070363|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
150070364|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
150070365|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
150070366|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
150070367|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
150070368|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
150070369|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
150070370|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
150070371|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
150070372|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
150070373|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Death|2|||
150070374|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Death|1|||
150070375|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Death|0|||
150070376|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Death|0|||
150070377|NCT02607930|541399967|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
150070378|NCT02607930|541399968|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
150070379|NCT02607930|541399969|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
150070380|NCT02607930|541399970|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
150070381|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
150070382|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
150070383|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
150070384|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
150070385|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
150070386|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
150070387|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
150070388|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
150070389|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
150070390|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
150070391|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
150070392|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
150070393|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
150070394|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
150070395|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
150070396|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
150070397|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
150070398|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
150070399|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
150070400|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
150070401|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
150070402|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
150070403|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
150070404|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
150070405|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
150070406|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
150070407|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
150070408|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
150070409|NCT02607930|541399967|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
150070410|NCT02607930|541399968|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
150070411|NCT02607930|541399969|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
150070412|NCT02607930|541399970|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
150070413|NCT01676727|541399971|FG000|Overall Study|Death|18|||
150070414|NCT01676727|541399971|FG000|Overall Study|Withdrawal by Subject|6|||
150070415|NCT01676727|541399971|FG000|Overall Study|Screening failure|5|||
150070416|NCT01676727|541399971|FG000|Overall Study|Not willing to attend 1-year visit|2|||
150070417|NCT01676727|541399971|FG000|Overall Study|Valve explanted|1|||
150070418|NCT03387683|541399972|FG000|Overall Study|In receipt of disallowed medication|1|||
150070419|NCT03387683|541399973|FG001|Overall Study|In receipt of disallowed medication|0|||
150070420|NCT03387683|541399972|FG000|Overall Study|Did not receive treatment|1|||
150070421|NCT03387683|541399973|FG001|Overall Study|Did not receive treatment|0|||
150070422|NCT00629772|541399974|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
150070423|NCT00629772|541399975|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
150070424|NCT00629772|541399974|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
150070425|NCT00629772|541399975|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
150070426|NCT03840174|541399976|FG000|Overall Study|Withdrawal by Subject|1|||
150070427|NCT03840174|541399977|FG001|Overall Study|Withdrawal by Subject|0|||
150070428|NCT03840174|541399978|FG002|Overall Study|Withdrawal by Subject|0|||
150070429|NCT03840174|541399979|FG003|Overall Study|Withdrawal by Subject|0|||
150070430|NCT00722423|541399980|FG000|Overall Study|Protocol Violation|0|||
150070431|NCT00722423|541399981|FG001|Overall Study|Protocol Violation|1|||
150070432|NCT01986140|541399991|FG000|Overall Study|Withdrawal by Subject|31|||
150070433|NCT01986140|541399992|FG001|Overall Study|Withdrawal by Subject|25|||
150070434|NCT01986140|541399991|FG000|Overall Study|alternative treatment|1|||
150070435|NCT01986140|541399992|FG001|Overall Study|alternative treatment|1|||
150070436|NCT01986140|541399991|FG000|Overall Study|found not eligible|3|||
150070437|NCT01986140|541399992|FG001|Overall Study|found not eligible|0|||
150070438|NCT01986140|541399991|FG000|Overall Study|Adverse Event|0|||
150070439|NCT01986140|541399992|FG001|Overall Study|Adverse Event|1|||
150070440|NCT01986140|541399991|FG000|Overall Study|progression disease|0|||
150070441|NCT01986140|541399992|FG001|Overall Study|progression disease|1|||
150070442|NCT01484132|541399993|FG000|Overall Study|Lost to Follow-up|8|||
150070443|NCT01484132|541399993|FG000|Overall Study|Difficulty with time commitment|2|||
150070444|NCT01484132|541399993|FG000|Overall Study|Ineligible|1|||
150070445|NCT01484132|541399993|FG000|Overall Study|No pre-treatment urine sample collected|1|||
150070446|NCT01484132|541399993|FG000|Overall Study|No post-treatment urine sample collected|10|||
150070447|NCT01912963|541399994|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
150070448|NCT01912963|541399995|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
150070449|NCT01912963|541399996|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
150070450|NCT01912963|541399994|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
150070451|NCT01912963|541399995|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
150070452|NCT01912963|541399996|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
150070453|NCT01912963|541399994|FG000|Overall Study|Adverse Event|0|||
150070454|NCT01912963|541399995|FG001|Overall Study|Adverse Event|1|||
150070455|NCT01912963|541399996|FG002|Overall Study|Adverse Event|1|||
150070456|NCT01912963|541399994|FG000|Overall Study|Withdrawal by Subject|0|||
150070457|NCT01912963|541399995|FG001|Overall Study|Withdrawal by Subject|1|||
150070458|NCT01912963|541399996|FG002|Overall Study|Withdrawal by Subject|0|||
150070459|NCT01912963|541399994|FG000|Overall Study|Sought treatment locally|0|||
150070460|NCT01912963|541399995|FG001|Overall Study|Sought treatment locally|1|||
150070461|NCT01912963|541399996|FG002|Overall Study|Sought treatment locally|0|||
150070462|NCT01069627|541400004|FG000|Overall Study|Disease progression|7|||
150070463|NCT01069627|541400004|FG000|Overall Study|Adverse Event|12|||
150070464|NCT01069627|541400004|FG000|Overall Study|Protocol Violation|1|||
150070465|NCT00464269|541400005|FG000|Overall Study|Lack of Efficacy|1|||
150070466|NCT00464269|541400006|FG001|Overall Study|Lack of Efficacy|0|||
150070467|NCT00464269|541400007|FG002|Overall Study|Lack of Efficacy|0|||
150070468|NCT00464269|541400008|FG003|Overall Study|Lack of Efficacy|0|||
150070469|NCT00464269|541400005|FG000|Overall Study|Lost to Follow-up|0|||
150070470|NCT00464269|541400006|FG001|Overall Study|Lost to Follow-up|4|||
150070471|NCT00464269|541400007|FG002|Overall Study|Lost to Follow-up|0|||
150182087|NCT03398148|541804603|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
150182088|NCT03398148|541804604|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
150070472|NCT00464269|541400008|FG003|Overall Study|Lost to Follow-up|1|||
150070473|NCT00464269|541400005|FG000|Overall Study|Withdrawal by Subject|0|||
150070474|NCT00464269|541400006|FG001|Overall Study|Withdrawal by Subject|2|||
150070475|NCT00464269|541400007|FG002|Overall Study|Withdrawal by Subject|1|||
150070476|NCT00464269|541400008|FG003|Overall Study|Withdrawal by Subject|1|||
150070477|NCT00464269|541400005|FG000|Overall Study|Other reason|3|||
150070478|NCT00464269|541400006|FG001|Overall Study|Other reason|3|||
150070479|NCT00464269|541400007|FG002|Overall Study|Other reason|1|||
150070480|NCT00464269|541400008|FG003|Overall Study|Other reason|1|||
150070481|NCT00464269|541400005|FG000|Overall Study|AE, serious fatal|0|||
150070482|NCT00464269|541400006|FG001|Overall Study|AE, serious fatal|0|||
150070483|NCT00464269|541400007|FG002|Overall Study|AE, serious fatal|1|||
150070484|NCT00464269|541400008|FG003|Overall Study|AE, serious fatal|1|||
150070485|NCT00464269|541400005|FG000|Overall Study|SAE, non-fatal|0|||
150070486|NCT00464269|541400006|FG001|Overall Study|SAE, non-fatal|0|||
150070487|NCT00464269|541400007|FG002|Overall Study|SAE, non-fatal|0|||
150070488|NCT00464269|541400008|FG003|Overall Study|SAE, non-fatal|1|||
150070489|NCT00464269|541400005|FG000|Overall Study|AE, non-serious non-fatal|2|||
150070490|NCT00464269|541400006|FG001|Overall Study|AE, non-serious non-fatal|8|||
150070491|NCT00464269|541400007|FG002|Overall Study|AE, non-serious non-fatal|3|||
150070492|NCT00464269|541400008|FG003|Overall Study|AE, non-serious non-fatal|4|||
150070493|NCT00464269|541400005|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
150070494|NCT00464269|541400006|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
150070495|NCT00464269|541400007|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
150070496|NCT00464269|541400008|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
150070497|NCT00747461|541400009|FG000|Overall Study|study terminated by sponsor|5|||
150070498|NCT02149875|541400010|FG000|Overall Study|Lost to Follow-up|3|||
150070499|NCT02149875|541400011|FG001|Overall Study|Lost to Follow-up|4|||
150070500|NCT02149875|541400012|FG002|Overall Study|Lost to Follow-up|5|||
150070501|NCT02149875|541400010|FG000|Overall Study|Withdrawal by Subject|3|||
150070502|NCT02149875|541400011|FG001|Overall Study|Withdrawal by Subject|2|||
150070503|NCT02149875|541400012|FG002|Overall Study|Withdrawal by Subject|2|||
150070504|NCT02149875|541400010|FG000|Overall Study|Physician Decision|1|||
150070505|NCT02149875|541400011|FG001|Overall Study|Physician Decision|2|||
150070506|NCT02149875|541400012|FG002|Overall Study|Physician Decision|2|||
150070507|NCT00299182|541400014|FG000|Overall Study|Withdrawal by Subject|0|||
150070508|NCT00299182|541400015|FG001|Overall Study|Withdrawal by Subject|0|||
150070509|NCT00299182|541400016|FG002|Overall Study|Withdrawal by Subject|1|||
150070510|NCT00299182|541400017|FG003|Overall Study|Withdrawal by Subject|0|||
150070511|NCT00299182|541400018|FG004|Overall Study|Withdrawal by Subject|1|||
150070512|NCT00299182|541400019|FG005|Overall Study|Withdrawal by Subject|2|||
150070513|NCT00299182|541400020|FG006|Overall Study|Withdrawal by Subject|0|||
150070514|NCT00299182|541400014|FG000|Overall Study|Chemotherapy Changed|0|||
150070515|NCT00299182|541400015|FG001|Overall Study|Chemotherapy Changed|0|||
150070516|NCT00299182|541400016|FG002|Overall Study|Chemotherapy Changed|1|||
150070517|NCT00299182|541400017|FG003|Overall Study|Chemotherapy Changed|0|||
150070518|NCT00299182|541400018|FG004|Overall Study|Chemotherapy Changed|1|||
150070519|NCT00299182|541400019|FG005|Overall Study|Chemotherapy Changed|0|||
150070520|NCT00299182|541400020|FG006|Overall Study|Chemotherapy Changed|1|||
150070521|NCT00299182|541400014|FG000|Overall Study|Adverse Event|0|||
150070522|NCT00299182|541400015|FG001|Overall Study|Adverse Event|0|||
150070523|NCT00299182|541400016|FG002|Overall Study|Adverse Event|0|||
150070524|NCT00299182|541400017|FG003|Overall Study|Adverse Event|0|||
150070525|NCT00299182|541400018|FG004|Overall Study|Adverse Event|0|||
150070526|NCT00299182|541400019|FG005|Overall Study|Adverse Event|1|||
150070527|NCT00299182|541400020|FG006|Overall Study|Adverse Event|0|||
150070528|NCT00299182|541400014|FG000|Overall Study|Not Eligible|0|||
150070529|NCT00299182|541400015|FG001|Overall Study|Not Eligible|0|||
150070530|NCT00299182|541400016|FG002|Overall Study|Not Eligible|0|||
150070531|NCT00299182|541400017|FG003|Overall Study|Not Eligible|0|||
150070532|NCT00299182|541400018|FG004|Overall Study|Not Eligible|1|||
150070533|NCT00299182|541400019|FG005|Overall Study|Not Eligible|0|||
150070534|NCT00299182|541400020|FG006|Overall Study|Not Eligible|0|||
150070535|NCT03131453|541400023|FG000|Overall Study|Study terminated by Sponsor|424|||
150070536|NCT03131453|541400024|FG001|Overall Study|Study terminated by Sponsor|222|||
150070537|NCT03131453|541400025|FG002|Overall Study|Study terminated by Sponsor|438|||
150070538|NCT03131453|541400023|FG000|Overall Study|Withdrawal by Subject|18|||
150070539|NCT03131453|541400024|FG001|Overall Study|Withdrawal by Subject|7|||
150070540|NCT03131453|541400025|FG002|Overall Study|Withdrawal by Subject|13|||
150070541|NCT03131453|541400023|FG000|Overall Study|Adverse Event|10|||
150070542|NCT03131453|541400024|FG001|Overall Study|Adverse Event|3|||
150070543|NCT03131453|541400025|FG002|Overall Study|Adverse Event|3|||
150070544|NCT03131453|541400023|FG000|Overall Study|Lost to Follow-up|1|||
150070545|NCT03131453|541400024|FG001|Overall Study|Lost to Follow-up|0|||
150070546|NCT03131453|541400025|FG002|Overall Study|Lost to Follow-up|1|||
150070547|NCT03131453|541400023|FG000|Overall Study|Physician Decision|1|||
150070548|NCT03131453|541400024|FG001|Overall Study|Physician Decision|0|||
150070549|NCT03131453|541400025|FG002|Overall Study|Physician Decision|1|||
150070550|NCT03131453|541400023|FG000|Overall Study|Non-compliance with study treatment|1|||
150070551|NCT03131453|541400024|FG001|Overall Study|Non-compliance with study treatment|0|||
150070552|NCT03131453|541400025|FG002|Overall Study|Non-compliance with study treatment|0|||
150070553|NCT03131453|541400023|FG000|Overall Study|Technical problems|1|||
150070554|NCT03131453|541400024|FG001|Overall Study|Technical problems|0|||
150070555|NCT03131453|541400025|FG002|Overall Study|Technical problems|0|||
150070556|NCT03131453|541400023|FG000|Overall Study|Protocol deviation|0|||
150070557|NCT03131453|541400024|FG001|Overall Study|Protocol deviation|1|||
150070558|NCT03131453|541400025|FG002|Overall Study|Protocol deviation|0|||
150070559|NCT02024555|541400038|FG000|Overall Study|Lost to Follow-up|1|||
150070560|NCT02024555|541400039|FG001|Overall Study|Lost to Follow-up|1|||
150070561|NCT02024555|541400038|FG000|Overall Study|Withdrawal by Subject|5|||
150070562|NCT02024555|541400039|FG001|Overall Study|Withdrawal by Subject|1|||
150070563|NCT04916769|541400040|FG000|Period 1|Physician Decision|0|||
150070564|NCT04916769|541400041|FG001|Period 1|Physician Decision|0|||
150070565|NCT04916769|541400042|FG002|Period 1|Physician Decision|0|||
150070566|NCT04916769|541400043|FG003|Period 1|Physician Decision|0|||
150070567|NCT04916769|541400044|FG004|Period 1|Physician Decision|0|||
150070568|NCT04916769|541400045|FG005|Period 1|Physician Decision|1|||
150070569|NCT04916769|541400040|FG000|Period 2|Physician Decision|0|||
150070570|NCT04916769|541400041|FG001|Period 2|Physician Decision|1|||
150070571|NCT04916769|541400042|FG002|Period 2|Physician Decision|0|||
150070572|NCT04916769|541400043|FG003|Period 2|Physician Decision|0|||
150070573|NCT04916769|541400044|FG004|Period 2|Physician Decision|0|||
150070574|NCT04916769|541400045|FG005|Period 2|Physician Decision|0|||
150070575|NCT05736224|541400058|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
150070576|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
150070577|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070578|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070579|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070580|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070581|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070582|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
150070583|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
150070584|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070585|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070586|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070587|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070588|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070589|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
150070590|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
150070591|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070592|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070593|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070594|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070595|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070596|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
150070597|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
150070598|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070599|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070600|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070601|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070602|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070603|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
150070604|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
150070605|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150070606|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150070607|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150182089|NCT03398148|541804605|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
150070608|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150070609|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150070610|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
150070611|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
150070612|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070613|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070614|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070615|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070616|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070617|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
150070618|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
150070619|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070620|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070621|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070622|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070623|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070624|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
150070625|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
150070626|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070627|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070628|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070629|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070630|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070631|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
150070632|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
150070633|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070634|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070635|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070636|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070637|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070638|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
150070639|NCT04526509|541400059|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
150070640|NCT04526509|541400060|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150070641|NCT04526509|541400061|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150182090|NCT03398148|541804606|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
150182091|NCT03398148|541804607|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
150182092|NCT03398148|541804608|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
150182093|NCT03398148|541804609|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
150182094|NCT03398148|541804610|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
150070642|NCT04526509|541400062|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150070643|NCT04526509|541400063|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150070644|NCT04526509|541400064|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150070645|NCT04526509|541400065|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
150070646|NCT04526509|541400059|FG000|Enrolled|Study Terminated by Sponsor|0|||
150070647|NCT04526509|541400060|FG001|Enrolled|Study Terminated by Sponsor|0|||
150070648|NCT04526509|541400061|FG002|Enrolled|Study Terminated by Sponsor|0|||
150070649|NCT04526509|541400062|FG003|Enrolled|Study Terminated by Sponsor|0|||
150070650|NCT04526509|541400063|FG004|Enrolled|Study Terminated by Sponsor|0|||
150070651|NCT04526509|541400064|FG005|Enrolled|Study Terminated by Sponsor|0|||
150070652|NCT04526509|541400065|FG006|Enrolled|Study Terminated by Sponsor|1|||
150070653|NCT04526509|541400059|FG000|Enrolled|Death prior to lymphodepletion|0|||
150070654|NCT04526509|541400060|FG001|Enrolled|Death prior to lymphodepletion|0|||
150070655|NCT04526509|541400061|FG002|Enrolled|Death prior to lymphodepletion|0|||
150070656|NCT04526509|541400062|FG003|Enrolled|Death prior to lymphodepletion|1|||
150070657|NCT04526509|541400063|FG004|Enrolled|Death prior to lymphodepletion|0|||
150070658|NCT04526509|541400064|FG005|Enrolled|Death prior to lymphodepletion|0|||
150070659|NCT04526509|541400065|FG006|Enrolled|Death prior to lymphodepletion|0|||
150070660|NCT04526509|541400059|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150070661|NCT04526509|541400060|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150070662|NCT04526509|541400061|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150182095|NCT03398148|541804596|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182096|NCT03398148|541804597|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182097|NCT03398148|541804598|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182098|NCT03398148|541804599|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182099|NCT03398148|541804600|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182100|NCT03398148|541804601|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182101|NCT03398148|541804602|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182102|NCT03398148|541804603|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182103|NCT03398148|541804604|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182104|NCT03398148|541804605|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182105|NCT03398148|541804606|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182106|NCT03398148|541804607|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
150182107|NCT03398148|541804608|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
150182108|NCT03398148|541804609|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
150182109|NCT03398148|541804610|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
150182110|NCT03398148|541804596|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
150182111|NCT03398148|541804597|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
150182112|NCT03398148|541804598|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
150182113|NCT03398148|541804599|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
150182114|NCT03398148|541804600|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
150182115|NCT03398148|541804601|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
150182116|NCT03398148|541804602|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
150182117|NCT03398148|541804603|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
150182118|NCT03398148|541804604|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
150182119|NCT03398148|541804605|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
150182120|NCT03398148|541804606|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
150182121|NCT03398148|541804607|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
150182122|NCT03398148|541804608|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
150182123|NCT03398148|541804609|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
150182124|NCT03398148|541804610|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
150182125|NCT03398148|541804596|FG000|Substudy 2 Period 2|Other|0|||
150182126|NCT03398148|541804597|FG001|Substudy 2 Period 2|Other|0|||
150182127|NCT03398148|541804598|FG002|Substudy 2 Period 2|Other|0|||
150182128|NCT03398148|541804599|FG003|Substudy 2 Period 2|Other|0|||
150182129|NCT03398148|541804600|FG004|Substudy 2 Period 2|Other|0|||
150182130|NCT03398148|541804601|FG005|Substudy 2 Period 2|Other|0|||
150182131|NCT03398148|541804602|FG006|Substudy 2 Period 2|Other|0|||
150182132|NCT03398148|541804603|FG007|Substudy 2 Period 2|Other|0|||
150182133|NCT03398148|541804604|FG008|Substudy 2 Period 2|Other|0|||
150182134|NCT03398148|541804605|FG009|Substudy 2 Period 2|Other|0|||
150182135|NCT03398148|541804606|FG010|Substudy 2 Period 2|Other|0|||
150182136|NCT03398148|541804607|FG011|Substudy 2 Period 2|Other|0|||
150070663|NCT04526509|541400062|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
150070664|NCT04526509|541400063|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150182137|NCT03398148|541804608|FG012|Substudy 2 Period 2|Other|0|||
150182138|NCT03398148|541804609|FG013|Substudy 2 Period 2|Other|1|||
150182139|NCT03398148|541804610|FG014|Substudy 2 Period 2|Other|1|||
150182140|NCT03398148|541804596|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182141|NCT03398148|541804597|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182142|NCT03398148|541804598|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182143|NCT03398148|541804599|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182144|NCT03398148|541804600|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
150070665|NCT04526509|541400064|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150070666|NCT04526509|541400065|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
150070667|NCT04526509|541400059|FG000|Enrolled|Physician Decision|0|||
150070668|NCT04526509|541400060|FG001|Enrolled|Physician Decision|1|||
150070669|NCT04526509|541400061|FG002|Enrolled|Physician Decision|0|||
150070670|NCT04526509|541400062|FG003|Enrolled|Physician Decision|0|||
150070671|NCT04526509|541400063|FG004|Enrolled|Physician Decision|0|||
150070672|NCT04526509|541400064|FG005|Enrolled|Physician Decision|0|||
150070673|NCT04526509|541400065|FG006|Enrolled|Physician Decision|0|||
150070674|NCT02719327|541400071|FG000|Overall Study|Withdrawal by Subject|11|||
150070675|NCT02719327|541400072|FG001|Overall Study|Withdrawal by Subject|8|||
150070676|NCT04340193|541400073|FG000|Overall Study|Other reason|0|||
150070677|NCT04340193|541400074|FG001|Overall Study|Other reason|0|||
150070678|NCT04340193|541400075|FG002|Overall Study|Other reason|1|||
150070679|NCT04340193|541400073|FG000|Overall Study|Disease recurrence|0|||
150070680|NCT04340193|541400074|FG001|Overall Study|Disease recurrence|1|||
150070681|NCT04340193|541400075|FG002|Overall Study|Disease recurrence|0|||
150070682|NCT04340193|541400073|FG000|Overall Study|Study drug toxicity|1|||
150070683|NCT04340193|541400074|FG001|Overall Study|Study drug toxicity|0|||
150070684|NCT04340193|541400075|FG002|Overall Study|Study drug toxicity|0|||
150070685|NCT04340193|541400073|FG000|Overall Study|Disease progression|1|||
150070686|NCT04340193|541400074|FG001|Overall Study|Disease progression|2|||
150070687|NCT04340193|541400075|FG002|Overall Study|Disease progression|3|||
150070688|NCT04340193|541400073|FG000|Overall Study|Administrative reasons by sponsor|0|||
150070689|NCT04340193|541400074|FG001|Overall Study|Administrative reasons by sponsor|1|||
150070690|NCT04340193|541400075|FG002|Overall Study|Administrative reasons by sponsor|0|||
150070691|NCT04340193|541400073|FG000|Overall Study|Adverse Event|1|||
150070692|NCT04340193|541400074|FG001|Overall Study|Adverse Event|1|||
150070693|NCT04340193|541400075|FG002|Overall Study|Adverse Event|0|||
150070694|NCT00717093|541401723|FG000|Overall Study|Adverse Event|19|||
150070695|NCT00717093|541401724|FG001|Overall Study|Adverse Event|9|||
150070696|NCT00717093|541401723|FG000|Overall Study|Lack of Efficacy|3|||
150070697|NCT00717093|541401724|FG001|Overall Study|Lack of Efficacy|13|||
150070698|NCT00717093|541401723|FG000|Overall Study|Lost to Follow-up|9|||
150070699|NCT00717093|541401724|FG001|Overall Study|Lost to Follow-up|6|||
150070700|NCT00717093|541401723|FG000|Overall Study|Withdrawal by Subject|12|||
150070701|NCT00717093|541401724|FG001|Overall Study|Withdrawal by Subject|19|||
150070702|NCT00717093|541401723|FG000|Overall Study|Other|0|||
150070703|NCT00717093|541401724|FG001|Overall Study|Other|1|||
150070704|NCT00717093|541401723|FG000|Overall Study|Randomized but not treated|1|||
150070705|NCT00717093|541401724|FG001|Overall Study|Randomized but not treated|0|||
150070706|NCT01543698|541401729|FG000|Phase 1b|Disease progression|2|||
150070707|NCT01543698|541401730|FG001|Phase 1b|Disease progression|4|||
150070708|NCT01543698|541401731|FG002|Phase 1b|Disease progression|3|||
150070709|NCT01543698|541401732|FG003|Phase 1b|Disease progression|2|||
150070710|NCT01543698|541401733|FG004|Phase 1b|Disease progression|10|||
150070711|NCT01543698|541401734|FG005|Phase 1b|Disease progression|6|||
150070712|NCT01543698|541401735|FG006|Phase 1b|Disease progression|5|||
150070713|NCT01543698|541401736|FG007|Phase 1b|Disease progression|3|||
150070714|NCT01543698|541401737|FG008|Phase 1b|Disease progression|4|||
150070715|NCT01543698|541401738|FG009|Phase 1b|Disease progression|5|||
150070716|NCT01543698|541401739|FG010|Phase 1b|Disease progression|1|||
150070717|NCT01543698|541401740|FG011|Phase 1b|Disease progression|0|||
150070718|NCT01543698|541401741|FG012|Phase 1b|Disease progression|0|||
150070719|NCT01543698|541401742|FG013|Phase 1b|Disease progression|0|||
150070720|NCT01543698|541401743|FG014|Phase 1b|Disease progression|0|||
150070721|NCT01543698|541401729|FG000|Phase 1b|Death|0|||
150070722|NCT01543698|541401730|FG001|Phase 1b|Death|0|||
150070723|NCT01543698|541401731|FG002|Phase 1b|Death|1|||
150070724|NCT01543698|541401732|FG003|Phase 1b|Death|1|||
150070725|NCT01543698|541401733|FG004|Phase 1b|Death|0|||
150070726|NCT01543698|541401734|FG005|Phase 1b|Death|0|||
150070727|NCT01543698|541401735|FG006|Phase 1b|Death|0|||
150070728|NCT01543698|541401736|FG007|Phase 1b|Death|0|||
150070729|NCT01543698|541401737|FG008|Phase 1b|Death|0|||
150070730|NCT01543698|541401738|FG009|Phase 1b|Death|0|||
150070731|NCT01543698|541401739|FG010|Phase 1b|Death|1|||
150070732|NCT01543698|541401740|FG011|Phase 1b|Death|0|||
150070733|NCT01543698|541401741|FG012|Phase 1b|Death|0|||
150070734|NCT01543698|541401742|FG013|Phase 1b|Death|0|||
150070735|NCT01543698|541401743|FG014|Phase 1b|Death|0|||
150070736|NCT01543698|541401729|FG000|Phase 1b|Withdrawal by Subject|0|||
150070737|NCT01543698|541401730|FG001|Phase 1b|Withdrawal by Subject|1|||
150070738|NCT01543698|541401731|FG002|Phase 1b|Withdrawal by Subject|0|||
150070739|NCT01543698|541401732|FG003|Phase 1b|Withdrawal by Subject|1|||
150070740|NCT01543698|541401733|FG004|Phase 1b|Withdrawal by Subject|0|||
150070741|NCT01543698|541401734|FG005|Phase 1b|Withdrawal by Subject|0|||
150070742|NCT01543698|541401735|FG006|Phase 1b|Withdrawal by Subject|1|||
150070743|NCT01543698|541401736|FG007|Phase 1b|Withdrawal by Subject|0|||
150070744|NCT01543698|541401737|FG008|Phase 1b|Withdrawal by Subject|0|||
150070745|NCT01543698|541401738|FG009|Phase 1b|Withdrawal by Subject|0|||
150070746|NCT01543698|541401739|FG010|Phase 1b|Withdrawal by Subject|0|||
150070747|NCT01543698|541401740|FG011|Phase 1b|Withdrawal by Subject|0|||
150070748|NCT01543698|541401741|FG012|Phase 1b|Withdrawal by Subject|0|||
150070749|NCT01543698|541401742|FG013|Phase 1b|Withdrawal by Subject|0|||
150070750|NCT01543698|541401743|FG014|Phase 1b|Withdrawal by Subject|0|||
150070751|NCT01543698|541401729|FG000|Phase 1b|Adverse Event|1|||
150070752|NCT01543698|541401730|FG001|Phase 1b|Adverse Event|0|||
150070753|NCT01543698|541401731|FG002|Phase 1b|Adverse Event|0|||
150070754|NCT01543698|541401732|FG003|Phase 1b|Adverse Event|1|||
150070755|NCT01543698|541401733|FG004|Phase 1b|Adverse Event|2|||
150070756|NCT01543698|541401734|FG005|Phase 1b|Adverse Event|2|||
150070757|NCT01543698|541401735|FG006|Phase 1b|Adverse Event|0|||
150070758|NCT01543698|541401736|FG007|Phase 1b|Adverse Event|0|||
150070759|NCT01543698|541401737|FG008|Phase 1b|Adverse Event|1|||
150070760|NCT01543698|541401738|FG009|Phase 1b|Adverse Event|1|||
150070761|NCT01543698|541401739|FG010|Phase 1b|Adverse Event|2|||
150070762|NCT01543698|541401740|FG011|Phase 1b|Adverse Event|0|||
150070763|NCT01543698|541401741|FG012|Phase 1b|Adverse Event|0|||
150070764|NCT01543698|541401742|FG013|Phase 1b|Adverse Event|0|||
150070765|NCT01543698|541401743|FG014|Phase 1b|Adverse Event|0|||
150070766|NCT01543698|541401729|FG000|Phase 1b|Administrative problems|1|||
150070767|NCT01543698|541401730|FG001|Phase 1b|Administrative problems|0|||
150070768|NCT01543698|541401731|FG002|Phase 1b|Administrative problems|0|||
150070769|NCT01543698|541401732|FG003|Phase 1b|Administrative problems|0|||
150070770|NCT01543698|541401733|FG004|Phase 1b|Administrative problems|1|||
150070771|NCT01543698|541401734|FG005|Phase 1b|Administrative problems|0|||
150070772|NCT01543698|541401735|FG006|Phase 1b|Administrative problems|0|||
150182145|NCT03398148|541804601|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182146|NCT03398148|541804602|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182147|NCT03398148|541804603|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182148|NCT03398148|541804604|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182149|NCT03398148|541804605|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182150|NCT03398148|541804606|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182151|NCT03398148|541804607|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182152|NCT03398148|541804608|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
150182153|NCT03398148|541804609|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
150182154|NCT03398148|541804610|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
150182155|NCT04278586|541804611|FG000|Overall Study|Withdrawal by Subject|13|||
150182156|NCT04278586|541804612|FG001|Overall Study|Withdrawal by Subject|6|||
150182157|NCT04278586|541804611|FG000|Overall Study|Lost to Follow-up|37|||
150182158|NCT04278586|541804612|FG001|Overall Study|Lost to Follow-up|24|||
150182159|NCT02791230|541804613|FG000|Overall Study|Adverse Event|10|||
150182160|NCT02791230|541804614|FG001|Overall Study|Adverse Event|9|||
150182161|NCT02791230|541804615|FG002|Overall Study|Adverse Event|66|||
150182162|NCT02791230|541804613|FG000|Overall Study|Death|38|||
150182163|NCT02791230|541804614|FG001|Overall Study|Death|25|||
150182164|NCT02791230|541804615|FG002|Overall Study|Death|184|||
150182165|NCT02791230|541804613|FG000|Overall Study|Lack of Efficacy|1|||
150182166|NCT02791230|541804614|FG001|Overall Study|Lack of Efficacy|0|||
150182167|NCT02791230|541804615|FG002|Overall Study|Lack of Efficacy|3|||
150182168|NCT02791230|541804613|FG000|Overall Study|Lost to Follow-up|0|||
150182169|NCT02791230|541804614|FG001|Overall Study|Lost to Follow-up|0|||
150182170|NCT02791230|541804615|FG002|Overall Study|Lost to Follow-up|10|||
150182171|NCT02791230|541804613|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
150182172|NCT02791230|541804614|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
150182173|NCT02791230|541804615|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
150182174|NCT02791230|541804613|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
150182175|NCT02791230|541804614|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
150070773|NCT01543698|541401736|FG007|Phase 1b|Administrative problems|1|||
150070774|NCT01543698|541401737|FG008|Phase 1b|Administrative problems|0|||
150070775|NCT01543698|541401738|FG009|Phase 1b|Administrative problems|0|||
150182176|NCT02791230|541804615|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
150182177|NCT02791230|541804613|FG000|Overall Study|Study sites terminated by sponsor|1|||
150070776|NCT01543698|541401739|FG010|Phase 1b|Administrative problems|2|||
150070777|NCT01543698|541401740|FG011|Phase 1b|Administrative problems|0|||
150070778|NCT01543698|541401741|FG012|Phase 1b|Administrative problems|0|||
150070779|NCT01543698|541401742|FG013|Phase 1b|Administrative problems|0|||
150070780|NCT01543698|541401743|FG014|Phase 1b|Administrative problems|0|||
150070781|NCT01543698|541401729|FG000|Phase 1b|Protocol Violation|2|||
150070782|NCT01543698|541401730|FG001|Phase 1b|Protocol Violation|0|||
150070783|NCT01543698|541401731|FG002|Phase 1b|Protocol Violation|0|||
150070784|NCT01543698|541401732|FG003|Phase 1b|Protocol Violation|0|||
150070785|NCT01543698|541401733|FG004|Phase 1b|Protocol Violation|0|||
150070786|NCT01543698|541401734|FG005|Phase 1b|Protocol Violation|0|||
150070787|NCT01543698|541401735|FG006|Phase 1b|Protocol Violation|0|||
150070788|NCT01543698|541401736|FG007|Phase 1b|Protocol Violation|0|||
150070789|NCT01543698|541401737|FG008|Phase 1b|Protocol Violation|0|||
150070790|NCT01543698|541401738|FG009|Phase 1b|Protocol Violation|0|||
150070791|NCT01543698|541401739|FG010|Phase 1b|Protocol Violation|0|||
150070792|NCT01543698|541401740|FG011|Phase 1b|Protocol Violation|0|||
150070793|NCT01543698|541401741|FG012|Phase 1b|Protocol Violation|0|||
150070794|NCT01543698|541401742|FG013|Phase 1b|Protocol Violation|0|||
150070795|NCT01543698|541401743|FG014|Phase 1b|Protocol Violation|0|||
150070796|NCT01543698|541401729|FG000|Phase 2|Protocol Violation|0|||
150070797|NCT01543698|541401730|FG001|Phase 2|Protocol Violation|0|||
150070798|NCT01543698|541401731|FG002|Phase 2|Protocol Violation|0|||
150070799|NCT01543698|541401732|FG003|Phase 2|Protocol Violation|0|||
150070800|NCT01543698|541401733|FG004|Phase 2|Protocol Violation|0|||
150070801|NCT01543698|541401734|FG005|Phase 2|Protocol Violation|0|||
150070802|NCT01543698|541401735|FG006|Phase 2|Protocol Violation|0|||
150070803|NCT01543698|541401736|FG007|Phase 2|Protocol Violation|0|||
150070804|NCT01543698|541401737|FG008|Phase 2|Protocol Violation|0|||
150070805|NCT01543698|541401738|FG009|Phase 2|Protocol Violation|0|||
150070806|NCT01543698|541401739|FG010|Phase 2|Protocol Violation|0|||
150070807|NCT01543698|541401740|FG011|Phase 2|Protocol Violation|0|||
150070808|NCT01543698|541401741|FG012|Phase 2|Protocol Violation|1|||
150070809|NCT01543698|541401742|FG013|Phase 2|Protocol Violation|0|||
150070810|NCT01543698|541401743|FG014|Phase 2|Protocol Violation|0|||
150070811|NCT01543698|541401729|FG000|Phase 2|Disease progression|0|||
150070812|NCT01543698|541401730|FG001|Phase 2|Disease progression|0|||
150070813|NCT01543698|541401731|FG002|Phase 2|Disease progression|0|||
150070814|NCT01543698|541401732|FG003|Phase 2|Disease progression|0|||
150070815|NCT01543698|541401733|FG004|Phase 2|Disease progression|0|||
150070816|NCT01543698|541401734|FG005|Phase 2|Disease progression|0|||
150070817|NCT01543698|541401735|FG006|Phase 2|Disease progression|0|||
150070818|NCT01543698|541401736|FG007|Phase 2|Disease progression|0|||
150070819|NCT01543698|541401737|FG008|Phase 2|Disease progression|0|||
150070820|NCT01543698|541401738|FG009|Phase 2|Disease progression|0|||
150070821|NCT01543698|541401739|FG010|Phase 2|Disease progression|0|||
150070822|NCT01543698|541401740|FG011|Phase 2|Disease progression|10|||
150070823|NCT01543698|541401741|FG012|Phase 2|Disease progression|21|||
150070824|NCT01543698|541401742|FG013|Phase 2|Disease progression|30|||
150070825|NCT01543698|541401743|FG014|Phase 2|Disease progression|25|||
150070826|NCT01543698|541401729|FG000|Phase 2|Death|0|||
150070827|NCT01543698|541401730|FG001|Phase 2|Death|0|||
150070828|NCT01543698|541401731|FG002|Phase 2|Death|0|||
150070829|NCT01543698|541401732|FG003|Phase 2|Death|0|||
150070830|NCT01543698|541401733|FG004|Phase 2|Death|0|||
150070831|NCT01543698|541401734|FG005|Phase 2|Death|0|||
150070832|NCT01543698|541401735|FG006|Phase 2|Death|0|||
150070833|NCT01543698|541401736|FG007|Phase 2|Death|0|||
150070834|NCT01543698|541401737|FG008|Phase 2|Death|0|||
150070835|NCT01543698|541401738|FG009|Phase 2|Death|0|||
150070836|NCT01543698|541401739|FG010|Phase 2|Death|0|||
150070837|NCT01543698|541401740|FG011|Phase 2|Death|0|||
150070838|NCT01543698|541401741|FG012|Phase 2|Death|1|||
150070839|NCT01543698|541401742|FG013|Phase 2|Death|1|||
150070840|NCT01543698|541401743|FG014|Phase 2|Death|1|||
150070841|NCT01543698|541401729|FG000|Phase 2|Administrative problems|0|||
150070842|NCT01543698|541401730|FG001|Phase 2|Administrative problems|0|||
150070843|NCT01543698|541401731|FG002|Phase 2|Administrative problems|0|||
150070844|NCT01543698|541401732|FG003|Phase 2|Administrative problems|0|||
150070845|NCT01543698|541401733|FG004|Phase 2|Administrative problems|0|||
150070846|NCT01543698|541401734|FG005|Phase 2|Administrative problems|0|||
150070847|NCT01543698|541401735|FG006|Phase 2|Administrative problems|0|||
150070848|NCT01543698|541401736|FG007|Phase 2|Administrative problems|0|||
150070849|NCT01543698|541401737|FG008|Phase 2|Administrative problems|0|||
150070850|NCT01543698|541401738|FG009|Phase 2|Administrative problems|0|||
150070851|NCT01543698|541401739|FG010|Phase 2|Administrative problems|0|||
150070852|NCT01543698|541401740|FG011|Phase 2|Administrative problems|0|||
150070853|NCT01543698|541401741|FG012|Phase 2|Administrative problems|0|||
150070854|NCT01543698|541401742|FG013|Phase 2|Administrative problems|3|||
150070855|NCT01543698|541401743|FG014|Phase 2|Administrative problems|1|||
150070856|NCT01543698|541401729|FG000|Phase 2|Withdrawal by Subject|0|||
150070857|NCT01543698|541401730|FG001|Phase 2|Withdrawal by Subject|0|||
150070858|NCT01543698|541401731|FG002|Phase 2|Withdrawal by Subject|0|||
150070859|NCT01543698|541401732|FG003|Phase 2|Withdrawal by Subject|0|||
150070860|NCT01543698|541401733|FG004|Phase 2|Withdrawal by Subject|0|||
150070861|NCT01543698|541401734|FG005|Phase 2|Withdrawal by Subject|0|||
150070862|NCT01543698|541401735|FG006|Phase 2|Withdrawal by Subject|0|||
150070863|NCT01543698|541401736|FG007|Phase 2|Withdrawal by Subject|0|||
150070864|NCT01543698|541401737|FG008|Phase 2|Withdrawal by Subject|0|||
150070865|NCT01543698|541401738|FG009|Phase 2|Withdrawal by Subject|0|||
150070866|NCT01543698|541401739|FG010|Phase 2|Withdrawal by Subject|0|||
150070867|NCT01543698|541401740|FG011|Phase 2|Withdrawal by Subject|0|||
150070868|NCT01543698|541401741|FG012|Phase 2|Withdrawal by Subject|0|||
150070869|NCT01543698|541401742|FG013|Phase 2|Withdrawal by Subject|3|||
150070870|NCT01543698|541401743|FG014|Phase 2|Withdrawal by Subject|1|||
150070871|NCT01543698|541401729|FG000|Phase 2|Adverse Event|0|||
150070872|NCT01543698|541401730|FG001|Phase 2|Adverse Event|0|||
150070873|NCT01543698|541401731|FG002|Phase 2|Adverse Event|0|||
150070874|NCT01543698|541401732|FG003|Phase 2|Adverse Event|0|||
150070875|NCT01543698|541401733|FG004|Phase 2|Adverse Event|0|||
150070876|NCT01543698|541401734|FG005|Phase 2|Adverse Event|0|||
150070877|NCT01543698|541401735|FG006|Phase 2|Adverse Event|0|||
150070878|NCT01543698|541401736|FG007|Phase 2|Adverse Event|0|||
150070879|NCT01543698|541401737|FG008|Phase 2|Adverse Event|0|||
150070880|NCT01543698|541401738|FG009|Phase 2|Adverse Event|0|||
150070881|NCT01543698|541401739|FG010|Phase 2|Adverse Event|0|||
150070882|NCT01543698|541401740|FG011|Phase 2|Adverse Event|1|||
150070883|NCT01543698|541401741|FG012|Phase 2|Adverse Event|3|||
150070884|NCT01543698|541401742|FG013|Phase 2|Adverse Event|5|||
150070885|NCT01543698|541401743|FG014|Phase 2|Adverse Event|14|||
150070886|NCT00217620|541401744|FG000|Overall Study|Adverse Event|2|||
150070887|NCT00217620|541401744|FG000|Overall Study|Progression|31|||
150070888|NCT00217620|541401744|FG000|Overall Study|Not Protocol Specified|4|||
150070889|NCT00217620|541401744|FG000|Overall Study|Ineligible|13|||
150070890|NCT00217620|541401744|FG000|Overall Study|Never received treatment|1|||
150070891|NCT01863953|541401753|FG000|Overall Study|Adverse Event|0|||
150070892|NCT01863953|541401754|FG001|Overall Study|Adverse Event|0|||
150070893|NCT01863953|541401755|FG002|Overall Study|Adverse Event|1|||
150070894|NCT01797731|541401756|FG000|Overall Study|Didn't have proper radiographs required|3|||
150070895|NCT01797731|541401757|FG001|Overall Study|Didn't have proper radiographs required|3|||
150070896|NCT01453725|541401758|FG000|Overall Study|Adverse Event|3|||
150070897|NCT01453725|541401759|FG001|Overall Study|Adverse Event|3|||
150070898|NCT01453725|541401758|FG000|Overall Study|Lost to Follow-up|4|||
150070899|NCT01453725|541401759|FG001|Overall Study|Lost to Follow-up|0|||
150070900|NCT01453725|541401758|FG000|Overall Study|Non-compliance With Protocol|1|||
150070901|NCT01453725|541401759|FG001|Overall Study|Non-compliance With Protocol|2|||
150070902|NCT01453725|541401758|FG000|Overall Study|Protocol Violation|1|||
150070903|NCT01453725|541401759|FG001|Overall Study|Protocol Violation|0|||
150070904|NCT01453725|541401758|FG000|Overall Study|Withdrawal by Subject|2|||
150070905|NCT01453725|541401759|FG001|Overall Study|Withdrawal by Subject|3|||
150070906|NCT01453725|541401758|FG000|Overall Study|Pregnancy Wish|0|||
150070907|NCT01453725|541401759|FG001|Overall Study|Pregnancy Wish|2|||
150070908|NCT01453725|541401758|FG000|Overall Study|Pregnancy|1|||
150070909|NCT01453725|541401759|FG001|Overall Study|Pregnancy|0|||
150070910|NCT01453725|541401758|FG000|Overall Study|Physician Decision|1|||
150070911|NCT01453725|541401759|FG001|Overall Study|Physician Decision|1|||
150070912|NCT03945214|541401760|FG000|Overall Study|Lost to Follow-up|3|||
150070913|NCT03945214|541401761|FG001|Overall Study|Lost to Follow-up|4|||
150070914|NCT03945214|541401762|FG002|Overall Study|Lost to Follow-up|7|||
150070915|NCT03945214|541401763|FG003|Overall Study|Lost to Follow-up|4|||
150070916|NCT01436396|541401774|FG000|Overall Study|Protocol Violation|7|||
150070917|NCT01436396|541401775|FG001|Overall Study|Protocol Violation|5|||
150070918|NCT01436396|541401774|FG000|Overall Study|Adverse Event|1|||
150070919|NCT01436396|541401775|FG001|Overall Study|Adverse Event|2|||
150070920|NCT01436396|541401774|FG000|Overall Study|Withdrawal by Subject|19|||
150070921|NCT01436396|541401775|FG001|Overall Study|Withdrawal by Subject|29|||
150070922|NCT01436396|541401774|FG000|Overall Study|Serious adverse event|2|||
150070923|NCT01436396|541401775|FG001|Overall Study|Serious adverse event|3|||
150070924|NCT01436396|541401774|FG000|Overall Study|Lost to Follow-up|3|||
150070925|NCT01436396|541401775|FG001|Overall Study|Lost to Follow-up|3|||
150070926|NCT00875979|541401776|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
150070927|NCT00875979|541401777|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
150070928|NCT00875979|541401776|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
150070929|NCT00875979|541401777|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
150070930|NCT00875979|541401776|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
150070931|NCT00875979|541401777|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
150070932|NCT00875979|541401776|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
150070933|NCT00875979|541401777|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
150070934|NCT00875979|541401776|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
150070935|NCT00875979|541401777|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
150070936|NCT00875979|541401776|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
150070937|NCT00875979|541401777|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
150070938|NCT00875979|541401776|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
150070939|NCT00875979|541401777|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
150070940|NCT00875979|541401776|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
150070941|NCT00875979|541401777|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
150070942|NCT00875979|541401776|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
150070943|NCT00875979|541401777|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
150070944|NCT00216476|541401778|FG000|Overall Study|Withdrawal by Subject|59|||
150070945|NCT00216476|541401779|FG001|Overall Study|Withdrawal by Subject|72|||
150070946|NCT00216476|541401780|FG002|Overall Study|Withdrawal by Subject|9|||
150070947|NCT00216476|541401778|FG000|Overall Study|Lost to Follow-up|10|||
150070948|NCT00216476|541401779|FG001|Overall Study|Lost to Follow-up|9|||
150070949|NCT00216476|541401780|FG002|Overall Study|Lost to Follow-up|1|||
150070950|NCT00216476|541401778|FG000|Overall Study|Adverse Event|6|||
150070951|NCT00216476|541401779|FG001|Overall Study|Adverse Event|10|||
150070952|NCT00216476|541401780|FG002|Overall Study|Adverse Event|1|||
150070953|NCT00216476|541401778|FG000|Overall Study|Lack of Efficacy|4|||
150070954|NCT00216476|541401779|FG001|Overall Study|Lack of Efficacy|3|||
150070955|NCT00216476|541401780|FG002|Overall Study|Lack of Efficacy|0|||
150070956|NCT00216476|541401778|FG000|Overall Study|Death|2|||
150070957|NCT00216476|541401779|FG001|Overall Study|Death|0|||
150070958|NCT00216476|541401780|FG002|Overall Study|Death|0|||
150070959|NCT00216476|541401778|FG000|Overall Study|Pregnancy|0|||
150070960|NCT00216476|541401779|FG001|Overall Study|Pregnancy|1|||
150070961|NCT00216476|541401780|FG002|Overall Study|Pregnancy|1|||
150070962|NCT00216476|541401778|FG000|Overall Study|Other|0|||
150070963|NCT00216476|541401779|FG001|Overall Study|Other|0|||
150070964|NCT00216476|541401780|FG002|Overall Study|Other|1|||
150070965|NCT00216476|541401778|FG000|Overall Study|Refuses Injection|11|||
150070966|NCT00216476|541401779|FG001|Overall Study|Refuses Injection|0|||
150070967|NCT00216476|541401780|FG002|Overall Study|Refuses Injection|0|||
150070968|NCT00216476|541401778|FG000|Overall Study|No Further Need for Treatment|3|||
150070969|NCT00216476|541401779|FG001|Overall Study|No Further Need for Treatment|4|||
150070970|NCT00216476|541401780|FG002|Overall Study|No Further Need for Treatment|1|||
150070971|NCT00216476|541401778|FG000|Overall Study|Non-compliance|0|||
150070972|NCT00216476|541401779|FG001|Overall Study|Non-compliance|4|||
150070973|NCT00216476|541401780|FG002|Overall Study|Non-compliance|1|||
150070974|NCT00216476|541401778|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
150070975|NCT00216476|541401779|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
150070976|NCT00216476|541401780|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
150070977|NCT00216476|541401778|FG000|Overall Study|Administrative Reasons|1|||
150182178|NCT02791230|541804614|FG001|Overall Study|Study sites terminated by sponsor|0|||
150182179|NCT02791230|541804615|FG002|Overall Study|Study sites terminated by sponsor|5|||
150182180|NCT02791230|541804613|FG000|Overall Study|Other|9|||
150182181|NCT02791230|541804614|FG001|Overall Study|Other|1|||
150182182|NCT02791230|541804615|FG002|Overall Study|Other|28|||
150182183|NCT02791230|541804613|FG000|Overall Study|Protocol Violation|0|||
150182184|NCT02791230|541804614|FG001|Overall Study|Protocol Violation|0|||
150182185|NCT02791230|541804615|FG002|Overall Study|Protocol Violation|4|||
150182186|NCT02791230|541804613|FG000|Overall Study|Withdrawal by Subject|24|||
150182187|NCT02791230|541804614|FG001|Overall Study|Withdrawal by Subject|13|||
150182188|NCT02791230|541804615|FG002|Overall Study|Withdrawal by Subject|172|||
150182189|NCT02791230|541804613|FG000|Overall Study|Enrolled but not treated|0|||
150182190|NCT02791230|541804614|FG001|Overall Study|Enrolled but not treated|0|||
150182191|NCT02791230|541804615|FG002|Overall Study|Enrolled but not treated|5|||
150182192|NCT00212355|541804616|FG000|Overall Study|Adverse Event|1|||
150182193|NCT00212355|541804616|FG000|Overall Study|Withdrawal by Subject|1|||
150182194|NCT00212355|541804616|FG000|Overall Study|A change of address|1|||
150182195|NCT04310735|541804620|FG000|Overall Study|Withdrawal by Subject|1|||
150182196|NCT04310735|541804621|FG001|Overall Study|Withdrawal by Subject|3|||
150182197|NCT04310735|541804622|FG002|Overall Study|Withdrawal by Subject|8|||
150070978|NCT00216476|541401779|FG001|Overall Study|Administrative Reasons|1|||
150070979|NCT00216476|541401780|FG002|Overall Study|Administrative Reasons|0|||
150070980|NCT00216476|541401778|FG000|Overall Study|Protocol Deviation|5|||
150070981|NCT00216476|541401779|FG001|Overall Study|Protocol Deviation|1|||
150070982|NCT00216476|541401780|FG002|Overall Study|Protocol Deviation|0|||
150070983|NCT00216476|541401778|FG000|Overall Study|Patient Moved|2|||
150070984|NCT00216476|541401779|FG001|Overall Study|Patient Moved|2|||
150070985|NCT00216476|541401780|FG002|Overall Study|Patient Moved|0|||
150070986|NCT00369707|541401784|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
150070987|NCT00369707|541401784|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
150070988|NCT00369707|541401784|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
150070989|NCT00369707|541401784|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
150070990|NCT00369707|541401784|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
150070991|NCT00369707|541401784|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
150070992|NCT00369707|541401784|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
150070993|NCT00369707|541401784|FG000|Follow up for 2 Years After Treatment|Death|1|||
150070994|NCT00369707|541401784|FG000|Follow up for 2 Years After Treatment|Other|2|||
150070995|NCT03605212|541401789|FG000|Treatment Period|Adverse Event|1|||
150070996|NCT03605212|541401790|FG001|Treatment Period|Adverse Event|0|||
150070997|NCT03605212|541401791|FG002|Treatment Period|Adverse Event|0|||
150070998|NCT03605212|541401792|FG003|Treatment Period|Adverse Event|0|||
150070999|NCT03605212|541401793|FG004|Treatment Period|Adverse Event|0|||
150071000|NCT03605212|541401789|FG000|Treatment Period|Physician Decision|0|||
150071001|NCT03605212|541401790|FG001|Treatment Period|Physician Decision|0|||
150071002|NCT03605212|541401791|FG002|Treatment Period|Physician Decision|0|||
150071003|NCT03605212|541401792|FG003|Treatment Period|Physician Decision|0|||
150071004|NCT03605212|541401793|FG004|Treatment Period|Physician Decision|1|||
150071005|NCT01254292|541401794|FG000|Comparative Phase|Adverse Event|25|||
150071006|NCT01254292|541401795|FG001|Comparative Phase|Adverse Event|25|||
150071007|NCT01254292|541401794|FG000|Comparative Phase|Lost to Follow-up|3|||
150071008|NCT01254292|541401795|FG001|Comparative Phase|Lost to Follow-up|21|||
150071009|NCT01254292|541401794|FG000|Comparative Phase|Pregnancy|2|||
150071010|NCT01254292|541401795|FG001|Comparative Phase|Pregnancy|6|||
150071011|NCT01254292|541401794|FG000|Comparative Phase|Withdrawal by Subject|20|||
150071012|NCT01254292|541401795|FG001|Comparative Phase|Withdrawal by Subject|21|||
150071013|NCT01254292|541401794|FG000|Comparative Phase|Protocol Violation|1|||
150071014|NCT01254292|541401795|FG001|Comparative Phase|Protocol Violation|2|||
150071015|NCT01254292|541401794|FG000|Comparative Phase|Wish for pregnancy|4|||
150071016|NCT01254292|541401795|FG001|Comparative Phase|Wish for pregnancy|6|||
150071017|NCT01254292|541401794|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
150071018|NCT01254292|541401795|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
150071019|NCT01254292|541401794|FG000|LCS12 Extension Phase|Adverse Event|9|||
150071020|NCT01254292|541401795|FG001|LCS12 Extension Phase|Adverse Event|0|||
150071021|NCT01254292|541401794|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
150071022|NCT01254292|541401795|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
150071023|NCT01254292|541401794|FG000|LCS12 Extension Phase|Other unknown|4|||
150071024|NCT01254292|541401795|FG001|LCS12 Extension Phase|Other unknown|0|||
150071025|NCT01254292|541401794|FG000|LCS12 Extension Phase|Pregnancy|2|||
150071026|NCT01254292|541401795|FG001|LCS12 Extension Phase|Pregnancy|0|||
150071027|NCT01254292|541401794|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
150071028|NCT01254292|541401795|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
150071029|NCT02083081|541401796|FG000|Overall Study|Lost to Follow-up|31|||
150071030|NCT02083081|541401797|FG001|Overall Study|Lost to Follow-up|9|||
150071031|NCT01230710|541401800|FG000|Overall Study|Disease Progression|41|||
150071032|NCT01230710|541401800|FG000|Overall Study|Lost to Follow-up|3|||
150071033|NCT01230710|541401800|FG000|Overall Study|Death|4|||
150071034|NCT01230710|541401800|FG000|Overall Study|Withdrawal of Consent|1|||
150071035|NCT02905149|541401801|FG000|Overall Study|Lost to Follow-up|2|||
150071036|NCT02905149|541401802|FG001|Overall Study|Lost to Follow-up|0|||
150071037|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
150071038|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
150071039|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Physician Decision|1|||
150071040|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Physician Decision|0|||
150071041|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
150071042|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
150071043|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
150071044|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
150071045|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Adverse Event|15|||
150071046|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Adverse Event|0|||
150071047|NCT03277690|541401803|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
150071048|NCT03277690|541401804|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
150071049|NCT03277690|541401803|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
150071050|NCT03277690|541401804|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
150071051|NCT00747812|541401805|FG000|Overall Study|Research Site Staff Relocation|5|||
150071052|NCT00747812|541401806|FG001|Overall Study|Research Site Staff Relocation|3|||
150071053|NCT01708161|541401807|FG000|Overall Study|Adverse Event|1|||
150071054|NCT01708161|541401808|FG001|Overall Study|Adverse Event|3|||
150071055|NCT01708161|541401809|FG002|Overall Study|Adverse Event|4|||
150071056|NCT01708161|541401810|FG003|Overall Study|Adverse Event|2|||
150071057|NCT01708161|541401811|FG004|Overall Study|Adverse Event|3|||
150071058|NCT01708161|541401812|FG005|Overall Study|Adverse Event|0|||
150071059|NCT01708161|541401807|FG000|Overall Study|Death|0|||
150071060|NCT01708161|541401808|FG001|Overall Study|Death|0|||
150071061|NCT01708161|541401809|FG002|Overall Study|Death|0|||
150071062|NCT01708161|541401810|FG003|Overall Study|Death|1|||
150071063|NCT01708161|541401811|FG004|Overall Study|Death|0|||
150071064|NCT01708161|541401812|FG005|Overall Study|Death|1|||
150071065|NCT01708161|541401807|FG000|Overall Study|Withdrawal by Subject|0|||
150071066|NCT01708161|541401808|FG001|Overall Study|Withdrawal by Subject|1|||
150071067|NCT01708161|541401809|FG002|Overall Study|Withdrawal by Subject|1|||
150071068|NCT01708161|541401810|FG003|Overall Study|Withdrawal by Subject|0|||
150071069|NCT01708161|541401811|FG004|Overall Study|Withdrawal by Subject|0|||
150071070|NCT01708161|541401812|FG005|Overall Study|Withdrawal by Subject|0|||
150071071|NCT01708161|541401807|FG000|Overall Study|Administrative problems|0|||
150071072|NCT01708161|541401808|FG001|Overall Study|Administrative problems|1|||
150071073|NCT01708161|541401809|FG002|Overall Study|Administrative problems|0|||
150071074|NCT01708161|541401810|FG003|Overall Study|Administrative problems|0|||
150071075|NCT01708161|541401811|FG004|Overall Study|Administrative problems|0|||
150071076|NCT01708161|541401812|FG005|Overall Study|Administrative problems|0|||
150071077|NCT01708161|541401807|FG000|Overall Study|Disease progression|3|||
150071078|NCT01708161|541401808|FG001|Overall Study|Disease progression|5|||
150071079|NCT01708161|541401809|FG002|Overall Study|Disease progression|5|||
150071080|NCT01708161|541401810|FG003|Overall Study|Disease progression|13|||
150071081|NCT01708161|541401811|FG004|Overall Study|Disease progression|3|||
150071082|NCT01708161|541401812|FG005|Overall Study|Disease progression|0|||
150071083|NCT01147172|541401815|FG000|Overall Study|Withdrawal by Subject|2|||
150071084|NCT01147172|541401815|FG000|Overall Study|Lost to Follow-up|2|||
150071085|NCT04209348|541401821|FG000|Overall Study|Lost to Follow-up|1|||
150071086|NCT04209348|541401822|FG001|Overall Study|Lost to Follow-up|0|||
150071087|NCT05055128|541401827|FG000|Overall Study|Adverse Event|0|||
150071088|NCT05055128|541401828|FG001|Overall Study|Adverse Event|0|||
150071089|NCT05055128|541401829|FG002|Overall Study|Adverse Event|0|||
150182198|NCT04310735|541804620|FG000|Overall Study|Equipment malfunction|0|||
150182199|NCT04310735|541804621|FG001|Overall Study|Equipment malfunction|1|||
150182200|NCT04310735|541804622|FG002|Overall Study|Equipment malfunction|0|||
150182201|NCT03012841|541804623|FG000|Overall Study|Protocol Violation|0|||
150182202|NCT03012841|541804624|FG001|Overall Study|Protocol Violation|10|||
150182203|NCT03012841|541804623|FG000|Overall Study|Lost to Follow-up|6|||
150182204|NCT03012841|541804624|FG001|Overall Study|Lost to Follow-up|1|||
150182205|NCT03012841|541804623|FG000|Overall Study|Withdrawal by Subject|6|||
150182206|NCT03012841|541804624|FG001|Overall Study|Withdrawal by Subject|0|||
150182207|NCT03012841|541804623|FG000|Overall Study|Unable to complete 12 month visit|6|||
150182208|NCT03012841|541804624|FG001|Overall Study|Unable to complete 12 month visit|0|||
150182209|NCT03012841|541804623|FG000|Overall Study|Subject relocation|1|||
150182210|NCT03012841|541804624|FG001|Overall Study|Subject relocation|0|||
150182211|NCT03012841|541804623|FG000|Overall Study|Seasonal winter travel|1|||
150182212|NCT03012841|541804624|FG001|Overall Study|Seasonal winter travel|0|||
150182213|NCT03012841|541804623|FG000|Overall Study|Physician Decision|0|||
150182214|NCT03012841|541804624|FG001|Overall Study|Physician Decision|2|||
150182215|NCT03012841|541804623|FG000|Overall Study|No ablation performed|0|||
150182216|NCT03012841|541804624|FG001|Overall Study|No ablation performed|2|||
150182217|NCT03012841|541804623|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
150182218|NCT03012841|541804624|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
150182219|NCT03012841|541804623|FG000|Overall Study|Insurance change|0|||
150182220|NCT03012841|541804624|FG001|Overall Study|Insurance change|1|||
150182221|NCT00186992|541804625|FG000|Overall Study|Withdrawal by Subject|5|||
150182222|NCT00186992|541804625|FG000|Overall Study|Physician's discretion|13|||
150182223|NCT00186992|541804625|FG000|Overall Study|PI Discretion|4|||
150182224|NCT00186992|541804625|FG000|Overall Study|Ineligible|2|||
150182225|NCT00186992|541804625|FG000|Overall Study|Lost to Follow-up|2|||
150182226|NCT00186992|541804625|FG000|Overall Study|Still on Study|9|||
150182227|NCT05696080|541804626|FG000|Overall Study|Lost to Follow-up|2|||
150182228|NCT05696080|541804627|FG001|Overall Study|Lost to Follow-up|1|||
150182229|NCT05696080|541804626|FG000|Overall Study|Physician Decision|1|||
150071090|NCT05055128|541401830|FG003|Overall Study|Adverse Event|1|||
150071091|NCT05055128|541401831|FG004|Overall Study|Adverse Event|1|||
150071092|NCT05055128|541401827|FG000|Overall Study|Protocol Violation|0|||
150071093|NCT05055128|541401828|FG001|Overall Study|Protocol Violation|0|||
150071094|NCT05055128|541401829|FG002|Overall Study|Protocol Violation|0|||
150182230|NCT05696080|541804627|FG001|Overall Study|Physician Decision|0|||
150182231|NCT05696080|541804626|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150182232|NCT05696080|541804627|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
150182233|NCT05696080|541804626|FG000|Overall Study|Withdrawal by Subject|12|||
150182234|NCT05696080|541804627|FG001|Overall Study|Withdrawal by Subject|0|||
150071095|NCT05055128|541401830|FG003|Overall Study|Protocol Violation|1|||
150071096|NCT05055128|541401831|FG004|Overall Study|Protocol Violation|0|||
150071097|NCT05055128|541401827|FG000|Overall Study|Withdrawal by Subject|5|||
150071098|NCT05055128|541401828|FG001|Overall Study|Withdrawal by Subject|2|||
150071099|NCT05055128|541401829|FG002|Overall Study|Withdrawal by Subject|2|||
150071100|NCT05055128|541401830|FG003|Overall Study|Withdrawal by Subject|4|||
150071101|NCT05055128|541401831|FG004|Overall Study|Withdrawal by Subject|2|||
150071102|NCT05055128|541401827|FG000|Overall Study|Randomized By Mistake|0|||
150071103|NCT05055128|541401828|FG001|Overall Study|Randomized By Mistake|1|||
150071104|NCT05055128|541401829|FG002|Overall Study|Randomized By Mistake|0|||
150071105|NCT05055128|541401830|FG003|Overall Study|Randomized By Mistake|0|||
150071106|NCT05055128|541401831|FG004|Overall Study|Randomized By Mistake|0|||
150071107|NCT05055128|541401827|FG000|Overall Study|Other|1|||
150071108|NCT05055128|541401828|FG001|Overall Study|Other|0|||
150071109|NCT05055128|541401829|FG002|Overall Study|Other|0|||
150071110|NCT05055128|541401830|FG003|Overall Study|Other|0|||
150071111|NCT05055128|541401831|FG004|Overall Study|Other|0|||
150071112|NCT00936611|541401838|FG000|Overall Study|Progressive Disease|3|||
150071113|NCT00936611|541401838|FG000|Overall Study|New Systemic Therapy|22|||
150071114|NCT00936611|541401838|FG000|Overall Study|Lost to Follow-up|1|||
150071115|NCT00936611|541401838|FG000|Overall Study|Withdrawal by Subject|2|||
150071116|NCT00936611|541401838|FG000|Overall Study|Still on Follow-up|1|||
150071117|NCT00936611|541401838|FG000|Overall Study|Still on Active Therapy|7|||
150071118|NCT00936611|541401838|FG000|Overall Study|Ineligible for Study Drug|3|||
150071119|NCT01822496|541401842|FG000|Overall Study|Protocol Violation|2|||
150071120|NCT01822496|541401843|FG001|Overall Study|Protocol Violation|2|||
150071121|NCT01822496|541401844|FG002|Overall Study|Protocol Violation|0|||
150071122|NCT01822496|541401845|FG003|Overall Study|Protocol Violation|1|||
150071123|NCT01822496|541401842|FG000|Overall Study|Withdrawal by Subject|0|||
150071124|NCT01822496|541401843|FG001|Overall Study|Withdrawal by Subject|0|||
150071125|NCT01822496|541401844|FG002|Overall Study|Withdrawal by Subject|0|||
150071126|NCT01822496|541401845|FG003|Overall Study|Withdrawal by Subject|3|||
150071127|NCT02081183|541401846|FG000|Overall Study|Lost to Follow-up|0|||
150071128|NCT02081183|541401847|FG001|Overall Study|Lost to Follow-up|1|||
150071129|NCT02081183|541401846|FG000|Overall Study|Protocol Violation|1|||
150071130|NCT02081183|541401847|FG001|Overall Study|Protocol Violation|0|||
150071131|NCT02081183|541401846|FG000|Overall Study|Other|3|||
150071132|NCT02081183|541401847|FG001|Overall Study|Other|3|||
150071133|NCT00543543|541401848|FG000|Base Study|Adverse Event|1|||
150071134|NCT00543543|541401849|FG001|Base Study|Adverse Event|11|||
150071135|NCT00543543|541401850|FG002|Base Study|Adverse Event|0|||
150071136|NCT00543543|541401851|FG003|Base Study|Adverse Event|5|||
150071137|NCT00543543|541401848|FG000|Base Study|Lost to Follow-up|12|||
150071138|NCT00543543|541401849|FG001|Base Study|Lost to Follow-up|749|||
150071139|NCT00543543|541401850|FG002|Base Study|Lost to Follow-up|9|||
150071140|NCT00543543|541401851|FG003|Base Study|Lost to Follow-up|701|||
150071141|NCT00543543|541401848|FG000|Base Study|Physician Decision|0|||
150071142|NCT00543543|541401849|FG001|Base Study|Physician Decision|4|||
150071143|NCT00543543|541401850|FG002|Base Study|Physician Decision|0|||
150071144|NCT00543543|541401851|FG003|Base Study|Physician Decision|7|||
150071145|NCT00543543|541401848|FG000|Base Study|Protocol Violation|0|||
150071146|NCT00543543|541401849|FG001|Base Study|Protocol Violation|6|||
150071147|NCT00543543|541401850|FG002|Base Study|Protocol Violation|0|||
150071148|NCT00543543|541401851|FG003|Base Study|Protocol Violation|6|||
150071149|NCT00543543|541401848|FG000|Base Study|Withdrawal by Subject|7|||
150071150|NCT00543543|541401849|FG001|Base Study|Withdrawal by Subject|482|||
150071151|NCT00543543|541401850|FG002|Base Study|Withdrawal by Subject|5|||
150071152|NCT00543543|541401851|FG003|Base Study|Withdrawal by Subject|503|||
150071153|NCT00543543|541401848|FG000|Extension Study|Adverse Event|0|||
150071154|NCT00543543|541401849|FG001|Extension Study|Adverse Event|0|||
150071155|NCT00543543|541401850|FG002|Extension Study|Adverse Event|0|||
150071156|NCT00543543|541401851|FG003|Extension Study|Adverse Event|5|||
150071157|NCT00543543|541401848|FG000|Extension Study|Lost to Follow-up|0|||
150071158|NCT00543543|541401849|FG001|Extension Study|Lost to Follow-up|0|||
150071159|NCT00543543|541401850|FG002|Extension Study|Lost to Follow-up|0|||
150071160|NCT00543543|541401851|FG003|Extension Study|Lost to Follow-up|77|||
150071161|NCT00543543|541401848|FG000|Extension Study|Physician Decision|0|||
150071162|NCT00543543|541401849|FG001|Extension Study|Physician Decision|0|||
150071163|NCT00543543|541401850|FG002|Extension Study|Physician Decision|0|||
150071164|NCT00543543|541401851|FG003|Extension Study|Physician Decision|7|||
150071165|NCT00543543|541401848|FG000|Extension Study|Pregnancy|0|||
150071166|NCT00543543|541401849|FG001|Extension Study|Pregnancy|0|||
150071167|NCT00543543|541401850|FG002|Extension Study|Pregnancy|0|||
150071168|NCT00543543|541401851|FG003|Extension Study|Pregnancy|6|||
150071169|NCT00543543|541401848|FG000|Extension Study|Protocol Violation|0|||
150071170|NCT00543543|541401849|FG001|Extension Study|Protocol Violation|0|||
150071171|NCT00543543|541401850|FG002|Extension Study|Protocol Violation|0|||
150071172|NCT00543543|541401851|FG003|Extension Study|Protocol Violation|11|||
150071173|NCT00543543|541401848|FG000|Extension Study|Withdrawal by Subject|0|||
150071174|NCT00543543|541401849|FG001|Extension Study|Withdrawal by Subject|0|||
150071175|NCT00543543|541401850|FG002|Extension Study|Withdrawal by Subject|0|||
150071176|NCT00543543|541401851|FG003|Extension Study|Withdrawal by Subject|120|||
150071177|NCT04308304|541401852|FG000|Overall Study|Withdrawal by Subject|4|||
150071178|NCT04308304|541401853|FG001|Overall Study|Withdrawal by Subject|0|||
150071179|NCT04308304|541401852|FG000|Overall Study|Protocol Violation|1|||
150071180|NCT04308304|541401853|FG001|Overall Study|Protocol Violation|0|||
150071181|NCT00945555|541401854|FG000|Overall Study|Referred to another hospital|5|||
150071182|NCT00945555|541401854|FG000|Overall Study|Worsening condition, intensive care unit|1|||
150071183|NCT00945555|541401854|FG000|Overall Study|Withdrawal by Subject|2|||
150071184|NCT00945555|541401854|FG000|Overall Study|Participant continued treatment at home|1|||
150071185|NCT00945555|541401854|FG000|Overall Study|Death|18|||
150071186|NCT00945555|541401854|FG000|Overall Study|Other|1|||
150071187|NCT04502979|541401856|FG000|Overall Study|Lost to Follow-up|1|||
150071188|NCT04502979|541401857|FG001|Overall Study|Lost to Follow-up|3|||
150071189|NCT04502979|541401856|FG000|Overall Study|Withdrawal by Subject|2|||
150071190|NCT04502979|541401857|FG001|Overall Study|Withdrawal by Subject|1|||
150071191|NCT00165984|541401862|FG000|Overall Study|Death|15|||
150071192|NCT03945266|541401863|FG000|Overall Study|Withdrawal by Subject|1|||
150071193|NCT03945266|541401864|FG001|Overall Study|Withdrawal by Subject|0|||
150071194|NCT03945266|541401863|FG000|Overall Study|Miscarriage|0|||
150071195|NCT03945266|541401864|FG001|Overall Study|Miscarriage|2|||
150071196|NCT03945266|541401863|FG000|Overall Study|Lost to Follow-up|1|||
150071197|NCT03945266|541401864|FG001|Overall Study|Lost to Follow-up|0|||
150071198|NCT01686828|541401865|FG000|Overall Study|Physician Decision|1|||
150071199|NCT01686828|541401866|FG001|Overall Study|Physician Decision|0|||
150071200|NCT01686828|541401867|FG002|Overall Study|Physician Decision|0|||
150071201|NCT01686828|541401868|FG003|Overall Study|Physician Decision|0|||
150071202|NCT01686828|541401865|FG000|Overall Study|New Job|0|||
150071203|NCT01686828|541401866|FG001|Overall Study|New Job|1|||
150071204|NCT01686828|541401867|FG002|Overall Study|New Job|0|||
150071205|NCT01686828|541401868|FG003|Overall Study|New Job|0|||
150071206|NCT01686828|541401865|FG000|Overall Study|Weight Loss|0|||
150071207|NCT01686828|541401866|FG001|Overall Study|Weight Loss|0|||
150071208|NCT01686828|541401867|FG002|Overall Study|Weight Loss|1|||
150071209|NCT01686828|541401868|FG003|Overall Study|Weight Loss|0|||
150071210|NCT01736124|541401871|FG000|Post-intervention Assessment|Death|2|||
150071211|NCT01736124|541401872|FG001|Post-intervention Assessment|Death|2|||
150071212|NCT01736124|541401871|FG000|Post-intervention Assessment|lost computer access|1|||
150071213|NCT01736124|541401872|FG001|Post-intervention Assessment|lost computer access|1|||
150071214|NCT01736124|541401871|FG000|Post-intervention Assessment|Moved away|3|||
150071215|NCT01736124|541401872|FG001|Post-intervention Assessment|Moved away|1|||
150071216|NCT01736124|541401871|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
150071217|NCT01736124|541401872|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
150071218|NCT01736124|541401871|FG000|Post-intervention Assessment|Illness|3|||
150071219|NCT01736124|541401872|FG001|Post-intervention Assessment|Illness|2|||
150071220|NCT01736124|541401871|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
150071221|NCT01736124|541401872|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
150071222|NCT01736124|541401871|FG000|Post-intervention Assessment|Temporarily away|3|||
150071223|NCT01736124|541401872|FG001|Post-intervention Assessment|Temporarily away|1|||
150071224|NCT01736124|541401871|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
150071225|NCT01736124|541401872|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
150071226|NCT01736124|541401871|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
150071227|NCT01736124|541401872|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
150071228|NCT01736124|541401871|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
150071229|NCT01736124|541401872|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
150071230|NCT01736124|541401871|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
150071231|NCT01736124|541401872|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
150071232|NCT01736124|541401871|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
150071233|NCT01736124|541401872|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
150071234|NCT01736124|541401871|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
150071235|NCT01736124|541401872|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
150071236|NCT01736124|541401871|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
150071237|NCT01736124|541401872|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
150071238|NCT01736124|541401871|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
150071239|NCT01736124|541401872|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
150071240|NCT01736124|541401871|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
150071241|NCT01736124|541401872|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
150071242|NCT02734433|541401873|FG000|Overall Study|Disease progression|1|||
150071243|NCT02734433|541401874|FG001|Overall Study|Disease progression|5|||
150071244|NCT02734433|541401873|FG000|Overall Study|Clinical progression|0|||
150071245|NCT02734433|541401874|FG001|Overall Study|Clinical progression|1|||
150071246|NCT02734433|541401873|FG000|Overall Study|Withdrawal by Subject|1|||
150071247|NCT02734433|541401874|FG001|Overall Study|Withdrawal by Subject|2|||
150071248|NCT02628769|541401875|FG000|First Intervention|Adverse Event|1|||
150071249|NCT02628769|541401876|FG001|First Intervention|Adverse Event|0|||
150071250|NCT02628769|541401875|FG000|First Intervention|Withdrawal by Subject|0|||
150071251|NCT02628769|541401876|FG001|First Intervention|Withdrawal by Subject|1|||
150071252|NCT02628769|541401875|FG000|Second Intervention|Adverse Event|2|||
150071253|NCT02628769|541401876|FG001|Second Intervention|Adverse Event|0|||
150071254|NCT02628769|541401875|FG000|Second Intervention|Physician Decision|0|||
150071255|NCT02628769|541401876|FG001|Second Intervention|Physician Decision|1|||
150071256|NCT03698331|541401880|FG000|Overall Study|Adverse Event|2|||
150071257|NCT03698331|541401881|FG001|Overall Study|Adverse Event|3|||
150071258|NCT03698331|541401880|FG000|Overall Study|Withdrawal by Subject|1|||
150071259|NCT03698331|541401881|FG001|Overall Study|Withdrawal by Subject|1|||
150071260|NCT03698331|541401880|FG000|Overall Study|Lost to Follow-up|0|||
150071261|NCT03698331|541401881|FG001|Overall Study|Lost to Follow-up|2|||
150071262|NCT03698331|541401880|FG000|Overall Study|Non-compliance with study drug|1|||
150071263|NCT03698331|541401881|FG001|Overall Study|Non-compliance with study drug|0|||
150071264|NCT01467583|541401883|FG000|Overall Study|Death|1|||
150071265|NCT01467583|541401884|FG001|Overall Study|Death|1|||
150071266|NCT01467583|541401885|FG002|Overall Study|Death|0|||
150071267|NCT01467583|541401883|FG000|Overall Study|Withdrawal by Subject|1|||
150071268|NCT01467583|541401884|FG001|Overall Study|Withdrawal by Subject|0|||
150071269|NCT01467583|541401885|FG002|Overall Study|Withdrawal by Subject|0|||
150071270|NCT01467583|541401883|FG000|Overall Study|Protocol Violation|0|||
150071271|NCT01467583|541401884|FG001|Overall Study|Protocol Violation|0|||
150071272|NCT01467583|541401885|FG002|Overall Study|Protocol Violation|2|||
150071273|NCT02130024|541401886|FG000|Overall Study|Adverse Event|10|||
150071274|NCT02130024|541401887|FG001|Overall Study|Adverse Event|11|||
150071275|NCT02130024|541401886|FG000|Overall Study|Death|2|||
150071276|NCT02130024|541401887|FG001|Overall Study|Death|2|||
150071277|NCT02130024|541401886|FG000|Overall Study|Lost to Follow-up|1|||
150071278|NCT02130024|541401887|FG001|Overall Study|Lost to Follow-up|1|||
150071279|NCT02130024|541401886|FG000|Overall Study|Physician Decision|1|||
150071280|NCT02130024|541401887|FG001|Overall Study|Physician Decision|3|||
150071281|NCT02130024|541401886|FG000|Overall Study|Protocol Deviation|4|||
150071282|NCT02130024|541401887|FG001|Overall Study|Protocol Deviation|0|||
150071283|NCT02130024|541401886|FG000|Overall Study|Site Administration Problems|1|||
150071284|NCT02130024|541401887|FG001|Overall Study|Site Administration Problems|0|||
150071285|NCT02130024|541401886|FG000|Overall Study|Subject Withdrew Consent|6|||
150071286|NCT02130024|541401887|FG001|Overall Study|Subject Withdrew Consent|14|||
150071287|NCT05274165|541401891|FG000|Overall Study|Withdrawal by Subject|3|||
150071288|NCT05274165|541401892|FG001|Overall Study|Withdrawal by Subject|3|||
150071289|NCT03350620|541401895|FG000|Stage 2|Adverse Event|0|||
150071290|NCT03350620|541401896|FG001|Stage 2|Adverse Event|1|||
150071291|NCT03350620|541401897|FG002|Stage 2|Adverse Event|1|||
150071292|NCT03350620|541401895|FG000|Stage 2|Lack of Efficacy|0|||
150071293|NCT03350620|541401896|FG001|Stage 2|Lack of Efficacy|2|||
150071294|NCT03350620|541401897|FG002|Stage 2|Lack of Efficacy|0|||
150071295|NCT03350620|541401895|FG000|Stage 2|Lost to Follow-up|1|||
150071296|NCT03350620|541401896|FG001|Stage 2|Lost to Follow-up|2|||
150071297|NCT03350620|541401897|FG002|Stage 2|Lost to Follow-up|2|||
150071298|NCT03350620|541401895|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
150071299|NCT03350620|541401896|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
150071300|NCT03350620|541401897|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
150071301|NCT03507400|541401898|FG000|Overall Study|discontinued|5|||
150071302|NCT03507400|541401899|FG001|Overall Study|discontinued|1|||
150071303|NCT03507400|541401898|FG000|Overall Study|Lost to Follow-up|8|||
150071304|NCT03507400|541401899|FG001|Overall Study|Lost to Follow-up|6|||
150071305|NCT03507400|541401898|FG000|Overall Study|Protocol Violation|0|||
150071306|NCT03507400|541401899|FG001|Overall Study|Protocol Violation|1|||
150071307|NCT01555983|541401900|FG000|Overall Study|Withdrawal by Subject|1|||
150071308|NCT01555983|541401901|FG001|Overall Study|Withdrawal by Subject|0|||
150071309|NCT01555983|541401902|FG002|Overall Study|Withdrawal by Subject|0|||
150071310|NCT01555983|541401903|FG003|Overall Study|Withdrawal by Subject|0|||
150071311|NCT01555983|541401904|FG004|Overall Study|Withdrawal by Subject|1|||
150071312|NCT01555983|541401905|FG005|Overall Study|Withdrawal by Subject|1|||
150071313|NCT02008318|541403062|FG000|Overall Study|Adverse Event|4|||
150071314|NCT02008318|541403063|FG001|Overall Study|Adverse Event|0|||
150071315|NCT02008318|541403062|FG000|Overall Study|Physician Decision|2|||
150071316|NCT02008318|541403063|FG001|Overall Study|Physician Decision|0|||
150071317|NCT02008318|541403062|FG000|Overall Study|Progressive Disease|2|||
150071318|NCT02008318|541403063|FG001|Overall Study|Progressive Disease|0|||
150071319|NCT02008318|541403062|FG000|Overall Study|Protocol Violation|1|||
150071320|NCT02008318|541403063|FG001|Overall Study|Protocol Violation|1|||
150071321|NCT02008318|541403062|FG000|Overall Study|Withdrawal by Subject|3|||
150071322|NCT02008318|541403063|FG001|Overall Study|Withdrawal by Subject|0|||
150071323|NCT00573183|541403064|FG000|Overall Study|Lost to Follow-up|52|||
150071324|NCT00573183|541403065|FG001|Overall Study|Lost to Follow-up|50|||
150071325|NCT00573183|541403064|FG000|Overall Study|Withdrawal by Subject|8|||
150071326|NCT00573183|541403065|FG001|Overall Study|Withdrawal by Subject|2|||
150071327|NCT00573183|541403064|FG000|Overall Study|Death|0|||
150071328|NCT00573183|541403065|FG001|Overall Study|Death|1|||
150071329|NCT00573183|541403064|FG000|Overall Study|Adverse Event|2|||
150071330|NCT00573183|541403065|FG001|Overall Study|Adverse Event|0|||
150071331|NCT00573183|541403064|FG000|Overall Study|Incarceration|5|||
150071332|NCT00573183|541403065|FG001|Overall Study|Incarceration|8|||
150071333|NCT00573183|541403064|FG000|Overall Study|Other|5|||
150071334|NCT00573183|541403065|FG001|Overall Study|Other|2|||
150071335|NCT05439941|541403066|FG000|Overall Study|Lack of Efficacy|8|||
150071336|NCT05439941|541403067|FG001|Overall Study|Lack of Efficacy|5|||
150071337|NCT05439941|541403068|FG002|Overall Study|Lack of Efficacy|3|||
150071338|NCT05439941|541403066|FG000|Overall Study|Treatment Failure|0|||
150071339|NCT05439941|541403067|FG001|Overall Study|Treatment Failure|1|||
150071340|NCT05439941|541403068|FG002|Overall Study|Treatment Failure|0|||
150071341|NCT05439941|541403066|FG000|Overall Study|Adverse Event|1|||
150071342|NCT05439941|541403067|FG001|Overall Study|Adverse Event|3|||
150071343|NCT05439941|541403068|FG002|Overall Study|Adverse Event|0|||
150071344|NCT05439941|541403066|FG000|Overall Study|Adverse Event - Parent Study|1|||
150071345|NCT05439941|541403067|FG001|Overall Study|Adverse Event - Parent Study|0|||
150071346|NCT05439941|541403068|FG002|Overall Study|Adverse Event - Parent Study|0|||
150071347|NCT05439941|541403066|FG000|Overall Study|Pregnancy|1|||
150071348|NCT05439941|541403067|FG001|Overall Study|Pregnancy|0|||
150071349|NCT05439941|541403068|FG002|Overall Study|Pregnancy|0|||
150071350|NCT05439941|541403066|FG000|Overall Study|Withdrawal by Subject|9|||
150071351|NCT05439941|541403067|FG001|Overall Study|Withdrawal by Subject|6|||
150071352|NCT05439941|541403068|FG002|Overall Study|Withdrawal by Subject|10|||
150071353|NCT05439941|541403066|FG000|Overall Study|Non-Compliance|1|||
150071354|NCT05439941|541403067|FG001|Overall Study|Non-Compliance|1|||
150071355|NCT05439941|541403068|FG002|Overall Study|Non-Compliance|1|||
150071356|NCT05439941|541403066|FG000|Overall Study|Lost to Follow-up|2|||
150071357|NCT05439941|541403067|FG001|Overall Study|Lost to Follow-up|2|||
150071358|NCT05439941|541403068|FG002|Overall Study|Lost to Follow-up|0|||
150071359|NCT05439941|541403066|FG000|Overall Study|Physician Decision|1|||
150071360|NCT05439941|541403067|FG001|Overall Study|Physician Decision|0|||
150071361|NCT05439941|541403068|FG002|Overall Study|Physician Decision|0|||
150071362|NCT05439941|541403066|FG000|Overall Study|Trial Termination by Sponsor|78|||
150071363|NCT05439941|541403067|FG001|Overall Study|Trial Termination by Sponsor|83|||
150071364|NCT05439941|541403068|FG002|Overall Study|Trial Termination by Sponsor|65|||
150071365|NCT05439941|541403066|FG000|Overall Study|Other than Reasons Listed|2|||
150071366|NCT05439941|541403067|FG001|Overall Study|Other than Reasons Listed|1|||
150071367|NCT05439941|541403068|FG002|Overall Study|Other than Reasons Listed|0|||
150071368|NCT02336373|541403069|FG000|Overall Study|Protocol closed early|4|||
150071369|NCT02336373|541403069|FG000|Overall Study|Physician Decision|14|||
150071370|NCT01926015|541403072|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150071371|NCT01926015|541403073|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150071372|NCT01926015|541403072|FG000|Overall Study|Randomized not treated|2|||
150071373|NCT01926015|541403073|FG001|Overall Study|Randomized not treated|0|||
150071374|NCT01364649|541403074|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
150071375|NCT01364649|541403075|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
150071376|NCT01364649|541403074|FG000|Overall Study|Lack of Efficacy|6|||
150071377|NCT01364649|541403075|FG001|Overall Study|Lack of Efficacy|0|||
150071378|NCT01364649|541403074|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
150071379|NCT01364649|541403075|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
150071380|NCT01364649|541403074|FG000|Overall Study|Protocol Deviations|4|||
150071381|NCT01364649|541403075|FG001|Overall Study|Protocol Deviations|8|||
150071382|NCT01364649|541403074|FG000|Overall Study|Withdrawal of Consent|9|||
150071383|NCT01364649|541403075|FG001|Overall Study|Withdrawal of Consent|7|||
150071384|NCT01364649|541403074|FG000|Overall Study|Lost to Follow-up|12|||
150071385|NCT01364649|541403075|FG001|Overall Study|Lost to Follow-up|13|||
150071386|NCT01364649|541403074|FG000|Overall Study|Other|4|||
150071387|NCT01364649|541403075|FG001|Overall Study|Other|1|||
150071388|NCT00902668|541403076|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
150071389|NCT01788046|541403077|FG000|Overall Study|Withdrawal by Subject|12|||
150071390|NCT01788046|541403078|FG001|Overall Study|Withdrawal by Subject|12|||
150071391|NCT01788046|541403077|FG000|Overall Study|Lost to Follow-up|12|||
150071392|NCT01788046|541403078|FG001|Overall Study|Lost to Follow-up|19|||
150071393|NCT01788046|541403077|FG000|Overall Study|Death|7|||
150071394|NCT01788046|541403078|FG001|Overall Study|Death|5|||
150071395|NCT01788046|541403077|FG000|Overall Study|Protocol Specified Criteria|25|||
150071396|NCT01788046|541403078|FG001|Overall Study|Protocol Specified Criteria|1|||
150071397|NCT01147640|541403081|FG000|Overall Study|Adverse Event|2|||
150071398|NCT01147640|541403082|FG001|Overall Study|Adverse Event|0|||
150071399|NCT01147640|541403081|FG000|Overall Study|Physician Decision|1|||
150071400|NCT01147640|541403082|FG001|Overall Study|Physician Decision|0|||
150071401|NCT01147640|541403081|FG000|Overall Study|Withdrawal by Subject|1|||
150071402|NCT01147640|541403082|FG001|Overall Study|Withdrawal by Subject|0|||
150071403|NCT01147640|541403081|FG000|Overall Study|Lost to Follow-up|0|||
150071404|NCT01147640|541403082|FG001|Overall Study|Lost to Follow-up|1|||
150071405|NCT01147640|541403081|FG000|Overall Study|Didn't meet eligibility criteria|1|||
150071406|NCT01147640|541403082|FG001|Overall Study|Didn't meet eligibility criteria|0|||
150071407|NCT00091442|541403084|FG000|Overall Study|Progressive Disease|220|||
150071408|NCT00091442|541403085|FG001|Overall Study|Progressive Disease|189|||
150071409|NCT00091442|541403084|FG000|Overall Study|Physician Decision|61|||
150071410|NCT00091442|541403085|FG001|Overall Study|Physician Decision|58|||
150071411|NCT00091442|541403084|FG000|Overall Study|Withdrawal by Subject|38|||
150071412|NCT00091442|541403085|FG001|Overall Study|Withdrawal by Subject|46|||
150071413|NCT00091442|541403084|FG000|Overall Study|Adverse Event|29|||
150071414|NCT00091442|541403085|FG001|Overall Study|Adverse Event|48|||
150071415|NCT00091442|541403084|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
150071416|NCT00091442|541403085|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
150071417|NCT00091442|541403084|FG000|Overall Study|Death|9|||
150071418|NCT00091442|541403085|FG001|Overall Study|Death|7|||
150071419|NCT00091442|541403084|FG000|Overall Study|Lost to Follow-up|1|||
150071420|NCT00091442|541403085|FG001|Overall Study|Lost to Follow-up|3|||
150071421|NCT00091442|541403084|FG000|Overall Study|Other|2|||
150071422|NCT00091442|541403085|FG001|Overall Study|Other|6|||
150071423|NCT00917501|541403086|FG000|Overall Study|Lost to Follow-up|4|||
150071424|NCT00917501|541403087|FG001|Overall Study|Lost to Follow-up|1|||
150071425|NCT00917501|541403086|FG000|Overall Study|Withdrawal by Subject|3|||
150071426|NCT00917501|541403087|FG001|Overall Study|Withdrawal by Subject|1|||
150071427|NCT00917501|541403086|FG000|Overall Study|Lack of Efficacy|1|||
150071428|NCT00917501|541403087|FG001|Overall Study|Lack of Efficacy|2|||
150071429|NCT00917501|541403086|FG000|Overall Study|trouble swollowing capsules|0|||
150182235|NCT03398200|541804628|FG000|Overall Study|Withdrawal by Subject|0|||
150182236|NCT03398200|541804629|FG001|Overall Study|Withdrawal by Subject|1|||
150182237|NCT01649271|541804630|FG000|Overall Study|Progressive disease|4|||
150182238|NCT01649271|541804631|FG001|Overall Study|Progressive disease|5|||
150071430|NCT00917501|541403087|FG001|Overall Study|trouble swollowing capsules|1|||
150182239|NCT01649271|541804630|FG000|Overall Study|Other Adverse Event|0|||
150182240|NCT01649271|541804631|FG001|Overall Study|Other Adverse Event|2|||
150071431|NCT00986830|541403096|FG000|Overall Study|Death|1|||
150071432|NCT00986830|541403096|FG000|Overall Study|Lost to Follow-up|1|||
150071433|NCT00986830|541403096|FG000|Overall Study|Lack of Efficacy|1|||
150071434|NCT00986830|541403096|FG000|Overall Study|Unable to access sinus with device|5|||
150071435|NCT01495975|541403097|FG000|Overall Study|Lost to Follow-up|1|||
150071436|NCT01495975|541403098|FG001|Overall Study|Lost to Follow-up|0|||
150071437|NCT00808483|541403101|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
150071438|NCT00808483|541403102|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
150071439|NCT00808483|541403101|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
150071440|NCT00808483|541403102|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
150071441|NCT00808483|541403101|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
150071442|NCT00808483|541403102|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
150071443|NCT02038881|541403103|FG000|Overall Study|Withdrawal by Subject|0|||
150071444|NCT02038881|541403104|FG001|Overall Study|Withdrawal by Subject|0|||
150071445|NCT02038881|541403105|FG002|Overall Study|Withdrawal by Subject|1|||
150071446|NCT02038881|541403103|FG000|Overall Study|Lost to Follow-up|2|||
150071447|NCT02038881|541403104|FG001|Overall Study|Lost to Follow-up|0|||
150071448|NCT02038881|541403105|FG002|Overall Study|Lost to Follow-up|0|||
150071449|NCT02038881|541403103|FG000|Overall Study|incarcerated|1|||
150071450|NCT02038881|541403104|FG001|Overall Study|incarcerated|0|||
150071451|NCT02038881|541403105|FG002|Overall Study|incarcerated|0|||
150071452|NCT00333840|541403106|FG000|First-line Treatment Period|Adverse Event|38|||
150071453|NCT00333840|541403107|FG001|First-line Treatment Period|Adverse Event|37|||
150071454|NCT00333840|541403108|FG002|First-line Treatment Period|Adverse Event|0|||
150071455|NCT00333840|541403109|FG003|First-line Treatment Period|Adverse Event|0|||
150071456|NCT00333840|541403106|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
150071457|NCT00333840|541403107|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
150071458|NCT00333840|541403108|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
150071459|NCT00333840|541403109|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
150071460|NCT00333840|541403106|FG000|First-line Treatment Period|Abnormal procedure|2|||
150071461|NCT00333840|541403107|FG001|First-line Treatment Period|Abnormal procedure|0|||
150071462|NCT00333840|541403108|FG002|First-line Treatment Period|Abnormal procedure|0|||
150071463|NCT00333840|541403109|FG003|First-line Treatment Period|Abnormal procedure|0|||
150071464|NCT00333840|541403106|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
150071465|NCT00333840|541403107|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
150071466|NCT00333840|541403108|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
150071467|NCT00333840|541403109|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
150071468|NCT00333840|541403106|FG000|First-line Treatment Period|No longer required study drug|21|||
150071469|NCT00333840|541403107|FG001|First-line Treatment Period|No longer required study drug|8|||
150071470|NCT00333840|541403108|FG002|First-line Treatment Period|No longer required study drug|0|||
150071471|NCT00333840|541403109|FG003|First-line Treatment Period|No longer required study drug|0|||
150071472|NCT00333840|541403106|FG000|First-line Treatment Period|Protocol Violation|17|||
150071473|NCT00333840|541403107|FG001|First-line Treatment Period|Protocol Violation|17|||
150071474|NCT00333840|541403108|FG002|First-line Treatment Period|Protocol Violation|0|||
150071475|NCT00333840|541403109|FG003|First-line Treatment Period|Protocol Violation|0|||
150071476|NCT00333840|541403106|FG000|First-line Treatment Period|Subject withdrew consent|57|||
150071477|NCT00333840|541403107|FG001|First-line Treatment Period|Subject withdrew consent|77|||
150071478|NCT00333840|541403108|FG002|First-line Treatment Period|Subject withdrew consent|0|||
150071479|NCT00333840|541403109|FG003|First-line Treatment Period|Subject withdrew consent|0|||
150071480|NCT00333840|541403106|FG000|First-line Treatment Period|Lost to Follow-up|15|||
150071481|NCT00333840|541403107|FG001|First-line Treatment Period|Lost to Follow-up|6|||
150071482|NCT00333840|541403108|FG002|First-line Treatment Period|Lost to Follow-up|0|||
150071483|NCT00333840|541403109|FG003|First-line Treatment Period|Lost to Follow-up|0|||
150071484|NCT00333840|541403106|FG000|First-line Treatment Period|Administrative problems|12|||
150071485|NCT00333840|541403107|FG001|First-line Treatment Period|Administrative problems|6|||
150071486|NCT00333840|541403108|FG002|First-line Treatment Period|Administrative problems|0|||
150071487|NCT00333840|541403109|FG003|First-line Treatment Period|Administrative problems|0|||
150071488|NCT00333840|541403106|FG000|First-line Treatment Period|Death|19|||
150071489|NCT00333840|541403107|FG001|First-line Treatment Period|Death|2|||
150071490|NCT00333840|541403108|FG002|First-line Treatment Period|Death|0|||
150071491|NCT00333840|541403109|FG003|First-line Treatment Period|Death|0|||
150071492|NCT00333840|541403106|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
150071493|NCT00333840|541403107|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
150182241|NCT01649271|541804630|FG000|Overall Study|Withdrawal by Subject|1|||
150182242|NCT01649271|541804631|FG001|Overall Study|Withdrawal by Subject|0|||
150182243|NCT01649271|541804630|FG000|Overall Study|Other than stated above|1|||
150071494|NCT00333840|541403108|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
150071495|NCT00333840|541403109|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
150071496|NCT00333840|541403106|FG000|Second-line Treatment Period|Adverse Event|0|||
150071497|NCT00333840|541403107|FG001|Second-line Treatment Period|Adverse Event|0|||
150071498|NCT00333840|541403108|FG002|Second-line Treatment Period|Adverse Event|3|||
150071499|NCT00333840|541403109|FG003|Second-line Treatment Period|Adverse Event|34|||
150071500|NCT00333840|541403106|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
150071501|NCT00333840|541403107|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
150071502|NCT00333840|541403108|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
150071503|NCT00333840|541403109|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
150071504|NCT00333840|541403106|FG000|Second-line Treatment Period|Abnormal procedure|0|||
150071505|NCT00333840|541403107|FG001|Second-line Treatment Period|Abnormal procedure|0|||
150071506|NCT00333840|541403108|FG002|Second-line Treatment Period|Abnormal procedure|0|||
150071507|NCT00333840|541403109|FG003|Second-line Treatment Period|Abnormal procedure|1|||
150071508|NCT00333840|541403106|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
150071509|NCT00333840|541403107|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
150071510|NCT00333840|541403108|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
150071511|NCT00333840|541403109|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
150071512|NCT00333840|541403106|FG000|Second-line Treatment Period|No longer required study drug|0|||
150071513|NCT00333840|541403107|FG001|Second-line Treatment Period|No longer required study drug|0|||
150071514|NCT00333840|541403108|FG002|Second-line Treatment Period|No longer required study drug|1|||
150071515|NCT00333840|541403109|FG003|Second-line Treatment Period|No longer required study drug|14|||
150071516|NCT00333840|541403106|FG000|Second-line Treatment Period|Protocol Violation|0|||
150071517|NCT00333840|541403107|FG001|Second-line Treatment Period|Protocol Violation|0|||
150071518|NCT00333840|541403108|FG002|Second-line Treatment Period|Protocol Violation|1|||
150071519|NCT00333840|541403109|FG003|Second-line Treatment Period|Protocol Violation|10|||
150071520|NCT00333840|541403106|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
150071521|NCT00333840|541403107|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
150071522|NCT00333840|541403108|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
150071523|NCT00333840|541403109|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
150071524|NCT00333840|541403106|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
150071525|NCT00333840|541403107|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
150071526|NCT00333840|541403108|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
150071527|NCT00333840|541403109|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
150071528|NCT00333840|541403106|FG000|Second-line Treatment Period|Administrative problems|0|||
150071529|NCT00333840|541403107|FG001|Second-line Treatment Period|Administrative problems|0|||
150071530|NCT00333840|541403108|FG002|Second-line Treatment Period|Administrative problems|0|||
150071531|NCT00333840|541403109|FG003|Second-line Treatment Period|Administrative problems|7|||
150071532|NCT00333840|541403106|FG000|Second-line Treatment Period|Death|0|||
150071533|NCT00333840|541403107|FG001|Second-line Treatment Period|Death|0|||
150071534|NCT00333840|541403108|FG002|Second-line Treatment Period|Death|0|||
150071535|NCT00333840|541403109|FG003|Second-line Treatment Period|Death|9|||
150071536|NCT01904058|541403110|FG000|Overall Study|Adverse Event|2|||
150071537|NCT01904058|541403111|FG001|Overall Study|Adverse Event|0|||
150071538|NCT01904058|541403112|FG002|Overall Study|Adverse Event|0|||
150071539|NCT01904058|541403113|FG003|Overall Study|Adverse Event|0|||
150071540|NCT01904058|541403110|FG000|Overall Study|Withdrawal by Subject|1|||
150071541|NCT01904058|541403111|FG001|Overall Study|Withdrawal by Subject|0|||
150071542|NCT01904058|541403112|FG002|Overall Study|Withdrawal by Subject|1|||
150071543|NCT01904058|541403113|FG003|Overall Study|Withdrawal by Subject|0|||
150071544|NCT01904058|541403110|FG000|Overall Study|Pregnancy|0|||
150071545|NCT01904058|541403111|FG001|Overall Study|Pregnancy|0|||
150071546|NCT01904058|541403112|FG002|Overall Study|Pregnancy|0|||
150071547|NCT01904058|541403113|FG003|Overall Study|Pregnancy|1|||
150071548|NCT03096483|541403114|FG000|Overall Study|Withdrawal by site|1|||
150071549|NCT04810481|541403117|FG000|Overall Study|Disqualified data sets|10|||
150071550|NCT04810481|541403118|FG001|Overall Study|Disqualified data sets|28|||
150071551|NCT02808650|541403125|FG000|Overall Study|Death|0|||
150071552|NCT02808650|541403126|FG001|Overall Study|Death|0|||
150071553|NCT02808650|541403127|FG002|Overall Study|Death|0|||
150071554|NCT02808650|541403128|FG003|Overall Study|Death|0|||
150071555|NCT02808650|541403129|FG004|Overall Study|Death|1|||
150071556|NCT02808650|541403125|FG000|Overall Study|Lack of Efficacy|5|||
150071557|NCT02808650|541403126|FG001|Overall Study|Lack of Efficacy|5|||
150071558|NCT02808650|541403127|FG002|Overall Study|Lack of Efficacy|6|||
150071559|NCT02808650|541403128|FG003|Overall Study|Lack of Efficacy|5|||
150071560|NCT02808650|541403129|FG004|Overall Study|Lack of Efficacy|4|||
150071561|NCT02808650|541403125|FG000|Overall Study|Physician Decision|1|||
150071562|NCT02808650|541403126|FG001|Overall Study|Physician Decision|1|||
150071563|NCT02808650|541403127|FG002|Overall Study|Physician Decision|0|||
150071564|NCT02808650|541403128|FG003|Overall Study|Physician Decision|0|||
150071565|NCT02808650|541403129|FG004|Overall Study|Physician Decision|0|||
150071566|NCT02808650|541403125|FG000|Overall Study|Withdrawal by Subject|0|||
150071567|NCT02808650|541403126|FG001|Overall Study|Withdrawal by Subject|0|||
150071568|NCT02808650|541403127|FG002|Overall Study|Withdrawal by Subject|0|||
150071569|NCT02808650|541403128|FG003|Overall Study|Withdrawal by Subject|1|||
150071570|NCT02808650|541403129|FG004|Overall Study|Withdrawal by Subject|1|||
150071571|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
150071572|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
150071573|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Death|1|||
150071574|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Death|0|||
150071575|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
150071576|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
150071577|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
150071578|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
150071579|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
150071580|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
150071581|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
150071582|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
150071583|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
150071584|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
150071585|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
150071586|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
150071587|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
150071588|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
150071589|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
150071590|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
150071591|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
150071592|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
150071593|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
150071594|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
150071595|NCT02927262|541403130|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
150071596|NCT02927262|541403131|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
150071597|NCT02927262|541403130|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
150071598|NCT02927262|541403131|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
150071599|NCT02927262|541403130|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
150071600|NCT02927262|541403131|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
150071601|NCT02927262|541403130|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
150071602|NCT02927262|541403131|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
150071603|NCT04043728|541403139|FG000|Overall Study|Lost to Follow-up|1|||
150071604|NCT04043728|541403140|FG001|Overall Study|Lost to Follow-up|2|||
150071605|NCT04043728|541403141|FG002|Overall Study|Lost to Follow-up|0|||
150071606|NCT03841448|541403142|FG000|Double-blind Treatment (DBT) Period|Death|1|||
150071607|NCT03841448|541403143|FG001|Double-blind Treatment (DBT) Period|Death|1|||
150071608|NCT03841448|541403144|FG002|Double-blind Treatment (DBT) Period|Death|0|||
150071609|NCT03841448|541403145|FG003|Double-blind Treatment (DBT) Period|Death|0|||
150071610|NCT03841448|541403142|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
150071611|NCT03841448|541403143|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
150071612|NCT03841448|541403144|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
150071613|NCT03841448|541403145|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
150071614|NCT03841448|541403142|FG000|Open-Label Extension (OLE) Period|Death|0|||
150071615|NCT03841448|541403143|FG001|Open-Label Extension (OLE) Period|Death|0|||
150071616|NCT03841448|541403144|FG002|Open-Label Extension (OLE) Period|Death|0|||
150071617|NCT03841448|541403145|FG003|Open-Label Extension (OLE) Period|Death|1|||
150071618|NCT03841448|541403142|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
150071619|NCT03841448|541403143|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
150071620|NCT03841448|541403144|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
150071621|NCT03841448|541403145|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
150071622|NCT03841448|541403142|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
150071623|NCT03841448|541403143|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
150071624|NCT03841448|541403144|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
150071625|NCT03841448|541403145|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
150071626|NCT03841448|541403142|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
150071627|NCT03841448|541403143|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
150071628|NCT03841448|541403144|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
150071629|NCT03841448|541403145|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
150071630|NCT00072176|541403146|FG000|Overall Study|Withdrawal by Subject|1|||
150071631|NCT00072176|541403147|FG001|Overall Study|Withdrawal by Subject|0|||
150071632|NCT00072176|541403146|FG000|Overall Study|Protocol Violation|0|||
150071633|NCT00072176|541403147|FG001|Overall Study|Protocol Violation|1|||
150071634|NCT04128371|541403150|FG000|Overall Study|Lack of Efficacy|1|||
150071635|NCT00968864|541403153|FG000|Overall Study|Protocol exception/ not evaluable|1|||
150071636|NCT00586625|541403154|FG000|Overall Study|Adverse Event|6|||
150071637|NCT00586625|541403155|FG001|Overall Study|Adverse Event|6|||
150071638|NCT00586625|541403154|FG000|Overall Study|Protocol Violation|3|||
150071639|NCT00586625|541403155|FG001|Overall Study|Protocol Violation|0|||
150071640|NCT00586625|541403154|FG000|Overall Study|Withdrawal by Subject|32|||
150071641|NCT00586625|541403155|FG001|Overall Study|Withdrawal by Subject|10|||
150071642|NCT00586625|541403154|FG000|Overall Study|Subject non-compliance|0|||
150071643|NCT00586625|541403155|FG001|Overall Study|Subject non-compliance|1|||
150071644|NCT00586625|541403154|FG000|Overall Study|Subject unable to return for visit|2|||
150071645|NCT00586625|541403155|FG001|Overall Study|Subject unable to return for visit|0|||
150071646|NCT04032652|541403157|FG000|Overall Study|The study was terminated and the PI has|1|||
150071647|NCT04032652|541403158|FG001|Overall Study|The study was terminated and the PI has|1|||
150071648|NCT02423772|541403159|FG000|Overall Study|Lost to Follow-up|3|||
150071649|NCT02423772|541403160|FG001|Overall Study|Lost to Follow-up|3|||
150071650|NCT02423772|541403159|FG000|Overall Study|Did not begin intervention|2|||
150071651|NCT02423772|541403160|FG001|Overall Study|Did not begin intervention|5|||
150071652|NCT03672643|541403161|FG000|Overall Study|Adverse Event|3|||
150071653|NCT03672643|541403161|FG000|Overall Study|Death|2|||
150071654|NCT03672643|541403161|FG000|Overall Study|Withdrawal by Subject|1|||
150071655|NCT03672643|541403161|FG000|Overall Study|Progressive disease|11|||
150071656|NCT03672643|541403161|FG000|Overall Study|Global deterioration of health status|1|||
150071657|NCT03672643|541403161|FG000|Overall Study|Refused further treatment|7|||
150071658|NCT03672643|541403161|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
150071659|NCT01066000|541403164|FG000|Overall Study|Protocol Violation|4|||
150071660|NCT01066000|541403164|FG000|Overall Study|Death|3|||
150071661|NCT01066000|541403164|FG000|Overall Study|Withdrawal by Subject|1|||
150071662|NCT01066000|541403164|FG000|Overall Study|Adverse Event|1|||
150071663|NCT03001882|541403165|FG000|Overall Study|Death|1|||
150071664|NCT03001882|541403166|FG001|Overall Study|Death|0|||
150071665|NCT03001882|541403167|FG002|Overall Study|Death|0|||
150071666|NCT03001882|541403168|FG003|Overall Study|Death|3|||
150071667|NCT03001882|541403165|FG000|Overall Study|Participant withdrew consent|0|||
150071668|NCT03001882|541403166|FG001|Overall Study|Participant withdrew consent|1|||
150071669|NCT03001882|541403167|FG002|Overall Study|Participant withdrew consent|0|||
150071670|NCT03001882|541403168|FG003|Overall Study|Participant withdrew consent|5|||
150071671|NCT03001882|541403165|FG000|Overall Study|Other reasons|1|||
150071672|NCT03001882|541403166|FG001|Overall Study|Other reasons|2|||
150071673|NCT03001882|541403167|FG002|Overall Study|Other reasons|0|||
150071674|NCT03001882|541403168|FG003|Overall Study|Other reasons|5|||
150071675|NCT03001882|541403165|FG000|Overall Study|Administrative reason by sponsor|0|||
150071676|NCT03001882|541403166|FG001|Overall Study|Administrative reason by sponsor|0|||
150071677|NCT03001882|541403167|FG002|Overall Study|Administrative reason by sponsor|0|||
150071678|NCT03001882|541403168|FG003|Overall Study|Administrative reason by sponsor|1|||
150071679|NCT03001882|541403165|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
150071680|NCT03001882|541403166|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
150071681|NCT03001882|541403167|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
150071682|NCT03001882|541403168|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
150071683|NCT03001882|541403165|FG000|Overall Study|Not reported|0|||
150071684|NCT03001882|541403166|FG001|Overall Study|Not reported|0|||
150071685|NCT03001882|541403167|FG002|Overall Study|Not reported|0|||
150071686|NCT03001882|541403168|FG003|Overall Study|Not reported|6|||
150071687|NCT03001882|541403165|FG000|Overall Study|Maximum clinical benefit|2|||
150071688|NCT03001882|541403166|FG001|Overall Study|Maximum clinical benefit|3|||
150071689|NCT03001882|541403167|FG002|Overall Study|Maximum clinical benefit|0|||
150071690|NCT03001882|541403168|FG003|Overall Study|Maximum clinical benefit|10|||
150071691|NCT03001882|541403165|FG000|Overall Study|AE unrelated to study drug|3|||
150071692|NCT03001882|541403166|FG001|Overall Study|AE unrelated to study drug|3|||
150071693|NCT03001882|541403167|FG002|Overall Study|AE unrelated to study drug|0|||
150071694|NCT03001882|541403168|FG003|Overall Study|AE unrelated to study drug|11|||
150071695|NCT03001882|541403165|FG000|Overall Study|Study Drug Toxicity|8|||
150071696|NCT03001882|541403166|FG001|Overall Study|Study Drug Toxicity|5|||
150182244|NCT01649271|541804631|FG001|Overall Study|Other than stated above|0|||
150182245|NCT05644002|541804632|FG000|Overall Study|Lost to Follow-up|1|||
150182246|NCT05644002|541804633|FG001|Overall Study|Lost to Follow-up|2|||
150182247|NCT05644002|541804632|FG000|Overall Study|Withdrawal by Subject|0|||
150182248|NCT05644002|541804633|FG001|Overall Study|Withdrawal by Subject|1|||
150182249|NCT05756075|541804634|FG000|Overall Study|Withdrawal by Subject|16|||
150071697|NCT03001882|541403167|FG002|Overall Study|Study Drug Toxicity|0|||
150071698|NCT03001882|541403168|FG003|Overall Study|Study Drug Toxicity|37|||
150071699|NCT03001882|541403165|FG000|Overall Study|Disease progression|16|||
150071700|NCT03001882|541403166|FG001|Overall Study|Disease progression|14|||
150071701|NCT03001882|541403167|FG002|Overall Study|Disease progression|1|||
150071702|NCT03001882|541403168|FG003|Overall Study|Disease progression|90|||
150071703|NCT01386008|541403169|FG000|Overall Study|exited w/o incident /study discontinued|17|||
150071704|NCT01386008|541403169|FG000|Overall Study|Adverse Event|3|||
150071705|NCT00566111|541403170|FG000|Overall Study|Adverse Event|0|||
150071706|NCT00566111|541403171|FG001|Overall Study|Adverse Event|2|||
150071707|NCT04449861|541403172|FG000|Overall Study|Withdrawal by Subject|4|||
150071708|NCT04449861|541403172|FG000|Overall Study|Lost to Follow-up|5|||
150071709|NCT04449861|541403172|FG000|Overall Study|Death|112|||
150071710|NCT05268055|541403173|FG000|Overall Study|Lost to Follow-up|68|||
150071711|NCT05268055|541403174|FG001|Overall Study|Lost to Follow-up|68|||
150182250|NCT05756075|541804635|FG001|Overall Study|Withdrawal by Subject|9|||
150182251|NCT04065048|541804639|FG000|Overall Study|Withdrawal by Subject|1|||
150071712|NCT05268055|541403173|FG000|Overall Study|Withdrawal by Subject|12|||
150071713|NCT05268055|541403174|FG001|Overall Study|Withdrawal by Subject|8|||
150071714|NCT02468232|541404728|FG000|Core Part of Study|Adverse Event|0|||
150071715|NCT02468232|541404729|FG001|Core Part of Study|Adverse Event|1|||
150071716|NCT02468232|541404730|FG002|Core Part of Study|Adverse Event|0|||
150071717|NCT02468232|541404731|FG003|Core Part of Study|Adverse Event|0|||
150071718|NCT02468232|541404728|FG000|Core Part of Study|Death|20|||
150071719|NCT02468232|541404729|FG001|Core Part of Study|Death|17|||
150071720|NCT02468232|541404730|FG002|Core Part of Study|Death|0|||
150071721|NCT02468232|541404731|FG003|Core Part of Study|Death|0|||
150071722|NCT02468232|541404728|FG000|Core Part of Study|Technical Problems|1|||
150071723|NCT02468232|541404729|FG001|Core Part of Study|Technical Problems|1|||
150071724|NCT02468232|541404730|FG002|Core Part of Study|Technical Problems|0|||
150071725|NCT02468232|541404731|FG003|Core Part of Study|Technical Problems|0|||
150071726|NCT02468232|541404728|FG000|OLE Part of Study|Adverse Event|0|||
150071727|NCT02468232|541404729|FG001|OLE Part of Study|Adverse Event|0|||
150071728|NCT02468232|541404730|FG002|OLE Part of Study|Adverse Event|4|||
150071729|NCT02468232|541404731|FG003|OLE Part of Study|Adverse Event|5|||
150071730|NCT02468232|541404728|FG000|OLE Part of Study|Death|0|||
150071731|NCT02468232|541404729|FG001|OLE Part of Study|Death|0|||
150071732|NCT02468232|541404730|FG002|OLE Part of Study|Death|4|||
150071733|NCT02468232|541404731|FG003|OLE Part of Study|Death|2|||
150071734|NCT02468232|541404728|FG000|OLE Part of Study|Physician Decision|0|||
150071735|NCT02468232|541404729|FG001|OLE Part of Study|Physician Decision|0|||
150071736|NCT02468232|541404730|FG002|OLE Part of Study|Physician Decision|4|||
150071737|NCT02468232|541404731|FG003|OLE Part of Study|Physician Decision|0|||
150071738|NCT02468232|541404728|FG000|OLE Part of Study|Subject/Guardian decision|0|||
150071739|NCT02468232|541404729|FG001|OLE Part of Study|Subject/Guardian decision|0|||
150071740|NCT02468232|541404730|FG002|OLE Part of Study|Subject/Guardian decision|2|||
150071741|NCT02468232|541404731|FG003|OLE Part of Study|Subject/Guardian decision|5|||
150071742|NCT01826604|541404732|FG000|Overall Study|Lost to Follow-up|8|||
150071743|NCT01826604|541404733|FG001|Overall Study|Lost to Follow-up|9|||
150071744|NCT00615108|541404734|FG000|Overall Study|Adverse Event|122|||
150071745|NCT00615108|541404734|FG000|Overall Study|Other|370|||
150071746|NCT00615108|541404734|FG000|Overall Study|Lost to Follow-up|15|||
150071747|NCT01914757|541404735|FG000|Overall Study|Severe non-compliance to protocol|3|||
150071748|NCT01914757|541404736|FG001|Overall Study|Severe non-compliance to protocol|1|||
150071749|NCT01914757|541404737|FG002|Overall Study|Severe non-compliance to protocol|2|||
150071750|NCT01914757|541404735|FG000|Overall Study|Lost to Follow-up|5|||
150071751|NCT01914757|541404736|FG001|Overall Study|Lost to Follow-up|8|||
150071752|NCT01914757|541404737|FG002|Overall Study|Lost to Follow-up|6|||
150071753|NCT01914757|541404735|FG000|Overall Study|Withdrawal by Subject|15|||
150071754|NCT01914757|541404736|FG001|Overall Study|Withdrawal by Subject|27|||
150071755|NCT01914757|541404737|FG002|Overall Study|Withdrawal by Subject|19|||
150071756|NCT01914757|541404735|FG000|Overall Study|Death|2|||
150071757|NCT01914757|541404736|FG001|Overall Study|Death|2|||
150182252|NCT04065048|541804640|FG001|Overall Study|Withdrawal by Subject|2|||
150071758|NCT01914757|541404737|FG002|Overall Study|Death|1|||
150071759|NCT01914757|541404735|FG000|Overall Study|Adverse Event|4|||
150071760|NCT01914757|541404736|FG001|Overall Study|Adverse Event|3|||
150071761|NCT01914757|541404737|FG002|Overall Study|Adverse Event|4|||
150025769|NCT00430716|541230408|FG000|Open Label Phase|Other|3|||
150025770|NCT00430716|541230409|FG001|Open Label Phase|Other|1|||
150025771|NCT00430716|541230410|FG002|Open Label Phase|Other|1|||
150025772|NCT00430716|541230408|FG000|Open Label Phase|Protocol Violation|1|||
150025773|NCT00430716|541230409|FG001|Open Label Phase|Protocol Violation|0|||
150025774|NCT00430716|541230410|FG002|Open Label Phase|Protocol Violation|0|||
150025775|NCT00430716|541230408|FG000|Open Label Phase|Study terminated by sponsor|4|||
150025776|NCT00430716|541230409|FG001|Open Label Phase|Study terminated by sponsor|5|||
150025777|NCT00430716|541230410|FG002|Open Label Phase|Study terminated by sponsor|4|||
150025778|NCT01329978|541230415|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
150025779|NCT01329978|541230416|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
150025780|NCT01329978|541230417|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
150025781|NCT01329978|541230418|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
150025782|NCT01329978|541230419|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
150025783|NCT01329978|541230415|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
150025784|NCT01329978|541230416|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
150025785|NCT01329978|541230417|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
150025786|NCT01329978|541230418|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
150025787|NCT01329978|541230419|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
150025788|NCT01329978|541230415|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
150025789|NCT01329978|541230416|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
150025790|NCT01329978|541230417|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
150025791|NCT01329978|541230418|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
150025792|NCT01329978|541230419|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
150025793|NCT01329978|541230415|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
150025794|NCT01329978|541230416|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
150025795|NCT01329978|541230417|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
150025796|NCT01329978|541230418|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
150025797|NCT01329978|541230419|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
150025798|NCT01329978|541230415|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
150025799|NCT01329978|541230416|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
150025800|NCT01329978|541230417|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
150025801|NCT01329978|541230418|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
150025802|NCT01329978|541230419|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
150025803|NCT01329978|541230415|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
150071762|NCT01914757|541404735|FG000|Overall Study|Study specific withdrawal criteria|0|||
150071763|NCT01914757|541404736|FG001|Overall Study|Study specific withdrawal criteria|1|||
150071764|NCT01914757|541404737|FG002|Overall Study|Study specific withdrawal criteria|0|||
150071765|NCT01914757|541404735|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
150071766|NCT01914757|541404736|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150071767|NCT01914757|541404737|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
150071768|NCT01914757|541404735|FG000|Overall Study|Other reasons|5|||
150071769|NCT01914757|541404736|FG001|Overall Study|Other reasons|9|||
150071770|NCT01914757|541404737|FG002|Overall Study|Other reasons|4|||
150071771|NCT02024529|541404740|FG000|Overall Study|Withdrawal by Subject|11|||
150071772|NCT02024529|541404741|FG001|Overall Study|Withdrawal by Subject|21|||
150071773|NCT02024529|541404740|FG000|Overall Study|Lost to Follow-up|2|||
150071774|NCT02024529|541404741|FG001|Overall Study|Lost to Follow-up|4|||
150071775|NCT00354614|541404742|FG000|Overall Study|Lack of Efficacy|28|||
150071776|NCT02476201|541404743|FG000|Overall Study|Unable to program MPP|9|||
150071777|NCT02476201|541404743|FG000|Overall Study|Study echo not performed|5|||
150071778|NCT02476201|541404743|FG000|Overall Study|Adverse Event|4|||
150071779|NCT02476201|541404743|FG000|Overall Study|Death|2|||
150071780|NCT02476201|541404743|FG000|Overall Study|Lost to Follow-up|2|||
150071781|NCT02476201|541404743|FG000|Overall Study|MPP programmed to OFF|2|||
150071782|NCT02476201|541404743|FG000|Overall Study|Withdrawal by Subject|1|||
150071783|NCT02476201|541404743|FG000|Overall Study|Unsuccessful implant|1|||
150071784|NCT03650556|541404744|FG000|Overall Study|Death|2|||
150071785|NCT03650556|541404744|FG000|Overall Study|Withdrawal by Subject|20|||
150071786|NCT03650556|541404744|FG000|Overall Study|Physician Decision|2|||
150071787|NCT03650556|541404744|FG000|Overall Study|Lost to Follow-up|8|||
150071788|NCT03650556|541404744|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
150071789|NCT03650556|541404744|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
150071790|NCT01856907|541404747|FG000|Overall Study|Pregnancy|0|||
150071791|NCT01856907|541404748|FG001|Overall Study|Pregnancy|1|||
150071792|NCT01856907|541404749|FG002|Overall Study|Pregnancy|0|||
150071793|NCT01856907|541404747|FG000|Overall Study|Pregnancy|0|||
150071794|NCT01856907|541404748|FG001|Overall Study|Pregnancy|1|||
150071795|NCT01856907|541404749|FG002|Overall Study|Pregnancy|0|||
150071796|NCT01856907|541404747|FG000|Overall Study|Withdrawal by Subject|0|||
150071797|NCT01856907|541404748|FG001|Overall Study|Withdrawal by Subject|1|||
150071798|NCT01856907|541404749|FG002|Overall Study|Withdrawal by Subject|0|||
150071799|NCT02191137|541404752|FG000|Treatment|Death|4|||
150071800|NCT02191137|541404752|FG000|Treatment|Withdrawal by Subject|3|||
150071801|NCT02191137|541404752|FG000|Treatment|Adverse Event|2|||
150071802|NCT02191137|541404752|FG000|Treatment|Other|1|||
150071803|NCT02191137|541404752|FG000|Follow-up|Lost to Follow-up|2|||
150071804|NCT02191137|541404752|FG000|Follow-up|Ongoing/unknown|2|||
150071805|NCT02191137|541404752|FG000|Follow-up|Adverse Event|1|||
150071806|NCT00694707|541404753|FG000|Overall Study|Did Not Receive Treatment|0|||
150071807|NCT00694707|541404754|FG001|Overall Study|Did Not Receive Treatment|0|||
150071808|NCT00694707|541404755|FG002|Overall Study|Did Not Receive Treatment|1|||
150071809|NCT00694707|541404756|FG003|Overall Study|Did Not Receive Treatment|1|||
150071810|NCT00694707|541404757|FG004|Overall Study|Did Not Receive Treatment|1|||
150071811|NCT00694707|541404753|FG000|Overall Study|Adverse Event|22|||
150071812|NCT00694707|541404754|FG001|Overall Study|Adverse Event|14|||
150071813|NCT00694707|541404755|FG002|Overall Study|Adverse Event|8|||
150071814|NCT00694707|541404756|FG003|Overall Study|Adverse Event|12|||
150071815|NCT00694707|541404757|FG004|Overall Study|Adverse Event|13|||
150071816|NCT00694707|541404753|FG000|Overall Study|Insufficient Therapeutic Response|33|||
150071817|NCT00694707|541404754|FG001|Overall Study|Insufficient Therapeutic Response|18|||
150071818|NCT00694707|541404755|FG002|Overall Study|Insufficient Therapeutic Response|17|||
150071819|NCT00694707|541404756|FG003|Overall Study|Insufficient Therapeutic Response|15|||
150071820|NCT00694707|541404757|FG004|Overall Study|Insufficient Therapeutic Response|10|||
150071821|NCT00694707|541404753|FG000|Overall Study|Protocol Violation|1|||
150071822|NCT00694707|541404754|FG001|Overall Study|Protocol Violation|2|||
150071823|NCT00694707|541404755|FG002|Overall Study|Protocol Violation|1|||
150071824|NCT00694707|541404756|FG003|Overall Study|Protocol Violation|3|||
150071825|NCT00694707|541404757|FG004|Overall Study|Protocol Violation|1|||
150071826|NCT00694707|541404753|FG000|Overall Study|Withdrawal of Consent|14|||
150071827|NCT00694707|541404754|FG001|Overall Study|Withdrawal of Consent|18|||
150071828|NCT00694707|541404755|FG002|Overall Study|Withdrawal of Consent|22|||
150071829|NCT00694707|541404756|FG003|Overall Study|Withdrawal of Consent|16|||
150071830|NCT00694707|541404757|FG004|Overall Study|Withdrawal of Consent|15|||
150071831|NCT00694707|541404753|FG000|Overall Study|Lost to Follow-up|0|||
150071832|NCT00694707|541404754|FG001|Overall Study|Lost to Follow-up|1|||
150071833|NCT00694707|541404755|FG002|Overall Study|Lost to Follow-up|2|||
150071834|NCT00694707|541404756|FG003|Overall Study|Lost to Follow-up|0|||
150071835|NCT00694707|541404757|FG004|Overall Study|Lost to Follow-up|0|||
150071836|NCT00694707|541404753|FG000|Overall Study|Jeopardizing Parole Status|1|||
150071837|NCT00694707|541404754|FG001|Overall Study|Jeopardizing Parole Status|0|||
150071838|NCT00694707|541404755|FG002|Overall Study|Jeopardizing Parole Status|0|||
150071839|NCT00694707|541404756|FG003|Overall Study|Jeopardizing Parole Status|0|||
150071840|NCT00694707|541404757|FG004|Overall Study|Jeopardizing Parole Status|0|||
150071841|NCT00694707|541404753|FG000|Overall Study|Death in the Family|1|||
150071842|NCT00694707|541404754|FG001|Overall Study|Death in the Family|0|||
150071843|NCT00694707|541404755|FG002|Overall Study|Death in the Family|0|||
150071844|NCT00694707|541404756|FG003|Overall Study|Death in the Family|0|||
150071845|NCT00694707|541404757|FG004|Overall Study|Death in the Family|0|||
150071846|NCT00694707|541404753|FG000|Overall Study|Arrest by Police|0|||
150071847|NCT00694707|541404754|FG001|Overall Study|Arrest by Police|1|||
150071848|NCT00694707|541404755|FG002|Overall Study|Arrest by Police|0|||
150071849|NCT00694707|541404756|FG003|Overall Study|Arrest by Police|0|||
150071850|NCT00694707|541404757|FG004|Overall Study|Arrest by Police|0|||
150071851|NCT00694707|541404753|FG000|Overall Study|Administrative Reasons|0|||
150071852|NCT00694707|541404754|FG001|Overall Study|Administrative Reasons|1|||
150071853|NCT00694707|541404755|FG002|Overall Study|Administrative Reasons|0|||
150071854|NCT00694707|541404756|FG003|Overall Study|Administrative Reasons|2|||
150071855|NCT00694707|541404757|FG004|Overall Study|Administrative Reasons|0|||
150071856|NCT00694707|541404753|FG000|Overall Study|Notification of Past Head Injury|0|||
150071857|NCT00694707|541404754|FG001|Overall Study|Notification of Past Head Injury|0|||
150071858|NCT00694707|541404755|FG002|Overall Study|Notification of Past Head Injury|0|||
150071859|NCT00694707|541404756|FG003|Overall Study|Notification of Past Head Injury|1|||
150071860|NCT00694707|541404757|FG004|Overall Study|Notification of Past Head Injury|0|||
150071861|NCT02046733|541404759|FG000|Overall Study|never initiated 'treatment visits'|6|||
150071862|NCT02046733|541404760|FG001|Overall Study|never initiated 'treatment visits'|0|||
150071863|NCT04041375|541404764|FG000|Intervention Phase|Withdrawal by Subject|2|||
150071864|NCT04041375|541404765|FG001|Intervention Phase|Withdrawal by Subject|2|||
150071865|NCT04041375|541404764|FG000|Follow-up Phase|Death|2|||
150071866|NCT04041375|541404765|FG001|Follow-up Phase|Death|0|||
150071867|NCT04041375|541404764|FG000|Follow-up Phase|Lost to Follow-up|2|||
150071868|NCT04041375|541404765|FG001|Follow-up Phase|Lost to Follow-up|1|||
150071869|NCT04041375|541404764|FG000|Follow-up Phase|Too ill|3|||
150071870|NCT04041375|541404765|FG001|Follow-up Phase|Too ill|0|||
150071871|NCT04674644|541404771|FG000|Overall Study|with missing data|37|||
150071872|NCT01268150|541404772|FG000|Treatment Phase|Progression of disease|18|||
150071873|NCT01268150|541404772|FG000|Treatment Phase|Adverse Event|3|||
150071874|NCT01268150|541404772|FG000|Treatment Phase|Withdrawal by Subject|3|||
150071875|NCT01268150|541404772|FG000|Treatment Phase|Other|4|||
150071876|NCT01268150|541404772|FG000|Extension Phase|Adverse Event|3|||
150071877|NCT01268150|541404772|FG000|Extension Phase|Disease progression|18|||
150071878|NCT01268150|541404772|FG000|Extension Phase|Other|6|||
150071879|NCT00395733|541404773|FG000|Period 2|Withdrawal by Subject|1|||
150071880|NCT00395733|541404774|FG001|Period 2|Withdrawal by Subject|2|||
150071881|NCT00395733|541404773|FG000|Period 2|Protocol Violation|0|||
150071882|NCT00395733|541404774|FG001|Period 2|Protocol Violation|1|||
150071883|NCT00395733|541404773|FG000|Period 2|Adverse Event|0|||
150071884|NCT00395733|541404774|FG001|Period 2|Adverse Event|2|||
150071885|NCT00395733|541404773|FG000|Period 2|Technical problems|1|||
150071886|NCT00395733|541404774|FG001|Period 2|Technical problems|0|||
150071887|NCT03725852|541404775|FG000|Overall Study|Death|1|||
150071888|NCT03725852|541404776|FG001|Overall Study|Death|0|||
150071889|NCT03725852|541404775|FG000|Overall Study|Withdrawal by Subject|1|||
150071890|NCT03725852|541404776|FG001|Overall Study|Withdrawal by Subject|0|||
150071891|NCT03725852|541404775|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
150071892|NCT03725852|541404776|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
150071893|NCT01672736|541404782|FG000|Overall Study|Available drug expired on 31 May 16|3|||
150071894|NCT01697358|541404783|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
150071895|NCT01697358|541404784|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
150182253|NCT04065048|541804641|FG002|Overall Study|Withdrawal by Subject|1|||
150071896|NCT01697358|541404783|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
150071897|NCT01697358|541404784|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
150182254|NCT04065048|541804642|FG003|Overall Study|Withdrawal by Subject|1|||
150071898|NCT01697358|541404783|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
150071899|NCT01697358|541404784|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
150071900|NCT01697358|541404783|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
150071901|NCT01697358|541404784|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
150071902|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
150071903|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
150071904|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
150071905|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
150071906|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
150071907|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
150071908|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
150071909|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
150071910|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
150071911|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
150071912|NCT01697358|541404783|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
150071913|NCT01697358|541404784|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
150071914|NCT02853344|541404787|FG000|Overall Study|Lost to Follow-up|1|||
150071915|NCT02853344|541404788|FG001|Overall Study|Lost to Follow-up|1|||
150071916|NCT02853344|541404787|FG000|Overall Study|Withdrawal by Subject|2|||
150071917|NCT02853344|541404788|FG001|Overall Study|Withdrawal by Subject|4|||
150071918|NCT02853344|541404787|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
150071919|NCT02853344|541404788|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
150071920|NCT02853344|541404787|FG000|Overall Study|Death|70|||
150071921|NCT02853344|541404788|FG001|Overall Study|Death|112|||
150071922|NCT02913612|541404789|FG000|Overall Study|Lost to Follow-up|6|||
150071923|NCT02913612|541404790|FG001|Overall Study|Lost to Follow-up|5|||
150071924|NCT02913612|541404791|FG002|Overall Study|Lost to Follow-up|2|||
150071925|NCT02913612|541404792|FG003|Overall Study|Lost to Follow-up|0|||
150071926|NCT02913612|541404789|FG000|Overall Study|Physician Decision|1|||
150071927|NCT02913612|541404790|FG001|Overall Study|Physician Decision|4|||
150071928|NCT02913612|541404791|FG002|Overall Study|Physician Decision|1|||
150071929|NCT02913612|541404792|FG003|Overall Study|Physician Decision|0|||
150071930|NCT02913612|541404789|FG000|Overall Study|Withdrawal by Subject|2|||
150071931|NCT02913612|541404790|FG001|Overall Study|Withdrawal by Subject|4|||
150071932|NCT02913612|541404791|FG002|Overall Study|Withdrawal by Subject|0|||
150071933|NCT02913612|541404792|FG003|Overall Study|Withdrawal by Subject|0|||
150071934|NCT02913612|541404789|FG000|Overall Study|Hemangioma resolved|1|||
150071935|NCT02913612|541404790|FG001|Overall Study|Hemangioma resolved|0|||
150071936|NCT02913612|541404791|FG002|Overall Study|Hemangioma resolved|0|||
150071937|NCT02913612|541404792|FG003|Overall Study|Hemangioma resolved|0|||
150071938|NCT02913612|541404789|FG000|Overall Study|Local IRB decision|1|||
150071939|NCT02913612|541404790|FG001|Overall Study|Local IRB decision|0|||
150071940|NCT02913612|541404791|FG002|Overall Study|Local IRB decision|0|||
150071941|NCT02913612|541404792|FG003|Overall Study|Local IRB decision|0|||
150071942|NCT02913612|541404789|FG000|Overall Study|Study drug non-compliance|1|||
150071943|NCT02913612|541404790|FG001|Overall Study|Study drug non-compliance|1|||
150071944|NCT02913612|541404791|FG002|Overall Study|Study drug non-compliance|0|||
150071945|NCT02913612|541404792|FG003|Overall Study|Study drug non-compliance|0|||
150071946|NCT02913612|541404789|FG000|Overall Study|Insurance issues|0|||
150071947|NCT02913612|541404790|FG001|Overall Study|Insurance issues|1|||
150071948|NCT02913612|541404791|FG002|Overall Study|Insurance issues|0|||
150071949|NCT02913612|541404792|FG003|Overall Study|Insurance issues|0|||
150071950|NCT02913612|541404789|FG000|Overall Study|Needed to treat second hemangioma|0|||
150071951|NCT02913612|541404790|FG001|Overall Study|Needed to treat second hemangioma|1|||
150071952|NCT02913612|541404791|FG002|Overall Study|Needed to treat second hemangioma|0|||
150071953|NCT02913612|541404792|FG003|Overall Study|Needed to treat second hemangioma|0|||
150071954|NCT02913612|541404789|FG000|Overall Study|Study completion criteria not met|0|||
150071955|NCT02913612|541404790|FG001|Overall Study|Study completion criteria not met|1|||
150071956|NCT02913612|541404791|FG002|Overall Study|Study completion criteria not met|0|||
150071957|NCT02913612|541404792|FG003|Overall Study|Study completion criteria not met|0|||
150071958|NCT02913612|541404789|FG000|Overall Study|Ineligible|0|||
150071959|NCT02913612|541404790|FG001|Overall Study|Ineligible|1|||
150071960|NCT02913612|541404791|FG002|Overall Study|Ineligible|0|||
150071961|NCT02913612|541404792|FG003|Overall Study|Ineligible|0|||
150071962|NCT00669396|541404793|FG000|Overall Study|Lost to Follow-up|10|||
150071963|NCT00669396|541404794|FG001|Overall Study|Lost to Follow-up|12|||
150071964|NCT01262573|541404795|FG000|Overall Study|Withdrawal by Subject|0|||
150071965|NCT01262573|541404796|FG001|Overall Study|Withdrawal by Subject|1|||
150071966|NCT04251273|541404797|FG000|Overall Study|Lost to Follow-up|331|||
150071967|NCT04251273|541404798|FG001|Overall Study|Lost to Follow-up|290|||
150071968|NCT04402060|541404799|FG000|Overall Study|Death|1|||
150071969|NCT04402060|541404800|FG001|Overall Study|Death|12|||
150071970|NCT04402060|541404801|FG002|Overall Study|Death|7|||
150071971|NCT04402060|541404799|FG000|Overall Study|Adverse Event|0|||
150071972|NCT04402060|541404800|FG001|Overall Study|Adverse Event|0|||
150071973|NCT04402060|541404801|FG002|Overall Study|Adverse Event|1|||
150071974|NCT04402060|541404799|FG000|Overall Study|Withdrawal by Subject|0|||
150071975|NCT04402060|541404800|FG001|Overall Study|Withdrawal by Subject|1|||
150071976|NCT04402060|541404801|FG002|Overall Study|Withdrawal by Subject|2|||
150071977|NCT04402060|541404799|FG000|Overall Study|Sponsor Request|0|||
150071978|NCT04402060|541404800|FG001|Overall Study|Sponsor Request|2|||
150071979|NCT04402060|541404801|FG002|Overall Study|Sponsor Request|0|||
150071980|NCT04402060|541404799|FG000|Overall Study|Physician Decision|0|||
150071981|NCT04402060|541404800|FG001|Overall Study|Physician Decision|0|||
150071982|NCT04402060|541404801|FG002|Overall Study|Physician Decision|1|||
150071983|NCT04402060|541404799|FG000|Overall Study|Other|0|||
150071984|NCT04402060|541404800|FG001|Overall Study|Other|1|||
150071985|NCT04402060|541404801|FG002|Overall Study|Other|0|||
150071986|NCT00810693|541404802|FG000|Treatment Period|Adverse Event|8|||
150071987|NCT00810693|541404803|FG001|Treatment Period|Adverse Event|1|||
150071988|NCT00810693|541404804|FG002|Treatment Period|Adverse Event|7|||
150071989|NCT00810693|541404802|FG000|Treatment Period|Death|0|||
150071990|NCT00810693|541404803|FG001|Treatment Period|Death|1|||
150071991|NCT00810693|541404804|FG002|Treatment Period|Death|2|||
150071992|NCT00810693|541404802|FG000|Treatment Period|Lack of Efficacy|0|||
150071993|NCT00810693|541404803|FG001|Treatment Period|Lack of Efficacy|0|||
150071994|NCT00810693|541404804|FG002|Treatment Period|Lack of Efficacy|1|||
150071995|NCT00810693|541404802|FG000|Treatment Period|Lost to Follow-up|1|||
150071996|NCT00810693|541404803|FG001|Treatment Period|Lost to Follow-up|0|||
150071997|NCT00810693|541404804|FG002|Treatment Period|Lost to Follow-up|0|||
150071998|NCT00810693|541404802|FG000|Treatment Period|Non-compliance|1|||
150071999|NCT00810693|541404803|FG001|Treatment Period|Non-compliance|0|||
150072000|NCT00810693|541404804|FG002|Treatment Period|Non-compliance|0|||
150072001|NCT00810693|541404802|FG000|Treatment Period|Protocol Violation|1|||
150072002|NCT00810693|541404803|FG001|Treatment Period|Protocol Violation|2|||
150072003|NCT00810693|541404804|FG002|Treatment Period|Protocol Violation|2|||
150072004|NCT00810693|541404802|FG000|Treatment Period|Withdrawal by Subject|6|||
150072005|NCT00810693|541404803|FG001|Treatment Period|Withdrawal by Subject|2|||
150072006|NCT00810693|541404804|FG002|Treatment Period|Withdrawal by Subject|3|||
150072007|NCT00810693|541404802|FG000|Treatment Period|Not treated|0|||
150072008|NCT00810693|541404803|FG001|Treatment Period|Not treated|1|||
150072009|NCT00810693|541404804|FG002|Treatment Period|Not treated|1|||
150072010|NCT00810693|541404802|FG000|Follow-up Period (FUP)|Adverse Event|3|||
150072011|NCT00810693|541404803|FG001|Follow-up Period (FUP)|Adverse Event|1|||
150072012|NCT00810693|541404804|FG002|Follow-up Period (FUP)|Adverse Event|1|||
150072013|NCT00810693|541404802|FG000|Follow-up Period (FUP)|Death|2|||
150072014|NCT00810693|541404803|FG001|Follow-up Period (FUP)|Death|0|||
150072015|NCT00810693|541404804|FG002|Follow-up Period (FUP)|Death|1|||
150072016|NCT00810693|541404802|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
150072017|NCT00810693|541404803|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
150072018|NCT00810693|541404804|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
150072019|NCT00810693|541404802|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
150072020|NCT00810693|541404803|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
150072021|NCT00810693|541404804|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
150072022|NCT00810693|541404802|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
150072023|NCT00810693|541404803|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
150072024|NCT00810693|541404804|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
150072025|NCT02507973|541404811|FG000|Overall Study|Adverse Event|1|||
150072026|NCT00331422|541404812|FG000|Overall Study|Did not receive entire study regimen|5|||
150072027|NCT02345226|541404813|FG000|Double-Blind Phase|Adverse Event|5|||
150072028|NCT02345226|541404814|FG001|Double-Blind Phase|Adverse Event|6|||
150072029|NCT02345226|541404813|FG000|Double-Blind Phase|Death|3|||
150072030|NCT02345226|541404814|FG001|Double-Blind Phase|Death|0|||
150072031|NCT02345226|541404813|FG000|Double-Blind Phase|Pregnancy|0|||
150072032|NCT02345226|541404814|FG001|Double-Blind Phase|Pregnancy|1|||
150072033|NCT02345226|541404813|FG000|Double-Blind Phase|Lack of Efficacy|1|||
150072034|NCT02345226|541404814|FG001|Double-Blind Phase|Lack of Efficacy|0|||
150072035|NCT02345226|541404813|FG000|Double-Blind Phase|Investigator's Discretion|4|||
150072036|NCT02345226|541404814|FG001|Double-Blind Phase|Investigator's Discretion|3|||
150072037|NCT02345226|541404813|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
150072038|NCT02345226|541404814|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
150072039|NCT02345226|541404813|FG000|Double-Blind Phase|Withdrew Consent|41|||
150072040|NCT02345226|541404814|FG001|Double-Blind Phase|Withdrew Consent|39|||
150072041|NCT02345226|541404813|FG000|Double-Blind Phase|Lost to Follow-up|12|||
150072042|NCT02345226|541404814|FG001|Double-Blind Phase|Lost to Follow-up|16|||
150072043|NCT02345226|541404813|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
150072044|NCT02345226|541404814|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
150072045|NCT02345226|541404813|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
150072046|NCT02345226|541404814|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
150072047|NCT01710046|541404817|FG000|Overall Study|Lost to Follow-up|1|||
150072048|NCT01710046|541404818|FG001|Overall Study|Lost to Follow-up|0|||
150072049|NCT03386474|541404821|FG000|Overall Study|Death|1|||
150072050|NCT03386474|541404822|FG001|Overall Study|Death|0|||
150072051|NCT03386474|541404821|FG000|Overall Study|Adverse Event|0|||
150072052|NCT03386474|541404822|FG001|Overall Study|Adverse Event|1|||
150072053|NCT02282358|541404827|FG000|Overall Study|Nonevaluable|1|||
150072054|NCT01898208|541404828|FG000|Overall Study|Positive blood culture|17|||
150072055|NCT01898208|541404829|FG001|Overall Study|Positive blood culture|23|||
150072056|NCT01898208|541404830|FG002|Overall Study|Positive blood culture|15|||
150072057|NCT01898208|541404828|FG000|Overall Study|Death/comfort care within 24 hours|10|||
150072058|NCT01898208|541404829|FG001|Overall Study|Death/comfort care within 24 hours|9|||
150072059|NCT01898208|541404830|FG002|Overall Study|Death/comfort care within 24 hours|8|||
150072060|NCT01898208|541404828|FG000|Overall Study|Negative Gram Stain|6|||
150072061|NCT01898208|541404829|FG001|Overall Study|Negative Gram Stain|9|||
150072062|NCT01898208|541404830|FG002|Overall Study|Negative Gram Stain|6|||
150072063|NCT01898208|541404828|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
150072064|NCT01898208|541404829|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
150072065|NCT01898208|541404830|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
150072066|NCT01898208|541404828|FG000|Overall Study|System/Technical Error|1|||
150072067|NCT01898208|541404829|FG001|Overall Study|System/Technical Error|2|||
150072068|NCT01898208|541404830|FG002|Overall Study|System/Technical Error|3|||
150072069|NCT01898208|541404828|FG000|Overall Study|Lost to Follow-up|3|||
150072070|NCT01898208|541404829|FG001|Overall Study|Lost to Follow-up|1|||
150072071|NCT01898208|541404830|FG002|Overall Study|Lost to Follow-up|1|||
150072072|NCT00961649|541404832|FG000|Overall Study|Adverse Event|4|||
150072073|NCT00961649|541404833|FG001|Overall Study|Adverse Event|0|||
150072074|NCT00961649|541404834|FG002|Overall Study|Adverse Event|0|||
150072075|NCT00961649|541404835|FG003|Overall Study|Adverse Event|2|||
150072076|NCT00961649|541404832|FG000|Overall Study|Inadequate control of IOP|0|||
150072077|NCT00961649|541404833|FG001|Overall Study|Inadequate control of IOP|0|||
150072078|NCT00961649|541404834|FG002|Overall Study|Inadequate control of IOP|0|||
150072079|NCT00961649|541404835|FG003|Overall Study|Inadequate control of IOP|1|||
150072080|NCT00961649|541404832|FG000|Overall Study|Patient has travel plans during holidays|0|||
150072081|NCT00961649|541404833|FG001|Overall Study|Patient has travel plans during holidays|0|||
150072082|NCT00961649|541404834|FG002|Overall Study|Patient has travel plans during holidays|1|||
150072083|NCT00961649|541404835|FG003|Overall Study|Patient has travel plans during holidays|0|||
150072084|NCT00961649|541404832|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
150072085|NCT00961649|541404833|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
150072086|NCT00961649|541404834|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
150072087|NCT00961649|541404835|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
150072088|NCT00961649|541404832|FG000|Overall Study|Study terminated by sponsor|4|||
150072089|NCT00961649|541404833|FG001|Overall Study|Study terminated by sponsor|4|||
150072090|NCT00961649|541404834|FG002|Overall Study|Study terminated by sponsor|4|||
150072091|NCT00961649|541404835|FG003|Overall Study|Study terminated by sponsor|1|||
150072092|NCT02155881|541404836|FG000|Overall Study|Withdrawal by Subject|0|||
150072093|NCT02155881|541404837|FG001|Overall Study|Withdrawal by Subject|2|||
150072094|NCT02155881|541404836|FG000|Overall Study|Inappropriately randomized|2|||
150072095|NCT02155881|541404837|FG001|Overall Study|Inappropriately randomized|2|||
150072096|NCT02711345|541404838|FG000|Overall Study|Adverse Event|0|||
150072097|NCT02711345|541404839|FG001|Overall Study|Adverse Event|0|||
150072098|NCT02711345|541404840|FG002|Overall Study|Adverse Event|0|||
150072099|NCT02711345|541404841|FG003|Overall Study|Adverse Event|1|||
150072100|NCT02711345|541404842|FG004|Overall Study|Adverse Event|1|||
150072101|NCT02711345|541404843|FG005|Overall Study|Adverse Event|2|||
150182255|NCT04065048|541804639|FG000|Overall Study|Adverse Event|1|||
150182256|NCT04065048|541804640|FG001|Overall Study|Adverse Event|0|||
150182257|NCT04065048|541804641|FG002|Overall Study|Adverse Event|1|||
150182258|NCT04065048|541804642|FG003|Overall Study|Adverse Event|0|||
150182259|NCT02605837|541804643|FG000|Overall Study|Adverse Event|3|||
150182260|NCT02605837|541804644|FG001|Overall Study|Adverse Event|1|||
150182261|NCT02605837|541804643|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150182262|NCT02605837|541804644|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150182263|NCT02605837|541804643|FG000|Overall Study|Withdrawal by Subject|8|||
150182264|NCT02605837|541804644|FG001|Overall Study|Withdrawal by Subject|8|||
150182265|NCT02605837|541804643|FG000|Overall Study|Physician Decision|0|||
150182266|NCT02605837|541804644|FG001|Overall Study|Physician Decision|1|||
150182267|NCT05104697|541804645|FG000|Overall Study|Withdrawal by Subject|0|||
150182268|NCT05104697|541804646|FG001|Overall Study|Withdrawal by Subject|1|||
150182269|NCT04468776|541804649|FG000|Overall Study|Lost to Follow-up|4|||
150182270|NCT04468776|541804650|FG001|Overall Study|Lost to Follow-up|3|||
150182271|NCT04468776|541804651|FG002|Overall Study|Lost to Follow-up|4|||
150072102|NCT02711345|541404844|FG006|Overall Study|Adverse Event|1|||
150072103|NCT02711345|541404845|FG007|Overall Study|Adverse Event|0|||
150072104|NCT02711345|541404846|FG008|Overall Study|Adverse Event|0|||
150072105|NCT02711345|541404847|FG009|Overall Study|Adverse Event|2|||
150072106|NCT02711345|541404838|FG000|Overall Study|Physician Decision|0|||
150072107|NCT02711345|541404839|FG001|Overall Study|Physician Decision|0|||
150072108|NCT02711345|541404840|FG002|Overall Study|Physician Decision|1|||
150182272|NCT04468776|541804649|FG000|Overall Study|Withdrawal by Subject|1|||
150072109|NCT02711345|541404841|FG003|Overall Study|Physician Decision|0|||
150072110|NCT02711345|541404842|FG004|Overall Study|Physician Decision|0|||
150072111|NCT02711345|541404843|FG005|Overall Study|Physician Decision|0|||
150072112|NCT02711345|541404844|FG006|Overall Study|Physician Decision|0|||
150072113|NCT02711345|541404845|FG007|Overall Study|Physician Decision|0|||
150072114|NCT02711345|541404846|FG008|Overall Study|Physician Decision|1|||
150072115|NCT02711345|541404847|FG009|Overall Study|Physician Decision|0|||
150072116|NCT02711345|541404838|FG000|Overall Study|Progressive disease|1|||
150072117|NCT02711345|541404839|FG001|Overall Study|Progressive disease|3|||
150072118|NCT02711345|541404840|FG002|Overall Study|Progressive disease|5|||
150072119|NCT02711345|541404841|FG003|Overall Study|Progressive disease|3|||
150072120|NCT02711345|541404842|FG004|Overall Study|Progressive disease|7|||
150072121|NCT02711345|541404843|FG005|Overall Study|Progressive disease|2|||
150072122|NCT02711345|541404844|FG006|Overall Study|Progressive disease|8|||
150072123|NCT02711345|541404845|FG007|Overall Study|Progressive disease|4|||
150072124|NCT02711345|541404846|FG008|Overall Study|Progressive disease|5|||
150072125|NCT02711345|541404847|FG009|Overall Study|Progressive disease|6|||
150072126|NCT02711345|541404838|FG000|Overall Study|Subject/guardian decision|0|||
150072127|NCT02711345|541404839|FG001|Overall Study|Subject/guardian decision|0|||
150072128|NCT02711345|541404840|FG002|Overall Study|Subject/guardian decision|0|||
150072129|NCT02711345|541404841|FG003|Overall Study|Subject/guardian decision|0|||
150072130|NCT02711345|541404842|FG004|Overall Study|Subject/guardian decision|0|||
150072131|NCT02711345|541404843|FG005|Overall Study|Subject/guardian decision|2|||
150072132|NCT02711345|541404844|FG006|Overall Study|Subject/guardian decision|3|||
150072133|NCT02711345|541404845|FG007|Overall Study|Subject/guardian decision|1|||
150072134|NCT02711345|541404846|FG008|Overall Study|Subject/guardian decision|0|||
150072135|NCT02711345|541404847|FG009|Overall Study|Subject/guardian decision|4|||
150072136|NCT02711345|541404838|FG000|Overall Study|Death|1|||
150072137|NCT02711345|541404839|FG001|Overall Study|Death|0|||
150072138|NCT02711345|541404840|FG002|Overall Study|Death|0|||
150072139|NCT02711345|541404841|FG003|Overall Study|Death|0|||
150072140|NCT02711345|541404842|FG004|Overall Study|Death|0|||
150072141|NCT02711345|541404843|FG005|Overall Study|Death|0|||
150072142|NCT02711345|541404844|FG006|Overall Study|Death|0|||
150072143|NCT02711345|541404845|FG007|Overall Study|Death|1|||
150072144|NCT02711345|541404846|FG008|Overall Study|Death|0|||
150072145|NCT02711345|541404847|FG009|Overall Study|Death|0|||
150072146|NCT04357782|541404848|FG000|Overall Study|Discharged from hospital|1|||
150072147|NCT04357782|541404849|FG001|Overall Study|Discharged from hospital|0|||
150072148|NCT04357782|541404848|FG000|Overall Study|Death|0|||
150072149|NCT04357782|541404849|FG001|Overall Study|Death|2|||
150072150|NCT01786148|541404850|FG000|Overall Study|Lost to Follow-up|21|||
150072151|NCT01786148|541404851|FG001|Overall Study|Lost to Follow-up|13|||
150072152|NCT01786148|541404850|FG000|Overall Study|Death|0|||
150072153|NCT01786148|541404851|FG001|Overall Study|Death|1|||
150072154|NCT01786148|541404850|FG000|Overall Study|Withdrawal by Subject|0|||
150072155|NCT01786148|541404851|FG001|Overall Study|Withdrawal by Subject|7|||
150072156|NCT01786148|541404850|FG000|Overall Study|Incarceration|1|||
150072157|NCT01786148|541404851|FG001|Overall Study|Incarceration|1|||
150072158|NCT03780543|541404853|FG000|Overall Study|Adverse Event|1|||
150072159|NCT03780543|541404854|FG001|Overall Study|Adverse Event|0|||
150072160|NCT03780543|541404855|FG002|Overall Study|Adverse Event|2|||
150072161|NCT03780543|541404853|FG000|Overall Study|Lost to Follow-up|2|||
150072162|NCT03780543|541404854|FG001|Overall Study|Lost to Follow-up|0|||
150072163|NCT03780543|541404855|FG002|Overall Study|Lost to Follow-up|1|||
150182273|NCT04468776|541804650|FG001|Overall Study|Withdrawal by Subject|10|||
150182274|NCT04468776|541804651|FG002|Overall Study|Withdrawal by Subject|4|||
150072164|NCT03780543|541404853|FG000|Overall Study|Study terminated by Sponsor|8|||
150072165|NCT03780543|541404854|FG001|Overall Study|Study terminated by Sponsor|7|||
150072166|NCT03780543|541404855|FG002|Overall Study|Study terminated by Sponsor|13|||
150072167|NCT03780543|541404853|FG000|Overall Study|Withdrawal by Subject|1|||
150072168|NCT03780543|541404854|FG001|Overall Study|Withdrawal by Subject|8|||
150072169|NCT03780543|541404855|FG002|Overall Study|Withdrawal by Subject|1|||
150072170|NCT03780543|541404853|FG000|Overall Study|Noncompliance with study drug|1|||
150072171|NCT03780543|541404854|FG001|Overall Study|Noncompliance with study drug|0|||
150072172|NCT03780543|541404855|FG002|Overall Study|Noncompliance with study drug|0|||
150072173|NCT01033851|541404856|FG000|Overall Study|Withdrawal by Subject|3|||
150072174|NCT01033851|541404857|FG001|Overall Study|Withdrawal by Subject|7|||
150072175|NCT00066729|541404858|FG000|Overall Study|Lost to Follow-up|1|||
150072176|NCT00066729|541404858|FG000|Overall Study|Disease progression|1|||
150072177|NCT02349542|541404859|FG000|Overall Study|Withdrawal by Subject|5|||
150072178|NCT02215096|541404860|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
150072179|NCT02215096|541404861|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
150072180|NCT02215096|541404862|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
150072181|NCT02215096|541404863|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
150072182|NCT02215096|541404864|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
150072183|NCT02215096|541404860|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
150072184|NCT02215096|541404861|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
150072185|NCT02215096|541404862|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
150072186|NCT02215096|541404863|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
150072187|NCT02215096|541404864|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
150072188|NCT02215096|541404860|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
150072189|NCT02215096|541404861|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
150072190|NCT02215096|541404862|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
150072191|NCT02215096|541404863|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
150072192|NCT02215096|541404864|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
150072193|NCT02215096|541404860|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
150072194|NCT02215096|541404861|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
150072195|NCT02215096|541404862|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
150072196|NCT02215096|541404863|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
150072197|NCT02215096|541404864|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
150072198|NCT01011738|541404865|FG000|Overall Study|Death|12|||
150072199|NCT01011738|541404866|FG001|Overall Study|Death|3|||
150072200|NCT01011738|541404867|FG002|Overall Study|Death|0|||
150072201|NCT01011738|541404865|FG000|Overall Study|Unknown reasons|312|||
150072202|NCT01011738|541404866|FG001|Overall Study|Unknown reasons|291|||
150072203|NCT01011738|541404867|FG002|Overall Study|Unknown reasons|17|||
150072204|NCT03896165|541404870|FG000|Overall Study|Withdrawal by Subject|2|||
150072205|NCT00691301|541407018|FG000|Overall Study|Adverse Event|10|||
150072206|NCT00691301|541407018|FG000|Overall Study|Death|2|||
150072207|NCT00691301|541407018|FG000|Overall Study|Lack of Efficacy|32|||
150072208|NCT00691301|541407018|FG000|Overall Study|Withdrawal by Subject|4|||
150072209|NCT00691301|541407018|FG000|Overall Study|Concurrent illness|2|||
150072210|NCT00691301|541407018|FG000|Overall Study|other reason|3|||
150072211|NCT00691301|541407018|FG000|Overall Study|Did not initiate study treatment|1|||
150072212|NCT02642029|541407019|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
150072213|NCT02642029|541407020|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
150072214|NCT02642029|541407021|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
150072215|NCT02642029|541407022|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
150072216|NCT02642029|541407023|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
150072217|NCT02642029|541407024|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
150072218|NCT02642029|541407019|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
150072219|NCT02642029|541407020|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
150072220|NCT02642029|541407021|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
150072221|NCT02642029|541407022|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
150072222|NCT02642029|541407023|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
150072223|NCT02642029|541407024|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
150072224|NCT02642029|541407019|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
150072225|NCT02642029|541407020|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
150072226|NCT02642029|541407021|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
150072227|NCT02642029|541407022|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
150072228|NCT02642029|541407023|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
150072229|NCT02642029|541407024|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
150072230|NCT02642029|541407019|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
150072231|NCT02642029|541407020|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
150072232|NCT02642029|541407021|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
150072233|NCT02642029|541407022|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
150072234|NCT02642029|541407023|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
150072235|NCT02642029|541407024|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
150072236|NCT02642029|541407019|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
150072237|NCT02642029|541407020|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
150072238|NCT02642029|541407021|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
150072239|NCT02642029|541407022|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
150072240|NCT02642029|541407023|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
150072241|NCT02642029|541407024|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
150072242|NCT02642029|541407019|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
150072243|NCT02642029|541407020|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
150072244|NCT02642029|541407021|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
150072245|NCT02642029|541407022|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
150072246|NCT02642029|541407023|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
150072247|NCT02642029|541407024|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
150072248|NCT01823146|541407025|FG000|Overall Study|Withdrawal by Subject|0|||
150072249|NCT01823146|541407026|FG001|Overall Study|Withdrawal by Subject|1|||
150072250|NCT01823146|541407025|FG000|Overall Study|Lost to Follow-up|2|||
150072251|NCT01823146|541407026|FG001|Overall Study|Lost to Follow-up|1|||
150072252|NCT00463580|541407027|FG000|Overall Study|Lost to Follow-up|1|||
150072253|NCT00463580|541407028|FG001|Overall Study|Lost to Follow-up|0|||
150072254|NCT00463580|541407027|FG000|Overall Study|Schedule conflict|2|||
150072255|NCT00463580|541407028|FG001|Overall Study|Schedule conflict|0|||
150072256|NCT00463580|541407027|FG000|Overall Study|Medical/psychiatric complications|0|||
150072257|NCT00463580|541407028|FG001|Overall Study|Medical/psychiatric complications|2|||
150072258|NCT00676338|541407029|FG000|Overall Study|Adverse Event|6|||
150072259|NCT00676338|541407030|FG001|Overall Study|Adverse Event|6|||
150072260|NCT00676338|541407031|FG002|Overall Study|Adverse Event|5|||
150072261|NCT00676338|541407032|FG003|Overall Study|Adverse Event|1|||
150072262|NCT00676338|541407029|FG000|Overall Study|Lost to Follow-up|4|||
150072263|NCT00676338|541407030|FG001|Overall Study|Lost to Follow-up|1|||
150072264|NCT00676338|541407031|FG002|Overall Study|Lost to Follow-up|3|||
150072265|NCT00676338|541407032|FG003|Overall Study|Lost to Follow-up|4|||
150072266|NCT00676338|541407029|FG000|Overall Study|Physician Decision|3|||
150072267|NCT00676338|541407030|FG001|Overall Study|Physician Decision|3|||
150072268|NCT00676338|541407031|FG002|Overall Study|Physician Decision|2|||
150072269|NCT00676338|541407032|FG003|Overall Study|Physician Decision|3|||
150072270|NCT00676338|541407029|FG000|Overall Study|Protocol Violation|5|||
150072271|NCT00676338|541407030|FG001|Overall Study|Protocol Violation|9|||
150072272|NCT00676338|541407031|FG002|Overall Study|Protocol Violation|2|||
150072273|NCT00676338|541407032|FG003|Overall Study|Protocol Violation|5|||
150072274|NCT00676338|541407029|FG000|Overall Study|Withdrawal by Subject|17|||
150072275|NCT00676338|541407030|FG001|Overall Study|Withdrawal by Subject|9|||
150072276|NCT00676338|541407031|FG002|Overall Study|Withdrawal by Subject|12|||
150072277|NCT00676338|541407032|FG003|Overall Study|Withdrawal by Subject|6|||
150072278|NCT00676338|541407029|FG000|Overall Study|Entry Criteria Not Met|0|||
150072279|NCT00676338|541407030|FG001|Overall Study|Entry Criteria Not Met|2|||
150072280|NCT00676338|541407031|FG002|Overall Study|Entry Criteria Not Met|1|||
150072281|NCT00676338|541407032|FG003|Overall Study|Entry Criteria Not Met|1|||
150072282|NCT00676338|541407029|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
150072283|NCT00676338|541407030|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
150072284|NCT00676338|541407031|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
150072285|NCT00676338|541407032|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
150072286|NCT02122458|541407033|FG000|Overall Study|Withdrawal by Subject|0|||
150072287|NCT02122458|541407034|FG001|Overall Study|Withdrawal by Subject|0|||
150072288|NCT02122458|541407035|FG002|Overall Study|Withdrawal by Subject|0|||
150072289|NCT02122458|541407036|FG003|Overall Study|Withdrawal by Subject|4|||
150072290|NCT02122458|541407037|FG004|Overall Study|Withdrawal by Subject|4|||
150072291|NCT02122458|541407038|FG005|Overall Study|Withdrawal by Subject|4|||
150072292|NCT02122458|541407039|FG006|Overall Study|Withdrawal by Subject|0|||
150072293|NCT02122458|541407033|FG000|Overall Study|Lost to Follow-up|1|||
150072294|NCT02122458|541407034|FG001|Overall Study|Lost to Follow-up|3|||
150072295|NCT02122458|541407035|FG002|Overall Study|Lost to Follow-up|0|||
150072296|NCT02122458|541407036|FG003|Overall Study|Lost to Follow-up|7|||
150072297|NCT02122458|541407037|FG004|Overall Study|Lost to Follow-up|5|||
150072298|NCT02122458|541407038|FG005|Overall Study|Lost to Follow-up|15|||
150072299|NCT02122458|541407039|FG006|Overall Study|Lost to Follow-up|1|||
150072300|NCT02122458|541407033|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
150072301|NCT02122458|541407034|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072302|NCT02122458|541407035|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072303|NCT02122458|541407036|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072304|NCT02122458|541407037|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072305|NCT02122458|541407038|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072306|NCT02122458|541407039|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
150072307|NCT02122458|541407033|FG000|Overall Study|Adverse Event|1|||
150072308|NCT02122458|541407034|FG001|Overall Study|Adverse Event|0|||
150072309|NCT02122458|541407035|FG002|Overall Study|Adverse Event|0|||
150072310|NCT02122458|541407036|FG003|Overall Study|Adverse Event|0|||
150072311|NCT02122458|541407037|FG004|Overall Study|Adverse Event|0|||
150072312|NCT02122458|541407038|FG005|Overall Study|Adverse Event|0|||
150072313|NCT02122458|541407039|FG006|Overall Study|Adverse Event|0|||
150072314|NCT02122458|541407033|FG000|Overall Study|Experimental Error|0|||
150072315|NCT02122458|541407034|FG001|Overall Study|Experimental Error|0|||
150072316|NCT02122458|541407035|FG002|Overall Study|Experimental Error|0|||
150072317|NCT02122458|541407036|FG003|Overall Study|Experimental Error|0|||
150072318|NCT02122458|541407037|FG004|Overall Study|Experimental Error|3|||
150072319|NCT02122458|541407038|FG005|Overall Study|Experimental Error|0|||
150072320|NCT02122458|541407039|FG006|Overall Study|Experimental Error|0|||
150072321|NCT02122458|541407033|FG000|Overall Study|Deployed or Moved|0|||
150072322|NCT02122458|541407034|FG001|Overall Study|Deployed or Moved|0|||
150072323|NCT02122458|541407035|FG002|Overall Study|Deployed or Moved|0|||
150072324|NCT02122458|541407036|FG003|Overall Study|Deployed or Moved|0|||
150072325|NCT02122458|541407037|FG004|Overall Study|Deployed or Moved|1|||
150072326|NCT02122458|541407038|FG005|Overall Study|Deployed or Moved|0|||
150072327|NCT02122458|541407039|FG006|Overall Study|Deployed or Moved|0|||
150072328|NCT02122458|541407033|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
150072329|NCT02122458|541407034|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
150072330|NCT02122458|541407035|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
150072331|NCT02122458|541407036|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
150072332|NCT02122458|541407037|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
150072333|NCT02122458|541407038|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
150072334|NCT02122458|541407039|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
150072335|NCT02122458|541407033|FG000|Overall Study|Noncompliance|0|||
150072336|NCT02122458|541407034|FG001|Overall Study|Noncompliance|1|||
150072337|NCT02122458|541407035|FG002|Overall Study|Noncompliance|0|||
150072338|NCT02122458|541407036|FG003|Overall Study|Noncompliance|0|||
150072339|NCT02122458|541407037|FG004|Overall Study|Noncompliance|0|||
150072340|NCT02122458|541407038|FG005|Overall Study|Noncompliance|0|||
150072341|NCT02122458|541407039|FG006|Overall Study|Noncompliance|0|||
150072342|NCT00412542|541407040|FG000|Overall Study|Withdrawal by Subject|0|||
150072343|NCT00412542|541407041|FG001|Overall Study|Withdrawal by Subject|2|||
150072344|NCT00412542|541407040|FG000|Overall Study|Not Eligible|0|||
150072345|NCT00412542|541407041|FG001|Overall Study|Not Eligible|1|||
150072346|NCT02833350|541407042|FG000|Overall Study|Adverse Event|0|||
150072347|NCT02833350|541407043|FG001|Overall Study|Adverse Event|3|||
150072348|NCT02833350|541407044|FG002|Overall Study|Adverse Event|4|||
150072349|NCT02833350|541407045|FG003|Overall Study|Adverse Event|4|||
150072350|NCT02833350|541407046|FG004|Overall Study|Adverse Event|1|||
150072351|NCT02833350|541407047|FG005|Overall Study|Adverse Event|0|||
150072352|NCT02833350|541407048|FG006|Overall Study|Adverse Event|1|||
150072353|NCT02833350|541407042|FG000|Overall Study|Death|0|||
150072354|NCT02833350|541407043|FG001|Overall Study|Death|0|||
150072355|NCT02833350|541407044|FG002|Overall Study|Death|1|||
150072356|NCT02833350|541407045|FG003|Overall Study|Death|0|||
150072357|NCT02833350|541407046|FG004|Overall Study|Death|0|||
150072358|NCT02833350|541407047|FG005|Overall Study|Death|0|||
150072359|NCT02833350|541407048|FG006|Overall Study|Death|0|||
150072360|NCT02833350|541407042|FG000|Overall Study|Lack of Efficacy|0|||
150072361|NCT02833350|541407043|FG001|Overall Study|Lack of Efficacy|2|||
150072362|NCT02833350|541407044|FG002|Overall Study|Lack of Efficacy|1|||
150072363|NCT02833350|541407045|FG003|Overall Study|Lack of Efficacy|4|||
150072364|NCT02833350|541407046|FG004|Overall Study|Lack of Efficacy|0|||
150072365|NCT02833350|541407047|FG005|Overall Study|Lack of Efficacy|1|||
150072366|NCT02833350|541407048|FG006|Overall Study|Lack of Efficacy|1|||
150072367|NCT02833350|541407042|FG000|Overall Study|Lost to Follow-up|0|||
150072368|NCT02833350|541407043|FG001|Overall Study|Lost to Follow-up|1|||
150072369|NCT02833350|541407044|FG002|Overall Study|Lost to Follow-up|0|||
150072370|NCT02833350|541407045|FG003|Overall Study|Lost to Follow-up|0|||
150072371|NCT02833350|541407046|FG004|Overall Study|Lost to Follow-up|0|||
150072372|NCT02833350|541407047|FG005|Overall Study|Lost to Follow-up|0|||
150072373|NCT02833350|541407048|FG006|Overall Study|Lost to Follow-up|1|||
150072374|NCT02833350|541407042|FG000|Overall Study|Withdrawal by Subject|3|||
150072375|NCT02833350|541407043|FG001|Overall Study|Withdrawal by Subject|3|||
150072376|NCT02833350|541407044|FG002|Overall Study|Withdrawal by Subject|2|||
150072377|NCT02833350|541407045|FG003|Overall Study|Withdrawal by Subject|0|||
150072378|NCT02833350|541407046|FG004|Overall Study|Withdrawal by Subject|2|||
150072379|NCT02833350|541407047|FG005|Overall Study|Withdrawal by Subject|0|||
150072380|NCT02833350|541407048|FG006|Overall Study|Withdrawal by Subject|2|||
150072381|NCT01604408|541407054|FG000|Treatment Period 1|Protocol Violation|0|||
150072382|NCT01604408|541407055|FG001|Treatment Period 1|Protocol Violation|1|||
150072383|NCT01604408|541407054|FG000|Treatment Period 2|Withdrawal by Subject|1|||
150072384|NCT01604408|541407055|FG001|Treatment Period 2|Withdrawal by Subject|1|||
150072385|NCT01604408|541407054|FG000|Treatment Period 2|Protocol Violation|1|||
150072386|NCT01604408|541407055|FG001|Treatment Period 2|Protocol Violation|0|||
150072387|NCT01604408|541407054|FG000|Treatment Period 2|Adverse Event|0|||
150072388|NCT01604408|541407055|FG001|Treatment Period 2|Adverse Event|1|||
150072389|NCT01604408|541407054|FG000|Treatment Period 3|Protocol Violation|1|||
150072390|NCT01604408|541407055|FG001|Treatment Period 3|Protocol Violation|1|||
150072391|NCT01604408|541407054|FG000|Treatment Period 3|Adverse Event|0|||
150072392|NCT01604408|541407055|FG001|Treatment Period 3|Adverse Event|3|||
150072393|NCT01604408|541407054|FG000|Treatment Period 3|Withdrawal by Subject|3|||
150072394|NCT01604408|541407055|FG001|Treatment Period 3|Withdrawal by Subject|1|||
150182275|NCT04468776|541804649|FG000|Overall Study|Physician Decision|0|||
150072395|NCT01604408|541407054|FG000|Treatment Period 3|Sponsor Decision|1|||
150072396|NCT01604408|541407055|FG001|Treatment Period 3|Sponsor Decision|0|||
150072397|NCT01604408|541407054|FG000|Treatment Period 4|Death|1|||
150072398|NCT01604408|541407055|FG001|Treatment Period 4|Death|0|||
150072399|NCT01604408|541407054|FG000|Treatment Period 4|Withdrawal by Subject|2|||
150072400|NCT01604408|541407055|FG001|Treatment Period 4|Withdrawal by Subject|1|||
150072401|NCT01604408|541407054|FG000|Treatment Period 4|Adverse Event|0|||
150072402|NCT01604408|541407055|FG001|Treatment Period 4|Adverse Event|1|||
150072403|NCT01604408|541407054|FG000|Treatment Period 5|Adverse Event|4|||
150072404|NCT01604408|541407055|FG001|Treatment Period 5|Adverse Event|0|||
150072405|NCT01604408|541407054|FG000|Treatment Period 6|Lost to Follow-up|0|||
150072406|NCT01604408|541407055|FG001|Treatment Period 6|Lost to Follow-up|1|||
150072407|NCT01604408|541407054|FG000|Treatment Period 6|Adverse Event|2|||
150072408|NCT01604408|541407055|FG001|Treatment Period 6|Adverse Event|0|||
150072409|NCT01604408|541407054|FG000|Treatment Period 6|Sponsor decision|0|||
150072410|NCT01604408|541407055|FG001|Treatment Period 6|Sponsor decision|1|||
150072411|NCT01604408|541407054|FG000|Observation Period|Adverse Event|1|||
150072412|NCT01604408|541407055|FG001|Observation Period|Adverse Event|1|||
150072413|NCT01604408|541407054|FG000|Observation Period|Withdrawal by Subject|0|||
150072414|NCT01604408|541407055|FG001|Observation Period|Withdrawal by Subject|2|||
150072415|NCT00075218|541407056|FG000|Double-Blind Treatment|Adverse Event|23|||
150072416|NCT00075218|541407057|FG001|Double-Blind Treatment|Adverse Event|4|||
150072417|NCT00075218|541407058|FG002|Double-Blind Treatment|Adverse Event|0|||
150072418|NCT00075218|541407056|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
150072419|NCT00075218|541407057|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
150072420|NCT00075218|541407058|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
150072421|NCT00075218|541407056|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
150072422|NCT00075218|541407057|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
150072423|NCT00075218|541407058|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
150072424|NCT00075218|541407056|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
150072425|NCT00075218|541407057|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
150072426|NCT00075218|541407058|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
150072427|NCT00075218|541407056|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
150072428|NCT00075218|541407057|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
150072429|NCT00075218|541407058|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
150072430|NCT00075218|541407056|FG000|Double-Blind Treatment|No study medication taken|2|||
150072431|NCT00075218|541407057|FG001|Double-Blind Treatment|No study medication taken|0|||
150072432|NCT00075218|541407058|FG002|Double-Blind Treatment|No study medication taken|0|||
150072433|NCT00075218|541407056|FG000|Open-Label Treatment|Lack of Efficacy|0|||
150072434|NCT00075218|541407057|FG001|Open-Label Treatment|Lack of Efficacy|0|||
150072435|NCT00075218|541407058|FG002|Open-Label Treatment|Lack of Efficacy|174|||
150072436|NCT00075218|541407056|FG000|Open-Label Treatment|Adverse Event|0|||
150072437|NCT00075218|541407057|FG001|Open-Label Treatment|Adverse Event|0|||
150072438|NCT00075218|541407058|FG002|Open-Label Treatment|Adverse Event|51|||
150072439|NCT00075218|541407056|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
150072440|NCT00075218|541407057|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
150072441|NCT00075218|541407058|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
150072442|NCT00075218|541407056|FG000|Open-Label Treatment|Decision of Sponsor|0|||
150072443|NCT00075218|541407057|FG001|Open-Label Treatment|Decision of Sponsor|0|||
150072444|NCT00075218|541407058|FG002|Open-Label Treatment|Decision of Sponsor|8|||
150072445|NCT00075218|541407056|FG000|Open-Label Treatment|Protocol Violation|0|||
150072446|NCT00075218|541407057|FG001|Open-Label Treatment|Protocol Violation|0|||
150072447|NCT00075218|541407058|FG002|Open-Label Treatment|Protocol Violation|1|||
150072448|NCT00075218|541407056|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
150072449|NCT00075218|541407057|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
150072450|NCT00075218|541407058|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
150072451|NCT01189604|541407061|FG000|Overall Study|Impossible to visit|0|||
150072452|NCT01189604|541407062|FG001|Overall Study|Impossible to visit|0|||
150182276|NCT04468776|541804650|FG001|Overall Study|Physician Decision|1|||
150182277|NCT04468776|541804651|FG002|Overall Study|Physician Decision|1|||
150182278|NCT05952076|541804657|FG000|Overall Study|Death|1|||
150182279|NCT05952076|541804658|FG001|Overall Study|Death|1|||
150182280|NCT05952076|541804657|FG000|Overall Study|Lost to Follow-up|0|||
150182281|NCT05952076|541804658|FG001|Overall Study|Lost to Follow-up|1|||
150182282|NCT04143061|541804660|FG000|Overall Study|Protocol Deviation|0|||
150182283|NCT04143061|541804661|FG001|Overall Study|Protocol Deviation|0|||
150182284|NCT04143061|541804662|FG002|Overall Study|Protocol Deviation|0|||
150072453|NCT01189604|541407063|FG002|Overall Study|Impossible to visit|0|||
150072454|NCT01189604|541407064|FG003|Overall Study|Impossible to visit|0|||
150072455|NCT01189604|541407065|FG004|Overall Study|Impossible to visit|0|||
150072456|NCT01189604|541407066|FG005|Overall Study|Impossible to visit|1|||
150072457|NCT01189604|541407067|FG006|Overall Study|Impossible to visit|0|||
150072458|NCT01189604|541407061|FG000|Overall Study|Adverse Event|0|||
150072459|NCT01189604|541407062|FG001|Overall Study|Adverse Event|1|||
150072460|NCT01189604|541407063|FG002|Overall Study|Adverse Event|0|||
150182285|NCT04143061|541804663|FG003|Overall Study|Protocol Deviation|0|||
150072461|NCT01189604|541407064|FG003|Overall Study|Adverse Event|0|||
150072462|NCT01189604|541407065|FG004|Overall Study|Adverse Event|2|||
150072463|NCT01189604|541407066|FG005|Overall Study|Adverse Event|0|||
150072464|NCT01189604|541407067|FG006|Overall Study|Adverse Event|1|||
150072465|NCT01189604|541407061|FG000|Overall Study|Withdrawal by Subject|1|||
150072466|NCT01189604|541407062|FG001|Overall Study|Withdrawal by Subject|0|||
150072467|NCT01189604|541407063|FG002|Overall Study|Withdrawal by Subject|0|||
150072468|NCT01189604|541407064|FG003|Overall Study|Withdrawal by Subject|0|||
150072469|NCT01189604|541407065|FG004|Overall Study|Withdrawal by Subject|0|||
150072470|NCT01189604|541407066|FG005|Overall Study|Withdrawal by Subject|0|||
150072471|NCT01189604|541407067|FG006|Overall Study|Withdrawal by Subject|0|||
150072472|NCT03626168|541407068|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
150072473|NCT03626168|541407069|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
150072474|NCT03626168|541407068|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
150072475|NCT03626168|541407069|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
150072476|NCT03626168|541407068|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
150072477|NCT03626168|541407069|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
150072478|NCT02357979|541407070|FG000|Overall Study|Lost to Follow-up|5|||
150072479|NCT02357979|541407071|FG001|Overall Study|Lost to Follow-up|5|||
150072480|NCT01772160|541407076|FG000|Overall Study|Death|3|||
150072481|NCT01772160|541407076|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
150072482|NCT01772160|541407076|FG000|Overall Study|Consent withdrawal|3|||
150072483|NCT01772160|541407076|FG000|Overall Study|Migrated / moved from the study area|4|||
150072484|NCT01772160|541407076|FG000|Overall Study|Lost to Follow-up|30|||
150072485|NCT01772160|541407076|FG000|Overall Study|Other|5|||
150072486|NCT01332331|541407079|FG000|Overall Study|Lost to Follow-up|0|||
150072487|NCT01332331|541407080|FG001|Overall Study|Lost to Follow-up|1|||
150072488|NCT01332331|541407079|FG000|Overall Study|Adverse Event|1|||
150072489|NCT01332331|541407080|FG001|Overall Study|Adverse Event|1|||
150072490|NCT01332331|541407079|FG000|Overall Study|Physician Decision|1|||
150072491|NCT01332331|541407080|FG001|Overall Study|Physician Decision|0|||
150072492|NCT00538291|541407081|FG000|Overall Study|Adverse Event|2|||
150072493|NCT00538291|541407081|FG000|Overall Study|Withdrawal by Subject|1|||
150072494|NCT01696695|541407082|FG000|Overall Study|Disease progression|373|||
150072495|NCT01696695|541407082|FG000|Overall Study|Death|29|||
150072496|NCT01696695|541407082|FG000|Overall Study|Adverse Event|74|||
150072497|NCT01696695|541407082|FG000|Overall Study|Withdrawal by Subject|92|||
150072498|NCT01696695|541407082|FG000|Overall Study|Lost to Follow-up|48|||
150072499|NCT01696695|541407082|FG000|Overall Study|Other|74|||
150072500|NCT01696695|541407082|FG000|Overall Study|Major Protocol Violation|192|||
150072501|NCT01756053|541407092|FG000|Period 1 (10 Days)|Protocol Violation|1|||
150072502|NCT01756053|541407093|FG001|Period 1 (10 Days)|Protocol Violation|1|||
150072503|NCT01756053|541407092|FG000|Period 2 (10 Days)|Protocol Violation|0|||
150072504|NCT01756053|541407093|FG001|Period 2 (10 Days)|Protocol Violation|2|||
150072505|NCT00285818|541407094|FG000|Overall Study|Withdrawal by Subject|3|||
150072506|NCT00285818|541407095|FG001|Overall Study|Withdrawal by Subject|2|||
150072507|NCT00285818|541407094|FG000|Overall Study|Lost to Follow-up|1|||
150072508|NCT00285818|541407095|FG001|Overall Study|Lost to Follow-up|0|||
150072509|NCT02404220|541407096|FG000|Overall Study|Adverse Event|0|||
150072510|NCT02404220|541407097|FG001|Overall Study|Adverse Event|0|||
150072511|NCT02404220|541407098|FG002|Overall Study|Adverse Event|1|||
150072512|NCT02404220|541407099|FG003|Overall Study|Adverse Event|0|||
150072513|NCT02404220|541407096|FG000|Overall Study|Death|5|||
150072514|NCT02404220|541407097|FG001|Overall Study|Death|5|||
150072515|NCT02404220|541407098|FG002|Overall Study|Death|3|||
150072516|NCT02404220|541407099|FG003|Overall Study|Death|8|||
150072517|NCT02404220|541407096|FG000|Overall Study|Progressive Disease|0|||
150072518|NCT02404220|541407097|FG001|Overall Study|Progressive Disease|0|||
150072519|NCT02404220|541407098|FG002|Overall Study|Progressive Disease|1|||
150072520|NCT02404220|541407099|FG003|Overall Study|Progressive Disease|1|||
150072521|NCT02404220|541407096|FG000|Overall Study|Study Terminated by Sponsor|0|||
150072522|NCT02404220|541407097|FG001|Overall Study|Study Terminated by Sponsor|0|||
150072523|NCT02404220|541407098|FG002|Overall Study|Study Terminated by Sponsor|2|||
150072524|NCT02404220|541407099|FG003|Overall Study|Study Terminated by Sponsor|1|||
150072525|NCT02404220|541407096|FG000|Overall Study|Withdrawal by Subject|0|||
150072526|NCT02404220|541407097|FG001|Overall Study|Withdrawal by Subject|1|||
150072527|NCT02404220|541407098|FG002|Overall Study|Withdrawal by Subject|0|||
150072528|NCT02404220|541407099|FG003|Overall Study|Withdrawal by Subject|0|||
150072529|NCT02404220|541407096|FG000|Overall Study|Enrolled but Never Treated|0|||
150072530|NCT02404220|541407097|FG001|Overall Study|Enrolled but Never Treated|2|||
150072531|NCT02404220|541407098|FG002|Overall Study|Enrolled but Never Treated|0|||
150072532|NCT02404220|541407099|FG003|Overall Study|Enrolled but Never Treated|0|||
150072533|NCT01024231|541407103|FG000|Overall Study|Other Reasons|1|||
150072534|NCT01024231|541407104|FG001|Overall Study|Other Reasons|2|||
150072535|NCT01024231|541407105|FG002|Overall Study|Other Reasons|0|||
150072536|NCT01024231|541407106|FG003|Overall Study|Other Reasons|0|||
150072537|NCT01024231|541407107|FG004|Overall Study|Other Reasons|2|||
150072538|NCT01024231|541407108|FG005|Overall Study|Other Reasons|0|||
150072539|NCT01024231|541407109|FG006|Overall Study|Other Reasons|1|||
150072540|NCT01024231|541407103|FG000|Overall Study|Maximum Clinical Benefit|1|||
150072541|NCT01024231|541407104|FG001|Overall Study|Maximum Clinical Benefit|2|||
150072542|NCT01024231|541407105|FG002|Overall Study|Maximum Clinical Benefit|0|||
150072543|NCT01024231|541407106|FG003|Overall Study|Maximum Clinical Benefit|1|||
150072544|NCT01024231|541407107|FG004|Overall Study|Maximum Clinical Benefit|1|||
150072545|NCT01024231|541407108|FG005|Overall Study|Maximum Clinical Benefit|0|||
150072546|NCT01024231|541407109|FG006|Overall Study|Maximum Clinical Benefit|0|||
150072547|NCT01024231|541407103|FG000|Overall Study|Disease Progression|3|||
150072548|NCT01024231|541407104|FG001|Overall Study|Disease Progression|1|||
150072549|NCT01024231|541407105|FG002|Overall Study|Disease Progression|3|||
150072550|NCT01024231|541407106|FG003|Overall Study|Disease Progression|0|||
150072551|NCT01024231|541407107|FG004|Overall Study|Disease Progression|4|||
150072552|NCT01024231|541407108|FG005|Overall Study|Disease Progression|11|||
150072553|NCT01024231|541407109|FG006|Overall Study|Disease Progression|6|||
150072554|NCT01024231|541407103|FG000|Overall Study|AE unrelated to Study Drug|0|||
150072555|NCT01024231|541407104|FG001|Overall Study|AE unrelated to Study Drug|1|||
150072556|NCT01024231|541407105|FG002|Overall Study|AE unrelated to Study Drug|0|||
150072557|NCT01024231|541407106|FG003|Overall Study|AE unrelated to Study Drug|0|||
150072558|NCT01024231|541407107|FG004|Overall Study|AE unrelated to Study Drug|0|||
150072559|NCT01024231|541407108|FG005|Overall Study|AE unrelated to Study Drug|0|||
150072560|NCT01024231|541407109|FG006|Overall Study|AE unrelated to Study Drug|0|||
150072561|NCT01024231|541407103|FG000|Overall Study|No longer meets criteria|0|||
150072562|NCT01024231|541407104|FG001|Overall Study|No longer meets criteria|0|||
150072563|NCT01024231|541407105|FG002|Overall Study|No longer meets criteria|0|||
150072564|NCT01024231|541407106|FG003|Overall Study|No longer meets criteria|0|||
150072565|NCT01024231|541407107|FG004|Overall Study|No longer meets criteria|1|||
150072566|NCT01024231|541407108|FG005|Overall Study|No longer meets criteria|0|||
150072567|NCT01024231|541407109|FG006|Overall Study|No longer meets criteria|1|||
150072568|NCT01024231|541407103|FG000|Overall Study|Study Drug Toxicity|1|||
150072569|NCT01024231|541407104|FG001|Overall Study|Study Drug Toxicity|6|||
150072570|NCT01024231|541407105|FG002|Overall Study|Study Drug Toxicity|6|||
150072571|NCT01024231|541407106|FG003|Overall Study|Study Drug Toxicity|4|||
150072572|NCT01024231|541407107|FG004|Overall Study|Study Drug Toxicity|2|||
150072573|NCT01024231|541407108|FG005|Overall Study|Study Drug Toxicity|0|||
150072574|NCT01024231|541407109|FG006|Overall Study|Study Drug Toxicity|7|||
150072575|NCT01024231|541407103|FG000|Overall Study|Death|6|||
150072576|NCT01024231|541407104|FG001|Overall Study|Death|2|||
150072577|NCT01024231|541407105|FG002|Overall Study|Death|1|||
150072578|NCT01024231|541407106|FG003|Overall Study|Death|0|||
150072579|NCT01024231|541407107|FG004|Overall Study|Death|4|||
150072580|NCT01024231|541407108|FG005|Overall Study|Death|3|||
150072581|NCT01024231|541407109|FG006|Overall Study|Death|5|||
150072582|NCT01024231|541407103|FG000|Overall Study|Lost to Follow-up|0|||
150072583|NCT01024231|541407104|FG001|Overall Study|Lost to Follow-up|0|||
150072584|NCT01024231|541407105|FG002|Overall Study|Lost to Follow-up|0|||
150072585|NCT01024231|541407106|FG003|Overall Study|Lost to Follow-up|0|||
150072586|NCT01024231|541407107|FG004|Overall Study|Lost to Follow-up|0|||
150072587|NCT01024231|541407108|FG005|Overall Study|Lost to Follow-up|0|||
150072588|NCT01024231|541407109|FG006|Overall Study|Lost to Follow-up|1|||
150072589|NCT01024231|541407103|FG000|Overall Study|Withdrew Consent|0|||
150072590|NCT01024231|541407104|FG001|Overall Study|Withdrew Consent|1|||
150072591|NCT01024231|541407105|FG002|Overall Study|Withdrew Consent|0|||
150072592|NCT01024231|541407106|FG003|Overall Study|Withdrew Consent|0|||
150072593|NCT01024231|541407107|FG004|Overall Study|Withdrew Consent|0|||
150072594|NCT01024231|541407108|FG005|Overall Study|Withdrew Consent|0|||
150072595|NCT01024231|541407109|FG006|Overall Study|Withdrew Consent|0|||
150072596|NCT01024231|541407103|FG000|Overall Study|Continuing on Treatment|0|||
150072597|NCT01024231|541407104|FG001|Overall Study|Continuing on Treatment|0|||
150072598|NCT01024231|541407105|FG002|Overall Study|Continuing on Treatment|0|||
150072599|NCT01024231|541407106|FG003|Overall Study|Continuing on Treatment|0|||
150072600|NCT01024231|541407107|FG004|Overall Study|Continuing on Treatment|3|||
150072601|NCT01024231|541407108|FG005|Overall Study|Continuing on Treatment|2|||
150072602|NCT01024231|541407109|FG006|Overall Study|Continuing on Treatment|0|||
150072603|NCT01163266|541407110|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
150072604|NCT01163266|541407111|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
150072605|NCT01163266|541407112|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
150072606|NCT01163266|541407110|FG000|Overall Study|Lack of Efficacy|1|||
150072607|NCT01163266|541407111|FG001|Overall Study|Lack of Efficacy|3|||
150072608|NCT01163266|541407112|FG002|Overall Study|Lack of Efficacy|1|||
150072609|NCT01163266|541407110|FG000|Overall Study|Noncompliance with Study Drug|0|||
150072610|NCT01163266|541407111|FG001|Overall Study|Noncompliance with Study Drug|2|||
150072611|NCT01163266|541407112|FG002|Overall Study|Noncompliance with Study Drug|0|||
150072612|NCT01163266|541407110|FG000|Overall Study|Protocol Deviations|2|||
150072613|NCT01163266|541407111|FG001|Overall Study|Protocol Deviations|2|||
150072614|NCT01163266|541407112|FG002|Overall Study|Protocol Deviations|5|||
150072615|NCT01163266|541407110|FG000|Overall Study|Withdrawal of Consent|5|||
150072616|NCT01163266|541407111|FG001|Overall Study|Withdrawal of Consent|7|||
150072617|NCT01163266|541407112|FG002|Overall Study|Withdrawal of Consent|3|||
150072618|NCT01163266|541407110|FG000|Overall Study|Lost to Follow-up|7|||
150072619|NCT01163266|541407111|FG001|Overall Study|Lost to Follow-up|7|||
150072620|NCT01163266|541407112|FG002|Overall Study|Lost to Follow-up|10|||
150072621|NCT01163266|541407110|FG000|Overall Study|Other|1|||
150072622|NCT01163266|541407111|FG001|Overall Study|Other|1|||
150072623|NCT01163266|541407112|FG002|Overall Study|Other|2|||
150072624|NCT02586064|541407113|FG000|Overall Study|Other Obligations|6|||
150072625|NCT02586064|541407114|FG001|Overall Study|Other Obligations|6|||
150072626|NCT02586064|541407113|FG000|Overall Study|Other|3|||
150072627|NCT02586064|541407114|FG001|Overall Study|Other|7|||
150072628|NCT02586064|541407113|FG000|Overall Study|Never Started|3|||
150072629|NCT02586064|541407114|FG001|Overall Study|Never Started|3|||
150072630|NCT02586064|541407113|FG000|Overall Study|Lost Interest|1|||
150072631|NCT02586064|541407114|FG001|Overall Study|Lost Interest|4|||
150072632|NCT02586064|541407113|FG000|Overall Study|Miscellaneous Life Issues|0|||
150072633|NCT02586064|541407114|FG001|Overall Study|Miscellaneous Life Issues|5|||
150072634|NCT02586064|541407113|FG000|Overall Study|Infrequent Attendance|2|||
150072635|NCT02586064|541407114|FG001|Overall Study|Infrequent Attendance|1|||
150072636|NCT02586064|541407113|FG000|Overall Study|Timed Out|2|||
150072637|NCT02586064|541407114|FG001|Overall Study|Timed Out|0|||
150072638|NCT02586064|541407113|FG000|Overall Study|AUD relapse|0|||
150072639|NCT02586064|541407114|FG001|Overall Study|AUD relapse|2|||
150072640|NCT02586064|541407113|FG000|Overall Study|Legal Issue|1|||
150072641|NCT02586064|541407114|FG001|Overall Study|Legal Issue|0|||
150072642|NCT02919696|541407115|FG000|Overall Study|Adverse Event|1|||
150072643|NCT02919696|541407116|FG001|Overall Study|Adverse Event|2|||
150072644|NCT02919696|541407115|FG000|Overall Study|Withdrawal by Subject|2|||
150072645|NCT02919696|541407116|FG001|Overall Study|Withdrawal by Subject|1|||
150072646|NCT02919696|541407115|FG000|Overall Study|Sponsor Decision|1|||
150072647|NCT02919696|541407116|FG001|Overall Study|Sponsor Decision|1|||
150072648|NCT02919696|541407115|FG000|Overall Study|Never Treated|0|||
150072649|NCT02919696|541407116|FG001|Overall Study|Never Treated|1|||
150072650|NCT03181893|541407117|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072651|NCT03181893|541407118|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
150072652|NCT03181893|541407119|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072653|NCT03181893|541407120|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072654|NCT03181893|541407121|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072655|NCT03181893|541407122|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072656|NCT03181893|541407123|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072657|NCT03181893|541407124|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072658|NCT03181893|541407125|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072659|NCT03181893|541407126|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072660|NCT03181893|541407127|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
150072661|NCT03181893|541407117|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
150072662|NCT03181893|541407118|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
150072663|NCT03181893|541407119|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072664|NCT03181893|541407120|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072665|NCT03181893|541407121|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072666|NCT03181893|541407122|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072667|NCT03181893|541407123|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072668|NCT03181893|541407124|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072669|NCT03181893|541407125|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072670|NCT03181893|541407126|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072671|NCT03181893|541407127|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
150072672|NCT03181893|541407117|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072673|NCT03181893|541407118|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072674|NCT03181893|541407119|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072675|NCT03181893|541407120|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072676|NCT03181893|541407121|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072677|NCT03181893|541407122|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072678|NCT03181893|541407123|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072679|NCT03181893|541407124|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
150072680|NCT03181893|541407125|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
150072681|NCT03181893|541407126|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072682|NCT03181893|541407127|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
150072683|NCT03181893|541407117|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072684|NCT03181893|541407118|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072685|NCT03181893|541407119|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072686|NCT03181893|541407120|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072687|NCT03181893|541407121|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072688|NCT03181893|541407122|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072689|NCT03181893|541407123|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072690|NCT03181893|541407124|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072691|NCT03181893|541407125|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072692|NCT03181893|541407126|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
150072693|NCT03181893|541407127|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
150072694|NCT03181893|541407117|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072695|NCT03181893|541407118|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072696|NCT03181893|541407119|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072697|NCT03181893|541407120|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072698|NCT03181893|541407121|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072699|NCT03181893|541407122|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072700|NCT03181893|541407123|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072701|NCT03181893|541407124|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072702|NCT03181893|541407125|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072703|NCT03181893|541407126|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
150072704|NCT03181893|541407127|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
150072705|NCT02158975|541407128|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
150072706|NCT02840721|541407130|FG000|Treatment Period|Adverse Event|1|||
150072707|NCT02840721|541407130|FG000|Follow-Up|Lack of Efficacy|1|||
150072708|NCT02840721|541407130|FG000|Follow-Up|Withdrawal by Subject|4|||
150072709|NCT02840721|541407130|FG000|Follow-Up|Withdrawal of Consent|2|||
150072710|NCT01967173|541407131|FG000|Overall Study|Lost to Follow-up|5|||
150072711|NCT01967173|541407132|FG001|Overall Study|Lost to Follow-up|3|||
150072712|NCT01967173|541407133|FG002|Overall Study|Lost to Follow-up|2|||
150072713|NCT01967173|541407134|FG003|Overall Study|Lost to Follow-up|4|||
150072714|NCT01967173|541407135|FG004|Overall Study|Lost to Follow-up|8|||
150072715|NCT01967173|541407136|FG005|Overall Study|Lost to Follow-up|12|||
150072716|NCT01967173|541407137|FG006|Overall Study|Lost to Follow-up|6|||
150072717|NCT01967173|541407138|FG007|Overall Study|Lost to Follow-up|8|||
150072718|NCT01967173|541407131|FG000|Overall Study|Physician Decision|2|||
150072719|NCT01967173|541407132|FG001|Overall Study|Physician Decision|0|||
150072720|NCT01967173|541407133|FG002|Overall Study|Physician Decision|2|||
150072721|NCT01967173|541407134|FG003|Overall Study|Physician Decision|1|||
150072722|NCT01967173|541407135|FG004|Overall Study|Physician Decision|1|||
150072723|NCT01967173|541407136|FG005|Overall Study|Physician Decision|1|||
150072724|NCT01967173|541407137|FG006|Overall Study|Physician Decision|1|||
150072725|NCT01967173|541407138|FG007|Overall Study|Physician Decision|0|||
150072726|NCT01967173|541407131|FG000|Overall Study|Lack of Efficacy|2|||
150072727|NCT01967173|541407132|FG001|Overall Study|Lack of Efficacy|0|||
150072728|NCT01967173|541407133|FG002|Overall Study|Lack of Efficacy|2|||
150072729|NCT01967173|541407134|FG003|Overall Study|Lack of Efficacy|2|||
150072730|NCT01967173|541407135|FG004|Overall Study|Lack of Efficacy|0|||
150072731|NCT01967173|541407136|FG005|Overall Study|Lack of Efficacy|1|||
150072732|NCT01967173|541407137|FG006|Overall Study|Lack of Efficacy|0|||
150072733|NCT01967173|541407138|FG007|Overall Study|Lack of Efficacy|2|||
150072734|NCT01967173|541407131|FG000|Overall Study|Pregnancy|0|||
150072735|NCT01967173|541407132|FG001|Overall Study|Pregnancy|0|||
150072736|NCT01967173|541407133|FG002|Overall Study|Pregnancy|0|||
150072737|NCT01967173|541407134|FG003|Overall Study|Pregnancy|0|||
150072738|NCT01967173|541407135|FG004|Overall Study|Pregnancy|0|||
150072739|NCT01967173|541407136|FG005|Overall Study|Pregnancy|0|||
150072740|NCT01967173|541407137|FG006|Overall Study|Pregnancy|1|||
150072741|NCT01967173|541407138|FG007|Overall Study|Pregnancy|1|||
150072742|NCT01967173|541407131|FG000|Overall Study|Adverse Event|0|||
150072743|NCT01967173|541407132|FG001|Overall Study|Adverse Event|0|||
150072744|NCT01967173|541407133|FG002|Overall Study|Adverse Event|0|||
150072745|NCT01967173|541407134|FG003|Overall Study|Adverse Event|0|||
150072746|NCT01967173|541407135|FG004|Overall Study|Adverse Event|0|||
150072747|NCT01967173|541407136|FG005|Overall Study|Adverse Event|0|||
150072748|NCT01967173|541407137|FG006|Overall Study|Adverse Event|0|||
150072749|NCT01967173|541407138|FG007|Overall Study|Adverse Event|1|||
150072750|NCT01967173|541407131|FG000|Overall Study|Withdrawal by Subject|15|||
150072751|NCT01967173|541407132|FG001|Overall Study|Withdrawal by Subject|14|||
150072752|NCT01967173|541407133|FG002|Overall Study|Withdrawal by Subject|10|||
150072753|NCT01967173|541407134|FG003|Overall Study|Withdrawal by Subject|7|||
150072754|NCT01967173|541407135|FG004|Overall Study|Withdrawal by Subject|8|||
150072755|NCT01967173|541407136|FG005|Overall Study|Withdrawal by Subject|9|||
150072756|NCT01967173|541407137|FG006|Overall Study|Withdrawal by Subject|10|||
150072757|NCT01967173|541407138|FG007|Overall Study|Withdrawal by Subject|12|||
150182286|NCT04143061|541804664|FG004|Overall Study|Protocol Deviation|0|||
150072758|NCT01346969|541407139|FG000|Overall Study|Withdrawal by Subject|0|||
150072759|NCT01346969|541407140|FG001|Overall Study|Withdrawal by Subject|0|||
150072760|NCT01346969|541407141|FG002|Overall Study|Withdrawal by Subject|1|||
150072761|NCT01346969|541407142|FG003|Overall Study|Withdrawal by Subject|0|||
150072762|NCT01346969|541407139|FG000|Overall Study|Lost to Follow-up|1|||
150072763|NCT01346969|541407140|FG001|Overall Study|Lost to Follow-up|0|||
150072764|NCT01346969|541407141|FG002|Overall Study|Lost to Follow-up|2|||
150072765|NCT01346969|541407142|FG003|Overall Study|Lost to Follow-up|0|||
150072766|NCT01346969|541407139|FG000|Overall Study|Physician Decision|0|||
150072767|NCT01346969|541407140|FG001|Overall Study|Physician Decision|0|||
150072768|NCT01346969|541407141|FG002|Overall Study|Physician Decision|0|||
150072769|NCT01346969|541407142|FG003|Overall Study|Physician Decision|1|||
150072770|NCT01346969|541407139|FG000|Overall Study|Randomized but not treated|1|||
150072771|NCT01346969|541407140|FG001|Overall Study|Randomized but not treated|0|||
150072772|NCT01346969|541407141|FG002|Overall Study|Randomized but not treated|0|||
150072773|NCT01346969|541407142|FG003|Overall Study|Randomized but not treated|0|||
150072774|NCT03540030|541407146|FG000|Overall Study|Withdrawal by Subject|2|||
150072775|NCT03540030|541407147|FG001|Overall Study|Withdrawal by Subject|1|||
150072776|NCT03540030|541407146|FG000|Overall Study|screen fail|7|||
150072777|NCT03540030|541407147|FG001|Overall Study|screen fail|1|||
150072778|NCT03540030|541407146|FG000|Overall Study|never had surgery after signing consent|9|||
150072779|NCT03540030|541407147|FG001|Overall Study|never had surgery after signing consent|1|||
150072780|NCT03666624|541407148|FG000|Overall Study|participant grieving over recent death of parent|1|||
150072781|NCT03666624|541407149|FG001|Overall Study|participant grieving over recent death of parent|0|||
150072782|NCT04815031|541407155|FG000|Overall Study|No adverse event information (missing information)|33|||
150072783|NCT03021304|541407156|FG000|Overall Study|Lack of Efficacy|1|||
150072784|NCT00397215|541407164|FG000|Month 0 (Day 0)|Adverse Event|0|||
150072785|NCT00397215|541407165|FG001|Month 0 (Day 0)|Adverse Event|1|||
150072786|NCT00397215|541407166|FG002|Month 0 (Day 0)|Adverse Event|0|||
150072787|NCT00397215|541407167|FG003|Month 0 (Day 0)|Adverse Event|0|||
150072788|NCT00397215|541407164|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
150072789|NCT00397215|541407165|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
150072790|NCT00397215|541407166|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
150072791|NCT00397215|541407167|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
150072792|NCT00397215|541407164|FG000|Month 0 (Day 0)|Other|4|||
150072793|NCT00397215|541407165|FG001|Month 0 (Day 0)|Other|1|||
150072794|NCT00397215|541407166|FG002|Month 0 (Day 0)|Other|3|||
150072795|NCT00397215|541407167|FG003|Month 0 (Day 0)|Other|3|||
150072796|NCT00397215|541407164|FG000|Month 6 (Day 180)|Adverse Event|0|||
150072797|NCT00397215|541407165|FG001|Month 6 (Day 180)|Adverse Event|3|||
150072798|NCT00397215|541407166|FG002|Month 6 (Day 180)|Adverse Event|2|||
150072799|NCT00397215|541407167|FG003|Month 6 (Day 180)|Adverse Event|0|||
150072800|NCT00397215|541407164|FG000|Month 6 (Day 180)|Other|2|||
150072801|NCT00397215|541407165|FG001|Month 6 (Day 180)|Other|0|||
150072802|NCT00397215|541407166|FG002|Month 6 (Day 180)|Other|3|||
150072803|NCT00397215|541407167|FG003|Month 6 (Day 180)|Other|0|||
150072804|NCT02959983|541407168|FG000|Overall Study|Protocol Violation|0|||
150072805|NCT02959983|541407169|FG001|Overall Study|Protocol Violation|1|||
150072806|NCT02959983|541407168|FG000|Overall Study|Lack of Efficacy|0|||
150072807|NCT02959983|541407169|FG001|Overall Study|Lack of Efficacy|1|||
150072808|NCT02959983|541407168|FG000|Overall Study|Lost to Follow-up|12|||
150072809|NCT02959983|541407169|FG001|Overall Study|Lost to Follow-up|9|||
150072810|NCT02959983|541407168|FG000|Overall Study|Other|1|||
150072811|NCT02959983|541407169|FG001|Overall Study|Other|1|||
150072812|NCT02959983|541407168|FG000|Overall Study|Physician Decision|1|||
150072813|NCT02959983|541407169|FG001|Overall Study|Physician Decision|0|||
150072814|NCT02959983|541407168|FG000|Overall Study|Adverse Event|5|||
150072815|NCT02959983|541407169|FG001|Overall Study|Adverse Event|1|||
150072816|NCT02959983|541407168|FG000|Overall Study|Withdrawal by Subject|7|||
150072817|NCT02959983|541407169|FG001|Overall Study|Withdrawal by Subject|12|||
150072818|NCT00484094|541407170|FG000|Overall Study|Discontinued|39|||
150072819|NCT00484094|541407170|FG000|Overall Study|Other|3|||
150072820|NCT02728596|541407171|FG000|Overall Study|Refusal unrelated to adverse event|3|||
150072821|NCT02728596|541407172|FG001|Overall Study|Refusal unrelated to adverse event|6|||
150072822|NCT02728596|541407173|FG002|Overall Study|Refusal unrelated to adverse event|7|||
150072823|NCT02728596|541407174|FG003|Overall Study|Refusal unrelated to adverse event|7|||
150072824|NCT02728596|541407171|FG000|Overall Study|Death|44|||
150072825|NCT02728596|541407172|FG001|Overall Study|Death|42|||
150072826|NCT02728596|541407173|FG002|Overall Study|Death|123|||
150072827|NCT02728596|541407174|FG003|Overall Study|Death|68|||
150072828|NCT03439657|541407179|FG000|Overall Study|Adverse Event|2|||
150072829|NCT03439657|541407180|FG001|Overall Study|Adverse Event|3|||
150072830|NCT03439657|541407179|FG000|Overall Study|Lost to Follow-up|1|||
150072831|NCT03439657|541407180|FG001|Overall Study|Lost to Follow-up|0|||
150072832|NCT03439657|541407179|FG000|Overall Study|Protocol Violation|1|||
150072833|NCT03439657|541407180|FG001|Overall Study|Protocol Violation|1|||
150072834|NCT03439657|541407179|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
150072835|NCT03439657|541407180|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
150072836|NCT00370071|541407182|FG000|Overall Study|Withdrawal by Subject|2|||
150072837|NCT01558739|541407188|FG000|Overall Study|Adverse Event|7|||
150072838|NCT01558739|541407188|FG000|Overall Study|Withdrawal by Subject|2|||
150072839|NCT01558739|541407188|FG000|Overall Study|Death|3|||
150072840|NCT01558739|541407188|FG000|Overall Study|Disease Progression|4|||
150072841|NCT01558739|541407188|FG000|Overall Study|Protocol Violation|1|||
150072842|NCT01193842|541407192|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
150072843|NCT01193842|541407193|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
150072844|NCT01193842|541407194|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
150072845|NCT01193842|541407195|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
150072846|NCT01193842|541407196|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
150072847|NCT01193842|541407192|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
150072848|NCT01193842|541407193|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
150072849|NCT01193842|541407194|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
150072850|NCT01193842|541407195|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
150072851|NCT01193842|541407196|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
150072852|NCT01193842|541407192|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
150072853|NCT01193842|541407193|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
150072854|NCT01193842|541407194|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
150072855|NCT01193842|541407195|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
150072856|NCT01193842|541407196|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
150072857|NCT01193842|541407192|FG000|Phase II: Randomized Groups|Death|0|||
150072858|NCT01193842|541407193|FG001|Phase II: Randomized Groups|Death|0|||
150072859|NCT01193842|541407194|FG002|Phase II: Randomized Groups|Death|0|||
150072860|NCT01193842|541407195|FG003|Phase II: Randomized Groups|Death|1|||
150072861|NCT01193842|541407196|FG004|Phase II: Randomized Groups|Death|1|||
150072862|NCT01193842|541407192|FG000|Phase II: Randomized Groups|Adverse Event|0|||
150072863|NCT01193842|541407193|FG001|Phase II: Randomized Groups|Adverse Event|0|||
150072864|NCT01193842|541407194|FG002|Phase II: Randomized Groups|Adverse Event|0|||
150072865|NCT01193842|541407195|FG003|Phase II: Randomized Groups|Adverse Event|5|||
150072866|NCT01193842|541407196|FG004|Phase II: Randomized Groups|Adverse Event|3|||
150072867|NCT01193842|541407192|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
150072868|NCT01193842|541407193|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
150072869|NCT01193842|541407194|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
150072870|NCT01193842|541407195|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
150072871|NCT01193842|541407196|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
150072872|NCT01193842|541407192|FG000|Phase II: Randomized Groups|Ineligible|0|||
150072873|NCT01193842|541407193|FG001|Phase II: Randomized Groups|Ineligible|0|||
150072874|NCT01193842|541407194|FG002|Phase II: Randomized Groups|Ineligible|0|||
150072875|NCT01193842|541407195|FG003|Phase II: Randomized Groups|Ineligible|0|||
150072876|NCT01193842|541407196|FG004|Phase II: Randomized Groups|Ineligible|1|||
150072877|NCT01193842|541407192|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
150072878|NCT01193842|541407193|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
150072879|NCT01193842|541407194|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
150072880|NCT01193842|541407195|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
150072881|NCT01193842|541407196|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
150072882|NCT02484690|541407198|FG000|Overall Study|Adverse Event|1|||
150072883|NCT02484690|541407199|FG001|Overall Study|Adverse Event|3|||
150072884|NCT02484690|541407200|FG002|Overall Study|Adverse Event|0|||
150072885|NCT02484690|541407201|FG003|Overall Study|Adverse Event|0|||
150072886|NCT02484690|541407202|FG004|Overall Study|Adverse Event|5|||
150072887|NCT02484690|541407198|FG000|Overall Study|Death|0|||
150072888|NCT02484690|541407199|FG001|Overall Study|Death|0|||
150072889|NCT02484690|541407200|FG002|Overall Study|Death|0|||
150072890|NCT02484690|541407201|FG003|Overall Study|Death|0|||
150072891|NCT02484690|541407202|FG004|Overall Study|Death|1|||
150072892|NCT02484690|541407198|FG000|Overall Study|Withdrawal by Subject|1|||
150072893|NCT02484690|541407199|FG001|Overall Study|Withdrawal by Subject|3|||
150072894|NCT02484690|541407200|FG002|Overall Study|Withdrawal by Subject|1|||
150072895|NCT02484690|541407201|FG003|Overall Study|Withdrawal by Subject|2|||
150072896|NCT02484690|541407202|FG004|Overall Study|Withdrawal by Subject|0|||
150072897|NCT02484690|541407198|FG000|Overall Study|Physician Decision|2|||
150072898|NCT02484690|541407199|FG001|Overall Study|Physician Decision|0|||
150072899|NCT02484690|541407200|FG002|Overall Study|Physician Decision|1|||
150072900|NCT02484690|541407201|FG003|Overall Study|Physician Decision|0|||
150072901|NCT02484690|541407202|FG004|Overall Study|Physician Decision|0|||
150072902|NCT02484690|541407198|FG000|Overall Study|Lost to Follow-up|0|||
150072903|NCT02484690|541407199|FG001|Overall Study|Lost to Follow-up|0|||
150072904|NCT02484690|541407200|FG002|Overall Study|Lost to Follow-up|1|||
150072905|NCT02484690|541407201|FG003|Overall Study|Lost to Follow-up|0|||
150072906|NCT02484690|541407202|FG004|Overall Study|Lost to Follow-up|0|||
150072907|NCT02612129|541407203|FG000|Single Dose Treatment Period|Screening Failure|1|||
150072908|NCT02612129|541407204|FG001|Single Dose Treatment Period|Screening Failure|0|||
150072909|NCT02612129|541407205|FG002|Single Dose Treatment Period|Screening Failure|0|||
150072910|NCT02612129|541407203|FG000|Continuous Treatment Period|Early Escape|0|||
150072911|NCT02612129|541407204|FG001|Continuous Treatment Period|Early Escape|2|||
150072912|NCT02612129|541407205|FG002|Continuous Treatment Period|Early Escape|0|||
150072913|NCT02612129|541407203|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
150072914|NCT02612129|541407204|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
150072915|NCT02612129|541407205|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
150182287|NCT04143061|541804665|FG005|Overall Study|Protocol Deviation|0|||
150182288|NCT04143061|541804666|FG006|Overall Study|Protocol Deviation|5|||
150072916|NCT02612129|541407203|FG000|Continuous Treatment Period|Safety Reasons|0|||
150072917|NCT02612129|541407204|FG001|Continuous Treatment Period|Safety Reasons|3|||
150072918|NCT02612129|541407205|FG002|Continuous Treatment Period|Safety Reasons|0|||
150072919|NCT02612129|541407203|FG000|Continuous Treatment Period|Death|0|||
150072920|NCT02612129|541407204|FG001|Continuous Treatment Period|Death|1|||
150072921|NCT02612129|541407205|FG002|Continuous Treatment Period|Death|0|||
150072922|NCT02612129|541407203|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
150072923|NCT02612129|541407204|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
150072924|NCT02612129|541407205|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
150072925|NCT02557295|541407206|FG000|Overall Study|Withdrawal by Subject|9|||
150072926|NCT02557295|541407207|FG001|Overall Study|Withdrawal by Subject|2|||
150072927|NCT02557295|541407208|FG002|Overall Study|Withdrawal by Subject|4|||
150072928|NCT02557295|541407209|FG003|Overall Study|Withdrawal by Subject|0|||
150072929|NCT02557295|541407210|FG004|Overall Study|Withdrawal by Subject|0|||
150072930|NCT02557295|541407211|FG005|Overall Study|Withdrawal by Subject|0|||
150072931|NCT02557295|541407212|FG006|Overall Study|Withdrawal by Subject|15|||
150072932|NCT02557295|541407213|FG007|Overall Study|Withdrawal by Subject|1|||
150072933|NCT02557295|541407214|FG008|Overall Study|Withdrawal by Subject|3|||
150072934|NCT02557295|541407206|FG000|Overall Study|Disease Progression|0|||
150072935|NCT02557295|541407207|FG001|Overall Study|Disease Progression|0|||
150072936|NCT02557295|541407208|FG002|Overall Study|Disease Progression|0|||
150072937|NCT02557295|541407209|FG003|Overall Study|Disease Progression|0|||
150072938|NCT02557295|541407210|FG004|Overall Study|Disease Progression|0|||
150072939|NCT02557295|541407211|FG005|Overall Study|Disease Progression|0|||
150072940|NCT02557295|541407212|FG006|Overall Study|Disease Progression|1|||
150072941|NCT02557295|541407213|FG007|Overall Study|Disease Progression|0|||
150072942|NCT02557295|541407214|FG008|Overall Study|Disease Progression|0|||
150072943|NCT02557295|541407206|FG000|Overall Study|Lack of Efficacy|24|||
150072944|NCT02557295|541407207|FG001|Overall Study|Lack of Efficacy|1|||
150072945|NCT02557295|541407208|FG002|Overall Study|Lack of Efficacy|3|||
150072946|NCT02557295|541407209|FG003|Overall Study|Lack of Efficacy|0|||
150072947|NCT02557295|541407210|FG004|Overall Study|Lack of Efficacy|0|||
150072948|NCT02557295|541407211|FG005|Overall Study|Lack of Efficacy|0|||
150072949|NCT02557295|541407212|FG006|Overall Study|Lack of Efficacy|12|||
150072950|NCT02557295|541407213|FG007|Overall Study|Lack of Efficacy|1|||
150072951|NCT02557295|541407214|FG008|Overall Study|Lack of Efficacy|0|||
150072952|NCT02557295|541407206|FG000|Overall Study|Adverse Event|16|||
150072953|NCT02557295|541407207|FG001|Overall Study|Adverse Event|2|||
150072954|NCT02557295|541407208|FG002|Overall Study|Adverse Event|3|||
150072955|NCT02557295|541407209|FG003|Overall Study|Adverse Event|0|||
150072956|NCT02557295|541407210|FG004|Overall Study|Adverse Event|0|||
150072957|NCT02557295|541407211|FG005|Overall Study|Adverse Event|0|||
150072958|NCT02557295|541407212|FG006|Overall Study|Adverse Event|2|||
150072959|NCT02557295|541407213|FG007|Overall Study|Adverse Event|1|||
150072960|NCT02557295|541407214|FG008|Overall Study|Adverse Event|1|||
150072961|NCT02557295|541407206|FG000|Overall Study|Lost to Follow-up|4|||
150072962|NCT02557295|541407207|FG001|Overall Study|Lost to Follow-up|0|||
150072963|NCT02557295|541407208|FG002|Overall Study|Lost to Follow-up|0|||
150072964|NCT02557295|541407209|FG003|Overall Study|Lost to Follow-up|0|||
150072965|NCT02557295|541407210|FG004|Overall Study|Lost to Follow-up|0|||
150072966|NCT02557295|541407211|FG005|Overall Study|Lost to Follow-up|0|||
150072967|NCT02557295|541407212|FG006|Overall Study|Lost to Follow-up|9|||
150072968|NCT02557295|541407213|FG007|Overall Study|Lost to Follow-up|0|||
150072969|NCT02557295|541407214|FG008|Overall Study|Lost to Follow-up|0|||
150072970|NCT02557295|541407206|FG000|Overall Study|Study Close|54|||
150072971|NCT02557295|541407207|FG001|Overall Study|Study Close|3|||
150072972|NCT02557295|541407208|FG002|Overall Study|Study Close|5|||
150072973|NCT02557295|541407209|FG003|Overall Study|Study Close|3|||
150182289|NCT04143061|541804667|FG007|Overall Study|Protocol Deviation|5|||
150182290|NCT04143061|541804660|FG000|Overall Study|Withdrawal by Subject|2|||
150182291|NCT04143061|541804661|FG001|Overall Study|Withdrawal by Subject|0|||
150182292|NCT04143061|541804662|FG002|Overall Study|Withdrawal by Subject|0|||
150182293|NCT04143061|541804663|FG003|Overall Study|Withdrawal by Subject|0|||
150182294|NCT04143061|541804664|FG004|Overall Study|Withdrawal by Subject|0|||
150182295|NCT04143061|541804665|FG005|Overall Study|Withdrawal by Subject|1|||
150182296|NCT04143061|541804666|FG006|Overall Study|Withdrawal by Subject|0|||
150182297|NCT04143061|541804667|FG007|Overall Study|Withdrawal by Subject|0|||
150182298|NCT04143061|541804660|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150182299|NCT04143061|541804661|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150182300|NCT04143061|541804662|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150072974|NCT02557295|541407210|FG004|Overall Study|Study Close|0|||
150072975|NCT02557295|541407211|FG005|Overall Study|Study Close|0|||
150182301|NCT04143061|541804663|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
150072976|NCT02557295|541407212|FG006|Overall Study|Study Close|37|||
150072977|NCT02557295|541407213|FG007|Overall Study|Study Close|3|||
150182302|NCT04143061|541804664|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
150072978|NCT02557295|541407214|FG008|Overall Study|Study Close|19|||
150072979|NCT02557295|541407206|FG000|Overall Study|except for study close|4|||
150072980|NCT02557295|541407207|FG001|Overall Study|except for study close|0|||
150072981|NCT02557295|541407208|FG002|Overall Study|except for study close|0|||
150072982|NCT02557295|541407209|FG003|Overall Study|except for study close|0|||
150072983|NCT02557295|541407210|FG004|Overall Study|except for study close|0|||
150072984|NCT02557295|541407211|FG005|Overall Study|except for study close|0|||
150072985|NCT02557295|541407212|FG006|Overall Study|except for study close|5|||
150072986|NCT02557295|541407213|FG007|Overall Study|except for study close|1|||
150072987|NCT02557295|541407214|FG008|Overall Study|except for study close|0|||
150072988|NCT00589290|541407215|FG000|Overall Study|Withdrawal by Subject|1|||
150072989|NCT01067976|541407216|FG000|Overall Study|Study drug never administered|20|||
150072990|NCT01067976|541407216|FG000|Overall Study|Study prematurely discontinued|2|||
150072991|NCT00976677|541407217|FG000|Overall Study|Adverse Event|1|||
150072992|NCT00976677|541407218|FG001|Overall Study|Adverse Event|0|||
150072993|NCT00976677|541407217|FG000|Overall Study|Withdrawal by Subject|0|||
150072994|NCT00976677|541407218|FG001|Overall Study|Withdrawal by Subject|2|||
150072995|NCT00976677|541407217|FG000|Overall Study|Disease progression|1|||
150072996|NCT00976677|541407218|FG001|Overall Study|Disease progression|1|||
150072997|NCT00976677|541407217|FG000|Overall Study|Trial unblinded|2|||
150072998|NCT00976677|541407218|FG001|Overall Study|Trial unblinded|2|||
150072999|NCT00976677|541407217|FG000|Overall Study|Unknown/Missing|1|||
150073000|NCT00976677|541407218|FG001|Overall Study|Unknown/Missing|0|||
150073001|NCT03487549|541407223|FG000|Overall Study|Protocol Violation|0|||
150073002|NCT03487549|541407224|FG001|Overall Study|Protocol Violation|1|||
150073003|NCT03487549|541407223|FG000|Overall Study|Lost to Follow-up|2|||
150073004|NCT03487549|541407224|FG001|Overall Study|Lost to Follow-up|1|||
150073005|NCT03487549|541407223|FG000|Overall Study|Withdrawal by Subject|2|||
150073006|NCT03487549|541407224|FG001|Overall Study|Withdrawal by Subject|0|||
150073007|NCT00150709|541408841|FG000|Overall Study|Protocol Violation|7|||
150073008|NCT00150709|541408842|FG001|Overall Study|Protocol Violation|8|||
150073009|NCT00150709|541408843|FG002|Overall Study|Protocol Violation|3|||
150073010|NCT00150709|541408844|FG003|Overall Study|Protocol Violation|1|||
150073011|NCT00150709|541408841|FG000|Overall Study|Adverse Event|8|||
150073012|NCT00150709|541408842|FG001|Overall Study|Adverse Event|2|||
150073013|NCT00150709|541408843|FG002|Overall Study|Adverse Event|2|||
150073014|NCT00150709|541408844|FG003|Overall Study|Adverse Event|3|||
150073015|NCT00150709|541408841|FG000|Overall Study|Lack of Efficacy|6|||
150073016|NCT00150709|541408842|FG001|Overall Study|Lack of Efficacy|11|||
150073017|NCT00150709|541408843|FG002|Overall Study|Lack of Efficacy|9|||
150073018|NCT00150709|541408844|FG003|Overall Study|Lack of Efficacy|0|||
150073019|NCT00150709|541408841|FG000|Overall Study|Withdrawal by Subject|7|||
150073020|NCT00150709|541408842|FG001|Overall Study|Withdrawal by Subject|10|||
150073021|NCT00150709|541408843|FG002|Overall Study|Withdrawal by Subject|5|||
150073022|NCT00150709|541408844|FG003|Overall Study|Withdrawal by Subject|0|||
150073023|NCT00150709|541408841|FG000|Overall Study|Lost to Follow-up|3|||
150073024|NCT00150709|541408842|FG001|Overall Study|Lost to Follow-up|2|||
150073025|NCT00150709|541408843|FG002|Overall Study|Lost to Follow-up|0|||
150073026|NCT00150709|541408844|FG003|Overall Study|Lost to Follow-up|0|||
150073027|NCT00150709|541408841|FG000|Overall Study|Sponsor decision|0|||
150073028|NCT00150709|541408842|FG001|Overall Study|Sponsor decision|0|||
150073029|NCT00150709|541408843|FG002|Overall Study|Sponsor decision|0|||
150073030|NCT00150709|541408844|FG003|Overall Study|Sponsor decision|1|||
150073031|NCT00150709|541408841|FG000|Overall Study|Site/Investigator discontinued the study|5|||
150073032|NCT00150709|541408842|FG001|Overall Study|Site/Investigator discontinued the study|5|||
150073033|NCT00150709|541408843|FG002|Overall Study|Site/Investigator discontinued the study|2|||
150073034|NCT00150709|541408844|FG003|Overall Study|Site/Investigator discontinued the study|0|||
150073035|NCT00150709|541408841|FG000|Overall Study|Decision of parent(s)|1|||
150073036|NCT00150709|541408842|FG001|Overall Study|Decision of parent(s)|2|||
150073037|NCT00150709|541408843|FG002|Overall Study|Decision of parent(s)|0|||
150073038|NCT00150709|541408844|FG003|Overall Study|Decision of parent(s)|0|||
150073039|NCT00150709|541408841|FG000|Overall Study|Decision of parent(s) and investigator|3|||
150073040|NCT00150709|541408842|FG001|Overall Study|Decision of parent(s) and investigator|0|||
150073041|NCT00150709|541408843|FG002|Overall Study|Decision of parent(s) and investigator|0|||
150073042|NCT00150709|541408844|FG003|Overall Study|Decision of parent(s) and investigator|0|||
150073043|NCT00150709|541408841|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
150073044|NCT00150709|541408842|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
150182303|NCT04143061|541804665|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
150182304|NCT04143061|541804666|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
150182305|NCT04143061|541804667|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
150182306|NCT03602014|541804668|FG000|Overall Study|Lost to Follow-up|2|||
150182307|NCT03602014|541804669|FG001|Overall Study|Lost to Follow-up|0|||
150182308|NCT03602014|541804670|FG002|Overall Study|Lost to Follow-up|0|||
150182309|NCT04732494|541804673|FG000|Overall Study|Death|39|||
150182310|NCT04732494|541804674|FG001|Overall Study|Death|36|||
150182311|NCT04732494|541804673|FG000|Overall Study|Study Closed by Sponsor|20|||
150073045|NCT00150709|541408843|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
150073046|NCT00150709|541408844|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
150073047|NCT00150709|541408841|FG000|Overall Study|Investigator decision|1|||
150073048|NCT00150709|541408842|FG001|Overall Study|Investigator decision|0|||
150073049|NCT00150709|541408843|FG002|Overall Study|Investigator decision|0|||
150073050|NCT00150709|541408844|FG003|Overall Study|Investigator decision|1|||
150073051|NCT00150709|541408841|FG000|Overall Study|Subject relocated|2|||
150073052|NCT00150709|541408842|FG001|Overall Study|Subject relocated|2|||
150073053|NCT00150709|541408843|FG002|Overall Study|Subject relocated|1|||
150073054|NCT00150709|541408844|FG003|Overall Study|Subject relocated|0|||
150073055|NCT00150709|541408841|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
150073056|NCT00150709|541408842|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
150073057|NCT00150709|541408843|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
150073058|NCT00150709|541408844|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
150073059|NCT00150709|541408841|FG000|Overall Study|Convenience|0|||
150073060|NCT00150709|541408842|FG001|Overall Study|Convenience|1|||
150073061|NCT00150709|541408843|FG002|Overall Study|Convenience|0|||
150073062|NCT00150709|541408844|FG003|Overall Study|Convenience|0|||
150073063|NCT00150709|541408841|FG000|Overall Study|Subject entered new drug study|0|||
150073064|NCT00150709|541408842|FG001|Overall Study|Subject entered new drug study|1|||
150073065|NCT00150709|541408843|FG002|Overall Study|Subject entered new drug study|0|||
150073066|NCT00150709|541408844|FG003|Overall Study|Subject entered new drug study|0|||
150073067|NCT00150709|541408841|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
150073068|NCT00150709|541408842|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
150073069|NCT00150709|541408843|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
150073070|NCT00150709|541408844|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
150073071|NCT00150709|541408841|FG000|Overall Study|Lack of ease of swallowing|0|||
150073072|NCT00150709|541408842|FG001|Overall Study|Lack of ease of swallowing|1|||
150073073|NCT00150709|541408843|FG002|Overall Study|Lack of ease of swallowing|0|||
150073074|NCT00150709|541408844|FG003|Overall Study|Lack of ease of swallowing|0|||
150073075|NCT04092582|541408845|FG000|Overall Study|Death|1|||
150073076|NCT04092582|541408846|FG001|Overall Study|Death|1|||
150073077|NCT04092582|541408845|FG000|Overall Study|Withdrawal by Subject|4|||
150073078|NCT04092582|541408846|FG001|Overall Study|Withdrawal by Subject|1|||
150073079|NCT04092582|541408845|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
150073080|NCT04092582|541408846|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
150073081|NCT01313858|541408857|FG000|Overall Study|Premature Treatment Termination|251|||
150073082|NCT01313858|541408858|FG001|Overall Study|Premature Treatment Termination|219|||
150073083|NCT01313858|541408859|FG002|Overall Study|Premature Treatment Termination|191|||
150073084|NCT01313858|541408857|FG000|Overall Study|Lost to Follow-up|35|||
150073085|NCT01313858|541408858|FG001|Overall Study|Lost to Follow-up|51|||
150073086|NCT01313858|541408859|FG002|Overall Study|Lost to Follow-up|47|||
150073087|NCT01392443|541408866|FG000|Overall Study|Disease progression|30|||
150073088|NCT01392443|541408866|FG000|Overall Study|Adverse Event|24|||
150073089|NCT01392443|541408866|FG000|Overall Study|Death|7|||
150073090|NCT01392443|541408866|FG000|Overall Study|Withdrawal by Subject|5|||
150073091|NCT01392443|541408866|FG000|Overall Study|Lost to Follow-up|1|||
150073092|NCT01392443|541408866|FG000|Overall Study|Protocol Violation|1|||
150073093|NCT01626456|541408881|FG000|Overall Study|Withdrawal by Subject|21|||
150073094|NCT01626456|541408882|FG001|Overall Study|Withdrawal by Subject|46|||
150073095|NCT01626456|541408881|FG000|Overall Study|Adverse Event|2|||
150073096|NCT01626456|541408882|FG001|Overall Study|Adverse Event|27|||
150073097|NCT01626456|541408881|FG000|Overall Study|Lost to Follow-up|2|||
150073098|NCT01626456|541408882|FG001|Overall Study|Lost to Follow-up|27|||
150073099|NCT01626456|541408881|FG000|Overall Study|Lack of Efficacy|6|||
150073100|NCT01626456|541408882|FG001|Overall Study|Lack of Efficacy|7|||
150073101|NCT01626456|541408881|FG000|Overall Study|Physician Decision|1|||
150073102|NCT01626456|541408882|FG001|Overall Study|Physician Decision|4|||
150073103|NCT01626456|541408881|FG000|Overall Study|Protocol Violation|1|||
150073104|NCT01626456|541408882|FG001|Overall Study|Protocol Violation|1|||
150073105|NCT01626456|541408881|FG000|Overall Study|Site Closure|2|||
150073106|NCT01626456|541408882|FG001|Overall Study|Site Closure|3|||
150073107|NCT01626456|541408881|FG000|Overall Study|Incarceration|0|||
150073108|NCT01626456|541408882|FG001|Overall Study|Incarceration|2|||
150073109|NCT01816074|541408883|FG000|Phase 1|Time commitment issues|0|||
150073110|NCT01816074|541408884|FG001|Phase 1|Time commitment issues|0|||
150073111|NCT01816074|541408885|FG002|Phase 1|Time commitment issues|1|||
150073112|NCT01816074|541408886|FG003|Phase 1|Time commitment issues|0|||
150073113|NCT01816074|541408883|FG000|Phase 2|Time commitment Issues|0|||
150073114|NCT01816074|541408884|FG001|Phase 2|Time commitment Issues|2|||
150182312|NCT04732494|541804674|FG001|Overall Study|Study Closed by Sponsor|15|||
150073115|NCT01816074|541408885|FG002|Phase 2|Time commitment Issues|0|||
150073116|NCT01816074|541408886|FG003|Phase 2|Time commitment Issues|0|||
150073117|NCT01816074|541408883|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
150073118|NCT01816074|541408884|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
150073119|NCT01816074|541408885|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
150073120|NCT01816074|541408886|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
150073121|NCT01816074|541408883|FG000|Phase 2|Physician Decision|0|||
150073122|NCT01816074|541408884|FG001|Phase 2|Physician Decision|0|||
150073123|NCT01816074|541408885|FG002|Phase 2|Physician Decision|0|||
150073124|NCT01816074|541408886|FG003|Phase 2|Physician Decision|1|||
150073125|NCT01816074|541408883|FG000|Phase 2|Withdrawal by Subject|1|||
150073126|NCT01816074|541408884|FG001|Phase 2|Withdrawal by Subject|0|||
150073127|NCT01816074|541408885|FG002|Phase 2|Withdrawal by Subject|0|||
150073128|NCT01816074|541408886|FG003|Phase 2|Withdrawal by Subject|0|||
150073129|NCT03270644|541408892|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
150182313|NCT04732494|541804673|FG000|Overall Study|Withdrawal by Subject|2|||
150182314|NCT04732494|541804674|FG001|Overall Study|Withdrawal by Subject|7|||
150182315|NCT04732494|541804673|FG000|Overall Study|Lost to Follow-up|1|||
150182316|NCT04732494|541804674|FG001|Overall Study|Lost to Follow-up|5|||
150182317|NCT02728557|541804675|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
150182318|NCT02728557|541804676|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
150182319|NCT02728557|541804675|FG000|Overall Study|Dissatisfaction with research tasks|0|||
150182320|NCT02728557|541804676|FG001|Overall Study|Dissatisfaction with research tasks|1|||
150182321|NCT02728557|541804675|FG000|Overall Study|Scheduling or change in availability|1|||
150182322|NCT02728557|541804676|FG001|Overall Study|Scheduling or change in availability|1|||
150182323|NCT03416010|541804677|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
150182324|NCT03416010|541804678|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
150182325|NCT03416010|541804677|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
150182326|NCT03416010|541804678|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
150182327|NCT03416010|541804677|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
150182328|NCT03416010|541804678|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
150182329|NCT03416010|541804677|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
150182330|NCT03416010|541804678|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
150182331|NCT03416010|541804677|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
150182332|NCT03416010|541804678|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
150182333|NCT03416010|541804677|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
150182334|NCT03416010|541804678|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
150182335|NCT03416010|541804677|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
150182336|NCT03416010|541804678|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
150182337|NCT03948763|541804682|FG000|Overall Study|Sponsor's decision|0|||
150182338|NCT03948763|541804683|FG001|Overall Study|Sponsor's decision|2|||
150182339|NCT03948763|541804684|FG002|Overall Study|Sponsor's decision|6|||
150182340|NCT03948763|541804685|FG003|Overall Study|Sponsor's decision|4|||
150182341|NCT03948763|541804686|FG004|Overall Study|Sponsor's decision|0|||
150182342|NCT03948763|541804682|FG000|Overall Study|Physician Decision|0|||
150182343|NCT03948763|541804683|FG001|Overall Study|Physician Decision|0|||
150182344|NCT03948763|541804684|FG002|Overall Study|Physician Decision|1|||
150182345|NCT03948763|541804685|FG003|Overall Study|Physician Decision|0|||
150182346|NCT03948763|541804686|FG004|Overall Study|Physician Decision|0|||
150182347|NCT03948763|541804682|FG000|Overall Study|Lost to Follow-up|0|||
150182348|NCT03948763|541804683|FG001|Overall Study|Lost to Follow-up|0|||
150182349|NCT03948763|541804684|FG002|Overall Study|Lost to Follow-up|0|||
150182350|NCT03948763|541804685|FG003|Overall Study|Lost to Follow-up|0|||
150182351|NCT03948763|541804686|FG004|Overall Study|Lost to Follow-up|1|||
150182352|NCT03948763|541804682|FG000|Overall Study|Death|2|||
150182353|NCT03948763|541804683|FG001|Overall Study|Death|12|||
150182354|NCT03948763|541804684|FG002|Overall Study|Death|13|||
150182355|NCT03948763|541804685|FG003|Overall Study|Death|10|||
150182356|NCT03948763|541804686|FG004|Overall Study|Death|11|||
150182357|NCT03948763|541804682|FG000|Overall Study|Withdrawal by Subject|1|||
150182358|NCT03948763|541804683|FG001|Overall Study|Withdrawal by Subject|1|||
150182359|NCT03948763|541804684|FG002|Overall Study|Withdrawal by Subject|0|||
150182360|NCT03948763|541804685|FG003|Overall Study|Withdrawal by Subject|2|||
150182361|NCT03948763|541804686|FG004|Overall Study|Withdrawal by Subject|4|||
150182362|NCT06629454|541804690|FG000|Overall Study|Withdraw by Clinician Decision|1|||
150182363|NCT00505934|541804701|FG000|Overall Study|Adverse Event|1|||
150182364|NCT00505934|541804701|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
150182365|NCT00505934|541804701|FG000|Overall Study|Other: IV dose needed to be changed|1|||
150073130|NCT03270644|541408892|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
150073131|NCT00736944|541408897|FG000|Induction|Death|1|||
150073132|NCT00736944|541408897|FG000|Definitive Treatment|Physician Decision|1|||
150073133|NCT01426438|541408898|FG000|Overall Study|Lost to Follow-up|1|||
150182366|NCT02461628|541804704|FG000|Overall Study|Refused to complete survey|4|||
150182367|NCT02461628|541804705|FG001|Overall Study|Refused to complete survey|7|||
150182368|NCT02015520|541804706|FG000|Overall Study|Lack of Efficacy|1|||
150073134|NCT01426438|541408899|FG001|Overall Study|Lost to Follow-up|3|||
150182369|NCT02015520|541804707|FG001|Overall Study|Lack of Efficacy|0|||
150182370|NCT02015520|541804708|FG002|Overall Study|Lack of Efficacy|3|||
150073135|NCT01426438|541408898|FG000|Overall Study|Off study Treatment|9|||
150073136|NCT01426438|541408899|FG001|Overall Study|Off study Treatment|3|||
150073137|NCT01426438|541408898|FG000|Overall Study|Poor scan quality|3|||
150073138|NCT01426438|541408899|FG001|Overall Study|Poor scan quality|2|||
150073139|NCT01426438|541408898|FG000|Overall Study|Missed Scan|2|||
150073140|NCT01426438|541408899|FG001|Overall Study|Missed Scan|2|||
150073141|NCT01500031|541408900|FG000|Overall Study|Death|1|||
150073142|NCT01500031|541408900|FG000|Overall Study|Withdrawal by Subject|4|||
150073143|NCT03643575|541408901|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
150073144|NCT03643575|541408902|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
150073145|NCT03643575|541408903|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
150073146|NCT03643575|541408904|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
150073147|NCT03643575|541408905|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
150073148|NCT03643575|541408906|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
150073149|NCT03643575|541408901|FG000|Washout: 7 Days|Adverse Event|1|||
150073150|NCT03643575|541408902|FG001|Washout: 7 Days|Adverse Event|0|||
150073151|NCT03643575|541408903|FG002|Washout: 7 Days|Adverse Event|0|||
150073152|NCT03643575|541408904|FG003|Washout: 7 Days|Adverse Event|0|||
150073153|NCT03643575|541408905|FG004|Washout: 7 Days|Adverse Event|0|||
150073154|NCT03643575|541408906|FG005|Washout: 7 Days|Adverse Event|0|||
150073155|NCT03643575|541408901|FG000|Washout: 7 Days|Non compliance check in|0|||
150073156|NCT03643575|541408902|FG001|Washout: 7 Days|Non compliance check in|1|||
150073157|NCT03643575|541408903|FG002|Washout: 7 Days|Non compliance check in|0|||
150073158|NCT03643575|541408904|FG003|Washout: 7 Days|Non compliance check in|0|||
150073159|NCT03643575|541408905|FG004|Washout: 7 Days|Non compliance check in|0|||
150073160|NCT03643575|541408906|FG005|Washout: 7 Days|Non compliance check in|0|||
150073161|NCT00845858|541408907|FG000|Overall Study|Withdrawal by Subject|5|||
150073162|NCT00845858|541408908|FG001|Overall Study|Withdrawal by Subject|1|||
150073163|NCT00845858|541408909|FG002|Overall Study|Withdrawal by Subject|1|||
150073164|NCT00845858|541408907|FG000|Overall Study|Adverse Event|3|||
150073165|NCT00845858|541408908|FG001|Overall Study|Adverse Event|8|||
150073166|NCT00845858|541408909|FG002|Overall Study|Adverse Event|4|||
150073167|NCT00845858|541408907|FG000|Overall Study|Protocol Violation|0|||
150073168|NCT00845858|541408908|FG001|Overall Study|Protocol Violation|0|||
150073169|NCT00845858|541408909|FG002|Overall Study|Protocol Violation|1|||
150073170|NCT00845858|541408907|FG000|Overall Study|not eligible|0|||
150073171|NCT00845858|541408908|FG001|Overall Study|not eligible|3|||
150073172|NCT00845858|541408909|FG002|Overall Study|not eligible|2|||
150073173|NCT01927627|541408910|FG000|Overall Study|Adverse Event|3|||
150073174|NCT01927627|541408910|FG000|Overall Study|Lack of Efficacy|1|||
150073175|NCT01927627|541408910|FG000|Overall Study|Financial Concerns|1|||
150073176|NCT00910273|541408911|FG000|Overall Study|Lack of Efficacy|6|||
150073177|NCT00910273|541408912|FG001|Overall Study|Lack of Efficacy|9|||
150073178|NCT00910273|541408911|FG000|Overall Study|Adverse Event|1|||
150073179|NCT00910273|541408912|FG001|Overall Study|Adverse Event|1|||
150073180|NCT00910273|541408911|FG000|Overall Study|Withdrawal by Subject|1|||
150182371|NCT02015520|541804709|FG003|Overall Study|Lack of Efficacy|2|||
150182372|NCT02015520|541804706|FG000|Overall Study|Adverse Event|0|||
150182373|NCT02015520|541804707|FG001|Overall Study|Adverse Event|0|||
150182374|NCT02015520|541804708|FG002|Overall Study|Adverse Event|0|||
150182375|NCT02015520|541804709|FG003|Overall Study|Adverse Event|1|||
150182376|NCT02015520|541804706|FG000|Overall Study|Withdrawal by Subject|2|||
150073181|NCT00910273|541408912|FG001|Overall Study|Withdrawal by Subject|0|||
150073182|NCT00910273|541408911|FG000|Overall Study|Discontinuation of study by sponsor|8|||
150073183|NCT00910273|541408912|FG001|Overall Study|Discontinuation of study by sponsor|2|||
150073184|NCT00910273|541408911|FG000|Overall Study|Protocol Violation|1|||
150073185|NCT00910273|541408912|FG001|Overall Study|Protocol Violation|0|||
150073186|NCT00910273|541408911|FG000|Overall Study|Lost to Follow-up|1|||
150073187|NCT00910273|541408912|FG001|Overall Study|Lost to Follow-up|1|||
150073188|NCT00338104|541408915|FG000|Overall Study|Protocol Violation|2|||
150073189|NCT00338104|541408916|FG001|Overall Study|Protocol Violation|1|||
150073190|NCT00338104|541408917|FG002|Overall Study|Protocol Violation|3|||
150073191|NCT00633750|541408918|FG000|Overall Study|Adverse Event|2|||
150073192|NCT00633750|541408918|FG000|Overall Study|Withdrawal by Subject|3|||
150073193|NCT02362269|541408921|FG000|Overall Study|Moved|1|||
150073194|NCT02362269|541408922|FG001|Overall Study|Moved|0|||
150073195|NCT02362269|541408921|FG000|Overall Study|Lost to Follow-up|0|||
150073196|NCT02362269|541408922|FG001|Overall Study|Lost to Follow-up|6|||
150073197|NCT00423514|541408923|FG000|Overall Study|Ineligible|1|||
150073198|NCT00423514|541408924|FG001|Overall Study|Ineligible|0|||
150073199|NCT01361568|541408925|FG000|Overall Study|Adverse Event|0|||
150073200|NCT01361568|541408926|FG001|Overall Study|Adverse Event|0|||
150073201|NCT01361568|541408927|FG002|Overall Study|Adverse Event|0|||
150073202|NCT01361568|541408928|FG003|Overall Study|Adverse Event|0|||
150073203|NCT01361568|541408929|FG004|Overall Study|Adverse Event|1|||
150073204|NCT01361568|541408930|FG005|Overall Study|Adverse Event|0|||
150073205|NCT01361568|541408925|FG000|Overall Study|Physician Decision|0|||
150073206|NCT01361568|541408926|FG001|Overall Study|Physician Decision|0|||
150073207|NCT01361568|541408927|FG002|Overall Study|Physician Decision|0|||
150073208|NCT01361568|541408928|FG003|Overall Study|Physician Decision|0|||
150073209|NCT01361568|541408929|FG004|Overall Study|Physician Decision|0|||
150073210|NCT01361568|541408930|FG005|Overall Study|Physician Decision|1|||
150073211|NCT01361568|541408925|FG000|Overall Study|Withdrawal by Subject|2|||
150073212|NCT01361568|541408926|FG001|Overall Study|Withdrawal by Subject|1|||
150073213|NCT01361568|541408927|FG002|Overall Study|Withdrawal by Subject|0|||
150073214|NCT01361568|541408928|FG003|Overall Study|Withdrawal by Subject|0|||
150073215|NCT01361568|541408929|FG004|Overall Study|Withdrawal by Subject|0|||
150073216|NCT01361568|541408930|FG005|Overall Study|Withdrawal by Subject|1|||
150073217|NCT01254630|541408935|FG000|Overall Study|Adverse Event|36|||
150073218|NCT01254630|541408936|FG001|Overall Study|Adverse Event|15|||
150073219|NCT01254630|541408937|FG002|Overall Study|Adverse Event|40|||
150073220|NCT01254630|541408938|FG003|Overall Study|Adverse Event|8|||
150073221|NCT01254630|541408935|FG000|Overall Study|Death|461|||
150073222|NCT01254630|541408936|FG001|Overall Study|Death|151|||
150073223|NCT01254630|541408937|FG002|Overall Study|Death|478|||
150073224|NCT01254630|541408938|FG003|Overall Study|Death|139|||
150073225|NCT01254630|541408935|FG000|Overall Study|Lost to Follow-up|80|||
150073226|NCT01254630|541408936|FG001|Overall Study|Lost to Follow-up|26|||
150073227|NCT01254630|541408937|FG002|Overall Study|Lost to Follow-up|89|||
150073228|NCT01254630|541408938|FG003|Overall Study|Lost to Follow-up|32|||
150073229|NCT01254630|541408935|FG000|Overall Study|Physician Decision|24|||
150073230|NCT01254630|541408936|FG001|Overall Study|Physician Decision|8|||
150073231|NCT01254630|541408937|FG002|Overall Study|Physician Decision|16|||
150073232|NCT01254630|541408938|FG003|Overall Study|Physician Decision|7|||
150073233|NCT01254630|541408935|FG000|Overall Study|Withdrawal by Subject|201|||
150073234|NCT01254630|541408936|FG001|Overall Study|Withdrawal by Subject|94|||
150073235|NCT01254630|541408937|FG002|Overall Study|Withdrawal by Subject|188|||
150073236|NCT01254630|541408938|FG003|Overall Study|Withdrawal by Subject|89|||
150073237|NCT01254630|541408935|FG000|Overall Study|Study terminated by sponsor|0|||
150073238|NCT01254630|541408936|FG001|Overall Study|Study terminated by sponsor|994|||
150073239|NCT01254630|541408937|FG002|Overall Study|Study terminated by sponsor|0|||
150073240|NCT01254630|541408938|FG003|Overall Study|Study terminated by sponsor|1010|||
150073241|NCT01254630|541408935|FG000|Overall Study|Status not recorded|0|||
150073242|NCT01254630|541408936|FG001|Overall Study|Status not recorded|0|||
150073243|NCT01254630|541408937|FG002|Overall Study|Status not recorded|1|||
150073244|NCT01254630|541408938|FG003|Overall Study|Status not recorded|0|||
150073245|NCT02020577|541408939|FG000|Overall Study|Progressive disease|3|||
150073246|NCT02020577|541408940|FG001|Overall Study|Progressive disease|38|||
150073247|NCT02020577|541408939|FG000|Overall Study|Other AE or clinical progression|0|||
150073248|NCT02020577|541408940|FG001|Overall Study|Other AE or clinical progression|15|||
150073249|NCT02020577|541408939|FG000|Overall Study|Withdrawal by Subject|0|||
150073250|NCT02020577|541408940|FG001|Overall Study|Withdrawal by Subject|1|||
150073251|NCT02020577|541408939|FG000|Overall Study|Other than stated above|0|||
150073252|NCT02020577|541408940|FG001|Overall Study|Other than stated above|1|||
150073253|NCT01999868|541408941|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
150073254|NCT01999868|541408942|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
150073255|NCT01999868|541408943|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
150073256|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
150073257|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
150073258|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
150073259|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
150073260|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
150073261|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
150073262|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
150073263|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
150073264|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
150073265|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
150073266|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
150073267|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
150073268|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
150073269|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
150073270|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
150073271|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
150073272|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
150073273|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
150073274|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
150073275|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
150073276|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
150182377|NCT02015520|541804707|FG001|Overall Study|Withdrawal by Subject|2|||
150182378|NCT02015520|541804708|FG002|Overall Study|Withdrawal by Subject|1|||
150182379|NCT02015520|541804709|FG003|Overall Study|Withdrawal by Subject|0|||
150182380|NCT02015520|541804706|FG000|Overall Study|Death|1|||
150073277|NCT01999868|541408941|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
150073278|NCT01999868|541408942|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
150073279|NCT01999868|541408943|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
150073280|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
150073281|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
150073282|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
150073283|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
150073284|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
150073285|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
150073286|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
150073287|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
150073288|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
150073289|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
150073290|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
150073291|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
150073292|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
150073293|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
150073294|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
150073295|NCT01999868|541408941|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
150073296|NCT01999868|541408942|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
150073297|NCT01999868|541408943|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
150073298|NCT00761631|541408944|FG000|Overall Study|Parent/legal guardian request|8|||
150073299|NCT00761631|541408945|FG001|Overall Study|Parent/legal guardian request|3|||
150073300|NCT00761631|541408946|FG002|Overall Study|Parent/legal guardian request|8|||
150073301|NCT00761631|541408947|FG003|Overall Study|Parent/legal guardian request|0|||
150073302|NCT00761631|541408948|FG004|Overall Study|Parent/legal guardian request|5|||
150073303|NCT00761631|541408949|FG005|Overall Study|Parent/legal guardian request|0|||
150073304|NCT00761631|541408944|FG000|Overall Study|Lost to Follow-up|2|||
150073305|NCT00761631|541408945|FG001|Overall Study|Lost to Follow-up|4|||
150073306|NCT00761631|541408946|FG002|Overall Study|Lost to Follow-up|7|||
150073307|NCT00761631|541408947|FG003|Overall Study|Lost to Follow-up|1|||
150073308|NCT00761631|541408948|FG004|Overall Study|Lost to Follow-up|6|||
150073309|NCT00761631|541408949|FG005|Overall Study|Lost to Follow-up|1|||
150073310|NCT00761631|541408944|FG000|Overall Study|Protocol Violation|2|||
150073311|NCT00761631|541408945|FG001|Overall Study|Protocol Violation|0|||
150073312|NCT00761631|541408946|FG002|Overall Study|Protocol Violation|0|||
150073313|NCT00761631|541408947|FG003|Overall Study|Protocol Violation|1|||
150073314|NCT00761631|541408948|FG004|Overall Study|Protocol Violation|5|||
150073315|NCT00761631|541408949|FG005|Overall Study|Protocol Violation|1|||
150073316|NCT00761631|541408944|FG000|Overall Study|Randomized, not treated|1|||
150073317|NCT00761631|541408945|FG001|Overall Study|Randomized, not treated|0|||
150073318|NCT00761631|541408946|FG002|Overall Study|Randomized, not treated|0|||
150073319|NCT00761631|541408947|FG003|Overall Study|Randomized, not treated|0|||
150073320|NCT00761631|541408948|FG004|Overall Study|Randomized, not treated|0|||
150073321|NCT00761631|541408949|FG005|Overall Study|Randomized, not treated|0|||
150073322|NCT00761631|541408944|FG000|Overall Study|Failed to return|1|||
150073323|NCT00761631|541408945|FG001|Overall Study|Failed to return|0|||
150073324|NCT00761631|541408946|FG002|Overall Study|Failed to return|1|||
150073325|NCT00761631|541408947|FG003|Overall Study|Failed to return|1|||
150073326|NCT00761631|541408948|FG004|Overall Study|Failed to return|5|||
150073327|NCT00761631|541408949|FG005|Overall Study|Failed to return|2|||
150073328|NCT00761631|541408944|FG000|Overall Study|Physician Decision|1|||
150073329|NCT00761631|541408945|FG001|Overall Study|Physician Decision|0|||
150073330|NCT00761631|541408946|FG002|Overall Study|Physician Decision|0|||
150073331|NCT00761631|541408947|FG003|Overall Study|Physician Decision|0|||
150073332|NCT00761631|541408948|FG004|Overall Study|Physician Decision|0|||
150073333|NCT00761631|541408949|FG005|Overall Study|Physician Decision|0|||
150073334|NCT00761631|541408944|FG000|Overall Study|Other|0|||
150073335|NCT00761631|541408945|FG001|Overall Study|Other|0|||
150073336|NCT00761631|541408946|FG002|Overall Study|Other|0|||
150182381|NCT02015520|541804707|FG001|Overall Study|Death|0|||
150182382|NCT02015520|541804708|FG002|Overall Study|Death|0|||
150073337|NCT00761631|541408947|FG003|Overall Study|Other|0|||
150073338|NCT00761631|541408948|FG004|Overall Study|Other|1|||
150073339|NCT00761631|541408949|FG005|Overall Study|Other|1|||
150073340|NCT00289016|541408954|FG000|Overall Study|Disease Progression|29|||
150073341|NCT00289016|541408954|FG000|Overall Study|Death|2|||
150073342|NCT00289016|541408954|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
150073343|NCT00289016|541408954|FG000|Overall Study|Withdrawal by Subject|2|||
150073344|NCT00289016|541408954|FG000|Overall Study|Adverse Event|1|||
150073345|NCT00289016|541408954|FG000|Overall Study|Other|1|||
150073346|NCT00319501|541408955|FG000|Double-blind Period|Withdrawal by Subject|0|||
150073347|NCT00319501|541408956|FG001|Double-blind Period|Withdrawal by Subject|3|||
150073348|NCT00319501|541408955|FG000|Double-blind Period|Sponsor Request|1|||
150073349|NCT00319501|541408956|FG001|Double-blind Period|Sponsor Request|0|||
150073350|NCT00319501|541408955|FG000|Double-blind Period|Did not receive treatment|42|||
150073351|NCT00319501|541408956|FG001|Double-blind Period|Did not receive treatment|29|||
150073352|NCT00319501|541408955|FG000|Open-label Period|Adverse Event|5|||
150073353|NCT00319501|541408956|FG001|Open-label Period|Adverse Event|0|||
150073354|NCT00319501|541408955|FG000|Open-label Period|Protocol Violation|6|||
150073355|NCT00319501|541408956|FG001|Open-label Period|Protocol Violation|0|||
150073356|NCT00319501|541408955|FG000|Open-label Period|Withdrawal by Subject|38|||
150073357|NCT00319501|541408956|FG001|Open-label Period|Withdrawal by Subject|0|||
150073358|NCT00319501|541408955|FG000|Open-label Period|Principal Investigator decision|6|||
150073359|NCT00319501|541408956|FG001|Open-label Period|Principal Investigator decision|0|||
150073360|NCT00319501|541408955|FG000|Open-label Period|Sponsor request|12|||
150073361|NCT00319501|541408956|FG001|Open-label Period|Sponsor request|0|||
150073362|NCT00319501|541408955|FG000|Open-label Period|Lost to Follow-up|5|||
150073363|NCT00319501|541408956|FG001|Open-label Period|Lost to Follow-up|0|||
150073364|NCT00319501|541408955|FG000|Open-label Period|Did not receive treatment|33|||
150073365|NCT00319501|541408956|FG001|Open-label Period|Did not receive treatment|0|||
150073366|NCT00319501|541408955|FG000|Open-label Period|Other|11|||
150073367|NCT00319501|541408956|FG001|Open-label Period|Other|0|||
150073368|NCT00319501|541408955|FG000|Open-label Extension Period|Adverse Event|2|||
150073369|NCT00319501|541408956|FG001|Open-label Extension Period|Adverse Event|0|||
150073370|NCT00319501|541408955|FG000|Open-label Extension Period|Did not receive treatment|18|||
150073371|NCT00319501|541408956|FG001|Open-label Extension Period|Did not receive treatment|0|||
150073372|NCT00319501|541408955|FG000|Open-label Extension Period|Other|1|||
150073373|NCT00319501|541408956|FG001|Open-label Extension Period|Other|0|||
150073374|NCT00319501|541408955|FG000|Open-label Extension Period|Principal investigator decision|2|||
150073375|NCT00319501|541408956|FG001|Open-label Extension Period|Principal investigator decision|0|||
150073376|NCT00319501|541408955|FG000|Open-label Extension Period|Sponsor request|26|||
150073377|NCT00319501|541408956|FG001|Open-label Extension Period|Sponsor request|0|||
150073378|NCT00319501|541408955|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
150073379|NCT00319501|541408956|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
150073380|NCT00667875|541408958|FG000|Overall Study|Adverse Event|0|||
150073381|NCT00667875|541408959|FG001|Overall Study|Adverse Event|2|||
150073382|NCT00667875|541408960|FG002|Overall Study|Adverse Event|6|||
150073383|NCT00667875|541408958|FG000|Overall Study|Withdrawal by Subject|10|||
150073384|NCT00667875|541408959|FG001|Overall Study|Withdrawal by Subject|9|||
150073385|NCT00667875|541408960|FG002|Overall Study|Withdrawal by Subject|7|||
150073386|NCT00450255|541408961|FG000|Overall Study|Prior RFA ablation of liver|1|||
150073387|NCT03553927|541408964|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
150073388|NCT03553927|541408965|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
150073389|NCT03553927|541408964|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
150073390|NCT03553927|541408965|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
150073391|NCT01441180|541408966|FG000|Overall Study|Lost to Follow-up|1|||
150073392|NCT01441180|541408967|FG001|Overall Study|Lost to Follow-up|1|||
150073393|NCT01441180|541408968|FG002|Overall Study|Lost to Follow-up|1|||
150073394|NCT01441180|541408966|FG000|Overall Study|Discontinued|0|||
150073395|NCT01441180|541408967|FG001|Overall Study|Discontinued|0|||
150073396|NCT01441180|541408968|FG002|Overall Study|Discontinued|2|||
150073397|NCT01402011|541408969|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
150073398|NCT01402011|541408970|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
150073399|NCT01402011|541408971|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
150073400|NCT01402011|541408969|FG000|Active Treatment Period|Withdrawal by Subject|1|||
150073401|NCT01402011|541408970|FG001|Active Treatment Period|Withdrawal by Subject|3|||
150073402|NCT01402011|541408971|FG002|Active Treatment Period|Withdrawal by Subject|0|||
150073403|NCT01402011|541408969|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
150073404|NCT01402011|541408970|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
150073405|NCT01402011|541408971|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
150073406|NCT00142298|541408972|FG000|Overall Study|Adverse Event|10|||
150073407|NCT00142298|541408973|FG001|Overall Study|Adverse Event|10|||
150073408|NCT00142298|541408974|FG002|Overall Study|Adverse Event|1|||
150073409|NCT00142298|541408975|FG003|Overall Study|Adverse Event|5|||
150073410|NCT00142298|541408976|FG004|Overall Study|Adverse Event|2|||
150073411|NCT00142298|541408977|FG005|Overall Study|Adverse Event|2|||
150073412|NCT00142298|541408978|FG006|Overall Study|Adverse Event|0|||
150073413|NCT00142298|541408979|FG007|Overall Study|Adverse Event|0|||
150073414|NCT00142298|541408980|FG008|Overall Study|Adverse Event|0|||
150073415|NCT00142298|541408981|FG009|Overall Study|Adverse Event|0|||
150073416|NCT00142298|541408972|FG000|Overall Study|Clinical disease progression|1|||
150073417|NCT00142298|541408973|FG001|Overall Study|Clinical disease progression|0|||
150073418|NCT00142298|541408974|FG002|Overall Study|Clinical disease progression|0|||
150073419|NCT00142298|541408975|FG003|Overall Study|Clinical disease progression|0|||
150073420|NCT00142298|541408976|FG004|Overall Study|Clinical disease progression|0|||
150073421|NCT00142298|541408977|FG005|Overall Study|Clinical disease progression|0|||
150073422|NCT00142298|541408978|FG006|Overall Study|Clinical disease progression|0|||
150073423|NCT00142298|541408979|FG007|Overall Study|Clinical disease progression|0|||
150073424|NCT00142298|541408980|FG008|Overall Study|Clinical disease progression|0|||
150073425|NCT00142298|541408981|FG009|Overall Study|Clinical disease progression|0|||
150073426|NCT00142298|541408972|FG000|Overall Study|Death|1|||
150073427|NCT00142298|541408973|FG001|Overall Study|Death|1|||
150073428|NCT00142298|541408974|FG002|Overall Study|Death|1|||
150073429|NCT00142298|541408975|FG003|Overall Study|Death|0|||
150073430|NCT00142298|541408976|FG004|Overall Study|Death|0|||
150073431|NCT00142298|541408977|FG005|Overall Study|Death|6|||
150073432|NCT00142298|541408978|FG006|Overall Study|Death|0|||
150073433|NCT00142298|541408979|FG007|Overall Study|Death|0|||
150073434|NCT00142298|541408980|FG008|Overall Study|Death|0|||
150073435|NCT00142298|541408981|FG009|Overall Study|Death|0|||
150073436|NCT00142298|541408972|FG000|Overall Study|Lack of Efficacy|44|||
150073437|NCT00142298|541408973|FG001|Overall Study|Lack of Efficacy|62|||
150073438|NCT00142298|541408974|FG002|Overall Study|Lack of Efficacy|9|||
150073439|NCT00142298|541408975|FG003|Overall Study|Lack of Efficacy|12|||
150073440|NCT00142298|541408976|FG004|Overall Study|Lack of Efficacy|1|||
150073441|NCT00142298|541408977|FG005|Overall Study|Lack of Efficacy|0|||
150073442|NCT00142298|541408978|FG006|Overall Study|Lack of Efficacy|0|||
150073443|NCT00142298|541408979|FG007|Overall Study|Lack of Efficacy|1|||
150073444|NCT00142298|541408980|FG008|Overall Study|Lack of Efficacy|0|||
150073445|NCT00142298|541408981|FG009|Overall Study|Lack of Efficacy|0|||
150073446|NCT00142298|541408972|FG000|Overall Study|Non-compliance|15|||
150073447|NCT00142298|541408973|FG001|Overall Study|Non-compliance|13|||
150073448|NCT00142298|541408974|FG002|Overall Study|Non-compliance|0|||
150073449|NCT00142298|541408975|FG003|Overall Study|Non-compliance|6|||
150073450|NCT00142298|541408976|FG004|Overall Study|Non-compliance|1|||
150073451|NCT00142298|541408977|FG005|Overall Study|Non-compliance|0|||
150073452|NCT00142298|541408978|FG006|Overall Study|Non-compliance|0|||
150073453|NCT00142298|541408979|FG007|Overall Study|Non-compliance|3|||
150073454|NCT00142298|541408980|FG008|Overall Study|Non-compliance|3|||
150073455|NCT00142298|541408981|FG009|Overall Study|Non-compliance|0|||
150073456|NCT00142298|541408972|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
150073457|NCT00142298|541408973|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
150073458|NCT00142298|541408974|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
150073459|NCT00142298|541408975|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
150073460|NCT00142298|541408976|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
150073461|NCT00142298|541408977|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
150073462|NCT00142298|541408978|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
150073463|NCT00142298|541408979|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
150073464|NCT00142298|541408980|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
150073465|NCT00142298|541408981|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
150073466|NCT00142298|541408972|FG000|Overall Study|Pregnancy|4|||
150073467|NCT00142298|541408973|FG001|Overall Study|Pregnancy|4|||
150073468|NCT00142298|541408974|FG002|Overall Study|Pregnancy|2|||
150073469|NCT00142298|541408975|FG003|Overall Study|Pregnancy|3|||
150073470|NCT00142298|541408976|FG004|Overall Study|Pregnancy|0|||
150073471|NCT00142298|541408977|FG005|Overall Study|Pregnancy|0|||
150073472|NCT00142298|541408978|FG006|Overall Study|Pregnancy|0|||
150073473|NCT00142298|541408979|FG007|Overall Study|Pregnancy|0|||
150073474|NCT00142298|541408980|FG008|Overall Study|Pregnancy|1|||
150073475|NCT00142298|541408981|FG009|Overall Study|Pregnancy|0|||
150073476|NCT00142298|541408972|FG000|Overall Study|Virologic breakthrough|19|||
150073477|NCT00142298|541408973|FG001|Overall Study|Virologic breakthrough|23|||
150073478|NCT00142298|541408974|FG002|Overall Study|Virologic breakthrough|9|||
150073479|NCT00142298|541408975|FG003|Overall Study|Virologic breakthrough|7|||
150073480|NCT00142298|541408976|FG004|Overall Study|Virologic breakthrough|2|||
150073481|NCT00142298|541408977|FG005|Overall Study|Virologic breakthrough|3|||
150073482|NCT00142298|541408978|FG006|Overall Study|Virologic breakthrough|3|||
150073483|NCT00142298|541408979|FG007|Overall Study|Virologic breakthrough|0|||
150073484|NCT00142298|541408980|FG008|Overall Study|Virologic breakthrough|0|||
150073485|NCT00142298|541408981|FG009|Overall Study|Virologic breakthrough|0|||
150073486|NCT00142298|541408972|FG000|Overall Study|Other- not specified|0|||
150073487|NCT00142298|541408973|FG001|Overall Study|Other- not specified|3|||
150073488|NCT00142298|541408974|FG002|Overall Study|Other- not specified|0|||
150073489|NCT00142298|541408975|FG003|Overall Study|Other- not specified|1|||
150073490|NCT00142298|541408976|FG004|Overall Study|Other- not specified|0|||
150073491|NCT00142298|541408977|FG005|Overall Study|Other- not specified|0|||
150182383|NCT02015520|541804709|FG003|Overall Study|Death|0|||
150073492|NCT00142298|541408978|FG006|Overall Study|Other- not specified|0|||
150073493|NCT00142298|541408979|FG007|Overall Study|Other- not specified|0|||
150073494|NCT00142298|541408980|FG008|Overall Study|Other- not specified|0|||
150073495|NCT00142298|541408981|FG009|Overall Study|Other- not specified|0|||
150073496|NCT00142298|541408972|FG000|Overall Study|Lost to Follow-up|0|||
150073497|NCT00142298|541408973|FG001|Overall Study|Lost to Follow-up|0|||
150073498|NCT00142298|541408974|FG002|Overall Study|Lost to Follow-up|0|||
150073499|NCT00142298|541408975|FG003|Overall Study|Lost to Follow-up|0|||
150073500|NCT00142298|541408976|FG004|Overall Study|Lost to Follow-up|0|||
150073501|NCT00142298|541408977|FG005|Overall Study|Lost to Follow-up|0|||
150073502|NCT00142298|541408978|FG006|Overall Study|Lost to Follow-up|2|||
150073503|NCT00142298|541408979|FG007|Overall Study|Lost to Follow-up|0|||
150073504|NCT00142298|541408980|FG008|Overall Study|Lost to Follow-up|0|||
150073505|NCT00142298|541408981|FG009|Overall Study|Lost to Follow-up|0|||
150073506|NCT00142298|541408972|FG000|Overall Study|Treatment Failure|0|||
150073507|NCT00142298|541408973|FG001|Overall Study|Treatment Failure|0|||
150073508|NCT00142298|541408974|FG002|Overall Study|Treatment Failure|0|||
150073509|NCT00142298|541408975|FG003|Overall Study|Treatment Failure|0|||
150073510|NCT00142298|541408976|FG004|Overall Study|Treatment Failure|0|||
150073511|NCT00142298|541408977|FG005|Overall Study|Treatment Failure|2|||
150073512|NCT00142298|541408978|FG006|Overall Study|Treatment Failure|2|||
150073513|NCT00142298|541408979|FG007|Overall Study|Treatment Failure|0|||
150073514|NCT00142298|541408980|FG008|Overall Study|Treatment Failure|0|||
150073515|NCT00142298|541408981|FG009|Overall Study|Treatment Failure|0|||
150073516|NCT03360747|541408983|FG000|Overall Study|Voluntary Withdrawal|1|||
150073517|NCT01759511|541408984|FG000|Overall Study|Adverse Event|4|||
150073518|NCT01759511|541408984|FG000|Overall Study|Death|2|||
150073519|NCT01759511|541408984|FG000|Overall Study|Lack of Efficacy|2|||
150073520|NCT01759511|541408984|FG000|Overall Study|Physician Decision|1|||
150073521|NCT01759511|541408984|FG000|Overall Study|Progressive Disease|5|||
150073522|NCT01759511|541408984|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
150073523|NCT01759511|541408984|FG000|Overall Study|Study Terminated by Sponsor|13|||
150073524|NCT01759511|541408984|FG000|Overall Study|Withdrawal by Subject|3|||
150073525|NCT02569671|541408985|FG000|Overall Study|Lost to Follow-up|2|||
150073526|NCT02569671|541408986|FG001|Overall Study|Lost to Follow-up|1|||
150073527|NCT02569671|541408985|FG000|Overall Study|Withdrawal by Subject|1|||
150073528|NCT02569671|541408986|FG001|Overall Study|Withdrawal by Subject|3|||
150073529|NCT01757535|541408987|FG000|Overall Study|Disease Relapse|151|||
150073530|NCT01757535|541408988|FG001|Overall Study|Disease Relapse|181|||
150073531|NCT01757535|541408987|FG000|Overall Study|Other Reasons|28|||
150073532|NCT01757535|541408988|FG001|Overall Study|Other Reasons|27|||
150073533|NCT01757535|541408987|FG000|Overall Study|Adverse Event|31|||
150073534|NCT01757535|541408988|FG001|Overall Study|Adverse Event|11|||
150073535|NCT01757535|541408987|FG000|Overall Study|Withdrew Consent|19|||
150073536|NCT01757535|541408988|FG001|Overall Study|Withdrew Consent|13|||
150073537|NCT01757535|541408987|FG000|Overall Study|Physician Decision|7|||
150073538|NCT01757535|541408988|FG001|Overall Study|Physician Decision|0|||
150073539|NCT01757535|541408987|FG000|Overall Study|Death|2|||
150073540|NCT01757535|541408988|FG001|Overall Study|Death|2|||
150073541|NCT06238362|541408989|FG000|Overall Study|Insufficient total sleep time|1|||
150073542|NCT06238362|541408990|FG001|Overall Study|Insufficient total sleep time|0|||
150073543|NCT06238362|541408989|FG000|Overall Study|Inadequate signal quality|1|||
150073544|NCT06238362|541408990|FG001|Overall Study|Inadequate signal quality|0|||
150073545|NCT00531934|541410794|FG000|Overall Study|Adverse Event|4|||
150073546|NCT00531934|541410795|FG001|Overall Study|Adverse Event|8|||
150073547|NCT00531934|541410794|FG000|Overall Study|Progression|52|||
150073548|NCT00531934|541410795|FG001|Overall Study|Progression|42|||
150073549|NCT00531934|541410794|FG000|Overall Study|Death|7|||
150073550|NCT00531934|541410795|FG001|Overall Study|Death|10|||
150073551|NCT00531934|541410794|FG000|Overall Study|Withdrawal by Subject|1|||
150073552|NCT00531934|541410795|FG001|Overall Study|Withdrawal by Subject|1|||
150073553|NCT00531934|541410794|FG000|Overall Study|Other|2|||
150073554|NCT00531934|541410795|FG001|Overall Study|Other|2|||
150073555|NCT02323113|541410796|FG000|Overall Study|Adverse Event|3|||
150073556|NCT02323113|541410797|FG001|Overall Study|Adverse Event|3|||
150073557|NCT02323113|541410798|FG002|Overall Study|Adverse Event|2|||
150073558|NCT02323113|541410799|FG003|Overall Study|Adverse Event|5|||
150073559|NCT02323113|541410800|FG004|Overall Study|Adverse Event|8|||
150073560|NCT02323113|541410801|FG005|Overall Study|Adverse Event|3|||
150073561|NCT02323113|541410802|FG006|Overall Study|Adverse Event|6|||
150073562|NCT02323113|541410803|FG007|Overall Study|Adverse Event|0|||
150073563|NCT02323113|541410796|FG000|Overall Study|Progressive Disease|0|||
150073564|NCT02323113|541410797|FG001|Overall Study|Progressive Disease|1|||
150073565|NCT02323113|541410798|FG002|Overall Study|Progressive Disease|1|||
150073566|NCT02323113|541410799|FG003|Overall Study|Progressive Disease|0|||
150073567|NCT02323113|541410800|FG004|Overall Study|Progressive Disease|0|||
150073568|NCT02323113|541410801|FG005|Overall Study|Progressive Disease|3|||
150073569|NCT02323113|541410802|FG006|Overall Study|Progressive Disease|0|||
150073570|NCT02323113|541410803|FG007|Overall Study|Progressive Disease|0|||
150073571|NCT02323113|541410796|FG000|Overall Study|Symptomatic Deterioration|0|||
150073572|NCT02323113|541410797|FG001|Overall Study|Symptomatic Deterioration|0|||
150073573|NCT02323113|541410798|FG002|Overall Study|Symptomatic Deterioration|1|||
150073574|NCT02323113|541410799|FG003|Overall Study|Symptomatic Deterioration|0|||
150073575|NCT02323113|541410800|FG004|Overall Study|Symptomatic Deterioration|1|||
150073576|NCT02323113|541410801|FG005|Overall Study|Symptomatic Deterioration|0|||
150073577|NCT02323113|541410802|FG006|Overall Study|Symptomatic Deterioration|0|||
150073578|NCT02323113|541410803|FG007|Overall Study|Symptomatic Deterioration|0|||
150073579|NCT02323113|541410796|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
150073580|NCT02323113|541410797|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
150073581|NCT02323113|541410798|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
150073582|NCT02323113|541410799|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
150073583|NCT02323113|541410800|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
150073584|NCT02323113|541410801|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
150073585|NCT02323113|541410802|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
150073586|NCT02323113|541410803|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
150073587|NCT02323113|541410796|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073588|NCT02323113|541410797|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
150073589|NCT02323113|541410798|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073590|NCT02323113|541410799|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150182384|NCT02015520|541804706|FG000|Overall Study|Lost to Follow-up|0|||
150073591|NCT02323113|541410800|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073592|NCT02323113|541410801|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073593|NCT02323113|541410802|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073594|NCT02323113|541410803|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
150073595|NCT00316719|541410804|FG000|Overall Study|Adverse Event|0|||
150182385|NCT02015520|541804707|FG001|Overall Study|Lost to Follow-up|0|||
150182386|NCT02015520|541804708|FG002|Overall Study|Lost to Follow-up|1|||
150073596|NCT00316719|541410805|FG001|Overall Study|Adverse Event|6|||
150073597|NCT00316719|541410804|FG000|Overall Study|Consent withdrawn|2|||
150182387|NCT02015520|541804709|FG003|Overall Study|Lost to Follow-up|0|||
150073598|NCT00316719|541410805|FG001|Overall Study|Consent withdrawn|0|||
150073599|NCT02280304|541410808|FG000|Overall Study|Lost to Follow-up|7|||
150073600|NCT02280304|541410809|FG001|Overall Study|Lost to Follow-up|8|||
150073601|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Adverse Event|16|||
150073602|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Adverse Event|17|||
150073603|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Adverse Event|13|||
150073604|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Adverse Event|18|||
150073605|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Adverse Event|0|||
150073606|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Adverse Event|0|||
150073607|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Adverse Event|0|||
150073608|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Adverse Event|0|||
150073609|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
150073610|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
150073611|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
150073612|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
150073613|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
150073614|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
150073615|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
150073616|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
150073617|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
150073618|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
150073619|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
150073620|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
150073621|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
150073622|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
150073623|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
150073624|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
150073625|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
150073626|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
150073627|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
150073628|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
150073629|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
150073630|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
150073631|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
150073632|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
150073633|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
150073634|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
150073635|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
150073636|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
150073637|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
150073638|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
150073639|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
150073640|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
150073641|NCT02975336|541410810|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
150073642|NCT02975336|541410811|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
150073643|NCT02975336|541410812|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
150073644|NCT02975336|541410813|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
150073645|NCT02975336|541410814|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
150073646|NCT02975336|541410815|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
150073647|NCT02975336|541410816|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
150073648|NCT02975336|541410817|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
150073649|NCT02975336|541410810|FG000|LTE (104 Weeks)|Adverse Event|0|||
150073650|NCT02975336|541410811|FG001|LTE (104 Weeks)|Adverse Event|0|||
150073651|NCT02975336|541410812|FG002|LTE (104 Weeks)|Adverse Event|0|||
150073652|NCT02975336|541410813|FG003|LTE (104 Weeks)|Adverse Event|0|||
150073653|NCT02975336|541410814|FG004|LTE (104 Weeks)|Adverse Event|7|||
150073654|NCT02975336|541410815|FG005|LTE (104 Weeks)|Adverse Event|4|||
150073655|NCT02975336|541410816|FG006|LTE (104 Weeks)|Adverse Event|2|||
150073656|NCT02975336|541410817|FG007|LTE (104 Weeks)|Adverse Event|0|||
150073657|NCT02975336|541410810|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
150073658|NCT02975336|541410811|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
150073659|NCT02975336|541410812|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
150073660|NCT02975336|541410813|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
150073661|NCT02975336|541410814|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
150073662|NCT02975336|541410815|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
150073663|NCT02975336|541410816|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
150182388|NCT02015520|541804706|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
150073664|NCT02975336|541410817|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
150073665|NCT02975336|541410810|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
150073666|NCT02975336|541410811|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
150073667|NCT02975336|541410812|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
150073668|NCT02975336|541410813|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
150073669|NCT02975336|541410814|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
150073670|NCT02975336|541410815|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
150073671|NCT02975336|541410816|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
150073672|NCT02975336|541410817|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
150073673|NCT02975336|541410810|FG000|LTE (104 Weeks)|Other|0|||
150073674|NCT02975336|541410811|FG001|LTE (104 Weeks)|Other|0|||
150073675|NCT02975336|541410812|FG002|LTE (104 Weeks)|Other|0|||
150073676|NCT02975336|541410813|FG003|LTE (104 Weeks)|Other|0|||
150073677|NCT02975336|541410814|FG004|LTE (104 Weeks)|Other|55|||
150073678|NCT02975336|541410815|FG005|LTE (104 Weeks)|Other|63|||
150073679|NCT02975336|541410816|FG006|LTE (104 Weeks)|Other|76|||
150073680|NCT02975336|541410817|FG007|LTE (104 Weeks)|Other|72|||
150073681|NCT03689530|541410819|FG000|Overall Study|Withdrawal by Subject|53|||
150073682|NCT03689530|541410820|FG001|Overall Study|Withdrawal by Subject|16|||
150073683|NCT01977794|541410821|FG000|Overall Study|Adverse Event|2|||
150073684|NCT01977794|541410822|FG001|Overall Study|Adverse Event|2|||
150073685|NCT01977794|541410821|FG000|Overall Study|Lost to Follow-up|2|||
150073686|NCT01977794|541410822|FG001|Overall Study|Lost to Follow-up|1|||
150073687|NCT01977794|541410821|FG000|Overall Study|Protocol Violation|1|||
150073688|NCT01977794|541410822|FG001|Overall Study|Protocol Violation|0|||
150073689|NCT01977794|541410821|FG000|Overall Study|Death|1|||
150073690|NCT01977794|541410822|FG001|Overall Study|Death|1|||
150073691|NCT01977794|541410821|FG000|Overall Study|Withdrew consent|2|||
150073692|NCT01977794|541410822|FG001|Overall Study|Withdrew consent|1|||
150073693|NCT01977794|541410821|FG000|Overall Study|Other|0|||
150073694|NCT01977794|541410822|FG001|Overall Study|Other|1|||
150073695|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
150073696|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
150073697|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
150073698|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
150073699|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
150073700|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
150073701|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
150073702|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
150073703|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
150073704|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073705|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073706|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073707|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073708|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073709|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073710|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
150073711|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
150073712|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073713|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073714|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073715|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073716|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073717|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073718|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
150073719|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
150073720|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073721|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073722|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073723|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073724|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073725|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073726|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
150073727|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
150073728|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073729|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073730|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073731|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073732|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073733|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073734|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
150073735|NCT00533897|541410823|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
150073736|NCT00533897|541410824|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073737|NCT00533897|541410825|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073738|NCT00533897|541410826|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073739|NCT00533897|541410827|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073740|NCT00533897|541410828|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073741|NCT00533897|541410829|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073742|NCT00533897|541410830|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
150073743|NCT00533897|541410823|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073744|NCT00533897|541410824|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
150073745|NCT00533897|541410825|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
150073746|NCT00533897|541410826|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073747|NCT00533897|541410827|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073748|NCT00533897|541410828|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073749|NCT00533897|541410829|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073750|NCT00533897|541410830|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
150073751|NCT00533897|541410823|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073752|NCT00533897|541410824|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073753|NCT00533897|541410825|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
150073754|NCT00533897|541410826|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073755|NCT00533897|541410827|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073756|NCT00533897|541410828|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073757|NCT00533897|541410829|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073758|NCT00533897|541410830|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
150073759|NCT00533897|541410823|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073760|NCT00533897|541410824|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073761|NCT00533897|541410825|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073762|NCT00533897|541410826|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073763|NCT00533897|541410827|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073764|NCT00533897|541410828|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
150073765|NCT00533897|541410829|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073766|NCT00533897|541410830|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
150073767|NCT00533897|541410823|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073768|NCT00533897|541410824|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073769|NCT00533897|541410825|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073770|NCT00533897|541410826|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073771|NCT00533897|541410827|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073772|NCT00533897|541410828|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
150073773|NCT00533897|541410829|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073774|NCT00533897|541410830|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
150073775|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073776|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073777|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073778|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073779|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073780|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
150073781|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
150073782|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
150073783|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Death|0|||
150073784|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Death|0|||
150073785|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Death|0|||
150073786|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Death|0|||
150073787|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Death|0|||
150073788|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Death|0|||
150073789|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Death|1|||
150073790|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Death|3|||
150073791|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073792|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073793|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073794|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073795|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073796|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
150073797|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
150073798|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
150073799|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073800|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073801|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073802|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073803|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073804|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073805|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
150073806|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
150073807|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Adverse Event|0|||
150073808|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Adverse Event|0|||
150073809|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Adverse Event|0|||
150073810|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Adverse Event|0|||
150073811|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Adverse Event|0|||
150073812|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Adverse Event|0|||
150073813|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Adverse Event|2|||
150073814|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Adverse Event|5|||
150073815|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Pregnancy|0|||
150073816|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Pregnancy|0|||
150073817|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Pregnancy|0|||
150073818|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Pregnancy|0|||
150073819|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Pregnancy|0|||
150073820|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Pregnancy|0|||
150073821|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Pregnancy|0|||
150073822|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Pregnancy|2|||
150073823|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073824|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073825|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073826|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073827|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073828|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
150073829|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
150073830|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
150073831|NCT00533897|541410823|FG000|Long Term Extension (LTE)|Other|0|||
150073832|NCT00533897|541410824|FG001|Long Term Extension (LTE)|Other|0|||
150073833|NCT00533897|541410825|FG002|Long Term Extension (LTE)|Other|0|||
150073834|NCT00533897|541410826|FG003|Long Term Extension (LTE)|Other|0|||
150073835|NCT00533897|541410827|FG004|Long Term Extension (LTE)|Other|0|||
150073836|NCT00533897|541410828|FG005|Long Term Extension (LTE)|Other|0|||
150073837|NCT00533897|541410829|FG006|Long Term Extension (LTE)|Other|1|||
150073838|NCT00533897|541410830|FG007|Long Term Extension (LTE)|Other|6|||
150073839|NCT00713323|541410833|FG000|Overall Study|Adverse Event|75|||
150073840|NCT00713323|541410833|FG000|Overall Study|Withdrawal by Subject|15|||
150073841|NCT00713323|541410833|FG000|Overall Study|Lost to Follow-up|11|||
150073842|NCT00713323|541410833|FG000|Overall Study|Lack of Efficacy|36|||
150073843|NCT00713323|541410833|FG000|Overall Study|Low creatine clearance at screening|1|||
150073844|NCT00713323|541410833|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
150073845|NCT00713323|541410833|FG000|Overall Study|Surgery cured allodynic pain|1|||
150073846|NCT00713323|541410833|FG000|Overall Study|Pain free|1|||
150073847|NCT00713323|541410833|FG000|Overall Study|Non-compliance|1|||
150073848|NCT00713323|541410833|FG000|Overall Study|Pain resolved|1|||
150073849|NCT00713323|541410833|FG000|Overall Study|Subject travelling to USA|1|||
150073850|NCT00713323|541410833|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
150073851|NCT00713323|541410833|FG000|Overall Study|Treatment that may interact with Sativex|1|||
150073852|NCT00491075|541410835|FG000|Overall Study|Withdrawal by Subject|1|||
150073853|NCT00491075|541410835|FG000|Overall Study|Physician Decision|1|||
150073854|NCT01603355|541410836|FG000|Overall Study|Lack of Efficacy|2|||
150073855|NCT00246753|541410840|FG000|Overall Study|Withdrawal by Subject|2|||
150073856|NCT00246753|541410840|FG000|Overall Study|Physician Decision|2|||
150073857|NCT00246753|541410840|FG000|Overall Study|Adverse Event|2|||
150073858|NCT00246753|541410840|FG000|Overall Study|Unacceptable toxicity|2|||
150073859|NCT01303861|541410848|FG000|Overall Study|Lost to Follow-up|34|||
150073860|NCT01303861|541410849|FG001|Overall Study|Lost to Follow-up|14|||
150073861|NCT01303861|541410850|FG002|Overall Study|Lost to Follow-up|27|||
150073862|NCT01303861|541410851|FG003|Overall Study|Lost to Follow-up|31|||
150073863|NCT01303861|541410848|FG000|Overall Study|Lack of Efficacy|3|||
150073864|NCT01303861|541410849|FG001|Overall Study|Lack of Efficacy|2|||
150073865|NCT01303861|541410850|FG002|Overall Study|Lack of Efficacy|1|||
150073866|NCT01303861|541410851|FG003|Overall Study|Lack of Efficacy|0|||
150073867|NCT01303861|541410848|FG000|Overall Study|Withdrawal by Subject|16|||
150073868|NCT01303861|541410849|FG001|Overall Study|Withdrawal by Subject|8|||
150073869|NCT01303861|541410850|FG002|Overall Study|Withdrawal by Subject|8|||
150073870|NCT01303861|541410851|FG003|Overall Study|Withdrawal by Subject|23|||
150073871|NCT01303861|541410848|FG000|Overall Study|Adverse Event|4|||
150073872|NCT01303861|541410849|FG001|Overall Study|Adverse Event|1|||
150073873|NCT01303861|541410850|FG002|Overall Study|Adverse Event|0|||
150073874|NCT01303861|541410851|FG003|Overall Study|Adverse Event|5|||
150073875|NCT01303861|541410848|FG000|Overall Study|Pregnancy|1|||
150073876|NCT01303861|541410849|FG001|Overall Study|Pregnancy|0|||
150073877|NCT01303861|541410850|FG002|Overall Study|Pregnancy|0|||
150073878|NCT01303861|541410851|FG003|Overall Study|Pregnancy|0|||
150073879|NCT01868503|541410863|FG000|Overall Study|Withdrawal by Subject|1|||
150073880|NCT01868503|541410863|FG000|Overall Study|Protocol Violation|1|||
150073881|NCT03917459|541410865|FG000|Overall Study|Adverse Event|1|||
150073882|NCT03917459|541410866|FG001|Overall Study|Adverse Event|0|||
150073883|NCT03917459|541410865|FG000|Overall Study|Withdrawal by Subject|0|||
150073884|NCT03917459|541410866|FG001|Overall Study|Withdrawal by Subject|1|||
150073885|NCT00131508|541410869|FG000|Overall Study|Disease progression|0|||
150073886|NCT00131508|541410870|FG001|Overall Study|Disease progression|2|||
150073887|NCT00131508|541410869|FG000|Overall Study|Non-Compliance|2|||
150073888|NCT00131508|541410870|FG001|Overall Study|Non-Compliance|4|||
150073889|NCT00131508|541410869|FG000|Overall Study|Withdrawal by Subject|1|||
150073890|NCT00131508|541410870|FG001|Overall Study|Withdrawal by Subject|2|||
150073891|NCT01330030|541410871|FG000|Overall Study|Lost to Follow-up|16|||
150073892|NCT01330030|541410872|FG001|Overall Study|Lost to Follow-up|17|||
150073893|NCT02980783|541410873|FG000|Overall Study|Lost to Follow-up|1|||
150073894|NCT00850070|541410874|FG000|Overall Study|Lack of Efficacy|1|||
150073895|NCT00850070|541410875|FG001|Overall Study|Lack of Efficacy|1|||
150073896|NCT00850070|541410874|FG000|Overall Study|Adverse Event|2|||
150073897|NCT00850070|541410875|FG001|Overall Study|Adverse Event|0|||
150073898|NCT05047770|541410876|FG000|Overall Study|Withdrawal by Subject|15|||
150073899|NCT05047770|541410877|FG001|Overall Study|Withdrawal by Subject|10|||
150073900|NCT05047770|541410878|FG002|Overall Study|Withdrawal by Subject|6|||
150073901|NCT05047770|541410879|FG003|Overall Study|Withdrawal by Subject|12|||
150073902|NCT05047770|541410876|FG000|Overall Study|Lost to Follow-up|7|||
150073903|NCT05047770|541410877|FG001|Overall Study|Lost to Follow-up|5|||
150073904|NCT05047770|541410878|FG002|Overall Study|Lost to Follow-up|12|||
150073905|NCT05047770|541410879|FG003|Overall Study|Lost to Follow-up|13|||
150073906|NCT05047770|541410876|FG000|Overall Study|Other|1|||
150073907|NCT05047770|541410877|FG001|Overall Study|Other|0|||
150073908|NCT05047770|541410878|FG002|Overall Study|Other|1|||
150073909|NCT05047770|541410879|FG003|Overall Study|Other|0|||
150073910|NCT03758443|541410880|FG000|Induction Period|Adverse Event|2|||
150073911|NCT03758443|541410881|FG001|Induction Period|Adverse Event|4|||
150073912|NCT03758443|541410882|FG002|Induction Period|Adverse Event|2|||
150073913|NCT03758443|541410883|FG003|Induction Period|Adverse Event|3|||
150073914|NCT03758443|541410880|FG000|Induction Period|Physician Decision|1|||
150073915|NCT03758443|541410881|FG001|Induction Period|Physician Decision|1|||
150073916|NCT03758443|541410882|FG002|Induction Period|Physician Decision|3|||
150073917|NCT03758443|541410883|FG003|Induction Period|Physician Decision|0|||
150073918|NCT03758443|541410880|FG000|Induction Period|Protocol Violation|0|||
150073919|NCT03758443|541410881|FG001|Induction Period|Protocol Violation|0|||
150073920|NCT03758443|541410882|FG002|Induction Period|Protocol Violation|0|||
150073921|NCT03758443|541410883|FG003|Induction Period|Protocol Violation|1|||
150073922|NCT03758443|541410880|FG000|Induction Period|Withdrawal by Subject|3|||
150073923|NCT03758443|541410881|FG001|Induction Period|Withdrawal by Subject|2|||
150073924|NCT03758443|541410882|FG002|Induction Period|Withdrawal by Subject|2|||
150073925|NCT03758443|541410883|FG003|Induction Period|Withdrawal by Subject|4|||
150073926|NCT03758443|541410880|FG000|Extended Induction Period|Adverse Event|1|||
150073927|NCT03758443|541410881|FG001|Extended Induction Period|Adverse Event|1|||
150073928|NCT03758443|541410882|FG002|Extended Induction Period|Adverse Event|0|||
150073929|NCT03758443|541410883|FG003|Extended Induction Period|Adverse Event|1|||
150073930|NCT03758443|541410880|FG000|Extended Induction Period|Lost to Follow-up|1|||
150073931|NCT03758443|541410881|FG001|Extended Induction Period|Lost to Follow-up|0|||
150073932|NCT03758443|541410882|FG002|Extended Induction Period|Lost to Follow-up|0|||
150073933|NCT03758443|541410883|FG003|Extended Induction Period|Lost to Follow-up|0|||
150073934|NCT03758443|541410880|FG000|Extended Induction Period|Physician Decision|2|||
150073935|NCT03758443|541410881|FG001|Extended Induction Period|Physician Decision|1|||
150073936|NCT03758443|541410882|FG002|Extended Induction Period|Physician Decision|2|||
150073937|NCT03758443|541410883|FG003|Extended Induction Period|Physician Decision|2|||
150073938|NCT03758443|541410880|FG000|Extended Induction Period|Protocol Violation|0|||
150073939|NCT03758443|541410881|FG001|Extended Induction Period|Protocol Violation|0|||
150073940|NCT03758443|541410882|FG002|Extended Induction Period|Protocol Violation|0|||
150073941|NCT03758443|541410883|FG003|Extended Induction Period|Protocol Violation|1|||
150073942|NCT03758443|541410880|FG000|Extended Induction Period|Withdrawal by Subject|8|||
150073943|NCT03758443|541410881|FG001|Extended Induction Period|Withdrawal by Subject|1|||
150073944|NCT03758443|541410882|FG002|Extended Induction Period|Withdrawal by Subject|7|||
150073945|NCT03758443|541410883|FG003|Extended Induction Period|Withdrawal by Subject|3|||
150073946|NCT03758443|541410880|FG000|Extended Induction Period|Miscellaneous|1|||
150073947|NCT03758443|541410881|FG001|Extended Induction Period|Miscellaneous|0|||
150073948|NCT03758443|541410882|FG002|Extended Induction Period|Miscellaneous|0|||
150073949|NCT03758443|541410883|FG003|Extended Induction Period|Miscellaneous|0|||
150073950|NCT03758443|541410880|FG000|Maintenance Period|Adverse Event|1|||
150073951|NCT03758443|541410881|FG001|Maintenance Period|Adverse Event|2|||
150073952|NCT03758443|541410882|FG002|Maintenance Period|Adverse Event|0|||
150073953|NCT03758443|541410883|FG003|Maintenance Period|Adverse Event|0|||
150073954|NCT03758443|541410880|FG000|Maintenance Period|Lost to Follow-up|0|||
150073955|NCT03758443|541410881|FG001|Maintenance Period|Lost to Follow-up|0|||
150073956|NCT03758443|541410882|FG002|Maintenance Period|Lost to Follow-up|0|||
150073957|NCT03758443|541410883|FG003|Maintenance Period|Lost to Follow-up|1|||
150073958|NCT03758443|541410880|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
150073959|NCT03758443|541410881|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
150073960|NCT03758443|541410882|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
150073961|NCT03758443|541410883|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
150073962|NCT03758443|541410880|FG000|Maintenance Period|Protocol Violation|0|||
150073963|NCT03758443|541410881|FG001|Maintenance Period|Protocol Violation|1|||
150073964|NCT03758443|541410882|FG002|Maintenance Period|Protocol Violation|0|||
150073965|NCT03758443|541410883|FG003|Maintenance Period|Protocol Violation|0|||
150073966|NCT03758443|541410880|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
150073967|NCT03758443|541410881|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
150073968|NCT03758443|541410882|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
150073969|NCT03758443|541410883|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
150073970|NCT03758443|541410880|FG000|Maintenance Period|Withdrawal by Subject|1|||
150073971|NCT03758443|541410881|FG001|Maintenance Period|Withdrawal by Subject|0|||
150073972|NCT03758443|541410882|FG002|Maintenance Period|Withdrawal by Subject|1|||
150073973|NCT03758443|541410883|FG003|Maintenance Period|Withdrawal by Subject|1|||
150073974|NCT03758443|541410880|FG000|Maintenance Period|Miscellaneous|0|||
150073975|NCT03758443|541410881|FG001|Maintenance Period|Miscellaneous|0|||
150073976|NCT03758443|541410882|FG002|Maintenance Period|Miscellaneous|1|||
150073977|NCT03758443|541410883|FG003|Maintenance Period|Miscellaneous|0|||
150073978|NCT01522248|541410884|FG000|Overall Study|Lost to Follow-up|1|||
150073979|NCT01522248|541410885|FG001|Overall Study|Lost to Follow-up|0|||
150073980|NCT00696800|541410887|FG000|Overall Study|Adverse Event|16|||
150073981|NCT00696800|541410888|FG001|Overall Study|Adverse Event|3|||
150073982|NCT00696800|541410887|FG000|Overall Study|Insufficient compliance with medication|2|||
150073983|NCT00696800|541410888|FG001|Overall Study|Insufficient compliance with medication|1|||
150073984|NCT00696800|541410887|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
150073985|NCT00696800|541410888|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
150073986|NCT00696800|541410887|FG000|Overall Study|Insufficient ovarian response|4|||
150073987|NCT00696800|541410888|FG001|Overall Study|Insufficient ovarian response|1|||
150073988|NCT00696800|541410887|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
150073989|NCT00696800|541410888|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
150073990|NCT00696800|541410887|FG000|Overall Study|Too high ovarian response|6|||
150073991|NCT00696800|541410888|FG001|Overall Study|Too high ovarian response|1|||
150073992|NCT00696800|541410887|FG000|Overall Study|No/too few/bad quality oocytes|4|||
150073993|NCT00696800|541410888|FG001|Overall Study|No/too few/bad quality oocytes|3|||
150073994|NCT00696800|541410887|FG000|Overall Study|No/abnormal fertilization|11|||
150073995|NCT00696800|541410888|FG001|Overall Study|No/abnormal fertilization|13|||
150073996|NCT00696800|541410887|FG000|Overall Study|No/too few/bad quality embryos|24|||
150073997|NCT00696800|541410888|FG001|Overall Study|No/too few/bad quality embryos|18|||
150073998|NCT00696800|541410887|FG000|Overall Study|Other Reasons|5|||
150073999|NCT00696800|541410888|FG001|Overall Study|Other Reasons|3|||
150074000|NCT00696800|541410887|FG000|Overall Study|Not treated|1|||
150074001|NCT00696800|541410888|FG001|Overall Study|Not treated|2|||
150074002|NCT05224141|541410889|FG000|Overall Study|Ongoing|75|||
150074003|NCT05224141|541410890|FG001|Overall Study|Ongoing|88|||
150074004|NCT05224141|541410889|FG000|Overall Study|Withdrawal by Subject|2|||
150074005|NCT05224141|541410890|FG001|Overall Study|Withdrawal by Subject|4|||
150074006|NCT05224141|541410889|FG000|Overall Study|Death|153|||
150074007|NCT05224141|541410890|FG001|Overall Study|Death|138|||
150074008|NCT00199875|541410903|FG000|Overall Study|Withdrawal by Subject|0|||
150074009|NCT00199875|541410904|FG001|Overall Study|Withdrawal by Subject|0|||
150074010|NCT00199875|541410905|FG002|Overall Study|Withdrawal by Subject|0|||
150074011|NCT00199875|541410906|FG003|Overall Study|Withdrawal by Subject|0|||
150074012|NCT00199875|541410907|FG004|Overall Study|Withdrawal by Subject|1|||
150074013|NCT03469934|541410910|FG000|Overall Study|Withdrawal by Subject|0|||
150074014|NCT03469934|541410911|FG001|Overall Study|Withdrawal by Subject|1|||
150074015|NCT01691898|541410914|FG000|Overall Study|Death|34|||
150074016|NCT01691898|541410915|FG001|Overall Study|Death|32|||
150074017|NCT01691898|541410916|FG002|Overall Study|Death|6|||
150074018|NCT01691898|541410917|FG003|Overall Study|Death|3|||
150074019|NCT01691898|541410918|FG004|Overall Study|Death|8|||
150074020|NCT01691898|541410919|FG005|Overall Study|Death|31|||
150074021|NCT01691898|541410914|FG000|Overall Study|Adverse Event|0|||
150074022|NCT01691898|541410915|FG001|Overall Study|Adverse Event|1|||
150074023|NCT01691898|541410916|FG002|Overall Study|Adverse Event|0|||
150074024|NCT01691898|541410917|FG003|Overall Study|Adverse Event|1|||
150074025|NCT01691898|541410918|FG004|Overall Study|Adverse Event|1|||
150182389|NCT02015520|541804707|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
150074026|NCT01691898|541410919|FG005|Overall Study|Adverse Event|0|||
150074027|NCT01691898|541410914|FG000|Overall Study|Progression of Disease|1|||
150074028|NCT01691898|541410915|FG001|Overall Study|Progression of Disease|2|||
150182390|NCT02015520|541804708|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
150074029|NCT01691898|541410916|FG002|Overall Study|Progression of Disease|1|||
150074030|NCT01691898|541410917|FG003|Overall Study|Progression of Disease|0|||
150074031|NCT01691898|541410918|FG004|Overall Study|Progression of Disease|0|||
150074032|NCT01691898|541410919|FG005|Overall Study|Progression of Disease|1|||
150074033|NCT01691898|541410914|FG000|Overall Study|Lost to Follow-up|3|||
150074034|NCT01691898|541410915|FG001|Overall Study|Lost to Follow-up|1|||
150074035|NCT01691898|541410916|FG002|Overall Study|Lost to Follow-up|0|||
150074036|NCT01691898|541410917|FG003|Overall Study|Lost to Follow-up|0|||
150074037|NCT01691898|541410918|FG004|Overall Study|Lost to Follow-up|1|||
150074038|NCT01691898|541410919|FG005|Overall Study|Lost to Follow-up|0|||
150074039|NCT01691898|541410914|FG000|Overall Study|Withdrawal by Subject|9|||
150074040|NCT01691898|541410915|FG001|Overall Study|Withdrawal by Subject|8|||
150074041|NCT01691898|541410916|FG002|Overall Study|Withdrawal by Subject|2|||
150074042|NCT01691898|541410917|FG003|Overall Study|Withdrawal by Subject|1|||
150074043|NCT01691898|541410918|FG004|Overall Study|Withdrawal by Subject|3|||
150074044|NCT01691898|541410919|FG005|Overall Study|Withdrawal by Subject|3|||
150074045|NCT01691898|541410914|FG000|Overall Study|Non-Compliance|0|||
150074046|NCT01691898|541410915|FG001|Overall Study|Non-Compliance|0|||
150074047|NCT01691898|541410916|FG002|Overall Study|Non-Compliance|0|||
150074048|NCT01691898|541410917|FG003|Overall Study|Non-Compliance|0|||
150074049|NCT01691898|541410918|FG004|Overall Study|Non-Compliance|1|||
150074050|NCT01691898|541410919|FG005|Overall Study|Non-Compliance|0|||
150074051|NCT01013350|541410920|FG000|Overall Study|Lost to Follow-up|15|||
150074052|NCT01013350|541410921|FG001|Overall Study|Lost to Follow-up|95|||
150074053|NCT01013350|541410920|FG000|Overall Study|Adverse Event|0|||
150074054|NCT01013350|541410921|FG001|Overall Study|Adverse Event|1|||
150074055|NCT01013350|541410920|FG000|Overall Study|Physician Decision|4|||
150074056|NCT01013350|541410921|FG001|Overall Study|Physician Decision|20|||
150074057|NCT01013350|541410920|FG000|Overall Study|Withdrawal by Subject|15|||
150074058|NCT01013350|541410921|FG001|Overall Study|Withdrawal by Subject|38|||
150074059|NCT01013350|541410920|FG000|Overall Study|Death|3|||
150074060|NCT01013350|541410921|FG001|Overall Study|Death|5|||
150074061|NCT01013350|541410920|FG000|Overall Study|Participant entered interventional study|0|||
150074062|NCT01013350|541410921|FG001|Overall Study|Participant entered interventional study|8|||
150074063|NCT01013350|541410920|FG000|Overall Study|Other|1|||
150074064|NCT01013350|541410921|FG001|Overall Study|Other|25|||
150074065|NCT02019277|541410928|FG000|Overall Study|Withdrawal by Subject|3|||
150074066|NCT02019277|541410928|FG000|Overall Study|Death|7|||
150074067|NCT02019277|541410928|FG000|Overall Study|Did no Cooperate|1|||
150074068|NCT02019277|541410928|FG000|Overall Study|Adverse Event|1|||
150074069|NCT04738734|541410929|FG000|Overall Study|Withdrawal by Subject|2|||
150074070|NCT04738734|541410930|FG001|Overall Study|Withdrawal by Subject|4|||
150074071|NCT04738734|541410929|FG000|Overall Study|Lost to Follow-up|5|||
150074072|NCT04738734|541410930|FG001|Overall Study|Lost to Follow-up|2|||
150074073|NCT04738734|541410929|FG000|Overall Study|Physician Decision|0|||
150074074|NCT04738734|541410930|FG001|Overall Study|Physician Decision|1|||
150074075|NCT04738734|541410929|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
150074076|NCT04738734|541410930|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
150074077|NCT03212690|541410933|FG000|Overall Study|Protocol Violation|1|||
150074078|NCT01297920|541410934|FG000|Overall Study|Adverse Event|42|||
150074079|NCT01297920|541410935|FG001|Overall Study|Adverse Event|10|||
150074080|NCT01297920|541410936|FG002|Overall Study|Adverse Event|38|||
150074081|NCT01297920|541410934|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
150074082|NCT01297920|541410935|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
150074083|NCT01297920|541410936|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
150074084|NCT01297920|541410934|FG000|Overall Study|Noncompliance|1|||
150074085|NCT01297920|541410935|FG001|Overall Study|Noncompliance|0|||
150074086|NCT01297920|541410936|FG002|Overall Study|Noncompliance|0|||
150074087|NCT01297920|541410934|FG000|Overall Study|Protocol Violation|1|||
150074088|NCT01297920|541410935|FG001|Overall Study|Protocol Violation|3|||
150074089|NCT01297920|541410936|FG002|Overall Study|Protocol Violation|0|||
150074090|NCT01297920|541410934|FG000|Overall Study|Inadequate Control of IOP|7|||
150074091|NCT01297920|541410935|FG001|Overall Study|Inadequate Control of IOP|9|||
150074092|NCT01297920|541410936|FG002|Overall Study|Inadequate Control of IOP|17|||
150074093|NCT01297920|541410934|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
150074094|NCT01297920|541410935|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
150074095|NCT01297920|541410936|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
150074096|NCT00474760|541410937|FG000|Overall Study|Death|0|||
150074097|NCT00474760|541410938|FG001|Overall Study|Death|0|||
150074098|NCT00474760|541410939|FG002|Overall Study|Death|0|||
150074099|NCT00474760|541410940|FG003|Overall Study|Death|0|||
150074100|NCT00474760|541410941|FG004|Overall Study|Death|2|||
150074101|NCT00474760|541410942|FG005|Overall Study|Death|0|||
150074102|NCT00474760|541410943|FG006|Overall Study|Death|0|||
150074103|NCT00474760|541410937|FG000|Overall Study|Adverse Event|0|||
150074104|NCT00474760|541410938|FG001|Overall Study|Adverse Event|0|||
150074105|NCT00474760|541410939|FG002|Overall Study|Adverse Event|0|||
150074106|NCT00474760|541410940|FG003|Overall Study|Adverse Event|0|||
150074107|NCT00474760|541410941|FG004|Overall Study|Adverse Event|1|||
150074108|NCT00474760|541410942|FG005|Overall Study|Adverse Event|7|||
150074109|NCT00474760|541410943|FG006|Overall Study|Adverse Event|0|||
150074110|NCT00474760|541410937|FG000|Overall Study|Laboratory abnormality|0|||
150074111|NCT00474760|541410938|FG001|Overall Study|Laboratory abnormality|0|||
150074112|NCT00474760|541410939|FG002|Overall Study|Laboratory abnormality|0|||
150074113|NCT00474760|541410940|FG003|Overall Study|Laboratory abnormality|0|||
150074114|NCT00474760|541410941|FG004|Overall Study|Laboratory abnormality|0|||
150074115|NCT00474760|541410942|FG005|Overall Study|Laboratory abnormality|1|||
150074116|NCT00474760|541410943|FG006|Overall Study|Laboratory abnormality|0|||
150074117|NCT00474760|541410937|FG000|Overall Study|Withdrawal by Subject|0|||
150074118|NCT00474760|541410938|FG001|Overall Study|Withdrawal by Subject|0|||
150074119|NCT00474760|541410939|FG002|Overall Study|Withdrawal by Subject|0|||
150074120|NCT00474760|541410940|FG003|Overall Study|Withdrawal by Subject|1|||
150074121|NCT00474760|541410941|FG004|Overall Study|Withdrawal by Subject|0|||
150074122|NCT00474760|541410942|FG005|Overall Study|Withdrawal by Subject|1|||
150074123|NCT00474760|541410943|FG006|Overall Study|Withdrawal by Subject|1|||
150074124|NCT00474760|541410937|FG000|Overall Study|Other|0|||
150074125|NCT00474760|541410938|FG001|Overall Study|Other|1|||
150074126|NCT00474760|541410939|FG002|Overall Study|Other|0|||
150074127|NCT00474760|541410940|FG003|Overall Study|Other|0|||
150074128|NCT00474760|541410941|FG004|Overall Study|Other|1|||
150074129|NCT00474760|541410942|FG005|Overall Study|Other|0|||
150074130|NCT00474760|541410943|FG006|Overall Study|Other|0|||
150074131|NCT00474760|541410937|FG000|Overall Study|Progressive disease|3|||
150074132|NCT00474760|541410938|FG001|Overall Study|Progressive disease|2|||
150074133|NCT00474760|541410939|FG002|Overall Study|Progressive disease|3|||
150074134|NCT00474760|541410940|FG003|Overall Study|Progressive disease|2|||
150074135|NCT00474760|541410941|FG004|Overall Study|Progressive disease|8|||
150074136|NCT00474760|541410942|FG005|Overall Study|Progressive disease|20|||
150074137|NCT00474760|541410943|FG006|Overall Study|Progressive disease|7|||
150074138|NCT00474760|541410937|FG000|Overall Study|Terminated by sponsor|0|||
150074139|NCT00474760|541410938|FG001|Overall Study|Terminated by sponsor|0|||
150074140|NCT00474760|541410939|FG002|Overall Study|Terminated by sponsor|0|||
150074141|NCT00474760|541410940|FG003|Overall Study|Terminated by sponsor|0|||
150074142|NCT00474760|541410941|FG004|Overall Study|Terminated by sponsor|0|||
150074143|NCT00474760|541410942|FG005|Overall Study|Terminated by sponsor|0|||
150074144|NCT00474760|541410943|FG006|Overall Study|Terminated by sponsor|2|||
150074145|NCT01546207|541412726|FG000|Overall Study|Death|1|||
150074146|NCT00506662|541412727|FG000|Overall Study|Adverse Event|0|||
150074147|NCT00506662|541412728|FG001|Overall Study|Adverse Event|2|||
150074148|NCT00506662|541412727|FG000|Overall Study|Lack of Efficacy|1|||
150074149|NCT00506662|541412728|FG001|Overall Study|Lack of Efficacy|0|||
150074150|NCT00506662|541412727|FG000|Overall Study|Protocol Violation|2|||
150074151|NCT00506662|541412728|FG001|Overall Study|Protocol Violation|4|||
150074152|NCT00506662|541412727|FG000|Overall Study|Trial terminated|10|||
150074153|NCT00506662|541412728|FG001|Overall Study|Trial terminated|16|||
150074154|NCT00506662|541412727|FG000|Overall Study|Not recorded|4|||
150074155|NCT00506662|541412728|FG001|Overall Study|Not recorded|6|||
150074156|NCT03019185|541412729|FG000|Overall Study|Lost to Follow-up|3|||
150074157|NCT03019185|541412730|FG001|Overall Study|Lost to Follow-up|0|||
150074158|NCT03019185|541412731|FG002|Overall Study|Lost to Follow-up|2|||
150074159|NCT03019185|541412729|FG000|Overall Study|Withdrawal by Subject|1|||
150074160|NCT03019185|541412730|FG001|Overall Study|Withdrawal by Subject|1|||
150074161|NCT03019185|541412731|FG002|Overall Study|Withdrawal by Subject|0|||
150074162|NCT03019185|541412729|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
150074163|NCT03019185|541412730|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
150074164|NCT03019185|541412731|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
150074165|NCT03019185|541412729|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
150074166|NCT03019185|541412730|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
150074167|NCT03019185|541412731|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
150074168|NCT02764333|541412732|FG000|Overall Study|Ineligible|1|||
150074169|NCT03355365|541412733|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
150074170|NCT03355365|541412734|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
150074171|NCT03355365|541412733|FG000|Year 1, First Intervention|Protocol Violation|1|||
150074172|NCT03355365|541412734|FG001|Year 1, First Intervention|Protocol Violation|0|||
150074173|NCT03355365|541412733|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
150182391|NCT02015520|541804709|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
150182392|NCT02015520|541804706|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
150182393|NCT02015520|541804707|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
150074174|NCT03355365|541412734|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
150074175|NCT03355365|541412733|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
150074176|NCT03355365|541412734|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
150074177|NCT03355365|541412733|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
150074178|NCT03355365|541412734|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
150074179|NCT03355365|541412733|FG000|Year 2, Crossover Intervention|severe COVID|0|||
150074180|NCT03355365|541412734|FG001|Year 2, Crossover Intervention|severe COVID|1|||
150074181|NCT03355365|541412733|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
150182394|NCT02015520|541804708|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
150182395|NCT02015520|541804709|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
150182396|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
150182397|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
150182398|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
150182399|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
150182400|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
150182401|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
150182402|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
150182403|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
150182404|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
150182405|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
150182406|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
150182407|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
150182408|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
150182409|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
150182410|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
150182411|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
150182412|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
150182413|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
150182414|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
150182415|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
150182416|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
150182417|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
150182418|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
150182419|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
150182420|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
150182421|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
150182422|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
150182423|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
150182424|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
150182425|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
150182426|NCT04759833|541804710|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
150182427|NCT04759833|541804711|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
150182428|NCT04759833|541804712|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
150182429|NCT04759833|541804713|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
150182430|NCT04759833|541804714|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
150182431|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
150182432|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
150182433|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
150182434|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
150182435|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
150182436|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
150182437|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
150182438|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
150182439|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
150182440|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
150182441|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
150182442|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
150182443|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
150182444|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
150182445|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
150182446|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
150182447|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
150182448|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
150182449|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
150182450|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
150182451|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
150182452|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
150182453|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
150182454|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
150182455|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
150182456|NCT04759833|541804710|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
150182457|NCT04759833|541804711|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
150182458|NCT04759833|541804712|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
150182459|NCT04759833|541804713|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
150182460|NCT04759833|541804714|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
150182461|NCT03446157|541804715|FG000|Overall Study|Death|11|||
150182462|NCT03446157|541804716|FG001|Overall Study|Death|9|||
150182463|NCT03446157|541804715|FG000|Overall Study|Lost to Follow-up|0|||
150182464|NCT03446157|541804716|FG001|Overall Study|Lost to Follow-up|1|||
150182465|NCT03446157|541804715|FG000|Overall Study|Withdrawal by Subject|2|||
150182466|NCT03446157|541804716|FG001|Overall Study|Withdrawal by Subject|1|||
150182467|NCT01619410|541804720|FG000|Overall Study|Lost to Follow-up|7|||
150182468|NCT01619410|541804721|FG001|Overall Study|Lost to Follow-up|4|||
150182469|NCT02462759|541804726|FG000|Part 1: Double Blind|Death|1|||
150182470|NCT02462759|541804727|FG001|Part 1: Double Blind|Death|0|||
150074182|NCT03355365|541412734|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
150074183|NCT04622306|541412735|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
150074184|NCT04622306|541412736|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
150074185|NCT04622306|541412737|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
150074186|NCT04622306|541412738|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
150074187|NCT04622306|541412739|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
150074188|NCT04622306|541412740|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
150074189|NCT04622306|541412735|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
150074190|NCT04622306|541412736|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
150074191|NCT04622306|541412737|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
150074192|NCT04622306|541412738|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
150074193|NCT04622306|541412739|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
150074194|NCT04622306|541412740|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
150074195|NCT00617851|541412741|FG000|Overall Study|Death|0|||
150074196|NCT00617851|541412742|FG001|Overall Study|Death|0|||
150074197|NCT00617851|541412743|FG002|Overall Study|Death|0|||
150074198|NCT00617851|541412744|FG003|Overall Study|Death|1|||
150074199|NCT00617851|541412741|FG000|Overall Study|Withdrawal by Subject|14|||
150074200|NCT00617851|541412742|FG001|Overall Study|Withdrawal by Subject|7|||
150074201|NCT00617851|541412743|FG002|Overall Study|Withdrawal by Subject|12|||
150074202|NCT00617851|541412744|FG003|Overall Study|Withdrawal by Subject|4|||
150074203|NCT00617851|541412741|FG000|Overall Study|Lost to Follow-up|27|||
150074204|NCT00617851|541412742|FG001|Overall Study|Lost to Follow-up|29|||
150074205|NCT00617851|541412743|FG002|Overall Study|Lost to Follow-up|31|||
150074206|NCT00617851|541412744|FG003|Overall Study|Lost to Follow-up|19|||
150074207|NCT00617851|541412741|FG000|Overall Study|Inappropriate Enrollment|5|||
150074208|NCT00617851|541412742|FG001|Overall Study|Inappropriate Enrollment|4|||
150074209|NCT00617851|541412743|FG002|Overall Study|Inappropriate Enrollment|1|||
150074210|NCT00617851|541412744|FG003|Overall Study|Inappropriate Enrollment|1|||
150074211|NCT00617851|541412741|FG000|Overall Study|Unable to classify|1|||
150074212|NCT00617851|541412742|FG001|Overall Study|Unable to classify|0|||
150074213|NCT00617851|541412743|FG002|Overall Study|Unable to classify|1|||
150074214|NCT00617851|541412744|FG003|Overall Study|Unable to classify|0|||
150074215|NCT01200524|541412745|FG000|Overall Study|Withdrawal by Subject|1|||
150074216|NCT01200524|541412746|FG001|Overall Study|Withdrawal by Subject|1|||
150074217|NCT01200524|541412747|FG002|Overall Study|Withdrawal by Subject|3|||
150074218|NCT01200524|541412745|FG000|Overall Study|Adverse Event|1|||
150074219|NCT01200524|541412746|FG001|Overall Study|Adverse Event|0|||
150074220|NCT01200524|541412747|FG002|Overall Study|Adverse Event|0|||
150074221|NCT01200524|541412745|FG000|Overall Study|Non availability of study nurse|0|||
150074222|NCT01200524|541412746|FG001|Overall Study|Non availability of study nurse|0|||
150074223|NCT01200524|541412747|FG002|Overall Study|Non availability of study nurse|1|||
150074224|NCT00697788|541412753|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074225|NCT00697788|541412754|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
150074226|NCT00697788|541412755|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074227|NCT00697788|541412756|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074228|NCT00697788|541412757|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074229|NCT00697788|541412758|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074230|NCT00697788|541412759|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074231|NCT00697788|541412760|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
150074232|NCT00697788|541412753|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074233|NCT00697788|541412754|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074234|NCT00697788|541412755|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074235|NCT00697788|541412756|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074236|NCT00697788|541412757|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
150074237|NCT00697788|541412758|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074238|NCT00697788|541412759|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074239|NCT00697788|541412760|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
150074240|NCT03228433|541412761|FG000|Overall Study|Lost to Follow-up|1|||
150074241|NCT03228433|541412762|FG001|Overall Study|Lost to Follow-up|0|||
150074242|NCT03228433|541412763|FG002|Overall Study|Lost to Follow-up|0|||
150074243|NCT03228433|541412764|FG003|Overall Study|Lost to Follow-up|0|||
150074244|NCT03228433|541412765|FG004|Overall Study|Lost to Follow-up|0|||
150074245|NCT03228433|541412766|FG005|Overall Study|Lost to Follow-up|0|||
150074246|NCT03228433|541412761|FG000|Overall Study|Positive alcohol test|0|||
150074247|NCT03228433|541412762|FG001|Overall Study|Positive alcohol test|0|||
150074248|NCT03228433|541412763|FG002|Overall Study|Positive alcohol test|0|||
150074249|NCT03228433|541412764|FG003|Overall Study|Positive alcohol test|1|||
150074250|NCT03228433|541412765|FG004|Overall Study|Positive alcohol test|0|||
150074251|NCT03228433|541412766|FG005|Overall Study|Positive alcohol test|0|||
150074252|NCT01365052|541412773|FG000|Overall Study|Adverse Event|4|||
150074253|NCT01365052|541412774|FG001|Overall Study|Adverse Event|4|||
150074254|NCT04515394|541412784|FG000|Overall Study|Participant did not receive treatment|1|||
150074255|NCT01058655|541412785|FG000|Overall Study|Withdrawal by Subject|1|||
150074256|NCT01058655|541412786|FG001|Overall Study|Withdrawal by Subject|0|||
150074257|NCT01058655|541412787|FG002|Overall Study|Withdrawal by Subject|3|||
150074258|NCT01058655|541412788|FG003|Overall Study|Withdrawal by Subject|4|||
150074259|NCT01058655|541412785|FG000|Overall Study|Prolonged Treatment Delay|0|||
150074260|NCT01058655|541412786|FG001|Overall Study|Prolonged Treatment Delay|0|||
150074261|NCT01058655|541412787|FG002|Overall Study|Prolonged Treatment Delay|0|||
150074262|NCT01058655|541412788|FG003|Overall Study|Prolonged Treatment Delay|2|||
150074263|NCT01058655|541412785|FG000|Overall Study|Symptomatic Deterioration|0|||
150074264|NCT01058655|541412786|FG001|Overall Study|Symptomatic Deterioration|0|||
150074265|NCT01058655|541412787|FG002|Overall Study|Symptomatic Deterioration|0|||
150074266|NCT01058655|541412788|FG003|Overall Study|Symptomatic Deterioration|1|||
150074267|NCT01058655|541412785|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
150074268|NCT01058655|541412786|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
150074269|NCT01058655|541412787|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
150074270|NCT01058655|541412788|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
150074271|NCT01058655|541412785|FG000|Overall Study|Death|0|||
150074272|NCT01058655|541412786|FG001|Overall Study|Death|1|||
150074273|NCT01058655|541412787|FG002|Overall Study|Death|1|||
150074274|NCT01058655|541412788|FG003|Overall Study|Death|0|||
150074275|NCT01058655|541412785|FG000|Overall Study|Disease Progression|1|||
150074276|NCT01058655|541412786|FG001|Overall Study|Disease Progression|2|||
150074277|NCT01058655|541412787|FG002|Overall Study|Disease Progression|4|||
150074278|NCT01058655|541412788|FG003|Overall Study|Disease Progression|24|||
150074279|NCT01058655|541412785|FG000|Overall Study|Other|0|||
150074280|NCT01058655|541412786|FG001|Overall Study|Other|0|||
150074281|NCT01058655|541412787|FG002|Overall Study|Other|0|||
150074282|NCT01058655|541412788|FG003|Overall Study|Other|4|||
150074283|NCT02435147|541412792|FG000|Overall Study|non-evaluable DXA scan|11|||
150074284|NCT02939079|541412793|FG000|Overall Study|Adverse Event|2|||
150074285|NCT02939079|541412794|FG001|Overall Study|Adverse Event|1|||
150074286|NCT02939079|541412793|FG000|Overall Study|Lost to Follow-up|0|||
150074287|NCT02939079|541412794|FG001|Overall Study|Lost to Follow-up|2|||
150074288|NCT02939079|541412793|FG000|Overall Study|Protocol Violation|1|||
150074289|NCT02939079|541412794|FG001|Overall Study|Protocol Violation|0|||
150074290|NCT02939079|541412793|FG000|Overall Study|Withdrawal by Subject|0|||
150074291|NCT02939079|541412794|FG001|Overall Study|Withdrawal by Subject|1|||
150074292|NCT02939079|541412793|FG000|Overall Study|relapse during the study|1|||
150074293|NCT02939079|541412794|FG001|Overall Study|relapse during the study|1|||
150074294|NCT04093414|541412795|FG000|3 Month Follow up|Physician Decision|0|||
150074295|NCT04093414|541412796|FG001|3 Month Follow up|Physician Decision|1|||
150074296|NCT04093414|541412795|FG000|6month Follow up|Physician Decision|1|||
150074297|NCT04093414|541412796|FG001|6month Follow up|Physician Decision|3|||
150074298|NCT04889222|541412797|FG000|Overall Study|Did not meet eligibility criteria|8|||
150074299|NCT04889222|541412797|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
150074300|NCT04889222|541412797|FG000|Overall Study|Did not proceed due to time constraints|5|||
150074301|NCT02639546|541412800|FG000|Overall Study|Death|2|||
150074302|NCT02639546|541412801|FG001|Overall Study|Death|2|||
150074303|NCT02639546|541412802|FG002|Overall Study|Death|1|||
150074304|NCT02639546|541412803|FG003|Overall Study|Death|2|||
150074305|NCT02639546|541412804|FG004|Overall Study|Death|2|||
150074306|NCT02639546|541412805|FG005|Overall Study|Death|2|||
150074307|NCT02639546|541412806|FG006|Overall Study|Death|0|||
150074308|NCT02639546|541412807|FG007|Overall Study|Death|0|||
150074309|NCT02639546|541412800|FG000|Overall Study|Lost to Follow-up|0|||
150074310|NCT02639546|541412801|FG001|Overall Study|Lost to Follow-up|0|||
150074311|NCT02639546|541412802|FG002|Overall Study|Lost to Follow-up|1|||
150074312|NCT02639546|541412803|FG003|Overall Study|Lost to Follow-up|0|||
150074313|NCT02639546|541412804|FG004|Overall Study|Lost to Follow-up|1|||
150074314|NCT02639546|541412805|FG005|Overall Study|Lost to Follow-up|1|||
150074315|NCT02639546|541412806|FG006|Overall Study|Lost to Follow-up|0|||
150182471|NCT02462759|541804728|FG002|Part 1: Double Blind|Death|0|||
150074316|NCT02639546|541412807|FG007|Overall Study|Lost to Follow-up|1|||
150074317|NCT02639546|541412800|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
150074318|NCT02639546|541412801|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
150074319|NCT02639546|541412802|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
150074320|NCT02639546|541412803|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
150074321|NCT02639546|541412804|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
150074322|NCT02639546|541412805|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
150074323|NCT02639546|541412806|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
150074324|NCT02639546|541412807|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
150074325|NCT02639546|541412800|FG000|Overall Study|Study Terminated By Sponsor|0|||
150074326|NCT02639546|541412801|FG001|Overall Study|Study Terminated By Sponsor|2|||
150074327|NCT02639546|541412802|FG002|Overall Study|Study Terminated By Sponsor|3|||
150074328|NCT02639546|541412803|FG003|Overall Study|Study Terminated By Sponsor|4|||
150074329|NCT02639546|541412804|FG004|Overall Study|Study Terminated By Sponsor|4|||
150074330|NCT02639546|541412805|FG005|Overall Study|Study Terminated By Sponsor|3|||
150074331|NCT02639546|541412806|FG006|Overall Study|Study Terminated By Sponsor|3|||
150074332|NCT02639546|541412807|FG007|Overall Study|Study Terminated By Sponsor|9|||
150074333|NCT02639546|541412800|FG000|Overall Study|Withdrawal by Subject|2|||
150074334|NCT02639546|541412801|FG001|Overall Study|Withdrawal by Subject|2|||
150074335|NCT02639546|541412802|FG002|Overall Study|Withdrawal by Subject|1|||
150074336|NCT02639546|541412803|FG003|Overall Study|Withdrawal by Subject|0|||
150074337|NCT02639546|541412804|FG004|Overall Study|Withdrawal by Subject|0|||
150074338|NCT02639546|541412805|FG005|Overall Study|Withdrawal by Subject|1|||
150074339|NCT02639546|541412806|FG006|Overall Study|Withdrawal by Subject|2|||
150074340|NCT02639546|541412807|FG007|Overall Study|Withdrawal by Subject|1|||
150074341|NCT02478372|541412808|FG000|Overall Study|Protocol Violation|12|||
150074342|NCT02478372|541412809|FG001|Overall Study|Protocol Violation|8|||
150074343|NCT02478372|541412808|FG000|Overall Study|Lost to Follow-up|1|||
150074344|NCT02478372|541412809|FG001|Overall Study|Lost to Follow-up|4|||
150074345|NCT02478372|541412808|FG000|Overall Study|Death|0|||
150074346|NCT02478372|541412809|FG001|Overall Study|Death|2|||
150074347|NCT00113087|541412810|FG000|Overall Study|Death or Transplant|14|||
150074348|NCT00113087|541412811|FG001|Overall Study|Death or Transplant|16|||
150074349|NCT00113087|541412810|FG000|Overall Study|Family or MD withdrew subject|10|||
150074350|NCT00113087|541412811|FG001|Overall Study|Family or MD withdrew subject|5|||
150074351|NCT03452228|541412812|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
150074352|NCT03452228|541412813|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
150074353|NCT03452228|541412814|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
150074354|NCT03452228|541412812|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
150074355|NCT03452228|541412813|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
150074356|NCT03452228|541412814|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
150074357|NCT03452228|541412812|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
150074358|NCT03452228|541412813|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
150074359|NCT03452228|541412814|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
150074360|NCT03452228|541412812|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150074361|NCT03452228|541412813|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
150074362|NCT03452228|541412814|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
150074363|NCT00386607|541412815|FG000|Core|Adverse Event|40|||
150074364|NCT00386607|541412816|FG001|Core|Adverse Event|0|||
150074365|NCT00386607|541412815|FG000|Core|Abnormal laboratory value(s)|3|||
150074366|NCT00386607|541412816|FG001|Core|Abnormal laboratory value(s)|0|||
150074367|NCT00386607|541412815|FG000|Core|Unsatisfactory therapeutic effect|23|||
150074368|NCT00386607|541412816|FG001|Core|Unsatisfactory therapeutic effect|0|||
150074369|NCT00386607|541412815|FG000|Core|Condition no longer requires study drug|4|||
150074370|NCT00386607|541412816|FG001|Core|Condition no longer requires study drug|0|||
150074371|NCT00386607|541412815|FG000|Core|Patient withdrew consent|15|||
150074372|NCT00386607|541412816|FG001|Core|Patient withdrew consent|0|||
150074373|NCT00386607|541412815|FG000|Core|Lost to Follow-up|23|||
150074374|NCT00386607|541412816|FG001|Core|Lost to Follow-up|0|||
150074375|NCT00386607|541412815|FG000|Core|Administrative problems|1|||
150074376|NCT00386607|541412816|FG001|Core|Administrative problems|0|||
150074377|NCT00386607|541412815|FG000|Core|Protocol Deviation|6|||
150074378|NCT00386607|541412816|FG001|Core|Protocol Deviation|0|||
150074379|NCT00386607|541412815|FG000|Extension|Adverse Event|0|||
150074380|NCT00386607|541412816|FG001|Extension|Adverse Event|6|||
150074381|NCT00386607|541412815|FG000|Extension|Abnormal laboratory value(s)|0|||
150074382|NCT00386607|541412816|FG001|Extension|Abnormal laboratory value(s)|1|||
150074383|NCT00386607|541412815|FG000|Extension|Administrative problems|0|||
150074384|NCT00386607|541412816|FG001|Extension|Administrative problems|1|||
150074385|NCT00386607|541412815|FG000|Extension|Lost to Follow-up|0|||
150074386|NCT00386607|541412816|FG001|Extension|Lost to Follow-up|3|||
150074387|NCT00386607|541412815|FG000|Extension|Patient withdrew consent|0|||
150074388|NCT00386607|541412816|FG001|Extension|Patient withdrew consent|5|||
150074389|NCT00386607|541412815|FG000|Extension|Unsatisfactory therapeutic effect|0|||
150074390|NCT00386607|541412816|FG001|Extension|Unsatisfactory therapeutic effect|1|||
150074391|NCT02761733|541412817|FG000|Overall Study|Death|3|||
150074392|NCT02761733|541412818|FG001|Overall Study|Death|5|||
150074393|NCT02761733|541412819|FG002|Overall Study|Death|1|||
150074394|NCT02761733|541412820|FG003|Overall Study|Death|1|||
150074395|NCT02761733|541412817|FG000|Overall Study|Lost to Follow-up|6|||
150074396|NCT02761733|541412818|FG001|Overall Study|Lost to Follow-up|7|||
150074397|NCT02761733|541412819|FG002|Overall Study|Lost to Follow-up|0|||
150074398|NCT02761733|541412820|FG003|Overall Study|Lost to Follow-up|3|||
150074399|NCT02761733|541412817|FG000|Overall Study|Physician Decision|4|||
150074400|NCT02761733|541412818|FG001|Overall Study|Physician Decision|0|||
150074401|NCT02761733|541412819|FG002|Overall Study|Physician Decision|0|||
150074402|NCT02761733|541412820|FG003|Overall Study|Physician Decision|0|||
150074403|NCT02761733|541412817|FG000|Overall Study|Withdrawal by Subject|2|||
150074404|NCT02761733|541412818|FG001|Overall Study|Withdrawal by Subject|0|||
150074405|NCT02761733|541412819|FG002|Overall Study|Withdrawal by Subject|0|||
150074406|NCT02761733|541412820|FG003|Overall Study|Withdrawal by Subject|0|||
150074407|NCT02761733|541412817|FG000|Overall Study|Discharged from Study Site|10|||
150074408|NCT02761733|541412818|FG001|Overall Study|Discharged from Study Site|9|||
150074409|NCT02761733|541412819|FG002|Overall Study|Discharged from Study Site|25|||
150074410|NCT02761733|541412820|FG003|Overall Study|Discharged from Study Site|11|||
150074411|NCT02761733|541412817|FG000|Overall Study|Cognitive Impairment|5|||
150074412|NCT02761733|541412818|FG001|Overall Study|Cognitive Impairment|0|||
150074413|NCT02761733|541412819|FG002|Overall Study|Cognitive Impairment|1|||
150074414|NCT02761733|541412820|FG003|Overall Study|Cognitive Impairment|0|||
150074415|NCT02713204|541412821|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
150074416|NCT02713204|541412822|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074417|NCT02713204|541412823|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
150074418|NCT02713204|541412824|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074419|NCT02713204|541412825|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074420|NCT02713204|541412826|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074421|NCT02713204|541412827|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074422|NCT02713204|541412828|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
150074423|NCT02713204|541412821|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074424|NCT02713204|541412822|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074425|NCT02713204|541412823|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
150074426|NCT02713204|541412824|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074427|NCT02713204|541412825|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074428|NCT02713204|541412826|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074429|NCT02713204|541412827|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074430|NCT02713204|541412828|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
150074431|NCT02713204|541412821|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074432|NCT02713204|541412822|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
150074433|NCT02713204|541412823|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074434|NCT02713204|541412824|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074435|NCT02713204|541412825|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074436|NCT02713204|541412826|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074437|NCT02713204|541412827|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074438|NCT02713204|541412828|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
150074439|NCT02713204|541412821|FG000|From Week 12 up to Week 36|Adverse Event|1|||
150074440|NCT02713204|541412822|FG001|From Week 12 up to Week 36|Adverse Event|0|||
150074441|NCT02713204|541412823|FG002|From Week 12 up to Week 36|Adverse Event|0|||
150074442|NCT02713204|541412824|FG003|From Week 12 up to Week 36|Adverse Event|1|||
150074443|NCT02713204|541412825|FG004|From Week 12 up to Week 36|Adverse Event|1|||
150074444|NCT02713204|541412826|FG005|From Week 12 up to Week 36|Adverse Event|0|||
150074445|NCT02713204|541412827|FG006|From Week 12 up to Week 36|Adverse Event|2|||
150074446|NCT02713204|541412828|FG007|From Week 12 up to Week 36|Adverse Event|1|||
150074447|NCT02713204|541412821|FG000|From Week 12 up to Week 36|Death|0|||
150074448|NCT02713204|541412822|FG001|From Week 12 up to Week 36|Death|0|||
150074449|NCT02713204|541412823|FG002|From Week 12 up to Week 36|Death|0|||
150074450|NCT02713204|541412824|FG003|From Week 12 up to Week 36|Death|1|||
150074451|NCT02713204|541412825|FG004|From Week 12 up to Week 36|Death|0|||
150074452|NCT02713204|541412826|FG005|From Week 12 up to Week 36|Death|1|||
150074453|NCT02713204|541412827|FG006|From Week 12 up to Week 36|Death|0|||
150074454|NCT02713204|541412828|FG007|From Week 12 up to Week 36|Death|3|||
150074455|NCT02713204|541412821|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074456|NCT02713204|541412822|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074457|NCT02713204|541412823|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074458|NCT02713204|541412824|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
150074459|NCT02713204|541412825|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074460|NCT02713204|541412826|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074461|NCT02713204|541412827|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074462|NCT02713204|541412828|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
150074463|NCT02713204|541412821|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
150074464|NCT02713204|541412822|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
150074465|NCT02713204|541412823|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
150074466|NCT02713204|541412824|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
150074467|NCT02713204|541412825|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
150074468|NCT02713204|541412826|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
150074469|NCT02713204|541412827|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
150074470|NCT02713204|541412828|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
150074471|NCT00788073|541412835|FG000|STX209 Then Placebo|Adverse Event|1|||
150074472|NCT00788073|541412836|FG001|STX209 Then Placebo|Adverse Event|0|||
150074473|NCT00788073|541412835|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
150074474|NCT00788073|541412836|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
150074475|NCT00788073|541412835|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
150074476|NCT00788073|541412836|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
150074477|NCT00788073|541412835|FG000|STX209 Then Placebo|unable to return due to travel|0|||
150074478|NCT00788073|541412836|FG001|STX209 Then Placebo|unable to return due to travel|1|||
150074479|NCT00788073|541412835|FG000|Placebo Then STX209|Adverse Event|2|||
150074480|NCT00788073|541412836|FG001|Placebo Then STX209|Adverse Event|0|||
150074481|NCT00788073|541412835|FG000|Placebo Then STX209|Protocol Violation|0|||
150074482|NCT00788073|541412836|FG001|Placebo Then STX209|Protocol Violation|1|||
150074483|NCT03608254|541412837|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
150074484|NCT03608254|541412837|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
150074485|NCT00660673|541412838|FG000|Overall Study|Adverse Event|84|||
150074486|NCT00660673|541412838|FG000|Overall Study|Lack of Efficacy|7|||
150074487|NCT00660673|541412838|FG000|Overall Study|Withdrawal by Subject|22|||
150074488|NCT00660673|541412838|FG000|Overall Study|Administrative|2|||
150074489|NCT00660673|541412838|FG000|Overall Study|Protocol Violation|2|||
150074490|NCT03208127|541412839|FG000|Overall Study|Death|1|||
150074491|NCT01903031|541412850|FG000|Overall Study|Not Able to Attend Clinic|1|||
150074492|NCT01903031|541412851|FG001|Overall Study|Not Able to Attend Clinic|1|||
150074493|NCT01903031|541412852|FG002|Overall Study|Not Able to Attend Clinic|0|||
150074494|NCT01903031|541412850|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
150074495|NCT01903031|541412851|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
150074496|NCT01903031|541412852|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
150074497|NCT01903031|541412850|FG000|Overall Study|Adverse Event|0|||
150074498|NCT01903031|541412851|FG001|Overall Study|Adverse Event|1|||
150074499|NCT01903031|541412852|FG002|Overall Study|Adverse Event|0|||
150074500|NCT01903031|541412850|FG000|Overall Study|Withdrawal by Subject|0|||
150074501|NCT01903031|541412851|FG001|Overall Study|Withdrawal by Subject|1|||
150074502|NCT01903031|541412852|FG002|Overall Study|Withdrawal by Subject|1|||
150074503|NCT01903031|541412850|FG000|Overall Study|Protocol Violation|0|||
150074504|NCT01903031|541412851|FG001|Overall Study|Protocol Violation|0|||
150074505|NCT01903031|541412852|FG002|Overall Study|Protocol Violation|2|||
150074506|NCT01903031|541412850|FG000|Overall Study|Lost to Follow-up|0|||
150074507|NCT01903031|541412851|FG001|Overall Study|Lost to Follow-up|0|||
150074508|NCT01903031|541412852|FG002|Overall Study|Lost to Follow-up|1|||
150074509|NCT01903031|541412850|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
150074510|NCT01903031|541412851|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
150074511|NCT01903031|541412852|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
150074512|NCT03000569|541412853|FG000|Overall Study|Withdrawal by Subject|1|||
150074513|NCT03000569|541412854|FG001|Overall Study|Withdrawal by Subject|0|||
150074514|NCT02298023|541412855|FG000|Overall Study|Withdrawal by Subject|1|||
150074515|NCT02298023|541412856|FG001|Overall Study|Withdrawal by Subject|0|||
150074516|NCT02298023|541412857|FG002|Overall Study|Withdrawal by Subject|0|||
150074517|NCT00569270|541412859|FG000|Period: First Intervention|Protocol Violation|0|||
150074518|NCT00569270|541412860|FG001|Period: First Intervention|Protocol Violation|1|||
150074519|NCT00447005|541412861|FG000|Overall Study|Adverse Event|1|||
150074520|NCT00447005|541412861|FG000|Overall Study|Lack of Efficacy|11|||
150074521|NCT00492531|541412862|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
150074522|NCT00492531|541412863|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
150074523|NCT04122534|541412864|FG000|Overall Study|Lost to Follow-up|4|||
150074524|NCT02128932|541412875|FG000|Overall Study|Withdrawal by Subject|11|||
150074525|NCT02128932|541412876|FG001|Overall Study|Withdrawal by Subject|7|||
150074526|NCT02128932|541412877|FG002|Overall Study|Withdrawal by Subject|8|||
150074527|NCT02128932|541412875|FG000|Overall Study|Death|2|||
150074528|NCT02128932|541412876|FG001|Overall Study|Death|0|||
150074529|NCT02128932|541412877|FG002|Overall Study|Death|2|||
150074530|NCT02128932|541412875|FG000|Overall Study|Lost to Follow-up|2|||
150074531|NCT02128932|541412876|FG001|Overall Study|Lost to Follow-up|1|||
150074532|NCT02128932|541412877|FG002|Overall Study|Lost to Follow-up|1|||
150074533|NCT02128932|541412875|FG000|Overall Study|No reason for withdrawal|12|||
150074534|NCT02128932|541412876|FG001|Overall Study|No reason for withdrawal|11|||
150074535|NCT02128932|541412877|FG002|Overall Study|No reason for withdrawal|7|||
150074536|NCT03685123|541412878|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
150074537|NCT03685123|541412879|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
150074538|NCT03685123|541412880|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
150074539|NCT03685123|541412878|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
150074540|NCT03685123|541412879|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
150074541|NCT03685123|541412880|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
150182472|NCT04110054|541804729|FG000|Overall Study|COVID-19 reason other than AE|0|||
150074542|NCT03685123|541412878|FG000|Weight Loss Phase|Lost to Follow-up|1|||
150074543|NCT03685123|541412879|FG001|Weight Loss Phase|Lost to Follow-up|0|||
150074544|NCT03685123|541412880|FG002|Weight Loss Phase|Lost to Follow-up|0|||
150074545|NCT03685123|541412878|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
150074546|NCT03685123|541412879|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
150182473|NCT04110054|541804730|FG001|Overall Study|COVID-19 reason other than AE|0|||
150074547|NCT03685123|541412880|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
150074548|NCT03685123|541412878|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
150074549|NCT03685123|541412879|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
150074550|NCT03685123|541412880|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
150074551|NCT03685123|541412878|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
150074552|NCT03685123|541412879|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
150074553|NCT03685123|541412880|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
150074554|NCT03113916|541412884|FG000|Overall Study|Withdrawal by Subject|9|||
150074555|NCT03113916|541412885|FG001|Overall Study|Withdrawal by Subject|7|||
150074556|NCT03113916|541412884|FG000|Overall Study|Pregnancy|1|||
150074557|NCT03113916|541412885|FG001|Overall Study|Pregnancy|3|||
150074558|NCT03113916|541412884|FG000|Overall Study|Lost to Follow-up|1|||
150074559|NCT03113916|541412885|FG001|Overall Study|Lost to Follow-up|2|||
150074560|NCT01758523|541412886|FG000|Overall Study|Adverse Event|2|||
150074561|NCT01758523|541412887|FG001|Overall Study|Adverse Event|1|||
150074562|NCT01758523|541412886|FG000|Overall Study|Lack of Efficacy|4|||
150074563|NCT01758523|541412887|FG001|Overall Study|Lack of Efficacy|2|||
150074564|NCT01758523|541412886|FG000|Overall Study|Lost to Follow-up|3|||
150074565|NCT01758523|541412887|FG001|Overall Study|Lost to Follow-up|4|||
150074566|NCT01758523|541412886|FG000|Overall Study|Withdrawal by Subject|12|||
150074567|NCT01758523|541412887|FG001|Overall Study|Withdrawal by Subject|7|||
150074568|NCT01893203|541412888|FG000|Overall Study|Withdrawal by Subject|1|||
150074569|NCT04729621|541412889|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
150074570|NCT04729621|541412890|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
150074571|NCT04729621|541412891|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
150074572|NCT04729621|541412892|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
150074573|NCT04729621|541412893|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
150074574|NCT04729621|541412889|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
150074575|NCT04729621|541412890|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
150074576|NCT04729621|541412891|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
150074577|NCT04729621|541412892|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
150074578|NCT04729621|541412893|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
150074579|NCT04729621|541412889|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
150074580|NCT04729621|541412890|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
150074581|NCT04729621|541412891|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
150074582|NCT04729621|541412892|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
150074583|NCT04729621|541412893|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
150074584|NCT04729621|541412889|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
150074585|NCT04729621|541412890|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
150074586|NCT04729621|541412891|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
150074587|NCT04729621|541412892|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
150074588|NCT04729621|541412893|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
150074589|NCT04729621|541412889|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
150074590|NCT04729621|541412890|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
150074591|NCT04729621|541412891|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
150074592|NCT04729621|541412892|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
150074593|NCT04729621|541412893|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
150074594|NCT04729621|541412889|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
150074595|NCT04729621|541412890|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
150074596|NCT04729621|541412891|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
150074597|NCT04729621|541412892|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
150074598|NCT04729621|541412893|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
150074599|NCT02663908|541412894|FG000|Overall Study|Withdrawal by Subject|8|||
150074600|NCT02663908|541412895|FG001|Overall Study|Withdrawal by Subject|5|||
150074601|NCT02663908|541412894|FG000|Overall Study|Lost to Follow-up|1|||
150074602|NCT02663908|541412895|FG001|Overall Study|Lost to Follow-up|5|||
150074603|NCT02663908|541412894|FG000|Overall Study|Adverse Event|13|||
150074604|NCT02663908|541412895|FG001|Overall Study|Adverse Event|11|||
150074605|NCT02663908|541412894|FG000|Overall Study|Protocol Violation|1|||
150074606|NCT02663908|541412895|FG001|Overall Study|Protocol Violation|2|||
150074607|NCT02663908|541412894|FG000|Overall Study|Lack of therapeutic response|2|||
150074608|NCT02663908|541412895|FG001|Overall Study|Lack of therapeutic response|0|||
150074609|NCT02663908|541412894|FG000|Overall Study|COVID-19|1|||
150074610|NCT02663908|541412895|FG001|Overall Study|COVID-19|0|||
150074611|NCT02663908|541412894|FG000|Overall Study|Site closed|1|||
150182474|NCT04110054|541804731|FG002|Overall Study|COVID-19 reason other than AE|2|||
150074612|NCT02663908|541412895|FG001|Overall Study|Site closed|0|||
150074613|NCT02663908|541412894|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
150074614|NCT02663908|541412895|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
150074615|NCT02663908|541412894|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
150074616|NCT02663908|541412895|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
150074617|NCT02663908|541412894|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
150074618|NCT02663908|541412895|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
150074619|NCT02663908|541412894|FG000|Overall Study|Death|1|||
150074620|NCT02663908|541412895|FG001|Overall Study|Death|0|||
150074621|NCT02663908|541412894|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
150074622|NCT02663908|541412895|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
150074623|NCT02663908|541412894|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
150074624|NCT02663908|541412895|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
150074625|NCT03308786|541412896|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
150074626|NCT02004522|541412897|FG000|Overall Study|Adverse Event|55|||
150074627|NCT02004522|541412898|FG001|Overall Study|Adverse Event|6|||
150074628|NCT02004522|541412897|FG000|Overall Study|Withdrawal by Subject|13|||
150074629|NCT02004522|541412898|FG001|Overall Study|Withdrawal by Subject|7|||
150074630|NCT02004522|541412897|FG000|Overall Study|Death|12|||
150074631|NCT02004522|541412898|FG001|Overall Study|Death|3|||
150074632|NCT02004522|541412897|FG000|Overall Study|Physician Decision|3|||
150074633|NCT02004522|541412898|FG001|Overall Study|Physician Decision|4|||
150074634|NCT02004522|541412897|FG000|Overall Study|Protocol Violation|1|||
150074635|NCT02004522|541412898|FG001|Overall Study|Protocol Violation|0|||
150074636|NCT02004522|541412897|FG000|Overall Study|Other is reason listed by PI|4|||
150074637|NCT02004522|541412898|FG001|Overall Study|Other is reason listed by PI|1|||
150074638|NCT02004522|541412897|FG000|Overall Study|Never Dosed|2|||
150074639|NCT02004522|541412898|FG001|Overall Study|Never Dosed|4|||
150074640|NCT02004522|541412897|FG000|Overall Study|Disease Progression|35|||
150074641|NCT02004522|541412898|FG001|Overall Study|Disease Progression|31|||
150074642|NCT02004522|541412897|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
150074643|NCT02004522|541412898|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
150074644|NCT01787331|541412899|FG000|Overall Study|Physician Decision|1|||
150074645|NCT01787331|541412899|FG000|Overall Study|Withdrawal by Subject|1|||
150074646|NCT03281577|541414121|FG000|Overall Study|Adverse Event|0|||
150074647|NCT03281577|541414122|FG001|Overall Study|Adverse Event|0|||
150074648|NCT03281577|541414123|FG002|Overall Study|Adverse Event|0|||
150074649|NCT03281577|541414124|FG003|Overall Study|Adverse Event|1|||
150074650|NCT03281577|541414121|FG000|Overall Study|Withdrawal by Subject|1|||
150074651|NCT03281577|541414122|FG001|Overall Study|Withdrawal by Subject|0|||
150074652|NCT03281577|541414123|FG002|Overall Study|Withdrawal by Subject|0|||
150074653|NCT03281577|541414124|FG003|Overall Study|Withdrawal by Subject|0|||
150074654|NCT01897454|541414125|FG000|Overall Study|Withdrawal by Subject|1|||
150074655|NCT04015336|541414126|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
150074656|NCT00491764|541414127|FG000|Overall Study|Adverse Event|1|||
150074657|NCT00491764|541414128|FG001|Overall Study|Adverse Event|2|||
150074658|NCT00491764|541414129|FG002|Overall Study|Adverse Event|4|||
150074659|NCT00491764|541414130|FG003|Overall Study|Adverse Event|4|||
150074660|NCT00491764|541414131|FG004|Overall Study|Adverse Event|0|||
150074661|NCT00491764|541414132|FG005|Overall Study|Adverse Event|1|||
150074662|NCT00491764|541414127|FG000|Overall Study|Lost to Follow-up|0|||
150074663|NCT00491764|541414128|FG001|Overall Study|Lost to Follow-up|1|||
150074664|NCT00491764|541414129|FG002|Overall Study|Lost to Follow-up|0|||
150074665|NCT00491764|541414130|FG003|Overall Study|Lost to Follow-up|1|||
150074666|NCT00491764|541414131|FG004|Overall Study|Lost to Follow-up|0|||
150074667|NCT00491764|541414132|FG005|Overall Study|Lost to Follow-up|3|||
150074668|NCT00491764|541414127|FG000|Overall Study|Withdrawal by Subject|2|||
150074669|NCT00491764|541414128|FG001|Overall Study|Withdrawal by Subject|3|||
150074670|NCT00491764|541414129|FG002|Overall Study|Withdrawal by Subject|1|||
150074671|NCT00491764|541414130|FG003|Overall Study|Withdrawal by Subject|2|||
150074672|NCT00491764|541414131|FG004|Overall Study|Withdrawal by Subject|2|||
150074673|NCT00491764|541414132|FG005|Overall Study|Withdrawal by Subject|4|||
150074674|NCT00491764|541414127|FG000|Overall Study|Non Compliance with the Protocol|1|||
150074675|NCT00491764|541414128|FG001|Overall Study|Non Compliance with the Protocol|0|||
150074676|NCT00491764|541414129|FG002|Overall Study|Non Compliance with the Protocol|0|||
150074677|NCT00491764|541414130|FG003|Overall Study|Non Compliance with the Protocol|0|||
150074678|NCT00491764|541414131|FG004|Overall Study|Non Compliance with the Protocol|0|||
150074679|NCT00491764|541414132|FG005|Overall Study|Non Compliance with the Protocol|0|||
150074680|NCT00491764|541414127|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
150074681|NCT00491764|541414128|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
150074682|NCT00491764|541414129|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
150074683|NCT00491764|541414130|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
150074684|NCT00491764|541414131|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
150074685|NCT00491764|541414132|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
150074686|NCT00491764|541414127|FG000|Overall Study|Administrative|1|||
150074687|NCT00491764|541414128|FG001|Overall Study|Administrative|0|||
150074688|NCT00491764|541414129|FG002|Overall Study|Administrative|2|||
150074689|NCT00491764|541414130|FG003|Overall Study|Administrative|1|||
150074690|NCT00491764|541414131|FG004|Overall Study|Administrative|0|||
150074691|NCT00491764|541414132|FG005|Overall Study|Administrative|0|||
150074692|NCT00894166|541414133|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
150074693|NCT00894166|541414134|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
150074694|NCT00894166|541414135|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
150074695|NCT00894166|541414136|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
150074696|NCT00894166|541414137|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
150074697|NCT00894166|541414138|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
150074698|NCT00894166|541414139|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
150074699|NCT00894166|541414140|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
150074700|NCT00894166|541414133|FG000|Overall Study|Death|0|||
150074701|NCT00894166|541414134|FG001|Overall Study|Death|0|||
150074702|NCT00894166|541414135|FG002|Overall Study|Death|0|||
150074703|NCT00894166|541414136|FG003|Overall Study|Death|1|||
150074704|NCT00894166|541414137|FG004|Overall Study|Death|0|||
150074705|NCT00894166|541414138|FG005|Overall Study|Death|0|||
150074706|NCT00894166|541414139|FG006|Overall Study|Death|0|||
150074707|NCT00894166|541414140|FG007|Overall Study|Death|0|||
150074708|NCT05350410|541414141|FG000|Overall Study|Withdrawal by Subject|1|||
150074709|NCT01601132|541414142|FG000|Overall Study|Patient withdrew consent|1|||
150074710|NCT01601132|541414142|FG000|Overall Study|Protocol deviation|1|||
150074711|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Adverse Event|3|||
150074712|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Adverse Event|0|||
150074713|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
150074714|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
150074715|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
150074716|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
150074717|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Physician Decision|0|||
150074718|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Physician Decision|2|||
150074719|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
150074720|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
150074721|NCT02110238|541414144|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
150074722|NCT02110238|541414145|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
150074723|NCT02110238|541414144|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
150074724|NCT02110238|541414145|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
150074725|NCT02110238|541414144|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
150074726|NCT02110238|541414145|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
150074727|NCT02110238|541414144|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
150074728|NCT02110238|541414145|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
150074729|NCT02110238|541414144|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
150074730|NCT02110238|541414145|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
150074731|NCT02110238|541414144|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
150074732|NCT02110238|541414145|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
150074733|NCT00142935|541414150|FG000|Overall Study|Other reason|1|||
150074734|NCT00142935|541414151|FG001|Overall Study|Other reason|1|||
150074735|NCT00142935|541414152|FG002|Overall Study|Other reason|1|||
150074736|NCT00142935|541414150|FG000|Overall Study|Lost to Follow-up|2|||
150074737|NCT00142935|541414151|FG001|Overall Study|Lost to Follow-up|5|||
150074738|NCT00142935|541414152|FG002|Overall Study|Lost to Follow-up|5|||
150074739|NCT00142935|541414150|FG000|Overall Study|Death|0|||
150074740|NCT00142935|541414151|FG001|Overall Study|Death|2|||
150074741|NCT00142935|541414152|FG002|Overall Study|Death|1|||
150074742|NCT00129272|541414155|FG000|Overall Study|Lost to Follow-up|12|||
150074743|NCT00129272|541414156|FG001|Overall Study|Lost to Follow-up|11|||
150074744|NCT00129272|541414155|FG000|Overall Study|Withdrawal by Subject|5|||
150074745|NCT00129272|541414156|FG001|Overall Study|Withdrawal by Subject|11|||
150074746|NCT01146912|541414160|FG000|Overall Study|Already received influenza vaccination|817|||
150074747|NCT01146912|541414161|FG001|Overall Study|Already received influenza vaccination|822|||
150074748|NCT01146912|541414162|FG002|Overall Study|Already received influenza vaccination|13|||
150074749|NCT01146912|541414163|FG003|Overall Study|Already received influenza vaccination|15|||
150074750|NCT01146912|541414164|FG004|Overall Study|Already received influenza vaccination|41|||
150074751|NCT01146912|541414165|FG005|Overall Study|Already received influenza vaccination|61|||
150074752|NCT01146912|541414166|FG006|Overall Study|Already received influenza vaccination|56|||
150074753|NCT01146912|541414167|FG007|Overall Study|Already received influenza vaccination|0|||
150074754|NCT01146912|541414160|FG000|Overall Study|< 14 weeks gestational age|0|||
150074755|NCT01146912|541414161|FG001|Overall Study|< 14 weeks gestational age|0|||
150074756|NCT01146912|541414162|FG002|Overall Study|< 14 weeks gestational age|3|||
150074757|NCT01146912|541414163|FG003|Overall Study|< 14 weeks gestational age|2|||
150074758|NCT01146912|541414164|FG004|Overall Study|< 14 weeks gestational age|0|||
150074759|NCT01146912|541414165|FG005|Overall Study|< 14 weeks gestational age|0|||
150074760|NCT01146912|541414166|FG006|Overall Study|< 14 weeks gestational age|0|||
150074761|NCT01146912|541414167|FG007|Overall Study|< 14 weeks gestational age|0|||
150074762|NCT01146912|541414160|FG000|Overall Study|Duplicate patient|0|||
150074763|NCT01146912|541414161|FG001|Overall Study|Duplicate patient|0|||
150074764|NCT01146912|541414162|FG002|Overall Study|Duplicate patient|1|||
150074765|NCT01146912|541414163|FG003|Overall Study|Duplicate patient|0|||
150074766|NCT01146912|541414164|FG004|Overall Study|Duplicate patient|0|||
150074767|NCT01146912|541414165|FG005|Overall Study|Duplicate patient|0|||
150074768|NCT01146912|541414166|FG006|Overall Study|Duplicate patient|0|||
150074769|NCT01146912|541414167|FG007|Overall Study|Duplicate patient|0|||
150074770|NCT00074984|541414168|FG000|Overall Study|Death|1|||
150074771|NCT00074984|541414169|FG001|Overall Study|Death|2|||
150074772|NCT00074984|541414168|FG000|Overall Study|Withdrawal by Subject|2|||
150074773|NCT00074984|541414169|FG001|Overall Study|Withdrawal by Subject|3|||
150074774|NCT00074984|541414168|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
150074775|NCT00074984|541414169|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
150074776|NCT03080454|541414170|FG000|Baseline|Adverse Event|2|||
150074777|NCT03080454|541414170|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
150074778|NCT03080454|541414170|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
150074779|NCT02202980|541414171|FG000|Overall Study|Lack of Efficacy|1|||
150074780|NCT02202980|541414172|FG001|Overall Study|Lack of Efficacy|0|||
150074781|NCT02202980|541414173|FG002|Overall Study|Lack of Efficacy|7|||
150074782|NCT02202980|541414174|FG003|Overall Study|Lack of Efficacy|0|||
150074783|NCT02202980|541414175|FG004|Overall Study|Lack of Efficacy|3|||
150074784|NCT02202980|541414176|FG005|Overall Study|Lack of Efficacy|1|||
150074785|NCT02202980|541414177|FG006|Overall Study|Lack of Efficacy|11|||
150074786|NCT02202980|541414178|FG007|Overall Study|Lack of Efficacy|2|||
150074787|NCT02202980|541414179|FG008|Overall Study|Lack of Efficacy|2|||
150074788|NCT02202980|541414180|FG009|Overall Study|Lack of Efficacy|0|||
150074789|NCT02202980|541414181|FG010|Overall Study|Lack of Efficacy|0|||
150074790|NCT02202980|541414182|FG011|Overall Study|Lack of Efficacy|3|||
150074791|NCT02202980|541414183|FG012|Overall Study|Lack of Efficacy|10|||
150074792|NCT02202980|541414184|FG013|Overall Study|Lack of Efficacy|0|||
150074793|NCT02202980|541414171|FG000|Overall Study|Protocol Violation|0|||
150074794|NCT02202980|541414172|FG001|Overall Study|Protocol Violation|0|||
150074795|NCT02202980|541414173|FG002|Overall Study|Protocol Violation|0|||
150074796|NCT02202980|541414174|FG003|Overall Study|Protocol Violation|3|||
150074797|NCT02202980|541414175|FG004|Overall Study|Protocol Violation|3|||
150074798|NCT02202980|541414176|FG005|Overall Study|Protocol Violation|0|||
150074799|NCT02202980|541414177|FG006|Overall Study|Protocol Violation|0|||
150074800|NCT02202980|541414178|FG007|Overall Study|Protocol Violation|0|||
150074801|NCT02202980|541414179|FG008|Overall Study|Protocol Violation|0|||
150074802|NCT02202980|541414180|FG009|Overall Study|Protocol Violation|0|||
150074803|NCT02202980|541414181|FG010|Overall Study|Protocol Violation|0|||
150074804|NCT02202980|541414182|FG011|Overall Study|Protocol Violation|0|||
150074805|NCT02202980|541414183|FG012|Overall Study|Protocol Violation|0|||
150074806|NCT02202980|541414184|FG013|Overall Study|Protocol Violation|0|||
150074807|NCT02202980|541414171|FG000|Overall Study|Lost to Follow-up|0|||
150074808|NCT02202980|541414172|FG001|Overall Study|Lost to Follow-up|1|||
150074809|NCT02202980|541414173|FG002|Overall Study|Lost to Follow-up|1|||
150074810|NCT02202980|541414174|FG003|Overall Study|Lost to Follow-up|1|||
150074811|NCT02202980|541414175|FG004|Overall Study|Lost to Follow-up|0|||
150074812|NCT02202980|541414176|FG005|Overall Study|Lost to Follow-up|0|||
150074813|NCT02202980|541414177|FG006|Overall Study|Lost to Follow-up|0|||
150074814|NCT02202980|541414178|FG007|Overall Study|Lost to Follow-up|1|||
150074815|NCT02202980|541414179|FG008|Overall Study|Lost to Follow-up|1|||
150074816|NCT02202980|541414180|FG009|Overall Study|Lost to Follow-up|0|||
150074817|NCT02202980|541414181|FG010|Overall Study|Lost to Follow-up|0|||
150074818|NCT02202980|541414182|FG011|Overall Study|Lost to Follow-up|0|||
150074819|NCT02202980|541414183|FG012|Overall Study|Lost to Follow-up|1|||
150074820|NCT02202980|541414184|FG013|Overall Study|Lost to Follow-up|0|||
150074821|NCT02202980|541414171|FG000|Overall Study|Withdrew Consent|0|||
150074822|NCT02202980|541414172|FG001|Overall Study|Withdrew Consent|1|||
150074823|NCT02202980|541414173|FG002|Overall Study|Withdrew Consent|2|||
150074824|NCT02202980|541414174|FG003|Overall Study|Withdrew Consent|0|||
150074825|NCT02202980|541414175|FG004|Overall Study|Withdrew Consent|0|||
150074826|NCT02202980|541414176|FG005|Overall Study|Withdrew Consent|0|||
150074827|NCT02202980|541414177|FG006|Overall Study|Withdrew Consent|0|||
150074828|NCT02202980|541414178|FG007|Overall Study|Withdrew Consent|0|||
150074829|NCT02202980|541414179|FG008|Overall Study|Withdrew Consent|1|||
150074830|NCT02202980|541414180|FG009|Overall Study|Withdrew Consent|0|||
150074831|NCT02202980|541414181|FG010|Overall Study|Withdrew Consent|0|||
150074832|NCT02202980|541414182|FG011|Overall Study|Withdrew Consent|0|||
150074833|NCT02202980|541414183|FG012|Overall Study|Withdrew Consent|0|||
150074834|NCT02202980|541414184|FG013|Overall Study|Withdrew Consent|0|||
150074835|NCT01952145|541414185|FG000|Overall Study|Protocol Violation|2|||
150074836|NCT01952145|541414186|FG001|Overall Study|Protocol Violation|1|||
150074837|NCT01952145|541414185|FG000|Overall Study|Death|0|||
150074838|NCT01952145|541414186|FG001|Overall Study|Death|1|||
150074839|NCT01952145|541414185|FG000|Overall Study|Adverse Event|9|||
150074840|NCT01952145|541414186|FG001|Overall Study|Adverse Event|0|||
150074841|NCT01952145|541414185|FG000|Overall Study|Withdrawal Criteria|16|||
150074842|NCT01952145|541414186|FG001|Overall Study|Withdrawal Criteria|11|||
150074843|NCT01952145|541414185|FG000|Overall Study|Unclassified|1|||
150074844|NCT01952145|541414186|FG001|Overall Study|Unclassified|1|||
150074845|NCT04138810|541414193|FG000|Overall Study|Withdrawal by Subject|0|||
150074846|NCT04138810|541414194|FG001|Overall Study|Withdrawal by Subject|1|||
150074847|NCT04138810|541414193|FG000|Overall Study|Subject cancelled surgery|1|||
150074848|NCT04138810|541414194|FG001|Overall Study|Subject cancelled surgery|0|||
150074849|NCT00591344|541414195|FG000|Overall Study|Transportation issues|1|||
150074850|NCT00591344|541414196|FG001|Overall Study|Transportation issues|0|||
150074851|NCT00591344|541414195|FG000|Overall Study|Moved out of state|1|||
150074852|NCT00591344|541414196|FG001|Overall Study|Moved out of state|0|||
150074853|NCT00591344|541414195|FG000|Overall Study|Medical complications|1|||
150074854|NCT00591344|541414196|FG001|Overall Study|Medical complications|3|||
150074855|NCT00591344|541414195|FG000|Overall Study|Underwent DBS|2|||
150074856|NCT00591344|541414196|FG001|Overall Study|Underwent DBS|2|||
150074857|NCT00591344|541414195|FG000|Overall Study|Death|0|||
150074858|NCT00591344|541414196|FG001|Overall Study|Death|1|||
150074859|NCT00591344|541414195|FG000|Overall Study|Lost to Follow-up|0|||
150074860|NCT00591344|541414196|FG001|Overall Study|Lost to Follow-up|1|||
150074861|NCT00591344|541414195|FG000|Overall Study|Did not want to come off medication|0|||
150074862|NCT00591344|541414196|FG001|Overall Study|Did not want to come off medication|1|||
150074863|NCT00413244|541414200|FG000|Overall Study|Withdrawal by Subject|10|||
150074864|NCT00413244|541414201|FG001|Overall Study|Withdrawal by Subject|1|||
150074865|NCT00619177|541414203|FG000|Overall Study|Adverse Event|18|||
150074866|NCT00619177|541414203|FG000|Overall Study|Lost to Follow-up|2|||
150074867|NCT00619177|541414203|FG000|Overall Study|Lack of Efficacy|1|||
150074868|NCT00619177|541414203|FG000|Overall Study|Missing termination information|481|||
150074869|NCT00619177|541414203|FG000|Overall Study|Not specified reasons|6|||
150074870|NCT01609231|541414204|FG000|Overall Study|Adverse Event|1|||
150074871|NCT01609231|541414205|FG001|Overall Study|Adverse Event|3|||
150074872|NCT01609231|541414204|FG000|Overall Study|Physician Decision|1|||
150074873|NCT01609231|541414205|FG001|Overall Study|Physician Decision|0|||
150074874|NCT01609231|541414204|FG000|Overall Study|Withdrawal by Subject|1|||
150074875|NCT01609231|541414205|FG001|Overall Study|Withdrawal by Subject|0|||
150074876|NCT01180647|541414206|FG000|Overall Study|Lost to Follow-up|5|||
150074877|NCT01180647|541414207|FG001|Overall Study|Lost to Follow-up|6|||
150025804|NCT01329978|541230416|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
150025805|NCT01329978|541230417|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
150025806|NCT01329978|541230418|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
150025807|NCT01329978|541230419|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
150025808|NCT01329978|541230415|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
150025809|NCT01329978|541230416|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
150025810|NCT01329978|541230417|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
150074878|NCT00071396|541414216|FG000|Overall Study|Withdrawal by Subject|1|||
150074879|NCT00071396|541414216|FG000|Overall Study|Physician Decision|2|||
150074880|NCT04545554|541414217|FG000|Overall Study|Withdrawal by Subject|0|||
150074881|NCT04545554|541414218|FG001|Overall Study|Withdrawal by Subject|0|||
150074882|NCT04545554|541414219|FG002|Overall Study|Withdrawal by Subject|0|||
150074883|NCT04545554|541414220|FG003|Overall Study|Withdrawal by Subject|1|||
150074884|NCT04545554|541414221|FG004|Overall Study|Withdrawal by Subject|0|||
150074885|NCT04545554|541414222|FG005|Overall Study|Withdrawal by Subject|0|||
150074886|NCT00116428|541414223|FG000|Overall Study|Withdrawal by Subject|2|||
150074887|NCT00116428|541414224|FG001|Overall Study|Withdrawal by Subject|5|||
150074888|NCT00116428|541414223|FG000|Overall Study|Did not meet inclusion criteria|1|||
150074889|NCT00116428|541414224|FG001|Overall Study|Did not meet inclusion criteria|0|||
150074890|NCT01032174|541414225|FG000|Overall Study|Adverse Event|0|||
150074891|NCT01032174|541414226|FG001|Overall Study|Adverse Event|1|||
150074892|NCT04295772|541414231|FG000|Overall Study|Protocol Violation|1|||
150074893|NCT04295772|541414232|FG001|Overall Study|Protocol Violation|0|||
150074894|NCT04295772|541414231|FG000|Overall Study|Ongoing for safety monitoring|14|||
150074895|NCT04295772|541414232|FG001|Overall Study|Ongoing for safety monitoring|1|||
150074896|NCT04295772|541414231|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
150074897|NCT04295772|541414232|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
150074898|NCT02635776|541414233|FG000|Overall Study|Physician Decision|1|||
150074899|NCT02635776|541414234|FG001|Overall Study|Physician Decision|0|||
150074900|NCT02635776|541414233|FG000|Overall Study|Adverse Event|51|||
150074901|NCT02635776|541414234|FG001|Overall Study|Adverse Event|3|||
150074902|NCT02635776|541414233|FG000|Overall Study|Withdrawal by Subject|41|||
150074903|NCT02635776|541414234|FG001|Overall Study|Withdrawal by Subject|7|||
150074904|NCT02635776|541414233|FG000|Overall Study|Lost to Follow-up|4|||
150074905|NCT02635776|541414234|FG001|Overall Study|Lost to Follow-up|0|||
150074906|NCT02635776|541414233|FG000|Overall Study|Other reasons|5|||
150074907|NCT02635776|541414234|FG001|Overall Study|Other reasons|1|||
150074908|NCT01811225|541414235|FG000|Treatment Period 1|Adverse Event|2|||
150074909|NCT01811225|541414236|FG001|Treatment Period 1|Adverse Event|3|||
150074910|NCT01811225|541414235|FG000|Treatment Period 1|Lost to Follow-up|12|||
150074911|NCT01811225|541414236|FG001|Treatment Period 1|Lost to Follow-up|8|||
150074912|NCT01811225|541414235|FG000|Treatment Period 1|transporation|1|||
150074913|NCT01811225|541414236|FG001|Treatment Period 1|transporation|0|||
150074914|NCT01811225|541414235|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
150074915|NCT01811225|541414236|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
150074916|NCT01811225|541414235|FG000|Treatment Period 2|Lost to Follow-up|1|||
150074917|NCT01811225|541414236|FG001|Treatment Period 2|Lost to Follow-up|2|||
150074918|NCT01811225|541414235|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
150074919|NCT01811225|541414236|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
150074920|NCT00287365|541414237|FG000|Overall Study|sample not acquired|13|||
150074921|NCT00400764|541414238|FG000|Phase Ib|Adverse Event|1|||
150074922|NCT00400764|541414239|FG001|Phase Ib|Adverse Event|0|||
150074923|NCT00400764|541414240|FG002|Phase Ib|Adverse Event|0|||
150074924|NCT00400764|541414241|FG003|Phase Ib|Adverse Event|0|||
150074925|NCT00400764|541414242|FG004|Phase Ib|Adverse Event|0|||
150074926|NCT00400764|541414238|FG000|Phase Ib|Death|1|||
150074927|NCT00400764|541414239|FG001|Phase Ib|Death|0|||
150074928|NCT00400764|541414240|FG002|Phase Ib|Death|0|||
150074929|NCT00400764|541414241|FG003|Phase Ib|Death|0|||
150074930|NCT00400764|541414242|FG004|Phase Ib|Death|0|||
150074931|NCT00400764|541414238|FG000|Phase Ib|Disease Progression|4|||
150074932|NCT00400764|541414239|FG001|Phase Ib|Disease Progression|4|||
150074933|NCT00400764|541414240|FG002|Phase Ib|Disease Progression|0|||
150074934|NCT00400764|541414241|FG003|Phase Ib|Disease Progression|0|||
150074935|NCT00400764|541414242|FG004|Phase Ib|Disease Progression|0|||
150074936|NCT00400764|541414238|FG000|Phase II|Death|0|||
150074937|NCT00400764|541414239|FG001|Phase II|Death|0|||
150074938|NCT00400764|541414240|FG002|Phase II|Death|1|||
150074939|NCT00400764|541414241|FG003|Phase II|Death|2|||
150074940|NCT00400764|541414242|FG004|Phase II|Death|0|||
150074941|NCT00400764|541414238|FG000|Phase II|Lost to Follow-up|0|||
150074942|NCT00400764|541414239|FG001|Phase II|Lost to Follow-up|0|||
150074943|NCT00400764|541414240|FG002|Phase II|Lost to Follow-up|1|||
150074944|NCT00400764|541414241|FG003|Phase II|Lost to Follow-up|0|||
150074945|NCT00400764|541414242|FG004|Phase II|Lost to Follow-up|0|||
150074946|NCT00400764|541414238|FG000|Phase II|Physician Decision|0|||
150074947|NCT00400764|541414239|FG001|Phase II|Physician Decision|0|||
150074948|NCT00400764|541414240|FG002|Phase II|Physician Decision|1|||
150074949|NCT00400764|541414241|FG003|Phase II|Physician Decision|1|||
150074950|NCT00400764|541414242|FG004|Phase II|Physician Decision|0|||
150074951|NCT00400764|541414238|FG000|Phase II|Sponsor's decision to terminate|0|||
150074952|NCT00400764|541414239|FG001|Phase II|Sponsor's decision to terminate|0|||
150074953|NCT00400764|541414240|FG002|Phase II|Sponsor's decision to terminate|18|||
150074954|NCT00400764|541414241|FG003|Phase II|Sponsor's decision to terminate|22|||
150074955|NCT00400764|541414242|FG004|Phase II|Sponsor's decision to terminate|11|||
150074956|NCT00400764|541414238|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
150074957|NCT00400764|541414239|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
150074958|NCT00400764|541414240|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
150074959|NCT00400764|541414241|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
150074960|NCT00400764|541414242|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
150074961|NCT00400764|541414238|FG000|Phase II|Withdrawal by Subject|0|||
150074962|NCT00400764|541414239|FG001|Phase II|Withdrawal by Subject|0|||
150074963|NCT00400764|541414240|FG002|Phase II|Withdrawal by Subject|1|||
150074964|NCT00400764|541414241|FG003|Phase II|Withdrawal by Subject|1|||
150074965|NCT00400764|541414242|FG004|Phase II|Withdrawal by Subject|0|||
150074966|NCT02925117|541414244|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
150074967|NCT02925117|541414245|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
150074968|NCT02925117|541414246|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
150074969|NCT02925117|541414247|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
150074970|NCT02925117|541414248|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074971|NCT02925117|541414249|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074972|NCT02925117|541414250|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074973|NCT02925117|541414251|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074974|NCT02925117|541414252|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074975|NCT02925117|541414253|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074976|NCT02925117|541414254|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074977|NCT02925117|541414255|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
150074978|NCT02925117|541414244|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
150074979|NCT02925117|541414245|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
150074980|NCT02925117|541414246|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
150074981|NCT02925117|541414247|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074982|NCT02925117|541414248|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074983|NCT02925117|541414249|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074984|NCT02925117|541414250|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074985|NCT02925117|541414251|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074986|NCT02925117|541414252|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074987|NCT02925117|541414253|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074988|NCT02925117|541414254|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074989|NCT02925117|541414255|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
150074990|NCT02925117|541414244|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
150074991|NCT02925117|541414245|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
150074992|NCT02925117|541414246|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074993|NCT02925117|541414247|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074994|NCT02925117|541414248|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074995|NCT02925117|541414249|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074996|NCT02925117|541414250|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074997|NCT02925117|541414251|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074998|NCT02925117|541414252|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150074999|NCT02925117|541414253|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150075000|NCT02925117|541414254|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150075001|NCT02925117|541414255|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
150075002|NCT02925117|541414244|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
150075003|NCT02925117|541414245|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
150075004|NCT02925117|541414246|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
150075005|NCT02925117|541414247|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
150075006|NCT02925117|541414248|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
150075007|NCT02925117|541414249|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
150075008|NCT02925117|541414250|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
150075009|NCT02925117|541414251|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
150075010|NCT02925117|541414252|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
150075011|NCT02925117|541414253|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
150075012|NCT02925117|541414254|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
150075013|NCT02925117|541414255|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
150075014|NCT02925117|541414244|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075015|NCT02925117|541414245|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075016|NCT02925117|541414246|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075017|NCT02925117|541414247|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075018|NCT02925117|541414248|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075019|NCT02925117|541414249|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
150075020|NCT02925117|541414250|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075021|NCT02925117|541414251|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075022|NCT02925117|541414252|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075023|NCT02925117|541414253|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
150075024|NCT02925117|541414254|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
150075025|NCT02925117|541414255|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
150075026|NCT02925117|541414244|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
150075027|NCT02925117|541414245|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
150075028|NCT02925117|541414246|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
150075029|NCT02925117|541414247|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
150075030|NCT02925117|541414248|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
150075031|NCT02925117|541414249|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
150075032|NCT02925117|541414250|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
150075033|NCT02925117|541414251|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
150075034|NCT02925117|541414252|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
150075035|NCT02925117|541414253|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
150075036|NCT02925117|541414254|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
150182475|NCT04110054|541804732|FG003|Overall Study|COVID-19 reason other than AE|0|||
150182476|NCT04110054|541804729|FG000|Overall Study|Withdrawal by Subject|0|||
150182477|NCT04110054|541804730|FG001|Overall Study|Withdrawal by Subject|3|||
150182478|NCT04110054|541804731|FG002|Overall Study|Withdrawal by Subject|2|||
150182479|NCT04110054|541804732|FG003|Overall Study|Withdrawal by Subject|0|||
150182480|NCT04110054|541804729|FG000|Overall Study|Adverse Event|1|||
150182481|NCT04110054|541804730|FG001|Overall Study|Adverse Event|1|||
150075037|NCT02925117|541414255|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
150075038|NCT02925117|541414244|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075039|NCT02925117|541414245|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075040|NCT02925117|541414246|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075041|NCT02925117|541414247|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075042|NCT02925117|541414248|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
150075043|NCT02925117|541414249|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
150075044|NCT02925117|541414250|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
150075045|NCT02925117|541414251|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
150075046|NCT02925117|541414252|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
150075047|NCT02925117|541414253|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075048|NCT02925117|541414254|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
150075049|NCT02925117|541414255|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
150075050|NCT02925117|541414244|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
150075051|NCT02925117|541414245|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
150075052|NCT02925117|541414246|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
150182482|NCT04110054|541804731|FG002|Overall Study|Adverse Event|4|||
150075053|NCT02925117|541414247|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
150075054|NCT02925117|541414248|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
150075055|NCT02925117|541414249|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
150075056|NCT02925117|541414250|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
150075057|NCT02925117|541414251|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
150075058|NCT02925117|541414252|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
150075059|NCT02925117|541414253|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
150075060|NCT02925117|541414254|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
150075061|NCT02925117|541414255|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
150075062|NCT03113071|541414257|FG000|Overall Study|Withdrawal by Subject|1|||
150075063|NCT03113071|541414258|FG001|Overall Study|Withdrawal by Subject|0|||
150075064|NCT00302107|541414262|FG000|Overall Study|Lost to Follow-up|6|||
150075065|NCT00302107|541414263|FG001|Overall Study|Lost to Follow-up|5|||
150075066|NCT00302107|541414262|FG000|Overall Study|Protocol Violation|1|||
150075067|NCT00302107|541414263|FG001|Overall Study|Protocol Violation|0|||
150075068|NCT00302107|541414262|FG000|Overall Study|Relocation|0|||
150075069|NCT00302107|541414263|FG001|Overall Study|Relocation|1|||
150075070|NCT00302107|541414262|FG000|Overall Study|Withdrawal by Subject|0|||
150075071|NCT00302107|541414263|FG001|Overall Study|Withdrawal by Subject|3|||
150075072|NCT00302107|541414262|FG000|Overall Study|Adverse Event|1|||
150075073|NCT00302107|541414263|FG001|Overall Study|Adverse Event|0|||
150075074|NCT00437983|541414264|FG000|Overall Study|Adverse Event|6|||
150075075|NCT00437983|541414265|FG001|Overall Study|Adverse Event|6|||
150075076|NCT00437983|541414264|FG000|Overall Study|Protocol Violation|2|||
150075077|NCT00437983|541414265|FG001|Overall Study|Protocol Violation|1|||
150075078|NCT00437983|541414264|FG000|Overall Study|Withdrawal by Subject|5|||
150075079|NCT00437983|541414265|FG001|Overall Study|Withdrawal by Subject|6|||
150075080|NCT00621959|541414266|FG000|Overall Study|Adverse Event|4|||
150075081|NCT00621959|541414267|FG001|Overall Study|Adverse Event|2|||
150075082|NCT00621959|541414266|FG000|Overall Study|Lack of Efficacy|1|||
150075083|NCT00621959|541414267|FG001|Overall Study|Lack of Efficacy|1|||
150075084|NCT00621959|541414266|FG000|Overall Study|Lost to Follow-up|0|||
150075085|NCT00621959|541414267|FG001|Overall Study|Lost to Follow-up|2|||
150075086|NCT00621959|541414266|FG000|Overall Study|Withdrawal by Subject|1|||
150075087|NCT00621959|541414267|FG001|Overall Study|Withdrawal by Subject|1|||
150075088|NCT00621959|541414266|FG000|Overall Study|Other|1|||
150075089|NCT00621959|541414267|FG001|Overall Study|Other|3|||
150075090|NCT00594659|541414270|FG000|Overall Study|Lost to Follow-up|13|||
150075091|NCT00594659|541414271|FG001|Overall Study|Lost to Follow-up|9|||
150075092|NCT00594659|541414272|FG002|Overall Study|Lost to Follow-up|7|||
150075093|NCT04439201|541414273|FG000|Overall Study|Ineligible|2|||
150075094|NCT04439201|541414273|FG000|Overall Study|Never start protocol therapy|1|||
150075095|NCT04439201|541414273|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
150075096|NCT04439201|541414273|FG000|Overall Study|Mutation status not confirmed|4|||
150075097|NCT04439201|541414273|FG000|Overall Study|Adverse Event|1|||
150075098|NCT04439201|541414273|FG000|Overall Study|Death|7|||
150075099|NCT04439201|541414273|FG000|Overall Study|Withdrawal by Subject|2|||
150075100|NCT04439201|541414273|FG000|Overall Study|Disease progression|20|||
150075101|NCT04439201|541414273|FG000|Overall Study|Alternative therapy|1|||
150075102|NCT04439201|541414273|FG000|Overall Study|Physician Decision|1|||
150075103|NCT03320057|541415991|FG000|Overall Study|Lost to Follow-up|4|||
150075104|NCT03320057|541415992|FG001|Overall Study|Lost to Follow-up|17|||
150075105|NCT03320057|541415991|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
150075106|NCT03320057|541415992|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
150075107|NCT00403234|541415993|FG000|Overall Study|Withdrawal by Subject|0|||
150075108|NCT00403234|541415994|FG001|Overall Study|Withdrawal by Subject|1|||
150075109|NCT00403234|541415995|FG002|Overall Study|Withdrawal by Subject|0|||
150075110|NCT00403234|541415996|FG003|Overall Study|Withdrawal by Subject|0|||
150075111|NCT00403234|541415993|FG000|Overall Study|Adverse Event|1|||
150075112|NCT00403234|541415994|FG001|Overall Study|Adverse Event|0|||
150075113|NCT00403234|541415995|FG002|Overall Study|Adverse Event|1|||
150075114|NCT00403234|541415996|FG003|Overall Study|Adverse Event|0|||
150075115|NCT02468674|541415997|FG000|Overall Study|Adverse Event|0|||
150075116|NCT02468674|541415998|FG001|Overall Study|Adverse Event|0|||
150075117|NCT02468674|541415999|FG002|Overall Study|Adverse Event|0|||
150075118|NCT02468674|541416000|FG003|Overall Study|Adverse Event|1|||
150075119|NCT02468674|541416001|FG004|Overall Study|Adverse Event|0|||
150075120|NCT02468674|541416002|FG005|Overall Study|Adverse Event|1|||
150075121|NCT02468674|541416003|FG006|Overall Study|Adverse Event|0|||
150075122|NCT02468674|541416004|FG007|Overall Study|Adverse Event|0|||
150075123|NCT02468674|541416005|FG008|Overall Study|Adverse Event|0|||
150075124|NCT02468674|541415997|FG000|Overall Study|Lost to Follow-up|1|||
150075125|NCT02468674|541415998|FG001|Overall Study|Lost to Follow-up|0|||
150075126|NCT02468674|541415999|FG002|Overall Study|Lost to Follow-up|0|||
150075127|NCT02468674|541416000|FG003|Overall Study|Lost to Follow-up|0|||
150075128|NCT02468674|541416001|FG004|Overall Study|Lost to Follow-up|0|||
150075129|NCT02468674|541416002|FG005|Overall Study|Lost to Follow-up|0|||
150075130|NCT02468674|541416003|FG006|Overall Study|Lost to Follow-up|0|||
150075131|NCT02468674|541416004|FG007|Overall Study|Lost to Follow-up|1|||
150075132|NCT02468674|541416005|FG008|Overall Study|Lost to Follow-up|1|||
150075133|NCT02468674|541415997|FG000|Overall Study|Physician Decision|0|||
150075134|NCT02468674|541415998|FG001|Overall Study|Physician Decision|0|||
150075135|NCT02468674|541415999|FG002|Overall Study|Physician Decision|0|||
150075136|NCT02468674|541416000|FG003|Overall Study|Physician Decision|0|||
150075137|NCT02468674|541416001|FG004|Overall Study|Physician Decision|0|||
150075138|NCT02468674|541416002|FG005|Overall Study|Physician Decision|0|||
150075139|NCT02468674|541416003|FG006|Overall Study|Physician Decision|1|||
150075140|NCT02468674|541416004|FG007|Overall Study|Physician Decision|0|||
150075141|NCT02468674|541416005|FG008|Overall Study|Physician Decision|0|||
150075142|NCT02468674|541415997|FG000|Overall Study|Patient/Guardian Decision|0|||
150075143|NCT02468674|541415998|FG001|Overall Study|Patient/Guardian Decision|0|||
150075144|NCT02468674|541415999|FG002|Overall Study|Patient/Guardian Decision|0|||
150075145|NCT02468674|541416000|FG003|Overall Study|Patient/Guardian Decision|0|||
150075146|NCT02468674|541416001|FG004|Overall Study|Patient/Guardian Decision|1|||
150075147|NCT02468674|541416002|FG005|Overall Study|Patient/Guardian Decision|0|||
150075148|NCT02468674|541416003|FG006|Overall Study|Patient/Guardian Decision|0|||
150075149|NCT02468674|541416004|FG007|Overall Study|Patient/Guardian Decision|2|||
150075150|NCT02468674|541416005|FG008|Overall Study|Patient/Guardian Decision|1|||
150075151|NCT02468674|541415997|FG000|Overall Study|Protocol Deviation|0|||
150075152|NCT02468674|541415998|FG001|Overall Study|Protocol Deviation|0|||
150075153|NCT02468674|541415999|FG002|Overall Study|Protocol Deviation|0|||
150075154|NCT02468674|541416000|FG003|Overall Study|Protocol Deviation|0|||
150075155|NCT02468674|541416001|FG004|Overall Study|Protocol Deviation|0|||
150075156|NCT02468674|541416002|FG005|Overall Study|Protocol Deviation|0|||
150075157|NCT02468674|541416003|FG006|Overall Study|Protocol Deviation|0|||
150075158|NCT02468674|541416004|FG007|Overall Study|Protocol Deviation|1|||
150075159|NCT02468674|541416005|FG008|Overall Study|Protocol Deviation|1|||
150075160|NCT01644565|541416007|FG000|Overall Study|Undisclosed Medical History|1|||
150075161|NCT01644565|541416008|FG001|Overall Study|Undisclosed Medical History|0|||
150075162|NCT01644565|541416009|FG002|Overall Study|Undisclosed Medical History|0|||
150075163|NCT01644565|541416010|FG003|Overall Study|Undisclosed Medical History|0|||
150075164|NCT01644565|541416011|FG004|Overall Study|Undisclosed Medical History|0|||
150075165|NCT01644565|541416012|FG005|Overall Study|Undisclosed Medical History|0|||
150075166|NCT01644565|541416013|FG006|Overall Study|Undisclosed Medical History|0|||
150075167|NCT01644565|541416014|FG007|Overall Study|Undisclosed Medical History|0|||
150075168|NCT01644565|541416015|FG008|Overall Study|Undisclosed Medical History|0|||
150075169|NCT01644565|541416007|FG000|Overall Study|Lost to Follow-up|0|||
150075170|NCT01644565|541416008|FG001|Overall Study|Lost to Follow-up|0|||
150075171|NCT01644565|541416009|FG002|Overall Study|Lost to Follow-up|0|||
150075172|NCT01644565|541416010|FG003|Overall Study|Lost to Follow-up|1|||
150075173|NCT01644565|541416011|FG004|Overall Study|Lost to Follow-up|0|||
150075174|NCT01644565|541416012|FG005|Overall Study|Lost to Follow-up|0|||
150075175|NCT01644565|541416013|FG006|Overall Study|Lost to Follow-up|0|||
150075176|NCT01644565|541416014|FG007|Overall Study|Lost to Follow-up|2|||
150075177|NCT01644565|541416015|FG008|Overall Study|Lost to Follow-up|0|||
150075178|NCT01644565|541416007|FG000|Overall Study|Family emergency|0|||
150075179|NCT01644565|541416008|FG001|Overall Study|Family emergency|0|||
150075180|NCT01644565|541416009|FG002|Overall Study|Family emergency|0|||
150075181|NCT01644565|541416010|FG003|Overall Study|Family emergency|0|||
150075182|NCT01644565|541416011|FG004|Overall Study|Family emergency|1|||
150075183|NCT01644565|541416012|FG005|Overall Study|Family emergency|0|||
150075184|NCT01644565|541416013|FG006|Overall Study|Family emergency|0|||
150075185|NCT01644565|541416014|FG007|Overall Study|Family emergency|0|||
150075186|NCT01644565|541416015|FG008|Overall Study|Family emergency|0|||
150075187|NCT01644565|541416007|FG000|Overall Study|Relocation|0|||
150075188|NCT01644565|541416008|FG001|Overall Study|Relocation|0|||
150075189|NCT01644565|541416009|FG002|Overall Study|Relocation|0|||
150075190|NCT01644565|541416010|FG003|Overall Study|Relocation|0|||
150075191|NCT01644565|541416011|FG004|Overall Study|Relocation|0|||
150075192|NCT01644565|541416012|FG005|Overall Study|Relocation|0|||
150075193|NCT01644565|541416013|FG006|Overall Study|Relocation|0|||
150075194|NCT01644565|541416014|FG007|Overall Study|Relocation|0|||
150075195|NCT01644565|541416015|FG008|Overall Study|Relocation|1|||
150075196|NCT01550289|541416016|FG000|Overall Study|Protocol Violation|1|||
150075197|NCT01550289|541416017|FG001|Overall Study|Protocol Violation|0|||
150075198|NCT01550289|541416016|FG000|Overall Study|Lost to Follow-up|1|||
150075199|NCT01550289|541416017|FG001|Overall Study|Lost to Follow-up|1|||
150075200|NCT01550289|541416016|FG000|Overall Study|Withdrawal by Subject|11|||
150075201|NCT01550289|541416017|FG001|Overall Study|Withdrawal by Subject|3|||
150075202|NCT00541931|541416019|FG000|Overall Study|Adverse Event|1|||
150075203|NCT00541931|541416020|FG001|Overall Study|Adverse Event|0|||
150075204|NCT00541931|541416019|FG000|Overall Study|Lost to Follow-up|3|||
150075205|NCT00541931|541416020|FG001|Overall Study|Lost to Follow-up|3|||
150075206|NCT00541931|541416019|FG000|Overall Study|Withdrawal by Subject|1|||
150075207|NCT00541931|541416020|FG001|Overall Study|Withdrawal by Subject|0|||
150075208|NCT00541931|541416019|FG000|Overall Study|Transportation Issue|0|||
150075209|NCT00541931|541416020|FG001|Overall Study|Transportation Issue|1|||
150075210|NCT05154578|541416021|FG000|Overall Study|Withdrawal by Subject|2|||
150075211|NCT05154578|541416022|FG001|Overall Study|Withdrawal by Subject|3|||
150075212|NCT05154578|541416023|FG002|Overall Study|Withdrawal by Subject|2|||
150075213|NCT05154578|541416024|FG003|Overall Study|Withdrawal by Subject|4|||
150075214|NCT05154578|541416025|FG004|Overall Study|Withdrawal by Subject|0|||
150075215|NCT05154578|541416021|FG000|Overall Study|Lost to Follow-up|0|||
150075216|NCT05154578|541416022|FG001|Overall Study|Lost to Follow-up|1|||
150075217|NCT05154578|541416023|FG002|Overall Study|Lost to Follow-up|0|||
150075218|NCT05154578|541416024|FG003|Overall Study|Lost to Follow-up|3|||
150075219|NCT05154578|541416025|FG004|Overall Study|Lost to Follow-up|0|||
150075220|NCT05154578|541416021|FG000|Overall Study|Adverse Event|0|||
150075221|NCT05154578|541416022|FG001|Overall Study|Adverse Event|0|||
150075222|NCT05154578|541416023|FG002|Overall Study|Adverse Event|0|||
150075223|NCT05154578|541416024|FG003|Overall Study|Adverse Event|1|||
150075224|NCT05154578|541416025|FG004|Overall Study|Adverse Event|0|||
150075225|NCT05154578|541416021|FG000|Overall Study|Relocated to another province|0|||
150075226|NCT05154578|541416022|FG001|Overall Study|Relocated to another province|0|||
150075227|NCT05154578|541416023|FG002|Overall Study|Relocated to another province|1|||
150075228|NCT05154578|541416024|FG003|Overall Study|Relocated to another province|0|||
150075229|NCT05154578|541416025|FG004|Overall Study|Relocated to another province|1|||
150075230|NCT05154578|541416021|FG000|Overall Study|Baby loss|0|||
150075231|NCT05154578|541416022|FG001|Overall Study|Baby loss|1|||
150075232|NCT05154578|541416023|FG002|Overall Study|Baby loss|0|||
150075233|NCT05154578|541416024|FG003|Overall Study|Baby loss|0|||
150075234|NCT05154578|541416025|FG004|Overall Study|Baby loss|0|||
150075235|NCT01180985|541416037|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
150075236|NCT01180985|541416038|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
150075237|NCT00705289|541416039|FG000|Overall Study|Subject or treating physician's choice|131|||
150075238|NCT01030536|541416040|FG000|Overall Study|Withdrawal by Subject|0|||
150075239|NCT01030536|541416041|FG001|Overall Study|Withdrawal by Subject|0|||
150075240|NCT01030536|541416042|FG002|Overall Study|Withdrawal by Subject|1|||
150075241|NCT01030536|541416043|FG003|Overall Study|Withdrawal by Subject|0|||
150075242|NCT01030536|541416044|FG004|Overall Study|Withdrawal by Subject|0|||
150075243|NCT01030536|541416040|FG000|Overall Study|undefined|1|||
150075244|NCT01030536|541416041|FG001|Overall Study|undefined|0|||
150075245|NCT01030536|541416042|FG002|Overall Study|undefined|1|||
150075246|NCT01030536|541416043|FG003|Overall Study|undefined|1|||
150075247|NCT01030536|541416044|FG004|Overall Study|undefined|0|||
150075248|NCT01030536|541416040|FG000|Overall Study|Adverse Event|0|||
150075249|NCT01030536|541416041|FG001|Overall Study|Adverse Event|3|||
150075250|NCT01030536|541416042|FG002|Overall Study|Adverse Event|1|||
150075251|NCT01030536|541416043|FG003|Overall Study|Adverse Event|0|||
150075252|NCT01030536|541416044|FG004|Overall Study|Adverse Event|1|||
150075253|NCT01030536|541416040|FG000|Overall Study|Progressive disease|6|||
150075254|NCT01030536|541416041|FG001|Overall Study|Progressive disease|2|||
150075255|NCT01030536|541416042|FG002|Overall Study|Progressive disease|3|||
150075256|NCT01030536|541416043|FG003|Overall Study|Progressive disease|2|||
150075257|NCT01030536|541416044|FG004|Overall Study|Progressive disease|0|||
150075258|NCT01030536|541416040|FG000|Overall Study|Death|0|||
150075259|NCT01030536|541416041|FG001|Overall Study|Death|1|||
150075260|NCT01030536|541416042|FG002|Overall Study|Death|0|||
150075261|NCT01030536|541416043|FG003|Overall Study|Death|0|||
150075262|NCT01030536|541416044|FG004|Overall Study|Death|0|||
150075263|NCT02601027|541416046|FG000|Registration to Surgery|Withdrawal by Subject|20|||
150075264|NCT02601027|541416047|FG001|Registration to Surgery|Withdrawal by Subject|10|||
150075265|NCT01419626|541416048|FG000|Overall Study|Protocol Violation|3|||
150075266|NCT01419626|541416049|FG001|Overall Study|Protocol Violation|2|||
150075267|NCT01419626|541416050|FG002|Overall Study|Protocol Violation|2|||
150075268|NCT01419626|541416048|FG000|Overall Study|Withdrawal by Subject|1|||
150075269|NCT01419626|541416049|FG001|Overall Study|Withdrawal by Subject|0|||
150075270|NCT01419626|541416050|FG002|Overall Study|Withdrawal by Subject|0|||
150075271|NCT01419626|541416048|FG000|Overall Study|Lost to Follow-up|0|||
150075272|NCT01419626|541416049|FG001|Overall Study|Lost to Follow-up|1|||
150075273|NCT01419626|541416050|FG002|Overall Study|Lost to Follow-up|1|||
150075274|NCT02248701|541416053|FG000|Overall Study|Withdrawal by Subject|2|||
150075275|NCT02248701|541416054|FG001|Overall Study|Withdrawal by Subject|1|||
150075276|NCT02248701|541416053|FG000|Overall Study|Physician Decision|0|||
150075277|NCT02248701|541416054|FG001|Overall Study|Physician Decision|1|||
150075278|NCT02248701|541416053|FG000|Overall Study|Adverse Event|1|||
150075279|NCT02248701|541416054|FG001|Overall Study|Adverse Event|0|||
150075280|NCT02248701|541416053|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
150075281|NCT02248701|541416054|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
150075282|NCT01145625|541416055|FG000|Overall Study|Lost to Follow-up|8|||
150075283|NCT01145625|541416056|FG001|Overall Study|Lost to Follow-up|9|||
150075284|NCT01145625|541416055|FG000|Overall Study|Adverse Event|6|||
150075285|NCT01145625|541416056|FG001|Overall Study|Adverse Event|4|||
150075286|NCT01145625|541416055|FG000|Overall Study|Protocol Violation|3|||
150075287|NCT01145625|541416056|FG001|Overall Study|Protocol Violation|1|||
150075288|NCT01145625|541416055|FG000|Overall Study|Withdrawal by Subject|7|||
150075289|NCT01145625|541416056|FG001|Overall Study|Withdrawal by Subject|16|||
150075290|NCT01145625|541416055|FG000|Overall Study|Pregnancy|0|||
150075291|NCT01145625|541416056|FG001|Overall Study|Pregnancy|1|||
150075292|NCT04289623|541416057|FG000|Wave 1 Emails|Email was not delivered|268|||
150075293|NCT04289623|541416058|FG001|Wave 1 Emails|Email was not delivered|257|||
150075294|NCT04289623|541416059|FG002|Wave 1 Emails|Email was not delivered|0|||
150075295|NCT04289623|541416060|FG003|Wave 1 Emails|Email was not delivered|0|||
150075296|NCT04289623|541416061|FG004|Wave 1 Emails|Email was not delivered|0|||
150075297|NCT04289623|541416062|FG005|Wave 1 Emails|Email was not delivered|0|||
150075298|NCT00762385|541416064|FG000|First Intervention|Lens Issue|1|||
150075299|NCT00762385|541416065|FG001|First Intervention|Lens Issue|1|||
150075300|NCT00762385|541416064|FG000|First Intervention|Lost to Follow-up|0|||
150075301|NCT00762385|541416065|FG001|First Intervention|Lost to Follow-up|2|||
150075302|NCT00762385|541416064|FG000|First Intervention|Ineligible|1|||
150075303|NCT00762385|541416065|FG001|First Intervention|Ineligible|0|||
150075304|NCT00762385|541416064|FG000|First Intervention|Protocol Violation|0|||
150075305|NCT00762385|541416065|FG001|First Intervention|Protocol Violation|1|||
150075306|NCT00762385|541416064|FG000|Second Intervention|Protocol Violation|3|||
150075307|NCT00762385|541416065|FG001|Second Intervention|Protocol Violation|3|||
150075308|NCT01540838|541416066|FG000|Overall Study|Open nasogastric tube|9|||
150075309|NCT01540838|541416067|FG001|Overall Study|Open nasogastric tube|7|||
150075310|NCT01540838|541416066|FG000|Overall Study|Treatment doses missing|8|||
150075311|NCT01540838|541416067|FG001|Overall Study|Treatment doses missing|12|||
150075312|NCT01540838|541416066|FG000|Overall Study|Additional antibiotic treatment|1|||
150075313|NCT01540838|541416067|FG001|Overall Study|Additional antibiotic treatment|2|||
150075314|NCT01540838|541416066|FG000|Overall Study|Died before treatment initiation|1|||
150075315|NCT01540838|541416067|FG001|Overall Study|Died before treatment initiation|1|||
150075316|NCT01540838|541416066|FG000|Overall Study|Not BM. Other treatment|3|||
150075317|NCT01540838|541416067|FG001|Overall Study|Not BM. Other treatment|1|||
150075318|NCT02130570|541416068|FG000|Overall Study|Death|3|||
150075319|NCT02130570|541416069|FG001|Overall Study|Death|5|||
150075320|NCT02130570|541416068|FG000|Overall Study|Withdrawal by Subject|6|||
150075321|NCT02130570|541416069|FG001|Overall Study|Withdrawal by Subject|3|||
150075322|NCT02130570|541416068|FG000|Overall Study|Part of practice that discontinued study|0|||
150075323|NCT02130570|541416069|FG001|Overall Study|Part of practice that discontinued study|5|||
150075324|NCT00493025|541416072|FG000|Overall Study|Physician Decision|19|||
150075325|NCT03863197|541416073|FG000|Overall Study|Lost to Follow-up|2|||
150075326|NCT03863197|541416074|FG001|Overall Study|Lost to Follow-up|3|||
150075327|NCT03863197|541416073|FG000|Overall Study|Withdrawal by Subject|4|||
150075328|NCT03863197|541416074|FG001|Overall Study|Withdrawal by Subject|0|||
150075329|NCT03863197|541416073|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
150075330|NCT03863197|541416074|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
150075331|NCT01065597|541416075|FG000|Overall Study|Adverse Event|1|||
150075332|NCT01781975|541416076|FG000|Overall Study|Death|1|||
150075333|NCT01781975|541416077|FG001|Overall Study|Death|0|||
150075334|NCT01781975|541416076|FG000|Overall Study|Withdrawal by Subject|1|||
150075335|NCT01781975|541416077|FG001|Overall Study|Withdrawal by Subject|1|||
150075336|NCT01622231|541416078|FG000|Overall Study|Physician Decision|1|||
150075337|NCT01622231|541416078|FG000|Overall Study|Withdrawal by Subject|1|||
150075338|NCT04545060|541416079|FG000|Overall Study|Adverse Event|0|||
150075339|NCT04545060|541416080|FG001|Overall Study|Adverse Event|1|||
150075340|NCT04545060|541416079|FG000|Overall Study|Death|0|||
150075341|NCT04545060|541416080|FG001|Overall Study|Death|5|||
150075342|NCT04545060|541416079|FG000|Overall Study|Lost to Follow-up|10|||
150075343|NCT04545060|541416080|FG001|Overall Study|Lost to Follow-up|13|||
150075344|NCT04545060|541416079|FG000|Overall Study|Physician Decision|3|||
150075345|NCT04545060|541416080|FG001|Overall Study|Physician Decision|0|||
150075346|NCT04545060|541416079|FG000|Overall Study|Withdrawal by Subject|17|||
150075347|NCT04545060|541416080|FG001|Overall Study|Withdrawal by Subject|22|||
150075348|NCT00973674|541416083|FG000|Overall Study|Protocol Violation|2|||
150075349|NCT00973674|541416084|FG001|Overall Study|Protocol Violation|0|||
150075350|NCT03082261|541416091|FG000|Overall Study|Death|4|||
150075351|NCT03082261|541416091|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
150075352|NCT03082261|541416091|FG000|Overall Study|Insurance denial|1|||
150075353|NCT03082261|541416091|FG000|Overall Study|Peripheral lead added|1|||
150075354|NCT03082261|541416091|FG000|Overall Study|Withdrawal by Subject|40|||
150075355|NCT03082261|541416091|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
150075356|NCT03082261|541416091|FG000|Overall Study|Subject implanted with device other than study device|1|||
150075357|NCT03082261|541416091|FG000|Overall Study|Lost to Follow-up|14|||
150075358|NCT03082261|541416091|FG000|Overall Study|Subject moved to a different state|1|||
150075359|NCT03082261|541416091|FG000|Overall Study|Subject non-compliance|2|||
150075360|NCT03082261|541416091|FG000|Overall Study|Subject participation terminated by investigator|9|||
150075361|NCT03082261|541416091|FG000|Overall Study|Subject participation terminated by sponsor|4|||
150075362|NCT03082261|541416091|FG000|Overall Study|System explant|19|||
150075363|NCT03082261|541416091|FG000|Overall Study|Unable to place lead(s)|2|||
150075364|NCT03082261|541416091|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
150075365|NCT00839852|541416092|FG000|Overall Study|Adverse Event|10|||
150075366|NCT00839852|541416092|FG000|Overall Study|Insufficient Therapeutic Response|3|||
150075367|NCT00839852|541416092|FG000|Overall Study|Protocol Violation|9|||
150075368|NCT00839852|541416092|FG000|Overall Study|Withdrawal of Consent|16|||
150075369|NCT00839852|541416092|FG000|Overall Study|Lost to Follow-up|7|||
150075370|NCT00839852|541416092|FG000|Overall Study|Lack of Compliance While in Jail|1|||
150075371|NCT00839852|541416092|FG000|Overall Study|Pregnancy|1|||
150075372|NCT00494299|541416095|FG000|Overall Study|Adverse Event|93|||
150075373|NCT00494299|541416096|FG001|Overall Study|Adverse Event|13|||
150075374|NCT00494299|541416095|FG000|Overall Study|Lost to Follow-up|1|||
150075375|NCT00494299|541416096|FG001|Overall Study|Lost to Follow-up|0|||
150075376|NCT00494299|541416095|FG000|Overall Study|Physician Decision|0|||
150075377|NCT00494299|541416096|FG001|Overall Study|Physician Decision|2|||
150075378|NCT00494299|541416095|FG000|Overall Study|Protocol Violation|1|||
150075379|NCT00494299|541416096|FG001|Overall Study|Protocol Violation|2|||
150075380|NCT00494299|541416095|FG000|Overall Study|Withdrawal by Subject|8|||
150075381|NCT00494299|541416096|FG001|Overall Study|Withdrawal by Subject|3|||
150075382|NCT00494299|541416095|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
150075383|NCT00494299|541416096|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
150075384|NCT00494299|541416095|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
150075385|NCT00494299|541416096|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
150075386|NCT00494299|541416095|FG000|Overall Study|Site Closed by Sponsor|6|||
150075387|NCT00494299|541416096|FG001|Overall Study|Site Closed by Sponsor|0|||
150075388|NCT00494299|541416095|FG000|Overall Study|Protocol Driven Decision Point|11|||
150075389|NCT00494299|541416096|FG001|Overall Study|Protocol Driven Decision Point|22|||
150075390|NCT01281137|541416097|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
150075391|NCT01281137|541416098|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
150075392|NCT01281137|541416097|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
150075393|NCT01281137|541416098|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
150075394|NCT01281137|541416097|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
150075395|NCT01281137|541416098|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
150075396|NCT01281137|541416097|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
150075397|NCT01281137|541416098|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
150075398|NCT01281137|541416097|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
150075399|NCT01281137|541416098|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
150075400|NCT01986907|541416101|FG000|Overall Study|Adverse Event|11|||
150075401|NCT01986907|541416101|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
150075402|NCT01986907|541416101|FG000|Overall Study|Protocol Violation|4|||
150182483|NCT04110054|541804732|FG003|Overall Study|Adverse Event|3|||
150182484|NCT01000480|541804734|FG000|Induction Phase|Adverse Event|2|||
150075403|NCT01986907|541416101|FG000|Overall Study|Withdrawal by Subject|76|||
150075404|NCT01986907|541416101|FG000|Overall Study|Lost to Follow-up|38|||
150075405|NCT01986907|541416101|FG000|Overall Study|Death|9|||
150075406|NCT03800173|541416102|FG000|Overall Study|Lost to Follow-up|0|||
150075407|NCT03800173|541416103|FG001|Overall Study|Lost to Follow-up|0|||
150075408|NCT03800173|541416104|FG002|Overall Study|Lost to Follow-up|0|||
150075409|NCT03800173|541416105|FG003|Overall Study|Lost to Follow-up|0|||
150075410|NCT03800173|541416106|FG004|Overall Study|Lost to Follow-up|1|||
150075411|NCT02846324|541416107|FG000|Overall Study|Other|1|||
150075412|NCT02846324|541416108|FG001|Overall Study|Other|0|||
150075413|NCT02846324|541416109|FG002|Overall Study|Other|0|||
150075414|NCT02846324|541416110|FG003|Overall Study|Other|0|||
150075415|NCT02846324|541416107|FG000|Overall Study|Withdrawal by Subject|1|||
150075416|NCT02846324|541416108|FG001|Overall Study|Withdrawal by Subject|0|||
150075417|NCT02846324|541416109|FG002|Overall Study|Withdrawal by Subject|4|||
150075418|NCT02846324|541416110|FG003|Overall Study|Withdrawal by Subject|0|||
150075419|NCT00579098|541416111|FG000|Overall Study|Lost to Follow-up|2|||
150075420|NCT00579098|541416112|FG001|Overall Study|Lost to Follow-up|0|||
150075421|NCT00579098|541416111|FG000|Overall Study|Adverse Event|2|||
150075422|NCT00579098|541416112|FG001|Overall Study|Adverse Event|3|||
150075423|NCT00579098|541416111|FG000|Overall Study|Withdrawal by Subject|2|||
150075424|NCT00579098|541416112|FG001|Overall Study|Withdrawal by Subject|3|||
150075425|NCT00579098|541416111|FG000|Overall Study|AF returned after ablation|3|||
150075426|NCT00579098|541416112|FG001|Overall Study|AF returned after ablation|2|||
150075427|NCT01254331|541416113|FG000|Initial Phase|Adverse Event|3|||
150075428|NCT01254331|541416113|FG000|Initial Phase|Withdrawal by Subject|1|||
150075429|NCT01254331|541416113|FG000|Initial Phase|Pregnancy|1|||
150075430|NCT01254331|541416113|FG000|Extension Phase|Lack of Efficacy|1|||
150075431|NCT01254331|541416113|FG000|Extension Phase|Lost to Follow-up|3|||
150075432|NCT05213481|541416114|FG000|Overall Study|Adverse Event|3|||
150075433|NCT05213481|541416114|FG000|Overall Study|Lost to Follow-up|1|||
150075434|NCT00722800|541416117|FG000|Overall Study|Withdrawal by Subject|1|||
150075435|NCT00722800|541416118|FG001|Overall Study|Withdrawal by Subject|0|||
150075436|NCT00722800|541416117|FG000|Overall Study|Physician Decision|1|||
150075437|NCT00722800|541416118|FG001|Overall Study|Physician Decision|0|||
150075438|NCT02130297|541416125|FG000|Overall Study|Lost to Follow-up|4|||
150075439|NCT00347360|541416126|FG000|Overall Study|Adverse Event|1|||
150075440|NCT00347360|541416127|FG001|Overall Study|Adverse Event|2|||
150075441|NCT00347360|541416128|FG002|Overall Study|Adverse Event|0|||
150075442|NCT00347360|541416129|FG003|Overall Study|Adverse Event|4|||
150075443|NCT00347360|541416130|FG004|Overall Study|Adverse Event|1|||
150075444|NCT00347360|541416131|FG005|Overall Study|Adverse Event|2|||
150075445|NCT00347360|541416132|FG006|Overall Study|Adverse Event|2|||
150075446|NCT00347360|541416133|FG007|Overall Study|Adverse Event|0|||
150075447|NCT00347360|541416134|FG008|Overall Study|Adverse Event|2|||
150075448|NCT00347360|541416135|FG009|Overall Study|Adverse Event|3|||
150075449|NCT00347360|541416136|FG010|Overall Study|Adverse Event|3|||
150075450|NCT00347360|541416137|FG011|Overall Study|Adverse Event|1|||
150075451|NCT00347360|541416138|FG012|Overall Study|Adverse Event|3|||
150075452|NCT00347360|541416139|FG013|Overall Study|Adverse Event|2|||
150075453|NCT00347360|541416140|FG014|Overall Study|Adverse Event|2|||
150075454|NCT00347360|541416126|FG000|Overall Study|Lost to Follow-up|0|||
150075455|NCT00347360|541416127|FG001|Overall Study|Lost to Follow-up|0|||
150075456|NCT00347360|541416128|FG002|Overall Study|Lost to Follow-up|0|||
150075457|NCT00347360|541416129|FG003|Overall Study|Lost to Follow-up|2|||
150075458|NCT00347360|541416130|FG004|Overall Study|Lost to Follow-up|1|||
150075459|NCT00347360|541416131|FG005|Overall Study|Lost to Follow-up|1|||
150075460|NCT00347360|541416132|FG006|Overall Study|Lost to Follow-up|0|||
150075461|NCT00347360|541416133|FG007|Overall Study|Lost to Follow-up|1|||
150075462|NCT00347360|541416134|FG008|Overall Study|Lost to Follow-up|1|||
150075463|NCT00347360|541416135|FG009|Overall Study|Lost to Follow-up|2|||
150075464|NCT00347360|541416136|FG010|Overall Study|Lost to Follow-up|0|||
150075465|NCT00347360|541416137|FG011|Overall Study|Lost to Follow-up|0|||
150075466|NCT00347360|541416138|FG012|Overall Study|Lost to Follow-up|1|||
150075467|NCT00347360|541416139|FG013|Overall Study|Lost to Follow-up|0|||
150075468|NCT00347360|541416140|FG014|Overall Study|Lost to Follow-up|0|||
150075469|NCT00347360|541416126|FG000|Overall Study|Protocol Violation|2|||
150075470|NCT00347360|541416127|FG001|Overall Study|Protocol Violation|3|||
150075471|NCT00347360|541416128|FG002|Overall Study|Protocol Violation|1|||
150075472|NCT00347360|541416129|FG003|Overall Study|Protocol Violation|2|||
150075473|NCT00347360|541416130|FG004|Overall Study|Protocol Violation|1|||
150075474|NCT00347360|541416131|FG005|Overall Study|Protocol Violation|2|||
150075475|NCT00347360|541416132|FG006|Overall Study|Protocol Violation|0|||
150075476|NCT00347360|541416133|FG007|Overall Study|Protocol Violation|0|||
150075477|NCT00347360|541416134|FG008|Overall Study|Protocol Violation|1|||
150075478|NCT00347360|541416135|FG009|Overall Study|Protocol Violation|2|||
150075479|NCT00347360|541416136|FG010|Overall Study|Protocol Violation|0|||
150075480|NCT00347360|541416137|FG011|Overall Study|Protocol Violation|0|||
150075481|NCT00347360|541416138|FG012|Overall Study|Protocol Violation|0|||
150075482|NCT00347360|541416139|FG013|Overall Study|Protocol Violation|1|||
150075483|NCT00347360|541416140|FG014|Overall Study|Protocol Violation|0|||
150075484|NCT00347360|541416126|FG000|Overall Study|Withdrawal by Subject|0|||
150075485|NCT00347360|541416127|FG001|Overall Study|Withdrawal by Subject|1|||
150075486|NCT00347360|541416128|FG002|Overall Study|Withdrawal by Subject|2|||
150075487|NCT00347360|541416129|FG003|Overall Study|Withdrawal by Subject|4|||
150075488|NCT00347360|541416130|FG004|Overall Study|Withdrawal by Subject|1|||
150075489|NCT00347360|541416131|FG005|Overall Study|Withdrawal by Subject|2|||
150075490|NCT00347360|541416132|FG006|Overall Study|Withdrawal by Subject|1|||
150075491|NCT00347360|541416133|FG007|Overall Study|Withdrawal by Subject|1|||
150075492|NCT00347360|541416134|FG008|Overall Study|Withdrawal by Subject|1|||
150075493|NCT00347360|541416135|FG009|Overall Study|Withdrawal by Subject|1|||
150075494|NCT00347360|541416136|FG010|Overall Study|Withdrawal by Subject|0|||
150075495|NCT00347360|541416137|FG011|Overall Study|Withdrawal by Subject|3|||
150075496|NCT00347360|541416138|FG012|Overall Study|Withdrawal by Subject|4|||
150075497|NCT00347360|541416139|FG013|Overall Study|Withdrawal by Subject|2|||
150075498|NCT00347360|541416140|FG014|Overall Study|Withdrawal by Subject|1|||
150075499|NCT00347360|541416126|FG000|Overall Study|Lack of Efficacy|1|||
150075500|NCT00347360|541416127|FG001|Overall Study|Lack of Efficacy|1|||
150075501|NCT00347360|541416128|FG002|Overall Study|Lack of Efficacy|3|||
150075502|NCT00347360|541416129|FG003|Overall Study|Lack of Efficacy|1|||
150075503|NCT00347360|541416130|FG004|Overall Study|Lack of Efficacy|0|||
150075504|NCT00347360|541416131|FG005|Overall Study|Lack of Efficacy|1|||
150075505|NCT00347360|541416132|FG006|Overall Study|Lack of Efficacy|0|||
150075506|NCT00347360|541416133|FG007|Overall Study|Lack of Efficacy|1|||
150075507|NCT00347360|541416134|FG008|Overall Study|Lack of Efficacy|1|||
150075508|NCT00347360|541416135|FG009|Overall Study|Lack of Efficacy|0|||
150075509|NCT00347360|541416136|FG010|Overall Study|Lack of Efficacy|0|||
150075510|NCT00347360|541416137|FG011|Overall Study|Lack of Efficacy|0|||
150075511|NCT00347360|541416138|FG012|Overall Study|Lack of Efficacy|0|||
150075512|NCT00347360|541416139|FG013|Overall Study|Lack of Efficacy|0|||
150075513|NCT00347360|541416140|FG014|Overall Study|Lack of Efficacy|0|||
150075514|NCT00347360|541416126|FG000|Overall Study|Reason not listed/blank|1|||
150075515|NCT00347360|541416127|FG001|Overall Study|Reason not listed/blank|0|||
150075516|NCT00347360|541416128|FG002|Overall Study|Reason not listed/blank|0|||
150075517|NCT00347360|541416129|FG003|Overall Study|Reason not listed/blank|0|||
150075518|NCT00347360|541416130|FG004|Overall Study|Reason not listed/blank|0|||
150075519|NCT00347360|541416131|FG005|Overall Study|Reason not listed/blank|0|||
150075520|NCT00347360|541416132|FG006|Overall Study|Reason not listed/blank|1|||
150075521|NCT00347360|541416133|FG007|Overall Study|Reason not listed/blank|0|||
150075522|NCT00347360|541416134|FG008|Overall Study|Reason not listed/blank|0|||
150075523|NCT00347360|541416135|FG009|Overall Study|Reason not listed/blank|0|||
150075524|NCT00347360|541416136|FG010|Overall Study|Reason not listed/blank|0|||
150075525|NCT00347360|541416137|FG011|Overall Study|Reason not listed/blank|0|||
150075526|NCT00347360|541416138|FG012|Overall Study|Reason not listed/blank|0|||
150075527|NCT00347360|541416139|FG013|Overall Study|Reason not listed/blank|1|||
150075528|NCT00347360|541416140|FG014|Overall Study|Reason not listed/blank|0|||
150075529|NCT00347360|541416126|FG000|Overall Study|Per sponsors instruction|0|||
150075530|NCT00347360|541416127|FG001|Overall Study|Per sponsors instruction|1|||
150075531|NCT00347360|541416128|FG002|Overall Study|Per sponsors instruction|0|||
150075532|NCT00347360|541416129|FG003|Overall Study|Per sponsors instruction|0|||
150075533|NCT00347360|541416130|FG004|Overall Study|Per sponsors instruction|0|||
150075534|NCT00347360|541416131|FG005|Overall Study|Per sponsors instruction|0|||
150075535|NCT00347360|541416132|FG006|Overall Study|Per sponsors instruction|0|||
150075536|NCT00347360|541416133|FG007|Overall Study|Per sponsors instruction|0|||
150182485|NCT01000480|541804734|FG000|Induction Phase|Lost to Follow-up|1|||
150075537|NCT00347360|541416134|FG008|Overall Study|Per sponsors instruction|0|||
150075538|NCT00347360|541416135|FG009|Overall Study|Per sponsors instruction|0|||
150075539|NCT00347360|541416136|FG010|Overall Study|Per sponsors instruction|0|||
150075540|NCT00347360|541416137|FG011|Overall Study|Per sponsors instruction|0|||
150075541|NCT00347360|541416138|FG012|Overall Study|Per sponsors instruction|0|||
150075542|NCT00347360|541416139|FG013|Overall Study|Per sponsors instruction|0|||
150075543|NCT00347360|541416140|FG014|Overall Study|Per sponsors instruction|0|||
150075544|NCT00347360|541416126|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
150075545|NCT00347360|541416127|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
150182486|NCT01000480|541804734|FG000|Induction Phase|Physician Decision|1|||
150075546|NCT00347360|541416128|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
150075547|NCT00347360|541416129|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
150075548|NCT00347360|541416130|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
150075549|NCT00347360|541416131|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
150075550|NCT00347360|541416132|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
150075551|NCT00347360|541416133|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
150075552|NCT00347360|541416134|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
150075553|NCT00347360|541416135|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
150075554|NCT00347360|541416136|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
150075555|NCT00347360|541416137|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
150075556|NCT00347360|541416138|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
150075557|NCT00347360|541416139|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
150075558|NCT00347360|541416140|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
150075559|NCT00347360|541416126|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
150075560|NCT00347360|541416127|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
150075561|NCT00347360|541416128|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
150075562|NCT00347360|541416129|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
150075563|NCT00347360|541416130|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
150075564|NCT00347360|541416131|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
150075565|NCT00347360|541416132|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
150075566|NCT00347360|541416133|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
150075567|NCT00347360|541416134|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
150075568|NCT00347360|541416135|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
150075569|NCT00347360|541416136|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
150075570|NCT00347360|541416137|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
150075571|NCT00347360|541416138|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
150075572|NCT00347360|541416139|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
150075573|NCT00347360|541416140|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
150075574|NCT00347360|541416126|FG000|Overall Study|Abnormal lab values|0|||
150075575|NCT00347360|541416127|FG001|Overall Study|Abnormal lab values|0|||
150075576|NCT00347360|541416128|FG002|Overall Study|Abnormal lab values|0|||
150075577|NCT00347360|541416129|FG003|Overall Study|Abnormal lab values|0|||
150075578|NCT00347360|541416130|FG004|Overall Study|Abnormal lab values|0|||
150075579|NCT00347360|541416131|FG005|Overall Study|Abnormal lab values|0|||
150075580|NCT00347360|541416132|FG006|Overall Study|Abnormal lab values|1|||
150075581|NCT00347360|541416133|FG007|Overall Study|Abnormal lab values|0|||
150075582|NCT00347360|541416134|FG008|Overall Study|Abnormal lab values|0|||
150075583|NCT00347360|541416135|FG009|Overall Study|Abnormal lab values|0|||
150075584|NCT00347360|541416136|FG010|Overall Study|Abnormal lab values|0|||
150075585|NCT00347360|541416137|FG011|Overall Study|Abnormal lab values|0|||
150075586|NCT00347360|541416138|FG012|Overall Study|Abnormal lab values|0|||
150075587|NCT00347360|541416139|FG013|Overall Study|Abnormal lab values|0|||
150075588|NCT00347360|541416140|FG014|Overall Study|Abnormal lab values|0|||
150075589|NCT00347360|541416126|FG000|Overall Study|PI recommended early withdrawal|0|||
150075590|NCT00347360|541416127|FG001|Overall Study|PI recommended early withdrawal|0|||
150075591|NCT00347360|541416128|FG002|Overall Study|PI recommended early withdrawal|0|||
150075592|NCT00347360|541416129|FG003|Overall Study|PI recommended early withdrawal|0|||
150075593|NCT00347360|541416130|FG004|Overall Study|PI recommended early withdrawal|0|||
150075594|NCT00347360|541416131|FG005|Overall Study|PI recommended early withdrawal|0|||
150075595|NCT00347360|541416132|FG006|Overall Study|PI recommended early withdrawal|0|||
150075596|NCT00347360|541416133|FG007|Overall Study|PI recommended early withdrawal|0|||
150075597|NCT00347360|541416134|FG008|Overall Study|PI recommended early withdrawal|0|||
150075598|NCT00347360|541416135|FG009|Overall Study|PI recommended early withdrawal|1|||
150075599|NCT00347360|541416136|FG010|Overall Study|PI recommended early withdrawal|0|||
150075600|NCT00347360|541416137|FG011|Overall Study|PI recommended early withdrawal|0|||
150075601|NCT00347360|541416138|FG012|Overall Study|PI recommended early withdrawal|0|||
150075602|NCT00347360|541416139|FG013|Overall Study|PI recommended early withdrawal|0|||
150075603|NCT00347360|541416140|FG014|Overall Study|PI recommended early withdrawal|0|||
150075604|NCT00347360|541416126|FG000|Overall Study|Did not meet criteria before ABPM|0|||
150075605|NCT00347360|541416127|FG001|Overall Study|Did not meet criteria before ABPM|0|||
150075606|NCT00347360|541416128|FG002|Overall Study|Did not meet criteria before ABPM|0|||
150075607|NCT00347360|541416129|FG003|Overall Study|Did not meet criteria before ABPM|0|||
150075608|NCT00347360|541416130|FG004|Overall Study|Did not meet criteria before ABPM|0|||
150075609|NCT00347360|541416131|FG005|Overall Study|Did not meet criteria before ABPM|0|||
150075610|NCT00347360|541416132|FG006|Overall Study|Did not meet criteria before ABPM|0|||
150075611|NCT00347360|541416133|FG007|Overall Study|Did not meet criteria before ABPM|0|||
150075612|NCT00347360|541416134|FG008|Overall Study|Did not meet criteria before ABPM|0|||
150075613|NCT00347360|541416135|FG009|Overall Study|Did not meet criteria before ABPM|0|||
150075614|NCT00347360|541416136|FG010|Overall Study|Did not meet criteria before ABPM|1|||
150075615|NCT00347360|541416137|FG011|Overall Study|Did not meet criteria before ABPM|0|||
150075616|NCT00347360|541416138|FG012|Overall Study|Did not meet criteria before ABPM|0|||
150075617|NCT00347360|541416139|FG013|Overall Study|Did not meet criteria before ABPM|0|||
150075618|NCT00347360|541416140|FG014|Overall Study|Did not meet criteria before ABPM|0|||
150075619|NCT00347360|541416126|FG000|Overall Study|Randomized in error|0|||
150075620|NCT00347360|541416127|FG001|Overall Study|Randomized in error|0|||
150075621|NCT00347360|541416128|FG002|Overall Study|Randomized in error|0|||
150075622|NCT00347360|541416129|FG003|Overall Study|Randomized in error|0|||
150075623|NCT00347360|541416130|FG004|Overall Study|Randomized in error|0|||
150075624|NCT00347360|541416131|FG005|Overall Study|Randomized in error|0|||
150075625|NCT00347360|541416132|FG006|Overall Study|Randomized in error|0|||
150075626|NCT00347360|541416133|FG007|Overall Study|Randomized in error|0|||
150075627|NCT00347360|541416134|FG008|Overall Study|Randomized in error|0|||
150075628|NCT00347360|541416135|FG009|Overall Study|Randomized in error|0|||
150075629|NCT00347360|541416136|FG010|Overall Study|Randomized in error|0|||
150075630|NCT00347360|541416137|FG011|Overall Study|Randomized in error|1|||
150075631|NCT00347360|541416138|FG012|Overall Study|Randomized in error|0|||
150075632|NCT00347360|541416139|FG013|Overall Study|Randomized in error|0|||
150075633|NCT00347360|541416140|FG014|Overall Study|Randomized in error|0|||
150075634|NCT00347360|541416126|FG000|Overall Study|Failed inclusion criteria #4|0|||
150075635|NCT00347360|541416127|FG001|Overall Study|Failed inclusion criteria #4|0|||
150075636|NCT00347360|541416128|FG002|Overall Study|Failed inclusion criteria #4|0|||
150075637|NCT00347360|541416129|FG003|Overall Study|Failed inclusion criteria #4|0|||
150075638|NCT00347360|541416130|FG004|Overall Study|Failed inclusion criteria #4|0|||
150075639|NCT00347360|541416131|FG005|Overall Study|Failed inclusion criteria #4|0|||
150075640|NCT00347360|541416132|FG006|Overall Study|Failed inclusion criteria #4|0|||
150075641|NCT00347360|541416133|FG007|Overall Study|Failed inclusion criteria #4|0|||
150075642|NCT00347360|541416134|FG008|Overall Study|Failed inclusion criteria #4|0|||
150075643|NCT00347360|541416135|FG009|Overall Study|Failed inclusion criteria #4|0|||
150075644|NCT00347360|541416136|FG010|Overall Study|Failed inclusion criteria #4|0|||
150075645|NCT00347360|541416137|FG011|Overall Study|Failed inclusion criteria #4|1|||
150075646|NCT00347360|541416138|FG012|Overall Study|Failed inclusion criteria #4|0|||
150075647|NCT00347360|541416139|FG013|Overall Study|Failed inclusion criteria #4|0|||
150075648|NCT00347360|541416140|FG014|Overall Study|Failed inclusion criteria #4|0|||
150075649|NCT00347360|541416126|FG000|Overall Study|Prolonged duration between visits|0|||
150075650|NCT00347360|541416127|FG001|Overall Study|Prolonged duration between visits|0|||
150075651|NCT00347360|541416128|FG002|Overall Study|Prolonged duration between visits|0|||
150075652|NCT00347360|541416129|FG003|Overall Study|Prolonged duration between visits|0|||
150075653|NCT00347360|541416130|FG004|Overall Study|Prolonged duration between visits|0|||
150075654|NCT00347360|541416131|FG005|Overall Study|Prolonged duration between visits|0|||
150075655|NCT00347360|541416132|FG006|Overall Study|Prolonged duration between visits|0|||
150075656|NCT00347360|541416133|FG007|Overall Study|Prolonged duration between visits|0|||
150075657|NCT00347360|541416134|FG008|Overall Study|Prolonged duration between visits|0|||
150075658|NCT00347360|541416135|FG009|Overall Study|Prolonged duration between visits|0|||
150075659|NCT00347360|541416136|FG010|Overall Study|Prolonged duration between visits|0|||
150075660|NCT00347360|541416137|FG011|Overall Study|Prolonged duration between visits|0|||
150075661|NCT00347360|541416138|FG012|Overall Study|Prolonged duration between visits|1|||
150075662|NCT00347360|541416139|FG013|Overall Study|Prolonged duration between visits|0|||
150075663|NCT00347360|541416140|FG014|Overall Study|Prolonged duration between visits|0|||
150075664|NCT00347360|541416126|FG000|Overall Study|Subject left town, ran out of study drug|0|||
150075665|NCT00347360|541416127|FG001|Overall Study|Subject left town, ran out of study drug|0|||
150075666|NCT00347360|541416128|FG002|Overall Study|Subject left town, ran out of study drug|0|||
150075667|NCT00347360|541416129|FG003|Overall Study|Subject left town, ran out of study drug|0|||
150075668|NCT00347360|541416130|FG004|Overall Study|Subject left town, ran out of study drug|0|||
150075669|NCT00347360|541416131|FG005|Overall Study|Subject left town, ran out of study drug|0|||
150075670|NCT00347360|541416132|FG006|Overall Study|Subject left town, ran out of study drug|0|||
150075671|NCT00347360|541416133|FG007|Overall Study|Subject left town, ran out of study drug|0|||
150075672|NCT00347360|541416134|FG008|Overall Study|Subject left town, ran out of study drug|0|||
150075673|NCT00347360|541416135|FG009|Overall Study|Subject left town, ran out of study drug|0|||
150075674|NCT00347360|541416136|FG010|Overall Study|Subject left town, ran out of study drug|0|||
150075675|NCT00347360|541416137|FG011|Overall Study|Subject left town, ran out of study drug|0|||
150075676|NCT00347360|541416138|FG012|Overall Study|Subject left town, ran out of study drug|0|||
150075677|NCT00347360|541416139|FG013|Overall Study|Subject left town, ran out of study drug|1|||
150075678|NCT00347360|541416140|FG014|Overall Study|Subject left town, ran out of study drug|0|||
150075679|NCT00347360|541416126|FG000|Overall Study|Subject refuse to sign updated consent|0|||
150075680|NCT00347360|541416127|FG001|Overall Study|Subject refuse to sign updated consent|0|||
150075681|NCT00347360|541416128|FG002|Overall Study|Subject refuse to sign updated consent|0|||
150075682|NCT00347360|541416129|FG003|Overall Study|Subject refuse to sign updated consent|0|||
150075683|NCT00347360|541416130|FG004|Overall Study|Subject refuse to sign updated consent|0|||
150075684|NCT00347360|541416131|FG005|Overall Study|Subject refuse to sign updated consent|0|||
150075685|NCT00347360|541416132|FG006|Overall Study|Subject refuse to sign updated consent|0|||
150075686|NCT00347360|541416133|FG007|Overall Study|Subject refuse to sign updated consent|0|||
150075687|NCT00347360|541416134|FG008|Overall Study|Subject refuse to sign updated consent|0|||
150075688|NCT00347360|541416135|FG009|Overall Study|Subject refuse to sign updated consent|0|||
150075689|NCT00347360|541416136|FG010|Overall Study|Subject refuse to sign updated consent|0|||
150075690|NCT00347360|541416137|FG011|Overall Study|Subject refuse to sign updated consent|0|||
150075691|NCT00347360|541416138|FG012|Overall Study|Subject refuse to sign updated consent|0|||
150075692|NCT00347360|541416139|FG013|Overall Study|Subject refuse to sign updated consent|0|||
150075693|NCT00347360|541416140|FG014|Overall Study|Subject refuse to sign updated consent|1|||
150075694|NCT00347360|541416126|FG000|Overall Study|Visits conflicted with new job|0|||
150075695|NCT00347360|541416127|FG001|Overall Study|Visits conflicted with new job|0|||
150075696|NCT00347360|541416128|FG002|Overall Study|Visits conflicted with new job|0|||
150075697|NCT00347360|541416129|FG003|Overall Study|Visits conflicted with new job|0|||
150075698|NCT00347360|541416130|FG004|Overall Study|Visits conflicted with new job|0|||
150075699|NCT00347360|541416131|FG005|Overall Study|Visits conflicted with new job|0|||
150075700|NCT00347360|541416132|FG006|Overall Study|Visits conflicted with new job|1|||
150075701|NCT00347360|541416133|FG007|Overall Study|Visits conflicted with new job|0|||
150075702|NCT00347360|541416134|FG008|Overall Study|Visits conflicted with new job|0|||
150075703|NCT00347360|541416135|FG009|Overall Study|Visits conflicted with new job|0|||
150075704|NCT00347360|541416136|FG010|Overall Study|Visits conflicted with new job|0|||
150075705|NCT00347360|541416137|FG011|Overall Study|Visits conflicted with new job|0|||
150075706|NCT00347360|541416138|FG012|Overall Study|Visits conflicted with new job|0|||
150075707|NCT00347360|541416139|FG013|Overall Study|Visits conflicted with new job|0|||
150075708|NCT00347360|541416140|FG014|Overall Study|Visits conflicted with new job|0|||
150075709|NCT01449539|541416141|FG000|Overall Study|Withdrawal by Subject|3|||
150075710|NCT01449539|541416141|FG000|Overall Study|Toxicity not study related|1|||
150075711|NCT01187433|541416144|FG000|Overall Study|Protocol Violation|6|||
150075712|NCT01187433|541416145|FG001|Overall Study|Protocol Violation|2|||
150075713|NCT01187433|541416144|FG000|Overall Study|Withdrawal by Subject|5|||
150075714|NCT01187433|541416145|FG001|Overall Study|Withdrawal by Subject|2|||
150075715|NCT01790932|541416148|FG000|Overall Study|Disease Progression|41|||
150075716|NCT01790932|541416148|FG000|Overall Study|Adverse Event|7|||
150075717|NCT01790932|541416148|FG000|Overall Study|Physician Decision|1|||
150075718|NCT01790932|541416148|FG000|Overall Study|Withdrawal by Subject|1|||
150075719|NCT04223973|541416149|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
150075720|NCT04223973|541416150|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
150075721|NCT04223973|541416149|FG000|Overall Study|Adverse Event|4|||
150075722|NCT04223973|541416150|FG001|Overall Study|Adverse Event|0|||
150075723|NCT04223973|541416149|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
150075724|NCT04223973|541416150|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
150075725|NCT04223973|541416149|FG000|Overall Study|Physician Decision|1|||
150075726|NCT04223973|541416150|FG001|Overall Study|Physician Decision|1|||
150075727|NCT04223973|541416149|FG000|Overall Study|Withdrawal by Subject|0|||
150075728|NCT04223973|541416150|FG001|Overall Study|Withdrawal by Subject|1|||
150075729|NCT00300274|541416156|FG000|Overall Study|Withdrawal by Subject|12|||
150075730|NCT00300274|541416157|FG001|Overall Study|Withdrawal by Subject|3|||
150075731|NCT00300274|541416158|FG002|Overall Study|Withdrawal by Subject|14|||
150075732|NCT00300274|541416156|FG000|Overall Study|Lost to Follow-up|3|||
150075733|NCT00300274|541416157|FG001|Overall Study|Lost to Follow-up|4|||
150075734|NCT00300274|541416158|FG002|Overall Study|Lost to Follow-up|5|||
150075735|NCT00300274|541416156|FG000|Overall Study|Death|31|||
150075736|NCT00300274|541416157|FG001|Overall Study|Death|20|||
150075737|NCT00300274|541416158|FG002|Overall Study|Death|25|||
150075738|NCT00300274|541416156|FG000|Overall Study|Re-transplant|0|||
150075739|NCT00300274|541416157|FG001|Overall Study|Re-transplant|0|||
150075740|NCT00300274|541416158|FG002|Overall Study|Re-transplant|1|||
150075741|NCT00242216|541416159|FG000|Overall Study|Lost to Follow-up|12|||
150075742|NCT00242216|541416160|FG001|Overall Study|Lost to Follow-up|17|||
150075743|NCT00242216|541416159|FG000|Overall Study|Death|4|||
150075744|NCT00242216|541416160|FG001|Overall Study|Death|2|||
150075745|NCT00242216|541416159|FG000|Overall Study|Lack of Efficacy|1|||
150075746|NCT00242216|541416160|FG001|Overall Study|Lack of Efficacy|2|||
150075747|NCT00242216|541416159|FG000|Overall Study|no medicaiton dispensed|1|||
150075748|NCT00242216|541416160|FG001|Overall Study|no medicaiton dispensed|1|||
150075749|NCT00678080|541416162|FG000|Overall Study|Physician Decision|2|||
150075750|NCT00678080|541416163|FG001|Overall Study|Physician Decision|0|||
150075751|NCT00678080|541416162|FG000|Overall Study|Lost to Follow-up|1|||
150075752|NCT00678080|541416163|FG001|Overall Study|Lost to Follow-up|0|||
150075753|NCT00678080|541416162|FG000|Overall Study|Withdrawal by Subject|0|||
150075754|NCT00678080|541416163|FG001|Overall Study|Withdrawal by Subject|1|||
150075755|NCT05136690|541416173|FG000|Period 1|Withdrawal by Subject|0|||
150075756|NCT05136690|541416174|FG001|Period 1|Withdrawal by Subject|1|||
150075757|NCT05136690|541416173|FG000|Period 2|Lost to Follow-up|0|||
150075758|NCT05136690|541416174|FG001|Period 2|Lost to Follow-up|3|||
150075759|NCT05136690|541416173|FG000|Period 2|Withdrawal by Subject|0|||
150075760|NCT05136690|541416174|FG001|Period 2|Withdrawal by Subject|1|||
150075761|NCT03730012|541416175|FG000|Overall Study|Adverse Event|0|||
150075762|NCT03730012|541416176|FG001|Overall Study|Adverse Event|1|||
150075763|NCT03730012|541416175|FG000|Overall Study|Lack of Efficacy|1|||
150075764|NCT03730012|541416176|FG001|Overall Study|Lack of Efficacy|5|||
150075765|NCT03730012|541416175|FG000|Overall Study|Withdrawal by Subject|0|||
150075766|NCT03730012|541416176|FG001|Overall Study|Withdrawal by Subject|1|||
150075767|NCT03730012|541416175|FG000|Overall Study|Miscellaneous|2|||
150075768|NCT03730012|541416176|FG001|Overall Study|Miscellaneous|1|||
150075769|NCT00443261|541417260|FG000|Overall Study|Death|1|||
150075770|NCT02025621|541417261|FG000|Overall Study|Withdrawal by Subject|1|||
150075771|NCT02025621|541417262|FG001|Overall Study|Withdrawal by Subject|0|||
150075772|NCT02025621|541417261|FG000|Overall Study|Death|0|||
150075773|NCT02025621|541417262|FG001|Overall Study|Death|1|||
150075774|NCT02025621|541417261|FG000|Overall Study|No longer eligible|10|||
150075775|NCT02025621|541417262|FG001|Overall Study|No longer eligible|15|||
150075776|NCT02025621|541417261|FG000|Overall Study|Surgery initiated before infusion|3|||
150075777|NCT02025621|541417262|FG001|Overall Study|Surgery initiated before infusion|3|||
150075778|NCT00739674|541417263|FG000|Overall Study|Screening failures|19|||
150075779|NCT00739674|541417264|FG001|Overall Study|Screening failures|17|||
150075780|NCT00739674|541417263|FG000|Overall Study|Site 212 removal|19|||
150075781|NCT00739674|541417264|FG001|Overall Study|Site 212 removal|13|||
150075782|NCT00739674|541417263|FG000|Overall Study|No follow-up data|33|||
150075783|NCT00739674|541417264|FG001|Overall Study|No follow-up data|18|||
150075784|NCT00739674|541417263|FG000|Overall Study|Dietician consultation >30 days|1|||
150075785|NCT00739674|541417264|FG001|Overall Study|Dietician consultation >30 days|9|||
150075786|NCT00739674|541417263|FG000|Overall Study|Adverse Event|22|||
150075787|NCT00739674|541417264|FG001|Overall Study|Adverse Event|13|||
150075788|NCT00739674|541417263|FG000|Overall Study|Death|1|||
150075789|NCT00739674|541417264|FG001|Overall Study|Death|0|||
150075790|NCT00739674|541417263|FG000|Overall Study|Lack of Efficacy|1|||
150075791|NCT00739674|541417264|FG001|Overall Study|Lack of Efficacy|0|||
150075792|NCT00739674|541417263|FG000|Overall Study|Lost to Follow-up|52|||
150075793|NCT00739674|541417264|FG001|Overall Study|Lost to Follow-up|30|||
150075794|NCT00739674|541417263|FG000|Overall Study|Protocol Violation|5|||
150075795|NCT00739674|541417264|FG001|Overall Study|Protocol Violation|5|||
150075796|NCT00739674|541417263|FG000|Overall Study|Withdrawal by Subject|9|||
150075797|NCT00739674|541417264|FG001|Overall Study|Withdrawal by Subject|9|||
150075798|NCT00739674|541417263|FG000|Overall Study|Reason missing|2|||
150075799|NCT00739674|541417264|FG001|Overall Study|Reason missing|0|||
150075800|NCT00739674|541417263|FG000|Overall Study|Clinic closed|6|||
150075801|NCT00739674|541417264|FG001|Overall Study|Clinic closed|4|||
150075802|NCT00739674|541417263|FG000|Overall Study|Patient moved|3|||
150075803|NCT00739674|541417264|FG001|Overall Study|Patient moved|2|||
150075804|NCT00739674|541417263|FG000|Overall Study|Non compliant|4|||
150075805|NCT00739674|541417264|FG001|Overall Study|Non compliant|0|||
150075806|NCT00739674|541417263|FG000|Overall Study|Unable to attend visit|3|||
150075807|NCT00739674|541417264|FG001|Overall Study|Unable to attend visit|1|||
150075808|NCT00739674|541417263|FG000|Overall Study|Home monitoring off meds|1|||
150075809|NCT00739674|541417264|FG001|Overall Study|Home monitoring off meds|0|||
150075810|NCT00739674|541417263|FG000|Overall Study|Erectile dysfunction|0|||
150075811|NCT00739674|541417264|FG001|Overall Study|Erectile dysfunction|1|||
150075812|NCT01560403|541417268|FG000|Overall Study|Lost to Follow-up|0|||
150075813|NCT01560403|541417269|FG001|Overall Study|Lost to Follow-up|1|||
150075814|NCT01947582|541417275|FG000|Overall Study|Withdrawal by Subject|1|||
150075815|NCT00064337|541417276|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
150075816|NCT00064337|541417276|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
150075817|NCT00064337|541417276|FG000|PBSCC or Induction/PBSCC|Progression|3|||
150075818|NCT00064337|541417276|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
150075819|NCT00064337|541417276|FG000|PBSCC or Induction/PBSCC|Death|2|||
150075820|NCT00064337|541417276|FG000|Transplant|Adverse Event|9|||
150075821|NCT00064337|541417276|FG000|Transplant|Not protocol-specified|5|||
150075822|NCT00064337|541417276|FG000|Transplant|Death|3|||
150075823|NCT00064337|541417276|FG000|Transplant|Patient Refusal|2|||
150075824|NCT00064337|541417276|FG000|Transplant|Progression|2|||
150075825|NCT00064337|541417276|FG000|Maintenance|Adverse Event|3|||
150075826|NCT00064337|541417276|FG000|Maintenance|Progression|2|||
150075827|NCT00064337|541417276|FG000|Maintenance|On treatment at time of analysis|2|||
150075828|NCT00064337|541417276|FG000|Maintenance|Not protocol-specified|2|||
150075829|NCT00064337|541417276|FG000|Maintenance|Death|1|||
150075830|NCT01397890|541417281|FG000|Overall Study|Withdrawal by Subject|7|||
150075831|NCT01397890|541417282|FG001|Overall Study|Withdrawal by Subject|11|||
150075832|NCT01397890|541417281|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
150075833|NCT01397890|541417282|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
150075834|NCT01397890|541417281|FG000|Overall Study|Death|2|||
150075835|NCT01397890|541417282|FG001|Overall Study|Death|3|||
150075836|NCT01397890|541417281|FG000|Overall Study|Lost to Follow-up|1|||
150075837|NCT01397890|541417282|FG001|Overall Study|Lost to Follow-up|4|||
150075838|NCT01397890|541417281|FG000|Overall Study|Condition under Investigation Worsened|1|||
150075839|NCT01397890|541417282|FG001|Overall Study|Condition under Investigation Worsened|3|||
150075840|NCT01397890|541417281|FG000|Overall Study|Adverse Event|1|||
150075841|NCT01397890|541417282|FG001|Overall Study|Adverse Event|2|||
150075842|NCT01397890|541417281|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
150075843|NCT01397890|541417282|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
150075844|NCT01397890|541417281|FG000|Overall Study|Others|2|||
150075845|NCT01397890|541417282|FG001|Overall Study|Others|1|||
150075846|NCT00434954|541417283|FG000|Overall Study|Adverse Event|17|||
150075847|NCT00434954|541417284|FG001|Overall Study|Adverse Event|2|||
150075848|NCT00434954|541417283|FG000|Overall Study|Entry criteria not met|14|||
150075849|NCT00434954|541417284|FG001|Overall Study|Entry criteria not met|16|||
150075850|NCT00434954|541417283|FG000|Overall Study|Lost to Follow-up|0|||
150075851|NCT00434954|541417284|FG001|Overall Study|Lost to Follow-up|1|||
150075852|NCT00434954|541417283|FG000|Overall Study|Physician Decision|6|||
150075853|NCT00434954|541417284|FG001|Overall Study|Physician Decision|3|||
150075854|NCT00434954|541417283|FG000|Overall Study|Protocol Violation|36|||
150075855|NCT00434954|541417284|FG001|Overall Study|Protocol Violation|27|||
150075856|NCT00434954|541417283|FG000|Overall Study|Sponsor decision|1|||
150075857|NCT00434954|541417284|FG001|Overall Study|Sponsor decision|0|||
150075858|NCT00434954|541417283|FG000|Overall Study|Subject decision|8|||
150075859|NCT00434954|541417284|FG001|Overall Study|Subject decision|22|||
150075860|NCT02329080|541417285|FG000|Overall Study|Adverse Event|1|||
150075861|NCT02329080|541417285|FG000|Overall Study|Death|4|||
150075862|NCT02329080|541417285|FG000|Overall Study|Lack of Efficacy|22|||
150075863|NCT02329080|541417285|FG000|Overall Study|Lost to Follow-up|1|||
150075864|NCT02329080|541417285|FG000|Overall Study|Physician Decision|2|||
150075865|NCT02329080|541417285|FG000|Overall Study|Partial response|4|||
150075866|NCT02329080|541417285|FG000|Overall Study|Complete response|4|||
150075867|NCT01313312|541417291|FG000|Overall Study|Adverse Event|5|||
150075868|NCT01313312|541417291|FG000|Overall Study|Withdrawal by Subject|18|||
150075869|NCT01313312|541417291|FG000|Overall Study|Lack of Efficacy|3|||
150075870|NCT01313312|541417291|FG000|Overall Study|Investigator Decision|1|||
150182487|NCT01000480|541804734|FG000|Induction Phase|Entry Criteria Not Met|3|||
150075871|NCT01313312|541417291|FG000|Overall Study|Observational Phase|1|||
150075872|NCT01313312|541417291|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
150075873|NCT01313312|541417291|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
150075874|NCT01206166|541417299|FG000|Overall Study|No evaluable data|2|||
150075875|NCT01206166|541417300|FG001|Overall Study|No evaluable data|3|||
150075876|NCT00932126|541417301|FG000|Overall Study|Adverse Event|0|||
150075877|NCT00932126|541417302|FG001|Overall Study|Adverse Event|0|||
150075878|NCT00932126|541417303|FG002|Overall Study|Adverse Event|0|||
150075879|NCT00932126|541417304|FG003|Overall Study|Adverse Event|0|||
150075880|NCT00932126|541417305|FG004|Overall Study|Adverse Event|0|||
150075881|NCT00932126|541417306|FG005|Overall Study|Adverse Event|0|||
150075882|NCT00932126|541417307|FG006|Overall Study|Adverse Event|1|||
150075883|NCT00932126|541417308|FG007|Overall Study|Adverse Event|2|||
150075884|NCT00932126|541417301|FG000|Overall Study|Protocol Violation|0|||
150075885|NCT00932126|541417302|FG001|Overall Study|Protocol Violation|0|||
150075886|NCT00932126|541417303|FG002|Overall Study|Protocol Violation|0|||
150075887|NCT00932126|541417304|FG003|Overall Study|Protocol Violation|0|||
150075888|NCT00932126|541417305|FG004|Overall Study|Protocol Violation|1|||
150075889|NCT00932126|541417306|FG005|Overall Study|Protocol Violation|0|||
150075890|NCT00932126|541417307|FG006|Overall Study|Protocol Violation|0|||
150075891|NCT00932126|541417308|FG007|Overall Study|Protocol Violation|0|||
150075892|NCT00932126|541417301|FG000|Overall Study|Withdrawal by Subject|0|||
150075893|NCT00932126|541417302|FG001|Overall Study|Withdrawal by Subject|0|||
150075894|NCT00932126|541417303|FG002|Overall Study|Withdrawal by Subject|1|||
150075895|NCT00932126|541417304|FG003|Overall Study|Withdrawal by Subject|0|||
150075896|NCT00932126|541417305|FG004|Overall Study|Withdrawal by Subject|0|||
150075897|NCT00932126|541417306|FG005|Overall Study|Withdrawal by Subject|0|||
150075898|NCT00932126|541417307|FG006|Overall Study|Withdrawal by Subject|0|||
150075899|NCT00932126|541417308|FG007|Overall Study|Withdrawal by Subject|1|||
150075900|NCT00932126|541417301|FG000|Overall Study|Objective progression or relapse|3|||
150075901|NCT00932126|541417302|FG001|Overall Study|Objective progression or relapse|3|||
150075902|NCT00932126|541417303|FG002|Overall Study|Objective progression or relapse|2|||
150075903|NCT00932126|541417304|FG003|Overall Study|Objective progression or relapse|3|||
150075904|NCT00932126|541417305|FG004|Overall Study|Objective progression or relapse|3|||
150075905|NCT00932126|541417306|FG005|Overall Study|Objective progression or relapse|3|||
150075906|NCT00932126|541417307|FG006|Overall Study|Objective progression or relapse|3|||
150075907|NCT00932126|541417308|FG007|Overall Study|Objective progression or relapse|5|||
150075908|NCT00932126|541417301|FG000|Overall Study|Other|0|||
150075909|NCT00932126|541417302|FG001|Overall Study|Other|0|||
150075910|NCT00932126|541417303|FG002|Overall Study|Other|0|||
150075911|NCT00932126|541417304|FG003|Overall Study|Other|0|||
150075912|NCT00932126|541417305|FG004|Overall Study|Other|1|||
150075913|NCT00932126|541417306|FG005|Overall Study|Other|0|||
150075914|NCT00932126|541417307|FG006|Overall Study|Other|1|||
150075915|NCT00932126|541417308|FG007|Overall Study|Other|2|||
150075916|NCT02716805|541417309|FG000|Overall Study|Progressive disease|2|||
150075917|NCT02716805|541417310|FG001|Overall Study|Progressive disease|0|||
150075918|NCT02716805|541417311|FG002|Overall Study|Progressive disease|0|||
150075919|NCT02716805|541417312|FG003|Overall Study|Progressive disease|0|||
150075920|NCT00066365|541417313|FG000|Overall Study|Adverse Event|1|||
150075921|NCT00066365|541417314|FG001|Overall Study|Adverse Event|0|||
150075922|NCT00066365|541417313|FG000|Overall Study|Lack of Efficacy|15|||
150075923|NCT00066365|541417314|FG001|Overall Study|Lack of Efficacy|12|||
150075924|NCT00066365|541417313|FG000|Overall Study|Physician Decision|1|||
150075925|NCT00066365|541417314|FG001|Overall Study|Physician Decision|0|||
150075926|NCT00066365|541417313|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
150075927|NCT00066365|541417314|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
150075928|NCT00066365|541417313|FG000|Overall Study|Ineligible|4|||
150075929|NCT00066365|541417314|FG001|Overall Study|Ineligible|2|||
150075930|NCT00467857|541417317|FG000|Overall Study|Adverse Event|1|||
150075931|NCT00467857|541417318|FG001|Overall Study|Adverse Event|0|||
150075932|NCT00467857|541417317|FG000|Overall Study|Withdrew consent|2|||
150075933|NCT00467857|541417318|FG001|Overall Study|Withdrew consent|0|||
150075934|NCT00467857|541417317|FG000|Overall Study|Death|0|||
150075935|NCT00467857|541417318|FG001|Overall Study|Death|1|||
150075936|NCT00467857|541417317|FG000|Overall Study|Discharged from court service|0|||
150075937|NCT00467857|541417318|FG001|Overall Study|Discharged from court service|1|||
150075938|NCT00467857|541417317|FG000|Overall Study|Emergency care required|0|||
150075939|NCT00467857|541417318|FG001|Overall Study|Emergency care required|1|||
150075940|NCT00467857|541417317|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
150075941|NCT00467857|541417318|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
150075942|NCT00467857|541417317|FG000|Overall Study|Discontinuation reason missing|0|||
150075943|NCT00467857|541417318|FG001|Overall Study|Discontinuation reason missing|3|||
150075944|NCT03576495|541417322|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
150075945|NCT03576495|541417323|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
150075946|NCT00516074|541417328|FG000|Overall Study|Adverse Event|0|||
150075947|NCT00516074|541417329|FG001|Overall Study|Adverse Event|1|||
150075948|NCT00516074|541417328|FG000|Overall Study|Subject Decision|4|||
150075949|NCT00516074|541417329|FG001|Overall Study|Subject Decision|2|||
150075950|NCT00516074|541417328|FG000|Overall Study|Loss of Glucose Control|2|||
150075951|NCT00516074|541417329|FG001|Overall Study|Loss of Glucose Control|0|||
150075952|NCT03822182|541417335|FG000|Overall Study|Protocol Violation|0|||
150075953|NCT03822182|541417336|FG001|Overall Study|Protocol Violation|1|||
150075954|NCT03822182|541417337|FG002|Overall Study|Protocol Violation|1|||
150075955|NCT00810355|541417338|FG000|Overall Study|Lost to Follow-up|13|||
150075956|NCT00810355|541417339|FG001|Overall Study|Lost to Follow-up|17|||
150075957|NCT00810355|541417340|FG002|Overall Study|Lost to Follow-up|11|||
150075958|NCT00810355|541417338|FG000|Overall Study|Withdrawal by Subject|1|||
150075959|NCT00810355|541417339|FG001|Overall Study|Withdrawal by Subject|0|||
150075960|NCT00810355|541417340|FG002|Overall Study|Withdrawal by Subject|0|||
150075961|NCT01612858|541417342|FG000|Overall Study|Withdrawal by Subject|5|||
150075962|NCT01612858|541417343|FG001|Overall Study|Withdrawal by Subject|1|||
150075963|NCT01484275|541417344|FG000|Overall Study|Study terminated by sponsor|28|||
150075964|NCT01484275|541417345|FG001|Overall Study|Study terminated by sponsor|32|||
150075965|NCT01484275|541417344|FG000|Overall Study|Other|10|||
150075966|NCT01484275|541417345|FG001|Overall Study|Other|0|||
150075967|NCT01484275|541417344|FG000|Overall Study|Death|3|||
150075968|NCT01484275|541417345|FG001|Overall Study|Death|4|||
150075969|NCT01484275|541417344|FG000|Overall Study|Withdrawal by Subject|1|||
150075970|NCT01484275|541417345|FG001|Overall Study|Withdrawal by Subject|5|||
150075971|NCT01484275|541417344|FG000|Overall Study|Lost to Follow-up|1|||
150075972|NCT01484275|541417345|FG001|Overall Study|Lost to Follow-up|1|||
150075973|NCT01387789|541417348|FG000|Overall Study|Adverse Event|5|||
150075974|NCT01387789|541417348|FG000|Overall Study|Lack of Efficacy|2|||
150075975|NCT01387789|541417348|FG000|Overall Study|Lost to Follow-up|1|||
150075976|NCT00913380|541417349|FG000|Clinical Outcomes|Lost to Follow-up|6|||
150075977|NCT00913380|541417350|FG001|Clinical Outcomes|Lost to Follow-up|6|||
150075978|NCT02187744|541417351|FG000|Study|Participant refused further follow-up|1|||
150075979|NCT02187744|541417352|FG001|Study|Participant refused further follow-up|0|||
150075980|NCT02187744|541417351|FG000|Study|Other|2|||
150075981|NCT02187744|541417352|FG001|Study|Other|1|||
150075982|NCT02187744|541417351|FG000|Study|Lost to Follow-up|0|||
150075983|NCT02187744|541417352|FG001|Study|Lost to Follow-up|2|||
150075984|NCT02187744|541417351|FG000|Study|Related adverse event, not serious|0|||
150075985|NCT02187744|541417352|FG001|Study|Related adverse event, not serious|2|||
150075986|NCT02187744|541417351|FG000|Study|Death|1|||
150075987|NCT02187744|541417352|FG001|Study|Death|0|||
150075988|NCT02187744|541417351|FG000|Study|Related adverse event, serious non-fatal|0|||
150075989|NCT02187744|541417352|FG001|Study|Related adverse event, serious non-fatal|1|||
150075990|NCT02187744|541417351|FG000|Treatment|Death|1|||
150075991|NCT02187744|541417352|FG001|Treatment|Death|0|||
150075992|NCT02187744|541417351|FG000|Treatment|Related adverse event, serious non-fatal|0|||
150075993|NCT02187744|541417352|FG001|Treatment|Related adverse event, serious non-fatal|1|||
150075994|NCT02187744|541417351|FG000|Treatment|Related adverse event, not serious|0|||
150075995|NCT02187744|541417352|FG001|Treatment|Related adverse event, not serious|2|||
150075996|NCT02187744|541417351|FG000|Treatment|Lost to Follow-up|0|||
150075997|NCT02187744|541417352|FG001|Treatment|Lost to Follow-up|1|||
150075998|NCT02187744|541417351|FG000|Treatment|Other|2|||
150075999|NCT02187744|541417352|FG001|Treatment|Other|0|||
150076000|NCT02187744|541417351|FG000|Treatment|Participant refused continued treatment|1|||
150076001|NCT02187744|541417352|FG001|Treatment|Participant refused continued treatment|1|||
150076002|NCT01788228|541417357|FG000|Overall Study|Migrated/moved from study area|1|||
150182488|NCT01000480|541804734|FG000|Concurrent Therapy Phase|Adverse Event|4|||
150182489|NCT01000480|541804734|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
150182490|NCT01000480|541804734|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
150182491|NCT01000480|541804734|FG000|Concurrent Therapy Phase|Physician Decision|1|||
150182492|NCT03101930|541804738|FG000|Overall Study|Withdrawal by Subject|2|||
150182493|NCT03101930|541804739|FG001|Overall Study|Withdrawal by Subject|1|||
150182494|NCT03101930|541804740|FG002|Overall Study|Withdrawal by Subject|2|||
150182495|NCT00262301|541804741|FG000|Double-blind Phase|Lost to Follow-up|1|||
150182496|NCT00262301|541804742|FG001|Double-blind Phase|Lost to Follow-up|0|||
150182497|NCT00262301|541804743|FG002|Double-blind Phase|Lost to Follow-up|0|||
150182498|NCT00262301|541804741|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
150076003|NCT01788228|541417358|FG001|Overall Study|Migrated/moved from study area|0|||
150182499|NCT00262301|541804742|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
150076004|NCT00508755|541417363|FG000|Overall Study|Withdrawal by Subject|1|||
150076005|NCT00945893|541417364|FG000|Overall Study|Lost to Follow-up|2|||
150076006|NCT00945893|541417365|FG001|Overall Study|Lost to Follow-up|8|||
150076007|NCT00945893|541417364|FG000|Overall Study|Withdrawal of consent|1|||
150076008|NCT00945893|541417365|FG001|Overall Study|Withdrawal of consent|2|||
150076009|NCT01602120|541417368|FG000|Overall Study|Adverse Event|3|||
150076010|NCT01602120|541417369|FG001|Overall Study|Adverse Event|6|||
150076011|NCT01602120|541417370|FG002|Overall Study|Adverse Event|0|||
150076012|NCT01602120|541417371|FG003|Overall Study|Adverse Event|2|||
150076013|NCT01602120|541417368|FG000|Overall Study|Death|0|||
150076014|NCT01602120|541417369|FG001|Overall Study|Death|4|||
150076015|NCT01602120|541417370|FG002|Overall Study|Death|0|||
150076016|NCT01602120|541417371|FG003|Overall Study|Death|0|||
150076017|NCT01602120|541417368|FG000|Overall Study|Lost to Follow-up|0|||
150076018|NCT01602120|541417369|FG001|Overall Study|Lost to Follow-up|1|||
150076019|NCT01602120|541417370|FG002|Overall Study|Lost to Follow-up|0|||
150076020|NCT01602120|541417371|FG003|Overall Study|Lost to Follow-up|1|||
150076021|NCT01602120|541417368|FG000|Overall Study|Protocol Violation|1|||
150076022|NCT01602120|541417369|FG001|Overall Study|Protocol Violation|1|||
150076023|NCT01602120|541417370|FG002|Overall Study|Protocol Violation|0|||
150076024|NCT01602120|541417371|FG003|Overall Study|Protocol Violation|0|||
150076025|NCT01602120|541417368|FG000|Overall Study|Non-compliance|0|||
150076026|NCT01602120|541417369|FG001|Overall Study|Non-compliance|3|||
150076027|NCT01602120|541417370|FG002|Overall Study|Non-compliance|0|||
150076028|NCT01602120|541417371|FG003|Overall Study|Non-compliance|1|||
150076029|NCT01602120|541417368|FG000|Overall Study|Withdrawal by Subject|8|||
150076030|NCT01602120|541417369|FG001|Overall Study|Withdrawal by Subject|17|||
150076031|NCT01602120|541417370|FG002|Overall Study|Withdrawal by Subject|0|||
150076032|NCT01602120|541417371|FG003|Overall Study|Withdrawal by Subject|3|||
150076033|NCT01602120|541417368|FG000|Overall Study|Study Terminated by Sponsor|12|||
150076034|NCT01602120|541417369|FG001|Overall Study|Study Terminated by Sponsor|24|||
150076035|NCT01602120|541417370|FG002|Overall Study|Study Terminated by Sponsor|17|||
150076036|NCT01602120|541417371|FG003|Overall Study|Study Terminated by Sponsor|44|||
150076037|NCT01602120|541417368|FG000|Overall Study|Physician Decision|2|||
150076038|NCT01602120|541417369|FG001|Overall Study|Physician Decision|3|||
150076039|NCT01602120|541417370|FG002|Overall Study|Physician Decision|0|||
150076040|NCT01602120|541417371|FG003|Overall Study|Physician Decision|0|||
150076041|NCT01602120|541417368|FG000|Overall Study|Unspecified Reason|3|||
150076042|NCT01602120|541417369|FG001|Overall Study|Unspecified Reason|1|||
150076043|NCT01602120|541417370|FG002|Overall Study|Unspecified Reason|0|||
150076044|NCT01602120|541417371|FG003|Overall Study|Unspecified Reason|2|||
150076045|NCT02764697|541417375|FG000|Overall Study|Lack of Efficacy|3|||
150076046|NCT03298867|541417384|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
150076047|NCT03298867|541417385|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
150076048|NCT03298867|541417384|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
150076049|NCT03298867|541417385|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
150076050|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
150076051|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
150076052|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
150076053|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
150076054|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
150076055|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
150076056|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
150076057|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
150076058|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
150076059|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
150076060|NCT03298867|541417384|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
150076061|NCT03298867|541417385|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
150076062|NCT03298867|541417384|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
150076063|NCT03298867|541417385|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
150076064|NCT01995825|541419405|FG000|Overall Study|Withdrawal by Subject|1|||
150076065|NCT01995825|541419406|FG001|Overall Study|Withdrawal by Subject|0|||
150076066|NCT01798004|541419407|FG000|Overall Study|Death|2|||
150076067|NCT01798004|541419407|FG000|Overall Study|Lack of Efficacy|8|||
150076068|NCT01798004|541419407|FG000|Overall Study|Physician Decision|25|||
150076069|NCT01798004|541419407|FG000|Overall Study|Withdrawal by Subject|4|||
150076070|NCT01798004|541419407|FG000|Overall Study|Ineligible|4|||
150076071|NCT01798004|541419407|FG000|Overall Study|Patient/parent refusal|7|||
150076072|NCT01798004|541419407|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
150076073|NCT01798004|541419407|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
150076074|NCT04680052|541419408|FG000|Overall Study|Ongoing|244|||
150076075|NCT04680052|541419409|FG001|Overall Study|Ongoing|229|||
150076076|NCT04680052|541419410|FG002|Overall Study|Ongoing|39|||
150076077|NCT04680052|541419411|FG003|Overall Study|Ongoing|46|||
150076078|NCT04680052|541419408|FG000|Overall Study|Death|15|||
150076079|NCT04680052|541419409|FG001|Overall Study|Death|22|||
150076080|NCT04680052|541419410|FG002|Overall Study|Death|7|||
150076081|NCT04680052|541419411|FG003|Overall Study|Death|1|||
150076082|NCT04680052|541419408|FG000|Overall Study|Lost to Follow-up|3|||
150076083|NCT04680052|541419409|FG001|Overall Study|Lost to Follow-up|2|||
150076084|NCT04680052|541419410|FG002|Overall Study|Lost to Follow-up|0|||
150076085|NCT04680052|541419411|FG003|Overall Study|Lost to Follow-up|1|||
150076086|NCT04680052|541419408|FG000|Overall Study|Withdrawal by Subject|11|||
150076087|NCT04680052|541419409|FG001|Overall Study|Withdrawal by Subject|19|||
150076088|NCT04680052|541419410|FG002|Overall Study|Withdrawal by Subject|7|||
150076089|NCT04680052|541419411|FG003|Overall Study|Withdrawal by Subject|5|||
150076090|NCT04680052|541419408|FG000|Overall Study|Missing|0|||
150076091|NCT04680052|541419409|FG001|Overall Study|Missing|1|||
150076092|NCT04680052|541419410|FG002|Overall Study|Missing|0|||
150076093|NCT04680052|541419411|FG003|Overall Study|Missing|0|||
150076094|NCT04680052|541419408|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
150076095|NCT04680052|541419409|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
150076096|NCT04680052|541419410|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
150076097|NCT04680052|541419411|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
150076098|NCT04680052|541419408|FG000|Overall Study|Physician Decision|0|||
150076099|NCT04680052|541419409|FG001|Overall Study|Physician Decision|1|||
150076100|NCT04680052|541419410|FG002|Overall Study|Physician Decision|0|||
150076101|NCT04680052|541419411|FG003|Overall Study|Physician Decision|0|||
150076102|NCT01367002|541419412|FG000|Overall Study|Withdrawal by Subject|1|||
150076103|NCT01367002|541419413|FG001|Overall Study|Withdrawal by Subject|0|||
150076104|NCT01367002|541419412|FG000|Overall Study|Physician Decision|0|||
150076105|NCT01367002|541419413|FG001|Overall Study|Physician Decision|2|||
150076106|NCT06956170|541419414|FG000|Overall Study|Death|2|||
150076107|NCT06956170|541419415|FG001|Overall Study|Death|1|||
150076108|NCT06956170|541419414|FG000|Overall Study|Withdrawal by Subject|1|||
150076109|NCT06956170|541419415|FG001|Overall Study|Withdrawal by Subject|0|||
150076110|NCT06956170|541419414|FG000|Overall Study|Ongoing|7|||
150076111|NCT06956170|541419415|FG001|Overall Study|Ongoing|10|||
150076112|NCT01516437|541419416|FG000|Overall Study|Reason not specified|0|||
150076113|NCT01516437|541419417|FG001|Overall Study|Reason not specified|0|||
150076114|NCT01516437|541419418|FG002|Overall Study|Reason not specified|1|||
150076115|NCT01516437|541419419|FG003|Overall Study|Reason not specified|1|||
150076116|NCT01687998|541419426|FG000|Overall Study|Withdrawal by Subject|49|||
150076117|NCT01687998|541419427|FG001|Overall Study|Withdrawal by Subject|51|||
150076118|NCT01687998|541419426|FG000|Overall Study|Known to be Alive at Study End|54|||
150076119|NCT01687998|541419427|FG001|Overall Study|Known to be Alive at Study End|62|||
150076120|NCT01687998|541419426|FG000|Overall Study|Lost to Follow-up|9|||
150076121|NCT01687998|541419427|FG001|Overall Study|Lost to Follow-up|7|||
150076122|NCT01663532|541419428|FG000|Overall Study|Lost to Follow-up|9|||
150076123|NCT01663532|541419429|FG001|Overall Study|Lost to Follow-up|10|||
150076124|NCT01663532|541419428|FG000|Overall Study|Adverse Event|7|||
150076125|NCT01663532|541419429|FG001|Overall Study|Adverse Event|13|||
150076126|NCT01663532|541419428|FG000|Overall Study|Met Withdrawal Criteria|7|||
150076127|NCT01663532|541419429|FG001|Overall Study|Met Withdrawal Criteria|6|||
150076128|NCT01663532|541419428|FG000|Overall Study|Physician Decision|1|||
150076129|NCT01663532|541419429|FG001|Overall Study|Physician Decision|1|||
150076130|NCT01663532|541419428|FG000|Overall Study|Withdrawal by Subject|35|||
150076131|NCT01663532|541419429|FG001|Overall Study|Withdrawal by Subject|17|||
150076132|NCT01663532|541419428|FG000|Overall Study|Lack of Efficacy|15|||
150076133|NCT01663532|541419429|FG001|Overall Study|Lack of Efficacy|60|||
150076134|NCT04805541|541419431|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
150076135|NCT02195583|541419437|FG000|Overall Study|Lost to Follow-up|1|||
150076136|NCT02195583|541419437|FG000|Overall Study|Withdrawal by Subject|4|||
150076137|NCT02195583|541419437|FG000|Overall Study|Adverse Event|2|||
150076138|NCT02195583|541419437|FG000|Overall Study|Other Reason|2|||
150076139|NCT00354744|541419438|FG000|Overall Study|Adverse Event|2|||
150076140|NCT00354744|541419438|FG000|Overall Study|Death|2|||
150076141|NCT00354744|541419438|FG000|Overall Study|Lack of Efficacy|11|||
150076142|NCT00354744|541419438|FG000|Overall Study|Lost to Follow-up|2|||
150076143|NCT00354744|541419438|FG000|Overall Study|Physician Decision|11|||
150076144|NCT00354744|541419438|FG000|Overall Study|Withdrawal by Subject|14|||
150076145|NCT00983437|541419439|FG000|Overall Study|Adverse Event|9|||
150076146|NCT00983437|541419439|FG000|Overall Study|Lack of Efficacy|1|||
150076147|NCT00983437|541419439|FG000|Overall Study|Withdrawal by Subject|8|||
150076148|NCT00983437|541419439|FG000|Overall Study|Noncompliance to Study Procedures|1|||
150076149|NCT00983437|541419439|FG000|Overall Study|Lost to Follow-up|2|||
150076150|NCT00983437|541419439|FG000|Overall Study|Other Reason|26|||
150076151|NCT00094172|541419440|FG000|Overall Study|Adverse Event|0|||
150076152|NCT00094172|541419441|FG001|Overall Study|Adverse Event|1|||
150076153|NCT00094172|541419440|FG000|Overall Study|Lost to Follow-up|2|||
150076154|NCT00094172|541419441|FG001|Overall Study|Lost to Follow-up|0|||
150076155|NCT00094172|541419440|FG000|Overall Study|Protocol Violation|0|||
150076156|NCT00094172|541419441|FG001|Overall Study|Protocol Violation|1|||
150076157|NCT00094172|541419440|FG000|Overall Study|Withdrawal by Subject|10|||
150076158|NCT00094172|541419441|FG001|Overall Study|Withdrawal by Subject|5|||
150076159|NCT00094172|541419440|FG000|Overall Study|Primary endpoint met.|1|||
150076160|NCT00094172|541419441|FG001|Overall Study|Primary endpoint met.|0|||
150076161|NCT00094172|541419440|FG000|Overall Study|Started other MS therapy due to disease|1|||
150076162|NCT00094172|541419441|FG001|Overall Study|Started other MS therapy due to disease|0|||
150076163|NCT01020981|541419442|FG000|Overall Study|Did not return mailed survey|74|||
150076164|NCT01020981|541419443|FG001|Overall Study|Did not return mailed survey|58|||
150076165|NCT01020981|541419442|FG000|Overall Study|Survey returned undeliverable|8|||
150076166|NCT01020981|541419443|FG001|Overall Study|Survey returned undeliverable|32|||
150076167|NCT01020981|541419442|FG000|Overall Study|Participant declined to complete survey|2|||
150076168|NCT01020981|541419443|FG001|Overall Study|Participant declined to complete survey|0|||
150076169|NCT00289133|541419446|FG000|Overall Study|Non-study device implanted|12|||
150076170|NCT00289133|541419447|FG001|Overall Study|Non-study device implanted|0|||
150076171|NCT00289133|541419446|FG000|Overall Study|Protocol Violation|32|||
150076172|NCT00289133|541419447|FG001|Overall Study|Protocol Violation|38|||
150076173|NCT00289133|541419446|FG000|Overall Study|Withdrawal by Subject|9|||
150076174|NCT00289133|541419447|FG001|Overall Study|Withdrawal by Subject|10|||
150076175|NCT00289133|541419446|FG000|Overall Study|Death|5|||
150076176|NCT00289133|541419447|FG001|Overall Study|Death|10|||
150076177|NCT00289133|541419446|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
150076178|NCT00289133|541419447|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
150076179|NCT00289133|541419446|FG000|Overall Study|Physician Decision|41|||
150076180|NCT00289133|541419447|FG001|Overall Study|Physician Decision|45|||
150076181|NCT00289133|541419446|FG000|Overall Study|Revision|8|||
150076182|NCT00289133|541419447|FG001|Overall Study|Revision|6|||
150076183|NCT00289133|541419446|FG000|Overall Study|Lost to Follow-up|92|||
150076184|NCT00289133|541419447|FG001|Overall Study|Lost to Follow-up|115|||
150076185|NCT02555683|541419452|FG000|Overall Study|Physician Decision|1|||
150076186|NCT02555683|541419453|FG001|Overall Study|Physician Decision|0|||
150076187|NCT02555683|541419454|FG002|Overall Study|Physician Decision|2|||
150076188|NCT02555683|541419452|FG000|Overall Study|Lost to Follow-up|2|||
150076189|NCT02555683|541419453|FG001|Overall Study|Lost to Follow-up|1|||
150076190|NCT02555683|541419454|FG002|Overall Study|Lost to Follow-up|2|||
150076191|NCT02555683|541419452|FG000|Overall Study|Technical Problems|1|||
150076192|NCT02555683|541419453|FG001|Overall Study|Technical Problems|1|||
150076193|NCT02555683|541419454|FG002|Overall Study|Technical Problems|0|||
150076194|NCT02555683|541419452|FG000|Overall Study|Protocol deviation|0|||
150076195|NCT02555683|541419453|FG001|Overall Study|Protocol deviation|1|||
150076196|NCT02555683|541419454|FG002|Overall Study|Protocol deviation|0|||
150076197|NCT02555683|541419452|FG000|Overall Study|Lack of Efficacy|2|||
150076198|NCT02555683|541419453|FG001|Overall Study|Lack of Efficacy|0|||
150076199|NCT02555683|541419454|FG002|Overall Study|Lack of Efficacy|0|||
150076200|NCT02555683|541419452|FG000|Overall Study|Death|0|||
150076201|NCT02555683|541419453|FG001|Overall Study|Death|1|||
150076202|NCT02555683|541419454|FG002|Overall Study|Death|2|||
150182500|NCT00262301|541804743|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
150182501|NCT01771731|541804744|FG000|Overall Study|Physician Decision|1|||
150076203|NCT02555683|541419452|FG000|Overall Study|Adverse Event|1|||
150076204|NCT02555683|541419453|FG001|Overall Study|Adverse Event|0|||
150076205|NCT02555683|541419454|FG002|Overall Study|Adverse Event|1|||
150076206|NCT02555683|541419452|FG000|Overall Study|Subject/guardian decision|12|||
150076207|NCT02555683|541419453|FG001|Overall Study|Subject/guardian decision|12|||
150076208|NCT02555683|541419454|FG002|Overall Study|Subject/guardian decision|22|||
150076209|NCT02555683|541419452|FG000|Overall Study|Death post Treatment/safety period|0|||
150076210|NCT02555683|541419453|FG001|Overall Study|Death post Treatment/safety period|1|||
150076211|NCT02555683|541419454|FG002|Overall Study|Death post Treatment/safety period|0|||
150076212|NCT00612040|541419455|FG000|Overall Study|Adverse Event|0|||
150076213|NCT00612040|541419456|FG001|Overall Study|Adverse Event|2|||
150076214|NCT00612040|541419457|FG002|Overall Study|Adverse Event|1|||
150076215|NCT00612040|541419455|FG000|Overall Study|Protocol Violation|1|||
150076216|NCT00612040|541419456|FG001|Overall Study|Protocol Violation|2|||
150076217|NCT00612040|541419457|FG002|Overall Study|Protocol Violation|1|||
150076218|NCT00612040|541419455|FG000|Overall Study|Lack of Efficacy|2|||
150076219|NCT00612040|541419456|FG001|Overall Study|Lack of Efficacy|1|||
150076220|NCT00612040|541419457|FG002|Overall Study|Lack of Efficacy|0|||
150076221|NCT00612040|541419455|FG000|Overall Study|Unclassified|2|||
150076222|NCT00612040|541419456|FG001|Overall Study|Unclassified|2|||
150076223|NCT00612040|541419457|FG002|Overall Study|Unclassified|5|||
150076224|NCT00827502|541419458|FG000|Overall Study|randomized but not treated|11|||
150076225|NCT00827502|541419458|FG000|Overall Study|Adverse Event|1|||
150076226|NCT00827502|541419458|FG000|Overall Study|Lost to Follow-up|4|||
150076227|NCT00827502|541419458|FG000|Overall Study|Withdrawal by Subject|5|||
150076228|NCT02924571|541419460|FG000|Overall Study|Lost to Follow-up|1|||
150076229|NCT02924571|541419461|FG001|Overall Study|Lost to Follow-up|1|||
150076230|NCT02924571|541419462|FG002|Overall Study|Lost to Follow-up|0|||
150076231|NCT00002651|541419466|FG000|Induction|Adverse Event|44|||
150076232|NCT00002651|541419467|FG001|Induction|Adverse Event|0|||
150076233|NCT00002651|541419468|FG002|Induction|Adverse Event|0|||
150076234|NCT00002651|541419466|FG000|Induction|Refusal unrelated to adverse event|50|||
150076235|NCT00002651|541419467|FG001|Induction|Refusal unrelated to adverse event|0|||
150076236|NCT00002651|541419468|FG002|Induction|Refusal unrelated to adverse event|0|||
150076237|NCT00002651|541419466|FG000|Induction|Progression/relapse|274|||
150076238|NCT00002651|541419467|FG001|Induction|Progression/relapse|0|||
150076239|NCT00002651|541419468|FG002|Induction|Progression/relapse|0|||
150076240|NCT00002651|541419466|FG000|Induction|Death|62|||
150076241|NCT00002651|541419467|FG001|Induction|Death|0|||
150076242|NCT00002651|541419468|FG002|Induction|Death|0|||
150076243|NCT00002651|541419466|FG000|Induction|Other|823|||
150076244|NCT00002651|541419467|FG001|Induction|Other|0|||
150076245|NCT00002651|541419468|FG002|Induction|Other|0|||
150076246|NCT00002651|541419466|FG000|Induction|not eligible|90|||
150076247|NCT00002651|541419467|FG001|Induction|not eligible|0|||
150076248|NCT00002651|541419468|FG002|Induction|not eligible|0|||
150076249|NCT00002651|541419466|FG000|Consolidation and Randomization|Adverse Event|0|||
150076250|NCT00002651|541419467|FG001|Consolidation and Randomization|Adverse Event|36|||
150076251|NCT00002651|541419468|FG002|Consolidation and Randomization|Adverse Event|14|||
150076252|NCT00002651|541419466|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
150076253|NCT00002651|541419467|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
150076254|NCT00002651|541419468|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
150076255|NCT00002651|541419466|FG000|Consolidation and Randomization|Progression/relapse|0|||
150076256|NCT00002651|541419467|FG001|Consolidation and Randomization|Progression/relapse|295|||
150076257|NCT00002651|541419468|FG002|Consolidation and Randomization|Progression/relapse|298|||
150076258|NCT00002651|541419466|FG000|Consolidation and Randomization|Death|0|||
150076259|NCT00002651|541419467|FG001|Consolidation and Randomization|Death|38|||
150076260|NCT00002651|541419468|FG002|Consolidation and Randomization|Death|48|||
150076261|NCT00002651|541419466|FG000|Consolidation and Randomization|Other|0|||
150076262|NCT00002651|541419467|FG001|Consolidation and Randomization|Other|314|||
150076263|NCT00002651|541419468|FG002|Consolidation and Randomization|Other|313|||
150076264|NCT00002651|541419466|FG000|Consolidation and Randomization|not eligible|0|||
150076265|NCT00002651|541419467|FG001|Consolidation and Randomization|not eligible|102|||
150076266|NCT00002651|541419468|FG002|Consolidation and Randomization|not eligible|112|||
150076267|NCT03750955|541419475|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
150076268|NCT03750955|541419476|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
150076269|NCT03750955|541419475|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
150076270|NCT03750955|541419476|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
150076271|NCT02763462|541419481|FG000|Overall Study|Protocol Violation|6|||
150076272|NCT02100514|541419482|FG000|Treatment Period|Adverse Event|0|||
150076273|NCT02100514|541419483|FG001|Treatment Period|Adverse Event|5|||
150076274|NCT02100514|541419484|FG002|Treatment Period|Adverse Event|0|||
150076275|NCT02100514|541419485|FG003|Treatment Period|Adverse Event|0|||
150076276|NCT02100514|541419486|FG004|Treatment Period|Adverse Event|0|||
150076277|NCT02100514|541419482|FG000|Treatment Period|Death|2|||
150076278|NCT02100514|541419483|FG001|Treatment Period|Death|2|||
150076279|NCT02100514|541419484|FG002|Treatment Period|Death|0|||
150076280|NCT02100514|541419485|FG003|Treatment Period|Death|0|||
150076281|NCT02100514|541419486|FG004|Treatment Period|Death|0|||
150182502|NCT01771731|541804745|FG001|Overall Study|Physician Decision|0|||
150076282|NCT02100514|541419482|FG000|Treatment Period|Lost to Follow-up|5|||
150076283|NCT02100514|541419483|FG001|Treatment Period|Lost to Follow-up|17|||
150076284|NCT02100514|541419484|FG002|Treatment Period|Lost to Follow-up|0|||
150076285|NCT02100514|541419485|FG003|Treatment Period|Lost to Follow-up|0|||
150182503|NCT01771731|541804744|FG000|Overall Study|Protocol Violation|0|||
150076286|NCT02100514|541419486|FG004|Treatment Period|Lost to Follow-up|0|||
150076287|NCT02100514|541419482|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
150076288|NCT02100514|541419483|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
150076289|NCT02100514|541419484|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
150076290|NCT02100514|541419485|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
150076291|NCT02100514|541419486|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
150076292|NCT02100514|541419482|FG000|Treatment Period|Protocol Violation|1|||
150076293|NCT02100514|541419483|FG001|Treatment Period|Protocol Violation|1|||
150076294|NCT02100514|541419484|FG002|Treatment Period|Protocol Violation|0|||
150076295|NCT02100514|541419485|FG003|Treatment Period|Protocol Violation|0|||
150076296|NCT02100514|541419486|FG004|Treatment Period|Protocol Violation|0|||
150076297|NCT02100514|541419482|FG000|Treatment Period|Withdrawal by Subject|12|||
150076298|NCT02100514|541419483|FG001|Treatment Period|Withdrawal by Subject|37|||
150076299|NCT02100514|541419484|FG002|Treatment Period|Withdrawal by Subject|0|||
150076300|NCT02100514|541419485|FG003|Treatment Period|Withdrawal by Subject|0|||
150076301|NCT02100514|541419486|FG004|Treatment Period|Withdrawal by Subject|0|||
150076302|NCT02100514|541419482|FG000|Treatment Period|Other|9|||
150076303|NCT02100514|541419483|FG001|Treatment Period|Other|11|||
150076304|NCT02100514|541419484|FG002|Treatment Period|Other|0|||
150076305|NCT02100514|541419485|FG003|Treatment Period|Other|0|||
150076306|NCT02100514|541419486|FG004|Treatment Period|Other|0|||
150076307|NCT02100514|541419482|FG000|Extension Period|Withdrew consent|0|||
150076308|NCT02100514|541419483|FG001|Extension Period|Withdrew consent|0|||
150076309|NCT02100514|541419484|FG002|Extension Period|Withdrew consent|2|||
150076310|NCT02100514|541419485|FG003|Extension Period|Withdrew consent|0|||
150076311|NCT02100514|541419486|FG004|Extension Period|Withdrew consent|0|||
150076312|NCT00319553|541419487|FG000|Overall Study|Protocol Violation|1|||
150076313|NCT00319553|541419488|FG001|Overall Study|Protocol Violation|2|||
150076314|NCT00319553|541419487|FG000|Overall Study|Lost to Follow-up|2|||
150076315|NCT00319553|541419488|FG001|Overall Study|Lost to Follow-up|1|||
150076316|NCT00319553|541419487|FG000|Overall Study|Withdrawal by Subject|1|||
150076317|NCT00319553|541419488|FG001|Overall Study|Withdrawal by Subject|1|||
150076318|NCT00885846|541419490|FG000|Overall Study|Withdrawal by Subject|2|||
150076319|NCT00885846|541419491|FG001|Overall Study|Withdrawal by Subject|5|||
150076320|NCT00885846|541419492|FG002|Overall Study|Withdrawal by Subject|2|||
150076321|NCT00880542|541419493|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
150076322|NCT00880542|541419493|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
150076323|NCT00880542|541419493|FG000|REP: Surgical Resection|progressive disease|1|||
150076324|NCT00003487|541419505|FG000|Overall Study|Not evaluable|2|||
150076325|NCT04154930|541419510|FG000|Overall Study|Withdrawal by Subject|15|||
150076326|NCT04154930|541419511|FG001|Overall Study|Withdrawal by Subject|6|||
150076327|NCT04154930|541419510|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
150076328|NCT04154930|541419511|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
150076329|NCT04154930|541419510|FG000|Overall Study|Lost to Follow-up|14|||
150076330|NCT04154930|541419511|FG001|Overall Study|Lost to Follow-up|6|||
150076331|NCT04154930|541419510|FG000|Overall Study|Other|6|||
150076332|NCT04154930|541419511|FG001|Overall Study|Other|0|||
150076333|NCT00657358|541419512|FG000|Overall Study|Lack of Efficacy|6|||
150076334|NCT02628938|541419516|FG000|Overall Study|Did not attend the follow up recall|2|||
150076335|NCT02628938|541419517|FG001|Overall Study|Did not attend the follow up recall|2|||
150076336|NCT02628938|541419518|FG002|Overall Study|Did not attend the follow up recall|1|||
150076337|NCT02628938|541419516|FG000|Overall Study|Failure to comply with the instructions|3|||
150076338|NCT02628938|541419517|FG001|Overall Study|Failure to comply with the instructions|0|||
150076339|NCT02628938|541419518|FG002|Overall Study|Failure to comply with the instructions|3|||
150076340|NCT02058693|541419519|FG000|Phase 1|Withdrawal by Subject|3|||
150076341|NCT02058693|541419520|FG001|Phase 1|Withdrawal by Subject|2|||
150076342|NCT02058693|541419519|FG000|Phase 1|Adverse Event|0|||
150076343|NCT02058693|541419520|FG001|Phase 1|Adverse Event|1|||
150076344|NCT02058693|541419519|FG000|Phase 1|Lack of Efficacy|1|||
150076345|NCT02058693|541419520|FG001|Phase 1|Lack of Efficacy|0|||
150076346|NCT02058693|541419519|FG000|Phase 1|Physician Decision|1|||
150076347|NCT02058693|541419520|FG001|Phase 1|Physician Decision|1|||
150076348|NCT02058693|541419519|FG000|Phase 2|Withdrawal by Subject|0|||
150076349|NCT02058693|541419520|FG001|Phase 2|Withdrawal by Subject|2|||
150076350|NCT00241358|541419521|FG000|Overall Study|Determined to be not ineligible|0|||
150076351|NCT00241358|541419522|FG001|Overall Study|Determined to be not ineligible|1|||
150076352|NCT00241358|541419523|FG002|Overall Study|Determined to be not ineligible|1|||
150076353|NCT00843856|541419524|FG000|Overall Study|Lost to Follow-up|1|||
150076354|NCT00843856|541419525|FG001|Overall Study|Lost to Follow-up|2|||
150076355|NCT03855228|541419526|FG000|Overall Study|Adverse Event|2|||
150076356|NCT03855228|541419527|FG001|Overall Study|Adverse Event|4|||
150076357|NCT03855228|541419528|FG002|Overall Study|Adverse Event|4|||
150076358|NCT03855228|541419529|FG003|Overall Study|Adverse Event|8|||
150076359|NCT03855228|541419526|FG000|Overall Study|Treatment Failure|1|||
150076360|NCT03855228|541419527|FG001|Overall Study|Treatment Failure|2|||
150076361|NCT03855228|541419528|FG002|Overall Study|Treatment Failure|1|||
150076362|NCT03855228|541419529|FG003|Overall Study|Treatment Failure|8|||
150076363|NCT03855228|541419526|FG000|Overall Study|Lost to Follow-up|0|||
150076364|NCT03855228|541419527|FG001|Overall Study|Lost to Follow-up|0|||
150076365|NCT03855228|541419528|FG002|Overall Study|Lost to Follow-up|0|||
150076366|NCT03855228|541419529|FG003|Overall Study|Lost to Follow-up|1|||
150076367|NCT03855228|541419526|FG000|Overall Study|Protocol Violation|0|||
150076368|NCT03855228|541419527|FG001|Overall Study|Protocol Violation|1|||
150076369|NCT03855228|541419528|FG002|Overall Study|Protocol Violation|2|||
150076370|NCT03855228|541419529|FG003|Overall Study|Protocol Violation|1|||
150076371|NCT03855228|541419526|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
150076372|NCT03855228|541419527|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
150076373|NCT03855228|541419528|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
150076374|NCT03855228|541419529|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
150076375|NCT00590135|541419530|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
150076376|NCT01972568|541419543|FG000|Overall Study|Other events|3|||
150076377|NCT01972568|541419544|FG001|Overall Study|Other events|0|||
150076378|NCT01972568|541419545|FG002|Overall Study|Other events|0|||
150076379|NCT01972568|541419543|FG000|Overall Study|Lack of Efficacy|0|||
150076380|NCT01972568|541419544|FG001|Overall Study|Lack of Efficacy|1|||
150076381|NCT01972568|541419545|FG002|Overall Study|Lack of Efficacy|2|||
150076382|NCT01972568|541419543|FG000|Overall Study|Protocol Violation|1|||
150076383|NCT01972568|541419544|FG001|Overall Study|Protocol Violation|2|||
150076384|NCT01972568|541419545|FG002|Overall Study|Protocol Violation|2|||
150076385|NCT01972568|541419543|FG000|Overall Study|Withdrawal by Subject|6|||
150076386|NCT01972568|541419544|FG001|Overall Study|Withdrawal by Subject|3|||
150076387|NCT01972568|541419545|FG002|Overall Study|Withdrawal by Subject|7|||
150076388|NCT01972568|541419543|FG000|Overall Study|Lost to Follow-up|1|||
150076389|NCT01972568|541419544|FG001|Overall Study|Lost to Follow-up|0|||
150076390|NCT01972568|541419545|FG002|Overall Study|Lost to Follow-up|0|||
150076391|NCT01972568|541419543|FG000|Overall Study|Adverse Event|5|||
150076392|NCT01972568|541419544|FG001|Overall Study|Adverse Event|6|||
150076393|NCT01972568|541419545|FG002|Overall Study|Adverse Event|5|||
150076394|NCT02059408|541419546|FG000|Overall Study|Did not get tested|0|||
150076395|NCT02059408|541419547|FG001|Overall Study|Did not get tested|330|||
150076396|NCT02059408|541419548|FG002|Overall Study|Did not get tested|358|||
150076397|NCT00957580|541419549|FG000|Overall Study|Ongoing at data cut-off|0|||
150076398|NCT00957580|541419550|FG001|Overall Study|Ongoing at data cut-off|1|||
150076399|NCT00957580|541419551|FG002|Overall Study|Ongoing at data cut-off|0|||
150076400|NCT00957580|541419549|FG000|Overall Study|Enrolled but not treated|0|||
150076401|NCT00957580|541419550|FG001|Overall Study|Enrolled but not treated|1|||
150076402|NCT00957580|541419551|FG002|Overall Study|Enrolled but not treated|0|||
150076403|NCT00190671|541419560|FG000|Overall Study|Satisfactory Response|4|||
150076404|NCT00190671|541419561|FG001|Overall Study|Satisfactory Response|7|||
150076405|NCT00190671|541419560|FG000|Overall Study|Lack of Efficacy|19|||
150076406|NCT00190671|541419561|FG001|Overall Study|Lack of Efficacy|24|||
150076407|NCT00190671|541419560|FG000|Overall Study|Death from Study Disease|1|||
150076408|NCT00190671|541419561|FG001|Overall Study|Death from Study Disease|1|||
150076409|NCT00190671|541419560|FG000|Overall Study|Adverse Event|3|||
150076410|NCT00190671|541419561|FG001|Overall Study|Adverse Event|2|||
150076411|NCT00190671|541419560|FG000|Overall Study|Clinical Relapse|0|||
150076412|NCT00190671|541419561|FG001|Overall Study|Clinical Relapse|1|||
150076413|NCT00190671|541419560|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
150076414|NCT00190671|541419561|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
150076415|NCT00190671|541419560|FG000|Overall Study|Death from Other Causes|0|||
150076416|NCT00190671|541419561|FG001|Overall Study|Death from Other Causes|2|||
150076417|NCT00190671|541419560|FG000|Overall Study|Protocol Violation|0|||
150076418|NCT00190671|541419561|FG001|Overall Study|Protocol Violation|1|||
150076419|NCT00190671|541419560|FG000|Overall Study|Withdrawal by Subject|0|||
150076420|NCT00190671|541419561|FG001|Overall Study|Withdrawal by Subject|2|||
150076421|NCT04502433|541419562|FG000|Overall Study|Death|2|||
150076422|NCT04502433|541419563|FG001|Overall Study|Death|4|||
150076423|NCT04502433|541419562|FG000|Overall Study|Lost to Follow-up|1|||
150076424|NCT04502433|541419563|FG001|Overall Study|Lost to Follow-up|0|||
150076425|NCT04502433|541419562|FG000|Overall Study|Physician Decision|0|||
150076426|NCT04502433|541419563|FG001|Overall Study|Physician Decision|1|||
150076427|NCT02699593|541419564|FG000|Period 1|Unsatisfactory Visual Response|0|||
150076428|NCT02699593|541419565|FG001|Period 1|Unsatisfactory Visual Response|1|||
150076429|NCT02699593|541419564|FG000|Period 1|Torn Contact Len|4|||
150076430|NCT02699593|541419565|FG001|Period 1|Torn Contact Len|3|||
150076431|NCT02699593|541419564|FG000|Period 1|Protocol Violation|0|||
150076432|NCT02699593|541419565|FG001|Period 1|Protocol Violation|1|||
150076433|NCT02699593|541419564|FG000|Period 1|Withdrawal by Subject|0|||
150076434|NCT02699593|541419565|FG001|Period 1|Withdrawal by Subject|1|||
150076435|NCT02699593|541419564|FG000|Period 1|Adverse Event|1|||
150076436|NCT02699593|541419565|FG001|Period 1|Adverse Event|1|||
150076437|NCT02699593|541419564|FG000|Period 2|Adverse Event|1|||
150076438|NCT02699593|541419565|FG001|Period 2|Adverse Event|1|||
150076439|NCT02699593|541419564|FG000|Period 2|Lost Contact Lens|0|||
150076440|NCT02699593|541419565|FG001|Period 2|Lost Contact Lens|1|||
150076441|NCT02699593|541419564|FG000|Period 2|Torn Contact Lens|1|||
150076442|NCT02699593|541419565|FG001|Period 2|Torn Contact Lens|0|||
150076443|NCT01681472|541419566|FG000|Overall Study|Adverse Event|0|||
150076444|NCT01681472|541419567|FG001|Overall Study|Adverse Event|1|||
150076445|NCT01681472|541419568|FG002|Overall Study|Adverse Event|0|||
150076446|NCT01681472|541419569|FG003|Overall Study|Adverse Event|0|||
150076447|NCT01696071|541419582|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
150076448|NCT01696071|541419583|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
150076449|NCT04203797|541419584|FG000|Overall Study|Adverse Event|1|||
150076450|NCT04203797|541419585|FG001|Overall Study|Adverse Event|0|||
150076451|NCT04203797|541419584|FG000|Overall Study|Did not complete End of Study follow-up|1|||
150076452|NCT04203797|541419585|FG001|Overall Study|Did not complete End of Study follow-up|0|||
150076453|NCT01999179|541419586|FG000|Overall Study|Adverse Event|1|||
150076454|NCT01999179|541419586|FG000|Overall Study|Lost to Follow-up|1|||
150076455|NCT01999179|541419586|FG000|Overall Study|Change in Therapy|3|||
150076456|NCT01999179|541419586|FG000|Overall Study|New catheter|2|||
150076457|NCT01752985|541419587|FG000|Treatment Period|Subject request to discontinue treatment|1|||
150076458|NCT01752985|541419588|FG001|Treatment Period|Subject request to discontinue treatment|0|||
150076459|NCT01752985|541419589|FG002|Treatment Period|Subject request to discontinue treatment|1|||
150076460|NCT01752985|541419587|FG000|Treatment Period|Subject no longer meets study criteria|0|||
150076461|NCT01752985|541419588|FG001|Treatment Period|Subject no longer meets study criteria|1|||
150076462|NCT01752985|541419589|FG002|Treatment Period|Subject no longer meets study criteria|1|||
150076463|NCT01752985|541419587|FG000|Treatment Period|Adverse Event|2|||
150076464|NCT01752985|541419588|FG001|Treatment Period|Adverse Event|1|||
150076465|NCT01752985|541419589|FG002|Treatment Period|Adverse Event|2|||
150076466|NCT01752985|541419587|FG000|Treatment Period|Withdrawal by Subject|1|||
150076467|NCT01752985|541419588|FG001|Treatment Period|Withdrawal by Subject|1|||
150076468|NCT01752985|541419589|FG002|Treatment Period|Withdrawal by Subject|0|||
150076469|NCT01752985|541419587|FG000|Treatment Period|Lost to Follow-up|0|||
150076470|NCT01752985|541419588|FG001|Treatment Period|Lost to Follow-up|0|||
150076471|NCT01752985|541419589|FG002|Treatment Period|Lost to Follow-up|1|||
150076472|NCT06934993|541419590|FG000|Overall Study|Withdrawal by Subject|29|||
150076473|NCT06934993|541419590|FG000|Overall Study|elevated postoperative creatinine level|11|||
150076474|NCT06934993|541419590|FG000|Overall Study|Death|3|||
150076475|NCT05147428|541419591|FG000|Overall Study|Removed prior to mailing|289|||
150076476|NCT05147428|541419592|FG001|Overall Study|Removed prior to mailing|306|||
150076477|NCT05147428|541419593|FG002|Overall Study|Removed prior to mailing|270|||
150076478|NCT05147428|541419591|FG000|Overall Study|Died or disenrolled during blackout period|239|||
150076479|NCT05147428|541419592|FG001|Overall Study|Died or disenrolled during blackout period|278|||
150076480|NCT05147428|541419593|FG002|Overall Study|Died or disenrolled during blackout period|273|||
150076481|NCT01385566|541421817|FG000|Overall Study|Lost to Follow-up|1|||
150076482|NCT01385566|541421818|FG001|Overall Study|Lost to Follow-up|0|||
150076483|NCT01385566|541421819|FG002|Overall Study|Lost to Follow-up|0|||
150076484|NCT01385566|541421820|FG003|Overall Study|Lost to Follow-up|0|||
150076485|NCT01385566|541421821|FG004|Overall Study|Lost to Follow-up|0|||
150076486|NCT01385566|541421822|FG005|Overall Study|Lost to Follow-up|0|||
150076487|NCT01385566|541421817|FG000|Overall Study|Withdrawal by Subject|0|||
150076488|NCT01385566|541421818|FG001|Overall Study|Withdrawal by Subject|0|||
150076489|NCT01385566|541421819|FG002|Overall Study|Withdrawal by Subject|0|||
150076490|NCT01385566|541421820|FG003|Overall Study|Withdrawal by Subject|1|||
150076491|NCT01385566|541421821|FG004|Overall Study|Withdrawal by Subject|0|||
150076492|NCT01385566|541421822|FG005|Overall Study|Withdrawal by Subject|0|||
150076493|NCT00825682|541421823|FG000|Overall Study|personal reasons/ inconvenience|13|||
150076494|NCT00825682|541421824|FG001|Overall Study|personal reasons/ inconvenience|5|||
150076495|NCT00560105|541421831|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
150076496|NCT00560105|541421832|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
150076497|NCT02400333|541421833|FG000|Overall Study|Withdrawal by Subject|0|||
150076498|NCT02400333|541421834|FG001|Overall Study|Withdrawal by Subject|1|||
150076499|NCT02400333|541421835|FG002|Overall Study|Withdrawal by Subject|0|||
150076500|NCT02400333|541421836|FG003|Overall Study|Withdrawal by Subject|1|||
150076501|NCT02400333|541421833|FG000|Overall Study|Protocol Violation|1|||
150076502|NCT02400333|541421834|FG001|Overall Study|Protocol Violation|0|||
150076503|NCT02400333|541421835|FG002|Overall Study|Protocol Violation|2|||
150076504|NCT02400333|541421836|FG003|Overall Study|Protocol Violation|1|||
150076505|NCT03539081|541421841|FG000|Overall Study|Withdrawal by Subject|2|||
150076506|NCT03539081|541421842|FG001|Overall Study|Withdrawal by Subject|3|||
150076507|NCT03539081|541421843|FG002|Overall Study|Withdrawal by Subject|0|||
150076508|NCT03539081|541421841|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
150076509|NCT03539081|541421842|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
150076510|NCT03539081|541421843|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
150076511|NCT00283400|541421844|FG000|Overall Study|Withdrawal by Subject|1|||
150076512|NCT00283400|541421845|FG001|Overall Study|Withdrawal by Subject|1|||
150076513|NCT00283400|541421846|FG002|Overall Study|Withdrawal by Subject|0|||
150076514|NCT00283400|541421847|FG003|Overall Study|Withdrawal by Subject|0|||
150076515|NCT00283400|541421844|FG000|Overall Study|Death|1|||
150076516|NCT00283400|541421845|FG001|Overall Study|Death|0|||
150076517|NCT00283400|541421846|FG002|Overall Study|Death|1|||
150076518|NCT00283400|541421847|FG003|Overall Study|Death|0|||
150076519|NCT03372096|541421851|FG000|Overall Study|Study Closed|8|||
150076520|NCT00040365|541421852|FG000|Overall Study|Death|1|||
150076521|NCT00040365|541421852|FG000|Overall Study|Progressive disease|7|||
150076522|NCT00040365|541421852|FG000|Overall Study|Lost to Follow-up|3|||
150076523|NCT00680017|541421853|FG000|Overall Study|Adverse Event|13|||
150076524|NCT00680017|541421854|FG001|Overall Study|Adverse Event|7|||
150076525|NCT00680017|541421853|FG000|Overall Study|Withdrawal by Subject|2|||
150076526|NCT00680017|541421854|FG001|Overall Study|Withdrawal by Subject|5|||
150076527|NCT00680017|541421853|FG000|Overall Study|Lost to Follow-up|2|||
150076528|NCT00680017|541421854|FG001|Overall Study|Lost to Follow-up|0|||
150076529|NCT02279420|541421862|FG000|Overall Study|Lost to Follow-up|23|||
150076530|NCT01153347|541421863|FG000|Overall Study|Withdrawal by Subject|7|||
150076531|NCT01153347|541421864|FG001|Overall Study|Withdrawal by Subject|7|||
150076532|NCT01153347|541421865|FG002|Overall Study|Withdrawal by Subject|7|||
150076533|NCT01153347|541421866|FG003|Overall Study|Withdrawal by Subject|7|||
150076534|NCT01153347|541421863|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150076535|NCT01153347|541421864|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
150076536|NCT01153347|541421865|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
150076537|NCT01153347|541421866|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
150076538|NCT01153347|541421863|FG000|Overall Study|Adverse Event|3|||
150076539|NCT01153347|541421864|FG001|Overall Study|Adverse Event|9|||
150076540|NCT01153347|541421865|FG002|Overall Study|Adverse Event|21|||
150076541|NCT01153347|541421866|FG003|Overall Study|Adverse Event|7|||
150076542|NCT01153347|541421863|FG000|Overall Study|Severe non-compliance to protocol|6|||
150076543|NCT01153347|541421864|FG001|Overall Study|Severe non-compliance to protocol|7|||
150076544|NCT01153347|541421865|FG002|Overall Study|Severe non-compliance to protocol|4|||
150076545|NCT01153347|541421866|FG003|Overall Study|Severe non-compliance to protocol|3|||
150076546|NCT01153347|541421863|FG000|Overall Study|Condition under investigation worsened|1|||
150076547|NCT01153347|541421864|FG001|Overall Study|Condition under investigation worsened|1|||
150076548|NCT01153347|541421865|FG002|Overall Study|Condition under investigation worsened|0|||
150076549|NCT01153347|541421866|FG003|Overall Study|Condition under investigation worsened|0|||
150076550|NCT01153347|541421863|FG000|Overall Study|Lack of Efficacy|2|||
150076551|NCT01153347|541421864|FG001|Overall Study|Lack of Efficacy|2|||
150076552|NCT01153347|541421865|FG002|Overall Study|Lack of Efficacy|0|||
150076553|NCT01153347|541421866|FG003|Overall Study|Lack of Efficacy|4|||
150076554|NCT01153347|541421863|FG000|Overall Study|Study-specific withdrawal criteria|4|||
150076555|NCT01153347|541421864|FG001|Overall Study|Study-specific withdrawal criteria|3|||
150076556|NCT01153347|541421865|FG002|Overall Study|Study-specific withdrawal criteria|1|||
150076557|NCT01153347|541421866|FG003|Overall Study|Study-specific withdrawal criteria|2|||
150076558|NCT01153347|541421863|FG000|Overall Study|Lost to Follow-up|4|||
150076559|NCT01153347|541421864|FG001|Overall Study|Lost to Follow-up|9|||
150076560|NCT01153347|541421865|FG002|Overall Study|Lost to Follow-up|11|||
150076561|NCT01153347|541421866|FG003|Overall Study|Lost to Follow-up|8|||
150076562|NCT01153347|541421863|FG000|Overall Study|Other|5|||
150076563|NCT01153347|541421864|FG001|Overall Study|Other|5|||
150076564|NCT01153347|541421865|FG002|Overall Study|Other|4|||
150076565|NCT01153347|541421866|FG003|Overall Study|Other|0|||
150076566|NCT01153347|541421863|FG000|Overall Study|Death|1|||
150076567|NCT01153347|541421864|FG001|Overall Study|Death|0|||
150076568|NCT01153347|541421865|FG002|Overall Study|Death|0|||
150076569|NCT01153347|541421866|FG003|Overall Study|Death|0|||
150076570|NCT02835820|541421867|FG000|Overall Study|Baseline Screen Failure|0|||
150076571|NCT02835820|541421868|FG001|Overall Study|Baseline Screen Failure|3|||
150076572|NCT05096221|541421873|FG000|Part 2|Physician Decision|0|||
150076573|NCT05096221|541421874|FG001|Part 2|Physician Decision|1|||
150076574|NCT02478632|541421877|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
150076575|NCT02478632|541421878|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
150076576|NCT02478632|541421877|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
150076577|NCT02478632|541421878|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
150076578|NCT02478632|541421877|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
150076579|NCT02478632|541421878|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
150076580|NCT04678661|541421879|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
150076581|NCT04678661|541421880|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
150076582|NCT04678661|541421879|FG000|Overall Study|Protocol Violation|2|||
150076583|NCT04678661|541421880|FG001|Overall Study|Protocol Violation|0|||
150076584|NCT04678661|541421879|FG000|Overall Study|Withdrawal by Subject|1|||
150076585|NCT04678661|541421880|FG001|Overall Study|Withdrawal by Subject|0|||
150076586|NCT04678661|541421879|FG000|Overall Study|Lost to Follow-up|2|||
150076587|NCT04678661|541421880|FG001|Overall Study|Lost to Follow-up|0|||
150076588|NCT04678661|541421879|FG000|Overall Study|Death|2|||
150076589|NCT04678661|541421880|FG001|Overall Study|Death|0|||
150076590|NCT01086033|541421881|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
150076591|NCT01086033|541421881|FG000|Overall Study|Lost to Follow-up|86|||
150076592|NCT01086033|541421881|FG000|Overall Study|Adverse Event|42|||
150076593|NCT01086033|541421881|FG000|Overall Study|Withdrawal by Subject|41|||
150076594|NCT01086033|541421881|FG000|Overall Study|Other|14|||
150076595|NCT01086033|541421881|FG000|Overall Study|Other|13|||
150076596|NCT01086033|541421881|FG000|Overall Study|AE and Withdrew Consent|5|||
150076597|NCT01086033|541421881|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
150076598|NCT01086033|541421881|FG000|Overall Study|Withdrew consent and Other Reason|4|||
150076599|NCT01086033|541421881|FG000|Overall Study|AE and Lack of Efficacy|4|||
150076600|NCT01086033|541421881|FG000|Overall Study|Death|1|||
150076601|NCT01086033|541421881|FG000|Overall Study|AE and Lost to Follow-up|1|||
150076602|NCT01086033|541421881|FG000|Overall Study|AE and Other Reason|1|||
150076603|NCT01086033|541421881|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
150076604|NCT03094169|541421882|FG000|Overall Study|Lack of Efficacy|0|||
150076605|NCT03094169|541421883|FG001|Overall Study|Lack of Efficacy|0|||
150076606|NCT03094169|541421884|FG002|Overall Study|Lack of Efficacy|0|||
150076607|NCT03094169|541421885|FG003|Overall Study|Lack of Efficacy|0|||
150076608|NCT03094169|541421886|FG004|Overall Study|Lack of Efficacy|0|||
150076609|NCT03094169|541421887|FG005|Overall Study|Lack of Efficacy|0|||
150076610|NCT03094169|541421888|FG006|Overall Study|Lack of Efficacy|0|||
150076611|NCT03094169|541421889|FG007|Overall Study|Lack of Efficacy|21|||
150076612|NCT03094169|541421882|FG000|Overall Study|Adverse Event|0|||
150076613|NCT03094169|541421883|FG001|Overall Study|Adverse Event|0|||
150076614|NCT03094169|541421884|FG002|Overall Study|Adverse Event|0|||
150076615|NCT03094169|541421885|FG003|Overall Study|Adverse Event|0|||
150076616|NCT03094169|541421886|FG004|Overall Study|Adverse Event|0|||
150076617|NCT03094169|541421887|FG005|Overall Study|Adverse Event|0|||
150076618|NCT03094169|541421888|FG006|Overall Study|Adverse Event|0|||
150076619|NCT03094169|541421889|FG007|Overall Study|Adverse Event|2|||
150076620|NCT03094169|541421882|FG000|Overall Study|Withdrawal by Subject|0|||
150076621|NCT03094169|541421883|FG001|Overall Study|Withdrawal by Subject|0|||
150076622|NCT03094169|541421884|FG002|Overall Study|Withdrawal by Subject|0|||
150076623|NCT03094169|541421885|FG003|Overall Study|Withdrawal by Subject|0|||
150076624|NCT03094169|541421886|FG004|Overall Study|Withdrawal by Subject|0|||
150076625|NCT03094169|541421887|FG005|Overall Study|Withdrawal by Subject|0|||
150076626|NCT03094169|541421888|FG006|Overall Study|Withdrawal by Subject|1|||
150076627|NCT03094169|541421889|FG007|Overall Study|Withdrawal by Subject|1|||
150076628|NCT03094169|541421882|FG000|Overall Study|Trial Termination|0|||
150076629|NCT03094169|541421883|FG001|Overall Study|Trial Termination|0|||
150076630|NCT03094169|541421884|FG002|Overall Study|Trial Termination|0|||
150076631|NCT03094169|541421885|FG003|Overall Study|Trial Termination|0|||
150076632|NCT03094169|541421886|FG004|Overall Study|Trial Termination|0|||
150076633|NCT03094169|541421887|FG005|Overall Study|Trial Termination|0|||
150076634|NCT03094169|541421888|FG006|Overall Study|Trial Termination|0|||
150076635|NCT03094169|541421889|FG007|Overall Study|Trial Termination|1|||
150076636|NCT04645953|541421890|FG000|Overall Study|Lost to Follow-up|2|||
150076637|NCT04645953|541421891|FG001|Overall Study|Lost to Follow-up|1|||
150076638|NCT04645953|541421892|FG002|Overall Study|Lost to Follow-up|1|||
150076639|NCT04645953|541421890|FG000|Overall Study|Withdrawal by Subject|0|||
150076640|NCT04645953|541421891|FG001|Overall Study|Withdrawal by Subject|1|||
150076641|NCT04645953|541421892|FG002|Overall Study|Withdrawal by Subject|0|||
150076642|NCT04645953|541421890|FG000|Overall Study|Physician Decision|0|||
150076643|NCT04645953|541421891|FG001|Overall Study|Physician Decision|1|||
150076644|NCT04645953|541421892|FG002|Overall Study|Physician Decision|0|||
150076645|NCT04645953|541421890|FG000|Overall Study|Discontinued Prior to Dosing|0|||
150076646|NCT04645953|541421891|FG001|Overall Study|Discontinued Prior to Dosing|0|||
150076647|NCT04645953|541421892|FG002|Overall Study|Discontinued Prior to Dosing|2|||
150076648|NCT00864721|541421893|FG000|Overall Study|Patient request|11|||
150076649|NCT00864721|541421893|FG000|Overall Study|Hospitalized|1|||
150076650|NCT00864721|541421893|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
150076651|NCT00864721|541421893|FG000|Overall Study|Adverse Event|21|||
150076652|NCT01705730|541421896|FG000|Overall Study|Lack of Efficacy|1|||
150076653|NCT01705730|541421896|FG000|Overall Study|Adverse Event|3|||
150076654|NCT01705730|541421896|FG000|Overall Study|Lost to Follow-up|1|||
150076655|NCT01705730|541421896|FG000|Overall Study|Reason not Specified|4|||
150076656|NCT01773733|541421897|FG000|Overall Study|Adverse Event|3286|||
150076657|NCT01773733|541421898|FG001|Overall Study|Adverse Event|540|||
150076658|NCT01773733|541421897|FG000|Overall Study|Pregnancy|28|||
150076659|NCT01773733|541421898|FG001|Overall Study|Pregnancy|0|||
150076660|NCT01773733|541421897|FG000|Overall Study|Other different categories of not compl|55415|||
150076661|NCT01773733|541421898|FG001|Overall Study|Other different categories of not compl|7781|||
150076662|NCT03741062|541421899|FG000|Overall Study|Protocol Violation|1|||
150076663|NCT03741062|541421900|FG001|Overall Study|Protocol Violation|0|||
150076664|NCT03417219|541421904|FG000|Overall Study|Lost to Follow-up|0|||
150076665|NCT03417219|541421905|FG001|Overall Study|Lost to Follow-up|3|||
150076666|NCT03345914|541421906|FG000|Overall Study|Transition to another study at week 16|80|||
150076667|NCT03345914|541421907|FG001|Overall Study|Transition to another study at week 16|86|||
150076668|NCT03345914|541421908|FG002|Overall Study|Transition to another study at week 16|78|||
150076669|NCT03345914|541421906|FG000|Overall Study|Transition to OLE during follow-up|37|||
150076670|NCT03345914|541421907|FG001|Overall Study|Transition to OLE during follow-up|33|||
150076671|NCT03345914|541421908|FG002|Overall Study|Transition to OLE during follow-up|39|||
150076672|NCT03345914|541421906|FG000|Overall Study|Physician Decision|0|||
150076673|NCT03345914|541421907|FG001|Overall Study|Physician Decision|1|||
150076674|NCT03345914|541421908|FG002|Overall Study|Physician Decision|1|||
150076675|NCT03345914|541421906|FG000|Overall Study|Withdrawal by Subject|5|||
150076676|NCT03345914|541421907|FG001|Overall Study|Withdrawal by Subject|1|||
150076677|NCT03345914|541421908|FG002|Overall Study|Withdrawal by Subject|2|||
150076678|NCT03345914|541421906|FG000|Overall Study|Other|1|||
150076679|NCT03345914|541421907|FG001|Overall Study|Other|1|||
150076680|NCT03345914|541421908|FG002|Overall Study|Other|1|||
150076681|NCT03345914|541421906|FG000|Overall Study|Ongoing|0|||
150076682|NCT03345914|541421907|FG001|Overall Study|Ongoing|0|||
150076683|NCT03345914|541421908|FG002|Overall Study|Ongoing|1|||
150076684|NCT00261807|541421909|FG000|Overall Study|Lost to Follow-up|2|||
150076685|NCT00261807|541421909|FG000|Overall Study|Adverse Event|2|||
150076686|NCT00261807|541421909|FG000|Overall Study|Death|1|||
150076687|NCT00261807|541421909|FG000|Overall Study|Protocol Violation|2|||
150076688|NCT01706146|541421910|FG000|Overall Study|Withdrawal by Subject|1|||
150076689|NCT01706146|541421910|FG000|Overall Study|Adverse Event|3|||
150076690|NCT01706146|541421910|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
150076691|NCT00675948|541421912|FG000|Overall Study|Adverse Event|23|||
150076692|NCT00675948|541421913|FG001|Overall Study|Adverse Event|1|||
150076693|NCT00675948|541421912|FG000|Overall Study|Lack of Efficacy|3|||
150076694|NCT00675948|541421913|FG001|Overall Study|Lack of Efficacy|0|||
150076695|NCT00675948|541421912|FG000|Overall Study|Withdrawal by Subject|7|||
150076696|NCT00675948|541421913|FG001|Overall Study|Withdrawal by Subject|0|||
150076697|NCT00675948|541421912|FG000|Overall Study|Lost to Follow-up|2|||
150076698|NCT00675948|541421913|FG001|Overall Study|Lost to Follow-up|0|||
150076699|NCT00675948|541421912|FG000|Overall Study|Protocol Violation|1|||
150076700|NCT00675948|541421913|FG001|Overall Study|Protocol Violation|0|||
150076701|NCT00675948|541421912|FG000|Overall Study|Pain under control|1|||
150076702|NCT00675948|541421913|FG001|Overall Study|Pain under control|0|||
150076703|NCT00675948|541421912|FG000|Overall Study|Sponsor decision|0|||
150076704|NCT00675948|541421913|FG001|Overall Study|Sponsor decision|1|||
150076705|NCT00675948|541421912|FG000|Overall Study|Patient died|1|||
150076706|NCT00675948|541421913|FG001|Overall Study|Patient died|0|||
150076707|NCT00675948|541421912|FG000|Overall Study|Patient unable to comply with diaries|1|||
150076708|NCT00675948|541421913|FG001|Overall Study|Patient unable to comply with diaries|0|||
150076709|NCT00675948|541421912|FG000|Overall Study|Patient feels unable to take medication|0|||
150076710|NCT00675948|541421913|FG001|Overall Study|Patient feels unable to take medication|1|||
150076711|NCT02527161|541421914|FG000|Overall Study|Failed MRI|52|||
150076712|NCT02527161|541421914|FG000|Overall Study|Withdrawal by Subject|19|||
150076713|NCT02527161|541421914|FG000|Overall Study|Delay in or unfit for surgery|16|||
150076714|NCT02527161|541421914|FG000|Overall Study|MRI contraindication|6|||
150076715|NCT02527161|541421914|FG000|Overall Study|Consent violation|4|||
150076716|NCT02527161|541421914|FG000|Overall Study|Only Recruited to Part A|27|||
150076717|NCT02527161|541421914|FG000|Overall Study|Physician Decision|1|||
150076718|NCT02527161|541421914|FG000|Overall Study|Adverse Event|1|||
150076719|NCT02527161|541421914|FG000|Overall Study|Lost to Follow-up|6|||
150076720|NCT00762229|541421915|FG000|Overall Study|Lost to Follow-up|1|||
150076721|NCT00762229|541421916|FG001|Overall Study|Lost to Follow-up|1|||
150076722|NCT00762229|541421915|FG000|Overall Study|did not recveive intervention|0|||
150076723|NCT00762229|541421916|FG001|Overall Study|did not recveive intervention|1|||
150076724|NCT02609828|541421919|FG000|Overall Study|Adverse Event|8|||
150076725|NCT02609828|541421920|FG001|Overall Study|Adverse Event|1|||
150076726|NCT02609828|541421921|FG002|Overall Study|Adverse Event|0|||
150076727|NCT02609828|541421922|FG003|Overall Study|Adverse Event|6|||
150076728|NCT02609828|541421919|FG000|Overall Study|Death|15|||
150076729|NCT02609828|541421920|FG001|Overall Study|Death|1|||
150076730|NCT02609828|541421921|FG002|Overall Study|Death|1|||
150076731|NCT02609828|541421922|FG003|Overall Study|Death|19|||
150076732|NCT02609828|541421919|FG000|Overall Study|Insufficient clinical response|2|||
150076733|NCT02609828|541421920|FG001|Overall Study|Insufficient clinical response|1|||
150076734|NCT02609828|541421921|FG002|Overall Study|Insufficient clinical response|0|||
150076735|NCT02609828|541421922|FG003|Overall Study|Insufficient clinical response|0|||
150076736|NCT02609828|541421919|FG000|Overall Study|Lost to Follow-up|0|||
150076737|NCT02609828|541421920|FG001|Overall Study|Lost to Follow-up|0|||
150076738|NCT02609828|541421921|FG002|Overall Study|Lost to Follow-up|0|||
150076739|NCT02609828|541421922|FG003|Overall Study|Lost to Follow-up|1|||
150076740|NCT02609828|541421919|FG000|Overall Study|Protocol Violation|2|||
150076741|NCT02609828|541421920|FG001|Overall Study|Protocol Violation|0|||
150076742|NCT02609828|541421921|FG002|Overall Study|Protocol Violation|0|||
150076743|NCT02609828|541421922|FG003|Overall Study|Protocol Violation|1|||
150076744|NCT02609828|541421919|FG000|Overall Study|Withdrawal by Subject|12|||
150076745|NCT02609828|541421920|FG001|Overall Study|Withdrawal by Subject|1|||
150076746|NCT02609828|541421921|FG002|Overall Study|Withdrawal by Subject|0|||
150076747|NCT02609828|541421922|FG003|Overall Study|Withdrawal by Subject|10|||
150076748|NCT02609828|541421919|FG000|Overall Study|Other|3|||
150076749|NCT02609828|541421920|FG001|Overall Study|Other|0|||
150076750|NCT02609828|541421921|FG002|Overall Study|Other|0|||
150076751|NCT02609828|541421922|FG003|Overall Study|Other|6|||
150076752|NCT02609828|541421919|FG000|Overall Study|Randomized but not treated|1|||
150076753|NCT02609828|541421920|FG001|Overall Study|Randomized but not treated|0|||
150076754|NCT02609828|541421921|FG002|Overall Study|Randomized but not treated|0|||
150076755|NCT02609828|541421922|FG003|Overall Study|Randomized but not treated|0|||
150076756|NCT01896102|541421925|FG000|Overall Study|Death|1|||
150076757|NCT01896102|541421925|FG000|Overall Study|Participant to receive allogenic transplant|2|||
150076758|NCT01751178|541421926|FG000|Overall Study|Adverse Event|2|||
150076759|NCT01751178|541421927|FG001|Overall Study|Adverse Event|0|||
150076760|NCT01751178|541421928|FG002|Overall Study|Adverse Event|0|||
150076761|NCT01751178|541421926|FG000|Overall Study|Other Reason (unknown)|1|||
150076762|NCT01751178|541421927|FG001|Overall Study|Other Reason (unknown)|0|||
150076763|NCT01751178|541421928|FG002|Overall Study|Other Reason (unknown)|2|||
150076764|NCT02747875|541421929|FG000|Overall Study|Physician Decision|1|||
150076765|NCT02747875|541421930|FG001|Overall Study|Physician Decision|0|||
150076766|NCT02747875|541421929|FG000|Overall Study|Adverse Event|0|||
150076767|NCT02747875|541421930|FG001|Overall Study|Adverse Event|1|||
150076768|NCT02693119|541421932|FG000|Open-Label Period|Withdrawal by Subject|0|||
150076769|NCT02693119|541421933|FG001|Open-Label Period|Withdrawal by Subject|1|||
150076770|NCT01719783|541421934|FG000|Dose 2|Physician Decision|1|||
150076771|NCT01719783|541421935|FG001|Dose 2|Physician Decision|0|||
150076772|NCT02805972|541421940|FG000|Washout Period|Lost to Follow-up|3|||
150076773|NCT02805972|541421941|FG001|Washout Period|Lost to Follow-up|0|||
150076774|NCT00939640|541421942|FG000|Overall Study|Physician Decision|1|||
150076775|NCT02121522|541421943|FG000|Overall Study|Adverse Event|1|||
150076776|NCT00892047|541421949|FG000|Overall Study|Adverse Event|2|||
150076777|NCT00892047|541421950|FG001|Overall Study|Adverse Event|2|||
150076778|NCT00892047|541421949|FG000|Overall Study|subject burden|2|||
150076779|NCT00892047|541421950|FG001|Overall Study|subject burden|3|||
150076780|NCT00892047|541421949|FG000|Overall Study|Lack of Efficacy|0|||
150076781|NCT00892047|541421950|FG001|Overall Study|Lack of Efficacy|2|||
150076782|NCT05306977|541421951|FG000|Overall Study|Withdrawal by Subject|1|||
150076783|NCT00369824|541421952|FG000|Overall Study|Adverse Event|0|||
150076784|NCT00369824|541421953|FG001|Overall Study|Adverse Event|2|||
150076785|NCT00369824|541421954|FG002|Overall Study|Adverse Event|0|||
150076786|NCT00369824|541421955|FG003|Overall Study|Adverse Event|0|||
150076787|NCT00369824|541421956|FG004|Overall Study|Adverse Event|1|||
150076788|NCT00369824|541421957|FG005|Overall Study|Adverse Event|0|||
150076789|NCT00369824|541421952|FG000|Overall Study|Protocol Violation|0|||
150076790|NCT00369824|541421953|FG001|Overall Study|Protocol Violation|1|||
150076791|NCT00369824|541421954|FG002|Overall Study|Protocol Violation|0|||
150076792|NCT00369824|541421955|FG003|Overall Study|Protocol Violation|1|||
150076793|NCT00369824|541421956|FG004|Overall Study|Protocol Violation|1|||
150076794|NCT00369824|541421957|FG005|Overall Study|Protocol Violation|0|||
150076795|NCT00369824|541421952|FG000|Overall Study|Withdrawal by Subject|9|||
150076796|NCT00369824|541421953|FG001|Overall Study|Withdrawal by Subject|5|||
150076797|NCT00369824|541421954|FG002|Overall Study|Withdrawal by Subject|5|||
150076798|NCT00369824|541421955|FG003|Overall Study|Withdrawal by Subject|4|||
150076799|NCT00369824|541421956|FG004|Overall Study|Withdrawal by Subject|6|||
150076800|NCT00369824|541421957|FG005|Overall Study|Withdrawal by Subject|2|||
150076801|NCT00369824|541421952|FG000|Overall Study|Lost to Follow-up|6|||
150076802|NCT00369824|541421953|FG001|Overall Study|Lost to Follow-up|11|||
150076803|NCT00369824|541421954|FG002|Overall Study|Lost to Follow-up|7|||
150076804|NCT00369824|541421955|FG003|Overall Study|Lost to Follow-up|8|||
150076805|NCT00369824|541421956|FG004|Overall Study|Lost to Follow-up|9|||
150076806|NCT00369824|541421957|FG005|Overall Study|Lost to Follow-up|6|||
150076807|NCT00369824|541421952|FG000|Overall Study|Other|0|||
150076808|NCT00369824|541421953|FG001|Overall Study|Other|0|||
150076809|NCT00369824|541421954|FG002|Overall Study|Other|0|||
150076810|NCT00369824|541421955|FG003|Overall Study|Other|2|||
150076811|NCT00369824|541421956|FG004|Overall Study|Other|1|||
150076812|NCT00369824|541421957|FG005|Overall Study|Other|3|||
150076813|NCT00415168|541421958|FG000|Overall Study|Death|26|||
150076814|NCT00415168|541421958|FG000|Overall Study|Lost to Follow-up|3|||
150076815|NCT00415168|541421958|FG000|Overall Study|Physician Decision|13|||
150076816|NCT00415168|541421958|FG000|Overall Study|Sponsor Decision|4|||
150076817|NCT00415168|541421958|FG000|Overall Study|Withdrawal by Subject|6|||
150076818|NCT02106975|541421959|FG000|Overall Study|Death|25|||
150076819|NCT02106975|541421960|FG001|Overall Study|Death|39|||
150076820|NCT00806351|541421961|FG000|Overall Study|Death|5|||
150076821|NCT00806351|541421962|FG001|Overall Study|Death|4|||
150076822|NCT00306189|541421963|FG000|Overall Study|Physician Decision|0|||
150076823|NCT00306189|541421964|FG001|Overall Study|Physician Decision|0|||
150076824|NCT00306189|541421965|FG002|Overall Study|Physician Decision|0|||
150076825|NCT00306189|541421966|FG003|Overall Study|Physician Decision|1|||
150076826|NCT00306189|541421963|FG000|Overall Study|Adverse Event|3|||
150076827|NCT00306189|541421964|FG001|Overall Study|Adverse Event|3|||
150076828|NCT00306189|541421965|FG002|Overall Study|Adverse Event|2|||
150076829|NCT00306189|541421966|FG003|Overall Study|Adverse Event|2|||
150076830|NCT00306189|541421963|FG000|Overall Study|Withdrawal by Subject|4|||
150076831|NCT00306189|541421964|FG001|Overall Study|Withdrawal by Subject|2|||
150076832|NCT00306189|541421965|FG002|Overall Study|Withdrawal by Subject|8|||
150076833|NCT00306189|541421966|FG003|Overall Study|Withdrawal by Subject|1|||
150076834|NCT00306189|541421963|FG000|Overall Study|Ineligibility determined|1|||
150076835|NCT00306189|541421964|FG001|Overall Study|Ineligibility determined|1|||
150076836|NCT00306189|541421965|FG002|Overall Study|Ineligibility determined|1|||
150076837|NCT00306189|541421966|FG003|Overall Study|Ineligibility determined|1|||
150076838|NCT00306189|541421963|FG000|Overall Study|Other|1|||
150076839|NCT00306189|541421964|FG001|Overall Study|Other|0|||
150076840|NCT00306189|541421965|FG002|Overall Study|Other|0|||
150076841|NCT00306189|541421966|FG003|Overall Study|Other|0|||
150076842|NCT00087607|541421967|FG000|Overall Study|Adverse Event|14|||
150076843|NCT00087607|541421968|FG001|Overall Study|Adverse Event|24|||
150076844|NCT00087607|541421967|FG000|Overall Study|Death|0|||
150076845|NCT00087607|541421968|FG001|Overall Study|Death|1|||
150076846|NCT00087607|541421967|FG000|Overall Study|Insufficient Therapeutic Response|53|||
150076847|NCT00087607|541421968|FG001|Overall Study|Insufficient Therapeutic Response|42|||
150076848|NCT00087607|541421967|FG000|Overall Study|Failure to return|21|||
150076849|NCT00087607|541421968|FG001|Overall Study|Failure to return|17|||
150076850|NCT00087607|541421967|FG000|Overall Study|Withdrew Consent|12|||
150076851|NCT00087607|541421968|FG001|Overall Study|Withdrew Consent|16|||
150076852|NCT00087607|541421967|FG000|Overall Study|Administrative|12|||
150076853|NCT00087607|541421968|FG001|Overall Study|Administrative|12|||
150076854|NCT00087607|541421967|FG000|Overall Study|Refused Treatment|5|||
150076855|NCT00087607|541421968|FG001|Overall Study|Refused Treatment|7|||
150076856|NCT00087607|541421967|FG000|Overall Study|Other Protocol Violation|5|||
150076857|NCT00087607|541421968|FG001|Overall Study|Other Protocol Violation|2|||
150076858|NCT00087607|541421967|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
150076859|NCT00087607|541421968|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
150076860|NCT02015754|541421969|FG000|Overall Study|Disease progression|5|||
150076861|NCT02015754|541421969|FG000|Overall Study|Change in treatment modality|5|||
150076862|NCT02015754|541421969|FG000|Overall Study|Lost to Follow-up|1|||
150076863|NCT00672646|541421975|FG000|Overall Study|Lost to Follow-up|0|||
150076864|NCT00672646|541421976|FG001|Overall Study|Lost to Follow-up|1|||
150076865|NCT00672646|541421977|FG002|Overall Study|Lost to Follow-up|2|||
150076866|NCT00672646|541421975|FG000|Overall Study|Withdrawal by Subject|0|||
150076867|NCT00672646|541421976|FG001|Overall Study|Withdrawal by Subject|0|||
150076868|NCT00672646|541421977|FG002|Overall Study|Withdrawal by Subject|1|||
150076869|NCT00289783|541421978|FG000|Primary Phase|Adverse Event|10|||
150076870|NCT00289783|541421979|FG001|Primary Phase|Adverse Event|1|||
150076871|NCT00289783|541421978|FG000|Primary Phase|Protocol Violation|27|||
150076872|NCT00289783|541421979|FG001|Primary Phase|Protocol Violation|6|||
150076873|NCT00289783|541421978|FG000|Primary Phase|Withdrawal by Subject|93|||
150076874|NCT00289783|541421979|FG001|Primary Phase|Withdrawal by Subject|40|||
150076875|NCT00289783|541421978|FG000|Primary Phase|Lost to Follow-up|60|||
150076876|NCT00289783|541421979|FG001|Primary Phase|Lost to Follow-up|14|||
150076877|NCT00289783|541421978|FG000|Primary Phase|Migration from the study area|26|||
150076878|NCT00289783|541421979|FG001|Primary Phase|Migration from the study area|10|||
150076879|NCT00289783|541421978|FG000|Primary Phase|Other|32|||
150076880|NCT00289783|541421979|FG001|Primary Phase|Other|12|||
150076881|NCT00289783|541421978|FG000|Fourth Dose Phase|Adverse Event|1|||
150076882|NCT00289783|541421979|FG001|Fourth Dose Phase|Adverse Event|0|||
150076883|NCT00289783|541421978|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
150076884|NCT00289783|541421979|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
150076885|NCT00289783|541421978|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
150076886|NCT00289783|541421979|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
150076887|NCT00289783|541421978|FG000|Fourth Dose Phase|Migration from the study area|1|||
150076888|NCT00289783|541421979|FG001|Fourth Dose Phase|Migration from the study area|1|||
150076889|NCT00289783|541421978|FG000|Fourth Dose Phase|Other|22|||
150076890|NCT00289783|541421979|FG001|Fourth Dose Phase|Other|10|||
150076891|NCT01453361|541421982|FG000|Overall Study|Disease Progression|6|||
150076892|NCT01453361|541421982|FG000|Overall Study|Screen-Failures|10|||
150076893|NCT03128047|541421983|FG000|Overall Study|Withdrawal by Subject|1|||
150076894|NCT01594281|541422951|FG000|Interventional Core Phase|Protocol Deviation|1|||
150076895|NCT01594281|541422952|FG001|Interventional Core Phase|Protocol Deviation|0|||
150076896|NCT01594281|541422953|FG002|Interventional Core Phase|Protocol Deviation|0|||
150182504|NCT01771731|541804745|FG001|Overall Study|Protocol Violation|1|||
150076897|NCT01594281|541422951|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
150076898|NCT01594281|541422952|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
150076899|NCT01594281|541422953|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
150076900|NCT01594281|541422951|FG000|Interventional Core Phase|Death|1|||
150076901|NCT01594281|541422952|FG001|Interventional Core Phase|Death|1|||
150076902|NCT01594281|541422953|FG002|Interventional Core Phase|Death|2|||
150076903|NCT01594281|541422951|FG000|Interventional Core Phase|Lost to Follow-up|1|||
150076904|NCT01594281|541422952|FG001|Interventional Core Phase|Lost to Follow-up|4|||
150076905|NCT01594281|541422953|FG002|Interventional Core Phase|Lost to Follow-up|1|||
150076906|NCT01594281|541422951|FG000|Interventional Core Phase|Adverse Event|4|||
150076907|NCT01594281|541422952|FG001|Interventional Core Phase|Adverse Event|4|||
150076908|NCT01594281|541422953|FG002|Interventional Core Phase|Adverse Event|4|||
150076909|NCT01594281|541422951|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
150076910|NCT01594281|541422952|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
150076911|NCT01594281|541422953|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
150076912|NCT01594281|541422951|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
150076913|NCT01594281|541422952|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
150076914|NCT01594281|541422953|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
150076915|NCT01594281|541422951|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
150076916|NCT01594281|541422952|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
150076917|NCT01594281|541422953|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
150076918|NCT01871532|541422954|FG000|Overall Study|Withdrawal by Subject|1|||
150076919|NCT01871532|541422955|FG001|Overall Study|Withdrawal by Subject|2|||
150076920|NCT01673867|541422957|FG000|Randomization|Adverse event unrelated to study drug|1|||
150076921|NCT01673867|541422958|FG001|Randomization|Adverse event unrelated to study drug|0|||
150076922|NCT01673867|541422957|FG000|Randomization|Participant request to discontinue study treatment|0|||
150076923|NCT01673867|541422958|FG001|Randomization|Participant request to discontinue study treatment|4|||
150076924|NCT01673867|541422957|FG000|Randomization|Withdrawal by participant|0|||
150076925|NCT01673867|541422958|FG001|Randomization|Withdrawal by participant|12|||
150182505|NCT01771731|541804744|FG000|Overall Study|Adverse event: Pain Crisis|1|||
150182506|NCT01771731|541804745|FG001|Overall Study|Adverse event: Pain Crisis|1|||
150182507|NCT03201562|541804746|FG000|Overall Study|Physician Decision|0|||
150182508|NCT03201562|541804747|FG001|Overall Study|Physician Decision|0|||
150182509|NCT03201562|541804748|FG002|Overall Study|Physician Decision|1|||
150182510|NCT03201562|541804746|FG000|Overall Study|Adverse Event|0|||
150182511|NCT03201562|541804747|FG001|Overall Study|Adverse Event|0|||
150182512|NCT03201562|541804748|FG002|Overall Study|Adverse Event|1|||
150182513|NCT03201562|541804746|FG000|Overall Study|Lost to Follow-up|0|||
150182514|NCT03201562|541804747|FG001|Overall Study|Lost to Follow-up|1|||
150182515|NCT03201562|541804748|FG002|Overall Study|Lost to Follow-up|2|||
150182516|NCT00001277|541804749|FG000|Overall Study|Adverse Event|0|||
150182517|NCT00001277|541804750|FG001|Overall Study|Adverse Event|0|||
150182518|NCT00001277|541804751|FG002|Overall Study|Adverse Event|1|||
150182519|NCT00001277|541804749|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
150182520|NCT00001277|541804750|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
150182521|NCT00001277|541804751|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
150182522|NCT00065260|541804752|FG000|Overall Study|Death|0|||
150076926|NCT01673867|541422957|FG000|Randomization|Lost to Follow-up|0|||
150076927|NCT01673867|541422958|FG001|Randomization|Lost to Follow-up|1|||
150076928|NCT01673867|541422957|FG000|Randomization|Participant no longer meets study criteria|4|||
150076929|NCT01673867|541422958|FG001|Randomization|Participant no longer meets study criteria|5|||
150076930|NCT01673867|541422957|FG000|Treatment|Disease Progression|208|||
150076931|NCT01673867|541422958|FG001|Treatment|Disease Progression|178|||
150076932|NCT01673867|541422957|FG000|Treatment|Study Drug Toxicity|23|||
150076933|NCT01673867|541422958|FG001|Treatment|Study Drug Toxicity|43|||
150076934|NCT01673867|541422957|FG000|Treatment|Death|2|||
150076935|NCT01673867|541422958|FG001|Treatment|Death|3|||
150076936|NCT01673867|541422957|FG000|Treatment|Adverse event unrelated to study drug|23|||
150076937|NCT01673867|541422958|FG001|Treatment|Adverse event unrelated to study drug|10|||
150076938|NCT01673867|541422957|FG000|Treatment|Participant request to discontinue study treatment|7|||
150076939|NCT01673867|541422958|FG001|Treatment|Participant request to discontinue study treatment|17|||
150076940|NCT01673867|541422957|FG000|Treatment|Withdrawal by participant|5|||
150076941|NCT01673867|541422958|FG001|Treatment|Withdrawal by participant|5|||
150076942|NCT01673867|541422957|FG000|Treatment|Maximum clinical benefit|1|||
150076943|NCT01673867|541422958|FG001|Treatment|Maximum clinical benefit|10|||
150076944|NCT01673867|541422957|FG000|Treatment|Participant no longer meets study criteria|2|||
150076945|NCT01673867|541422958|FG001|Treatment|Participant no longer meets study criteria|0|||
150182523|NCT00065260|541804753|FG001|Overall Study|Death|1|||
150182524|NCT01976312|541804755|FG000|Overall Study|Pregnancy|0|||
150182525|NCT01976312|541804756|FG001|Overall Study|Pregnancy|1|||
150182526|NCT01976312|541804755|FG000|Overall Study|Lost to Follow-up|2|||
150182527|NCT01976312|541804756|FG001|Overall Study|Lost to Follow-up|0|||
150182528|NCT01976312|541804755|FG000|Overall Study|Withdrawal by Subject|7|||
150076946|NCT01673867|541422957|FG000|Treatment|Administrative reason by sponsor|3|||
150076947|NCT01673867|541422958|FG001|Treatment|Administrative reason by sponsor|0|||
150076948|NCT01673867|541422957|FG000|Treatment|Other reason|11|||
150076949|NCT01673867|541422958|FG001|Treatment|Other reason|2|||
150076950|NCT02550106|541422961|FG000|Overall Study|Adverse Event|1|||
150076951|NCT02550106|541422961|FG000|Overall Study|Lack of Efficacy|3|||
150076952|NCT02550106|541422961|FG000|Overall Study|Protocol Violation|6|||
150076953|NCT02550106|541422961|FG000|Overall Study|Withdrawal by Subject|2|||
150076954|NCT03166735|541422962|FG000|Overall Study|Not Treated|1|||
150076955|NCT03166735|541422963|FG001|Overall Study|Not Treated|0|||
150076956|NCT03166735|541422964|FG002|Overall Study|Not Treated|0|||
150076957|NCT03166735|541422965|FG003|Overall Study|Not Treated|0|||
150076958|NCT03166735|541422966|FG004|Overall Study|Not Treated|0|||
150076959|NCT03166735|541422962|FG000|Overall Study|follow-up not completed as planned|0|||
150076960|NCT03166735|541422963|FG001|Overall Study|follow-up not completed as planned|1|||
150076961|NCT03166735|541422964|FG002|Overall Study|follow-up not completed as planned|1|||
150076962|NCT03166735|541422965|FG003|Overall Study|follow-up not completed as planned|0|||
150076963|NCT03166735|541422966|FG004|Overall Study|follow-up not completed as planned|1|||
150076964|NCT03166735|541422962|FG000|Overall Study|Withdrawal by Subject|0|||
150076965|NCT03166735|541422963|FG001|Overall Study|Withdrawal by Subject|0|||
150076966|NCT03166735|541422964|FG002|Overall Study|Withdrawal by Subject|1|||
150076967|NCT03166735|541422965|FG003|Overall Study|Withdrawal by Subject|1|||
150076968|NCT03166735|541422966|FG004|Overall Study|Withdrawal by Subject|2|||
150076969|NCT03166735|541422962|FG000|Overall Study|Lost to Follow-up|0|||
150076970|NCT03166735|541422963|FG001|Overall Study|Lost to Follow-up|2|||
150076971|NCT03166735|541422964|FG002|Overall Study|Lost to Follow-up|1|||
150076972|NCT03166735|541422965|FG003|Overall Study|Lost to Follow-up|0|||
150076973|NCT03166735|541422966|FG004|Overall Study|Lost to Follow-up|1|||
150076974|NCT01543958|541422967|FG000|Overall Study|Loss to follow-up|3|||
150076975|NCT01543958|541422967|FG000|Overall Study|ART initiation|1|||
150076976|NCT04019288|541422968|FG000|Overall Study|Death|1|||
150076977|NCT04019288|541422969|FG001|Overall Study|Death|0|||
150076978|NCT04019288|541422970|FG002|Overall Study|Death|0|||
150076979|NCT00726986|541422974|FG000|Induction Phase|Adverse Event|4|||
150076980|NCT00726986|541422974|FG000|Induction Phase|Withdrawal by Subject|2|||
150076981|NCT00726986|541422974|FG000|Induction Phase|Death|2|||
150076982|NCT00726986|541422974|FG000|Induction Phase|Lack of Efficacy|5|||
150076983|NCT00726986|541422974|FG000|Induction Phase|Secondary Disease|2|||
150076984|NCT00726986|541422974|FG000|Maintenance Phase|Adverse Event|1|||
150076985|NCT00726986|541422974|FG000|Maintenance Phase|Lack of Efficacy|2|||
150076986|NCT04613375|541422979|FG000|Overall Study|Death|198|||
150076987|NCT04613375|541422979|FG000|Overall Study|Withdrawal by Subject|3|||
150076988|NCT02589405|541422982|FG000|Overall Study|Adverse Event|3|||
150076989|NCT02589405|541422982|FG000|Overall Study|Withdrawal by Subject|1|||
150076990|NCT02264639|541422986|FG000|Overall Study|Death (after completing single-dose phase)|1|||
150182529|NCT01976312|541804756|FG001|Overall Study|Withdrawal by Subject|2|||
150182530|NCT01976312|541804755|FG000|Overall Study|Adverse Event|6|||
150182531|NCT01976312|541804756|FG001|Overall Study|Adverse Event|6|||
150182532|NCT01976312|541804755|FG000|Overall Study|Protocol Violation|2|||
150182533|NCT01976312|541804756|FG001|Overall Study|Protocol Violation|0|||
150182534|NCT01538719|541804757|FG000|Overall Study|Lost to Follow-up|2|||
150182535|NCT01538719|541804758|FG001|Overall Study|Lost to Follow-up|0|||
150182536|NCT02556138|541804763|FG000|Overall Study|Withdrawal by Subject|1|||
150182537|NCT01609218|541804765|FG000|Period 1|Adverse Event|3|||
150182538|NCT01609218|541804766|FG001|Period 1|Adverse Event|5|||
150182539|NCT01609218|541804765|FG000|Period 1|Sponsor Decision|0|||
150182540|NCT01609218|541804766|FG001|Period 1|Sponsor Decision|1|||
150182541|NCT01609218|541804765|FG000|Period 2|Adverse Event|1|||
150182542|NCT01609218|541804766|FG001|Period 2|Adverse Event|0|||
150182543|NCT00774852|541804769|FG000|Overall Study|Adverse Event|9|||
150182544|NCT00774852|541804770|FG001|Overall Study|Adverse Event|6|||
150182545|NCT00774852|541804769|FG000|Overall Study|Death|2|||
150182546|NCT00774852|541804770|FG001|Overall Study|Death|1|||
150076991|NCT02264639|541422987|FG001|Overall Study|Death (after completing single-dose phase)|0|||
150076992|NCT02264639|541422988|FG002|Overall Study|Death (after completing single-dose phase)|0|||
150076993|NCT02264639|541422989|FG003|Overall Study|Death (after completing single-dose phase)|0|||
150076994|NCT02264639|541422990|FG004|Overall Study|Death (after completing single-dose phase)|0|||
150076995|NCT02264639|541422986|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
150076996|NCT02264639|541422987|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
150076997|NCT02264639|541422988|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
150076998|NCT02264639|541422989|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
150076999|NCT02264639|541422990|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
150077000|NCT02264639|541422986|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
150077001|NCT02264639|541422987|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
150182547|NCT00774852|541804769|FG000|Overall Study|Lack of Efficacy|3|||
150182548|NCT00774852|541804770|FG001|Overall Study|Lack of Efficacy|7|||
150182549|NCT00774852|541804769|FG000|Overall Study|Lost to Follow-up|9|||
150077002|NCT02264639|541422988|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
150077003|NCT02264639|541422989|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
150077004|NCT02264639|541422990|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
150077005|NCT02264639|541422986|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
150077006|NCT02264639|541422987|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
150077007|NCT02264639|541422988|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
150077008|NCT02264639|541422989|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
150077009|NCT02264639|541422990|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
150077010|NCT01350492|541422997|FG000|Intervention|Lost to Follow-up|2|||
150077011|NCT01350492|541422998|FG001|Intervention|Lost to Follow-up|5|||
150077012|NCT01350492|541422997|FG000|Intervention|Withdrawal by Subject|3|||
150077013|NCT01350492|541422998|FG001|Intervention|Withdrawal by Subject|1|||
150077014|NCT01350492|541422997|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
150077015|NCT01350492|541422998|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
150077016|NCT01350492|541422997|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
150077017|NCT01350492|541422998|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
150077018|NCT02319837|541422999|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
150077019|NCT02319837|541423000|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
150077020|NCT02319837|541423001|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
150077021|NCT02319837|541422999|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
150077022|NCT02319837|541423000|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
150077023|NCT02319837|541423001|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
150077024|NCT02319837|541422999|FG000|Study Treatment Phase|Adverse Event|73|||
150077025|NCT02319837|541423000|FG001|Study Treatment Phase|Adverse Event|36|||
150077026|NCT02319837|541423001|FG002|Study Treatment Phase|Adverse Event|63|||
150077027|NCT02319837|541422999|FG000|Study Treatment Phase|Development of castration resistance|0|||
150077028|NCT02319837|541423000|FG001|Study Treatment Phase|Development of castration resistance|2|||
150077029|NCT02319837|541423001|FG002|Study Treatment Phase|Development of castration resistance|0|||
150077030|NCT02319837|541422999|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
150077031|NCT02319837|541423000|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
150077032|NCT02319837|541423001|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
150077033|NCT02319837|541422999|FG000|Study Treatment Phase|Protocol Violation|2|||
150077034|NCT02319837|541423000|FG001|Study Treatment Phase|Protocol Violation|2|||
150077035|NCT02319837|541423001|FG002|Study Treatment Phase|Protocol Violation|1|||
150077036|NCT02319837|541422999|FG000|Study Treatment Phase|Lost to Follow-up|0|||
150077037|NCT02319837|541423000|FG001|Study Treatment Phase|Lost to Follow-up|1|||
150077038|NCT02319837|541423001|FG002|Study Treatment Phase|Lost to Follow-up|0|||
150077039|NCT02319837|541422999|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
150077040|NCT02319837|541423000|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
150077041|NCT02319837|541423001|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
150077042|NCT02319837|541422999|FG000|Study Treatment Phase|Other|0|||
150077043|NCT02319837|541423000|FG001|Study Treatment Phase|Other|1|||
150077044|NCT02319837|541423001|FG002|Study Treatment Phase|Other|0|||
150077045|NCT02319837|541422999|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
150077046|NCT02319837|541423000|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
150077047|NCT02319837|541423001|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
150077048|NCT02319837|541422999|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
150077049|NCT02319837|541423000|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
150077050|NCT02319837|541423001|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
150077051|NCT02319837|541422999|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
150077052|NCT02319837|541423000|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
150077053|NCT02319837|541423001|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
150077054|NCT02319837|541422999|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
150077055|NCT02319837|541423000|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
150077056|NCT02319837|541423001|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
150077057|NCT02319837|541422999|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
150077058|NCT02319837|541423000|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
150077059|NCT02319837|541423001|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
150077060|NCT02319837|541422999|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
150077061|NCT02319837|541423000|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
150077062|NCT02319837|541423001|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
150077063|NCT02319837|541422999|FG000|Long-Term Follow-Up Phase|Death|33|||
150077064|NCT02319837|541423000|FG001|Long-Term Follow-Up Phase|Death|54|||
150077065|NCT02319837|541423001|FG002|Long-Term Follow-Up Phase|Death|42|||
150077066|NCT00753766|541423002|FG000|Overall Study|Physician Decision|1|||
150077067|NCT00753766|541423003|FG001|Overall Study|Physician Decision|0|||
150077068|NCT00702689|541423004|FG000|Overall Study|Withdrawal by Subject|4|||
150077069|NCT00702689|541423004|FG000|Overall Study|Recurrent malignancy|1|||
150077070|NCT00702689|541423004|FG000|Overall Study|Adverse Event|1|||
150077071|NCT00239590|541423008|FG000|Randomized|Lost to Follow-up|0|||
150077072|NCT00239590|541423009|FG001|Randomized|Lost to Follow-up|1|||
150077073|NCT00239590|541423008|FG000|Randomized|Withdrawal by Subject|0|||
150077074|NCT00239590|541423009|FG001|Randomized|Withdrawal by Subject|1|||
150077075|NCT00239590|541423008|FG000|Completed Study Protocol|Adverse Event|1|||
150077076|NCT00239590|541423009|FG001|Completed Study Protocol|Adverse Event|1|||
150077077|NCT00239590|541423008|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
150077078|NCT00239590|541423009|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
150077079|NCT02993757|541423013|FG000|Overall Study|Non compliance with the protocol|155|||
150077080|NCT02993757|541423014|FG001|Overall Study|Non compliance with the protocol|170|||
150077081|NCT02993757|541423013|FG000|Overall Study|Lost to Follow-up|1|||
150077082|NCT02993757|541423014|FG001|Overall Study|Lost to Follow-up|0|||
150077083|NCT02993757|541423013|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
150077084|NCT02993757|541423014|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
150077085|NCT01611155|541423016|FG000|Overall Study|Adverse Event|1|||
150077086|NCT01611155|541423017|FG001|Overall Study|Adverse Event|1|||
150077087|NCT01611155|541423016|FG000|Overall Study|Refused further treatment|6|||
150077088|NCT01611155|541423017|FG001|Overall Study|Refused further treatment|4|||
150077089|NCT01611155|541423016|FG000|Overall Study|Disease progression|1|||
150077090|NCT01611155|541423017|FG001|Overall Study|Disease progression|0|||
150077091|NCT01611155|541423016|FG000|Overall Study|Withdrawal by Subject|1|||
150077092|NCT01611155|541423017|FG001|Overall Study|Withdrawal by Subject|0|||
150077093|NCT01611155|541423016|FG000|Overall Study|Alternative treatment|0|||
150077094|NCT01611155|541423017|FG001|Overall Study|Alternative treatment|1|||
150077095|NCT01611155|541423016|FG000|Overall Study|Ineligible patient|0|||
150077096|NCT01611155|541423017|FG001|Overall Study|Ineligible patient|1|||
150077097|NCT02369016|541423018|FG000|Overall Study|AE associated with clinical disease progression|2|||
150077098|NCT02369016|541423019|FG001|Overall Study|AE associated with clinical disease progression|1|||
150077099|NCT02369016|541423018|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
150077100|NCT02369016|541423019|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
150077101|NCT02369016|541423018|FG000|Overall Study|Progressive disease - clinical progression|1|||
150077102|NCT02369016|541423019|FG001|Overall Study|Progressive disease - clinical progression|4|||
150077103|NCT02369016|541423018|FG000|Overall Study|withdrawal by patient|4|||
150077104|NCT02369016|541423019|FG001|Overall Study|withdrawal by patient|0|||
150077105|NCT02369016|541423018|FG000|Overall Study|Progressive disease - radiological progression|6|||
150077106|NCT02369016|541423019|FG001|Overall Study|Progressive disease - radiological progression|2|||
150077107|NCT02229383|541423020|FG000|Overall Study|Adverse Event|7|||
150077108|NCT02229383|541423021|FG001|Overall Study|Adverse Event|4|||
150077109|NCT02229383|541423020|FG000|Overall Study|Death|0|||
150077110|NCT02229383|541423021|FG001|Overall Study|Death|1|||
150077111|NCT02229383|541423020|FG000|Overall Study|Lost to Follow-up|5|||
150077112|NCT02229383|541423021|FG001|Overall Study|Lost to Follow-up|3|||
150077113|NCT02229383|541423020|FG000|Overall Study|Withdrawal by Subject|4|||
150077114|NCT02229383|541423021|FG001|Overall Study|Withdrawal by Subject|6|||
150077115|NCT02229383|541423020|FG000|Overall Study|Did not receive treatment|1|||
150077116|NCT02229383|541423021|FG001|Overall Study|Did not receive treatment|0|||
150077117|NCT02229383|541423020|FG000|Overall Study|Other|3|||
150077118|NCT02229383|541423021|FG001|Overall Study|Other|8|||
150077119|NCT05248867|541423026|FG000|Double-blind Period|Lost to Follow-up|0|||
150182550|NCT00774852|541804770|FG001|Overall Study|Lost to Follow-up|5|||
150182551|NCT00774852|541804769|FG000|Overall Study|Physician Decision|2|||
150182552|NCT00774852|541804770|FG001|Overall Study|Physician Decision|6|||
150182553|NCT00774852|541804769|FG000|Overall Study|Pregnancy|1|||
150182554|NCT00774852|541804770|FG001|Overall Study|Pregnancy|2|||
150077120|NCT05248867|541423027|FG001|Double-blind Period|Lost to Follow-up|3|||
150077121|NCT05248867|541423028|FG002|Double-blind Period|Lost to Follow-up|0|||
150077122|NCT05248867|541423029|FG003|Double-blind Period|Lost to Follow-up|0|||
150182555|NCT00774852|541804769|FG000|Overall Study|Withdrawal by Subject|2|||
150077123|NCT05248867|541423030|FG004|Double-blind Period|Lost to Follow-up|0|||
150077124|NCT05248867|541423031|FG005|Double-blind Period|Lost to Follow-up|0|||
150077125|NCT05248867|541423026|FG000|Double-blind Period|Withdrawal by Subject|5|||
150077126|NCT05248867|541423027|FG001|Double-blind Period|Withdrawal by Subject|14|||
150077127|NCT05248867|541423028|FG002|Double-blind Period|Withdrawal by Subject|0|||
150077128|NCT05248867|541423029|FG003|Double-blind Period|Withdrawal by Subject|0|||
150077129|NCT05248867|541423030|FG004|Double-blind Period|Withdrawal by Subject|0|||
150077130|NCT05248867|541423031|FG005|Double-blind Period|Withdrawal by Subject|0|||
150077131|NCT05248867|541423026|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
150182556|NCT00774852|541804770|FG001|Overall Study|Withdrawal by Subject|2|||
150077132|NCT05248867|541423027|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
150077133|NCT05248867|541423028|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
150077134|NCT05248867|541423029|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
150077135|NCT05248867|541423030|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
150077136|NCT05248867|541423031|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
150077137|NCT05248867|541423026|FG000|Double-blind Period|Other, not specified|3|||
150077138|NCT05248867|541423027|FG001|Double-blind Period|Other, not specified|8|||
150077139|NCT05248867|541423028|FG002|Double-blind Period|Other, not specified|0|||
150077140|NCT05248867|541423029|FG003|Double-blind Period|Other, not specified|0|||
150077141|NCT05248867|541423030|FG004|Double-blind Period|Other, not specified|0|||
150077142|NCT05248867|541423031|FG005|Double-blind Period|Other, not specified|0|||
150077143|NCT05248867|541423026|FG000|Open-label Period|Withdrawal by Subject|0|||
150077144|NCT05248867|541423027|FG001|Open-label Period|Withdrawal by Subject|0|||
150077145|NCT05248867|541423028|FG002|Open-label Period|Withdrawal by Subject|3|||
150077146|NCT05248867|541423029|FG003|Open-label Period|Withdrawal by Subject|1|||
150077147|NCT05248867|541423030|FG004|Open-label Period|Withdrawal by Subject|7|||
150077148|NCT05248867|541423031|FG005|Open-label Period|Withdrawal by Subject|9|||
150077149|NCT05248867|541423026|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
150077150|NCT05248867|541423027|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
150077151|NCT05248867|541423028|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
150077152|NCT05248867|541423029|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
150077153|NCT05248867|541423030|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
150077154|NCT05248867|541423031|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
150077155|NCT05248867|541423026|FG000|Open-label Period|Lost to Follow-up|0|||
150077156|NCT05248867|541423027|FG001|Open-label Period|Lost to Follow-up|0|||
150077157|NCT05248867|541423028|FG002|Open-label Period|Lost to Follow-up|0|||
150077158|NCT05248867|541423029|FG003|Open-label Period|Lost to Follow-up|0|||
150077159|NCT05248867|541423030|FG004|Open-label Period|Lost to Follow-up|5|||
150077160|NCT05248867|541423031|FG005|Open-label Period|Lost to Follow-up|2|||
150077161|NCT05248867|541423026|FG000|Open-label Period|COVID-19 Infection|0|||
150077162|NCT05248867|541423027|FG001|Open-label Period|COVID-19 Infection|0|||
150077163|NCT05248867|541423028|FG002|Open-label Period|COVID-19 Infection|0|||
150077164|NCT05248867|541423029|FG003|Open-label Period|COVID-19 Infection|0|||
150077165|NCT05248867|541423030|FG004|Open-label Period|COVID-19 Infection|1|||
150077166|NCT05248867|541423031|FG005|Open-label Period|COVID-19 Infection|0|||
150077167|NCT05248867|541423026|FG000|Open-label Period|Other, not specified|0|||
150077168|NCT05248867|541423027|FG001|Open-label Period|Other, not specified|0|||
150077169|NCT05248867|541423028|FG002|Open-label Period|Other, not specified|0|||
150077170|NCT05248867|541423029|FG003|Open-label Period|Other, not specified|0|||
150077171|NCT05248867|541423030|FG004|Open-label Period|Other, not specified|4|||
150077172|NCT05248867|541423031|FG005|Open-label Period|Other, not specified|0|||
150077173|NCT00660699|541423033|FG000|Overall Study|Withdrawal by Subject|2|||
150077174|NCT00967668|541424307|FG000|Overall Study|Withdrawal by Subject|13|||
150077175|NCT00967668|541424308|FG001|Overall Study|Withdrawal by Subject|8|||
150077176|NCT00967668|541424309|FG002|Overall Study|Withdrawal by Subject|8|||
150077177|NCT00967668|541424307|FG000|Overall Study|Death|0|||
150077178|NCT00967668|541424308|FG001|Overall Study|Death|2|||
150077179|NCT00967668|541424309|FG002|Overall Study|Death|4|||
150077180|NCT00967668|541424307|FG000|Overall Study|Removed due to behavior|1|||
150077181|NCT00967668|541424308|FG001|Overall Study|Removed due to behavior|1|||
150077182|NCT00967668|541424309|FG002|Overall Study|Removed due to behavior|2|||
150077183|NCT00967668|541424307|FG000|Overall Study|Refused Year 2|11|||
150077184|NCT00967668|541424308|FG001|Overall Study|Refused Year 2|6|||
150077185|NCT00967668|541424309|FG002|Overall Study|Refused Year 2|4|||
150077186|NCT00967668|541424307|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
150077187|NCT00967668|541424308|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
150077188|NCT00967668|541424309|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
150077189|NCT00967668|541424307|FG000|Overall Study|Lost to Follow-up|15|||
150077190|NCT00967668|541424308|FG001|Overall Study|Lost to Follow-up|9|||
150077191|NCT00967668|541424309|FG002|Overall Study|Lost to Follow-up|16|||
150077192|NCT00967668|541424307|FG000|Overall Study|Refused 12-mo assessment|3|||
150077193|NCT00967668|541424308|FG001|Overall Study|Refused 12-mo assessment|1|||
150077194|NCT00967668|541424309|FG002|Overall Study|Refused 12-mo assessment|9|||
150077195|NCT00967668|541424307|FG000|Overall Study|Pregnancy|1|||
150182557|NCT00774852|541804769|FG000|Overall Study|Non-responder|15|||
150077196|NCT00967668|541424308|FG001|Overall Study|Pregnancy|0|||
150077197|NCT00967668|541424309|FG002|Overall Study|Pregnancy|0|||
150077198|NCT01709513|541424313|FG000|Overall Study|Randomized but not treated|0|||
150077199|NCT01709513|541424314|FG001|Overall Study|Randomized but not treated|1|||
150077200|NCT01709513|541424315|FG002|Overall Study|Randomized but not treated|0|||
150077201|NCT01709513|541424313|FG000|Overall Study|Adverse Event|16|||
150077202|NCT01709513|541424314|FG001|Overall Study|Adverse Event|31|||
150077203|NCT01709513|541424315|FG002|Overall Study|Adverse Event|23|||
150077204|NCT01709513|541424313|FG000|Overall Study|Poor compliance to protocol|2|||
150077205|NCT01709513|541424314|FG001|Overall Study|Poor compliance to protocol|0|||
150077206|NCT01709513|541424315|FG002|Overall Study|Poor compliance to protocol|0|||
150077207|NCT01709513|541424313|FG000|Overall Study|Other|3|||
150077208|NCT01709513|541424314|FG001|Overall Study|Other|11|||
150077209|NCT01709513|541424315|FG002|Overall Study|Other|7|||
150077210|NCT01034631|541424316|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
150077211|NCT01034631|541424317|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
150077212|NCT01034631|541424318|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
150077213|NCT01034631|541424316|FG000|Phase II|Not Evaluable per protocol|0|||
150077214|NCT01034631|541424317|FG001|Phase II|Not Evaluable per protocol|0|||
150077215|NCT01034631|541424318|FG002|Phase II|Not Evaluable per protocol|2|||
150077216|NCT01034631|541424316|FG000|Phase II|Determined Ineligible per protocol|0|||
150077217|NCT01034631|541424317|FG001|Phase II|Determined Ineligible per protocol|1|||
150077218|NCT01034631|541424318|FG002|Phase II|Determined Ineligible per protocol|0|||
150077219|NCT01193530|541424321|FG000|Overall Study|Withdrawal by Subject|2|||
150077220|NCT01193530|541424322|FG001|Overall Study|Withdrawal by Subject|2|||
150077221|NCT01193530|541424321|FG000|Overall Study|Began Contraindicated Therapy|1|||
150077222|NCT01193530|541424322|FG001|Overall Study|Began Contraindicated Therapy|0|||
150077223|NCT01193530|541424321|FG000|Overall Study|Lost Light Box|0|||
150077224|NCT01193530|541424322|FG001|Overall Study|Lost Light Box|1|||
150077225|NCT01193530|541424321|FG000|Overall Study|Returned home - out of state|0|||
150077226|NCT01193530|541424322|FG001|Overall Study|Returned home - out of state|1|||
150077227|NCT01193530|541424321|FG000|Overall Study|Non-Compliance|0|||
150077228|NCT01193530|541424322|FG001|Overall Study|Non-Compliance|1|||
150077229|NCT04218695|541424323|FG000|Overall Study|Adverse Event|1|||
150077230|NCT04218695|541424324|FG001|Overall Study|Adverse Event|0|||
150077231|NCT01890473|541424325|FG000|Overall Study|Lost to Follow-up|1|||
150077232|NCT01890473|541424326|FG001|Overall Study|Lost to Follow-up|0|||
150077233|NCT01890473|541424325|FG000|Overall Study|Poor/non-compliance|1|||
150077234|NCT01890473|541424326|FG001|Overall Study|Poor/non-compliance|0|||
150077235|NCT00934089|541424327|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
150077236|NCT00934089|541424328|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
150077237|NCT00934089|541424327|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
150077238|NCT00934089|541424328|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
150077239|NCT01945281|541424329|FG000|Overall Study|Adverse Event|1|||
150077240|NCT01945281|541424330|FG001|Overall Study|Adverse Event|0|||
150077241|NCT01945281|541424329|FG000|Overall Study|Death|3|||
150077242|NCT01945281|541424330|FG001|Overall Study|Death|3|||
150077243|NCT01945281|541424329|FG000|Overall Study|Physician Decision|1|||
150077244|NCT01945281|541424330|FG001|Overall Study|Physician Decision|1|||
150077245|NCT01945281|541424329|FG000|Overall Study|Technical Problems|1|||
150077246|NCT01945281|541424330|FG001|Overall Study|Technical Problems|0|||
150077247|NCT00799383|541424331|FG000|Overall Study|Protocol Violation|1|||
150077248|NCT00799383|541424332|FG001|Overall Study|Protocol Violation|1|||
150077249|NCT00799383|541424331|FG000|Overall Study|Adverse Event|0|||
150077250|NCT00799383|541424332|FG001|Overall Study|Adverse Event|1|||
150077251|NCT00799383|541424331|FG000|Overall Study|Lost to Follow-up|1|||
150077252|NCT00799383|541424332|FG001|Overall Study|Lost to Follow-up|2|||
150077253|NCT00799383|541424331|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
150077254|NCT00799383|541424332|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
150077255|NCT00799383|541424331|FG000|Overall Study|Withdrawal by Subject|0|||
150077256|NCT00799383|541424332|FG001|Overall Study|Withdrawal by Subject|1|||
150077257|NCT00926328|541424333|FG000|Overall Study|Lost to Follow-up|12|||
150077258|NCT00926328|541424334|FG001|Overall Study|Lost to Follow-up|14|||
150077259|NCT01434667|541424343|FG000|Overall Study|Lost to Follow-up|5|||
150077260|NCT01434667|541424344|FG001|Overall Study|Lost to Follow-up|10|||
150077261|NCT02165215|541424347|FG000|Induction Phase|Adverse Event|1|||
150077262|NCT02165215|541424348|FG001|Induction Phase|Adverse Event|0|||
150077263|NCT02165215|541424349|FG002|Induction Phase|Adverse Event|0|||
150077264|NCT02165215|541424347|FG000|Induction Phase|Withdrawal by Subject|10|||
150077265|NCT02165215|541424348|FG001|Induction Phase|Withdrawal by Subject|0|||
150077266|NCT02165215|541424349|FG002|Induction Phase|Withdrawal by Subject|0|||
150077267|NCT02165215|541424347|FG000|Induction Phase|Protocol Violation|1|||
150077268|NCT02165215|541424348|FG001|Induction Phase|Protocol Violation|0|||
150182558|NCT00774852|541804770|FG001|Overall Study|Non-responder|11|||
150182559|NCT00774852|541804769|FG000|Overall Study|Subject non-compliance|0|||
150077269|NCT02165215|541424349|FG002|Induction Phase|Protocol Violation|0|||
150077270|NCT02165215|541424347|FG000|Induction Phase|Physician Decision|1|||
150077271|NCT02165215|541424348|FG001|Induction Phase|Physician Decision|0|||
150077272|NCT02165215|541424349|FG002|Induction Phase|Physician Decision|0|||
150077273|NCT02165215|541424347|FG000|Induction Phase|Lack of Efficacy|2|||
150077274|NCT02165215|541424348|FG001|Induction Phase|Lack of Efficacy|0|||
150077275|NCT02165215|541424349|FG002|Induction Phase|Lack of Efficacy|0|||
150077276|NCT02165215|541424347|FG000|Induction Phase|Non-Compliance|2|||
150077277|NCT02165215|541424348|FG001|Induction Phase|Non-Compliance|0|||
150077278|NCT02165215|541424349|FG002|Induction Phase|Non-Compliance|0|||
150077279|NCT02165215|541424347|FG000|Induction Phase|Lost to Follow-up|6|||
150077280|NCT02165215|541424348|FG001|Induction Phase|Lost to Follow-up|0|||
150077281|NCT02165215|541424349|FG002|Induction Phase|Lost to Follow-up|0|||
150077282|NCT02165215|541424347|FG000|Maintenance Phase|Withdrawal by Subject|0|||
150077283|NCT02165215|541424348|FG001|Maintenance Phase|Withdrawal by Subject|7|||
150077284|NCT02165215|541424349|FG002|Maintenance Phase|Withdrawal by Subject|3|||
150077285|NCT02165215|541424347|FG000|Maintenance Phase|Multiple reasons|0|||
150077286|NCT02165215|541424348|FG001|Maintenance Phase|Multiple reasons|2|||
150077287|NCT02165215|541424349|FG002|Maintenance Phase|Multiple reasons|1|||
150077288|NCT02165215|541424347|FG000|Maintenance Phase|Lost to Follow-up|0|||
150077289|NCT02165215|541424348|FG001|Maintenance Phase|Lost to Follow-up|2|||
150077290|NCT02165215|541424349|FG002|Maintenance Phase|Lost to Follow-up|0|||
150077291|NCT02165215|541424347|FG000|Maintenance Phase|Adverse Event|0|||
150077292|NCT02165215|541424348|FG001|Maintenance Phase|Adverse Event|1|||
150077293|NCT02165215|541424349|FG002|Maintenance Phase|Adverse Event|1|||
150077294|NCT05074667|541424350|FG000|Overall Study|Death|1|||
150077295|NCT05074667|541424350|FG000|Overall Study|Withdrawal by Subject|4|||
150077296|NCT05074667|541424350|FG000|Overall Study|Lost to Follow-up|10|||
150077297|NCT03535844|541424353|FG000|Overall Study|Withdrawal by Subject|0|||
150077298|NCT03535844|541424354|FG001|Overall Study|Withdrawal by Subject|1|||
150077299|NCT00297830|541424355|FG000|6 Month Visit|Death|1|||
150077300|NCT00297830|541424356|FG001|6 Month Visit|Death|0|||
150077301|NCT00297830|541424357|FG002|6 Month Visit|Death|2|||
150077302|NCT00297830|541424355|FG000|6 Month Visit|Withdrawal by Subject|2|||
150077303|NCT00297830|541424356|FG001|6 Month Visit|Withdrawal by Subject|1|||
150077304|NCT00297830|541424357|FG002|6 Month Visit|Withdrawal by Subject|1|||
150077305|NCT00297830|541424355|FG000|6 Month Visit|Adverse Event|0|||
150077306|NCT00297830|541424356|FG001|6 Month Visit|Adverse Event|1|||
150077307|NCT00297830|541424357|FG002|6 Month Visit|Adverse Event|0|||
150077308|NCT00297830|541424355|FG000|12 Month Visit|Lost to Follow-up|1|||
150077309|NCT00297830|541424356|FG001|12 Month Visit|Lost to Follow-up|0|||
150077310|NCT00297830|541424357|FG002|12 Month Visit|Lost to Follow-up|0|||
150077311|NCT00297830|541424355|FG000|12 Month Visit|Adverse Event|0|||
150077312|NCT00297830|541424356|FG001|12 Month Visit|Adverse Event|3|||
150077313|NCT00297830|541424357|FG002|12 Month Visit|Adverse Event|0|||
150077314|NCT00297830|541424355|FG000|12 Month Visit|Withdrawal by Subject|0|||
150182560|NCT00774852|541804770|FG001|Overall Study|Subject non-compliance|1|||
150077315|NCT00297830|541424356|FG001|12 Month Visit|Withdrawal by Subject|3|||
150077316|NCT00297830|541424357|FG002|12 Month Visit|Withdrawal by Subject|0|||
150077317|NCT00003473|541424358|FG000|Overall Study|Three patients were not evaluable.|3|||
150182561|NCT00774852|541804769|FG000|Overall Study|Protocol Violation|1|||
150077318|NCT04401423|541424359|FG000|Overall Study|Withdrawal by Subject|3|||
150077319|NCT04401423|541424360|FG001|Overall Study|Withdrawal by Subject|1|||
150077320|NCT04401423|541424359|FG000|Overall Study|Physician Decision|2|||
150077321|NCT04401423|541424360|FG001|Overall Study|Physician Decision|1|||
150077322|NCT02193867|541424364|FG000|Overall Study|Death|2|||
150077323|NCT02193867|541424364|FG000|Overall Study|Sponsor Study Termination|2|||
150077324|NCT01867424|541424365|FG000|Overall Study|Patient noncompliance|2|||
150077325|NCT01867424|541424366|FG001|Overall Study|Patient noncompliance|1|||
150077326|NCT01921387|541424367|FG000|Overall Study|Adverse Event|1|||
150077327|NCT02582983|541424368|FG000|Overall Study|Death|3|||
150077328|NCT02582983|541424368|FG000|Overall Study|Withdrawal by Subject|2|||
150077329|NCT02582983|541424368|FG000|Overall Study|Adverse Event|1|||
150077330|NCT05209360|541424369|FG000|Overall Study|Withdrawal by Subject|0|||
150077331|NCT05209360|541424370|FG001|Overall Study|Withdrawal by Subject|0|||
150077332|NCT05209360|541424371|FG002|Overall Study|Withdrawal by Subject|1|||
150077333|NCT05209360|541424372|FG003|Overall Study|Withdrawal by Subject|0|||
150077334|NCT05209360|541424373|FG004|Overall Study|Withdrawal by Subject|0|||
150077335|NCT05209360|541424374|FG005|Overall Study|Withdrawal by Subject|0|||
150077336|NCT02021331|541424377|FG000|Overall Study|Adverse Event|0|||
150077337|NCT02021331|541424378|FG001|Overall Study|Adverse Event|2|||
150077338|NCT01776840|541424386|FG000|Overall Study|Lost to Follow-up|12|||
150077339|NCT01776840|541424387|FG001|Overall Study|Lost to Follow-up|7|||
150077340|NCT01776840|541424386|FG000|Overall Study|Withdrawal by Subject|32|||
150077341|NCT01776840|541424387|FG001|Overall Study|Withdrawal by Subject|48|||
150077342|NCT01776840|541424386|FG000|Overall Study|Sponsor decision|89|||
150077343|NCT01776840|541424387|FG001|Overall Study|Sponsor decision|87|||
150077344|NCT03641339|541424388|FG000|Overall Study|Physician Decision|1|||
150077345|NCT03641339|541424389|FG001|Overall Study|Physician Decision|0|||
150077346|NCT03641339|541424390|FG002|Overall Study|Physician Decision|0|||
150077347|NCT03641339|541424391|FG003|Overall Study|Physician Decision|0|||
150077348|NCT03641339|541424392|FG004|Overall Study|Physician Decision|0|||
150077349|NCT03641339|541424393|FG005|Overall Study|Physician Decision|0|||
150077350|NCT03641339|541424388|FG000|Overall Study|Withdrawal by Subject|0|||
150077351|NCT03641339|541424389|FG001|Overall Study|Withdrawal by Subject|2|||
150077352|NCT03641339|541424390|FG002|Overall Study|Withdrawal by Subject|0|||
150077353|NCT03641339|541424391|FG003|Overall Study|Withdrawal by Subject|2|||
150077354|NCT03641339|541424392|FG004|Overall Study|Withdrawal by Subject|0|||
150077355|NCT03641339|541424393|FG005|Overall Study|Withdrawal by Subject|1|||
150077356|NCT04457336|541424395|FG000|Period 2: Part A|Withdrawal by Subject|0|||
150077357|NCT04457336|541424396|FG001|Period 2: Part A|Withdrawal by Subject|1|||
150077358|NCT04457336|541424397|FG002|Period 2: Part A|Withdrawal by Subject|1|||
150077359|NCT04457336|541424398|FG003|Period 2: Part A|Withdrawal by Subject|1|||
150077360|NCT04457336|541424399|FG004|Period 2: Part A|Withdrawal by Subject|0|||
150077361|NCT04457336|541424400|FG005|Period 2: Part A|Withdrawal by Subject|0|||
150077362|NCT04457336|541424401|FG006|Period 2: Part A|Withdrawal by Subject|0|||
150077363|NCT04457336|541424402|FG007|Period 2: Part A|Withdrawal by Subject|0|||
150077364|NCT04457336|541424395|FG000|Period 2: Part A|Adverse Event|0|||
150077365|NCT04457336|541424396|FG001|Period 2: Part A|Adverse Event|0|||
150077366|NCT04457336|541424397|FG002|Period 2: Part A|Adverse Event|1|||
150077367|NCT04457336|541424398|FG003|Period 2: Part A|Adverse Event|1|||
150077368|NCT04457336|541424399|FG004|Period 2: Part A|Adverse Event|0|||
150077369|NCT04457336|541424400|FG005|Period 2: Part A|Adverse Event|0|||
150077370|NCT04457336|541424401|FG006|Period 2: Part A|Adverse Event|0|||
150077371|NCT04457336|541424402|FG007|Period 2: Part A|Adverse Event|0|||
150077372|NCT04457336|541424395|FG000|Period 2: Part A|Study Terminated|0|||
150077373|NCT04457336|541424396|FG001|Period 2: Part A|Study Terminated|0|||
150077374|NCT04457336|541424397|FG002|Period 2: Part A|Study Terminated|1|||
150077375|NCT04457336|541424398|FG003|Period 2: Part A|Study Terminated|0|||
150077376|NCT04457336|541424399|FG004|Period 2: Part A|Study Terminated|0|||
150077377|NCT04457336|541424400|FG005|Period 2: Part A|Study Terminated|0|||
150077378|NCT04457336|541424401|FG006|Period 2: Part A|Study Terminated|0|||
150077379|NCT04457336|541424402|FG007|Period 2: Part A|Study Terminated|0|||
150077380|NCT04457336|541424395|FG000|Period 2: Part A|Protocol Violation|0|||
150077381|NCT04457336|541424396|FG001|Period 2: Part A|Protocol Violation|1|||
150077382|NCT04457336|541424397|FG002|Period 2: Part A|Protocol Violation|0|||
150077383|NCT04457336|541424398|FG003|Period 2: Part A|Protocol Violation|0|||
150077384|NCT04457336|541424399|FG004|Period 2: Part A|Protocol Violation|0|||
150077385|NCT04457336|541424400|FG005|Period 2: Part A|Protocol Violation|0|||
150077386|NCT04457336|541424401|FG006|Period 2: Part A|Protocol Violation|0|||
150077387|NCT04457336|541424402|FG007|Period 2: Part A|Protocol Violation|0|||
150077388|NCT04457336|541424395|FG000|Period 2: Part A|Lost to Follow-up|0|||
150077389|NCT04457336|541424396|FG001|Period 2: Part A|Lost to Follow-up|1|||
150077390|NCT04457336|541424397|FG002|Period 2: Part A|Lost to Follow-up|0|||
150077391|NCT04457336|541424398|FG003|Period 2: Part A|Lost to Follow-up|0|||
150182562|NCT00774852|541804770|FG001|Overall Study|Protocol Violation|0|||
150077392|NCT04457336|541424399|FG004|Period 2: Part A|Lost to Follow-up|0|||
150077393|NCT04457336|541424400|FG005|Period 2: Part A|Lost to Follow-up|0|||
150077394|NCT04457336|541424401|FG006|Period 2: Part A|Lost to Follow-up|0|||
150077395|NCT04457336|541424402|FG007|Period 2: Part A|Lost to Follow-up|0|||
150077396|NCT04457336|541424395|FG000|Period 2: Part A|Other|0|||
150077397|NCT04457336|541424396|FG001|Period 2: Part A|Other|1|||
150077398|NCT04457336|541424397|FG002|Period 2: Part A|Other|0|||
150077399|NCT04457336|541424398|FG003|Period 2: Part A|Other|0|||
150077400|NCT04457336|541424399|FG004|Period 2: Part A|Other|0|||
150077401|NCT04457336|541424400|FG005|Period 2: Part A|Other|0|||
150077402|NCT04457336|541424401|FG006|Period 2: Part A|Other|0|||
150077403|NCT04457336|541424402|FG007|Period 2: Part A|Other|0|||
150077404|NCT04457336|541424395|FG000|Period 2: Part A|Physician Decision|0|||
150077405|NCT04457336|541424396|FG001|Period 2: Part A|Physician Decision|0|||
150077406|NCT04457336|541424397|FG002|Period 2: Part A|Physician Decision|0|||
150077407|NCT04457336|541424398|FG003|Period 2: Part A|Physician Decision|1|||
150077408|NCT04457336|541424399|FG004|Period 2: Part A|Physician Decision|0|||
150077409|NCT04457336|541424400|FG005|Period 2: Part A|Physician Decision|0|||
150077410|NCT04457336|541424401|FG006|Period 2: Part A|Physician Decision|0|||
150077411|NCT04457336|541424402|FG007|Period 2: Part A|Physician Decision|0|||
150077412|NCT04457336|541424395|FG000|Period 3: Part B|Study Terminated|0|||
150077413|NCT04457336|541424396|FG001|Period 3: Part B|Study Terminated|0|||
150077414|NCT04457336|541424397|FG002|Period 3: Part B|Study Terminated|0|||
150077415|NCT04457336|541424398|FG003|Period 3: Part B|Study Terminated|0|||
150077416|NCT04457336|541424399|FG004|Period 3: Part B|Study Terminated|1|||
150077417|NCT04457336|541424400|FG005|Period 3: Part B|Study Terminated|10|||
150077418|NCT04457336|541424401|FG006|Period 3: Part B|Study Terminated|13|||
150077419|NCT04457336|541424402|FG007|Period 3: Part B|Study Terminated|0|||
150077420|NCT04457336|541424395|FG000|Period 3: Part B|Withdrawal by Subject|0|||
150077421|NCT04457336|541424396|FG001|Period 3: Part B|Withdrawal by Subject|0|||
150077422|NCT04457336|541424397|FG002|Period 3: Part B|Withdrawal by Subject|0|||
150077423|NCT04457336|541424398|FG003|Period 3: Part B|Withdrawal by Subject|0|||
150077424|NCT04457336|541424399|FG004|Period 3: Part B|Withdrawal by Subject|0|||
150077425|NCT04457336|541424400|FG005|Period 3: Part B|Withdrawal by Subject|1|||
150077426|NCT04457336|541424401|FG006|Period 3: Part B|Withdrawal by Subject|2|||
150077427|NCT04457336|541424402|FG007|Period 3: Part B|Withdrawal by Subject|0|||
150077428|NCT04457336|541424395|FG000|Period 4: Part C|Study Terminated|0|||
150077429|NCT04457336|541424396|FG001|Period 4: Part C|Study Terminated|0|||
150077430|NCT04457336|541424397|FG002|Period 4: Part C|Study Terminated|0|||
150077431|NCT04457336|541424398|FG003|Period 4: Part C|Study Terminated|0|||
150077432|NCT04457336|541424399|FG004|Period 4: Part C|Study Terminated|0|||
150077433|NCT04457336|541424400|FG005|Period 4: Part C|Study Terminated|0|||
150077434|NCT04457336|541424401|FG006|Period 4: Part C|Study Terminated|0|||
150077435|NCT04457336|541424402|FG007|Period 4: Part C|Study Terminated|30|||
150077436|NCT04457336|541424395|FG000|Period 4: Part C|Adverse Event|0|||
150077437|NCT04457336|541424396|FG001|Period 4: Part C|Adverse Event|0|||
150077438|NCT04457336|541424397|FG002|Period 4: Part C|Adverse Event|0|||
150077439|NCT04457336|541424398|FG003|Period 4: Part C|Adverse Event|0|||
150077440|NCT04457336|541424399|FG004|Period 4: Part C|Adverse Event|0|||
150077441|NCT04457336|541424400|FG005|Period 4: Part C|Adverse Event|0|||
150077442|NCT04457336|541424401|FG006|Period 4: Part C|Adverse Event|0|||
150077443|NCT04457336|541424402|FG007|Period 4: Part C|Adverse Event|2|||
150077444|NCT04457336|541424395|FG000|Period 4: Part C|Site Terminated|0|||
150077445|NCT04457336|541424396|FG001|Period 4: Part C|Site Terminated|0|||
150077446|NCT04457336|541424397|FG002|Period 4: Part C|Site Terminated|0|||
150077447|NCT04457336|541424398|FG003|Period 4: Part C|Site Terminated|0|||
150077448|NCT04457336|541424399|FG004|Period 4: Part C|Site Terminated|0|||
150077449|NCT04457336|541424400|FG005|Period 4: Part C|Site Terminated|0|||
150077450|NCT04457336|541424401|FG006|Period 4: Part C|Site Terminated|0|||
150077451|NCT04457336|541424402|FG007|Period 4: Part C|Site Terminated|1|||
150077452|NCT04457336|541424395|FG000|Period 4: Part C|Other|0|||
150077453|NCT04457336|541424396|FG001|Period 4: Part C|Other|0|||
150077454|NCT04457336|541424397|FG002|Period 4: Part C|Other|0|||
150077455|NCT04457336|541424398|FG003|Period 4: Part C|Other|0|||
150077456|NCT04457336|541424399|FG004|Period 4: Part C|Other|0|||
150077457|NCT04457336|541424400|FG005|Period 4: Part C|Other|0|||
150077458|NCT04457336|541424401|FG006|Period 4: Part C|Other|0|||
150077459|NCT04457336|541424402|FG007|Period 4: Part C|Other|2|||
150077460|NCT04457336|541424395|FG000|Period 4: Part C|Withdrawal by Subject|0|||
150077461|NCT04457336|541424396|FG001|Period 4: Part C|Withdrawal by Subject|0|||
150077462|NCT04457336|541424397|FG002|Period 4: Part C|Withdrawal by Subject|0|||
150077463|NCT04457336|541424398|FG003|Period 4: Part C|Withdrawal by Subject|0|||
150077464|NCT04457336|541424399|FG004|Period 4: Part C|Withdrawal by Subject|0|||
150077465|NCT04457336|541424400|FG005|Period 4: Part C|Withdrawal by Subject|0|||
150077466|NCT04457336|541424401|FG006|Period 4: Part C|Withdrawal by Subject|0|||
150077467|NCT04457336|541424402|FG007|Period 4: Part C|Withdrawal by Subject|3|||
150077468|NCT00446251|541424403|FG000|Overall Study|On-study Transplants|2|||
150077469|NCT00446251|541424403|FG000|Overall Study|Rituximab Infusion Reaction|2|||
150077470|NCT00446251|541424403|FG000|Overall Study|Lost to Follow-up|1|||
150077471|NCT01416272|541424408|FG000|Overall Study|Unacceptable distance visual acuity|2|||
150077472|NCT01416272|541424408|FG000|Overall Study|Lost to Follow-up|1|||
150077473|NCT01416272|541424408|FG000|Overall Study|Study related complaints|1|||
150077474|NCT02217878|541424409|FG000|Overall Study|required morphine due to chest pain|1|||
150077475|NCT02217878|541424410|FG001|Overall Study|required morphine due to chest pain|2|||
150077476|NCT02217878|541424409|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
150077477|NCT02217878|541424410|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
150077478|NCT01201785|541424412|FG000|Overall Study|Lost to Follow-up|16|||
150077479|NCT02151110|541424413|FG000|Overall Study|Withdrawal by Subject|0|||
150077480|NCT02151110|541424414|FG001|Overall Study|Withdrawal by Subject|0|||
150077481|NCT02151110|541424415|FG002|Overall Study|Withdrawal by Subject|0|||
150077482|NCT02151110|541424416|FG003|Overall Study|Withdrawal by Subject|0|||
150077483|NCT02151110|541424417|FG004|Overall Study|Withdrawal by Subject|0|||
150077484|NCT02151110|541424418|FG005|Overall Study|Withdrawal by Subject|0|||
150077485|NCT02151110|541424419|FG006|Overall Study|Withdrawal by Subject|0|||
150077486|NCT02151110|541424420|FG007|Overall Study|Withdrawal by Subject|1|||
150077487|NCT02151110|541424413|FG000|Overall Study|Lost to Follow-up|0|||
150077488|NCT02151110|541424414|FG001|Overall Study|Lost to Follow-up|0|||
150077489|NCT02151110|541424415|FG002|Overall Study|Lost to Follow-up|0|||
150077490|NCT02151110|541424416|FG003|Overall Study|Lost to Follow-up|0|||
150077491|NCT02151110|541424417|FG004|Overall Study|Lost to Follow-up|0|||
150077492|NCT02151110|541424418|FG005|Overall Study|Lost to Follow-up|0|||
150077493|NCT02151110|541424419|FG006|Overall Study|Lost to Follow-up|0|||
150077494|NCT02151110|541424420|FG007|Overall Study|Lost to Follow-up|2|||
150077495|NCT01064310|541424421|FG000|Period 1|Adverse Event|7|||
150077496|NCT01064310|541424422|FG001|Period 1|Adverse Event|10|||
150077497|NCT01064310|541424423|FG002|Period 1|Adverse Event|0|||
150077498|NCT01064310|541424421|FG000|Period 1|Physician Decision|1|||
150077499|NCT01064310|541424422|FG001|Period 1|Physician Decision|0|||
150077500|NCT01064310|541424423|FG002|Period 1|Physician Decision|0|||
150077501|NCT01064310|541424421|FG000|Period 1|Withdrawal by Subject|2|||
150077502|NCT01064310|541424422|FG001|Period 1|Withdrawal by Subject|2|||
150077503|NCT01064310|541424423|FG002|Period 1|Withdrawal by Subject|0|||
150077504|NCT01064310|541424421|FG000|Period 1|Lack of Efficacy|3|||
150077505|NCT01064310|541424422|FG001|Period 1|Lack of Efficacy|5|||
150077506|NCT01064310|541424423|FG002|Period 1|Lack of Efficacy|0|||
150077507|NCT01064310|541424421|FG000|Period 1|Entered Open-label Period|1|||
150077508|NCT01064310|541424422|FG001|Period 1|Entered Open-label Period|1|||
150077509|NCT01064310|541424423|FG002|Period 1|Entered Open-label Period|0|||
150077510|NCT01064310|541424421|FG000|Period 2|Adverse Event|2|||
150077511|NCT01064310|541424422|FG001|Period 2|Adverse Event|1|||
150077512|NCT01064310|541424423|FG002|Period 2|Adverse Event|0|||
150077513|NCT01064310|541424421|FG000|Period 2|Physician Decision|0|||
150077514|NCT01064310|541424422|FG001|Period 2|Physician Decision|1|||
150077515|NCT01064310|541424423|FG002|Period 2|Physician Decision|0|||
150077516|NCT01064310|541424421|FG000|Period 2|Entered Open-label Period|1|||
150077517|NCT01064310|541424422|FG001|Period 2|Entered Open-label Period|0|||
150077518|NCT01064310|541424423|FG002|Period 2|Entered Open-label Period|0|||
150077519|NCT01064310|541424421|FG000|Period 2|Lack of Efficacy|1|||
150077520|NCT01064310|541424422|FG001|Period 2|Lack of Efficacy|4|||
150077521|NCT01064310|541424423|FG002|Period 2|Lack of Efficacy|0|||
150077522|NCT01064310|541424421|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
150077523|NCT01064310|541424422|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
150077524|NCT01064310|541424423|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
150077525|NCT01064310|541424421|FG000|Open Label Pazopinib|Adverse Event|0|||
150182563|NCT00774852|541804769|FG000|Overall Study|Subject received prohibited medication|1|||
150182564|NCT00774852|541804770|FG001|Overall Study|Subject received prohibited medication|0|||
150077526|NCT01064310|541424422|FG001|Open Label Pazopinib|Adverse Event|0|||
150077527|NCT01064310|541424423|FG002|Open Label Pazopinib|Adverse Event|12|||
150077528|NCT01064310|541424421|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
150077529|NCT01064310|541424422|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
150077530|NCT01064310|541424423|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
150077531|NCT01064310|541424421|FG000|Open Label Pazopinib|Physician Decision|0|||
150077532|NCT01064310|541424422|FG001|Open Label Pazopinib|Physician Decision|0|||
150077533|NCT01064310|541424423|FG002|Open Label Pazopinib|Physician Decision|20|||
150077534|NCT00001880|541424424|FG000|Overall Study|Death|14|||
150077535|NCT02639065|541424425|FG000|Study Treatment|Disease Progression|13|||
150255187|NCT00037830|542070587|FG000|Overall Study|Withdrawal by Subject|4|||
150077536|NCT02639065|541424425|FG000|Study Treatment|Adverse Event|9|||
150077537|NCT02639065|541424425|FG000|Study Treatment|Withdrawal by Subject|1|||
150077538|NCT02639065|541424425|FG000|Follow up|Subject refused to follow up|1|||
150077539|NCT02639065|541424425|FG000|Follow up|Symptomatic Deterioration|2|||
150077540|NCT02639065|541424425|FG000|Follow up|Death|2|||
150077541|NCT02639065|541424425|FG000|Follow up|Study Terminated|1|||
150077542|NCT02639065|541424425|FG000|Follow up|Disease Progression|3|||
150077543|NCT00481078|541424426|FG000|Overall Study|Progression of disease|11|||
150077544|NCT00481078|541424427|FG001|Overall Study|Progression of disease|11|||
150077545|NCT00481078|541424426|FG000|Overall Study|Adverse Event|15|||
150077546|NCT00481078|541424427|FG001|Overall Study|Adverse Event|3|||
150077547|NCT00481078|541424426|FG000|Overall Study|Death|5|||
150077548|NCT00481078|541424427|FG001|Overall Study|Death|3|||
150077549|NCT00481078|541424426|FG000|Overall Study|Intercurrent illness|1|||
150077550|NCT00481078|541424427|FG001|Overall Study|Intercurrent illness|0|||
150077551|NCT00481078|541424426|FG000|Overall Study|Withdrawal by Subject|7|||
150077552|NCT00481078|541424427|FG001|Overall Study|Withdrawal by Subject|1|||
150077553|NCT00481078|541424426|FG000|Overall Study|Information not available|1|||
150077554|NCT00481078|541424427|FG001|Overall Study|Information not available|0|||
150077555|NCT00481078|541424426|FG000|Overall Study|Received other treatment|2|||
150077556|NCT00481078|541424427|FG001|Overall Study|Received other treatment|1|||
150077557|NCT00481078|541424426|FG000|Overall Study|Brain metastasis|0|||
150077558|NCT00481078|541424427|FG001|Overall Study|Brain metastasis|1|||
150077559|NCT00873015|541424430|FG000|Overall Study|Withdrawal by Subject|0|||
150077560|NCT00873015|541424431|FG001|Overall Study|Withdrawal by Subject|1|||
150077561|NCT00873015|541424432|FG002|Overall Study|Withdrawal by Subject|0|||
150077562|NCT00873015|541424433|FG003|Overall Study|Withdrawal by Subject|0|||
150077563|NCT03128411|541424434|FG000|Treatment Phase|Adverse Event|21|||
150077564|NCT03128411|541424434|FG000|Treatment Phase|Physician Decision|1|||
150077565|NCT03128411|541424434|FG000|Treatment Phase|Other|2|||
150077566|NCT03128411|541424434|FG000|Long Term Follow-up Phase|Death|2|||
150077567|NCT00345839|541424435|FG000|Overall Study|Withdrawal by Subject|91|||
150077568|NCT00345839|541424436|FG001|Overall Study|Withdrawal by Subject|98|||
150077569|NCT00345839|541424435|FG000|Overall Study|Lost to Follow-up|58|||
150077570|NCT00345839|541424436|FG001|Overall Study|Lost to Follow-up|61|||
150077571|NCT03749447|541426175|FG000|Overall Study|Adverse Event|11|||
150077572|NCT03749447|541426176|FG001|Overall Study|Adverse Event|3|||
150077573|NCT03749447|541426175|FG000|Overall Study|Death|1|||
150077574|NCT03749447|541426176|FG001|Overall Study|Death|1|||
150077575|NCT03749447|541426175|FG000|Overall Study|Lost to Follow-up|2|||
150077576|NCT03749447|541426176|FG001|Overall Study|Lost to Follow-up|2|||
150077577|NCT03749447|541426175|FG000|Overall Study|Reason Not Specified|0|||
150077578|NCT03749447|541426176|FG001|Overall Study|Reason Not Specified|3|||
150077579|NCT03749447|541426175|FG000|Overall Study|Physician Decision|4|||
150077580|NCT03749447|541426176|FG001|Overall Study|Physician Decision|3|||
150077581|NCT03749447|541426175|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
150077582|NCT03749447|541426176|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
150077583|NCT03749447|541426175|FG000|Overall Study|Study Terminated By Sponsor|112|||
150077584|NCT03749447|541426176|FG001|Overall Study|Study Terminated By Sponsor|105|||
150077585|NCT03749447|541426175|FG000|Overall Study|Withdrawal by Subject|12|||
150077586|NCT03749447|541426176|FG001|Overall Study|Withdrawal by Subject|6|||
150077587|NCT03749447|541426175|FG000|Overall Study|Non-compliance With Study Drug|0|||
150077588|NCT03749447|541426176|FG001|Overall Study|Non-compliance With Study Drug|1|||
150077589|NCT00259649|541426177|FG000|Overall Study|Lost to Follow-up|7|||
150077590|NCT00259649|541426177|FG000|Overall Study|irregular menses|3|||
150077591|NCT01433991|541426178|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
150077592|NCT01433991|541426179|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
150077593|NCT01433991|541426180|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
150077594|NCT01433991|541426181|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
150077595|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
150077596|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
150077597|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
150077598|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
150077599|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
150077600|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
150077601|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
150077602|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
150077603|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
150077604|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
150077605|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
150077606|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
150077607|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
150182565|NCT04428112|541804771|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
150182566|NCT04428112|541804772|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
150077608|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
150077609|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
150077610|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
150077611|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
150077612|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
150077613|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
150077614|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
150077615|NCT01433991|541426178|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
150077616|NCT01433991|541426179|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
150077617|NCT01433991|541426180|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
150077618|NCT01433991|541426181|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
150077619|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
150077620|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
150077621|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
150077622|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
150077623|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
150077624|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
150077625|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
150077626|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
150077627|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
150077628|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
150077629|NCT00787891|541426182|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
150077630|NCT00787891|541426183|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
150077631|NCT00787891|541426182|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
150077632|NCT00787891|541426183|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
150077633|NCT00787891|541426182|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
150077634|NCT00787891|541426183|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
150077635|NCT00787891|541426182|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
150077636|NCT00787891|541426183|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
150077637|NCT00787891|541426182|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
150077638|NCT00787891|541426183|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
150077639|NCT03486223|541426188|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
150077640|NCT03486223|541426189|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
150077641|NCT01819831|541426190|FG000|Overall Study|Withdrawal by Subject|1|||
150077642|NCT02034110|541426191|FG000|Overall Study|Physician Decision|0|||
150077643|NCT02034110|541426192|FG001|Overall Study|Physician Decision|0|||
150077644|NCT02034110|541426193|FG002|Overall Study|Physician Decision|0|||
150077645|NCT02034110|541426194|FG003|Overall Study|Physician Decision|0|||
150077646|NCT02034110|541426195|FG004|Overall Study|Physician Decision|2|||
150077647|NCT02034110|541426196|FG005|Overall Study|Physician Decision|0|||
150077648|NCT02034110|541426197|FG006|Overall Study|Physician Decision|1|||
150077649|NCT02034110|541426198|FG007|Overall Study|Physician Decision|0|||
150077650|NCT02034110|541426191|FG000|Overall Study|Lost to Follow-up|1|||
150077651|NCT02034110|541426192|FG001|Overall Study|Lost to Follow-up|0|||
150077652|NCT02034110|541426193|FG002|Overall Study|Lost to Follow-up|0|||
150077653|NCT02034110|541426194|FG003|Overall Study|Lost to Follow-up|0|||
150077654|NCT02034110|541426195|FG004|Overall Study|Lost to Follow-up|1|||
150077655|NCT02034110|541426196|FG005|Overall Study|Lost to Follow-up|0|||
150077656|NCT02034110|541426197|FG006|Overall Study|Lost to Follow-up|1|||
150077657|NCT02034110|541426198|FG007|Overall Study|Lost to Follow-up|0|||
150077658|NCT02034110|541426191|FG000|Overall Study|Withdrawal by Subject|5|||
150077659|NCT02034110|541426192|FG001|Overall Study|Withdrawal by Subject|7|||
150077660|NCT02034110|541426193|FG002|Overall Study|Withdrawal by Subject|0|||
150077661|NCT02034110|541426194|FG003|Overall Study|Withdrawal by Subject|3|||
150077662|NCT02034110|541426195|FG004|Overall Study|Withdrawal by Subject|7|||
150077663|NCT02034110|541426196|FG005|Overall Study|Withdrawal by Subject|0|||
150077664|NCT02034110|541426197|FG006|Overall Study|Withdrawal by Subject|3|||
150077665|NCT02034110|541426198|FG007|Overall Study|Withdrawal by Subject|1|||
150077666|NCT02034110|541426191|FG000|Overall Study|Study closed by sponsor|6|||
150077667|NCT02034110|541426192|FG001|Overall Study|Study closed by sponsor|2|||
150077668|NCT02034110|541426193|FG002|Overall Study|Study closed by sponsor|0|||
150077669|NCT02034110|541426194|FG003|Overall Study|Study closed by sponsor|6|||
150077670|NCT02034110|541426195|FG004|Overall Study|Study closed by sponsor|7|||
150077671|NCT02034110|541426196|FG005|Overall Study|Study closed by sponsor|0|||
150077672|NCT02034110|541426197|FG006|Overall Study|Study closed by sponsor|42|||
150077673|NCT02034110|541426198|FG007|Overall Study|Study closed by sponsor|0|||
150077674|NCT02587234|541426199|FG000|Overall Study|Withdrawal by Subject|1|||
150077675|NCT02587234|541426200|FG001|Overall Study|Withdrawal by Subject|1|||
150255188|NCT00037830|542070588|FG001|Overall Study|Withdrawal by Subject|5|||
150255189|NCT00037830|542070589|FG002|Overall Study|Withdrawal by Subject|1|||
150255190|NCT00037830|542070587|FG000|Overall Study|Protocol Violation|2|||
150255191|NCT00037830|542070588|FG001|Overall Study|Protocol Violation|2|||
150255192|NCT00037830|542070589|FG002|Overall Study|Protocol Violation|0|||
150255193|NCT00037830|542070587|FG000|Overall Study|Unrelated Medical Problem|2|||
150255194|NCT00037830|542070588|FG001|Overall Study|Unrelated Medical Problem|0|||
150255195|NCT00037830|542070589|FG002|Overall Study|Unrelated Medical Problem|0|||
150182567|NCT04428112|541804771|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
150182568|NCT04428112|541804772|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
150182569|NCT04428112|541804771|FG000|Overall Study|Withdrawal by Subject|9|||
150182570|NCT04428112|541804772|FG001|Overall Study|Withdrawal by Subject|4|||
150182571|NCT04428112|541804771|FG000|Overall Study|Lost to Follow-up|27|||
150182572|NCT04428112|541804772|FG001|Overall Study|Lost to Follow-up|7|||
150182573|NCT02807779|541804774|FG000|Overall Study|Lost to Follow-up|1|||
150182574|NCT02807779|541804775|FG001|Overall Study|Lost to Follow-up|0|||
150182575|NCT02807779|541804776|FG002|Overall Study|Lost to Follow-up|0|||
150182576|NCT02807779|541804774|FG000|Overall Study|Physician Decision|2|||
150182577|NCT02807779|541804775|FG001|Overall Study|Physician Decision|0|||
150182578|NCT02807779|541804776|FG002|Overall Study|Physician Decision|1|||
150077676|NCT02587234|541426199|FG000|Overall Study|Lost to Follow-up|0|||
150077677|NCT02587234|541426200|FG001|Overall Study|Lost to Follow-up|2|||
150077678|NCT01877265|541426201|FG000|Treatment Period 1|Sponsor Decision|0|||
150077679|NCT01877265|541426202|FG001|Treatment Period 1|Sponsor Decision|0|||
150077680|NCT01877265|541426203|FG002|Treatment Period 1|Sponsor Decision|1|||
150077681|NCT01877265|541426204|FG003|Treatment Period 1|Sponsor Decision|0|||
150077682|NCT01877265|541426205|FG004|Treatment Period 1|Sponsor Decision|0|||
150077683|NCT01877265|541426206|FG005|Treatment Period 1|Sponsor Decision|0|||
150077684|NCT01877265|541426201|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
150077685|NCT01877265|541426202|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
150077686|NCT01877265|541426203|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
150077687|NCT01877265|541426204|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
150077688|NCT01877265|541426205|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
150077689|NCT01877265|541426206|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
150077690|NCT01877265|541426201|FG000|Treatment Period 3|Lost to Follow-up|1|||
150077691|NCT01877265|541426202|FG001|Treatment Period 3|Lost to Follow-up|0|||
150077692|NCT01877265|541426203|FG002|Treatment Period 3|Lost to Follow-up|0|||
150077693|NCT01877265|541426204|FG003|Treatment Period 3|Lost to Follow-up|0|||
150077694|NCT01877265|541426205|FG004|Treatment Period 3|Lost to Follow-up|0|||
150077695|NCT01877265|541426206|FG005|Treatment Period 3|Lost to Follow-up|0|||
150077696|NCT00590720|541426212|FG000|Overall Study|Lost to Follow-up|1|||
150077697|NCT00590720|541426213|FG001|Overall Study|Lost to Follow-up|0|||
150077698|NCT00590720|541426212|FG000|Overall Study|Withdrawal by Subject|0|||
150077699|NCT00590720|541426213|FG001|Overall Study|Withdrawal by Subject|1|||
150077700|NCT03039283|541426215|FG000|Overall Study|Protocol Violation|2|||
150077701|NCT01056653|541426216|FG000|Overall Study|Lost to Follow-up|0|||
150077702|NCT01056653|541426217|FG001|Overall Study|Lost to Follow-up|0|||
150077703|NCT01056653|541426218|FG002|Overall Study|Lost to Follow-up|2|||
150077704|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
150077705|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
150077706|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
150077707|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
150077708|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077709|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077710|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077711|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077712|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077713|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077714|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
150077715|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
150077716|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
150077717|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
150077718|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
150077719|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150077720|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150182579|NCT02807779|541804774|FG000|Overall Study|Death|1|||
150077721|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150077722|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150182580|NCT02807779|541804775|FG001|Overall Study|Death|1|||
150077723|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150077724|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150077725|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
150077726|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
150077727|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
150077728|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
150077729|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
150077730|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077731|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077732|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077733|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077734|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077735|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077736|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
150077737|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077738|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077739|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077740|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
150077741|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077742|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077743|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077744|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077745|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077746|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077747|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
150077748|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
150077749|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
150077750|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
150077751|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
150077752|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077753|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077754|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077755|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077756|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077757|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077758|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
150077759|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
150077760|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
150077761|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
150077762|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
150077763|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077764|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077765|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077766|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077767|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077768|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077769|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
150077770|NCT01847274|541426219|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
150077771|NCT01847274|541426220|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
150077772|NCT01847274|541426221|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
150077773|NCT01847274|541426222|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
150077774|NCT01847274|541426223|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077775|NCT01847274|541426224|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077776|NCT01847274|541426225|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077777|NCT01847274|541426226|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077778|NCT01847274|541426227|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077779|NCT01847274|541426228|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077780|NCT01847274|541426229|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
150077781|NCT01847274|541426219|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077782|NCT01847274|541426220|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077783|NCT01847274|541426221|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077784|NCT01847274|541426222|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077785|NCT01847274|541426223|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077786|NCT01847274|541426224|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
150077787|NCT01847274|541426225|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077788|NCT01847274|541426226|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077789|NCT01847274|541426227|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077790|NCT01847274|541426228|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077791|NCT01847274|541426229|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
150077792|NCT01847274|541426219|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077793|NCT01847274|541426220|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077794|NCT01847274|541426221|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077795|NCT01847274|541426222|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077796|NCT01847274|541426223|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
150077797|NCT01847274|541426224|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077798|NCT01847274|541426225|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077799|NCT01847274|541426226|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077800|NCT01847274|541426227|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077801|NCT01847274|541426228|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077802|NCT01847274|541426229|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
150077803|NCT01847274|541426219|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077804|NCT01847274|541426220|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077805|NCT01847274|541426221|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077806|NCT01847274|541426222|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077807|NCT01847274|541426223|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077808|NCT01847274|541426224|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077809|NCT01847274|541426225|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
150077810|NCT01847274|541426226|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077811|NCT01847274|541426227|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077812|NCT01847274|541426228|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077813|NCT01847274|541426229|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
150077814|NCT01847274|541426219|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077815|NCT01847274|541426220|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077816|NCT01847274|541426221|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077817|NCT01847274|541426222|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077818|NCT01847274|541426223|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077819|NCT01847274|541426224|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077820|NCT01847274|541426225|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
150077821|NCT01847274|541426226|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077822|NCT01847274|541426227|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077823|NCT01847274|541426228|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077824|NCT01847274|541426229|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
150077825|NCT01847274|541426219|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077826|NCT01847274|541426220|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077827|NCT01847274|541426221|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077828|NCT01847274|541426222|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077829|NCT01847274|541426223|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077830|NCT01847274|541426224|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077831|NCT01847274|541426225|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
150077832|NCT01847274|541426226|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077833|NCT01847274|541426227|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077834|NCT01847274|541426228|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077835|NCT01847274|541426229|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
150077836|NCT01847274|541426219|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077837|NCT01847274|541426220|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077838|NCT01847274|541426221|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077839|NCT01847274|541426222|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077840|NCT01847274|541426223|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077841|NCT01847274|541426224|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077842|NCT01847274|541426225|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
150077843|NCT01847274|541426226|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
150077844|NCT01847274|541426227|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
150077845|NCT01847274|541426228|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
150077846|NCT01847274|541426229|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
150077847|NCT01847274|541426219|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077848|NCT01847274|541426220|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077849|NCT01847274|541426221|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077850|NCT01847274|541426222|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077851|NCT01847274|541426223|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077852|NCT01847274|541426224|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077853|NCT01847274|541426225|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077854|NCT01847274|541426226|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
150077855|NCT01847274|541426227|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077856|NCT01847274|541426228|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
150077857|NCT01847274|541426229|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
150077858|NCT01847274|541426219|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077859|NCT01847274|541426220|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077860|NCT01847274|541426221|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077861|NCT01847274|541426222|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077862|NCT01847274|541426223|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077863|NCT01847274|541426224|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077864|NCT01847274|541426225|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077865|NCT01847274|541426226|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
150077866|NCT01847274|541426227|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
150077867|NCT01847274|541426228|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
150077868|NCT01847274|541426229|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
150077869|NCT01847274|541426219|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077870|NCT01847274|541426220|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077871|NCT01847274|541426221|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077872|NCT01847274|541426222|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077873|NCT01847274|541426223|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077874|NCT01847274|541426224|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077875|NCT01847274|541426225|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077876|NCT01847274|541426226|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077877|NCT01847274|541426227|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077878|NCT01847274|541426228|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
150077879|NCT01847274|541426229|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
150077880|NCT01081678|541426232|FG000|Overall Study|Ineligibility Determined|0|||
150077881|NCT01081678|541426233|FG001|Overall Study|Ineligibility Determined|0|||
150077882|NCT01081678|541426234|FG002|Overall Study|Ineligibility Determined|1|||
150077883|NCT01081678|541426235|FG003|Overall Study|Ineligibility Determined|1|||
150077884|NCT01081678|541426232|FG000|Overall Study|Noncompliance|3|||
150077885|NCT01081678|541426233|FG001|Overall Study|Noncompliance|4|||
150077886|NCT01081678|541426234|FG002|Overall Study|Noncompliance|5|||
150077887|NCT01081678|541426235|FG003|Overall Study|Noncompliance|2|||
150077888|NCT01081678|541426232|FG000|Overall Study|Adverse Event|2|||
150077889|NCT01081678|541426233|FG001|Overall Study|Adverse Event|1|||
150077890|NCT01081678|541426234|FG002|Overall Study|Adverse Event|2|||
150077891|NCT01081678|541426235|FG003|Overall Study|Adverse Event|2|||
150077892|NCT01081678|541426232|FG000|Overall Study|Withdrawal by Subject|15|||
150077893|NCT01081678|541426233|FG001|Overall Study|Withdrawal by Subject|7|||
150077894|NCT01081678|541426234|FG002|Overall Study|Withdrawal by Subject|17|||
150077895|NCT01081678|541426235|FG003|Overall Study|Withdrawal by Subject|14|||
150077896|NCT01081678|541426232|FG000|Overall Study|Administrative Decision|1|||
150077897|NCT01081678|541426233|FG001|Overall Study|Administrative Decision|0|||
150077898|NCT01081678|541426234|FG002|Overall Study|Administrative Decision|0|||
150077899|NCT01081678|541426235|FG003|Overall Study|Administrative Decision|1|||
150077900|NCT01081678|541426232|FG000|Overall Study|Lost to Follow-up|4|||
150077901|NCT01081678|541426233|FG001|Overall Study|Lost to Follow-up|1|||
150077902|NCT01081678|541426234|FG002|Overall Study|Lost to Follow-up|4|||
150182581|NCT02807779|541804776|FG002|Overall Study|Death|0|||
150077903|NCT01081678|541426235|FG003|Overall Study|Lost to Follow-up|3|||
150077904|NCT01081678|541426232|FG000|Overall Study|Death|2|||
150077905|NCT01081678|541426233|FG001|Overall Study|Death|2|||
150077906|NCT01081678|541426234|FG002|Overall Study|Death|2|||
150077907|NCT01081678|541426235|FG003|Overall Study|Death|6|||
150077908|NCT01081678|541426232|FG000|Overall Study|Other|0|||
150077909|NCT01081678|541426233|FG001|Overall Study|Other|1|||
150077910|NCT01081678|541426234|FG002|Overall Study|Other|0|||
150077911|NCT01081678|541426235|FG003|Overall Study|Other|0|||
150077912|NCT01619423|541426241|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
150077913|NCT01619423|541426242|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
150077914|NCT01619423|541426243|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
150077915|NCT01619423|541426244|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
150077916|NCT01281865|541426245|FG000|Overall Study|Adverse Event|1|||
150077917|NCT01281865|541426246|FG001|Overall Study|Adverse Event|1|||
150077918|NCT01281865|541426245|FG000|Overall Study|Withdrawal by Subject|1|||
150077919|NCT01281865|541426246|FG001|Overall Study|Withdrawal by Subject|0|||
150077920|NCT01281865|541426245|FG000|Overall Study|Lack of Efficacy|1|||
150077921|NCT01281865|541426246|FG001|Overall Study|Lack of Efficacy|0|||
150077922|NCT03478657|541426248|FG000|Overall Study|Withdrawal by Subject|0|||
150077923|NCT03478657|541426249|FG001|Overall Study|Withdrawal by Subject|1|||
150077924|NCT02590003|541426250|FG000|Overall Study|Death|1|||
150077925|NCT02590003|541426251|FG001|Overall Study|Death|2|||
150077926|NCT03733470|541426254|FG000|Overall Study|PI Decision|1|||
150077927|NCT03733470|541426255|FG001|Overall Study|PI Decision|1|||
150077928|NCT01786668|541426256|FG000|Overall Study|Adverse Event|0|||
150077929|NCT01786668|541426257|FG001|Overall Study|Adverse Event|1|||
150077930|NCT01786668|541426258|FG002|Overall Study|Adverse Event|1|||
150077931|NCT01786668|541426259|FG003|Overall Study|Adverse Event|2|||
150077932|NCT01786668|541426256|FG000|Overall Study|Withdrawal by Subject|0|||
150077933|NCT01786668|541426257|FG001|Overall Study|Withdrawal by Subject|0|||
150077934|NCT01786668|541426258|FG002|Overall Study|Withdrawal by Subject|3|||
150077935|NCT01786668|541426259|FG003|Overall Study|Withdrawal by Subject|1|||
150077936|NCT01786668|541426256|FG000|Overall Study|Pregnancy|0|||
150077937|NCT01786668|541426257|FG001|Overall Study|Pregnancy|0|||
150077938|NCT01786668|541426258|FG002|Overall Study|Pregnancy|0|||
150077939|NCT01786668|541426259|FG003|Overall Study|Pregnancy|1|||
150077940|NCT01786668|541426256|FG000|Overall Study|Lost to Follow-up|1|||
150077941|NCT01786668|541426257|FG001|Overall Study|Lost to Follow-up|0|||
150182582|NCT06024174|541804777|FG000|Overall Study|Other Reasons|1|||
150182583|NCT06024174|541804777|FG000|Overall Study|Study terminated by Sponsor|4|||
150182584|NCT03725722|541806423|FG000|Overall Study|Lack of Efficacy|2|||
150182585|NCT03725722|541806424|FG001|Overall Study|Lack of Efficacy|1|||
150182586|NCT03725722|541806425|FG002|Overall Study|Lack of Efficacy|2|||
150182587|NCT03725722|541806426|FG003|Overall Study|Lack of Efficacy|0|||
150182588|NCT03725722|541806427|FG004|Overall Study|Lack of Efficacy|2|||
150182589|NCT03725722|541806423|FG000|Overall Study|Adverse Event|2|||
150182590|NCT03725722|541806424|FG001|Overall Study|Adverse Event|2|||
150182591|NCT03725722|541806425|FG002|Overall Study|Adverse Event|1|||
150182592|NCT03725722|541806426|FG003|Overall Study|Adverse Event|0|||
150182593|NCT03725722|541806427|FG004|Overall Study|Adverse Event|6|||
150182594|NCT03725722|541806423|FG000|Overall Study|Withdrawal by Subject|4|||
150182595|NCT03725722|541806424|FG001|Overall Study|Withdrawal by Subject|1|||
150182596|NCT03725722|541806425|FG002|Overall Study|Withdrawal by Subject|0|||
150182597|NCT03725722|541806426|FG003|Overall Study|Withdrawal by Subject|4|||
150182598|NCT03725722|541806427|FG004|Overall Study|Withdrawal by Subject|4|||
150182599|NCT03725722|541806423|FG000|Overall Study|Lost to Follow-up|3|||
150182600|NCT03725722|541806424|FG001|Overall Study|Lost to Follow-up|1|||
150182601|NCT03725722|541806425|FG002|Overall Study|Lost to Follow-up|2|||
150182602|NCT03725722|541806426|FG003|Overall Study|Lost to Follow-up|2|||
150182603|NCT03725722|541806427|FG004|Overall Study|Lost to Follow-up|1|||
150182604|NCT03725722|541806423|FG000|Overall Study|Personal reasons|0|||
150182605|NCT03725722|541806424|FG001|Overall Study|Personal reasons|0|||
150182606|NCT03725722|541806425|FG002|Overall Study|Personal reasons|1|||
150182607|NCT03725722|541806426|FG003|Overall Study|Personal reasons|0|||
150182608|NCT03725722|541806427|FG004|Overall Study|Personal reasons|1|||
150077942|NCT01786668|541426258|FG002|Overall Study|Lost to Follow-up|1|||
150077943|NCT01786668|541426259|FG003|Overall Study|Lost to Follow-up|0|||
150077944|NCT04891978|541426260|FG000|Baseline|Protocol Violation|2|||
150077945|NCT04891978|541426261|FG001|Baseline|Protocol Violation|1|||
150077946|NCT04891978|541426262|FG002|Baseline|Protocol Violation|0|||
150077947|NCT04891978|541426260|FG000|Baseline|Missing AIRQ|1|||
150077948|NCT04891978|541426261|FG001|Baseline|Missing AIRQ|0|||
150182609|NCT03725722|541806423|FG000|Overall Study|COVID-19 situation|0|||
150182610|NCT03725722|541806424|FG001|Overall Study|COVID-19 situation|1|||
150182611|NCT03725722|541806425|FG002|Overall Study|COVID-19 situation|0|||
150182612|NCT03725722|541806426|FG003|Overall Study|COVID-19 situation|0|||
150077949|NCT04891978|541426262|FG002|Baseline|Missing AIRQ|0|||
150077950|NCT04891978|541426260|FG000|Baseline|Did not attend a baseline visit|0|||
150077951|NCT04891978|541426261|FG001|Baseline|Did not attend a baseline visit|0|||
150077952|NCT04891978|541426262|FG002|Baseline|Did not attend a baseline visit|9|||
150077953|NCT03570697|541426263|FG000|Overall Study|Lost to Follow-up|0|||
150182613|NCT03725722|541806427|FG004|Overall Study|COVID-19 situation|0|||
150182614|NCT04038957|541806437|FG000|Overall Study|Withdrawal by Subject|1|||
150077954|NCT03570697|541426264|FG001|Overall Study|Lost to Follow-up|1|||
150077955|NCT03570697|541426263|FG000|Overall Study|Death|2|||
150077956|NCT03570697|541426264|FG001|Overall Study|Death|0|||
150077957|NCT03570697|541426263|FG000|Overall Study|Withdrawal by Subject|4|||
150077958|NCT03570697|541426264|FG001|Overall Study|Withdrawal by Subject|2|||
150077959|NCT01849783|541426265|FG000|Overall Study|Adverse Event|5|||
150077960|NCT01849783|541426265|FG000|Overall Study|Death|2|||
150077961|NCT01849783|541426265|FG000|Overall Study|Physician Decision|1|||
150077962|NCT01849783|541426265|FG000|Overall Study|Withdrawal by Subject|1|||
150077963|NCT01849783|541426265|FG000|Overall Study|Unable to comply|2|||
150077964|NCT01849783|541426265|FG000|Overall Study|Disease progression|11|||
150077965|NCT03948581|541426266|FG000|Overall Study|Lost to Follow-up|0|||
150077966|NCT03948581|541426267|FG001|Overall Study|Lost to Follow-up|1|||
150077967|NCT03068455|541426270|FG000|Pre-treatment Period|Disease progression|0|||
150077968|NCT03068455|541426271|FG001|Pre-treatment Period|Disease progression|1|||
150077969|NCT03068455|541426270|FG000|Pre-treatment Period|Participant withdrew consent|1|||
150077970|NCT03068455|541426271|FG001|Pre-treatment Period|Participant withdrew consent|1|||
150077971|NCT03068455|541426270|FG000|Pre-treatment Period|Poor/non-compliance|0|||
150077972|NCT03068455|541426271|FG001|Pre-treatment Period|Poor/non-compliance|1|||
150077973|NCT03068455|541426270|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
150077974|NCT03068455|541426271|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
150077975|NCT03068455|541426270|FG000|Pre-treatment Period|Not reported|2|||
150077976|NCT03068455|541426271|FG001|Pre-treatment Period|Not reported|1|||
150077977|NCT03068455|541426270|FG000|Treatment Period|Disease progression|166|||
150077978|NCT03068455|541426271|FG001|Treatment Period|Disease progression|208|||
150077979|NCT03068455|541426270|FG000|Treatment Period|Study drug toxicity|317|||
150077980|NCT03068455|541426271|FG001|Treatment Period|Study drug toxicity|104|||
150077981|NCT03068455|541426270|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
150077982|NCT03068455|541426271|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
150077983|NCT03068455|541426270|FG000|Treatment Period|Participant request to stop therapy|33|||
150077984|NCT03068455|541426271|FG001|Treatment Period|Participant request to stop therapy|20|||
150077985|NCT03068455|541426270|FG000|Treatment Period|Participant withdrew consent|5|||
150077986|NCT03068455|541426271|FG001|Treatment Period|Participant withdrew consent|10|||
150077987|NCT03068455|541426270|FG000|Treatment Period|Poor/non-compliance|3|||
150077988|NCT03068455|541426271|FG001|Treatment Period|Poor/non-compliance|0|||
150077989|NCT03068455|541426270|FG000|Treatment Period|Participant no longer meets study criteria|1|||
150077990|NCT03068455|541426271|FG001|Treatment Period|Participant no longer meets study criteria|3|||
150077991|NCT03068455|541426270|FG000|Treatment Period|Other reasons|12|||
150077992|NCT03068455|541426271|FG001|Treatment Period|Other reasons|4|||
150077993|NCT01876420|541426272|FG000|Overall Study|Missed 30 day visit|1|||
150077994|NCT03173313|541426273|FG000|Overall Study|Lost to Follow-up|2|||
150077995|NCT03173313|541426274|FG001|Overall Study|Lost to Follow-up|3|||
150077996|NCT03173313|541426273|FG000|Overall Study|Withdrawal by Subject|0|||
150077997|NCT03173313|541426274|FG001|Overall Study|Withdrawal by Subject|1|||
150077998|NCT03173313|541426273|FG000|Overall Study|Death|5|||
150077999|NCT03173313|541426274|FG001|Overall Study|Death|0|||
150078000|NCT03173313|541426273|FG000|Overall Study|Physician Decision|1|||
150078001|NCT03173313|541426274|FG001|Overall Study|Physician Decision|0|||
150078002|NCT03173313|541426273|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
150078003|NCT03173313|541426274|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
150078004|NCT03173313|541426273|FG000|Overall Study|Bone Fracture|1|||
150078005|NCT03173313|541426274|FG001|Overall Study|Bone Fracture|0|||
150078006|NCT05338216|541426277|FG000|Overall Study|Withdrawal by Subject|1|||
150078007|NCT05338216|541426278|FG001|Overall Study|Withdrawal by Subject|1|||
150078008|NCT03330288|541426293|FG000|Overall Study|Other reason|1|||
150078009|NCT03330288|541426294|FG001|Overall Study|Other reason|1|||
150078010|NCT03330288|541426293|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
150078011|NCT03330288|541426294|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
150078012|NCT03330288|541426293|FG000|Overall Study|Adverse Event|1|||
150078013|NCT03330288|541426294|FG001|Overall Study|Adverse Event|0|||
150078014|NCT03330288|541426293|FG000|Overall Study|Withdrawal by Subject|1|||
150078015|NCT03330288|541426294|FG001|Overall Study|Withdrawal by Subject|0|||
150078016|NCT03330288|541426293|FG000|Overall Study|Lost to Follow-up|26|||
150078017|NCT03330288|541426294|FG001|Overall Study|Lost to Follow-up|7|||
150078018|NCT04447794|541426295|FG000|Overall Study|Lost to Follow-up|2|||
150078019|NCT04447794|541426296|FG001|Overall Study|Lost to Follow-up|3|||
150078020|NCT04447794|541426297|FG002|Overall Study|Lost to Follow-up|8|||
150078021|NCT04447794|541426295|FG000|Overall Study|Withdrawal by Subject|1|||
150078022|NCT04447794|541426296|FG001|Overall Study|Withdrawal by Subject|1|||
150078023|NCT04447794|541426297|FG002|Overall Study|Withdrawal by Subject|0|||
150078024|NCT01042678|541426298|FG000|Overall Study|Physician Decision|1|||
150078025|NCT01042678|541426299|FG001|Overall Study|Physician Decision|0|||
150078026|NCT01042678|541426300|FG002|Overall Study|Physician Decision|0|||
150078027|NCT01042678|541426301|FG003|Overall Study|Physician Decision|0|||
150078028|NCT01042678|541426302|FG004|Overall Study|Physician Decision|0|||
150078029|NCT01042678|541426303|FG005|Overall Study|Physician Decision|0|||
150078030|NCT00205881|541426306|FG000|Overall Study|Withdrawal by Subject|16|||
150078031|NCT04203498|541426311|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
150078032|NCT04203498|541426312|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
150078033|NCT04203498|541426311|FG000|Overall Study|Withdrawal of patient consent|7|||
150078034|NCT04203498|541426312|FG001|Overall Study|Withdrawal of patient consent|2|||
150078035|NCT04203498|541426311|FG000|Overall Study|Adverse Event|4|||
150078036|NCT04203498|541426312|FG001|Overall Study|Adverse Event|1|||
150078037|NCT04203498|541426311|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
150078038|NCT04203498|541426312|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
150078039|NCT04203498|541426311|FG000|Overall Study|Did not receive IMP|2|||
150078040|NCT04203498|541426312|FG001|Overall Study|Did not receive IMP|0|||
150078041|NCT01235689|541426314|FG000|Overall Study|Adverse Event|12|||
150078042|NCT01235689|541426315|FG001|Overall Study|Adverse Event|16|||
150078043|NCT01235689|541426314|FG000|Overall Study|Lack of Efficacy|12|||
150078044|NCT01235689|541426315|FG001|Overall Study|Lack of Efficacy|5|||
150078045|NCT01235689|541426314|FG000|Overall Study|Withdrawal by Subject|3|||
150078046|NCT01235689|541426315|FG001|Overall Study|Withdrawal by Subject|4|||
150078047|NCT01235689|541426314|FG000|Overall Study|Lost to Follow-up|1|||
150078048|NCT01235689|541426315|FG001|Overall Study|Lost to Follow-up|2|||
150078049|NCT01235689|541426314|FG000|Overall Study|Miscellaneous|1|||
150078050|NCT01235689|541426315|FG001|Overall Study|Miscellaneous|5|||
150078051|NCT01443078|541426316|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
150078052|NCT01443078|541426316|FG000|Overall Study|Withdrawal by Subject|1|||
150078053|NCT01443078|541426316|FG000|Overall Study|Patient had brain mets|1|||
150078054|NCT00005044|541426327|FG000|Overall Study|Protocol Violation|37|||
150078055|NCT00005044|541426328|FG001|Overall Study|Protocol Violation|46|||
150078056|NCT00005044|541426327|FG000|Overall Study|Withdrawal by Subject|1|||
150078057|NCT00005044|541426328|FG001|Overall Study|Withdrawal by Subject|5|||
150078058|NCT00005044|541426327|FG000|Overall Study|No protocol treatment|0|||
150078059|NCT00005044|541426328|FG001|Overall Study|No protocol treatment|1|||
150078060|NCT03546062|541426329|FG000|Overall Study|Adverse Event|6|||
150078061|NCT03546062|541426330|FG001|Overall Study|Adverse Event|5|||
150078062|NCT03546062|541426331|FG002|Overall Study|Adverse Event|8|||
150078063|NCT00181155|541426332|FG000|Overall Study|Physician Decision|1|||
150078064|NCT00181155|541426333|FG001|Overall Study|Physician Decision|0|||
150078065|NCT00181155|541426332|FG000|Overall Study|Withdrawal by Subject|1|||
150078066|NCT00181155|541426333|FG001|Overall Study|Withdrawal by Subject|0|||
150078067|NCT02572401|541426334|FG000|Overall Study|Lost to Follow-up|5|||
150078068|NCT02572401|541426335|FG001|Overall Study|Lost to Follow-up|8|||
150078069|NCT02572401|541426336|FG002|Overall Study|Lost to Follow-up|9|||
150078070|NCT02572401|541426337|FG003|Overall Study|Lost to Follow-up|9|||
150078071|NCT02572401|541426334|FG000|Overall Study|Death|0|||
150078072|NCT02572401|541426335|FG001|Overall Study|Death|0|||
150078073|NCT02572401|541426336|FG002|Overall Study|Death|0|||
150078074|NCT02572401|541426337|FG003|Overall Study|Death|1|||
150078075|NCT01548287|541426338|FG000|Screening|No reason provided|0|||
150078076|NCT01548287|541426339|FG001|Screening|No reason provided|0|||
150078077|NCT01548287|541426340|FG002|Screening|No reason provided|0|||
150078078|NCT01548287|541426341|FG003|Screening|No reason provided|0|||
150078079|NCT01548287|541426342|FG004|Screening|No reason provided|9|||
150078080|NCT01548287|541426338|FG000|Screening|Did not meet eligibility criteria|0|||
150078081|NCT01548287|541426339|FG001|Screening|Did not meet eligibility criteria|0|||
150078082|NCT01548287|541426340|FG002|Screening|Did not meet eligibility criteria|0|||
150078083|NCT01548287|541426341|FG003|Screening|Did not meet eligibility criteria|0|||
150078084|NCT01548287|541426342|FG004|Screening|Did not meet eligibility criteria|74|||
150078085|NCT01548287|541426338|FG000|Randomized Period|Did not meet inclusion criteria|0|||
150078086|NCT01548287|541426339|FG001|Randomized Period|Did not meet inclusion criteria|0|||
150078087|NCT01548287|541426340|FG002|Randomized Period|Did not meet inclusion criteria|2|||
150078088|NCT01548287|541426341|FG003|Randomized Period|Did not meet inclusion criteria|0|||
150078089|NCT01548287|541426342|FG004|Randomized Period|Did not meet inclusion criteria|0|||
150078090|NCT01548287|541426338|FG000|Randomized Period|Adverse Event|0|||
150078091|NCT01548287|541426339|FG001|Randomized Period|Adverse Event|2|||
150078092|NCT01548287|541426340|FG002|Randomized Period|Adverse Event|5|||
150078093|NCT01548287|541426341|FG003|Randomized Period|Adverse Event|0|||
150078094|NCT01548287|541426342|FG004|Randomized Period|Adverse Event|0|||
150078095|NCT00259610|541426347|FG000|Overall Study|Withdrawal by Subject|33|||
150078096|NCT00259610|541426348|FG001|Overall Study|Withdrawal by Subject|25|||
150078097|NCT00259610|541426349|FG002|Overall Study|Withdrawal by Subject|29|||
150078098|NCT00259610|541426350|FG003|Overall Study|Withdrawal by Subject|19|||
150078099|NCT00259610|541426347|FG000|Overall Study|Lost to Follow-up|19|||
150078100|NCT00259610|541426348|FG001|Overall Study|Lost to Follow-up|8|||
150078101|NCT00259610|541426349|FG002|Overall Study|Lost to Follow-up|18|||
150078102|NCT00259610|541426350|FG003|Overall Study|Lost to Follow-up|15|||
150078103|NCT00259610|541426347|FG000|Overall Study|Physician Decision|6|||
150078104|NCT00259610|541426348|FG001|Overall Study|Physician Decision|4|||
150078105|NCT00259610|541426349|FG002|Overall Study|Physician Decision|7|||
150078106|NCT00259610|541426350|FG003|Overall Study|Physician Decision|2|||
150078107|NCT00259610|541426347|FG000|Overall Study|Death|1|||
150078108|NCT00259610|541426348|FG001|Overall Study|Death|1|||
150078109|NCT00259610|541426349|FG002|Overall Study|Death|2|||
150078110|NCT00259610|541426350|FG003|Overall Study|Death|0|||
150078111|NCT00259610|541426347|FG000|Overall Study|non medical reason|6|||
150078112|NCT00259610|541426348|FG001|Overall Study|non medical reason|2|||
150078113|NCT00259610|541426349|FG002|Overall Study|non medical reason|10|||
150078114|NCT00259610|541426350|FG003|Overall Study|non medical reason|3|||
150078115|NCT00259610|541426347|FG000|Overall Study|Adverse Event|3|||
150078116|NCT00259610|541426348|FG001|Overall Study|Adverse Event|4|||
150078117|NCT00259610|541426349|FG002|Overall Study|Adverse Event|5|||
150078118|NCT00259610|541426350|FG003|Overall Study|Adverse Event|2|||
150078119|NCT00259610|541426347|FG000|Overall Study|Serious Adverse Event|8|||
150078120|NCT00259610|541426348|FG001|Overall Study|Serious Adverse Event|2|||
150078121|NCT00259610|541426349|FG002|Overall Study|Serious Adverse Event|2|||
150078122|NCT00259610|541426350|FG003|Overall Study|Serious Adverse Event|2|||
150078123|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
150078124|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
150078125|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
150078126|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
150078127|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
150078128|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
150078129|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
150078130|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
150078131|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078132|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
150078133|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078134|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078135|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078136|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078137|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
150078138|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
150078139|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078140|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078141|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
150078142|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078143|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078144|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078145|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150182615|NCT04038957|541806437|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
150078146|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078147|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Other|0|||
150078148|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Other|0|||
150078149|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Other|1|||
150078150|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Other|1|||
150078151|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Other|2|||
150078152|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Other|0|||
150078153|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Other|0|||
150078154|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Other|0|||
150078155|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078156|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078157|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078158|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078159|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
150078160|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078161|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078162|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
150078163|NCT01090492|541426353|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
150078164|NCT01090492|541426354|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
150078165|NCT01090492|541426355|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
150078166|NCT01090492|541426356|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
150078167|NCT01090492|541426357|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
150078168|NCT01090492|541426358|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
150078169|NCT01090492|541426359|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
150078170|NCT01090492|541426360|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
150078171|NCT01090492|541426353|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
150078172|NCT01090492|541426354|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
150078173|NCT01090492|541426355|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
150078174|NCT01090492|541426356|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
150078175|NCT01090492|541426357|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
150078176|NCT01090492|541426358|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
150078177|NCT01090492|541426359|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
150078178|NCT01090492|541426360|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
150078179|NCT01090492|541426353|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078180|NCT01090492|541426354|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
150078181|NCT01090492|541426355|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078182|NCT01090492|541426356|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078183|NCT01090492|541426357|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078184|NCT01090492|541426358|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078185|NCT01090492|541426359|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078186|NCT01090492|541426360|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
150078187|NCT01090492|541426353|FG000|Second Intervention Period (4 Weeks)|Other|0|||
150078188|NCT01090492|541426354|FG001|Second Intervention Period (4 Weeks)|Other|1|||
150078189|NCT01090492|541426355|FG002|Second Intervention Period (4 Weeks)|Other|1|||
150078190|NCT01090492|541426356|FG003|Second Intervention Period (4 Weeks)|Other|0|||
150078191|NCT01090492|541426357|FG004|Second Intervention Period (4 Weeks)|Other|0|||
150078192|NCT01090492|541426358|FG005|Second Intervention Period (4 Weeks)|Other|0|||
150078193|NCT01090492|541426359|FG006|Second Intervention Period (4 Weeks)|Other|0|||
150078194|NCT01090492|541426360|FG007|Second Intervention Period (4 Weeks)|Other|0|||
150078195|NCT01090492|541426353|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
150078196|NCT01090492|541426354|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
150078197|NCT01090492|541426355|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
150078198|NCT01090492|541426356|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
150078199|NCT01090492|541426357|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
150078200|NCT01090492|541426358|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
150078201|NCT01090492|541426359|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
150078202|NCT01090492|541426360|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
150078203|NCT01090492|541426353|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078204|NCT01090492|541426354|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078205|NCT01090492|541426355|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078206|NCT01090492|541426356|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078207|NCT01090492|541426357|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078208|NCT01090492|541426358|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078209|NCT01090492|541426359|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
150078210|NCT01090492|541426360|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
150078211|NCT01768286|541426361|FG000|Overall Study|Randomized But Not Treated|0|||
150078212|NCT01768286|541426362|FG001|Overall Study|Randomized But Not Treated|0|||
150078213|NCT01768286|541426363|FG002|Overall Study|Randomized But Not Treated|1|||
150078214|NCT01768286|541426364|FG003|Overall Study|Randomized But Not Treated|0|||
150078215|NCT01768286|541426361|FG000|Overall Study|Lack of Efficacy|7|||
150078216|NCT01768286|541426362|FG001|Overall Study|Lack of Efficacy|4|||
150078217|NCT01768286|541426363|FG002|Overall Study|Lack of Efficacy|0|||
150078218|NCT01768286|541426364|FG003|Overall Study|Lack of Efficacy|1|||
150078219|NCT01768286|541426361|FG000|Overall Study|Withdrew Consent|0|||
150078220|NCT01768286|541426362|FG001|Overall Study|Withdrew Consent|0|||
150078221|NCT01768286|541426363|FG002|Overall Study|Withdrew Consent|1|||
150078222|NCT01768286|541426364|FG003|Overall Study|Withdrew Consent|0|||
150078223|NCT02083965|541426365|FG000|Treatment Period|Other|1|||
150078224|NCT02083965|541426366|FG001|Treatment Period|Other|0|||
150078225|NCT00868608|541426368|FG000|Overall Study|Withdrawal by Subject|3|||
150078226|NCT00868608|541426369|FG001|Overall Study|Withdrawal by Subject|1|||
150078227|NCT00868608|541426370|FG002|Overall Study|Withdrawal by Subject|0|||
150078228|NCT00868608|541426368|FG000|Overall Study|Lost to Follow-up|3|||
150078229|NCT00868608|541426369|FG001|Overall Study|Lost to Follow-up|0|||
150078230|NCT00868608|541426370|FG002|Overall Study|Lost to Follow-up|1|||
150078231|NCT00868608|541426368|FG000|Overall Study|Death|16|||
150078232|NCT00868608|541426369|FG001|Overall Study|Death|2|||
150078233|NCT00868608|541426370|FG002|Overall Study|Death|4|||
150078234|NCT00868608|541426368|FG000|Overall Study|Other - Unspecified|1|||
150078235|NCT00868608|541426369|FG001|Overall Study|Other - Unspecified|0|||
150078236|NCT00868608|541426370|FG002|Overall Study|Other - Unspecified|0|||
150078237|NCT00365508|541426371|FG000|Overall Study|Lost to Follow-up|139|||
150078238|NCT00365508|541426372|FG001|Overall Study|Lost to Follow-up|154|||
150078239|NCT02538029|541426374|FG000|Overall Study|unable to complete cognitive assessments|1|||
150078240|NCT02538029|541426375|FG001|Overall Study|unable to complete cognitive assessments|0|||
150078241|NCT02538029|541426376|FG002|Overall Study|unable to complete cognitive assessments|1|||
150078242|NCT01218113|541427886|FG000|Overall Study|Withdrawal by Subject|1|||
150078243|NCT01218113|541427887|FG001|Overall Study|Withdrawal by Subject|0|||
150078244|NCT01218113|541427888|FG002|Overall Study|Withdrawal by Subject|1|||
150078245|NCT01218113|541427886|FG000|Overall Study|Lost to Follow-up|4|||
150078246|NCT01218113|541427887|FG001|Overall Study|Lost to Follow-up|1|||
150078247|NCT01218113|541427888|FG002|Overall Study|Lost to Follow-up|4|||
150078248|NCT01218113|541427886|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
150078249|NCT01218113|541427887|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
150078250|NCT01218113|541427888|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
150078251|NCT00115739|541427889|FG000|Overall Study|Lost to Follow-up|3|||
150078252|NCT00745823|541427893|FG000|Overall Study|Adverse Event|5|||
150078253|NCT00745823|541427894|FG001|Overall Study|Adverse Event|3|||
150078254|NCT00745823|541427893|FG000|Overall Study|Lack of Efficacy|20|||
150078255|NCT00745823|541427894|FG001|Overall Study|Lack of Efficacy|6|||
150078256|NCT00745823|541427893|FG000|Overall Study|Lost to Follow-up|10|||
150078257|NCT00745823|541427894|FG001|Overall Study|Lost to Follow-up|11|||
150078258|NCT00745823|541427893|FG000|Overall Study|Physician Decision|10|||
150078259|NCT00745823|541427894|FG001|Overall Study|Physician Decision|5|||
150078260|NCT00745823|541427893|FG000|Overall Study|Pregnancy|0|||
150078261|NCT00745823|541427894|FG001|Overall Study|Pregnancy|4|||
150078262|NCT00745823|541427893|FG000|Overall Study|Withdrawal by Subject|14|||
150078263|NCT00745823|541427894|FG001|Overall Study|Withdrawal by Subject|8|||
150078264|NCT00745823|541427893|FG000|Overall Study|Study Terminated by Sponsor|326|||
150078265|NCT00745823|541427894|FG001|Overall Study|Study Terminated by Sponsor|349|||
150078266|NCT00290888|541427908|FG000|Overall Study|Physician Decision|3|||
150078267|NCT00290888|541427909|FG001|Overall Study|Physician Decision|1|||
150078268|NCT01513343|541427916|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
150078269|NCT01513343|541427917|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
150078270|NCT01513343|541427916|FG000|Post Data Collection|Dropped/withdrew from study|7|||
150078271|NCT01513343|541427917|FG001|Post Data Collection|Dropped/withdrew from study|1|||
150078272|NCT01513343|541427916|FG000|Post Data Collection|Lost to Follow-up|10|||
150078273|NCT01513343|541427917|FG001|Post Data Collection|Lost to Follow-up|23|||
150078274|NCT01513343|541427916|FG000|6-month Follow-up|Lost to Follow-up|28|||
150078275|NCT01513343|541427917|FG001|6-month Follow-up|Lost to Follow-up|17|||
150078276|NCT01513343|541427916|FG000|12-month Follow-up|Lost to Follow-up|10|||
150078277|NCT01513343|541427917|FG001|12-month Follow-up|Lost to Follow-up|3|||
150078278|NCT01001377|541427929|FG000|Overall Study|Ineligibility determined|2|||
150078279|NCT01001377|541427930|FG001|Overall Study|Ineligibility determined|0|||
150078280|NCT01001377|541427929|FG000|Overall Study|Withdrawal by Subject|19|||
150078281|NCT01001377|541427930|FG001|Overall Study|Withdrawal by Subject|20|||
150078282|NCT01001377|541427929|FG000|Overall Study|Lost to Follow-up|14|||
150078283|NCT01001377|541427930|FG001|Overall Study|Lost to Follow-up|17|||
150078284|NCT01001377|541427929|FG000|Overall Study|Death|391|||
150078285|NCT01001377|541427930|FG001|Overall Study|Death|384|||
150078286|NCT00964860|541427931|FG000|Overall Study|Withdrawal by Subject|0|||
150078287|NCT00964860|541427932|FG001|Overall Study|Withdrawal by Subject|1|||
150078288|NCT00867568|541427933|FG000|Overall Study|Lack of Efficacy|10|||
150078289|NCT00867568|541427933|FG000|Overall Study|Adverse Event|4|||
150078290|NCT00867568|541427933|FG000|Overall Study|Withdrawal by Subject|1|||
150078291|NCT03727230|541427935|FG000|Overall Study|Lost to Follow-up|12|||
150078292|NCT02059395|541427937|FG000|Overall Study|Lost to Follow-up|2|||
150078293|NCT02059395|541427938|FG001|Overall Study|Lost to Follow-up|4|||
150078294|NCT04377620|541427939|FG000|Overall Study|Death|42|||
150078295|NCT04377620|541427940|FG001|Overall Study|Death|48|||
150078296|NCT04377620|541427941|FG002|Overall Study|Death|36|||
150078297|NCT04377620|541427939|FG000|Overall Study|Withdrawal by Subject|0|||
150078298|NCT04377620|541427940|FG001|Overall Study|Withdrawal by Subject|2|||
150078299|NCT04377620|541427941|FG002|Overall Study|Withdrawal by Subject|0|||
150078300|NCT00134082|541427942|FG000|Overall Study|Adverse Event|2|||
150078301|NCT00134082|541427942|FG000|Overall Study|Death|1|||
150078302|NCT00724932|541427943|FG000|Overall Study|Lost to Follow-up|1|||
150078303|NCT00724932|541427944|FG001|Overall Study|Lost to Follow-up|0|||
150078304|NCT00724932|541427943|FG000|Overall Study|Not treated|4|||
150078305|NCT00724932|541427944|FG001|Overall Study|Not treated|3|||
150078306|NCT00289991|541427945|FG000|Overall Study|Death|35|||
150078307|NCT00289991|541427946|FG001|Overall Study|Death|38|||
150078308|NCT00289991|541427945|FG000|Overall Study|Adverse Event|15|||
150078309|NCT00289991|541427946|FG001|Overall Study|Adverse Event|13|||
150078310|NCT00289991|541427945|FG000|Overall Study|Failure of prophylaxis|1|||
150078311|NCT00289991|541427946|FG001|Overall Study|Failure of prophylaxis|1|||
150078312|NCT00289991|541427945|FG000|Overall Study|Fungal breakthrough infection|0|||
150078313|NCT00289991|541427946|FG001|Overall Study|Fungal breakthrough infection|1|||
150078314|NCT00289991|541427945|FG000|Overall Study|Lost to Follow-up|0|||
150078315|NCT00289991|541427946|FG001|Overall Study|Lost to Follow-up|1|||
150078316|NCT00289991|541427945|FG000|Overall Study|Withdrawal by Subject|2|||
150078317|NCT00289991|541427946|FG001|Overall Study|Withdrawal by Subject|12|||
150078318|NCT00289991|541427945|FG000|Overall Study|Other|5|||
150078319|NCT00289991|541427946|FG001|Overall Study|Other|14|||
150078320|NCT00444912|541427962|FG000|Overall Study|Death|1|||
150078321|NCT00444912|541427963|FG001|Overall Study|Death|2|||
150078322|NCT00444912|541427962|FG000|Overall Study|Lost to Follow-up|1|||
150078323|NCT00444912|541427963|FG001|Overall Study|Lost to Follow-up|0|||
150078324|NCT00444912|541427962|FG000|Overall Study|Participant Failed Mobilization|1|||
150078325|NCT00444912|541427963|FG001|Overall Study|Participant Failed Mobilization|0|||
150078326|NCT01606007|541427964|FG000|Overall Study|Reason 'Other' in the protocol|0|||
150078327|NCT01606007|541427965|FG001|Overall Study|Reason 'Other' in the protocol|1|||
150078328|NCT01606007|541427966|FG002|Overall Study|Reason 'Other' in the protocol|1|||
150078329|NCT01606007|541427964|FG000|Overall Study|Pregnancy|0|||
150078330|NCT01606007|541427965|FG001|Overall Study|Pregnancy|1|||
150078331|NCT01606007|541427966|FG002|Overall Study|Pregnancy|1|||
150078332|NCT01606007|541427964|FG000|Overall Study|Withdrawal by Subject|8|||
150078333|NCT01606007|541427965|FG001|Overall Study|Withdrawal by Subject|6|||
150078334|NCT01606007|541427966|FG002|Overall Study|Withdrawal by Subject|1|||
150078335|NCT01606007|541427964|FG000|Overall Study|Adverse Event|0|||
150078336|NCT01606007|541427965|FG001|Overall Study|Adverse Event|1|||
150078337|NCT01606007|541427966|FG002|Overall Study|Adverse Event|1|||
150078338|NCT01606007|541427964|FG000|Overall Study|discontinue study treatment|0|||
150078339|NCT01606007|541427965|FG001|Overall Study|discontinue study treatment|2|||
150078340|NCT01606007|541427966|FG002|Overall Study|discontinue study treatment|1|||
150078341|NCT01606007|541427964|FG000|Overall Study|Lost to Follow-up|6|||
150078342|NCT01606007|541427965|FG001|Overall Study|Lost to Follow-up|8|||
150078343|NCT01606007|541427966|FG002|Overall Study|Lost to Follow-up|5|||
150078344|NCT01606007|541427964|FG000|Overall Study|Poor/Non-compliance|1|||
150078345|NCT01606007|541427965|FG001|Overall Study|Poor/Non-compliance|0|||
150078346|NCT01606007|541427966|FG002|Overall Study|Poor/Non-compliance|0|||
150078347|NCT03758066|541427967|FG000|Overall Study|Lost to Follow-up|14|||
150078348|NCT02340975|541427970|FG000|Overall Study|Death|6|||
150078349|NCT02340975|541427971|FG001|Overall Study|Death|23|||
150078350|NCT02340975|541427972|FG002|Overall Study|Death|21|||
150078351|NCT02340975|541427973|FG003|Overall Study|Death|7|||
150078352|NCT02340975|541427974|FG004|Overall Study|Death|21|||
150078353|NCT02340975|541427975|FG005|Overall Study|Death|13|||
150078354|NCT02340975|541427970|FG000|Overall Study|Lost to Follow-up|0|||
150078355|NCT02340975|541427971|FG001|Overall Study|Lost to Follow-up|0|||
150078356|NCT02340975|541427972|FG002|Overall Study|Lost to Follow-up|0|||
150078357|NCT02340975|541427973|FG003|Overall Study|Lost to Follow-up|0|||
150078358|NCT02340975|541427974|FG004|Overall Study|Lost to Follow-up|2|||
150078359|NCT02340975|541427975|FG005|Overall Study|Lost to Follow-up|0|||
150078360|NCT02340975|541427970|FG000|Overall Study|Withdrawal by Subject|0|||
150078361|NCT02340975|541427971|FG001|Overall Study|Withdrawal by Subject|0|||
150078362|NCT02340975|541427972|FG002|Overall Study|Withdrawal by Subject|3|||
150078363|NCT02340975|541427973|FG003|Overall Study|Withdrawal by Subject|3|||
150078364|NCT02340975|541427974|FG004|Overall Study|Withdrawal by Subject|2|||
150078365|NCT02340975|541427975|FG005|Overall Study|Withdrawal by Subject|0|||
150078366|NCT02340975|541427970|FG000|Overall Study|Other|0|||
150078367|NCT02340975|541427971|FG001|Overall Study|Other|4|||
150078368|NCT02340975|541427972|FG002|Overall Study|Other|0|||
150078369|NCT02340975|541427973|FG003|Overall Study|Other|2|||
150078370|NCT02340975|541427974|FG004|Overall Study|Other|0|||
150078371|NCT02340975|541427975|FG005|Overall Study|Other|6|||
150078372|NCT01007812|541427976|FG000|Period 1, One Week|Lost to Follow-up|0|||
150078373|NCT01007812|541427977|FG001|Period 1, One Week|Lost to Follow-up|1|||
150078374|NCT01007812|541427976|FG000|Period 1, One Week|Discomfort|1|||
150078375|NCT01007812|541427977|FG001|Period 1, One Week|Discomfort|0|||
150078376|NCT01091974|541427980|FG000|Overall Study|Did not start intervention|3|||
150078377|NCT01091974|541427981|FG001|Overall Study|Did not start intervention|1|||
150078378|NCT01091974|541427982|FG002|Overall Study|Did not start intervention|3|||
150078379|NCT01091974|541427983|FG003|Overall Study|Did not start intervention|1|||
150078380|NCT01091974|541427980|FG000|Overall Study|resumed sleep medication|0|||
150078381|NCT01091974|541427981|FG001|Overall Study|resumed sleep medication|0|||
150078382|NCT01091974|541427982|FG002|Overall Study|resumed sleep medication|1|||
150078383|NCT01091974|541427983|FG003|Overall Study|resumed sleep medication|2|||
150078384|NCT01091974|541427980|FG000|Overall Study|Withdrawal by Subject|1|||
150078385|NCT01091974|541427981|FG001|Overall Study|Withdrawal by Subject|3|||
150078386|NCT01091974|541427982|FG002|Overall Study|Withdrawal by Subject|2|||
150078387|NCT01091974|541427983|FG003|Overall Study|Withdrawal by Subject|2|||
150078388|NCT01091974|541427980|FG000|Overall Study|side-effects|1|||
150078389|NCT01091974|541427981|FG001|Overall Study|side-effects|1|||
150078390|NCT01091974|541427982|FG002|Overall Study|side-effects|0|||
150078391|NCT01091974|541427983|FG003|Overall Study|side-effects|2|||
150078392|NCT05379231|541427988|FG000|Home Visit|Withdrawal by Subject|2|||
150078393|NCT05379231|541427988|FG000|In-lab Visit|Withdrawal by Subject|2|||
150078394|NCT01496807|541427992|FG000|Overall Study|Progressive Disease|21|||
150078395|NCT01496807|541427992|FG000|Overall Study|Participant preference/toxicity|8|||
150078396|NCT01496807|541427992|FG000|Overall Study|Change in diagnosis|1|||
150078397|NCT03095612|541427996|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078398|NCT03095612|541427997|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
150078399|NCT03095612|541427998|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078400|NCT03095612|541427999|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078401|NCT03095612|541428000|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078402|NCT03095612|541428001|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078403|NCT03095612|541428002|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
150078404|NCT01390649|541428003|FG000|Overall Study|Physician Decision|1|||
150182616|NCT05656911|541806438|FG000|Treatment Phase|Physician Decision|2|||
150182617|NCT05656911|541806439|FG001|Treatment Phase|Physician Decision|0|||
150182618|NCT05656911|541806438|FG000|Treatment Phase|Lack of Efficacy|6|||
150078405|NCT00389597|541428004|FG000|Overall Study|Lost to Follow-up|8|||
150078406|NCT00389597|541428005|FG001|Overall Study|Lost to Follow-up|6|||
150078407|NCT00389597|541428006|FG002|Overall Study|Lost to Follow-up|4|||
150078408|NCT00389597|541428007|FG003|Overall Study|Lost to Follow-up|6|||
150078409|NCT02762578|541428008|FG000|Overall Study|Adverse Event|1|||
150078410|NCT02762578|541428009|FG001|Overall Study|Adverse Event|6|||
150078411|NCT02762578|541428008|FG000|Overall Study|Protocol Violation|4|||
150078412|NCT02762578|541428009|FG001|Overall Study|Protocol Violation|2|||
150078413|NCT02762578|541428008|FG000|Overall Study|Withdrawal by Subject|4|||
150078414|NCT02762578|541428009|FG001|Overall Study|Withdrawal by Subject|2|||
150078415|NCT02762578|541428008|FG000|Overall Study|Unclassified|6|||
150078416|NCT02762578|541428009|FG001|Overall Study|Unclassified|0|||
150078417|NCT02935842|541428010|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
150078418|NCT02935842|541428011|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
150078419|NCT02935842|541428012|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
150078420|NCT02935842|541428013|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
150078421|NCT02935842|541428010|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
150078422|NCT02935842|541428011|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
150078423|NCT02935842|541428012|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
150078424|NCT02935842|541428013|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
150078425|NCT02935842|541428010|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
150078426|NCT02935842|541428011|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
150078427|NCT02935842|541428012|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
150078428|NCT02935842|541428013|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
150078429|NCT02935842|541428010|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
150078430|NCT02935842|541428011|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
150078431|NCT02935842|541428012|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
150078432|NCT02935842|541428013|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
150078433|NCT02935842|541428010|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
150078434|NCT02935842|541428011|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
150078435|NCT02935842|541428012|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
150078436|NCT02935842|541428013|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
150078437|NCT00911547|541428014|FG000|Overall Study|Adverse Event|8|||
150078438|NCT00911547|541428015|FG001|Overall Study|Adverse Event|27|||
150078439|NCT00911547|541428016|FG002|Overall Study|Adverse Event|11|||
150078440|NCT00911547|541428017|FG003|Overall Study|Adverse Event|6|||
150078441|NCT00911547|541428014|FG000|Overall Study|Lost to Follow-up|0|||
150078442|NCT00911547|541428015|FG001|Overall Study|Lost to Follow-up|0|||
150078443|NCT00911547|541428016|FG002|Overall Study|Lost to Follow-up|2|||
150078444|NCT00911547|541428017|FG003|Overall Study|Lost to Follow-up|1|||
150078445|NCT00911547|541428014|FG000|Overall Study|Protocol Violation|0|||
150078446|NCT00911547|541428015|FG001|Overall Study|Protocol Violation|5|||
150078447|NCT00911547|541428016|FG002|Overall Study|Protocol Violation|5|||
150078448|NCT00911547|541428017|FG003|Overall Study|Protocol Violation|1|||
150078449|NCT00911547|541428014|FG000|Overall Study|Withdrawal by Subject|3|||
150078450|NCT00911547|541428015|FG001|Overall Study|Withdrawal by Subject|10|||
150078451|NCT00911547|541428016|FG002|Overall Study|Withdrawal by Subject|4|||
150078452|NCT00911547|541428017|FG003|Overall Study|Withdrawal by Subject|8|||
150078453|NCT03344796|541428018|FG000|Overall Study|Lost to Follow-up|0|||
150078454|NCT03344796|541428019|FG001|Overall Study|Lost to Follow-up|0|||
150078455|NCT03344796|541428020|FG002|Overall Study|Lost to Follow-up|0|||
150078456|NCT03344796|541428021|FG003|Overall Study|Lost to Follow-up|0|||
150078457|NCT03344796|541428022|FG004|Overall Study|Lost to Follow-up|0|||
150078458|NCT03344796|541428023|FG005|Overall Study|Lost to Follow-up|2|||
150078459|NCT00939770|541428026|FG000|Overall Study|Adverse Event|1|||
150078460|NCT00939770|541428027|FG001|Overall Study|Adverse Event|1|||
150078461|NCT00939770|541428028|FG002|Overall Study|Adverse Event|0|||
150078462|NCT00939770|541428029|FG003|Overall Study|Adverse Event|0|||
150078463|NCT00939770|541428030|FG004|Overall Study|Adverse Event|6|||
150078464|NCT00939770|541428031|FG005|Overall Study|Adverse Event|2|||
150078465|NCT00939770|541428032|FG006|Overall Study|Adverse Event|1|||
150078466|NCT00939770|541428033|FG007|Overall Study|Adverse Event|1|||
150078467|NCT00939770|541428026|FG000|Overall Study|Lack of Efficacy|4|||
150078468|NCT00939770|541428027|FG001|Overall Study|Lack of Efficacy|6|||
150078469|NCT00939770|541428028|FG002|Overall Study|Lack of Efficacy|13|||
150182619|NCT05656911|541806439|FG001|Treatment Phase|Lack of Efficacy|3|||
150078470|NCT00939770|541428029|FG003|Overall Study|Lack of Efficacy|9|||
150078471|NCT00939770|541428030|FG004|Overall Study|Lack of Efficacy|16|||
150078472|NCT00939770|541428031|FG005|Overall Study|Lack of Efficacy|8|||
150078473|NCT00939770|541428032|FG006|Overall Study|Lack of Efficacy|11|||
150078474|NCT00939770|541428033|FG007|Overall Study|Lack of Efficacy|1|||
150078475|NCT00939770|541428026|FG000|Overall Study|Lost to Follow-up|0|||
150078476|NCT00939770|541428027|FG001|Overall Study|Lost to Follow-up|0|||
150078477|NCT00939770|541428028|FG002|Overall Study|Lost to Follow-up|0|||
150078478|NCT00939770|541428029|FG003|Overall Study|Lost to Follow-up|0|||
150078479|NCT00939770|541428030|FG004|Overall Study|Lost to Follow-up|1|||
150078480|NCT00939770|541428031|FG005|Overall Study|Lost to Follow-up|0|||
150078481|NCT00939770|541428032|FG006|Overall Study|Lost to Follow-up|0|||
150078482|NCT00939770|541428033|FG007|Overall Study|Lost to Follow-up|0|||
150078483|NCT00939770|541428026|FG000|Overall Study|Physician Decision|0|||
150078484|NCT00939770|541428027|FG001|Overall Study|Physician Decision|0|||
150078485|NCT00939770|541428028|FG002|Overall Study|Physician Decision|2|||
150078486|NCT00939770|541428029|FG003|Overall Study|Physician Decision|0|||
150078487|NCT00939770|541428030|FG004|Overall Study|Physician Decision|7|||
150078488|NCT00939770|541428031|FG005|Overall Study|Physician Decision|1|||
150078489|NCT00939770|541428032|FG006|Overall Study|Physician Decision|0|||
150078490|NCT00939770|541428033|FG007|Overall Study|Physician Decision|6|||
150078491|NCT00939770|541428026|FG000|Overall Study|Protocol Violation|0|||
150078492|NCT00939770|541428027|FG001|Overall Study|Protocol Violation|0|||
150078493|NCT00939770|541428028|FG002|Overall Study|Protocol Violation|0|||
150078494|NCT00939770|541428029|FG003|Overall Study|Protocol Violation|0|||
150078495|NCT00939770|541428030|FG004|Overall Study|Protocol Violation|1|||
150078496|NCT00939770|541428031|FG005|Overall Study|Protocol Violation|0|||
150078497|NCT00939770|541428032|FG006|Overall Study|Protocol Violation|0|||
150078498|NCT00939770|541428033|FG007|Overall Study|Protocol Violation|0|||
150078499|NCT00939770|541428026|FG000|Overall Study|Withdrawal by Subject|0|||
150078500|NCT00939770|541428027|FG001|Overall Study|Withdrawal by Subject|1|||
150078501|NCT00939770|541428028|FG002|Overall Study|Withdrawal by Subject|5|||
150078502|NCT00939770|541428029|FG003|Overall Study|Withdrawal by Subject|2|||
150078503|NCT00939770|541428030|FG004|Overall Study|Withdrawal by Subject|6|||
150078504|NCT00939770|541428031|FG005|Overall Study|Withdrawal by Subject|0|||
150078505|NCT00939770|541428032|FG006|Overall Study|Withdrawal by Subject|2|||
150078506|NCT00939770|541428033|FG007|Overall Study|Withdrawal by Subject|2|||
150078507|NCT01146665|541428034|FG000|Overall Study|Withdrawal by Subject|10|||
150078508|NCT01146665|541428035|FG001|Overall Study|Withdrawal by Subject|16|||
150078509|NCT00566995|541428042|FG000|Overall Study|Toxicity|4|||
150078510|NCT00566995|541428042|FG000|Overall Study|Withdrew consent|3|||
150078511|NCT00404235|541428043|FG000|Overall Study|Withdrawal by Subject|1|||
150182620|NCT05656911|541806438|FG000|Treatment Phase|Subject Decision|4|||
150182621|NCT05656911|541806439|FG001|Treatment Phase|Subject Decision|2|||
150182622|NCT05656911|541806438|FG000|Treatment Phase|Other Reasons|1|||
150182623|NCT05656911|541806439|FG001|Treatment Phase|Other Reasons|0|||
150182624|NCT05656911|541806438|FG000|Treatment Phase|Adverse Event|3|||
150182625|NCT05656911|541806439|FG001|Treatment Phase|Adverse Event|1|||
150182626|NCT05656911|541806438|FG000|Follow-up Phase|Subject Decision|0|||
150182627|NCT05656911|541806439|FG001|Follow-up Phase|Subject Decision|1|||
150182628|NCT05656911|541806438|FG000|Follow-up Phase|Missing|1|||
150182629|NCT05656911|541806439|FG001|Follow-up Phase|Missing|0|||
150182630|NCT04607044|541806446|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
150182631|NCT04607044|541806446|FG000|Overall Study|Adverse Event|1|||
150182632|NCT04607044|541806446|FG000|Overall Study|Did not receive study device|3|||
150182633|NCT04607044|541806446|FG000|Overall Study|Death|1|||
150182634|NCT05403801|541806447|FG000|Overall Study|Withdrawal by Subject|2|||
150078512|NCT00404235|541428044|FG001|Overall Study|Withdrawal by Subject|2|||
150078513|NCT00688753|541430126|FG000|Overall Study|Disease progression|55|||
150078514|NCT00688753|541430126|FG000|Overall Study|Missing|1|||
150078515|NCT00688753|541430126|FG000|Overall Study|Death|9|||
150078516|NCT00688753|541430126|FG000|Overall Study|Withdrawal by Subject|3|||
150182635|NCT05075408|541806448|FG000|Overall Study|Withdrawal by Subject|5|||
150182636|NCT05075408|541806449|FG001|Overall Study|Withdrawal by Subject|3|||
150182637|NCT05075408|541806450|FG002|Overall Study|Withdrawal by Subject|4|||
150078517|NCT00688753|541430126|FG000|Overall Study|Adverse Event|20|||
150078518|NCT00688753|541430126|FG000|Overall Study|Protocol Violation|1|||
150182638|NCT05075408|541806448|FG000|Overall Study|Adverse Event|5|||
150182639|NCT05075408|541806449|FG001|Overall Study|Adverse Event|7|||
150078519|NCT00688753|541430126|FG000|Overall Study|Lost to Follow-up|3|||
150078520|NCT05996718|541430127|FG000|Overall Study|Lost to Follow-up|3|||
150182640|NCT05075408|541806450|FG002|Overall Study|Adverse Event|8|||
150078521|NCT01713686|541430128|FG000|Overall Study|Lost to Follow-up|9|||
150078522|NCT01713686|541430128|FG000|Overall Study|Withdrawal by Subject|6|||
150078523|NCT03187197|541430132|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
150078524|NCT03187197|541430133|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
150078525|NCT03187197|541430134|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
150078526|NCT03187197|541430132|FG000|Overall Study|Withdrawal by Subject|8|||
150078527|NCT03187197|541430133|FG001|Overall Study|Withdrawal by Subject|63|||
150078528|NCT03187197|541430134|FG002|Overall Study|Withdrawal by Subject|4|||
150078529|NCT03187197|541430132|FG000|Overall Study|Lost to Follow-up|1|||
150078530|NCT03187197|541430133|FG001|Overall Study|Lost to Follow-up|60|||
150078531|NCT03187197|541430134|FG002|Overall Study|Lost to Follow-up|7|||
150078532|NCT03187197|541430132|FG000|Overall Study|Adverse Event|6|||
150078533|NCT03187197|541430133|FG001|Overall Study|Adverse Event|29|||
150078534|NCT03187197|541430134|FG002|Overall Study|Adverse Event|0|||
150078535|NCT03187197|541430132|FG000|Overall Study|Death|0|||
150078536|NCT03187197|541430133|FG001|Overall Study|Death|11|||
150078537|NCT03187197|541430134|FG002|Overall Study|Death|0|||
150078538|NCT03187197|541430132|FG000|Overall Study|Administrative problem|1|||
150078539|NCT03187197|541430133|FG001|Overall Study|Administrative problem|1|||
150078540|NCT03187197|541430134|FG002|Overall Study|Administrative problem|0|||
150078541|NCT03187197|541430132|FG000|Overall Study|Reason not listed|2|||
150078542|NCT03187197|541430133|FG001|Overall Study|Reason not listed|54|||
150078543|NCT03187197|541430134|FG002|Overall Study|Reason not listed|1|||
150078544|NCT03187197|541430132|FG000|Overall Study|Missing|1|||
150078545|NCT03187197|541430133|FG001|Overall Study|Missing|32|||
150078546|NCT03187197|541430134|FG002|Overall Study|Missing|3|||
150078547|NCT03187197|541430132|FG000|Overall Study|Status missing|2|||
150078548|NCT03187197|541430133|FG001|Overall Study|Status missing|33|||
150078549|NCT03187197|541430134|FG002|Overall Study|Status missing|3|||
150078550|NCT03187197|541430132|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
150078551|NCT03187197|541430133|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
150078552|NCT03187197|541430134|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
150078553|NCT02385045|541430135|FG000|Overall Study|Endoscopy could not be completed|4|||
150078554|NCT02200211|541430138|FG000|Overall Study|Lost to Follow-up|7|||
150078555|NCT02200211|541430139|FG001|Overall Study|Lost to Follow-up|7|||
150078556|NCT02200211|541430140|FG002|Overall Study|Lost to Follow-up|1|||
150078557|NCT02200211|541430141|FG003|Overall Study|Lost to Follow-up|2|||
150078558|NCT02200211|541430138|FG000|Overall Study|Withdrawal by Subject|1|||
150078559|NCT02200211|541430139|FG001|Overall Study|Withdrawal by Subject|0|||
150078560|NCT02200211|541430140|FG002|Overall Study|Withdrawal by Subject|0|||
150078561|NCT02200211|541430141|FG003|Overall Study|Withdrawal by Subject|0|||
150078562|NCT00381485|541430142|FG000|Open-Label Run-In Period|Adverse Event|9|||
150078563|NCT00381485|541430143|FG001|Open-Label Run-In Period|Adverse Event|0|||
150078564|NCT00381485|541430144|FG002|Open-Label Run-In Period|Adverse Event|0|||
150078565|NCT00381485|541430145|FG003|Open-Label Run-In Period|Adverse Event|0|||
150078566|NCT00381485|541430142|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
150078567|NCT00381485|541430143|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
150078568|NCT00381485|541430144|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
150078569|NCT00381485|541430145|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
150078570|NCT00381485|541430142|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
150078571|NCT00381485|541430143|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
150078572|NCT00381485|541430144|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
150078573|NCT00381485|541430145|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
150078574|NCT00381485|541430142|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
150078575|NCT00381485|541430143|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
150078576|NCT00381485|541430144|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
150078577|NCT00381485|541430145|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
150078578|NCT00381485|541430142|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
150078579|NCT00381485|541430143|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
150078580|NCT00381485|541430144|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
150078581|NCT00381485|541430145|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
150078582|NCT00381485|541430142|FG000|Open-Label Run-In Period|Treatment failure|1|||
150078583|NCT00381485|541430143|FG001|Open-Label Run-In Period|Treatment failure|0|||
150078584|NCT00381485|541430144|FG002|Open-Label Run-In Period|Treatment failure|0|||
150078585|NCT00381485|541430145|FG003|Open-Label Run-In Period|Treatment failure|0|||
150078586|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Adverse Event|0|||
150078587|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Adverse Event|2|||
150078588|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Adverse Event|2|||
150078589|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Adverse Event|5|||
150078590|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
150078591|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
150078592|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
150078593|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
150078594|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150078595|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
150078596|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
150078597|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
150078598|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
150078599|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
150078600|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
150078601|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
150078602|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
150078603|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
150078604|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
150078605|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
150078606|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
150078607|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
150078608|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
150078609|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
150078610|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
150078611|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
150078612|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
150078613|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
150078614|NCT00381485|541430142|FG000|Double-Blind Treatment Period|Administrative|0|||
150078615|NCT00381485|541430143|FG001|Double-Blind Treatment Period|Administrative|1|||
150182641|NCT05075408|541806448|FG000|Overall Study|Protocol Violation|0|||
150078616|NCT00381485|541430144|FG002|Double-Blind Treatment Period|Administrative|0|||
150078617|NCT00381485|541430145|FG003|Double-Blind Treatment Period|Administrative|1|||
150078618|NCT01235351|541430146|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
150078619|NCT01235351|541430147|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
150078620|NCT00126191|541430148|FG000|Overall Study|Physician Decision|0|||
150078621|NCT00126191|541430149|FG001|Overall Study|Physician Decision|1|||
150078622|NCT00126191|541430148|FG000|Overall Study|Death|0|||
150078623|NCT00126191|541430149|FG001|Overall Study|Death|1|||
150078624|NCT00307294|541430150|FG000|Overall Study|Withdrawal by Subject|1|||
150078625|NCT02955602|541430157|FG000|Overall Study|Adverse Event|0|||
150078626|NCT02955602|541430158|FG001|Overall Study|Adverse Event|3|||
150078627|NCT02955602|541430159|FG002|Overall Study|Adverse Event|0|||
150078628|NCT02955602|541430157|FG000|Overall Study|Withdrawal of informed consent|1|||
150078629|NCT02955602|541430158|FG001|Overall Study|Withdrawal of informed consent|3|||
150078630|NCT02955602|541430159|FG002|Overall Study|Withdrawal of informed consent|2|||
150078631|NCT02955602|541430157|FG000|Overall Study|Lost to Follow-up|0|||
150078632|NCT02955602|541430158|FG001|Overall Study|Lost to Follow-up|0|||
150078633|NCT02955602|541430159|FG002|Overall Study|Lost to Follow-up|1|||
150078634|NCT02955602|541430157|FG000|Overall Study|Other|0|||
150078635|NCT02955602|541430158|FG001|Overall Study|Other|1|||
150078636|NCT02955602|541430159|FG002|Overall Study|Other|3|||
150078637|NCT02980601|541430160|FG000|Overall Study|Lost to Follow-up|2|||
150078638|NCT02980601|541430161|FG001|Overall Study|Lost to Follow-up|2|||
150078639|NCT02980601|541430160|FG000|Overall Study|Death|0|||
150078640|NCT02980601|541430161|FG001|Overall Study|Death|1|||
150078641|NCT02980601|541430160|FG000|Overall Study|Graft loss|1|||
150078642|NCT02980601|541430161|FG001|Overall Study|Graft loss|0|||
150078643|NCT02980601|541430160|FG000|Overall Study|Failed to sign consent|2|||
150078644|NCT02980601|541430161|FG001|Overall Study|Failed to sign consent|0|||
150078645|NCT01575769|541430162|FG000|Overall Study|Adverse Event|1|||
150078646|NCT01575769|541430162|FG000|Overall Study|Study terminated by sponsor|40|||
150078647|NCT03068130|541430169|FG000|Overall Study|Adverse Event|19|||
150078648|NCT03068130|541430169|FG000|Overall Study|Death|14|||
150078649|NCT03068130|541430169|FG000|Overall Study|Lost to Follow-up|4|||
150078650|NCT03068130|541430169|FG000|Overall Study|Withdrawal by Subject|26|||
150078651|NCT03068130|541430169|FG000|Overall Study|Administrative Reasons|3|||
150078652|NCT03068130|541430169|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
150078653|NCT03068130|541430169|FG000|Overall Study|Study terminated by sponsor|194|||
150078654|NCT02732119|541430174|FG000|Phase I|Adverse Event|1|||
150078655|NCT02732119|541430175|FG001|Phase I|Adverse Event|3|||
150078656|NCT02732119|541430176|FG002|Phase I|Adverse Event|1|||
150078657|NCT02732119|541430177|FG003|Phase I|Adverse Event|0|||
150078658|NCT02732119|541430178|FG004|Phase I|Adverse Event|0|||
150078659|NCT02732119|541430174|FG000|Phase I|Progressive disease|7|||
150078660|NCT02732119|541430175|FG001|Phase I|Progressive disease|3|||
150078661|NCT02732119|541430176|FG002|Phase I|Progressive disease|2|||
150078662|NCT02732119|541430177|FG003|Phase I|Progressive disease|0|||
150078663|NCT02732119|541430178|FG004|Phase I|Progressive disease|0|||
150078664|NCT02732119|541430174|FG000|Phase I|Protocol deviation|0|||
150078665|NCT02732119|541430175|FG001|Phase I|Protocol deviation|1|||
150078666|NCT02732119|541430176|FG002|Phase I|Protocol deviation|0|||
150078667|NCT02732119|541430177|FG003|Phase I|Protocol deviation|0|||
150078668|NCT02732119|541430178|FG004|Phase I|Protocol deviation|0|||
150078669|NCT02732119|541430174|FG000|Phase I|Physician Decision|0|||
150078670|NCT02732119|541430175|FG001|Phase I|Physician Decision|3|||
150078671|NCT02732119|541430176|FG002|Phase I|Physician Decision|4|||
150078672|NCT02732119|541430177|FG003|Phase I|Physician Decision|0|||
150078673|NCT02732119|541430178|FG004|Phase I|Physician Decision|0|||
150078674|NCT02732119|541430174|FG000|Phase II|Adverse Event|0|||
150078675|NCT02732119|541430175|FG001|Phase II|Adverse Event|0|||
150078676|NCT02732119|541430176|FG002|Phase II|Adverse Event|0|||
150078677|NCT02732119|541430177|FG003|Phase II|Adverse Event|3|||
150078678|NCT02732119|541430178|FG004|Phase II|Adverse Event|3|||
150078679|NCT02732119|541430174|FG000|Phase II|Death|0|||
150078680|NCT02732119|541430175|FG001|Phase II|Death|0|||
150078681|NCT02732119|541430176|FG002|Phase II|Death|0|||
150078682|NCT02732119|541430177|FG003|Phase II|Death|1|||
150078683|NCT02732119|541430178|FG004|Phase II|Death|0|||
150078684|NCT02732119|541430174|FG000|Phase II|Progressive dissease|0|||
150078685|NCT02732119|541430175|FG001|Phase II|Progressive dissease|0|||
150078686|NCT02732119|541430176|FG002|Phase II|Progressive dissease|0|||
150078687|NCT02732119|541430177|FG003|Phase II|Progressive dissease|30|||
150078688|NCT02732119|541430178|FG004|Phase II|Progressive dissease|23|||
150078689|NCT02732119|541430174|FG000|Phase II|Study terminated by sponsor|0|||
150078690|NCT02732119|541430175|FG001|Phase II|Study terminated by sponsor|0|||
150078691|NCT02732119|541430176|FG002|Phase II|Study terminated by sponsor|0|||
150078692|NCT02732119|541430177|FG003|Phase II|Study terminated by sponsor|2|||
150078693|NCT02732119|541430178|FG004|Phase II|Study terminated by sponsor|2|||
150078694|NCT02732119|541430174|FG000|Phase II|Other|0|||
150078695|NCT02732119|541430175|FG001|Phase II|Other|0|||
150078696|NCT02732119|541430176|FG002|Phase II|Other|0|||
150078697|NCT02732119|541430177|FG003|Phase II|Other|2|||
150078698|NCT02732119|541430178|FG004|Phase II|Other|0|||
150078699|NCT02732119|541430174|FG000|Phase II|Physician Decision|0|||
150078700|NCT02732119|541430175|FG001|Phase II|Physician Decision|0|||
150078701|NCT02732119|541430176|FG002|Phase II|Physician Decision|0|||
150078702|NCT02732119|541430177|FG003|Phase II|Physician Decision|8|||
150078703|NCT02732119|541430178|FG004|Phase II|Physician Decision|5|||
150078704|NCT05275400|541430179|FG000|Treatment Period|Adverse Event|7|||
150078705|NCT05275400|541430180|FG001|Treatment Period|Adverse Event|1|||
150078706|NCT05275400|541430179|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
150078707|NCT05275400|541430180|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
150078708|NCT05275400|541430179|FG000|Treatment Period|Death|5|||
150078709|NCT05275400|541430180|FG001|Treatment Period|Death|2|||
150078710|NCT05275400|541430179|FG000|Treatment Period|Protocol Violation|1|||
150078711|NCT05275400|541430180|FG001|Treatment Period|Protocol Violation|0|||
150078712|NCT05275400|541430179|FG000|Treatment Period|Physician Decision|5|||
150078713|NCT05275400|541430180|FG001|Treatment Period|Physician Decision|4|||
150078714|NCT05275400|541430179|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
150078715|NCT05275400|541430180|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
150078716|NCT05275400|541430179|FG000|Treatment Period|Withdrawal by Subject|30|||
150078717|NCT05275400|541430180|FG001|Treatment Period|Withdrawal by Subject|12|||
150078718|NCT05275400|541430179|FG000|Treatment Period|Lost to Follow-up|1|||
150078719|NCT05275400|541430180|FG001|Treatment Period|Lost to Follow-up|5|||
150078720|NCT05275400|541430179|FG000|Treatment Period|Lack of Efficacy|1|||
150078721|NCT05275400|541430180|FG001|Treatment Period|Lack of Efficacy|0|||
150078722|NCT05275400|541430179|FG000|Treatment Period|Sponsor Decision|1|||
150078723|NCT05275400|541430180|FG001|Treatment Period|Sponsor Decision|0|||
150078724|NCT05275400|541430179|FG000|Follow-Up Period|Death|2|||
150078725|NCT05275400|541430180|FG001|Follow-Up Period|Death|0|||
150078726|NCT05275400|541430179|FG000|Follow-Up Period|Protocol Violation|1|||
150078727|NCT05275400|541430180|FG001|Follow-Up Period|Protocol Violation|0|||
150078728|NCT05275400|541430179|FG000|Follow-Up Period|Withdrawal by Subject|3|||
150078729|NCT05275400|541430180|FG001|Follow-Up Period|Withdrawal by Subject|0|||
150078730|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Physician Decision|0|||
150078731|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Physician Decision|1|||
150078732|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Physician Decision|0|||
150078733|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
150078734|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
150078735|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
150078736|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
150078737|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
150078738|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
150078739|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Other|4|||
150078740|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Other|4|||
150078741|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Other|0|||
150078742|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
150078743|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
150078744|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
150078745|NCT02585960|541430181|FG000|PK/Safety Assessment Period|Screen Failure|0|||
150078746|NCT02585960|541430182|FG001|PK/Safety Assessment Period|Screen Failure|0|||
150078747|NCT02585960|541430183|FG002|PK/Safety Assessment Period|Screen Failure|1|||
150078748|NCT02585960|541430181|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
150078749|NCT02585960|541430182|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
150078750|NCT02585960|541430183|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
150078751|NCT02585960|541430181|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
150078752|NCT02585960|541430182|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
150078753|NCT02585960|541430183|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
150078754|NCT03639935|541430184|FG000|Overall Study|Death|3|||
150078755|NCT03639935|541430184|FG000|Overall Study|Adverse Event|1|||
150078756|NCT04930965|541430186|FG000|Overall Study|Lost to Follow-up|7|||
150078757|NCT04930965|541430187|FG001|Overall Study|Lost to Follow-up|5|||
150078758|NCT02849678|541430188|FG000|Overall Study|Protocol Violation|3|||
150078759|NCT02849678|541430189|FG001|Overall Study|Protocol Violation|6|||
150078760|NCT00288054|541430190|FG000|Overall Study|Protocol Violation|2|||
150078761|NCT00288054|541430190|FG000|Overall Study|Lack of Efficacy|16|||
150078762|NCT00288054|541430190|FG000|Overall Study|Adverse Event|3|||
150078763|NCT00288054|541430190|FG000|Overall Study|Withdrawal by Subject|1|||
150078764|NCT00288054|541430190|FG000|Overall Study|Not protocol specified|2|||
150078765|NCT03988088|541430194|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
150078766|NCT03988088|541430195|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
150078767|NCT03988088|541430196|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
150078768|NCT03988088|541430197|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
150078769|NCT03988088|541430194|FG000|Open-Label Addendum|Lost to Follow-up|0|||
150078770|NCT03988088|541430195|FG001|Open-Label Addendum|Lost to Follow-up|0|||
150078771|NCT03988088|541430196|FG002|Open-Label Addendum|Lost to Follow-up|1|||
150078772|NCT03988088|541430197|FG003|Open-Label Addendum|Lost to Follow-up|0|||
150078773|NCT00781274|541430198|FG000|Overall Study|Withdrawal by Subject|2|||
150078774|NCT00282984|541430199|FG000|Overall Study|Death|2|||
150078775|NCT00282984|541430200|FG001|Overall Study|Death|5|||
150078776|NCT00282984|541430199|FG000|Overall Study|Adverse Event|8|||
150078777|NCT00282984|541430200|FG001|Overall Study|Adverse Event|5|||
150078778|NCT00282984|541430199|FG000|Overall Study|Lack of Efficacy|0|||
150078779|NCT00282984|541430200|FG001|Overall Study|Lack of Efficacy|2|||
150078780|NCT00282984|541430199|FG000|Overall Study|Lost to Follow-up|14|||
150078781|NCT00282984|541430200|FG001|Overall Study|Lost to Follow-up|10|||
150078782|NCT00282984|541430199|FG000|Overall Study|Withdrawal by Participant|22|||
150078783|NCT00282984|541430200|FG001|Overall Study|Withdrawal by Participant|34|||
150078784|NCT00282984|541430199|FG000|Overall Study|Participant stopped study medication|2|||
150078785|NCT00282984|541430200|FG001|Overall Study|Participant stopped study medication|2|||
150078786|NCT00282984|541430199|FG000|Overall Study|Participant only allowed phone follow-up|0|||
150078787|NCT00282984|541430200|FG001|Overall Study|Participant only allowed phone follow-up|1|||
150078788|NCT00282984|541430199|FG000|Overall Study|Participant used antipsychosis meds|0|||
150078789|NCT00282984|541430200|FG001|Overall Study|Participant used antipsychosis meds|1|||
150078790|NCT00282984|541430199|FG000|Overall Study|lack of motivation|1|||
150078791|NCT00282984|541430200|FG001|Overall Study|lack of motivation|0|||
150078792|NCT00282984|541430199|FG000|Overall Study|in prison|0|||
150078793|NCT00282984|541430200|FG001|Overall Study|in prison|1|||
150078794|NCT00282984|541430199|FG000|Overall Study|Protocol Violation|2|||
150078795|NCT00282984|541430200|FG001|Overall Study|Protocol Violation|0|||
150078796|NCT00191269|541430201|FG000|Overall Study|Protocol Violation|0|||
150078797|NCT00191269|541430202|FG001|Overall Study|Protocol Violation|2|||
150078798|NCT00191269|541430201|FG000|Overall Study|Adverse Event|1|||
150078799|NCT00191269|541430202|FG001|Overall Study|Adverse Event|4|||
150078800|NCT00191269|541430201|FG000|Overall Study|Progression of Disease|4|||
150078801|NCT00191269|541430202|FG001|Overall Study|Progression of Disease|42|||
150078802|NCT00191269|541430201|FG000|Overall Study|Lack of Efficacy|1|||
150078803|NCT00191269|541430202|FG001|Overall Study|Lack of Efficacy|5|||
150078804|NCT00191269|541430201|FG000|Overall Study|Withdrawal by Subject|0|||
150078805|NCT00191269|541430202|FG001|Overall Study|Withdrawal by Subject|1|||
150078806|NCT00191269|541430201|FG000|Overall Study|Pathologic Aggrevation|0|||
150078807|NCT00191269|541430202|FG001|Overall Study|Pathologic Aggrevation|1|||
150078808|NCT00191269|541430201|FG000|Overall Study|Physician Decision|0|||
150078809|NCT00191269|541430202|FG001|Overall Study|Physician Decision|3|||
150078810|NCT00674362|541430212|FG000|Double Blind|Adverse Event|6|||
150078811|NCT00674362|541430213|FG001|Double Blind|Adverse Event|6|||
150078812|NCT00674362|541430212|FG000|Double Blind|Lack of Efficacy|2|||
150078813|NCT00674362|541430213|FG001|Double Blind|Lack of Efficacy|6|||
150078814|NCT00674362|541430212|FG000|Double Blind|Loss of efficacy|0|||
150078815|NCT00674362|541430213|FG001|Double Blind|Loss of efficacy|1|||
150078816|NCT00674362|541430212|FG000|Double Blind|Withdrawal by Subject|4|||
150078817|NCT00674362|541430213|FG001|Double Blind|Withdrawal by Subject|3|||
150078818|NCT00674362|541430212|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
150078819|NCT00674362|541430213|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
150078820|NCT00674362|541430212|FG000|Double Blind|Other: Surgery|0|||
150078821|NCT00674362|541430213|FG001|Double Blind|Other: Surgery|1|||
150078822|NCT00674362|541430212|FG000|Open Label|Adverse Event|1|||
150078823|NCT00674362|541430213|FG001|Open Label|Adverse Event|0|||
150078824|NCT00674362|541430212|FG000|Open Label|Other: Subject moved to extension study|1|||
150078825|NCT00674362|541430213|FG001|Open Label|Other: Subject moved to extension study|0|||
150078826|NCT00923156|541430216|FG000|Overall Study|Adverse Event|0|||
150078827|NCT00923156|541430217|FG001|Overall Study|Adverse Event|2|||
150078828|NCT00923156|541430218|FG002|Overall Study|Adverse Event|1|||
150078829|NCT00923156|541430216|FG000|Overall Study|Abnormal laboratory values|0|||
150078830|NCT00923156|541430217|FG001|Overall Study|Abnormal laboratory values|0|||
150078831|NCT00923156|541430218|FG002|Overall Study|Abnormal laboratory values|1|||
150078832|NCT00923156|541430216|FG000|Overall Study|Withdrawal by Subject|0|||
150078833|NCT00923156|541430217|FG001|Overall Study|Withdrawal by Subject|1|||
150078834|NCT00923156|541430218|FG002|Overall Study|Withdrawal by Subject|0|||
150078835|NCT00923156|541430216|FG000|Overall Study|Death|0|||
150078836|NCT00923156|541430217|FG001|Overall Study|Death|1|||
150078837|NCT00923156|541430218|FG002|Overall Study|Death|0|||
150078838|NCT00923156|541430216|FG000|Overall Study|Lack of Efficacy|0|||
150078839|NCT00923156|541430217|FG001|Overall Study|Lack of Efficacy|0|||
150078840|NCT00923156|541430218|FG002|Overall Study|Lack of Efficacy|1|||
150078841|NCT04066023|541430219|FG000|Overall Study|Adverse Event|0|||
150078842|NCT04066023|541430220|FG001|Overall Study|Adverse Event|0|||
150078843|NCT04066023|541430221|FG002|Overall Study|Adverse Event|1|||
150078844|NCT04066023|541430219|FG000|Overall Study|Sponsor decision|3|||
150078845|NCT04066023|541430220|FG001|Overall Study|Sponsor decision|6|||
150078846|NCT04066023|541430221|FG002|Overall Study|Sponsor decision|2|||
150078847|NCT04066023|541430219|FG000|Overall Study|Physician Decision|0|||
150078848|NCT04066023|541430220|FG001|Overall Study|Physician Decision|0|||
150078849|NCT04066023|541430221|FG002|Overall Study|Physician Decision|1|||
150078850|NCT04066023|541430219|FG000|Overall Study|Lost to Follow-up|0|||
150078851|NCT04066023|541430220|FG001|Overall Study|Lost to Follow-up|1|||
150078852|NCT04066023|541430221|FG002|Overall Study|Lost to Follow-up|1|||
150078853|NCT04066023|541430219|FG000|Overall Study|Noncompliance|0|||
150078854|NCT04066023|541430220|FG001|Overall Study|Noncompliance|1|||
150078855|NCT04066023|541430221|FG002|Overall Study|Noncompliance|1|||
150078856|NCT04665856|541430222|FG000|Overall Study|Site Terminated by Sponsor|1|||
150078857|NCT04665856|541430223|FG001|Overall Study|Site Terminated by Sponsor|0|||
150078858|NCT04665856|541430222|FG000|Overall Study|Withdrawal by Subject|2|||
150078859|NCT04665856|541430223|FG001|Overall Study|Withdrawal by Subject|0|||
150078860|NCT04665856|541430222|FG000|Overall Study|Lost to Follow-up|3|||
150078861|NCT04665856|541430223|FG001|Overall Study|Lost to Follow-up|2|||
150078862|NCT04665856|541430222|FG000|Overall Study|Death|39|||
150078863|NCT04665856|541430223|FG001|Overall Study|Death|44|||
150078864|NCT04665856|541430222|FG000|Overall Study|Ongoing in study|17|||
150078865|NCT04665856|541430223|FG001|Overall Study|Ongoing in study|15|||
150078866|NCT03386448|541430224|FG000|Overall Study|Adverse Event|0|||
150078867|NCT03386448|541430225|FG001|Overall Study|Adverse Event|2|||
150078868|NCT03338010|541430226|FG000|Overall Study|Withdrawal by Subject|14|||
150078869|NCT03338010|541430227|FG001|Overall Study|Withdrawal by Subject|8|||
150078870|NCT03338010|541430226|FG000|Overall Study|Lost to Follow-up|4|||
150078871|NCT03338010|541430227|FG001|Overall Study|Lost to Follow-up|2|||
150078872|NCT03338010|541430226|FG000|Overall Study|Adverse Event|3|||
150078873|NCT03338010|541430227|FG001|Overall Study|Adverse Event|2|||
150078874|NCT03338010|541430226|FG000|Overall Study|Physician Decision|2|||
150078875|NCT03338010|541430227|FG001|Overall Study|Physician Decision|2|||
150078876|NCT03338010|541430226|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150078877|NCT03338010|541430227|FG001|Overall Study|Non-Compliance with Study Drug|3|||
150078878|NCT03338010|541430226|FG000|Overall Study|Protocol Violation|0|||
150078879|NCT03338010|541430227|FG001|Overall Study|Protocol Violation|1|||
150078880|NCT02564796|541430230|FG000|Overall Study|Physician Decision|2|||
150078881|NCT02564796|541430231|FG001|Overall Study|Physician Decision|2|||
150078882|NCT00816595|541430232|FG000|Overall Study|Withdrawal by Subject|2|||
150078883|NCT00816595|541430233|FG001|Overall Study|Withdrawal by Subject|0|||
150078884|NCT00293033|541430234|FG000|Open-label Titration Period|Adverse Event|10|||
150078885|NCT00293033|541430234|FG000|Open-label Titration Period|Death|3|||
150078886|NCT00293033|541430234|FG000|Open-label Titration Period|Lack of Efficacy|5|||
150078887|NCT00293033|541430234|FG000|Open-label Titration Period|Protocol Violation|2|||
150078888|NCT00293033|541430234|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
150078889|NCT00293033|541430234|FG000|Open-label Titration Period|Noncompliance and other|27|||
150078890|NCT00293033|541430234|FG000|Double-blind Treatment Period|Adverse Event|3|||
150078891|NCT00293033|541430234|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
150078892|NCT00293033|541430234|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
150078893|NCT00293033|541430234|FG000|Double-blind Treatment Period|Noncompliance|4|||
150078894|NCT03583697|541430235|FG000|Overall Study|Withdrawal by Subject|0|||
150078895|NCT03583697|541430236|FG001|Overall Study|Withdrawal by Subject|0|||
150078896|NCT03583697|541430237|FG002|Overall Study|Withdrawal by Subject|1|||
150078897|NCT03583697|541430235|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
150078898|NCT03583697|541430236|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
150078899|NCT03583697|541430237|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
150078900|NCT00453063|541430238|FG000|Overall Study|Adverse Event|1|||
150078901|NCT00453063|541430239|FG001|Overall Study|Adverse Event|2|||
150078902|NCT00453063|541430238|FG000|Overall Study|Withdrawal by Subject|1|||
150078903|NCT00453063|541430239|FG001|Overall Study|Withdrawal by Subject|1|||
150078904|NCT00453063|541430238|FG000|Overall Study|Protocol Violation|1|||
150078905|NCT00453063|541430239|FG001|Overall Study|Protocol Violation|0|||
150078906|NCT00114530|541430240|FG000|Overall Study|Death|3|||
150078907|NCT00114530|541430241|FG001|Overall Study|Death|11|||
150078908|NCT00114530|541430240|FG000|Overall Study|Lost to Follow-up|1|||
150078909|NCT00114530|541430241|FG001|Overall Study|Lost to Follow-up|1|||
150078910|NCT00114530|541430240|FG000|Overall Study|Physician Decision|1|||
150078911|NCT00114530|541430241|FG001|Overall Study|Physician Decision|1|||
150078912|NCT00114530|541430240|FG000|Overall Study|Withdrawal by Subject|2|||
150078913|NCT00114530|541430241|FG001|Overall Study|Withdrawal by Subject|6|||
150078914|NCT00114530|541430240|FG000|Overall Study|Breast Cancer|1|||
150078915|NCT00114530|541430241|FG001|Overall Study|Breast Cancer|0|||
150078916|NCT00114530|541430240|FG000|Overall Study|Subject decision after endpoint failure|0|||
150078917|NCT00114530|541430241|FG001|Overall Study|Subject decision after endpoint failure|1|||
150078918|NCT00114530|541430240|FG000|Overall Study|Ineligible|1|||
150078919|NCT00114530|541430241|FG001|Overall Study|Ineligible|0|||
150078920|NCT03724032|541430245|FG000|Overall Study|Physician Decision|1|||
150078921|NCT03724032|541430246|FG001|Overall Study|Physician Decision|0|||
150078922|NCT03724032|541430247|FG002|Overall Study|Physician Decision|0|||
150078923|NCT03724032|541430245|FG000|Overall Study|Protocol Violation|2|||
150078924|NCT03724032|541430246|FG001|Overall Study|Protocol Violation|2|||
150078925|NCT03724032|541430247|FG002|Overall Study|Protocol Violation|1|||
150078926|NCT00751933|541430248|FG000|Overall Study|Withdrawal by Subject|0|||
150078927|NCT00751933|541430249|FG001|Overall Study|Withdrawal by Subject|1|||
150078928|NCT00751933|541430250|FG002|Overall Study|Withdrawal by Subject|0|||
150078929|NCT00751933|541430251|FG003|Overall Study|Withdrawal by Subject|0|||
150078930|NCT00751933|541430248|FG000|Overall Study|Physician Decision|0|||
150078931|NCT00751933|541430249|FG001|Overall Study|Physician Decision|0|||
150078932|NCT00751933|541430250|FG002|Overall Study|Physician Decision|1|||
150078933|NCT00751933|541430251|FG003|Overall Study|Physician Decision|1|||
150078934|NCT01817530|541430253|FG000|Overall Study|Exclusionary Medication Received|0|||
150078935|NCT01817530|541430254|FG001|Overall Study|Exclusionary Medication Received|0|||
150078936|NCT01817530|541430255|FG002|Overall Study|Exclusionary Medication Received|0|||
150078937|NCT01817530|541430256|FG003|Overall Study|Exclusionary Medication Received|0|||
150078938|NCT01817530|541430257|FG004|Overall Study|Exclusionary Medication Received|1|||
150078939|NCT01817530|541430258|FG005|Overall Study|Exclusionary Medication Received|0|||
150078940|NCT01817530|541430259|FG006|Overall Study|Exclusionary Medication Received|0|||
150078941|NCT01817530|541430260|FG007|Overall Study|Exclusionary Medication Received|0|||
150078942|NCT01817530|541430253|FG000|Overall Study|Adverse Event|6|||
150078943|NCT01817530|541430254|FG001|Overall Study|Adverse Event|3|||
150078944|NCT01817530|541430255|FG002|Overall Study|Adverse Event|2|||
150078945|NCT01817530|541430256|FG003|Overall Study|Adverse Event|5|||
150078946|NCT01817530|541430257|FG004|Overall Study|Adverse Event|0|||
150078947|NCT01817530|541430258|FG005|Overall Study|Adverse Event|10|||
150078948|NCT01817530|541430259|FG006|Overall Study|Adverse Event|5|||
150078949|NCT01817530|541430260|FG007|Overall Study|Adverse Event|8|||
150078950|NCT01817530|541430253|FG000|Overall Study|Subject Noncompliant|3|||
150078951|NCT01817530|541430254|FG001|Overall Study|Subject Noncompliant|1|||
150078952|NCT01817530|541430255|FG002|Overall Study|Subject Noncompliant|0|||
150078953|NCT01817530|541430256|FG003|Overall Study|Subject Noncompliant|4|||
150078954|NCT01817530|541430257|FG004|Overall Study|Subject Noncompliant|0|||
150078955|NCT01817530|541430258|FG005|Overall Study|Subject Noncompliant|1|||
150078956|NCT01817530|541430259|FG006|Overall Study|Subject Noncompliant|1|||
150078957|NCT01817530|541430260|FG007|Overall Study|Subject Noncompliant|1|||
150078958|NCT01817530|541430253|FG000|Overall Study|Lack of Efficacy|1|||
150078959|NCT01817530|541430254|FG001|Overall Study|Lack of Efficacy|0|||
150078960|NCT01817530|541430255|FG002|Overall Study|Lack of Efficacy|0|||
150078961|NCT01817530|541430256|FG003|Overall Study|Lack of Efficacy|0|||
150078962|NCT01817530|541430257|FG004|Overall Study|Lack of Efficacy|0|||
150078963|NCT01817530|541430258|FG005|Overall Study|Lack of Efficacy|1|||
150078964|NCT01817530|541430259|FG006|Overall Study|Lack of Efficacy|0|||
150078965|NCT01817530|541430260|FG007|Overall Study|Lack of Efficacy|1|||
150078966|NCT01817530|541430253|FG000|Overall Study|Pregnancy|0|||
150078967|NCT01817530|541430254|FG001|Overall Study|Pregnancy|0|||
150078968|NCT01817530|541430255|FG002|Overall Study|Pregnancy|0|||
150078969|NCT01817530|541430256|FG003|Overall Study|Pregnancy|0|||
150078970|NCT01817530|541430257|FG004|Overall Study|Pregnancy|0|||
150078971|NCT01817530|541430258|FG005|Overall Study|Pregnancy|1|||
150078972|NCT01817530|541430259|FG006|Overall Study|Pregnancy|0|||
150078973|NCT01817530|541430260|FG007|Overall Study|Pregnancy|0|||
150078974|NCT01817530|541430253|FG000|Overall Study|Other|0|||
150078975|NCT01817530|541430254|FG001|Overall Study|Other|1|||
150078976|NCT01817530|541430255|FG002|Overall Study|Other|0|||
150078977|NCT01817530|541430256|FG003|Overall Study|Other|0|||
150078978|NCT01817530|541430257|FG004|Overall Study|Other|1|||
150078979|NCT01817530|541430258|FG005|Overall Study|Other|0|||
150078980|NCT01817530|541430259|FG006|Overall Study|Other|5|||
150078981|NCT01817530|541430260|FG007|Overall Study|Other|0|||
150078982|NCT01817530|541430253|FG000|Overall Study|Surgery or Invasive Intervention|1|||
150078983|NCT01817530|541430254|FG001|Overall Study|Surgery or Invasive Intervention|0|||
150078984|NCT01817530|541430255|FG002|Overall Study|Surgery or Invasive Intervention|0|||
150078985|NCT01817530|541430256|FG003|Overall Study|Surgery or Invasive Intervention|0|||
150078986|NCT01817530|541430257|FG004|Overall Study|Surgery or Invasive Intervention|1|||
150078987|NCT01817530|541430258|FG005|Overall Study|Surgery or Invasive Intervention|1|||
150078988|NCT01817530|541430259|FG006|Overall Study|Surgery or Invasive Intervention|1|||
150078989|NCT01817530|541430260|FG007|Overall Study|Surgery or Invasive Intervention|0|||
150078990|NCT01817530|541430253|FG000|Overall Study|Consent Withdrawn by Subject|3|||
150078991|NCT01817530|541430254|FG001|Overall Study|Consent Withdrawn by Subject|4|||
150078992|NCT01817530|541430255|FG002|Overall Study|Consent Withdrawn by Subject|7|||
150078993|NCT01817530|541430256|FG003|Overall Study|Consent Withdrawn by Subject|3|||
150078994|NCT01817530|541430257|FG004|Overall Study|Consent Withdrawn by Subject|5|||
150078995|NCT01817530|541430258|FG005|Overall Study|Consent Withdrawn by Subject|3|||
150078996|NCT01817530|541430259|FG006|Overall Study|Consent Withdrawn by Subject|3|||
150078997|NCT01817530|541430260|FG007|Overall Study|Consent Withdrawn by Subject|10|||
150078998|NCT01817530|541430253|FG000|Overall Study|Lost to Follow-up|1|||
150078999|NCT01817530|541430254|FG001|Overall Study|Lost to Follow-up|4|||
150079000|NCT01817530|541430255|FG002|Overall Study|Lost to Follow-up|2|||
150079001|NCT01817530|541430256|FG003|Overall Study|Lost to Follow-up|1|||
150079002|NCT01817530|541430257|FG004|Overall Study|Lost to Follow-up|3|||
150079003|NCT01817530|541430258|FG005|Overall Study|Lost to Follow-up|2|||
150079004|NCT01817530|541430259|FG006|Overall Study|Lost to Follow-up|8|||
150079005|NCT01817530|541430260|FG007|Overall Study|Lost to Follow-up|4|||
150079006|NCT00679432|541430262|FG000|Overall Study|Adverse Event|5|||
150079007|NCT00679432|541430263|FG001|Overall Study|Adverse Event|6|||
150079008|NCT00679432|541430264|FG002|Overall Study|Adverse Event|10|||
150079009|NCT00679432|541430265|FG003|Overall Study|Adverse Event|7|||
150079010|NCT00679432|541430262|FG000|Overall Study|Protocol Violation|1|||
150079011|NCT00679432|541430263|FG001|Overall Study|Protocol Violation|1|||
150079012|NCT00679432|541430264|FG002|Overall Study|Protocol Violation|2|||
150079013|NCT00679432|541430265|FG003|Overall Study|Protocol Violation|1|||
150079014|NCT00679432|541430262|FG000|Overall Study|Withdrawal by Subject|8|||
150079015|NCT00679432|541430263|FG001|Overall Study|Withdrawal by Subject|11|||
150079016|NCT00679432|541430264|FG002|Overall Study|Withdrawal by Subject|10|||
150079017|NCT00679432|541430265|FG003|Overall Study|Withdrawal by Subject|9|||
150079018|NCT00679432|541430262|FG000|Overall Study|Lost to Follow-up|1|||
150079019|NCT00679432|541430263|FG001|Overall Study|Lost to Follow-up|5|||
150079020|NCT00679432|541430264|FG002|Overall Study|Lost to Follow-up|4|||
150079021|NCT00679432|541430265|FG003|Overall Study|Lost to Follow-up|2|||
150079022|NCT00679432|541430262|FG000|Overall Study|Physician Decision|3|||
150079023|NCT00679432|541430263|FG001|Overall Study|Physician Decision|2|||
150079024|NCT00679432|541430264|FG002|Overall Study|Physician Decision|2|||
150079025|NCT00679432|541430265|FG003|Overall Study|Physician Decision|2|||
150079026|NCT00679432|541430262|FG000|Overall Study|Sponsor decision|1|||
150079027|NCT00679432|541430263|FG001|Overall Study|Sponsor decision|0|||
150079028|NCT00679432|541430264|FG002|Overall Study|Sponsor decision|0|||
150079029|NCT00679432|541430265|FG003|Overall Study|Sponsor decision|0|||
150079030|NCT00679432|541430262|FG000|Overall Study|Lack of Efficacy|13|||
150079031|NCT00679432|541430263|FG001|Overall Study|Lack of Efficacy|9|||
150079032|NCT00679432|541430264|FG002|Overall Study|Lack of Efficacy|14|||
150079033|NCT00679432|541430265|FG003|Overall Study|Lack of Efficacy|8|||
150079034|NCT00679432|541430262|FG000|Overall Study|Infectious colitis, normal histology|5|||
150079035|NCT00679432|541430263|FG001|Overall Study|Infectious colitis, normal histology|4|||
150079036|NCT00679432|541430264|FG002|Overall Study|Infectious colitis, normal histology|8|||
150079037|NCT00679432|541430265|FG003|Overall Study|Infectious colitis, normal histology|3|||
150079038|NCT00679432|541430262|FG000|Overall Study|Randomization error, return to prior Rx|0|||
150079039|NCT00679432|541430263|FG001|Overall Study|Randomization error, return to prior Rx|0|||
150079040|NCT00679432|541430264|FG002|Overall Study|Randomization error, return to prior Rx|3|||
150079041|NCT00679432|541430265|FG003|Overall Study|Randomization error, return to prior Rx|0|||
150079042|NCT01558271|541430266|FG000|Overall Study|Adverse Event|6|||
150079043|NCT01558271|541430267|FG001|Overall Study|Adverse Event|3|||
150079044|NCT01558271|541430268|FG002|Overall Study|Adverse Event|4|||
150079045|NCT01558271|541430266|FG000|Overall Study|Lost to Follow-up|1|||
150079046|NCT01558271|541430267|FG001|Overall Study|Lost to Follow-up|0|||
150079047|NCT01558271|541430268|FG002|Overall Study|Lost to Follow-up|0|||
150079048|NCT01558271|541430266|FG000|Overall Study|Protocol Violation|1|||
150079049|NCT01558271|541430267|FG001|Overall Study|Protocol Violation|0|||
150079050|NCT01558271|541430268|FG002|Overall Study|Protocol Violation|0|||
150079051|NCT01558271|541430266|FG000|Overall Study|Withdrawal by Subject|10|||
150079052|NCT01558271|541430267|FG001|Overall Study|Withdrawal by Subject|6|||
150079053|NCT01558271|541430268|FG002|Overall Study|Withdrawal by Subject|12|||
150079054|NCT01558271|541430266|FG000|Overall Study|Physician Decision|0|||
150079055|NCT01558271|541430267|FG001|Overall Study|Physician Decision|2|||
150079056|NCT01558271|541430268|FG002|Overall Study|Physician Decision|1|||
150079057|NCT01084083|541430269|FG000|Overall Study|Adverse Event|5|||
150079058|NCT01084083|541430269|FG000|Overall Study|Death|1|||
150079059|NCT01084083|541430269|FG000|Overall Study|Withdrawal by Subject|2|||
150079060|NCT01084083|541430269|FG000|Overall Study|Complicating disease|1|||
150079061|NCT01084083|541430269|FG000|Overall Study|Other|2|||
150079062|NCT01084083|541430269|FG000|Overall Study|Never started assigned therapy|1|||
150079063|NCT00228384|541430270|FG000|Overall Study|Death|9|||
150079064|NCT00228384|541430271|FG001|Overall Study|Death|3|||
150079065|NCT00228384|541430270|FG000|Overall Study|Lost to Follow-up|6|||
150079066|NCT00228384|541430271|FG001|Overall Study|Lost to Follow-up|10|||
150079067|NCT00228384|541430270|FG000|Overall Study|Surgical Intervention (bypass)|5|||
150079068|NCT00228384|541430271|FG001|Overall Study|Surgical Intervention (bypass)|5|||
150079069|NCT00228384|541430270|FG000|Overall Study|Withdrawal by Subject|9|||
150079070|NCT00228384|541430271|FG001|Overall Study|Withdrawal by Subject|10|||
150079071|NCT00228384|541430270|FG000|Overall Study|Physician Decision|0|||
150079072|NCT00228384|541430271|FG001|Overall Study|Physician Decision|1|||
150079073|NCT00873912|541430272|FG000|Overall Study|Withdrawal by Subject|1|||
150079074|NCT00873912|541430273|FG001|Overall Study|Withdrawal by Subject|0|||
150079075|NCT00873912|541430272|FG000|Overall Study|Lost to Follow-up|2|||
150079076|NCT00873912|541430273|FG001|Overall Study|Lost to Follow-up|0|||
150079077|NCT01466153|541430274|FG000|Overall Study|Disease Progression|2|||
150079078|NCT01466153|541430275|FG001|Overall Study|Disease Progression|2|||
150079079|NCT01466153|541430276|FG002|Overall Study|Disease Progression|0|||
150079080|NCT01466153|541430274|FG000|Overall Study|Adverse Event|14|||
150079081|NCT01466153|541430275|FG001|Overall Study|Adverse Event|13|||
150079082|NCT01466153|541430276|FG002|Overall Study|Adverse Event|17|||
150079083|NCT01466153|541430274|FG000|Overall Study|Withdrawal of Consent|2|||
150079084|NCT01466153|541430275|FG001|Overall Study|Withdrawal of Consent|0|||
150079085|NCT01466153|541430276|FG002|Overall Study|Withdrawal of Consent|0|||
150079086|NCT01466153|541430274|FG000|Overall Study|Investigator Discretion|3|||
150079087|NCT01466153|541430275|FG001|Overall Study|Investigator Discretion|2|||
150079088|NCT01466153|541430276|FG002|Overall Study|Investigator Discretion|2|||
150079089|NCT01466153|541430274|FG000|Overall Study|Randomized-Not Treated|2|||
150079090|NCT01466153|541430275|FG001|Overall Study|Randomized-Not Treated|3|||
150079091|NCT01466153|541430276|FG002|Overall Study|Randomized-Not Treated|4|||
150079092|NCT01466153|541430274|FG000|Overall Study|Other-Unspecified|6|||
150079093|NCT01466153|541430275|FG001|Overall Study|Other-Unspecified|4|||
150079094|NCT01466153|541430276|FG002|Overall Study|Other-Unspecified|2|||
150079095|NCT05695209|541430285|FG000|3-months|Withdrawal by Subject|2|||
150079096|NCT05695209|541430286|FG001|3-months|Withdrawal by Subject|0|||
150079097|NCT05695209|541430285|FG000|3-months|Unable to contact for 3-month data collection|0|||
150079098|NCT05695209|541430286|FG001|3-months|Unable to contact for 3-month data collection|1|||
150079099|NCT05695209|541430285|FG000|6-months|Lost to Follow-up|1|||
150079100|NCT05695209|541430286|FG001|6-months|Lost to Follow-up|1|||
150079101|NCT04362072|541430289|FG000|Treatment|Adverse Event|1|||
150079102|NCT04362072|541430289|FG000|Treatment|Death|9|||
150079103|NCT04362072|541430289|FG000|Treatment|Physician Decision|2|||
150079104|NCT04362072|541430289|FG000|Treatment|Progressive disease|27|||
150079105|NCT04362072|541430289|FG000|Treatment|Withdrawal by Subject|4|||
150079106|NCT04362072|541430289|FG000|Treatment|Global deterioration of health status|1|||
150079107|NCT04362072|541430289|FG000|Treatment|Switched to commercial Lorlatinib|13|||
150079108|NCT04362072|541430289|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
150079109|NCT04362072|541430289|FG000|Treatment|Other|3|||
150079110|NCT04362072|541430289|FG000|Follow up|Death|2|||
150079111|NCT04362072|541430289|FG000|Follow up|Other|2|||
150079112|NCT04731363|541430290|FG000|Overall Study|Could not obtain samples|0|||
150079113|NCT04731363|541430291|FG001|Overall Study|Could not obtain samples|1|||
150079114|NCT04731363|541430292|FG002|Overall Study|Could not obtain samples|0|||
150079115|NCT04731363|541430293|FG003|Overall Study|Could not obtain samples|0|||
150079116|NCT04731363|541430290|FG000|Overall Study|Physician Decision|0|||
150079117|NCT04731363|541430291|FG001|Overall Study|Physician Decision|1|||
150079118|NCT04731363|541430292|FG002|Overall Study|Physician Decision|0|||
150079119|NCT04731363|541430293|FG003|Overall Study|Physician Decision|0|||
150079120|NCT01918774|541432283|FG000|Overall Study|Lost prior to first CBTw session|4|||
150079121|NCT01918774|541432283|FG000|Overall Study|Lost to Follow-up|1|||
150079122|NCT01606800|541432284|FG000|Overall Study|Adverse Event|3|||
150079123|NCT01606800|541432285|FG001|Overall Study|Adverse Event|1|||
150079124|NCT01606800|541432284|FG000|Overall Study|Participant withdrew consent|0|||
150079125|NCT01606800|541432285|FG001|Overall Study|Participant withdrew consent|1|||
150079126|NCT01606800|541432284|FG000|Overall Study|Missing completion status|2|||
150079127|NCT01606800|541432285|FG001|Overall Study|Missing completion status|0|||
150079128|NCT02501473|541432292|FG000|Overall Study|Study Terminated|2|||
150079129|NCT02501473|541432293|FG001|Overall Study|Study Terminated|3|||
150079130|NCT02501473|541432294|FG002|Overall Study|Study Terminated|7|||
150079131|NCT02501473|541432295|FG003|Overall Study|Study Terminated|9|||
150079132|NCT02501473|541432296|FG004|Overall Study|Study Terminated|2|||
150079133|NCT02501473|541432297|FG005|Overall Study|Study Terminated|10|||
150079134|NCT02501473|541432298|FG006|Overall Study|Study Terminated|1|||
150079135|NCT02501473|541432299|FG007|Overall Study|Study Terminated|0|||
150079136|NCT02501473|541432292|FG000|Overall Study|Withdrawal by Subject|0|||
150079137|NCT02501473|541432293|FG001|Overall Study|Withdrawal by Subject|0|||
150079138|NCT02501473|541432294|FG002|Overall Study|Withdrawal by Subject|3|||
150079139|NCT02501473|541432295|FG003|Overall Study|Withdrawal by Subject|3|||
150079140|NCT02501473|541432296|FG004|Overall Study|Withdrawal by Subject|2|||
150079141|NCT02501473|541432297|FG005|Overall Study|Withdrawal by Subject|2|||
150079142|NCT02501473|541432298|FG006|Overall Study|Withdrawal by Subject|0|||
150079143|NCT02501473|541432299|FG007|Overall Study|Withdrawal by Subject|0|||
150079144|NCT02501473|541432292|FG000|Overall Study|Death|0|||
150079145|NCT02501473|541432293|FG001|Overall Study|Death|0|||
150079146|NCT02501473|541432294|FG002|Overall Study|Death|1|||
150079147|NCT02501473|541432295|FG003|Overall Study|Death|1|||
150079148|NCT02501473|541432296|FG004|Overall Study|Death|0|||
150079149|NCT02501473|541432297|FG005|Overall Study|Death|1|||
150079150|NCT02501473|541432298|FG006|Overall Study|Death|0|||
150079151|NCT02501473|541432299|FG007|Overall Study|Death|0|||
150079152|NCT02501473|541432292|FG000|Overall Study|Lost to Follow-up|1|||
150079153|NCT02501473|541432293|FG001|Overall Study|Lost to Follow-up|0|||
150079154|NCT02501473|541432294|FG002|Overall Study|Lost to Follow-up|1|||
150079155|NCT02501473|541432295|FG003|Overall Study|Lost to Follow-up|0|||
150079156|NCT02501473|541432296|FG004|Overall Study|Lost to Follow-up|0|||
150079157|NCT02501473|541432297|FG005|Overall Study|Lost to Follow-up|1|||
150079158|NCT02501473|541432298|FG006|Overall Study|Lost to Follow-up|0|||
150079159|NCT02501473|541432299|FG007|Overall Study|Lost to Follow-up|0|||
150079160|NCT02501473|541432292|FG000|Overall Study|Reason not specified|0|||
150079161|NCT02501473|541432293|FG001|Overall Study|Reason not specified|0|||
150079162|NCT02501473|541432294|FG002|Overall Study|Reason not specified|1|||
150079163|NCT02501473|541432295|FG003|Overall Study|Reason not specified|1|||
150079164|NCT02501473|541432296|FG004|Overall Study|Reason not specified|0|||
150079165|NCT02501473|541432297|FG005|Overall Study|Reason not specified|0|||
150079166|NCT02501473|541432298|FG006|Overall Study|Reason not specified|0|||
150079167|NCT02501473|541432299|FG007|Overall Study|Reason not specified|0|||
150079168|NCT01473836|541432302|FG000|Overall Study|Adverse Event|4|||
150079169|NCT01473836|541432302|FG000|Overall Study|Lack of Efficacy|1|||
150079170|NCT01473836|541432302|FG000|Overall Study|Does not meet entrance criteria|1|||
150079171|NCT00599924|541432303|FG000|Overall Study|Lack of Efficacy|3|||
150079172|NCT00599924|541432304|FG001|Overall Study|Lack of Efficacy|5|||
150079173|NCT00599924|541432305|FG002|Overall Study|Lack of Efficacy|1|||
150079174|NCT00599924|541432306|FG003|Overall Study|Lack of Efficacy|2|||
150079175|NCT00599924|541432307|FG004|Overall Study|Lack of Efficacy|3|||
150079176|NCT00599924|541432308|FG005|Overall Study|Lack of Efficacy|2|||
150079177|NCT00599924|541432309|FG006|Overall Study|Lack of Efficacy|0|||
150079178|NCT00599924|541432303|FG000|Overall Study|Adverse Event|0|||
150079179|NCT00599924|541432304|FG001|Overall Study|Adverse Event|0|||
150079180|NCT00599924|541432305|FG002|Overall Study|Adverse Event|0|||
150079181|NCT00599924|541432306|FG003|Overall Study|Adverse Event|2|||
150079182|NCT00599924|541432307|FG004|Overall Study|Adverse Event|0|||
150079183|NCT00599924|541432308|FG005|Overall Study|Adverse Event|0|||
150079184|NCT00599924|541432309|FG006|Overall Study|Adverse Event|2|||
150079185|NCT00599924|541432303|FG000|Overall Study|Death|0|||
150079186|NCT00599924|541432304|FG001|Overall Study|Death|0|||
150079187|NCT00599924|541432305|FG002|Overall Study|Death|0|||
150079188|NCT00599924|541432306|FG003|Overall Study|Death|2|||
150079189|NCT00599924|541432307|FG004|Overall Study|Death|0|||
150079190|NCT00599924|541432308|FG005|Overall Study|Death|2|||
150079191|NCT00599924|541432309|FG006|Overall Study|Death|1|||
150079192|NCT00599924|541432303|FG000|Overall Study|Protocol Violation|0|||
150079193|NCT00599924|541432304|FG001|Overall Study|Protocol Violation|0|||
150079194|NCT00599924|541432305|FG002|Overall Study|Protocol Violation|0|||
150079195|NCT00599924|541432306|FG003|Overall Study|Protocol Violation|1|||
150079196|NCT00599924|541432307|FG004|Overall Study|Protocol Violation|0|||
150079197|NCT00599924|541432308|FG005|Overall Study|Protocol Violation|0|||
150079198|NCT00599924|541432309|FG006|Overall Study|Protocol Violation|0|||
150079199|NCT00599924|541432303|FG000|Overall Study|Withdrawal by Subject|0|||
150079200|NCT00599924|541432304|FG001|Overall Study|Withdrawal by Subject|0|||
150079201|NCT00599924|541432305|FG002|Overall Study|Withdrawal by Subject|1|||
150079202|NCT00599924|541432306|FG003|Overall Study|Withdrawal by Subject|0|||
150079203|NCT00599924|541432307|FG004|Overall Study|Withdrawal by Subject|1|||
150079204|NCT00599924|541432308|FG005|Overall Study|Withdrawal by Subject|0|||
150079205|NCT00599924|541432309|FG006|Overall Study|Withdrawal by Subject|0|||
150079206|NCT00599924|541432303|FG000|Overall Study|Other|0|||
150079207|NCT00599924|541432304|FG001|Overall Study|Other|0|||
150079208|NCT00599924|541432305|FG002|Overall Study|Other|0|||
150079209|NCT00599924|541432306|FG003|Overall Study|Other|1|||
150079210|NCT00599924|541432307|FG004|Overall Study|Other|2|||
150079211|NCT00599924|541432308|FG005|Overall Study|Other|0|||
150079212|NCT00599924|541432309|FG006|Overall Study|Other|2|||
150079213|NCT01806298|541432310|FG000|Overall Study|Adverse Event|3|||
150079214|NCT01806298|541432310|FG000|Overall Study|Protocol Non-compliance|1|||
150079215|NCT01806298|541432310|FG000|Overall Study|Withdrawal by Subject|1|||
150079216|NCT01806298|541432310|FG000|Overall Study|Other|5|||
150079217|NCT00980057|541432315|FG000|Overall Study|Death|13|||
150079218|NCT00980057|541432316|FG001|Overall Study|Death|3|||
150079219|NCT00980057|541432315|FG000|Overall Study|Adverse Event|0|||
150079220|NCT00980057|541432316|FG001|Overall Study|Adverse Event|1|||
150079221|NCT00980057|541432315|FG000|Overall Study|Physician Decision|4|||
150079222|NCT00980057|541432316|FG001|Overall Study|Physician Decision|0|||
150079223|NCT00980057|541432315|FG000|Overall Study|Lost to Follow-up|1|||
150079224|NCT00980057|541432316|FG001|Overall Study|Lost to Follow-up|0|||
150079225|NCT00980057|541432315|FG000|Overall Study|Withdrawal by Subject|1|||
150079226|NCT00980057|541432316|FG001|Overall Study|Withdrawal by Subject|1|||
150079227|NCT04980040|541432317|FG000|Overall Study|Violated the Inclusion Criteria|260|||
150079228|NCT04980040|541432317|FG000|Overall Study|Violated the Administration & Dosage|225|||
150079229|NCT04980040|541432317|FG000|Overall Study|Lost to Safety-Follow-up|4|||
150079230|NCT04980040|541432317|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
150079231|NCT00691015|541432321|FG000|Overall Study|Refused further treatment|1|||
150079232|NCT04160195|541432324|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
150079233|NCT04160195|541432325|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
150079234|NCT00592384|541432328|FG000|Overall Study|Withdrawal by Subject|5|||
150079235|NCT00592384|541432329|FG001|Overall Study|Withdrawal by Subject|6|||
150079236|NCT06333613|541432330|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
150079237|NCT02499783|541432332|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
150079238|NCT02499783|541432333|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
150079239|NCT02499783|541432334|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
150079240|NCT02499783|541432332|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
150079241|NCT02499783|541432333|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
150079242|NCT02499783|541432334|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
150079243|NCT02499783|541432332|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
150079244|NCT02499783|541432333|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
150079245|NCT02499783|541432334|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
150079246|NCT02499783|541432332|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
150079247|NCT02499783|541432333|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
150079248|NCT02499783|541432334|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
150079249|NCT02499783|541432332|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
150079250|NCT02499783|541432333|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
150079251|NCT02499783|541432334|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
150079252|NCT02499783|541432332|FG000|DB Period: Weeks 0-8|Other|1|||
150079253|NCT02499783|541432333|FG001|DB Period: Weeks 0-8|Other|1|||
150079254|NCT02499783|541432334|FG002|DB Period: Weeks 0-8|Other|0|||
150079255|NCT02499783|541432332|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
150079256|NCT02499783|541432333|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
150079257|NCT02499783|541432334|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
150079258|NCT02499783|541432332|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
150079259|NCT02499783|541432333|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
150079260|NCT02499783|541432334|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
150079261|NCT02499783|541432332|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
150079262|NCT02499783|541432333|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
150079263|NCT02499783|541432334|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
150079264|NCT02499783|541432332|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
150079265|NCT02499783|541432333|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
150079266|NCT02499783|541432334|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
150079267|NCT01243892|541432335|FG000|Overall Study|Did not meet eligibility criteria|2|||
150079268|NCT01243892|541432336|FG001|Overall Study|Did not meet eligibility criteria|0|||
150079269|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
150079270|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
150079271|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
150079272|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
150079273|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
150079274|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
150079275|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
150079276|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
150079277|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
150079278|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
150079279|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
150079280|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
150079281|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
150079282|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
150079283|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
150079284|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
150079285|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
150079286|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
150079287|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
150079288|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
150079289|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
150079290|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
150079291|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
150079292|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
150079293|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
150079294|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
150079295|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
150079296|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
150079297|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
150079298|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
150079299|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
150079300|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
150079301|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
150079302|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
150079303|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
150079304|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
150079305|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
150079306|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
150079307|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
150079308|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
150079309|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
150079310|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
150079311|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
150079312|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
150079313|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
150079314|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
150079315|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
150079316|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
150079317|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
150079318|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
150079319|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
150079320|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
150079321|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
150079322|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
150079323|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
150079324|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
150079325|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
150079326|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
150079327|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
150079328|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
150079329|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
150079330|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
150079331|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
150079332|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
150079333|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
150079334|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
150182642|NCT05075408|541806449|FG001|Overall Study|Protocol Violation|1|||
150182643|NCT05075408|541806450|FG002|Overall Study|Protocol Violation|0|||
150079335|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
150079336|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
150079337|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
150079338|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
150079339|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Change of location|0|||
150079340|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Change of location|0|||
150079341|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Change of location|0|||
150079342|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Change of location|1|||
150079343|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Change of location|0|||
150079344|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
150079345|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
150079346|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
150079347|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
150079348|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
150079349|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
150079350|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
150079351|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
150079352|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
150079353|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
150079354|NCT00730405|541432341|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
150079355|NCT00730405|541432342|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
150079356|NCT00730405|541432343|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
150079357|NCT00730405|541432344|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
150079358|NCT00730405|541432345|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
150079359|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
150182644|NCT05075408|541806448|FG000|Overall Study|Lost to Follow-up|2|||
150182645|NCT05075408|541806449|FG001|Overall Study|Lost to Follow-up|1|||
150182646|NCT05075408|541806450|FG002|Overall Study|Lost to Follow-up|1|||
150182647|NCT05075408|541806448|FG000|Overall Study|Physician Decision|1|||
150182648|NCT05075408|541806449|FG001|Overall Study|Physician Decision|0|||
150182649|NCT05075408|541806450|FG002|Overall Study|Physician Decision|0|||
150182650|NCT05075408|541806448|FG000|Overall Study|Other-unspecified|3|||
150182651|NCT05075408|541806449|FG001|Overall Study|Other-unspecified|2|||
150182652|NCT05075408|541806450|FG002|Overall Study|Other-unspecified|0|||
150182653|NCT03416023|541806451|FG000|Overall Study|Exclusion criteria failure|1|||
150182654|NCT03416023|541806451|FG000|Overall Study|Withdrawal by Subject|6|||
150182655|NCT03416023|541806451|FG000|Overall Study|Explanted|7|||
150182656|NCT03416023|541806451|FG000|Overall Study|Physician Decision|1|||
150182657|NCT03416023|541806451|FG000|Overall Study|Lost to Follow-up|1|||
150182658|NCT03416023|541806451|FG000|Overall Study|Death|1|||
150182659|NCT02780388|541806453|FG000|Overall Study|Lost to Follow-up|0|||
150182660|NCT02780388|541806454|FG001|Overall Study|Lost to Follow-up|1|||
150182661|NCT02780388|541806455|FG002|Overall Study|Lost to Follow-up|0|||
150182662|NCT02780388|541806456|FG003|Overall Study|Lost to Follow-up|0|||
150182663|NCT02780388|541806457|FG004|Overall Study|Lost to Follow-up|0|||
150182664|NCT02780388|541806453|FG000|Overall Study|Withdrawal by Subject|1|||
150182665|NCT02780388|541806454|FG001|Overall Study|Withdrawal by Subject|1|||
150182666|NCT02780388|541806455|FG002|Overall Study|Withdrawal by Subject|0|||
150182667|NCT02780388|541806456|FG003|Overall Study|Withdrawal by Subject|0|||
150182668|NCT02780388|541806457|FG004|Overall Study|Withdrawal by Subject|0|||
150182669|NCT04527146|541806458|FG000|Overall Study|Withdrawal by Subject|12|||
150182670|NCT04527146|541806459|FG001|Overall Study|Withdrawal by Subject|15|||
150182671|NCT04527146|541806460|FG002|Overall Study|Withdrawal by Subject|7|||
150182672|NCT04527146|541806461|FG003|Overall Study|Withdrawal by Subject|16|||
150182673|NCT04527146|541806458|FG000|Overall Study|Lost to Follow-up|13|||
150182674|NCT04527146|541806459|FG001|Overall Study|Lost to Follow-up|9|||
150182675|NCT04527146|541806460|FG002|Overall Study|Lost to Follow-up|16|||
150182676|NCT04527146|541806461|FG003|Overall Study|Lost to Follow-up|13|||
150182677|NCT04527146|541806458|FG000|Overall Study|Death|0|||
150182678|NCT04527146|541806459|FG001|Overall Study|Death|1|||
150182679|NCT04527146|541806460|FG002|Overall Study|Death|1|||
150182680|NCT04527146|541806461|FG003|Overall Study|Death|0|||
150182681|NCT04527146|541806458|FG000|Overall Study|Adverse Event|0|||
150182682|NCT04527146|541806459|FG001|Overall Study|Adverse Event|0|||
150182683|NCT04527146|541806460|FG002|Overall Study|Adverse Event|1|||
150182684|NCT04527146|541806461|FG003|Overall Study|Adverse Event|0|||
150182685|NCT04527146|541806458|FG000|Overall Study|Ineligible after randomization|2|||
150182686|NCT04527146|541806459|FG001|Overall Study|Ineligible after randomization|0|||
150182687|NCT04527146|541806460|FG002|Overall Study|Ineligible after randomization|2|||
150182688|NCT04527146|541806461|FG003|Overall Study|Ineligible after randomization|2|||
150182689|NCT04527146|541806458|FG000|Overall Study|Moved to a different group|6|||
150182690|NCT04527146|541806459|FG001|Overall Study|Moved to a different group|3|||
150182691|NCT04527146|541806460|FG002|Overall Study|Moved to a different group|0|||
150182692|NCT04527146|541806461|FG003|Overall Study|Moved to a different group|2|||
150079360|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
150079361|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
150079362|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
150079363|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
150079364|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
150079365|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
150079366|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
150079367|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
150079368|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
150079369|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
150079370|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
150079371|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
150079372|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
150079373|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
150079374|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Death|0|||
150079375|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Death|1|||
150079376|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Death|0|||
150079377|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Death|1|||
150079378|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Death|0|||
150079379|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Change of location|1|||
150079380|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Change of location|1|||
150079381|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Change of location|0|||
150079382|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Change of location|1|||
150079383|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Change of location|0|||
150079384|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
150079385|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
150079386|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
150079387|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
150079388|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
150079389|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
150079390|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
150079391|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
150079392|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
150079393|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
150079394|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
150079395|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
150079396|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
150079397|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
150079398|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
150182693|NCT05107401|541806462|FG000|Overall Study|Lost to Follow-up|13|||
150182694|NCT05107401|541806463|FG001|Overall Study|Lost to Follow-up|12|||
150182695|NCT03857620|541806464|FG000|Overall Study|Death|4|||
150079399|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
150079400|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
150079401|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
150079402|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
150079403|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
150079404|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
150079405|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
150079406|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
150079407|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
150079408|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
150079409|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
150079410|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
150079411|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
150079412|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
150079413|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
150182696|NCT03857620|541806465|FG001|Overall Study|Death|5|||
150182697|NCT03857620|541806466|FG002|Overall Study|Death|7|||
150182698|NCT03857620|541806464|FG000|Overall Study|Lost to Follow-up|2|||
150182699|NCT03857620|541806465|FG001|Overall Study|Lost to Follow-up|5|||
150182700|NCT03857620|541806466|FG002|Overall Study|Lost to Follow-up|3|||
150182701|NCT03857620|541806464|FG000|Overall Study|Disease progression or relapse after study registration|1|||
150182702|NCT03857620|541806465|FG001|Overall Study|Disease progression or relapse after study registration|5|||
150182703|NCT03857620|541806466|FG002|Overall Study|Disease progression or relapse after study registration|1|||
150079414|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
150079415|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
150079416|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
150079417|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
150079418|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
150079419|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
150079420|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
150079421|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
150079422|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
150079423|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
150079424|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
150079425|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
150079426|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
150079427|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
150079428|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
150079429|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
150079430|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
150079431|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
150079432|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
150079433|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
150079434|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Missing|0|||
150079435|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Missing|0|||
150079436|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Missing|2|||
150079437|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Missing|0|||
150079438|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Missing|0|||
150079439|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
150182704|NCT03857620|541806464|FG000|Overall Study|Ineligible|5|||
150182705|NCT03857620|541806465|FG001|Overall Study|Ineligible|0|||
150182706|NCT03857620|541806466|FG002|Overall Study|Ineligible|2|||
150182707|NCT03857620|541806464|FG000|Overall Study|No malignancy|1|||
150182708|NCT03857620|541806465|FG001|Overall Study|No malignancy|0|||
150182709|NCT03857620|541806466|FG002|Overall Study|No malignancy|1|||
150182710|NCT03857620|541806464|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
150182711|NCT03857620|541806465|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
150182712|NCT03857620|541806466|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
150182713|NCT03857620|541806464|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
150182714|NCT03857620|541806465|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
150182715|NCT03857620|541806466|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
150182716|NCT03857620|541806464|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
150182717|NCT03857620|541806465|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
150182718|NCT03857620|541806466|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
150182719|NCT03857620|541806464|FG000|Overall Study|Surgery not performed, patient decision|0|||
150182720|NCT03857620|541806465|FG001|Overall Study|Surgery not performed, patient decision|3|||
150182721|NCT03857620|541806466|FG002|Overall Study|Surgery not performed, patient decision|1|||
150182722|NCT03857620|541806464|FG000|Overall Study|Surgery not performed, other reason|3|||
150182723|NCT03857620|541806465|FG001|Overall Study|Surgery not performed, other reason|1|||
150182724|NCT03857620|541806466|FG002|Overall Study|Surgery not performed, other reason|4|||
150182725|NCT03857620|541806464|FG000|Overall Study|Worsening performance status after surgery performed|0|||
150182726|NCT03857620|541806465|FG001|Overall Study|Worsening performance status after surgery performed|1|||
150182727|NCT03857620|541806466|FG002|Overall Study|Worsening performance status after surgery performed|1|||
150182728|NCT02201108|541806467|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
150182729|NCT02201108|541806468|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
150182730|NCT02201108|541806469|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
150182731|NCT02201108|541806467|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
150182732|NCT02201108|541806468|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
150182733|NCT02201108|541806469|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
150182734|NCT02201108|541806467|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
150182735|NCT02201108|541806468|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
150182736|NCT02201108|541806469|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
150182737|NCT02201108|541806467|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
150182738|NCT02201108|541806468|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
150182739|NCT02201108|541806469|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
150182740|NCT02201108|541806467|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
150182741|NCT02201108|541806468|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
150182742|NCT02201108|541806469|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
150079440|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
150079441|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
150079442|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
150079443|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
150079444|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
150079445|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
150079446|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
150079447|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
150079448|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
150079449|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
150079450|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
150079451|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
150079452|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
150079453|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
150079454|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
150079455|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
150079456|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
150079457|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
150079458|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
150079459|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
150079460|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
150079461|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
150079462|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
150079463|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
150079464|NCT00730405|541432341|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
150079465|NCT00730405|541432342|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
150079466|NCT00730405|541432343|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
150079467|NCT00730405|541432344|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
150079468|NCT00730405|541432345|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
150079469|NCT00963937|541432348|FG000|Overall Study|Protocol Violation|1|||
150079470|NCT00963937|541432349|FG001|Overall Study|Protocol Violation|1|||
150079471|NCT00963937|541432350|FG002|Overall Study|Protocol Violation|0|||
150079472|NCT00963937|541432348|FG000|Overall Study|Physician Decision|18|||
150079473|NCT00963937|541432349|FG001|Overall Study|Physician Decision|10|||
150079474|NCT00963937|541432350|FG002|Overall Study|Physician Decision|4|||
150079475|NCT00334958|541432351|FG000|Overall Study|Medication Noncompliance|0|||
150079476|NCT00334958|541432352|FG001|Overall Study|Medication Noncompliance|3|||
150079477|NCT00334958|541432351|FG000|Overall Study|Protocol Violation|2|||
150079478|NCT00334958|541432352|FG001|Overall Study|Protocol Violation|2|||
150079479|NCT00334958|541432351|FG000|Overall Study|Request of the investigator or sponsor|0|||
150079480|NCT00334958|541432352|FG001|Overall Study|Request of the investigator or sponsor|1|||
150079481|NCT00334958|541432351|FG000|Overall Study|Withdrawal by Subject|7|||
150079482|NCT00334958|541432352|FG001|Overall Study|Withdrawal by Subject|4|||
150079483|NCT00334958|541432351|FG000|Overall Study|Adverse Event|27|||
150079484|NCT00334958|541432352|FG001|Overall Study|Adverse Event|12|||
150079485|NCT00334958|541432351|FG000|Overall Study|Other|1|||
150182743|NCT02201108|541806467|FG000|Open Label Period (up to Week 192)|Other reason|4|||
150182744|NCT02201108|541806468|FG001|Open Label Period (up to Week 192)|Other reason|7|||
150079486|NCT00334958|541432352|FG001|Overall Study|Other|2|||
150182745|NCT02201108|541806469|FG002|Open Label Period (up to Week 192)|Other reason|0|||
150182746|NCT02201108|541806467|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
150182747|NCT02201108|541806468|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
150182748|NCT02201108|541806469|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
150182749|NCT02201108|541806467|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
150182750|NCT02201108|541806468|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
150182751|NCT02201108|541806469|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
150182752|NCT02201108|541806467|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
150182753|NCT02201108|541806468|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
150182754|NCT02201108|541806469|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
150182755|NCT03438188|541806470|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
150182756|NCT03438188|541806471|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
150182757|NCT03438188|541806472|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
150182758|NCT03438188|541806470|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
150182759|NCT03438188|541806471|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
150182760|NCT03438188|541806472|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
150182761|NCT03438188|541806470|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
150182762|NCT03438188|541806471|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
150079487|NCT04431453|541432353|FG000|Overall Study|Withdrew Consent|0|||
150079488|NCT04431453|541432354|FG001|Overall Study|Withdrew Consent|1|||
150079489|NCT04431453|541432355|FG002|Overall Study|Withdrew Consent|0|||
150079490|NCT04431453|541432356|FG003|Overall Study|Withdrew Consent|2|||
150079491|NCT04431453|541432357|FG004|Overall Study|Withdrew Consent|0|||
150079492|NCT04431453|541432358|FG005|Overall Study|Withdrew Consent|0|||
150079493|NCT04431453|541432359|FG006|Overall Study|Withdrew Consent|0|||
150079494|NCT04431453|541432360|FG007|Overall Study|Withdrew Consent|0|||
150079495|NCT04431453|541432353|FG000|Overall Study|Death|1|||
150079496|NCT04431453|541432354|FG001|Overall Study|Death|0|||
150079497|NCT04431453|541432355|FG002|Overall Study|Death|0|||
150079498|NCT04431453|541432356|FG003|Overall Study|Death|0|||
150079499|NCT04431453|541432357|FG004|Overall Study|Death|0|||
150079500|NCT04431453|541432358|FG005|Overall Study|Death|0|||
150079501|NCT04431453|541432359|FG006|Overall Study|Death|0|||
150079502|NCT04431453|541432360|FG007|Overall Study|Death|1|||
150079503|NCT04431453|541432353|FG000|Overall Study|Lost to Follow-up|0|||
150079504|NCT04431453|541432354|FG001|Overall Study|Lost to Follow-up|0|||
150079505|NCT04431453|541432355|FG002|Overall Study|Lost to Follow-up|1|||
150079506|NCT04431453|541432356|FG003|Overall Study|Lost to Follow-up|1|||
150079507|NCT04431453|541432357|FG004|Overall Study|Lost to Follow-up|0|||
150079508|NCT04431453|541432358|FG005|Overall Study|Lost to Follow-up|0|||
150079509|NCT04431453|541432359|FG006|Overall Study|Lost to Follow-up|0|||
150079510|NCT04431453|541432360|FG007|Overall Study|Lost to Follow-up|0|||
150079511|NCT04431453|541432353|FG000|Overall Study|Enrolled but Never Treated|0|||
150079512|NCT04431453|541432354|FG001|Overall Study|Enrolled but Never Treated|0|||
150079513|NCT04431453|541432355|FG002|Overall Study|Enrolled but Never Treated|0|||
150079514|NCT04431453|541432356|FG003|Overall Study|Enrolled but Never Treated|0|||
150079515|NCT04431453|541432357|FG004|Overall Study|Enrolled but Never Treated|1|||
150079516|NCT04431453|541432358|FG005|Overall Study|Enrolled but Never Treated|0|||
150079517|NCT04431453|541432359|FG006|Overall Study|Enrolled but Never Treated|0|||
150079518|NCT04431453|541432360|FG007|Overall Study|Enrolled but Never Treated|0|||
150079519|NCT00622401|541432361|FG000|Overall Study|Disease progression prior to treatment|3|||
150079520|NCT00622401|541432362|FG001|Overall Study|Disease progression prior to treatment|2|||
150079521|NCT00622401|541432363|FG002|Overall Study|Disease progression prior to treatment|0|||
150079522|NCT02021773|541432374|FG000|Overall Study|Adverse Event|1|||
150079523|NCT02021773|541432375|FG001|Overall Study|Adverse Event|4|||
150079524|NCT02021773|541432376|FG002|Overall Study|Adverse Event|3|||
150079525|NCT02021773|541432374|FG000|Overall Study|Lack of Efficacy|2|||
150079526|NCT02021773|541432375|FG001|Overall Study|Lack of Efficacy|2|||
150079527|NCT02021773|541432376|FG002|Overall Study|Lack of Efficacy|2|||
150079528|NCT02021773|541432374|FG000|Overall Study|Protocol Violation|2|||
150079529|NCT02021773|541432375|FG001|Overall Study|Protocol Violation|3|||
150079530|NCT02021773|541432376|FG002|Overall Study|Protocol Violation|1|||
150079531|NCT02021773|541432374|FG000|Overall Study|Withdrawal by Subject|3|||
150079532|NCT02021773|541432375|FG001|Overall Study|Withdrawal by Subject|4|||
150079533|NCT02021773|541432376|FG002|Overall Study|Withdrawal by Subject|5|||
150079534|NCT02021773|541432374|FG000|Overall Study|Lost to Follow-up|1|||
150079535|NCT02021773|541432375|FG001|Overall Study|Lost to Follow-up|3|||
150079536|NCT02021773|541432376|FG002|Overall Study|Lost to Follow-up|0|||
150079537|NCT02021773|541432374|FG000|Overall Study|Reason not specified|3|||
150079538|NCT02021773|541432375|FG001|Overall Study|Reason not specified|0|||
150079539|NCT02021773|541432376|FG002|Overall Study|Reason not specified|0|||
150079540|NCT02243696|541432378|FG000|Overall Study|Death|282|||
150079541|NCT02243696|541432378|FG000|Overall Study|Withdrawal by Subject|79|||
150079542|NCT02243696|541432378|FG000|Overall Study|Lost to Follow-up|57|||
150079543|NCT02243696|541432378|FG000|Overall Study|Subject No Longer has Study System|42|||
150079544|NCT02243696|541432378|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
150079545|NCT02243696|541432378|FG000|Overall Study|Study Terminated for EP PASSION|961|||
150079546|NCT01534962|541432379|FG000|Overall Study|Randomized but did not start treatment|2|||
150079547|NCT01534962|541432380|FG001|Overall Study|Randomized but did not start treatment|0|||
150079548|NCT01534962|541432381|FG002|Overall Study|Randomized but did not start treatment|0|||
150079549|NCT01534962|541432382|FG003|Overall Study|Randomized but did not start treatment|1|||
150079550|NCT01534962|541432379|FG000|Overall Study|Discontinued at AF recurrence|35|||
150079551|NCT01534962|541432380|FG001|Overall Study|Discontinued at AF recurrence|26|||
150079552|NCT01534962|541432381|FG002|Overall Study|Discontinued at AF recurrence|24|||
150079553|NCT01534962|541432382|FG003|Overall Study|Discontinued at AF recurrence|31|||
150079554|NCT00622284|541432383|FG000|Overall Study|Lack of Efficacy|45|||
150079555|NCT00622284|541432384|FG001|Overall Study|Lack of Efficacy|15|||
150079556|NCT00622284|541432383|FG000|Overall Study|Adverse Event|61|||
150079557|NCT00622284|541432384|FG001|Overall Study|Adverse Event|90|||
150079558|NCT00622284|541432383|FG000|Overall Study|Protocol Violation|12|||
150079559|NCT00622284|541432384|FG001|Overall Study|Protocol Violation|5|||
150079560|NCT00622284|541432383|FG000|Overall Study|Lost to Follow-up|11|||
150079561|NCT00622284|541432384|FG001|Overall Study|Lost to Follow-up|13|||
150079562|NCT00622284|541432383|FG000|Overall Study|Withdrawal by Subject|27|||
150079563|NCT00622284|541432384|FG001|Overall Study|Withdrawal by Subject|24|||
150079564|NCT00622284|541432383|FG000|Overall Study|Other reason (not specified)|33|||
150079565|NCT00622284|541432384|FG001|Overall Study|Other reason (not specified)|24|||
150079566|NCT00457301|541432385|FG000|Overall Study|Withdrawal by Subject|3|||
150079567|NCT00457301|541432386|FG001|Overall Study|Withdrawal by Subject|3|||
150079568|NCT00457301|541432385|FG000|Overall Study|Censored out of the study|15|||
150079569|NCT00457301|541432386|FG001|Overall Study|Censored out of the study|14|||
150079570|NCT00457301|541432385|FG000|Overall Study|Death|5|||
150079571|NCT00457301|541432386|FG001|Overall Study|Death|7|||
150079572|NCT00915278|541432390|FG000|Overall Study|Death|1|||
150079573|NCT00915278|541432391|FG001|Overall Study|Death|0|||
150079574|NCT00915278|541432392|FG002|Overall Study|Death|0|||
150079575|NCT00915278|541432393|FG003|Overall Study|Death|0|||
150079576|NCT00915278|541432394|FG004|Overall Study|Death|0|||
150079577|NCT00915278|541432395|FG005|Overall Study|Death|0|||
150079578|NCT00915278|541432390|FG000|Overall Study|Lost to Follow-up|0|||
150079579|NCT00915278|541432391|FG001|Overall Study|Lost to Follow-up|1|||
150079580|NCT00915278|541432392|FG002|Overall Study|Lost to Follow-up|0|||
150079581|NCT00915278|541432393|FG003|Overall Study|Lost to Follow-up|0|||
150079582|NCT00915278|541432394|FG004|Overall Study|Lost to Follow-up|0|||
150079583|NCT00915278|541432395|FG005|Overall Study|Lost to Follow-up|0|||
150079584|NCT00915278|541432390|FG000|Overall Study|Withdrawal by Subject|0|||
150079585|NCT00915278|541432391|FG001|Overall Study|Withdrawal by Subject|1|||
150079586|NCT00915278|541432392|FG002|Overall Study|Withdrawal by Subject|0|||
150079587|NCT00915278|541432393|FG003|Overall Study|Withdrawal by Subject|0|||
150079588|NCT00915278|541432394|FG004|Overall Study|Withdrawal by Subject|1|||
150079589|NCT00915278|541432395|FG005|Overall Study|Withdrawal by Subject|4|||
150079590|NCT00915278|541432390|FG000|Overall Study|Adverse Event|4|||
150079591|NCT00915278|541432391|FG001|Overall Study|Adverse Event|1|||
150079592|NCT00915278|541432392|FG002|Overall Study|Adverse Event|0|||
150079593|NCT00915278|541432393|FG003|Overall Study|Adverse Event|0|||
150079594|NCT00915278|541432394|FG004|Overall Study|Adverse Event|0|||
150079595|NCT00915278|541432395|FG005|Overall Study|Adverse Event|0|||
150079596|NCT00915278|541432390|FG000|Overall Study|Progressive disease/clinical progression|0|||
150079597|NCT00915278|541432391|FG001|Overall Study|Progressive disease/clinical progression|0|||
150079598|NCT00915278|541432392|FG002|Overall Study|Progressive disease/clinical progression|0|||
150079599|NCT00915278|541432393|FG003|Overall Study|Progressive disease/clinical progression|3|||
150079600|NCT00915278|541432394|FG004|Overall Study|Progressive disease/clinical progression|1|||
150079601|NCT00915278|541432395|FG005|Overall Study|Progressive disease/clinical progression|2|||
150079602|NCT00915278|541432390|FG000|Overall Study|Infusion related AEs|0|||
150079603|NCT00915278|541432391|FG001|Overall Study|Infusion related AEs|0|||
150079604|NCT00915278|541432392|FG002|Overall Study|Infusion related AEs|0|||
150079605|NCT00915278|541432393|FG003|Overall Study|Infusion related AEs|0|||
150079606|NCT00915278|541432394|FG004|Overall Study|Infusion related AEs|0|||
150079607|NCT00915278|541432395|FG005|Overall Study|Infusion related AEs|2|||
150079608|NCT00915278|541432390|FG000|Overall Study|Admission to hospice|0|||
150079609|NCT00915278|541432391|FG001|Overall Study|Admission to hospice|0|||
150079610|NCT00915278|541432392|FG002|Overall Study|Admission to hospice|1|||
150079611|NCT00915278|541432393|FG003|Overall Study|Admission to hospice|0|||
150079612|NCT00915278|541432394|FG004|Overall Study|Admission to hospice|0|||
150079613|NCT00915278|541432395|FG005|Overall Study|Admission to hospice|0|||
150079614|NCT05399641|541432404|FG000|Overall Study|Adverse Event|0|||
150079615|NCT05399641|541432405|FG001|Overall Study|Adverse Event|1|||
150079616|NCT05399641|541432406|FG002|Overall Study|Adverse Event|1|||
150079617|NCT05399641|541432404|FG000|Overall Study|Lost to Follow-up|1|||
150079618|NCT05399641|541432405|FG001|Overall Study|Lost to Follow-up|2|||
150079619|NCT05399641|541432406|FG002|Overall Study|Lost to Follow-up|2|||
150079620|NCT05399641|541432404|FG000|Overall Study|Physician Decision|1|||
150079621|NCT05399641|541432405|FG001|Overall Study|Physician Decision|3|||
150079622|NCT05399641|541432406|FG002|Overall Study|Physician Decision|3|||
150079623|NCT05399641|541432404|FG000|Overall Study|Withdrawal by Subject|4|||
150079624|NCT05399641|541432405|FG001|Overall Study|Withdrawal by Subject|11|||
150079625|NCT05399641|541432406|FG002|Overall Study|Withdrawal by Subject|7|||
150079626|NCT05399641|541432404|FG000|Overall Study|Reason not defined|3|||
150079627|NCT05399641|541432405|FG001|Overall Study|Reason not defined|5|||
150079628|NCT05399641|541432406|FG002|Overall Study|Reason not defined|6|||
150079629|NCT02094677|541432407|FG000|Overall Study|Screening|3|||
150079630|NCT02094677|541432408|FG001|Overall Study|Screening|1|||
150079631|NCT03408483|541432409|FG000|Overall Study|Physician Decision|3|||
150079632|NCT03408483|541432410|FG001|Overall Study|Physician Decision|3|||
150079633|NCT03408483|541432409|FG000|Overall Study|Lost to Follow-up|3|||
150079634|NCT03408483|541432410|FG001|Overall Study|Lost to Follow-up|0|||
150079635|NCT00478231|541432411|FG000|Overall Study|Death|7|||
150079636|NCT00478231|541432411|FG000|Overall Study|Lack of Efficacy|47|||
150079637|NCT00478231|541432411|FG000|Overall Study|Lost to Follow-up|7|||
150079638|NCT00478231|541432411|FG000|Overall Study|Withdrawal by Subject|6|||
150079639|NCT00478231|541432411|FG000|Overall Study|Other|9|||
150079640|NCT00478231|541432411|FG000|Overall Study|Adverse Event|5|||
150079641|NCT00478231|541432411|FG000|Overall Study|Randomized, not treated|3|||
150079642|NCT01300650|541432412|FG000|Overall Study|Adverse Event|1|||
150079643|NCT01702961|541432413|FG000|Overall Study|Additional treatment|3|||
150079644|NCT01702961|541432413|FG000|Overall Study|Progressive disease|5|||
150079645|NCT01702961|541432413|FG000|Overall Study|Relapse|20|||
150079646|NCT01702961|541432413|FG000|Overall Study|Death|6|||
150079647|NCT01702961|541432413|FG000|Overall Study|Lost to Follow-up|2|||
150079648|NCT01702961|541432413|FG000|Overall Study|Ongoing|11|||
150079649|NCT01201850|541432418|FG000|Overall Study|Tumor progression|4|||
150079650|NCT03137537|541432419|FG000|Overall Study|Adverse Event|0|||
150079651|NCT03137537|541432420|FG001|Overall Study|Adverse Event|1|||
150079652|NCT01552694|541432421|FG000|Overall Study|Lost to Follow-up|0|||
150079653|NCT01552694|541432422|FG001|Overall Study|Lost to Follow-up|1|||
150079654|NCT01552694|541432421|FG000|Overall Study|Protocol Violation|0|||
150079655|NCT01552694|541432422|FG001|Overall Study|Protocol Violation|1|||
150079656|NCT00191139|541432424|FG000|Overall Study|Adverse Event|2|||
150079657|NCT00191139|541432425|FG001|Overall Study|Adverse Event|6|||
150079658|NCT00191139|541432424|FG000|Overall Study|Death|2|||
150079659|NCT00191139|541432425|FG001|Overall Study|Death|0|||
150079660|NCT00191139|541432424|FG000|Overall Study|Withdrawal by Subject|0|||
150079661|NCT00191139|541432425|FG001|Overall Study|Withdrawal by Subject|3|||
150079662|NCT00191139|541432424|FG000|Overall Study|Disease Progression|0|||
150079663|NCT00191139|541432425|FG001|Overall Study|Disease Progression|1|||
150079664|NCT00191139|541432424|FG000|Overall Study|Other|1|||
150079665|NCT00191139|541432425|FG001|Overall Study|Other|2|||
150079666|NCT02465515|541432426|FG000|Overall Study|Investigator site closed|4|||
150182763|NCT03438188|541806472|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
150182764|NCT03438188|541806470|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
150182765|NCT03438188|541806471|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
150182766|NCT03438188|541806472|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
150182767|NCT03438188|541806470|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
150182768|NCT03438188|541806471|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
150182769|NCT03438188|541806472|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
150182770|NCT05215847|541806473|FG000|Overall Study|Lost to Follow-up|1|||
150182771|NCT03433339|541806474|FG000|Overall Study|Lost to Follow-up|2|||
150182772|NCT03433339|541806475|FG001|Overall Study|Lost to Follow-up|0|||
150182773|NCT03433339|541806474|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
150182774|NCT03433339|541806475|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
150182775|NCT03433339|541806474|FG000|Overall Study|Withdrawal by Subject|0|||
150182776|NCT03433339|541806475|FG001|Overall Study|Withdrawal by Subject|2|||
150182777|NCT03289039|541806483|FG000|Overall Study|Withdrawal by Subject|0|||
150182778|NCT03289039|541806484|FG001|Overall Study|Withdrawal by Subject|1|||
150182779|NCT03289039|541806483|FG000|Overall Study|Became ineligible prior to treatment start|0|||
150182780|NCT03289039|541806484|FG001|Overall Study|Became ineligible prior to treatment start|1|||
150079667|NCT02465515|541432427|FG001|Overall Study|Investigator site closed|5|||
150079668|NCT02465515|541432426|FG000|Overall Study|Withdrawal by Subject|74|||
150079669|NCT02465515|541432427|FG001|Overall Study|Withdrawal by Subject|43|||
150079670|NCT02465515|541432426|FG000|Overall Study|Physician Decision|8|||
150079671|NCT02465515|541432427|FG001|Overall Study|Physician Decision|12|||
150079672|NCT02465515|541432426|FG000|Overall Study|Lost to Follow-up|68|||
150079673|NCT02465515|541432427|FG001|Overall Study|Lost to Follow-up|51|||
150079674|NCT03846804|541432428|FG000|Overall Study|Refused blood draw|1|||
150079675|NCT03846804|541432428|FG000|Overall Study|Protocol Violation|1|||
150079676|NCT00824720|541432429|FG000|Overall Study|failed plug insertion|3|||
150079677|NCT00824720|541432430|FG001|Overall Study|failed plug insertion|1|||
150079678|NCT00824720|541432431|FG002|Overall Study|failed plug insertion|0|||
150079679|NCT00824720|541432429|FG000|Overall Study|Protocol Violation|0|||
150079680|NCT00824720|541432430|FG001|Overall Study|Protocol Violation|0|||
150079681|NCT00824720|541432431|FG002|Overall Study|Protocol Violation|1|||
150079682|NCT02339584|541432432|FG000|Overall Study|Adverse Event|11|||
150079683|NCT02339584|541432433|FG001|Overall Study|Adverse Event|7|||
150079684|NCT02339584|541432432|FG000|Overall Study|Lack of Efficacy|0|||
150079685|NCT02339584|541432433|FG001|Overall Study|Lack of Efficacy|1|||
150079686|NCT02339584|541432432|FG000|Overall Study|Physician Decision|1|||
150079687|NCT02339584|541432433|FG001|Overall Study|Physician Decision|2|||
150079688|NCT02339584|541432432|FG000|Overall Study|Protocol Violation|1|||
150079689|NCT02339584|541432433|FG001|Overall Study|Protocol Violation|1|||
150079690|NCT02339584|541432432|FG000|Overall Study|Withdrawal by Subject|2|||
150079691|NCT02339584|541432433|FG001|Overall Study|Withdrawal by Subject|4|||
150182781|NCT03289039|541806483|FG000|Overall Study|progressed before treatment start|1|||
150182782|NCT03289039|541806484|FG001|Overall Study|progressed before treatment start|0|||
150182783|NCT03055858|541806485|FG000|Overall Study|Death|9|||
150182784|NCT03055858|541806485|FG000|Overall Study|Withdrawal by Subject|11|||
150182785|NCT03055858|541806485|FG000|Overall Study|Lost to Follow-up|6|||
150182786|NCT03055858|541806485|FG000|Overall Study|Missed Follow-Up Visits|18|||
150079692|NCT02610725|541432434|FG000|Overall Study|Lost to Follow-up|197|||
150079693|NCT02610725|541432434|FG000|Overall Study|self-reported contraindication|9|||
150079694|NCT04094883|541432435|FG000|Overall Study|Withdrawal by Subject|1|||
150079695|NCT00743483|541432436|FG000|Baseline Period|Physician Decision|1|||
150079696|NCT00743483|541432436|FG000|Treatment Period|Adverse Event|1|||
150079697|NCT01273597|541432437|FG000|Overall Study|Adverse Event|5|||
150079698|NCT01273597|541432437|FG000|Overall Study|Underwent Kidney Transplantation|2|||
150079699|NCT01273597|541432437|FG000|Overall Study|Reason Not Reported|1|||
150079700|NCT01785069|541432443|FG000|Overall Study|Implanted with nonstudy device|1|||
150079701|NCT01785069|541432444|FG001|Overall Study|Implanted with nonstudy device|2|||
150079702|NCT01785069|541432445|FG002|Overall Study|Implanted with nonstudy device|1|||
150079703|NCT01785069|541432446|FG003|Overall Study|Implanted with nonstudy device|0|||
150079704|NCT01785069|541432443|FG000|Overall Study|Death|0|||
150079705|NCT01785069|541432444|FG001|Overall Study|Death|0|||
150079706|NCT01785069|541432445|FG002|Overall Study|Death|2|||
150079707|NCT01785069|541432446|FG003|Overall Study|Death|0|||
150079708|NCT01785069|541432443|FG000|Overall Study|Subject choice|2|||
150079709|NCT01785069|541432444|FG001|Overall Study|Subject choice|2|||
150079710|NCT01785069|541432445|FG002|Overall Study|Subject choice|0|||
150182787|NCT04586920|541806486|FG000|Overall Study|Lost to Follow-up|0|||
150182788|NCT04586920|541806487|FG001|Overall Study|Lost to Follow-up|0|||
150182789|NCT04586920|541806488|FG002|Overall Study|Lost to Follow-up|0|||
150182790|NCT04586920|541806489|FG003|Overall Study|Lost to Follow-up|0|||
150182791|NCT04586920|541806490|FG004|Overall Study|Lost to Follow-up|0|||
150182792|NCT04586920|541806491|FG005|Overall Study|Lost to Follow-up|0|||
150182793|NCT04586920|541806492|FG006|Overall Study|Lost to Follow-up|1|||
150182794|NCT04586920|541806493|FG007|Overall Study|Lost to Follow-up|1|||
150182795|NCT04586920|541806494|FG008|Overall Study|Lost to Follow-up|0|||
150182796|NCT04586920|541806495|FG009|Overall Study|Lost to Follow-up|1|||
150182797|NCT04586920|541806496|FG010|Overall Study|Lost to Follow-up|0|||
150182798|NCT04586920|541806497|FG011|Overall Study|Lost to Follow-up|0|||
150182799|NCT04586920|541806498|FG012|Overall Study|Lost to Follow-up|0|||
150182800|NCT04586920|541806499|FG013|Overall Study|Lost to Follow-up|1|||
150182801|NCT04586920|541806500|FG014|Overall Study|Lost to Follow-up|0|||
150182802|NCT04586920|541806501|FG015|Overall Study|Lost to Follow-up|0|||
150182803|NCT04586920|541806502|FG016|Overall Study|Lost to Follow-up|0|||
150182804|NCT04586920|541806503|FG017|Overall Study|Lost to Follow-up|0|||
150182805|NCT04586920|541806486|FG000|Overall Study|Withdrawal by Subject|0|||
150182806|NCT04586920|541806487|FG001|Overall Study|Withdrawal by Subject|0|||
150182807|NCT04586920|541806488|FG002|Overall Study|Withdrawal by Subject|0|||
150182808|NCT04586920|541806489|FG003|Overall Study|Withdrawal by Subject|0|||
150182809|NCT04586920|541806490|FG004|Overall Study|Withdrawal by Subject|0|||
150182810|NCT04586920|541806491|FG005|Overall Study|Withdrawal by Subject|0|||
150182811|NCT04586920|541806492|FG006|Overall Study|Withdrawal by Subject|0|||
150182812|NCT04586920|541806493|FG007|Overall Study|Withdrawal by Subject|1|||
150182813|NCT04586920|541806494|FG008|Overall Study|Withdrawal by Subject|0|||
150182814|NCT04586920|541806495|FG009|Overall Study|Withdrawal by Subject|1|||
150182815|NCT04586920|541806496|FG010|Overall Study|Withdrawal by Subject|0|||
150182816|NCT04586920|541806497|FG011|Overall Study|Withdrawal by Subject|1|||
150182817|NCT04586920|541806498|FG012|Overall Study|Withdrawal by Subject|0|||
150182818|NCT04586920|541806499|FG013|Overall Study|Withdrawal by Subject|0|||
150182819|NCT04586920|541806500|FG014|Overall Study|Withdrawal by Subject|0|||
150182820|NCT04586920|541806501|FG015|Overall Study|Withdrawal by Subject|0|||
150182821|NCT04586920|541806502|FG016|Overall Study|Withdrawal by Subject|0|||
150182822|NCT04586920|541806503|FG017|Overall Study|Withdrawal by Subject|0|||
150182823|NCT01718743|541806508|FG000|Overall Study|Physician Decision|7|||
150182824|NCT01718743|541806508|FG000|Overall Study|Withdrawal by Subject|14|||
150182825|NCT01718743|541806508|FG000|Overall Study|Progressive Disease|22|||
150182826|NCT01718743|541806508|FG000|Overall Study|Toxicity|1|||
150182827|NCT01718743|541806508|FG000|Overall Study|Malignancy|1|||
150182828|NCT05136404|541806510|FG000|Period 1|Adverse Event|0|||
150182829|NCT05136404|541806511|FG001|Period 1|Adverse Event|1|||
150079711|NCT01785069|541432446|FG003|Overall Study|Subject choice|1|||
150079712|NCT01785069|541432443|FG000|Overall Study|Lost to Follow-up|1|||
150079713|NCT01785069|541432444|FG001|Overall Study|Lost to Follow-up|2|||
150079714|NCT01785069|541432445|FG002|Overall Study|Lost to Follow-up|4|||
150182830|NCT05136404|541806512|FG002|Period 1|Adverse Event|1|||
150182831|NCT05136404|541806510|FG000|Period 2|Inappropriate Behavior|0|||
150182832|NCT05136404|541806511|FG001|Period 2|Inappropriate Behavior|0|||
150182833|NCT05136404|541806512|FG002|Period 2|Inappropriate Behavior|1|||
150079715|NCT01785069|541432446|FG003|Overall Study|Lost to Follow-up|1|||
150182834|NCT05136404|541806510|FG000|Period 3|Adverse Event|0|||
150182835|NCT05136404|541806511|FG001|Period 3|Adverse Event|0|||
150182836|NCT05136404|541806512|FG002|Period 3|Adverse Event|1|||
150182837|NCT00632203|541806513|FG000|Overall Study|Did not start study treatment|1|||
150182838|NCT00632203|541806514|FG001|Overall Study|Did not start study treatment|0|||
150079716|NCT01785069|541432443|FG000|Overall Study|Reason not Specified|1|||
150079717|NCT01785069|541432444|FG001|Overall Study|Reason not Specified|2|||
150182839|NCT04452318|541806517|FG000|Overall Study|Physician Decision|1|||
150182840|NCT04452318|541806518|FG001|Overall Study|Physician Decision|2|||
150182841|NCT04452318|541806519|FG002|Overall Study|Physician Decision|0|||
150182842|NCT04452318|541806520|FG003|Overall Study|Physician Decision|2|||
150182843|NCT04452318|541806521|FG004|Overall Study|Physician Decision|0|||
150182844|NCT04452318|541806522|FG005|Overall Study|Physician Decision|2|||
150182845|NCT04452318|541806523|FG006|Overall Study|Physician Decision|5|||
150182846|NCT04452318|541806517|FG000|Overall Study|Death|2|||
150182847|NCT04452318|541806518|FG001|Overall Study|Death|3|||
150182848|NCT04452318|541806519|FG002|Overall Study|Death|0|||
150182849|NCT04452318|541806520|FG003|Overall Study|Death|0|||
150182850|NCT04452318|541806521|FG004|Overall Study|Death|0|||
150182851|NCT04452318|541806522|FG005|Overall Study|Death|0|||
150182852|NCT04452318|541806523|FG006|Overall Study|Death|0|||
150182853|NCT04452318|541806517|FG000|Overall Study|Lost to Follow-up|38|||
150182854|NCT04452318|541806518|FG001|Overall Study|Lost to Follow-up|28|||
150182855|NCT04452318|541806519|FG002|Overall Study|Lost to Follow-up|0|||
150182856|NCT04452318|541806520|FG003|Overall Study|Lost to Follow-up|3|||
150182857|NCT04452318|541806521|FG004|Overall Study|Lost to Follow-up|3|||
150182858|NCT04452318|541806522|FG005|Overall Study|Lost to Follow-up|2|||
150182859|NCT04452318|541806523|FG006|Overall Study|Lost to Follow-up|1|||
150182860|NCT04452318|541806517|FG000|Overall Study|Withdrawal by Subject|46|||
150182861|NCT04452318|541806518|FG001|Overall Study|Withdrawal by Subject|40|||
150182862|NCT04452318|541806519|FG002|Overall Study|Withdrawal by Subject|0|||
150182863|NCT04452318|541806520|FG003|Overall Study|Withdrawal by Subject|18|||
150182864|NCT04452318|541806521|FG004|Overall Study|Withdrawal by Subject|6|||
150182865|NCT04452318|541806522|FG005|Overall Study|Withdrawal by Subject|8|||
150182866|NCT04452318|541806523|FG006|Overall Study|Withdrawal by Subject|6|||
150182867|NCT01426412|541806524|FG000|Overall Study|Withdrawal by Subject|1|||
150182868|NCT01426412|541806525|FG001|Overall Study|Withdrawal by Subject|0|||
150182869|NCT01426412|541806526|FG002|Overall Study|Withdrawal by Subject|0|||
150182870|NCT01426412|541806527|FG003|Overall Study|Withdrawal by Subject|0|||
150182871|NCT01426412|541806528|FG004|Overall Study|Withdrawal by Subject|1|||
150182872|NCT01426412|541806529|FG005|Overall Study|Withdrawal by Subject|0|||
150182873|NCT01426412|541806530|FG006|Overall Study|Withdrawal by Subject|0|||
150182874|NCT01426412|541806531|FG007|Overall Study|Withdrawal by Subject|3|||
150182875|NCT01426412|541806532|FG008|Overall Study|Withdrawal by Subject|1|||
150182876|NCT02376790|541806534|FG000|Overall Study|Withdrawal by Subject|43|||
150182877|NCT02376790|541806535|FG001|Overall Study|Withdrawal by Subject|36|||
150182878|NCT02376790|541806536|FG002|Overall Study|Withdrawal by Subject|37|||
150182879|NCT02376790|541806534|FG000|Overall Study|Decision by Sponsor|2|||
150182880|NCT02376790|541806535|FG001|Overall Study|Decision by Sponsor|1|||
150182881|NCT02376790|541806536|FG002|Overall Study|Decision by Sponsor|4|||
150079718|NCT01785069|541432445|FG002|Overall Study|Reason not Specified|1|||
150079719|NCT01785069|541432446|FG003|Overall Study|Reason not Specified|4|||
150079720|NCT01785069|541432443|FG000|Overall Study|Not evaluable|7|||
150079721|NCT01785069|541432444|FG001|Overall Study|Not evaluable|4|||
150079722|NCT01785069|541432445|FG002|Overall Study|Not evaluable|5|||
150079723|NCT01785069|541432446|FG003|Overall Study|Not evaluable|8|||
150079724|NCT01088997|541432447|FG000|Overall Study|Physician Decision|1|||
150079725|NCT01088997|541432448|FG001|Overall Study|Physician Decision|1|||
150079726|NCT01088997|541432447|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
150079727|NCT01088997|541432448|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
150079728|NCT01088997|541432447|FG000|Overall Study|Excluded prior to receiving drug|1|||
150079729|NCT01088997|541432448|FG001|Overall Study|Excluded prior to receiving drug|1|||
150079730|NCT05570500|541432453|FG000|Overall Study|Lost to Follow-up|7|||
150079731|NCT05570500|541432454|FG001|Overall Study|Lost to Follow-up|5|||
150079732|NCT02302807|541432457|FG000|Overall Study|Withdrawal by Subject|28|||
150079733|NCT02302807|541432458|FG001|Overall Study|Withdrawal by Subject|11|||
150079734|NCT02302807|541432457|FG000|Overall Study|Lost to Follow-up|4|||
150079735|NCT02302807|541432458|FG001|Overall Study|Lost to Follow-up|6|||
150079736|NCT02302807|541432457|FG000|Overall Study|Death|397|||
150079737|NCT02302807|541432458|FG001|Overall Study|Death|385|||
150079738|NCT02302807|541432457|FG000|Overall Study|Study Terminated By Sponsor|35|||
150079739|NCT02302807|541432458|FG001|Overall Study|Study Terminated By Sponsor|64|||
150079740|NCT02302807|541432457|FG000|Overall Study|Physician Decision|0|||
150079741|NCT02302807|541432458|FG001|Overall Study|Physician Decision|1|||
150079742|NCT01980940|541432459|FG000|Overall Study|Protocol Violation|0|||
150079743|NCT01980940|541432460|FG001|Overall Study|Protocol Violation|0|||
150079744|NCT01980940|541432461|FG002|Overall Study|Protocol Violation|0|||
150079745|NCT01980940|541432462|FG003|Overall Study|Protocol Violation|0|||
150079746|NCT01980940|541432463|FG004|Overall Study|Protocol Violation|0|||
150079747|NCT01980940|541432464|FG005|Overall Study|Protocol Violation|2|||
150182882|NCT02376790|541806534|FG000|Overall Study|Lost to Follow-up|15|||
150182883|NCT02376790|541806535|FG001|Overall Study|Lost to Follow-up|10|||
150182884|NCT02376790|541806536|FG002|Overall Study|Lost to Follow-up|12|||
150182885|NCT03014453|541806537|FG000|Overall Study|Lost to Follow-up|12|||
150079748|NCT01980940|541432465|FG006|Overall Study|Protocol Violation|0|||
150079749|NCT01980940|541432466|FG007|Overall Study|Protocol Violation|0|||
150182886|NCT03014453|541806537|FG000|Overall Study|Discontinued GER|3|||
150182887|NCT03014453|541806537|FG000|Overall Study|Excluded|19|||
150182888|NCT03014453|541806537|FG000|Overall Study|Refused to take part in|37|||
150079750|NCT05358444|541432468|FG000|Overall Study|Withdrawal by Subject|0|||
150079751|NCT05358444|541432469|FG001|Overall Study|Withdrawal by Subject|1|||
150079752|NCT05358444|541432468|FG000|Overall Study|Lost to Follow-up|0|||
150079753|NCT05358444|541432469|FG001|Overall Study|Lost to Follow-up|3|||
150079754|NCT05372419|541432473|FG000|Overall Study|Protocol Deviation|1|||
150079755|NCT05372419|541432473|FG000|Overall Study|Withdrawal by Subject|5|||
150079756|NCT05372419|541432473|FG000|Overall Study|Lost to Follow-up|7|||
150079757|NCT01133522|541432477|FG000|Overall Study|Withdrawal by Subject|0|||
150079758|NCT01133522|541432478|FG001|Overall Study|Withdrawal by Subject|1|||
150079759|NCT01133522|541432479|FG002|Overall Study|Withdrawal by Subject|0|||
150079760|NCT01133522|541432480|FG003|Overall Study|Withdrawal by Subject|1|||
150079761|NCT01133522|541432481|FG004|Overall Study|Withdrawal by Subject|0|||
150079762|NCT01133522|541432482|FG005|Overall Study|Withdrawal by Subject|0|||
150079763|NCT01133522|541432483|FG006|Overall Study|Withdrawal by Subject|0|||
150079764|NCT01133522|541432484|FG007|Overall Study|Withdrawal by Subject|0|||
150079765|NCT01133522|541432485|FG008|Overall Study|Withdrawal by Subject|0|||
150079766|NCT01133522|541432486|FG009|Overall Study|Withdrawal by Subject|0|||
150079767|NCT01133522|541432477|FG000|Overall Study|Physician Decision|0|||
150079768|NCT01133522|541432478|FG001|Overall Study|Physician Decision|0|||
150079769|NCT01133522|541432479|FG002|Overall Study|Physician Decision|0|||
150079770|NCT01133522|541432480|FG003|Overall Study|Physician Decision|0|||
150079771|NCT01133522|541432481|FG004|Overall Study|Physician Decision|1|||
150079772|NCT01133522|541432482|FG005|Overall Study|Physician Decision|0|||
150079773|NCT01133522|541432483|FG006|Overall Study|Physician Decision|0|||
150079774|NCT01133522|541432484|FG007|Overall Study|Physician Decision|0|||
150079775|NCT01133522|541432485|FG008|Overall Study|Physician Decision|0|||
150079776|NCT01133522|541432486|FG009|Overall Study|Physician Decision|0|||
150079777|NCT03192462|541434226|FG000|Overall Study|Death|13|||
150079778|NCT03192462|541434227|FG001|Overall Study|Death|11|||
150079779|NCT03192462|541434228|FG002|Overall Study|Death|10|||
150079780|NCT03192462|541434226|FG000|Overall Study|Lost to Follow-up|0|||
150079781|NCT03192462|541434227|FG001|Overall Study|Lost to Follow-up|1|||
150079782|NCT03192462|541434228|FG002|Overall Study|Lost to Follow-up|0|||
150079783|NCT04840615|541434229|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
150079784|NCT04840615|541434230|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
150079785|NCT04840615|541434231|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
150079786|NCT00717197|541434232|FG000|Overall Study|Unable to purchase study drug|5|||
150182889|NCT05450458|541806538|FG000|Overall Study|Lost to Follow-up|4|||
150182890|NCT02141074|541806543|FG000|Pre-prophylaxis|Adverse Event|3|||
150182891|NCT02141074|541806544|FG001|Pre-prophylaxis|Adverse Event|0|||
150182892|NCT02141074|541806543|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
150182893|NCT02141074|541806544|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
150079787|NCT00717197|541434232|FG000|Overall Study|Tumor Progression|1|||
150182894|NCT02141074|541806543|FG000|Prophylaxis|Adverse Event|0|||
150182895|NCT02141074|541806544|FG001|Prophylaxis|Adverse Event|4|||
150182896|NCT02141074|541806543|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
150182897|NCT02141074|541806544|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
150079788|NCT00717197|541434232|FG000|Overall Study|Physician Decision|1|||
150079789|NCT00982137|541434233|FG000|Overall Study|Lost to Follow-up|0|||
150079790|NCT00982137|541434234|FG001|Overall Study|Lost to Follow-up|0|||
150079791|NCT00982137|541434235|FG002|Overall Study|Lost to Follow-up|0|||
150079792|NCT00982137|541434236|FG003|Overall Study|Lost to Follow-up|1|||
150079793|NCT00982137|541434233|FG000|Overall Study|Withdrawal by Subject|0|||
150182898|NCT02141074|541806543|FG000|Prophylaxis|Withdrawal by Subject|0|||
150182899|NCT02141074|541806544|FG001|Prophylaxis|Withdrawal by Subject|1|||
150182900|NCT00539734|541806545|FG000|Overall Study|Protocol Violation|1|||
150182901|NCT04484935|541806548|FG000|Overall Study|Other|0|||
150182902|NCT04484935|541806549|FG001|Overall Study|Other|1|||
150182903|NCT04484935|541806548|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150182904|NCT04484935|541806549|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150182905|NCT04484935|541806548|FG000|Overall Study|Lost to Follow-up|1|||
150079794|NCT00982137|541434234|FG001|Overall Study|Withdrawal by Subject|1|||
150182906|NCT04484935|541806549|FG001|Overall Study|Lost to Follow-up|0|||
150079795|NCT00982137|541434235|FG002|Overall Study|Withdrawal by Subject|0|||
150182907|NCT04484935|541806548|FG000|Overall Study|Death|2|||
150182908|NCT04484935|541806549|FG001|Overall Study|Death|1|||
150182909|NCT04820686|541806550|FG000|Overall Study|Withdrawal by Subject|5|||
150182910|NCT04820686|541806551|FG001|Overall Study|Withdrawal by Subject|2|||
150182911|NCT04820686|541806552|FG002|Overall Study|Withdrawal by Subject|3|||
150182912|NCT04820686|541806550|FG000|Overall Study|Study Termination|25|||
150182913|NCT04820686|541806551|FG001|Overall Study|Study Termination|13|||
150182914|NCT04820686|541806552|FG002|Overall Study|Study Termination|14|||
150182915|NCT04820686|541806550|FG000|Overall Study|Adverse Event|0|||
150182916|NCT04820686|541806551|FG001|Overall Study|Adverse Event|1|||
150182917|NCT04820686|541806552|FG002|Overall Study|Adverse Event|0|||
150182918|NCT04377308|541806553|FG000|Overall Study|Withdrawal by Subject|0|||
150182919|NCT04377308|541806554|FG001|Overall Study|Withdrawal by Subject|1|||
150182920|NCT03988842|541806555|FG000|Overall Study|Death|1|||
150182921|NCT04048382|541806559|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
150182922|NCT04048382|541806560|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
150182923|NCT04048382|541806559|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
150182924|NCT04048382|541806560|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
150182925|NCT04048382|541806559|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
150182926|NCT04048382|541806560|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
150182927|NCT01037985|541806563|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
150182928|NCT01037985|541806564|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
150182929|NCT01037985|541806563|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
150182930|NCT01037985|541806564|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
150182931|NCT01037985|541806563|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
150182932|NCT01037985|541806564|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
150182933|NCT01037985|541806563|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
150182934|NCT01037985|541806564|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
150182935|NCT03582722|541806565|FG000|Overall Study|Lost to Follow-up|1|||
150182936|NCT03582722|541806566|FG001|Overall Study|Lost to Follow-up|4|||
150182937|NCT03582722|541806565|FG000|Overall Study|Withdrawal by Subject|3|||
150182938|NCT03582722|541806566|FG001|Overall Study|Withdrawal by Subject|3|||
150182939|NCT05134337|541808654|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
150182940|NCT05134337|541808655|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
150182941|NCT01259401|541808656|FG000|4-month Follow-up|Death|0|||
150182942|NCT01259401|541808657|FG001|4-month Follow-up|Death|1|||
150182943|NCT01259401|541808656|FG000|4-month Follow-up|Lost to Follow-up|0|||
150182944|NCT01259401|541808657|FG001|4-month Follow-up|Lost to Follow-up|1|||
150182945|NCT03683069|541808658|FG000|Overall Study|see limitations|12|||
150182946|NCT03683069|541808659|FG001|Overall Study|see limitations|13|||
150182947|NCT03845465|541808660|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
150182948|NCT03845465|541808661|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
150079796|NCT00982137|541434236|FG003|Overall Study|Withdrawal by Subject|0|||
150079797|NCT03003390|541434237|FG000|Overall Study|Physician Decision|2|||
150079798|NCT03003390|541434238|FG001|Overall Study|Physician Decision|0|||
150079799|NCT03003390|541434237|FG000|Overall Study|Parent refused intervention|2|||
150079800|NCT03003390|541434238|FG001|Overall Study|Parent refused intervention|0|||
150079801|NCT01648101|541434239|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
150079802|NCT01648101|541434240|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
150079803|NCT01648101|541434241|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
150079804|NCT01648101|541434239|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
150079805|NCT01648101|541434240|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
150079806|NCT01648101|541434241|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
150079807|NCT01648101|541434239|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
150079808|NCT01648101|541434240|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
150079809|NCT01648101|541434241|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
150079810|NCT01648101|541434239|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
150079811|NCT01648101|541434240|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
150079812|NCT01648101|541434241|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
150079813|NCT01648101|541434239|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
150079814|NCT01648101|541434240|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
150079815|NCT01648101|541434241|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
150079816|NCT01648101|541434239|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
150079817|NCT01648101|541434240|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
150079818|NCT01648101|541434241|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
150182949|NCT03845465|541808660|FG000|6-month Data Collection|Withdrawal by Subject|0|||
150079819|NCT01648101|541434239|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
150079820|NCT01648101|541434240|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
150182950|NCT03845465|541808661|FG001|6-month Data Collection|Withdrawal by Subject|2|||
150182951|NCT03845465|541808660|FG000|12-month Data Collection|Withdrawal by Subject|0|||
150182952|NCT03845465|541808661|FG001|12-month Data Collection|Withdrawal by Subject|2|||
150079821|NCT01648101|541434241|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
150079822|NCT01648101|541434239|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
150182953|NCT05307978|541808662|FG000|Overall Study|Lost to Follow-up|0|||
150182954|NCT05307978|541808663|FG001|Overall Study|Lost to Follow-up|1|||
150182955|NCT05307978|541808664|FG002|Overall Study|Lost to Follow-up|0|||
150079823|NCT01648101|541434240|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
150079824|NCT01648101|541434241|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
150079825|NCT01648101|541434239|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
150079826|NCT01648101|541434240|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
150079827|NCT01648101|541434241|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
150079828|NCT01648101|541434239|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
150079829|NCT01648101|541434240|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
150079830|NCT01648101|541434241|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
150079831|NCT01648101|541434239|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
150079832|NCT01648101|541434240|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
150079833|NCT01648101|541434241|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
150079834|NCT03000439|541434246|FG000|Open Label Part 1|Adverse Event|6|||
150079835|NCT03000439|541434247|FG001|Open Label Part 1|Adverse Event|0|||
150079836|NCT03000439|541434248|FG002|Open Label Part 1|Adverse Event|0|||
150079837|NCT03000439|541434249|FG003|Open Label Part 1|Adverse Event|0|||
150079838|NCT03000439|541434246|FG000|Open Label Part 1|Other|2|||
150079839|NCT03000439|541434247|FG001|Open Label Part 1|Other|0|||
150079840|NCT03000439|541434248|FG002|Open Label Part 1|Other|0|||
150079841|NCT03000439|541434249|FG003|Open Label Part 1|Other|0|||
150079842|NCT03000439|541434246|FG000|Open Label Part 1|Insufficient clinical response|16|||
150079843|NCT03000439|541434247|FG001|Open Label Part 1|Insufficient clinical response|0|||
150079844|NCT03000439|541434248|FG002|Open Label Part 1|Insufficient clinical response|0|||
150079845|NCT03000439|541434249|FG003|Open Label Part 1|Insufficient clinical response|0|||
150079846|NCT03000439|541434246|FG000|Open Label Part 2|Other|0|||
150079847|NCT03000439|541434247|FG001|Open Label Part 2|Other|5|||
150079848|NCT03000439|541434248|FG002|Open Label Part 2|Other|0|||
150079849|NCT03000439|541434249|FG003|Open Label Part 2|Other|0|||
150079850|NCT03000439|541434246|FG000|Open Label Part 2|Insufficient clinical response|0|||
150079851|NCT03000439|541434247|FG001|Open Label Part 2|Insufficient clinical response|12|||
150079852|NCT03000439|541434248|FG002|Open Label Part 2|Insufficient clinical response|0|||
150079853|NCT03000439|541434249|FG003|Open Label Part 2|Insufficient clinical response|0|||
150079854|NCT03000439|541434246|FG000|Double Blind Phase|Adverse Event|0|||
150079855|NCT03000439|541434247|FG001|Double Blind Phase|Adverse Event|0|||
150079856|NCT03000439|541434248|FG002|Double Blind Phase|Adverse Event|2|||
150079857|NCT03000439|541434249|FG003|Double Blind Phase|Adverse Event|1|||
150079858|NCT03000439|541434246|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
150079859|NCT03000439|541434247|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
150079860|NCT03000439|541434248|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
150079861|NCT03000439|541434249|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
150079862|NCT03000439|541434246|FG000|Double Blind Phase|Other|0|||
150079863|NCT03000439|541434247|FG001|Double Blind Phase|Other|0|||
150079864|NCT03000439|541434248|FG002|Double Blind Phase|Other|10|||
150079865|NCT03000439|541434249|FG003|Double Blind Phase|Other|11|||
150079866|NCT03000439|541434246|FG000|Double Blind Phase|Insufficient clinical response|0|||
150079867|NCT03000439|541434247|FG001|Double Blind Phase|Insufficient clinical response|0|||
150079868|NCT03000439|541434248|FG002|Double Blind Phase|Insufficient clinical response|0|||
150079869|NCT03000439|541434249|FG003|Double Blind Phase|Insufficient clinical response|2|||
150079870|NCT02370160|541434252|FG000|Overall Study|Death|3|||
150079871|NCT02370160|541434253|FG001|Overall Study|Death|4|||
150079872|NCT02370160|541434254|FG002|Overall Study|Death|1|||
150079873|NCT01581931|541434259|FG000|Washout|Adverse Event|0|||
150079874|NCT01581931|541434260|FG001|Washout|Adverse Event|1|||
150079875|NCT02954237|541434263|FG000|Overall Study|Withdrawal by Subject|25|||
150079876|NCT02954237|541434263|FG000|Overall Study|Missed visit|16|||
150079877|NCT02954237|541434263|FG000|Overall Study|Death|2|||
150079878|NCT01508650|541434265|FG000|Overall Study|Lost to Follow-up|0|||
150079879|NCT01508650|541434266|FG001|Overall Study|Lost to Follow-up|3|||
150079880|NCT00160693|541434267|FG000|Overall Study|Adverse Event|97|||
150079881|NCT00160693|541434267|FG000|Overall Study|Lack of Efficacy|30|||
150079882|NCT00160693|541434267|FG000|Overall Study|Protocol Violation|24|||
150079883|NCT00160693|541434267|FG000|Overall Study|Lost to Follow-up|15|||
150079884|NCT00160693|541434267|FG000|Overall Study|Withdrawal by Subject|54|||
150079885|NCT00160693|541434267|FG000|Overall Study|Study terminated by sponsor|15|||
150079886|NCT05988619|541434269|FG000|Overall Study|Lost to Follow-up|1|||
150079887|NCT05988619|541434270|FG001|Overall Study|Lost to Follow-up|4|||
150079888|NCT05988619|541434269|FG000|Overall Study|Withdrawal by Subject|2|||
150079889|NCT05988619|541434270|FG001|Overall Study|Withdrawal by Subject|9|||
150079890|NCT00587054|541434273|FG000|Overall Study|Patient not treated|9|||
150079891|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Death|0|||
150079892|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Death|0|||
150079893|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Death|0|||
150079894|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Death|0|||
150079895|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Death|1|||
150079896|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Death|0|||
150079897|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Death|0|||
150079898|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Death|0|||
150079899|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
150079900|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
150079901|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
150079902|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
150079903|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
150079904|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
150079905|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
150079906|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
150079907|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
150079908|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
150079909|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
150079910|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
150079911|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
150079912|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
150079913|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
150079914|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
150079915|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
150079916|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
150079917|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
150079918|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
150079919|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
150079920|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
150079921|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
150079922|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
150079923|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
150079924|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
150079925|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
150079926|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
150079927|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
150079928|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
150079929|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
150079930|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
150079931|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
150079932|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
150079933|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
150079934|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
150079935|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
150079936|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
150079937|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
150079938|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
150079939|NCT00726232|541434275|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
150079940|NCT00726232|541434276|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079941|NCT00726232|541434277|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079942|NCT00726232|541434278|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079943|NCT00726232|541434279|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079944|NCT00726232|541434280|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079945|NCT00726232|541434281|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079946|NCT00726232|541434282|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
150079947|NCT00726232|541434275|FG000|Expansion Phase|Death|0|||
150079948|NCT00726232|541434276|FG001|Expansion Phase|Death|0|||
150079949|NCT00726232|541434277|FG002|Expansion Phase|Death|0|||
150079950|NCT00726232|541434278|FG003|Expansion Phase|Death|0|||
150079951|NCT00726232|541434279|FG004|Expansion Phase|Death|0|||
150079952|NCT00726232|541434280|FG005|Expansion Phase|Death|0|||
150079953|NCT00726232|541434281|FG006|Expansion Phase|Death|0|||
150079954|NCT00726232|541434282|FG007|Expansion Phase|Death|1|||
150079955|NCT00726232|541434275|FG000|Expansion Phase|Adverse Event|0|||
150079956|NCT00726232|541434276|FG001|Expansion Phase|Adverse Event|0|||
150079957|NCT00726232|541434277|FG002|Expansion Phase|Adverse Event|0|||
150079958|NCT00726232|541434278|FG003|Expansion Phase|Adverse Event|0|||
150079959|NCT00726232|541434279|FG004|Expansion Phase|Adverse Event|0|||
150079960|NCT00726232|541434280|FG005|Expansion Phase|Adverse Event|0|||
150079961|NCT00726232|541434281|FG006|Expansion Phase|Adverse Event|6|||
150079962|NCT00726232|541434282|FG007|Expansion Phase|Adverse Event|11|||
150079963|NCT00726232|541434275|FG000|Expansion Phase|Withdrawal by Subject|0|||
150079964|NCT00726232|541434276|FG001|Expansion Phase|Withdrawal by Subject|0|||
150079965|NCT00726232|541434277|FG002|Expansion Phase|Withdrawal by Subject|0|||
150079966|NCT00726232|541434278|FG003|Expansion Phase|Withdrawal by Subject|0|||
150079967|NCT00726232|541434279|FG004|Expansion Phase|Withdrawal by Subject|0|||
150079968|NCT00726232|541434280|FG005|Expansion Phase|Withdrawal by Subject|0|||
150079969|NCT00726232|541434281|FG006|Expansion Phase|Withdrawal by Subject|2|||
150079970|NCT00726232|541434282|FG007|Expansion Phase|Withdrawal by Subject|3|||
150079971|NCT00726232|541434275|FG000|Expansion Phase|Disease progression|0|||
150079972|NCT00726232|541434276|FG001|Expansion Phase|Disease progression|0|||
150079973|NCT00726232|541434277|FG002|Expansion Phase|Disease progression|0|||
150079974|NCT00726232|541434278|FG003|Expansion Phase|Disease progression|0|||
150079975|NCT00726232|541434279|FG004|Expansion Phase|Disease progression|0|||
150079976|NCT00726232|541434280|FG005|Expansion Phase|Disease progression|0|||
150079977|NCT00726232|541434281|FG006|Expansion Phase|Disease progression|4|||
150079978|NCT00726232|541434282|FG007|Expansion Phase|Disease progression|0|||
150079979|NCT00726232|541434275|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
150079980|NCT00726232|541434276|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
150079981|NCT00726232|541434277|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
150079982|NCT00726232|541434278|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
150079983|NCT00726232|541434279|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
150079984|NCT00726232|541434280|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
150079985|NCT00726232|541434281|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
150079986|NCT00726232|541434282|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
150079987|NCT00726232|541434275|FG000|Expansion Phase|Per Investigator: lack of response|0|||
150079988|NCT00726232|541434276|FG001|Expansion Phase|Per Investigator: lack of response|0|||
150079989|NCT00726232|541434277|FG002|Expansion Phase|Per Investigator: lack of response|0|||
150079990|NCT00726232|541434278|FG003|Expansion Phase|Per Investigator: lack of response|0|||
150079991|NCT00726232|541434279|FG004|Expansion Phase|Per Investigator: lack of response|0|||
150079992|NCT00726232|541434280|FG005|Expansion Phase|Per Investigator: lack of response|0|||
150079993|NCT00726232|541434281|FG006|Expansion Phase|Per Investigator: lack of response|1|||
150079994|NCT00726232|541434282|FG007|Expansion Phase|Per Investigator: lack of response|7|||
150079995|NCT00726232|541434275|FG000|Expansion Phase|Unspecified reason|0|||
150079996|NCT00726232|541434276|FG001|Expansion Phase|Unspecified reason|0|||
150079997|NCT00726232|541434277|FG002|Expansion Phase|Unspecified reason|0|||
150079998|NCT00726232|541434278|FG003|Expansion Phase|Unspecified reason|0|||
150079999|NCT00726232|541434279|FG004|Expansion Phase|Unspecified reason|0|||
150080000|NCT00726232|541434280|FG005|Expansion Phase|Unspecified reason|0|||
150080001|NCT00726232|541434281|FG006|Expansion Phase|Unspecified reason|1|||
150080002|NCT00726232|541434282|FG007|Expansion Phase|Unspecified reason|0|||
150080003|NCT01651039|541434283|FG000|Overall Study|Non-evaluables|5|||
150080004|NCT01651039|541434283|FG000|Overall Study|Physician Decision|2|||
150080005|NCT01651039|541434283|FG000|Overall Study|Withdrawal by Subject|1|||
150080006|NCT01651039|541434283|FG000|Overall Study|Progressive Disease|22|||
150080007|NCT00709761|541434284|FG000|Overall Study|Withdrawal by Subject|8|||
150080008|NCT00709761|541434284|FG000|Overall Study|study closed/terminated|17|||
150080009|NCT00709761|541434284|FG000|Overall Study|Lost to Follow-up|2|||
150080010|NCT03600818|541434285|FG000|Overall Study|Adverse Event|4|||
150080011|NCT03600818|541434286|FG001|Overall Study|Adverse Event|7|||
150080012|NCT03600818|541434285|FG000|Overall Study|Lack of Efficacy|9|||
150080013|NCT03600818|541434286|FG001|Overall Study|Lack of Efficacy|4|||
150080014|NCT03600818|541434285|FG000|Overall Study|Withdrawal by Subject|4|||
150080015|NCT03600818|541434286|FG001|Overall Study|Withdrawal by Subject|3|||
150080016|NCT03600818|541434285|FG000|Overall Study|Other-unspecified|5|||
150080017|NCT03600818|541434286|FG001|Overall Study|Other-unspecified|3|||
150080018|NCT03600818|541434285|FG000|Overall Study|Randomized and not treated|0|||
150080019|NCT03600818|541434286|FG001|Overall Study|Randomized and not treated|1|||
150080020|NCT01488370|541434287|FG000|Overall Study|Protocol Violation|0|||
150080021|NCT01488370|541434288|FG001|Overall Study|Protocol Violation|1|||
150080022|NCT01488370|541434289|FG002|Overall Study|Protocol Violation|1|||
150080023|NCT03478930|541434291|FG000|Overall Study|Adverse Event|0|||
150080024|NCT03478930|541434292|FG001|Overall Study|Adverse Event|1|||
150080025|NCT03478930|541434291|FG000|Overall Study|Lack of Efficacy|3|||
150080026|NCT03478930|541434292|FG001|Overall Study|Lack of Efficacy|3|||
150080027|NCT03478930|541434291|FG000|Overall Study|Withdrawal by Subject|6|||
150080028|NCT03478930|541434292|FG001|Overall Study|Withdrawal by Subject|5|||
150080029|NCT04189081|541434293|FG000|Overall Study|Lost to Follow-up|1|||
150080030|NCT04189081|541434294|FG001|Overall Study|Lost to Follow-up|0|||
150080031|NCT04189081|541434295|FG002|Overall Study|Lost to Follow-up|0|||
150080032|NCT04189081|541434293|FG000|Overall Study|Withdrawal by Subject|0|||
150080033|NCT04189081|541434294|FG001|Overall Study|Withdrawal by Subject|0|||
150080034|NCT04189081|541434295|FG002|Overall Study|Withdrawal by Subject|1|||
150080035|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
150080036|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
150080037|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
150080038|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
150080039|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
150182956|NCT05307978|541808665|FG003|Overall Study|Lost to Follow-up|4|||
150080040|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
150080041|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
150080042|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
150080043|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
150080044|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
150080045|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
150080046|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
150080047|NCT00044083|541434296|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
150080048|NCT00044083|541434297|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
150080049|NCT00044083|541434296|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
150080050|NCT00044083|541434297|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
150080051|NCT00044083|541434296|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
150080052|NCT00044083|541434297|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
150080053|NCT00044083|541434296|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
150080054|NCT00044083|541434297|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
150080055|NCT00553644|541434298|FG000|Overall Study|Adverse Event|17|||
150080056|NCT00553644|541434298|FG000|Overall Study|Withdrawal by Subject|4|||
150080057|NCT00553644|541434298|FG000|Overall Study|Physician Decision|1|||
150080058|NCT00553644|541434298|FG000|Overall Study|Alternative therapy|6|||
150080059|NCT00705484|541434299|FG000|Overall Study|Adverse Event|28|||
150080060|NCT00705484|541434300|FG001|Overall Study|Adverse Event|27|||
150080061|NCT00705484|541434299|FG000|Overall Study|Lost to Follow-up|169|||
150080062|NCT00705484|541434300|FG001|Overall Study|Lost to Follow-up|250|||
150080063|NCT00705484|541434299|FG000|Overall Study|Withdrawal by Subject|96|||
150080064|NCT00705484|541434300|FG001|Overall Study|Withdrawal by Subject|72|||
150080065|NCT00705484|541434299|FG000|Overall Study|Administrative|89|||
150080066|NCT00705484|541434300|FG001|Overall Study|Administrative|59|||
150080067|NCT00851747|541434302|FG000|Overall Study|Physician Decision|6|||
150080068|NCT00851747|541434303|FG001|Overall Study|Physician Decision|6|||
150080069|NCT00851747|541434304|FG002|Overall Study|Physician Decision|6|||
150080070|NCT02228460|541434309|FG000|Overall Study|Adverse Event|1|||
150182957|NCT05307978|541808666|FG004|Overall Study|Lost to Follow-up|0|||
150182958|NCT05307978|541808667|FG005|Overall Study|Lost to Follow-up|0|||
150182959|NCT05307978|541808668|FG006|Overall Study|Lost to Follow-up|1|||
150182960|NCT03651895|541808669|FG000|First Drug Assignment|Adverse Event|4|||
150182961|NCT03651895|541808670|FG001|First Drug Assignment|Adverse Event|5|||
150182962|NCT03651895|541808669|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
150182963|NCT03651895|541808670|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
150182964|NCT02837510|541808671|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
150182965|NCT02837510|541808672|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
150182966|NCT02837510|541808671|FG000|Washout (2 Weeks)|Adverse Event|0|||
150080071|NCT02228460|541434309|FG000|Overall Study|Lost to Follow-up|1|||
150080072|NCT00119106|541434310|FG000|Overall Study|HIV infected at baseline|179|||
150080073|NCT00119106|541434311|FG001|Overall Study|HIV infected at baseline|178|||
150080074|NCT01010061|541434312|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
150080075|NCT01010061|541434313|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
150080076|NCT01010061|541434312|FG000|Overall Study|Disease Progression|2|||
150080077|NCT01010061|541434313|FG001|Overall Study|Disease Progression|8|||
150080078|NCT01010061|541434312|FG000|Overall Study|Withdrew Consent|5|||
150080079|NCT01010061|541434313|FG001|Overall Study|Withdrew Consent|1|||
150080080|NCT01010061|541434312|FG000|Overall Study|Death|3|||
150080081|NCT01010061|541434313|FG001|Overall Study|Death|6|||
150080082|NCT01010061|541434312|FG000|Overall Study|Administrative/Other|0|||
150080083|NCT01010061|541434313|FG001|Overall Study|Administrative/Other|1|||
150080084|NCT01010061|541434312|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
150080085|NCT01010061|541434313|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
150080086|NCT01010061|541434312|FG000|Overall Study|Insufficient Therapeutic Response|1|||
150080087|NCT01010061|541434313|FG001|Overall Study|Insufficient Therapeutic Response|5|||
150080088|NCT01010061|541434312|FG000|Overall Study|Violation of Selection Criteria|0|||
150080089|NCT01010061|541434313|FG001|Overall Study|Violation of Selection Criteria|1|||
150080090|NCT01010061|541434312|FG000|Overall Study|Did Not Receive Treatment|2|||
150080091|NCT01010061|541434313|FG001|Overall Study|Did Not Receive Treatment|2|||
150080092|NCT01866293|541434314|FG000|Overall Study|Adverse Event|2|||
150080093|NCT03066804|541434315|FG000|Overall Study|Physician Decision|0|||
150080094|NCT03066804|541434316|FG001|Overall Study|Physician Decision|4|||
150080095|NCT03066804|541434315|FG000|Overall Study|Death|23|||
150080096|NCT03066804|541434316|FG001|Overall Study|Death|17|||
150080097|NCT03066804|541434315|FG000|Overall Study|Withdrawal by Subject|19|||
150080098|NCT03066804|541434316|FG001|Overall Study|Withdrawal by Subject|25|||
150080099|NCT03066804|541434315|FG000|Overall Study|Lost to Follow-up|2|||
150182967|NCT02837510|541808672|FG001|Washout (2 Weeks)|Adverse Event|1|||
150080100|NCT03066804|541434316|FG001|Overall Study|Lost to Follow-up|0|||
150080101|NCT03066804|541434315|FG000|Overall Study|Adverse Event|2|||
150182968|NCT02837510|541808671|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
150080102|NCT03066804|541434316|FG001|Overall Study|Adverse Event|3|||
150080103|NCT03066804|541434315|FG000|Overall Study|Technical problems|5|||
150080104|NCT03066804|541434316|FG001|Overall Study|Technical problems|1|||
150080105|NCT00555971|541434321|FG000|Overall Study|Adverse Event|1|||
150080106|NCT00555971|541434322|FG001|Overall Study|Adverse Event|1|||
150080107|NCT03470441|541434323|FG000|Overall Study|Death|0|||
150080108|NCT03470441|541434324|FG001|Overall Study|Death|1|||
150080109|NCT03470441|541434325|FG002|Overall Study|Death|1|||
150080110|NCT03470441|541434326|FG003|Overall Study|Death|0|||
150080111|NCT03470441|541434323|FG000|Overall Study|Adverse Event|0|||
150080112|NCT03470441|541434324|FG001|Overall Study|Adverse Event|0|||
150080113|NCT03470441|541434325|FG002|Overall Study|Adverse Event|0|||
150080114|NCT03470441|541434326|FG003|Overall Study|Adverse Event|1|||
150080115|NCT03470441|541434323|FG000|Overall Study|Withdrawal by Subject|1|||
150080116|NCT03470441|541434324|FG001|Overall Study|Withdrawal by Subject|4|||
150080117|NCT03470441|541434325|FG002|Overall Study|Withdrawal by Subject|1|||
150080118|NCT03470441|541434326|FG003|Overall Study|Withdrawal by Subject|3|||
150080119|NCT03982368|541434327|FG000|Overall Study|Adverse Event|6|||
150080120|NCT03982368|541434328|FG001|Overall Study|Adverse Event|4|||
150080121|NCT03982368|541434329|FG002|Overall Study|Adverse Event|3|||
150080122|NCT03982368|541434327|FG000|Overall Study|Lost to Follow-up|2|||
150080123|NCT03982368|541434328|FG001|Overall Study|Lost to Follow-up|1|||
150080124|NCT03982368|541434329|FG002|Overall Study|Lost to Follow-up|0|||
150080125|NCT03982368|541434327|FG000|Overall Study|Withdrawal by Subject|1|||
150080126|NCT03982368|541434328|FG001|Overall Study|Withdrawal by Subject|2|||
150080127|NCT03982368|541434329|FG002|Overall Study|Withdrawal by Subject|0|||
150080128|NCT03982368|541434327|FG000|Overall Study|unknow|4|||
150080129|NCT03982368|541434328|FG001|Overall Study|unknow|0|||
150080130|NCT03982368|541434329|FG002|Overall Study|unknow|2|||
150080131|NCT00518284|541434330|FG000|Overall Study|Adverse Event|0|||
150080132|NCT00518284|541434331|FG001|Overall Study|Adverse Event|1|||
150080133|NCT00518284|541434332|FG002|Overall Study|Adverse Event|0|||
150080134|NCT00518284|541434333|FG003|Overall Study|Adverse Event|0|||
150080135|NCT00518284|541434330|FG000|Overall Study|Study Termination|0|||
150080136|NCT00518284|541434331|FG001|Overall Study|Study Termination|2|||
150080137|NCT00518284|541434332|FG002|Overall Study|Study Termination|1|||
150080138|NCT00518284|541434333|FG003|Overall Study|Study Termination|2|||
150080139|NCT03768414|541434334|FG000|Overall Study|Adverse Event or side effects|72|||
150080140|NCT03768414|541434335|FG001|Overall Study|Adverse Event or side effects|28|||
150080141|NCT03768414|541434334|FG000|Overall Study|Refusal unrelated to adverse event|33|||
150080142|NCT03768414|541434335|FG001|Overall Study|Refusal unrelated to adverse event|33|||
150080143|NCT03768414|541434334|FG000|Overall Study|Progression/relapse|132|||
150080144|NCT03768414|541434335|FG001|Overall Study|Progression/relapse|60|||
150080145|NCT03768414|541434334|FG000|Overall Study|Death|9|||
150080146|NCT03768414|541434335|FG001|Overall Study|Death|6|||
150080147|NCT03768414|541434334|FG000|Overall Study|Other - not protocol specified|45|||
150080148|NCT03768414|541434335|FG001|Overall Study|Other - not protocol specified|18|||
150080149|NCT03768414|541434334|FG000|Overall Study|Reason under review|3|||
150080150|NCT03768414|541434335|FG001|Overall Study|Reason under review|2|||
150080151|NCT02571777|541434337|FG000|Overall Study|Subject/guardian decision|34|||
150080152|NCT02571777|541434338|FG001|Overall Study|Subject/guardian decision|26|||
150080153|NCT02571777|541434339|FG002|Overall Study|Subject/guardian decision|26|||
150080154|NCT02571777|541434340|FG003|Overall Study|Subject/guardian decision|25|||
150080155|NCT02571777|541434341|FG004|Overall Study|Subject/guardian decision|27|||
150080156|NCT02571777|541434337|FG000|Overall Study|Protocol Deviation|2|||
150080157|NCT02571777|541434338|FG001|Overall Study|Protocol Deviation|3|||
150080158|NCT02571777|541434339|FG002|Overall Study|Protocol Deviation|4|||
150080159|NCT02571777|541434340|FG003|Overall Study|Protocol Deviation|8|||
150080160|NCT02571777|541434341|FG004|Overall Study|Protocol Deviation|4|||
150080161|NCT02571777|541434337|FG000|Overall Study|Death|1|||
150080162|NCT02571777|541434338|FG001|Overall Study|Death|1|||
150080163|NCT02571777|541434339|FG002|Overall Study|Death|4|||
150080164|NCT02571777|541434340|FG003|Overall Study|Death|0|||
150080165|NCT02571777|541434341|FG004|Overall Study|Death|0|||
150080166|NCT02571777|541434337|FG000|Overall Study|Lost to Follow-up|1|||
150080167|NCT02571777|541434338|FG001|Overall Study|Lost to Follow-up|1|||
150080168|NCT02571777|541434339|FG002|Overall Study|Lost to Follow-up|2|||
150080169|NCT02571777|541434340|FG003|Overall Study|Lost to Follow-up|0|||
150080170|NCT02571777|541434341|FG004|Overall Study|Lost to Follow-up|1|||
150080171|NCT02571777|541434337|FG000|Overall Study|Physician Decision|1|||
150080172|NCT02571777|541434338|FG001|Overall Study|Physician Decision|7|||
150080173|NCT02571777|541434339|FG002|Overall Study|Physician Decision|5|||
150080174|NCT02571777|541434340|FG003|Overall Study|Physician Decision|2|||
150080175|NCT02571777|541434341|FG004|Overall Study|Physician Decision|4|||
150080176|NCT02571777|541434337|FG000|Overall Study|Pregnancy|0|||
150080177|NCT02571777|541434338|FG001|Overall Study|Pregnancy|0|||
150080178|NCT02571777|541434339|FG002|Overall Study|Pregnancy|0|||
150080179|NCT02571777|541434340|FG003|Overall Study|Pregnancy|2|||
150080180|NCT02571777|541434341|FG004|Overall Study|Pregnancy|0|||
150080181|NCT03706079|541434342|FG000|Predecessor Study|Death|0|||
150080182|NCT03706079|541434343|FG001|Predecessor Study|Death|2|||
150080183|NCT03706079|541434344|FG002|Predecessor Study|Death|0|||
150080184|NCT03706079|541434345|FG003|Predecessor Study|Death|1|||
150080185|NCT03706079|541434346|FG004|Predecessor Study|Death|0|||
150080186|NCT03706079|541434347|FG005|Predecessor Study|Death|0|||
150080187|NCT03706079|541434342|FG000|Predecessor Study|Lost to Follow-up|5|||
150080188|NCT03706079|541434343|FG001|Predecessor Study|Lost to Follow-up|2|||
150080189|NCT03706079|541434344|FG002|Predecessor Study|Lost to Follow-up|0|||
150080190|NCT03706079|541434345|FG003|Predecessor Study|Lost to Follow-up|0|||
150080191|NCT03706079|541434346|FG004|Predecessor Study|Lost to Follow-up|1|||
150080192|NCT03706079|541434347|FG005|Predecessor Study|Lost to Follow-up|0|||
150080193|NCT03706079|541434342|FG000|Predecessor Study|Withdrawal by Subject|8|||
150080194|NCT03706079|541434343|FG001|Predecessor Study|Withdrawal by Subject|15|||
150080195|NCT03706079|541434344|FG002|Predecessor Study|Withdrawal by Subject|0|||
150080196|NCT03706079|541434345|FG003|Predecessor Study|Withdrawal by Subject|5|||
150080197|NCT03706079|541434346|FG004|Predecessor Study|Withdrawal by Subject|2|||
150080198|NCT03706079|541434347|FG005|Predecessor Study|Withdrawal by Subject|0|||
150080199|NCT03706079|541434342|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
150080200|NCT03706079|541434343|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
150080201|NCT03706079|541434344|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
150080202|NCT03706079|541434345|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
150080203|NCT03706079|541434346|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
150080204|NCT03706079|541434347|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
150080205|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
150080206|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
150080207|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
150080208|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
150080209|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
150080210|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
150080211|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
150080212|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
150080213|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
150080214|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
150080215|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
150080216|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
150080217|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
150080218|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
150080219|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
150080220|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
150080221|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
150080222|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
150080223|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
150080224|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
150080225|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
150080226|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
150080227|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
150080228|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
150080229|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
150080230|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
150080231|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
150080232|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
150080233|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
150080234|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
150080235|NCT03706079|541434342|FG000|Long Term Extension (DESTINATION)|Death|8|||
150080236|NCT03706079|541434343|FG001|Long Term Extension (DESTINATION)|Death|2|||
150080237|NCT03706079|541434344|FG002|Long Term Extension (DESTINATION)|Death|2|||
150080238|NCT03706079|541434345|FG003|Long Term Extension (DESTINATION)|Death|1|||
150080239|NCT03706079|541434346|FG004|Long Term Extension (DESTINATION)|Death|0|||
150080240|NCT03706079|541434347|FG005|Long Term Extension (DESTINATION)|Death|0|||
150080241|NCT00329238|541434348|FG000|Overall Study|Adverse Event|147|||
150080242|NCT00329238|541434349|FG001|Overall Study|Adverse Event|129|||
150080243|NCT00329238|541434348|FG000|Overall Study|Protocol Violation|23|||
150080244|NCT00329238|541434349|FG001|Overall Study|Protocol Violation|34|||
150080245|NCT00329238|541434348|FG000|Overall Study|Lost to Follow-up|2|||
150080246|NCT00329238|541434349|FG001|Overall Study|Lost to Follow-up|6|||
150080247|NCT00329238|541434348|FG000|Overall Study|Withdrawal by Subject|64|||
150080248|NCT00329238|541434349|FG001|Overall Study|Withdrawal by Subject|58|||
150080249|NCT00329238|541434348|FG000|Overall Study|Other reason (not specified)|40|||
150080250|NCT00329238|541434349|FG001|Overall Study|Other reason (not specified)|54|||
150080251|NCT00801632|541434350|FG000|Overall Study|Re-transplant|1|||
150080252|NCT01203098|541434360|FG000|Overall Study|Adverse Event|3|||
150080253|NCT01203098|541434361|FG001|Overall Study|Adverse Event|1|||
150080254|NCT01203098|541434362|FG002|Overall Study|Adverse Event|7|||
150080255|NCT01203098|541434360|FG000|Overall Study|Lost to Follow-up|0|||
150080256|NCT01203098|541434361|FG001|Overall Study|Lost to Follow-up|0|||
150080257|NCT01203098|541434362|FG002|Overall Study|Lost to Follow-up|1|||
150080258|NCT01203098|541434360|FG000|Overall Study|Physician Decision|2|||
150080259|NCT01203098|541434361|FG001|Overall Study|Physician Decision|2|||
150080260|NCT01203098|541434362|FG002|Overall Study|Physician Decision|0|||
150080261|NCT01203098|541434360|FG000|Overall Study|Withdrawal by Subject|1|||
150080262|NCT01203098|541434361|FG001|Overall Study|Withdrawal by Subject|1|||
150080263|NCT01203098|541434362|FG002|Overall Study|Withdrawal by Subject|3|||
150080264|NCT02197520|541434365|FG000|Period 1|Withdrawal by Subject|1|||
150080265|NCT02197520|541434366|FG001|Period 1|Withdrawal by Subject|0|||
150080266|NCT02197520|541434365|FG000|Period 2|Adverse Event|0|||
150080267|NCT02197520|541434366|FG001|Period 2|Adverse Event|2|||
150080268|NCT02197520|541434365|FG000|Period 2|Withdrawal by Subject|1|||
150080269|NCT02197520|541434366|FG001|Period 2|Withdrawal by Subject|0|||
150080270|NCT00913497|541434367|FG000|Overall Study|Adverse Event|1|||
150080271|NCT00913497|541434367|FG000|Overall Study|Withdrawal by Subject|2|||
150080272|NCT03385564|541434368|FG000|Overall Study|Adverse Event|0|||
150080273|NCT03385564|541434369|FG001|Overall Study|Adverse Event|0|||
150080274|NCT03385564|541434370|FG002|Overall Study|Adverse Event|3|||
150080275|NCT03385564|541434371|FG003|Overall Study|Adverse Event|3|||
150080276|NCT03385564|541434368|FG000|Overall Study|Other than listed|0|||
150080277|NCT03385564|541434369|FG001|Overall Study|Other than listed|0|||
150080278|NCT03385564|541434370|FG002|Overall Study|Other than listed|0|||
150080279|NCT03385564|541434371|FG003|Overall Study|Other than listed|5|||
150080280|NCT03385564|541434368|FG000|Overall Study|Withdrawal by Subject|0|||
150080281|NCT03385564|541434369|FG001|Overall Study|Withdrawal by Subject|1|||
150080282|NCT03385564|541434370|FG002|Overall Study|Withdrawal by Subject|1|||
150080283|NCT03385564|541434371|FG003|Overall Study|Withdrawal by Subject|0|||
150080284|NCT03385564|541434368|FG000|Overall Study|Lack of Efficacy|0|||
150080285|NCT03385564|541434369|FG001|Overall Study|Lack of Efficacy|0|||
150080286|NCT03385564|541434370|FG002|Overall Study|Lack of Efficacy|0|||
150080287|NCT03385564|541434371|FG003|Overall Study|Lack of Efficacy|1|||
150080288|NCT03385564|541434368|FG000|Overall Study|Death|0|||
150080289|NCT03385564|541434369|FG001|Overall Study|Death|0|||
150080290|NCT03385564|541434370|FG002|Overall Study|Death|1|||
150080291|NCT03385564|541434371|FG003|Overall Study|Death|0|||
150080292|NCT03087643|541434372|FG000|Overall Study|Withdrawal by Subject|2|||
150080293|NCT03087643|541434373|FG001|Overall Study|Withdrawal by Subject|4|||
150080294|NCT03087643|541434372|FG000|Overall Study|Death|2|||
150080295|NCT03087643|541434373|FG001|Overall Study|Death|2|||
150080296|NCT01427972|541434376|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080297|NCT01427972|541434377|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080298|NCT01427972|541434378|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150182969|NCT02837510|541808672|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
150182970|NCT02837510|541808671|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
150182971|NCT02837510|541808672|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
150182972|NCT02837510|541808671|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
150182973|NCT02837510|541808672|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
150182974|NCT02837510|541808671|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
150182975|NCT02837510|541808672|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
150182976|NCT05419505|541808673|FG000|Overall Study|Adverse Event|0|||
150080299|NCT01427972|541434379|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080300|NCT01427972|541434380|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150182977|NCT05419505|541808674|FG001|Overall Study|Adverse Event|0|||
150080301|NCT01427972|541434381|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080302|NCT01427972|541434382|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080303|NCT01427972|541434383|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
150182978|NCT05419505|541808675|FG002|Overall Study|Adverse Event|0|||
150080304|NCT01427972|541434384|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080305|NCT01427972|541434385|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080306|NCT01427972|541434386|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080307|NCT01427972|541434387|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
150080308|NCT01427972|541434376|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080309|NCT01427972|541434377|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080310|NCT01427972|541434378|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080311|NCT01427972|541434379|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080312|NCT01427972|541434380|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080313|NCT01427972|541434381|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
150080314|NCT01427972|541434382|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080315|NCT01427972|541434383|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080316|NCT01427972|541434384|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080317|NCT01427972|541434385|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080318|NCT01427972|541434386|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080319|NCT01427972|541434387|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
150080320|NCT01427972|541434376|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080321|NCT01427972|541434377|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
150080322|NCT01427972|541434378|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080323|NCT01427972|541434379|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080324|NCT01427972|541434380|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080325|NCT01427972|541434381|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080326|NCT01427972|541434382|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080327|NCT01427972|541434383|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080328|NCT01427972|541434384|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080329|NCT01427972|541434385|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080330|NCT01427972|541434386|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080331|NCT01427972|541434387|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
150080332|NCT01095731|541434388|FG000|Overall Study|Protocol Violation|1|||
150080333|NCT01095731|541434389|FG001|Overall Study|Protocol Violation|1|||
150080334|NCT01095731|541434388|FG000|Overall Study|Withdrawal by Subject|0|||
150080335|NCT01095731|541434389|FG001|Overall Study|Withdrawal by Subject|1|||
150080336|NCT02578316|541434390|FG000|Extension Phase|Progression of disease|6|||
150080337|NCT04997304|541434391|FG000|Overall Study|Lost to Follow-up|11|||
150080338|NCT04997304|541434391|FG000|Overall Study|Death|1|||
150080339|NCT04997304|541434391|FG000|Overall Study|Withdrawal by Subject|14|||
150080340|NCT02469298|541436402|FG000|Overall Study|Protocol Violation|0|||
150080341|NCT02469298|541436403|FG001|Overall Study|Protocol Violation|1|||
150080342|NCT02469298|541436404|FG002|Overall Study|Protocol Violation|1|||
150080343|NCT02469298|541436405|FG003|Overall Study|Protocol Violation|0|||
150080344|NCT02469298|541436402|FG000|Overall Study|Lost to Follow-up|1|||
150080345|NCT02469298|541436403|FG001|Overall Study|Lost to Follow-up|0|||
150080346|NCT02469298|541436404|FG002|Overall Study|Lost to Follow-up|1|||
150080347|NCT02469298|541436405|FG003|Overall Study|Lost to Follow-up|0|||
150080348|NCT02469298|541436402|FG000|Overall Study|Physician Decision|0|||
150080349|NCT02469298|541436403|FG001|Overall Study|Physician Decision|0|||
150080350|NCT02469298|541436404|FG002|Overall Study|Physician Decision|0|||
150080351|NCT02469298|541436405|FG003|Overall Study|Physician Decision|1|||
150080352|NCT02469298|541436402|FG000|Overall Study|Withdrawal by Subject|0|||
150080353|NCT02469298|541436403|FG001|Overall Study|Withdrawal by Subject|0|||
150080354|NCT02469298|541436404|FG002|Overall Study|Withdrawal by Subject|0|||
150080355|NCT02469298|541436405|FG003|Overall Study|Withdrawal by Subject|1|||
150080356|NCT03311724|541436408|FG000|Overall Study|Physician Decision|0|||
150080357|NCT03311724|541436409|FG001|Overall Study|Physician Decision|0|||
150080358|NCT03311724|541436410|FG002|Overall Study|Physician Decision|0|||
150080359|NCT03311724|541436411|FG003|Overall Study|Physician Decision|1|||
150080360|NCT03311724|541436408|FG000|Overall Study|Protocol Violation|1|||
150080361|NCT03311724|541436409|FG001|Overall Study|Protocol Violation|0|||
150080362|NCT03311724|541436410|FG002|Overall Study|Protocol Violation|1|||
150182979|NCT05419505|541808676|FG003|Overall Study|Adverse Event|1|||
150182980|NCT05419505|541808677|FG004|Overall Study|Adverse Event|0|||
150182981|NCT05419505|541808678|FG005|Overall Study|Adverse Event|0|||
150182982|NCT05419505|541808679|FG006|Overall Study|Adverse Event|0|||
150182983|NCT05419505|541808680|FG007|Overall Study|Adverse Event|0|||
150182984|NCT05419505|541808673|FG000|Overall Study|Withdrawal by Subject|1|||
150182985|NCT05419505|541808674|FG001|Overall Study|Withdrawal by Subject|2|||
150182986|NCT05419505|541808675|FG002|Overall Study|Withdrawal by Subject|0|||
150182987|NCT05419505|541808676|FG003|Overall Study|Withdrawal by Subject|0|||
150080363|NCT03311724|541436411|FG003|Overall Study|Protocol Violation|0|||
150080364|NCT03311724|541436408|FG000|Overall Study|Withdrawal by Subject|1|||
150080365|NCT03311724|541436409|FG001|Overall Study|Withdrawal by Subject|1|||
150182988|NCT05419505|541808677|FG004|Overall Study|Withdrawal by Subject|0|||
150182989|NCT05419505|541808678|FG005|Overall Study|Withdrawal by Subject|0|||
150182990|NCT05419505|541808679|FG006|Overall Study|Withdrawal by Subject|1|||
150080366|NCT03311724|541436410|FG002|Overall Study|Withdrawal by Subject|0|||
150080367|NCT03311724|541436411|FG003|Overall Study|Withdrawal by Subject|0|||
150080368|NCT03311724|541436408|FG000|Overall Study|Lost to Follow-up|1|||
150080369|NCT03311724|541436409|FG001|Overall Study|Lost to Follow-up|0|||
150080370|NCT03311724|541436410|FG002|Overall Study|Lost to Follow-up|0|||
150080371|NCT03311724|541436411|FG003|Overall Study|Lost to Follow-up|0|||
150080372|NCT03311724|541436408|FG000|Overall Study|Sponsor Decision|0|||
150080373|NCT03311724|541436409|FG001|Overall Study|Sponsor Decision|0|||
150080374|NCT03311724|541436410|FG002|Overall Study|Sponsor Decision|1|||
150080375|NCT03311724|541436411|FG003|Overall Study|Sponsor Decision|0|||
150080376|NCT00674700|541436418|FG000|Year 1|Adverse Event|17|||
150080377|NCT00674700|541436419|FG001|Year 1|Adverse Event|20|||
150080378|NCT00674700|541436420|FG002|Year 1|Adverse Event|5|||
150080379|NCT00674700|541436418|FG000|Year 1|Withdrawal by Subject|7|||
150080380|NCT00674700|541436419|FG001|Year 1|Withdrawal by Subject|7|||
150080381|NCT00674700|541436420|FG002|Year 1|Withdrawal by Subject|6|||
150080382|NCT00674700|541436418|FG000|Year 1|Any other reason not above-mentioned|7|||
150080383|NCT00674700|541436419|FG001|Year 1|Any other reason not above-mentioned|7|||
150080384|NCT00674700|541436420|FG002|Year 1|Any other reason not above-mentioned|6|||
150080385|NCT00674700|541436418|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
150080386|NCT00674700|541436419|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
150080387|NCT00674700|541436420|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
150080388|NCT00674700|541436418|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
150080389|NCT00674700|541436419|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
150080390|NCT00674700|541436420|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
150080391|NCT00674700|541436418|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
150080392|NCT00674700|541436419|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
150080393|NCT00674700|541436420|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
150080394|NCT00395304|541436421|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150080395|NCT00395304|541436422|FG001|Treatment Period 1|Withdrawal by Subject|3|||
150080396|NCT00395304|541436423|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150080397|NCT00395304|541436424|FG003|Treatment Period 1|Withdrawal by Subject|2|||
150080398|NCT00395304|541436425|FG004|Treatment Period 1|Withdrawal by Subject|1|||
150080399|NCT00395304|541436426|FG005|Treatment Period 1|Withdrawal by Subject|1|||
150080400|NCT00395304|541436421|FG000|Treatment Period 1|Lost to Follow-up|1|||
150080401|NCT00395304|541436422|FG001|Treatment Period 1|Lost to Follow-up|0|||
150080402|NCT00395304|541436423|FG002|Treatment Period 1|Lost to Follow-up|0|||
150080403|NCT00395304|541436424|FG003|Treatment Period 1|Lost to Follow-up|1|||
150080404|NCT00395304|541436425|FG004|Treatment Period 1|Lost to Follow-up|0|||
150080405|NCT00395304|541436426|FG005|Treatment Period 1|Lost to Follow-up|1|||
150080406|NCT00395304|541436421|FG000|Treatment Period 1|Physician Decision|0|||
150080407|NCT00395304|541436422|FG001|Treatment Period 1|Physician Decision|1|||
150080408|NCT00395304|541436423|FG002|Treatment Period 1|Physician Decision|0|||
150080409|NCT00395304|541436424|FG003|Treatment Period 1|Physician Decision|0|||
150080410|NCT00395304|541436425|FG004|Treatment Period 1|Physician Decision|0|||
150080411|NCT00395304|541436426|FG005|Treatment Period 1|Physician Decision|0|||
150080412|NCT00395304|541436421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150080413|NCT00395304|541436422|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150080414|NCT00395304|541436423|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150080415|NCT00395304|541436424|FG003|Treatment Period 2|Withdrawal by Subject|1|||
150080416|NCT00395304|541436425|FG004|Treatment Period 2|Withdrawal by Subject|0|||
150080417|NCT00395304|541436426|FG005|Treatment Period 2|Withdrawal by Subject|2|||
150080418|NCT00395304|541436421|FG000|Treatment Period 2|Lost to Follow-up|0|||
150080419|NCT00395304|541436422|FG001|Treatment Period 2|Lost to Follow-up|3|||
150080420|NCT00395304|541436423|FG002|Treatment Period 2|Lost to Follow-up|0|||
150080421|NCT00395304|541436424|FG003|Treatment Period 2|Lost to Follow-up|0|||
150080422|NCT00395304|541436425|FG004|Treatment Period 2|Lost to Follow-up|0|||
150080423|NCT00395304|541436426|FG005|Treatment Period 2|Lost to Follow-up|0|||
150080424|NCT00395304|541436421|FG000|Treatment Period 2|Physician Decision|0|||
150080425|NCT00395304|541436422|FG001|Treatment Period 2|Physician Decision|0|||
150080426|NCT00395304|541436423|FG002|Treatment Period 2|Physician Decision|1|||
150080427|NCT00395304|541436424|FG003|Treatment Period 2|Physician Decision|0|||
150080428|NCT00395304|541436425|FG004|Treatment Period 2|Physician Decision|0|||
150080429|NCT00395304|541436426|FG005|Treatment Period 2|Physician Decision|0|||
150080430|NCT00395304|541436421|FG000|Treatment Period 2|Other|0|||
150080431|NCT00395304|541436422|FG001|Treatment Period 2|Other|1|||
150080432|NCT00395304|541436423|FG002|Treatment Period 2|Other|0|||
150080433|NCT00395304|541436424|FG003|Treatment Period 2|Other|0|||
150080434|NCT00395304|541436425|FG004|Treatment Period 2|Other|0|||
150080435|NCT00395304|541436426|FG005|Treatment Period 2|Other|0|||
150080436|NCT00395304|541436421|FG000|Treatment Period 3|Withdrawal by Subject|0|||
150080437|NCT00395304|541436422|FG001|Treatment Period 3|Withdrawal by Subject|0|||
150080438|NCT00395304|541436423|FG002|Treatment Period 3|Withdrawal by Subject|0|||
150080439|NCT00395304|541436424|FG003|Treatment Period 3|Withdrawal by Subject|1|||
150080440|NCT00395304|541436425|FG004|Treatment Period 3|Withdrawal by Subject|0|||
150080441|NCT00395304|541436426|FG005|Treatment Period 3|Withdrawal by Subject|1|||
150080442|NCT00395304|541436421|FG000|Treatment Period 3|Lost to Follow-up|1|||
150080443|NCT00395304|541436422|FG001|Treatment Period 3|Lost to Follow-up|1|||
150080444|NCT00395304|541436423|FG002|Treatment Period 3|Lost to Follow-up|0|||
150080445|NCT00395304|541436424|FG003|Treatment Period 3|Lost to Follow-up|0|||
150080446|NCT00395304|541436425|FG004|Treatment Period 3|Lost to Follow-up|0|||
150080447|NCT00395304|541436426|FG005|Treatment Period 3|Lost to Follow-up|0|||
150080448|NCT00395304|541436421|FG000|Treatment Period 3|Physician Decision|0|||
150080449|NCT00395304|541436422|FG001|Treatment Period 3|Physician Decision|1|||
150080450|NCT00395304|541436423|FG002|Treatment Period 3|Physician Decision|0|||
150080451|NCT00395304|541436424|FG003|Treatment Period 3|Physician Decision|0|||
150080452|NCT00395304|541436425|FG004|Treatment Period 3|Physician Decision|0|||
150080453|NCT00395304|541436426|FG005|Treatment Period 3|Physician Decision|0|||
150080454|NCT00395304|541436421|FG000|Treatment Period 3|Other|0|||
150080455|NCT00395304|541436422|FG001|Treatment Period 3|Other|0|||
150080456|NCT00395304|541436423|FG002|Treatment Period 3|Other|0|||
150080457|NCT00395304|541436424|FG003|Treatment Period 3|Other|1|||
150080458|NCT00395304|541436425|FG004|Treatment Period 3|Other|0|||
150080459|NCT00395304|541436426|FG005|Treatment Period 3|Other|0|||
150080460|NCT01749137|541436427|FG000|Overall Study|Adverse Event|4|||
150080461|NCT01749137|541436428|FG001|Overall Study|Adverse Event|4|||
150080462|NCT01749137|541436427|FG000|Overall Study|Lost to Follow-up|2|||
150080463|NCT01749137|541436428|FG001|Overall Study|Lost to Follow-up|3|||
150080464|NCT01749137|541436427|FG000|Overall Study|Physician Decision|1|||
150080465|NCT01749137|541436428|FG001|Overall Study|Physician Decision|0|||
150080466|NCT01749137|541436427|FG000|Overall Study|Withdrawal by Subject|8|||
150080467|NCT01749137|541436428|FG001|Overall Study|Withdrawal by Subject|4|||
150080468|NCT00621985|541436429|FG000|Dexamethasone Admission|Adverse Event|1|||
150080469|NCT01408485|541436430|FG000|Overall Study|Withdrawal by Subject|21|||
150080470|NCT01397084|541436431|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
150080471|NCT01397084|541436431|FG000|Overall Study|Protocol Violation|2|||
150080472|NCT01397084|541436431|FG000|Overall Study|Adverse Event|2|||
150080473|NCT01397084|541436431|FG000|Overall Study|Withdrawal by Subject|1|||
150080474|NCT01397084|541436431|FG000|Overall Study|Lost to Follow-up|1|||
150080475|NCT01397084|541436431|FG000|Overall Study|Used other proton pump inhibitor|1|||
150080476|NCT03130257|541436432|FG000|Overall Study|Withdrawal by Subject|1|||
150080477|NCT03130257|541436433|FG001|Overall Study|Withdrawal by Subject|0|||
150080478|NCT03130257|541436434|FG002|Overall Study|Withdrawal by Subject|2|||
150080479|NCT01751867|541436435|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
150080480|NCT01751867|541436436|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
150080481|NCT01751867|541436435|FG000|Overall Study|Diease Progression|4|||
150080482|NCT01751867|541436436|FG001|Overall Study|Diease Progression|18|||
150080483|NCT01751867|541436435|FG000|Overall Study|Adverse Event|8|||
150080484|NCT01751867|541436436|FG001|Overall Study|Adverse Event|15|||
150080485|NCT01751867|541436435|FG000|Overall Study|Poor Compliance|0|||
150080486|NCT01751867|541436436|FG001|Overall Study|Poor Compliance|5|||
150080487|NCT01751867|541436435|FG000|Overall Study|Withdrawal by Subject|3|||
150080488|NCT01751867|541436436|FG001|Overall Study|Withdrawal by Subject|1|||
150182991|NCT05419505|541808680|FG007|Overall Study|Withdrawal by Subject|0|||
150182992|NCT05419505|541808673|FG000|Overall Study|Lost to Follow-up|2|||
150182993|NCT05419505|541808674|FG001|Overall Study|Lost to Follow-up|1|||
150182994|NCT05419505|541808675|FG002|Overall Study|Lost to Follow-up|0|||
150182995|NCT05419505|541808676|FG003|Overall Study|Lost to Follow-up|0|||
150182996|NCT05419505|541808677|FG004|Overall Study|Lost to Follow-up|1|||
150182997|NCT05419505|541808678|FG005|Overall Study|Lost to Follow-up|2|||
150182998|NCT05419505|541808679|FG006|Overall Study|Lost to Follow-up|0|||
150182999|NCT05419505|541808680|FG007|Overall Study|Lost to Follow-up|1|||
150183000|NCT00979576|541808690|FG000|Combination Treatment Phase|Progressive disease|3|||
150183001|NCT00979576|541808691|FG001|Combination Treatment Phase|Progressive disease|1|||
150183002|NCT00979576|541808692|FG002|Combination Treatment Phase|Progressive disease|5|||
150183003|NCT00979576|541808690|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
150183004|NCT00979576|541808691|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
150183005|NCT00979576|541808692|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
150183006|NCT00979576|541808690|FG000|Combination Treatment Phase|Adverse Event|0|||
150183007|NCT00979576|541808691|FG001|Combination Treatment Phase|Adverse Event|2|||
150183008|NCT00979576|541808692|FG002|Combination Treatment Phase|Adverse Event|2|||
150183009|NCT00979576|541808690|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
150080489|NCT01751867|541436435|FG000|Overall Study|Physician Decision|4|||
150080490|NCT01751867|541436436|FG001|Overall Study|Physician Decision|7|||
150080491|NCT01751867|541436435|FG000|Overall Study|Protocol Violation|0|||
150080492|NCT01751867|541436436|FG001|Overall Study|Protocol Violation|2|||
150080493|NCT01751867|541436435|FG000|Overall Study|Death|0|||
150080494|NCT01751867|541436436|FG001|Overall Study|Death|5|||
150183010|NCT00979576|541808691|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
150080495|NCT01751867|541436435|FG000|Overall Study|Other|11|||
150080496|NCT01751867|541436436|FG001|Overall Study|Other|37|||
150080497|NCT01751867|541436435|FG000|Overall Study|Randomized but not treated.|2|||
150080498|NCT01751867|541436436|FG001|Overall Study|Randomized but not treated.|1|||
150080499|NCT04932096|541436437|FG000|Overall Study|Withdrawal by Subject|1|||
150080500|NCT04932096|541436438|FG001|Overall Study|Withdrawal by Subject|1|||
150080501|NCT04932096|541436437|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
150080502|NCT04932096|541436438|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
150080503|NCT02064894|541436439|FG000|Overall Study|Withdrawal by Subject|43|||
150080504|NCT02064894|541436440|FG001|Overall Study|Withdrawal by Subject|102|||
150080505|NCT02064894|541436441|FG002|Overall Study|Withdrawal by Subject|115|||
150080506|NCT01396148|541436442|FG000|Overall Study|Patient Decision|1|||
150080507|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
150080508|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
150080509|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080510|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080511|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080512|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080513|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080514|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
150080515|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
150080516|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
150080517|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080518|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080519|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080520|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080521|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080522|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
150080523|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
150080524|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
150080525|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080526|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080527|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080528|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080529|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080530|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
150080531|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080532|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
150080533|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080534|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080535|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080536|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080537|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080538|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
150080539|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
150080540|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
150080541|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080542|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080543|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080544|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080545|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080546|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
150080547|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
150080548|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080549|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080550|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080551|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080552|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080553|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080554|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
150080555|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
150080556|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
150080557|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080558|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080559|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080560|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080561|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080562|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
150080563|NCT03095066|541436445|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
150080564|NCT03095066|541436446|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
150080565|NCT03095066|541436447|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080566|NCT03095066|541436448|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080567|NCT03095066|541436449|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080568|NCT03095066|541436450|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080569|NCT03095066|541436451|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080570|NCT03095066|541436452|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
150080571|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080572|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080573|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
150080574|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080575|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080576|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080577|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
150080578|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
150080579|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080580|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080581|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
150080582|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080583|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080584|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080585|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
150080586|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
150080587|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080588|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080589|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
150080590|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080591|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080592|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080593|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
150080594|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
150080595|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080596|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080597|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
150080598|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080599|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080600|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080601|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
150080602|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
150080603|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080604|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080605|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
150080606|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080607|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080608|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080609|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080610|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
150080611|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080612|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080613|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
150080614|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080615|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080616|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080617|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
150080618|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
150080619|NCT03095066|541436445|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080620|NCT03095066|541436446|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080621|NCT03095066|541436447|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080622|NCT03095066|541436448|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080623|NCT03095066|541436449|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080624|NCT03095066|541436450|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080625|NCT03095066|541436451|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
150080626|NCT03095066|541436452|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
150080627|NCT03095066|541436445|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080628|NCT03095066|541436446|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080629|NCT03095066|541436447|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080630|NCT03095066|541436448|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080631|NCT03095066|541436449|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080632|NCT03095066|541436450|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
150080633|NCT03095066|541436451|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080634|NCT03095066|541436452|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
150080635|NCT03095066|541436445|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080636|NCT03095066|541436446|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080637|NCT03095066|541436447|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080638|NCT03095066|541436448|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080639|NCT03095066|541436449|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
150080640|NCT03095066|541436450|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080641|NCT03095066|541436451|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
150080642|NCT03095066|541436452|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
150080643|NCT03095066|541436445|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080644|NCT03095066|541436446|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080645|NCT03095066|541436447|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080646|NCT03095066|541436448|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080647|NCT03095066|541436449|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
150080648|NCT03095066|541436450|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080649|NCT03095066|541436451|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
150080650|NCT03095066|541436452|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
150080651|NCT03095066|541436445|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080652|NCT03095066|541436446|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080653|NCT03095066|541436447|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080654|NCT03095066|541436448|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080655|NCT03095066|541436449|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
150080656|NCT03095066|541436450|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080657|NCT03095066|541436451|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
150080658|NCT03095066|541436452|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
150080659|NCT03095066|541436445|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080660|NCT03095066|541436446|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080661|NCT03095066|541436447|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080662|NCT03095066|541436448|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
150080663|NCT03095066|541436449|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080664|NCT03095066|541436450|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
150080665|NCT03095066|541436451|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080666|NCT03095066|541436452|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
150080667|NCT03766581|541436453|FG000|Randomization|Other reasons|2|||
150080668|NCT03766581|541436454|FG001|Randomization|Other reasons|1|||
150080669|NCT03766581|541436455|FG002|Randomization|Other reasons|0|||
150080670|NCT03766581|541436456|FG003|Randomization|Other reasons|1|||
150080671|NCT03766581|541436457|FG004|Randomization|Other reasons|0|||
150080672|NCT03766581|541436458|FG005|Randomization|Other reasons|0|||
150080673|NCT03766581|541436459|FG006|Randomization|Other reasons|0|||
150080674|NCT03766581|541436460|FG007|Randomization|Other reasons|0|||
150080675|NCT03766581|541436453|FG000|Randomization|Participant no longer meets study criteria|5|||
150080676|NCT03766581|541436454|FG001|Randomization|Participant no longer meets study criteria|3|||
150080677|NCT03766581|541436455|FG002|Randomization|Participant no longer meets study criteria|4|||
150080678|NCT03766581|541436456|FG003|Randomization|Participant no longer meets study criteria|0|||
150080679|NCT03766581|541436457|FG004|Randomization|Participant no longer meets study criteria|2|||
150080680|NCT03766581|541436458|FG005|Randomization|Participant no longer meets study criteria|3|||
150080681|NCT03766581|541436459|FG006|Randomization|Participant no longer meets study criteria|0|||
150080682|NCT03766581|541436460|FG007|Randomization|Participant no longer meets study criteria|1|||
150080683|NCT03766581|541436453|FG000|Randomization|Participant request to discontinue study treatment|1|||
150080684|NCT03766581|541436454|FG001|Randomization|Participant request to discontinue study treatment|0|||
150080685|NCT03766581|541436455|FG002|Randomization|Participant request to discontinue study treatment|0|||
150080686|NCT03766581|541436456|FG003|Randomization|Participant request to discontinue study treatment|0|||
150080687|NCT03766581|541436457|FG004|Randomization|Participant request to discontinue study treatment|1|||
150080688|NCT03766581|541436458|FG005|Randomization|Participant request to discontinue study treatment|2|||
150080689|NCT03766581|541436459|FG006|Randomization|Participant request to discontinue study treatment|0|||
150080690|NCT03766581|541436460|FG007|Randomization|Participant request to discontinue study treatment|0|||
150080691|NCT03766581|541436453|FG000|Randomization|Participant withdrew consent|1|||
150080692|NCT03766581|541436454|FG001|Randomization|Participant withdrew consent|0|||
150080693|NCT03766581|541436455|FG002|Randomization|Participant withdrew consent|1|||
150080694|NCT03766581|541436456|FG003|Randomization|Participant withdrew consent|2|||
150080695|NCT03766581|541436457|FG004|Randomization|Participant withdrew consent|1|||
150080696|NCT03766581|541436458|FG005|Randomization|Participant withdrew consent|1|||
150080697|NCT03766581|541436459|FG006|Randomization|Participant withdrew consent|0|||
150080698|NCT03766581|541436460|FG007|Randomization|Participant withdrew consent|0|||
150080699|NCT03766581|541436453|FG000|Treatment|Adverse Event|82|||
150080700|NCT03766581|541436454|FG001|Treatment|Adverse Event|44|||
150080701|NCT03766581|541436455|FG002|Treatment|Adverse Event|47|||
150080702|NCT03766581|541436456|FG003|Treatment|Adverse Event|46|||
150080703|NCT03766581|541436457|FG004|Treatment|Adverse Event|50|||
150080704|NCT03766581|541436458|FG005|Treatment|Adverse Event|77|||
150080705|NCT03766581|541436459|FG006|Treatment|Adverse Event|5|||
150080706|NCT03766581|541436460|FG007|Treatment|Adverse Event|2|||
150080707|NCT03766581|541436453|FG000|Treatment|Participant request to discontinue treatment|34|||
150080708|NCT03766581|541436454|FG001|Treatment|Participant request to discontinue treatment|6|||
150080709|NCT03766581|541436455|FG002|Treatment|Participant request to discontinue treatment|10|||
150080710|NCT03766581|541436456|FG003|Treatment|Participant request to discontinue treatment|10|||
150080711|NCT03766581|541436457|FG004|Treatment|Participant request to discontinue treatment|14|||
150080712|NCT03766581|541436458|FG005|Treatment|Participant request to discontinue treatment|15|||
150080713|NCT03766581|541436459|FG006|Treatment|Participant request to discontinue treatment|0|||
150080714|NCT03766581|541436460|FG007|Treatment|Participant request to discontinue treatment|1|||
150080715|NCT03766581|541436453|FG000|Treatment|Participant withdrew consent|11|||
150080716|NCT03766581|541436454|FG001|Treatment|Participant withdrew consent|4|||
150080717|NCT03766581|541436455|FG002|Treatment|Participant withdrew consent|5|||
150080718|NCT03766581|541436456|FG003|Treatment|Participant withdrew consent|5|||
150080719|NCT03766581|541436457|FG004|Treatment|Participant withdrew consent|4|||
150080720|NCT03766581|541436458|FG005|Treatment|Participant withdrew consent|4|||
150080721|NCT03766581|541436459|FG006|Treatment|Participant withdrew consent|0|||
150080722|NCT03766581|541436460|FG007|Treatment|Participant withdrew consent|0|||
150080723|NCT03766581|541436453|FG000|Treatment|Death|1|||
150080724|NCT03766581|541436454|FG001|Treatment|Death|0|||
150080725|NCT03766581|541436455|FG002|Treatment|Death|0|||
150080726|NCT03766581|541436456|FG003|Treatment|Death|0|||
150080727|NCT03766581|541436457|FG004|Treatment|Death|0|||
150080728|NCT03766581|541436458|FG005|Treatment|Death|0|||
150080729|NCT03766581|541436459|FG006|Treatment|Death|0|||
150080730|NCT03766581|541436460|FG007|Treatment|Death|0|||
150080731|NCT03766581|541436453|FG000|Treatment|Lost to Follow-up|1|||
150080732|NCT03766581|541436454|FG001|Treatment|Lost to Follow-up|0|||
150080733|NCT03766581|541436455|FG002|Treatment|Lost to Follow-up|0|||
150080734|NCT03766581|541436456|FG003|Treatment|Lost to Follow-up|1|||
150080735|NCT03766581|541436457|FG004|Treatment|Lost to Follow-up|0|||
150080736|NCT03766581|541436458|FG005|Treatment|Lost to Follow-up|0|||
150080737|NCT03766581|541436459|FG006|Treatment|Lost to Follow-up|0|||
150080738|NCT03766581|541436460|FG007|Treatment|Lost to Follow-up|0|||
150080739|NCT03766581|541436453|FG000|Treatment|Poor/Non compliance|2|||
150080740|NCT03766581|541436454|FG001|Treatment|Poor/Non compliance|2|||
150080741|NCT03766581|541436455|FG002|Treatment|Poor/Non compliance|1|||
150080742|NCT03766581|541436456|FG003|Treatment|Poor/Non compliance|1|||
150080743|NCT03766581|541436457|FG004|Treatment|Poor/Non compliance|1|||
150080744|NCT03766581|541436458|FG005|Treatment|Poor/Non compliance|1|||
150080745|NCT03766581|541436459|FG006|Treatment|Poor/Non compliance|0|||
150080746|NCT03766581|541436460|FG007|Treatment|Poor/Non compliance|0|||
150080747|NCT03766581|541436453|FG000|Treatment|Participant no longer meets study criteria|9|||
150080748|NCT03766581|541436454|FG001|Treatment|Participant no longer meets study criteria|1|||
150080749|NCT03766581|541436455|FG002|Treatment|Participant no longer meets study criteria|5|||
150080750|NCT03766581|541436456|FG003|Treatment|Participant no longer meets study criteria|4|||
150080751|NCT03766581|541436457|FG004|Treatment|Participant no longer meets study criteria|4|||
150080752|NCT03766581|541436458|FG005|Treatment|Participant no longer meets study criteria|4|||
150080753|NCT03766581|541436459|FG006|Treatment|Participant no longer meets study criteria|2|||
150080754|NCT03766581|541436460|FG007|Treatment|Participant no longer meets study criteria|0|||
150080755|NCT03766581|541436453|FG000|Treatment|Other reasons|13|||
150080756|NCT03766581|541436454|FG001|Treatment|Other reasons|8|||
150080757|NCT03766581|541436455|FG002|Treatment|Other reasons|3|||
150080758|NCT03766581|541436456|FG003|Treatment|Other reasons|7|||
150080759|NCT03766581|541436457|FG004|Treatment|Other reasons|3|||
150080760|NCT03766581|541436458|FG005|Treatment|Other reasons|3|||
150080761|NCT03766581|541436459|FG006|Treatment|Other reasons|0|||
150080762|NCT03766581|541436460|FG007|Treatment|Other reasons|0|||
150080763|NCT03716024|541436461|FG000|Overall Study|Randomized, not Treated|7|||
150080764|NCT03716024|541436462|FG001|Overall Study|Randomized, not Treated|8|||
150080765|NCT03716024|541436461|FG000|Overall Study|Adverse Event|1|||
150080766|NCT03716024|541436462|FG001|Overall Study|Adverse Event|2|||
150080767|NCT03716024|541436461|FG000|Overall Study|Treatment Failure|1|||
150080768|NCT03716024|541436462|FG001|Overall Study|Treatment Failure|0|||
150080769|NCT03716024|541436461|FG000|Overall Study|Lost to Follow-up|2|||
150080770|NCT03716024|541436462|FG001|Overall Study|Lost to Follow-up|6|||
150080771|NCT03716024|541436461|FG000|Overall Study|Withdrawal by Subject|0|||
150080772|NCT03716024|541436462|FG001|Overall Study|Withdrawal by Subject|1|||
150080773|NCT03716024|541436461|FG000|Overall Study|Missing Reason|0|||
150080774|NCT03716024|541436462|FG001|Overall Study|Missing Reason|1|||
150080775|NCT04343261|541436463|FG000|Overall Study|Adverse Event|1|||
150080776|NCT04343261|541436463|FG000|Overall Study|received inadequate amount of antibodies|7|||
150080777|NCT02197247|541436471|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
150080778|NCT02197247|541436471|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
150080779|NCT02197247|541436471|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
150080780|NCT02197247|541436471|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
150080781|NCT02197247|541436471|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
150080782|NCT02197247|541436471|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
150080783|NCT02197247|541436471|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
150080784|NCT02197247|541436471|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
150080785|NCT03851705|541436476|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
150080786|NCT03851705|541436477|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150080787|NCT03851705|541436478|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150080788|NCT03851705|541436479|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150080789|NCT03851705|541436476|FG000|Part 1: Double-Blind Period|Other reason|1|||
150080790|NCT03851705|541436477|FG001|Part 1: Double-Blind Period|Other reason|0|||
150080791|NCT03851705|541436478|FG002|Part 1: Double-Blind Period|Other reason|0|||
150080792|NCT03851705|541436479|FG003|Part 1: Double-Blind Period|Other reason|0|||
150080793|NCT03851705|541436476|FG000|Part 2: Open-Label Period|Other reason|0|||
150080794|NCT03851705|541436477|FG001|Part 2: Open-Label Period|Other reason|0|||
150080795|NCT03851705|541436478|FG002|Part 2: Open-Label Period|Other reason|0|||
150080796|NCT03851705|541436479|FG003|Part 2: Open-Label Period|Other reason|1|||
150080797|NCT03851705|541436476|FG000|Part 2: Open-Label Period|Death|0|||
150080798|NCT03851705|541436477|FG001|Part 2: Open-Label Period|Death|0|||
150080799|NCT03851705|541436478|FG002|Part 2: Open-Label Period|Death|3|||
150080800|NCT03851705|541436479|FG003|Part 2: Open-Label Period|Death|0|||
150080801|NCT03851705|541436476|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
150080802|NCT03851705|541436477|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
150080803|NCT03851705|541436478|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
150080804|NCT03851705|541436479|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
150080805|NCT01964430|541436483|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
150080806|NCT01964430|541436484|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
150080807|NCT01964430|541436483|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
150080808|NCT01964430|541436484|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
150080809|NCT01964430|541436483|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
150080810|NCT01964430|541436484|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
150080811|NCT01964430|541436483|FG000|Treatment Period|Adverse Event|71|||
150080812|NCT01964430|541436484|FG001|Treatment Period|Adverse Event|37|||
150080813|NCT01964430|541436483|FG000|Treatment Period|Withdrawal by Subject|36|||
150080814|NCT01964430|541436484|FG001|Treatment Period|Withdrawal by Subject|27|||
150080815|NCT01964430|541436483|FG000|Treatment Period|Death|1|||
150080816|NCT01964430|541436484|FG001|Treatment Period|Death|3|||
150080817|NCT01964430|541436483|FG000|Treatment Period|Protocol Deviation|0|||
150080818|NCT01964430|541436484|FG001|Treatment Period|Protocol Deviation|1|||
150080819|NCT01964430|541436483|FG000|Treatment Period|Physician Decision|5|||
150080820|NCT01964430|541436484|FG001|Treatment Period|Physician Decision|4|||
150080821|NCT01964430|541436483|FG000|Treatment Period|Disease Relapse|28|||
150080822|NCT01964430|541436484|FG001|Treatment Period|Disease Relapse|38|||
150080823|NCT01964430|541436483|FG000|Treatment Period|Other reasons|1|||
150080824|NCT01964430|541436484|FG001|Treatment Period|Other reasons|3|||
150080825|NCT02591290|541436485|FG000|Overall Study|Withdrawal by Subject|2|||
150080826|NCT02571075|541436486|FG000|Overall Study|Lost to Follow-up|20|||
150080827|NCT02571075|541436487|FG001|Overall Study|Lost to Follow-up|24|||
150080828|NCT03190915|541436488|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
150080829|NCT03190915|541436488|FG000|Overall Study|Progressive Disease|3|||
150080830|NCT02083783|541436494|FG000|Overall Study|Withdrawal by Subject|1|||
150080831|NCT02083783|541436495|FG001|Overall Study|Withdrawal by Subject|0|||
150080832|NCT01546883|541436496|FG000|Overall Study|Withdrawal by Subject|3|||
150080833|NCT01546883|541436496|FG000|Overall Study|Adverse Event|4|||
150080834|NCT01546883|541436496|FG000|Overall Study|Lost to Follow-up|2|||
150080835|NCT01546883|541436496|FG000|Overall Study|early closure of study|2|||
150080836|NCT01546883|541436496|FG000|Overall Study|other unrelated illness|1|||
150080837|NCT02256631|541436497|FG000|Overall Study|Lost to Follow-up|1|||
150080838|NCT02256631|541436498|FG001|Overall Study|Lost to Follow-up|1|||
150080839|NCT02256631|541436499|FG002|Overall Study|Lost to Follow-up|0|||
150080840|NCT02256631|541436500|FG003|Overall Study|Lost to Follow-up|2|||
150080841|NCT02256631|541436501|FG004|Overall Study|Lost to Follow-up|0|||
150080842|NCT02256631|541436502|FG005|Overall Study|Lost to Follow-up|4|||
150080843|NCT02256631|541436503|FG006|Overall Study|Lost to Follow-up|1|||
150080844|NCT02256631|541436497|FG000|Overall Study|Withdrawal by Subject|0|||
150080845|NCT02256631|541436498|FG001|Overall Study|Withdrawal by Subject|0|||
150080846|NCT02256631|541436499|FG002|Overall Study|Withdrawal by Subject|0|||
150080847|NCT02256631|541436500|FG003|Overall Study|Withdrawal by Subject|1|||
150080848|NCT02256631|541436501|FG004|Overall Study|Withdrawal by Subject|1|||
150080849|NCT02256631|541436502|FG005|Overall Study|Withdrawal by Subject|0|||
150080850|NCT02256631|541436503|FG006|Overall Study|Withdrawal by Subject|1|||
150080851|NCT02256631|541436497|FG000|Overall Study|Unable to get to clinic|0|||
150080852|NCT02256631|541436498|FG001|Overall Study|Unable to get to clinic|2|||
150080853|NCT02256631|541436499|FG002|Overall Study|Unable to get to clinic|0|||
150080854|NCT02256631|541436500|FG003|Overall Study|Unable to get to clinic|1|||
150080855|NCT02256631|541436501|FG004|Overall Study|Unable to get to clinic|0|||
150080856|NCT02256631|541436502|FG005|Overall Study|Unable to get to clinic|1|||
150080857|NCT02256631|541436503|FG006|Overall Study|Unable to get to clinic|2|||
150080858|NCT00530946|541436504|FG000|Overall Study|Adverse Event|1|||
150080859|NCT00530946|541436505|FG001|Overall Study|Adverse Event|2|||
150080860|NCT00530946|541436506|FG002|Overall Study|Adverse Event|1|||
150080861|NCT00530946|541436507|FG003|Overall Study|Adverse Event|1|||
150080862|NCT00530946|541436504|FG000|Overall Study|Protocol Violation|0|||
150080863|NCT00530946|541436505|FG001|Overall Study|Protocol Violation|0|||
150080864|NCT00530946|541436506|FG002|Overall Study|Protocol Violation|0|||
150080865|NCT00530946|541436507|FG003|Overall Study|Protocol Violation|1|||
150080866|NCT00530946|541436504|FG000|Overall Study|Noncompliance|1|||
150080867|NCT00530946|541436505|FG001|Overall Study|Noncompliance|0|||
150080868|NCT00530946|541436506|FG002|Overall Study|Noncompliance|0|||
150080869|NCT00530946|541436507|FG003|Overall Study|Noncompliance|0|||
150080870|NCT04545385|541436508|FG000|Overall Study|Withdrawal by Subject|2|||
150080871|NCT04545385|541436509|FG001|Overall Study|Withdrawal by Subject|0|||
150080872|NCT04545385|541436508|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
150080873|NCT04545385|541436509|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
150080874|NCT04545385|541436508|FG000|Overall Study|Study termination|10|||
150080875|NCT04545385|541436509|FG001|Overall Study|Study termination|10|||
150080876|NCT04545385|541436508|FG000|Overall Study|Sponsor decision|2|||
150080877|NCT04545385|541436509|FG001|Overall Study|Sponsor decision|2|||
150080878|NCT04545385|541436508|FG000|Overall Study|Other than specified|1|||
150080879|NCT04545385|541436509|FG001|Overall Study|Other than specified|0|||
150080880|NCT01128842|541436510|FG000|Overall Study|Adverse Event|1|||
150080881|NCT01128842|541436510|FG000|Overall Study|Disease Progression|6|||
150080882|NCT04528732|541436511|FG000|Overall Study|Death|1|||
150080883|NCT04528732|541436512|FG001|Overall Study|Death|0|||
150080884|NCT04528732|541436513|FG002|Overall Study|Death|1|||
150080885|NCT04528732|541436511|FG000|Overall Study|Lost to Follow-up|0|||
150080886|NCT04528732|541436512|FG001|Overall Study|Lost to Follow-up|1|||
150080887|NCT04528732|541436513|FG002|Overall Study|Lost to Follow-up|2|||
150080888|NCT00668707|541436516|FG000|Overall Study|Cancer Recurrence|58|||
150080889|NCT00668707|541436517|FG001|Overall Study|Cancer Recurrence|58|||
150080890|NCT00668707|541436516|FG000|Overall Study|Withdrawal by Subject|117|||
150080891|NCT00668707|541436517|FG001|Overall Study|Withdrawal by Subject|100|||
150080892|NCT00668707|541436516|FG000|Overall Study|Lost to Follow-up|3|||
150080893|NCT00668707|541436517|FG001|Overall Study|Lost to Follow-up|6|||
150080894|NCT00668707|541436516|FG000|Overall Study|Protocol Violation|10|||
150080895|NCT00668707|541436517|FG001|Overall Study|Protocol Violation|12|||
150080896|NCT00668707|541436516|FG000|Overall Study|Death|11|||
150080897|NCT00668707|541436517|FG001|Overall Study|Death|4|||
150080898|NCT03943147|541436520|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
150080899|NCT03943147|541436521|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
150080900|NCT03943147|541436520|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
150080901|NCT03943147|541436521|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
150080902|NCT03943147|541436520|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
150080903|NCT03943147|541436521|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
150080904|NCT03943147|541436520|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
150080905|NCT03943147|541436521|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
150080906|NCT03943147|541436520|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
150080907|NCT03943147|541436521|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
150080908|NCT03943147|541436520|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
150080909|NCT03943147|541436521|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
150080910|NCT00629707|541436524|FG000|Overall Study|Withdrawal by Subject|0|||
150080911|NCT00629707|541436525|FG001|Overall Study|Withdrawal by Subject|1|||
150080912|NCT00629707|541436524|FG000|Overall Study|Physician Decision|0|||
150080913|NCT00629707|541436525|FG001|Overall Study|Physician Decision|1|||
150080914|NCT00968201|541436527|FG000|Base Study - (Period II)|Adverse Event|8|||
150080915|NCT00968201|541436528|FG001|Base Study - (Period II)|Adverse Event|0|||
150080916|NCT00968201|541436529|FG002|Base Study - (Period II)|Adverse Event|16|||
150080917|NCT00968201|541436527|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
150080918|NCT00968201|541436528|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
150080919|NCT00968201|541436529|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
150080920|NCT00968201|541436527|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
150080921|NCT00968201|541436528|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
150080922|NCT00968201|541436529|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
150080923|NCT00968201|541436527|FG000|Base Study - (Period II)|Protocol Violation|12|||
150080924|NCT00968201|541436528|FG001|Base Study - (Period II)|Protocol Violation|0|||
150080925|NCT00968201|541436529|FG002|Base Study - (Period II)|Protocol Violation|12|||
150080926|NCT00968201|541436527|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
150080927|NCT00968201|541436528|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
150080928|NCT00968201|541436529|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
150080929|NCT00968201|541436527|FG000|Base Study - (Period II)|Site Error|0|||
150080930|NCT00968201|541436528|FG001|Base Study - (Period II)|Site Error|0|||
150080931|NCT00968201|541436529|FG002|Base Study - (Period II)|Site Error|1|||
150080932|NCT00968201|541436527|FG000|Extension Study - (Period III)|Adverse Event|0|||
150080933|NCT00968201|541436528|FG001|Extension Study - (Period III)|Adverse Event|5|||
150080934|NCT00968201|541436529|FG002|Extension Study - (Period III)|Adverse Event|22|||
150080935|NCT00968201|541436527|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
150080936|NCT00968201|541436528|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
150080937|NCT00968201|541436529|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
150080938|NCT00968201|541436527|FG000|Extension Study - (Period III)|Protocol Violation|0|||
150080939|NCT00968201|541436528|FG001|Extension Study - (Period III)|Protocol Violation|17|||
150080940|NCT00968201|541436529|FG002|Extension Study - (Period III)|Protocol Violation|14|||
150080941|NCT00968201|541436527|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
150080942|NCT00968201|541436528|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
150080943|NCT00968201|541436529|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
150080944|NCT00968201|541436527|FG000|Extension Study - (Period III)|Patient Relocated|0|||
150080945|NCT00968201|541436528|FG001|Extension Study - (Period III)|Patient Relocated|1|||
150080946|NCT00968201|541436529|FG002|Extension Study - (Period III)|Patient Relocated|1|||
150080947|NCT00968201|541436527|FG000|Extension Study - (Period III)|Noncompliance|0|||
150080948|NCT00968201|541436528|FG001|Extension Study - (Period III)|Noncompliance|0|||
150080949|NCT00968201|541436529|FG002|Extension Study - (Period III)|Noncompliance|3|||
150080950|NCT00968201|541436527|FG000|Extension Study - (Period III)|Other|0|||
150080951|NCT00968201|541436528|FG001|Extension Study - (Period III)|Other|0|||
150080952|NCT00968201|541436529|FG002|Extension Study - (Period III)|Other|2|||
150080953|NCT00968201|541436527|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
150080954|NCT00968201|541436528|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
150080955|NCT00968201|541436529|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
150080956|NCT02619175|541436530|FG000|Overall Study|Withdrawal by Subject|1|||
150080957|NCT02619175|541436531|FG001|Overall Study|Withdrawal by Subject|0|||
150080958|NCT02619175|541436530|FG000|Overall Study|foot pain|1|||
150080959|NCT02619175|541436531|FG001|Overall Study|foot pain|0|||
150080960|NCT02784431|541436532|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
150080961|NCT02784431|541436532|FG000|Overall Study|Early Study Termination|19|||
150080962|NCT02657369|541436533|FG000|Overall Study|Death|27|||
150080963|NCT02657369|541436533|FG000|Overall Study|Study terminated by sponsor|7|||
150080964|NCT00361569|541436534|FG000|Overall Study|Protocol Violation|3|||
150080965|NCT00361569|541436535|FG001|Overall Study|Protocol Violation|2|||
150080966|NCT00361569|541436536|FG002|Overall Study|Protocol Violation|4|||
150080967|NCT00361569|541436537|FG003|Overall Study|Protocol Violation|2|||
150080968|NCT00361569|541436534|FG000|Overall Study|Withdrawal by Subject|2|||
150080969|NCT00361569|541436535|FG001|Overall Study|Withdrawal by Subject|1|||
150080970|NCT00361569|541436536|FG002|Overall Study|Withdrawal by Subject|9|||
150080971|NCT00361569|541436537|FG003|Overall Study|Withdrawal by Subject|14|||
150080972|NCT00361569|541436534|FG000|Overall Study|Adverse Event|3|||
150080973|NCT00361569|541436535|FG001|Overall Study|Adverse Event|5|||
150080974|NCT00361569|541436536|FG002|Overall Study|Adverse Event|2|||
150080975|NCT00361569|541436537|FG003|Overall Study|Adverse Event|2|||
150080976|NCT00361569|541436534|FG000|Overall Study|Lost to Follow-up|2|||
150080977|NCT00361569|541436535|FG001|Overall Study|Lost to Follow-up|3|||
150080978|NCT00361569|541436536|FG002|Overall Study|Lost to Follow-up|3|||
150080979|NCT00361569|541436537|FG003|Overall Study|Lost to Follow-up|2|||
150080980|NCT00361569|541436534|FG000|Overall Study|Not specified by investigator|2|||
150080981|NCT00361569|541436535|FG001|Overall Study|Not specified by investigator|0|||
150080982|NCT00361569|541436536|FG002|Overall Study|Not specified by investigator|0|||
150080983|NCT00361569|541436537|FG003|Overall Study|Not specified by investigator|1|||
150080984|NCT02605824|541436538|FG000|Overall Study|Physician Decision|1|||
150080985|NCT02605824|541436539|FG001|Overall Study|Physician Decision|0|||
150080986|NCT04875195|541436540|FG000|Overall Study|Death|9|||
150080987|NCT04875195|541436541|FG001|Overall Study|Death|3|||
150080988|NCT04875195|541436540|FG000|Overall Study|Withdrawal by Subject|2|||
150080989|NCT04875195|541436541|FG001|Overall Study|Withdrawal by Subject|1|||
150080990|NCT04875195|541436540|FG000|Overall Study|Ongoing in study|49|||
150080991|NCT04875195|541436541|FG001|Overall Study|Ongoing in study|2|||
150080992|NCT00826943|541436542|FG000|Overall Study|Withdrawal by Subject|0|||
150080993|NCT00826943|541436543|FG001|Overall Study|Withdrawal by Subject|0|||
150080994|NCT00826943|541436544|FG002|Overall Study|Withdrawal by Subject|0|||
150080995|NCT00826943|541436545|FG003|Overall Study|Withdrawal by Subject|0|||
150080996|NCT00826943|541436546|FG004|Overall Study|Withdrawal by Subject|1|||
150080997|NCT00826943|541436547|FG005|Overall Study|Withdrawal by Subject|0|||
150080998|NCT00074152|541436548|FG000|Overall Study|Death|21|||
150080999|NCT00074152|541436549|FG001|Overall Study|Death|9|||
150081000|NCT00074152|541436548|FG000|Overall Study|Lack of Efficacy|34|||
150081001|NCT00074152|541436549|FG001|Overall Study|Lack of Efficacy|24|||
150081002|NCT01382212|541436550|FG000|Overall Study|Kidney transplant|1|||
150081003|NCT01382212|541436550|FG000|Overall Study|Withdrew consent|1|||
150081004|NCT03715530|541436551|FG000|Overall Study|Lost to Follow-up|3|||
150081005|NCT03715530|541436552|FG001|Overall Study|Lost to Follow-up|1|||
150081006|NCT03715530|541436553|FG002|Overall Study|Lost to Follow-up|2|||
150081007|NCT01594762|541436557|FG000|Overall Study|Withdrawal by Subject|1|||
150081008|NCT01594762|541436558|FG001|Overall Study|Withdrawal by Subject|0|||
150081009|NCT01594762|541436557|FG000|Overall Study|Lost to Follow-up|10|||
150081010|NCT01594762|541436558|FG001|Overall Study|Lost to Follow-up|10|||
150081011|NCT03288129|541436559|FG000|Overall Study|Adverse Event|10|||
150081012|NCT03288129|541436559|FG000|Overall Study|Lost to Follow-up|3|||
150081013|NCT03288129|541436559|FG000|Overall Study|Withdrawal by Subject|3|||
150081014|NCT03288129|541436559|FG000|Overall Study|Withdrawal of consent/assent|1|||
150081015|NCT03288129|541436559|FG000|Overall Study|Other|5|||
150081016|NCT02777333|541436562|FG000|Overall Study|Withdrawal by Subject|0|||
150081017|NCT02777333|541436563|FG001|Overall Study|Withdrawal by Subject|1|||
150081018|NCT02777333|541436562|FG000|Overall Study|Lost to Follow-up|0|||
150081019|NCT02777333|541436563|FG001|Overall Study|Lost to Follow-up|1|||
150081020|NCT00837811|541436564|FG000|Overall Study|Adverse Event|4|||
150081021|NCT00837811|541436565|FG001|Overall Study|Adverse Event|6|||
150081022|NCT00837811|541436566|FG002|Overall Study|Adverse Event|0|||
150081023|NCT00837811|541436564|FG000|Overall Study|Death|1|||
150081024|NCT00837811|541436565|FG001|Overall Study|Death|1|||
150081025|NCT00837811|541436566|FG002|Overall Study|Death|0|||
150081026|NCT00837811|541436564|FG000|Overall Study|Lack of Efficacy|0|||
150081027|NCT00837811|541436565|FG001|Overall Study|Lack of Efficacy|11|||
150081028|NCT00837811|541436566|FG002|Overall Study|Lack of Efficacy|0|||
150081029|NCT00837811|541436564|FG000|Overall Study|Lost to Follow-up|1|||
150081030|NCT00837811|541436565|FG001|Overall Study|Lost to Follow-up|3|||
150081031|NCT00837811|541436566|FG002|Overall Study|Lost to Follow-up|0|||
150081032|NCT00837811|541436564|FG000|Overall Study|Physician Decision|0|||
150081033|NCT00837811|541436565|FG001|Overall Study|Physician Decision|2|||
150081034|NCT00837811|541436566|FG002|Overall Study|Physician Decision|1|||
150081035|NCT00837811|541436564|FG000|Overall Study|Withdrawal by Subject|1|||
150081036|NCT00837811|541436565|FG001|Overall Study|Withdrawal by Subject|9|||
150081037|NCT00837811|541436566|FG002|Overall Study|Withdrawal by Subject|0|||
150081038|NCT00837811|541436564|FG000|Overall Study|Sponsor Decision|0|||
150081039|NCT00837811|541436565|FG001|Overall Study|Sponsor Decision|2|||
150081040|NCT00837811|541436566|FG002|Overall Study|Sponsor Decision|0|||
150081041|NCT03307967|541436567|FG000|Overall Study|Lost to Follow-up|4|||
150081042|NCT03268954|541436571|FG000|Overall Study|Withdrawal by Subject|27|||
150081043|NCT03268954|541436572|FG001|Overall Study|Withdrawal by Subject|17|||
150081044|NCT03268954|541436571|FG000|Overall Study|Lost to Follow-up|2|||
150081045|NCT03268954|541436572|FG001|Overall Study|Lost to Follow-up|3|||
150081046|NCT03268954|541436571|FG000|Overall Study|Reason Not Specified|3|||
150081047|NCT03268954|541436572|FG001|Overall Study|Reason Not Specified|8|||
150081048|NCT02993146|541436575|FG000|Overall Study|Withdrawal by Subject|0|||
150081049|NCT02993146|541436576|FG001|Overall Study|Withdrawal by Subject|0|||
150081050|NCT02993146|541436577|FG002|Overall Study|Withdrawal by Subject|1|||
150081051|NCT02993146|541436578|FG003|Overall Study|Withdrawal by Subject|1|||
150081052|NCT04524689|541436579|FG000|Overall Study|Withdrawal by Subject|1|||
150081053|NCT04524689|541436580|FG001|Overall Study|Withdrawal by Subject|1|||
150081054|NCT04524689|541436581|FG002|Overall Study|Withdrawal by Subject|0|||
150081055|NCT04524689|541436582|FG003|Overall Study|Withdrawal by Subject|0|||
150081056|NCT04524689|541436583|FG004|Overall Study|Withdrawal by Subject|2|||
150081057|NCT04524689|541436584|FG005|Overall Study|Withdrawal by Subject|0|||
150081058|NCT04524689|541436579|FG000|Overall Study|Study terminated by Sponsor|6|||
150081059|NCT04524689|541436580|FG001|Overall Study|Study terminated by Sponsor|0|||
150081060|NCT04524689|541436581|FG002|Overall Study|Study terminated by Sponsor|1|||
150081061|NCT04524689|541436582|FG003|Overall Study|Study terminated by Sponsor|0|||
150081062|NCT04524689|541436583|FG004|Overall Study|Study terminated by Sponsor|4|||
150081063|NCT04524689|541436584|FG005|Overall Study|Study terminated by Sponsor|0|||
150081064|NCT04524689|541436579|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
150081065|NCT04524689|541436580|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
150081066|NCT04524689|541436581|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
150081067|NCT04524689|541436582|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
150081068|NCT04524689|541436583|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
150081069|NCT04524689|541436584|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
150081070|NCT01898806|541438638|FG000|Overall Study|Withdrawal by Subject|2|||
150081071|NCT01898806|541438638|FG000|Overall Study|Physician Decision|1|||
150081072|NCT03156543|541438639|FG000|Overall Study|Withdrawal by Subject|1|||
150081073|NCT03156543|541438640|FG001|Overall Study|Withdrawal by Subject|0|||
150081074|NCT01389817|541438647|FG000|Overall Study|Physician Decision|1|||
150081075|NCT01389817|541438648|FG001|Overall Study|Physician Decision|0|||
150081076|NCT01389817|541438647|FG000|Overall Study|Lost to Follow-up|1|||
150081077|NCT01389817|541438648|FG001|Overall Study|Lost to Follow-up|0|||
150081078|NCT01389817|541438647|FG000|Overall Study|Withdrawal by Subject|2|||
150081079|NCT01389817|541438648|FG001|Overall Study|Withdrawal by Subject|0|||
150081080|NCT02966028|541438656|FG000|Overall Study|Adverse Event|7|||
150081081|NCT02966028|541438657|FG001|Overall Study|Adverse Event|13|||
150081082|NCT02966028|541438658|FG002|Overall Study|Adverse Event|10|||
150081083|NCT02966028|541438656|FG000|Overall Study|Physician Decision|1|||
150081084|NCT02966028|541438657|FG001|Overall Study|Physician Decision|0|||
150081085|NCT02966028|541438658|FG002|Overall Study|Physician Decision|2|||
150081086|NCT02966028|541438656|FG000|Overall Study|Withdrawal by Subject|7|||
150081087|NCT02966028|541438657|FG001|Overall Study|Withdrawal by Subject|5|||
150081088|NCT02966028|541438658|FG002|Overall Study|Withdrawal by Subject|5|||
150081089|NCT02966028|541438656|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
150081090|NCT02966028|541438657|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
150081091|NCT02966028|541438658|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
150081092|NCT03052725|541438668|FG000|Overall Study|Adverse Event|2|||
150081093|NCT03052725|541438669|FG001|Overall Study|Adverse Event|0|||
150081094|NCT03052725|541438668|FG000|Overall Study|Withdrawal by Subject|3|||
150081095|NCT03052725|541438669|FG001|Overall Study|Withdrawal by Subject|4|||
150081096|NCT03052725|541438668|FG000|Overall Study|Pregnancy|0|||
150081097|NCT03052725|541438669|FG001|Overall Study|Pregnancy|1|||
150081098|NCT03052725|541438668|FG000|Overall Study|Site closure|0|||
150081099|NCT03052725|541438669|FG001|Overall Study|Site closure|1|||
150081100|NCT03052725|541438668|FG000|Overall Study|Study terminated by sponsor|143|||
150081101|NCT03052725|541438669|FG001|Overall Study|Study terminated by sponsor|144|||
150081102|NCT01976338|541438674|FG000|Overall Study|Physician Decision|0|||
150081103|NCT01976338|541438675|FG001|Overall Study|Physician Decision|1|||
150081104|NCT01976338|541438674|FG000|Overall Study|Lost to Follow-up|3|||
150081105|NCT01976338|541438675|FG001|Overall Study|Lost to Follow-up|0|||
150081106|NCT01976338|541438674|FG000|Overall Study|Withdrawal by Subject|5|||
150081107|NCT01976338|541438675|FG001|Overall Study|Withdrawal by Subject|2|||
150081108|NCT01976338|541438674|FG000|Overall Study|Adverse Event|5|||
150081109|NCT01976338|541438675|FG001|Overall Study|Adverse Event|1|||
150081110|NCT03616600|541438676|FG000|Overall Study|Withdrawal by Subject|1|||
150081111|NCT03616600|541438677|FG001|Overall Study|Withdrawal by Subject|0|||
150081112|NCT03897465|541438678|FG000|Overall Study|Lost to Follow-up|2|||
150081113|NCT03897465|541438679|FG001|Overall Study|Lost to Follow-up|1|||
150081114|NCT03897465|541438678|FG000|Overall Study|Adverse Event|2|||
150081115|NCT03897465|541438679|FG001|Overall Study|Adverse Event|0|||
150081116|NCT03897465|541438678|FG000|Overall Study|complete healing by V2|1|||
150081117|NCT03897465|541438679|FG001|Overall Study|complete healing by V2|0|||
150081118|NCT03897465|541438678|FG000|Overall Study|occurence of exclusion criterion|1|||
150081119|NCT03897465|541438679|FG001|Overall Study|occurence of exclusion criterion|1|||
150081120|NCT03897465|541438678|FG000|Overall Study|Other|1|||
150081121|NCT03897465|541438679|FG001|Overall Study|Other|0|||
150081122|NCT00621582|541438680|FG000|Overall Study|Adverse Event|7|||
150081123|NCT00621582|541438680|FG000|Overall Study|Protocol Violation|57|||
150081124|NCT00621582|541438680|FG000|Overall Study|Lost to Follow-up|24|||
150081125|NCT00621582|541438680|FG000|Overall Study|issues not identified by investigators|18|||
150081126|NCT03617185|541438681|FG000|Baseline|Lost to Follow-up|0|||
150081127|NCT03617185|541438682|FG001|Baseline|Lost to Follow-up|2|||
150081128|NCT03617185|541438683|FG002|Baseline|Lost to Follow-up|1|||
150081129|NCT03617185|541438684|FG003|Baseline|Lost to Follow-up|1|||
150081130|NCT03617185|541438681|FG000|Baseline|Withdrawal by Subject|0|||
150081131|NCT03617185|541438682|FG001|Baseline|Withdrawal by Subject|1|||
150081132|NCT03617185|541438683|FG002|Baseline|Withdrawal by Subject|0|||
150081133|NCT03617185|541438684|FG003|Baseline|Withdrawal by Subject|1|||
150081134|NCT03617185|541438681|FG000|Baseline|Driving Distance/Travel|0|||
150081135|NCT03617185|541438682|FG001|Baseline|Driving Distance/Travel|0|||
150081136|NCT03617185|541438683|FG002|Baseline|Driving Distance/Travel|2|||
150081137|NCT03617185|541438684|FG003|Baseline|Driving Distance/Travel|0|||
150081138|NCT03617185|541438681|FG000|Baseline|Family Obligations|0|||
150081139|NCT03617185|541438682|FG001|Baseline|Family Obligations|0|||
150081140|NCT03617185|541438683|FG002|Baseline|Family Obligations|0|||
150081141|NCT03617185|541438684|FG003|Baseline|Family Obligations|1|||
150081142|NCT03617185|541438681|FG000|3 Months|Lost to Follow-up|4|||
150081143|NCT03617185|541438682|FG001|3 Months|Lost to Follow-up|1|||
150081144|NCT03617185|541438683|FG002|3 Months|Lost to Follow-up|0|||
150081145|NCT03617185|541438684|FG003|3 Months|Lost to Follow-up|2|||
150081146|NCT03617185|541438681|FG000|3 Months|Withdrawal by Subject|1|||
150081147|NCT03617185|541438682|FG001|3 Months|Withdrawal by Subject|3|||
150183011|NCT00979576|541808692|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
150183012|NCT04855760|541808695|FG000|Overall Study|Adverse Event|21|||
150183013|NCT04855760|541808695|FG000|Overall Study|Withdrawal by Subject|116|||
150183014|NCT04855760|541808695|FG000|Overall Study|Lack of Efficacy|21|||
150183015|NCT04855760|541808695|FG000|Overall Study|Lost to Follow-up|49|||
150183016|NCT04855760|541808695|FG000|Overall Study|Protocol Violation|2|||
150183017|NCT04855760|541808695|FG000|Overall Study|Physician Decision|5|||
150183018|NCT04855760|541808695|FG000|Overall Study|Pregnancy|1|||
150183019|NCT04855760|541808695|FG000|Overall Study|Non-Compliance with Study Drug|11|||
150081148|NCT03617185|541438683|FG002|3 Months|Withdrawal by Subject|0|||
150081149|NCT03617185|541438684|FG003|3 Months|Withdrawal by Subject|0|||
150081150|NCT03617185|541438681|FG000|3 Months|Driving Distance/Travel|1|||
150081151|NCT03617185|541438682|FG001|3 Months|Driving Distance/Travel|0|||
150081152|NCT03617185|541438683|FG002|3 Months|Driving Distance/Travel|0|||
150081153|NCT03617185|541438684|FG003|3 Months|Driving Distance/Travel|0|||
150081154|NCT03617185|541438681|FG000|3 Months|Family Obligations|0|||
150081155|NCT03617185|541438682|FG001|3 Months|Family Obligations|0|||
150081156|NCT03617185|541438683|FG002|3 Months|Family Obligations|0|||
150081157|NCT03617185|541438684|FG003|3 Months|Family Obligations|1|||
150081158|NCT03617185|541438681|FG000|12 Months|Lost to Follow-up|3|||
150081159|NCT03617185|541438682|FG001|12 Months|Lost to Follow-up|1|||
150081160|NCT03617185|541438683|FG002|12 Months|Lost to Follow-up|3|||
150081161|NCT03617185|541438684|FG003|12 Months|Lost to Follow-up|0|||
150081162|NCT03617185|541438681|FG000|12 Months|Withdrawal by Subject|0|||
150081163|NCT03617185|541438682|FG001|12 Months|Withdrawal by Subject|0|||
150081164|NCT03617185|541438683|FG002|12 Months|Withdrawal by Subject|0|||
150081165|NCT03617185|541438684|FG003|12 Months|Withdrawal by Subject|1|||
150081166|NCT03617185|541438681|FG000|12 Months|Driving Distance/Travel|0|||
150183020|NCT04855760|541808695|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
150183021|NCT04855760|541808695|FG000|Overall Study|Study Completed by Sponsor|202|||
150081167|NCT03617185|541438682|FG001|12 Months|Driving Distance/Travel|0|||
150081168|NCT03617185|541438683|FG002|12 Months|Driving Distance/Travel|1|||
150081169|NCT03617185|541438684|FG003|12 Months|Driving Distance/Travel|0|||
150081170|NCT01387932|541438686|FG000|Randomized and Treated|Physician Decision|3|||
150081171|NCT01387932|541438687|FG001|Randomized and Treated|Physician Decision|2|||
150081172|NCT01387932|541438686|FG000|Randomized and Treated|Withdrawal by Subject|4|||
150081173|NCT01387932|541438687|FG001|Randomized and Treated|Withdrawal by Subject|2|||
150081174|NCT01387932|541438686|FG000|Survival Follow-up|Liver Transplant|24|||
150081175|NCT01387932|541438687|FG001|Survival Follow-up|Liver Transplant|28|||
150081176|NCT01387932|541438686|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
150081177|NCT01387932|541438687|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
150081178|NCT01387932|541438686|FG000|Survival Follow-up|Withdrawal by Subject|2|||
150081179|NCT01387932|541438687|FG001|Survival Follow-up|Withdrawal by Subject|4|||
150081180|NCT01387932|541438686|FG000|Survival Follow-up|Lost to Follow-up|6|||
150081181|NCT01387932|541438687|FG001|Survival Follow-up|Lost to Follow-up|5|||
150081182|NCT02801396|541438693|FG000|Period 1|Withdrawal by Subject|0|||
150081183|NCT02801396|541438694|FG001|Period 1|Withdrawal by Subject|0|||
150081184|NCT02801396|541438695|FG002|Period 1|Withdrawal by Subject|0|||
150081185|NCT02801396|541438696|FG003|Period 1|Withdrawal by Subject|0|||
150081186|NCT02801396|541438697|FG004|Period 1|Withdrawal by Subject|1|||
150081187|NCT02801396|541438698|FG005|Period 1|Withdrawal by Subject|0|||
150081188|NCT01306942|541438699|FG000|Phase I|Adverse Event|2|||
150081189|NCT01306942|541438700|FG001|Phase I|Adverse Event|2|||
150081190|NCT01306942|541438701|FG002|Phase I|Adverse Event|0|||
150081191|NCT01306942|541438702|FG003|Phase I|Adverse Event|0|||
150081192|NCT01306942|541438699|FG000|Phase I|Physician Decision|3|||
150081193|NCT01306942|541438700|FG001|Phase I|Physician Decision|1|||
150081194|NCT01306942|541438701|FG002|Phase I|Physician Decision|0|||
150081195|NCT01306942|541438702|FG003|Phase I|Physician Decision|0|||
150081196|NCT01306942|541438699|FG000|Phase II|Adverse Event|0|||
150081197|NCT01306942|541438700|FG001|Phase II|Adverse Event|0|||
150081198|NCT01306942|541438701|FG002|Phase II|Adverse Event|0|||
150081199|NCT01306942|541438702|FG003|Phase II|Adverse Event|6|||
150081200|NCT01306942|541438699|FG000|Phase II|Physician Decision|2|||
150081201|NCT01306942|541438700|FG001|Phase II|Physician Decision|0|||
150081202|NCT01306942|541438701|FG002|Phase II|Physician Decision|0|||
150081203|NCT01306942|541438702|FG003|Phase II|Physician Decision|5|||
150081204|NCT01306942|541438699|FG000|Phase II|Withdrawal by Subject|0|||
150081205|NCT01306942|541438700|FG001|Phase II|Withdrawal by Subject|0|||
150081206|NCT01306942|541438701|FG002|Phase II|Withdrawal by Subject|0|||
150081207|NCT01306942|541438702|FG003|Phase II|Withdrawal by Subject|2|||
150081208|NCT01306942|541438699|FG000|Phase II|Death|0|||
150081209|NCT01306942|541438700|FG001|Phase II|Death|0|||
150081210|NCT01306942|541438701|FG002|Phase II|Death|0|||
150081211|NCT01306942|541438702|FG003|Phase II|Death|1|||
150081212|NCT01306942|541438699|FG000|Phase II|Not finished treatment|0|||
150081213|NCT01306942|541438700|FG001|Phase II|Not finished treatment|0|||
150081214|NCT01306942|541438701|FG002|Phase II|Not finished treatment|0|||
150081215|NCT01306942|541438702|FG003|Phase II|Not finished treatment|1|||
150081216|NCT01306942|541438699|FG000|Phase II|Protocol Violation|0|||
150081217|NCT01306942|541438700|FG001|Phase II|Protocol Violation|0|||
150081218|NCT01306942|541438701|FG002|Phase II|Protocol Violation|0|||
150081219|NCT01306942|541438702|FG003|Phase II|Protocol Violation|1|||
150081220|NCT03322631|541438722|FG000|Overall Study|Withdrawal by Subject|0|||
150081221|NCT03322631|541438723|FG001|Overall Study|Withdrawal by Subject|1|||
150081222|NCT03322631|541438724|FG002|Overall Study|Withdrawal by Subject|0|||
150081223|NCT03322631|541438725|FG003|Overall Study|Withdrawal by Subject|0|||
150081224|NCT03322631|541438722|FG000|Overall Study|Adverse Event|0|||
150081225|NCT03322631|541438723|FG001|Overall Study|Adverse Event|0|||
150081226|NCT03322631|541438724|FG002|Overall Study|Adverse Event|1|||
150081227|NCT03322631|541438725|FG003|Overall Study|Adverse Event|0|||
150081228|NCT02412618|541438726|FG000|Overall Study|Withdrawal by Subject|1|||
150081229|NCT02412618|541438727|FG001|Overall Study|Withdrawal by Subject|1|||
150081230|NCT02412618|541438726|FG000|Overall Study|Expulsion|1|||
150081231|NCT02412618|541438727|FG001|Overall Study|Expulsion|1|||
150081232|NCT02378961|541438729|FG000|Overall Study|Lack of Efficacy|4|||
150081233|NCT02378961|541438730|FG001|Overall Study|Lack of Efficacy|2|||
150081234|NCT02378961|541438731|FG002|Overall Study|Lack of Efficacy|0|||
150081235|NCT02378961|541438732|FG003|Overall Study|Lack of Efficacy|1|||
150081236|NCT02378961|541438729|FG000|Overall Study|Death|0|||
150081237|NCT02378961|541438730|FG001|Overall Study|Death|0|||
150081238|NCT02378961|541438731|FG002|Overall Study|Death|1|||
150081239|NCT02378961|541438732|FG003|Overall Study|Death|0|||
150081240|NCT01253408|541438733|FG000|Overall Study|Adverse Event|0|||
150081241|NCT01253408|541438734|FG001|Overall Study|Adverse Event|1|||
150081242|NCT01253408|541438735|FG002|Overall Study|Adverse Event|0|||
150081243|NCT04967443|541438742|FG000|Open Label Treatment|Death|1|||
150081244|NCT04967443|541438743|FG001|Open Label Treatment|Death|0|||
150081245|NCT04967443|541438744|FG002|Open Label Treatment|Death|0|||
150081246|NCT04967443|541438745|FG003|Open Label Treatment|Death|0|||
150081247|NCT04967443|541438746|FG004|Open Label Treatment|Death|0|||
150081248|NCT04967443|541438747|FG005|Open Label Treatment|Death|0|||
150081249|NCT04967443|541438748|FG006|Open Label Treatment|Death|0|||
150081250|NCT04967443|541438749|FG007|Open Label Treatment|Death|0|||
150081251|NCT04967443|541438742|FG000|Open Label Treatment|Lost to Follow-up|0|||
150081252|NCT04967443|541438743|FG001|Open Label Treatment|Lost to Follow-up|0|||
150183022|NCT04855760|541808695|FG000|Overall Study|Other|13|||
150183023|NCT04840199|541808696|FG000|Overall Study|Study Terminated by Sponsor|8|||
150183024|NCT04840199|541808697|FG001|Overall Study|Study Terminated by Sponsor|9|||
150183025|NCT04840199|541808696|FG000|Overall Study|Lost to Follow-up|0|||
150183026|NCT04840199|541808697|FG001|Overall Study|Lost to Follow-up|2|||
150183027|NCT04840199|541808696|FG000|Overall Study|Withdrawal by Subject|2|||
150183028|NCT04840199|541808697|FG001|Overall Study|Withdrawal by Subject|0|||
150183029|NCT04840199|541808696|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
150081253|NCT04967443|541438744|FG002|Open Label Treatment|Lost to Follow-up|1|||
150081254|NCT04967443|541438745|FG003|Open Label Treatment|Lost to Follow-up|0|||
150081255|NCT04967443|541438746|FG004|Open Label Treatment|Lost to Follow-up|0|||
150081256|NCT04967443|541438747|FG005|Open Label Treatment|Lost to Follow-up|0|||
150081257|NCT04967443|541438748|FG006|Open Label Treatment|Lost to Follow-up|0|||
150081258|NCT04967443|541438749|FG007|Open Label Treatment|Lost to Follow-up|0|||
150081259|NCT04967443|541438742|FG000|Open Label Treatment|Withdrawal by Subject|0|||
150081260|NCT04967443|541438743|FG001|Open Label Treatment|Withdrawal by Subject|1|||
150081261|NCT04967443|541438744|FG002|Open Label Treatment|Withdrawal by Subject|0|||
150081262|NCT04967443|541438745|FG003|Open Label Treatment|Withdrawal by Subject|1|||
150081263|NCT04967443|541438746|FG004|Open Label Treatment|Withdrawal by Subject|0|||
150081264|NCT04967443|541438747|FG005|Open Label Treatment|Withdrawal by Subject|1|||
150081265|NCT04967443|541438748|FG006|Open Label Treatment|Withdrawal by Subject|2|||
150081266|NCT04967443|541438749|FG007|Open Label Treatment|Withdrawal by Subject|3|||
150081267|NCT04967443|541438742|FG000|Follow-Up|Death|1|||
150081268|NCT04967443|541438743|FG001|Follow-Up|Death|0|||
150081269|NCT04967443|541438744|FG002|Follow-Up|Death|0|||
150081270|NCT04967443|541438745|FG003|Follow-Up|Death|0|||
150081271|NCT04967443|541438746|FG004|Follow-Up|Death|0|||
150081272|NCT04967443|541438747|FG005|Follow-Up|Death|0|||
150081273|NCT04967443|541438748|FG006|Follow-Up|Death|0|||
150081274|NCT04967443|541438749|FG007|Follow-Up|Death|0|||
150081275|NCT04967443|541438742|FG000|Follow-Up|Lost to Follow-up|0|||
150081276|NCT04967443|541438743|FG001|Follow-Up|Lost to Follow-up|0|||
150081277|NCT04967443|541438744|FG002|Follow-Up|Lost to Follow-up|1|||
150081278|NCT04967443|541438745|FG003|Follow-Up|Lost to Follow-up|1|||
150081279|NCT04967443|541438746|FG004|Follow-Up|Lost to Follow-up|0|||
150081280|NCT04967443|541438747|FG005|Follow-Up|Lost to Follow-up|0|||
150081281|NCT04967443|541438748|FG006|Follow-Up|Lost to Follow-up|0|||
150081282|NCT04967443|541438749|FG007|Follow-Up|Lost to Follow-up|0|||
150081283|NCT04967443|541438742|FG000|Follow-Up|Withdrawal by Subject|0|||
150081284|NCT04967443|541438743|FG001|Follow-Up|Withdrawal by Subject|1|||
150081285|NCT04967443|541438744|FG002|Follow-Up|Withdrawal by Subject|0|||
150081286|NCT04967443|541438745|FG003|Follow-Up|Withdrawal by Subject|1|||
150081287|NCT04967443|541438746|FG004|Follow-Up|Withdrawal by Subject|0|||
150081288|NCT04967443|541438747|FG005|Follow-Up|Withdrawal by Subject|1|||
150081289|NCT04967443|541438748|FG006|Follow-Up|Withdrawal by Subject|2|||
150081290|NCT04967443|541438749|FG007|Follow-Up|Withdrawal by Subject|3|||
150081291|NCT02405780|541438750|FG000|Period I|Adverse Event|8|||
150081292|NCT02405780|541438751|FG001|Period I|Adverse Event|0|||
150081293|NCT02405780|541438752|FG002|Period I|Adverse Event|3|||
150081294|NCT02405780|541438753|FG003|Period I|Adverse Event|7|||
150081295|NCT02405780|541438750|FG000|Period I|Medical reasons|1|||
150081296|NCT02405780|541438751|FG001|Period I|Medical reasons|1|||
150081297|NCT02405780|541438752|FG002|Period I|Medical reasons|0|||
150081298|NCT02405780|541438753|FG003|Period I|Medical reasons|1|||
150081299|NCT02405780|541438750|FG000|Period I|Screening Failure|1|||
150081300|NCT02405780|541438751|FG001|Period I|Screening Failure|0|||
150081301|NCT02405780|541438752|FG002|Period I|Screening Failure|1|||
150081302|NCT02405780|541438753|FG003|Period I|Screening Failure|0|||
150081303|NCT02405780|541438750|FG000|Period I|Withdrawal by Subject|9|||
150081304|NCT02405780|541438751|FG001|Period I|Withdrawal by Subject|1|||
150081305|NCT02405780|541438752|FG002|Period I|Withdrawal by Subject|3|||
150081306|NCT02405780|541438753|FG003|Period I|Withdrawal by Subject|4|||
150081307|NCT02405780|541438750|FG000|Period I|Non-compliance with study procedures|8|||
150081308|NCT02405780|541438751|FG001|Period I|Non-compliance with study procedures|6|||
150081309|NCT02405780|541438752|FG002|Period I|Non-compliance with study procedures|8|||
150081310|NCT02405780|541438753|FG003|Period I|Non-compliance with study procedures|11|||
150081311|NCT02405780|541438750|FG000|Period II|Adverse Event|3|||
150081312|NCT02405780|541438751|FG001|Period II|Adverse Event|5|||
150081313|NCT02405780|541438752|FG002|Period II|Adverse Event|4|||
150081314|NCT02405780|541438753|FG003|Period II|Adverse Event|11|||
150081315|NCT02405780|541438750|FG000|Period II|Medical reason|0|||
150081316|NCT02405780|541438751|FG001|Period II|Medical reason|1|||
150081317|NCT02405780|541438752|FG002|Period II|Medical reason|0|||
150081318|NCT02405780|541438753|FG003|Period II|Medical reason|0|||
150183030|NCT04840199|541808697|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
150081319|NCT02405780|541438750|FG000|Period II|Pregnancy|0|||
150081320|NCT02405780|541438751|FG001|Period II|Pregnancy|0|||
150081321|NCT02405780|541438752|FG002|Period II|Pregnancy|1|||
150081322|NCT02405780|541438753|FG003|Period II|Pregnancy|0|||
150081323|NCT02405780|541438750|FG000|Period II|Withdrawal by Subject|7|||
150081324|NCT02405780|541438751|FG001|Period II|Withdrawal by Subject|4|||
150081325|NCT02405780|541438752|FG002|Period II|Withdrawal by Subject|0|||
150081326|NCT02405780|541438753|FG003|Period II|Withdrawal by Subject|3|||
150081327|NCT02405780|541438750|FG000|Period II|Non-compliance with study procedures|5|||
150081328|NCT02405780|541438751|FG001|Period II|Non-compliance with study procedures|2|||
150081329|NCT02405780|541438752|FG002|Period II|Non-compliance with study procedures|7|||
150081330|NCT02405780|541438753|FG003|Period II|Non-compliance with study procedures|4|||
150081331|NCT01654536|541438754|FG000|Overall Study|Lost to Follow-up|5|||
150081332|NCT01654536|541438755|FG001|Overall Study|Lost to Follow-up|5|||
150081333|NCT01654536|541438754|FG000|Overall Study|Physician Decision|12|||
150081334|NCT01654536|541438755|FG001|Overall Study|Physician Decision|8|||
150081335|NCT01654536|541438754|FG000|Overall Study|Withdrawal by Subject|27|||
150081336|NCT01654536|541438755|FG001|Overall Study|Withdrawal by Subject|25|||
150081337|NCT04502693|541438760|FG000|Overall Study|Adverse Event|7|||
150081338|NCT04502693|541438761|FG001|Overall Study|Adverse Event|6|||
150081339|NCT04502693|541438762|FG002|Overall Study|Adverse Event|11|||
150081340|NCT04502693|541438763|FG003|Overall Study|Adverse Event|1|||
150081341|NCT04502693|541438760|FG000|Overall Study|Lost to Follow-up|32|||
150081342|NCT04502693|541438761|FG001|Overall Study|Lost to Follow-up|36|||
150081343|NCT04502693|541438762|FG002|Overall Study|Lost to Follow-up|69|||
150081344|NCT04502693|541438763|FG003|Overall Study|Lost to Follow-up|4|||
150081345|NCT04502693|541438760|FG000|Overall Study|Protocol Violation|8|||
150081346|NCT04502693|541438761|FG001|Overall Study|Protocol Violation|8|||
150081347|NCT04502693|541438762|FG002|Overall Study|Protocol Violation|16|||
150081348|NCT04502693|541438763|FG003|Overall Study|Protocol Violation|1|||
150081349|NCT04502693|541438760|FG000|Overall Study|Withdrawal by Subject|46|||
150081350|NCT04502693|541438761|FG001|Overall Study|Withdrawal by Subject|38|||
150081351|NCT04502693|541438762|FG002|Overall Study|Withdrawal by Subject|54|||
150081352|NCT04502693|541438763|FG003|Overall Study|Withdrawal by Subject|7|||
150081353|NCT04502693|541438760|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
150081354|NCT04502693|541438761|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
150081355|NCT04502693|541438762|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
150081356|NCT04502693|541438763|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150081357|NCT04502693|541438760|FG000|Overall Study|Other|1|||
150081358|NCT04502693|541438761|FG001|Overall Study|Other|0|||
150081359|NCT04502693|541438762|FG002|Overall Study|Other|1|||
150081360|NCT04502693|541438763|FG003|Overall Study|Other|1|||
150081361|NCT00602797|541438764|FG000|Overall Study|Adverse Event|1|||
150081362|NCT03736447|541438765|FG000|Overall Study|Adverse Event|5|||
150081363|NCT03736447|541438766|FG001|Overall Study|Adverse Event|1|||
150081364|NCT03736447|541438765|FG000|Overall Study|Withdrawal by Subject|5|||
150081365|NCT03736447|541438766|FG001|Overall Study|Withdrawal by Subject|1|||
150081366|NCT03736447|541438765|FG000|Overall Study|Lost to Follow-up|1|||
150081367|NCT03736447|541438766|FG001|Overall Study|Lost to Follow-up|0|||
150081368|NCT03736447|541438765|FG000|Overall Study|Physician Decision|1|||
150081369|NCT03736447|541438766|FG001|Overall Study|Physician Decision|0|||
150081370|NCT03736447|541438765|FG000|Overall Study|Continued commitment to study treatment|3|||
150081371|NCT03736447|541438766|FG001|Overall Study|Continued commitment to study treatment|0|||
150081372|NCT03736447|541438765|FG000|Overall Study|Taste aversion to study product|0|||
150081373|NCT03736447|541438766|FG001|Overall Study|Taste aversion to study product|1|||
150081374|NCT03547583|541438770|FG000|Overall Study|Adverse Event|16|||
150081375|NCT03547583|541438771|FG001|Overall Study|Adverse Event|11|||
150081376|NCT03547583|541438772|FG002|Overall Study|Adverse Event|10|||
150081377|NCT03547583|541438770|FG000|Overall Study|Death|11|||
150081378|NCT03547583|541438771|FG001|Overall Study|Death|7|||
150081379|NCT03547583|541438772|FG002|Overall Study|Death|4|||
150081380|NCT03547583|541438770|FG000|Overall Study|Lost to Follow-up|1|||
150081381|NCT03547583|541438771|FG001|Overall Study|Lost to Follow-up|0|||
150081382|NCT03547583|541438772|FG002|Overall Study|Lost to Follow-up|0|||
150081383|NCT03547583|541438770|FG000|Overall Study|Non-compliance with study drug|0|||
150081384|NCT03547583|541438771|FG001|Overall Study|Non-compliance with study drug|0|||
150081385|NCT03547583|541438772|FG002|Overall Study|Non-compliance with study drug|1|||
150081386|NCT03547583|541438770|FG000|Overall Study|Physician Decision|1|||
150081387|NCT03547583|541438771|FG001|Overall Study|Physician Decision|0|||
150081388|NCT03547583|541438772|FG002|Overall Study|Physician Decision|3|||
150081389|NCT03547583|541438770|FG000|Overall Study|Protocol Violation|2|||
150081390|NCT03547583|541438771|FG001|Overall Study|Protocol Violation|1|||
150081391|NCT03547583|541438772|FG002|Overall Study|Protocol Violation|1|||
150081392|NCT03547583|541438770|FG000|Overall Study|Withdrawal by Subject|12|||
150081393|NCT03547583|541438771|FG001|Overall Study|Withdrawal by Subject|19|||
150081394|NCT03547583|541438772|FG002|Overall Study|Withdrawal by Subject|10|||
150081395|NCT03547583|541438770|FG000|Overall Study|Other|2|||
150081396|NCT03547583|541438771|FG001|Overall Study|Other|2|||
150081397|NCT03547583|541438772|FG002|Overall Study|Other|3|||
150081398|NCT00382252|541438773|FG000|Overall Study|Death|4|||
150081399|NCT00382252|541438773|FG000|Overall Study|Protocol Violation|8|||
150081400|NCT00382252|541438773|FG000|Overall Study|Not treated by RFA|1|||
150081401|NCT03338998|541438775|FG000|Treatment Period|Withdrawal by Subject|1|||
150081402|NCT03338998|541438776|FG001|Treatment Period|Withdrawal by Subject|1|||
150081403|NCT03338998|541438775|FG000|Treatment Period|Adverse Event|0|||
150081404|NCT03338998|541438776|FG001|Treatment Period|Adverse Event|2|||
150081405|NCT03338998|541438775|FG000|Treatment Period|Protocol deviation|1|||
150081406|NCT03338998|541438776|FG001|Treatment Period|Protocol deviation|0|||
150081407|NCT03338998|541438775|FG000|Treatment Period|Physician Decision|2|||
150081408|NCT03338998|541438776|FG001|Treatment Period|Physician Decision|0|||
150081409|NCT03338998|541438775|FG000|Treatment Period|Subject failed swallow test|4|||
150081410|NCT03338998|541438776|FG001|Treatment Period|Subject failed swallow test|0|||
150081411|NCT03338998|541438775|FG000|Safety Follow-Up Period|Adverse Event|0|||
150081412|NCT03338998|541438776|FG001|Safety Follow-Up Period|Adverse Event|1|||
150081413|NCT03338998|541438775|FG000|Safety Follow-Up Period|Protocol deviation|1|||
150081414|NCT03338998|541438776|FG001|Safety Follow-Up Period|Protocol deviation|0|||
150081415|NCT03338998|541438775|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
150081416|NCT03338998|541438776|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
150081417|NCT00039130|541438777|FG000|Overall Study|Adverse Event|11|||
150081418|NCT00039130|541438777|FG000|Overall Study|Death|9|||
150081419|NCT00039130|541438777|FG000|Overall Study|Withdrawal by Subject|3|||
150081420|NCT00039130|541438777|FG000|Overall Study|Progression|2|||
150081421|NCT00039130|541438777|FG000|Overall Study|Subsequent treatment|2|||
150081422|NCT00039130|541438777|FG000|Overall Study|Physician Decision|3|||
150081423|NCT01744197|541438785|FG000|Overall Study|Received 1 patch|2|||
150081424|NCT01744197|541438786|FG001|Overall Study|Received 1 patch|1|||
150081425|NCT01744197|541438785|FG000|Overall Study|No patch received|2|||
150081426|NCT01744197|541438786|FG001|Overall Study|No patch received|2|||
150081427|NCT04706091|541438787|FG000|Treatment 2|Withdrawal by Subject|1|||
150081428|NCT04706091|541438788|FG001|Treatment 2|Withdrawal by Subject|0|||
150081429|NCT01063868|541438789|FG000|Overall Study|Adverse Event|9|||
150081430|NCT01063868|541438790|FG001|Overall Study|Adverse Event|7|||
150081431|NCT01063868|541438789|FG000|Overall Study|Withdrawal by Subject|3|||
150081432|NCT01063868|541438790|FG001|Overall Study|Withdrawal by Subject|1|||
150081433|NCT01063868|541438789|FG000|Overall Study|Study Terminated By Sponsor|23|||
150081434|NCT01063868|541438790|FG001|Overall Study|Study Terminated By Sponsor|4|||
150081435|NCT01949506|541438791|FG000|Overall Study|Physician Decision|1|||
150081436|NCT01446289|541438792|FG000|Overall Study|Withdrawal by Subject|1|||
150081437|NCT01446289|541438793|FG001|Overall Study|Withdrawal by Subject|0|||
150081438|NCT01446289|541438794|FG002|Overall Study|Withdrawal by Subject|1|||
150081439|NCT01446289|541438795|FG003|Overall Study|Withdrawal by Subject|0|||
150081440|NCT03329573|541438796|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
150081441|NCT03329573|541438797|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
150081442|NCT03329573|541438798|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
150081443|NCT03329573|541438799|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
150081444|NCT03329573|541438796|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
150081445|NCT03329573|541438797|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
150081446|NCT03329573|541438798|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150081447|NCT03329573|541438799|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150183031|NCT03271151|541808698|FG000|Overall Study|Lost to Follow-up|1|||
150183032|NCT03271151|541808699|FG001|Overall Study|Lost to Follow-up|3|||
150183033|NCT03271151|541808698|FG000|Overall Study|Withdrawal by Subject|1|||
150183034|NCT03271151|541808699|FG001|Overall Study|Withdrawal by Subject|0|||
150183035|NCT04118452|541808700|FG000|Overall Study|Lost to Follow-up|5|||
150183036|NCT04118452|541808701|FG001|Overall Study|Lost to Follow-up|5|||
150183037|NCT04118452|541808700|FG000|Overall Study|Withdrawal by Subject|17|||
150183038|NCT04118452|541808701|FG001|Overall Study|Withdrawal by Subject|17|||
150183039|NCT02553642|541808704|FG000|Overall Study|Withdrawal by Subject|0|||
150183040|NCT02553642|541808705|FG001|Overall Study|Withdrawal by Subject|3|||
150183041|NCT02553642|541808704|FG000|Overall Study|Physician Decision|0|||
150183042|NCT02553642|541808705|FG001|Overall Study|Physician Decision|1|||
150183043|NCT02553642|541808704|FG000|Overall Study|Additional cancer dx|0|||
150183044|NCT02553642|541808705|FG001|Overall Study|Additional cancer dx|1|||
150081448|NCT03329573|541438796|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
150081449|NCT03329573|541438797|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
150081450|NCT03329573|541438798|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
150081451|NCT03329573|541438799|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
150081452|NCT03329573|541438796|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
150183045|NCT02553642|541808704|FG000|Overall Study|Never started treatment|0|||
150081453|NCT03329573|541438797|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
150183046|NCT02553642|541808705|FG001|Overall Study|Never started treatment|1|||
150081454|NCT03329573|541438798|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
150081455|NCT03329573|541438799|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
150081456|NCT02915016|541438800|FG000|Overall Study|Lost to Follow-up|4|||
150081457|NCT02915016|541438801|FG001|Overall Study|Lost to Follow-up|2|||
150081458|NCT02915016|541438802|FG002|Overall Study|Lost to Follow-up|5|||
150081459|NCT02915016|541438803|FG003|Overall Study|Lost to Follow-up|3|||
150081460|NCT02915016|541438804|FG004|Overall Study|Lost to Follow-up|5|||
150081461|NCT02915016|541438805|FG005|Overall Study|Lost to Follow-up|2|||
150081462|NCT02915016|541438806|FG006|Overall Study|Lost to Follow-up|8|||
150081463|NCT02915016|541438807|FG007|Overall Study|Lost to Follow-up|2|||
150081464|NCT02915016|541438800|FG000|Overall Study|Physician Decision|0|||
150081465|NCT02915016|541438801|FG001|Overall Study|Physician Decision|0|||
150081466|NCT02915016|541438802|FG002|Overall Study|Physician Decision|1|||
150081467|NCT02915016|541438803|FG003|Overall Study|Physician Decision|0|||
150081468|NCT02915016|541438804|FG004|Overall Study|Physician Decision|0|||
150081469|NCT02915016|541438805|FG005|Overall Study|Physician Decision|1|||
150081470|NCT02915016|541438806|FG006|Overall Study|Physician Decision|2|||
150081471|NCT02915016|541438807|FG007|Overall Study|Physician Decision|0|||
150081472|NCT02915016|541438800|FG000|Overall Study|Withdrawal by Subject|2|||
150081473|NCT02915016|541438801|FG001|Overall Study|Withdrawal by Subject|0|||
150081474|NCT02915016|541438802|FG002|Overall Study|Withdrawal by Subject|1|||
150081475|NCT02915016|541438803|FG003|Overall Study|Withdrawal by Subject|0|||
150081476|NCT02915016|541438804|FG004|Overall Study|Withdrawal by Subject|1|||
150081477|NCT02915016|541438805|FG005|Overall Study|Withdrawal by Subject|3|||
150081478|NCT02915016|541438806|FG006|Overall Study|Withdrawal by Subject|1|||
150081479|NCT02915016|541438807|FG007|Overall Study|Withdrawal by Subject|1|||
150081480|NCT02915016|541438800|FG000|Overall Study|Elected not to continue|0|||
150081481|NCT02915016|541438801|FG001|Overall Study|Elected not to continue|0|||
150081482|NCT02915016|541438802|FG002|Overall Study|Elected not to continue|0|||
150081483|NCT02915016|541438803|FG003|Overall Study|Elected not to continue|1|||
150081484|NCT02915016|541438804|FG004|Overall Study|Elected not to continue|0|||
150081485|NCT02915016|541438805|FG005|Overall Study|Elected not to continue|0|||
150081486|NCT02915016|541438806|FG006|Overall Study|Elected not to continue|1|||
150081487|NCT02915016|541438807|FG007|Overall Study|Elected not to continue|0|||
150081488|NCT02915016|541438800|FG000|Overall Study|HIV infection|1|||
150081489|NCT02915016|541438801|FG001|Overall Study|HIV infection|1|||
150081490|NCT02915016|541438802|FG002|Overall Study|HIV infection|1|||
150081491|NCT02915016|541438803|FG003|Overall Study|HIV infection|0|||
150081492|NCT02915016|541438804|FG004|Overall Study|HIV infection|1|||
150081493|NCT02915016|541438805|FG005|Overall Study|HIV infection|0|||
150081494|NCT02915016|541438806|FG006|Overall Study|HIV infection|0|||
150081495|NCT02915016|541438807|FG007|Overall Study|HIV infection|0|||
150081496|NCT02915016|541438800|FG000|Overall Study|Participant unable to adhere|0|||
150081497|NCT02915016|541438801|FG001|Overall Study|Participant unable to adhere|0|||
150081498|NCT02915016|541438802|FG002|Overall Study|Participant unable to adhere|0|||
150081499|NCT02915016|541438803|FG003|Overall Study|Participant unable to adhere|0|||
150081500|NCT02915016|541438804|FG004|Overall Study|Participant unable to adhere|0|||
150081501|NCT02915016|541438805|FG005|Overall Study|Participant unable to adhere|0|||
150081502|NCT02915016|541438806|FG006|Overall Study|Participant unable to adhere|0|||
150081503|NCT02915016|541438807|FG007|Overall Study|Participant unable to adhere|1|||
150081504|NCT02166905|541438808|FG000|Overall Study|Withdrawal by Subject|1|||
150081505|NCT02166905|541438809|FG001|Overall Study|Withdrawal by Subject|0|||
150081506|NCT02166905|541438810|FG002|Overall Study|Withdrawal by Subject|0|||
150081507|NCT02166905|541438811|FG003|Overall Study|Withdrawal by Subject|0|||
150081508|NCT02617628|541438812|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
150081509|NCT02617628|541438813|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
150081510|NCT05243641|541438814|FG000|Overall Study|Adverse Event|3|||
150081511|NCT05243641|541438815|FG001|Overall Study|Adverse Event|0|||
150081512|NCT05243641|541438816|FG002|Overall Study|Adverse Event|0|||
150081513|NCT05243641|541438817|FG003|Overall Study|Adverse Event|1|||
150081514|NCT05243641|541438818|FG004|Overall Study|Adverse Event|0|||
150081515|NCT05243641|541438819|FG005|Overall Study|Adverse Event|0|||
150081516|NCT05243641|541438814|FG000|Overall Study|Disease progression|4|||
150081517|NCT05243641|541438815|FG001|Overall Study|Disease progression|0|||
150081518|NCT05243641|541438816|FG002|Overall Study|Disease progression|0|||
150081519|NCT05243641|541438817|FG003|Overall Study|Disease progression|2|||
150081520|NCT05243641|541438818|FG004|Overall Study|Disease progression|0|||
150081521|NCT05243641|541438819|FG005|Overall Study|Disease progression|0|||
150081522|NCT04698187|541438832|FG000|Overall Study|Withdrawal by Subject|7|||
150081523|NCT04698187|541438832|FG000|Overall Study|Death|21|||
150081524|NCT04698187|541438832|FG000|Overall Study|Sponsor Decision|15|||
150081525|NCT04698187|541438832|FG000|Overall Study|In-transit Disease|1|||
150081526|NCT03820986|541438833|FG000|Overall Study|Death|201|||
150081527|NCT03820986|541438834|FG001|Overall Study|Death|175|||
150081528|NCT03820986|541438833|FG000|Overall Study|Lost to Follow-up|1|||
150081529|NCT03820986|541438834|FG001|Overall Study|Lost to Follow-up|1|||
150081530|NCT03820986|541438833|FG000|Overall Study|Physician Decision|1|||
150081531|NCT03820986|541438834|FG001|Overall Study|Physician Decision|0|||
150081532|NCT03820986|541438833|FG000|Overall Study|Sponsor Decision|122|||
150081533|NCT03820986|541438834|FG001|Overall Study|Sponsor Decision|160|||
150081534|NCT03820986|541438833|FG000|Overall Study|Withdrawal by Subject|9|||
150081535|NCT03820986|541438834|FG001|Overall Study|Withdrawal by Subject|4|||
150081536|NCT02513394|541438839|FG000|Overall Study|Withdrawal by Subject|11|||
150081537|NCT02513394|541438840|FG001|Overall Study|Withdrawal by Subject|23|||
150081538|NCT02513394|541438839|FG000|Overall Study|Ineligible|1|||
150081539|NCT02513394|541438840|FG001|Overall Study|Ineligible|0|||
150081540|NCT04487730|541440570|FG000|Overall Study|Withdrawal by Subject|3|||
150081541|NCT04487730|541440571|FG001|Overall Study|Withdrawal by Subject|1|||
150081542|NCT04487730|541440570|FG000|Overall Study|Lost to Follow-up|0|||
150081543|NCT04487730|541440571|FG001|Overall Study|Lost to Follow-up|1|||
150081544|NCT04487730|541440570|FG000|Overall Study|Physician Decision|0|||
150081545|NCT04487730|541440571|FG001|Overall Study|Physician Decision|1|||
150081546|NCT00907777|541440572|FG000|Overall Study|Withdrawal by Subject|0|||
150081547|NCT00907777|541440573|FG001|Overall Study|Withdrawal by Subject|1|||
150081548|NCT03364023|541440576|FG000|Overall Study|Lost to Follow-up|3|||
150081549|NCT03364023|541440576|FG000|Overall Study|Death|14|||
150081550|NCT02891850|541440577|FG000|Overall Study|Adverse Event|3|||
150081551|NCT02891850|541440578|FG001|Overall Study|Adverse Event|0|||
150081552|NCT02891850|541440577|FG000|Overall Study|Death|0|||
150081553|NCT02891850|541440578|FG001|Overall Study|Death|4|||
150081554|NCT02891850|541440577|FG000|Overall Study|Physician Decision|1|||
150081555|NCT02891850|541440578|FG001|Overall Study|Physician Decision|0|||
150081556|NCT02891850|541440577|FG000|Overall Study|Pregnancy|1|||
150081557|NCT02891850|541440578|FG001|Overall Study|Pregnancy|0|||
150081558|NCT02891850|541440577|FG000|Overall Study|Withdrawal by Subject|2|||
150081559|NCT02891850|541440578|FG001|Overall Study|Withdrawal by Subject|3|||
150081560|NCT02674529|541440579|FG000|Overall Study|Lost to Follow-up|1|||
150081561|NCT02674529|541440580|FG001|Overall Study|Lost to Follow-up|2|||
150081562|NCT02674529|541440579|FG000|Overall Study|Withdrawal by Subject|2|||
150081563|NCT02674529|541440580|FG001|Overall Study|Withdrawal by Subject|1|||
150081564|NCT02674529|541440579|FG000|Overall Study|Physician Decision|0|||
150081565|NCT02674529|541440580|FG001|Overall Study|Physician Decision|1|||
150081566|NCT02674529|541440579|FG000|Overall Study|Protocol Violation|0|||
150081567|NCT02674529|541440580|FG001|Overall Study|Protocol Violation|1|||
150081568|NCT03797014|541440585|FG000|Overall Study|Withdrawal by Subject|1|||
150081569|NCT03797014|541440585|FG000|Overall Study|Lost to Follow-up|1|||
150081570|NCT03797014|541440585|FG000|Overall Study|Protocol Violation|1|||
150081571|NCT01970397|541440586|FG000|Overall Study|Adverse Event|0|||
150081572|NCT01970397|541440587|FG001|Overall Study|Adverse Event|1|||
150081573|NCT01970397|541440586|FG000|Overall Study|Lost to Follow-up|0|||
150081574|NCT01970397|541440587|FG001|Overall Study|Lost to Follow-up|1|||
150081575|NCT01970397|541440586|FG000|Overall Study|Personal Reasons|1|||
150081576|NCT01970397|541440587|FG001|Overall Study|Personal Reasons|2|||
150081577|NCT01970397|541440586|FG000|Overall Study|Protocol Violation|1|||
150081578|NCT01970397|541440587|FG001|Overall Study|Protocol Violation|1|||
150081579|NCT03305575|541440590|FG000|Overall Study|Physician Decision|1|||
150081580|NCT03305575|541440591|FG001|Overall Study|Physician Decision|0|||
150081581|NCT00105469|541440592|FG000|Overall Study|Adverse Event|9|||
150081582|NCT00105469|541440593|FG001|Overall Study|Adverse Event|8|||
150183047|NCT04424927|541808706|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
150183048|NCT04424927|541808707|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
150183049|NCT04424927|541808708|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
150183050|NCT04424927|541808709|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
150183051|NCT04424927|541808710|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
150081583|NCT00105469|541440592|FG000|Overall Study|Protocol Violation|4|||
150081584|NCT00105469|541440593|FG001|Overall Study|Protocol Violation|0|||
150081585|NCT00105469|541440592|FG000|Overall Study|Withdrawal by Subject|2|||
150081586|NCT00105469|541440593|FG001|Overall Study|Withdrawal by Subject|3|||
150081587|NCT00105469|541440592|FG000|Overall Study|Lost to Follow-up|1|||
150081588|NCT00105469|541440593|FG001|Overall Study|Lost to Follow-up|0|||
150081589|NCT00105469|541440592|FG000|Overall Study|Lack of Efficacy|2|||
150081590|NCT00105469|541440593|FG001|Overall Study|Lack of Efficacy|0|||
150081591|NCT00105469|541440592|FG000|Overall Study|Other Reason|4|||
150081592|NCT00105469|541440593|FG001|Overall Study|Other Reason|0|||
150081593|NCT02871297|541440595|FG000|Overall Study|Adverse Event|34|||
150081594|NCT02871297|541440595|FG000|Overall Study|Lack of Efficacy|10|||
150081595|NCT02871297|541440595|FG000|Overall Study|Non-compliance with study drug|15|||
150081596|NCT02871297|541440595|FG000|Overall Study|Protocol Violation|3|||
150081597|NCT02871297|541440595|FG000|Overall Study|Withdrawal by Subject|20|||
150081598|NCT02871297|541440595|FG000|Overall Study|Lost to Follow-up|13|||
150081599|NCT02871297|541440595|FG000|Overall Study|Rolled over to 13546A|2|||
150081600|NCT02871297|541440595|FG000|Overall Study|Other than specified|39|||
150081601|NCT04115839|541440599|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
150081602|NCT04115839|541440600|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
150081603|NCT04115839|541440601|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
150081604|NCT04115839|541440602|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
150081605|NCT04115839|541440603|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
150081606|NCT04115839|541440604|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
150081607|NCT04115839|541440605|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
150081608|NCT04115839|541440599|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
150081609|NCT04115839|541440600|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
150081610|NCT04115839|541440601|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
150081611|NCT04115839|541440602|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
150081612|NCT04115839|541440603|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
150081613|NCT04115839|541440604|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
150081614|NCT04115839|541440605|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
150081615|NCT04115839|541440599|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
150081616|NCT04115839|541440600|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081617|NCT04115839|541440601|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081618|NCT04115839|541440602|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081619|NCT04115839|541440603|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081620|NCT04115839|541440604|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081621|NCT04115839|541440605|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
150081622|NCT04115839|541440599|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081623|NCT04115839|541440600|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081624|NCT04115839|541440601|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
150081625|NCT04115839|541440602|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081626|NCT04115839|541440603|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081627|NCT04115839|541440604|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081628|NCT04115839|541440605|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
150081629|NCT04115839|541440599|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
150081630|NCT04115839|541440600|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
150081631|NCT04115839|541440601|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
150081632|NCT04115839|541440602|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
150081633|NCT04115839|541440603|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
150081634|NCT04115839|541440604|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
150081635|NCT04115839|541440605|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
150081636|NCT04115839|541440599|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
150081637|NCT04115839|541440600|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
150081638|NCT04115839|541440601|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
150081639|NCT04115839|541440602|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
150081640|NCT04115839|541440603|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
150081641|NCT04115839|541440604|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
150081642|NCT04115839|541440605|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
150081643|NCT03808545|541440606|FG000|Overall Study|Withdrawal by Subject|1|||
150081644|NCT03808545|541440607|FG001|Overall Study|Withdrawal by Subject|1|||
150081645|NCT02820753|541440608|FG000|2 Month|Withdrawal by Subject|3|||
150081646|NCT02820753|541440609|FG001|2 Month|Withdrawal by Subject|3|||
150081647|NCT02820753|541440608|FG000|2 Month|Lost to Follow-up|24|||
150081648|NCT02820753|541440609|FG001|2 Month|Lost to Follow-up|26|||
150081649|NCT02820753|541440608|FG000|2 Month|Stopped per NIH Hold|51|||
150081650|NCT02820753|541440609|FG001|2 Month|Stopped per NIH Hold|13|||
150081651|NCT02820753|541440608|FG000|6 Month|Withdrawal by Subject|2|||
150081652|NCT02820753|541440609|FG001|6 Month|Withdrawal by Subject|2|||
150081653|NCT02820753|541440608|FG000|6 Month|Lost to Follow-up|20|||
150081654|NCT02820753|541440609|FG001|6 Month|Lost to Follow-up|27|||
150081655|NCT02820753|541440608|FG000|6 Month|Stopped per NIH Hold|81|||
150081656|NCT02820753|541440609|FG001|6 Month|Stopped per NIH Hold|81|||
150081657|NCT02820753|541440608|FG000|6 Month|Death|0|||
150081658|NCT02820753|541440609|FG001|6 Month|Death|1|||
150081659|NCT00790023|541440610|FG000|Overall Study|Adverse Event|2|||
150081660|NCT00790023|541440611|FG001|Overall Study|Adverse Event|1|||
150081661|NCT00790023|541440612|FG002|Overall Study|Adverse Event|4|||
150081662|NCT00790023|541440610|FG000|Overall Study|Protocol Violation|2|||
150081663|NCT00790023|541440611|FG001|Overall Study|Protocol Violation|4|||
150081664|NCT00790023|541440612|FG002|Overall Study|Protocol Violation|2|||
150081665|NCT00790023|541440610|FG000|Overall Study|Withdrawal by Subject|2|||
150081666|NCT00790023|541440611|FG001|Overall Study|Withdrawal by Subject|0|||
150081667|NCT00790023|541440612|FG002|Overall Study|Withdrawal by Subject|6|||
150081668|NCT00790023|541440610|FG000|Overall Study|Lost to Follow-up|0|||
150081669|NCT00790023|541440611|FG001|Overall Study|Lost to Follow-up|0|||
150081670|NCT00790023|541440612|FG002|Overall Study|Lost to Follow-up|1|||
150081671|NCT00790023|541440610|FG000|Overall Study|Other|5|||
150081672|NCT00790023|541440611|FG001|Overall Study|Other|5|||
150081673|NCT00790023|541440612|FG002|Overall Study|Other|8|||
150081674|NCT00331682|541440613|FG000|Overall Study|Adverse Event|1|||
150081675|NCT00573469|541440614|FG000|Overall Study|Adverse Event|1|||
150081676|NCT00573469|541440615|FG001|Overall Study|Adverse Event|1|||
150081677|NCT00573469|541440616|FG002|Overall Study|Adverse Event|1|||
150081678|NCT00573469|541440614|FG000|Overall Study|Withdrawal by Subject|0|||
150081679|NCT00573469|541440615|FG001|Overall Study|Withdrawal by Subject|2|||
150081680|NCT00573469|541440616|FG002|Overall Study|Withdrawal by Subject|0|||
150081681|NCT00573469|541440614|FG000|Overall Study|Other|5|||
150081682|NCT00573469|541440615|FG001|Overall Study|Other|1|||
150081683|NCT00573469|541440616|FG002|Overall Study|Other|3|||
150081684|NCT01338792|541440617|FG000|Overall Study|Adverse Event|2|||
150081685|NCT01338792|541440617|FG000|Overall Study|Death|1|||
150081686|NCT01338792|541440617|FG000|Overall Study|Withdrawal by Subject|1|||
150081687|NCT00618072|541440618|FG000|Overall Study|Lost to Follow-up|2|||
150081688|NCT00618072|541440619|FG001|Overall Study|Lost to Follow-up|0|||
150081689|NCT00618072|541440620|FG002|Overall Study|Lost to Follow-up|3|||
150081690|NCT00618072|541440618|FG000|Overall Study|Physician Decision|0|||
150081691|NCT00618072|541440619|FG001|Overall Study|Physician Decision|1|||
150081692|NCT00618072|541440620|FG002|Overall Study|Physician Decision|1|||
150081693|NCT02151591|541440622|FG000|Overall Study|Lost to Follow-up|6|||
150081694|NCT02151591|541440623|FG001|Overall Study|Lost to Follow-up|3|||
150081695|NCT00187486|541440626|FG000|Overall Study|Protocol Violation|1|||
150081696|NCT00684593|541440627|FG000|Overall Study|Adverse Event|0|||
150081697|NCT00684593|541440628|FG001|Overall Study|Adverse Event|2|||
150081698|NCT02599129|541440629|FG000|Overall Study|Lack of Efficacy|2|||
150081699|NCT02599129|541440630|FG001|Overall Study|Lack of Efficacy|2|||
150081700|NCT02599129|541440629|FG000|Overall Study|Lost to Follow-up|1|||
150081701|NCT02599129|541440630|FG001|Overall Study|Lost to Follow-up|0|||
150081702|NCT02599129|541440629|FG000|Overall Study|Withdrawal by Subject|2|||
150081703|NCT02599129|541440630|FG001|Overall Study|Withdrawal by Subject|1|||
150081704|NCT05526716|541440634|FG000|Overall Study|Death|1|||
150081705|NCT05526716|541440635|FG001|Overall Study|Death|2|||
150081706|NCT05526716|541440634|FG000|Overall Study|Lost to Follow-up|17|||
150081707|NCT05526716|541440635|FG001|Overall Study|Lost to Follow-up|15|||
150081708|NCT05526716|541440634|FG000|Overall Study|Physician Decision|0|||
150081709|NCT05526716|541440635|FG001|Overall Study|Physician Decision|1|||
150081710|NCT05526716|541440634|FG000|Overall Study|Randomized by mistake without study treatment|0|||
150081711|NCT05526716|541440635|FG001|Overall Study|Randomized by mistake without study treatment|1|||
150081712|NCT05526716|541440634|FG000|Overall Study|Withdrawal by Subject|12|||
150081713|NCT05526716|541440635|FG001|Overall Study|Withdrawal by Subject|12|||
150081714|NCT05526716|541440634|FG000|Overall Study|Not reported|0|||
150081715|NCT05526716|541440635|FG001|Overall Study|Not reported|2|||
150081716|NCT04213079|541440636|FG000|Overall Study|Lost to Follow-up|0|||
150081717|NCT04213079|541440637|FG001|Overall Study|Lost to Follow-up|2|||
150081718|NCT00520936|541440639|FG000|Overall Study|Physician Decision|0|||
150081719|NCT00520936|541440640|FG001|Overall Study|Physician Decision|2|||
150081720|NCT00520936|541440641|FG002|Overall Study|Physician Decision|1|||
150081721|NCT00520936|541440642|FG003|Overall Study|Physician Decision|0|||
150081722|NCT00520936|541440643|FG004|Overall Study|Physician Decision|0|||
150081723|NCT00520936|541440644|FG005|Overall Study|Physician Decision|0|||
150081724|NCT00520936|541440645|FG006|Overall Study|Physician Decision|0|||
150081725|NCT00520936|541440646|FG007|Overall Study|Physician Decision|0|||
150081726|NCT00520936|541440639|FG000|Overall Study|Withdrawal by Subject|0|||
150081727|NCT00520936|541440640|FG001|Overall Study|Withdrawal by Subject|0|||
150081728|NCT00520936|541440641|FG002|Overall Study|Withdrawal by Subject|0|||
150081729|NCT00520936|541440642|FG003|Overall Study|Withdrawal by Subject|0|||
150081730|NCT00520936|541440643|FG004|Overall Study|Withdrawal by Subject|0|||
150081731|NCT00520936|541440644|FG005|Overall Study|Withdrawal by Subject|0|||
150081732|NCT00520936|541440645|FG006|Overall Study|Withdrawal by Subject|0|||
150081733|NCT00520936|541440646|FG007|Overall Study|Withdrawal by Subject|1|||
150081734|NCT00520936|541440639|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
150081735|NCT00520936|541440640|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
150081736|NCT00520936|541440641|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
150081737|NCT00520936|541440642|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
150081738|NCT00520936|541440643|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
150081739|NCT00520936|541440644|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
150081740|NCT00520936|541440645|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
150081741|NCT00520936|541440646|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
150081742|NCT00520936|541440639|FG000|Overall Study|Death|0|||
150081743|NCT00520936|541440640|FG001|Overall Study|Death|0|||
150081744|NCT00520936|541440641|FG002|Overall Study|Death|0|||
150081745|NCT00520936|541440642|FG003|Overall Study|Death|0|||
150081746|NCT00520936|541440643|FG004|Overall Study|Death|0|||
150081747|NCT00520936|541440644|FG005|Overall Study|Death|0|||
150081748|NCT00520936|541440645|FG006|Overall Study|Death|1|||
150081749|NCT00520936|541440646|FG007|Overall Study|Death|0|||
150081750|NCT00520936|541440639|FG000|Overall Study|Protocol Violation|0|||
150081751|NCT00520936|541440640|FG001|Overall Study|Protocol Violation|1|||
150081752|NCT00520936|541440641|FG002|Overall Study|Protocol Violation|1|||
150081753|NCT00520936|541440642|FG003|Overall Study|Protocol Violation|0|||
150081754|NCT00520936|541440643|FG004|Overall Study|Protocol Violation|1|||
150081755|NCT00520936|541440644|FG005|Overall Study|Protocol Violation|0|||
150081756|NCT00520936|541440645|FG006|Overall Study|Protocol Violation|1|||
150081757|NCT00520936|541440646|FG007|Overall Study|Protocol Violation|0|||
150081758|NCT04182763|541440650|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
150081759|NCT04182763|541440651|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
150081760|NCT04182763|541440652|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
150081761|NCT04182763|541440653|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
150081762|NCT04182763|541440654|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
150081763|NCT04182763|541440650|FG000|Double-Blind Period, initial 6 months|Death|0|||
150081764|NCT04182763|541440651|FG001|Double-Blind Period, initial 6 months|Death|1|||
150081765|NCT04182763|541440652|FG002|Double-Blind Period, initial 6 months|Death|0|||
150081766|NCT04182763|541440653|FG003|Double-Blind Period, initial 6 months|Death|0|||
150081767|NCT04182763|541440654|FG004|Double-Blind Period, initial 6 months|Death|0|||
150081768|NCT04182763|541440650|FG000|Open-Label Period, subsequent 18 months|Death|3|||
150081769|NCT04182763|541440651|FG001|Open-Label Period, subsequent 18 months|Death|2|||
150081770|NCT04182763|541440652|FG002|Open-Label Period, subsequent 18 months|Death|2|||
150081771|NCT04182763|541440653|FG003|Open-Label Period, subsequent 18 months|Death|0|||
150081772|NCT04182763|541440654|FG004|Open-Label Period, subsequent 18 months|Death|1|||
150081773|NCT04182763|541440650|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
150081774|NCT04182763|541440651|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
150081775|NCT04182763|541440652|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
150081776|NCT04182763|541440653|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
150081777|NCT04182763|541440654|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
150081778|NCT04182763|541440650|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
150081779|NCT04182763|541440651|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
150081780|NCT04182763|541440652|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
150081781|NCT04182763|541440653|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
150081782|NCT04182763|541440654|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
150081783|NCT03984994|541440655|FG000|Overall Study|Withdrawal by Subject|2|||
150081784|NCT03984994|541440656|FG001|Overall Study|Withdrawal by Subject|1|||
150081785|NCT03010176|541440657|FG000|Overall Study|Death|21|||
150081786|NCT03010176|541440658|FG001|Overall Study|Death|35|||
150081787|NCT03010176|541440659|FG002|Overall Study|Death|19|||
150081788|NCT03010176|541440660|FG003|Overall Study|Death|19|||
150081789|NCT03010176|541440661|FG004|Overall Study|Death|14|||
150081790|NCT03010176|541440662|FG005|Overall Study|Death|0|||
150081791|NCT03010176|541440657|FG000|Overall Study|Lost to Follow-up|0|||
150081792|NCT03010176|541440658|FG001|Overall Study|Lost to Follow-up|0|||
150081793|NCT03010176|541440659|FG002|Overall Study|Lost to Follow-up|0|||
150081794|NCT03010176|541440660|FG003|Overall Study|Lost to Follow-up|0|||
150081795|NCT03010176|541440661|FG004|Overall Study|Lost to Follow-up|1|||
150081796|NCT03010176|541440662|FG005|Overall Study|Lost to Follow-up|0|||
150081797|NCT03010176|541440657|FG000|Overall Study|Physician Decision|0|||
150081798|NCT03010176|541440658|FG001|Overall Study|Physician Decision|4|||
150081799|NCT03010176|541440659|FG002|Overall Study|Physician Decision|0|||
150081800|NCT03010176|541440660|FG003|Overall Study|Physician Decision|1|||
150081801|NCT03010176|541440661|FG004|Overall Study|Physician Decision|0|||
150081802|NCT03010176|541440662|FG005|Overall Study|Physician Decision|0|||
150081803|NCT03010176|541440657|FG000|Overall Study|Sponsor Decision|0|||
150081804|NCT03010176|541440658|FG001|Overall Study|Sponsor Decision|4|||
150081805|NCT03010176|541440659|FG002|Overall Study|Sponsor Decision|4|||
150081806|NCT03010176|541440660|FG003|Overall Study|Sponsor Decision|1|||
150081807|NCT03010176|541440661|FG004|Overall Study|Sponsor Decision|6|||
150081808|NCT03010176|541440662|FG005|Overall Study|Sponsor Decision|0|||
150081809|NCT03010176|541440657|FG000|Overall Study|Withdrawal by Subject|11|||
150081810|NCT03010176|541440658|FG001|Overall Study|Withdrawal by Subject|9|||
150081811|NCT03010176|541440659|FG002|Overall Study|Withdrawal by Subject|3|||
150081812|NCT03010176|541440660|FG003|Overall Study|Withdrawal by Subject|0|||
150081813|NCT03010176|541440661|FG004|Overall Study|Withdrawal by Subject|4|||
150081814|NCT03010176|541440662|FG005|Overall Study|Withdrawal by Subject|0|||
150081815|NCT04220866|541440663|FG000|Overall Study|Death|4|||
150081816|NCT04220866|541440664|FG001|Overall Study|Death|5|||
150081817|NCT04220866|541440663|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
150081818|NCT04220866|541440664|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
150081819|NCT04220866|541440663|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
150081820|NCT04220866|541440664|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
150081821|NCT04220866|541440663|FG000|Overall Study|Withdrawal by Subject|0|||
150081822|NCT04220866|541440664|FG001|Overall Study|Withdrawal by Subject|1|||
150081823|NCT01471171|541440675|FG000|Treatment Period 1|Adverse Event|4|||
150081824|NCT01471171|541440676|FG001|Treatment Period 1|Adverse Event|1|||
150081825|NCT01471171|541440675|FG000|Treatment Period 2|Adverse Event|1|||
150081826|NCT01471171|541440676|FG001|Treatment Period 2|Adverse Event|0|||
150081827|NCT00378378|541440677|FG000|Overall Study|Withdrawal by Subject|0|||
150081828|NCT00378378|541440678|FG001|Overall Study|Withdrawal by Subject|1|||
150081829|NCT00378378|541440679|FG002|Overall Study|Withdrawal by Subject|0|||
150081830|NCT00378378|541440677|FG000|Overall Study|Treatment Failure|0|||
150081831|NCT00378378|541440678|FG001|Overall Study|Treatment Failure|0|||
150081832|NCT00378378|541440679|FG002|Overall Study|Treatment Failure|1|||
150081833|NCT00378378|541440677|FG000|Overall Study|Non-compliance with protocol|0|||
150081834|NCT00378378|541440678|FG001|Overall Study|Non-compliance with protocol|0|||
150081835|NCT00378378|541440679|FG002|Overall Study|Non-compliance with protocol|1|||
150081836|NCT00407797|541440680|FG000|Overall Study|Lost to Follow-up|2|||
150081837|NCT00407797|541440680|FG000|Overall Study|Adverse Event|6|||
150081838|NCT00407797|541440680|FG000|Overall Study|Other|7|||
150081839|NCT00407797|541440680|FG000|Overall Study|Withdrawal by Subject|3|||
150081840|NCT01812174|541440681|FG000|Overall Study|Death|1|||
150081841|NCT01812174|541440682|FG001|Overall Study|Death|0|||
150081842|NCT01812174|541440681|FG000|Overall Study|Protocol Violation|2|||
150081843|NCT01812174|541440682|FG001|Overall Study|Protocol Violation|0|||
150081844|NCT03132220|541440690|FG000|Overall Study|Lost to Follow-up|17|||
150081845|NCT03132220|541440691|FG001|Overall Study|Lost to Follow-up|8|||
150081846|NCT03132220|541440690|FG000|Overall Study|Withdrawal by Subject|1|||
150081847|NCT03132220|541440691|FG001|Overall Study|Withdrawal by Subject|4|||
150081848|NCT00601458|541440692|FG000|Overall Study|Dosing Error|1|||
150081849|NCT00601458|541440693|FG001|Overall Study|Dosing Error|0|||
150081850|NCT00601458|541440694|FG002|Overall Study|Dosing Error|0|||
150081851|NCT00601458|541440692|FG000|Overall Study|Incomplete Data|0|||
150081852|NCT00601458|541440693|FG001|Overall Study|Incomplete Data|2|||
150081853|NCT00601458|541440694|FG002|Overall Study|Incomplete Data|0|||
150081854|NCT00601458|541440692|FG000|Overall Study|Protocol Violation|3|||
150081855|NCT00601458|541440693|FG001|Overall Study|Protocol Violation|2|||
150081856|NCT00601458|541440694|FG002|Overall Study|Protocol Violation|1|||
150081857|NCT00601458|541440692|FG000|Overall Study|Early Termination|0|||
150081858|NCT00601458|541440693|FG001|Overall Study|Early Termination|1|||
150081859|NCT00601458|541440694|FG002|Overall Study|Early Termination|1|||
150081860|NCT00370032|541440695|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
150081861|NCT00370032|541440696|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
150081862|NCT00370032|541440695|FG000|Washout Period|Withdrawal by Subject|0|||
150081863|NCT00370032|541440696|FG001|Washout Period|Withdrawal by Subject|1|||
150081864|NCT00370032|541440695|FG000|Washout Period|Lost to Follow-up|0|||
150081865|NCT00370032|541440696|FG001|Washout Period|Lost to Follow-up|1|||
150081866|NCT00370032|541440695|FG000|Washout Period|Adverse Event|1|||
150081867|NCT00370032|541440696|FG001|Washout Period|Adverse Event|0|||
150081868|NCT00370032|541440695|FG000|Follow-up Period|Withdrawal by Subject|1|||
150081869|NCT00370032|541440696|FG001|Follow-up Period|Withdrawal by Subject|0|||
150081870|NCT00518986|541440697|FG000|Overall Study|Adverse Event|12|||
150081871|NCT00518986|541440698|FG001|Overall Study|Adverse Event|7|||
150081872|NCT00518986|541440697|FG000|Overall Study|Lack of Efficacy|0|||
150081873|NCT00518986|541440698|FG001|Overall Study|Lack of Efficacy|2|||
150081874|NCT00518986|541440697|FG000|Overall Study|Lost to Follow-up|3|||
150081875|NCT00518986|541440698|FG001|Overall Study|Lost to Follow-up|2|||
150081876|NCT00518986|541440697|FG000|Overall Study|Physician Decision|0|||
150081877|NCT00518986|541440698|FG001|Overall Study|Physician Decision|3|||
150081878|NCT00518986|541440697|FG000|Overall Study|Protocol Violation|5|||
150081879|NCT00518986|541440698|FG001|Overall Study|Protocol Violation|7|||
150081880|NCT00518986|541440697|FG000|Overall Study|Withdrawal by Subject|4|||
150081881|NCT00518986|541440698|FG001|Overall Study|Withdrawal by Subject|4|||
150081882|NCT00518986|541440697|FG000|Overall Study|Non-Specific|2|||
150081883|NCT00518986|541440698|FG001|Overall Study|Non-Specific|1|||
150081884|NCT05683249|541440699|FG000|Overall Study|Adverse Event|3|||
150081885|NCT05683249|541440700|FG001|Overall Study|Adverse Event|1|||
150081886|NCT05683249|541440699|FG000|Overall Study|Lack of Efficacy|0|||
150081887|NCT05683249|541440700|FG001|Overall Study|Lack of Efficacy|2|||
150081888|NCT05683249|541440699|FG000|Overall Study|Lost to Follow-up|6|||
150081889|NCT05683249|541440700|FG001|Overall Study|Lost to Follow-up|5|||
150081890|NCT05683249|541440699|FG000|Overall Study|Non-compliance with Study Drug|2|||
150081891|NCT05683249|541440700|FG001|Overall Study|Non-compliance with Study Drug|0|||
150081892|NCT05683249|541440699|FG000|Overall Study|Protocol Violation|6|||
150081893|NCT05683249|541440700|FG001|Overall Study|Protocol Violation|3|||
150081894|NCT05683249|541440699|FG000|Overall Study|Withdrawal by Subject|9|||
150081895|NCT05683249|541440700|FG001|Overall Study|Withdrawal by Subject|8|||
150081896|NCT05683249|541440699|FG000|Overall Study|Other|0|||
150081897|NCT05683249|541440700|FG001|Overall Study|Other|2|||
150081898|NCT05469178|541440701|FG000|Overall Study|Death|1|||
150081899|NCT05469178|541440702|FG001|Overall Study|Death|1|||
150081900|NCT05469178|541440703|FG002|Overall Study|Death|3|||
150081901|NCT05469178|541440704|FG003|Overall Study|Death|6|||
150081902|NCT05469178|541440701|FG000|Overall Study|Lack of Efficacy|2|||
150081903|NCT05469178|541440702|FG001|Overall Study|Lack of Efficacy|2|||
150081904|NCT05469178|541440703|FG002|Overall Study|Lack of Efficacy|1|||
150081905|NCT05469178|541440704|FG003|Overall Study|Lack of Efficacy|10|||
150081906|NCT05393895|541440705|FG000|Overall Study|Adverse Event|2|||
150081907|NCT05393895|541440706|FG001|Overall Study|Adverse Event|3|||
150081908|NCT05393895|541440705|FG000|Overall Study|Lost to Follow-up|4|||
150081909|NCT05393895|541440706|FG001|Overall Study|Lost to Follow-up|3|||
150081910|NCT05393895|541440705|FG000|Overall Study|Protocol Violation|1|||
150081911|NCT05393895|541440706|FG001|Overall Study|Protocol Violation|0|||
150081912|NCT05393895|541440705|FG000|Overall Study|Withdrawal by Subject|1|||
150081913|NCT05393895|541440706|FG001|Overall Study|Withdrawal by Subject|4|||
150081914|NCT00968513|541440707|FG000|Overall Study|Death|4|||
150081915|NCT00968513|541440708|FG001|Overall Study|Death|10|||
150081916|NCT00968513|541440709|FG002|Overall Study|Death|15|||
150081917|NCT01328431|541440710|FG000|Baseline|Protocol Violation|0|||
150081918|NCT01328431|541440711|FG001|Baseline|Protocol Violation|2|||
150081919|NCT01328431|541440710|FG000|1 Month (1M)|Lost to Follow-up|55|||
150081920|NCT01328431|541440711|FG001|1 Month (1M)|Lost to Follow-up|58|||
150081921|NCT01328431|541440710|FG000|3 Month (3M)|Death|2|||
150081922|NCT01328431|541440711|FG001|3 Month (3M)|Death|2|||
150081923|NCT01328431|541440710|FG000|3 Month (3M)|Lost to Follow-up|75|||
150081924|NCT01328431|541440711|FG001|3 Month (3M)|Lost to Follow-up|70|||
150081925|NCT01328431|541440710|FG000|12 Month (12M)|Death|2|||
150081926|NCT01328431|541440711|FG001|12 Month (12M)|Death|6|||
150081927|NCT01328431|541440710|FG000|12 Month (12M)|Lost to Follow-up|82|||
150081928|NCT01328431|541440711|FG001|12 Month (12M)|Lost to Follow-up|91|||
150081929|NCT03310021|541440720|FG000|Overall Study|Withdrawal by Subject|0|||
150081930|NCT03310021|541440721|FG001|Overall Study|Withdrawal by Subject|0|||
150081931|NCT03310021|541440722|FG002|Overall Study|Withdrawal by Subject|0|||
150081932|NCT03310021|541440723|FG003|Overall Study|Withdrawal by Subject|0|||
150081933|NCT03310021|541440724|FG004|Overall Study|Withdrawal by Subject|0|||
150081934|NCT03310021|541440725|FG005|Overall Study|Withdrawal by Subject|0|||
150081935|NCT03310021|541440726|FG006|Overall Study|Withdrawal by Subject|1|||
150081936|NCT03310021|541440727|FG007|Overall Study|Withdrawal by Subject|0|||
150081937|NCT03310021|541440728|FG008|Overall Study|Withdrawal by Subject|0|||
150081938|NCT03310021|541440729|FG009|Overall Study|Withdrawal by Subject|0|||
150081939|NCT03310021|541440730|FG010|Overall Study|Withdrawal by Subject|0|||
150081940|NCT03310021|541440731|FG011|Overall Study|Withdrawal by Subject|0|||
150081941|NCT03310021|541440732|FG012|Overall Study|Withdrawal by Subject|0|||
150081942|NCT03310021|541440733|FG013|Overall Study|Withdrawal by Subject|0|||
150081943|NCT03310021|541440734|FG014|Overall Study|Withdrawal by Subject|0|||
150081944|NCT03310021|541440735|FG015|Overall Study|Withdrawal by Subject|0|||
150081945|NCT03310021|541440736|FG016|Overall Study|Withdrawal by Subject|0|||
150081946|NCT03310021|541440737|FG017|Overall Study|Withdrawal by Subject|0|||
150081947|NCT03310021|541440738|FG018|Overall Study|Withdrawal by Subject|0|||
150081948|NCT03310021|541440739|FG019|Overall Study|Withdrawal by Subject|0|||
150081949|NCT03310021|541440720|FG000|Overall Study|Lost to Follow-up|0|||
150081950|NCT03310021|541440721|FG001|Overall Study|Lost to Follow-up|0|||
150081951|NCT03310021|541440722|FG002|Overall Study|Lost to Follow-up|0|||
150081952|NCT03310021|541440723|FG003|Overall Study|Lost to Follow-up|0|||
150081953|NCT03310021|541440724|FG004|Overall Study|Lost to Follow-up|0|||
150081954|NCT03310021|541440725|FG005|Overall Study|Lost to Follow-up|0|||
150081955|NCT03310021|541440726|FG006|Overall Study|Lost to Follow-up|0|||
150081956|NCT03310021|541440727|FG007|Overall Study|Lost to Follow-up|0|||
150081957|NCT03310021|541440728|FG008|Overall Study|Lost to Follow-up|0|||
150081958|NCT03310021|541440729|FG009|Overall Study|Lost to Follow-up|0|||
150081959|NCT03310021|541440730|FG010|Overall Study|Lost to Follow-up|1|||
150081960|NCT03310021|541440731|FG011|Overall Study|Lost to Follow-up|0|||
150081961|NCT03310021|541440732|FG012|Overall Study|Lost to Follow-up|0|||
150081962|NCT03310021|541440733|FG013|Overall Study|Lost to Follow-up|0|||
150081963|NCT03310021|541440734|FG014|Overall Study|Lost to Follow-up|0|||
150081964|NCT03310021|541440735|FG015|Overall Study|Lost to Follow-up|0|||
150081965|NCT03310021|541440736|FG016|Overall Study|Lost to Follow-up|0|||
150081966|NCT03310021|541440737|FG017|Overall Study|Lost to Follow-up|0|||
150081967|NCT03310021|541440738|FG018|Overall Study|Lost to Follow-up|0|||
150081968|NCT03310021|541440739|FG019|Overall Study|Lost to Follow-up|0|||
150081969|NCT00702923|541440742|FG000|Overall Study|Adverse Event|1|||
150081970|NCT02002091|541440743|FG000|Screening|Lost to Follow-up|10|||
150081971|NCT02002091|541440744|FG001|Screening|Lost to Follow-up|12|||
150081972|NCT02002091|541440743|FG000|Screening|Death|3|||
150081973|NCT02002091|541440744|FG001|Screening|Death|2|||
150081974|NCT00393029|541440749|FG000|Overall Study|Not treated|0|||
150081975|NCT00393029|541440750|FG001|Overall Study|Not treated|1|||
150081976|NCT02612727|541440751|FG000|Overall Study|Parent request|4|||
150081977|NCT02612727|541440752|FG001|Overall Study|Parent request|1|||
150081978|NCT02612727|541440751|FG000|Overall Study|Needed treatment incompatible with PT|1|||
150081979|NCT02612727|541440752|FG001|Overall Study|Needed treatment incompatible with PT|1|||
150081980|NCT02612727|541440751|FG000|Overall Study|Direct hyperbilirubinemia|0|||
150081981|NCT02612727|541440752|FG001|Overall Study|Direct hyperbilirubinemia|2|||
150081982|NCT04292743|541440755|FG000|Overall Study|Physician Decision|1|||
150081983|NCT04292743|541440756|FG001|Overall Study|Physician Decision|3|||
150081984|NCT04292743|541440757|FG002|Overall Study|Physician Decision|0|||
150081985|NCT04292743|541440758|FG003|Overall Study|Physician Decision|0|||
150081986|NCT04292743|541440755|FG000|Overall Study|Withdrawal by Subject|0|||
150081987|NCT04292743|541440756|FG001|Overall Study|Withdrawal by Subject|5|||
150081988|NCT04292743|541440757|FG002|Overall Study|Withdrawal by Subject|0|||
150081989|NCT04292743|541440758|FG003|Overall Study|Withdrawal by Subject|0|||
150081990|NCT04292743|541440755|FG000|Overall Study|Death|0|||
150081991|NCT04292743|541440756|FG001|Overall Study|Death|1|||
150081992|NCT04292743|541440757|FG002|Overall Study|Death|0|||
150081993|NCT04292743|541440758|FG003|Overall Study|Death|0|||
150081994|NCT04292743|541440755|FG000|Overall Study|Progression of Disease|2|||
150081995|NCT04292743|541440756|FG001|Overall Study|Progression of Disease|5|||
150081996|NCT04292743|541440757|FG002|Overall Study|Progression of Disease|0|||
150081997|NCT04292743|541440758|FG003|Overall Study|Progression of Disease|0|||
150081998|NCT04292743|541440755|FG000|Overall Study|No Treatment per protocol|0|||
150081999|NCT04292743|541440756|FG001|Overall Study|No Treatment per protocol|2|||
150082000|NCT04292743|541440757|FG002|Overall Study|No Treatment per protocol|0|||
150082001|NCT04292743|541440758|FG003|Overall Study|No Treatment per protocol|0|||
150082002|NCT05766423|541440759|FG000|Overall Study|Withdrawal by Subject|1|||
150082003|NCT05766423|541440760|FG001|Overall Study|Withdrawal by Subject|0|||
150082004|NCT05766423|541440759|FG000|Overall Study|Consented, not scheduled|3|||
150082005|NCT05766423|541440760|FG001|Overall Study|Consented, not scheduled|5|||
150082006|NCT02161731|541442653|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
150082007|NCT02161731|541442654|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
150082008|NCT02161731|541442653|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
150082009|NCT02161731|541442654|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
150082010|NCT02468414|541442659|FG000|Overall Study|Early Study Termination by Sponsor|1|||
150082011|NCT02468414|541442660|FG001|Overall Study|Early Study Termination by Sponsor|0|||
150082012|NCT02468414|541442659|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
150082013|NCT02468414|541442660|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
150082014|NCT02468414|541442659|FG000|Overall Study|Screen Failure|1|||
150082015|NCT02468414|541442660|FG001|Overall Study|Screen Failure|0|||
150082016|NCT00004978|541442661|FG000|Overall Study|Death|107|||
150082017|NCT00004978|541442662|FG001|Overall Study|Death|116|||
150082018|NCT00004978|541442661|FG000|Overall Study|Lost to Follow-up|101|||
150082019|NCT00004978|541442662|FG001|Overall Study|Lost to Follow-up|108|||
150082020|NCT00004978|541442661|FG000|Overall Study|Withdrawal by Subject|17|||
150082021|NCT00004978|541442662|FG001|Overall Study|Withdrawal by Subject|26|||
150082022|NCT00004978|541442661|FG000|Overall Study|site closure - not in analysis cohort|19|||
150082023|NCT00004978|541442662|FG001|Overall Study|site closure - not in analysis cohort|20|||
150082024|NCT01652703|541442666|FG000|Overall Study|Withdrawal by Subject|0|||
150082025|NCT01652703|541442667|FG001|Overall Study|Withdrawal by Subject|1|||
150082026|NCT01652703|541442668|FG002|Overall Study|Withdrawal by Subject|3|||
150082027|NCT01652703|541442669|FG003|Overall Study|Withdrawal by Subject|1|||
150082028|NCT01652703|541442670|FG004|Overall Study|Withdrawal by Subject|0|||
150082029|NCT01652703|541442671|FG005|Overall Study|Withdrawal by Subject|1|||
150082030|NCT01652703|541442666|FG000|Overall Study|Other|0|||
150082031|NCT01652703|541442667|FG001|Overall Study|Other|0|||
150082032|NCT01652703|541442668|FG002|Overall Study|Other|0|||
150082033|NCT01652703|541442669|FG003|Overall Study|Other|1|||
150082034|NCT01652703|541442670|FG004|Overall Study|Other|1|||
150082035|NCT01652703|541442671|FG005|Overall Study|Other|1|||
150082036|NCT00062374|541442672|FG000|Overall Study|Not treated|12|||
150082037|NCT02155608|541442673|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
150082038|NCT02155608|541442674|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
150082039|NCT02155608|541442673|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
150082040|NCT02155608|541442674|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
150082041|NCT03555591|541442675|FG000|Overall Study|Protocol Violation|77|||
150082042|NCT01532414|541442676|FG000|Overall Study|Lost to Follow-up|3|||
150082043|NCT01532414|541442677|FG001|Overall Study|Lost to Follow-up|0|||
150082044|NCT01532414|541442678|FG002|Overall Study|Lost to Follow-up|1|||
150082045|NCT01532414|541442676|FG000|Overall Study|Withdrawal by Subject|3|||
150082046|NCT01532414|541442677|FG001|Overall Study|Withdrawal by Subject|0|||
150082047|NCT01532414|541442678|FG002|Overall Study|Withdrawal by Subject|0|||
150082048|NCT01532414|541442676|FG000|Overall Study|No V6 semen sample|0|||
150082049|NCT01532414|541442677|FG001|Overall Study|No V6 semen sample|1|||
150082050|NCT01532414|541442678|FG002|Overall Study|No V6 semen sample|0|||
150082051|NCT01532414|541442676|FG000|Overall Study|Adverse Event|0|||
150082052|NCT01532414|541442677|FG001|Overall Study|Adverse Event|1|||
150082053|NCT01532414|541442678|FG002|Overall Study|Adverse Event|1|||
150082054|NCT01532414|541442676|FG000|Overall Study|Unable to complete 24 hour PK|0|||
150082055|NCT01532414|541442677|FG001|Overall Study|Unable to complete 24 hour PK|0|||
150082056|NCT01532414|541442678|FG002|Overall Study|Unable to complete 24 hour PK|1|||
150082057|NCT01532414|541442676|FG000|Overall Study|Withdrawn by sponsor|1|||
150082058|NCT01532414|541442677|FG001|Overall Study|Withdrawn by sponsor|0|||
150082059|NCT01532414|541442678|FG002|Overall Study|Withdrawn by sponsor|0|||
150082060|NCT02380677|541442686|FG000|Overall Study|Adverse Event|0|||
150082061|NCT02380677|541442687|FG001|Overall Study|Adverse Event|0|||
150082062|NCT02380677|541442688|FG002|Overall Study|Adverse Event|0|||
150082063|NCT02380677|541442689|FG003|Overall Study|Adverse Event|1|||
150082064|NCT02380677|541442690|FG004|Overall Study|Adverse Event|1|||
150082065|NCT02380677|541442691|FG005|Overall Study|Adverse Event|4|||
150082066|NCT02380677|541442692|FG006|Overall Study|Adverse Event|2|||
150082067|NCT02380677|541442693|FG007|Overall Study|Adverse Event|2|||
150082068|NCT02380677|541442694|FG008|Overall Study|Adverse Event|2|||
150082069|NCT02380677|541442695|FG009|Overall Study|Adverse Event|1|||
150082070|NCT02380677|541442696|FG010|Overall Study|Adverse Event|2|||
150082071|NCT02380677|541442697|FG011|Overall Study|Adverse Event|1|||
150082072|NCT02380677|541442686|FG000|Overall Study|Physician Decision|1|||
150082073|NCT02380677|541442687|FG001|Overall Study|Physician Decision|0|||
150082074|NCT02380677|541442688|FG002|Overall Study|Physician Decision|1|||
150082075|NCT02380677|541442689|FG003|Overall Study|Physician Decision|1|||
150082076|NCT02380677|541442690|FG004|Overall Study|Physician Decision|0|||
150082077|NCT02380677|541442691|FG005|Overall Study|Physician Decision|0|||
150082078|NCT02380677|541442692|FG006|Overall Study|Physician Decision|0|||
150082079|NCT02380677|541442693|FG007|Overall Study|Physician Decision|0|||
150082080|NCT02380677|541442694|FG008|Overall Study|Physician Decision|0|||
150082081|NCT02380677|541442695|FG009|Overall Study|Physician Decision|0|||
150082082|NCT02380677|541442696|FG010|Overall Study|Physician Decision|0|||
150082083|NCT02380677|541442697|FG011|Overall Study|Physician Decision|0|||
150082084|NCT02380677|541442686|FG000|Overall Study|Lack of Efficacy|0|||
150082085|NCT02380677|541442687|FG001|Overall Study|Lack of Efficacy|1|||
150082086|NCT02380677|541442688|FG002|Overall Study|Lack of Efficacy|2|||
150082087|NCT02380677|541442689|FG003|Overall Study|Lack of Efficacy|0|||
150082088|NCT02380677|541442690|FG004|Overall Study|Lack of Efficacy|4|||
150082089|NCT02380677|541442691|FG005|Overall Study|Lack of Efficacy|1|||
150082090|NCT02380677|541442692|FG006|Overall Study|Lack of Efficacy|1|||
150082091|NCT02380677|541442693|FG007|Overall Study|Lack of Efficacy|2|||
150183052|NCT04424927|541808706|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
150082092|NCT02380677|541442694|FG008|Overall Study|Lack of Efficacy|2|||
150082093|NCT02380677|541442695|FG009|Overall Study|Lack of Efficacy|0|||
150082094|NCT02380677|541442696|FG010|Overall Study|Lack of Efficacy|2|||
150082095|NCT02380677|541442697|FG011|Overall Study|Lack of Efficacy|1|||
150082096|NCT02380677|541442686|FG000|Overall Study|Withdrawal by Subject|0|||
150082097|NCT02380677|541442687|FG001|Overall Study|Withdrawal by Subject|0|||
150082098|NCT02380677|541442688|FG002|Overall Study|Withdrawal by Subject|0|||
150082099|NCT02380677|541442689|FG003|Overall Study|Withdrawal by Subject|0|||
150082100|NCT02380677|541442690|FG004|Overall Study|Withdrawal by Subject|0|||
150082101|NCT02380677|541442691|FG005|Overall Study|Withdrawal by Subject|0|||
150082102|NCT02380677|541442692|FG006|Overall Study|Withdrawal by Subject|0|||
150082103|NCT02380677|541442693|FG007|Overall Study|Withdrawal by Subject|0|||
150082104|NCT02380677|541442694|FG008|Overall Study|Withdrawal by Subject|0|||
150082105|NCT02380677|541442695|FG009|Overall Study|Withdrawal by Subject|1|||
150082106|NCT02380677|541442696|FG010|Overall Study|Withdrawal by Subject|0|||
150082107|NCT02380677|541442697|FG011|Overall Study|Withdrawal by Subject|3|||
150082108|NCT02380677|541442686|FG000|Overall Study|Other|0|||
150082109|NCT02380677|541442687|FG001|Overall Study|Other|0|||
150082110|NCT02380677|541442688|FG002|Overall Study|Other|0|||
150082111|NCT02380677|541442689|FG003|Overall Study|Other|1|||
150082112|NCT02380677|541442690|FG004|Overall Study|Other|1|||
150082113|NCT02380677|541442691|FG005|Overall Study|Other|1|||
150082114|NCT02380677|541442692|FG006|Overall Study|Other|0|||
150082115|NCT02380677|541442693|FG007|Overall Study|Other|0|||
150082116|NCT02380677|541442694|FG008|Overall Study|Other|0|||
150082117|NCT02380677|541442695|FG009|Overall Study|Other|0|||
150082118|NCT02380677|541442696|FG010|Overall Study|Other|0|||
150082119|NCT02380677|541442697|FG011|Overall Study|Other|0|||
150082120|NCT00617773|541442703|FG000|Overall Study|Physician Decision|1|||
150082121|NCT00617773|541442703|FG000|Overall Study|Lack of compliance with the protocol|1|||
150082122|NCT00617773|541442703|FG000|Overall Study|Withdrawal by Subject|1|||
150082123|NCT00617773|541442703|FG000|Overall Study|Death|1|||
150082124|NCT00617773|541442703|FG000|Overall Study|Progressive disease|19|||
150082125|NCT00617773|541442703|FG000|Overall Study|Protocol Violation|1|||
150082126|NCT03217175|541442704|FG000|Overall Study|Physician Decision|4|||
150082127|NCT03217175|541442705|FG001|Overall Study|Physician Decision|1|||
150082128|NCT05035550|541442715|FG000|Overall Study|Withdrawal by Subject|3|||
150082129|NCT05035550|541442716|FG001|Overall Study|Withdrawal by Subject|0|||
150082130|NCT01438957|541442717|FG000|Overall Study|Physician Decision|1|||
150082131|NCT01438957|541442718|FG001|Overall Study|Physician Decision|1|||
150082132|NCT01438957|541442719|FG002|Overall Study|Physician Decision|0|||
150082133|NCT01438957|541442720|FG003|Overall Study|Physician Decision|1|||
150082134|NCT01438957|541442721|FG004|Overall Study|Physician Decision|0|||
150082135|NCT00224042|541442722|FG000|Overall Study|Adverse Event|2|||
150082136|NCT00224042|541442723|FG001|Overall Study|Adverse Event|1|||
150082137|NCT00224042|541442722|FG000|Overall Study|Protocol Violation|0|||
150082138|NCT00224042|541442723|FG001|Overall Study|Protocol Violation|1|||
150082139|NCT00224042|541442722|FG000|Overall Study|Physician Decision|0|||
150082140|NCT00224042|541442723|FG001|Overall Study|Physician Decision|1|||
150082141|NCT00224042|541442722|FG000|Overall Study|Did not meet lab incusion criteria|2|||
150082142|NCT00224042|541442723|FG001|Overall Study|Did not meet lab incusion criteria|3|||
150082143|NCT00224042|541442722|FG000|Overall Study|Other|2|||
150082144|NCT00224042|541442723|FG001|Overall Study|Other|0|||
150082145|NCT00840450|541442724|FG000|Overall Study|Adverse Event|1|||
150082146|NCT00840450|541442724|FG000|Overall Study|Lack of Efficacy|2|||
150082147|NCT02170298|541442726|FG000|Overall Study|Withdrawal by Subject|0|||
150082148|NCT02170298|541442727|FG001|Overall Study|Withdrawal by Subject|1|||
150082149|NCT02170298|541442726|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
150082150|NCT02170298|541442727|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
150082151|NCT00777608|541442728|FG000|Overall Study|Lost to Follow-up|1|||
150082152|NCT00777608|541442729|FG001|Overall Study|Lost to Follow-up|1|||
150082153|NCT00777608|541442728|FG000|Overall Study|Withdrawal by Subject|1|||
150082154|NCT00777608|541442729|FG001|Overall Study|Withdrawal by Subject|3|||
150082155|NCT00777608|541442728|FG000|Overall Study|Protocol Violation|1|||
150082156|NCT00777608|541442729|FG001|Overall Study|Protocol Violation|0|||
150082157|NCT00777608|541442728|FG000|Overall Study|Investigator Decision|1|||
150082158|NCT00777608|541442729|FG001|Overall Study|Investigator Decision|2|||
150082159|NCT02853604|541442732|FG000|Overall Study|Withdrawal by Subject|12|||
150082160|NCT02853604|541442733|FG001|Overall Study|Withdrawal by Subject|35|||
150082161|NCT02853604|541442732|FG000|Overall Study|Lost to Follow-up|4|||
150082162|NCT02853604|541442733|FG001|Overall Study|Lost to Follow-up|8|||
150082163|NCT02853604|541442732|FG000|Overall Study|Death|1|||
150082164|NCT02853604|541442733|FG001|Overall Study|Death|5|||
150082165|NCT02853604|541442732|FG000|Overall Study|Miscellaneous|11|||
150082166|NCT02853604|541442733|FG001|Overall Study|Miscellaneous|2|||
150082167|NCT02853604|541442732|FG000|Overall Study|Progressive Disease|0|||
150082168|NCT02853604|541442733|FG001|Overall Study|Progressive Disease|2|||
150082169|NCT01061177|541442738|FG000|Overall Study|Adverse Event|117|||
150082170|NCT01061177|541442738|FG000|Overall Study|Withdrawal by Subject|27|||
150082171|NCT01061177|541442738|FG000|Overall Study|Disease progression|17|||
150082172|NCT01061177|541442738|FG000|Overall Study|Protocol Violation|11|||
150082173|NCT01061177|541442738|FG000|Overall Study|Lost to Follow-up|9|||
150082174|NCT01061177|541442738|FG000|Overall Study|New cancer therapy|9|||
150082175|NCT01061177|541442738|FG000|Overall Study|Abnormal laboratory values|6|||
150082176|NCT01061177|541442738|FG000|Overall Study|Abnormal test procedure results|4|||
150082177|NCT01061177|541442738|FG000|Overall Study|Administratie problems|4|||
150082178|NCT01061177|541442738|FG000|Overall Study|Death|4|||
150082179|NCT03858309|541442739|FG000|Overall Study|Withdrawal by Subject|2|||
150082180|NCT03858309|541442740|FG001|Overall Study|Withdrawal by Subject|3|||
150082181|NCT01539538|541442741|FG000|Overall Study|Adverse Event|13|||
150082182|NCT01539538|541442742|FG001|Overall Study|Adverse Event|18|||
150082183|NCT01539538|541442741|FG000|Overall Study|Lack of Efficacy|13|||
150082184|NCT01539538|541442742|FG001|Overall Study|Lack of Efficacy|16|||
150082185|NCT01539538|541442741|FG000|Overall Study|Withdrawal by Subject|2|||
150082186|NCT01539538|541442742|FG001|Overall Study|Withdrawal by Subject|3|||
150082187|NCT01539538|541442741|FG000|Overall Study|PCA no longer required or PCA problem|3|||
150082188|NCT01539538|541442742|FG001|Overall Study|PCA no longer required or PCA problem|7|||
150082189|NCT00847379|541442743|FG000|Overall Study|Study terminated by Sponsor|59|||
150082190|NCT00847379|541442744|FG001|Overall Study|Study terminated by Sponsor|57|||
150082191|NCT00847379|541442745|FG002|Overall Study|Study terminated by Sponsor|57|||
150082192|NCT04390191|541442746|FG000|Overall Study|Withdrawal by Subject|1|||
150082193|NCT04390191|541442747|FG001|Overall Study|Withdrawal by Subject|0|||
150082194|NCT03978832|541442748|FG000|Overall Study|Adverse Event|1|||
150082195|NCT03978832|541442748|FG000|Overall Study|Lost to Follow-up|1|||
150082196|NCT03978832|541442748|FG000|Overall Study|Withdrawal by Subject|6|||
150082197|NCT03978832|541442748|FG000|Overall Study|Physician Decision|2|||
150082198|NCT03978832|541442748|FG000|Overall Study|did not pass screening criteria|44|||
150082199|NCT00003499|541442749|FG000|Overall Study|Not evaluable|8|||
150082200|NCT02864498|541442754|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
150082201|NCT02864498|541442755|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
150082202|NCT02864498|541442756|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
150082203|NCT02864498|541442754|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
150082204|NCT02864498|541442755|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
150082205|NCT02864498|541442756|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
150082206|NCT02864498|541442754|FG000|Overall Study|Investigator Discretion|0|||
150082207|NCT02864498|541442755|FG001|Overall Study|Investigator Discretion|2|||
150082208|NCT02864498|541442756|FG002|Overall Study|Investigator Discretion|1|||
150082209|NCT02864498|541442754|FG000|Overall Study|Lost to Follow-up|8|||
150082210|NCT02864498|541442755|FG001|Overall Study|Lost to Follow-up|6|||
150082211|NCT02864498|541442756|FG002|Overall Study|Lost to Follow-up|3|||
150082212|NCT02864498|541442754|FG000|Overall Study|Lack of Efficacy|5|||
150082213|NCT02864498|541442755|FG001|Overall Study|Lack of Efficacy|3|||
150082214|NCT02864498|541442756|FG002|Overall Study|Lack of Efficacy|3|||
150082215|NCT02864498|541442754|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
150082216|NCT02864498|541442755|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
150082217|NCT02864498|541442756|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
150082218|NCT02864498|541442754|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
150082219|NCT02864498|541442755|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
150082220|NCT02864498|541442756|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
150082221|NCT02864498|541442754|FG000|Overall Study|Subject moved out of the country.|0|||
150082222|NCT02864498|541442755|FG001|Overall Study|Subject moved out of the country.|0|||
150082223|NCT02864498|541442756|FG002|Overall Study|Subject moved out of the country.|1|||
150082224|NCT01256008|541442757|FG000|Overall Study|Lost to Follow-up|6|||
150082225|NCT01256008|541442758|FG001|Overall Study|Lost to Follow-up|4|||
150082226|NCT01256008|541442759|FG002|Overall Study|Lost to Follow-up|11|||
150082227|NCT01256008|541442757|FG000|Overall Study|Withdrawal by Subject|2|||
150082228|NCT01256008|541442758|FG001|Overall Study|Withdrawal by Subject|3|||
150082229|NCT01256008|541442759|FG002|Overall Study|Withdrawal by Subject|10|||
150082230|NCT01854710|541442772|FG000|Overall Study|Withdrawal by Subject|2|||
150082231|NCT01854710|541442773|FG001|Overall Study|Withdrawal by Subject|1|||
150082232|NCT01854710|541442774|FG002|Overall Study|Withdrawal by Subject|0|||
150082233|NCT01854710|541442775|FG003|Overall Study|Withdrawal by Subject|0|||
150082234|NCT01854710|541442776|FG004|Overall Study|Withdrawal by Subject|0|||
150082235|NCT01854710|541442777|FG005|Overall Study|Withdrawal by Subject|0|||
150082236|NCT01854710|541442772|FG000|Overall Study|CRI procedural error|2|||
150082237|NCT01854710|541442773|FG001|Overall Study|CRI procedural error|2|||
150082238|NCT01854710|541442774|FG002|Overall Study|CRI procedural error|2|||
150082239|NCT01854710|541442775|FG003|Overall Study|CRI procedural error|2|||
150082240|NCT01854710|541442776|FG004|Overall Study|CRI procedural error|2|||
150082241|NCT01854710|541442777|FG005|Overall Study|CRI procedural error|2|||
150082242|NCT00730132|541442778|FG000|Overall Study|Protocol Violation|154|||
150082243|NCT00730132|541442778|FG000|Overall Study|Death|1|||
150082244|NCT02296320|541442780|FG000|Overall Study|Withdrawal by Subject|4|||
150082245|NCT02296320|541442781|FG001|Overall Study|Withdrawal by Subject|0|||
150082246|NCT02296320|541442782|FG002|Overall Study|Withdrawal by Subject|2|||
150082247|NCT02296320|541442780|FG000|Overall Study|Death|24|||
150082248|NCT02296320|541442781|FG001|Overall Study|Death|3|||
150082249|NCT02296320|541442782|FG002|Overall Study|Death|27|||
150082250|NCT02296320|541442780|FG000|Overall Study|Lost to Follow-up|5|||
150082251|NCT02296320|541442781|FG001|Overall Study|Lost to Follow-up|2|||
150082252|NCT02296320|541442782|FG002|Overall Study|Lost to Follow-up|7|||
150082253|NCT02296320|541442780|FG000|Overall Study|Not treated|2|||
150082254|NCT02296320|541442781|FG001|Overall Study|Not treated|0|||
150082255|NCT02296320|541442782|FG002|Overall Study|Not treated|0|||
150082256|NCT02296320|541442780|FG000|Overall Study|Not - specified|0|||
150082257|NCT02296320|541442781|FG001|Overall Study|Not - specified|0|||
150082258|NCT02296320|541442782|FG002|Overall Study|Not - specified|1|||
150082259|NCT05466682|541442786|FG000|Overall Study|Withdrawal by Subject|0|||
150082260|NCT05466682|541442787|FG001|Overall Study|Withdrawal by Subject|2|||
150082261|NCT05466682|541442786|FG000|Overall Study|Lost to Follow-up|2|||
150082262|NCT05466682|541442787|FG001|Overall Study|Lost to Follow-up|1|||
150082263|NCT01930123|541442788|FG000|Overall Study|Adverse Event|1|||
150082264|NCT01930123|541442789|FG001|Overall Study|Adverse Event|0|||
150082265|NCT01930123|541442788|FG000|Overall Study|Physician Decision|21|||
150082266|NCT01930123|541442789|FG001|Overall Study|Physician Decision|8|||
150082267|NCT01930123|541442788|FG000|Overall Study|Withdrawal by Subject|1|||
150082268|NCT01930123|541442789|FG001|Overall Study|Withdrawal by Subject|0|||
150082269|NCT02695329|541442790|FG000|Overall Study|Adverse Event|1|||
150082270|NCT02695329|541442791|FG001|Overall Study|Adverse Event|0|||
150082271|NCT02695329|541442790|FG000|Overall Study|Poor X-ray quality for measurement|4|||
150082272|NCT02695329|541442791|FG001|Overall Study|Poor X-ray quality for measurement|5|||
150082273|NCT01348165|541442792|FG000|Overall Study|Adverse Event|0|||
150082274|NCT01348165|541442793|FG001|Overall Study|Adverse Event|0|||
150082275|NCT01348165|541442794|FG002|Overall Study|Adverse Event|0|||
150082276|NCT01348165|541442795|FG003|Overall Study|Adverse Event|0|||
150082277|NCT01348165|541442796|FG004|Overall Study|Adverse Event|0|||
150082278|NCT01348165|541442797|FG005|Overall Study|Adverse Event|0|||
150082279|NCT01348165|541442798|FG006|Overall Study|Adverse Event|1|||
150082280|NCT01929343|541442799|FG000|Overall Study|Physician Decision|0|||
150082281|NCT01929343|541442800|FG001|Overall Study|Physician Decision|2|||
150082282|NCT01929343|541442801|FG002|Overall Study|Physician Decision|0|||
150082283|NCT01929343|541442799|FG000|Overall Study|Withdrawal by Subject|1|||
150082284|NCT01929343|541442800|FG001|Overall Study|Withdrawal by Subject|0|||
150082285|NCT01929343|541442801|FG002|Overall Study|Withdrawal by Subject|0|||
150082286|NCT01269463|541442802|FG000|First Intervention|Withdrawal by Subject|1|||
150082287|NCT01269463|541442803|FG001|First Intervention|Withdrawal by Subject|0|||
150082288|NCT01269463|541442802|FG000|First Intervention|Adverse Event|1|||
150082289|NCT01269463|541442803|FG001|First Intervention|Adverse Event|0|||
150082290|NCT01269463|541442802|FG000|First Intervention|Lack of Efficacy|0|||
150082291|NCT01269463|541442803|FG001|First Intervention|Lack of Efficacy|1|||
150082292|NCT01269463|541442802|FG000|First Intervention|Physician Decision|0|||
150082293|NCT01269463|541442803|FG001|First Intervention|Physician Decision|1|||
150082294|NCT02549937|541442805|FG000|Overall Study|Death|0|||
150082295|NCT02549937|541442806|FG001|Overall Study|Death|1|||
150082296|NCT02549937|541442807|FG002|Overall Study|Death|0|||
150082297|NCT02549937|541442808|FG003|Overall Study|Death|1|||
150082298|NCT02549937|541442809|FG004|Overall Study|Death|0|||
150082299|NCT02549937|541442810|FG005|Overall Study|Death|8|||
150082300|NCT02549937|541442811|FG006|Overall Study|Death|0|||
150082301|NCT02549937|541442812|FG007|Overall Study|Death|0|||
150082302|NCT02549937|541442813|FG008|Overall Study|Death|19|||
150082303|NCT02549937|541442805|FG000|Overall Study|No follow up required|3|||
150082304|NCT02549937|541442806|FG001|Overall Study|No follow up required|6|||
150082305|NCT02549937|541442807|FG002|Overall Study|No follow up required|3|||
150082306|NCT02549937|541442808|FG003|Overall Study|No follow up required|8|||
150082307|NCT02549937|541442809|FG004|Overall Study|No follow up required|12|||
150082308|NCT02549937|541442810|FG005|Overall Study|No follow up required|21|||
150082309|NCT02549937|541442811|FG006|Overall Study|No follow up required|9|||
150082310|NCT02549937|541442812|FG007|Overall Study|No follow up required|11|||
150082311|NCT02549937|541442813|FG008|Overall Study|No follow up required|0|||
150082312|NCT02549937|541442805|FG000|Overall Study|Other|0|||
150082313|NCT02549937|541442806|FG001|Overall Study|Other|0|||
150082314|NCT02549937|541442807|FG002|Overall Study|Other|0|||
150082315|NCT02549937|541442808|FG003|Overall Study|Other|0|||
150082316|NCT02549937|541442809|FG004|Overall Study|Other|1|||
150082317|NCT02549937|541442810|FG005|Overall Study|Other|0|||
150082318|NCT02549937|541442811|FG006|Overall Study|Other|3|||
150082319|NCT02549937|541442812|FG007|Overall Study|Other|2|||
150082320|NCT02549937|541442813|FG008|Overall Study|Other|3|||
150082321|NCT02549937|541442805|FG000|Overall Study|Lost to Follow-up|0|||
150082322|NCT02549937|541442806|FG001|Overall Study|Lost to Follow-up|0|||
150082323|NCT02549937|541442807|FG002|Overall Study|Lost to Follow-up|0|||
150082324|NCT02549937|541442808|FG003|Overall Study|Lost to Follow-up|0|||
150082325|NCT02549937|541442809|FG004|Overall Study|Lost to Follow-up|0|||
150082326|NCT02549937|541442810|FG005|Overall Study|Lost to Follow-up|0|||
150082327|NCT02549937|541442811|FG006|Overall Study|Lost to Follow-up|0|||
150082328|NCT02549937|541442812|FG007|Overall Study|Lost to Follow-up|0|||
150082329|NCT02549937|541442813|FG008|Overall Study|Lost to Follow-up|3|||
150082330|NCT02549937|541442805|FG000|Overall Study|Withdrawal by Subject|0|||
150082331|NCT02549937|541442806|FG001|Overall Study|Withdrawal by Subject|0|||
150082332|NCT02549937|541442807|FG002|Overall Study|Withdrawal by Subject|0|||
150082333|NCT02549937|541442808|FG003|Overall Study|Withdrawal by Subject|0|||
150082334|NCT02549937|541442809|FG004|Overall Study|Withdrawal by Subject|0|||
150082335|NCT02549937|541442810|FG005|Overall Study|Withdrawal by Subject|1|||
150082336|NCT02549937|541442811|FG006|Overall Study|Withdrawal by Subject|4|||
150082337|NCT02549937|541442812|FG007|Overall Study|Withdrawal by Subject|3|||
150082338|NCT02549937|541442813|FG008|Overall Study|Withdrawal by Subject|2|||
150082339|NCT02549937|541442805|FG000|Overall Study|Sponsor Decision|0|||
150082340|NCT02549937|541442806|FG001|Overall Study|Sponsor Decision|0|||
150082341|NCT02549937|541442807|FG002|Overall Study|Sponsor Decision|0|||
150082342|NCT02549937|541442808|FG003|Overall Study|Sponsor Decision|0|||
150082343|NCT02549937|541442809|FG004|Overall Study|Sponsor Decision|0|||
150082344|NCT02549937|541442810|FG005|Overall Study|Sponsor Decision|0|||
150082345|NCT02549937|541442811|FG006|Overall Study|Sponsor Decision|0|||
150082346|NCT02549937|541442812|FG007|Overall Study|Sponsor Decision|0|||
150082347|NCT02549937|541442813|FG008|Overall Study|Sponsor Decision|6|||
150082348|NCT03199274|541442814|FG000|Overall Study|Withdrawal by Subject|4|||
150082349|NCT03199274|541442815|FG001|Overall Study|Withdrawal by Subject|0|||
150082350|NCT03199274|541442814|FG000|Overall Study|Lost to Follow-up|0|||
150082351|NCT03199274|541442815|FG001|Overall Study|Lost to Follow-up|1|||
150082352|NCT03199274|541442814|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
150082353|NCT03199274|541442815|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
150082354|NCT03278873|541442816|FG000|Overall Study|Withdrawal by Subject|0|||
150082355|NCT03278873|541442817|FG001|Overall Study|Withdrawal by Subject|1|||
150082356|NCT03278873|541442818|FG002|Overall Study|Withdrawal by Subject|0|||
150082357|NCT03278873|541442819|FG003|Overall Study|Withdrawal by Subject|0|||
150082358|NCT03278873|541442816|FG000|Overall Study|Sponsor's decision|0|||
150082359|NCT03278873|541442817|FG001|Overall Study|Sponsor's decision|1|||
150082360|NCT03278873|541442818|FG002|Overall Study|Sponsor's decision|0|||
150082361|NCT03278873|541442819|FG003|Overall Study|Sponsor's decision|0|||
150082362|NCT03278873|541442816|FG000|Overall Study|Early Termination|2|||
150082363|NCT03278873|541442817|FG001|Overall Study|Early Termination|6|||
150082364|NCT03278873|541442818|FG002|Overall Study|Early Termination|0|||
150082365|NCT03278873|541442819|FG003|Overall Study|Early Termination|4|||
150082366|NCT03278873|541442816|FG000|Overall Study|Lost to Follow-up|0|||
150082367|NCT03278873|541442817|FG001|Overall Study|Lost to Follow-up|0|||
150082368|NCT03278873|541442818|FG002|Overall Study|Lost to Follow-up|2|||
150082369|NCT03278873|541442819|FG003|Overall Study|Lost to Follow-up|0|||
150082370|NCT03278873|541442816|FG000|Overall Study|The patient decided to withdraw via email|1|||
150082371|NCT03278873|541442817|FG001|Overall Study|The patient decided to withdraw via email|0|||
150082372|NCT03278873|541442818|FG002|Overall Study|The patient decided to withdraw via email|0|||
150082373|NCT03278873|541442819|FG003|Overall Study|The patient decided to withdraw via email|0|||
150082374|NCT03278873|541442816|FG000|Overall Study|The patient was unresponsive to contact|0|||
150082375|NCT03278873|541442817|FG001|Overall Study|The patient was unresponsive to contact|0|||
150082376|NCT03278873|541442818|FG002|Overall Study|The patient was unresponsive to contact|0|||
150082377|NCT03278873|541442819|FG003|Overall Study|The patient was unresponsive to contact|4|||
150082378|NCT03278873|541442816|FG000|Overall Study|The patient wished to participate no longer|0|||
150082379|NCT03278873|541442817|FG001|Overall Study|The patient wished to participate no longer|1|||
150082380|NCT03278873|541442818|FG002|Overall Study|The patient wished to participate no longer|0|||
150082381|NCT03278873|541442819|FG003|Overall Study|The patient wished to participate no longer|0|||
150082382|NCT03278873|541442816|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
150082383|NCT03278873|541442817|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
150082384|NCT03278873|541442818|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
150082385|NCT03278873|541442819|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
150082386|NCT04518306|541442825|FG000|Double-Blind Period|Run in failure|0|||
150082387|NCT04518306|541442826|FG001|Double-Blind Period|Run in failure|0|||
150082388|NCT04518306|541442827|FG002|Double-Blind Period|Run in failure|1|||
150082389|NCT04518306|541442825|FG000|Double-Blind Period|Adverse Event|0|||
150082390|NCT04518306|541442826|FG001|Double-Blind Period|Adverse Event|2|||
150082391|NCT04518306|541442827|FG002|Double-Blind Period|Adverse Event|2|||
150082392|NCT04518306|541442825|FG000|Double-Blind Period|Lost to Follow-up|1|||
150082393|NCT04518306|541442826|FG001|Double-Blind Period|Lost to Follow-up|2|||
150082394|NCT04518306|541442827|FG002|Double-Blind Period|Lost to Follow-up|2|||
150082395|NCT04518306|541442825|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
150082396|NCT04518306|541442826|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
150082397|NCT04518306|541442827|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
150082398|NCT04518306|541442825|FG000|Double-Blind Period|Other|0|||
150082399|NCT04518306|541442826|FG001|Double-Blind Period|Other|2|||
150082400|NCT04518306|541442827|FG002|Double-Blind Period|Other|0|||
150082401|NCT04518306|541442825|FG000|Double-Blind Period|Missing|0|||
150082402|NCT04518306|541442826|FG001|Double-Blind Period|Missing|1|||
150082403|NCT04518306|541442827|FG002|Double-Blind Period|Missing|0|||
150082404|NCT02801331|541442828|FG000|Overall Study|Transferred to another hospital|8|||
150082405|NCT02801331|541442829|FG001|Overall Study|Transferred to another hospital|7|||
150082406|NCT02801331|541442828|FG000|Overall Study|Withdrawal by Subject|0|||
150082407|NCT02801331|541442829|FG001|Overall Study|Withdrawal by Subject|4|||
150082408|NCT02801331|541442828|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
150082409|NCT02801331|541442829|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
150082410|NCT02443987|541442830|FG000|Overall Study|Bladder injury|1|||
150082411|NCT02443987|541442831|FG001|Overall Study|Bladder injury|1|||
150082412|NCT02443987|541442830|FG000|Overall Study|Other|0|||
150082413|NCT02443987|541442831|FG001|Overall Study|Other|1|||
150082414|NCT03069378|541442836|FG000|Overall Study|Withdrawal by Subject|1|||
150082415|NCT01397708|541442837|FG000|Overall Study|Withdrawal by Subject|0|||
150082416|NCT01397708|541442838|FG001|Overall Study|Withdrawal by Subject|0|||
150082417|NCT01397708|541442839|FG002|Overall Study|Withdrawal by Subject|1|||
150082418|NCT01397708|541442840|FG003|Overall Study|Withdrawal by Subject|0|||
150082419|NCT01397708|541442841|FG004|Overall Study|Withdrawal by Subject|0|||
150082420|NCT01397708|541442842|FG005|Overall Study|Withdrawal by Subject|0|||
150082421|NCT01397708|541442843|FG006|Overall Study|Withdrawal by Subject|0|||
150082422|NCT01397708|541442844|FG007|Overall Study|Withdrawal by Subject|1|||
150082423|NCT01397708|541442837|FG000|Overall Study|Death|0|||
150082424|NCT01397708|541442838|FG001|Overall Study|Death|0|||
150082425|NCT01397708|541442839|FG002|Overall Study|Death|1|||
150082426|NCT01397708|541442840|FG003|Overall Study|Death|1|||
150082427|NCT01397708|541442841|FG004|Overall Study|Death|0|||
150082428|NCT01397708|541442842|FG005|Overall Study|Death|0|||
150082429|NCT01397708|541442843|FG006|Overall Study|Death|0|||
150082430|NCT01397708|541442844|FG007|Overall Study|Death|0|||
150082431|NCT01397708|541442837|FG000|Overall Study|Lost to Follow-up|0|||
150082432|NCT01397708|541442838|FG001|Overall Study|Lost to Follow-up|0|||
150082433|NCT01397708|541442839|FG002|Overall Study|Lost to Follow-up|0|||
150082434|NCT01397708|541442840|FG003|Overall Study|Lost to Follow-up|0|||
150082435|NCT01397708|541442841|FG004|Overall Study|Lost to Follow-up|1|||
150082436|NCT01397708|541442842|FG005|Overall Study|Lost to Follow-up|0|||
150082437|NCT01397708|541442843|FG006|Overall Study|Lost to Follow-up|0|||
150082438|NCT01397708|541442844|FG007|Overall Study|Lost to Follow-up|0|||
150082439|NCT01397708|541442837|FG000|Overall Study|Other|0|||
150082440|NCT01397708|541442838|FG001|Overall Study|Other|0|||
150082441|NCT01397708|541442839|FG002|Overall Study|Other|0|||
150082442|NCT01397708|541442840|FG003|Overall Study|Other|0|||
150082443|NCT01397708|541442841|FG004|Overall Study|Other|0|||
150082444|NCT01397708|541442842|FG005|Overall Study|Other|0|||
150082445|NCT01397708|541442843|FG006|Overall Study|Other|1|||
150082446|NCT01397708|541442844|FG007|Overall Study|Other|0|||
150082447|NCT01638546|541442847|FG000|Overall Study|Adverse Event|1|||
150082448|NCT01638546|541442848|FG001|Overall Study|Adverse Event|3|||
150082449|NCT00612690|541444098|FG000|Overall Study|Lost to Follow-up|72|||
150082450|NCT00612690|541444099|FG001|Overall Study|Lost to Follow-up|98|||
150082451|NCT00612690|541444098|FG000|Overall Study|Withdrawal by Subject|32|||
150082452|NCT00612690|541444099|FG001|Overall Study|Withdrawal by Subject|20|||
150082453|NCT00612690|541444098|FG000|Overall Study|Withdrawal by Site|11|||
150082454|NCT00612690|541444099|FG001|Overall Study|Withdrawal by Site|0|||
150082455|NCT01664533|541444100|FG000|Overall Study|Death|42|||
150082456|NCT01664533|541444100|FG000|Overall Study|Lost to Follow-up|3|||
150082457|NCT01664533|541444100|FG000|Overall Study|Study termination|9|||
150082458|NCT01664533|541444100|FG000|Overall Study|Protocol Violation|3|||
150082459|NCT00844831|541444102|FG000|Overall Study|Withdrawal by Subject|4|||
150082460|NCT00844831|541444102|FG000|Overall Study|Adverse Event|1|||
150082461|NCT00844831|541444102|FG000|Overall Study|Physician Decision|1|||
150082462|NCT05255068|541444103|FG000|Overall Study|Lost to Follow-up|0|||
150082463|NCT05255068|541444104|FG001|Overall Study|Lost to Follow-up|1|||
150082464|NCT00540514|541444106|FG000|Overall Study|Still on treatment|3|||
150082465|NCT00540514|541444107|FG001|Overall Study|Still on treatment|0|||
150082466|NCT00540514|541444106|FG000|Overall Study|Unacceptable Toxicity|61|||
150082467|NCT00540514|541444107|FG001|Overall Study|Unacceptable Toxicity|62|||
150082468|NCT00540514|541444106|FG000|Overall Study|Adverse Event|20|||
150082469|NCT00540514|541444107|FG001|Overall Study|Adverse Event|24|||
150082470|NCT00540514|541444106|FG000|Overall Study|Physician Decision|86|||
150082471|NCT00540514|541444107|FG001|Overall Study|Physician Decision|99|||
150082472|NCT00540514|541444106|FG000|Overall Study|Protocol Deviation|3|||
150082473|NCT00540514|541444107|FG001|Overall Study|Protocol Deviation|4|||
150082474|NCT00540514|541444106|FG000|Overall Study|Lost to Follow-up|1|||
150082475|NCT00540514|541444107|FG001|Overall Study|Lost to Follow-up|1|||
150082476|NCT00540514|541444106|FG000|Overall Study|Withdrawal by Subject|65|||
150082477|NCT00540514|541444107|FG001|Overall Study|Withdrawal by Subject|67|||
150082478|NCT00540514|541444106|FG000|Overall Study|Excluded prior to treatment|7|||
150082479|NCT00540514|541444107|FG001|Overall Study|Excluded prior to treatment|7|||
150082480|NCT00540514|541444106|FG000|Overall Study|Paclitaxel not available|0|||
150183053|NCT04424927|541808707|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
150183054|NCT04424927|541808708|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
150082481|NCT00540514|541444107|FG001|Overall Study|Paclitaxel not available|2|||
150082482|NCT03291808|541444108|FG000|Overall Study|Lost to Follow-up|6|||
150082483|NCT03291808|541444108|FG000|Overall Study|Research burden|4|||
150082484|NCT02397278|541444116|FG000|Overall Study|Withdrawal by Subject|0|||
150082485|NCT02397278|541444117|FG001|Overall Study|Withdrawal by Subject|2|||
150082486|NCT02397278|541444116|FG000|Overall Study|Deemed ineligible following surgery|1|||
150082487|NCT02397278|541444117|FG001|Overall Study|Deemed ineligible following surgery|1|||
150082488|NCT01315678|541444119|FG000|Overall Study|Withdrawal by Subject|7|||
150082489|NCT01315678|541444120|FG001|Overall Study|Withdrawal by Subject|3|||
150082490|NCT01315678|541444119|FG000|Overall Study|Adverse Event|3|||
150183055|NCT04424927|541808709|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
150082491|NCT01315678|541444120|FG001|Overall Study|Adverse Event|1|||
150082492|NCT01315678|541444119|FG000|Overall Study|Lost to Follow-up|1|||
150082493|NCT01315678|541444120|FG001|Overall Study|Lost to Follow-up|0|||
150082494|NCT01315678|541444119|FG000|Overall Study|similar reason to those listed above|3|||
150082495|NCT01315678|541444120|FG001|Overall Study|similar reason to those listed above|2|||
150082496|NCT00429273|541444126|FG000|Overall Study|Lost to Follow-up|1|||
150082497|NCT00429273|541444127|FG001|Overall Study|Lost to Follow-up|2|||
150082498|NCT00429273|541444128|FG002|Overall Study|Lost to Follow-up|2|||
150082499|NCT00429273|541444126|FG000|Overall Study|Physician Decision|6|||
150082500|NCT00429273|541444127|FG001|Overall Study|Physician Decision|5|||
150082501|NCT00429273|541444128|FG002|Overall Study|Physician Decision|5|||
150082502|NCT00429273|541444126|FG000|Overall Study|Adverse Event|1|||
150082503|NCT00429273|541444127|FG001|Overall Study|Adverse Event|1|||
150082504|NCT00429273|541444128|FG002|Overall Study|Adverse Event|2|||
150082505|NCT00521014|541444133|FG000|Overall Study|Inevaluable, not treated|1|||
150082506|NCT03208244|541444135|FG000|Overall Study|Death|1|||
150082507|NCT01233258|541444137|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
150082508|NCT01233258|541444138|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
150082509|NCT01233258|541444139|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
150082510|NCT01233258|541444140|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
150082511|NCT01233258|541444141|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
150082512|NCT01233258|541444142|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
150082513|NCT01233258|541444137|FG000|First Intervention (6 Months)|Protocol Violation|0|||
150082514|NCT01233258|541444138|FG001|First Intervention (6 Months)|Protocol Violation|0|||
150082515|NCT01233258|541444139|FG002|First Intervention (6 Months)|Protocol Violation|1|||
150082516|NCT01233258|541444140|FG003|First Intervention (6 Months)|Protocol Violation|0|||
150082517|NCT01233258|541444141|FG004|First Intervention (6 Months)|Protocol Violation|0|||
150082518|NCT01233258|541444142|FG005|First Intervention (6 Months)|Protocol Violation|0|||
150082519|NCT01233258|541444137|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
150082520|NCT01233258|541444138|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
150082521|NCT01233258|541444139|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
150082522|NCT01233258|541444140|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
150082523|NCT01233258|541444141|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
150082524|NCT01233258|541444142|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
150082525|NCT00390468|541444143|FG000|Overall Study|Protocol Violation|2|||
150082526|NCT00390468|541444143|FG000|Overall Study|Lack of Efficacy|1|||
150082527|NCT01049308|541444144|FG000|Pill Counts|Withdrawal by Subject|83|||
150082528|NCT03845985|541444145|FG000|Overall Study|Lost to Follow-up|2|||
150082529|NCT03845985|541444146|FG001|Overall Study|Lost to Follow-up|1|||
150082530|NCT03845985|541444145|FG000|Overall Study|Physician Decision|1|||
150082531|NCT03845985|541444146|FG001|Overall Study|Physician Decision|0|||
150082532|NCT03845985|541444145|FG000|Overall Study|Withdrawal by Subject|4|||
150082533|NCT03845985|541444146|FG001|Overall Study|Withdrawal by Subject|1|||
150082534|NCT01318993|541444147|FG000|Overall Study|Adverse Event|53|||
150082535|NCT01318993|541444147|FG000|Overall Study|Lack of Efficacy|121|||
150082536|NCT01318993|541444147|FG000|Overall Study|Protocol Violation|3|||
150082537|NCT01318993|541444147|FG000|Overall Study|Protocol based stopping criteria|6|||
150082538|NCT01318993|541444147|FG000|Overall Study|Study closed or terminated|174|||
150082539|NCT01318993|541444147|FG000|Overall Study|Lost to Follow-up|4|||
150082540|NCT01318993|541444147|FG000|Overall Study|Physician Decision|13|||
150082541|NCT01318993|541444147|FG000|Overall Study|Withdrawal by Subject|24|||
150082542|NCT03334539|541444148|FG000|Overall Study|Adverse Event|3|||
150082543|NCT03334539|541444149|FG001|Overall Study|Adverse Event|5|||
150082544|NCT03334539|541444150|FG002|Overall Study|Adverse Event|0|||
150082545|NCT03334539|541444148|FG000|Overall Study|Withdrawal by Subject|0|||
150082546|NCT03334539|541444149|FG001|Overall Study|Withdrawal by Subject|1|||
150082547|NCT03334539|541444150|FG002|Overall Study|Withdrawal by Subject|1|||
150082548|NCT03334539|541444148|FG000|Overall Study|Administrative Reasons|1|||
150082549|NCT03334539|541444149|FG001|Overall Study|Administrative Reasons|0|||
150082550|NCT03334539|541444150|FG002|Overall Study|Administrative Reasons|0|||
150082551|NCT03334539|541444148|FG000|Overall Study|Hypertension Not Controlled|0|||
150082552|NCT03334539|541444149|FG001|Overall Study|Hypertension Not Controlled|1|||
150082553|NCT03334539|541444150|FG002|Overall Study|Hypertension Not Controlled|0|||
150082554|NCT04974697|541444154|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
150082555|NCT04974697|541444154|FG000|Overall Study|Lens discomfort|1|||
150082556|NCT03706456|541444155|FG000|Overall Study|Adverse Event|1|||
150082557|NCT03706456|541444155|FG000|Overall Study|Lack of Efficacy|2|||
150082558|NCT03302234|541444156|FG000|Overall Study|Death|191|||
150082559|NCT03302234|541444157|FG001|Overall Study|Death|192|||
150082560|NCT03302234|541444156|FG000|Overall Study|Withdrawal by Subject|2|||
150082561|NCT03302234|541444157|FG001|Overall Study|Withdrawal by Subject|2|||
150082562|NCT03302234|541444156|FG000|Overall Study|Sponsor Decision|90|||
150082563|NCT03302234|541444157|FG001|Overall Study|Sponsor Decision|89|||
150082564|NCT03302234|541444156|FG000|Overall Study|Laryngeal carcinoma|0|||
150082565|NCT03302234|541444157|FG001|Overall Study|Laryngeal carcinoma|1|||
150082566|NCT03302234|541444156|FG000|Overall Study|Not Reported|1|||
150082567|NCT03302234|541444157|FG001|Overall Study|Not Reported|0|||
150082568|NCT02795832|541444161|FG000|Overall Study|Adverse Event|0|||
150082569|NCT02795832|541444162|FG001|Overall Study|Adverse Event|0|||
150082570|NCT02795832|541444163|FG002|Overall Study|Adverse Event|0|||
150082571|NCT02795832|541444164|FG003|Overall Study|Adverse Event|0|||
150082572|NCT02795832|541444165|FG004|Overall Study|Adverse Event|0|||
150082573|NCT02795832|541444166|FG005|Overall Study|Adverse Event|3|||
150082574|NCT04112784|541444167|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
150082575|NCT04112784|541444167|FG000|Overall Study|Screen Failures|4|||
150082576|NCT01845831|541444169|FG000|Inpatient Phase|Withdrawal by Subject|1|||
150082577|NCT01845831|541444170|FG001|Inpatient Phase|Withdrawal by Subject|1|||
150082578|NCT01845831|541444171|FG002|Inpatient Phase|Withdrawal by Subject|0|||
150082579|NCT01845831|541444172|FG003|Inpatient Phase|Withdrawal by Subject|0|||
150082580|NCT01845831|541444173|FG004|Inpatient Phase|Withdrawal by Subject|0|||
150082581|NCT00221403|541444174|FG000|Overall Study|Protocol Violation|1|||
150082582|NCT00221403|541444175|FG001|Overall Study|Protocol Violation|0|||
150082583|NCT00221403|541444176|FG002|Overall Study|Protocol Violation|0|||
150082584|NCT00221403|541444174|FG000|Overall Study|Physician Decision|1|||
150082585|NCT00221403|541444175|FG001|Overall Study|Physician Decision|0|||
150082586|NCT00221403|541444176|FG002|Overall Study|Physician Decision|0|||
150082587|NCT00221403|541444174|FG000|Overall Study|Withdrawal by Subject|0|||
150082588|NCT00221403|541444175|FG001|Overall Study|Withdrawal by Subject|3|||
150082589|NCT00221403|541444176|FG002|Overall Study|Withdrawal by Subject|0|||
150082590|NCT00221403|541444174|FG000|Overall Study|Lack of Efficacy|0|||
150082591|NCT00221403|541444175|FG001|Overall Study|Lack of Efficacy|1|||
150082592|NCT00221403|541444176|FG002|Overall Study|Lack of Efficacy|0|||
150082593|NCT00221403|541444174|FG000|Overall Study|Adverse Event|0|||
150082594|NCT00221403|541444175|FG001|Overall Study|Adverse Event|1|||
150082595|NCT00221403|541444176|FG002|Overall Study|Adverse Event|0|||
150082596|NCT00256750|541444178|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
150082597|NCT00256750|541444179|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
150082598|NCT00256750|541444180|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
150082599|NCT00256750|541444178|FG000|Transplanted Pre-Treatment|Other|2|||
150082600|NCT00256750|541444179|FG001|Transplanted Pre-Treatment|Other|0|||
150082601|NCT00256750|541444180|FG002|Transplanted Pre-Treatment|Other|0|||
150082602|NCT00256750|541444178|FG000|Transplanted Pre-Treatment|Death|1|||
150082603|NCT00256750|541444179|FG001|Transplanted Pre-Treatment|Death|0|||
150082604|NCT00256750|541444180|FG002|Transplanted Pre-Treatment|Death|0|||
150082605|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
150082606|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
150082607|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
150082608|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Death|3|||
150082609|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Death|2|||
150082610|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Death|4|||
150082611|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
150082612|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
150082613|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
150082614|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
150082615|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
150082616|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
150082617|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Other|5|||
150082618|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Other|4|||
150082619|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Other|2|||
150082620|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
150082621|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
150082622|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
150082623|NCT00256750|541444178|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
150082624|NCT00256750|541444179|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
150082625|NCT00256750|541444180|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
150082626|NCT00256750|541444178|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
150082627|NCT00256750|541444179|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
150082628|NCT00256750|541444180|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
150082629|NCT00256750|541444178|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
150183056|NCT04424927|541808710|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
150082630|NCT00256750|541444179|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
150082631|NCT00256750|541444180|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
150082632|NCT00256750|541444178|FG000|Post-Transplant Treated (24 Months)|Death|3|||
150082633|NCT00256750|541444179|FG001|Post-Transplant Treated (24 Months)|Death|0|||
150082634|NCT00256750|541444180|FG002|Post-Transplant Treated (24 Months)|Death|0|||
150082635|NCT00256750|541444178|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
150082636|NCT00256750|541444179|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
150082637|NCT00256750|541444180|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
150082638|NCT00256750|541444178|FG000|Post-Transplant Treated (24 Months)|Other|2|||
150082639|NCT00256750|541444179|FG001|Post-Transplant Treated (24 Months)|Other|0|||
150082640|NCT00256750|541444180|FG002|Post-Transplant Treated (24 Months)|Other|1|||
150082641|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
150082642|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
150082643|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
150082644|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
150082645|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
150082646|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
150082647|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Death|0|||
150082648|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Death|2|||
150082649|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Death|1|||
150082650|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
150082651|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
150082652|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
150082653|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
150082654|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
150082655|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
150082656|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
150082657|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
150082658|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
150082659|NCT00256750|541444178|FG000|Post-Transplant Treated (36 Months)|Other|0|||
150082660|NCT00256750|541444179|FG001|Post-Transplant Treated (36 Months)|Other|1|||
150082661|NCT00256750|541444180|FG002|Post-Transplant Treated (36 Months)|Other|1|||
150082662|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
150082663|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
150082664|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
150082665|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
150082666|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
150082667|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
150082668|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
150082669|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
150082670|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
150082671|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
150082672|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
150082673|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
150082674|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
150082675|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
150082676|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
150082677|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
150082678|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
150082679|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
150082680|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
150082681|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
150082682|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
150082683|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
150082684|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
150082685|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
150082686|NCT00256750|541444178|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
150082687|NCT00256750|541444179|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
150082688|NCT00256750|541444180|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
150082689|NCT04659161|541444182|FG000|Overall Study|Adverse Event|10|||
150082690|NCT04659161|541444183|FG001|Overall Study|Adverse Event|6|||
150082691|NCT04659161|541444182|FG000|Overall Study|Withdrawal by Subject|13|||
150082692|NCT04659161|541444183|FG001|Overall Study|Withdrawal by Subject|12|||
150082693|NCT04659161|541444182|FG000|Overall Study|Other|9|||
150082694|NCT04659161|541444183|FG001|Overall Study|Other|8|||
150183057|NCT04424927|541808706|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
150183058|NCT04424927|541808707|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
150082695|NCT02197130|541444186|FG000|Overall Study|Adverse Event|13|||
150082696|NCT02197130|541444187|FG001|Overall Study|Adverse Event|4|||
150082697|NCT02197130|541444188|FG002|Overall Study|Adverse Event|23|||
150082698|NCT02197130|541444186|FG000|Overall Study|Death|0|||
150082699|NCT02197130|541444187|FG001|Overall Study|Death|1|||
150082700|NCT02197130|541444188|FG002|Overall Study|Death|0|||
150082701|NCT02197130|541444186|FG000|Overall Study|Lost to Follow-up|2|||
150082702|NCT02197130|541444187|FG001|Overall Study|Lost to Follow-up|0|||
150082703|NCT02197130|541444188|FG002|Overall Study|Lost to Follow-up|1|||
150082704|NCT02197130|541444186|FG000|Overall Study|Does not meet entrance criteria|0|||
150082705|NCT02197130|541444187|FG001|Overall Study|Does not meet entrance criteria|0|||
150082706|NCT02197130|541444188|FG002|Overall Study|Does not meet entrance criteria|1|||
150082707|NCT02197130|541444186|FG000|Overall Study|Withdrawal by Subject|0|||
150082708|NCT02197130|541444187|FG001|Overall Study|Withdrawal by Subject|3|||
150082709|NCT02197130|541444188|FG002|Overall Study|Withdrawal by Subject|4|||
150082710|NCT02197130|541444186|FG000|Overall Study|Other|1|||
150082711|NCT02197130|541444187|FG001|Overall Study|Other|0|||
150082712|NCT02197130|541444188|FG002|Overall Study|Other|3|||
150082713|NCT02615145|541444189|FG000|Overall Study|Did Not Start Treatment|0|||
150082714|NCT02615145|541444190|FG001|Overall Study|Did Not Start Treatment|0|||
150082715|NCT02615145|541444191|FG002|Overall Study|Did Not Start Treatment|1|||
150082716|NCT02615145|541444192|FG003|Overall Study|Did Not Start Treatment|1|||
150082717|NCT02615145|541444189|FG000|Overall Study|Failure to Return|20|||
150082718|NCT02615145|541444190|FG001|Overall Study|Failure to Return|10|||
150082719|NCT02615145|541444191|FG002|Overall Study|Failure to Return|7|||
150082720|NCT02615145|541444192|FG003|Overall Study|Failure to Return|0|||
150082721|NCT02615145|541444189|FG000|Overall Study|Death|2|||
150082722|NCT02615145|541444190|FG001|Overall Study|Death|3|||
150082723|NCT02615145|541444191|FG002|Overall Study|Death|0|||
150082724|NCT02615145|541444192|FG003|Overall Study|Death|0|||
150082725|NCT02615145|541444189|FG000|Overall Study|Other, Not Specified|5|||
150082726|NCT02615145|541444190|FG001|Overall Study|Other, Not Specified|2|||
150082727|NCT02615145|541444191|FG002|Overall Study|Other, Not Specified|0|||
150082728|NCT02615145|541444192|FG003|Overall Study|Other, Not Specified|0|||
150082729|NCT03648983|541444197|FG000|Overall Study|Study was terminated due to PI departure|95|||
150082730|NCT04404361|541444201|FG000|Overall Study|Death|12|||
150082731|NCT04404361|541444202|FG001|Overall Study|Death|12|||
150082732|NCT04404361|541444201|FG000|Overall Study|Withdrawal by Subject|13|||
150082733|NCT04404361|541444202|FG001|Overall Study|Withdrawal by Subject|5|||
150082734|NCT04404361|541444201|FG000|Overall Study|Lost to Follow-up|6|||
150082735|NCT04404361|541444202|FG001|Overall Study|Lost to Follow-up|3|||
150082736|NCT04404361|541444201|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
150082737|NCT04404361|541444202|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
150082738|NCT05330702|541444211|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
150082739|NCT05330702|541444212|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
150082740|NCT05330702|541444213|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
150082741|NCT02881554|541444214|FG000|Overall Study|Withdrawal by Subject|2|||
150082742|NCT02881554|541444215|FG001|Overall Study|Withdrawal by Subject|0|||
150082743|NCT00638378|541445564|FG000|Overall Study|Death|2|||
150082744|NCT00638378|541445564|FG000|Overall Study|Adverse Event|1|||
150082745|NCT00638378|541445564|FG000|Overall Study|Disease progression|15|||
150082746|NCT00638378|541445564|FG000|Overall Study|Physician Decision|4|||
150082747|NCT01892293|541445567|FG000|Overall Study|Apheresed but not treated|4|||
150082748|NCT03602482|541445568|FG000|Overall Study|Withdrawal by Subject|6|||
150082749|NCT03602482|541445569|FG001|Overall Study|Withdrawal by Subject|7|||
150082750|NCT03602482|541445570|FG002|Overall Study|Withdrawal by Subject|0|||
150082751|NCT03602482|541445571|FG003|Overall Study|Withdrawal by Subject|0|||
150082752|NCT02601469|541445574|FG000|Overall Study|Enrolled in Error|1|||
150082753|NCT02601469|541445575|FG001|Overall Study|Enrolled in Error|0|||
150082754|NCT01411774|541445580|FG000|Overall Study|Withdrawal by Subject|0|||
150082755|NCT01411774|541445581|FG001|Overall Study|Withdrawal by Subject|3|||
150082756|NCT00056316|541445582|FG000|Overall Study|Withdrawal by Subject|2|||
150082757|NCT00056316|541445583|FG001|Overall Study|Withdrawal by Subject|2|||
150082758|NCT00056316|541445582|FG000|Overall Study|Death/NH placement of pt|1|||
150082759|NCT00056316|541445583|FG001|Overall Study|Death/NH placement of pt|1|||
150082760|NCT03633695|541445587|FG000|Overall Study|Lost to Follow-up|4|||
150082761|NCT03633695|541445588|FG001|Overall Study|Lost to Follow-up|5|||
150082762|NCT03633695|541445587|FG000|Overall Study|Discontinued|8|||
150082763|NCT03633695|541445588|FG001|Overall Study|Discontinued|4|||
150082764|NCT00684307|541445589|FG000|Overall Study|Adverse Event|11|||
150082765|NCT00684307|541445590|FG001|Overall Study|Adverse Event|6|||
150082766|NCT00684307|541445591|FG002|Overall Study|Adverse Event|15|||
150082767|NCT00684307|541445592|FG003|Overall Study|Adverse Event|16|||
150082768|NCT00684307|541445593|FG004|Overall Study|Adverse Event|8|||
150082769|NCT00684307|541445589|FG000|Overall Study|Development of increasing Liver Function|0|||
150082770|NCT00684307|541445590|FG001|Overall Study|Development of increasing Liver Function|2|||
150082771|NCT00684307|541445591|FG002|Overall Study|Development of increasing Liver Function|0|||
150082772|NCT00684307|541445592|FG003|Overall Study|Development of increasing Liver Function|1|||
150082773|NCT00684307|541445593|FG004|Overall Study|Development of increasing Liver Function|0|||
150082774|NCT00684307|541445589|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
150082775|NCT00684307|541445590|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
150082776|NCT00684307|541445591|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
150082777|NCT00684307|541445592|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
150082778|NCT00684307|541445593|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
150082779|NCT00684307|541445589|FG000|Overall Study|Incorrect enrolment or randomization|4|||
150082780|NCT00684307|541445590|FG001|Overall Study|Incorrect enrolment or randomization|0|||
150082781|NCT00684307|541445591|FG002|Overall Study|Incorrect enrolment or randomization|0|||
150082782|NCT00684307|541445592|FG003|Overall Study|Incorrect enrolment or randomization|0|||
150082783|NCT00684307|541445593|FG004|Overall Study|Incorrect enrolment or randomization|0|||
150082784|NCT00684307|541445589|FG000|Overall Study|Interupted IP for more than 7 days|0|||
150082785|NCT00684307|541445590|FG001|Overall Study|Interupted IP for more than 7 days|4|||
150082786|NCT00684307|541445591|FG002|Overall Study|Interupted IP for more than 7 days|1|||
150082787|NCT00684307|541445592|FG003|Overall Study|Interupted IP for more than 7 days|3|||
150082788|NCT00684307|541445593|FG004|Overall Study|Interupted IP for more than 7 days|3|||
150082789|NCT00684307|541445589|FG000|Overall Study|Severe non compliance to protocol|1|||
150082790|NCT00684307|541445590|FG001|Overall Study|Severe non compliance to protocol|0|||
150082791|NCT00684307|541445591|FG002|Overall Study|Severe non compliance to protocol|0|||
150082792|NCT00684307|541445592|FG003|Overall Study|Severe non compliance to protocol|1|||
150082793|NCT00684307|541445593|FG004|Overall Study|Severe non compliance to protocol|2|||
150082794|NCT00684307|541445589|FG000|Overall Study|Participant not willing to continue|7|||
150082795|NCT00684307|541445590|FG001|Overall Study|Participant not willing to continue|10|||
150082796|NCT00684307|541445591|FG002|Overall Study|Participant not willing to continue|11|||
150082797|NCT00684307|541445592|FG003|Overall Study|Participant not willing to continue|5|||
150082798|NCT00684307|541445593|FG004|Overall Study|Participant not willing to continue|8|||
150082799|NCT00684307|541445589|FG000|Overall Study|Criteria from the CSR|0|||
150082800|NCT00684307|541445590|FG001|Overall Study|Criteria from the CSR|0|||
150082801|NCT00684307|541445591|FG002|Overall Study|Criteria from the CSR|1|||
150082802|NCT00684307|541445592|FG003|Overall Study|Criteria from the CSR|3|||
150082803|NCT00684307|541445593|FG004|Overall Study|Criteria from the CSR|3|||
150082804|NCT01029795|541445600|FG000|Overall Study|Entry Criteria Not Met|2|||
150082805|NCT01029795|541445601|FG001|Overall Study|Entry Criteria Not Met|1|||
150082806|NCT01029795|541445600|FG000|Overall Study|Physician Decision|2|||
150082807|NCT01029795|541445601|FG001|Overall Study|Physician Decision|1|||
150082808|NCT01029795|541445600|FG000|Overall Study|Sponsor Decision|11|||
150082809|NCT01029795|541445601|FG001|Overall Study|Sponsor Decision|17|||
150082810|NCT01029795|541445600|FG000|Overall Study|Withdrawal by Subject|1|||
150082811|NCT01029795|541445601|FG001|Overall Study|Withdrawal by Subject|3|||
150082812|NCT01806545|541445602|FG000|Overall Study|Adverse Event|2|||
150082813|NCT01806545|541445603|FG001|Overall Study|Adverse Event|3|||
150082814|NCT01806545|541445602|FG000|Overall Study|Lost to Follow-up|1|||
150082815|NCT01806545|541445603|FG001|Overall Study|Lost to Follow-up|0|||
150082816|NCT01806545|541445602|FG000|Overall Study|Withdrawal by Subject|3|||
150082817|NCT01806545|541445603|FG001|Overall Study|Withdrawal by Subject|2|||
150082818|NCT00884312|541445604|FG000|Overall Study|Non-fatal Progressive Disease|0|||
150082819|NCT00884312|541445605|FG001|Overall Study|Non-fatal Progressive Disease|8|||
150082820|NCT00884312|541445604|FG000|Overall Study|Fatal Progressive Disease|0|||
150082821|NCT00884312|541445605|FG001|Overall Study|Fatal Progressive Disease|1|||
150082822|NCT00884312|541445604|FG000|Overall Study|Non-fatal Adverse Event|1|||
150183059|NCT04424927|541808708|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
150183060|NCT04424927|541808709|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
150183061|NCT04424927|541808710|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
150183062|NCT04424927|541808706|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
150183063|NCT04424927|541808707|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
150183064|NCT04424927|541808708|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
150183065|NCT04424927|541808709|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
150183066|NCT04424927|541808710|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
150082823|NCT00884312|541445605|FG001|Overall Study|Non-fatal Adverse Event|0|||
150082824|NCT00884312|541445604|FG000|Overall Study|Fatal Adverse Event|1|||
150082825|NCT00884312|541445605|FG001|Overall Study|Fatal Adverse Event|4|||
150082826|NCT00884312|541445604|FG000|Overall Study|Withdrawal by Subject|0|||
150082827|NCT00884312|541445605|FG001|Overall Study|Withdrawal by Subject|6|||
150082828|NCT00884312|541445604|FG000|Overall Study|Physician Decision|0|||
150183067|NCT04424927|541808706|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
150183068|NCT04424927|541808707|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
150183069|NCT04424927|541808708|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
150082829|NCT00884312|541445605|FG001|Overall Study|Physician Decision|1|||
150082830|NCT00884312|541445604|FG000|Overall Study|Other|0|||
150082831|NCT00884312|541445605|FG001|Overall Study|Other|4|||
150082832|NCT00884312|541445604|FG000|Overall Study|Did Not Receive Study Drug|0|||
150082833|NCT00884312|541445605|FG001|Overall Study|Did Not Receive Study Drug|1|||
150082834|NCT00617123|541445606|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
150082835|NCT00617123|541445607|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
150082836|NCT00617123|541445606|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
150082837|NCT00617123|541445607|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
150082838|NCT00617123|541445606|FG000|Referral Screening Period|Adverse Event|0|||
150082839|NCT00617123|541445607|FG001|Referral Screening Period|Adverse Event|1|||
150082840|NCT00617123|541445606|FG000|Study Treatment Period|Withdrawal by Subject|8|||
150082841|NCT00617123|541445607|FG001|Study Treatment Period|Withdrawal by Subject|12|||
150082842|NCT00617123|541445606|FG000|Study Treatment Period|Adverse Event|7|||
150082843|NCT00617123|541445607|FG001|Study Treatment Period|Adverse Event|3|||
150082844|NCT00617123|541445606|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
150082845|NCT00617123|541445607|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
150082846|NCT00617123|541445606|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
150082847|NCT00617123|541445607|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
150082848|NCT00133952|541445609|FG000|Overall Study|Adverse Event|1|||
150082849|NCT00133952|541445610|FG001|Overall Study|Adverse Event|2|||
150082850|NCT00133952|541445609|FG000|Overall Study|Death|3|||
150082851|NCT00133952|541445610|FG001|Overall Study|Death|2|||
150082852|NCT00133952|541445609|FG000|Overall Study|Lost to Follow-up|9|||
150082853|NCT00133952|541445610|FG001|Overall Study|Lost to Follow-up|14|||
150082854|NCT00133952|541445609|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
150082855|NCT00133952|541445610|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
150082856|NCT00133952|541445609|FG000|Overall Study|Protocol Violation|1|||
150082857|NCT00133952|541445610|FG001|Overall Study|Protocol Violation|1|||
150082858|NCT00133952|541445609|FG000|Overall Study|Withdrawal by Subject|20|||
150082859|NCT00133952|541445610|FG001|Overall Study|Withdrawal by Subject|4|||
150082860|NCT00133952|541445609|FG000|Overall Study|Physician Decision|4|||
150082861|NCT00133952|541445610|FG001|Overall Study|Physician Decision|3|||
150082862|NCT00133952|541445609|FG000|Overall Study|Sponsor Decision|0|||
150082863|NCT00133952|541445610|FG001|Overall Study|Sponsor Decision|1|||
150082864|NCT05048784|541445614|FG000|Period 1|Adverse Event|3|||
150082865|NCT05048784|541445615|FG001|Period 1|Adverse Event|1|||
150082866|NCT05048784|541445616|FG002|Period 1|Adverse Event|0|||
150183070|NCT04424927|541808709|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
150183071|NCT04424927|541808710|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
150183072|NCT04424927|541808706|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
150183073|NCT04424927|541808707|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
150183074|NCT04424927|541808708|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
150183075|NCT04424927|541808709|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
150183076|NCT04424927|541808710|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
150183077|NCT04424927|541808706|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
150183078|NCT04424927|541808707|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
150183079|NCT04424927|541808708|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
150183080|NCT04424927|541808709|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
150183081|NCT04424927|541808710|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
150183082|NCT04424927|541808706|FG000|Double-blind Period (24 Weeks)|Other|0|||
150183083|NCT04424927|541808707|FG001|Double-blind Period (24 Weeks)|Other|1|||
150183084|NCT04424927|541808708|FG002|Double-blind Period (24 Weeks)|Other|3|||
150183085|NCT04424927|541808709|FG003|Double-blind Period (24 Weeks)|Other|1|||
150183086|NCT04424927|541808710|FG004|Double-blind Period (24 Weeks)|Other|0|||
150183087|NCT01376700|541808714|FG000|Overall Study|Sponsor terminated study early|8|||
150183088|NCT01376700|541808714|FG000|Overall Study|Low or high titer inhibitor|8|||
150183089|NCT05623345|541808715|FG000|Overall Study|Withdrawal by Subject|14|||
150183090|NCT05623345|541808716|FG001|Overall Study|Withdrawal by Subject|0|||
150183091|NCT05623345|541808717|FG002|Overall Study|Withdrawal by Subject|9|||
150183092|NCT05623345|541808718|FG003|Overall Study|Withdrawal by Subject|20|||
150183093|NCT05623345|541808715|FG000|Overall Study|Lost to Follow-up|3|||
150183094|NCT05623345|541808716|FG001|Overall Study|Lost to Follow-up|0|||
150183095|NCT05623345|541808717|FG002|Overall Study|Lost to Follow-up|7|||
150183096|NCT05623345|541808718|FG003|Overall Study|Lost to Follow-up|2|||
150183097|NCT05623345|541808715|FG000|Overall Study|Termination of Study By Sponsor|37|||
150183098|NCT05623345|541808716|FG001|Overall Study|Termination of Study By Sponsor|4|||
150183099|NCT05623345|541808717|FG002|Overall Study|Termination of Study By Sponsor|40|||
150183100|NCT05623345|541808718|FG003|Overall Study|Termination of Study By Sponsor|38|||
150183101|NCT05384730|541808719|FG000|Overall Study|Adverse Event|1|||
150183102|NCT05384730|541808720|FG001|Overall Study|Adverse Event|0|||
150082867|NCT05048784|541445617|FG003|Period 1|Adverse Event|0|||
150082868|NCT05048784|541445614|FG000|Period 2|Lost to Follow-up|0|||
150082869|NCT05048784|541445615|FG001|Period 2|Lost to Follow-up|1|||
150082870|NCT05048784|541445616|FG002|Period 2|Lost to Follow-up|0|||
150082871|NCT05048784|541445617|FG003|Period 2|Lost to Follow-up|0|||
150082872|NCT02270957|541445620|FG000|Overall Study|Lack of Efficacy|2|||
150082873|NCT02270957|541445621|FG001|Overall Study|Lack of Efficacy|4|||
150082874|NCT02270957|541445620|FG000|Overall Study|Adverse Event|2|||
150082875|NCT02270957|541445621|FG001|Overall Study|Adverse Event|0|||
150082876|NCT03462082|541445625|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082877|NCT03462082|541445626|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082878|NCT03462082|541445627|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082879|NCT03462082|541445628|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082880|NCT03462082|541445629|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082881|NCT03462082|541445630|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
150082882|NCT03462082|541445631|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
150082883|NCT03462082|541445632|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
150082884|NCT00166114|541445637|FG000|Overall Study|Protocol Violation|2|||
150082885|NCT00166114|541445638|FG001|Overall Study|Protocol Violation|1|||
150082886|NCT00166114|541445637|FG000|Overall Study|Withdrawal by Subject|10|||
150082887|NCT00166114|541445638|FG001|Overall Study|Withdrawal by Subject|4|||
150082888|NCT00166114|541445637|FG000|Overall Study|Adverse Event|2|||
150082889|NCT00166114|541445638|FG001|Overall Study|Adverse Event|1|||
150082890|NCT00545168|541445645|FG000|Overall Study|Lost to Follow-up|5|||
150082891|NCT00545168|541445646|FG001|Overall Study|Lost to Follow-up|5|||
150082892|NCT00545168|541445647|FG002|Overall Study|Lost to Follow-up|5|||
150082893|NCT00545168|541445645|FG000|Overall Study|Withdrawal by Subject|9|||
150082894|NCT00545168|541445646|FG001|Overall Study|Withdrawal by Subject|0|||
150082895|NCT00545168|541445647|FG002|Overall Study|Withdrawal by Subject|13|||
150082896|NCT00545168|541445645|FG000|Overall Study|Protocol Violation|1|||
150082897|NCT00545168|541445646|FG001|Overall Study|Protocol Violation|0|||
150082898|NCT00545168|541445647|FG002|Overall Study|Protocol Violation|1|||
150082899|NCT00545168|541445645|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
150082900|NCT00545168|541445646|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
150082901|NCT00545168|541445647|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
150082902|NCT00743340|541445650|FG000|Overall Study|Study medication non-compliance|1|||
150082903|NCT00743340|541445650|FG000|Overall Study|Lost to Follow-up|1|||
150082904|NCT00743340|541445650|FG000|Overall Study|Withdrawal from the Study|5|||
150082905|NCT00743340|541445650|FG000|Overall Study|Protocol Violation|1|||
150082906|NCT00743340|541445650|FG000|Overall Study|Virologic failure|8|||
150082907|NCT00743340|541445650|FG000|Overall Study|Pregnancy|1|||
150082908|NCT00743340|541445650|FG000|Overall Study|Rolled over to other Gilead Study|23|||
150082909|NCT00743340|541445650|FG000|Overall Study|Participant Relocated|1|||
150082910|NCT03266107|541445657|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
150082911|NCT03266107|541445657|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
150082912|NCT03266107|541445657|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
150082913|NCT03266107|541445657|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
150082914|NCT02548650|541445660|FG000|Triple Therapy|Adverse Event|1|||
150082915|NCT02548650|541445661|FG001|Triple Therapy|Adverse Event|0|||
150082916|NCT02548650|541445660|FG000|Triple Therapy|Withdrawal by Subject|0|||
150082917|NCT02548650|541445661|FG001|Triple Therapy|Withdrawal by Subject|4|||
150082918|NCT02548650|541445660|FG000|Double Therapy|Adverse Event|1|||
150082919|NCT02548650|541445661|FG001|Double Therapy|Adverse Event|1|||
150082920|NCT02548650|541445660|FG000|Double Therapy|Withdrawal by Subject|0|||
150082921|NCT02548650|541445661|FG001|Double Therapy|Withdrawal by Subject|1|||
150082922|NCT02128113|541445663|FG000|Overall Study|Withdrawal by Subject|3|||
150082923|NCT02128113|541445664|FG001|Overall Study|Withdrawal by Subject|1|||
150082924|NCT02128113|541445665|FG002|Overall Study|Withdrawal by Subject|0|||
150082925|NCT02128113|541445663|FG000|Overall Study|Protocol Violation|0|||
150082926|NCT02128113|541445664|FG001|Overall Study|Protocol Violation|1|||
150082927|NCT02128113|541445665|FG002|Overall Study|Protocol Violation|0|||
150082928|NCT02128113|541445663|FG000|Overall Study|Surgery cancelled|0|||
150082929|NCT02128113|541445664|FG001|Overall Study|Surgery cancelled|1|||
150082930|NCT02128113|541445665|FG002|Overall Study|Surgery cancelled|0|||
150082931|NCT02128113|541445663|FG000|Overall Study|Adverse Event|0|||
150082932|NCT02128113|541445664|FG001|Overall Study|Adverse Event|0|||
150183103|NCT05384730|541808719|FG000|Overall Study|Lack of social support|2|||
150183104|NCT05384730|541808720|FG001|Overall Study|Lack of social support|0|||
150183105|NCT05384730|541808719|FG000|Overall Study|Hospital readmission|2|||
150183106|NCT05384730|541808720|FG001|Overall Study|Hospital readmission|0|||
150183107|NCT05384730|541808719|FG000|Overall Study|Disease progression|5|||
150183108|NCT05384730|541808720|FG001|Overall Study|Disease progression|0|||
150183109|NCT05384730|541808719|FG000|Overall Study|Overwhelmed with College commitments|0|||
150183110|NCT05384730|541808720|FG001|Overall Study|Overwhelmed with College commitments|2|||
150082933|NCT02128113|541445665|FG002|Overall Study|Adverse Event|1|||
150082934|NCT00299104|541445666|FG000|Treatment Period|Adverse Event|14|||
150082935|NCT00299104|541445667|FG001|Treatment Period|Adverse Event|9|||
150082936|NCT00299104|541445668|FG002|Treatment Period|Adverse Event|7|||
150082937|NCT00299104|541445666|FG000|Treatment Period|Death|1|||
150082938|NCT00299104|541445667|FG001|Treatment Period|Death|1|||
150082939|NCT00299104|541445668|FG002|Treatment Period|Death|1|||
150082940|NCT00299104|541445666|FG000|Treatment Period|Insufficient therapeutic response|34|||
150082941|NCT00299104|541445667|FG001|Treatment Period|Insufficient therapeutic response|13|||
150082942|NCT00299104|541445668|FG002|Treatment Period|Insufficient therapeutic response|8|||
150082943|NCT00299104|541445666|FG000|Treatment Period|Failure to return|9|||
150082944|NCT00299104|541445667|FG001|Treatment Period|Failure to return|8|||
150082945|NCT00299104|541445668|FG002|Treatment Period|Failure to return|8|||
150082946|NCT00299104|541445666|FG000|Treatment Period|Violation of selection criteria|1|||
150082947|NCT00299104|541445667|FG001|Treatment Period|Violation of selection criteria|2|||
150082948|NCT00299104|541445668|FG002|Treatment Period|Violation of selection criteria|0|||
150082949|NCT00299104|541445666|FG000|Treatment Period|Protocol Violation|1|||
150082950|NCT00299104|541445667|FG001|Treatment Period|Protocol Violation|1|||
150082951|NCT00299104|541445668|FG002|Treatment Period|Protocol Violation|0|||
150082952|NCT00299104|541445666|FG000|Treatment Period|Refused treatment|9|||
150082953|NCT00299104|541445667|FG001|Treatment Period|Refused treatment|2|||
150082954|NCT00299104|541445668|FG002|Treatment Period|Refused treatment|2|||
150082955|NCT00299104|541445666|FG000|Treatment Period|Withdrew consent|14|||
150082956|NCT00299104|541445667|FG001|Treatment Period|Withdrew consent|19|||
150082957|NCT00299104|541445668|FG002|Treatment Period|Withdrew consent|9|||
150082958|NCT00299104|541445666|FG000|Treatment Period|Administrative reasons|106|||
150082959|NCT00299104|541445667|FG001|Treatment Period|Administrative reasons|120|||
150082960|NCT00299104|541445668|FG002|Treatment Period|Administrative reasons|137|||
150082961|NCT00299104|541445666|FG000|Safety Follow-Up (SFU) Period|Death|3|||
150082962|NCT00299104|541445667|FG001|Safety Follow-Up (SFU) Period|Death|2|||
150082963|NCT00299104|541445668|FG002|Safety Follow-Up (SFU) Period|Death|1|||
150082964|NCT00299104|541445666|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
150082965|NCT00299104|541445667|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
150082966|NCT00299104|541445668|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
150082967|NCT00299104|541445666|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
150082968|NCT00299104|541445667|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
150082969|NCT00299104|541445668|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
150082970|NCT00299104|541445666|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
150082971|NCT00299104|541445667|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
150082972|NCT00299104|541445668|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
150082973|NCT00299104|541445666|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
150082974|NCT00299104|541445667|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
150082975|NCT00299104|541445668|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
150082976|NCT00299104|541445666|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
150082977|NCT00299104|541445667|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
150082978|NCT00299104|541445668|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
150082979|NCT00299104|541445666|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
150082980|NCT00299104|541445667|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
150082981|NCT00299104|541445668|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
150082982|NCT00299104|541445666|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
150082983|NCT00299104|541445667|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
150082984|NCT00299104|541445668|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
150082985|NCT02244606|541445681|FG000|Overall Study|Adverse Event|0|||
150082986|NCT02244606|541445682|FG001|Overall Study|Adverse Event|1|||
150082987|NCT02244606|541445683|FG002|Overall Study|Adverse Event|1|||
150082988|NCT02244606|541445684|FG003|Overall Study|Adverse Event|0|||
150082989|NCT02244606|541445681|FG000|Overall Study|Lost to Follow-up|2|||
150082990|NCT02244606|541445682|FG001|Overall Study|Lost to Follow-up|2|||
150082991|NCT02244606|541445683|FG002|Overall Study|Lost to Follow-up|1|||
150082992|NCT02244606|541445684|FG003|Overall Study|Lost to Follow-up|0|||
150082993|NCT02244606|541445681|FG000|Overall Study|Protocol Violation|0|||
150082994|NCT02244606|541445682|FG001|Overall Study|Protocol Violation|0|||
150082995|NCT02244606|541445683|FG002|Overall Study|Protocol Violation|0|||
150082996|NCT02244606|541445684|FG003|Overall Study|Protocol Violation|1|||
150082997|NCT02244606|541445681|FG000|Overall Study|Withdrawal by Subject|1|||
150082998|NCT02244606|541445682|FG001|Overall Study|Withdrawal by Subject|1|||
150082999|NCT02244606|541445683|FG002|Overall Study|Withdrawal by Subject|0|||
150083000|NCT02244606|541445684|FG003|Overall Study|Withdrawal by Subject|0|||
150083001|NCT02244606|541445681|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
150183111|NCT03732820|541808721|FG000|Overall Study|Death|168|||
150083002|NCT02244606|541445682|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
150083003|NCT02244606|541445683|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
150083004|NCT02244606|541445684|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
150083005|NCT01402492|541445685|FG000|Overall Study|Withdrawal by Subject|17|||
150183112|NCT03732820|541808722|FG001|Overall Study|Death|203|||
150083006|NCT01402492|541445686|FG001|Overall Study|Withdrawal by Subject|11|||
150083007|NCT01402492|541445687|FG002|Overall Study|Withdrawal by Subject|11|||
150083008|NCT01402492|541445685|FG000|Overall Study|Adverse Event|2|||
150083009|NCT01402492|541445686|FG001|Overall Study|Adverse Event|3|||
150083010|NCT01402492|541445687|FG002|Overall Study|Adverse Event|4|||
150083011|NCT01402492|541445685|FG000|Overall Study|Physician Decision|0|||
150083012|NCT01402492|541445686|FG001|Overall Study|Physician Decision|3|||
150083013|NCT01402492|541445687|FG002|Overall Study|Physician Decision|0|||
150083014|NCT01402492|541445685|FG000|Overall Study|Incarcerated (N=3)|2|||
150083015|NCT01402492|541445686|FG001|Overall Study|Incarcerated (N=3)|0|||
150083016|NCT01402492|541445687|FG002|Overall Study|Incarcerated (N=3)|1|||
150083017|NCT00982878|541445689|FG000|Overall Study|Physician Decision|1|||
150083018|NCT01336764|541445694|FG000|Overall Study|Withdrawal by Subject|5|||
150083019|NCT01336764|541445695|FG001|Overall Study|Withdrawal by Subject|5|||
150083020|NCT01626391|541445696|FG000|Overall Study|Physician Decision|1|||
150083021|NCT01626391|541445697|FG001|Overall Study|Physician Decision|0|||
150083022|NCT01626391|541445696|FG000|Overall Study|Withdrawal by Subject|1|||
150083023|NCT01626391|541445697|FG001|Overall Study|Withdrawal by Subject|0|||
150083024|NCT02573311|541445698|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
150083025|NCT02573311|541445699|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
150083026|NCT02573311|541445698|FG000|Disposition for Part 2|Physician Decision|25|||
150083027|NCT02573311|541445699|FG001|Disposition for Part 2|Physician Decision|7|||
150083028|NCT02573311|541445698|FG000|Disposition for Part 2|Adverse Event|36|||
150083029|NCT02573311|541445699|FG001|Disposition for Part 2|Adverse Event|5|||
150083030|NCT02573311|541445698|FG000|Disposition for Part 2|Lost to Follow-up|76|||
150083031|NCT02573311|541445699|FG001|Disposition for Part 2|Lost to Follow-up|7|||
150083032|NCT02573311|541445698|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
150083033|NCT02573311|541445699|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
150083034|NCT02573311|541445698|FG000|Disposition for Part 2|Investigator decision|0|||
150083035|NCT02573311|541445699|FG001|Disposition for Part 2|Investigator decision|1|||
150083036|NCT02573311|541445698|FG000|Disposition for Part 2|Other than specified above|13|||
150083037|NCT02573311|541445699|FG001|Disposition for Part 2|Other than specified above|3|||
150083038|NCT05537883|541445700|FG000|Overall Study|revisional surgery|4|||
150083039|NCT05537883|541445701|FG001|Overall Study|revisional surgery|2|||
150083040|NCT05537883|541445700|FG000|Overall Study|surgeries were cancelled|0|||
150083041|NCT05537883|541445701|FG001|Overall Study|surgeries were cancelled|2|||
150083042|NCT05537883|541445700|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
150083043|NCT05537883|541445701|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
150083044|NCT02099708|541445702|FG000|Overall Study|Data Not Available|30|||
150083045|NCT02099708|541445702|FG000|Overall Study|Lost to Follow-up|141|||
150083046|NCT02099708|541445702|FG000|Overall Study|Other|29|||
150083047|NCT05229406|541445703|FG000|Overall Study|Withdrawal by Subject|1|||
150083048|NCT05229406|541445704|FG001|Overall Study|Withdrawal by Subject|2|||
150083049|NCT01370356|541445709|FG000|Overall Study|Death|1|||
150083050|NCT01370356|541445710|FG001|Overall Study|Death|0|||
150083051|NCT01370356|541445709|FG000|Overall Study|Lack of Efficacy|6|||
150083052|NCT01370356|541445710|FG001|Overall Study|Lack of Efficacy|28|||
150083053|NCT01370356|541445709|FG000|Overall Study|Lost to Follow-up|76|||
150083054|NCT01370356|541445710|FG001|Overall Study|Lost to Follow-up|81|||
150083055|NCT01370356|541445709|FG000|Overall Study|Withdrawal by Subject|54|||
150083056|NCT01370356|541445710|FG001|Overall Study|Withdrawal by Subject|59|||
150083057|NCT01370356|541445709|FG000|Overall Study|Reason not specified|39|||
150083058|NCT01370356|541445710|FG001|Overall Study|Reason not specified|43|||
150083059|NCT01370356|541445709|FG000|Overall Study|Protocol Violation|3|||
150083060|NCT01370356|541445710|FG001|Overall Study|Protocol Violation|3|||
150083061|NCT01370356|541445709|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
150083062|NCT01370356|541445710|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
150083063|NCT01370356|541445709|FG000|Overall Study|AE Not Related to Study Drug|1|||
150083064|NCT01370356|541445710|FG001|Overall Study|AE Not Related to Study Drug|4|||
150083065|NCT01658072|541445711|FG000|Overall Study|Protocol Violation|4|||
150083066|NCT01658072|541445712|FG001|Overall Study|Protocol Violation|2|||
150083067|NCT00040664|541445713|FG000|Overall Study|Adverse Event|12|||
150083068|NCT00040664|541445714|FG001|Overall Study|Adverse Event|3|||
150083069|NCT00040664|541445715|FG002|Overall Study|Adverse Event|2|||
150083070|NCT00040664|541445716|FG003|Overall Study|Adverse Event|7|||
150083071|NCT00040664|541445713|FG000|Overall Study|Lack of Efficacy|9|||
150083072|NCT00040664|541445714|FG001|Overall Study|Lack of Efficacy|2|||
150083073|NCT00040664|541445715|FG002|Overall Study|Lack of Efficacy|3|||
150083074|NCT00040664|541445716|FG003|Overall Study|Lack of Efficacy|4|||
150083075|NCT00040664|541445713|FG000|Overall Study|Insufficient CD4 response|1|||
150083076|NCT00040664|541445714|FG001|Overall Study|Insufficient CD4 response|0|||
150083077|NCT00040664|541445715|FG002|Overall Study|Insufficient CD4 response|1|||
150083078|NCT00040664|541445716|FG003|Overall Study|Insufficient CD4 response|0|||
150083079|NCT00040664|541445713|FG000|Overall Study|Lost to Follow-up|4|||
150083080|NCT00040664|541445714|FG001|Overall Study|Lost to Follow-up|2|||
150083081|NCT00040664|541445715|FG002|Overall Study|Lost to Follow-up|0|||
150083082|NCT00040664|541445716|FG003|Overall Study|Lost to Follow-up|2|||
150083083|NCT00040664|541445713|FG000|Overall Study|Protocol Violation|2|||
150083084|NCT00040664|541445714|FG001|Overall Study|Protocol Violation|1|||
150083085|NCT00040664|541445715|FG002|Overall Study|Protocol Violation|0|||
150083086|NCT00040664|541445716|FG003|Overall Study|Protocol Violation|1|||
150083087|NCT00040664|541445713|FG000|Overall Study|Withdrawal by Subject|7|||
150083088|NCT00040664|541445714|FG001|Overall Study|Withdrawal by Subject|0|||
150083089|NCT00040664|541445715|FG002|Overall Study|Withdrawal by Subject|3|||
150083090|NCT00040664|541445716|FG003|Overall Study|Withdrawal by Subject|4|||
150083091|NCT00040664|541445713|FG000|Overall Study|Pregnancy|3|||
150083092|NCT00040664|541445714|FG001|Overall Study|Pregnancy|0|||
150083093|NCT00040664|541445715|FG002|Overall Study|Pregnancy|0|||
150083094|NCT00040664|541445716|FG003|Overall Study|Pregnancy|3|||
150083095|NCT00040664|541445713|FG000|Overall Study|Medication adherence/compliance problems|8|||
150083096|NCT00040664|541445714|FG001|Overall Study|Medication adherence/compliance problems|2|||
150083097|NCT00040664|541445715|FG002|Overall Study|Medication adherence/compliance problems|1|||
150083098|NCT00040664|541445716|FG003|Overall Study|Medication adherence/compliance problems|5|||
150083099|NCT00040664|541445713|FG000|Overall Study|Poor taste|2|||
150083100|NCT00040664|541445714|FG001|Overall Study|Poor taste|0|||
150083101|NCT00040664|541445715|FG002|Overall Study|Poor taste|2|||
150083102|NCT00040664|541445716|FG003|Overall Study|Poor taste|0|||
150083103|NCT00040664|541445713|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
150083104|NCT00040664|541445714|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
150083105|NCT00040664|541445715|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
150083106|NCT00040664|541445716|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
150083107|NCT00040664|541445713|FG000|Overall Study|Change of formulation|2|||
150083108|NCT00040664|541445714|FG001|Overall Study|Change of formulation|2|||
150083109|NCT00040664|541445715|FG002|Overall Study|Change of formulation|0|||
150083110|NCT00040664|541445716|FG003|Overall Study|Change of formulation|0|||
150083111|NCT00040664|541445713|FG000|Overall Study|Non-viability of oral suspension|1|||
150083112|NCT00040664|541445714|FG001|Overall Study|Non-viability of oral suspension|0|||
150083113|NCT00040664|541445715|FG002|Overall Study|Non-viability of oral suspension|1|||
150083114|NCT00040664|541445716|FG003|Overall Study|Non-viability of oral suspension|0|||
150083115|NCT03953820|541445718|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
150083116|NCT03953820|541445719|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
150083117|NCT03953820|541445720|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
150083118|NCT03953820|541445718|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
150083119|NCT03953820|541445719|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
150083120|NCT03953820|541445720|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
150083121|NCT00799422|541445725|FG000|First Week of Wear|Lost to Follow-up|0|||
150083122|NCT00799422|541445726|FG001|First Week of Wear|Lost to Follow-up|0|||
150083123|NCT00799422|541445727|FG002|First Week of Wear|Lost to Follow-up|1|||
150083124|NCT00799422|541445728|FG003|First Week of Wear|Lost to Follow-up|0|||
150083125|NCT00799422|541445729|FG004|First Week of Wear|Lost to Follow-up|0|||
150083126|NCT00799422|541445730|FG005|First Week of Wear|Lost to Follow-up|0|||
150083127|NCT00799422|541445725|FG000|First Week of Wear|Adverse Event|0|||
150083128|NCT00799422|541445726|FG001|First Week of Wear|Adverse Event|0|||
150083129|NCT00799422|541445727|FG002|First Week of Wear|Adverse Event|0|||
150083130|NCT00799422|541445728|FG003|First Week of Wear|Adverse Event|1|||
150083131|NCT00799422|541445729|FG004|First Week of Wear|Adverse Event|0|||
150083132|NCT00799422|541445730|FG005|First Week of Wear|Adverse Event|0|||
150083133|NCT03292588|541447739|FG000|Overall Study|Death|1|||
150083134|NCT03292588|541447740|FG001|Overall Study|Death|0|||
150083135|NCT03292588|541447739|FG000|Overall Study|Lost to Follow-up|12|||
150083136|NCT03292588|541447740|FG001|Overall Study|Lost to Follow-up|16|||
150083137|NCT03292588|541447739|FG000|Overall Study|Physician Decision|0|||
150083138|NCT03292588|541447740|FG001|Overall Study|Physician Decision|1|||
150083139|NCT03292588|541447739|FG000|Overall Study|Withdrawal by Subject|4|||
150083140|NCT03292588|541447740|FG001|Overall Study|Withdrawal by Subject|4|||
150083141|NCT03292588|541447739|FG000|Overall Study|Move out of town|1|||
150083142|NCT03292588|541447740|FG001|Overall Study|Move out of town|0|||
150083143|NCT03292588|541447739|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
150083144|NCT03292588|541447740|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
150083145|NCT03761277|541447741|FG000|Enrollment to Implant|Screen Failure|17|||
150083146|NCT03761277|541447741|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
150083147|NCT03761277|541447741|FG000|Enrollment to Implant|Physician Decision|2|||
150083148|NCT03761277|541447741|FG000|Enrollment to Implant|Site Closure|3|||
150083149|NCT03761277|541447741|FG000|Enrollment to Implant|Sponsor Request|2|||
150083150|NCT03761277|541447741|FG000|Post-Implant to 6 Months|Adverse Event|2|||
150083151|NCT03761277|541447741|FG000|Post-Implant to 6 Months|Death|1|||
150083152|NCT03761277|541447741|FG000|Post-Implant to 6 Months|Site Closure|2|||
150083153|NCT03761277|541447741|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
150083154|NCT03761277|541447741|FG000|6 Months to 12 Months|Physician Decision|2|||
150083155|NCT03761277|541447741|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
150083156|NCT00759031|541447742|FG000|First Intervention (1 Day)|Physician Decision|1|||
150083157|NCT00759031|541447743|FG001|First Intervention (1 Day)|Physician Decision|0|||
150083158|NCT00759031|541447742|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
150083159|NCT00759031|541447743|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
150083160|NCT00759031|541447742|FG000|First Intervention (1 Day)|Screening failure|1|||
150083161|NCT00759031|541447743|FG001|First Intervention (1 Day)|Screening failure|0|||
150083162|NCT00543140|541447744|FG000|Overall Study|Lost to Follow-up|33|||
150083163|NCT00543140|541447744|FG000|Overall Study|Withdrawal by Subject|13|||
150083164|NCT00543140|541447744|FG000|Overall Study|Protocol Violation|10|||
150083165|NCT00543140|541447744|FG000|Overall Study|Insufficient weight loss|10|||
150083166|NCT00543140|541447744|FG000|Overall Study|SAE leading to explant of SAGB|3|||
150083167|NCT00543140|541447744|FG000|Overall Study|Death|1|||
150083168|NCT00543140|541447744|FG000|Overall Study|Subject moved|1|||
150083169|NCT00543140|541447744|FG000|Overall Study|Conversion to different procedure|1|||
150083170|NCT00578812|541447745|FG000|Overall Study|Not treated|6|||
150083171|NCT00578812|541447746|FG001|Overall Study|Not treated|7|||
150083172|NCT00309387|541447748|FG000|Overall Study|Death|72|||
150083173|NCT00309387|541447749|FG001|Overall Study|Death|73|||
150083174|NCT00309387|541447748|FG000|Overall Study|Lost to Follow-up|70|||
150083175|NCT00309387|541447749|FG001|Overall Study|Lost to Follow-up|86|||
150083176|NCT04532164|541447750|FG000|Overall Study|Adverse Event|1|||
150083177|NCT04532164|541447750|FG000|Overall Study|Protocol Violation|5|||
150083178|NCT04532164|541447750|FG000|Overall Study|Lost to Follow-up|1|||
150083179|NCT04532164|541447750|FG000|Overall Study|Found to be Ineligible|3|||
150083180|NCT04532164|541447750|FG000|Overall Study|Withdrawal by Subject|14|||
150083181|NCT02483520|541447751|FG000|Overall Study|Lost to Follow-up|3|||
150083182|NCT02483520|541447752|FG001|Overall Study|Lost to Follow-up|4|||
150083183|NCT02483520|541447751|FG000|Overall Study|Withdrawal by Subject|4|||
150083184|NCT02483520|541447752|FG001|Overall Study|Withdrawal by Subject|14|||
150083185|NCT02483520|541447751|FG000|Overall Study|Hospitalized|2|||
150083186|NCT02483520|541447752|FG001|Overall Study|Hospitalized|3|||
150083187|NCT02483520|541447751|FG000|Overall Study|Moved to LTC|2|||
150083188|NCT02483520|541447752|FG001|Overall Study|Moved to LTC|3|||
150083189|NCT01104493|541447753|FG000|Overall Study|Lost to Follow-up|0|||
150083190|NCT01104493|541447754|FG001|Overall Study|Lost to Follow-up|2|||
150083191|NCT01342796|541447756|FG000|Overall Study|Withdrawal by Subject|2|||
150083192|NCT01342796|541447757|FG001|Overall Study|Withdrawal by Subject|0|||
150083193|NCT01342796|541447756|FG000|Overall Study|Lost to Follow-up|0|||
150083194|NCT01342796|541447757|FG001|Overall Study|Lost to Follow-up|3|||
150083195|NCT01342796|541447756|FG000|Overall Study|Inappropriate enrollment|1|||
150083196|NCT01342796|541447757|FG001|Overall Study|Inappropriate enrollment|0|||
150083197|NCT01599234|541447758|FG000|Overall Study|Adverse Event|9|||
150083198|NCT01599234|541447759|FG001|Overall Study|Adverse Event|5|||
150083199|NCT01599234|541447758|FG000|Overall Study|Withdrawal by Subject|2|||
150083200|NCT01599234|541447759|FG001|Overall Study|Withdrawal by Subject|1|||
150083201|NCT01599234|541447758|FG000|Overall Study|Lost to Follow-up|1|||
150083202|NCT01599234|541447759|FG001|Overall Study|Lost to Follow-up|2|||
150083203|NCT01599234|541447758|FG000|Overall Study|Lack of Efficacy|2|||
150083204|NCT01599234|541447759|FG001|Overall Study|Lack of Efficacy|4|||
150083205|NCT01599234|541447758|FG000|Overall Study|Unable to operate spray|1|||
150083206|NCT01599234|541447759|FG001|Overall Study|Unable to operate spray|0|||
150083207|NCT01599234|541447758|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
150083208|NCT01599234|541447759|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
150083209|NCT01599234|541447758|FG000|Overall Study|Death|1|||
150083210|NCT01599234|541447759|FG001|Overall Study|Death|0|||
150083211|NCT01599234|541447758|FG000|Overall Study|Patient would not stop driving|1|||
150083212|NCT01599234|541447759|FG001|Overall Study|Patient would not stop driving|0|||
150083213|NCT01599234|541447758|FG000|Overall Study|Contra-indication discovered|0|||
150083214|NCT01599234|541447759|FG001|Overall Study|Contra-indication discovered|1|||
150083215|NCT01599234|541447758|FG000|Overall Study|Pregnancy|0|||
150083216|NCT01599234|541447759|FG001|Overall Study|Pregnancy|1|||
150083217|NCT03489720|541447771|FG000|Overall Study|Withdrawal by Subject|2|||
150083218|NCT03489720|541447772|FG001|Overall Study|Withdrawal by Subject|0|||
150083219|NCT02269241|541447785|FG000|Overall Study|Lost to Follow-up|269|||
150083220|NCT02269241|541447785|FG000|Overall Study|Withdrawal by Subject|155|||
150083221|NCT02269241|541447785|FG000|Overall Study|Protocol Violation|1|||
150083222|NCT02269241|541447785|FG000|Overall Study|Physician Decision|7|||
150083223|NCT02269241|541447785|FG000|Overall Study|Pregnancy|15|||
150083224|NCT02269241|541447785|FG000|Overall Study|Wish for pregnancy|5|||
150083225|NCT02269241|541447785|FG000|Overall Study|Development of an exclusion criteria|16|||
150083226|NCT02269241|541447785|FG000|Overall Study|Adverse Event|113|||
150083227|NCT02269241|541447785|FG000|Overall Study|At the specific request of the sponsor|20|||
150083228|NCT02269241|541447785|FG000|Overall Study|Several reasons not classified|53|||
150083229|NCT02269241|541447785|FG000|Overall Study|Screening failures|546|||
150083230|NCT03020160|541447786|FG000|Overall Study|Withdrawal by Subject|1|||
150083231|NCT03020160|541447787|FG001|Overall Study|Withdrawal by Subject|0|||
150083232|NCT01513473|541447788|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
150083233|NCT01513473|541447789|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
150083234|NCT01513473|541447788|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
150083235|NCT01513473|541447789|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
150083236|NCT01513473|541447788|FG000|Main Trial (26 Weeks)|Unclassified|0|||
150083237|NCT01513473|541447789|FG001|Main Trial (26 Weeks)|Unclassified|2|||
150083238|NCT01513473|541447788|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
150083239|NCT01513473|541447789|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
150083240|NCT01513473|541447788|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
150083241|NCT01513473|541447789|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
150083242|NCT04166435|541447790|FG000|Overall Study|2 patients ineligible for response|2|||
150083243|NCT01218204|541447791|FG000|Part B Washout|Adverse Event|0|||
150083244|NCT01218204|541447792|FG001|Part B Washout|Adverse Event|1|||
150083245|NCT01218204|541447793|FG002|Part B Washout|Adverse Event|0|||
150083246|NCT01218204|541447794|FG003|Part B Washout|Adverse Event|0|||
150083247|NCT01218204|541447791|FG000|Part B Washout|Lost to Follow-up|0|||
150083248|NCT01218204|541447792|FG001|Part B Washout|Lost to Follow-up|2|||
150083249|NCT01218204|541447793|FG002|Part B Washout|Lost to Follow-up|0|||
150083250|NCT01218204|541447794|FG003|Part B Washout|Lost to Follow-up|0|||
150083251|NCT01218204|541447791|FG000|Part B Washout|Physician Decision|0|||
150083252|NCT01218204|541447792|FG001|Part B Washout|Physician Decision|14|||
150083253|NCT01218204|541447793|FG002|Part B Washout|Physician Decision|0|||
150083254|NCT01218204|541447794|FG003|Part B Washout|Physician Decision|0|||
150083255|NCT01218204|541447791|FG000|Part B Washout|Withdrawal by Subject|0|||
150083256|NCT01218204|541447792|FG001|Part B Washout|Withdrawal by Subject|14|||
150083257|NCT01218204|541447793|FG002|Part B Washout|Withdrawal by Subject|0|||
150083258|NCT01218204|541447794|FG003|Part B Washout|Withdrawal by Subject|0|||
150083259|NCT01218204|541447791|FG000|Part B Washout|Reached defined stopping criteria|0|||
150083260|NCT01218204|541447792|FG001|Part B Washout|Reached defined stopping criteria|2|||
150083261|NCT01218204|541447793|FG002|Part B Washout|Reached defined stopping criteria|0|||
150083262|NCT01218204|541447794|FG003|Part B Washout|Reached defined stopping criteria|0|||
150083263|NCT01218204|541447791|FG000|Part B Washout|Did not meet continuation criteria|0|||
150083264|NCT01218204|541447792|FG001|Part B Washout|Did not meet continuation criteria|112|||
150083265|NCT01218204|541447793|FG002|Part B Washout|Did not meet continuation criteria|0|||
150083266|NCT01218204|541447794|FG003|Part B Washout|Did not meet continuation criteria|0|||
150083267|NCT01218204|541447791|FG000|Part B Run-in|Adverse Event|0|||
150083268|NCT01218204|541447792|FG001|Part B Run-in|Adverse Event|0|||
150083269|NCT01218204|541447793|FG002|Part B Run-in|Adverse Event|1|||
150083270|NCT01218204|541447794|FG003|Part B Run-in|Adverse Event|0|||
150083271|NCT01218204|541447791|FG000|Part B Run-in|Protocol Violation|0|||
150083272|NCT01218204|541447792|FG001|Part B Run-in|Protocol Violation|0|||
150083273|NCT01218204|541447793|FG002|Part B Run-in|Protocol Violation|2|||
150083274|NCT01218204|541447794|FG003|Part B Run-in|Protocol Violation|0|||
150083275|NCT01218204|541447791|FG000|Part B Run-in|Withdrawal by Subject|0|||
150083276|NCT01218204|541447792|FG001|Part B Run-in|Withdrawal by Subject|0|||
150083277|NCT01218204|541447793|FG002|Part B Run-in|Withdrawal by Subject|3|||
150083278|NCT01218204|541447794|FG003|Part B Run-in|Withdrawal by Subject|0|||
150083279|NCT01218204|541447791|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
150083280|NCT01218204|541447792|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
150083281|NCT01218204|541447793|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
150083282|NCT01218204|541447794|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
150083283|NCT01218204|541447791|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
150083284|NCT01218204|541447792|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
150083285|NCT01218204|541447793|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
150083286|NCT01218204|541447794|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
150083287|NCT00127660|541447795|FG000|Overall Study|Protocol Violation|3|||
150083288|NCT00127660|541447796|FG001|Overall Study|Protocol Violation|3|||
150083289|NCT00127660|541447797|FG002|Overall Study|Protocol Violation|5|||
150083290|NCT00127660|541447798|FG003|Overall Study|Protocol Violation|0|||
150083291|NCT01833520|541447799|FG000|Overall Study|Lack of Efficacy|3|||
150083292|NCT01833520|541447800|FG001|Overall Study|Lack of Efficacy|3|||
150083293|NCT01833520|541447801|FG002|Overall Study|Lack of Efficacy|8|||
150083294|NCT01833520|541447802|FG003|Overall Study|Lack of Efficacy|3|||
150083295|NCT00489541|541447803|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
150083296|NCT00489541|541447804|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
150083297|NCT00489541|541447803|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
150083298|NCT00489541|541447804|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
150083299|NCT00489541|541447803|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
150083300|NCT00489541|541447804|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
150083301|NCT00489541|541447803|FG000|12-Month Clinical Follow-up|Death|3|||
150083302|NCT00489541|541447804|FG001|12-Month Clinical Follow-up|Death|2|||
150083303|NCT00489541|541447803|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
150083304|NCT00489541|541447804|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
150083305|NCT00489541|541447803|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
150083306|NCT00489541|541447804|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
150083307|NCT05131646|541447805|FG000|Overall Study|Withdrawal by Subject|1|||
150083308|NCT05131646|541447806|FG001|Overall Study|Withdrawal by Subject|0|||
150083309|NCT05131646|541447807|FG002|Overall Study|Withdrawal by Subject|0|||
150083310|NCT01191801|541447812|FG000|Overall Study|Death|36|||
150083311|NCT01191801|541447813|FG001|Overall Study|Death|12|||
150083312|NCT01191801|541447812|FG000|Overall Study|Lack of Efficacy|176|||
150083313|NCT01191801|541447813|FG001|Overall Study|Lack of Efficacy|258|||
150083314|NCT01191801|541447812|FG000|Overall Study|Adverse Event|9|||
150083315|NCT01191801|541447813|FG001|Overall Study|Adverse Event|8|||
150083316|NCT01191801|541447812|FG000|Overall Study|Protocol Violation|2|||
150083317|NCT01191801|541447813|FG001|Overall Study|Protocol Violation|4|||
150083318|NCT01191801|541447812|FG000|Overall Study|Physician Decision|47|||
150083319|NCT01191801|541447813|FG001|Overall Study|Physician Decision|24|||
150083320|NCT01191801|541447812|FG000|Overall Study|Withdrawal by Subject|1|||
150083321|NCT01191801|541447813|FG001|Overall Study|Withdrawal by Subject|4|||
150083322|NCT01191801|541447812|FG000|Overall Study|Not Provided|45|||
150083323|NCT01191801|541447813|FG001|Overall Study|Not Provided|27|||
150083324|NCT00003479|541447814|FG000|Overall Study|Not evaluable|3|||
150083325|NCT02042183|541447816|FG000|Overall Study|Physician Decision|7|||
150083326|NCT02042183|541447817|FG001|Overall Study|Physician Decision|2|||
150083327|NCT02042183|541447816|FG000|Overall Study|Lack of Efficacy|4|||
150083328|NCT02042183|541447817|FG001|Overall Study|Lack of Efficacy|3|||
150083329|NCT02042183|541447816|FG000|Overall Study|Non-compliance with Study Drug|2|||
150083330|NCT02042183|541447817|FG001|Overall Study|Non-compliance with Study Drug|3|||
150083331|NCT02042183|541447816|FG000|Overall Study|Adverse Event|17|||
150083332|NCT02042183|541447817|FG001|Overall Study|Adverse Event|6|||
150083333|NCT02042183|541447816|FG000|Overall Study|Other|3|||
150083334|NCT02042183|541447817|FG001|Overall Study|Other|3|||
150083335|NCT02042183|541447816|FG000|Overall Study|Withdrawal by Subject|21|||
150083336|NCT02042183|541447817|FG001|Overall Study|Withdrawal by Subject|16|||
150083337|NCT02042183|541447816|FG000|Overall Study|Site Terminated by Sponsor|2|||
150083338|NCT02042183|541447817|FG001|Overall Study|Site Terminated by Sponsor|1|||
150083339|NCT02042183|541447816|FG000|Overall Study|Lost to Follow-up|9|||
150083340|NCT02042183|541447817|FG001|Overall Study|Lost to Follow-up|2|||
150083341|NCT01192516|541447818|FG000|Overall Study|Lost to Follow-up|7|||
150083342|NCT01192516|541447819|FG001|Overall Study|Lost to Follow-up|10|||
150083343|NCT01192516|541447820|FG002|Overall Study|Lost to Follow-up|7|||
150083344|NCT01192516|541447818|FG000|Overall Study|Withdrawal by Subject|4|||
150083345|NCT01192516|541447819|FG001|Overall Study|Withdrawal by Subject|4|||
150083346|NCT01192516|541447820|FG002|Overall Study|Withdrawal by Subject|1|||
150083347|NCT01192516|541447818|FG000|Overall Study|started new treatment|5|||
150083348|NCT01192516|541447819|FG001|Overall Study|started new treatment|1|||
150083349|NCT01192516|541447820|FG002|Overall Study|started new treatment|0|||
150083350|NCT01192516|541447818|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
150083351|NCT01192516|541447819|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
150083352|NCT01192516|541447820|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
150083353|NCT02321800|541447823|FG000|Overall Study|Withdrawal by Subject|3|||
150083354|NCT02321800|541447824|FG001|Overall Study|Withdrawal by Subject|3|||
150083355|NCT02321800|541447823|FG000|Overall Study|Death|1|||
150083356|NCT02321800|541447824|FG001|Overall Study|Death|0|||
150083357|NCT02321800|541447823|FG000|Overall Study|Protocol Violation|1|||
150083358|NCT02321800|541447824|FG001|Overall Study|Protocol Violation|0|||
150083359|NCT02321800|541447823|FG000|Overall Study|Lost to Follow-up|10|||
150083360|NCT02321800|541447824|FG001|Overall Study|Lost to Follow-up|4|||
150083361|NCT02321800|541447823|FG000|Overall Study|Adverse Event|2|||
150083362|NCT02321800|541447824|FG001|Overall Study|Adverse Event|3|||
150083363|NCT02321800|541447823|FG000|Overall Study|Other, Miscellaneous|3|||
150083364|NCT02321800|541447824|FG001|Overall Study|Other, Miscellaneous|1|||
150083365|NCT01051323|541447825|FG000|Overall Study|Discontinuation of treatment|103|||
150083366|NCT01051323|541447825|FG000|Overall Study|Transplantation|28|||
150083367|NCT01051323|541447825|FG000|Overall Study|Dialysis dependency|22|||
150083368|NCT01051323|541447825|FG000|Overall Study|Withdrawal by Subject|13|||
150083369|NCT01051323|541447825|FG000|Overall Study|Lost to Follow-up|31|||
150083370|NCT01051323|541447825|FG000|Overall Study|Death|129|||
150083371|NCT01051323|541447825|FG000|Overall Study|Hospitalization|28|||
150083372|NCT01051323|541447825|FG000|Overall Study|Other|148|||
150183113|NCT03732820|541808721|FG000|Overall Study|Other|2|||
150183114|NCT03732820|541808722|FG001|Overall Study|Other|2|||
150083373|NCT01051323|541447825|FG000|Overall Study|Missing|37|||
150083374|NCT04605484|541447829|FG000|Overall Study|Lost to Follow-up|0|||
150083375|NCT04605484|541447830|FG001|Overall Study|Lost to Follow-up|1|||
150083376|NCT04605484|541447831|FG002|Overall Study|Lost to Follow-up|1|||
150083377|NCT04605484|541447829|FG000|Overall Study|Other|0|||
150083378|NCT04605484|541447830|FG001|Overall Study|Other|1|||
150083379|NCT04605484|541447831|FG002|Overall Study|Other|0|||
150083380|NCT04171531|541447832|FG000|Overall Study|Lost to Follow-up|4|||
150083381|NCT04171531|541447833|FG001|Overall Study|Lost to Follow-up|5|||
150083382|NCT04171531|541447832|FG000|Overall Study|Consent only through 6 months|1|||
150083383|NCT04171531|541447833|FG001|Overall Study|Consent only through 6 months|1|||
150083384|NCT04171531|541447832|FG000|Overall Study|Insurance did not cover procedure|0|||
150083385|NCT04171531|541447833|FG001|Overall Study|Insurance did not cover procedure|1|||
150083386|NCT04171531|541447832|FG000|Overall Study|Physician Decision|0|||
150083387|NCT04171531|541447833|FG001|Overall Study|Physician Decision|3|||
150083388|NCT04171531|541447832|FG000|Overall Study|Withdrawal by Subject|1|||
150083389|NCT04171531|541447833|FG001|Overall Study|Withdrawal by Subject|5|||
150083390|NCT04862585|541447837|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
150083391|NCT04862585|541447838|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
150083392|NCT04862585|541447837|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
150083393|NCT04862585|541447838|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
150083394|NCT04862585|541447837|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
150083395|NCT04862585|541447838|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
150083396|NCT04862585|541447837|FG000|Overall Study|one withdrew without providing a reason|0|||
150083397|NCT04862585|541447838|FG001|Overall Study|one withdrew without providing a reason|1|||
150083398|NCT03366337|541447841|FG000|Overall Study|Lost to Follow-up|1|||
150083399|NCT03366337|541447842|FG001|Overall Study|Lost to Follow-up|0|||
150083400|NCT03366337|541447843|FG002|Overall Study|Lost to Follow-up|1|||
150083401|NCT03366337|541447844|FG003|Overall Study|Lost to Follow-up|0|||
150083402|NCT03366337|541447841|FG000|Overall Study|Withdrawal by Subject|2|||
150083403|NCT03366337|541447842|FG001|Overall Study|Withdrawal by Subject|0|||
150083404|NCT03366337|541447843|FG002|Overall Study|Withdrawal by Subject|1|||
150083405|NCT03366337|541447844|FG003|Overall Study|Withdrawal by Subject|1|||
150083406|NCT00880009|541447845|FG000|Overall Study|Study terminated by sponsor|14|||
150083407|NCT00880009|541447845|FG000|Overall Study|Withdrawal by Subject|1|||
150083408|NCT00880009|541447845|FG000|Overall Study|Protocol Violation|1|||
150083409|NCT01217801|541447846|FG000|Period 1|Protocol Violation|1|||
150083410|NCT01217801|541447847|FG001|Period 1|Protocol Violation|1|||
150083411|NCT01217801|541447846|FG000|Period 1|Withdrawal by Subject|0|||
150083412|NCT01217801|541447847|FG001|Period 1|Withdrawal by Subject|1|||
150083413|NCT04584645|541447848|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
150083414|NCT04584645|541447849|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
150083415|NCT03926169|541447854|FG000|Period A|Adverse Event|2|||
150083416|NCT03926169|541447855|FG001|Period A|Adverse Event|2|||
150083417|NCT03926169|541447856|FG002|Period A|Adverse Event|1|||
150083418|NCT03926169|541447854|FG000|Period A|Withdrawal by Subject|2|||
150083419|NCT03926169|541447855|FG001|Period A|Withdrawal by Subject|2|||
150083420|NCT03926169|541447856|FG002|Period A|Withdrawal by Subject|2|||
150083421|NCT03926169|541447854|FG000|Period A|Lost to Follow-up|3|||
150083422|NCT03926169|541447855|FG001|Period A|Lost to Follow-up|1|||
150083423|NCT03926169|541447856|FG002|Period A|Lost to Follow-up|0|||
150083424|NCT03926169|541447854|FG000|Period A|Lack of Efficacy|0|||
150083425|NCT03926169|541447855|FG001|Period A|Lack of Efficacy|2|||
150083426|NCT03926169|541447856|FG002|Period A|Lack of Efficacy|2|||
150083427|NCT03926169|541447854|FG000|Period A|COVID-19 Infection|0|||
150083428|NCT03926169|541447855|FG001|Period A|COVID-19 Infection|1|||
150083429|NCT03926169|541447856|FG002|Period A|COVID-19 Infection|0|||
150083430|NCT03926169|541447854|FG000|Period A|COVID-19 Logistical Restrictions|0|||
150083431|NCT03926169|541447855|FG001|Period A|COVID-19 Logistical Restrictions|2|||
150083432|NCT03926169|541447856|FG002|Period A|COVID-19 Logistical Restrictions|1|||
150083433|NCT03926169|541447854|FG000|Period A|Other, Not Specified|1|||
150083434|NCT03926169|541447855|FG001|Period A|Other, Not Specified|0|||
150083435|NCT03926169|541447856|FG002|Period A|Other, Not Specified|0|||
150183115|NCT03732820|541808721|FG000|Overall Study|Failure to meet randomisation criteria|1|||
150083436|NCT03926169|541447854|FG000|Period B|Adverse Event|3|||
150083437|NCT03926169|541447855|FG001|Period B|Adverse Event|1|||
150183116|NCT03732820|541808722|FG001|Overall Study|Failure to meet randomisation criteria|1|||
150183117|NCT03732820|541808721|FG000|Overall Study|Patient decision|14|||
150083438|NCT03926169|541447856|FG002|Period B|Adverse Event|1|||
150083439|NCT03926169|541447854|FG000|Period B|Withdrawal by Subject|1|||
150083440|NCT03926169|541447855|FG001|Period B|Withdrawal by Subject|3|||
150083441|NCT03926169|541447856|FG002|Period B|Withdrawal by Subject|0|||
150183118|NCT03732820|541808722|FG001|Overall Study|Patient decision|10|||
150083442|NCT03926169|541447854|FG000|Period B|Lack of Efficacy|3|||
150083443|NCT03926169|541447855|FG001|Period B|Lack of Efficacy|1|||
150083444|NCT03926169|541447856|FG002|Period B|Lack of Efficacy|1|||
150083445|NCT03926169|541447854|FG000|Period B|Lost to Follow-up|1|||
150083446|NCT03926169|541447855|FG001|Period B|Lost to Follow-up|1|||
150083447|NCT03926169|541447856|FG002|Period B|Lost to Follow-up|4|||
150083448|NCT03926169|541447854|FG000|Period B|Other, Not Specified|62|||
150083449|NCT03926169|541447855|FG001|Period B|Other, Not Specified|57|||
150083450|NCT03926169|541447856|FG002|Period B|Other, Not Specified|65|||
150083451|NCT03708328|541447859|FG000|Overall Study|Death|3|||
150083452|NCT03708328|541447860|FG001|Overall Study|Death|3|||
150083453|NCT03708328|541447861|FG002|Overall Study|Death|4|||
150083454|NCT03708328|541447862|FG003|Overall Study|Death|2|||
150083455|NCT03708328|541447863|FG004|Overall Study|Death|2|||
150083456|NCT03708328|541447864|FG005|Overall Study|Death|13|||
150083457|NCT03708328|541447865|FG006|Overall Study|Death|26|||
150083458|NCT03708328|541447866|FG007|Overall Study|Death|18|||
150083459|NCT03708328|541447867|FG008|Overall Study|Death|13|||
150083460|NCT03708328|541447868|FG009|Overall Study|Death|8|||
150083461|NCT03708328|541447859|FG000|Overall Study|Lost to Follow-up|0|||
150083462|NCT03708328|541447860|FG001|Overall Study|Lost to Follow-up|1|||
150083463|NCT03708328|541447861|FG002|Overall Study|Lost to Follow-up|0|||
150083464|NCT03708328|541447862|FG003|Overall Study|Lost to Follow-up|1|||
150083465|NCT03708328|541447863|FG004|Overall Study|Lost to Follow-up|0|||
150083466|NCT03708328|541447864|FG005|Overall Study|Lost to Follow-up|3|||
150083467|NCT03708328|541447865|FG006|Overall Study|Lost to Follow-up|3|||
150083468|NCT03708328|541447866|FG007|Overall Study|Lost to Follow-up|0|||
150083469|NCT03708328|541447867|FG008|Overall Study|Lost to Follow-up|0|||
150083470|NCT03708328|541447868|FG009|Overall Study|Lost to Follow-up|1|||
150083471|NCT03708328|541447859|FG000|Overall Study|Physician Decision|0|||
150083472|NCT03708328|541447860|FG001|Overall Study|Physician Decision|0|||
150083473|NCT03708328|541447861|FG002|Overall Study|Physician Decision|0|||
150083474|NCT03708328|541447862|FG003|Overall Study|Physician Decision|0|||
150083475|NCT03708328|541447863|FG004|Overall Study|Physician Decision|0|||
150083476|NCT03708328|541447864|FG005|Overall Study|Physician Decision|1|||
150083477|NCT03708328|541447865|FG006|Overall Study|Physician Decision|0|||
150083478|NCT03708328|541447866|FG007|Overall Study|Physician Decision|0|||
150083479|NCT03708328|541447867|FG008|Overall Study|Physician Decision|0|||
150083480|NCT03708328|541447868|FG009|Overall Study|Physician Decision|0|||
150083481|NCT03708328|541447859|FG000|Overall Study|Withdrawal by Subject|0|||
150083482|NCT03708328|541447860|FG001|Overall Study|Withdrawal by Subject|0|||
150083483|NCT03708328|541447861|FG002|Overall Study|Withdrawal by Subject|0|||
150083484|NCT03708328|541447862|FG003|Overall Study|Withdrawal by Subject|0|||
150083485|NCT03708328|541447863|FG004|Overall Study|Withdrawal by Subject|1|||
150083486|NCT03708328|541447864|FG005|Overall Study|Withdrawal by Subject|0|||
150083487|NCT03708328|541447865|FG006|Overall Study|Withdrawal by Subject|2|||
150083488|NCT03708328|541447866|FG007|Overall Study|Withdrawal by Subject|4|||
150083489|NCT03708328|541447867|FG008|Overall Study|Withdrawal by Subject|1|||
150083490|NCT03708328|541447868|FG009|Overall Study|Withdrawal by Subject|5|||
150083491|NCT03708328|541447859|FG000|Overall Study|Study Closed Locally|0|||
150083492|NCT03708328|541447860|FG001|Overall Study|Study Closed Locally|0|||
150083493|NCT03708328|541447861|FG002|Overall Study|Study Closed Locally|0|||
150083494|NCT03708328|541447862|FG003|Overall Study|Study Closed Locally|0|||
150083495|NCT03708328|541447863|FG004|Overall Study|Study Closed Locally|0|||
150083496|NCT03708328|541447864|FG005|Overall Study|Study Closed Locally|0|||
150083497|NCT03708328|541447865|FG006|Overall Study|Study Closed Locally|0|||
150083498|NCT03708328|541447866|FG007|Overall Study|Study Closed Locally|1|||
150083499|NCT03708328|541447867|FG008|Overall Study|Study Closed Locally|0|||
150083500|NCT03708328|541447868|FG009|Overall Study|Study Closed Locally|0|||
150083501|NCT03708328|541447859|FG000|Overall Study|Study Ended By Sponsor|0|||
150083502|NCT03708328|541447860|FG001|Overall Study|Study Ended By Sponsor|0|||
150083503|NCT03708328|541447861|FG002|Overall Study|Study Ended By Sponsor|0|||
150083504|NCT03708328|541447862|FG003|Overall Study|Study Ended By Sponsor|0|||
150083505|NCT03708328|541447863|FG004|Overall Study|Study Ended By Sponsor|0|||
150083506|NCT03708328|541447864|FG005|Overall Study|Study Ended By Sponsor|1|||
150083507|NCT03708328|541447865|FG006|Overall Study|Study Ended By Sponsor|0|||
150083508|NCT03708328|541447866|FG007|Overall Study|Study Ended By Sponsor|1|||
150083509|NCT03708328|541447867|FG008|Overall Study|Study Ended By Sponsor|0|||
150083510|NCT03708328|541447868|FG009|Overall Study|Study Ended By Sponsor|0|||
150083511|NCT03708328|541447859|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083512|NCT03708328|541447860|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083513|NCT03708328|541447861|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083514|NCT03708328|541447862|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083515|NCT03708328|541447863|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083516|NCT03708328|541447864|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083517|NCT03708328|541447865|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083518|NCT03708328|541447866|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083519|NCT03708328|541447867|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
150083520|NCT03708328|541447868|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
150083521|NCT04523220|541447869|FG000|Main Treatment Period|Physician Decision|1|||
150083522|NCT04523220|541447870|FG001|Main Treatment Period|Physician Decision|1|||
150083523|NCT04523220|541447871|FG002|Main Treatment Period|Physician Decision|0|||
150083524|NCT04523220|541447869|FG000|Main Treatment Period|Other|5|||
150083525|NCT04523220|541447870|FG001|Main Treatment Period|Other|2|||
150083526|NCT04523220|541447871|FG002|Main Treatment Period|Other|4|||
150083527|NCT04523220|541447869|FG000|Main Treatment Period|Subject Decision|5|||
150083528|NCT04523220|541447870|FG001|Main Treatment Period|Subject Decision|7|||
150083529|NCT04523220|541447871|FG002|Main Treatment Period|Subject Decision|3|||
150083530|NCT04523220|541447869|FG000|Main Treatment Period|Death|5|||
150083531|NCT04523220|541447870|FG001|Main Treatment Period|Death|11|||
150083532|NCT04523220|541447871|FG002|Main Treatment Period|Death|4|||
150083533|NCT04523220|541447869|FG000|Main Treatment Period|Adverse Event|11|||
150083534|NCT04523220|541447870|FG001|Main Treatment Period|Adverse Event|9|||
150083535|NCT04523220|541447871|FG002|Main Treatment Period|Adverse Event|9|||
150083536|NCT04523220|541447869|FG000|Main Treatment Period|Withdrawal by Subject|3|||
150083537|NCT04523220|541447870|FG001|Main Treatment Period|Withdrawal by Subject|3|||
150083538|NCT04523220|541447871|FG002|Main Treatment Period|Withdrawal by Subject|4|||
150083539|NCT04523220|541447869|FG000|Main Treatment Period|Study drug never adminstered|10|||
150083540|NCT04523220|541447870|FG001|Main Treatment Period|Study drug never adminstered|3|||
150083541|NCT04523220|541447871|FG002|Main Treatment Period|Study drug never adminstered|5|||
150083542|NCT04523220|541447869|FG000|Extension Treatment Period|Physician Decision|1|||
150083543|NCT04523220|541447870|FG001|Extension Treatment Period|Physician Decision|0|||
150083544|NCT04523220|541447871|FG002|Extension Treatment Period|Physician Decision|3|||
150083545|NCT04523220|541447869|FG000|Extension Treatment Period|Other|2|||
150083546|NCT04523220|541447870|FG001|Extension Treatment Period|Other|6|||
150083547|NCT04523220|541447871|FG002|Extension Treatment Period|Other|6|||
150083548|NCT04523220|541447869|FG000|Extension Treatment Period|Subject Decision|5|||
150083549|NCT04523220|541447870|FG001|Extension Treatment Period|Subject Decision|2|||
150083550|NCT04523220|541447871|FG002|Extension Treatment Period|Subject Decision|4|||
150083551|NCT04523220|541447869|FG000|Extension Treatment Period|Death|6|||
150083552|NCT04523220|541447870|FG001|Extension Treatment Period|Death|4|||
150083553|NCT04523220|541447871|FG002|Extension Treatment Period|Death|7|||
150083554|NCT04523220|541447869|FG000|Extension Treatment Period|Adverse Event|6|||
150083555|NCT04523220|541447870|FG001|Extension Treatment Period|Adverse Event|7|||
150083556|NCT04523220|541447871|FG002|Extension Treatment Period|Adverse Event|9|||
150083557|NCT04523220|541447869|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
150083558|NCT04523220|541447870|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
150083559|NCT04523220|541447871|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
150083560|NCT04523220|541447869|FG000|Extension Treatment Period|Study drug never administered|0|||
150083561|NCT04523220|541447870|FG001|Extension Treatment Period|Study drug never administered|1|||
150083562|NCT04523220|541447871|FG002|Extension Treatment Period|Study drug never administered|0|||
150083563|NCT00571948|541447872|FG000|Overall Study|Lost to Follow-up|2|||
150083564|NCT00571948|541447873|FG001|Overall Study|Lost to Follow-up|0|||
150083565|NCT00571948|541447872|FG000|Overall Study|Withdrawal by Subject|1|||
150083566|NCT00571948|541447873|FG001|Overall Study|Withdrawal by Subject|2|||
150083567|NCT00571948|541447872|FG000|Overall Study|Protocol Violation|3|||
150083568|NCT00571948|541447873|FG001|Overall Study|Protocol Violation|3|||
150083569|NCT00571948|541447872|FG000|Overall Study|infant refused study meal|3|||
150083570|NCT00571948|541447873|FG001|Overall Study|infant refused study meal|4|||
150083571|NCT00571948|541447872|FG000|Overall Study|Parent were afraid of blood colection|2|||
150083572|NCT00571948|541447873|FG001|Overall Study|Parent were afraid of blood colection|5|||
150083573|NCT02006719|541447874|FG000|Overall Study|Withdrawal by Subject|10|||
150083574|NCT02006719|541447875|FG001|Overall Study|Withdrawal by Subject|2|||
150183119|NCT03732820|541808721|FG000|Overall Study|Screen failure|0|||
150183120|NCT03732820|541808722|FG001|Overall Study|Screen failure|1|||
150083575|NCT02006719|541447874|FG000|Overall Study|Lost to Follow-up|5|||
150083576|NCT02006719|541447875|FG001|Overall Study|Lost to Follow-up|1|||
150083577|NCT02006719|541447874|FG000|Overall Study|Protocol Violation|2|||
150083578|NCT02006719|541447875|FG001|Overall Study|Protocol Violation|0|||
150083579|NCT02006719|541447874|FG000|Overall Study|Adverse Event|1|||
150083580|NCT02006719|541447875|FG001|Overall Study|Adverse Event|1|||
150083581|NCT02006719|541447874|FG000|Overall Study|Other/Unknown|0|||
150083582|NCT02006719|541447875|FG001|Overall Study|Other/Unknown|1|||
150083583|NCT02439138|541447881|FG000|Overall Study|Adverse Event|1|||
150083584|NCT02439138|541447881|FG000|Overall Study|PI decision to terminate the study|2|||
150083585|NCT03727347|541447882|FG000|Overall Study|Withdrawal by Subject|2|||
150083586|NCT03727347|541447882|FG000|Overall Study|Lost to Follow-up|1|||
150083587|NCT00006237|541447885|FG000|Overall Study|Adverse Event|39|||
150083588|NCT00006237|541447886|FG001|Overall Study|Adverse Event|29|||
150083589|NCT00006237|541447885|FG000|Overall Study|Death|1|||
150083590|NCT00006237|541447886|FG001|Overall Study|Death|0|||
150083591|NCT00006237|541447885|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
150083592|NCT00006237|541447886|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
150083593|NCT00006237|541447885|FG000|Overall Study|Progression/relapse|54|||
150083594|NCT00006237|541447886|FG001|Overall Study|Progression/relapse|2|||
150083595|NCT00006237|541447885|FG000|Overall Study|Not eligible|9|||
150083596|NCT00006237|541447886|FG001|Overall Study|Not eligible|20|||
150083597|NCT00006237|541447885|FG000|Overall Study|Withdrawal by Subject|0|||
150083598|NCT00006237|541447886|FG001|Overall Study|Withdrawal by Subject|1|||
150083599|NCT00006237|541447885|FG000|Overall Study|Not protocol specified|14|||
150083600|NCT00006237|541447886|FG001|Overall Study|Not protocol specified|5|||
150083601|NCT01846416|541447891|FG000|Treatment Phase|Death|2|||
150083602|NCT01846416|541447892|FG001|Treatment Phase|Death|9|||
150083603|NCT01846416|541447893|FG002|Treatment Phase|Death|1|||
150083604|NCT01846416|541447891|FG000|Treatment Phase|Withdrawal by Subject|2|||
150083605|NCT01846416|541447892|FG001|Treatment Phase|Withdrawal by Subject|4|||
150083606|NCT01846416|541447893|FG002|Treatment Phase|Withdrawal by Subject|2|||
150083607|NCT01846416|541447891|FG000|Treatment Phase|Other|1|||
150083608|NCT01846416|541447892|FG001|Treatment Phase|Other|5|||
150083609|NCT01846416|541447893|FG002|Treatment Phase|Other|1|||
150083610|NCT01846416|541447891|FG000|Treatment Phase|Physician Decision|1|||
150083611|NCT01846416|541447892|FG001|Treatment Phase|Physician Decision|2|||
150083612|NCT01846416|541447893|FG002|Treatment Phase|Physician Decision|0|||
150083613|NCT01846416|541447891|FG000|Treatment Phase|Adverse Event|3|||
150083614|NCT01846416|541447892|FG001|Treatment Phase|Adverse Event|4|||
150083615|NCT01846416|541447893|FG002|Treatment Phase|Adverse Event|0|||
150083616|NCT01846416|541447891|FG000|Treatment Phase|Non-compliance|0|||
150083617|NCT01846416|541447892|FG001|Treatment Phase|Non-compliance|2|||
150083618|NCT01846416|541447893|FG002|Treatment Phase|Non-compliance|0|||
150083619|NCT01846416|541447891|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
150083620|NCT01846416|541447892|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
150083621|NCT01846416|541447893|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
150083622|NCT01846416|541447891|FG000|Treatment Phase|Progressive Disease|21|||
150083623|NCT01846416|541447892|FG001|Treatment Phase|Progressive Disease|63|||
150083624|NCT01846416|541447893|FG002|Treatment Phase|Progressive Disease|9|||
150083625|NCT01846416|541447891|FG000|Survival Follow-up|Death|21|||
150083626|NCT01846416|541447892|FG001|Survival Follow-up|Death|62|||
150083627|NCT01846416|541447893|FG002|Survival Follow-up|Death|9|||
150083628|NCT01846416|541447891|FG000|Survival Follow-up|Lost to Follow-up|0|||
150083629|NCT01846416|541447892|FG001|Survival Follow-up|Lost to Follow-up|2|||
150083630|NCT01846416|541447893|FG002|Survival Follow-up|Lost to Follow-up|2|||
150083631|NCT01846416|541447891|FG000|Survival Follow-up|Withdrawal by Subject|2|||
150083632|NCT01846416|541447892|FG001|Survival Follow-up|Withdrawal by Subject|7|||
150083633|NCT01846416|541447893|FG002|Survival Follow-up|Withdrawal by Subject|0|||
150083634|NCT01846416|541447891|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
150083635|NCT01846416|541447892|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
150083636|NCT01846416|541447893|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
150083637|NCT01846416|541447891|FG000|Survival Follow-up|Other|3|||
150083638|NCT01846416|541447892|FG001|Survival Follow-up|Other|1|||
150083639|NCT01846416|541447893|FG002|Survival Follow-up|Other|1|||
150083640|NCT00558558|541447894|FG000|Overall Study|Unable to swallow|1|||
150083641|NCT00558558|541447894|FG000|Overall Study|Withdrawal by Subject|1|||
150083642|NCT00558558|541447894|FG000|Overall Study|Lack of Efficacy|4|||
150083643|NCT00317356|541447896|FG000|Overall Study|Adverse Event|0|||
150083644|NCT00317356|541447897|FG001|Overall Study|Adverse Event|0|||
150083645|NCT00317356|541447898|FG002|Overall Study|Adverse Event|1|||
150083646|NCT00317356|541447899|FG003|Overall Study|Adverse Event|0|||
150083647|NCT00317356|541447896|FG000|Overall Study|Lack of Efficacy|1|||
150083648|NCT00317356|541447897|FG001|Overall Study|Lack of Efficacy|1|||
150083649|NCT00317356|541447898|FG002|Overall Study|Lack of Efficacy|0|||
150083650|NCT00317356|541447899|FG003|Overall Study|Lack of Efficacy|3|||
150083651|NCT00317356|541447896|FG000|Overall Study|Physician Decision|0|||
150083652|NCT00317356|541447897|FG001|Overall Study|Physician Decision|1|||
150083653|NCT00317356|541447898|FG002|Overall Study|Physician Decision|0|||
150083654|NCT00317356|541447899|FG003|Overall Study|Physician Decision|0|||
150083655|NCT05980182|541447902|FG000|Overall Study|Lost to Follow-up|10|||
150083656|NCT04492618|541449523|FG000|Overall Study|Withdrawal by Subject|1|||
150083657|NCT02511184|541449524|FG000|Overall Study|Death|1|||
150083658|NCT02511184|541449525|FG001|Overall Study|Death|0|||
150083659|NCT02511184|541449524|FG000|Overall Study|Lost to Follow-up|0|||
150083660|NCT02511184|541449525|FG001|Overall Study|Lost to Follow-up|1|||
150083661|NCT02511184|541449524|FG000|Overall Study|Study terminated by sponsor|1|||
150083662|NCT02511184|541449525|FG001|Overall Study|Study terminated by sponsor|5|||
150083663|NCT02511184|541449524|FG000|Overall Study|Withdrawal by Subject|0|||
150083664|NCT02511184|541449525|FG001|Overall Study|Withdrawal by Subject|1|||
150083665|NCT00085631|541449536|FG000|Overall Study|Missing Data|4|||
150083666|NCT00085631|541449537|FG001|Overall Study|Missing Data|11|||
150083667|NCT00085631|541449538|FG002|Overall Study|Missing Data|7|||
150083668|NCT01349790|541449539|FG000|Overall Study|Investigator Judgement|3|||
150083669|NCT01349790|541449539|FG000|Overall Study|Death|2|||
150083670|NCT01349790|541449539|FG000|Overall Study|Withdrawal by Patient|2|||
150083671|NCT01349790|541449539|FG000|Overall Study|Adverse Event|1|||
150083672|NCT01349790|541449539|FG000|Overall Study|Lost to Follow-up|1|||
150083673|NCT03902574|541449540|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
150083674|NCT03902574|541449541|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
150083675|NCT03902574|541449542|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
150083676|NCT03521934|541449543|FG000|Overall Study|Death|65|||
150083677|NCT03521934|541449544|FG001|Overall Study|Death|73|||
150083678|NCT03521934|541449543|FG000|Overall Study|Withdrawal by Subject|18|||
150083679|NCT03521934|541449544|FG001|Overall Study|Withdrawal by Subject|23|||
150083680|NCT03521934|541449543|FG000|Overall Study|Site Terminated by Sponsor|39|||
150083681|NCT03521934|541449544|FG001|Overall Study|Site Terminated by Sponsor|35|||
150083682|NCT03521934|541449543|FG000|Overall Study|Study Terminated by Sponsor|483|||
150083683|NCT03521934|541449544|FG001|Overall Study|Study Terminated by Sponsor|477|||
150083684|NCT03521934|541449543|FG000|Overall Study|Reason not Specified|3|||
150083685|NCT03521934|541449544|FG001|Overall Study|Reason not Specified|6|||
150083686|NCT00727025|541449545|FG000|Overall Study|Physician Decision|23|||
150083687|NCT02101060|541449546|FG000|Overall Study|Adverse Event|1|||
150083688|NCT02101060|541449547|FG001|Overall Study|Adverse Event|0|||
150083689|NCT02101060|541449546|FG000|Overall Study|Withdrawal by Subject|1|||
150083690|NCT02101060|541449547|FG001|Overall Study|Withdrawal by Subject|1|||
150083691|NCT02101060|541449546|FG000|Overall Study|Lost to Follow-up|3|||
150083692|NCT02101060|541449547|FG001|Overall Study|Lost to Follow-up|3|||
150083693|NCT01425281|541449553|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
150083694|NCT01425281|541449554|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
150083695|NCT01425281|541449553|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
150083696|NCT01425281|541449554|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
150083697|NCT01425281|541449553|FG000|At 180-day Clinical Follow-up|Death|0|||
150083698|NCT01425281|541449554|FG001|At 180-day Clinical Follow-up|Death|1|||
150083699|NCT01425281|541449553|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
150083700|NCT01425281|541449554|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
150083701|NCT01425281|541449553|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
150083702|NCT01425281|541449554|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
150083703|NCT01425281|541449553|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
150083704|NCT01425281|541449554|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
150083705|NCT01425281|541449553|FG000|At 2-year Clinical Follow-up|Death|2|||
150083706|NCT01425281|541449554|FG001|At 2-year Clinical Follow-up|Death|0|||
150083707|NCT01425281|541449553|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
150083708|NCT01425281|541449554|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
150083709|NCT01425281|541449553|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
150083710|NCT01425281|541449554|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
150083711|NCT01425281|541449553|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
150083712|NCT01425281|541449554|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
150083713|NCT01425281|541449553|FG000|At 3-year Clinical Follow-up|Death|2|||
150083714|NCT01425281|541449554|FG001|At 3-year Clinical Follow-up|Death|3|||
150083715|NCT01425281|541449553|FG000|At 4-year Clinical Follow-up|Death|7|||
150083716|NCT01425281|541449554|FG001|At 4-year Clinical Follow-up|Death|3|||
150083717|NCT01425281|541449553|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
150083718|NCT01425281|541449554|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
150083719|NCT01425281|541449553|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
150083720|NCT01425281|541449554|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
150083721|NCT01425281|541449553|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
150083722|NCT01425281|541449554|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
150083723|NCT01425281|541449553|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
150083724|NCT01425281|541449554|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
150083725|NCT01425281|541449553|FG000|At 5-year Clinical Follow-up|Death|2|||
150083726|NCT01425281|541449554|FG001|At 5-year Clinical Follow-up|Death|0|||
150083727|NCT01425281|541449553|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
150083728|NCT01425281|541449554|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
150083729|NCT01425281|541449553|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
150083730|NCT01425281|541449554|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
150183121|NCT03732820|541808721|FG000|Overall Study|Patients ongoing study at data cut off|210|||
150083731|NCT01425281|541449553|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
150083732|NCT01425281|541449554|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
150083733|NCT05288062|541449555|FG000|Overall Study|Ineligible|0|||
150083734|NCT05288062|541449556|FG001|Overall Study|Ineligible|0|||
150083735|NCT05288062|541449557|FG002|Overall Study|Ineligible|1|||
150083736|NCT05288062|541449558|FG003|Overall Study|Ineligible|0|||
150083737|NCT05288062|541449555|FG000|Overall Study|Withdrawal by Subject|0|||
150083738|NCT05288062|541449556|FG001|Overall Study|Withdrawal by Subject|0|||
150083739|NCT05288062|541449557|FG002|Overall Study|Withdrawal by Subject|1|||
150083740|NCT05288062|541449558|FG003|Overall Study|Withdrawal by Subject|0|||
150083741|NCT01025752|541449562|FG000|Overall Study|Lost to Follow-up|7|||
150083742|NCT01025752|541449563|FG001|Overall Study|Lost to Follow-up|10|||
150083743|NCT01025752|541449562|FG000|Overall Study|Physician Decision|1|||
150083744|NCT01025752|541449563|FG001|Overall Study|Physician Decision|3|||
150083745|NCT01537393|541449564|FG000|Overall Study|Exclude prior to study|32|||
150083746|NCT01537393|541449565|FG001|Overall Study|Exclude prior to study|44|||
150083747|NCT01537393|541449564|FG000|Overall Study|Death|20|||
150083748|NCT01537393|541449565|FG001|Overall Study|Death|32|||
150083749|NCT01537393|541449564|FG000|Overall Study|Withdrawal by Subject|18|||
150083750|NCT01537393|541449565|FG001|Overall Study|Withdrawal by Subject|17|||
150083751|NCT01537393|541449564|FG000|Overall Study|Lost to Follow-up|53|||
150083752|NCT01537393|541449565|FG001|Overall Study|Lost to Follow-up|48|||
150083753|NCT01537393|541449564|FG000|Overall Study|Failure - Regrafted|28|||
150083754|NCT01537393|541449565|FG001|Overall Study|Failure - Regrafted|43|||
150083755|NCT01537393|541449564|FG000|Overall Study|Failure - Not regrafted|2|||
150083756|NCT01537393|541449565|FG001|Overall Study|Failure - Not regrafted|6|||
150083757|NCT01537393|541449564|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
150083758|NCT01537393|541449565|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
150083759|NCT01697566|541449566|FG000|Overall Study|Withdrawal by Subject|0|||
150083760|NCT01697566|541449567|FG001|Overall Study|Withdrawal by Subject|0|||
150083761|NCT01697566|541449568|FG002|Overall Study|Withdrawal by Subject|1|||
150083762|NCT01697566|541449569|FG003|Overall Study|Withdrawal by Subject|1|||
150083763|NCT01697566|541449566|FG000|Overall Study|Final biopsy not obtained|0|||
150083764|NCT01697566|541449567|FG001|Overall Study|Final biopsy not obtained|0|||
150083765|NCT01697566|541449568|FG002|Overall Study|Final biopsy not obtained|1|||
150083766|NCT01697566|541449569|FG003|Overall Study|Final biopsy not obtained|0|||
150083767|NCT00459953|541449570|FG000|Overall Study|not analyzed-household member in study|1|||
150083768|NCT00459953|541449571|FG001|Overall Study|not analyzed-household member in study|1|||
150083769|NCT01447433|541449572|FG000|Overall Study|Lost to Follow-up|0|||
150083770|NCT01447433|541449573|FG001|Overall Study|Lost to Follow-up|2|||
150083771|NCT01447433|541449572|FG000|Overall Study|Withdrawal by Subject|3|||
150083772|NCT01447433|541449573|FG001|Overall Study|Withdrawal by Subject|3|||
150083773|NCT01447433|541449572|FG000|Overall Study|Protocol Violation|1|||
150083774|NCT01447433|541449573|FG001|Overall Study|Protocol Violation|1|||
150083775|NCT00036270|541449574|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
150083776|NCT00036270|541449575|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
150083777|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
150083778|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
150083779|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
150083780|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
150083781|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
150083782|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
150083783|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Other|277|||
150083784|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Other|288|||
150083785|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
150083786|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
150083787|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
150083788|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
150083789|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
150083790|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
150083791|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
150083792|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
150083793|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
150083794|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
150083795|NCT00036270|541449574|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
150083796|NCT00036270|541449575|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
150083797|NCT01578187|541449576|FG000|Usability Phase|Withdrawal by Subject|1|||
150083798|NCT02516163|541449581|FG000|Overall Study|Withdrawal by Subject|1|||
150083799|NCT02516163|541449581|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
150083800|NCT02516163|541449581|FG000|Overall Study|Unfit/delay in surgery|3|||
150083801|NCT02516163|541449581|FG000|Overall Study|Use of incorrect measurement technique|5|||
150083802|NCT02516163|541449581|FG000|Overall Study|Data not recorded|2|||
150083803|NCT02516163|541449581|FG000|Overall Study|MRI contraindication exclusion|6|||
150083804|NCT01709162|541449584|FG000|Overall Study|Disease progression|3|||
150083805|NCT01709162|541449585|FG001|Overall Study|Disease progression|3|||
150083806|NCT01709162|541449584|FG000|Overall Study|Study drug toxicity|2|||
150083807|NCT01709162|541449585|FG001|Overall Study|Study drug toxicity|0|||
150083808|NCT01709162|541449584|FG000|Overall Study|Administrative reason by sponsor|0|||
150083809|NCT01709162|541449585|FG001|Overall Study|Administrative reason by sponsor|1|||
150083810|NCT01709162|541449584|FG000|Overall Study|Other|1|||
150083811|NCT01709162|541449585|FG001|Overall Study|Other|0|||
150083812|NCT01709162|541449584|FG000|Overall Study|Withdrawal by Subject|0|||
150083813|NCT01709162|541449585|FG001|Overall Study|Withdrawal by Subject|1|||
150083814|NCT01874054|541449586|FG000|Overall Study|Withdrawal by Subject|3|||
150083815|NCT01874054|541449586|FG000|Overall Study|Study Termination by Sponsor|42|||
150083816|NCT01874054|541449586|FG000|Overall Study|Lost to Follow-up|5|||
150083817|NCT01874054|541449586|FG000|Overall Study|Death|5|||
150083818|NCT02010775|541449587|FG000|Overall Study|Adverse Event|0|||
150083819|NCT02010775|541449588|FG001|Overall Study|Adverse Event|0|||
150083820|NCT02010775|541449589|FG002|Overall Study|Adverse Event|0|||
150083821|NCT02010775|541449590|FG003|Overall Study|Adverse Event|0|||
150083822|NCT02010775|541449591|FG004|Overall Study|Adverse Event|1|||
150083823|NCT02010775|541449587|FG000|Overall Study|Pregnancy|0|||
150083824|NCT02010775|541449588|FG001|Overall Study|Pregnancy|0|||
150083825|NCT02010775|541449589|FG002|Overall Study|Pregnancy|2|||
150083826|NCT02010775|541449590|FG003|Overall Study|Pregnancy|0|||
150083827|NCT02010775|541449591|FG004|Overall Study|Pregnancy|0|||
150083828|NCT02010775|541449587|FG000|Overall Study|Lost to Follow-up|2|||
150083829|NCT02010775|541449588|FG001|Overall Study|Lost to Follow-up|0|||
150083830|NCT02010775|541449589|FG002|Overall Study|Lost to Follow-up|0|||
150083831|NCT02010775|541449590|FG003|Overall Study|Lost to Follow-up|1|||
150083832|NCT02010775|541449591|FG004|Overall Study|Lost to Follow-up|1|||
150083833|NCT02010775|541449587|FG000|Overall Study|Personal Reasons|3|||
150083834|NCT02010775|541449588|FG001|Overall Study|Personal Reasons|3|||
150083835|NCT02010775|541449589|FG002|Overall Study|Personal Reasons|1|||
150083836|NCT02010775|541449590|FG003|Overall Study|Personal Reasons|2|||
150083837|NCT02010775|541449591|FG004|Overall Study|Personal Reasons|4|||
150083838|NCT02030041|541449593|FG000|Overall Study|Withdrawal by Subject|2|||
150083839|NCT02030041|541449594|FG001|Overall Study|Withdrawal by Subject|2|||
150083840|NCT02030041|541449595|FG002|Overall Study|Withdrawal by Subject|1|||
150083841|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
150083842|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
150083843|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
150083844|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
150083845|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
150083846|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
150083847|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
150083848|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
150083849|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
150083850|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
150083851|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
150083852|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
150083853|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
150083854|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
150083855|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
150083856|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
150083857|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
150083858|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
150083859|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
150083860|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
150083861|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
150083862|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
150083863|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
150083864|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
150083865|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
150083866|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
150083867|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
150083868|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
150083869|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
150083870|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
150083871|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
150083872|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
150083873|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
150083874|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
150083875|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
150083876|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
150083877|NCT00843024|541449596|FG000|Single-blind Placebo Run-In Phase|Other|0|||
150083878|NCT00843024|541449597|FG001|Single-blind Placebo Run-In Phase|Other|1|||
150083879|NCT00843024|541449598|FG002|Single-blind Placebo Run-In Phase|Other|0|||
150083880|NCT00843024|541449599|FG003|Single-blind Placebo Run-In Phase|Other|0|||
150083881|NCT00843024|541449600|FG004|Single-blind Placebo Run-In Phase|Other|0|||
150083882|NCT00843024|541449601|FG005|Single-blind Placebo Run-In Phase|Other|0|||
150083883|NCT00843024|541449596|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
150083884|NCT00843024|541449597|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
150083885|NCT00843024|541449598|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
150183122|NCT03732820|541808722|FG001|Overall Study|Patients ongoing study at data cut off|178|||
150183123|NCT03732820|541808721|FG000|Overall Study|Lost to Follow-up|4|||
150183124|NCT03732820|541808722|FG001|Overall Study|Lost to Follow-up|2|||
150183125|NCT02374307|541808725|FG000|3-months Follow-up|Lost to Follow-up|1|||
150183126|NCT02374307|541808726|FG001|3-months Follow-up|Lost to Follow-up|2|||
150183127|NCT02374307|541808725|FG000|3-months Follow-up|Withdrawal by Subject|1|||
150183128|NCT02374307|541808726|FG001|3-months Follow-up|Withdrawal by Subject|4|||
150183129|NCT02374307|541808725|FG000|3-months Follow-up|Death|1|||
150183130|NCT02374307|541808726|FG001|3-months Follow-up|Death|2|||
150183131|NCT02374307|541808725|FG000|3-months Follow-up|Missed first follow-up|5|||
150183132|NCT02374307|541808726|FG001|3-months Follow-up|Missed first follow-up|1|||
150183133|NCT02374307|541808725|FG000|6-months Follow-up|Lost to Follow-up|1|||
150183134|NCT02374307|541808726|FG001|6-months Follow-up|Lost to Follow-up|2|||
150183135|NCT02374307|541808725|FG000|6-months Follow-up|Death|2|||
150183136|NCT02374307|541808726|FG001|6-months Follow-up|Death|1|||
150183137|NCT02374307|541808725|FG000|6-months Follow-up|Withdrawal by Subject|0|||
150183138|NCT02374307|541808726|FG001|6-months Follow-up|Withdrawal by Subject|3|||
150183139|NCT01989455|541808727|FG000|Overall Study|Adverse Event|0|||
150183140|NCT01989455|541808728|FG001|Overall Study|Adverse Event|1|||
150183141|NCT01989455|541808729|FG002|Overall Study|Adverse Event|0|||
150183142|NCT01989455|541808730|FG003|Overall Study|Adverse Event|0|||
150183143|NCT01989455|541808731|FG004|Overall Study|Adverse Event|0|||
150183144|NCT01989455|541808727|FG000|Overall Study|Withdrawal by Subject|0|||
150183145|NCT01989455|541808728|FG001|Overall Study|Withdrawal by Subject|1|||
150183146|NCT01989455|541808729|FG002|Overall Study|Withdrawal by Subject|0|||
150183147|NCT01989455|541808730|FG003|Overall Study|Withdrawal by Subject|0|||
150183148|NCT01989455|541808731|FG004|Overall Study|Withdrawal by Subject|0|||
150183149|NCT01989455|541808727|FG000|Overall Study|Technical problems with infusion|0|||
150183150|NCT01989455|541808728|FG001|Overall Study|Technical problems with infusion|0|||
150183151|NCT01989455|541808729|FG002|Overall Study|Technical problems with infusion|1|||
150183152|NCT01989455|541808730|FG003|Overall Study|Technical problems with infusion|0|||
150183153|NCT01989455|541808731|FG004|Overall Study|Technical problems with infusion|1|||
150183154|NCT04287985|541808739|FG000|Overall Study|Adverse Event|1|||
150183155|NCT04287985|541808740|FG001|Overall Study|Adverse Event|0|||
150183156|NCT04287985|541808741|FG002|Overall Study|Adverse Event|0|||
150183157|NCT04287985|541808742|FG003|Overall Study|Adverse Event|0|||
150183158|NCT04287985|541808739|FG000|Overall Study|Protocol Violation|0|||
150183159|NCT04287985|541808740|FG001|Overall Study|Protocol Violation|1|||
150183160|NCT04287985|541808741|FG002|Overall Study|Protocol Violation|0|||
150183161|NCT04287985|541808742|FG003|Overall Study|Protocol Violation|0|||
150183162|NCT04287985|541808739|FG000|Overall Study|Physician Decision|0|||
150183163|NCT04287985|541808740|FG001|Overall Study|Physician Decision|0|||
150183164|NCT04287985|541808741|FG002|Overall Study|Physician Decision|0|||
150183165|NCT04287985|541808742|FG003|Overall Study|Physician Decision|1|||
150183166|NCT04287985|541808739|FG000|Overall Study|Withdrawal by Subject|2|||
150183167|NCT04287985|541808740|FG001|Overall Study|Withdrawal by Subject|1|||
150183168|NCT04287985|541808741|FG002|Overall Study|Withdrawal by Subject|1|||
150183169|NCT04287985|541808742|FG003|Overall Study|Withdrawal by Subject|2|||
150183170|NCT02638337|541808743|FG000|Overall Study|Adverse Event|6|||
150183171|NCT02638337|541808744|FG001|Overall Study|Adverse Event|10|||
150183172|NCT02638337|541808743|FG000|Overall Study|Protocol Violation|3|||
150183173|NCT02638337|541808744|FG001|Overall Study|Protocol Violation|0|||
150183174|NCT02638337|541808743|FG000|Overall Study|Withdrawal by Subject|13|||
150183175|NCT02638337|541808744|FG001|Overall Study|Withdrawal by Subject|16|||
150183176|NCT02638337|541808743|FG000|Overall Study|Lost to Follow-up|7|||
150183177|NCT02638337|541808744|FG001|Overall Study|Lost to Follow-up|7|||
150183178|NCT02638337|541808743|FG000|Overall Study|Other - Miscellaneous|4|||
150183179|NCT02638337|541808744|FG001|Overall Study|Other - Miscellaneous|3|||
150183180|NCT00604669|541808745|FG000|Overall Study|lack of information in chart|7|||
150183181|NCT01340066|541808746|FG000|Placebo Run in Period|Screen Failures|27|||
150183182|NCT01340066|541808747|FG001|Placebo Run in Period|Screen Failures|0|||
150083886|NCT00843024|541449599|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
150083887|NCT00843024|541449600|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
150083888|NCT00843024|541449601|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
150083889|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
150083890|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
150083891|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
150083892|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
150083893|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
150083894|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
150083895|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150083896|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150083897|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150083898|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
150083899|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150083900|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
150083901|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
150083902|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
150083903|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
150083904|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
150083905|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
150083906|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
150083907|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Physician Decision|0|||
150083908|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Physician Decision|0|||
150083909|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Physician Decision|0|||
150083910|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Physician Decision|3|||
150083911|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Physician Decision|1|||
150083912|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Physician Decision|1|||
150083913|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Adverse Event|0|||
150083914|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Adverse Event|0|||
150083915|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Adverse Event|0|||
150083916|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Adverse Event|0|||
150083917|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Adverse Event|1|||
150083918|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Adverse Event|1|||
150083919|NCT00843024|541449596|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
150083920|NCT00843024|541449597|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
150083921|NCT00843024|541449598|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
150083922|NCT00843024|541449599|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
150083923|NCT00843024|541449600|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
150083924|NCT00843024|541449601|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
150083925|NCT01032837|541449602|FG000|Overall Study|Adverse event/internal illness|0|||
150083926|NCT01032837|541449603|FG001|Overall Study|Adverse event/internal illness|1|||
150083927|NCT01032837|541449604|FG002|Overall Study|Adverse event/internal illness|0|||
150083928|NCT01032837|541449605|FG003|Overall Study|Adverse event/internal illness|1|||
150083929|NCT01032837|541449602|FG000|Overall Study|Withdrew consent|0|||
150083930|NCT01032837|541449603|FG001|Overall Study|Withdrew consent|2|||
150083931|NCT01032837|541449604|FG002|Overall Study|Withdrew consent|0|||
150083932|NCT01032837|541449605|FG003|Overall Study|Withdrew consent|1|||
150083933|NCT01032837|541449602|FG000|Overall Study|Failed to return|0|||
150083934|NCT01032837|541449603|FG001|Overall Study|Failed to return|0|||
150083935|NCT01032837|541449604|FG002|Overall Study|Failed to return|1|||
150083936|NCT01032837|541449605|FG003|Overall Study|Failed to return|0|||
150083937|NCT01032837|541449602|FG000|Overall Study|Refused treatment|0|||
150083938|NCT01032837|541449603|FG001|Overall Study|Refused treatment|0|||
150083939|NCT01032837|541449604|FG002|Overall Study|Refused treatment|0|||
150083940|NCT01032837|541449605|FG003|Overall Study|Refused treatment|1|||
150083941|NCT05201703|541449606|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
150083942|NCT05201703|541449607|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
150083943|NCT05201703|541449606|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
150083944|NCT05201703|541449607|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
150083945|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083946|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
150083947|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083948|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
150083949|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
150083950|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083951|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083952|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083953|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083954|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083955|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083956|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083957|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083958|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083959|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
150083960|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
150083961|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
150083962|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
150083963|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083964|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083965|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083966|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083967|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083968|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083969|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083970|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083971|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083972|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083973|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083974|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
150083975|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083976|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083977|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083978|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
150083979|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083980|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083981|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083982|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083983|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083984|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083985|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083986|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083987|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083988|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083989|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
150083990|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083991|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
150083992|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083993|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083994|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150183183|NCT01340066|541808748|FG002|Placebo Run in Period|Screen Failures|0|||
150083995|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083996|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083997|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083998|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150083999|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084000|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084001|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084002|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084003|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084004|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
150084005|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084006|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084007|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084008|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084009|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
150084010|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084011|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084012|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084013|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084014|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084015|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084016|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084017|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084018|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084019|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
150084020|NCT01737697|541449610|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084021|NCT01737697|541449611|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
150084022|NCT01737697|541449612|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
150084023|NCT01737697|541449613|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
150084024|NCT01737697|541449614|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
150084025|NCT01737697|541449615|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084026|NCT01737697|541449616|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084027|NCT01737697|541449617|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084028|NCT01737697|541449618|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084029|NCT01737697|541449619|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084030|NCT01737697|541449620|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084031|NCT01737697|541449621|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084032|NCT01737697|541449622|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084033|NCT01737697|541449623|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084034|NCT01737697|541449624|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
150084035|NCT01737697|541449610|FG000|Subacute Phase|Adverse Event|0|||
150084036|NCT01737697|541449611|FG001|Subacute Phase|Adverse Event|0|||
150084037|NCT01737697|541449612|FG002|Subacute Phase|Adverse Event|0|||
150084038|NCT01737697|541449613|FG003|Subacute Phase|Adverse Event|0|||
150084039|NCT01737697|541449614|FG004|Subacute Phase|Adverse Event|0|||
150084040|NCT01737697|541449615|FG005|Subacute Phase|Adverse Event|1|||
150084041|NCT01737697|541449616|FG006|Subacute Phase|Adverse Event|1|||
150084042|NCT01737697|541449617|FG007|Subacute Phase|Adverse Event|1|||
150084043|NCT01737697|541449618|FG008|Subacute Phase|Adverse Event|1|||
150084044|NCT01737697|541449619|FG009|Subacute Phase|Adverse Event|1|||
150084045|NCT01737697|541449620|FG010|Subacute Phase|Adverse Event|4|||
150084046|NCT01737697|541449621|FG011|Subacute Phase|Adverse Event|1|||
150084047|NCT01737697|541449622|FG012|Subacute Phase|Adverse Event|1|||
150084048|NCT01737697|541449623|FG013|Subacute Phase|Adverse Event|0|||
150084049|NCT01737697|541449624|FG014|Subacute Phase|Adverse Event|0|||
150084050|NCT01737697|541449610|FG000|Subacute Phase|Withdrawal by Subject|0|||
150084051|NCT01737697|541449611|FG001|Subacute Phase|Withdrawal by Subject|0|||
150084052|NCT01737697|541449612|FG002|Subacute Phase|Withdrawal by Subject|0|||
150084053|NCT01737697|541449613|FG003|Subacute Phase|Withdrawal by Subject|0|||
150084054|NCT01737697|541449614|FG004|Subacute Phase|Withdrawal by Subject|0|||
150084055|NCT01737697|541449615|FG005|Subacute Phase|Withdrawal by Subject|1|||
150084056|NCT01737697|541449616|FG006|Subacute Phase|Withdrawal by Subject|0|||
150084057|NCT01737697|541449617|FG007|Subacute Phase|Withdrawal by Subject|2|||
150084058|NCT01737697|541449618|FG008|Subacute Phase|Withdrawal by Subject|0|||
150084059|NCT01737697|541449619|FG009|Subacute Phase|Withdrawal by Subject|1|||
150084060|NCT01737697|541449620|FG010|Subacute Phase|Withdrawal by Subject|0|||
150084061|NCT01737697|541449621|FG011|Subacute Phase|Withdrawal by Subject|1|||
150084062|NCT01737697|541449622|FG012|Subacute Phase|Withdrawal by Subject|1|||
150084063|NCT01737697|541449623|FG013|Subacute Phase|Withdrawal by Subject|1|||
150084064|NCT01737697|541449624|FG014|Subacute Phase|Withdrawal by Subject|0|||
150084065|NCT01737697|541449610|FG000|Subacute Phase|Lost to Follow-up|0|||
150084066|NCT01737697|541449611|FG001|Subacute Phase|Lost to Follow-up|0|||
150084067|NCT01737697|541449612|FG002|Subacute Phase|Lost to Follow-up|0|||
150084068|NCT01737697|541449613|FG003|Subacute Phase|Lost to Follow-up|0|||
150084069|NCT01737697|541449614|FG004|Subacute Phase|Lost to Follow-up|0|||
150084070|NCT01737697|541449615|FG005|Subacute Phase|Lost to Follow-up|0|||
150084071|NCT01737697|541449616|FG006|Subacute Phase|Lost to Follow-up|0|||
150084072|NCT01737697|541449617|FG007|Subacute Phase|Lost to Follow-up|0|||
150084073|NCT01737697|541449618|FG008|Subacute Phase|Lost to Follow-up|0|||
150084074|NCT01737697|541449619|FG009|Subacute Phase|Lost to Follow-up|0|||
150084075|NCT01737697|541449620|FG010|Subacute Phase|Lost to Follow-up|0|||
150084076|NCT01737697|541449621|FG011|Subacute Phase|Lost to Follow-up|0|||
150084077|NCT01737697|541449622|FG012|Subacute Phase|Lost to Follow-up|0|||
150084078|NCT01737697|541449623|FG013|Subacute Phase|Lost to Follow-up|0|||
150084079|NCT01737697|541449624|FG014|Subacute Phase|Lost to Follow-up|1|||
150084080|NCT01737697|541449610|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
150084081|NCT01737697|541449611|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
150084082|NCT01737697|541449612|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
150084083|NCT01737697|541449613|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
150084084|NCT01737697|541449614|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
150084085|NCT01737697|541449615|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
150084086|NCT01737697|541449616|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
150084087|NCT01737697|541449617|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
150084088|NCT01737697|541449618|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
150084089|NCT01737697|541449619|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
150084090|NCT01737697|541449620|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
150084091|NCT01737697|541449621|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
150084092|NCT01737697|541449622|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
150084093|NCT01737697|541449623|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
150084094|NCT01737697|541449624|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
150084095|NCT01737697|541449610|FG000|Subacute Phase|Protocol Violation|0|||
150084096|NCT01737697|541449611|FG001|Subacute Phase|Protocol Violation|0|||
150084097|NCT01737697|541449612|FG002|Subacute Phase|Protocol Violation|0|||
150084098|NCT01737697|541449613|FG003|Subacute Phase|Protocol Violation|0|||
150084099|NCT01737697|541449614|FG004|Subacute Phase|Protocol Violation|0|||
150084100|NCT01737697|541449615|FG005|Subacute Phase|Protocol Violation|1|||
150084101|NCT01737697|541449616|FG006|Subacute Phase|Protocol Violation|0|||
150084102|NCT01737697|541449617|FG007|Subacute Phase|Protocol Violation|0|||
150084103|NCT01737697|541449618|FG008|Subacute Phase|Protocol Violation|0|||
150084104|NCT01737697|541449619|FG009|Subacute Phase|Protocol Violation|0|||
150084105|NCT01737697|541449620|FG010|Subacute Phase|Protocol Violation|1|||
150084106|NCT01737697|541449621|FG011|Subacute Phase|Protocol Violation|0|||
150084107|NCT01737697|541449622|FG012|Subacute Phase|Protocol Violation|0|||
150084108|NCT01737697|541449623|FG013|Subacute Phase|Protocol Violation|0|||
150084109|NCT01737697|541449624|FG014|Subacute Phase|Protocol Violation|0|||
150084110|NCT01737697|541449610|FG000|Subacute Phase|Physician Decision|0|||
150084111|NCT01737697|541449611|FG001|Subacute Phase|Physician Decision|0|||
150084112|NCT01737697|541449612|FG002|Subacute Phase|Physician Decision|0|||
150084113|NCT01737697|541449613|FG003|Subacute Phase|Physician Decision|0|||
150084114|NCT01737697|541449614|FG004|Subacute Phase|Physician Decision|0|||
150084115|NCT01737697|541449615|FG005|Subacute Phase|Physician Decision|0|||
150084116|NCT01737697|541449616|FG006|Subacute Phase|Physician Decision|0|||
150084117|NCT01737697|541449617|FG007|Subacute Phase|Physician Decision|0|||
150084118|NCT01737697|541449618|FG008|Subacute Phase|Physician Decision|1|||
150084119|NCT01737697|541449619|FG009|Subacute Phase|Physician Decision|0|||
150084120|NCT01737697|541449620|FG010|Subacute Phase|Physician Decision|0|||
150084121|NCT01737697|541449621|FG011|Subacute Phase|Physician Decision|0|||
150084122|NCT01737697|541449622|FG012|Subacute Phase|Physician Decision|0|||
150084123|NCT01737697|541449623|FG013|Subacute Phase|Physician Decision|0|||
150084124|NCT01737697|541449624|FG014|Subacute Phase|Physician Decision|0|||
150084125|NCT01737697|541449610|FG000|Subacute Phase|Death|0|||
150084126|NCT01737697|541449611|FG001|Subacute Phase|Death|0|||
150084127|NCT01737697|541449612|FG002|Subacute Phase|Death|0|||
150084128|NCT01737697|541449613|FG003|Subacute Phase|Death|0|||
150084129|NCT01737697|541449614|FG004|Subacute Phase|Death|0|||
150084130|NCT01737697|541449615|FG005|Subacute Phase|Death|0|||
150084131|NCT01737697|541449616|FG006|Subacute Phase|Death|0|||
150084132|NCT01737697|541449617|FG007|Subacute Phase|Death|0|||
150084133|NCT01737697|541449618|FG008|Subacute Phase|Death|0|||
150084134|NCT01737697|541449619|FG009|Subacute Phase|Death|0|||
150084135|NCT01737697|541449620|FG010|Subacute Phase|Death|1|||
150084136|NCT01737697|541449621|FG011|Subacute Phase|Death|0|||
150084137|NCT01737697|541449622|FG012|Subacute Phase|Death|0|||
150084138|NCT01737697|541449623|FG013|Subacute Phase|Death|0|||
150084139|NCT01737697|541449624|FG014|Subacute Phase|Death|0|||
150084140|NCT01866930|541449626|FG000|Treatment Period|Other|1|||
150084141|NCT01866930|541449627|FG001|Treatment Period|Other|0|||
150084142|NCT01866930|541449626|FG000|Treatment Period|Death|0|||
150084143|NCT01866930|541449627|FG001|Treatment Period|Death|2|||
150084144|NCT01866930|541449626|FG000|Treatment Period|Poor/non compliance|0|||
150084145|NCT01866930|541449627|FG001|Treatment Period|Poor/non compliance|2|||
150084146|NCT01866930|541449626|FG000|Treatment Period|No longer meets study criteria|0|||
150084147|NCT01866930|541449627|FG001|Treatment Period|No longer meets study criteria|1|||
150084148|NCT01866930|541449626|FG000|Treatment Period|Withdrawal by Subject|2|||
150084149|NCT01866930|541449627|FG001|Treatment Period|Withdrawal by Subject|8|||
150084150|NCT01866930|541449626|FG000|Treatment Period|Lack of Efficacy|1|||
150084151|NCT01866930|541449627|FG001|Treatment Period|Lack of Efficacy|9|||
150084152|NCT01866930|541449626|FG000|Treatment Period|Adverse Event|4|||
150084153|NCT01866930|541449627|FG001|Treatment Period|Adverse Event|12|||
150084154|NCT01866930|541449626|FG000|Treatment Period|Lost to Follow-up|1|||
150084155|NCT01866930|541449627|FG001|Treatment Period|Lost to Follow-up|1|||
150084156|NCT01866930|541449626|FG000|Follow-up Period|Lost to Follow-up|1|||
150084157|NCT01866930|541449627|FG001|Follow-up Period|Lost to Follow-up|1|||
150084158|NCT01866930|541449626|FG000|Follow-up Period|Other|1|||
150084159|NCT01866930|541449627|FG001|Follow-up Period|Other|5|||
150084160|NCT01866930|541449626|FG000|Follow-up Period|No longer required per protocol|1|||
150084161|NCT01866930|541449627|FG001|Follow-up Period|No longer required per protocol|0|||
150084162|NCT01866930|541449626|FG000|Follow-up Period|Withdrawal by Subject|3|||
150084163|NCT01866930|541449627|FG001|Follow-up Period|Withdrawal by Subject|3|||
150084164|NCT02521870|541449632|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084165|NCT02521870|541449633|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
150084166|NCT02521870|541449634|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084167|NCT02521870|541449635|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084168|NCT02521870|541449636|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084169|NCT02521870|541449637|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084170|NCT02521870|541449638|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084171|NCT02521870|541449639|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084172|NCT02521870|541449640|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084173|NCT02521870|541449641|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084174|NCT02521870|541449642|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084175|NCT02521870|541449643|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150084176|NCT02521870|541449632|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
150084177|NCT02521870|541449633|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
150084178|NCT02521870|541449634|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
150084179|NCT02521870|541449635|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
150084180|NCT02521870|541449636|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
150084181|NCT02521870|541449637|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
150084182|NCT02521870|541449638|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
150084183|NCT02521870|541449639|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
150084184|NCT02521870|541449640|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
150084185|NCT02521870|541449641|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
150084186|NCT02521870|541449642|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
150084187|NCT02521870|541449643|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
150084188|NCT02521870|541449632|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
150084189|NCT02521870|541449633|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
150084190|NCT02521870|541449634|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
150084191|NCT02521870|541449635|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
150084192|NCT02521870|541449636|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
150084193|NCT02521870|541449637|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
150084194|NCT02521870|541449638|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
150084195|NCT02521870|541449639|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
150084196|NCT02521870|541449640|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
150084197|NCT02521870|541449641|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
150084198|NCT02521870|541449642|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
150084199|NCT02521870|541449643|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
150084200|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084201|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084202|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084203|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084204|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
150084205|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
150084206|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
150183184|NCT01340066|541808746|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
150084207|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084208|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
150084209|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
150084210|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
150084211|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150084212|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
150084213|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
150084214|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
150084215|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
150084216|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
150084217|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
150084218|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
150084219|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
150084220|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
150084221|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
150084222|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
150084223|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
150084224|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
150084225|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
150084226|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
150084227|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
150084228|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
150084229|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
150084230|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
150084231|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
150084232|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
150084233|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
150084234|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
150084235|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
150084236|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Death|0|||
150084237|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Death|0|||
150084238|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Death|0|||
150084239|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Death|0|||
150084240|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Death|1|||
150084241|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Death|1|||
150084242|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Death|3|||
150084243|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Death|1|||
150084244|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Death|1|||
150084245|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Death|5|||
150084246|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Death|2|||
150084247|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Death|2|||
150084248|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Other|0|||
150084249|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Other|0|||
150084250|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Other|0|||
150084251|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Other|0|||
150084252|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Other|10|||
150084253|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Other|3|||
150084254|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Other|2|||
150084255|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Other|0|||
150084256|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Other|10|||
150084257|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Other|5|||
150084258|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Other|1|||
150084259|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Other|7|||
150084260|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084261|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084262|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084263|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084264|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
150084265|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084266|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084267|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084268|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084269|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084270|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084271|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150084272|NCT02521870|541449632|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084273|NCT02521870|541449633|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084274|NCT02521870|541449634|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084275|NCT02521870|541449635|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084276|NCT02521870|541449636|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
150084277|NCT02521870|541449637|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084278|NCT02521870|541449638|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084279|NCT02521870|541449639|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084280|NCT02521870|541449640|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084281|NCT02521870|541449641|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084282|NCT02521870|541449642|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084283|NCT02521870|541449643|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
150084284|NCT00279305|541449646|FG000|Overall Study|Pregnancy|1|||
150084285|NCT00279305|541449647|FG001|Overall Study|Pregnancy|0|||
150084286|NCT00279305|541449646|FG000|Overall Study|Withdrawal by Subject|2|||
150084287|NCT00279305|541449647|FG001|Overall Study|Withdrawal by Subject|0|||
150084288|NCT00279305|541449646|FG000|Overall Study|Dificulting establishing IV|1|||
150084289|NCT00279305|541449647|FG001|Overall Study|Dificulting establishing IV|0|||
150084290|NCT00279305|541449646|FG000|Overall Study|FDA Safety Alert|4|||
150084291|NCT00279305|541449647|FG001|Overall Study|FDA Safety Alert|1|||
150084292|NCT02862171|541449648|FG000|Overall Study|Death|1|||
150084293|NCT02862171|541449648|FG000|Overall Study|Lost to Follow-up|13|||
150084294|NCT02862171|541449648|FG000|Overall Study|Withdrawal by Subject|57|||
150084295|NCT02862171|541449648|FG000|Overall Study|Non-compliance|4|||
150084296|NCT02862171|541449648|FG000|Overall Study|HIV-1 seroconversion|18|||
150084297|NCT03930797|541449649|FG000|Overall Study|Lost to Follow-up|3|||
150084298|NCT03930797|541449650|FG001|Overall Study|Lost to Follow-up|10|||
150084299|NCT00662012|541449651|FG000|Overall Study|Lost to Follow-up|85|||
150084300|NCT00662012|541449651|FG000|Overall Study|Death|1|||
150084301|NCT00662012|541449651|FG000|Overall Study|Withdrawal by Subject|1|||
150084302|NCT02144012|541449654|FG000|Overall Study|Adverse Event|1|||
150084303|NCT02144012|541449655|FG001|Overall Study|Adverse Event|0|||
150084304|NCT02144012|541449654|FG000|Overall Study|Death|1|||
150084305|NCT02144012|541449655|FG001|Overall Study|Death|0|||
150084306|NCT02144012|541449654|FG000|Overall Study|Withdrawal by Subject|11|||
150084307|NCT02144012|541449655|FG001|Overall Study|Withdrawal by Subject|3|||
150084308|NCT02144012|541449654|FG000|Overall Study|Study Terminated by Sponsor|18|||
150084309|NCT02144012|541449655|FG001|Overall Study|Study Terminated by Sponsor|12|||
150084310|NCT02144012|541449654|FG000|Overall Study|Other|3|||
150084311|NCT02144012|541449655|FG001|Overall Study|Other|0|||
150084312|NCT00753415|541449656|FG000|Part A|Disease progression|1|||
150084313|NCT00753415|541449657|FG001|Part A|Disease progression|0|||
150084314|NCT00753415|541449658|FG002|Part A|Disease progression|1|||
150084315|NCT00753415|541449659|FG003|Part A|Disease progression|2|||
150084316|NCT00753415|541449660|FG004|Part A|Disease progression|0|||
150084317|NCT00753415|541449661|FG005|Part A|Disease progression|0|||
150084318|NCT00753415|541449662|FG006|Part A|Disease progression|0|||
150084319|NCT00753415|541449663|FG007|Part A|Disease progression|0|||
150084320|NCT00753415|541449664|FG008|Part A|Disease progression|0|||
150084321|NCT00753415|541449665|FG009|Part A|Disease progression|0|||
150084322|NCT00753415|541449656|FG000|Part A|Withdrawal by Subject|0|||
150084323|NCT00753415|541449657|FG001|Part A|Withdrawal by Subject|0|||
150084324|NCT00753415|541449658|FG002|Part A|Withdrawal by Subject|1|||
150084325|NCT00753415|541449659|FG003|Part A|Withdrawal by Subject|0|||
150084326|NCT00753415|541449660|FG004|Part A|Withdrawal by Subject|0|||
150084327|NCT00753415|541449661|FG005|Part A|Withdrawal by Subject|0|||
150084328|NCT00753415|541449662|FG006|Part A|Withdrawal by Subject|0|||
150084329|NCT00753415|541449663|FG007|Part A|Withdrawal by Subject|0|||
150084330|NCT00753415|541449664|FG008|Part A|Withdrawal by Subject|0|||
150084331|NCT00753415|541449665|FG009|Part A|Withdrawal by Subject|0|||
150084332|NCT00753415|541449656|FG000|Part B|Lost to Follow-up|0|||
150084333|NCT00753415|541449657|FG001|Part B|Lost to Follow-up|0|||
150084334|NCT00753415|541449658|FG002|Part B|Lost to Follow-up|0|||
150084335|NCT00753415|541449659|FG003|Part B|Lost to Follow-up|0|||
150084336|NCT00753415|541449660|FG004|Part B|Lost to Follow-up|0|||
150084337|NCT00753415|541449661|FG005|Part B|Lost to Follow-up|0|||
150084338|NCT00753415|541449662|FG006|Part B|Lost to Follow-up|0|||
150084339|NCT00753415|541449663|FG007|Part B|Lost to Follow-up|1|||
150084340|NCT00753415|541449664|FG008|Part B|Lost to Follow-up|1|||
150084341|NCT00753415|541449665|FG009|Part B|Lost to Follow-up|0|||
150084342|NCT00753415|541449656|FG000|Part B|Disease progression|0|||
150084343|NCT00753415|541449657|FG001|Part B|Disease progression|0|||
150084344|NCT00753415|541449658|FG002|Part B|Disease progression|0|||
150084345|NCT00753415|541449659|FG003|Part B|Disease progression|0|||
150084346|NCT00753415|541449660|FG004|Part B|Disease progression|0|||
150084347|NCT00753415|541449661|FG005|Part B|Disease progression|0|||
150084348|NCT00753415|541449662|FG006|Part B|Disease progression|0|||
150084349|NCT00753415|541449663|FG007|Part B|Disease progression|0|||
150084350|NCT00753415|541449664|FG008|Part B|Disease progression|2|||
150084351|NCT00753415|541449665|FG009|Part B|Disease progression|1|||
150084352|NCT04212650|541449666|FG000|Overall Study|Withdrawal by Subject|1|||
150084353|NCT04212650|541449667|FG001|Overall Study|Withdrawal by Subject|0|||
150084354|NCT04656691|541449669|FG000|Overall Study|Adverse Event|1|||
150084355|NCT02846779|541449672|FG000|Overall Study|Lost Enrollment|83|||
150084356|NCT02846779|541449673|FG001|Overall Study|Lost Enrollment|82|||
150084357|NCT02846779|541449674|FG002|Overall Study|Lost Enrollment|86|||
150084358|NCT02846779|541449672|FG000|Overall Study|Less than 31 days of follow-up|56|||
150084359|NCT02846779|541449673|FG001|Overall Study|Less than 31 days of follow-up|45|||
150084360|NCT02846779|541449674|FG002|Overall Study|Less than 31 days of follow-up|52|||
150084361|NCT01753856|541449677|FG000|Overall Study|Adverse Event|1|||
150084362|NCT01753856|541449678|FG001|Overall Study|Adverse Event|0|||
150084363|NCT01753856|541449677|FG000|Overall Study|Withdrawal by Subject|0|||
150084364|NCT01753856|541449678|FG001|Overall Study|Withdrawal by Subject|2|||
150084365|NCT01753856|541449677|FG000|Overall Study|Sponsor Decision|2|||
150084366|NCT01753856|541449678|FG001|Overall Study|Sponsor Decision|0|||
150084367|NCT00887978|541449679|FG000|Overall Study|Adverse Event|18|||
150084368|NCT00887978|541449680|FG001|Overall Study|Adverse Event|5|||
150084369|NCT00887978|541449679|FG000|Overall Study|Clinical Worsening|4|||
150084370|NCT00887978|541449680|FG001|Overall Study|Clinical Worsening|4|||
150084371|NCT00887978|541449679|FG000|Overall Study|Death|2|||
150084372|NCT00887978|541449680|FG001|Overall Study|Death|3|||
150084373|NCT00887978|541449679|FG000|Overall Study|Withdrawal by Subject|1|||
150084374|NCT00887978|541449680|FG001|Overall Study|Withdrawal by Subject|2|||
150084375|NCT00887978|541449679|FG000|Overall Study|Lost to Follow-up|0|||
150084376|NCT00887978|541449680|FG001|Overall Study|Lost to Follow-up|1|||
150084377|NCT02700815|541451658|FG000|Overall Study|Adverse Event|0|||
150084378|NCT02700815|541451659|FG001|Overall Study|Adverse Event|6|||
150084379|NCT02700815|541451660|FG002|Overall Study|Adverse Event|2|||
150084380|NCT02700815|541451661|FG003|Overall Study|Adverse Event|3|||
150084381|NCT02700815|541451658|FG000|Overall Study|Lack of Efficacy|0|||
150084382|NCT02700815|541451659|FG001|Overall Study|Lack of Efficacy|0|||
150084383|NCT02700815|541451660|FG002|Overall Study|Lack of Efficacy|1|||
150084384|NCT02700815|541451661|FG003|Overall Study|Lack of Efficacy|2|||
150084385|NCT02700815|541451658|FG000|Overall Study|Lost to Follow-up|1|||
150084386|NCT02700815|541451659|FG001|Overall Study|Lost to Follow-up|0|||
150084387|NCT02700815|541451660|FG002|Overall Study|Lost to Follow-up|0|||
150084388|NCT02700815|541451661|FG003|Overall Study|Lost to Follow-up|1|||
150084389|NCT02700815|541451658|FG000|Overall Study|Refusal to continue medication|0|||
150084390|NCT02700815|541451659|FG001|Overall Study|Refusal to continue medication|1|||
150084391|NCT02700815|541451660|FG002|Overall Study|Refusal to continue medication|0|||
150084392|NCT02700815|541451661|FG003|Overall Study|Refusal to continue medication|1|||
150084393|NCT02700815|541451658|FG000|Overall Study|Withdrawal by Subject|0|||
150084394|NCT02700815|541451659|FG001|Overall Study|Withdrawal by Subject|0|||
150084395|NCT02700815|541451660|FG002|Overall Study|Withdrawal by Subject|1|||
150084396|NCT02700815|541451661|FG003|Overall Study|Withdrawal by Subject|0|||
150084397|NCT04023526|541451662|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
150084398|NCT04023526|541451663|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
150084399|NCT04023526|541451662|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
150084400|NCT04023526|541451663|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
150084401|NCT02324569|541451673|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
150084402|NCT02324569|541451674|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
150084403|NCT02324569|541451673|FG000|Overall Study|Voluntary Withdrawal|3|||
150084404|NCT02324569|541451674|FG001|Overall Study|Voluntary Withdrawal|6|||
150084405|NCT02324569|541451673|FG000|Overall Study|Lack of Efficacy|2|||
150084406|NCT02324569|541451674|FG001|Overall Study|Lack of Efficacy|3|||
150084407|NCT02324569|541451673|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
150084408|NCT02324569|541451674|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
150084409|NCT02324569|541451673|FG000|Overall Study|Inconvenient Schedule|2|||
150084410|NCT02324569|541451674|FG001|Overall Study|Inconvenient Schedule|0|||
150084411|NCT01943292|541451681|FG000|Overall Study|Withdrawal by Subject|1|||
150084412|NCT01943292|541451682|FG001|Overall Study|Withdrawal by Subject|0|||
150084413|NCT01943292|541451683|FG002|Overall Study|Withdrawal by Subject|0|||
150084414|NCT00911820|541451684|FG000|Overall Study|RECIST progression|12|||
150084415|NCT00911820|541451685|FG001|Overall Study|RECIST progression|8|||
150084416|NCT00911820|541451684|FG000|Overall Study|Adverse Event|8|||
150084417|NCT00911820|541451685|FG001|Overall Study|Adverse Event|8|||
150084418|NCT00911820|541451684|FG000|Overall Study|Clinical Progression|7|||
150084419|NCT00911820|541451685|FG001|Overall Study|Clinical Progression|5|||
150084420|NCT00911820|541451684|FG000|Overall Study|Physician Decision|5|||
150084421|NCT00911820|541451685|FG001|Overall Study|Physician Decision|9|||
150084422|NCT00911820|541451684|FG000|Overall Study|Decline in Performance Status|4|||
150084423|NCT00911820|541451685|FG001|Overall Study|Decline in Performance Status|2|||
150084424|NCT00911820|541451684|FG000|Overall Study|Withdrawal by Subject|3|||
150084425|NCT00911820|541451685|FG001|Overall Study|Withdrawal by Subject|4|||
150084426|NCT00911820|541451684|FG000|Overall Study|Death|1|||
150084427|NCT00911820|541451685|FG001|Overall Study|Death|2|||
150084428|NCT00911820|541451684|FG000|Overall Study|Pursue surgery|1|||
150084429|NCT00911820|541451685|FG001|Overall Study|Pursue surgery|1|||
150084430|NCT00911820|541451684|FG000|Overall Study|Pursue Radiation|1|||
150084431|NCT00911820|541451685|FG001|Overall Study|Pursue Radiation|0|||
150084432|NCT00911820|541451684|FG000|Overall Study|Still on Therapy|2|||
150084433|NCT00911820|541451685|FG001|Overall Study|Still on Therapy|2|||
150084434|NCT00911820|541451684|FG000|Overall Study|Pathology Not Confirmed|1|||
150084435|NCT00911820|541451685|FG001|Overall Study|Pathology Not Confirmed|0|||
150084436|NCT00911820|541451684|FG000|Overall Study|Withdraw before Receive Treatment|0|||
150084437|NCT00911820|541451685|FG001|Overall Study|Withdraw before Receive Treatment|2|||
150084438|NCT00996216|541451686|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
150084439|NCT00996216|541451686|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
150084440|NCT00996216|541451686|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
150084441|NCT00963547|541451697|FG000|Overall Study|Adverse Event|0|||
150084442|NCT00963547|541451698|FG001|Overall Study|Adverse Event|1|||
150084443|NCT00963547|541451699|FG002|Overall Study|Adverse Event|0|||
150084444|NCT00963547|541451700|FG003|Overall Study|Adverse Event|1|||
150084445|NCT00963547|541451701|FG004|Overall Study|Adverse Event|0|||
150084446|NCT00963547|541451702|FG005|Overall Study|Adverse Event|0|||
150084447|NCT00963547|541451703|FG006|Overall Study|Adverse Event|0|||
150084448|NCT00963547|541451697|FG000|Overall Study|Physician Decision|1|||
150084449|NCT00963547|541451698|FG001|Overall Study|Physician Decision|1|||
150084450|NCT00963547|541451699|FG002|Overall Study|Physician Decision|0|||
150084451|NCT00963547|541451700|FG003|Overall Study|Physician Decision|0|||
150084452|NCT00963547|541451701|FG004|Overall Study|Physician Decision|0|||
150084453|NCT00963547|541451702|FG005|Overall Study|Physician Decision|0|||
150084454|NCT00963547|541451703|FG006|Overall Study|Physician Decision|0|||
150084455|NCT00963547|541451697|FG000|Overall Study|Progressive Disease|3|||
150084456|NCT00963547|541451698|FG001|Overall Study|Progressive Disease|8|||
150084457|NCT00963547|541451699|FG002|Overall Study|Progressive Disease|9|||
150084458|NCT00963547|541451700|FG003|Overall Study|Progressive Disease|5|||
150084459|NCT00963547|541451701|FG004|Overall Study|Progressive Disease|0|||
150084460|NCT00963547|541451702|FG005|Overall Study|Progressive Disease|0|||
150084461|NCT00963547|541451703|FG006|Overall Study|Progressive Disease|0|||
150084462|NCT00963547|541451697|FG000|Overall Study|Withdrawal by Subject|0|||
150084463|NCT00963547|541451698|FG001|Overall Study|Withdrawal by Subject|0|||
150084464|NCT00963547|541451699|FG002|Overall Study|Withdrawal by Subject|3|||
150084465|NCT00963547|541451700|FG003|Overall Study|Withdrawal by Subject|0|||
150084466|NCT00963547|541451701|FG004|Overall Study|Withdrawal by Subject|0|||
150084467|NCT00963547|541451702|FG005|Overall Study|Withdrawal by Subject|0|||
150084468|NCT00963547|541451703|FG006|Overall Study|Withdrawal by Subject|0|||
150084469|NCT00963547|541451697|FG000|Overall Study|Reason Unknown|0|||
150084470|NCT00963547|541451698|FG001|Overall Study|Reason Unknown|1|||
150084471|NCT00963547|541451699|FG002|Overall Study|Reason Unknown|0|||
150084472|NCT00963547|541451700|FG003|Overall Study|Reason Unknown|0|||
150084473|NCT00963547|541451701|FG004|Overall Study|Reason Unknown|0|||
150084474|NCT00963547|541451702|FG005|Overall Study|Reason Unknown|0|||
150084475|NCT00963547|541451703|FG006|Overall Study|Reason Unknown|0|||
150084476|NCT00903695|541451707|FG000|Overall Study|medical exclusion after 1st testing|1|||
150084477|NCT00903695|541451708|FG001|Overall Study|medical exclusion after 1st testing|0|||
150084478|NCT00903695|541451707|FG000|Overall Study|lung cancer|1|||
150084479|NCT00903695|541451708|FG001|Overall Study|lung cancer|0|||
150084480|NCT02430311|541451710|FG000|Part A|Adverse Event|0|||
150084481|NCT02430311|541451711|FG001|Part A|Adverse Event|1|||
150084482|NCT02430311|541451710|FG000|Part A|Withdrawal by Subject|1|||
150084483|NCT02430311|541451711|FG001|Part A|Withdrawal by Subject|0|||
150084484|NCT02430311|541451710|FG000|Part B|Meet study-specific withdrawal criteria|6|||
150084485|NCT02430311|541451711|FG001|Part B|Meet study-specific withdrawal criteria|6|||
150084486|NCT02430311|541451710|FG000|Part B|Withdrawal by Subject|2|||
150084487|NCT02430311|541451711|FG001|Part B|Withdrawal by Subject|2|||
150084488|NCT02430311|541451710|FG000|Part B|Adverse Event|1|||
150084489|NCT02430311|541451711|FG001|Part B|Adverse Event|0|||
150084490|NCT02430311|541451710|FG000|Part B|Death|1|||
150084491|NCT02430311|541451711|FG001|Part B|Death|0|||
150084492|NCT02495168|541451714|FG000|Overall Study|Other than Specified|18|||
150084493|NCT02495168|541451715|FG001|Overall Study|Other than Specified|22|||
150084494|NCT02495168|541451716|FG002|Overall Study|Other than Specified|5|||
150084495|NCT02495168|541451714|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
150084496|NCT02495168|541451715|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
150084497|NCT02495168|541451716|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
150084498|NCT02495168|541451714|FG000|Overall Study|Physician Decision|1|||
150084499|NCT02495168|541451715|FG001|Overall Study|Physician Decision|1|||
150084500|NCT02495168|541451716|FG002|Overall Study|Physician Decision|0|||
150084501|NCT02495168|541451714|FG000|Overall Study|Lost to Follow-up|10|||
150084502|NCT02495168|541451715|FG001|Overall Study|Lost to Follow-up|6|||
150084503|NCT02495168|541451716|FG002|Overall Study|Lost to Follow-up|1|||
150084504|NCT02495168|541451714|FG000|Overall Study|Withdrawal by Subject|1|||
150084505|NCT02495168|541451715|FG001|Overall Study|Withdrawal by Subject|4|||
150084506|NCT02495168|541451716|FG002|Overall Study|Withdrawal by Subject|2|||
150084507|NCT02495168|541451714|FG000|Overall Study|Protocol Violation|0|||
150084508|NCT02495168|541451715|FG001|Overall Study|Protocol Violation|10|||
150084509|NCT02495168|541451716|FG002|Overall Study|Protocol Violation|1|||
150084510|NCT02495168|541451714|FG000|Overall Study|Adverse Event|4|||
150084511|NCT02495168|541451715|FG001|Overall Study|Adverse Event|8|||
150084512|NCT02495168|541451716|FG002|Overall Study|Adverse Event|3|||
150084513|NCT02495168|541451714|FG000|Overall Study|Lack of Efficacy|0|||
150084514|NCT02495168|541451715|FG001|Overall Study|Lack of Efficacy|0|||
150084515|NCT02495168|541451716|FG002|Overall Study|Lack of Efficacy|3|||
150084516|NCT00284050|541451719|FG000|Overall Study|Adverse Event|1|||
150084517|NCT00284050|541451720|FG001|Overall Study|Adverse Event|1|||
150084518|NCT00284050|541451721|FG002|Overall Study|Adverse Event|1|||
150084519|NCT00284050|541451719|FG000|Overall Study|Lack of Efficacy|0|||
150084520|NCT00284050|541451720|FG001|Overall Study|Lack of Efficacy|1|||
150084521|NCT00284050|541451721|FG002|Overall Study|Lack of Efficacy|3|||
150084522|NCT00284050|541451719|FG000|Overall Study|Protocol Violation|0|||
150084523|NCT00284050|541451720|FG001|Overall Study|Protocol Violation|1|||
150084524|NCT00284050|541451721|FG002|Overall Study|Protocol Violation|2|||
150084525|NCT00284050|541451719|FG000|Overall Study|Withdrawal by Subject|2|||
150084526|NCT00284050|541451720|FG001|Overall Study|Withdrawal by Subject|2|||
150084527|NCT00284050|541451721|FG002|Overall Study|Withdrawal by Subject|2|||
150084528|NCT00284050|541451719|FG000|Overall Study|Lost to Follow-up|1|||
150084529|NCT00284050|541451720|FG001|Overall Study|Lost to Follow-up|0|||
150084530|NCT00284050|541451721|FG002|Overall Study|Lost to Follow-up|1|||
150084531|NCT00284050|541451719|FG000|Overall Study|Death|1|||
150084532|NCT00284050|541451720|FG001|Overall Study|Death|0|||
150084533|NCT00284050|541451721|FG002|Overall Study|Death|0|||
150084534|NCT02573350|541451722|FG000|Overall Study|Lost to Follow-up|2|||
150084535|NCT02573350|541451723|FG001|Overall Study|Lost to Follow-up|1|||
150084536|NCT02573350|541451722|FG000|Overall Study|Adverse Event|3|||
150084537|NCT02573350|541451723|FG001|Overall Study|Adverse Event|4|||
150084538|NCT02573350|541451722|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
150084539|NCT02573350|541451723|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
150084540|NCT02573350|541451722|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
150084541|NCT02573350|541451723|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
150084542|NCT02573350|541451722|FG000|Overall Study|Subject withdrew consent to participate|6|||
150084543|NCT02573350|541451723|FG001|Overall Study|Subject withdrew consent to participate|1|||
150084544|NCT02573350|541451722|FG000|Overall Study|Protocol Deviation|1|||
150084545|NCT02573350|541451723|FG001|Overall Study|Protocol Deviation|1|||
150084546|NCT02708121|541451724|FG000|Overall Study|Withdrawn by Study Team|1|||
150084547|NCT02708121|541451725|FG001|Overall Study|Withdrawn by Study Team|1|||
150084548|NCT02708121|541451724|FG000|Overall Study|Withdrawal by Subject|0|||
150084549|NCT02708121|541451725|FG001|Overall Study|Withdrawal by Subject|4|||
150084550|NCT01987505|541451726|FG000|Overall Study|Other|9|||
150084551|NCT01987505|541451726|FG000|Overall Study|Withdrawal by Subject|2|||
150084552|NCT01987505|541451726|FG000|Overall Study|Other Reason|2|||
150084553|NCT01987505|541451726|FG000|Overall Study|Lost to Follow-up|15|||
150084554|NCT01987505|541451726|FG000|Overall Study|Investigator Decision|2|||
150084555|NCT01987505|541451726|FG000|Overall Study|Death|4|||
150084556|NCT03454997|541451727|FG000|Overall Study|Staff Coach - Left Oranization|1|||
150084557|NCT03454997|541451728|FG001|Overall Study|Staff Coach - Left Oranization|1|||
150084558|NCT03454997|541451727|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
150084559|NCT03454997|541451728|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
150084560|NCT03454997|541451727|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
150084561|NCT03454997|541451728|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
150084562|NCT03454997|541451727|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
150084563|NCT03454997|541451728|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
150084564|NCT03454997|541451727|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
150084565|NCT03454997|541451728|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
150084566|NCT03454997|541451727|FG000|Overall Study|Client with SMI - Left organization|0|||
150084567|NCT03454997|541451728|FG001|Overall Study|Client with SMI - Left organization|1|||
150084568|NCT03454997|541451727|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
150084569|NCT03454997|541451728|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
150084570|NCT01111149|541451729|FG000|Overall Study|Protocol Violation|1|||
150084571|NCT01111149|541451730|FG001|Overall Study|Protocol Violation|1|||
150084572|NCT01111149|541451731|FG002|Overall Study|Protocol Violation|2|||
150084573|NCT01111149|541451729|FG000|Overall Study|Withdrawal by Subject|1|||
150084574|NCT01111149|541451730|FG001|Overall Study|Withdrawal by Subject|0|||
150084575|NCT01111149|541451731|FG002|Overall Study|Withdrawal by Subject|2|||
150084576|NCT03765918|541451741|FG000|Overall Study|Death|109|||
150084577|NCT03765918|541451742|FG001|Overall Study|Death|127|||
150084578|NCT03765918|541451741|FG000|Overall Study|Lost to Follow-up|2|||
150084579|NCT03765918|541451742|FG001|Overall Study|Lost to Follow-up|3|||
150084580|NCT03765918|541451741|FG000|Overall Study|Withdrawal by Subject|12|||
150084581|NCT03765918|541451742|FG001|Overall Study|Withdrawal by Subject|16|||
150084582|NCT03765918|541451741|FG000|Overall Study|Participants Ongoing|240|||
150084583|NCT03765918|541451742|FG001|Overall Study|Participants Ongoing|205|||
150084584|NCT04202965|541451743|FG000|Overall Study|Adverse Event|3|||
150084585|NCT04202965|541451743|FG000|Overall Study|Did not meet inclusion criteria|1|||
150084586|NCT02794883|541451747|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
150084587|NCT02794883|541451748|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
150084588|NCT02794883|541451749|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
150084589|NCT02794883|541451747|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
150084590|NCT02794883|541451748|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
150084591|NCT02794883|541451749|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
150084592|NCT02794883|541451747|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
150084593|NCT02794883|541451748|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
150084594|NCT02794883|541451749|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
150084595|NCT02794883|541451747|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
150084596|NCT02794883|541451748|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
150084597|NCT02794883|541451749|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
150084598|NCT02794883|541451747|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
150084599|NCT02794883|541451748|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
150084600|NCT02794883|541451749|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
150084601|NCT02794883|541451747|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
150084602|NCT02794883|541451748|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
150084603|NCT02794883|541451749|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
150084604|NCT02794883|541451747|FG000|Follow-up Period (up to 2 Years)|Death|12|||
150084605|NCT02794883|541451748|FG001|Follow-up Period (up to 2 Years)|Death|10|||
150084606|NCT02794883|541451749|FG002|Follow-up Period (up to 2 Years)|Death|10|||
150084607|NCT01484197|541451754|FG000|Treatment Period 1|Adverse Event|1|||
150084608|NCT01484197|541451755|FG001|Treatment Period 1|Adverse Event|0|||
150084609|NCT01484197|541451756|FG002|Treatment Period 1|Adverse Event|0|||
150084610|NCT01484197|541451757|FG003|Treatment Period 1|Adverse Event|0|||
150084611|NCT01484197|541451754|FG000|Treatment Period 2|Subject withdrew consent|0|||
150084612|NCT01484197|541451755|FG001|Treatment Period 2|Subject withdrew consent|0|||
150084613|NCT01484197|541451756|FG002|Treatment Period 2|Subject withdrew consent|0|||
150084614|NCT01484197|541451757|FG003|Treatment Period 2|Subject withdrew consent|1|||
150084615|NCT01727297|541451758|FG000|Overall Study|Death|13|||
150084616|NCT01727297|541451759|FG001|Overall Study|Death|0|||
150084617|NCT01727297|541451758|FG000|Overall Study|Protocol Violation|1|||
150183185|NCT01340066|541808747|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
150183186|NCT01340066|541808748|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
150183187|NCT01340066|541808746|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
150183188|NCT01340066|541808747|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
150084618|NCT01727297|541451759|FG001|Overall Study|Protocol Violation|10|||
150084619|NCT01727297|541451758|FG000|Overall Study|Adverse Event|3|||
150084620|NCT01727297|541451759|FG001|Overall Study|Adverse Event|1|||
150084621|NCT01727297|541451758|FG000|Overall Study|Lost to Follow-up|11|||
150084622|NCT01727297|541451759|FG001|Overall Study|Lost to Follow-up|0|||
150084623|NCT01727297|541451758|FG000|Overall Study|Withdrawal by Subject|26|||
150084624|NCT01727297|541451759|FG001|Overall Study|Withdrawal by Subject|27|||
150084625|NCT01727297|541451758|FG000|Overall Study|Physician Decision|19|||
150084626|NCT01727297|541451759|FG001|Overall Study|Physician Decision|5|||
150084627|NCT01727297|541451758|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
150183189|NCT01340066|541808748|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
150183190|NCT01340066|541808746|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
150084628|NCT01727297|541451759|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
150084629|NCT00814164|541451767|FG000|Overall Study|Progression|7|||
150084630|NCT00814164|541451767|FG000|Overall Study|not stated|7|||
150084631|NCT00814164|541451767|FG000|Overall Study|Death|5|||
150084632|NCT01980992|541451768|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
150084633|NCT01980992|541451769|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
150084634|NCT01980992|541451768|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
150084635|NCT01980992|541451769|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
150084636|NCT01980992|541451768|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
150084637|NCT01980992|541451769|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
150084638|NCT01980992|541451768|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
150084639|NCT01980992|541451769|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
150084640|NCT01980992|541451768|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
150084641|NCT01980992|541451769|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
150084642|NCT01980992|541451768|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
150084643|NCT01980992|541451769|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
150084644|NCT00299975|541451770|FG000|Overall Study|Adverse Event|1|||
150084645|NCT00299975|541451771|FG001|Overall Study|Adverse Event|0|||
150084646|NCT00299975|541451772|FG002|Overall Study|Adverse Event|2|||
150084647|NCT00299975|541451770|FG000|Overall Study|Pregnancy|0|||
150084648|NCT00299975|541451771|FG001|Overall Study|Pregnancy|0|||
150084649|NCT00299975|541451772|FG002|Overall Study|Pregnancy|1|||
150084650|NCT00299975|541451770|FG000|Overall Study|Lack of Efficacy|1|||
150084651|NCT00299975|541451771|FG001|Overall Study|Lack of Efficacy|0|||
150084652|NCT00299975|541451772|FG002|Overall Study|Lack of Efficacy|1|||
150084653|NCT00299975|541451770|FG000|Overall Study|Lost to Follow-up|1|||
150084654|NCT00299975|541451771|FG001|Overall Study|Lost to Follow-up|0|||
150084655|NCT00299975|541451772|FG002|Overall Study|Lost to Follow-up|0|||
150084656|NCT00299975|541451770|FG000|Overall Study|Withdrawal by Subject|0|||
150084657|NCT00299975|541451771|FG001|Overall Study|Withdrawal by Subject|1|||
150084658|NCT00299975|541451772|FG002|Overall Study|Withdrawal by Subject|3|||
150084659|NCT00299975|541451770|FG000|Overall Study|Physician Decision|0|||
150084660|NCT00299975|541451771|FG001|Overall Study|Physician Decision|0|||
150084661|NCT00299975|541451772|FG002|Overall Study|Physician Decision|1|||
150084662|NCT01169493|541451779|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
150084663|NCT01169493|541451780|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
150084664|NCT01169493|541451781|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
150084665|NCT01169493|541451782|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
150084666|NCT01169493|541451783|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
150084667|NCT01169493|541451784|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
150084668|NCT01169493|541451779|FG000|Period 3 (6 Months)|Adverse Event|0|||
150084669|NCT01169493|541451780|FG001|Period 3 (6 Months)|Adverse Event|1|||
150084670|NCT01169493|541451781|FG002|Period 3 (6 Months)|Adverse Event|0|||
150084671|NCT01169493|541451782|FG003|Period 3 (6 Months)|Adverse Event|0|||
150084672|NCT01169493|541451783|FG004|Period 3 (6 Months)|Adverse Event|0|||
150084673|NCT01169493|541451784|FG005|Period 3 (6 Months)|Adverse Event|0|||
150084674|NCT01169493|541451779|FG000|Period 3 (6 Months)|Physician Decision|0|||
150084675|NCT01169493|541451780|FG001|Period 3 (6 Months)|Physician Decision|1|||
150084676|NCT01169493|541451781|FG002|Period 3 (6 Months)|Physician Decision|1|||
150084677|NCT01169493|541451782|FG003|Period 3 (6 Months)|Physician Decision|0|||
150084678|NCT01169493|541451783|FG004|Period 3 (6 Months)|Physician Decision|0|||
150084679|NCT01169493|541451784|FG005|Period 3 (6 Months)|Physician Decision|0|||
150084680|NCT05228132|541451785|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
150084681|NCT05228132|541451785|FG000|Overall Study|Adverse Event|3|||
150084682|NCT05228132|541451785|FG000|Overall Study|Lost to Follow-up|1|||
150084683|NCT05228132|541451785|FG000|Overall Study|Arteriovenous-fistula mature|1|||
150084684|NCT00642460|541451793|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
150084685|NCT00642460|541451794|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
150084686|NCT00642460|541451795|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
150084687|NCT00642460|541451796|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
150084688|NCT00642460|541451797|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
150084689|NCT00642460|541451798|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
150084690|NCT00642460|541451793|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
150084691|NCT00642460|541451794|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
150084692|NCT00642460|541451795|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
150084693|NCT00642460|541451796|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
150084694|NCT00642460|541451797|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
150084695|NCT00642460|541451798|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
150084696|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
150084697|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
150084698|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
150084699|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
150084700|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
150084701|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
150084702|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Death|0|||
150084703|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Death|1|||
150084704|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Death|0|||
150084705|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Death|2|||
150084706|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Death|0|||
150084707|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Death|0|||
150084708|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
150084709|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
150084710|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
150084711|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
150084712|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
150084713|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
150084714|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
150084715|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
150084716|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
150084717|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
150084718|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
150084719|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
150084720|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
150084721|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
150084722|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
150084723|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
150084724|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
150084725|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
150084726|NCT00642460|541451793|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
150084727|NCT00642460|541451794|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
150084728|NCT00642460|541451795|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
150084729|NCT00642460|541451796|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
150084730|NCT00642460|541451797|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
150084731|NCT00642460|541451798|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
150084732|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
150084733|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
150084734|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
150084735|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
150084736|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
150084737|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
150084738|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
150084739|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
150084740|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
150084741|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
150084742|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
150084743|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
150084744|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
150084745|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
150084746|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
150084747|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
150084748|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
150084749|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
150084750|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
150084751|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
150084752|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
150084753|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
150084754|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
150084755|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
150084756|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Other|0|||
150084757|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Other|0|||
150084758|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Other|0|||
150084759|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Other|0|||
150084760|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Other|2|||
150084761|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Other|2|||
150084762|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Death|0|||
150084763|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Death|0|||
150084764|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Death|0|||
150084765|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Death|0|||
150084766|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Death|0|||
150084767|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Death|3|||
150084768|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
150084769|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
150084770|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
150084771|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
150084772|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
150084773|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
150084774|NCT00642460|541451793|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
150084775|NCT00642460|541451794|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
150084776|NCT00642460|541451795|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
150084777|NCT00642460|541451796|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
150084778|NCT00642460|541451797|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
150084779|NCT00642460|541451798|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
150084780|NCT01844518|541451804|FG000|Overall Study|Adverse Event|7|||
150084781|NCT01844518|541451805|FG001|Overall Study|Adverse Event|1|||
150084782|NCT01844518|541451804|FG000|Overall Study|Lack of Efficacy|17|||
150084783|NCT01844518|541451805|FG001|Overall Study|Lack of Efficacy|5|||
150084784|NCT01844518|541451804|FG000|Overall Study|Participant's request to discontinue|4|||
150084785|NCT01844518|541451805|FG001|Overall Study|Participant's request to discontinue|1|||
150183191|NCT01340066|541808747|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
150183192|NCT01340066|541808748|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
150183193|NCT03771352|541808757|FG000|Overall Study|Screen failure|2|||
150183194|NCT03771352|541808757|FG000|Overall Study|Withdrawal by Subject|2|||
150084786|NCT01844518|541451804|FG000|Overall Study|Poor/Non-compliance|1|||
150084787|NCT01844518|541451805|FG001|Overall Study|Poor/Non-compliance|0|||
150084788|NCT01844518|541451804|FG000|Overall Study|No Longer Met Study Criteria|2|||
150084789|NCT01844518|541451805|FG001|Overall Study|No Longer Met Study Criteria|0|||
150084790|NCT01844518|541451804|FG000|Overall Study|Withdrawal by Subject|9|||
150084791|NCT01844518|541451805|FG001|Overall Study|Withdrawal by Subject|0|||
150084792|NCT01844518|541451804|FG000|Overall Study|Pregnancy|1|||
150084793|NCT01844518|541451805|FG001|Overall Study|Pregnancy|0|||
150084794|NCT02756013|541451806|FG000|Overall Study|Adverse Event|1|||
150084795|NCT02756013|541451806|FG000|Overall Study|Hypersensitivity|1|||
150084796|NCT01197560|541451807|FG000|Overall Study|Adverse Event|6|||
150084797|NCT01197560|541451808|FG001|Overall Study|Adverse Event|8|||
150084798|NCT01197560|541451807|FG000|Overall Study|Death|3|||
150084799|NCT01197560|541451808|FG001|Overall Study|Death|5|||
150084800|NCT01197560|541451807|FG000|Overall Study|Withdrawal by Subject|1|||
150084801|NCT01197560|541451808|FG001|Overall Study|Withdrawal by Subject|1|||
150084802|NCT01197560|541451807|FG000|Overall Study|Disease progression|40|||
150084803|NCT01197560|541451808|FG001|Overall Study|Disease progression|35|||
150084804|NCT01197560|541451807|FG000|Overall Study|Miscellaneous|4|||
150084805|NCT01197560|541451808|FG001|Overall Study|Miscellaneous|3|||
150084806|NCT01197560|541451807|FG000|Overall Study|Missing|0|||
150084807|NCT01197560|541451808|FG001|Overall Study|Missing|1|||
150084808|NCT00211510|541451809|FG000|Overall Study|Physician Decision|3|||
150084809|NCT00211510|541451810|FG001|Overall Study|Physician Decision|1|||
150084810|NCT00211510|541451809|FG000|Overall Study|Withdrawal by Subject|3|||
150084811|NCT00211510|541451810|FG001|Overall Study|Withdrawal by Subject|1|||
150084812|NCT02216591|541451811|FG000|Overall Study|Lost to Follow-up|0|||
150084813|NCT02216591|541451812|FG001|Overall Study|Lost to Follow-up|1|||
150084814|NCT02854631|541451815|FG000|Overall Study|Adverse Event|1|||
150084815|NCT02854631|541451816|FG001|Overall Study|Adverse Event|2|||
150183195|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
150183196|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
150084816|NCT02854631|541451815|FG000|Overall Study|Withdrew Consent|3|||
150084817|NCT02854631|541451816|FG001|Overall Study|Withdrew Consent|2|||
150084818|NCT02854631|541451815|FG000|Overall Study|Investigator's Discretion|2|||
150084819|NCT02854631|541451816|FG001|Overall Study|Investigator's Discretion|0|||
150084820|NCT02854631|541451815|FG000|Overall Study|Death|12|||
150084821|NCT02854631|541451816|FG001|Overall Study|Death|8|||
150084822|NCT02854631|541451815|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
150084823|NCT02854631|541451816|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
150084824|NCT02854631|541451815|FG000|Overall Study|Protocol Violation|0|||
150084825|NCT02854631|541451816|FG001|Overall Study|Protocol Violation|1|||
150084826|NCT02854631|541451815|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
150084827|NCT02854631|541451816|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
150084828|NCT02854631|541451815|FG000|Overall Study|Lost to Follow-up|4|||
150084829|NCT02854631|541451816|FG001|Overall Study|Lost to Follow-up|2|||
150084830|NCT00621153|541451820|FG000|Overall Study|Safety Reason|8|||
150084831|NCT00621153|541451821|FG001|Overall Study|Safety Reason|7|||
150084832|NCT00621153|541451820|FG000|Overall Study|Adverse Event|3|||
150183197|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
150183198|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
150183199|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
150084833|NCT00621153|541451821|FG001|Overall Study|Adverse Event|2|||
150183200|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
150084834|NCT00621153|541451820|FG000|Overall Study|Lost to Follow-up|5|||
150084835|NCT00621153|541451821|FG001|Overall Study|Lost to Follow-up|1|||
150084836|NCT00621153|541451820|FG000|Overall Study|Withdrawal by Subject|4|||
150084837|NCT00621153|541451821|FG001|Overall Study|Withdrawal by Subject|5|||
150183201|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
150084838|NCT00598832|541451826|FG000|Overall Study|Lack of Efficacy|3|||
150084839|NCT00598832|541451827|FG001|Overall Study|Lack of Efficacy|7|||
150084840|NCT00598832|541451826|FG000|Overall Study|Adverse Event|6|||
150084841|NCT00598832|541451827|FG001|Overall Study|Adverse Event|2|||
150084842|NCT00598832|541451826|FG000|Overall Study|Withdrawal by Subject|25|||
150084843|NCT00598832|541451827|FG001|Overall Study|Withdrawal by Subject|36|||
150084844|NCT00598832|541451826|FG000|Overall Study|Protocol Violation|0|||
150084845|NCT00598832|541451827|FG001|Overall Study|Protocol Violation|2|||
150084846|NCT00598832|541451826|FG000|Overall Study|Lost to Follow-up|24|||
150084847|NCT00598832|541451827|FG001|Overall Study|Lost to Follow-up|29|||
150084848|NCT00598832|541451826|FG000|Overall Study|Pregnancy|2|||
150084849|NCT00598832|541451827|FG001|Overall Study|Pregnancy|2|||
150084850|NCT00598832|541451826|FG000|Overall Study|Physician Decision|1|||
150084851|NCT00598832|541451827|FG001|Overall Study|Physician Decision|4|||
150084852|NCT00598832|541451826|FG000|Overall Study|Non compliance|1|||
150084853|NCT00598832|541451827|FG001|Overall Study|Non compliance|0|||
150084854|NCT00357968|541451835|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
150084855|NCT00357968|541451836|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
150084856|NCT00357968|541451835|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
150084857|NCT00357968|541451836|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
150084858|NCT02142959|541451838|FG000|Overall Study|Adverse Event|1|||
150084859|NCT02142959|541451839|FG001|Overall Study|Adverse Event|0|||
150084860|NCT02142959|541451840|FG002|Overall Study|Adverse Event|0|||
150084861|NCT02142959|541451838|FG000|Overall Study|Death|0|||
150084862|NCT02142959|541451839|FG001|Overall Study|Death|1|||
150084863|NCT02142959|541451840|FG002|Overall Study|Death|0|||
150084864|NCT02142959|541451838|FG000|Overall Study|Withdrawal by Subject|3|||
150084865|NCT02142959|541451839|FG001|Overall Study|Withdrawal by Subject|1|||
150084866|NCT02142959|541451840|FG002|Overall Study|Withdrawal by Subject|3|||
150084867|NCT02142959|541451838|FG000|Overall Study|Administrative Reasons|1|||
150084868|NCT02142959|541451839|FG001|Overall Study|Administrative Reasons|0|||
150084869|NCT02142959|541451840|FG002|Overall Study|Administrative Reasons|1|||
150084870|NCT02142959|541451838|FG000|Overall Study|Missing|0|||
150084871|NCT02142959|541451839|FG001|Overall Study|Missing|1|||
150084872|NCT02142959|541451840|FG002|Overall Study|Missing|0|||
150084873|NCT02142959|541451838|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
150084874|NCT02142959|541451839|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
150084875|NCT02142959|541451840|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
150084876|NCT02142959|541451838|FG000|Overall Study|Patient didn't complete end of study visit|0|||
150084877|NCT02142959|541451839|FG001|Overall Study|Patient didn't complete end of study visit|0|||
150084878|NCT02142959|541451840|FG002|Overall Study|Patient didn't complete end of study visit|1|||
150084879|NCT00679302|541451841|FG000|Overall Study|Lost to Follow-up|8|||
150084880|NCT00679302|541451842|FG001|Overall Study|Lost to Follow-up|4|||
150084881|NCT03547687|541451843|FG000|Overall Study|Withdrawal by Subject|1|||
150084882|NCT03547687|541451843|FG000|Overall Study|Death|1|||
150084883|NCT00793403|541453601|FG000|Overall Study|Other|73|||
150084884|NCT02899988|541453602|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
150084885|NCT02899988|541453603|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
150084886|NCT02899988|541453604|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084887|NCT02899988|541453605|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084888|NCT02899988|541453606|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084889|NCT02899988|541453607|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084890|NCT02899988|541453608|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084891|NCT02899988|541453609|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084892|NCT02899988|541453610|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084893|NCT02899988|541453611|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084894|NCT02899988|541453612|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
150084895|NCT02899988|541453602|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
150084896|NCT02899988|541453603|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
150084897|NCT02899988|541453604|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
150084898|NCT02899988|541453605|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
150084899|NCT02899988|541453606|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
150084900|NCT02899988|541453607|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
150084901|NCT02899988|541453608|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
150084902|NCT02899988|541453609|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
150084903|NCT02899988|541453610|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
150084904|NCT02899988|541453611|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
150084905|NCT02899988|541453612|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
150084906|NCT02899988|541453602|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
150084907|NCT02899988|541453603|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
150084908|NCT02899988|541453604|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
150084909|NCT02899988|541453605|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
150084910|NCT02899988|541453606|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
150084911|NCT02899988|541453607|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
150084912|NCT02899988|541453608|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
150084913|NCT02899988|541453609|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
150084914|NCT02899988|541453610|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
150084915|NCT02899988|541453611|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
150084916|NCT02899988|541453612|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
150183202|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
150084917|NCT02899988|541453602|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
150084918|NCT02899988|541453603|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
150084919|NCT02899988|541453604|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
150084920|NCT02899988|541453605|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
150084921|NCT02899988|541453606|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
150084922|NCT02899988|541453607|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
150084923|NCT02899988|541453608|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
150084924|NCT02899988|541453609|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
150084925|NCT02899988|541453610|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
150084926|NCT02899988|541453611|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
150084927|NCT02899988|541453612|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
150084928|NCT02899988|541453602|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084929|NCT02899988|541453603|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084930|NCT02899988|541453604|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084931|NCT02899988|541453605|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084932|NCT02899988|541453606|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084933|NCT02899988|541453607|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
150084934|NCT02899988|541453608|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084935|NCT02899988|541453609|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
150084936|NCT02899988|541453610|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084937|NCT02899988|541453611|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084938|NCT02899988|541453612|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
150084939|NCT02899988|541453602|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084940|NCT02899988|541453603|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084941|NCT02899988|541453604|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084942|NCT02899988|541453605|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084943|NCT02899988|541453606|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
150084944|NCT02899988|541453607|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084945|NCT02899988|541453608|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
150084946|NCT02899988|541453609|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
150084947|NCT02899988|541453610|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
150084948|NCT02899988|541453611|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
150084949|NCT02899988|541453612|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
150084950|NCT02485301|541453616|FG000|Overall Study|Serious Adverse Events|2|||
150084951|NCT02485301|541453617|FG001|Overall Study|Serious Adverse Events|1|||
150084952|NCT02485301|541453616|FG000|Overall Study|Protocol Violation|0|||
150084953|NCT02485301|541453617|FG001|Overall Study|Protocol Violation|1|||
150084954|NCT02485301|541453616|FG000|Overall Study|Withdrawal by Subject|6|||
150084955|NCT02485301|541453617|FG001|Overall Study|Withdrawal by Subject|7|||
150084956|NCT02485301|541453616|FG000|Overall Study|Migrated/moved from study area|10|||
150084957|NCT02485301|541453617|FG001|Overall Study|Migrated/moved from study area|19|||
150084958|NCT02485301|541453616|FG000|Overall Study|Lost to Follow-up|17|||
150084959|NCT02485301|541453617|FG001|Overall Study|Lost to Follow-up|17|||
150084960|NCT02485301|541453616|FG000|Overall Study|Other|3|||
150084961|NCT02485301|541453617|FG001|Overall Study|Other|4|||
150084962|NCT02041286|541453618|FG000|Overall Study|Adverse Event|1|||
150084963|NCT01750242|541453623|FG000|Overall Study|Unreadable Images|3|||
150084964|NCT03167411|541453626|FG000|Overall Study|Adverse Event|0|||
150084965|NCT03167411|541453627|FG001|Overall Study|Adverse Event|1|||
150084966|NCT02627144|541453630|FG000|Overall Study|Serious adverse event|32|||
150084967|NCT02627144|541453630|FG000|Overall Study|Cancer progression|171|||
150084968|NCT02627144|541453630|FG000|Overall Study|Death from cancer|20|||
150084969|NCT02627144|541453630|FG000|Overall Study|Death from other cause|8|||
150084970|NCT02627144|541453630|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
150084971|NCT02627144|541453630|FG000|Overall Study|Administrative reasons|65|||
150084972|NCT02627144|541453630|FG000|Overall Study|Lost to Follow-up|8|||
150084973|NCT02627144|541453630|FG000|Overall Study|Enrolled, not treated|6|||
150084974|NCT02627144|541453630|FG000|Overall Study|Other|17|||
150084975|NCT02651922|541453633|FG000|Overall Study|due to exclusion criteria|2|||
150084976|NCT01366209|541453634|FG000|Overall Study|Adverse Event|6|||
150084977|NCT01366209|541453635|FG001|Overall Study|Adverse Event|7|||
150084978|NCT01366209|541453634|FG000|Overall Study|Withdrawal by Subject|4|||
150084979|NCT01366209|541453635|FG001|Overall Study|Withdrawal by Subject|4|||
150084980|NCT01366209|541453634|FG000|Overall Study|Death|12|||
150084981|NCT01366209|541453635|FG001|Overall Study|Death|19|||
150084982|NCT01366209|541453634|FG000|Overall Study|Lung transplantation|6|||
150084983|NCT01366209|541453635|FG001|Overall Study|Lung transplantation|1|||
150084984|NCT01366209|541453634|FG000|Overall Study|Lost to Follow-up|2|||
150084985|NCT01366209|541453635|FG001|Overall Study|Lost to Follow-up|1|||
150084986|NCT01366209|541453634|FG000|Overall Study|Physician Decision|1|||
150084987|NCT01366209|541453635|FG001|Overall Study|Physician Decision|0|||
150084988|NCT01366209|541453634|FG000|Overall Study|Sponsors decision|0|||
150084989|NCT01366209|541453635|FG001|Overall Study|Sponsors decision|1|||
150084990|NCT01366209|541453634|FG000|Overall Study|Withdrew consent|4|||
150084991|NCT01366209|541453635|FG001|Overall Study|Withdrew consent|3|||
150084992|NCT01053221|541453636|FG000|Overall Study|The study was closed prematurely|5|||
150084993|NCT01053221|541453637|FG001|Overall Study|The study was closed prematurely|9|||
150084994|NCT02266225|541453638|FG000|Overall Study|Lost to Follow-up|2|||
150084995|NCT02266225|541453638|FG000|Overall Study|Death|1|||
150084996|NCT02266225|541453638|FG000|Overall Study|Withdrawal by Subject|13|||
150084997|NCT00420927|541453639|FG000|Period 1|Adverse Event|19|||
150084998|NCT00420927|541453640|FG001|Period 1|Adverse Event|15|||
150084999|NCT00420927|541453641|FG002|Period 1|Adverse Event|0|||
150085000|NCT00420927|541453642|FG003|Period 1|Adverse Event|0|||
150085001|NCT00420927|541453643|FG004|Period 1|Adverse Event|0|||
150085002|NCT00420927|541453644|FG005|Period 1|Adverse Event|0|||
150085003|NCT00420927|541453645|FG006|Period 1|Adverse Event|0|||
150085004|NCT00420927|541453639|FG000|Period 1|Withdrawal by Subject|7|||
150085005|NCT00420927|541453640|FG001|Period 1|Withdrawal by Subject|12|||
150085006|NCT00420927|541453641|FG002|Period 1|Withdrawal by Subject|0|||
150085007|NCT00420927|541453642|FG003|Period 1|Withdrawal by Subject|0|||
150085008|NCT00420927|541453643|FG004|Period 1|Withdrawal by Subject|0|||
150085009|NCT00420927|541453644|FG005|Period 1|Withdrawal by Subject|0|||
150085010|NCT00420927|541453645|FG006|Period 1|Withdrawal by Subject|0|||
150085011|NCT00420927|541453639|FG000|Period 1|Lost to Follow-up|8|||
150085012|NCT00420927|541453640|FG001|Period 1|Lost to Follow-up|6|||
150085013|NCT00420927|541453641|FG002|Period 1|Lost to Follow-up|0|||
150085014|NCT00420927|541453642|FG003|Period 1|Lost to Follow-up|0|||
150085015|NCT00420927|541453643|FG004|Period 1|Lost to Follow-up|0|||
150085016|NCT00420927|541453644|FG005|Period 1|Lost to Follow-up|0|||
150183203|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
150183204|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
150183205|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
150085017|NCT00420927|541453645|FG006|Period 1|Lost to Follow-up|0|||
150085018|NCT00420927|541453639|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
150183206|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
150085019|NCT00420927|541453640|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
150085020|NCT00420927|541453641|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
150085021|NCT00420927|541453642|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
150085022|NCT00420927|541453643|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
150085023|NCT00420927|541453644|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
150085024|NCT00420927|541453645|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
150085025|NCT00420927|541453639|FG000|Period 1|Death|2|||
150085026|NCT00420927|541453640|FG001|Period 1|Death|0|||
150085027|NCT00420927|541453641|FG002|Period 1|Death|0|||
150085028|NCT00420927|541453642|FG003|Period 1|Death|0|||
150085029|NCT00420927|541453643|FG004|Period 1|Death|0|||
150085030|NCT00420927|541453644|FG005|Period 1|Death|0|||
150085031|NCT00420927|541453645|FG006|Period 1|Death|0|||
150085032|NCT00420927|541453639|FG000|Period 1|Subject moved/relocated|0|||
150085033|NCT00420927|541453640|FG001|Period 1|Subject moved/relocated|2|||
150085034|NCT00420927|541453641|FG002|Period 1|Subject moved/relocated|0|||
150085035|NCT00420927|541453642|FG003|Period 1|Subject moved/relocated|0|||
150085036|NCT00420927|541453643|FG004|Period 1|Subject moved/relocated|0|||
150085037|NCT00420927|541453644|FG005|Period 1|Subject moved/relocated|0|||
150085038|NCT00420927|541453645|FG006|Period 1|Subject moved/relocated|0|||
150085039|NCT00420927|541453639|FG000|Period 1|Noncompliant with study drug|1|||
150085040|NCT00420927|541453640|FG001|Period 1|Noncompliant with study drug|1|||
150085041|NCT00420927|541453641|FG002|Period 1|Noncompliant with study drug|0|||
150085042|NCT00420927|541453642|FG003|Period 1|Noncompliant with study drug|0|||
150085043|NCT00420927|541453643|FG004|Period 1|Noncompliant with study drug|0|||
150085044|NCT00420927|541453644|FG005|Period 1|Noncompliant with study drug|0|||
150085045|NCT00420927|541453645|FG006|Period 1|Noncompliant with study drug|0|||
150085046|NCT00420927|541453639|FG000|Period 1|Randomization error|1|||
150085047|NCT00420927|541453640|FG001|Period 1|Randomization error|0|||
150085048|NCT00420927|541453641|FG002|Period 1|Randomization error|0|||
150085049|NCT00420927|541453642|FG003|Period 1|Randomization error|0|||
150085050|NCT00420927|541453643|FG004|Period 1|Randomization error|0|||
150085051|NCT00420927|541453644|FG005|Period 1|Randomization error|0|||
150085052|NCT00420927|541453645|FG006|Period 1|Randomization error|0|||
150085053|NCT00420927|541453639|FG000|Period 1|Suspected tuberculosis/positive test|1|||
150085054|NCT00420927|541453640|FG001|Period 1|Suspected tuberculosis/positive test|1|||
150085055|NCT00420927|541453641|FG002|Period 1|Suspected tuberculosis/positive test|0|||
150085056|NCT00420927|541453642|FG003|Period 1|Suspected tuberculosis/positive test|0|||
150085057|NCT00420927|541453643|FG004|Period 1|Suspected tuberculosis/positive test|0|||
150085058|NCT00420927|541453644|FG005|Period 1|Suspected tuberculosis/positive test|0|||
150085059|NCT00420927|541453645|FG006|Period 1|Suspected tuberculosis/positive test|0|||
150085060|NCT00420927|541453639|FG000|Period 1|Study site closure|0|||
150085061|NCT00420927|541453640|FG001|Period 1|Study site closure|1|||
150085062|NCT00420927|541453641|FG002|Period 1|Study site closure|0|||
150085063|NCT00420927|541453642|FG003|Period 1|Study site closure|0|||
150085064|NCT00420927|541453643|FG004|Period 1|Study site closure|0|||
150085065|NCT00420927|541453644|FG005|Period 1|Study site closure|0|||
150085066|NCT00420927|541453645|FG006|Period 1|Study site closure|0|||
150085067|NCT00420927|541453639|FG000|Period 1|Subject received new diagnosis|0|||
150085068|NCT00420927|541453640|FG001|Period 1|Subject received new diagnosis|2|||
150085069|NCT00420927|541453641|FG002|Period 1|Subject received new diagnosis|0|||
150085070|NCT00420927|541453642|FG003|Period 1|Subject received new diagnosis|0|||
150085071|NCT00420927|541453643|FG004|Period 1|Subject received new diagnosis|0|||
150085072|NCT00420927|541453644|FG005|Period 1|Subject received new diagnosis|0|||
150085073|NCT00420927|541453645|FG006|Period 1|Subject received new diagnosis|0|||
150085074|NCT00420927|541453639|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
150085075|NCT00420927|541453640|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
150085076|NCT00420927|541453641|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
150085077|NCT00420927|541453642|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
150085078|NCT00420927|541453643|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
150085079|NCT00420927|541453644|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
150085080|NCT00420927|541453645|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
150085081|NCT00420927|541453639|FG000|Period 1|Failed to meet entry criteria|8|||
150085082|NCT00420927|541453640|FG001|Period 1|Failed to meet entry criteria|7|||
150085083|NCT00420927|541453641|FG002|Period 1|Failed to meet entry criteria|0|||
150085084|NCT00420927|541453642|FG003|Period 1|Failed to meet entry criteria|0|||
150085085|NCT00420927|541453643|FG004|Period 1|Failed to meet entry criteria|0|||
150085086|NCT00420927|541453644|FG005|Period 1|Failed to meet entry criteria|0|||
150085087|NCT00420927|541453645|FG006|Period 1|Failed to meet entry criteria|0|||
150085088|NCT00420927|541453639|FG000|Period 1|Took prohibited medication|1|||
150085089|NCT00420927|541453640|FG001|Period 1|Took prohibited medication|3|||
150085090|NCT00420927|541453641|FG002|Period 1|Took prohibited medication|0|||
150085091|NCT00420927|541453642|FG003|Period 1|Took prohibited medication|0|||
150085092|NCT00420927|541453643|FG004|Period 1|Took prohibited medication|0|||
150085093|NCT00420927|541453644|FG005|Period 1|Took prohibited medication|0|||
150085094|NCT00420927|541453645|FG006|Period 1|Took prohibited medication|0|||
150085095|NCT00420927|541453639|FG000|Period 2|Adverse Event|0|||
150085096|NCT00420927|541453640|FG001|Period 2|Adverse Event|0|||
150085097|NCT00420927|541453641|FG002|Period 2|Adverse Event|7|||
150085098|NCT00420927|541453642|FG003|Period 2|Adverse Event|3|||
150085099|NCT00420927|541453643|FG004|Period 2|Adverse Event|17|||
150085100|NCT00420927|541453644|FG005|Period 2|Adverse Event|6|||
150085101|NCT00420927|541453645|FG006|Period 2|Adverse Event|20|||
150085102|NCT00420927|541453639|FG000|Period 2|Withdrawal by Subject|0|||
150085103|NCT00420927|541453640|FG001|Period 2|Withdrawal by Subject|0|||
150085104|NCT00420927|541453641|FG002|Period 2|Withdrawal by Subject|1|||
150085105|NCT00420927|541453642|FG003|Period 2|Withdrawal by Subject|3|||
150085106|NCT00420927|541453643|FG004|Period 2|Withdrawal by Subject|11|||
150085107|NCT00420927|541453644|FG005|Period 2|Withdrawal by Subject|2|||
150085108|NCT00420927|541453645|FG006|Period 2|Withdrawal by Subject|12|||
150085109|NCT00420927|541453639|FG000|Period 2|Lost to Follow-up|0|||
150085110|NCT00420927|541453640|FG001|Period 2|Lost to Follow-up|0|||
150085111|NCT00420927|541453641|FG002|Period 2|Lost to Follow-up|2|||
150085112|NCT00420927|541453642|FG003|Period 2|Lost to Follow-up|2|||
150085113|NCT00420927|541453643|FG004|Period 2|Lost to Follow-up|6|||
150085114|NCT00420927|541453644|FG005|Period 2|Lost to Follow-up|3|||
150085115|NCT00420927|541453645|FG006|Period 2|Lost to Follow-up|9|||
150085116|NCT00420927|541453639|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
150085117|NCT00420927|541453640|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
150085118|NCT00420927|541453641|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
150085119|NCT00420927|541453642|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
150085120|NCT00420927|541453643|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
150085121|NCT00420927|541453644|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
150085122|NCT00420927|541453645|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
150085123|NCT00420927|541453639|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
150085124|NCT00420927|541453640|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
150085125|NCT00420927|541453641|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
150085126|NCT00420927|541453642|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
150085127|NCT00420927|541453643|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
150085128|NCT00420927|541453644|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
150085129|NCT00420927|541453645|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
150085130|NCT00420927|541453639|FG000|Period 2|Subject unable to find transportation|0|||
150085131|NCT00420927|541453640|FG001|Period 2|Subject unable to find transportation|0|||
150085132|NCT00420927|541453641|FG002|Period 2|Subject unable to find transportation|0|||
150085133|NCT00420927|541453642|FG003|Period 2|Subject unable to find transportation|0|||
150085134|NCT00420927|541453643|FG004|Period 2|Subject unable to find transportation|0|||
150085135|NCT00420927|541453644|FG005|Period 2|Subject unable to find transportation|0|||
150085136|NCT00420927|541453645|FG006|Period 2|Subject unable to find transportation|1|||
150085137|NCT00420927|541453639|FG000|Period 2|Physician Decision|0|||
150085138|NCT00420927|541453640|FG001|Period 2|Physician Decision|0|||
150085139|NCT00420927|541453641|FG002|Period 2|Physician Decision|0|||
150085140|NCT00420927|541453642|FG003|Period 2|Physician Decision|0|||
150085141|NCT00420927|541453643|FG004|Period 2|Physician Decision|1|||
150085142|NCT00420927|541453644|FG005|Period 2|Physician Decision|1|||
150085143|NCT00420927|541453645|FG006|Period 2|Physician Decision|0|||
150085144|NCT00420927|541453639|FG000|Period 2|Sponsor decision|0|||
150085145|NCT00420927|541453640|FG001|Period 2|Sponsor decision|0|||
150085146|NCT00420927|541453641|FG002|Period 2|Sponsor decision|1|||
150085147|NCT00420927|541453642|FG003|Period 2|Sponsor decision|0|||
150085148|NCT00420927|541453643|FG004|Period 2|Sponsor decision|0|||
150085149|NCT00420927|541453644|FG005|Period 2|Sponsor decision|0|||
150085150|NCT00420927|541453645|FG006|Period 2|Sponsor decision|1|||
150085151|NCT00420927|541453639|FG000|Period 2|Randomization error|0|||
150085152|NCT00420927|541453640|FG001|Period 2|Randomization error|0|||
150085153|NCT00420927|541453641|FG002|Period 2|Randomization error|0|||
150085154|NCT00420927|541453642|FG003|Period 2|Randomization error|0|||
150085155|NCT00420927|541453643|FG004|Period 2|Randomization error|1|||
150085156|NCT00420927|541453644|FG005|Period 2|Randomization error|1|||
150085157|NCT00420927|541453645|FG006|Period 2|Randomization error|0|||
150085158|NCT00420927|541453639|FG000|Period 2|Noncompliant with study drug|0|||
150085159|NCT00420927|541453640|FG001|Period 2|Noncompliant with study drug|0|||
150085160|NCT00420927|541453641|FG002|Period 2|Noncompliant with study drug|0|||
150085161|NCT00420927|541453642|FG003|Period 2|Noncompliant with study drug|1|||
150085162|NCT00420927|541453643|FG004|Period 2|Noncompliant with study drug|0|||
150085163|NCT00420927|541453644|FG005|Period 2|Noncompliant with study drug|0|||
150085164|NCT00420927|541453645|FG006|Period 2|Noncompliant with study drug|2|||
150085165|NCT00420927|541453639|FG000|Period 2|Methotrexate intolerance|0|||
150085166|NCT00420927|541453640|FG001|Period 2|Methotrexate intolerance|0|||
150085167|NCT00420927|541453641|FG002|Period 2|Methotrexate intolerance|0|||
150085168|NCT00420927|541453642|FG003|Period 2|Methotrexate intolerance|0|||
150085169|NCT00420927|541453643|FG004|Period 2|Methotrexate intolerance|0|||
150085170|NCT00420927|541453644|FG005|Period 2|Methotrexate intolerance|0|||
150085171|NCT00420927|541453645|FG006|Period 2|Methotrexate intolerance|1|||
150085172|NCT00420927|541453639|FG000|Period 2|Took prohibited medication|0|||
150085173|NCT00420927|541453640|FG001|Period 2|Took prohibited medication|0|||
150085174|NCT00420927|541453641|FG002|Period 2|Took prohibited medication|0|||
150085175|NCT00420927|541453642|FG003|Period 2|Took prohibited medication|0|||
150085176|NCT00420927|541453643|FG004|Period 2|Took prohibited medication|1|||
150085177|NCT00420927|541453644|FG005|Period 2|Took prohibited medication|0|||
150085178|NCT00420927|541453645|FG006|Period 2|Took prohibited medication|0|||
150085179|NCT03018704|541453646|FG000|Overall Study|Lost to Follow-up|1|||
150085180|NCT03018704|541453647|FG001|Overall Study|Lost to Follow-up|1|||
150085181|NCT00320411|541453648|FG000|Overall Study|No investigational product admin.|4|||
150085182|NCT04448171|541453649|FG000|Overall Study|Procedure Cancelled|1|||
150085183|NCT04448171|541453650|FG001|Overall Study|Procedure Cancelled|0|||
150085184|NCT04448171|541453649|FG000|Overall Study|Protocol Violation|1|||
150085185|NCT04448171|541453650|FG001|Overall Study|Protocol Violation|0|||
150085186|NCT02088047|541453651|FG000|Overall Study|Withdrawal by Subject|1|||
150085187|NCT02088047|541453652|FG001|Overall Study|Withdrawal by Subject|0|||
150085188|NCT00660309|541453655|FG000|Overall Study|Adverse Event|2|||
150085189|NCT00660309|541453656|FG001|Overall Study|Adverse Event|0|||
150085190|NCT00660309|541453655|FG000|Overall Study|Withdrawal by Subject|0|||
150085191|NCT00660309|541453656|FG001|Overall Study|Withdrawal by Subject|3|||
150085192|NCT00211809|541453659|FG000|Overall Study|Lack of Efficacy|1|||
150085193|NCT00211809|541453659|FG000|Overall Study|Lost to Follow-up|2|||
150085194|NCT00211809|541453659|FG000|Overall Study|Pregnancy|1|||
150085195|NCT00211809|541453659|FG000|Overall Study|side effects|2|||
150085196|NCT01417234|541453660|FG000|Overall Study|Subject non-compliant|3|||
150085197|NCT00023764|541453661|FG000|Overall Study|Other|1|||
150085198|NCT00023764|541453661|FG000|Overall Study|Adverse Event|4|||
150085199|NCT00023764|541453661|FG000|Overall Study|Withdrawal by Subject|1|||
150085200|NCT00023764|541453661|FG000|Overall Study|Progression of disease|6|||
150085201|NCT00023764|541453661|FG000|Overall Study|patient received other treatment|1|||
150085202|NCT00023764|541453661|FG000|Overall Study|delay in obtaining staging images|1|||
150085203|NCT00496470|541453663|FG000|Overall Study|Adverse Event|8|||
150085204|NCT00496470|541453664|FG001|Overall Study|Adverse Event|10|||
150085205|NCT00496470|541453663|FG000|Overall Study|Withdrawal by Subject|5|||
150085206|NCT00496470|541453664|FG001|Overall Study|Withdrawal by Subject|12|||
150085207|NCT00496470|541453663|FG000|Overall Study|Incorrectly enrolled|13|||
150085208|NCT00496470|541453664|FG001|Overall Study|Incorrectly enrolled|5|||
150025811|NCT01329978|541230418|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
150025812|NCT01329978|541230419|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
150025813|NCT03259555|541230439|FG000|Overall Study|Adverse Event|6|||
150025814|NCT03259555|541230440|FG001|Overall Study|Adverse Event|4|||
150025815|NCT03259555|541230439|FG000|Overall Study|Lack of Efficacy|6|||
150025816|NCT03259555|541230440|FG001|Overall Study|Lack of Efficacy|4|||
150025817|NCT03259555|541230439|FG000|Overall Study|Lost to Follow-up|0|||
150025818|NCT03259555|541230440|FG001|Overall Study|Lost to Follow-up|2|||
150025819|NCT03259555|541230439|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150025820|NCT03259555|541230440|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150025821|NCT03259555|541230439|FG000|Overall Study|Progressive Disease|0|||
150025822|NCT03259555|541230440|FG001|Overall Study|Progressive Disease|2|||
150025823|NCT03259555|541230439|FG000|Overall Study|Withdrawal by Subject|19|||
150025824|NCT03259555|541230440|FG001|Overall Study|Withdrawal by Subject|16|||
150025825|NCT03259555|541230439|FG000|Overall Study|Physician Decision|1|||
150025826|NCT03259555|541230440|FG001|Overall Study|Physician Decision|2|||
150025827|NCT03259555|541230439|FG000|Overall Study|Other|1|||
150025828|NCT03259555|541230440|FG001|Overall Study|Other|0|||
150025829|NCT02800863|541230441|FG000|Overall Study|Adverse Event|14|||
150025830|NCT02800863|541230441|FG000|Overall Study|Another Device Implanted|1|||
150025831|NCT02800863|541230441|FG000|Overall Study|Device Explanted|1|||
150025832|NCT02800863|541230441|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
150025833|NCT02800863|541230441|FG000|Overall Study|Health Issues|1|||
150025834|NCT02800863|541230441|FG000|Overall Study|Insurance Denial|8|||
150025835|NCT02800863|541230441|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
150025836|NCT02800863|541230441|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
150025837|NCT02800863|541230441|FG000|Overall Study|Screen Failure|1|||
150025838|NCT02800863|541230441|FG000|Overall Study|Sponsor Request|6|||
150025839|NCT02800863|541230441|FG000|Overall Study|Death|3|||
150025840|NCT02800863|541230441|FG000|Overall Study|Subject Implant at Another Facility|1|||
150025841|NCT02800863|541230441|FG000|Overall Study|Lost to Follow-up|26|||
150025842|NCT02800863|541230441|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
150025843|NCT02800863|541230441|FG000|Overall Study|Subject and/or Family Request|64|||
150025844|NCT02800863|541230441|FG000|Overall Study|Trial Failure|81|||
150025845|NCT02800863|541230441|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
150025846|NCT03957551|541230442|FG000|Overall Study|Adverse Event|2|||
150025847|NCT03957551|541230443|FG001|Overall Study|Adverse Event|2|||
150025848|NCT03957551|541230444|FG002|Overall Study|Adverse Event|6|||
150025849|NCT03957551|541230442|FG000|Overall Study|Physician Decision|1|||
150025850|NCT03957551|541230443|FG001|Overall Study|Physician Decision|0|||
150025851|NCT03957551|541230444|FG002|Overall Study|Physician Decision|2|||
150025852|NCT03957551|541230442|FG000|Overall Study|Withdrawal by Subject|1|||
150025853|NCT03957551|541230443|FG001|Overall Study|Withdrawal by Subject|0|||
150025854|NCT03957551|541230444|FG002|Overall Study|Withdrawal by Subject|2|||
150025855|NCT03957551|541230442|FG000|Overall Study|Disease progression|1|||
150025856|NCT03957551|541230443|FG001|Overall Study|Disease progression|0|||
150025857|NCT03957551|541230444|FG002|Overall Study|Disease progression|8|||
150025858|NCT00607087|541230445|FG000|Overall Study|Withdrawal by Subject|9|||
150025859|NCT00607087|541230446|FG001|Overall Study|Withdrawal by Subject|4|||
150025860|NCT00607087|541230447|FG002|Overall Study|Withdrawal by Subject|4|||
150025861|NCT00607087|541230445|FG000|Overall Study|Adverse Event|3|||
150025862|NCT00607087|541230446|FG001|Overall Study|Adverse Event|2|||
150025863|NCT00607087|541230447|FG002|Overall Study|Adverse Event|3|||
150025864|NCT00607087|541230445|FG000|Overall Study|Other reason|1|||
150025865|NCT00607087|541230446|FG001|Overall Study|Other reason|5|||
150025866|NCT00607087|541230447|FG002|Overall Study|Other reason|2|||
150025867|NCT00607087|541230445|FG000|Overall Study|Poor compliance to protocol|1|||
150025868|NCT00607087|541230446|FG001|Overall Study|Poor compliance to protocol|0|||
150025869|NCT00607087|541230447|FG002|Overall Study|Poor compliance to protocol|1|||
150025870|NCT00607087|541230445|FG000|Overall Study|Lost to Follow-up|1|||
150025871|NCT00607087|541230446|FG001|Overall Study|Lost to Follow-up|0|||
150025872|NCT00607087|541230447|FG002|Overall Study|Lost to Follow-up|0|||
150025873|NCT00607087|541230445|FG000|Period 1|Withdrawal by Subject|7|||
150025874|NCT00607087|541230446|FG001|Period 1|Withdrawal by Subject|2|||
150085209|NCT00496470|541453663|FG000|Overall Study|Other reason|0|||
150085210|NCT00496470|541453664|FG001|Overall Study|Other reason|2|||
150025875|NCT00607087|541230447|FG002|Period 1|Withdrawal by Subject|3|||
150025876|NCT00607087|541230445|FG000|Period 1|Adverse Event|3|||
150025877|NCT00607087|541230446|FG001|Period 1|Adverse Event|0|||
150025878|NCT00607087|541230447|FG002|Period 1|Adverse Event|0|||
150025879|NCT00607087|541230445|FG000|Period 1|Poor compliance to protocol|1|||
150025880|NCT00607087|541230446|FG001|Period 1|Poor compliance to protocol|0|||
150025881|NCT00607087|541230447|FG002|Period 1|Poor compliance to protocol|0|||
150025882|NCT00607087|541230445|FG000|Period 1|Lost to Follow-up|1|||
150025883|NCT00607087|541230446|FG001|Period 1|Lost to Follow-up|0|||
150025884|NCT00607087|541230447|FG002|Period 1|Lost to Follow-up|0|||
150025885|NCT00607087|541230445|FG000|Period 1|Other reason|0|||
150025886|NCT00607087|541230446|FG001|Period 1|Other reason|4|||
150025887|NCT00607087|541230447|FG002|Period 1|Other reason|2|||
150025888|NCT00607087|541230445|FG000|Period 2|Withdrawal by Subject|0|||
150025889|NCT00607087|541230446|FG001|Period 2|Withdrawal by Subject|1|||
150025890|NCT00607087|541230447|FG002|Period 2|Withdrawal by Subject|1|||
150025891|NCT00607087|541230445|FG000|Period 2|Other reason|1|||
150025892|NCT00607087|541230446|FG001|Period 2|Other reason|1|||
150025893|NCT00607087|541230447|FG002|Period 2|Other reason|0|||
150025894|NCT00607087|541230445|FG000|Period 2|Adverse Event|0|||
150025895|NCT00607087|541230446|FG001|Period 2|Adverse Event|1|||
150025896|NCT00607087|541230447|FG002|Period 2|Adverse Event|3|||
150025897|NCT00607087|541230445|FG000|Period 2|Poor compliance to protocol|0|||
150025898|NCT00607087|541230446|FG001|Period 2|Poor compliance to protocol|0|||
150025899|NCT00607087|541230447|FG002|Period 2|Poor compliance to protocol|1|||
150025900|NCT00607087|541230445|FG000|Period 3|Withdrawal by Subject|2|||
150025901|NCT00607087|541230446|FG001|Period 3|Withdrawal by Subject|1|||
150025902|NCT00607087|541230447|FG002|Period 3|Withdrawal by Subject|0|||
150025903|NCT00607087|541230445|FG000|Period 3|Adverse Event|0|||
150025904|NCT00607087|541230446|FG001|Period 3|Adverse Event|1|||
150025905|NCT00607087|541230447|FG002|Period 3|Adverse Event|0|||
150025906|NCT02717494|541230451|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
150025907|NCT02717494|541230452|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
150025908|NCT02717494|541230453|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
150025909|NCT02717494|541230451|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
150025910|NCT02717494|541230452|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
150025911|NCT02717494|541230453|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
150025912|NCT02717494|541230451|FG000|First Intervention (Step 1)|Death|0|||
150085211|NCT00729651|541453665|FG000|Overall Study|Withdrawal by Subject|5|||
150085212|NCT00729651|541453666|FG001|Overall Study|Withdrawal by Subject|6|||
150085213|NCT00729651|541453665|FG000|Overall Study|Lost to Follow-up|5|||
150085214|NCT00729651|541453666|FG001|Overall Study|Lost to Follow-up|4|||
150085215|NCT00729651|541453665|FG000|Overall Study|Protocol Violation|0|||
150085216|NCT00729651|541453666|FG001|Overall Study|Protocol Violation|1|||
150085217|NCT00729651|541453665|FG000|Overall Study|Adverse Event|7|||
150085218|NCT00729651|541453666|FG001|Overall Study|Adverse Event|3|||
150085219|NCT00729651|541453665|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
150085220|NCT00729651|541453666|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
150085221|NCT00729651|541453665|FG000|Overall Study|Subject's private reason|2|||
150085222|NCT00729651|541453666|FG001|Overall Study|Subject's private reason|0|||
150085223|NCT01218243|541453667|FG000|Overall Study|Lack of Efficacy|1|||
150085224|NCT01218243|541453668|FG001|Overall Study|Lack of Efficacy|1|||
150085225|NCT01218243|541453667|FG000|Overall Study|Lost to Follow-up|3|||
150085226|NCT01218243|541453668|FG001|Overall Study|Lost to Follow-up|3|||
150085227|NCT01218243|541453667|FG000|Overall Study|Protocol Violation|5|||
150085228|NCT01218243|541453668|FG001|Overall Study|Protocol Violation|10|||
150085229|NCT00291577|541453671|FG000|Overall Study|Adverse Event|1|||
150085230|NCT00291577|541453671|FG000|Overall Study|Other|4|||
150085231|NCT00291577|541453671|FG000|Overall Study|Withdrawal by Subject|2|||
150025913|NCT02717494|541230452|FG001|First Intervention (Step 1)|Death|0|||
150025914|NCT02717494|541230453|FG002|First Intervention (Step 1)|Death|1|||
150025915|NCT02717494|541230451|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
150025916|NCT02717494|541230452|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
150025917|NCT02717494|541230453|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
150025918|NCT00154297|541230456|FG000|Overall Study|Death|5|||
150025919|NCT00154297|541230457|FG001|Overall Study|Death|2|||
150025920|NCT00154297|541230456|FG000|Overall Study|Withdrawal by Subject|0|||
150025921|NCT00154297|541230457|FG001|Overall Study|Withdrawal by Subject|5|||
150025922|NCT00154297|541230456|FG000|Overall Study|Lost to Follow-up|3|||
150025923|NCT00154297|541230457|FG001|Overall Study|Lost to Follow-up|0|||
150025924|NCT01125800|541230460|FG000|Phase I|Protocol Violation|0|||
150025925|NCT01125800|541230461|FG001|Phase I|Protocol Violation|3|||
150025926|NCT01125800|541230462|FG002|Phase I|Protocol Violation|1|||
150025927|NCT01125800|541230463|FG003|Phase I|Protocol Violation|1|||
150025928|NCT01125800|541230464|FG004|Phase I|Protocol Violation|0|||
150025929|NCT01125800|541230460|FG000|Phase I|Adverse Event|2|||
150025930|NCT01125800|541230461|FG001|Phase I|Adverse Event|2|||
150025931|NCT01125800|541230462|FG002|Phase I|Adverse Event|1|||
150025932|NCT01125800|541230463|FG003|Phase I|Adverse Event|7|||
150025933|NCT01125800|541230464|FG004|Phase I|Adverse Event|0|||
150025934|NCT01125800|541230460|FG000|Phase I|Administrative problems|1|||
150085232|NCT00291577|541453671|FG000|Overall Study|Lack of Efficacy|14|||
150183207|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
150025935|NCT01125800|541230461|FG001|Phase I|Administrative problems|0|||
150025936|NCT01125800|541230462|FG002|Phase I|Administrative problems|0|||
150025937|NCT01125800|541230463|FG003|Phase I|Administrative problems|0|||
150025938|NCT01125800|541230464|FG004|Phase I|Administrative problems|0|||
150085233|NCT03129100|541453676|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
150025939|NCT01125800|541230460|FG000|Phase I|Withdrawal by Subject|0|||
150025940|NCT01125800|541230461|FG001|Phase I|Withdrawal by Subject|0|||
150025941|NCT01125800|541230462|FG002|Phase I|Withdrawal by Subject|1|||
150025942|NCT01125800|541230463|FG003|Phase I|Withdrawal by Subject|0|||
150025943|NCT01125800|541230464|FG004|Phase I|Withdrawal by Subject|0|||
150025944|NCT01125800|541230460|FG000|Phase I|Disease progression|5|||
150025945|NCT01125800|541230461|FG001|Phase I|Disease progression|4|||
150025946|NCT01125800|541230462|FG002|Phase I|Disease progression|1|||
150025947|NCT01125800|541230463|FG003|Phase I|Disease progression|3|||
150025948|NCT01125800|541230464|FG004|Phase I|Disease progression|0|||
150025949|NCT01125800|541230460|FG000|Phase II|Protocol Violation|0|||
150025950|NCT01125800|541230461|FG001|Phase II|Protocol Violation|0|||
150025951|NCT01125800|541230462|FG002|Phase II|Protocol Violation|0|||
150025952|NCT01125800|541230463|FG003|Phase II|Protocol Violation|0|||
150025953|NCT01125800|541230464|FG004|Phase II|Protocol Violation|1|||
150025954|NCT01125800|541230460|FG000|Phase II|Adverse Event|0|||
150025955|NCT01125800|541230461|FG001|Phase II|Adverse Event|0|||
150025956|NCT01125800|541230462|FG002|Phase II|Adverse Event|0|||
150025957|NCT01125800|541230463|FG003|Phase II|Adverse Event|0|||
150025958|NCT01125800|541230464|FG004|Phase II|Adverse Event|2|||
150025959|NCT01125800|541230460|FG000|Phase II|Disease progression|0|||
150025960|NCT01125800|541230461|FG001|Phase II|Disease progression|0|||
150025961|NCT01125800|541230462|FG002|Phase II|Disease progression|0|||
150025962|NCT01125800|541230463|FG003|Phase II|Disease progression|1|||
150025963|NCT01125800|541230464|FG004|Phase II|Disease progression|8|||
150025964|NCT03370718|541230468|FG000|Overall Study|Withdrawal by Subject|1|||
150025965|NCT03775486|541230475|FG000|Initial Therapy Phase|Other reason provided|0|||
150025966|NCT03775486|541230476|FG001|Initial Therapy Phase|Other reason provided|15|||
150025967|NCT03775486|541230475|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
150025968|NCT03775486|541230476|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
150025969|NCT03775486|541230475|FG000|Initial Therapy Phase|Protocol Violation|0|||
150025970|NCT03775486|541230476|FG001|Initial Therapy Phase|Protocol Violation|2|||
150025971|NCT03775486|541230475|FG000|Initial Therapy Phase|Adverse Event|0|||
150025972|NCT03775486|541230476|FG001|Initial Therapy Phase|Adverse Event|34|||
150025973|NCT03775486|541230475|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
150025974|NCT03775486|541230476|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
150025975|NCT03775486|541230475|FG000|Maintenance Phase|Withdrawal by Subject|13|||
150025976|NCT03775486|541230476|FG001|Maintenance Phase|Withdrawal by Subject|12|||
150025977|NCT03775486|541230475|FG000|Maintenance Phase|Death|44|||
150025978|NCT03775486|541230476|FG001|Maintenance Phase|Death|45|||
150025979|NCT05477485|541230477|FG000|Overall Study|Lost to Follow-up|0|||
150025980|NCT05477485|541230478|FG001|Overall Study|Lost to Follow-up|4|||
150025981|NCT01572480|541230479|FG000|Participants Enrolled|Withdrawal by Subject|1|||
150025982|NCT01572480|541230479|FG000|Drug Administration|Discontinued drug/Off Study|1|||
150025983|NCT01572480|541230479|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
150025984|NCT01572480|541230479|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
150025985|NCT04194944|541230480|FG000|Overall Study|Lost to Follow-up|3|||
150025986|NCT04194944|541230481|FG001|Overall Study|Lost to Follow-up|0|||
150025987|NCT04194944|541230480|FG000|Overall Study|Withdrawal by Subject|2|||
150025988|NCT04194944|541230481|FG001|Overall Study|Withdrawal by Subject|2|||
150025989|NCT04194944|541230480|FG000|Overall Study|On Treatment|93|||
150025990|NCT04194944|541230481|FG001|Overall Study|On Treatment|30|||
150025991|NCT00801216|541230482|FG000|Overall Study|Screening Failure|2|||
150025992|NCT05214768|541230483|FG000|Induction Period|Withdrawal by Subject|1|||
150025993|NCT05214768|541230484|FG001|Induction Period|Withdrawal by Subject|0|||
150025994|NCT05214768|541230485|FG002|Induction Period|Withdrawal by Subject|0|||
150025995|NCT05214768|541230486|FG003|Induction Period|Withdrawal by Subject|0|||
150025996|NCT05214768|541230487|FG004|Induction Period|Withdrawal by Subject|0|||
150025997|NCT05214768|541230488|FG005|Induction Period|Withdrawal by Subject|0|||
150025998|NCT05214768|541230483|FG000|Induction Period|Physician Decision|1|||
150025999|NCT05214768|541230484|FG001|Induction Period|Physician Decision|0|||
150026000|NCT05214768|541230485|FG002|Induction Period|Physician Decision|0|||
150026001|NCT05214768|541230486|FG003|Induction Period|Physician Decision|0|||
150026002|NCT05214768|541230487|FG004|Induction Period|Physician Decision|0|||
150026003|NCT05214768|541230488|FG005|Induction Period|Physician Decision|0|||
150026004|NCT05214768|541230483|FG000|Maintenance Period|Other Reasons|0|||
150026005|NCT05214768|541230484|FG001|Maintenance Period|Other Reasons|0|||
150026006|NCT05214768|541230485|FG002|Maintenance Period|Other Reasons|1|||
150026007|NCT05214768|541230486|FG003|Maintenance Period|Other Reasons|1|||
150026008|NCT05214768|541230487|FG004|Maintenance Period|Other Reasons|0|||
150026009|NCT05214768|541230488|FG005|Maintenance Period|Other Reasons|0|||
150026010|NCT05214768|541230483|FG000|Maintenance Period|Withdrawal by Subject|0|||
150026011|NCT05214768|541230484|FG001|Maintenance Period|Withdrawal by Subject|0|||
150026012|NCT05214768|541230485|FG002|Maintenance Period|Withdrawal by Subject|0|||
150026013|NCT05214768|541230486|FG003|Maintenance Period|Withdrawal by Subject|1|||
150026014|NCT05214768|541230487|FG004|Maintenance Period|Withdrawal by Subject|0|||
150026015|NCT05214768|541230488|FG005|Maintenance Period|Withdrawal by Subject|0|||
150026016|NCT05214768|541230483|FG000|Maintenance Period|Lack of Efficacy|0|||
150026017|NCT05214768|541230484|FG001|Maintenance Period|Lack of Efficacy|0|||
150026018|NCT05214768|541230485|FG002|Maintenance Period|Lack of Efficacy|1|||
150026019|NCT05214768|541230486|FG003|Maintenance Period|Lack of Efficacy|0|||
150026020|NCT05214768|541230487|FG004|Maintenance Period|Lack of Efficacy|1|||
150026021|NCT05214768|541230488|FG005|Maintenance Period|Lack of Efficacy|0|||
150026022|NCT05214768|541230483|FG000|Open Label Extension Period|Physician Decision|0|||
150026023|NCT05214768|541230484|FG001|Open Label Extension Period|Physician Decision|0|||
150026024|NCT05214768|541230485|FG002|Open Label Extension Period|Physician Decision|0|||
150026025|NCT05214768|541230486|FG003|Open Label Extension Period|Physician Decision|0|||
150026026|NCT05214768|541230487|FG004|Open Label Extension Period|Physician Decision|0|||
150026027|NCT05214768|541230488|FG005|Open Label Extension Period|Physician Decision|1|||
150026028|NCT05214768|541230483|FG000|Open Label Extension Period|Lack of Efficacy|0|||
150026029|NCT05214768|541230484|FG001|Open Label Extension Period|Lack of Efficacy|0|||
150026030|NCT05214768|541230485|FG002|Open Label Extension Period|Lack of Efficacy|0|||
150026031|NCT05214768|541230486|FG003|Open Label Extension Period|Lack of Efficacy|0|||
150026032|NCT05214768|541230487|FG004|Open Label Extension Period|Lack of Efficacy|0|||
150026033|NCT05214768|541230488|FG005|Open Label Extension Period|Lack of Efficacy|1|||
150026034|NCT05214768|541230483|FG000|Open Label Extension Period|Ongoing Study|0|||
150026035|NCT05214768|541230484|FG001|Open Label Extension Period|Ongoing Study|0|||
150026036|NCT05214768|541230485|FG002|Open Label Extension Period|Ongoing Study|0|||
150026037|NCT05214768|541230486|FG003|Open Label Extension Period|Ongoing Study|0|||
150026038|NCT05214768|541230487|FG004|Open Label Extension Period|Ongoing Study|0|||
150026039|NCT05214768|541230488|FG005|Open Label Extension Period|Ongoing Study|42|||
150026040|NCT05481359|541230489|FG000|Overall Study|Lost to Follow-up|3|||
150026041|NCT05481359|541230489|FG000|Overall Study|Withdrawal by Subject|1|||
150026042|NCT06235905|541230495|FG000|Overall Study|Adverse Event|1|||
150026043|NCT06235905|541230495|FG000|Overall Study|Non-compliant with protocol procedures|1|||
150026044|NCT05579977|541230496|FG000|Treatment Phase|Other|0|||
150026045|NCT05579977|541230497|FG001|Treatment Phase|Other|0|||
150026046|NCT05579977|541230498|FG002|Treatment Phase|Other|0|||
150026047|NCT05579977|541230499|FG003|Treatment Phase|Other|2|||
150026048|NCT05579977|541230500|FG004|Treatment Phase|Other|1|||
150026049|NCT05579977|541230501|FG005|Treatment Phase|Other|2|||
150026050|NCT05579977|541230502|FG006|Treatment Phase|Other|1|||
150026051|NCT05579977|541230503|FG007|Treatment Phase|Other|2|||
150026052|NCT05579977|541230504|FG008|Treatment Phase|Other|2|||
150026053|NCT05579977|541230505|FG009|Treatment Phase|Other|1|||
150026054|NCT05579977|541230506|FG010|Treatment Phase|Other|0|||
150026055|NCT05579977|541230507|FG011|Treatment Phase|Other|0|||
150026056|NCT05579977|541230508|FG012|Treatment Phase|Other|3|||
150026057|NCT05579977|541230496|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
150026058|NCT05579977|541230497|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
150026059|NCT05579977|541230498|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
150026060|NCT05579977|541230499|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
150026061|NCT05579977|541230500|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
150026062|NCT05579977|541230501|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
150026063|NCT05579977|541230502|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
150026064|NCT05579977|541230503|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
150026065|NCT05579977|541230504|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
150026066|NCT05579977|541230505|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
150026067|NCT05579977|541230506|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
150026068|NCT05579977|541230507|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
150026069|NCT05579977|541230508|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
150026070|NCT05579977|541230496|FG000|Treatment Phase|Withdrawal by Subject|2|||
150026071|NCT05579977|541230497|FG001|Treatment Phase|Withdrawal by Subject|0|||
150026072|NCT05579977|541230498|FG002|Treatment Phase|Withdrawal by Subject|0|||
150026073|NCT05579977|541230499|FG003|Treatment Phase|Withdrawal by Subject|1|||
150026074|NCT05579977|541230500|FG004|Treatment Phase|Withdrawal by Subject|2|||
150026075|NCT05579977|541230501|FG005|Treatment Phase|Withdrawal by Subject|0|||
150026076|NCT05579977|541230502|FG006|Treatment Phase|Withdrawal by Subject|1|||
150026077|NCT05579977|541230503|FG007|Treatment Phase|Withdrawal by Subject|8|||
150026078|NCT05579977|541230504|FG008|Treatment Phase|Withdrawal by Subject|3|||
150026079|NCT05579977|541230505|FG009|Treatment Phase|Withdrawal by Subject|3|||
150026080|NCT05579977|541230506|FG010|Treatment Phase|Withdrawal by Subject|5|||
150026081|NCT05579977|541230507|FG011|Treatment Phase|Withdrawal by Subject|1|||
150026082|NCT05579977|541230508|FG012|Treatment Phase|Withdrawal by Subject|3|||
150026083|NCT05579977|541230496|FG000|Treatment Phase|Study terminated by sponsor|70|||
150026084|NCT05579977|541230497|FG001|Treatment Phase|Study terminated by sponsor|70|||
150026085|NCT05579977|541230498|FG002|Treatment Phase|Study terminated by sponsor|61|||
150026086|NCT05579977|541230499|FG003|Treatment Phase|Study terminated by sponsor|59|||
150026087|NCT05579977|541230500|FG004|Treatment Phase|Study terminated by sponsor|63|||
150026088|NCT05579977|541230501|FG005|Treatment Phase|Study terminated by sponsor|53|||
150026089|NCT05579977|541230502|FG006|Treatment Phase|Study terminated by sponsor|66|||
150026090|NCT05579977|541230503|FG007|Treatment Phase|Study terminated by sponsor|48|||
150026091|NCT05579977|541230504|FG008|Treatment Phase|Study terminated by sponsor|47|||
150026092|NCT05579977|541230505|FG009|Treatment Phase|Study terminated by sponsor|37|||
150026093|NCT05579977|541230506|FG010|Treatment Phase|Study terminated by sponsor|44|||
150026094|NCT05579977|541230507|FG011|Treatment Phase|Study terminated by sponsor|36|||
150026095|NCT05579977|541230508|FG012|Treatment Phase|Study terminated by sponsor|32|||
150026096|NCT05579977|541230496|FG000|Treatment Phase|Pregnancy|0|||
150026097|NCT05579977|541230497|FG001|Treatment Phase|Pregnancy|0|||
150026098|NCT05579977|541230498|FG002|Treatment Phase|Pregnancy|0|||
150026099|NCT05579977|541230499|FG003|Treatment Phase|Pregnancy|0|||
150026100|NCT05579977|541230500|FG004|Treatment Phase|Pregnancy|0|||
150026101|NCT05579977|541230501|FG005|Treatment Phase|Pregnancy|0|||
150026102|NCT05579977|541230502|FG006|Treatment Phase|Pregnancy|0|||
150026103|NCT05579977|541230503|FG007|Treatment Phase|Pregnancy|0|||
150026104|NCT05579977|541230504|FG008|Treatment Phase|Pregnancy|0|||
150026105|NCT05579977|541230505|FG009|Treatment Phase|Pregnancy|1|||
150026106|NCT05579977|541230506|FG010|Treatment Phase|Pregnancy|0|||
150026107|NCT05579977|541230507|FG011|Treatment Phase|Pregnancy|0|||
150026108|NCT05579977|541230508|FG012|Treatment Phase|Pregnancy|0|||
150026109|NCT05579977|541230496|FG000|Treatment Phase|Physician Decision|0|||
150026110|NCT05579977|541230497|FG001|Treatment Phase|Physician Decision|0|||
150026111|NCT05579977|541230498|FG002|Treatment Phase|Physician Decision|0|||
150026112|NCT05579977|541230499|FG003|Treatment Phase|Physician Decision|0|||
150026113|NCT05579977|541230500|FG004|Treatment Phase|Physician Decision|0|||
150026114|NCT05579977|541230501|FG005|Treatment Phase|Physician Decision|0|||
150026115|NCT05579977|541230502|FG006|Treatment Phase|Physician Decision|0|||
150026116|NCT05579977|541230503|FG007|Treatment Phase|Physician Decision|0|||
150026117|NCT05579977|541230504|FG008|Treatment Phase|Physician Decision|0|||
150026118|NCT05579977|541230505|FG009|Treatment Phase|Physician Decision|0|||
150026119|NCT05579977|541230506|FG010|Treatment Phase|Physician Decision|0|||
150026120|NCT05579977|541230507|FG011|Treatment Phase|Physician Decision|1|||
150026121|NCT05579977|541230508|FG012|Treatment Phase|Physician Decision|0|||
150026122|NCT05579977|541230496|FG000|Treatment Phase|Lost to Follow-up|0|||
150026123|NCT05579977|541230497|FG001|Treatment Phase|Lost to Follow-up|0|||
150026124|NCT05579977|541230498|FG002|Treatment Phase|Lost to Follow-up|0|||
150026125|NCT05579977|541230499|FG003|Treatment Phase|Lost to Follow-up|1|||
150026126|NCT05579977|541230500|FG004|Treatment Phase|Lost to Follow-up|1|||
150026127|NCT05579977|541230501|FG005|Treatment Phase|Lost to Follow-up|1|||
150026128|NCT05579977|541230502|FG006|Treatment Phase|Lost to Follow-up|0|||
150026129|NCT05579977|541230503|FG007|Treatment Phase|Lost to Follow-up|1|||
150026130|NCT05579977|541230504|FG008|Treatment Phase|Lost to Follow-up|2|||
150026131|NCT05579977|541230505|FG009|Treatment Phase|Lost to Follow-up|2|||
150026132|NCT05579977|541230506|FG010|Treatment Phase|Lost to Follow-up|1|||
150026133|NCT05579977|541230507|FG011|Treatment Phase|Lost to Follow-up|4|||
150026134|NCT05579977|541230508|FG012|Treatment Phase|Lost to Follow-up|3|||
150026135|NCT05579977|541230496|FG000|Treatment Phase|Death|1|||
150026136|NCT05579977|541230497|FG001|Treatment Phase|Death|0|||
150026137|NCT05579977|541230498|FG002|Treatment Phase|Death|0|||
150026138|NCT05579977|541230499|FG003|Treatment Phase|Death|0|||
150026139|NCT05579977|541230500|FG004|Treatment Phase|Death|0|||
150026140|NCT05579977|541230501|FG005|Treatment Phase|Death|0|||
150026141|NCT05579977|541230502|FG006|Treatment Phase|Death|0|||
150026142|NCT05579977|541230503|FG007|Treatment Phase|Death|0|||
150026143|NCT05579977|541230504|FG008|Treatment Phase|Death|0|||
150026144|NCT05579977|541230505|FG009|Treatment Phase|Death|0|||
150026145|NCT05579977|541230506|FG010|Treatment Phase|Death|0|||
150026146|NCT05579977|541230507|FG011|Treatment Phase|Death|0|||
150026147|NCT05579977|541230508|FG012|Treatment Phase|Death|0|||
150026148|NCT05579977|541230496|FG000|Treatment Phase|Adverse Event|0|||
150026149|NCT05579977|541230497|FG001|Treatment Phase|Adverse Event|3|||
150026150|NCT05579977|541230498|FG002|Treatment Phase|Adverse Event|11|||
150026151|NCT05579977|541230499|FG003|Treatment Phase|Adverse Event|10|||
150026152|NCT05579977|541230500|FG004|Treatment Phase|Adverse Event|5|||
150026153|NCT05579977|541230501|FG005|Treatment Phase|Adverse Event|17|||
150026154|NCT05579977|541230502|FG006|Treatment Phase|Adverse Event|5|||
150026155|NCT05579977|541230503|FG007|Treatment Phase|Adverse Event|5|||
150026156|NCT05579977|541230504|FG008|Treatment Phase|Adverse Event|12|||
150026157|NCT05579977|541230505|FG009|Treatment Phase|Adverse Event|20|||
150026158|NCT05579977|541230506|FG010|Treatment Phase|Adverse Event|15|||
150026159|NCT05579977|541230507|FG011|Treatment Phase|Adverse Event|24|||
150026160|NCT05579977|541230508|FG012|Treatment Phase|Adverse Event|23|||
150026161|NCT05579977|541230496|FG000|Treatment Phase|Randomized not treated|0|||
150026162|NCT05579977|541230497|FG001|Treatment Phase|Randomized not treated|0|||
150026163|NCT05579977|541230498|FG002|Treatment Phase|Randomized not treated|0|||
150026164|NCT05579977|541230499|FG003|Treatment Phase|Randomized not treated|0|||
150026165|NCT05579977|541230500|FG004|Treatment Phase|Randomized not treated|1|||
150026166|NCT05579977|541230501|FG005|Treatment Phase|Randomized not treated|0|||
150026167|NCT05579977|541230502|FG006|Treatment Phase|Randomized not treated|0|||
150026168|NCT05579977|541230503|FG007|Treatment Phase|Randomized not treated|0|||
150026169|NCT05579977|541230504|FG008|Treatment Phase|Randomized not treated|0|||
150026170|NCT05579977|541230505|FG009|Treatment Phase|Randomized not treated|0|||
150026171|NCT05579977|541230506|FG010|Treatment Phase|Randomized not treated|0|||
150026172|NCT05579977|541230507|FG011|Treatment Phase|Randomized not treated|0|||
150026173|NCT05579977|541230508|FG012|Treatment Phase|Randomized not treated|0|||
150026174|NCT05579977|541230496|FG000|Follow up|Death|1|||
150026175|NCT05579977|541230497|FG001|Follow up|Death|0|||
150026176|NCT05579977|541230498|FG002|Follow up|Death|0|||
150026177|NCT05579977|541230499|FG003|Follow up|Death|0|||
150026178|NCT05579977|541230500|FG004|Follow up|Death|0|||
150026179|NCT05579977|541230501|FG005|Follow up|Death|0|||
150026180|NCT05579977|541230502|FG006|Follow up|Death|0|||
150026181|NCT05579977|541230503|FG007|Follow up|Death|0|||
150026182|NCT05579977|541230504|FG008|Follow up|Death|0|||
150026183|NCT05579977|541230505|FG009|Follow up|Death|0|||
150026184|NCT05579977|541230506|FG010|Follow up|Death|0|||
150026185|NCT05579977|541230507|FG011|Follow up|Death|0|||
150026186|NCT05579977|541230508|FG012|Follow up|Death|0|||
150026187|NCT05579977|541230496|FG000|Follow up|Lost to Follow-up|0|||
150026188|NCT05579977|541230497|FG001|Follow up|Lost to Follow-up|0|||
150026189|NCT05579977|541230498|FG002|Follow up|Lost to Follow-up|0|||
150026190|NCT05579977|541230499|FG003|Follow up|Lost to Follow-up|1|||
150026191|NCT05579977|541230500|FG004|Follow up|Lost to Follow-up|1|||
150026192|NCT05579977|541230501|FG005|Follow up|Lost to Follow-up|2|||
150026193|NCT05579977|541230502|FG006|Follow up|Lost to Follow-up|1|||
150026194|NCT05579977|541230503|FG007|Follow up|Lost to Follow-up|1|||
150026195|NCT05579977|541230504|FG008|Follow up|Lost to Follow-up|3|||
150026196|NCT05579977|541230505|FG009|Follow up|Lost to Follow-up|2|||
150026197|NCT05579977|541230506|FG010|Follow up|Lost to Follow-up|2|||
150026198|NCT05579977|541230507|FG011|Follow up|Lost to Follow-up|4|||
150026199|NCT05579977|541230508|FG012|Follow up|Lost to Follow-up|4|||
150026200|NCT05579977|541230496|FG000|Follow up|Withdrawal by Subject|2|||
150026201|NCT05579977|541230497|FG001|Follow up|Withdrawal by Subject|0|||
150026202|NCT05579977|541230498|FG002|Follow up|Withdrawal by Subject|0|||
150026203|NCT05579977|541230499|FG003|Follow up|Withdrawal by Subject|0|||
150026204|NCT05579977|541230500|FG004|Follow up|Withdrawal by Subject|1|||
150026205|NCT05579977|541230501|FG005|Follow up|Withdrawal by Subject|0|||
150026206|NCT05579977|541230502|FG006|Follow up|Withdrawal by Subject|1|||
150026207|NCT05579977|541230503|FG007|Follow up|Withdrawal by Subject|4|||
150026208|NCT05579977|541230504|FG008|Follow up|Withdrawal by Subject|2|||
150026209|NCT05579977|541230505|FG009|Follow up|Withdrawal by Subject|3|||
150026210|NCT05579977|541230506|FG010|Follow up|Withdrawal by Subject|3|||
150026211|NCT05579977|541230507|FG011|Follow up|Withdrawal by Subject|1|||
150026212|NCT05579977|541230508|FG012|Follow up|Withdrawal by Subject|3|||
150026213|NCT01611194|541230510|FG000|Overall Study|Lost to Follow-up|0|||
150026214|NCT01611194|541230511|FG001|Overall Study|Lost to Follow-up|1|||
150026215|NCT01611194|541230510|FG000|Overall Study|Withdrawal by Subject|0|||
150026216|NCT01611194|541230511|FG001|Overall Study|Withdrawal by Subject|1|||
150026217|NCT01611194|541230510|FG000|Overall Study|drug use|0|||
150026218|NCT01611194|541230511|FG001|Overall Study|drug use|1|||
150026219|NCT00348673|541230513|FG000|Stage 1|Randomized but not Treated|0|||
150026220|NCT00348673|541230514|FG001|Stage 1|Randomized but not Treated|0|||
150026221|NCT00348673|541230515|FG002|Stage 1|Randomized but not Treated|1|||
150026222|NCT00348673|541230516|FG003|Stage 1|Randomized but not Treated|0|||
150026223|NCT00348673|541230517|FG004|Stage 1|Randomized but not Treated|0|||
150026224|NCT00348673|541230518|FG005|Stage 1|Randomized but not Treated|0|||
150026225|NCT00348673|541230519|FG006|Stage 1|Randomized but not Treated|0|||
150026226|NCT00348673|541230520|FG007|Stage 1|Randomized but not Treated|0|||
150026227|NCT00348673|541230521|FG008|Stage 1|Randomized but not Treated|0|||
150026228|NCT00319254|541230523|FG000|Overall Study|Withdrawal by Subject|4|||
150026229|NCT00319254|541230523|FG000|Overall Study|Death|46|||
150026230|NCT00319254|541230523|FG000|Overall Study|Lost to Follow-up|2|||
150026231|NCT00319254|541230523|FG000|Overall Study|Enrolled, Not Treated|2|||
150026232|NCT00794950|541230524|FG000|BCG Induction|Withdrawal by Subject|2|||
150026233|NCT00794950|541230524|FG000|BCG Induction|ineligible|3|||
150026234|NCT00794950|541230524|FG000|BCG Induction|noncompliant w. BCG|1|||
150026235|NCT00794950|541230524|FG000|BCG Induction|Adverse Event|1|||
150026236|NCT00794950|541230524|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
150026237|NCT00794950|541230524|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
150026238|NCT00794950|541230524|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
150026239|NCT00794950|541230524|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
150026240|NCT02485704|541230525|FG000|Overall Study|Lost to Follow-up|4|||
150026241|NCT02485704|541230526|FG001|Overall Study|Lost to Follow-up|5|||
150026242|NCT02485704|541230525|FG000|Overall Study|Withdrawal by Subject|0|||
150026243|NCT02485704|541230526|FG001|Overall Study|Withdrawal by Subject|3|||
150026244|NCT02485704|541230525|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
150026245|NCT02485704|541230526|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
150026246|NCT04177212|541230528|FG000|Overall Study|Withdrawal by Subject|9|||
150026247|NCT04177212|541230529|FG001|Overall Study|Withdrawal by Subject|7|||
150026248|NCT04177212|541230528|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
150026249|NCT04177212|541230529|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
150026250|NCT04177212|541230528|FG000|Overall Study|Physician Decision|1|||
150026251|NCT04177212|541230529|FG001|Overall Study|Physician Decision|0|||
150026252|NCT04177212|541230528|FG000|Overall Study|Lost to Follow-up|0|||
150026253|NCT04177212|541230529|FG001|Overall Study|Lost to Follow-up|3|||
150026254|NCT04177212|541230528|FG000|Overall Study|Adverse Event|0|||
150026255|NCT04177212|541230529|FG001|Overall Study|Adverse Event|1|||
150026256|NCT04177212|541230528|FG000|Overall Study|Other|1|||
150026257|NCT04177212|541230529|FG001|Overall Study|Other|2|||
150026258|NCT01279681|541230530|FG000|Overall Study|Disease Progression|9|||
150026259|NCT01279681|541230531|FG001|Overall Study|Disease Progression|6|||
150026260|NCT01279681|541230530|FG000|Overall Study|Withdrawal by Subject|3|||
150026261|NCT01279681|541230531|FG001|Overall Study|Withdrawal by Subject|4|||
150026262|NCT01279681|541230530|FG000|Overall Study|Adverse Event|2|||
150026263|NCT01279681|541230531|FG001|Overall Study|Adverse Event|3|||
150026264|NCT01279681|541230530|FG000|Overall Study|Death|0|||
150026265|NCT01279681|541230531|FG001|Overall Study|Death|1|||
150026266|NCT01279681|541230530|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
150026267|NCT01279681|541230531|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
150026268|NCT01279681|541230530|FG000|Overall Study|Physician Decision|1|||
150026269|NCT01279681|541230531|FG001|Overall Study|Physician Decision|0|||
150026270|NCT01279681|541230530|FG000|Overall Study|Other Reason|0|||
150026271|NCT01279681|541230531|FG001|Overall Study|Other Reason|2|||
150026272|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
150026273|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
150026274|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
150026275|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
150026276|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
150026277|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
150026278|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
150026279|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
150026280|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
150026281|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
150026282|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
150026283|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
150026284|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
150026285|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
150026286|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
150026287|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
150026288|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
150026289|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
150026290|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
150026291|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
150026292|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
150026293|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
150026294|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
150026295|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
150026296|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
150026297|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
150026298|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
150026299|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
150026300|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
150026301|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
150026302|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
150026303|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
150026304|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
150026305|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
150026306|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
150026307|NCT02831764|541233064|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
150026308|NCT02831764|541233065|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
150026309|NCT02831764|541233066|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
150026310|NCT02831764|541233067|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
150026311|NCT02831764|541233068|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
150026312|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150026313|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150026314|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
150026315|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
150026316|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
150026317|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150026318|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150026319|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
150026320|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150026321|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
150026322|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150026323|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150026324|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
150026325|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
150026326|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
150026327|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
150026328|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
150026329|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
150026330|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
150026331|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
150026332|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150026333|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150026334|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
150026335|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
150026336|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
150026337|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150026338|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150026339|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
150085234|NCT03129100|541453677|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
150026340|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
150026341|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
150026342|NCT02831764|541233064|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150026343|NCT02831764|541233065|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150026344|NCT02831764|541233066|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
150026345|NCT02831764|541233067|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
150026346|NCT02831764|541233068|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
150026347|NCT02831764|541233064|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150026348|NCT02831764|541233065|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150026349|NCT02831764|541233066|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150026350|NCT02831764|541233067|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
150026351|NCT02831764|541233068|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
150026352|NCT02831764|541233064|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150026353|NCT02831764|541233065|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150026354|NCT02831764|541233066|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150026355|NCT02831764|541233067|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
150026356|NCT02831764|541233068|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
150026357|NCT02831764|541233064|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150026358|NCT02831764|541233065|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150026359|NCT02831764|541233066|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150026360|NCT02831764|541233067|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
150026361|NCT02831764|541233068|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
150026362|NCT02831764|541233064|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150026363|NCT02831764|541233065|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150026364|NCT02831764|541233066|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150026365|NCT02831764|541233067|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
150026366|NCT02831764|541233068|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
150026367|NCT00101686|541233074|FG000|Overall Study|Progressive Disease|37|||
150026368|NCT00101686|541233075|FG001|Overall Study|Progressive Disease|28|||
150026369|NCT00101686|541233076|FG002|Overall Study|Progressive Disease|37|||
150026370|NCT00101686|541233077|FG003|Overall Study|Progressive Disease|38|||
150026371|NCT00101686|541233078|FG004|Overall Study|Progressive Disease|28|||
150026372|NCT00101686|541233079|FG005|Overall Study|Progressive Disease|25|||
150026373|NCT00101686|541233080|FG006|Overall Study|Progressive Disease|5|||
150026374|NCT00101686|541233081|FG007|Overall Study|Progressive Disease|7|||
150026375|NCT00101686|541233082|FG008|Overall Study|Progressive Disease|10|||
150026376|NCT00101686|541233083|FG009|Overall Study|Progressive Disease|8|||
150026377|NCT00101686|541233074|FG000|Overall Study|initiation other anti-cancer treatment|4|||
150026378|NCT00101686|541233075|FG001|Overall Study|initiation other anti-cancer treatment|3|||
150026379|NCT00101686|541233076|FG002|Overall Study|initiation other anti-cancer treatment|4|||
150026380|NCT00101686|541233077|FG003|Overall Study|initiation other anti-cancer treatment|3|||
150026381|NCT00101686|541233078|FG004|Overall Study|initiation other anti-cancer treatment|1|||
150026382|NCT00101686|541233079|FG005|Overall Study|initiation other anti-cancer treatment|1|||
150026383|NCT00101686|541233080|FG006|Overall Study|initiation other anti-cancer treatment|2|||
150183208|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
150183209|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
150183210|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
150183211|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
150183212|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
150183213|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
150183214|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
150183215|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
150183216|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
150183217|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
150183218|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
150183219|NCT03338816|541808767|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
150183220|NCT03338816|541808768|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
150183221|NCT03338816|541808769|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
150183222|NCT03338816|541808770|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
150183223|NCT01948661|541808772|FG000|Overall Study|Withdrawal by Subject|2|||
150183224|NCT01948661|541808773|FG001|Overall Study|Withdrawal by Subject|4|||
150183225|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Adverse Event|4|||
150183226|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Adverse Event|1|||
150183227|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
150026384|NCT00101686|541233081|FG007|Overall Study|initiation other anti-cancer treatment|2|||
150026385|NCT00101686|541233082|FG008|Overall Study|initiation other anti-cancer treatment|3|||
150026386|NCT00101686|541233083|FG009|Overall Study|initiation other anti-cancer treatment|3|||
150026387|NCT00101686|541233074|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
150026388|NCT00101686|541233075|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
150026389|NCT00101686|541233076|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
150026390|NCT00101686|541233077|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
150026391|NCT00101686|541233078|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
150026392|NCT00101686|541233079|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
150026393|NCT00101686|541233080|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
150026394|NCT00101686|541233081|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
150026395|NCT00101686|541233082|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
150026396|NCT00101686|541233083|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
150026397|NCT00101686|541233074|FG000|Overall Study|unacceptable toxicity|3|||
150026398|NCT00101686|541233075|FG001|Overall Study|unacceptable toxicity|9|||
150026399|NCT00101686|541233076|FG002|Overall Study|unacceptable toxicity|10|||
150026400|NCT00101686|541233077|FG003|Overall Study|unacceptable toxicity|6|||
150026401|NCT00101686|541233078|FG004|Overall Study|unacceptable toxicity|16|||
150026402|NCT00101686|541233079|FG005|Overall Study|unacceptable toxicity|10|||
150026403|NCT00101686|541233080|FG006|Overall Study|unacceptable toxicity|4|||
150026404|NCT00101686|541233081|FG007|Overall Study|unacceptable toxicity|2|||
150026405|NCT00101686|541233082|FG008|Overall Study|unacceptable toxicity|1|||
150026406|NCT00101686|541233083|FG009|Overall Study|unacceptable toxicity|4|||
150026407|NCT00101686|541233074|FG000|Overall Study|Randomized but did not receive treament|1|||
150026408|NCT00101686|541233075|FG001|Overall Study|Randomized but did not receive treament|6|||
150026409|NCT00101686|541233076|FG002|Overall Study|Randomized but did not receive treament|2|||
150026410|NCT00101686|541233077|FG003|Overall Study|Randomized but did not receive treament|2|||
150026411|NCT00101686|541233078|FG004|Overall Study|Randomized but did not receive treament|2|||
150026412|NCT00101686|541233079|FG005|Overall Study|Randomized but did not receive treament|2|||
150026413|NCT00101686|541233080|FG006|Overall Study|Randomized but did not receive treament|0|||
150026414|NCT00101686|541233081|FG007|Overall Study|Randomized but did not receive treament|1|||
150026415|NCT00101686|541233082|FG008|Overall Study|Randomized but did not receive treament|0|||
150026416|NCT00101686|541233083|FG009|Overall Study|Randomized but did not receive treament|1|||
150026417|NCT00101686|541233074|FG000|Overall Study|intercurrent non-cancer related illness|0|||
150026418|NCT00101686|541233075|FG001|Overall Study|intercurrent non-cancer related illness|0|||
150026419|NCT00101686|541233076|FG002|Overall Study|intercurrent non-cancer related illness|2|||
150026420|NCT00101686|541233077|FG003|Overall Study|intercurrent non-cancer related illness|0|||
150026421|NCT00101686|541233078|FG004|Overall Study|intercurrent non-cancer related illness|1|||
150026422|NCT00101686|541233079|FG005|Overall Study|intercurrent non-cancer related illness|3|||
150026423|NCT00101686|541233080|FG006|Overall Study|intercurrent non-cancer related illness|1|||
150026424|NCT00101686|541233081|FG007|Overall Study|intercurrent non-cancer related illness|0|||
150026425|NCT00101686|541233082|FG008|Overall Study|intercurrent non-cancer related illness|1|||
150026426|NCT00101686|541233083|FG009|Overall Study|intercurrent non-cancer related illness|1|||
150026427|NCT00101686|541233074|FG000|Overall Study|Physician Decision|10|||
150026428|NCT00101686|541233075|FG001|Overall Study|Physician Decision|13|||
150026429|NCT00101686|541233076|FG002|Overall Study|Physician Decision|6|||
150026430|NCT00101686|541233077|FG003|Overall Study|Physician Decision|7|||
150026431|NCT00101686|541233078|FG004|Overall Study|Physician Decision|8|||
150026432|NCT00101686|541233079|FG005|Overall Study|Physician Decision|9|||
150026433|NCT00101686|541233080|FG006|Overall Study|Physician Decision|5|||
150026434|NCT00101686|541233081|FG007|Overall Study|Physician Decision|5|||
150026435|NCT00101686|541233082|FG008|Overall Study|Physician Decision|1|||
150026436|NCT00101686|541233083|FG009|Overall Study|Physician Decision|1|||
150026437|NCT00101686|541233074|FG000|Overall Study|Other|1|||
150026438|NCT00101686|541233075|FG001|Overall Study|Other|4|||
150026439|NCT00101686|541233076|FG002|Overall Study|Other|1|||
150026440|NCT00101686|541233077|FG003|Overall Study|Other|6|||
150026441|NCT00101686|541233078|FG004|Overall Study|Other|2|||
150026442|NCT00101686|541233079|FG005|Overall Study|Other|12|||
150026443|NCT00101686|541233080|FG006|Overall Study|Other|1|||
150026444|NCT00101686|541233081|FG007|Overall Study|Other|5|||
150026445|NCT00101686|541233082|FG008|Overall Study|Other|3|||
150026446|NCT00101686|541233083|FG009|Overall Study|Other|3|||
150026447|NCT00101686|541233074|FG000|Overall Study|Withdrawal by Subject|9|||
150026448|NCT00101686|541233075|FG001|Overall Study|Withdrawal by Subject|8|||
150026449|NCT00101686|541233076|FG002|Overall Study|Withdrawal by Subject|6|||
150026450|NCT00101686|541233077|FG003|Overall Study|Withdrawal by Subject|8|||
150026451|NCT00101686|541233078|FG004|Overall Study|Withdrawal by Subject|8|||
150026452|NCT00101686|541233079|FG005|Overall Study|Withdrawal by Subject|7|||
150026453|NCT00101686|541233080|FG006|Overall Study|Withdrawal by Subject|7|||
150026454|NCT00101686|541233081|FG007|Overall Study|Withdrawal by Subject|7|||
150026455|NCT00101686|541233082|FG008|Overall Study|Withdrawal by Subject|8|||
150026456|NCT00101686|541233083|FG009|Overall Study|Withdrawal by Subject|9|||
150026457|NCT00985465|541233084|FG000|Overall Study|Withdrawal by Subject|1|||
150026458|NCT00985465|541233085|FG001|Overall Study|Withdrawal by Subject|2|||
150026459|NCT00985465|541233084|FG000|Overall Study|Considered to be part of the other group|0|||
150026460|NCT00985465|541233085|FG001|Overall Study|Considered to be part of the other group|1|||
150026461|NCT01054456|541233086|FG000|Overall Study|Other|1|||
150026462|NCT00687401|541233088|FG000|Overall Study|Protocol Violation|7|||
150026463|NCT00687401|541233088|FG000|Overall Study|Adverse Event|6|||
150026464|NCT00687401|541233088|FG000|Overall Study|Lack of Efficacy|6|||
150026465|NCT00687401|541233088|FG000|Overall Study|Withdrawal by Subject|4|||
150026466|NCT00687401|541233088|FG000|Overall Study|Did not return for visit|3|||
150026467|NCT00687401|541233088|FG000|Overall Study|For reasons different from those above|4|||
150026468|NCT02336607|541233089|FG000|Overall Study|Physician Decision|1|||
150026469|NCT02336607|541233090|FG001|Overall Study|Physician Decision|4|||
150026470|NCT02336607|541233091|FG002|Overall Study|Physician Decision|3|||
150026471|NCT02336607|541233092|FG003|Overall Study|Physician Decision|15|||
150026472|NCT02336607|541233089|FG000|Overall Study|Lack of Efficacy|1|||
150026473|NCT02336607|541233090|FG001|Overall Study|Lack of Efficacy|0|||
150026474|NCT02336607|541233091|FG002|Overall Study|Lack of Efficacy|0|||
150026475|NCT02336607|541233092|FG003|Overall Study|Lack of Efficacy|2|||
150026476|NCT02336607|541233089|FG000|Overall Study|Lost to Follow-up|2|||
150026477|NCT02336607|541233090|FG001|Overall Study|Lost to Follow-up|1|||
150026478|NCT02336607|541233091|FG002|Overall Study|Lost to Follow-up|0|||
150026479|NCT02336607|541233092|FG003|Overall Study|Lost to Follow-up|21|||
150026480|NCT02336607|541233089|FG000|Overall Study|Protocol Violation|0|||
150026481|NCT02336607|541233090|FG001|Overall Study|Protocol Violation|1|||
150026482|NCT02336607|541233091|FG002|Overall Study|Protocol Violation|1|||
150026483|NCT02336607|541233092|FG003|Overall Study|Protocol Violation|3|||
150026484|NCT02336607|541233089|FG000|Overall Study|Adverse Event|0|||
150026485|NCT02336607|541233090|FG001|Overall Study|Adverse Event|2|||
150026486|NCT02336607|541233091|FG002|Overall Study|Adverse Event|2|||
150026487|NCT02336607|541233092|FG003|Overall Study|Adverse Event|26|||
150026488|NCT02336607|541233089|FG000|Overall Study|Withdrawal by Subject|0|||
150026489|NCT02336607|541233090|FG001|Overall Study|Withdrawal by Subject|2|||
150026490|NCT02336607|541233091|FG002|Overall Study|Withdrawal by Subject|0|||
150026491|NCT02336607|541233092|FG003|Overall Study|Withdrawal by Subject|20|||
150026492|NCT00721396|541233098|FG000|Overall Study|Adverse Event|4|||
150026493|NCT00721396|541233099|FG001|Overall Study|Adverse Event|7|||
150026494|NCT00721396|541233100|FG002|Overall Study|Adverse Event|2|||
150026495|NCT00721396|541233101|FG003|Overall Study|Adverse Event|0|||
150026496|NCT00721396|541233098|FG000|Overall Study|Withdrawal by Subject|12|||
150026497|NCT00721396|541233099|FG001|Overall Study|Withdrawal by Subject|15|||
150026498|NCT00721396|541233100|FG002|Overall Study|Withdrawal by Subject|3|||
150026499|NCT00721396|541233101|FG003|Overall Study|Withdrawal by Subject|7|||
150026500|NCT00721396|541233098|FG000|Overall Study|Lost to Follow-up|7|||
150026501|NCT00721396|541233099|FG001|Overall Study|Lost to Follow-up|9|||
150026502|NCT00721396|541233100|FG002|Overall Study|Lost to Follow-up|3|||
150026503|NCT00721396|541233101|FG003|Overall Study|Lost to Follow-up|3|||
150026504|NCT00721396|541233098|FG000|Overall Study|Protocol Violation|4|||
150026505|NCT00721396|541233099|FG001|Overall Study|Protocol Violation|3|||
150026506|NCT00721396|541233100|FG002|Overall Study|Protocol Violation|1|||
150026507|NCT00721396|541233101|FG003|Overall Study|Protocol Violation|0|||
150026508|NCT00721396|541233098|FG000|Overall Study|Inappropriate enrollment|0|||
150026509|NCT00721396|541233099|FG001|Overall Study|Inappropriate enrollment|2|||
150026510|NCT00721396|541233100|FG002|Overall Study|Inappropriate enrollment|0|||
150026511|NCT00721396|541233101|FG003|Overall Study|Inappropriate enrollment|0|||
150026512|NCT00721396|541233098|FG000|Overall Study|Administrative reason|3|||
150026513|NCT00721396|541233099|FG001|Overall Study|Administrative reason|0|||
150026514|NCT00721396|541233100|FG002|Overall Study|Administrative reason|1|||
150026515|NCT00721396|541233101|FG003|Overall Study|Administrative reason|0|||
150026516|NCT01721161|541233102|FG000|Overall Study|Adverse Event|2|||
150026517|NCT01721161|541233103|FG001|Overall Study|Adverse Event|3|||
150026518|NCT01721161|541233102|FG000|Overall Study|Lost to Follow-up|1|||
150026519|NCT01721161|541233103|FG001|Overall Study|Lost to Follow-up|2|||
150026520|NCT01721161|541233102|FG000|Overall Study|Withdrawal by Subject|1|||
150026521|NCT01721161|541233103|FG001|Overall Study|Withdrawal by Subject|1|||
150026522|NCT01721161|541233102|FG000|Overall Study|Other|0|||
150026523|NCT01721161|541233103|FG001|Overall Study|Other|1|||
150026524|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026525|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026526|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026527|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
150026528|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026529|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026530|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026531|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026532|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026533|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
150026534|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
150026535|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
150026536|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
150026537|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
150026538|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
150026539|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
150026540|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
150026541|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
150026542|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
150026543|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
150026544|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
150026545|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
150026546|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
150026547|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
150026548|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
150026549|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
150026550|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
150026551|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
150026552|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
150026553|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
150026554|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
150026555|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
150026556|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
150026557|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
150026558|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
150026559|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
150026560|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
150026561|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
150026562|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
150085235|NCT03129100|541453678|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
150085236|NCT03129100|541453679|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
150085237|NCT03129100|541453680|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
150085238|NCT03129100|541453681|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
150085239|NCT03129100|541453682|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
150085240|NCT03129100|541453683|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
150085241|NCT03129100|541453684|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
150085242|NCT03129100|541453685|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
150026563|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
150026564|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
150085243|NCT03129100|541453686|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
150085244|NCT03129100|541453687|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
150085245|NCT03129100|541453688|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
150085246|NCT03129100|541453689|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
150085247|NCT03129100|541453690|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
150085248|NCT03129100|541453691|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
150085249|NCT03129100|541453692|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
150085250|NCT03129100|541453693|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
150085251|NCT03129100|541453694|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
150085252|NCT03129100|541453695|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
150085253|NCT03129100|541453696|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
150085254|NCT03129100|541453697|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
150026565|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026566|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
150026567|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026568|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
150026569|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026570|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026571|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026572|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026573|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
150026574|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
150026575|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026576|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026577|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026578|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
150026579|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
150026580|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026581|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026582|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026583|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
150026584|NCT02365649|541233107|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026585|NCT02365649|541233108|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026586|NCT02365649|541233109|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
150026587|NCT02365649|541233110|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026588|NCT02365649|541233111|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026589|NCT02365649|541233112|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026590|NCT02365649|541233113|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026591|NCT02365649|541233114|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026592|NCT02365649|541233115|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026593|NCT02365649|541233116|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
150026594|NCT02365649|541233107|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026595|NCT02365649|541233108|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026596|NCT02365649|541233109|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150085255|NCT03129100|541453698|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
150085256|NCT03129100|541453699|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
150085257|NCT03129100|541453700|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
150085258|NCT03129100|541453701|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
150085259|NCT03129100|541453676|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
150085260|NCT03129100|541453677|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085261|NCT03129100|541453678|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085262|NCT03129100|541453679|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085263|NCT03129100|541453680|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085264|NCT03129100|541453681|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085265|NCT03129100|541453682|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085266|NCT03129100|541453683|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085267|NCT03129100|541453684|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085268|NCT03129100|541453685|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085269|NCT03129100|541453686|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085270|NCT03129100|541453687|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085271|NCT03129100|541453688|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085272|NCT03129100|541453689|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085273|NCT03129100|541453690|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085274|NCT03129100|541453691|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085275|NCT03129100|541453692|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085276|NCT03129100|541453693|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085277|NCT03129100|541453694|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085278|NCT03129100|541453695|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085279|NCT03129100|541453696|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085280|NCT03129100|541453697|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085281|NCT03129100|541453698|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085282|NCT03129100|541453699|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085283|NCT03129100|541453700|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085284|NCT03129100|541453701|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
150085285|NCT03129100|541453676|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
150085286|NCT03129100|541453677|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
150085287|NCT03129100|541453678|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085288|NCT03129100|541453679|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085289|NCT03129100|541453680|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085290|NCT03129100|541453681|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085291|NCT03129100|541453682|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085292|NCT03129100|541453683|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026597|NCT02365649|541233110|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026598|NCT02365649|541233111|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026599|NCT02365649|541233112|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026600|NCT02365649|541233113|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
150026601|NCT02365649|541233114|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026602|NCT02365649|541233115|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026603|NCT02365649|541233116|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
150026604|NCT02365649|541233107|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026605|NCT02365649|541233108|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026606|NCT02365649|541233109|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026607|NCT02365649|541233110|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026608|NCT02365649|541233111|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026609|NCT02365649|541233112|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026610|NCT02365649|541233113|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
150026611|NCT02365649|541233114|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
150026612|NCT02365649|541233115|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
150026613|NCT02365649|541233116|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
150026614|NCT02365649|541233107|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026615|NCT02365649|541233108|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026616|NCT02365649|541233109|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026617|NCT02365649|541233110|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026618|NCT02365649|541233111|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026619|NCT02365649|541233112|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
150026620|NCT02365649|541233113|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
150026621|NCT02365649|541233114|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
150026622|NCT02365649|541233115|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
150026623|NCT02365649|541233116|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
150026624|NCT02365649|541233107|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026625|NCT02365649|541233108|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026626|NCT02365649|541233109|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026627|NCT02365649|541233110|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026628|NCT02365649|541233111|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026629|NCT02365649|541233112|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026630|NCT02365649|541233113|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
150026631|NCT02365649|541233114|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
150026632|NCT02365649|541233115|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
150026633|NCT02365649|541233116|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
150026634|NCT02365649|541233107|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026635|NCT02365649|541233108|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026636|NCT02365649|541233109|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026637|NCT02365649|541233110|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026638|NCT02365649|541233111|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026639|NCT02365649|541233112|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026640|NCT02365649|541233113|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
150026641|NCT02365649|541233114|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026642|NCT02365649|541233115|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
150026643|NCT02365649|541233116|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
150026644|NCT02021565|541233131|FG000|Baseline Through Intervention|Death|0|||
150026645|NCT02021565|541233132|FG001|Baseline Through Intervention|Death|1|||
150026646|NCT02021565|541233131|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
150026647|NCT02021565|541233132|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
150026648|NCT02021565|541233131|FG000|Baseline Through Intervention|Protocol Violation|0|||
150026649|NCT02021565|541233132|FG001|Baseline Through Intervention|Protocol Violation|7|||
150026650|NCT02021565|541233131|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
150026651|NCT02021565|541233132|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
150026652|NCT02021565|541233131|FG000|3-month Follow-up|Death|3|||
150026653|NCT02021565|541233132|FG001|3-month Follow-up|Death|0|||
150026654|NCT02021565|541233131|FG000|3-month Follow-up|Withdrawal by Subject|4|||
150026655|NCT02021565|541233132|FG001|3-month Follow-up|Withdrawal by Subject|0|||
150026656|NCT02021565|541233131|FG000|3-month Follow-up|Protocol Violation|3|||
150026657|NCT02021565|541233132|FG001|3-month Follow-up|Protocol Violation|2|||
150026658|NCT01188772|541233135|FG000|Overall Study|Randomized but Not Treated|0|||
150026659|NCT01188772|541233136|FG001|Overall Study|Randomized but Not Treated|1|||
150026660|NCT01188772|541233137|FG002|Overall Study|Randomized but Not Treated|0|||
150026661|NCT01188772|541233138|FG003|Overall Study|Randomized but Not Treated|0|||
150026662|NCT01188772|541233135|FG000|Overall Study|Adverse Event|0|||
150026663|NCT01188772|541233136|FG001|Overall Study|Adverse Event|1|||
150026664|NCT01188772|541233137|FG002|Overall Study|Adverse Event|2|||
150026665|NCT01188772|541233138|FG003|Overall Study|Adverse Event|0|||
150026666|NCT01188772|541233135|FG000|Overall Study|Lost to Follow-up|4|||
150026667|NCT01188772|541233136|FG001|Overall Study|Lost to Follow-up|1|||
150026668|NCT01188772|541233137|FG002|Overall Study|Lost to Follow-up|1|||
150026669|NCT01188772|541233138|FG003|Overall Study|Lost to Follow-up|1|||
150026670|NCT01188772|541233135|FG000|Overall Study|Non-responder|0|||
150026671|NCT01188772|541233136|FG001|Overall Study|Non-responder|0|||
150026672|NCT01188772|541233137|FG002|Overall Study|Non-responder|3|||
150026673|NCT01188772|541233138|FG003|Overall Study|Non-responder|0|||
150026674|NCT01188772|541233135|FG000|Overall Study|Physician Decision|0|||
150026675|NCT01188772|541233136|FG001|Overall Study|Physician Decision|0|||
150026676|NCT01188772|541233137|FG002|Overall Study|Physician Decision|1|||
150026677|NCT01188772|541233138|FG003|Overall Study|Physician Decision|0|||
150026678|NCT01188772|541233135|FG000|Overall Study|Terminated by Sponsor|0|||
150026679|NCT01188772|541233136|FG001|Overall Study|Terminated by Sponsor|0|||
150026680|NCT01188772|541233137|FG002|Overall Study|Terminated by Sponsor|1|||
150026681|NCT01188772|541233138|FG003|Overall Study|Terminated by Sponsor|0|||
150026682|NCT01188772|541233135|FG000|Overall Study|Treatment Failure|0|||
150026683|NCT01188772|541233136|FG001|Overall Study|Treatment Failure|0|||
150026684|NCT01188772|541233137|FG002|Overall Study|Treatment Failure|1|||
150026685|NCT01188772|541233138|FG003|Overall Study|Treatment Failure|0|||
150026686|NCT01188772|541233135|FG000|Overall Study|Virologic Failure|1|||
150026687|NCT01188772|541233136|FG001|Overall Study|Virologic Failure|0|||
150026688|NCT01188772|541233137|FG002|Overall Study|Virologic Failure|0|||
150026689|NCT01188772|541233138|FG003|Overall Study|Virologic Failure|0|||
150026690|NCT01188772|541233135|FG000|Overall Study|Withdrawal by Subject|0|||
150026691|NCT01188772|541233136|FG001|Overall Study|Withdrawal by Subject|0|||
150026692|NCT01188772|541233137|FG002|Overall Study|Withdrawal by Subject|2|||
150026693|NCT01188772|541233138|FG003|Overall Study|Withdrawal by Subject|0|||
150026694|NCT01433172|541233139|FG000|Overall Study|Withdrawal by Subject|0|||
150026695|NCT01433172|541233140|FG001|Overall Study|Withdrawal by Subject|1|||
150026696|NCT01433172|541233141|FG002|Overall Study|Withdrawal by Subject|0|||
150026697|NCT01433172|541233139|FG000|Overall Study|Disease Progression|0|||
150026698|NCT01433172|541233140|FG001|Overall Study|Disease Progression|0|||
150026699|NCT01433172|541233141|FG002|Overall Study|Disease Progression|1|||
150026700|NCT01433172|541233139|FG000|Overall Study|Death|0|||
150026701|NCT01433172|541233140|FG001|Overall Study|Death|2|||
150026702|NCT01433172|541233141|FG002|Overall Study|Death|0|||
150026703|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
150026704|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
150026705|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
150026706|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
150026707|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
150026708|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
150026709|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Death|7|||
150026710|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Death|5|||
150026711|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Death|6|||
150026712|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
150026713|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
150026714|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
150026715|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
150026716|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
150026717|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
150026718|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Other|1|||
150026719|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Other|0|||
150026720|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Other|0|||
150026721|NCT00104650|541233142|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
150026722|NCT00104650|541233143|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
150026723|NCT00104650|541233144|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
150026724|NCT00104650|541233142|FG000|Follow-up Period|Physician Decision|1|||
150026725|NCT00104650|541233143|FG001|Follow-up Period|Physician Decision|1|||
150026726|NCT00104650|541233144|FG002|Follow-up Period|Physician Decision|0|||
150026727|NCT00104650|541233142|FG000|Follow-up Period|Adverse Event|1|||
150026728|NCT00104650|541233143|FG001|Follow-up Period|Adverse Event|0|||
150026729|NCT00104650|541233144|FG002|Follow-up Period|Adverse Event|1|||
150026730|NCT00104650|541233142|FG000|Follow-up Period|Withdrawal by Subject|0|||
150026731|NCT00104650|541233143|FG001|Follow-up Period|Withdrawal by Subject|3|||
150026732|NCT00104650|541233144|FG002|Follow-up Period|Withdrawal by Subject|3|||
150026733|NCT00104650|541233142|FG000|Follow-up Period|Death|6|||
150026734|NCT00104650|541233143|FG001|Follow-up Period|Death|6|||
150026735|NCT00104650|541233144|FG002|Follow-up Period|Death|4|||
150026736|NCT00104650|541233142|FG000|Follow-up Period|Disease progression|3|||
150026737|NCT00104650|541233143|FG001|Follow-up Period|Disease progression|1|||
150026738|NCT00104650|541233144|FG002|Follow-up Period|Disease progression|0|||
150026739|NCT00104650|541233142|FG000|Follow-up Period|Lost to Follow-up|0|||
150026740|NCT00104650|541233143|FG001|Follow-up Period|Lost to Follow-up|1|||
150026741|NCT00104650|541233144|FG002|Follow-up Period|Lost to Follow-up|2|||
150026742|NCT00104650|541233142|FG000|Follow-up Period|Other|0|||
150026743|NCT00104650|541233143|FG001|Follow-up Period|Other|1|||
150026744|NCT00104650|541233144|FG002|Follow-up Period|Other|0|||
150026745|NCT02294058|541233145|FG000|Overall Study|Adverse Event|16|||
150026746|NCT02294058|541233146|FG001|Overall Study|Adverse Event|7|||
150026747|NCT02294058|541233147|FG002|Overall Study|Adverse Event|13|||
150026748|NCT02294058|541233145|FG000|Overall Study|Lack of Efficacy|3|||
150026749|NCT02294058|541233146|FG001|Overall Study|Lack of Efficacy|3|||
150026750|NCT02294058|541233147|FG002|Overall Study|Lack of Efficacy|0|||
150026751|NCT02294058|541233145|FG000|Overall Study|Lost to Follow-up|1|||
150026752|NCT02294058|541233146|FG001|Overall Study|Lost to Follow-up|0|||
150026753|NCT02294058|541233147|FG002|Overall Study|Lost to Follow-up|2|||
150026754|NCT02294058|541233145|FG000|Overall Study|Withdrawal by Subject|10|||
150026755|NCT02294058|541233146|FG001|Overall Study|Withdrawal by Subject|14|||
150026756|NCT02294058|541233147|FG002|Overall Study|Withdrawal by Subject|13|||
150026757|NCT02294058|541233145|FG000|Overall Study|Physician Decision|2|||
150026758|NCT02294058|541233146|FG001|Overall Study|Physician Decision|1|||
150026759|NCT02294058|541233147|FG002|Overall Study|Physician Decision|0|||
150026760|NCT02294058|541233145|FG000|Overall Study|Miscellaneous|4|||
150026761|NCT02294058|541233146|FG001|Overall Study|Miscellaneous|1|||
150026762|NCT02294058|541233147|FG002|Overall Study|Miscellaneous|1|||
150026763|NCT01894607|541233148|FG000|Overall Study|Ineligible|1|||
150026764|NCT03084796|541233149|FG000|Overall Study|Adverse Event|4|||
150026765|NCT03084796|541233150|FG001|Overall Study|Adverse Event|5|||
150026766|NCT03084796|541233151|FG002|Overall Study|Adverse Event|6|||
150026767|NCT03084796|541233152|FG003|Overall Study|Adverse Event|2|||
150026768|NCT03084796|541233153|FG004|Overall Study|Adverse Event|3|||
150026769|NCT03084796|541233154|FG005|Overall Study|Adverse Event|5|||
150026770|NCT03084796|541233149|FG000|Overall Study|Withdrawal by Subject|3|||
150026771|NCT03084796|541233150|FG001|Overall Study|Withdrawal by Subject|5|||
150026772|NCT03084796|541233151|FG002|Overall Study|Withdrawal by Subject|2|||
150026773|NCT03084796|541233152|FG003|Overall Study|Withdrawal by Subject|1|||
150026774|NCT03084796|541233153|FG004|Overall Study|Withdrawal by Subject|3|||
150026775|NCT03084796|541233154|FG005|Overall Study|Withdrawal by Subject|0|||
150026776|NCT03084796|541233149|FG000|Overall Study|Protocol Violation|0|||
150026777|NCT03084796|541233150|FG001|Overall Study|Protocol Violation|0|||
150026778|NCT03084796|541233151|FG002|Overall Study|Protocol Violation|1|||
150026779|NCT03084796|541233152|FG003|Overall Study|Protocol Violation|0|||
150026780|NCT03084796|541233153|FG004|Overall Study|Protocol Violation|1|||
150026781|NCT03084796|541233154|FG005|Overall Study|Protocol Violation|1|||
150026782|NCT03084796|541233149|FG000|Overall Study|Lack of Efficacy|0|||
150026783|NCT03084796|541233150|FG001|Overall Study|Lack of Efficacy|0|||
150026784|NCT03084796|541233151|FG002|Overall Study|Lack of Efficacy|1|||
150026785|NCT03084796|541233152|FG003|Overall Study|Lack of Efficacy|0|||
150026786|NCT03084796|541233153|FG004|Overall Study|Lack of Efficacy|1|||
150026787|NCT03084796|541233154|FG005|Overall Study|Lack of Efficacy|0|||
150026788|NCT03084796|541233149|FG000|Overall Study|Lost to Follow-up|0|||
150085293|NCT03129100|541453684|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085294|NCT03129100|541453685|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026789|NCT03084796|541233150|FG001|Overall Study|Lost to Follow-up|0|||
150026790|NCT03084796|541233151|FG002|Overall Study|Lost to Follow-up|1|||
150026791|NCT03084796|541233152|FG003|Overall Study|Lost to Follow-up|1|||
150026792|NCT03084796|541233153|FG004|Overall Study|Lost to Follow-up|3|||
150026793|NCT03084796|541233154|FG005|Overall Study|Lost to Follow-up|1|||
150026794|NCT03084796|541233149|FG000|Overall Study|Randomization error|0|||
150026795|NCT03084796|541233150|FG001|Overall Study|Randomization error|0|||
150026796|NCT03084796|541233151|FG002|Overall Study|Randomization error|1|||
150026797|NCT03084796|541233152|FG003|Overall Study|Randomization error|0|||
150026798|NCT03084796|541233153|FG004|Overall Study|Randomization error|0|||
150026799|NCT03084796|541233154|FG005|Overall Study|Randomization error|0|||
150026800|NCT00650767|541233161|FG000|Overall Study|Adverse Event|0|||
150026801|NCT00650767|541233162|FG001|Overall Study|Adverse Event|3|||
150026802|NCT00650767|541233163|FG002|Overall Study|Adverse Event|10|||
150026803|NCT00650767|541233164|FG003|Overall Study|Adverse Event|8|||
150026804|NCT00650767|541233161|FG000|Overall Study|Death|1|||
150026805|NCT00650767|541233162|FG001|Overall Study|Death|0|||
150026806|NCT00650767|541233163|FG002|Overall Study|Death|0|||
150026807|NCT00650767|541233164|FG003|Overall Study|Death|0|||
150026808|NCT00650767|541233161|FG000|Overall Study|Withdrawal by Subject|2|||
150026809|NCT00650767|541233162|FG001|Overall Study|Withdrawal by Subject|4|||
150026810|NCT00650767|541233163|FG002|Overall Study|Withdrawal by Subject|3|||
150026811|NCT00650767|541233164|FG003|Overall Study|Withdrawal by Subject|3|||
150026812|NCT00650767|541233161|FG000|Overall Study|Lost to Follow-up|1|||
150026813|NCT00650767|541233162|FG001|Overall Study|Lost to Follow-up|1|||
150085295|NCT03129100|541453686|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026814|NCT00650767|541233163|FG002|Overall Study|Lost to Follow-up|1|||
150085296|NCT03129100|541453687|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085297|NCT03129100|541453688|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085298|NCT03129100|541453689|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026815|NCT00650767|541233164|FG003|Overall Study|Lost to Follow-up|0|||
150085299|NCT03129100|541453690|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026816|NCT00650767|541233161|FG000|Overall Study|Other|1|||
150026817|NCT00650767|541233162|FG001|Overall Study|Other|1|||
150026818|NCT00650767|541233163|FG002|Overall Study|Other|0|||
150026819|NCT00650767|541233164|FG003|Overall Study|Other|0|||
150026820|NCT01808196|541233168|FG000|Overall Study|Lost to Follow-up|1|||
150026821|NCT00479713|541233169|FG000|Overall Study|Adverse Event|8|||
150026822|NCT00479713|541233170|FG001|Overall Study|Adverse Event|6|||
150026823|NCT00479713|541233169|FG000|Overall Study|Death|1|||
150026824|NCT00479713|541233170|FG001|Overall Study|Death|0|||
150026825|NCT00479713|541233169|FG000|Overall Study|Lost to Follow-up|0|||
150026826|NCT00479713|541233170|FG001|Overall Study|Lost to Follow-up|1|||
150026827|NCT00479713|541233169|FG000|Overall Study|Protocol Violation|0|||
150026828|NCT00479713|541233170|FG001|Overall Study|Protocol Violation|1|||
150026829|NCT00479713|541233169|FG000|Overall Study|Withdrawal by Subject|4|||
150026830|NCT00479713|541233170|FG001|Overall Study|Withdrawal by Subject|1|||
150026831|NCT00141102|541233171|FG000|Overall Study|Adverse Event|233|||
150026832|NCT00141102|541233172|FG001|Overall Study|Adverse Event|305|||
150026833|NCT00141102|541233171|FG000|Overall Study|Laboratory Abnormality|9|||
150026834|NCT00141102|541233172|FG001|Overall Study|Laboratory Abnormality|33|||
150026835|NCT00141102|541233171|FG000|Overall Study|Lack of Efficacy|21|||
150026836|NCT00141102|541233172|FG001|Overall Study|Lack of Efficacy|26|||
150026837|NCT00141102|541233171|FG000|Overall Study|Lost to Follow-up|29|||
150026838|NCT00141102|541233172|FG001|Overall Study|Lost to Follow-up|32|||
150026839|NCT00141102|541233171|FG000|Overall Study|Other|87|||
150026840|NCT00141102|541233172|FG001|Overall Study|Other|76|||
150026841|NCT00141102|541233171|FG000|Overall Study|Withdrawal by Subject|112|||
150026842|NCT00141102|541233172|FG001|Overall Study|Withdrawal by Subject|142|||
150026843|NCT00141102|541233171|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
150026844|NCT00141102|541233172|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
150026845|NCT00141102|541233171|FG000|Overall Study|Death|2|||
150026846|NCT00141102|541233172|FG001|Overall Study|Death|2|||
150026847|NCT03061201|541233173|FG000|Overall Study|Participants Terminated at Month 36|0|||
150085300|NCT03129100|541453691|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085301|NCT03129100|541453692|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085302|NCT03129100|541453693|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085303|NCT03129100|541453694|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085304|NCT03129100|541453695|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085305|NCT03129100|541453696|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085306|NCT03129100|541453697|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085307|NCT03129100|541453698|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085308|NCT03129100|541453699|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150026848|NCT03061201|541233174|FG001|Overall Study|Participants Terminated at Month 36|1|||
150026849|NCT03061201|541233175|FG002|Overall Study|Participants Terminated at Month 36|0|||
150026850|NCT03061201|541233176|FG003|Overall Study|Participants Terminated at Month 36|1|||
150026851|NCT03061201|541233173|FG000|Overall Study|Lost to Follow-up|1|||
150026852|NCT03061201|541233174|FG001|Overall Study|Lost to Follow-up|0|||
150026853|NCT03061201|541233175|FG002|Overall Study|Lost to Follow-up|0|||
150026854|NCT03061201|541233176|FG003|Overall Study|Lost to Follow-up|0|||
150026855|NCT06172348|541233177|FG000|Treatment Period 2|Adverse Event|0|||
150026856|NCT06172348|541233178|FG001|Treatment Period 2|Adverse Event|0|||
150026857|NCT06172348|541233179|FG002|Treatment Period 2|Adverse Event|1|||
150026858|NCT06172348|541233180|FG003|Treatment Period 2|Adverse Event|0|||
150026859|NCT06172348|541233181|FG004|Treatment Period 2|Adverse Event|0|||
150026860|NCT06172348|541233182|FG005|Treatment Period 2|Adverse Event|0|||
150026861|NCT03116685|541233183|FG000|Overall Study|Physician Decision|0|||
150026862|NCT03116685|541233184|FG001|Overall Study|Physician Decision|1|||
150026863|NCT05274958|541233185|FG000|Overall Study|Only completed 1 set of PROMs|22|||
150026864|NCT05274958|541233186|FG001|Overall Study|Only completed 1 set of PROMs|35|||
150026865|NCT00866814|541233194|FG000|Overall Study|Lost to Follow-up|12|||
150026866|NCT00866814|541233194|FG000|Overall Study|Adverse Event|2|||
150026867|NCT00866814|541233194|FG000|Overall Study|Physician Decision|1|||
150026868|NCT00866814|541233194|FG000|Overall Study|Death|1|||
150026869|NCT00866814|541233194|FG000|Overall Study|No longer wished to participate|1|||
150026870|NCT00866814|541233194|FG000|Overall Study|Unable to meet follow-up requirements|2|||
150026871|NCT00866814|541233194|FG000|Overall Study|Moved to area without study site|1|||
150026872|NCT04491136|541233195|FG000|Overall Study|Patient withdraw informed consent|9|||
150026873|NCT04491136|541233195|FG000|Overall Study|Adverse Event|2|||
150026874|NCT04491136|541233195|FG000|Overall Study|Death|3|||
150026875|NCT04491136|541233195|FG000|Overall Study|Lost to Follow-up|3|||
150026876|NCT04491136|541233195|FG000|Overall Study|Physician Decision|45|||
150026877|NCT04491136|541233195|FG000|Overall Study|sponsor terminated the study early|16|||
150026878|NCT04491136|541233195|FG000|Overall Study|Patient/guardian's decision|1|||
150026879|NCT01505374|541233199|FG000|Overall Study|Lost to Follow-up|1|||
150026880|NCT01505374|541233200|FG001|Overall Study|Lost to Follow-up|0|||
150026881|NCT02360228|541233201|FG000|Overall Study|Withdrawal by Subject|1|||
150026882|NCT02360228|541233202|FG001|Overall Study|Withdrawal by Subject|0|||
150026883|NCT02360228|541233203|FG002|Overall Study|Withdrawal by Subject|0|||
150026884|NCT02360228|541233201|FG000|Overall Study|Self-discontinued medication|0|||
150026885|NCT02360228|541233202|FG001|Overall Study|Self-discontinued medication|1|||
150026886|NCT02360228|541233203|FG002|Overall Study|Self-discontinued medication|0|||
150026887|NCT02360228|541233201|FG000|Overall Study|Unstable symptoms during screening|0|||
150026888|NCT02360228|541233202|FG001|Overall Study|Unstable symptoms during screening|0|||
150026889|NCT02360228|541233203|FG002|Overall Study|Unstable symptoms during screening|1|||
150026890|NCT01712204|541233204|FG000|Overall Study|Adverse Event|3|||
150026891|NCT01712204|541233205|FG001|Overall Study|Adverse Event|1|||
150026892|NCT01712204|541233204|FG000|Overall Study|Withdrawal by Subject|3|||
150026893|NCT01712204|541233205|FG001|Overall Study|Withdrawal by Subject|3|||
150026894|NCT01712204|541233204|FG000|Overall Study|Lost to Follow-up|1|||
150026895|NCT01712204|541233205|FG001|Overall Study|Lost to Follow-up|0|||
150026896|NCT01712204|541233204|FG000|Overall Study|Protocol Violation|1|||
150026897|NCT01712204|541233205|FG001|Overall Study|Protocol Violation|1|||
150026898|NCT02464410|541233208|FG000|Overall Study|Death|3|||
150026899|NCT02464410|541233209|FG001|Overall Study|Death|4|||
150026900|NCT02464410|541233208|FG000|Overall Study|Lost to Follow-up|7|||
150026901|NCT02464410|541233209|FG001|Overall Study|Lost to Follow-up|9|||
150026902|NCT02464410|541233208|FG000|Overall Study|Withdrawal by Subject|12|||
150026903|NCT02464410|541233209|FG001|Overall Study|Withdrawal by Subject|3|||
150026904|NCT02679287|541233210|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
150026905|NCT02679287|541233211|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
150026906|NCT02679287|541233210|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
150026907|NCT02679287|541233211|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
150026908|NCT02679287|541233210|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
150026909|NCT02679287|541233211|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
150026910|NCT02679287|541233210|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
150026911|NCT02679287|541233211|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
150026912|NCT02679287|541233210|FG000|Period 2|Work/Scheduling Conflict|1|||
150026913|NCT02679287|541233211|FG001|Period 2|Work/Scheduling Conflict|0|||
150026914|NCT02679287|541233210|FG000|Period 2|Disliked Mobile System|2|||
150026915|NCT02679287|541233211|FG001|Period 2|Disliked Mobile System|0|||
150026916|NCT02679287|541233210|FG000|Period 3|Work/Scheduling Conflict|0|||
150026917|NCT02679287|541233211|FG001|Period 3|Work/Scheduling Conflict|1|||
150026918|NCT01114828|541233212|FG000|Overall Study|Adverse Event|1|||
150026919|NCT01114828|541233213|FG001|Overall Study|Adverse Event|1|||
150026920|NCT01114828|541233212|FG000|Overall Study|Lack of Efficacy|0|||
150026921|NCT01114828|541233213|FG001|Overall Study|Lack of Efficacy|2|||
150026922|NCT01114828|541233212|FG000|Overall Study|Protocol Violation|2|||
150026923|NCT01114828|541233213|FG001|Overall Study|Protocol Violation|0|||
150026924|NCT01114828|541233212|FG000|Overall Study|Withdrawal by Subject|0|||
150026925|NCT01114828|541233213|FG001|Overall Study|Withdrawal by Subject|1|||
150026926|NCT01777776|541233214|FG000|Overall Study|Adverse Event|2|||
150026927|NCT01777776|541233215|FG001|Overall Study|Adverse Event|4|||
150026928|NCT01777776|541233216|FG002|Overall Study|Adverse Event|0|||
150026929|NCT01777776|541233217|FG003|Overall Study|Adverse Event|0|||
150026930|NCT01777776|541233214|FG000|Overall Study|Disease Progression|4|||
150026931|NCT01777776|541233215|FG001|Overall Study|Disease Progression|8|||
150183228|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
150183229|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
150026932|NCT01777776|541233216|FG002|Overall Study|Disease Progression|6|||
150026933|NCT01777776|541233217|FG003|Overall Study|Disease Progression|3|||
150026934|NCT01777776|541233214|FG000|Overall Study|Withdrawal by Subject|0|||
150026935|NCT01777776|541233215|FG001|Overall Study|Withdrawal by Subject|0|||
150026936|NCT01777776|541233216|FG002|Overall Study|Withdrawal by Subject|0|||
150026937|NCT01777776|541233217|FG003|Overall Study|Withdrawal by Subject|1|||
150026938|NCT00851786|541233220|FG000|Overall Study|Withdrawal by Subject|0|||
150026939|NCT00851786|541233221|FG001|Overall Study|Withdrawal by Subject|1|||
150026940|NCT00851786|541233220|FG000|Overall Study|Protocol Violation|0|||
150026941|NCT00851786|541233221|FG001|Overall Study|Protocol Violation|1|||
150026942|NCT00851786|541233220|FG000|Overall Study|Lost to Follow-up|1|||
150026943|NCT00851786|541233221|FG001|Overall Study|Lost to Follow-up|0|||
150026944|NCT00851786|541233220|FG000|Overall Study|Incarceration|1|||
150026945|NCT00851786|541233221|FG001|Overall Study|Incarceration|0|||
150026946|NCT00851786|541233220|FG000|Overall Study|Site Closure|1|||
150026947|NCT00851786|541233221|FG001|Overall Study|Site Closure|0|||
150026948|NCT00851786|541233220|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
150026949|NCT00851786|541233221|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
150026950|NCT01943591|541233224|FG000|Overall Study|Lost to Follow-up|3|||
150026951|NCT01943591|541233225|FG001|Overall Study|Lost to Follow-up|4|||
150026952|NCT01943591|541233224|FG000|Overall Study|Death|2|||
150026953|NCT01943591|541233225|FG001|Overall Study|Death|7|||
150026954|NCT00865345|541234498|FG000|Overall Study|Withdrawal by Subject|2|||
150026955|NCT01519323|541234499|FG000|Overall Study|Death|3|||
150026956|NCT01519323|541234500|FG001|Overall Study|Death|2|||
150026957|NCT01519323|541234499|FG000|Overall Study|Study terminated by sponsor|0|||
150026958|NCT01519323|541234500|FG001|Overall Study|Study terminated by sponsor|1|||
150026959|NCT03858049|541234501|FG000|Overall Study|Adverse Event|16|||
150026960|NCT03858049|541234502|FG001|Overall Study|Adverse Event|9|||
150026961|NCT03858049|541234501|FG000|Overall Study|Other|1|||
150026962|NCT03858049|541234502|FG001|Overall Study|Other|1|||
150026963|NCT02079740|541234503|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
150026964|NCT02079740|541234504|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
150026965|NCT02079740|541234505|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
150026966|NCT02079740|541234506|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
150026967|NCT02079740|541234507|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
150026968|NCT02079740|541234508|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
150026969|NCT02079740|541234509|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
150026970|NCT02079740|541234510|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
150026971|NCT02079740|541234511|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
150026972|NCT02079740|541234512|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
150026973|NCT02079740|541234513|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
150026974|NCT02079740|541234514|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
150026975|NCT02079740|541234515|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
150026976|NCT02079740|541234503|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
150026977|NCT02079740|541234504|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
150026978|NCT02079740|541234505|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
150026979|NCT02079740|541234506|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
150026980|NCT02079740|541234507|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
150026981|NCT02079740|541234508|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
150026982|NCT02079740|541234509|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
150026983|NCT02079740|541234510|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
150026984|NCT02079740|541234511|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
150026985|NCT02079740|541234512|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
150026986|NCT02079740|541234513|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
150026987|NCT02079740|541234514|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
150026988|NCT02079740|541234515|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
150026989|NCT02079740|541234503|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026990|NCT02079740|541234504|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026991|NCT02079740|541234505|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026992|NCT02079740|541234506|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026993|NCT02079740|541234507|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026994|NCT02079740|541234508|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026995|NCT02079740|541234509|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026996|NCT02079740|541234510|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
150026997|NCT02079740|541234511|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026998|NCT02079740|541234512|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
150026999|NCT02079740|541234513|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
150027000|NCT02079740|541234514|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
150027001|NCT02079740|541234515|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
150027002|NCT02079740|541234503|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027003|NCT02079740|541234504|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027004|NCT02079740|541234505|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027005|NCT02079740|541234506|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150085309|NCT03129100|541453700|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150027006|NCT02079740|541234507|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027007|NCT02079740|541234508|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027008|NCT02079740|541234509|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027009|NCT02079740|541234510|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
150027010|NCT02079740|541234511|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027011|NCT02079740|541234512|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027012|NCT02079740|541234513|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027013|NCT02079740|541234514|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027014|NCT02079740|541234515|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
150027015|NCT02079740|541234503|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027016|NCT02079740|541234504|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027017|NCT02079740|541234505|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027018|NCT02079740|541234506|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027019|NCT02079740|541234507|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027020|NCT02079740|541234508|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027021|NCT02079740|541234509|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027022|NCT02079740|541234510|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027023|NCT02079740|541234511|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027024|NCT02079740|541234512|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
150027025|NCT02079740|541234513|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
150027026|NCT02079740|541234514|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
150027027|NCT02079740|541234515|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
150027028|NCT04617782|541234516|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
150027029|NCT04617782|541234516|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
150027030|NCT04617782|541234516|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
150027031|NCT04617782|541234516|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
150027032|NCT04617782|541234516|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
150027033|NCT04617782|541234516|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
150027034|NCT00387881|541234524|FG000|Overall Study|Lost to Follow-up|23|||
150027035|NCT00387881|541234525|FG001|Overall Study|Lost to Follow-up|23|||
150027036|NCT00387881|541234524|FG000|Overall Study|Protocol Violation|2|||
150027037|NCT00387881|541234525|FG001|Overall Study|Protocol Violation|12|||
150027038|NCT00387881|541234524|FG000|Overall Study|Withdrawal by Subject|15|||
150027039|NCT00387881|541234525|FG001|Overall Study|Withdrawal by Subject|18|||
150027040|NCT00387881|541234524|FG000|Overall Study|Sponsor terminated Study|0|||
150027041|NCT00387881|541234525|FG001|Overall Study|Sponsor terminated Study|1|||
150027042|NCT00387881|541234524|FG000|Overall Study|Not eligible|6|||
150027043|NCT00387881|541234525|FG001|Overall Study|Not eligible|7|||
150027044|NCT00387881|541234524|FG000|Overall Study|No opportunity to treat headache|32|||
150027045|NCT00387881|541234525|FG001|Overall Study|No opportunity to treat headache|34|||
150027046|NCT00387881|541234524|FG000|Overall Study|Not otherwise specified|11|||
150027047|NCT00387881|541234525|FG001|Overall Study|Not otherwise specified|7|||
150027048|NCT05473026|541234527|FG000|Overall Study|Lost to Follow-up|5|||
150027049|NCT05473026|541234528|FG001|Overall Study|Lost to Follow-up|2|||
150027050|NCT00496015|541234529|FG000|Overall Study|Other|1|||
150027051|NCT00496015|541234530|FG001|Overall Study|Other|0|||
150027052|NCT00496015|541234531|FG002|Overall Study|Other|0|||
150027053|NCT00496015|541234532|FG003|Overall Study|Other|1|||
150027054|NCT00496015|541234533|FG004|Overall Study|Other|0|||
150027055|NCT01535807|541234535|FG000|Overall Study|Withdrawal by Subject|1|||
150027056|NCT01535807|541234536|FG001|Overall Study|Withdrawal by Subject|1|||
150027057|NCT01535807|541234535|FG000|Overall Study|Data collection error|1|||
150027058|NCT01535807|541234536|FG001|Overall Study|Data collection error|1|||
150027059|NCT02730728|541234539|FG000|Overall Study|Withdrawal by Subject|0|||
150027060|NCT02730728|541234540|FG001|Overall Study|Withdrawal by Subject|1|||
150027061|NCT02730728|541234541|FG002|Overall Study|Withdrawal by Subject|0|||
150027062|NCT02730728|541234539|FG000|Overall Study|Lack of Efficacy|0|||
150027063|NCT02730728|541234540|FG001|Overall Study|Lack of Efficacy|1|||
150027064|NCT02730728|541234541|FG002|Overall Study|Lack of Efficacy|1|||
150027065|NCT02193776|541234553|FG000|Overall Study|Consent withdrawn|1|||
150027066|NCT02193776|541234554|FG001|Overall Study|Consent withdrawn|0|||
150027067|NCT02193776|541234555|FG002|Overall Study|Consent withdrawn|0|||
150027068|NCT02193776|541234556|FG003|Overall Study|Consent withdrawn|0|||
150027069|NCT02193776|541234553|FG000|Overall Study|Failure to comply with protocol|0|||
150027070|NCT02193776|541234554|FG001|Overall Study|Failure to comply with protocol|1|||
150027071|NCT02193776|541234555|FG002|Overall Study|Failure to comply with protocol|0|||
150027072|NCT02193776|541234556|FG003|Overall Study|Failure to comply with protocol|0|||
150027073|NCT02193776|541234553|FG000|Overall Study|Investigator/Sponsor decision|1|||
150027074|NCT02193776|541234554|FG001|Overall Study|Investigator/Sponsor decision|1|||
150027075|NCT02193776|541234555|FG002|Overall Study|Investigator/Sponsor decision|0|||
150027076|NCT02193776|541234556|FG003|Overall Study|Investigator/Sponsor decision|0|||
150027077|NCT02193776|541234553|FG000|Overall Study|Death|1|||
150027078|NCT02193776|541234554|FG001|Overall Study|Death|0|||
150027079|NCT02193776|541234555|FG002|Overall Study|Death|0|||
150027080|NCT02193776|541234556|FG003|Overall Study|Death|0|||
150027081|NCT02193776|541234553|FG000|Overall Study|Adverse event/Specific toxicity|5|||
150027082|NCT02193776|541234554|FG001|Overall Study|Adverse event/Specific toxicity|5|||
150027083|NCT02193776|541234555|FG002|Overall Study|Adverse event/Specific toxicity|2|||
150027084|NCT02193776|541234556|FG003|Overall Study|Adverse event/Specific toxicity|2|||
150027085|NCT00248495|541234562|FG000|Overall Study|Withdrawal by Subject|1|||
150027086|NCT03812380|541234563|FG000|Overall Study|Protocol Violation|3|||
150027087|NCT03812380|541234564|FG001|Overall Study|Protocol Violation|3|||
150027088|NCT03812380|541234563|FG000|Overall Study|Withdrawal by Subject|5|||
150027089|NCT03812380|541234564|FG001|Overall Study|Withdrawal by Subject|4|||
150027090|NCT03812380|541234563|FG000|Overall Study|Early termination of study|14|||
150027091|NCT03812380|541234564|FG001|Overall Study|Early termination of study|14|||
150027092|NCT00981149|541234565|FG000|Overall Study|Lost to Follow-up|1|||
150027093|NCT00981149|541234566|FG001|Overall Study|Lost to Follow-up|2|||
150027094|NCT00981149|541234565|FG000|Overall Study|Withdrawal by Subject|1|||
150027095|NCT00981149|541234566|FG001|Overall Study|Withdrawal by Subject|1|||
150027096|NCT04244253|541234572|FG000|Overall Study|Adverse Event|2|||
150027097|NCT04244253|541234573|FG001|Overall Study|Adverse Event|2|||
150027098|NCT04244253|541234574|FG002|Overall Study|Adverse Event|4|||
150027099|NCT04244253|541234572|FG000|Overall Study|Protocol Violation|1|||
150027100|NCT04244253|541234573|FG001|Overall Study|Protocol Violation|2|||
150027101|NCT04244253|541234574|FG002|Overall Study|Protocol Violation|1|||
150027102|NCT04244253|541234572|FG000|Overall Study|Withdrawal by Subject|0|||
150027103|NCT04244253|541234573|FG001|Overall Study|Withdrawal by Subject|1|||
150027104|NCT04244253|541234574|FG002|Overall Study|Withdrawal by Subject|6|||
150027105|NCT04244253|541234572|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150027106|NCT04244253|541234573|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150027107|NCT04244253|541234574|FG002|Overall Study|Non-Compliance With Study Drug|1|||
150027108|NCT00619515|541234575|FG000|Overall Study|Study Termination by IRB|73|||
150027109|NCT03294590|541234576|FG000|Overall Study|Lost to Follow-up|105|||
150027110|NCT03294590|541234577|FG001|Overall Study|Lost to Follow-up|107|||
150027111|NCT00474955|541234579|FG000|Overall Study|Adverse Event|2|||
150027112|NCT00474955|541234579|FG000|Overall Study|Drug unavailability|1|||
150027113|NCT00474955|541234579|FG000|Overall Study|Personal reasons|5|||
150027114|NCT02576639|541234580|FG000|Overall Study|Withdrawal by Subject|1|||
150027115|NCT02576639|541234581|FG001|Overall Study|Withdrawal by Subject|2|||
150027116|NCT02576639|541234582|FG002|Overall Study|Withdrawal by Subject|1|||
150027117|NCT02576639|541234583|FG003|Overall Study|Withdrawal by Subject|0|||
150027118|NCT02576639|541234584|FG004|Overall Study|Withdrawal by Subject|1|||
150027119|NCT02576639|541234580|FG000|Overall Study|Adverse Event|1|||
150027120|NCT02576639|541234581|FG001|Overall Study|Adverse Event|0|||
150027121|NCT02576639|541234582|FG002|Overall Study|Adverse Event|1|||
150027122|NCT02576639|541234583|FG003|Overall Study|Adverse Event|1|||
150027123|NCT02576639|541234584|FG004|Overall Study|Adverse Event|2|||
150027124|NCT02576639|541234580|FG000|Overall Study|Physician Decision|0|||
150027125|NCT02576639|541234581|FG001|Overall Study|Physician Decision|0|||
150027126|NCT02576639|541234582|FG002|Overall Study|Physician Decision|0|||
150027127|NCT02576639|541234583|FG003|Overall Study|Physician Decision|0|||
150027128|NCT02576639|541234584|FG004|Overall Study|Physician Decision|1|||
150027129|NCT00628030|541234585|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
150027130|NCT00628030|541234586|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
150183230|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
150183231|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
150027131|NCT00628030|541234585|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
150027132|NCT00628030|541234586|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
150183232|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
150183233|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
150027133|NCT00628030|541234585|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
150027134|NCT00628030|541234586|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
150027135|NCT04701333|541234599|FG000|Overall Study|Lost to Follow-up|3|||
150027136|NCT04701333|541234600|FG001|Overall Study|Lost to Follow-up|7|||
150027137|NCT04701333|541234599|FG000|Overall Study|Withdrawal by Subject|0|||
150027138|NCT04701333|541234600|FG001|Overall Study|Withdrawal by Subject|1|||
150027139|NCT01292187|541234601|FG000|Overall Study|Adverse Event|10|||
150027140|NCT01292187|541234602|FG001|Overall Study|Adverse Event|5|||
150027141|NCT01292187|541234601|FG000|Overall Study|Withdrawal by Subject|6|||
150027142|NCT01292187|541234602|FG001|Overall Study|Withdrawal by Subject|5|||
150183234|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
150183235|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Other|6|||
150027143|NCT01292187|541234601|FG000|Overall Study|All other reasons|1|||
150027144|NCT01292187|541234602|FG001|Overall Study|All other reasons|3|||
150027145|NCT02920892|541234603|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
150027146|NCT02920892|541234604|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
150027147|NCT02920892|541234605|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
150027148|NCT02920892|541234603|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
150027149|NCT02920892|541234604|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
150027150|NCT02920892|541234605|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
150027151|NCT02920892|541234603|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
150027152|NCT02920892|541234604|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
150027153|NCT02920892|541234605|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
150027154|NCT02920892|541234603|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
150027155|NCT02920892|541234604|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
150027156|NCT02920892|541234605|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
150027157|NCT02920892|541234603|FG000|Placebo-Controlled Period|Physician Decision|0|||
150027158|NCT02920892|541234604|FG001|Placebo-Controlled Period|Physician Decision|0|||
150027159|NCT02920892|541234605|FG002|Placebo-Controlled Period|Physician Decision|1|||
150027160|NCT02920892|541234603|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
150027161|NCT02920892|541234604|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
150027162|NCT02920892|541234605|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
150027163|NCT02920892|541234603|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150027164|NCT02920892|541234604|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
150027165|NCT02920892|541234605|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
150027166|NCT02920892|541234603|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
150027167|NCT02920892|541234604|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
150027168|NCT02920892|541234605|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
150027169|NCT03827655|541234606|FG000|Overall Study|Death|0|||
150085310|NCT03129100|541453701|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
150085311|NCT03129100|541453676|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
150085312|NCT03129100|541453677|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
150085313|NCT03129100|541453678|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085314|NCT03129100|541453679|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085315|NCT03129100|541453680|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085316|NCT03129100|541453681|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085317|NCT03129100|541453682|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085318|NCT03129100|541453683|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085319|NCT03129100|541453684|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085320|NCT03129100|541453685|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085321|NCT03129100|541453686|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085322|NCT03129100|541453687|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150183236|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Other|1|||
150027170|NCT03827655|541234607|FG001|Overall Study|Death|0|||
150027171|NCT03827655|541234608|FG002|Overall Study|Death|0|||
150027172|NCT03827655|541234609|FG003|Overall Study|Death|0|||
150027173|NCT03827655|541234610|FG004|Overall Study|Death|1|||
150027174|NCT03827655|541234606|FG000|Overall Study|Protocol Deviation|1|||
150027175|NCT03827655|541234607|FG001|Overall Study|Protocol Deviation|0|||
150027176|NCT03827655|541234608|FG002|Overall Study|Protocol Deviation|1|||
150027177|NCT03827655|541234609|FG003|Overall Study|Protocol Deviation|1|||
150027178|NCT03827655|541234610|FG004|Overall Study|Protocol Deviation|0|||
150027179|NCT03827655|541234606|FG000|Overall Study|Withdrawal by Subject|3|||
150027180|NCT03827655|541234607|FG001|Overall Study|Withdrawal by Subject|2|||
150027181|NCT03827655|541234608|FG002|Overall Study|Withdrawal by Subject|2|||
150027182|NCT03827655|541234609|FG003|Overall Study|Withdrawal by Subject|0|||
150027183|NCT03827655|541234610|FG004|Overall Study|Withdrawal by Subject|1|||
150027184|NCT03827655|541234606|FG000|Overall Study|Reason not Specified|3|||
150027185|NCT03827655|541234607|FG001|Overall Study|Reason not Specified|1|||
150027186|NCT03827655|541234608|FG002|Overall Study|Reason not Specified|1|||
150027187|NCT03827655|541234609|FG003|Overall Study|Reason not Specified|1|||
150027188|NCT03827655|541234610|FG004|Overall Study|Reason not Specified|1|||
150027189|NCT01092728|541234611|FG000|Overall Study|Withdrawal by Subject|2|||
150027190|NCT01092728|541234612|FG001|Overall Study|Withdrawal by Subject|0|||
150027191|NCT01092728|541234611|FG000|Overall Study|Adverse Event|0|||
150027192|NCT01092728|541234612|FG001|Overall Study|Adverse Event|1|||
150027193|NCT01092728|541234611|FG000|Overall Study|Disease Progression|1|||
150027194|NCT01092728|541234612|FG001|Overall Study|Disease Progression|13|||
150027195|NCT01092728|541234611|FG000|Overall Study|Prohibited Concomitant Medications|1|||
150027196|NCT01092728|541234612|FG001|Overall Study|Prohibited Concomitant Medications|0|||
150027197|NCT03649217|541234613|FG000|Overall Study|subject had severe ataxia not initially found|1|||
150027198|NCT03649217|541234613|FG000|Overall Study|subject had cognitive issues not initially found|1|||
150027199|NCT02520726|541234614|FG000|Overall Study|Lost to Follow-up|3|||
150027200|NCT02520726|541234615|FG001|Overall Study|Lost to Follow-up|2|||
150027201|NCT02552966|541234616|FG000|Overall Study|Lost to Follow-up|2|||
150027202|NCT02552966|541234616|FG000|Overall Study|Withdrawal by Subject|3|||
150027203|NCT01216202|541234617|FG000|Overall Study|Withdrawal by Subject|8|||
150027204|NCT01216202|541234618|FG001|Overall Study|Withdrawal by Subject|0|||
150027205|NCT01216202|541234617|FG000|Overall Study|Death|0|||
150027206|NCT01216202|541234618|FG001|Overall Study|Death|2|||
150027207|NCT01216202|541234617|FG000|Overall Study|Lost to Follow-up|14|||
150027208|NCT01216202|541234618|FG001|Overall Study|Lost to Follow-up|0|||
150027209|NCT01774799|541234621|FG000|Overall Study|Lost to Follow-up|1|||
150027210|NCT01774799|541234622|FG001|Overall Study|Lost to Follow-up|1|||
150027211|NCT01774799|541234623|FG002|Overall Study|Lost to Follow-up|0|||
150027212|NCT01774799|541234624|FG003|Overall Study|Lost to Follow-up|0|||
150027213|NCT04332107|541234625|FG000|Day 3|Lost to Follow-up|23|||
150027214|NCT04332107|541234626|FG001|Day 3|Lost to Follow-up|14|||
150027215|NCT04332107|541234625|FG000|Day 3|Missing outcome data|3|||
150027216|NCT04332107|541234626|FG001|Day 3|Missing outcome data|6|||
150027217|NCT04332107|541234625|FG000|Day 14|Lost to Follow-up|13|||
150027218|NCT04332107|541234626|FG001|Day 14|Lost to Follow-up|4|||
150027219|NCT04332107|541234625|FG000|Day 14|Missing outcome data|4|||
150027220|NCT04332107|541234626|FG001|Day 14|Missing outcome data|4|||
150027221|NCT04332107|541234625|FG000|Day 21|Lost to Follow-up|10|||
150027222|NCT04332107|541234626|FG001|Day 21|Lost to Follow-up|2|||
150027223|NCT00717249|541234627|FG000|Overall Study|Lens Discomfort|4|||
150027224|NCT00717249|541234628|FG001|Overall Study|Lens Discomfort|1|||
150027225|NCT00717249|541234627|FG000|Overall Study|Unsatisfactory visual Response|0|||
150027226|NCT00717249|541234628|FG001|Overall Study|Unsatisfactory visual Response|2|||
150027227|NCT00717249|541234627|FG000|Overall Study|Adverse Event|4|||
150027228|NCT00717249|541234628|FG001|Overall Study|Adverse Event|2|||
150027229|NCT00717249|541234627|FG000|Overall Study|Lost to Follow-up|2|||
150027230|NCT00717249|541234628|FG001|Overall Study|Lost to Follow-up|0|||
150027231|NCT00717249|541234627|FG000|Overall Study|Withdrawal by Subject|1|||
150027232|NCT00717249|541234628|FG001|Overall Study|Withdrawal by Subject|2|||
150027233|NCT00717249|541234627|FG000|Overall Study|Pregnancy|6|||
150027234|NCT00717249|541234628|FG001|Overall Study|Pregnancy|3|||
150027235|NCT00717249|541234627|FG000|Overall Study|Protocol Violation|0|||
150027236|NCT00717249|541234628|FG001|Overall Study|Protocol Violation|2|||
150027237|NCT00717249|541234627|FG000|Overall Study|Subject became Ineligible|1|||
150027238|NCT00717249|541234628|FG001|Overall Study|Subject became Ineligible|1|||
150027239|NCT00717249|541234627|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
150027240|NCT00717249|541234628|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
150027241|NCT00717249|541234627|FG000|Overall Study|Gastric Surgery|0|||
150027242|NCT00717249|541234628|FG001|Overall Study|Gastric Surgery|1|||
150027243|NCT00717249|541234627|FG000|Overall Study|Diagnosed with Diabetes|1|||
150027244|NCT00717249|541234628|FG001|Overall Study|Diagnosed with Diabetes|0|||
150027245|NCT00717249|541234627|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
150027246|NCT00717249|541234628|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
150027247|NCT00717249|541234627|FG000|Overall Study|Subject relocated|1|||
150027248|NCT00717249|541234628|FG001|Overall Study|Subject relocated|0|||
150027249|NCT00717249|541234627|FG000|Overall Study|Headaches|1|||
150027250|NCT00717249|541234628|FG001|Overall Study|Headaches|0|||
150027251|NCT01670721|541234629|FG000|Overall Study|Participant's decision|15|||
150027252|NCT01670721|541234629|FG000|Overall Study|Other than specified above|38|||
150027253|NCT03799341|541234630|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
150027254|NCT03799341|541234631|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
150027255|NCT03799341|541234632|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
150027256|NCT03799341|541234630|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
150027257|NCT03799341|541234631|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
150027258|NCT03799341|541234632|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
150027259|NCT03799341|541234630|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
150027260|NCT03799341|541234631|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
150027261|NCT03799341|541234632|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
150027262|NCT03799341|541234630|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
150027263|NCT03799341|541234631|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
150027264|NCT03799341|541234632|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
150027265|NCT03799341|541234630|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
150027266|NCT03799341|541234631|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
150027267|NCT03799341|541234632|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
150027268|NCT03799341|541234630|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
150027269|NCT03799341|541234631|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
150027270|NCT03799341|541234632|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
150027271|NCT04037891|541234633|FG000|Open-label Period|Withdrawal by Subject|1|||
150027272|NCT04037891|541234634|FG001|Open-label Period|Withdrawal by Subject|0|||
150027273|NCT04037891|541234635|FG002|Open-label Period|Withdrawal by Subject|0|||
150027274|NCT04037891|541234633|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
150027275|NCT04037891|541234634|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
150027276|NCT04037891|541234635|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
150027277|NCT03446313|541234637|FG000|Overall Study|Lost to Follow-up|1|||
150027278|NCT03446313|541234638|FG001|Overall Study|Lost to Follow-up|2|||
150027279|NCT03446313|541234637|FG000|Overall Study|Failed primary screening|3|||
150027280|NCT03446313|541234638|FG001|Overall Study|Failed primary screening|0|||
150027281|NCT03446313|541234637|FG000|Overall Study|Diagnosed with terminal cancer|1|||
150027282|NCT03446313|541234638|FG001|Overall Study|Diagnosed with terminal cancer|0|||
150027283|NCT03446313|541234637|FG000|Overall Study|Excluded from analysis|1|||
150027284|NCT03446313|541234638|FG001|Overall Study|Excluded from analysis|1|||
150027285|NCT03100149|541234639|FG000|Overall Study|Adverse Event|0|||
150027286|NCT03100149|541234640|FG001|Overall Study|Adverse Event|1|||
150027287|NCT03100149|541234641|FG002|Overall Study|Adverse Event|0|||
150027288|NCT03100149|541234639|FG000|Overall Study|Participant Moved out of Country|0|||
150027289|NCT03100149|541234640|FG001|Overall Study|Participant Moved out of Country|0|||
150027290|NCT03100149|541234641|FG002|Overall Study|Participant Moved out of Country|1|||
150027291|NCT03100149|541234639|FG000|Overall Study|Withdrawal by Subject|0|||
150027292|NCT03100149|541234640|FG001|Overall Study|Withdrawal by Subject|3|||
150027293|NCT03100149|541234641|FG002|Overall Study|Withdrawal by Subject|1|||
150027294|NCT01871519|541234647|FG000|Overall Study|Death|26|||
150027295|NCT01871519|541234647|FG000|Overall Study|Lost to Follow-up|15|||
150027296|NCT01871519|541234647|FG000|Overall Study|Withdrawal by Subject|49|||
150027297|NCT00320515|541234648|FG000|Overall Study|Death|33|||
150027298|NCT00320515|541234648|FG000|Overall Study|Lost to Follow-up|6|||
150027299|NCT00320515|541234648|FG000|Overall Study|Physician Decision|2|||
150027300|NCT00320515|541234648|FG000|Overall Study|Withdrawal by Subject|8|||
150027301|NCT01063153|541234649|FG000|Overall Study|Found Ineligible During Screening|2|||
150027302|NCT01063153|541234650|FG001|Overall Study|Found Ineligible During Screening|0|||
150027303|NCT01063153|541234649|FG000|Overall Study|Lost to Follow-up|0|||
150027304|NCT01063153|541234650|FG001|Overall Study|Lost to Follow-up|7|||
150027305|NCT01063153|541234649|FG000|Overall Study|Withdrawal by Subject|0|||
150027306|NCT01063153|541234650|FG001|Overall Study|Withdrawal by Subject|1|||
150027307|NCT01063153|541234649|FG000|Overall Study|Physician Decision|0|||
150027308|NCT01063153|541234650|FG001|Overall Study|Physician Decision|4|||
150027309|NCT00350844|541234651|FG000|Overall Study|Lost to Follow-up|1|||
150027310|NCT01420926|541234652|FG000|Overall Study|Adverse Event|6|||
150027311|NCT01420926|541234653|FG001|Overall Study|Adverse Event|4|||
150027312|NCT01420926|541234652|FG000|Overall Study|Death|18|||
150027313|NCT01420926|541234653|FG001|Overall Study|Death|17|||
150027314|NCT01420926|541234652|FG000|Overall Study|Withdrawal by Subject|11|||
150027315|NCT01420926|541234653|FG001|Overall Study|Withdrawal by Subject|17|||
150027316|NCT01420926|541234652|FG000|Overall Study|Non-protocol treatment|17|||
150027317|NCT01420926|541234653|FG001|Overall Study|Non-protocol treatment|20|||
150027318|NCT01420926|541234652|FG000|Overall Study|Physician Decision|8|||
150027319|NCT01420926|541234653|FG001|Overall Study|Physician Decision|5|||
150027320|NCT01232868|541235906|FG000|Overall Study|Lost to Follow-up|2|||
150027321|NCT01232868|541235907|FG001|Overall Study|Lost to Follow-up|4|||
150027322|NCT03737123|541235908|FG000|Study Treatment|Adverse Event|2|||
150027323|NCT03737123|541235909|FG001|Study Treatment|Adverse Event|0|||
150027324|NCT03737123|541235908|FG000|Study Treatment|Disease Progression|2|||
150027325|NCT03737123|541235909|FG001|Study Treatment|Disease Progression|0|||
150027326|NCT03737123|541235908|FG000|Study Treatment|Withdrawal by Subject|2|||
150027327|NCT03737123|541235909|FG001|Study Treatment|Withdrawal by Subject|0|||
150027328|NCT03737123|541235908|FG000|Follow up|Death|1|||
150027329|NCT03737123|541235909|FG001|Follow up|Death|0|||
150027330|NCT03737123|541235908|FG000|Follow up|Withdrawal by Subject|1|||
150027331|NCT03737123|541235909|FG001|Follow up|Withdrawal by Subject|0|||
150027332|NCT03737123|541235908|FG000|Follow up|Termination of study|4|||
150027333|NCT03737123|541235909|FG001|Follow up|Termination of study|0|||
150027334|NCT01474317|541235926|FG000|Overall Study|Adverse Event|1|||
150027335|NCT01474317|541235926|FG000|Overall Study|Subject ineligible for study|1|||
150027336|NCT00453154|541235929|FG000|Double BIind Maintenance|Adverse Event|0|||
150027337|NCT00453154|541235930|FG001|Double BIind Maintenance|Adverse Event|0|||
150027338|NCT00453154|541235931|FG002|Double BIind Maintenance|Adverse Event|3|||
150027339|NCT00453154|541235932|FG003|Double BIind Maintenance|Adverse Event|12|||
150027340|NCT00453154|541235929|FG000|Double BIind Maintenance|Death|0|||
150027341|NCT00453154|541235930|FG001|Double BIind Maintenance|Death|0|||
150027342|NCT00453154|541235931|FG002|Double BIind Maintenance|Death|2|||
150027343|NCT00453154|541235932|FG003|Double BIind Maintenance|Death|1|||
150027344|NCT00453154|541235929|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
150027345|NCT00453154|541235930|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
150027346|NCT00453154|541235931|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
150027347|NCT00453154|541235932|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
150027348|NCT00453154|541235929|FG000|Double BIind Maintenance|Progression|0|||
150027349|NCT00453154|541235930|FG001|Double BIind Maintenance|Progression|0|||
150027350|NCT00453154|541235931|FG002|Double BIind Maintenance|Progression|29|||
150027351|NCT00453154|541235932|FG003|Double BIind Maintenance|Progression|26|||
150027352|NCT00453154|541235929|FG000|Double BIind Maintenance|Medical Issues|0|||
150027353|NCT00453154|541235930|FG001|Double BIind Maintenance|Medical Issues|0|||
150027354|NCT00453154|541235931|FG002|Double BIind Maintenance|Medical Issues|3|||
150027355|NCT00453154|541235932|FG003|Double BIind Maintenance|Medical Issues|1|||
150027356|NCT00453154|541235929|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
150027357|NCT00453154|541235930|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
150027358|NCT00453154|541235931|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
150027359|NCT00453154|541235932|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
150027360|NCT03629886|541235933|FG000|Overall Study|Migrated / moved from the study area|0|||
150027361|NCT03629886|541235934|FG001|Overall Study|Migrated / moved from the study area|55|||
150027362|NCT03629886|541235933|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
150027363|NCT03629886|541235934|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
150027364|NCT03629886|541235933|FG000|Overall Study|Study vaccine not administrated|0|||
150027365|NCT03629886|541235934|FG001|Overall Study|Study vaccine not administrated|3|||
150027366|NCT03629886|541235933|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
150027367|NCT03629886|541235934|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
150027368|NCT03629886|541235933|FG000|Overall Study|Refused vaccination step of the study|0|||
150027369|NCT03629886|541235934|FG001|Overall Study|Refused vaccination step of the study|44|||
150027370|NCT03291067|541235935|FG000|Overall Study|Adverse Event|0|||
150027371|NCT03291067|541235936|FG001|Overall Study|Adverse Event|2|||
150027372|NCT03291067|541235937|FG002|Overall Study|Adverse Event|17|||
150027373|NCT03291067|541235938|FG003|Overall Study|Adverse Event|3|||
150027374|NCT03291067|541235935|FG000|Overall Study|Lost to Follow-up|2|||
150027375|NCT03291067|541235936|FG001|Overall Study|Lost to Follow-up|1|||
150027376|NCT03291067|541235937|FG002|Overall Study|Lost to Follow-up|0|||
150027377|NCT03291067|541235938|FG003|Overall Study|Lost to Follow-up|1|||
150027378|NCT03291067|541235935|FG000|Overall Study|Physician Decision|0|||
150027379|NCT03291067|541235936|FG001|Overall Study|Physician Decision|0|||
150027380|NCT03291067|541235937|FG002|Overall Study|Physician Decision|1|||
150027381|NCT03291067|541235938|FG003|Overall Study|Physician Decision|0|||
150027382|NCT03291067|541235935|FG000|Overall Study|Protocol Violation|5|||
150027383|NCT03291067|541235936|FG001|Overall Study|Protocol Violation|3|||
150027384|NCT03291067|541235937|FG002|Overall Study|Protocol Violation|4|||
150027385|NCT03291067|541235938|FG003|Overall Study|Protocol Violation|2|||
150027386|NCT03291067|541235935|FG000|Overall Study|Withdrawal by Subject|3|||
150027387|NCT03291067|541235936|FG001|Overall Study|Withdrawal by Subject|4|||
150027388|NCT03291067|541235937|FG002|Overall Study|Withdrawal by Subject|7|||
150027389|NCT03291067|541235938|FG003|Overall Study|Withdrawal by Subject|5|||
150027390|NCT03291067|541235935|FG000|Overall Study|Other|0|||
150027391|NCT03291067|541235936|FG001|Overall Study|Other|4|||
150027392|NCT03291067|541235937|FG002|Overall Study|Other|4|||
150027393|NCT03291067|541235938|FG003|Overall Study|Other|6|||
150027394|NCT03683173|541235939|FG000|Completed Follow-up|Unavailable|235|||
150027395|NCT03683173|541235940|FG001|Completed Follow-up|Unavailable|217|||
150027396|NCT03683173|541235939|FG000|Completed Follow-up|Refused|69|||
150027397|NCT03683173|541235940|FG001|Completed Follow-up|Refused|59|||
150027398|NCT03683173|541235939|FG000|Completed Follow-up|Disconnected phone|65|||
150027399|NCT03683173|541235940|FG001|Completed Follow-up|Disconnected phone|95|||
150027400|NCT03683173|541235939|FG000|Completed Follow-up|Health issue/deceased|10|||
150027401|NCT03683173|541235940|FG001|Completed Follow-up|Health issue/deceased|4|||
150027402|NCT03683173|541235939|FG000|Completed Follow-up|Moved away|8|||
150027403|NCT03683173|541235940|FG001|Completed Follow-up|Moved away|1|||
150027404|NCT03016312|541235941|FG000|Overall Study|discontinued before the treatment started|0|||
150027405|NCT03016312|541235942|FG001|Overall Study|discontinued before the treatment started|1|||
150085323|NCT03129100|541453688|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085324|NCT03129100|541453689|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085325|NCT03129100|541453690|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085326|NCT03129100|541453691|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085327|NCT03129100|541453692|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085328|NCT03129100|541453693|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085329|NCT03129100|541453694|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085330|NCT03129100|541453695|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150027406|NCT03016312|541235941|FG000|Overall Study|Withdrawal by Subject|37|||
150085331|NCT03129100|541453696|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085332|NCT03129100|541453697|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085333|NCT03129100|541453698|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085334|NCT03129100|541453699|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085335|NCT03129100|541453700|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085336|NCT03129100|541453701|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
150085337|NCT03129100|541453676|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085338|NCT03129100|541453677|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
150085339|NCT03129100|541453678|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085340|NCT03129100|541453679|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085341|NCT03129100|541453680|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085342|NCT03129100|541453681|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
150183237|NCT03271489|541808774|FG000|Double-Blind (DB) Period|Missing|1|||
150027407|NCT03016312|541235942|FG001|Overall Study|Withdrawal by Subject|44|||
150027408|NCT03016312|541235941|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
150027409|NCT03016312|541235942|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
150027410|NCT03016312|541235941|FG000|Overall Study|Physician Decision|1|||
150027411|NCT03016312|541235942|FG001|Overall Study|Physician Decision|3|||
150027412|NCT03016312|541235941|FG000|Overall Study|Lost to Follow-up|12|||
150027413|NCT03016312|541235942|FG001|Overall Study|Lost to Follow-up|12|||
150027414|NCT03016312|541235941|FG000|Overall Study|Death|210|||
150027415|NCT03016312|541235942|FG001|Overall Study|Death|184|||
150027416|NCT03016312|541235941|FG000|Overall Study|loss to contact|1|||
150027417|NCT03016312|541235942|FG001|Overall Study|loss to contact|0|||
150027418|NCT03016312|541235941|FG000|Overall Study|started a new cancer therapy|1|||
150027419|NCT03016312|541235942|FG001|Overall Study|started a new cancer therapy|0|||
150027420|NCT02123134|541235943|FG000|Overall Study|Withdrawal of consent|3|||
150027421|NCT02123134|541235944|FG001|Overall Study|Withdrawal of consent|2|||
150027422|NCT02123134|541235943|FG000|Overall Study|Administrative decision|0|||
150027423|NCT02123134|541235944|FG001|Overall Study|Administrative decision|1|||
150027424|NCT02995980|541235950|FG000|Overall Study|Lost to Follow-up|14|||
150027425|NCT01731912|541235952|FG000|Overall Study|noncompliance|2|||
150027426|NCT01169103|541235953|FG000|Overall Study|Lost to Follow-up|3|||
150027427|NCT01169103|541235954|FG001|Overall Study|Lost to Follow-up|3|||
150027428|NCT01169103|541235953|FG000|Overall Study|Withdrawal by Subject|3|||
150027429|NCT01169103|541235954|FG001|Overall Study|Withdrawal by Subject|1|||
150027430|NCT02043938|541235955|FG000|Overall Study|Withdrawal by Subject|7|||
150027431|NCT02043938|541235955|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
150027432|NCT02043938|541235955|FG000|Overall Study|No show by subject|1|||
150027433|NCT02043938|541235955|FG000|Overall Study|Investigator decision|1|||
150027434|NCT03010527|541235956|FG000|Overall Study|Death|0|||
150027435|NCT03010527|541235957|FG001|Overall Study|Death|0|||
150027436|NCT03010527|541235958|FG002|Overall Study|Death|1|||
150027437|NCT03010527|541235956|FG000|Overall Study|Adverse Event|0|||
150027438|NCT03010527|541235957|FG001|Overall Study|Adverse Event|4|||
150027439|NCT03010527|541235958|FG002|Overall Study|Adverse Event|2|||
150027440|NCT03010527|541235956|FG000|Overall Study|Protocol Violation|0|||
150027441|NCT03010527|541235957|FG001|Overall Study|Protocol Violation|1|||
150027442|NCT03010527|541235958|FG002|Overall Study|Protocol Violation|0|||
150027443|NCT03010527|541235956|FG000|Overall Study|Lost to Follow-up|0|||
150027444|NCT03010527|541235957|FG001|Overall Study|Lost to Follow-up|2|||
150027445|NCT03010527|541235958|FG002|Overall Study|Lost to Follow-up|1|||
150027446|NCT03010527|541235956|FG000|Overall Study|Withdrawal by Subject|0|||
150027447|NCT03010527|541235957|FG001|Overall Study|Withdrawal by Subject|3|||
150027448|NCT03010527|541235958|FG002|Overall Study|Withdrawal by Subject|4|||
150027449|NCT03010527|541235956|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
150027450|NCT03010527|541235957|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
150027451|NCT03010527|541235958|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
150027452|NCT03010527|541235956|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
150027453|NCT03010527|541235957|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
150027454|NCT03010527|541235958|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
150027455|NCT03010527|541235956|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
150027456|NCT03010527|541235957|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
150027457|NCT03010527|541235958|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
150027458|NCT01458639|541235959|FG000|Overall Study|Physician Decision|4|||
150027459|NCT01458639|541235959|FG000|Overall Study|Equipment issue|1|||
150027460|NCT01458639|541235959|FG000|Overall Study|Inability to obtain subject blood sample|1|||
150027461|NCT02656017|541235960|FG000|Overall Study|Study burden|3|||
150027462|NCT02656017|541235961|FG001|Overall Study|Study burden|3|||
150027463|NCT02656017|541235960|FG000|Overall Study|Adverse Event|2|||
150027464|NCT02656017|541235961|FG001|Overall Study|Adverse Event|1|||
150027465|NCT02656017|541235960|FG000|Overall Study|Unable/unwilling to take study medication|2|||
150027466|NCT02656017|541235961|FG001|Overall Study|Unable/unwilling to take study medication|1|||
150027467|NCT02656017|541235960|FG000|Overall Study|Began Tolvaptan|1|||
150027468|NCT02656017|541235961|FG001|Overall Study|Began Tolvaptan|1|||
150027469|NCT02656017|541235960|FG000|Overall Study|Withdrawal by Subject|1|||
150027470|NCT02656017|541235961|FG001|Overall Study|Withdrawal by Subject|0|||
150027471|NCT01755234|541235962|FG000|Overall Study|Lost to Follow-up|11|||
150027472|NCT01755234|541235963|FG001|Overall Study|Lost to Follow-up|6|||
150027473|NCT01755234|541235962|FG000|Overall Study|Change in surgical case|2|||
150027474|NCT01755234|541235963|FG001|Overall Study|Change in surgical case|1|||
150027475|NCT01755234|541235962|FG000|Overall Study|case cancelled|1|||
150027476|NCT01755234|541235963|FG001|Overall Study|case cancelled|0|||
150027477|NCT01755234|541235962|FG000|Overall Study|Withdrawal by Subject|0|||
150027478|NCT01755234|541235963|FG001|Overall Study|Withdrawal by Subject|1|||
150027479|NCT01755234|541235962|FG000|Overall Study|unblinded|1|||
150027480|NCT01755234|541235963|FG001|Overall Study|unblinded|0|||
150027481|NCT00622505|541235964|FG000|Overall Study|Adverse Event|9|||
150027482|NCT00622505|541235965|FG001|Overall Study|Adverse Event|7|||
150027483|NCT00622505|541235964|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
150027484|NCT00622505|541235965|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
150027485|NCT00622505|541235964|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
150027486|NCT00622505|541235965|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
150027487|NCT00622505|541235964|FG000|Overall Study|Withdrawal by Subject|12|||
150027488|NCT00622505|541235965|FG001|Overall Study|Withdrawal by Subject|5|||
150027489|NCT00622505|541235964|FG000|Overall Study|Administrative Problems|2|||
150027490|NCT00622505|541235965|FG001|Overall Study|Administrative Problems|4|||
150027491|NCT00622505|541235964|FG000|Overall Study|Death|2|||
150027492|NCT00622505|541235965|FG001|Overall Study|Death|2|||
150027493|NCT00614380|541235974|FG000|Overall Study|Adverse Event|14|||
150027494|NCT00614380|541235975|FG001|Overall Study|Adverse Event|4|||
150027495|NCT00614380|541235976|FG002|Overall Study|Adverse Event|0|||
150027496|NCT00614380|541235977|FG003|Overall Study|Adverse Event|0|||
150027497|NCT00614380|541235974|FG000|Overall Study|Lost to Follow-up|6|||
150027498|NCT00614380|541235975|FG001|Overall Study|Lost to Follow-up|1|||
150027499|NCT00614380|541235976|FG002|Overall Study|Lost to Follow-up|0|||
150027500|NCT00614380|541235977|FG003|Overall Study|Lost to Follow-up|0|||
150027501|NCT00614380|541235974|FG000|Overall Study|Non compliant with the protocol|12|||
150027502|NCT00614380|541235975|FG001|Overall Study|Non compliant with the protocol|2|||
150027503|NCT00614380|541235976|FG002|Overall Study|Non compliant with the protocol|1|||
150027504|NCT00614380|541235977|FG003|Overall Study|Non compliant with the protocol|2|||
150027505|NCT00614380|541235974|FG000|Overall Study|Consent withdrawn|3|||
150027506|NCT00614380|541235975|FG001|Overall Study|Consent withdrawn|1|||
150027507|NCT00614380|541235976|FG002|Overall Study|Consent withdrawn|0|||
150027508|NCT00614380|541235977|FG003|Overall Study|Consent withdrawn|0|||
150027509|NCT01506271|541235978|FG000|Overall Study|Progressive disease|0|||
150027510|NCT01506271|541235979|FG001|Overall Study|Progressive disease|1|||
150027511|NCT01506271|541235980|FG002|Overall Study|Progressive disease|0|||
150027512|NCT01506271|541235978|FG000|Overall Study|Protocol Violation|3|||
150027513|NCT01506271|541235979|FG001|Overall Study|Protocol Violation|1|||
150027514|NCT01506271|541235980|FG002|Overall Study|Protocol Violation|0|||
150027515|NCT01506271|541235978|FG000|Overall Study|Death|0|||
150027516|NCT01506271|541235979|FG001|Overall Study|Death|1|||
150027517|NCT01506271|541235980|FG002|Overall Study|Death|0|||
150027518|NCT01506271|541235978|FG000|Overall Study|Adverse Event|0|||
150027519|NCT01506271|541235979|FG001|Overall Study|Adverse Event|2|||
150027520|NCT01506271|541235980|FG002|Overall Study|Adverse Event|0|||
150027521|NCT01506271|541235978|FG000|Overall Study|Insufficient supply of study drug|1|||
150027522|NCT01506271|541235979|FG001|Overall Study|Insufficient supply of study drug|0|||
150027523|NCT01506271|541235980|FG002|Overall Study|Insufficient supply of study drug|0|||
150027524|NCT01506271|541235978|FG000|Overall Study|Withdrawal by Subject|0|||
150027525|NCT01506271|541235979|FG001|Overall Study|Withdrawal by Subject|1|||
150027526|NCT01506271|541235980|FG002|Overall Study|Withdrawal by Subject|1|||
150027527|NCT01506271|541235978|FG000|Overall Study|Lost to Follow-up|0|||
150027528|NCT01506271|541235979|FG001|Overall Study|Lost to Follow-up|1|||
150027529|NCT01506271|541235980|FG002|Overall Study|Lost to Follow-up|2|||
150027530|NCT01391663|541235981|FG000|Overall Study|Withdrawal by Subject|0|||
150027531|NCT01391663|541235982|FG001|Overall Study|Withdrawal by Subject|0|||
150027532|NCT01391663|541235983|FG002|Overall Study|Withdrawal by Subject|1|||
150027533|NCT01391663|541235984|FG003|Overall Study|Withdrawal by Subject|0|||
150027534|NCT00462306|541235985|FG000|Overall Study|insufficient data|0|||
150027535|NCT00462306|541235986|FG001|Overall Study|insufficient data|13|||
150027536|NCT03515824|541235987|FG000|Overall Study|Death|3|||
150027537|NCT03515824|541235988|FG001|Overall Study|Death|2|||
150027538|NCT03515824|541235989|FG002|Overall Study|Death|6|||
150027539|NCT03515824|541235990|FG003|Overall Study|Death|0|||
150027540|NCT03515824|541235987|FG000|Overall Study|Lost to Follow-up|0|||
150027541|NCT03515824|541235988|FG001|Overall Study|Lost to Follow-up|1|||
150027542|NCT03515824|541235989|FG002|Overall Study|Lost to Follow-up|1|||
150027543|NCT03515824|541235990|FG003|Overall Study|Lost to Follow-up|0|||
150027544|NCT03515824|541235987|FG000|Overall Study|Study terminated by sponsor|0|||
150027545|NCT03515824|541235988|FG001|Overall Study|Study terminated by sponsor|1|||
150027546|NCT03515824|541235989|FG002|Overall Study|Study terminated by sponsor|6|||
150027547|NCT03515824|541235990|FG003|Overall Study|Study terminated by sponsor|0|||
150027548|NCT03515824|541235987|FG000|Overall Study|Status not recorded|0|||
150027549|NCT03515824|541235988|FG001|Overall Study|Status not recorded|0|||
150027550|NCT03515824|541235989|FG002|Overall Study|Status not recorded|2|||
150027551|NCT03515824|541235990|FG003|Overall Study|Status not recorded|0|||
150027552|NCT00920855|541235991|FG000|Overall Study|Adverse Event|1|||
150027553|NCT00920855|541235992|FG001|Overall Study|Adverse Event|1|||
150027554|NCT00920855|541235993|FG002|Overall Study|Adverse Event|4|||
150027555|NCT00920855|541235991|FG000|Overall Study|Withdrawal by Subject|2|||
150027556|NCT00920855|541235992|FG001|Overall Study|Withdrawal by Subject|1|||
150027557|NCT00920855|541235993|FG002|Overall Study|Withdrawal by Subject|6|||
150027558|NCT00920855|541235991|FG000|Overall Study|Disease progression|2|||
150027559|NCT00920855|541235992|FG001|Overall Study|Disease progression|1|||
150027560|NCT00920855|541235993|FG002|Overall Study|Disease progression|10|||
150027561|NCT00920855|541235991|FG000|Overall Study|Noncompliance to study medication|0|||
150027562|NCT00920855|541235992|FG001|Overall Study|Noncompliance to study medication|0|||
150027563|NCT00920855|541235993|FG002|Overall Study|Noncompliance to study medication|1|||
150027564|NCT00920855|541235991|FG000|Overall Study|Response plateau; started maintenance|0|||
150027565|NCT00920855|541235992|FG001|Overall Study|Response plateau; started maintenance|0|||
150027566|NCT00920855|541235993|FG002|Overall Study|Response plateau; started maintenance|1|||
150027567|NCT00510835|541235995|FG000|Overall Study|Withdrawal by Subject|6|||
150027568|NCT00510835|541235996|FG001|Overall Study|Withdrawal by Subject|2|||
150027569|NCT00510835|541235997|FG002|Overall Study|Withdrawal by Subject|2|||
150027570|NCT01787461|541235998|FG000|Overall Study|Adverse Event|4|||
150027571|NCT01787461|541235999|FG001|Overall Study|Adverse Event|3|||
150027572|NCT01787461|541235998|FG000|Overall Study|Lost to Follow-up|3|||
150027573|NCT01787461|541235999|FG001|Overall Study|Lost to Follow-up|2|||
150027574|NCT01787461|541235998|FG000|Overall Study|No longer met eligibility criteria|1|||
150027575|NCT01787461|541235999|FG001|Overall Study|No longer met eligibility criteria|0|||
150027576|NCT01787461|541235998|FG000|Overall Study|Withdrawal by Subject|3|||
150027577|NCT01787461|541235999|FG001|Overall Study|Withdrawal by Subject|4|||
150027578|NCT01787461|541235998|FG000|Overall Study|Protocol Violation|3|||
150027579|NCT01787461|541235999|FG001|Overall Study|Protocol Violation|0|||
150027580|NCT00152503|541236000|FG000|Overall Study|Adverse Event|4|||
150027581|NCT04816214|541236002|FG000|Overall Study|Progressive Disease|4|||
150027582|NCT04816214|541236003|FG001|Overall Study|Progressive Disease|0|||
150027583|NCT04816214|541236004|FG002|Overall Study|Progressive Disease|0|||
150027584|NCT04816214|541236002|FG000|Overall Study|Death|1|||
150027585|NCT04816214|541236003|FG001|Overall Study|Death|0|||
150027586|NCT04816214|541236004|FG002|Overall Study|Death|0|||
150027587|NCT04816214|541236002|FG000|Overall Study|Study Terminated by Sponsor|1|||
150027588|NCT04816214|541236003|FG001|Overall Study|Study Terminated by Sponsor|0|||
150027589|NCT04816214|541236004|FG002|Overall Study|Study Terminated by Sponsor|0|||
150027590|NCT03649074|541236005|FG000|Overall Study|Lost to Follow-up|2|||
150027591|NCT03649074|541236006|FG001|Overall Study|Lost to Follow-up|1|||
150027592|NCT03649074|541236005|FG000|Overall Study|Adverse Event|1|||
150027593|NCT03649074|541236006|FG001|Overall Study|Adverse Event|0|||
150027594|NCT03649074|541236005|FG000|Overall Study|Physician Decision|1|||
150027595|NCT03649074|541236006|FG001|Overall Study|Physician Decision|0|||
150027596|NCT03649074|541236005|FG000|Overall Study|Withdrawal by Subject|0|||
150027597|NCT03649074|541236006|FG001|Overall Study|Withdrawal by Subject|2|||
150027598|NCT03649074|541236005|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
150027599|NCT03649074|541236006|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
150027600|NCT03649074|541236005|FG000|Overall Study|Other|1|||
150027601|NCT03649074|541236006|FG001|Overall Study|Other|0|||
150027602|NCT04393493|541236009|FG000|First 4 Days of Intervention|Early improvement|5|||
150027603|NCT04393493|541236010|FG001|First 4 Days of Intervention|Early improvement|7|||
150027604|NCT02910466|541236011|FG000|Overall Study|Adverse Event|1|||
150027605|NCT02910466|541236011|FG000|Overall Study|Withdrawal by Subject|3|||
150085343|NCT03129100|541453682|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085344|NCT03129100|541453683|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085345|NCT03129100|541453684|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085346|NCT03129100|541453685|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085347|NCT03129100|541453686|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085348|NCT03129100|541453687|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085349|NCT03129100|541453688|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085350|NCT03129100|541453689|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085351|NCT03129100|541453690|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085352|NCT03129100|541453691|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085353|NCT03129100|541453692|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085354|NCT03129100|541453693|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085355|NCT03129100|541453694|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085356|NCT03129100|541453695|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085357|NCT03129100|541453696|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085358|NCT03129100|541453697|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
150027606|NCT02910466|541236011|FG000|Overall Study|Lost to Follow-up|5|||
150027607|NCT02910466|541236011|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
150085359|NCT03129100|541453698|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085360|NCT03129100|541453699|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
150027608|NCT02910466|541236011|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
150027609|NCT05051579|541236016|FG000|Overall Study|Withdrawal by Subject|3|||
150027610|NCT05051579|541236017|FG001|Overall Study|Withdrawal by Subject|5|||
150027611|NCT05051579|541236018|FG002|Overall Study|Withdrawal by Subject|2|||
150027612|NCT05051579|541236019|FG003|Overall Study|Withdrawal by Subject|1|||
150027613|NCT05051579|541236020|FG004|Overall Study|Withdrawal by Subject|4|||
150027614|NCT05051579|541236021|FG005|Overall Study|Withdrawal by Subject|0|||
150027615|NCT05051579|541236022|FG006|Overall Study|Withdrawal by Subject|4|||
150027616|NCT05051579|541236016|FG000|Overall Study|Lost to Follow-up|1|||
150027617|NCT05051579|541236017|FG001|Overall Study|Lost to Follow-up|0|||
150027618|NCT05051579|541236018|FG002|Overall Study|Lost to Follow-up|0|||
150027619|NCT05051579|541236019|FG003|Overall Study|Lost to Follow-up|0|||
150027620|NCT05051579|541236020|FG004|Overall Study|Lost to Follow-up|1|||
150027621|NCT05051579|541236021|FG005|Overall Study|Lost to Follow-up|0|||
150027622|NCT05051579|541236022|FG006|Overall Study|Lost to Follow-up|1|||
150027623|NCT05051579|541236016|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027624|NCT05051579|541236017|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027625|NCT05051579|541236018|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027626|NCT05051579|541236019|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027627|NCT05051579|541236020|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027628|NCT05051579|541236021|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
150027629|NCT05051579|541236022|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
150027630|NCT05051579|541236016|FG000|Overall Study|Adverse Event|2|||
150027631|NCT05051579|541236017|FG001|Overall Study|Adverse Event|1|||
150027632|NCT05051579|541236018|FG002|Overall Study|Adverse Event|0|||
150027633|NCT05051579|541236019|FG003|Overall Study|Adverse Event|4|||
150027634|NCT05051579|541236020|FG004|Overall Study|Adverse Event|1|||
150027635|NCT05051579|541236021|FG005|Overall Study|Adverse Event|2|||
150027636|NCT05051579|541236022|FG006|Overall Study|Adverse Event|0|||
150027637|NCT05051579|541236016|FG000|Overall Study|Inadvertent Enrollment|0|||
150027638|NCT05051579|541236017|FG001|Overall Study|Inadvertent Enrollment|0|||
150027639|NCT05051579|541236018|FG002|Overall Study|Inadvertent Enrollment|0|||
150027640|NCT05051579|541236019|FG003|Overall Study|Inadvertent Enrollment|0|||
150027641|NCT05051579|541236020|FG004|Overall Study|Inadvertent Enrollment|0|||
150027642|NCT05051579|541236021|FG005|Overall Study|Inadvertent Enrollment|0|||
150027643|NCT05051579|541236022|FG006|Overall Study|Inadvertent Enrollment|1|||
150027644|NCT05051579|541236016|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027645|NCT05051579|541236017|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
150027646|NCT05051579|541236018|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027647|NCT05051579|541236019|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027648|NCT05051579|541236020|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027649|NCT05051579|541236021|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027650|NCT05051579|541236022|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
150027651|NCT05051579|541236016|FG000|Overall Study|Sponsor Decision|0|||
150027652|NCT05051579|541236017|FG001|Overall Study|Sponsor Decision|0|||
150027653|NCT05051579|541236018|FG002|Overall Study|Sponsor Decision|0|||
150027654|NCT05051579|541236019|FG003|Overall Study|Sponsor Decision|0|||
150027655|NCT05051579|541236020|FG004|Overall Study|Sponsor Decision|1|||
150027656|NCT05051579|541236021|FG005|Overall Study|Sponsor Decision|0|||
150027657|NCT05051579|541236022|FG006|Overall Study|Sponsor Decision|0|||
150027658|NCT05051579|541236016|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027659|NCT05051579|541236017|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027660|NCT05051579|541236018|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027661|NCT05051579|541236019|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027662|NCT05051579|541236020|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
150027663|NCT05051579|541236021|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027664|NCT05051579|541236022|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
150027665|NCT04481243|541237695|FG000|Overall Study|Withdrawal by Subject|4|||
150027666|NCT04564846|541237696|FG000|Overall Study|Withdrawal by Subject|2|||
150027667|NCT04564846|541237697|FG001|Overall Study|Withdrawal by Subject|1|||
150027668|NCT04564846|541237696|FG000|Overall Study|Physician Decision|0|||
150027669|NCT04564846|541237697|FG001|Overall Study|Physician Decision|1|||
150027670|NCT04564846|541237696|FG000|Overall Study|Lost to Follow-up|0|||
150027671|NCT04564846|541237697|FG001|Overall Study|Lost to Follow-up|1|||
150027672|NCT04564846|541237696|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
150027673|NCT04564846|541237697|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
150027674|NCT04564846|541237696|FG000|Overall Study|Subject non-compliance|1|||
150027675|NCT04564846|541237697|FG001|Overall Study|Subject non-compliance|0|||
150027676|NCT00445549|541237698|FG000|Overall Study|progressive disease|12|||
150027677|NCT06039579|541237699|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027678|NCT06039579|541237700|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027679|NCT06039579|541237701|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027680|NCT06039579|541237702|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027681|NCT06039579|541237703|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027682|NCT06039579|541237704|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027683|NCT06039579|541237705|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
150027684|NCT06039579|541237706|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
150027685|NCT04073186|541237707|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
150027686|NCT04073186|541237707|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
150027687|NCT04073186|541237707|FG000|First Wearing Cycle|Protocol Violation|1|||
150027688|NCT04073186|541237707|FG000|First Wearing Cycle|Lens Discomfort|2|||
150027689|NCT04073186|541237707|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
150085361|NCT03129100|541453700|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
150027690|NCT04073186|541237707|FG000|Second Wearing Cycle|Adverse Event|1|||
150027691|NCT02349633|541237708|FG000|Overall Study|Death|0|||
150027692|NCT02349633|541237709|FG001|Overall Study|Death|1|||
150027693|NCT02349633|541237710|FG002|Overall Study|Death|0|||
150027694|NCT02349633|541237711|FG003|Overall Study|Death|0|||
150027695|NCT02349633|541237712|FG004|Overall Study|Death|0|||
150027696|NCT02349633|541237713|FG005|Overall Study|Death|1|||
150027697|NCT02349633|541237714|FG006|Overall Study|Death|1|||
150027698|NCT02349633|541237715|FG007|Overall Study|Death|1|||
150027699|NCT02349633|541237716|FG008|Overall Study|Death|0|||
150027700|NCT02349633|541237717|FG009|Overall Study|Death|1|||
150027701|NCT02349633|541237718|FG010|Overall Study|Death|0|||
150027702|NCT02349633|541237719|FG011|Overall Study|Death|0|||
150027703|NCT02349633|541237720|FG012|Overall Study|Death|0|||
150027704|NCT02349633|541237721|FG013|Overall Study|Death|0|||
150027705|NCT02349633|541237708|FG000|Overall Study|Withdrawal by Subject|0|||
150027706|NCT02349633|541237709|FG001|Overall Study|Withdrawal by Subject|0|||
150027707|NCT02349633|541237710|FG002|Overall Study|Withdrawal by Subject|0|||
150027708|NCT02349633|541237711|FG003|Overall Study|Withdrawal by Subject|1|||
150027709|NCT02349633|541237712|FG004|Overall Study|Withdrawal by Subject|0|||
150027710|NCT02349633|541237713|FG005|Overall Study|Withdrawal by Subject|0|||
150027711|NCT02349633|541237714|FG006|Overall Study|Withdrawal by Subject|0|||
150027712|NCT02349633|541237715|FG007|Overall Study|Withdrawal by Subject|2|||
150027713|NCT02349633|541237716|FG008|Overall Study|Withdrawal by Subject|2|||
150027714|NCT02349633|541237717|FG009|Overall Study|Withdrawal by Subject|1|||
150027715|NCT02349633|541237718|FG010|Overall Study|Withdrawal by Subject|0|||
150027716|NCT02349633|541237719|FG011|Overall Study|Withdrawal by Subject|0|||
150027717|NCT02349633|541237720|FG012|Overall Study|Withdrawal by Subject|0|||
150027718|NCT02349633|541237721|FG013|Overall Study|Withdrawal by Subject|0|||
150027719|NCT02349633|541237708|FG000|Overall Study|Withdrawal of informed consent|0|||
150027720|NCT02349633|541237709|FG001|Overall Study|Withdrawal of informed consent|0|||
150027721|NCT02349633|541237710|FG002|Overall Study|Withdrawal of informed consent|0|||
150027722|NCT02349633|541237711|FG003|Overall Study|Withdrawal of informed consent|1|||
150027723|NCT02349633|541237712|FG004|Overall Study|Withdrawal of informed consent|1|||
150027724|NCT02349633|541237713|FG005|Overall Study|Withdrawal of informed consent|0|||
150027725|NCT02349633|541237714|FG006|Overall Study|Withdrawal of informed consent|0|||
150027726|NCT02349633|541237715|FG007|Overall Study|Withdrawal of informed consent|3|||
150027727|NCT02349633|541237716|FG008|Overall Study|Withdrawal of informed consent|0|||
150027728|NCT02349633|541237717|FG009|Overall Study|Withdrawal of informed consent|0|||
150085362|NCT03129100|541453701|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
150085363|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085364|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085365|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
150085366|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
150085367|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085368|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
150085369|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085370|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085371|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085372|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085373|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085374|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085375|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085376|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085377|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085378|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085379|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085380|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150183238|NCT03271489|541808775|FG001|Double-Blind (DB) Period|Missing|0|||
150027729|NCT02349633|541237718|FG010|Overall Study|Withdrawal of informed consent|0|||
150027730|NCT02349633|541237719|FG011|Overall Study|Withdrawal of informed consent|0|||
150027731|NCT02349633|541237720|FG012|Overall Study|Withdrawal of informed consent|0|||
150027732|NCT02349633|541237721|FG013|Overall Study|Withdrawal of informed consent|0|||
150027733|NCT02349633|541237708|FG000|Overall Study|Transition to compassionate use|0|||
150027734|NCT02349633|541237709|FG001|Overall Study|Transition to compassionate use|0|||
150027735|NCT02349633|541237710|FG002|Overall Study|Transition to compassionate use|0|||
150027736|NCT02349633|541237711|FG003|Overall Study|Transition to compassionate use|0|||
150027737|NCT02349633|541237712|FG004|Overall Study|Transition to compassionate use|1|||
150027738|NCT02349633|541237713|FG005|Overall Study|Transition to compassionate use|0|||
150027739|NCT02349633|541237714|FG006|Overall Study|Transition to compassionate use|0|||
150027740|NCT02349633|541237715|FG007|Overall Study|Transition to compassionate use|3|||
150027741|NCT02349633|541237716|FG008|Overall Study|Transition to compassionate use|0|||
150027742|NCT02349633|541237717|FG009|Overall Study|Transition to compassionate use|1|||
150027743|NCT02349633|541237718|FG010|Overall Study|Transition to compassionate use|0|||
150027744|NCT02349633|541237719|FG011|Overall Study|Transition to compassionate use|0|||
150027745|NCT02349633|541237720|FG012|Overall Study|Transition to compassionate use|0|||
150027746|NCT02349633|541237721|FG013|Overall Study|Transition to compassionate use|0|||
150027747|NCT02349633|541237708|FG000|Overall Study|Early termination of survival follow-up|0|||
150027748|NCT02349633|541237709|FG001|Overall Study|Early termination of survival follow-up|0|||
150027749|NCT02349633|541237710|FG002|Overall Study|Early termination of survival follow-up|0|||
150027750|NCT02349633|541237711|FG003|Overall Study|Early termination of survival follow-up|0|||
150027751|NCT02349633|541237712|FG004|Overall Study|Early termination of survival follow-up|0|||
150027752|NCT02349633|541237713|FG005|Overall Study|Early termination of survival follow-up|0|||
150027753|NCT02349633|541237714|FG006|Overall Study|Early termination of survival follow-up|0|||
150027754|NCT02349633|541237715|FG007|Overall Study|Early termination of survival follow-up|4|||
150027755|NCT02349633|541237716|FG008|Overall Study|Early termination of survival follow-up|0|||
150027756|NCT02349633|541237717|FG009|Overall Study|Early termination of survival follow-up|0|||
150027757|NCT02349633|541237718|FG010|Overall Study|Early termination of survival follow-up|0|||
150027758|NCT02349633|541237719|FG011|Overall Study|Early termination of survival follow-up|0|||
150027759|NCT02349633|541237720|FG012|Overall Study|Early termination of survival follow-up|0|||
150027760|NCT02349633|541237721|FG013|Overall Study|Early termination of survival follow-up|0|||
150027761|NCT02349633|541237708|FG000|Overall Study|Termination by sponsor|0|||
150027762|NCT02349633|541237709|FG001|Overall Study|Termination by sponsor|0|||
150027763|NCT02349633|541237710|FG002|Overall Study|Termination by sponsor|0|||
150027764|NCT02349633|541237711|FG003|Overall Study|Termination by sponsor|0|||
150027765|NCT02349633|541237712|FG004|Overall Study|Termination by sponsor|0|||
150085381|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085382|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085383|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085384|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085385|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085386|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085387|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085388|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
150085389|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Death|0|||
150085390|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Death|0|||
150085391|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Death|1|||
150085392|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Death|0|||
150085393|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Death|0|||
150085394|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Death|0|||
150085395|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Death|0|||
150085396|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Death|0|||
150085397|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Death|0|||
150085398|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Death|0|||
150085399|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Death|0|||
150027766|NCT02349633|541237713|FG005|Overall Study|Termination by sponsor|0|||
150027767|NCT02349633|541237714|FG006|Overall Study|Termination by sponsor|0|||
150027768|NCT02349633|541237715|FG007|Overall Study|Termination by sponsor|1|||
150027769|NCT02349633|541237716|FG008|Overall Study|Termination by sponsor|0|||
150027770|NCT02349633|541237717|FG009|Overall Study|Termination by sponsor|2|||
150027771|NCT02349633|541237718|FG010|Overall Study|Termination by sponsor|0|||
150027772|NCT02349633|541237719|FG011|Overall Study|Termination by sponsor|0|||
150027773|NCT02349633|541237720|FG012|Overall Study|Termination by sponsor|0|||
150027774|NCT02349633|541237721|FG013|Overall Study|Termination by sponsor|0|||
150027775|NCT02349633|541237708|FG000|Overall Study|Other|0|||
150027776|NCT02349633|541237709|FG001|Overall Study|Other|0|||
150027777|NCT02349633|541237710|FG002|Overall Study|Other|0|||
150027778|NCT02349633|541237711|FG003|Overall Study|Other|0|||
150027779|NCT02349633|541237712|FG004|Overall Study|Other|0|||
150027780|NCT02349633|541237713|FG005|Overall Study|Other|0|||
150027781|NCT02349633|541237714|FG006|Overall Study|Other|0|||
150027782|NCT02349633|541237715|FG007|Overall Study|Other|2|||
150027783|NCT02349633|541237716|FG008|Overall Study|Other|0|||
150027784|NCT02349633|541237717|FG009|Overall Study|Other|0|||
150027785|NCT02349633|541237718|FG010|Overall Study|Other|0|||
150027786|NCT02349633|541237719|FG011|Overall Study|Other|0|||
150027787|NCT02349633|541237720|FG012|Overall Study|Other|0|||
150027788|NCT02349633|541237721|FG013|Overall Study|Other|0|||
150027789|NCT01220167|541237725|FG000|Period 3|Urine positive for substance abuse|0|||
150027790|NCT01220167|541237726|FG001|Period 3|Urine positive for substance abuse|1|||
150027791|NCT01220167|541237727|FG002|Period 3|Urine positive for substance abuse|0|||
150027792|NCT00667628|541237730|FG000|Overall Study|Lost to Follow-up|1|||
150027793|NCT00667628|541237731|FG001|Overall Study|Lost to Follow-up|0|||
150027794|NCT00667628|541237730|FG000|Overall Study|Death|6|||
150027795|NCT00667628|541237731|FG001|Overall Study|Death|6|||
150027796|NCT00667628|541237730|FG000|Overall Study|Investigator Considers in Best Interest|1|||
150027797|NCT00667628|541237731|FG001|Overall Study|Investigator Considers in Best Interest|0|||
150027798|NCT00667628|541237730|FG000|Overall Study|Sponsor Terminated Study|17|||
150027799|NCT00667628|541237731|FG001|Overall Study|Sponsor Terminated Study|21|||
150027800|NCT04663321|541237732|FG000|Overall Study|Study terminated by Sponsor|2|||
150027801|NCT04663321|541237733|FG001|Overall Study|Study terminated by Sponsor|1|||
150027802|NCT04663321|541237734|FG002|Overall Study|Study terminated by Sponsor|2|||
150027803|NCT04663321|541237732|FG000|Overall Study|Withdrawal by Subject|10|||
150027804|NCT04663321|541237733|FG001|Overall Study|Withdrawal by Subject|3|||
150027805|NCT04663321|541237734|FG002|Overall Study|Withdrawal by Subject|2|||
150027806|NCT04663321|541237732|FG000|Overall Study|Not provided|0|||
150027807|NCT04663321|541237733|FG001|Overall Study|Not provided|0|||
150027808|NCT04663321|541237734|FG002|Overall Study|Not provided|1|||
150027809|NCT03360682|541237735|FG000|Overall Study|Adverse Event|3|||
150027810|NCT01962441|541237738|FG000|Randomized Period|Randomized but Never Treated|4|||
150027811|NCT01962441|541237739|FG001|Randomized Period|Randomized but Never Treated|2|||
150027812|NCT01962441|541237740|FG002|Randomized Period|Randomized but Never Treated|3|||
150027813|NCT01962441|541237738|FG000|Randomized Period|Lost to Follow-up|2|||
150027814|NCT01962441|541237739|FG001|Randomized Period|Lost to Follow-up|4|||
150027815|NCT01962441|541237740|FG002|Randomized Period|Lost to Follow-up|4|||
150027816|NCT01962441|541237738|FG000|Randomized Period|Withdrew Consent|3|||
150027817|NCT01962441|541237739|FG001|Randomized Period|Withdrew Consent|3|||
150027818|NCT01962441|541237740|FG002|Randomized Period|Withdrew Consent|2|||
150027819|NCT01962441|541237738|FG000|Randomized Period|Adverse Event|1|||
150027820|NCT01962441|541237739|FG001|Randomized Period|Adverse Event|1|||
150027821|NCT01962441|541237740|FG002|Randomized Period|Adverse Event|0|||
150027822|NCT01962441|541237738|FG000|Randomized Period|Death|0|||
150027823|NCT01962441|541237739|FG001|Randomized Period|Death|0|||
150027824|NCT01962441|541237740|FG002|Randomized Period|Death|2|||
150027825|NCT01962441|541237738|FG000|Randomized Period|Protocol Violation|0|||
150027826|NCT01962441|541237739|FG001|Randomized Period|Protocol Violation|1|||
150027827|NCT01962441|541237740|FG002|Randomized Period|Protocol Violation|0|||
150027828|NCT01962441|541237738|FG000|Retreatment Substudy|Lack of Efficacy|1|||
150027829|NCT01962441|541237739|FG001|Retreatment Substudy|Lack of Efficacy|0|||
150027830|NCT01962441|541237740|FG002|Retreatment Substudy|Lack of Efficacy|0|||
150183239|NCT03271489|541808774|FG000|Open-Label (OL) Period|Adverse Event|2|||
150183240|NCT03271489|541808775|FG001|Open-Label (OL) Period|Adverse Event|0|||
150183241|NCT03271489|541808774|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
150183242|NCT03271489|541808775|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
150183243|NCT03271489|541808774|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
150183244|NCT03271489|541808775|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
150183245|NCT03271489|541808774|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
150183246|NCT03271489|541808775|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
150183247|NCT03271489|541808774|FG000|Open-Label (OL) Period|No Specified|2|||
150183248|NCT03271489|541808775|FG001|Open-Label (OL) Period|No Specified|2|||
150183249|NCT03271489|541808774|FG000|Open-Label (OL) Period|Missing|2|||
150183250|NCT03271489|541808775|FG001|Open-Label (OL) Period|Missing|0|||
150027831|NCT01962441|541237738|FG000|Retreatment Substudy|Lost to Follow-up|1|||
150027832|NCT01962441|541237739|FG001|Retreatment Substudy|Lost to Follow-up|0|||
150027833|NCT01962441|541237740|FG002|Retreatment Substudy|Lost to Follow-up|0|||
150027834|NCT04862065|541237741|FG000|Screening|Protocol Violation|54|||
150027835|NCT04862065|541237742|FG001|Screening|Protocol Violation|0|||
150027836|NCT04862065|541237743|FG002|Screening|Protocol Violation|0|||
150027837|NCT04862065|541237741|FG000|Screening|Insufficient Sample|1|||
150027838|NCT04862065|541237742|FG001|Screening|Insufficient Sample|0|||
150027839|NCT04862065|541237743|FG002|Screening|Insufficient Sample|0|||
150027840|NCT04862065|541237741|FG000|Follow-Up|Lost to Follow-up|3|||
150027841|NCT04862065|541237742|FG001|Follow-Up|Lost to Follow-up|0|||
150027842|NCT04862065|541237743|FG002|Follow-Up|Lost to Follow-up|0|||
150027843|NCT01453140|541237744|FG000|Overall Study|Adverse Event|3|||
150027844|NCT02634333|541237745|FG000|Overall Study|Completed out of Window|3|||
150027845|NCT02634333|541237746|FG001|Overall Study|Completed out of Window|2|||
150027846|NCT02634333|541237745|FG000|Overall Study|Missed Visit|5|||
150027847|NCT02634333|541237746|FG001|Overall Study|Missed Visit|2|||
150027848|NCT02634333|541237745|FG000|Overall Study|Lost to Follow-up|12|||
150027849|NCT02634333|541237746|FG001|Overall Study|Lost to Follow-up|7|||
150027850|NCT02634333|541237745|FG000|Overall Study|Withdrawal by Subject|9|||
150027851|NCT02634333|541237746|FG001|Overall Study|Withdrawal by Subject|13|||
150027852|NCT02634333|541237745|FG000|Overall Study|Death|11|||
150027853|NCT02634333|541237746|FG001|Overall Study|Death|8|||
150027854|NCT02611479|541237747|FG000|Baseline Enrollment|Exited study|13|||
150027855|NCT02611479|541237747|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
150027856|NCT02611479|541237747|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
150027857|NCT02611479|541237747|FG000|Data Cleaning|No baseline function or pain metrics|2|||
150027858|NCT00743249|541237748|FG000|Overall Study|Adverse Event|0|||
150027859|NCT00743249|541237749|FG001|Overall Study|Adverse Event|4|||
150027860|NCT00743249|541237748|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
150027861|NCT00743249|541237749|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
150027862|NCT00743249|541237748|FG000|Overall Study|Unsuccessful insertion of stent|2|||
150027863|NCT00743249|541237749|FG001|Overall Study|Unsuccessful insertion of stent|1|||
150027864|NCT02748863|541237752|FG000|Treatment Period 1|Adverse Event|0|||
150027865|NCT02748863|541237753|FG001|Treatment Period 1|Adverse Event|1|||
150027866|NCT02748863|541237754|FG002|Treatment Period 1|Adverse Event|0|||
150027867|NCT02748863|541237755|FG003|Treatment Period 1|Adverse Event|0|||
150027868|NCT02748863|541237756|FG004|Treatment Period 1|Adverse Event|0|||
150027869|NCT02748863|541237752|FG000|Treatment Period 1|Lack of Efficacy|0|||
150027870|NCT02748863|541237753|FG001|Treatment Period 1|Lack of Efficacy|0|||
150027871|NCT02748863|541237754|FG002|Treatment Period 1|Lack of Efficacy|1|||
150027872|NCT02748863|541237755|FG003|Treatment Period 1|Lack of Efficacy|0|||
150027873|NCT02748863|541237756|FG004|Treatment Period 1|Lack of Efficacy|0|||
150027874|NCT02748863|541237752|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150027875|NCT02748863|541237753|FG001|Treatment Period 1|Withdrawal by Subject|1|||
150027876|NCT02748863|541237754|FG002|Treatment Period 1|Withdrawal by Subject|1|||
150027877|NCT02748863|541237755|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150027878|NCT02748863|541237756|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150027879|NCT02748863|541237752|FG000|Treatment Period 2|Lost to Follow-up|2|||
150027880|NCT02748863|541237753|FG001|Treatment Period 2|Lost to Follow-up|0|||
150027881|NCT02748863|541237754|FG002|Treatment Period 2|Lost to Follow-up|0|||
150183251|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
150027882|NCT02748863|541237755|FG003|Treatment Period 2|Lost to Follow-up|0|||
150027883|NCT02748863|541237756|FG004|Treatment Period 2|Lost to Follow-up|0|||
150027884|NCT02748863|541237752|FG000|Treatment Period 2|Adverse Event|3|||
150027885|NCT02748863|541237753|FG001|Treatment Period 2|Adverse Event|2|||
150027886|NCT02748863|541237754|FG002|Treatment Period 2|Adverse Event|0|||
150027887|NCT02748863|541237755|FG003|Treatment Period 2|Adverse Event|2|||
150027888|NCT02748863|541237756|FG004|Treatment Period 2|Adverse Event|0|||
150027889|NCT02748863|541237752|FG000|Treatment Period 2|Lack of Efficacy|0|||
150027890|NCT02748863|541237753|FG001|Treatment Period 2|Lack of Efficacy|1|||
150027891|NCT02748863|541237754|FG002|Treatment Period 2|Lack of Efficacy|0|||
150027892|NCT02748863|541237755|FG003|Treatment Period 2|Lack of Efficacy|0|||
150027893|NCT02748863|541237756|FG004|Treatment Period 2|Lack of Efficacy|0|||
150027894|NCT02748863|541237752|FG000|Treatment Period 2|Pregnancy|0|||
150027895|NCT02748863|541237753|FG001|Treatment Period 2|Pregnancy|0|||
150027896|NCT02748863|541237754|FG002|Treatment Period 2|Pregnancy|0|||
150027897|NCT02748863|541237755|FG003|Treatment Period 2|Pregnancy|0|||
150027898|NCT02748863|541237756|FG004|Treatment Period 2|Pregnancy|1|||
150027899|NCT00231777|541237757|FG000|Overall Study|Lost to Follow-up|3|||
150027900|NCT00231777|541237758|FG001|Overall Study|Lost to Follow-up|0|||
150027901|NCT00231777|541237757|FG000|Overall Study|Other|3|||
150027902|NCT00231777|541237758|FG001|Overall Study|Other|2|||
150027903|NCT03275740|541237759|FG000|Overall Study|Adverse Event|0|||
150085400|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Death|0|||
150085401|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Death|0|||
150085402|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Death|0|||
150085403|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Death|0|||
150085404|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Death|0|||
150085405|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Death|0|||
150085406|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Death|0|||
150085407|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Death|0|||
150027904|NCT03275740|541237760|FG001|Overall Study|Adverse Event|0|||
150027905|NCT03275740|541237761|FG002|Overall Study|Adverse Event|0|||
150027906|NCT03275740|541237762|FG003|Overall Study|Adverse Event|0|||
150027907|NCT03275740|541237763|FG004|Overall Study|Adverse Event|1|||
150027908|NCT03275740|541237764|FG005|Overall Study|Adverse Event|0|||
150027909|NCT03275740|541237765|FG006|Overall Study|Adverse Event|0|||
150027910|NCT03275740|541237766|FG007|Overall Study|Adverse Event|0|||
150027911|NCT03275740|541237767|FG008|Overall Study|Adverse Event|0|||
150027912|NCT03275740|541237768|FG009|Overall Study|Adverse Event|0|||
150027913|NCT03275740|541237769|FG010|Overall Study|Adverse Event|0|||
150027914|NCT03275740|541237770|FG011|Overall Study|Adverse Event|0|||
150027915|NCT03275740|541237759|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027916|NCT03275740|541237760|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027917|NCT03275740|541237761|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027918|NCT03275740|541237762|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027919|NCT03275740|541237763|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027920|NCT03275740|541237764|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
150027921|NCT03275740|541237765|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027922|NCT03275740|541237766|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027923|NCT03275740|541237767|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027924|NCT03275740|541237768|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027925|NCT03275740|541237769|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027926|NCT03275740|541237770|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
150027927|NCT03275740|541237759|FG000|Overall Study|Withdrawal by Subject|0|||
150027928|NCT03275740|541237760|FG001|Overall Study|Withdrawal by Subject|0|||
150027929|NCT03275740|541237761|FG002|Overall Study|Withdrawal by Subject|0|||
150027930|NCT03275740|541237762|FG003|Overall Study|Withdrawal by Subject|0|||
150027931|NCT03275740|541237763|FG004|Overall Study|Withdrawal by Subject|0|||
150027932|NCT03275740|541237764|FG005|Overall Study|Withdrawal by Subject|0|||
150027933|NCT03275740|541237765|FG006|Overall Study|Withdrawal by Subject|0|||
150027934|NCT03275740|541237766|FG007|Overall Study|Withdrawal by Subject|0|||
150027935|NCT03275740|541237767|FG008|Overall Study|Withdrawal by Subject|1|||
150027936|NCT03275740|541237768|FG009|Overall Study|Withdrawal by Subject|1|||
150027937|NCT03275740|541237769|FG010|Overall Study|Withdrawal by Subject|0|||
150027938|NCT03275740|541237770|FG011|Overall Study|Withdrawal by Subject|0|||
150085408|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Death|0|||
150027939|NCT00890825|541237771|FG000|Overall Study|Withdrawal by Subject|1|||
150027940|NCT00890825|541237772|FG001|Overall Study|Withdrawal by Subject|0|||
150027941|NCT00890825|541237771|FG000|Overall Study|Alive at data cut off (DCO)|13|||
150027942|NCT00890825|541237772|FG001|Overall Study|Alive at data cut off (DCO)|14|||
150027943|NCT00844376|541237773|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
150027944|NCT00844376|541237774|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
150027945|NCT00988884|541237775|FG000|Overall Study|Adverse Event|0|||
150027946|NCT00988884|541237776|FG001|Overall Study|Adverse Event|1|||
150027947|NCT00988884|541237775|FG000|Overall Study|Lost to Follow-up|20|||
150027948|NCT00988884|541237776|FG001|Overall Study|Lost to Follow-up|16|||
150027949|NCT00988884|541237775|FG000|Overall Study|Protocol Violation|0|||
150027950|NCT00988884|541237776|FG001|Overall Study|Protocol Violation|1|||
150027951|NCT00988884|541237775|FG000|Overall Study|Withdrawal by Subject|15|||
150027952|NCT00988884|541237776|FG001|Overall Study|Withdrawal by Subject|18|||
150027953|NCT04621448|541237777|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
150027954|NCT04621448|541237778|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
150027955|NCT04621448|541237779|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
150027956|NCT04621448|541237780|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
150027957|NCT04621448|541237777|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
150027958|NCT04621448|541237778|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
150027959|NCT04621448|541237779|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
150027960|NCT04621448|541237780|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
150027961|NCT04621448|541237777|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
150027962|NCT04621448|541237778|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
150027963|NCT04621448|541237779|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
150027964|NCT04621448|541237780|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
150027965|NCT04621448|541237777|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
150027966|NCT04621448|541237778|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
150027967|NCT04621448|541237779|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
150027968|NCT04621448|541237780|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
150027969|NCT00468299|541237791|FG000|Overall Study|Withdrawal by Subject|0|||
150027970|NCT00468299|541237792|FG001|Overall Study|Withdrawal by Subject|1|||
150027971|NCT03546621|541237793|FG000|Overall Study|Withdrawal by Subject|0|||
150027972|NCT03546621|541237794|FG001|Overall Study|Withdrawal by Subject|1|||
150027973|NCT03546621|541237795|FG002|Overall Study|Withdrawal by Subject|2|||
150027974|NCT03546621|541237796|FG003|Overall Study|Withdrawal by Subject|1|||
150027975|NCT03546621|541237793|FG000|Overall Study|Lost to Follow-up|0|||
150027976|NCT03546621|541237794|FG001|Overall Study|Lost to Follow-up|1|||
150027977|NCT03546621|541237795|FG002|Overall Study|Lost to Follow-up|0|||
150027978|NCT03546621|541237796|FG003|Overall Study|Lost to Follow-up|0|||
150027979|NCT03546621|541237793|FG000|Overall Study|Adverse Event|0|||
150027980|NCT03546621|541237794|FG001|Overall Study|Adverse Event|1|||
150027981|NCT03546621|541237795|FG002|Overall Study|Adverse Event|0|||
150027982|NCT03546621|541237796|FG003|Overall Study|Adverse Event|1|||
150027983|NCT03546621|541237793|FG000|Overall Study|Progressive disease|0|||
150027984|NCT03546621|541237794|FG001|Overall Study|Progressive disease|0|||
150027985|NCT03546621|541237795|FG002|Overall Study|Progressive disease|0|||
150027986|NCT03546621|541237796|FG003|Overall Study|Progressive disease|1|||
150027987|NCT00660192|541237802|FG000|Overall Study|Lost to Follow-up|2|||
150027988|NCT00660192|541237803|FG001|Overall Study|Lost to Follow-up|3|||
150027989|NCT00377520|541237804|FG000|Overall Study|Ineligible (Prior radiation)|1|||
150027990|NCT04908397|541237810|FG000|Overall Study|Withdrawal by Subject|2|||
150027991|NCT03318549|541237811|FG000|Overall Study|Withdrawal by Subject|5|||
150027992|NCT03318549|541237812|FG001|Overall Study|Withdrawal by Subject|19|||
150027993|NCT03318549|541237813|FG002|Overall Study|Withdrawal by Subject|2|||
150027994|NCT03318549|541237814|FG003|Overall Study|Withdrawal by Subject|0|||
150027995|NCT03318549|541237815|FG004|Overall Study|Withdrawal by Subject|0|||
150027996|NCT03318549|541237816|FG005|Overall Study|Withdrawal by Subject|0|||
150027997|NCT03318549|541237817|FG006|Overall Study|Withdrawal by Subject|0|||
150027998|NCT03318549|541237811|FG000|Overall Study|Physician Decision|0|||
150027999|NCT03318549|541237812|FG001|Overall Study|Physician Decision|4|||
150028000|NCT03318549|541237813|FG002|Overall Study|Physician Decision|1|||
150028001|NCT03318549|541237814|FG003|Overall Study|Physician Decision|0|||
150028002|NCT03318549|541237815|FG004|Overall Study|Physician Decision|0|||
150028003|NCT03318549|541237816|FG005|Overall Study|Physician Decision|0|||
150028004|NCT03318549|541237817|FG006|Overall Study|Physician Decision|0|||
150028005|NCT03318549|541237811|FG000|Overall Study|Lost to Follow-up|0|||
150028006|NCT03318549|541237812|FG001|Overall Study|Lost to Follow-up|3|||
150028007|NCT03318549|541237813|FG002|Overall Study|Lost to Follow-up|3|||
150028008|NCT03318549|541237814|FG003|Overall Study|Lost to Follow-up|0|||
150028009|NCT03318549|541237815|FG004|Overall Study|Lost to Follow-up|0|||
150028010|NCT03318549|541237816|FG005|Overall Study|Lost to Follow-up|0|||
150028011|NCT03318549|541237817|FG006|Overall Study|Lost to Follow-up|0|||
150028012|NCT00539994|541237818|FG000|Overall Study|Lost to Follow-up|2|||
150028013|NCT00539994|541237819|FG001|Overall Study|Lost to Follow-up|1|||
150028014|NCT00539994|541237820|FG002|Overall Study|Lost to Follow-up|0|||
150028015|NCT00539994|541237818|FG000|Overall Study|Withdrawal by Subject|1|||
150028016|NCT00539994|541237819|FG001|Overall Study|Withdrawal by Subject|0|||
150028017|NCT00539994|541237820|FG002|Overall Study|Withdrawal by Subject|1|||
150028018|NCT00539994|541237818|FG000|Overall Study|Physician Decision|0|||
150028019|NCT00539994|541237819|FG001|Overall Study|Physician Decision|0|||
150028020|NCT00539994|541237820|FG002|Overall Study|Physician Decision|1|||
150028021|NCT05470985|541237824|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
150028022|NCT05470985|541237825|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
150028023|NCT05470985|541237824|FG000|Double Blind Treatment Period|Physician Decision|0|||
150028024|NCT05470985|541237825|FG001|Double Blind Treatment Period|Physician Decision|1|||
150028025|NCT05470985|541237824|FG000|Long Term Extension|Adverse Event|0|||
150028026|NCT05470985|541237825|FG001|Long Term Extension|Adverse Event|1|||
150028027|NCT05470985|541237824|FG000|Long Term Extension|Study terminated by sponsor|2|||
150028028|NCT05470985|541237825|FG001|Long Term Extension|Study terminated by sponsor|0|||
150028029|NCT01917747|541237826|FG000|Overall Study|Withdrawal by Subject|1|||
150028030|NCT01917747|541237827|FG001|Overall Study|Withdrawal by Subject|2|||
150028031|NCT01917747|541237826|FG000|Overall Study|Lost to Follow-up|18|||
150028032|NCT01917747|541237827|FG001|Overall Study|Lost to Follow-up|9|||
150028033|NCT02741245|541237832|FG000|Overall Study|Adverse Event|0|||
150028034|NCT02741245|541237833|FG001|Overall Study|Adverse Event|0|||
150028035|NCT02741245|541237834|FG002|Overall Study|Adverse Event|0|||
150028036|NCT02741245|541237835|FG003|Overall Study|Adverse Event|2|||
150028037|NCT02741245|541237836|FG004|Overall Study|Adverse Event|2|||
150028038|NCT02741245|541237832|FG000|Overall Study|Protocol Violation|0|||
150028039|NCT02741245|541237833|FG001|Overall Study|Protocol Violation|1|||
150028040|NCT02741245|541237834|FG002|Overall Study|Protocol Violation|0|||
150028041|NCT02741245|541237835|FG003|Overall Study|Protocol Violation|1|||
150028042|NCT02741245|541237836|FG004|Overall Study|Protocol Violation|0|||
150028043|NCT02741245|541237832|FG000|Overall Study|Withdrawal by Subject|0|||
150028044|NCT02741245|541237833|FG001|Overall Study|Withdrawal by Subject|0|||
150028045|NCT02741245|541237834|FG002|Overall Study|Withdrawal by Subject|0|||
150028046|NCT02741245|541237835|FG003|Overall Study|Withdrawal by Subject|1|||
150028047|NCT02741245|541237836|FG004|Overall Study|Withdrawal by Subject|0|||
150028048|NCT03253679|541237838|FG000|Overall Study|Screen Failure|1|||
150028049|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
150028050|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
150028051|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
150028052|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
150028053|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
150028054|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
150028055|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
150028056|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
150028057|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
150028058|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
150028059|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
150028060|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
150028061|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
150028062|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
150028063|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
150028064|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
150028065|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
150028066|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
150028067|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
150028068|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
150028069|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
150028070|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
150028071|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
150028072|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
150028073|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
150028074|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
150028075|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
150028076|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
150028077|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
150028078|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
150028079|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
150028080|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
150028081|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
150028082|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
150028083|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
150183252|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
150028084|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
150028085|NCT02586623|541237839|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
150028086|NCT02586623|541237840|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
150028087|NCT02586623|541237841|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
150028088|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
150028089|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
150028090|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
150028091|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
150028092|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
150028093|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
150028094|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
150028095|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
150028096|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
150028097|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
150028098|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
150028099|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
150028100|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
150028101|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
150028102|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
150028103|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
150028104|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
150028105|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
150028106|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
150028107|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
150028108|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
150028109|NCT02586623|541237839|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
150028110|NCT02586623|541237840|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
150028111|NCT02586623|541237841|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
150028112|NCT01116648|541237842|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
150028113|NCT01116648|541237843|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
150028114|NCT01116648|541237844|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
150028115|NCT01116648|541237845|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
150028116|NCT01116648|541237846|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
150028117|NCT01116648|541237847|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
150028118|NCT01116648|541237848|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
150028119|NCT01116648|541237849|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
150028120|NCT01116648|541237850|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
150028121|NCT01116648|541237851|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
150028122|NCT01116648|541237852|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
150028123|NCT01116648|541237853|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
150028124|NCT01116648|541237854|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
150028125|NCT01116648|541237855|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
150028126|NCT01116648|541237856|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
150028127|NCT04539938|541237857|FG000|Overall Study|Death|30|||
150028128|NCT04539938|541237857|FG000|Overall Study|Withdrawal by Subject|4|||
150028129|NCT00990106|541237858|FG000|Overall Study|"too busy to continue"|1|||
150028130|NCT00990106|541237859|FG001|Overall Study|"too busy to continue"|2|||
150028131|NCT00990106|541237858|FG000|Overall Study|Lost to Follow-up|1|||
150028132|NCT00990106|541237859|FG001|Overall Study|Lost to Follow-up|3|||
150028133|NCT00990106|541237858|FG000|Overall Study|Withdrawal by Subject|2|||
150028134|NCT00990106|541237859|FG001|Overall Study|Withdrawal by Subject|1|||
150028135|NCT00990106|541237858|FG000|Overall Study|opted for open label prazosin|1|||
150183253|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
150183254|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
150028136|NCT00990106|541237859|FG001|Overall Study|opted for open label prazosin|1|||
150028137|NCT00990106|541237858|FG000|Overall Study|relocation/deployment|4|||
150028138|NCT00990106|541237859|FG001|Overall Study|relocation/deployment|1|||
150028139|NCT00990106|541237858|FG000|Overall Study|started exclusionary medication|0|||
150028140|NCT00990106|541237859|FG001|Overall Study|started exclusionary medication|1|||
150028141|NCT00990106|541237858|FG000|Overall Study|planned major surgery|0|||
150028142|NCT00990106|541237859|FG001|Overall Study|planned major surgery|1|||
150028143|NCT00990106|541237858|FG000|Overall Study|scheduling conflicts|0|||
150028144|NCT00990106|541237859|FG001|Overall Study|scheduling conflicts|2|||
150028145|NCT02926638|541237861|FG000|Overall Study|Progression|2|||
150028146|NCT02926638|541237862|FG001|Overall Study|Progression|5|||
150028147|NCT02926638|541237861|FG000|Overall Study|Ineligible|1|||
150028148|NCT02926638|541237862|FG001|Overall Study|Ineligible|0|||
150028149|NCT02926638|541237861|FG000|Overall Study|Not protocol specified|1|||
150028150|NCT02926638|541237862|FG001|Overall Study|Not protocol specified|0|||
150028151|NCT01405768|541239131|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
150028152|NCT01405768|541239132|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
150028153|NCT00882440|541239135|FG000|Overall Study|Adverse Event|2|||
150028154|NCT00882440|541239136|FG001|Overall Study|Adverse Event|2|||
150028155|NCT00882440|541239137|FG002|Overall Study|Adverse Event|2|||
150028156|NCT00882440|541239138|FG003|Overall Study|Adverse Event|1|||
150028157|NCT00882440|541239139|FG004|Overall Study|Adverse Event|1|||
150028158|NCT00882440|541239140|FG005|Overall Study|Adverse Event|4|||
150028159|NCT00882440|541239141|FG006|Overall Study|Adverse Event|2|||
150028160|NCT00882440|541239135|FG000|Overall Study|Lack of Efficacy|3|||
150028161|NCT00882440|541239136|FG001|Overall Study|Lack of Efficacy|5|||
150028162|NCT00882440|541239137|FG002|Overall Study|Lack of Efficacy|2|||
150028163|NCT00882440|541239138|FG003|Overall Study|Lack of Efficacy|0|||
150028164|NCT00882440|541239139|FG004|Overall Study|Lack of Efficacy|0|||
150028165|NCT00882440|541239140|FG005|Overall Study|Lack of Efficacy|3|||
150028166|NCT00882440|541239141|FG006|Overall Study|Lack of Efficacy|0|||
150028167|NCT00882440|541239135|FG000|Overall Study|Lost to Follow-up|2|||
150028168|NCT00882440|541239136|FG001|Overall Study|Lost to Follow-up|0|||
150028169|NCT00882440|541239137|FG002|Overall Study|Lost to Follow-up|1|||
150028170|NCT00882440|541239138|FG003|Overall Study|Lost to Follow-up|1|||
150028171|NCT00882440|541239139|FG004|Overall Study|Lost to Follow-up|1|||
150028172|NCT00882440|541239140|FG005|Overall Study|Lost to Follow-up|0|||
150028173|NCT00882440|541239141|FG006|Overall Study|Lost to Follow-up|1|||
150028174|NCT00882440|541239135|FG000|Overall Study|Protocol Violation|0|||
150028175|NCT00882440|541239136|FG001|Overall Study|Protocol Violation|0|||
150028176|NCT00882440|541239137|FG002|Overall Study|Protocol Violation|1|||
150028177|NCT00882440|541239138|FG003|Overall Study|Protocol Violation|1|||
150028178|NCT00882440|541239139|FG004|Overall Study|Protocol Violation|1|||
150028179|NCT00882440|541239140|FG005|Overall Study|Protocol Violation|0|||
150028180|NCT00882440|541239141|FG006|Overall Study|Protocol Violation|0|||
150028181|NCT00882440|541239135|FG000|Overall Study|Withdrawal by Subject|2|||
150028182|NCT00882440|541239136|FG001|Overall Study|Withdrawal by Subject|1|||
150028183|NCT00882440|541239137|FG002|Overall Study|Withdrawal by Subject|1|||
150028184|NCT00882440|541239138|FG003|Overall Study|Withdrawal by Subject|0|||
150028185|NCT00882440|541239139|FG004|Overall Study|Withdrawal by Subject|6|||
150183255|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
150183256|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
150183257|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
150183258|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
150183259|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
150183260|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
150183261|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
150183262|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
150183263|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
150183264|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
150183265|NCT03271489|541808774|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
150183266|NCT03271489|541808775|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
150183267|NCT01467427|541808776|FG000|Overall Study|Withdrawal by Subject|1|||
150028186|NCT00882440|541239140|FG005|Overall Study|Withdrawal by Subject|0|||
150183268|NCT01467427|541808777|FG001|Overall Study|Withdrawal by Subject|0|||
150028187|NCT00882440|541239141|FG006|Overall Study|Withdrawal by Subject|1|||
150028188|NCT00882440|541239135|FG000|Overall Study|Patient Uncooperative|2|||
150028189|NCT00882440|541239136|FG001|Overall Study|Patient Uncooperative|0|||
150028190|NCT00882440|541239137|FG002|Overall Study|Patient Uncooperative|0|||
150028191|NCT00882440|541239138|FG003|Overall Study|Patient Uncooperative|0|||
150028192|NCT00882440|541239139|FG004|Overall Study|Patient Uncooperative|1|||
150028193|NCT00882440|541239140|FG005|Overall Study|Patient Uncooperative|0|||
150028194|NCT00882440|541239141|FG006|Overall Study|Patient Uncooperative|0|||
150028195|NCT01342913|541239142|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
150028196|NCT01342913|541239143|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150028197|NCT01342913|541239144|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
150028198|NCT01342913|541239142|FG000|2-week Run-in Period|Physician Decision|6|||
150028199|NCT01342913|541239143|FG001|2-week Run-in Period|Physician Decision|0|||
150028200|NCT01342913|541239144|FG002|2-week Run-in Period|Physician Decision|0|||
150028201|NCT01342913|541239142|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
150028202|NCT01342913|541239143|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
150028203|NCT01342913|541239144|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
150028204|NCT01342913|541239142|FG000|2-week Run-in Period|Adverse Event|2|||
150028205|NCT01342913|541239143|FG001|2-week Run-in Period|Adverse Event|0|||
150028206|NCT01342913|541239144|FG002|2-week Run-in Period|Adverse Event|0|||
150028207|NCT01342913|541239142|FG000|2-week Run-in Period|Protocol Violation|5|||
150028208|NCT01342913|541239143|FG001|2-week Run-in Period|Protocol Violation|0|||
150028209|NCT01342913|541239144|FG002|2-week Run-in Period|Protocol Violation|0|||
150028210|NCT01342913|541239142|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
150028211|NCT01342913|541239143|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
150028212|NCT01342913|541239144|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
150028213|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Adverse Event|0|||
150028214|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Adverse Event|3|||
150028215|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Adverse Event|6|||
150028216|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
150028217|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
150028218|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
150028219|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
150183269|NCT01467427|541808776|FG000|Overall Study|Not continuing in extension phase|0|||
150183270|NCT01467427|541808777|FG001|Overall Study|Not continuing in extension phase|2|||
150028220|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
150028221|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
150028222|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150028223|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
150028224|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
150028225|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Physician Decision|0|||
150028226|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Physician Decision|2|||
150028227|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Physician Decision|0|||
150028228|NCT01342913|541239142|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150183271|NCT01467427|541808776|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
150028229|NCT01342913|541239143|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
150183272|NCT01467427|541808777|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
150183273|NCT01467427|541808776|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
150183274|NCT01467427|541808777|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
150183275|NCT01467427|541808776|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
150183276|NCT01467427|541808777|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
150183277|NCT01467427|541808776|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
150183278|NCT01467427|541808777|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
150028230|NCT01342913|541239144|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
150028231|NCT01381016|541239146|FG000|Overall Study|Lost to Follow-up|1|||
150028232|NCT01381016|541239147|FG001|Overall Study|Lost to Follow-up|1|||
150028233|NCT01381016|541239146|FG000|Overall Study|Screen Failure|2|||
150028234|NCT01381016|541239147|FG001|Overall Study|Screen Failure|2|||
150028235|NCT01381016|541239146|FG000|Overall Study|Withdrawal by Subject|0|||
150028236|NCT01381016|541239147|FG001|Overall Study|Withdrawal by Subject|1|||
150028237|NCT01381016|541239146|FG000|Overall Study|Physician Decision|0|||
150028238|NCT01381016|541239147|FG001|Overall Study|Physician Decision|2|||
150028239|NCT05482308|541239148|FG000|Overall Study|Withdrawal by Subject|1|||
150028240|NCT05482308|541239149|FG001|Overall Study|Withdrawal by Subject|0|||
150028241|NCT05482308|541239148|FG000|Overall Study|No longer meets eligibility criteria|0|||
150028242|NCT05482308|541239149|FG001|Overall Study|No longer meets eligibility criteria|1|||
150028243|NCT04319198|541239150|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
150028244|NCT04319198|541239151|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
150028245|NCT04319198|541239152|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
150028246|NCT04319198|541239150|FG000|Overall Study|Death|0|||
150028247|NCT04319198|541239151|FG001|Overall Study|Death|3|||
150028248|NCT04319198|541239152|FG002|Overall Study|Death|3|||
150028249|NCT04319198|541239150|FG000|Overall Study|Reason Not Specified|0|||
150028250|NCT04319198|541239151|FG001|Overall Study|Reason Not Specified|2|||
150028251|NCT04319198|541239152|FG002|Overall Study|Reason Not Specified|4|||
150028252|NCT04319198|541239150|FG000|Overall Study|Withdrawal of Consent|0|||
150028253|NCT04319198|541239151|FG001|Overall Study|Withdrawal of Consent|0|||
150028254|NCT04319198|541239152|FG002|Overall Study|Withdrawal of Consent|5|||
150028255|NCT04319198|541239150|FG000|Overall Study|Site Terminated by Sponsor|0|||
150028256|NCT04319198|541239151|FG001|Overall Study|Site Terminated by Sponsor|1|||
150028257|NCT04319198|541239152|FG002|Overall Study|Site Terminated by Sponsor|0|||
150028258|NCT05801991|541239161|FG000|Overall Study|Lost to Follow-up|1|||
150028259|NCT05801991|541239162|FG001|Overall Study|Lost to Follow-up|0|||
150028260|NCT01451723|541239164|FG000|Overall Study|study halted|6|||
150028261|NCT01451723|541239165|FG001|Overall Study|study halted|5|||
150028262|NCT01631435|541239168|FG000|Overall Study|Adverse Event|2|||
150028263|NCT01631435|541239168|FG000|Overall Study|Withdrawal by Subject|2|||
150028264|NCT01631435|541239168|FG000|Overall Study|incomplete study procedure|5|||
150028265|NCT01421017|541239169|FG000|Overall Study|Withdrawal by Subject|2|||
150028266|NCT01421017|541239170|FG001|Overall Study|Withdrawal by Subject|0|||
150028267|NCT01421017|541239171|FG002|Overall Study|Withdrawal by Subject|0|||
150028268|NCT01421017|541239169|FG000|Overall Study|POD|0|||
150028269|NCT01421017|541239170|FG001|Overall Study|POD|6|||
150028270|NCT01421017|541239171|FG002|Overall Study|POD|3|||
150028271|NCT00833040|541239172|FG000|Overall Study|Adverse Event|0|||
150028272|NCT00833040|541239173|FG001|Overall Study|Adverse Event|0|||
150028273|NCT00833040|541239174|FG002|Overall Study|Adverse Event|0|||
150028274|NCT00833040|541239175|FG003|Overall Study|Adverse Event|0|||
150028275|NCT00833040|541239176|FG004|Overall Study|Adverse Event|0|||
150028276|NCT00833040|541239177|FG005|Overall Study|Adverse Event|1|||
150028277|NCT02313766|541239178|FG000|Overall Study|surgery cancelled|1|||
150028278|NCT02313766|541239179|FG001|Overall Study|surgery cancelled|0|||
150183279|NCT06061081|541808778|FG000|Overall Study|Withdrawal by Subject|1|||
150183280|NCT06061081|541808779|FG001|Overall Study|Withdrawal by Subject|0|||
150183281|NCT06061081|541808780|FG002|Overall Study|Withdrawal by Subject|0|||
150183282|NCT06061081|541808781|FG003|Overall Study|Withdrawal by Subject|0|||
150183283|NCT06061081|541808782|FG004|Overall Study|Withdrawal by Subject|0|||
150183284|NCT02252172|541808783|FG000|Overall Study|Lost to Follow-up|9|||
150183285|NCT02252172|541808784|FG001|Overall Study|Lost to Follow-up|6|||
150028279|NCT02313766|541239180|FG002|Overall Study|surgery cancelled|0|||
150028280|NCT02313766|541239178|FG000|Overall Study|Lost to Follow-up|0|||
150028281|NCT02313766|541239179|FG001|Overall Study|Lost to Follow-up|2|||
150028282|NCT02313766|541239180|FG002|Overall Study|Lost to Follow-up|0|||
150028283|NCT02313766|541239178|FG000|Overall Study|Adverse Event|0|||
150028284|NCT02313766|541239179|FG001|Overall Study|Adverse Event|1|||
150028285|NCT02313766|541239180|FG002|Overall Study|Adverse Event|0|||
150028286|NCT00416624|541239186|FG000|Overall Study|Withdrawal by Subject|1|||
150028287|NCT00416624|541239187|FG001|Overall Study|Withdrawal by Subject|6|||
150028288|NCT00416624|541239188|FG002|Overall Study|Withdrawal by Subject|4|||
150028289|NCT00416624|541239189|FG003|Overall Study|Withdrawal by Subject|9|||
150028290|NCT00416624|541239186|FG000|Overall Study|Death|4|||
150028291|NCT00416624|541239187|FG001|Overall Study|Death|7|||
150028292|NCT00416624|541239188|FG002|Overall Study|Death|7|||
150028293|NCT00416624|541239189|FG003|Overall Study|Death|1|||
150028294|NCT00416624|541239186|FG000|Overall Study|Adverse Event|8|||
150028295|NCT00416624|541239187|FG001|Overall Study|Adverse Event|3|||
150028296|NCT00416624|541239188|FG002|Overall Study|Adverse Event|2|||
150028297|NCT00416624|541239189|FG003|Overall Study|Adverse Event|2|||
150028298|NCT00416624|541239186|FG000|Overall Study|Other|8|||
150028299|NCT00416624|541239187|FG001|Overall Study|Other|11|||
150028300|NCT00416624|541239188|FG002|Overall Study|Other|5|||
150028301|NCT00416624|541239189|FG003|Overall Study|Other|5|||
150028302|NCT00416624|541239186|FG000|Overall Study|Cancel|1|||
150028303|NCT00416624|541239187|FG001|Overall Study|Cancel|0|||
150028304|NCT00416624|541239188|FG002|Overall Study|Cancel|0|||
150028305|NCT00416624|541239189|FG003|Overall Study|Cancel|0|||
150028306|NCT03489863|541239191|FG000|Overall Study|Withdrawal by Subject|0|||
150028307|NCT03489863|541239192|FG001|Overall Study|Withdrawal by Subject|1|||
150028308|NCT01005251|541239193|FG000|Overall Study|Withdrawal by Subject|2|||
150028309|NCT01005251|541239194|FG001|Overall Study|Withdrawal by Subject|5|||
150028310|NCT01005251|541239195|FG002|Overall Study|Withdrawal by Subject|3|||
150028311|NCT01005251|541239196|FG003|Overall Study|Withdrawal by Subject|4|||
150028312|NCT01005251|541239197|FG004|Overall Study|Withdrawal by Subject|9|||
150028313|NCT01005251|541239193|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
150085409|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Death|0|||
150028314|NCT01005251|541239194|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150085410|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Death|0|||
150028315|NCT01005251|541239195|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
150028316|NCT01005251|541239196|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
150028317|NCT01005251|541239197|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
150028318|NCT01005251|541239193|FG000|Overall Study|Adverse Event|2|||
150028319|NCT01005251|541239194|FG001|Overall Study|Adverse Event|6|||
150028320|NCT01005251|541239195|FG002|Overall Study|Adverse Event|8|||
150028321|NCT01005251|541239196|FG003|Overall Study|Adverse Event|5|||
150028322|NCT01005251|541239197|FG004|Overall Study|Adverse Event|4|||
150028323|NCT01005251|541239193|FG000|Overall Study|Protocol Violation|1|||
150028324|NCT01005251|541239194|FG001|Overall Study|Protocol Violation|0|||
150028325|NCT01005251|541239195|FG002|Overall Study|Protocol Violation|0|||
150028326|NCT01005251|541239196|FG003|Overall Study|Protocol Violation|0|||
150028327|NCT01005251|541239197|FG004|Overall Study|Protocol Violation|2|||
150028328|NCT01005251|541239193|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
150028329|NCT01005251|541239194|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
150028330|NCT01005251|541239195|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
150028331|NCT01005251|541239196|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
150028332|NCT01005251|541239197|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
150028333|NCT01005251|541239193|FG000|Overall Study|Lost to Follow-up|1|||
150028334|NCT01005251|541239194|FG001|Overall Study|Lost to Follow-up|4|||
150028335|NCT01005251|541239195|FG002|Overall Study|Lost to Follow-up|2|||
150028336|NCT01005251|541239196|FG003|Overall Study|Lost to Follow-up|0|||
150028337|NCT01005251|541239197|FG004|Overall Study|Lost to Follow-up|0|||
150028338|NCT01005251|541239193|FG000|Overall Study|Physician Decision|0|||
150028339|NCT01005251|541239194|FG001|Overall Study|Physician Decision|0|||
150028340|NCT01005251|541239195|FG002|Overall Study|Physician Decision|0|||
150028341|NCT01005251|541239196|FG003|Overall Study|Physician Decision|0|||
150028342|NCT01005251|541239197|FG004|Overall Study|Physician Decision|2|||
150028343|NCT01005251|541239193|FG000|Overall Study|Patient moved|1|||
150028344|NCT01005251|541239194|FG001|Overall Study|Patient moved|0|||
150028345|NCT01005251|541239195|FG002|Overall Study|Patient moved|0|||
150028346|NCT01005251|541239196|FG003|Overall Study|Patient moved|0|||
150028347|NCT01005251|541239197|FG004|Overall Study|Patient moved|0|||
150028348|NCT01005251|541239193|FG000|Overall Study|Wrong drug dispensed|0|||
150028349|NCT01005251|541239194|FG001|Overall Study|Wrong drug dispensed|1|||
150028350|NCT01005251|541239195|FG002|Overall Study|Wrong drug dispensed|0|||
150028351|NCT01005251|541239196|FG003|Overall Study|Wrong drug dispensed|0|||
150028352|NCT01005251|541239197|FG004|Overall Study|Wrong drug dispensed|0|||
150028353|NCT01005251|541239193|FG000|Overall Study|Randomized in error|0|||
150028354|NCT01005251|541239194|FG001|Overall Study|Randomized in error|0|||
150028355|NCT01005251|541239195|FG002|Overall Study|Randomized in error|1|||
150028356|NCT01005251|541239196|FG003|Overall Study|Randomized in error|1|||
150028357|NCT01005251|541239197|FG004|Overall Study|Randomized in error|0|||
150028358|NCT01005251|541239193|FG000|Overall Study|Lack of Efficacy|0|||
150028359|NCT01005251|541239194|FG001|Overall Study|Lack of Efficacy|0|||
150028360|NCT01005251|541239195|FG002|Overall Study|Lack of Efficacy|1|||
150028361|NCT01005251|541239196|FG003|Overall Study|Lack of Efficacy|1|||
150028362|NCT01005251|541239197|FG004|Overall Study|Lack of Efficacy|0|||
150028363|NCT00962208|541239199|FG000|Overall Study|Could not achieve good vision|9|||
150028364|NCT00962208|541239200|FG001|Overall Study|Could not achieve good vision|0|||
150028365|NCT00962208|541239199|FG000|Overall Study|Contraindicated to continue study|5|||
150028366|NCT00962208|541239200|FG001|Overall Study|Contraindicated to continue study|1|||
150028367|NCT00962208|541239199|FG000|Overall Study|Lost to Follow-up|0|||
150028368|NCT00962208|541239200|FG001|Overall Study|Lost to Follow-up|9|||
150028369|NCT00657540|541239201|FG000|Overall Study|Lost to Follow-up|1|||
150028370|NCT00657540|541239202|FG001|Overall Study|Lost to Follow-up|4|||
150028371|NCT00141453|541239203|FG000|Overall Study|Protocol Violation|6|||
150028372|NCT00141453|541239204|FG001|Overall Study|Protocol Violation|5|||
150028373|NCT04245111|541239207|FG000|Overall Study|Lost to Follow-up|5|||
150028374|NCT04245111|541239208|FG001|Overall Study|Lost to Follow-up|1|||
150028375|NCT04245111|541239209|FG002|Overall Study|Lost to Follow-up|1|||
150028376|NCT02792231|541239218|FG000|Overall Study|Patient/guardian decision|32|||
150028377|NCT02792231|541239219|FG001|Overall Study|Patient/guardian decision|42|||
150028378|NCT02792231|541239218|FG000|Overall Study|Adverse Event|15|||
150028379|NCT02792231|541239219|FG001|Overall Study|Adverse Event|11|||
150028380|NCT02792231|541239218|FG000|Overall Study|Physician Decision|14|||
150028381|NCT02792231|541239219|FG001|Overall Study|Physician Decision|12|||
150028382|NCT02792231|541239218|FG000|Overall Study|Lack of Efficacy|7|||
150028383|NCT02792231|541239219|FG001|Overall Study|Lack of Efficacy|9|||
150028384|NCT02792231|541239218|FG000|Overall Study|Lost to Follow-up|9|||
150028385|NCT02792231|541239219|FG001|Overall Study|Lost to Follow-up|5|||
150028386|NCT02792231|541239218|FG000|Overall Study|Pregnancy|1|||
150028387|NCT02792231|541239219|FG001|Overall Study|Pregnancy|3|||
150028388|NCT02792231|541239218|FG000|Overall Study|Non-compliance with study treatment|2|||
150028389|NCT02792231|541239219|FG001|Overall Study|Non-compliance with study treatment|1|||
150028390|NCT02792231|541239218|FG000|Overall Study|Protocol deviation|2|||
150028391|NCT02792231|541239219|FG001|Overall Study|Protocol deviation|0|||
150028392|NCT02792231|541239218|FG000|Overall Study|Technical problems|0|||
150028393|NCT02792231|541239219|FG001|Overall Study|Technical problems|1|||
150028394|NCT05196828|541239220|FG000|Overall Study|Withdrawal by Subject|2|||
150028395|NCT05196828|541239221|FG001|Overall Study|Withdrawal by Subject|0|||
150028396|NCT05196828|541239220|FG000|Overall Study|Lost to Follow-up|0|||
150028397|NCT05196828|541239221|FG001|Overall Study|Lost to Follow-up|4|||
150028398|NCT05196828|541239220|FG000|Overall Study|Adverse Event|1|||
150028399|NCT05196828|541239221|FG001|Overall Study|Adverse Event|0|||
150028400|NCT00473434|541239222|FG000|Overall Study|Physician Decision|3|||
150028401|NCT00473434|541239222|FG000|Overall Study|Withdrawal by Subject|9|||
150028402|NCT00473434|541239222|FG000|Overall Study|Compliance|3|||
150028403|NCT00473434|541239222|FG000|Overall Study|Lack of Efficacy|3|||
150028404|NCT00473434|541239222|FG000|Overall Study|Adverse Event|3|||
150028405|NCT00473434|541239222|FG000|Overall Study|Patient was selling medication to others|1|||
150028406|NCT00473434|541239222|FG000|Overall Study|Safety evaluation|1|||
150028407|NCT00473434|541239222|FG000|Overall Study|Reason not specified|6|||
150028408|NCT00473434|541239222|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
150028409|NCT00473434|541239222|FG000|Overall Study|Switching to trial medication|1|||
150085411|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Death|0|||
150085412|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Death|0|||
150085413|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Death|0|||
150085414|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Death|0|||
150085415|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085416|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085417|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
150085418|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
150085419|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
150085420|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
150085421|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
150085422|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085423|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085424|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085425|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085426|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085427|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085428|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085429|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085430|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085431|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085432|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085433|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085434|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085435|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085436|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085437|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085438|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085439|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085440|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
150085441|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085442|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085443|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
150085444|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085445|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085446|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085447|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085448|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085449|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085450|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085451|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085452|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085453|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085454|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085455|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085456|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085457|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085458|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085459|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085460|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085461|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085462|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085463|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085464|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085465|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085466|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
150085467|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085468|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085469|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
150085470|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085471|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085472|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085473|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085474|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150183286|NCT02252172|541808783|FG000|Overall Study|Death|218|||
150183287|NCT02252172|541808784|FG001|Overall Study|Death|175|||
150183288|NCT02252172|541808783|FG000|Overall Study|Withdrawal by Subject|20|||
150183289|NCT02252172|541808784|FG001|Overall Study|Withdrawal by Subject|15|||
150183290|NCT02252172|541808783|FG000|Overall Study|Physician Decision|0|||
150183291|NCT02252172|541808784|FG001|Overall Study|Physician Decision|1|||
150183292|NCT02252172|541808783|FG000|Overall Study|End of data collection|122|||
150183293|NCT02252172|541808784|FG001|Overall Study|End of data collection|170|||
150183294|NCT02252172|541808783|FG000|Overall Study|Site closure|0|||
150183295|NCT02252172|541808784|FG001|Overall Study|Site closure|1|||
150183296|NCT05575076|541808785|FG000|Overall Study|Adverse Event|24|||
150183297|NCT05575076|541808785|FG000|Overall Study|Death|7|||
150183298|NCT05575076|541808785|FG000|Overall Study|Lost to Follow-up|16|||
150183299|NCT05575076|541808785|FG000|Overall Study|Non-Compliance|3|||
150183300|NCT05575076|541808785|FG000|Overall Study|Physician Decision|6|||
150183301|NCT05575076|541808785|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
150183302|NCT05575076|541808785|FG000|Overall Study|Withdrawal by Subject|71|||
150183303|NCT05575076|541808785|FG000|Overall Study|Study Terminated by Sponsor|630|||
150183304|NCT05575076|541808785|FG000|Overall Study|Other|17|||
150183305|NCT03380390|541808786|FG000|Overall Study|Adverse Event|3|||
150183306|NCT02886286|541808787|FG000|Overall Study|pump motor stall|0|||
150183307|NCT02886286|541808788|FG001|Overall Study|pump motor stall|1|||
150183308|NCT01127373|541808789|FG000|Overall Study|Not Treated|3|||
150183309|NCT01127373|541808789|FG000|Overall Study|Lost to Follow-up|7|||
150183310|NCT01127373|541808789|FG000|Overall Study|Withdrawal by Subject|1|||
150183311|NCT01127373|541808789|FG000|Overall Study|Disease progression|1|||
150183312|NCT01017146|541808794|FG000|Overall Study|Adverse Event|11|||
150183313|NCT01017146|541808795|FG001|Overall Study|Adverse Event|1|||
150183314|NCT01017146|541808794|FG000|Overall Study|Lost to Follow-up|14|||
150183315|NCT01017146|541808795|FG001|Overall Study|Lost to Follow-up|14|||
150183316|NCT01017146|541808794|FG000|Overall Study|Noncompliance with Study Product|1|||
150183317|NCT01017146|541808795|FG001|Overall Study|Noncompliance with Study Product|1|||
150183318|NCT01017146|541808794|FG000|Overall Study|Withdrawal by Subject|32|||
150183319|NCT01017146|541808795|FG001|Overall Study|Withdrawal by Subject|16|||
150085475|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085476|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085477|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085478|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085479|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085480|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085481|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085482|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085483|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085484|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085485|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085486|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085487|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085488|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085489|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085490|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085491|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150183320|NCT01017146|541808794|FG000|Overall Study|Relocation|0|||
150183321|NCT01017146|541808795|FG001|Overall Study|Relocation|4|||
150183322|NCT01017146|541808794|FG000|Overall Study|Pregnancy|2|||
150183323|NCT01017146|541808795|FG001|Overall Study|Pregnancy|1|||
150183324|NCT01017146|541808794|FG000|Overall Study|Protocol Violation|2|||
150183325|NCT01017146|541808795|FG001|Overall Study|Protocol Violation|0|||
150183326|NCT01017146|541808794|FG000|Overall Study|Took Excluded Medication|2|||
150183327|NCT01017146|541808795|FG001|Overall Study|Took Excluded Medication|0|||
150085492|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
150085493|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085494|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085495|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
150085496|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085497|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085498|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085499|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085500|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085501|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085502|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085503|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085504|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150183328|NCT01017146|541808794|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
150183329|NCT01017146|541808795|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
150085505|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085506|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085507|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085508|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085509|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085510|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150183330|NCT01017146|541808794|FG000|Overall Study|Change in Work Situation|1|||
150183331|NCT01017146|541808795|FG001|Overall Study|Change in Work Situation|0|||
150183332|NCT00087139|541808796|FG000|Overall Study|Adverse Event|18|||
150183333|NCT00087139|541808797|FG001|Overall Study|Adverse Event|17|||
150183334|NCT00087139|541808798|FG002|Overall Study|Adverse Event|13|||
150183335|NCT00087139|541808796|FG000|Overall Study|Death|2|||
150183336|NCT00087139|541808797|FG001|Overall Study|Death|1|||
150183337|NCT00087139|541808798|FG002|Overall Study|Death|0|||
150183338|NCT00087139|541808796|FG000|Overall Study|Withdrawal by Subject|3|||
150183339|NCT00087139|541808797|FG001|Overall Study|Withdrawal by Subject|2|||
150183340|NCT00087139|541808798|FG002|Overall Study|Withdrawal by Subject|2|||
150183341|NCT00087139|541808796|FG000|Overall Study|Physician Decision|1|||
150183342|NCT00087139|541808797|FG001|Overall Study|Physician Decision|1|||
150183343|NCT00087139|541808798|FG002|Overall Study|Physician Decision|1|||
150183344|NCT00087139|541808796|FG000|Overall Study|Disease progression|9|||
150183345|NCT00087139|541808797|FG001|Overall Study|Disease progression|19|||
150183346|NCT00087139|541808798|FG002|Overall Study|Disease progression|12|||
150183347|NCT00087139|541808796|FG000|Overall Study|Ineligible|4|||
150183348|NCT00087139|541808797|FG001|Overall Study|Ineligible|7|||
150183349|NCT00087139|541808798|FG002|Overall Study|Ineligible|4|||
150183350|NCT00087139|541808796|FG000|Overall Study|Symptomatic deterioration|1|||
150183351|NCT00087139|541808797|FG001|Overall Study|Symptomatic deterioration|1|||
150183352|NCT00087139|541808798|FG002|Overall Study|Symptomatic deterioration|3|||
150183353|NCT00087139|541808796|FG000|Overall Study|Use of coumadin|1|||
150183354|NCT00087139|541808797|FG001|Overall Study|Use of coumadin|0|||
150183355|NCT00087139|541808798|FG002|Overall Study|Use of coumadin|0|||
150183356|NCT00087139|541808796|FG000|Overall Study|Response achieved|0|||
150183357|NCT00087139|541808797|FG001|Overall Study|Response achieved|1|||
150183358|NCT00087139|541808798|FG002|Overall Study|Response achieved|0|||
150183359|NCT00087139|541808796|FG000|Overall Study|Extradural disease|0|||
150183360|NCT00087139|541808797|FG001|Overall Study|Extradural disease|0|||
150183361|NCT00087139|541808798|FG002|Overall Study|Extradural disease|1|||
150183362|NCT00976495|541808799|FG000|Overall Study|Withdrawal by Subject|0|||
150183363|NCT00976495|541808800|FG001|Overall Study|Withdrawal by Subject|1|||
150183364|NCT00976495|541808801|FG002|Overall Study|Withdrawal by Subject|0|||
150183365|NCT02272816|541808802|FG000|Overall Study|Adverse Event|1|||
150183366|NCT04154384|541808803|FG000|Overall Study|Lost to Follow-up|24|||
150183367|NCT04154384|541808804|FG001|Overall Study|Lost to Follow-up|33|||
150183368|NCT04154384|541808805|FG002|Overall Study|Lost to Follow-up|0|||
150183369|NCT04154384|541808803|FG000|Overall Study|Withdrawal by Subject|7|||
150183370|NCT04154384|541808804|FG001|Overall Study|Withdrawal by Subject|18|||
150183371|NCT04154384|541808805|FG002|Overall Study|Withdrawal by Subject|0|||
150183372|NCT04154384|541808803|FG000|Overall Study|Missing outcome data|1|||
150183373|NCT04154384|541808804|FG001|Overall Study|Missing outcome data|0|||
150183374|NCT04154384|541808805|FG002|Overall Study|Missing outcome data|0|||
150183375|NCT01136876|541808806|FG000|Overall Study|Lost to Follow-up|0|||
150183376|NCT01136876|541808807|FG001|Overall Study|Lost to Follow-up|1|||
150183377|NCT01136876|541808806|FG000|Overall Study|Physician Decision|3|||
150085511|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085512|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085513|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085514|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085515|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085516|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085517|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085518|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
150085519|NCT03129100|541453676|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085520|NCT03129100|541453677|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085521|NCT03129100|541453678|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085522|NCT03129100|541453679|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085523|NCT03129100|541453680|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
150085524|NCT03129100|541453681|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
150085525|NCT03129100|541453682|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
150085526|NCT03129100|541453683|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085527|NCT03129100|541453684|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085528|NCT03129100|541453685|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150183378|NCT01136876|541808807|FG001|Overall Study|Physician Decision|5|||
150183379|NCT01136876|541808806|FG000|Overall Study|Missing NGAL measurement|2|||
150183380|NCT01136876|541808807|FG001|Overall Study|Missing NGAL measurement|5|||
150183381|NCT05321069|541808808|FG000|Overall Study|Adverse Event|52|||
150183382|NCT05321069|541808809|FG001|Overall Study|Adverse Event|52|||
150183383|NCT05321069|541808810|FG002|Overall Study|Adverse Event|64|||
150183384|NCT05321069|541808808|FG000|Overall Study|Protocol Violation|1|||
150183385|NCT05321069|541808809|FG001|Overall Study|Protocol Violation|1|||
150028410|NCT00473434|541239222|FG000|Overall Study|No longer required|1|||
150028411|NCT00423657|541239223|FG000|Overall Study|Withdrew consent|10|||
150028412|NCT00423657|541239224|FG001|Overall Study|Withdrew consent|8|||
150028413|NCT00423657|541239223|FG000|Overall Study|Non-compliance|0|||
150028414|NCT00423657|541239224|FG001|Overall Study|Non-compliance|1|||
150028415|NCT00423657|541239223|FG000|Overall Study|Other|15|||
150028416|NCT00423657|541239224|FG001|Overall Study|Other|16|||
150028417|NCT00423657|541239223|FG000|Overall Study|Request of sponsor/investigator|1|||
150028418|NCT00423657|541239224|FG001|Overall Study|Request of sponsor/investigator|0|||
150028419|NCT02422498|541239225|FG000|Overall Study|Inevaluable|4|||
150028420|NCT02653326|541239226|FG000|Overall Study|Lost to Follow-up|10|||
150028421|NCT02653326|541239227|FG001|Overall Study|Lost to Follow-up|7|||
150028422|NCT03206216|541239231|FG000|Overall Study|Withdrawal by Subject|0|||
150028423|NCT03206216|541239232|FG001|Overall Study|Withdrawal by Subject|1|||
150028424|NCT00657046|541239233|FG000|Overall Study|Adverse Event|1|||
150028425|NCT00657046|541239234|FG001|Overall Study|Adverse Event|1|||
150028426|NCT00657046|541239235|FG002|Overall Study|Adverse Event|0|||
150028427|NCT00657046|541239233|FG000|Overall Study|Protocol Violation|2|||
150028428|NCT00657046|541239234|FG001|Overall Study|Protocol Violation|2|||
150028429|NCT00657046|541239235|FG002|Overall Study|Protocol Violation|0|||
150028430|NCT00657046|541239233|FG000|Overall Study|Withdrawal by Subject|1|||
150028431|NCT00657046|541239234|FG001|Overall Study|Withdrawal by Subject|0|||
150028432|NCT00657046|541239235|FG002|Overall Study|Withdrawal by Subject|0|||
150028433|NCT00657046|541239233|FG000|Overall Study|Death|0|||
150028434|NCT00657046|541239234|FG001|Overall Study|Death|0|||
150028435|NCT00657046|541239235|FG002|Overall Study|Death|1|||
150028436|NCT00657046|541239233|FG000|Overall Study|Surgery|0|||
150028437|NCT00657046|541239234|FG001|Overall Study|Surgery|0|||
150028438|NCT00657046|541239235|FG002|Overall Study|Surgery|1|||
150028439|NCT00499681|541239241|FG000|Overall Study|toxicity|0|||
150028440|NCT00499681|541239242|FG001|Overall Study|toxicity|1|||
150085529|NCT03129100|541453686|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085530|NCT03129100|541453687|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085531|NCT03129100|541453688|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085532|NCT03129100|541453689|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085533|NCT03129100|541453690|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085534|NCT03129100|541453691|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085535|NCT03129100|541453692|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085536|NCT03129100|541453693|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085537|NCT03129100|541453694|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085538|NCT03129100|541453695|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085539|NCT03129100|541453696|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085540|NCT03129100|541453697|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085541|NCT03129100|541453698|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085542|NCT03129100|541453699|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085543|NCT03129100|541453700|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085544|NCT03129100|541453701|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
150085545|NCT03129100|541453676|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085546|NCT03129100|541453677|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085547|NCT03129100|541453678|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085548|NCT03129100|541453679|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085549|NCT03129100|541453680|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085550|NCT03129100|541453681|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085551|NCT03129100|541453682|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085552|NCT03129100|541453683|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085553|NCT03129100|541453684|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085554|NCT03129100|541453685|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
150183386|NCT05321069|541808810|FG002|Overall Study|Protocol Violation|0|||
150028441|NCT00499681|541239241|FG000|Overall Study|disease progression|0|||
150028442|NCT00499681|541239242|FG001|Overall Study|disease progression|1|||
150028443|NCT00739401|541239243|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
150028444|NCT00739401|541239243|FG000|Overall Study|Death|3|||
150028445|NCT00739401|541239243|FG000|Overall Study|Withdrawal by Subject|4|||
150028446|NCT04575155|541239244|FG000|2 Month|Withdrawal by Subject|1|||
150028447|NCT04575155|541239245|FG001|2 Month|Withdrawal by Subject|1|||
150028448|NCT04575155|541239244|FG000|2 Month|Lost to Follow-up|5|||
150028449|NCT04575155|541239245|FG001|2 Month|Lost to Follow-up|3|||
150028450|NCT04575155|541239244|FG000|2 Month|Ineligible|1|||
150028451|NCT04575155|541239245|FG001|2 Month|Ineligible|0|||
150028452|NCT03915717|541239248|FG000|Overall Study|EchoMark Not Implanted|6|||
150028453|NCT01239381|541239250|FG000|Overall Study|Protocol Violation|1|||
150028454|NCT01239381|541239250|FG000|Overall Study|Withdrawal by Subject|1|||
150028455|NCT06237049|541239251|FG000|Overall Study|Death|0|||
150028456|NCT06237049|541239252|FG001|Overall Study|Death|0|||
150028457|NCT06237049|541239253|FG002|Overall Study|Death|0|||
150028458|NCT06237049|541239254|FG003|Overall Study|Death|1|||
150028459|NCT06237049|541239251|FG000|Overall Study|Lost to Follow-up|11|||
150028460|NCT06237049|541239252|FG001|Overall Study|Lost to Follow-up|5|||
150028461|NCT06237049|541239253|FG002|Overall Study|Lost to Follow-up|8|||
150028462|NCT06237049|541239254|FG003|Overall Study|Lost to Follow-up|8|||
150028463|NCT06237049|541239251|FG000|Overall Study|Protocol Violation|0|||
150028464|NCT06237049|541239252|FG001|Overall Study|Protocol Violation|1|||
150028465|NCT06237049|541239253|FG002|Overall Study|Protocol Violation|0|||
150028466|NCT06237049|541239254|FG003|Overall Study|Protocol Violation|1|||
150028467|NCT06237049|541239251|FG000|Overall Study|Withdrawal by Subject|4|||
150028468|NCT06237049|541239252|FG001|Overall Study|Withdrawal by Subject|2|||
150028469|NCT06237049|541239253|FG002|Overall Study|Withdrawal by Subject|1|||
150028470|NCT06237049|541239254|FG003|Overall Study|Withdrawal by Subject|0|||
150028471|NCT03748823|541239255|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
150028472|NCT03748823|541239256|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
150028473|NCT03748823|541239255|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
150028474|NCT03748823|541239256|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
150028475|NCT03748823|541239255|FG000|Extension Period|Withdrawal by Subject|9|||
150028476|NCT03748823|541239256|FG001|Extension Period|Withdrawal by Subject|12|||
150028477|NCT03748823|541239255|FG000|Extension Period|Death|2|||
150028478|NCT03748823|541239256|FG001|Extension Period|Death|2|||
150028479|NCT03748823|541239255|FG000|Extension Period|Other than Specified|0|||
150028480|NCT03748823|541239256|FG001|Extension Period|Other than Specified|1|||
150028481|NCT03748823|541239255|FG000|Extension Period|Protocol Violation|1|||
150028482|NCT03748823|541239256|FG001|Extension Period|Protocol Violation|0|||
150028483|NCT03748823|541239255|FG000|Extension Period|Lost to Follow-up|0|||
150028484|NCT03748823|541239256|FG001|Extension Period|Lost to Follow-up|1|||
150028485|NCT03748823|541239255|FG000|Extension Period|Lack of Efficacy|0|||
150028486|NCT03748823|541239256|FG001|Extension Period|Lack of Efficacy|1|||
150028487|NCT03748823|541239255|FG000|Extension Period|Physician Decision|1|||
150028488|NCT03748823|541239256|FG001|Extension Period|Physician Decision|2|||
150028489|NCT02525471|541239257|FG000|Overall Study|Screen Failure|6|||
150028490|NCT02525471|541239257|FG000|Overall Study|Withdrawal by Subject|4|||
150028491|NCT02525471|541239257|FG000|Overall Study|Death|1|||
150028492|NCT04678115|541239258|FG000|Overall Study|Lost to Follow-up|1|||
150028493|NCT04678115|541239259|FG001|Overall Study|Lost to Follow-up|0|||
150028494|NCT02738008|541239260|FG000|Overall Study|Study Terminated by Sponsor|1|||
150028495|NCT02738008|541239261|FG001|Overall Study|Study Terminated by Sponsor|5|||
150028496|NCT02738008|541239262|FG002|Overall Study|Study Terminated by Sponsor|3|||
150028497|NCT02738008|541239260|FG000|Overall Study|Adverse Event|0|||
150028498|NCT02738008|541239261|FG001|Overall Study|Adverse Event|1|||
150028499|NCT02738008|541239262|FG002|Overall Study|Adverse Event|2|||
150028500|NCT04486235|541239263|FG000|Overall Study|Pregnancy|1|||
150028501|NCT04486235|541239264|FG001|Overall Study|Pregnancy|0|||
150028502|NCT04486235|541239263|FG000|Overall Study|Lost to Follow-up|1|||
150028503|NCT04486235|541239264|FG001|Overall Study|Lost to Follow-up|0|||
150028504|NCT04590014|541239265|FG000|Overall Study|Withdrawal by Subject|1|||
150028505|NCT04590014|541239266|FG001|Overall Study|Withdrawal by Subject|0|||
150028506|NCT03935126|541239267|FG000|Overall Study|Study termination by sponsor|3|||
150028507|NCT00982735|541239268|FG000|Overall Study|Lost to Follow-up|6|||
150028508|NCT00982735|541239268|FG000|Overall Study|Patient ineligible for trial|224|||
150028509|NCT01091675|541239269|FG000|Overall Study|Adverse Event|7|||
150028510|NCT01091675|541239269|FG000|Overall Study|Lack of Efficacy|27|||
150028511|NCT00948064|541240836|FG000|Phase I|No treatment received|1|||
150028512|NCT00948064|541240837|FG001|Phase I|No treatment received|0|||
150028513|NCT00948064|541240838|FG002|Phase I|No treatment received|0|||
150028514|NCT00948064|541240836|FG000|Phase II|Physician Decision|0|||
150028515|NCT00948064|541240837|FG001|Phase II|Physician Decision|0|||
150028516|NCT00948064|541240838|FG002|Phase II|Physician Decision|1|||
150028517|NCT00948064|541240836|FG000|Phase II|Withdrawal by Subject|0|||
150028518|NCT00948064|541240837|FG001|Phase II|Withdrawal by Subject|1|||
150028519|NCT00948064|541240838|FG002|Phase II|Withdrawal by Subject|0|||
150028520|NCT02426580|541240842|FG000|Overall Study|Death|2|||
150028521|NCT02426580|541240843|FG001|Overall Study|Death|2|||
150028522|NCT02426580|541240842|FG000|Overall Study|Lost to Follow-up|0|||
150028523|NCT02426580|541240843|FG001|Overall Study|Lost to Follow-up|9|||
150028524|NCT02426580|541240842|FG000|Overall Study|transfer to hemodialysis|5|||
150028525|NCT02426580|541240843|FG001|Overall Study|transfer to hemodialysis|5|||
150028526|NCT02426580|541240842|FG000|Overall Study|Kidney transplant|3|||
150028527|NCT02426580|541240843|FG001|Overall Study|Kidney transplant|0|||
150028528|NCT02426580|541240842|FG000|Overall Study|Allergic to egg white|1|||
150028529|NCT02426580|541240843|FG001|Overall Study|Allergic to egg white|0|||
150028530|NCT00383552|541240846|FG000|Overall Study|Adverse Event|7|||
150028531|NCT00383552|541240847|FG001|Overall Study|Adverse Event|6|||
150028532|NCT00383552|541240848|FG002|Overall Study|Adverse Event|9|||
150028533|NCT00383552|541240849|FG003|Overall Study|Adverse Event|6|||
150028534|NCT00383552|541240846|FG000|Overall Study|Lack of Efficacy|4|||
150028535|NCT00383552|541240847|FG001|Overall Study|Lack of Efficacy|13|||
150028536|NCT00383552|541240848|FG002|Overall Study|Lack of Efficacy|29|||
150028537|NCT00383552|541240849|FG003|Overall Study|Lack of Efficacy|42|||
150028538|NCT00383552|541240846|FG000|Overall Study|Lost to Follow-up|0|||
150028539|NCT00383552|541240847|FG001|Overall Study|Lost to Follow-up|1|||
150028540|NCT00383552|541240848|FG002|Overall Study|Lost to Follow-up|5|||
150028541|NCT00383552|541240849|FG003|Overall Study|Lost to Follow-up|1|||
150028542|NCT00383552|541240846|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
150028543|NCT00383552|541240847|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
150028544|NCT00383552|541240848|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
150085555|NCT03129100|541453686|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150028545|NCT00383552|541240849|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
150028546|NCT00383552|541240846|FG000|Overall Study|Did not wish to continue (related)|1|||
150028547|NCT00383552|541240847|FG001|Overall Study|Did not wish to continue (related)|0|||
150028548|NCT00383552|541240848|FG002|Overall Study|Did not wish to continue (related)|2|||
150028549|NCT00383552|541240849|FG003|Overall Study|Did not wish to continue (related)|3|||
150028550|NCT00383552|541240846|FG000|Overall Study|Noncompliance with the protocol|11|||
150028551|NCT00383552|541240847|FG001|Overall Study|Noncompliance with the protocol|6|||
150028552|NCT00383552|541240848|FG002|Overall Study|Noncompliance with the protocol|8|||
150028553|NCT00383552|541240849|FG003|Overall Study|Noncompliance with the protocol|10|||
150028554|NCT00383552|541240846|FG000|Overall Study|Did not meet protocol eligibility|8|||
150028555|NCT00383552|541240847|FG001|Overall Study|Did not meet protocol eligibility|6|||
150028556|NCT00383552|541240848|FG002|Overall Study|Did not meet protocol eligibility|2|||
150028557|NCT00383552|541240849|FG003|Overall Study|Did not meet protocol eligibility|3|||
150028558|NCT00383552|541240846|FG000|Overall Study|Administrative|1|||
150028559|NCT00383552|541240847|FG001|Overall Study|Administrative|0|||
150028560|NCT00383552|541240848|FG002|Overall Study|Administrative|1|||
150028561|NCT00383552|541240849|FG003|Overall Study|Administrative|1|||
150028562|NCT03096834|541240850|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
150028563|NCT03096834|541240851|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
150028564|NCT03096834|541240852|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
150028565|NCT03096834|541240853|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
150028566|NCT03096834|541240850|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
150028567|NCT03096834|541240851|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
150028568|NCT03096834|541240852|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
150028569|NCT03096834|541240853|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
150028570|NCT03096834|541240850|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
150028571|NCT03096834|541240851|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
150028572|NCT03096834|541240852|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
150028573|NCT03096834|541240853|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
150028574|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
150028575|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
150028576|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
150028577|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
150028578|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
150028579|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
150028580|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
150028581|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
150028582|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
150028583|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
150028584|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
150028585|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
150028586|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
150028587|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
150085556|NCT03129100|541453687|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085557|NCT03129100|541453688|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085558|NCT03129100|541453689|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085559|NCT03129100|541453690|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085560|NCT03129100|541453691|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085561|NCT03129100|541453692|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150183387|NCT05321069|541808808|FG000|Overall Study|Withdrawal by Subject|23|||
150183388|NCT05321069|541808809|FG001|Overall Study|Withdrawal by Subject|18|||
150028588|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
150028589|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
150028590|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
150028591|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
150028592|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
150028593|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
150028594|NCT03096834|541240850|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
150028595|NCT03096834|541240851|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
150028596|NCT03096834|541240852|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
150028597|NCT03096834|541240853|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
150028598|NCT03096834|541240850|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
150028599|NCT03096834|541240851|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
150028600|NCT03096834|541240852|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
150028601|NCT03096834|541240853|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
150028602|NCT03096834|541240850|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
150028603|NCT03096834|541240851|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
150028604|NCT03096834|541240852|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
150028605|NCT03096834|541240853|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
150028606|NCT03096834|541240850|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
150183389|NCT05321069|541808810|FG002|Overall Study|Withdrawal by Subject|12|||
150183390|NCT05321069|541808808|FG000|Overall Study|Lost to Follow-up|1|||
150183391|NCT05321069|541808809|FG001|Overall Study|Lost to Follow-up|0|||
150183392|NCT05321069|541808810|FG002|Overall Study|Lost to Follow-up|1|||
150183393|NCT05321069|541808808|FG000|Overall Study|No reason stated by the participants|23|||
150183394|NCT05321069|541808809|FG001|Overall Study|No reason stated by the participants|22|||
150183395|NCT05321069|541808810|FG002|Overall Study|No reason stated by the participants|16|||
150183396|NCT05321069|541808808|FG000|Overall Study|Lack of Efficacy|1|||
150028607|NCT03096834|541240851|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
150028608|NCT03096834|541240852|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
150028609|NCT03096834|541240853|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
150028610|NCT00966654|541240854|FG000|Overall Study|Study was terminated,PI left institution|12|||
150028611|NCT01393158|541240857|FG000|Overall Study|Adverse Event|1|||
150183397|NCT05321069|541808809|FG001|Overall Study|Lack of Efficacy|1|||
150028612|NCT01393158|541240858|FG001|Overall Study|Adverse Event|0|||
150028613|NCT00762359|541240860|FG000|Overall Study|Adverse Event|20|||
150028614|NCT00762359|541240861|FG001|Overall Study|Adverse Event|23|||
150028615|NCT00762359|541240860|FG000|Overall Study|Protocol Violation|21|||
150028616|NCT00762359|541240861|FG001|Overall Study|Protocol Violation|13|||
150028617|NCT00762359|541240860|FG000|Overall Study|Withdrawal by Subject|13|||
150028618|NCT00762359|541240861|FG001|Overall Study|Withdrawal by Subject|10|||
150028619|NCT00762359|541240860|FG000|Overall Study|Lack of Efficacy|0|||
150028620|NCT00762359|541240861|FG001|Overall Study|Lack of Efficacy|4|||
150028621|NCT00762359|541240860|FG000|Overall Study|Institution closed|2|||
150028622|NCT00762359|541240861|FG001|Overall Study|Institution closed|3|||
150028623|NCT00762359|541240860|FG000|Overall Study|Physician Decision|2|||
150028624|NCT00762359|541240861|FG001|Overall Study|Physician Decision|3|||
150028625|NCT00762359|541240860|FG000|Overall Study|Removal|0|||
150028626|NCT00762359|541240861|FG001|Overall Study|Removal|1|||
150028627|NCT00762359|541240860|FG000|Overall Study|Withdrew consent|1|||
150085562|NCT03129100|541453693|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085563|NCT03129100|541453694|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085564|NCT03129100|541453695|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085565|NCT03129100|541453696|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085566|NCT03129100|541453697|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085567|NCT03129100|541453698|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085568|NCT03129100|541453699|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085569|NCT03129100|541453700|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085570|NCT03129100|541453701|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
150085571|NCT03129100|541453676|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085572|NCT03129100|541453677|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085573|NCT03129100|541453678|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085574|NCT03129100|541453679|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085575|NCT03129100|541453680|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150183398|NCT05321069|541808810|FG002|Overall Study|Lack of Efficacy|0|||
150183399|NCT02412748|541808813|FG000|Overall Study|Lost to Follow-up|38|||
150183400|NCT02412748|541808814|FG001|Overall Study|Lost to Follow-up|39|||
150028628|NCT00762359|541240861|FG001|Overall Study|Withdrew consent|0|||
150028629|NCT02891174|541240870|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
150028630|NCT02891174|541240871|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
150085576|NCT03129100|541453681|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085577|NCT03129100|541453682|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085578|NCT03129100|541453683|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085579|NCT03129100|541453684|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085580|NCT03129100|541453685|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085581|NCT03129100|541453686|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085582|NCT03129100|541453687|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
150085583|NCT03129100|541453688|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085584|NCT03129100|541453689|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085585|NCT03129100|541453690|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085586|NCT03129100|541453691|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085587|NCT03129100|541453692|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085588|NCT03129100|541453693|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085589|NCT03129100|541453694|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085590|NCT03129100|541453695|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085591|NCT03129100|541453696|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085592|NCT03129100|541453697|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085593|NCT03129100|541453698|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085594|NCT03129100|541453699|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085595|NCT03129100|541453700|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085596|NCT03129100|541453701|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
150085597|NCT03129100|541453676|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085598|NCT03129100|541453677|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085599|NCT03129100|541453678|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085600|NCT03129100|541453679|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085601|NCT03129100|541453680|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085602|NCT03129100|541453681|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085603|NCT03129100|541453682|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085604|NCT03129100|541453683|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085605|NCT03129100|541453684|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150183401|NCT04128319|541808815|FG000|Overall Study|Death|3|||
150028631|NCT02891174|541240870|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
150028632|NCT02891174|541240871|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
150028633|NCT02891174|541240870|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
150028634|NCT02891174|541240871|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
150028635|NCT02891174|541240870|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
150028636|NCT02891174|541240871|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
150028637|NCT02891174|541240870|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
150028638|NCT02891174|541240871|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
150028639|NCT02891174|541240870|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
150028640|NCT02891174|541240871|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
150028641|NCT02891174|541240870|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
150028642|NCT02891174|541240871|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
150028643|NCT01693029|541240872|FG000|Overall Study|Withdrawal by Subject|15|||
150028644|NCT01693029|541240873|FG001|Overall Study|Withdrawal by Subject|22|||
150028645|NCT01693029|541240872|FG000|Overall Study|Kidney transplantation|7|||
150028646|NCT01693029|541240873|FG001|Overall Study|Kidney transplantation|7|||
150028647|NCT01693029|541240872|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
150028648|NCT01693029|541240873|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
150028649|NCT01693029|541240872|FG000|Overall Study|Protocol Violation|6|||
150028650|NCT01693029|541240873|FG001|Overall Study|Protocol Violation|7|||
150028651|NCT01693029|541240872|FG000|Overall Study|Change in dialysis modality|2|||
150028652|NCT01693029|541240873|FG001|Overall Study|Change in dialysis modality|1|||
150028653|NCT01693029|541240872|FG000|Overall Study|Physician Decision|0|||
150028654|NCT01693029|541240873|FG001|Overall Study|Physician Decision|2|||
150028655|NCT01693029|541240872|FG000|Overall Study|Lost to Follow-up|0|||
150028656|NCT01693029|541240873|FG001|Overall Study|Lost to Follow-up|1|||
150028657|NCT01693029|541240872|FG000|Overall Study|Adverse Event|1|||
150028658|NCT01693029|541240873|FG001|Overall Study|Adverse Event|6|||
150028659|NCT01693029|541240872|FG000|Overall Study|Death|5|||
150028660|NCT01693029|541240873|FG001|Overall Study|Death|8|||
150028661|NCT01693029|541240872|FG000|Overall Study|Non-compliance|2|||
150028662|NCT01693029|541240873|FG001|Overall Study|Non-compliance|1|||
150028663|NCT01329263|541240874|FG000|Overall Study|Lost to Follow-up|4|||
150028664|NCT01329263|541240875|FG001|Overall Study|Lost to Follow-up|21|||
150028665|NCT01329263|541240874|FG000|Overall Study|Withdrawal by Subject|1|||
150028666|NCT01329263|541240875|FG001|Overall Study|Withdrawal by Subject|2|||
150028667|NCT00308139|541240877|FG000|Overall Study|Adverse Event|20|||
150028668|NCT00308139|541240878|FG001|Overall Study|Adverse Event|14|||
150028669|NCT00308139|541240877|FG000|Overall Study|Lost to Follow-up|13|||
150028670|NCT00308139|541240878|FG001|Overall Study|Lost to Follow-up|8|||
150028671|NCT00308139|541240877|FG000|Overall Study|Protocol Violation|3|||
150028672|NCT00308139|541240878|FG001|Overall Study|Protocol Violation|2|||
150028673|NCT00308139|541240877|FG000|Overall Study|Withdrawal of Consent|40|||
150028674|NCT00308139|541240878|FG001|Overall Study|Withdrawal of Consent|42|||
150028675|NCT00308139|541240877|FG000|Overall Study|Investigator Decision|11|||
150028676|NCT00308139|541240878|FG001|Overall Study|Investigator Decision|10|||
150028677|NCT00308139|541240877|FG000|Overall Study|Loss of Glucose Control|5|||
150028678|NCT00308139|541240878|FG001|Overall Study|Loss of Glucose Control|7|||
150183402|NCT02891915|541808818|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
150028679|NCT00308139|541240877|FG000|Overall Study|Administrative|1|||
150183403|NCT02891915|541808819|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
150028680|NCT00308139|541240878|FG001|Overall Study|Administrative|4|||
150028681|NCT00308139|541240877|FG000|Overall Study|Other|1|||
150028682|NCT00308139|541240878|FG001|Overall Study|Other|0|||
150028683|NCT02469623|541240882|FG000|Overall Study|Not consented for long-term follow-up|4|||
150028684|NCT02469623|541240882|FG000|Overall Study|Lost to Follow-up|4|||
150028685|NCT02469623|541240882|FG000|Overall Study|Withdrawal by Subject|2|||
150028686|NCT02469623|541240882|FG000|Overall Study|Death|3|||
150028687|NCT03309878|541240883|FG000|Overall Study|Adverse Event|1|||
150028688|NCT03309878|541240884|FG001|Overall Study|Adverse Event|0|||
150028689|NCT03309878|541240885|FG002|Overall Study|Adverse Event|0|||
150028690|NCT03309878|541240886|FG003|Overall Study|Adverse Event|0|||
150028691|NCT03309878|541240883|FG000|Overall Study|Did not maintain eligibility|2|||
150028692|NCT03309878|541240884|FG001|Overall Study|Did not maintain eligibility|1|||
150028693|NCT03309878|541240885|FG002|Overall Study|Did not maintain eligibility|0|||
150028694|NCT03309878|541240886|FG003|Overall Study|Did not maintain eligibility|0|||
150028695|NCT03309878|541240883|FG000|Overall Study|Withdrawal by Subject|0|||
150028696|NCT03309878|541240884|FG001|Overall Study|Withdrawal by Subject|1|||
150028697|NCT03309878|541240885|FG002|Overall Study|Withdrawal by Subject|0|||
150028698|NCT03309878|541240886|FG003|Overall Study|Withdrawal by Subject|0|||
150028699|NCT01096316|541240887|FG000|Overall Study|Lost to Follow-up|15|||
150028700|NCT01096316|541240888|FG001|Overall Study|Lost to Follow-up|9|||
150028701|NCT01884077|541240889|FG000|Overall Study|screen fail|0|||
150028702|NCT01884077|541240890|FG001|Overall Study|screen fail|2|||
150028703|NCT01884077|541240889|FG000|Overall Study|canceled surgery|2|||
150028704|NCT01884077|541240890|FG001|Overall Study|canceled surgery|0|||
150028705|NCT01884077|541240889|FG000|Overall Study|Lost to Follow-up|0|||
150028706|NCT01884077|541240890|FG001|Overall Study|Lost to Follow-up|4|||
150028707|NCT01884077|541240889|FG000|Overall Study|study closed|6|||
150028708|NCT01884077|541240890|FG001|Overall Study|study closed|4|||
150028709|NCT02836652|541240891|FG000|Overall Study|Death|3|||
150028710|NCT02836652|541240892|FG001|Overall Study|Death|3|||
150028711|NCT02836652|541240891|FG000|Overall Study|Transplant/Explant|3|||
150183404|NCT02891915|541808818|FG000|Overall Study|Withdrawal by Subject|3|||
150183405|NCT02891915|541808819|FG001|Overall Study|Withdrawal by Subject|3|||
150183406|NCT02891915|541808818|FG000|Overall Study|Became Ineligible After Enrollment|2|||
150183407|NCT02891915|541808819|FG001|Overall Study|Became Ineligible After Enrollment|1|||
150183408|NCT02891915|541808818|FG000|Overall Study|Lost to Follow-up|1|||
150183409|NCT02891915|541808819|FG001|Overall Study|Lost to Follow-up|4|||
150183410|NCT02891915|541808818|FG000|Overall Study|Physician Decision|1|||
150183411|NCT02891915|541808819|FG001|Overall Study|Physician Decision|0|||
150183412|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
150183413|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
150183414|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
150183415|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
150183416|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
150183417|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
150183418|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
150183419|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
150183420|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
150183421|NCT03939312|541808822|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
150183422|NCT03939312|541808822|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
150183423|NCT03939312|541808822|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
150183424|NCT03481816|541808824|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
150183425|NCT03481816|541808825|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
150183426|NCT03481816|541808824|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
150183427|NCT03481816|541808825|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
150183428|NCT03481816|541808824|FG000|Dose Expansion|Withdrawal by Subject|0|||
150183429|NCT03481816|541808825|FG001|Dose Expansion|Withdrawal by Subject|2|||
150183430|NCT03481816|541808824|FG000|Dose Expansion|Physician Decision|0|||
150183431|NCT03481816|541808825|FG001|Dose Expansion|Physician Decision|5|||
150183432|NCT02730871|541808828|FG000|Overall Study|Adverse Event|6|||
150183433|NCT02730871|541808829|FG001|Overall Study|Adverse Event|0|||
150183434|NCT05368558|541808830|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
150183435|NCT05368558|541808831|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
150183436|NCT05368558|541808832|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
150183437|NCT05368558|541808833|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150028712|NCT02836652|541240892|FG001|Overall Study|Transplant/Explant|4|||
150028713|NCT02836652|541240891|FG000|Overall Study|Withdrawn|9|||
150028714|NCT02836652|541240892|FG001|Overall Study|Withdrawn|9|||
150028715|NCT02836652|541240891|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
150028716|NCT02836652|541240892|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
150028717|NCT02648204|541240894|FG000|Overall Study|Withdrawal by Subject|12|||
150028718|NCT02648204|541240895|FG001|Overall Study|Withdrawal by Subject|8|||
150028719|NCT02648204|541240896|FG002|Overall Study|Withdrawal by Subject|2|||
150183438|NCT05368558|541808834|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150028720|NCT02648204|541240897|FG003|Overall Study|Withdrawal by Subject|6|||
150028721|NCT02648204|541240894|FG000|Overall Study|Lost to Follow-up|5|||
150028722|NCT02648204|541240895|FG001|Overall Study|Lost to Follow-up|8|||
150028723|NCT02648204|541240896|FG002|Overall Study|Lost to Follow-up|4|||
150028724|NCT02648204|541240897|FG003|Overall Study|Lost to Follow-up|6|||
150028725|NCT02648204|541240894|FG000|Overall Study|Missing follow-up information|4|||
150028726|NCT02648204|541240895|FG001|Overall Study|Missing follow-up information|4|||
150028727|NCT02648204|541240896|FG002|Overall Study|Missing follow-up information|4|||
150028728|NCT02648204|541240897|FG003|Overall Study|Missing follow-up information|2|||
150028729|NCT02648204|541240894|FG000|Overall Study|Death|1|||
150028730|NCT02648204|541240895|FG001|Overall Study|Death|1|||
150028731|NCT02648204|541240896|FG002|Overall Study|Death|2|||
150028732|NCT02648204|541240897|FG003|Overall Study|Death|2|||
150183439|NCT05368558|541808835|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183440|NCT05368558|541808836|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183441|NCT05368558|541808837|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183442|NCT05368558|541808838|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183443|NCT05368558|541808839|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183444|NCT05368558|541808840|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183445|NCT05368558|541808841|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
150183446|NCT05368558|541808830|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183447|NCT05368558|541808831|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183448|NCT05368558|541808832|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183449|NCT05368558|541808833|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
150183450|NCT05368558|541808834|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183451|NCT05368558|541808835|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
150183452|NCT05368558|541808836|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183453|NCT05368558|541808837|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183454|NCT05368558|541808838|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183455|NCT05368558|541808839|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183456|NCT05368558|541808840|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183457|NCT05368558|541808841|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
150183458|NCT05368558|541808830|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183459|NCT05368558|541808831|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183460|NCT05368558|541808832|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183461|NCT05368558|541808833|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
150183462|NCT05368558|541808834|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183463|NCT05368558|541808835|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183464|NCT05368558|541808836|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183465|NCT05368558|541808837|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183466|NCT05368558|541808838|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183467|NCT05368558|541808839|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183468|NCT05368558|541808840|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183469|NCT05368558|541808841|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
150183470|NCT05368558|541808830|FG000|Blinded Extension Period (BEP)|other|0|||
150183471|NCT05368558|541808831|FG001|Blinded Extension Period (BEP)|other|0|||
150183472|NCT05368558|541808832|FG002|Blinded Extension Period (BEP)|other|0|||
150183473|NCT05368558|541808833|FG003|Blinded Extension Period (BEP)|other|0|||
150183474|NCT05368558|541808834|FG004|Blinded Extension Period (BEP)|other|0|||
150183475|NCT05368558|541808835|FG005|Blinded Extension Period (BEP)|other|1|||
150183476|NCT05368558|541808836|FG006|Blinded Extension Period (BEP)|other|0|||
150183477|NCT05368558|541808837|FG007|Blinded Extension Period (BEP)|other|0|||
150183478|NCT05368558|541808838|FG008|Blinded Extension Period (BEP)|other|0|||
150183479|NCT05368558|541808839|FG009|Blinded Extension Period (BEP)|other|0|||
150183480|NCT05368558|541808840|FG010|Blinded Extension Period (BEP)|other|0|||
150183481|NCT05368558|541808841|FG011|Blinded Extension Period (BEP)|other|0|||
150255196|NCT01639560|542070592|FG000|Overall Study|Withdrawal by Subject|9|||
150255197|NCT01639560|542070593|FG001|Overall Study|Withdrawal by Subject|14|||
150255198|NCT01639560|542070592|FG000|Overall Study|Lack of Efficacy|1|||
150255199|NCT01639560|542070593|FG001|Overall Study|Lack of Efficacy|2|||
150255200|NCT01639560|542070592|FG000|Overall Study|Lost to Follow-up|9|||
150255201|NCT01639560|542070593|FG001|Overall Study|Lost to Follow-up|11|||
150255202|NCT01639560|542070592|FG000|Overall Study|Adverse Event|0|||
150255203|NCT01639560|542070593|FG001|Overall Study|Adverse Event|2|||
150028733|NCT02648204|541240894|FG000|Overall Study|Adverse Event|0|||
150028734|NCT02648204|541240895|FG001|Overall Study|Adverse Event|0|||
150028735|NCT02648204|541240896|FG002|Overall Study|Adverse Event|1|||
150028736|NCT02648204|541240897|FG003|Overall Study|Adverse Event|0|||
150028737|NCT01008943|541240901|FG000|Overall Study|Withdrawal by Subject|1|||
150028738|NCT02356159|541240902|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
150028739|NCT02356159|541240903|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
150028740|NCT02356159|541240904|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
150028741|NCT02356159|541240905|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
150028742|NCT02356159|541240906|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
150028743|NCT02356159|541240907|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
150028744|NCT00861705|541240908|FG000|Overall Study|Never Began Treatment|7|||
150028745|NCT00861705|541240909|FG001|Overall Study|Never Began Treatment|3|||
150028746|NCT00861705|541240910|FG002|Overall Study|Never Began Treatment|0|||
150028747|NCT00861705|541240911|FG003|Overall Study|Never Began Treatment|1|||
150028748|NCT06418152|541240912|FG000|Overall Study|Frequent DBS setting changes|1|||
150028749|NCT06418152|541240912|FG000|Overall Study|Withdrawal by Subject|2|||
150028750|NCT05789745|541240913|FG000|Overall Study|Withdrawal by Subject|0|||
150028751|NCT05789745|541240914|FG001|Overall Study|Withdrawal by Subject|0|||
150028752|NCT05789745|541240915|FG002|Overall Study|Withdrawal by Subject|0|||
150028753|NCT05789745|541240916|FG003|Overall Study|Withdrawal by Subject|0|||
150028754|NCT05789745|541240917|FG004|Overall Study|Withdrawal by Subject|1|||
150028755|NCT02055898|541240920|FG000|First Intervention (5 Days)|Physician Decision|2|||
150028756|NCT02055898|541240921|FG001|First Intervention (5 Days)|Physician Decision|0|||
150028757|NCT02055898|541240920|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
150028758|NCT02055898|541240921|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
150028759|NCT00718510|541240923|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
150028760|NCT00718510|541240924|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
150028761|NCT00718510|541240923|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
150028762|NCT00718510|541240924|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
150028763|NCT02201524|541240925|FG000|Overall Study|Adverse Event|0|||
150028764|NCT02201524|541240926|FG001|Overall Study|Adverse Event|2|||
150028765|NCT02201524|541240927|FG002|Overall Study|Adverse Event|1|||
150028766|NCT02201524|541240928|FG003|Overall Study|Adverse Event|0|||
150028767|NCT02201524|541240925|FG000|Overall Study|Insufficient clinical response|1|||
150028768|NCT02201524|541240926|FG001|Overall Study|Insufficient clinical response|0|||
150028769|NCT02201524|541240927|FG002|Overall Study|Insufficient clinical response|0|||
150028770|NCT02201524|541240928|FG003|Overall Study|Insufficient clinical response|0|||
150028771|NCT02201524|541240925|FG000|Overall Study|Lost to Follow-up|0|||
150028772|NCT02201524|541240926|FG001|Overall Study|Lost to Follow-up|0|||
150028773|NCT02201524|541240927|FG002|Overall Study|Lost to Follow-up|2|||
150028774|NCT02201524|541240928|FG003|Overall Study|Lost to Follow-up|0|||
150028775|NCT02201524|541240925|FG000|Overall Study|No longer meets eligibility criteria|0|||
150028776|NCT02201524|541240926|FG001|Overall Study|No longer meets eligibility criteria|0|||
150028777|NCT02201524|541240927|FG002|Overall Study|No longer meets eligibility criteria|0|||
150028778|NCT02201524|541240928|FG003|Overall Study|No longer meets eligibility criteria|2|||
150028779|NCT02201524|541240925|FG000|Overall Study|Protocol Violation|0|||
150028780|NCT02201524|541240926|FG001|Overall Study|Protocol Violation|0|||
150028781|NCT02201524|541240927|FG002|Overall Study|Protocol Violation|0|||
150028782|NCT02201524|541240928|FG003|Overall Study|Protocol Violation|1|||
150028783|NCT02201524|541240925|FG000|Overall Study|Withdrawal by Subject|0|||
150085606|NCT03129100|541453685|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085607|NCT03129100|541453686|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085608|NCT03129100|541453687|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
150085609|NCT03129100|541453688|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
150085610|NCT03129100|541453689|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
150085611|NCT03129100|541453690|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
150085612|NCT03129100|541453691|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085613|NCT03129100|541453692|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150028784|NCT02201524|541240926|FG001|Overall Study|Withdrawal by Subject|0|||
150183482|NCT04994509|541808842|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
150183483|NCT04994509|541808843|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
150183484|NCT04994509|541808844|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
150183485|NCT04994509|541808842|FG000|Overall Study|Withdrew Consent|73|||
150183486|NCT04994509|541808843|FG001|Overall Study|Withdrew Consent|72|||
150183487|NCT04994509|541808844|FG002|Overall Study|Withdrew Consent|46|||
150183488|NCT04994509|541808842|FG000|Overall Study|Lost to Follow-up|39|||
150028785|NCT02201524|541240927|FG002|Overall Study|Withdrawal by Subject|1|||
150028786|NCT02201524|541240928|FG003|Overall Study|Withdrawal by Subject|1|||
150085614|NCT03129100|541453693|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085615|NCT03129100|541453694|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085616|NCT03129100|541453695|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085617|NCT03129100|541453696|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085618|NCT03129100|541453697|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085619|NCT03129100|541453698|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085620|NCT03129100|541453699|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085621|NCT03129100|541453700|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085622|NCT03129100|541453701|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
150085623|NCT03129100|541453676|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085624|NCT03129100|541453677|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085625|NCT03129100|541453678|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085626|NCT03129100|541453679|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085627|NCT03129100|541453680|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085628|NCT03129100|541453681|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085629|NCT03129100|541453682|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085630|NCT03129100|541453683|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085631|NCT03129100|541453684|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085632|NCT03129100|541453685|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085633|NCT03129100|541453686|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085634|NCT03129100|541453687|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
150085635|NCT03129100|541453688|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085636|NCT03129100|541453689|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
150085637|NCT03129100|541453690|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
150085638|NCT03129100|541453691|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085639|NCT03129100|541453692|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085640|NCT03129100|541453693|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085641|NCT03129100|541453694|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085642|NCT03129100|541453695|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085643|NCT03129100|541453696|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085644|NCT03129100|541453697|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085645|NCT03129100|541453698|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085646|NCT03129100|541453699|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085647|NCT03129100|541453700|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085648|NCT03129100|541453701|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
150085649|NCT03129100|541453676|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085650|NCT03129100|541453677|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085651|NCT03129100|541453678|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085652|NCT03129100|541453679|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085653|NCT03129100|541453680|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085654|NCT03129100|541453681|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085655|NCT03129100|541453682|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085656|NCT03129100|541453683|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085657|NCT03129100|541453684|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085658|NCT03129100|541453685|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085659|NCT03129100|541453686|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085660|NCT03129100|541453687|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085661|NCT03129100|541453688|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085662|NCT03129100|541453689|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085663|NCT03129100|541453690|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085664|NCT03129100|541453691|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
150085665|NCT03129100|541453692|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085666|NCT03129100|541453693|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085667|NCT03129100|541453694|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085668|NCT03129100|541453695|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085669|NCT03129100|541453696|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085670|NCT03129100|541453697|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085671|NCT03129100|541453698|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085672|NCT03129100|541453699|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085673|NCT03129100|541453700|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085674|NCT03129100|541453701|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
150085675|NCT03129100|541453676|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085676|NCT03129100|541453677|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150183489|NCT04994509|541808843|FG001|Overall Study|Lost to Follow-up|36|||
150085677|NCT03129100|541453678|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085678|NCT03129100|541453679|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085679|NCT03129100|541453680|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085680|NCT03129100|541453681|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085681|NCT03129100|541453682|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085682|NCT03129100|541453683|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085683|NCT03129100|541453684|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085684|NCT03129100|541453685|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085685|NCT03129100|541453686|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085686|NCT03129100|541453687|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085687|NCT03129100|541453688|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
150085688|NCT03129100|541453689|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085689|NCT03129100|541453690|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
150085690|NCT03129100|541453691|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
150085691|NCT03129100|541453692|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085692|NCT03129100|541453693|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085693|NCT03129100|541453694|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085694|NCT03129100|541453695|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085695|NCT03129100|541453696|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085696|NCT03129100|541453697|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085697|NCT03129100|541453698|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085698|NCT03129100|541453699|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085699|NCT03129100|541453700|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085700|NCT03129100|541453701|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
150085701|NCT03129100|541453676|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085702|NCT03129100|541453677|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085703|NCT03129100|541453678|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085704|NCT03129100|541453679|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085705|NCT03129100|541453680|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085706|NCT03129100|541453681|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085707|NCT03129100|541453682|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085708|NCT03129100|541453683|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085709|NCT03129100|541453684|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085710|NCT03129100|541453685|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085711|NCT03129100|541453686|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085712|NCT03129100|541453687|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085713|NCT03129100|541453688|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085714|NCT03129100|541453689|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150183490|NCT04994509|541808844|FG002|Overall Study|Lost to Follow-up|26|||
150183491|NCT04994509|541808842|FG000|Overall Study|HIV-1 Infection|4|||
150085715|NCT03129100|541453690|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085716|NCT03129100|541453691|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085717|NCT03129100|541453692|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085718|NCT03129100|541453693|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
150085719|NCT03129100|541453694|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085720|NCT03129100|541453695|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
150085721|NCT03129100|541453696|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085722|NCT03129100|541453697|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085723|NCT03129100|541453698|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085724|NCT03129100|541453699|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085725|NCT03129100|541453700|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085726|NCT03129100|541453701|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
150085727|NCT03129100|541453676|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085728|NCT03129100|541453677|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085729|NCT03129100|541453678|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085730|NCT03129100|541453679|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085731|NCT03129100|541453680|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085732|NCT03129100|541453681|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085733|NCT03129100|541453682|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085734|NCT03129100|541453683|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085735|NCT03129100|541453684|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085736|NCT03129100|541453685|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085737|NCT03129100|541453686|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085738|NCT03129100|541453687|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085739|NCT03129100|541453688|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085740|NCT03129100|541453689|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085741|NCT03129100|541453690|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085742|NCT03129100|541453691|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085743|NCT03129100|541453692|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085744|NCT03129100|541453693|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085745|NCT03129100|541453694|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085746|NCT03129100|541453695|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085747|NCT03129100|541453696|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
150085748|NCT03129100|541453697|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085749|NCT03129100|541453698|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085750|NCT03129100|541453699|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085751|NCT03129100|541453700|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085752|NCT03129100|541453701|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
150085753|NCT03129100|541453676|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
150085754|NCT03129100|541453677|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
150085755|NCT03129100|541453678|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
150085756|NCT03129100|541453679|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
150085757|NCT03129100|541453680|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
150085758|NCT03129100|541453681|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
150085759|NCT03129100|541453682|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
150085760|NCT03129100|541453683|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
150085761|NCT03129100|541453684|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
150085762|NCT03129100|541453685|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
150085763|NCT03129100|541453686|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
150085764|NCT03129100|541453687|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
150085765|NCT03129100|541453688|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
150085766|NCT03129100|541453689|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
150085767|NCT03129100|541453690|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
150085768|NCT03129100|541453691|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
150085769|NCT03129100|541453692|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
150085770|NCT03129100|541453693|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
150085771|NCT03129100|541453694|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
150085772|NCT03129100|541453695|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
150085773|NCT03129100|541453696|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
150085774|NCT03129100|541453697|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
150085775|NCT03129100|541453698|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
150085776|NCT03129100|541453699|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
150085777|NCT03129100|541453700|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
150085778|NCT03129100|541453701|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
150085779|NCT03129100|541453676|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085780|NCT03129100|541453677|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085781|NCT03129100|541453678|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085782|NCT03129100|541453679|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085783|NCT03129100|541453680|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085784|NCT03129100|541453681|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085785|NCT03129100|541453682|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085786|NCT03129100|541453683|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085787|NCT03129100|541453684|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085788|NCT03129100|541453685|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085789|NCT03129100|541453686|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085790|NCT03129100|541453687|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085791|NCT03129100|541453688|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085792|NCT03129100|541453689|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085793|NCT03129100|541453690|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085794|NCT03129100|541453691|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085795|NCT03129100|541453692|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085796|NCT03129100|541453693|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085797|NCT03129100|541453694|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085798|NCT03129100|541453695|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085799|NCT03129100|541453696|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
150085800|NCT03129100|541453697|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085801|NCT03129100|541453698|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085802|NCT03129100|541453699|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085803|NCT03129100|541453700|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150085804|NCT03129100|541453701|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
150183492|NCT04994509|541808843|FG001|Overall Study|HIV-1 Infection|20|||
150085805|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
150085806|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
150085807|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
150085808|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
150085809|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
150085810|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
150085811|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
150085812|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
150085813|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
150085814|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
150085815|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
150085816|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
150085817|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
150085818|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
150085819|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
150085820|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
150085821|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
150085822|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
150085823|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
150085824|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
150085825|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
150085826|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
150085827|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
150085828|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
150085829|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
150085830|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
150085831|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085832|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085833|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085834|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085835|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085836|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085837|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085838|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085839|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085840|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085841|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085842|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150183493|NCT04994509|541808844|FG002|Overall Study|HIV-1 Infection|12|||
150183494|NCT04994509|541808842|FG000|Overall Study|Investigator's Discretion|9|||
150183495|NCT04994509|541808843|FG001|Overall Study|Investigator's Discretion|8|||
150028787|NCT02201524|541240925|FG000|Overall Study|Other|1|||
150028788|NCT02201524|541240926|FG001|Overall Study|Other|1|||
150028789|NCT02201524|541240927|FG002|Overall Study|Other|0|||
150028790|NCT02201524|541240928|FG003|Overall Study|Other|0|||
150028791|NCT02314052|541240929|FG000|Cycle One|Adverse Event|0|||
150028792|NCT02314052|541240930|FG001|Cycle One|Adverse Event|0|||
150028793|NCT02314052|541240931|FG002|Cycle One|Adverse Event|0|||
150028794|NCT02314052|541240932|FG003|Cycle One|Adverse Event|1|||
150028795|NCT02314052|541240933|FG004|Cycle One|Adverse Event|0|||
150028796|NCT02314052|541240934|FG005|Cycle One|Adverse Event|0|||
150028797|NCT01960140|541240938|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
150028798|NCT04551989|541240939|FG000|Overall Study|Adverse Event|4|||
150028799|NCT04551989|541240939|FG000|Overall Study|Protocol Violation|3|||
150028800|NCT04551989|541240939|FG000|Overall Study|Lost to Follow-up|1|||
150028801|NCT04551989|541240939|FG000|Overall Study|Physician Decision|3|||
150028802|NCT02694744|541240940|FG000|Overall Study|Adverse Event|2|||
150028803|NCT02694744|541240941|FG001|Overall Study|Adverse Event|1|||
150028804|NCT02694744|541240940|FG000|Overall Study|Withdrawal by Subject|2|||
150028805|NCT02694744|541240941|FG001|Overall Study|Withdrawal by Subject|1|||
150028806|NCT02694744|541240940|FG000|Overall Study|Physician Decision|1|||
150028807|NCT02694744|541240941|FG001|Overall Study|Physician Decision|2|||
150028808|NCT02694744|541240940|FG000|Overall Study|Lost to Follow-up|1|||
150028809|NCT02694744|541240941|FG001|Overall Study|Lost to Follow-up|0|||
150028810|NCT02694744|541240940|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
150028811|NCT02694744|541240941|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
150028812|NCT00686777|541240942|FG000|Overall Study|Adverse Event|2|||
150028813|NCT00686777|541240942|FG000|Overall Study|Pregnancy|1|||
150028814|NCT00686777|541240942|FG000|Overall Study|Withdrawal by Subject|2|||
150028815|NCT00686777|541240942|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
150028816|NCT00686777|541240942|FG000|Overall Study|No Visit|1|||
150028817|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
150028818|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
150028819|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Disease progression|75|||
150028820|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Disease progression|59|||
150028821|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Adverse Event|16|||
150028822|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Adverse Event|16|||
150028823|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Death|2|||
150028824|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Death|3|||
150028825|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
150028826|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
150028827|NCT00883779|541240943|FG000|Primary Study Treatment Phase|Other|3|||
150028828|NCT00883779|541240944|FG001|Primary Study Treatment Phase|Other|0|||
150028829|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Adverse Event|2|||
150028830|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Adverse Event|3|||
150028831|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Death|1|||
150028832|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Death|3|||
150028833|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
150028834|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
150028835|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
150028836|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
150028837|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Disease progression|103|||
150028838|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Disease progression|122|||
150028839|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Other|3|||
150028840|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Other|0|||
150183496|NCT04994509|541808844|FG002|Overall Study|Investigator's Discretion|11|||
150085843|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085844|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085845|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085846|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085847|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085848|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085849|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085850|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085851|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085852|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085853|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150255204|NCT01631227|542070595|FG000|Overall Study|withdrawn consent|27|||
150255205|NCT01631227|542070596|FG001|Overall Study|withdrawn consent|21|||
150255206|NCT01631227|542070595|FG000|Overall Study|Adverse Event|1|||
150255207|NCT01631227|542070596|FG001|Overall Study|Adverse Event|0|||
150255208|NCT01631227|542070595|FG000|Overall Study|administrative|2|||
150255209|NCT01631227|542070596|FG001|Overall Study|administrative|1|||
150255210|NCT00766363|542070597|FG000|Overall Study|Withdrawal by Subject|1|||
150255211|NCT00766363|542070598|FG001|Overall Study|Withdrawal by Subject|0|||
150255212|NCT00766363|542070599|FG002|Overall Study|Withdrawal by Subject|0|||
150255213|NCT00766363|542070600|FG003|Overall Study|Withdrawal by Subject|0|||
150255214|NCT00766363|542070597|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
150255215|NCT00766363|542070598|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
150255216|NCT00766363|542070599|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
150255217|NCT00766363|542070600|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
150255218|NCT03292432|542070601|FG000|Overall Study|Lost to Follow-up|11|||
150255219|NCT03292432|542070602|FG001|Overall Study|Lost to Follow-up|8|||
150255220|NCT03292432|542070601|FG000|Overall Study|Death|2|||
150255221|NCT03292432|542070602|FG001|Overall Study|Death|1|||
150255222|NCT03292432|542070601|FG000|Overall Study|Withdrawal by Subject|1|||
150255223|NCT03292432|542070602|FG001|Overall Study|Withdrawal by Subject|2|||
150255224|NCT03292432|542070601|FG000|Overall Study|Site closed before any data collected|1|||
150255225|NCT03292432|542070602|FG001|Overall Study|Site closed before any data collected|0|||
150255226|NCT03020576|542070603|FG000|Overall Study|Withdrawal by Subject|1|||
150255227|NCT03020576|542070604|FG001|Overall Study|Withdrawal by Subject|2|||
150255228|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
150255229|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
150255230|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
150255231|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
150255232|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
150255233|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
150255234|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
150255235|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
150255236|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
150255237|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
150255238|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
150255239|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
150255240|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
150255241|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
150255242|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
150255243|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
150255244|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
150255245|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
150255246|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
150255247|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
150255248|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
150255249|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
150255250|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
150255251|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
150255252|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
150255253|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
150255254|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
150255255|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
150255256|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
150255257|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
150085854|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
150085855|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
150085856|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
150085857|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085858|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085859|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085860|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085861|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085862|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085863|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085864|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085865|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085866|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085867|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085868|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085869|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085870|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085871|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085872|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085873|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085874|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085875|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085876|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085877|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085878|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085879|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
150085880|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
150085881|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
150085882|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
150085883|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085884|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085885|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085886|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085887|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085888|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085889|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085890|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085891|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085892|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085893|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085894|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085895|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085896|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085897|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085898|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085899|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085900|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085901|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085902|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085903|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085904|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085905|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085906|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085907|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
150085908|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
150085909|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085910|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085911|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085912|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085913|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150183497|NCT04994509|541808842|FG000|Overall Study|Randomized but Never Treated|10|||
150183498|NCT04994509|541808843|FG001|Overall Study|Randomized but Never Treated|10|||
150183499|NCT04994509|541808844|FG002|Overall Study|Randomized but Never Treated|3|||
150183500|NCT04994509|541808842|FG000|Overall Study|Pregnancy|5|||
150183501|NCT04994509|541808843|FG001|Overall Study|Pregnancy|5|||
150183502|NCT04994509|541808844|FG002|Overall Study|Pregnancy|0|||
150183503|NCT04994509|541808842|FG000|Overall Study|Death|0|||
150183504|NCT04994509|541808843|FG001|Overall Study|Death|5|||
150183505|NCT04994509|541808844|FG002|Overall Study|Death|0|||
150183506|NCT04994509|541808842|FG000|Overall Study|Adverse Event|2|||
150183507|NCT04994509|541808843|FG001|Overall Study|Adverse Event|1|||
150183508|NCT04994509|541808844|FG002|Overall Study|Adverse Event|0|||
150183509|NCT04994509|541808842|FG000|Overall Study|Non-compliance With Study Drug|1|||
150183510|NCT04994509|541808843|FG001|Overall Study|Non-compliance With Study Drug|1|||
150183511|NCT04994509|541808844|FG002|Overall Study|Non-compliance With Study Drug|1|||
150183512|NCT04994509|541808842|FG000|Overall Study|Withdrew Assent|3|||
150183513|NCT04994509|541808843|FG001|Overall Study|Withdrew Assent|0|||
150183514|NCT04994509|541808844|FG002|Overall Study|Withdrew Assent|0|||
150183515|NCT04994509|541808842|FG000|Overall Study|Protocol Violation|1|||
150183516|NCT04994509|541808843|FG001|Overall Study|Protocol Violation|0|||
150183517|NCT04994509|541808844|FG002|Overall Study|Protocol Violation|0|||
150183518|NCT04402294|541808845|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
150183519|NCT04402294|541808846|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
150183520|NCT04402294|541808845|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
150183521|NCT04402294|541808846|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
150183522|NCT04459416|541810604|FG000|Overall Study|Lost to Follow-up|2|||
150183523|NCT04459416|541810605|FG001|Overall Study|Lost to Follow-up|0|||
150183524|NCT04459416|541810604|FG000|Overall Study|Withdrawal by Subject|8|||
150183525|NCT04459416|541810605|FG001|Overall Study|Withdrawal by Subject|10|||
150183526|NCT04459416|541810604|FG000|Overall Study|Disease progression|0|||
150183527|NCT04459416|541810605|FG001|Overall Study|Disease progression|3|||
150183528|NCT03744312|541810606|FG000|Overall Study|Withdrawal by Subject|0|||
150183529|NCT03744312|541810607|FG001|Overall Study|Withdrawal by Subject|1|||
150183530|NCT03744312|541810606|FG000|Overall Study|Screen fail|0|||
150183531|NCT03744312|541810607|FG001|Overall Study|Screen fail|1|||
150183532|NCT04579380|541810608|FG000|Overall Study|Death|9|||
150183533|NCT04579380|541810609|FG001|Overall Study|Death|22|||
150183534|NCT04579380|541810610|FG002|Overall Study|Death|22|||
150183535|NCT04579380|541810611|FG003|Overall Study|Death|17|||
150183536|NCT04579380|541810612|FG004|Overall Study|Death|6|||
150183537|NCT04579380|541810613|FG005|Overall Study|Death|21|||
150183538|NCT04579380|541810614|FG006|Overall Study|Death|10|||
150183539|NCT04579380|541810615|FG007|Overall Study|Death|11|||
150183540|NCT04579380|541810616|FG008|Overall Study|Death|25|||
150183541|NCT04579380|541810608|FG000|Overall Study|Withdrawal by Subject|0|||
150183542|NCT04579380|541810609|FG001|Overall Study|Withdrawal by Subject|3|||
150183543|NCT04579380|541810610|FG002|Overall Study|Withdrawal by Subject|4|||
150183544|NCT04579380|541810611|FG003|Overall Study|Withdrawal by Subject|0|||
150183545|NCT04579380|541810612|FG004|Overall Study|Withdrawal by Subject|1|||
150183546|NCT04579380|541810613|FG005|Overall Study|Withdrawal by Subject|2|||
150183547|NCT04579380|541810614|FG006|Overall Study|Withdrawal by Subject|0|||
150183548|NCT04579380|541810615|FG007|Overall Study|Withdrawal by Subject|1|||
150183549|NCT04579380|541810616|FG008|Overall Study|Withdrawal by Subject|2|||
150183550|NCT04579380|541810608|FG000|Overall Study|Ongoing|2|||
150183551|NCT04579380|541810609|FG001|Overall Study|Ongoing|6|||
150183552|NCT04579380|541810610|FG002|Overall Study|Ongoing|4|||
150183553|NCT04579380|541810611|FG003|Overall Study|Ongoing|8|||
150183554|NCT04579380|541810612|FG004|Overall Study|Ongoing|5|||
150183555|NCT04579380|541810613|FG005|Overall Study|Ongoing|8|||
150183556|NCT04579380|541810614|FG006|Overall Study|Ongoing|3|||
150183557|NCT04579380|541810615|FG007|Overall Study|Ongoing|19|||
150183558|NCT04579380|541810616|FG008|Overall Study|Ongoing|6|||
150183559|NCT05478525|541810619|FG000|Overall Study|Withdrawal by Subject|0|||
150183560|NCT05478525|541810620|FG001|Overall Study|Withdrawal by Subject|1|||
150183561|NCT05478525|541810621|FG002|Overall Study|Withdrawal by Subject|2|||
150183562|NCT05478525|541810622|FG003|Overall Study|Withdrawal by Subject|0|||
150183563|NCT05478525|541810619|FG000|Overall Study|COVID-19 Infection|2|||
150183564|NCT05478525|541810620|FG001|Overall Study|COVID-19 Infection|0|||
150183565|NCT05478525|541810621|FG002|Overall Study|COVID-19 Infection|1|||
150183566|NCT05478525|541810622|FG003|Overall Study|COVID-19 Infection|1|||
150183567|NCT01991977|541810623|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
150183568|NCT01991977|541810623|FG000|Overall Study|Withdrew after start of treatment|5|||
150183569|NCT03821844|541810624|FG000|Overall Study|Death|37|||
150183570|NCT03821844|541810625|FG001|Overall Study|Death|31|||
150183571|NCT03821844|541810624|FG000|Overall Study|Discharged|10|||
150183572|NCT03821844|541810625|FG001|Overall Study|Discharged|14|||
150183573|NCT03821844|541810624|FG000|Overall Study|Not present in facility at followup|2|||
150183574|NCT03821844|541810625|FG001|Overall Study|Not present in facility at followup|3|||
150183575|NCT03913195|541810627|FG000|Overall Study|Adverse Event|0|||
150183576|NCT03913195|541810628|FG001|Overall Study|Adverse Event|0|||
150183577|NCT03913195|541810629|FG002|Overall Study|Adverse Event|1|||
150183578|NCT03913195|541810630|FG003|Overall Study|Adverse Event|1|||
150085914|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085915|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085916|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085917|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085918|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085919|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085920|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085921|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085922|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085923|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085924|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085925|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085926|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085927|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085928|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085929|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085930|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085931|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085932|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085933|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
150085934|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
150085935|NCT03129100|541453676|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
150085936|NCT03129100|541453677|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
150085937|NCT03129100|541453678|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
150085938|NCT03129100|541453679|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
150085939|NCT03129100|541453680|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
150085940|NCT03129100|541453681|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
150085941|NCT03129100|541453682|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
150085942|NCT03129100|541453683|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
150085943|NCT03129100|541453684|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
150085944|NCT03129100|541453685|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
150085945|NCT03129100|541453686|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
150085946|NCT03129100|541453687|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
150085947|NCT03129100|541453688|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
150085948|NCT03129100|541453689|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
150085949|NCT03129100|541453690|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
150085950|NCT03129100|541453691|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
150085951|NCT03129100|541453692|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
150085952|NCT03129100|541453693|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
150085953|NCT03129100|541453694|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
150085954|NCT03129100|541453695|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
150085955|NCT03129100|541453696|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
150085956|NCT03129100|541453697|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
150085957|NCT03129100|541453698|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
150085958|NCT03129100|541453699|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
150085959|NCT03129100|541453700|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
150085960|NCT03129100|541453701|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
150085961|NCT01587001|541453702|FG000|Overall Study|Lost to Follow-up|2|||
150085962|NCT01587001|541453703|FG001|Overall Study|Lost to Follow-up|0|||
150085963|NCT01587001|541453702|FG000|Overall Study|Insufficient samples to complete testing|4|||
150085964|NCT01587001|541453703|FG001|Overall Study|Insufficient samples to complete testing|1|||
150085965|NCT01487200|541453704|FG000|Overall Study|Withdrawal by Subject|0|||
150085966|NCT01487200|541453705|FG001|Overall Study|Withdrawal by Subject|1|||
150085967|NCT01487200|541453706|FG002|Overall Study|Withdrawal by Subject|0|||
150085968|NCT01487200|541453707|FG003|Overall Study|Withdrawal by Subject|0|||
150085969|NCT00833794|541453708|FG000|Open-label Phase|Adverse Event|225|||
150085970|NCT00833794|541453709|FG001|Open-label Phase|Adverse Event|0|||
150085971|NCT00833794|541453708|FG000|Open-label Phase|Lack of Efficacy|28|||
150085972|NCT00833794|541453709|FG001|Open-label Phase|Lack of Efficacy|0|||
150183579|NCT03913195|541810631|FG004|Overall Study|Adverse Event|0|||
150085973|NCT00833794|541453708|FG000|Open-label Phase|Withdrawal by Subject|48|||
150085974|NCT00833794|541453709|FG001|Open-label Phase|Withdrawal by Subject|0|||
150085975|NCT00833794|541453708|FG000|Open-label Phase|Physician Decision|20|||
150085976|NCT00833794|541453709|FG001|Open-label Phase|Physician Decision|0|||
150085977|NCT00833794|541453708|FG000|Open-label Phase|Administrative reason|1|||
150085978|NCT00833794|541453709|FG001|Open-label Phase|Administrative reason|0|||
150085979|NCT00833794|541453708|FG000|Open-label Phase|Protocol Violation|47|||
150085980|NCT00833794|541453709|FG001|Open-label Phase|Protocol Violation|0|||
150085981|NCT00833794|541453708|FG000|Open-label Phase|Did not complete wash-out period|12|||
150085982|NCT00833794|541453709|FG001|Open-label Phase|Did not complete wash-out period|0|||
150085983|NCT00833794|541453708|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
150085984|NCT00833794|541453709|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
150085985|NCT00833794|541453708|FG000|Double-blind Phase|Adverse Event|44|||
150085986|NCT00833794|541453709|FG001|Double-blind Phase|Adverse Event|11|||
150085987|NCT00833794|541453708|FG000|Double-blind Phase|Lack of Efficacy|34|||
150085988|NCT00833794|541453709|FG001|Double-blind Phase|Lack of Efficacy|22|||
150085989|NCT00833794|541453708|FG000|Double-blind Phase|Withdrawal by Subject|23|||
150085990|NCT00833794|541453709|FG001|Double-blind Phase|Withdrawal by Subject|6|||
150085991|NCT00833794|541453708|FG000|Double-blind Phase|Physician Decision|4|||
150085992|NCT00833794|541453709|FG001|Double-blind Phase|Physician Decision|7|||
150085993|NCT00833794|541453708|FG000|Double-blind Phase|Administrative reason|1|||
150085994|NCT00833794|541453709|FG001|Double-blind Phase|Administrative reason|3|||
150085995|NCT00496054|541453714|FG000|Overall Study|Adverse Event|1|||
150085996|NCT00496054|541453714|FG000|Overall Study|Lost to Follow-up|7|||
150085997|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
150085998|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
150085999|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
150086000|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086001|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086002|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086003|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086004|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086005|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086006|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086007|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
150086008|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
150086009|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086010|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
150086011|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086012|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086013|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086014|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086015|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086016|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086017|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086018|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
150086019|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
150086020|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
150086021|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
150086022|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086023|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086024|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086025|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086026|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086027|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086028|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150086029|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
150183580|NCT03913195|541810627|FG000|Overall Study|Withdrawal by Subject|0|||
150183581|NCT03913195|541810628|FG001|Overall Study|Withdrawal by Subject|0|||
150183582|NCT03913195|541810629|FG002|Overall Study|Withdrawal by Subject|1|||
150183583|NCT03913195|541810630|FG003|Overall Study|Withdrawal by Subject|0|||
150183584|NCT03913195|541810631|FG004|Overall Study|Withdrawal by Subject|1|||
150183585|NCT03913195|541810627|FG000|Overall Study|non adherence to study|0|||
150183586|NCT03913195|541810628|FG001|Overall Study|non adherence to study|0|||
150183587|NCT03913195|541810629|FG002|Overall Study|non adherence to study|1|||
150183588|NCT03913195|541810630|FG003|Overall Study|non adherence to study|0|||
150183589|NCT03913195|541810631|FG004|Overall Study|non adherence to study|0|||
150183590|NCT03899961|541810632|FG000|Overall Study|-delivery prior to|2|||
150183591|NCT03899961|541810633|FG001|Overall Study|-delivery prior to|7|||
150183592|NCT03899961|541810632|FG000|Overall Study|req general anesth|1|||
150183593|NCT03899961|541810633|FG001|Overall Study|req general anesth|2|||
150183594|NCT03899961|541810632|FG000|Overall Study|capacity|5|||
150183595|NCT03899961|541810633|FG001|Overall Study|capacity|6|||
150183596|NCT03899961|541810632|FG000|Overall Study|Withdrawal by Subject|1|||
150183597|NCT03899961|541810633|FG001|Overall Study|Withdrawal by Subject|1|||
150183598|NCT03547908|541810634|FG000|Blinded Phase|Lost to Follow-up|3|||
150183599|NCT03547908|541810635|FG001|Blinded Phase|Lost to Follow-up|3|||
150183600|NCT03547908|541810636|FG002|Blinded Phase|Lost to Follow-up|0|||
150183601|NCT03547908|541810637|FG003|Blinded Phase|Lost to Follow-up|0|||
150183602|NCT03547908|541810634|FG000|Blinded Phase|Withdrew Consent|2|||
150183603|NCT03547908|541810635|FG001|Blinded Phase|Withdrew Consent|3|||
150183604|NCT03547908|541810636|FG002|Blinded Phase|Withdrew Consent|0|||
150183605|NCT03547908|541810637|FG003|Blinded Phase|Withdrew Consent|0|||
150183606|NCT03547908|541810634|FG000|Blinded Phase|Investigator's Discretion|2|||
150183607|NCT03547908|541810635|FG001|Blinded Phase|Investigator's Discretion|1|||
150183608|NCT03547908|541810636|FG002|Blinded Phase|Investigator's Discretion|0|||
150183609|NCT03547908|541810637|FG003|Blinded Phase|Investigator's Discretion|0|||
150183610|NCT03547908|541810634|FG000|Blinded Phase|Death|2|||
150183611|NCT03547908|541810635|FG001|Blinded Phase|Death|0|||
150183612|NCT03547908|541810636|FG002|Blinded Phase|Death|0|||
150183613|NCT03547908|541810637|FG003|Blinded Phase|Death|0|||
150183614|NCT03547908|541810634|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
150183615|NCT03547908|541810635|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
150183616|NCT03547908|541810636|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
150183617|NCT03547908|541810637|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
150183618|NCT03547908|541810634|FG000|Blinded Phase|Adverse Event|1|||
150183619|NCT03547908|541810635|FG001|Blinded Phase|Adverse Event|0|||
150183620|NCT03547908|541810636|FG002|Blinded Phase|Adverse Event|0|||
150183621|NCT03547908|541810637|FG003|Blinded Phase|Adverse Event|0|||
150183622|NCT03547908|541810634|FG000|Blinded Phase|Randomized But Never Treated|1|||
150183623|NCT03547908|541810635|FG001|Blinded Phase|Randomized But Never Treated|0|||
150183624|NCT03547908|541810636|FG002|Blinded Phase|Randomized But Never Treated|0|||
150183625|NCT03547908|541810637|FG003|Blinded Phase|Randomized But Never Treated|0|||
150183626|NCT03547908|541810634|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
150183627|NCT03547908|541810635|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
150183628|NCT03547908|541810636|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
150183629|NCT03547908|541810637|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
150183630|NCT03547908|541810634|FG000|Open-label Extension Phase|Death|0|||
150183631|NCT03547908|541810635|FG001|Open-label Extension Phase|Death|0|||
150086030|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
150086031|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
150086032|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086033|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086034|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086035|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086036|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086037|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086038|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086039|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086040|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
150086041|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
150086042|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
150086043|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
150086044|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086045|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086046|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086047|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086048|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086049|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086050|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086051|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
150086052|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086053|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
150086054|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
150086055|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086056|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086057|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086058|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086059|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086060|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086061|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086062|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
150086063|NCT02207244|541453717|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086064|NCT02207244|541453718|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
150086065|NCT02207244|541453719|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086066|NCT02207244|541453720|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086067|NCT02207244|541453721|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
150183632|NCT03547908|541810636|FG002|Open-label Extension Phase|Death|1|||
150086068|NCT02207244|541453722|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086069|NCT02207244|541453723|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086070|NCT02207244|541453724|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086071|NCT02207244|541453725|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086072|NCT02207244|541453726|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086073|NCT02207244|541453727|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
150086074|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086075|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086076|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086077|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150183633|NCT03547908|541810637|FG003|Open-label Extension Phase|Death|0|||
150086078|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
150086079|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
150086080|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086081|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086082|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086083|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086084|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
150086085|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086086|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086087|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086088|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086089|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086090|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
150086091|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086092|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086093|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086094|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086095|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
150086096|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086097|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086098|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086099|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
150086100|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
150086101|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
150086102|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086103|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086104|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086105|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086106|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
150086107|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086108|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086109|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086110|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
150086111|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
150086112|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
150086113|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086114|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086115|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086116|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086117|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
150086118|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086119|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086120|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086121|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
150086122|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086123|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
150086124|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086125|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086126|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086127|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086128|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
150086129|NCT02207244|541453717|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086130|NCT02207244|541453718|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086131|NCT02207244|541453719|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086132|NCT02207244|541453720|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
150086133|NCT02207244|541453721|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086134|NCT02207244|541453722|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
150183634|NCT02525692|541810638|FG000|Overall Study|Withdrawal by Subject|1|||
150183635|NCT02525692|541810639|FG001|Overall Study|Withdrawal by Subject|1|||
150183636|NCT02525692|541810640|FG002|Overall Study|Withdrawal by Subject|0|||
150183637|NCT02525692|541810641|FG003|Overall Study|Withdrawal by Subject|5|||
150183638|NCT02525692|541810642|FG004|Overall Study|Withdrawal by Subject|0|||
150183639|NCT02525692|541810643|FG005|Overall Study|Withdrawal by Subject|1|||
150183640|NCT02525692|541810638|FG000|Overall Study|Death|16|||
150183641|NCT02525692|541810639|FG001|Overall Study|Death|18|||
150183642|NCT02525692|541810640|FG002|Overall Study|Death|7|||
150183643|NCT02525692|541810641|FG003|Overall Study|Death|20|||
150183644|NCT02525692|541810642|FG004|Overall Study|Death|3|||
150183645|NCT02525692|541810643|FG005|Overall Study|Death|6|||
150183646|NCT02525692|541810638|FG000|Overall Study|Lost to Follow-up|0|||
150183647|NCT02525692|541810639|FG001|Overall Study|Lost to Follow-up|0|||
150183648|NCT02525692|541810640|FG002|Overall Study|Lost to Follow-up|1|||
150183649|NCT02525692|541810641|FG003|Overall Study|Lost to Follow-up|5|||
150183650|NCT02525692|541810642|FG004|Overall Study|Lost to Follow-up|0|||
150183651|NCT02525692|541810643|FG005|Overall Study|Lost to Follow-up|0|||
150183652|NCT05510232|541810644|FG000|Overall Study|Withdrawal by Subject|2|||
150183653|NCT05510232|541810645|FG001|Overall Study|Withdrawal by Subject|7|||
150183654|NCT05510232|541810646|FG002|Overall Study|Withdrawal by Subject|6|||
150183655|NCT00567398|541810649|FG000|Overall Study|Adverse Event|6|||
150183656|NCT00567398|541810650|FG001|Overall Study|Adverse Event|14|||
150183657|NCT00567398|541810649|FG000|Overall Study|Physician Decision|0|||
150183658|NCT00567398|541810650|FG001|Overall Study|Physician Decision|4|||
150183659|NCT00567398|541810649|FG000|Overall Study|Withdrawal by Subject|0|||
150183660|NCT00567398|541810650|FG001|Overall Study|Withdrawal by Subject|2|||
150183661|NCT00567398|541810649|FG000|Overall Study|Renal Transplantation|0|||
150183662|NCT00567398|541810650|FG001|Overall Study|Renal Transplantation|3|||
150183663|NCT00567398|541810649|FG000|Overall Study|Other|1|||
150183664|NCT00567398|541810650|FG001|Overall Study|Other|0|||
150183665|NCT03517553|541810651|FG000|Overall Study|Withdrawal by Subject|2|||
150183666|NCT04093362|541810654|FG000|Overall Study|Study Termination|1|||
150183667|NCT04093362|541810655|FG001|Overall Study|Study Termination|1|||
150183668|NCT04093362|541810654|FG000|Overall Study|Withdrawal of Consent|1|||
150183669|NCT04093362|541810655|FG001|Overall Study|Withdrawal of Consent|0|||
150183670|NCT04093362|541810654|FG000|Overall Study|Death|1|||
150183671|NCT04093362|541810655|FG001|Overall Study|Death|3|||
150183672|NCT04093362|541810654|FG000|Overall Study|Reason not Specified|1|||
150183673|NCT04093362|541810655|FG001|Overall Study|Reason not Specified|2|||
150183674|NCT04247542|541810658|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
150183675|NCT04247542|541810659|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
150183676|NCT04247542|541810660|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
150183677|NCT04247542|541810658|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
150183678|NCT04247542|541810659|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
150183679|NCT04247542|541810660|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
150183680|NCT03055377|541810661|FG000|Treatment Phase|Lost to Follow-up|28|||
150183681|NCT03055377|541810662|FG001|Treatment Phase|Lost to Follow-up|24|||
150183682|NCT03055377|541810661|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
150183683|NCT03055377|541810662|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
150183684|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
150183685|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
150183686|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
150183687|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
150183688|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
150183689|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
150183690|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
150183691|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
150183692|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
150183693|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
150086135|NCT02207244|541453723|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086136|NCT02207244|541453724|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086137|NCT02207244|541453725|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086138|NCT02207244|541453726|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086139|NCT02207244|541453727|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
150086140|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086141|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086142|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086143|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086144|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086145|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086146|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
150086147|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
150086148|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
150086149|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
150086150|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
150086151|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086152|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086153|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086154|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086155|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086156|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086157|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086158|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
150086159|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086160|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086161|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
150086162|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086163|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086164|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086165|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086166|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086167|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086168|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
150086169|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
150086170|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
150086171|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
150086172|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
150086173|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086174|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086175|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086176|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086177|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086178|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086179|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
150086180|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
150086181|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086182|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
150086183|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
150086184|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086185|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086186|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086187|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086188|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086189|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086190|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
150086191|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
150183694|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
150183695|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
150086192|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
150086193|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
150086194|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
150086195|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086196|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086197|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086198|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086199|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086200|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086201|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086202|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
150086203|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
150086204|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086205|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
150086206|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086207|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086208|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086209|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086210|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086211|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086212|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086213|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086214|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
150086215|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086216|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
150086217|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086218|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086219|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086220|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086221|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086222|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086223|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086224|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
150086225|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086226|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086227|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
150086228|NCT02207244|541453717|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086229|NCT02207244|541453718|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086230|NCT02207244|541453719|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086231|NCT02207244|541453720|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086232|NCT02207244|541453721|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086233|NCT02207244|541453722|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086234|NCT02207244|541453723|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
150086235|NCT02207244|541453724|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086236|NCT02207244|541453725|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086237|NCT02207244|541453726|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150183696|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
150183697|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
150183698|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
150183699|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
150183700|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
150183701|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
150183702|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
150183703|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
150183704|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
150183705|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
150183706|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
150183707|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
150183708|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
150183709|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
150183710|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
150183711|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
150183712|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
150183713|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
150183714|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
150183715|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
150183716|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
150183717|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
150183718|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
150183719|NCT01898494|541810666|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
150183720|NCT01898494|541810667|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
150183721|NCT01898494|541810668|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
150183722|NCT01898494|541810669|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
150183723|NCT01898494|541810670|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
150183724|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
150183725|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
150183726|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
150183727|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
150183728|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
150183729|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
150183730|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
150183731|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
150183732|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
150183733|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
150183734|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
150183735|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
150183736|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
150183737|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
150183738|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
150183739|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
150183740|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
150183741|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
150183742|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
150183743|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
150183744|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
150183745|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
150183746|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
150183747|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
150183748|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
150183749|NCT01898494|541810666|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
150183750|NCT01898494|541810667|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
150183751|NCT01898494|541810668|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
150183752|NCT01898494|541810669|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
150183753|NCT01898494|541810670|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
150183754|NCT02819843|541810671|FG000|Overall Study|Disease progression before RT|0|||
150183755|NCT02819843|541810672|FG001|Overall Study|Disease progression before RT|1|||
150183756|NCT04905407|541810674|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
150183757|NCT04905407|541810675|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
150183758|NCT04905407|541810676|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
150183759|NCT04905407|541810677|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
150183760|NCT04905407|541810674|FG000|Part 1 and Part 2|Death|7|||
150183761|NCT04905407|541810675|FG001|Part 1 and Part 2|Death|7|||
150183762|NCT04905407|541810676|FG002|Part 1 and Part 2|Death|7|||
150183763|NCT04905407|541810677|FG003|Part 1 and Part 2|Death|0|||
150183764|NCT04905407|541810674|FG000|Part 1 and Part 2|Other than specified|0|||
150183765|NCT04905407|541810675|FG001|Part 1 and Part 2|Other than specified|0|||
150086238|NCT02207244|541453727|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
150086239|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086240|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086241|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086242|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086243|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086244|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086245|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086246|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086247|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
150086248|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
150086249|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
150086250|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086251|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086252|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086253|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086254|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086255|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086256|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086257|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086258|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
150086259|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
150086260|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
150086261|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086262|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086263|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086264|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086265|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086266|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086267|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086268|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086269|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
150086270|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
150086271|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
150183766|NCT04905407|541810676|FG002|Part 1 and Part 2|Other than specified|1|||
150183767|NCT04905407|541810677|FG003|Part 1 and Part 2|Other than specified|0|||
150183768|NCT04905407|541810674|FG000|Part 3|Death|0|||
150183769|NCT04905407|541810675|FG001|Part 3|Death|0|||
150183770|NCT04905407|541810676|FG002|Part 3|Death|0|||
150183771|NCT04905407|541810677|FG003|Part 3|Death|2|||
150183772|NCT01938547|541810680|FG000|Overall Study|Physician Decision|1|||
150183773|NCT01673984|541810688|FG000|Overall Study|Adverse Event|1|||
150183774|NCT01673984|541810689|FG001|Overall Study|Adverse Event|0|||
150183775|NCT01673984|541810688|FG000|Overall Study|Study termination|9|||
150183776|NCT01673984|541810689|FG001|Overall Study|Study termination|6|||
150183777|NCT00150813|541810694|FG000|Overall Study|Adverse Event|1|||
150183778|NCT00150813|541810694|FG000|Overall Study|Lack of Efficacy|1|||
150183779|NCT00150813|541810694|FG000|Overall Study|Lost to Follow-up|5|||
150183780|NCT00150813|541810694|FG000|Overall Study|Withdrawal by Subject|5|||
150183781|NCT00150813|541810694|FG000|Overall Study|Remission|3|||
150183782|NCT00150813|541810694|FG000|Overall Study|Planned pregancy|1|||
150183783|NCT00150813|541810694|FG000|Overall Study|Switch to commercially available LEV|2|||
150183784|NCT01820260|541810696|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183785|NCT01820260|541810697|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183786|NCT01820260|541810698|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183787|NCT01820260|541810699|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183788|NCT01820260|541810700|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183789|NCT01820260|541810701|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183790|NCT01820260|541810702|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
150183791|NCT01820260|541810703|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183792|NCT01820260|541810704|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183793|NCT01820260|541810705|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183794|NCT01820260|541810706|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183795|NCT01820260|541810707|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183796|NCT01820260|541810708|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183797|NCT01820260|541810709|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
150183798|NCT01820260|541810696|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183799|NCT01820260|541810697|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183800|NCT01820260|541810698|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183801|NCT01820260|541810699|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183802|NCT01820260|541810700|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183803|NCT01820260|541810701|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183804|NCT01820260|541810702|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183805|NCT01820260|541810703|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183806|NCT01820260|541810704|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183807|NCT01820260|541810705|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
150183808|NCT01820260|541810706|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183809|NCT01820260|541810707|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183810|NCT01820260|541810708|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183811|NCT01820260|541810709|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
150183812|NCT05444192|541810710|FG000|Overall Study|Lost to Follow-up|1|||
150183813|NCT05444192|541810711|FG001|Overall Study|Lost to Follow-up|0|||
150183814|NCT00894543|541810713|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
150183815|NCT00894543|541810714|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
150183816|NCT00894543|541810713|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
150183817|NCT00894543|541810714|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
150183818|NCT04048681|541810715|FG000|Overall Study|family emergency|0|||
150183819|NCT04048681|541810716|FG001|Overall Study|family emergency|0|||
150183820|NCT04048681|541810717|FG002|Overall Study|family emergency|0|||
150183821|NCT04048681|541810718|FG003|Overall Study|family emergency|1|||
150183822|NCT04048681|541810719|FG004|Overall Study|family emergency|0|||
150183823|NCT02919449|541810725|FG000|Overall Study|Withdrawal by Subject|1|||
150183824|NCT02919449|541810725|FG000|Overall Study|Investigator decision|1|||
150183825|NCT02058108|541810726|FG000|Overall Study|Abnormal Laboratory Values|0|||
150183826|NCT02058108|541810727|FG001|Overall Study|Abnormal Laboratory Values|1|||
150086272|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086273|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086274|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086275|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086276|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086277|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086278|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086279|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086280|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
150086281|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
150086282|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
150086283|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
150086284|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
150086285|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
150086286|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
150086287|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
150086288|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
150086289|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
150086290|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
150086291|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
150086292|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
150086293|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
150086294|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
150086295|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
150086296|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
150086297|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
150086298|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
150086299|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
150086300|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
150086301|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
150086302|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
150086303|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
150086304|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
150086305|NCT02207244|541453717|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086306|NCT02207244|541453718|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086307|NCT02207244|541453719|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086308|NCT02207244|541453720|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086309|NCT02207244|541453721|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086310|NCT02207244|541453722|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086311|NCT02207244|541453723|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086312|NCT02207244|541453724|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086313|NCT02207244|541453725|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086314|NCT02207244|541453726|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
150086315|NCT02207244|541453727|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
150086316|NCT01950741|541453728|FG000|Overall Study|Lost to Follow-up|1|||
150086317|NCT01950741|541453728|FG000|Overall Study|Death|1|||
150086318|NCT01950741|541453728|FG000|Overall Study|Withdrawal by Subject|1|||
150086319|NCT00471328|541453731|FG000|Core Phase|Adverse Event|18|||
150086320|NCT00471328|541453732|FG001|Core Phase|Adverse Event|6|||
150086321|NCT00471328|541453731|FG000|Core Phase|Death|8|||
150086322|NCT00471328|541453732|FG001|Core Phase|Death|4|||
150086323|NCT00471328|541453731|FG000|Core Phase|Withdrawal by Subject|2|||
150086324|NCT00471328|541453732|FG001|Core Phase|Withdrawal by Subject|2|||
150086325|NCT00471328|541453731|FG000|Core Phase|Abnormal laboratory value|1|||
150086326|NCT00471328|541453732|FG001|Core Phase|Abnormal laboratory value|0|||
150086327|NCT00471328|541453731|FG000|Core Phase|Disease Progression|78|||
150086328|NCT00471328|541453732|FG001|Core Phase|Disease Progression|53|||
150086329|NCT00471328|541453731|FG000|Core Phase|Administrative Problem|0|||
150086330|NCT00471328|541453732|FG001|Core Phase|Administrative Problem|1|||
150086331|NCT00471328|541453731|FG000|Core Phase|Protocol Deviation|0|||
150086332|NCT00471328|541453732|FG001|Core Phase|Protocol Deviation|1|||
150086333|NCT00471328|541453731|FG000|Extension Phase|Adverse Event|3|||
150086334|NCT00471328|541453732|FG001|Extension Phase|Adverse Event|12|||
150086335|NCT00471328|541453731|FG000|Extension Phase|Withdrawal by Subject|0|||
150086336|NCT00471328|541453732|FG001|Extension Phase|Withdrawal by Subject|2|||
150086337|NCT00471328|541453731|FG000|Extension Phase|Death|1|||
150086338|NCT00471328|541453732|FG001|Extension Phase|Death|7|||
150086339|NCT00471328|541453731|FG000|Extension Phase|Protocol Deviation|3|||
150086340|NCT00471328|541453732|FG001|Extension Phase|Protocol Deviation|1|||
150086341|NCT00471328|541453731|FG000|Extension Phase|Treatment duration as per protocol|0|||
150086342|NCT00471328|541453732|FG001|Extension Phase|Treatment duration as per protocol|1|||
150086343|NCT00471328|541453731|FG000|Extension Phase|Disease Progression|32|||
150086344|NCT00471328|541453732|FG001|Extension Phase|Disease Progression|44|||
150086345|NCT00471328|541453731|FG000|Extension Phase|New cancer Therapy|1|||
150086346|NCT00471328|541453732|FG001|Extension Phase|New cancer Therapy|0|||
150086347|NCT00471328|541453731|FG000|Extension Phase|Administrative Problem|1|||
150086348|NCT00471328|541453732|FG001|Extension Phase|Administrative Problem|0|||
150086349|NCT00519831|541453733|FG000|Overall Study|Adverse Event|3|||
150086350|NCT04051008|541453734|FG000|Overall Study|Withdrawal by Subject|2|||
150086351|NCT04051008|541453735|FG001|Overall Study|Withdrawal by Subject|0|||
150086352|NCT04051008|541453736|FG002|Overall Study|Withdrawal by Subject|1|||
150086353|NCT01962896|541453737|FG000|Overall Study|Lack of Efficacy|4|||
150086354|NCT02837783|541453738|FG000|Overall Study|Adverse Event|1|||
150086355|NCT02837783|541453739|FG001|Overall Study|Adverse Event|0|||
150086356|NCT02837783|541453738|FG000|Overall Study|Other, Not Specified|1|||
150086357|NCT02837783|541453739|FG001|Overall Study|Other, Not Specified|2|||
150086358|NCT03200860|541453740|FG000|Overall Study|Withdrawal by Subject|1|||
150086359|NCT03200860|541453741|FG001|Overall Study|Withdrawal by Subject|0|||
150086360|NCT00844896|541453742|FG000|Overall Study|Lost to Follow-up|12|||
150086361|NCT00844896|541453743|FG001|Overall Study|Lost to Follow-up|16|||
150086362|NCT00844896|541453742|FG000|Overall Study|Parents did not have time to complete|0|||
150086363|NCT00844896|541453743|FG001|Overall Study|Parents did not have time to complete|1|||
150086364|NCT02233647|541453747|FG000|Overall Study|Adverse Event|1|||
150086365|NCT00458211|541453748|FG000|Overall Study|Lack of Efficacy|12|||
150086366|NCT00458211|541453748|FG000|Overall Study|Withdrawal by Subject|2|||
150086367|NCT00458211|541453748|FG000|Overall Study|Protocol Violation|2|||
150086368|NCT04342897|541453749|FG000|Overall Study|Death|7|||
150086369|NCT04342897|541453750|FG001|Overall Study|Death|4|||
150086370|NCT04342897|541453749|FG000|Overall Study|Lost to Follow-up|6|||
150086371|NCT04342897|541453750|FG001|Overall Study|Lost to Follow-up|6|||
150086372|NCT04342897|541453749|FG000|Overall Study|Withdrawal by Subject|1|||
150086373|NCT04342897|541453750|FG001|Overall Study|Withdrawal by Subject|2|||
150086374|NCT02634320|541453751|FG000|Overall Study|Adverse Event|2|||
150086375|NCT02634320|541453751|FG000|Overall Study|Lost to Follow-up|3|||
150086376|NCT02634320|541453751|FG000|Overall Study|Moved out of area|2|||
150086377|NCT02634320|541453751|FG000|Overall Study|Out of window for study visits|1|||
150086378|NCT02634320|541453751|FG000|Overall Study|Protocol Violation|1|||
150086379|NCT02634320|541453751|FG000|Overall Study|Withdrawal by Subject|5|||
150086380|NCT02634320|541453751|FG000|Overall Study|Lack of Efficacy|2|||
150086381|NCT00687323|541453752|FG000|Overall Study|Death|25|||
150086382|NCT00687323|541453752|FG000|Overall Study|Withdrawal by Subject|1|||
150086383|NCT00687323|541453752|FG000|Overall Study|Excluded from efficacy evaluations|6|||
150086384|NCT00687323|541453752|FG000|Overall Study|Screen failure|148|||
150086385|NCT00838578|541453753|FG000|Overall Study|Protocol Violation|2|||
150086386|NCT03919799|541453759|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
150086387|NCT03919799|541453760|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
150086388|NCT03919799|541453761|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
150086389|NCT03919799|541453762|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
150086390|NCT03919799|541453763|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
150086391|NCT03919799|541453759|FG000|DB Period (28 Weeks)|Adverse Event|1|||
150086392|NCT03919799|541453760|FG001|DB Period (28 Weeks)|Adverse Event|1|||
150086393|NCT03919799|541453761|FG002|DB Period (28 Weeks)|Adverse Event|1|||
150086394|NCT03919799|541453762|FG003|DB Period (28 Weeks)|Adverse Event|0|||
150086395|NCT03919799|541453763|FG004|DB Period (28 Weeks)|Adverse Event|0|||
150086396|NCT03919799|541453759|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
150086397|NCT03919799|541453760|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
150086398|NCT03919799|541453761|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
150086399|NCT03919799|541453762|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
150183827|NCT02058108|541810726|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
150183828|NCT02058108|541810727|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
150183829|NCT02058108|541810726|FG000|Overall Study|No longer requires study drug|0|||
150183830|NCT02058108|541810727|FG001|Overall Study|No longer requires study drug|1|||
150183831|NCT02058108|541810726|FG000|Overall Study|Withdrawal by Subject|1|||
150183832|NCT02058108|541810727|FG001|Overall Study|Withdrawal by Subject|0|||
150183833|NCT02058108|541810726|FG000|Overall Study|Administrative problems|3|||
150183834|NCT02058108|541810727|FG001|Overall Study|Administrative problems|3|||
150183835|NCT02058108|541810726|FG000|Overall Study|Protocol Violation|0|||
150183836|NCT02058108|541810727|FG001|Overall Study|Protocol Violation|1|||
150183837|NCT00727909|541810731|FG000|Overall Study|Withdrawal by Subject|5|||
150183838|NCT00727909|541810732|FG001|Overall Study|Withdrawal by Subject|11|||
150183839|NCT00727909|541810733|FG002|Overall Study|Withdrawal by Subject|8|||
150183840|NCT00727909|541810734|FG003|Overall Study|Withdrawal by Subject|5|||
150183841|NCT00727909|541810731|FG000|Overall Study|Death|0|||
150183842|NCT00727909|541810732|FG001|Overall Study|Death|0|||
150183843|NCT00727909|541810733|FG002|Overall Study|Death|1|||
150183844|NCT00727909|541810734|FG003|Overall Study|Death|0|||
150183845|NCT01696773|541810735|FG000|Days 15-27, Washout|Adverse Event|1|||
150183846|NCT01696773|541810736|FG001|Days 15-27, Washout|Adverse Event|0|||
150183847|NCT00411151|541810745|FG000|Overall Study|Death|38|||
150183848|NCT00411151|541810745|FG000|Overall Study|Withdrawal by Subject|2|||
150183849|NCT00411151|541810745|FG000|Overall Study|Lost to Follow-up|2|||
150183850|NCT00411151|541810745|FG000|Overall Study|Protocol Violation|1|||
150183851|NCT00411151|541810745|FG000|Overall Study|Trial prematurely closed|4|||
150183852|NCT04600752|541810750|FG000|Overall Study|Physician Decision|0|||
150183853|NCT04600752|541810751|FG001|Overall Study|Physician Decision|0|||
150183854|NCT04600752|541810752|FG002|Overall Study|Physician Decision|1|||
150183855|NCT04600752|541810750|FG000|Overall Study|Adverse Event|0|||
150183856|NCT04600752|541810751|FG001|Overall Study|Adverse Event|1|||
150183857|NCT04600752|541810752|FG002|Overall Study|Adverse Event|0|||
150183858|NCT04600752|541810750|FG000|Overall Study|Withdrawal by Subject|2|||
150183859|NCT04600752|541810751|FG001|Overall Study|Withdrawal by Subject|1|||
150183860|NCT04600752|541810752|FG002|Overall Study|Withdrawal by Subject|0|||
150183861|NCT04600752|541810750|FG000|Overall Study|Lack of Efficacy|1|||
150183862|NCT04600752|541810751|FG001|Overall Study|Lack of Efficacy|0|||
150183863|NCT04600752|541810752|FG002|Overall Study|Lack of Efficacy|0|||
150183864|NCT00448669|541810753|FG000|Overall Study|Lost to Follow-up|52|||
150183865|NCT00448669|541810754|FG001|Overall Study|Lost to Follow-up|63|||
150183866|NCT00448669|541810753|FG000|Overall Study|Withdrawal by Subject|90|||
150183867|NCT00448669|541810754|FG001|Overall Study|Withdrawal by Subject|74|||
150183868|NCT00448669|541810753|FG000|Overall Study|Relocated|49|||
150183869|NCT00448669|541810754|FG001|Overall Study|Relocated|36|||
150183870|NCT00448669|541810753|FG000|Overall Study|Were withdrawn by investigator|10|||
150183871|NCT00448669|541810754|FG001|Overall Study|Were withdrawn by investigator|6|||
150183872|NCT00448669|541810753|FG000|Overall Study|Death|2|||
150183873|NCT00448669|541810754|FG001|Overall Study|Death|4|||
150183874|NCT00448669|541810753|FG000|Overall Study|Had other reasons|5|||
150183875|NCT00448669|541810754|FG001|Overall Study|Had other reasons|6|||
150183876|NCT00448669|541810753|FG000|Overall Study|HIV-infected at enrollment|1|||
150183877|NCT00448669|541810754|FG001|Overall Study|HIV-infected at enrollment|2|||
150183878|NCT00448669|541810753|FG000|Overall Study|Never started drug|9|||
150183879|NCT00448669|541810754|FG001|Overall Study|Never started drug|7|||
150183880|NCT02789020|541810759|FG000|Overall Study|Withdrawal by Subject|6|||
150086400|NCT03919799|541453763|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
150086401|NCT03919799|541453759|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
150086402|NCT03919799|541453760|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
150086403|NCT03919799|541453761|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
150086404|NCT03919799|541453762|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
150086405|NCT03919799|541453763|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
150086406|NCT03919799|541453759|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
150086407|NCT03919799|541453760|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
150086408|NCT03919799|541453761|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
150086409|NCT03919799|541453762|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
150086410|NCT03919799|541453763|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
150086411|NCT04600921|541453769|FG000|Overall Study|Withdrawal by Subject|3|||
150086412|NCT04600921|541453770|FG001|Overall Study|Withdrawal by Subject|5|||
150086413|NCT04600921|541453769|FG000|Overall Study|Death|0|||
150086414|NCT04600921|541453770|FG001|Overall Study|Death|1|||
150183881|NCT02789020|541810760|FG001|Overall Study|Withdrawal by Subject|5|||
150183882|NCT05512962|541810763|FG000|Overall Study|Withdrawal by Subject|1|||
150183883|NCT05512962|541810764|FG001|Overall Study|Withdrawal by Subject|0|||
150183884|NCT04950127|541810765|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
150183885|NCT04950127|541810766|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
150183886|NCT04950127|541810767|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
150183887|NCT04950127|541810768|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
150183888|NCT04950127|541810769|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
150183889|NCT04950127|541810770|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
150183890|NCT04950127|541810765|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
150183891|NCT04950127|541810766|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
150183892|NCT04950127|541810767|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
150183893|NCT04950127|541810768|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
150183894|NCT04950127|541810769|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
150183895|NCT04950127|541810770|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
150183896|NCT04950127|541810765|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
150183897|NCT04950127|541810766|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
150183898|NCT04950127|541810767|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
150183899|NCT04950127|541810768|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
150183900|NCT04950127|541810769|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
150183901|NCT04950127|541810770|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
150183902|NCT04950127|541810765|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
150183903|NCT04950127|541810766|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
150183904|NCT04950127|541810767|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
150183905|NCT04950127|541810768|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
150183906|NCT04950127|541810769|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
150183907|NCT04950127|541810770|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
150183908|NCT04950127|541810765|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
150183909|NCT04950127|541810766|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
150183910|NCT04950127|541810767|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
150183911|NCT04950127|541810768|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
150183912|NCT04950127|541810769|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
150183913|NCT04950127|541810770|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
150183914|NCT01711632|541810771|FG000|Overall Study|Adverse Event|4|||
150183915|NCT01711632|541810771|FG000|Overall Study|Death|3|||
150183916|NCT01711632|541810771|FG000|Overall Study|Lost to Follow-up|3|||
150183917|NCT01711632|541810771|FG000|Overall Study|Withdrawal by Subject|4|||
150183918|NCT01711632|541810771|FG000|Overall Study|Progressive disease|2|||
150183919|NCT01711632|541810771|FG000|Overall Study|No follow up required in re-treatment|3|||
150183920|NCT01711632|541810771|FG000|Overall Study|No follow up required in re-treatment|3|||
150183921|NCT04315181|541810772|FG000|Overall Study|Non-responsive to drug conditions.|1|||
150183922|NCT00522951|541810773|FG000|Period 1|body motion|0|||
150183923|NCT00522951|541810774|FG001|Period 1|body motion|1|||
150183924|NCT00522951|541810773|FG000|Washout Period|Adverse Event|0|||
150183925|NCT00522951|541810774|FG001|Washout Period|Adverse Event|1|||
150183926|NCT00522951|541810773|FG000|Washout Period|Death|0|||
150183927|NCT00522951|541810774|FG001|Washout Period|Death|1|||
150183928|NCT00522951|541810773|FG000|Period 2|Withdrawal by Subject|1|||
150183929|NCT00522951|541810774|FG001|Period 2|Withdrawal by Subject|0|||
150183930|NCT00522951|541810773|FG000|Period 2|residual contrast medium|1|||
150183931|NCT00522951|541810774|FG001|Period 2|residual contrast medium|1|||
150183932|NCT05494788|541810779|FG000|Initial Treatment Period|Adverse Event|2|||
150183933|NCT05494788|541810779|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
150183934|NCT05494788|541810779|FG000|Extension Period|Adverse Event|1|||
150183935|NCT05494788|541810779|FG000|Extension Period|Withdrawal by Subject|1|||
150183936|NCT05480943|541810780|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
150183937|NCT05480943|541810780|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
150183938|NCT05480943|541810780|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
150183939|NCT05480943|541810780|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
150183940|NCT00136435|541810781|FG000|Overall Study|Ineligible|8|||
150183941|NCT00136435|541810781|FG000|Overall Study|Induction Death|1|||
150183942|NCT00136435|541810781|FG000|Overall Study|Induction Failure|10|||
150183943|NCT00136435|541810781|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
150183944|NCT00136435|541810781|FG000|Overall Study|Withdrawal by Subject|3|||
150183945|NCT00136435|541810781|FG000|Overall Study|Adverse Event|19|||
150183946|NCT00136435|541810781|FG000|Overall Study|Relapse|4|||
150086415|NCT02239978|541455611|FG000|Overall Study|Withdrawal by Subject|2|||
150086416|NCT02239978|541455612|FG001|Overall Study|Withdrawal by Subject|0|||
150086417|NCT01852110|541455620|FG000|Overall Study|Adverse Event|12|||
150086418|NCT01852110|541455621|FG001|Overall Study|Adverse Event|5|||
150086419|NCT01852110|541455622|FG002|Overall Study|Adverse Event|0|||
150086420|NCT01852110|541455623|FG003|Overall Study|Adverse Event|0|||
150086421|NCT01852110|541455624|FG004|Overall Study|Adverse Event|0|||
150086422|NCT01852110|541455625|FG005|Overall Study|Adverse Event|0|||
150086423|NCT01852110|541455620|FG000|Overall Study|Lost to Follow-up|1|||
150086424|NCT01852110|541455621|FG001|Overall Study|Lost to Follow-up|3|||
150086425|NCT01852110|541455622|FG002|Overall Study|Lost to Follow-up|0|||
150086426|NCT01852110|541455623|FG003|Overall Study|Lost to Follow-up|0|||
150086427|NCT01852110|541455624|FG004|Overall Study|Lost to Follow-up|0|||
150086428|NCT01852110|541455625|FG005|Overall Study|Lost to Follow-up|0|||
150086429|NCT01852110|541455620|FG000|Overall Study|Non-compliance with Study Drug|2|||
150086430|NCT01852110|541455621|FG001|Overall Study|Non-compliance with Study Drug|1|||
150086431|NCT01852110|541455622|FG002|Overall Study|Non-compliance with Study Drug|0|||
150086432|NCT01852110|541455623|FG003|Overall Study|Non-compliance with Study Drug|0|||
150086433|NCT01852110|541455624|FG004|Overall Study|Non-compliance with Study Drug|0|||
150086434|NCT01852110|541455625|FG005|Overall Study|Non-compliance with Study Drug|0|||
150086435|NCT01852110|541455620|FG000|Overall Study|Physician Decision|1|||
150086436|NCT01852110|541455621|FG001|Overall Study|Physician Decision|0|||
150086437|NCT01852110|541455622|FG002|Overall Study|Physician Decision|0|||
150086438|NCT01852110|541455623|FG003|Overall Study|Physician Decision|0|||
150086439|NCT01852110|541455624|FG004|Overall Study|Physician Decision|0|||
150086440|NCT01852110|541455625|FG005|Overall Study|Physician Decision|0|||
150086441|NCT01852110|541455620|FG000|Overall Study|Protocol Violation|0|||
150086442|NCT01852110|541455621|FG001|Overall Study|Protocol Violation|1|||
150086443|NCT01852110|541455622|FG002|Overall Study|Protocol Violation|0|||
150086444|NCT01852110|541455623|FG003|Overall Study|Protocol Violation|0|||
150086445|NCT01852110|541455624|FG004|Overall Study|Protocol Violation|0|||
150086446|NCT01852110|541455625|FG005|Overall Study|Protocol Violation|0|||
150086447|NCT01852110|541455620|FG000|Overall Study|Study Terminated by Sponsor|30|||
150086448|NCT01852110|541455621|FG001|Overall Study|Study Terminated by Sponsor|32|||
150086449|NCT01852110|541455622|FG002|Overall Study|Study Terminated by Sponsor|0|||
150086450|NCT01852110|541455623|FG003|Overall Study|Study Terminated by Sponsor|0|||
150086451|NCT01852110|541455624|FG004|Overall Study|Study Terminated by Sponsor|0|||
150086452|NCT01852110|541455625|FG005|Overall Study|Study Terminated by Sponsor|0|||
150086453|NCT01852110|541455620|FG000|Overall Study|Withdrawal by Subject|4|||
150086454|NCT01852110|541455621|FG001|Overall Study|Withdrawal by Subject|4|||
150086455|NCT01852110|541455622|FG002|Overall Study|Withdrawal by Subject|0|||
150086456|NCT01852110|541455623|FG003|Overall Study|Withdrawal by Subject|0|||
150086457|NCT01852110|541455624|FG004|Overall Study|Withdrawal by Subject|0|||
150086458|NCT01852110|541455625|FG005|Overall Study|Withdrawal by Subject|0|||
150086459|NCT00410046|541455628|FG000|Overall Study|Adverse Event|3|||
150086460|NCT00410046|541455628|FG000|Overall Study|Withdrawal by Subject|1|||
150086461|NCT00410046|541455628|FG000|Overall Study|Lost to Follow-up|1|||
150086462|NCT03909295|541455629|FG000|Overall Study|Adverse Event|2|||
150086463|NCT03909295|541455629|FG000|Overall Study|Study terminated by sponsor|50|||
150086464|NCT02141282|541455631|FG000|Overall Study|Adverse event, not related to progression|8|||
150086465|NCT02141282|541455632|FG001|Overall Study|Adverse event, not related to progression|1|||
150086466|NCT02141282|541455633|FG002|Overall Study|Adverse event, not related to progression|3|||
150086467|NCT02141282|541455634|FG003|Overall Study|Adverse event, not related to progression|1|||
150086468|NCT02141282|541455631|FG000|Overall Study|Adverse event, related to progression|1|||
150086469|NCT02141282|541455632|FG001|Overall Study|Adverse event, related to progression|0|||
150086470|NCT02141282|541455633|FG002|Overall Study|Adverse event, related to progression|2|||
150086471|NCT02141282|541455634|FG003|Overall Study|Adverse event, related to progression|0|||
150086472|NCT02141282|541455631|FG000|Overall Study|COVID-19 infection|1|||
150086473|NCT02141282|541455632|FG001|Overall Study|COVID-19 infection|0|||
150086474|NCT02141282|541455633|FG002|Overall Study|COVID-19 infection|0|||
150086475|NCT02141282|541455634|FG003|Overall Study|COVID-19 infection|0|||
150086476|NCT02141282|541455631|FG000|Overall Study|Lost to Follow-up|0|||
150086477|NCT02141282|541455632|FG001|Overall Study|Lost to Follow-up|0|||
150086478|NCT02141282|541455633|FG002|Overall Study|Lost to Follow-up|4|||
150086479|NCT02141282|541455634|FG003|Overall Study|Lost to Follow-up|2|||
150086480|NCT02141282|541455631|FG000|Overall Study|Other, not specified|14|||
150086481|NCT02141282|541455632|FG001|Overall Study|Other, not specified|11|||
150086482|NCT02141282|541455633|FG002|Overall Study|Other, not specified|23|||
150086483|NCT02141282|541455634|FG003|Overall Study|Other, not specified|9|||
150086484|NCT02141282|541455631|FG000|Overall Study|Progressive disease, Richter's|4|||
150086485|NCT02141282|541455632|FG001|Overall Study|Progressive disease, Richter's|1|||
150086486|NCT02141282|541455633|FG002|Overall Study|Progressive disease, Richter's|1|||
150086487|NCT02141282|541455634|FG003|Overall Study|Progressive disease, Richter's|1|||
150086488|NCT02141282|541455631|FG000|Overall Study|Progressive disease per protocol|12|||
150086489|NCT02141282|541455632|FG001|Overall Study|Progressive disease per protocol|7|||
150086490|NCT02141282|541455633|FG002|Overall Study|Progressive disease per protocol|9|||
150086491|NCT02141282|541455634|FG003|Overall Study|Progressive disease per protocol|2|||
150086492|NCT02141282|541455631|FG000|Overall Study|Stem cell transplant|1|||
150086493|NCT02141282|541455632|FG001|Overall Study|Stem cell transplant|0|||
150086494|NCT02141282|541455633|FG002|Overall Study|Stem cell transplant|1|||
150086495|NCT02141282|541455634|FG003|Overall Study|Stem cell transplant|0|||
150086496|NCT02141282|541455631|FG000|Overall Study|Study terminated by Sponsor|0|||
150086497|NCT02141282|541455632|FG001|Overall Study|Study terminated by Sponsor|1|||
150183947|NCT00136435|541810781|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
150086498|NCT02141282|541455633|FG002|Overall Study|Study terminated by Sponsor|0|||
150086499|NCT02141282|541455634|FG003|Overall Study|Study terminated by Sponsor|0|||
150086500|NCT02141282|541455631|FG000|Overall Study|Subject non-compliance|0|||
150086501|NCT02141282|541455632|FG001|Overall Study|Subject non-compliance|0|||
150086502|NCT02141282|541455633|FG002|Overall Study|Subject non-compliance|1|||
150086503|NCT02141282|541455634|FG003|Overall Study|Subject non-compliance|0|||
150086504|NCT02141282|541455631|FG000|Overall Study|Withdrew consent|2|||
150086505|NCT02141282|541455632|FG001|Overall Study|Withdrew consent|0|||
150086506|NCT02141282|541455633|FG002|Overall Study|Withdrew consent|4|||
150086507|NCT02141282|541455634|FG003|Overall Study|Withdrew consent|0|||
150086508|NCT03312933|541455637|FG000|Overall Study|Protocol Violation|15|||
150086509|NCT03312933|541455637|FG000|Overall Study|Lost to Follow-up|36|||
150086510|NCT03312933|541455637|FG000|Overall Study|Withdrawal by Subject|3|||
150086511|NCT01752907|541455639|FG000|Overall Study|Withdrawal by Subject|4|||
150086512|NCT01752907|541455640|FG001|Overall Study|Withdrawal by Subject|10|||
150086513|NCT01752907|541455639|FG000|Overall Study|Lost to Follow-up|2|||
150086514|NCT01752907|541455640|FG001|Overall Study|Lost to Follow-up|1|||
150086515|NCT01752907|541455639|FG000|Overall Study|Decision by Sponsor|6|||
150086516|NCT01752907|541455640|FG001|Overall Study|Decision by Sponsor|9|||
150086517|NCT03098550|541455641|FG000|Overall Study|Disease Progression|30|||
150086518|NCT03098550|541455642|FG001|Overall Study|Disease Progression|19|||
150086519|NCT03098550|541455643|FG002|Overall Study|Disease Progression|41|||
150086520|NCT03098550|541455641|FG000|Overall Study|Study Drug Toxicity|2|||
150086521|NCT03098550|541455642|FG001|Overall Study|Study Drug Toxicity|1|||
150086522|NCT03098550|541455643|FG002|Overall Study|Study Drug Toxicity|0|||
150086523|NCT03098550|541455641|FG000|Overall Study|Death|1|||
150086524|NCT03098550|541455642|FG001|Overall Study|Death|0|||
150086525|NCT03098550|541455643|FG002|Overall Study|Death|0|||
150086526|NCT03098550|541455641|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
150086527|NCT03098550|541455642|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
150086528|NCT03098550|541455643|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
150086529|NCT03098550|541455641|FG000|Overall Study|Administrative reason by sponsor|0|||
150086530|NCT03098550|541455642|FG001|Overall Study|Administrative reason by sponsor|0|||
150086531|NCT03098550|541455643|FG002|Overall Study|Administrative reason by sponsor|1|||
150086532|NCT03098550|541455641|FG000|Overall Study|Other reasons|2|||
150086533|NCT03098550|541455642|FG001|Overall Study|Other reasons|0|||
150086534|NCT03098550|541455643|FG002|Overall Study|Other reasons|0|||
150086535|NCT01384760|541455645|FG000|Overall Study|Lost to Follow-up|0|||
150086536|NCT01384760|541455646|FG001|Overall Study|Lost to Follow-up|6|||
150086537|NCT01384760|541455645|FG000|Overall Study|Protocol Violation|16|||
150086538|NCT01384760|541455646|FG001|Overall Study|Protocol Violation|0|||
150086539|NCT00630396|541455647|FG000|Overall Study|Death|4|||
150086540|NCT00630396|541455647|FG000|Overall Study|Lost to Follow-up|3|||
150086541|NCT02990910|541455651|FG000|Overall Study|Lack of Efficacy|6|||
150086542|NCT02990910|541455652|FG001|Overall Study|Lack of Efficacy|10|||
150086543|NCT02989194|541455662|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
150086544|NCT02989194|541455663|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
150086545|NCT02989194|541455664|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
150086546|NCT02989194|541455662|FG000|Overall Study|Lost to Follow-up|0|||
150086547|NCT02989194|541455663|FG001|Overall Study|Lost to Follow-up|1|||
150086548|NCT02989194|541455664|FG002|Overall Study|Lost to Follow-up|0|||
150086549|NCT02989194|541455662|FG000|Overall Study|Withdrawal by Subject|0|||
150086550|NCT02989194|541455663|FG001|Overall Study|Withdrawal by Subject|1|||
150086551|NCT02989194|541455664|FG002|Overall Study|Withdrawal by Subject|0|||
150086552|NCT01549860|541455665|FG000|Overall Study|Withdrawal by Subject|1|||
150086553|NCT01549860|541455666|FG001|Overall Study|Withdrawal by Subject|0|||
150086554|NCT01549860|541455665|FG000|Overall Study|Physician Decision|1|||
150086555|NCT01549860|541455666|FG001|Overall Study|Physician Decision|1|||
150086556|NCT01366521|541455667|FG000|Overall Study|Adverse Event|1|||
150086557|NCT01366521|541455668|FG001|Overall Study|Adverse Event|0|||
150086558|NCT01366521|541455669|FG002|Overall Study|Adverse Event|0|||
150086559|NCT01366521|541455670|FG003|Overall Study|Adverse Event|0|||
150086560|NCT01366521|541455667|FG000|Overall Study|Protocol Violation|0|||
150086561|NCT01366521|541455668|FG001|Overall Study|Protocol Violation|0|||
150086562|NCT01366521|541455669|FG002|Overall Study|Protocol Violation|1|||
150086563|NCT01366521|541455670|FG003|Overall Study|Protocol Violation|0|||
150086564|NCT01366521|541455667|FG000|Overall Study|Physician Decision|0|||
150086565|NCT01366521|541455668|FG001|Overall Study|Physician Decision|0|||
150086566|NCT01366521|541455669|FG002|Overall Study|Physician Decision|1|||
150086567|NCT01366521|541455670|FG003|Overall Study|Physician Decision|0|||
150086568|NCT01366521|541455667|FG000|Overall Study|Withdrawal by Subject|0|||
150086569|NCT01366521|541455668|FG001|Overall Study|Withdrawal by Subject|1|||
150086570|NCT01366521|541455669|FG002|Overall Study|Withdrawal by Subject|0|||
150086571|NCT01366521|541455670|FG003|Overall Study|Withdrawal by Subject|0|||
150086572|NCT00660023|541455671|FG000|Overall Study|Adverse Event|2|||
150086573|NCT00660023|541455671|FG000|Overall Study|Death|8|||
150086574|NCT00660023|541455671|FG000|Overall Study|Blood Transfusion|5|||
150086575|NCT00660023|541455671|FG000|Overall Study|Renal Transplantation|3|||
150183948|NCT02965846|541810782|FG000|Overall Study|Lost to Follow-up|1|||
150086576|NCT00660023|541455671|FG000|Overall Study|Withdrawal by Subject|1|||
150086577|NCT00660023|541455671|FG000|Overall Study|Missed Pregnancy Test|1|||
150086578|NCT00660023|541455671|FG000|Overall Study|Other Screening Failure|9|||
150086579|NCT04180488|541455672|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
150086580|NCT04180488|541455673|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
150086581|NCT04180488|541455674|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
150086582|NCT04180488|541455675|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
150086583|NCT04180488|541455676|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
150086584|NCT04180488|541455677|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
150086585|NCT04180488|541455672|FG000|Overall Study|Withdrawal by Subject|8|||
150086586|NCT04180488|541455673|FG001|Overall Study|Withdrawal by Subject|4|||
150086587|NCT04180488|541455674|FG002|Overall Study|Withdrawal by Subject|5|||
150086588|NCT04180488|541455675|FG003|Overall Study|Withdrawal by Subject|2|||
150086589|NCT04180488|541455676|FG004|Overall Study|Withdrawal by Subject|8|||
150086590|NCT04180488|541455677|FG005|Overall Study|Withdrawal by Subject|6|||
150086591|NCT04180488|541455672|FG000|Overall Study|Adverse Event|3|||
150086592|NCT04180488|541455673|FG001|Overall Study|Adverse Event|2|||
150086593|NCT04180488|541455674|FG002|Overall Study|Adverse Event|0|||
150086594|NCT04180488|541455675|FG003|Overall Study|Adverse Event|0|||
150086595|NCT04180488|541455676|FG004|Overall Study|Adverse Event|0|||
150086596|NCT04180488|541455677|FG005|Overall Study|Adverse Event|0|||
150086597|NCT04180488|541455672|FG000|Overall Study|Poor compliance to protocol|0|||
150086598|NCT04180488|541455673|FG001|Overall Study|Poor compliance to protocol|0|||
150086599|NCT04180488|541455674|FG002|Overall Study|Poor compliance to protocol|1|||
150086600|NCT04180488|541455675|FG003|Overall Study|Poor compliance to protocol|0|||
150086601|NCT04180488|541455676|FG004|Overall Study|Poor compliance to protocol|0|||
150086602|NCT04180488|541455677|FG005|Overall Study|Poor compliance to protocol|0|||
150086603|NCT03506815|541455678|FG000|Overall Study|Adverse Event|8|||
150086604|NCT03506815|541455679|FG001|Overall Study|Adverse Event|0|||
150086605|NCT03506815|541455678|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
150086606|NCT03506815|541455679|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
150086607|NCT03506815|541455678|FG000|Overall Study|Protocol Violation|1|||
150086608|NCT03506815|541455679|FG001|Overall Study|Protocol Violation|0|||
150086609|NCT03506815|541455678|FG000|Overall Study|Elective Surgery|1|||
150086610|NCT03506815|541455679|FG001|Overall Study|Elective Surgery|0|||
150086611|NCT04160091|541455682|FG000|Overall Study|Terminated by Sponsor|7|||
150086612|NCT04160091|541455683|FG001|Overall Study|Terminated by Sponsor|3|||
150086613|NCT04160091|541455684|FG002|Overall Study|Terminated by Sponsor|5|||
150086614|NCT04160091|541455685|FG003|Overall Study|Terminated by Sponsor|2|||
150086615|NCT04160091|541455682|FG000|Overall Study|Noncompliance|0|||
150086616|NCT04160091|541455683|FG001|Overall Study|Noncompliance|0|||
150086617|NCT04160091|541455684|FG002|Overall Study|Noncompliance|0|||
150086618|NCT04160091|541455685|FG003|Overall Study|Noncompliance|1|||
150086619|NCT04160091|541455682|FG000|Overall Study|Withdrawal by Subject|0|||
150086620|NCT04160091|541455683|FG001|Overall Study|Withdrawal by Subject|0|||
150086621|NCT04160091|541455684|FG002|Overall Study|Withdrawal by Subject|0|||
150086622|NCT04160091|541455685|FG003|Overall Study|Withdrawal by Subject|1|||
150086623|NCT00381095|541455690|FG000|Overall Study|Death|3|||
150086624|NCT00381095|541455691|FG001|Overall Study|Death|4|||
150086625|NCT00381095|541455690|FG000|Overall Study|Lack of Efficacy|2|||
150086626|NCT00381095|541455691|FG001|Overall Study|Lack of Efficacy|4|||
150086627|NCT00381095|541455690|FG000|Overall Study|Other|2|||
150086628|NCT00381095|541455691|FG001|Overall Study|Other|2|||
150086629|NCT00381095|541455690|FG000|Overall Study|Protocol Violation|1|||
150086630|NCT00381095|541455691|FG001|Overall Study|Protocol Violation|1|||
150086631|NCT00381095|541455690|FG000|Overall Study|Withdrawal by Subject|3|||
150086632|NCT00381095|541455691|FG001|Overall Study|Withdrawal by Subject|3|||
150086633|NCT00381095|541455690|FG000|Overall Study|Adverse Event|2|||
150086634|NCT00381095|541455691|FG001|Overall Study|Adverse Event|7|||
150086635|NCT02692716|541455693|FG000|Overall Study|Lost to Follow-up|2|||
150086636|NCT02692716|541455694|FG001|Overall Study|Lost to Follow-up|5|||
150086637|NCT02692716|541455693|FG000|Overall Study|Withdrawal by Subject|3|||
150086638|NCT02692716|541455694|FG001|Overall Study|Withdrawal by Subject|1|||
150086639|NCT00856284|541455703|FG000|Overall Study|Hyperglycemic rescue|231|||
150086640|NCT00856284|541455704|FG001|Overall Study|Hyperglycemic rescue|201|||
150086641|NCT00856284|541455705|FG002|Overall Study|Hyperglycemic rescue|235|||
150086642|NCT00856284|541455703|FG000|Overall Study|Adverse Event|60|||
150086643|NCT00856284|541455704|FG001|Overall Study|Adverse Event|74|||
150086644|NCT00856284|541455705|FG002|Overall Study|Adverse Event|82|||
150086645|NCT00856284|541455703|FG000|Overall Study|Major protocol deviation|24|||
150086646|NCT00856284|541455704|FG001|Overall Study|Major protocol deviation|16|||
150086647|NCT00856284|541455705|FG002|Overall Study|Major protocol deviation|15|||
150086648|NCT00856284|541455703|FG000|Overall Study|Lost to Follow-up|20|||
150086649|NCT00856284|541455704|FG001|Overall Study|Lost to Follow-up|22|||
150086650|NCT00856284|541455705|FG002|Overall Study|Lost to Follow-up|28|||
150086651|NCT00856284|541455703|FG000|Overall Study|Voluntary withdrawal|48|||
150086652|NCT00856284|541455704|FG001|Overall Study|Voluntary withdrawal|52|||
150086653|NCT00856284|541455705|FG002|Overall Study|Voluntary withdrawal|62|||
150086654|NCT00856284|541455703|FG000|Overall Study|Pregnancy|1|||
150086655|NCT00856284|541455704|FG001|Overall Study|Pregnancy|2|||
150086656|NCT00856284|541455705|FG002|Overall Study|Pregnancy|0|||
150086657|NCT00856284|541455703|FG000|Overall Study|Investigator discretion|9|||
150086658|NCT00856284|541455704|FG001|Overall Study|Investigator discretion|8|||
150086659|NCT00856284|541455705|FG002|Overall Study|Investigator discretion|10|||
150086660|NCT00856284|541455703|FG000|Overall Study|Other|15|||
150086661|NCT00856284|541455704|FG001|Overall Study|Other|17|||
150086662|NCT00856284|541455705|FG002|Overall Study|Other|14|||
150086663|NCT00856284|541455703|FG000|Overall Study|Randomized in error|0|||
150086664|NCT00856284|541455704|FG001|Overall Study|Randomized in error|0|||
150086665|NCT00856284|541455705|FG002|Overall Study|Randomized in error|1|||
150086666|NCT01327885|541455709|FG000|Overall Study|Disease progression-according to RECIST|173|||
150086667|NCT01327885|541455710|FG001|Overall Study|Disease progression-according to RECIST|165|||
150086668|NCT01327885|541455709|FG000|Overall Study|Clinical progression|24|||
150086669|NCT01327885|541455710|FG001|Overall Study|Clinical progression|27|||
150086670|NCT01327885|541455709|FG000|Overall Study|Adverse Event|14|||
150086671|NCT01327885|541455710|FG001|Overall Study|Adverse Event|10|||
150086672|NCT01327885|541455709|FG000|Overall Study|Subject choice|5|||
150086673|NCT01327885|541455710|FG001|Overall Study|Subject choice|10|||
150086674|NCT01327885|541455709|FG000|Overall Study|Other|8|||
150086675|NCT01327885|541455710|FG001|Overall Study|Other|6|||
150086676|NCT01327885|541455709|FG000|Overall Study|Withdrawal of consent from study|3|||
150086677|NCT01327885|541455710|FG001|Overall Study|Withdrawal of consent from study|4|||
150086678|NCT01327885|541455709|FG000|Overall Study|Not treated|1|||
150086679|NCT01327885|541455710|FG001|Overall Study|Not treated|1|||
150086680|NCT01327885|541455709|FG000|Overall Study|Administrative decision|0|||
150086681|NCT01327885|541455710|FG001|Overall Study|Administrative decision|1|||
150086682|NCT04271605|541455713|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
150086683|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086684|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086685|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086686|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086687|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086688|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
150086689|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
150086690|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086691|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086692|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086693|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086694|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086695|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
150086696|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
150086697|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086698|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086699|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086700|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086701|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086702|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
150086703|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
150086704|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150086705|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150086706|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150086707|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150086708|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150086709|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
150183949|NCT02965846|541810783|FG001|Overall Study|Lost to Follow-up|0|||
150183950|NCT02965846|541810784|FG002|Overall Study|Lost to Follow-up|0|||
150086710|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
150086711|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
150086712|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
150086713|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
150086714|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
150086715|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
150086716|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
150086717|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
150086718|NCT01059825|541455715|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
150086719|NCT01059825|541455716|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
150086720|NCT01059825|541455717|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
150086721|NCT01059825|541455718|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
150086722|NCT01059825|541455719|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
150086723|NCT01059825|541455720|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
150086724|NCT01059825|541455721|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
150086725|NCT01059825|541455715|FG000|Treatment Period|Lost to Follow-up|2|||
150086726|NCT01059825|541455716|FG001|Treatment Period|Lost to Follow-up|1|||
150086727|NCT01059825|541455717|FG002|Treatment Period|Lost to Follow-up|0|||
150086728|NCT01059825|541455718|FG003|Treatment Period|Lost to Follow-up|1|||
150086729|NCT01059825|541455719|FG004|Treatment Period|Lost to Follow-up|2|||
150086730|NCT01059825|541455720|FG005|Treatment Period|Lost to Follow-up|0|||
150086731|NCT01059825|541455721|FG006|Treatment Period|Lost to Follow-up|0|||
150086732|NCT01059825|541455715|FG000|Treatment Period|Withdrawal by Subject|3|||
150086733|NCT01059825|541455716|FG001|Treatment Period|Withdrawal by Subject|0|||
150086734|NCT01059825|541455717|FG002|Treatment Period|Withdrawal by Subject|1|||
150086735|NCT01059825|541455718|FG003|Treatment Period|Withdrawal by Subject|5|||
150086736|NCT01059825|541455719|FG004|Treatment Period|Withdrawal by Subject|4|||
150086737|NCT01059825|541455720|FG005|Treatment Period|Withdrawal by Subject|1|||
150086738|NCT01059825|541455721|FG006|Treatment Period|Withdrawal by Subject|0|||
150086739|NCT01059825|541455715|FG000|Treatment Period|Other reason not specified|1|||
150086740|NCT01059825|541455716|FG001|Treatment Period|Other reason not specified|2|||
150086741|NCT01059825|541455717|FG002|Treatment Period|Other reason not specified|1|||
150086742|NCT01059825|541455718|FG003|Treatment Period|Other reason not specified|2|||
150086743|NCT01059825|541455719|FG004|Treatment Period|Other reason not specified|0|||
150086744|NCT01059825|541455720|FG005|Treatment Period|Other reason not specified|0|||
150086745|NCT01059825|541455721|FG006|Treatment Period|Other reason not specified|0|||
150086746|NCT01059825|541455715|FG000|Treatment Period|Protocol Violation|0|||
150086747|NCT01059825|541455716|FG001|Treatment Period|Protocol Violation|0|||
150086748|NCT01059825|541455717|FG002|Treatment Period|Protocol Violation|1|||
150086749|NCT01059825|541455718|FG003|Treatment Period|Protocol Violation|1|||
150086750|NCT01059825|541455719|FG004|Treatment Period|Protocol Violation|1|||
150086751|NCT01059825|541455720|FG005|Treatment Period|Protocol Violation|1|||
150086752|NCT01059825|541455721|FG006|Treatment Period|Protocol Violation|0|||
150086753|NCT01059825|541455715|FG000|Treatment Period|Adverse event related to study drug|1|||
150086754|NCT01059825|541455716|FG001|Treatment Period|Adverse event related to study drug|0|||
150086755|NCT01059825|541455717|FG002|Treatment Period|Adverse event related to study drug|1|||
150086756|NCT01059825|541455718|FG003|Treatment Period|Adverse event related to study drug|1|||
150086757|NCT01059825|541455719|FG004|Treatment Period|Adverse event related to study drug|0|||
150086758|NCT01059825|541455720|FG005|Treatment Period|Adverse event related to study drug|0|||
150086759|NCT01059825|541455721|FG006|Treatment Period|Adverse event related to study drug|0|||
150086760|NCT01059825|541455715|FG000|Treatment Period|Insufficient clinical response|3|||
150086761|NCT01059825|541455716|FG001|Treatment Period|Insufficient clinical response|0|||
150086762|NCT01059825|541455717|FG002|Treatment Period|Insufficient clinical response|0|||
150086763|NCT01059825|541455718|FG003|Treatment Period|Insufficient clinical response|0|||
150086764|NCT01059825|541455719|FG004|Treatment Period|Insufficient clinical response|0|||
150086765|NCT01059825|541455720|FG005|Treatment Period|Insufficient clinical response|0|||
150086766|NCT01059825|541455721|FG006|Treatment Period|Insufficient clinical response|0|||
150086767|NCT01059825|541455715|FG000|Treatment Period|Adverse event not related to study drug|0|||
150086768|NCT01059825|541455716|FG001|Treatment Period|Adverse event not related to study drug|1|||
150086769|NCT01059825|541455717|FG002|Treatment Period|Adverse event not related to study drug|2|||
150086770|NCT01059825|541455718|FG003|Treatment Period|Adverse event not related to study drug|1|||
150086771|NCT01059825|541455719|FG004|Treatment Period|Adverse event not related to study drug|1|||
150086772|NCT01059825|541455720|FG005|Treatment Period|Adverse event not related to study drug|1|||
150086773|NCT01059825|541455721|FG006|Treatment Period|Adverse event not related to study drug|0|||
150086774|NCT03342690|541455726|FG000|Overall Study|Missing Information|9|||
150183951|NCT02965846|541810782|FG000|Overall Study|Withdrawal by Subject|0|||
150086775|NCT03342690|541455726|FG000|Overall Study|Protocol Violation|16|||
150086776|NCT03138889|541455727|FG000|Overall Study|Withdrawal by Subject|5|||
150183952|NCT02965846|541810783|FG001|Overall Study|Withdrawal by Subject|1|||
150183953|NCT02965846|541810784|FG002|Overall Study|Withdrawal by Subject|0|||
150183954|NCT02965846|541810782|FG000|Overall Study|Study Terminated By Sponsor|4|||
150183955|NCT02965846|541810783|FG001|Overall Study|Study Terminated By Sponsor|4|||
150183956|NCT02965846|541810784|FG002|Overall Study|Study Terminated By Sponsor|0|||
150183957|NCT02965846|541810782|FG000|Overall Study|Participants not randomized|0|||
150183958|NCT02965846|541810783|FG001|Overall Study|Participants not randomized|0|||
150183959|NCT02965846|541810784|FG002|Overall Study|Participants not randomized|33|||
150183960|NCT01424670|541810785|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
150183961|NCT01424670|541810786|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
150183962|NCT01424670|541810785|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
150183963|NCT01424670|541810786|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
150183964|NCT01424670|541810785|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
150183965|NCT01424670|541810786|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
150183966|NCT01424670|541810785|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
150183967|NCT01424670|541810786|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
150183968|NCT01424670|541810785|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
150183969|NCT01424670|541810786|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
150183970|NCT01424670|541810785|FG000|Continuation Period|Adverse Event|13|||
150183971|NCT01424670|541810786|FG001|Continuation Period|Adverse Event|5|||
150183972|NCT01424670|541810785|FG000|Continuation Period|Lost to Follow-up|2|||
150183973|NCT01424670|541810786|FG001|Continuation Period|Lost to Follow-up|0|||
150183974|NCT01424670|541810785|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
150183975|NCT01424670|541810786|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
150183976|NCT01424670|541810785|FG000|Continuation Period|Physician Decision|5|||
150183977|NCT01424670|541810786|FG001|Continuation Period|Physician Decision|4|||
150183978|NCT01424670|541810785|FG000|Continuation Period|Withdrawal by Subject|13|||
150183979|NCT01424670|541810786|FG001|Continuation Period|Withdrawal by Subject|4|||
150183980|NCT00761189|541810787|FG000|Overall Study|Adverse Event|42|||
150183981|NCT00761189|541810787|FG000|Overall Study|Lack of Efficacy|45|||
150183982|NCT00761189|541810787|FG000|Overall Study|Lost to Follow-up|36|||
150183983|NCT00761189|541810787|FG000|Overall Study|Withdrawal by Subject|49|||
150183984|NCT00761189|541810787|FG000|Overall Study|Other|13|||
150183985|NCT01494922|541810788|FG000|Overall Study|Adverse Event|1|||
150183986|NCT02759016|541810789|FG000|Overall Study|Not treated with BI 836826|1|||
150183987|NCT02759016|541810790|FG001|Overall Study|Not treated with BI 836826|0|||
150183988|NCT02759016|541810789|FG000|Overall Study|Progressive disease|1|||
150183989|NCT02759016|541810790|FG001|Overall Study|Progressive disease|0|||
150183990|NCT02759016|541810789|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
150183991|NCT02759016|541810790|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
150183992|NCT02759016|541810789|FG000|Overall Study|Other not defined above|2|||
150183993|NCT02759016|541810790|FG001|Overall Study|Other not defined above|1|||
150183994|NCT00709098|541810791|FG000|Double-blind Period|Withdrawal of consent|3|||
150183995|NCT00709098|541810792|FG001|Double-blind Period|Withdrawal of consent|3|||
150183996|NCT00709098|541810793|FG002|Double-blind Period|Withdrawal of consent|0|||
150183997|NCT00709098|541810791|FG000|Double-blind Period|Administrative reason|1|||
150183998|NCT00709098|541810792|FG001|Double-blind Period|Administrative reason|3|||
150183999|NCT00709098|541810793|FG002|Double-blind Period|Administrative reason|0|||
150184000|NCT00709098|541810791|FG000|Double-blind Period|Death|1|||
150086777|NCT03138889|541455728|FG001|Overall Study|Withdrawal by Subject|5|||
150086778|NCT03138889|541455729|FG002|Overall Study|Withdrawal by Subject|0|||
150086779|NCT03138889|541455730|FG003|Overall Study|Withdrawal by Subject|2|||
150184001|NCT00709098|541810792|FG001|Double-blind Period|Death|1|||
150184002|NCT00709098|541810793|FG002|Double-blind Period|Death|0|||
150184003|NCT00709098|541810791|FG000|Double-blind Period|Lost to Follow-up|1|||
150184004|NCT00709098|541810792|FG001|Double-blind Period|Lost to Follow-up|1|||
150184005|NCT00709098|541810793|FG002|Double-blind Period|Lost to Follow-up|0|||
150184006|NCT00709098|541810791|FG000|Open-label Period|Withdrawal of consent|0|||
150184007|NCT00709098|541810792|FG001|Open-label Period|Withdrawal of consent|0|||
150184008|NCT00709098|541810793|FG002|Open-label Period|Withdrawal of consent|7|||
150086780|NCT03138889|541455731|FG004|Overall Study|Withdrawal by Subject|1|||
150086781|NCT03138889|541455732|FG005|Overall Study|Withdrawal by Subject|3|||
150086782|NCT03138889|541455733|FG006|Overall Study|Withdrawal by Subject|0|||
150086783|NCT03138889|541455734|FG007|Overall Study|Withdrawal by Subject|1|||
150086784|NCT00105482|541455735|FG000|Overall Study|Adverse Event|1|||
150086785|NCT00105482|541455736|FG001|Overall Study|Adverse Event|1|||
150086786|NCT00105482|541455735|FG000|Overall Study|Lost to Follow-up|26|||
150086787|NCT00105482|541455736|FG001|Overall Study|Lost to Follow-up|17|||
150086788|NCT00105482|541455735|FG000|Overall Study|Withdrawal by Subject|0|||
150086789|NCT00105482|541455736|FG001|Overall Study|Withdrawal by Subject|1|||
150086790|NCT00105482|541455735|FG000|Overall Study|Lost Interest|29|||
150086791|NCT00105482|541455736|FG001|Overall Study|Lost Interest|32|||
150086792|NCT00105482|541455735|FG000|Overall Study|Scheduling Conflict|2|||
150086793|NCT00105482|541455736|FG001|Overall Study|Scheduling Conflict|3|||
150086794|NCT00105482|541455735|FG000|Overall Study|Withdrawn by PI|1|||
150086795|NCT00105482|541455736|FG001|Overall Study|Withdrawn by PI|1|||
150086796|NCT00411645|541455737|FG000|Overall Study|Consent Withdrawn|13|||
150086797|NCT00411645|541455738|FG001|Overall Study|Consent Withdrawn|22|||
150086798|NCT00411645|541455737|FG000|Overall Study|Death|56|||
150086799|NCT00411645|541455738|FG001|Overall Study|Death|135|||
150086800|NCT00411645|541455737|FG000|Overall Study|Investigator/Sponsor Decision|10|||
150086801|NCT00411645|541455738|FG001|Overall Study|Investigator/Sponsor Decision|7|||
150086802|NCT00411645|541455737|FG000|Overall Study|Lost to Follow-up|2|||
150086803|NCT00411645|541455738|FG001|Overall Study|Lost to Follow-up|0|||
150086804|NCT04016285|541455739|FG000|Overall Study|Did not progress to surgery|2|||
150086805|NCT04016285|541455740|FG001|Overall Study|Did not progress to surgery|5|||
150086806|NCT04016285|541455739|FG000|Overall Study|Failed to collect outcome data|5|||
150086807|NCT04016285|541455740|FG001|Overall Study|Failed to collect outcome data|3|||
150086808|NCT01749514|541455743|FG000|Overall Study|Lost to Follow-up|0|||
150086809|NCT01749514|541455744|FG001|Overall Study|Lost to Follow-up|0|||
150086810|NCT01749514|541455745|FG002|Overall Study|Lost to Follow-up|0|||
150086811|NCT01749514|541455746|FG003|Overall Study|Lost to Follow-up|0|||
150086812|NCT01749514|541455747|FG004|Overall Study|Lost to Follow-up|0|||
150086813|NCT01749514|541455748|FG005|Overall Study|Lost to Follow-up|0|||
150086814|NCT01749514|541455749|FG006|Overall Study|Lost to Follow-up|0|||
150086815|NCT01749514|541455750|FG007|Overall Study|Lost to Follow-up|1|||
150086816|NCT01749514|541455743|FG000|Overall Study|Withdrawal by Subject|0|||
150086817|NCT01749514|541455744|FG001|Overall Study|Withdrawal by Subject|0|||
150086818|NCT01749514|541455745|FG002|Overall Study|Withdrawal by Subject|0|||
150086819|NCT01749514|541455746|FG003|Overall Study|Withdrawal by Subject|0|||
150086820|NCT01749514|541455747|FG004|Overall Study|Withdrawal by Subject|0|||
150086821|NCT01749514|541455748|FG005|Overall Study|Withdrawal by Subject|1|||
150086822|NCT01749514|541455749|FG006|Overall Study|Withdrawal by Subject|0|||
150086823|NCT01749514|541455750|FG007|Overall Study|Withdrawal by Subject|1|||
150086824|NCT01749514|541455743|FG000|Overall Study|Not Reported|0|||
150086825|NCT01749514|541455744|FG001|Overall Study|Not Reported|0|||
150086826|NCT01749514|541455745|FG002|Overall Study|Not Reported|0|||
150086827|NCT01749514|541455746|FG003|Overall Study|Not Reported|0|||
150086828|NCT01749514|541455747|FG004|Overall Study|Not Reported|0|||
150086829|NCT01749514|541455748|FG005|Overall Study|Not Reported|0|||
150086830|NCT01749514|541455749|FG006|Overall Study|Not Reported|0|||
150086831|NCT01749514|541455750|FG007|Overall Study|Not Reported|5|||
150086832|NCT00006903|541455754|FG000|Overall Study|Still receiving treatment|0|||
150086833|NCT00006903|541455755|FG001|Overall Study|Still receiving treatment|0|||
150086834|NCT00006903|541455756|FG002|Overall Study|Still receiving treatment|1|||
150086835|NCT00006903|541455754|FG000|Overall Study|Refused further treatment|0|||
150086836|NCT00006903|541455755|FG001|Overall Study|Refused further treatment|2|||
150086837|NCT00006903|541455756|FG002|Overall Study|Refused further treatment|1|||
150086838|NCT00006903|541455754|FG000|Overall Study|Adverse Event|0|||
150086839|NCT00006903|541455755|FG001|Overall Study|Adverse Event|0|||
150086840|NCT00006903|541455756|FG002|Overall Study|Adverse Event|1|||
150086841|NCT00006903|541455754|FG000|Overall Study|Death|0|||
150086842|NCT00006903|541455755|FG001|Overall Study|Death|1|||
150086843|NCT00006903|541455756|FG002|Overall Study|Death|0|||
150086844|NCT00006903|541455754|FG000|Overall Study|Patient never treated|0|||
150086845|NCT00006903|541455755|FG001|Overall Study|Patient never treated|0|||
150086846|NCT00006903|541455756|FG002|Overall Study|Patient never treated|1|||
150086847|NCT00006903|541455754|FG000|Overall Study|Ineligible|10|||
150086848|NCT00006903|541455755|FG001|Overall Study|Ineligible|1|||
150086849|NCT00006903|541455756|FG002|Overall Study|Ineligible|2|||
150086850|NCT01909674|541455757|FG000|Overall Study|Withdrawal by Subject|5|||
150086851|NCT01909674|541455758|FG001|Overall Study|Withdrawal by Subject|2|||
150086852|NCT02969369|541455759|FG000|Study|Adverse Event|1|||
150086853|NCT02969369|541455760|FG001|Study|Adverse Event|6|||
150086854|NCT02969369|541455759|FG000|Study|Lack of Efficacy|0|||
150086855|NCT02969369|541455760|FG001|Study|Lack of Efficacy|1|||
150086856|NCT02969369|541455759|FG000|Study|Lost to Follow-up|0|||
150086857|NCT02969369|541455760|FG001|Study|Lost to Follow-up|1|||
150086858|NCT02969369|541455759|FG000|Study|Withdrawal by Subject|3|||
150086859|NCT02969369|541455760|FG001|Study|Withdrawal by Subject|5|||
150086860|NCT02969369|541455759|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
150086861|NCT02969369|541455760|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
150086862|NCT02969369|541455759|FG000|Double-blind Period|Adverse Event|1|||
150086863|NCT02969369|541455760|FG001|Double-blind Period|Adverse Event|5|||
150086864|NCT02969369|541455759|FG000|Double-blind Period|Lost to Follow-up|0|||
150086865|NCT02969369|541455760|FG001|Double-blind Period|Lost to Follow-up|1|||
150086866|NCT02969369|541455759|FG000|Double-blind Period|Withdrawal by Subject|2|||
150086867|NCT02969369|541455760|FG001|Double-blind Period|Withdrawal by Subject|3|||
150086868|NCT02969369|541455759|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
150086869|NCT02969369|541455760|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
150086870|NCT02969369|541455759|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
150086871|NCT02969369|541455760|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
150086872|NCT02969369|541455759|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
150086873|NCT02969369|541455760|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
150086874|NCT02969369|541455759|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
150086875|NCT02969369|541455760|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
150086876|NCT01217814|541455763|FG000|Overall Study|Adverse Event|1|||
150086877|NCT01217814|541455764|FG001|Overall Study|Adverse Event|1|||
150086878|NCT01217814|541455765|FG002|Overall Study|Adverse Event|0|||
150086879|NCT01217814|541455763|FG000|Overall Study|Lack of Efficacy|0|||
150086880|NCT01217814|541455764|FG001|Overall Study|Lack of Efficacy|0|||
150086881|NCT01217814|541455765|FG002|Overall Study|Lack of Efficacy|1|||
150086882|NCT01637272|541455768|FG000|Overall Study|Adverse Event|6|||
150086883|NCT01637272|541455768|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150086884|NCT01637272|541455768|FG000|Overall Study|Withdrawal by Subject|3|||
150086885|NCT01637272|541455768|FG000|Overall Study|Lost to Follow-up|2|||
150086886|NCT01637272|541455768|FG000|Overall Study|completed core, did not enter ext. phase|4|||
150086887|NCT01637272|541455768|FG000|Overall Study|Administrative problems|1|||
150086888|NCT01637272|541455768|FG000|Overall Study|Protocol Violation|2|||
150086889|NCT01496612|541455769|FG000|1st Intervention|Adverse Event|1|||
150086890|NCT01496612|541455770|FG001|1st Intervention|Adverse Event|0|||
150086891|NCT01496612|541455769|FG000|1st Intervention|Withdrawal by Subject|1|||
150086892|NCT01496612|541455770|FG001|1st Intervention|Withdrawal by Subject|0|||
150086893|NCT01666782|541455775|FG000|Overall Study|Received 2 doses of vaccine|0|||
150086894|NCT01666782|541455776|FG001|Overall Study|Received 2 doses of vaccine|1|||
150086895|NCT01666782|541455775|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
150086896|NCT01666782|541455776|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
150086897|NCT05425745|541455782|FG000|Overall Study|Withdrawal of Consent|3|||
150086898|NCT05425745|541455783|FG001|Overall Study|Withdrawal of Consent|3|||
150086899|NCT05425745|541455782|FG000|Overall Study|Death|2|||
150086900|NCT05425745|541455783|FG001|Overall Study|Death|3|||
150086901|NCT05425745|541455782|FG000|Overall Study|Lost to Follow-up|1|||
150086902|NCT05425745|541455783|FG001|Overall Study|Lost to Follow-up|2|||
150086903|NCT05425745|541455782|FG000|Overall Study|Adverse Event|0|||
150086904|NCT05425745|541455783|FG001|Overall Study|Adverse Event|1|||
150086905|NCT05425745|541455782|FG000|Overall Study|Did not return for end of study visit|0|||
150086906|NCT05425745|541455783|FG001|Overall Study|Did not return for end of study visit|1|||
150086907|NCT05425745|541455782|FG000|Overall Study|End of study visit completed by phone|1|||
150086908|NCT05425745|541455783|FG001|Overall Study|End of study visit completed by phone|0|||
150086909|NCT05425745|541455782|FG000|Overall Study|Subject decision|1|||
150086910|NCT05425745|541455783|FG001|Overall Study|Subject decision|0|||
150086911|NCT00524368|541457818|FG000|Overall Study|Adverse Event|10|||
150086912|NCT00524368|541457819|FG001|Overall Study|Adverse Event|12|||
150086913|NCT00524368|541457818|FG000|Overall Study|Lost to Follow-up|9|||
150086914|NCT00524368|541457819|FG001|Overall Study|Lost to Follow-up|13|||
150086915|NCT00524368|541457818|FG000|Overall Study|Withdrawal by Subject|4|||
150086916|NCT00524368|541457819|FG001|Overall Study|Withdrawal by Subject|5|||
150086917|NCT00524368|541457818|FG000|Overall Study|Non-compliant|8|||
150086918|NCT00524368|541457819|FG001|Overall Study|Non-compliant|9|||
150086919|NCT00524368|541457818|FG000|Overall Study|Reached a Virologic Endpoint|3|||
150086920|NCT00524368|541457819|FG001|Overall Study|Reached a Virologic Endpoint|2|||
150086921|NCT00524368|541457818|FG000|Overall Study|Sponsor's Decision|2|||
150086922|NCT00524368|541457819|FG001|Overall Study|Sponsor's Decision|0|||
150086923|NCT00524368|541457818|FG000|Overall Study|Ineligible to Continue the study|2|||
150086924|NCT00524368|541457819|FG001|Overall Study|Ineligible to Continue the study|5|||
150086925|NCT00524368|541457818|FG000|Overall Study|Other|3|||
150086926|NCT00524368|541457819|FG001|Overall Study|Other|2|||
150086927|NCT01955733|541457821|FG000|Period 1|Lost to Follow-up|1|||
150086928|NCT01955733|541457822|FG001|Period 1|Lost to Follow-up|0|||
150086929|NCT01955733|541457823|FG002|Period 1|Lost to Follow-up|0|||
150086930|NCT01955733|541457821|FG000|Period 2|Adverse Event|1|||
150086931|NCT01955733|541457822|FG001|Period 2|Adverse Event|0|||
150086932|NCT01955733|541457823|FG002|Period 2|Adverse Event|0|||
150086933|NCT01955733|541457821|FG000|Period 2|Physician Decision|0|||
150086934|NCT01955733|541457822|FG001|Period 2|Physician Decision|0|||
150086935|NCT01955733|541457823|FG002|Period 2|Physician Decision|1|||
150086936|NCT01955733|541457821|FG000|Period 2|Withdrawal by Subject|1|||
150086937|NCT01955733|541457822|FG001|Period 2|Withdrawal by Subject|3|||
150086938|NCT01955733|541457823|FG002|Period 2|Withdrawal by Subject|2|||
150086939|NCT01955733|541457821|FG000|Period 2|Study terminated by sponsor|8|||
150086940|NCT01955733|541457822|FG001|Period 2|Study terminated by sponsor|14|||
150086941|NCT01955733|541457823|FG002|Period 2|Study terminated by sponsor|16|||
150086942|NCT01955733|541457821|FG000|Period 2|Lost to Follow-up|2|||
150086943|NCT01955733|541457822|FG001|Period 2|Lost to Follow-up|0|||
150086944|NCT01955733|541457823|FG002|Period 2|Lost to Follow-up|0|||
150086945|NCT01955733|541457821|FG000|Period 2|Other not defined above|0|||
150086946|NCT01955733|541457822|FG001|Period 2|Other not defined above|2|||
150086947|NCT01955733|541457823|FG002|Period 2|Other not defined above|2|||
150086948|NCT02762266|541457824|FG000|Overall Study|Physician Decision|2|||
150086949|NCT02762266|541457825|FG001|Overall Study|Physician Decision|0|||
150086950|NCT02961751|541457838|FG000|Overall Study|Lost to Follow-up|11|||
150086951|NCT02961751|541457838|FG000|Overall Study|Physician Decision|2|||
150086952|NCT02961751|541457838|FG000|Overall Study|Not Eligible at Enrollment|1|||
150086953|NCT02961751|541457838|FG000|Overall Study|Protocol Violation|1|||
150086954|NCT00842712|541457839|FG000|Safety Run-in Part|Adverse Event|0|||
150086955|NCT00842712|541457840|FG001|Safety Run-in Part|Adverse Event|1|||
150086956|NCT00842712|541457841|FG002|Safety Run-in Part|Adverse Event|0|||
150086957|NCT00842712|541457842|FG003|Safety Run-in Part|Adverse Event|0|||
150086958|NCT00842712|541457843|FG004|Safety Run-in Part|Adverse Event|0|||
150086959|NCT00842712|541457844|FG005|Safety Run-in Part|Adverse Event|0|||
150086960|NCT00842712|541457845|FG006|Safety Run-in Part|Adverse Event|0|||
150086961|NCT00842712|541457839|FG000|Safety Run-in Part|Progressive disease|3|||
150086962|NCT00842712|541457840|FG001|Safety Run-in Part|Progressive disease|1|||
150086963|NCT00842712|541457841|FG002|Safety Run-in Part|Progressive disease|0|||
150086964|NCT00842712|541457842|FG003|Safety Run-in Part|Progressive disease|1|||
150086965|NCT00842712|541457843|FG004|Safety Run-in Part|Progressive disease|0|||
150086966|NCT00842712|541457844|FG005|Safety Run-in Part|Progressive disease|0|||
150086967|NCT00842712|541457845|FG006|Safety Run-in Part|Progressive disease|0|||
150086968|NCT00842712|541457839|FG000|Randomized Part|Randomized but not treated|0|||
150184009|NCT00709098|541810791|FG000|Open-label Period|Administrative reason|0|||
150184010|NCT00709098|541810792|FG001|Open-label Period|Administrative reason|0|||
150184011|NCT00709098|541810793|FG002|Open-label Period|Administrative reason|5|||
150184012|NCT00709098|541810791|FG000|Open-label Period|Death|0|||
150184013|NCT00709098|541810792|FG001|Open-label Period|Death|0|||
150184014|NCT00709098|541810793|FG002|Open-label Period|Death|1|||
150184015|NCT00709098|541810791|FG000|Open-label Period|Lost to Follow-up|0|||
150184016|NCT00709098|541810792|FG001|Open-label Period|Lost to Follow-up|0|||
150184017|NCT00709098|541810793|FG002|Open-label Period|Lost to Follow-up|1|||
150184018|NCT02119650|541810795|FG000|Overall Study|Adverse Event|3|||
150184019|NCT02119650|541810796|FG001|Overall Study|Adverse Event|4|||
150184020|NCT02119650|541810795|FG000|Overall Study|Subject decision|2|||
150184021|NCT02119650|541810796|FG001|Overall Study|Subject decision|3|||
150184022|NCT02119650|541810795|FG000|Overall Study|Disease progression|11|||
150184023|NCT02119650|541810796|FG001|Overall Study|Disease progression|14|||
150184024|NCT02119650|541810795|FG000|Overall Study|Death|5|||
150184025|NCT02119650|541810796|FG001|Overall Study|Death|1|||
150184026|NCT02119650|541810795|FG000|Overall Study|Noncompliance with study treatment|1|||
150184027|NCT02119650|541810796|FG001|Overall Study|Noncompliance with study treatment|1|||
150184028|NCT02119650|541810795|FG000|Overall Study|Study terminated by the sponsor|1|||
150184029|NCT02119650|541810796|FG001|Overall Study|Study terminated by the sponsor|0|||
150184030|NCT02119650|541810795|FG000|Overall Study|Physician Decision|0|||
150184031|NCT02119650|541810796|FG001|Overall Study|Physician Decision|2|||
150086969|NCT00842712|541457840|FG001|Randomized Part|Randomized but not treated|0|||
150086970|NCT00842712|541457841|FG002|Randomized Part|Randomized but not treated|0|||
150086971|NCT00842712|541457842|FG003|Randomized Part|Randomized but not treated|0|||
150086972|NCT00842712|541457843|FG004|Randomized Part|Randomized but not treated|0|||
150086973|NCT00842712|541457844|FG005|Randomized Part|Randomized but not treated|1|||
150086974|NCT00842712|541457845|FG006|Randomized Part|Randomized but not treated|4|||
150086975|NCT00842712|541457839|FG000|Randomized Part|Ongoing at cut-off date|0|||
150086976|NCT00842712|541457840|FG001|Randomized Part|Ongoing at cut-off date|0|||
150086977|NCT00842712|541457841|FG002|Randomized Part|Ongoing at cut-off date|0|||
150086978|NCT00842712|541457842|FG003|Randomized Part|Ongoing at cut-off date|0|||
150086979|NCT00842712|541457843|FG004|Randomized Part|Ongoing at cut-off date|0|||
150086980|NCT00842712|541457844|FG005|Randomized Part|Ongoing at cut-off date|0|||
150086981|NCT00842712|541457845|FG006|Randomized Part|Ongoing at cut-off date|2|||
150086982|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
150086983|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
150086984|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
150086985|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
150086986|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
150086987|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
150086988|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
150086989|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
150086990|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
150086991|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
150086992|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|Other|1|||
150086993|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|Other|1|||
150086994|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|Other|0|||
150086995|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|Other|0|||
150086996|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|Other|0|||
150086997|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
150086998|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
150086999|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
150087000|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
150087001|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
150087002|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
150087003|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
150087004|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
150087005|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
150184032|NCT02119650|541810795|FG000|Overall Study|Multiple reasons for termination|2|||
150184033|NCT02119650|541810796|FG001|Overall Study|Multiple reasons for termination|1|||
150184034|NCT02269475|541810797|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
150087006|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
150087007|NCT02310568|541457856|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
150184035|NCT02269475|541810798|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
150184036|NCT02269475|541810797|FG000|Overall Study|Withdrawal by Subject|0|||
150184037|NCT02269475|541810798|FG001|Overall Study|Withdrawal by Subject|1|||
150184038|NCT01303445|541810801|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
150087008|NCT02310568|541457857|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
150087009|NCT02310568|541457858|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
150087010|NCT02310568|541457859|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
150087011|NCT02310568|541457860|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
150087012|NCT02310568|541457856|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
150087013|NCT02310568|541457857|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
150087014|NCT02310568|541457858|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
150087015|NCT02310568|541457859|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
150087016|NCT02310568|541457860|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
150087017|NCT02310568|541457856|FG000|Stage 2 (4 Weeks)|Other|0|||
150087018|NCT02310568|541457857|FG001|Stage 2 (4 Weeks)|Other|1|||
150087019|NCT02310568|541457858|FG002|Stage 2 (4 Weeks)|Other|1|||
150087020|NCT02310568|541457859|FG003|Stage 2 (4 Weeks)|Other|0|||
150087021|NCT02310568|541457860|FG004|Stage 2 (4 Weeks)|Other|0|||
150087022|NCT02310568|541457856|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
150087023|NCT02310568|541457857|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
150087024|NCT02310568|541457858|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
150087025|NCT02310568|541457859|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
150087026|NCT02310568|541457860|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
150087027|NCT02310568|541457856|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
150087028|NCT02310568|541457857|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
150087029|NCT02310568|541457858|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
150087030|NCT02310568|541457859|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
150087031|NCT02310568|541457860|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
150087032|NCT02310568|541457856|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
150087033|NCT02310568|541457857|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
150087034|NCT02310568|541457858|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
150087035|NCT02310568|541457859|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
150087036|NCT02310568|541457860|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
150087037|NCT02289690|541457870|FG000|Overall Study|Adverse Event Related to Progression|0|||
150087038|NCT02289690|541457871|FG001|Overall Study|Adverse Event Related to Progression|1|||
150087039|NCT02289690|541457872|FG002|Overall Study|Adverse Event Related to Progression|1|||
150087040|NCT02289690|541457873|FG003|Overall Study|Adverse Event Related to Progression|0|||
150087041|NCT02289690|541457874|FG004|Overall Study|Adverse Event Related to Progression|1|||
150087042|NCT02289690|541457875|FG005|Overall Study|Adverse Event Related to Progression|0|||
150087043|NCT02289690|541457876|FG006|Overall Study|Adverse Event Related to Progression|1|||
150087044|NCT02289690|541457877|FG007|Overall Study|Adverse Event Related to Progression|0|||
150087045|NCT02289690|541457878|FG008|Overall Study|Adverse Event Related to Progression|0|||
150087046|NCT02289690|541457879|FG009|Overall Study|Adverse Event Related to Progression|0|||
150087047|NCT02289690|541457870|FG000|Overall Study|Withdrawal by Subject|1|||
150087048|NCT02289690|541457871|FG001|Overall Study|Withdrawal by Subject|0|||
150087049|NCT02289690|541457872|FG002|Overall Study|Withdrawal by Subject|0|||
150087050|NCT02289690|541457873|FG003|Overall Study|Withdrawal by Subject|0|||
150087051|NCT02289690|541457874|FG004|Overall Study|Withdrawal by Subject|1|||
150087052|NCT02289690|541457875|FG005|Overall Study|Withdrawal by Subject|1|||
150087053|NCT02289690|541457876|FG006|Overall Study|Withdrawal by Subject|0|||
150087054|NCT02289690|541457877|FG007|Overall Study|Withdrawal by Subject|0|||
150087055|NCT02289690|541457878|FG008|Overall Study|Withdrawal by Subject|4|||
150087056|NCT02289690|541457879|FG009|Overall Study|Withdrawal by Subject|2|||
150087057|NCT02289690|541457870|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
150087058|NCT02289690|541457871|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
150087059|NCT02289690|541457872|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
150087060|NCT02289690|541457873|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
150087061|NCT02289690|541457874|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
150087062|NCT02289690|541457875|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
150087063|NCT02289690|541457876|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
150087064|NCT02289690|541457877|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
150087065|NCT02289690|541457878|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
150087066|NCT02289690|541457879|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
150087067|NCT02289690|541457870|FG000|Overall Study|Lost to Follow-up|0|||
150087068|NCT02289690|541457871|FG001|Overall Study|Lost to Follow-up|0|||
150184039|NCT01303445|541810802|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
150087069|NCT02289690|541457872|FG002|Overall Study|Lost to Follow-up|0|||
150184040|NCT01303445|541810801|FG000|Second Intervention (7 Days)|Adverse Event|0|||
150087070|NCT02289690|541457873|FG003|Overall Study|Lost to Follow-up|0|||
150087071|NCT02289690|541457874|FG004|Overall Study|Lost to Follow-up|0|||
150087072|NCT02289690|541457875|FG005|Overall Study|Lost to Follow-up|0|||
150087073|NCT02289690|541457876|FG006|Overall Study|Lost to Follow-up|0|||
150087074|NCT02289690|541457877|FG007|Overall Study|Lost to Follow-up|1|||
150087075|NCT02289690|541457878|FG008|Overall Study|Lost to Follow-up|0|||
150087076|NCT02289690|541457879|FG009|Overall Study|Lost to Follow-up|2|||
150087077|NCT02289690|541457870|FG000|Overall Study|Death|0|||
150087078|NCT02289690|541457871|FG001|Overall Study|Death|0|||
150087079|NCT02289690|541457872|FG002|Overall Study|Death|0|||
150087080|NCT02289690|541457873|FG003|Overall Study|Death|0|||
150087081|NCT02289690|541457874|FG004|Overall Study|Death|0|||
150087082|NCT02289690|541457875|FG005|Overall Study|Death|0|||
150087083|NCT02289690|541457876|FG006|Overall Study|Death|0|||
150087084|NCT02289690|541457877|FG007|Overall Study|Death|49|||
150087085|NCT02289690|541457878|FG008|Overall Study|Death|45|||
150087086|NCT02289690|541457879|FG009|Overall Study|Death|41|||
150087087|NCT02289690|541457870|FG000|Overall Study|Sponsor Discontinued Study|0|||
150087088|NCT02289690|541457871|FG001|Overall Study|Sponsor Discontinued Study|0|||
150087089|NCT02289690|541457872|FG002|Overall Study|Sponsor Discontinued Study|0|||
150087090|NCT02289690|541457873|FG003|Overall Study|Sponsor Discontinued Study|0|||
150087091|NCT02289690|541457874|FG004|Overall Study|Sponsor Discontinued Study|0|||
150087092|NCT02289690|541457875|FG005|Overall Study|Sponsor Discontinued Study|0|||
150087093|NCT02289690|541457876|FG006|Overall Study|Sponsor Discontinued Study|0|||
150087094|NCT02289690|541457877|FG007|Overall Study|Sponsor Discontinued Study|9|||
150087095|NCT02289690|541457878|FG008|Overall Study|Sponsor Discontinued Study|7|||
150087096|NCT02289690|541457879|FG009|Overall Study|Sponsor Discontinued Study|15|||
150087097|NCT02289690|541457870|FG000|Overall Study|Other|0|||
150087098|NCT02289690|541457871|FG001|Overall Study|Other|0|||
150087099|NCT02289690|541457872|FG002|Overall Study|Other|0|||
150087100|NCT02289690|541457873|FG003|Overall Study|Other|1|||
150087101|NCT02289690|541457874|FG004|Overall Study|Other|1|||
150087102|NCT02289690|541457875|FG005|Overall Study|Other|0|||
150087103|NCT02289690|541457876|FG006|Overall Study|Other|1|||
150087104|NCT02289690|541457877|FG007|Overall Study|Other|2|||
150087105|NCT02289690|541457878|FG008|Overall Study|Other|3|||
150087106|NCT02289690|541457879|FG009|Overall Study|Other|1|||
150087107|NCT00779467|541457882|FG000|Overall Study|Lack of Efficacy|11|||
150087108|NCT00779467|541457883|FG001|Overall Study|Lack of Efficacy|2|||
150087109|NCT00779467|541457884|FG002|Overall Study|Lack of Efficacy|6|||
150087110|NCT00779467|541457885|FG003|Overall Study|Lack of Efficacy|11|||
150087111|NCT00779467|541457882|FG000|Overall Study|failed inclusion criteria|3|||
150087112|NCT00779467|541457883|FG001|Overall Study|failed inclusion criteria|3|||
150087113|NCT00779467|541457884|FG002|Overall Study|failed inclusion criteria|1|||
150087114|NCT00779467|541457885|FG003|Overall Study|failed inclusion criteria|2|||
150087115|NCT00779467|541457882|FG000|Overall Study|missing data|1|||
150087116|NCT00779467|541457883|FG001|Overall Study|missing data|0|||
150087117|NCT00779467|541457884|FG002|Overall Study|missing data|1|||
150087118|NCT00779467|541457885|FG003|Overall Study|missing data|4|||
150087119|NCT00779467|541457882|FG000|Overall Study|technical issue|0|||
150087120|NCT00779467|541457883|FG001|Overall Study|technical issue|0|||
150087121|NCT00779467|541457884|FG002|Overall Study|technical issue|2|||
150087122|NCT00779467|541457885|FG003|Overall Study|technical issue|1|||
150087123|NCT00779467|541457882|FG000|Overall Study|unavailable research staff|0|||
150087124|NCT00779467|541457883|FG001|Overall Study|unavailable research staff|0|||
150087125|NCT00779467|541457884|FG002|Overall Study|unavailable research staff|0|||
150087126|NCT00779467|541457885|FG003|Overall Study|unavailable research staff|1|||
150087127|NCT00644995|541457886|FG000|Overall Study|Lost to Follow-up|1|||
150087128|NCT00644995|541457887|FG001|Overall Study|Lost to Follow-up|4|||
150087129|NCT00644995|541457886|FG000|Overall Study|Refused|1|||
150087130|NCT00644995|541457887|FG001|Overall Study|Refused|0|||
150087131|NCT00865124|541457894|FG000|Overall Study|Physician Decision|2|||
150087132|NCT00865124|541457895|FG001|Overall Study|Physician Decision|1|||
150087133|NCT00865124|541457896|FG002|Overall Study|Physician Decision|0|||
150087134|NCT00865124|541457894|FG000|Overall Study|Withdrawn consent|2|||
150087135|NCT00865124|541457895|FG001|Overall Study|Withdrawn consent|0|||
150087136|NCT00865124|541457896|FG002|Overall Study|Withdrawn consent|0|||
150087137|NCT02743520|541457897|FG000|Overall Study|Withdrawal by Subject|1|||
150087138|NCT03247530|541457898|FG000|Overall Study|Withdrawal by caregiver|19|||
150087139|NCT03247530|541457899|FG001|Overall Study|Withdrawal by caregiver|8|||
150087140|NCT03247530|541457900|FG002|Overall Study|Withdrawal by caregiver|10|||
150087141|NCT03247530|541457898|FG000|Overall Study|Lost to Follow-up|3|||
150087142|NCT03247530|541457899|FG001|Overall Study|Lost to Follow-up|9|||
150087143|NCT03247530|541457900|FG002|Overall Study|Lost to Follow-up|6|||
150087144|NCT03247530|541457898|FG000|Overall Study|Adverse Event|2|||
150087145|NCT03247530|541457899|FG001|Overall Study|Adverse Event|5|||
150087146|NCT03247530|541457900|FG002|Overall Study|Adverse Event|2|||
150087147|NCT03247530|541457898|FG000|Overall Study|Failure to follow procedure|1|||
150087148|NCT03247530|541457899|FG001|Overall Study|Failure to follow procedure|1|||
150087149|NCT03247530|541457900|FG002|Overall Study|Failure to follow procedure|1|||
150087150|NCT03247530|541457898|FG000|Overall Study|Withdrawal by Subject|1|||
150087151|NCT03247530|541457899|FG001|Overall Study|Withdrawal by Subject|1|||
150087152|NCT03247530|541457900|FG002|Overall Study|Withdrawal by Subject|0|||
150087153|NCT03247530|541457898|FG000|Overall Study|Study medication misuse|0|||
150087154|NCT03247530|541457899|FG001|Overall Study|Study medication misuse|1|||
150087155|NCT03247530|541457900|FG002|Overall Study|Study medication misuse|0|||
150087156|NCT03247530|541457898|FG000|Overall Study|Other, multiple categories|1|||
150087157|NCT03247530|541457899|FG001|Overall Study|Other, multiple categories|3|||
150087158|NCT03247530|541457900|FG002|Overall Study|Other, multiple categories|1|||
150087159|NCT02509156|541457904|FG000|Randomized Phase|Death|1|||
150087160|NCT02509156|541457905|FG001|Randomized Phase|Death|0|||
150087161|NCT02509156|541457904|FG000|Randomized Phase|Withdrawal by Subject|1|||
150087162|NCT02509156|541457905|FG001|Randomized Phase|Withdrawal by Subject|1|||
150087163|NCT03042533|541457906|FG000|Overall Study|MD left program|1|||
150087164|NCT03042533|541457907|FG001|Overall Study|MD left program|4|||
150087165|NCT03042533|541457908|FG002|Overall Study|MD left program|1|||
150087166|NCT02547649|541457909|FG000|Overall Study|Lost to Follow-up|3|||
150087167|NCT02547649|541457910|FG001|Overall Study|Lost to Follow-up|1|||
150087168|NCT02547649|541457911|FG002|Overall Study|Lost to Follow-up|1|||
150087169|NCT02547649|541457909|FG000|Overall Study|Not vaccinated|0|||
150087170|NCT02547649|541457910|FG001|Overall Study|Not vaccinated|0|||
150087171|NCT02547649|541457911|FG002|Overall Study|Not vaccinated|1|||
150087172|NCT02547649|541457909|FG000|Overall Study|Withdrawal by Subject|0|||
150087173|NCT02547649|541457910|FG001|Overall Study|Withdrawal by Subject|4|||
150087174|NCT02547649|541457911|FG002|Overall Study|Withdrawal by Subject|2|||
150087175|NCT02551731|541457913|FG000|Overall Study|Withdrawal by Subject|2|||
150087176|NCT01678911|541457916|FG000|Second Intervention|Lost to Follow-up|2|||
150087177|NCT01678911|541457917|FG001|Second Intervention|Lost to Follow-up|0|||
150087178|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
150087179|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
150087180|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
150087181|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
150087182|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
150087183|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
150087184|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
150087185|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
150087186|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Patient Request|1|||
150087187|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Patient Request|0|||
150087188|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
150087189|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
150087190|NCT04649060|541457918|FG000|Arm A/Arm B Treatment|Other|1|||
150087191|NCT04649060|541457919|FG001|Arm A/Arm B Treatment|Other|0|||
150087192|NCT04649060|541457918|FG000|Crossover (Arm B)|Adverse Event|0|||
150087193|NCT04649060|541457919|FG001|Crossover (Arm B)|Adverse Event|1|||
150087194|NCT04649060|541457918|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
150087195|NCT04649060|541457919|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
150087196|NCT01906008|541457923|FG000|Overall Study|Lost to Follow-up|2|||
150087197|NCT01906008|541457924|FG001|Overall Study|Lost to Follow-up|0|||
150087198|NCT01906008|541457923|FG000|Overall Study|Oxaliplatin toxicity|2|||
150087199|NCT01906008|541457924|FG001|Overall Study|Oxaliplatin toxicity|0|||
150087200|NCT01906008|541457923|FG000|Overall Study|Protocol Violation|0|||
150087201|NCT01906008|541457924|FG001|Overall Study|Protocol Violation|1|||
150087202|NCT01906008|541457923|FG000|Overall Study|Withdrawal by Subject|1|||
150087203|NCT01906008|541457924|FG001|Overall Study|Withdrawal by Subject|5|||
150087204|NCT01906008|541457923|FG000|Overall Study|Did not start study med|3|||
150087205|NCT01906008|541457924|FG001|Overall Study|Did not start study med|4|||
150087206|NCT01906008|541457923|FG000|Overall Study|Oxaliplatin stops|10|||
150087207|NCT01906008|541457924|FG001|Overall Study|Oxaliplatin stops|8|||
150087208|NCT01906008|541457923|FG000|Overall Study|Hospice|1|||
150087209|NCT01906008|541457924|FG001|Overall Study|Hospice|0|||
150184041|NCT01303445|541810802|FG001|Second Intervention (7 Days)|Adverse Event|2|||
150184042|NCT01303445|541810801|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
150184043|NCT01303445|541810802|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
150184044|NCT01303445|541810801|FG000|Washout (14 Days)|Protocol Violation|1|||
150087210|NCT01906008|541457923|FG000|Overall Study|Physician Decision|3|||
150087211|NCT01906008|541457924|FG001|Overall Study|Physician Decision|3|||
150087212|NCT01906008|541457923|FG000|Overall Study|Lack of compliance of study med|5|||
150087213|NCT01906008|541457924|FG001|Overall Study|Lack of compliance of study med|3|||
150087214|NCT01906008|541457923|FG000|Overall Study|Adverse Event|0|||
150087215|NCT01906008|541457924|FG001|Overall Study|Adverse Event|3|||
150087216|NCT02117648|541457925|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
150087217|NCT02117648|541457925|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
150087218|NCT02117648|541457925|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
150087219|NCT02117648|541457925|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
150087220|NCT02117648|541457925|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
150087221|NCT02117648|541457925|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
150087222|NCT02117648|541457925|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
150087223|NCT02117648|541457925|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
150087224|NCT02117648|541457925|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
150087225|NCT02117648|541457925|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
150087226|NCT02117648|541457925|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
150087227|NCT00171730|541457927|FG000|Overall Study|Adverse Event|3|||
150087228|NCT00171730|541457927|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
150087229|NCT00171730|541457927|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
150087230|NCT00171730|541457927|FG000|Overall Study|Withdrawal by Subject|3|||
150087231|NCT05025241|541457928|FG000|Screening|Failed Screening|5|||
150087232|NCT05025241|541457928|FG000|Treatment and Follow Up|Adverse Event|3|||
150087233|NCT02670837|541457929|FG000|Overall Study|Death|2|||
150087234|NCT02670837|541457930|FG001|Overall Study|Death|0|||
150087235|NCT02670837|541457931|FG002|Overall Study|Death|0|||
150087236|NCT01985867|541457932|FG000|Overall Study|Lost to Follow-up|3|||
150087237|NCT01985867|541457933|FG001|Overall Study|Lost to Follow-up|4|||
150087238|NCT01985867|541457932|FG000|Overall Study|Adverse Event|3|||
150087239|NCT01985867|541457933|FG001|Overall Study|Adverse Event|2|||
150087240|NCT01985867|541457932|FG000|Overall Study|Lack of Efficacy|1|||
150087241|NCT01985867|541457933|FG001|Overall Study|Lack of Efficacy|0|||
150087242|NCT02220205|541457934|FG000|Overall Study|Withdrawal by Subject|1|||
150087243|NCT02220205|541457935|FG001|Overall Study|Withdrawal by Subject|0|||
150087244|NCT01465997|541457936|FG000|Overall Study|Adverse Event|12|||
150087245|NCT01465997|541457937|FG001|Overall Study|Adverse Event|22|||
150087246|NCT01465997|541457936|FG000|Overall Study|Lack of Efficacy|13|||
150087247|NCT01465997|541457937|FG001|Overall Study|Lack of Efficacy|1|||
150087248|NCT01465997|541457936|FG000|Overall Study|Protocol Violation|1|||
150087249|NCT01465997|541457937|FG001|Overall Study|Protocol Violation|4|||
150087250|NCT01465997|541457936|FG000|Overall Study|Lost to Follow-up|6|||
150087251|NCT01465997|541457937|FG001|Overall Study|Lost to Follow-up|9|||
150087252|NCT01465997|541457936|FG000|Overall Study|Withdrawal by Subject|32|||
150087253|NCT01465997|541457937|FG001|Overall Study|Withdrawal by Subject|35|||
150087254|NCT01465997|541457936|FG000|Overall Study|investigator's decision|1|||
150087255|NCT01465997|541457937|FG001|Overall Study|investigator's decision|1|||
150087256|NCT01465997|541457936|FG000|Overall Study|Death|0|||
150087257|NCT01465997|541457937|FG001|Overall Study|Death|1|||
150087258|NCT01465997|541457936|FG000|Overall Study|sponsor's decision|1|||
150087259|NCT01465997|541457937|FG001|Overall Study|sponsor's decision|1|||
150087260|NCT01465997|541457936|FG000|Overall Study|subject withdrew consent|1|||
150087261|NCT01465997|541457937|FG001|Overall Study|subject withdrew consent|0|||
150087262|NCT01465997|541457936|FG000|Overall Study|local lab unblinded site|1|||
150087263|NCT01465997|541457937|FG001|Overall Study|local lab unblinded site|0|||
150087264|NCT01465997|541457936|FG000|Overall Study|withdrew before follow-up|0|||
150087265|NCT01465997|541457937|FG001|Overall Study|withdrew before follow-up|13|||
150087266|NCT01465997|541457936|FG000|Overall Study|decision by site staff|0|||
150087267|NCT01465997|541457937|FG001|Overall Study|decision by site staff|1|||
150087268|NCT01465997|541457936|FG000|Overall Study|subject left participation SP0993|0|||
150087269|NCT01465997|541457937|FG001|Overall Study|subject left participation SP0993|1|||
150087270|NCT02246660|541457938|FG000|Overall Study|Withdrawal by Subject|0|||
150087271|NCT02246660|541457939|FG001|Overall Study|Withdrawal by Subject|1|||
150087272|NCT02246660|541457940|FG002|Overall Study|Withdrawal by Subject|0|||
150087273|NCT02246660|541457938|FG000|Overall Study|Death|0|||
150087274|NCT02246660|541457939|FG001|Overall Study|Death|0|||
150087275|NCT02246660|541457940|FG002|Overall Study|Death|1|||
150087276|NCT02557646|541457943|FG000|Overall Study|Adverse Event|40|||
150087277|NCT02557646|541457943|FG000|Overall Study|Death|1|||
150087278|NCT02557646|541457943|FG000|Overall Study|Lack of Efficacy|186|||
150087279|NCT02557646|541457943|FG000|Overall Study|Withdrawal by Subject|18|||
150087280|NCT02557646|541457943|FG000|Overall Study|Lost to Follow-up|17|||
150087281|NCT02557646|541457943|FG000|Overall Study|Other|14|||
150087282|NCT03944954|541457944|FG000|Overall Study|Withdrawal by Subject|22|||
150087283|NCT03944954|541457945|FG001|Overall Study|Withdrawal by Subject|4|||
150087284|NCT03944954|541457944|FG000|Overall Study|Lost to Follow-up|18|||
150087285|NCT03944954|541457945|FG001|Overall Study|Lost to Follow-up|0|||
150087286|NCT03944954|541457944|FG000|Overall Study|Failed Medical Screening|7|||
150087287|NCT03944954|541457945|FG001|Overall Study|Failed Medical Screening|0|||
150087288|NCT02268084|541457948|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
150087289|NCT02268084|541457949|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
150087290|NCT02268084|541457948|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
150087291|NCT02268084|541457949|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
150087292|NCT05227027|541457950|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
150087293|NCT05227027|541457951|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
150087294|NCT00855920|541457956|FG000|Overall Study|Protocol Violation|0|||
150087295|NCT00855920|541457957|FG001|Overall Study|Protocol Violation|0|||
150087296|NCT00855920|541457958|FG002|Overall Study|Protocol Violation|2|||
150087297|NCT00855920|541457956|FG000|Overall Study|Adverse Event|2|||
150087298|NCT00855920|541457957|FG001|Overall Study|Adverse Event|1|||
150087299|NCT00855920|541457958|FG002|Overall Study|Adverse Event|1|||
150087300|NCT00855920|541457956|FG000|Overall Study|Lack of Efficacy|2|||
150087301|NCT00855920|541457957|FG001|Overall Study|Lack of Efficacy|2|||
150087302|NCT00855920|541457958|FG002|Overall Study|Lack of Efficacy|2|||
150087303|NCT00855920|541457956|FG000|Overall Study|Withdrawal by Subject|2|||
150087304|NCT00855920|541457957|FG001|Overall Study|Withdrawal by Subject|3|||
150087305|NCT00855920|541457958|FG002|Overall Study|Withdrawal by Subject|2|||
150087306|NCT00855920|541457956|FG000|Overall Study|Lost to Follow-up|1|||
150087307|NCT00855920|541457957|FG001|Overall Study|Lost to Follow-up|0|||
150087308|NCT00855920|541457958|FG002|Overall Study|Lost to Follow-up|2|||
150087309|NCT00855920|541457956|FG000|Overall Study|Death|0|||
150087310|NCT00855920|541457957|FG001|Overall Study|Death|1|||
150087311|NCT00855920|541457958|FG002|Overall Study|Death|0|||
150087312|NCT00855920|541457956|FG000|Overall Study|Decision by the sponsor|0|||
150087313|NCT00855920|541457957|FG001|Overall Study|Decision by the sponsor|1|||
150087314|NCT00855920|541457958|FG002|Overall Study|Decision by the sponsor|1|||
150087315|NCT00855920|541457956|FG000|Overall Study|Other than specified above|1|||
150087316|NCT00855920|541457957|FG001|Overall Study|Other than specified above|1|||
150087317|NCT00855920|541457958|FG002|Overall Study|Other than specified above|1|||
150087318|NCT04786990|541457959|FG000|Overall Study|Withdrawal by Subject|1|||
150087319|NCT04786990|541457959|FG000|Overall Study|Adverse Event|1|||
150087320|NCT04786990|541457959|FG000|Overall Study|Lost to Follow-up|1|||
150087321|NCT04786990|541457959|FG000|Overall Study|Noncompliance|1|||
150087322|NCT04786990|541457959|FG000|Overall Study|Unable to complete site visits|1|||
150087323|NCT04786990|541457959|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
150087324|NCT01782222|541457973|FG000|Overall Study|Adverse Event|4|||
150087325|NCT01782222|541457974|FG001|Overall Study|Adverse Event|5|||
150087326|NCT01782222|541457975|FG002|Overall Study|Adverse Event|3|||
150087327|NCT01782222|541457973|FG000|Overall Study|Lack of Efficacy|2|||
150087328|NCT01782222|541457974|FG001|Overall Study|Lack of Efficacy|1|||
150087329|NCT01782222|541457975|FG002|Overall Study|Lack of Efficacy|0|||
150087330|NCT01782222|541457973|FG000|Overall Study|Protocol Violation|1|||
150087331|NCT01782222|541457974|FG001|Overall Study|Protocol Violation|0|||
150087332|NCT01782222|541457975|FG002|Overall Study|Protocol Violation|0|||
150087333|NCT01782222|541457973|FG000|Overall Study|Withdrawal by Subject|1|||
150087334|NCT01782222|541457974|FG001|Overall Study|Withdrawal by Subject|4|||
150087335|NCT01782222|541457975|FG002|Overall Study|Withdrawal by Subject|1|||
150087336|NCT01782222|541457973|FG000|Overall Study|Moved to other state|0|||
150087337|NCT01782222|541457974|FG001|Overall Study|Moved to other state|1|||
150087338|NCT01782222|541457975|FG002|Overall Study|Moved to other state|0|||
150087339|NCT01756898|541457979|FG000|Overall Study|Adverse Event|7|||
150087340|NCT01756898|541457980|FG001|Overall Study|Adverse Event|1|||
150087341|NCT01756898|541457981|FG002|Overall Study|Adverse Event|0|||
150087342|NCT01756898|541457982|FG003|Overall Study|Adverse Event|0|||
150087343|NCT01756898|541457979|FG000|Overall Study|Lack of Efficacy|4|||
150087344|NCT01756898|541457980|FG001|Overall Study|Lack of Efficacy|7|||
150087345|NCT01756898|541457981|FG002|Overall Study|Lack of Efficacy|6|||
150087346|NCT01756898|541457982|FG003|Overall Study|Lack of Efficacy|6|||
150087347|NCT01756898|541457979|FG000|Overall Study|Lost to Follow-up|2|||
150087348|NCT01756898|541457980|FG001|Overall Study|Lost to Follow-up|4|||
150087349|NCT01756898|541457981|FG002|Overall Study|Lost to Follow-up|2|||
150087350|NCT01756898|541457982|FG003|Overall Study|Lost to Follow-up|3|||
150087351|NCT01756898|541457979|FG000|Overall Study|Protocol Violation|1|||
150087352|NCT01756898|541457980|FG001|Overall Study|Protocol Violation|2|||
150087353|NCT01756898|541457981|FG002|Overall Study|Protocol Violation|2|||
150087354|NCT01756898|541457982|FG003|Overall Study|Protocol Violation|1|||
150087355|NCT01756898|541457979|FG000|Overall Study|Withdrew Consent|5|||
150087356|NCT01756898|541457980|FG001|Overall Study|Withdrew Consent|3|||
150087357|NCT01756898|541457981|FG002|Overall Study|Withdrew Consent|5|||
150087358|NCT01756898|541457982|FG003|Overall Study|Withdrew Consent|6|||
150087359|NCT01756898|541457979|FG000|Overall Study|Other|0|||
150087360|NCT01756898|541457980|FG001|Overall Study|Other|2|||
150087361|NCT01756898|541457981|FG002|Overall Study|Other|2|||
150087362|NCT01756898|541457982|FG003|Overall Study|Other|0|||
150087363|NCT01500694|541457983|FG000|Overall Study|Adverse Event|4|||
150087364|NCT01500694|541457984|FG001|Overall Study|Adverse Event|3|||
150087365|NCT01500694|541457983|FG000|Overall Study|Protocol Violation|0|||
150087366|NCT01500694|541457984|FG001|Overall Study|Protocol Violation|1|||
150087367|NCT01500694|541457983|FG000|Overall Study|Withdrawal by Subject|23|||
150087368|NCT01500694|541457984|FG001|Overall Study|Withdrawal by Subject|14|||
150087369|NCT01500694|541457983|FG000|Overall Study|Lost to Follow-up|2|||
150087370|NCT01500694|541457984|FG001|Overall Study|Lost to Follow-up|3|||
150087371|NCT01500694|541457983|FG000|Overall Study|Lack of Efficacy|14|||
150087372|NCT01500694|541457984|FG001|Overall Study|Lack of Efficacy|5|||
150087373|NCT01500694|541457983|FG000|Overall Study|Other|9|||
150087374|NCT01500694|541457984|FG001|Overall Study|Other|3|||
150087375|NCT02007109|541457985|FG000|Overall Study|Diary not returned or excluded|102|||
150087376|NCT02007109|541457985|FG000|Overall Study|Excluded - Age<7yo|9|||
150087377|NCT01605877|541457987|FG000|Overall Study|Withdrawal by Subject|1|||
150087378|NCT02132130|541457994|FG000|Overall Study|Lost to Follow-up|0|||
150087379|NCT02132130|541457995|FG001|Overall Study|Lost to Follow-up|2|||
150087380|NCT02132130|541457996|FG002|Overall Study|Lost to Follow-up|0|||
150087381|NCT02132130|541457997|FG003|Overall Study|Lost to Follow-up|0|||
150087382|NCT02132130|541457994|FG000|Overall Study|Withdrawal by Subject|0|||
150087383|NCT02132130|541457995|FG001|Overall Study|Withdrawal by Subject|0|||
150087384|NCT02132130|541457996|FG002|Overall Study|Withdrawal by Subject|0|||
150087385|NCT02132130|541457997|FG003|Overall Study|Withdrawal by Subject|1|||
150087386|NCT02760069|541457998|FG000|Overall Study|Withdrawal by Subject|0|||
150087387|NCT02760069|541457999|FG001|Overall Study|Withdrawal by Subject|1|||
150087388|NCT02760069|541458000|FG002|Overall Study|Withdrawal by Subject|1|||
150087389|NCT00646776|541458003|FG000|Overall Study|Adverse Event|1|||
150087390|NCT00646776|541458004|FG001|Overall Study|Adverse Event|9|||
150087391|NCT00646776|541458003|FG000|Overall Study|Investigator discretion|0|||
150087392|NCT00646776|541458004|FG001|Overall Study|Investigator discretion|4|||
150087393|NCT03031678|541458012|FG000|Overall Study|Study closed prior to completion|1|||
150087394|NCT00439244|541458013|FG000|Overall Study|Adverse Event|5|||
150087395|NCT00439244|541458014|FG001|Overall Study|Adverse Event|2|||
150087396|NCT00439244|541458015|FG002|Overall Study|Adverse Event|3|||
150087397|NCT00439244|541458013|FG000|Overall Study|Withdrawal by Subject|3|||
150087398|NCT00439244|541458014|FG001|Overall Study|Withdrawal by Subject|1|||
150087399|NCT00439244|541458015|FG002|Overall Study|Withdrawal by Subject|2|||
150087400|NCT00439244|541458013|FG000|Overall Study|Lost to Follow-up|2|||
150087401|NCT00439244|541458014|FG001|Overall Study|Lost to Follow-up|1|||
150087402|NCT00439244|541458015|FG002|Overall Study|Lost to Follow-up|2|||
150087403|NCT00439244|541458013|FG000|Overall Study|Death|0|||
150087404|NCT00439244|541458014|FG001|Overall Study|Death|1|||
150087405|NCT00439244|541458015|FG002|Overall Study|Death|0|||
150087406|NCT00439244|541458013|FG000|Overall Study|Protocol Violation|0|||
150087407|NCT00439244|541458014|FG001|Overall Study|Protocol Violation|1|||
150087408|NCT00439244|541458015|FG002|Overall Study|Protocol Violation|0|||
150087409|NCT00439244|541458013|FG000|Overall Study|Administrative problems|1|||
150087410|NCT00439244|541458014|FG001|Overall Study|Administrative problems|0|||
150087411|NCT00439244|541458015|FG002|Overall Study|Administrative problems|0|||
150087412|NCT04557371|541458018|FG000|Overall Study|Covid-19-related|0|||
150087413|NCT04557371|541458019|FG001|Overall Study|Covid-19-related|1|||
150087414|NCT04557371|541458020|FG002|Overall Study|Covid-19-related|0|||
150087415|NCT04557371|541458018|FG000|Overall Study|Withdrawal by Subject|0|||
150087416|NCT04557371|541458019|FG001|Overall Study|Withdrawal by Subject|1|||
150087417|NCT04557371|541458020|FG002|Overall Study|Withdrawal by Subject|0|||
150087418|NCT04557371|541458018|FG000|Overall Study|Adverse Event|1|||
150087419|NCT04557371|541458019|FG001|Overall Study|Adverse Event|0|||
150087420|NCT04557371|541458020|FG002|Overall Study|Adverse Event|0|||
150087421|NCT01482884|541458023|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
150087422|NCT01482884|541458024|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
150087423|NCT01482884|541458023|FG000|Overall Study|Protocol Violation|1|||
150087424|NCT01482884|541458024|FG001|Overall Study|Protocol Violation|0|||
150087425|NCT01482884|541458023|FG000|Overall Study|Lost to Follow-up|2|||
150087426|NCT01482884|541458024|FG001|Overall Study|Lost to Follow-up|2|||
150087427|NCT01482884|541458023|FG000|Overall Study|Lack of Efficacy|0|||
150087428|NCT01482884|541458024|FG001|Overall Study|Lack of Efficacy|1|||
150087429|NCT01482884|541458023|FG000|Overall Study|Adverse Event|2|||
150087430|NCT01482884|541458024|FG001|Overall Study|Adverse Event|1|||
150087431|NCT01482884|541458023|FG000|Overall Study|Withdrawal by Subject|8|||
150087432|NCT01482884|541458024|FG001|Overall Study|Withdrawal by Subject|13|||
150087433|NCT04419714|541458027|FG000|Overall Study|Technical Fault|5|||
150087434|NCT04419714|541458027|FG000|Overall Study|Protocol Deviation|2|||
150087435|NCT04419714|541458027|FG000|Overall Study|Withdrawal by Subject|1|||
150087436|NCT04221009|541459496|FG000|Overall Study|Withdrawal by Subject|4|||
150087437|NCT00793598|541459497|FG000|Overall Study|Patient Request|0|||
150087438|NCT00793598|541459498|FG001|Overall Study|Patient Request|1|||
150087439|NCT00793598|541459499|FG002|Overall Study|Patient Request|0|||
150087440|NCT00793598|541459500|FG003|Overall Study|Patient Request|0|||
150087441|NCT00793598|541459501|FG004|Overall Study|Patient Request|0|||
150087442|NCT00793598|541459502|FG005|Overall Study|Patient Request|0|||
150087443|NCT00793598|541459503|FG006|Overall Study|Patient Request|0|||
150087444|NCT00793598|541459504|FG007|Overall Study|Patient Request|0|||
150087445|NCT00793598|541459497|FG000|Overall Study|Protocol Violation|0|||
150087446|NCT00793598|541459498|FG001|Overall Study|Protocol Violation|0|||
150087447|NCT00793598|541459499|FG002|Overall Study|Protocol Violation|0|||
150087448|NCT00793598|541459500|FG003|Overall Study|Protocol Violation|0|||
150087449|NCT00793598|541459501|FG004|Overall Study|Protocol Violation|0|||
150087450|NCT00793598|541459502|FG005|Overall Study|Protocol Violation|0|||
150087451|NCT00793598|541459503|FG006|Overall Study|Protocol Violation|0|||
150087452|NCT00793598|541459504|FG007|Overall Study|Protocol Violation|1|||
150087453|NCT00793598|541459497|FG000|Overall Study|Subject not dosed|0|||
150087454|NCT00793598|541459498|FG001|Overall Study|Subject not dosed|0|||
150087455|NCT00793598|541459499|FG002|Overall Study|Subject not dosed|0|||
150087456|NCT00793598|541459500|FG003|Overall Study|Subject not dosed|0|||
150087457|NCT00793598|541459501|FG004|Overall Study|Subject not dosed|0|||
150087458|NCT00793598|541459502|FG005|Overall Study|Subject not dosed|1|||
150087459|NCT00793598|541459503|FG006|Overall Study|Subject not dosed|0|||
150087460|NCT00793598|541459504|FG007|Overall Study|Subject not dosed|0|||
150087461|NCT02154490|541459505|FG000|Overall Study|No tissue submitted|23|||
150087462|NCT02154490|541459505|FG000|Overall Study|No biomarker results|167|||
150087463|NCT02154490|541459505|FG000|Overall Study|Not assigned to a sub-study|270|||
150087464|NCT02154490|541459505|FG000|Overall Study|Did not register to a sub-study|749|||
150087465|NCT02373202|541459507|FG000|Overall Study|Adverse Event|2|||
150087466|NCT02373202|541459508|FG001|Overall Study|Adverse Event|5|||
150087467|NCT02373202|541459509|FG002|Overall Study|Adverse Event|2|||
150087468|NCT02373202|541459510|FG003|Overall Study|Adverse Event|1|||
150087469|NCT02373202|541459507|FG000|Overall Study|Lack of Efficacy|0|||
150087470|NCT02373202|541459508|FG001|Overall Study|Lack of Efficacy|0|||
150087471|NCT02373202|541459509|FG002|Overall Study|Lack of Efficacy|1|||
150087472|NCT02373202|541459510|FG003|Overall Study|Lack of Efficacy|0|||
150087473|NCT02373202|541459507|FG000|Overall Study|Other|0|||
150087474|NCT02373202|541459508|FG001|Overall Study|Other|1|||
150087475|NCT02373202|541459509|FG002|Overall Study|Other|0|||
150087476|NCT02373202|541459510|FG003|Overall Study|Other|0|||
150087477|NCT00482612|541459513|FG000|In-treatment Period|No study medication administered|0|||
150087478|NCT00482612|541459514|FG001|In-treatment Period|No study medication administered|0|||
150087479|NCT00482612|541459515|FG002|In-treatment Period|No study medication administered|1|||
150087480|NCT00482612|541459516|FG003|In-treatment Period|No study medication administered|0|||
150087481|NCT00482612|541459513|FG000|Follow-up Period|Other|4|||
150087482|NCT00482612|541459514|FG001|Follow-up Period|Other|2|||
150087483|NCT00482612|541459515|FG002|Follow-up Period|Other|1|||
150087484|NCT00482612|541459516|FG003|Follow-up Period|Other|2|||
150087485|NCT00482612|541459513|FG000|Follow-up Period|Lack of compliance|0|||
150087486|NCT00482612|541459514|FG001|Follow-up Period|Lack of compliance|0|||
150087487|NCT00482612|541459515|FG002|Follow-up Period|Lack of compliance|1|||
150087488|NCT00482612|541459516|FG003|Follow-up Period|Lack of compliance|0|||
150087489|NCT00482612|541459513|FG000|Follow-up Period|Lost to Follow-up|0|||
150087490|NCT00482612|541459514|FG001|Follow-up Period|Lost to Follow-up|4|||
150087491|NCT00482612|541459515|FG002|Follow-up Period|Lost to Follow-up|2|||
150087492|NCT00482612|541459516|FG003|Follow-up Period|Lost to Follow-up|1|||
150087493|NCT00482612|541459513|FG000|Follow-up Period|Adverse Event|4|||
150087494|NCT00482612|541459514|FG001|Follow-up Period|Adverse Event|7|||
150087495|NCT00482612|541459515|FG002|Follow-up Period|Adverse Event|9|||
150087496|NCT00482612|541459516|FG003|Follow-up Period|Adverse Event|0|||
150087497|NCT00482612|541459513|FG000|Follow-up Period|Lack of Efficacy|2|||
150087498|NCT00482612|541459514|FG001|Follow-up Period|Lack of Efficacy|0|||
150087499|NCT00482612|541459515|FG002|Follow-up Period|Lack of Efficacy|1|||
150087500|NCT00482612|541459516|FG003|Follow-up Period|Lack of Efficacy|0|||
150087501|NCT00482612|541459513|FG000|Follow-up Period|Withdrawal by Subject|3|||
150087502|NCT00482612|541459514|FG001|Follow-up Period|Withdrawal by Subject|5|||
150087503|NCT00482612|541459515|FG002|Follow-up Period|Withdrawal by Subject|7|||
150087504|NCT00482612|541459516|FG003|Follow-up Period|Withdrawal by Subject|2|||
150087505|NCT00482612|541459513|FG000|Follow-up Period|Reasons not related to trial|1|||
150087506|NCT00482612|541459514|FG001|Follow-up Period|Reasons not related to trial|0|||
150087507|NCT00482612|541459515|FG002|Follow-up Period|Reasons not related to trial|1|||
150087508|NCT00482612|541459516|FG003|Follow-up Period|Reasons not related to trial|3|||
150087509|NCT00464087|541459517|FG000|Overall Study|No PCI per inclusion criteria|0|||
150087510|NCT00464087|541459518|FG001|Overall Study|No PCI per inclusion criteria|0|||
150087511|NCT00464087|541459519|FG002|Overall Study|No PCI per inclusion criteria|29|||
150087512|NCT01224431|541459521|FG000|Overall Study|not randomized|0|||
150087513|NCT01224431|541459522|FG001|Overall Study|not randomized|4|||
150087514|NCT01224431|541459521|FG000|Overall Study|no video record|0|||
150087515|NCT01224431|541459522|FG001|Overall Study|no video record|1|||
150087516|NCT03654651|541459524|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
150087517|NCT03654651|541459525|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
150087518|NCT01401283|541459526|FG000|Overall Study|surgery cancelled|5|||
150087519|NCT01401283|541459527|FG001|Overall Study|surgery cancelled|8|||
150087520|NCT01401283|541459526|FG000|Overall Study|preoperative arrhythmia|5|||
150087521|NCT01401283|541459527|FG001|Overall Study|preoperative arrhythmia|0|||
150087522|NCT01401283|541459526|FG000|Overall Study|no central venous access|0|||
150087523|NCT01401283|541459527|FG001|Overall Study|no central venous access|1|||
150087524|NCT01401283|541459526|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
150087525|NCT01401283|541459527|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
150087526|NCT02433483|541459528|FG000|Overall Study|Unacceptable toxicity|1|||
150087527|NCT02433483|541459528|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
150087528|NCT01606436|541459530|FG000|Overall Study|Withdrawal by Subject|0|||
150087529|NCT01606436|541459531|FG001|Overall Study|Withdrawal by Subject|0|||
150087530|NCT01606436|541459532|FG002|Overall Study|Withdrawal by Subject|1|||
150087531|NCT01606436|541459533|FG003|Overall Study|Withdrawal by Subject|1|||
150087532|NCT01606436|541459534|FG004|Overall Study|Withdrawal by Subject|1|||
150087533|NCT01606436|541459535|FG005|Overall Study|Withdrawal by Subject|0|||
150087534|NCT01606436|541459530|FG000|Overall Study|Adverse Event|0|||
150087535|NCT01606436|541459531|FG001|Overall Study|Adverse Event|0|||
150087536|NCT01606436|541459532|FG002|Overall Study|Adverse Event|1|||
150087537|NCT01606436|541459533|FG003|Overall Study|Adverse Event|0|||
150087538|NCT01606436|541459534|FG004|Overall Study|Adverse Event|0|||
150087539|NCT01606436|541459535|FG005|Overall Study|Adverse Event|0|||
150087540|NCT01606436|541459530|FG000|Overall Study|Sponsor Decision|0|||
150087541|NCT01606436|541459531|FG001|Overall Study|Sponsor Decision|0|||
150087542|NCT01606436|541459532|FG002|Overall Study|Sponsor Decision|0|||
150087543|NCT01606436|541459533|FG003|Overall Study|Sponsor Decision|1|||
150087544|NCT01606436|541459534|FG004|Overall Study|Sponsor Decision|0|||
150087545|NCT01606436|541459535|FG005|Overall Study|Sponsor Decision|0|||
150087546|NCT04294472|541459538|FG000|Overall Study|Adverse Event|0|||
150087547|NCT04294472|541459539|FG001|Overall Study|Adverse Event|1|||
150087548|NCT04294472|541459540|FG002|Overall Study|Adverse Event|1|||
150087549|NCT04294472|541459538|FG000|Overall Study|Randomized but not treated|0|||
150087550|NCT04294472|541459539|FG001|Overall Study|Randomized but not treated|1|||
150087551|NCT04294472|541459540|FG002|Overall Study|Randomized but not treated|1|||
150087552|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
150087553|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
150087554|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
150087555|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
150087556|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
150087557|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
150087558|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
150087559|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
150087560|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
150087561|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
150087562|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
150087563|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
150087564|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
150087565|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
150087566|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
150087567|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
150087568|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
150087569|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
150087570|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
150087571|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
150087572|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
150087573|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
150087574|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
150087575|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
150087576|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
150087577|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
150087578|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
150087579|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
150087580|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
150087581|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
150087582|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
150087583|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
150087584|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
150087585|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
150087586|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
150087587|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
150087588|NCT02603419|541459541|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
150087589|NCT02603419|541459542|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
150087590|NCT02603419|541459543|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
150087591|NCT02603419|541459544|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
150087592|NCT02603419|541459545|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
150087593|NCT02603419|541459546|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
150087594|NCT02603419|541459541|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
150087595|NCT02603419|541459542|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
150087596|NCT02603419|541459543|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
150087597|NCT02603419|541459544|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
150087598|NCT02603419|541459545|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
150087599|NCT02603419|541459546|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
150087600|NCT02603419|541459541|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
150087601|NCT02603419|541459542|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
150087602|NCT02603419|541459543|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
150087603|NCT02603419|541459544|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
150087604|NCT02603419|541459545|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
150087605|NCT02603419|541459546|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
150087606|NCT02603419|541459541|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
150087607|NCT02603419|541459542|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
150087608|NCT02603419|541459543|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
150087609|NCT02603419|541459544|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
150087610|NCT02603419|541459545|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
150087611|NCT02603419|541459546|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
150087612|NCT03552198|541459547|FG000|Overall Study|Lost to Follow-up|42|||
150087613|NCT03552198|541459548|FG001|Overall Study|Lost to Follow-up|48|||
150087614|NCT03552198|541459549|FG002|Overall Study|Lost to Follow-up|15|||
150087615|NCT03552198|541459550|FG003|Overall Study|Lost to Follow-up|19|||
150087616|NCT03552198|541459547|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
150087617|NCT03552198|541459548|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
150087618|NCT03552198|541459549|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
150087619|NCT03552198|541459550|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
150087620|NCT03552198|541459547|FG000|Overall Study|Did not receive air alerts|1|||
150087621|NCT03552198|541459548|FG001|Overall Study|Did not receive air alerts|0|||
150087622|NCT03552198|541459549|FG002|Overall Study|Did not receive air alerts|0|||
150087623|NCT03552198|541459550|FG003|Overall Study|Did not receive air alerts|1|||
150087624|NCT06149247|541459551|FG000|Overall Study|Adverse Event|0|||
150087625|NCT06149247|541459552|FG001|Overall Study|Adverse Event|1|||
150087626|NCT02289417|541459553|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
150087627|NCT02289417|541459554|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087628|NCT02289417|541459555|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
150087629|NCT02289417|541459556|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087630|NCT02289417|541459557|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087631|NCT02289417|541459558|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087632|NCT02289417|541459559|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087633|NCT02289417|541459560|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087634|NCT02289417|541459561|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
150087635|NCT02289417|541459553|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
150087636|NCT02289417|541459554|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
150087637|NCT02289417|541459555|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
150087638|NCT02289417|541459556|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087639|NCT02289417|541459557|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087640|NCT02289417|541459558|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087641|NCT02289417|541459559|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087642|NCT02289417|541459560|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087643|NCT02289417|541459561|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
150087644|NCT02289417|541459553|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087645|NCT02289417|541459554|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
150087646|NCT02289417|541459555|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087647|NCT02289417|541459556|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087648|NCT02289417|541459557|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087649|NCT02289417|541459558|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087650|NCT02289417|541459559|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087651|NCT02289417|541459560|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087652|NCT02289417|541459561|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
150087653|NCT02289417|541459553|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
150087654|NCT02289417|541459554|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087655|NCT02289417|541459555|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087656|NCT02289417|541459556|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087657|NCT02289417|541459557|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087658|NCT02289417|541459558|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087659|NCT02289417|541459559|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087660|NCT02289417|541459560|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087661|NCT02289417|541459561|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
150087662|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
150087663|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
150087664|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
150087665|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
150087666|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
150087667|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
150087668|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
150087669|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
150087670|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
150184045|NCT01303445|541810802|FG001|Washout (14 Days)|Protocol Violation|0|||
150087671|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087672|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087673|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
150184046|NCT01303445|541810801|FG000|Washout (14 Days)|Lost to Follow-up|0|||
150184047|NCT01303445|541810802|FG001|Washout (14 Days)|Lost to Follow-up|2|||
150184048|NCT01303445|541810801|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
150184049|NCT01303445|541810802|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
150184050|NCT01303445|541810801|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
150087674|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087675|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087676|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087677|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087678|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087679|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
150087680|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
150087681|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
150087682|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
150087683|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
150087684|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
150087685|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
150087686|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
150087687|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
150087688|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
150087689|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087690|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087691|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
150087692|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087693|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
150087694|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
150087695|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087696|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087697|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
150087698|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087699|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087700|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087701|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087702|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087703|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087704|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
150087705|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087706|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
150087707|NCT02289417|541459553|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087708|NCT02289417|541459554|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087709|NCT02289417|541459555|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087710|NCT02289417|541459556|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
150087711|NCT02289417|541459557|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087712|NCT02289417|541459558|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087713|NCT02289417|541459559|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
150087714|NCT02289417|541459560|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087715|NCT02289417|541459561|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
150087716|NCT02289417|541459553|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
150087717|NCT02289417|541459554|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
150087718|NCT02289417|541459555|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
150087719|NCT02289417|541459556|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
150087720|NCT02289417|541459557|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
150087721|NCT02289417|541459558|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
150087722|NCT02289417|541459559|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
150087723|NCT02289417|541459560|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
150087724|NCT02289417|541459561|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
150087725|NCT02289417|541459553|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087726|NCT02289417|541459554|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087727|NCT02289417|541459555|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087728|NCT02289417|541459556|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087729|NCT02289417|541459557|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087730|NCT02289417|541459558|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087731|NCT02289417|541459559|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
150087732|NCT02289417|541459560|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
150087733|NCT02289417|541459561|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
150087734|NCT02289417|541459553|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087735|NCT02289417|541459554|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087736|NCT02289417|541459555|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087737|NCT02289417|541459556|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087738|NCT02289417|541459557|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087739|NCT02289417|541459558|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087740|NCT02289417|541459559|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
150087741|NCT02289417|541459560|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
150087742|NCT02289417|541459561|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
150087743|NCT02289417|541459553|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087744|NCT02289417|541459554|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087745|NCT02289417|541459555|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087746|NCT02289417|541459556|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087747|NCT02289417|541459557|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087748|NCT02289417|541459558|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087749|NCT02289417|541459559|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087750|NCT02289417|541459560|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
150087751|NCT02289417|541459561|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
150087752|NCT02725710|541459562|FG000|Overall Study|Lost to Follow-up|1|||
150087753|NCT02725710|541459563|FG001|Overall Study|Lost to Follow-up|0|||
150087754|NCT03572062|541459564|FG000|Overall Study|Adverse Event|0|||
150087755|NCT03572062|541459565|FG001|Overall Study|Adverse Event|0|||
150087756|NCT03572062|541459566|FG002|Overall Study|Adverse Event|0|||
150087757|NCT03572062|541459567|FG003|Overall Study|Adverse Event|0|||
150087758|NCT03572062|541459568|FG004|Overall Study|Adverse Event|0|||
150087759|NCT03572062|541459569|FG005|Overall Study|Adverse Event|0|||
150087760|NCT03572062|541459570|FG006|Overall Study|Adverse Event|0|||
150087761|NCT03572062|541459571|FG007|Overall Study|Adverse Event|0|||
150087762|NCT03572062|541459572|FG008|Overall Study|Adverse Event|1|||
150087763|NCT03572062|541459573|FG009|Overall Study|Adverse Event|3|||
150087764|NCT03572062|541459564|FG000|Overall Study|Death|0|||
150087765|NCT03572062|541459565|FG001|Overall Study|Death|0|||
150087766|NCT03572062|541459566|FG002|Overall Study|Death|0|||
150087767|NCT03572062|541459567|FG003|Overall Study|Death|0|||
150087768|NCT03572062|541459568|FG004|Overall Study|Death|0|||
150087769|NCT03572062|541459569|FG005|Overall Study|Death|1|||
150087770|NCT03572062|541459570|FG006|Overall Study|Death|0|||
150087771|NCT03572062|541459571|FG007|Overall Study|Death|0|||
150087772|NCT03572062|541459572|FG008|Overall Study|Death|0|||
150087773|NCT03572062|541459573|FG009|Overall Study|Death|0|||
150087774|NCT03572062|541459564|FG000|Overall Study|Lost to Follow-up|0|||
150087775|NCT03572062|541459565|FG001|Overall Study|Lost to Follow-up|0|||
150087776|NCT03572062|541459566|FG002|Overall Study|Lost to Follow-up|0|||
150087777|NCT03572062|541459567|FG003|Overall Study|Lost to Follow-up|0|||
150087778|NCT03572062|541459568|FG004|Overall Study|Lost to Follow-up|0|||
150087779|NCT03572062|541459569|FG005|Overall Study|Lost to Follow-up|1|||
150087780|NCT03572062|541459570|FG006|Overall Study|Lost to Follow-up|1|||
150087781|NCT03572062|541459571|FG007|Overall Study|Lost to Follow-up|0|||
150087782|NCT03572062|541459572|FG008|Overall Study|Lost to Follow-up|0|||
150087783|NCT03572062|541459573|FG009|Overall Study|Lost to Follow-up|0|||
150087784|NCT03572062|541459564|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087785|NCT03572062|541459565|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087786|NCT03572062|541459566|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087787|NCT03572062|541459567|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087788|NCT03572062|541459568|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087789|NCT03572062|541459569|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087790|NCT03572062|541459570|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087791|NCT03572062|541459571|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087792|NCT03572062|541459572|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
150087793|NCT03572062|541459573|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
150087794|NCT03572062|541459564|FG000|Overall Study|Study Terminated By Sponsor|0|||
150087795|NCT03572062|541459565|FG001|Overall Study|Study Terminated By Sponsor|0|||
150087796|NCT03572062|541459566|FG002|Overall Study|Study Terminated By Sponsor|0|||
150087797|NCT03572062|541459567|FG003|Overall Study|Study Terminated By Sponsor|0|||
150087798|NCT03572062|541459568|FG004|Overall Study|Study Terminated By Sponsor|0|||
150087799|NCT03572062|541459569|FG005|Overall Study|Study Terminated By Sponsor|0|||
150087800|NCT03572062|541459570|FG006|Overall Study|Study Terminated By Sponsor|0|||
150087801|NCT03572062|541459571|FG007|Overall Study|Study Terminated By Sponsor|0|||
150087802|NCT03572062|541459572|FG008|Overall Study|Study Terminated By Sponsor|29|||
150087803|NCT03572062|541459573|FG009|Overall Study|Study Terminated By Sponsor|27|||
150184051|NCT01303445|541810802|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
150087804|NCT03572062|541459564|FG000|Overall Study|Physician Decision|0|||
150087805|NCT03572062|541459565|FG001|Overall Study|Physician Decision|0|||
150087806|NCT03572062|541459566|FG002|Overall Study|Physician Decision|0|||
150087807|NCT03572062|541459567|FG003|Overall Study|Physician Decision|0|||
150087808|NCT03572062|541459568|FG004|Overall Study|Physician Decision|0|||
150087809|NCT03572062|541459569|FG005|Overall Study|Physician Decision|0|||
150087810|NCT03572062|541459570|FG006|Overall Study|Physician Decision|0|||
150087811|NCT03572062|541459571|FG007|Overall Study|Physician Decision|0|||
150087812|NCT03572062|541459572|FG008|Overall Study|Physician Decision|1|||
150087813|NCT03572062|541459573|FG009|Overall Study|Physician Decision|0|||
150087814|NCT03572062|541459564|FG000|Overall Study|Withdrawal by Subject|0|||
150087815|NCT03572062|541459565|FG001|Overall Study|Withdrawal by Subject|0|||
150087816|NCT03572062|541459566|FG002|Overall Study|Withdrawal by Subject|0|||
150087817|NCT03572062|541459567|FG003|Overall Study|Withdrawal by Subject|0|||
150087818|NCT03572062|541459568|FG004|Overall Study|Withdrawal by Subject|0|||
150087819|NCT03572062|541459569|FG005|Overall Study|Withdrawal by Subject|0|||
150087820|NCT03572062|541459570|FG006|Overall Study|Withdrawal by Subject|0|||
150087821|NCT03572062|541459571|FG007|Overall Study|Withdrawal by Subject|0|||
150087822|NCT03572062|541459572|FG008|Overall Study|Withdrawal by Subject|0|||
150087823|NCT03572062|541459573|FG009|Overall Study|Withdrawal by Subject|1|||
150184052|NCT04924062|541813222|FG000|Overall Study|Death|49|||
150184053|NCT04924062|541813223|FG001|Overall Study|Death|63|||
150184054|NCT04924062|541813222|FG000|Overall Study|Participant On-going|26|||
150184055|NCT04924062|541813223|FG001|Overall Study|Participant On-going|20|||
150184056|NCT04059354|541813228|FG000|Overall Study|COVID-19 pandemic|3|||
150184057|NCT03424811|541813236|FG000|Overall Study|Lost to Follow-up|9|||
150184058|NCT03424811|541813237|FG001|Overall Study|Lost to Follow-up|0|||
150184059|NCT04868110|541813241|FG000|Overall Study|Withdrawal by Subject|3|||
150184060|NCT04868110|541813242|FG001|Overall Study|Withdrawal by Subject|4|||
150184061|NCT03263026|541813243|FG000|Overall Study|Withdrawal by Subject|1|||
150184062|NCT03263026|541813244|FG001|Overall Study|Withdrawal by Subject|0|||
150184063|NCT03263026|541813243|FG000|Overall Study|Death|1|||
150184064|NCT03263026|541813244|FG001|Overall Study|Death|0|||
150184065|NCT03263026|541813243|FG000|Overall Study|Other/ Various|41|||
150184066|NCT03263026|541813244|FG001|Overall Study|Other/ Various|29|||
150184067|NCT04823611|541813245|FG000|Overall Study|Adverse Event|2|||
150184068|NCT04823611|541813246|FG001|Overall Study|Adverse Event|0|||
150184069|NCT04823611|541813247|FG002|Overall Study|Adverse Event|1|||
150184070|NCT04823611|541813248|FG003|Overall Study|Adverse Event|0|||
150184071|NCT04823611|541813249|FG004|Overall Study|Adverse Event|0|||
150184072|NCT04823611|541813250|FG005|Overall Study|Adverse Event|0|||
150184073|NCT04823611|541813251|FG006|Overall Study|Adverse Event|0|||
150184074|NCT03655132|541813254|FG000|Overall Study|Lost to Follow-up|2|||
150184075|NCT03655132|541813255|FG001|Overall Study|Lost to Follow-up|1|||
150184076|NCT03655132|541813254|FG000|Overall Study|Withdrawal by Subject|0|||
150184077|NCT03655132|541813255|FG001|Overall Study|Withdrawal by Subject|1|||
150184078|NCT03655132|541813254|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
150184079|NCT03655132|541813255|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
150184080|NCT05919082|541813256|FG000|Overall Study|Adverse Event|3|||
150184081|NCT05919082|541813257|FG001|Overall Study|Adverse Event|0|||
150184082|NCT05919082|541813256|FG000|Overall Study|Lost to Follow-up|0|||
150184083|NCT05919082|541813257|FG001|Overall Study|Lost to Follow-up|1|||
150184084|NCT05919082|541813256|FG000|Overall Study|Withdrawal by Subject|8|||
150184085|NCT05919082|541813257|FG001|Overall Study|Withdrawal by Subject|9|||
150184086|NCT05919082|541813256|FG000|Overall Study|Lack of Efficacy|0|||
150184087|NCT05919082|541813257|FG001|Overall Study|Lack of Efficacy|1|||
150184088|NCT05919082|541813256|FG000|Overall Study|Investigator Decision|1|||
150184089|NCT05919082|541813257|FG001|Overall Study|Investigator Decision|0|||
150184090|NCT05415410|541813261|FG000|Overall Study|Death|3|||
150184091|NCT05415410|541813262|FG001|Overall Study|Death|6|||
150184092|NCT05415410|541813263|FG002|Overall Study|Death|1|||
150087824|NCT03572062|541459564|FG000|Overall Study|Randomized But Not Treated|0|||
150087825|NCT03572062|541459565|FG001|Overall Study|Randomized But Not Treated|0|||
150087826|NCT03572062|541459566|FG002|Overall Study|Randomized But Not Treated|0|||
150087827|NCT03572062|541459567|FG003|Overall Study|Randomized But Not Treated|0|||
150184093|NCT05415410|541813261|FG000|Overall Study|Trial Terminated by Sponsor|1|||
150184094|NCT05415410|541813262|FG001|Overall Study|Trial Terminated by Sponsor|5|||
150184095|NCT05415410|541813263|FG002|Overall Study|Trial Terminated by Sponsor|0|||
150184096|NCT05415410|541813261|FG000|Overall Study|Adverse Event|2|||
150184097|NCT05415410|541813262|FG001|Overall Study|Adverse Event|1|||
150184098|NCT05415410|541813263|FG002|Overall Study|Adverse Event|0|||
150184099|NCT05415410|541813261|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
150087828|NCT03572062|541459568|FG004|Overall Study|Randomized But Not Treated|1|||
150087829|NCT03572062|541459569|FG005|Overall Study|Randomized But Not Treated|2|||
150184100|NCT05415410|541813262|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
150184101|NCT05415410|541813263|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
150087830|NCT03572062|541459570|FG006|Overall Study|Randomized But Not Treated|0|||
150087831|NCT03572062|541459571|FG007|Overall Study|Randomized But Not Treated|1|||
150087832|NCT03572062|541459572|FG008|Overall Study|Randomized But Not Treated|0|||
150087833|NCT03572062|541459573|FG009|Overall Study|Randomized But Not Treated|0|||
150087834|NCT01858389|541459574|FG000|Overall Study|Death|1|||
150087835|NCT01858389|541459575|FG001|Overall Study|Death|3|||
150087836|NCT01858389|541459574|FG000|Overall Study|Study terminated by sponsor|0|||
150087837|NCT01858389|541459575|FG001|Overall Study|Study terminated by sponsor|2|||
150087838|NCT01858389|541459574|FG000|Overall Study|Withdrawal by Subject|0|||
150087839|NCT01858389|541459575|FG001|Overall Study|Withdrawal by Subject|1|||
150087840|NCT01858389|541459574|FG000|Overall Study|Progressive disease|10|||
150087841|NCT01858389|541459575|FG001|Overall Study|Progressive disease|11|||
150087842|NCT01858389|541459574|FG000|Overall Study|Other|2|||
150087843|NCT01858389|541459575|FG001|Overall Study|Other|4|||
150087844|NCT01858389|541459574|FG000|Overall Study|Adverse Event|3|||
150087845|NCT01858389|541459575|FG001|Overall Study|Adverse Event|1|||
150087846|NCT01858389|541459574|FG000|Overall Study|Did not receive treatment|0|||
150087847|NCT01858389|541459575|FG001|Overall Study|Did not receive treatment|3|||
150087848|NCT01691781|541459576|FG000|Overall Study|Withdrawal by Subject|4|||
150087849|NCT01691781|541459577|FG001|Overall Study|Withdrawal by Subject|3|||
150087850|NCT01691781|541459576|FG000|Overall Study|Physician Decision|1|||
150087851|NCT01691781|541459577|FG001|Overall Study|Physician Decision|1|||
150087852|NCT01691781|541459576|FG000|Overall Study|Protocol Violation|2|||
150087853|NCT01691781|541459577|FG001|Overall Study|Protocol Violation|2|||
150087854|NCT01691781|541459576|FG000|Overall Study|Adverse Event|0|||
150087855|NCT01691781|541459577|FG001|Overall Study|Adverse Event|1|||
150087856|NCT03978520|541459578|FG000|Overall Study|Adverse Event|2|||
150087857|NCT03978520|541459579|FG001|Overall Study|Adverse Event|5|||
150087858|NCT03978520|541459580|FG002|Overall Study|Adverse Event|3|||
150087859|NCT03978520|541459581|FG003|Overall Study|Adverse Event|5|||
150087860|NCT03978520|541459582|FG004|Overall Study|Adverse Event|6|||
150087861|NCT03978520|541459578|FG000|Overall Study|Withdrawal by Subject|10|||
150087862|NCT03978520|541459579|FG001|Overall Study|Withdrawal by Subject|4|||
150087863|NCT03978520|541459580|FG002|Overall Study|Withdrawal by Subject|5|||
150087864|NCT03978520|541459581|FG003|Overall Study|Withdrawal by Subject|6|||
150087865|NCT03978520|541459582|FG004|Overall Study|Withdrawal by Subject|5|||
150087866|NCT03978520|541459578|FG000|Overall Study|Lost to Follow-up|2|||
150087867|NCT03978520|541459579|FG001|Overall Study|Lost to Follow-up|2|||
150087868|NCT03978520|541459580|FG002|Overall Study|Lost to Follow-up|2|||
150087869|NCT03978520|541459581|FG003|Overall Study|Lost to Follow-up|0|||
150087870|NCT03978520|541459582|FG004|Overall Study|Lost to Follow-up|1|||
150087871|NCT03978520|541459578|FG000|Overall Study|COVID-19 infection|0|||
150087872|NCT03978520|541459579|FG001|Overall Study|COVID-19 infection|1|||
150087873|NCT03978520|541459580|FG002|Overall Study|COVID-19 infection|0|||
150087874|NCT03978520|541459581|FG003|Overall Study|COVID-19 infection|0|||
150087875|NCT03978520|541459582|FG004|Overall Study|COVID-19 infection|0|||
150087876|NCT03978520|541459578|FG000|Overall Study|Other, not specified|9|||
150087877|NCT03978520|541459579|FG001|Overall Study|Other, not specified|4|||
150087878|NCT03978520|541459580|FG002|Overall Study|Other, not specified|1|||
150087879|NCT03978520|541459581|FG003|Overall Study|Other, not specified|1|||
150087880|NCT03978520|541459582|FG004|Overall Study|Other, not specified|2|||
150087881|NCT03978520|541459578|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
150087882|NCT03978520|541459579|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
150087883|NCT03978520|541459580|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
150087884|NCT03978520|541459581|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
150087885|NCT03978520|541459582|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
150087886|NCT01918085|541459583|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
150087887|NCT01918085|541459584|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
150087888|NCT00600483|541459593|FG000|Overall Study|Lost to Follow-up|26|||
150184102|NCT05415410|541813261|FG000|Overall Study|Withdrawal by Subject|1|||
150087889|NCT00600483|541459594|FG001|Overall Study|Lost to Follow-up|47|||
150087890|NCT00600483|541459593|FG000|Overall Study|Randomized but not treated|10|||
150087891|NCT00600483|541459594|FG001|Overall Study|Randomized but not treated|0|||
150087892|NCT02547454|541459606|FG000|Overall Study|Due to hemodialysis|53|||
150087893|NCT02547454|541459606|FG000|Overall Study|Due to transplantation|1|||
150087894|NCT02547454|541459606|FG000|Overall Study|Due to no further need to treat|4|||
150087895|NCT02547454|541459606|FG000|Overall Study|Death|38|||
150087896|NCT02547454|541459606|FG000|Overall Study|Lost to Follow-up|26|||
150087897|NCT02547454|541459606|FG000|Overall Study|Other|39|||
150087898|NCT02547454|541459606|FG000|Overall Study|No data|11|||
150087899|NCT00580606|541459607|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
150087900|NCT00580606|541459608|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
150087901|NCT00580606|541459607|FG000|Open Label (OL)|Withdrawal by Subject|4|||
150087902|NCT00580606|541459608|FG001|Open Label (OL)|Withdrawal by Subject|6|||
150087903|NCT00580606|541459607|FG000|Open Label (OL)|Dosing Symptoms|0|||
150087904|NCT00580606|541459608|FG001|Open Label (OL)|Dosing Symptoms|1|||
150087905|NCT00580606|541459607|FG000|Open Label (OL)|Lost to Follow-up|0|||
150087906|NCT00580606|541459608|FG001|Open Label (OL)|Lost to Follow-up|1|||
150087907|NCT00580606|541459607|FG000|Open Label (OL)|Pregnancy|0|||
150087908|NCT00580606|541459608|FG001|Open Label (OL)|Pregnancy|1|||
150087909|NCT00580606|541459607|FG000|Open Label (OL)|Non-compliance|2|||
150087910|NCT00580606|541459608|FG001|Open Label (OL)|Non-compliance|0|||
150087911|NCT00580606|541459607|FG000|Open Label (OL)|Physician Decision|1|||
150087912|NCT00580606|541459608|FG001|Open Label (OL)|Physician Decision|1|||
150087913|NCT00580606|541459607|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
150087914|NCT00580606|541459608|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
150087915|NCT03655691|541459612|FG000|Overall Study|Adverse Event|0|||
150087916|NCT03655691|541459613|FG001|Overall Study|Adverse Event|0|||
150087917|NCT03655691|541459614|FG002|Overall Study|Adverse Event|1|||
150087918|NCT03655691|541459612|FG000|Overall Study|Lost to Follow-up|1|||
150087919|NCT03655691|541459613|FG001|Overall Study|Lost to Follow-up|1|||
150087920|NCT03655691|541459614|FG002|Overall Study|Lost to Follow-up|2|||
150087921|NCT03655691|541459612|FG000|Overall Study|Protocol Violation|0|||
150087922|NCT03655691|541459613|FG001|Overall Study|Protocol Violation|1|||
150087923|NCT03655691|541459614|FG002|Overall Study|Protocol Violation|0|||
150184103|NCT05415410|541813262|FG001|Overall Study|Withdrawal by Subject|0|||
150184104|NCT05415410|541813263|FG002|Overall Study|Withdrawal by Subject|0|||
150184105|NCT05415410|541813261|FG000|Overall Study|Pregnancy|5|||
150184106|NCT05415410|541813262|FG001|Overall Study|Pregnancy|2|||
150184107|NCT05415410|541813263|FG002|Overall Study|Pregnancy|0|||
150184108|NCT02365766|541813267|FG000|Overall Study|Withdrawal by Subject|0|||
150184109|NCT02365766|541813268|FG001|Overall Study|Withdrawal by Subject|0|||
150184110|NCT02365766|541813269|FG002|Overall Study|Withdrawal by Subject|1|||
150184111|NCT02365766|541813267|FG000|Overall Study|Eligibility Criteria Not Met|0|||
150184112|NCT02365766|541813268|FG001|Overall Study|Eligibility Criteria Not Met|0|||
150184113|NCT02365766|541813269|FG002|Overall Study|Eligibility Criteria Not Met|1|||
150184114|NCT04791709|541813278|FG000|Overall Study|Withdrawal by Subject|3|||
150184115|NCT02724956|541813279|FG000|Overall Study|Physician Decision|1|||
150184116|NCT02724956|541813280|FG001|Overall Study|Physician Decision|0|||
150184117|NCT02724956|541813279|FG000|Overall Study|Lack of Efficacy|0|||
150184118|NCT02724956|541813280|FG001|Overall Study|Lack of Efficacy|1|||
150184119|NCT02724956|541813279|FG000|Overall Study|Withdrawal by Subject|0|||
150184120|NCT02724956|541813280|FG001|Overall Study|Withdrawal by Subject|1|||
150184121|NCT00650104|541813281|FG000|Overall Study|Adverse Event|17|||
150184122|NCT00650104|541813281|FG000|Overall Study|Death|2|||
150184123|NCT00650104|541813281|FG000|Overall Study|Withdrawal by Subject|11|||
150184124|NCT00650104|541813281|FG000|Overall Study|Physician Decision|7|||
150184125|NCT00650104|541813281|FG000|Overall Study|Lost to Follow-up|1|||
150184126|NCT00650104|541813281|FG000|Overall Study|Non-compliance|2|||
150184127|NCT00650104|541813281|FG000|Overall Study|Sponsor Terminated Dosing|1|||
150184128|NCT01532388|541813282|FG000|3-month Follow-up|Lost to Follow-up|68|||
150184129|NCT01532388|541813283|FG001|3-month Follow-up|Lost to Follow-up|68|||
150184130|NCT01532388|541813282|FG000|6-month Follow-up|Lost to Follow-up|74|||
150184131|NCT01532388|541813283|FG001|6-month Follow-up|Lost to Follow-up|66|||
150184132|NCT01532388|541813282|FG000|12-month Follow-up|Lost to Follow-up|69|||
150184133|NCT01532388|541813283|FG001|12-month Follow-up|Lost to Follow-up|67|||
150184134|NCT03385629|541813284|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
150184135|NCT03385629|541813285|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
150184136|NCT03385629|541813284|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
150184137|NCT03385629|541813285|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
150184138|NCT03385629|541813284|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
150184139|NCT03385629|541813285|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
150184140|NCT00792636|541813286|FG000|Overall Study|Protocol Violation|17|||
150184141|NCT00792636|541813287|FG001|Overall Study|Protocol Violation|23|||
150184142|NCT00792636|541813288|FG002|Overall Study|Protocol Violation|20|||
150087924|NCT03655691|541459612|FG000|Overall Study|Withdrawal by Subject|1|||
150087925|NCT03655691|541459613|FG001|Overall Study|Withdrawal by Subject|1|||
150087926|NCT03655691|541459614|FG002|Overall Study|Withdrawal by Subject|0|||
150087927|NCT03694821|541459617|FG000|Overall Study|Study terminated|4|||
150087928|NCT03694821|541459618|FG001|Overall Study|Study terminated|8|||
150087929|NCT03694821|541459619|FG002|Overall Study|Study terminated|4|||
150087930|NCT04102020|541459622|FG000|Overall Study|Adverse Event|1|||
150087931|NCT04102020|541459623|FG001|Overall Study|Adverse Event|0|||
150087932|NCT04102020|541459624|FG002|Overall Study|Adverse Event|0|||
150087933|NCT04102020|541459625|FG003|Overall Study|Adverse Event|1|||
150087934|NCT04102020|541459626|FG004|Overall Study|Adverse Event|0|||
150087935|NCT04102020|541459622|FG000|Overall Study|Withdrawal by Subject|0|||
150087936|NCT04102020|541459623|FG001|Overall Study|Withdrawal by Subject|1|||
150087937|NCT04102020|541459624|FG002|Overall Study|Withdrawal by Subject|1|||
150087938|NCT04102020|541459625|FG003|Overall Study|Withdrawal by Subject|1|||
150087939|NCT04102020|541459626|FG004|Overall Study|Withdrawal by Subject|1|||
150184143|NCT00792636|541813286|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
150184144|NCT00792636|541813287|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
150087940|NCT04102020|541459622|FG000|Overall Study|Death|1|||
150087941|NCT04102020|541459623|FG001|Overall Study|Death|4|||
150087942|NCT04102020|541459624|FG002|Overall Study|Death|1|||
150087943|NCT04102020|541459625|FG003|Overall Study|Death|1|||
150087944|NCT04102020|541459626|FG004|Overall Study|Death|0|||
150087945|NCT04102020|541459622|FG000|Overall Study|Physician Decision|1|||
150087946|NCT04102020|541459623|FG001|Overall Study|Physician Decision|2|||
150087947|NCT04102020|541459624|FG002|Overall Study|Physician Decision|2|||
150184145|NCT00792636|541813288|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
150184146|NCT00792636|541813286|FG000|Overall Study|Lost to Follow-up|13|||
150184147|NCT00792636|541813287|FG001|Overall Study|Lost to Follow-up|19|||
150184148|NCT00792636|541813288|FG002|Overall Study|Lost to Follow-up|14|||
150087948|NCT04102020|541459625|FG003|Overall Study|Physician Decision|0|||
150184149|NCT00792636|541813286|FG000|Overall Study|Withdrew Consent|10|||
150184150|NCT00792636|541813287|FG001|Overall Study|Withdrew Consent|13|||
150184151|NCT00792636|541813288|FG002|Overall Study|Withdrew Consent|9|||
150184152|NCT00792636|541813286|FG000|Overall Study|Lack of Efficacy|3|||
150184153|NCT00792636|541813287|FG001|Overall Study|Lack of Efficacy|4|||
150184154|NCT00792636|541813288|FG002|Overall Study|Lack of Efficacy|13|||
150087949|NCT04102020|541459626|FG004|Overall Study|Physician Decision|1|||
150087950|NCT04102020|541459622|FG000|Overall Study|COVID-19 Infection|1|||
150087951|NCT04102020|541459623|FG001|Overall Study|COVID-19 Infection|0|||
150087952|NCT04102020|541459624|FG002|Overall Study|COVID-19 Infection|0|||
150087953|NCT04102020|541459625|FG003|Overall Study|COVID-19 Infection|0|||
150087954|NCT04102020|541459626|FG004|Overall Study|COVID-19 Infection|0|||
150087955|NCT04102020|541459622|FG000|Overall Study|Not disclosed|5|||
150087956|NCT04102020|541459623|FG001|Overall Study|Not disclosed|3|||
150087957|NCT04102020|541459624|FG002|Overall Study|Not disclosed|8|||
150087958|NCT04102020|541459625|FG003|Overall Study|Not disclosed|0|||
150087959|NCT04102020|541459626|FG004|Overall Study|Not disclosed|1|||
150087960|NCT04102020|541459622|FG000|Overall Study|MIssing|1|||
150087961|NCT04102020|541459623|FG001|Overall Study|MIssing|0|||
150087962|NCT04102020|541459624|FG002|Overall Study|MIssing|1|||
150087963|NCT04102020|541459625|FG003|Overall Study|MIssing|1|||
150087964|NCT04102020|541459626|FG004|Overall Study|MIssing|1|||
150087965|NCT04102020|541459622|FG000|Overall Study|Continuing in ongoing study|13|||
150087966|NCT04102020|541459623|FG001|Overall Study|Continuing in ongoing study|13|||
150087967|NCT04102020|541459624|FG002|Overall Study|Continuing in ongoing study|7|||
150087968|NCT04102020|541459625|FG003|Overall Study|Continuing in ongoing study|26|||
150087969|NCT04102020|541459626|FG004|Overall Study|Continuing in ongoing study|12|||
150087970|NCT05109442|541459627|FG000|Overall Study|Withdrawal by Subject|0|||
150087971|NCT05109442|541459628|FG001|Overall Study|Withdrawal by Subject|0|||
150087972|NCT05109442|541459629|FG002|Overall Study|Withdrawal by Subject|1|||
150087973|NCT05109442|541459630|FG003|Overall Study|Withdrawal by Subject|0|||
150087974|NCT05109442|541459631|FG004|Overall Study|Withdrawal by Subject|0|||
150087975|NCT05109442|541459632|FG005|Overall Study|Withdrawal by Subject|0|||
150087976|NCT05109442|541459627|FG000|Overall Study|Adverse Event|0|||
150087977|NCT05109442|541459628|FG001|Overall Study|Adverse Event|1|||
150087978|NCT05109442|541459629|FG002|Overall Study|Adverse Event|5|||
150087979|NCT05109442|541459630|FG003|Overall Study|Adverse Event|0|||
150087980|NCT05109442|541459631|FG004|Overall Study|Adverse Event|0|||
150087981|NCT05109442|541459632|FG005|Overall Study|Adverse Event|2|||
150087982|NCT05109442|541459627|FG000|Overall Study|Death|0|||
150087983|NCT05109442|541459628|FG001|Overall Study|Death|0|||
150087984|NCT05109442|541459629|FG002|Overall Study|Death|4|||
150087985|NCT05109442|541459630|FG003|Overall Study|Death|0|||
150087986|NCT05109442|541459631|FG004|Overall Study|Death|0|||
150087987|NCT05109442|541459632|FG005|Overall Study|Death|1|||
150087988|NCT05109442|541459627|FG000|Overall Study|Physician Decision|1|||
150087989|NCT05109442|541459628|FG001|Overall Study|Physician Decision|0|||
150087990|NCT05109442|541459629|FG002|Overall Study|Physician Decision|1|||
150087991|NCT05109442|541459630|FG003|Overall Study|Physician Decision|0|||
150087992|NCT05109442|541459631|FG004|Overall Study|Physician Decision|0|||
150087993|NCT05109442|541459632|FG005|Overall Study|Physician Decision|2|||
150087994|NCT05109442|541459627|FG000|Overall Study|Other than listed|0|||
150087995|NCT05109442|541459628|FG001|Overall Study|Other than listed|0|||
150087996|NCT05109442|541459629|FG002|Overall Study|Other than listed|9|||
150087997|NCT05109442|541459630|FG003|Overall Study|Other than listed|2|||
150087998|NCT05109442|541459631|FG004|Overall Study|Other than listed|0|||
150087999|NCT05109442|541459632|FG005|Overall Study|Other than listed|8|||
150088000|NCT05109442|541459627|FG000|Overall Study|Lack of Efficacy|3|||
150088001|NCT05109442|541459628|FG001|Overall Study|Lack of Efficacy|5|||
150088002|NCT05109442|541459629|FG002|Overall Study|Lack of Efficacy|29|||
150088003|NCT05109442|541459630|FG003|Overall Study|Lack of Efficacy|10|||
150088004|NCT05109442|541459631|FG004|Overall Study|Lack of Efficacy|11|||
150088005|NCT05109442|541459632|FG005|Overall Study|Lack of Efficacy|17|||
150088006|NCT03918447|541459637|FG000|Overall Study|Death|1|||
150088007|NCT03918447|541459638|FG001|Overall Study|Death|0|||
150088008|NCT03918447|541459637|FG000|Overall Study|Lost to Follow-up|13|||
150088009|NCT03918447|541459638|FG001|Overall Study|Lost to Follow-up|6|||
150088010|NCT03918447|541459637|FG000|Overall Study|Withdrawal by Subject|19|||
150088011|NCT03918447|541459638|FG001|Overall Study|Withdrawal by Subject|17|||
150088012|NCT03918447|541459637|FG000|Overall Study|Study Terminated by Sponsor|195|||
150088013|NCT03918447|541459638|FG001|Overall Study|Study Terminated by Sponsor|197|||
150088014|NCT03918447|541459637|FG000|Overall Study|Reason not Specified|0|||
150088015|NCT03918447|541459638|FG001|Overall Study|Reason not Specified|1|||
150088016|NCT03278613|541459639|FG000|Overall Study|Lost to Follow-up|3|||
150088017|NCT03278613|541459640|FG001|Overall Study|Lost to Follow-up|1|||
150088018|NCT01405456|541459641|FG000|Overall Study|Lost to Follow-up|2|||
150088019|NCT01405456|541459642|FG001|Overall Study|Lost to Follow-up|1|||
150088020|NCT01405456|541459641|FG000|Overall Study|Physician Decision|1|||
150088021|NCT01405456|541459642|FG001|Overall Study|Physician Decision|0|||
150088022|NCT01774968|541459644|FG000|Overall Study|Adverse Event|4|||
150088023|NCT01774968|541459645|FG001|Overall Study|Adverse Event|4|||
150088024|NCT01774968|541459644|FG000|Overall Study|Death|0|||
150088025|NCT01774968|541459645|FG001|Overall Study|Death|1|||
150088026|NCT01774968|541459644|FG000|Overall Study|Lost to Follow-up|1|||
150088027|NCT01774968|541459645|FG001|Overall Study|Lost to Follow-up|3|||
150088028|NCT01774968|541459644|FG000|Overall Study|Physician Decision|5|||
150088029|NCT01774968|541459645|FG001|Overall Study|Physician Decision|1|||
150088030|NCT01774968|541459644|FG000|Overall Study|Protocol Violation|14|||
150088031|NCT01774968|541459645|FG001|Overall Study|Protocol Violation|13|||
150088032|NCT01774968|541459644|FG000|Overall Study|Sponsor Decision|0|||
150088033|NCT01774968|541459645|FG001|Overall Study|Sponsor Decision|2|||
150088034|NCT01774968|541459644|FG000|Overall Study|Withdrawal by Subject|6|||
150088035|NCT01774968|541459645|FG001|Overall Study|Withdrawal by Subject|11|||
150088036|NCT05353985|541459646|FG000|Overall Study|Adverse Event|5|||
150088037|NCT05353985|541459647|FG001|Overall Study|Adverse Event|7|||
150088038|NCT05353985|541459646|FG000|Overall Study|Lost to Follow-up|1|||
150088039|NCT05353985|541459647|FG001|Overall Study|Lost to Follow-up|1|||
150088040|NCT05353985|541459646|FG000|Overall Study|Protocol Violation|1|||
150088041|NCT05353985|541459647|FG001|Overall Study|Protocol Violation|0|||
150088042|NCT05353985|541459646|FG000|Overall Study|Withdrawal by Subject|13|||
150088043|NCT05353985|541459647|FG001|Overall Study|Withdrawal by Subject|17|||
150088044|NCT05353985|541459646|FG000|Overall Study|Reason Not Specified|1|||
150088045|NCT05353985|541459647|FG001|Overall Study|Reason Not Specified|0|||
150088046|NCT05353985|541459646|FG000|Overall Study|Randomized in Error & Not Treated|0|||
150088047|NCT05353985|541459647|FG001|Overall Study|Randomized in Error & Not Treated|1|||
150088048|NCT04847557|541459650|FG000|Overall Study|Adverse Event|1|||
150088049|NCT04847557|541459651|FG001|Overall Study|Adverse Event|0|||
150088050|NCT04847557|541459650|FG000|Overall Study|Death|19|||
150088051|NCT04847557|541459651|FG001|Overall Study|Death|15|||
150088052|NCT04847557|541459650|FG000|Overall Study|Lost to Follow-up|3|||
150088053|NCT04847557|541459651|FG001|Overall Study|Lost to Follow-up|6|||
150088054|NCT04847557|541459650|FG000|Overall Study|Physician Decision|1|||
150088055|NCT04847557|541459651|FG001|Overall Study|Physician Decision|0|||
150088056|NCT04847557|541459650|FG000|Overall Study|Protocol Violation|0|||
150088057|NCT04847557|541459651|FG001|Overall Study|Protocol Violation|1|||
150088058|NCT04847557|541459650|FG000|Overall Study|Withdrawal by Subject|8|||
150088059|NCT04847557|541459651|FG001|Overall Study|Withdrawal by Subject|14|||
150088060|NCT01325584|541459652|FG000|Overall Study|Death|1|||
150088061|NCT03010254|541461082|FG000|Overall Study|Adverse Event|0|||
150088062|NCT03010254|541461083|FG001|Overall Study|Adverse Event|1|||
150088063|NCT03010254|541461082|FG000|Overall Study|Lost to Follow-up|4|||
150088064|NCT03010254|541461083|FG001|Overall Study|Lost to Follow-up|0|||
150088065|NCT03010254|541461082|FG000|Overall Study|Withdrawal by Subject|1|||
150088066|NCT03010254|541461083|FG001|Overall Study|Withdrawal by Subject|1|||
150088067|NCT03010254|541461082|FG000|Overall Study|Other|2|||
150088068|NCT03010254|541461083|FG001|Overall Study|Other|3|||
150088069|NCT00848081|541461084|FG000|Overall Study|Adverse Event|6|||
150088070|NCT00848081|541461085|FG001|Overall Study|Adverse Event|7|||
150088071|NCT00848081|541461084|FG000|Overall Study|Protocol Violation|8|||
150088072|NCT00848081|541461085|FG001|Overall Study|Protocol Violation|5|||
150088073|NCT00848081|541461084|FG000|Overall Study|Lost to Follow-up|1|||
150088074|NCT00848081|541461085|FG001|Overall Study|Lost to Follow-up|0|||
150088075|NCT00848081|541461084|FG000|Overall Study|Physician Decision|0|||
150088076|NCT00848081|541461085|FG001|Overall Study|Physician Decision|3|||
150088077|NCT00848081|541461084|FG000|Overall Study|Withdrawal by Subject|5|||
150088078|NCT00848081|541461085|FG001|Overall Study|Withdrawal by Subject|3|||
150088079|NCT02064868|541461088|FG000|Overall Study|Lost to Follow-up|14|||
150088080|NCT02064868|541461089|FG001|Overall Study|Lost to Follow-up|8|||
150088081|NCT02064868|541461088|FG000|Overall Study|Physician Decision|1|||
150088082|NCT02064868|541461089|FG001|Overall Study|Physician Decision|0|||
150088083|NCT02064868|541461088|FG000|Overall Study|Withdrawal by Subject|14|||
150088084|NCT02064868|541461089|FG001|Overall Study|Withdrawal by Subject|3|||
150088085|NCT02064868|541461088|FG000|Overall Study|Technical Problems or Missing|5|||
150088086|NCT02064868|541461089|FG001|Overall Study|Technical Problems or Missing|2|||
150088087|NCT00418314|541461093|FG000|Overall Study|Withdrawal by Subject|1|||
150088088|NCT00418314|541461094|FG001|Overall Study|Withdrawal by Subject|2|||
150088089|NCT02057406|541461095|FG000|Overall Study|Physician Decision|0|||
150088090|NCT02057406|541461096|FG001|Overall Study|Physician Decision|0|||
150088091|NCT02057406|541461097|FG002|Overall Study|Physician Decision|2|||
150088092|NCT02057406|541461095|FG000|Overall Study|Withdrawal by Subject|0|||
150088093|NCT02057406|541461096|FG001|Overall Study|Withdrawal by Subject|2|||
150088094|NCT02057406|541461097|FG002|Overall Study|Withdrawal by Subject|0|||
150088095|NCT02057406|541461095|FG000|Overall Study|Lost to Follow-up|0|||
150088096|NCT02057406|541461096|FG001|Overall Study|Lost to Follow-up|0|||
150088097|NCT02057406|541461097|FG002|Overall Study|Lost to Follow-up|1|||
150088098|NCT02057406|541461095|FG000|Overall Study|Death|1|||
150088099|NCT02057406|541461096|FG001|Overall Study|Death|0|||
150088100|NCT02057406|541461097|FG002|Overall Study|Death|0|||
150088101|NCT02057406|541461095|FG000|Overall Study|Protocol Violation|0|||
150088102|NCT02057406|541461096|FG001|Overall Study|Protocol Violation|1|||
150088103|NCT02057406|541461097|FG002|Overall Study|Protocol Violation|0|||
150088104|NCT02057406|541461095|FG000|Overall Study|Patient transportation issues|0|||
150088105|NCT02057406|541461096|FG001|Overall Study|Patient transportation issues|0|||
150088106|NCT02057406|541461097|FG002|Overall Study|Patient transportation issues|1|||
150088107|NCT02782780|541461098|FG000|Overall Study|dropped out after randomization.|7|||
150088108|NCT02782780|541461099|FG001|Overall Study|dropped out after randomization.|5|||
150088109|NCT02782780|541461098|FG000|Overall Study|Protocol Violation|0|||
150088110|NCT02782780|541461099|FG001|Overall Study|Protocol Violation|2|||
150088111|NCT03562481|541461100|FG000|First Intervention|Lost to Follow-up|1|||
150088112|NCT03562481|541461101|FG001|First Intervention|Lost to Follow-up|0|||
150088113|NCT03824912|541461102|FG000|Overall Study|Lost to Follow-up|18|||
150088114|NCT03824912|541461103|FG001|Overall Study|Lost to Follow-up|15|||
150088115|NCT03824912|541461104|FG002|Overall Study|Lost to Follow-up|8|||
150088116|NCT03824912|541461102|FG000|Overall Study|Negative Baseline Culture Result|118|||
150088117|NCT03824912|541461103|FG001|Overall Study|Negative Baseline Culture Result|112|||
150088118|NCT03824912|541461104|FG002|Overall Study|Negative Baseline Culture Result|57|||
150088119|NCT03824912|541461102|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150088120|NCT03824912|541461103|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150088121|NCT03824912|541461104|FG002|Overall Study|Non-Compliance with Study Drug|1|||
150088122|NCT03824912|541461102|FG000|Overall Study|Protocol Violation|1|||
150088123|NCT03824912|541461103|FG001|Overall Study|Protocol Violation|4|||
150088124|NCT03824912|541461104|FG002|Overall Study|Protocol Violation|1|||
150088125|NCT03824912|541461102|FG000|Overall Study|Withdrawal by Subject|3|||
150088126|NCT03824912|541461103|FG001|Overall Study|Withdrawal by Subject|2|||
150088127|NCT03824912|541461104|FG002|Overall Study|Withdrawal by Subject|1|||
150088128|NCT03824912|541461102|FG000|Overall Study|Participation in another study|0|||
150088129|NCT03824912|541461103|FG001|Overall Study|Participation in another study|1|||
150088130|NCT03824912|541461104|FG002|Overall Study|Participation in another study|0|||
150088131|NCT02904512|541461105|FG000|Overall Study|Withdrawal by Subject|1|||
150088132|NCT02904512|541461106|FG001|Overall Study|Withdrawal by Subject|0|||
150088133|NCT02904512|541461105|FG000|Overall Study|Transferred to ICU|1|||
150088134|NCT02904512|541461106|FG001|Overall Study|Transferred to ICU|0|||
150088135|NCT02904512|541461105|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
150088136|NCT02904512|541461106|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
150088137|NCT01963403|541461116|FG000|Overall Study|Lost to Follow-up|2|||
150088138|NCT01963403|541461117|FG001|Overall Study|Lost to Follow-up|3|||
150088139|NCT01963403|541461116|FG000|Overall Study|Implant removal|0|||
150088140|NCT01963403|541461117|FG001|Overall Study|Implant removal|1|||
150088141|NCT00549302|541461124|FG000|Double-Blind|Death|2|||
150088142|NCT00549302|541461125|FG001|Double-Blind|Death|9|||
150088143|NCT00549302|541461126|FG002|Double-Blind|Death|0|||
150088144|NCT00549302|541461124|FG000|Double-Blind|Adverse Event|3|||
150088145|NCT00549302|541461125|FG001|Double-Blind|Adverse Event|16|||
150088146|NCT00549302|541461126|FG002|Double-Blind|Adverse Event|0|||
150088147|NCT00549302|541461124|FG000|Double-Blind|Withdrawal by Subject|3|||
150088148|NCT00549302|541461125|FG001|Double-Blind|Withdrawal by Subject|8|||
150088149|NCT00549302|541461126|FG002|Double-Blind|Withdrawal by Subject|0|||
150088150|NCT00549302|541461124|FG000|Double-Blind|Investigator Decision|1|||
150088151|NCT00549302|541461125|FG001|Double-Blind|Investigator Decision|5|||
150088152|NCT00549302|541461126|FG002|Double-Blind|Investigator Decision|0|||
150088153|NCT00549302|541461124|FG000|Double-Blind|Sponsor Decision|0|||
150088154|NCT00549302|541461125|FG001|Double-Blind|Sponsor Decision|1|||
150088155|NCT00549302|541461126|FG002|Double-Blind|Sponsor Decision|0|||
150088156|NCT00549302|541461124|FG000|Double-Blind|Lost to Follow-up|1|||
150088157|NCT00549302|541461125|FG001|Double-Blind|Lost to Follow-up|2|||
150088158|NCT00549302|541461126|FG002|Double-Blind|Lost to Follow-up|0|||
150088159|NCT00549302|541461124|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
150088160|NCT00549302|541461125|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
150088161|NCT00549302|541461126|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
150088162|NCT00549302|541461124|FG000|Double-Blind|New condition or starts new therapy|0|||
150088163|NCT00549302|541461125|FG001|Double-Blind|New condition or starts new therapy|2|||
150088164|NCT00549302|541461126|FG002|Double-Blind|New condition or starts new therapy|0|||
150088165|NCT00549302|541461124|FG000|Open-Label|Adverse Event|0|||
150088166|NCT00549302|541461125|FG001|Open-Label|Adverse Event|0|||
150088167|NCT00549302|541461126|FG002|Open-Label|Adverse Event|11|||
150088168|NCT00549302|541461124|FG000|Open-Label|Death|0|||
150088169|NCT00549302|541461125|FG001|Open-Label|Death|0|||
150088170|NCT00549302|541461126|FG002|Open-Label|Death|40|||
150088171|NCT00549302|541461124|FG000|Open-Label|Investigator Decision|0|||
150088172|NCT00549302|541461125|FG001|Open-Label|Investigator Decision|0|||
150088173|NCT00549302|541461126|FG002|Open-Label|Investigator Decision|5|||
150088174|NCT00549302|541461124|FG000|Open-Label|Lost to Follow-up|0|||
150088175|NCT00549302|541461125|FG001|Open-Label|Lost to Follow-up|0|||
150088176|NCT00549302|541461126|FG002|Open-Label|Lost to Follow-up|2|||
150088177|NCT00549302|541461124|FG000|Open-Label|Other|0|||
150088178|NCT00549302|541461125|FG001|Open-Label|Other|0|||
150088179|NCT00549302|541461126|FG002|Open-Label|Other|3|||
150088180|NCT00549302|541461124|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
150088181|NCT00549302|541461125|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
150088182|NCT00549302|541461126|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
150088183|NCT00549302|541461124|FG000|Open-Label|Withdrawal by Subject|0|||
150088184|NCT00549302|541461125|FG001|Open-Label|Withdrawal by Subject|0|||
150088185|NCT00549302|541461126|FG002|Open-Label|Withdrawal by Subject|6|||
150088186|NCT03585504|541461127|FG000|Overall Study|Lost to Follow-up|26|||
150088187|NCT03585504|541461128|FG001|Overall Study|Lost to Follow-up|29|||
150088188|NCT01414114|541461129|FG000|Overall Study|Adverse Event|2|||
150088189|NCT01414114|541461129|FG000|Overall Study|Withdrawal by Subject|1|||
150088190|NCT01414114|541461129|FG000|Overall Study|Other|2|||
150088191|NCT05620563|541461134|FG000|Overall Study|Adverse Event|3|||
150088192|NCT05620563|541461135|FG001|Overall Study|Adverse Event|1|||
150088193|NCT05620563|541461134|FG000|Overall Study|Lost to Follow-up|0|||
150088194|NCT05620563|541461135|FG001|Overall Study|Lost to Follow-up|2|||
150088195|NCT05620563|541461134|FG000|Overall Study|Protocol Deviation|1|||
150088196|NCT05620563|541461135|FG001|Overall Study|Protocol Deviation|2|||
150088197|NCT05620563|541461134|FG000|Overall Study|Withdrawal by Subject|3|||
150088198|NCT05620563|541461135|FG001|Overall Study|Withdrawal by Subject|3|||
150088199|NCT05620563|541461134|FG000|Overall Study|Physician Decision|0|||
150088200|NCT05620563|541461135|FG001|Overall Study|Physician Decision|1|||
150088201|NCT02085785|541461139|FG000|Overall Study|Withdrawal by Subject|2|||
150088202|NCT02085785|541461140|FG001|Overall Study|Withdrawal by Subject|1|||
150088203|NCT02085785|541461139|FG000|Overall Study|Lost to Follow-up|0|||
150088204|NCT02085785|541461140|FG001|Overall Study|Lost to Follow-up|1|||
150088205|NCT03590041|541461141|FG000|Overall Study|Protocol Violation|4|||
150088206|NCT03590041|541461142|FG001|Overall Study|Protocol Violation|3|||
150088207|NCT03590041|541461141|FG000|Overall Study|No session data recorded|14|||
150088208|NCT03590041|541461142|FG001|Overall Study|No session data recorded|2|||
150088209|NCT02692703|541461143|FG000|Overall Study|Lost to Follow-up|1|||
150088210|NCT02692703|541461143|FG000|Overall Study|Other|1|||
150088211|NCT04626297|541461144|FG000|Overall Study|Adverse Event|5|||
150088212|NCT04626297|541461145|FG001|Overall Study|Adverse Event|3|||
150088213|NCT04626297|541461144|FG000|Overall Study|Lost to Follow-up|7|||
150088214|NCT04626297|541461145|FG001|Overall Study|Lost to Follow-up|3|||
150088215|NCT04626297|541461144|FG000|Overall Study|Protocol Violation|5|||
150088216|NCT04626297|541461145|FG001|Overall Study|Protocol Violation|1|||
150088217|NCT04626297|541461144|FG000|Overall Study|Withdrawal by Subject|20|||
150088218|NCT04626297|541461145|FG001|Overall Study|Withdrawal by Subject|6|||
150088219|NCT04626297|541461144|FG000|Overall Study|Sponsor decision|2|||
150088220|NCT04626297|541461145|FG001|Overall Study|Sponsor decision|1|||
150088221|NCT04118166|541461146|FG000|Overall Study|Adverse Event|1|||
150088222|NCT03519932|541461149|FG000|First Intervention|Adverse Event|1|||
150088223|NCT03519932|541461150|FG001|First Intervention|Adverse Event|3|||
150088224|NCT02254486|541461151|FG000|Overall Study|Adverse Event|1|||
150088225|NCT02254486|541461152|FG001|Overall Study|Adverse Event|1|||
150088226|NCT02254486|541461151|FG000|Overall Study|Lack of Efficacy|1|||
150088227|NCT02254486|541461152|FG001|Overall Study|Lack of Efficacy|0|||
150088228|NCT02254486|541461151|FG000|Overall Study|Lost to Follow-up|2|||
150088229|NCT02254486|541461152|FG001|Overall Study|Lost to Follow-up|4|||
150088230|NCT02254486|541461151|FG000|Overall Study|Protocol Violation|1|||
150088231|NCT02254486|541461152|FG001|Overall Study|Protocol Violation|2|||
150088232|NCT02254486|541461151|FG000|Overall Study|Withdrawal by Subject|17|||
150088233|NCT02254486|541461152|FG001|Overall Study|Withdrawal by Subject|15|||
150088234|NCT02254486|541461151|FG000|Overall Study|GFR<60mL/min|16|||
150088235|NCT02254486|541461152|FG001|Overall Study|GFR<60mL/min|21|||
150088236|NCT02254486|541461151|FG000|Overall Study|Various|12|||
150088237|NCT02254486|541461152|FG001|Overall Study|Various|12|||
150088238|NCT01350414|541461153|FG000|Overall Study|Lost to Follow-up|13|||
150088239|NCT01350414|541461153|FG000|Overall Study|Withdrawal by Subject|4|||
150088240|NCT01350414|541461153|FG000|Overall Study|Physician Decision|2|||
150088241|NCT00460408|541461154|FG000|Overall Study|Adverse Event|1|||
150088242|NCT00460408|541461155|FG001|Overall Study|Adverse Event|0|||
150088243|NCT00460408|541461156|FG002|Overall Study|Adverse Event|0|||
150088244|NCT00460408|541461157|FG003|Overall Study|Adverse Event|0|||
150088245|NCT00460408|541461154|FG000|Overall Study|Death|7|||
150088246|NCT00460408|541461155|FG001|Overall Study|Death|0|||
150088247|NCT00460408|541461156|FG002|Overall Study|Death|0|||
150088248|NCT00460408|541461157|FG003|Overall Study|Death|0|||
150088249|NCT00460408|541461154|FG000|Overall Study|Lost to Follow-up|11|||
150088250|NCT00460408|541461155|FG001|Overall Study|Lost to Follow-up|0|||
150088251|NCT00460408|541461156|FG002|Overall Study|Lost to Follow-up|1|||
150088252|NCT00460408|541461157|FG003|Overall Study|Lost to Follow-up|0|||
150088253|NCT00460408|541461154|FG000|Overall Study|Withdrawal by Subject|31|||
150088254|NCT00460408|541461155|FG001|Overall Study|Withdrawal by Subject|0|||
150088255|NCT00460408|541461156|FG002|Overall Study|Withdrawal by Subject|0|||
150088256|NCT00460408|541461157|FG003|Overall Study|Withdrawal by Subject|0|||
150088257|NCT00460408|541461154|FG000|Overall Study|Insufficient clinical response|5|||
150088258|NCT00460408|541461155|FG001|Overall Study|Insufficient clinical response|1|||
150088259|NCT00460408|541461156|FG002|Overall Study|Insufficient clinical response|5|||
150088260|NCT00460408|541461157|FG003|Overall Study|Insufficient clinical response|0|||
150088261|NCT00460408|541461154|FG000|Overall Study|Other|12|||
150088262|NCT00460408|541461155|FG001|Overall Study|Other|2|||
150088263|NCT00460408|541461156|FG002|Overall Study|Other|0|||
150088264|NCT00460408|541461157|FG003|Overall Study|Other|0|||
150088265|NCT03303079|541461162|FG000|Overall Study|Adverse Event|0|||
150088266|NCT03303079|541461163|FG001|Overall Study|Adverse Event|1|||
150088267|NCT03303079|541461164|FG002|Overall Study|Adverse Event|3|||
150088268|NCT03303079|541461162|FG000|Overall Study|Protocol Violation|5|||
150088269|NCT03303079|541461163|FG001|Overall Study|Protocol Violation|4|||
150088270|NCT03303079|541461164|FG002|Overall Study|Protocol Violation|7|||
150088271|NCT03303079|541461162|FG000|Overall Study|Withdrawal by Subject|2|||
150088272|NCT03303079|541461163|FG001|Overall Study|Withdrawal by Subject|4|||
150088273|NCT03303079|541461164|FG002|Overall Study|Withdrawal by Subject|2|||
150088274|NCT03303079|541461162|FG000|Overall Study|Other than specified|0|||
150088275|NCT03303079|541461163|FG001|Overall Study|Other than specified|2|||
150088276|NCT03303079|541461164|FG002|Overall Study|Other than specified|0|||
150088277|NCT00010374|541461165|FG000|Overall Study|False positive phrenic nerve test|1|||
150088278|NCT00372112|541461168|FG000|Overall Study|Adverse Event|0|||
150088279|NCT00372112|541461169|FG001|Overall Study|Adverse Event|1|||
150088280|NCT00372112|541461170|FG002|Overall Study|Adverse Event|1|||
150088281|NCT00372112|541461171|FG003|Overall Study|Adverse Event|1|||
150088282|NCT00372112|541461168|FG000|Overall Study|Withdrawal by Subject|0|||
150088283|NCT00372112|541461169|FG001|Overall Study|Withdrawal by Subject|0|||
150088284|NCT00372112|541461170|FG002|Overall Study|Withdrawal by Subject|2|||
150088285|NCT00372112|541461171|FG003|Overall Study|Withdrawal by Subject|1|||
150088286|NCT00372112|541461168|FG000|Overall Study|Exacerbation|0|||
150088287|NCT00372112|541461169|FG001|Overall Study|Exacerbation|0|||
150088288|NCT00372112|541461170|FG002|Overall Study|Exacerbation|0|||
150088289|NCT00372112|541461171|FG003|Overall Study|Exacerbation|1|||
150088290|NCT00372112|541461168|FG000|Overall Study|PR >240 at Visit 3|0|||
150088291|NCT00372112|541461169|FG001|Overall Study|PR >240 at Visit 3|0|||
150088292|NCT00372112|541461170|FG002|Overall Study|PR >240 at Visit 3|0|||
150088293|NCT00372112|541461171|FG003|Overall Study|PR >240 at Visit 3|1|||
150088294|NCT00372112|541461168|FG000|Overall Study|Hepatitis B|1|||
150088295|NCT00372112|541461169|FG001|Overall Study|Hepatitis B|0|||
150088296|NCT00372112|541461170|FG002|Overall Study|Hepatitis B|0|||
150088297|NCT00372112|541461171|FG003|Overall Study|Hepatitis B|0|||
150088298|NCT00372112|541461168|FG000|Overall Study|Other-protocol violation|0|||
150088299|NCT00372112|541461169|FG001|Overall Study|Other-protocol violation|0|||
150088300|NCT00372112|541461170|FG002|Overall Study|Other-protocol violation|1|||
150088301|NCT00372112|541461171|FG003|Overall Study|Other-protocol violation|0|||
150088302|NCT01426373|541461172|FG000|Overall Study|Adverse Event|6|||
150088303|NCT01426373|541461172|FG000|Overall Study|Lost to Follow-up|14|||
150088304|NCT01426373|541461172|FG000|Overall Study|Participant Convenience|10|||
150088305|NCT01426373|541461172|FG000|Overall Study|Miscellaneous Reasons|4|||
150088306|NCT01574326|541461175|FG000|Overall Study|Randomized but not treated|0|||
150088307|NCT01574326|541461176|FG001|Overall Study|Randomized but not treated|1|||
150088308|NCT01574326|541461175|FG000|Overall Study|Withdrawal by Participant|2|||
150088309|NCT01574326|541461176|FG001|Overall Study|Withdrawal by Participant|4|||
150088310|NCT01574326|541461175|FG000|Overall Study|Physician Decision|5|||
150088311|NCT01574326|541461176|FG001|Overall Study|Physician Decision|3|||
150088312|NCT01574326|541461175|FG000|Overall Study|Adverse Event|1|||
150088313|NCT01574326|541461176|FG001|Overall Study|Adverse Event|3|||
150088314|NCT01574326|541461175|FG000|Overall Study|Other: Mainly kidney transplant|8|||
150088315|NCT01574326|541461176|FG001|Overall Study|Other: Mainly kidney transplant|8|||
150088316|NCT01919723|541461179|FG000|Overall Study|Blood Samples Hemolyzed|2|||
150088317|NCT01919723|541461180|FG001|Overall Study|Blood Samples Hemolyzed|2|||
150088318|NCT04502589|541461181|FG000|Overall Study|Physician Decision|1|||
150088319|NCT04502589|541461182|FG001|Overall Study|Physician Decision|0|||
150088320|NCT00137046|541461188|FG000|Overall Study|Death|2|||
150088321|NCT00137046|541461189|FG001|Overall Study|Death|1|||
150088322|NCT00137046|541461188|FG000|Overall Study|Adverse Event|16|||
150088323|NCT00137046|541461189|FG001|Overall Study|Adverse Event|5|||
150088324|NCT00137046|541461188|FG000|Overall Study|Laboratory Abnormality|2|||
150088325|NCT00137046|541461189|FG001|Overall Study|Laboratory Abnormality|0|||
150088326|NCT00137046|541461188|FG000|Overall Study|Lack of Efficacy|13|||
150088327|NCT00137046|541461189|FG001|Overall Study|Lack of Efficacy|1|||
150088328|NCT00137046|541461188|FG000|Overall Study|Lost to Follow-up|8|||
150088329|NCT00137046|541461189|FG001|Overall Study|Lost to Follow-up|24|||
150088330|NCT00137046|541461188|FG000|Overall Study|Other|23|||
150088331|NCT00137046|541461189|FG001|Overall Study|Other|19|||
150088332|NCT00137046|541461188|FG000|Overall Study|Withdrawal by Subject|33|||
150088333|NCT00137046|541461189|FG001|Overall Study|Withdrawal by Subject|42|||
150088334|NCT00137046|541461188|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
150088335|NCT00137046|541461189|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
150088336|NCT00137046|541461188|FG000|Overall Study|Withdrew prior to study treatment|1|||
150088337|NCT00137046|541461189|FG001|Overall Study|Withdrew prior to study treatment|1|||
150088338|NCT01288469|541461190|FG000|Overall Study|Adverse Event|4|||
150088339|NCT01288469|541461191|FG001|Overall Study|Adverse Event|1|||
150088340|NCT01288469|541461192|FG002|Overall Study|Adverse Event|1|||
150088341|NCT01288469|541461190|FG000|Overall Study|Poor compliance to protocol|0|||
150088342|NCT01288469|541461191|FG001|Overall Study|Poor compliance to protocol|1|||
150088343|NCT01288469|541461192|FG002|Overall Study|Poor compliance to protocol|0|||
150088344|NCT01288469|541461190|FG000|Overall Study|Participant Moved|1|||
150088345|NCT01288469|541461191|FG001|Overall Study|Participant Moved|0|||
150088346|NCT01288469|541461192|FG002|Overall Study|Participant Moved|0|||
150088347|NCT01288469|541461190|FG000|Overall Study|Consent withdrawn by subject|1|||
150088348|NCT01288469|541461191|FG001|Overall Study|Consent withdrawn by subject|1|||
150088349|NCT01288469|541461192|FG002|Overall Study|Consent withdrawn by subject|1|||
150088350|NCT01288469|541461190|FG000|Overall Study|Exclusion criteria finally met|1|||
150088351|NCT01288469|541461191|FG001|Overall Study|Exclusion criteria finally met|0|||
150088352|NCT01288469|541461192|FG002|Overall Study|Exclusion criteria finally met|0|||
150088353|NCT00582166|541461194|FG000|Overall Study|Death|1|||
150088354|NCT00582166|541461194|FG000|Overall Study|Ineligible pathology|1|||
150088355|NCT02859454|541461195|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
150088356|NCT00110149|541461196|FG000|Overall Study|Physician Decision|3|||
150088357|NCT03334448|541461197|FG000|Washout|Personal Reason|0|||
150088358|NCT03334448|541461198|FG001|Washout|Personal Reason|1|||
150088359|NCT03334448|541461199|FG002|Washout|Personal Reason|0|||
150088360|NCT03334448|541461200|FG003|Washout|Personal Reason|0|||
150088361|NCT03334448|541461197|FG000|Washout|Protocol Violation|0|||
150088362|NCT03334448|541461198|FG001|Washout|Protocol Violation|0|||
150088363|NCT03334448|541461199|FG002|Washout|Protocol Violation|0|||
150088364|NCT03334448|541461200|FG003|Washout|Protocol Violation|1|||
150088365|NCT01365910|541461204|FG000|Overall Study|Withdrawal by Subject|7|||
150088366|NCT01365910|541461204|FG000|Overall Study|disease progression|18|||
150088367|NCT01365910|541461204|FG000|Overall Study|Adverse Event|3|||
150088368|NCT01365910|541461204|FG000|Overall Study|other complicating disease|1|||
150088369|NCT01365910|541461204|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
150088370|NCT00371137|541461205|FG000|Overall Study|Adverse Event|20|||
150088371|NCT00371137|541461206|FG001|Overall Study|Adverse Event|35|||
150088372|NCT00371137|541461207|FG002|Overall Study|Adverse Event|42|||
150088373|NCT00371137|541461205|FG000|Overall Study|Withdrawal by Subject|11|||
150088374|NCT00371137|541461206|FG001|Overall Study|Withdrawal by Subject|10|||
150088375|NCT00371137|541461207|FG002|Overall Study|Withdrawal by Subject|15|||
150088376|NCT00371137|541461205|FG000|Overall Study|Lost to Follow-up|6|||
150088377|NCT00371137|541461206|FG001|Overall Study|Lost to Follow-up|3|||
150088378|NCT00371137|541461207|FG002|Overall Study|Lost to Follow-up|5|||
150088379|NCT00371137|541461205|FG000|Overall Study|Lack of Efficacy|30|||
150088380|NCT00371137|541461206|FG001|Overall Study|Lack of Efficacy|12|||
150088381|NCT00371137|541461207|FG002|Overall Study|Lack of Efficacy|13|||
150088382|NCT00371137|541461205|FG000|Overall Study|Sponsor Decision|2|||
150088383|NCT00371137|541461206|FG001|Overall Study|Sponsor Decision|1|||
150088384|NCT00371137|541461207|FG002|Overall Study|Sponsor Decision|2|||
150088385|NCT00371137|541461205|FG000|Overall Study|Physician Decision|1|||
150088386|NCT00371137|541461206|FG001|Overall Study|Physician Decision|1|||
150088387|NCT00371137|541461207|FG002|Overall Study|Physician Decision|1|||
150088388|NCT00371137|541461205|FG000|Overall Study|Protocol Violation|2|||
150088389|NCT00371137|541461206|FG001|Overall Study|Protocol Violation|1|||
150088390|NCT00371137|541461207|FG002|Overall Study|Protocol Violation|1|||
150088391|NCT02013791|541461208|FG000|Period 1|Lost to Follow-up|0|||
150088392|NCT02013791|541461209|FG001|Period 1|Lost to Follow-up|0|||
150088393|NCT02013791|541461210|FG002|Period 1|Lost to Follow-up|0|||
150088394|NCT02013791|541461211|FG003|Period 1|Lost to Follow-up|1|||
150088395|NCT02013791|541461212|FG004|Period 1|Lost to Follow-up|0|||
150088396|NCT02013791|541461213|FG005|Period 1|Lost to Follow-up|0|||
150088397|NCT02013791|541461214|FG006|Period 1|Lost to Follow-up|1|||
150088398|NCT02013791|541461215|FG007|Period 1|Lost to Follow-up|1|||
150088399|NCT02013791|541461216|FG008|Period 1|Lost to Follow-up|0|||
150088400|NCT02013791|541461208|FG000|Period 1|Other Miscellaneous Reasons|0|||
150088401|NCT02013791|541461209|FG001|Period 1|Other Miscellaneous Reasons|2|||
150088402|NCT02013791|541461210|FG002|Period 1|Other Miscellaneous Reasons|0|||
150088403|NCT02013791|541461211|FG003|Period 1|Other Miscellaneous Reasons|0|||
150088404|NCT02013791|541461212|FG004|Period 1|Other Miscellaneous Reasons|0|||
150088405|NCT02013791|541461213|FG005|Period 1|Other Miscellaneous Reasons|0|||
150088406|NCT02013791|541461214|FG006|Period 1|Other Miscellaneous Reasons|0|||
150088407|NCT02013791|541461215|FG007|Period 1|Other Miscellaneous Reasons|0|||
150088408|NCT02013791|541461216|FG008|Period 1|Other Miscellaneous Reasons|0|||
150088409|NCT03798483|541461217|FG000|Overall Study|Lost to Follow-up|2|||
150088410|NCT01835587|541461220|FG000|Overall Study|Disease Recurrence or Relapse|0|||
150088411|NCT01835587|541461221|FG001|Overall Study|Disease Recurrence or Relapse|3|||
150088412|NCT01835587|541461222|FG002|Overall Study|Disease Recurrence or Relapse|0|||
150088413|NCT01835587|541461223|FG003|Overall Study|Disease Recurrence or Relapse|3|||
150088414|NCT01835587|541461220|FG000|Overall Study|Withdrawal by Subject|2|||
150088415|NCT01835587|541461221|FG001|Overall Study|Withdrawal by Subject|0|||
150088416|NCT01835587|541461222|FG002|Overall Study|Withdrawal by Subject|0|||
150088417|NCT01835587|541461223|FG003|Overall Study|Withdrawal by Subject|3|||
150088418|NCT01835587|541461220|FG000|Overall Study|Adverse Event|0|||
150088419|NCT01835587|541461221|FG001|Overall Study|Adverse Event|0|||
150088420|NCT01835587|541461222|FG002|Overall Study|Adverse Event|2|||
150088421|NCT01835587|541461223|FG003|Overall Study|Adverse Event|2|||
150088422|NCT01835587|541461220|FG000|Overall Study|Death|0|||
150088423|NCT01835587|541461221|FG001|Overall Study|Death|0|||
150088424|NCT01835587|541461222|FG002|Overall Study|Death|0|||
150088425|NCT01835587|541461223|FG003|Overall Study|Death|1|||
150088426|NCT01835587|541461220|FG000|Overall Study|Miscellaneous|0|||
150088427|NCT01835587|541461221|FG001|Overall Study|Miscellaneous|1|||
150088428|NCT01835587|541461222|FG002|Overall Study|Miscellaneous|0|||
150088429|NCT01835587|541461223|FG003|Overall Study|Miscellaneous|0|||
150088430|NCT03310775|541461226|FG000|Overall Study|Lost to Follow-up|2|||
150088431|NCT03310775|541461227|FG001|Overall Study|Lost to Follow-up|3|||
150088432|NCT03310775|541461226|FG000|Overall Study|aggravation of depression|0|||
150088433|NCT03310775|541461227|FG001|Overall Study|aggravation of depression|1|||
150088434|NCT00126568|541461228|FG000|Overall Study|Death|2|||
150088435|NCT03064451|541461229|FG000|Overall Study|Lost to Follow-up|1|||
150088436|NCT03064451|541461229|FG000|Overall Study|Mapping Failure|4|||
150088437|NCT03064451|541461229|FG000|Overall Study|Exited prior to procedure|8|||
150088438|NCT03064451|541461229|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
150088439|NCT05475236|541461230|FG000|Overall Study|Withdrawal by Subject|0|||
150088440|NCT05475236|541461231|FG001|Overall Study|Withdrawal by Subject|1|||
150088441|NCT00477971|541461232|FG000|Overall Study|Disease progression|6|||
150088442|NCT00477971|541461233|FG001|Overall Study|Disease progression|0|||
150088443|NCT00477971|541461232|FG000|Overall Study|Withdrawal by Subject|3|||
150088444|NCT00477971|541461233|FG001|Overall Study|Withdrawal by Subject|1|||
150088445|NCT00477971|541461232|FG000|Overall Study|Adverse Event|3|||
150088446|NCT00477971|541461233|FG001|Overall Study|Adverse Event|0|||
150088447|NCT00477971|541461232|FG000|Overall Study|Death|2|||
150088448|NCT00477971|541461233|FG001|Overall Study|Death|4|||
150088449|NCT00477971|541461232|FG000|Overall Study|Alternative treatment|3|||
150088450|NCT00477971|541461233|FG001|Overall Study|Alternative treatment|1|||
150088451|NCT05355805|541461234|FG000|Overall Study|Lost to Follow-up|6|||
150088452|NCT05355805|541461235|FG001|Overall Study|Lost to Follow-up|11|||
150088453|NCT05355805|541461236|FG002|Overall Study|Lost to Follow-up|10|||
150088454|NCT05355805|541461237|FG003|Overall Study|Lost to Follow-up|6|||
150088455|NCT05355805|541461234|FG000|Overall Study|Decision by Sponsor|0|||
150088456|NCT05355805|541461235|FG001|Overall Study|Decision by Sponsor|0|||
150088457|NCT05355805|541461236|FG002|Overall Study|Decision by Sponsor|1|||
150088458|NCT05355805|541461237|FG003|Overall Study|Decision by Sponsor|0|||
150088459|NCT05355805|541461234|FG000|Overall Study|Withdrawal by Subject|7|||
150088460|NCT05355805|541461235|FG001|Overall Study|Withdrawal by Subject|14|||
150088461|NCT05355805|541461236|FG002|Overall Study|Withdrawal by Subject|15|||
150088462|NCT05355805|541461237|FG003|Overall Study|Withdrawal by Subject|13|||
150088463|NCT00609492|541462744|FG000|Overall Study|Withdrawal by Subject|0|||
150088464|NCT00609492|541462745|FG001|Overall Study|Withdrawal by Subject|2|||
150088465|NCT00609492|541462746|FG002|Overall Study|Withdrawal by Subject|3|||
150088466|NCT00609492|541462744|FG000|Overall Study|Lost to Follow-up|1|||
150088467|NCT00609492|541462745|FG001|Overall Study|Lost to Follow-up|1|||
150088468|NCT00609492|541462746|FG002|Overall Study|Lost to Follow-up|4|||
150088469|NCT00589914|541462753|FG000|Overall Study|Adverse Event|19|||
150088470|NCT00589914|541462754|FG001|Overall Study|Adverse Event|10|||
150088471|NCT00589914|541462753|FG000|Overall Study|Death|2|||
150088472|NCT00589914|541462754|FG001|Overall Study|Death|0|||
150088473|NCT00589914|541462753|FG000|Overall Study|Lack of Efficacy|40|||
150088474|NCT00589914|541462754|FG001|Overall Study|Lack of Efficacy|43|||
150088475|NCT00589914|541462753|FG000|Overall Study|Lost to Follow-up|11|||
150088476|NCT00589914|541462754|FG001|Overall Study|Lost to Follow-up|18|||
150088477|NCT00589914|541462753|FG000|Overall Study|Pregnancy|1|||
150088478|NCT00589914|541462754|FG001|Overall Study|Pregnancy|0|||
150088479|NCT00589914|541462753|FG000|Overall Study|Withdrawal by Subject|55|||
150088480|NCT00589914|541462754|FG001|Overall Study|Withdrawal by Subject|49|||
150184155|NCT00792636|541813286|FG000|Overall Study|Adverse Event|4|||
150088481|NCT00589914|541462753|FG000|Overall Study|Other|22|||
150088482|NCT00589914|541462754|FG001|Overall Study|Other|17|||
150088483|NCT01356966|541462755|FG000|Overall Study|Withdrawal by Subject|1|||
150088484|NCT01356966|541462756|FG001|Overall Study|Withdrawal by Subject|2|||
150088485|NCT01356966|541462755|FG000|Overall Study|Physician Decision|1|||
150088486|NCT01356966|541462756|FG001|Overall Study|Physician Decision|0|||
150088487|NCT00103142|541462757|FG000|Overall Study|Adverse Event|1|||
150088488|NCT00103142|541462758|FG001|Overall Study|Adverse Event|0|||
150088489|NCT00103142|541462757|FG000|Overall Study|Progression of disease|2|||
150088490|NCT00103142|541462758|FG001|Overall Study|Progression of disease|1|||
150088491|NCT03315208|541462763|FG000|Overall Study|Lost to Follow-up|11|||
150088492|NCT03315208|541462764|FG001|Overall Study|Lost to Follow-up|6|||
150088493|NCT03315208|541462763|FG000|Overall Study|Withdrawal by Subject|2|||
150088494|NCT03315208|541462764|FG001|Overall Study|Withdrawal by Subject|0|||
150088495|NCT02706691|541462779|FG000|Overall Study|Adverse Event|1|||
150088496|NCT00356369|541462780|FG000|Active Phase|Withdrawal by Subject|2|||
150088497|NCT00356369|541462781|FG001|Active Phase|Withdrawal by Subject|1|||
150088498|NCT01830972|541462783|FG000|Part II|Withdrawal by Subject|2|||
150088499|NCT01830972|541462784|FG001|Part II|Withdrawal by Subject|2|||
150088500|NCT01830972|541462783|FG000|Part III|Withdrawal by Subject|1|||
150088501|NCT01830972|541462784|FG001|Part III|Withdrawal by Subject|0|||
150088502|NCT01830972|541462783|FG000|Part III|Noncompliance|1|||
150088503|NCT01830972|541462784|FG001|Part III|Noncompliance|0|||
150088504|NCT01830972|541462783|FG000|Part IV|Withdrawal by Subject|2|||
150088505|NCT01830972|541462784|FG001|Part IV|Withdrawal by Subject|1|||
150088506|NCT01830972|541462783|FG000|Part IV|Non-Compliance|1|||
150088507|NCT01830972|541462784|FG001|Part IV|Non-Compliance|0|||
150088508|NCT00673465|541462787|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088509|NCT00673465|541462788|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088510|NCT00673465|541462789|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088511|NCT00673465|541462790|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088512|NCT00673465|541462791|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
150088513|NCT00673465|541462792|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
150088514|NCT00673465|541462793|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088515|NCT00673465|541462794|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088516|NCT00673465|541462795|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088517|NCT00673465|541462796|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088518|NCT00673465|541462797|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088519|NCT00673465|541462798|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
150088520|NCT00673465|541462787|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088521|NCT00673465|541462788|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088522|NCT00673465|541462789|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088523|NCT00673465|541462790|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088524|NCT00673465|541462791|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
150088525|NCT00673465|541462792|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088526|NCT00673465|541462793|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088527|NCT00673465|541462794|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088528|NCT00673465|541462795|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088529|NCT00673465|541462796|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088530|NCT00673465|541462797|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088531|NCT00673465|541462798|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
150088532|NCT01829191|541462799|FG000|Overall Study|Relocation|0|||
150088533|NCT01829191|541462800|FG001|Overall Study|Relocation|1|||
150088534|NCT01829191|541462799|FG000|Overall Study|Lens discomfort|0|||
150088535|NCT01829191|541462800|FG001|Overall Study|Lens discomfort|3|||
150088536|NCT01829191|541462799|FG000|Overall Study|Lens handling difficulty|1|||
150088537|NCT01829191|541462800|FG001|Overall Study|Lens handling difficulty|4|||
150088538|NCT01829191|541462799|FG000|Overall Study|Protocol Violation|4|||
150088539|NCT01829191|541462800|FG001|Overall Study|Protocol Violation|1|||
150088540|NCT01829191|541462799|FG000|Overall Study|Withdrawal by Subject|2|||
150088541|NCT01829191|541462800|FG001|Overall Study|Withdrawal by Subject|3|||
150088542|NCT01829191|541462799|FG000|Overall Study|Lost to Follow-up|0|||
150088543|NCT01829191|541462800|FG001|Overall Study|Lost to Follow-up|1|||
150088544|NCT01829191|541462799|FG000|Overall Study|Subject was fit for ortho - k|0|||
150088545|NCT01829191|541462800|FG001|Overall Study|Subject was fit for ortho - k|1|||
150088546|NCT01276353|541462801|FG000|Double-blind|Adverse Event|2|||
150088547|NCT01276353|541462802|FG001|Double-blind|Adverse Event|0|||
150088548|NCT01276353|541462801|FG000|Double-blind|Withdrawal by Subject|1|||
150088549|NCT01276353|541462802|FG001|Double-blind|Withdrawal by Subject|0|||
150088550|NCT01276353|541462801|FG000|Extension|Adverse Event|2|||
150088551|NCT01276353|541462802|FG001|Extension|Adverse Event|5|||
150088552|NCT01276353|541462801|FG000|Extension|Withdrawal by Subject|1|||
150088553|NCT01276353|541462802|FG001|Extension|Withdrawal by Subject|2|||
150088554|NCT01276353|541462801|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
150088555|NCT01276353|541462802|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
150088556|NCT01276353|541462801|FG000|Extension|Physician Decision|1|||
150088557|NCT01276353|541462802|FG001|Extension|Physician Decision|0|||
150088558|NCT01276353|541462801|FG000|Extension|Prohibited concomitant medications|0|||
150088559|NCT01276353|541462802|FG001|Extension|Prohibited concomitant medications|1|||
150088560|NCT00553514|541462808|FG000|Overall Study|Protocol deviation|0|||
150088561|NCT00553514|541462809|FG001|Overall Study|Protocol deviation|0|||
150088562|NCT00553514|541462810|FG002|Overall Study|Protocol deviation|0|||
150088563|NCT00553514|541462811|FG003|Overall Study|Protocol deviation|1|||
150088564|NCT00553514|541462812|FG004|Overall Study|Protocol deviation|0|||
150088565|NCT00553514|541462808|FG000|Overall Study|Lack of ovarian response|4|||
150088566|NCT00553514|541462809|FG001|Overall Study|Lack of ovarian response|5|||
150088567|NCT00553514|541462810|FG002|Overall Study|Lack of ovarian response|5|||
150088568|NCT00553514|541462811|FG003|Overall Study|Lack of ovarian response|5|||
150088569|NCT00553514|541462812|FG004|Overall Study|Lack of ovarian response|6|||
150088570|NCT00553514|541462808|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
150088571|NCT00553514|541462809|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
150088572|NCT00553514|541462810|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
150088573|NCT00553514|541462811|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
150088574|NCT00553514|541462812|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
150088575|NCT00553514|541462808|FG000|Overall Study|Risk of multiple pregnancy|0|||
150088576|NCT00553514|541462809|FG001|Overall Study|Risk of multiple pregnancy|2|||
150088577|NCT00553514|541462810|FG002|Overall Study|Risk of multiple pregnancy|0|||
150088578|NCT00553514|541462811|FG003|Overall Study|Risk of multiple pregnancy|1|||
150088579|NCT00553514|541462812|FG004|Overall Study|Risk of multiple pregnancy|0|||
150088580|NCT00553514|541462808|FG000|Overall Study|Other|1|||
150088581|NCT00553514|541462809|FG001|Overall Study|Other|1|||
150088582|NCT00553514|541462810|FG002|Overall Study|Other|0|||
150088583|NCT00553514|541462811|FG003|Overall Study|Other|0|||
150088584|NCT00553514|541462812|FG004|Overall Study|Other|1|||
150088585|NCT02205814|541462813|FG000|Overall Study|Lost to Follow-up|0|||
150088586|NCT02205814|541462814|FG001|Overall Study|Lost to Follow-up|0|||
150088587|NCT02205814|541462815|FG002|Overall Study|Lost to Follow-up|0|||
150088588|NCT02205814|541462816|FG003|Overall Study|Lost to Follow-up|1|||
150088589|NCT02205814|541462813|FG000|Overall Study|Lack of Efficacy|1|||
150088590|NCT02205814|541462814|FG001|Overall Study|Lack of Efficacy|0|||
150088591|NCT02205814|541462815|FG002|Overall Study|Lack of Efficacy|1|||
150088592|NCT02205814|541462816|FG003|Overall Study|Lack of Efficacy|1|||
150088593|NCT02205814|541462813|FG000|Overall Study|Physician Decision|0|||
150088594|NCT02205814|541462814|FG001|Overall Study|Physician Decision|0|||
150088595|NCT02205814|541462815|FG002|Overall Study|Physician Decision|1|||
150088596|NCT02205814|541462816|FG003|Overall Study|Physician Decision|0|||
150088597|NCT02205814|541462813|FG000|Overall Study|Protocol Violation|1|||
150088598|NCT02205814|541462814|FG001|Overall Study|Protocol Violation|0|||
150088599|NCT02205814|541462815|FG002|Overall Study|Protocol Violation|0|||
150088600|NCT02205814|541462816|FG003|Overall Study|Protocol Violation|1|||
150088601|NCT02205814|541462813|FG000|Overall Study|Withdrawal by Subject|0|||
150088602|NCT02205814|541462814|FG001|Overall Study|Withdrawal by Subject|1|||
150088603|NCT02205814|541462815|FG002|Overall Study|Withdrawal by Subject|2|||
150088604|NCT02205814|541462816|FG003|Overall Study|Withdrawal by Subject|1|||
150088605|NCT02205814|541462813|FG000|Overall Study|not compliant with study procedures|0|||
150088606|NCT02205814|541462814|FG001|Overall Study|not compliant with study procedures|0|||
150088607|NCT02205814|541462815|FG002|Overall Study|not compliant with study procedures|1|||
150088608|NCT02205814|541462816|FG003|Overall Study|not compliant with study procedures|0|||
150088609|NCT04952402|541462817|FG000|Overall Study|Lost to Follow-up|1|||
150088610|NCT04952402|541462818|FG001|Overall Study|Lost to Follow-up|3|||
150088611|NCT04952402|541462817|FG000|Overall Study|Lack Of Venous Access|0|||
150088612|NCT04952402|541462818|FG001|Overall Study|Lack Of Venous Access|1|||
150088613|NCT00726661|541462819|FG000|Overall Study|Lost to Follow-up|36|||
150088614|NCT00726661|541462820|FG001|Overall Study|Lost to Follow-up|11|||
150088615|NCT00726661|541462819|FG000|Overall Study|Withdrawal by Subject|17|||
150088616|NCT00726661|541462820|FG001|Overall Study|Withdrawal by Subject|13|||
150088617|NCT00726661|541462819|FG000|Overall Study|Trial terminated by sponsor|214|||
150088618|NCT00726661|541462820|FG001|Overall Study|Trial terminated by sponsor|187|||
150088619|NCT00726661|541462819|FG000|Overall Study|Death|475|||
150088620|NCT00726661|541462820|FG001|Overall Study|Death|159|||
150088621|NCT00726661|541462819|FG000|Overall Study|Physician Decision|25|||
150088622|NCT00726661|541462820|FG001|Overall Study|Physician Decision|13|||
150088623|NCT00726661|541462819|FG000|Overall Study|Other|47|||
150088624|NCT00726661|541462820|FG001|Overall Study|Other|35|||
150088625|NCT00143403|541462823|FG000|Overall Study|Adverse Event|3|||
150088626|NCT00143403|541462824|FG001|Overall Study|Adverse Event|8|||
150088627|NCT00143403|541462823|FG000|Overall Study|Death|1|||
150088628|NCT00143403|541462824|FG001|Overall Study|Death|0|||
150088629|NCT00143403|541462823|FG000|Overall Study|Withdrawal by Subject|3|||
150088630|NCT00143403|541462824|FG001|Overall Study|Withdrawal by Subject|12|||
150088631|NCT00143403|541462823|FG000|Overall Study|Relapse|15|||
150088632|NCT00143403|541462824|FG001|Overall Study|Relapse|7|||
150088633|NCT00143403|541462823|FG000|Overall Study|Protocol Violation|2|||
150088634|NCT00143403|541462824|FG001|Overall Study|Protocol Violation|2|||
150088635|NCT00143403|541462823|FG000|Overall Study|specified by site|4|||
150088636|NCT00143403|541462824|FG001|Overall Study|specified by site|9|||
150088637|NCT00143403|541462823|FG000|Overall Study|Randomized Not Treated|7|||
150088638|NCT00143403|541462824|FG001|Overall Study|Randomized Not Treated|8|||
150088639|NCT00587639|541462825|FG000|Overall Study|Withdrawal by Subject|1|||
150088640|NCT00160251|541462830|FG000|Prior to Amendment 2|Adverse Event|2|||
150088641|NCT00160251|541462831|FG001|Prior to Amendment 2|Adverse Event|1|||
150088642|NCT00160251|541462832|FG002|Prior to Amendment 2|Adverse Event|3|||
150088643|NCT00160251|541462833|FG003|Prior to Amendment 2|Adverse Event|1|||
150088644|NCT00160251|541462834|FG004|Prior to Amendment 2|Adverse Event|1|||
150088645|NCT00160251|541462835|FG005|Prior to Amendment 2|Adverse Event|1|||
150088646|NCT00160251|541462836|FG006|Prior to Amendment 2|Adverse Event|1|||
150088647|NCT00160251|541462837|FG007|Prior to Amendment 2|Adverse Event|0|||
150088648|NCT00160251|541462830|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
150088649|NCT00160251|541462831|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
150088650|NCT00160251|541462832|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
150088651|NCT00160251|541462833|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
150088652|NCT00160251|541462834|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
150088653|NCT00160251|541462835|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
150088654|NCT00160251|541462836|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
150088655|NCT00160251|541462837|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
150088656|NCT00160251|541462830|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
150088657|NCT00160251|541462831|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
150088658|NCT00160251|541462832|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
150088659|NCT00160251|541462833|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
150088660|NCT00160251|541462834|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
150088661|NCT00160251|541462835|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
150088662|NCT00160251|541462836|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
150088663|NCT00160251|541462837|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
150088664|NCT00160251|541462830|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
150088665|NCT00160251|541462831|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
150088666|NCT00160251|541462832|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
150088667|NCT00160251|541462833|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
150088668|NCT00160251|541462834|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
150088669|NCT00160251|541462835|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
150088670|NCT00160251|541462836|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
150088671|NCT00160251|541462837|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
150088672|NCT00160251|541462830|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
150088673|NCT00160251|541462831|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
150088674|NCT00160251|541462832|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
150088675|NCT00160251|541462833|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
150088676|NCT00160251|541462834|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
150088677|NCT00160251|541462835|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
150088678|NCT00160251|541462836|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
150088679|NCT00160251|541462837|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
150088680|NCT00160251|541462830|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
150088681|NCT00160251|541462831|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
150088682|NCT00160251|541462832|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
150088683|NCT00160251|541462833|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
150088684|NCT00160251|541462834|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
150088685|NCT00160251|541462835|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
150088686|NCT00160251|541462836|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
150088687|NCT00160251|541462837|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
150088688|NCT00160251|541462830|FG000|Post-amendment 2|Adverse Event|0|||
150088689|NCT00160251|541462831|FG001|Post-amendment 2|Adverse Event|0|||
150088690|NCT00160251|541462832|FG002|Post-amendment 2|Adverse Event|0|||
150088691|NCT00160251|541462833|FG003|Post-amendment 2|Adverse Event|0|||
150088692|NCT00160251|541462834|FG004|Post-amendment 2|Adverse Event|0|||
150088693|NCT00160251|541462835|FG005|Post-amendment 2|Adverse Event|0|||
150088694|NCT00160251|541462836|FG006|Post-amendment 2|Adverse Event|0|||
150088695|NCT00160251|541462837|FG007|Post-amendment 2|Adverse Event|20|||
150088696|NCT00160251|541462830|FG000|Post-amendment 2|Lack of Efficacy|0|||
150088697|NCT00160251|541462831|FG001|Post-amendment 2|Lack of Efficacy|0|||
150088698|NCT00160251|541462832|FG002|Post-amendment 2|Lack of Efficacy|0|||
150088699|NCT00160251|541462833|FG003|Post-amendment 2|Lack of Efficacy|0|||
150088700|NCT00160251|541462834|FG004|Post-amendment 2|Lack of Efficacy|0|||
150088701|NCT00160251|541462835|FG005|Post-amendment 2|Lack of Efficacy|0|||
150184156|NCT00792636|541813287|FG001|Overall Study|Adverse Event|2|||
150184157|NCT00792636|541813288|FG002|Overall Study|Adverse Event|3|||
150088702|NCT00160251|541462836|FG006|Post-amendment 2|Lack of Efficacy|0|||
150088703|NCT00160251|541462837|FG007|Post-amendment 2|Lack of Efficacy|24|||
150088704|NCT00160251|541462830|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150088705|NCT00160251|541462831|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150184158|NCT00792636|541813286|FG000|Overall Study|Investigator Discretion|2|||
150088706|NCT00160251|541462832|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150088707|NCT00160251|541462833|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150088708|NCT00160251|541462834|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150088709|NCT00160251|541462835|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150184159|NCT00792636|541813287|FG001|Overall Study|Investigator Discretion|0|||
150088710|NCT00160251|541462836|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
150088711|NCT00160251|541462837|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
150088712|NCT02452398|541462842|FG000|Overall Study|Adverse Event|1|||
150088713|NCT02452398|541462842|FG000|Overall Study|Lost to Follow-up|28|||
150088714|NCT02452398|541462842|FG000|Overall Study|Physician Decision|2|||
150088715|NCT02452398|541462842|FG000|Overall Study|Withdrawal by Subject|6|||
150088716|NCT02452398|541462842|FG000|Overall Study|Moved away|4|||
150088717|NCT00748033|541462845|FG000|Overall Study|Adverse Event|0|||
150088718|NCT00748033|541462846|FG001|Overall Study|Adverse Event|1|||
150088719|NCT01018186|541462847|FG000|2-week Run-in Period|Protocol Violation|1|||
150088720|NCT01018186|541462848|FG001|2-week Run-in Period|Protocol Violation|0|||
150088721|NCT01018186|541462849|FG002|2-week Run-in Period|Protocol Violation|0|||
150088722|NCT01018186|541462850|FG003|2-week Run-in Period|Protocol Violation|0|||
150088723|NCT01018186|541462847|FG000|2-week Run-in Period|Lost to Follow-up|2|||
150088724|NCT01018186|541462848|FG001|2-week Run-in Period|Lost to Follow-up|0|||
150088725|NCT01018186|541462849|FG002|2-week Run-in Period|Lost to Follow-up|0|||
150088726|NCT01018186|541462850|FG003|2-week Run-in Period|Lost to Follow-up|0|||
150088727|NCT01018186|541462847|FG000|2-week Run-in Period|Physician Decision|3|||
150088728|NCT01018186|541462848|FG001|2-week Run-in Period|Physician Decision|0|||
150088729|NCT01018186|541462849|FG002|2-week Run-in Period|Physician Decision|0|||
150088730|NCT01018186|541462850|FG003|2-week Run-in Period|Physician Decision|0|||
150088731|NCT01018186|541462847|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
150088732|NCT01018186|541462848|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
150088733|NCT01018186|541462849|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
150088734|NCT01018186|541462850|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
150088735|NCT01018186|541462847|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
150088736|NCT01018186|541462848|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
150088737|NCT01018186|541462849|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
150088738|NCT01018186|541462850|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
150088739|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
150088740|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
150088741|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
150088742|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
150088743|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
150088744|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
150088745|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
150088746|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
150088747|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
150088748|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
150088749|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
150088750|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
150088751|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
150088752|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
150088753|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
150088754|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
150088755|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
150088756|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
150088757|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
150088758|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
150088759|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
150088760|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
150088761|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
150088762|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
150088763|NCT01018186|541462847|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
150088764|NCT01018186|541462848|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
150088765|NCT01018186|541462849|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
150088766|NCT01018186|541462850|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
150088767|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
150088768|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
150088769|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
150088770|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
150088771|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
150088772|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
150088773|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
150088774|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
150088775|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Other|1|||
150088776|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Other|4|||
150088777|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Other|3|||
150088778|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Other|6|||
150088779|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
150088780|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
150088781|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
150088782|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
150088783|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
150088784|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
150088785|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
150088786|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
150088787|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
150088788|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
150088789|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
150088790|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
150088791|NCT02925494|541462851|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
150088792|NCT02925494|541462852|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
150088793|NCT02925494|541462853|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
150088794|NCT02925494|541462854|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
150088795|NCT00165776|541462860|FG000|Overall Study|Lack of Efficacy|0|||
150088796|NCT00165776|541462861|FG001|Overall Study|Lack of Efficacy|0|||
150088797|NCT00165776|541462862|FG002|Overall Study|Lack of Efficacy|0|||
150088798|NCT00165776|541462863|FG003|Overall Study|Lack of Efficacy|1|||
150088799|NCT00165776|541462860|FG000|Overall Study|Withdrawal by Subject|4|||
150088800|NCT00165776|541462861|FG001|Overall Study|Withdrawal by Subject|1|||
150088801|NCT00165776|541462862|FG002|Overall Study|Withdrawal by Subject|2|||
150088802|NCT00165776|541462863|FG003|Overall Study|Withdrawal by Subject|0|||
150088803|NCT00165776|541462860|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
150088804|NCT00165776|541462861|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
150088805|NCT00165776|541462862|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
150088806|NCT00165776|541462863|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
150088807|NCT00750204|541462869|FG000|Overall Study|study halted prematurely|1|||
150088808|NCT00750204|541462870|FG001|Overall Study|study halted prematurely|1|||
150088809|NCT00434330|541462871|FG000|Overall Study|Adverse Event|0|||
150088810|NCT00434330|541462872|FG001|Overall Study|Adverse Event|0|||
150088811|NCT00434330|541462873|FG002|Overall Study|Adverse Event|1|||
150088812|NCT00434330|541462874|FG003|Overall Study|Adverse Event|0|||
150088813|NCT00434330|541462875|FG004|Overall Study|Adverse Event|0|||
150088814|NCT00434330|541462876|FG005|Overall Study|Adverse Event|0|||
150088815|NCT00434330|541462871|FG000|Overall Study|Death|1|||
150088816|NCT00434330|541462872|FG001|Overall Study|Death|0|||
150184160|NCT00792636|541813288|FG002|Overall Study|Investigator Discretion|2|||
150184161|NCT01046136|541813289|FG000|Overall Study|Withdrawal by Subject|0|||
150184162|NCT01046136|541813290|FG001|Overall Study|Withdrawal by Subject|4|||
150184163|NCT01046136|541813289|FG000|Overall Study|Physician Decision|1|||
150184164|NCT01046136|541813290|FG001|Overall Study|Physician Decision|1|||
150184165|NCT01046136|541813289|FG000|Overall Study|Lost to Follow-up|3|||
150184166|NCT01046136|541813290|FG001|Overall Study|Lost to Follow-up|3|||
150184167|NCT04579250|541813291|FG000|Overall Study|Withdrawal by Subject|1|||
150184168|NCT04579250|541813292|FG001|Overall Study|Withdrawal by Subject|1|||
150184169|NCT04579250|541813293|FG002|Overall Study|Withdrawal by Subject|0|||
150088817|NCT00434330|541462873|FG002|Overall Study|Death|0|||
150088818|NCT00434330|541462874|FG003|Overall Study|Death|0|||
150088819|NCT00434330|541462875|FG004|Overall Study|Death|1|||
150088820|NCT00434330|541462876|FG005|Overall Study|Death|1|||
150184170|NCT04579250|541813291|FG000|Overall Study|Lost to Follow-up|1|||
150184171|NCT04579250|541813292|FG001|Overall Study|Lost to Follow-up|1|||
150088821|NCT00434330|541462871|FG000|Overall Study|Withdrawal by Subject|0|||
150088822|NCT00434330|541462872|FG001|Overall Study|Withdrawal by Subject|0|||
150088823|NCT00434330|541462873|FG002|Overall Study|Withdrawal by Subject|1|||
150088824|NCT00434330|541462874|FG003|Overall Study|Withdrawal by Subject|1|||
150088825|NCT00434330|541462875|FG004|Overall Study|Withdrawal by Subject|0|||
150088826|NCT00434330|541462876|FG005|Overall Study|Withdrawal by Subject|0|||
150088827|NCT00434330|541462871|FG000|Overall Study|Renal transplant|0|||
150088828|NCT00434330|541462872|FG001|Overall Study|Renal transplant|0|||
150088829|NCT00434330|541462873|FG002|Overall Study|Renal transplant|0|||
150088830|NCT00434330|541462874|FG003|Overall Study|Renal transplant|1|||
150088831|NCT00434330|541462875|FG004|Overall Study|Renal transplant|0|||
150088832|NCT00434330|541462876|FG005|Overall Study|Renal transplant|0|||
150088833|NCT00434330|541462871|FG000|Overall Study|Subject Not Compliant With Study|0|||
150088834|NCT00434330|541462872|FG001|Overall Study|Subject Not Compliant With Study|0|||
150088835|NCT00434330|541462873|FG002|Overall Study|Subject Not Compliant With Study|1|||
150088836|NCT00434330|541462874|FG003|Overall Study|Subject Not Compliant With Study|0|||
150088837|NCT00434330|541462875|FG004|Overall Study|Subject Not Compliant With Study|0|||
150088838|NCT00434330|541462876|FG005|Overall Study|Subject Not Compliant With Study|0|||
150088839|NCT04853225|541462879|FG000|Overall Study|Withdrawal by Subject|81|||
150088840|NCT04853225|541462880|FG001|Overall Study|Withdrawal by Subject|4|||
150184172|NCT04579250|541813293|FG002|Overall Study|Lost to Follow-up|0|||
150184173|NCT04579250|541813291|FG000|Overall Study|Moved from area|0|||
150184174|NCT04579250|541813292|FG001|Overall Study|Moved from area|1|||
150184175|NCT04579250|541813293|FG002|Overall Study|Moved from area|2|||
150184176|NCT04711135|541813294|FG000|Overall Study|Physician Decision|0|||
150184177|NCT04711135|541813295|FG001|Overall Study|Physician Decision|1|||
150184178|NCT04711135|541813294|FG000|Overall Study|Ongoing treatment|0|||
150184179|NCT04711135|541813295|FG001|Overall Study|Ongoing treatment|1|||
150184180|NCT04436107|541813299|FG000|Overall Study|Sponsor Ended Study|2|||
150088841|NCT04853225|541462881|FG002|Overall Study|Withdrawal by Subject|1|||
150088842|NCT04853225|541462879|FG000|Overall Study|Physician Decision|12|||
150088843|NCT04853225|541462880|FG001|Overall Study|Physician Decision|4|||
150088844|NCT04853225|541462881|FG002|Overall Study|Physician Decision|1|||
150088845|NCT04853225|541462879|FG000|Overall Study|Lost to Follow-up|50|||
150088846|NCT04853225|541462880|FG001|Overall Study|Lost to Follow-up|0|||
150184181|NCT04436107|541813300|FG001|Overall Study|Sponsor Ended Study|4|||
150184182|NCT04436107|541813301|FG002|Overall Study|Sponsor Ended Study|8|||
150184183|NCT04436107|541813302|FG003|Overall Study|Sponsor Ended Study|20|||
150184184|NCT04436107|541813299|FG000|Overall Study|Death|3|||
150088847|NCT04853225|541462881|FG002|Overall Study|Lost to Follow-up|0|||
150088848|NCT04853225|541462879|FG000|Overall Study|Other|102|||
150088849|NCT04853225|541462880|FG001|Overall Study|Other|11|||
150088850|NCT04853225|541462881|FG002|Overall Study|Other|5|||
150184185|NCT04436107|541813300|FG001|Overall Study|Death|5|||
150184186|NCT04436107|541813301|FG002|Overall Study|Death|3|||
150184187|NCT04436107|541813302|FG003|Overall Study|Death|18|||
150088851|NCT04853225|541462879|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
150088852|NCT04853225|541462880|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
150088853|NCT04853225|541462881|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
150088854|NCT04853225|541462879|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
150088855|NCT04853225|541462880|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
150088856|NCT04853225|541462881|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
150088857|NCT00850564|541462882|FG000|Overall Study|Withdrawal by Subject|2|||
150088858|NCT01404325|541465039|FG000|Overall Study|Lost to Follow-up|1|||
150088859|NCT01404325|541465040|FG001|Overall Study|Lost to Follow-up|0|||
150088860|NCT01404325|541465039|FG000|Overall Study|Death|2|||
150088861|NCT01404325|541465040|FG001|Overall Study|Death|0|||
150088862|NCT01404325|541465039|FG000|Overall Study|Graft loss/Retransplantation|1|||
150088863|NCT01404325|541465040|FG001|Overall Study|Graft loss/Retransplantation|0|||
150088864|NCT01404325|541465039|FG000|Overall Study|non-specified reason|0|||
150088865|NCT01404325|541465040|FG001|Overall Study|non-specified reason|2|||
150088866|NCT01986855|541465044|FG000|Overall Study|Adverse Event|1|||
150088867|NCT01986855|541465045|FG001|Overall Study|Adverse Event|0|||
150088868|NCT01986855|541465046|FG002|Overall Study|Adverse Event|0|||
150088869|NCT01986855|541465044|FG000|Overall Study|Death|3|||
150088870|NCT01986855|541465045|FG001|Overall Study|Death|4|||
150088871|NCT01986855|541465046|FG002|Overall Study|Death|4|||
150088872|NCT01986855|541465044|FG000|Overall Study|Lost to Follow-up|2|||
150088873|NCT01986855|541465045|FG001|Overall Study|Lost to Follow-up|1|||
150088874|NCT01986855|541465046|FG002|Overall Study|Lost to Follow-up|0|||
150088875|NCT01986855|541465044|FG000|Overall Study|Screen Failure|0|||
150088876|NCT01986855|541465045|FG001|Overall Study|Screen Failure|1|||
150088877|NCT01986855|541465046|FG002|Overall Study|Screen Failure|0|||
150088878|NCT01986855|541465044|FG000|Overall Study|Participant Moved|0|||
150088879|NCT01986855|541465045|FG001|Overall Study|Participant Moved|0|||
150088880|NCT01986855|541465046|FG002|Overall Study|Participant Moved|2|||
150088881|NCT01986855|541465044|FG000|Overall Study|Withdrawal by Subject|7|||
150088882|NCT01986855|541465045|FG001|Overall Study|Withdrawal by Subject|8|||
150088883|NCT01986855|541465046|FG002|Overall Study|Withdrawal by Subject|5|||
150088884|NCT04317066|541465047|FG000|Overall Study|Sponsor decision|5|||
150088885|NCT04317066|541465047|FG000|Overall Study|Death|2|||
150088886|NCT02825992|541465051|FG000|Overall Study|Withdrawal by Subject|4|||
150088887|NCT02825992|541465051|FG000|Overall Study|Lost to Follow-up|2|||
150088888|NCT02825992|541465051|FG000|Overall Study|Procedure terminated|2|||
150088889|NCT02279173|541465055|FG000|Overall Study|Protocol-specified Criteria|67|||
150088890|NCT02279173|541465055|FG000|Overall Study|Withdrawal by Subject|20|||
150088891|NCT02279173|541465055|FG000|Overall Study|Decision by Sponsor|4|||
150088892|NCT02279173|541465055|FG000|Overall Study|Lost to Follow-up|3|||
150088893|NCT01164956|541465057|FG000|Overall Study|Side Effects|1|||
150088894|NCT01164956|541465058|FG001|Overall Study|Side Effects|0|||
150088895|NCT01164956|541465059|FG002|Overall Study|Side Effects|1|||
150088896|NCT00720434|541465060|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
150088897|NCT00720434|541465061|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
150088898|NCT00720434|541465062|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
150088899|NCT00720434|541465063|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
150088900|NCT00720434|541465060|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
150088901|NCT00720434|541465061|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
150088902|NCT00720434|541465062|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
150088903|NCT00720434|541465063|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
150088904|NCT00720434|541465060|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
150088905|NCT00720434|541465061|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
150088906|NCT00720434|541465062|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
150088907|NCT00720434|541465063|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
150184188|NCT04436107|541813299|FG000|Overall Study|Withdrawal by Subject|1|||
150184189|NCT04436107|541813300|FG001|Overall Study|Withdrawal by Subject|1|||
150184190|NCT04436107|541813301|FG002|Overall Study|Withdrawal by Subject|0|||
150184191|NCT04436107|541813302|FG003|Overall Study|Withdrawal by Subject|1|||
150184192|NCT01095796|541813303|FG000|Overall Study|Randomized but Not Treated|5|||
150184193|NCT01095796|541813304|FG001|Overall Study|Randomized but Not Treated|2|||
150184194|NCT01095796|541813303|FG000|Overall Study|Adverse Event|9|||
150184195|NCT01095796|541813304|FG001|Overall Study|Adverse Event|19|||
150184196|NCT01095796|541813303|FG000|Overall Study|Death|3|||
150184197|NCT01095796|541813304|FG001|Overall Study|Death|2|||
150184198|NCT01095796|541813303|FG000|Overall Study|Pregnancy|2|||
150184199|NCT01095796|541813304|FG001|Overall Study|Pregnancy|0|||
150184200|NCT01095796|541813303|FG000|Overall Study|Lack of Efficacy|5|||
150184201|NCT01095796|541813304|FG001|Overall Study|Lack of Efficacy|3|||
150184202|NCT01095796|541813303|FG000|Overall Study|Investigator's Discretion|7|||
150184203|NCT01095796|541813304|FG001|Overall Study|Investigator's Discretion|2|||
150184204|NCT01095796|541813303|FG000|Overall Study|Withdrew Consent|16|||
150184205|NCT01095796|541813304|FG001|Overall Study|Withdrew Consent|22|||
150184206|NCT01095796|541813303|FG000|Overall Study|Lost to Follow-up|27|||
150184207|NCT01095796|541813304|FG001|Overall Study|Lost to Follow-up|29|||
150184208|NCT01095796|541813303|FG000|Overall Study|Participant Noncompliance|5|||
150184209|NCT01095796|541813304|FG001|Overall Study|Participant Noncompliance|10|||
150088908|NCT00720434|541465060|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
150088909|NCT00720434|541465061|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
150088910|NCT00720434|541465062|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
150184210|NCT01095796|541813303|FG000|Overall Study|Protocol Violation|1|||
150184211|NCT01095796|541813304|FG001|Overall Study|Protocol Violation|0|||
150184212|NCT01095796|541813303|FG000|Overall Study|Participant Transferred to Another Study|215|||
150184213|NCT01095796|541813304|FG001|Overall Study|Participant Transferred to Another Study|200|||
150184214|NCT00999167|541813305|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
150184215|NCT00999167|541813306|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
150184216|NCT00999167|541813307|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
150088911|NCT00720434|541465063|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
150088912|NCT00720434|541465060|FG000|Open-Label Period (Week 5-72)|Other|4|||
150088913|NCT00720434|541465061|FG001|Open-Label Period (Week 5-72)|Other|3|||
150088914|NCT00720434|541465062|FG002|Open-Label Period (Week 5-72)|Other|3|||
150088915|NCT00720434|541465063|FG003|Open-Label Period (Week 5-72)|Other|2|||
150088916|NCT02425046|541465064|FG000|Overall Study|Lost to Follow-up|52|||
150088917|NCT02425046|541465065|FG001|Overall Study|Lost to Follow-up|50|||
150088918|NCT02425046|541465066|FG002|Overall Study|Lost to Follow-up|56|||
150088919|NCT02425046|541465064|FG000|Overall Study|Withdrawal by Subject|16|||
150088920|NCT02425046|541465065|FG001|Overall Study|Withdrawal by Subject|12|||
150088921|NCT02425046|541465066|FG002|Overall Study|Withdrawal by Subject|0|||
150088922|NCT00267046|541465071|FG000|Overall Study|Disease progression|4|||
150088923|NCT00267046|541465072|FG001|Overall Study|Disease progression|2|||
150088924|NCT00267046|541465071|FG000|Overall Study|Chemotoxicity|2|||
150088925|NCT00267046|541465072|FG001|Overall Study|Chemotoxicity|0|||
150088926|NCT00267046|541465071|FG000|Overall Study|Open-label palifermin|2|||
150088927|NCT00267046|541465072|FG001|Overall Study|Open-label palifermin|7|||
150088928|NCT00267046|541465071|FG000|Overall Study|Surgery|3|||
150088929|NCT00267046|541465072|FG001|Overall Study|Surgery|1|||
150088930|NCT00267046|541465071|FG000|Overall Study|Withdrawal by Subject|1|||
150088931|NCT00267046|541465072|FG001|Overall Study|Withdrawal by Subject|0|||
150088932|NCT00267046|541465071|FG000|Overall Study|Radiation|0|||
150088933|NCT00267046|541465072|FG001|Overall Study|Radiation|1|||
150088934|NCT02066233|541465073|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
150088935|NCT02066233|541465074|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
150088936|NCT01979016|541465078|FG000|Overall Study|Withdrawal by Subject|2|||
150088937|NCT01979016|541465079|FG001|Overall Study|Withdrawal by Subject|0|||
150088938|NCT01979016|541465078|FG000|Overall Study|Adverse Event|0|||
150088939|NCT01979016|541465079|FG001|Overall Study|Adverse Event|1|||
150088940|NCT04983264|541465080|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
150088941|NCT04983264|541465081|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
150088942|NCT04983264|541465082|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
150088943|NCT04983264|541465080|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
150088944|NCT04983264|541465081|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
150088945|NCT04983264|541465082|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
150088946|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
150088947|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
150088948|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
150088949|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
150088950|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
150088951|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
150088952|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
150088953|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
150088954|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
150088955|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
150088956|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
150088957|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
150088958|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
150088959|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
150088960|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
150088961|NCT01124422|541465083|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
150088962|NCT01124422|541465084|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
150088963|NCT01124422|541465085|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
150088964|NCT01124422|541465083|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
150088965|NCT01124422|541465084|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
150088966|NCT01124422|541465085|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
150088967|NCT01124422|541465083|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
150088968|NCT01124422|541465084|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
150088969|NCT01124422|541465085|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
150088970|NCT01124422|541465083|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
150088971|NCT01124422|541465084|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
150088972|NCT01124422|541465085|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
150088973|NCT01124422|541465083|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
150088974|NCT01124422|541465084|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
150088975|NCT01124422|541465085|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
150088976|NCT01442493|541465086|FG000|Overall Study|withdrawn from study|3|||
150088977|NCT01442493|541465087|FG001|Overall Study|withdrawn from study|2|||
150088978|NCT00938639|541465088|FG000|Overall Study|Moved away from study area|0|||
150088979|NCT00938639|541465089|FG001|Overall Study|Moved away from study area|1|||
150088980|NCT00938639|541465088|FG000|Overall Study|Lost to Follow-up|1|||
150088981|NCT00938639|541465089|FG001|Overall Study|Lost to Follow-up|2|||
150088982|NCT00938639|541465088|FG000|Overall Study|Family issues|1|||
150088983|NCT00938639|541465089|FG001|Overall Study|Family issues|1|||
150088984|NCT00938639|541465088|FG000|Overall Study|Participant noncompliance|1|||
150088985|NCT00938639|541465089|FG001|Overall Study|Participant noncompliance|0|||
150088986|NCT04326231|541465090|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
150088987|NCT00759954|541465091|FG000|Overall Study|Personal reason|1|||
150088988|NCT00759954|541465092|FG001|Overall Study|Personal reason|0|||
150088989|NCT00759954|541465091|FG000|Overall Study|Adverse Event|1|||
150088990|NCT00759954|541465092|FG001|Overall Study|Adverse Event|2|||
150088991|NCT02875860|541465097|FG000|Overall Study|Withdrawal by Subject|0|||
150088992|NCT02875860|541465098|FG001|Overall Study|Withdrawal by Subject|1|||
150088993|NCT01741701|541465099|FG000|Overall Study|Adverse Event|5|||
150088994|NCT01741701|541465100|FG001|Overall Study|Adverse Event|1|||
150088995|NCT01741701|541465099|FG000|Overall Study|Withdrawal by Subject|0|||
150088996|NCT01741701|541465100|FG001|Overall Study|Withdrawal by Subject|1|||
150088997|NCT03033394|541465103|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
150088998|NCT03033394|541465103|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
150088999|NCT03033394|541465103|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
150089000|NCT03033394|541465103|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
150089001|NCT03033394|541465103|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
150089002|NCT02927431|541465104|FG000|Overall Study|Withdrawal by Subject|0|||
150089003|NCT02927431|541465105|FG001|Overall Study|Withdrawal by Subject|0|||
150089004|NCT02927431|541465106|FG002|Overall Study|Withdrawal by Subject|1|||
150089005|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
150089006|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
150089007|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
150089008|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
150089009|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
150089010|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
150089011|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
150089012|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
150089013|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
150089014|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
150089015|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
150089016|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
150089017|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
150089018|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
150089019|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
150089020|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
150089021|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
150089022|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
150089023|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
150089024|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
150089025|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
150089026|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
150089027|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
150089028|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
150089029|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
150089030|NCT01285310|541465107|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
150089031|NCT01285310|541465108|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
150089032|NCT01285310|541465109|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
150089033|NCT01285310|541465110|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
150089034|NCT01285310|541465111|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
150089035|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
150089036|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
150089037|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
150089038|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
150089039|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
150089040|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
150089041|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
150089042|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
150089043|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
150089044|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
150089045|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
150089046|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
150089047|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
150089048|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
150089049|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
150089050|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
150089051|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
150089052|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
150089053|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
150089054|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
150089055|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
150089056|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
150089057|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
150089058|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
150089059|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
150089060|NCT01285310|541465107|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
150089061|NCT01285310|541465108|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
150089062|NCT01285310|541465109|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
150089063|NCT01285310|541465110|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
150089064|NCT01285310|541465111|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
150089065|NCT01195415|541465114|FG000|Overall Study|No repeat biopsy due to progression|2|||
150089066|NCT01442675|541465115|FG000|Overall Study|Protocol Violation|6|||
150089067|NCT01442675|541465115|FG000|Overall Study|Lost to Follow-up|2|||
150089068|NCT01442675|541465115|FG000|Overall Study|Withdrawal by Subject|4|||
150089069|NCT00752232|541465116|FG000|Overall Study|Protocol Violation|0|||
150089070|NCT00752232|541465117|FG001|Overall Study|Protocol Violation|0|||
150089071|NCT00752232|541465118|FG002|Overall Study|Protocol Violation|0|||
150089072|NCT00752232|541465119|FG003|Overall Study|Protocol Violation|0|||
150089073|NCT00752232|541465120|FG004|Overall Study|Protocol Violation|0|||
150089074|NCT00752232|541465121|FG005|Overall Study|Protocol Violation|1|||
150089075|NCT00752232|541465122|FG006|Overall Study|Protocol Violation|0|||
150089076|NCT00752232|541465116|FG000|Overall Study|Caregiver request|2|||
150089077|NCT00752232|541465117|FG001|Overall Study|Caregiver request|0|||
150089078|NCT00752232|541465118|FG002|Overall Study|Caregiver request|0|||
150089079|NCT00752232|541465119|FG003|Overall Study|Caregiver request|0|||
150089080|NCT00752232|541465120|FG004|Overall Study|Caregiver request|1|||
150089081|NCT00752232|541465121|FG005|Overall Study|Caregiver request|0|||
150089082|NCT00752232|541465122|FG006|Overall Study|Caregiver request|0|||
150089083|NCT00752232|541465116|FG000|Overall Study|Investigator request|0|||
150089084|NCT00752232|541465117|FG001|Overall Study|Investigator request|0|||
150089085|NCT00752232|541465118|FG002|Overall Study|Investigator request|0|||
150089086|NCT00752232|541465119|FG003|Overall Study|Investigator request|0|||
150089087|NCT00752232|541465120|FG004|Overall Study|Investigator request|1|||
150089088|NCT00752232|541465121|FG005|Overall Study|Investigator request|0|||
150089089|NCT00752232|541465122|FG006|Overall Study|Investigator request|0|||
150089090|NCT00752232|541465116|FG000|Overall Study|Subject request|0|||
150089091|NCT00752232|541465117|FG001|Overall Study|Subject request|0|||
150089092|NCT00752232|541465118|FG002|Overall Study|Subject request|1|||
150089093|NCT00752232|541465119|FG003|Overall Study|Subject request|0|||
150089094|NCT00752232|541465120|FG004|Overall Study|Subject request|0|||
150089095|NCT00752232|541465121|FG005|Overall Study|Subject request|0|||
150089096|NCT00752232|541465122|FG006|Overall Study|Subject request|0|||
150089097|NCT00752232|541465116|FG000|Overall Study|Group home admission|0|||
150089098|NCT00752232|541465117|FG001|Overall Study|Group home admission|0|||
150089099|NCT00752232|541465118|FG002|Overall Study|Group home admission|0|||
150089100|NCT00752232|541465119|FG003|Overall Study|Group home admission|1|||
150089101|NCT00752232|541465120|FG004|Overall Study|Group home admission|0|||
150089102|NCT00752232|541465121|FG005|Overall Study|Group home admission|0|||
150089103|NCT00752232|541465122|FG006|Overall Study|Group home admission|0|||
150089104|NCT00752232|541465116|FG000|Overall Study|Caregiver could not attend the subject|0|||
150089105|NCT00752232|541465117|FG001|Overall Study|Caregiver could not attend the subject|0|||
150089106|NCT00752232|541465118|FG002|Overall Study|Caregiver could not attend the subject|0|||
150089107|NCT00752232|541465119|FG003|Overall Study|Caregiver could not attend the subject|0|||
150089108|NCT00752232|541465120|FG004|Overall Study|Caregiver could not attend the subject|1|||
150089109|NCT00752232|541465121|FG005|Overall Study|Caregiver could not attend the subject|0|||
150089110|NCT00752232|541465122|FG006|Overall Study|Caregiver could not attend the subject|0|||
150089111|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
150089112|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
150089113|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
150089114|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
150089115|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
150089116|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
150089117|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
150089118|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
150089119|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
150089120|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
150089121|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Death|2|||
150089122|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Death|1|||
150089123|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Death|4|||
150089124|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Death|0|||
150089125|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Death|0|||
150089126|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
150089127|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
150089128|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
150089129|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
150089130|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
150089131|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Other Reason|1|||
150089132|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Other Reason|3|||
150089133|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Other Reason|2|||
150089134|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Other Reason|0|||
150089135|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Other Reason|0|||
150089136|NCT00555321|541465123|FG000|Treatment Phase up to 12-months|Never treated|2|||
150089137|NCT00555321|541465124|FG001|Treatment Phase up to 12-months|Never treated|3|||
150089138|NCT00555321|541465125|FG002|Treatment Phase up to 12-months|Never treated|1|||
150089139|NCT00555321|541465126|FG003|Treatment Phase up to 12-months|Never treated|0|||
150089140|NCT00555321|541465127|FG004|Treatment Phase up to 12-months|Never treated|4|||
150089141|NCT00555321|541465123|FG000|Long-term Extension Phase|Adverse Event|2|||
150089142|NCT00555321|541465124|FG001|Long-term Extension Phase|Adverse Event|5|||
150089143|NCT00555321|541465125|FG002|Long-term Extension Phase|Adverse Event|2|||
150089144|NCT00555321|541465126|FG003|Long-term Extension Phase|Adverse Event|1|||
150089145|NCT00555321|541465127|FG004|Long-term Extension Phase|Adverse Event|0|||
150089146|NCT00555321|541465123|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
150089147|NCT00555321|541465124|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
150089148|NCT00555321|541465125|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
150089149|NCT00555321|541465126|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
150089150|NCT00555321|541465127|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
150089151|NCT00555321|541465123|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
150089152|NCT00555321|541465124|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
150089153|NCT00555321|541465125|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
150089154|NCT00555321|541465126|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
150089155|NCT00555321|541465127|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
150089156|NCT00555321|541465123|FG000|Long-term Extension Phase|Death|2|||
150089157|NCT00555321|541465124|FG001|Long-term Extension Phase|Death|0|||
150089158|NCT00555321|541465125|FG002|Long-term Extension Phase|Death|0|||
150089159|NCT00555321|541465126|FG003|Long-term Extension Phase|Death|3|||
150089160|NCT00555321|541465127|FG004|Long-term Extension Phase|Death|0|||
150089161|NCT00555321|541465123|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
150089162|NCT00555321|541465124|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
150089163|NCT00555321|541465125|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
150089164|NCT00555321|541465126|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
150089165|NCT00555321|541465127|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
150089166|NCT00555321|541465123|FG000|Long-term Extension Phase|Other Reason|1|||
150089167|NCT00555321|541465124|FG001|Long-term Extension Phase|Other Reason|0|||
150089168|NCT00555321|541465125|FG002|Long-term Extension Phase|Other Reason|2|||
150089169|NCT00555321|541465126|FG003|Long-term Extension Phase|Other Reason|0|||
150089170|NCT00555321|541465127|FG004|Long-term Extension Phase|Other Reason|0|||
150089171|NCT00005937|541465128|FG000|Overall Study|Lack of Efficacy|5|||
150089172|NCT01574612|541465129|FG000|Overall Study|Adverse Event|3|||
150089173|NCT01574612|541465129|FG000|Overall Study|non compliant with drug|2|||
150089174|NCT01574612|541465129|FG000|Overall Study|Withdrawal by Subject|1|||
150089175|NCT01574612|541465129|FG000|Overall Study|Lost to Follow-up|2|||
150089176|NCT02532972|541465130|FG000|Overall Study|Withdrawal by Subject|1|||
150089177|NCT02407704|541465131|FG000|Overall Study|Lost to Follow-up|0|||
150089178|NCT02407704|541465132|FG001|Overall Study|Lost to Follow-up|0|||
150089179|NCT02407704|541465133|FG002|Overall Study|Lost to Follow-up|0|||
150089180|NCT02407704|541465134|FG003|Overall Study|Lost to Follow-up|2|||
150089181|NCT02407704|541465131|FG000|Overall Study|Protocol Violation|0|||
150089182|NCT02407704|541465132|FG001|Overall Study|Protocol Violation|0|||
150089183|NCT02407704|541465133|FG002|Overall Study|Protocol Violation|0|||
150089184|NCT02407704|541465134|FG003|Overall Study|Protocol Violation|1|||
150089185|NCT02407704|541465131|FG000|Overall Study|Withdrawal by Subject|0|||
150089186|NCT02407704|541465132|FG001|Overall Study|Withdrawal by Subject|0|||
150089187|NCT02407704|541465133|FG002|Overall Study|Withdrawal by Subject|1|||
150089188|NCT02407704|541465134|FG003|Overall Study|Withdrawal by Subject|0|||
150089189|NCT01348347|541465135|FG000|Overall Study|Withdrawal by Subject|1|||
150089190|NCT01348347|541465136|FG001|Overall Study|Withdrawal by Subject|1|||
150089191|NCT01348347|541465137|FG002|Overall Study|Withdrawal by Subject|1|||
150089192|NCT01348347|541465135|FG000|Overall Study|Progressive disease|2|||
150089193|NCT01348347|541465136|FG001|Overall Study|Progressive disease|5|||
150089194|NCT01348347|541465137|FG002|Overall Study|Progressive disease|5|||
150089195|NCT03235154|541465138|FG000|Overall Study|Withdrawal by Subject|1|||
150089196|NCT03235154|541465138|FG000|Overall Study|Adverse Event|1|||
150089197|NCT03235154|541465138|FG000|Overall Study|Lost to Follow-up|2|||
150089198|NCT01922089|541465143|FG000|Overall Study|Adverse Event|18|||
150089199|NCT01922089|541465144|FG001|Overall Study|Adverse Event|13|||
150089200|NCT01922089|541465143|FG000|Overall Study|Protocol Deviation|10|||
150089201|NCT01922089|541465144|FG001|Overall Study|Protocol Deviation|7|||
150089202|NCT01922089|541465143|FG000|Overall Study|Withdrawal by Subject|3|||
150089203|NCT01922089|541465144|FG001|Overall Study|Withdrawal by Subject|4|||
150089204|NCT01922089|541465143|FG000|Overall Study|administrative problems|4|||
150089205|NCT01922089|541465144|FG001|Overall Study|administrative problems|1|||
150089206|NCT01922089|541465143|FG000|Overall Study|Physician Decision|2|||
150089207|NCT01922089|541465144|FG001|Overall Study|Physician Decision|3|||
150089208|NCT01922089|541465143|FG000|Overall Study|Death|2|||
150089209|NCT01922089|541465144|FG001|Overall Study|Death|1|||
150089210|NCT01922089|541465143|FG000|Overall Study|Lost to Follow-up|0|||
150089211|NCT01922089|541465144|FG001|Overall Study|Lost to Follow-up|1|||
150089212|NCT01683383|541465146|FG000|Overall Study|Infant was not transported|1|||
150089213|NCT01683383|541465147|FG001|Overall Study|Infant was not transported|0|||
150089214|NCT00996307|541465148|FG000|Overall Study|Adverse Event|0|||
150089215|NCT00996307|541465149|FG001|Overall Study|Adverse Event|1|||
150089216|NCT00996307|541465150|FG002|Overall Study|Adverse Event|0|||
150089217|NCT00996307|541465151|FG003|Overall Study|Adverse Event|0|||
150089218|NCT00996307|541465148|FG000|Overall Study|Withdrawal by Subject|3|||
150089219|NCT00996307|541465149|FG001|Overall Study|Withdrawal by Subject|2|||
150089220|NCT00996307|541465150|FG002|Overall Study|Withdrawal by Subject|5|||
150089221|NCT00996307|541465151|FG003|Overall Study|Withdrawal by Subject|5|||
150089222|NCT00996307|541465148|FG000|Overall Study|Lost to Follow-up|13|||
150089223|NCT00996307|541465149|FG001|Overall Study|Lost to Follow-up|13|||
150089224|NCT00996307|541465150|FG002|Overall Study|Lost to Follow-up|7|||
150089225|NCT00996307|541465151|FG003|Overall Study|Lost to Follow-up|15|||
150089226|NCT00996307|541465148|FG000|Overall Study|Administrative reason|0|||
150089227|NCT00996307|541465149|FG001|Overall Study|Administrative reason|1|||
150089228|NCT00996307|541465150|FG002|Overall Study|Administrative reason|0|||
150028841|NCT00883779|541240943|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
150028842|NCT00883779|541240944|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
150028843|NCT00883779|541240943|FG000|Off-study Phase|Death|185|||
150028844|NCT00883779|541240944|FG001|Off-study Phase|Death|174|||
150028845|NCT00883779|541240943|FG000|Off-study Phase|Refused treatment|1|||
150028846|NCT00883779|541240944|FG001|Off-study Phase|Refused treatment|1|||
150028847|NCT00883779|541240943|FG000|Off-study Phase|Failure to return|5|||
150028848|NCT00883779|541240944|FG001|Off-study Phase|Failure to return|6|||
150028849|NCT00883779|541240943|FG000|Off-study Phase|Other|18|||
150028850|NCT00883779|541240944|FG001|Off-study Phase|Other|21|||
150028851|NCT00399516|541240945|FG000|Overall Study|Lost to Follow-up|2|||
150028852|NCT03040141|541240946|FG000|Overall Study|Death|1|||
150028853|NCT03040141|541240947|FG001|Overall Study|Death|2|||
150028854|NCT03040141|541240948|FG002|Overall Study|Death|3|||
150028855|NCT03040141|541240946|FG000|Overall Study|Withdrawal by Subject|3|||
150028856|NCT03040141|541240947|FG001|Overall Study|Withdrawal by Subject|1|||
150028857|NCT03040141|541240948|FG002|Overall Study|Withdrawal by Subject|1|||
150028858|NCT03040141|541240946|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
150028859|NCT03040141|541240947|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
150028860|NCT03040141|541240948|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
150028861|NCT03040141|541240946|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
150028862|NCT03040141|541240947|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
150028863|NCT03040141|541240948|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
150028864|NCT04879628|541240949|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
150028865|NCT04879628|541240950|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
150028866|NCT04879628|541240951|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
150028867|NCT04879628|541240952|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
150028868|NCT04879628|541240949|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
150028869|NCT04879628|541240950|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
150028870|NCT04879628|541240951|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
150028871|NCT04879628|541240952|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
150028872|NCT04879628|541240949|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
150028873|NCT04879628|541240950|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
150028874|NCT04879628|541240951|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
150028875|NCT04879628|541240952|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
150028876|NCT04879628|541240949|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
150028877|NCT04879628|541240950|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
150028878|NCT04879628|541240951|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
150028879|NCT04879628|541240952|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
150028880|NCT00871871|541240958|FG000|Part I|Adverse Event|0|||
150028881|NCT00871871|541240959|FG001|Part I|Adverse Event|2|||
150028882|NCT00871871|541240960|FG002|Part I|Adverse Event|0|||
150028883|NCT00871871|541240961|FG003|Part I|Adverse Event|0|||
150028884|NCT00871871|541240958|FG000|Part I|Withdrawal by Subject|3|||
150028885|NCT00871871|541240959|FG001|Part I|Withdrawal by Subject|0|||
150028886|NCT00871871|541240960|FG002|Part I|Withdrawal by Subject|0|||
150028887|NCT00871871|541240961|FG003|Part I|Withdrawal by Subject|0|||
150028888|NCT00871871|541240958|FG000|Part I|Laboratory abnormality|0|||
150028889|NCT00871871|541240959|FG001|Part I|Laboratory abnormality|1|||
150028890|NCT00871871|541240960|FG002|Part I|Laboratory abnormality|0|||
150028891|NCT00871871|541240961|FG003|Part I|Laboratory abnormality|0|||
150028892|NCT00871871|541240958|FG000|Part II|Lack of Efficacy|0|||
150028893|NCT00871871|541240959|FG001|Part II|Lack of Efficacy|0|||
150028894|NCT00871871|541240960|FG002|Part II|Lack of Efficacy|1|||
150028895|NCT00871871|541240961|FG003|Part II|Lack of Efficacy|0|||
150028896|NCT00871871|541240958|FG000|Part II|Withdrawal by Subject|0|||
150028897|NCT00871871|541240959|FG001|Part II|Withdrawal by Subject|0|||
150028898|NCT00871871|541240960|FG002|Part II|Withdrawal by Subject|2|||
150028899|NCT00871871|541240961|FG003|Part II|Withdrawal by Subject|1|||
150028900|NCT00871871|541240958|FG000|Part II|Adverse Event|0|||
150028901|NCT00871871|541240959|FG001|Part II|Adverse Event|0|||
150028902|NCT00871871|541240960|FG002|Part II|Adverse Event|1|||
150028903|NCT00871871|541240961|FG003|Part II|Adverse Event|2|||
150028904|NCT00871871|541240958|FG000|Part II|Protocol Violation|0|||
150028905|NCT00871871|541240959|FG001|Part II|Protocol Violation|0|||
150028906|NCT00871871|541240960|FG002|Part II|Protocol Violation|0|||
150028907|NCT00871871|541240961|FG003|Part II|Protocol Violation|1|||
150028908|NCT03863509|541240962|FG000|Overall Study|COVID-19 shutdown period|0|||
150028909|NCT03863509|541240963|FG001|Overall Study|COVID-19 shutdown period|4|||
150089229|NCT00996307|541465151|FG003|Overall Study|Administrative reason|0|||
150089230|NCT00996307|541465148|FG000|Overall Study|Unable to classify|4|||
150089231|NCT00996307|541465149|FG001|Overall Study|Unable to classify|0|||
150089232|NCT00996307|541465150|FG002|Overall Study|Unable to classify|2|||
150089233|NCT00996307|541465151|FG003|Overall Study|Unable to classify|1|||
150089234|NCT02496611|541465152|FG000|Overall Study|Lost to Follow-up|2|||
150089235|NCT02496611|541465153|FG001|Overall Study|Lost to Follow-up|1|||
150089236|NCT02496611|541465152|FG000|Overall Study|Withdrawal by Subject|5|||
150089237|NCT02496611|541465153|FG001|Overall Study|Withdrawal by Subject|2|||
150089238|NCT02850965|541465154|FG000|Overall Study|Other than listed|3|||
150089239|NCT02850965|541465155|FG001|Overall Study|Other than listed|4|||
150089240|NCT02850965|541465154|FG000|Overall Study|Protocol Violation|0|||
150089241|NCT02850965|541465155|FG001|Overall Study|Protocol Violation|2|||
150089242|NCT02850965|541465154|FG000|Overall Study|Lost to Follow-up|5|||
150089243|NCT02850965|541465155|FG001|Overall Study|Lost to Follow-up|3|||
150089244|NCT02850965|541465154|FG000|Overall Study|Lack of Efficacy|4|||
150089245|NCT02850965|541465155|FG001|Overall Study|Lack of Efficacy|8|||
150089246|NCT02850965|541465154|FG000|Overall Study|Adverse Event|3|||
150089247|NCT02850965|541465155|FG001|Overall Study|Adverse Event|2|||
150089248|NCT02850965|541465154|FG000|Overall Study|Withdrawal by Subject|3|||
150089249|NCT02850965|541465155|FG001|Overall Study|Withdrawal by Subject|4|||
150089250|NCT02850965|541465154|FG000|Overall Study|Physician Decision|0|||
150089251|NCT02850965|541465155|FG001|Overall Study|Physician Decision|1|||
150089252|NCT02850965|541465154|FG000|Overall Study|Randomized but not treated|0|||
150089253|NCT02850965|541465155|FG001|Overall Study|Randomized but not treated|1|||
150089254|NCT00001723|541465156|FG000|Overall Study|Lack of Efficacy|6|||
150089255|NCT00001723|541465157|FG001|Overall Study|Lack of Efficacy|7|||
150089256|NCT00001723|541465156|FG000|Overall Study|Lack of family interest|4|||
150089257|NCT00001723|541465157|FG001|Overall Study|Lack of family interest|5|||
150089258|NCT00001723|541465156|FG000|Overall Study|Lost to Follow-up|2|||
150089259|NCT00001723|541465157|FG001|Overall Study|Lost to Follow-up|2|||
150089260|NCT00001723|541465156|FG000|Overall Study|medication intolerance|1|||
150089261|NCT00001723|541465157|FG001|Overall Study|medication intolerance|2|||
150089262|NCT02788357|541465158|FG000|Overall Study|Lost to Follow-up|3|||
150089263|NCT02788357|541465159|FG001|Overall Study|Lost to Follow-up|0|||
150089264|NCT00536198|541465160|FG000|Overall Study|Lost to Follow-up|15|||
150089265|NCT00536198|541465161|FG001|Overall Study|Lost to Follow-up|14|||
150089266|NCT00536198|541465160|FG000|Overall Study|Withdrawal by Subject|16|||
150184217|NCT00999167|541813305|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
150089267|NCT00536198|541465161|FG001|Overall Study|Withdrawal by Subject|12|||
150089268|NCT00536198|541465160|FG000|Overall Study|Adverse Event|2|||
150089269|NCT00536198|541465161|FG001|Overall Study|Adverse Event|2|||
150089270|NCT00536198|541465160|FG000|Overall Study|Rescue|3|||
150089271|NCT00536198|541465161|FG001|Overall Study|Rescue|9|||
150089272|NCT00536198|541465160|FG000|Overall Study|Pregnancy|1|||
150089273|NCT00536198|541465161|FG001|Overall Study|Pregnancy|1|||
150089274|NCT00536198|541465160|FG000|Overall Study|Protocol Violation|0|||
150089275|NCT00536198|541465161|FG001|Overall Study|Protocol Violation|1|||
150089276|NCT02170051|541465162|FG000|Overall Study|Withdrawal by Subject|10|||
150089277|NCT02170051|541465163|FG001|Overall Study|Withdrawal by Subject|10|||
150089278|NCT02170051|541465162|FG000|Overall Study|Lost to Follow-up|1|||
150089279|NCT02170051|541465163|FG001|Overall Study|Lost to Follow-up|3|||
150089280|NCT02643082|541465164|FG000|Period 1|Adverse Event|1|||
150089281|NCT02643082|541465165|FG001|Period 1|Adverse Event|0|||
150089282|NCT00881712|541465166|FG000|Overall Study|Death|1|||
150089283|NCT00881712|541465167|FG001|Overall Study|Death|0|||
150089284|NCT00881712|541465168|FG002|Overall Study|Death|0|||
150089285|NCT00881712|541465166|FG000|Overall Study|Withdrawal by Subject|1|||
150089286|NCT00881712|541465167|FG001|Overall Study|Withdrawal by Subject|0|||
150089287|NCT00881712|541465168|FG002|Overall Study|Withdrawal by Subject|0|||
150089288|NCT01324999|541465169|FG000|Overall Study|Adverse Event|3|||
150089289|NCT01324999|541465169|FG000|Overall Study|Withdrawal by Subject|2|||
150089290|NCT00276744|541465170|FG000|PART A|Reason unknown|98|||
150089291|NCT02505867|541465176|FG000|Overall Study|Lack of Efficacy|6|||
150089292|NCT02505867|541465177|FG001|Overall Study|Lack of Efficacy|6|||
150089293|NCT00230607|541465182|FG000|Overall Study|Other|3|||
150089294|NCT02860169|541465183|FG000|Part A|Withdrawal by Subject|1|||
150089295|NCT02860169|541465183|FG000|Part A|Other (Screening failure)|6|||
150089296|NCT02860169|541465183|FG000|Part A|Other (Survey not completed)|3|||
150089297|NCT02860169|541465183|FG000|Part A|Other (did not completed consent)|1|||
150089298|NCT02860169|541465183|FG000|Part B|Other (Screening failure)|10|||
150089299|NCT02860169|541465183|FG000|Part B|Withdrawal by Subject|1|||
150089300|NCT02860169|541465183|FG000|Part C|Other (Screening failure)|1|||
150089301|NCT01648205|541465186|FG000|Placebo|Pregnancy|1|||
150089302|NCT01648205|541465186|FG000|Placebo|Withdrawal by Subject|1|||
150089303|NCT01648205|541465186|FG000|Placebo|Protocol Violation|2|||
150089304|NCT01648205|541465186|FG000|Ranolazine|Death|1|||
150089305|NCT01648205|541465186|FG000|Ranolazine|Withdrawal by Subject|1|||
150089306|NCT01648205|541465186|FG000|Ranolazine|Protocol Violation|3|||
150089307|NCT01958008|541465187|FG000|Overall Study|Worsening of disease under study|0|||
150089308|NCT01958008|541465188|FG001|Overall Study|Worsening of disease under study|0|||
150089309|NCT01958008|541465189|FG002|Overall Study|Worsening of disease under study|1|||
150089310|NCT01958008|541465190|FG003|Overall Study|Worsening of disease under study|0|||
150089311|NCT01958008|541465187|FG000|Overall Study|Other adverse event|1|||
150089312|NCT01958008|541465188|FG001|Overall Study|Other adverse event|0|||
150089313|NCT01958008|541465189|FG002|Overall Study|Other adverse event|0|||
150089314|NCT01958008|541465190|FG003|Overall Study|Other adverse event|0|||
150089315|NCT01428453|541465191|FG000|Overall Study|Adverse Event|2|||
150089316|NCT01428453|541465192|FG001|Overall Study|Adverse Event|7|||
150089317|NCT01428453|541465191|FG000|Overall Study|Protocol Violation|1|||
150089318|NCT01428453|541465192|FG001|Overall Study|Protocol Violation|0|||
150089319|NCT01428453|541465191|FG000|Overall Study|Lost to Follow-up|0|||
150089320|NCT01428453|541465192|FG001|Overall Study|Lost to Follow-up|1|||
150089321|NCT01428453|541465191|FG000|Overall Study|Withdrawal by Subject|3|||
150089322|NCT01428453|541465192|FG001|Overall Study|Withdrawal by Subject|1|||
150089323|NCT01996709|541465193|FG000|Overall Study|Withdrawal by Subject|1|||
150089324|NCT01996709|541465194|FG001|Overall Study|Withdrawal by Subject|0|||
150089325|NCT01996709|541465193|FG000|Overall Study|Lost to Follow-up|3|||
150089326|NCT01996709|541465194|FG001|Overall Study|Lost to Follow-up|0|||
150089327|NCT01996709|541465193|FG000|Overall Study|Subject Non-Compliant|1|||
150089328|NCT01996709|541465194|FG001|Overall Study|Subject Non-Compliant|0|||
150089329|NCT01996709|541465193|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
150089330|NCT01996709|541465194|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
150089331|NCT02167893|541465195|FG000|Overall Study|Investigator transferred|85|||
150089332|NCT02167893|541465195|FG000|Overall Study|Investigator health reasons|10|||
150089333|NCT02167893|541465195|FG000|Overall Study|Case report forms not collected|68|||
150089334|NCT01438424|541466927|FG000|Overall Study|Continuing treatment|29|||
150089335|NCT01438424|541466927|FG000|Overall Study|Minimal virologic response|95|||
150089336|NCT01438424|541466927|FG000|Overall Study|Not identified|55|||
150089337|NCT01438424|541466927|FG000|Overall Study|Withdrawal by Subject|104|||
150089338|NCT01438424|541466927|FG000|Overall Study|Progression of chronic hepatitis B|22|||
150089339|NCT01438424|541466927|FG000|Overall Study|Death|22|||
150089340|NCT01438424|541466927|FG000|Overall Study|Adverse Event|17|||
150089341|NCT01438424|541466927|FG000|Overall Study|Lost to Follow-up|17|||
150089342|NCT01438424|541466927|FG000|Overall Study|Abnormal laboratory test result|14|||
150089343|NCT01438424|541466927|FG000|Overall Study|Need for drug prohibited by protocol|14|||
150089344|NCT01438424|541466927|FG000|Overall Study|Pregnancy|7|||
150089345|NCT01438424|541466927|FG000|Overall Study|No longer met inclusion criteria|1|||
150089346|NCT01438424|541466927|FG000|Overall Study|Participant noncompliance|20|||
150089347|NCT02927080|541466928|FG000|Overall Study|Withdrawal by Subject|0|||
150089348|NCT02927080|541466929|FG001|Overall Study|Withdrawal by Subject|0|||
150089349|NCT02927080|541466930|FG002|Overall Study|Withdrawal by Subject|0|||
150089350|NCT02927080|541466931|FG003|Overall Study|Withdrawal by Subject|0|||
150089351|NCT02927080|541466932|FG004|Overall Study|Withdrawal by Subject|1|||
150089352|NCT02927080|541466933|FG005|Overall Study|Withdrawal by Subject|0|||
150089353|NCT02927080|541466934|FG006|Overall Study|Withdrawal by Subject|1|||
150089354|NCT02927080|541466935|FG007|Overall Study|Withdrawal by Subject|1|||
150089355|NCT02927080|541466936|FG008|Overall Study|Withdrawal by Subject|0|||
150089356|NCT02927080|541466937|FG009|Overall Study|Withdrawal by Subject|2|||
150089357|NCT02927080|541466928|FG000|Overall Study|Willingness to comply with protocol|0|||
150089358|NCT02927080|541466929|FG001|Overall Study|Willingness to comply with protocol|0|||
150089359|NCT02927080|541466930|FG002|Overall Study|Willingness to comply with protocol|0|||
150089360|NCT02927080|541466931|FG003|Overall Study|Willingness to comply with protocol|0|||
150089361|NCT02927080|541466932|FG004|Overall Study|Willingness to comply with protocol|0|||
150089362|NCT02927080|541466933|FG005|Overall Study|Willingness to comply with protocol|0|||
150089363|NCT02927080|541466934|FG006|Overall Study|Willingness to comply with protocol|0|||
150089364|NCT02927080|541466935|FG007|Overall Study|Willingness to comply with protocol|0|||
150089365|NCT02927080|541466936|FG008|Overall Study|Willingness to comply with protocol|0|||
150089366|NCT02927080|541466937|FG009|Overall Study|Willingness to comply with protocol|1|||
150089367|NCT02927080|541466928|FG000|Overall Study|Study terminated by Sponsor|0|||
150089368|NCT02927080|541466929|FG001|Overall Study|Study terminated by Sponsor|0|||
150089369|NCT02927080|541466930|FG002|Overall Study|Study terminated by Sponsor|0|||
150089370|NCT02927080|541466931|FG003|Overall Study|Study terminated by Sponsor|0|||
150089371|NCT02927080|541466932|FG004|Overall Study|Study terminated by Sponsor|0|||
150089372|NCT02927080|541466933|FG005|Overall Study|Study terminated by Sponsor|0|||
150089373|NCT02927080|541466934|FG006|Overall Study|Study terminated by Sponsor|6|||
150089374|NCT02927080|541466935|FG007|Overall Study|Study terminated by Sponsor|7|||
150089375|NCT02927080|541466936|FG008|Overall Study|Study terminated by Sponsor|2|||
150089376|NCT02927080|541466937|FG009|Overall Study|Study terminated by Sponsor|3|||
150089377|NCT02927080|541466928|FG000|Overall Study|Adverse Event|0|||
150089378|NCT02927080|541466929|FG001|Overall Study|Adverse Event|1|||
150089379|NCT02927080|541466930|FG002|Overall Study|Adverse Event|0|||
150089380|NCT02927080|541466931|FG003|Overall Study|Adverse Event|0|||
150089381|NCT02927080|541466932|FG004|Overall Study|Adverse Event|0|||
150089382|NCT02927080|541466933|FG005|Overall Study|Adverse Event|0|||
150089383|NCT02927080|541466934|FG006|Overall Study|Adverse Event|0|||
150089384|NCT02927080|541466935|FG007|Overall Study|Adverse Event|1|||
150089385|NCT02927080|541466936|FG008|Overall Study|Adverse Event|0|||
150089386|NCT02927080|541466937|FG009|Overall Study|Adverse Event|1|||
150089387|NCT02927080|541466928|FG000|Overall Study|Other|0|||
150089388|NCT02927080|541466929|FG001|Overall Study|Other|0|||
150089389|NCT02927080|541466930|FG002|Overall Study|Other|0|||
150089390|NCT02927080|541466931|FG003|Overall Study|Other|0|||
150089391|NCT02927080|541466932|FG004|Overall Study|Other|0|||
150089392|NCT02927080|541466933|FG005|Overall Study|Other|0|||
150089393|NCT02927080|541466934|FG006|Overall Study|Other|1|||
150089394|NCT02927080|541466935|FG007|Overall Study|Other|0|||
150089395|NCT02927080|541466936|FG008|Overall Study|Other|1|||
150089396|NCT02927080|541466937|FG009|Overall Study|Other|0|||
150089397|NCT01411228|541466938|FG000|Overall Study|Lost to Follow-up|0|||
150089398|NCT01411228|541466939|FG001|Overall Study|Lost to Follow-up|0|||
150089399|NCT01411228|541466940|FG002|Overall Study|Lost to Follow-up|1|||
150089400|NCT01411228|541466938|FG000|Overall Study|Withdrawal by Subject|1|||
150089401|NCT01411228|541466939|FG001|Overall Study|Withdrawal by Subject|0|||
150089402|NCT01411228|541466940|FG002|Overall Study|Withdrawal by Subject|0|||
150089403|NCT00664742|541466941|FG000|Overall Study|Withdrawn due to adverse events|3|||
150089404|NCT00664742|541466941|FG000|Overall Study|Withdrawal by Subject|31|||
150089405|NCT00664742|541466941|FG000|Overall Study|Lost to Follow-up|92|||
150089406|NCT02670083|541466942|FG000|Overall Study|Adverse Event|16|||
150089407|NCT02670083|541466943|FG001|Overall Study|Adverse Event|13|||
150089408|NCT02670083|541466942|FG000|Overall Study|Death|4|||
150089409|NCT02670083|541466943|FG001|Overall Study|Death|6|||
150089410|NCT02670083|541466942|FG000|Overall Study|Lost to Follow-up|2|||
150089411|NCT02670083|541466943|FG001|Overall Study|Lost to Follow-up|2|||
150089412|NCT02670083|541466942|FG000|Overall Study|Multiple Reasons|9|||
150089413|NCT02670083|541466943|FG001|Overall Study|Multiple Reasons|9|||
150089414|NCT02670083|541466942|FG000|Overall Study|Physician Decision|0|||
150089415|NCT02670083|541466943|FG001|Overall Study|Physician Decision|2|||
150089416|NCT02670083|541466942|FG000|Overall Study|Study Terminated By Sponsor|257|||
150089417|NCT02670083|541466943|FG001|Overall Study|Study Terminated By Sponsor|254|||
150089418|NCT02670083|541466942|FG000|Overall Study|Symptomatic Deterioration|0|||
150089419|NCT02670083|541466943|FG001|Overall Study|Symptomatic Deterioration|2|||
150089420|NCT02670083|541466942|FG000|Overall Study|Withdrawal by Subject|32|||
150089421|NCT02670083|541466943|FG001|Overall Study|Withdrawal by Subject|31|||
150089422|NCT02670083|541466942|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150089423|NCT02670083|541466943|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150089424|NCT01413191|541466945|FG000|Overall Study|Lost to Follow-up|5|||
150089425|NCT01413191|541466945|FG000|Overall Study|Disease Progression|5|||
150089426|NCT01413191|541466945|FG000|Overall Study|Death|1|||
150089427|NCT02564042|541466946|FG000|Overall Study|Adverse Event|4|||
150089428|NCT02564042|541466947|FG001|Overall Study|Adverse Event|4|||
150089429|NCT02564042|541466948|FG002|Overall Study|Adverse Event|3|||
150089430|NCT02564042|541466949|FG003|Overall Study|Adverse Event|0|||
150089431|NCT02564042|541466950|FG004|Overall Study|Adverse Event|0|||
150089432|NCT02564042|541466951|FG005|Overall Study|Adverse Event|1|||
150089433|NCT02564042|541466946|FG000|Overall Study|Lost to Follow-up|1|||
150089434|NCT02564042|541466947|FG001|Overall Study|Lost to Follow-up|1|||
150089435|NCT02564042|541466948|FG002|Overall Study|Lost to Follow-up|1|||
150089436|NCT02564042|541466949|FG003|Overall Study|Lost to Follow-up|0|||
150089437|NCT02564042|541466950|FG004|Overall Study|Lost to Follow-up|1|||
150089438|NCT02564042|541466951|FG005|Overall Study|Lost to Follow-up|1|||
150089439|NCT02564042|541466946|FG000|Overall Study|Physician Decision|1|||
150089440|NCT02564042|541466947|FG001|Overall Study|Physician Decision|0|||
150089441|NCT02564042|541466948|FG002|Overall Study|Physician Decision|0|||
150089442|NCT02564042|541466949|FG003|Overall Study|Physician Decision|1|||
150089443|NCT02564042|541466950|FG004|Overall Study|Physician Decision|0|||
150089444|NCT02564042|541466951|FG005|Overall Study|Physician Decision|0|||
150089445|NCT02564042|541466946|FG000|Overall Study|Withdrawal by Subject|5|||
150089446|NCT02564042|541466947|FG001|Overall Study|Withdrawal by Subject|3|||
150089447|NCT02564042|541466948|FG002|Overall Study|Withdrawal by Subject|2|||
150089448|NCT02564042|541466949|FG003|Overall Study|Withdrawal by Subject|2|||
150089449|NCT02564042|541466950|FG004|Overall Study|Withdrawal by Subject|10|||
150089450|NCT02564042|541466951|FG005|Overall Study|Withdrawal by Subject|12|||
150089451|NCT04429061|541466956|FG000|Overall Study|Lost to Follow-up|62|||
150089452|NCT04429061|541466957|FG001|Overall Study|Lost to Follow-up|87|||
150089453|NCT04429061|541466956|FG000|Overall Study|Withdrawal by Subject|3|||
150089454|NCT04429061|541466957|FG001|Overall Study|Withdrawal by Subject|4|||
150089455|NCT02289898|541466965|FG000|Overall Study|Death|5|||
150089456|NCT02289898|541466966|FG001|Overall Study|Death|4|||
150089457|NCT02289898|541466967|FG002|Overall Study|Death|3|||
150089458|NCT02289898|541466965|FG000|Overall Study|Physician Decision|2|||
150089459|NCT02289898|541466966|FG001|Overall Study|Physician Decision|5|||
150089460|NCT02289898|541466967|FG002|Overall Study|Physician Decision|2|||
150089461|NCT02289898|541466965|FG000|Overall Study|Withdrawal by Subject|0|||
150089462|NCT02289898|541466966|FG001|Overall Study|Withdrawal by Subject|4|||
150089463|NCT02289898|541466967|FG002|Overall Study|Withdrawal by Subject|1|||
150089464|NCT02289898|541466965|FG000|Overall Study|Adverse Event|3|||
150089465|NCT02289898|541466966|FG001|Overall Study|Adverse Event|5|||
150089466|NCT02289898|541466967|FG002|Overall Study|Adverse Event|5|||
150089467|NCT02289898|541466965|FG000|Overall Study|Disease progression|34|||
150089468|NCT02289898|541466966|FG001|Overall Study|Disease progression|28|||
150089469|NCT02289898|541466967|FG002|Overall Study|Disease progression|34|||
150089470|NCT02289898|541466965|FG000|Overall Study|Use of another anticancer therapy|0|||
150089471|NCT02289898|541466966|FG001|Overall Study|Use of another anticancer therapy|0|||
150089472|NCT02289898|541466967|FG002|Overall Study|Use of another anticancer therapy|1|||
150089473|NCT02289898|541466965|FG000|Overall Study|Other|8|||
150089474|NCT02289898|541466966|FG001|Overall Study|Other|7|||
150089475|NCT02289898|541466967|FG002|Overall Study|Other|10|||
150089476|NCT01402544|541466969|FG000|Overall Study|Withdrawal by Subject|6|||
150089477|NCT01828281|541466970|FG000|Overall Study|Withdrawal by Subject|1|||
150089478|NCT01828281|541466971|FG001|Overall Study|Withdrawal by Subject|0|||
150089479|NCT00142584|541466972|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
150089480|NCT00142584|541466973|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
150089481|NCT00142584|541466972|FG000|Overall Study|Withdrawal by Subject|30|||
150089482|NCT00142584|541466973|FG001|Overall Study|Withdrawal by Subject|16|||
150089483|NCT00142584|541466972|FG000|Overall Study|Lost to Follow-up|22|||
150089484|NCT00142584|541466973|FG001|Overall Study|Lost to Follow-up|12|||
150089485|NCT00142584|541466972|FG000|Overall Study|Adverse Event|14|||
150089486|NCT00142584|541466973|FG001|Overall Study|Adverse Event|5|||
150089487|NCT00142584|541466972|FG000|Overall Study|Protocol Violation|4|||
150089488|NCT00142584|541466973|FG001|Overall Study|Protocol Violation|7|||
150089489|NCT00142584|541466972|FG000|Overall Study|Treatment Failure|2|||
150089490|NCT00142584|541466973|FG001|Overall Study|Treatment Failure|0|||
150089491|NCT02709785|541466977|FG000|Overall Study|Withdrawal by Subject|1|||
150089492|NCT02709785|541466978|FG001|Overall Study|Withdrawal by Subject|2|||
150089493|NCT02709785|541466979|FG002|Overall Study|Withdrawal by Subject|1|||
150089494|NCT01961323|541466980|FG000|Overall Study|Withdrawal by Subject|7|||
150089495|NCT01961323|541466980|FG000|Overall Study|Lost to Follow-up|8|||
150089496|NCT01961323|541466980|FG000|Overall Study|screen failure|34|||
150089497|NCT01156311|541466984|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
150089498|NCT01156311|541466985|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
150089499|NCT01156311|541466986|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
150089500|NCT01156311|541466987|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
150089501|NCT01156311|541466984|FG000|2-Month Monotherapy Period|Physician Decision|0|||
150089502|NCT01156311|541466985|FG001|2-Month Monotherapy Period|Physician Decision|1|||
150089503|NCT01156311|541466986|FG002|2-Month Monotherapy Period|Physician Decision|0|||
150089504|NCT01156311|541466987|FG003|2-Month Monotherapy Period|Physician Decision|0|||
150184218|NCT00999167|541813306|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
150089505|NCT01156311|541466984|FG000|2-Month Monotherapy Period|Other|1|||
150089506|NCT01156311|541466985|FG001|2-Month Monotherapy Period|Other|0|||
150089507|NCT01156311|541466986|FG002|2-Month Monotherapy Period|Other|0|||
150089508|NCT01156311|541466987|FG003|2-Month Monotherapy Period|Other|0|||
150089509|NCT01156311|541466984|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
150089510|NCT01156311|541466985|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
150089511|NCT01156311|541466986|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
150089512|NCT01156311|541466987|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
150089513|NCT01156311|541466984|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
150089514|NCT01156311|541466985|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
150089515|NCT01156311|541466986|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
150089516|NCT01156311|541466987|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
150089517|NCT01156311|541466984|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
150089518|NCT01156311|541466985|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
150089519|NCT01156311|541466986|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
150089520|NCT01156311|541466987|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
150089521|NCT01156311|541466984|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
150089522|NCT01156311|541466985|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
150089523|NCT01156311|541466986|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
150089524|NCT01156311|541466987|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
150089525|NCT01156311|541466984|FG000|6-month Add-on Therapy Period|Other|0|||
150089526|NCT01156311|541466985|FG001|6-month Add-on Therapy Period|Other|0|||
150089527|NCT01156311|541466986|FG002|6-month Add-on Therapy Period|Other|1|||
150089528|NCT01156311|541466987|FG003|6-month Add-on Therapy Period|Other|2|||
150089529|NCT06133348|541466988|FG000|Overall Study|Death|3|||
150089530|NCT06133348|541466988|FG000|Overall Study|Lost to Follow-up|1|||
150089531|NCT06133348|541466988|FG000|Overall Study|Physician Decision|1|||
150089532|NCT06133348|541466988|FG000|Overall Study|Withdrawal by Subject|5|||
150089533|NCT00514540|541467003|FG000|First-Line Chemo|Withdrawal by Subject|1|||
150089534|NCT00514540|541467003|FG000|First-Line Chemo|Protocol Violation|7|||
150089535|NCT00514540|541467003|FG000|Second-Line|Physician/Patient Decision|31|||
150089536|NCT01996982|541467006|FG000|Overall Study|PI/team left institution|7|||
150089537|NCT00533845|541467027|FG000|Overall Study|Physician Decision|1|||
150089538|NCT00533845|541467028|FG001|Overall Study|Physician Decision|0|||
150089539|NCT00563381|541467040|FG000|Overall Study|Adverse Event|264|||
150089540|NCT00563381|541467041|FG001|Overall Study|Adverse Event|292|||
150089541|NCT00563381|541467040|FG000|Overall Study|Protocol Violation|66|||
150089542|NCT00563381|541467041|FG001|Overall Study|Protocol Violation|74|||
150089543|NCT00563381|541467040|FG000|Overall Study|Lost to Follow-up|7|||
150089544|NCT00563381|541467041|FG001|Overall Study|Lost to Follow-up|15|||
150089545|NCT00563381|541467040|FG000|Overall Study|Withdrawal by Subject|192|||
150089546|NCT00563381|541467041|FG001|Overall Study|Withdrawal by Subject|209|||
150089547|NCT00563381|541467040|FG000|Overall Study|Lack of Efficacy|32|||
150089548|NCT00563381|541467041|FG001|Overall Study|Lack of Efficacy|24|||
150089549|NCT00563381|541467040|FG000|Overall Study|Individual different reasons|24|||
150089550|NCT00563381|541467041|FG001|Overall Study|Individual different reasons|34|||
150089551|NCT01957644|541467044|FG000|Overall Study|Adverse Event|4|||
150089552|NCT01957644|541467045|FG001|Overall Study|Adverse Event|2|||
150089553|NCT01957644|541467046|FG002|Overall Study|Adverse Event|0|||
150089554|NCT01957644|541467047|FG003|Overall Study|Adverse Event|0|||
150089555|NCT01957644|541467048|FG004|Overall Study|Adverse Event|1|||
150089556|NCT01957644|541467044|FG000|Overall Study|Progressive disease / relapse|0|||
150089557|NCT01957644|541467045|FG001|Overall Study|Progressive disease / relapse|1|||
150089558|NCT01957644|541467046|FG002|Overall Study|Progressive disease / relapse|0|||
150089559|NCT01957644|541467047|FG003|Overall Study|Progressive disease / relapse|1|||
150089560|NCT01957644|541467048|FG004|Overall Study|Progressive disease / relapse|0|||
150089561|NCT01957644|541467044|FG000|Overall Study|Other reason|1|||
150089562|NCT01957644|541467045|FG001|Overall Study|Other reason|2|||
150089563|NCT01957644|541467046|FG002|Overall Study|Other reason|1|||
150184219|NCT00999167|541813307|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
150184220|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
150089564|NCT01957644|541467047|FG003|Overall Study|Other reason|1|||
150089565|NCT01957644|541467048|FG004|Overall Study|Other reason|0|||
150089566|NCT01957644|541467044|FG000|Overall Study|Withdrawal by Subject|1|||
150089567|NCT01957644|541467045|FG001|Overall Study|Withdrawal by Subject|0|||
150089568|NCT01957644|541467046|FG002|Overall Study|Withdrawal by Subject|0|||
150089569|NCT01957644|541467047|FG003|Overall Study|Withdrawal by Subject|0|||
150089570|NCT01957644|541467048|FG004|Overall Study|Withdrawal by Subject|0|||
150089571|NCT01957644|541467044|FG000|Overall Study|Protocol Violation|0|||
150089572|NCT01957644|541467045|FG001|Overall Study|Protocol Violation|1|||
150089573|NCT01957644|541467046|FG002|Overall Study|Protocol Violation|0|||
150089574|NCT01957644|541467047|FG003|Overall Study|Protocol Violation|0|||
150089575|NCT01957644|541467048|FG004|Overall Study|Protocol Violation|0|||
150184221|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
150028910|NCT03863509|541240964|FG002|Overall Study|COVID-19 shutdown period|0|||
150028911|NCT03863509|541240962|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
150028912|NCT03863509|541240963|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
150028913|NCT03863509|541240964|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
150028914|NCT03863509|541240962|FG000|Overall Study|Lost to Follow-up|8|||
150028915|NCT03863509|541240963|FG001|Overall Study|Lost to Follow-up|0|||
150028916|NCT03863509|541240964|FG002|Overall Study|Lost to Follow-up|2|||
150028917|NCT03863509|541240962|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
150028918|NCT03863509|541240963|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
150028919|NCT03863509|541240964|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
150028920|NCT03863509|541240962|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
150028921|NCT03863509|541240963|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
150028922|NCT03863509|541240964|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
150028923|NCT03861273|541240965|FG000|Screening Phase (3 Weeks)|Other|1|||
150028924|NCT03861273|541240965|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
150028925|NCT03861273|541240965|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
150028926|NCT03861273|541240965|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
150028927|NCT03861273|541240965|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
150028928|NCT00191334|541240968|FG000|Overall Study|Adverse Event|4|||
150028929|NCT00191334|541240968|FG000|Overall Study|Disease Progression or Relapse|8|||
150028930|NCT00191334|541240968|FG000|Overall Study|Physician Decision|1|||
150028931|NCT00191334|541240968|FG000|Overall Study|Withdrawal by Subject|4|||
150028932|NCT03064490|541240969|FG000|Overall Study|Physician Decision|5|||
150028933|NCT02775916|541240974|FG000|Overall Study|Adverse Event|1|||
150028934|NCT02775916|541240975|FG001|Overall Study|Adverse Event|0|||
150028935|NCT02775916|541240974|FG000|Overall Study|Subject/Guardian Decision|2|||
150028936|NCT02775916|541240975|FG001|Overall Study|Subject/Guardian Decision|0|||
150028937|NCT01600326|541242497|FG000|Overall Study|Lost to Follow-up|1|||
150028938|NCT01600326|541242498|FG001|Overall Study|Lost to Follow-up|1|||
150028939|NCT04456504|541242499|FG000|Overall Study|Lost to Follow-up|2|||
150028940|NCT04233801|541242500|FG000|Overall Study|Other than listed|0|||
150028941|NCT04233801|541242501|FG001|Overall Study|Other than listed|0|||
150028942|NCT04233801|541242502|FG002|Overall Study|Other than listed|1|||
150028943|NCT04233801|541242500|FG000|Overall Study|Withdrawal by Subject|0|||
150028944|NCT04233801|541242501|FG001|Overall Study|Withdrawal by Subject|2|||
150028945|NCT04233801|541242502|FG002|Overall Study|Withdrawal by Subject|3|||
150028946|NCT02173769|541242503|FG000|Overall Study|Protocol Violation|4|||
150028947|NCT01690052|541242508|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
150028948|NCT01690052|541242509|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
150028949|NCT01453049|541242510|FG000|Overall Study|Protocol Violation|2|||
150028950|NCT01453049|541242511|FG001|Overall Study|Protocol Violation|5|||
150028951|NCT01453049|541242510|FG000|Overall Study|Lost to Follow-up|2|||
150028952|NCT01453049|541242511|FG001|Overall Study|Lost to Follow-up|1|||
150028953|NCT01453049|541242510|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
150028954|NCT01453049|541242511|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
150028955|NCT01453049|541242510|FG000|Overall Study|Withdrawal by Subject|1|||
150028956|NCT01453049|541242511|FG001|Overall Study|Withdrawal by Subject|0|||
150028957|NCT01453049|541242510|FG000|Overall Study|Randomized in Error|1|||
150028958|NCT01453049|541242511|FG001|Overall Study|Randomized in Error|0|||
150028959|NCT02421172|541242512|FG000|Period 1|Adverse Event|1|||
150028960|NCT02421172|541242513|FG001|Period 1|Adverse Event|0|||
150028961|NCT02421172|541242514|FG002|Period 1|Adverse Event|0|||
150028962|NCT02421172|541242515|FG003|Period 1|Adverse Event|0|||
150028963|NCT02421172|541242516|FG004|Period 1|Adverse Event|0|||
150028964|NCT02421172|541242512|FG000|Period 1|Lost to Follow-up|3|||
150028965|NCT02421172|541242513|FG001|Period 1|Lost to Follow-up|1|||
150028966|NCT02421172|541242514|FG002|Period 1|Lost to Follow-up|0|||
150028967|NCT02421172|541242515|FG003|Period 1|Lost to Follow-up|0|||
150028968|NCT02421172|541242516|FG004|Period 1|Lost to Follow-up|0|||
150028969|NCT02421172|541242512|FG000|Period 1|Patient/guardian decision|0|||
150028970|NCT02421172|541242513|FG001|Period 1|Patient/guardian decision|1|||
150028971|NCT02421172|541242514|FG002|Period 1|Patient/guardian decision|0|||
150028972|NCT02421172|541242515|FG003|Period 1|Patient/guardian decision|0|||
150028973|NCT02421172|541242516|FG004|Period 1|Patient/guardian decision|0|||
150028974|NCT02421172|541242512|FG000|Period 2|Adverse Event|0|||
150028975|NCT02421172|541242513|FG001|Period 2|Adverse Event|0|||
150028976|NCT02421172|541242514|FG002|Period 2|Adverse Event|4|||
150028977|NCT02421172|541242515|FG003|Period 2|Adverse Event|0|||
150028978|NCT02421172|541242516|FG004|Period 2|Adverse Event|0|||
150028979|NCT02421172|541242512|FG000|Period 2|Lost to Follow-up|0|||
150028980|NCT02421172|541242513|FG001|Period 2|Lost to Follow-up|0|||
150028981|NCT02421172|541242514|FG002|Period 2|Lost to Follow-up|0|||
150089576|NCT04044716|541467049|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
150089577|NCT04044716|541467050|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
150089578|NCT04044716|541467051|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
150089579|NCT04044716|541467049|FG000|Overall Study|Lost to Follow-up|2|||
150089580|NCT04044716|541467050|FG001|Overall Study|Lost to Follow-up|3|||
150089581|NCT04044716|541467051|FG002|Overall Study|Lost to Follow-up|0|||
150089582|NCT01957553|541467052|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
150089583|NCT01957553|541467053|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
150089584|NCT01957553|541467052|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
150089585|NCT01957553|541467053|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
150089586|NCT01957553|541467052|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
150089587|NCT01957553|541467053|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
150089588|NCT01957553|541467052|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
150089589|NCT01957553|541467053|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
150089590|NCT01957553|541467052|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
150089591|NCT01957553|541467053|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
150089592|NCT01957553|541467052|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
150089593|NCT01957553|541467053|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
150089594|NCT01957553|541467052|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
150089595|NCT01957553|541467053|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
150089596|NCT01957553|541467052|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
150089597|NCT01957553|541467053|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
150089598|NCT01957553|541467052|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
150089599|NCT01957553|541467053|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
150089600|NCT02730455|541467054|FG000|Overall Study|Death|5|||
150089601|NCT02730455|541467055|FG001|Overall Study|Death|6|||
150089602|NCT02730455|541467056|FG002|Overall Study|Death|4|||
150089603|NCT02730455|541467054|FG000|Overall Study|Consent withdrawn|2|||
150089604|NCT02730455|541467055|FG001|Overall Study|Consent withdrawn|4|||
150089605|NCT02730455|541467056|FG002|Overall Study|Consent withdrawn|1|||
150089606|NCT02730455|541467054|FG000|Overall Study|Lost to Follow-up|3|||
150089607|NCT02730455|541467055|FG001|Overall Study|Lost to Follow-up|1|||
150089608|NCT02730455|541467056|FG002|Overall Study|Lost to Follow-up|4|||
150089609|NCT02730455|541467054|FG000|Overall Study|Other|1|||
150089610|NCT02730455|541467055|FG001|Overall Study|Other|1|||
150089611|NCT02730455|541467056|FG002|Overall Study|Other|2|||
150089612|NCT02730455|541467054|FG000|Overall Study|Other|2|||
150089613|NCT02730455|541467055|FG001|Overall Study|Other|2|||
150089614|NCT02730455|541467056|FG002|Overall Study|Other|0|||
150089615|NCT02733367|541467057|FG000|Overall Study|Withdrawal by Subject|6|||
150089616|NCT03049280|541467064|FG000|Overall Study|Physician Decision|1|||
150089617|NCT02326025|541467065|FG000|Overall Study|Adverse Event|3|||
150089618|NCT02326025|541467066|FG001|Overall Study|Adverse Event|0|||
150089619|NCT02326025|541467065|FG000|Overall Study|Physician Decision|1|||
150089620|NCT02326025|541467066|FG001|Overall Study|Physician Decision|2|||
150089621|NCT02326025|541467065|FG000|Overall Study|Physician and Participant Decision|1|||
150089622|NCT02326025|541467066|FG001|Overall Study|Physician and Participant Decision|0|||
150089623|NCT02326025|541467065|FG000|Overall Study|Withdrawal by Subject|0|||
150089624|NCT02326025|541467066|FG001|Overall Study|Withdrawal by Subject|2|||
150089625|NCT02326025|541467065|FG000|Overall Study|Protocol Violation|0|||
150089626|NCT02326025|541467066|FG001|Overall Study|Protocol Violation|1|||
150089627|NCT01867021|541467067|FG000|Overall Study|Adverse Event|0|||
150089628|NCT01867021|541467068|FG001|Overall Study|Adverse Event|1|||
150089629|NCT01867021|541467067|FG000|Overall Study|Not Eligible|0|||
150089630|NCT01867021|541467068|FG001|Overall Study|Not Eligible|1|||
150089631|NCT01867021|541467067|FG000|Overall Study|Death|1|||
150089632|NCT01867021|541467068|FG001|Overall Study|Death|0|||
150089633|NCT01867021|541467067|FG000|Overall Study|Lost to Follow-up|0|||
150089634|NCT01867021|541467068|FG001|Overall Study|Lost to Follow-up|2|||
150089635|NCT01867021|541467067|FG000|Overall Study|Withdrawal by Subject|1|||
150089636|NCT01867021|541467068|FG001|Overall Study|Withdrawal by Subject|6|||
150089637|NCT00640601|541467069|FG000|Overall Study|Adverse Event|43|||
150089638|NCT00640601|541467069|FG000|Overall Study|Withdrawal by Subject|20|||
150089639|NCT00640601|541467069|FG000|Overall Study|Protocol Violation|6|||
150089640|NCT00640601|541467069|FG000|Overall Study|Lack of Efficacy|16|||
150089641|NCT00640601|541467069|FG000|Overall Study|Lost to Follow-up|9|||
150089642|NCT00640601|541467069|FG000|Overall Study|Physician Decision|8|||
150089643|NCT00640601|541467069|FG000|Overall Study|treatment naive, combination therapy|10|||
150089644|NCT03681405|541467070|FG000|Overall Study|Found to be ineligible after randomized|1|||
150089645|NCT03681405|541467071|FG001|Overall Study|Found to be ineligible after randomized|0|||
150089646|NCT00733408|541469293|FG000|Overall Study|Adverse Event|4|||
150089647|NCT00531232|541469294|FG000|Overall Study|Investigator decision|0|||
150089648|NCT00531232|541469295|FG001|Overall Study|Investigator decision|0|||
150089649|NCT00531232|541469296|FG002|Overall Study|Investigator decision|4|||
150089650|NCT00531232|541469294|FG000|Overall Study|Participants refused further treatment|0|||
150089651|NCT00531232|541469295|FG001|Overall Study|Participants refused further treatment|1|||
150089652|NCT00531232|541469296|FG002|Overall Study|Participants refused further treatment|2|||
150089653|NCT00531232|541469294|FG000|Overall Study|Adverse events (AEs)|1|||
150089654|NCT00531232|541469295|FG001|Overall Study|Adverse events (AEs)|2|||
150089655|NCT00531232|541469296|FG002|Overall Study|Adverse events (AEs)|2|||
150089656|NCT00531232|541469294|FG000|Overall Study|Treatment failure|1|||
150089657|NCT00531232|541469295|FG001|Overall Study|Treatment failure|3|||
150089658|NCT00531232|541469296|FG002|Overall Study|Treatment failure|7|||
150089659|NCT00531232|541469294|FG000|Overall Study|Disease recurrence|0|||
150089660|NCT00531232|541469295|FG001|Overall Study|Disease recurrence|0|||
150089661|NCT00531232|541469296|FG002|Overall Study|Disease recurrence|1|||
150089662|NCT00531232|541469294|FG000|Overall Study|Deceased|2|||
150089663|NCT00531232|541469295|FG001|Overall Study|Deceased|2|||
150089664|NCT00531232|541469296|FG002|Overall Study|Deceased|2|||
150089665|NCT00531232|541469294|FG000|Overall Study|Withdrawal by Subject|0|||
150089666|NCT00531232|541469295|FG001|Overall Study|Withdrawal by Subject|1|||
150089667|NCT00531232|541469296|FG002|Overall Study|Withdrawal by Subject|2|||
150089668|NCT00531232|541469294|FG000|Overall Study|Other|0|||
150089669|NCT00531232|541469295|FG001|Overall Study|Other|0|||
150089670|NCT00531232|541469296|FG002|Overall Study|Other|5|||
150089671|NCT04232124|541469297|FG000|Overall Study|Lost to Follow-up|3|||
150089672|NCT02329730|541469303|FG000|Overall Study|Protocol Violation|0|||
150089673|NCT02329730|541469304|FG001|Overall Study|Protocol Violation|0|||
150089674|NCT02329730|541469305|FG002|Overall Study|Protocol Violation|0|||
150089675|NCT02329730|541469306|FG003|Overall Study|Protocol Violation|0|||
150089676|NCT02329730|541469307|FG004|Overall Study|Protocol Violation|2|||
150089677|NCT02329730|541469308|FG005|Overall Study|Protocol Violation|2|||
150089678|NCT02329730|541469309|FG006|Overall Study|Protocol Violation|0|||
150089679|NCT02329730|541469310|FG007|Overall Study|Protocol Violation|0|||
150089680|NCT02329730|541469311|FG008|Overall Study|Protocol Violation|0|||
150089681|NCT02329730|541469312|FG009|Overall Study|Protocol Violation|0|||
150089682|NCT02329730|541469313|FG010|Overall Study|Protocol Violation|0|||
150089683|NCT02329730|541469314|FG011|Overall Study|Protocol Violation|0|||
150089684|NCT02329730|541469303|FG000|Overall Study|Withdrawal by Subject|0|||
150089685|NCT02329730|541469304|FG001|Overall Study|Withdrawal by Subject|0|||
150089686|NCT02329730|541469305|FG002|Overall Study|Withdrawal by Subject|0|||
150089687|NCT02329730|541469306|FG003|Overall Study|Withdrawal by Subject|0|||
150089688|NCT02329730|541469307|FG004|Overall Study|Withdrawal by Subject|1|||
150089689|NCT02329730|541469308|FG005|Overall Study|Withdrawal by Subject|0|||
150089690|NCT02329730|541469309|FG006|Overall Study|Withdrawal by Subject|1|||
150089691|NCT02329730|541469310|FG007|Overall Study|Withdrawal by Subject|1|||
150089692|NCT02329730|541469311|FG008|Overall Study|Withdrawal by Subject|1|||
150089693|NCT02329730|541469312|FG009|Overall Study|Withdrawal by Subject|1|||
150089694|NCT02329730|541469313|FG010|Overall Study|Withdrawal by Subject|0|||
150089695|NCT02329730|541469314|FG011|Overall Study|Withdrawal by Subject|0|||
150089696|NCT02345850|541469317|FG000|Overall Study|Not transplanted|10|||
150089697|NCT02345850|541469318|FG001|Overall Study|Not transplanted|5|||
150089698|NCT02345850|541469319|FG002|Overall Study|Not transplanted|4|||
150089699|NCT02345850|541469317|FG000|Overall Study|Lost to Follow-up|2|||
150089700|NCT02345850|541469318|FG001|Overall Study|Lost to Follow-up|3|||
150089701|NCT02345850|541469319|FG002|Overall Study|Lost to Follow-up|2|||
150089702|NCT02345850|541469317|FG000|Overall Study|Withdrawal by Subject|1|||
150089703|NCT02345850|541469318|FG001|Overall Study|Withdrawal by Subject|0|||
150089704|NCT02345850|541469319|FG002|Overall Study|Withdrawal by Subject|0|||
150089705|NCT02392247|541469322|FG000|Overall Study|Withdrawal by Subject|1|||
150089706|NCT02392247|541469322|FG000|Overall Study|Surgery cancelled; no data|1|||
150089707|NCT01991067|541469324|FG000|Overall Study|Lost to Follow-up|6|||
150089708|NCT01991067|541469325|FG001|Overall Study|Lost to Follow-up|5|||
150089709|NCT00224055|541469327|FG000|Overall Study|Adverse Event|9|||
150089710|NCT00224055|541469328|FG001|Overall Study|Adverse Event|3|||
150089711|NCT00224055|541469327|FG000|Overall Study|Lost to Follow-up|1|||
150089712|NCT00224055|541469328|FG001|Overall Study|Lost to Follow-up|2|||
150089713|NCT00224055|541469327|FG000|Overall Study|Protocol Violation|1|||
150089714|NCT00224055|541469328|FG001|Overall Study|Protocol Violation|1|||
150089715|NCT00224055|541469327|FG000|Overall Study|Inclusion Violation|3|||
150089716|NCT00224055|541469328|FG001|Overall Study|Inclusion Violation|6|||
150089717|NCT00224055|541469327|FG000|Overall Study|Withdrawal by Subject|0|||
150089718|NCT00224055|541469328|FG001|Overall Study|Withdrawal by Subject|2|||
150089719|NCT00224055|541469327|FG000|Overall Study|Other|1|||
150089720|NCT00224055|541469328|FG001|Overall Study|Other|0|||
150089721|NCT02068443|541469329|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
150089722|NCT02068443|541469330|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
150089723|NCT02068443|541469331|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
150089724|NCT02068443|541469329|FG000|Overall Study|Voluntary Withdrawal|4|||
150089725|NCT02068443|541469330|FG001|Overall Study|Voluntary Withdrawal|0|||
150089726|NCT02068443|541469331|FG002|Overall Study|Voluntary Withdrawal|1|||
150089727|NCT02068443|541469329|FG000|Overall Study|Lack of Efficacy|2|||
150089728|NCT02068443|541469330|FG001|Overall Study|Lack of Efficacy|1|||
150089729|NCT02068443|541469331|FG002|Overall Study|Lack of Efficacy|0|||
150089730|NCT02068443|541469329|FG000|Overall Study|Other Reason Not Specified|1|||
150089731|NCT02068443|541469330|FG001|Overall Study|Other Reason Not Specified|0|||
150089732|NCT02068443|541469331|FG002|Overall Study|Other Reason Not Specified|0|||
150089733|NCT02014597|541469334|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
150089734|NCT02014597|541469335|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
150089735|NCT05126901|541469336|FG000|Overall Study|Withdrawal by Subject|1|||
150089736|NCT05126901|541469337|FG001|Overall Study|Withdrawal by Subject|1|||
150089737|NCT05126901|541469338|FG002|Overall Study|Withdrawal by Subject|4|||
150089738|NCT05126901|541469336|FG000|Overall Study|Adverse Event|0|||
150089739|NCT05126901|541469337|FG001|Overall Study|Adverse Event|0|||
150089740|NCT05126901|541469338|FG002|Overall Study|Adverse Event|1|||
150089741|NCT05126901|541469336|FG000|Overall Study|Lost to Follow-up|0|||
150089742|NCT05126901|541469337|FG001|Overall Study|Lost to Follow-up|2|||
150089743|NCT05126901|541469338|FG002|Overall Study|Lost to Follow-up|0|||
150089744|NCT00754624|541469339|FG000|Overall Study|Adverse Event|16|||
150089745|NCT00754624|541469339|FG000|Overall Study|Death|1|||
150089746|NCT00754624|541469339|FG000|Overall Study|Physician Decision|8|||
150089747|NCT00754624|541469339|FG000|Overall Study|Protocol Violation|1|||
150089748|NCT00754624|541469339|FG000|Overall Study|Withdrawal by Subject|28|||
150089749|NCT00754624|541469339|FG000|Overall Study|Various|12|||
150089750|NCT00754624|541469339|FG000|Overall Study|Lost to Follow-up|3|||
150089751|NCT04067544|541469340|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
150089752|NCT00931762|541469341|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
150089753|NCT00931762|541469341|FG000|Overall Study|Administrative Problems|5|||
150184222|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
150184223|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
150184224|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
150184225|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
150184226|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
150184227|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
150184228|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
150184229|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
150184230|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
150184231|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
150184232|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
150184233|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
150184234|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
150184235|NCT00999167|541813305|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
150184236|NCT00999167|541813306|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
150184237|NCT00999167|541813307|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
150184238|NCT00274469|541813308|FG000|Overall Study|Death|63|||
150184239|NCT00274469|541813309|FG001|Overall Study|Death|74|||
150184240|NCT00274469|541813308|FG000|Overall Study|Did not consent to OS follow-up|16|||
150184241|NCT00274469|541813309|FG001|Overall Study|Did not consent to OS follow-up|19|||
150184242|NCT04238247|541813310|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
150184243|NCT04238247|541813311|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
150184244|NCT04238247|541813312|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
150184245|NCT04238247|541813313|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
150184246|NCT04238247|541813310|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
150184247|NCT04238247|541813311|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
150184248|NCT04238247|541813312|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
150184249|NCT04238247|541813313|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
150184250|NCT04238247|541813310|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
150184251|NCT04238247|541813311|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
150184252|NCT04238247|541813312|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
150184253|NCT04238247|541813313|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
150184254|NCT04238247|541813310|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
150184255|NCT04238247|541813311|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
150184256|NCT04238247|541813312|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
150184257|NCT04238247|541813313|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
150184258|NCT03833167|541813314|FG000|Overall Study|Withdrawal by Subject|4|||
150184259|NCT03833167|541813315|FG001|Overall Study|Withdrawal by Subject|6|||
150184260|NCT03833167|541813314|FG000|Overall Study|Ongoing|186|||
150184261|NCT03833167|541813315|FG001|Overall Study|Ongoing|194|||
150184262|NCT03833167|541813314|FG000|Overall Study|Lost to Follow-up|1|||
150184263|NCT03833167|541813315|FG001|Overall Study|Lost to Follow-up|1|||
150184264|NCT03833167|541813314|FG000|Overall Study|Physician Decision|0|||
150184265|NCT03833167|541813315|FG001|Overall Study|Physician Decision|2|||
150184266|NCT03833167|541813314|FG000|Overall Study|Death|34|||
150184267|NCT03833167|541813315|FG001|Overall Study|Death|22|||
150184268|NCT03517969|541813316|FG000|Overall Study|Never started protocol treatment|3|||
150184269|NCT03517969|541813317|FG001|Overall Study|Never started protocol treatment|5|||
150184270|NCT03517969|541813316|FG000|Overall Study|Disease progression|11|||
150184271|NCT03517969|541813317|FG001|Overall Study|Disease progression|16|||
150184272|NCT03517969|541813316|FG000|Overall Study|PSA progression|8|||
150184273|NCT03517969|541813317|FG001|Overall Study|PSA progression|1|||
150089754|NCT00931762|541469341|FG000|Overall Study|Death|1|||
150089755|NCT00931762|541469341|FG000|Overall Study|Disease Progression|3|||
150089756|NCT00931762|541469341|FG000|Overall Study|Adverse Event (s)|11|||
150089757|NCT00931762|541469341|FG000|Overall Study|Subject withdrew consent|13|||
150184274|NCT03517969|541813316|FG000|Overall Study|Clinical progression|4|||
150184275|NCT03517969|541813317|FG001|Overall Study|Clinical progression|2|||
150184276|NCT03517969|541813316|FG000|Overall Study|Adverse Event|5|||
150184277|NCT03517969|541813317|FG001|Overall Study|Adverse Event|4|||
150184278|NCT03517969|541813316|FG000|Overall Study|Intercurrent illness|1|||
150184279|NCT03517969|541813317|FG001|Overall Study|Intercurrent illness|2|||
150089758|NCT01320085|541469342|FG000|Overall Study|Disease Progression|26|||
150089759|NCT01320085|541469343|FG001|Overall Study|Disease Progression|93|||
150089760|NCT01320085|541469344|FG002|Overall Study|Disease Progression|17|||
150089761|NCT01320085|541469342|FG000|Overall Study|Adverse Event|12|||
150089762|NCT01320085|541469343|FG001|Overall Study|Adverse Event|20|||
150089763|NCT01320085|541469344|FG002|Overall Study|Adverse Event|5|||
150089764|NCT01320085|541469342|FG000|Overall Study|Withdrawal by Subject|2|||
150089765|NCT01320085|541469343|FG001|Overall Study|Withdrawal by Subject|4|||
150089766|NCT01320085|541469344|FG002|Overall Study|Withdrawal by Subject|1|||
150089767|NCT01320085|541469342|FG000|Overall Study|Protocol Deviation|1|||
150089768|NCT01320085|541469343|FG001|Overall Study|Protocol Deviation|0|||
150089769|NCT01320085|541469344|FG002|Overall Study|Protocol Deviation|1|||
150089770|NCT01320085|541469342|FG000|Overall Study|Administrative problems|0|||
150089771|NCT01320085|541469343|FG001|Overall Study|Administrative problems|0|||
150089772|NCT01320085|541469344|FG002|Overall Study|Administrative problems|1|||
150089773|NCT01702454|541469345|FG000|Overall Study|Consent withdrawal|0|||
150089774|NCT01702454|541469346|FG001|Overall Study|Consent withdrawal|1|||
150089775|NCT01702454|541469345|FG000|Overall Study|Migrated/moved from study area|0|||
150089776|NCT01702454|541469346|FG001|Overall Study|Migrated/moved from study area|1|||
150089777|NCT01702454|541469345|FG000|Overall Study|Lost to Follow-up|3|||
150089778|NCT01702454|541469346|FG001|Overall Study|Lost to Follow-up|6|||
150089779|NCT00710710|541469347|FG000|Overall Study|Consent withdrawn|2|||
150089780|NCT00710710|541469348|FG001|Overall Study|Consent withdrawn|2|||
150089781|NCT00710710|541469347|FG000|Overall Study|Protocol Violation|0|||
150089782|NCT00710710|541469348|FG001|Overall Study|Protocol Violation|1|||
150089783|NCT00710710|541469347|FG000|Overall Study|Adverse Event|3|||
150089784|NCT00710710|541469348|FG001|Overall Study|Adverse Event|3|||
150089785|NCT00710710|541469347|FG000|Overall Study|Progressive disease|40|||
150089786|NCT00710710|541469348|FG001|Overall Study|Progressive disease|38|||
150089787|NCT03510884|541469349|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
150089788|NCT03510884|541469350|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
150089789|NCT03510884|541469351|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
150089790|NCT03510884|541469352|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
150089791|NCT03510884|541469349|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
150089792|NCT03510884|541469350|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
150089793|NCT03510884|541469351|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
150089794|NCT03510884|541469352|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
150089795|NCT03510884|541469349|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
150089796|NCT03510884|541469350|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
150089797|NCT03510884|541469351|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
150089798|NCT03510884|541469352|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
150089799|NCT03510884|541469349|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
150089800|NCT03510884|541469350|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
150089801|NCT03510884|541469351|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
150089802|NCT03510884|541469352|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
150089803|NCT03510884|541469349|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
150089804|NCT03510884|541469350|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
150089805|NCT03510884|541469351|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
150089806|NCT03510884|541469352|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
150089807|NCT03510884|541469349|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
150089808|NCT03510884|541469350|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
150089809|NCT03510884|541469351|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
150089810|NCT03510884|541469352|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
150089811|NCT03510884|541469349|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
150089812|NCT03510884|541469350|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
150089813|NCT03510884|541469351|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
150089814|NCT03510884|541469352|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
150089815|NCT03510884|541469349|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
150089816|NCT03510884|541469350|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
150089817|NCT03510884|541469351|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
150089818|NCT03510884|541469352|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
150089819|NCT03510884|541469349|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
150089820|NCT03510884|541469350|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
150089821|NCT03510884|541469351|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
150089822|NCT03510884|541469352|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
150089823|NCT03510884|541469349|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
150089824|NCT03510884|541469350|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
150089825|NCT03510884|541469351|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
150089826|NCT03510884|541469352|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
150089827|NCT02282020|541469353|FG000|Overall Study|Objective Disease Progression|128|||
150089828|NCT02282020|541469354|FG001|Overall Study|Objective Disease Progression|30|||
150089829|NCT02282020|541469353|FG000|Overall Study|Adverse Event|18|||
150089830|NCT02282020|541469354|FG001|Overall Study|Adverse Event|15|||
150089831|NCT02282020|541469353|FG000|Overall Study|Withdrawal by Subject|7|||
150089832|NCT02282020|541469354|FG001|Overall Study|Withdrawal by Subject|10|||
150089833|NCT02282020|541469353|FG000|Overall Study|Miscellaneous|5|||
150089834|NCT02282020|541469354|FG001|Overall Study|Miscellaneous|19|||
150089835|NCT02282020|541469353|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
150089836|NCT02282020|541469354|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
150089837|NCT02282020|541469353|FG000|Overall Study|Developed Discontinuation Criteria|0|||
150089838|NCT02282020|541469354|FG001|Overall Study|Developed Discontinuation Criteria|2|||
150089839|NCT02282020|541469353|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
150089840|NCT02282020|541469354|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
150089841|NCT01500629|541469355|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
150089842|NCT01500629|541469356|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
150089843|NCT00249444|541469357|FG000|Overall Study|Lost to Follow-up|2|||
150089844|NCT00249444|541469358|FG001|Overall Study|Lost to Follow-up|2|||
150089845|NCT00249444|541469357|FG000|Overall Study|non-compliant|9|||
150089846|NCT00249444|541469358|FG001|Overall Study|non-compliant|11|||
150089847|NCT00249444|541469357|FG000|Overall Study|Adverse Event|1|||
150089848|NCT00249444|541469358|FG001|Overall Study|Adverse Event|1|||
150089849|NCT00249444|541469357|FG000|Overall Study|life event|0|||
150089850|NCT00249444|541469358|FG001|Overall Study|life event|1|||
150089851|NCT01499667|541469359|FG000|Overall Study|administrative problems|4|||
150089852|NCT01499667|541469360|FG001|Overall Study|administrative problems|5|||
150089853|NCT01499667|541469361|FG002|Overall Study|administrative problems|5|||
150089854|NCT01499667|541469359|FG000|Overall Study|Protocol Violation|1|||
150089855|NCT01499667|541469360|FG001|Overall Study|Protocol Violation|3|||
150089856|NCT01499667|541469361|FG002|Overall Study|Protocol Violation|2|||
150089857|NCT01499667|541469359|FG000|Overall Study|Adverse Event|0|||
150089858|NCT01499667|541469360|FG001|Overall Study|Adverse Event|2|||
150089859|NCT01499667|541469361|FG002|Overall Study|Adverse Event|2|||
150089860|NCT01499667|541469359|FG000|Overall Study|Withdrawal by Subject|2|||
150089861|NCT01499667|541469360|FG001|Overall Study|Withdrawal by Subject|1|||
150089862|NCT01499667|541469361|FG002|Overall Study|Withdrawal by Subject|1|||
150089863|NCT01499667|541469359|FG000|Overall Study|Lack of Efficacy|2|||
150089864|NCT01499667|541469360|FG001|Overall Study|Lack of Efficacy|0|||
150089865|NCT01499667|541469361|FG002|Overall Study|Lack of Efficacy|0|||
150089866|NCT02673489|541469362|FG000|Treatment Period|Lost to Follow-up|3|||
150089867|NCT02673489|541469363|FG001|Treatment Period|Lost to Follow-up|0|||
150089868|NCT02673489|541469362|FG000|Treatment Period|Participant request to discontinue|1|||
150089869|NCT02673489|541469363|FG001|Treatment Period|Participant request to discontinue|1|||
150089870|NCT02673489|541469362|FG000|Treatment Period|Participant moved to another province|1|||
150089871|NCT02673489|541469363|FG001|Treatment Period|Participant moved to another province|0|||
150089872|NCT02673489|541469362|FG000|Treatment Period|Participant was incarcerated|0|||
150089873|NCT02673489|541469363|FG001|Treatment Period|Participant was incarcerated|1|||
150089874|NCT02673489|541469362|FG000|Treatment Period|Adverse Event|0|||
150089875|NCT02673489|541469363|FG001|Treatment Period|Adverse Event|1|||
150089876|NCT02673489|541469362|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
150089877|NCT02673489|541469363|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
150089878|NCT02673489|541469362|FG000|Follow Up Period|Unable to return for follow-up|0|||
150089879|NCT02673489|541469363|FG001|Follow Up Period|Unable to return for follow-up|1|||
150089880|NCT00759863|541469364|FG000|Overall Study|Death, moved, or lost contact|20|||
150089881|NCT00759863|541469365|FG001|Overall Study|Death, moved, or lost contact|18|||
150089882|NCT01549392|541469367|FG000|Overall Study|Withdrawal by Subject|1|||
150089883|NCT01549392|541469368|FG001|Overall Study|Withdrawal by Subject|0|||
150089884|NCT02743806|541469369|FG000|Overall Study|Adverse Event|9|||
150089885|NCT02743806|541469369|FG000|Overall Study|Lost to Follow-up|8|||
150089886|NCT02743806|541469369|FG000|Overall Study|Voluntary Withdrawal|54|||
150089887|NCT02743806|541469369|FG000|Overall Study|Study Termination|65|||
150089888|NCT02743806|541469369|FG000|Overall Study|Pregnancy|6|||
150089889|NCT02743806|541469369|FG000|Overall Study|No Longer Clinically Benefiting|27|||
150089890|NCT02743806|541469369|FG000|Overall Study|Reason Not Specified|12|||
150089891|NCT00849381|541469370|FG000|Overall Study|Adverse Event|1|||
150089892|NCT00849381|541469370|FG000|Overall Study|Lost to Follow-up|129|||
150089893|NCT00849381|541469370|FG000|Overall Study|Protocol Violation|5|||
150089894|NCT00849381|541469370|FG000|Overall Study|Withdrawal by Subject|6|||
150089895|NCT00849381|541469370|FG000|Overall Study|Other|4|||
150089896|NCT00460031|541469371|FG000|Overall Study|Adverse Event|5|||
150089897|NCT00460031|541469371|FG000|Overall Study|Withdrawal by Subject|5|||
150089898|NCT00460031|541469371|FG000|Overall Study|Death|1|||
150089899|NCT02618434|541469372|FG000|Overall Study|Withdrawal by Subject|0|||
150089900|NCT02618434|541469373|FG001|Overall Study|Withdrawal by Subject|2|||
150089901|NCT02618434|541469374|FG002|Overall Study|Withdrawal by Subject|3|||
150089902|NCT02618434|541469372|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
150089903|NCT02618434|541469373|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
150089904|NCT02618434|541469374|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
150089905|NCT02618434|541469372|FG000|Overall Study|Lost to Follow-up|3|||
150089906|NCT02618434|541469373|FG001|Overall Study|Lost to Follow-up|1|||
150089907|NCT02618434|541469374|FG002|Overall Study|Lost to Follow-up|3|||
150089908|NCT02618434|541469372|FG000|Overall Study|Adverse Event|1|||
150089909|NCT02618434|541469373|FG001|Overall Study|Adverse Event|0|||
150089910|NCT02618434|541469374|FG002|Overall Study|Adverse Event|12|||
150089911|NCT02618434|541469372|FG000|Overall Study|Physician Decision|0|||
150089912|NCT02618434|541469373|FG001|Overall Study|Physician Decision|1|||
150089913|NCT02618434|541469374|FG002|Overall Study|Physician Decision|0|||
150089914|NCT02618434|541469372|FG000|Overall Study|Protocol Violation|0|||
150089915|NCT02618434|541469373|FG001|Overall Study|Protocol Violation|0|||
150089916|NCT02618434|541469374|FG002|Overall Study|Protocol Violation|1|||
150089917|NCT02618434|541469372|FG000|Overall Study|Other, Multiple categories|1|||
150089918|NCT02618434|541469373|FG001|Overall Study|Other, Multiple categories|1|||
150089919|NCT02618434|541469374|FG002|Overall Study|Other, Multiple categories|1|||
150089920|NCT01988103|541469375|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
150089921|NCT01988103|541469376|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
150089922|NCT01988103|541469377|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
150089923|NCT01988103|541469378|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
150089924|NCT01988103|541469379|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
150089925|NCT01988103|541469375|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
150089926|NCT01988103|541469376|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
150089927|NCT01988103|541469377|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
150089928|NCT01988103|541469378|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
150089929|NCT01988103|541469379|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
150089930|NCT01988103|541469375|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
150089931|NCT01988103|541469376|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
150089932|NCT01988103|541469377|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
150089933|NCT01988103|541469378|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
150089934|NCT01988103|541469379|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
150089935|NCT01988103|541469375|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
150089936|NCT01988103|541469376|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
150089937|NCT01988103|541469377|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
150089938|NCT01988103|541469378|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
150089939|NCT01988103|541469379|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
150089940|NCT01988103|541469375|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
150089941|NCT01988103|541469376|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
150089942|NCT01988103|541469377|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
150089943|NCT01988103|541469378|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
150089944|NCT01988103|541469379|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
150089945|NCT01988103|541469375|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
150089946|NCT01988103|541469376|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
150089947|NCT01988103|541469377|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
150089948|NCT01988103|541469378|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
150089949|NCT01988103|541469379|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
150089950|NCT01988103|541469375|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
150089951|NCT01988103|541469376|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
150089952|NCT01988103|541469377|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
150089953|NCT01988103|541469378|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
150089954|NCT01988103|541469379|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
150089955|NCT02506153|541469380|FG000|Overall Study|Adverse Event|359|||
150089956|NCT02506153|541469381|FG001|Overall Study|Adverse Event|114|||
150089957|NCT02506153|541469380|FG000|Overall Study|Refused unrelated to adverse event|127|||
150089958|NCT02506153|541469381|FG001|Overall Study|Refused unrelated to adverse event|18|||
150089959|NCT02506153|541469380|FG000|Overall Study|Progression/relapse|91|||
150089960|NCT02506153|541469381|FG001|Overall Study|Progression/relapse|136|||
150089961|NCT02506153|541469380|FG000|Overall Study|Death|2|||
150089962|NCT02506153|541469381|FG001|Overall Study|Death|1|||
150089963|NCT02506153|541469380|FG000|Overall Study|Other - not protocol specified|23|||
150089964|NCT02506153|541469381|FG001|Overall Study|Other - not protocol specified|12|||
150089965|NCT00885105|541469382|FG000|Overall Study|Withdrawal by Subject|0|||
150089966|NCT00885105|541469383|FG001|Overall Study|Withdrawal by Subject|8|||
150089967|NCT00885105|541469382|FG000|Overall Study|Adverse Event|1|||
150089968|NCT00885105|541469383|FG001|Overall Study|Adverse Event|0|||
150089969|NCT00885105|541469382|FG000|Overall Study|Protocol Violation|0|||
150089970|NCT00885105|541469383|FG001|Overall Study|Protocol Violation|2|||
150089971|NCT02772081|541469389|FG000|Overall Study|Physician Decision|1|||
150089972|NCT02772081|541469390|FG001|Overall Study|Physician Decision|1|||
150089973|NCT02772081|541469389|FG000|Overall Study|Death|1|||
150089974|NCT02772081|541469390|FG001|Overall Study|Death|1|||
150089975|NCT02598076|541469395|FG000|Overall Study|Lost to Follow-up|2|||
150089976|NCT02598076|541469396|FG001|Overall Study|Lost to Follow-up|3|||
150089977|NCT04876274|541469401|FG000|Overall Study|Lost to Follow-up|9|||
150089978|NCT04876274|541469402|FG001|Overall Study|Lost to Follow-up|12|||
150089979|NCT03454893|541469403|FG000|Overall Study|Study Terminated by the Sponsor|5|||
150089980|NCT03454893|541469403|FG000|Overall Study|Did not pass screening|4|||
150089981|NCT03070782|541469404|FG000|Overall Study|Adverse Event|3|||
150089982|NCT03070782|541469405|FG001|Overall Study|Adverse Event|0|||
150089983|NCT03070782|541469406|FG002|Overall Study|Adverse Event|3|||
150089984|NCT03070782|541469407|FG003|Overall Study|Adverse Event|1|||
150089985|NCT03070782|541469408|FG004|Overall Study|Adverse Event|6|||
150089986|NCT03070782|541469409|FG005|Overall Study|Adverse Event|2|||
150089987|NCT03070782|541469404|FG000|Overall Study|Withdrawal by Subject|2|||
150089988|NCT03070782|541469405|FG001|Overall Study|Withdrawal by Subject|1|||
150089989|NCT03070782|541469406|FG002|Overall Study|Withdrawal by Subject|1|||
150089990|NCT03070782|541469407|FG003|Overall Study|Withdrawal by Subject|0|||
150089991|NCT03070782|541469408|FG004|Overall Study|Withdrawal by Subject|4|||
150089992|NCT03070782|541469409|FG005|Overall Study|Withdrawal by Subject|3|||
150089993|NCT03070782|541469404|FG000|Overall Study|Reason Not Specified|2|||
150089994|NCT03070782|541469405|FG001|Overall Study|Reason Not Specified|0|||
150089995|NCT03070782|541469406|FG002|Overall Study|Reason Not Specified|0|||
150089996|NCT03070782|541469407|FG003|Overall Study|Reason Not Specified|1|||
150089997|NCT03070782|541469408|FG004|Overall Study|Reason Not Specified|2|||
150089998|NCT03070782|541469409|FG005|Overall Study|Reason Not Specified|1|||
150089999|NCT03070782|541469404|FG000|Overall Study|Ineligibility|0|||
150090000|NCT03070782|541469405|FG001|Overall Study|Ineligibility|0|||
150090001|NCT03070782|541469406|FG002|Overall Study|Ineligibility|0|||
150090002|NCT03070782|541469407|FG003|Overall Study|Ineligibility|1|||
150090003|NCT03070782|541469408|FG004|Overall Study|Ineligibility|0|||
150090004|NCT03070782|541469409|FG005|Overall Study|Ineligibility|1|||
150090005|NCT03070782|541469404|FG000|Overall Study|Pregnancy|0|||
150090006|NCT03070782|541469405|FG001|Overall Study|Pregnancy|0|||
150090007|NCT03070782|541469406|FG002|Overall Study|Pregnancy|0|||
150090008|NCT03070782|541469407|FG003|Overall Study|Pregnancy|1|||
150090009|NCT03070782|541469408|FG004|Overall Study|Pregnancy|0|||
150090010|NCT03070782|541469409|FG005|Overall Study|Pregnancy|0|||
150090011|NCT03070782|541469404|FG000|Overall Study|Investigator Judgement|0|||
150090012|NCT03070782|541469405|FG001|Overall Study|Investigator Judgement|0|||
150090013|NCT03070782|541469406|FG002|Overall Study|Investigator Judgement|0|||
150090014|NCT03070782|541469407|FG003|Overall Study|Investigator Judgement|1|||
150090015|NCT03070782|541469408|FG004|Overall Study|Investigator Judgement|0|||
150090016|NCT03070782|541469409|FG005|Overall Study|Investigator Judgement|0|||
150090017|NCT02320149|541469410|FG000|Overall Study|Adverse Event|3|||
150090018|NCT02320149|541469411|FG001|Overall Study|Adverse Event|7|||
150090019|NCT02320149|541469410|FG000|Overall Study|Withdrawal of Consent|28|||
150090020|NCT02320149|541469411|FG001|Overall Study|Withdrawal of Consent|32|||
150090021|NCT02320149|541469410|FG000|Overall Study|Lost to Follow-up|21|||
150090022|NCT02320149|541469411|FG001|Overall Study|Lost to Follow-up|34|||
150090023|NCT02320149|541469410|FG000|Overall Study|Protocol Violation|2|||
150090024|NCT02320149|541469411|FG001|Overall Study|Protocol Violation|1|||
150090025|NCT02320149|541469410|FG000|Overall Study|Noncompliance with Study Treatment|7|||
150090026|NCT02320149|541469411|FG001|Overall Study|Noncompliance with Study Treatment|2|||
150090027|NCT02320149|541469410|FG000|Overall Study|Lack of Efficacy|0|||
150090028|NCT02320149|541469411|FG001|Overall Study|Lack of Efficacy|1|||
150090029|NCT02320149|541469410|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150090030|NCT02320149|541469411|FG001|Overall Study|Other Miscellaneous Reasons|3|||
150184280|NCT03517969|541813316|FG000|Overall Study|Death|1|||
150184281|NCT03517969|541813317|FG001|Overall Study|Death|1|||
150184282|NCT03517969|541813316|FG000|Overall Study|Withdrawal by Subject|1|||
150090031|NCT00022633|541469412|FG000|Overall Study|Adverse Event|11|||
150090032|NCT00022633|541469413|FG001|Overall Study|Adverse Event|1|||
150090033|NCT00022633|541469412|FG000|Overall Study|Refusal unrelated to adverse event|1|||
150090034|NCT00022633|541469413|FG001|Overall Study|Refusal unrelated to adverse event|0|||
150090035|NCT00022633|541469412|FG000|Overall Study|Progression/relapse|9|||
150090036|NCT00022633|541469413|FG001|Overall Study|Progression/relapse|2|||
150090037|NCT00022633|541469412|FG000|Overall Study|Death|4|||
150090038|NCT00022633|541469413|FG001|Overall Study|Death|0|||
150090039|NCT00022633|541469412|FG000|Overall Study|Other - not protocol specified|3|||
150090040|NCT00022633|541469413|FG001|Overall Study|Other - not protocol specified|2|||
150090041|NCT00022633|541469412|FG000|Overall Study|Ineligible|4|||
150090042|NCT00022633|541469413|FG001|Overall Study|Ineligible|0|||
150090043|NCT01714635|541469425|FG000|Overall Study|Discontinued|1|||
150090044|NCT01714635|541469426|FG001|Overall Study|Discontinued|0|||
150090045|NCT01714635|541469427|FG002|Overall Study|Discontinued|2|||
150090046|NCT01714635|541469425|FG000|Overall Study|Missed 6-month exam|1|||
150090047|NCT01714635|541469426|FG001|Overall Study|Missed 6-month exam|0|||
150090048|NCT01714635|541469427|FG002|Overall Study|Missed 6-month exam|0|||
150090049|NCT03358290|541469431|FG000|Overall Study|Study discontinued by Sponsor|0|||
150090050|NCT03358290|541469432|FG001|Overall Study|Study discontinued by Sponsor|1|||
150090051|NCT03358290|541469433|FG002|Overall Study|Study discontinued by Sponsor|1|||
150090052|NCT03358290|541469434|FG003|Overall Study|Study discontinued by Sponsor|0|||
150090053|NCT03358290|541469435|FG004|Overall Study|Study discontinued by Sponsor|0|||
150090054|NCT03358290|541469431|FG000|Overall Study|Adverse Event|0|||
150090055|NCT03358290|541469432|FG001|Overall Study|Adverse Event|0|||
150090056|NCT03358290|541469433|FG002|Overall Study|Adverse Event|1|||
150090057|NCT03358290|541469434|FG003|Overall Study|Adverse Event|2|||
150090058|NCT03358290|541469435|FG004|Overall Study|Adverse Event|0|||
150090059|NCT03358290|541469431|FG000|Overall Study|Withdrawal by Subject|0|||
150090060|NCT03358290|541469432|FG001|Overall Study|Withdrawal by Subject|0|||
150090061|NCT03358290|541469433|FG002|Overall Study|Withdrawal by Subject|0|||
150090062|NCT03358290|541469434|FG003|Overall Study|Withdrawal by Subject|0|||
150090063|NCT03358290|541469435|FG004|Overall Study|Withdrawal by Subject|1|||
150090064|NCT00203996|541469436|FG000|Overall Study|Lost to Follow-up|0|||
150090065|NCT00203996|541469437|FG001|Overall Study|Lost to Follow-up|0|||
150090066|NCT00203996|541469438|FG002|Overall Study|Lost to Follow-up|0|||
150090067|NCT00203996|541469439|FG003|Overall Study|Lost to Follow-up|1|||
150090068|NCT00203996|541469440|FG004|Overall Study|Lost to Follow-up|0|||
150090069|NCT00203996|541469441|FG005|Overall Study|Lost to Follow-up|0|||
150090070|NCT00203996|541469442|FG006|Overall Study|Lost to Follow-up|0|||
150090071|NCT00203996|541469443|FG007|Overall Study|Lost to Follow-up|0|||
150090072|NCT00203996|541469444|FG008|Overall Study|Lost to Follow-up|0|||
150090073|NCT00203996|541469445|FG009|Overall Study|Lost to Follow-up|0|||
150090074|NCT00203996|541469436|FG000|Overall Study|Protocol Violation|0|||
150090075|NCT00203996|541469437|FG001|Overall Study|Protocol Violation|0|||
150090076|NCT00203996|541469438|FG002|Overall Study|Protocol Violation|0|||
150090077|NCT00203996|541469439|FG003|Overall Study|Protocol Violation|6|||
150090078|NCT00203996|541469440|FG004|Overall Study|Protocol Violation|1|||
150090079|NCT00203996|541469441|FG005|Overall Study|Protocol Violation|0|||
150090080|NCT00203996|541469442|FG006|Overall Study|Protocol Violation|0|||
150090081|NCT00203996|541469443|FG007|Overall Study|Protocol Violation|0|||
150090082|NCT00203996|541469444|FG008|Overall Study|Protocol Violation|0|||
150090083|NCT00203996|541469445|FG009|Overall Study|Protocol Violation|0|||
150090084|NCT00203996|541469436|FG000|Overall Study|Physician Decision|0|||
150090085|NCT00203996|541469437|FG001|Overall Study|Physician Decision|0|||
150090086|NCT00203996|541469438|FG002|Overall Study|Physician Decision|0|||
150090087|NCT00203996|541469439|FG003|Overall Study|Physician Decision|2|||
150090088|NCT00203996|541469440|FG004|Overall Study|Physician Decision|0|||
150090089|NCT00203996|541469441|FG005|Overall Study|Physician Decision|0|||
150090090|NCT00203996|541469442|FG006|Overall Study|Physician Decision|0|||
150090091|NCT00203996|541469443|FG007|Overall Study|Physician Decision|0|||
150090092|NCT00203996|541469444|FG008|Overall Study|Physician Decision|0|||
150090093|NCT00203996|541469445|FG009|Overall Study|Physician Decision|1|||
150090094|NCT00203996|541469436|FG000|Overall Study|CPAP machine malfunction|0|||
150090095|NCT00203996|541469437|FG001|Overall Study|CPAP machine malfunction|0|||
150090096|NCT00203996|541469438|FG002|Overall Study|CPAP machine malfunction|0|||
150090097|NCT00203996|541469439|FG003|Overall Study|CPAP machine malfunction|1|||
150090098|NCT00203996|541469440|FG004|Overall Study|CPAP machine malfunction|0|||
150090099|NCT00203996|541469441|FG005|Overall Study|CPAP machine malfunction|0|||
150090100|NCT00203996|541469442|FG006|Overall Study|CPAP machine malfunction|0|||
150090101|NCT00203996|541469443|FG007|Overall Study|CPAP machine malfunction|0|||
150090102|NCT00203996|541469444|FG008|Overall Study|CPAP machine malfunction|0|||
150090103|NCT00203996|541469445|FG009|Overall Study|CPAP machine malfunction|0|||
150090104|NCT00203996|541469436|FG000|Overall Study|Scheduling issue|0|||
150090105|NCT00203996|541469437|FG001|Overall Study|Scheduling issue|0|||
150090106|NCT00203996|541469438|FG002|Overall Study|Scheduling issue|0|||
150090107|NCT00203996|541469439|FG003|Overall Study|Scheduling issue|0|||
150090108|NCT00203996|541469440|FG004|Overall Study|Scheduling issue|0|||
150090109|NCT00203996|541469441|FG005|Overall Study|Scheduling issue|0|||
150090110|NCT00203996|541469442|FG006|Overall Study|Scheduling issue|0|||
150090111|NCT00203996|541469443|FG007|Overall Study|Scheduling issue|2|||
150090112|NCT00203996|541469444|FG008|Overall Study|Scheduling issue|0|||
150090113|NCT00203996|541469445|FG009|Overall Study|Scheduling issue|0|||
150090114|NCT00897104|541469446|FG000|Overall Study|Lost to Follow-up|12|||
150090115|NCT00897104|541469447|FG001|Overall Study|Lost to Follow-up|17|||
150090116|NCT00897104|541469448|FG002|Overall Study|Lost to Follow-up|2|||
150090117|NCT00897104|541469446|FG000|Overall Study|Pregnancy|0|||
150090118|NCT00897104|541469447|FG001|Overall Study|Pregnancy|1|||
150090119|NCT00897104|541469448|FG002|Overall Study|Pregnancy|0|||
150090120|NCT00897104|541469446|FG000|Overall Study|Protocol Violation|0|||
150090121|NCT00897104|541469447|FG001|Overall Study|Protocol Violation|1|||
150090122|NCT00897104|541469448|FG002|Overall Study|Protocol Violation|0|||
150090123|NCT00897104|541469446|FG000|Overall Study|Withdrawal by Subject|23|||
150090124|NCT00897104|541469447|FG001|Overall Study|Withdrawal by Subject|27|||
150090125|NCT00897104|541469448|FG002|Overall Study|Withdrawal by Subject|3|||
150090126|NCT00897104|541469446|FG000|Overall Study|Abnormal Prestudy Labs|2|||
150090127|NCT00897104|541469447|FG001|Overall Study|Abnormal Prestudy Labs|0|||
150090128|NCT00897104|541469448|FG002|Overall Study|Abnormal Prestudy Labs|0|||
150090129|NCT00897104|541469446|FG000|Overall Study|Abnormal Baseline ECG|2|||
150090130|NCT00897104|541469447|FG001|Overall Study|Abnormal Baseline ECG|2|||
150090131|NCT00897104|541469448|FG002|Overall Study|Abnormal Baseline ECG|0|||
150090132|NCT00897104|541469446|FG000|Overall Study|Need for Concom. Med.|0|||
150090133|NCT00897104|541469447|FG001|Overall Study|Need for Concom. Med.|1|||
150090134|NCT00897104|541469448|FG002|Overall Study|Need for Concom. Med.|1|||
150090135|NCT00897104|541469446|FG000|Overall Study|Lack of Migraine Attack|20|||
150090136|NCT00897104|541469447|FG001|Overall Study|Lack of Migraine Attack|22|||
150090137|NCT00897104|541469448|FG002|Overall Study|Lack of Migraine Attack|1|||
150090138|NCT00897104|541469446|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
150090139|NCT00897104|541469447|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150090140|NCT00897104|541469448|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150090141|NCT00897104|541469446|FG000|Overall Study|Other|3|||
150090142|NCT00897104|541469447|FG001|Overall Study|Other|0|||
150090143|NCT00897104|541469448|FG002|Overall Study|Other|0|||
150090144|NCT00897104|541469446|FG000|Overall Study|Protocol Violation|1|||
150090145|NCT00897104|541469447|FG001|Overall Study|Protocol Violation|0|||
150090146|NCT00897104|541469448|FG002|Overall Study|Protocol Violation|0|||
150090147|NCT00897104|541469446|FG000|Overall Study|Withdrawal by Subject|0|||
150090148|NCT00897104|541469447|FG001|Overall Study|Withdrawal by Subject|0|||
150090149|NCT00897104|541469448|FG002|Overall Study|Withdrawal by Subject|1|||
150090150|NCT03789318|541469451|FG000|Overall Study|Adverse Event|0|||
150090151|NCT03789318|541469452|FG001|Overall Study|Adverse Event|0|||
150090152|NCT03789318|541469453|FG002|Overall Study|Adverse Event|1|||
150090153|NCT03789318|541469454|FG003|Overall Study|Adverse Event|1|||
150090154|NCT03789318|541469455|FG004|Overall Study|Adverse Event|0|||
150090155|NCT03789318|541469451|FG000|Overall Study|Lost to Follow-up|0|||
150090156|NCT03789318|541469452|FG001|Overall Study|Lost to Follow-up|0|||
150090157|NCT03789318|541469453|FG002|Overall Study|Lost to Follow-up|1|||
150090158|NCT03789318|541469454|FG003|Overall Study|Lost to Follow-up|0|||
150090159|NCT03789318|541469455|FG004|Overall Study|Lost to Follow-up|0|||
150090160|NCT03789318|541469451|FG000|Overall Study|Withdrawal by Subject|0|||
150090161|NCT03789318|541469452|FG001|Overall Study|Withdrawal by Subject|0|||
150090162|NCT03789318|541469453|FG002|Overall Study|Withdrawal by Subject|1|||
150090163|NCT03789318|541469454|FG003|Overall Study|Withdrawal by Subject|0|||
150090164|NCT03789318|541469455|FG004|Overall Study|Withdrawal by Subject|0|||
150090165|NCT01937559|541469456|FG000|Overall Study|Physician Decision|3|||
150090166|NCT01937559|541469457|FG001|Overall Study|Physician Decision|3|||
150090167|NCT01937559|541469458|FG002|Overall Study|Physician Decision|0|||
150090168|NCT01937559|541469456|FG000|Overall Study|Withdrawal by Subject|6|||
150090169|NCT01937559|541469457|FG001|Overall Study|Withdrawal by Subject|4|||
150090170|NCT01937559|541469458|FG002|Overall Study|Withdrawal by Subject|0|||
150090171|NCT01937559|541469456|FG000|Overall Study|screen fail|2|||
150090172|NCT01937559|541469457|FG001|Overall Study|screen fail|4|||
150090173|NCT01937559|541469458|FG002|Overall Study|screen fail|0|||
150090174|NCT04818840|541469459|FG000|Overall Study|Lost to Follow-up|0|||
150090175|NCT04818840|541469460|FG001|Overall Study|Lost to Follow-up|5|||
150090176|NCT04818840|541469459|FG000|Overall Study|Physician Decision|1|||
150090177|NCT04818840|541469460|FG001|Overall Study|Physician Decision|0|||
150090178|NCT04818840|541469459|FG000|Overall Study|Site Terminated by Sponsor|0|||
150090179|NCT04818840|541469460|FG001|Overall Study|Site Terminated by Sponsor|3|||
150090180|NCT04818840|541469459|FG000|Overall Study|Study Terminated by Sponsor|43|||
150090181|NCT04818840|541469460|FG001|Overall Study|Study Terminated by Sponsor|7|||
150090182|NCT04818840|541469459|FG000|Overall Study|Withdrawal by Subject|0|||
150090183|NCT04818840|541469460|FG001|Overall Study|Withdrawal by Subject|1|||
150090184|NCT00407563|541471375|FG000|Overall Study|Patient continues on treatment|1|||
150090185|NCT05040386|541471376|FG000|Overall Study|Withdrawal by Subject|1|||
150090186|NCT05040386|541471377|FG001|Overall Study|Withdrawal by Subject|0|||
150090187|NCT05040386|541471378|FG002|Overall Study|Withdrawal by Subject|1|||
150090188|NCT05040386|541471379|FG003|Overall Study|Withdrawal by Subject|0|||
150090189|NCT05040386|541471376|FG000|Overall Study|Lost to Follow-up|0|||
150090190|NCT05040386|541471377|FG001|Overall Study|Lost to Follow-up|0|||
150090191|NCT05040386|541471378|FG002|Overall Study|Lost to Follow-up|1|||
150090192|NCT05040386|541471379|FG003|Overall Study|Lost to Follow-up|0|||
150090193|NCT00386776|541471385|FG000|Overall Study|Withdrawal by Subject|8|||
150090194|NCT00588848|541471386|FG000|Overall Study|Physician Decision|0|||
150090195|NCT00588848|541471387|FG001|Overall Study|Physician Decision|3|||
150090196|NCT00412854|541471388|FG000|Overall Study|Withdrawn due to adverse events|1|||
150090197|NCT00412854|541471389|FG001|Overall Study|Withdrawn due to adverse events|5|||
150090198|NCT00412854|541471388|FG000|Overall Study|Withdrawn for other reasons|13|||
150090199|NCT00412854|541471389|FG001|Overall Study|Withdrawn for other reasons|11|||
150090200|NCT01484873|541471390|FG000|Overall Study|Withdrawal by Subject|2|||
150090201|NCT00311623|541471391|FG000|Overall Study|Physician Decision|0|||
150090202|NCT00311623|541471392|FG001|Overall Study|Physician Decision|0|||
150090203|NCT00311623|541471393|FG002|Overall Study|Physician Decision|2|||
150090204|NCT03414424|541471394|FG000|Overall Study|Screened out after consent|0|||
150090205|NCT03414424|541471395|FG001|Overall Study|Screened out after consent|2|||
150090206|NCT03414424|541471394|FG000|Overall Study|Lost to Follow-up|0|||
150090207|NCT03414424|541471395|FG001|Overall Study|Lost to Follow-up|1|||
150090208|NCT01083576|541471397|FG000|Overall Study|Treatment Failure|6|||
150090209|NCT01083576|541471398|FG001|Overall Study|Treatment Failure|1|||
150090210|NCT03527966|541471399|FG000|Overall Study|Lost to Follow-up|3|||
150090211|NCT03527966|541471400|FG001|Overall Study|Lost to Follow-up|0|||
150090212|NCT01948050|541471401|FG000|Overall Study|Withdrawal by Subject|0|||
150090213|NCT01948050|541471402|FG001|Overall Study|Withdrawal by Subject|1|||
150090214|NCT00558025|541471403|FG000|Overall Study|Adverse Event|1|||
150090215|NCT00558025|541471404|FG001|Overall Study|Adverse Event|1|||
150090216|NCT00558025|541471403|FG000|Overall Study|Withdrawal by Subject|2|||
150090217|NCT00558025|541471404|FG001|Overall Study|Withdrawal by Subject|2|||
150090218|NCT00558025|541471403|FG000|Overall Study|Protocol Violation|1|||
150090219|NCT00558025|541471404|FG001|Overall Study|Protocol Violation|0|||
150090220|NCT02288559|541471405|FG000|Overall Study|Adverse Event|1|||
150090221|NCT02288559|541471406|FG001|Overall Study|Adverse Event|1|||
150090222|NCT02288559|541471407|FG002|Overall Study|Adverse Event|5|||
150090223|NCT02288559|541471408|FG003|Overall Study|Adverse Event|0|||
150090224|NCT02288559|541471405|FG000|Overall Study|Death|0|||
150090225|NCT02288559|541471406|FG001|Overall Study|Death|0|||
150090226|NCT02288559|541471407|FG002|Overall Study|Death|1|||
150090227|NCT02288559|541471408|FG003|Overall Study|Death|0|||
150090228|NCT02288559|541471405|FG000|Overall Study|Lost to Follow-up|0|||
150090229|NCT02288559|541471406|FG001|Overall Study|Lost to Follow-up|0|||
150090230|NCT02288559|541471407|FG002|Overall Study|Lost to Follow-up|0|||
150090231|NCT02288559|541471408|FG003|Overall Study|Lost to Follow-up|1|||
150090232|NCT02288559|541471405|FG000|Overall Study|Withdrawal by Subject|0|||
150090233|NCT02288559|541471406|FG001|Overall Study|Withdrawal by Subject|0|||
150090234|NCT02288559|541471407|FG002|Overall Study|Withdrawal by Subject|2|||
150090235|NCT02288559|541471408|FG003|Overall Study|Withdrawal by Subject|1|||
150090236|NCT02288559|541471405|FG000|Overall Study|Reason Not Specified|0|||
150090237|NCT02288559|541471406|FG001|Overall Study|Reason Not Specified|0|||
150090238|NCT02288559|541471407|FG002|Overall Study|Reason Not Specified|3|||
150090239|NCT02288559|541471408|FG003|Overall Study|Reason Not Specified|0|||
150090240|NCT00449540|541471409|FG000|Pretreatment Phase|No migraine experienced|66|||
150090241|NCT00449540|541471410|FG001|Pretreatment Phase|No migraine experienced|0|||
150090242|NCT00449540|541471411|FG002|Pretreatment Phase|No migraine experienced|0|||
150090243|NCT00449540|541471409|FG000|Treatment Phase|did not experience or treat migraine|0|||
150090244|NCT00449540|541471410|FG001|Treatment Phase|did not experience or treat migraine|20|||
150090245|NCT00449540|541471411|FG002|Treatment Phase|did not experience or treat migraine|17|||
150090246|NCT01881776|541471414|FG000|Overall Study|Lost to Follow-up|1|||
150090247|NCT01881776|541471415|FG001|Overall Study|Lost to Follow-up|2|||
150090248|NCT01881776|541471416|FG002|Overall Study|Lost to Follow-up|1|||
150090249|NCT01881776|541471414|FG000|Overall Study|Protocol Violation|0|||
150090250|NCT01881776|541471415|FG001|Overall Study|Protocol Violation|2|||
150090251|NCT01881776|541471416|FG002|Overall Study|Protocol Violation|1|||
150090252|NCT00333866|541471417|FG000|Overall Study|Adverse Event|23|||
150090253|NCT00333866|541471418|FG001|Overall Study|Adverse Event|37|||
150090254|NCT00333866|541471419|FG002|Overall Study|Adverse Event|38|||
150090255|NCT00333866|541471420|FG003|Overall Study|Adverse Event|47|||
150090256|NCT00333866|541471417|FG000|Overall Study|Other|3|||
150090257|NCT00333866|541471418|FG001|Overall Study|Other|2|||
150090258|NCT00333866|541471419|FG002|Overall Study|Other|2|||
150090259|NCT00333866|541471420|FG003|Overall Study|Other|2|||
150090260|NCT00333866|541471417|FG000|Overall Study|Lack of Efficacy|8|||
150090261|NCT00333866|541471418|FG001|Overall Study|Lack of Efficacy|6|||
150090262|NCT00333866|541471419|FG002|Overall Study|Lack of Efficacy|3|||
150090263|NCT00333866|541471420|FG003|Overall Study|Lack of Efficacy|5|||
150090264|NCT00333866|541471417|FG000|Overall Study|Lost to Follow-up|1|||
150090265|NCT00333866|541471418|FG001|Overall Study|Lost to Follow-up|2|||
150090266|NCT00333866|541471419|FG002|Overall Study|Lost to Follow-up|2|||
150090267|NCT00333866|541471420|FG003|Overall Study|Lost to Follow-up|2|||
150090268|NCT00333866|541471417|FG000|Overall Study|Withdrawal by Subject|8|||
150090269|NCT00333866|541471418|FG001|Overall Study|Withdrawal by Subject|14|||
150090270|NCT00333866|541471419|FG002|Overall Study|Withdrawal by Subject|4|||
150090271|NCT00333866|541471420|FG003|Overall Study|Withdrawal by Subject|9|||
150090272|NCT00333866|541471417|FG000|Overall Study|Randomized but not Treated|5|||
150090273|NCT00333866|541471418|FG001|Overall Study|Randomized but not Treated|3|||
150090274|NCT00333866|541471419|FG002|Overall Study|Randomized but not Treated|2|||
150090275|NCT00333866|541471420|FG003|Overall Study|Randomized but not Treated|1|||
150090276|NCT06073119|541471421|FG000|Overall Study|Adverse Event|1|||
150090277|NCT06073119|541471422|FG001|Overall Study|Adverse Event|3|||
150090278|NCT06073119|541471423|FG002|Overall Study|Adverse Event|0|||
150090279|NCT06073119|541471424|FG003|Overall Study|Adverse Event|0|||
150090280|NCT06073119|541471425|FG004|Overall Study|Adverse Event|1|||
150090281|NCT06073119|541471426|FG005|Overall Study|Adverse Event|0|||
150090282|NCT06073119|541471421|FG000|Overall Study|Non-compliance with study schedule|1|||
150090283|NCT06073119|541471422|FG001|Overall Study|Non-compliance with study schedule|0|||
150090284|NCT06073119|541471423|FG002|Overall Study|Non-compliance with study schedule|0|||
150090285|NCT06073119|541471424|FG003|Overall Study|Non-compliance with study schedule|0|||
150090286|NCT06073119|541471425|FG004|Overall Study|Non-compliance with study schedule|1|||
150090287|NCT06073119|541471426|FG005|Overall Study|Non-compliance with study schedule|0|||
150090288|NCT06073119|541471421|FG000|Overall Study|Withdrawal by Subject|4|||
150090289|NCT06073119|541471422|FG001|Overall Study|Withdrawal by Subject|4|||
150090290|NCT06073119|541471423|FG002|Overall Study|Withdrawal by Subject|3|||
150090291|NCT06073119|541471424|FG003|Overall Study|Withdrawal by Subject|5|||
150090292|NCT06073119|541471425|FG004|Overall Study|Withdrawal by Subject|3|||
150090293|NCT06073119|541471426|FG005|Overall Study|Withdrawal by Subject|1|||
150090294|NCT06073119|541471421|FG000|Overall Study|Other|2|||
150090295|NCT06073119|541471422|FG001|Overall Study|Other|4|||
150090296|NCT06073119|541471423|FG002|Overall Study|Other|1|||
150090297|NCT06073119|541471424|FG003|Overall Study|Other|0|||
150090298|NCT06073119|541471425|FG004|Overall Study|Other|1|||
150090299|NCT06073119|541471426|FG005|Overall Study|Other|0|||
150090300|NCT02036294|541471427|FG000|Overall Study|Death|7|||
150090301|NCT02036294|541471428|FG001|Overall Study|Death|8|||
150090302|NCT02036294|541471427|FG000|Overall Study|Withdrawal by Subject|2|||
150090303|NCT02036294|541471428|FG001|Overall Study|Withdrawal by Subject|3|||
150090304|NCT02393547|541471429|FG000|Overall Study|Adverse Event|2|||
150090305|NCT02393547|541471429|FG000|Overall Study|Withdrawal by Subject|3|||
150090306|NCT02393547|541471429|FG000|Overall Study|Lost to Follow-up|1|||
150090307|NCT05185089|541471430|FG000|First Intervention (4 weeks)|Adverse Event|0|||
150090308|NCT05185089|541471431|FG001|First Intervention (4 weeks)|Adverse Event|0|||
150090309|NCT05185089|541471432|FG002|First Intervention (4 weeks)|Adverse Event|0|||
150090310|NCT05185089|541471433|FG003|First Intervention (4 weeks)|Adverse Event|1|||
150090311|NCT05185089|541471430|FG000|Second Intervention (4 weeks)|Death|0|||
150090312|NCT05185089|541471431|FG001|Second Intervention (4 weeks)|Death|1|||
150090313|NCT05185089|541471432|FG002|Second Intervention (4 weeks)|Death|0|||
150090314|NCT05185089|541471433|FG003|Second Intervention (4 weeks)|Death|0|||
150090315|NCT05185089|541471430|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
150090316|NCT05185089|541471431|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
150090317|NCT05185089|541471432|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
150090318|NCT05185089|541471433|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
150090319|NCT04997161|541471438|FG000|Overall Study|Study terminated by sponsor|3|||
150090320|NCT01408914|541471442|FG000|Overall Study|Could not complete tx in protocol period|5|||
150090321|NCT01408914|541471443|FG001|Overall Study|Could not complete tx in protocol period|5|||
150090322|NCT01408914|541471444|FG002|Overall Study|Could not complete tx in protocol period|6|||
150090323|NCT01408914|541471442|FG000|Overall Study|Lost to Follow-up|4|||
150090324|NCT01408914|541471443|FG001|Overall Study|Lost to Follow-up|1|||
150090325|NCT01408914|541471444|FG002|Overall Study|Lost to Follow-up|2|||
150090326|NCT01408914|541471442|FG000|Overall Study|Physician Decision|1|||
150090327|NCT01408914|541471443|FG001|Overall Study|Physician Decision|1|||
150090328|NCT01408914|541471444|FG002|Overall Study|Physician Decision|0|||
150090329|NCT01408914|541471442|FG000|Overall Study|Withdrawal by Subject|1|||
150090330|NCT01408914|541471443|FG001|Overall Study|Withdrawal by Subject|0|||
150090331|NCT01408914|541471444|FG002|Overall Study|Withdrawal by Subject|1|||
150090332|NCT01408914|541471442|FG000|Overall Study|Moved out of study jurisdiction|1|||
150090333|NCT01408914|541471443|FG001|Overall Study|Moved out of study jurisdiction|1|||
150090334|NCT01408914|541471444|FG002|Overall Study|Moved out of study jurisdiction|0|||
150184283|NCT03517969|541813317|FG001|Overall Study|Withdrawal by Subject|2|||
150184284|NCT03517969|541813316|FG000|Overall Study|Physician Decision|1|||
150184285|NCT03517969|541813317|FG001|Overall Study|Physician Decision|1|||
150184286|NCT03517969|541813316|FG000|Overall Study|No clinical benefit|1|||
150184287|NCT03517969|541813317|FG001|Overall Study|No clinical benefit|0|||
150184288|NCT03517969|541813316|FG000|Overall Study|Delayed treatment for dental treatment|1|||
150184289|NCT03517969|541813317|FG001|Overall Study|Delayed treatment for dental treatment|0|||
150184290|NCT03517969|541813316|FG000|Overall Study|Difficult to maintain appointment|0|||
150184291|NCT03517969|541813317|FG001|Overall Study|Difficult to maintain appointment|1|||
150184292|NCT03517969|541813316|FG000|Overall Study|Protocol Violation|0|||
150184293|NCT03517969|541813317|FG001|Overall Study|Protocol Violation|1|||
150184294|NCT02860130|541813318|FG000|Overall Study|Adverse Event|2|||
150184295|NCT02860130|541813319|FG001|Overall Study|Adverse Event|3|||
150184296|NCT02860130|541813318|FG000|Overall Study|Protocol Violation|1|||
150090335|NCT01408914|541471442|FG000|Overall Study|Late exclusion|0|||
150090336|NCT01408914|541471443|FG001|Overall Study|Late exclusion|3|||
150090337|NCT01408914|541471444|FG002|Overall Study|Late exclusion|3|||
150090338|NCT01408914|541471442|FG000|Overall Study|Change in local TB/HIV norms|0|||
150090339|NCT01408914|541471443|FG001|Overall Study|Change in local TB/HIV norms|1|||
150090340|NCT01408914|541471444|FG002|Overall Study|Change in local TB/HIV norms|1|||
150090341|NCT06112756|541471449|FG000|Overall Study|Withdrawal by Subject|0|||
150090342|NCT06112756|541471450|FG001|Overall Study|Withdrawal by Subject|2|||
150090343|NCT06112756|541471449|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
150090344|NCT06112756|541471450|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
150090345|NCT06112756|541471449|FG000|Overall Study|Adverse Event|2|||
150090346|NCT06112756|541471450|FG001|Overall Study|Adverse Event|2|||
150090347|NCT04551092|541471451|FG000|Overall Study|Lost to Follow-up|7|||
150090348|NCT04551092|541471451|FG000|Overall Study|Withdrawal by Subject|4|||
150090349|NCT01712490|541471452|FG000|Overall Study|Ongoing|601|||
150090350|NCT01712490|541471453|FG001|Overall Study|Ongoing|586|||
150090351|NCT01712490|541471452|FG000|Overall Study|Other|11|||
150090352|NCT01712490|541471453|FG001|Overall Study|Other|11|||
150090353|NCT01712490|541471452|FG000|Overall Study|Withdrawal by Subject|36|||
150090354|NCT01712490|541471453|FG001|Overall Study|Withdrawal by Subject|44|||
150090355|NCT01712490|541471452|FG000|Overall Study|Lost to Follow-up|16|||
150090356|NCT01712490|541471453|FG001|Overall Study|Lost to Follow-up|29|||
150090357|NCT03060629|541471458|FG000|Overall Study|Death|4|||
150090358|NCT03060629|541471459|FG001|Overall Study|Death|5|||
150090359|NCT03060629|541471458|FG000|Overall Study|Withdrawal by Subject|50|||
150090360|NCT03060629|541471459|FG001|Overall Study|Withdrawal by Subject|35|||
150090361|NCT03060629|541471458|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
150090362|NCT03060629|541471459|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
150090363|NCT03060629|541471458|FG000|Overall Study|Participant Relocate|15|||
150090364|NCT03060629|541471459|FG001|Overall Study|Participant Relocate|15|||
150090365|NCT03060629|541471458|FG000|Overall Study|Unable to Contact Participant|34|||
150090366|NCT03060629|541471459|FG001|Overall Study|Unable to Contact Participant|23|||
150090367|NCT03060629|541471458|FG000|Overall Study|Investigator Decision|7|||
150090368|NCT03060629|541471459|FG001|Overall Study|Investigator Decision|7|||
150090369|NCT03060629|541471458|FG000|Overall Study|Study Terminated by Sponsor|1100|||
150090370|NCT03060629|541471459|FG001|Overall Study|Study Terminated by Sponsor|1123|||
150090371|NCT03060629|541471458|FG000|Overall Study|Other|4|||
150090372|NCT03060629|541471459|FG001|Overall Study|Other|4|||
150090373|NCT01862874|541471460|FG000|Overall Study|Randomized not treated|1|||
150090374|NCT01862874|541471461|FG001|Overall Study|Randomized not treated|0|||
150090375|NCT01862874|541471460|FG000|Overall Study|Adverse Event|0|||
150090376|NCT01862874|541471461|FG001|Overall Study|Adverse Event|3|||
150090377|NCT01862874|541471460|FG000|Overall Study|Lost to Follow-up|26|||
150090378|NCT01862874|541471461|FG001|Overall Study|Lost to Follow-up|29|||
150090379|NCT01862874|541471460|FG000|Overall Study|Physician Decision|5|||
150090380|NCT01862874|541471461|FG001|Overall Study|Physician Decision|3|||
150090381|NCT01862874|541471460|FG000|Overall Study|Withdrawn by parent/guardian|1|||
150090382|NCT01862874|541471461|FG001|Overall Study|Withdrawn by parent/guardian|1|||
150090383|NCT01862874|541471460|FG000|Overall Study|Withdrawal by Subject|46|||
150090384|NCT01862874|541471461|FG001|Overall Study|Withdrawal by Subject|40|||
150184297|NCT02860130|541813319|FG001|Overall Study|Protocol Violation|1|||
150184298|NCT02860130|541813318|FG000|Overall Study|Withdrawal by Subject|0|||
150184299|NCT02860130|541813319|FG001|Overall Study|Withdrawal by Subject|2|||
150090385|NCT01862874|541471460|FG000|Overall Study|Death|0|||
150090386|NCT01862874|541471461|FG001|Overall Study|Death|1|||
150090387|NCT01129960|541471466|FG000|Overall Study|Withdrawal by Subject|3|||
150090388|NCT01129960|541471467|FG001|Overall Study|Withdrawal by Subject|0|||
150090389|NCT01129960|541471468|FG002|Overall Study|Withdrawal by Subject|3|||
150090390|NCT01129960|541471469|FG003|Overall Study|Withdrawal by Subject|2|||
150184300|NCT02860130|541813318|FG000|Overall Study|Physician Decision|2|||
150184301|NCT02860130|541813319|FG001|Overall Study|Physician Decision|2|||
150184302|NCT02860130|541813318|FG000|Overall Study|Other|2|||
150090391|NCT01129960|541471466|FG000|Overall Study|Lack of Efficacy|1|||
150090392|NCT01129960|541471467|FG001|Overall Study|Lack of Efficacy|1|||
150090393|NCT01129960|541471468|FG002|Overall Study|Lack of Efficacy|1|||
150090394|NCT01129960|541471469|FG003|Overall Study|Lack of Efficacy|1|||
150090395|NCT01129960|541471466|FG000|Overall Study|Adverse Event|23|||
150090396|NCT01129960|541471467|FG001|Overall Study|Adverse Event|16|||
150090397|NCT01129960|541471468|FG002|Overall Study|Adverse Event|16|||
150090398|NCT01129960|541471469|FG003|Overall Study|Adverse Event|7|||
150090399|NCT01129960|541471466|FG000|Overall Study|Protocol Violation|1|||
150090400|NCT01129960|541471467|FG001|Overall Study|Protocol Violation|2|||
150090401|NCT01129960|541471468|FG002|Overall Study|Protocol Violation|3|||
150090402|NCT01129960|541471469|FG003|Overall Study|Protocol Violation|0|||
150090403|NCT01129960|541471466|FG000|Overall Study|Lost to Follow-up|0|||
150090404|NCT01129960|541471467|FG001|Overall Study|Lost to Follow-up|2|||
150090405|NCT01129960|541471468|FG002|Overall Study|Lost to Follow-up|3|||
150090406|NCT01129960|541471469|FG003|Overall Study|Lost to Follow-up|3|||
150090407|NCT01129960|541471466|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
150090408|NCT01129960|541471467|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
150090409|NCT01129960|541471468|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
150090410|NCT01129960|541471469|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
150090411|NCT01129960|541471466|FG000|Overall Study|Physician Decision|1|||
150090412|NCT01129960|541471467|FG001|Overall Study|Physician Decision|0|||
150090413|NCT01129960|541471468|FG002|Overall Study|Physician Decision|0|||
150090414|NCT01129960|541471469|FG003|Overall Study|Physician Decision|0|||
150090415|NCT01129960|541471466|FG000|Overall Study|Pregnancy|1|||
150090416|NCT01129960|541471467|FG001|Overall Study|Pregnancy|0|||
150090417|NCT01129960|541471468|FG002|Overall Study|Pregnancy|0|||
150090418|NCT01129960|541471469|FG003|Overall Study|Pregnancy|0|||
150090419|NCT03672747|541471470|FG000|Overall Study|Lost to Follow-up|1|||
150090420|NCT03672747|541471471|FG001|Overall Study|Lost to Follow-up|1|||
150090421|NCT03672747|541471472|FG002|Overall Study|Lost to Follow-up|2|||
150090422|NCT03672747|541471473|FG003|Overall Study|Lost to Follow-up|2|||
150090423|NCT03672747|541471474|FG004|Overall Study|Lost to Follow-up|2|||
150090424|NCT03672747|541471475|FG005|Overall Study|Lost to Follow-up|1|||
150090425|NCT03198234|541471476|FG000|Overall Study|Relapse of primary disease|0|||
150090426|NCT03198234|541471477|FG001|Overall Study|Relapse of primary disease|1|||
150090427|NCT03198234|541471478|FG002|Overall Study|Relapse of primary disease|0|||
150090428|NCT04285879|541471479|FG000|Overall Study|Lost to Follow-up|1|||
150090429|NCT04285879|541471480|FG001|Overall Study|Lost to Follow-up|8|||
150090430|NCT04285879|541471479|FG000|Overall Study|medical/surgical exclusion|16|||
150090431|NCT04285879|541471480|FG001|Overall Study|medical/surgical exclusion|0|||
150090432|NCT03228537|541471485|FG000|Neoadjuvant|Adverse Event|2|||
150090433|NCT03228537|541471485|FG000|Neoadjuvant|Progression/Relapse|4|||
150090434|NCT03228537|541471485|FG000|Neoadjuvant|Death|1|||
150090435|NCT03228537|541471485|FG000|Surgery|Death|1|||
150090436|NCT03228537|541471485|FG000|Surgery|Other - Not Protocol Specified|2|||
150090437|NCT03228537|541471485|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
150090438|NCT03228537|541471485|FG000|Maintenance|Progression/Relapse|10|||
150090439|NCT01927367|541471486|FG000|Overall Study|Withdrawal by Subject|7|||
150090440|NCT01927367|541471487|FG001|Overall Study|Withdrawal by Subject|4|||
150090441|NCT01927367|541471486|FG000|Overall Study|No baseline data|0|||
150090442|NCT01927367|541471487|FG001|Overall Study|No baseline data|1|||
150090443|NCT00071513|541471490|FG000|Intervention Component|Withdrawal by Subject|2|||
150090444|NCT00071513|541471491|FG001|Intervention Component|Withdrawal by Subject|3|||
150090445|NCT00071513|541471490|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
150090446|NCT00071513|541471491|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
150090447|NCT02622321|541471492|FG000|Overall Study|Withdrawal by Subject|2|||
150090448|NCT02622321|541471493|FG001|Overall Study|Withdrawal by Subject|0|||
150090449|NCT02622321|541471494|FG002|Overall Study|Withdrawal by Subject|0|||
150090450|NCT02622321|541471495|FG003|Overall Study|Withdrawal by Subject|0|||
150090451|NCT02622321|541471492|FG000|Overall Study|Death|0|||
150090452|NCT02622321|541471493|FG001|Overall Study|Death|0|||
150090453|NCT02622321|541471494|FG002|Overall Study|Death|1|||
150090454|NCT02622321|541471495|FG003|Overall Study|Death|0|||
150090455|NCT02622321|541471492|FG000|Overall Study|Physician Decision|1|||
150090456|NCT02622321|541471493|FG001|Overall Study|Physician Decision|0|||
150090457|NCT02622321|541471494|FG002|Overall Study|Physician Decision|0|||
150090458|NCT02622321|541471495|FG003|Overall Study|Physician Decision|0|||
150090459|NCT00965718|541471498|FG000|Overall Study|Withdrawal by Subject|4|||
150090460|NCT00241280|541471500|FG000|Overall Study|Adverse Event|2|||
150090461|NCT00241280|541471501|FG001|Overall Study|Adverse Event|6|||
150090462|NCT00241280|541471500|FG000|Overall Study|Discomfort|11|||
150090463|NCT00241280|541471501|FG001|Overall Study|Discomfort|16|||
150090464|NCT00241280|541471500|FG000|Overall Study|Pregnancy|1|||
150090465|NCT00241280|541471501|FG001|Overall Study|Pregnancy|5|||
150090466|NCT00241280|541471500|FG000|Overall Study|Lost to Follow-up|5|||
150090467|NCT00241280|541471501|FG001|Overall Study|Lost to Follow-up|8|||
150184303|NCT02860130|541813319|FG001|Overall Study|Other|1|||
150090468|NCT00241280|541471500|FG000|Overall Study|Withdrawal by Subject|7|||
150090469|NCT00241280|541471501|FG001|Overall Study|Withdrawal by Subject|4|||
150090470|NCT00241280|541471500|FG000|Overall Study|Protocol Violation|4|||
150090471|NCT00241280|541471501|FG001|Overall Study|Protocol Violation|10|||
150090472|NCT00241280|541471500|FG000|Overall Study|Relocation|4|||
150090473|NCT00241280|541471501|FG001|Overall Study|Relocation|4|||
150090474|NCT00241280|541471500|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
150184304|NCT02140645|541813322|FG000|Overall Study|Not linked|5489|||
150090475|NCT00241280|541471501|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
150090476|NCT00241280|541471500|FG000|Overall Study|Unsatisfactory Visual Response|1|||
150090477|NCT00241280|541471501|FG001|Overall Study|Unsatisfactory Visual Response|1|||
150090478|NCT00241280|541471500|FG000|Overall Study|Diabetic|1|||
150090479|NCT00241280|541471501|FG001|Overall Study|Diabetic|0|||
150090480|NCT00241280|541471500|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
150090481|NCT00241280|541471501|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
150090482|NCT00241280|541471500|FG000|Overall Study|Dispensed incorrect test article|1|||
150090483|NCT00241280|541471501|FG001|Overall Study|Dispensed incorrect test article|2|||
150090484|NCT00241280|541471500|FG000|Overall Study|Unacceptable Fit|0|||
150090485|NCT00241280|541471501|FG001|Overall Study|Unacceptable Fit|1|||
150090486|NCT00241280|541471500|FG000|Overall Study|Scheduling Conflict|0|||
150090487|NCT00241280|541471501|FG001|Overall Study|Scheduling Conflict|2|||
150090488|NCT00241280|541471500|FG000|Overall Study|History of Ocular Surgery|0|||
150090489|NCT00241280|541471501|FG001|Overall Study|History of Ocular Surgery|1|||
150090490|NCT00241280|541471500|FG000|Overall Study|Coating on Lens|1|||
150090491|NCT00241280|541471501|FG001|Overall Study|Coating on Lens|0|||
150090492|NCT00241280|541471500|FG000|Overall Study|Excessive Dryness|0|||
150090493|NCT00241280|541471501|FG001|Overall Study|Excessive Dryness|1|||
150090494|NCT01634360|541471502|FG000|Overall Study|Adverse Event|10|||
150090495|NCT01634360|541471503|FG001|Overall Study|Adverse Event|34|||
150090496|NCT01634360|541471502|FG000|Overall Study|subject withdrew consent|13|||
150090497|NCT01634360|541471503|FG001|Overall Study|subject withdrew consent|23|||
150090498|NCT01634360|541471502|FG000|Overall Study|Protocol Violation|1|||
150090499|NCT01634360|541471503|FG001|Overall Study|Protocol Violation|1|||
150090500|NCT01634360|541471502|FG000|Overall Study|Lack of Efficacy|4|||
150090501|NCT01634360|541471503|FG001|Overall Study|Lack of Efficacy|14|||
150090502|NCT01634360|541471502|FG000|Overall Study|Other|3|||
150090503|NCT01634360|541471503|FG001|Overall Study|Other|20|||
150090504|NCT01634360|541471502|FG000|Overall Study|Study termination by sponsor|18|||
150090505|NCT01634360|541471503|FG001|Overall Study|Study termination by sponsor|44|||
150090506|NCT03667924|541471504|FG000|Baseline Completed|Lost to Follow-up|0|||
150090507|NCT03667924|541471505|FG001|Baseline Completed|Lost to Follow-up|2|||
150184305|NCT02140645|541813323|FG001|Overall Study|Not linked|61654|||
150184306|NCT02140645|541813324|FG002|Overall Study|Not linked|4236|||
150184307|NCT02140645|541813325|FG003|Overall Study|Not linked|13833|||
150184308|NCT02140645|541813326|FG004|Overall Study|Not linked|3286|||
150184309|NCT02140645|541813327|FG005|Overall Study|Not linked|70896|||
150090508|NCT03667924|541471506|FG002|Baseline Completed|Lost to Follow-up|0|||
150090509|NCT03667924|541471504|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
150090510|NCT03667924|541471505|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
150184310|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
150184311|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
150184312|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
150184313|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
150184314|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
150184315|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
150090511|NCT03667924|541471506|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
150090512|NCT03667924|541471504|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
150090513|NCT03667924|541471505|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
150090514|NCT03667924|541471506|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
150090515|NCT03667924|541471504|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
150090516|NCT03667924|541471505|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
150090517|NCT03667924|541471506|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
150090518|NCT03667924|541471504|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
150090519|NCT03667924|541471505|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
150090520|NCT03667924|541471506|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
150090521|NCT03667924|541471504|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
150184316|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
150184317|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
150090522|NCT03667924|541471505|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
150090523|NCT03667924|541471506|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
150090524|NCT03667924|541471504|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
150090525|NCT03667924|541471505|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
150090526|NCT03667924|541471506|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
150090527|NCT02260921|541471513|FG000|Overall Study|Adverse Event|1|||
150090528|NCT02260921|541471514|FG001|Overall Study|Adverse Event|0|||
150090529|NCT02260921|541471513|FG000|Overall Study|Lost to Follow-up|4|||
150090530|NCT02260921|541471514|FG001|Overall Study|Lost to Follow-up|3|||
150090531|NCT02260921|541471513|FG000|Overall Study|Withdraw Consent|4|||
150090532|NCT02260921|541471514|FG001|Overall Study|Withdraw Consent|1|||
150090533|NCT02260921|541471513|FG000|Overall Study|Death|1|||
150090534|NCT02260921|541471514|FG001|Overall Study|Death|0|||
150090535|NCT02260921|541471513|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
150090536|NCT02260921|541471514|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
150090537|NCT01244425|541471515|FG000|Overall Study|Withdrawal by Subject|2|||
150090538|NCT01244425|541471516|FG001|Overall Study|Withdrawal by Subject|2|||
150090539|NCT01244425|541471515|FG000|Overall Study|Adverse Event|1|||
150090540|NCT01244425|541471516|FG001|Overall Study|Adverse Event|1|||
150090541|NCT02743871|541471517|FG000|Overall Study|Lost to Follow-up|0|||
150090542|NCT02743871|541471518|FG001|Overall Study|Lost to Follow-up|0|||
150090543|NCT02743871|541471519|FG002|Overall Study|Lost to Follow-up|0|||
150090544|NCT02743871|541471520|FG003|Overall Study|Lost to Follow-up|1|||
150090545|NCT02743871|541471521|FG004|Overall Study|Lost to Follow-up|0|||
150090546|NCT02743871|541471522|FG005|Overall Study|Lost to Follow-up|0|||
150090547|NCT02743871|541471523|FG006|Overall Study|Lost to Follow-up|1|||
150090548|NCT02743871|541471524|FG007|Overall Study|Lost to Follow-up|0|||
150090549|NCT02743871|541471525|FG008|Overall Study|Lost to Follow-up|0|||
150090550|NCT02743871|541471526|FG009|Overall Study|Lost to Follow-up|0|||
150090551|NCT02743871|541471527|FG010|Overall Study|Lost to Follow-up|0|||
150090552|NCT02743871|541471528|FG011|Overall Study|Lost to Follow-up|2|||
150090553|NCT02743871|541471529|FG012|Overall Study|Lost to Follow-up|0|||
150090554|NCT02743871|541471530|FG013|Overall Study|Lost to Follow-up|0|||
150090555|NCT02743871|541471517|FG000|Overall Study|Withdrawal by Subject|0|||
150090556|NCT02743871|541471518|FG001|Overall Study|Withdrawal by Subject|0|||
150090557|NCT02743871|541471519|FG002|Overall Study|Withdrawal by Subject|0|||
150090558|NCT02743871|541471520|FG003|Overall Study|Withdrawal by Subject|0|||
150090559|NCT02743871|541471521|FG004|Overall Study|Withdrawal by Subject|0|||
150090560|NCT02743871|541471522|FG005|Overall Study|Withdrawal by Subject|0|||
150090561|NCT02743871|541471523|FG006|Overall Study|Withdrawal by Subject|0|||
150090562|NCT02743871|541471524|FG007|Overall Study|Withdrawal by Subject|0|||
150090563|NCT02743871|541471525|FG008|Overall Study|Withdrawal by Subject|0|||
150090564|NCT02743871|541471526|FG009|Overall Study|Withdrawal by Subject|0|||
150090565|NCT02743871|541471527|FG010|Overall Study|Withdrawal by Subject|1|||
150090566|NCT02743871|541471528|FG011|Overall Study|Withdrawal by Subject|0|||
150090567|NCT02743871|541471529|FG012|Overall Study|Withdrawal by Subject|12|||
150090568|NCT02743871|541471530|FG013|Overall Study|Withdrawal by Subject|6|||
150090569|NCT02743871|541471517|FG000|Overall Study|Adverse Event|1|||
150090570|NCT02743871|541471518|FG001|Overall Study|Adverse Event|0|||
150090571|NCT02743871|541471519|FG002|Overall Study|Adverse Event|0|||
150090572|NCT02743871|541471520|FG003|Overall Study|Adverse Event|0|||
150090573|NCT02743871|541471521|FG004|Overall Study|Adverse Event|0|||
150090574|NCT02743871|541471522|FG005|Overall Study|Adverse Event|0|||
150090575|NCT02743871|541471523|FG006|Overall Study|Adverse Event|0|||
150090576|NCT02743871|541471524|FG007|Overall Study|Adverse Event|0|||
150184318|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
150184319|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
150090577|NCT02743871|541471525|FG008|Overall Study|Adverse Event|0|||
150090578|NCT02743871|541471526|FG009|Overall Study|Adverse Event|0|||
150090579|NCT02743871|541471527|FG010|Overall Study|Adverse Event|0|||
150090580|NCT02743871|541471528|FG011|Overall Study|Adverse Event|0|||
150090581|NCT02743871|541471529|FG012|Overall Study|Adverse Event|0|||
150090582|NCT02743871|541471530|FG013|Overall Study|Adverse Event|0|||
150090583|NCT02743871|541471517|FG000|Overall Study|Other|0|||
150090584|NCT02743871|541471518|FG001|Overall Study|Other|0|||
150090585|NCT02743871|541471519|FG002|Overall Study|Other|0|||
150090586|NCT02743871|541471520|FG003|Overall Study|Other|0|||
150090587|NCT02743871|541471521|FG004|Overall Study|Other|0|||
150090588|NCT02743871|541471522|FG005|Overall Study|Other|0|||
150090589|NCT02743871|541471523|FG006|Overall Study|Other|0|||
150090590|NCT02743871|541471524|FG007|Overall Study|Other|0|||
150090591|NCT02743871|541471525|FG008|Overall Study|Other|0|||
150090592|NCT02743871|541471526|FG009|Overall Study|Other|0|||
150090593|NCT02743871|541471527|FG010|Overall Study|Other|0|||
150090594|NCT02743871|541471528|FG011|Overall Study|Other|1|||
150090595|NCT02743871|541471529|FG012|Overall Study|Other|1|||
150090596|NCT02743871|541471530|FG013|Overall Study|Other|1|||
150090597|NCT02743871|541471517|FG000|Overall Study|Protocol Violation|0|||
150090598|NCT02743871|541471518|FG001|Overall Study|Protocol Violation|0|||
150090599|NCT02743871|541471519|FG002|Overall Study|Protocol Violation|0|||
150090600|NCT02743871|541471520|FG003|Overall Study|Protocol Violation|0|||
150090601|NCT02743871|541471521|FG004|Overall Study|Protocol Violation|0|||
150090602|NCT02743871|541471522|FG005|Overall Study|Protocol Violation|0|||
150090603|NCT02743871|541471523|FG006|Overall Study|Protocol Violation|0|||
150090604|NCT02743871|541471524|FG007|Overall Study|Protocol Violation|0|||
150090605|NCT02743871|541471525|FG008|Overall Study|Protocol Violation|0|||
150090606|NCT02743871|541471526|FG009|Overall Study|Protocol Violation|0|||
150090607|NCT02743871|541471527|FG010|Overall Study|Protocol Violation|0|||
150090608|NCT02743871|541471528|FG011|Overall Study|Protocol Violation|0|||
150090609|NCT02743871|541471529|FG012|Overall Study|Protocol Violation|2|||
150090610|NCT02743871|541471530|FG013|Overall Study|Protocol Violation|0|||
150090611|NCT02484729|541471531|FG000|Overall Study|Failure of IntelliCap Error|0|||
150090612|NCT02484729|541471532|FG001|Overall Study|Failure of IntelliCap Error|0|||
150090613|NCT02484729|541471533|FG002|Overall Study|Failure of IntelliCap Error|0|||
150090614|NCT02484729|541471534|FG003|Overall Study|Failure of IntelliCap Error|0|||
150090615|NCT02484729|541471535|FG004|Overall Study|Failure of IntelliCap Error|0|||
150090616|NCT02484729|541471536|FG005|Overall Study|Failure of IntelliCap Error|0|||
150090617|NCT02484729|541471537|FG006|Overall Study|Failure of IntelliCap Error|0|||
150090618|NCT02484729|541471538|FG007|Overall Study|Failure of IntelliCap Error|0|||
150090619|NCT02484729|541471539|FG008|Overall Study|Failure of IntelliCap Error|0|||
150090620|NCT02484729|541471540|FG009|Overall Study|Failure of IntelliCap Error|1|||
150090621|NCT02480114|541471543|FG000|Overall Study|Not completing surveys|3|||
150090622|NCT02480114|541471544|FG001|Overall Study|Not completing surveys|2|||
150090623|NCT02480114|541471543|FG000|Overall Study|Withdrawal by Subject|2|||
150090624|NCT02480114|541471544|FG001|Overall Study|Withdrawal by Subject|4|||
150090625|NCT02480114|541471543|FG000|Overall Study|Disease progression|3|||
150090626|NCT02480114|541471544|FG001|Overall Study|Disease progression|0|||
150090627|NCT02480114|541471543|FG000|Overall Study|Improper completion of survey|1|||
150090628|NCT02480114|541471544|FG001|Overall Study|Improper completion of survey|1|||
150090629|NCT02480114|541471543|FG000|Overall Study|Not eligible|0|||
150090630|NCT02480114|541471544|FG001|Overall Study|Not eligible|1|||
150090631|NCT01535053|541471545|FG000|Overall Study|Ineligible|1|||
150090632|NCT01535053|541471546|FG001|Overall Study|Ineligible|2|||
150090633|NCT01031069|541471547|FG000|Overall Study|Serious Adverse Event|0|||
150090634|NCT01031069|541471548|FG001|Overall Study|Serious Adverse Event|1|||
150090635|NCT01031069|541471549|FG002|Overall Study|Serious Adverse Event|0|||
150090636|NCT01031069|541471550|FG003|Overall Study|Serious Adverse Event|0|||
150090637|NCT01031069|541471547|FG000|Overall Study|Withdrawal by Subject|2|||
150090638|NCT01031069|541471548|FG001|Overall Study|Withdrawal by Subject|3|||
150090639|NCT01031069|541471549|FG002|Overall Study|Withdrawal by Subject|18|||
150090640|NCT01031069|541471550|FG003|Overall Study|Withdrawal by Subject|18|||
150090641|NCT01031069|541471547|FG000|Overall Study|Migrated/moved from study area|1|||
150090642|NCT01031069|541471548|FG001|Overall Study|Migrated/moved from study area|2|||
150090643|NCT01031069|541471549|FG002|Overall Study|Migrated/moved from study area|1|||
150090644|NCT01031069|541471550|FG003|Overall Study|Migrated/moved from study area|1|||
150090645|NCT01031069|541471547|FG000|Overall Study|Lost to Follow-up|9|||
150090646|NCT01031069|541471548|FG001|Overall Study|Lost to Follow-up|5|||
150090647|NCT01031069|541471549|FG002|Overall Study|Lost to Follow-up|21|||
150090648|NCT01031069|541471550|FG003|Overall Study|Lost to Follow-up|15|||
150090649|NCT01031069|541471547|FG000|Overall Study|Other|0|||
150090650|NCT01031069|541471548|FG001|Overall Study|Other|0|||
150090651|NCT01031069|541471549|FG002|Overall Study|Other|1|||
150090652|NCT01031069|541471550|FG003|Overall Study|Other|0|||
150090653|NCT00512707|541471551|FG000|Overall Study|Lost to Follow-up|5|||
150090654|NCT00512707|541471552|FG001|Overall Study|Lost to Follow-up|11|||
150090655|NCT00512707|541471551|FG000|Overall Study|Developed skin irritation|2|||
150090656|NCT00512707|541471552|FG001|Overall Study|Developed skin irritation|1|||
150090657|NCT00512707|541471551|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
150090658|NCT00512707|541471552|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
150090659|NCT00512707|541471551|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
150090660|NCT00512707|541471552|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
150090661|NCT01317160|541471553|FG000|Overall Study|Incorrect inclusion|1|||
150090662|NCT01317160|541471554|FG001|Overall Study|Incorrect inclusion|1|||
150090663|NCT01317160|541471553|FG000|Overall Study|Lost to Follow-up|3|||
150090664|NCT01317160|541471554|FG001|Overall Study|Lost to Follow-up|3|||
150090665|NCT01317160|541471553|FG000|Overall Study|Withdrawal by Subject|0|||
150090666|NCT01317160|541471554|FG001|Overall Study|Withdrawal by Subject|2|||
150090667|NCT03032705|541471556|FG000|Overall Study|Lost to Follow-up|16|||
150090668|NCT03032705|541471557|FG001|Overall Study|Lost to Follow-up|17|||
150090669|NCT03032705|541471556|FG000|Overall Study|did not quality|6|||
150090670|NCT03032705|541471557|FG001|Overall Study|did not quality|6|||
150090671|NCT04405037|541471560|FG000|Overall Study|Withdrawal by Subject|1|||
150090672|NCT04405037|541471561|FG001|Overall Study|Withdrawal by Subject|0|||
150090673|NCT04405037|541471560|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
150090674|NCT04405037|541471561|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
150090675|NCT01853826|541473452|FG000|Overall Study|Patients who switched to commercial drug|11|||
150090676|NCT01853826|541473452|FG000|Overall Study|Patient refused to continue medication|21|||
150090677|NCT01853826|541473452|FG000|Overall Study|Lost to Follow-up|2|||
150090678|NCT01853826|541473452|FG000|Overall Study|Non-compliant with protocol|4|||
150090679|NCT01853826|541473452|FG000|Overall Study|Other adverse events (AE)|62|||
150090680|NCT01853826|541473452|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
150090681|NCT01853826|541473452|FG000|Overall Study|Progressive disease|342|||
150090682|NCT01853826|541473452|FG000|Overall Study|Other than listed|13|||
150090683|NCT01853826|541473452|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
150090684|NCT05661942|541473453|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
150090685|NCT05661942|541473454|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
150090686|NCT01134783|541473455|FG000|Overall Study|Pregnancy|16|||
150090687|NCT01134783|541473456|FG001|Overall Study|Pregnancy|8|||
150090688|NCT01134783|541473455|FG000|Overall Study|Withdrawal by Subject|15|||
150090689|NCT01134783|541473456|FG001|Overall Study|Withdrawal by Subject|9|||
150090690|NCT01134783|541473455|FG000|Overall Study|Lost to Follow-up|5|||
150090691|NCT01134783|541473456|FG001|Overall Study|Lost to Follow-up|20|||
150090692|NCT00397982|541473459|FG000|Overall Study|Withdrawal by Subject|1|||
150090693|NCT00397982|541473459|FG000|Overall Study|Adverse Event|1|||
150090694|NCT00397982|541473459|FG000|Overall Study|noncompliance|1|||
150090695|NCT00397982|541473459|FG000|Overall Study|Unrelated health issues|1|||
150090696|NCT02450903|541473460|FG000|Overall Study|Adverse Event|3|||
150090697|NCT02450903|541473460|FG000|Overall Study|Progressive disease|15|||
150090698|NCT02450903|541473460|FG000|Overall Study|Switched to commercial drug|1|||
150090699|NCT02450903|541473460|FG000|Overall Study|Subject/guardian decision|1|||
150090700|NCT00967798|541473461|FG000|Overall Study|Withdrawal by Subject|5|||
150090701|NCT00967798|541473462|FG001|Overall Study|Withdrawal by Subject|2|||
150090702|NCT00967798|541473461|FG000|Overall Study|Lost to Follow-up|4|||
150090703|NCT00967798|541473462|FG001|Overall Study|Lost to Follow-up|1|||
150090704|NCT01409564|541473465|FG000|Overall Study|low medication compliance|4|||
150090705|NCT01409564|541473466|FG001|Overall Study|low medication compliance|3|||
150090706|NCT01409564|541473465|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
150090707|NCT01409564|541473466|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
150090708|NCT00225251|541473467|FG000|Overall Study|Withdrawal by Subject|1|||
150090709|NCT00225251|541473468|FG001|Overall Study|Withdrawal by Subject|1|||
150090710|NCT02664441|541473469|FG000|Randomization|Withdrawal by Subject|0|||
150090711|NCT02664441|541473470|FG001|Randomization|Withdrawal by Subject|1|||
150090712|NCT02664441|541473469|FG000|36-week Randomized Trial|Adverse Event|2|||
150090713|NCT02664441|541473470|FG001|36-week Randomized Trial|Adverse Event|0|||
150090714|NCT02664441|541473469|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
150090715|NCT02664441|541473470|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
150028982|NCT02421172|541242515|FG003|Period 2|Lost to Follow-up|1|||
150028983|NCT02421172|541242516|FG004|Period 2|Lost to Follow-up|0|||
150028984|NCT02421172|541242512|FG000|Period 2|Patient/guardian decision|0|||
150028985|NCT02421172|541242513|FG001|Period 2|Patient/guardian decision|0|||
150028986|NCT02421172|541242514|FG002|Period 2|Patient/guardian decision|3|||
150028987|NCT02421172|541242515|FG003|Period 2|Patient/guardian decision|2|||
150028988|NCT02421172|541242516|FG004|Period 2|Patient/guardian decision|1|||
150028989|NCT00928486|541242517|FG000|Overall Study|Adverse Event|2|||
150028990|NCT00928486|541242517|FG000|Overall Study|Disease Progression|7|||
150028991|NCT00928486|541242517|FG000|Overall Study|Withdrawal by Subject|1|||
150028992|NCT00683878|541242522|FG000|Overall Study|Lack of Efficacy|3|||
150028993|NCT00683878|541242523|FG001|Overall Study|Lack of Efficacy|0|||
150028994|NCT00683878|541242524|FG002|Overall Study|Lack of Efficacy|1|||
150028995|NCT00683878|541242522|FG000|Overall Study|Adverse Event|4|||
150028996|NCT00683878|541242523|FG001|Overall Study|Adverse Event|3|||
150028997|NCT00683878|541242524|FG002|Overall Study|Adverse Event|3|||
150028998|NCT00683878|541242522|FG000|Overall Study|Withdrawal by Subject|9|||
150028999|NCT00683878|541242523|FG001|Overall Study|Withdrawal by Subject|8|||
150029000|NCT00683878|541242524|FG002|Overall Study|Withdrawal by Subject|6|||
150029001|NCT00683878|541242522|FG000|Overall Study|Death|0|||
150029002|NCT00683878|541242523|FG001|Overall Study|Death|1|||
150029003|NCT00683878|541242524|FG002|Overall Study|Death|0|||
150029004|NCT00683878|541242522|FG000|Overall Study|Lost to Follow-up|4|||
150029005|NCT00683878|541242523|FG001|Overall Study|Lost to Follow-up|2|||
150029006|NCT00683878|541242524|FG002|Overall Study|Lost to Follow-up|4|||
150029007|NCT00683878|541242522|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
150029008|NCT00683878|541242523|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
150029009|NCT00683878|541242524|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
150029010|NCT02869633|541242528|FG000|Overall Study|Death|2|||
150029011|NCT02869633|541242529|FG001|Overall Study|Death|1|||
150029012|NCT02869633|541242528|FG000|Overall Study|Patient refused follow-up|1|||
150029013|NCT02869633|541242529|FG001|Overall Study|Patient refused follow-up|0|||
150029014|NCT02869633|541242528|FG000|Overall Study|Provider discretion|1|||
150029015|NCT02869633|541242529|FG001|Overall Study|Provider discretion|0|||
150029016|NCT02869633|541242528|FG000|Overall Study|Investigator decision|1|||
150029017|NCT02869633|541242529|FG001|Overall Study|Investigator decision|0|||
150029018|NCT02869633|541242528|FG000|Overall Study|Lost to Follow-up|0|||
150029019|NCT02869633|541242529|FG001|Overall Study|Lost to Follow-up|1|||
150029020|NCT02869633|541242528|FG000|Overall Study|Not eligible|6|||
150029021|NCT02869633|541242529|FG001|Overall Study|Not eligible|1|||
150029022|NCT02869633|541242528|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
150029023|NCT02869633|541242529|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
150029024|NCT02869633|541242528|FG000|Overall Study|Withdrawal by Subject|0|||
150184320|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
150184321|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
150184322|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
150184323|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
150184324|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
150184325|NCT02137850|541813331|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
150184326|NCT02137850|541813332|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
150184327|NCT02137850|541813333|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
150184328|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
150184329|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
150184330|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
150184331|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
150184332|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
150184333|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
150184334|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
150184335|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
150184336|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
150184337|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
150184338|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
150184339|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
150090716|NCT02664441|541473469|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
150090717|NCT02664441|541473470|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
150090718|NCT02664441|541473469|FG000|18-week Open Label Extension|Adverse Event|1|||
150090719|NCT02664441|541473470|FG001|18-week Open Label Extension|Adverse Event|0|||
150090720|NCT02664441|541473469|FG000|18-week Open Label Extension|Physician Decision|1|||
150090721|NCT02664441|541473470|FG001|18-week Open Label Extension|Physician Decision|0|||
150090722|NCT02664441|541473469|FG000|18-week Open Label Extension|Death|1|||
150090723|NCT02664441|541473470|FG001|18-week Open Label Extension|Death|0|||
150090724|NCT02664441|541473469|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
150090725|NCT02664441|541473470|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
150090726|NCT03045328|541473471|FG000|Overall Study|Withdrawal by Subject|2|||
150090727|NCT00715078|541473477|FG000|Overall Study|Death|29|||
150090728|NCT00715078|541473478|FG001|Overall Study|Death|36|||
150090729|NCT00715078|541473479|FG002|Overall Study|Death|36|||
150090730|NCT00715078|541473477|FG000|Overall Study|Withdrawal by Subject|1|||
150090731|NCT00715078|541473478|FG001|Overall Study|Withdrawal by Subject|0|||
150090732|NCT00715078|541473479|FG002|Overall Study|Withdrawal by Subject|1|||
150090733|NCT00715078|541473477|FG000|Overall Study|Unable to start due to disease prog.|0|||
150090734|NCT00715078|541473478|FG001|Overall Study|Unable to start due to disease prog.|0|||
150090735|NCT00715078|541473479|FG002|Overall Study|Unable to start due to disease prog.|1|||
150090736|NCT00592839|541473480|FG000|Overall Study|Withdrawal by Subject|1|||
150184340|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Other|0|||
150184341|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Other|1|||
150184342|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Other|0|||
150184343|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
150090737|NCT00592839|541473481|FG001|Overall Study|Withdrawal by Subject|1|||
150184344|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
150184345|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
150184346|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Early site closure|0|||
150184347|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Early site closure|2|||
150184348|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Early site closure|0|||
150184349|NCT02137850|541813331|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
150029025|NCT02869633|541242529|FG001|Overall Study|Withdrawal by Subject|1|||
150029026|NCT04024891|541242530|FG000|Overall Study|Pregnancy|0|||
150029027|NCT04024891|541242531|FG001|Overall Study|Pregnancy|1|||
150029028|NCT03287791|541242534|FG000|Overall Study|Insufficient Therapeutic Response|0|||
150029029|NCT03287791|541242535|FG001|Overall Study|Insufficient Therapeutic Response|0|||
150029030|NCT03287791|541242536|FG002|Overall Study|Insufficient Therapeutic Response|1|||
150029031|NCT03287791|541242534|FG000|Overall Study|Adverse Event|0|||
150029032|NCT03287791|541242535|FG001|Overall Study|Adverse Event|4|||
150029033|NCT03287791|541242536|FG002|Overall Study|Adverse Event|3|||
150029034|NCT03287791|541242534|FG000|Overall Study|Withdrawal by Subject|12|||
150029035|NCT03287791|541242535|FG001|Overall Study|Withdrawal by Subject|12|||
150029036|NCT03287791|541242536|FG002|Overall Study|Withdrawal by Subject|17|||
150029037|NCT03287791|541242534|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
150029038|NCT03287791|541242535|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
150029039|NCT03287791|541242536|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
150029040|NCT03287791|541242534|FG000|Overall Study|Lost to Follow-up|8|||
150029041|NCT03287791|541242535|FG001|Overall Study|Lost to Follow-up|14|||
150029042|NCT03287791|541242536|FG002|Overall Study|Lost to Follow-up|11|||
150029043|NCT03287791|541242534|FG000|Overall Study|Protocol Violation|7|||
150029044|NCT03287791|541242535|FG001|Overall Study|Protocol Violation|2|||
150029045|NCT03287791|541242536|FG002|Overall Study|Protocol Violation|1|||
150029046|NCT03287791|541242534|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
150029047|NCT03287791|541242535|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
150029048|NCT03287791|541242536|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
150029049|NCT03287791|541242534|FG000|Overall Study|Too much time between 2 visits|0|||
150029050|NCT03287791|541242535|FG001|Overall Study|Too much time between 2 visits|1|||
150029051|NCT03287791|541242536|FG002|Overall Study|Too much time between 2 visits|0|||
150029052|NCT03287791|541242534|FG000|Overall Study|Non-compliance|0|||
150029053|NCT03287791|541242535|FG001|Overall Study|Non-compliance|1|||
150029054|NCT03287791|541242536|FG002|Overall Study|Non-compliance|0|||
150029055|NCT03287791|541242534|FG000|Overall Study|Did not meet inclusion criteria|1|||
150029056|NCT03287791|541242535|FG001|Overall Study|Did not meet inclusion criteria|0|||
150029057|NCT03287791|541242536|FG002|Overall Study|Did not meet inclusion criteria|0|||
150029058|NCT03095651|541242538|FG000|Overall Study|Lost to Follow-up|1|||
150029059|NCT03095651|541242539|FG001|Overall Study|Lost to Follow-up|1|||
150029060|NCT03095651|541242540|FG002|Overall Study|Lost to Follow-up|0|||
150029061|NCT03095651|541242541|FG003|Overall Study|Lost to Follow-up|1|||
150029062|NCT03095651|541242542|FG004|Overall Study|Lost to Follow-up|0|||
150029063|NCT03095651|541242543|FG005|Overall Study|Lost to Follow-up|0|||
150029064|NCT03095651|541242544|FG006|Overall Study|Lost to Follow-up|0|||
150029065|NCT03095651|541242545|FG007|Overall Study|Lost to Follow-up|0|||
150029066|NCT03095651|541242538|FG000|Overall Study|Withdrawal by Subject|0|||
150029067|NCT03095651|541242539|FG001|Overall Study|Withdrawal by Subject|0|||
150029068|NCT03095651|541242540|FG002|Overall Study|Withdrawal by Subject|0|||
150029069|NCT03095651|541242541|FG003|Overall Study|Withdrawal by Subject|0|||
150029070|NCT03095651|541242542|FG004|Overall Study|Withdrawal by Subject|0|||
150029071|NCT03095651|541242543|FG005|Overall Study|Withdrawal by Subject|1|||
150029072|NCT03095651|541242544|FG006|Overall Study|Withdrawal by Subject|0|||
150029073|NCT03095651|541242545|FG007|Overall Study|Withdrawal by Subject|0|||
150029074|NCT02210000|541242552|FG000|Overall Study|Study Terminated|11|||
150029075|NCT02210000|541242553|FG001|Overall Study|Study Terminated|12|||
150029076|NCT02210000|541242552|FG000|Overall Study|Withdrawal by Subject|7|||
150029077|NCT02210000|541242553|FG001|Overall Study|Withdrawal by Subject|1|||
150029078|NCT02210000|541242552|FG000|Overall Study|Adverse Event|1|||
150029079|NCT02210000|541242553|FG001|Overall Study|Adverse Event|5|||
150029080|NCT02210000|541242552|FG000|Overall Study|Lost to Follow-up|0|||
150029081|NCT02210000|541242553|FG001|Overall Study|Lost to Follow-up|2|||
150029082|NCT02210000|541242552|FG000|Overall Study|Physician Decision|0|||
150029083|NCT02210000|541242553|FG001|Overall Study|Physician Decision|1|||
150029084|NCT00791388|541242556|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
150029085|NCT00791388|541242557|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
150029086|NCT00791388|541242558|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
150029087|NCT00791388|541242559|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
150029088|NCT00791388|541242560|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
150029089|NCT00791388|541242556|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
150029090|NCT00791388|541242557|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
150029091|NCT00791388|541242558|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
150029092|NCT00791388|541242559|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
150029093|NCT00791388|541242560|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
150029094|NCT00791388|541242556|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
150029095|NCT00791388|541242557|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
150090738|NCT00592839|541473482|FG002|Overall Study|Withdrawal by Subject|3|||
150090739|NCT00592839|541473480|FG000|Overall Study|Protocol Violation|1|||
150090740|NCT00592839|541473481|FG001|Overall Study|Protocol Violation|1|||
150090741|NCT00592839|541473482|FG002|Overall Study|Protocol Violation|2|||
150090742|NCT00592839|541473480|FG000|Overall Study|Adverse Event|0|||
150090743|NCT00592839|541473481|FG001|Overall Study|Adverse Event|1|||
150090744|NCT00592839|541473482|FG002|Overall Study|Adverse Event|0|||
150090745|NCT00592839|541473480|FG000|Overall Study|Lost to Follow-up|0|||
150090746|NCT00592839|541473481|FG001|Overall Study|Lost to Follow-up|1|||
150090747|NCT00592839|541473482|FG002|Overall Study|Lost to Follow-up|1|||
150090748|NCT01313767|541473483|FG000|Overall Study|Adverse Event|1|||
150090749|NCT01313767|541473484|FG001|Overall Study|Adverse Event|0|||
150090750|NCT01313767|541473483|FG000|Overall Study|Lost to Follow-up|1|||
150090751|NCT01313767|541473484|FG001|Overall Study|Lost to Follow-up|0|||
150090752|NCT01313767|541473483|FG000|Overall Study|Withdrawal by Subject|2|||
150090753|NCT01313767|541473484|FG001|Overall Study|Withdrawal by Subject|1|||
150090754|NCT01313767|541473483|FG000|Overall Study|Protocol Violation|3|||
150090755|NCT01313767|541473484|FG001|Overall Study|Protocol Violation|1|||
150090756|NCT00157950|541473485|FG000|Overall Study|Death|1|||
150090757|NCT00157950|541473486|FG001|Overall Study|Death|0|||
150090758|NCT01529346|541473487|FG000|Overall Study|Lost to Follow-up|2|||
150090759|NCT01529346|541473488|FG001|Overall Study|Lost to Follow-up|0|||
150090760|NCT01529346|541473489|FG002|Overall Study|Lost to Follow-up|1|||
150090761|NCT01529346|541473490|FG003|Overall Study|Lost to Follow-up|0|||
150090762|NCT01529346|541473491|FG004|Overall Study|Lost to Follow-up|0|||
150090763|NCT01529346|541473487|FG000|Overall Study|Other|0|||
150090764|NCT01529346|541473488|FG001|Overall Study|Other|1|||
150090765|NCT01529346|541473489|FG002|Overall Study|Other|1|||
150090766|NCT01529346|541473490|FG003|Overall Study|Other|0|||
150090767|NCT01529346|541473491|FG004|Overall Study|Other|0|||
150090768|NCT02892760|541473495|FG000|Overall Study|Withdrawal by Subject|3|||
150090769|NCT00082355|541473502|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
150090770|NCT00082355|541473502|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
150090771|NCT00082355|541473502|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
150090772|NCT02233309|541473503|FG000|Overall Study|Physician Decision|5|||
150090773|NCT00232817|541473506|FG000|Overall Study|Protocol Violation|2|||
150090774|NCT00232817|541473507|FG001|Overall Study|Protocol Violation|1|||
150090775|NCT00799487|541473508|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
150090776|NCT00799487|541473509|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
150090777|NCT00799487|541473510|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
150090778|NCT00799487|541473508|FG000|Dose Adjustment Period|Adverse Event|2|||
150090779|NCT00799487|541473509|FG001|Dose Adjustment Period|Adverse Event|0|||
150090780|NCT00799487|541473510|FG002|Dose Adjustment Period|Adverse Event|0|||
150090781|NCT00799487|541473508|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
150090782|NCT00799487|541473509|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
150090783|NCT00799487|541473510|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
150090784|NCT00799487|541473508|FG000|Dose Adjustment Period|Investigator Discretion|2|||
150090785|NCT00799487|541473509|FG001|Dose Adjustment Period|Investigator Discretion|0|||
150090786|NCT00799487|541473510|FG002|Dose Adjustment Period|Investigator Discretion|0|||
150090787|NCT00799487|541473508|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
150090788|NCT00799487|541473509|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
150090789|NCT00799487|541473510|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
150090790|NCT00799487|541473508|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
150090791|NCT00799487|541473509|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
150090792|NCT00799487|541473510|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
150090793|NCT00799487|541473508|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
150090794|NCT00799487|541473509|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
150090795|NCT00799487|541473510|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
150090796|NCT00799487|541473508|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
150090797|NCT00799487|541473509|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
150090798|NCT00799487|541473510|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
150090799|NCT00799487|541473508|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
150090800|NCT00799487|541473509|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
150090801|NCT00799487|541473510|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
150090802|NCT00799487|541473508|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
150090803|NCT00799487|541473509|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
150090804|NCT00799487|541473510|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
150090805|NCT00799487|541473508|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
150090806|NCT00799487|541473509|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
150090807|NCT00799487|541473510|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
150090808|NCT00799487|541473508|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
150090809|NCT00799487|541473509|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
150090810|NCT00799487|541473510|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
150090811|NCT03263442|541473511|FG000|Inpatient Phase|Death|1|||
150090812|NCT03263442|541473512|FG001|Inpatient Phase|Death|0|||
150090813|NCT03263442|541473511|FG000|Inpatient Phase|Withdrawal by Subject|1|||
150090814|NCT03263442|541473512|FG001|Inpatient Phase|Withdrawal by Subject|0|||
150090815|NCT03263442|541473511|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
150090816|NCT03263442|541473512|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
150090817|NCT03263442|541473511|FG000|1-month Follow-Up|Lost to Follow-up|1|||
150090818|NCT03263442|541473512|FG001|1-month Follow-Up|Lost to Follow-up|0|||
150090819|NCT03263442|541473511|FG000|3-month Follow-Up|Lost to Follow-up|1|||
150090820|NCT03263442|541473512|FG001|3-month Follow-Up|Lost to Follow-up|3|||
150090821|NCT03263442|541473511|FG000|6-month Follow-Up|Lost to Follow-up|2|||
150090822|NCT03263442|541473512|FG001|6-month Follow-Up|Lost to Follow-up|2|||
150090823|NCT01084174|541473513|FG000|Overall Study|gastrointestinal symptoms|1|||
150090824|NCT01084174|541473514|FG001|Overall Study|gastrointestinal symptoms|1|||
150090825|NCT01084174|541473513|FG000|Overall Study|Eosinophilic esophagitis|0|||
150090826|NCT01084174|541473514|FG001|Overall Study|Eosinophilic esophagitis|1|||
150090827|NCT01084174|541473513|FG000|Overall Study|Anaphylaxis|0|||
150090828|NCT01084174|541473514|FG001|Overall Study|Anaphylaxis|1|||
150090829|NCT01084174|541473513|FG000|Overall Study|Participant noncompliance|0|||
150090830|NCT01084174|541473514|FG001|Overall Study|Participant noncompliance|1|||
150090831|NCT00708643|541473515|FG000|Overall Study|Adverse Event|0|||
150090832|NCT00708643|541473516|FG001|Overall Study|Adverse Event|1|||
150090833|NCT01594125|541473517|FG000|Overall Study|Withdrawal by Subject|1|||
150090834|NCT01594125|541473518|FG001|Overall Study|Withdrawal by Subject|0|||
150090835|NCT01594125|541473519|FG002|Overall Study|Withdrawal by Subject|0|||
150090836|NCT01594125|541473520|FG003|Overall Study|Withdrawal by Subject|1|||
150090837|NCT01594125|541473521|FG004|Overall Study|Withdrawal by Subject|0|||
150090838|NCT01594125|541473517|FG000|Overall Study|Progressive Disease|3|||
150090839|NCT01594125|541473518|FG001|Overall Study|Progressive Disease|12|||
150090840|NCT01594125|541473519|FG002|Overall Study|Progressive Disease|3|||
150090841|NCT01594125|541473520|FG003|Overall Study|Progressive Disease|3|||
150090842|NCT01594125|541473521|FG004|Overall Study|Progressive Disease|7|||
150090843|NCT05492942|541473524|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
150090844|NCT05492942|541473525|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
150090845|NCT05492942|541473526|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
150090846|NCT05492942|541473527|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
150090847|NCT01946425|541473529|FG000|Overall Study|Protocol Violation|1|||
150090848|NCT01946425|541473530|FG001|Overall Study|Protocol Violation|0|||
150090849|NCT01946425|541473529|FG000|Overall Study|Withdrawal by Subject|1|||
150090850|NCT01946425|541473530|FG001|Overall Study|Withdrawal by Subject|0|||
150090851|NCT03103919|541473533|FG000|Overall Study|Adverse Event|2|||
150090852|NCT03103919|541473534|FG001|Overall Study|Adverse Event|2|||
150090853|NCT05682326|541473535|FG000|Overall Study|Withdrawal by Subject|1|||
150090854|NCT05682326|541473536|FG001|Overall Study|Withdrawal by Subject|0|||
150090855|NCT03998189|541473537|FG000|Overall Study|Lack of Efficacy|0|||
150090856|NCT03998189|541473538|FG001|Overall Study|Lack of Efficacy|1|||
150090857|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Death|3|||
150090858|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Death|3|||
150090859|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Death|0|||
150090860|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Death|0|||
150090861|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
150184350|NCT02137850|541813332|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
150184351|NCT02137850|541813333|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
150184352|NCT02137850|541813331|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
150090862|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
150090863|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
150090864|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
150090865|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
150090866|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
150090867|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
150090868|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
150090869|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
150090870|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
150090871|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
150090872|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
150090873|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
150184353|NCT02137850|541813332|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
150184354|NCT02137850|541813333|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
150184355|NCT02137850|541813331|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
150184356|NCT02137850|541813332|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
150184357|NCT02137850|541813333|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
150184358|NCT02137850|541813331|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
150184359|NCT02137850|541813332|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
150184360|NCT02137850|541813333|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
150184361|NCT02137850|541813331|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
150184362|NCT02137850|541813332|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
150090874|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
150090875|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
150090876|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
150090877|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
150090878|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
150090879|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
150090880|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
150090881|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
150090882|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
150090883|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
150090884|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
150090885|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Other|6|||
150090886|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Other|3|||
150090887|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Other|0|||
150090888|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Other|0|||
150090889|NCT02051608|541473539|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
150090890|NCT02051608|541473540|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
150090891|NCT02051608|541473541|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
150090892|NCT02051608|541473542|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
150090893|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Adverse Event|0|||
150090894|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Adverse Event|0|||
150090895|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Adverse Event|6|||
150090896|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Adverse Event|8|||
150090897|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Death|0|||
150090898|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Death|0|||
150090899|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Death|7|||
150090900|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Death|4|||
150090901|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
150090902|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
150090903|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
150090904|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
150090905|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
150090906|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
150184363|NCT02137850|541813333|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
150184364|NCT02137850|541813331|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
150090907|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
150090908|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
150090909|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
150184365|NCT02137850|541813332|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
150184366|NCT02137850|541813333|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
150090910|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
150090911|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
150090912|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
150090913|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
150090914|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
150090915|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
150090916|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
150090917|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Physician Decision|0|||
150090918|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Physician Decision|0|||
150090919|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Physician Decision|8|||
150090920|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Physician Decision|5|||
150090921|NCT02051608|541473539|FG000|Part 2: Open-label Extension|Other|0|||
150090922|NCT02051608|541473540|FG001|Part 2: Open-label Extension|Other|0|||
150090923|NCT02051608|541473541|FG002|Part 2: Open-label Extension|Other|9|||
150090924|NCT02051608|541473542|FG003|Part 2: Open-label Extension|Other|9|||
150090925|NCT01986985|541473543|FG000|Overall Study|Withdrawal by Subject|4|||
150090926|NCT01986985|541473543|FG000|Overall Study|Scan not completed due to malfunction|3|||
150090927|NCT02005445|541473544|FG000|Overall Study|Dual study enrollment|0|||
150090928|NCT02005445|541473545|FG001|Overall Study|Dual study enrollment|1|||
150090929|NCT01314443|541473546|FG000|Overall Study|Withdrawal by Subject|2|||
150090930|NCT01314443|541473547|FG001|Overall Study|Withdrawal by Subject|1|||
150090931|NCT01314443|541473548|FG002|Overall Study|Withdrawal by Subject|1|||
150090932|NCT01314443|541473549|FG003|Overall Study|Withdrawal by Subject|1|||
150090933|NCT01314443|541473546|FG000|Overall Study|Protocol Violation|2|||
150090934|NCT01314443|541473547|FG001|Overall Study|Protocol Violation|2|||
150184367|NCT02137850|541813331|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
150090935|NCT01314443|541473548|FG002|Overall Study|Protocol Violation|1|||
150090936|NCT01314443|541473549|FG003|Overall Study|Protocol Violation|1|||
150090937|NCT04545866|541473551|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
150090938|NCT04545866|541473552|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
150090939|NCT04545866|541473551|FG000|Overall Study|Withdrawal by Physician|1|||
150090940|NCT04545866|541473552|FG001|Overall Study|Withdrawal by Physician|0|||
150090941|NCT05247866|541473553|FG000|Overall Study|Adverse Event|2|||
150090942|NCT05247866|541473553|FG000|Overall Study|Lack of Efficacy|1|||
150090943|NCT05247866|541473553|FG000|Overall Study|Protocol Violation|1|||
150090944|NCT05247866|541473553|FG000|Overall Study|Withdrawal by Subject|3|||
150090945|NCT04463719|541473554|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
150090946|NCT04463719|541473555|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
150090947|NCT04463719|541473556|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
150090948|NCT00487747|541473557|FG000|Overall Study|Adverse Event|1|||
150090949|NCT00487747|541473557|FG000|Overall Study|Lost to Follow-up|9|||
150090950|NCT00487747|541473557|FG000|Overall Study|Lack of Efficacy|1|||
150090951|NCT01359449|541473560|FG000|Overall Study|Lost to Follow-up|1|||
150090952|NCT01359449|541473561|FG001|Overall Study|Lost to Follow-up|0|||
150090953|NCT01359449|541473560|FG000|Overall Study|Protocol Violation|0|||
150090954|NCT01359449|541473561|FG001|Overall Study|Protocol Violation|2|||
150090955|NCT01359449|541473560|FG000|Overall Study|Withdrawal by Subject|3|||
150090956|NCT01359449|541473561|FG001|Overall Study|Withdrawal by Subject|2|||
150090957|NCT02979522|541473563|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
150090958|NCT02979522|541473564|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
150090959|NCT02979522|541473563|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
150090960|NCT02979522|541473564|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
150090961|NCT00429104|541473567|FG000|Overall Study|Protocol Violation|1|||
150090962|NCT01907815|541473568|FG000|Overall Study|Withdrawal by Subject|1|||
150090963|NCT01907815|541473569|FG001|Overall Study|Withdrawal by Subject|0|||
150090964|NCT02485574|541473572|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
150090965|NCT00667368|541473574|FG000|Overall Study|Lost to Follow-up|176|||
150090966|NCT00667368|541473575|FG001|Overall Study|Lost to Follow-up|155|||
150090967|NCT00667368|541473574|FG000|Overall Study|Discontinued early|24|||
150090968|NCT00667368|541473575|FG001|Overall Study|Discontinued early|17|||
150090969|NCT00191789|541473577|FG000|Overall Study|Adverse Event|5|||
150090970|NCT00191789|541473577|FG000|Overall Study|Patient: Satisfactory Response|5|||
150090971|NCT00191789|541473577|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
150090972|NCT00191789|541473577|FG000|Overall Study|Withdrawal by Subject|4|||
150090973|NCT00191789|541473577|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
150090974|NCT00191789|541473577|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
150090975|NCT00191789|541473577|FG000|Overall Study|Death - Not Study-Drug Related|1|||
150090976|NCT05582889|541473578|FG000|Overall Study|Health event|3|||
150090977|NCT05582889|541473579|FG001|Overall Study|Health event|2|||
150090978|NCT05582889|541473578|FG000|Overall Study|Lost to Follow-up|2|||
150090979|NCT05582889|541473579|FG001|Overall Study|Lost to Follow-up|4|||
150090980|NCT01782495|541473580|FG000|Overall Study|Adverse Event|0|||
150090981|NCT01782495|541473581|FG001|Overall Study|Adverse Event|0|||
150090982|NCT01782495|541473582|FG002|Overall Study|Adverse Event|0|||
150090983|NCT01782495|541473583|FG003|Overall Study|Adverse Event|0|||
150090984|NCT01782495|541473584|FG004|Overall Study|Adverse Event|0|||
150090985|NCT01782495|541473585|FG005|Overall Study|Adverse Event|0|||
150090986|NCT01782495|541473586|FG006|Overall Study|Adverse Event|0|||
150090987|NCT01782495|541473587|FG007|Overall Study|Adverse Event|2|||
150090988|NCT01782495|541473588|FG008|Overall Study|Adverse Event|0|||
150090989|NCT01782495|541473589|FG009|Overall Study|Adverse Event|0|||
150090990|NCT01782495|541473590|FG010|Overall Study|Adverse Event|0|||
150090991|NCT01782495|541473580|FG000|Overall Study|Withdrew Consent|0|||
150090992|NCT01782495|541473581|FG001|Overall Study|Withdrew Consent|1|||
150090993|NCT01782495|541473582|FG002|Overall Study|Withdrew Consent|0|||
150090994|NCT01782495|541473583|FG003|Overall Study|Withdrew Consent|0|||
150090995|NCT01782495|541473584|FG004|Overall Study|Withdrew Consent|0|||
150090996|NCT01782495|541473585|FG005|Overall Study|Withdrew Consent|0|||
150090997|NCT01782495|541473586|FG006|Overall Study|Withdrew Consent|0|||
150090998|NCT01782495|541473587|FG007|Overall Study|Withdrew Consent|1|||
150090999|NCT01782495|541473588|FG008|Overall Study|Withdrew Consent|0|||
150091000|NCT01782495|541473589|FG009|Overall Study|Withdrew Consent|0|||
150091001|NCT01782495|541473590|FG010|Overall Study|Withdrew Consent|0|||
150091002|NCT02999854|541473594|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
150091003|NCT02999854|541473595|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
150091004|NCT02999854|541473594|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
150091005|NCT02999854|541473595|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
150091006|NCT02999854|541473594|FG000|Active Study Phase (up to 18 Months)|Death|7|||
150091007|NCT02999854|541473595|FG001|Active Study Phase (up to 18 Months)|Death|5|||
150184368|NCT02137850|541813332|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
150184369|NCT02137850|541813333|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
150184370|NCT02137850|541813331|FG000|Extension Phase: Prophylaxis|Other|0|||
150184371|NCT02137850|541813332|FG001|Extension Phase: Prophylaxis|Other|1|||
150184372|NCT02137850|541813333|FG002|Extension Phase: Prophylaxis|Other|0|||
150184373|NCT02137850|541813331|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
150184374|NCT02137850|541813332|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
150184375|NCT02137850|541813333|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
150184376|NCT02794480|541813334|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
150184377|NCT02794480|541813335|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
150184378|NCT02794480|541813336|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
150184379|NCT02794480|541813337|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
150184380|NCT02794480|541813334|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
150184381|NCT02794480|541813335|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
150184382|NCT02794480|541813336|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
150184383|NCT02794480|541813337|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
150184384|NCT02794480|541813334|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150184385|NCT02794480|541813335|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150184386|NCT02794480|541813336|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150184387|NCT02794480|541813337|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
150184388|NCT02794480|541813334|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150184389|NCT02794480|541813335|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
150184390|NCT02794480|541813336|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150184391|NCT02794480|541813337|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
150184392|NCT02794480|541813334|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
150184393|NCT02794480|541813335|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150184394|NCT02794480|541813336|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150184395|NCT02794480|541813337|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
150184396|NCT02814838|541813338|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
150184397|NCT02814838|541813339|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
150184398|NCT02814838|541813338|FG000|Overall Study|Consent withdrawal|1|||
150184399|NCT02814838|541813339|FG001|Overall Study|Consent withdrawal|1|||
150184400|NCT00593489|541813340|FG000|Allocation|did not attend workshop; allocation not|2|||
150184401|NCT00593489|541813341|FG001|Allocation|did not attend workshop; allocation not|1|||
150184402|NCT01747486|541813342|FG000|Stage 1|Physician Decision|3|||
150184403|NCT01747486|541813343|FG001|Stage 1|Physician Decision|0|||
150184404|NCT01747486|541813342|FG000|Stage 1|Withdrawal by Subject|4|||
150184405|NCT01747486|541813343|FG001|Stage 1|Withdrawal by Subject|3|||
150184406|NCT01747486|541813342|FG000|Stage 1|Disease progression|4|||
150184407|NCT01747486|541813343|FG001|Stage 1|Disease progression|9|||
150184408|NCT01747486|541813342|FG000|Stage 1|Death|1|||
150184409|NCT01747486|541813343|FG001|Stage 1|Death|1|||
150184410|NCT01747486|541813342|FG000|Stage 2|Physician Decision|2|||
150184411|NCT01747486|541813343|FG001|Stage 2|Physician Decision|0|||
150184412|NCT01747486|541813342|FG000|Stage 2|Withdrawal by Subject|1|||
150184413|NCT01747486|541813343|FG001|Stage 2|Withdrawal by Subject|0|||
150184414|NCT01747486|541813342|FG000|Stage 2|New Cancer Therapy|3|||
150184415|NCT01747486|541813343|FG001|Stage 2|New Cancer Therapy|0|||
150184416|NCT01747486|541813342|FG000|Stage 2|Disease Progression|3|||
150184417|NCT01747486|541813343|FG001|Stage 2|Disease Progression|0|||
150184418|NCT01084707|541813347|FG000|Overall Study|Withdrawal by Subject|6|||
150184419|NCT00901901|541813348|FG000|Treatment Period|Adverse Event|120|||
150184420|NCT00901901|541813349|FG001|Treatment Period|Adverse Event|128|||
150184421|NCT00901901|541813348|FG000|Treatment Period|Withdrawal by Subject|26|||
150184422|NCT00901901|541813349|FG001|Treatment Period|Withdrawal by Subject|24|||
150184423|NCT00901901|541813348|FG000|Treatment Period|Physician Decision|2|||
150184424|NCT00901901|541813349|FG001|Treatment Period|Physician Decision|2|||
150184425|NCT00901901|541813348|FG000|Treatment Period|Lost to Follow-up|3|||
150184426|NCT00901901|541813349|FG001|Treatment Period|Lost to Follow-up|5|||
150184427|NCT00901901|541813348|FG000|Treatment Period|Noncompliance with study medication|4|||
150184428|NCT00901901|541813349|FG001|Treatment Period|Noncompliance with study medication|1|||
150184429|NCT00901901|541813348|FG000|Treatment Period|Missing|1|||
150184430|NCT00901901|541813349|FG001|Treatment Period|Missing|0|||
150184431|NCT00901901|541813348|FG000|Treatment Period|Never treated|0|||
150184432|NCT00901901|541813349|FG001|Treatment Period|Never treated|3|||
150184433|NCT00901901|541813348|FG000|Treatment Period|Protocol driven decision point|0|||
150184434|NCT00901901|541813349|FG001|Treatment Period|Protocol driven decision point|2|||
150184435|NCT00901901|541813348|FG000|Treatment Period|Study terminated by sponsor|2|||
150184436|NCT00901901|541813349|FG001|Treatment Period|Study terminated by sponsor|0|||
150184437|NCT00901901|541813348|FG000|Treatment Period|Protocol Violation|5|||
150184438|NCT00901901|541813349|FG001|Treatment Period|Protocol Violation|9|||
150184439|NCT00901901|541813348|FG000|Treatment Period|Switch to commercial drug|1|||
150184440|NCT00901901|541813349|FG001|Treatment Period|Switch to commercial drug|1|||
150184441|NCT00901901|541813348|FG000|Treatment Period|Transfer to treatment continuation study|5|||
150184442|NCT00901901|541813349|FG001|Treatment Period|Transfer to treatment continuation study|2|||
150184443|NCT00901901|541813348|FG000|Follow-up Period|Death|181|||
150184444|NCT00901901|541813349|FG001|Follow-up Period|Death|208|||
150184445|NCT00901901|541813348|FG000|Follow-up Period|Protocol driven decision point|47|||
150184446|NCT00901901|541813349|FG001|Follow-up Period|Protocol driven decision point|36|||
150184447|NCT00901901|541813348|FG000|Follow-up Period|Withdrawal by Subject|6|||
150184448|NCT00901901|541813349|FG001|Follow-up Period|Withdrawal by Subject|9|||
150184449|NCT00901901|541813348|FG000|Follow-up Period|Lost to Follow-up|12|||
150184450|NCT00901901|541813349|FG001|Follow-up Period|Lost to Follow-up|8|||
150184451|NCT00901901|541813348|FG000|Follow-up Period|Missing|94|||
150184452|NCT00901901|541813349|FG001|Follow-up Period|Missing|80|||
150184453|NCT00073749|541813350|FG000|Overall Study|Disease Progression|2|||
150184454|NCT00073749|541813351|FG001|Overall Study|Disease Progression|0|||
150184455|NCT00073749|541813352|FG002|Overall Study|Disease Progression|3|||
150184456|NCT00073749|541813353|FG003|Overall Study|Disease Progression|2|||
150184457|NCT00073749|541813354|FG004|Overall Study|Disease Progression|3|||
150184458|NCT00073749|541813355|FG005|Overall Study|Disease Progression|1|||
150184459|NCT00073749|541813356|FG006|Overall Study|Disease Progression|3|||
150184460|NCT00073749|541813350|FG000|Overall Study|Death|0|||
150184461|NCT00073749|541813351|FG001|Overall Study|Death|1|||
150184462|NCT00073749|541813352|FG002|Overall Study|Death|1|||
150184463|NCT00073749|541813353|FG003|Overall Study|Death|0|||
150184464|NCT00073749|541813354|FG004|Overall Study|Death|0|||
150184465|NCT00073749|541813355|FG005|Overall Study|Death|0|||
150184466|NCT00073749|541813356|FG006|Overall Study|Death|29|||
150184467|NCT00073749|541813350|FG000|Overall Study|Adverse Event|0|||
150184468|NCT00073749|541813351|FG001|Overall Study|Adverse Event|3|||
150184469|NCT00073749|541813352|FG002|Overall Study|Adverse Event|6|||
150091008|NCT02999854|541473594|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
150091009|NCT02999854|541473595|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
150091010|NCT02999854|541473594|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
150091011|NCT02999854|541473595|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
150091012|NCT02999854|541473594|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
150091013|NCT02999854|541473595|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
150091014|NCT02999854|541473594|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
150091015|NCT02999854|541473595|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
150091016|NCT02999854|541473594|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
150091017|NCT02999854|541473595|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
150091018|NCT02848651|541473596|FG000|Overall Study|Death|85|||
150091019|NCT02848651|541473596|FG000|Overall Study|Lost to Follow-up|1|||
150091020|NCT02848651|541473596|FG000|Overall Study|Non-Compliance|1|||
150091021|NCT02848651|541473596|FG000|Overall Study|Symptomatic Deterioration|1|||
150091022|NCT02848651|541473596|FG000|Overall Study|Physician Decision|4|||
150091023|NCT02848651|541473596|FG000|Overall Study|Withdrawal by Subject|14|||
150091024|NCT04140292|541473597|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
150091025|NCT04140292|541473598|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
150091026|NCT01013701|541473599|FG000|Overall Study|study prematurely terminated|7|||
150091027|NCT03241342|541473603|FG000|Overall Study|Adverse Event|5|||
150091028|NCT03241342|541473604|FG001|Overall Study|Adverse Event|8|||
150091029|NCT03241342|541473605|FG002|Overall Study|Adverse Event|4|||
150091030|NCT03241342|541473603|FG000|Overall Study|Lack of Efficacy|0|||
150091031|NCT03241342|541473604|FG001|Overall Study|Lack of Efficacy|0|||
150091032|NCT03241342|541473605|FG002|Overall Study|Lack of Efficacy|1|||
150091033|NCT03241342|541473603|FG000|Overall Study|noncompliance with study drug|2|||
150091034|NCT03241342|541473604|FG001|Overall Study|noncompliance with study drug|1|||
150091035|NCT03241342|541473605|FG002|Overall Study|noncompliance with study drug|1|||
150091036|NCT03241342|541473603|FG000|Overall Study|sponsor decision|0|||
150091037|NCT03241342|541473604|FG001|Overall Study|sponsor decision|1|||
150091038|NCT03241342|541473605|FG002|Overall Study|sponsor decision|2|||
150091039|NCT03241342|541473603|FG000|Overall Study|not reported|15|||
150091040|NCT03241342|541473604|FG001|Overall Study|not reported|21|||
150091041|NCT03241342|541473605|FG002|Overall Study|not reported|19|||
150091042|NCT00556712|541473606|FG000|Overall Study|Adverse Event|7|||
150091043|NCT00556712|541473607|FG001|Overall Study|Adverse Event|19|||
150091044|NCT00556712|541473606|FG000|Overall Study|Death|5|||
150091045|NCT00556712|541473607|FG001|Overall Study|Death|10|||
150091046|NCT00556712|541473606|FG000|Overall Study|Progressive Disease|383|||
150091047|NCT00556712|541473607|FG001|Overall Study|Progressive Disease|320|||
150091048|NCT00556712|541473606|FG000|Overall Study|Protocol Violation|3|||
150091049|NCT00556712|541473607|FG001|Overall Study|Protocol Violation|2|||
150091050|NCT00556712|541473606|FG000|Overall Study|Refused Treatment|17|||
150184470|NCT00073749|541813353|FG003|Overall Study|Adverse Event|4|||
150184471|NCT00073749|541813354|FG004|Overall Study|Adverse Event|2|||
150184472|NCT00073749|541813355|FG005|Overall Study|Adverse Event|1|||
150184473|NCT00073749|541813356|FG006|Overall Study|Adverse Event|0|||
150184474|NCT00073749|541813350|FG000|Overall Study|Physician Decision|0|||
150184475|NCT00073749|541813351|FG001|Overall Study|Physician Decision|0|||
150091051|NCT00556712|541473607|FG001|Overall Study|Refused Treatment|16|||
150091052|NCT00556712|541473606|FG000|Overall Study|Failure to Return|2|||
150184476|NCT00073749|541813352|FG002|Overall Study|Physician Decision|1|||
150091053|NCT00556712|541473607|FG001|Overall Study|Failure to Return|3|||
150091054|NCT00556712|541473606|FG000|Overall Study|Other|2|||
150091055|NCT00556712|541473607|FG001|Overall Study|Other|2|||
150091056|NCT00556712|541473606|FG000|Overall Study|Ongoing at Data Cutoff|32|||
150091057|NCT00556712|541473607|FG001|Overall Study|Ongoing at Data Cutoff|66|||
150091058|NCT01059799|541473610|FG000|Overall Study|Adverse Event|2|||
150091059|NCT01059799|541473611|FG001|Overall Study|Adverse Event|3|||
150091060|NCT01059799|541473610|FG000|Overall Study|Lack of Efficacy|1|||
150091061|NCT01059799|541473611|FG001|Overall Study|Lack of Efficacy|0|||
150091062|NCT01059799|541473610|FG000|Overall Study|Protocol Violation|3|||
150091063|NCT01059799|541473611|FG001|Overall Study|Protocol Violation|2|||
150091064|NCT01059799|541473610|FG000|Overall Study|Withdrawal criteria|13|||
150091065|NCT01059799|541473611|FG001|Overall Study|Withdrawal criteria|2|||
150091066|NCT01059799|541473610|FG000|Overall Study|Other|12|||
150091067|NCT01059799|541473611|FG001|Overall Study|Other|3|||
150091068|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
150091069|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
150091070|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
150091071|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
150091072|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
150091073|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
150091074|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
150091075|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
150091076|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
150091077|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
150091078|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
150091079|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
150091080|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
150091081|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
150091082|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
150091083|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
150091084|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
150091085|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
150091086|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
150091087|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
150091088|NCT01962207|541473614|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
150091089|NCT01962207|541473615|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
150091090|NCT01962207|541473616|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
150091091|NCT01962207|541473617|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
150091092|NCT03653637|541475252|FG000|Overall Study|Death|1|||
150091093|NCT03653637|541475253|FG001|Overall Study|Death|3|||
150091094|NCT03653637|541475252|FG000|Overall Study|Lost to Follow-up|29|||
150091095|NCT03653637|541475253|FG001|Overall Study|Lost to Follow-up|30|||
150091096|NCT03653637|541475252|FG000|Overall Study|Physician Decision|1|||
150091097|NCT03653637|541475253|FG001|Overall Study|Physician Decision|1|||
150091098|NCT03653637|541475252|FG000|Overall Study|Withdrawal by Subject|7|||
150091099|NCT03653637|541475253|FG001|Overall Study|Withdrawal by Subject|4|||
150091100|NCT02081690|541475264|FG000|Overall Study|Death|3|||
150091101|NCT02081690|541475264|FG000|Overall Study|Physician Decision|3|||
150091102|NCT02081690|541475264|FG000|Overall Study|Withdrawal by Subject|1|||
150091103|NCT00982488|541475268|FG000|Overall Study|Administrative reason by sponsor|81|||
150091104|NCT00982488|541475269|FG001|Overall Study|Administrative reason by sponsor|3|||
150091105|NCT00982488|541475270|FG002|Overall Study|Administrative reason by sponsor|11|||
150091106|NCT00982488|541475271|FG003|Overall Study|Administrative reason by sponsor|0|||
150091107|NCT00982488|541475272|FG004|Overall Study|Administrative reason by sponsor|0|||
150091108|NCT00982488|541475268|FG000|Overall Study|Adverse event unrelated to study drug|5|||
150091109|NCT00982488|541475269|FG001|Overall Study|Adverse event unrelated to study drug|1|||
150091110|NCT00982488|541475270|FG002|Overall Study|Adverse event unrelated to study drug|0|||
150091111|NCT00982488|541475271|FG003|Overall Study|Adverse event unrelated to study drug|0|||
150091112|NCT00982488|541475272|FG004|Overall Study|Adverse event unrelated to study drug|0|||
150091113|NCT00982488|541475268|FG000|Overall Study|Death|11|||
150091114|NCT00982488|541475269|FG001|Overall Study|Death|0|||
150091115|NCT00982488|541475270|FG002|Overall Study|Death|2|||
150091116|NCT00982488|541475271|FG003|Overall Study|Death|0|||
150091117|NCT00982488|541475272|FG004|Overall Study|Death|0|||
150091118|NCT00982488|541475268|FG000|Overall Study|Disease progression|30|||
150091119|NCT00982488|541475269|FG001|Overall Study|Disease progression|5|||
150091120|NCT00982488|541475270|FG002|Overall Study|Disease progression|10|||
150091121|NCT00982488|541475271|FG003|Overall Study|Disease progression|1|||
150091122|NCT00982488|541475272|FG004|Overall Study|Disease progression|1|||
150091123|NCT00982488|541475268|FG000|Overall Study|Lost to Follow-up|1|||
150091124|NCT00982488|541475269|FG001|Overall Study|Lost to Follow-up|0|||
150091125|NCT00982488|541475270|FG002|Overall Study|Lost to Follow-up|0|||
150091126|NCT00982488|541475271|FG003|Overall Study|Lost to Follow-up|0|||
150091127|NCT00982488|541475272|FG004|Overall Study|Lost to Follow-up|0|||
150091128|NCT00982488|541475268|FG000|Overall Study|Maximum clinical benefit|1|||
150091129|NCT00982488|541475269|FG001|Overall Study|Maximum clinical benefit|1|||
150091130|NCT00982488|541475270|FG002|Overall Study|Maximum clinical benefit|1|||
150091131|NCT00982488|541475271|FG003|Overall Study|Maximum clinical benefit|0|||
150091132|NCT00982488|541475272|FG004|Overall Study|Maximum clinical benefit|0|||
150091133|NCT00982488|541475268|FG000|Overall Study|Other|15|||
150091134|NCT00982488|541475269|FG001|Overall Study|Other|1|||
150091135|NCT00982488|541475270|FG002|Overall Study|Other|3|||
150091136|NCT00982488|541475271|FG003|Overall Study|Other|1|||
150091137|NCT00982488|541475272|FG004|Overall Study|Other|0|||
150091138|NCT00982488|541475268|FG000|Overall Study|Poor compliance/noncompliance|0|||
150091139|NCT00982488|541475269|FG001|Overall Study|Poor compliance/noncompliance|1|||
150091140|NCT00982488|541475270|FG002|Overall Study|Poor compliance/noncompliance|0|||
150091141|NCT00982488|541475271|FG003|Overall Study|Poor compliance/noncompliance|0|||
150091142|NCT00982488|541475272|FG004|Overall Study|Poor compliance/noncompliance|0|||
150091143|NCT00982488|541475268|FG000|Overall Study|Stem cell transplant|2|||
150091144|NCT00982488|541475269|FG001|Overall Study|Stem cell transplant|0|||
150091145|NCT00982488|541475270|FG002|Overall Study|Stem cell transplant|0|||
150091146|NCT00982488|541475271|FG003|Overall Study|Stem cell transplant|1|||
150091147|NCT00982488|541475272|FG004|Overall Study|Stem cell transplant|0|||
150091148|NCT00982488|541475268|FG000|Overall Study|Study drug toxicity|34|||
150091149|NCT00982488|541475269|FG001|Overall Study|Study drug toxicity|1|||
150091150|NCT00982488|541475270|FG002|Overall Study|Study drug toxicity|6|||
150184477|NCT00073749|541813353|FG003|Overall Study|Physician Decision|0|||
150184478|NCT00073749|541813354|FG004|Overall Study|Physician Decision|0|||
150184479|NCT00073749|541813355|FG005|Overall Study|Physician Decision|2|||
150091151|NCT00982488|541475271|FG003|Overall Study|Study drug toxicity|0|||
150091152|NCT00982488|541475272|FG004|Overall Study|Study drug toxicity|0|||
150091153|NCT00982488|541475268|FG000|Overall Study|Withdrawal by Subject|5|||
150091154|NCT00982488|541475269|FG001|Overall Study|Withdrawal by Subject|1|||
150091155|NCT00982488|541475270|FG002|Overall Study|Withdrawal by Subject|1|||
150091156|NCT00982488|541475271|FG003|Overall Study|Withdrawal by Subject|0|||
150091157|NCT00982488|541475272|FG004|Overall Study|Withdrawal by Subject|0|||
150091158|NCT04203238|541475273|FG000|Overall Study|Withdrawal by Subject|1|||
150091159|NCT04203238|541475274|FG001|Overall Study|Withdrawal by Subject|1|||
150091160|NCT04203238|541475273|FG000|Overall Study|Covid-19|3|||
150091161|NCT04203238|541475274|FG001|Overall Study|Covid-19|0|||
150091162|NCT00001596|541475275|FG000|Overall Study|Death|1|||
150091163|NCT00001596|541475276|FG001|Overall Study|Death|0|||
150184480|NCT00073749|541813356|FG006|Overall Study|Physician Decision|0|||
150091164|NCT00001596|541475275|FG000|Overall Study|Withdrawal by Subject|3|||
150091165|NCT00001596|541475276|FG001|Overall Study|Withdrawal by Subject|1|||
150091166|NCT00001596|541475275|FG000|Overall Study|Study Termination|12|||
150091167|NCT00001596|541475276|FG001|Overall Study|Study Termination|9|||
150091168|NCT00001596|541475275|FG000|Overall Study|Adverse Event|1|||
150091169|NCT00001596|541475276|FG001|Overall Study|Adverse Event|0|||
150091170|NCT00180414|541475288|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
150091171|NCT00180414|541475289|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
150091172|NCT00463346|541475291|FG000|Overall Study|Withdrawal by Subject|3|||
150091173|NCT00463346|541475292|FG001|Overall Study|Withdrawal by Subject|3|||
150091174|NCT01572909|541475293|FG000|Overall Study|Adverse Event|7|||
150091175|NCT01572909|541475294|FG001|Overall Study|Adverse Event|2|||
150091176|NCT01572909|541475293|FG000|Overall Study|Death|3|||
150091177|NCT01572909|541475294|FG001|Overall Study|Death|1|||
150091178|NCT01572909|541475293|FG000|Overall Study|Lost to Follow-up|8|||
150091179|NCT01572909|541475294|FG001|Overall Study|Lost to Follow-up|7|||
150091180|NCT01572909|541475293|FG000|Overall Study|Physician Decision|1|||
150091181|NCT01572909|541475294|FG001|Overall Study|Physician Decision|1|||
150091182|NCT01572909|541475293|FG000|Overall Study|Technical Issues|1|||
150091183|NCT01572909|541475294|FG001|Overall Study|Technical Issues|0|||
150091184|NCT01572909|541475293|FG000|Overall Study|Withdrawal by Subject|12|||
150091185|NCT01572909|541475294|FG001|Overall Study|Withdrawal by Subject|11|||
150091186|NCT01572909|541475293|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
150091187|NCT01572909|541475294|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
150091188|NCT03641651|541475299|FG000|Overall Study|organizational issues at one study site|1|||
150091189|NCT04779489|541475300|FG000|Overall Study|Physician Decision|1|||
150091190|NCT00951665|541475301|FG000|Phase 1b|Adverse Event|2|||
150091191|NCT00951665|541475302|FG001|Phase 1b|Adverse Event|1|||
150091192|NCT00951665|541475303|FG002|Phase 1b|Adverse Event|0|||
150091193|NCT00951665|541475304|FG003|Phase 1b|Adverse Event|1|||
150091194|NCT00951665|541475305|FG004|Phase 1b|Adverse Event|0|||
150091195|NCT00951665|541475306|FG005|Phase 1b|Adverse Event|0|||
150091196|NCT00951665|541475301|FG000|Phase 1b|Death|1|||
150091197|NCT00951665|541475302|FG001|Phase 1b|Death|0|||
150091198|NCT00951665|541475303|FG002|Phase 1b|Death|2|||
150091199|NCT00951665|541475304|FG003|Phase 1b|Death|0|||
150091200|NCT00951665|541475305|FG004|Phase 1b|Death|0|||
150091201|NCT00951665|541475306|FG005|Phase 1b|Death|0|||
150091202|NCT00951665|541475301|FG000|Phase 1b|Physician Decision|4|||
150091203|NCT00951665|541475302|FG001|Phase 1b|Physician Decision|0|||
150091204|NCT00951665|541475303|FG002|Phase 1b|Physician Decision|1|||
150091205|NCT00951665|541475304|FG003|Phase 1b|Physician Decision|0|||
150091206|NCT00951665|541475305|FG004|Phase 1b|Physician Decision|0|||
150091207|NCT00951665|541475306|FG005|Phase 1b|Physician Decision|0|||
150091208|NCT00951665|541475301|FG000|Phase 1b|Withdrawal by Subject|0|||
150091209|NCT00951665|541475302|FG001|Phase 1b|Withdrawal by Subject|1|||
150091210|NCT00951665|541475303|FG002|Phase 1b|Withdrawal by Subject|0|||
150091211|NCT00951665|541475304|FG003|Phase 1b|Withdrawal by Subject|0|||
150091212|NCT00951665|541475305|FG004|Phase 1b|Withdrawal by Subject|0|||
150091213|NCT00951665|541475306|FG005|Phase 1b|Withdrawal by Subject|0|||
150091214|NCT00951665|541475301|FG000|Phase 1b|Disease Progression|13|||
150091215|NCT00951665|541475302|FG001|Phase 1b|Disease Progression|2|||
150091216|NCT00951665|541475303|FG002|Phase 1b|Disease Progression|14|||
150091217|NCT00951665|541475304|FG003|Phase 1b|Disease Progression|0|||
150091218|NCT00951665|541475305|FG004|Phase 1b|Disease Progression|0|||
150091219|NCT00951665|541475306|FG005|Phase 1b|Disease Progression|0|||
150091220|NCT00951665|541475301|FG000|Phase 1b|Protocol Violation|2|||
150091221|NCT00951665|541475302|FG001|Phase 1b|Protocol Violation|0|||
150091222|NCT00951665|541475303|FG002|Phase 1b|Protocol Violation|0|||
150091223|NCT00951665|541475304|FG003|Phase 1b|Protocol Violation|0|||
150091224|NCT00951665|541475305|FG004|Phase 1b|Protocol Violation|0|||
150091225|NCT00951665|541475306|FG005|Phase 1b|Protocol Violation|0|||
150091226|NCT00951665|541475301|FG000|Phase 2a|Adverse Event|0|||
150091227|NCT00951665|541475302|FG001|Phase 2a|Adverse Event|0|||
150091228|NCT00951665|541475303|FG002|Phase 2a|Adverse Event|0|||
150091229|NCT00951665|541475304|FG003|Phase 2a|Adverse Event|0|||
150091230|NCT00951665|541475305|FG004|Phase 2a|Adverse Event|2|||
150091231|NCT00951665|541475306|FG005|Phase 2a|Adverse Event|0|||
150091232|NCT00951665|541475301|FG000|Phase 2a|Death|0|||
150091233|NCT00951665|541475302|FG001|Phase 2a|Death|0|||
150091234|NCT00951665|541475303|FG002|Phase 2a|Death|0|||
150091235|NCT00951665|541475304|FG003|Phase 2a|Death|0|||
150091236|NCT00951665|541475305|FG004|Phase 2a|Death|1|||
150091237|NCT00951665|541475306|FG005|Phase 2a|Death|1|||
150091238|NCT00951665|541475301|FG000|Phase 2a|Lost to Follow-up|0|||
150091239|NCT00951665|541475302|FG001|Phase 2a|Lost to Follow-up|0|||
150091240|NCT00951665|541475303|FG002|Phase 2a|Lost to Follow-up|0|||
150091241|NCT00951665|541475304|FG003|Phase 2a|Lost to Follow-up|0|||
150091242|NCT00951665|541475305|FG004|Phase 2a|Lost to Follow-up|1|||
150091243|NCT00951665|541475306|FG005|Phase 2a|Lost to Follow-up|0|||
150091244|NCT00951665|541475301|FG000|Phase 2a|Physician Decision|0|||
150091245|NCT00951665|541475302|FG001|Phase 2a|Physician Decision|0|||
150091246|NCT00951665|541475303|FG002|Phase 2a|Physician Decision|0|||
150091247|NCT00951665|541475304|FG003|Phase 2a|Physician Decision|0|||
150091248|NCT00951665|541475305|FG004|Phase 2a|Physician Decision|0|||
150091249|NCT00951665|541475306|FG005|Phase 2a|Physician Decision|1|||
150091250|NCT00951665|541475301|FG000|Phase 2a|Withdrawal by Subject|0|||
150091251|NCT00951665|541475302|FG001|Phase 2a|Withdrawal by Subject|0|||
150091252|NCT00951665|541475303|FG002|Phase 2a|Withdrawal by Subject|0|||
150091253|NCT00951665|541475304|FG003|Phase 2a|Withdrawal by Subject|0|||
150091254|NCT00951665|541475305|FG004|Phase 2a|Withdrawal by Subject|2|||
150091255|NCT00951665|541475306|FG005|Phase 2a|Withdrawal by Subject|0|||
150091256|NCT00951665|541475301|FG000|Phase 2a|Disease Progression|0|||
150091257|NCT00951665|541475302|FG001|Phase 2a|Disease Progression|0|||
150091258|NCT00951665|541475303|FG002|Phase 2a|Disease Progression|0|||
150091259|NCT00951665|541475304|FG003|Phase 2a|Disease Progression|0|||
150091260|NCT00951665|541475305|FG004|Phase 2a|Disease Progression|6|||
150091261|NCT00951665|541475306|FG005|Phase 2a|Disease Progression|5|||
150091262|NCT01199289|541475307|FG000|Overall Study|Ineligibility determined|2|||
150091263|NCT01199289|541475308|FG001|Overall Study|Ineligibility determined|1|||
150091264|NCT01199289|541475309|FG002|Overall Study|Ineligibility determined|0|||
150091265|NCT01199289|541475310|FG003|Overall Study|Ineligibility determined|0|||
150091266|NCT01199289|541475307|FG000|Overall Study|Protocol Violation|1|||
150091267|NCT01199289|541475308|FG001|Overall Study|Protocol Violation|0|||
150091268|NCT01199289|541475309|FG002|Overall Study|Protocol Violation|0|||
150091269|NCT01199289|541475310|FG003|Overall Study|Protocol Violation|1|||
150091270|NCT01199289|541475307|FG000|Overall Study|Noncompliance|1|||
150091271|NCT01199289|541475308|FG001|Overall Study|Noncompliance|0|||
150091272|NCT01199289|541475309|FG002|Overall Study|Noncompliance|2|||
150091273|NCT01199289|541475310|FG003|Overall Study|Noncompliance|0|||
150091274|NCT01199289|541475307|FG000|Overall Study|Adverse Event|0|||
150091275|NCT01199289|541475308|FG001|Overall Study|Adverse Event|3|||
150091276|NCT01199289|541475309|FG002|Overall Study|Adverse Event|1|||
150091277|NCT01199289|541475310|FG003|Overall Study|Adverse Event|4|||
150091278|NCT01199289|541475307|FG000|Overall Study|Full consent withdrawn|2|||
150091279|NCT01199289|541475308|FG001|Overall Study|Full consent withdrawn|2|||
150091280|NCT01199289|541475309|FG002|Overall Study|Full consent withdrawn|2|||
150091281|NCT01199289|541475310|FG003|Overall Study|Full consent withdrawn|3|||
150091282|NCT01199289|541475307|FG000|Overall Study|Administrative decision|0|||
150091283|NCT01199289|541475308|FG001|Overall Study|Administrative decision|0|||
150091284|NCT01199289|541475309|FG002|Overall Study|Administrative decision|0|||
150091285|NCT01199289|541475310|FG003|Overall Study|Administrative decision|1|||
150091286|NCT01199289|541475307|FG000|Overall Study|Lost to Follow-up|0|||
150091287|NCT01199289|541475308|FG001|Overall Study|Lost to Follow-up|0|||
150091288|NCT01199289|541475309|FG002|Overall Study|Lost to Follow-up|0|||
150091289|NCT01199289|541475310|FG003|Overall Study|Lost to Follow-up|1|||
150091290|NCT01199289|541475307|FG000|Overall Study|Protocol-specified criteria|3|||
150091291|NCT01199289|541475308|FG001|Overall Study|Protocol-specified criteria|0|||
150091292|NCT01199289|541475309|FG002|Overall Study|Protocol-specified criteria|0|||
150091293|NCT01199289|541475310|FG003|Overall Study|Protocol-specified criteria|1|||
150091294|NCT01199289|541475307|FG000|Overall Study|Pregnancy|0|||
150091295|NCT01199289|541475308|FG001|Overall Study|Pregnancy|1|||
150091296|NCT01199289|541475309|FG002|Overall Study|Pregnancy|0|||
150091297|NCT01199289|541475310|FG003|Overall Study|Pregnancy|1|||
150091298|NCT02723084|541475313|FG000|Overall Study|Withdrawal by Subject|1|||
150091299|NCT02723084|541475314|FG001|Overall Study|Withdrawal by Subject|1|||
150091300|NCT02723084|541475313|FG000|Overall Study|Lost to Follow-up|3|||
150091301|NCT02723084|541475314|FG001|Overall Study|Lost to Follow-up|0|||
150091302|NCT00415909|541475317|FG000|Overall Study|Withdrawal by Subject|2|||
150091303|NCT00415909|541475317|FG000|Overall Study|Death|1|||
150091304|NCT05024058|541475318|FG000|Treatment|Study terminated by sponsor|5|||
150091305|NCT05024058|541475319|FG001|Treatment|Study terminated by sponsor|6|||
150091306|NCT05024058|541475320|FG002|Treatment|Study terminated by sponsor|4|||
150091307|NCT05024058|541475321|FG003|Treatment|Study terminated by sponsor|2|||
150091308|NCT05024058|541475322|FG004|Treatment|Study terminated by sponsor|3|||
150091309|NCT05024058|541475323|FG005|Treatment|Study terminated by sponsor|3|||
150091310|NCT05024058|541475324|FG006|Treatment|Study terminated by sponsor|1|||
150091311|NCT05024058|541475325|FG007|Treatment|Study terminated by sponsor|3|||
150091312|NCT05024058|541475326|FG008|Treatment|Study terminated by sponsor|6|||
150091313|NCT05024058|541475327|FG009|Treatment|Study terminated by sponsor|6|||
150091314|NCT05024058|541475318|FG000|Follow-up|Withdrawal by Subject|1|||
150091315|NCT05024058|541475319|FG001|Follow-up|Withdrawal by Subject|0|||
150091316|NCT05024058|541475320|FG002|Follow-up|Withdrawal by Subject|1|||
150091317|NCT05024058|541475321|FG003|Follow-up|Withdrawal by Subject|0|||
150091318|NCT05024058|541475322|FG004|Follow-up|Withdrawal by Subject|0|||
150091319|NCT05024058|541475323|FG005|Follow-up|Withdrawal by Subject|0|||
150091320|NCT05024058|541475324|FG006|Follow-up|Withdrawal by Subject|0|||
150091321|NCT05024058|541475325|FG007|Follow-up|Withdrawal by Subject|1|||
150091322|NCT05024058|541475326|FG008|Follow-up|Withdrawal by Subject|0|||
150091323|NCT05024058|541475327|FG009|Follow-up|Withdrawal by Subject|1|||
150091324|NCT02734810|541475331|FG000|Overall Study|Adverse Event|1|||
150091325|NCT02734810|541475332|FG001|Overall Study|Adverse Event|0|||
150029096|NCT00791388|541242558|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
150029097|NCT00791388|541242559|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
150029098|NCT00791388|541242560|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
150029099|NCT00443040|541242567|FG000|Overall Study|Withdrawal by Subject|1|||
150029100|NCT00443040|541242568|FG001|Overall Study|Withdrawal by Subject|0|||
150029101|NCT00443040|541242569|FG002|Overall Study|Withdrawal by Subject|0|||
150091326|NCT02734810|541475331|FG000|Overall Study|Lack of Efficacy|1|||
150091327|NCT02734810|541475332|FG001|Overall Study|Lack of Efficacy|0|||
150091328|NCT00127712|541475336|FG000|Overall Study|Adverse Event|3|||
150091329|NCT00127712|541475337|FG001|Overall Study|Adverse Event|0|||
150091330|NCT00127712|541475336|FG000|Overall Study|Lack of GI access to continue|2|||
150091331|NCT00127712|541475337|FG001|Overall Study|Lack of GI access to continue|0|||
150091332|NCT03055260|541475338|FG000|Overall Study|Withdrawal by Subject|1|||
150091333|NCT03055260|541475339|FG001|Overall Study|Withdrawal by Subject|0|||
150091334|NCT02507505|541475340|FG000|Overall Study|Withdrawal by Subject|13|||
150091335|NCT02507505|541475341|FG001|Overall Study|Withdrawal by Subject|11|||
150091336|NCT02507505|541475340|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
150091337|NCT02507505|541475341|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
150091338|NCT02507505|541475340|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
150091339|NCT02507505|541475341|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
150091340|NCT02507505|541475340|FG000|Overall Study|Death before receipt of anesthesia|0|||
150091341|NCT02507505|541475341|FG001|Overall Study|Death before receipt of anesthesia|1|||
150029102|NCT00443040|541242567|FG000|Overall Study|Converted to an open laparotomy|3|||
150029103|NCT00443040|541242568|FG001|Overall Study|Converted to an open laparotomy|0|||
150091342|NCT02335489|541475342|FG000|Overall Study|Sponsor terminated study|4|||
150091343|NCT02335489|541475342|FG000|Overall Study|Lost to Follow-up|1|||
150091344|NCT02335489|541475342|FG000|Overall Study|Withdrawal by Subject|2|||
150091345|NCT02335489|541475342|FG000|Overall Study|Physician Decision|2|||
150029104|NCT00443040|541242569|FG002|Overall Study|Converted to an open laparotomy|1|||
150029105|NCT03585660|541242570|FG000|Overall Study|operator error|1|||
150029106|NCT03585660|541242570|FG000|Overall Study|technical error|2|||
150029107|NCT03585660|541242570|FG000|Overall Study|hip prosthesis|2|||
150029108|NCT03585660|541242570|FG000|Overall Study|did not undergo biopsy|8|||
150029109|NCT03585660|541242570|FG000|Overall Study|scanner problem|2|||
150091346|NCT02335489|541475342|FG000|Overall Study|Lack of Efficacy|1|||
150091347|NCT00531050|541475350|FG000|Part 1: Period 1|Adverse Event|0|||
150091348|NCT00531050|541475351|FG001|Part 1: Period 1|Adverse Event|1|||
150091349|NCT00531050|541475352|FG002|Part 1: Period 1|Adverse Event|0|||
150091350|NCT00531050|541475353|FG003|Part 1: Period 1|Adverse Event|0|||
150091351|NCT00531050|541475354|FG004|Part 1: Period 1|Adverse Event|0|||
150091352|NCT00531050|541475355|FG005|Part 1: Period 1|Adverse Event|0|||
150091353|NCT00531050|541475350|FG000|Part 1: Period 1|Protocol Deviation|0|||
150091354|NCT00531050|541475351|FG001|Part 1: Period 1|Protocol Deviation|0|||
150091355|NCT00531050|541475352|FG002|Part 1: Period 1|Protocol Deviation|0|||
150091356|NCT00531050|541475353|FG003|Part 1: Period 1|Protocol Deviation|1|||
150091357|NCT00531050|541475354|FG004|Part 1: Period 1|Protocol Deviation|0|||
150091358|NCT00531050|541475355|FG005|Part 1: Period 1|Protocol Deviation|0|||
150091359|NCT00531050|541475350|FG000|Part 1: Period 3|Adverse Event|1|||
150091360|NCT00531050|541475351|FG001|Part 1: Period 3|Adverse Event|0|||
150091361|NCT00531050|541475352|FG002|Part 1: Period 3|Adverse Event|0|||
150091362|NCT00531050|541475353|FG003|Part 1: Period 3|Adverse Event|0|||
150091363|NCT00531050|541475354|FG004|Part 1: Period 3|Adverse Event|0|||
150091364|NCT00531050|541475355|FG005|Part 1: Period 3|Adverse Event|0|||
150091365|NCT00531050|541475350|FG000|Part 2: Period 1|Adverse Event|0|||
150091366|NCT00531050|541475351|FG001|Part 2: Period 1|Adverse Event|0|||
150091367|NCT00531050|541475352|FG002|Part 2: Period 1|Adverse Event|0|||
150091368|NCT00531050|541475353|FG003|Part 2: Period 1|Adverse Event|0|||
150091369|NCT00531050|541475354|FG004|Part 2: Period 1|Adverse Event|0|||
150091370|NCT00531050|541475355|FG005|Part 2: Period 1|Adverse Event|1|||
150091371|NCT00531050|541475350|FG000|Part 2: Period 3|Abnormal test procedure|1|||
150091372|NCT00531050|541475351|FG001|Part 2: Period 3|Abnormal test procedure|0|||
150091373|NCT00531050|541475352|FG002|Part 2: Period 3|Abnormal test procedure|0|||
150091374|NCT00531050|541475353|FG003|Part 2: Period 3|Abnormal test procedure|0|||
150091375|NCT00531050|541475354|FG004|Part 2: Period 3|Abnormal test procedure|0|||
150091376|NCT00531050|541475355|FG005|Part 2: Period 3|Abnormal test procedure|1|||
150091377|NCT01034462|541475359|FG000|Overall Study|Adverse Event|7|||
150091378|NCT01034462|541475360|FG001|Overall Study|Adverse Event|17|||
150091379|NCT01034462|541475359|FG000|Overall Study|Lack of Efficacy|4|||
150091380|NCT01034462|541475360|FG001|Overall Study|Lack of Efficacy|4|||
150091381|NCT01034462|541475359|FG000|Overall Study|Protocol Violation|10|||
150091382|NCT01034462|541475360|FG001|Overall Study|Protocol Violation|7|||
150091383|NCT01034462|541475359|FG000|Overall Study|Withdrawal by Subject|9|||
150091384|NCT01034462|541475360|FG001|Overall Study|Withdrawal by Subject|8|||
150091385|NCT01034462|541475359|FG000|Overall Study|Lost to Follow-up|14|||
150091386|NCT01034462|541475360|FG001|Overall Study|Lost to Follow-up|16|||
150029110|NCT02763644|541242571|FG000|Overall Study|Patient/guardian decision|1|||
150029111|NCT02763644|541242572|FG001|Overall Study|Patient/guardian decision|0|||
150029112|NCT02763644|541242571|FG000|Overall Study|Death|1|||
150029113|NCT02763644|541242572|FG001|Overall Study|Death|1|||
150029114|NCT02763644|541242571|FG000|Overall Study|Adverse Event|1|||
150029115|NCT02763644|541242572|FG001|Overall Study|Adverse Event|1|||
150029116|NCT00472108|541242583|FG000|Overall Study|Lost to Follow-up|0|||
150029117|NCT00472108|541242584|FG001|Overall Study|Lost to Follow-up|1|||
150029118|NCT00005906|541242591|FG000|Overall Study|Lack of Efficacy|3|||
150029119|NCT04201431|541242592|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
150029120|NCT04201431|541242593|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
150029121|NCT04201431|541242594|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
150029122|NCT01945021|541242595|FG000|Overall Study|Adverse Event|1|||
150029123|NCT01945021|541242595|FG000|Overall Study|Withdrawal of consent|12|||
150029124|NCT01945021|541242595|FG000|Overall Study|Lost to Follow-up|5|||
150029125|NCT01945021|541242595|FG000|Overall Study|Death|65|||
150029126|NCT02163902|541242596|FG000|Overall Study|Subject's Request|3|||
150029127|NCT02163902|541242597|FG001|Overall Study|Subject's Request|4|||
150029128|NCT02163902|541242596|FG000|Overall Study|Lost to Follow-up|6|||
150029129|NCT02163902|541242597|FG001|Overall Study|Lost to Follow-up|7|||
150029130|NCT02163902|541242596|FG000|Overall Study|Administrative Decision|2|||
150029131|NCT02163902|541242597|FG001|Overall Study|Administrative Decision|2|||
150029132|NCT02903160|541242602|FG000|Overall Study|Adverse Event|2|||
150029133|NCT02903160|541242602|FG000|Overall Study|Death|1|||
150029134|NCT02903160|541242602|FG000|Overall Study|Lost to Follow-up|2|||
150029135|NCT02903160|541242602|FG000|Overall Study|Withdrawal by Subject|1|||
150029136|NCT02903160|541242602|FG000|Overall Study|Medical Insurance Barriers|1|||
150029137|NCT01664910|541242605|FG000|Overall Study|Adverse Event|0|||
150029138|NCT01664910|541242606|FG001|Overall Study|Adverse Event|0|||
150029139|NCT01664910|541242607|FG002|Overall Study|Adverse Event|1|||
150029140|NCT00867165|541242612|FG000|Overall Study|Adverse Event|3|||
150029141|NCT00867165|541242613|FG001|Overall Study|Adverse Event|0|||
150029142|NCT00867165|541242612|FG000|Overall Study|Withdrawal by Subject|1|||
150091387|NCT01034462|541475359|FG000|Overall Study|Other reasons|1|||
150091388|NCT01034462|541475360|FG001|Overall Study|Other reasons|2|||
150091389|NCT00227903|541475361|FG000|Overall Study|Withdrawal by Subject|2|||
150091390|NCT00227903|541475362|FG001|Overall Study|Withdrawal by Subject|5|||
150091391|NCT00227903|541475361|FG000|Overall Study|Subject moved out of area|1|||
150091392|NCT00227903|541475362|FG001|Overall Study|Subject moved out of area|2|||
150091393|NCT00227903|541475361|FG000|Overall Study|Lost to Follow-up|1|||
150091394|NCT00227903|541475362|FG001|Overall Study|Lost to Follow-up|3|||
150091395|NCT00227903|541475361|FG000|Overall Study|Miscarriage|1|||
150091396|NCT00227903|541475362|FG001|Overall Study|Miscarriage|0|||
150091397|NCT04273217|541475363|FG000|Overall Study|Lost to Follow-up|0|||
150091398|NCT04273217|541475364|FG001|Overall Study|Lost to Follow-up|0|||
150091399|NCT04273217|541475365|FG002|Overall Study|Lost to Follow-up|0|||
150091400|NCT04273217|541475366|FG003|Overall Study|Lost to Follow-up|0|||
150091401|NCT04273217|541475367|FG004|Overall Study|Lost to Follow-up|0|||
150091402|NCT04273217|541475368|FG005|Overall Study|Lost to Follow-up|1|||
150091403|NCT04273217|541475363|FG000|Overall Study|Participant non-compliance|0|||
150091404|NCT04273217|541475364|FG001|Overall Study|Participant non-compliance|0|||
150091405|NCT04273217|541475365|FG002|Overall Study|Participant non-compliance|0|||
150091406|NCT04273217|541475366|FG003|Overall Study|Participant non-compliance|0|||
150091407|NCT04273217|541475367|FG004|Overall Study|Participant non-compliance|1|||
150091408|NCT04273217|541475368|FG005|Overall Study|Participant non-compliance|0|||
150091409|NCT04273217|541475363|FG000|Overall Study|Positive urine drug screen|1|||
150091410|NCT04273217|541475364|FG001|Overall Study|Positive urine drug screen|0|||
150091411|NCT04273217|541475365|FG002|Overall Study|Positive urine drug screen|1|||
150091412|NCT04273217|541475366|FG003|Overall Study|Positive urine drug screen|0|||
150091413|NCT04273217|541475367|FG004|Overall Study|Positive urine drug screen|0|||
150091414|NCT04273217|541475368|FG005|Overall Study|Positive urine drug screen|1|||
150091415|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
150091416|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
150091417|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
150091418|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
150091419|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
150091420|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
150091421|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
150091422|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
150091423|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
150091424|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
150091425|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
150091426|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
150091427|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
150091428|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
150091429|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
150091430|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
150091431|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
150091432|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
150091433|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
150091434|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
150091435|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
150091436|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
150091437|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
150091438|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
150091439|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
150091440|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
150091441|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
150091442|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
150091443|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
150091444|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
150091445|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
150091446|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
150091447|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
150091448|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
150091449|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
150091450|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
150184481|NCT00073749|541813350|FG000|Overall Study|Withdrawal by Subject|0|||
150184482|NCT00073749|541813351|FG001|Overall Study|Withdrawal by Subject|1|||
150184483|NCT00073749|541813352|FG002|Overall Study|Withdrawal by Subject|0|||
150091451|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
150091452|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
150184484|NCT00073749|541813353|FG003|Overall Study|Withdrawal by Subject|0|||
150091453|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
150184485|NCT00073749|541813354|FG004|Overall Study|Withdrawal by Subject|1|||
150184486|NCT00073749|541813355|FG005|Overall Study|Withdrawal by Subject|0|||
150091454|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
150091455|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
150091456|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
150091457|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
150091458|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
150091459|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
150091460|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
150091461|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
150091462|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
150091463|NCT03720470|541475371|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
150091464|NCT03720470|541475372|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
150091465|NCT03720470|541475373|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
150091466|NCT03720470|541475374|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
150091467|NCT03720470|541475375|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
150091468|NCT03720470|541475376|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
150091469|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
150091470|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
150091471|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
150091472|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
150091473|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
150091474|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
150091475|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
150091476|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
150091477|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
150091478|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
150091479|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
150091480|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
150091481|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
150091482|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
150091483|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
150091484|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
150091485|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
150091486|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
150091487|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
150091488|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
150091489|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
150091490|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
150091491|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
150091492|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
150091493|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
150091494|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
150091495|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
150091496|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
150091497|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
150091498|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
150091499|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
150091500|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
150091501|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
150091502|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
150091503|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
150091504|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
150091505|NCT03720470|541475371|FG000|Treatment Period: Final 4 Weeks|Other|0|||
150091506|NCT03720470|541475372|FG001|Treatment Period: Final 4 Weeks|Other|1|||
150091507|NCT03720470|541475373|FG002|Treatment Period: Final 4 Weeks|Other|0|||
150091508|NCT03720470|541475374|FG003|Treatment Period: Final 4 Weeks|Other|2|||
150091509|NCT03720470|541475375|FG004|Treatment Period: Final 4 Weeks|Other|1|||
150091510|NCT03720470|541475376|FG005|Treatment Period: Final 4 Weeks|Other|0|||
150091511|NCT02056340|541475380|FG000|Overall Study|Lost to Follow-up|5|||
150091512|NCT02056340|541475381|FG001|Overall Study|Lost to Follow-up|5|||
150091513|NCT02056340|541475380|FG000|Overall Study|Withdrawal by Subject|2|||
150091514|NCT02056340|541475381|FG001|Overall Study|Withdrawal by Subject|6|||
150091515|NCT01414855|541475384|FG000|Overall Study|Death|17|||
150091516|NCT01414855|541475384|FG000|Overall Study|Lost to Follow-up|5|||
150091517|NCT01414855|541475384|FG000|Overall Study|Withdrawal by Subject|7|||
150091518|NCT04851314|541475385|FG000|Overall Study|Unable to complete research set-up procedures|0|||
150091519|NCT04851314|541475386|FG001|Overall Study|Unable to complete research set-up procedures|2|||
150091520|NCT04851314|541475385|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
150091521|NCT04851314|541475386|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
150091522|NCT00867009|541475387|FG000|Induction Period|Nonserious Adverse Event|5|||
150091523|NCT00867009|541475387|FG000|Induction Period|Serious Adverse Event|10|||
150091524|NCT00867009|541475387|FG000|Induction Period|Death due to serious adverse event|6|||
150091525|NCT00867009|541475387|FG000|Induction Period|Death due to Study Disease|4|||
150091526|NCT00867009|541475387|FG000|Induction Period|Protocol Violation|1|||
150091527|NCT00867009|541475387|FG000|Induction Period|Withdrawal by Subject|8|||
150091528|NCT00867009|541475387|FG000|Induction Period|Physician Decision|3|||
150091529|NCT00867009|541475387|FG000|Induction Period|Progressive Disease (PD)|25|||
150091530|NCT00867009|541475387|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
150091531|NCT02289079|541475388|FG000|Overall Study|Physician Decision|2|||
150091532|NCT02289079|541475389|FG001|Overall Study|Physician Decision|0|||
150091533|NCT02289079|541475388|FG000|Overall Study|Lost to Follow-up|0|||
150091534|NCT02289079|541475389|FG001|Overall Study|Lost to Follow-up|1|||
150091535|NCT03036072|541475390|FG000|Overall Study|Death|0|||
150091536|NCT03036072|541475391|FG001|Overall Study|Death|1|||
150091537|NCT03036072|541475390|FG000|Overall Study|Withdrawal by Subject|0|||
150091538|NCT03036072|541475391|FG001|Overall Study|Withdrawal by Subject|1|||
150091539|NCT03036072|541475390|FG000|Overall Study|Physician Decision|0|||
150091540|NCT03036072|541475391|FG001|Overall Study|Physician Decision|1|||
150091541|NCT02671422|541475392|FG000|Overall Study|Lost to Follow-up|1|||
150091542|NCT02671422|541475392|FG000|Overall Study|Adverse Event|68|||
150091543|NCT02671422|541475392|FG000|Overall Study|Lack of Efficacy|1|||
150091544|NCT02671422|541475392|FG000|Overall Study|Lost to Follow-up|4|||
150091545|NCT02671422|541475392|FG000|Overall Study|Withdrawal by Subject|7|||
150091546|NCT02671422|541475392|FG000|Overall Study|Progressive Disease|156|||
150091547|NCT02671422|541475392|FG000|Overall Study|Worsening of Disease|4|||
150091548|NCT02671422|541475392|FG000|Overall Study|Sponsor decision|5|||
150091549|NCT02671422|541475392|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
150091550|NCT02671422|541475392|FG000|Overall Study|Not treated with Vargatef®|3|||
150091551|NCT02671422|541475392|FG000|Overall Study|Other not defined above|3|||
150091552|NCT04772755|541475393|FG000|Overall Study|Withdrawal by Subject|1|||
150091553|NCT04772755|541475394|FG001|Overall Study|Withdrawal by Subject|0|||
150091554|NCT04772755|541475393|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
150091555|NCT04772755|541475394|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
150091556|NCT00662363|541475395|FG000|Overall Study|Withdrawal by Subject|6|||
150091557|NCT00662363|541475396|FG001|Overall Study|Withdrawal by Subject|5|||
150091558|NCT00662363|541475395|FG000|Overall Study|Adverse Event|0|||
150091559|NCT00662363|541475396|FG001|Overall Study|Adverse Event|3|||
150091560|NCT00662363|541475395|FG000|Overall Study|Discharged early from rehab|4|||
150091561|NCT00662363|541475396|FG001|Overall Study|Discharged early from rehab|1|||
150091562|NCT00662363|541475395|FG000|Overall Study|Protocol Violation|1|||
150091563|NCT00662363|541475396|FG001|Overall Study|Protocol Violation|1|||
150091564|NCT05838742|541475397|FG000|Overall Study|Adverse Event|2|||
150091565|NCT05838742|541475398|FG001|Overall Study|Adverse Event|0|||
150091566|NCT05838742|541475399|FG002|Overall Study|Adverse Event|1|||
150091567|NCT05838742|541475400|FG003|Overall Study|Adverse Event|0|||
150091568|NCT05838742|541475401|FG004|Overall Study|Adverse Event|1|||
150091569|NCT05838742|541475397|FG000|Overall Study|Lost to Follow-up|1|||
150091570|NCT05838742|541475398|FG001|Overall Study|Lost to Follow-up|1|||
150091571|NCT05838742|541475399|FG002|Overall Study|Lost to Follow-up|1|||
150091572|NCT05838742|541475400|FG003|Overall Study|Lost to Follow-up|0|||
150091573|NCT05838742|541475401|FG004|Overall Study|Lost to Follow-up|0|||
150091574|NCT05838742|541475397|FG000|Overall Study|Physician Decision|0|||
150091575|NCT05838742|541475398|FG001|Overall Study|Physician Decision|0|||
150091576|NCT05838742|541475399|FG002|Overall Study|Physician Decision|0|||
150091577|NCT05838742|541475400|FG003|Overall Study|Physician Decision|0|||
150091578|NCT05838742|541475401|FG004|Overall Study|Physician Decision|1|||
150091579|NCT05838742|541475397|FG000|Overall Study|Withdrawal by Subject|8|||
150091580|NCT05838742|541475398|FG001|Overall Study|Withdrawal by Subject|3|||
150091581|NCT05838742|541475399|FG002|Overall Study|Withdrawal by Subject|3|||
150091582|NCT05838742|541475400|FG003|Overall Study|Withdrawal by Subject|1|||
150091583|NCT05838742|541475401|FG004|Overall Study|Withdrawal by Subject|4|||
150091584|NCT05838742|541475397|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
150091585|NCT05838742|541475398|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
150091586|NCT05838742|541475399|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
150091587|NCT05838742|541475400|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
150091588|NCT05838742|541475401|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
150091589|NCT05838742|541475397|FG000|Overall Study|Lack of Efficacy|0|||
150091590|NCT05838742|541475398|FG001|Overall Study|Lack of Efficacy|0|||
150091591|NCT05838742|541475399|FG002|Overall Study|Lack of Efficacy|0|||
150091592|NCT05838742|541475400|FG003|Overall Study|Lack of Efficacy|1|||
150091593|NCT05838742|541475401|FG004|Overall Study|Lack of Efficacy|0|||
150091594|NCT05838742|541475397|FG000|Overall Study|Randomized, not treated|2|||
150091595|NCT05838742|541475398|FG001|Overall Study|Randomized, not treated|1|||
150091596|NCT05838742|541475399|FG002|Overall Study|Randomized, not treated|0|||
150091597|NCT05838742|541475400|FG003|Overall Study|Randomized, not treated|1|||
150091598|NCT05838742|541475401|FG004|Overall Study|Randomized, not treated|0|||
150091599|NCT05119569|541475402|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
150091600|NCT05119569|541475403|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
150091601|NCT05119569|541475404|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
150091602|NCT05119569|541475405|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
150091603|NCT05119569|541475402|FG000|Double Blind Treatment Phase|Adverse Event|6|||
150091604|NCT05119569|541475403|FG001|Double Blind Treatment Phase|Adverse Event|0|||
150091605|NCT05119569|541475404|FG002|Double Blind Treatment Phase|Adverse Event|0|||
150091606|NCT05119569|541475405|FG003|Double Blind Treatment Phase|Adverse Event|0|||
150091607|NCT05119569|541475402|FG000|Open Label Extension Phase|Ongoing in the study|0|||
150091608|NCT05119569|541475403|FG001|Open Label Extension Phase|Ongoing in the study|0|||
150091609|NCT05119569|541475404|FG002|Open Label Extension Phase|Ongoing in the study|65|||
150091610|NCT05119569|541475405|FG003|Open Label Extension Phase|Ongoing in the study|34|||
150091611|NCT03700671|541475409|FG000|Overall Study|Lack of Efficacy|1|||
150091612|NCT03700671|541475410|FG001|Overall Study|Lack of Efficacy|2|||
150091613|NCT03578367|541475415|FG000|Overall Study|Adverse Event|0|||
150091614|NCT03578367|541475416|FG001|Overall Study|Adverse Event|3|||
150091615|NCT03578367|541475417|FG002|Overall Study|Adverse Event|0|||
150091616|NCT03578367|541475418|FG003|Overall Study|Adverse Event|5|||
150091617|NCT03578367|541475415|FG000|Overall Study|Withdrawal by Subject|2|||
150091618|NCT03578367|541475416|FG001|Overall Study|Withdrawal by Subject|2|||
150091619|NCT03578367|541475417|FG002|Overall Study|Withdrawal by Subject|1|||
150091620|NCT03578367|541475418|FG003|Overall Study|Withdrawal by Subject|3|||
150091621|NCT03578367|541475415|FG000|Overall Study|Physician Decision|0|||
150091622|NCT03578367|541475416|FG001|Overall Study|Physician Decision|0|||
150091623|NCT03578367|541475417|FG002|Overall Study|Physician Decision|14|||
150091624|NCT03578367|541475418|FG003|Overall Study|Physician Decision|0|||
150091625|NCT03578367|541475415|FG000|Overall Study|Death|1|||
150091626|NCT03578367|541475416|FG001|Overall Study|Death|0|||
150091627|NCT03578367|541475417|FG002|Overall Study|Death|0|||
150091628|NCT03578367|541475418|FG003|Overall Study|Death|0|||
150091629|NCT03578367|541475415|FG000|Overall Study|Not treated|0|||
150091630|NCT03578367|541475416|FG001|Overall Study|Not treated|0|||
150091631|NCT03578367|541475417|FG002|Overall Study|Not treated|1|||
150091632|NCT03578367|541475418|FG003|Overall Study|Not treated|0|||
150091633|NCT00254540|541476831|FG000|Overall Study|Adverse Event|6|||
150091634|NCT00254540|541476832|FG001|Overall Study|Adverse Event|7|||
150091635|NCT00254540|541476831|FG000|Overall Study|Lack of Efficacy|13|||
150091636|NCT00254540|541476832|FG001|Overall Study|Lack of Efficacy|13|||
150091637|NCT00254540|541476831|FG000|Overall Study|Death|0|||
150091638|NCT00254540|541476832|FG001|Overall Study|Death|1|||
150091639|NCT00254540|541476831|FG000|Overall Study|Laboratory Test Abnormality|0|||
150091640|NCT00254540|541476832|FG001|Overall Study|Laboratory Test Abnormality|1|||
150091641|NCT01287897|541476833|FG000|Overall Study|Adverse Event|5|||
150091642|NCT01287897|541476834|FG001|Overall Study|Adverse Event|3|||
150091643|NCT01287897|541476835|FG002|Overall Study|Adverse Event|6|||
150091644|NCT01287897|541476836|FG003|Overall Study|Adverse Event|4|||
150091645|NCT01287897|541476833|FG000|Overall Study|Lack of Efficacy|2|||
150091646|NCT01287897|541476834|FG001|Overall Study|Lack of Efficacy|0|||
150091647|NCT01287897|541476835|FG002|Overall Study|Lack of Efficacy|0|||
150091648|NCT01287897|541476836|FG003|Overall Study|Lack of Efficacy|0|||
150091649|NCT01287897|541476833|FG000|Overall Study|Protocol Violation|1|||
150091650|NCT01287897|541476834|FG001|Overall Study|Protocol Violation|1|||
150091651|NCT01287897|541476835|FG002|Overall Study|Protocol Violation|0|||
150091652|NCT01287897|541476836|FG003|Overall Study|Protocol Violation|1|||
150091653|NCT01287897|541476833|FG000|Overall Study|Lost to Follow-up|0|||
150091654|NCT01287897|541476834|FG001|Overall Study|Lost to Follow-up|0|||
150091655|NCT01287897|541476835|FG002|Overall Study|Lost to Follow-up|2|||
150091656|NCT01287897|541476836|FG003|Overall Study|Lost to Follow-up|0|||
150091657|NCT01287897|541476833|FG000|Overall Study|Withdrawal by Subject|1|||
150091658|NCT01287897|541476834|FG001|Overall Study|Withdrawal by Subject|5|||
150091659|NCT01287897|541476835|FG002|Overall Study|Withdrawal by Subject|3|||
150091660|NCT01287897|541476836|FG003|Overall Study|Withdrawal by Subject|2|||
150091661|NCT01287897|541476833|FG000|Overall Study|Not consented properly|0|||
150091662|NCT01287897|541476834|FG001|Overall Study|Not consented properly|1|||
150091663|NCT01287897|541476835|FG002|Overall Study|Not consented properly|0|||
150091664|NCT01287897|541476836|FG003|Overall Study|Not consented properly|0|||
150091665|NCT01287897|541476833|FG000|Overall Study|Not meeting entrance criteria|1|||
150091666|NCT01287897|541476834|FG001|Overall Study|Not meeting entrance criteria|1|||
150091667|NCT01287897|541476835|FG002|Overall Study|Not meeting entrance criteria|0|||
150091668|NCT01287897|541476836|FG003|Overall Study|Not meeting entrance criteria|0|||
150091669|NCT01287897|541476833|FG000|Overall Study|Other|1|||
150091670|NCT01287897|541476834|FG001|Overall Study|Other|0|||
150091671|NCT01287897|541476835|FG002|Overall Study|Other|1|||
150091672|NCT01287897|541476836|FG003|Overall Study|Other|0|||
150091673|NCT02902965|541476837|FG000|Overall Study|Withdrawal by Subject|10|||
150091674|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
150091675|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
150091676|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
150091677|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
150091678|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
150091679|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
150091680|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
150091681|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
150091682|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
150091683|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
150091684|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
150091685|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
150091686|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
150091687|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
150091688|NCT00293254|541476838|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
150091689|NCT00293254|541476839|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
150091690|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
150091691|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
150091692|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Death|4|||
150091693|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Death|1|||
150091694|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
150091695|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
150091696|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
150091697|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
150091698|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
150091699|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
150091700|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
150091701|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
150091702|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
150091703|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
150091704|NCT00293254|541476838|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
150091705|NCT00293254|541476839|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
150091706|NCT00293254|541476838|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
150091707|NCT00293254|541476839|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
150091708|NCT00293254|541476838|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
150091709|NCT00293254|541476839|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
150091710|NCT00293254|541476838|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
150091711|NCT00293254|541476839|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
150091712|NCT00293254|541476838|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
150091713|NCT00293254|541476839|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
150091714|NCT00293254|541476838|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
150091715|NCT00293254|541476839|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
150091716|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
150091717|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
150091718|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
150091719|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
150091720|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
150091721|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
150091722|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
150091723|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
150091724|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
150091725|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
150091726|NCT00293254|541476838|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
150091727|NCT00293254|541476839|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
150091728|NCT00503308|541476840|FG000|Overall Study|Protocol Violation|2|||
150091729|NCT00503308|541476841|FG001|Overall Study|Protocol Violation|1|||
150091730|NCT04481750|541476842|FG000|Period 1 (Fasted)|Adverse Event|0|||
150091731|NCT04481750|541476843|FG001|Period 1 (Fasted)|Adverse Event|0|||
150091732|NCT04481750|541476844|FG002|Period 1 (Fasted)|Adverse Event|1|||
150091733|NCT04481750|541476845|FG003|Period 1 (Fasted)|Adverse Event|0|||
150091734|NCT04481750|541476846|FG004|Period 1 (Fasted)|Adverse Event|0|||
150091735|NCT04481750|541476847|FG005|Period 1 (Fasted)|Adverse Event|0|||
150091736|NCT04481750|541476848|FG006|Period 1 (Fasted)|Adverse Event|0|||
150091737|NCT04481750|541476849|FG007|Period 1 (Fasted)|Adverse Event|0|||
150091738|NCT04481750|541476850|FG008|Period 1 (Fasted)|Adverse Event|0|||
150091739|NCT04481750|541476851|FG009|Period 1 (Fasted)|Adverse Event|0|||
150091740|NCT04481750|541476852|FG010|Period 1 (Fasted)|Adverse Event|0|||
150091741|NCT01475331|541476853|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
150091742|NCT01475331|541476854|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
150091743|NCT01475331|541476853|FG000|Overall Study|excessive main duct communication|1|||
150091744|NCT01475331|541476854|FG001|Overall Study|excessive main duct communication|1|||
150091745|NCT01475331|541476853|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
150091746|NCT01475331|541476854|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
150091747|NCT01475331|541476853|FG000|Overall Study|Sign of malignancy during the procedure|2|||
150091748|NCT01475331|541476854|FG001|Overall Study|Sign of malignancy during the procedure|0|||
150091749|NCT01475331|541476853|FG000|Overall Study|cyst found to be prohibitively small|0|||
150091750|NCT01475331|541476854|FG001|Overall Study|cyst found to be prohibitively small|1|||
150091751|NCT00462761|541476855|FG000|Overall Study|Adverse Event|6|||
150091752|NCT00462761|541476855|FG000|Overall Study|Withdrawal by Subject|9|||
150091753|NCT00462761|541476855|FG000|Overall Study|Physician Decision|5|||
150091754|NCT00462761|541476855|FG000|Overall Study|Disease progression|43|||
150091755|NCT00462761|541476855|FG000|Overall Study|Death|12|||
150091756|NCT00462761|541476855|FG000|Overall Study|Other|1|||
150091757|NCT00723892|541476856|FG000|Overall Study|Participant not tracked|33|||
150091758|NCT00723892|541476857|FG001|Overall Study|Participant not tracked|35|||
150091759|NCT00723892|541476856|FG000|Overall Study|Virological criterion|24|||
150091760|NCT00723892|541476857|FG001|Overall Study|Virological criterion|9|||
150091761|NCT00723892|541476856|FG000|Overall Study|Withdrawal by Subject|6|||
150091762|NCT00723892|541476857|FG001|Overall Study|Withdrawal by Subject|9|||
150091763|NCT00723892|541476856|FG000|Overall Study|End planned|11|||
150091764|NCT00723892|541476857|FG001|Overall Study|End planned|7|||
150091765|NCT00723892|541476856|FG000|Overall Study|Bad tolerance|5|||
150091766|NCT00723892|541476857|FG001|Overall Study|Bad tolerance|5|||
150091767|NCT00723892|541476856|FG000|Overall Study|Multiple reasons|17|||
150091768|NCT00723892|541476857|FG001|Overall Study|Multiple reasons|12|||
150091769|NCT00723892|541476856|FG000|Overall Study|Other|6|||
150091770|NCT00723892|541476857|FG001|Overall Study|Other|3|||
150091771|NCT00723892|541476856|FG000|Overall Study|Study end|1|||
150091772|NCT00723892|541476857|FG001|Overall Study|Study end|3|||
150091773|NCT00723892|541476856|FG000|Overall Study|Weight loss|1|||
150091774|NCT00723892|541476857|FG001|Overall Study|Weight loss|3|||
150091775|NCT00723892|541476856|FG000|Overall Study|Alcohol abuse|0|||
150091776|NCT00723892|541476857|FG001|Overall Study|Alcohol abuse|1|||
150091777|NCT00723892|541476856|FG000|Overall Study|Intercurrent infection|2|||
150091778|NCT00723892|541476857|FG001|Overall Study|Intercurrent infection|0|||
150091779|NCT00723892|541476856|FG000|Overall Study|Drug addiction|1|||
150091780|NCT00723892|541476857|FG001|Overall Study|Drug addiction|0|||
150091781|NCT04532099|541476858|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
150091782|NCT04532099|541476859|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
150091783|NCT04532099|541476860|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
150091784|NCT01949051|541476870|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
150091785|NCT01949051|541476871|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
150091786|NCT01949051|541476872|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
150091787|NCT01949051|541476873|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
150091788|NCT01949051|541476874|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
150091789|NCT01949051|541476875|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
150091790|NCT01949051|541476870|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
150091791|NCT01949051|541476871|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150091792|NCT01949051|541476872|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150091793|NCT01949051|541476873|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150091794|NCT01949051|541476874|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150091795|NCT01949051|541476875|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
150091796|NCT01949051|541476870|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
150091797|NCT01949051|541476871|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
150091798|NCT01949051|541476872|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
150091799|NCT01949051|541476873|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
150091800|NCT01949051|541476874|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
150091801|NCT01949051|541476875|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
150091802|NCT01949051|541476870|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
150091803|NCT01949051|541476871|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
150091804|NCT01949051|541476872|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
150091805|NCT01949051|541476873|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
150091806|NCT01949051|541476874|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
150091807|NCT01949051|541476875|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
150091808|NCT01949051|541476870|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
150091809|NCT01949051|541476871|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
150091810|NCT01949051|541476872|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
150091811|NCT01949051|541476873|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
150091812|NCT01949051|541476874|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
150091813|NCT01949051|541476875|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
150091814|NCT01506479|541476877|FG000|Overall Study|Lost to Follow-up|1|||
150091815|NCT01506479|541476878|FG001|Overall Study|Lost to Follow-up|2|||
150091816|NCT01506479|541476879|FG002|Overall Study|Lost to Follow-up|2|||
150091817|NCT01506479|541476877|FG000|Overall Study|Withdrawal by Subject|1|||
150091818|NCT01506479|541476878|FG001|Overall Study|Withdrawal by Subject|2|||
150091819|NCT01506479|541476879|FG002|Overall Study|Withdrawal by Subject|1|||
150091820|NCT01506479|541476877|FG000|Overall Study|Missing assessment|1|||
150091821|NCT01506479|541476878|FG001|Overall Study|Missing assessment|0|||
150091822|NCT01506479|541476879|FG002|Overall Study|Missing assessment|0|||
150091823|NCT01506479|541476877|FG000|Overall Study|Adverse Event|0|||
150091824|NCT01506479|541476878|FG001|Overall Study|Adverse Event|1|||
150091825|NCT01506479|541476879|FG002|Overall Study|Adverse Event|0|||
150091826|NCT01846507|541476880|FG000|Overall Study|Lost to Follow-up|4|||
150091827|NCT01846507|541476880|FG000|Overall Study|Protocol Violation|1|||
150091828|NCT01846507|541476880|FG000|Overall Study|Missing data|2|||
150091829|NCT01782859|541476881|FG000|Overall Study|Protocol Violation|6|||
150091830|NCT01782859|541476882|FG001|Overall Study|Protocol Violation|6|||
150091831|NCT01782859|541476881|FG000|Overall Study|Withdrawal by Subject|0|||
150091832|NCT01782859|541476882|FG001|Overall Study|Withdrawal by Subject|1|||
150091833|NCT04900220|541476885|FG000|Overall Study|Lost to Follow-up|1|||
150091834|NCT04900220|541476886|FG001|Overall Study|Lost to Follow-up|1|||
150091835|NCT03266094|541476891|FG000|Overall Study|Lost to Follow-up|1|||
150091836|NCT03266094|541476891|FG000|Overall Study|Withdrawal by Subject|1|||
150091837|NCT03128892|541476892|FG000|Overall Study|Withdrawal by Subject|2|||
150091838|NCT03128892|541476892|FG000|Overall Study|Physician Decision|1|||
150091839|NCT01850524|541476893|FG000|Overall Study|Lost to Follow-up|5|||
150091840|NCT01850524|541476894|FG001|Overall Study|Lost to Follow-up|10|||
150091841|NCT01850524|541476893|FG000|Overall Study|Withdrawal by Subject|24|||
150091842|NCT01850524|541476894|FG001|Overall Study|Withdrawal by Subject|22|||
150091843|NCT01850524|541476893|FG000|Overall Study|Reason not Specified|142|||
150091844|NCT01850524|541476894|FG001|Overall Study|Reason not Specified|141|||
150091845|NCT00368355|541476895|FG000|Overall Study|Adverse Event|1|||
150091846|NCT00368355|541476896|FG001|Overall Study|Adverse Event|0|||
150091847|NCT00368355|541476895|FG000|Overall Study|Death|2|||
150091848|NCT00368355|541476896|FG001|Overall Study|Death|4|||
150091849|NCT00368355|541476895|FG000|Overall Study|Relapse|6|||
150091850|NCT00368355|541476896|FG001|Overall Study|Relapse|10|||
150091851|NCT00368355|541476895|FG000|Overall Study|Subsequent transplant|0|||
150091852|NCT00368355|541476896|FG001|Overall Study|Subsequent transplant|3|||
150091853|NCT00368355|541476895|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
150091854|NCT00368355|541476896|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
150091855|NCT03473808|541476900|FG000|Overall Study|Withdrawal by Subject|1|||
150091856|NCT03171415|541476903|FG000|Overall Study|Lost to Follow-up|0|||
150091857|NCT03171415|541476904|FG001|Overall Study|Lost to Follow-up|0|||
150091858|NCT03171415|541476905|FG002|Overall Study|Lost to Follow-up|0|||
150091859|NCT03171415|541476906|FG003|Overall Study|Lost to Follow-up|0|||
150091860|NCT03171415|541476907|FG004|Overall Study|Lost to Follow-up|2|||
150091861|NCT01085591|541476912|FG000|Overall Study|Adverse Event|0|||
150091862|NCT01085591|541476913|FG001|Overall Study|Adverse Event|1|||
150091863|NCT01085591|541476914|FG002|Overall Study|Adverse Event|3|||
150091864|NCT01085591|541476912|FG000|Overall Study|Physician Decision|1|||
150091865|NCT01085591|541476913|FG001|Overall Study|Physician Decision|0|||
150091866|NCT01085591|541476914|FG002|Overall Study|Physician Decision|1|||
150091867|NCT01085591|541476912|FG000|Overall Study|Withdrawal by Subject|0|||
150091868|NCT01085591|541476913|FG001|Overall Study|Withdrawal by Subject|2|||
150091869|NCT01085591|541476914|FG002|Overall Study|Withdrawal by Subject|1|||
150091870|NCT01085591|541476912|FG000|Overall Study|Lost to Follow-up|0|||
150091871|NCT01085591|541476913|FG001|Overall Study|Lost to Follow-up|1|||
150091872|NCT01085591|541476914|FG002|Overall Study|Lost to Follow-up|1|||
150091873|NCT01085591|541476912|FG000|Overall Study|Protocol Violation|1|||
150091874|NCT01085591|541476913|FG001|Overall Study|Protocol Violation|1|||
150091875|NCT01085591|541476914|FG002|Overall Study|Protocol Violation|1|||
150091876|NCT01085591|541476912|FG000|Overall Study|Other|0|||
150091877|NCT01085591|541476913|FG001|Overall Study|Other|1|||
150091878|NCT01085591|541476914|FG002|Overall Study|Other|0|||
150091879|NCT01085591|541476912|FG000|Overall Study|Not Properly Consented|1|||
150091880|NCT01085591|541476913|FG001|Overall Study|Not Properly Consented|0|||
150091881|NCT01085591|541476914|FG002|Overall Study|Not Properly Consented|0|||
150091882|NCT00459667|541476919|FG000|Overall Study|Adverse Event|9|||
150091883|NCT00459667|541476920|FG001|Overall Study|Adverse Event|12|||
150091884|NCT00459667|541476921|FG002|Overall Study|Adverse Event|8|||
150091885|NCT00459667|541476919|FG000|Overall Study|Lost to Follow-up|5|||
150091886|NCT00459667|541476920|FG001|Overall Study|Lost to Follow-up|9|||
150091887|NCT00459667|541476921|FG002|Overall Study|Lost to Follow-up|3|||
150091888|NCT00459667|541476919|FG000|Overall Study|Pregnancy|1|||
150091889|NCT00459667|541476920|FG001|Overall Study|Pregnancy|1|||
150091890|NCT00459667|541476921|FG002|Overall Study|Pregnancy|1|||
150091891|NCT00459667|541476919|FG000|Overall Study|Protocol Violation|1|||
150091892|NCT00459667|541476920|FG001|Overall Study|Protocol Violation|0|||
150091893|NCT00459667|541476921|FG002|Overall Study|Protocol Violation|0|||
150091894|NCT00459667|541476919|FG000|Overall Study|Withdrawal by Subject|3|||
150091895|NCT00459667|541476920|FG001|Overall Study|Withdrawal by Subject|5|||
150091896|NCT00459667|541476921|FG002|Overall Study|Withdrawal by Subject|5|||
150091897|NCT00459667|541476919|FG000|Overall Study|Other disease modifying treatment|1|||
150091898|NCT00459667|541476920|FG001|Overall Study|Other disease modifying treatment|2|||
150091899|NCT00459667|541476921|FG002|Overall Study|Other disease modifying treatment|1|||
150091900|NCT00459667|541476919|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
150091901|NCT00459667|541476920|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
150091902|NCT00459667|541476921|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
150091903|NCT00459667|541476919|FG000|Overall Study|No treatment administered|6|||
150091904|NCT00459667|541476920|FG001|Overall Study|No treatment administered|3|||
150091905|NCT00459667|541476921|FG002|Overall Study|No treatment administered|1|||
150091906|NCT00396591|541476924|FG000|Overall Study|Disease Progression|13|||
150091907|NCT00396591|541476924|FG000|Overall Study|Adverse Event|2|||
150091908|NCT00396591|541476924|FG000|Overall Study|Participant request|1|||
150091909|NCT01846611|541476928|FG000|Overall Study|Lost to Follow-up|4|||
150091910|NCT01846611|541476929|FG001|Overall Study|Lost to Follow-up|6|||
150091911|NCT01846611|541476928|FG000|Overall Study|Withdrawal by Subject|15|||
150091912|NCT01846611|541476929|FG001|Overall Study|Withdrawal by Subject|19|||
150091913|NCT01846611|541476928|FG000|Overall Study|Other|19|||
150091914|NCT01846611|541476929|FG001|Overall Study|Other|18|||
150091915|NCT00541034|541476930|FG000|Overall Study|Non-Compliance|3|||
150091916|NCT00847704|541476932|FG000|Overall Study|Withdrawal by Subject|1|||
150091917|NCT03061331|541476933|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
150091918|NCT03061331|541476934|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
150091919|NCT01905657|541476935|FG000|Overall Study|Adverse Event|23|||
150091920|NCT01905657|541476936|FG001|Overall Study|Adverse Event|17|||
150091921|NCT01905657|541476937|FG002|Overall Study|Adverse Event|18|||
150091922|NCT01905657|541476935|FG000|Overall Study|Clinical Progression|103|||
150091923|NCT01905657|541476936|FG001|Overall Study|Clinical Progression|78|||
150091924|NCT01905657|541476937|FG002|Overall Study|Clinical Progression|59|||
150091925|NCT01905657|541476935|FG000|Overall Study|Death|40|||
150091926|NCT01905657|541476936|FG001|Overall Study|Death|43|||
150091927|NCT01905657|541476937|FG002|Overall Study|Death|47|||
150091928|NCT01905657|541476935|FG000|Overall Study|Excluded Medication|13|||
150091929|NCT01905657|541476936|FG001|Overall Study|Excluded Medication|16|||
150091930|NCT01905657|541476937|FG002|Overall Study|Excluded Medication|9|||
150091931|NCT01905657|541476935|FG000|Overall Study|Lost to Follow-up|1|||
150091932|NCT01905657|541476936|FG001|Overall Study|Lost to Follow-up|2|||
150091933|NCT01905657|541476937|FG002|Overall Study|Lost to Follow-up|1|||
150091934|NCT01905657|541476935|FG000|Overall Study|Physician Decision|5|||
150091935|NCT01905657|541476936|FG001|Overall Study|Physician Decision|8|||
150091936|NCT01905657|541476937|FG002|Overall Study|Physician Decision|12|||
150091937|NCT01905657|541476935|FG000|Overall Study|Protocol Violation|2|||
150091938|NCT01905657|541476936|FG001|Overall Study|Protocol Violation|1|||
150091939|NCT01905657|541476937|FG002|Overall Study|Protocol Violation|1|||
150091940|NCT01905657|541476935|FG000|Overall Study|Screen Failure|0|||
150091941|NCT01905657|541476936|FG001|Overall Study|Screen Failure|1|||
150091942|NCT01905657|541476937|FG002|Overall Study|Screen Failure|0|||
150091943|NCT01905657|541476935|FG000|Overall Study|Withdrawal by Subject|15|||
150091944|NCT01905657|541476936|FG001|Overall Study|Withdrawal by Subject|21|||
150091945|NCT01905657|541476937|FG002|Overall Study|Withdrawal by Subject|53|||
150091946|NCT01905657|541476935|FG000|Overall Study|Sponsor Decision|1|||
150091947|NCT01905657|541476936|FG001|Overall Study|Sponsor Decision|0|||
150091948|NCT01905657|541476937|FG002|Overall Study|Sponsor Decision|0|||
150091949|NCT04080297|541476939|FG000|Overall Study|Adverse Event|1|||
150091950|NCT04080297|541476940|FG001|Overall Study|Adverse Event|3|||
150091951|NCT04080297|541476939|FG000|Overall Study|concurrent illness|1|||
150091952|NCT04080297|541476940|FG001|Overall Study|concurrent illness|0|||
150091953|NCT02744391|541476941|FG000|Overall Study|Lost to Follow-up|9|||
150091954|NCT02744391|541476941|FG000|Overall Study|Physician Decision|2|||
150091955|NCT02744391|541476941|FG000|Overall Study|Withdrawal by Subject|3|||
150091956|NCT02623439|541476946|FG000|Overall Study|Withdrawal by Subject|1|||
150091957|NCT02623439|541476946|FG000|Overall Study|Screen Failure|1|||
150091958|NCT04484142|541476949|FG000|Overall Study|Adverse Event|13|||
150091959|NCT04484142|541476949|FG000|Overall Study|Progressive Disease|87|||
150091960|NCT04484142|541476949|FG000|Overall Study|Clinical Progression|10|||
150091961|NCT04484142|541476949|FG000|Overall Study|Withdrawal by Subject|6|||
150091962|NCT04484142|541476949|FG000|Overall Study|Physician Decision|1|||
150091963|NCT05371509|541476950|FG000|Overall Study|Physician Decision|1|||
150091964|NCT05371509|541476951|FG001|Overall Study|Physician Decision|0|||
150091965|NCT03851302|541476954|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
150091966|NCT03851302|541476955|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
150091967|NCT03851302|541476956|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
150091968|NCT03851302|541476957|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
150091969|NCT03851302|541476958|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
150091970|NCT03851302|541476959|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
150091971|NCT03851302|541476954|FG000|Screening (1 Day)|Screened out|0|||
150091972|NCT03851302|541476955|FG001|Screening (1 Day)|Screened out|0|||
150091973|NCT03851302|541476956|FG002|Screening (1 Day)|Screened out|1|||
150029143|NCT00867165|541242613|FG001|Overall Study|Withdrawal by Subject|0|||
150184487|NCT00073749|541813356|FG006|Overall Study|Withdrawal by Subject|2|||
150029144|NCT03550378|541242614|FG000|Overall Study|Death|0|||
150029145|NCT03550378|541242615|FG001|Overall Study|Death|1|||
150029146|NCT00689390|541242619|FG000|Overall Study|Adverse Event|19|||
150029147|NCT00689390|541242620|FG001|Overall Study|Adverse Event|0|||
150029148|NCT00689390|541242619|FG000|Overall Study|Lost to Follow-up|179|||
150029149|NCT00689390|541242620|FG001|Overall Study|Lost to Follow-up|7|||
150029150|NCT00689390|541242619|FG000|Overall Study|Withdrawal by Subject|117|||
150029151|NCT00689390|541242620|FG001|Overall Study|Withdrawal by Subject|3|||
150029152|NCT00689390|541242619|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
150029153|NCT00689390|541242620|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
150029154|NCT00689390|541242619|FG000|Overall Study|Non-Compliance With Protocol|21|||
150029155|NCT00689390|541242620|FG001|Overall Study|Non-Compliance With Protocol|0|||
150029156|NCT00689390|541242619|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
150029157|NCT00689390|541242620|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
150029158|NCT00689390|541242619|FG000|Overall Study|Administrative|37|||
150029159|NCT00689390|541242620|FG001|Overall Study|Administrative|0|||
150029160|NCT02343263|541242621|FG000|Overall Study|Physician Decision|5|||
150029161|NCT02343263|541242622|FG001|Overall Study|Physician Decision|3|||
150029162|NCT02343263|541242623|FG002|Overall Study|Physician Decision|1|||
150029163|NCT01384734|541242624|FG000|Overall Study|Adverse Event|0|||
150029164|NCT01384734|541242625|FG001|Overall Study|Adverse Event|3|||
150029165|NCT01384734|541242626|FG002|Overall Study|Adverse Event|0|||
150029166|NCT01384734|541242627|FG003|Overall Study|Adverse Event|2|||
150029167|NCT01384734|541242628|FG004|Overall Study|Adverse Event|7|||
150029168|NCT01384734|541242624|FG000|Overall Study|Death|1|||
150029169|NCT01384734|541242625|FG001|Overall Study|Death|0|||
150029170|NCT01384734|541242626|FG002|Overall Study|Death|1|||
150029171|NCT01384734|541242627|FG003|Overall Study|Death|0|||
150029172|NCT01384734|541242628|FG004|Overall Study|Death|0|||
150029173|NCT01384734|541242624|FG000|Overall Study|Continuation criteria not met|0|||
150029174|NCT01384734|541242625|FG001|Overall Study|Continuation criteria not met|0|||
150029175|NCT01384734|541242626|FG002|Overall Study|Continuation criteria not met|1|||
150029176|NCT01384734|541242627|FG003|Overall Study|Continuation criteria not met|1|||
150029177|NCT01384734|541242628|FG004|Overall Study|Continuation criteria not met|0|||
150029178|NCT01384734|541242624|FG000|Overall Study|Lack of Efficacy|3|||
150184488|NCT00073749|541813350|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
150029179|NCT01384734|541242625|FG001|Overall Study|Lack of Efficacy|7|||
150029180|NCT01384734|541242626|FG002|Overall Study|Lack of Efficacy|4|||
150029181|NCT01384734|541242627|FG003|Overall Study|Lack of Efficacy|4|||
150029182|NCT01384734|541242628|FG004|Overall Study|Lack of Efficacy|2|||
150029183|NCT01384734|541242624|FG000|Overall Study|Lost to Follow-up|5|||
150029184|NCT01384734|541242625|FG001|Overall Study|Lost to Follow-up|3|||
150029185|NCT01384734|541242626|FG002|Overall Study|Lost to Follow-up|3|||
150029186|NCT01384734|541242627|FG003|Overall Study|Lost to Follow-up|8|||
150029187|NCT01384734|541242628|FG004|Overall Study|Lost to Follow-up|5|||
150091974|NCT03851302|541476957|FG003|Screening (1 Day)|Screened out|1|||
150091975|NCT03851302|541476958|FG004|Screening (1 Day)|Screened out|0|||
150091976|NCT03851302|541476959|FG005|Screening (1 Day)|Screened out|0|||
150091977|NCT03851302|541476954|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
150091978|NCT03851302|541476955|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
150091979|NCT03851302|541476956|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
150091980|NCT03851302|541476957|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
150091981|NCT03851302|541476958|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
150091982|NCT03851302|541476959|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
150091983|NCT04434092|541476960|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
150091984|NCT04434092|541476961|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
150091985|NCT04434092|541476962|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
150091986|NCT04434092|541476960|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
150091987|NCT04434092|541476961|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
150091988|NCT04434092|541476962|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
150091989|NCT04434092|541476960|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
150091990|NCT04434092|541476961|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
150091991|NCT04434092|541476962|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
150091992|NCT04434092|541476960|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
150091993|NCT04434092|541476961|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
150091994|NCT04434092|541476962|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
150091995|NCT04434092|541476960|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
150091996|NCT04434092|541476961|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
150091997|NCT04434092|541476962|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
150091998|NCT04434092|541476960|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
150091999|NCT04434092|541476961|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
150092000|NCT04434092|541476962|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
150092001|NCT04434092|541476960|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
150092002|NCT04434092|541476961|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
150092003|NCT04434092|541476962|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
150092004|NCT02879305|541476963|FG000|Overall Study|Investigator Site Closed|55|||
150092005|NCT02879305|541476964|FG001|Overall Study|Investigator Site Closed|57|||
150092006|NCT02879305|541476963|FG000|Overall Study|Withdrawal by Subject|44|||
150092007|NCT02879305|541476964|FG001|Overall Study|Withdrawal by Subject|42|||
150092008|NCT02879305|541476963|FG000|Overall Study|Lost to Follow-up|17|||
150092009|NCT02879305|541476964|FG001|Overall Study|Lost to Follow-up|12|||
150092010|NCT02879305|541476963|FG000|Overall Study|Other|1|||
150092011|NCT02879305|541476964|FG001|Overall Study|Other|0|||
150092012|NCT03204981|541478806|FG000|Overall Study|Physician Decision|2|||
150092013|NCT03204981|541478806|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
150092014|NCT00623727|541478807|FG000|Double Blind (DB)|Adverse Event|1|||
150092015|NCT00623727|541478808|FG001|Double Blind (DB)|Adverse Event|3|||
150092016|NCT00623727|541478807|FG000|Double Blind (DB)|Physician Decision|0|||
150092017|NCT00623727|541478808|FG001|Double Blind (DB)|Physician Decision|1|||
150092018|NCT00623727|541478807|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
150092019|NCT00623727|541478808|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
150092020|NCT00623727|541478807|FG000|Double Blind (DB)|Lack of Efficacy|2|||
150092021|NCT00623727|541478808|FG001|Double Blind (DB)|Lack of Efficacy|2|||
150092022|NCT00623727|541478807|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
150092023|NCT00623727|541478808|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
150092024|NCT00623727|541478807|FG000|Double Blind (DB)|Lost to Follow-up|1|||
150092025|NCT00623727|541478808|FG001|Double Blind (DB)|Lost to Follow-up|1|||
150092026|NCT00623727|541478807|FG000|Double Blind (DB)|Protocol Violation|2|||
150092027|NCT00623727|541478808|FG001|Double Blind (DB)|Protocol Violation|2|||
150092028|NCT00623727|541478807|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
150092029|NCT00623727|541478808|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
150092030|NCT00623727|541478807|FG000|Open Label Follow-up|Study termination|0|||
150092031|NCT00623727|541478808|FG001|Open Label Follow-up|Study termination|6|||
150092032|NCT00623727|541478807|FG000|Open Label Follow-up|Participant convenience|0|||
150092033|NCT00623727|541478808|FG001|Open Label Follow-up|Participant convenience|1|||
150092034|NCT03220217|541478809|FG000|Overall Study|Withdrawal by Subject|0|||
150092035|NCT03220217|541478810|FG001|Overall Study|Withdrawal by Subject|1|||
150092036|NCT03220217|541478811|FG002|Overall Study|Withdrawal by Subject|0|||
150092037|NCT03220217|541478809|FG000|Overall Study|Subject Missed Procedure|0|||
150092038|NCT03220217|541478810|FG001|Overall Study|Subject Missed Procedure|0|||
150092039|NCT03220217|541478811|FG002|Overall Study|Subject Missed Procedure|1|||
150092040|NCT00501293|541478812|FG000|Optimization Period|Enrolled in error|1|||
150092041|NCT00501293|541478813|FG001|Optimization Period|Enrolled in error|0|||
150092042|NCT00501293|541478812|FG000|Maintenance Period|Withdrawal by Subject|14|||
150092043|NCT00501293|541478813|FG001|Maintenance Period|Withdrawal by Subject|13|||
150092044|NCT00501293|541478812|FG000|Maintenance Period|Lost to Follow-up|12|||
150092045|NCT00501293|541478813|FG001|Maintenance Period|Lost to Follow-up|7|||
150092046|NCT00501293|541478812|FG000|Maintenance Period|Adverse Event|6|||
150092047|NCT00501293|541478813|FG001|Maintenance Period|Adverse Event|6|||
150092048|NCT00501293|541478812|FG000|Maintenance Period|Protocol Violation|2|||
150092049|NCT00501293|541478813|FG001|Maintenance Period|Protocol Violation|1|||
150092050|NCT00501293|541478812|FG000|Maintenance Period|Lack of Efficacy|4|||
150092051|NCT00501293|541478813|FG001|Maintenance Period|Lack of Efficacy|1|||
150092052|NCT00501293|541478812|FG000|Maintenance Period|Noncompliant with study medication|5|||
150092053|NCT00501293|541478813|FG001|Maintenance Period|Noncompliant with study medication|0|||
150092054|NCT00501293|541478812|FG000|Maintenance Period|Went into rehabilitation|1|||
150092055|NCT00501293|541478813|FG001|Maintenance Period|Went into rehabilitation|0|||
150092056|NCT00501293|541478812|FG000|Maintenance Period|Would not wear patch|1|||
150092057|NCT00501293|541478813|FG001|Maintenance Period|Would not wear patch|0|||
150092058|NCT00501293|541478812|FG000|Maintenance Period|Application site reaction|1|||
150092059|NCT00501293|541478813|FG001|Maintenance Period|Application site reaction|0|||
150092060|NCT00488345|541478814|FG000|Overall Study|Adverse Event|0|||
150092061|NCT00488345|541478815|FG001|Overall Study|Adverse Event|1|||
150092062|NCT00488345|541478816|FG002|Overall Study|Adverse Event|1|||
150092063|NCT00488345|541478814|FG000|Overall Study|Unable to administer antibiotics at home|0|||
150092064|NCT00488345|541478815|FG001|Overall Study|Unable to administer antibiotics at home|1|||
150092065|NCT00488345|541478816|FG002|Overall Study|Unable to administer antibiotics at home|0|||
150092066|NCT00488345|541478814|FG000|Overall Study|Institutional Review Board review|0|||
150092067|NCT00488345|541478815|FG001|Overall Study|Institutional Review Board review|0|||
150092068|NCT00488345|541478816|FG002|Overall Study|Institutional Review Board review|1|||
150092069|NCT00488345|541478814|FG000|Overall Study|Surgical team recommendation|0|||
150092070|NCT00488345|541478815|FG001|Overall Study|Surgical team recommendation|1|||
150092071|NCT00488345|541478816|FG002|Overall Study|Surgical team recommendation|0|||
150092072|NCT00488345|541478814|FG000|Overall Study|Parent/legal guardian request|0|||
150092073|NCT00488345|541478815|FG001|Overall Study|Parent/legal guardian request|1|||
150092074|NCT00488345|541478816|FG002|Overall Study|Parent/legal guardian request|1|||
150092075|NCT00903617|541478819|FG000|Overall Study|Adverse Event|0|||
150092076|NCT00903617|541478820|FG001|Overall Study|Adverse Event|1|||
150092077|NCT00903617|541478821|FG002|Overall Study|Adverse Event|1|||
150092078|NCT00903617|541478822|FG003|Overall Study|Adverse Event|0|||
150092079|NCT00903617|541478819|FG000|Overall Study|Protocol-defined stopping criteria|0|||
150092080|NCT00903617|541478820|FG001|Overall Study|Protocol-defined stopping criteria|2|||
150092081|NCT00903617|541478821|FG002|Overall Study|Protocol-defined stopping criteria|0|||
150092082|NCT00903617|541478822|FG003|Overall Study|Protocol-defined stopping criteria|0|||
150092083|NCT00903617|541478819|FG000|Overall Study|Lost to Follow-up|2|||
150092084|NCT00903617|541478820|FG001|Overall Study|Lost to Follow-up|0|||
150092085|NCT00903617|541478821|FG002|Overall Study|Lost to Follow-up|1|||
150092086|NCT00903617|541478822|FG003|Overall Study|Lost to Follow-up|1|||
150092087|NCT00903617|541478819|FG000|Overall Study|Withdrawal by Subject|1|||
150092088|NCT00903617|541478820|FG001|Overall Study|Withdrawal by Subject|2|||
150092089|NCT00903617|541478821|FG002|Overall Study|Withdrawal by Subject|3|||
150092090|NCT00903617|541478822|FG003|Overall Study|Withdrawal by Subject|0|||
150092091|NCT01104636|541478823|FG000|Overall Study|Lack of Efficacy|43|||
150092092|NCT01104636|541478823|FG000|Overall Study|Lost to Follow-up|24|||
150092093|NCT01104636|541478823|FG000|Overall Study|Withdrawal by Subject|4|||
150092094|NCT01104636|541478823|FG000|Overall Study|Other|43|||
150092095|NCT01104636|541478823|FG000|Overall Study|Study terminated by sponsor|1|||
150092096|NCT01104636|541478823|FG000|Overall Study|Pregnancy|2|||
150092097|NCT01104636|541478823|FG000|Overall Study|Adverse Event|40|||
150092098|NCT01104636|541478823|FG000|Overall Study|Ongoing|21|||
150184489|NCT00073749|541813351|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
150184490|NCT00073749|541813352|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
150184491|NCT00073749|541813353|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
150184492|NCT00073749|541813354|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
150092099|NCT02259582|541478828|FG000|Overall Study|Physician Decision|0|||
150092100|NCT02259582|541478829|FG001|Overall Study|Physician Decision|1|||
150092101|NCT02259582|541478830|FG002|Overall Study|Physician Decision|0|||
150092102|NCT02259582|541478828|FG000|Overall Study|Death|0|||
150092103|NCT02259582|541478829|FG001|Overall Study|Death|0|||
150092104|NCT02259582|541478830|FG002|Overall Study|Death|1|||
150092105|NCT02259582|541478828|FG000|Overall Study|Adverse Event|1|||
150092106|NCT02259582|541478829|FG001|Overall Study|Adverse Event|0|||
150092107|NCT02259582|541478830|FG002|Overall Study|Adverse Event|1|||
150092108|NCT02259582|541478828|FG000|Overall Study|Withdrawal by Subject|0|||
150092109|NCT02259582|541478829|FG001|Overall Study|Withdrawal by Subject|0|||
150092110|NCT02259582|541478830|FG002|Overall Study|Withdrawal by Subject|1|||
150092111|NCT02259582|541478828|FG000|Overall Study|Disease progression|14|||
150092112|NCT02259582|541478829|FG001|Overall Study|Disease progression|15|||
150092113|NCT02259582|541478830|FG002|Overall Study|Disease progression|17|||
150092114|NCT02259582|541478828|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
150092115|NCT02259582|541478829|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
150092116|NCT02259582|541478830|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
150092117|NCT03518073|541478831|FG000|Overall Study|Adverse Event|2|||
150092118|NCT03518073|541478832|FG001|Overall Study|Adverse Event|4|||
150092119|NCT03518073|541478833|FG002|Overall Study|Adverse Event|2|||
150092120|NCT03518073|541478831|FG000|Overall Study|Death|2|||
150092121|NCT03518073|541478832|FG001|Overall Study|Death|1|||
150092122|NCT03518073|541478833|FG002|Overall Study|Death|3|||
150092123|NCT03518073|541478831|FG000|Overall Study|Lost to Follow-up|1|||
150092124|NCT03518073|541478832|FG001|Overall Study|Lost to Follow-up|0|||
150092125|NCT03518073|541478833|FG002|Overall Study|Lost to Follow-up|1|||
150092126|NCT03518073|541478831|FG000|Overall Study|Physician Decision|5|||
150092127|NCT03518073|541478832|FG001|Overall Study|Physician Decision|0|||
150092128|NCT03518073|541478833|FG002|Overall Study|Physician Decision|2|||
150092129|NCT03518073|541478831|FG000|Overall Study|Progressive disease|1|||
150092130|NCT03518073|541478832|FG001|Overall Study|Progressive disease|1|||
150092131|NCT03518073|541478833|FG002|Overall Study|Progressive disease|1|||
150092132|NCT03518073|541478831|FG000|Overall Study|Protocol Violation|1|||
150092133|NCT03518073|541478832|FG001|Overall Study|Protocol Violation|0|||
150092134|NCT03518073|541478833|FG002|Overall Study|Protocol Violation|0|||
150092135|NCT03518073|541478831|FG000|Overall Study|Withdrawal by Subject|30|||
150092136|NCT03518073|541478832|FG001|Overall Study|Withdrawal by Subject|34|||
150092137|NCT03518073|541478833|FG002|Overall Study|Withdrawal by Subject|29|||
150092138|NCT03518073|541478831|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
150092139|NCT03518073|541478832|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
150092140|NCT03518073|541478833|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
150092141|NCT03518073|541478831|FG000|Overall Study|Covid-19|1|||
150092142|NCT03518073|541478832|FG001|Overall Study|Covid-19|2|||
150092143|NCT03518073|541478833|FG002|Overall Study|Covid-19|1|||
150092144|NCT03045081|541478834|FG000|Overall Study|Withdrawal by Subject|6|||
150092145|NCT03045081|541478835|FG001|Overall Study|Withdrawal by Subject|11|||
150092146|NCT00475176|541478836|FG000|Overall Study|Adverse Event|2|||
150092147|NCT00475176|541478836|FG000|Overall Study|Withdrawal by Subject|1|||
150092148|NCT00475176|541478836|FG000|Overall Study|Protocol Violation|1|||
150092149|NCT01853046|541478837|FG000|Overall Study|Withdrawal by Subject|1|||
150092150|NCT01853046|541478838|FG001|Overall Study|Withdrawal by Subject|1|||
150092151|NCT01853046|541478837|FG000|Overall Study|Adverse Event|4|||
150092152|NCT01853046|541478838|FG001|Overall Study|Adverse Event|2|||
150092153|NCT01853046|541478837|FG000|Overall Study|Disease progression|13|||
150092154|NCT01853046|541478838|FG001|Overall Study|Disease progression|3|||
150092155|NCT01463878|541478842|FG000|Overall Study|no longer met criteria for tube feed|2|||
150092156|NCT01463878|541478843|FG001|Overall Study|no longer met criteria for tube feed|2|||
150092157|NCT03804879|541478844|FG000|Overall Study|Adverse Event|3|||
150092158|NCT03804879|541478845|FG001|Overall Study|Adverse Event|0|||
150092159|NCT03804879|541478844|FG000|Overall Study|Study Terminated By Sponsor|10|||
150092160|NCT03804879|541478845|FG001|Overall Study|Study Terminated By Sponsor|12|||
150092161|NCT03804879|541478844|FG000|Overall Study|Withdrawal by Subject|3|||
150092162|NCT03804879|541478845|FG001|Overall Study|Withdrawal by Subject|1|||
150092163|NCT02436889|541478846|FG000|Overall Study|No improvement in symptoms|1|||
150092164|NCT02436889|541478847|FG001|Overall Study|No improvement in symptoms|0|||
150092165|NCT02436889|541478846|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
150092166|NCT02436889|541478847|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
150092167|NCT00100815|541478850|FG000|Overall Study|Progression|24|||
150092168|NCT00100815|541478850|FG000|Overall Study|Adverse Event|18|||
150092169|NCT00100815|541478850|FG000|Overall Study|Death|4|||
150092170|NCT00100815|541478850|FG000|Overall Study|Other|3|||
150092171|NCT01710033|541478851|FG000|Stage 2|Adverse Event|0|||
150092172|NCT01710033|541478852|FG001|Stage 2|Adverse Event|0|||
150092173|NCT01710033|541478853|FG002|Stage 2|Adverse Event|0|||
150092174|NCT01710033|541478854|FG003|Stage 2|Adverse Event|0|||
150092175|NCT01710033|541478855|FG004|Stage 2|Adverse Event|1|||
150092176|NCT01244906|541478856|FG000|Overall Study|Death|2|||
150092177|NCT01244906|541478856|FG000|Overall Study|Progression of disease post treatment|6|||
150092178|NCT02746874|541478857|FG000|Overall Study|Withdrawal by Subject|0|||
150092179|NCT02746874|541478858|FG001|Overall Study|Withdrawal by Subject|1|||
150092180|NCT02746874|541478857|FG000|Overall Study|Surgery Date Changed|0|||
150092181|NCT02746874|541478858|FG001|Overall Study|Surgery Date Changed|2|||
150092182|NCT04483011|541478859|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
150092183|NCT04483011|541478860|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
150184493|NCT00073749|541813355|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
150092184|NCT00276159|541478861|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
150029188|NCT01384734|541242624|FG000|Overall Study|Non-compliance with study drug|1|||
150029189|NCT01384734|541242625|FG001|Overall Study|Non-compliance with study drug|2|||
150029190|NCT01384734|541242626|FG002|Overall Study|Non-compliance with study drug|6|||
150029191|NCT01384734|541242627|FG003|Overall Study|Non-compliance with study drug|0|||
150029192|NCT01384734|541242628|FG004|Overall Study|Non-compliance with study drug|2|||
150029193|NCT01384734|541242624|FG000|Overall Study|Pregnancy|0|||
150029194|NCT01384734|541242625|FG001|Overall Study|Pregnancy|1|||
150029195|NCT01384734|541242626|FG002|Overall Study|Pregnancy|0|||
150029196|NCT01384734|541242627|FG003|Overall Study|Pregnancy|0|||
150029197|NCT01384734|541242628|FG004|Overall Study|Pregnancy|1|||
150029198|NCT01384734|541242624|FG000|Overall Study|Sponsor terminated|0|||
150029199|NCT01384734|541242625|FG001|Overall Study|Sponsor terminated|0|||
150029200|NCT01384734|541242626|FG002|Overall Study|Sponsor terminated|0|||
150029201|NCT01384734|541242627|FG003|Overall Study|Sponsor terminated|0|||
150029202|NCT01384734|541242628|FG004|Overall Study|Sponsor terminated|1|||
150029203|NCT01384734|541242624|FG000|Overall Study|Withdrawal by Subject|5|||
150029204|NCT01384734|541242625|FG001|Overall Study|Withdrawal by Subject|5|||
150029205|NCT01384734|541242626|FG002|Overall Study|Withdrawal by Subject|6|||
150029206|NCT01384734|541242627|FG003|Overall Study|Withdrawal by Subject|7|||
150029207|NCT01384734|541242628|FG004|Overall Study|Withdrawal by Subject|9|||
150029208|NCT01384734|541242624|FG000|Overall Study|Investigator relocating|0|||
150029209|NCT01384734|541242625|FG001|Overall Study|Investigator relocating|2|||
150029210|NCT01384734|541242626|FG002|Overall Study|Investigator relocating|0|||
150029211|NCT01384734|541242627|FG003|Overall Study|Investigator relocating|3|||
150029212|NCT01384734|541242628|FG004|Overall Study|Investigator relocating|1|||
150029213|NCT01384734|541242624|FG000|Overall Study|Unable to come back for visit|1|||
150029214|NCT01384734|541242625|FG001|Overall Study|Unable to come back for visit|0|||
150029215|NCT01384734|541242626|FG002|Overall Study|Unable to come back for visit|1|||
150029216|NCT01384734|541242627|FG003|Overall Study|Unable to come back for visit|1|||
150029217|NCT01384734|541242628|FG004|Overall Study|Unable to come back for visit|0|||
150029218|NCT01384734|541242624|FG000|Overall Study|Prison|0|||
150029219|NCT01384734|541242625|FG001|Overall Study|Prison|0|||
150029220|NCT01384734|541242626|FG002|Overall Study|Prison|1|||
150029221|NCT01384734|541242627|FG003|Overall Study|Prison|0|||
150029222|NCT01384734|541242628|FG004|Overall Study|Prison|0|||
150092185|NCT02426892|541478864|FG000|Overall Study|Adverse Event|2|||
150092186|NCT02426892|541478864|FG000|Overall Study|Lack of Efficacy|17|||
150092187|NCT02426892|541478864|FG000|Overall Study|Withdrawal by Subject|1|||
150092188|NCT03178773|541478865|FG000|Overall Study|Death|0|||
150092189|NCT03178773|541478866|FG001|Overall Study|Death|1|||
150092190|NCT03178773|541478865|FG000|Overall Study|Lost to Follow-up|29|||
150092191|NCT03178773|541478866|FG001|Overall Study|Lost to Follow-up|25|||
150092192|NCT03178773|541478865|FG000|Overall Study|Withdrawal by Subject|10|||
150092193|NCT03178773|541478866|FG001|Overall Study|Withdrawal by Subject|14|||
150092194|NCT03402386|541478867|FG000|Overall Study|Adverse Event|3|||
150092195|NCT03402386|541478867|FG000|Overall Study|Physician Decision|1|||
150092196|NCT03402386|541478867|FG000|Overall Study|Difficult to control Hb|2|||
150092197|NCT01896531|541478868|FG000|Overall Study|Death|57|||
150092198|NCT01896531|541478869|FG001|Overall Study|Death|59|||
150092199|NCT01896531|541478868|FG000|Overall Study|Lost to Follow-up|3|||
150092200|NCT01896531|541478869|FG001|Overall Study|Lost to Follow-up|0|||
150092201|NCT01896531|541478868|FG000|Overall Study|Non-compliance|0|||
150092202|NCT01896531|541478869|FG001|Overall Study|Non-compliance|1|||
150092203|NCT01896531|541478868|FG000|Overall Study|Study Ended by Sponsor|7|||
150092204|NCT01896531|541478869|FG001|Overall Study|Study Ended by Sponsor|20|||
150092205|NCT01896531|541478868|FG000|Overall Study|Withdrawal by Subject|3|||
150092206|NCT01896531|541478869|FG001|Overall Study|Withdrawal by Subject|2|||
150092207|NCT01896531|541478868|FG000|Overall Study|Death Prior to Treatment|1|||
150092208|NCT01896531|541478869|FG001|Overall Study|Death Prior to Treatment|0|||
150092209|NCT00268996|541478870|FG000|Overall Study|Adverse Event|11|||
150092210|NCT00268996|541478871|FG001|Overall Study|Adverse Event|7|||
150092211|NCT00268996|541478870|FG000|Overall Study|Lost to Follow-up|3|||
150092212|NCT00268996|541478871|FG001|Overall Study|Lost to Follow-up|1|||
150092213|NCT00268996|541478870|FG000|Overall Study|Withdrawal by Subject|5|||
150092214|NCT00268996|541478871|FG001|Overall Study|Withdrawal by Subject|11|||
150092215|NCT00268996|541478870|FG000|Overall Study|Non-compliance|1|||
150092216|NCT00268996|541478871|FG001|Overall Study|Non-compliance|0|||
150092217|NCT00268996|541478870|FG000|Overall Study|Other|1|||
150092218|NCT00268996|541478871|FG001|Overall Study|Other|1|||
150092219|NCT02956486|541478872|FG000|Core Phase|Adverse Event|51|||
150092220|NCT02956486|541478873|FG001|Core Phase|Adverse Event|88|||
150092221|NCT02956486|541478874|FG002|Core Phase|Adverse Event|0|||
150092222|NCT02956486|541478872|FG000|Core Phase|Lost to Follow-up|8|||
150092223|NCT02956486|541478873|FG001|Core Phase|Lost to Follow-up|6|||
150092224|NCT02956486|541478874|FG002|Core Phase|Lost to Follow-up|0|||
150092225|NCT02956486|541478872|FG000|Core Phase|Inadequate therapeutic effect|4|||
150092226|NCT02956486|541478873|FG001|Core Phase|Inadequate therapeutic effect|5|||
150092227|NCT02956486|541478874|FG002|Core Phase|Inadequate therapeutic effect|0|||
150092228|NCT02956486|541478872|FG000|Core Phase|Withdrawal by Subject|101|||
150092229|NCT02956486|541478873|FG001|Core Phase|Withdrawal by Subject|104|||
150092230|NCT02956486|541478874|FG002|Core Phase|Withdrawal by Subject|0|||
150092231|NCT02956486|541478872|FG000|Core Phase|Study terminated by sponsor|888|||
150092232|NCT02956486|541478873|FG001|Core Phase|Study terminated by sponsor|848|||
150092233|NCT02956486|541478874|FG002|Core Phase|Study terminated by sponsor|0|||
150092234|NCT02956486|541478872|FG000|Core Phase|Other|27|||
150092235|NCT02956486|541478873|FG001|Core Phase|Other|18|||
150092236|NCT02956486|541478874|FG002|Core Phase|Other|0|||
150092237|NCT02956486|541478872|FG000|Core Phase|Not treated|0|||
150092238|NCT02956486|541478873|FG001|Core Phase|Not treated|3|||
150092239|NCT02956486|541478874|FG002|Core Phase|Not treated|0|||
150092240|NCT02956486|541478872|FG000|Extension Phase|Adverse Event|0|||
150092241|NCT02956486|541478873|FG001|Extension Phase|Adverse Event|0|||
150092242|NCT02956486|541478874|FG002|Extension Phase|Adverse Event|2|||
150092243|NCT02956486|541478872|FG000|Extension Phase|Study terminated by sponsor|0|||
150092244|NCT02956486|541478873|FG001|Extension Phase|Study terminated by sponsor|0|||
150092245|NCT02956486|541478874|FG002|Extension Phase|Study terminated by sponsor|16|||
150092246|NCT02956486|541478872|FG000|Extension Phase|Not Treated|0|||
150092247|NCT02956486|541478873|FG001|Extension Phase|Not Treated|0|||
150092248|NCT02956486|541478874|FG002|Extension Phase|Not Treated|1|||
150092249|NCT03325075|541478877|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
150092250|NCT03325075|541478878|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
150092251|NCT03325075|541478879|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
150092252|NCT03325075|541478880|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
150092253|NCT03325075|541478877|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
150092254|NCT03325075|541478878|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
150092255|NCT03325075|541478879|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
150092256|NCT03325075|541478880|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
150092257|NCT03325075|541478877|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
150092258|NCT03325075|541478878|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
150092259|NCT03325075|541478879|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
150092260|NCT03325075|541478880|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
150092261|NCT04210310|541478881|FG000|Overall Study|Lost to Follow-up|32|||
150092262|NCT04210310|541478882|FG001|Overall Study|Lost to Follow-up|1|||
150092263|NCT02617511|541478889|FG000|Overall Study|Withdrawal by Subject|1|||
150092264|NCT02617511|541478890|FG001|Overall Study|Withdrawal by Subject|0|||
150184494|NCT00073749|541813356|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
150092265|NCT00255047|541478891|FG000|Overall Study|Serious Adverse Events|2|||
150092266|NCT00255047|541478892|FG001|Overall Study|Serious Adverse Events|1|||
150184495|NCT00073749|541813350|FG000|Overall Study|Lost to Follow-up|0|||
150092267|NCT00255047|541478893|FG002|Overall Study|Serious Adverse Events|2|||
150092268|NCT00255047|541478894|FG003|Overall Study|Serious Adverse Events|1|||
150092269|NCT00255047|541478891|FG000|Overall Study|Adverse Event|0|||
150092270|NCT00255047|541478892|FG001|Overall Study|Adverse Event|3|||
150092271|NCT00255047|541478893|FG002|Overall Study|Adverse Event|2|||
150184496|NCT00073749|541813351|FG001|Overall Study|Lost to Follow-up|0|||
150184497|NCT00073749|541813352|FG002|Overall Study|Lost to Follow-up|0|||
150092272|NCT00255047|541478894|FG003|Overall Study|Adverse Event|1|||
150092273|NCT00255047|541478891|FG000|Overall Study|Protocol Violation|13|||
150092274|NCT00255047|541478892|FG001|Overall Study|Protocol Violation|13|||
150092275|NCT00255047|541478893|FG002|Overall Study|Protocol Violation|16|||
150092276|NCT00255047|541478894|FG003|Overall Study|Protocol Violation|20|||
150092277|NCT00255047|541478891|FG000|Overall Study|Lost to Follow-up|9|||
150092278|NCT00255047|541478892|FG001|Overall Study|Lost to Follow-up|8|||
150092279|NCT00255047|541478893|FG002|Overall Study|Lost to Follow-up|5|||
150092280|NCT00255047|541478894|FG003|Overall Study|Lost to Follow-up|6|||
150092281|NCT00255047|541478891|FG000|Overall Study|Withdrawal by Subject|24|||
150092282|NCT00255047|541478892|FG001|Overall Study|Withdrawal by Subject|23|||
150092283|NCT00255047|541478893|FG002|Overall Study|Withdrawal by Subject|25|||
150092284|NCT00255047|541478894|FG003|Overall Study|Withdrawal by Subject|18|||
150092285|NCT00811473|541478895|FG000|Overall Study|Adverse Event|3|||
150092286|NCT00811473|541478896|FG001|Overall Study|Adverse Event|12|||
150092287|NCT00811473|541478895|FG000|Overall Study|Lost to Follow-up|5|||
150092288|NCT00811473|541478896|FG001|Overall Study|Lost to Follow-up|1|||
150092289|NCT00811473|541478895|FG000|Overall Study|Withdrawal by Subject|2|||
150092290|NCT00811473|541478896|FG001|Overall Study|Withdrawal by Subject|4|||
150092291|NCT00811473|541478895|FG000|Overall Study|Severe non-compliance to protocol|2|||
150092292|NCT00811473|541478896|FG001|Overall Study|Severe non-compliance to protocol|4|||
150092293|NCT00811473|541478895|FG000|Overall Study|Lack of therapeutic response|4|||
150092294|NCT00811473|541478896|FG001|Overall Study|Lack of therapeutic response|1|||
150092295|NCT00811473|541478895|FG000|Overall Study|Condition under investigation worsened|1|||
150092296|NCT00811473|541478896|FG001|Overall Study|Condition under investigation worsened|3|||
150092297|NCT00811473|541478895|FG000|Overall Study|Other 2|4|||
150092298|NCT00811473|541478896|FG001|Overall Study|Other 2|1|||
150092299|NCT00811473|541478895|FG000|Overall Study|Incorrect Enrollment|1|||
150092300|NCT00811473|541478896|FG001|Overall Study|Incorrect Enrollment|0|||
150092301|NCT00811473|541478895|FG000|Overall Study|Safety Reasons|1|||
150092302|NCT00811473|541478896|FG001|Overall Study|Safety Reasons|0|||
150092303|NCT01585194|541478902|FG000|Overall Study|Withdrawal by Subject|1|||
150092304|NCT01585194|541478902|FG000|Overall Study|Physician Decision|2|||
150092305|NCT01585194|541478902|FG000|Overall Study|Lack of insurance|1|||
150092306|NCT00732615|541478903|FG000|Overall Study|Withdrawal by Subject|3|||
150092307|NCT00732615|541478904|FG001|Overall Study|Withdrawal by Subject|1|||
150092308|NCT00732615|541478903|FG000|Overall Study|Lost to Follow-up|0|||
150092309|NCT00732615|541478904|FG001|Overall Study|Lost to Follow-up|1|||
150092310|NCT00732615|541478903|FG000|Overall Study|Adverse Event|0|||
150092311|NCT00732615|541478904|FG001|Overall Study|Adverse Event|2|||
150092312|NCT00732615|541478903|FG000|Overall Study|Physician Decision|3|||
150092313|NCT00732615|541478904|FG001|Overall Study|Physician Decision|0|||
150092314|NCT00732615|541478903|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
150092315|NCT00732615|541478904|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
150092316|NCT01333059|541478905|FG000|Overall Study|Physician Decision|3|||
150092317|NCT01333059|541478906|FG001|Overall Study|Physician Decision|3|||
150092318|NCT01333059|541478905|FG000|Overall Study|Protocol Violation|3|||
150092319|NCT01333059|541478906|FG001|Overall Study|Protocol Violation|0|||
150092320|NCT04446377|541478907|FG000|Overall Study|Withdrawal by Subject|6|||
150092321|NCT04446377|541478908|FG001|Overall Study|Withdrawal by Subject|1|||
150092322|NCT04446377|541478907|FG000|Overall Study|Physician Decision|1|||
150092323|NCT04446377|541478908|FG001|Overall Study|Physician Decision|1|||
150092324|NCT04446377|541478907|FG000|Overall Study|Lost to Follow-up|0|||
150092325|NCT04446377|541478908|FG001|Overall Study|Lost to Follow-up|2|||
150092326|NCT04446377|541478907|FG000|Overall Study|Not eligible|0|||
150092327|NCT04446377|541478908|FG001|Overall Study|Not eligible|1|||
150092328|NCT01414075|541478920|FG000|Overall Study|Adverse Event|1|||
150092329|NCT01414075|541478921|FG001|Overall Study|Adverse Event|0|||
150092330|NCT01414075|541478922|FG002|Overall Study|Adverse Event|1|||
150092331|NCT01414075|541478923|FG003|Overall Study|Adverse Event|0|||
150092332|NCT01414075|541478920|FG000|Overall Study|Death|1|||
150092333|NCT01414075|541478921|FG001|Overall Study|Death|0|||
150092334|NCT01414075|541478922|FG002|Overall Study|Death|0|||
150092335|NCT01414075|541478923|FG003|Overall Study|Death|1|||
150092336|NCT01414075|541478920|FG000|Overall Study|Withdrawal by Subject|0|||
150092337|NCT01414075|541478921|FG001|Overall Study|Withdrawal by Subject|0|||
150092338|NCT01414075|541478922|FG002|Overall Study|Withdrawal by Subject|0|||
150092339|NCT01414075|541478923|FG003|Overall Study|Withdrawal by Subject|1|||
150092340|NCT01414075|541478920|FG000|Overall Study|Other than specified|1|||
150092341|NCT01414075|541478921|FG001|Overall Study|Other than specified|0|||
150092342|NCT01414075|541478922|FG002|Overall Study|Other than specified|1|||
150092343|NCT01414075|541478923|FG003|Overall Study|Other than specified|0|||
150092344|NCT01187043|541478925|FG000|Overall Study|Adverse Event|0|||
150092345|NCT01187043|541478926|FG001|Overall Study|Adverse Event|0|||
150092346|NCT01187043|541478927|FG002|Overall Study|Adverse Event|0|||
150092347|NCT01187043|541478928|FG003|Overall Study|Adverse Event|0|||
150092348|NCT01187043|541478929|FG004|Overall Study|Adverse Event|1|||
150092349|NCT01187043|541478925|FG000|Overall Study|Unable to make scheduled visits|1|||
150092350|NCT01187043|541478926|FG001|Overall Study|Unable to make scheduled visits|0|||
150092351|NCT01187043|541478927|FG002|Overall Study|Unable to make scheduled visits|4|||
150092352|NCT01187043|541478928|FG003|Overall Study|Unable to make scheduled visits|0|||
150092353|NCT01187043|541478929|FG004|Overall Study|Unable to make scheduled visits|1|||
150092354|NCT04903626|541478930|FG000|Overall Study|Lost to Follow-up|6|||
150092355|NCT04903626|541478930|FG000|Overall Study|Withdrawal by Subject|1|||
150092356|NCT04903626|541478930|FG000|Overall Study|Other, Not Specified|1|||
150092357|NCT00573534|541478931|FG000|Overall Study|oppositional behavior|3|||
150092358|NCT03035409|541478932|FG000|Overall Study|Adverse Event|5|||
150092359|NCT03035409|541478932|FG000|Overall Study|Death|2|||
150092360|NCT03035409|541478932|FG000|Overall Study|Withdrawal by Subject|2|||
150092361|NCT03035409|541478932|FG000|Overall Study|Non compliance|4|||
150092362|NCT03035409|541478932|FG000|Overall Study|Patient was jittery|1|||
150092363|NCT03035409|541478932|FG000|Overall Study|Did not like Questionnaire|1|||
150092364|NCT03035409|541478932|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
150092365|NCT03035409|541478932|FG000|Overall Study|Did not like taking drugs|1|||
150092366|NCT00927784|541478937|FG000|Overall Study|Death|1|||
150092367|NCT00927784|541478938|FG001|Overall Study|Death|0|||
150092368|NCT00927784|541478937|FG000|Overall Study|Withdrawal by Subject|1|||
150092369|NCT00927784|541478938|FG001|Overall Study|Withdrawal by Subject|0|||
150092370|NCT02457910|541478939|FG000|Overall Study|Withdrawal by Subject|0|||
150092371|NCT02457910|541478940|FG001|Overall Study|Withdrawal by Subject|0|||
150092372|NCT02457910|541478941|FG002|Overall Study|Withdrawal by Subject|0|||
150092373|NCT02457910|541478942|FG003|Overall Study|Withdrawal by Subject|0|||
150092374|NCT02457910|541478943|FG004|Overall Study|Withdrawal by Subject|0|||
150092375|NCT02457910|541478944|FG005|Overall Study|Withdrawal by Subject|1|||
150092376|NCT02457910|541478939|FG000|Overall Study|Adverse Event|0|||
150092377|NCT02457910|541478940|FG001|Overall Study|Adverse Event|2|||
150092378|NCT02457910|541478941|FG002|Overall Study|Adverse Event|1|||
150092379|NCT02457910|541478942|FG003|Overall Study|Adverse Event|1|||
150092380|NCT02457910|541478943|FG004|Overall Study|Adverse Event|1|||
150092381|NCT02457910|541478944|FG005|Overall Study|Adverse Event|3|||
150092382|NCT02457910|541478939|FG000|Overall Study|Disease progression|3|||
150092383|NCT02457910|541478940|FG001|Overall Study|Disease progression|3|||
150092384|NCT02457910|541478941|FG002|Overall Study|Disease progression|1|||
150092385|NCT02457910|541478942|FG003|Overall Study|Disease progression|1|||
150092386|NCT02457910|541478943|FG004|Overall Study|Disease progression|4|||
150092387|NCT02457910|541478944|FG005|Overall Study|Disease progression|6|||
150092388|NCT02457910|541478939|FG000|Overall Study|Other complicating illness|0|||
150092389|NCT02457910|541478940|FG001|Overall Study|Other complicating illness|0|||
150092390|NCT02457910|541478941|FG002|Overall Study|Other complicating illness|0|||
150092391|NCT02457910|541478942|FG003|Overall Study|Other complicating illness|0|||
150092392|NCT02457910|541478943|FG004|Overall Study|Other complicating illness|0|||
150092393|NCT02457910|541478944|FG005|Overall Study|Other complicating illness|1|||
150092394|NCT02457910|541478939|FG000|Overall Study|Death|0|||
150092395|NCT02457910|541478940|FG001|Overall Study|Death|0|||
150092396|NCT02457910|541478941|FG002|Overall Study|Death|1|||
150092397|NCT02457910|541478942|FG003|Overall Study|Death|0|||
150092398|NCT02457910|541478943|FG004|Overall Study|Death|0|||
150092399|NCT02457910|541478944|FG005|Overall Study|Death|0|||
150092400|NCT00467259|541478945|FG000|Overall Study|Adverse Event|24|||
150092401|NCT00467259|541478946|FG001|Overall Study|Adverse Event|90|||
150092402|NCT00467259|541478945|FG000|Overall Study|Protocol Violation|1|||
150092403|NCT00467259|541478946|FG001|Overall Study|Protocol Violation|7|||
150092404|NCT00467259|541478945|FG000|Overall Study|Withdrawal by Subject|34|||
150092405|NCT00467259|541478946|FG001|Overall Study|Withdrawal by Subject|108|||
150092406|NCT00467259|541478945|FG000|Overall Study|Physician Decision|0|||
150092407|NCT00467259|541478946|FG001|Overall Study|Physician Decision|2|||
150092408|NCT00467259|541478945|FG000|Overall Study|Lost to Follow-up|14|||
150092409|NCT00467259|541478946|FG001|Overall Study|Lost to Follow-up|34|||
150092410|NCT00467259|541478945|FG000|Overall Study|Site Closed|2|||
150092411|NCT00467259|541478946|FG001|Overall Study|Site Closed|1|||
150092412|NCT06079320|541478947|FG000|Follow up Phase|Lost to Follow-up|1|||
150092413|NCT06079320|541478948|FG001|Follow up Phase|Lost to Follow-up|0|||
150092414|NCT01405742|541478949|FG000|Overall Study|Lost to Follow-up|1|||
150092415|NCT01405742|541478950|FG001|Overall Study|Lost to Follow-up|0|||
150092416|NCT02196558|541478951|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
150092417|NCT02196558|541478952|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
150092418|NCT02196558|541478953|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
150092419|NCT02196558|541478951|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
150092420|NCT02196558|541478952|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
150092421|NCT02196558|541478953|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
150092422|NCT02196558|541478951|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
150092423|NCT02196558|541478952|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
150092424|NCT02196558|541478953|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
150092425|NCT02196558|541478951|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
150092426|NCT02196558|541478952|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
150092427|NCT02196558|541478953|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
150092428|NCT02196558|541478951|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
150092429|NCT02196558|541478952|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
150092430|NCT02196558|541478953|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
150092431|NCT03428360|541478954|FG000|Overall Study|Informed consent withdrawn|5|||
150092432|NCT03428360|541478954|FG000|Overall Study|Withdrawal by Subject|4|||
150092433|NCT03428360|541478954|FG000|Overall Study|Lost to Follow-up|5|||
150092434|NCT03428360|541478954|FG000|Overall Study|Physician Decision|2|||
150092435|NCT03428360|541478954|FG000|Overall Study|Informed consent withdrawn|5|||
150092436|NCT03428360|541478954|FG000|Overall Study|Study terminated by sponsor|10|||
150092437|NCT03428360|541478954|FG000|Overall Study|Non-compliant with study|1|||
150092438|NCT03428360|541478954|FG000|Overall Study|Non-compliant with study drug|3|||
150092439|NCT03428360|541478954|FG000|Overall Study|Death|3|||
150092440|NCT03428360|541478954|FG000|Overall Study|Adverse Event|1|||
150092441|NCT03428360|541478954|FG000|Overall Study|Not on antiepileptic drug|1|||
150092442|NCT02028065|541478955|FG000|Randomization Through Start Treatment|Not treated|1|||
150092443|NCT02028065|541478956|FG001|Randomization Through Start Treatment|Not treated|3|||
150092444|NCT02028065|541478957|FG002|Randomization Through Start Treatment|Not treated|3|||
150092445|NCT02028065|541478955|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
150092446|NCT02028065|541478956|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
150092447|NCT02028065|541478957|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
150092448|NCT02028065|541478955|FG000|Treatment Through Study Completion|Physician Decision|1|||
150092449|NCT02028065|541478956|FG001|Treatment Through Study Completion|Physician Decision|0|||
150092450|NCT02028065|541478957|FG002|Treatment Through Study Completion|Physician Decision|0|||
150092451|NCT02028065|541478955|FG000|Treatment Through Study Completion|Protocol Violation|1|||
150092452|NCT02028065|541478956|FG001|Treatment Through Study Completion|Protocol Violation|4|||
150092453|NCT02028065|541478957|FG002|Treatment Through Study Completion|Protocol Violation|0|||
150092454|NCT02028065|541478955|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
150092455|NCT02028065|541478956|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
150092456|NCT02028065|541478957|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
150092457|NCT02028065|541478955|FG000|Treatment Through Study Completion|Adverse Event|3|||
150092458|NCT02028065|541478956|FG001|Treatment Through Study Completion|Adverse Event|3|||
150092459|NCT02028065|541478957|FG002|Treatment Through Study Completion|Adverse Event|5|||
150092460|NCT02107482|541478961|FG000|Overall Study|inconveinence|2|||
150092461|NCT02107482|541478961|FG000|Overall Study|Lost to Follow-up|1|||
150092462|NCT02107482|541478961|FG000|Overall Study|Lack of Efficacy|1|||
150092463|NCT00576927|541478962|FG000|Clinical Assessment|Lack of Efficacy|24|||
150092464|NCT00576927|541478962|FG000|Clinical Assessment|Death|1|||
150092465|NCT00576927|541478962|FG000|Clinical Assessment|Withdrawal by Subject|10|||
150092466|NCT00576927|541478962|FG000|Clinical Assessment|Physician Decision|1|||
150092467|NCT00576927|541478962|FG000|Baseline|Physician Decision|9|||
150092468|NCT00576927|541478962|FG000|Baseline|Medication Change by PCP of subject|1|||
150092469|NCT00576927|541478962|FG000|Baseline|Withdrawal by Subject|3|||
150092470|NCT00576927|541478962|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
150092471|NCT00576927|541478962|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
150092472|NCT00576927|541478962|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
150092473|NCT00576927|541478962|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
150092474|NCT00576927|541478962|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
150092475|NCT04059094|541478971|FG000|Overall Study|Adverse Event|0|||
150092476|NCT04059094|541478972|FG001|Overall Study|Adverse Event|0|||
150092477|NCT04059094|541478973|FG002|Overall Study|Adverse Event|0|||
150092478|NCT04059094|541478974|FG003|Overall Study|Adverse Event|0|||
150092479|NCT04059094|541478975|FG004|Overall Study|Adverse Event|1|||
150092480|NCT04059094|541478971|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
150092481|NCT04059094|541478972|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
150092482|NCT04059094|541478973|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
150092483|NCT04059094|541478974|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
150092484|NCT04059094|541478975|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
150092485|NCT01339429|541478976|FG000|Overall Study|Withdrawal by Subject|1|||
150092486|NCT01339429|541478976|FG000|Overall Study|Physician Decision|3|||
150092487|NCT00680043|541478979|FG000|Overall Study|Withdrawal by Subject|1|||
150092488|NCT00680043|541478980|FG001|Overall Study|Withdrawal by Subject|0|||
150092489|NCT00680043|541478981|FG002|Overall Study|Withdrawal by Subject|0|||
150092490|NCT00680043|541478979|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
150092491|NCT00680043|541478980|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
150092492|NCT00680043|541478981|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
150092493|NCT00680043|541478979|FG000|Overall Study|Renal Transplant|1|||
150092494|NCT00680043|541478980|FG001|Overall Study|Renal Transplant|0|||
150092495|NCT00680043|541478981|FG002|Overall Study|Renal Transplant|4|||
150092496|NCT02111850|541478982|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092497|NCT02111850|541478983|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092498|NCT02111850|541478984|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092499|NCT02111850|541478985|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092500|NCT02111850|541478986|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
150092501|NCT02111850|541478987|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092502|NCT02111850|541478988|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092503|NCT02111850|541478989|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092504|NCT02111850|541478990|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092505|NCT02111850|541478991|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092506|NCT02111850|541478992|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
150092507|NCT01980875|541478993|FG000|Overall Study|Withdrew Consent|1|||
150092508|NCT01980875|541478994|FG001|Overall Study|Withdrew Consent|1|||
150092509|NCT01980875|541478995|FG002|Overall Study|Withdrew Consent|1|||
150092510|NCT01980875|541478993|FG000|Overall Study|Study Terminated by Sponsor|7|||
150092511|NCT01980875|541478994|FG001|Overall Study|Study Terminated by Sponsor|24|||
150092512|NCT01980875|541478995|FG002|Overall Study|Study Terminated by Sponsor|22|||
150092513|NCT01980875|541478993|FG000|Overall Study|Lost to Follow-up|0|||
150184498|NCT00073749|541813353|FG003|Overall Study|Lost to Follow-up|0|||
150092514|NCT01980875|541478994|FG001|Overall Study|Lost to Follow-up|0|||
150184499|NCT00073749|541813354|FG004|Overall Study|Lost to Follow-up|0|||
150184500|NCT00073749|541813355|FG005|Overall Study|Lost to Follow-up|0|||
150092515|NCT01980875|541478995|FG002|Overall Study|Lost to Follow-up|1|||
150092516|NCT00513474|541478996|FG000|Overall Study|Death|6|||
150092517|NCT00513474|541478997|FG001|Overall Study|Death|9|||
150092518|NCT00513474|541478996|FG000|Overall Study|Participant Withdrew Consent|1|||
150092519|NCT00513474|541478997|FG001|Overall Study|Participant Withdrew Consent|0|||
150092520|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Adverse Event|82|||
150092521|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Death|6|||
150092522|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
150092523|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
150092524|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
150092525|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
150092526|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
150092527|NCT00195676|541478998|FG000|Period O - Open-label Treatment|Other reasons|68|||
150092528|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
150092529|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
150092530|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
150092531|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
150092532|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
150092533|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
150092534|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
150092535|NCT00195676|541478998|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
150092536|NCT00195676|541478998|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
150092537|NCT00195676|541478998|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
150092538|NCT00195676|541478998|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
150092539|NCT00195676|541478998|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
150092540|NCT00195676|541478998|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
150092541|NCT01189812|541478999|FG000|Overall Study|Withdrawal by Subject|2|||
150092542|NCT01189812|541479000|FG001|Overall Study|Withdrawal by Subject|3|||
150092543|NCT01189812|541478999|FG000|Overall Study|Adverse Event|1|||
150092544|NCT01189812|541479000|FG001|Overall Study|Adverse Event|0|||
150092545|NCT01189812|541478999|FG000|Overall Study|Out of Window|4|||
150092546|NCT01189812|541479000|FG001|Overall Study|Out of Window|3|||
150092547|NCT01189812|541478999|FG000|Overall Study|Moved out of State|1|||
150092548|NCT01189812|541479000|FG001|Overall Study|Moved out of State|2|||
150092549|NCT02200445|541479002|FG000|Overall Study|Lack of Efficacy|1|||
150092550|NCT02200445|541479003|FG001|Overall Study|Lack of Efficacy|2|||
150092551|NCT02200445|541479004|FG002|Overall Study|Lack of Efficacy|2|||
150092552|NCT02200445|541479002|FG000|Overall Study|Adverse Event|0|||
150092553|NCT02200445|541479003|FG001|Overall Study|Adverse Event|2|||
150092554|NCT02200445|541479004|FG002|Overall Study|Adverse Event|0|||
150092555|NCT03334903|541479005|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
150092556|NCT03334903|541479006|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
150092557|NCT03334903|541479005|FG000|Overall Study|Protocol Violation|1|||
150092558|NCT03334903|541479006|FG001|Overall Study|Protocol Violation|3|||
150092559|NCT03334903|541479005|FG000|Overall Study|Surgery postponed|1|||
150092560|NCT03334903|541479006|FG001|Overall Study|Surgery postponed|0|||
150092561|NCT03334903|541479005|FG000|Overall Study|Adverse Event|1|||
150092562|NCT03334903|541479006|FG001|Overall Study|Adverse Event|1|||
150092563|NCT03334903|541479005|FG000|Overall Study|Withdrawal by Subject|0|||
150092564|NCT03334903|541479006|FG001|Overall Study|Withdrawal by Subject|1|||
150092565|NCT00587561|541480603|FG000|Overall Study|Lost to Follow-up|6|||
150092566|NCT00587561|541480604|FG001|Overall Study|Lost to Follow-up|4|||
150092567|NCT04244786|541480608|FG000|Overall Study|Adverse Event|0|||
150092568|NCT04244786|541480609|FG001|Overall Study|Adverse Event|0|||
150092569|NCT04244786|541480610|FG002|Overall Study|Adverse Event|2|||
150092570|NCT04244786|541480608|FG000|Overall Study|Withdrawal by Subject|0|||
150092571|NCT04244786|541480609|FG001|Overall Study|Withdrawal by Subject|0|||
150092572|NCT04244786|541480610|FG002|Overall Study|Withdrawal by Subject|5|||
150092573|NCT03274687|541480611|FG000|Overall Study|Protocol Violation|1|||
150092574|NCT03274687|541480612|FG001|Overall Study|Protocol Violation|1|||
150092575|NCT00613938|541480613|FG000|Overall Study|Withdrawal by Subject|2|||
150092576|NCT00613938|541480614|FG001|Overall Study|Withdrawal by Subject|4|||
150092577|NCT00613938|541480615|FG002|Overall Study|Withdrawal by Subject|9|||
150092578|NCT00613938|541480616|FG003|Overall Study|Withdrawal by Subject|9|||
150092579|NCT00613938|541480613|FG000|Overall Study|Adverse Event|1|||
150092580|NCT00613938|541480614|FG001|Overall Study|Adverse Event|4|||
150092581|NCT00613938|541480615|FG002|Overall Study|Adverse Event|8|||
150092582|NCT00613938|541480616|FG003|Overall Study|Adverse Event|5|||
150092583|NCT00613938|541480613|FG000|Overall Study|Lack of Efficacy|16|||
150092584|NCT00613938|541480614|FG001|Overall Study|Lack of Efficacy|18|||
150092585|NCT00613938|541480615|FG002|Overall Study|Lack of Efficacy|5|||
150092586|NCT00613938|541480616|FG003|Overall Study|Lack of Efficacy|9|||
150092587|NCT00613938|541480613|FG000|Overall Study|Other|1|||
150092588|NCT00613938|541480614|FG001|Overall Study|Other|2|||
150092589|NCT00613938|541480615|FG002|Overall Study|Other|1|||
150092590|NCT00613938|541480616|FG003|Overall Study|Other|3|||
150092591|NCT02636868|541480617|FG000|Overall Study|Death|0|||
150092592|NCT02636868|541480618|FG001|Overall Study|Death|1|||
150092593|NCT02636868|541480619|FG002|Overall Study|Death|2|||
150092594|NCT03025542|541480620|FG000|Overall Study|Adverse Event|0|||
150092595|NCT03025542|541480621|FG001|Overall Study|Adverse Event|2|||
150092596|NCT03025542|541480620|FG000|Overall Study|Lost to Follow-up|1|||
150092597|NCT03025542|541480621|FG001|Overall Study|Lost to Follow-up|0|||
150092598|NCT03025542|541480620|FG000|Overall Study|Withdrawal by Subject|1|||
150092599|NCT03025542|541480621|FG001|Overall Study|Withdrawal by Subject|0|||
150092600|NCT03745937|541480622|FG000|Overall Study|Withdrawal by Subject|0|||
150092601|NCT03745937|541480623|FG001|Overall Study|Withdrawal by Subject|0|||
150092602|NCT03745937|541480624|FG002|Overall Study|Withdrawal by Subject|0|||
150092603|NCT03745937|541480625|FG003|Overall Study|Withdrawal by Subject|1|||
150092604|NCT03745937|541480622|FG000|Overall Study|Not-specifed|0|||
150092605|NCT03745937|541480623|FG001|Overall Study|Not-specifed|1|||
150092606|NCT03745937|541480624|FG002|Overall Study|Not-specifed|0|||
150092607|NCT03745937|541480625|FG003|Overall Study|Not-specifed|1|||
150092608|NCT00312494|541480627|FG000|Overall Study|Randomized; not treated with study drug|9|||
150092609|NCT00312494|541480628|FG001|Overall Study|Randomized; not treated with study drug|10|||
150092610|NCT00312494|541480629|FG002|Overall Study|Randomized; not treated with study drug|5|||
150092611|NCT00312494|541480627|FG000|Overall Study|Adverse Event|33|||
150092612|NCT00312494|541480628|FG001|Overall Study|Adverse Event|15|||
150092613|NCT00312494|541480629|FG002|Overall Study|Adverse Event|11|||
150092614|NCT00312494|541480627|FG000|Overall Study|Lack of Efficacy|4|||
150092615|NCT00312494|541480628|FG001|Overall Study|Lack of Efficacy|6|||
150092616|NCT00312494|541480629|FG002|Overall Study|Lack of Efficacy|8|||
150092617|NCT00312494|541480627|FG000|Overall Study|Laboratory abnormality|1|||
150092618|NCT00312494|541480628|FG001|Overall Study|Laboratory abnormality|0|||
150092619|NCT00312494|541480629|FG002|Overall Study|Laboratory abnormality|0|||
150092620|NCT00312494|541480627|FG000|Overall Study|Lost to Follow-up|8|||
150092621|NCT00312494|541480628|FG001|Overall Study|Lost to Follow-up|8|||
150092622|NCT00312494|541480629|FG002|Overall Study|Lost to Follow-up|8|||
150092623|NCT00312494|541480627|FG000|Overall Study|Withdrawal by Subject|6|||
150092624|NCT00312494|541480628|FG001|Overall Study|Withdrawal by Subject|9|||
150092625|NCT00312494|541480629|FG002|Overall Study|Withdrawal by Subject|10|||
150092626|NCT00312494|541480627|FG000|Overall Study|Other|10|||
150092627|NCT00312494|541480628|FG001|Overall Study|Other|10|||
150092628|NCT00312494|541480629|FG002|Overall Study|Other|1|||
150092629|NCT03316131|541480633|FG000|Treatment Period 2|Protocol deviation|1|||
150092630|NCT03316131|541480634|FG001|Treatment Period 2|Protocol deviation|0|||
150092631|NCT00708162|541480636|FG000|Randomized Phase|Randomized but Not Treated|7|||
150092632|NCT00708162|541480637|FG001|Randomized Phase|Randomized but Not Treated|5|||
150092633|NCT00708162|541480636|FG000|Randomized Phase|Participant Noncompliance|40|||
150092634|NCT00708162|541480637|FG001|Randomized Phase|Participant Noncompliance|32|||
150092635|NCT00708162|541480636|FG000|Randomized Phase|Lost to Follow-up|34|||
150092636|NCT00708162|541480637|FG001|Randomized Phase|Lost to Follow-up|34|||
150092637|NCT00708162|541480636|FG000|Randomized Phase|Withdrew Consent|31|||
150092638|NCT00708162|541480637|FG001|Randomized Phase|Withdrew Consent|22|||
150092639|NCT00708162|541480636|FG000|Randomized Phase|Lack of Efficacy|14|||
150092640|NCT00708162|541480637|FG001|Randomized Phase|Lack of Efficacy|19|||
150092641|NCT00708162|541480636|FG000|Randomized Phase|Protocol Violation|10|||
150092642|NCT00708162|541480637|FG001|Randomized Phase|Protocol Violation|11|||
150092643|NCT00708162|541480636|FG000|Randomized Phase|Adverse Event|8|||
150092644|NCT00708162|541480637|FG001|Randomized Phase|Adverse Event|12|||
150092645|NCT00708162|541480636|FG000|Randomized Phase|Investigator's Discretion|7|||
150092646|NCT00708162|541480637|FG001|Randomized Phase|Investigator's Discretion|10|||
150092647|NCT00708162|541480636|FG000|Randomized Phase|Death|2|||
150092648|NCT00708162|541480637|FG001|Randomized Phase|Death|9|||
150092649|NCT00708162|541480636|FG000|Randomized Phase|Pregnancy|3|||
150092650|NCT00708162|541480637|FG001|Randomized Phase|Pregnancy|0|||
150092651|NCT00708162|541480636|FG000|Open-Label Phase|Lost to Follow-up|10|||
150092652|NCT00708162|541480637|FG001|Open-Label Phase|Lost to Follow-up|8|||
150092653|NCT00708162|541480636|FG000|Open-Label Phase|Withdrew Consent|12|||
150092654|NCT00708162|541480637|FG001|Open-Label Phase|Withdrew Consent|6|||
150092655|NCT00708162|541480636|FG000|Open-Label Phase|Participant Noncompliance|7|||
150092656|NCT00708162|541480637|FG001|Open-Label Phase|Participant Noncompliance|7|||
150092657|NCT00708162|541480636|FG000|Open-Label Phase|Lack of Efficacy|7|||
150092658|NCT00708162|541480637|FG001|Open-Label Phase|Lack of Efficacy|4|||
150092659|NCT00708162|541480636|FG000|Open-Label Phase|Investigator's Discretion|3|||
150092660|NCT00708162|541480637|FG001|Open-Label Phase|Investigator's Discretion|2|||
150092661|NCT00708162|541480636|FG000|Open-Label Phase|Death|3|||
150092662|NCT00708162|541480637|FG001|Open-Label Phase|Death|1|||
150092663|NCT00708162|541480636|FG000|Open-Label Phase|Adverse Event|1|||
150092664|NCT00708162|541480637|FG001|Open-Label Phase|Adverse Event|2|||
150092665|NCT00708162|541480636|FG000|Open-Label Phase|Other|1|||
150092666|NCT00708162|541480637|FG001|Open-Label Phase|Other|0|||
150092667|NCT02169739|541480638|FG000|Overall Study|Lost to Follow-up|0|||
150092668|NCT02169739|541480639|FG001|Overall Study|Lost to Follow-up|4|||
150092669|NCT01525550|541480646|FG000|Overall Study|Lost to Follow-up|8|||
150092670|NCT01525550|541480647|FG001|Overall Study|Lost to Follow-up|2|||
150092671|NCT01525550|541480646|FG000|Overall Study|Death|19|||
150092672|NCT01525550|541480647|FG001|Overall Study|Death|28|||
150092673|NCT01525550|541480646|FG000|Overall Study|Other|0|||
150092674|NCT01525550|541480647|FG001|Overall Study|Other|4|||
150092675|NCT01525550|541480646|FG000|Overall Study|Sponsor's Decision|30|||
150092676|NCT01525550|541480647|FG001|Overall Study|Sponsor's Decision|11|||
150092677|NCT01525550|541480646|FG000|Overall Study|Withdrawal by Subject|4|||
150092678|NCT01525550|541480647|FG001|Overall Study|Withdrawal by Subject|0|||
150092679|NCT02877082|541480648|FG000|Overall Study|Trial was closed early|5|||
150092680|NCT03480750|541480649|FG000|Overall Study|Withdrawal by Subject|0|||
150092681|NCT03480750|541480650|FG001|Overall Study|Withdrawal by Subject|1|||
150092682|NCT03480750|541480651|FG002|Overall Study|Withdrawal by Subject|0|||
150092683|NCT03480750|541480652|FG003|Overall Study|Withdrawal by Subject|0|||
150092684|NCT03480750|541480653|FG004|Overall Study|Withdrawal by Subject|0|||
150092685|NCT03480750|541480654|FG005|Overall Study|Withdrawal by Subject|0|||
150092686|NCT03480750|541480649|FG000|Overall Study|The interruption in Trientine shippment|0|||
150092687|NCT03480750|541480650|FG001|Overall Study|The interruption in Trientine shippment|0|||
150092688|NCT03480750|541480651|FG002|Overall Study|The interruption in Trientine shippment|0|||
150092689|NCT03480750|541480652|FG003|Overall Study|The interruption in Trientine shippment|0|||
150092690|NCT03480750|541480653|FG004|Overall Study|The interruption in Trientine shippment|0|||
150092691|NCT03480750|541480654|FG005|Overall Study|The interruption in Trientine shippment|1|||
150092692|NCT03060447|541480657|FG000|Overall Study|Withdrawal by Subject|2|||
150092693|NCT03060447|541480658|FG001|Overall Study|Withdrawal by Subject|0|||
150092694|NCT02232425|541480659|FG000|Overall Study|Lost to Follow-up|6|||
150092695|NCT02232425|541480660|FG001|Overall Study|Lost to Follow-up|2|||
150092696|NCT02232425|541480659|FG000|Overall Study|Adverse Event|2|||
150092697|NCT02232425|541480660|FG001|Overall Study|Adverse Event|0|||
150092698|NCT02232425|541480659|FG000|Overall Study|Withdrawal by Subject|5|||
150092699|NCT02232425|541480660|FG001|Overall Study|Withdrawal by Subject|6|||
150092700|NCT02232425|541480659|FG000|Overall Study|Lack of Efficacy|1|||
150092701|NCT02232425|541480660|FG001|Overall Study|Lack of Efficacy|0|||
150092702|NCT00498602|541480661|FG000|Overall Study|Death|0|||
150092703|NCT00498602|541480662|FG001|Overall Study|Death|0|||
150092704|NCT00498602|541480663|FG002|Overall Study|Death|0|||
150092705|NCT00498602|541480664|FG003|Overall Study|Death|0|||
150092706|NCT00498602|541480665|FG004|Overall Study|Death|0|||
150092707|NCT00498602|541480666|FG005|Overall Study|Death|1|||
150092708|NCT00498602|541480667|FG006|Overall Study|Death|0|||
150092709|NCT00498602|541480661|FG000|Overall Study|Lack of Efficacy|1|||
150092710|NCT00498602|541480662|FG001|Overall Study|Lack of Efficacy|0|||
150092711|NCT00498602|541480663|FG002|Overall Study|Lack of Efficacy|0|||
150092712|NCT00498602|541480664|FG003|Overall Study|Lack of Efficacy|0|||
150092713|NCT00498602|541480665|FG004|Overall Study|Lack of Efficacy|0|||
150092714|NCT00498602|541480666|FG005|Overall Study|Lack of Efficacy|0|||
150092715|NCT00498602|541480667|FG006|Overall Study|Lack of Efficacy|0|||
150092716|NCT00498602|541480661|FG000|Overall Study|Lost to Follow-up|0|||
150092717|NCT00498602|541480662|FG001|Overall Study|Lost to Follow-up|2|||
150092718|NCT00498602|541480663|FG002|Overall Study|Lost to Follow-up|0|||
150092719|NCT00498602|541480664|FG003|Overall Study|Lost to Follow-up|2|||
150092720|NCT00498602|541480665|FG004|Overall Study|Lost to Follow-up|0|||
150092721|NCT00498602|541480666|FG005|Overall Study|Lost to Follow-up|0|||
150092722|NCT00498602|541480667|FG006|Overall Study|Lost to Follow-up|0|||
150092723|NCT00498602|541480661|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
150092724|NCT00498602|541480662|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
150092725|NCT00498602|541480663|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
150092726|NCT00498602|541480664|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
150092727|NCT00498602|541480665|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
150092728|NCT00498602|541480666|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
150092729|NCT00498602|541480667|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
150092730|NCT00498602|541480661|FG000|Overall Study|AE not related to Study Drug|1|||
150092731|NCT00498602|541480662|FG001|Overall Study|AE not related to Study Drug|3|||
150092732|NCT00498602|541480663|FG002|Overall Study|AE not related to Study Drug|0|||
150092733|NCT00498602|541480664|FG003|Overall Study|AE not related to Study Drug|0|||
150092734|NCT00498602|541480665|FG004|Overall Study|AE not related to Study Drug|2|||
150092735|NCT00498602|541480666|FG005|Overall Study|AE not related to Study Drug|2|||
150092736|NCT00498602|541480667|FG006|Overall Study|AE not related to Study Drug|1|||
150092737|NCT00498602|541480661|FG000|Overall Study|Caregiver Request|2|||
150092738|NCT00498602|541480662|FG001|Overall Study|Caregiver Request|2|||
150092739|NCT00498602|541480663|FG002|Overall Study|Caregiver Request|2|||
150092740|NCT00498602|541480664|FG003|Overall Study|Caregiver Request|0|||
150092741|NCT00498602|541480665|FG004|Overall Study|Caregiver Request|1|||
150092742|NCT00498602|541480666|FG005|Overall Study|Caregiver Request|2|||
150092743|NCT00498602|541480667|FG006|Overall Study|Caregiver Request|0|||
150092744|NCT00498602|541480661|FG000|Overall Study|Investigator Request|0|||
150092745|NCT00498602|541480662|FG001|Overall Study|Investigator Request|0|||
150092746|NCT00498602|541480663|FG002|Overall Study|Investigator Request|1|||
150092747|NCT00498602|541480664|FG003|Overall Study|Investigator Request|0|||
150092748|NCT00498602|541480665|FG004|Overall Study|Investigator Request|0|||
150092749|NCT00498602|541480666|FG005|Overall Study|Investigator Request|0|||
150092750|NCT00498602|541480667|FG006|Overall Study|Investigator Request|0|||
150092751|NCT00498602|541480661|FG000|Overall Study|Subject Request|3|||
150092752|NCT00498602|541480662|FG001|Overall Study|Subject Request|0|||
150092753|NCT00498602|541480663|FG002|Overall Study|Subject Request|1|||
150092754|NCT00498602|541480664|FG003|Overall Study|Subject Request|1|||
150092755|NCT00498602|541480665|FG004|Overall Study|Subject Request|1|||
150092756|NCT00498602|541480666|FG005|Overall Study|Subject Request|4|||
150092757|NCT00498602|541480667|FG006|Overall Study|Subject Request|1|||
150092758|NCT00498602|541480661|FG000|Overall Study|Other|2|||
150092759|NCT00498602|541480662|FG001|Overall Study|Other|3|||
150092760|NCT00498602|541480663|FG002|Overall Study|Other|1|||
150092761|NCT00498602|541480664|FG003|Overall Study|Other|0|||
150092762|NCT00498602|541480665|FG004|Overall Study|Other|0|||
150092763|NCT00498602|541480666|FG005|Overall Study|Other|3|||
150092764|NCT00498602|541480667|FG006|Overall Study|Other|0|||
150092765|NCT01113801|541480668|FG000|Overall Study|Adverse Event|4|||
150092766|NCT01113801|541480669|FG001|Overall Study|Adverse Event|0|||
150092767|NCT01113801|541480670|FG002|Overall Study|Adverse Event|2|||
150092768|NCT01113801|541480671|FG003|Overall Study|Adverse Event|6|||
150092769|NCT01113801|541480668|FG000|Overall Study|Death|4|||
150092770|NCT01113801|541480669|FG001|Overall Study|Death|5|||
150092771|NCT01113801|541480670|FG002|Overall Study|Death|3|||
150092772|NCT01113801|541480671|FG003|Overall Study|Death|4|||
150092773|NCT01113801|541480668|FG000|Overall Study|Protocol Violation|0|||
150092774|NCT01113801|541480669|FG001|Overall Study|Protocol Violation|1|||
150092775|NCT01113801|541480670|FG002|Overall Study|Protocol Violation|0|||
150092776|NCT01113801|541480671|FG003|Overall Study|Protocol Violation|0|||
150092777|NCT01113801|541480668|FG000|Overall Study|Withdrawal by Subject|9|||
150092778|NCT01113801|541480669|FG001|Overall Study|Withdrawal by Subject|7|||
150092779|NCT01113801|541480670|FG002|Overall Study|Withdrawal by Subject|7|||
150092780|NCT01113801|541480671|FG003|Overall Study|Withdrawal by Subject|8|||
150092781|NCT01113801|541480668|FG000|Overall Study|Physician Decision|2|||
150092782|NCT01113801|541480669|FG001|Overall Study|Physician Decision|2|||
150092783|NCT01113801|541480670|FG002|Overall Study|Physician Decision|3|||
150092784|NCT01113801|541480671|FG003|Overall Study|Physician Decision|3|||
150092785|NCT01113801|541480668|FG000|Overall Study|Sponsor Decision|15|||
150092786|NCT01113801|541480669|FG001|Overall Study|Sponsor Decision|21|||
150092787|NCT01113801|541480670|FG002|Overall Study|Sponsor Decision|20|||
150092788|NCT01113801|541480671|FG003|Overall Study|Sponsor Decision|15|||
150092789|NCT01113801|541480668|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
150092790|NCT01113801|541480669|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
150092791|NCT01113801|541480670|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
150092792|NCT01113801|541480671|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
150092793|NCT02436356|541480672|FG000|Overall Study|Excluded by MRI Screening|0|||
150092794|NCT02436356|541480673|FG001|Overall Study|Excluded by MRI Screening|0|||
150092795|NCT02436356|541480674|FG002|Overall Study|Excluded by MRI Screening|2|||
150092796|NCT02436356|541480672|FG000|Overall Study|Lost to Follow-up|0|||
150092797|NCT02436356|541480673|FG001|Overall Study|Lost to Follow-up|1|||
150092798|NCT02436356|541480674|FG002|Overall Study|Lost to Follow-up|0|||
150092799|NCT02436356|541480672|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
150092800|NCT02436356|541480673|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
150092801|NCT02436356|541480674|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
150092802|NCT02436356|541480672|FG000|Overall Study|Excluded due to other medical conditions|3|||
150092803|NCT02436356|541480673|FG001|Overall Study|Excluded due to other medical conditions|0|||
150092804|NCT02436356|541480674|FG002|Overall Study|Excluded due to other medical conditions|0|||
150092805|NCT02436356|541480672|FG000|Overall Study|Withdrawal by Subject|1|||
150092806|NCT02436356|541480673|FG001|Overall Study|Withdrawal by Subject|0|||
150092807|NCT02436356|541480674|FG002|Overall Study|Withdrawal by Subject|0|||
150092808|NCT04577118|541480675|FG000|Overall Study|Withdrawal by Subject|4|||
150092809|NCT00810407|541480676|FG000|Overall Study|Protocol Violation|3|||
150092810|NCT00810407|541480676|FG000|Overall Study|No Visit After First Day of Treatment|3|||
150092811|NCT03287804|541480677|FG000|Overall Study|Death|1|||
150092812|NCT03287804|541480677|FG000|Overall Study|Physician Decision|2|||
150092813|NCT03287804|541480677|FG000|Overall Study|Progressive disease|8|||
150092814|NCT04008030|541480680|FG000|Pre-Treatment|Withdrawal by Subject|0|||
150092815|NCT04008030|541480681|FG001|Pre-Treatment|Withdrawal by Subject|0|||
150092816|NCT04008030|541480682|FG002|Pre-Treatment|Withdrawal by Subject|9|||
150092817|NCT04008030|541480680|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
150092818|NCT04008030|541480681|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
150092819|NCT04008030|541480682|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
150092820|NCT04008030|541480680|FG000|Pre-Treatment|Other reasons|0|||
150092821|NCT04008030|541480681|FG001|Pre-Treatment|Other reasons|1|||
150092822|NCT04008030|541480682|FG002|Pre-Treatment|Other reasons|6|||
150092823|NCT04008030|541480680|FG000|Treatment|Withdrawal by Subject|1|||
150092824|NCT04008030|541480681|FG001|Treatment|Withdrawal by Subject|1|||
150092825|NCT04008030|541480682|FG002|Treatment|Withdrawal by Subject|1|||
150092826|NCT04008030|541480680|FG000|Treatment|Death|2|||
150092827|NCT04008030|541480681|FG001|Treatment|Death|4|||
150092828|NCT04008030|541480682|FG002|Treatment|Death|0|||
150092829|NCT04008030|541480680|FG000|Treatment|Pregnancy|0|||
150092830|NCT04008030|541480681|FG001|Treatment|Pregnancy|1|||
150092831|NCT04008030|541480682|FG002|Treatment|Pregnancy|0|||
150092832|NCT04008030|541480680|FG000|Treatment|Participant no longer meets study criteria|0|||
150092833|NCT04008030|541480681|FG001|Treatment|Participant no longer meets study criteria|1|||
150092834|NCT04008030|541480682|FG002|Treatment|Participant no longer meets study criteria|0|||
150092835|NCT04008030|541480680|FG000|Treatment|Other reasons|5|||
150092836|NCT04008030|541480681|FG001|Treatment|Other reasons|13|||
150092837|NCT04008030|541480682|FG002|Treatment|Other reasons|6|||
150092838|NCT04008030|541480680|FG000|Treatment|Disease Progression|137|||
150092839|NCT04008030|541480681|FG001|Treatment|Disease Progression|82|||
150092840|NCT04008030|541480682|FG002|Treatment|Disease Progression|85|||
150092841|NCT04008030|541480680|FG000|Treatment|Study drug toxicity|28|||
150092842|NCT04008030|541480681|FG001|Treatment|Study drug toxicity|48|||
150092843|NCT04008030|541480682|FG002|Treatment|Study drug toxicity|8|||
150092844|NCT04008030|541480680|FG000|Treatment|Adverse Event unrelated to study drug|28|||
150092845|NCT04008030|541480681|FG001|Treatment|Adverse Event unrelated to study drug|22|||
150092846|NCT04008030|541480682|FG002|Treatment|Adverse Event unrelated to study drug|6|||
150092847|NCT04008030|541480680|FG000|Treatment|Maximum Clinical Benefit|0|||
150092848|NCT04008030|541480681|FG001|Treatment|Maximum Clinical Benefit|1|||
150092849|NCT04008030|541480682|FG002|Treatment|Maximum Clinical Benefit|9|||
150092850|NCT04008030|541480680|FG000|Treatment|On-going treatment|13|||
150092851|NCT04008030|541480681|FG001|Treatment|On-going treatment|20|||
150092852|NCT04008030|541480682|FG002|Treatment|On-going treatment|0|||
150092853|NCT03108027|541480695|FG000|Period 1|Subject/Guardian Decision|0|||
150092854|NCT03108027|541480696|FG001|Period 1|Subject/Guardian Decision|0|||
150092855|NCT03108027|541480697|FG002|Period 1|Subject/Guardian Decision|0|||
150092856|NCT03108027|541480698|FG003|Period 1|Subject/Guardian Decision|2|||
150092857|NCT03108027|541480699|FG004|Period 1|Subject/Guardian Decision|0|||
150092858|NCT03108027|541480700|FG005|Period 1|Subject/Guardian Decision|0|||
150092859|NCT03108027|541480695|FG000|Period 3|Adverse Event|0|||
150092860|NCT03108027|541480696|FG001|Period 3|Adverse Event|1|||
150092861|NCT03108027|541480697|FG002|Period 3|Adverse Event|0|||
150092862|NCT03108027|541480698|FG003|Period 3|Adverse Event|0|||
150092863|NCT03108027|541480699|FG004|Period 3|Adverse Event|0|||
150092864|NCT03108027|541480700|FG005|Period 3|Adverse Event|0|||
150092865|NCT02574247|541480701|FG000|Overall Study|Withdrawal by Subject|1|||
150092866|NCT02574247|541480702|FG001|Overall Study|Withdrawal by Subject|0|||
150092867|NCT02574247|541480703|FG002|Overall Study|Withdrawal by Subject|0|||
150092868|NCT02574247|541480701|FG000|Overall Study|Did not meet inclusion criteria|4|||
150092869|NCT02574247|541480702|FG001|Overall Study|Did not meet inclusion criteria|3|||
150092870|NCT02574247|541480703|FG002|Overall Study|Did not meet inclusion criteria|5|||
150092871|NCT01382446|541480704|FG000|Overall Study|Withdrawal by Subject|0|||
150092872|NCT01382446|541480705|FG001|Overall Study|Withdrawal by Subject|1|||
150092873|NCT01382446|541480704|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
150092874|NCT01382446|541480705|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
150092875|NCT00770289|541480715|FG000|Overall Study|Other|6|||
150092876|NCT02733991|541480716|FG000|Overall Study|Adverse Event|1|||
150092877|NCT02733991|541480717|FG001|Overall Study|Adverse Event|0|||
150092878|NCT02733991|541480716|FG000|Overall Study|Withdrawal by Subject|0|||
150092879|NCT02733991|541480717|FG001|Overall Study|Withdrawal by Subject|5|||
150092880|NCT00422591|541480720|FG000|Overall Study|Physician Decision|4|||
150092881|NCT00422591|541480720|FG000|Overall Study|Withdrawal by Subject|2|||
150092882|NCT02659631|541480723|FG000|Overall Study|Lost to Follow-up|0|||
150092883|NCT02659631|541480724|FG001|Overall Study|Lost to Follow-up|0|||
150092884|NCT02659631|541480725|FG002|Overall Study|Lost to Follow-up|2|||
150092885|NCT02659631|541480726|FG003|Overall Study|Lost to Follow-up|0|||
150092886|NCT02659631|541480727|FG004|Overall Study|Lost to Follow-up|0|||
150092887|NCT02659631|541480728|FG005|Overall Study|Lost to Follow-up|1|||
150092888|NCT02659631|541480729|FG006|Overall Study|Lost to Follow-up|0|||
150092889|NCT02659631|541480730|FG007|Overall Study|Lost to Follow-up|0|||
150092890|NCT02659631|541480731|FG008|Overall Study|Lost to Follow-up|0|||
150092891|NCT02659631|541480732|FG009|Overall Study|Lost to Follow-up|0|||
150092892|NCT02659631|541480723|FG000|Overall Study|Withdrawal prior to treatment|0|||
150092893|NCT02659631|541480724|FG001|Overall Study|Withdrawal prior to treatment|0|||
150029223|NCT01384734|541242624|FG000|Overall Study|As per Exclusion criteria|0|||
150029224|NCT01384734|541242625|FG001|Overall Study|As per Exclusion criteria|1|||
150029225|NCT01384734|541242626|FG002|Overall Study|As per Exclusion criteria|0|||
150029226|NCT01384734|541242627|FG003|Overall Study|As per Exclusion criteria|0|||
150029227|NCT01384734|541242628|FG004|Overall Study|As per Exclusion criteria|0|||
150029228|NCT01384734|541242624|FG000|Overall Study|Missed End of treatment visit|0|||
150029229|NCT01384734|541242625|FG001|Overall Study|Missed End of treatment visit|0|||
150029230|NCT01384734|541242626|FG002|Overall Study|Missed End of treatment visit|0|||
150029231|NCT01384734|541242627|FG003|Overall Study|Missed End of treatment visit|1|||
150029232|NCT01384734|541242628|FG004|Overall Study|Missed End of treatment visit|0|||
150029233|NCT01384734|541242624|FG000|Overall Study|Adhesion problem|0|||
150029234|NCT01384734|541242625|FG001|Overall Study|Adhesion problem|0|||
150029235|NCT01384734|541242626|FG002|Overall Study|Adhesion problem|0|||
150029236|NCT01384734|541242627|FG003|Overall Study|Adhesion problem|1|||
150029237|NCT01384734|541242628|FG004|Overall Study|Adhesion problem|0|||
150029238|NCT01384734|541242624|FG000|Overall Study|Early termination|0|||
150029239|NCT01384734|541242625|FG001|Overall Study|Early termination|0|||
150029240|NCT01384734|541242626|FG002|Overall Study|Early termination|0|||
150029241|NCT01384734|541242627|FG003|Overall Study|Early termination|0|||
150029242|NCT01384734|541242628|FG004|Overall Study|Early termination|1|||
150029243|NCT01384734|541242624|FG000|Overall Study|Physician Decision|1|||
150092894|NCT02659631|541480725|FG002|Overall Study|Withdrawal prior to treatment|0|||
150092895|NCT02659631|541480726|FG003|Overall Study|Withdrawal prior to treatment|0|||
150092896|NCT02659631|541480727|FG004|Overall Study|Withdrawal prior to treatment|1|||
150092897|NCT02659631|541480728|FG005|Overall Study|Withdrawal prior to treatment|0|||
150092898|NCT02659631|541480729|FG006|Overall Study|Withdrawal prior to treatment|0|||
150092899|NCT02659631|541480730|FG007|Overall Study|Withdrawal prior to treatment|0|||
150092900|NCT02659631|541480731|FG008|Overall Study|Withdrawal prior to treatment|0|||
150092901|NCT02659631|541480732|FG009|Overall Study|Withdrawal prior to treatment|0|||
150092902|NCT02659631|541480723|FG000|Overall Study|Participant refused further follow-up|0|||
150092903|NCT02659631|541480724|FG001|Overall Study|Participant refused further follow-up|0|||
150092904|NCT02659631|541480725|FG002|Overall Study|Participant refused further follow-up|0|||
150092905|NCT02659631|541480726|FG003|Overall Study|Participant refused further follow-up|1|||
150092906|NCT02659631|541480727|FG004|Overall Study|Participant refused further follow-up|0|||
150092907|NCT02659631|541480728|FG005|Overall Study|Participant refused further follow-up|0|||
150092908|NCT02659631|541480729|FG006|Overall Study|Participant refused further follow-up|0|||
150092909|NCT02659631|541480730|FG007|Overall Study|Participant refused further follow-up|0|||
150092910|NCT02659631|541480731|FG008|Overall Study|Participant refused further follow-up|1|||
150092911|NCT02659631|541480732|FG009|Overall Study|Participant refused further follow-up|0|||
150092912|NCT02659631|541480723|FG000|Overall Study|Death (follow-up phase)|1|||
150092913|NCT02659631|541480724|FG001|Overall Study|Death (follow-up phase)|2|||
150092914|NCT02659631|541480725|FG002|Overall Study|Death (follow-up phase)|1|||
150092915|NCT02659631|541480726|FG003|Overall Study|Death (follow-up phase)|1|||
150092916|NCT02659631|541480727|FG004|Overall Study|Death (follow-up phase)|3|||
150092917|NCT02659631|541480728|FG005|Overall Study|Death (follow-up phase)|2|||
150092918|NCT02659631|541480729|FG006|Overall Study|Death (follow-up phase)|0|||
150092919|NCT02659631|541480730|FG007|Overall Study|Death (follow-up phase)|3|||
150092920|NCT02659631|541480731|FG008|Overall Study|Death (follow-up phase)|1|||
150092921|NCT02659631|541480732|FG009|Overall Study|Death (follow-up phase)|0|||
150092922|NCT02659631|541480723|FG000|Overall Study|Death (treatment phase)|0|||
150092923|NCT02659631|541480724|FG001|Overall Study|Death (treatment phase)|0|||
150092924|NCT02659631|541480725|FG002|Overall Study|Death (treatment phase)|0|||
150092925|NCT02659631|541480726|FG003|Overall Study|Death (treatment phase)|0|||
150092926|NCT02659631|541480727|FG004|Overall Study|Death (treatment phase)|1|||
150092927|NCT02659631|541480728|FG005|Overall Study|Death (treatment phase)|0|||
150092928|NCT02659631|541480729|FG006|Overall Study|Death (treatment phase)|1|||
150092929|NCT02659631|541480730|FG007|Overall Study|Death (treatment phase)|0|||
150092930|NCT02659631|541480731|FG008|Overall Study|Death (treatment phase)|0|||
150092931|NCT02659631|541480732|FG009|Overall Study|Death (treatment phase)|0|||
150092932|NCT02377466|541480733|FG000|Overall Study|Other: Randomized and not treated|0|||
150092933|NCT02377466|541480734|FG001|Overall Study|Other: Randomized and not treated|2|||
150092934|NCT00495170|541480735|FG000|Overall Study|Lost to Follow-up|9|||
150092935|NCT00495170|541480735|FG000|Overall Study|Withdrawal by Subject|3|||
150092936|NCT00495170|541480735|FG000|Overall Study|Inappropriate staging|8|||
150092937|NCT04191499|541480736|FG000|Overall Study|Adverse Event|1|||
150092938|NCT04191499|541480737|FG001|Overall Study|Adverse Event|0|||
150092939|NCT04191499|541480736|FG000|Overall Study|Death|42|||
150092940|NCT04191499|541480737|FG001|Overall Study|Death|55|||
150092941|NCT04191499|541480736|FG000|Overall Study|Lost to Follow-up|4|||
150092942|NCT04191499|541480737|FG001|Overall Study|Lost to Follow-up|1|||
150092943|NCT04191499|541480736|FG000|Overall Study|Physician Decision|1|||
150092944|NCT04191499|541480737|FG001|Overall Study|Physician Decision|0|||
150092945|NCT04191499|541480736|FG000|Overall Study|Progressive Disease|1|||
150092946|NCT04191499|541480737|FG001|Overall Study|Progressive Disease|0|||
150092947|NCT04191499|541480736|FG000|Overall Study|Symptomatic Deterioration|1|||
150092948|NCT04191499|541480737|FG001|Overall Study|Symptomatic Deterioration|0|||
150092949|NCT04191499|541480736|FG000|Overall Study|Withdrawal by Subject|7|||
150092950|NCT04191499|541480737|FG001|Overall Study|Withdrawal by Subject|11|||
150092951|NCT04191499|541480736|FG000|Overall Study|Ongoing in the study|104|||
150092952|NCT04191499|541480737|FG001|Overall Study|Ongoing in the study|97|||
150092953|NCT00680745|541480738|FG000|Overall Study|Withdrawal by Subject|8|||
150092954|NCT00680745|541480739|FG001|Overall Study|Withdrawal by Subject|3|||
150092955|NCT00680745|541480740|FG002|Overall Study|Withdrawal by Subject|2|||
150092956|NCT00680745|541480741|FG003|Overall Study|Withdrawal by Subject|8|||
150092957|NCT00680745|541480738|FG000|Overall Study|Lost to Follow-up|0|||
150092958|NCT00680745|541480739|FG001|Overall Study|Lost to Follow-up|1|||
150092959|NCT00680745|541480740|FG002|Overall Study|Lost to Follow-up|1|||
150092960|NCT00680745|541480741|FG003|Overall Study|Lost to Follow-up|0|||
150092961|NCT00680745|541480738|FG000|Overall Study|Death|1|||
150092962|NCT00680745|541480739|FG001|Overall Study|Death|0|||
150092963|NCT00680745|541480740|FG002|Overall Study|Death|1|||
150092964|NCT00680745|541480741|FG003|Overall Study|Death|0|||
150092965|NCT00680745|541480738|FG000|Overall Study|Adverse Event|5|||
150092966|NCT00680745|541480739|FG001|Overall Study|Adverse Event|3|||
150092967|NCT00680745|541480740|FG002|Overall Study|Adverse Event|3|||
150092968|NCT00680745|541480741|FG003|Overall Study|Adverse Event|3|||
150092969|NCT00680745|541480738|FG000|Overall Study|Poor/Non-compliance|0|||
150092970|NCT00680745|541480739|FG001|Overall Study|Poor/Non-compliance|3|||
150092971|NCT00680745|541480740|FG002|Overall Study|Poor/Non-compliance|0|||
150092972|NCT00680745|541480741|FG003|Overall Study|Poor/Non-compliance|0|||
150092973|NCT00680745|541480738|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
150092974|NCT00680745|541480739|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
150092975|NCT00680745|541480740|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
150184501|NCT00073749|541813356|FG006|Overall Study|Lost to Follow-up|2|||
150092976|NCT00680745|541480741|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
150092977|NCT00680745|541480738|FG000|Overall Study|False Treatment|0|||
150092978|NCT00680745|541480739|FG001|Overall Study|False Treatment|1|||
150092979|NCT00680745|541480740|FG002|Overall Study|False Treatment|3|||
150092980|NCT00680745|541480741|FG003|Overall Study|False Treatment|0|||
150092981|NCT01928329|541480742|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
150092982|NCT01928329|541480743|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
150092983|NCT01928329|541480742|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
150092984|NCT01928329|541480743|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
150092985|NCT01928329|541480742|FG000|Overall Study|Adverse Event|5|||
150092986|NCT01928329|541480743|FG001|Overall Study|Adverse Event|3|||
150092987|NCT01928329|541480742|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
150092988|NCT01928329|541480743|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
150092989|NCT01928329|541480742|FG000|Overall Study|Withdrawal by Subject|1|||
150092990|NCT01928329|541480743|FG001|Overall Study|Withdrawal by Subject|5|||
150092991|NCT01928329|541480742|FG000|Overall Study|Physician Decision|1|||
150092992|NCT01928329|541480743|FG001|Overall Study|Physician Decision|1|||
150092993|NCT00330616|541480744|FG000|Overall Study|Adverse Event|13|||
150092994|NCT00330616|541480744|FG000|Overall Study|Lack of Efficacy|1|||
150092995|NCT00330616|541480744|FG000|Overall Study|Lost to Follow-up|2|||
150092996|NCT00330616|541480744|FG000|Overall Study|Withdrawal by Subject|4|||
150092997|NCT00330616|541480744|FG000|Overall Study|Other|1|||
150092998|NCT01119131|541480749|FG000|Overall Study|Adverse Event|1|||
150092999|NCT01119131|541480750|FG001|Overall Study|Adverse Event|1|||
150093000|NCT01119131|541480751|FG002|Overall Study|Adverse Event|1|||
150093001|NCT01119131|541480749|FG000|Overall Study|Non-Compliance|1|||
150093002|NCT01119131|541480750|FG001|Overall Study|Non-Compliance|0|||
150093003|NCT01119131|541480751|FG002|Overall Study|Non-Compliance|4|||
150093004|NCT01119131|541480749|FG000|Overall Study|Physician Decision|0|||
150093005|NCT01119131|541480750|FG001|Overall Study|Physician Decision|0|||
150093006|NCT01119131|541480751|FG002|Overall Study|Physician Decision|1|||
150093007|NCT00993291|541480752|FG000|Overall Study|Withdrawal by Subject|1|||
150093008|NCT00003492|541480753|FG000|Overall Study|Not evaluable|6|||
150093009|NCT03566823|541480754|FG000|Overall Study|Lack of Efficacy|0|||
150093010|NCT03566823|541480755|FG001|Overall Study|Lack of Efficacy|1|||
150093011|NCT03566823|541480756|FG002|Overall Study|Lack of Efficacy|0|||
150093012|NCT03566823|541480754|FG000|Overall Study|Withdrawal by Subject|1|||
150093013|NCT03566823|541480755|FG001|Overall Study|Withdrawal by Subject|2|||
150093014|NCT03566823|541480756|FG002|Overall Study|Withdrawal by Subject|0|||
150093015|NCT03566823|541480754|FG000|Overall Study|Adverse Event|1|||
150093016|NCT03566823|541480755|FG001|Overall Study|Adverse Event|0|||
150093017|NCT03566823|541480756|FG002|Overall Study|Adverse Event|2|||
150093018|NCT01706003|541483100|FG000|Overall Study|Withdrawal by Subject|2|||
150093019|NCT01706003|541483101|FG001|Overall Study|Withdrawal by Subject|0|||
150093020|NCT01706003|541483100|FG000|Overall Study|Not scheduled|3|||
150093021|NCT01706003|541483101|FG001|Overall Study|Not scheduled|0|||
150093022|NCT01706003|541483100|FG000|Overall Study|Lost to Follow-up|6|||
150093023|NCT01706003|541483101|FG001|Overall Study|Lost to Follow-up|4|||
150093024|NCT03182829|541483102|FG000|Overall Study|Protocol Violation|12|||
150093025|NCT03182829|541483103|FG001|Overall Study|Protocol Violation|12|||
150093026|NCT03182829|541483102|FG000|Overall Study|Other|4|||
150093027|NCT03182829|541483103|FG001|Overall Study|Other|3|||
150093028|NCT05608005|541483104|FG000|Overall Study|Adverse Event|2|||
150093029|NCT05608005|541483105|FG001|Overall Study|Adverse Event|1|||
150093030|NCT05608005|541483106|FG002|Overall Study|Adverse Event|3|||
150093031|NCT05608005|541483104|FG000|Overall Study|Protocol Violation|2|||
150093032|NCT05608005|541483105|FG001|Overall Study|Protocol Violation|3|||
150093033|NCT05608005|541483106|FG002|Overall Study|Protocol Violation|0|||
150093034|NCT05608005|541483104|FG000|Overall Study|Withdrawal by Subject|10|||
150093035|NCT05608005|541483105|FG001|Overall Study|Withdrawal by Subject|12|||
150093036|NCT05608005|541483106|FG002|Overall Study|Withdrawal by Subject|4|||
150093037|NCT05608005|541483104|FG000|Overall Study|Lost to Follow-up|25|||
150093038|NCT05608005|541483105|FG001|Overall Study|Lost to Follow-up|27|||
150093039|NCT05608005|541483106|FG002|Overall Study|Lost to Follow-up|15|||
150093040|NCT05608005|541483104|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
150093041|NCT05608005|541483105|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
150093042|NCT05608005|541483106|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
150093043|NCT03020407|541483110|FG000|Overall Study|Withdrawal by Subject|2|||
150093044|NCT03020407|541483111|FG001|Overall Study|Withdrawal by Subject|1|||
150093045|NCT03020407|541483110|FG000|Overall Study|Lost to Follow-up|2|||
150093046|NCT03020407|541483111|FG001|Overall Study|Lost to Follow-up|3|||
150093047|NCT03020407|541483110|FG000|Overall Study|Protocol Violation|0|||
150093048|NCT03020407|541483111|FG001|Overall Study|Protocol Violation|1|||
150093049|NCT01585428|541483112|FG000|Overall Study|Death during treatment|1|||
150093050|NCT01585428|541483113|FG001|Overall Study|Death during treatment|0|||
150093051|NCT02699554|541483115|FG000|Overall Study|Lost to Follow-up|9|||
150093052|NCT00788151|541483116|FG000|Overall Study|Other adverse event|0|||
150093053|NCT00788151|541483117|FG001|Overall Study|Other adverse event|2|||
150093054|NCT00788151|541483116|FG000|Overall Study|Protocol Violation|0|||
150093055|NCT00788151|541483117|FG001|Overall Study|Protocol Violation|1|||
150093056|NCT00788151|541483116|FG000|Overall Study|Withdrawal by Subject|13|||
150093057|NCT00788151|541483117|FG001|Overall Study|Withdrawal by Subject|6|||
150093058|NCT00788151|541483116|FG000|Overall Study|Enrolled but not treated|1|||
150093059|NCT00788151|541483117|FG001|Overall Study|Enrolled but not treated|1|||
150093060|NCT00065507|541483120|FG000|Overall Study|Death|16|||
150093061|NCT00065507|541483121|FG001|Overall Study|Death|17|||
150093062|NCT00065507|541483120|FG000|Overall Study|Adverse Event|4|||
150093063|NCT00065507|541483121|FG001|Overall Study|Adverse Event|3|||
150093064|NCT00065507|541483120|FG000|Overall Study|Lack of Efficacy|0|||
150093065|NCT00065507|541483121|FG001|Overall Study|Lack of Efficacy|6|||
150093066|NCT00065507|541483120|FG000|Overall Study|Poor/Non-compliance|3|||
150093067|NCT00065507|541483121|FG001|Overall Study|Poor/Non-compliance|2|||
150093068|NCT00065507|541483120|FG000|Overall Study|Lost to Follow-up|3|||
150093069|NCT00065507|541483121|FG001|Overall Study|Lost to Follow-up|0|||
150093070|NCT00065507|541483120|FG000|Overall Study|Subject Withdrew Consent|2|||
150093071|NCT00065507|541483121|FG001|Overall Study|Subject Withdrew Consent|1|||
150093072|NCT00065507|541483120|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
150093073|NCT00065507|541483121|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
150093074|NCT03635957|541483122|FG000|Run-In Period|Lost to Follow-up|1|||
150093075|NCT03635957|541483122|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
150093076|NCT00350636|541483123|FG000|Overall Study|Adverse Event|19|||
150093077|NCT00350636|541483124|FG001|Overall Study|Adverse Event|13|||
150093078|NCT00350636|541483123|FG000|Overall Study|Protocol Violation|1|||
150093079|NCT00350636|541483124|FG001|Overall Study|Protocol Violation|3|||
150093080|NCT00350636|541483123|FG000|Overall Study|Withdrawal by Subject|13|||
150093081|NCT00350636|541483124|FG001|Overall Study|Withdrawal by Subject|17|||
150093082|NCT00350636|541483123|FG000|Overall Study|Lost to Follow-up|9|||
150093083|NCT00350636|541483124|FG001|Overall Study|Lost to Follow-up|8|||
150093084|NCT00350636|541483123|FG000|Overall Study|Physician Decision|0|||
150093085|NCT00350636|541483124|FG001|Overall Study|Physician Decision|2|||
150093086|NCT00350636|541483123|FG000|Overall Study|Other|1|||
150093087|NCT00350636|541483124|FG001|Overall Study|Other|2|||
150093088|NCT01647282|541483127|FG000|Overall Study|Physician Decision|7|||
150093089|NCT01647282|541483128|FG001|Overall Study|Physician Decision|5|||
150093090|NCT01042236|541483129|FG000|Treatment Period 1|Adverse Event|0|||
150093091|NCT01042236|541483130|FG001|Treatment Period 1|Adverse Event|1|||
150093092|NCT01042236|541483131|FG002|Treatment Period 1|Adverse Event|0|||
150093093|NCT01042236|541483132|FG003|Treatment Period 1|Adverse Event|0|||
150093094|NCT01042236|541483133|FG004|Treatment Period 1|Adverse Event|1|||
150093095|NCT01042236|541483134|FG005|Treatment Period 1|Adverse Event|0|||
150093096|NCT01042236|541483129|FG000|Treatment Period 3|Adverse Event|0|||
150093097|NCT01042236|541483130|FG001|Treatment Period 3|Adverse Event|0|||
150093098|NCT01042236|541483131|FG002|Treatment Period 3|Adverse Event|0|||
150093099|NCT01042236|541483132|FG003|Treatment Period 3|Adverse Event|1|||
150093100|NCT01042236|541483133|FG004|Treatment Period 3|Adverse Event|0|||
150093101|NCT01042236|541483134|FG005|Treatment Period 3|Adverse Event|0|||
150093102|NCT01042236|541483129|FG000|Treatment Period 3|Protocol Violation|0|||
150093103|NCT01042236|541483130|FG001|Treatment Period 3|Protocol Violation|0|||
150093104|NCT01042236|541483131|FG002|Treatment Period 3|Protocol Violation|0|||
150093105|NCT01042236|541483132|FG003|Treatment Period 3|Protocol Violation|1|||
150093106|NCT01042236|541483133|FG004|Treatment Period 3|Protocol Violation|0|||
150093107|NCT01042236|541483134|FG005|Treatment Period 3|Protocol Violation|0|||
150093108|NCT02522286|541483136|FG000|Overall Study|Withdrawal by Subject|3|||
150093109|NCT02522286|541483137|FG001|Overall Study|Withdrawal by Subject|0|||
150093110|NCT02522286|541483138|FG002|Overall Study|Withdrawal by Subject|0|||
150093111|NCT02522286|541483139|FG003|Overall Study|Withdrawal by Subject|3|||
150093112|NCT02411292|541483142|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
150093113|NCT02411292|541483142|FG000|Overall Study|Death|2|||
150093114|NCT02411292|541483142|FG000|Overall Study|Lost to Follow-up|3|||
150093115|NCT00453921|541483143|FG000|Overall Study|Withdrawal by Subject|1|||
150093116|NCT00453921|541483144|FG001|Overall Study|Withdrawal by Subject|1|||
150093117|NCT00453921|541483145|FG002|Overall Study|Withdrawal by Subject|1|||
150093118|NCT00453921|541483146|FG003|Overall Study|Withdrawal by Subject|1|||
150093119|NCT00453921|541483143|FG000|Overall Study|Lost to Follow-up|0|||
150093120|NCT00453921|541483144|FG001|Overall Study|Lost to Follow-up|0|||
150093121|NCT00453921|541483145|FG002|Overall Study|Lost to Follow-up|1|||
150093122|NCT00453921|541483146|FG003|Overall Study|Lost to Follow-up|0|||
150093123|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
150093124|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
150093125|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
150093126|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
150093127|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
150093128|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
150093129|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
150093130|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
150093131|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Other|4|||
150093132|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Other|1|||
150093133|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
150093134|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
150093135|NCT00303498|541483147|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
150093136|NCT00303498|541483148|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
150093137|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
150093138|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
150093139|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Death|1|||
150093140|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Death|0|||
150093141|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
150093142|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
150093143|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
150093144|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
150093145|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
150093146|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
150093147|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
150093148|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
150093149|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Other|1|||
150093150|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Other|0|||
150093151|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
150093152|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
150093153|NCT00303498|541483147|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
150093154|NCT00303498|541483148|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
150093155|NCT00174915|541483149|FG000|Overall Study|Lost to Follow-up|19|||
150093156|NCT00174915|541483150|FG001|Overall Study|Lost to Follow-up|17|||
150093157|NCT00174915|541483151|FG002|Overall Study|Lost to Follow-up|9|||
150093158|NCT00174915|541483152|FG003|Overall Study|Lost to Follow-up|17|||
150093159|NCT00174915|541483153|FG004|Overall Study|Lost to Follow-up|10|||
150093160|NCT00174915|541483149|FG000|Overall Study|Adverse Event|18|||
150093161|NCT00174915|541483150|FG001|Overall Study|Adverse Event|16|||
150093162|NCT00174915|541483151|FG002|Overall Study|Adverse Event|11|||
150093163|NCT00174915|541483152|FG003|Overall Study|Adverse Event|18|||
150093164|NCT00174915|541483153|FG004|Overall Study|Adverse Event|5|||
150093165|NCT00174915|541483149|FG000|Overall Study|Personal Reason(s)|16|||
150093166|NCT00174915|541483150|FG001|Overall Study|Personal Reason(s)|16|||
150093167|NCT00174915|541483151|FG002|Overall Study|Personal Reason(s)|9|||
150093168|NCT00174915|541483152|FG003|Overall Study|Personal Reason(s)|9|||
150093169|NCT00174915|541483153|FG004|Overall Study|Personal Reason(s)|9|||
150093170|NCT00174915|541483149|FG000|Overall Study|Other|15|||
150093171|NCT00174915|541483150|FG001|Overall Study|Other|8|||
150093172|NCT00174915|541483151|FG002|Overall Study|Other|6|||
150093173|NCT00174915|541483152|FG003|Overall Study|Other|5|||
150093174|NCT00174915|541483153|FG004|Overall Study|Other|3|||
150093175|NCT00174915|541483149|FG000|Overall Study|Gout Flare|13|||
150093176|NCT00174915|541483150|FG001|Overall Study|Gout Flare|6|||
150093177|NCT00174915|541483151|FG002|Overall Study|Gout Flare|8|||
150093178|NCT00174915|541483152|FG003|Overall Study|Gout Flare|1|||
150184502|NCT00073749|541813350|FG000|Overall Study|Other|0|||
150093179|NCT00174915|541483153|FG004|Overall Study|Gout Flare|0|||
150093180|NCT00174915|541483149|FG000|Overall Study|Protocol Violation|6|||
150093181|NCT00174915|541483150|FG001|Overall Study|Protocol Violation|3|||
150093182|NCT00174915|541483151|FG002|Overall Study|Protocol Violation|3|||
150093183|NCT00174915|541483152|FG003|Overall Study|Protocol Violation|6|||
150093184|NCT00174915|541483153|FG004|Overall Study|Protocol Violation|3|||
150093185|NCT00174915|541483149|FG000|Overall Study|Therapeutic Failure|6|||
150093186|NCT00174915|541483150|FG001|Overall Study|Therapeutic Failure|3|||
150093187|NCT00174915|541483151|FG002|Overall Study|Therapeutic Failure|2|||
150093188|NCT00174915|541483152|FG003|Overall Study|Therapeutic Failure|1|||
150093189|NCT00174915|541483153|FG004|Overall Study|Therapeutic Failure|3|||
150093190|NCT02132767|541483154|FG000|Overall Study|Death|3|||
150093191|NCT02132767|541483155|FG001|Overall Study|Death|2|||
150093192|NCT02132767|541483154|FG000|Overall Study|Withdrawal by Subject|10|||
150093193|NCT02132767|541483155|FG001|Overall Study|Withdrawal by Subject|9|||
150093194|NCT02132767|541483154|FG000|Overall Study|Lost to Follow-up|4|||
150093195|NCT02132767|541483155|FG001|Overall Study|Lost to Follow-up|4|||
150093196|NCT00778700|541483156|FG000|Overall Study|Adverse Event|6|||
150093197|NCT00778700|541483157|FG001|Overall Study|Adverse Event|1|||
150093198|NCT00778700|541483158|FG002|Overall Study|Adverse Event|3|||
150093199|NCT00778700|541483159|FG003|Overall Study|Adverse Event|5|||
150093200|NCT00778700|541483156|FG000|Overall Study|Protocol Violation|1|||
150093201|NCT00778700|541483157|FG001|Overall Study|Protocol Violation|1|||
150093202|NCT00778700|541483158|FG002|Overall Study|Protocol Violation|0|||
150093203|NCT00778700|541483159|FG003|Overall Study|Protocol Violation|0|||
150093204|NCT00778700|541483156|FG000|Overall Study|Subject Withdrew Consent|6|||
150093205|NCT00778700|541483157|FG001|Overall Study|Subject Withdrew Consent|4|||
150093206|NCT00778700|541483158|FG002|Overall Study|Subject Withdrew Consent|1|||
150093207|NCT00778700|541483159|FG003|Overall Study|Subject Withdrew Consent|4|||
150093208|NCT00778700|541483156|FG000|Overall Study|Lost to Follow-up|3|||
150093209|NCT00778700|541483157|FG001|Overall Study|Lost to Follow-up|1|||
150093210|NCT00778700|541483158|FG002|Overall Study|Lost to Follow-up|0|||
150093211|NCT00778700|541483159|FG003|Overall Study|Lost to Follow-up|1|||
150093212|NCT00778700|541483156|FG000|Overall Study|Reason not Specified|2|||
150093213|NCT00778700|541483157|FG001|Overall Study|Reason not Specified|0|||
150093214|NCT00778700|541483158|FG002|Overall Study|Reason not Specified|1|||
150093215|NCT00778700|541483159|FG003|Overall Study|Reason not Specified|3|||
150093216|NCT00778700|541483156|FG000|Overall Study|Other|0|||
150093217|NCT00778700|541483157|FG001|Overall Study|Other|0|||
150093218|NCT00778700|541483158|FG002|Overall Study|Other|1|||
150093219|NCT00778700|541483159|FG003|Overall Study|Other|0|||
150093220|NCT03227029|541483160|FG000|Overall Study|Child Wheezed (no treatment)|0|||
150093221|NCT03227029|541483161|FG001|Overall Study|Child Wheezed (no treatment)|1|||
150093222|NCT03227029|541483162|FG002|Overall Study|Child Wheezed (no treatment)|0|||
150093223|NCT03227029|541483160|FG000|Overall Study|No post RSV season visit due to COVID|3|||
150093224|NCT03227029|541483161|FG001|Overall Study|No post RSV season visit due to COVID|3|||
150093225|NCT03227029|541483162|FG002|Overall Study|No post RSV season visit due to COVID|2|||
150093226|NCT03227029|541483160|FG000|Overall Study|Not able to get to clinic|0|||
150093227|NCT03227029|541483161|FG001|Overall Study|Not able to get to clinic|0|||
150093228|NCT03227029|541483162|FG002|Overall Study|Not able to get to clinic|1|||
150093229|NCT03227029|541483160|FG000|Overall Study|Withdrawal by Subject|1|||
150093230|NCT03227029|541483161|FG001|Overall Study|Withdrawal by Subject|0|||
150093231|NCT03227029|541483162|FG002|Overall Study|Withdrawal by Subject|0|||
150093232|NCT03227029|541483160|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
150093233|NCT03227029|541483161|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
150093234|NCT03227029|541483162|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
150093235|NCT04984993|541483163|FG000|Overall Study|Withdrawal by Subject|8|||
150093236|NCT04984993|541483164|FG001|Overall Study|Withdrawal by Subject|2|||
150093237|NCT04984993|541483163|FG000|Overall Study|Lost to Follow-up|2|||
150093238|NCT04984993|541483164|FG001|Overall Study|Lost to Follow-up|2|||
150093239|NCT04984993|541483163|FG000|Overall Study|Both patients moved to another country|4|||
150093240|NCT04984993|541483164|FG001|Overall Study|Both patients moved to another country|0|||
150093241|NCT03318315|541483165|FG000|Overall Study|Lost to Follow-up|3|||
150093242|NCT03318315|541483166|FG001|Overall Study|Lost to Follow-up|2|||
150093243|NCT03318315|541483167|FG002|Overall Study|Lost to Follow-up|1|||
150093244|NCT03318315|541483165|FG000|Overall Study|Protocol Violation|1|||
150093245|NCT03318315|541483166|FG001|Overall Study|Protocol Violation|1|||
150093246|NCT03318315|541483167|FG002|Overall Study|Protocol Violation|1|||
150093247|NCT03318315|541483165|FG000|Overall Study|Withdrawal by Subject|0|||
150093248|NCT03318315|541483166|FG001|Overall Study|Withdrawal by Subject|0|||
150093249|NCT03318315|541483167|FG002|Overall Study|Withdrawal by Subject|2|||
150093250|NCT02611778|541483172|FG000|Overall Study|Withdrawal by Subject|2|||
150093251|NCT02611778|541483173|FG001|Overall Study|Withdrawal by Subject|8|||
150093252|NCT02611778|541483172|FG000|Overall Study|Adverse Event|1|||
150093253|NCT02611778|541483173|FG001|Overall Study|Adverse Event|2|||
150093254|NCT02611778|541483172|FG000|Overall Study|Death|2|||
150093255|NCT02611778|541483173|FG001|Overall Study|Death|1|||
150093256|NCT02611778|541483172|FG000|Overall Study|Protocol Violation|1|||
150093257|NCT02611778|541483173|FG001|Overall Study|Protocol Violation|0|||
150093258|NCT02611778|541483172|FG000|Overall Study|Lost to Follow-up|3|||
150093259|NCT02611778|541483173|FG001|Overall Study|Lost to Follow-up|1|||
150093260|NCT02611778|541483172|FG000|Overall Study|Need for alternative treatment|1|||
150093261|NCT02611778|541483173|FG001|Overall Study|Need for alternative treatment|0|||
150093262|NCT02611778|541483172|FG000|Overall Study|Other Reason|2|||
150093263|NCT02611778|541483173|FG001|Overall Study|Other Reason|1|||
150093264|NCT02968563|541483174|FG000|Overall Study|Adverse Event|0|||
150093265|NCT02968563|541483175|FG001|Overall Study|Adverse Event|6|||
150093266|NCT02968563|541483174|FG000|Overall Study|Death|1|||
150093267|NCT02968563|541483175|FG001|Overall Study|Death|1|||
150093268|NCT02968563|541483174|FG000|Overall Study|Lost to Follow-up|0|||
150093269|NCT02968563|541483175|FG001|Overall Study|Lost to Follow-up|1|||
150093270|NCT01496313|541483178|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
150093271|NCT01496313|541483179|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
150093272|NCT01496313|541483180|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
150093273|NCT01496313|541483181|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
150093274|NCT01496313|541483182|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
150093275|NCT01496313|541483183|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
150093276|NCT01496313|541483178|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
150093277|NCT01496313|541483179|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
150093278|NCT01496313|541483180|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
150093279|NCT01496313|541483181|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
150093280|NCT01496313|541483182|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
150184503|NCT00073749|541813351|FG001|Overall Study|Other|0|||
150093281|NCT01496313|541483183|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
150093282|NCT01496313|541483178|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
150093283|NCT01496313|541483179|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
150093284|NCT01496313|541483180|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
150093285|NCT01496313|541483181|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
150093286|NCT01496313|541483182|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
150093287|NCT01496313|541483183|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
150093288|NCT01496313|541483178|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
150093289|NCT01496313|541483179|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
150093290|NCT01496313|541483180|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
150093291|NCT01496313|541483181|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
150093292|NCT01496313|541483182|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
150093293|NCT01496313|541483183|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
150093294|NCT01496313|541483178|FG000|Randomized Period (up to 14 Months)|Other|1|||
150093295|NCT01496313|541483179|FG001|Randomized Period (up to 14 Months)|Other|2|||
150093296|NCT01496313|541483180|FG002|Randomized Period (up to 14 Months)|Other|0|||
150093297|NCT01496313|541483181|FG003|Randomized Period (up to 14 Months)|Other|0|||
150093298|NCT01496313|541483182|FG004|Randomized Period (up to 14 Months)|Other|0|||
150093299|NCT01496313|541483183|FG005|Randomized Period (up to 14 Months)|Other|0|||
150093300|NCT01496313|541483178|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
150093301|NCT01496313|541483179|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
150093302|NCT01496313|541483180|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
150093303|NCT01496313|541483181|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
150093304|NCT01496313|541483182|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
150093305|NCT01496313|541483183|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
150093306|NCT01496313|541483178|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
150093307|NCT01496313|541483179|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
150093308|NCT01496313|541483180|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
150093309|NCT01496313|541483181|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
150093310|NCT01496313|541483182|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
150093311|NCT01496313|541483183|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
150093312|NCT01496313|541483178|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
150093313|NCT01496313|541483179|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
150093314|NCT01496313|541483180|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
150093315|NCT01496313|541483181|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
150093316|NCT01496313|541483182|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
150093317|NCT01496313|541483183|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
150093318|NCT00909389|541483187|FG000|Overall Study|Adverse Event|6|||
150093319|NCT00909389|541483187|FG000|Overall Study|Death|4|||
150093320|NCT00909389|541483187|FG000|Overall Study|Poor Compliance|16|||
150093321|NCT00909389|541483187|FG000|Overall Study|Lost to Follow-up|4|||
150093322|NCT00909389|541483187|FG000|Overall Study|No Information|103|||
150093323|NCT01528254|541483188|FG000|Overall Study|Administrative problems|96|||
150093324|NCT01528254|541483189|FG001|Overall Study|Administrative problems|94|||
150093325|NCT01528254|541483188|FG000|Overall Study|Adverse Event|28|||
150093326|NCT01528254|541483189|FG001|Overall Study|Adverse Event|44|||
150093327|NCT01528254|541483188|FG000|Overall Study|Lost to Follow-up|17|||
150093328|NCT01528254|541483189|FG001|Overall Study|Lost to Follow-up|24|||
150093329|NCT01528254|541483188|FG000|Overall Study|Death|13|||
150093330|NCT01528254|541483189|FG001|Overall Study|Death|9|||
150093331|NCT01528254|541483188|FG000|Overall Study|Protocol deviation|9|||
150093332|NCT01528254|541483189|FG001|Overall Study|Protocol deviation|19|||
150093333|NCT01528254|541483188|FG000|Overall Study|New therapy for study indication|8|||
150093334|NCT01528254|541483189|FG001|Overall Study|New therapy for study indication|6|||
150093335|NCT01528254|541483188|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
150093336|NCT01528254|541483189|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
150093337|NCT01528254|541483188|FG000|Overall Study|Withdrawal by Subject|5|||
150093338|NCT01528254|541483189|FG001|Overall Study|Withdrawal by Subject|4|||
150093339|NCT01528254|541483188|FG000|Overall Study|Abnormal laboratory value(s)|3|||
150093340|NCT01528254|541483189|FG001|Overall Study|Abnormal laboratory value(s)|7|||
150093341|NCT01528254|541483188|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150093342|NCT01528254|541483189|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150093343|NCT01528254|541483188|FG000|Overall Study|No longer requires study drug|1|||
150093344|NCT01528254|541483189|FG001|Overall Study|No longer requires study drug|1|||
150093345|NCT00737282|541483191|FG000|Overall Study|Study prematurely terminated|175|||
150093346|NCT02763189|541483192|FG000|Overall Study|Device failure|0|||
150093347|NCT02763189|541483193|FG001|Overall Study|Device failure|2|||
150093348|NCT02049957|541483194|FG000|Overall Study|Progressive Disease|5|||
150093349|NCT02049957|541483195|FG001|Overall Study|Progressive Disease|4|||
150093350|NCT02049957|541483196|FG002|Overall Study|Progressive Disease|2|||
150093351|NCT02049957|541483197|FG003|Overall Study|Progressive Disease|2|||
150093352|NCT02049957|541483198|FG004|Overall Study|Progressive Disease|6|||
150093353|NCT02049957|541483199|FG005|Overall Study|Progressive Disease|35|||
150093354|NCT02049957|541483200|FG006|Overall Study|Progressive Disease|7|||
150093355|NCT02049957|541483201|FG007|Overall Study|Progressive Disease|26|||
150093356|NCT02049957|541483202|FG008|Overall Study|Progressive Disease|6|||
150093357|NCT02049957|541483194|FG000|Overall Study|Adverse Event|1|||
150093358|NCT02049957|541483195|FG001|Overall Study|Adverse Event|1|||
150093359|NCT02049957|541483196|FG002|Overall Study|Adverse Event|1|||
150093360|NCT02049957|541483197|FG003|Overall Study|Adverse Event|0|||
150093361|NCT02049957|541483198|FG004|Overall Study|Adverse Event|0|||
150093362|NCT02049957|541483199|FG005|Overall Study|Adverse Event|5|||
150093363|NCT02049957|541483200|FG006|Overall Study|Adverse Event|0|||
150093364|NCT02049957|541483201|FG007|Overall Study|Adverse Event|6|||
150093365|NCT02049957|541483202|FG008|Overall Study|Adverse Event|1|||
150093366|NCT02049957|541483194|FG000|Overall Study|Study Terminated by Sponsor|0|||
150093367|NCT02049957|541483195|FG001|Overall Study|Study Terminated by Sponsor|1|||
150093368|NCT02049957|541483196|FG002|Overall Study|Study Terminated by Sponsor|0|||
150093369|NCT02049957|541483197|FG003|Overall Study|Study Terminated by Sponsor|0|||
150093370|NCT02049957|541483198|FG004|Overall Study|Study Terminated by Sponsor|0|||
150093371|NCT02049957|541483199|FG005|Overall Study|Study Terminated by Sponsor|0|||
150093372|NCT02049957|541483200|FG006|Overall Study|Study Terminated by Sponsor|1|||
150093373|NCT02049957|541483201|FG007|Overall Study|Study Terminated by Sponsor|0|||
150093374|NCT02049957|541483202|FG008|Overall Study|Study Terminated by Sponsor|0|||
150093375|NCT02049957|541483194|FG000|Overall Study|Withdrawal by Subject|0|||
150093376|NCT02049957|541483195|FG001|Overall Study|Withdrawal by Subject|0|||
150093377|NCT02049957|541483196|FG002|Overall Study|Withdrawal by Subject|0|||
150093378|NCT02049957|541483197|FG003|Overall Study|Withdrawal by Subject|1|||
150093379|NCT02049957|541483198|FG004|Overall Study|Withdrawal by Subject|0|||
150093380|NCT02049957|541483199|FG005|Overall Study|Withdrawal by Subject|2|||
150093381|NCT02049957|541483200|FG006|Overall Study|Withdrawal by Subject|0|||
150093382|NCT02049957|541483201|FG007|Overall Study|Withdrawal by Subject|3|||
150093383|NCT02049957|541483202|FG008|Overall Study|Withdrawal by Subject|1|||
150093384|NCT02049957|541483194|FG000|Overall Study|Physician Decision|0|||
150093385|NCT02049957|541483195|FG001|Overall Study|Physician Decision|0|||
150093386|NCT02049957|541483196|FG002|Overall Study|Physician Decision|0|||
150093387|NCT02049957|541483197|FG003|Overall Study|Physician Decision|0|||
150093388|NCT02049957|541483198|FG004|Overall Study|Physician Decision|0|||
150093389|NCT02049957|541483199|FG005|Overall Study|Physician Decision|1|||
150093390|NCT02049957|541483200|FG006|Overall Study|Physician Decision|0|||
150093391|NCT02049957|541483201|FG007|Overall Study|Physician Decision|0|||
150093392|NCT02049957|541483202|FG008|Overall Study|Physician Decision|0|||
150093393|NCT03557151|541483203|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
150093394|NCT03557151|541483204|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
150093395|NCT03557151|541483203|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
150093396|NCT03557151|541483204|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
150093397|NCT03557151|541483203|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
150093398|NCT03557151|541483204|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
150093399|NCT02810392|541483205|FG000|Overall Study|Subject too ill to continue|1|||
150093400|NCT02810392|541483206|FG001|Overall Study|Subject too ill to continue|0|||
150093401|NCT02810392|541483205|FG000|Overall Study|COVID 19 research restrictions|0|||
150093402|NCT02810392|541483206|FG001|Overall Study|COVID 19 research restrictions|1|||
150093403|NCT00840294|541483207|FG000|Overall Study|Withdrawal by Subject|2|||
150093404|NCT00840294|541483208|FG001|Overall Study|Withdrawal by Subject|1|||
150093405|NCT00840294|541483207|FG000|Overall Study|Protocol Violation|1|||
150093406|NCT00840294|541483208|FG001|Overall Study|Protocol Violation|3|||
150093407|NCT00840294|541483207|FG000|Overall Study|Illness|0|||
150093408|NCT00840294|541483208|FG001|Overall Study|Illness|1|||
150093409|NCT04868890|541483218|FG000|Overall Study|Death|2|||
150093410|NCT04868890|541483219|FG001|Overall Study|Death|1|||
150093411|NCT04868890|541483218|FG000|Overall Study|Withdrawal by Subject|1|||
150093412|NCT04868890|541483219|FG001|Overall Study|Withdrawal by Subject|5|||
150093413|NCT02669433|541483222|FG000|Overall Study|Protocol Violation|0|||
150093414|NCT02669433|541483223|FG001|Overall Study|Protocol Violation|4|||
150093415|NCT02669433|541483224|FG002|Overall Study|Protocol Violation|1|||
150093416|NCT02669433|541483222|FG000|Overall Study|Disease Progression|1|||
150093417|NCT02669433|541483223|FG001|Overall Study|Disease Progression|0|||
150093418|NCT02669433|541483224|FG002|Overall Study|Disease Progression|0|||
150093419|NCT02669433|541483222|FG000|Overall Study|Physician Decision|1|||
150184504|NCT00073749|541813352|FG002|Overall Study|Other|0|||
150093420|NCT02669433|541483223|FG001|Overall Study|Physician Decision|1|||
150093421|NCT02669433|541483224|FG002|Overall Study|Physician Decision|0|||
150093422|NCT02669433|541483222|FG000|Overall Study|Adverse Event|6|||
150184505|NCT00073749|541813353|FG003|Overall Study|Other|0|||
150093423|NCT02669433|541483223|FG001|Overall Study|Adverse Event|7|||
150093424|NCT02669433|541483224|FG002|Overall Study|Adverse Event|10|||
150093425|NCT02669433|541483222|FG000|Overall Study|Sponsor Termination|1|||
150093426|NCT02669433|541483223|FG001|Overall Study|Sponsor Termination|0|||
150093427|NCT02669433|541483224|FG002|Overall Study|Sponsor Termination|1|||
150093428|NCT02669433|541483222|FG000|Overall Study|Withdrawal by Subject|5|||
150093429|NCT02669433|541483223|FG001|Overall Study|Withdrawal by Subject|1|||
150093430|NCT02669433|541483224|FG002|Overall Study|Withdrawal by Subject|0|||
150093431|NCT02669433|541483222|FG000|Overall Study|Withdrawal by Caregiver|1|||
150093432|NCT02669433|541483223|FG001|Overall Study|Withdrawal by Caregiver|0|||
150093433|NCT02669433|541483224|FG002|Overall Study|Withdrawal by Caregiver|2|||
150093434|NCT02669433|541483222|FG000|Overall Study|Death|0|||
150093435|NCT02669433|541483223|FG001|Overall Study|Death|1|||
150093436|NCT02669433|541483224|FG002|Overall Study|Death|1|||
150093437|NCT02157298|541483232|FG000|Overall Study|Adverse Event|1|||
150093438|NCT02157298|541483233|FG001|Overall Study|Adverse Event|0|||
150093439|NCT02157298|541483232|FG000|Overall Study|Subject no longer meets study criteria|1|||
150093440|NCT02157298|541483233|FG001|Overall Study|Subject no longer meets study criteria|2|||
150093441|NCT02157298|541483232|FG000|Overall Study|Poor/Non-compliance|1|||
150093442|NCT02157298|541483233|FG001|Overall Study|Poor/Non-compliance|0|||
150093443|NCT02157298|541483232|FG000|Overall Study|Withdrawal by Subject|1|||
150093444|NCT02157298|541483233|FG001|Overall Study|Withdrawal by Subject|0|||
150093445|NCT00883116|541483238|FG000|Overall Study|Adverse event unrelated to study drug|5|||
150093446|NCT00883116|541483239|FG001|Overall Study|Adverse event unrelated to study drug|10|||
150093447|NCT00883116|541483238|FG000|Overall Study|Death|6|||
150093448|NCT00883116|541483239|FG001|Overall Study|Death|2|||
150093449|NCT00883116|541483238|FG000|Overall Study|Disease progression|130|||
150093450|NCT00883116|541483239|FG001|Overall Study|Disease progression|128|||
150093451|NCT00883116|541483238|FG000|Overall Study|Lost to Follow-up|0|||
150093452|NCT00883116|541483239|FG001|Overall Study|Lost to Follow-up|1|||
150093453|NCT00883116|541483238|FG000|Overall Study|Maximum clinical benefit|13|||
150093454|NCT00883116|541483239|FG001|Overall Study|Maximum clinical benefit|46|||
150093455|NCT00883116|541483238|FG000|Overall Study|Not identified|3|||
150093456|NCT00883116|541483239|FG001|Overall Study|Not identified|6|||
150093457|NCT00883116|541483238|FG000|Overall Study|Study drug toxicity|36|||
150093458|NCT00883116|541483239|FG001|Overall Study|Study drug toxicity|16|||
150093459|NCT00883116|541483238|FG000|Overall Study|Withdrawal by Subject|14|||
150093460|NCT00883116|541483239|FG001|Overall Study|Withdrawal by Subject|8|||
150184506|NCT00073749|541813354|FG004|Overall Study|Other|0|||
150093461|NCT00883116|541483238|FG000|Overall Study|No longer meets study criteria|2|||
150093462|NCT00883116|541483239|FG001|Overall Study|No longer meets study criteria|2|||
150093463|NCT03715764|541483240|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
150093464|NCT03715764|541483241|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
150093465|NCT03715764|541483240|FG000|3 Month Follow-up|Lost to Follow-up|2|||
150093466|NCT03715764|541483241|FG001|3 Month Follow-up|Lost to Follow-up|2|||
150093467|NCT03715764|541483240|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
150093468|NCT03715764|541483241|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
150093469|NCT03715764|541483240|FG000|6 Month Follow-up|Lost to Follow-up|3|||
150093470|NCT03715764|541483241|FG001|6 Month Follow-up|Lost to Follow-up|0|||
150093471|NCT03715764|541483240|FG000|12 Month Follow-up|Lost to Follow-up|2|||
150093472|NCT03715764|541483241|FG001|12 Month Follow-up|Lost to Follow-up|3|||
150093473|NCT03715764|541483240|FG000|12 Month Follow-up|Pregnancy|0|||
150093474|NCT03715764|541483241|FG001|12 Month Follow-up|Pregnancy|1|||
150093475|NCT03715764|541483240|FG000|12 Month Follow-up|Surgery|2|||
150093476|NCT03715764|541483241|FG001|12 Month Follow-up|Surgery|0|||
150093477|NCT03715764|541483240|FG000|12 Month Follow-up|Wrong address|1|||
150093478|NCT03715764|541483241|FG001|12 Month Follow-up|Wrong address|0|||
150093479|NCT03715764|541483240|FG000|12 Month Follow-up|No symptoms|1|||
150093480|NCT03715764|541483241|FG001|12 Month Follow-up|No symptoms|0|||
150093481|NCT03715764|541483240|FG000|12 Month Follow-up|Changed primary care centre|0|||
150093482|NCT03715764|541483241|FG001|12 Month Follow-up|Changed primary care centre|1|||
150093483|NCT01361464|541483244|FG000|Overall Study|Death|1|||
150093484|NCT01361464|541483244|FG000|Overall Study|Withdrawal by Subject|2|||
150093485|NCT03021265|541483245|FG000|Overall Study|Adverse Event|29|||
150093486|NCT03021265|541483245|FG000|Overall Study|Lack of Efficacy|3|||
150093487|NCT03021265|541483245|FG000|Overall Study|Improved|17|||
150093488|NCT03021265|541483245|FG000|Overall Study|Lost to Follow-up|67|||
150093489|NCT03021265|541483245|FG000|Overall Study|No reason given|2|||
150093490|NCT03021265|541483245|FG000|Overall Study|No visit since the first visit|4|||
150093491|NCT00818662|541483246|FG000|Overall Study|Adverse Event|5|||
150093492|NCT00818662|541483247|FG001|Overall Study|Adverse Event|14|||
150093493|NCT00818662|541483248|FG002|Overall Study|Adverse Event|4|||
150093494|NCT00818662|541483249|FG003|Overall Study|Adverse Event|3|||
150093495|NCT00818662|541483246|FG000|Overall Study|Withdrawal by Subject|5|||
150093496|NCT00818662|541483247|FG001|Overall Study|Withdrawal by Subject|4|||
150093497|NCT00818662|541483248|FG002|Overall Study|Withdrawal by Subject|2|||
150093498|NCT00818662|541483249|FG003|Overall Study|Withdrawal by Subject|2|||
150093499|NCT00818662|541483246|FG000|Overall Study|Death|1|||
150093500|NCT00818662|541483247|FG001|Overall Study|Death|3|||
150093501|NCT00818662|541483248|FG002|Overall Study|Death|0|||
150093502|NCT00818662|541483249|FG003|Overall Study|Death|0|||
150093503|NCT00818662|541483246|FG000|Overall Study|Physician Decision|1|||
150093504|NCT00818662|541483247|FG001|Overall Study|Physician Decision|0|||
150093505|NCT00818662|541483248|FG002|Overall Study|Physician Decision|0|||
150093506|NCT00818662|541483249|FG003|Overall Study|Physician Decision|0|||
150093507|NCT00818662|541483246|FG000|Overall Study|Lost to Follow-up|0|||
150093508|NCT00818662|541483247|FG001|Overall Study|Lost to Follow-up|0|||
150093509|NCT00818662|541483248|FG002|Overall Study|Lost to Follow-up|0|||
150093510|NCT00818662|541483249|FG003|Overall Study|Lost to Follow-up|1|||
150093511|NCT00818662|541483246|FG000|Overall Study|Unwilling or Unable to Participate|4|||
150093512|NCT00818662|541483247|FG001|Overall Study|Unwilling or Unable to Participate|6|||
150093513|NCT00818662|541483248|FG002|Overall Study|Unwilling or Unable to Participate|2|||
150093514|NCT00818662|541483249|FG003|Overall Study|Unwilling or Unable to Participate|4|||
150093515|NCT00818662|541483246|FG000|Overall Study|Protocol Violation|1|||
150093516|NCT00818662|541483247|FG001|Overall Study|Protocol Violation|1|||
150093517|NCT00818662|541483248|FG002|Overall Study|Protocol Violation|0|||
150093518|NCT00818662|541483249|FG003|Overall Study|Protocol Violation|0|||
150093519|NCT00818662|541483246|FG000|Overall Study|Requires a Prohibited Medication|1|||
150093520|NCT00818662|541483247|FG001|Overall Study|Requires a Prohibited Medication|0|||
150093521|NCT00818662|541483248|FG002|Overall Study|Requires a Prohibited Medication|0|||
150093522|NCT00818662|541483249|FG003|Overall Study|Requires a Prohibited Medication|0|||
150093523|NCT00818662|541483246|FG000|Overall Study|Safety Risk|1|||
150093524|NCT00818662|541483247|FG001|Overall Study|Safety Risk|1|||
150093525|NCT00818662|541483248|FG002|Overall Study|Safety Risk|0|||
150093526|NCT00818662|541483249|FG003|Overall Study|Safety Risk|1|||
150093527|NCT00818662|541483246|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
150093528|NCT00818662|541483247|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
150093529|NCT00818662|541483248|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
150093530|NCT00818662|541483249|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
150093531|NCT00818662|541483246|FG000|Overall Study|Participant's health declined|0|||
150093532|NCT00818662|541483247|FG001|Overall Study|Participant's health declined|0|||
150093533|NCT00818662|541483248|FG002|Overall Study|Participant's health declined|0|||
150093534|NCT00818662|541483249|FG003|Overall Study|Participant's health declined|1|||
150093535|NCT00818662|541483246|FG000|Overall Study|Caregiver to pursue other treatment|0|||
150093536|NCT00818662|541483247|FG001|Overall Study|Caregiver to pursue other treatment|1|||
150093537|NCT00818662|541483248|FG002|Overall Study|Caregiver to pursue other treatment|0|||
150093538|NCT00818662|541483249|FG003|Overall Study|Caregiver to pursue other treatment|0|||
150093539|NCT00818662|541483246|FG000|Overall Study|Moving out of state|0|||
150093540|NCT00818662|541483247|FG001|Overall Study|Moving out of state|0|||
150093541|NCT00818662|541483248|FG002|Overall Study|Moving out of state|0|||
150093542|NCT00818662|541483249|FG003|Overall Study|Moving out of state|1|||
150093543|NCT00818662|541483246|FG000|Overall Study|Declined move to another study site|1|||
150093544|NCT00818662|541483247|FG001|Overall Study|Declined move to another study site|0|||
150093545|NCT00818662|541483248|FG002|Overall Study|Declined move to another study site|0|||
150093546|NCT00818662|541483249|FG003|Overall Study|Declined move to another study site|0|||
150093547|NCT00818662|541483246|FG000|Overall Study|Change in living situation|0|||
150093548|NCT00818662|541483247|FG001|Overall Study|Change in living situation|0|||
150093549|NCT00818662|541483248|FG002|Overall Study|Change in living situation|0|||
150093550|NCT00818662|541483249|FG003|Overall Study|Change in living situation|1|||
150093551|NCT00818662|541483246|FG000|Overall Study|Study partner decision|0|||
150093552|NCT00818662|541483247|FG001|Overall Study|Study partner decision|0|||
150093553|NCT00818662|541483248|FG002|Overall Study|Study partner decision|0|||
150093554|NCT00818662|541483249|FG003|Overall Study|Study partner decision|1|||
150093555|NCT00818662|541483246|FG000|Overall Study|Admitted to long term nursing care|0|||
150093556|NCT00818662|541483247|FG001|Overall Study|Admitted to long term nursing care|1|||
150093557|NCT00818662|541483248|FG002|Overall Study|Admitted to long term nursing care|0|||
150093558|NCT00818662|541483249|FG003|Overall Study|Admitted to long term nursing care|0|||
150093559|NCT01722071|541483250|FG000|Overall Study|Protocol Violation|1|||
150093560|NCT01722071|541483251|FG001|Overall Study|Protocol Violation|0|||
150093561|NCT01106898|541483252|FG000|Overall Study|Adverse Event|6|||
150093562|NCT01338493|541483253|FG000|Enrolled|Withdrawal by Subject|1|||
150093563|NCT01338493|541483253|FG000|Enrolled|Patient not implanted|4|||
150093564|NCT01338493|541483253|FG000|Discharge|Death|1|||
150093565|NCT01338493|541483253|FG000|Discharge|Missed visit|1|||
150093566|NCT01338493|541483253|FG000|6 Months Follow up|Lost to Follow-up|11|||
150093567|NCT01338493|541483253|FG000|6 Months Follow up|Missed visit|8|||
150093568|NCT01338493|541483253|FG000|12 Months Follow up|Lost to Follow-up|9|||
150093569|NCT01698801|541483254|FG000|Treatment Phase|Adverse Event|4|||
150093570|NCT01698801|541483254|FG000|Treatment Phase|Protocol Violation|1|||
150093571|NCT01698801|541483254|FG000|Treatment Phase|Other|4|||
150093572|NCT01698801|541483254|FG000|Treatment Phase|Withdrawal by Subject|1|||
150093573|NCT01698801|541483254|FG000|Treatment Phase|Disease progression|1|||
150093574|NCT01698801|541483254|FG000|Follow Up Phase|Withdrawal by Subject|1|||
150093575|NCT01698801|541483254|FG000|Follow Up Phase|Death|4|||
150093576|NCT02625259|541483257|FG000|First Intervention (Day 1)|Other|0|||
150093577|NCT02625259|541483258|FG001|First Intervention (Day 1)|Other|0|||
150093578|NCT02625259|541483259|FG002|First Intervention (Day 1)|Other|1|||
150093579|NCT02625259|541483260|FG003|First Intervention (Day 1)|Other|0|||
150093580|NCT02625259|541483261|FG004|First Intervention (Day 1)|Other|0|||
150093581|NCT02625259|541483257|FG000|First Intervention (Day 1)|Adverse Event|2|||
150093582|NCT02625259|541483258|FG001|First Intervention (Day 1)|Adverse Event|1|||
150093583|NCT02625259|541483259|FG002|First Intervention (Day 1)|Adverse Event|0|||
150093584|NCT02625259|541483260|FG003|First Intervention (Day 1)|Adverse Event|0|||
150093585|NCT02625259|541483261|FG004|First Intervention (Day 1)|Adverse Event|0|||
150093586|NCT02625259|541483257|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
150093587|NCT02625259|541483258|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
150093588|NCT02625259|541483259|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
150093589|NCT02625259|541483260|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
150093590|NCT02625259|541483261|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
150029244|NCT01384734|541242625|FG001|Overall Study|Physician Decision|0|||
150029245|NCT01384734|541242626|FG002|Overall Study|Physician Decision|0|||
150029246|NCT01384734|541242627|FG003|Overall Study|Physician Decision|0|||
150029247|NCT01384734|541242628|FG004|Overall Study|Physician Decision|0|||
150029248|NCT00647296|541242629|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
150029249|NCT00647296|541242630|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
150029250|NCT00647296|541242631|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
150029251|NCT00647296|541242632|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
150029252|NCT00647296|541242629|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
150029253|NCT00647296|541242630|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
150029254|NCT00647296|541242631|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
150029255|NCT00647296|541242632|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
150029256|NCT00647296|541242629|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
150029257|NCT00647296|541242630|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
150029258|NCT00647296|541242631|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
150029259|NCT00647296|541242632|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
150029260|NCT00647296|541242629|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
150029261|NCT00647296|541242630|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
150029262|NCT00647296|541242631|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
150029263|NCT00647296|541242632|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
150093591|NCT02998840|541483265|FG000|Overall Study|Lost to Follow-up|1|||
150093592|NCT02998840|541483266|FG001|Overall Study|Lost to Follow-up|1|||
150093593|NCT02998840|541483267|FG002|Overall Study|Lost to Follow-up|2|||
150093594|NCT02998840|541483268|FG003|Overall Study|Lost to Follow-up|3|||
150093595|NCT02998840|541483265|FG000|Overall Study|Withdrawal by Subject|1|||
150093596|NCT02998840|541483266|FG001|Overall Study|Withdrawal by Subject|1|||
150093597|NCT02998840|541483267|FG002|Overall Study|Withdrawal by Subject|0|||
150093598|NCT02998840|541483268|FG003|Overall Study|Withdrawal by Subject|1|||
150093599|NCT02998840|541483265|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
150093600|NCT02998840|541483266|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
150093601|NCT02998840|541483267|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
150093602|NCT02998840|541483268|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
150093603|NCT00665847|541483269|FG000|Overall Study|Adverse Event|8|||
150093604|NCT00665847|541483269|FG000|Overall Study|Withdrawal by Subject|2|||
150093605|NCT00665847|541483269|FG000|Overall Study|Subject non-compliant|8|||
150093606|NCT00665847|541483269|FG000|Overall Study|Subject reached a virologic endpoint|4|||
150093607|NCT00665847|541483269|FG000|Overall Study|Resistance to TMC125|1|||
150093608|NCT00665847|541483269|FG000|Overall Study|Subject ineligible to continue the trial|1|||
150093609|NCT00665847|541483269|FG000|Overall Study|Switch to Commercial Medication|1|||
150093610|NCT01686633|541483270|FG000|Overall Study|Lack of Efficacy|33|||
150093611|NCT01686633|541483271|FG001|Overall Study|Lack of Efficacy|13|||
150093612|NCT01686633|541483272|FG002|Overall Study|Lack of Efficacy|11|||
150093613|NCT01686633|541483270|FG000|Overall Study|Withdrawal by Subject|8|||
150093614|NCT01686633|541483271|FG001|Overall Study|Withdrawal by Subject|8|||
150093615|NCT01686633|541483272|FG002|Overall Study|Withdrawal by Subject|5|||
150093616|NCT01686633|541483270|FG000|Overall Study|Physician Decision|3|||
150093617|NCT01686633|541483271|FG001|Overall Study|Physician Decision|4|||
150093618|NCT01686633|541483272|FG002|Overall Study|Physician Decision|4|||
150093619|NCT01686633|541483270|FG000|Overall Study|Adverse Event|4|||
150093620|NCT01686633|541483271|FG001|Overall Study|Adverse Event|3|||
150093621|NCT01686633|541483272|FG002|Overall Study|Adverse Event|3|||
150093622|NCT01686633|541483270|FG000|Overall Study|Protocol Violation|2|||
150093623|NCT01686633|541483271|FG001|Overall Study|Protocol Violation|3|||
150093624|NCT01686633|541483272|FG002|Overall Study|Protocol Violation|0|||
150093625|NCT01686633|541483270|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
150093626|NCT01686633|541483271|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
150093627|NCT01686633|541483272|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
150093628|NCT01686633|541483270|FG000|Overall Study|Lost to Follow-up|0|||
150093629|NCT01686633|541483271|FG001|Overall Study|Lost to Follow-up|1|||
150093630|NCT01686633|541483272|FG002|Overall Study|Lost to Follow-up|1|||
150093631|NCT00511667|541483278|FG000|Overall Study|Adverse Event|1|||
150093632|NCT00511667|541483279|FG001|Overall Study|Adverse Event|0|||
150093633|NCT00511667|541483278|FG000|Overall Study|Protocol Violation|1|||
150093634|NCT00511667|541483279|FG001|Overall Study|Protocol Violation|1|||
150093635|NCT00511667|541483278|FG000|Overall Study|Withdrawal by Subject|2|||
150093636|NCT00511667|541483279|FG001|Overall Study|Withdrawal by Subject|0|||
150093637|NCT00511667|541483278|FG000|Overall Study|Site terminated|6|||
150093638|NCT00511667|541483279|FG001|Overall Study|Site terminated|1|||
150093639|NCT00511667|541483278|FG000|Overall Study|Other|2|||
150093640|NCT00511667|541483279|FG001|Overall Study|Other|1|||
150093641|NCT03605303|541483280|FG000|Period 1|Study Terminated|2|||
150093642|NCT03605303|541483281|FG001|Period 1|Study Terminated|1|||
150093643|NCT01472081|541483282|FG000|Overall Study|Continuing treatment at time of analysis|1|||
150093644|NCT01472081|541483283|FG001|Overall Study|Continuing treatment at time of analysis|4|||
150093645|NCT01472081|541483284|FG002|Overall Study|Continuing treatment at time of analysis|1|||
150093646|NCT01472081|541483285|FG003|Overall Study|Continuing treatment at time of analysis|8|||
150093647|NCT01472081|541483286|FG004|Overall Study|Continuing treatment at time of analysis|9|||
150093648|NCT01472081|541483287|FG005|Overall Study|Continuing treatment at time of analysis|0|||
150093649|NCT01472081|541483282|FG000|Overall Study|Disease Progression|4|||
150093650|NCT01472081|541483283|FG001|Overall Study|Disease Progression|10|||
150093651|NCT01472081|541483284|FG002|Overall Study|Disease Progression|12|||
150093652|NCT01472081|541483285|FG003|Overall Study|Disease Progression|31|||
150093653|NCT01472081|541483286|FG004|Overall Study|Disease Progression|22|||
150093654|NCT01472081|541483287|FG005|Overall Study|Disease Progression|3|||
150093655|NCT01472081|541483282|FG000|Overall Study|Study drug toxicity|2|||
150093656|NCT01472081|541483283|FG001|Overall Study|Study drug toxicity|9|||
150093657|NCT01472081|541483284|FG002|Overall Study|Study drug toxicity|4|||
150184507|NCT00073749|541813355|FG005|Overall Study|Other|2|||
150093658|NCT01472081|541483285|FG003|Overall Study|Study drug toxicity|6|||
150093659|NCT01472081|541483286|FG004|Overall Study|Study drug toxicity|13|||
150093660|NCT01472081|541483287|FG005|Overall Study|Study drug toxicity|2|||
150093661|NCT01472081|541483282|FG000|Overall Study|Death|0|||
150093662|NCT01472081|541483283|FG001|Overall Study|Death|0|||
150093663|NCT01472081|541483284|FG002|Overall Study|Death|0|||
150093664|NCT01472081|541483285|FG003|Overall Study|Death|0|||
150093665|NCT01472081|541483286|FG004|Overall Study|Death|1|||
150093666|NCT01472081|541483287|FG005|Overall Study|Death|0|||
150093667|NCT01472081|541483282|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
150093668|NCT01472081|541483283|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
150093669|NCT01472081|541483284|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
150093670|NCT01472081|541483285|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
150093671|NCT01472081|541483286|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
150093672|NCT01472081|541483287|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
150093673|NCT01472081|541483282|FG000|Overall Study|Withdrawal by Subject|0|||
150093674|NCT01472081|541483283|FG001|Overall Study|Withdrawal by Subject|0|||
150093675|NCT01472081|541483284|FG002|Overall Study|Withdrawal by Subject|0|||
150093676|NCT01472081|541483285|FG003|Overall Study|Withdrawal by Subject|0|||
150093677|NCT01472081|541483286|FG004|Overall Study|Withdrawal by Subject|0|||
150093678|NCT01472081|541483287|FG005|Overall Study|Withdrawal by Subject|1|||
150093679|NCT01472081|541483282|FG000|Overall Study|Poor/non-compliance|0|||
150093680|NCT01472081|541483283|FG001|Overall Study|Poor/non-compliance|0|||
150093681|NCT01472081|541483284|FG002|Overall Study|Poor/non-compliance|1|||
150093682|NCT01472081|541483285|FG003|Overall Study|Poor/non-compliance|0|||
150093683|NCT01472081|541483286|FG004|Overall Study|Poor/non-compliance|1|||
150093684|NCT01472081|541483287|FG005|Overall Study|Poor/non-compliance|0|||
150093685|NCT01472081|541483282|FG000|Overall Study|No longer meets study criteria|0|||
150093686|NCT01472081|541483283|FG001|Overall Study|No longer meets study criteria|0|||
150093687|NCT01472081|541483284|FG002|Overall Study|No longer meets study criteria|1|||
150093688|NCT01472081|541483285|FG003|Overall Study|No longer meets study criteria|0|||
150093689|NCT01472081|541483286|FG004|Overall Study|No longer meets study criteria|0|||
150093690|NCT01472081|541483287|FG005|Overall Study|No longer meets study criteria|0|||
150093691|NCT01472081|541483282|FG000|Overall Study|Subject request to discontinue treatment|0|||
150093692|NCT01472081|541483283|FG001|Overall Study|Subject request to discontinue treatment|3|||
150093693|NCT01472081|541483284|FG002|Overall Study|Subject request to discontinue treatment|1|||
150093694|NCT01472081|541483285|FG003|Overall Study|Subject request to discontinue treatment|1|||
150093695|NCT01472081|541483286|FG004|Overall Study|Subject request to discontinue treatment|0|||
150093696|NCT01472081|541483287|FG005|Overall Study|Subject request to discontinue treatment|0|||
150093697|NCT04702997|541483288|FG000|Overall Study|Withdrawal by Subject|1|||
150093698|NCT04702997|541483289|FG001|Overall Study|Withdrawal by Subject|1|||
150093699|NCT01386554|541483290|FG000|Overall Study|Lost to Follow-up|0|||
150093700|NCT01386554|541483291|FG001|Overall Study|Lost to Follow-up|0|||
150093701|NCT01386554|541483292|FG002|Overall Study|Lost to Follow-up|1|||
150093702|NCT01386554|541483290|FG000|Overall Study|Adverse Event|2|||
150093703|NCT01386554|541483291|FG001|Overall Study|Adverse Event|5|||
150093704|NCT01386554|541483292|FG002|Overall Study|Adverse Event|2|||
150093705|NCT01386554|541483290|FG000|Overall Study|Progressive disease|1|||
150093706|NCT01386554|541483291|FG001|Overall Study|Progressive disease|2|||
150093707|NCT01386554|541483292|FG002|Overall Study|Progressive disease|2|||
150093708|NCT01386554|541483290|FG000|Overall Study|Administration of live vaccines|0|||
150093709|NCT01386554|541483291|FG001|Overall Study|Administration of live vaccines|1|||
150093710|NCT01386554|541483292|FG002|Overall Study|Administration of live vaccines|0|||
150093711|NCT01386554|541483290|FG000|Overall Study|Investigator discretion|0|||
150093712|NCT01386554|541483291|FG001|Overall Study|Investigator discretion|0|||
150093713|NCT01386554|541483292|FG002|Overall Study|Investigator discretion|1|||
150093714|NCT01386554|541483290|FG000|Overall Study|Reason not collected|0|||
150093715|NCT01386554|541483291|FG001|Overall Study|Reason not collected|1|||
150093716|NCT01386554|541483292|FG002|Overall Study|Reason not collected|0|||
150093717|NCT02759471|541483293|FG000|Overall Study|discomfort|2|||
150093718|NCT02554812|541483294|FG000|Overall Study|Adverse Event|2|||
150093719|NCT02554812|541483295|FG001|Overall Study|Adverse Event|5|||
150184508|NCT00073749|541813356|FG006|Overall Study|Other|0|||
150184509|NCT00632749|541813357|FG000|Overall Study|Progressive disease|3|||
150093720|NCT02554812|541483296|FG002|Overall Study|Adverse Event|3|||
150093721|NCT02554812|541483297|FG003|Overall Study|Adverse Event|0|||
150093722|NCT02554812|541483298|FG004|Overall Study|Adverse Event|5|||
150093723|NCT02554812|541483299|FG005|Overall Study|Adverse Event|0|||
150093724|NCT02554812|541483300|FG006|Overall Study|Adverse Event|1|||
150093725|NCT02554812|541483301|FG007|Overall Study|Adverse Event|6|||
150093726|NCT02554812|541483302|FG008|Overall Study|Adverse Event|2|||
150093727|NCT02554812|541483303|FG009|Overall Study|Adverse Event|2|||
150093728|NCT02554812|541483304|FG010|Overall Study|Adverse Event|1|||
150093729|NCT02554812|541483305|FG011|Overall Study|Adverse Event|2|||
150093730|NCT02554812|541483306|FG012|Overall Study|Adverse Event|0|||
150093731|NCT02554812|541483307|FG013|Overall Study|Adverse Event|3|||
150093732|NCT02554812|541483308|FG014|Overall Study|Adverse Event|2|||
150093733|NCT02554812|541483309|FG015|Overall Study|Adverse Event|1|||
150093734|NCT02554812|541483310|FG016|Overall Study|Adverse Event|0|||
150093735|NCT02554812|541483311|FG017|Overall Study|Adverse Event|1|||
150093736|NCT02554812|541483312|FG018|Overall Study|Adverse Event|0|||
150093737|NCT02554812|541483313|FG019|Overall Study|Adverse Event|0|||
150093738|NCT02554812|541483314|FG020|Overall Study|Adverse Event|0|||
150093739|NCT02554812|541483315|FG021|Overall Study|Adverse Event|2|||
150093740|NCT02554812|541483316|FG022|Overall Study|Adverse Event|1|||
150093741|NCT02554812|541483317|FG023|Overall Study|Adverse Event|1|||
150093742|NCT02554812|541483318|FG024|Overall Study|Adverse Event|1|||
150093743|NCT02554812|541483319|FG025|Overall Study|Adverse Event|2|||
150093744|NCT02554812|541483320|FG026|Overall Study|Adverse Event|1|||
150093745|NCT02554812|541483294|FG000|Overall Study|Death|1|||
150093746|NCT02554812|541483295|FG001|Overall Study|Death|2|||
150093747|NCT02554812|541483296|FG002|Overall Study|Death|2|||
150093748|NCT02554812|541483297|FG003|Overall Study|Death|2|||
150093749|NCT02554812|541483298|FG004|Overall Study|Death|0|||
150093750|NCT02554812|541483299|FG005|Overall Study|Death|1|||
150093751|NCT02554812|541483300|FG006|Overall Study|Death|1|||
150093752|NCT02554812|541483301|FG007|Overall Study|Death|1|||
150093753|NCT02554812|541483302|FG008|Overall Study|Death|0|||
150093754|NCT02554812|541483303|FG009|Overall Study|Death|0|||
150093755|NCT02554812|541483304|FG010|Overall Study|Death|0|||
150093756|NCT02554812|541483305|FG011|Overall Study|Death|0|||
150093757|NCT02554812|541483306|FG012|Overall Study|Death|0|||
150093758|NCT02554812|541483307|FG013|Overall Study|Death|0|||
150093759|NCT02554812|541483308|FG014|Overall Study|Death|1|||
150093760|NCT02554812|541483309|FG015|Overall Study|Death|1|||
150093761|NCT02554812|541483310|FG016|Overall Study|Death|1|||
150093762|NCT02554812|541483311|FG017|Overall Study|Death|0|||
150093763|NCT02554812|541483312|FG018|Overall Study|Death|1|||
150093764|NCT02554812|541483313|FG019|Overall Study|Death|2|||
150093765|NCT02554812|541483314|FG020|Overall Study|Death|0|||
150093766|NCT02554812|541483315|FG021|Overall Study|Death|1|||
150093767|NCT02554812|541483316|FG022|Overall Study|Death|1|||
150093768|NCT02554812|541483317|FG023|Overall Study|Death|0|||
150093769|NCT02554812|541483318|FG024|Overall Study|Death|0|||
150093770|NCT02554812|541483319|FG025|Overall Study|Death|0|||
150093771|NCT02554812|541483320|FG026|Overall Study|Death|0|||
150093772|NCT02554812|541483294|FG000|Overall Study|Lost to Follow-up|0|||
150093773|NCT02554812|541483295|FG001|Overall Study|Lost to Follow-up|1|||
150093774|NCT02554812|541483296|FG002|Overall Study|Lost to Follow-up|0|||
150093775|NCT02554812|541483297|FG003|Overall Study|Lost to Follow-up|0|||
150093776|NCT02554812|541483298|FG004|Overall Study|Lost to Follow-up|0|||
150093777|NCT02554812|541483299|FG005|Overall Study|Lost to Follow-up|0|||
150184510|NCT00632749|541813358|FG001|Overall Study|Progressive disease|2|||
150184511|NCT00632749|541813359|FG002|Overall Study|Progressive disease|2|||
150184512|NCT00632749|541813360|FG003|Overall Study|Progressive disease|2|||
150184513|NCT00632749|541813361|FG004|Overall Study|Progressive disease|4|||
150184514|NCT00632749|541813362|FG005|Overall Study|Progressive disease|4|||
150184515|NCT00632749|541813363|FG006|Overall Study|Progressive disease|3|||
150184516|NCT00632749|541813364|FG007|Overall Study|Progressive disease|2|||
150093778|NCT02554812|541483300|FG006|Overall Study|Lost to Follow-up|0|||
150093779|NCT02554812|541483301|FG007|Overall Study|Lost to Follow-up|0|||
150093780|NCT02554812|541483302|FG008|Overall Study|Lost to Follow-up|0|||
150093781|NCT02554812|541483303|FG009|Overall Study|Lost to Follow-up|0|||
150093782|NCT02554812|541483304|FG010|Overall Study|Lost to Follow-up|0|||
150093783|NCT02554812|541483305|FG011|Overall Study|Lost to Follow-up|0|||
150093784|NCT02554812|541483306|FG012|Overall Study|Lost to Follow-up|0|||
150093785|NCT02554812|541483307|FG013|Overall Study|Lost to Follow-up|0|||
150093786|NCT02554812|541483308|FG014|Overall Study|Lost to Follow-up|0|||
150093787|NCT02554812|541483309|FG015|Overall Study|Lost to Follow-up|0|||
150093788|NCT02554812|541483310|FG016|Overall Study|Lost to Follow-up|0|||
150093789|NCT02554812|541483311|FG017|Overall Study|Lost to Follow-up|0|||
150093790|NCT02554812|541483312|FG018|Overall Study|Lost to Follow-up|0|||
150093791|NCT02554812|541483313|FG019|Overall Study|Lost to Follow-up|0|||
150093792|NCT02554812|541483314|FG020|Overall Study|Lost to Follow-up|0|||
150093793|NCT02554812|541483315|FG021|Overall Study|Lost to Follow-up|0|||
150093794|NCT02554812|541483316|FG022|Overall Study|Lost to Follow-up|0|||
150184517|NCT00632749|541813365|FG008|Overall Study|Progressive disease|3|||
150184518|NCT00632749|541813366|FG009|Overall Study|Progressive disease|2|||
150184519|NCT00632749|541813367|FG010|Overall Study|Progressive disease|4|||
150184520|NCT00632749|541813368|FG011|Overall Study|Progressive disease|3|||
150184521|NCT00632749|541813369|FG012|Overall Study|Progressive disease|2|||
150184522|NCT00632749|541813370|FG013|Overall Study|Progressive disease|4|||
150184523|NCT00632749|541813357|FG000|Overall Study|Other Adverse event|1|||
150184524|NCT00632749|541813358|FG001|Overall Study|Other Adverse event|1|||
150184525|NCT00632749|541813359|FG002|Overall Study|Other Adverse event|1|||
150184526|NCT00632749|541813360|FG003|Overall Study|Other Adverse event|1|||
150184527|NCT00632749|541813361|FG004|Overall Study|Other Adverse event|2|||
150184528|NCT00632749|541813362|FG005|Overall Study|Other Adverse event|4|||
150184529|NCT00632749|541813363|FG006|Overall Study|Other Adverse event|1|||
150184530|NCT00632749|541813364|FG007|Overall Study|Other Adverse event|2|||
150184531|NCT00632749|541813365|FG008|Overall Study|Other Adverse event|2|||
150093795|NCT02554812|541483317|FG023|Overall Study|Lost to Follow-up|0|||
150093796|NCT02554812|541483318|FG024|Overall Study|Lost to Follow-up|0|||
150093797|NCT02554812|541483319|FG025|Overall Study|Lost to Follow-up|0|||
150093798|NCT02554812|541483320|FG026|Overall Study|Lost to Follow-up|0|||
150093799|NCT02554812|541483294|FG000|Overall Study|Global deterioration of health status|4|||
150093800|NCT02554812|541483295|FG001|Overall Study|Global deterioration of health status|3|||
150093801|NCT02554812|541483296|FG002|Overall Study|Global deterioration of health status|3|||
150093802|NCT02554812|541483297|FG003|Overall Study|Global deterioration of health status|2|||
150093803|NCT02554812|541483298|FG004|Overall Study|Global deterioration of health status|5|||
150093804|NCT02554812|541483299|FG005|Overall Study|Global deterioration of health status|0|||
150093805|NCT02554812|541483300|FG006|Overall Study|Global deterioration of health status|2|||
150093806|NCT02554812|541483301|FG007|Overall Study|Global deterioration of health status|1|||
150093807|NCT02554812|541483302|FG008|Overall Study|Global deterioration of health status|1|||
150093808|NCT02554812|541483303|FG009|Overall Study|Global deterioration of health status|1|||
150093809|NCT02554812|541483304|FG010|Overall Study|Global deterioration of health status|2|||
150093810|NCT02554812|541483305|FG011|Overall Study|Global deterioration of health status|1|||
150093811|NCT02554812|541483306|FG012|Overall Study|Global deterioration of health status|0|||
150093812|NCT02554812|541483307|FG013|Overall Study|Global deterioration of health status|0|||
150093813|NCT02554812|541483308|FG014|Overall Study|Global deterioration of health status|0|||
150093814|NCT02554812|541483309|FG015|Overall Study|Global deterioration of health status|1|||
150093815|NCT02554812|541483310|FG016|Overall Study|Global deterioration of health status|0|||
150093816|NCT02554812|541483311|FG017|Overall Study|Global deterioration of health status|0|||
150093817|NCT02554812|541483312|FG018|Overall Study|Global deterioration of health status|0|||
150093818|NCT02554812|541483313|FG019|Overall Study|Global deterioration of health status|0|||
150093819|NCT02554812|541483314|FG020|Overall Study|Global deterioration of health status|0|||
150093820|NCT02554812|541483315|FG021|Overall Study|Global deterioration of health status|0|||
150093821|NCT02554812|541483316|FG022|Overall Study|Global deterioration of health status|0|||
150093822|NCT02554812|541483317|FG023|Overall Study|Global deterioration of health status|0|||
150093823|NCT02554812|541483318|FG024|Overall Study|Global deterioration of health status|0|||
150093824|NCT02554812|541483319|FG025|Overall Study|Global deterioration of health status|0|||
150093825|NCT02554812|541483320|FG026|Overall Study|Global deterioration of health status|0|||
150093826|NCT02554812|541483294|FG000|Overall Study|Progressive disease|20|||
150093827|NCT02554812|541483295|FG001|Overall Study|Progressive disease|16|||
150093828|NCT02554812|541483296|FG002|Overall Study|Progressive disease|19|||
150184532|NCT00632749|541813366|FG009|Overall Study|Other Adverse event|0|||
150184533|NCT00632749|541813367|FG010|Overall Study|Other Adverse event|1|||
150184534|NCT00632749|541813368|FG011|Overall Study|Other Adverse event|0|||
150184535|NCT00632749|541813369|FG012|Overall Study|Other Adverse event|1|||
150184536|NCT00632749|541813370|FG013|Overall Study|Other Adverse event|0|||
150184537|NCT00632749|541813357|FG000|Overall Study|Refuse to continue medication|0|||
150184538|NCT00632749|541813358|FG001|Overall Study|Refuse to continue medication|0|||
150184539|NCT00632749|541813359|FG002|Overall Study|Refuse to continue medication|0|||
150184540|NCT00632749|541813360|FG003|Overall Study|Refuse to continue medication|1|||
150184541|NCT00632749|541813361|FG004|Overall Study|Refuse to continue medication|0|||
150184542|NCT00632749|541813362|FG005|Overall Study|Refuse to continue medication|0|||
150184543|NCT00632749|541813363|FG006|Overall Study|Refuse to continue medication|0|||
150184544|NCT00632749|541813364|FG007|Overall Study|Refuse to continue medication|0|||
150184545|NCT00632749|541813365|FG008|Overall Study|Refuse to continue medication|0|||
150184546|NCT00632749|541813366|FG009|Overall Study|Refuse to continue medication|1|||
150184547|NCT00632749|541813367|FG010|Overall Study|Refuse to continue medication|0|||
150184548|NCT00632749|541813368|FG011|Overall Study|Refuse to continue medication|0|||
150184549|NCT00632749|541813369|FG012|Overall Study|Refuse to continue medication|0|||
150184550|NCT00632749|541813370|FG013|Overall Study|Refuse to continue medication|0|||
150184551|NCT00632749|541813357|FG000|Overall Study|Reason other than those specified above|0|||
150184552|NCT00632749|541813358|FG001|Overall Study|Reason other than those specified above|2|||
150184553|NCT00632749|541813359|FG002|Overall Study|Reason other than those specified above|0|||
150184554|NCT00632749|541813360|FG003|Overall Study|Reason other than those specified above|0|||
150184555|NCT00632749|541813361|FG004|Overall Study|Reason other than those specified above|1|||
150184556|NCT00632749|541813362|FG005|Overall Study|Reason other than those specified above|0|||
150184557|NCT00632749|541813363|FG006|Overall Study|Reason other than those specified above|1|||
150184558|NCT00632749|541813364|FG007|Overall Study|Reason other than those specified above|0|||
150184559|NCT00632749|541813365|FG008|Overall Study|Reason other than those specified above|0|||
150184560|NCT00632749|541813366|FG009|Overall Study|Reason other than those specified above|0|||
150184561|NCT00632749|541813367|FG010|Overall Study|Reason other than those specified above|2|||
150184562|NCT00632749|541813368|FG011|Overall Study|Reason other than those specified above|1|||
150184563|NCT00632749|541813369|FG012|Overall Study|Reason other than those specified above|0|||
150184564|NCT00632749|541813370|FG013|Overall Study|Reason other than those specified above|2|||
150184565|NCT04999592|541813371|FG000|Overall Study|Withdrawal by Subject|1|||
150184566|NCT04999592|541813372|FG001|Overall Study|Withdrawal by Subject|0|||
150184567|NCT02671435|541813381|FG000|Overall Study|Death|1|||
150184568|NCT02671435|541813382|FG001|Overall Study|Death|3|||
150184569|NCT02671435|541813383|FG002|Overall Study|Death|0|||
150184570|NCT02671435|541813384|FG003|Overall Study|Death|16|||
150184571|NCT02671435|541813385|FG004|Overall Study|Death|14|||
150184572|NCT02671435|541813386|FG005|Overall Study|Death|29|||
150184573|NCT02671435|541813387|FG006|Overall Study|Death|34|||
150184574|NCT02671435|541813388|FG007|Overall Study|Death|28|||
150093829|NCT02554812|541483297|FG003|Overall Study|Progressive disease|18|||
150093830|NCT02554812|541483298|FG004|Overall Study|Progressive disease|21|||
150093831|NCT02554812|541483299|FG005|Overall Study|Progressive disease|15|||
150093832|NCT02554812|541483300|FG006|Overall Study|Progressive disease|6|||
150093833|NCT02554812|541483301|FG007|Overall Study|Progressive disease|13|||
150093834|NCT02554812|541483302|FG008|Overall Study|Progressive disease|6|||
150093835|NCT02554812|541483303|FG009|Overall Study|Progressive disease|6|||
150093836|NCT02554812|541483304|FG010|Overall Study|Progressive disease|8|||
150093837|NCT02554812|541483305|FG011|Overall Study|Progressive disease|8|||
150093838|NCT02554812|541483306|FG012|Overall Study|Progressive disease|6|||
150093839|NCT02554812|541483307|FG013|Overall Study|Progressive disease|10|||
150093840|NCT02554812|541483308|FG014|Overall Study|Progressive disease|20|||
150093841|NCT02554812|541483309|FG015|Overall Study|Progressive disease|6|||
150093842|NCT02554812|541483310|FG016|Overall Study|Progressive disease|3|||
150093843|NCT02554812|541483311|FG017|Overall Study|Progressive disease|3|||
150093844|NCT02554812|541483312|FG018|Overall Study|Progressive disease|11|||
150093845|NCT02554812|541483313|FG019|Overall Study|Progressive disease|7|||
150093846|NCT02554812|541483314|FG020|Overall Study|Progressive disease|11|||
150093847|NCT02554812|541483315|FG021|Overall Study|Progressive disease|6|||
150093848|NCT02554812|541483316|FG022|Overall Study|Progressive disease|9|||
150093849|NCT02554812|541483317|FG023|Overall Study|Progressive disease|9|||
150093850|NCT02554812|541483318|FG024|Overall Study|Progressive disease|4|||
150093851|NCT02554812|541483319|FG025|Overall Study|Progressive disease|5|||
150093852|NCT02554812|541483320|FG026|Overall Study|Progressive disease|5|||
150093853|NCT02554812|541483294|FG000|Overall Study|Other|0|||
150184575|NCT02671435|541813389|FG008|Overall Study|Death|19|||
150184576|NCT02671435|541813390|FG009|Overall Study|Death|10|||
150184577|NCT02671435|541813391|FG010|Overall Study|Death|8|||
150184578|NCT02671435|541813392|FG011|Overall Study|Death|29|||
150184579|NCT02671435|541813393|FG012|Overall Study|Death|29|||
150184580|NCT02671435|541813394|FG013|Overall Study|Death|29|||
150184581|NCT02671435|541813395|FG014|Overall Study|Death|27|||
150093854|NCT02554812|541483295|FG001|Overall Study|Other|0|||
150093855|NCT02554812|541483296|FG002|Overall Study|Other|2|||
150093856|NCT02554812|541483297|FG003|Overall Study|Other|3|||
150093857|NCT02554812|541483298|FG004|Overall Study|Other|2|||
150093858|NCT02554812|541483299|FG005|Overall Study|Other|1|||
150093859|NCT02554812|541483300|FG006|Overall Study|Other|0|||
150093860|NCT02554812|541483301|FG007|Overall Study|Other|0|||
150093861|NCT02554812|541483302|FG008|Overall Study|Other|1|||
150093862|NCT02554812|541483303|FG009|Overall Study|Other|1|||
150093863|NCT02554812|541483304|FG010|Overall Study|Other|0|||
150093864|NCT02554812|541483305|FG011|Overall Study|Other|0|||
150093865|NCT02554812|541483306|FG012|Overall Study|Other|1|||
150093866|NCT02554812|541483307|FG013|Overall Study|Other|0|||
150093867|NCT02554812|541483308|FG014|Overall Study|Other|1|||
150093868|NCT02554812|541483309|FG015|Overall Study|Other|0|||
150093869|NCT02554812|541483310|FG016|Overall Study|Other|0|||
150093870|NCT02554812|541483311|FG017|Overall Study|Other|0|||
150093871|NCT02554812|541483312|FG018|Overall Study|Other|0|||
150093872|NCT02554812|541483313|FG019|Overall Study|Other|0|||
150093873|NCT02554812|541483314|FG020|Overall Study|Other|0|||
150093874|NCT02554812|541483315|FG021|Overall Study|Other|2|||
150093875|NCT02554812|541483316|FG022|Overall Study|Other|0|||
150093876|NCT02554812|541483317|FG023|Overall Study|Other|0|||
150093877|NCT02554812|541483318|FG024|Overall Study|Other|0|||
150093878|NCT02554812|541483319|FG025|Overall Study|Other|0|||
150093879|NCT02554812|541483320|FG026|Overall Study|Other|0|||
150093880|NCT02554812|541483294|FG000|Overall Study|Withdrawal by Subject|1|||
150093881|NCT02554812|541483295|FG001|Overall Study|Withdrawal by Subject|0|||
150093882|NCT02554812|541483296|FG002|Overall Study|Withdrawal by Subject|0|||
150093883|NCT02554812|541483297|FG003|Overall Study|Withdrawal by Subject|2|||
150093884|NCT02554812|541483298|FG004|Overall Study|Withdrawal by Subject|2|||
150093885|NCT02554812|541483299|FG005|Overall Study|Withdrawal by Subject|3|||
150093886|NCT02554812|541483300|FG006|Overall Study|Withdrawal by Subject|0|||
150093887|NCT02554812|541483301|FG007|Overall Study|Withdrawal by Subject|0|||
150093888|NCT02554812|541483302|FG008|Overall Study|Withdrawal by Subject|1|||
150093889|NCT02554812|541483303|FG009|Overall Study|Withdrawal by Subject|1|||
150093890|NCT02554812|541483304|FG010|Overall Study|Withdrawal by Subject|0|||
150093891|NCT02554812|541483305|FG011|Overall Study|Withdrawal by Subject|1|||
150093892|NCT02554812|541483306|FG012|Overall Study|Withdrawal by Subject|1|||
150093893|NCT02554812|541483307|FG013|Overall Study|Withdrawal by Subject|1|||
150093894|NCT02554812|541483308|FG014|Overall Study|Withdrawal by Subject|1|||
150093895|NCT02554812|541483309|FG015|Overall Study|Withdrawal by Subject|1|||
150093896|NCT02554812|541483310|FG016|Overall Study|Withdrawal by Subject|3|||
150093897|NCT02554812|541483311|FG017|Overall Study|Withdrawal by Subject|1|||
150093898|NCT02554812|541483312|FG018|Overall Study|Withdrawal by Subject|0|||
150093899|NCT02554812|541483313|FG019|Overall Study|Withdrawal by Subject|2|||
150093900|NCT02554812|541483314|FG020|Overall Study|Withdrawal by Subject|0|||
150093901|NCT02554812|541483315|FG021|Overall Study|Withdrawal by Subject|1|||
150093902|NCT02554812|541483316|FG022|Overall Study|Withdrawal by Subject|0|||
150093903|NCT02554812|541483317|FG023|Overall Study|Withdrawal by Subject|1|||
150093904|NCT02554812|541483318|FG024|Overall Study|Withdrawal by Subject|0|||
150093905|NCT02554812|541483319|FG025|Overall Study|Withdrawal by Subject|0|||
150093906|NCT02554812|541483320|FG026|Overall Study|Withdrawal by Subject|1|||
150093907|NCT02554812|541483294|FG000|Overall Study|Physician Decision|1|||
150093908|NCT02554812|541483295|FG001|Overall Study|Physician Decision|0|||
150093909|NCT02554812|541483296|FG002|Overall Study|Physician Decision|0|||
150093910|NCT02554812|541483297|FG003|Overall Study|Physician Decision|1|||
150093911|NCT02554812|541483298|FG004|Overall Study|Physician Decision|0|||
150093912|NCT02554812|541483299|FG005|Overall Study|Physician Decision|1|||
150093913|NCT02554812|541483300|FG006|Overall Study|Physician Decision|0|||
150093914|NCT02554812|541483301|FG007|Overall Study|Physician Decision|0|||
150093915|NCT02554812|541483302|FG008|Overall Study|Physician Decision|0|||
150093916|NCT02554812|541483303|FG009|Overall Study|Physician Decision|0|||
150093917|NCT02554812|541483304|FG010|Overall Study|Physician Decision|1|||
150093918|NCT02554812|541483305|FG011|Overall Study|Physician Decision|0|||
150093919|NCT02554812|541483306|FG012|Overall Study|Physician Decision|0|||
150093920|NCT02554812|541483307|FG013|Overall Study|Physician Decision|0|||
150093921|NCT02554812|541483308|FG014|Overall Study|Physician Decision|0|||
150093922|NCT02554812|541483309|FG015|Overall Study|Physician Decision|0|||
150093923|NCT02554812|541483310|FG016|Overall Study|Physician Decision|1|||
150093924|NCT02554812|541483311|FG017|Overall Study|Physician Decision|1|||
150093925|NCT02554812|541483312|FG018|Overall Study|Physician Decision|0|||
150093926|NCT02554812|541483313|FG019|Overall Study|Physician Decision|1|||
150093927|NCT02554812|541483314|FG020|Overall Study|Physician Decision|1|||
150093928|NCT02554812|541483315|FG021|Overall Study|Physician Decision|0|||
150093929|NCT02554812|541483316|FG022|Overall Study|Physician Decision|1|||
150093930|NCT02554812|541483317|FG023|Overall Study|Physician Decision|0|||
150093931|NCT02554812|541483318|FG024|Overall Study|Physician Decision|0|||
150093932|NCT02554812|541483319|FG025|Overall Study|Physician Decision|0|||
150093933|NCT02554812|541483320|FG026|Overall Study|Physician Decision|0|||
150093934|NCT02554812|541483294|FG000|Overall Study|Study terminated by sponsor|0|||
150093935|NCT02554812|541483295|FG001|Overall Study|Study terminated by sponsor|0|||
150093936|NCT02554812|541483296|FG002|Overall Study|Study terminated by sponsor|0|||
150093937|NCT02554812|541483297|FG003|Overall Study|Study terminated by sponsor|0|||
150093938|NCT02554812|541483298|FG004|Overall Study|Study terminated by sponsor|0|||
150093939|NCT02554812|541483299|FG005|Overall Study|Study terminated by sponsor|0|||
150093940|NCT02554812|541483300|FG006|Overall Study|Study terminated by sponsor|0|||
150093941|NCT02554812|541483301|FG007|Overall Study|Study terminated by sponsor|0|||
150093942|NCT02554812|541483302|FG008|Overall Study|Study terminated by sponsor|0|||
150093943|NCT02554812|541483303|FG009|Overall Study|Study terminated by sponsor|0|||
150093944|NCT02554812|541483304|FG010|Overall Study|Study terminated by sponsor|0|||
150093945|NCT02554812|541483305|FG011|Overall Study|Study terminated by sponsor|0|||
150093946|NCT02554812|541483306|FG012|Overall Study|Study terminated by sponsor|0|||
150093947|NCT02554812|541483307|FG013|Overall Study|Study terminated by sponsor|0|||
150093948|NCT02554812|541483308|FG014|Overall Study|Study terminated by sponsor|0|||
150093949|NCT02554812|541483309|FG015|Overall Study|Study terminated by sponsor|0|||
150093950|NCT02554812|541483310|FG016|Overall Study|Study terminated by sponsor|0|||
150093951|NCT02554812|541483311|FG017|Overall Study|Study terminated by sponsor|0|||
150093952|NCT02554812|541483312|FG018|Overall Study|Study terminated by sponsor|0|||
150093953|NCT02554812|541483313|FG019|Overall Study|Study terminated by sponsor|0|||
150093954|NCT02554812|541483314|FG020|Overall Study|Study terminated by sponsor|0|||
150093955|NCT02554812|541483315|FG021|Overall Study|Study terminated by sponsor|0|||
150093956|NCT02554812|541483316|FG022|Overall Study|Study terminated by sponsor|0|||
150093957|NCT02554812|541483317|FG023|Overall Study|Study terminated by sponsor|0|||
150093958|NCT02554812|541483318|FG024|Overall Study|Study terminated by sponsor|1|||
150093959|NCT02554812|541483319|FG025|Overall Study|Study terminated by sponsor|0|||
150093960|NCT02554812|541483320|FG026|Overall Study|Study terminated by sponsor|0|||
150093961|NCT02554812|541483294|FG000|Overall Study|No longer meets eligibility criteria|0|||
150093962|NCT02554812|541483295|FG001|Overall Study|No longer meets eligibility criteria|1|||
150093963|NCT02554812|541483296|FG002|Overall Study|No longer meets eligibility criteria|0|||
150093964|NCT02554812|541483297|FG003|Overall Study|No longer meets eligibility criteria|0|||
150093965|NCT02554812|541483298|FG004|Overall Study|No longer meets eligibility criteria|0|||
150093966|NCT02554812|541483299|FG005|Overall Study|No longer meets eligibility criteria|0|||
150093967|NCT02554812|541483300|FG006|Overall Study|No longer meets eligibility criteria|0|||
150093968|NCT02554812|541483301|FG007|Overall Study|No longer meets eligibility criteria|0|||
150093969|NCT02554812|541483302|FG008|Overall Study|No longer meets eligibility criteria|0|||
150093970|NCT02554812|541483303|FG009|Overall Study|No longer meets eligibility criteria|0|||
150093971|NCT02554812|541483304|FG010|Overall Study|No longer meets eligibility criteria|0|||
150093972|NCT02554812|541483305|FG011|Overall Study|No longer meets eligibility criteria|0|||
150093973|NCT02554812|541483306|FG012|Overall Study|No longer meets eligibility criteria|0|||
150093974|NCT02554812|541483307|FG013|Overall Study|No longer meets eligibility criteria|0|||
150093975|NCT02554812|541483308|FG014|Overall Study|No longer meets eligibility criteria|0|||
150093976|NCT02554812|541483309|FG015|Overall Study|No longer meets eligibility criteria|0|||
150093977|NCT02554812|541483310|FG016|Overall Study|No longer meets eligibility criteria|0|||
150093978|NCT02554812|541483311|FG017|Overall Study|No longer meets eligibility criteria|0|||
150093979|NCT02554812|541483312|FG018|Overall Study|No longer meets eligibility criteria|0|||
150093980|NCT02554812|541483313|FG019|Overall Study|No longer meets eligibility criteria|0|||
150093981|NCT02554812|541483314|FG020|Overall Study|No longer meets eligibility criteria|0|||
150093982|NCT02554812|541483315|FG021|Overall Study|No longer meets eligibility criteria|0|||
150093983|NCT02554812|541483316|FG022|Overall Study|No longer meets eligibility criteria|0|||
150093984|NCT02554812|541483317|FG023|Overall Study|No longer meets eligibility criteria|0|||
150093985|NCT02554812|541483318|FG024|Overall Study|No longer meets eligibility criteria|0|||
150093986|NCT02554812|541483319|FG025|Overall Study|No longer meets eligibility criteria|0|||
150093987|NCT02554812|541483320|FG026|Overall Study|No longer meets eligibility criteria|0|||
150093988|NCT01103284|541483321|FG000|Overall Study|Death|2|||
150184582|NCT02671435|541813381|FG000|Overall Study|Lost to Follow-up|0|||
150184583|NCT02671435|541813382|FG001|Overall Study|Lost to Follow-up|0|||
150184584|NCT02671435|541813383|FG002|Overall Study|Lost to Follow-up|1|||
150184585|NCT02671435|541813384|FG003|Overall Study|Lost to Follow-up|0|||
150093989|NCT01103284|541483322|FG001|Overall Study|Death|0|||
150093990|NCT01103284|541483321|FG000|Overall Study|Lost to Follow-up|9|||
150093991|NCT01103284|541483322|FG001|Overall Study|Lost to Follow-up|10|||
150093992|NCT01103284|541483321|FG000|Overall Study|Pregnancy|3|||
150093993|NCT01103284|541483322|FG001|Overall Study|Pregnancy|1|||
150093994|NCT01103284|541483321|FG000|Overall Study|Protocol Violation|12|||
150093995|NCT01103284|541483322|FG001|Overall Study|Protocol Violation|5|||
150093996|NCT01103284|541483321|FG000|Overall Study|Adverse Event|0|||
150093997|NCT01103284|541483322|FG001|Overall Study|Adverse Event|5|||
150093998|NCT01103284|541483321|FG000|Overall Study|Withdrawal by Subject|14|||
150093999|NCT01103284|541483322|FG001|Overall Study|Withdrawal by Subject|18|||
150094000|NCT01103284|541483321|FG000|Overall Study|Dermal Hypersensitivity|0|||
150094001|NCT01103284|541483322|FG001|Overall Study|Dermal Hypersensitivity|1|||
150094002|NCT01103284|541483321|FG000|Overall Study|Termination by the Sponsor|0|||
150094003|NCT01103284|541483322|FG001|Overall Study|Termination by the Sponsor|1|||
150094004|NCT01103284|541483321|FG000|Overall Study|Not described|2|||
150094005|NCT01103284|541483322|FG001|Overall Study|Not described|1|||
150094006|NCT01103284|541483321|FG000|Overall Study|Missing CRF entries for study completion|0|||
150094007|NCT01103284|541483322|FG001|Overall Study|Missing CRF entries for study completion|2|||
150094008|NCT00936910|541484805|FG000|Overall Study|Lack of Efficacy|3|||
150094009|NCT02057198|541484806|FG000|Overall Study|Death|0|||
150094010|NCT02057198|541484807|FG001|Overall Study|Death|0|||
150094011|NCT02057198|541484808|FG002|Overall Study|Death|1|||
150094012|NCT02057198|541484806|FG000|Overall Study|Discharged early; lost to followup|0|||
150094013|NCT02057198|541484807|FG001|Overall Study|Discharged early; lost to followup|1|||
150094014|NCT02057198|541484808|FG002|Overall Study|Discharged early; lost to followup|0|||
150094015|NCT00503009|541484809|FG000|Overall Study|Protocol Violation|1|||
150094016|NCT00503009|541484810|FG001|Overall Study|Protocol Violation|0|||
150094017|NCT00503009|541484811|FG002|Overall Study|Protocol Violation|1|||
150094018|NCT00503009|541484809|FG000|Overall Study|Withdrawal by Subject|0|||
150094019|NCT00503009|541484810|FG001|Overall Study|Withdrawal by Subject|1|||
150094020|NCT00503009|541484811|FG002|Overall Study|Withdrawal by Subject|1|||
150094021|NCT00503009|541484809|FG000|Overall Study|Physician Decision|0|||
150094022|NCT00503009|541484810|FG001|Overall Study|Physician Decision|1|||
150094023|NCT00503009|541484811|FG002|Overall Study|Physician Decision|1|||
150094024|NCT02355691|541484813|FG000|Overall Study|Loss of Research Personnel|7|||
150094025|NCT02355691|541484814|FG001|Overall Study|Loss of Research Personnel|9|||
150094026|NCT01349803|541484816|FG000|Overall Study|Adverse Event|0|||
150094027|NCT01349803|541484817|FG001|Overall Study|Adverse Event|0|||
150094028|NCT01349803|541484818|FG002|Overall Study|Adverse Event|0|||
150094029|NCT01349803|541484819|FG003|Overall Study|Adverse Event|2|||
150094030|NCT01349803|541484816|FG000|Overall Study|Withdrawal by Subject|1|||
150094031|NCT01349803|541484817|FG001|Overall Study|Withdrawal by Subject|0|||
150094032|NCT01349803|541484818|FG002|Overall Study|Withdrawal by Subject|0|||
150094033|NCT01349803|541484819|FG003|Overall Study|Withdrawal by Subject|0|||
150094034|NCT01349803|541484816|FG000|Overall Study|Protocol-specified criteria|0|||
150094035|NCT01349803|541484817|FG001|Overall Study|Protocol-specified criteria|1|||
150094036|NCT01349803|541484818|FG002|Overall Study|Protocol-specified criteria|3|||
150094037|NCT01349803|541484819|FG003|Overall Study|Protocol-specified criteria|0|||
150094038|NCT03232281|541484820|FG000|Overall Study|Adverse Event|1|||
150094039|NCT03232281|541484821|FG001|Overall Study|Adverse Event|1|||
150094040|NCT03232281|541484820|FG000|Overall Study|Withdrawal by Subject|5|||
150094041|NCT03232281|541484821|FG001|Overall Study|Withdrawal by Subject|4|||
150094042|NCT03232281|541484820|FG000|Overall Study|Protocol Deviation|1|||
150094043|NCT03232281|541484821|FG001|Overall Study|Protocol Deviation|1|||
150094044|NCT02345811|541484823|FG000|First Intervention|Withdrawal by Subject|1|||
150094045|NCT02345811|541484824|FG001|First Intervention|Withdrawal by Subject|1|||
150094046|NCT03683758|541484829|FG000|Overall Study|Non-study commitment conflict|1|||
150094047|NCT03683758|541484830|FG001|Overall Study|Non-study commitment conflict|3|||
150094048|NCT03683758|541484829|FG000|Overall Study|Illness preventing participation|1|||
150094049|NCT03683758|541484830|FG001|Overall Study|Illness preventing participation|0|||
150094050|NCT03683758|541484829|FG000|Overall Study|Adverse Event|1|||
150094051|NCT03683758|541484830|FG001|Overall Study|Adverse Event|0|||
150094052|NCT01172847|541484831|FG000|Overall Study|Withdrawal by Subject|3|||
150094053|NCT01163279|541484832|FG000|Overall Study|Withdrawal by Subject|2|||
150094054|NCT01163279|541484833|FG001|Overall Study|Withdrawal by Subject|0|||
150094055|NCT00665353|541484835|FG000|Study Step 1|Adverse Event|1|||
150094056|NCT00665353|541484835|FG000|Study Step 1|Withdrawal by Subject|2|||
150094057|NCT00665353|541484835|FG000|Study Step 2|Lost to Follow-up|2|||
150094058|NCT00665353|541484835|FG000|Study Step 2|Lack of Efficacy|12|||
150094059|NCT01601626|541484843|FG000|Overall Study|Death|1|||
150094060|NCT01601626|541484844|FG001|Overall Study|Death|1|||
150094061|NCT01601626|541484845|FG002|Overall Study|Death|1|||
150094062|NCT01601626|541484843|FG000|Overall Study|Lost to Follow-up|1|||
150094063|NCT01601626|541484844|FG001|Overall Study|Lost to Follow-up|2|||
150094064|NCT01601626|541484845|FG002|Overall Study|Lost to Follow-up|0|||
150094065|NCT01601626|541484843|FG000|Overall Study|Unable to Get to Clinic|0|||
150094066|NCT01601626|541484844|FG001|Overall Study|Unable to Get to Clinic|1|||
150094067|NCT01601626|541484845|FG002|Overall Study|Unable to Get to Clinic|0|||
150094068|NCT01601626|541484843|FG000|Overall Study|Withdrawal by Subject|0|||
150094069|NCT01601626|541484844|FG001|Overall Study|Withdrawal by Subject|1|||
150094070|NCT01601626|541484845|FG002|Overall Study|Withdrawal by Subject|1|||
150184586|NCT02671435|541813385|FG004|Overall Study|Lost to Follow-up|1|||
150184587|NCT02671435|541813386|FG005|Overall Study|Lost to Follow-up|1|||
150184588|NCT02671435|541813387|FG006|Overall Study|Lost to Follow-up|2|||
150184589|NCT02671435|541813388|FG007|Overall Study|Lost to Follow-up|2|||
150184590|NCT02671435|541813389|FG008|Overall Study|Lost to Follow-up|0|||
150184591|NCT02671435|541813390|FG009|Overall Study|Lost to Follow-up|2|||
150184592|NCT02671435|541813391|FG010|Overall Study|Lost to Follow-up|0|||
150184593|NCT02671435|541813392|FG011|Overall Study|Lost to Follow-up|3|||
150184594|NCT02671435|541813393|FG012|Overall Study|Lost to Follow-up|3|||
150184595|NCT02671435|541813394|FG013|Overall Study|Lost to Follow-up|2|||
150184596|NCT02671435|541813395|FG014|Overall Study|Lost to Follow-up|0|||
150184597|NCT02671435|541813381|FG000|Overall Study|Withdrawal by Subject|2|||
150184598|NCT02671435|541813382|FG001|Overall Study|Withdrawal by Subject|0|||
150184599|NCT02671435|541813383|FG002|Overall Study|Withdrawal by Subject|2|||
150184600|NCT02671435|541813384|FG003|Overall Study|Withdrawal by Subject|2|||
150184601|NCT02671435|541813385|FG004|Overall Study|Withdrawal by Subject|2|||
150184602|NCT02671435|541813386|FG005|Overall Study|Withdrawal by Subject|7|||
150184603|NCT02671435|541813387|FG006|Overall Study|Withdrawal by Subject|2|||
150184604|NCT02671435|541813388|FG007|Overall Study|Withdrawal by Subject|7|||
150184605|NCT02671435|541813389|FG008|Overall Study|Withdrawal by Subject|1|||
150184606|NCT02671435|541813390|FG009|Overall Study|Withdrawal by Subject|1|||
150184607|NCT02671435|541813391|FG010|Overall Study|Withdrawal by Subject|2|||
150184608|NCT02671435|541813392|FG011|Overall Study|Withdrawal by Subject|4|||
150184609|NCT02671435|541813393|FG012|Overall Study|Withdrawal by Subject|4|||
150184610|NCT02671435|541813394|FG013|Overall Study|Withdrawal by Subject|4|||
150184611|NCT02671435|541813395|FG014|Overall Study|Withdrawal by Subject|2|||
150184612|NCT02671435|541813381|FG000|Overall Study|Un-specified|0|||
150184613|NCT02671435|541813382|FG001|Overall Study|Un-specified|0|||
150184614|NCT02671435|541813383|FG002|Overall Study|Un-specified|0|||
150184615|NCT02671435|541813384|FG003|Overall Study|Un-specified|0|||
150184616|NCT02671435|541813385|FG004|Overall Study|Un-specified|1|||
150184617|NCT02671435|541813386|FG005|Overall Study|Un-specified|3|||
150184618|NCT02671435|541813387|FG006|Overall Study|Un-specified|2|||
150184619|NCT02671435|541813388|FG007|Overall Study|Un-specified|3|||
150184620|NCT02671435|541813389|FG008|Overall Study|Un-specified|0|||
150184621|NCT02671435|541813390|FG009|Overall Study|Un-specified|5|||
150184622|NCT02671435|541813391|FG010|Overall Study|Un-specified|8|||
150184623|NCT02671435|541813392|FG011|Overall Study|Un-specified|4|||
150184624|NCT02671435|541813393|FG012|Overall Study|Un-specified|5|||
150184625|NCT02671435|541813394|FG013|Overall Study|Un-specified|9|||
150184626|NCT02671435|541813395|FG014|Overall Study|Un-specified|8|||
150184627|NCT04095104|541813396|FG000|Overall Study|Withdrawal by Subject|0|||
150184628|NCT04095104|541813397|FG001|Overall Study|Withdrawal by Subject|1|||
150184629|NCT05048186|541813400|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
150184630|NCT05048186|541813401|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
150184631|NCT05048186|541813400|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
150184632|NCT05048186|541813401|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
150184633|NCT00976937|541813402|FG000|Overall Study|Adverse Event|4|||
150184634|NCT00976937|541813403|FG001|Overall Study|Adverse Event|5|||
150184635|NCT00976937|541813402|FG000|Overall Study|Lost to Follow-up|2|||
150184636|NCT00976937|541813403|FG001|Overall Study|Lost to Follow-up|1|||
150094071|NCT01601626|541484843|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
150094072|NCT01601626|541484844|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
150094073|NCT01601626|541484845|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
150094074|NCT03045887|541484847|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
150094075|NCT03045887|541484848|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094076|NCT03045887|541484849|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094077|NCT03045887|541484850|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094078|NCT03045887|541484851|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094079|NCT03045887|541484852|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094080|NCT03045887|541484853|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094081|NCT03045887|541484854|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094082|NCT03045887|541484855|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150094083|NCT03045887|541484856|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
150184637|NCT00976937|541813402|FG000|Overall Study|Withdrawal by Subject|5|||
150184638|NCT00976937|541813403|FG001|Overall Study|Withdrawal by Subject|3|||
150184639|NCT00976937|541813402|FG000|Overall Study|Poor compliance to protocol|3|||
150184640|NCT00976937|541813403|FG001|Overall Study|Poor compliance to protocol|0|||
150184641|NCT00976937|541813402|FG000|Overall Study|Personal and Familial Reason|2|||
150184642|NCT00976937|541813403|FG001|Overall Study|Personal and Familial Reason|2|||
150184643|NCT03069313|541813404|FG000|Overall Study|Adverse Event|5|||
150184644|NCT04218266|541813405|FG000|Overall Study|Death|1|||
150184645|NCT04218266|541813406|FG001|Overall Study|Death|2|||
150184646|NCT04218266|541813407|FG002|Overall Study|Death|3|||
150094084|NCT03045887|541484847|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094085|NCT03045887|541484848|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094086|NCT03045887|541484849|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094087|NCT03045887|541484850|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
150094088|NCT03045887|541484851|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094089|NCT03045887|541484852|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150029264|NCT00647296|541242629|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
150029265|NCT00647296|541242630|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
150029266|NCT00647296|541242631|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
150029267|NCT00647296|541242632|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
150029268|NCT00647296|541242629|FG000|Part 2: 4-week Placebo Washout|Death|3|||
150029269|NCT00647296|541242630|FG001|Part 2: 4-week Placebo Washout|Death|0|||
150029270|NCT00647296|541242631|FG002|Part 2: 4-week Placebo Washout|Death|0|||
150029271|NCT00647296|541242632|FG003|Part 2: 4-week Placebo Washout|Death|0|||
150029272|NCT00647296|541242629|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
150029273|NCT00647296|541242630|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
150029274|NCT00647296|541242631|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
150029275|NCT00647296|541242632|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
150029276|NCT00647296|541242629|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
150029277|NCT00647296|541242630|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
150029278|NCT00647296|541242631|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
150029279|NCT00647296|541242632|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
150029280|NCT00647296|541242629|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
150029281|NCT00647296|541242630|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
150029282|NCT00647296|541242631|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
150029283|NCT00647296|541242632|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
150029284|NCT00647296|541242629|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
150029285|NCT00647296|541242630|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
150029286|NCT00647296|541242631|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
150029287|NCT00647296|541242632|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
150029288|NCT00647296|541242629|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
150029289|NCT00647296|541242630|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
150029290|NCT00647296|541242631|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
150029291|NCT00647296|541242632|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
150029292|NCT02922725|541242633|FG000|Overall Study|Withdrawal by Subject|1|||
150029293|NCT02922725|541242634|FG001|Overall Study|Withdrawal by Subject|0|||
150029294|NCT02922725|541242635|FG002|Overall Study|Withdrawal by Subject|0|||
150029295|NCT01300234|541242636|FG000|Overall Study|Adverse Event|1|||
150029296|NCT01300234|541242637|FG001|Overall Study|Adverse Event|1|||
150029297|NCT01300234|541242636|FG000|Overall Study|Protocol Violation|2|||
150029298|NCT01300234|541242637|FG001|Overall Study|Protocol Violation|3|||
150029299|NCT01300234|541242636|FG000|Overall Study|Withdrawal by Subject|5|||
150029300|NCT01300234|541242637|FG001|Overall Study|Withdrawal by Subject|9|||
150029301|NCT01300234|541242636|FG000|Overall Study|Lost to Follow-up|14|||
150029302|NCT01300234|541242637|FG001|Overall Study|Lost to Follow-up|12|||
150029303|NCT01300234|541242636|FG000|Overall Study|Pregnancy|2|||
150029304|NCT01300234|541242637|FG001|Overall Study|Pregnancy|1|||
150029305|NCT01300234|541242636|FG000|Overall Study|Participant reached stopping critera|2|||
150029306|NCT01300234|541242637|FG001|Overall Study|Participant reached stopping critera|0|||
150029307|NCT01300234|541242636|FG000|Overall Study|Participant stopped medication|1|||
150029308|NCT01300234|541242637|FG001|Overall Study|Participant stopped medication|1|||
150029309|NCT01300234|541242636|FG000|Overall Study|Participant refused return to hospital|1|||
150029310|NCT01300234|541242637|FG001|Overall Study|Participant refused return to hospital|0|||
150029311|NCT00360412|541242638|FG000|Overall Study|Adverse Event|37|||
150029312|NCT00360412|541242639|FG001|Overall Study|Adverse Event|65|||
150029313|NCT00360412|541242638|FG000|Overall Study|Protocol Violation|2|||
150029314|NCT00360412|541242639|FG001|Overall Study|Protocol Violation|5|||
150029315|NCT00360412|541242638|FG000|Overall Study|Patient withdrew consent|27|||
150029316|NCT00360412|541242639|FG001|Overall Study|Patient withdrew consent|52|||
150029317|NCT00360412|541242638|FG000|Overall Study|Lack of therapeutic efficacy|46|||
150029318|NCT00360412|541242639|FG001|Overall Study|Lack of therapeutic efficacy|61|||
150029319|NCT00360412|541242638|FG000|Overall Study|Physician Decision|2|||
150029320|NCT00360412|541242639|FG001|Overall Study|Physician Decision|4|||
150029321|NCT00360412|541242638|FG000|Overall Study|Other|5|||
150029322|NCT00360412|541242639|FG001|Overall Study|Other|6|||
150029323|NCT00360412|541242638|FG000|Overall Study|Study termination by Sponsor|214|||
150029324|NCT00360412|541242639|FG001|Overall Study|Study termination by Sponsor|469|||
150029325|NCT04612725|541242640|FG000|Overall Study|Adverse Event|1|||
150029326|NCT04612725|541242641|FG001|Overall Study|Adverse Event|3|||
150094090|NCT03045887|541484853|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150184647|NCT04218266|541813405|FG000|Overall Study|Adverse Event|13|||
150094091|NCT03045887|541484854|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094092|NCT03045887|541484855|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094093|NCT03045887|541484856|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
150094094|NCT03045887|541484847|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
150094095|NCT03045887|541484848|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094096|NCT03045887|541484849|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094097|NCT03045887|541484850|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094098|NCT03045887|541484851|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094099|NCT03045887|541484852|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094100|NCT03045887|541484853|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094101|NCT03045887|541484854|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094102|NCT03045887|541484855|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094103|NCT03045887|541484856|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
150094104|NCT03045887|541484847|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094105|NCT03045887|541484848|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094106|NCT03045887|541484849|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
150094107|NCT03045887|541484850|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
150094108|NCT03045887|541484851|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094109|NCT03045887|541484852|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094110|NCT03045887|541484853|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094111|NCT03045887|541484854|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094112|NCT03045887|541484855|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094113|NCT03045887|541484856|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
150094114|NCT03045887|541484847|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094115|NCT03045887|541484848|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094116|NCT03045887|541484849|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094117|NCT03045887|541484850|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
150094118|NCT03045887|541484851|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094119|NCT03045887|541484852|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094120|NCT03045887|541484853|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150184648|NCT04218266|541813406|FG001|Overall Study|Adverse Event|14|||
150184649|NCT04218266|541813407|FG002|Overall Study|Adverse Event|11|||
150184650|NCT04218266|541813405|FG000|Overall Study|Other|7|||
150184651|NCT04218266|541813406|FG001|Overall Study|Other|5|||
150184652|NCT04218266|541813407|FG002|Overall Study|Other|14|||
150184653|NCT04218266|541813405|FG000|Overall Study|Physician Decision|1|||
150184654|NCT04218266|541813406|FG001|Overall Study|Physician Decision|3|||
150184655|NCT04218266|541813407|FG002|Overall Study|Physician Decision|2|||
150184656|NCT04218266|541813405|FG000|Overall Study|Non-compliance with study drug|0|||
150094121|NCT03045887|541484854|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094122|NCT03045887|541484855|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094123|NCT03045887|541484856|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
150094124|NCT02632552|541484857|FG000|Overall Study|Lost to Follow-up|14|||
150094125|NCT02632552|541484858|FG001|Overall Study|Lost to Follow-up|8|||
150094126|NCT02632552|541484857|FG000|Overall Study|Withdrawal by Subject|2|||
150094127|NCT02632552|541484858|FG001|Overall Study|Withdrawal by Subject|0|||
150094128|NCT02632552|541484857|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
150094129|NCT02632552|541484858|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
150094130|NCT00546637|541484863|FG000|Overall Study|Adverse Event|46|||
150094131|NCT00546637|541484864|FG001|Overall Study|Adverse Event|20|||
150094132|NCT00546637|541484863|FG000|Overall Study|Lack of Efficacy|5|||
150094133|NCT00546637|541484864|FG001|Overall Study|Lack of Efficacy|5|||
150094134|NCT00546637|541484863|FG000|Overall Study|Lost to Follow-up|2|||
150094135|NCT00546637|541484864|FG001|Overall Study|Lost to Follow-up|2|||
150094136|NCT00546637|541484863|FG000|Overall Study|Other|10|||
150094137|NCT00546637|541484864|FG001|Overall Study|Other|12|||
150094138|NCT00546637|541484863|FG000|Overall Study|Withdrawal by Subject|7|||
150094139|NCT00546637|541484864|FG001|Overall Study|Withdrawal by Subject|9|||
150094140|NCT00546637|541484863|FG000|Overall Study|Randomized, but not treated|3|||
150094141|NCT00546637|541484864|FG001|Overall Study|Randomized, but not treated|1|||
150094142|NCT03274440|541484865|FG000|Overall Study|Time commitment too great|1|||
150094143|NCT03274440|541484866|FG001|Overall Study|Time commitment too great|0|||
150094144|NCT03274440|541484867|FG002|Overall Study|Time commitment too great|0|||
150094145|NCT03274440|541484868|FG003|Overall Study|Time commitment too great|1|||
150094146|NCT03274440|541484869|FG004|Overall Study|Time commitment too great|0|||
150094147|NCT03274440|541484870|FG005|Overall Study|Time commitment too great|0|||
150184657|NCT04218266|541813406|FG001|Overall Study|Non-compliance with study drug|0|||
150184658|NCT04218266|541813407|FG002|Overall Study|Non-compliance with study drug|1|||
150184659|NCT04218266|541813405|FG000|Overall Study|Withdrawal by Subject|1|||
150184660|NCT04218266|541813406|FG001|Overall Study|Withdrawal by Subject|3|||
150184661|NCT04218266|541813407|FG002|Overall Study|Withdrawal by Subject|1|||
150094148|NCT01291173|541484871|FG000|Overall Study|Adverse Event|0|||
150094149|NCT01291173|541484872|FG001|Overall Study|Adverse Event|3|||
150094150|NCT01291173|541484873|FG002|Overall Study|Adverse Event|1|||
150094151|NCT01291173|541484874|FG003|Overall Study|Adverse Event|3|||
150094152|NCT01291173|541484871|FG000|Overall Study|Protocol Violation|7|||
150094153|NCT01291173|541484872|FG001|Overall Study|Protocol Violation|2|||
150094154|NCT01291173|541484873|FG002|Overall Study|Protocol Violation|2|||
150094155|NCT01291173|541484874|FG003|Overall Study|Protocol Violation|5|||
150094156|NCT01291173|541484871|FG000|Overall Study|Withdrawal by Subject|6|||
150094157|NCT01291173|541484872|FG001|Overall Study|Withdrawal by Subject|4|||
150094158|NCT01291173|541484873|FG002|Overall Study|Withdrawal by Subject|4|||
150094159|NCT01291173|541484874|FG003|Overall Study|Withdrawal by Subject|2|||
150094160|NCT01291173|541484871|FG000|Overall Study|Lost to Follow-up|4|||
150094161|NCT01291173|541484872|FG001|Overall Study|Lost to Follow-up|6|||
150094162|NCT01291173|541484873|FG002|Overall Study|Lost to Follow-up|3|||
150094163|NCT01291173|541484874|FG003|Overall Study|Lost to Follow-up|2|||
150094164|NCT01291173|541484871|FG000|Overall Study|Unable to meet visit schedule|0|||
150094165|NCT01291173|541484872|FG001|Overall Study|Unable to meet visit schedule|0|||
150094166|NCT01291173|541484873|FG002|Overall Study|Unable to meet visit schedule|1|||
150094167|NCT01291173|541484874|FG003|Overall Study|Unable to meet visit schedule|0|||
150094168|NCT01291173|541484871|FG000|Overall Study|Lack of compliance|0|||
150094169|NCT01291173|541484872|FG001|Overall Study|Lack of compliance|0|||
150094170|NCT01291173|541484873|FG002|Overall Study|Lack of compliance|0|||
150094171|NCT01291173|541484874|FG003|Overall Study|Lack of compliance|1|||
150094172|NCT01291173|541484871|FG000|Overall Study|Subject was unblinded|0|||
150094173|NCT01291173|541484872|FG001|Overall Study|Subject was unblinded|0|||
150094174|NCT01291173|541484873|FG002|Overall Study|Subject was unblinded|1|||
150094175|NCT01291173|541484874|FG003|Overall Study|Subject was unblinded|0|||
150094176|NCT01291173|541484871|FG000|Overall Study|Excluded therapy|0|||
150094177|NCT01291173|541484872|FG001|Overall Study|Excluded therapy|0|||
150094178|NCT01291173|541484873|FG002|Overall Study|Excluded therapy|1|||
150094179|NCT01291173|541484874|FG003|Overall Study|Excluded therapy|0|||
150094180|NCT00390858|541484875|FG000|Overall Study|Adverse Event|6|||
150094181|NCT00390858|541484876|FG001|Overall Study|Adverse Event|2|||
150094182|NCT00390858|541484875|FG000|Overall Study|Lack of Efficacy|0|||
150094183|NCT00390858|541484876|FG001|Overall Study|Lack of Efficacy|1|||
150094184|NCT00390858|541484875|FG000|Overall Study|Withdrawal by Subject|3|||
150094185|NCT00390858|541484876|FG001|Overall Study|Withdrawal by Subject|4|||
150094186|NCT00450450|541484880|FG000|Overall Study|Death|1|||
150094187|NCT00450450|541484881|FG001|Overall Study|Death|3|||
150094188|NCT00450450|541484880|FG000|Overall Study|Relapse|2|||
150094189|NCT00450450|541484881|FG001|Overall Study|Relapse|0|||
150094190|NCT00450450|541484880|FG000|Overall Study|Missing Data|2|||
150094191|NCT00450450|541484881|FG001|Overall Study|Missing Data|0|||
150094192|NCT02024867|541484884|FG000|Overall Study|Protocol Violation|3|||
150094193|NCT02024867|541484885|FG001|Overall Study|Protocol Violation|3|||
150094194|NCT02024867|541484884|FG000|Overall Study|Lost to Follow-up|6|||
150094195|NCT02024867|541484885|FG001|Overall Study|Lost to Follow-up|4|||
150094196|NCT02865187|541484886|FG000|Overall Study|Lost to Follow-up|12|||
150094197|NCT02865187|541484887|FG001|Overall Study|Lost to Follow-up|7|||
150094198|NCT02865187|541484886|FG000|Overall Study|Adverse Event|1|||
150094199|NCT02865187|541484887|FG001|Overall Study|Adverse Event|0|||
150094200|NCT04267133|541484888|FG000|Overall Study|Withdrawal by Subject|1|||
150094201|NCT04267133|541484888|FG000|Overall Study|Adverse Event|4|||
150094202|NCT01110707|541484889|FG000|Overall Study|Protocol Violation|0|||
150094203|NCT01110707|541484890|FG001|Overall Study|Protocol Violation|3|||
150094204|NCT00003901|541484896|FG000|Overall Study|Adverse Event|1|||
150094205|NCT00003901|541484896|FG000|Overall Study|Withdrawal by Subject|1|||
150094206|NCT00003901|541484896|FG000|Overall Study|Ineligible|6|||
150094207|NCT00003901|541484896|FG000|Overall Study|CT Scan not within protocol requirement|2|||
150094208|NCT00003901|541484896|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
150094209|NCT00003901|541484896|FG000|Overall Study|Medical problems|6|||
150094210|NCT02268864|541484898|FG000|Overall Study|Withdrawal by Subject|2|||
150094211|NCT02268864|541484899|FG001|Overall Study|Withdrawal by Subject|0|||
150094212|NCT02268864|541484900|FG002|Overall Study|Withdrawal by Subject|0|||
150094213|NCT02268864|541484898|FG000|Overall Study|Death|0|||
150094214|NCT02268864|541484899|FG001|Overall Study|Death|1|||
150094215|NCT02268864|541484900|FG002|Overall Study|Death|0|||
150094216|NCT02612428|541484903|FG000|VTL-308|Death|14|||
150094217|NCT02612428|541484904|FG001|VTL-308|Death|16|||
150094218|NCT02612428|541484903|FG000|VTL-308|Withdrawal by Subject|0|||
150094219|NCT02612428|541484904|FG001|VTL-308|Withdrawal by Subject|1|||
150094220|NCT02612428|541484903|FG000|VTL-308E|Death|9|||
150094221|NCT02612428|541484904|FG001|VTL-308E|Death|7|||
150094222|NCT02612428|541484903|FG000|VTL-308E|Lost to Follow-up|2|||
150094223|NCT02612428|541484904|FG001|VTL-308E|Lost to Follow-up|0|||
150094224|NCT02141997|541484906|FG000|Overall Study|Adverse Event|0|||
150094225|NCT02141997|541484907|FG001|Overall Study|Adverse Event|2|||
150094226|NCT02141997|541484908|FG002|Overall Study|Adverse Event|0|||
150094227|NCT02141997|541484909|FG003|Overall Study|Adverse Event|1|||
150094228|NCT02141997|541484906|FG000|Overall Study|Participant noncompliance|1|||
150094229|NCT02141997|541484907|FG001|Overall Study|Participant noncompliance|0|||
150094230|NCT02141997|541484908|FG002|Overall Study|Participant noncompliance|0|||
150094231|NCT02141997|541484909|FG003|Overall Study|Participant noncompliance|0|||
150094232|NCT02141997|541484906|FG000|Overall Study|Withdrew consent|1|||
150094233|NCT02141997|541484907|FG001|Overall Study|Withdrew consent|0|||
150094234|NCT02141997|541484908|FG002|Overall Study|Withdrew consent|3|||
150094235|NCT02141997|541484909|FG003|Overall Study|Withdrew consent|0|||
150094236|NCT02141997|541484906|FG000|Overall Study|Other|1|||
150094237|NCT02141997|541484907|FG001|Overall Study|Other|4|||
150094238|NCT02141997|541484908|FG002|Overall Study|Other|0|||
150094239|NCT02141997|541484909|FG003|Overall Study|Other|0|||
150094240|NCT00451321|541484915|FG000|Overall Study|Lost to Follow-up|3|||
150094241|NCT00451321|541484916|FG001|Overall Study|Lost to Follow-up|3|||
150094242|NCT00451321|541484917|FG002|Overall Study|Lost to Follow-up|1|||
150094243|NCT00451321|541484918|FG003|Overall Study|Lost to Follow-up|3|||
150094244|NCT00451321|541484919|FG004|Overall Study|Lost to Follow-up|0|||
150094245|NCT00451321|541484920|FG005|Overall Study|Lost to Follow-up|1|||
150094246|NCT00451321|541484921|FG006|Overall Study|Lost to Follow-up|0|||
150094247|NCT00451321|541484922|FG007|Overall Study|Lost to Follow-up|0|||
150094248|NCT00451321|541484915|FG000|Overall Study|Withdrawal by Subject|3|||
150094249|NCT00451321|541484916|FG001|Overall Study|Withdrawal by Subject|1|||
150094250|NCT00451321|541484917|FG002|Overall Study|Withdrawal by Subject|0|||
150094251|NCT00451321|541484918|FG003|Overall Study|Withdrawal by Subject|4|||
150094252|NCT00451321|541484919|FG004|Overall Study|Withdrawal by Subject|0|||
150094253|NCT00451321|541484920|FG005|Overall Study|Withdrawal by Subject|0|||
150094254|NCT00451321|541484921|FG006|Overall Study|Withdrawal by Subject|0|||
150094255|NCT00451321|541484922|FG007|Overall Study|Withdrawal by Subject|0|||
150094256|NCT00451321|541484915|FG000|Overall Study|Study closed/terminated|1|||
150094257|NCT00451321|541484916|FG001|Overall Study|Study closed/terminated|1|||
150094258|NCT00451321|541484917|FG002|Overall Study|Study closed/terminated|17|||
150094259|NCT00451321|541484918|FG003|Overall Study|Study closed/terminated|5|||
150094260|NCT00451321|541484919|FG004|Overall Study|Study closed/terminated|7|||
150094261|NCT00451321|541484920|FG005|Overall Study|Study closed/terminated|7|||
150094262|NCT00451321|541484921|FG006|Overall Study|Study closed/terminated|5|||
150094263|NCT00451321|541484922|FG007|Overall Study|Study closed/terminated|3|||
150094264|NCT00451321|541484915|FG000|Overall Study|Sponsor decision to amend protocol|0|||
150094265|NCT00451321|541484916|FG001|Overall Study|Sponsor decision to amend protocol|0|||
150094266|NCT00451321|541484917|FG002|Overall Study|Sponsor decision to amend protocol|0|||
150094267|NCT00451321|541484918|FG003|Overall Study|Sponsor decision to amend protocol|0|||
150094268|NCT00451321|541484919|FG004|Overall Study|Sponsor decision to amend protocol|0|||
150094269|NCT00451321|541484920|FG005|Overall Study|Sponsor decision to amend protocol|1|||
150094270|NCT00451321|541484921|FG006|Overall Study|Sponsor decision to amend protocol|1|||
150094271|NCT00451321|541484922|FG007|Overall Study|Sponsor decision to amend protocol|3|||
150094272|NCT00670800|541486292|FG000|Overall Study|2 controls were insulin resistant|0|||
150094273|NCT00670800|541486293|FG001|Overall Study|2 controls were insulin resistant|2|||
150094274|NCT01786629|541486294|FG000|Overall Study|Lack of Efficacy|0|||
150094275|NCT01786629|541486295|FG001|Overall Study|Lack of Efficacy|4|||
150094276|NCT01786629|541486294|FG000|Overall Study|Adverse Event|0|||
150094277|NCT01786629|541486295|FG001|Overall Study|Adverse Event|1|||
150094278|NCT00410761|541486296|FG000|Randomized Treatment Period|Adverse Event|34|||
150094279|NCT00410761|541486297|FG001|Randomized Treatment Period|Adverse Event|3|||
150094280|NCT00410761|541486296|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
150094281|NCT00410761|541486297|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
150094282|NCT00410761|541486296|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
150094283|NCT00410761|541486297|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
150094284|NCT00410761|541486296|FG000|Randomized Treatment Period|Other|69|||
150094285|NCT00410761|541486297|FG001|Randomized Treatment Period|Other|21|||
150094286|NCT00410761|541486296|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
150094287|NCT00410761|541486297|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
150094288|NCT00410761|541486296|FG000|Open-Label Treatment Period|Adverse Event|13|||
150094289|NCT00410761|541486297|FG001|Open-Label Treatment Period|Adverse Event|15|||
150094290|NCT00410761|541486296|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
150094291|NCT00410761|541486297|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
150094292|NCT00410761|541486296|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
150094293|NCT00410761|541486297|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
150094294|NCT00410761|541486296|FG000|Open-Label Treatment Period|Other|18|||
150094295|NCT00410761|541486297|FG001|Open-Label Treatment Period|Other|9|||
150094296|NCT01852942|541486299|FG000|Overall Study|Physician Decision|1|||
150094297|NCT01852942|541486300|FG001|Overall Study|Physician Decision|0|||
150094298|NCT01852942|541486299|FG000|Overall Study|Death|1|||
150094299|NCT01852942|541486300|FG001|Overall Study|Death|1|||
150094300|NCT01852942|541486299|FG000|Overall Study|Withdrawal by Subject|2|||
150094301|NCT01852942|541486300|FG001|Overall Study|Withdrawal by Subject|3|||
150094302|NCT01852942|541486299|FG000|Overall Study|Lost to Follow-up|1|||
150094303|NCT01852942|541486300|FG001|Overall Study|Lost to Follow-up|2|||
150094304|NCT00696696|541486301|FG000|Overall Study|Adverse Event|5|||
150094305|NCT00696696|541486301|FG000|Overall Study|Withdrawal by Subject|8|||
150094306|NCT00696696|541486301|FG000|Overall Study|Physician Decision|2|||
150094307|NCT00696696|541486301|FG000|Overall Study|Death|3|||
150094308|NCT02642614|541486302|FG000|Overall Study|Adverse Event|1|||
150094309|NCT02642614|541486303|FG001|Overall Study|Adverse Event|1|||
150094310|NCT02642614|541486304|FG002|Overall Study|Adverse Event|2|||
150094311|NCT02642614|541486305|FG003|Overall Study|Adverse Event|2|||
150094312|NCT02642614|541486302|FG000|Overall Study|Lost to Follow-up|1|||
150094313|NCT02642614|541486303|FG001|Overall Study|Lost to Follow-up|0|||
150094314|NCT02642614|541486304|FG002|Overall Study|Lost to Follow-up|0|||
150094315|NCT02642614|541486305|FG003|Overall Study|Lost to Follow-up|0|||
150094316|NCT02642614|541486302|FG000|Overall Study|Withdrawal by Subject|1|||
150094317|NCT02642614|541486303|FG001|Overall Study|Withdrawal by Subject|1|||
150094318|NCT02642614|541486304|FG002|Overall Study|Withdrawal by Subject|0|||
150094319|NCT02642614|541486305|FG003|Overall Study|Withdrawal by Subject|0|||
150094320|NCT01485640|541486306|FG000|Overall Study|Adverse Event|10|||
150094321|NCT01485640|541486306|FG000|Overall Study|Lack of Efficacy|2|||
150094322|NCT01485640|541486306|FG000|Overall Study|Protocol Violation|1|||
150094323|NCT01485640|541486306|FG000|Overall Study|Withdrawal by Subject|14|||
150094324|NCT01485640|541486306|FG000|Overall Study|Terminated by Sponsor|95|||
150094325|NCT02489344|541486310|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
150094326|NCT02489344|541486310|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
150094327|NCT02489344|541486310|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
150094328|NCT02489344|541486310|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
150094329|NCT00605813|541486311|FG000|Overall Study|Protocol Violation|25|||
150094330|NCT00573755|541486316|FG000|Overall Study|Still receiving treatment|1|||
150094331|NCT00573755|541486317|FG001|Overall Study|Still receiving treatment|0|||
150094332|NCT01870583|541486322|FG000|Overall Study|Protocol Violation|0|||
150094333|NCT01870583|541486323|FG001|Overall Study|Protocol Violation|5|||
150094334|NCT01870583|541486324|FG002|Overall Study|Protocol Violation|3|||
150094335|NCT01870583|541486322|FG000|Overall Study|Lost to Follow-up|11|||
150094336|NCT01870583|541486323|FG001|Overall Study|Lost to Follow-up|13|||
150094337|NCT01870583|541486324|FG002|Overall Study|Lost to Follow-up|5|||
150094338|NCT00674661|541486329|FG000|Overall Study|Other|5|||
150094339|NCT00674661|541486330|FG001|Overall Study|Other|7|||
150094340|NCT00674661|541486329|FG000|Overall Study|Lost to Follow-up|6|||
150094341|NCT00674661|541486330|FG001|Overall Study|Lost to Follow-up|3|||
150094342|NCT00674661|541486329|FG000|Overall Study|Withdrawal by Subject|0|||
150094343|NCT00674661|541486330|FG001|Overall Study|Withdrawal by Subject|5|||
150094344|NCT02064166|541486331|FG000|Overall Study|Adverse Event|1|||
150094345|NCT02064166|541486332|FG001|Overall Study|Adverse Event|0|||
150094346|NCT00597766|541486337|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
150094347|NCT00597766|541486338|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
150094348|NCT00597766|541486339|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
150094349|NCT00597766|541486337|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
150094350|NCT00597766|541486338|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
150094351|NCT00597766|541486339|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
150094352|NCT01166763|541486341|FG000|Overall Study|Withdrawal by Subject|3|||
150094353|NCT01909479|541486342|FG000|From Baseline to Week 26|Adverse Event|3|||
150094354|NCT01909479|541486343|FG001|From Baseline to Week 26|Adverse Event|2|||
150094355|NCT01909479|541486342|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
150094356|NCT01909479|541486343|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
150094357|NCT01909479|541486342|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
150094358|NCT01909479|541486343|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
150094359|NCT01909479|541486342|FG000|26 - 52 Weeks|Adverse Event|0|||
150094360|NCT01909479|541486343|FG001|26 - 52 Weeks|Adverse Event|1|||
150094361|NCT01909479|541486342|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
150094362|NCT01909479|541486343|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
150094363|NCT01909479|541486342|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
150094364|NCT01909479|541486343|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
150094365|NCT01909479|541486342|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
150094366|NCT01909479|541486343|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
150094367|NCT01909479|541486342|FG000|52 Weeks to End of Study|Adverse Event|2|||
150094368|NCT01909479|541486343|FG001|52 Weeks to End of Study|Adverse Event|1|||
150094369|NCT01909479|541486342|FG000|52 Weeks to End of Study|Death|0|||
150094370|NCT01909479|541486343|FG001|52 Weeks to End of Study|Death|1|||
150094371|NCT01909479|541486342|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
150094372|NCT01909479|541486343|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
150094373|NCT01909479|541486342|FG000|52 Weeks to End of Study|Protocol Violation|1|||
150094374|NCT01909479|541486343|FG001|52 Weeks to End of Study|Protocol Violation|0|||
150094375|NCT01909479|541486342|FG000|52 Weeks to End of Study|Progressive disease|1|||
150094376|NCT01909479|541486343|FG001|52 Weeks to End of Study|Progressive disease|1|||
150094377|NCT01909479|541486342|FG000|52 Weeks to End of Study|Personal reasons|2|||
150094378|NCT01909479|541486343|FG001|52 Weeks to End of Study|Personal reasons|1|||
150094379|NCT01909479|541486342|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
150094380|NCT01909479|541486343|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
150094381|NCT01909479|541486342|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
150094382|NCT01909479|541486343|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
150094383|NCT01909479|541486342|FG000|52 Weeks to End of Study|Lack of contact|1|||
150094384|NCT01909479|541486343|FG001|52 Weeks to End of Study|Lack of contact|0|||
150094385|NCT01909479|541486342|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
150094386|NCT01909479|541486343|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
150094387|NCT01909479|541486342|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
150094388|NCT01909479|541486343|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
150094389|NCT00383149|541486345|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
150094390|NCT00383149|541486345|FG000|Overall Study|Death|2|||
150094391|NCT00383149|541486345|FG000|Overall Study|Disease Progression|38|||
150094392|NCT00383149|541486345|FG000|Overall Study|Lost to Follow-up|1|||
150094393|NCT00383149|541486345|FG000|Overall Study|Other|1|||
150094394|NCT00383149|541486345|FG000|Overall Study|Study Drug Toxicity|4|||
150094395|NCT00383149|541486345|FG000|Overall Study|Request to Discontinue Treatment|4|||
150094396|NCT00383149|541486345|FG000|Overall Study|Participant Withdrew Consent|1|||
150094397|NCT03721276|541486348|FG000|Overall Study|Lost to Follow-up|5|||
150184662|NCT04218266|541813405|FG000|Overall Study|Study drug never administered|2|||
150184663|NCT04218266|541813406|FG001|Overall Study|Study drug never administered|0|||
150184664|NCT04218266|541813407|FG002|Overall Study|Study drug never administered|0|||
150184665|NCT01011946|541813409|FG000|Overall Study|Transferred to another hospital|2|||
150184666|NCT01011946|541813409|FG000|Overall Study|No pathological lab value|1|||
150184667|NCT01227265|541813411|FG000|Overall Study|Did Not Receive Treatment|1|||
150184668|NCT01227265|541813412|FG001|Overall Study|Did Not Receive Treatment|2|||
150184669|NCT01227265|541813413|FG002|Overall Study|Did Not Receive Treatment|0|||
150184670|NCT01227265|541813411|FG000|Overall Study|Administrative|1|||
150184671|NCT01227265|541813412|FG001|Overall Study|Administrative|0|||
150184672|NCT01227265|541813413|FG002|Overall Study|Administrative|2|||
150184673|NCT01227265|541813411|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
150184674|NCT01227265|541813412|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
150184675|NCT01227265|541813413|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
150184676|NCT01227265|541813411|FG000|Overall Study|Protocol Violation|2|||
150184677|NCT01227265|541813412|FG001|Overall Study|Protocol Violation|1|||
150184678|NCT01227265|541813413|FG002|Overall Study|Protocol Violation|0|||
150184679|NCT01227265|541813411|FG000|Overall Study|Withdrawal by Subject|7|||
150184680|NCT01227265|541813412|FG001|Overall Study|Withdrawal by Subject|7|||
150184681|NCT01227265|541813413|FG002|Overall Study|Withdrawal by Subject|3|||
150184682|NCT01227265|541813411|FG000|Overall Study|Lost to Follow-up|2|||
150184683|NCT01227265|541813412|FG001|Overall Study|Lost to Follow-up|0|||
150184684|NCT01227265|541813413|FG002|Overall Study|Lost to Follow-up|3|||
150184685|NCT01227265|541813411|FG000|Overall Study|Adverse Event|6|||
150184686|NCT01227265|541813412|FG001|Overall Study|Adverse Event|10|||
150184687|NCT01227265|541813413|FG002|Overall Study|Adverse Event|5|||
150184688|NCT04623775|541813414|FG000|Randomization|No Longer Meets Study Criteria|2|||
150184689|NCT04623775|541813415|FG001|Randomization|No Longer Meets Study Criteria|1|||
150184690|NCT04623775|541813416|FG002|Randomization|No Longer Meets Study Criteria|0|||
150184691|NCT04623775|541813417|FG003|Randomization|No Longer Meets Study Criteria|0|||
150184692|NCT04623775|541813414|FG000|Randomization|Withdrew Consent|0|||
150029327|NCT04612725|541242642|FG002|Overall Study|Adverse Event|1|||
150029328|NCT04612725|541242643|FG003|Overall Study|Adverse Event|0|||
150029329|NCT04612725|541242644|FG004|Overall Study|Adverse Event|1|||
150029330|NCT04612725|541242640|FG000|Overall Study|Lost to Follow-up|0|||
150029331|NCT04612725|541242641|FG001|Overall Study|Lost to Follow-up|1|||
150029332|NCT04612725|541242642|FG002|Overall Study|Lost to Follow-up|0|||
150029333|NCT04612725|541242643|FG003|Overall Study|Lost to Follow-up|0|||
150029334|NCT04612725|541242644|FG004|Overall Study|Lost to Follow-up|0|||
150029335|NCT04612725|541242640|FG000|Overall Study|Physician Decision|2|||
150029336|NCT04612725|541242641|FG001|Overall Study|Physician Decision|0|||
150029337|NCT04612725|541242642|FG002|Overall Study|Physician Decision|0|||
150029338|NCT04612725|541242643|FG003|Overall Study|Physician Decision|0|||
150029339|NCT04612725|541242644|FG004|Overall Study|Physician Decision|0|||
150029340|NCT04612725|541242640|FG000|Overall Study|Study terminated by sponsor|3|||
150029341|NCT04612725|541242641|FG001|Overall Study|Study terminated by sponsor|1|||
150029342|NCT04612725|541242642|FG002|Overall Study|Study terminated by sponsor|2|||
150029343|NCT04612725|541242643|FG003|Overall Study|Study terminated by sponsor|4|||
150029344|NCT04612725|541242644|FG004|Overall Study|Study terminated by sponsor|5|||
150029345|NCT04612725|541242640|FG000|Overall Study|Withdrawal by Subject|8|||
150029346|NCT04612725|541242641|FG001|Overall Study|Withdrawal by Subject|3|||
150029347|NCT04612725|541242642|FG002|Overall Study|Withdrawal by Subject|5|||
150029348|NCT04612725|541242643|FG003|Overall Study|Withdrawal by Subject|1|||
150029349|NCT04612725|541242644|FG004|Overall Study|Withdrawal by Subject|9|||
150029350|NCT04612725|541242640|FG000|Overall Study|Other|0|||
150029351|NCT04612725|541242641|FG001|Overall Study|Other|0|||
150029352|NCT04612725|541242642|FG002|Overall Study|Other|0|||
150184693|NCT04623775|541813415|FG001|Randomization|Withdrew Consent|0|||
150184694|NCT04623775|541813416|FG002|Randomization|Withdrew Consent|0|||
150184695|NCT04623775|541813417|FG003|Randomization|Withdrew Consent|1|||
150184696|NCT04623775|541813414|FG000|Randomization|Other Reasons|0|||
150184697|NCT04623775|541813415|FG001|Randomization|Other Reasons|0|||
150184698|NCT04623775|541813416|FG002|Randomization|Other Reasons|0|||
150184699|NCT04623775|541813417|FG003|Randomization|Other Reasons|1|||
150184700|NCT04623775|541813414|FG000|Treatment Period|participant withdrew consent|4|||
150184701|NCT04623775|541813415|FG001|Treatment Period|participant withdrew consent|0|||
150184702|NCT04623775|541813416|FG002|Treatment Period|participant withdrew consent|1|||
150184703|NCT04623775|541813417|FG003|Treatment Period|participant withdrew consent|2|||
150184704|NCT04623775|541813414|FG000|Treatment Period|Death|3|||
150184705|NCT04623775|541813415|FG001|Treatment Period|Death|1|||
150184706|NCT04623775|541813416|FG002|Treatment Period|Death|4|||
150184707|NCT04623775|541813417|FG003|Treatment Period|Death|2|||
150184708|NCT04623775|541813414|FG000|Treatment Period|Lost to Follow-up|0|||
150184709|NCT04623775|541813415|FG001|Treatment Period|Lost to Follow-up|2|||
150184710|NCT04623775|541813416|FG002|Treatment Period|Lost to Follow-up|0|||
150184711|NCT04623775|541813417|FG003|Treatment Period|Lost to Follow-up|0|||
150184712|NCT04623775|541813414|FG000|Treatment Period|poor/non compliance|0|||
150184713|NCT04623775|541813415|FG001|Treatment Period|poor/non compliance|0|||
150094398|NCT03721276|541486349|FG001|Overall Study|Lost to Follow-up|3|||
150094399|NCT03721276|541486348|FG000|Overall Study|Adverse Event|0|||
150094400|NCT03721276|541486349|FG001|Overall Study|Adverse Event|1|||
150094401|NCT01340898|541486352|FG000|Primary Phase|Serious Adverse Events|0|||
150094402|NCT01340898|541486353|FG001|Primary Phase|Serious Adverse Events|0|||
150094403|NCT01340898|541486354|FG002|Primary Phase|Serious Adverse Events|1|||
150094404|NCT01340898|541486352|FG000|Primary Phase|Withdrawal by Subject|8|||
150094405|NCT01340898|541486353|FG001|Primary Phase|Withdrawal by Subject|7|||
150094406|NCT01340898|541486354|FG002|Primary Phase|Withdrawal by Subject|5|||
150094407|NCT01340898|541486352|FG000|Primary Phase|Migrated/moved from study area|4|||
150094408|NCT01340898|541486353|FG001|Primary Phase|Migrated/moved from study area|1|||
150094409|NCT01340898|541486354|FG002|Primary Phase|Migrated/moved from study area|0|||
150094410|NCT01340898|541486352|FG000|Primary Phase|Lost to Follow-up|4|||
150094411|NCT01340898|541486353|FG001|Primary Phase|Lost to Follow-up|1|||
150094412|NCT01340898|541486354|FG002|Primary Phase|Lost to Follow-up|0|||
150094413|NCT01340898|541486352|FG000|Booster Phase|Withdrawal by Subject|3|||
150094414|NCT01340898|541486353|FG001|Booster Phase|Withdrawal by Subject|0|||
150094415|NCT01340898|541486354|FG002|Booster Phase|Withdrawal by Subject|4|||
150094416|NCT01340898|541486352|FG000|Booster Phase|Migrated/moved from study area|3|||
150094417|NCT01340898|541486353|FG001|Booster Phase|Migrated/moved from study area|0|||
150094418|NCT01340898|541486354|FG002|Booster Phase|Migrated/moved from study area|0|||
150094419|NCT01340898|541486352|FG000|Booster Phase|Lost to Follow-up|4|||
150094420|NCT01340898|541486353|FG001|Booster Phase|Lost to Follow-up|2|||
150094421|NCT01340898|541486354|FG002|Booster Phase|Lost to Follow-up|3|||
150094422|NCT02375113|541486356|FG000|Overall Study|Undisclosed Reason(s).|1|||
150094423|NCT02375113|541486357|FG001|Overall Study|Undisclosed Reason(s).|1|||
150094424|NCT02375113|541486356|FG000|Overall Study|Poor adherence (<70%).|1|||
150094425|NCT02375113|541486357|FG001|Overall Study|Poor adherence (<70%).|0|||
150094426|NCT02375113|541486356|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
150094427|NCT02375113|541486357|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
150094428|NCT01214629|541486358|FG000|Overall Study|Progressive Disease|1|||
150094429|NCT01214629|541486359|FG001|Overall Study|Progressive Disease|1|||
150094430|NCT01214629|541486360|FG002|Overall Study|Progressive Disease|0|||
150094431|NCT01214629|541486361|FG003|Overall Study|Progressive Disease|1|||
150094432|NCT01214629|541486362|FG004|Overall Study|Progressive Disease|2|||
150094433|NCT01214629|541486363|FG005|Overall Study|Progressive Disease|3|||
150184714|NCT04623775|541813416|FG002|Treatment Period|poor/non compliance|1|||
150094434|NCT01214629|541486364|FG006|Overall Study|Progressive Disease|1|||
150094435|NCT01214629|541486365|FG007|Overall Study|Progressive Disease|1|||
150184715|NCT04623775|541813417|FG003|Treatment Period|poor/non compliance|0|||
150184716|NCT04623775|541813414|FG000|Treatment Period|participant no longer meets study criteria|0|||
150184717|NCT04623775|541813415|FG001|Treatment Period|participant no longer meets study criteria|1|||
150184718|NCT04623775|541813416|FG002|Treatment Period|participant no longer meets study criteria|0|||
150184719|NCT04623775|541813417|FG003|Treatment Period|participant no longer meets study criteria|0|||
150184720|NCT04623775|541813414|FG000|Treatment Period|administrative reasons by sponsor|3|||
150184721|NCT04623775|541813415|FG001|Treatment Period|administrative reasons by sponsor|2|||
150184722|NCT04623775|541813416|FG002|Treatment Period|administrative reasons by sponsor|0|||
150184723|NCT04623775|541813417|FG003|Treatment Period|administrative reasons by sponsor|0|||
150184724|NCT04623775|541813414|FG000|Treatment Period|other reasons|2|||
150184725|NCT04623775|541813415|FG001|Treatment Period|other reasons|0|||
150094436|NCT01214629|541486366|FG008|Overall Study|Progressive Disease|1|||
150094437|NCT01214629|541486367|FG009|Overall Study|Progressive Disease|5|||
150094438|NCT01214629|541486368|FG010|Overall Study|Progressive Disease|1|||
150094439|NCT01214629|541486358|FG000|Overall Study|Adverse Event|0|||
150094440|NCT01214629|541486359|FG001|Overall Study|Adverse Event|0|||
150094441|NCT01214629|541486360|FG002|Overall Study|Adverse Event|0|||
150094442|NCT01214629|541486361|FG003|Overall Study|Adverse Event|1|||
150094443|NCT01214629|541486362|FG004|Overall Study|Adverse Event|0|||
150094444|NCT01214629|541486363|FG005|Overall Study|Adverse Event|1|||
150094445|NCT01214629|541486364|FG006|Overall Study|Adverse Event|0|||
150094446|NCT01214629|541486365|FG007|Overall Study|Adverse Event|0|||
150094447|NCT01214629|541486366|FG008|Overall Study|Adverse Event|0|||
150094448|NCT01214629|541486367|FG009|Overall Study|Adverse Event|1|||
150094449|NCT01214629|541486368|FG010|Overall Study|Adverse Event|0|||
150094450|NCT01214629|541486358|FG000|Overall Study|Physician Decision|0|||
150094451|NCT01214629|541486359|FG001|Overall Study|Physician Decision|0|||
150094452|NCT01214629|541486360|FG002|Overall Study|Physician Decision|0|||
150094453|NCT01214629|541486361|FG003|Overall Study|Physician Decision|0|||
150184726|NCT04623775|541813416|FG002|Treatment Period|other reasons|1|||
150184727|NCT04623775|541813417|FG003|Treatment Period|other reasons|1|||
150184728|NCT04623775|541813414|FG000|Treatment Period|disease progression|40|||
150184729|NCT04623775|541813415|FG001|Treatment Period|disease progression|35|||
150184730|NCT04623775|541813416|FG002|Treatment Period|disease progression|63|||
150184731|NCT04623775|541813417|FG003|Treatment Period|disease progression|63|||
150184732|NCT04623775|541813414|FG000|Treatment Period|study drug toxicity|12|||
150184733|NCT04623775|541813415|FG001|Treatment Period|study drug toxicity|15|||
150094454|NCT01214629|541486362|FG004|Overall Study|Physician Decision|0|||
150094455|NCT01214629|541486363|FG005|Overall Study|Physician Decision|0|||
150094456|NCT01214629|541486364|FG006|Overall Study|Physician Decision|0|||
150094457|NCT01214629|541486365|FG007|Overall Study|Physician Decision|0|||
150094458|NCT01214629|541486366|FG008|Overall Study|Physician Decision|0|||
150094459|NCT01214629|541486367|FG009|Overall Study|Physician Decision|0|||
150094460|NCT01214629|541486368|FG010|Overall Study|Physician Decision|1|||
150094461|NCT01214629|541486358|FG000|Overall Study|Withdrawal by Subject|0|||
150094462|NCT01214629|541486359|FG001|Overall Study|Withdrawal by Subject|0|||
150094463|NCT01214629|541486360|FG002|Overall Study|Withdrawal by Subject|0|||
150094464|NCT01214629|541486361|FG003|Overall Study|Withdrawal by Subject|0|||
150094465|NCT01214629|541486362|FG004|Overall Study|Withdrawal by Subject|0|||
150094466|NCT01214629|541486363|FG005|Overall Study|Withdrawal by Subject|0|||
150094467|NCT01214629|541486364|FG006|Overall Study|Withdrawal by Subject|0|||
150094468|NCT01214629|541486365|FG007|Overall Study|Withdrawal by Subject|0|||
150094469|NCT01214629|541486366|FG008|Overall Study|Withdrawal by Subject|0|||
150094470|NCT01214629|541486367|FG009|Overall Study|Withdrawal by Subject|1|||
150094471|NCT01214629|541486368|FG010|Overall Study|Withdrawal by Subject|0|||
150094472|NCT00877383|541486373|FG000|Overall Study|Adverse Event|13|||
150094473|NCT00877383|541486374|FG001|Overall Study|Adverse Event|14|||
150094474|NCT00877383|541486373|FG000|Overall Study|Lost to Follow-up|5|||
150094475|NCT00877383|541486374|FG001|Overall Study|Lost to Follow-up|3|||
150094476|NCT00877383|541486373|FG000|Overall Study|Subject withdrew consent|3|||
150094477|NCT00877383|541486374|FG001|Overall Study|Subject withdrew consent|12|||
150094478|NCT00877383|541486373|FG000|Overall Study|Subject no longer requires study drug|2|||
150094479|NCT00877383|541486374|FG001|Overall Study|Subject no longer requires study drug|0|||
150094480|NCT00877383|541486373|FG000|Overall Study|Administrative problems|2|||
150094481|NCT00877383|541486374|FG001|Overall Study|Administrative problems|0|||
150094482|NCT00877383|541486373|FG000|Overall Study|Protocol deviation|2|||
150094483|NCT00877383|541486374|FG001|Overall Study|Protocol deviation|6|||
150094484|NCT00877383|541486373|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150094485|NCT00877383|541486374|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150094486|NCT00877383|541486373|FG000|Overall Study|Death|1|||
150094487|NCT00877383|541486374|FG001|Overall Study|Death|2|||
150094488|NCT00459108|541486375|FG000|Overall Study|Withdrawal by Subject|5|||
150094489|NCT00459108|541486375|FG000|Overall Study|Adverse Event|3|||
150094490|NCT00459108|541486375|FG000|Overall Study|Death|2|||
150094491|NCT00459108|541486375|FG000|Overall Study|Progression|1|||
150094492|NCT00416078|541486381|FG000|Overall Study|Death|3|||
150094493|NCT00416078|541486382|FG001|Overall Study|Death|4|||
150094494|NCT00416078|541486381|FG000|Overall Study|Withdrawal by Subject|3|||
150094495|NCT00416078|541486382|FG001|Overall Study|Withdrawal by Subject|2|||
150094496|NCT00416078|541486381|FG000|Overall Study|Physician Decision|1|||
150094497|NCT00416078|541486382|FG001|Overall Study|Physician Decision|0|||
150094498|NCT00416078|541486381|FG000|Overall Study|Lost to Follow-up|4|||
150094499|NCT00416078|541486382|FG001|Overall Study|Lost to Follow-up|2|||
150094500|NCT01705652|541486385|FG000|Overall Study|Adverse Event|1|||
150094501|NCT01705652|541486386|FG001|Overall Study|Adverse Event|0|||
150094502|NCT01705652|541486385|FG000|Overall Study|Withdrawal by Subject|1|||
150094503|NCT01705652|541486386|FG001|Overall Study|Withdrawal by Subject|2|||
150094504|NCT01705652|541486385|FG000|Overall Study|non-compliance|1|||
150094505|NCT01705652|541486386|FG001|Overall Study|non-compliance|1|||
150094506|NCT00656474|541486387|FG000|Overall Study|Other Reason|1|||
150094507|NCT01614067|541486388|FG000|Overall Study|Pregnancy|1|||
150094508|NCT01614067|541486389|FG001|Overall Study|Pregnancy|0|||
150094509|NCT01614067|541486388|FG000|Overall Study|Physician Decision|6|||
150094510|NCT01614067|541486389|FG001|Overall Study|Physician Decision|5|||
150094511|NCT01614067|541486388|FG000|Overall Study|Withdrawal by Subject|0|||
150094512|NCT01614067|541486389|FG001|Overall Study|Withdrawal by Subject|1|||
150094513|NCT01614067|541486388|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
150094514|NCT01614067|541486389|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
150094515|NCT01505868|541486390|FG000|Overall Study|Withdrawal by Subject|1|||
150094516|NCT01505868|541486391|FG001|Overall Study|Withdrawal by Subject|0|||
150094517|NCT01505868|541486392|FG002|Overall Study|Withdrawal by Subject|0|||
150094518|NCT01505868|541486393|FG003|Overall Study|Withdrawal by Subject|0|||
150094519|NCT01505868|541486394|FG004|Overall Study|Withdrawal by Subject|0|||
150094520|NCT02062879|541486395|FG000|Overall Study|Withdrawal by Subject|4|||
150094521|NCT02062879|541486396|FG001|Overall Study|Withdrawal by Subject|1|||
150094522|NCT00056407|541486397|FG000|Overall Study|Adverse Event|282|||
150094523|NCT00056407|541486398|FG001|Overall Study|Adverse Event|364|||
150094524|NCT00056407|541486397|FG000|Overall Study|Withdrawal by Subject|377|||
150094525|NCT00056407|541486398|FG001|Overall Study|Withdrawal by Subject|361|||
150094526|NCT00056407|541486397|FG000|Overall Study|Lost to Follow-up|123|||
150094527|NCT00056407|541486398|FG001|Overall Study|Lost to Follow-up|113|||
150094528|NCT00056407|541486397|FG000|Overall Study|Protocol Violation|104|||
150094529|NCT00056407|541486398|FG001|Overall Study|Protocol Violation|95|||
150094530|NCT00056407|541486397|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
150184734|NCT04623775|541813416|FG002|Treatment Period|study drug toxicity|13|||
150184735|NCT04623775|541813417|FG003|Treatment Period|study drug toxicity|12|||
150184736|NCT04623775|541813414|FG000|Treatment Period|AE unrelated to study drug|4|||
150094531|NCT00056407|541486398|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
150094532|NCT00056407|541486397|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
150094533|NCT00056407|541486398|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
150094534|NCT00056407|541486397|FG000|Overall Study|Missing|25|||
150094535|NCT00056407|541486398|FG001|Overall Study|Missing|34|||
150094536|NCT00616655|541486399|FG000|Overall Study|Adverse Event|10|||
150094537|NCT00616655|541486400|FG001|Overall Study|Adverse Event|7|||
150094538|NCT00616655|541486401|FG002|Overall Study|Adverse Event|12|||
150094539|NCT00616655|541486399|FG000|Overall Study|Lack of Efficacy|5|||
150094540|NCT00616655|541486400|FG001|Overall Study|Lack of Efficacy|5|||
150094541|NCT00616655|541486401|FG002|Overall Study|Lack of Efficacy|5|||
150094542|NCT00616655|541486399|FG000|Overall Study|Lost to Follow-up|3|||
150094543|NCT00616655|541486400|FG001|Overall Study|Lost to Follow-up|12|||
150094544|NCT00616655|541486401|FG002|Overall Study|Lost to Follow-up|10|||
150094545|NCT00616655|541486399|FG000|Overall Study|Protocol Violation|2|||
150094546|NCT00616655|541486400|FG001|Overall Study|Protocol Violation|4|||
150094547|NCT00616655|541486401|FG002|Overall Study|Protocol Violation|3|||
150094548|NCT00616655|541486399|FG000|Overall Study|Withdrawal by Subject|9|||
150094549|NCT00616655|541486400|FG001|Overall Study|Withdrawal by Subject|7|||
150094550|NCT00616655|541486401|FG002|Overall Study|Withdrawal by Subject|11|||
150094551|NCT00616655|541486399|FG000|Overall Study|Does not meet in/ex criteria|0|||
150094552|NCT00616655|541486400|FG001|Overall Study|Does not meet in/ex criteria|0|||
150094553|NCT00616655|541486401|FG002|Overall Study|Does not meet in/ex criteria|2|||
150094554|NCT00616655|541486399|FG000|Overall Study|Other|6|||
150094555|NCT00616655|541486400|FG001|Overall Study|Other|6|||
150094556|NCT00616655|541486401|FG002|Overall Study|Other|5|||
150094557|NCT03761147|541486402|FG000|Overall Study|Withdrawal by Subject|6|||
150094558|NCT03761147|541486403|FG001|Overall Study|Withdrawal by Subject|1|||
150094559|NCT03761147|541486402|FG000|Overall Study|Adverse Event|1|||
150094560|NCT03761147|541486403|FG001|Overall Study|Adverse Event|3|||
150094561|NCT00309842|541486404|FG000|Overall Study|Lost to Follow-up|1|||
150094562|NCT01026792|541486405|FG000|Overall Study|Protocol Violation|1|||
150094563|NCT00492115|541486407|FG000|Overall Study|Withdrawal by Subject|3|||
150094564|NCT00492115|541486408|FG001|Overall Study|Withdrawal by Subject|4|||
150094565|NCT03564145|541486411|FG000|Overall Study|Adverse Event|4|||
150094566|NCT03564145|541486411|FG000|Overall Study|Lost to Follow-up|21|||
150094567|NCT03564145|541486411|FG000|Overall Study|Protocol Violation|2|||
150094568|NCT03564145|541486411|FG000|Overall Study|Withdrawal by Subject|48|||
150094569|NCT03564145|541486411|FG000|Overall Study|Study Terminated by Sponsor|146|||
150094570|NCT03564145|541486411|FG000|Overall Study|Physician Decision|1|||
150094571|NCT03564145|541486411|FG000|Overall Study|Other Than Specified|1|||
150094572|NCT03564145|541486411|FG000|Overall Study|Pregnancy|1|||
150094573|NCT02045797|541486412|FG000|Overall Study|Adverse Event|3|||
150094574|NCT02045797|541486413|FG001|Overall Study|Adverse Event|1|||
150094575|NCT02045797|541486414|FG002|Overall Study|Adverse Event|0|||
150094576|NCT02045797|541486412|FG000|Overall Study|Lack of Efficacy|1|||
150094577|NCT02045797|541486413|FG001|Overall Study|Lack of Efficacy|0|||
150094578|NCT02045797|541486414|FG002|Overall Study|Lack of Efficacy|0|||
150094579|NCT02045797|541486412|FG000|Overall Study|Lost to Follow-up|2|||
150094580|NCT02045797|541486413|FG001|Overall Study|Lost to Follow-up|3|||
150094581|NCT02045797|541486414|FG002|Overall Study|Lost to Follow-up|1|||
150094582|NCT02045797|541486412|FG000|Overall Study|Physician Decision|0|||
150094583|NCT02045797|541486413|FG001|Overall Study|Physician Decision|1|||
150094584|NCT02045797|541486414|FG002|Overall Study|Physician Decision|0|||
150094585|NCT02045797|541486412|FG000|Overall Study|Withdrawal by Subject|1|||
150094586|NCT02045797|541486413|FG001|Overall Study|Withdrawal by Subject|2|||
150094587|NCT02045797|541486414|FG002|Overall Study|Withdrawal by Subject|0|||
150094588|NCT00353262|541486417|FG000|Overall Study|Adverse Event|8|||
150094589|NCT00353262|541486417|FG000|Overall Study|Withdrawal by Subject|2|||
150184737|NCT04623775|541813415|FG001|Treatment Period|AE unrelated to study drug|9|||
150184738|NCT04623775|541813416|FG002|Treatment Period|AE unrelated to study drug|12|||
150184739|NCT04623775|541813417|FG003|Treatment Period|AE unrelated to study drug|9|||
150184740|NCT04623775|541813414|FG000|Treatment Period|participant request to discontinue treatment|0|||
150094590|NCT00353262|541486417|FG000|Overall Study|Insufficient Therapeutic Response|13|||
150094591|NCT00353262|541486417|FG000|Overall Study|Progression|1|||
150094592|NCT00353262|541486417|FG000|Overall Study|Surgery|4|||
150094593|NCT00353262|541486417|FG000|Overall Study|Break from Chemotherapy|1|||
150094594|NCT05286307|541486418|FG000|Overall Study|Incomplete outcome assessments|2|||
150094595|NCT05286307|541486419|FG001|Overall Study|Incomplete outcome assessments|1|||
150094596|NCT05286307|541486418|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
150094597|NCT05286307|541486419|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
150094598|NCT05286307|541486418|FG000|Overall Study|Lost to follow up at 6 months|25|||
150094599|NCT05286307|541486419|FG001|Overall Study|Lost to follow up at 6 months|35|||
150184741|NCT04623775|541813415|FG001|Treatment Period|participant request to discontinue treatment|2|||
150184742|NCT04623775|541813416|FG002|Treatment Period|participant request to discontinue treatment|2|||
150184743|NCT04623775|541813417|FG003|Treatment Period|participant request to discontinue treatment|0|||
150184744|NCT01959698|541813418|FG000|Overall Study|Adverse Event|0|||
150184745|NCT01959698|541813419|FG001|Overall Study|Adverse Event|0|||
150184746|NCT01959698|541813420|FG002|Overall Study|Adverse Event|0|||
150184747|NCT01959698|541813421|FG003|Overall Study|Adverse Event|0|||
150184748|NCT01959698|541813422|FG004|Overall Study|Adverse Event|0|||
150184749|NCT01959698|541813423|FG005|Overall Study|Adverse Event|0|||
150184750|NCT01959698|541813424|FG006|Overall Study|Adverse Event|1|||
150184751|NCT01959698|541813418|FG000|Overall Study|Physician Decision|1|||
150184752|NCT01959698|541813419|FG001|Overall Study|Physician Decision|0|||
150184753|NCT01959698|541813420|FG002|Overall Study|Physician Decision|1|||
150184754|NCT01959698|541813421|FG003|Overall Study|Physician Decision|2|||
150184755|NCT01959698|541813422|FG004|Overall Study|Physician Decision|0|||
150184756|NCT01959698|541813423|FG005|Overall Study|Physician Decision|3|||
150184757|NCT01959698|541813424|FG006|Overall Study|Physician Decision|3|||
150184758|NCT02396199|541814435|FG000|Overall Study|Lost to Follow-up|1|||
150184759|NCT02396199|541814435|FG000|Overall Study|Death|4|||
150184760|NCT04112316|541814436|FG000|First Period (8 Weeks)|Protocol Violation|1|||
150184761|NCT04112316|541814437|FG001|First Period (8 Weeks)|Protocol Violation|0|||
150184762|NCT04112316|541814436|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
150184763|NCT04112316|541814437|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
150184764|NCT02597946|541814447|FG000|Overall Study|Withdrawal by Subject|1|||
150184765|NCT02597946|541814447|FG000|Overall Study|Progressive disease|16|||
150184766|NCT02597946|541814447|FG000|Overall Study|Other than above|1|||
150184767|NCT04178733|541814464|FG000|Overall Study|Investigator Decision|0|||
150184768|NCT04178733|541814465|FG001|Overall Study|Investigator Decision|0|||
150184769|NCT04178733|541814466|FG002|Overall Study|Investigator Decision|0|||
150184770|NCT04178733|541814467|FG003|Overall Study|Investigator Decision|1|||
150184771|NCT04178733|541814468|FG004|Overall Study|Investigator Decision|2|||
150184772|NCT04437433|541814472|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
150184773|NCT04437433|541814473|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
150184774|NCT04437433|541814472|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
150184775|NCT04437433|541814473|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
150184776|NCT04437433|541814472|FG000|Overall Study|Adverse Event|9|||
150184777|NCT04437433|541814473|FG001|Overall Study|Adverse Event|0|||
150184778|NCT04437433|541814472|FG000|Overall Study|Lack of Efficacy|4|||
150184779|NCT04437433|541814473|FG001|Overall Study|Lack of Efficacy|0|||
150184780|NCT04437433|541814472|FG000|Overall Study|Withdrawal by Subject|4|||
150184781|NCT04437433|541814473|FG001|Overall Study|Withdrawal by Subject|1|||
150184782|NCT04437433|541814472|FG000|Overall Study|Protocol Deviation|0|||
150184783|NCT04437433|541814473|FG001|Overall Study|Protocol Deviation|1|||
150184784|NCT04437433|541814472|FG000|Overall Study|Other, not specified|0|||
150184785|NCT04437433|541814473|FG001|Overall Study|Other, not specified|1|||
150184786|NCT00611559|541814474|FG000|Overall Study|Lost to Follow-up|0|||
150184787|NCT00611559|541814475|FG001|Overall Study|Lost to Follow-up|1|||
150184788|NCT00611559|541814476|FG002|Overall Study|Lost to Follow-up|0|||
150184789|NCT00611559|541814474|FG000|Overall Study|Protocol Violation|1|||
150184790|NCT00611559|541814475|FG001|Overall Study|Protocol Violation|0|||
150184791|NCT00611559|541814476|FG002|Overall Study|Protocol Violation|1|||
150184792|NCT00879333|541814477|FG000|Overall Study|Adverse Event|94|||
150184793|NCT00879333|541814478|FG001|Overall Study|Adverse Event|34|||
150184794|NCT00879333|541814477|FG000|Overall Study|Abnormal Laboratory Value|1|||
150184795|NCT00879333|541814478|FG001|Overall Study|Abnormal Laboratory Value|0|||
150184796|NCT00879333|541814477|FG000|Overall Study|Withdrawal by Subject|20|||
150184797|NCT00879333|541814478|FG001|Overall Study|Withdrawal by Subject|7|||
150184798|NCT00879333|541814477|FG000|Overall Study|Lost to Follow-up|2|||
150184799|NCT00879333|541814478|FG001|Overall Study|Lost to Follow-up|1|||
150184800|NCT00879333|541814477|FG000|Overall Study|Administrative Problems|2|||
150184801|NCT00879333|541814478|FG001|Overall Study|Administrative Problems|0|||
150184802|NCT00879333|541814477|FG000|Overall Study|Death|16|||
150184803|NCT00879333|541814478|FG001|Overall Study|Death|5|||
150184804|NCT00879333|541814477|FG000|Overall Study|Disease Progression|292|||
150184805|NCT00879333|541814478|FG001|Overall Study|Disease Progression|169|||
150184806|NCT00879333|541814477|FG000|Overall Study|Protocol Violation|1|||
150184807|NCT00879333|541814478|FG001|Overall Study|Protocol Violation|1|||
150094600|NCT05286307|541486418|FG000|Overall Study|Study medication not available|1|||
150094601|NCT05286307|541486419|FG001|Overall Study|Study medication not available|1|||
150094602|NCT04219891|541486422|FG000|Overall Study|Lost to Follow-up|3|||
150094603|NCT04219891|541486422|FG000|Overall Study|Withdrawal by Subject|2|||
150094604|NCT00597012|541486423|FG000|Overall Study|Death|1|||
150094605|NCT00597012|541486424|FG001|Overall Study|Death|1|||
150094606|NCT00597012|541486423|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
150094607|NCT00597012|541486424|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
150094608|NCT00597012|541486423|FG000|Overall Study|Withdrawal by Subject|7|||
150094609|NCT00597012|541486424|FG001|Overall Study|Withdrawal by Subject|4|||
150094610|NCT00597012|541486423|FG000|Overall Study|Ineligible|2|||
150094611|NCT00597012|541486424|FG001|Overall Study|Ineligible|0|||
150094612|NCT00597012|541486423|FG000|Overall Study|Lost to Follow-up|0|||
150094613|NCT00597012|541486424|FG001|Overall Study|Lost to Follow-up|2|||
150094614|NCT03712904|541488104|FG000|Overall Study|Death|0|||
150094615|NCT03712904|541488105|FG001|Overall Study|Death|1|||
150094616|NCT03712904|541488104|FG000|Overall Study|Withdrawal by Subject|0|||
150094617|NCT03712904|541488105|FG001|Overall Study|Withdrawal by Subject|1|||
150094618|NCT03712904|541488104|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
150094619|NCT03712904|541488105|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
150094620|NCT03525574|541488111|FG000|Overall Study|Adverse Event|15|||
150094621|NCT03525574|541488112|FG001|Overall Study|Adverse Event|0|||
150094622|NCT03525574|541488111|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
150094623|NCT03525574|541488112|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
150094624|NCT03525574|541488111|FG000|Overall Study|Lost to Follow-up|4|||
150094625|NCT03525574|541488112|FG001|Overall Study|Lost to Follow-up|0|||
150094626|NCT03525574|541488111|FG000|Overall Study|Commercial drug is Available for participant|48|||
150094627|NCT03525574|541488112|FG001|Overall Study|Commercial drug is Available for participant|0|||
150094628|NCT03525574|541488111|FG000|Overall Study|Death|1|||
150094629|NCT03525574|541488112|FG001|Overall Study|Death|0|||
150094630|NCT03525574|541488111|FG000|Overall Study|Other non-compliance|2|||
150094631|NCT03525574|541488112|FG001|Overall Study|Other non-compliance|0|||
150094632|NCT03525574|541488111|FG000|Overall Study|Physician Decision|6|||
150094633|NCT03525574|541488112|FG001|Overall Study|Physician Decision|0|||
150094634|NCT03525574|541488111|FG000|Overall Study|Other|58|||
150094635|NCT03525574|541488112|FG001|Overall Study|Other|0|||
150094636|NCT03525574|541488111|FG000|Overall Study|Enrolled but never dosed|1|||
150094637|NCT03525574|541488112|FG001|Overall Study|Enrolled but never dosed|0|||
150094638|NCT03525574|541488111|FG000|Overall Study|Not enrolled in 105 study|0|||
150094639|NCT03525574|541488112|FG001|Overall Study|Not enrolled in 105 study|3|||
150094640|NCT01074450|541488119|FG000|First Intervention|Emesis in Dosing Interval|0|||
150094641|NCT01074450|541488120|FG001|First Intervention|Emesis in Dosing Interval|2|||
150094642|NCT01074450|541488119|FG000|Second Intervention|Protocol Violation|1|||
150094643|NCT01074450|541488120|FG001|Second Intervention|Protocol Violation|0|||
150094644|NCT01074450|541488119|FG000|Second Intervention|Physician Decision|0|||
150094645|NCT01074450|541488120|FG001|Second Intervention|Physician Decision|1|||
150094646|NCT02369341|541488130|FG000|Overall Study|Migrated/moved from study area|1|||
150094647|NCT02369341|541488131|FG001|Overall Study|Migrated/moved from study area|0|||
150094648|NCT05407675|541488141|FG000|Overall Study|Withdrawal by Subject|0|||
150094649|NCT05407675|541488142|FG001|Overall Study|Withdrawal by Subject|2|||
150094650|NCT05407675|541488143|FG002|Overall Study|Withdrawal by Subject|3|||
150094651|NCT05407675|541488144|FG003|Overall Study|Withdrawal by Subject|5|||
150094652|NCT05407675|541488145|FG004|Overall Study|Withdrawal by Subject|0|||
150094653|NCT05407675|541488146|FG005|Overall Study|Withdrawal by Subject|2|||
150094654|NCT05407675|541488147|FG006|Overall Study|Withdrawal by Subject|0|||
150094655|NCT05407675|541488148|FG007|Overall Study|Withdrawal by Subject|0|||
150094656|NCT05407675|541488149|FG008|Overall Study|Withdrawal by Subject|2|||
150094657|NCT05407675|541488150|FG009|Overall Study|Withdrawal by Subject|0|||
150255258|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
150029353|NCT04612725|541242643|FG003|Overall Study|Other|0|||
150029354|NCT04612725|541242644|FG004|Overall Study|Other|1|||
150094658|NCT05407675|541488151|FG010|Overall Study|Withdrawal by Subject|1|||
150094659|NCT05407675|541488152|FG011|Overall Study|Withdrawal by Subject|0|||
150094660|NCT05407675|541488153|FG012|Overall Study|Withdrawal by Subject|0|||
150094661|NCT05407675|541488141|FG000|Overall Study|Site terminated by sponsor|0|||
150094662|NCT05407675|541488142|FG001|Overall Study|Site terminated by sponsor|0|||
150094663|NCT05407675|541488143|FG002|Overall Study|Site terminated by sponsor|1|||
150094664|NCT05407675|541488144|FG003|Overall Study|Site terminated by sponsor|0|||
150094665|NCT05407675|541488145|FG004|Overall Study|Site terminated by sponsor|2|||
150094666|NCT05407675|541488146|FG005|Overall Study|Site terminated by sponsor|0|||
150094667|NCT05407675|541488147|FG006|Overall Study|Site terminated by sponsor|1|||
150094668|NCT05407675|541488148|FG007|Overall Study|Site terminated by sponsor|0|||
150094669|NCT05407675|541488149|FG008|Overall Study|Site terminated by sponsor|0|||
150094670|NCT05407675|541488150|FG009|Overall Study|Site terminated by sponsor|2|||
150094671|NCT05407675|541488151|FG010|Overall Study|Site terminated by sponsor|2|||
150094672|NCT05407675|541488152|FG011|Overall Study|Site terminated by sponsor|2|||
150094673|NCT05407675|541488153|FG012|Overall Study|Site terminated by sponsor|1|||
150094674|NCT05407675|541488141|FG000|Overall Study|Disease Progression|0|||
150094675|NCT05407675|541488142|FG001|Overall Study|Disease Progression|0|||
150094676|NCT05407675|541488143|FG002|Overall Study|Disease Progression|0|||
150094677|NCT05407675|541488144|FG003|Overall Study|Disease Progression|0|||
150094678|NCT05407675|541488145|FG004|Overall Study|Disease Progression|0|||
150094679|NCT05407675|541488146|FG005|Overall Study|Disease Progression|0|||
150094680|NCT05407675|541488147|FG006|Overall Study|Disease Progression|0|||
150094681|NCT05407675|541488148|FG007|Overall Study|Disease Progression|0|||
150094682|NCT05407675|541488149|FG008|Overall Study|Disease Progression|0|||
150094683|NCT05407675|541488150|FG009|Overall Study|Disease Progression|0|||
150094684|NCT05407675|541488151|FG010|Overall Study|Disease Progression|1|||
150094685|NCT05407675|541488152|FG011|Overall Study|Disease Progression|0|||
150094686|NCT05407675|541488153|FG012|Overall Study|Disease Progression|0|||
150094687|NCT05407675|541488141|FG000|Overall Study|Physician Decision|0|||
150094688|NCT05407675|541488142|FG001|Overall Study|Physician Decision|0|||
150094689|NCT05407675|541488143|FG002|Overall Study|Physician Decision|0|||
150094690|NCT05407675|541488144|FG003|Overall Study|Physician Decision|0|||
150094691|NCT05407675|541488145|FG004|Overall Study|Physician Decision|0|||
150094692|NCT05407675|541488146|FG005|Overall Study|Physician Decision|0|||
150094693|NCT05407675|541488147|FG006|Overall Study|Physician Decision|0|||
150094694|NCT05407675|541488148|FG007|Overall Study|Physician Decision|0|||
150094695|NCT05407675|541488149|FG008|Overall Study|Physician Decision|0|||
150094696|NCT05407675|541488150|FG009|Overall Study|Physician Decision|0|||
150094697|NCT05407675|541488151|FG010|Overall Study|Physician Decision|1|||
150094698|NCT05407675|541488152|FG011|Overall Study|Physician Decision|0|||
150094699|NCT05407675|541488153|FG012|Overall Study|Physician Decision|0|||
150094700|NCT05407675|541488141|FG000|Overall Study|Other reasons|0|||
150094701|NCT05407675|541488142|FG001|Overall Study|Other reasons|0|||
150094702|NCT05407675|541488143|FG002|Overall Study|Other reasons|0|||
150094703|NCT05407675|541488144|FG003|Overall Study|Other reasons|0|||
150094704|NCT05407675|541488145|FG004|Overall Study|Other reasons|0|||
150094705|NCT05407675|541488146|FG005|Overall Study|Other reasons|0|||
150094706|NCT05407675|541488147|FG006|Overall Study|Other reasons|0|||
150094707|NCT05407675|541488148|FG007|Overall Study|Other reasons|0|||
150094708|NCT05407675|541488149|FG008|Overall Study|Other reasons|1|||
150094709|NCT05407675|541488150|FG009|Overall Study|Other reasons|1|||
150094710|NCT05407675|541488151|FG010|Overall Study|Other reasons|1|||
150094711|NCT05407675|541488152|FG011|Overall Study|Other reasons|1|||
150094712|NCT05407675|541488153|FG012|Overall Study|Other reasons|0|||
150094713|NCT05407675|541488141|FG000|Overall Study|Death|3|||
150094714|NCT05407675|541488142|FG001|Overall Study|Death|4|||
150094715|NCT05407675|541488143|FG002|Overall Study|Death|3|||
150094716|NCT05407675|541488144|FG003|Overall Study|Death|6|||
150094717|NCT05407675|541488145|FG004|Overall Study|Death|0|||
150094718|NCT05407675|541488146|FG005|Overall Study|Death|2|||
150255259|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
150255260|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
150255261|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
150255262|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
150255263|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
150094719|NCT05407675|541488147|FG006|Overall Study|Death|4|||
150094720|NCT05407675|541488148|FG007|Overall Study|Death|2|||
150094721|NCT05407675|541488149|FG008|Overall Study|Death|2|||
150094722|NCT05407675|541488150|FG009|Overall Study|Death|4|||
150094723|NCT05407675|541488151|FG010|Overall Study|Death|2|||
150094724|NCT05407675|541488152|FG011|Overall Study|Death|1|||
150094725|NCT05407675|541488153|FG012|Overall Study|Death|0|||
150094726|NCT05407675|541488141|FG000|Overall Study|Adverse Event|0|||
150094727|NCT05407675|541488142|FG001|Overall Study|Adverse Event|0|||
150094728|NCT05407675|541488143|FG002|Overall Study|Adverse Event|0|||
150094729|NCT05407675|541488144|FG003|Overall Study|Adverse Event|0|||
150094730|NCT05407675|541488145|FG004|Overall Study|Adverse Event|1|||
150094731|NCT05407675|541488146|FG005|Overall Study|Adverse Event|0|||
150094732|NCT05407675|541488147|FG006|Overall Study|Adverse Event|0|||
150094733|NCT05407675|541488148|FG007|Overall Study|Adverse Event|0|||
150094734|NCT05407675|541488149|FG008|Overall Study|Adverse Event|0|||
150094735|NCT05407675|541488150|FG009|Overall Study|Adverse Event|0|||
150094736|NCT05407675|541488151|FG010|Overall Study|Adverse Event|0|||
150094737|NCT05407675|541488152|FG011|Overall Study|Adverse Event|1|||
150094738|NCT05407675|541488153|FG012|Overall Study|Adverse Event|0|||
150094739|NCT05407675|541488141|FG000|Overall Study|Ongoing Treatment|0|||
150094740|NCT05407675|541488142|FG001|Overall Study|Ongoing Treatment|0|||
150094741|NCT05407675|541488143|FG002|Overall Study|Ongoing Treatment|0|||
150094742|NCT05407675|541488144|FG003|Overall Study|Ongoing Treatment|0|||
150094743|NCT05407675|541488145|FG004|Overall Study|Ongoing Treatment|0|||
150094744|NCT05407675|541488146|FG005|Overall Study|Ongoing Treatment|0|||
150094745|NCT05407675|541488147|FG006|Overall Study|Ongoing Treatment|0|||
150094746|NCT05407675|541488148|FG007|Overall Study|Ongoing Treatment|0|||
150094747|NCT05407675|541488149|FG008|Overall Study|Ongoing Treatment|1|||
150094748|NCT05407675|541488150|FG009|Overall Study|Ongoing Treatment|0|||
150094749|NCT05407675|541488151|FG010|Overall Study|Ongoing Treatment|0|||
150094750|NCT05407675|541488152|FG011|Overall Study|Ongoing Treatment|0|||
150094751|NCT05407675|541488153|FG012|Overall Study|Ongoing Treatment|0|||
150094752|NCT00857220|541488154|FG000|Overall Study|Adverse Event|35|||
150094753|NCT00857220|541488154|FG000|Overall Study|Death|1|||
150094754|NCT00857220|541488154|FG000|Overall Study|Lack of Efficacy|11|||
150094755|NCT00857220|541488154|FG000|Overall Study|Lost to Follow-up|30|||
150094756|NCT00857220|541488154|FG000|Overall Study|Physician Decision|4|||
150094757|NCT00857220|541488154|FG000|Overall Study|Protocol Violation|16|||
150094758|NCT00857220|541488154|FG000|Overall Study|Withdrawal by Subject|67|||
150094759|NCT00857220|541488154|FG000|Overall Study|Clinical Hold|6|||
150094760|NCT00857220|541488154|FG000|Overall Study|Site Closed|5|||
150094761|NCT00857220|541488154|FG000|Overall Study|Miscellaneous|8|||
150094762|NCT00742001|541488155|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
150094763|NCT00742001|541488156|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
150094764|NCT00742001|541488157|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
150094765|NCT00137423|541488158|FG000|Overall Study|Adverse Event|7|||
150094766|NCT00137423|541488159|FG001|Overall Study|Adverse Event|9|||
150094767|NCT00137423|541488158|FG000|Overall Study|consent withdrawn|1|||
150094768|NCT00137423|541488159|FG001|Overall Study|consent withdrawn|1|||
150094769|NCT00137423|541488158|FG000|Overall Study|Lack of Efficacy|31|||
150094770|NCT00137423|541488159|FG001|Overall Study|Lack of Efficacy|33|||
150094771|NCT00137423|541488158|FG000|Overall Study|Death|0|||
150094772|NCT00137423|541488159|FG001|Overall Study|Death|1|||
150094773|NCT03187262|541488160|FG000|Induction|Lack of Efficacy|2|||
150094774|NCT03187262|541488160|FG000|Induction|Progressive Disease|4|||
150094775|NCT03187262|541488160|FG000|Consolidation|Progressive Disease|5|||
150094776|NCT04105998|541488162|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
150094777|NCT04105998|541488163|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
150094778|NCT01050257|541488164|FG000|Overall Study|Adverse Event|4|||
150094779|NCT01050257|541488165|FG001|Overall Study|Adverse Event|4|||
150094780|NCT01050257|541488166|FG002|Overall Study|Adverse Event|2|||
150094781|NCT01050257|541488164|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
150094782|NCT01050257|541488165|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
150094783|NCT01050257|541488166|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
150094784|NCT01050257|541488164|FG000|Overall Study|Withdrawal by Subject|0|||
150094785|NCT01050257|541488165|FG001|Overall Study|Withdrawal by Subject|3|||
150094786|NCT01050257|541488166|FG002|Overall Study|Withdrawal by Subject|0|||
150094787|NCT01050257|541488164|FG000|Overall Study|No reason specified|0|||
150094788|NCT01050257|541488165|FG001|Overall Study|No reason specified|0|||
150094789|NCT01050257|541488166|FG002|Overall Study|No reason specified|2|||
150094790|NCT01050257|541488164|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
150094791|NCT01050257|541488165|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
150094792|NCT01050257|541488166|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
150094793|NCT01050257|541488164|FG000|Overall Study|Violation criteria|0|||
150094794|NCT01050257|541488165|FG001|Overall Study|Violation criteria|1|||
150094795|NCT01050257|541488166|FG002|Overall Study|Violation criteria|0|||
150094796|NCT01050257|541488164|FG000|Overall Study|Failure to return|0|||
150094797|NCT01050257|541488165|FG001|Overall Study|Failure to return|2|||
150094798|NCT01050257|541488166|FG002|Overall Study|Failure to return|0|||
150094799|NCT01050257|541488164|FG000|Overall Study|Death|0|||
150094800|NCT01050257|541488165|FG001|Overall Study|Death|0|||
150094801|NCT01050257|541488166|FG002|Overall Study|Death|1|||
150094802|NCT00171223|541488167|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
150094803|NCT00171223|541488168|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
150094804|NCT00171223|541488169|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
150094805|NCT00171223|541488167|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
150094806|NCT00171223|541488168|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
150094807|NCT00171223|541488169|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
150094808|NCT00171223|541488167|FG000|Overall Study|Abnormal Procedure|1|||
150094809|NCT00171223|541488168|FG001|Overall Study|Abnormal Procedure|0|||
150094810|NCT00171223|541488169|FG002|Overall Study|Abnormal Procedure|0|||
150094811|NCT00171223|541488167|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
150094812|NCT00171223|541488168|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
150094813|NCT00171223|541488169|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
150094814|NCT00171223|541488167|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
150094815|NCT00171223|541488168|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
150094816|NCT00171223|541488169|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
150094817|NCT00171223|541488167|FG000|Overall Study|Protocol Violation|2|||
150094818|NCT00171223|541488168|FG001|Overall Study|Protocol Violation|2|||
150094819|NCT00171223|541488169|FG002|Overall Study|Protocol Violation|3|||
150094820|NCT00171223|541488167|FG000|Overall Study|Participant Withdrew Consent|12|||
150094821|NCT00171223|541488168|FG001|Overall Study|Participant Withdrew Consent|21|||
150094822|NCT00171223|541488169|FG002|Overall Study|Participant Withdrew Consent|15|||
150094823|NCT00171223|541488167|FG000|Overall Study|Lost to Follow-up|5|||
150094824|NCT00171223|541488168|FG001|Overall Study|Lost to Follow-up|2|||
150094825|NCT00171223|541488169|FG002|Overall Study|Lost to Follow-up|3|||
150094826|NCT00171223|541488167|FG000|Overall Study|Administrative Problems|4|||
150094827|NCT00171223|541488168|FG001|Overall Study|Administrative Problems|7|||
150094828|NCT00171223|541488169|FG002|Overall Study|Administrative Problems|6|||
150094829|NCT00171223|541488167|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
150094830|NCT00171223|541488168|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
150094831|NCT00171223|541488169|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
150094832|NCT00171223|541488167|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
150094833|NCT00171223|541488168|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
150094834|NCT00171223|541488169|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
150094835|NCT02604212|541488171|FG000|Overall Study|Study Terminated by Sponsor|2|||
150094836|NCT02604212|541488172|FG001|Overall Study|Study Terminated by Sponsor|1|||
150094837|NCT02604212|541488173|FG002|Overall Study|Study Terminated by Sponsor|3|||
150094838|NCT02604212|541488174|FG003|Overall Study|Study Terminated by Sponsor|3|||
150094839|NCT02604212|541488171|FG000|Overall Study|Withdrawal by Subject|0|||
150094840|NCT02604212|541488172|FG001|Overall Study|Withdrawal by Subject|0|||
150094841|NCT02604212|541488173|FG002|Overall Study|Withdrawal by Subject|1|||
150094842|NCT02604212|541488174|FG003|Overall Study|Withdrawal by Subject|0|||
150094843|NCT00278109|541488175|FG000|Overall Study|Adverse Event|3|||
150094844|NCT00278109|541488175|FG000|Overall Study|social circumstances|1|||
150094845|NCT02580357|541488176|FG000|Overall Study|Lost to Follow-up|2|||
150094846|NCT02580357|541488177|FG001|Overall Study|Lost to Follow-up|0|||
150094847|NCT02580357|541488178|FG002|Overall Study|Lost to Follow-up|0|||
150094848|NCT02580357|541488176|FG000|Overall Study|Protocol Violation|1|||
150094849|NCT02580357|541488177|FG001|Overall Study|Protocol Violation|0|||
150094850|NCT02580357|541488178|FG002|Overall Study|Protocol Violation|0|||
150094851|NCT04339296|541488179|FG000|Overall Study|Refuse to participate after allocation|1|||
150094852|NCT04339296|541488180|FG001|Overall Study|Refuse to participate after allocation|1|||
150094853|NCT04339296|541488179|FG000|Overall Study|Withdrew after completion of baseline|2|||
150094854|NCT04339296|541488180|FG001|Overall Study|Withdrew after completion of baseline|1|||
150094855|NCT04339296|541488179|FG000|Overall Study|Lost to Follow-up|0|||
150094856|NCT04339296|541488180|FG001|Overall Study|Lost to Follow-up|4|||
150094857|NCT04339296|541488179|FG000|Overall Study|Discontinued intervention|5|||
150094858|NCT04339296|541488180|FG001|Overall Study|Discontinued intervention|3|||
150094859|NCT00450333|541488181|FG000|Overall Study|Study terminated|47|||
150094860|NCT00450333|541488182|FG001|Overall Study|Study terminated|54|||
150094861|NCT00450333|541488183|FG002|Overall Study|Study terminated|16|||
150094862|NCT00450333|541488184|FG003|Overall Study|Study terminated|21|||
150094863|NCT00450333|541488181|FG000|Overall Study|Adverse Event|1|||
150094864|NCT00450333|541488182|FG001|Overall Study|Adverse Event|7|||
150094865|NCT00450333|541488183|FG002|Overall Study|Adverse Event|2|||
150094866|NCT00450333|541488184|FG003|Overall Study|Adverse Event|2|||
150094867|NCT00450333|541488181|FG000|Overall Study|Protocol Violation|1|||
150094868|NCT00450333|541488182|FG001|Overall Study|Protocol Violation|0|||
150094869|NCT00450333|541488183|FG002|Overall Study|Protocol Violation|1|||
150094870|NCT00450333|541488184|FG003|Overall Study|Protocol Violation|0|||
150094871|NCT00450333|541488181|FG000|Overall Study|Withdrawal by Subject|1|||
150094872|NCT00450333|541488182|FG001|Overall Study|Withdrawal by Subject|0|||
150094873|NCT00450333|541488183|FG002|Overall Study|Withdrawal by Subject|3|||
150094874|NCT00450333|541488184|FG003|Overall Study|Withdrawal by Subject|0|||
150094875|NCT00450333|541488181|FG000|Overall Study|Kidney transplant|1|||
150094876|NCT00450333|541488182|FG001|Overall Study|Kidney transplant|0|||
150094877|NCT00450333|541488183|FG002|Overall Study|Kidney transplant|1|||
150094878|NCT00450333|541488184|FG003|Overall Study|Kidney transplant|3|||
150184808|NCT02742519|541814480|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
150184809|NCT02742519|541814481|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
150184810|NCT02742519|541814482|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
150184811|NCT02742519|541814480|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
150184812|NCT02742519|541814481|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
150184813|NCT02742519|541814482|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
150184814|NCT02742519|541814480|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
150184815|NCT02742519|541814481|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
150184816|NCT02742519|541814482|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
150184817|NCT03432858|541814484|FG000|Overall Study|Protocol Violation|2|||
150184818|NCT03432858|541814485|FG001|Overall Study|Protocol Violation|1|||
150094879|NCT00450333|541488181|FG000|Overall Study|Death|3|||
150094880|NCT00450333|541488182|FG001|Overall Study|Death|2|||
150094881|NCT00450333|541488183|FG002|Overall Study|Death|2|||
150094882|NCT00450333|541488184|FG003|Overall Study|Death|2|||
150094883|NCT01829230|541488189|FG000|Overall Study|Protocol Violation|0|||
150094884|NCT01829230|541488190|FG001|Overall Study|Protocol Violation|2|||
150094885|NCT01829230|541488189|FG000|Overall Study|Withdrawal by Subject|0|||
150094886|NCT01829230|541488190|FG001|Overall Study|Withdrawal by Subject|1|||
150094887|NCT01829230|541488189|FG000|Overall Study|Lost to Follow-up|1|||
150094888|NCT01829230|541488190|FG001|Overall Study|Lost to Follow-up|1|||
150094889|NCT00969150|541488191|FG000|Overall Study|Adverse Event|4|||
150094890|NCT00969150|541488192|FG001|Overall Study|Adverse Event|14|||
150094891|NCT00969150|541488191|FG000|Overall Study|Lack of Efficacy|1|||
150094892|NCT00969150|541488192|FG001|Overall Study|Lack of Efficacy|1|||
150094893|NCT00969150|541488191|FG000|Overall Study|Protocol Violation|9|||
150094894|NCT00969150|541488192|FG001|Overall Study|Protocol Violation|12|||
150094895|NCT00969150|541488191|FG000|Overall Study|Withdrawal by Subject|13|||
150094896|NCT00969150|541488192|FG001|Overall Study|Withdrawal by Subject|9|||
150094897|NCT00969150|541488191|FG000|Overall Study|Lost to Follow-up|5|||
150094898|NCT00969150|541488192|FG001|Overall Study|Lost to Follow-up|4|||
150094899|NCT00969150|541488191|FG000|Overall Study|Other reasons|1|||
150094900|NCT00969150|541488192|FG001|Overall Study|Other reasons|0|||
150094901|NCT04128267|541488198|FG000|Overall Study|Withdrawal by Subject|6|||
150094902|NCT04128267|541488198|FG000|Overall Study|Death|2|||
150094903|NCT04128267|541488198|FG000|Overall Study|Disease progression|1|||
150094904|NCT04128267|541488198|FG000|Overall Study|Participant had other medical issues|4|||
150094905|NCT04128267|541488198|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
150094906|NCT04501666|541488199|FG000|Overall Study|Physician Decision|0|||
150094907|NCT04501666|541488200|FG001|Overall Study|Physician Decision|1|||
150094908|NCT04501666|541488199|FG000|Overall Study|Adverse Event|12|||
150094909|NCT04501666|541488200|FG001|Overall Study|Adverse Event|4|||
150094910|NCT04501666|541488199|FG000|Overall Study|Subject's request|10|||
150094911|NCT04501666|541488200|FG001|Overall Study|Subject's request|6|||
150094912|NCT04501666|541488199|FG000|Overall Study|Protocol Deviation|2|||
150094913|NCT04501666|541488200|FG001|Overall Study|Protocol Deviation|1|||
150094914|NCT04501666|541488199|FG000|Overall Study|Other-- site permanently closing|0|||
150094915|NCT04501666|541488200|FG001|Overall Study|Other-- site permanently closing|1|||
150094916|NCT02626520|541488212|FG000|Overall Study|Physician Decision|1|||
150094917|NCT02626520|541488213|FG001|Overall Study|Physician Decision|1|||
150094918|NCT02626520|541488212|FG000|Overall Study|Adverse Event|0|||
150094919|NCT02626520|541488213|FG001|Overall Study|Adverse Event|4|||
150184819|NCT03432858|541814486|FG002|Overall Study|Protocol Violation|9|||
150094920|NCT02626520|541488212|FG000|Overall Study|Lack of Efficacy|0|||
150094921|NCT02626520|541488213|FG001|Overall Study|Lack of Efficacy|2|||
150094922|NCT02626520|541488212|FG000|Overall Study|Did not start protocol therapy|0|||
150094923|NCT02626520|541488213|FG001|Overall Study|Did not start protocol therapy|2|||
150094924|NCT02626520|541488212|FG000|Overall Study|Study terminated|0|||
150094925|NCT02626520|541488213|FG001|Overall Study|Study terminated|1|||
150094926|NCT00535223|541488214|FG000|Overall Study|Withdrawal by Subject|4|||
150094927|NCT00535223|541488215|FG001|Overall Study|Withdrawal by Subject|1|||
150094928|NCT01765153|541488216|FG000|Training Phase 1|Format of intervention differed|1|||
150094929|NCT01765153|541488217|FG001|Training Phase 1|Format of intervention differed|0|||
150094930|NCT01765153|541488216|FG000|Training Phase 1|Poor participation in intervention|0|||
150094931|NCT01765153|541488217|FG001|Training Phase 1|Poor participation in intervention|1|||
150094932|NCT01765153|541488216|FG000|Rest Phase 1|Withdrawal by Subject|0|||
150094933|NCT01765153|541488217|FG001|Rest Phase 1|Withdrawal by Subject|1|||
150094934|NCT01765153|541488216|FG000|Training Phase 2|Withdrawal by Subject|0|||
150094935|NCT01765153|541488217|FG001|Training Phase 2|Withdrawal by Subject|1|||
150094936|NCT01765153|541488216|FG000|Rest Phase 2|Lost to Follow-up|2|||
150094937|NCT01765153|541488217|FG001|Rest Phase 2|Lost to Follow-up|1|||
150094938|NCT03915496|541488220|FG000|Overall Study|Adverse Event|2|||
150094939|NCT03915496|541488221|FG001|Overall Study|Adverse Event|1|||
150094940|NCT03915496|541488222|FG002|Overall Study|Adverse Event|2|||
150094941|NCT02663674|541488223|FG000|Overall Study|Lost to Follow-up|5|||
150094942|NCT02663674|541488224|FG001|Overall Study|Lost to Follow-up|4|||
150094943|NCT02663674|541488223|FG000|Overall Study|Withdrawal by Subject|1|||
150094944|NCT02663674|541488224|FG001|Overall Study|Withdrawal by Subject|4|||
150094945|NCT02663674|541488223|FG000|Overall Study|Physician Decision|1|||
150094946|NCT02663674|541488224|FG001|Overall Study|Physician Decision|1|||
150094947|NCT02663674|541488223|FG000|Overall Study|Other Event (Health Related)|0|||
150094948|NCT02663674|541488224|FG001|Overall Study|Other Event (Health Related)|1|||
150094949|NCT02472795|541488228|FG000|Overall Study|Adverse Event|0|||
150094950|NCT02472795|541488229|FG001|Overall Study|Adverse Event|1|||
150094951|NCT02472795|541488230|FG002|Overall Study|Adverse Event|0|||
150094952|NCT02472795|541488231|FG003|Overall Study|Adverse Event|0|||
150094953|NCT02472795|541488232|FG004|Overall Study|Adverse Event|2|||
150094954|NCT02472795|541488228|FG000|Overall Study|Withdrawal by Subject|0|||
150094955|NCT02472795|541488229|FG001|Overall Study|Withdrawal by Subject|0|||
150094956|NCT02472795|541488230|FG002|Overall Study|Withdrawal by Subject|0|||
150094957|NCT02472795|541488231|FG003|Overall Study|Withdrawal by Subject|0|||
150094958|NCT02472795|541488232|FG004|Overall Study|Withdrawal by Subject|1|||
150094959|NCT04166513|541488233|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
150094960|NCT04166513|541488234|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
150094961|NCT04166513|541488235|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
150094962|NCT04166513|541488236|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
150094963|NCT04166513|541488233|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
150094964|NCT04166513|541488234|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
150094965|NCT04166513|541488235|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
150094966|NCT04166513|541488236|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
150094967|NCT04166513|541488233|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
150094968|NCT04166513|541488234|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
150094969|NCT04166513|541488235|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
150094970|NCT04166513|541488236|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
150094971|NCT04166513|541488233|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
150094972|NCT04166513|541488234|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
150094973|NCT04166513|541488235|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
150094974|NCT04166513|541488236|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
150094975|NCT04166513|541488233|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
150094976|NCT04166513|541488234|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
150094977|NCT04166513|541488235|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
150094978|NCT04166513|541488236|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
150094979|NCT01132482|541489497|FG000|Overall Study|Adverse Event|1|||
150094980|NCT01132482|541489498|FG001|Overall Study|Adverse Event|0|||
150094981|NCT05333900|541489499|FG000|Overall Study|Protocol Violation|0|||
150094982|NCT05333900|541489500|FG001|Overall Study|Protocol Violation|1|||
150094983|NCT05333900|541489499|FG000|Overall Study|Withdrawal by Subject|0|||
150094984|NCT05333900|541489500|FG001|Overall Study|Withdrawal by Subject|1|||
150094985|NCT05333900|541489499|FG000|Overall Study|COVID-19 Pandemic|1|||
150094986|NCT05333900|541489500|FG001|Overall Study|COVID-19 Pandemic|1|||
150094987|NCT01277523|541489501|FG000|Overall Study|Adverse Event|1|||
150094988|NCT01277523|541489502|FG001|Overall Study|Adverse Event|0|||
150094989|NCT01277523|541489503|FG002|Overall Study|Adverse Event|0|||
150094990|NCT01277523|541489501|FG000|Overall Study|Protocol Violation|2|||
150094991|NCT01277523|541489502|FG001|Overall Study|Protocol Violation|0|||
150094992|NCT01277523|541489503|FG002|Overall Study|Protocol Violation|0|||
150094993|NCT01277523|541489501|FG000|Overall Study|Other Reason not Defined|0|||
150094994|NCT01277523|541489502|FG001|Overall Study|Other Reason not Defined|1|||
150094995|NCT01277523|541489503|FG002|Overall Study|Other Reason not Defined|0|||
150094996|NCT03724812|541489506|FG000|Overall Study|Missed Visit|1|||
150094997|NCT03724812|541489506|FG000|Overall Study|Death|2|||
150094998|NCT03724812|541489506|FG000|Overall Study|Withdrawal by Subject|1|||
150094999|NCT01851720|541489507|FG000|Overall Study|Lost to Follow-up|0|||
150095000|NCT01851720|541489508|FG001|Overall Study|Lost to Follow-up|1|||
150095001|NCT01394523|541489509|FG000|Overall Study|Unable to place block|1|||
150095002|NCT01394523|541489510|FG001|Overall Study|Unable to place block|0|||
150095003|NCT01394523|541489511|FG002|Overall Study|Unable to place block|0|||
150184820|NCT03432858|541814484|FG000|Overall Study|Withdrawal by Subject|0|||
150184821|NCT03432858|541814485|FG001|Overall Study|Withdrawal by Subject|1|||
150184822|NCT03432858|541814486|FG002|Overall Study|Withdrawal by Subject|1|||
150184823|NCT03432858|541814484|FG000|Overall Study|Procedure canceled/rescheduled|0|||
150184824|NCT03432858|541814485|FG001|Overall Study|Procedure canceled/rescheduled|9|||
150184825|NCT03432858|541814486|FG002|Overall Study|Procedure canceled/rescheduled|6|||
150184826|NCT03432858|541814484|FG000|Overall Study|Required postop mobilization with splinting|0|||
150184827|NCT03432858|541814485|FG001|Overall Study|Required postop mobilization with splinting|0|||
150095004|NCT02389998|541489512|FG000|Overall Study|car accident|1|||
150184828|NCT03432858|541814486|FG002|Overall Study|Required postop mobilization with splinting|1|||
150184829|NCT01872078|541814487|FG000|Overall Study|Adverse Event|0|||
150184830|NCT01872078|541814488|FG001|Overall Study|Adverse Event|0|||
150184831|NCT01872078|541814489|FG002|Overall Study|Adverse Event|1|||
150184832|NCT01872078|541814490|FG003|Overall Study|Adverse Event|0|||
150095005|NCT02389998|541489513|FG001|Overall Study|car accident|0|||
150095006|NCT01770379|541489514|FG000|Overall Study|Technical issues|1|||
150095007|NCT01770379|541489515|FG001|Overall Study|Technical issues|0|||
150095008|NCT01770379|541489516|FG002|Overall Study|Technical issues|0|||
150095009|NCT01770379|541489514|FG000|Overall Study|Withdrawal by Subject|7|||
150095010|NCT01770379|541489515|FG001|Overall Study|Withdrawal by Subject|10|||
150095011|NCT01770379|541489516|FG002|Overall Study|Withdrawal by Subject|7|||
150095012|NCT01770379|541489514|FG000|Overall Study|study terminated by sponsor|22|||
150095013|NCT01770379|541489515|FG001|Overall Study|study terminated by sponsor|23|||
150095014|NCT01770379|541489516|FG002|Overall Study|study terminated by sponsor|22|||
150095015|NCT01770379|541489514|FG000|Overall Study|Protocol Violation|0|||
150095016|NCT01770379|541489515|FG001|Overall Study|Protocol Violation|1|||
150095017|NCT01770379|541489516|FG002|Overall Study|Protocol Violation|1|||
150095018|NCT01770379|541489514|FG000|Overall Study|Physician Decision|0|||
150095019|NCT01770379|541489515|FG001|Overall Study|Physician Decision|1|||
150095020|NCT01770379|541489516|FG002|Overall Study|Physician Decision|2|||
150095021|NCT01770379|541489514|FG000|Overall Study|Lost to Follow-up|0|||
150095022|NCT01770379|541489515|FG001|Overall Study|Lost to Follow-up|0|||
150095023|NCT01770379|541489516|FG002|Overall Study|Lost to Follow-up|2|||
150095024|NCT01770379|541489514|FG000|Overall Study|Lack of Efficacy|8|||
150095025|NCT01770379|541489515|FG001|Overall Study|Lack of Efficacy|6|||
150095026|NCT01770379|541489516|FG002|Overall Study|Lack of Efficacy|6|||
150095027|NCT01770379|541489514|FG000|Overall Study|Adverse Event|1|||
150095028|NCT01770379|541489515|FG001|Overall Study|Adverse Event|3|||
150095029|NCT01770379|541489516|FG002|Overall Study|Adverse Event|2|||
150184833|NCT01872078|541814487|FG000|Overall Study|Dose administration non-compliance|0|||
150184834|NCT01872078|541814488|FG001|Overall Study|Dose administration non-compliance|0|||
150184835|NCT01872078|541814489|FG002|Overall Study|Dose administration non-compliance|0|||
150095030|NCT02728895|541489525|FG000|Overall Study|Other|1|||
150095031|NCT02728895|541489526|FG001|Overall Study|Other|2|||
150095032|NCT02728895|541489525|FG000|Overall Study|Withdrawal by Subject|0|||
150095033|NCT02728895|541489526|FG001|Overall Study|Withdrawal by Subject|3|||
150095034|NCT02769247|541489527|FG000|Overall Study|Withdrawal by Subject|1|||
150095035|NCT02769247|541489528|FG001|Overall Study|Withdrawal by Subject|0|||
150095036|NCT02769247|541489529|FG002|Overall Study|Withdrawal by Subject|0|||
150095037|NCT02769247|541489530|FG003|Overall Study|Withdrawal by Subject|1|||
150095038|NCT02769247|541489527|FG000|Overall Study|Protocol Violation|0|||
150095039|NCT02769247|541489528|FG001|Overall Study|Protocol Violation|0|||
150095040|NCT02769247|541489529|FG002|Overall Study|Protocol Violation|1|||
150095041|NCT02769247|541489530|FG003|Overall Study|Protocol Violation|0|||
150095042|NCT02769247|541489527|FG000|Overall Study|Physician Decision|1|||
150095043|NCT02769247|541489528|FG001|Overall Study|Physician Decision|0|||
150095044|NCT02769247|541489529|FG002|Overall Study|Physician Decision|0|||
150095045|NCT02769247|541489530|FG003|Overall Study|Physician Decision|0|||
150095046|NCT04788953|541489531|FG000|Overall Study|Adverse Event|1|||
150095047|NCT04788953|541489532|FG001|Overall Study|Adverse Event|1|||
150095048|NCT04788953|541489531|FG000|Overall Study|Withdrawal by Subject|1|||
150095049|NCT04788953|541489532|FG001|Overall Study|Withdrawal by Subject|0|||
150095050|NCT04788953|541489531|FG000|Overall Study|Protocol Violation|0|||
150095051|NCT04788953|541489532|FG001|Overall Study|Protocol Violation|1|||
150095052|NCT00469092|541489533|FG000|Overall Study|Adverse Event|5|||
150095053|NCT00469092|541489534|FG001|Overall Study|Adverse Event|4|||
150095054|NCT00469092|541489533|FG000|Overall Study|Lack of Efficacy|1|||
150095055|NCT00469092|541489534|FG001|Overall Study|Lack of Efficacy|0|||
150095056|NCT00469092|541489533|FG000|Overall Study|Lost to Follow-up|1|||
150095057|NCT00469092|541489534|FG001|Overall Study|Lost to Follow-up|2|||
150095058|NCT00469092|541489533|FG000|Overall Study|Protocol Violation|3|||
150095059|NCT00469092|541489534|FG001|Overall Study|Protocol Violation|3|||
150095060|NCT00469092|541489533|FG000|Overall Study|Withdrawal by Subject|4|||
150095061|NCT00469092|541489534|FG001|Overall Study|Withdrawal by Subject|4|||
150095062|NCT00469092|541489533|FG000|Overall Study|Withdrawal Criteria|3|||
150095063|NCT00469092|541489534|FG001|Overall Study|Withdrawal Criteria|4|||
150095064|NCT00469092|541489533|FG000|Overall Study|Incorrectly Randomised|4|||
150095065|NCT00469092|541489534|FG001|Overall Study|Incorrectly Randomised|3|||
150095066|NCT00469092|541489533|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
150095067|NCT00469092|541489534|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
150095068|NCT00469092|541489533|FG000|Overall Study|Use of lipid lowering drug|1|||
150095069|NCT00469092|541489534|FG001|Overall Study|Use of lipid lowering drug|0|||
150095070|NCT00469092|541489533|FG000|Overall Study|Hypoglycaemic Episodes|1|||
150095071|NCT00469092|541489534|FG001|Overall Study|Hypoglycaemic Episodes|1|||
150095072|NCT00469092|541489533|FG000|Overall Study|Abnormal lab value|1|||
150095073|NCT00469092|541489534|FG001|Overall Study|Abnormal lab value|0|||
150095074|NCT00469092|541489533|FG000|Overall Study|Use of Corticosteroid|1|||
150095075|NCT00469092|541489534|FG001|Overall Study|Use of Corticosteroid|0|||
150095076|NCT02150954|541489535|FG000|Overall Study|Protocol Violation|1|||
150095077|NCT02150954|541489536|FG001|Overall Study|Protocol Violation|0|||
150095078|NCT01086540|541489538|FG000|Overall Study|Death|3|||
150095079|NCT01086540|541489539|FG001|Overall Study|Death|1|||
150095080|NCT01086540|541489538|FG000|Overall Study|Physician Decision|2|||
150095081|NCT01086540|541489539|FG001|Overall Study|Physician Decision|1|||
150095082|NCT01086540|541489538|FG000|Overall Study|Addition of new therapy for PAH|1|||
150095083|NCT01086540|541489539|FG001|Overall Study|Addition of new therapy for PAH|0|||
150095084|NCT03164928|541489540|FG000|Overall Study|Lost to Follow-up|1|||
150095085|NCT03164928|541489541|FG001|Overall Study|Lost to Follow-up|0|||
150095086|NCT05811234|541489544|FG000|Overall Study|Loss of Effectiveness|2|||
150095087|NCT05811234|541489544|FG000|Overall Study|Adverse Event|4|||
150095088|NCT05811234|541489544|FG000|Overall Study|Pregnancy|1|||
150095089|NCT05811234|541489544|FG000|Overall Study|Disease progression|1|||
150095090|NCT05811234|541489544|FG000|Overall Study|Withdrawal by Subject|4|||
150095091|NCT05811234|541489544|FG000|Overall Study|Lost to Follow-up|13|||
150095092|NCT05811234|541489544|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
150095093|NCT02707991|541489545|FG000|Overall Study|Protocol Violation|1|||
150095094|NCT02707991|541489546|FG001|Overall Study|Protocol Violation|0|||
150095095|NCT02707991|541489545|FG000|Overall Study|Became ineligible|0|||
150095096|NCT02707991|541489546|FG001|Overall Study|Became ineligible|1|||
150095097|NCT04519645|541489551|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
150095098|NCT04519645|541489552|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
150095099|NCT04519645|541489553|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
150095100|NCT04519645|541489551|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
150095101|NCT04519645|541489552|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
150095102|NCT04519645|541489553|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
150095103|NCT04519645|541489551|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
150095104|NCT04519645|541489552|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
150095105|NCT04519645|541489553|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
150095106|NCT04519645|541489551|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
150095107|NCT04519645|541489552|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
150095108|NCT04519645|541489553|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
150095109|NCT00453544|541489566|FG000|Overall Study|Withdrawal by Subject|1|||
150095110|NCT00453544|541489567|FG001|Overall Study|Withdrawal by Subject|0|||
150095111|NCT00453544|541489568|FG002|Overall Study|Withdrawal by Subject|0|||
150095112|NCT00453544|541489569|FG003|Overall Study|Withdrawal by Subject|0|||
150095113|NCT00453544|541489566|FG000|Overall Study|Primary outcome measure not completed|1|||
150095114|NCT00453544|541489567|FG001|Overall Study|Primary outcome measure not completed|1|||
150095115|NCT00453544|541489568|FG002|Overall Study|Primary outcome measure not completed|0|||
150095116|NCT00453544|541489569|FG003|Overall Study|Primary outcome measure not completed|1|||
150095117|NCT00619801|541489572|FG000|Overall Study|Lack of Efficacy|0|||
150095118|NCT00619801|541489573|FG001|Overall Study|Lack of Efficacy|1|||
150095119|NCT00619801|541489572|FG000|Overall Study|Withdrawal by Subject|1|||
150095120|NCT00619801|541489573|FG001|Overall Study|Withdrawal by Subject|1|||
150095121|NCT00619801|541489572|FG000|Overall Study|Loss of efficacy|0|||
150095122|NCT00619801|541489573|FG001|Overall Study|Loss of efficacy|1|||
150095123|NCT03855280|541489582|FG000|Treatment Phase|Adverse Event|1|||
150095124|NCT03855280|541489582|FG000|Treatment Phase|Withdrawal by Subject|1|||
150095125|NCT03855280|541489582|FG000|Continuation Phase|Protocol Violation|1|||
150095126|NCT03855280|541489582|FG000|Continuation Phase|Adverse Event|1|||
150095127|NCT03855280|541489582|FG000|Continuation Phase|Sponsor Concluded Study|1|||
150095128|NCT00461682|541489586|FG000|Overall Study|Protocol Violation|1|||
150095129|NCT00642941|541489589|FG000|Overall Study|Physician Decision|3|||
150095130|NCT00642941|541489590|FG001|Overall Study|Physician Decision|1|||
150095131|NCT00642941|541489591|FG002|Overall Study|Physician Decision|0|||
150095132|NCT00642941|541489592|FG003|Overall Study|Physician Decision|0|||
150095133|NCT00642941|541489593|FG004|Overall Study|Physician Decision|0|||
150095134|NCT00642941|541489594|FG005|Overall Study|Physician Decision|0|||
150095135|NCT00642941|541489595|FG006|Overall Study|Physician Decision|1|||
150095136|NCT00642941|541489596|FG007|Overall Study|Physician Decision|0|||
150095137|NCT00642941|541489597|FG008|Overall Study|Physician Decision|0|||
150095138|NCT00642941|541489598|FG009|Overall Study|Physician Decision|1|||
150095139|NCT00642941|541489599|FG010|Overall Study|Physician Decision|0|||
150095140|NCT00642941|541489600|FG011|Overall Study|Physician Decision|1|||
150095141|NCT00642941|541489589|FG000|Overall Study|Death|4|||
150095142|NCT00642941|541489590|FG001|Overall Study|Death|0|||
150095143|NCT00642941|541489591|FG002|Overall Study|Death|1|||
150095144|NCT00642941|541489592|FG003|Overall Study|Death|1|||
150095145|NCT00642941|541489593|FG004|Overall Study|Death|2|||
150095146|NCT00642941|541489594|FG005|Overall Study|Death|1|||
150095147|NCT00642941|541489595|FG006|Overall Study|Death|0|||
150095148|NCT00642941|541489596|FG007|Overall Study|Death|0|||
150095149|NCT00642941|541489597|FG008|Overall Study|Death|0|||
150095150|NCT00642941|541489598|FG009|Overall Study|Death|0|||
150095151|NCT00642941|541489599|FG010|Overall Study|Death|0|||
150095152|NCT00642941|541489600|FG011|Overall Study|Death|1|||
150095153|NCT00642941|541489589|FG000|Overall Study|Study closed by Sponsor|0|||
150095154|NCT00642941|541489590|FG001|Overall Study|Study closed by Sponsor|1|||
150095155|NCT00642941|541489591|FG002|Overall Study|Study closed by Sponsor|0|||
150095156|NCT00642941|541489592|FG003|Overall Study|Study closed by Sponsor|0|||
150095157|NCT00642941|541489593|FG004|Overall Study|Study closed by Sponsor|0|||
150095158|NCT00642941|541489594|FG005|Overall Study|Study closed by Sponsor|0|||
150095159|NCT00642941|541489595|FG006|Overall Study|Study closed by Sponsor|0|||
150095160|NCT00642941|541489596|FG007|Overall Study|Study closed by Sponsor|0|||
150095161|NCT00642941|541489597|FG008|Overall Study|Study closed by Sponsor|0|||
150095162|NCT00642941|541489598|FG009|Overall Study|Study closed by Sponsor|0|||
150095163|NCT00642941|541489599|FG010|Overall Study|Study closed by Sponsor|0|||
150095164|NCT00642941|541489600|FG011|Overall Study|Study closed by Sponsor|0|||
150095165|NCT00642941|541489589|FG000|Overall Study|Withdrawal by Subject|1|||
150095166|NCT00642941|541489590|FG001|Overall Study|Withdrawal by Subject|0|||
150095167|NCT00642941|541489591|FG002|Overall Study|Withdrawal by Subject|0|||
150095168|NCT00642941|541489592|FG003|Overall Study|Withdrawal by Subject|2|||
150095169|NCT00642941|541489593|FG004|Overall Study|Withdrawal by Subject|0|||
150095170|NCT00642941|541489594|FG005|Overall Study|Withdrawal by Subject|0|||
150095171|NCT00642941|541489595|FG006|Overall Study|Withdrawal by Subject|2|||
150095172|NCT00642941|541489596|FG007|Overall Study|Withdrawal by Subject|0|||
150095173|NCT00642941|541489597|FG008|Overall Study|Withdrawal by Subject|1|||
150095174|NCT00642941|541489598|FG009|Overall Study|Withdrawal by Subject|0|||
150095175|NCT00642941|541489599|FG010|Overall Study|Withdrawal by Subject|0|||
150095176|NCT00642941|541489600|FG011|Overall Study|Withdrawal by Subject|1|||
150095177|NCT00642941|541489589|FG000|Overall Study|Protocol Violation|0|||
150095178|NCT00642941|541489590|FG001|Overall Study|Protocol Violation|0|||
150095179|NCT00642941|541489591|FG002|Overall Study|Protocol Violation|0|||
150095180|NCT00642941|541489592|FG003|Overall Study|Protocol Violation|0|||
150095181|NCT00642941|541489593|FG004|Overall Study|Protocol Violation|0|||
150095182|NCT00642941|541489594|FG005|Overall Study|Protocol Violation|0|||
150095183|NCT00642941|541489595|FG006|Overall Study|Protocol Violation|1|||
150095184|NCT00642941|541489596|FG007|Overall Study|Protocol Violation|0|||
150095185|NCT00642941|541489597|FG008|Overall Study|Protocol Violation|0|||
150095186|NCT00642941|541489598|FG009|Overall Study|Protocol Violation|0|||
150095187|NCT00642941|541489599|FG010|Overall Study|Protocol Violation|0|||
150095188|NCT00642941|541489600|FG011|Overall Study|Protocol Violation|0|||
150095189|NCT00642941|541489589|FG000|Overall Study|Adverse Event|1|||
150095190|NCT00642941|541489590|FG001|Overall Study|Adverse Event|1|||
150095191|NCT00642941|541489591|FG002|Overall Study|Adverse Event|0|||
150095192|NCT00642941|541489592|FG003|Overall Study|Adverse Event|0|||
150095193|NCT00642941|541489593|FG004|Overall Study|Adverse Event|0|||
150095194|NCT00642941|541489594|FG005|Overall Study|Adverse Event|0|||
150095195|NCT00642941|541489595|FG006|Overall Study|Adverse Event|1|||
150095196|NCT00642941|541489596|FG007|Overall Study|Adverse Event|1|||
150095197|NCT00642941|541489597|FG008|Overall Study|Adverse Event|0|||
150095198|NCT00642941|541489598|FG009|Overall Study|Adverse Event|1|||
150095199|NCT00642941|541489599|FG010|Overall Study|Adverse Event|0|||
150095200|NCT00642941|541489600|FG011|Overall Study|Adverse Event|0|||
150095201|NCT00642941|541489589|FG000|Overall Study|Other|1|||
150095202|NCT00642941|541489590|FG001|Overall Study|Other|1|||
150095203|NCT00642941|541489591|FG002|Overall Study|Other|1|||
150095204|NCT00642941|541489592|FG003|Overall Study|Other|1|||
150095205|NCT00642941|541489593|FG004|Overall Study|Other|0|||
150095206|NCT00642941|541489594|FG005|Overall Study|Other|1|||
150095207|NCT00642941|541489595|FG006|Overall Study|Other|0|||
150095208|NCT00642941|541489596|FG007|Overall Study|Other|1|||
150095209|NCT00642941|541489597|FG008|Overall Study|Other|0|||
150095210|NCT00642941|541489598|FG009|Overall Study|Other|0|||
150095211|NCT00642941|541489599|FG010|Overall Study|Other|0|||
150095212|NCT00642941|541489600|FG011|Overall Study|Other|1|||
150095213|NCT00642941|541489589|FG000|Overall Study|Disease progression|60|||
150095214|NCT00642941|541489590|FG001|Overall Study|Disease progression|50|||
150095215|NCT00642941|541489591|FG002|Overall Study|Disease progression|5|||
150095216|NCT00642941|541489592|FG003|Overall Study|Disease progression|36|||
150095217|NCT00642941|541489593|FG004|Overall Study|Disease progression|23|||
150095218|NCT00642941|541489594|FG005|Overall Study|Disease progression|39|||
150095219|NCT00642941|541489595|FG006|Overall Study|Disease progression|18|||
150095220|NCT00642941|541489596|FG007|Overall Study|Disease progression|12|||
150095221|NCT00642941|541489597|FG008|Overall Study|Disease progression|10|||
150095222|NCT00642941|541489598|FG009|Overall Study|Disease progression|7|||
150095223|NCT00642941|541489599|FG010|Overall Study|Disease progression|12|||
150095224|NCT00642941|541489600|FG011|Overall Study|Disease progression|7|||
150095225|NCT00553150|541489601|FG000|Overall Study|Withdrawal by Subject|0|||
150095226|NCT00553150|541489602|FG001|Overall Study|Withdrawal by Subject|0|||
150095227|NCT00553150|541489603|FG002|Overall Study|Withdrawal by Subject|0|||
150095228|NCT00553150|541489604|FG003|Overall Study|Withdrawal by Subject|2|||
150095229|NCT00553150|541489601|FG000|Overall Study|Protocol Violation|0|||
150095230|NCT00553150|541489602|FG001|Overall Study|Protocol Violation|0|||
150095231|NCT00553150|541489603|FG002|Overall Study|Protocol Violation|0|||
150095232|NCT00553150|541489604|FG003|Overall Study|Protocol Violation|1|||
150095233|NCT00553150|541489601|FG000|Overall Study|Ineligible|0|||
150095234|NCT00553150|541489602|FG001|Overall Study|Ineligible|0|||
150095235|NCT00553150|541489603|FG002|Overall Study|Ineligible|0|||
150095236|NCT00553150|541489604|FG003|Overall Study|Ineligible|1|||
150095237|NCT03559257|541489607|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
150095238|NCT03559257|541489608|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
150095239|NCT03559257|541489607|FG000|Double Blind Treatment Period|Protocol Violation|1|||
150095240|NCT03559257|541489608|FG001|Double Blind Treatment Period|Protocol Violation|4|||
150095241|NCT03559257|541489607|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
150095242|NCT03559257|541489608|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
150095243|NCT03559257|541489607|FG000|Double Blind Treatment Period|Adverse Event|0|||
150095244|NCT03559257|541489608|FG001|Double Blind Treatment Period|Adverse Event|1|||
150095245|NCT03559257|541489607|FG000|Double Blind Treatment Period|Screen Failure|0|||
150095246|NCT03559257|541489608|FG001|Double Blind Treatment Period|Screen Failure|1|||
150095247|NCT03559257|541489607|FG000|Open-label Treatment Period|Adverse Event|1|||
150095248|NCT03559257|541489608|FG001|Open-label Treatment Period|Adverse Event|4|||
150095249|NCT03559257|541489607|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
150095250|NCT03559257|541489608|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
150095251|NCT03559257|541489607|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
150095252|NCT03559257|541489608|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
150095253|NCT03559257|541489607|FG000|Open-label Treatment Period|Protocol Violation|2|||
150095254|NCT03559257|541489608|FG001|Open-label Treatment Period|Protocol Violation|0|||
150095255|NCT03559257|541489607|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
150095256|NCT03559257|541489608|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
150095257|NCT03559257|541489607|FG000|Open-label Treatment Period|Physician Decision|0|||
150095258|NCT03559257|541489608|FG001|Open-label Treatment Period|Physician Decision|1|||
150095259|NCT03204305|541489609|FG000|Overall Study|Lost to Follow-up|6|||
150095260|NCT03204305|541489610|FG001|Overall Study|Lost to Follow-up|4|||
150095261|NCT03204305|541489611|FG002|Overall Study|Lost to Follow-up|0|||
150095262|NCT03204305|541489612|FG003|Overall Study|Lost to Follow-up|0|||
150095263|NCT03204305|541489609|FG000|Overall Study|Physician Decision|1|||
150095264|NCT03204305|541489610|FG001|Overall Study|Physician Decision|0|||
150095265|NCT03204305|541489611|FG002|Overall Study|Physician Decision|0|||
150095266|NCT03204305|541489612|FG003|Overall Study|Physician Decision|0|||
150095267|NCT03204305|541489609|FG000|Overall Study|failure to place arterial line|2|||
150095268|NCT03204305|541489610|FG001|Overall Study|failure to place arterial line|1|||
150095269|NCT03204305|541489611|FG002|Overall Study|failure to place arterial line|0|||
150095270|NCT03204305|541489612|FG003|Overall Study|failure to place arterial line|0|||
150095271|NCT03204305|541489609|FG000|Overall Study|Withdrawal by Subject|2|||
150095272|NCT03204305|541489610|FG001|Overall Study|Withdrawal by Subject|0|||
150095273|NCT03204305|541489611|FG002|Overall Study|Withdrawal by Subject|0|||
150095274|NCT03204305|541489612|FG003|Overall Study|Withdrawal by Subject|0|||
150095275|NCT00455429|541489613|FG000|Overall Study|Study Terminated by Sponsor|0|||
150095276|NCT00455429|541489614|FG001|Overall Study|Study Terminated by Sponsor|0|||
150095277|NCT00455429|541489615|FG002|Overall Study|Study Terminated by Sponsor|0|||
150095278|NCT00455429|541489616|FG003|Overall Study|Study Terminated by Sponsor|3|||
150095279|NCT00455429|541489613|FG000|Overall Study|Lost to Follow-up|1|||
150095280|NCT00455429|541489614|FG001|Overall Study|Lost to Follow-up|0|||
150095281|NCT00455429|541489615|FG002|Overall Study|Lost to Follow-up|0|||
150095282|NCT00455429|541489616|FG003|Overall Study|Lost to Follow-up|3|||
150095283|NCT00455429|541489613|FG000|Overall Study|Withdrawal by Subject|0|||
150095284|NCT00455429|541489614|FG001|Overall Study|Withdrawal by Subject|1|||
150095285|NCT00455429|541489615|FG002|Overall Study|Withdrawal by Subject|1|||
150095286|NCT00455429|541489616|FG003|Overall Study|Withdrawal by Subject|0|||
150095287|NCT00455429|541489613|FG000|Overall Study|Lack of Efficacy|0|||
150095288|NCT00455429|541489614|FG001|Overall Study|Lack of Efficacy|1|||
150095289|NCT00455429|541489615|FG002|Overall Study|Lack of Efficacy|0|||
150095290|NCT00455429|541489616|FG003|Overall Study|Lack of Efficacy|1|||
150095291|NCT00455429|541489613|FG000|Overall Study|Adverse Event|0|||
150095292|NCT00455429|541489614|FG001|Overall Study|Adverse Event|1|||
150095293|NCT00455429|541489615|FG002|Overall Study|Adverse Event|0|||
150095294|NCT00455429|541489616|FG003|Overall Study|Adverse Event|3|||
150095295|NCT00455429|541489613|FG000|Overall Study|Randomly assigned but not treated|0|||
150095296|NCT00455429|541489614|FG001|Overall Study|Randomly assigned but not treated|0|||
150095297|NCT00455429|541489615|FG002|Overall Study|Randomly assigned but not treated|0|||
150095298|NCT00455429|541489616|FG003|Overall Study|Randomly assigned but not treated|2|||
150095299|NCT00455429|541489613|FG000|Overall Study|Personal Reason|1|||
150095300|NCT00455429|541489614|FG001|Overall Study|Personal Reason|0|||
150095301|NCT00455429|541489615|FG002|Overall Study|Personal Reason|0|||
150095302|NCT00455429|541489616|FG003|Overall Study|Personal Reason|0|||
150095303|NCT00455429|541489613|FG000|Overall Study|Non-compliance|0|||
150095304|NCT00455429|541489614|FG001|Overall Study|Non-compliance|0|||
150095305|NCT00455429|541489615|FG002|Overall Study|Non-compliance|0|||
150095306|NCT00455429|541489616|FG003|Overall Study|Non-compliance|1|||
150095307|NCT00455429|541489613|FG000|Overall Study|Other|0|||
150095308|NCT00455429|541489614|FG001|Overall Study|Other|2|||
150095309|NCT00455429|541489615|FG002|Overall Study|Other|0|||
150095310|NCT00455429|541489616|FG003|Overall Study|Other|1|||
150095311|NCT01165554|541489617|FG000|Overall Study|Withdrawal by Subject|23|||
150095312|NCT00101907|541489622|FG000|Overall Study|Adverse Event|1|||
150095313|NCT00101907|541489623|FG001|Overall Study|Adverse Event|0|||
150095314|NCT00101907|541489624|FG002|Overall Study|Adverse Event|0|||
150095315|NCT00101907|541489625|FG003|Overall Study|Adverse Event|0|||
150095316|NCT00101907|541489626|FG004|Overall Study|Adverse Event|0|||
150095317|NCT00101907|541489627|FG005|Overall Study|Adverse Event|0|||
150095318|NCT00101907|541489622|FG000|Overall Study|Death|0|||
150095319|NCT00101907|541489623|FG001|Overall Study|Death|1|||
150095320|NCT00101907|541489624|FG002|Overall Study|Death|0|||
150095321|NCT00101907|541489625|FG003|Overall Study|Death|0|||
150095322|NCT00101907|541489626|FG004|Overall Study|Death|3|||
150095323|NCT00101907|541489627|FG005|Overall Study|Death|0|||
150095324|NCT00101907|541489622|FG000|Overall Study|Physician Decision|0|||
150095325|NCT00101907|541489623|FG001|Overall Study|Physician Decision|0|||
150095326|NCT00101907|541489624|FG002|Overall Study|Physician Decision|0|||
150095327|NCT00101907|541489625|FG003|Overall Study|Physician Decision|1|||
150184836|NCT01872078|541814490|FG003|Overall Study|Dose administration non-compliance|1|||
150184837|NCT01872078|541814487|FG000|Overall Study|Protocol Violation|0|||
150184838|NCT01872078|541814488|FG001|Overall Study|Protocol Violation|0|||
150184839|NCT01872078|541814489|FG002|Overall Study|Protocol Violation|1|||
150184840|NCT01872078|541814490|FG003|Overall Study|Protocol Violation|0|||
150184841|NCT01872078|541814487|FG000|Overall Study|Withdrawal by Subject|0|||
150184842|NCT01872078|541814488|FG001|Overall Study|Withdrawal by Subject|0|||
150184843|NCT01872078|541814489|FG002|Overall Study|Withdrawal by Subject|1|||
150184844|NCT01872078|541814490|FG003|Overall Study|Withdrawal by Subject|0|||
150184845|NCT01872078|541814487|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
150184846|NCT01872078|541814488|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
150184847|NCT01872078|541814489|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
150184848|NCT01872078|541814490|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
150095328|NCT00101907|541489626|FG004|Overall Study|Physician Decision|1|||
150095329|NCT00101907|541489627|FG005|Overall Study|Physician Decision|0|||
150184849|NCT01721291|541814494|FG000|Overall Study|Withdrawal by Subject|1|||
150095330|NCT00101907|541489622|FG000|Overall Study|Withdrawal by Subject|1|||
150095331|NCT00101907|541489623|FG001|Overall Study|Withdrawal by Subject|0|||
150095332|NCT00101907|541489624|FG002|Overall Study|Withdrawal by Subject|1|||
150095333|NCT00101907|541489625|FG003|Overall Study|Withdrawal by Subject|0|||
150095334|NCT00101907|541489626|FG004|Overall Study|Withdrawal by Subject|1|||
150095335|NCT00101907|541489627|FG005|Overall Study|Withdrawal by Subject|0|||
150095336|NCT04568590|541491512|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
150095337|NCT04708886|541491519|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
150095338|NCT04708886|541491519|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
150095339|NCT01729754|541491520|FG000|Part 1|Adverse Event|2|||
150095340|NCT01729754|541491521|FG001|Part 1|Adverse Event|0|||
150095341|NCT01729754|541491522|FG002|Part 1|Adverse Event|0|||
150095342|NCT01729754|541491523|FG003|Part 1|Adverse Event|1|||
150095343|NCT01729754|541491524|FG004|Part 1|Adverse Event|0|||
150095344|NCT01729754|541491525|FG005|Part 1|Adverse Event|0|||
150095345|NCT01729754|541491526|FG006|Part 1|Adverse Event|2|||
150095346|NCT01729754|541491527|FG007|Part 1|Adverse Event|0|||
150095347|NCT01729754|541491528|FG008|Part 1|Adverse Event|0|||
150095348|NCT01729754|541491529|FG009|Part 1|Adverse Event|5|||
150095349|NCT01729754|541491520|FG000|Part 1|Lack of Efficacy|1|||
150095350|NCT01729754|541491521|FG001|Part 1|Lack of Efficacy|0|||
150095351|NCT01729754|541491522|FG002|Part 1|Lack of Efficacy|0|||
150095352|NCT01729754|541491523|FG003|Part 1|Lack of Efficacy|0|||
150095353|NCT01729754|541491524|FG004|Part 1|Lack of Efficacy|0|||
150095354|NCT01729754|541491525|FG005|Part 1|Lack of Efficacy|0|||
150095355|NCT01729754|541491526|FG006|Part 1|Lack of Efficacy|2|||
150095356|NCT01729754|541491527|FG007|Part 1|Lack of Efficacy|0|||
150095357|NCT01729754|541491528|FG008|Part 1|Lack of Efficacy|0|||
150095358|NCT01729754|541491529|FG009|Part 1|Lack of Efficacy|0|||
150095359|NCT01729754|541491520|FG000|Part 1|Lost to Follow-up|1|||
150095360|NCT01729754|541491521|FG001|Part 1|Lost to Follow-up|0|||
150095361|NCT01729754|541491522|FG002|Part 1|Lost to Follow-up|0|||
150095362|NCT01729754|541491523|FG003|Part 1|Lost to Follow-up|2|||
150095363|NCT01729754|541491524|FG004|Part 1|Lost to Follow-up|0|||
150095364|NCT01729754|541491525|FG005|Part 1|Lost to Follow-up|0|||
150095365|NCT01729754|541491526|FG006|Part 1|Lost to Follow-up|3|||
150095366|NCT01729754|541491527|FG007|Part 1|Lost to Follow-up|0|||
150095367|NCT01729754|541491528|FG008|Part 1|Lost to Follow-up|0|||
150095368|NCT01729754|541491529|FG009|Part 1|Lost to Follow-up|3|||
150095369|NCT01729754|541491520|FG000|Part 1|Non-compliance with Study Drug|1|||
150095370|NCT01729754|541491521|FG001|Part 1|Non-compliance with Study Drug|0|||
150095371|NCT01729754|541491522|FG002|Part 1|Non-compliance with Study Drug|0|||
150095372|NCT01729754|541491523|FG003|Part 1|Non-compliance with Study Drug|0|||
150095373|NCT01729754|541491524|FG004|Part 1|Non-compliance with Study Drug|0|||
150095374|NCT01729754|541491525|FG005|Part 1|Non-compliance with Study Drug|0|||
150095375|NCT01729754|541491526|FG006|Part 1|Non-compliance with Study Drug|0|||
150095376|NCT01729754|541491527|FG007|Part 1|Non-compliance with Study Drug|0|||
150095377|NCT01729754|541491528|FG008|Part 1|Non-compliance with Study Drug|0|||
150095378|NCT01729754|541491529|FG009|Part 1|Non-compliance with Study Drug|0|||
150095379|NCT01729754|541491520|FG000|Part 1|Physician Decision|0|||
150095380|NCT01729754|541491521|FG001|Part 1|Physician Decision|0|||
150095381|NCT01729754|541491522|FG002|Part 1|Physician Decision|0|||
150095382|NCT01729754|541491523|FG003|Part 1|Physician Decision|0|||
150095383|NCT01729754|541491524|FG004|Part 1|Physician Decision|0|||
150095384|NCT01729754|541491525|FG005|Part 1|Physician Decision|0|||
150095385|NCT01729754|541491526|FG006|Part 1|Physician Decision|0|||
150095386|NCT01729754|541491527|FG007|Part 1|Physician Decision|0|||
150095387|NCT01729754|541491528|FG008|Part 1|Physician Decision|0|||
150095388|NCT01729754|541491529|FG009|Part 1|Physician Decision|4|||
150095389|NCT01729754|541491520|FG000|Part 1|Pregnancy|0|||
150095390|NCT01729754|541491521|FG001|Part 1|Pregnancy|0|||
150095391|NCT01729754|541491522|FG002|Part 1|Pregnancy|0|||
150095392|NCT01729754|541491523|FG003|Part 1|Pregnancy|1|||
150095393|NCT01729754|541491524|FG004|Part 1|Pregnancy|0|||
150095394|NCT01729754|541491525|FG005|Part 1|Pregnancy|0|||
150095395|NCT01729754|541491526|FG006|Part 1|Pregnancy|0|||
150095396|NCT01729754|541491527|FG007|Part 1|Pregnancy|0|||
150095397|NCT01729754|541491528|FG008|Part 1|Pregnancy|0|||
150095398|NCT01729754|541491529|FG009|Part 1|Pregnancy|1|||
150095399|NCT01729754|541491520|FG000|Part 1|Progressive Disease|0|||
150095400|NCT01729754|541491521|FG001|Part 1|Progressive Disease|0|||
150095401|NCT01729754|541491522|FG002|Part 1|Progressive Disease|0|||
150095402|NCT01729754|541491523|FG003|Part 1|Progressive Disease|0|||
150095403|NCT01729754|541491524|FG004|Part 1|Progressive Disease|0|||
150095404|NCT01729754|541491525|FG005|Part 1|Progressive Disease|0|||
150095405|NCT01729754|541491526|FG006|Part 1|Progressive Disease|0|||
150095406|NCT01729754|541491527|FG007|Part 1|Progressive Disease|0|||
150095407|NCT01729754|541491528|FG008|Part 1|Progressive Disease|0|||
150095408|NCT01729754|541491529|FG009|Part 1|Progressive Disease|1|||
150095409|NCT01729754|541491520|FG000|Part 1|Protocol Violation|2|||
150095410|NCT01729754|541491521|FG001|Part 1|Protocol Violation|0|||
150095411|NCT01729754|541491522|FG002|Part 1|Protocol Violation|0|||
150095412|NCT01729754|541491523|FG003|Part 1|Protocol Violation|1|||
150095413|NCT01729754|541491524|FG004|Part 1|Protocol Violation|0|||
150095414|NCT01729754|541491525|FG005|Part 1|Protocol Violation|0|||
150095415|NCT01729754|541491526|FG006|Part 1|Protocol Violation|1|||
150095416|NCT01729754|541491527|FG007|Part 1|Protocol Violation|0|||
150095417|NCT01729754|541491528|FG008|Part 1|Protocol Violation|0|||
150095418|NCT01729754|541491529|FG009|Part 1|Protocol Violation|0|||
150095419|NCT01729754|541491520|FG000|Part 1|Withdrawal by Subject|5|||
150095420|NCT01729754|541491521|FG001|Part 1|Withdrawal by Subject|0|||
150095421|NCT01729754|541491522|FG002|Part 1|Withdrawal by Subject|0|||
150095422|NCT01729754|541491523|FG003|Part 1|Withdrawal by Subject|7|||
150095423|NCT01729754|541491524|FG004|Part 1|Withdrawal by Subject|0|||
150095424|NCT01729754|541491525|FG005|Part 1|Withdrawal by Subject|0|||
150095425|NCT01729754|541491526|FG006|Part 1|Withdrawal by Subject|5|||
150095426|NCT01729754|541491527|FG007|Part 1|Withdrawal by Subject|0|||
150095427|NCT01729754|541491528|FG008|Part 1|Withdrawal by Subject|0|||
150095428|NCT01729754|541491529|FG009|Part 1|Withdrawal by Subject|6|||
150095429|NCT01729754|541491520|FG000|Part 1|Other Protocol Specified Criteria|2|||
150095430|NCT01729754|541491521|FG001|Part 1|Other Protocol Specified Criteria|0|||
150095431|NCT01729754|541491522|FG002|Part 1|Other Protocol Specified Criteria|0|||
150095432|NCT01729754|541491523|FG003|Part 1|Other Protocol Specified Criteria|0|||
150095433|NCT01729754|541491524|FG004|Part 1|Other Protocol Specified Criteria|0|||
150095434|NCT01729754|541491525|FG005|Part 1|Other Protocol Specified Criteria|0|||
150095435|NCT01729754|541491526|FG006|Part 1|Other Protocol Specified Criteria|1|||
150095436|NCT01729754|541491527|FG007|Part 1|Other Protocol Specified Criteria|0|||
150095437|NCT01729754|541491528|FG008|Part 1|Other Protocol Specified Criteria|0|||
150095438|NCT01729754|541491529|FG009|Part 1|Other Protocol Specified Criteria|4|||
150095439|NCT01729754|541491520|FG000|Part 2|Adverse Event|2|||
150095440|NCT01729754|541491521|FG001|Part 2|Adverse Event|0|||
150095441|NCT01729754|541491522|FG002|Part 2|Adverse Event|0|||
150095442|NCT01729754|541491523|FG003|Part 2|Adverse Event|0|||
150095443|NCT01729754|541491524|FG004|Part 2|Adverse Event|0|||
150095444|NCT01729754|541491525|FG005|Part 2|Adverse Event|0|||
150095445|NCT01729754|541491526|FG006|Part 2|Adverse Event|0|||
150095446|NCT01729754|541491527|FG007|Part 2|Adverse Event|0|||
150095447|NCT01729754|541491528|FG008|Part 2|Adverse Event|1|||
150095448|NCT01729754|541491529|FG009|Part 2|Adverse Event|2|||
150095449|NCT01729754|541491520|FG000|Part 2|Lack of Efficacy|0|||
150095450|NCT01729754|541491521|FG001|Part 2|Lack of Efficacy|0|||
150095451|NCT01729754|541491522|FG002|Part 2|Lack of Efficacy|0|||
150095452|NCT01729754|541491523|FG003|Part 2|Lack of Efficacy|0|||
150095453|NCT01729754|541491524|FG004|Part 2|Lack of Efficacy|0|||
150095454|NCT01729754|541491525|FG005|Part 2|Lack of Efficacy|0|||
150095455|NCT01729754|541491526|FG006|Part 2|Lack of Efficacy|0|||
150095456|NCT01729754|541491527|FG007|Part 2|Lack of Efficacy|0|||
150095457|NCT01729754|541491528|FG008|Part 2|Lack of Efficacy|2|||
150095458|NCT01729754|541491529|FG009|Part 2|Lack of Efficacy|2|||
150095459|NCT01729754|541491520|FG000|Part 2|Lost to Follow-up|0|||
150095460|NCT01729754|541491521|FG001|Part 2|Lost to Follow-up|0|||
150095461|NCT01729754|541491522|FG002|Part 2|Lost to Follow-up|0|||
150095462|NCT01729754|541491523|FG003|Part 2|Lost to Follow-up|2|||
150095463|NCT01729754|541491524|FG004|Part 2|Lost to Follow-up|0|||
150095464|NCT01729754|541491525|FG005|Part 2|Lost to Follow-up|0|||
150095465|NCT01729754|541491526|FG006|Part 2|Lost to Follow-up|0|||
150095466|NCT01729754|541491527|FG007|Part 2|Lost to Follow-up|1|||
150184850|NCT01721291|541814495|FG001|Overall Study|Withdrawal by Subject|0|||
150184851|NCT01721291|541814494|FG000|Overall Study|did not like the treatment|1|||
150184852|NCT01721291|541814495|FG001|Overall Study|did not like the treatment|0|||
150184853|NCT01091168|541814496|FG000|Overall Study|Progressive disease|250|||
150184854|NCT01091168|541814497|FG001|Overall Study|Progressive disease|234|||
150184855|NCT01091168|541814496|FG000|Overall Study|Adverse Event|21|||
150184856|NCT01091168|541814497|FG001|Overall Study|Adverse Event|24|||
150184857|NCT01091168|541814496|FG000|Overall Study|Lost to Follow-up|0|||
150184858|NCT01091168|541814497|FG001|Overall Study|Lost to Follow-up|1|||
150184859|NCT01091168|541814496|FG000|Overall Study|Physician, patient's decision, other|27|||
150184860|NCT01091168|541814497|FG001|Overall Study|Physician, patient's decision, other|37|||
150184861|NCT03767517|541814502|FG000|Overall Study|Lost to Follow-up|16|||
150095467|NCT01729754|541491528|FG008|Part 2|Lost to Follow-up|0|||
150095468|NCT01729754|541491529|FG009|Part 2|Lost to Follow-up|2|||
150184862|NCT03767517|541814503|FG001|Overall Study|Lost to Follow-up|10|||
150184863|NCT03767517|541814502|FG000|Overall Study|Death|2|||
150095469|NCT01729754|541491520|FG000|Part 2|Non-Compliance with Study Drug|0|||
150095470|NCT01729754|541491521|FG001|Part 2|Non-Compliance with Study Drug|0|||
150184864|NCT03767517|541814503|FG001|Overall Study|Death|3|||
150184865|NCT05239039|541814505|FG000|Overall Study|Withdrawal by Subject|0|||
150095471|NCT01729754|541491522|FG002|Part 2|Non-Compliance with Study Drug|0|||
150095472|NCT01729754|541491523|FG003|Part 2|Non-Compliance with Study Drug|0|||
150095473|NCT01729754|541491524|FG004|Part 2|Non-Compliance with Study Drug|0|||
150095474|NCT01729754|541491525|FG005|Part 2|Non-Compliance with Study Drug|0|||
150095475|NCT01729754|541491526|FG006|Part 2|Non-Compliance with Study Drug|0|||
150095476|NCT01729754|541491527|FG007|Part 2|Non-Compliance with Study Drug|0|||
150095477|NCT01729754|541491528|FG008|Part 2|Non-Compliance with Study Drug|0|||
150095478|NCT01729754|541491529|FG009|Part 2|Non-Compliance with Study Drug|1|||
150095479|NCT01729754|541491520|FG000|Part 2|Pregnancy|0|||
150095480|NCT01729754|541491521|FG001|Part 2|Pregnancy|0|||
150095481|NCT01729754|541491522|FG002|Part 2|Pregnancy|0|||
150095482|NCT01729754|541491523|FG003|Part 2|Pregnancy|1|||
150095483|NCT01729754|541491524|FG004|Part 2|Pregnancy|0|||
150095484|NCT01729754|541491525|FG005|Part 2|Pregnancy|0|||
150095485|NCT01729754|541491526|FG006|Part 2|Pregnancy|0|||
150095486|NCT01729754|541491527|FG007|Part 2|Pregnancy|0|||
150095487|NCT01729754|541491528|FG008|Part 2|Pregnancy|0|||
150095488|NCT01729754|541491529|FG009|Part 2|Pregnancy|1|||
150095489|NCT01729754|541491520|FG000|Part 2|Withdrawal by Subject|3|||
150095490|NCT01729754|541491521|FG001|Part 2|Withdrawal by Subject|0|||
150095491|NCT01729754|541491522|FG002|Part 2|Withdrawal by Subject|0|||
150095492|NCT01729754|541491523|FG003|Part 2|Withdrawal by Subject|2|||
150095493|NCT01729754|541491524|FG004|Part 2|Withdrawal by Subject|0|||
150095494|NCT01729754|541491525|FG005|Part 2|Withdrawal by Subject|0|||
150095495|NCT01729754|541491526|FG006|Part 2|Withdrawal by Subject|0|||
150095496|NCT01729754|541491527|FG007|Part 2|Withdrawal by Subject|1|||
150095497|NCT01729754|541491528|FG008|Part 2|Withdrawal by Subject|1|||
150095498|NCT01729754|541491529|FG009|Part 2|Withdrawal by Subject|4|||
150095499|NCT01729754|541491520|FG000|Part 2|Other Protocol Specified Criteria|1|||
150095500|NCT01729754|541491521|FG001|Part 2|Other Protocol Specified Criteria|0|||
150095501|NCT01729754|541491522|FG002|Part 2|Other Protocol Specified Criteria|0|||
150095502|NCT01729754|541491523|FG003|Part 2|Other Protocol Specified Criteria|0|||
150095503|NCT01729754|541491524|FG004|Part 2|Other Protocol Specified Criteria|0|||
150095504|NCT01729754|541491525|FG005|Part 2|Other Protocol Specified Criteria|0|||
150095505|NCT01729754|541491526|FG006|Part 2|Other Protocol Specified Criteria|0|||
150095506|NCT01729754|541491527|FG007|Part 2|Other Protocol Specified Criteria|1|||
150095507|NCT01729754|541491528|FG008|Part 2|Other Protocol Specified Criteria|0|||
150095508|NCT01729754|541491529|FG009|Part 2|Other Protocol Specified Criteria|0|||
150095509|NCT01729754|541491520|FG000|Part 3|Adverse Event|0|||
150095510|NCT01729754|541491521|FG001|Part 3|Adverse Event|0|||
150095511|NCT01729754|541491522|FG002|Part 3|Adverse Event|1|||
150095512|NCT01729754|541491523|FG003|Part 3|Adverse Event|0|||
150095513|NCT01729754|541491524|FG004|Part 3|Adverse Event|0|||
150095514|NCT01729754|541491525|FG005|Part 3|Adverse Event|5|||
150095515|NCT01729754|541491526|FG006|Part 3|Adverse Event|0|||
150095516|NCT01729754|541491527|FG007|Part 3|Adverse Event|0|||
150095517|NCT01729754|541491528|FG008|Part 3|Adverse Event|0|||
150095518|NCT01729754|541491529|FG009|Part 3|Adverse Event|3|||
150095519|NCT01729754|541491520|FG000|Part 3|Death|0|||
150095520|NCT01729754|541491521|FG001|Part 3|Death|0|||
150095521|NCT01729754|541491522|FG002|Part 3|Death|0|||
150095522|NCT01729754|541491523|FG003|Part 3|Death|0|||
150095523|NCT01729754|541491524|FG004|Part 3|Death|0|||
150095524|NCT01729754|541491525|FG005|Part 3|Death|2|||
150095525|NCT01729754|541491526|FG006|Part 3|Death|0|||
150095526|NCT01729754|541491527|FG007|Part 3|Death|0|||
150095527|NCT01729754|541491528|FG008|Part 3|Death|0|||
150095528|NCT01729754|541491529|FG009|Part 3|Death|0|||
150095529|NCT01729754|541491520|FG000|Part 3|Lack of Efficacy|0|||
150095530|NCT01729754|541491521|FG001|Part 3|Lack of Efficacy|0|||
150095531|NCT01729754|541491522|FG002|Part 3|Lack of Efficacy|0|||
150095532|NCT01729754|541491523|FG003|Part 3|Lack of Efficacy|0|||
150095533|NCT01729754|541491524|FG004|Part 3|Lack of Efficacy|2|||
150095534|NCT01729754|541491525|FG005|Part 3|Lack of Efficacy|0|||
150095535|NCT01729754|541491526|FG006|Part 3|Lack of Efficacy|0|||
150095536|NCT01729754|541491527|FG007|Part 3|Lack of Efficacy|0|||
150095537|NCT01729754|541491528|FG008|Part 3|Lack of Efficacy|0|||
150095538|NCT01729754|541491529|FG009|Part 3|Lack of Efficacy|4|||
150095539|NCT01729754|541491520|FG000|Part 3|Lost to Follow-up|0|||
150095540|NCT01729754|541491521|FG001|Part 3|Lost to Follow-up|1|||
150095541|NCT01729754|541491522|FG002|Part 3|Lost to Follow-up|2|||
150095542|NCT01729754|541491523|FG003|Part 3|Lost to Follow-up|0|||
150095543|NCT01729754|541491524|FG004|Part 3|Lost to Follow-up|0|||
150095544|NCT01729754|541491525|FG005|Part 3|Lost to Follow-up|3|||
150095545|NCT01729754|541491526|FG006|Part 3|Lost to Follow-up|0|||
150095546|NCT01729754|541491527|FG007|Part 3|Lost to Follow-up|0|||
150095547|NCT01729754|541491528|FG008|Part 3|Lost to Follow-up|1|||
150095548|NCT01729754|541491529|FG009|Part 3|Lost to Follow-up|0|||
150095549|NCT01729754|541491520|FG000|Part 3|Physician Decision|0|||
150095550|NCT01729754|541491521|FG001|Part 3|Physician Decision|0|||
150095551|NCT01729754|541491522|FG002|Part 3|Physician Decision|1|||
150095552|NCT01729754|541491523|FG003|Part 3|Physician Decision|0|||
150095553|NCT01729754|541491524|FG004|Part 3|Physician Decision|0|||
150095554|NCT01729754|541491525|FG005|Part 3|Physician Decision|0|||
150095555|NCT01729754|541491526|FG006|Part 3|Physician Decision|0|||
150095556|NCT01729754|541491527|FG007|Part 3|Physician Decision|0|||
150095557|NCT01729754|541491528|FG008|Part 3|Physician Decision|0|||
150095558|NCT01729754|541491529|FG009|Part 3|Physician Decision|0|||
150095559|NCT01729754|541491520|FG000|Part 3|Withdrawal by Subject|0|||
150095560|NCT01729754|541491521|FG001|Part 3|Withdrawal by Subject|4|||
150095561|NCT01729754|541491522|FG002|Part 3|Withdrawal by Subject|1|||
150095562|NCT01729754|541491523|FG003|Part 3|Withdrawal by Subject|0|||
150095563|NCT01729754|541491524|FG004|Part 3|Withdrawal by Subject|2|||
150095564|NCT01729754|541491525|FG005|Part 3|Withdrawal by Subject|1|||
150095565|NCT01729754|541491526|FG006|Part 3|Withdrawal by Subject|0|||
150095566|NCT01729754|541491527|FG007|Part 3|Withdrawal by Subject|2|||
150095567|NCT01729754|541491528|FG008|Part 3|Withdrawal by Subject|0|||
150095568|NCT01729754|541491529|FG009|Part 3|Withdrawal by Subject|0|||
150095569|NCT01729754|541491520|FG000|Part 3|Other Protocol Specified Criteria|0|||
150095570|NCT01729754|541491521|FG001|Part 3|Other Protocol Specified Criteria|0|||
150095571|NCT01729754|541491522|FG002|Part 3|Other Protocol Specified Criteria|0|||
150095572|NCT01729754|541491523|FG003|Part 3|Other Protocol Specified Criteria|0|||
150095573|NCT01729754|541491524|FG004|Part 3|Other Protocol Specified Criteria|0|||
150095574|NCT01729754|541491525|FG005|Part 3|Other Protocol Specified Criteria|2|||
150095575|NCT01729754|541491526|FG006|Part 3|Other Protocol Specified Criteria|0|||
150095576|NCT01729754|541491527|FG007|Part 3|Other Protocol Specified Criteria|1|||
150095577|NCT01729754|541491528|FG008|Part 3|Other Protocol Specified Criteria|0|||
150095578|NCT01729754|541491529|FG009|Part 3|Other Protocol Specified Criteria|0|||
150095579|NCT00202644|541491530|FG000|Overall Study|Adverse Event|12|||
150095580|NCT00202644|541491531|FG001|Overall Study|Adverse Event|13|||
150095581|NCT00202644|541491530|FG000|Overall Study|Withdrawal by Subject|8|||
150095582|NCT00202644|541491531|FG001|Overall Study|Withdrawal by Subject|6|||
150095583|NCT00202644|541491530|FG000|Overall Study|Lack of Efficacy|6|||
150095584|NCT00202644|541491531|FG001|Overall Study|Lack of Efficacy|6|||
150095585|NCT00202644|541491530|FG000|Overall Study|Lost to Follow-up|0|||
150095586|NCT00202644|541491531|FG001|Overall Study|Lost to Follow-up|1|||
150095587|NCT00202644|541491530|FG000|Overall Study|Other|9|||
150095588|NCT00202644|541491531|FG001|Overall Study|Other|1|||
150095589|NCT02750592|541491532|FG000|Overall Study|Adverse Event|3|||
150095590|NCT02750592|541491532|FG000|Overall Study|Lack of Efficacy|2|||
150095591|NCT02981342|541491533|FG000|Overall Study|Adverse Event|0|||
150095592|NCT02981342|541491534|FG001|Overall Study|Adverse Event|0|||
150095593|NCT02981342|541491535|FG002|Overall Study|Adverse Event|0|||
150095594|NCT02981342|541491536|FG003|Overall Study|Adverse Event|1|||
150095595|NCT02981342|541491533|FG000|Overall Study|Death|0|||
150095596|NCT02981342|541491534|FG001|Overall Study|Death|9|||
150095597|NCT02981342|541491535|FG002|Overall Study|Death|9|||
150095598|NCT02981342|541491536|FG003|Overall Study|Death|4|||
150095599|NCT02981342|541491533|FG000|Overall Study|Withdrawal by Subject|0|||
150095600|NCT02981342|541491534|FG001|Overall Study|Withdrawal by Subject|0|||
150095601|NCT02981342|541491535|FG002|Overall Study|Withdrawal by Subject|3|||
150095602|NCT02981342|541491536|FG003|Overall Study|Withdrawal by Subject|1|||
150095603|NCT02981342|541491533|FG000|Overall Study|Study closed by sponsor|0|||
150095604|NCT02981342|541491534|FG001|Overall Study|Study closed by sponsor|0|||
150095605|NCT02981342|541491535|FG002|Overall Study|Study closed by sponsor|1|||
150095606|NCT02981342|541491536|FG003|Overall Study|Study closed by sponsor|1|||
150095607|NCT02981342|541491533|FG000|Overall Study|Randomized, Never Treated|0|||
150095608|NCT02981342|541491534|FG001|Overall Study|Randomized, Never Treated|1|||
150095609|NCT02981342|541491535|FG002|Overall Study|Randomized, Never Treated|0|||
150095610|NCT02981342|541491536|FG003|Overall Study|Randomized, Never Treated|7|||
150095611|NCT02981342|541491533|FG000|Overall Study|Lost to Follow-up|0|||
150095612|NCT02981342|541491534|FG001|Overall Study|Lost to Follow-up|1|||
150095613|NCT02981342|541491535|FG002|Overall Study|Lost to Follow-up|0|||
150095614|NCT02981342|541491536|FG003|Overall Study|Lost to Follow-up|0|||
150095615|NCT01372501|541491537|FG000|Overall Study|Adverse Event|4|||
150095616|NCT01372501|541491537|FG000|Overall Study|Device migration|1|||
150095617|NCT04741074|541491538|FG000|Overall Study|Withdrawal by Subject|1|||
150095618|NCT04741074|541491539|FG001|Overall Study|Withdrawal by Subject|1|||
150095619|NCT04741074|541491538|FG000|Overall Study|Study terminated prematurely|1|||
150095620|NCT04741074|541491539|FG001|Overall Study|Study terminated prematurely|0|||
150095621|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Death|3|||
150095622|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Death|2|||
150095623|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Death|4|||
150095624|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Death|3|||
150095625|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Death|0|||
150095626|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Death|0|||
150095627|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
150095628|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
150095629|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
150095630|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
150095631|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
150095632|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
150095633|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
150095634|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
150095635|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
150095636|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
150095637|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
150095638|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
150095639|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
150095640|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
150095641|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
150095642|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
150095643|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
150095644|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
150095645|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
150095646|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
150095647|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
150095648|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
150095649|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
150095650|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
150095651|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
150095652|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
150095653|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
150095654|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
150095655|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
150095656|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
150095657|NCT02432846|541491540|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
150095658|NCT02432846|541491541|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
150095659|NCT02432846|541491542|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
150095660|NCT02432846|541491543|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
150095661|NCT02432846|541491544|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
150095662|NCT02432846|541491545|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
150095663|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
150095664|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
150095665|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
150095666|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
150095667|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
150095668|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
150095669|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
150095670|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
150095671|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
150095672|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
150095673|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
150095674|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
150095675|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
150095676|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
150095677|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
150095678|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
150095679|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
150095680|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
150095681|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
150095682|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
150095683|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
150095684|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
150095685|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
150095686|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
150095687|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
150095688|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
150095689|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
150095690|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
150095691|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
150095692|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
150095693|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
150095694|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
150095695|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
150095696|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
150095697|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
150095698|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
150095699|NCT02432846|541491540|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
150095700|NCT02432846|541491541|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
150095701|NCT02432846|541491542|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
150095702|NCT02432846|541491543|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
150095703|NCT02432846|541491544|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
150095704|NCT02432846|541491545|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
150095705|NCT01912287|541491546|FG000|Overall Study|Ineligible|1|||
150095706|NCT01912287|541491547|FG001|Overall Study|Ineligible|0|||
150095707|NCT01912287|541491548|FG002|Overall Study|Ineligible|1|||
150095708|NCT01912287|541491546|FG000|Overall Study|No-show|0|||
150095709|NCT01912287|541491547|FG001|Overall Study|No-show|0|||
150095710|NCT01912287|541491548|FG002|Overall Study|No-show|1|||
150095711|NCT01912287|541491546|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
150095712|NCT01912287|541491547|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
150095713|NCT01912287|541491548|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
150095714|NCT01912287|541491546|FG000|Overall Study|Felt treatment no longer needed|0|||
150095715|NCT01912287|541491547|FG001|Overall Study|Felt treatment no longer needed|1|||
150095716|NCT01912287|541491548|FG002|Overall Study|Felt treatment no longer needed|0|||
150095717|NCT01912287|541491546|FG000|Overall Study|Life circumstances|4|||
150095718|NCT01912287|541491547|FG001|Overall Study|Life circumstances|2|||
150095719|NCT01912287|541491548|FG002|Overall Study|Life circumstances|0|||
150095720|NCT01912287|541491546|FG000|Overall Study|Lost Interest|1|||
150095721|NCT01912287|541491547|FG001|Overall Study|Lost Interest|0|||
150095722|NCT01912287|541491548|FG002|Overall Study|Lost Interest|0|||
150095723|NCT01912287|541491546|FG000|Overall Study|Uknown reason - subject drop out|5|||
150095724|NCT01912287|541491547|FG001|Overall Study|Uknown reason - subject drop out|7|||
150095725|NCT01912287|541491548|FG002|Overall Study|Uknown reason - subject drop out|3|||
150184866|NCT05239039|541814506|FG001|Overall Study|Withdrawal by Subject|1|||
150184867|NCT03690206|541814508|FG000|Overall Study|Withdrawal by Subject|2|||
150184868|NCT03690206|541814509|FG001|Overall Study|Withdrawal by Subject|0|||
150184869|NCT03690206|541814510|FG002|Overall Study|Withdrawal by Subject|0|||
150184870|NCT03690206|541814508|FG000|Overall Study|ICF withdrawal|2|||
150184871|NCT03690206|541814509|FG001|Overall Study|ICF withdrawal|0|||
150184872|NCT03690206|541814510|FG002|Overall Study|ICF withdrawal|0|||
150184873|NCT03978637|541814511|FG000|Overall Study|Death|0|||
150184874|NCT03978637|541814512|FG001|Overall Study|Death|2|||
150184875|NCT03978637|541814513|FG002|Overall Study|Death|2|||
150184876|NCT03978637|541814514|FG003|Overall Study|Death|0|||
150184877|NCT03978637|541814511|FG000|Overall Study|Withdrawal by Subject|0|||
150184878|NCT03978637|541814512|FG001|Overall Study|Withdrawal by Subject|0|||
150184879|NCT03978637|541814513|FG002|Overall Study|Withdrawal by Subject|1|||
150184880|NCT03978637|541814514|FG003|Overall Study|Withdrawal by Subject|0|||
150184881|NCT03978637|541814511|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
150184882|NCT03978637|541814512|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
150184883|NCT03978637|541814513|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
150184884|NCT03978637|541814514|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
150184885|NCT03152786|541815702|FG000|Overall Study|Withdrawal by Subject|2|||
150184886|NCT03152786|541815703|FG001|Overall Study|Withdrawal by Subject|1|||
150184887|NCT04923347|541815704|FG000|Overall Study|Withdrawal by Subject|14|||
150184888|NCT02349412|541815705|FG000|Overall Study|Withdrawal by Subject|7|||
150184889|NCT02349412|541815706|FG001|Overall Study|Withdrawal by Subject|7|||
150184890|NCT05320432|541815720|FG000|Overall Study|Withdrawal by Subject|0|||
150184891|NCT05320432|541815721|FG001|Overall Study|Withdrawal by Subject|2|||
150184892|NCT05038566|541815722|FG000|Overall Study|Technical Difficulties with the Device|0|||
150184893|NCT05038566|541815723|FG001|Overall Study|Technical Difficulties with the Device|1|||
150184894|NCT00739648|541815729|FG000|Overall Study|Adverse Event|3|||
150184895|NCT00739648|541815730|FG001|Overall Study|Adverse Event|15|||
150184896|NCT00739648|541815729|FG000|Overall Study|Withdrawal by Subject|13|||
150184897|NCT00739648|541815730|FG001|Overall Study|Withdrawal by Subject|25|||
150184898|NCT00739648|541815729|FG000|Overall Study|Lost to Follow-up|4|||
150184899|NCT00739648|541815730|FG001|Overall Study|Lost to Follow-up|7|||
150184900|NCT00739648|541815729|FG000|Overall Study|Death|2|||
150184901|NCT00739648|541815730|FG001|Overall Study|Death|0|||
150184902|NCT00739648|541815729|FG000|Overall Study|Do not know|4|||
150184903|NCT00739648|541815730|FG001|Overall Study|Do not know|6|||
150184904|NCT02840474|541815733|FG000|Overall Study|Lost to Follow-up|1|||
150184905|NCT02840474|541815734|FG001|Overall Study|Lost to Follow-up|0|||
150184906|NCT03192891|541815735|FG000|Overall Study|Lost to Follow-up|55|||
150184907|NCT04850807|541815736|FG000|Overall Study|Death|50|||
150184908|NCT04850807|541815737|FG001|Overall Study|Death|55|||
150184909|NCT04850807|541815736|FG000|Overall Study|Discharged|17|||
150184910|NCT04850807|541815737|FG001|Overall Study|Discharged|13|||
150184911|NCT04850807|541815736|FG000|Overall Study|Incomplete baseline data|3|||
150184912|NCT04850807|541815737|FG001|Overall Study|Incomplete baseline data|2|||
150184913|NCT03739996|541815738|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
150184914|NCT03739996|541815738|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
150184915|NCT03739996|541815738|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
150184916|NCT03739996|541815738|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
150184917|NCT03739996|541815738|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
150184918|NCT03739996|541815738|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
150184919|NCT03739996|541815738|FG000|Step 3 (SOC ART)|Death|1|||
150184920|NCT03739996|541815738|FG000|Step 3 (SOC ART)|Participant moved|1|||
150184921|NCT05141903|541815740|FG000|Overall Study|Withdrawal by Subject|0|||
150184922|NCT05141903|541815741|FG001|Overall Study|Withdrawal by Subject|1|||
150184923|NCT05141903|541815742|FG002|Overall Study|Withdrawal by Subject|1|||
150184924|NCT05141903|541815743|FG003|Overall Study|Withdrawal by Subject|0|||
150184925|NCT05141903|541815744|FG004|Overall Study|Withdrawal by Subject|0|||
150184926|NCT05141903|541815740|FG000|Overall Study|Other|1|||
150184927|NCT05141903|541815741|FG001|Overall Study|Other|1|||
150184928|NCT05141903|541815742|FG002|Overall Study|Other|0|||
150184929|NCT05141903|541815743|FG003|Overall Study|Other|0|||
150184930|NCT05141903|541815744|FG004|Overall Study|Other|0|||
150184931|NCT04716634|541815745|FG000|Overall Study|Death|24|||
150184932|NCT04716634|541815746|FG001|Overall Study|Death|24|||
150184933|NCT04716634|541815747|FG002|Overall Study|Death|8|||
150184934|NCT04716634|541815745|FG000|Overall Study|Closed by Sponsor|4|||
150184935|NCT04716634|541815746|FG001|Overall Study|Closed by Sponsor|4|||
150184936|NCT04716634|541815747|FG002|Overall Study|Closed by Sponsor|5|||
150184937|NCT04716634|541815745|FG000|Overall Study|Lost to Follow-up|1|||
150184938|NCT04716634|541815746|FG001|Overall Study|Lost to Follow-up|0|||
150184939|NCT04716634|541815747|FG002|Overall Study|Lost to Follow-up|1|||
150184940|NCT04716634|541815745|FG000|Overall Study|Withdrawal by Subject|0|||
150184941|NCT04716634|541815746|FG001|Overall Study|Withdrawal by Subject|0|||
150184942|NCT04716634|541815747|FG002|Overall Study|Withdrawal by Subject|1|||
150095726|NCT01912287|541491546|FG000|Overall Study|Missed Assesment|1|||
150095727|NCT01912287|541491547|FG001|Overall Study|Missed Assesment|1|||
150095728|NCT01912287|541491548|FG002|Overall Study|Missed Assesment|1|||
150095729|NCT01912287|541491546|FG000|Overall Study|Scheduling/change in availability|17|||
150095730|NCT01912287|541491547|FG001|Overall Study|Scheduling/change in availability|10|||
150095731|NCT01912287|541491548|FG002|Overall Study|Scheduling/change in availability|8|||
150095732|NCT03226392|541491549|FG000|Overall Study|Protocol Deviation|1|||
150095733|NCT03226392|541491550|FG001|Overall Study|Protocol Deviation|0|||
150095734|NCT03226392|541491549|FG000|Overall Study|Physician Decision|1|||
150095735|NCT03226392|541491550|FG001|Overall Study|Physician Decision|0|||
150095736|NCT03226392|541491549|FG000|Overall Study|Lost to Follow-up|1|||
150095737|NCT03226392|541491550|FG001|Overall Study|Lost to Follow-up|0|||
150095738|NCT03226392|541491549|FG000|Overall Study|Adverse Event|1|||
150095739|NCT03226392|541491550|FG001|Overall Study|Adverse Event|0|||
150095740|NCT03226392|541491549|FG000|Overall Study|Technical Problems|0|||
150095741|NCT03226392|541491550|FG001|Overall Study|Technical Problems|2|||
150095742|NCT03226392|541491549|FG000|Overall Study|Subject/Guardian Decision|7|||
150095743|NCT03226392|541491550|FG001|Overall Study|Subject/Guardian Decision|6|||
150095744|NCT00937157|541491551|FG000|Overall Study|Pregnancy|1|||
150095745|NCT00937157|541491551|FG000|Overall Study|Lost to Follow-up|3|||
150095746|NCT02278263|541491552|FG000|Overall Study|Protocol Violation|7|||
150095747|NCT02278263|541491553|FG001|Overall Study|Protocol Violation|0|||
150095748|NCT02278263|541491554|FG002|Overall Study|Protocol Violation|9|||
150095749|NCT01998737|541491556|FG000|Overall Study|Corrupted database|23|||
150095750|NCT01998737|541491557|FG001|Overall Study|Corrupted database|0|||
150095751|NCT00326950|541491561|FG000|Overall Study|Progressive Disease|1|||
150095752|NCT01514760|541491562|FG000|Overall Study|Lost to Follow-up|2|||
150095753|NCT02092662|541491564|FG000|Overall Study|Lost to Follow-up|13|||
150095754|NCT02092662|541491565|FG001|Overall Study|Lost to Follow-up|0|||
150095755|NCT01132547|541491566|FG000|Overall Study|Withdrawal by Subject|3|||
150095756|NCT01132547|541491567|FG001|Overall Study|Withdrawal by Subject|1|||
150095757|NCT01132547|541491566|FG000|Overall Study|Death|1|||
150095758|NCT01132547|541491567|FG001|Overall Study|Death|0|||
150095759|NCT02710045|541491568|FG000|Overall Study|Death|1|||
150095760|NCT02710045|541491569|FG001|Overall Study|Death|2|||
150095761|NCT02710045|541491570|FG002|Overall Study|Death|0|||
150095762|NCT02710045|541491568|FG000|Overall Study|Withdrawal by Subject|6|||
150095763|NCT02710045|541491569|FG001|Overall Study|Withdrawal by Subject|6|||
150095764|NCT02710045|541491570|FG002|Overall Study|Withdrawal by Subject|2|||
150095765|NCT02710045|541491568|FG000|Overall Study|Protocol Violation|1|||
150095766|NCT02710045|541491569|FG001|Overall Study|Protocol Violation|2|||
150095767|NCT02710045|541491570|FG002|Overall Study|Protocol Violation|3|||
150095768|NCT02710045|541491568|FG000|Overall Study|Lost to Follow-up|3|||
150095769|NCT02710045|541491569|FG001|Overall Study|Lost to Follow-up|6|||
150095770|NCT02710045|541491570|FG002|Overall Study|Lost to Follow-up|7|||
150095771|NCT02710045|541491568|FG000|Overall Study|Physician Decision|0|||
150095772|NCT02710045|541491569|FG001|Overall Study|Physician Decision|0|||
150095773|NCT02710045|541491570|FG002|Overall Study|Physician Decision|1|||
150095774|NCT02710045|541491568|FG000|Overall Study|Poor Attendance|0|||
150095775|NCT02710045|541491569|FG001|Overall Study|Poor Attendance|1|||
150095776|NCT02710045|541491570|FG002|Overall Study|Poor Attendance|0|||
150095777|NCT04499781|541491571|FG000|Overall Study|Lost to Follow-up|2|||
150095778|NCT04499781|541491572|FG001|Overall Study|Lost to Follow-up|3|||
150095779|NCT04499781|541491571|FG000|Overall Study|Withdrawal by Subject|2|||
150095780|NCT04499781|541491572|FG001|Overall Study|Withdrawal by Subject|0|||
150184943|NCT05387447|541815748|FG000|Overall Study|Participants changed their minds about study participation.|3|||
150184944|NCT05387447|541815749|FG001|Overall Study|Participants changed their minds about study participation.|5|||
150184945|NCT02651324|541815752|FG000|Overall Study|drug not administered, due dispensing issue|1|||
150095781|NCT01275833|541491573|FG000|Overall Study|Study terminated|1|||
150095782|NCT01275833|541491574|FG001|Overall Study|Study terminated|1|||
150095783|NCT00227305|541491575|FG000|Overall Study|Adverse Event|40|||
150095784|NCT00227305|541491575|FG000|Overall Study|Withdrawal by Subject|42|||
150095785|NCT00227305|541491575|FG000|Overall Study|Lost to Follow-up|33|||
150095786|NCT00227305|541491575|FG000|Overall Study|Study specific discontinuation|13|||
150095787|NCT00227305|541491575|FG000|Overall Study|MOVED OUT OF AREA|3|||
150184946|NCT02651324|541815753|FG001|Overall Study|drug not administered, due dispensing issue|0|||
150095788|NCT00227305|541491575|FG000|Overall Study|Lack of Efficacy|7|||
150095789|NCT00227305|541491575|FG000|Overall Study|Physician Decision|3|||
150095790|NCT00227305|541491575|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
150095791|NCT00227305|541491575|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
150095792|NCT00227305|541491575|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
150095793|NCT02118012|541491576|FG000|Overall Study|Adverse Event|0|||
150095794|NCT02118012|541491577|FG001|Overall Study|Adverse Event|1|||
150095795|NCT02118012|541491576|FG000|Overall Study|Physician Decision|0|||
150095796|NCT02118012|541491577|FG001|Overall Study|Physician Decision|1|||
150095797|NCT04447755|541491582|FG000|Overall Study|Death|9|||
150095798|NCT04447755|541491583|FG001|Overall Study|Death|16|||
150095799|NCT04447755|541491584|FG002|Overall Study|Death|8|||
150095800|NCT04447755|541491585|FG003|Overall Study|Death|9|||
150095801|NCT04447755|541491586|FG004|Overall Study|Death|8|||
150095802|NCT04447755|541491587|FG005|Overall Study|Death|9|||
150095803|NCT04447755|541491588|FG006|Overall Study|Death|55|||
150095804|NCT04447755|541491582|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150095805|NCT04447755|541491583|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150095806|NCT04447755|541491584|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150095807|NCT04447755|541491585|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
150095808|NCT04447755|541491586|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
150184947|NCT02249949|541815754|FG000|Overall Study|Cancelled prior to treatment|2|||
150184948|NCT05054374|541815755|FG000|Overall Study|Withdrawal by Subject|1|||
150095809|NCT04447755|541491587|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
150095810|NCT04447755|541491588|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
150095811|NCT04447755|541491582|FG000|Overall Study|Sponsor Decision|0|||
150095812|NCT04447755|541491583|FG001|Overall Study|Sponsor Decision|0|||
150095813|NCT04447755|541491584|FG002|Overall Study|Sponsor Decision|0|||
150095814|NCT04447755|541491585|FG003|Overall Study|Sponsor Decision|0|||
150095815|NCT04447755|541491586|FG004|Overall Study|Sponsor Decision|1|||
150095816|NCT04447755|541491587|FG005|Overall Study|Sponsor Decision|0|||
150095817|NCT04447755|541491588|FG006|Overall Study|Sponsor Decision|10|||
150095818|NCT04447755|541491582|FG000|Overall Study|Lost to Follow-up|0|||
150095819|NCT04447755|541491583|FG001|Overall Study|Lost to Follow-up|0|||
150095820|NCT04447755|541491584|FG002|Overall Study|Lost to Follow-up|0|||
150095821|NCT04447755|541491585|FG003|Overall Study|Lost to Follow-up|0|||
150095822|NCT04447755|541491586|FG004|Overall Study|Lost to Follow-up|0|||
150095823|NCT04447755|541491587|FG005|Overall Study|Lost to Follow-up|0|||
150095824|NCT04447755|541491588|FG006|Overall Study|Lost to Follow-up|1|||
150095825|NCT03424265|541491589|FG000|Overall Study|screening failure|1|||
150095826|NCT03424265|541491590|FG001|Overall Study|screening failure|0|||
150095827|NCT03424265|541491589|FG000|Overall Study|Withdrawal by Subject|0|||
150095828|NCT03424265|541491590|FG001|Overall Study|Withdrawal by Subject|2|||
150095829|NCT03051607|541491594|FG000|Overall Study|Adverse Event|66|||
150095830|NCT03338855|541491596|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
150095831|NCT03338855|541491597|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
150095832|NCT02738450|541491598|FG000|Overall Study|Withdrawal by Subject|0|||
150095833|NCT02738450|541491599|FG001|Overall Study|Withdrawal by Subject|2|||
150095834|NCT02738450|541491600|FG002|Overall Study|Withdrawal by Subject|0|||
150095835|NCT01387347|541491602|FG000|Overall Study|Lost to Follow-up|2|||
150095836|NCT01387347|541491603|FG001|Overall Study|Lost to Follow-up|1|||
150095837|NCT03251079|541491604|FG000|Overall Study|Withdrawal by Subject|1|||
150095838|NCT01603459|541491610|FG000|Overall Study|Adverse Event|5|||
150095839|NCT01603459|541491610|FG000|Overall Study|Withdrawal by Subject|5|||
150095840|NCT01603459|541491610|FG000|Overall Study|Lost to Follow-up|3|||
150095841|NCT01603459|541491610|FG000|Overall Study|Predefined discontinuation criteria|3|||
150095842|NCT01603459|541491610|FG000|Overall Study|Non-compliance|1|||
150095843|NCT01603459|541491610|FG000|Overall Study|Administrative reason|1|||
150095844|NCT00399360|541491611|FG000|Overall Study|Lost to Follow-up|2|||
150095845|NCT00399360|541491612|FG001|Overall Study|Lost to Follow-up|1|||
150095846|NCT00399360|541491613|FG002|Overall Study|Lost to Follow-up|2|||
150095847|NCT00399360|541491614|FG003|Overall Study|Lost to Follow-up|4|||
150095848|NCT00399360|541491611|FG000|Overall Study|Adverse Event|0|||
150095849|NCT00399360|541491612|FG001|Overall Study|Adverse Event|0|||
150095850|NCT00399360|541491613|FG002|Overall Study|Adverse Event|1|||
150095851|NCT00399360|541491614|FG003|Overall Study|Adverse Event|0|||
150095852|NCT00399360|541491611|FG000|Overall Study|Withdrawal by Subject|0|||
150095853|NCT00399360|541491612|FG001|Overall Study|Withdrawal by Subject|2|||
150095854|NCT00399360|541491613|FG002|Overall Study|Withdrawal by Subject|0|||
150095855|NCT00399360|541491614|FG003|Overall Study|Withdrawal by Subject|2|||
150095856|NCT02953314|541491617|FG000|Overall Study|Adverse Event|0|||
150095857|NCT02953314|541491618|FG001|Overall Study|Adverse Event|1|||
150095858|NCT02953314|541491617|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
150095859|NCT02953314|541491618|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
150095860|NCT02335099|541491619|FG000|Treatment|Withdrawal by Subject|1|||
150095861|NCT02335099|541491620|FG001|Treatment|Withdrawal by Subject|3|||
150095862|NCT02335099|541491619|FG000|Treatment|Lost to Follow-up|2|||
150095863|NCT02335099|541491620|FG001|Treatment|Lost to Follow-up|0|||
150095864|NCT02335099|541491619|FG000|Treatment|Death|1|||
150095865|NCT02335099|541491620|FG001|Treatment|Death|0|||
150095866|NCT02335099|541491619|FG000|Treatment|Adverse Event|1|||
150095867|NCT02335099|541491620|FG001|Treatment|Adverse Event|2|||
150095868|NCT02335099|541491619|FG000|Follow-up|Death|0|||
150095869|NCT02335099|541491620|FG001|Follow-up|Death|1|||
150095870|NCT04948450|541491621|FG000|Overall Study|Return home|1|||
150095871|NCT04948450|541491622|FG001|Overall Study|Return home|3|||
150095872|NCT01474876|541491629|FG000|Overall Study|Adverse Event|11|||
150095873|NCT01474876|541491630|FG001|Overall Study|Adverse Event|5|||
150095874|NCT01474876|541491631|FG002|Overall Study|Adverse Event|0|||
150095875|NCT01474876|541491629|FG000|Overall Study|Serious Adverse Event|2|||
150095876|NCT01474876|541491630|FG001|Overall Study|Serious Adverse Event|3|||
150095877|NCT01474876|541491631|FG002|Overall Study|Serious Adverse Event|0|||
150095878|NCT01474876|541491629|FG000|Overall Study|Lost to Follow-up|5|||
150095879|NCT01474876|541491630|FG001|Overall Study|Lost to Follow-up|4|||
150095880|NCT01474876|541491631|FG002|Overall Study|Lost to Follow-up|0|||
150095881|NCT01474876|541491629|FG000|Overall Study|Investigator's decision|28|||
150095882|NCT01474876|541491630|FG001|Overall Study|Investigator's decision|6|||
150095883|NCT01474876|541491631|FG002|Overall Study|Investigator's decision|0|||
150095884|NCT01474876|541491629|FG000|Overall Study|Patient's request|19|||
150095885|NCT01474876|541491630|FG001|Overall Study|Patient's request|5|||
150095886|NCT01474876|541491631|FG002|Overall Study|Patient's request|0|||
150095887|NCT01474876|541491629|FG000|Overall Study|Investigator's decision and pt request|1|||
150095888|NCT01474876|541491630|FG001|Overall Study|Investigator's decision and pt request|0|||
150184949|NCT05054374|541815756|FG001|Overall Study|Withdrawal by Subject|0|||
150095889|NCT01474876|541491631|FG002|Overall Study|Investigator's decision and pt request|0|||
150095890|NCT02291055|541491632|FG000|Overall Study|Death|2|||
150095891|NCT02291055|541491633|FG001|Overall Study|Death|2|||
150095892|NCT02291055|541491634|FG002|Overall Study|Death|5|||
150095893|NCT02291055|541491635|FG003|Overall Study|Death|8|||
150095894|NCT02291055|541491636|FG004|Overall Study|Death|12|||
150095895|NCT02291055|541491632|FG000|Overall Study|Lost to Follow-up|0|||
150095896|NCT02291055|541491633|FG001|Overall Study|Lost to Follow-up|0|||
150095897|NCT02291055|541491634|FG002|Overall Study|Lost to Follow-up|0|||
150095898|NCT02291055|541491635|FG003|Overall Study|Lost to Follow-up|1|||
150095899|NCT02291055|541491636|FG004|Overall Study|Lost to Follow-up|2|||
150095900|NCT02291055|541491632|FG000|Overall Study|Withdrawal by Subject|3|||
150095901|NCT02291055|541491633|FG001|Overall Study|Withdrawal by Subject|1|||
150095902|NCT02291055|541491634|FG002|Overall Study|Withdrawal by Subject|1|||
150095903|NCT02291055|541491635|FG003|Overall Study|Withdrawal by Subject|5|||
150095904|NCT02291055|541491636|FG004|Overall Study|Withdrawal by Subject|10|||
150095905|NCT02291055|541491632|FG000|Overall Study|Progressive Disease|0|||
150095906|NCT02291055|541491633|FG001|Overall Study|Progressive Disease|0|||
150095907|NCT02291055|541491634|FG002|Overall Study|Progressive Disease|1|||
150095908|NCT02291055|541491635|FG003|Overall Study|Progressive Disease|4|||
150095909|NCT02291055|541491636|FG004|Overall Study|Progressive Disease|2|||
150095910|NCT02291055|541491632|FG000|Overall Study|Study Terminated by Sponsor|0|||
150095911|NCT02291055|541491633|FG001|Overall Study|Study Terminated by Sponsor|0|||
150095912|NCT02291055|541491634|FG002|Overall Study|Study Terminated by Sponsor|0|||
150095913|NCT02291055|541491635|FG003|Overall Study|Study Terminated by Sponsor|5|||
150095914|NCT02291055|541491636|FG004|Overall Study|Study Terminated by Sponsor|1|||
150095915|NCT02291055|541491632|FG000|Overall Study|Other|0|||
150095916|NCT02291055|541491633|FG001|Overall Study|Other|2|||
150095917|NCT02291055|541491634|FG002|Overall Study|Other|1|||
150095918|NCT02291055|541491635|FG003|Overall Study|Other|4|||
150184950|NCT05054374|541815757|FG002|Overall Study|Withdrawal by Subject|0|||
150184951|NCT05054374|541815758|FG003|Overall Study|Withdrawal by Subject|0|||
150184952|NCT05054374|541815755|FG000|Overall Study|Progressive Disease|5|||
150095919|NCT02291055|541491636|FG004|Overall Study|Other|0|||
150184953|NCT05054374|541815756|FG001|Overall Study|Progressive Disease|0|||
150184954|NCT05054374|541815757|FG002|Overall Study|Progressive Disease|0|||
150184955|NCT05054374|541815758|FG003|Overall Study|Progressive Disease|0|||
150184956|NCT05691309|541815759|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
150095920|NCT01523886|541491640|FG000|Overall Study|surgery cancelled|0|||
150095921|NCT01523886|541491641|FG001|Overall Study|surgery cancelled|1|||
150095922|NCT00733746|541491645|FG000|Overall Study|Ineligible|5|||
150095923|NCT01367158|541491646|FG000|Overall Study|Withdrew consent|0|||
150095924|NCT01367158|541491647|FG001|Overall Study|Withdrew consent|2|||
150095925|NCT01367158|541491648|FG002|Overall Study|Withdrew consent|1|||
150095926|NCT01367158|541491649|FG003|Overall Study|Withdrew consent|0|||
150095927|NCT01367158|541491650|FG004|Overall Study|Withdrew consent|2|||
150095928|NCT01367158|541491651|FG005|Overall Study|Withdrew consent|0|||
150095929|NCT01367158|541491652|FG006|Overall Study|Withdrew consent|0|||
150095930|NCT01367158|541491653|FG007|Overall Study|Withdrew consent|1|||
150095931|NCT01367158|541491654|FG008|Overall Study|Withdrew consent|0|||
150095932|NCT01367158|541491655|FG009|Overall Study|Withdrew consent|0|||
150095933|NCT01367158|541491656|FG010|Overall Study|Withdrew consent|0|||
150095934|NCT01367158|541491646|FG000|Overall Study|Lost to Follow-up|0|||
150095935|NCT01367158|541491647|FG001|Overall Study|Lost to Follow-up|0|||
150095936|NCT01367158|541491648|FG002|Overall Study|Lost to Follow-up|0|||
150095937|NCT01367158|541491649|FG003|Overall Study|Lost to Follow-up|1|||
150095938|NCT01367158|541491650|FG004|Overall Study|Lost to Follow-up|0|||
150095939|NCT01367158|541491651|FG005|Overall Study|Lost to Follow-up|2|||
150095940|NCT01367158|541491652|FG006|Overall Study|Lost to Follow-up|0|||
150095941|NCT01367158|541491653|FG007|Overall Study|Lost to Follow-up|1|||
150095942|NCT01367158|541491654|FG008|Overall Study|Lost to Follow-up|0|||
150095943|NCT01367158|541491655|FG009|Overall Study|Lost to Follow-up|0|||
150095944|NCT01367158|541491656|FG010|Overall Study|Lost to Follow-up|1|||
150095945|NCT01367158|541491646|FG000|Overall Study|Protocol Violation|0|||
150095946|NCT01367158|541491647|FG001|Overall Study|Protocol Violation|1|||
150095947|NCT01367158|541491648|FG002|Overall Study|Protocol Violation|0|||
150095948|NCT01367158|541491649|FG003|Overall Study|Protocol Violation|0|||
150095949|NCT01367158|541491650|FG004|Overall Study|Protocol Violation|0|||
150095950|NCT01367158|541491651|FG005|Overall Study|Protocol Violation|0|||
150095951|NCT01367158|541491652|FG006|Overall Study|Protocol Violation|0|||
150095952|NCT01367158|541491653|FG007|Overall Study|Protocol Violation|0|||
150095953|NCT01367158|541491654|FG008|Overall Study|Protocol Violation|0|||
150095954|NCT01367158|541491655|FG009|Overall Study|Protocol Violation|0|||
150095955|NCT01367158|541491656|FG010|Overall Study|Protocol Violation|0|||
150095956|NCT03658538|541491657|FG000|Overall Study|Death|2|||
150095957|NCT03658538|541491658|FG001|Overall Study|Death|1|||
150095958|NCT03658538|541491657|FG000|Overall Study|Cancer diagnosis|1|||
150095959|NCT03658538|541491658|FG001|Overall Study|Cancer diagnosis|0|||
150095960|NCT03658538|541491657|FG000|Overall Study|Change residence|1|||
150095961|NCT03658538|541491658|FG001|Overall Study|Change residence|2|||
150095962|NCT03658538|541491657|FG000|Overall Study|Lost to Follow-up|3|||
150095963|NCT03658538|541491658|FG001|Overall Study|Lost to Follow-up|3|||
150095964|NCT03658538|541491657|FG000|Overall Study|Unblinded|2|||
150095965|NCT03658538|541491658|FG001|Overall Study|Unblinded|3|||
150095966|NCT03658538|541491657|FG000|Overall Study|Physician Decision|0|||
150095967|NCT03658538|541491658|FG001|Overall Study|Physician Decision|1|||
150095968|NCT03658538|541491657|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
150095969|NCT03658538|541491658|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
150095970|NCT03658538|541491657|FG000|Overall Study|Evicted from home|1|||
150095971|NCT03658538|541491658|FG001|Overall Study|Evicted from home|0|||
150095972|NCT02921776|541491659|FG000|Overall Study|patient deterioration, fatigue|2|||
150095973|NCT02921776|541491660|FG001|Overall Study|patient deterioration, fatigue|6|||
150095974|NCT02921776|541491661|FG002|Overall Study|patient deterioration, fatigue|0|||
150095975|NCT02921776|541491662|FG003|Overall Study|patient deterioration, fatigue|0|||
150095976|NCT02921776|541491663|FG004|Overall Study|patient deterioration, fatigue|0|||
150095977|NCT02921776|541491664|FG005|Overall Study|patient deterioration, fatigue|0|||
150095978|NCT02921776|541491665|FG006|Overall Study|patient deterioration, fatigue|0|||
150095979|NCT02921776|541491666|FG007|Overall Study|patient deterioration, fatigue|0|||
150095980|NCT02921776|541491659|FG000|Overall Study|Withdrawal by Subject|0|||
150095981|NCT02921776|541491660|FG001|Overall Study|Withdrawal by Subject|2|||
150095982|NCT02921776|541491661|FG002|Overall Study|Withdrawal by Subject|0|||
150095983|NCT02921776|541491662|FG003|Overall Study|Withdrawal by Subject|1|||
150095984|NCT02921776|541491663|FG004|Overall Study|Withdrawal by Subject|1|||
150095985|NCT02921776|541491664|FG005|Overall Study|Withdrawal by Subject|0|||
150095986|NCT02921776|541491665|FG006|Overall Study|Withdrawal by Subject|8|||
150095987|NCT02921776|541491666|FG007|Overall Study|Withdrawal by Subject|1|||
150095988|NCT02921776|541491659|FG000|Overall Study|Death|0|||
150095989|NCT02921776|541491660|FG001|Overall Study|Death|0|||
150095990|NCT02921776|541491661|FG002|Overall Study|Death|0|||
150095991|NCT02921776|541491662|FG003|Overall Study|Death|2|||
150095992|NCT02921776|541491663|FG004|Overall Study|Death|0|||
150095993|NCT02921776|541491664|FG005|Overall Study|Death|0|||
150095994|NCT02921776|541491665|FG006|Overall Study|Death|0|||
150095995|NCT02921776|541491666|FG007|Overall Study|Death|0|||
150095996|NCT02921776|541491659|FG000|Overall Study|extubation or early discharge|0|||
150095997|NCT02921776|541491660|FG001|Overall Study|extubation or early discharge|0|||
150095998|NCT02921776|541491661|FG002|Overall Study|extubation or early discharge|0|||
150095999|NCT02921776|541491662|FG003|Overall Study|extubation or early discharge|5|||
150096000|NCT02921776|541491663|FG004|Overall Study|extubation or early discharge|5|||
150096001|NCT02921776|541491664|FG005|Overall Study|extubation or early discharge|0|||
150096002|NCT02921776|541491665|FG006|Overall Study|extubation or early discharge|0|||
150096003|NCT02921776|541491666|FG007|Overall Study|extubation or early discharge|0|||
150096004|NCT02921776|541491659|FG000|Overall Study|Lost to Follow-up|0|||
150096005|NCT02921776|541491660|FG001|Overall Study|Lost to Follow-up|0|||
150096006|NCT02921776|541491661|FG002|Overall Study|Lost to Follow-up|0|||
150096007|NCT02921776|541491662|FG003|Overall Study|Lost to Follow-up|0|||
150096008|NCT02921776|541491663|FG004|Overall Study|Lost to Follow-up|0|||
150096009|NCT02921776|541491664|FG005|Overall Study|Lost to Follow-up|2|||
150096010|NCT02921776|541491665|FG006|Overall Study|Lost to Follow-up|3|||
150096011|NCT02921776|541491666|FG007|Overall Study|Lost to Follow-up|6|||
150096012|NCT02631850|541493760|FG000|Treatment Period|Lost to Follow-up|0|||
150096013|NCT02631850|541493761|FG001|Treatment Period|Lost to Follow-up|1|||
150096014|NCT02631850|541493762|FG002|Treatment Period|Lost to Follow-up|0|||
150096015|NCT02631850|541493763|FG003|Treatment Period|Lost to Follow-up|0|||
150096016|NCT02631850|541493760|FG000|Treatment Period|Protocol Violation|1|||
150096017|NCT02631850|541493761|FG001|Treatment Period|Protocol Violation|0|||
150096018|NCT02631850|541493762|FG002|Treatment Period|Protocol Violation|0|||
150096019|NCT02631850|541493763|FG003|Treatment Period|Protocol Violation|0|||
150096020|NCT02631850|541493760|FG000|Treatment Period|Withdrawal by Subject|0|||
150096021|NCT02631850|541493761|FG001|Treatment Period|Withdrawal by Subject|5|||
150096022|NCT02631850|541493762|FG002|Treatment Period|Withdrawal by Subject|2|||
150096023|NCT02631850|541493763|FG003|Treatment Period|Withdrawal by Subject|2|||
150096024|NCT02631850|541493760|FG000|Treatment Period|Adverse Event|1|||
150096025|NCT02631850|541493761|FG001|Treatment Period|Adverse Event|0|||
150096026|NCT02631850|541493762|FG002|Treatment Period|Adverse Event|2|||
150096027|NCT02631850|541493763|FG003|Treatment Period|Adverse Event|3|||
150096028|NCT02631850|541493760|FG000|Treatment Period|Family medical issue|1|||
150096029|NCT02631850|541493761|FG001|Treatment Period|Family medical issue|0|||
150096030|NCT02631850|541493762|FG002|Treatment Period|Family medical issue|0|||
150096031|NCT02631850|541493763|FG003|Treatment Period|Family medical issue|0|||
150096032|NCT02631850|541493760|FG000|6 Month Follow up|Lost to Follow-up|5|||
150096033|NCT02631850|541493761|FG001|6 Month Follow up|Lost to Follow-up|8|||
150096034|NCT02631850|541493762|FG002|6 Month Follow up|Lost to Follow-up|3|||
150096035|NCT02631850|541493763|FG003|6 Month Follow up|Lost to Follow-up|5|||
150096036|NCT02631850|541493760|FG000|6 Month Follow up|Withdrawal by Subject|1|||
150096037|NCT02631850|541493761|FG001|6 Month Follow up|Withdrawal by Subject|0|||
150096038|NCT02631850|541493762|FG002|6 Month Follow up|Withdrawal by Subject|0|||
150096039|NCT02631850|541493763|FG003|6 Month Follow up|Withdrawal by Subject|2|||
150096040|NCT02631850|541493760|FG000|6 Month Follow up|Adverse Event|1|||
150096041|NCT02631850|541493761|FG001|6 Month Follow up|Adverse Event|4|||
150096042|NCT02631850|541493762|FG002|6 Month Follow up|Adverse Event|1|||
150096043|NCT02631850|541493763|FG003|6 Month Follow up|Adverse Event|3|||
150096044|NCT02631850|541493760|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
150096045|NCT02631850|541493761|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
150096046|NCT02631850|541493762|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
150096047|NCT02631850|541493763|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
150096048|NCT01462084|541493764|FG000|Overall Study|Withdrawal by Subject|1|||
150096049|NCT01462084|541493765|FG001|Overall Study|Withdrawal by Subject|0|||
150096050|NCT01462084|541493764|FG000|Overall Study|Protocol Violation|1|||
150096051|NCT01462084|541493765|FG001|Overall Study|Protocol Violation|1|||
150096052|NCT03992781|541493766|FG000|Overall Study|Lost to Follow-up|5|||
150096053|NCT03992781|541493766|FG000|Overall Study|Adverse Event|1|||
150096054|NCT03992781|541493766|FG000|Overall Study|Lack of Efficacy|5|||
150096055|NCT01996826|541493767|FG000|Overall Study|Lost to Follow-up|6|||
150096056|NCT01996826|541493768|FG001|Overall Study|Lost to Follow-up|2|||
150096057|NCT01996826|541493767|FG000|Overall Study|Physician Decision|1|||
150096058|NCT01996826|541493768|FG001|Overall Study|Physician Decision|1|||
150096059|NCT00695396|541493769|FG000|Overall Study|Study Closed Prematurely|5|||
150096060|NCT00695396|541493770|FG001|Overall Study|Study Closed Prematurely|6|||
150096061|NCT00695396|541493771|FG002|Overall Study|Study Closed Prematurely|8|||
150096062|NCT00695396|541493769|FG000|Overall Study|Withdrawal by Subject|2|||
150096063|NCT00695396|541493770|FG001|Overall Study|Withdrawal by Subject|2|||
150096064|NCT00695396|541493771|FG002|Overall Study|Withdrawal by Subject|0|||
150096065|NCT00518323|541493773|FG000|Overall Study|Lack of Efficacy|14|||
150096066|NCT00518323|541493774|FG001|Overall Study|Lack of Efficacy|2|||
150096067|NCT00518323|541493775|FG002|Overall Study|Lack of Efficacy|4|||
150096068|NCT00518323|541493776|FG003|Overall Study|Lack of Efficacy|20|||
150096069|NCT00518323|541493773|FG000|Overall Study|Withdrawal by Subject|1|||
150096070|NCT00518323|541493774|FG001|Overall Study|Withdrawal by Subject|2|||
150096071|NCT00518323|541493775|FG002|Overall Study|Withdrawal by Subject|4|||
150096072|NCT00518323|541493776|FG003|Overall Study|Withdrawal by Subject|2|||
150096073|NCT00518323|541493773|FG000|Overall Study|Lost to Follow-up|0|||
150096074|NCT00518323|541493774|FG001|Overall Study|Lost to Follow-up|2|||
150096075|NCT00518323|541493775|FG002|Overall Study|Lost to Follow-up|1|||
150096076|NCT00518323|541493776|FG003|Overall Study|Lost to Follow-up|3|||
150096077|NCT00518323|541493773|FG000|Overall Study|Adverse Event|1|||
150096078|NCT00518323|541493774|FG001|Overall Study|Adverse Event|1|||
150096079|NCT00518323|541493775|FG002|Overall Study|Adverse Event|1|||
150096080|NCT00518323|541493776|FG003|Overall Study|Adverse Event|0|||
150096081|NCT00518323|541493773|FG000|Overall Study|Prohibited medication and others|3|||
150096082|NCT00518323|541493774|FG001|Overall Study|Prohibited medication and others|1|||
150096083|NCT00518323|541493775|FG002|Overall Study|Prohibited medication and others|1|||
150096084|NCT00518323|541493776|FG003|Overall Study|Prohibited medication and others|0|||
150096085|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096086|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
150096087|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096088|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096089|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096090|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096091|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
150096092|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
150096093|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
150096094|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
150096095|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
150096096|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
150096097|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
150096098|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
150096099|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
150096100|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
150096101|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
150096102|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
150096103|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
150096104|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
150096105|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
150096106|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
150096107|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
150096108|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
150096109|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
150096110|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
150184957|NCT05691309|541815759|FG000|Overall Study|vancomycin levels not evaluable|2|||
150096111|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
150096112|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
150096113|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
150096114|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
150096115|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
150096116|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
150096117|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
150096118|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
150096119|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
150096120|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096121|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096122|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096123|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096124|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096125|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
150096126|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
150096127|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
150096128|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
150096129|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
150096130|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
150096131|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
150096132|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
150096133|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
150096134|NCT03742037|541493784|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096135|NCT03742037|541493785|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096136|NCT03742037|541493786|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096137|NCT03742037|541493787|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096138|NCT03742037|541493788|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096139|NCT03742037|541493789|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
150096140|NCT03742037|541493790|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
150096141|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
150096142|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
150096143|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
150096144|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
150096145|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
150096146|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
150096147|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
150096148|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
150096149|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
150096150|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
150096151|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
150096152|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
150096153|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
150096154|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
150096155|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
150096156|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
150096157|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
150096158|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
150096159|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
150096160|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
150096161|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
150096162|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
150096163|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
150096164|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
150096165|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
150096166|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
150096167|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
150096168|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
150096169|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
150184958|NCT01707030|541815760|FG000|Overall Study|Death|1|||
150096170|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
150096171|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
150096172|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
150096173|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
150096174|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
150096175|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
150096176|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
150096177|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
150096178|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
150096179|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
150096180|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
150096181|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
150096182|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
150096183|NCT03742037|541493784|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096184|NCT03742037|541493785|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096185|NCT03742037|541493786|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
150096186|NCT03742037|541493787|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096187|NCT03742037|541493788|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096188|NCT03742037|541493789|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096189|NCT03742037|541493790|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
150096190|NCT01994629|541493791|FG000|Overall Study|Withdrawal by Subject|1|||
150096191|NCT01994629|541493792|FG001|Overall Study|Withdrawal by Subject|0|||
150096192|NCT01994629|541493791|FG000|Overall Study|Lost to Follow-up|0|||
150096193|NCT01994629|541493792|FG001|Overall Study|Lost to Follow-up|3|||
150096194|NCT03338062|541493793|FG000|Overall Study|Alternative Therapy|1|||
150096195|NCT03338062|541493794|FG001|Overall Study|Alternative Therapy|0|||
150096196|NCT00391274|541493801|FG000|Overall Study|Death Due to Study Disease|55|||
150096197|NCT00391274|541493802|FG001|Overall Study|Death Due to Study Disease|45|||
150096198|NCT00391274|541493801|FG000|Overall Study|Lost to Follow-up|0|||
150096199|NCT00391274|541493802|FG001|Overall Study|Lost to Follow-up|3|||
150096200|NCT00391274|541493801|FG000|Overall Study|Physician Decision|4|||
150096201|NCT00391274|541493802|FG001|Overall Study|Physician Decision|2|||
150096202|NCT00391274|541493801|FG000|Overall Study|Withdrawal by Subject|0|||
150096203|NCT00391274|541493802|FG001|Overall Study|Withdrawal by Subject|3|||
150096204|NCT00391274|541493801|FG000|Overall Study|Death Due to Adverse Event|1|||
150096205|NCT00391274|541493802|FG001|Overall Study|Death Due to Adverse Event|3|||
150096206|NCT00391274|541493801|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
150096207|NCT00391274|541493802|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
150096208|NCT00391274|541493801|FG000|Overall Study|Death Not Study Related|0|||
150096209|NCT00391274|541493802|FG001|Overall Study|Death Not Study Related|1|||
150096210|NCT00894322|541493804|FG000|Overall Study|Withdrawal by Subject|1|||
150096211|NCT00894322|541493805|FG001|Overall Study|Withdrawal by Subject|0|||
150096212|NCT00894322|541493806|FG002|Overall Study|Withdrawal by Subject|0|||
150096213|NCT00975481|541493816|FG000|Second Intervention Period|Adverse Event|2|||
150096214|NCT00975481|541493817|FG001|Second Intervention Period|Adverse Event|1|||
150096215|NCT00975481|541493818|FG002|Second Intervention Period|Adverse Event|0|||
150096216|NCT00975481|541493819|FG003|Second Intervention Period|Adverse Event|0|||
150096217|NCT00975481|541493820|FG004|Second Intervention Period|Adverse Event|0|||
150096218|NCT00975481|541493821|FG005|Second Intervention Period|Adverse Event|0|||
150096219|NCT00975481|541493816|FG000|Second Intervention Period|Withdrawal by Subject|0|||
150096220|NCT00975481|541493817|FG001|Second Intervention Period|Withdrawal by Subject|0|||
150096221|NCT00975481|541493818|FG002|Second Intervention Period|Withdrawal by Subject|1|||
150096222|NCT00975481|541493819|FG003|Second Intervention Period|Withdrawal by Subject|0|||
150096223|NCT00975481|541493820|FG004|Second Intervention Period|Withdrawal by Subject|0|||
150096224|NCT00975481|541493821|FG005|Second Intervention Period|Withdrawal by Subject|0|||
150096225|NCT00975481|541493816|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
150096226|NCT00975481|541493817|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
150096227|NCT00975481|541493818|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
150096228|NCT00975481|541493819|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
150096229|NCT00975481|541493820|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
150096230|NCT00975481|541493821|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
150184959|NCT01707030|541815761|FG001|Overall Study|Death|1|||
150184960|NCT01707030|541815760|FG000|Overall Study|Withdrawal by Subject|2|||
150184961|NCT01707030|541815761|FG001|Overall Study|Withdrawal by Subject|3|||
150184962|NCT01707030|541815760|FG000|Overall Study|Lost to Follow-up|8|||
150184963|NCT01707030|541815761|FG001|Overall Study|Lost to Follow-up|13|||
150184964|NCT04245501|541815762|FG000|Overall Study|Adverse Event|2|||
150184965|NCT04245501|541815763|FG001|Overall Study|Adverse Event|0|||
150096231|NCT00975481|541493816|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
150096232|NCT00975481|541493817|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
150096233|NCT00975481|541493818|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
150096234|NCT00975481|541493819|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
150096235|NCT00975481|541493820|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
150096236|NCT00975481|541493821|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
150096237|NCT03447990|541493823|FG000|Overall Study|Withdrawal by Subject|0|||
150096238|NCT03447990|541493824|FG001|Overall Study|Withdrawal by Subject|0|||
150096239|NCT03447990|541493825|FG002|Overall Study|Withdrawal by Subject|0|||
150096240|NCT03447990|541493826|FG003|Overall Study|Withdrawal by Subject|0|||
150096241|NCT03447990|541493827|FG004|Overall Study|Withdrawal by Subject|0|||
150096242|NCT03447990|541493828|FG005|Overall Study|Withdrawal by Subject|0|||
150096243|NCT03447990|541493829|FG006|Overall Study|Withdrawal by Subject|1|||
150096244|NCT03630120|541493830|FG000|Overall Study|Disease progression|0|||
150096245|NCT03630120|541493831|FG001|Overall Study|Disease progression|1|||
150096246|NCT03630120|541493832|FG002|Overall Study|Disease progression|1|||
150096247|NCT03630120|541493833|FG003|Overall Study|Disease progression|1|||
150096248|NCT01519960|541493834|FG000|Overall Study|Withdrawal from the study|26|||
150096249|NCT01519960|541493835|FG001|Overall Study|Withdrawal from the study|22|||
150096250|NCT01519960|541493836|FG002|Overall Study|Withdrawal from the study|5|||
150096251|NCT00423150|541493840|FG000|Overall Study|Adverse Event|11|||
150096252|NCT00423150|541493840|FG000|Overall Study|Progression of disease being studied|69|||
150096253|NCT00423150|541493840|FG000|Overall Study|Withdrawal by Subject|1|||
150096254|NCT00423150|541493840|FG000|Overall Study|Non-compliance with protocol|1|||
150096255|NCT00423150|541493840|FG000|Overall Study|Administrative|4|||
150096256|NCT01288287|541493841|FG000|Overall Study|Lost to Follow-up|8|||
150096257|NCT01288287|541493841|FG000|Overall Study|Withdrawal by Subject|4|||
150096258|NCT01288287|541493841|FG000|Overall Study|Lack of Efficacy|13|||
150096259|NCT01288287|541493841|FG000|Overall Study|Other Reason|13|||
150096260|NCT01288287|541493841|FG000|Overall Study|Unknown Reason|1|||
150096261|NCT01288287|541493841|FG000|Overall Study|Unknown Status|7|||
150096262|NCT03519347|541493842|FG000|Interventional Crossover Period 1|Death|0|||
150096263|NCT03519347|541493843|FG001|Interventional Crossover Period 1|Death|0|||
150096264|NCT03519347|541493844|FG002|Interventional Crossover Period 1|Death|0|||
150096265|NCT03519347|541493845|FG003|Interventional Crossover Period 1|Death|1|||
150096266|NCT01641692|541493851|FG000|Treatment Period 1|Adverse Event|1|||
150096267|NCT01641692|541493852|FG001|Treatment Period 1|Adverse Event|0|||
150096268|NCT01641692|541493853|FG002|Treatment Period 1|Adverse Event|0|||
150096269|NCT01641692|541493854|FG003|Treatment Period 1|Adverse Event|0|||
150096270|NCT01641692|541493855|FG004|Treatment Period 1|Adverse Event|0|||
150096271|NCT01641692|541493856|FG005|Treatment Period 1|Adverse Event|0|||
150096272|NCT01641692|541493857|FG006|Treatment Period 1|Adverse Event|0|||
150096273|NCT01641692|541493858|FG007|Treatment Period 1|Adverse Event|0|||
150096274|NCT01641692|541493851|FG000|Treatment Period 1|Lack of Efficacy|0|||
150096275|NCT01641692|541493852|FG001|Treatment Period 1|Lack of Efficacy|0|||
150096276|NCT01641692|541493853|FG002|Treatment Period 1|Lack of Efficacy|0|||
150096277|NCT01641692|541493854|FG003|Treatment Period 1|Lack of Efficacy|0|||
150096278|NCT01641692|541493855|FG004|Treatment Period 1|Lack of Efficacy|0|||
150096279|NCT01641692|541493856|FG005|Treatment Period 1|Lack of Efficacy|0|||
150096280|NCT01641692|541493857|FG006|Treatment Period 1|Lack of Efficacy|0|||
150096281|NCT01641692|541493858|FG007|Treatment Period 1|Lack of Efficacy|1|||
150096282|NCT01641692|541493851|FG000|Treatment Period 1|Protocol Violation|1|||
150096283|NCT01641692|541493852|FG001|Treatment Period 1|Protocol Violation|0|||
150096284|NCT01641692|541493853|FG002|Treatment Period 1|Protocol Violation|0|||
150096285|NCT01641692|541493854|FG003|Treatment Period 1|Protocol Violation|0|||
150096286|NCT01641692|541493855|FG004|Treatment Period 1|Protocol Violation|2|||
150096287|NCT01641692|541493856|FG005|Treatment Period 1|Protocol Violation|0|||
150096288|NCT01641692|541493857|FG006|Treatment Period 1|Protocol Violation|0|||
150096289|NCT01641692|541493858|FG007|Treatment Period 1|Protocol Violation|0|||
150096290|NCT01641692|541493851|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096291|NCT01641692|541493852|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096292|NCT01641692|541493853|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096293|NCT01641692|541493854|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096294|NCT01641692|541493855|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
150096295|NCT01641692|541493856|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096296|NCT01641692|541493857|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
150096297|NCT01641692|541493858|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
150096298|NCT01641692|541493851|FG000|Treatment Period 1|Lost to Follow-up|0|||
150096299|NCT01641692|541493852|FG001|Treatment Period 1|Lost to Follow-up|0|||
150096300|NCT01641692|541493853|FG002|Treatment Period 1|Lost to Follow-up|1|||
150096301|NCT01641692|541493854|FG003|Treatment Period 1|Lost to Follow-up|0|||
150096302|NCT01641692|541493855|FG004|Treatment Period 1|Lost to Follow-up|0|||
150096303|NCT01641692|541493856|FG005|Treatment Period 1|Lost to Follow-up|0|||
150096304|NCT01641692|541493857|FG006|Treatment Period 1|Lost to Follow-up|0|||
150096305|NCT01641692|541493858|FG007|Treatment Period 1|Lost to Follow-up|0|||
150184966|NCT04245501|541815762|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
150096306|NCT01641692|541493851|FG000|Treatment Period 1|Physician Decision|0|||
150096307|NCT01641692|541493852|FG001|Treatment Period 1|Physician Decision|0|||
150096308|NCT01641692|541493853|FG002|Treatment Period 1|Physician Decision|0|||
150096309|NCT01641692|541493854|FG003|Treatment Period 1|Physician Decision|0|||
150096310|NCT01641692|541493855|FG004|Treatment Period 1|Physician Decision|1|||
150096311|NCT01641692|541493856|FG005|Treatment Period 1|Physician Decision|0|||
150096312|NCT01641692|541493857|FG006|Treatment Period 1|Physician Decision|0|||
150096313|NCT01641692|541493858|FG007|Treatment Period 1|Physician Decision|0|||
150096314|NCT01641692|541493851|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150096315|NCT01641692|541493852|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150096316|NCT01641692|541493853|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150096317|NCT01641692|541493854|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150096318|NCT01641692|541493855|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150096319|NCT01641692|541493856|FG005|Treatment Period 1|Withdrawal by Subject|2|||
150096320|NCT01641692|541493857|FG006|Treatment Period 1|Withdrawal by Subject|0|||
150096321|NCT01641692|541493858|FG007|Treatment Period 1|Withdrawal by Subject|1|||
150096322|NCT01641692|541493851|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
150184967|NCT04245501|541815763|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
150184968|NCT02697136|541815768|FG000|Overall Study|Adverse Event|3|||
150096323|NCT01641692|541493852|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096324|NCT01641692|541493853|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096325|NCT01641692|541493854|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096326|NCT01641692|541493855|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096327|NCT01641692|541493856|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096328|NCT01641692|541493857|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096329|NCT01641692|541493858|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
150096330|NCT01641692|541493851|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096331|NCT01641692|541493852|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096332|NCT01641692|541493853|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096333|NCT01641692|541493854|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096334|NCT01641692|541493855|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096335|NCT01641692|541493856|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096336|NCT01641692|541493857|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
150096337|NCT01641692|541493858|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150096338|NCT01641692|541493851|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
150096339|NCT01641692|541493852|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096340|NCT01641692|541493853|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
150096341|NCT01641692|541493854|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
150096342|NCT01641692|541493855|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
150096343|NCT01641692|541493856|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096344|NCT01641692|541493857|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096345|NCT01641692|541493858|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
150096346|NCT01641692|541493851|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150096347|NCT01641692|541493852|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150096348|NCT01641692|541493853|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150096349|NCT01641692|541493854|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150096350|NCT01641692|541493855|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150096351|NCT01641692|541493856|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150096352|NCT01641692|541493857|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150096353|NCT01641692|541493858|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150096354|NCT01641692|541493851|FG000|Treatment Period 2|Lack of Efficacy|1|||
150096355|NCT01641692|541493852|FG001|Treatment Period 2|Lack of Efficacy|0|||
150096356|NCT01641692|541493853|FG002|Treatment Period 2|Lack of Efficacy|0|||
150096357|NCT01641692|541493854|FG003|Treatment Period 2|Lack of Efficacy|0|||
150096358|NCT01641692|541493855|FG004|Treatment Period 2|Lack of Efficacy|0|||
150096359|NCT01641692|541493856|FG005|Treatment Period 2|Lack of Efficacy|0|||
150096360|NCT01641692|541493857|FG006|Treatment Period 2|Lack of Efficacy|0|||
150096361|NCT01641692|541493858|FG007|Treatment Period 2|Lack of Efficacy|0|||
150096362|NCT01641692|541493851|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
150096363|NCT01641692|541493852|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096364|NCT01641692|541493853|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096365|NCT01641692|541493854|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096366|NCT01641692|541493855|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096367|NCT01641692|541493856|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096368|NCT01641692|541493857|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096369|NCT01641692|541493858|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
150096370|NCT01641692|541493851|FG000|Treatment Period 2|Lost to Follow-up|0|||
150096371|NCT01641692|541493852|FG001|Treatment Period 2|Lost to Follow-up|0|||
150096372|NCT01641692|541493853|FG002|Treatment Period 2|Lost to Follow-up|0|||
150096373|NCT01641692|541493854|FG003|Treatment Period 2|Lost to Follow-up|0|||
150096374|NCT01641692|541493855|FG004|Treatment Period 2|Lost to Follow-up|0|||
150096375|NCT01641692|541493856|FG005|Treatment Period 2|Lost to Follow-up|1|||
150096376|NCT01641692|541493857|FG006|Treatment Period 2|Lost to Follow-up|0|||
150096377|NCT01641692|541493858|FG007|Treatment Period 2|Lost to Follow-up|0|||
150096378|NCT01641692|541493851|FG000|Treatment Period 2|Withdrawal by Subject|1|||
150096379|NCT01641692|541493852|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150096380|NCT01641692|541493853|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150096381|NCT01641692|541493854|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150096382|NCT01641692|541493855|FG004|Treatment Period 2|Withdrawal by Subject|0|||
150096383|NCT01641692|541493856|FG005|Treatment Period 2|Withdrawal by Subject|1|||
150096384|NCT01641692|541493857|FG006|Treatment Period 2|Withdrawal by Subject|0|||
150096385|NCT01641692|541493858|FG007|Treatment Period 2|Withdrawal by Subject|1|||
150184969|NCT02697136|541815769|FG001|Overall Study|Adverse Event|0|||
150184970|NCT03578536|541815773|FG000|Overall Study|Lost to Follow-up|1|||
150096386|NCT01641692|541493851|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096387|NCT01641692|541493852|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096388|NCT01641692|541493853|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096389|NCT01641692|541493854|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096390|NCT01641692|541493855|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
150096391|NCT01641692|541493856|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096392|NCT01641692|541493857|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
150096393|NCT01641692|541493858|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
150096394|NCT01641692|541493851|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150096395|NCT01641692|541493852|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150096396|NCT01641692|541493853|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
150096397|NCT01641692|541493854|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150096398|NCT01641692|541493855|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150096399|NCT01641692|541493856|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
150096400|NCT01641692|541493857|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150096401|NCT01641692|541493858|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
150096402|NCT01641692|541493851|FG000|Treatment Period 3|Adverse Event|0|||
150096403|NCT01641692|541493852|FG001|Treatment Period 3|Adverse Event|0|||
150096404|NCT01641692|541493853|FG002|Treatment Period 3|Adverse Event|0|||
150096405|NCT01641692|541493854|FG003|Treatment Period 3|Adverse Event|0|||
150096406|NCT01641692|541493855|FG004|Treatment Period 3|Adverse Event|0|||
150096407|NCT01641692|541493856|FG005|Treatment Period 3|Adverse Event|0|||
150096408|NCT01641692|541493857|FG006|Treatment Period 3|Adverse Event|1|||
150096409|NCT01641692|541493858|FG007|Treatment Period 3|Adverse Event|0|||
150096410|NCT01641692|541493851|FG000|Treatment Period 3|Protocol Violation|0|||
150096411|NCT01641692|541493852|FG001|Treatment Period 3|Protocol Violation|0|||
150096412|NCT01641692|541493853|FG002|Treatment Period 3|Protocol Violation|1|||
150096413|NCT01641692|541493854|FG003|Treatment Period 3|Protocol Violation|0|||
150096414|NCT01641692|541493855|FG004|Treatment Period 3|Protocol Violation|0|||
150096415|NCT01641692|541493856|FG005|Treatment Period 3|Protocol Violation|0|||
150096416|NCT01641692|541493857|FG006|Treatment Period 3|Protocol Violation|0|||
150096417|NCT01641692|541493858|FG007|Treatment Period 3|Protocol Violation|0|||
150096418|NCT01641692|541493851|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096419|NCT01641692|541493852|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096420|NCT01641692|541493853|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096421|NCT01641692|541493854|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096422|NCT01641692|541493855|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096423|NCT01641692|541493856|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096424|NCT01641692|541493857|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
150096425|NCT01641692|541493858|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
150096426|NCT01641692|541493851|FG000|Treatment Period 3|Lost to Follow-up|0|||
150096427|NCT01641692|541493852|FG001|Treatment Period 3|Lost to Follow-up|1|||
150096428|NCT01641692|541493853|FG002|Treatment Period 3|Lost to Follow-up|0|||
150096429|NCT01641692|541493854|FG003|Treatment Period 3|Lost to Follow-up|0|||
150096430|NCT01641692|541493855|FG004|Treatment Period 3|Lost to Follow-up|0|||
150096431|NCT01641692|541493856|FG005|Treatment Period 3|Lost to Follow-up|0|||
150096432|NCT01641692|541493857|FG006|Treatment Period 3|Lost to Follow-up|0|||
150096433|NCT01641692|541493858|FG007|Treatment Period 3|Lost to Follow-up|0|||
150096434|NCT01641692|541493851|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096435|NCT01641692|541493852|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096436|NCT01641692|541493853|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096437|NCT01641692|541493854|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096438|NCT01641692|541493855|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096439|NCT01641692|541493856|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
150184971|NCT02538900|541815774|FG000|Overall Study|Death|2|||
150096440|NCT01641692|541493857|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
150184972|NCT02538900|541815775|FG001|Overall Study|Death|2|||
150184973|NCT02538900|541815776|FG002|Overall Study|Death|2|||
150184974|NCT02538900|541815774|FG000|Overall Study|Withdrawal by Subject|18|||
150184975|NCT02538900|541815775|FG001|Overall Study|Withdrawal by Subject|16|||
150184976|NCT02538900|541815776|FG002|Overall Study|Withdrawal by Subject|15|||
150096441|NCT01641692|541493858|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
150096442|NCT01641692|541493851|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
150096443|NCT01641692|541493852|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
150096444|NCT01641692|541493853|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
150096445|NCT01641692|541493854|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
150096446|NCT01641692|541493855|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
150096447|NCT01641692|541493856|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
150096448|NCT01641692|541493857|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
150096449|NCT01641692|541493858|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
150096450|NCT02515045|541493864|FG000|Overall Study|Adverse Event|0|||
150096451|NCT02515045|541493865|FG001|Overall Study|Adverse Event|3|||
150096452|NCT02515045|541493866|FG002|Overall Study|Adverse Event|3|||
150096453|NCT02515045|541493864|FG000|Overall Study|Lost to Follow-up|0|||
150096454|NCT02515045|541493865|FG001|Overall Study|Lost to Follow-up|1|||
150096455|NCT02515045|541493866|FG002|Overall Study|Lost to Follow-up|1|||
150096456|NCT01412021|541493867|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
150096457|NCT01412021|541493867|FG000|Overall Study|Treatment Prior to Approval|3|||
150096458|NCT01412021|541493867|FG000|Overall Study|Transferred to Other Hospital|9|||
150096459|NCT00238121|541493868|FG000|Overall Study|Withdrawal by Subject|1|||
150096460|NCT00238121|541493869|FG001|Overall Study|Withdrawal by Subject|1|||
150096461|NCT00238121|541493868|FG000|Overall Study|Adverse Event|2|||
150096462|NCT00238121|541493869|FG001|Overall Study|Adverse Event|1|||
150096463|NCT02221284|541493870|FG000|Overall Study|Case Report Forms Uncollected|56|||
150096464|NCT02221284|541493870|FG000|Overall Study|Protocol Deviation|5|||
150096465|NCT01166178|541493871|FG000|Overall Study|Withdrawal by Subject|1|||
150096466|NCT01166178|541493872|FG001|Overall Study|Withdrawal by Subject|0|||
150096467|NCT01166178|541493871|FG000|Overall Study|Study was terminated|20|||
150096468|NCT01166178|541493872|FG001|Overall Study|Study was terminated|8|||
150096469|NCT00484939|541493873|FG000|Overall Study|Death|9|||
150096470|NCT00484939|541493874|FG001|Overall Study|Death|13|||
150096471|NCT00484939|541493873|FG000|Overall Study|Adverse Event|22|||
150096472|NCT00484939|541493874|FG001|Overall Study|Adverse Event|12|||
150096473|NCT00484939|541493873|FG000|Overall Study|Patient Withdrew Consent|19|||
150096474|NCT00484939|541493874|FG001|Overall Study|Patient Withdrew Consent|10|||
150096475|NCT00484939|541493873|FG000|Overall Study|Protocol Violation|3|||
150096476|NCT00484939|541493874|FG001|Overall Study|Protocol Violation|3|||
150096477|NCT00484939|541493873|FG000|Overall Study|Lost to Follow-up|0|||
150096478|NCT00484939|541493874|FG001|Overall Study|Lost to Follow-up|3|||
150096479|NCT00484939|541493873|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
150096480|NCT00484939|541493874|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
150096481|NCT00484939|541493873|FG000|Overall Study|Disease progression|67|||
150096482|NCT00484939|541493874|FG001|Overall Study|Disease progression|88|||
150096483|NCT00484939|541493873|FG000|Overall Study|Screen Failure|2|||
150096484|NCT00484939|541493874|FG001|Overall Study|Screen Failure|2|||
150096485|NCT00484939|541493873|FG000|Overall Study|Reason Not Specified|11|||
150096486|NCT00484939|541493874|FG001|Overall Study|Reason Not Specified|6|||
150096487|NCT00624052|541493875|FG000|Overall Study|Adverse Event|7|||
150096488|NCT00624052|541493876|FG001|Overall Study|Adverse Event|6|||
150096489|NCT00624052|541493877|FG002|Overall Study|Adverse Event|0|||
150096490|NCT00624052|541493878|FG003|Overall Study|Adverse Event|3|||
150096491|NCT00624052|541493875|FG000|Overall Study|Lack of Efficacy|1|||
150096492|NCT00624052|541493876|FG001|Overall Study|Lack of Efficacy|1|||
150096493|NCT00624052|541493877|FG002|Overall Study|Lack of Efficacy|0|||
150096494|NCT00624052|541493878|FG003|Overall Study|Lack of Efficacy|0|||
150096495|NCT00624052|541493875|FG000|Overall Study|Lost to Follow-up|2|||
150096496|NCT00624052|541493876|FG001|Overall Study|Lost to Follow-up|3|||
150096497|NCT00624052|541493877|FG002|Overall Study|Lost to Follow-up|1|||
150096498|NCT00624052|541493878|FG003|Overall Study|Lost to Follow-up|0|||
150096499|NCT00624052|541493875|FG000|Overall Study|Non compliant with the protocol|2|||
150096500|NCT00624052|541493876|FG001|Overall Study|Non compliant with the protocol|1|||
150096501|NCT00624052|541493877|FG002|Overall Study|Non compliant with the protocol|1|||
150096502|NCT00624052|541493878|FG003|Overall Study|Non compliant with the protocol|1|||
150096503|NCT00624052|541493875|FG000|Overall Study|Consent withdrawn|3|||
150096504|NCT00624052|541493876|FG001|Overall Study|Consent withdrawn|1|||
150096505|NCT00624052|541493877|FG002|Overall Study|Consent withdrawn|1|||
150096506|NCT00624052|541493878|FG003|Overall Study|Consent withdrawn|0|||
150096507|NCT00624052|541493875|FG000|Overall Study|Changed job/ran out if meds|0|||
150096508|NCT00624052|541493876|FG001|Overall Study|Changed job/ran out if meds|2|||
150096509|NCT00624052|541493877|FG002|Overall Study|Changed job/ran out if meds|0|||
150096510|NCT00624052|541493878|FG003|Overall Study|Changed job/ran out if meds|0|||
150096511|NCT00529542|541493880|FG000|Overall Study|Withdrawal by Subject|1|||
150096512|NCT00529542|541493881|FG001|Overall Study|Withdrawal by Subject|0|||
150096513|NCT00529542|541493880|FG000|Overall Study|Lost to Follow-up|0|||
150096514|NCT00529542|541493881|FG001|Overall Study|Lost to Follow-up|1|||
150096515|NCT01499563|541493892|FG000|Overall Study|Withdrawal by Subject|10|||
150096516|NCT01499563|541493893|FG001|Overall Study|Withdrawal by Subject|11|||
150096517|NCT01499563|541493894|FG002|Overall Study|Withdrawal by Subject|7|||
150096518|NCT01499563|541493895|FG003|Overall Study|Withdrawal by Subject|8|||
150096519|NCT01499563|541493892|FG000|Overall Study|Physician Decision|2|||
150096520|NCT01499563|541493893|FG001|Overall Study|Physician Decision|1|||
150096521|NCT01499563|541493894|FG002|Overall Study|Physician Decision|3|||
150096522|NCT01499563|541493895|FG003|Overall Study|Physician Decision|0|||
150096523|NCT01499563|541493892|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
150096524|NCT01499563|541493893|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
150096525|NCT01499563|541493894|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
150096526|NCT01499563|541493895|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
150096527|NCT01499563|541493892|FG000|Overall Study|Adverse Event|2|||
150096528|NCT01499563|541493893|FG001|Overall Study|Adverse Event|0|||
150096529|NCT01499563|541493894|FG002|Overall Study|Adverse Event|1|||
150096530|NCT01499563|541493895|FG003|Overall Study|Adverse Event|3|||
150096531|NCT01499563|541493892|FG000|Overall Study|Lack of Efficacy|0|||
150096532|NCT01499563|541493893|FG001|Overall Study|Lack of Efficacy|1|||
150096533|NCT01499563|541493894|FG002|Overall Study|Lack of Efficacy|6|||
150096534|NCT01499563|541493895|FG003|Overall Study|Lack of Efficacy|3|||
150096535|NCT01499563|541493892|FG000|Overall Study|Other|8|||
150096536|NCT01499563|541493893|FG001|Overall Study|Other|6|||
150096537|NCT01499563|541493894|FG002|Overall Study|Other|6|||
150096538|NCT01499563|541493895|FG003|Overall Study|Other|4|||
150096539|NCT03333044|541493897|FG000|Overall Study|Pregnancy|1|||
150096540|NCT03333044|541493898|FG001|Overall Study|Pregnancy|0|||
150096541|NCT03333044|541493899|FG002|Overall Study|Pregnancy|0|||
150096542|NCT03333044|541493897|FG000|Overall Study|Lost to Follow-up|0|||
150096543|NCT03333044|541493898|FG001|Overall Study|Lost to Follow-up|14|||
150096544|NCT03333044|541493899|FG002|Overall Study|Lost to Follow-up|6|||
150096545|NCT03649711|541493900|FG000|Overall Study|Adverse Event|0|||
150096546|NCT03649711|541493901|FG001|Overall Study|Adverse Event|1|||
150096547|NCT03649711|541493902|FG002|Overall Study|Adverse Event|0|||
150096548|NCT03649711|541493900|FG000|Overall Study|Kidney Transplant|1|||
150096549|NCT03649711|541493901|FG001|Overall Study|Kidney Transplant|0|||
150096550|NCT03649711|541493902|FG002|Overall Study|Kidney Transplant|0|||
150096551|NCT01721330|541493903|FG000|Overall Study|Withdrawal by Subject|0|||
150096552|NCT01721330|541493904|FG001|Overall Study|Withdrawal by Subject|1|||
150096553|NCT00296374|541493905|FG000|Overall Study|Adverse Event|14|||
150096554|NCT00296374|541493906|FG001|Overall Study|Adverse Event|10|||
150096555|NCT00296374|541493907|FG002|Overall Study|Adverse Event|7|||
150096556|NCT00296374|541493905|FG000|Overall Study|Withdrawal by Subject|3|||
150096557|NCT00296374|541493906|FG001|Overall Study|Withdrawal by Subject|5|||
150096558|NCT00296374|541493907|FG002|Overall Study|Withdrawal by Subject|11|||
150096559|NCT00296374|541493905|FG000|Overall Study|Incorrect enrollment|3|||
150096560|NCT00296374|541493906|FG001|Overall Study|Incorrect enrollment|3|||
150096561|NCT00296374|541493907|FG002|Overall Study|Incorrect enrollment|4|||
150096562|NCT00296374|541493905|FG000|Overall Study|Protocol Violation|1|||
150096563|NCT00296374|541493906|FG001|Overall Study|Protocol Violation|2|||
150096564|NCT00296374|541493907|FG002|Overall Study|Protocol Violation|3|||
150096565|NCT00296374|541493905|FG000|Overall Study|Lost to Follow-up|3|||
150096566|NCT00296374|541493906|FG001|Overall Study|Lost to Follow-up|1|||
150096567|NCT00296374|541493907|FG002|Overall Study|Lost to Follow-up|1|||
150096568|NCT00296374|541493905|FG000|Overall Study|Relocated to another state|1|||
150096569|NCT00296374|541493906|FG001|Overall Study|Relocated to another state|0|||
150096570|NCT00296374|541493907|FG002|Overall Study|Relocated to another state|0|||
150096571|NCT00296374|541493905|FG000|Overall Study|Stopped drug before end of study visit|0|||
150096572|NCT00296374|541493906|FG001|Overall Study|Stopped drug before end of study visit|1|||
150096573|NCT00296374|541493907|FG002|Overall Study|Stopped drug before end of study visit|0|||
150096574|NCT00296374|541493905|FG000|Overall Study|Nephrologist introduced ACE|0|||
150096575|NCT00296374|541493906|FG001|Overall Study|Nephrologist introduced ACE|1|||
150096576|NCT00296374|541493907|FG002|Overall Study|Nephrologist introduced ACE|0|||
150096577|NCT00296374|541493905|FG000|Overall Study|Pregnancy|0|||
150096578|NCT00296374|541493906|FG001|Overall Study|Pregnancy|0|||
150096579|NCT00296374|541493907|FG002|Overall Study|Pregnancy|2|||
150096580|NCT00296374|541493905|FG000|Overall Study|Other|0|||
150096581|NCT00296374|541493906|FG001|Overall Study|Other|0|||
150096582|NCT00296374|541493907|FG002|Overall Study|Other|1|||
150096583|NCT06308822|541495763|FG000|Overall Study|Mutation Status Not Confirmed|17|||
150096584|NCT06308822|541495763|FG000|Overall Study|Adverse Event|1|||
150096585|NCT06308822|541495763|FG000|Overall Study|Death|5|||
150096586|NCT06308822|541495763|FG000|Overall Study|Disease progression|8|||
150096587|NCT06308822|541495763|FG000|Overall Study|Withdrawal by Subject|1|||
150096588|NCT06308822|541495763|FG000|Overall Study|Physician Decision|3|||
150096589|NCT04734652|541495769|FG000|Overall Study|Withdrawal by Subject|2|||
150096590|NCT04734652|541495770|FG001|Overall Study|Withdrawal by Subject|0|||
150096591|NCT04734652|541495769|FG000|Overall Study|Death|0|||
150096592|NCT04734652|541495770|FG001|Overall Study|Death|1|||
150096593|NCT01921179|541495774|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
150096594|NCT01921179|541495775|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
150096595|NCT01921179|541495774|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
150096596|NCT01921179|541495775|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
150096597|NCT01190254|541495778|FG000|Overall Study|Adverse Event|3|||
150096598|NCT01190254|541495779|FG001|Overall Study|Adverse Event|6|||
150096599|NCT01190254|541495780|FG002|Overall Study|Adverse Event|8|||
150096600|NCT01190254|541495778|FG000|Overall Study|Lack of Efficacy|7|||
150096601|NCT01190254|541495779|FG001|Overall Study|Lack of Efficacy|4|||
150096602|NCT01190254|541495780|FG002|Overall Study|Lack of Efficacy|5|||
150096603|NCT01190254|541495778|FG000|Overall Study|Lost to Follow-up|4|||
150184977|NCT04431726|541815777|FG000|Overall Study|Ongoing in the Study|55|||
150184978|NCT04281485|541815778|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
150184979|NCT04281485|541815779|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
150096604|NCT01190254|541495779|FG001|Overall Study|Lost to Follow-up|2|||
150096605|NCT01190254|541495780|FG002|Overall Study|Lost to Follow-up|0|||
150096606|NCT01190254|541495778|FG000|Overall Study|Withdrawal by Subject|4|||
150096607|NCT01190254|541495779|FG001|Overall Study|Withdrawal by Subject|5|||
150096608|NCT01190254|541495780|FG002|Overall Study|Withdrawal by Subject|7|||
150096609|NCT01190254|541495778|FG000|Overall Study|Protocol Violation|2|||
150096610|NCT01190254|541495779|FG001|Overall Study|Protocol Violation|0|||
150096611|NCT01190254|541495780|FG002|Overall Study|Protocol Violation|2|||
150096612|NCT01190254|541495778|FG000|Overall Study|Did not meet protocol eligibility|1|||
150096613|NCT01190254|541495779|FG001|Overall Study|Did not meet protocol eligibility|0|||
150096614|NCT01190254|541495780|FG002|Overall Study|Did not meet protocol eligibility|0|||
150096615|NCT04146545|541495781|FG000|Overall Study|deemed ineligible after randomization|1|||
150096616|NCT04146545|541495782|FG001|Overall Study|deemed ineligible after randomization|0|||
150096617|NCT00773292|541495783|FG000|Treatment 48 Weeks|Adverse Event|1|||
150096618|NCT00773292|541495783|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
150096619|NCT04729127|541495784|FG000|Overall Study|Suspended/Terminated EI Services|4|||
150096620|NCT04729127|541495785|FG001|Overall Study|Suspended/Terminated EI Services|0|||
150096621|NCT04729127|541495786|FG002|Overall Study|Suspended/Terminated EI Services|4|||
150096622|NCT04729127|541495787|FG003|Overall Study|Suspended/Terminated EI Services|6|||
150096623|NCT04729127|541495788|FG004|Overall Study|Suspended/Terminated EI Services|0|||
150096624|NCT04729127|541495789|FG005|Overall Study|Suspended/Terminated EI Services|6|||
150096625|NCT04729127|541495790|FG006|Overall Study|Suspended/Terminated EI Services|2|||
150096626|NCT04729127|541495791|FG007|Overall Study|Suspended/Terminated EI Services|0|||
150096627|NCT04729127|541495792|FG008|Overall Study|Suspended/Terminated EI Services|2|||
150096628|NCT04729127|541495784|FG000|Overall Study|Withdrawal by Subject|1|||
150096629|NCT04729127|541495785|FG001|Overall Study|Withdrawal by Subject|0|||
150096630|NCT04729127|541495786|FG002|Overall Study|Withdrawal by Subject|1|||
150096631|NCT04729127|541495787|FG003|Overall Study|Withdrawal by Subject|0|||
150096632|NCT04729127|541495788|FG004|Overall Study|Withdrawal by Subject|0|||
150096633|NCT04729127|541495789|FG005|Overall Study|Withdrawal by Subject|0|||
150096634|NCT04729127|541495790|FG006|Overall Study|Withdrawal by Subject|0|||
150096635|NCT04729127|541495791|FG007|Overall Study|Withdrawal by Subject|0|||
150096636|NCT04729127|541495792|FG008|Overall Study|Withdrawal by Subject|0|||
150096637|NCT04729127|541495784|FG000|Overall Study|Switched Agency/Setting|1|||
150096638|NCT04729127|541495785|FG001|Overall Study|Switched Agency/Setting|0|||
150096639|NCT04729127|541495786|FG002|Overall Study|Switched Agency/Setting|1|||
150096640|NCT04729127|541495787|FG003|Overall Study|Switched Agency/Setting|1|||
150096641|NCT04729127|541495788|FG004|Overall Study|Switched Agency/Setting|0|||
150096642|NCT04729127|541495789|FG005|Overall Study|Switched Agency/Setting|1|||
150096643|NCT04729127|541495790|FG006|Overall Study|Switched Agency/Setting|1|||
150096644|NCT04729127|541495791|FG007|Overall Study|Switched Agency/Setting|0|||
150096645|NCT04729127|541495792|FG008|Overall Study|Switched Agency/Setting|1|||
150096646|NCT00542919|541495795|FG000|Overall Study|Adverse Event|1|||
150096647|NCT00542919|541495796|FG001|Overall Study|Adverse Event|5|||
150096648|NCT00542919|541495797|FG002|Overall Study|Adverse Event|1|||
150096649|NCT00542919|541495795|FG000|Overall Study|Withdrawal by Subject|1|||
150096650|NCT00542919|541495796|FG001|Overall Study|Withdrawal by Subject|0|||
150096651|NCT00542919|541495797|FG002|Overall Study|Withdrawal by Subject|3|||
150096652|NCT00542919|541495795|FG000|Overall Study|Physician Decision|2|||
150096653|NCT00542919|541495796|FG001|Overall Study|Physician Decision|2|||
150096654|NCT00542919|541495797|FG002|Overall Study|Physician Decision|1|||
150096655|NCT00542919|541495795|FG000|Overall Study|Sponsor Decision|1|||
150096656|NCT00542919|541495796|FG001|Overall Study|Sponsor Decision|0|||
150096657|NCT00542919|541495797|FG002|Overall Study|Sponsor Decision|0|||
150096658|NCT00542919|541495795|FG000|Overall Study|Lost to Follow-up|2|||
150096659|NCT00542919|541495796|FG001|Overall Study|Lost to Follow-up|0|||
150096660|NCT00542919|541495797|FG002|Overall Study|Lost to Follow-up|1|||
150096661|NCT01998633|541495809|FG000|Overall Study|Death|1|||
150096662|NCT00536107|541495811|FG000|Overall Study|Death|5|||
150096663|NCT00536107|541495812|FG001|Overall Study|Death|1|||
150096664|NCT00536107|541495811|FG000|Overall Study|Incorrect enrolment|1|||
150096665|NCT00536107|541495812|FG001|Overall Study|Incorrect enrolment|0|||
150096666|NCT00536107|541495811|FG000|Overall Study|Withdrawal by Subject|0|||
150096667|NCT00536107|541495812|FG001|Overall Study|Withdrawal by Subject|1|||
150096668|NCT00536107|541495811|FG000|Overall Study|Study Termination|2|||
150096669|NCT00536107|541495812|FG001|Overall Study|Study Termination|4|||
150096670|NCT00371254|541495813|FG000|Overall Study|Disease progression|13|||
150096671|NCT00371254|541495814|FG001|Overall Study|Disease progression|13|||
150096672|NCT00371254|541495813|FG000|Overall Study|Study drug toxicity|3|||
150096673|NCT00371254|541495814|FG001|Overall Study|Study drug toxicity|5|||
150096674|NCT00371254|541495813|FG000|Overall Study|Subject request|5|||
150096675|NCT00371254|541495814|FG001|Overall Study|Subject request|0|||
150096676|NCT00371254|541495813|FG000|Overall Study|Investigator Decision|2|||
150096677|NCT00371254|541495814|FG001|Overall Study|Investigator Decision|0|||
150096678|NCT00371254|541495813|FG000|Overall Study|Adverse event unrelated to study drug|0|||
150096679|NCT00371254|541495814|FG001|Overall Study|Adverse event unrelated to study drug|1|||
150096680|NCT00371254|541495813|FG000|Overall Study|Lost to Follow-up|0|||
150096681|NCT00371254|541495814|FG001|Overall Study|Lost to Follow-up|1|||
150096682|NCT00371254|541495813|FG000|Overall Study|Withdrawal by Subject|0|||
150096683|NCT00371254|541495814|FG001|Overall Study|Withdrawal by Subject|1|||
150096684|NCT03329690|541495815|FG000|Overall Study|Progressive disease per RECIST|85|||
150096685|NCT03329690|541495816|FG001|Overall Study|Progressive disease per RECIST|44|||
150096686|NCT03329690|541495817|FG002|Overall Study|Progressive disease per RECIST|6|||
150096687|NCT03329690|541495818|FG003|Overall Study|Progressive disease per RECIST|16|||
150096688|NCT03329690|541495819|FG004|Overall Study|Progressive disease per RECIST|20|||
150096689|NCT03329690|541495815|FG000|Overall Study|Clinical progression|7|||
150096690|NCT03329690|541495816|FG001|Overall Study|Clinical progression|4|||
150096691|NCT03329690|541495817|FG002|Overall Study|Clinical progression|1|||
150096692|NCT03329690|541495818|FG003|Overall Study|Clinical progression|1|||
150096693|NCT03329690|541495819|FG004|Overall Study|Clinical progression|1|||
150096694|NCT03329690|541495815|FG000|Overall Study|Adverse Event|22|||
150096695|NCT03329690|541495816|FG001|Overall Study|Adverse Event|4|||
150096696|NCT03329690|541495817|FG002|Overall Study|Adverse Event|0|||
150096697|NCT03329690|541495818|FG003|Overall Study|Adverse Event|1|||
150096698|NCT03329690|541495819|FG004|Overall Study|Adverse Event|2|||
150096699|NCT03329690|541495815|FG000|Overall Study|Death|2|||
150096700|NCT03329690|541495816|FG001|Overall Study|Death|0|||
150096701|NCT03329690|541495817|FG002|Overall Study|Death|0|||
150096702|NCT03329690|541495818|FG003|Overall Study|Death|1|||
150096703|NCT03329690|541495819|FG004|Overall Study|Death|0|||
150096704|NCT03329690|541495815|FG000|Overall Study|Withdrawal by Subject|2|||
150096705|NCT03329690|541495816|FG001|Overall Study|Withdrawal by Subject|3|||
150096706|NCT03329690|541495817|FG002|Overall Study|Withdrawal by Subject|0|||
150096707|NCT03329690|541495818|FG003|Overall Study|Withdrawal by Subject|1|||
150096708|NCT03329690|541495819|FG004|Overall Study|Withdrawal by Subject|0|||
150096709|NCT03329690|541495815|FG000|Overall Study|Physician Decision|1|||
150096710|NCT03329690|541495816|FG001|Overall Study|Physician Decision|0|||
150096711|NCT03329690|541495817|FG002|Overall Study|Physician Decision|0|||
150096712|NCT03329690|541495818|FG003|Overall Study|Physician Decision|0|||
150096713|NCT03329690|541495819|FG004|Overall Study|Physician Decision|1|||
150096714|NCT03329690|541495815|FG000|Overall Study|Miscellaneous|6|||
150096715|NCT03329690|541495816|FG001|Overall Study|Miscellaneous|0|||
150096716|NCT03329690|541495817|FG002|Overall Study|Miscellaneous|0|||
150096717|NCT03329690|541495818|FG003|Overall Study|Miscellaneous|0|||
150096718|NCT03329690|541495819|FG004|Overall Study|Miscellaneous|0|||
150096719|NCT03329690|541495815|FG000|Overall Study|Did not receive treatment|1|||
150096720|NCT03329690|541495816|FG001|Overall Study|Did not receive treatment|0|||
150096721|NCT03329690|541495817|FG002|Overall Study|Did not receive treatment|0|||
150096722|NCT03329690|541495818|FG003|Overall Study|Did not receive treatment|1|||
150096723|NCT03329690|541495819|FG004|Overall Study|Did not receive treatment|0|||
150096724|NCT01817725|541495820|FG000|Overall Study|Withdrawal by Subject|1|||
150096725|NCT02337907|541495823|FG000|Overall Study|Other than listed|1|||
150096726|NCT02337907|541495824|FG001|Overall Study|Other than listed|0|||
150096727|NCT02337907|541495825|FG002|Overall Study|Other than listed|0|||
150096728|NCT02337907|541495826|FG003|Overall Study|Other than listed|1|||
150096729|NCT02337907|541495827|FG004|Overall Study|Other than listed|1|||
150096730|NCT02337907|541495828|FG005|Overall Study|Other than listed|0|||
150096731|NCT02337907|541495823|FG000|Overall Study|Withdrawal by Subject|2|||
150096732|NCT02337907|541495824|FG001|Overall Study|Withdrawal by Subject|3|||
150096733|NCT02337907|541495825|FG002|Overall Study|Withdrawal by Subject|0|||
150096734|NCT02337907|541495826|FG003|Overall Study|Withdrawal by Subject|2|||
150096735|NCT02337907|541495827|FG004|Overall Study|Withdrawal by Subject|5|||
150096736|NCT02337907|541495828|FG005|Overall Study|Withdrawal by Subject|0|||
150096737|NCT02337907|541495823|FG000|Overall Study|Lost to Follow-up|0|||
150096738|NCT02337907|541495824|FG001|Overall Study|Lost to Follow-up|0|||
150096739|NCT02337907|541495825|FG002|Overall Study|Lost to Follow-up|0|||
150096740|NCT02337907|541495826|FG003|Overall Study|Lost to Follow-up|0|||
150096741|NCT02337907|541495827|FG004|Overall Study|Lost to Follow-up|0|||
150096742|NCT02337907|541495828|FG005|Overall Study|Lost to Follow-up|1|||
150096743|NCT02337907|541495823|FG000|Overall Study|Adverse Event|1|||
150096744|NCT02337907|541495824|FG001|Overall Study|Adverse Event|1|||
150096745|NCT02337907|541495825|FG002|Overall Study|Adverse Event|1|||
150096746|NCT02337907|541495826|FG003|Overall Study|Adverse Event|1|||
150096747|NCT02337907|541495827|FG004|Overall Study|Adverse Event|4|||
150096748|NCT02337907|541495828|FG005|Overall Study|Adverse Event|0|||
150096749|NCT00613015|541495835|FG000|Overall Study|Lost to Follow-up|0|||
150096750|NCT00613015|541495836|FG001|Overall Study|Lost to Follow-up|1|||
150096751|NCT00613015|541495837|FG002|Overall Study|Lost to Follow-up|3|||
150096752|NCT00613015|541495838|FG003|Overall Study|Lost to Follow-up|3|||
150096753|NCT00613015|541495839|FG004|Overall Study|Lost to Follow-up|2|||
150096754|NCT00613015|541495840|FG005|Overall Study|Lost to Follow-up|3|||
150096755|NCT01179477|541495843|FG000|Overall Study|Death|542|||
150096756|NCT01179477|541495843|FG000|Overall Study|Unsuccessful implant|80|||
150096757|NCT01179477|541495843|FG000|Overall Study|Non-death withdrawal|438|||
150096758|NCT01179477|541495843|FG000|Overall Study|Did not complete final visit|27|||
150096759|NCT04327388|541495845|FG000|Overall Study|Adverse Event|17|||
150096760|NCT04327388|541495846|FG001|Overall Study|Adverse Event|18|||
150096761|NCT04327388|541495847|FG002|Overall Study|Adverse Event|9|||
150096762|NCT04327388|541495845|FG000|Overall Study|Other|1|||
150096763|NCT04327388|541495846|FG001|Overall Study|Other|2|||
150096764|NCT04327388|541495847|FG002|Overall Study|Other|0|||
150096765|NCT04327388|541495845|FG000|Overall Study|Randomized and not treated|2|||
150096766|NCT04327388|541495846|FG001|Overall Study|Randomized and not treated|0|||
150096767|NCT04327388|541495847|FG002|Overall Study|Randomized and not treated|2|||
150096768|NCT04829318|541495848|FG000|Overall Study|Adverse Event|6|||
150096769|NCT04829318|541495848|FG000|Overall Study|Death|1|||
150096770|NCT04829318|541495848|FG000|Overall Study|Lost to Follow-up|1|||
150096771|NCT04829318|541495848|FG000|Overall Study|Physician Decision|1|||
150096772|NCT04829318|541495848|FG000|Overall Study|Withdrawal by Subject|19|||
150096773|NCT04829318|541495848|FG000|Overall Study|Site terminated by sponsor|1|||
150096774|NCT04829318|541495848|FG000|Overall Study|Sponsor decision|5|||
150096775|NCT04829318|541495848|FG000|Overall Study|Other|1|||
150096776|NCT00728130|541495849|FG000|Overall Study|Withdrawal by Subject|1|||
150096777|NCT00728130|541495849|FG000|Overall Study|Paperwork not completed in time|1|||
150096778|NCT00728130|541495849|FG000|Overall Study|Physician Decision|1|||
150096779|NCT04053023|541495852|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
150096780|NCT04053023|541495853|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
150096781|NCT00071760|541495854|FG000|Overall Study|Adverse Event|2|||
150096782|NCT00071760|541495855|FG001|Overall Study|Adverse Event|1|||
150096783|NCT00071760|541495854|FG000|Overall Study|Lost to Follow-up|0|||
150096784|NCT00071760|541495855|FG001|Overall Study|Lost to Follow-up|3|||
150096785|NCT00071760|541495854|FG000|Overall Study|Protocol Violation|1|||
150096786|NCT00071760|541495855|FG001|Overall Study|Protocol Violation|0|||
150096787|NCT00071760|541495854|FG000|Overall Study|Withdrawal by Subject|0|||
150096788|NCT00071760|541495855|FG001|Overall Study|Withdrawal by Subject|1|||
150096789|NCT00071760|541495854|FG000|Overall Study|Insufficient Viral Load Response|1|||
150096790|NCT00071760|541495855|FG001|Overall Study|Insufficient Viral Load Response|1|||
150096791|NCT00071760|541495854|FG000|Overall Study|Lack of availability of RTV|1|||
150096792|NCT00071760|541495855|FG001|Overall Study|Lack of availability of RTV|0|||
150096793|NCT00071760|541495854|FG000|Overall Study|Physician Decision|2|||
150096794|NCT00071760|541495855|FG001|Overall Study|Physician Decision|1|||
150096795|NCT00071760|541495854|FG000|Overall Study|Relocation|0|||
150096796|NCT00071760|541495855|FG001|Overall Study|Relocation|1|||
150096797|NCT02073279|541495856|FG000|Double-blind Period|Adverse Event|1|||
150096798|NCT02073279|541495857|FG001|Double-blind Period|Adverse Event|1|||
150096799|NCT02073279|541495856|FG000|Double-blind Period|Switched to another treatment|1|||
150096800|NCT02073279|541495857|FG001|Double-blind Period|Switched to another treatment|2|||
150096801|NCT02073279|541495856|FG000|Double-blind Period|Protocol Violation|0|||
150096802|NCT02073279|541495857|FG001|Double-blind Period|Protocol Violation|1|||
150096803|NCT02073279|541495856|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
150096804|NCT02073279|541495857|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
150096805|NCT02073279|541495856|FG000|Double-blind Period|Withdrawal by Subject|2|||
150096806|NCT02073279|541495857|FG001|Double-blind Period|Withdrawal by Subject|2|||
150096807|NCT02073279|541495856|FG000|Open-label Extension Period|Adverse Event|1|||
150096808|NCT02073279|541495857|FG001|Open-label Extension Period|Adverse Event|0|||
150096809|NCT02073279|541495856|FG000|Open-label Extension Period|Lack of Efficacy|1|||
150096810|NCT02073279|541495857|FG001|Open-label Extension Period|Lack of Efficacy|0|||
150096811|NCT02073279|541495856|FG000|Open-label Extension Period|Lost to Follow-up|0|||
150096812|NCT02073279|541495857|FG001|Open-label Extension Period|Lost to Follow-up|4|||
150096813|NCT02073279|541495856|FG000|Open-label Extension Period|Switched to another treatment|1|||
150096814|NCT02073279|541495857|FG001|Open-label Extension Period|Switched to another treatment|4|||
150096815|NCT02073279|541495856|FG000|Open-label Extension Period|Protocol Violation|0|||
150096816|NCT02073279|541495857|FG001|Open-label Extension Period|Protocol Violation|1|||
150096817|NCT02073279|541495856|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
150096818|NCT02073279|541495857|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
150096819|NCT02073279|541495856|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
150096820|NCT02073279|541495857|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
150096821|NCT01558752|541495861|FG000|Overall Study|Physician Decision|2|||
150096822|NCT01558752|541495862|FG001|Overall Study|Physician Decision|0|||
150096823|NCT04340362|541495865|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
150096824|NCT04387435|541495870|FG000|Overall Study|Physician Decision|1|||
150096825|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
150096826|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
150096827|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
150096828|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
150096829|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
150096830|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
150096831|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
150096832|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
150096833|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
150096834|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
150096835|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
150096836|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
150096837|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
150096838|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
150096839|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
150096840|NCT00561080|541495871|FG000|Vaccination Period (up to Month 4)|Other|0|||
150096841|NCT00561080|541495872|FG001|Vaccination Period (up to Month 4)|Other|2|||
150096842|NCT00561080|541495873|FG002|Vaccination Period (up to Month 4)|Other|1|||
150096843|NCT00561080|541495871|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
150096844|NCT00561080|541495872|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
150096845|NCT00561080|541495873|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
150096846|NCT00561080|541495871|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
150096847|NCT00561080|541495872|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
150096848|NCT00561080|541495873|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
150096849|NCT00561080|541495871|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
150096850|NCT00561080|541495872|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
150096851|NCT00561080|541495873|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
150096852|NCT00561080|541495871|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
150096853|NCT00561080|541495872|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
150096854|NCT00561080|541495873|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
150096855|NCT02951156|541495874|FG000|Overall Study|Death|3|||
150096856|NCT02951156|541495875|FG001|Overall Study|Death|8|||
150096857|NCT02951156|541495876|FG002|Overall Study|Death|5|||
150096858|NCT02951156|541495874|FG000|Overall Study|Progressive disease|1|||
150096859|NCT02951156|541495875|FG001|Overall Study|Progressive disease|0|||
150096860|NCT02951156|541495876|FG002|Overall Study|Progressive disease|1|||
150096861|NCT02951156|541495874|FG000|Overall Study|Withdrawal by Subject|0|||
150096862|NCT02951156|541495875|FG001|Overall Study|Withdrawal by Subject|0|||
150096863|NCT02951156|541495876|FG002|Overall Study|Withdrawal by Subject|1|||
150096864|NCT02951156|541495874|FG000|Overall Study|Study terminated by sponsor|0|||
150096865|NCT02951156|541495875|FG001|Overall Study|Study terminated by sponsor|0|||
150096866|NCT02951156|541495876|FG002|Overall Study|Study terminated by sponsor|1|||
150096867|NCT02951156|541495874|FG000|Overall Study|Other|5|||
150096868|NCT02951156|541495875|FG001|Overall Study|Other|1|||
150096869|NCT02951156|541495876|FG002|Overall Study|Other|2|||
150096870|NCT01092182|541495877|FG000|Overall Study|Death|0|||
150096871|NCT01092182|541495878|FG001|Overall Study|Death|5|||
150096872|NCT01092182|541495879|FG002|Overall Study|Death|3|||
150096873|NCT01092182|541495877|FG000|Overall Study|participant safety|1|||
150096874|NCT01092182|541495878|FG001|Overall Study|participant safety|2|||
150096875|NCT01092182|541495879|FG002|Overall Study|participant safety|0|||
150096876|NCT01092182|541495877|FG000|Overall Study|Physician Decision|0|||
150096877|NCT01092182|541495878|FG001|Overall Study|Physician Decision|6|||
150096878|NCT01092182|541495879|FG002|Overall Study|Physician Decision|0|||
150096879|NCT01092182|541495877|FG000|Overall Study|Did not meet criteria|0|||
150096880|NCT01092182|541495878|FG001|Overall Study|Did not meet criteria|0|||
150096881|NCT01092182|541495879|FG002|Overall Study|Did not meet criteria|25|||
150096882|NCT01092182|541495877|FG000|Overall Study|Non-compliance|0|||
150096883|NCT01092182|541495878|FG001|Overall Study|Non-compliance|3|||
150096884|NCT01092182|541495879|FG002|Overall Study|Non-compliance|0|||
150096885|NCT01092182|541495877|FG000|Overall Study|Participant refused follow-up|0|||
150096886|NCT01092182|541495878|FG001|Overall Study|Participant refused follow-up|2|||
150096887|NCT01092182|541495879|FG002|Overall Study|Participant refused follow-up|0|||
150096888|NCT03255382|541495880|FG000|Overall Study|Adverse Event|3|||
150096889|NCT03255382|541495881|FG001|Overall Study|Adverse Event|0|||
150096890|NCT03255382|541495880|FG000|Overall Study|Lost to Follow-up|2|||
150096891|NCT03255382|541495881|FG001|Overall Study|Lost to Follow-up|0|||
150096892|NCT03255382|541495880|FG000|Overall Study|Withdrawal by Subject|2|||
150096893|NCT03255382|541495881|FG001|Overall Study|Withdrawal by Subject|0|||
150096894|NCT03255382|541495880|FG000|Overall Study|Other|6|||
150096895|NCT03255382|541495881|FG001|Overall Study|Other|0|||
150096896|NCT02466555|541495884|FG000|Overall Study|Lost to Follow-up|2|||
150096897|NCT03839212|541495887|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
150096898|NCT01173718|541495890|FG000|Overall Study|Death|17|||
150096899|NCT01173718|541495890|FG000|Overall Study|Abandonment of study graft|27|||
150096900|NCT02113956|541495891|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
150096901|NCT02113956|541495892|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
150096902|NCT02113956|541495891|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
150096903|NCT02113956|541495892|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
150096904|NCT02113956|541495891|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
150096905|NCT02113956|541495892|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
150096906|NCT01498458|541495893|FG000|Overall Study|Adverse Event|4|||
150096907|NCT01498458|541495893|FG000|Overall Study|Physician Decision|3|||
150096908|NCT02226003|541495894|FG000|Overall Study|Lost to Follow-up|2|||
150096909|NCT02226003|541495895|FG001|Overall Study|Lost to Follow-up|1|||
150096910|NCT02226003|541495896|FG002|Overall Study|Lost to Follow-up|3|||
150096911|NCT02226003|541495894|FG000|Overall Study|Withdrawal by Subject|0|||
150096912|NCT02226003|541495895|FG001|Overall Study|Withdrawal by Subject|0|||
150096913|NCT02226003|541495896|FG002|Overall Study|Withdrawal by Subject|3|||
150096914|NCT03279692|541495899|FG000|Overall Study|Withdrawal by Subject|1|||
150096915|NCT05198843|541495900|FG000|Overall Study|Lack of Efficacy|1|||
150096916|NCT02588833|541495901|FG000|Part 1|Withdrawal by Subject|1|||
150096917|NCT02588833|541495902|FG001|Part 1|Withdrawal by Subject|0|||
150096918|NCT02588833|541495901|FG000|Part 2A|Physician Decision|0|||
150096919|NCT02588833|541495902|FG001|Part 2A|Physician Decision|1|||
150096920|NCT02588833|541495901|FG000|Part 2A|Withdrawal by Subject|0|||
150096921|NCT02588833|541495902|FG001|Part 2A|Withdrawal by Subject|1|||
150096922|NCT02588833|541495901|FG000|Part 2B|Adverse Event|0|||
150096923|NCT02588833|541495902|FG001|Part 2B|Adverse Event|1|||
150096924|NCT02588833|541495901|FG000|Part 2C|Adverse Event|0|||
150096925|NCT02588833|541495902|FG001|Part 2C|Adverse Event|1|||
150096926|NCT02588833|541495901|FG000|Part 2C|Withdrawal by Subject|0|||
150096927|NCT02588833|541495902|FG001|Part 2C|Withdrawal by Subject|1|||
150096928|NCT02588833|541495901|FG000|Part 3 (Safety Follow-up)|Other|0|||
150096929|NCT02588833|541495902|FG001|Part 3 (Safety Follow-up)|Other|2|||
150096930|NCT04537234|541495908|FG000|Overall Study|Withdrawal by Subject|2|||
150096931|NCT04537234|541495909|FG001|Overall Study|Withdrawal by Subject|0|||
150096932|NCT07114198|541495910|FG000|Overall Study|Protocol Violation|1|||
150096933|NCT07114198|541495911|FG001|Overall Study|Protocol Violation|1|||
150096934|NCT04318080|541497308|FG000|Overall Study|Study closed by sponsor|10|||
150096935|NCT04318080|541497309|FG001|Overall Study|Study closed by sponsor|22|||
150096936|NCT04318080|541497308|FG000|Overall Study|Death|3|||
150096937|NCT04318080|541497309|FG001|Overall Study|Death|9|||
150096938|NCT04318080|541497308|FG000|Overall Study|Withdrawal by Subject|1|||
150096939|NCT04318080|541497309|FG001|Overall Study|Withdrawal by Subject|0|||
150096940|NCT04318080|541497308|FG000|Overall Study|Protocol Deviation|1|||
150096941|NCT04318080|541497309|FG001|Overall Study|Protocol Deviation|0|||
150096942|NCT02926924|541497310|FG000|Overall Study|withdrawal - reason unknown|0|||
150096943|NCT02926924|541497311|FG001|Overall Study|withdrawal - reason unknown|1|||
150096944|NCT00939809|541497314|FG000|Overall Study|Adverse Event|2|||
150096945|NCT00939809|541497314|FG000|Overall Study|Death|1|||
150096946|NCT02603809|541497315|FG000|Overall Study|Withdrawal by Subject|4|||
150096947|NCT02603809|541497316|FG001|Overall Study|Withdrawal by Subject|1|||
150096948|NCT02603809|541497317|FG002|Overall Study|Withdrawal by Subject|2|||
150096949|NCT02603809|541497318|FG003|Overall Study|Withdrawal by Subject|3|||
150096950|NCT02603809|541497319|FG004|Overall Study|Withdrawal by Subject|3|||
150096951|NCT02603809|541497320|FG005|Overall Study|Withdrawal by Subject|4|||
150096952|NCT02603809|541497315|FG000|Overall Study|Lost to Follow-up|2|||
150096953|NCT02603809|541497316|FG001|Overall Study|Lost to Follow-up|3|||
150096954|NCT02603809|541497317|FG002|Overall Study|Lost to Follow-up|1|||
150096955|NCT02603809|541497318|FG003|Overall Study|Lost to Follow-up|4|||
150096956|NCT02603809|541497319|FG004|Overall Study|Lost to Follow-up|2|||
150096957|NCT02603809|541497320|FG005|Overall Study|Lost to Follow-up|2|||
150096958|NCT02603809|541497315|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
150096959|NCT02603809|541497316|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
150096960|NCT02603809|541497317|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
150096961|NCT02603809|541497318|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
150096962|NCT02603809|541497319|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
150096963|NCT02603809|541497320|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
150096964|NCT02603809|541497315|FG000|Overall Study|Physician Decision|0|||
150096965|NCT02603809|541497316|FG001|Overall Study|Physician Decision|0|||
150096966|NCT02603809|541497317|FG002|Overall Study|Physician Decision|0|||
150096967|NCT02603809|541497318|FG003|Overall Study|Physician Decision|1|||
150096968|NCT02603809|541497319|FG004|Overall Study|Physician Decision|2|||
150096969|NCT02603809|541497320|FG005|Overall Study|Physician Decision|1|||
150096970|NCT02603809|541497315|FG000|Overall Study|Adverse Event|3|||
150096971|NCT02603809|541497316|FG001|Overall Study|Adverse Event|0|||
150096972|NCT02603809|541497317|FG002|Overall Study|Adverse Event|2|||
150096973|NCT02603809|541497318|FG003|Overall Study|Adverse Event|2|||
150096974|NCT02603809|541497319|FG004|Overall Study|Adverse Event|1|||
150096975|NCT02603809|541497320|FG005|Overall Study|Adverse Event|1|||
150096976|NCT02603809|541497315|FG000|Overall Study|Lack of Efficacy|0|||
150096977|NCT02603809|541497316|FG001|Overall Study|Lack of Efficacy|1|||
150096978|NCT02603809|541497317|FG002|Overall Study|Lack of Efficacy|0|||
150096979|NCT02603809|541497318|FG003|Overall Study|Lack of Efficacy|0|||
150096980|NCT02603809|541497319|FG004|Overall Study|Lack of Efficacy|0|||
150096981|NCT02603809|541497320|FG005|Overall Study|Lack of Efficacy|1|||
150096982|NCT03970733|541497321|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
150096983|NCT03970733|541497322|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
150096984|NCT03970733|541497323|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
150096985|NCT03970733|541497324|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
150096986|NCT03970733|541497325|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
150096987|NCT03970733|541497321|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
150096988|NCT03970733|541497322|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
150096989|NCT03970733|541497323|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
150096990|NCT03970733|541497324|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
150096991|NCT03970733|541497325|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
150096992|NCT03970733|541497321|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
150096993|NCT03970733|541497322|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
150096994|NCT03970733|541497323|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
150096995|NCT03970733|541497324|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
150096996|NCT03970733|541497325|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
150096997|NCT03970733|541497321|FG000|Main Study Phase (18 Months)|Other|1|||
150096998|NCT03970733|541497322|FG001|Main Study Phase (18 Months)|Other|1|||
150096999|NCT03970733|541497323|FG002|Main Study Phase (18 Months)|Other|0|||
150097000|NCT03970733|541497324|FG003|Main Study Phase (18 Months)|Other|0|||
150097001|NCT03970733|541497325|FG004|Main Study Phase (18 Months)|Other|0|||
150097002|NCT03970733|541497321|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
150097003|NCT03970733|541497322|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
150097004|NCT03970733|541497323|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
150097005|NCT03970733|541497324|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
150097006|NCT03970733|541497325|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
150097007|NCT01139450|541497329|FG000|Overall Study|Withdrawal by Subject|7|||
150097008|NCT01139450|541497330|FG001|Overall Study|Withdrawal by Subject|10|||
150097009|NCT01139450|541497331|FG002|Overall Study|Withdrawal by Subject|13|||
150097010|NCT01139450|541497329|FG000|Overall Study|Lack of Efficacy|3|||
150097011|NCT01139450|541497330|FG001|Overall Study|Lack of Efficacy|1|||
150097012|NCT01139450|541497331|FG002|Overall Study|Lack of Efficacy|8|||
150097013|NCT01139450|541497329|FG000|Overall Study|Protocol Violation|6|||
150097014|NCT01139450|541497330|FG001|Overall Study|Protocol Violation|5|||
150097015|NCT01139450|541497331|FG002|Overall Study|Protocol Violation|2|||
150097016|NCT01139450|541497329|FG000|Overall Study|Lost to Follow-up|9|||
150097017|NCT01139450|541497330|FG001|Overall Study|Lost to Follow-up|7|||
150097018|NCT01139450|541497331|FG002|Overall Study|Lost to Follow-up|11|||
150097019|NCT01139450|541497329|FG000|Overall Study|Administrative|0|||
150097020|NCT01139450|541497330|FG001|Overall Study|Administrative|0|||
150097021|NCT01139450|541497331|FG002|Overall Study|Administrative|1|||
150097022|NCT01139450|541497329|FG000|Overall Study|Adverse Event|2|||
150097023|NCT01139450|541497330|FG001|Overall Study|Adverse Event|2|||
150097024|NCT01139450|541497331|FG002|Overall Study|Adverse Event|3|||
150097025|NCT02385266|541497338|FG000|Overall Study|Withdrawal by Subject|1|||
150097026|NCT02385266|541497339|FG001|Overall Study|Withdrawal by Subject|3|||
150097027|NCT00265343|541497340|FG000|Overall Study|Adverse Event|10|||
150097028|NCT00265343|541497341|FG001|Overall Study|Adverse Event|7|||
150097029|NCT00265343|541497340|FG000|Overall Study|Withdrawal by Subject|3|||
150097030|NCT00265343|541497341|FG001|Overall Study|Withdrawal by Subject|9|||
150097031|NCT00265343|541497340|FG000|Overall Study|Other|8|||
150097032|NCT00265343|541497341|FG001|Overall Study|Other|3|||
150097033|NCT02535741|541497342|FG000|Overall Study|Adverse Event|3|||
150097034|NCT02535741|541497342|FG000|Overall Study|Withdrawal by Subject|9|||
150097035|NCT02535741|541497342|FG000|Overall Study|Lost to Follow-up|10|||
150097036|NCT02535741|541497342|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
150097037|NCT02535741|541497342|FG000|Overall Study|Missing data|6|||
150184980|NCT04281485|541815778|FG000|Overall Study|Ongoing (Safety data collection)|10|||
150184981|NCT04281485|541815779|FG001|Overall Study|Ongoing (Safety data collection)|5|||
150184982|NCT04093752|541815782|FG000|Overall Study|Adverse Event|7|||
150184983|NCT04093752|541815783|FG001|Overall Study|Adverse Event|19|||
150097038|NCT01030523|541497343|FG000|Initial Study (5 Years)|Death|1|||
150097039|NCT01030523|541497344|FG001|Initial Study (5 Years)|Death|0|||
150097040|NCT01030523|541497343|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
150097041|NCT01030523|541497344|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
150097042|NCT01030523|541497343|FG000|Initial Study (5 Years)|Implant failure|1|||
150097043|NCT01030523|541497344|FG001|Initial Study (5 Years)|Implant failure|0|||
150097044|NCT01030523|541497343|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
150097045|NCT01030523|541497344|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
150097046|NCT01030523|541497343|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
150097047|NCT01030523|541497344|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
150097048|NCT01030523|541497343|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
150097049|NCT01030523|541497344|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
150097050|NCT03662542|541497349|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
150097051|NCT03662542|541497350|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097052|NCT03662542|541497351|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097053|NCT03662542|541497352|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097054|NCT03662542|541497353|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097055|NCT03662542|541497354|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097056|NCT03662542|541497355|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097057|NCT03662542|541497356|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097058|NCT03662542|541497357|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
150097059|NCT03662542|541497349|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097060|NCT03662542|541497350|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
150097061|NCT03662542|541497351|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097062|NCT03662542|541497352|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097063|NCT03662542|541497353|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097064|NCT03662542|541497354|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097065|NCT03662542|541497355|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097066|NCT03662542|541497356|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097067|NCT03662542|541497357|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
150097068|NCT03662542|541497349|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
150097069|NCT03662542|541497350|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
150097070|NCT03662542|541497351|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
150097071|NCT03662542|541497352|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
150097072|NCT03662542|541497353|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
150097073|NCT03662542|541497354|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
150097074|NCT03662542|541497355|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
150097075|NCT03662542|541497356|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
150097076|NCT03662542|541497357|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
150097077|NCT03662542|541497349|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
150097078|NCT03662542|541497350|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097079|NCT03662542|541497351|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097080|NCT03662542|541497352|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097081|NCT03662542|541497353|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097082|NCT03662542|541497354|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097083|NCT03662542|541497355|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097084|NCT03662542|541497356|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097085|NCT03662542|541497357|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
150097086|NCT03662542|541497349|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097087|NCT03662542|541497350|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097088|NCT03662542|541497351|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097089|NCT03662542|541497352|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097090|NCT03662542|541497353|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097091|NCT03662542|541497354|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
150097092|NCT03662542|541497355|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097093|NCT03662542|541497356|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097094|NCT03662542|541497357|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
150097095|NCT03662542|541497349|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097096|NCT03662542|541497350|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097097|NCT03662542|541497351|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097098|NCT03662542|541497352|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
150184984|NCT04093752|541815784|FG002|Overall Study|Adverse Event|18|||
150184985|NCT04093752|541815785|FG003|Overall Study|Adverse Event|4|||
150184986|NCT04093752|541815782|FG000|Overall Study|Withdrawal by Subject|6|||
150184987|NCT04093752|541815783|FG001|Overall Study|Withdrawal by Subject|6|||
150184988|NCT04093752|541815784|FG002|Overall Study|Withdrawal by Subject|8|||
150184989|NCT04093752|541815785|FG003|Overall Study|Withdrawal by Subject|20|||
150184990|NCT04093752|541815782|FG000|Overall Study|Lost to Follow-up|2|||
150097099|NCT03662542|541497353|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
150097100|NCT03662542|541497354|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097101|NCT03662542|541497355|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097102|NCT03662542|541497356|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097103|NCT03662542|541497357|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
150097104|NCT03662542|541497349|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150097105|NCT03662542|541497350|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150184991|NCT04093752|541815783|FG001|Overall Study|Lost to Follow-up|1|||
150184992|NCT04093752|541815784|FG002|Overall Study|Lost to Follow-up|1|||
150097106|NCT03662542|541497351|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150097107|NCT03662542|541497352|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
150097108|NCT03662542|541497353|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
150097109|NCT03662542|541497354|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
150097110|NCT03662542|541497355|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150097111|NCT03662542|541497356|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150097112|NCT03662542|541497357|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
150184993|NCT04093752|541815785|FG003|Overall Study|Lost to Follow-up|1|||
150184994|NCT04093752|541815782|FG000|Overall Study|Death|0|||
150184995|NCT04093752|541815783|FG001|Overall Study|Death|0|||
150184996|NCT04093752|541815784|FG002|Overall Study|Death|1|||
150184997|NCT04093752|541815785|FG003|Overall Study|Death|2|||
150184998|NCT04093752|541815782|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
150184999|NCT04093752|541815783|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
150185000|NCT04093752|541815784|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
150185001|NCT04093752|541815785|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
150185002|NCT04093752|541815782|FG000|Overall Study|Covid 19|0|||
150185003|NCT04093752|541815783|FG001|Overall Study|Covid 19|0|||
150185004|NCT04093752|541815784|FG002|Overall Study|Covid 19|0|||
150185005|NCT04093752|541815785|FG003|Overall Study|Covid 19|1|||
150185006|NCT04093752|541815782|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
150185007|NCT04093752|541815783|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
150097113|NCT03662542|541497349|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097114|NCT03662542|541497350|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097115|NCT03662542|541497351|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097116|NCT03662542|541497352|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097117|NCT03662542|541497353|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
150097118|NCT03662542|541497354|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
150097119|NCT03662542|541497355|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097120|NCT03662542|541497356|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097121|NCT03662542|541497357|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
150097122|NCT03662542|541497349|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097123|NCT03662542|541497350|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097124|NCT03662542|541497351|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097125|NCT03662542|541497352|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097126|NCT03662542|541497353|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097127|NCT03662542|541497354|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
150097128|NCT03662542|541497355|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097129|NCT03662542|541497356|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097130|NCT03662542|541497357|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
150097131|NCT03662542|541497349|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097132|NCT03662542|541497350|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097133|NCT03662542|541497351|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097134|NCT03662542|541497352|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097135|NCT03662542|541497353|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097136|NCT03662542|541497354|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097137|NCT03662542|541497355|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097138|NCT03662542|541497356|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
150185008|NCT04093752|541815784|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
150185009|NCT04093752|541815785|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
150185010|NCT04093752|541815782|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
150185011|NCT04093752|541815783|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
150097139|NCT03662542|541497357|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
150097140|NCT03662542|541497349|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097141|NCT03662542|541497350|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097142|NCT03662542|541497351|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097143|NCT03662542|541497352|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097144|NCT03662542|541497353|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097145|NCT03662542|541497354|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097146|NCT03662542|541497355|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
150097147|NCT03662542|541497356|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
150097148|NCT03662542|541497357|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
150097149|NCT03662542|541497349|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097150|NCT03662542|541497350|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097151|NCT03662542|541497351|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097152|NCT03662542|541497352|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097153|NCT03662542|541497353|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097154|NCT03662542|541497354|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097155|NCT03662542|541497355|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
150097156|NCT03662542|541497356|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
150097157|NCT03662542|541497357|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
150097158|NCT03662542|541497349|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097159|NCT03662542|541497350|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097160|NCT03662542|541497351|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097161|NCT03662542|541497352|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097162|NCT03662542|541497353|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097163|NCT03662542|541497354|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
150097164|NCT03662542|541497355|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
150097165|NCT03662542|541497356|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
150097166|NCT03662542|541497357|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
150097167|NCT01217060|541497359|FG000|Overall Study|Withdrawal by Subject|1|||
150097168|NCT03388138|541497361|FG000|Overall Study|Protocol Violation|1|||
150097169|NCT03388138|541497362|FG001|Overall Study|Protocol Violation|0|||
150097170|NCT01528072|541497363|FG000|Overall Study|Withdrawal by Subject|5|||
150097171|NCT01528072|541497363|FG000|Overall Study|Physician Decision|1|||
150097172|NCT01528072|541497363|FG000|Overall Study|Determined not eligible by AEAC|1|||
150097173|NCT01528072|541497363|FG000|Overall Study|Missed Visit|2|||
150097174|NCT01528072|541497363|FG000|Overall Study|Lost to Follow-up|5|||
150097175|NCT01528072|541497363|FG000|Overall Study|Explanted|2|||
150097176|NCT01528072|541497363|FG000|Overall Study|Site Closure|4|||
150097177|NCT01528072|541497363|FG000|Overall Study|Death|2|||
150097178|NCT01528072|541497363|FG000|Overall Study|Early Termination of Study|52|||
150097179|NCT01859494|541497371|FG000|Overall Study|Adverse Event|1|||
150097180|NCT04014075|541497374|FG000|Overall Study|Progressive Disease|53|||
150097181|NCT04014075|541497374|FG000|Overall Study|Adverse Event|15|||
150097182|NCT04014075|541497374|FG000|Overall Study|Clinical Progression|4|||
150097183|NCT04014075|541497374|FG000|Overall Study|Death|2|||
150097184|NCT04014075|541497374|FG000|Overall Study|Withdrawal by Subject|2|||
150097185|NCT04014075|541497374|FG000|Overall Study|Miscellaneous|2|||
150097186|NCT04014075|541497374|FG000|Overall Study|Physician Decision|1|||
150097187|NCT02357901|541497380|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
150097188|NCT02357901|541497381|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
150185012|NCT04093752|541815784|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
150185013|NCT04093752|541815785|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
150185014|NCT04093752|541815782|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
150185015|NCT04093752|541815783|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
150185016|NCT04093752|541815784|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
150185017|NCT04093752|541815785|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
150185018|NCT01101451|541815786|FG000|Overall Study|Eligible and never treated|0|||
150185019|NCT01101451|541815787|FG001|Overall Study|Eligible and never treated|5|||
150185020|NCT01101451|541815786|FG000|Overall Study|Ineligible and treated|12|||
150185021|NCT01101451|541815787|FG001|Overall Study|Ineligible and treated|8|||
150185022|NCT01101451|541815786|FG000|Overall Study|Ineligible and never treated|2|||
150185023|NCT01101451|541815787|FG001|Overall Study|Ineligible and never treated|2|||
150185024|NCT04838613|541815790|FG000|Overall Study|Withdrawal by Subject|3|||
150185025|NCT04838613|541815791|FG001|Overall Study|Withdrawal by Subject|6|||
150185026|NCT04838613|541815790|FG000|Overall Study|Protocol Deviation|3|||
150185027|NCT04838613|541815791|FG001|Overall Study|Protocol Deviation|2|||
150185028|NCT04838613|541815790|FG000|Overall Study|Technical Problems|0|||
150097189|NCT02357901|541497382|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
150097190|NCT02357901|541497383|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
150097191|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
150097192|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
150097193|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
150097194|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
150097195|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
150097196|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
150097197|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
150097198|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
150097199|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
150097200|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
150097201|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
150097202|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
150097203|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
150097204|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
150097205|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
150097206|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
150097207|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
150097208|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
150097209|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
150097210|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
150097211|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
150097212|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
150097213|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
150097214|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
150097215|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
150097216|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
150097217|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
150097218|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
150097219|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
150097220|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
150097221|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
150097222|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
150097223|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
150097224|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
150097225|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
150097226|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
150097227|NCT02357901|541497380|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
150097228|NCT02357901|541497381|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
150097229|NCT02357901|541497382|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
150097230|NCT02357901|541497383|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
150097231|NCT00491387|541497392|FG000|Overall Study|study terminated|20|||
150097232|NCT00413192|541497395|FG000|Overall Study|Disease progression|26|||
150097233|NCT00413192|541497396|FG001|Overall Study|Disease progression|31|||
150097234|NCT00413192|541497397|FG002|Overall Study|Disease progression|16|||
150097235|NCT00413192|541497398|FG003|Overall Study|Disease progression|25|||
150097236|NCT00413192|541497395|FG000|Overall Study|Toxicity|3|||
150097237|NCT00413192|541497396|FG001|Overall Study|Toxicity|2|||
150097238|NCT00413192|541497397|FG002|Overall Study|Toxicity|2|||
150097239|NCT00413192|541497398|FG003|Overall Study|Toxicity|2|||
150097240|NCT00413192|541497395|FG000|Overall Study|Withdrawal by Subject|3|||
150097241|NCT00413192|541497396|FG001|Overall Study|Withdrawal by Subject|5|||
150097242|NCT00413192|541497397|FG002|Overall Study|Withdrawal by Subject|0|||
150097243|NCT00413192|541497398|FG003|Overall Study|Withdrawal by Subject|1|||
150097244|NCT00413192|541497395|FG000|Overall Study|Intercurrent illness|0|||
150097245|NCT00413192|541497396|FG001|Overall Study|Intercurrent illness|0|||
150097246|NCT00413192|541497397|FG002|Overall Study|Intercurrent illness|0|||
150097247|NCT00413192|541497398|FG003|Overall Study|Intercurrent illness|1|||
150097248|NCT00413192|541497395|FG000|Overall Study|Intercurrent death|0|||
150097249|NCT00413192|541497396|FG001|Overall Study|Intercurrent death|1|||
150097250|NCT00413192|541497397|FG002|Overall Study|Intercurrent death|0|||
150097251|NCT00413192|541497398|FG003|Overall Study|Intercurrent death|0|||
150097252|NCT00413192|541497395|FG000|Overall Study|Other|5|||
150097253|NCT00413192|541497396|FG001|Overall Study|Other|1|||
150097254|NCT00413192|541497397|FG002|Overall Study|Other|1|||
150097255|NCT00413192|541497398|FG003|Overall Study|Other|2|||
150097256|NCT00413192|541497395|FG000|Overall Study|Not treated|0|||
150097257|NCT00413192|541497396|FG001|Overall Study|Not treated|0|||
150097258|NCT00413192|541497397|FG002|Overall Study|Not treated|0|||
150097259|NCT00413192|541497398|FG003|Overall Study|Not treated|1|||
150097260|NCT03814746|541497399|FG000|Overall Study|Participant decision|9|||
150097261|NCT03814746|541497400|FG001|Overall Study|Participant decision|6|||
150097262|NCT03814746|541497401|FG002|Overall Study|Participant decision|15|||
150097263|NCT03814746|541497399|FG000|Overall Study|Physician Decision|2|||
150097264|NCT03814746|541497400|FG001|Overall Study|Physician Decision|2|||
150097265|NCT03814746|541497401|FG002|Overall Study|Physician Decision|4|||
150097266|NCT03814746|541497399|FG000|Overall Study|Death|2|||
150097267|NCT03814746|541497400|FG001|Overall Study|Death|2|||
150097268|NCT03814746|541497401|FG002|Overall Study|Death|2|||
150097269|NCT03814746|541497399|FG000|Overall Study|Adverse Event|2|||
150097270|NCT03814746|541497400|FG001|Overall Study|Adverse Event|2|||
150097271|NCT03814746|541497401|FG002|Overall Study|Adverse Event|1|||
150097272|NCT03814746|541497399|FG000|Overall Study|Lost to Follow-up|2|||
150097273|NCT03814746|541497400|FG001|Overall Study|Lost to Follow-up|1|||
150097274|NCT03814746|541497401|FG002|Overall Study|Lost to Follow-up|2|||
150097275|NCT03814746|541497399|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150097276|NCT03814746|541497400|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150097277|NCT03814746|541497401|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
150097278|NCT03814746|541497399|FG000|Overall Study|Pregnancy|0|||
150097279|NCT03814746|541497400|FG001|Overall Study|Pregnancy|1|||
150097280|NCT03814746|541497401|FG002|Overall Study|Pregnancy|1|||
150097281|NCT03814746|541497399|FG000|Overall Study|Protocol Violation|1|||
150097282|NCT03814746|541497400|FG001|Overall Study|Protocol Violation|0|||
150097283|NCT03814746|541497401|FG002|Overall Study|Protocol Violation|0|||
150097284|NCT05089682|541497402|FG000|Overall Study|Withdrawal by Subject|2|||
150097285|NCT00772707|541497403|FG000|Overall Study|Withdrawn|3|||
150097286|NCT00483379|541497409|FG000|Treatment Period|Adverse Event|1|||
150097287|NCT00483379|541497410|FG001|Treatment Period|Adverse Event|0|||
150097288|NCT00483379|541497409|FG000|Treatment Period|Withdrawal by Subject|1|||
150097289|NCT00483379|541497410|FG001|Treatment Period|Withdrawal by Subject|0|||
150097290|NCT01592344|541497414|FG000|Overall Study|Adverse Event|1|||
150097291|NCT01592344|541497415|FG001|Overall Study|Adverse Event|1|||
150097292|NCT01592344|541497414|FG000|Overall Study|Lack of Efficacy|1|||
150097293|NCT01592344|541497415|FG001|Overall Study|Lack of Efficacy|0|||
150097294|NCT01592344|541497414|FG000|Overall Study|not available at primary outcome visit|2|||
150097295|NCT01592344|541497415|FG001|Overall Study|not available at primary outcome visit|4|||
150097296|NCT03311659|541497419|FG000|Overall Study|Protocol Violation|1|||
150097297|NCT00449644|541497420|FG000|Overall Study|Adverse Event|0|||
150097298|NCT00449644|541497421|FG001|Overall Study|Adverse Event|0|||
150097299|NCT00449644|541497422|FG002|Overall Study|Adverse Event|3|||
150097300|NCT00449644|541497423|FG003|Overall Study|Adverse Event|5|||
150097301|NCT00449644|541497420|FG000|Overall Study|Death|1|||
150097302|NCT00449644|541497421|FG001|Overall Study|Death|0|||
150097303|NCT00449644|541497422|FG002|Overall Study|Death|6|||
150097304|NCT00449644|541497423|FG003|Overall Study|Death|1|||
150097305|NCT00449644|541497420|FG000|Overall Study|Lost to Follow-up|1|||
150097306|NCT00449644|541497421|FG001|Overall Study|Lost to Follow-up|1|||
150097307|NCT00449644|541497422|FG002|Overall Study|Lost to Follow-up|5|||
150097308|NCT00449644|541497423|FG003|Overall Study|Lost to Follow-up|3|||
150097309|NCT00449644|541497420|FG000|Overall Study|Pregnancy|0|||
150097310|NCT00449644|541497421|FG001|Overall Study|Pregnancy|0|||
150097311|NCT00449644|541497422|FG002|Overall Study|Pregnancy|3|||
150097312|NCT00449644|541497423|FG003|Overall Study|Pregnancy|2|||
150097313|NCT00449644|541497420|FG000|Overall Study|Protocol Violation|4|||
150097314|NCT00449644|541497421|FG001|Overall Study|Protocol Violation|4|||
150097315|NCT00449644|541497422|FG002|Overall Study|Protocol Violation|3|||
150097316|NCT00449644|541497423|FG003|Overall Study|Protocol Violation|7|||
150097317|NCT00449644|541497420|FG000|Overall Study|Withdrawal by Subject|3|||
150097318|NCT00449644|541497421|FG001|Overall Study|Withdrawal by Subject|4|||
150097319|NCT00449644|541497422|FG002|Overall Study|Withdrawal by Subject|6|||
150097320|NCT00449644|541497423|FG003|Overall Study|Withdrawal by Subject|7|||
150097321|NCT00449644|541497420|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
150097322|NCT00449644|541497421|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
150097323|NCT00449644|541497422|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
150097324|NCT00449644|541497423|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
150097325|NCT00449644|541497420|FG000|Overall Study|Other|1|||
150097326|NCT00449644|541497421|FG001|Overall Study|Other|4|||
150097327|NCT00449644|541497422|FG002|Overall Study|Other|1|||
150097328|NCT00449644|541497423|FG003|Overall Study|Other|0|||
150097329|NCT00449644|541497420|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
150097330|NCT00449644|541497421|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
150097331|NCT00449644|541497422|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
150097332|NCT00449644|541497423|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
150097333|NCT00679263|541497428|FG000|Visit 2/Dose 1|Adverse Event|1|||
150097334|NCT00679263|541497429|FG001|Visit 2/Dose 1|Adverse Event|0|||
150097335|NCT00679263|541497430|FG002|Visit 2/Dose 1|Adverse Event|0|||
150097336|NCT00679263|541497428|FG000|Visit 2/Dose 1|subject not compliance|1|||
150097337|NCT00679263|541497429|FG001|Visit 2/Dose 1|subject not compliance|1|||
150097338|NCT00679263|541497430|FG002|Visit 2/Dose 1|subject not compliance|0|||
150097339|NCT02446990|541497437|FG000|Overall Study|Death|485|||
150097340|NCT02446990|541497438|FG001|Overall Study|Death|458|||
150097341|NCT02446990|541497437|FG000|Overall Study|Lost to Follow-up|3|||
150097342|NCT02446990|541497438|FG001|Overall Study|Lost to Follow-up|1|||
150097343|NCT02446990|541497437|FG000|Overall Study|Physician Decision|1|||
150097344|NCT02446990|541497438|FG001|Overall Study|Physician Decision|0|||
150097345|NCT02446990|541497437|FG000|Overall Study|Withdrawal by Subject|231|||
150097346|NCT02446990|541497438|FG001|Overall Study|Withdrawal by Subject|199|||
150097347|NCT01064401|541497439|FG000|Overall Study|Adverse Event|47|||
150097348|NCT01064401|541497440|FG001|Overall Study|Adverse Event|56|||
150097349|NCT01064401|541497439|FG000|Overall Study|Lack of Efficacy|46|||
150097350|NCT01064401|541497440|FG001|Overall Study|Lack of Efficacy|23|||
150097351|NCT01064401|541497439|FG000|Overall Study|Lost to Follow-up|12|||
150097352|NCT01064401|541497440|FG001|Overall Study|Lost to Follow-up|9|||
150097353|NCT01064401|541497439|FG000|Overall Study|Consent Withdrawn|98|||
150097354|NCT01064401|541497440|FG001|Overall Study|Consent Withdrawn|80|||
150097355|NCT01064401|541497439|FG000|Overall Study|Investigator Decision|4|||
150097356|NCT01064401|541497440|FG001|Overall Study|Investigator Decision|6|||
150185029|NCT04838613|541815791|FG001|Overall Study|Technical Problems|5|||
150097357|NCT01064401|541497439|FG000|Overall Study|Death|4|||
150185030|NCT04838613|541815790|FG000|Overall Study|Physician Decision|2|||
150185031|NCT04838613|541815791|FG001|Overall Study|Physician Decision|0|||
150097358|NCT01064401|541497440|FG001|Overall Study|Death|0|||
150097359|NCT01064401|541497439|FG000|Overall Study|Pregnancy|4|||
150097360|NCT01064401|541497440|FG001|Overall Study|Pregnancy|7|||
150097361|NCT01064401|541497439|FG000|Overall Study|Noncompliance|7|||
150097362|NCT01064401|541497440|FG001|Overall Study|Noncompliance|8|||
150097363|NCT01064401|541497439|FG000|Overall Study|Site Closure|4|||
150097364|NCT01064401|541497440|FG001|Overall Study|Site Closure|5|||
150097365|NCT01064401|541497439|FG000|Overall Study|Other|2|||
150097366|NCT01064401|541497440|FG001|Overall Study|Other|1|||
150097367|NCT03158051|541497441|FG000|Overall Study|Lost to Follow-up|41|||
150097368|NCT03158051|541497442|FG001|Overall Study|Lost to Follow-up|47|||
150097369|NCT03158051|541497441|FG000|Overall Study|Physician Decision|6|||
150097370|NCT03158051|541497442|FG001|Overall Study|Physician Decision|7|||
150097371|NCT03158051|541497441|FG000|Overall Study|Withdrawal by Subject|24|||
150097372|NCT03158051|541497442|FG001|Overall Study|Withdrawal by Subject|15|||
150097373|NCT03158051|541497441|FG000|Overall Study|Death|0|||
150097374|NCT03158051|541497442|FG001|Overall Study|Death|1|||
150097375|NCT02738151|541497443|FG000|Overall Study|Randomized but not treated|4|||
150097376|NCT02738151|541497444|FG001|Overall Study|Randomized but not treated|1|||
150097377|NCT02738151|541497443|FG000|Overall Study|Adverse Event|4|||
150097378|NCT02738151|541497444|FG001|Overall Study|Adverse Event|5|||
150097379|NCT02738151|541497443|FG000|Overall Study|Hypoglycemia|0|||
150097380|NCT02738151|541497444|FG001|Overall Study|Hypoglycemia|1|||
150097381|NCT02738151|541497443|FG000|Overall Study|Poor Compliance to Protocol|4|||
150097382|NCT02738151|541497444|FG001|Overall Study|Poor Compliance to Protocol|3|||
150097383|NCT02738151|541497443|FG000|Overall Study|Other than specified above|11|||
150097384|NCT02738151|541497444|FG001|Overall Study|Other than specified above|21|||
150097385|NCT02070744|541497460|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
150097386|NCT02070744|541497461|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
150097387|NCT02070744|541497462|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
150097388|NCT02070744|541497463|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
150097389|NCT02070744|541497464|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
150097390|NCT02070744|541497460|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
150097391|NCT02070744|541497461|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
150097392|NCT02070744|541497462|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
150185032|NCT04854096|541815792|FG000|Overall Study|Adverse Event|1|||
150185033|NCT04854096|541815793|FG001|Overall Study|Adverse Event|0|||
150185034|NCT04854096|541815792|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
150185035|NCT04854096|541815793|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
150185036|NCT04854096|541815792|FG000|Overall Study|Withdrawal by Subject|1|||
150185037|NCT04854096|541815793|FG001|Overall Study|Withdrawal by Subject|0|||
150185038|NCT04854096|541815792|FG000|Overall Study|Other reasons|1|||
150185039|NCT04854096|541815793|FG001|Overall Study|Other reasons|0|||
150185040|NCT00951379|541815799|FG000|Overall Study|Adverse Event|4|||
150185041|NCT00951379|541815800|FG001|Overall Study|Adverse Event|1|||
150185042|NCT00951379|541815799|FG000|Overall Study|Withdrawal by Subject|1|||
150185043|NCT00951379|541815800|FG001|Overall Study|Withdrawal by Subject|0|||
150185044|NCT00951379|541815799|FG000|Overall Study|Noncompliance|1|||
150185045|NCT00951379|541815800|FG001|Overall Study|Noncompliance|0|||
150185046|NCT00951379|541815799|FG000|Overall Study|Disease Progression|0|||
150185047|NCT00951379|541815800|FG001|Overall Study|Disease Progression|1|||
150185048|NCT03912831|541815804|FG000|Overall Study|Death|1|||
150185049|NCT03912831|541815805|FG001|Overall Study|Death|1|||
150185050|NCT03912831|541815806|FG002|Overall Study|Death|1|||
150185051|NCT03912831|541815807|FG003|Overall Study|Death|1|||
150185052|NCT03912831|541815808|FG004|Overall Study|Death|1|||
150185053|NCT03912831|541815809|FG005|Overall Study|Death|1|||
150185054|NCT03912831|541815804|FG000|Overall Study|Reason not Specified|0|||
150185055|NCT03912831|541815805|FG001|Overall Study|Reason not Specified|0|||
150185056|NCT03912831|541815806|FG002|Overall Study|Reason not Specified|0|||
150185057|NCT03912831|541815807|FG003|Overall Study|Reason not Specified|0|||
150185058|NCT03912831|541815808|FG004|Overall Study|Reason not Specified|1|||
150185059|NCT03912831|541815809|FG005|Overall Study|Reason not Specified|0|||
150185060|NCT03912831|541815804|FG000|Overall Study|Withdrawal by Participant|0|||
150185061|NCT03912831|541815805|FG001|Overall Study|Withdrawal by Participant|0|||
150185062|NCT03912831|541815806|FG002|Overall Study|Withdrawal by Participant|0|||
150185063|NCT03912831|541815807|FG003|Overall Study|Withdrawal by Participant|0|||
150185064|NCT03912831|541815808|FG004|Overall Study|Withdrawal by Participant|1|||
150185065|NCT03912831|541815809|FG005|Overall Study|Withdrawal by Participant|0|||
150185066|NCT03580369|541815810|FG000|Overall Study|No treatment due to mis-randomization|1|||
150185067|NCT03580369|541815811|FG001|Overall Study|No treatment due to mis-randomization|0|||
150185068|NCT03580369|541815812|FG002|Overall Study|No treatment due to mis-randomization|0|||
150185069|NCT03580369|541815813|FG003|Overall Study|No treatment due to mis-randomization|0|||
150185070|NCT03580369|541815814|FG004|Overall Study|No treatment due to mis-randomization|3|||
150185071|NCT03580369|541815815|FG005|Overall Study|No treatment due to mis-randomization|0|||
150185072|NCT03580369|541815816|FG006|Overall Study|No treatment due to mis-randomization|0|||
150185073|NCT03580369|541815817|FG007|Overall Study|No treatment due to mis-randomization|0|||
150185074|NCT03580369|541815810|FG000|Overall Study|Reason unknown|0|||
150185075|NCT03580369|541815811|FG001|Overall Study|Reason unknown|0|||
150185076|NCT03580369|541815812|FG002|Overall Study|Reason unknown|1|||
150185077|NCT03580369|541815813|FG003|Overall Study|Reason unknown|0|||
150185078|NCT03580369|541815814|FG004|Overall Study|Reason unknown|0|||
150185079|NCT03580369|541815815|FG005|Overall Study|Reason unknown|0|||
150185080|NCT03580369|541815816|FG006|Overall Study|Reason unknown|0|||
150097393|NCT02070744|541497463|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
150097394|NCT02070744|541497464|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
150097395|NCT02070744|541497460|FG000|OLE Phase (48 Weeks)|Other|0|||
150097396|NCT02070744|541497461|FG001|OLE Phase (48 Weeks)|Other|0|||
150097397|NCT02070744|541497462|FG002|OLE Phase (48 Weeks)|Other|0|||
150097398|NCT02070744|541497463|FG003|OLE Phase (48 Weeks)|Other|0|||
150097399|NCT02070744|541497464|FG004|OLE Phase (48 Weeks)|Other|1|||
150097400|NCT03795298|541497468|FG000|Overall Study|Death|34|||
150097401|NCT03795298|541497469|FG001|Overall Study|Death|29|||
150097402|NCT03795298|541497468|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
150097403|NCT03795298|541497469|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
150097404|NCT03795298|541497468|FG000|Overall Study|Lost to Follow-up|28|||
150097405|NCT03795298|541497469|FG001|Overall Study|Lost to Follow-up|17|||
150097406|NCT03795298|541497468|FG000|Overall Study|Physician Decision|5|||
150097407|NCT03795298|541497469|FG001|Overall Study|Physician Decision|4|||
150097408|NCT03795298|541497468|FG000|Overall Study|Withdrawal by Subject|43|||
150097409|NCT03795298|541497469|FG001|Overall Study|Withdrawal by Subject|28|||
150097410|NCT03795298|541497468|FG000|Overall Study|Reason not reported|7|||
150097411|NCT03795298|541497469|FG001|Overall Study|Reason not reported|9|||
150097412|NCT01252940|541497470|FG000|Main Study Phase|Randomized but not treated|4|||
150097413|NCT01252940|541497471|FG001|Main Study Phase|Randomized but not treated|2|||
150097414|NCT01252940|541497470|FG000|Main Study Phase|Adverse Event|3|||
150097415|NCT01252940|541497471|FG001|Main Study Phase|Adverse Event|1|||
150097416|NCT01252940|541497470|FG000|Main Study Phase|Lack of Efficacy|1|||
150097417|NCT01252940|541497471|FG001|Main Study Phase|Lack of Efficacy|0|||
150097418|NCT01252940|541497470|FG000|Main Study Phase|Lost to Follow-up|6|||
150097419|NCT01252940|541497471|FG001|Main Study Phase|Lost to Follow-up|1|||
150097420|NCT01252940|541497470|FG000|Main Study Phase|Physician Decision|1|||
150097421|NCT01252940|541497471|FG001|Main Study Phase|Physician Decision|0|||
150097422|NCT01252940|541497470|FG000|Main Study Phase|Protocol Violation|4|||
150097423|NCT01252940|541497471|FG001|Main Study Phase|Protocol Violation|2|||
150097424|NCT01252940|541497470|FG000|Main Study Phase|Withdrawal by Subject|6|||
150097425|NCT01252940|541497471|FG001|Main Study Phase|Withdrawal by Subject|5|||
150097426|NCT01252940|541497470|FG000|Main Study Phase|Subject Non-compliance|1|||
150097427|NCT01252940|541497471|FG001|Main Study Phase|Subject Non-compliance|1|||
150097428|NCT01252940|541497470|FG000|Extension Phase|Adverse Event|2|||
150097429|NCT01252940|541497471|FG001|Extension Phase|Adverse Event|1|||
150097430|NCT01252940|541497470|FG000|Extension Phase|Lack of Efficacy|1|||
150185081|NCT03580369|541815817|FG007|Overall Study|Reason unknown|0|||
150185082|NCT03580369|541815810|FG000|Overall Study|Technical problems|0|||
150097431|NCT01252940|541497471|FG001|Extension Phase|Lack of Efficacy|0|||
150097432|NCT01252940|541497470|FG000|Extension Phase|Lost to Follow-up|5|||
150097433|NCT01252940|541497471|FG001|Extension Phase|Lost to Follow-up|0|||
150097434|NCT01252940|541497470|FG000|Extension Phase|Physician Decision|0|||
150097435|NCT01252940|541497471|FG001|Extension Phase|Physician Decision|1|||
150097436|NCT01252940|541497470|FG000|Extension Phase|Subject Non-compliance|1|||
150097437|NCT01252940|541497471|FG001|Extension Phase|Subject Non-compliance|0|||
150097438|NCT01252940|541497470|FG000|Extension Phase|Withdrawal by Subject|1|||
150097439|NCT01252940|541497471|FG001|Extension Phase|Withdrawal by Subject|1|||
150097440|NCT04199117|541497472|FG000|Overall Study|Withdrawal by Subject|3|||
150097441|NCT04199117|541497473|FG001|Overall Study|Withdrawal by Subject|0|||
150097442|NCT04199117|541497474|FG002|Overall Study|Withdrawal by Subject|0|||
150097443|NCT04199117|541497475|FG003|Overall Study|Withdrawal by Subject|1|||
150097444|NCT04199117|541497476|FG004|Overall Study|Withdrawal by Subject|1|||
150097445|NCT04199117|541497477|FG005|Overall Study|Withdrawal by Subject|0|||
150097446|NCT04199117|541497478|FG006|Overall Study|Withdrawal by Subject|0|||
150185083|NCT03580369|541815811|FG001|Overall Study|Technical problems|0|||
150097447|NCT04199117|541497479|FG007|Overall Study|Withdrawal by Subject|2|||
150097448|NCT04199117|541497480|FG008|Overall Study|Withdrawal by Subject|0|||
150097449|NCT04199117|541497481|FG009|Overall Study|Withdrawal by Subject|0|||
150097450|NCT04199117|541497482|FG010|Overall Study|Withdrawal by Subject|1|||
150097451|NCT04199117|541497483|FG011|Overall Study|Withdrawal by Subject|1|||
150097452|NCT04199117|541497484|FG012|Overall Study|Withdrawal by Subject|2|||
150097453|NCT04199117|541497485|FG013|Overall Study|Withdrawal by Subject|1|||
150097454|NCT04199117|541497486|FG014|Overall Study|Withdrawal by Subject|1|||
150097455|NCT04199117|541497487|FG015|Overall Study|Withdrawal by Subject|1|||
150097456|NCT04199117|541497472|FG000|Overall Study|Death|1|||
150097457|NCT04199117|541497473|FG001|Overall Study|Death|1|||
150097458|NCT04199117|541497474|FG002|Overall Study|Death|0|||
150097459|NCT04199117|541497475|FG003|Overall Study|Death|0|||
150097460|NCT04199117|541497476|FG004|Overall Study|Death|0|||
150097461|NCT04199117|541497477|FG005|Overall Study|Death|0|||
150097462|NCT04199117|541497478|FG006|Overall Study|Death|0|||
150097463|NCT04199117|541497479|FG007|Overall Study|Death|0|||
150097464|NCT04199117|541497480|FG008|Overall Study|Death|0|||
150097465|NCT04199117|541497481|FG009|Overall Study|Death|0|||
150097466|NCT04199117|541497482|FG010|Overall Study|Death|0|||
150097467|NCT04199117|541497483|FG011|Overall Study|Death|1|||
150097468|NCT04199117|541497484|FG012|Overall Study|Death|0|||
150097469|NCT04199117|541497485|FG013|Overall Study|Death|1|||
150097470|NCT04199117|541497486|FG014|Overall Study|Death|0|||
150097471|NCT04199117|541497487|FG015|Overall Study|Death|0|||
150097472|NCT04199117|541497472|FG000|Overall Study|Withdrawal by PI|0|||
150097473|NCT04199117|541497473|FG001|Overall Study|Withdrawal by PI|0|||
150097474|NCT04199117|541497474|FG002|Overall Study|Withdrawal by PI|0|||
150097475|NCT04199117|541497475|FG003|Overall Study|Withdrawal by PI|0|||
150097476|NCT04199117|541497476|FG004|Overall Study|Withdrawal by PI|0|||
150097477|NCT04199117|541497477|FG005|Overall Study|Withdrawal by PI|0|||
150097478|NCT04199117|541497478|FG006|Overall Study|Withdrawal by PI|0|||
150097479|NCT04199117|541497479|FG007|Overall Study|Withdrawal by PI|0|||
150097480|NCT04199117|541497480|FG008|Overall Study|Withdrawal by PI|0|||
150097481|NCT04199117|541497481|FG009|Overall Study|Withdrawal by PI|0|||
150097482|NCT04199117|541497482|FG010|Overall Study|Withdrawal by PI|0|||
150097483|NCT04199117|541497483|FG011|Overall Study|Withdrawal by PI|0|||
150097484|NCT04199117|541497484|FG012|Overall Study|Withdrawal by PI|1|||
150097485|NCT04199117|541497485|FG013|Overall Study|Withdrawal by PI|0|||
150097486|NCT04199117|541497486|FG014|Overall Study|Withdrawal by PI|0|||
150097487|NCT04199117|541497487|FG015|Overall Study|Withdrawal by PI|0|||
150097488|NCT04383743|541497488|FG000|Overall Study|Withdrawal by Subject|1|||
150097489|NCT04383743|541497488|FG000|Overall Study|Adverse Event|1|||
150097490|NCT02356783|541499403|FG000|Overall Study|Lost to Follow-up|1|||
150097491|NCT02356783|541499404|FG001|Overall Study|Lost to Follow-up|3|||
150097492|NCT05123222|541499405|FG000|Overall Study|Lost to Follow-up|2|||
150097493|NCT05123222|541499406|FG001|Overall Study|Lost to Follow-up|0|||
150097494|NCT05123222|541499407|FG002|Overall Study|Lost to Follow-up|0|||
150097495|NCT05123222|541499408|FG003|Overall Study|Lost to Follow-up|0|||
150097496|NCT05123222|541499405|FG000|Overall Study|Protocol Violation|0|||
150097497|NCT05123222|541499406|FG001|Overall Study|Protocol Violation|0|||
150097498|NCT05123222|541499407|FG002|Overall Study|Protocol Violation|1|||
150097499|NCT05123222|541499408|FG003|Overall Study|Protocol Violation|0|||
150097500|NCT02608268|541499409|FG000|Overall Study|Adverse Event|0|||
150097501|NCT02608268|541499410|FG001|Overall Study|Adverse Event|0|||
150097502|NCT02608268|541499411|FG002|Overall Study|Adverse Event|1|||
150097503|NCT02608268|541499412|FG003|Overall Study|Adverse Event|0|||
150097504|NCT02608268|541499413|FG004|Overall Study|Adverse Event|0|||
150097505|NCT02608268|541499414|FG005|Overall Study|Adverse Event|0|||
150097506|NCT02608268|541499415|FG006|Overall Study|Adverse Event|0|||
150097507|NCT02608268|541499416|FG007|Overall Study|Adverse Event|0|||
150097508|NCT02608268|541499417|FG008|Overall Study|Adverse Event|0|||
150097509|NCT02608268|541499418|FG009|Overall Study|Adverse Event|0|||
150097510|NCT02608268|541499419|FG010|Overall Study|Adverse Event|0|||
150097511|NCT02608268|541499420|FG011|Overall Study|Adverse Event|0|||
150097512|NCT02608268|541499421|FG012|Overall Study|Adverse Event|2|||
150097513|NCT02608268|541499422|FG013|Overall Study|Adverse Event|0|||
150097514|NCT02608268|541499423|FG014|Overall Study|Adverse Event|0|||
150097515|NCT02608268|541499424|FG015|Overall Study|Adverse Event|0|||
150097516|NCT02608268|541499425|FG016|Overall Study|Adverse Event|0|||
150097517|NCT02608268|541499426|FG017|Overall Study|Adverse Event|0|||
150097518|NCT02608268|541499427|FG018|Overall Study|Adverse Event|0|||
150097519|NCT02608268|541499428|FG019|Overall Study|Adverse Event|0|||
150097520|NCT02608268|541499429|FG020|Overall Study|Adverse Event|1|||
150097521|NCT02608268|541499430|FG021|Overall Study|Adverse Event|1|||
150097522|NCT02608268|541499431|FG022|Overall Study|Adverse Event|0|||
150097523|NCT02608268|541499432|FG023|Overall Study|Adverse Event|0|||
150097524|NCT02608268|541499433|FG024|Overall Study|Adverse Event|1|||
150097525|NCT02608268|541499434|FG025|Overall Study|Adverse Event|0|||
150097526|NCT02608268|541499435|FG026|Overall Study|Adverse Event|0|||
150097527|NCT02608268|541499436|FG027|Overall Study|Adverse Event|0|||
150097528|NCT02608268|541499437|FG028|Overall Study|Adverse Event|1|||
150097529|NCT02608268|541499438|FG029|Overall Study|Adverse Event|0|||
150097530|NCT02608268|541499409|FG000|Overall Study|Death|1|||
150097531|NCT02608268|541499410|FG001|Overall Study|Death|0|||
150097532|NCT02608268|541499411|FG002|Overall Study|Death|0|||
150097533|NCT02608268|541499412|FG003|Overall Study|Death|0|||
150097534|NCT02608268|541499413|FG004|Overall Study|Death|0|||
150097535|NCT02608268|541499414|FG005|Overall Study|Death|0|||
150097536|NCT02608268|541499415|FG006|Overall Study|Death|0|||
150097537|NCT02608268|541499416|FG007|Overall Study|Death|0|||
150097538|NCT02608268|541499417|FG008|Overall Study|Death|1|||
150097539|NCT02608268|541499418|FG009|Overall Study|Death|1|||
150097540|NCT02608268|541499419|FG010|Overall Study|Death|0|||
150097541|NCT02608268|541499420|FG011|Overall Study|Death|0|||
150097542|NCT02608268|541499421|FG012|Overall Study|Death|0|||
150097543|NCT02608268|541499422|FG013|Overall Study|Death|0|||
150097544|NCT02608268|541499423|FG014|Overall Study|Death|0|||
150097545|NCT02608268|541499424|FG015|Overall Study|Death|1|||
150097546|NCT02608268|541499425|FG016|Overall Study|Death|0|||
150097547|NCT02608268|541499426|FG017|Overall Study|Death|1|||
150097548|NCT02608268|541499427|FG018|Overall Study|Death|0|||
150097549|NCT02608268|541499428|FG019|Overall Study|Death|1|||
150097550|NCT02608268|541499429|FG020|Overall Study|Death|1|||
150097551|NCT02608268|541499430|FG021|Overall Study|Death|0|||
150097552|NCT02608268|541499431|FG022|Overall Study|Death|0|||
150097553|NCT02608268|541499432|FG023|Overall Study|Death|0|||
150097554|NCT02608268|541499433|FG024|Overall Study|Death|1|||
150097555|NCT02608268|541499434|FG025|Overall Study|Death|2|||
150097556|NCT02608268|541499435|FG026|Overall Study|Death|0|||
150097557|NCT02608268|541499436|FG027|Overall Study|Death|1|||
150097558|NCT02608268|541499437|FG028|Overall Study|Death|4|||
150097559|NCT02608268|541499438|FG029|Overall Study|Death|0|||
150097560|NCT02608268|541499409|FG000|Overall Study|Physician Decision|0|||
150097561|NCT02608268|541499410|FG001|Overall Study|Physician Decision|0|||
150097562|NCT02608268|541499411|FG002|Overall Study|Physician Decision|0|||
150097563|NCT02608268|541499412|FG003|Overall Study|Physician Decision|0|||
150097564|NCT02608268|541499413|FG004|Overall Study|Physician Decision|0|||
150097565|NCT02608268|541499414|FG005|Overall Study|Physician Decision|0|||
150097566|NCT02608268|541499415|FG006|Overall Study|Physician Decision|0|||
150097567|NCT02608268|541499416|FG007|Overall Study|Physician Decision|0|||
150097568|NCT02608268|541499417|FG008|Overall Study|Physician Decision|0|||
150097569|NCT02608268|541499418|FG009|Overall Study|Physician Decision|0|||
150097570|NCT02608268|541499419|FG010|Overall Study|Physician Decision|1|||
150097571|NCT02608268|541499420|FG011|Overall Study|Physician Decision|0|||
150097572|NCT02608268|541499421|FG012|Overall Study|Physician Decision|0|||
150097573|NCT02608268|541499422|FG013|Overall Study|Physician Decision|1|||
150097574|NCT02608268|541499423|FG014|Overall Study|Physician Decision|0|||
150097575|NCT02608268|541499424|FG015|Overall Study|Physician Decision|0|||
150097576|NCT02608268|541499425|FG016|Overall Study|Physician Decision|0|||
150097577|NCT02608268|541499426|FG017|Overall Study|Physician Decision|0|||
150097578|NCT02608268|541499427|FG018|Overall Study|Physician Decision|0|||
150097579|NCT02608268|541499428|FG019|Overall Study|Physician Decision|0|||
150097580|NCT02608268|541499429|FG020|Overall Study|Physician Decision|0|||
150097581|NCT02608268|541499430|FG021|Overall Study|Physician Decision|0|||
150097582|NCT02608268|541499431|FG022|Overall Study|Physician Decision|1|||
150097583|NCT02608268|541499432|FG023|Overall Study|Physician Decision|1|||
150097584|NCT02608268|541499433|FG024|Overall Study|Physician Decision|1|||
150097585|NCT02608268|541499434|FG025|Overall Study|Physician Decision|0|||
150097586|NCT02608268|541499435|FG026|Overall Study|Physician Decision|0|||
150097587|NCT02608268|541499436|FG027|Overall Study|Physician Decision|2|||
150097588|NCT02608268|541499437|FG028|Overall Study|Physician Decision|1|||
150097589|NCT02608268|541499438|FG029|Overall Study|Physician Decision|1|||
150097590|NCT02608268|541499409|FG000|Overall Study|Progressive disease|12|||
150097591|NCT02608268|541499410|FG001|Overall Study|Progressive disease|8|||
150097592|NCT02608268|541499411|FG002|Overall Study|Progressive disease|13|||
150097593|NCT02608268|541499412|FG003|Overall Study|Progressive disease|5|||
150097594|NCT02608268|541499413|FG004|Overall Study|Progressive disease|2|||
150097595|NCT02608268|541499414|FG005|Overall Study|Progressive disease|4|||
150097596|NCT02608268|541499415|FG006|Overall Study|Progressive disease|6|||
150097597|NCT02608268|541499416|FG007|Overall Study|Progressive disease|2|||
150097598|NCT02608268|541499417|FG008|Overall Study|Progressive disease|5|||
150097599|NCT02608268|541499418|FG009|Overall Study|Progressive disease|6|||
150097600|NCT02608268|541499419|FG010|Overall Study|Progressive disease|5|||
150097601|NCT02608268|541499420|FG011|Overall Study|Progressive disease|5|||
150097602|NCT02608268|541499421|FG012|Overall Study|Progressive disease|4|||
150097603|NCT02608268|541499422|FG013|Overall Study|Progressive disease|11|||
150097604|NCT02608268|541499423|FG014|Overall Study|Progressive disease|6|||
150097605|NCT02608268|541499424|FG015|Overall Study|Progressive disease|3|||
150097606|NCT02608268|541499425|FG016|Overall Study|Progressive disease|5|||
150097607|NCT02608268|541499426|FG017|Overall Study|Progressive disease|5|||
150097608|NCT02608268|541499427|FG018|Overall Study|Progressive disease|5|||
150097609|NCT02608268|541499428|FG019|Overall Study|Progressive disease|2|||
150097610|NCT02608268|541499429|FG020|Overall Study|Progressive disease|10|||
150097611|NCT02608268|541499430|FG021|Overall Study|Progressive disease|4|||
150097612|NCT02608268|541499431|FG022|Overall Study|Progressive disease|5|||
150097613|NCT02608268|541499432|FG023|Overall Study|Progressive disease|5|||
150097614|NCT02608268|541499433|FG024|Overall Study|Progressive disease|3|||
150097615|NCT02608268|541499434|FG025|Overall Study|Progressive disease|11|||
150097616|NCT02608268|541499435|FG026|Overall Study|Progressive disease|16|||
150097617|NCT02608268|541499436|FG027|Overall Study|Progressive disease|11|||
150097618|NCT02608268|541499437|FG028|Overall Study|Progressive disease|10|||
150097619|NCT02608268|541499438|FG029|Overall Study|Progressive disease|15|||
150097620|NCT02608268|541499409|FG000|Overall Study|Subject/guardian decision|1|||
150097621|NCT02608268|541499410|FG001|Overall Study|Subject/guardian decision|1|||
150097622|NCT02608268|541499411|FG002|Overall Study|Subject/guardian decision|2|||
150097623|NCT02608268|541499412|FG003|Overall Study|Subject/guardian decision|0|||
150097624|NCT02608268|541499413|FG004|Overall Study|Subject/guardian decision|0|||
150097625|NCT02608268|541499414|FG005|Overall Study|Subject/guardian decision|0|||
150097626|NCT02608268|541499415|FG006|Overall Study|Subject/guardian decision|0|||
150097627|NCT02608268|541499416|FG007|Overall Study|Subject/guardian decision|0|||
150097628|NCT02608268|541499417|FG008|Overall Study|Subject/guardian decision|2|||
150097629|NCT02608268|541499418|FG009|Overall Study|Subject/guardian decision|2|||
150097630|NCT02608268|541499419|FG010|Overall Study|Subject/guardian decision|0|||
150097631|NCT02608268|541499420|FG011|Overall Study|Subject/guardian decision|1|||
150097632|NCT02608268|541499421|FG012|Overall Study|Subject/guardian decision|0|||
150097633|NCT02608268|541499422|FG013|Overall Study|Subject/guardian decision|1|||
150097634|NCT02608268|541499423|FG014|Overall Study|Subject/guardian decision|0|||
150097635|NCT02608268|541499424|FG015|Overall Study|Subject/guardian decision|1|||
150097636|NCT02608268|541499425|FG016|Overall Study|Subject/guardian decision|0|||
150097637|NCT02608268|541499426|FG017|Overall Study|Subject/guardian decision|0|||
150097638|NCT02608268|541499427|FG018|Overall Study|Subject/guardian decision|1|||
150097639|NCT02608268|541499428|FG019|Overall Study|Subject/guardian decision|0|||
150097640|NCT02608268|541499429|FG020|Overall Study|Subject/guardian decision|0|||
150097641|NCT02608268|541499430|FG021|Overall Study|Subject/guardian decision|0|||
150097642|NCT02608268|541499431|FG022|Overall Study|Subject/guardian decision|1|||
150097643|NCT02608268|541499432|FG023|Overall Study|Subject/guardian decision|0|||
150097644|NCT02608268|541499433|FG024|Overall Study|Subject/guardian decision|0|||
150097645|NCT02608268|541499434|FG025|Overall Study|Subject/guardian decision|1|||
150097646|NCT02608268|541499435|FG026|Overall Study|Subject/guardian decision|1|||
150097647|NCT02608268|541499436|FG027|Overall Study|Subject/guardian decision|1|||
150097648|NCT02608268|541499437|FG028|Overall Study|Subject/guardian decision|1|||
150097649|NCT02608268|541499438|FG029|Overall Study|Subject/guardian decision|0|||
150097650|NCT01266460|541499448|FG000|Overall Study|Adverse Event|3|||
150097651|NCT01266460|541499448|FG000|Overall Study|Withdrawal by Subject|5|||
150097652|NCT01266460|541499448|FG000|Overall Study|Disease Progression|18|||
150097653|NCT01266460|541499448|FG000|Overall Study|Not otherwise specified|8|||
150097654|NCT00909779|541499450|FG000|Overall Study|Adverse Event|53|||
150097655|NCT00909779|541499451|FG001|Overall Study|Adverse Event|55|||
150097656|NCT00909779|541499450|FG000|Overall Study|Lack of Efficacy|7|||
150097657|NCT00909779|541499451|FG001|Overall Study|Lack of Efficacy|4|||
150097658|NCT00909779|541499450|FG000|Overall Study|Lost to Follow-up|19|||
150097659|NCT00909779|541499451|FG001|Overall Study|Lost to Follow-up|15|||
150097660|NCT00909779|541499450|FG000|Overall Study|Physician Decision|8|||
150097661|NCT00909779|541499451|FG001|Overall Study|Physician Decision|2|||
150097662|NCT00909779|541499450|FG000|Overall Study|Protocol Violation|2|||
150097663|NCT00909779|541499451|FG001|Overall Study|Protocol Violation|5|||
150097664|NCT00909779|541499450|FG000|Overall Study|Withdrawal by Subject|116|||
150097665|NCT00909779|541499451|FG001|Overall Study|Withdrawal by Subject|80|||
150097666|NCT00909779|541499450|FG000|Overall Study|Site Ceasing Operation|2|||
150097667|NCT00909779|541499451|FG001|Overall Study|Site Ceasing Operation|2|||
150097668|NCT00909779|541499450|FG000|Overall Study|Medical Monitor Decision|1|||
150097669|NCT00909779|541499451|FG001|Overall Study|Medical Monitor Decision|0|||
150097670|NCT00909779|541499450|FG000|Overall Study|Noncompliance|1|||
150097671|NCT00909779|541499451|FG001|Overall Study|Noncompliance|1|||
150097672|NCT00909779|541499450|FG000|Overall Study|Randomized in error|1|||
150097673|NCT00909779|541499451|FG001|Overall Study|Randomized in error|1|||
150097674|NCT02738333|541499453|FG000|Overall Study|Death|1|||
150097675|NCT02738333|541499454|FG001|Overall Study|Death|0|||
150097676|NCT02738333|541499455|FG002|Overall Study|Death|0|||
150097677|NCT02738333|541499453|FG000|Overall Study|Lost to Follow-up|1|||
150097678|NCT02738333|541499454|FG001|Overall Study|Lost to Follow-up|0|||
150097679|NCT02738333|541499455|FG002|Overall Study|Lost to Follow-up|0|||
150097680|NCT05413369|541499456|FG000|Overall Study|Adverse Event|1|||
150097681|NCT05413369|541499457|FG001|Overall Study|Adverse Event|1|||
150097682|NCT05413369|541499456|FG000|Overall Study|Withdrawal by Subject|13|||
150097683|NCT05413369|541499457|FG001|Overall Study|Withdrawal by Subject|4|||
150097684|NCT05413369|541499456|FG000|Overall Study|Non-compliance with study schedule|2|||
150097685|NCT05413369|541499457|FG001|Overall Study|Non-compliance with study schedule|1|||
150097686|NCT05413369|541499456|FG000|Overall Study|Other|1|||
150097687|NCT05413369|541499457|FG001|Overall Study|Other|1|||
150097688|NCT02809677|541499458|FG000|Overall Study|Withdrawal by Subject|8|||
150097689|NCT03165110|541499459|FG000|Overall Study|Anroid phone software incompatibility|1|||
150097690|NCT01679002|541499464|FG000|Overall Study|Adverse Event|1|||
150097691|NCT01679002|541499465|FG001|Overall Study|Adverse Event|1|||
150097692|NCT01679002|541499466|FG002|Overall Study|Adverse Event|0|||
150097693|NCT05172544|541499469|FG000|Overall Study|Withdrawal by Subject|1|||
150097694|NCT05172544|541499470|FG001|Overall Study|Withdrawal by Subject|0|||
150097695|NCT05172544|541499471|FG002|Overall Study|Withdrawal by Subject|0|||
150097696|NCT05172544|541499469|FG000|Overall Study|Physician Decision|0|||
150097697|NCT05172544|541499470|FG001|Overall Study|Physician Decision|0|||
150097698|NCT05172544|541499471|FG002|Overall Study|Physician Decision|1|||
150097699|NCT00730912|541499474|FG000|Overall Study|Discontinued|0|||
150097700|NCT00730912|541499475|FG001|Overall Study|Discontinued|0|||
150097701|NCT00730912|541499476|FG002|Overall Study|Discontinued|1|||
150097702|NCT04351087|541499480|FG000|Overall Study|Lost to Follow-up|7|||
150097703|NCT04351087|541499481|FG001|Overall Study|Lost to Follow-up|3|||
150097704|NCT04351087|541499480|FG000|Overall Study|Withdrawal by Subject|3|||
150097705|NCT04351087|541499481|FG001|Overall Study|Withdrawal by Subject|4|||
150097706|NCT04351087|541499480|FG000|Overall Study|Lack of Efficacy|3|||
150097707|NCT04351087|541499481|FG001|Overall Study|Lack of Efficacy|2|||
150097708|NCT05517382|541499482|FG000|Overall Study|Lost to Follow-up|0|||
150097709|NCT05517382|541499483|FG001|Overall Study|Lost to Follow-up|1|||
150097710|NCT01374087|541499491|FG000|Overall Study|Adverse Event|1|||
150097711|NCT01374087|541499492|FG001|Overall Study|Adverse Event|0|||
150097712|NCT01374087|541499491|FG000|Overall Study|Disease progression|2|||
150097713|NCT01374087|541499492|FG001|Overall Study|Disease progression|2|||
150097714|NCT01374087|541499491|FG000|Overall Study|Study discontinued|13|||
150097715|NCT01374087|541499492|FG001|Overall Study|Study discontinued|13|||
150097716|NCT00271947|541499495|FG000|Overall Study|Lost to Follow-up|1|||
150097717|NCT01522365|541499498|FG000|Overall Study|Withdrawal by Subject|1|||
150097718|NCT01522365|541499499|FG001|Overall Study|Withdrawal by Subject|1|||
150097719|NCT01522365|541499498|FG000|Overall Study|Lost to Follow-up|1|||
150097720|NCT01522365|541499499|FG001|Overall Study|Lost to Follow-up|1|||
150097721|NCT00651755|541499500|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
150097722|NCT00651755|541499501|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
150097723|NCT00651755|541499500|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
150097724|NCT00651755|541499501|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
150097725|NCT04170348|541499502|FG000|Overall Study|Lost to Follow-up|2|||
150097726|NCT04170348|541499503|FG001|Overall Study|Lost to Follow-up|2|||
150097727|NCT04170348|541499502|FG000|Overall Study|Withdrawal by Subject|1|||
150097728|NCT04170348|541499503|FG001|Overall Study|Withdrawal by Subject|5|||
150097729|NCT04170348|541499502|FG000|Overall Study|Non-adherence|1|||
150097730|NCT04170348|541499503|FG001|Overall Study|Non-adherence|1|||
150097731|NCT04170348|541499502|FG000|Overall Study|Adverse Event|1|||
150097732|NCT04170348|541499503|FG001|Overall Study|Adverse Event|0|||
150097733|NCT01120756|541499504|FG000|Overall Study|Withdrawal by Subject|1|||
150097734|NCT01120756|541499505|FG001|Overall Study|Withdrawal by Subject|1|||
150097735|NCT05104567|541499514|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097736|NCT05104567|541499515|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
150097737|NCT05104567|541499516|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097738|NCT05104567|541499517|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097739|NCT05104567|541499518|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097740|NCT05104567|541499519|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097741|NCT05104567|541499520|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
150097742|NCT05104567|541499514|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
150097743|NCT05104567|541499515|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
150097744|NCT05104567|541499516|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
150097745|NCT05104567|541499517|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
150097746|NCT05104567|541499518|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
150097747|NCT05104567|541499519|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
150097748|NCT05104567|541499520|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
150185084|NCT03580369|541815812|FG002|Overall Study|Technical problems|0|||
150097749|NCT05104567|541499514|FG000|Overall Study|Progressive disease|3|||
150097750|NCT05104567|541499515|FG001|Overall Study|Progressive disease|13|||
150097751|NCT05104567|541499516|FG002|Overall Study|Progressive disease|13|||
150097752|NCT05104567|541499517|FG003|Overall Study|Progressive disease|17|||
150097753|NCT05104567|541499518|FG004|Overall Study|Progressive disease|17|||
150097754|NCT05104567|541499519|FG005|Overall Study|Progressive disease|28|||
150097755|NCT05104567|541499520|FG006|Overall Study|Progressive disease|24|||
150097756|NCT05104567|541499514|FG000|Overall Study|Withdrawal by Subject|1|||
150097757|NCT05104567|541499515|FG001|Overall Study|Withdrawal by Subject|1|||
150097758|NCT05104567|541499516|FG002|Overall Study|Withdrawal by Subject|2|||
150097759|NCT05104567|541499517|FG003|Overall Study|Withdrawal by Subject|0|||
150097760|NCT05104567|541499518|FG004|Overall Study|Withdrawal by Subject|0|||
150097761|NCT05104567|541499519|FG005|Overall Study|Withdrawal by Subject|0|||
150097762|NCT05104567|541499520|FG006|Overall Study|Withdrawal by Subject|0|||
150097763|NCT05104567|541499514|FG000|Overall Study|Other|1|||
150097764|NCT05104567|541499515|FG001|Overall Study|Other|1|||
150097765|NCT05104567|541499516|FG002|Overall Study|Other|1|||
150097766|NCT05104567|541499517|FG003|Overall Study|Other|0|||
150097767|NCT05104567|541499518|FG004|Overall Study|Other|0|||
150097768|NCT05104567|541499519|FG005|Overall Study|Other|0|||
150097769|NCT05104567|541499520|FG006|Overall Study|Other|0|||
150097770|NCT01464346|541499521|FG000|Overall Study|Withdrawal by Subject|0|||
150097771|NCT01464346|541499522|FG001|Overall Study|Withdrawal by Subject|0|||
150097772|NCT01464346|541499523|FG002|Overall Study|Withdrawal by Subject|1|||
150097773|NCT02295995|541499524|FG000|Overall Study|Lost to Follow-up|5|||
150097774|NCT02295995|541499525|FG001|Overall Study|Lost to Follow-up|1|||
150097775|NCT02005250|541499527|FG000|Overall Study|Lost to Follow-up|15|||
150097776|NCT02005250|541499528|FG001|Overall Study|Lost to Follow-up|5|||
150097777|NCT04007094|541499529|FG000|Overall Study|Lost to Follow-up|1|||
150097778|NCT04007094|541499530|FG001|Overall Study|Lost to Follow-up|1|||
150097779|NCT04350788|541499536|FG000|Overall Study|Lost to Follow-up|6|||
150097780|NCT04350788|541499537|FG001|Overall Study|Lost to Follow-up|2|||
150097781|NCT04350788|541499536|FG000|Overall Study|Withdrawal by Subject|2|||
150097782|NCT04350788|541499537|FG001|Overall Study|Withdrawal by Subject|4|||
150097783|NCT04350788|541499536|FG000|Overall Study|Protocol Violation|4|||
150097784|NCT04350788|541499537|FG001|Overall Study|Protocol Violation|0|||
150097785|NCT01581307|541499538|FG000|Overall Study|Withdrawal by Subject|1|||
150097786|NCT00378209|541499543|FG000|Overall Study|Progressive disease|11|||
150097787|NCT00378209|541499543|FG000|Overall Study|Adverse Event|3|||
150097788|NCT00378209|541499543|FG000|Overall Study|Initiation of non-protocol therapy|3|||
150097789|NCT00378209|541499543|FG000|Overall Study|Physician Decision|3|||
150097790|NCT00378209|541499543|FG000|Overall Study|Death|1|||
150097791|NCT00378209|541499543|FG000|Overall Study|Treatment delay|1|||
150097792|NCT01894581|541499544|FG000|Overall Study|Withdrawal by Subject|2|||
150097793|NCT01894581|541499545|FG001|Overall Study|Withdrawal by Subject|3|||
150097794|NCT01894581|541499544|FG000|Overall Study|Screen Failure|3|||
150097795|NCT01894581|541499545|FG001|Overall Study|Screen Failure|4|||
150097796|NCT03482791|541499550|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
150097797|NCT03482791|541499551|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
150097798|NCT01816893|541499553|FG000|Washout Period|Withdrawal by Subject|2|||
150097799|NCT01816893|541499554|FG001|Washout Period|Withdrawal by Subject|0|||
150097800|NCT01239368|541501543|FG000|Overall Study|Principal investigator discretion|1|||
150097801|NCT01239368|541501544|FG001|Overall Study|Principal investigator discretion|0|||
150097802|NCT01239368|541501545|FG002|Overall Study|Principal investigator discretion|0|||
150097803|NCT01239368|541501546|FG003|Overall Study|Principal investigator discretion|0|||
150097804|NCT01239368|541501547|FG004|Overall Study|Principal investigator discretion|1|||
150097805|NCT01239368|541501548|FG005|Overall Study|Principal investigator discretion|2|||
150097806|NCT01239368|541501549|FG006|Overall Study|Principal investigator discretion|0|||
150097807|NCT01239368|541501550|FG007|Overall Study|Principal investigator discretion|0|||
150097808|NCT01239368|541501551|FG008|Overall Study|Principal investigator discretion|0|||
150097809|NCT01239368|541501552|FG009|Overall Study|Principal investigator discretion|1|||
150097810|NCT01239368|541501543|FG000|Overall Study|Disease progression on study|1|||
150097811|NCT01239368|541501544|FG001|Overall Study|Disease progression on study|1|||
150097812|NCT01239368|541501545|FG002|Overall Study|Disease progression on study|1|||
150097813|NCT01239368|541501546|FG003|Overall Study|Disease progression on study|1|||
150097814|NCT01239368|541501547|FG004|Overall Study|Disease progression on study|4|||
150097815|NCT01239368|541501548|FG005|Overall Study|Disease progression on study|2|||
150097816|NCT01239368|541501549|FG006|Overall Study|Disease progression on study|5|||
150097817|NCT01239368|541501550|FG007|Overall Study|Disease progression on study|0|||
150097818|NCT01239368|541501551|FG008|Overall Study|Disease progression on study|0|||
150097819|NCT01239368|541501552|FG009|Overall Study|Disease progression on study|2|||
150097820|NCT01239368|541501543|FG000|Overall Study|Refused further treatment|0|||
150097821|NCT01239368|541501544|FG001|Overall Study|Refused further treatment|0|||
150097822|NCT01239368|541501545|FG002|Overall Study|Refused further treatment|0|||
150097823|NCT01239368|541501546|FG003|Overall Study|Refused further treatment|0|||
150097824|NCT01239368|541501547|FG004|Overall Study|Refused further treatment|0|||
150097825|NCT01239368|541501548|FG005|Overall Study|Refused further treatment|0|||
150185085|NCT03580369|541815813|FG003|Overall Study|Technical problems|0|||
150185086|NCT03580369|541815814|FG004|Overall Study|Technical problems|1|||
150185087|NCT03580369|541815815|FG005|Overall Study|Technical problems|0|||
150185088|NCT03580369|541815816|FG006|Overall Study|Technical problems|2|||
150185089|NCT03580369|541815817|FG007|Overall Study|Technical problems|0|||
150185090|NCT03580369|541815810|FG000|Overall Study|Pregnancy|2|||
150185091|NCT03580369|541815811|FG001|Overall Study|Pregnancy|0|||
150185092|NCT03580369|541815812|FG002|Overall Study|Pregnancy|3|||
150185093|NCT03580369|541815813|FG003|Overall Study|Pregnancy|0|||
150185094|NCT03580369|541815814|FG004|Overall Study|Pregnancy|2|||
150185095|NCT03580369|541815815|FG005|Overall Study|Pregnancy|0|||
150097826|NCT01239368|541501549|FG006|Overall Study|Refused further treatment|0|||
150097827|NCT01239368|541501550|FG007|Overall Study|Refused further treatment|0|||
150097828|NCT01239368|541501551|FG008|Overall Study|Refused further treatment|0|||
150097829|NCT01239368|541501552|FG009|Overall Study|Refused further treatment|1|||
150097830|NCT01239368|541501543|FG000|Overall Study|Death|0|||
150097831|NCT01239368|541501544|FG001|Overall Study|Death|0|||
150097832|NCT01239368|541501545|FG002|Overall Study|Death|0|||
150097833|NCT01239368|541501546|FG003|Overall Study|Death|0|||
150097834|NCT01239368|541501547|FG004|Overall Study|Death|0|||
150097835|NCT01239368|541501548|FG005|Overall Study|Death|0|||
150097836|NCT01239368|541501549|FG006|Overall Study|Death|1|||
150097837|NCT01239368|541501550|FG007|Overall Study|Death|0|||
150097838|NCT01239368|541501551|FG008|Overall Study|Death|0|||
150097839|NCT01239368|541501552|FG009|Overall Study|Death|0|||
150097840|NCT04709575|541501553|FG000|Overall Study|Withdrawal by Subject|6|||
150097841|NCT04709575|541501554|FG001|Overall Study|Withdrawal by Subject|2|||
150097842|NCT04709575|541501553|FG000|Overall Study|Lost to Follow-up|2|||
150097843|NCT04709575|541501554|FG001|Overall Study|Lost to Follow-up|2|||
150097844|NCT04709575|541501553|FG000|Overall Study|Adverse Event|1|||
150097845|NCT04709575|541501554|FG001|Overall Study|Adverse Event|0|||
150097846|NCT04709575|541501553|FG000|Overall Study|Protocol Violation|1|||
150097847|NCT04709575|541501554|FG001|Overall Study|Protocol Violation|1|||
150097848|NCT03181399|541501556|FG000|6 Months on Treatment|Protocol non-compliance|7|||
150097849|NCT03181399|541501556|FG000|6 Months on Treatment|Adverse Event|4|||
150097850|NCT03181399|541501556|FG000|6 Months on Treatment|Tried alternative treatment|2|||
150097851|NCT03181399|541501556|FG000|6 Months on Treatment|Lost to Follow-up|2|||
150097852|NCT03181399|541501556|FG000|6 Months on Treatment|Personal reasons|1|||
150097853|NCT03181399|541501556|FG000|3 Months Off-treatment|Parent unable to travel|1|||
150097854|NCT01536379|541501557|FG000|Overall Study|Adverse Event|1|||
150097855|NCT01536379|541501558|FG001|Overall Study|Adverse Event|2|||
150097856|NCT01536379|541501557|FG000|Overall Study|Withdrawal by Subject|1|||
150097857|NCT01536379|541501558|FG001|Overall Study|Withdrawal by Subject|1|||
150097858|NCT04439253|541501567|FG000|Overall Study|Adverse Event|1|||
150097859|NCT04439253|541501567|FG000|Overall Study|Disease progression|2|||
150097860|NCT04439253|541501567|FG000|Overall Study|Complicating disease|1|||
150097861|NCT03971695|541501568|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097862|NCT03971695|541501569|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097863|NCT03971695|541501570|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097864|NCT03971695|541501571|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
150097865|NCT03971695|541501572|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
150097866|NCT03971695|541501573|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097867|NCT03971695|541501574|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097868|NCT03971695|541501575|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097869|NCT03971695|541501576|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
150097870|NCT03971695|541501577|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
150097871|NCT03971695|541501578|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
150097872|NCT03971695|541501579|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
150097873|NCT03971695|541501580|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
150097874|NCT04447417|541501581|FG000|Overall Study|Withdrawal by Subject|1|||
150097875|NCT04447417|541501582|FG001|Overall Study|Withdrawal by Subject|0|||
150097876|NCT04447417|541501581|FG000|Overall Study|Failure to meet inclusion criteria|1|||
150097877|NCT04447417|541501582|FG001|Overall Study|Failure to meet inclusion criteria|0|||
150097878|NCT04447417|541501581|FG000|Overall Study|Lost to Follow-up|1|||
150097879|NCT04447417|541501582|FG001|Overall Study|Lost to Follow-up|0|||
150097880|NCT00702403|541501584|FG000|From Consent to Engraftment|Progressive leukemia|6|||
150097881|NCT00702403|541501584|FG000|From Consent to Engraftment|Critically ill|2|||
150097882|NCT00702403|541501584|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
150097883|NCT00702403|541501584|FG000|From Consent to Engraftment|Myocardial infarction|1|||
150097884|NCT00702403|541501584|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
150097885|NCT00702403|541501584|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
150097886|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
150185096|NCT03580369|541815816|FG006|Overall Study|Pregnancy|0|||
150185097|NCT03580369|541815817|FG007|Overall Study|Pregnancy|0|||
150185098|NCT03580369|541815810|FG000|Overall Study|Lost to Follow-up|2|||
150185099|NCT03580369|541815811|FG001|Overall Study|Lost to Follow-up|0|||
150185100|NCT03580369|541815812|FG002|Overall Study|Lost to Follow-up|2|||
150185101|NCT03580369|541815813|FG003|Overall Study|Lost to Follow-up|0|||
150185102|NCT03580369|541815814|FG004|Overall Study|Lost to Follow-up|3|||
150185103|NCT03580369|541815815|FG005|Overall Study|Lost to Follow-up|0|||
150185104|NCT03580369|541815816|FG006|Overall Study|Lost to Follow-up|1|||
150185105|NCT03580369|541815817|FG007|Overall Study|Lost to Follow-up|0|||
150185106|NCT03580369|541815810|FG000|Overall Study|Physician Decision|4|||
150185107|NCT03580369|541815811|FG001|Overall Study|Physician Decision|0|||
150185108|NCT03580369|541815812|FG002|Overall Study|Physician Decision|4|||
150185109|NCT03580369|541815813|FG003|Overall Study|Physician Decision|1|||
150185110|NCT03580369|541815814|FG004|Overall Study|Physician Decision|1|||
150185111|NCT03580369|541815815|FG005|Overall Study|Physician Decision|0|||
150185112|NCT03580369|541815816|FG006|Overall Study|Physician Decision|0|||
150185113|NCT03580369|541815817|FG007|Overall Study|Physician Decision|0|||
150185114|NCT03580369|541815810|FG000|Overall Study|Lack of Efficacy|3|||
150185115|NCT03580369|541815811|FG001|Overall Study|Lack of Efficacy|0|||
150185116|NCT03580369|541815812|FG002|Overall Study|Lack of Efficacy|7|||
150185117|NCT03580369|541815813|FG003|Overall Study|Lack of Efficacy|0|||
150185118|NCT03580369|541815814|FG004|Overall Study|Lack of Efficacy|2|||
150185119|NCT03580369|541815815|FG005|Overall Study|Lack of Efficacy|0|||
150097887|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
150097888|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Non-compliance|2|||
150097889|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
150097890|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
150097891|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Suicide|1|||
150097892|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
150097893|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
150097894|NCT00702403|541501584|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
150097895|NCT00858442|541501588|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
150097896|NCT00858442|541501589|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
150097897|NCT02155738|541501592|FG000|Overall Study|Missing critical information|1|||
150097898|NCT02155738|541501593|FG001|Overall Study|Missing critical information|0|||
150097899|NCT02155738|541501594|FG002|Overall Study|Missing critical information|0|||
150097900|NCT02155738|541501595|FG003|Overall Study|Missing critical information|1|||
150097901|NCT02016625|541501596|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
150097902|NCT02016625|541501597|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
150097903|NCT02016625|541501596|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
150097904|NCT02016625|541501597|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
150097905|NCT02016625|541501596|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
150097906|NCT02016625|541501597|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
150097907|NCT00380978|541501600|FG000|Overall Study|Refused allocated intervention|0|||
150097908|NCT00380978|541501601|FG001|Overall Study|Refused allocated intervention|6|||
150097909|NCT00380978|541501600|FG000|Overall Study|Wrong study envelope|0|||
150097910|NCT00380978|541501601|FG001|Overall Study|Wrong study envelope|2|||
150097911|NCT00380978|541501600|FG000|Overall Study|Allocation prior to analgesia request|1|||
150097912|NCT00380978|541501601|FG001|Overall Study|Allocation prior to analgesia request|2|||
150097913|NCT00380978|541501600|FG000|Overall Study|Parous patient|1|||
150097914|NCT00380978|541501601|FG001|Overall Study|Parous patient|0|||
150097915|NCT02189473|541501604|FG000|Overall Study|Death|22|||
150097916|NCT02189473|541501605|FG001|Overall Study|Death|23|||
150097917|NCT02189473|541501604|FG000|Overall Study|Lost to Follow-up|1|||
150097918|NCT02189473|541501605|FG001|Overall Study|Lost to Follow-up|2|||
150097919|NCT04608500|541501606|FG000|Overall Study|Adverse Event|2|||
150097920|NCT04608500|541501607|FG001|Overall Study|Adverse Event|0|||
150097921|NCT04608500|541501606|FG000|Overall Study|Lost to Follow-up|15|||
150097922|NCT04608500|541501607|FG001|Overall Study|Lost to Follow-up|9|||
150097923|NCT04608500|541501606|FG000|Overall Study|Participant request|11|||
150097924|NCT04608500|541501607|FG001|Overall Study|Participant request|7|||
150097925|NCT04608500|541501606|FG000|Overall Study|Protocol Violation|1|||
150097926|NCT04608500|541501607|FG001|Overall Study|Protocol Violation|0|||
150097927|NCT04608500|541501606|FG000|Overall Study|Other|6|||
150097928|NCT04608500|541501607|FG001|Overall Study|Other|2|||
150097929|NCT01881230|541501608|FG000|Overall Study|Death|2|||
150097930|NCT01881230|541501609|FG001|Overall Study|Death|0|||
150097931|NCT01881230|541501610|FG002|Overall Study|Death|1|||
150097932|NCT01881230|541501608|FG000|Overall Study|Adverse Event|9|||
150097933|NCT01881230|541501609|FG001|Overall Study|Adverse Event|13|||
150097934|NCT01881230|541501610|FG002|Overall Study|Adverse Event|12|||
150097935|NCT01881230|541501608|FG000|Overall Study|Progressive Disease|31|||
150097936|NCT01881230|541501609|FG001|Overall Study|Progressive Disease|35|||
150097937|NCT01881230|541501610|FG002|Overall Study|Progressive Disease|36|||
150097938|NCT01881230|541501608|FG000|Overall Study|Symptomatic Deterioration|3|||
150097939|NCT01881230|541501609|FG001|Overall Study|Symptomatic Deterioration|3|||
150097940|NCT01881230|541501610|FG002|Overall Study|Symptomatic Deterioration|1|||
150097941|NCT01881230|541501608|FG000|Overall Study|Withdrawal by Subject|6|||
150097942|NCT01881230|541501609|FG001|Overall Study|Withdrawal by Subject|4|||
150097943|NCT01881230|541501610|FG002|Overall Study|Withdrawal by Subject|6|||
150097944|NCT01881230|541501608|FG000|Overall Study|Physician Decision|4|||
150097945|NCT01881230|541501609|FG001|Overall Study|Physician Decision|3|||
150097946|NCT01881230|541501610|FG002|Overall Study|Physician Decision|6|||
150097947|NCT01881230|541501608|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150097948|NCT01881230|541501609|FG001|Overall Study|Non-Compliance with Study Drug|2|||
150097949|NCT01881230|541501610|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150097950|NCT01881230|541501608|FG000|Overall Study|Given Commercially Available Drug|0|||
150097951|NCT01881230|541501609|FG001|Overall Study|Given Commercially Available Drug|0|||
150097952|NCT01881230|541501610|FG002|Overall Study|Given Commercially Available Drug|2|||
150097953|NCT01881230|541501608|FG000|Overall Study|Protocol Violation|1|||
150097954|NCT01881230|541501609|FG001|Overall Study|Protocol Violation|1|||
150097955|NCT01881230|541501610|FG002|Overall Study|Protocol Violation|0|||
150097956|NCT01881230|541501608|FG000|Overall Study|Miscellaneous|3|||
150097957|NCT01881230|541501609|FG001|Overall Study|Miscellaneous|3|||
150097958|NCT01881230|541501610|FG002|Overall Study|Miscellaneous|0|||
150097959|NCT01881230|541501608|FG000|Overall Study|Untreated: Other|0|||
150097960|NCT01881230|541501609|FG001|Overall Study|Untreated: Other|0|||
150185120|NCT03580369|541815816|FG006|Overall Study|Lack of Efficacy|3|||
150185121|NCT03580369|541815817|FG007|Overall Study|Lack of Efficacy|0|||
150185122|NCT03580369|541815810|FG000|Overall Study|Protocol Violation|6|||
150185123|NCT03580369|541815811|FG001|Overall Study|Protocol Violation|0|||
150185124|NCT03580369|541815812|FG002|Overall Study|Protocol Violation|6|||
150185125|NCT03580369|541815813|FG003|Overall Study|Protocol Violation|1|||
150185126|NCT03580369|541815814|FG004|Overall Study|Protocol Violation|8|||
150185127|NCT03580369|541815815|FG005|Overall Study|Protocol Violation|2|||
150185128|NCT03580369|541815816|FG006|Overall Study|Protocol Violation|1|||
150185129|NCT03580369|541815817|FG007|Overall Study|Protocol Violation|0|||
150185130|NCT03580369|541815810|FG000|Overall Study|Adverse Event|7|||
150185131|NCT03580369|541815811|FG001|Overall Study|Adverse Event|0|||
150185132|NCT03580369|541815812|FG002|Overall Study|Adverse Event|14|||
150185133|NCT03580369|541815813|FG003|Overall Study|Adverse Event|1|||
150185134|NCT03580369|541815814|FG004|Overall Study|Adverse Event|6|||
150185135|NCT03580369|541815815|FG005|Overall Study|Adverse Event|0|||
150185136|NCT03580369|541815816|FG006|Overall Study|Adverse Event|1|||
150185137|NCT03580369|541815817|FG007|Overall Study|Adverse Event|0|||
150185138|NCT03580369|541815810|FG000|Overall Study|Withdrawal by Subject|19|||
150185139|NCT03580369|541815811|FG001|Overall Study|Withdrawal by Subject|0|||
150185140|NCT03580369|541815812|FG002|Overall Study|Withdrawal by Subject|17|||
150185141|NCT03580369|541815813|FG003|Overall Study|Withdrawal by Subject|0|||
150185142|NCT03580369|541815814|FG004|Overall Study|Withdrawal by Subject|16|||
150097961|NCT01881230|541501610|FG002|Overall Study|Untreated: Other|1|||
150097962|NCT01881230|541501608|FG000|Overall Study|Untreated: Death|0|||
150097963|NCT01881230|541501609|FG001|Overall Study|Untreated: Death|0|||
150097964|NCT01881230|541501610|FG002|Overall Study|Untreated: Death|1|||
150097965|NCT01881230|541501608|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
150097966|NCT01881230|541501609|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
150097967|NCT01881230|541501610|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
150097968|NCT00112502|541501611|FG000|Overall Study|Withdrawal by Subject|0|||
150097969|NCT00112502|541501612|FG001|Overall Study|Withdrawal by Subject|1|||
150097970|NCT00112502|541501613|FG002|Overall Study|Withdrawal by Subject|1|||
150097971|NCT00112502|541501614|FG003|Overall Study|Withdrawal by Subject|4|||
150097972|NCT00112502|541501615|FG004|Overall Study|Withdrawal by Subject|2|||
150097973|NCT00112502|541501616|FG005|Overall Study|Withdrawal by Subject|5|||
150097974|NCT00112502|541501617|FG006|Overall Study|Withdrawal by Subject|3|||
150097975|NCT00112502|541501618|FG007|Overall Study|Withdrawal by Subject|7|||
150097976|NCT00914810|541501621|FG000|Overall Study|Withdrawal by Subject|1|||
150097977|NCT00914810|541501622|FG001|Overall Study|Withdrawal by Subject|0|||
150097978|NCT00914810|541501621|FG000|Overall Study|Relocated out of state|1|||
150097979|NCT00914810|541501622|FG001|Overall Study|Relocated out of state|0|||
150097980|NCT00914810|541501621|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
150097981|NCT00914810|541501622|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
150097982|NCT02747420|541501623|FG000|Overall Study|Lost to Follow-up|4|||
150097983|NCT02747420|541501624|FG001|Overall Study|Lost to Follow-up|2|||
150097984|NCT02747420|541501623|FG000|Overall Study|Withdrawal by Subject|3|||
150097985|NCT02747420|541501624|FG001|Overall Study|Withdrawal by Subject|2|||
150097986|NCT05129488|541501625|FG000|Overall Study|Protocol Violation|3|||
150097987|NCT00706641|541501626|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
150097988|NCT00706641|541501626|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
150097989|NCT00706641|541501626|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
150097990|NCT04782856|541501629|FG000|Overall Study|Withdrawal by Subject|0|||
150097991|NCT04782856|541501630|FG001|Overall Study|Withdrawal by Subject|1|||
150097992|NCT00798369|541501631|FG000|Overall Study|Subject withdrew consent|0|||
150097993|NCT00798369|541501632|FG001|Overall Study|Subject withdrew consent|0|||
150097994|NCT00798369|541501633|FG002|Overall Study|Subject withdrew consent|1|||
150097995|NCT00798369|541501634|FG003|Overall Study|Subject withdrew consent|1|||
150097996|NCT00798369|541501635|FG004|Overall Study|Subject withdrew consent|0|||
150097997|NCT00798369|541501636|FG005|Overall Study|Subject withdrew consent|2|||
150097998|NCT00798369|541501631|FG000|Overall Study|Lost to Follow-up|1|||
150185143|NCT03580369|541815815|FG005|Overall Study|Withdrawal by Subject|1|||
150185144|NCT03580369|541815816|FG006|Overall Study|Withdrawal by Subject|7|||
150185145|NCT03580369|541815817|FG007|Overall Study|Withdrawal by Subject|0|||
150185146|NCT03527160|541815818|FG000|Overall Study|No urine collected|13|||
150185147|NCT03527160|541815818|FG000|Overall Study|No clinical serum creatinine collected|6|||
150097999|NCT00798369|541501632|FG001|Overall Study|Lost to Follow-up|1|||
150098000|NCT00798369|541501633|FG002|Overall Study|Lost to Follow-up|1|||
150098001|NCT00798369|541501634|FG003|Overall Study|Lost to Follow-up|0|||
150098002|NCT00798369|541501635|FG004|Overall Study|Lost to Follow-up|1|||
150098003|NCT00798369|541501636|FG005|Overall Study|Lost to Follow-up|0|||
150098004|NCT00798369|541501631|FG000|Overall Study|Adminstrative problems|0|||
150185148|NCT03527160|541815818|FG000|Overall Study|Did not meet inclusion|2|||
150185149|NCT02910713|541815819|FG000|Overall Study|Protocol Violation|2|||
150185150|NCT02910713|541815819|FG000|Overall Study|Subject Choice|4|||
150185151|NCT02910713|541815819|FG000|Overall Study|Received One Application|10|||
150185152|NCT02910713|541815819|FG000|Overall Study|Received Neither Application|18|||
150185153|NCT02910713|541815819|FG000|Overall Study|Enrollment cap|7|||
150185154|NCT02910713|541815819|FG000|Overall Study|Investigator Discretion|1|||
150185155|NCT04442126|541815828|FG000|Overall Study|Withdrawal by Subject|0|||
150185156|NCT04442126|541815829|FG001|Overall Study|Withdrawal by Subject|0|||
150185157|NCT04442126|541815830|FG002|Overall Study|Withdrawal by Subject|0|||
150185158|NCT04442126|541815831|FG003|Overall Study|Withdrawal by Subject|2|||
150185159|NCT04442126|541815832|FG004|Overall Study|Withdrawal by Subject|1|||
150185160|NCT04442126|541815833|FG005|Overall Study|Withdrawal by Subject|0|||
150185161|NCT04442126|541815834|FG006|Overall Study|Withdrawal by Subject|1|||
150185162|NCT04442126|541815835|FG007|Overall Study|Withdrawal by Subject|1|||
150185163|NCT04442126|541815836|FG008|Overall Study|Withdrawal by Subject|3|||
150185164|NCT04442126|541815828|FG000|Overall Study|Death|1|||
150098005|NCT00798369|541501632|FG001|Overall Study|Adminstrative problems|0|||
150098006|NCT00798369|541501633|FG002|Overall Study|Adminstrative problems|0|||
150098007|NCT00798369|541501634|FG003|Overall Study|Adminstrative problems|0|||
150098008|NCT00798369|541501635|FG004|Overall Study|Adminstrative problems|0|||
150098009|NCT00798369|541501636|FG005|Overall Study|Adminstrative problems|1|||
150098010|NCT03739112|541501638|FG000|Overall Study|Adverse Event|2|||
150098011|NCT03739112|541501639|FG001|Overall Study|Adverse Event|2|||
150098012|NCT03739112|541501638|FG000|Overall Study|Withdrawal by Subject|38|||
150098013|NCT03739112|541501639|FG001|Overall Study|Withdrawal by Subject|19|||
150098014|NCT03739112|541501638|FG000|Overall Study|Lost to Follow-up|31|||
150098015|NCT03739112|541501639|FG001|Overall Study|Lost to Follow-up|33|||
150098016|NCT03739112|541501638|FG000|Overall Study|Protocol Deviation|12|||
150098017|NCT03739112|541501639|FG001|Overall Study|Protocol Deviation|9|||
150098018|NCT03739112|541501638|FG000|Overall Study|Physician Decision|1|||
150098019|NCT03739112|541501639|FG001|Overall Study|Physician Decision|0|||
150098020|NCT03739112|541501638|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
150098021|NCT03739112|541501639|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
150185165|NCT04442126|541815829|FG001|Overall Study|Death|0|||
150185166|NCT04442126|541815830|FG002|Overall Study|Death|0|||
150185167|NCT04442126|541815831|FG003|Overall Study|Death|1|||
150185168|NCT04442126|541815832|FG004|Overall Study|Death|2|||
150185169|NCT04442126|541815833|FG005|Overall Study|Death|2|||
150185170|NCT04442126|541815834|FG006|Overall Study|Death|4|||
150185171|NCT04442126|541815835|FG007|Overall Study|Death|1|||
150185172|NCT04442126|541815836|FG008|Overall Study|Death|5|||
150185173|NCT04442126|541815828|FG000|Overall Study|Study Terminated by Sponsor|0|||
150185174|NCT04442126|541815829|FG001|Overall Study|Study Terminated by Sponsor|0|||
150185175|NCT04442126|541815830|FG002|Overall Study|Study Terminated by Sponsor|0|||
150185176|NCT04442126|541815831|FG003|Overall Study|Study Terminated by Sponsor|0|||
150185177|NCT04442126|541815832|FG004|Overall Study|Study Terminated by Sponsor|0|||
150185178|NCT04442126|541815833|FG005|Overall Study|Study Terminated by Sponsor|1|||
150185179|NCT04442126|541815834|FG006|Overall Study|Study Terminated by Sponsor|4|||
150185180|NCT04442126|541815835|FG007|Overall Study|Study Terminated by Sponsor|2|||
150185181|NCT04442126|541815836|FG008|Overall Study|Study Terminated by Sponsor|10|||
150185182|NCT04442126|541815828|FG000|Overall Study|Lost to Follow-up|0|||
150185183|NCT04442126|541815829|FG001|Overall Study|Lost to Follow-up|0|||
150185184|NCT04442126|541815830|FG002|Overall Study|Lost to Follow-up|0|||
150185185|NCT04442126|541815831|FG003|Overall Study|Lost to Follow-up|0|||
150185186|NCT04442126|541815832|FG004|Overall Study|Lost to Follow-up|0|||
150185187|NCT04442126|541815833|FG005|Overall Study|Lost to Follow-up|0|||
150185188|NCT04442126|541815834|FG006|Overall Study|Lost to Follow-up|0|||
150185189|NCT04442126|541815835|FG007|Overall Study|Lost to Follow-up|1|||
150185190|NCT04442126|541815836|FG008|Overall Study|Lost to Follow-up|2|||
150185191|NCT04442126|541815828|FG000|Overall Study|Progressive Disease|0|||
150185192|NCT04442126|541815829|FG001|Overall Study|Progressive Disease|1|||
150185193|NCT04442126|541815830|FG002|Overall Study|Progressive Disease|3|||
150185194|NCT04442126|541815831|FG003|Overall Study|Progressive Disease|0|||
150185195|NCT04442126|541815832|FG004|Overall Study|Progressive Disease|3|||
150185196|NCT04442126|541815833|FG005|Overall Study|Progressive Disease|0|||
150185197|NCT04442126|541815834|FG006|Overall Study|Progressive Disease|0|||
150185198|NCT04442126|541815835|FG007|Overall Study|Progressive Disease|0|||
150185199|NCT04442126|541815836|FG008|Overall Study|Progressive Disease|0|||
150098022|NCT03739112|541501638|FG000|Overall Study|Site went on hold|65|||
150185200|NCT04442126|541815828|FG000|Overall Study|Other|0|||
150098023|NCT03739112|541501639|FG001|Overall Study|Site went on hold|67|||
150098024|NCT03739112|541501638|FG000|Overall Study|Other than specified|8|||
150185201|NCT04442126|541815829|FG001|Overall Study|Other|0|||
150185202|NCT04442126|541815830|FG002|Overall Study|Other|0|||
150185203|NCT04442126|541815831|FG003|Overall Study|Other|0|||
150185204|NCT04442126|541815832|FG004|Overall Study|Other|0|||
150185205|NCT04442126|541815833|FG005|Overall Study|Other|0|||
150185206|NCT04442126|541815834|FG006|Overall Study|Other|0|||
150185207|NCT04442126|541815835|FG007|Overall Study|Other|0|||
150098025|NCT03739112|541501639|FG001|Overall Study|Other than specified|5|||
150098026|NCT03739112|541501638|FG000|Overall Study|Randomized but not vaccinated|31|||
150098027|NCT03739112|541501639|FG001|Overall Study|Randomized but not vaccinated|25|||
150098028|NCT00588822|541501640|FG000|Overall Study|progression of disease|8|||
150098029|NCT02436759|541501643|FG000|Overall Study|Adverse Event|3|||
150098030|NCT02436759|541501644|FG001|Overall Study|Adverse Event|0|||
150098031|NCT02436759|541501643|FG000|Overall Study|Protocol Violation|1|||
150098032|NCT02436759|541501644|FG001|Overall Study|Protocol Violation|0|||
150098033|NCT02436759|541501643|FG000|Overall Study|Withdrawal by Subject|0|||
150098034|NCT02436759|541501644|FG001|Overall Study|Withdrawal by Subject|1|||
150098035|NCT02584504|541501645|FG000|Double-blind Treatment|Participant withdrew consent|0|||
150098036|NCT02584504|541501646|FG001|Double-blind Treatment|Participant withdrew consent|0|||
150098037|NCT02584504|541501647|FG002|Double-blind Treatment|Participant withdrew consent|1|||
150098038|NCT02584504|541501645|FG000|Double-blind Treatment|Adverse Event|0|||
150098039|NCT02584504|541501646|FG001|Double-blind Treatment|Adverse Event|1|||
150098040|NCT02584504|541501647|FG002|Double-blind Treatment|Adverse Event|0|||
150098041|NCT02584504|541501645|FG000|Double-blind Treatment|Family Matter|0|||
150098042|NCT02584504|541501646|FG001|Double-blind Treatment|Family Matter|1|||
150098043|NCT02584504|541501647|FG002|Double-blind Treatment|Family Matter|0|||
150098044|NCT02584504|541501645|FG000|Open-label Treatment|Participant withdrew consent|0|||
150098045|NCT02584504|541501646|FG001|Open-label Treatment|Participant withdrew consent|0|||
150098046|NCT02584504|541501647|FG002|Open-label Treatment|Participant withdrew consent|4|||
150098047|NCT02584504|541501645|FG000|Open-label Treatment|Adverse Event|2|||
150098048|NCT02584504|541501646|FG001|Open-label Treatment|Adverse Event|2|||
150098049|NCT02584504|541501647|FG002|Open-label Treatment|Adverse Event|3|||
150098050|NCT02584504|541501645|FG000|Open-label Treatment|Physician Decision|0|||
150098051|NCT02584504|541501646|FG001|Open-label Treatment|Physician Decision|1|||
150098052|NCT02584504|541501647|FG002|Open-label Treatment|Physician Decision|0|||
150098053|NCT02584504|541501645|FG000|Open-label Treatment|Entered but not treated|0|||
150098054|NCT02584504|541501646|FG001|Open-label Treatment|Entered but not treated|1|||
150098055|NCT02584504|541501647|FG002|Open-label Treatment|Entered but not treated|1|||
150098056|NCT01290666|541501649|FG000|Overall Study|Lost to Follow-up|11|||
150098057|NCT01290666|541501649|FG000|Overall Study|Withdrawal by Subject|23|||
150098058|NCT01290666|541501649|FG000|Overall Study|Early Termination of Study|4|||
150098059|NCT01652664|541501652|FG000|Overall Study|Treatment Failure|5|||
150098060|NCT01652664|541501653|FG001|Overall Study|Treatment Failure|1|||
150098061|NCT01652664|541501652|FG000|Overall Study|Inadequate IOP control|1|||
150098062|NCT01652664|541501653|FG001|Overall Study|Inadequate IOP control|0|||
150098063|NCT00297037|541501654|FG000|Overall Study|Withdrawal by Subject|2|||
150098064|NCT00297037|541501655|FG001|Overall Study|Withdrawal by Subject|0|||
150098065|NCT00581776|541501656|FG000|Overall Study|Disease progression or no response|3|||
150098066|NCT00099437|541501664|FG000|Overall Study|Lost to Follow-up|30|||
150098067|NCT00099437|541501665|FG001|Overall Study|Lost to Follow-up|33|||
150098068|NCT00099437|541501664|FG000|Overall Study|Death|293|||
150098069|NCT00099437|541501665|FG001|Overall Study|Death|261|||
150098070|NCT00099437|541501664|FG000|Overall Study|Withdrawal by Subject|6|||
150098071|NCT00099437|541501665|FG001|Overall Study|Withdrawal by Subject|10|||
150098072|NCT00099437|541501664|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
150098073|NCT00099437|541501665|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
150098074|NCT02410954|541501666|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
150098075|NCT02410954|541501667|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
150185208|NCT04442126|541815836|FG008|Overall Study|Other|1|||
150098076|NCT02410954|541501666|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
150098077|NCT02410954|541501667|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
150098078|NCT00454987|541501672|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
150098079|NCT00454987|541501673|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
150098080|NCT00454987|541501674|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
150098081|NCT00454987|541501672|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
150098082|NCT00454987|541501673|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
150098083|NCT00454987|541501674|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
150098084|NCT00454987|541501672|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
150098085|NCT00454987|541501673|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
150098086|NCT00454987|541501674|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
150098087|NCT02205333|541501675|FG000|Overall Study|Death|5|||
150098088|NCT02205333|541501676|FG001|Overall Study|Death|6|||
150098089|NCT02205333|541501677|FG002|Overall Study|Death|2|||
150098090|NCT02205333|541501678|FG003|Overall Study|Death|6|||
150098091|NCT02205333|541501679|FG004|Overall Study|Death|5|||
150098092|NCT02205333|541501680|FG005|Overall Study|Death|3|||
150098093|NCT02205333|541501681|FG006|Overall Study|Death|3|||
150098094|NCT02205333|541501682|FG007|Overall Study|Death|2|||
150098095|NCT02205333|541501683|FG008|Overall Study|Death|0|||
150098096|NCT02205333|541501675|FG000|Overall Study|Withdrawal by Subject|1|||
150098097|NCT02205333|541501676|FG001|Overall Study|Withdrawal by Subject|0|||
150098098|NCT02205333|541501677|FG002|Overall Study|Withdrawal by Subject|0|||
150098099|NCT02205333|541501678|FG003|Overall Study|Withdrawal by Subject|1|||
150098100|NCT02205333|541501679|FG004|Overall Study|Withdrawal by Subject|0|||
150098101|NCT02205333|541501680|FG005|Overall Study|Withdrawal by Subject|0|||
150098102|NCT02205333|541501681|FG006|Overall Study|Withdrawal by Subject|2|||
150098103|NCT02205333|541501682|FG007|Overall Study|Withdrawal by Subject|0|||
150098104|NCT02205333|541501683|FG008|Overall Study|Withdrawal by Subject|0|||
150098105|NCT01176266|541501685|FG000|Overall Study|Death|6|||
150098106|NCT01176266|541501685|FG000|Overall Study|Withdrawal by Subject|3|||
150098107|NCT01675128|541501687|FG000|Overall Study|Disease progression on study|1|||
150098108|NCT01675128|541501688|FG001|Overall Study|Disease progression on study|1|||
150098109|NCT01675128|541501689|FG002|Overall Study|Disease progression on study|1|||
150098110|NCT01675128|541501687|FG000|Overall Study|Refused further treatment|1|||
150098111|NCT01675128|541501688|FG001|Overall Study|Refused further treatment|0|||
150098112|NCT01675128|541501689|FG002|Overall Study|Refused further treatment|0|||
150098113|NCT01675128|541501687|FG000|Overall Study|Pulmonary complication; off study|0|||
150098114|NCT01675128|541501688|FG001|Overall Study|Pulmonary complication; off study|1|||
150098115|NCT01675128|541501689|FG002|Overall Study|Pulmonary complication; off study|0|||
150098116|NCT03011307|541501690|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
150098117|NCT03011307|541501691|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
150098118|NCT03011307|541501690|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
150098119|NCT03011307|541501691|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
150098120|NCT03011307|541501690|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
150098121|NCT03011307|541501691|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
150098122|NCT03526458|541501692|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
150098123|NCT03526458|541501693|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
150098124|NCT03526458|541501692|FG000|Overall Study|Stone passed, surgery cancelled|2|||
150098125|NCT03526458|541501693|FG001|Overall Study|Stone passed, surgery cancelled|1|||
150098126|NCT03526458|541501692|FG000|Overall Study|Withdrawal by Subject|1|||
150098127|NCT03526458|541501693|FG001|Overall Study|Withdrawal by Subject|0|||
150098128|NCT03526458|541501692|FG000|Overall Study|Physician Decision|2|||
150098129|NCT03526458|541501693|FG001|Overall Study|Physician Decision|1|||
150098130|NCT03526458|541501692|FG000|Overall Study|Lack of equipment|1|||
150098131|NCT03526458|541501693|FG001|Overall Study|Lack of equipment|1|||
150098132|NCT01782664|541501694|FG000|Overall Study|Adverse Event|2|||
150098133|NCT01782664|541501695|FG001|Overall Study|Adverse Event|2|||
150098134|NCT01782664|541501696|FG002|Overall Study|Adverse Event|2|||
150098135|NCT01782664|541501697|FG003|Overall Study|Adverse Event|2|||
150098136|NCT01782664|541501698|FG004|Overall Study|Adverse Event|0|||
150098137|NCT01782664|541501699|FG005|Overall Study|Adverse Event|0|||
150098138|NCT01782664|541501694|FG000|Overall Study|Lack of Efficacy|2|||
150098139|NCT01782664|541501695|FG001|Overall Study|Lack of Efficacy|0|||
150098140|NCT01782664|541501696|FG002|Overall Study|Lack of Efficacy|2|||
150098141|NCT01782664|541501697|FG003|Overall Study|Lack of Efficacy|2|||
150098142|NCT01782664|541501698|FG004|Overall Study|Lack of Efficacy|0|||
150098143|NCT01782664|541501699|FG005|Overall Study|Lack of Efficacy|0|||
150098144|NCT01782664|541501694|FG000|Overall Study|Protocol Violation|0|||
150098145|NCT01782664|541501695|FG001|Overall Study|Protocol Violation|1|||
150098146|NCT01782664|541501696|FG002|Overall Study|Protocol Violation|0|||
150098147|NCT01782664|541501697|FG003|Overall Study|Protocol Violation|1|||
150098148|NCT01782664|541501698|FG004|Overall Study|Protocol Violation|0|||
150098149|NCT01782664|541501699|FG005|Overall Study|Protocol Violation|0|||
150098150|NCT01782664|541501694|FG000|Overall Study|Withdrawal by Subject|2|||
150098151|NCT01782664|541501695|FG001|Overall Study|Withdrawal by Subject|2|||
150098152|NCT01782664|541501696|FG002|Overall Study|Withdrawal by Subject|0|||
150098153|NCT01782664|541501697|FG003|Overall Study|Withdrawal by Subject|0|||
150098154|NCT01782664|541501698|FG004|Overall Study|Withdrawal by Subject|0|||
150098155|NCT01782664|541501699|FG005|Overall Study|Withdrawal by Subject|0|||
150098156|NCT00698581|541501702|FG000|Overall Study|Lack of Efficacy|23|||
150098157|NCT00698581|541501703|FG001|Overall Study|Lack of Efficacy|11|||
150098158|NCT00698581|541501702|FG000|Overall Study|Withdrawal by Subject|6|||
150098159|NCT00698581|541501703|FG001|Overall Study|Withdrawal by Subject|0|||
150098160|NCT00698581|541501702|FG000|Overall Study|Other reason|9|||
150098161|NCT00698581|541501703|FG001|Overall Study|Other reason|1|||
150098162|NCT00698581|541501702|FG000|Overall Study|SAE, non-fatal|1|||
150098163|NCT00698581|541501703|FG001|Overall Study|SAE, non-fatal|0|||
150098164|NCT00698581|541501702|FG000|Overall Study|AE, non-serious non-fatal|4|||
150098165|NCT00698581|541501703|FG001|Overall Study|AE, non-serious non-fatal|0|||
150098166|NCT00698581|541501702|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
150098167|NCT00698581|541501703|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
150098168|NCT00698581|541501702|FG000|Overall Study|AE of unknown type|1|||
150098169|NCT00698581|541501703|FG001|Overall Study|AE of unknown type|0|||
150098170|NCT03760146|541501704|FG000|Overall Study|Adverse Event|11|||
150098171|NCT03760146|541501705|FG001|Overall Study|Adverse Event|8|||
150098172|NCT03760146|541501706|FG002|Overall Study|Adverse Event|0|||
150098173|NCT03760146|541501707|FG003|Overall Study|Adverse Event|0|||
150098174|NCT03760146|541501708|FG004|Overall Study|Adverse Event|0|||
150098175|NCT03760146|541501709|FG005|Overall Study|Adverse Event|0|||
150098176|NCT03760146|541501704|FG000|Overall Study|Death|1|||
150098177|NCT03760146|541501705|FG001|Overall Study|Death|0|||
150098178|NCT03760146|541501706|FG002|Overall Study|Death|0|||
150098179|NCT03760146|541501707|FG003|Overall Study|Death|0|||
150098180|NCT03760146|541501708|FG004|Overall Study|Death|0|||
150098181|NCT03760146|541501709|FG005|Overall Study|Death|0|||
150098182|NCT03760146|541501704|FG000|Overall Study|Lost to Follow-up|41|||
150098183|NCT03760146|541501705|FG001|Overall Study|Lost to Follow-up|28|||
150098184|NCT03760146|541501706|FG002|Overall Study|Lost to Follow-up|9|||
150098185|NCT03760146|541501707|FG003|Overall Study|Lost to Follow-up|2|||
150098186|NCT03760146|541501708|FG004|Overall Study|Lost to Follow-up|14|||
150098187|NCT03760146|541501709|FG005|Overall Study|Lost to Follow-up|8|||
150098188|NCT03760146|541501704|FG000|Overall Study|No longer met eligibility criteria|3|||
150098189|NCT03760146|541501705|FG001|Overall Study|No longer met eligibility criteria|9|||
150098190|NCT03760146|541501706|FG002|Overall Study|No longer met eligibility criteria|0|||
150098191|NCT03760146|541501707|FG003|Overall Study|No longer met eligibility criteria|0|||
150098192|NCT03760146|541501708|FG004|Overall Study|No longer met eligibility criteria|1|||
150098193|NCT03760146|541501709|FG005|Overall Study|No longer met eligibility criteria|0|||
150098194|NCT03760146|541501704|FG000|Overall Study|Protocol Violation|21|||
150098195|NCT03760146|541501705|FG001|Overall Study|Protocol Violation|13|||
150098196|NCT03760146|541501706|FG002|Overall Study|Protocol Violation|1|||
150098197|NCT03760146|541501707|FG003|Overall Study|Protocol Violation|0|||
150098198|NCT03760146|541501708|FG004|Overall Study|Protocol Violation|1|||
150098199|NCT03760146|541501709|FG005|Overall Study|Protocol Violation|0|||
150098200|NCT03760146|541501704|FG000|Overall Study|Withdrawal by Subject|19|||
150098201|NCT03760146|541501705|FG001|Overall Study|Withdrawal by Subject|20|||
150098202|NCT03760146|541501706|FG002|Overall Study|Withdrawal by Subject|1|||
150098203|NCT03760146|541501707|FG003|Overall Study|Withdrawal by Subject|0|||
150098204|NCT03760146|541501708|FG004|Overall Study|Withdrawal by Subject|1|||
150098205|NCT03760146|541501709|FG005|Overall Study|Withdrawal by Subject|0|||
150098206|NCT01082965|541501710|FG000|Overall Study|Protocol Violation|0|||
150098207|NCT01082965|541501711|FG001|Overall Study|Protocol Violation|1|||
150098208|NCT01082965|541501710|FG000|Overall Study|Other|1|||
150098209|NCT01082965|541501711|FG001|Overall Study|Other|1|||
150098210|NCT03642717|541501712|FG000|Overall Study|Lost to Follow-up|2|||
150098211|NCT03642717|541501712|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
150098212|NCT03642717|541501712|FG000|Overall Study|Taken study drug prior to contract date|3|||
150098213|NCT02587065|541501713|FG000|Overall Study|Adverse Event|14|||
150098214|NCT02587065|541501713|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
150098215|NCT02587065|541501713|FG000|Overall Study|Non-adherence to the Protocol|3|||
150098216|NCT02587065|541501713|FG000|Overall Study|Discontinuation of Study Medication|2|||
150098217|NCT02587065|541501713|FG000|Overall Study|Reason not Specified|3|||
150098218|NCT02642432|541501715|FG000|Overall Study|Adverse Event|2|||
150098219|NCT02642432|541501715|FG000|Overall Study|Withdrew Consent|1|||
150098220|NCT02642432|541501715|FG000|Overall Study|Lost to Follow-up|2|||
150098221|NCT02642432|541501715|FG000|Overall Study|Other|3|||
150098222|NCT03999892|541501716|FG000|Overall Study|Lost to Follow-up|1|||
150098223|NCT01848756|541501717|FG000|Overall Study|Adverse Event|1|||
150098224|NCT01848756|541501717|FG000|Overall Study|Withdrawal by Subject|1|||
150098225|NCT01848756|541501717|FG000|Overall Study|Enrolled in Error|1|||
150098226|NCT03245008|541501718|FG000|Overall Study|Adverse Event|15|||
150098227|NCT03245008|541501719|FG001|Overall Study|Adverse Event|18|||
150098228|NCT03245008|541501720|FG002|Overall Study|Adverse Event|15|||
150098229|NCT03245008|541501721|FG003|Overall Study|Adverse Event|0|||
150098230|NCT03245008|541501722|FG004|Overall Study|Adverse Event|1|||
150098231|NCT03245008|541501718|FG000|Overall Study|Lack of Efficacy|0|||
150098232|NCT03245008|541501719|FG001|Overall Study|Lack of Efficacy|1|||
150098233|NCT03245008|541501720|FG002|Overall Study|Lack of Efficacy|0|||
150098234|NCT03245008|541501721|FG003|Overall Study|Lack of Efficacy|0|||
150098235|NCT03245008|541501722|FG004|Overall Study|Lack of Efficacy|0|||
150098236|NCT03245008|541501718|FG000|Overall Study|Lost to Follow-up|4|||
150098237|NCT03245008|541501719|FG001|Overall Study|Lost to Follow-up|1|||
150098238|NCT03245008|541501720|FG002|Overall Study|Lost to Follow-up|0|||
150098239|NCT03245008|541501721|FG003|Overall Study|Lost to Follow-up|0|||
150098240|NCT03245008|541501722|FG004|Overall Study|Lost to Follow-up|1|||
150098241|NCT03245008|541501718|FG000|Overall Study|Physician Decision|1|||
150098242|NCT03245008|541501719|FG001|Overall Study|Physician Decision|3|||
150098243|NCT03245008|541501720|FG002|Overall Study|Physician Decision|4|||
150098244|NCT03245008|541501721|FG003|Overall Study|Physician Decision|0|||
150098245|NCT03245008|541501722|FG004|Overall Study|Physician Decision|0|||
150098246|NCT03245008|541501718|FG000|Overall Study|Protocol Violation|0|||
150098247|NCT03245008|541501719|FG001|Overall Study|Protocol Violation|1|||
150098248|NCT03245008|541501720|FG002|Overall Study|Protocol Violation|0|||
150098249|NCT03245008|541501721|FG003|Overall Study|Protocol Violation|0|||
150098250|NCT03245008|541501722|FG004|Overall Study|Protocol Violation|0|||
150098251|NCT03245008|541501718|FG000|Overall Study|Withdrawal by Subject|20|||
150098252|NCT03245008|541501719|FG001|Overall Study|Withdrawal by Subject|19|||
150098253|NCT03245008|541501720|FG002|Overall Study|Withdrawal by Subject|11|||
150098254|NCT03245008|541501721|FG003|Overall Study|Withdrawal by Subject|0|||
150098255|NCT03245008|541501722|FG004|Overall Study|Withdrawal by Subject|0|||
150098256|NCT03245008|541501718|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
150098257|NCT03245008|541501719|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
150098258|NCT03245008|541501720|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
150098259|NCT03245008|541501721|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
150098260|NCT03245008|541501722|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
150098261|NCT03245008|541501718|FG000|Overall Study|Failure to meet randomization criteria|0|||
150098262|NCT03245008|541501719|FG001|Overall Study|Failure to meet randomization criteria|1|||
150098263|NCT03245008|541501720|FG002|Overall Study|Failure to meet randomization criteria|0|||
150098264|NCT03245008|541501721|FG003|Overall Study|Failure to meet randomization criteria|1|||
150098265|NCT03245008|541501722|FG004|Overall Study|Failure to meet randomization criteria|0|||
150098266|NCT02075658|541501723|FG000|Overall Study|Physician Decision|2|||
150098267|NCT02075658|541501724|FG001|Overall Study|Physician Decision|2|||
150098268|NCT01286012|541501725|FG000|Overall Study|Adverse Event|3|||
150098269|NCT01286012|541501726|FG001|Overall Study|Adverse Event|3|||
150098270|NCT01286012|541501725|FG000|Overall Study|Death|2|||
150098271|NCT01286012|541501726|FG001|Overall Study|Death|3|||
150098272|NCT01286012|541501725|FG000|Overall Study|Protocol Violation|1|||
150098273|NCT01286012|541501726|FG001|Overall Study|Protocol Violation|1|||
150098274|NCT01286012|541501725|FG000|Overall Study|Withdrawal by Subject|4|||
150098275|NCT01286012|541501726|FG001|Overall Study|Withdrawal by Subject|4|||
150098276|NCT01286012|541501725|FG000|Overall Study|Physician Decision|2|||
150098277|NCT01286012|541501726|FG001|Overall Study|Physician Decision|0|||
150098278|NCT01286012|541501725|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
150098279|NCT01286012|541501726|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
150098280|NCT04056195|541501729|FG000|Overall Study|Adverse Event|1|||
150098281|NCT04056195|541501730|FG001|Overall Study|Adverse Event|0|||
150098282|NCT04056195|541501731|FG002|Overall Study|Adverse Event|0|||
150098283|NCT04056195|541501729|FG000|Overall Study|Withdrawal by Subject|0|||
150098284|NCT04056195|541501730|FG001|Overall Study|Withdrawal by Subject|1|||
150098285|NCT04056195|541501731|FG002|Overall Study|Withdrawal by Subject|1|||
150098286|NCT04056195|541501729|FG000|Overall Study|Physician Decision|1|||
150098287|NCT04056195|541501730|FG001|Overall Study|Physician Decision|1|||
150098288|NCT04056195|541501731|FG002|Overall Study|Physician Decision|1|||
150098289|NCT02406651|541501732|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
150098290|NCT00718328|541501733|FG000|Overall Study|Lost to Follow-up|1|||
150098291|NCT00718328|541501734|FG001|Overall Study|Lost to Follow-up|0|||
150098292|NCT00663052|541501737|FG000|Overall Study|Adverse Event|6|||
150098293|NCT00663052|541501738|FG001|Overall Study|Adverse Event|3|||
150098294|NCT00663052|541501737|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
150098295|NCT00663052|541501738|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
150098296|NCT00663052|541501737|FG000|Overall Study|Protocol Violation|1|||
150098297|NCT00663052|541501738|FG001|Overall Study|Protocol Violation|0|||
150098298|NCT00663052|541501737|FG000|Overall Study|Withdrawal by Subject|2|||
150098299|NCT00663052|541501738|FG001|Overall Study|Withdrawal by Subject|5|||
150098300|NCT00663052|541501737|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
150098301|NCT00663052|541501738|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
150098302|NCT00663052|541501737|FG000|Overall Study|Other|0|||
150098303|NCT00663052|541501738|FG001|Overall Study|Other|1|||
150098304|NCT01602380|541501742|FG000|Overall Study|Death|147|||
150098305|NCT01602380|541501743|FG001|Overall Study|Death|145|||
150098306|NCT01602380|541501742|FG000|Overall Study|Withdrawal by Subject|39|||
150098307|NCT01602380|541501743|FG001|Overall Study|Withdrawal by Subject|41|||
150098308|NCT01602380|541501742|FG000|Overall Study|Lost to Follow-up|15|||
150098309|NCT01602380|541501743|FG001|Overall Study|Lost to Follow-up|12|||
150098310|NCT01602380|541501742|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
150098311|NCT01602380|541501743|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
150098312|NCT01602380|541501742|FG000|Overall Study|Other|2|||
150098313|NCT01602380|541501743|FG001|Overall Study|Other|0|||
150098314|NCT01254227|541503485|FG000|Overall Study|Withdrawal by Subject|6|||
150098315|NCT01254227|541503485|FG000|Overall Study|Lost to Follow-up|6|||
150098316|NCT01254227|541503485|FG000|Overall Study|Adverse Event|5|||
150098317|NCT01254227|541503485|FG000|Overall Study|Abnormal test procedure result|5|||
150098318|NCT01254227|541503485|FG000|Overall Study|Administrative problems|2|||
150098319|NCT01254227|541503485|FG000|Overall Study|Death|1|||
150098320|NCT01254227|541503485|FG000|Overall Study|Protocol deviation|1|||
150098321|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
150098322|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
150098323|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
150098324|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
150098325|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
150098326|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
150098327|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
150098328|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
150098329|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
150098330|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
150098331|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
150098332|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
150098333|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
150098334|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
150098335|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
150098336|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
150098337|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
150098338|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
150098339|NCT00887354|541503486|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
150098340|NCT00887354|541503487|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
150098341|NCT00887354|541503486|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
150098342|NCT00887354|541503487|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
150098343|NCT00887354|541503486|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
150098344|NCT00887354|541503487|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
150098345|NCT00887354|541503486|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
150098346|NCT00887354|541503487|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
150098347|NCT00887354|541503486|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
150098348|NCT00887354|541503487|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
150098349|NCT00887354|541503486|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
150098350|NCT00887354|541503487|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
150185209|NCT06066541|541817074|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
150098351|NCT01466348|541503488|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
150098352|NCT01466348|541503489|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
150098353|NCT00192504|541503492|FG000|Overall Study|Lost to Follow-up|1|||
150098354|NCT00192504|541503493|FG001|Overall Study|Lost to Follow-up|0|||
150098355|NCT00192504|541503494|FG002|Overall Study|Lost to Follow-up|0|||
150098356|NCT00192504|541503495|FG003|Overall Study|Lost to Follow-up|0|||
150098357|NCT00192504|541503492|FG000|Overall Study|Dosing window missed|0|||
150098358|NCT00192504|541503493|FG001|Overall Study|Dosing window missed|0|||
150098359|NCT00192504|541503494|FG002|Overall Study|Dosing window missed|1|||
150098360|NCT00192504|541503495|FG003|Overall Study|Dosing window missed|0|||
150098361|NCT03989440|541503496|FG000|Overall Study|COVID-19 travel restrictions|0|||
150098362|NCT03989440|541503497|FG001|Overall Study|COVID-19 travel restrictions|0|||
150098363|NCT03989440|541503498|FG002|Overall Study|COVID-19 travel restrictions|1|||
150098364|NCT03989440|541503499|FG003|Overall Study|COVID-19 travel restrictions|0|||
150098365|NCT03989440|541503500|FG004|Overall Study|COVID-19 travel restrictions|0|||
150098366|NCT03989440|541503501|FG005|Overall Study|COVID-19 travel restrictions|0|||
150098367|NCT03989440|541503496|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
150098368|NCT03989440|541503497|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
150098369|NCT03989440|541503498|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
150098370|NCT03989440|541503499|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
150098371|NCT03989440|541503500|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
150098372|NCT03989440|541503501|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
150098373|NCT01955161|541503504|FG000|Overall Study|Withdrawal before treatment|2|||
150098374|NCT01955161|541503505|FG001|Overall Study|Withdrawal before treatment|0|||
150098375|NCT01955161|541503506|FG002|Overall Study|Withdrawal before treatment|1|||
150098376|NCT01955161|541503504|FG000|Overall Study|Adverse Event|10|||
150098377|NCT01955161|541503505|FG001|Overall Study|Adverse Event|14|||
150098378|NCT01955161|541503506|FG002|Overall Study|Adverse Event|15|||
150098379|NCT01955161|541503504|FG000|Overall Study|Death|1|||
150098380|NCT01955161|541503505|FG001|Overall Study|Death|1|||
150098381|NCT01955161|541503506|FG002|Overall Study|Death|3|||
150098382|NCT01955161|541503504|FG000|Overall Study|Withdrawal by Subject|9|||
150098383|NCT01955161|541503505|FG001|Overall Study|Withdrawal by Subject|8|||
150098384|NCT01955161|541503506|FG002|Overall Study|Withdrawal by Subject|12|||
150098385|NCT01955161|541503504|FG000|Overall Study|Protocol Violation|2|||
150098386|NCT01955161|541503505|FG001|Overall Study|Protocol Violation|0|||
150098387|NCT01955161|541503506|FG002|Overall Study|Protocol Violation|0|||
150098388|NCT01955161|541503504|FG000|Overall Study|Other reason: physician decision|0|||
150098389|NCT01955161|541503505|FG001|Overall Study|Other reason: physician decision|1|||
150098390|NCT01955161|541503506|FG002|Overall Study|Other reason: physician decision|1|||
150098391|NCT01955161|541503504|FG000|Overall Study|Other reason: disallowed medication|1|||
150098392|NCT01955161|541503505|FG001|Overall Study|Other reason: disallowed medication|0|||
150098393|NCT01955161|541503506|FG002|Overall Study|Other reason: disallowed medication|1|||
150098394|NCT01955161|541503504|FG000|Overall Study|Other reason: caregiver unavailable|1|||
150098395|NCT01955161|541503505|FG001|Overall Study|Other reason: caregiver unavailable|0|||
150098396|NCT01955161|541503506|FG002|Overall Study|Other reason: caregiver unavailable|0|||
150098397|NCT01955161|541503504|FG000|Overall Study|Other reason: moved to nursing home|0|||
150098398|NCT01955161|541503505|FG001|Overall Study|Other reason: moved to nursing home|1|||
150098399|NCT01955161|541503506|FG002|Overall Study|Other reason: moved to nursing home|0|||
150098400|NCT01955161|541503504|FG000|Overall Study|Other reason: insufficient compliance|0|||
150098401|NCT01955161|541503505|FG001|Overall Study|Other reason: insufficient compliance|0|||
150098402|NCT01955161|541503506|FG002|Overall Study|Other reason: insufficient compliance|1|||
150098403|NCT01955161|541503504|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
150098404|NCT01955161|541503505|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
150098405|NCT01955161|541503506|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
150098406|NCT01955161|541503504|FG000|Overall Study|Other reason: patient's will|0|||
150098407|NCT01955161|541503505|FG001|Overall Study|Other reason: patient's will|0|||
150098408|NCT01955161|541503506|FG002|Overall Study|Other reason: patient's will|1|||
150098409|NCT02784821|541503507|FG000|Overall Study|Death|0|||
150098410|NCT02784821|541503508|FG001|Overall Study|Death|5|||
150098411|NCT02784821|541503509|FG002|Overall Study|Death|4|||
150098412|NCT02784821|541503510|FG003|Overall Study|Death|5|||
150098413|NCT02794103|541503511|FG000|Overall Study|Loss to follow up due to high sedation|3|||
150098414|NCT04475588|541503517|FG000|Overall Study|Adverse Event|2|||
150185210|NCT06066541|541817075|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
150098415|NCT04475588|541503518|FG001|Overall Study|Adverse Event|0|||
150098416|NCT01327300|541503519|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
150098417|NCT01327300|541503520|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
150098418|NCT03020823|541503521|FG000|Overall Study|Physician Decision|4|||
150098419|NCT03020823|541503521|FG000|Overall Study|Lack of Efficacy|4|||
150098420|NCT03020823|541503521|FG000|Overall Study|Adverse Event|2|||
150098421|NCT02082210|541503522|FG000|Overall Study|Death|0|||
150098422|NCT02082210|541503523|FG001|Overall Study|Death|0|||
150098423|NCT02082210|541503524|FG002|Overall Study|Death|1|||
150098424|NCT02082210|541503525|FG003|Overall Study|Death|1|||
150098425|NCT02082210|541503526|FG004|Overall Study|Death|1|||
150098426|NCT02082210|541503527|FG005|Overall Study|Death|0|||
150098427|NCT02082210|541503522|FG000|Overall Study|Withdrawal by Subject|0|||
150098428|NCT02082210|541503523|FG001|Overall Study|Withdrawal by Subject|0|||
150098429|NCT02082210|541503524|FG002|Overall Study|Withdrawal by Subject|0|||
150098430|NCT02082210|541503525|FG003|Overall Study|Withdrawal by Subject|1|||
150098431|NCT02082210|541503526|FG004|Overall Study|Withdrawal by Subject|2|||
150098432|NCT02082210|541503527|FG005|Overall Study|Withdrawal by Subject|2|||
150098433|NCT02082210|541503522|FG000|Overall Study|Clinical Progression|0|||
150098434|NCT02082210|541503523|FG001|Overall Study|Clinical Progression|0|||
150098435|NCT02082210|541503524|FG002|Overall Study|Clinical Progression|0|||
150098436|NCT02082210|541503525|FG003|Overall Study|Clinical Progression|1|||
150098437|NCT02082210|541503526|FG004|Overall Study|Clinical Progression|0|||
150098438|NCT02082210|541503527|FG005|Overall Study|Clinical Progression|0|||
150098439|NCT02082210|541503522|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
150098440|NCT02082210|541503523|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
150098441|NCT02082210|541503524|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
150098442|NCT02082210|541503525|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
150098443|NCT02082210|541503526|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
150098444|NCT02082210|541503527|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
150098445|NCT02082210|541503522|FG000|Overall Study|Physician Decision|0|||
150098446|NCT02082210|541503523|FG001|Overall Study|Physician Decision|0|||
150098447|NCT02082210|541503524|FG002|Overall Study|Physician Decision|1|||
150098448|NCT02082210|541503525|FG003|Overall Study|Physician Decision|1|||
150098449|NCT02082210|541503526|FG004|Overall Study|Physician Decision|0|||
150098450|NCT02082210|541503527|FG005|Overall Study|Physician Decision|0|||
150098451|NCT04762680|541503528|FG000|Phase 2|Adverse Event|0|||
150098452|NCT04762680|541503529|FG001|Phase 2|Adverse Event|1|||
150098453|NCT04762680|541503530|FG002|Phase 2|Adverse Event|0|||
150098454|NCT04762680|541503531|FG003|Phase 2|Adverse Event|0|||
150098455|NCT04762680|541503532|FG004|Phase 2|Adverse Event|0|||
150098456|NCT04762680|541503533|FG005|Phase 2|Adverse Event|0|||
150098457|NCT04762680|541503534|FG006|Phase 2|Adverse Event|0|||
150098458|NCT04762680|541503535|FG007|Phase 2|Adverse Event|0|||
150098459|NCT04762680|541503536|FG008|Phase 2|Adverse Event|0|||
150098460|NCT04762680|541503537|FG009|Phase 2|Adverse Event|0|||
150098461|NCT04762680|541503538|FG010|Phase 2|Adverse Event|0|||
150098462|NCT04762680|541503539|FG011|Phase 2|Adverse Event|0|||
150098463|NCT04762680|541503540|FG012|Phase 2|Adverse Event|0|||
150098464|NCT04762680|541503541|FG013|Phase 2|Adverse Event|0|||
150098465|NCT04762680|541503542|FG014|Phase 2|Adverse Event|0|||
150098466|NCT04762680|541503543|FG015|Phase 2|Adverse Event|0|||
150098467|NCT04762680|541503544|FG016|Phase 2|Adverse Event|0|||
150098468|NCT04762680|541503545|FG017|Phase 2|Adverse Event|0|||
150098469|NCT04762680|541503546|FG018|Phase 2|Adverse Event|0|||
150098470|NCT04762680|541503547|FG019|Phase 2|Adverse Event|0|||
150098471|NCT04762680|541503548|FG020|Phase 2|Adverse Event|0|||
150098472|NCT04762680|541503549|FG021|Phase 2|Adverse Event|0|||
150098473|NCT04762680|541503528|FG000|Phase 2|Protocol Violation|5|||
150098474|NCT04762680|541503529|FG001|Phase 2|Protocol Violation|5|||
150098475|NCT04762680|541503530|FG002|Phase 2|Protocol Violation|1|||
150098476|NCT04762680|541503531|FG003|Phase 2|Protocol Violation|0|||
150098477|NCT04762680|541503532|FG004|Phase 2|Protocol Violation|0|||
150098478|NCT04762680|541503533|FG005|Phase 2|Protocol Violation|0|||
150098479|NCT04762680|541503534|FG006|Phase 2|Protocol Violation|0|||
150098480|NCT04762680|541503535|FG007|Phase 2|Protocol Violation|0|||
150098481|NCT04762680|541503536|FG008|Phase 2|Protocol Violation|0|||
150098482|NCT04762680|541503537|FG009|Phase 2|Protocol Violation|0|||
150098483|NCT04762680|541503538|FG010|Phase 2|Protocol Violation|0|||
150098484|NCT04762680|541503539|FG011|Phase 2|Protocol Violation|0|||
150098485|NCT04762680|541503540|FG012|Phase 2|Protocol Violation|0|||
150098486|NCT04762680|541503541|FG013|Phase 2|Protocol Violation|0|||
150098487|NCT04762680|541503542|FG014|Phase 2|Protocol Violation|0|||
150098488|NCT04762680|541503543|FG015|Phase 2|Protocol Violation|0|||
150098489|NCT04762680|541503544|FG016|Phase 2|Protocol Violation|0|||
150098490|NCT04762680|541503545|FG017|Phase 2|Protocol Violation|0|||
150098491|NCT04762680|541503546|FG018|Phase 2|Protocol Violation|0|||
150098492|NCT04762680|541503547|FG019|Phase 2|Protocol Violation|0|||
150098493|NCT04762680|541503548|FG020|Phase 2|Protocol Violation|0|||
150098494|NCT04762680|541503549|FG021|Phase 2|Protocol Violation|0|||
150098495|NCT04762680|541503528|FG000|Phase 2|Withdrawal by Subject|23|||
150098496|NCT04762680|541503529|FG001|Phase 2|Withdrawal by Subject|21|||
150098497|NCT04762680|541503530|FG002|Phase 2|Withdrawal by Subject|28|||
150098498|NCT04762680|541503531|FG003|Phase 2|Withdrawal by Subject|0|||
150098499|NCT04762680|541503532|FG004|Phase 2|Withdrawal by Subject|0|||
150098500|NCT04762680|541503533|FG005|Phase 2|Withdrawal by Subject|0|||
150098501|NCT04762680|541503534|FG006|Phase 2|Withdrawal by Subject|0|||
150098502|NCT04762680|541503535|FG007|Phase 2|Withdrawal by Subject|0|||
150098503|NCT04762680|541503536|FG008|Phase 2|Withdrawal by Subject|0|||
150098504|NCT04762680|541503537|FG009|Phase 2|Withdrawal by Subject|0|||
150098505|NCT04762680|541503538|FG010|Phase 2|Withdrawal by Subject|0|||
150098506|NCT04762680|541503539|FG011|Phase 2|Withdrawal by Subject|0|||
150098507|NCT04762680|541503540|FG012|Phase 2|Withdrawal by Subject|0|||
150098508|NCT04762680|541503541|FG013|Phase 2|Withdrawal by Subject|0|||
150098509|NCT04762680|541503542|FG014|Phase 2|Withdrawal by Subject|0|||
150098510|NCT04762680|541503543|FG015|Phase 2|Withdrawal by Subject|0|||
150098511|NCT04762680|541503544|FG016|Phase 2|Withdrawal by Subject|0|||
150098512|NCT04762680|541503545|FG017|Phase 2|Withdrawal by Subject|0|||
150098513|NCT04762680|541503546|FG018|Phase 2|Withdrawal by Subject|0|||
150098514|NCT04762680|541503547|FG019|Phase 2|Withdrawal by Subject|0|||
150098515|NCT04762680|541503548|FG020|Phase 2|Withdrawal by Subject|0|||
150098516|NCT04762680|541503549|FG021|Phase 2|Withdrawal by Subject|0|||
150098517|NCT04762680|541503528|FG000|Phase 2|Lost to Follow-up|14|||
150098518|NCT04762680|541503529|FG001|Phase 2|Lost to Follow-up|8|||
150098519|NCT04762680|541503530|FG002|Phase 2|Lost to Follow-up|9|||
150098520|NCT04762680|541503531|FG003|Phase 2|Lost to Follow-up|0|||
150098521|NCT04762680|541503532|FG004|Phase 2|Lost to Follow-up|0|||
150098522|NCT04762680|541503533|FG005|Phase 2|Lost to Follow-up|0|||
150098523|NCT04762680|541503534|FG006|Phase 2|Lost to Follow-up|0|||
150098524|NCT04762680|541503535|FG007|Phase 2|Lost to Follow-up|0|||
150098525|NCT04762680|541503536|FG008|Phase 2|Lost to Follow-up|0|||
150098526|NCT04762680|541503537|FG009|Phase 2|Lost to Follow-up|0|||
150098527|NCT04762680|541503538|FG010|Phase 2|Lost to Follow-up|0|||
150098528|NCT04762680|541503539|FG011|Phase 2|Lost to Follow-up|0|||
150098529|NCT04762680|541503540|FG012|Phase 2|Lost to Follow-up|0|||
150098530|NCT04762680|541503541|FG013|Phase 2|Lost to Follow-up|0|||
150098531|NCT04762680|541503542|FG014|Phase 2|Lost to Follow-up|0|||
150098532|NCT04762680|541503543|FG015|Phase 2|Lost to Follow-up|0|||
150098533|NCT04762680|541503544|FG016|Phase 2|Lost to Follow-up|0|||
150098534|NCT04762680|541503545|FG017|Phase 2|Lost to Follow-up|0|||
150098535|NCT04762680|541503546|FG018|Phase 2|Lost to Follow-up|0|||
150098536|NCT04762680|541503547|FG019|Phase 2|Lost to Follow-up|0|||
150098537|NCT04762680|541503548|FG020|Phase 2|Lost to Follow-up|0|||
150098538|NCT04762680|541503549|FG021|Phase 2|Lost to Follow-up|0|||
150098539|NCT04762680|541503528|FG000|Phase 3|Adverse Event|0|||
150098540|NCT04762680|541503529|FG001|Phase 3|Adverse Event|0|||
150098541|NCT04762680|541503530|FG002|Phase 3|Adverse Event|0|||
150098542|NCT04762680|541503531|FG003|Phase 3|Adverse Event|1|||
150098543|NCT04762680|541503532|FG004|Phase 3|Adverse Event|0|||
150098544|NCT04762680|541503533|FG005|Phase 3|Adverse Event|0|||
150098545|NCT04762680|541503534|FG006|Phase 3|Adverse Event|0|||
150098546|NCT04762680|541503535|FG007|Phase 3|Adverse Event|0|||
150098547|NCT04762680|541503536|FG008|Phase 3|Adverse Event|0|||
150098548|NCT04762680|541503537|FG009|Phase 3|Adverse Event|0|||
150098549|NCT04762680|541503538|FG010|Phase 3|Adverse Event|0|||
150098550|NCT04762680|541503539|FG011|Phase 3|Adverse Event|0|||
150098551|NCT04762680|541503540|FG012|Phase 3|Adverse Event|0|||
150098552|NCT04762680|541503541|FG013|Phase 3|Adverse Event|0|||
150098553|NCT04762680|541503542|FG014|Phase 3|Adverse Event|0|||
150098554|NCT04762680|541503543|FG015|Phase 3|Adverse Event|0|||
150098555|NCT04762680|541503544|FG016|Phase 3|Adverse Event|0|||
150098556|NCT04762680|541503545|FG017|Phase 3|Adverse Event|3|||
150098557|NCT04762680|541503546|FG018|Phase 3|Adverse Event|0|||
150098558|NCT04762680|541503547|FG019|Phase 3|Adverse Event|0|||
150098559|NCT04762680|541503548|FG020|Phase 3|Adverse Event|0|||
150098560|NCT04762680|541503549|FG021|Phase 3|Adverse Event|0|||
150098561|NCT04762680|541503528|FG000|Phase 3|Protocol Violation|0|||
150098562|NCT04762680|541503529|FG001|Phase 3|Protocol Violation|0|||
150098563|NCT04762680|541503530|FG002|Phase 3|Protocol Violation|0|||
150098564|NCT04762680|541503531|FG003|Phase 3|Protocol Violation|4|||
150098565|NCT04762680|541503532|FG004|Phase 3|Protocol Violation|1|||
150098566|NCT04762680|541503533|FG005|Phase 3|Protocol Violation|5|||
150098567|NCT04762680|541503534|FG006|Phase 3|Protocol Violation|1|||
150098568|NCT04762680|541503535|FG007|Phase 3|Protocol Violation|0|||
150098569|NCT04762680|541503536|FG008|Phase 3|Protocol Violation|0|||
150098570|NCT04762680|541503537|FG009|Phase 3|Protocol Violation|0|||
150098571|NCT04762680|541503538|FG010|Phase 3|Protocol Violation|0|||
150098572|NCT04762680|541503539|FG011|Phase 3|Protocol Violation|2|||
150098573|NCT04762680|541503540|FG012|Phase 3|Protocol Violation|3|||
150098574|NCT04762680|541503541|FG013|Phase 3|Protocol Violation|0|||
150098575|NCT04762680|541503542|FG014|Phase 3|Protocol Violation|0|||
150098576|NCT04762680|541503543|FG015|Phase 3|Protocol Violation|1|||
150098577|NCT04762680|541503544|FG016|Phase 3|Protocol Violation|0|||
150098578|NCT04762680|541503545|FG017|Phase 3|Protocol Violation|10|||
150098579|NCT04762680|541503546|FG018|Phase 3|Protocol Violation|0|||
150098580|NCT04762680|541503547|FG019|Phase 3|Protocol Violation|0|||
150098581|NCT04762680|541503548|FG020|Phase 3|Protocol Violation|0|||
150098582|NCT04762680|541503549|FG021|Phase 3|Protocol Violation|0|||
150098583|NCT04762680|541503528|FG000|Phase 3|Withdrawal by Subject|0|||
150098584|NCT04762680|541503529|FG001|Phase 3|Withdrawal by Subject|0|||
150098585|NCT04762680|541503530|FG002|Phase 3|Withdrawal by Subject|0|||
150098586|NCT04762680|541503531|FG003|Phase 3|Withdrawal by Subject|13|||
150098587|NCT04762680|541503532|FG004|Phase 3|Withdrawal by Subject|17|||
150098588|NCT04762680|541503533|FG005|Phase 3|Withdrawal by Subject|12|||
150098589|NCT04762680|541503534|FG006|Phase 3|Withdrawal by Subject|8|||
150098590|NCT04762680|541503535|FG007|Phase 3|Withdrawal by Subject|3|||
150098591|NCT04762680|541503536|FG008|Phase 3|Withdrawal by Subject|2|||
150098592|NCT04762680|541503537|FG009|Phase 3|Withdrawal by Subject|4|||
150098593|NCT04762680|541503538|FG010|Phase 3|Withdrawal by Subject|3|||
150098594|NCT04762680|541503539|FG011|Phase 3|Withdrawal by Subject|1|||
150098595|NCT04762680|541503540|FG012|Phase 3|Withdrawal by Subject|3|||
150098596|NCT04762680|541503541|FG013|Phase 3|Withdrawal by Subject|2|||
150098597|NCT04762680|541503542|FG014|Phase 3|Withdrawal by Subject|1|||
150098598|NCT04762680|541503543|FG015|Phase 3|Withdrawal by Subject|4|||
150098599|NCT04762680|541503544|FG016|Phase 3|Withdrawal by Subject|6|||
150098600|NCT04762680|541503545|FG017|Phase 3|Withdrawal by Subject|32|||
150098601|NCT04762680|541503546|FG018|Phase 3|Withdrawal by Subject|0|||
150098602|NCT04762680|541503547|FG019|Phase 3|Withdrawal by Subject|0|||
150098603|NCT04762680|541503548|FG020|Phase 3|Withdrawal by Subject|0|||
150098604|NCT04762680|541503549|FG021|Phase 3|Withdrawal by Subject|0|||
150098605|NCT04762680|541503528|FG000|Phase 3|Lost to Follow-up|0|||
150098606|NCT04762680|541503529|FG001|Phase 3|Lost to Follow-up|0|||
150098607|NCT04762680|541503530|FG002|Phase 3|Lost to Follow-up|0|||
150098608|NCT04762680|541503531|FG003|Phase 3|Lost to Follow-up|9|||
150098609|NCT04762680|541503532|FG004|Phase 3|Lost to Follow-up|22|||
150098610|NCT04762680|541503533|FG005|Phase 3|Lost to Follow-up|24|||
150098611|NCT04762680|541503534|FG006|Phase 3|Lost to Follow-up|2|||
150098612|NCT04762680|541503535|FG007|Phase 3|Lost to Follow-up|4|||
150098613|NCT04762680|541503536|FG008|Phase 3|Lost to Follow-up|6|||
150098614|NCT04762680|541503537|FG009|Phase 3|Lost to Follow-up|4|||
150098615|NCT04762680|541503538|FG010|Phase 3|Lost to Follow-up|3|||
150098616|NCT04762680|541503539|FG011|Phase 3|Lost to Follow-up|0|||
150098617|NCT04762680|541503540|FG012|Phase 3|Lost to Follow-up|5|||
150098618|NCT04762680|541503541|FG013|Phase 3|Lost to Follow-up|4|||
150098619|NCT04762680|541503542|FG014|Phase 3|Lost to Follow-up|6|||
150098620|NCT04762680|541503543|FG015|Phase 3|Lost to Follow-up|1|||
150098621|NCT04762680|541503544|FG016|Phase 3|Lost to Follow-up|1|||
150098622|NCT04762680|541503545|FG017|Phase 3|Lost to Follow-up|66|||
150098623|NCT04762680|541503546|FG018|Phase 3|Lost to Follow-up|0|||
150098624|NCT04762680|541503547|FG019|Phase 3|Lost to Follow-up|0|||
150098625|NCT04762680|541503548|FG020|Phase 3|Lost to Follow-up|0|||
150098626|NCT04762680|541503549|FG021|Phase 3|Lost to Follow-up|0|||
150098627|NCT04762680|541503528|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098628|NCT04762680|541503529|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098629|NCT04762680|541503530|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098630|NCT04762680|541503531|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098631|NCT04762680|541503532|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098632|NCT04762680|541503533|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098633|NCT04762680|541503534|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098634|NCT04762680|541503535|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098635|NCT04762680|541503536|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098636|NCT04762680|541503537|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098637|NCT04762680|541503538|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098638|NCT04762680|541503539|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098639|NCT04762680|541503540|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098640|NCT04762680|541503541|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098641|NCT04762680|541503542|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098642|NCT04762680|541503543|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098643|NCT04762680|541503544|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098644|NCT04762680|541503545|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098645|NCT04762680|541503546|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098646|NCT04762680|541503547|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098647|NCT04762680|541503548|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
150098648|NCT04762680|541503549|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
150098649|NCT04762680|541503528|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098650|NCT04762680|541503529|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098651|NCT04762680|541503530|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098652|NCT04762680|541503531|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098653|NCT04762680|541503532|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098654|NCT04762680|541503533|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098655|NCT04762680|541503534|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098656|NCT04762680|541503535|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098657|NCT04762680|541503536|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098658|NCT04762680|541503537|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098659|NCT04762680|541503538|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098660|NCT04762680|541503539|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098661|NCT04762680|541503540|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098662|NCT04762680|541503541|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098663|NCT04762680|541503542|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098664|NCT04762680|541503543|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098665|NCT04762680|541503544|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098666|NCT04762680|541503545|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098667|NCT04762680|541503546|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098668|NCT04762680|541503547|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
150098669|NCT04762680|541503548|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098670|NCT04762680|541503549|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
150098671|NCT04307446|541503556|FG000|Overall Study|Lost to Follow-up|2|||
150098672|NCT04307446|541503557|FG001|Overall Study|Lost to Follow-up|0|||
150098673|NCT01727141|541503561|FG000|Overall Study|Physician Decision|0|||
150098674|NCT01727141|541503562|FG001|Overall Study|Physician Decision|1|||
150098675|NCT01727141|541503563|FG002|Overall Study|Physician Decision|0|||
150098676|NCT01727141|541503564|FG003|Overall Study|Physician Decision|2|||
150098677|NCT01727141|541503561|FG000|Overall Study|Lost to Follow-up|0|||
150098678|NCT01727141|541503562|FG001|Overall Study|Lost to Follow-up|2|||
150098679|NCT01727141|541503563|FG002|Overall Study|Lost to Follow-up|0|||
150098680|NCT01727141|541503564|FG003|Overall Study|Lost to Follow-up|0|||
150098681|NCT01727141|541503561|FG000|Overall Study|Death|0|||
150098682|NCT01727141|541503562|FG001|Overall Study|Death|1|||
150098683|NCT01727141|541503563|FG002|Overall Study|Death|1|||
150098684|NCT01727141|541503564|FG003|Overall Study|Death|1|||
150098685|NCT01727141|541503561|FG000|Overall Study|Protocol deviation|1|||
150098686|NCT01727141|541503562|FG001|Overall Study|Protocol deviation|1|||
150098687|NCT01727141|541503563|FG002|Overall Study|Protocol deviation|0|||
150098688|NCT01727141|541503564|FG003|Overall Study|Protocol deviation|1|||
150098689|NCT01727141|541503561|FG000|Overall Study|Withdrawal by Subject|4|||
150098690|NCT01727141|541503562|FG001|Overall Study|Withdrawal by Subject|4|||
150098691|NCT01727141|541503563|FG002|Overall Study|Withdrawal by Subject|2|||
150098692|NCT01727141|541503564|FG003|Overall Study|Withdrawal by Subject|11|||
150098693|NCT03538158|541503565|FG000|Overall Study|Lost to Follow-up|13|||
150098694|NCT03538158|541503566|FG001|Overall Study|Lost to Follow-up|7|||
150098695|NCT03538158|541503565|FG000|Overall Study|Withdrawal by Subject|2|||
150098696|NCT03538158|541503566|FG001|Overall Study|Withdrawal by Subject|1|||
150098697|NCT03425331|541503567|FG000|Overall Study|Withdrawal by Subject|1|||
150098698|NCT03425331|541503567|FG000|Overall Study|Death|1|||
150098699|NCT03425331|541503567|FG000|Overall Study|Adverse Event|1|||
150098700|NCT03425331|541503567|FG000|Overall Study|Disease Progression|2|||
150098701|NCT01413360|541503570|FG000|Overall Study|Lost to Follow-up|2|||
150098702|NCT01413360|541503570|FG000|Overall Study|Adverse Event|1|||
150098703|NCT02246673|541503571|FG000|Overall Study|Sponsor Decision|1|||
150098704|NCT02246673|541503572|FG001|Overall Study|Sponsor Decision|0|||
150098705|NCT02246673|541503573|FG002|Overall Study|Sponsor Decision|0|||
150098706|NCT02246673|541503574|FG003|Overall Study|Sponsor Decision|0|||
150098707|NCT02246673|541503575|FG004|Overall Study|Sponsor Decision|0|||
150098708|NCT02246673|541503571|FG000|Overall Study|Withdrawal by Subject|0|||
150098709|NCT02246673|541503572|FG001|Overall Study|Withdrawal by Subject|0|||
150098710|NCT02246673|541503573|FG002|Overall Study|Withdrawal by Subject|0|||
150098711|NCT02246673|541503574|FG003|Overall Study|Withdrawal by Subject|0|||
150098712|NCT02246673|541503575|FG004|Overall Study|Withdrawal by Subject|1|||
150098713|NCT02246673|541503571|FG000|Overall Study|Lost to Follow-up|0|||
150098714|NCT02246673|541503572|FG001|Overall Study|Lost to Follow-up|0|||
150098715|NCT02246673|541503573|FG002|Overall Study|Lost to Follow-up|0|||
150098716|NCT02246673|541503574|FG003|Overall Study|Lost to Follow-up|1|||
150098717|NCT02246673|541503575|FG004|Overall Study|Lost to Follow-up|0|||
150098718|NCT02246673|541503571|FG000|Overall Study|Protocol Violation|0|||
150098719|NCT02246673|541503572|FG001|Overall Study|Protocol Violation|0|||
150098720|NCT02246673|541503573|FG002|Overall Study|Protocol Violation|0|||
150098721|NCT02246673|541503574|FG003|Overall Study|Protocol Violation|1|||
150098722|NCT02246673|541503575|FG004|Overall Study|Protocol Violation|0|||
150098723|NCT02418468|541503576|FG000|Overall Study|Adverse Event|1|||
150098724|NCT02418468|541503577|FG001|Overall Study|Adverse Event|0|||
150098725|NCT02418468|541503576|FG000|Overall Study|Withdrawal of informed consent|1|||
150098726|NCT02418468|541503577|FG001|Overall Study|Withdrawal of informed consent|1|||
150098727|NCT02914769|541503578|FG000|Overall Study|Protocol Violation|3|||
150098728|NCT02914769|541503579|FG001|Overall Study|Protocol Violation|2|||
150098729|NCT02914769|541503578|FG000|Overall Study|Withdrawal by Subject|0|||
150098730|NCT02914769|541503579|FG001|Overall Study|Withdrawal by Subject|1|||
150098731|NCT04356963|541503580|FG000|First Session|Withdrawal by Subject|1|||
150098732|NCT04356963|541503580|FG000|Second Session|Withdrawal by Subject|3|||
150098733|NCT04356963|541503580|FG000|Second Session|Lost to Follow-up|1|||
150098734|NCT04356963|541503580|FG000|Third Session|Lost to Follow-up|6|||
150098735|NCT04356963|541503580|FG000|Third Session|Withdrawal by Subject|1|||
150098736|NCT00791518|541503582|FG000|Overall Study|Protocol Violation|93|||
150098737|NCT02488681|541503583|FG000|Overall Study|Implant unsuccessful|7|||
150098738|NCT00720057|541503585|FG000|Overall Study|Lost to Follow-up|0|||
150098739|NCT00720057|541503586|FG001|Overall Study|Lost to Follow-up|2|||
150098740|NCT00720057|541503585|FG000|Overall Study|Protocol Violation|1|||
150098741|NCT00720057|541503586|FG001|Overall Study|Protocol Violation|0|||
150098742|NCT00720057|541503585|FG000|Overall Study|Withdrawal by Subject|0|||
150098743|NCT00720057|541503586|FG001|Overall Study|Withdrawal by Subject|1|||
150098744|NCT04969224|541503589|FG000|Overall Study|Adverse Event|1|||
150098745|NCT04969224|541503589|FG000|Overall Study|Enrolled but never dosed|1|||
150098746|NCT01498952|541503590|FG000|Overall Study|Death|2|||
150098747|NCT01498952|541503591|FG001|Overall Study|Death|2|||
150098748|NCT01498952|541503592|FG002|Overall Study|Death|0|||
150098749|NCT01498952|541503593|FG003|Overall Study|Death|0|||
150098750|NCT01498952|541503594|FG004|Overall Study|Death|0|||
150098751|NCT02726074|541503595|FG000|Overall Study|Withdrawal by Subject|4|||
150098752|NCT02726074|541503595|FG000|Overall Study|Adverse Event|14|||
150185211|NCT06066541|541817076|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
150185212|NCT06066541|541817077|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
150185213|NCT06066541|541817078|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
150185214|NCT06066541|541817079|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
150185215|NCT06066541|541817080|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
150185216|NCT06066541|541817074|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
150185217|NCT06066541|541817075|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
150185218|NCT06066541|541817076|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
150185219|NCT06066541|541817077|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
150185220|NCT06066541|541817078|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
150185221|NCT06066541|541817079|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
150185222|NCT06066541|541817080|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
150185223|NCT04533022|541817081|FG000|Overall Study|Withdrawal by Subject|15|||
150185224|NCT04533022|541817081|FG000|Overall Study|Adverse Event|6|||
150185225|NCT04533022|541817081|FG000|Overall Study|Death|1|||
150185226|NCT04533022|541817081|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
150185227|NCT04533022|541817081|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
150185228|NCT02163447|541817082|FG000|Overall Study|Withdrawal by Subject|2|||
150185229|NCT02163447|541817083|FG001|Overall Study|Withdrawal by Subject|0|||
150185230|NCT02163447|541817084|FG002|Overall Study|Withdrawal by Subject|1|||
150185231|NCT02163447|541817082|FG000|Overall Study|Lost to Follow-up|1|||
150185232|NCT02163447|541817083|FG001|Overall Study|Lost to Follow-up|3|||
150185233|NCT02163447|541817084|FG002|Overall Study|Lost to Follow-up|0|||
150185234|NCT02163447|541817082|FG000|Overall Study|Moved out of study area|2|||
150185235|NCT02163447|541817083|FG001|Overall Study|Moved out of study area|3|||
150185236|NCT02163447|541817084|FG002|Overall Study|Moved out of study area|2|||
150185237|NCT02163447|541817082|FG000|Overall Study|Became HIV infected at time of delivery|1|||
150185238|NCT02163447|541817083|FG001|Overall Study|Became HIV infected at time of delivery|0|||
150185239|NCT02163447|541817084|FG002|Overall Study|Became HIV infected at time of delivery|0|||
150185240|NCT05415436|541817086|FG000|Overall Study|Surgeon cancelled procedure|1|||
150185241|NCT05415436|541817087|FG001|Overall Study|Surgeon cancelled procedure|0|||
150185242|NCT05415436|541817086|FG000|Overall Study|Death|1|||
150185243|NCT05415436|541817087|FG001|Overall Study|Death|0|||
150185244|NCT03157167|541817090|FG000|Overall Study|Withdrawal by Subject|1|||
150185245|NCT03157167|541817091|FG001|Overall Study|Withdrawal by Subject|0|||
150098753|NCT02726074|541503595|FG000|Overall Study|Protocol Violation|3|||
150098754|NCT02726074|541503595|FG000|Overall Study|Lost to Follow-up|2|||
150098755|NCT02726074|541503595|FG000|Overall Study|Others|3|||
150098756|NCT00579826|541503596|FG000|Overall Study|Withdrawal by Subject|5|||
150098757|NCT00579826|541503597|FG001|Overall Study|Withdrawal by Subject|3|||
150098758|NCT02009046|541503598|FG000|Overall Study|Lost to Follow-up|256|||
150098759|NCT02009046|541503599|FG001|Overall Study|Lost to Follow-up|206|||
150185246|NCT03157167|541817092|FG002|Overall Study|Withdrawal by Subject|0|||
150098760|NCT01170091|541503600|FG000|Overall Study|Missing efficacy evaluation|3|||
150185247|NCT03484702|541817096|FG000|Treatment Period|Death|3|||
150098761|NCT01170091|541503600|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
150098762|NCT03194321|541503601|FG000|Overall Study|Withdrawal by Subject|1|||
150098763|NCT03194321|541503601|FG000|Overall Study|Lost to Follow-up|1|||
150098764|NCT03194321|541503601|FG000|Overall Study|Travel for Follow-up|1|||
150098765|NCT00643682|541503602|FG000|Overall Study|did not keep appointment|522|||
150098766|NCT00643682|541503603|FG001|Overall Study|did not keep appointment|509|||
150098767|NCT03755414|541503605|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
150098768|NCT03755414|541503606|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
150098769|NCT03755414|541503607|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
150098770|NCT03755414|541503605|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
150098771|NCT03755414|541503606|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
150098772|NCT03755414|541503607|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
150098773|NCT03755414|541503605|FG000|Overall Study|Non-compliance|0|||
150098774|NCT03755414|541503606|FG001|Overall Study|Non-compliance|1|||
150098775|NCT03755414|541503607|FG002|Overall Study|Non-compliance|0|||
150098776|NCT02865915|541503612|FG000|Overall Study|Pregnancy|1|||
150098777|NCT02865915|541503613|FG001|Overall Study|Pregnancy|0|||
150098778|NCT02865915|541503612|FG000|Overall Study|Withdrawal by Subject|1|||
150098779|NCT02865915|541503613|FG001|Overall Study|Withdrawal by Subject|1|||
150098780|NCT02865915|541503612|FG000|Overall Study|Adverse Event|0|||
150098781|NCT02865915|541503613|FG001|Overall Study|Adverse Event|4|||
150098782|NCT02865915|541503612|FG000|Overall Study|Lost to Follow-up|0|||
150098783|NCT02865915|541503613|FG001|Overall Study|Lost to Follow-up|1|||
150098784|NCT02865915|541503612|FG000|Overall Study|Protocol Violation|0|||
150098785|NCT02865915|541503613|FG001|Overall Study|Protocol Violation|1|||
150185248|NCT03484702|541817097|FG001|Treatment Period|Death|1|||
150185249|NCT03484702|541817098|FG002|Treatment Period|Death|0|||
150185250|NCT03484702|541817099|FG003|Treatment Period|Death|0|||
150185251|NCT03484702|541817100|FG004|Treatment Period|Death|0|||
150185252|NCT03484702|541817101|FG005|Treatment Period|Death|0|||
150185253|NCT03484702|541817096|FG000|Treatment Period|Adverse Event|1|||
150185254|NCT03484702|541817097|FG001|Treatment Period|Adverse Event|0|||
150185255|NCT03484702|541817098|FG002|Treatment Period|Adverse Event|0|||
150185256|NCT03484702|541817099|FG003|Treatment Period|Adverse Event|0|||
150185257|NCT03484702|541817100|FG004|Treatment Period|Adverse Event|0|||
150185258|NCT03484702|541817101|FG005|Treatment Period|Adverse Event|0|||
150185259|NCT03484702|541817096|FG000|Treatment Period|Participant Withdrew from Study|0|||
150185260|NCT03484702|541817097|FG001|Treatment Period|Participant Withdrew from Study|1|||
150185261|NCT03484702|541817098|FG002|Treatment Period|Participant Withdrew from Study|0|||
150185262|NCT03484702|541817099|FG003|Treatment Period|Participant Withdrew from Study|0|||
150185263|NCT03484702|541817100|FG004|Treatment Period|Participant Withdrew from Study|0|||
150185264|NCT03484702|541817101|FG005|Treatment Period|Participant Withdrew from Study|0|||
150185265|NCT03484702|541817096|FG000|Treatment Period|Physician Decision|0|||
150185266|NCT03484702|541817097|FG001|Treatment Period|Physician Decision|1|||
150185267|NCT03484702|541817098|FG002|Treatment Period|Physician Decision|0|||
150185268|NCT03484702|541817099|FG003|Treatment Period|Physician Decision|0|||
150185269|NCT03484702|541817100|FG004|Treatment Period|Physician Decision|0|||
150185270|NCT03484702|541817101|FG005|Treatment Period|Physician Decision|1|||
150185271|NCT02630823|541817103|FG000|Overall Study|Withdrawal by Subject|1|||
150185272|NCT02630823|541817103|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
150185273|NCT02287311|541817105|FG000|Cohort 1: Dose Level 1|Death|2|||
150185274|NCT02287311|541817106|FG001|Cohort 1: Dose Level 1|Death|0|||
150185275|NCT02287311|541817107|FG002|Cohort 1: Dose Level 1|Death|0|||
150185276|NCT02287311|541817108|FG003|Cohort 1: Dose Level 1|Death|3|||
150185277|NCT02287311|541817109|FG004|Cohort 1: Dose Level 1|Death|0|||
150185278|NCT02287311|541817110|FG005|Cohort 1: Dose Level 1|Death|0|||
150185279|NCT02287311|541817111|FG006|Cohort 1: Dose Level 1|Death|1|||
150185280|NCT02287311|541817112|FG007|Cohort 1: Dose Level 1|Death|0|||
150185281|NCT02287311|541817113|FG008|Cohort 1: Dose Level 1|Death|0|||
150098786|NCT02865915|541503612|FG000|Overall Study|Study terminated by sponsor|23|||
150098787|NCT02865915|541503613|FG001|Overall Study|Study terminated by sponsor|18|||
150098788|NCT02865915|541503612|FG000|Overall Study|Dosing group discontinued|0|||
150098789|NCT02865915|541503613|FG001|Overall Study|Dosing group discontinued|5|||
150098790|NCT05497284|541503616|FG000|Overall Study|Adverse Event|1|||
150098791|NCT05497284|541503617|FG001|Overall Study|Adverse Event|0|||
150098792|NCT05497284|541503616|FG000|Overall Study|Physician Decision|0|||
150185282|NCT02287311|541817105|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150185283|NCT02287311|541817106|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150185284|NCT02287311|541817107|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150185285|NCT02287311|541817108|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
150185286|NCT02287311|541817109|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150185287|NCT02287311|541817110|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150098793|NCT05497284|541503617|FG001|Overall Study|Physician Decision|1|||
150098794|NCT05497284|541503616|FG000|Overall Study|Study terminated by sponsor|7|||
150098795|NCT05497284|541503617|FG001|Overall Study|Study terminated by sponsor|4|||
150098796|NCT05497284|541503616|FG000|Overall Study|Subject Decision|0|||
150098797|NCT05497284|541503617|FG001|Overall Study|Subject Decision|1|||
150098798|NCT05760300|541503618|FG000|Overall Study|Adverse Event|0|||
150098799|NCT05760300|541503619|FG001|Overall Study|Adverse Event|0|||
150098800|NCT05760300|541503620|FG002|Overall Study|Adverse Event|1|||
150098801|NCT05760300|541503621|FG003|Overall Study|Adverse Event|0|||
150098802|NCT05760300|541503618|FG000|Overall Study|Participant Decision|1|||
150098803|NCT05760300|541503619|FG001|Overall Study|Participant Decision|0|||
150098804|NCT05760300|541503620|FG002|Overall Study|Participant Decision|0|||
150098805|NCT05760300|541503621|FG003|Overall Study|Participant Decision|0|||
150185288|NCT02287311|541817111|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
150185289|NCT02287311|541817112|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150185290|NCT02287311|541817113|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
150098806|NCT03878446|541503625|FG000|Overall Study|Withdrawn by parent or guardian|1|||
150098807|NCT03878446|541503626|FG001|Overall Study|Withdrawn by parent or guardian|0|||
150098808|NCT03878446|541503627|FG002|Overall Study|Withdrawn by parent or guardian|0|||
150098809|NCT03878446|541503628|FG003|Overall Study|Withdrawn by parent or guardian|0|||
150098810|NCT03878446|541503629|FG004|Overall Study|Withdrawn by parent or guardian|0|||
150098811|NCT03615105|541503632|FG000|Overall Study|Protocol Violation|1|||
150098812|NCT03615105|541503633|FG001|Overall Study|Protocol Violation|0|||
150098813|NCT03615105|541503634|FG002|Overall Study|Protocol Violation|0|||
150098814|NCT03615105|541503632|FG000|Overall Study|Death|0|||
150098815|NCT03615105|541503633|FG001|Overall Study|Death|2|||
150098816|NCT03615105|541503634|FG002|Overall Study|Death|0|||
150098817|NCT05041322|541503635|FG000|Baseline|Withdrawal by Subject|1|||
150098818|NCT05041322|541503636|FG001|Baseline|Withdrawal by Subject|0|||
150098819|NCT05041322|541503635|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
150098820|NCT05041322|541503636|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
150098821|NCT05041322|541503635|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
150098822|NCT05041322|541503636|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
150098823|NCT03313804|541503637|FG000|Treatment|Death|5|||
150098824|NCT03313804|541503637|FG000|Treatment|still on treatment|2|||
150098825|NCT03313804|541503637|FG000|Follow Up|still on follow up|3|||
150098826|NCT01502423|541503638|FG000|Overall Study|Withdrawal by Subject|0|||
150098827|NCT01502423|541503639|FG001|Overall Study|Withdrawal by Subject|1|||
150098828|NCT00567892|541503640|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
150098829|NCT00567892|541503641|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
150098830|NCT00567892|541503642|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
150098831|NCT00567892|541503643|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
150098832|NCT00567892|541503640|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
150098833|NCT00567892|541503641|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
150098834|NCT00567892|541503642|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
150098835|NCT00567892|541503643|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
150098836|NCT04814433|541503644|FG000|Overall Study|Survey not returned|4|||
150098837|NCT04814433|541503645|FG001|Overall Study|Survey not returned|8|||
150098838|NCT04814433|541503646|FG002|Overall Study|Survey not returned|4|||
150098839|NCT04814433|541503647|FG003|Overall Study|Survey not returned|5|||
150098840|NCT02967692|541505305|FG000|Overall Study|Progressive disease|3|||
150098841|NCT02967692|541505306|FG001|Overall Study|Progressive disease|15|||
150098842|NCT02967692|541505307|FG002|Overall Study|Progressive disease|114|||
150098843|NCT02967692|541505308|FG003|Overall Study|Progressive disease|151|||
150098844|NCT02967692|541505305|FG000|Overall Study|Subject/guardian decision|1|||
150098845|NCT02967692|541505306|FG001|Overall Study|Subject/guardian decision|1|||
150098846|NCT02967692|541505307|FG002|Overall Study|Subject/guardian decision|14|||
150098847|NCT02967692|541505308|FG003|Overall Study|Subject/guardian decision|22|||
150098848|NCT02967692|541505305|FG000|Overall Study|Death|0|||
150098849|NCT02967692|541505306|FG001|Overall Study|Death|1|||
150098850|NCT02967692|541505307|FG002|Overall Study|Death|13|||
150098851|NCT02967692|541505308|FG003|Overall Study|Death|13|||
150098852|NCT02967692|541505305|FG000|Overall Study|Protocol deviation|1|||
150098853|NCT02967692|541505306|FG001|Overall Study|Protocol deviation|0|||
150098854|NCT02967692|541505307|FG002|Overall Study|Protocol deviation|1|||
150098855|NCT02967692|541505308|FG003|Overall Study|Protocol deviation|1|||
150098856|NCT02967692|541505305|FG000|Overall Study|Lost to Follow-up|0|||
150098857|NCT02967692|541505306|FG001|Overall Study|Lost to Follow-up|0|||
150098858|NCT02967692|541505307|FG002|Overall Study|Lost to Follow-up|1|||
150098859|NCT02967692|541505308|FG003|Overall Study|Lost to Follow-up|0|||
150098860|NCT02967692|541505305|FG000|Overall Study|Physician Decision|0|||
150098861|NCT02967692|541505306|FG001|Overall Study|Physician Decision|0|||
150098862|NCT02967692|541505307|FG002|Overall Study|Physician Decision|22|||
150098863|NCT02967692|541505308|FG003|Overall Study|Physician Decision|13|||
150098864|NCT02967692|541505305|FG000|Overall Study|Adverse Event|2|||
150098865|NCT02967692|541505306|FG001|Overall Study|Adverse Event|9|||
150098866|NCT02967692|541505307|FG002|Overall Study|Adverse Event|60|||
150098867|NCT02967692|541505308|FG003|Overall Study|Adverse Event|28|||
150098868|NCT02967692|541505305|FG000|Overall Study|Study terminated by sponsor|2|||
150098869|NCT02967692|541505306|FG001|Overall Study|Study terminated by sponsor|1|||
150098870|NCT02967692|541505307|FG002|Overall Study|Study terminated by sponsor|42|||
150098871|NCT02967692|541505308|FG003|Overall Study|Study terminated by sponsor|37|||
150098872|NCT00066066|541505309|FG000|Overall Study|Lost to Follow-up|6|||
150098873|NCT00066066|541505310|FG001|Overall Study|Lost to Follow-up|4|||
150098874|NCT00066066|541505311|FG002|Overall Study|Lost to Follow-up|7|||
150098875|NCT00066066|541505312|FG003|Overall Study|Lost to Follow-up|4|||
150098876|NCT00066066|541505313|FG004|Overall Study|Lost to Follow-up|3|||
150098877|NCT00066066|541505314|FG005|Overall Study|Lost to Follow-up|5|||
150098878|NCT01063764|541505315|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
150098879|NCT01063764|541505315|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
150098880|NCT01063764|541505315|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
150098881|NCT01063764|541505315|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
150098882|NCT01063764|541505315|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
150098883|NCT01063764|541505315|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
150098884|NCT01063764|541505315|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
150098885|NCT00697515|541505316|FG000|Dose Optimization Period|Adverse Event|4|||
150098886|NCT00697515|541505317|FG001|Dose Optimization Period|Adverse Event|0|||
150098887|NCT00697515|541505316|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
150098888|NCT00697515|541505317|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
150098889|NCT00697515|541505316|FG000|Dose Optimization Period|Lost to Follow-up|2|||
150098890|NCT00697515|541505317|FG001|Dose Optimization Period|Lost to Follow-up|0|||
150098891|NCT00697515|541505316|FG000|Dose Optimization Period|sponsor request|2|||
150098892|NCT00697515|541505317|FG001|Dose Optimization Period|sponsor request|0|||
150098893|NCT00697515|541505316|FG000|Dose Optimization Period|called to active duty|1|||
150098894|NCT00697515|541505317|FG001|Dose Optimization Period|called to active duty|0|||
150098895|NCT00697515|541505316|FG000|Dose Optimization Period|elevated QTc|1|||
150098896|NCT00697515|541505317|FG001|Dose Optimization Period|elevated QTc|0|||
150098897|NCT00697515|541505316|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
150098898|NCT00697515|541505317|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
150098899|NCT00697515|541505316|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
150098900|NCT00697515|541505317|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
150098901|NCT00697515|541505316|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
150098902|NCT00697515|541505317|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
150098903|NCT00697515|541505316|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
150098904|NCT00697515|541505317|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
150098905|NCT02759120|541505322|FG000|Overall Study|Death|34|||
150098906|NCT02759120|541505323|FG001|Overall Study|Death|36|||
150098907|NCT02759120|541505322|FG000|Overall Study|Lost to Follow-up|4|||
150098908|NCT02759120|541505323|FG001|Overall Study|Lost to Follow-up|7|||
150098909|NCT02759120|541505322|FG000|Overall Study|Physician Decision|3|||
150098910|NCT02759120|541505323|FG001|Overall Study|Physician Decision|0|||
150098911|NCT02759120|541505322|FG000|Overall Study|Withdrawal by Subject|28|||
150098912|NCT02759120|541505323|FG001|Overall Study|Withdrawal by Subject|15|||
150098913|NCT02759120|541505322|FG000|Overall Study|Moved out of area|3|||
150098914|NCT02759120|541505323|FG001|Overall Study|Moved out of area|4|||
150098915|NCT02759120|541505322|FG000|Overall Study|Lung transplant|3|||
150098916|NCT02759120|541505323|FG001|Overall Study|Lung transplant|5|||
150098917|NCT02759120|541505322|FG000|Overall Study|Other reason not completed|10|||
150098918|NCT02759120|541505323|FG001|Overall Study|Other reason not completed|12|||
150098919|NCT02255981|541505327|FG000|Overall Study|Lost to Follow-up|3|||
150098920|NCT02255981|541505327|FG000|Overall Study|Withdrawal by Subject|1|||
150098921|NCT01454570|541505334|FG000|Overall Study|Withdrawal by Subject|2|||
150098922|NCT01454570|541505334|FG000|Overall Study|Screen Failure|7|||
150098923|NCT00949325|541505335|FG000|Overall Study|Adverse Event|0|||
150098924|NCT00949325|541505336|FG001|Overall Study|Adverse Event|2|||
150098925|NCT00949325|541505337|FG002|Overall Study|Adverse Event|0|||
150098926|NCT05533632|541505338|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
150098927|NCT05533632|541505338|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
150098928|NCT05533632|541505338|FG000|Overall Study|Lost to Follow-up|1|||
150098929|NCT05533632|541505338|FG000|Overall Study|Withdrawal by Subject|4|||
150098930|NCT05533632|541505338|FG000|Overall Study|Adverse Event|4|||
150098931|NCT03054870|541505342|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
150098932|NCT03054870|541505342|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
150098933|NCT00304356|541505344|FG000|Nitazoxanide|Physician Decision|5|||
150098934|NCT00304356|541505344|FG000|Nitazoxanide|Physician Decision|1|||
150098935|NCT00304356|541505344|FG000|Nitazoxanide|number is 0|1|||
150098936|NCT00304356|541505344|FG000|Nitazoxanide|Physician Decision|1|||
150098937|NCT00304356|541505344|FG000|Nitazoxanide|Physician Decision|1|||
150098938|NCT00304356|541505344|FG000|Nitazoxanide|Physician Decision|1|||
150098939|NCT04120974|541505348|FG000|Overall Study|Death|1|||
150098940|NCT04120974|541505348|FG000|Overall Study|Physician Decision|1|||
150098941|NCT04120974|541505348|FG000|Overall Study|Lost to Follow-up|6|||
150098942|NCT00973479|541505351|FG000|Overall Study|Lost to Follow-up|0|||
150098943|NCT00973479|541505352|FG001|Overall Study|Lost to Follow-up|3|||
150098944|NCT00973479|541505351|FG000|Overall Study|Death|2|||
150098945|NCT00973479|541505352|FG001|Overall Study|Death|2|||
150098946|NCT00973479|541505351|FG000|Overall Study|Withdrawal by Subject|15|||
150098947|NCT00973479|541505352|FG001|Overall Study|Withdrawal by Subject|16|||
150098948|NCT00973479|541505351|FG000|Overall Study|Lack of Efficacy|5|||
150098949|NCT00973479|541505352|FG001|Overall Study|Lack of Efficacy|7|||
150098950|NCT00973479|541505351|FG000|Overall Study|Adverse Event|12|||
150098951|NCT00973479|541505352|FG001|Overall Study|Adverse Event|32|||
150098952|NCT00973479|541505351|FG000|Overall Study|Protocol Violation|2|||
150098953|NCT00973479|541505352|FG001|Overall Study|Protocol Violation|2|||
150098954|NCT00973479|541505351|FG000|Overall Study|Other|1|||
150098955|NCT00973479|541505352|FG001|Overall Study|Other|7|||
150098956|NCT05075850|541505353|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
150098957|NCT04256785|541505354|FG000|Overall Study|Adverse Event|8|||
150098958|NCT04256785|541505355|FG001|Overall Study|Adverse Event|6|||
150098959|NCT04256785|541505354|FG000|Overall Study|Lack of Efficacy|3|||
150098960|NCT04256785|541505355|FG001|Overall Study|Lack of Efficacy|4|||
150098961|NCT04256785|541505354|FG000|Overall Study|Lost to Follow-up|7|||
150098962|NCT04256785|541505355|FG001|Overall Study|Lost to Follow-up|7|||
150098963|NCT04256785|541505354|FG000|Overall Study|Protocol Violation|1|||
150098964|NCT04256785|541505355|FG001|Overall Study|Protocol Violation|0|||
150098965|NCT04256785|541505354|FG000|Overall Study|Withdrawal by Subject|4|||
150098966|NCT04256785|541505355|FG001|Overall Study|Withdrawal by Subject|1|||
150098967|NCT04256785|541505354|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
150098968|NCT04256785|541505355|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
150098969|NCT01154218|541505356|FG000|Third Intervention Period|Adverse Event|0|||
150098970|NCT01154218|541505357|FG001|Third Intervention Period|Adverse Event|1|||
150098971|NCT01154218|541505358|FG002|Third Intervention Period|Adverse Event|0|||
150098972|NCT01154218|541505359|FG003|Third Intervention Period|Adverse Event|0|||
150098973|NCT01154218|541505356|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
150098974|NCT01154218|541505357|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
150098975|NCT01154218|541505358|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
150098976|NCT01154218|541505359|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
150098977|NCT01154218|541505356|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
150098978|NCT01154218|541505357|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
150098979|NCT01154218|541505358|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
150098980|NCT01154218|541505359|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
150098981|NCT01265849|541505360|FG000|Overall Study|Randomized//Treatment not initiated|1|||
150098982|NCT01265849|541505361|FG001|Overall Study|Randomized//Treatment not initiated|4|||
150098983|NCT01265849|541505362|FG002|Overall Study|Randomized//Treatment not initiated|0|||
150098984|NCT01265849|541505360|FG000|Overall Study|Physician Decision|1|||
150098985|NCT01265849|541505361|FG001|Overall Study|Physician Decision|2|||
150098986|NCT01265849|541505362|FG002|Overall Study|Physician Decision|0|||
150098987|NCT01265849|541505360|FG000|Overall Study|Lost to Follow-up|18|||
150098988|NCT01265849|541505361|FG001|Overall Study|Lost to Follow-up|15|||
150098989|NCT01265849|541505362|FG002|Overall Study|Lost to Follow-up|5|||
150098990|NCT01265849|541505360|FG000|Overall Study|Not otherwise specified|1|||
150098991|NCT01265849|541505361|FG001|Overall Study|Not otherwise specified|6|||
150098992|NCT01265849|541505362|FG002|Overall Study|Not otherwise specified|1|||
150098993|NCT01265849|541505360|FG000|Overall Study|Withdrawal by Subject|25|||
150098994|NCT01265849|541505361|FG001|Overall Study|Withdrawal by Subject|34|||
150098995|NCT01265849|541505362|FG002|Overall Study|Withdrawal by Subject|13|||
150098996|NCT00362115|541505363|FG000|Overall Study|Adverse Event|0|||
150098997|NCT00362115|541505364|FG001|Overall Study|Adverse Event|1|||
150098998|NCT00362115|541505365|FG002|Overall Study|Adverse Event|1|||
150098999|NCT00362115|541505366|FG003|Overall Study|Adverse Event|1|||
150099000|NCT00362115|541505367|FG004|Overall Study|Adverse Event|2|||
150099001|NCT00362115|541505368|FG005|Overall Study|Adverse Event|2|||
150099002|NCT00362115|541505369|FG006|Overall Study|Adverse Event|1|||
150099003|NCT00362115|541505363|FG000|Overall Study|Protocol Violation|0|||
150099004|NCT00362115|541505364|FG001|Overall Study|Protocol Violation|0|||
150099005|NCT00362115|541505365|FG002|Overall Study|Protocol Violation|0|||
150099006|NCT00362115|541505366|FG003|Overall Study|Protocol Violation|0|||
150099007|NCT00362115|541505367|FG004|Overall Study|Protocol Violation|0|||
150099008|NCT00362115|541505368|FG005|Overall Study|Protocol Violation|1|||
150099009|NCT00362115|541505369|FG006|Overall Study|Protocol Violation|0|||
150099010|NCT00362115|541505363|FG000|Overall Study|Lost to Follow-up|0|||
150099011|NCT00362115|541505364|FG001|Overall Study|Lost to Follow-up|1|||
150099012|NCT00362115|541505365|FG002|Overall Study|Lost to Follow-up|0|||
150185291|NCT02287311|541817105|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
150185292|NCT02287311|541817106|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
150099013|NCT00362115|541505366|FG003|Overall Study|Lost to Follow-up|0|||
150099014|NCT00362115|541505367|FG004|Overall Study|Lost to Follow-up|2|||
150099015|NCT00362115|541505368|FG005|Overall Study|Lost to Follow-up|0|||
150099016|NCT00362115|541505369|FG006|Overall Study|Lost to Follow-up|1|||
150099017|NCT00362115|541505363|FG000|Overall Study|Withdrawal by Subject|1|||
150099018|NCT00362115|541505364|FG001|Overall Study|Withdrawal by Subject|3|||
150099019|NCT00362115|541505365|FG002|Overall Study|Withdrawal by Subject|1|||
150099020|NCT00362115|541505366|FG003|Overall Study|Withdrawal by Subject|0|||
150099021|NCT00362115|541505367|FG004|Overall Study|Withdrawal by Subject|1|||
150099022|NCT00362115|541505368|FG005|Overall Study|Withdrawal by Subject|3|||
150099023|NCT00362115|541505369|FG006|Overall Study|Withdrawal by Subject|4|||
150099024|NCT00362115|541505363|FG000|Overall Study|Lack of Efficacy|1|||
150099025|NCT00362115|541505364|FG001|Overall Study|Lack of Efficacy|0|||
150099026|NCT00362115|541505365|FG002|Overall Study|Lack of Efficacy|5|||
150099027|NCT00362115|541505366|FG003|Overall Study|Lack of Efficacy|2|||
150099028|NCT00362115|541505367|FG004|Overall Study|Lack of Efficacy|2|||
150099029|NCT00362115|541505368|FG005|Overall Study|Lack of Efficacy|0|||
150099030|NCT00362115|541505369|FG006|Overall Study|Lack of Efficacy|3|||
150099031|NCT00362115|541505363|FG000|Overall Study|Physician Decision|0|||
150099032|NCT00362115|541505364|FG001|Overall Study|Physician Decision|0|||
150099033|NCT00362115|541505365|FG002|Overall Study|Physician Decision|0|||
150099034|NCT00362115|541505366|FG003|Overall Study|Physician Decision|0|||
150099035|NCT00362115|541505367|FG004|Overall Study|Physician Decision|0|||
150099036|NCT00362115|541505368|FG005|Overall Study|Physician Decision|0|||
150099037|NCT00362115|541505369|FG006|Overall Study|Physician Decision|3|||
150099038|NCT00362115|541505363|FG000|Overall Study|Other|0|||
150099039|NCT00362115|541505364|FG001|Overall Study|Other|1|||
150099040|NCT00362115|541505365|FG002|Overall Study|Other|0|||
150099041|NCT00362115|541505366|FG003|Overall Study|Other|1|||
150099042|NCT00362115|541505367|FG004|Overall Study|Other|0|||
150099043|NCT00362115|541505368|FG005|Overall Study|Other|1|||
150099044|NCT00362115|541505369|FG006|Overall Study|Other|0|||
150099045|NCT00271609|541505370|FG000|Overall Study|Adverse Event|11|||
150099046|NCT00271609|541505371|FG001|Overall Study|Adverse Event|3|||
150099047|NCT00271609|541505370|FG000|Overall Study|Withdrawal by Subject|2|||
150099048|NCT00271609|541505371|FG001|Overall Study|Withdrawal by Subject|0|||
150099049|NCT02188589|541505372|FG000|Overall Study|Withdrawal by Subject|5|||
150099050|NCT03341533|541505375|FG000|Overall Study|Withdrawal by Subject|1|||
150099051|NCT03341533|541505376|FG001|Overall Study|Withdrawal by Subject|1|||
150099052|NCT03341533|541505375|FG000|Overall Study|Not eligible after randomization|2|||
150099053|NCT03341533|541505376|FG001|Overall Study|Not eligible after randomization|1|||
150099054|NCT02153112|541505377|FG000|Overall Study|Adverse Event|0|||
150099055|NCT02153112|541505378|FG001|Overall Study|Adverse Event|0|||
150099056|NCT02153112|541505379|FG002|Overall Study|Adverse Event|1|||
150099057|NCT02153112|541505380|FG003|Overall Study|Adverse Event|0|||
150099058|NCT02153112|541505381|FG004|Overall Study|Adverse Event|0|||
150099059|NCT02153112|541505382|FG005|Overall Study|Adverse Event|0|||
150099060|NCT02153112|541505383|FG006|Overall Study|Adverse Event|0|||
150099061|NCT02153112|541505384|FG007|Overall Study|Adverse Event|0|||
150099062|NCT02153112|541505385|FG008|Overall Study|Adverse Event|0|||
150099063|NCT02153112|541505386|FG009|Overall Study|Adverse Event|0|||
150099064|NCT02153112|541505377|FG000|Overall Study|Lost to Follow-up|1|||
150099065|NCT02153112|541505378|FG001|Overall Study|Lost to Follow-up|1|||
150099066|NCT02153112|541505379|FG002|Overall Study|Lost to Follow-up|0|||
150099067|NCT02153112|541505380|FG003|Overall Study|Lost to Follow-up|0|||
150099068|NCT02153112|541505381|FG004|Overall Study|Lost to Follow-up|2|||
150099069|NCT02153112|541505382|FG005|Overall Study|Lost to Follow-up|1|||
150099070|NCT02153112|541505383|FG006|Overall Study|Lost to Follow-up|1|||
150099071|NCT02153112|541505384|FG007|Overall Study|Lost to Follow-up|0|||
150099072|NCT02153112|541505385|FG008|Overall Study|Lost to Follow-up|1|||
150099073|NCT02153112|541505386|FG009|Overall Study|Lost to Follow-up|1|||
150099074|NCT02153112|541505377|FG000|Overall Study|Withdrawal by Subject|3|||
150099075|NCT02153112|541505378|FG001|Overall Study|Withdrawal by Subject|1|||
150099076|NCT02153112|541505379|FG002|Overall Study|Withdrawal by Subject|2|||
150099077|NCT02153112|541505380|FG003|Overall Study|Withdrawal by Subject|2|||
150099078|NCT02153112|541505381|FG004|Overall Study|Withdrawal by Subject|1|||
150099079|NCT02153112|541505382|FG005|Overall Study|Withdrawal by Subject|1|||
150099080|NCT02153112|541505383|FG006|Overall Study|Withdrawal by Subject|7|||
150099081|NCT02153112|541505384|FG007|Overall Study|Withdrawal by Subject|2|||
150099082|NCT02153112|541505385|FG008|Overall Study|Withdrawal by Subject|13|||
150099083|NCT02153112|541505386|FG009|Overall Study|Withdrawal by Subject|12|||
150099084|NCT02153112|541505377|FG000|Overall Study|Reason not Specified|0|||
150185293|NCT02287311|541817107|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
150185294|NCT02287311|541817108|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
150099085|NCT02153112|541505378|FG001|Overall Study|Reason not Specified|0|||
150099086|NCT02153112|541505379|FG002|Overall Study|Reason not Specified|0|||
150099087|NCT02153112|541505380|FG003|Overall Study|Reason not Specified|0|||
150099088|NCT02153112|541505381|FG004|Overall Study|Reason not Specified|0|||
150099089|NCT02153112|541505382|FG005|Overall Study|Reason not Specified|0|||
150099090|NCT02153112|541505383|FG006|Overall Study|Reason not Specified|0|||
150099091|NCT02153112|541505384|FG007|Overall Study|Reason not Specified|0|||
150099092|NCT02153112|541505385|FG008|Overall Study|Reason not Specified|1|||
150099093|NCT02153112|541505386|FG009|Overall Study|Reason not Specified|1|||
150099094|NCT00003641|541505392|FG000|Overall Study|Withdrawal by Subject|0|||
150099095|NCT00003641|541505393|FG001|Overall Study|Withdrawal by Subject|100|||
150099096|NCT00003641|541505392|FG000|Overall Study|Adverse Event|0|||
150099097|NCT00003641|541505393|FG001|Overall Study|Adverse Event|38|||
150099098|NCT00003641|541505392|FG000|Overall Study|Disease progression|0|||
150099099|NCT00003641|541505393|FG001|Overall Study|Disease progression|2|||
150099100|NCT00003641|541505392|FG000|Overall Study|Unknown/missing|0|||
150099101|NCT00003641|541505393|FG001|Overall Study|Unknown/missing|22|||
150099102|NCT00003641|541505392|FG000|Overall Study|Should not receive interferon therapy|2|||
150099103|NCT00003641|541505393|FG001|Overall Study|Should not receive interferon therapy|0|||
150099104|NCT00003641|541505392|FG000|Overall Study|Never started interferon|567|||
150099105|NCT00003641|541505393|FG001|Overall Study|Never started interferon|12|||
150099106|NCT02154581|541505397|FG000|Overall Study|Lost to Follow-up|7|||
150099107|NCT02154581|541505398|FG001|Overall Study|Lost to Follow-up|8|||
150099108|NCT00878709|541505399|FG000|Overall Study|Withdrawal by Subject|197|||
150099109|NCT00878709|541505400|FG001|Overall Study|Withdrawal by Subject|120|||
150099110|NCT00878709|541505399|FG000|Overall Study|Lost to Follow-up|35|||
150099111|NCT00878709|541505400|FG001|Overall Study|Lost to Follow-up|33|||
150099112|NCT00878709|541505399|FG000|Overall Study|Other Reasons|93|||
150099113|NCT00878709|541505400|FG001|Overall Study|Other Reasons|84|||
150099114|NCT02225743|541505401|FG000|Overall Study|Withdrawal by Subject|18|||
150099115|NCT03886220|541505404|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
150099116|NCT03886220|541505405|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
150099117|NCT03886220|541505404|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
150099118|NCT03886220|541505405|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
150099119|NCT03886220|541505404|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
150099120|NCT03886220|541505405|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
150099121|NCT00768300|541505408|FG000|Overall Study|Randomized but not treated|1|||
150099122|NCT00768300|541505409|FG001|Overall Study|Randomized but not treated|1|||
150099123|NCT00768300|541505408|FG000|Overall Study|Adverse Event|10|||
150099124|NCT00768300|541505409|FG001|Overall Study|Adverse Event|2|||
150099125|NCT00768300|541505408|FG000|Overall Study|Protocol Violation|6|||
150099126|NCT00768300|541505409|FG001|Overall Study|Protocol Violation|1|||
150099127|NCT00768300|541505408|FG000|Overall Study|Withdrawal by Subject|13|||
150099128|NCT00768300|541505409|FG001|Overall Study|Withdrawal by Subject|7|||
150099129|NCT00768300|541505408|FG000|Overall Study|Physician Decision|2|||
150099130|NCT00768300|541505409|FG001|Overall Study|Physician Decision|3|||
150099131|NCT00768300|541505408|FG000|Overall Study|Study discontinued by Sponsor|271|||
150099132|NCT00768300|541505409|FG001|Overall Study|Study discontinued by Sponsor|140|||
150099133|NCT00768300|541505408|FG000|Overall Study|Death|21|||
150099134|NCT00768300|541505409|FG001|Overall Study|Death|5|||
150099135|NCT00768300|541505408|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
150099136|NCT00768300|541505409|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
150099137|NCT00768300|541505408|FG000|Overall Study|Screen failure following randomization|1|||
150099138|NCT00768300|541505409|FG001|Overall Study|Screen failure following randomization|0|||
150099139|NCT00768300|541505408|FG000|Overall Study|Received lung transplant|1|||
150099140|NCT00768300|541505409|FG001|Overall Study|Received lung transplant|1|||
150099141|NCT00768300|541505408|FG000|Overall Study|Lost to Follow-up|0|||
150099142|NCT00768300|541505409|FG001|Overall Study|Lost to Follow-up|1|||
150099143|NCT00768300|541505408|FG000|Overall Study|Began prohibited concomitant medication|0|||
150099144|NCT00768300|541505409|FG001|Overall Study|Began prohibited concomitant medication|1|||
150099145|NCT00768300|541505408|FG000|Overall Study|Treated but never dosed with Study drug|1|||
150099146|NCT00768300|541505409|FG001|Overall Study|Treated but never dosed with Study drug|0|||
150099147|NCT00768300|541505408|FG000|Overall Study|Missing data|1|||
150099148|NCT00768300|541505409|FG001|Overall Study|Missing data|0|||
150099149|NCT02068222|541505412|FG000|Overall Study|Lost to Follow-up|1|||
150099150|NCT03082599|541505413|FG000|Overall Study|Lost to Follow-up|1|||
150099151|NCT03082599|541505414|FG001|Overall Study|Lost to Follow-up|0|||
150099152|NCT00281684|541505417|FG000|Overall Study|Lost to Follow-up|0|||
150099153|NCT00281684|541505418|FG001|Overall Study|Lost to Follow-up|0|||
150099154|NCT00281684|541505419|FG002|Overall Study|Lost to Follow-up|1|||
150099155|NCT00281684|541505420|FG003|Overall Study|Lost to Follow-up|0|||
150099156|NCT00281684|541505417|FG000|Overall Study|Withdrawal by Subject|1|||
150099157|NCT00281684|541505418|FG001|Overall Study|Withdrawal by Subject|0|||
150099158|NCT00281684|541505419|FG002|Overall Study|Withdrawal by Subject|0|||
150099159|NCT00281684|541505420|FG003|Overall Study|Withdrawal by Subject|0|||
150099160|NCT01559012|541505423|FG000|Overall Study|Withdrawal by Subject|0|||
150099161|NCT01559012|541505424|FG001|Overall Study|Withdrawal by Subject|1|||
150099162|NCT00946712|541505425|FG000|Overall Study|Adverse Event|118|||
150099163|NCT00946712|541505426|FG001|Overall Study|Adverse Event|124|||
150099164|NCT00946712|541505425|FG000|Overall Study|Disease progression|308|||
150099165|NCT00946712|541505426|FG001|Overall Study|Disease progression|404|||
150099166|NCT00946712|541505425|FG000|Overall Study|Death|21|||
150099167|NCT00946712|541505426|FG001|Overall Study|Death|22|||
150099168|NCT00946712|541505425|FG000|Overall Study|No treatment given|25|||
150099169|NCT00946712|541505426|FG001|Overall Study|No treatment given|29|||
150099170|NCT00946712|541505425|FG000|Overall Study|Other reasons|61|||
150099171|NCT00946712|541505426|FG001|Overall Study|Other reasons|73|||
150099172|NCT00946712|541505425|FG000|Overall Study|On Treatment|0|||
150099173|NCT00946712|541505426|FG001|Overall Study|On Treatment|4|||
150099174|NCT00946712|541505425|FG000|Overall Study|Ineligible|14|||
150099175|NCT00946712|541505426|FG001|Overall Study|Ineligible|6|||
150099176|NCT00853723|541505427|FG000|Overall Study|Adverse Event|3|||
150099177|NCT00853723|541505428|FG001|Overall Study|Adverse Event|4|||
150099178|NCT00853723|541505429|FG002|Overall Study|Adverse Event|1|||
150099179|NCT00853723|541505427|FG000|Overall Study|Withdrawal by Subject|2|||
150099180|NCT00853723|541505428|FG001|Overall Study|Withdrawal by Subject|1|||
150099181|NCT00853723|541505429|FG002|Overall Study|Withdrawal by Subject|0|||
150099182|NCT00853723|541505427|FG000|Overall Study|Protocol Violation|1|||
150099183|NCT00853723|541505428|FG001|Overall Study|Protocol Violation|2|||
150099184|NCT00853723|541505429|FG002|Overall Study|Protocol Violation|1|||
150099185|NCT00445965|541505430|FG000|Overall Study|Adverse Event|2|||
150099186|NCT00445965|541505430|FG000|Overall Study|Physician Decision|1|||
150099187|NCT00445965|541505430|FG000|Overall Study|Enrolled but not treated|1|||
150099188|NCT00445965|541505430|FG000|Overall Study|Removed due to progressive disease|29|||
150099189|NCT02447081|541505431|FG000|Overall Study|Death|161|||
150099190|NCT02447081|541505431|FG000|Overall Study|Lost to Follow-up|36|||
150099191|NCT02447081|541505431|FG000|Overall Study|Visit not completed|17|||
150099192|NCT02447081|541505431|FG000|Overall Study|unsuccessful implant procedure|10|||
150099193|NCT05778786|541505434|FG000|Period 1|COVID-19 Related|3|||
150099194|NCT05778786|541505435|FG001|Period 1|COVID-19 Related|3|||
150099195|NCT05778786|541505434|FG000|Period 1|Withdrew Consent during Study|1|||
150099196|NCT05778786|541505435|FG001|Period 1|Withdrew Consent during Study|0|||
150099197|NCT05778786|541505434|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
150099198|NCT05778786|541505435|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
150099199|NCT05778786|541505434|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
150099200|NCT05778786|541505435|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
150099201|NCT03188094|541505436|FG000|Overall Study|Screen failure|1|||
150099202|NCT03188094|541505437|FG001|Overall Study|Screen failure|0|||
150099203|NCT03188094|541505438|FG002|Overall Study|Screen failure|0|||
150099204|NCT03188094|541505436|FG000|Overall Study|Pregnancy|3|||
150099205|NCT03188094|541505437|FG001|Overall Study|Pregnancy|0|||
150099206|NCT03188094|541505438|FG002|Overall Study|Pregnancy|0|||
150099207|NCT03188094|541505436|FG000|Overall Study|Ineligible|1|||
150099208|NCT03188094|541505437|FG001|Overall Study|Ineligible|0|||
150099209|NCT03188094|541505438|FG002|Overall Study|Ineligible|0|||
150099210|NCT03188094|541505436|FG000|Overall Study|Lost to Follow-up|0|||
150099211|NCT03188094|541505437|FG001|Overall Study|Lost to Follow-up|0|||
150099212|NCT03188094|541505438|FG002|Overall Study|Lost to Follow-up|17|||
150099213|NCT04690751|541505439|FG000|Overall Study|Protocol Violation|0|||
150099214|NCT04690751|541505440|FG001|Overall Study|Protocol Violation|1|||
150099215|NCT04690751|541505441|FG002|Overall Study|Protocol Violation|0|||
150099216|NCT04690751|541505442|FG003|Overall Study|Protocol Violation|1|||
150099217|NCT04690751|541505443|FG004|Overall Study|Protocol Violation|2|||
150099218|NCT04690751|541505444|FG005|Overall Study|Protocol Violation|0|||
150099219|NCT04690751|541505439|FG000|Overall Study|Adverse Event|0|||
150099220|NCT04690751|541505440|FG001|Overall Study|Adverse Event|0|||
150099221|NCT04690751|541505441|FG002|Overall Study|Adverse Event|1|||
150099222|NCT04690751|541505442|FG003|Overall Study|Adverse Event|0|||
150099223|NCT04690751|541505443|FG004|Overall Study|Adverse Event|0|||
150099224|NCT04690751|541505444|FG005|Overall Study|Adverse Event|0|||
150099225|NCT04690751|541505439|FG000|Overall Study|Positive urine drug screen test|0|||
150099226|NCT04690751|541505440|FG001|Overall Study|Positive urine drug screen test|0|||
150099227|NCT04690751|541505441|FG002|Overall Study|Positive urine drug screen test|0|||
150099228|NCT04690751|541505442|FG003|Overall Study|Positive urine drug screen test|0|||
150099229|NCT04690751|541505443|FG004|Overall Study|Positive urine drug screen test|1|||
150099230|NCT04690751|541505444|FG005|Overall Study|Positive urine drug screen test|0|||
150099231|NCT01545817|541506829|FG000|Pazopanib|Disease progression|51|||
150099232|NCT01545817|541506830|FG001|Pazopanib|Disease progression|0|||
150099233|NCT01545817|541506829|FG000|Pazopanib|Adverse Event|19|||
150099234|NCT01545817|541506830|FG001|Pazopanib|Adverse Event|0|||
150099235|NCT01545817|541506829|FG000|Pazopanib|Other reason|4|||
150099236|NCT01545817|541506830|FG001|Pazopanib|Other reason|0|||
150099237|NCT01545817|541506829|FG000|Everolimus|Other reason|0|||
150099238|NCT01545817|541506830|FG001|Everolimus|Other reason|7|||
150099239|NCT01545817|541506829|FG000|Everolimus|Disease progression|0|||
150099240|NCT01545817|541506830|FG001|Everolimus|Disease progression|25|||
150099241|NCT01545817|541506829|FG000|Everolimus|Adverse Event|0|||
150099242|NCT01545817|541506830|FG001|Everolimus|Adverse Event|6|||
150099243|NCT01012622|541506841|FG000|Overall Study|Withdrawal by Subject|6|||
150099244|NCT01012622|541506841|FG000|Overall Study|Lost to Follow-up|5|||
150099245|NCT01012622|541506841|FG000|Overall Study|Adverse Event|7|||
150099246|NCT01012622|541506841|FG000|Overall Study|non-compliance with the drug|9|||
150099247|NCT01012622|541506841|FG000|Overall Study|Other|1|||
150099248|NCT01012622|541506841|FG000|Overall Study|screening failure|1|||
150099249|NCT01012622|541506841|FG000|Overall Study|withdrawal of consent by a parent|2|||
150099250|NCT02515942|541506842|FG000|Overall Study|Adverse Event|5|||
150099251|NCT02515942|541506843|FG001|Overall Study|Adverse Event|0|||
150099252|NCT02515942|541506844|FG002|Overall Study|Adverse Event|0|||
150099253|NCT02515942|541506842|FG000|Overall Study|Death|0|||
150099254|NCT02515942|541506843|FG001|Overall Study|Death|0|||
150099255|NCT02515942|541506844|FG002|Overall Study|Death|1|||
150099256|NCT02515942|541506842|FG000|Overall Study|Lack of Efficacy|0|||
150099257|NCT02515942|541506843|FG001|Overall Study|Lack of Efficacy|0|||
150099258|NCT02515942|541506844|FG002|Overall Study|Lack of Efficacy|1|||
150099259|NCT02515942|541506842|FG000|Overall Study|Lost to Follow-up|2|||
150099260|NCT02515942|541506843|FG001|Overall Study|Lost to Follow-up|0|||
150099261|NCT02515942|541506844|FG002|Overall Study|Lost to Follow-up|0|||
150099262|NCT02515942|541506842|FG000|Overall Study|Withdrawal by Subject|0|||
150099263|NCT02515942|541506843|FG001|Overall Study|Withdrawal by Subject|3|||
150099264|NCT02515942|541506844|FG002|Overall Study|Withdrawal by Subject|2|||
150099265|NCT03257631|541506845|FG000|Overall Study|Death|1|||
150099266|NCT03257631|541506846|FG001|Overall Study|Death|0|||
150099267|NCT03257631|541506847|FG002|Overall Study|Death|1|||
150099268|NCT03257631|541506848|FG003|Overall Study|Death|1|||
150099269|NCT03257631|541506845|FG000|Overall Study|Progressive Disease|10|||
150099270|NCT03257631|541506846|FG001|Overall Study|Progressive Disease|9|||
150099271|NCT03257631|541506847|FG002|Overall Study|Progressive Disease|17|||
150099272|NCT03257631|541506848|FG003|Overall Study|Progressive Disease|8|||
150099273|NCT03257631|541506845|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150099274|NCT03257631|541506846|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150099275|NCT03257631|541506847|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
150099276|NCT03257631|541506848|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
150099277|NCT03257631|541506845|FG000|Overall Study|Adverse Event|0|||
150099278|NCT03257631|541506846|FG001|Overall Study|Adverse Event|0|||
150099279|NCT03257631|541506847|FG002|Overall Study|Adverse Event|2|||
150099280|NCT03257631|541506848|FG003|Overall Study|Adverse Event|0|||
150099281|NCT02603432|541506851|FG000|Overall Study|Adverse Event|1|||
150099282|NCT02603432|541506852|FG001|Overall Study|Adverse Event|0|||
150099283|NCT02603432|541506851|FG000|Overall Study|Death|221|||
150099284|NCT02603432|541506852|FG001|Overall Study|Death|242|||
150099285|NCT02603432|541506851|FG000|Overall Study|Lost to Follow-up|3|||
150099286|NCT02603432|541506852|FG001|Overall Study|Lost to Follow-up|9|||
150099287|NCT02603432|541506851|FG000|Overall Study|Progressive Disease|7|||
150099288|NCT02603432|541506852|FG001|Overall Study|Progressive Disease|5|||
150099289|NCT02603432|541506851|FG000|Overall Study|Withdrawal by Subject|12|||
150099290|NCT02603432|541506852|FG001|Overall Study|Withdrawal by Subject|18|||
150099291|NCT02603432|541506851|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
150099292|NCT02603432|541506852|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
150099293|NCT02603432|541506851|FG000|Overall Study|Study terminated by sponsor|74|||
150099294|NCT02603432|541506852|FG001|Overall Study|Study terminated by sponsor|75|||
150099295|NCT02603432|541506851|FG000|Overall Study|Other|13|||
150099296|NCT02603432|541506852|FG001|Overall Study|Other|0|||
150099297|NCT00666757|541506853|FG000|Overall Study|Lost to Follow-up|39|||
150099298|NCT00666757|541506854|FG001|Overall Study|Lost to Follow-up|35|||
150099299|NCT00666757|541506853|FG000|Overall Study|Protocol Violation|23|||
150099300|NCT00666757|541506854|FG001|Overall Study|Protocol Violation|24|||
150099301|NCT00666757|541506853|FG000|Overall Study|Adverse Event|22|||
150099302|NCT00666757|541506854|FG001|Overall Study|Adverse Event|12|||
150099303|NCT00666757|541506853|FG000|Overall Study|Withdrawal by Subject|13|||
150099304|NCT00666757|541506854|FG001|Overall Study|Withdrawal by Subject|17|||
150099305|NCT00666757|541506853|FG000|Overall Study|Lack of Efficacy|3|||
150099306|NCT00666757|541506854|FG001|Overall Study|Lack of Efficacy|6|||
150099307|NCT00666757|541506853|FG000|Overall Study|Physician Decision|0|||
150099308|NCT00666757|541506854|FG001|Overall Study|Physician Decision|2|||
150099309|NCT00666757|541506853|FG000|Overall Study|Sponsor decision|0|||
150099310|NCT00666757|541506854|FG001|Overall Study|Sponsor decision|1|||
150099311|NCT02529137|541506855|FG000|Overall Study|Discontinuation for different reasons|8|||
150099312|NCT01723163|541506858|FG000|Treatment Phase|Withdrawal by Subject|14|||
150099313|NCT01723163|541506859|FG001|Treatment Phase|Withdrawal by Subject|6|||
150099314|NCT01723163|541506858|FG000|Treatment Phase|Withdrawal by PI|5|||
150099315|NCT01723163|541506859|FG001|Treatment Phase|Withdrawal by PI|1|||
150099316|NCT01723163|541506858|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
150099317|NCT01723163|541506859|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
150099318|NCT01723163|541506858|FG000|3-Month Follow-up|Unable to Contact|12|||
150099319|NCT01723163|541506859|FG001|3-Month Follow-up|Unable to Contact|19|||
150099320|NCT01723163|541506858|FG000|6-Month Follow-up|Death|1|||
150099321|NCT01723163|541506859|FG001|6-Month Follow-up|Death|0|||
150099322|NCT01723163|541506858|FG000|6-Month Follow-up|Unable to Contact|17|||
150099323|NCT01723163|541506859|FG001|6-Month Follow-up|Unable to Contact|15|||
150099324|NCT01723163|541506858|FG000|12-Month Follow-up|Death|1|||
150099325|NCT01723163|541506859|FG001|12-Month Follow-up|Death|0|||
150099326|NCT01723163|541506858|FG000|12-Month Follow-up|Unable to Contact|23|||
150099327|NCT01723163|541506859|FG001|12-Month Follow-up|Unable to Contact|28|||
150099328|NCT02510794|541506860|FG000|Overall Study|Adverse Event|0|||
150099329|NCT02510794|541506861|FG001|Overall Study|Adverse Event|1|||
150099330|NCT02510794|541506862|FG002|Overall Study|Adverse Event|0|||
150185295|NCT02287311|541817109|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
150185296|NCT02287311|541817110|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
150099331|NCT02510794|541506863|FG003|Overall Study|Adverse Event|0|||
150099332|NCT02510794|541506860|FG000|Overall Study|Death|1|||
150099333|NCT02510794|541506861|FG001|Overall Study|Death|2|||
150099334|NCT02510794|541506862|FG002|Overall Study|Death|1|||
150099335|NCT02510794|541506863|FG003|Overall Study|Death|1|||
150099336|NCT02510794|541506860|FG000|Overall Study|Lack of Efficacy|3|||
150099337|NCT02510794|541506861|FG001|Overall Study|Lack of Efficacy|1|||
150099338|NCT02510794|541506862|FG002|Overall Study|Lack of Efficacy|1|||
150099339|NCT02510794|541506863|FG003|Overall Study|Lack of Efficacy|0|||
150099340|NCT02510794|541506860|FG000|Overall Study|Participant moved out of the area|0|||
150099341|NCT02510794|541506861|FG001|Overall Study|Participant moved out of the area|0|||
150099342|NCT02510794|541506862|FG002|Overall Study|Participant moved out of the area|0|||
150099343|NCT02510794|541506863|FG003|Overall Study|Participant moved out of the area|1|||
150099344|NCT02510794|541506860|FG000|Overall Study|Physician Decision|3|||
150099345|NCT02510794|541506861|FG001|Overall Study|Physician Decision|0|||
150099346|NCT02510794|541506862|FG002|Overall Study|Physician Decision|0|||
150099347|NCT02510794|541506863|FG003|Overall Study|Physician Decision|0|||
150099348|NCT02510794|541506860|FG000|Overall Study|Protocol Violation|0|||
150099349|NCT02510794|541506861|FG001|Overall Study|Protocol Violation|0|||
150099350|NCT02510794|541506862|FG002|Overall Study|Protocol Violation|1|||
150099351|NCT02510794|541506863|FG003|Overall Study|Protocol Violation|0|||
150099352|NCT02510794|541506860|FG000|Overall Study|Withdrawal by Subject|1|||
150099353|NCT02510794|541506861|FG001|Overall Study|Withdrawal by Subject|2|||
150099354|NCT02510794|541506862|FG002|Overall Study|Withdrawal by Subject|4|||
150099355|NCT02510794|541506863|FG003|Overall Study|Withdrawal by Subject|3|||
150099356|NCT01649375|541506864|FG000|Up to Week 16|Adverse Event|2|||
150099357|NCT01649375|541506865|FG001|Up to Week 16|Adverse Event|5|||
150099358|NCT01649375|541506866|FG002|Up to Week 16|Adverse Event|4|||
150099359|NCT01649375|541506867|FG003|Up to Week 16|Adverse Event|0|||
150099360|NCT01649375|541506868|FG004|Up to Week 16|Adverse Event|0|||
150099361|NCT01649375|541506864|FG000|Up to Week 16|Lack of Efficacy|0|||
150099362|NCT01649375|541506865|FG001|Up to Week 16|Lack of Efficacy|0|||
150099363|NCT01649375|541506866|FG002|Up to Week 16|Lack of Efficacy|1|||
150099364|NCT01649375|541506867|FG003|Up to Week 16|Lack of Efficacy|0|||
150099365|NCT01649375|541506868|FG004|Up to Week 16|Lack of Efficacy|0|||
150099366|NCT01649375|541506864|FG000|Up to Week 16|Physician Decision|0|||
150099367|NCT01649375|541506865|FG001|Up to Week 16|Physician Decision|0|||
150099368|NCT01649375|541506866|FG002|Up to Week 16|Physician Decision|1|||
150099369|NCT01649375|541506867|FG003|Up to Week 16|Physician Decision|0|||
150099370|NCT01649375|541506868|FG004|Up to Week 16|Physician Decision|0|||
150099371|NCT01649375|541506864|FG000|Up to Week 16|Withdrawal by Subject|2|||
150099372|NCT01649375|541506865|FG001|Up to Week 16|Withdrawal by Subject|1|||
150099373|NCT01649375|541506866|FG002|Up to Week 16|Withdrawal by Subject|2|||
150099374|NCT01649375|541506867|FG003|Up to Week 16|Withdrawal by Subject|0|||
150099375|NCT01649375|541506868|FG004|Up to Week 16|Withdrawal by Subject|0|||
150099376|NCT01649375|541506864|FG000|Up to Week 16|Death|1|||
150099377|NCT01649375|541506865|FG001|Up to Week 16|Death|0|||
150099378|NCT01649375|541506866|FG002|Up to Week 16|Death|0|||
150099379|NCT01649375|541506867|FG003|Up to Week 16|Death|0|||
150099380|NCT01649375|541506868|FG004|Up to Week 16|Death|0|||
150099381|NCT01649375|541506864|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
150099382|NCT01649375|541506865|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
150099383|NCT01649375|541506866|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
150099384|NCT01649375|541506867|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
150099385|NCT01649375|541506868|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
150099386|NCT01649375|541506864|FG000|Week 16 up to Week 260|Non-compliance|0|||
150099387|NCT01649375|541506865|FG001|Week 16 up to Week 260|Non-compliance|1|||
150099388|NCT01649375|541506866|FG002|Week 16 up to Week 260|Non-compliance|0|||
150099389|NCT01649375|541506867|FG003|Week 16 up to Week 260|Non-compliance|1|||
150099390|NCT01649375|541506868|FG004|Week 16 up to Week 260|Non-compliance|0|||
150099391|NCT01649375|541506864|FG000|Week 16 up to Week 260|Physician Decision|0|||
150099392|NCT01649375|541506865|FG001|Week 16 up to Week 260|Physician Decision|2|||
150099393|NCT01649375|541506866|FG002|Week 16 up to Week 260|Physician Decision|0|||
150099394|NCT01649375|541506867|FG003|Week 16 up to Week 260|Physician Decision|0|||
150099395|NCT01649375|541506868|FG004|Week 16 up to Week 260|Physician Decision|0|||
150099396|NCT01649375|541506864|FG000|Week 16 up to Week 260|Technical issues|0|||
150099397|NCT01649375|541506865|FG001|Week 16 up to Week 260|Technical issues|1|||
150099398|NCT01649375|541506866|FG002|Week 16 up to Week 260|Technical issues|0|||
150099399|NCT01649375|541506867|FG003|Week 16 up to Week 260|Technical issues|1|||
150099400|NCT01649375|541506868|FG004|Week 16 up to Week 260|Technical issues|0|||
150099401|NCT01649375|541506864|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
150099402|NCT01649375|541506865|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
150099403|NCT01649375|541506866|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
150099404|NCT01649375|541506867|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
150099405|NCT01649375|541506868|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
150099406|NCT01649375|541506864|FG000|Week 16 up to Week 260|Death|1|||
150099407|NCT01649375|541506865|FG001|Week 16 up to Week 260|Death|1|||
150099408|NCT01649375|541506866|FG002|Week 16 up to Week 260|Death|0|||
150099409|NCT01649375|541506867|FG003|Week 16 up to Week 260|Death|0|||
150099410|NCT01649375|541506868|FG004|Week 16 up to Week 260|Death|0|||
150099411|NCT01649375|541506864|FG000|Week 16 up to Week 260|Adverse Event|5|||
150099412|NCT01649375|541506865|FG001|Week 16 up to Week 260|Adverse Event|2|||
150099413|NCT01649375|541506866|FG002|Week 16 up to Week 260|Adverse Event|0|||
150099414|NCT01649375|541506867|FG003|Week 16 up to Week 260|Adverse Event|3|||
150099415|NCT01649375|541506868|FG004|Week 16 up to Week 260|Adverse Event|2|||
150099416|NCT02066467|541506875|FG000|Overall Study|Did not undergo implant procedure|24|||
150185297|NCT02287311|541817111|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
150185298|NCT02287311|541817112|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
150185299|NCT02287311|541817113|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
150185300|NCT02287311|541817105|FG000|Cohort 2: Dose Level 2|Death|0|||
150185301|NCT02287311|541817106|FG001|Cohort 2: Dose Level 2|Death|2|||
150185302|NCT02287311|541817107|FG002|Cohort 2: Dose Level 2|Death|0|||
150185303|NCT02287311|541817108|FG003|Cohort 2: Dose Level 2|Death|0|||
150185304|NCT02287311|541817109|FG004|Cohort 2: Dose Level 2|Death|2|||
150185305|NCT02287311|541817110|FG005|Cohort 2: Dose Level 2|Death|0|||
150185306|NCT02287311|541817111|FG006|Cohort 2: Dose Level 2|Death|0|||
150185307|NCT02287311|541817112|FG007|Cohort 2: Dose Level 2|Death|2|||
150185308|NCT02287311|541817113|FG008|Cohort 2: Dose Level 2|Death|0|||
150185309|NCT02287311|541817105|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185310|NCT02287311|541817106|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185311|NCT02287311|541817107|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185312|NCT02287311|541817108|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185313|NCT02287311|541817109|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
150185314|NCT02287311|541817110|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185315|NCT02287311|541817111|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185316|NCT02287311|541817112|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185317|NCT02287311|541817113|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
150185318|NCT02287311|541817105|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185319|NCT02287311|541817106|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
150185320|NCT02287311|541817107|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185321|NCT02287311|541817108|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185322|NCT02287311|541817109|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185323|NCT02287311|541817110|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185324|NCT02287311|541817111|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185325|NCT02287311|541817112|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185326|NCT02287311|541817113|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
150185327|NCT02287311|541817105|FG000|Cohort 3: Dose Level 3|Death|0|||
150185328|NCT02287311|541817106|FG001|Cohort 3: Dose Level 3|Death|0|||
150185329|NCT02287311|541817107|FG002|Cohort 3: Dose Level 3|Death|4|||
150185330|NCT02287311|541817108|FG003|Cohort 3: Dose Level 3|Death|0|||
150185331|NCT02287311|541817109|FG004|Cohort 3: Dose Level 3|Death|0|||
150185332|NCT02287311|541817110|FG005|Cohort 3: Dose Level 3|Death|4|||
150185333|NCT02287311|541817111|FG006|Cohort 3: Dose Level 3|Death|0|||
150099417|NCT02066467|541506875|FG000|Overall Study|Attempted to implant withoput success|43|||
150099418|NCT02066467|541506875|FG000|Overall Study|Consent ineligible|1|||
150099419|NCT02066467|541506875|FG000|Overall Study|Death|54|||
150099420|NCT02066467|541506875|FG000|Overall Study|Lost to Follow-up|51|||
150099421|NCT02066467|541506875|FG000|Overall Study|Adverse Event|20|||
150099422|NCT02066467|541506875|FG000|Overall Study|Withdrawal by Subject|16|||
150099423|NCT02066467|541506875|FG000|Overall Study|Physician Decision|2|||
150185334|NCT02287311|541817112|FG007|Cohort 3: Dose Level 3|Death|0|||
150185335|NCT02287311|541817113|FG008|Cohort 3: Dose Level 3|Death|2|||
150185336|NCT02287311|541817105|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185337|NCT02287311|541817106|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185338|NCT02287311|541817107|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
150185339|NCT02287311|541817108|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185340|NCT02287311|541817109|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185341|NCT02287311|541817110|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
150185342|NCT02287311|541817111|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185343|NCT02287311|541817112|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185344|NCT02287311|541817113|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
150185345|NCT02287311|541817105|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185346|NCT02287311|541817106|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185347|NCT02287311|541817107|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185348|NCT02287311|541817108|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185349|NCT02287311|541817109|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185350|NCT02287311|541817110|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
150185351|NCT02287311|541817111|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185352|NCT02287311|541817112|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
150185353|NCT02287311|541817113|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
150185354|NCT05059262|541817118|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
150185355|NCT05059262|541817119|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
150185356|NCT05059262|541817118|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
150185357|NCT05059262|541817119|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
150185358|NCT05059262|541817118|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
150099424|NCT02066467|541506875|FG000|Overall Study|Not defined|4|||
150099425|NCT04461015|541506878|FG000|Overall Study|IV access lost during the study|0|||
150185359|NCT05059262|541817119|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
150185360|NCT05059262|541817118|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
150185361|NCT05059262|541817119|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
150099426|NCT04461015|541506879|FG001|Overall Study|IV access lost during the study|1|||
150099427|NCT04461015|541506878|FG000|Overall Study|Withdrawal by Subject|0|||
150099428|NCT04461015|541506879|FG001|Overall Study|Withdrawal by Subject|1|||
150099429|NCT02063854|541506880|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
150099430|NCT02063854|541506881|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
150099431|NCT02063854|541506882|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
150099432|NCT02063854|541506883|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
150099433|NCT02063854|541506884|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
150099434|NCT02063854|541506885|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
150099435|NCT02063854|541506886|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
150099436|NCT02063854|541506880|FG000|Overall Study|Major Protocol Deviation|0|||
150099437|NCT02063854|541506881|FG001|Overall Study|Major Protocol Deviation|0|||
150099438|NCT02063854|541506882|FG002|Overall Study|Major Protocol Deviation|3|||
150099439|NCT02063854|541506883|FG003|Overall Study|Major Protocol Deviation|0|||
150099440|NCT02063854|541506884|FG004|Overall Study|Major Protocol Deviation|0|||
150099441|NCT02063854|541506885|FG005|Overall Study|Major Protocol Deviation|0|||
150099442|NCT02063854|541506886|FG006|Overall Study|Major Protocol Deviation|0|||
150099443|NCT02063854|541506880|FG000|Overall Study|Voluntary Withdrawal|2|||
150099444|NCT02063854|541506881|FG001|Overall Study|Voluntary Withdrawal|0|||
150099445|NCT02063854|541506882|FG002|Overall Study|Voluntary Withdrawal|8|||
150099446|NCT02063854|541506883|FG003|Overall Study|Voluntary Withdrawal|1|||
150099447|NCT02063854|541506884|FG004|Overall Study|Voluntary Withdrawal|3|||
150099448|NCT02063854|541506885|FG005|Overall Study|Voluntary Withdrawal|6|||
150099449|NCT02063854|541506886|FG006|Overall Study|Voluntary Withdrawal|1|||
150099450|NCT02063854|541506880|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
150099451|NCT02063854|541506881|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
150099452|NCT02063854|541506882|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
150099453|NCT02063854|541506883|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
150099454|NCT02063854|541506884|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
150099455|NCT02063854|541506885|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
150099456|NCT02063854|541506886|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
150099457|NCT02063854|541506880|FG000|Overall Study|Reason Not Specified|1|||
150099458|NCT02063854|541506881|FG001|Overall Study|Reason Not Specified|0|||
150099459|NCT02063854|541506882|FG002|Overall Study|Reason Not Specified|0|||
150099460|NCT02063854|541506883|FG003|Overall Study|Reason Not Specified|0|||
150099461|NCT02063854|541506884|FG004|Overall Study|Reason Not Specified|0|||
150099462|NCT02063854|541506885|FG005|Overall Study|Reason Not Specified|0|||
150099463|NCT02063854|541506886|FG006|Overall Study|Reason Not Specified|0|||
150099464|NCT02063854|541506880|FG000|Overall Study|Did Not Receive Study Drug|0|||
150099465|NCT02063854|541506881|FG001|Overall Study|Did Not Receive Study Drug|0|||
150099466|NCT02063854|541506882|FG002|Overall Study|Did Not Receive Study Drug|0|||
150099467|NCT02063854|541506883|FG003|Overall Study|Did Not Receive Study Drug|0|||
150099468|NCT02063854|541506884|FG004|Overall Study|Did Not Receive Study Drug|0|||
150099469|NCT02063854|541506885|FG005|Overall Study|Did Not Receive Study Drug|1|||
150099470|NCT02063854|541506886|FG006|Overall Study|Did Not Receive Study Drug|0|||
150099471|NCT00405587|541506887|FG000|Overall Study|Death|0|||
150099472|NCT00405587|541506888|FG001|Overall Study|Death|0|||
150099473|NCT00405587|541506889|FG002|Overall Study|Death|0|||
150099474|NCT00405587|541506890|FG003|Overall Study|Death|1|||
150099475|NCT00405587|541506887|FG000|Overall Study|Disease Progression|22|||
150099476|NCT00405587|541506888|FG001|Overall Study|Disease Progression|23|||
150099477|NCT00405587|541506889|FG002|Overall Study|Disease Progression|21|||
150099478|NCT00405587|541506890|FG003|Overall Study|Disease Progression|17|||
150099479|NCT00405587|541506887|FG000|Overall Study|Physician Decision|3|||
150099480|NCT00405587|541506888|FG001|Overall Study|Physician Decision|2|||
150099481|NCT00405587|541506889|FG002|Overall Study|Physician Decision|0|||
150099482|NCT00405587|541506890|FG003|Overall Study|Physician Decision|0|||
150099483|NCT00405587|541506887|FG000|Overall Study|Adverse Event|1|||
150099484|NCT00405587|541506888|FG001|Overall Study|Adverse Event|0|||
150099485|NCT00405587|541506889|FG002|Overall Study|Adverse Event|0|||
150099486|NCT00405587|541506890|FG003|Overall Study|Adverse Event|0|||
150099487|NCT00405587|541506887|FG000|Overall Study|Lost to Follow-up|0|||
150099488|NCT00405587|541506888|FG001|Overall Study|Lost to Follow-up|1|||
150099489|NCT00405587|541506889|FG002|Overall Study|Lost to Follow-up|1|||
150099490|NCT00405587|541506890|FG003|Overall Study|Lost to Follow-up|0|||
150099491|NCT00405587|541506887|FG000|Overall Study|Radiation induced necrosis|0|||
150099492|NCT00405587|541506888|FG001|Overall Study|Radiation induced necrosis|1|||
150099493|NCT00405587|541506889|FG002|Overall Study|Radiation induced necrosis|0|||
150099494|NCT00405587|541506890|FG003|Overall Study|Radiation induced necrosis|0|||
150099495|NCT00405587|541506887|FG000|Overall Study|Withdrawal by Subject|0|||
150099496|NCT00405587|541506888|FG001|Overall Study|Withdrawal by Subject|0|||
150099497|NCT00405587|541506889|FG002|Overall Study|Withdrawal by Subject|0|||
150099498|NCT00405587|541506890|FG003|Overall Study|Withdrawal by Subject|2|||
150099499|NCT00405587|541506887|FG000|Overall Study|Participant not dosed|0|||
150099500|NCT00405587|541506888|FG001|Overall Study|Participant not dosed|1|||
150099501|NCT00405587|541506889|FG002|Overall Study|Participant not dosed|0|||
150099502|NCT00405587|541506890|FG003|Overall Study|Participant not dosed|0|||
150099503|NCT02419742|541506895|FG000|Overall Study|Adverse Event|2|||
150099504|NCT02419742|541506896|FG001|Overall Study|Adverse Event|0|||
150099505|NCT02419742|541506895|FG000|Overall Study|Disease Progression|0|||
150099506|NCT02419742|541506896|FG001|Overall Study|Disease Progression|1|||
150099507|NCT02419742|541506895|FG000|Overall Study|Withdrew Consent|2|||
150099508|NCT02419742|541506896|FG001|Overall Study|Withdrew Consent|1|||
150099509|NCT02419742|541506895|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
150099510|NCT02419742|541506896|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
150099511|NCT00507442|541506897|FG000|Overall Study|Adverse Event|8|||
150099512|NCT00507442|541506898|FG001|Overall Study|Adverse Event|11|||
150099513|NCT00507442|541506899|FG002|Overall Study|Adverse Event|4|||
150099514|NCT00507442|541506900|FG003|Overall Study|Adverse Event|1|||
150099515|NCT00507442|541506897|FG000|Overall Study|Protocol Violation|0|||
150099516|NCT00507442|541506898|FG001|Overall Study|Protocol Violation|1|||
150099517|NCT00507442|541506899|FG002|Overall Study|Protocol Violation|0|||
150099518|NCT00507442|541506900|FG003|Overall Study|Protocol Violation|0|||
150099519|NCT00507442|541506897|FG000|Overall Study|Lost to Follow-up|0|||
150099520|NCT00507442|541506898|FG001|Overall Study|Lost to Follow-up|0|||
150099521|NCT00507442|541506899|FG002|Overall Study|Lost to Follow-up|1|||
150099522|NCT00507442|541506900|FG003|Overall Study|Lost to Follow-up|0|||
150099523|NCT00507442|541506897|FG000|Overall Study|Physician Decision|0|||
150099524|NCT00507442|541506898|FG001|Overall Study|Physician Decision|2|||
150099525|NCT00507442|541506899|FG002|Overall Study|Physician Decision|4|||
150099526|NCT00507442|541506900|FG003|Overall Study|Physician Decision|1|||
150099527|NCT00507442|541506897|FG000|Overall Study|Progressive Disease|2|||
150099528|NCT00507442|541506898|FG001|Overall Study|Progressive Disease|4|||
150099529|NCT00507442|541506899|FG002|Overall Study|Progressive Disease|2|||
150099530|NCT00507442|541506900|FG003|Overall Study|Progressive Disease|0|||
150099531|NCT00507442|541506897|FG000|Overall Study|Withdrawal by Subject|4|||
150099532|NCT00507442|541506898|FG001|Overall Study|Withdrawal by Subject|4|||
150099533|NCT00507442|541506899|FG002|Overall Study|Withdrawal by Subject|2|||
150099534|NCT00507442|541506900|FG003|Overall Study|Withdrawal by Subject|1|||
150099535|NCT00507442|541506897|FG000|Overall Study|Other|2|||
150099536|NCT00507442|541506898|FG001|Overall Study|Other|5|||
150099537|NCT00507442|541506899|FG002|Overall Study|Other|2|||
150099538|NCT00507442|541506900|FG003|Overall Study|Other|2|||
150099539|NCT01046682|541506905|FG000|Overall Study|Adverse Event|2|||
150099540|NCT01046682|541506906|FG001|Overall Study|Adverse Event|0|||
150099541|NCT02864251|541506914|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
150099542|NCT02864251|541506915|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
150099543|NCT02864251|541506916|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
150099544|NCT02864251|541506914|FG000|Pre-Treatment|Withdrawal by Participant|0|||
150099545|NCT02864251|541506915|FG001|Pre-Treatment|Withdrawal by Participant|0|||
150099546|NCT02864251|541506916|FG002|Pre-Treatment|Withdrawal by Participant|4|||
150099547|NCT02864251|541506914|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
150099548|NCT02864251|541506915|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
150099549|NCT02864251|541506916|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
150099550|NCT02864251|541506914|FG000|Pre-Treatment|Other Reasons|0|||
150099551|NCT02864251|541506915|FG001|Pre-Treatment|Other Reasons|1|||
150099552|NCT02864251|541506916|FG002|Pre-Treatment|Other Reasons|1|||
150099553|NCT02864251|541506914|FG000|Treatment|Disease Progression|109|||
150099554|NCT02864251|541506915|FG001|Treatment|Disease Progression|52|||
150099555|NCT02864251|541506916|FG002|Treatment|Disease Progression|101|||
150099556|NCT02864251|541506914|FG000|Treatment|Study Drug Toxicity|9|||
150099557|NCT02864251|541506915|FG001|Treatment|Study Drug Toxicity|4|||
150099558|NCT02864251|541506916|FG002|Treatment|Study Drug Toxicity|10|||
150099559|NCT02864251|541506914|FG000|Treatment|Death|0|||
150099560|NCT02864251|541506915|FG001|Treatment|Death|2|||
150099561|NCT02864251|541506916|FG002|Treatment|Death|3|||
150099562|NCT02864251|541506914|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
150099563|NCT02864251|541506915|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
150099564|NCT02864251|541506916|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
150099565|NCT02864251|541506914|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
150099566|NCT02864251|541506915|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
150099567|NCT02864251|541506916|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
150099568|NCT02864251|541506914|FG000|Treatment|Withdrawal by Participant|8|||
150099569|NCT02864251|541506915|FG001|Treatment|Withdrawal by Participant|5|||
150099570|NCT02864251|541506916|FG002|Treatment|Withdrawal by Participant|13|||
150099571|NCT02864251|541506914|FG000|Treatment|Maximum Clinical Benefit|1|||
150099572|NCT02864251|541506915|FG001|Treatment|Maximum Clinical Benefit|0|||
150099573|NCT02864251|541506916|FG002|Treatment|Maximum Clinical Benefit|1|||
150099574|NCT02864251|541506914|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
150099575|NCT02864251|541506915|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
150099576|NCT02864251|541506916|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
150099577|NCT02864251|541506914|FG000|Treatment|Other Reasons|1|||
150099578|NCT02864251|541506915|FG001|Treatment|Other Reasons|1|||
150099579|NCT02864251|541506916|FG002|Treatment|Other Reasons|4|||
150099580|NCT02864251|541506914|FG000|Treatment|Administrative Reason by Sponsor|1|||
150099581|NCT02864251|541506915|FG001|Treatment|Administrative Reason by Sponsor|0|||
150099582|NCT02864251|541506916|FG002|Treatment|Administrative Reason by Sponsor|0|||
150099583|NCT03506373|541506917|FG000|Overall Study|Adverse Event|6|||
150099584|NCT03506373|541506917|FG000|Overall Study|Withdrawal by Subject|2|||
150099585|NCT03506373|541506917|FG000|Overall Study|Disease progression|5|||
150099586|NCT03506373|541506917|FG000|Overall Study|Other|3|||
150099587|NCT00885755|541506918|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
150099588|NCT00885755|541506919|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
150099589|NCT00885755|541506920|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
150099590|NCT00885755|541506918|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
150099591|NCT00885755|541506919|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
150099592|NCT00885755|541506920|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
150099593|NCT00885755|541506918|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
150099594|NCT00885755|541506919|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
150099595|NCT00885755|541506920|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
150099596|NCT00885755|541506918|FG000|Part I: Trastuzumab+Taxane|Death|0|||
150099597|NCT00885755|541506919|FG001|Part I: Trastuzumab+Taxane|Death|0|||
150099598|NCT00885755|541506920|FG002|Part I: Trastuzumab+Taxane|Death|1|||
150099599|NCT00885755|541506918|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
150099600|NCT00885755|541506919|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
150099601|NCT00885755|541506920|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
150099602|NCT00107198|541506922|FG000|Overall Study|Lack of Efficacy|28|||
150099603|NCT00107198|541506922|FG000|Overall Study|Lost to Follow-up|12|||
150099604|NCT00107198|541506922|FG000|Overall Study|Protocol Violation|1|||
150099605|NCT00107198|541506922|FG000|Overall Study|Withdrawal by Subject|6|||
150099606|NCT00107198|541506922|FG000|Overall Study|Ineligible|5|||
150099607|NCT03340025|541506928|FG000|Overall Study|Lost to Follow-up|2|||
150099608|NCT03340025|541506929|FG001|Overall Study|Lost to Follow-up|2|||
150099609|NCT00322842|541506930|FG000|Overall Study|Withdrawal by Subject|0|||
150099610|NCT00322842|541506931|FG001|Overall Study|Withdrawal by Subject|1|||
150099611|NCT00322842|541506930|FG000|Overall Study|Lost to Follow-up|0|||
150099612|NCT00322842|541506931|FG001|Overall Study|Lost to Follow-up|1|||
150099613|NCT00322842|541506930|FG000|Overall Study|Refused transplant|1|||
150099614|NCT00322842|541506931|FG001|Overall Study|Refused transplant|0|||
150099615|NCT00322842|541506930|FG000|Overall Study|Death|1|||
150099616|NCT00322842|541506931|FG001|Overall Study|Death|0|||
150099617|NCT00832585|541506932|FG000|Overall Study|Withdrawal by Subject|1|||
150099618|NCT00832585|541506932|FG000|Overall Study|Lost to Follow-up|1|||
150099619|NCT00735878|541506933|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
150099620|NCT00735878|541506934|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
150099621|NCT00735878|541506935|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
150099622|NCT04404855|541506936|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
150099623|NCT04404855|541506937|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
150099624|NCT00302458|541506940|FG000|Overall Study|Lost to Follow-up|1|||
150099625|NCT00302458|541506940|FG000|Overall Study|Ineligible after screening|1|||
150099626|NCT00302458|541506940|FG000|Overall Study|Withdrawal by Subject|1|||
150099627|NCT02867709|541506941|FG000|Treatment Period|Adverse Event|1|||
150099628|NCT02867709|541506942|FG001|Treatment Period|Adverse Event|1|||
150099629|NCT02867709|541506943|FG002|Treatment Period|Adverse Event|2|||
150099630|NCT02867709|541506941|FG000|Treatment Period|Withdrawal of Consent|7|||
150099631|NCT02867709|541506942|FG001|Treatment Period|Withdrawal of Consent|9|||
150099632|NCT02867709|541506943|FG002|Treatment Period|Withdrawal of Consent|8|||
150099633|NCT02867709|541506941|FG000|Treatment Period|Lost to Follow-up|17|||
150099634|NCT02867709|541506942|FG001|Treatment Period|Lost to Follow-up|20|||
150099635|NCT02867709|541506943|FG002|Treatment Period|Lost to Follow-up|20|||
150099636|NCT02867709|541506941|FG000|Treatment Period|Lack of Qualifying Event|42|||
150099637|NCT02867709|541506942|FG001|Treatment Period|Lack of Qualifying Event|55|||
150099638|NCT02867709|541506943|FG002|Treatment Period|Lack of Qualifying Event|42|||
150099639|NCT02867709|541506941|FG000|Treatment Period|Protocol Violation|3|||
150099640|NCT02867709|541506942|FG001|Treatment Period|Protocol Violation|2|||
150099641|NCT02867709|541506943|FG002|Treatment Period|Protocol Violation|3|||
150099642|NCT02867709|541506941|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
150099643|NCT02867709|541506942|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
150099644|NCT02867709|541506943|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
150099645|NCT02867709|541506941|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
150099646|NCT02867709|541506942|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
150099647|NCT02867709|541506943|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
150099648|NCT02867709|541506941|FG000|Safety Follow-up Period|Pregnancy|0|||
150099649|NCT02867709|541506942|FG001|Safety Follow-up Period|Pregnancy|1|||
150099650|NCT02867709|541506943|FG002|Safety Follow-up Period|Pregnancy|0|||
150099651|NCT02867709|541506941|FG000|Safety Follow-up Period|Protocol Violation|0|||
150099652|NCT02867709|541506942|FG001|Safety Follow-up Period|Protocol Violation|1|||
150099653|NCT02867709|541506943|FG002|Safety Follow-up Period|Protocol Violation|1|||
150099654|NCT01400516|541506952|FG000|Primary Trial|Withdrawal by Subject|0|||
150099655|NCT01400516|541506953|FG001|Primary Trial|Withdrawal by Subject|2|||
150099656|NCT02946047|541506954|FG000|Overall Study|Adverse Event|1|||
150099657|NCT02946047|541506955|FG001|Overall Study|Adverse Event|0|||
150099658|NCT02946047|541506956|FG002|Overall Study|Adverse Event|0|||
150099659|NCT02946047|541506957|FG003|Overall Study|Adverse Event|0|||
150099660|NCT01344161|541506958|FG000|Overall Study|Lost to Follow-up|4|||
150099661|NCT01344161|541506959|FG001|Overall Study|Lost to Follow-up|1|||
150099662|NCT01344161|541506958|FG000|Overall Study|Pregnancy|0|||
150099663|NCT01344161|541506959|FG001|Overall Study|Pregnancy|1|||
150099664|NCT01344161|541506958|FG000|Overall Study|Protocol Violation|1|||
150099665|NCT01344161|541506959|FG001|Overall Study|Protocol Violation|1|||
150099666|NCT04364620|541506960|FG000|Overall Study|Disease Progression|20|||
150099667|NCT04364620|541506960|FG000|Overall Study|Adverse Event|5|||
150099668|NCT04364620|541506960|FG000|Overall Study|Physician Decision|4|||
150099669|NCT04364620|541506960|FG000|Overall Study|Death|3|||
150099670|NCT04364620|541506960|FG000|Overall Study|Other|2|||
150099671|NCT04364620|541506960|FG000|Overall Study|Withdrawal by Subject|1|||
150099672|NCT00156533|541508497|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
150099673|NCT00156533|541508498|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
150099674|NCT00156533|541508499|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
150099675|NCT00156533|541508500|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
150099676|NCT00156533|541508497|FG000|Overall Study|Withdrawal by Subject|1|||
150099677|NCT00156533|541508498|FG001|Overall Study|Withdrawal by Subject|0|||
150099678|NCT00156533|541508499|FG002|Overall Study|Withdrawal by Subject|0|||
150099679|NCT00156533|541508500|FG003|Overall Study|Withdrawal by Subject|1|||
150099680|NCT00156533|541508497|FG000|Overall Study|Failed Screening|1|||
150099681|NCT00156533|541508498|FG001|Overall Study|Failed Screening|0|||
150099682|NCT00156533|541508499|FG002|Overall Study|Failed Screening|1|||
150099683|NCT00156533|541508500|FG003|Overall Study|Failed Screening|1|||
150099684|NCT01541969|541508501|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
150099685|NCT01541969|541508502|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
150099686|NCT01541969|541508501|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
150099687|NCT01541969|541508502|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
150099688|NCT01541969|541508501|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
150099689|NCT01541969|541508502|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
150099690|NCT01541969|541508501|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
150099691|NCT01541969|541508502|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
150099692|NCT01541969|541508501|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
150099693|NCT01541969|541508502|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
150099694|NCT01541969|541508501|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
150099695|NCT01541969|541508502|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
150099696|NCT01541969|541508501|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
150099697|NCT01541969|541508502|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
150099698|NCT01541969|541508501|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
150099699|NCT01541969|541508502|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
150099700|NCT01541969|541508501|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
150099701|NCT01541969|541508502|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
150099702|NCT01541969|541508501|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
150099703|NCT01541969|541508502|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
150099704|NCT01365507|541508503|FG000|Overall Study|Withdrawal Criteria|8|||
150099705|NCT01365507|541508504|FG001|Overall Study|Withdrawal Criteria|5|||
150099706|NCT01365507|541508503|FG000|Overall Study|Unclassified|1|||
150099707|NCT01365507|541508504|FG001|Overall Study|Unclassified|4|||
150099708|NCT03265249|541508507|FG000|Overall Study|Withdrawal by Subject|0|||
150099709|NCT03265249|541508508|FG001|Overall Study|Withdrawal by Subject|1|||
150099710|NCT01614990|541508509|FG000|Overall Study|Protocol Violation|1|||
150099711|NCT01614990|541508510|FG001|Overall Study|Protocol Violation|1|||
150099712|NCT02255500|541508515|FG000|Overall Study|Withdrawal by Subject|1|||
150099713|NCT02255500|541508516|FG001|Overall Study|Withdrawal by Subject|0|||
150099714|NCT04254978|541508519|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
150099715|NCT04254978|541508519|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
150099716|NCT04254978|541508519|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
150099717|NCT04254978|541508519|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
150099718|NCT04254978|541508519|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
150099719|NCT04254978|541508519|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
150099720|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
150099721|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
150099722|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
150099723|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
150099724|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
150099725|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
150099726|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
150099727|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
150099728|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
150099729|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
150099730|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
150099731|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
150099732|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
150099733|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
150099734|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
150185362|NCT05059262|541817118|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
150185363|NCT05059262|541817119|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
150185364|NCT05059262|541817118|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
150185365|NCT05059262|541817119|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
150185366|NCT05059262|541817118|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
150185367|NCT05059262|541817119|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
150099735|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
150185368|NCT05059262|541817118|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
150185369|NCT05059262|541817119|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
150185370|NCT05059262|541817118|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
150099736|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
150099737|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
150099738|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
150099739|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
150099740|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
150099741|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
150099742|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
150099743|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
150099744|NCT00277212|541508521|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
150099745|NCT00277212|541508522|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
150099746|NCT00277212|541508523|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
150099747|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
150099748|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
150099749|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
150099750|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
150099751|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
150099752|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
150099753|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
150099754|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
150099755|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
150099756|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
150099757|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
150099758|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
150099759|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
150099760|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
150099761|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
150099762|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
150099763|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
150099764|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
150099765|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
150099766|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
150099767|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
150099768|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
150099769|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
150099770|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
150099771|NCT00277212|541508521|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
150099772|NCT00277212|541508522|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
150099773|NCT00277212|541508523|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
150099774|NCT00902564|541508524|FG000|Overall Study|Withdrawal by Subject|2|||
150099775|NCT03336216|541508530|FG000|Randomization|Not reported|2|||
150099776|NCT03336216|541508531|FG001|Randomization|Not reported|0|||
150099777|NCT03336216|541508532|FG002|Randomization|Not reported|1|||
150099778|NCT03336216|541508533|FG003|Randomization|Not reported|0|||
150099779|NCT03336216|541508530|FG000|Randomization|Other reasons|1|||
150099780|NCT03336216|541508531|FG001|Randomization|Other reasons|1|||
150099781|NCT03336216|541508532|FG002|Randomization|Other reasons|1|||
150099782|NCT03336216|541508533|FG003|Randomization|Other reasons|0|||
150099783|NCT03336216|541508530|FG000|Randomization|Participant no longer meets study criteria|0|||
150099784|NCT03336216|541508531|FG001|Randomization|Participant no longer meets study criteria|2|||
150099785|NCT03336216|541508532|FG002|Randomization|Participant no longer meets study criteria|4|||
150099786|NCT03336216|541508533|FG003|Randomization|Participant no longer meets study criteria|1|||
150099787|NCT03336216|541508530|FG000|Randomization|Lost to Follow-up|1|||
150099788|NCT03336216|541508531|FG001|Randomization|Lost to Follow-up|0|||
150099789|NCT03336216|541508532|FG002|Randomization|Lost to Follow-up|0|||
150099790|NCT03336216|541508533|FG003|Randomization|Lost to Follow-up|0|||
150099791|NCT03336216|541508530|FG000|Randomization|Participant withdrew consent|9|||
150099792|NCT03336216|541508531|FG001|Randomization|Participant withdrew consent|1|||
150099793|NCT03336216|541508532|FG002|Randomization|Participant withdrew consent|0|||
150099794|NCT03336216|541508533|FG003|Randomization|Participant withdrew consent|0|||
150099795|NCT03336216|541508530|FG000|Randomization|Adverse Event|1|||
150099796|NCT03336216|541508531|FG001|Randomization|Adverse Event|1|||
150099797|NCT03336216|541508532|FG002|Randomization|Adverse Event|0|||
150099798|NCT03336216|541508533|FG003|Randomization|Adverse Event|0|||
150099799|NCT03336216|541508530|FG000|Treatment|Adverse Event|2|||
150099800|NCT03336216|541508531|FG001|Treatment|Adverse Event|3|||
150099801|NCT03336216|541508532|FG002|Treatment|Adverse Event|4|||
150099802|NCT03336216|541508533|FG003|Treatment|Adverse Event|4|||
150099803|NCT03336216|541508530|FG000|Treatment|Participant request to discontinue treatment|2|||
150099804|NCT03336216|541508531|FG001|Treatment|Participant request to discontinue treatment|1|||
150099805|NCT03336216|541508532|FG002|Treatment|Participant request to discontinue treatment|2|||
150099806|NCT03336216|541508533|FG003|Treatment|Participant request to discontinue treatment|2|||
150099807|NCT03336216|541508530|FG000|Treatment|Participant withdrew consent|7|||
150099808|NCT03336216|541508531|FG001|Treatment|Participant withdrew consent|2|||
150099809|NCT03336216|541508532|FG002|Treatment|Participant withdrew consent|3|||
150099810|NCT03336216|541508533|FG003|Treatment|Participant withdrew consent|2|||
150099811|NCT03336216|541508530|FG000|Treatment|Death|2|||
150099812|NCT03336216|541508531|FG001|Treatment|Death|3|||
150099813|NCT03336216|541508532|FG002|Treatment|Death|3|||
150099814|NCT03336216|541508533|FG003|Treatment|Death|4|||
150099815|NCT03336216|541508530|FG000|Treatment|Participant no longer meets study criteria|0|||
150099816|NCT03336216|541508531|FG001|Treatment|Participant no longer meets study criteria|1|||
150099817|NCT03336216|541508532|FG002|Treatment|Participant no longer meets study criteria|0|||
150099818|NCT03336216|541508533|FG003|Treatment|Participant no longer meets study criteria|0|||
150099819|NCT03336216|541508530|FG000|Treatment|Other reasons|2|||
150099820|NCT03336216|541508531|FG001|Treatment|Other reasons|0|||
150099821|NCT03336216|541508532|FG002|Treatment|Other reasons|0|||
150099822|NCT03336216|541508533|FG003|Treatment|Other reasons|3|||
150099823|NCT03336216|541508530|FG000|Treatment|Disease progression|23|||
150099824|NCT03336216|541508531|FG001|Treatment|Disease progression|34|||
150099825|NCT03336216|541508532|FG002|Treatment|Disease progression|33|||
150099826|NCT03336216|541508533|FG003|Treatment|Disease progression|26|||
150099827|NCT03336216|541508530|FG000|Treatment|Study drug toxicity|0|||
150099828|NCT03336216|541508531|FG001|Treatment|Study drug toxicity|3|||
150099829|NCT03336216|541508532|FG002|Treatment|Study drug toxicity|2|||
150099830|NCT03336216|541508533|FG003|Treatment|Study drug toxicity|0|||
150099831|NCT03336216|541508530|FG000|Treatment|Adverse Event unrelated to study drug|1|||
150099832|NCT03336216|541508531|FG001|Treatment|Adverse Event unrelated to study drug|1|||
150099833|NCT03336216|541508532|FG002|Treatment|Adverse Event unrelated to study drug|1|||
150099834|NCT03336216|541508533|FG003|Treatment|Adverse Event unrelated to study drug|0|||
150099835|NCT03336216|541508530|FG000|Treatment|Disease Recurrence|1|||
150099836|NCT03336216|541508531|FG001|Treatment|Disease Recurrence|0|||
150099837|NCT03336216|541508532|FG002|Treatment|Disease Recurrence|0|||
150099838|NCT03336216|541508533|FG003|Treatment|Disease Recurrence|0|||
150099839|NCT05954052|541508539|FG000|Overall Study|Adverse Event|1|||
150185371|NCT05059262|541817119|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
150185372|NCT04737772|541817125|FG000|Phase 2 Study|Lost to Follow-up|15|||
150099840|NCT01957462|541508540|FG000|Test Period 1|Withdrawal by Subject|1|||
150099841|NCT01957462|541508541|FG001|Test Period 1|Withdrawal by Subject|0|||
150099842|NCT01957462|541508540|FG000|Test Period 1|Adverse Event|1|||
150099843|NCT01957462|541508541|FG001|Test Period 1|Adverse Event|0|||
150099844|NCT01856790|541508542|FG000|Closed Loop Control|Withdrawal by Subject|2|||
150099845|NCT01856790|541508542|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
150099846|NCT01124604|541508543|FG000|Overall Study|Adverse Event|10|||
150099847|NCT01124604|541508544|FG001|Overall Study|Adverse Event|1|||
150099848|NCT01124604|541508543|FG000|Overall Study|Lack of Efficacy|1|||
150099849|NCT01124604|541508544|FG001|Overall Study|Lack of Efficacy|0|||
150185373|NCT04737772|541817126|FG001|Phase 2 Study|Lost to Follow-up|15|||
150099850|NCT01124604|541508543|FG000|Overall Study|Withdrawal by Subject|4|||
150099851|NCT01124604|541508544|FG001|Overall Study|Withdrawal by Subject|0|||
150185374|NCT04737772|541817125|FG000|Phase 2 Study|Withdrawal by Subject|0|||
150099852|NCT01124604|541508543|FG000|Overall Study|Disease Progression|0|||
150099853|NCT01124604|541508544|FG001|Overall Study|Disease Progression|1|||
150099854|NCT03102918|541508547|FG000|Overall Study|Protocol Violation|1|||
150099855|NCT03102918|541508548|FG001|Overall Study|Protocol Violation|0|||
150099856|NCT01344447|541508549|FG000|Overall Study|Adverse Event|1|||
150099857|NCT01344447|541508549|FG000|Overall Study|Protocol Violation|1|||
150099858|NCT01344447|541508549|FG000|Overall Study|Withdrawal by Subject|1|||
150099859|NCT01344447|541508549|FG000|Overall Study|The contrast was not seen|1|||
150099860|NCT01344447|541508549|FG000|Overall Study|Physician Decision|1|||
150099861|NCT01344447|541508549|FG000|Overall Study|MRA unsuccessful|1|||
150099862|NCT01344447|541508549|FG000|Overall Study|Bolus tracking failed|1|||
150099863|NCT01344447|541508549|FG000|Overall Study|Error of power injector|1|||
150099864|NCT01660711|541508550|FG000|Overall Study|Adverse Event|7|||
150099865|NCT01660711|541508550|FG000|Overall Study|Withdrawal by Subject|1|||
150099866|NCT00952341|541508552|FG000|Cycle 1|Adverse Event|4|||
150099867|NCT00952341|541508553|FG001|Cycle 1|Adverse Event|1|||
150099868|NCT00952341|541508552|FG000|Cycle 1|Withdrawal by Subject|3|||
150099869|NCT00952341|541508553|FG001|Cycle 1|Withdrawal by Subject|8|||
150099870|NCT00952341|541508552|FG000|Cycle 1|Protocol Violation|2|||
150099871|NCT00952341|541508553|FG001|Cycle 1|Protocol Violation|1|||
150099872|NCT00952341|541508552|FG000|Cycle 1|Lost to Follow-up|11|||
150099873|NCT00952341|541508553|FG001|Cycle 1|Lost to Follow-up|2|||
150099874|NCT00952341|541508552|FG000|Cycle 1|Physician Decision|0|||
150099875|NCT00952341|541508553|FG001|Cycle 1|Physician Decision|1|||
150099876|NCT00952341|541508552|FG000|Cycle 2|Withdrawal by Subject|1|||
150099877|NCT00952341|541508553|FG001|Cycle 2|Withdrawal by Subject|1|||
150099878|NCT00952341|541508552|FG000|Cycle 2|Protocol Violation|1|||
150099879|NCT00952341|541508553|FG001|Cycle 2|Protocol Violation|0|||
150099880|NCT00952341|541508552|FG000|Cycle 2|Lost to Follow-up|6|||
150099881|NCT00952341|541508553|FG001|Cycle 2|Lost to Follow-up|9|||
150099882|NCT00952341|541508552|FG000|Cycle 2|Physician Decision|1|||
150099883|NCT00952341|541508553|FG001|Cycle 2|Physician Decision|1|||
150099884|NCT00952341|541508552|FG000|Cycle 2|Progressive Disease|0|||
150099885|NCT00952341|541508553|FG001|Cycle 2|Progressive Disease|1|||
150099886|NCT00456521|541508554|FG000|Overall Study|Adverse Event|150|||
150099887|NCT00456521|541508555|FG001|Overall Study|Adverse Event|25|||
150099888|NCT00456521|541508554|FG000|Overall Study|Withdrawal by Subject|43|||
150099889|NCT00456521|541508555|FG001|Overall Study|Withdrawal by Subject|24|||
150099890|NCT00456521|541508554|FG000|Overall Study|Lost to Follow-up|22|||
150099891|NCT00456521|541508555|FG001|Overall Study|Lost to Follow-up|17|||
150099892|NCT00456521|541508554|FG000|Overall Study|Lack of Efficacy|3|||
150099893|NCT00456521|541508555|FG001|Overall Study|Lack of Efficacy|6|||
150099894|NCT00456521|541508554|FG000|Overall Study|Protocol Violation|4|||
150099895|NCT00456521|541508555|FG001|Overall Study|Protocol Violation|0|||
150099896|NCT00456521|541508554|FG000|Overall Study|Pregnancy|1|||
150099897|NCT00456521|541508555|FG001|Overall Study|Pregnancy|1|||
150099898|NCT00456521|541508554|FG000|Overall Study|Drug non-compliance, moved, other|26|||
150099899|NCT00456521|541508555|FG001|Overall Study|Drug non-compliance, moved, other|11|||
150099900|NCT01316276|541508556|FG000|Overall Study|Death|1|||
150099901|NCT01316276|541508556|FG000|Overall Study|Adverse Event|19|||
150099902|NCT01316276|541508556|FG000|Overall Study|Withdrawal of consent|24|||
150099903|NCT01316276|541508556|FG000|Overall Study|Lost to Follow-up|1|||
150099904|NCT01316276|541508556|FG000|Overall Study|Other|22|||
150099905|NCT00076011|541508560|FG000|Overall Study|Death|1|||
150099906|NCT00076011|541508560|FG000|Overall Study|Adverse Event|10|||
150099907|NCT00076011|541508560|FG000|Overall Study|Lack of Efficacy|25|||
150099908|NCT00076011|541508560|FG000|Overall Study|Withdrawal by Subject|1|||
150099909|NCT00076011|541508560|FG000|Overall Study|Study terminated by sponsor|3|||
150099910|NCT00076011|541508560|FG000|Overall Study|Other|11|||
150099911|NCT00076011|541508560|FG000|Overall Study|Ongoing|1|||
150099912|NCT03056755|541508566|FG000|Treatment- Core Phase|Progressive disease|89|||
150099913|NCT03056755|541508567|FG001|Treatment- Core Phase|Progressive disease|88|||
150099914|NCT03056755|541508568|FG002|Treatment- Core Phase|Progressive disease|90|||
150099915|NCT03056755|541508566|FG000|Treatment- Core Phase|Adverse Event|20|||
150099916|NCT03056755|541508567|FG001|Treatment- Core Phase|Adverse Event|14|||
150099917|NCT03056755|541508568|FG002|Treatment- Core Phase|Adverse Event|13|||
150099918|NCT03056755|541508566|FG000|Treatment- Core Phase|Physician Decision|7|||
150099919|NCT03056755|541508567|FG001|Treatment- Core Phase|Physician Decision|13|||
150099920|NCT03056755|541508568|FG002|Treatment- Core Phase|Physician Decision|5|||
150099921|NCT03056755|541508566|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
150099922|NCT03056755|541508567|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
150099923|NCT03056755|541508568|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
150099924|NCT03056755|541508566|FG000|Treatment- Core Phase|Death|3|||
150099925|NCT03056755|541508567|FG001|Treatment- Core Phase|Death|2|||
150099926|NCT03056755|541508568|FG002|Treatment- Core Phase|Death|4|||
150099927|NCT03056755|541508566|FG000|Treatment- Core Phase|Protocol deviation|1|||
150099928|NCT03056755|541508567|FG001|Treatment- Core Phase|Protocol deviation|1|||
150099929|NCT03056755|541508568|FG002|Treatment- Core Phase|Protocol deviation|0|||
150099930|NCT03056755|541508566|FG000|Treatment- Core Phase|Technical problems|1|||
150099931|NCT03056755|541508567|FG001|Treatment- Core Phase|Technical problems|0|||
150099932|NCT03056755|541508568|FG002|Treatment- Core Phase|Technical problems|0|||
150099933|NCT03056755|541508566|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
150099934|NCT03056755|541508567|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
150099935|NCT03056755|541508568|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
150099936|NCT03056755|541508566|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
150099937|NCT03056755|541508567|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
150099938|NCT03056755|541508568|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
150099939|NCT03056755|541508566|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
150099940|NCT03056755|541508567|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
150099941|NCT03056755|541508568|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
150099942|NCT03056755|541508566|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
150099943|NCT03056755|541508567|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
150099944|NCT03056755|541508568|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
150099945|NCT00464568|541508571|FG000|Overall Study|Adverse Event|2|||
150099946|NCT03406858|541508576|FG000|Overall Study|Failure to receive treatment drug.|1|||
150099947|NCT03406858|541508576|FG000|Overall Study|ineligible|1|||
150099948|NCT06027866|541508577|FG000|Overall Study|Withdrawal by Subject|2|||
150099949|NCT00930579|541508578|FG000|Overall Study|Withdrawal by Subject|1|||
150099950|NCT00930579|541508578|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
150099951|NCT02672423|541508580|FG000|Period 1|Adverse Event|0|||
150099952|NCT02672423|541508581|FG001|Period 1|Adverse Event|0|||
150099953|NCT02672423|541508582|FG002|Period 1|Adverse Event|0|||
150099954|NCT02672423|541508583|FG003|Period 1|Adverse Event|0|||
150099955|NCT02672423|541508584|FG004|Period 1|Adverse Event|1|||
150099956|NCT02672423|541508585|FG005|Period 1|Adverse Event|0|||
150099957|NCT02672423|541508586|FG006|Period 1|Adverse Event|0|||
150099958|NCT02672423|541508587|FG007|Period 1|Adverse Event|0|||
150099959|NCT02672423|541508588|FG008|Period 1|Adverse Event|0|||
150099960|NCT02672423|541508589|FG009|Period 1|Adverse Event|0|||
150099961|NCT02672423|541508580|FG000|Period 2|Withdrawal by Subject|0|||
150099962|NCT02672423|541508581|FG001|Period 2|Withdrawal by Subject|0|||
150099963|NCT02672423|541508582|FG002|Period 2|Withdrawal by Subject|1|||
150099964|NCT02672423|541508583|FG003|Period 2|Withdrawal by Subject|0|||
150099965|NCT02672423|541508584|FG004|Period 2|Withdrawal by Subject|0|||
150099966|NCT02672423|541508585|FG005|Period 2|Withdrawal by Subject|0|||
150099967|NCT02672423|541508586|FG006|Period 2|Withdrawal by Subject|0|||
150099968|NCT02672423|541508587|FG007|Period 2|Withdrawal by Subject|0|||
150099969|NCT02672423|541508588|FG008|Period 2|Withdrawal by Subject|0|||
150099970|NCT02672423|541508589|FG009|Period 2|Withdrawal by Subject|0|||
150099971|NCT02672423|541508580|FG000|Period 3|Withdrawal by Subject|0|||
150099972|NCT02672423|541508581|FG001|Period 3|Withdrawal by Subject|0|||
150099973|NCT02672423|541508582|FG002|Period 3|Withdrawal by Subject|0|||
150099974|NCT02672423|541508583|FG003|Period 3|Withdrawal by Subject|0|||
150099975|NCT02672423|541508584|FG004|Period 3|Withdrawal by Subject|0|||
150099976|NCT02672423|541508585|FG005|Period 3|Withdrawal by Subject|0|||
150099977|NCT02672423|541508586|FG006|Period 3|Withdrawal by Subject|0|||
150099978|NCT02672423|541508587|FG007|Period 3|Withdrawal by Subject|1|||
150099979|NCT02672423|541508588|FG008|Period 3|Withdrawal by Subject|0|||
150099980|NCT02672423|541508589|FG009|Period 3|Withdrawal by Subject|0|||
150099981|NCT02672423|541508580|FG000|Period 3|Physician Decision|0|||
150099982|NCT02672423|541508581|FG001|Period 3|Physician Decision|0|||
150099983|NCT02672423|541508582|FG002|Period 3|Physician Decision|0|||
150099984|NCT02672423|541508583|FG003|Period 3|Physician Decision|0|||
150099985|NCT02672423|541508584|FG004|Period 3|Physician Decision|0|||
150099986|NCT02672423|541508585|FG005|Period 3|Physician Decision|1|||
150099987|NCT02672423|541508586|FG006|Period 3|Physician Decision|0|||
150099988|NCT02672423|541508587|FG007|Period 3|Physician Decision|0|||
150185375|NCT04737772|541817126|FG001|Phase 2 Study|Withdrawal by Subject|1|||
150099989|NCT02672423|541508588|FG008|Period 3|Physician Decision|0|||
150099990|NCT02672423|541508589|FG009|Period 3|Physician Decision|0|||
150099991|NCT05071183|541508590|FG000|Overall Study|Death|1|||
150185376|NCT04737772|541817125|FG000|Phase 2 Study|Did not take any coaching calls|4|||
150099992|NCT05071183|541508591|FG001|Overall Study|Death|2|||
150099993|NCT05071183|541508592|FG002|Overall Study|Death|0|||
150099994|NCT05071183|541508590|FG000|Overall Study|Other Reasons|1|||
150099995|NCT05071183|541508591|FG001|Overall Study|Other Reasons|3|||
150185377|NCT04737772|541817126|FG001|Phase 2 Study|Did not take any coaching calls|0|||
150185378|NCT04737772|541817125|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
150185379|NCT04737772|541817126|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
150185380|NCT04737772|541817125|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
150099996|NCT05071183|541508592|FG002|Overall Study|Other Reasons|2|||
150185381|NCT04737772|541817126|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
150185382|NCT02549339|541817127|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
150185383|NCT02549339|541817128|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
150185384|NCT02549339|541817127|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
150185385|NCT02549339|541817128|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
150185386|NCT02549339|541817127|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
150185387|NCT02549339|541817128|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
150099997|NCT02046148|541508593|FG000|Overall Study|Lost to Follow-up|1|||
150099998|NCT02046148|541508594|FG001|Overall Study|Lost to Follow-up|1|||
150099999|NCT02046148|541508593|FG000|Overall Study|Withdrawal by Subject|0|||
150100000|NCT02046148|541508594|FG001|Overall Study|Withdrawal by Subject|2|||
150100001|NCT02420691|541508597|FG000|Overall Study|Adverse Event|3|||
150100002|NCT02420691|541508597|FG000|Overall Study|Withdrawal by Subject|3|||
150100003|NCT02120950|541508600|FG000|Overall Study|Adverse Event|5|||
150100004|NCT02120950|541508601|FG001|Overall Study|Adverse Event|4|||
150100005|NCT02120950|541508602|FG002|Overall Study|Adverse Event|3|||
150100006|NCT02120950|541508600|FG000|Overall Study|Death|3|||
150100007|NCT02120950|541508601|FG001|Overall Study|Death|0|||
150100008|NCT02120950|541508602|FG002|Overall Study|Death|1|||
150185388|NCT02549339|541817127|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
150100009|NCT02120950|541508600|FG000|Overall Study|Withdrawal by Subject|6|||
150100010|NCT02120950|541508601|FG001|Overall Study|Withdrawal by Subject|3|||
150100011|NCT02120950|541508602|FG002|Overall Study|Withdrawal by Subject|2|||
150100012|NCT02120950|541508600|FG000|Overall Study|Protocol Violation|1|||
150100013|NCT02120950|541508601|FG001|Overall Study|Protocol Violation|1|||
150100014|NCT02120950|541508602|FG002|Overall Study|Protocol Violation|7|||
150100015|NCT02120950|541508600|FG000|Overall Study|Other reasons|5|||
150100016|NCT02120950|541508601|FG001|Overall Study|Other reasons|4|||
150100017|NCT02120950|541508602|FG002|Overall Study|Other reasons|1|||
150100018|NCT02120950|541508600|FG000|Overall Study|Lost to Follow-up|0|||
150100019|NCT02120950|541508601|FG001|Overall Study|Lost to Follow-up|2|||
150100020|NCT02120950|541508602|FG002|Overall Study|Lost to Follow-up|1|||
150100021|NCT01852812|541508603|FG000|Overall Study|Adverse Event|0|||
150100022|NCT01852812|541508604|FG001|Overall Study|Adverse Event|0|||
150100023|NCT01852812|541508605|FG002|Overall Study|Adverse Event|1|||
150100024|NCT01852812|541508603|FG000|Overall Study|Non-compliance With Study Drug|0|||
150100025|NCT01852812|541508604|FG001|Overall Study|Non-compliance With Study Drug|1|||
150100026|NCT01852812|541508605|FG002|Overall Study|Non-compliance With Study Drug|0|||
150100027|NCT01752855|541508608|FG000|Overall Study|Adverse Event|1|||
150100028|NCT01752855|541508609|FG001|Overall Study|Adverse Event|0|||
150100029|NCT01752855|541508608|FG000|Overall Study|Withdrew Consent|0|||
150100030|NCT01752855|541508609|FG001|Overall Study|Withdrew Consent|2|||
150100031|NCT01752855|541508608|FG000|Overall Study|Lack of Efficacy|0|||
150100032|NCT01752855|541508609|FG001|Overall Study|Lack of Efficacy|2|||
150100033|NCT02625090|541508610|FG000|Overall Study|Participant wants to be pregnant|2|||
150100034|NCT02625090|541508610|FG000|Overall Study|For the Promoter|1|||
150100035|NCT02625090|541508610|FG000|Overall Study|Sponsor's Decision|9|||
150100036|NCT02625090|541508610|FG000|Overall Study|Somnolence|1|||
150100037|NCT02625090|541508610|FG000|Overall Study|Study terminated by Sponsor|7|||
150100038|NCT02625090|541508610|FG000|Overall Study|Negative Benefit/Risk|1|||
150100039|NCT02625090|541508610|FG000|Overall Study|Protocol Deviation|2|||
150100040|NCT02625090|541508610|FG000|Overall Study|Lack of Efficacy|16|||
150100041|NCT02625090|541508610|FG000|Overall Study|Adverse Event|3|||
150100042|NCT03168464|541508611|FG000|Overall Study|Death|9|||
150100043|NCT03168464|541508611|FG000|Overall Study|Progression of disease|6|||
150100044|NCT04649164|541508612|FG000|Overall Study|Withdrawal by Subject|1|||
150100045|NCT04649164|541508613|FG001|Overall Study|Withdrawal by Subject|1|||
150100046|NCT04649164|541508614|FG002|Overall Study|Withdrawal by Subject|2|||
150100047|NCT04649164|541508612|FG000|Overall Study|Participant's care recipient expired|0|||
150100048|NCT04649164|541508613|FG001|Overall Study|Participant's care recipient expired|0|||
150100049|NCT04649164|541508614|FG002|Overall Study|Participant's care recipient expired|2|||
150100050|NCT02250443|541508615|FG000|Overall Study|Administrative problems|7|||
150100051|NCT02250443|541508615|FG000|Overall Study|Adverse Event|3|||
150100052|NCT01549964|541508616|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
150100053|NCT01549964|541508617|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
150100054|NCT01549964|541508618|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
150100055|NCT01549964|541508619|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
150100056|NCT01549964|541508616|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
150100057|NCT01549964|541508617|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
150100058|NCT01549964|541508618|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
150100059|NCT01549964|541508619|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
150100060|NCT01549964|541508616|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
150100061|NCT01549964|541508617|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
150100062|NCT01549964|541508618|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
150100063|NCT01549964|541508619|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
150100064|NCT01549964|541508616|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
150100065|NCT01549964|541508617|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
150100066|NCT01549964|541508618|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
150100067|NCT01549964|541508619|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
150100068|NCT01549964|541508616|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
150100069|NCT01549964|541508617|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
150100070|NCT01549964|541508618|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
150100071|NCT01549964|541508619|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
150100072|NCT01549964|541508616|FG000|24-Week Treatment Period|Other|1|||
150100073|NCT01549964|541508617|FG001|24-Week Treatment Period|Other|0|||
150100074|NCT01549964|541508618|FG002|24-Week Treatment Period|Other|1|||
150100075|NCT01549964|541508619|FG003|24-Week Treatment Period|Other|0|||
150100076|NCT01549964|541508616|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
150100077|NCT01549964|541508617|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
150100078|NCT01549964|541508618|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
150100079|NCT01549964|541508619|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
150100080|NCT01549964|541508616|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
150100081|NCT01549964|541508617|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
150100082|NCT01549964|541508618|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
150100083|NCT01549964|541508619|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
150100084|NCT01549964|541508616|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
150100085|NCT01549964|541508617|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
150100086|NCT01549964|541508618|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
150100087|NCT01549964|541508619|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
150100088|NCT01549964|541508616|FG000|80-Week Extension Period|Pregnancy|0|||
150100089|NCT01549964|541508617|FG001|80-Week Extension Period|Pregnancy|0|||
150100090|NCT01549964|541508618|FG002|80-Week Extension Period|Pregnancy|1|||
150100091|NCT01549964|541508619|FG003|80-Week Extension Period|Pregnancy|0|||
150100092|NCT01549964|541508616|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
150100093|NCT01549964|541508617|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
150100094|NCT01549964|541508618|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
150100095|NCT01549964|541508619|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
150100096|NCT01549964|541508616|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
150100097|NCT01549964|541508617|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
150100098|NCT01549964|541508618|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
150100099|NCT01549964|541508619|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
150100100|NCT01549964|541508616|FG000|80-Week Extension Period|Lost to Follow-up|1|||
150100101|NCT01549964|541508617|FG001|80-Week Extension Period|Lost to Follow-up|0|||
150100102|NCT01549964|541508618|FG002|80-Week Extension Period|Lost to Follow-up|2|||
150100103|NCT01549964|541508619|FG003|80-Week Extension Period|Lost to Follow-up|1|||
150100104|NCT01549964|541508616|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
150100105|NCT01549964|541508617|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
150100106|NCT01549964|541508618|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
150100107|NCT01549964|541508619|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
150100108|NCT00751348|541508622|FG000|Overall Study|Withdrawal by Subject|5|||
150100109|NCT00751348|541508623|FG001|Overall Study|Withdrawal by Subject|2|||
150100110|NCT00751348|541508622|FG000|Overall Study|Migration from study area|1|||
150100111|NCT00751348|541508623|FG001|Overall Study|Migration from study area|0|||
150100112|NCT03965962|541508632|FG000|Overall Study|Adverse Event|1|||
150100113|NCT03965962|541508633|FG001|Overall Study|Adverse Event|0|||
150100114|NCT03965962|541508634|FG002|Overall Study|Adverse Event|0|||
150100115|NCT03965962|541508635|FG003|Overall Study|Adverse Event|0|||
150100116|NCT03965962|541508632|FG000|Overall Study|Protocol Violation|21|||
150100117|NCT03965962|541508633|FG001|Overall Study|Protocol Violation|4|||
150100118|NCT03965962|541508634|FG002|Overall Study|Protocol Violation|10|||
150100119|NCT03965962|541508635|FG003|Overall Study|Protocol Violation|5|||
150100120|NCT03965962|541508632|FG000|Overall Study|Lost to Follow-up|0|||
150100121|NCT03965962|541508633|FG001|Overall Study|Lost to Follow-up|1|||
150100122|NCT03965962|541508634|FG002|Overall Study|Lost to Follow-up|0|||
150100123|NCT03965962|541508635|FG003|Overall Study|Lost to Follow-up|0|||
150100124|NCT03965962|541508632|FG000|Overall Study|Withdrawal by Subject|3|||
150100125|NCT03965962|541508633|FG001|Overall Study|Withdrawal by Subject|0|||
150100126|NCT03965962|541508634|FG002|Overall Study|Withdrawal by Subject|0|||
150100127|NCT03965962|541508635|FG003|Overall Study|Withdrawal by Subject|1|||
150100128|NCT00741039|541508636|FG000|Overall Study|Patient non-compliance|2|||
150100129|NCT00741039|541508637|FG001|Overall Study|Patient non-compliance|0|||
150100130|NCT01712854|541508638|FG000|Overall Study|Physician Decision|1|||
150100131|NCT01466387|541508641|FG000|Overall Study|Adverse Event|0|||
150100132|NCT01466387|541508642|FG001|Overall Study|Adverse Event|0|||
150100133|NCT01466387|541508643|FG002|Overall Study|Adverse Event|1|||
150100134|NCT01466387|541508644|FG003|Overall Study|Adverse Event|1|||
150100135|NCT01466387|541508645|FG004|Overall Study|Adverse Event|0|||
150100136|NCT01466387|541508646|FG005|Overall Study|Adverse Event|0|||
150100137|NCT01466387|541508641|FG000|Overall Study|Lost to Follow-up|0|||
150100138|NCT01466387|541508642|FG001|Overall Study|Lost to Follow-up|0|||
150100139|NCT01466387|541508643|FG002|Overall Study|Lost to Follow-up|0|||
150100140|NCT01466387|541508644|FG003|Overall Study|Lost to Follow-up|0|||
150100141|NCT01466387|541508645|FG004|Overall Study|Lost to Follow-up|0|||
150100142|NCT01466387|541508646|FG005|Overall Study|Lost to Follow-up|1|||
150100143|NCT01466387|541508641|FG000|Overall Study|Protocol Violation|1|||
150100144|NCT01466387|541508642|FG001|Overall Study|Protocol Violation|0|||
150100145|NCT01466387|541508643|FG002|Overall Study|Protocol Violation|0|||
150100146|NCT01466387|541508644|FG003|Overall Study|Protocol Violation|1|||
150100147|NCT01466387|541508645|FG004|Overall Study|Protocol Violation|0|||
150100148|NCT01466387|541508646|FG005|Overall Study|Protocol Violation|0|||
150100149|NCT01319877|541508647|FG000|Overall Study|Lost to Follow-up|100|||
150100150|NCT01319877|541508648|FG001|Overall Study|Lost to Follow-up|37|||
150100151|NCT01319877|541508647|FG000|Overall Study|Physician Decision|2|||
150100152|NCT01319877|541508648|FG001|Overall Study|Physician Decision|0|||
150100153|NCT01319877|541508647|FG000|Overall Study|Disease Progression|2|||
150100154|NCT01319877|541508648|FG001|Overall Study|Disease Progression|2|||
150100155|NCT01319877|541508647|FG000|Overall Study|Withdrawal by Subject|0|||
150100156|NCT01319877|541508648|FG001|Overall Study|Withdrawal by Subject|1|||
150100157|NCT01319877|541508647|FG000|Overall Study|Reason Not Specified|4|||
150100158|NCT01319877|541508648|FG001|Overall Study|Reason Not Specified|5|||
150100159|NCT02677987|541508657|FG000|Overall Study|Withdrawal by Subject|3|||
150100160|NCT02677987|541508658|FG001|Overall Study|Withdrawal by Subject|0|||
150100161|NCT02677987|541508657|FG000|Overall Study|Lost to Follow-up|1|||
150100162|NCT02677987|541508658|FG001|Overall Study|Lost to Follow-up|0|||
150100163|NCT03200899|541508659|FG000|Overall Study|Lost to Follow-up|10|||
150100164|NCT03200899|541508660|FG001|Overall Study|Lost to Follow-up|23|||
150100165|NCT00549562|541508663|FG000|Overall Study|Adverse Event|1|||
150100166|NCT00549562|541508663|FG000|Overall Study|Lack of Efficacy|1|||
150100167|NCT04439318|541508664|FG000|Overall Study|Ineligible|1|||
150100168|NCT04439318|541508664|FG000|Overall Study|Never Started Treatment|3|||
150100169|NCT04439318|541508664|FG000|Overall Study|Adverse Event|10|||
150100170|NCT04439318|541508664|FG000|Overall Study|Death|2|||
150100171|NCT04439318|541508664|FG000|Overall Study|Disease Progression|25|||
150100172|NCT04439318|541508664|FG000|Overall Study|Other Complicating Disease|2|||
150100173|NCT04439318|541508664|FG000|Overall Study|Withdrawal by Subject|4|||
150100174|NCT04439318|541508664|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
150100175|NCT04439318|541508664|FG000|Overall Study|Non-Compliance|1|||
150100176|NCT04439318|541508664|FG000|Overall Study|Still on Treatment|1|||
150100177|NCT00699972|541510760|FG000|Overall Study|Adverse Event|7|||
150100178|NCT00699972|541510761|FG001|Overall Study|Adverse Event|9|||
150100179|NCT00699972|541510762|FG002|Overall Study|Adverse Event|24|||
150100180|NCT00699972|541510760|FG000|Overall Study|Lost to Follow-up|0|||
150100181|NCT00699972|541510761|FG001|Overall Study|Lost to Follow-up|2|||
150100182|NCT00699972|541510762|FG002|Overall Study|Lost to Follow-up|0|||
150100183|NCT00699972|541510760|FG000|Overall Study|Withdrawal by Subject|3|||
150100184|NCT00699972|541510761|FG001|Overall Study|Withdrawal by Subject|7|||
150100185|NCT00699972|541510762|FG002|Overall Study|Withdrawal by Subject|4|||
150100186|NCT00699972|541510760|FG000|Overall Study|Lack of Efficacy|2|||
150100187|NCT00699972|541510761|FG001|Overall Study|Lack of Efficacy|0|||
150100188|NCT00699972|541510762|FG002|Overall Study|Lack of Efficacy|2|||
150100189|NCT00699972|541510760|FG000|Overall Study|Administrative/Other|3|||
150100190|NCT00699972|541510761|FG001|Overall Study|Administrative/Other|1|||
150100191|NCT00699972|541510762|FG002|Overall Study|Administrative/Other|4|||
150100192|NCT00699972|541510760|FG000|Overall Study|Randomized, Not Treated|1|||
150100193|NCT00699972|541510761|FG001|Overall Study|Randomized, Not Treated|0|||
150100194|NCT00699972|541510762|FG002|Overall Study|Randomized, Not Treated|1|||
150100195|NCT00922766|541510768|FG000|Overall Study|Death|3|||
150100196|NCT00922766|541510768|FG000|Overall Study|Withdrawal by Subject|2|||
150100197|NCT00922766|541510768|FG000|Overall Study|Other|1|||
150100198|NCT00922766|541510768|FG000|Overall Study|Adverse Event|1|||
150100199|NCT02622828|541510769|FG000|Overall Study|participant withdrew|3|||
150100200|NCT01231581|541510770|FG000|Overall Study|Lost to Follow-up|2|||
150100201|NCT01231581|541510771|FG001|Overall Study|Lost to Follow-up|2|||
150100202|NCT01231581|541510770|FG000|Overall Study|Withdrawal by Subject|6|||
150100203|NCT01231581|541510771|FG001|Overall Study|Withdrawal by Subject|9|||
150100204|NCT01231581|541510770|FG000|Overall Study|Study Closed/Terminated|6|||
150100205|NCT01231581|541510771|FG001|Overall Study|Study Closed/Terminated|5|||
150100206|NCT01231581|541510770|FG000|Overall Study|Death|65|||
150100207|NCT01231581|541510771|FG001|Overall Study|Death|64|||
150100208|NCT01231581|541510770|FG000|Overall Study|Ongoing|1|||
150100209|NCT01231581|541510771|FG001|Overall Study|Ongoing|0|||
150100210|NCT03616912|541510772|FG000|Overall Study|Adverse Event|17|||
150100211|NCT03616912|541510773|FG001|Overall Study|Adverse Event|21|||
150100212|NCT03616912|541510774|FG002|Overall Study|Adverse Event|9|||
150100213|NCT03616912|541510775|FG003|Overall Study|Adverse Event|0|||
150100214|NCT03616912|541510776|FG004|Overall Study|Adverse Event|0|||
150100215|NCT03616912|541510777|FG005|Overall Study|Adverse Event|0|||
150100216|NCT03616912|541510772|FG000|Overall Study|Death|1|||
150100217|NCT03616912|541510773|FG001|Overall Study|Death|1|||
150100218|NCT03616912|541510774|FG002|Overall Study|Death|0|||
150100219|NCT03616912|541510775|FG003|Overall Study|Death|0|||
150100220|NCT03616912|541510776|FG004|Overall Study|Death|0|||
150100221|NCT03616912|541510777|FG005|Overall Study|Death|0|||
150100222|NCT03616912|541510772|FG000|Overall Study|Lack of Efficacy|13|||
150100223|NCT03616912|541510773|FG001|Overall Study|Lack of Efficacy|6|||
150100224|NCT03616912|541510774|FG002|Overall Study|Lack of Efficacy|8|||
150100225|NCT03616912|541510775|FG003|Overall Study|Lack of Efficacy|4|||
150100226|NCT03616912|541510776|FG004|Overall Study|Lack of Efficacy|5|||
150100227|NCT03616912|541510777|FG005|Overall Study|Lack of Efficacy|1|||
150100228|NCT03616912|541510772|FG000|Overall Study|Lost to Follow-up|1|||
150100229|NCT03616912|541510773|FG001|Overall Study|Lost to Follow-up|2|||
150100230|NCT03616912|541510774|FG002|Overall Study|Lost to Follow-up|3|||
150100231|NCT03616912|541510775|FG003|Overall Study|Lost to Follow-up|0|||
150100232|NCT03616912|541510776|FG004|Overall Study|Lost to Follow-up|0|||
150100233|NCT03616912|541510777|FG005|Overall Study|Lost to Follow-up|0|||
150100234|NCT03616912|541510772|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
150100235|NCT03616912|541510773|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
150100236|NCT03616912|541510774|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
150100237|NCT03616912|541510775|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
150100238|NCT03616912|541510776|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
150100239|NCT03616912|541510777|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
150100240|NCT03616912|541510772|FG000|Overall Study|Withdrawal by Subject|12|||
150100241|NCT03616912|541510773|FG001|Overall Study|Withdrawal by Subject|12|||
150100242|NCT03616912|541510774|FG002|Overall Study|Withdrawal by Subject|15|||
150100243|NCT03616912|541510775|FG003|Overall Study|Withdrawal by Subject|2|||
150100244|NCT03616912|541510776|FG004|Overall Study|Withdrawal by Subject|0|||
150100245|NCT03616912|541510777|FG005|Overall Study|Withdrawal by Subject|2|||
150100246|NCT03616912|541510772|FG000|Overall Study|Study Terminated by Sponsor|0|||
150100247|NCT03616912|541510773|FG001|Overall Study|Study Terminated by Sponsor|0|||
150100248|NCT03616912|541510774|FG002|Overall Study|Study Terminated by Sponsor|0|||
150100249|NCT03616912|541510775|FG003|Overall Study|Study Terminated by Sponsor|10|||
150100250|NCT03616912|541510776|FG004|Overall Study|Study Terminated by Sponsor|9|||
150100251|NCT03616912|541510777|FG005|Overall Study|Study Terminated by Sponsor|11|||
150100252|NCT03616912|541510772|FG000|Overall Study|Protocol Deviation|1|||
150100253|NCT03616912|541510773|FG001|Overall Study|Protocol Deviation|1|||
150100254|NCT03616912|541510774|FG002|Overall Study|Protocol Deviation|0|||
150100255|NCT03616912|541510775|FG003|Overall Study|Protocol Deviation|0|||
150100256|NCT03616912|541510776|FG004|Overall Study|Protocol Deviation|0|||
150100257|NCT03616912|541510777|FG005|Overall Study|Protocol Deviation|0|||
150100258|NCT03616912|541510772|FG000|Overall Study|Pregnancy|1|||
150100259|NCT03616912|541510773|FG001|Overall Study|Pregnancy|0|||
150100260|NCT03616912|541510774|FG002|Overall Study|Pregnancy|4|||
150100261|NCT03616912|541510775|FG003|Overall Study|Pregnancy|0|||
150100262|NCT03616912|541510776|FG004|Overall Study|Pregnancy|0|||
150100263|NCT03616912|541510777|FG005|Overall Study|Pregnancy|0|||
150100264|NCT03616912|541510772|FG000|Overall Study|Protocol Violation|1|||
150100265|NCT03616912|541510773|FG001|Overall Study|Protocol Violation|0|||
150100266|NCT03616912|541510774|FG002|Overall Study|Protocol Violation|2|||
150100267|NCT03616912|541510775|FG003|Overall Study|Protocol Violation|0|||
150100268|NCT03616912|541510776|FG004|Overall Study|Protocol Violation|0|||
150100269|NCT03616912|541510777|FG005|Overall Study|Protocol Violation|0|||
150100270|NCT03616912|541510772|FG000|Overall Study|Physician Decision|2|||
150100271|NCT03616912|541510773|FG001|Overall Study|Physician Decision|0|||
150100272|NCT03616912|541510774|FG002|Overall Study|Physician Decision|0|||
150100273|NCT03616912|541510775|FG003|Overall Study|Physician Decision|0|||
150100274|NCT03616912|541510776|FG004|Overall Study|Physician Decision|1|||
150100275|NCT03616912|541510777|FG005|Overall Study|Physician Decision|0|||
150100276|NCT03616912|541510772|FG000|Overall Study|Randomized But Never Treated|0|||
150100277|NCT03616912|541510773|FG001|Overall Study|Randomized But Never Treated|2|||
150100278|NCT03616912|541510774|FG002|Overall Study|Randomized But Never Treated|0|||
150100279|NCT03616912|541510775|FG003|Overall Study|Randomized But Never Treated|0|||
150100280|NCT03616912|541510776|FG004|Overall Study|Randomized But Never Treated|0|||
150100281|NCT03616912|541510777|FG005|Overall Study|Randomized But Never Treated|0|||
150100282|NCT01921829|541510778|FG000|Overall Study|Withdrawal by Subject|0|||
150100283|NCT01921829|541510779|FG001|Overall Study|Withdrawal by Subject|1|||
150100284|NCT04091646|541510780|FG000|Overall Study|Adverse Event|2|||
150100285|NCT04091646|541510781|FG001|Overall Study|Adverse Event|1|||
150100286|NCT04091646|541510780|FG000|Overall Study|Lost to Follow-up|6|||
150100287|NCT04091646|541510781|FG001|Overall Study|Lost to Follow-up|2|||
150100288|NCT04091646|541510780|FG000|Overall Study|Protocol Violation|0|||
150100289|NCT04091646|541510781|FG001|Overall Study|Protocol Violation|1|||
150100290|NCT04091646|541510780|FG000|Overall Study|Withdrawal by Subject|4|||
150100291|NCT04091646|541510781|FG001|Overall Study|Withdrawal by Subject|1|||
150100292|NCT04091646|541510780|FG000|Overall Study|Participant Incarcerated|1|||
150100293|NCT04091646|541510781|FG001|Overall Study|Participant Incarcerated|0|||
150100294|NCT01762943|541510782|FG000|Overall Study|Physician Decision|1|||
150100295|NCT01762943|541510783|FG001|Overall Study|Physician Decision|1|||
150100296|NCT01762943|541510782|FG000|Overall Study|Protocol Violation|1|||
150100297|NCT01762943|541510783|FG001|Overall Study|Protocol Violation|0|||
150100298|NCT01762943|541510782|FG000|Overall Study|Withdrawal by Subject|2|||
150100299|NCT01762943|541510783|FG001|Overall Study|Withdrawal by Subject|1|||
150100300|NCT00539838|541510784|FG000|Overall Study|Fail to return|2|||
150100301|NCT00539838|541510785|FG001|Overall Study|Fail to return|0|||
150100302|NCT00539838|541510786|FG002|Overall Study|Fail to return|0|||
150100303|NCT00539838|541510784|FG000|Overall Study|Withdrawal by Subject|0|||
150100304|NCT00539838|541510785|FG001|Overall Study|Withdrawal by Subject|4|||
150100305|NCT00539838|541510786|FG002|Overall Study|Withdrawal by Subject|0|||
150100306|NCT00539838|541510784|FG000|Overall Study|Death|0|||
150100307|NCT00539838|541510785|FG001|Overall Study|Death|2|||
150100308|NCT00539838|541510786|FG002|Overall Study|Death|0|||
150100309|NCT00539838|541510784|FG000|Overall Study|Did not cooperate|1|||
150100310|NCT00539838|541510785|FG001|Overall Study|Did not cooperate|0|||
150100311|NCT00539838|541510786|FG002|Overall Study|Did not cooperate|1|||
150100312|NCT00539838|541510784|FG000|Overall Study|Administrative|4|||
150185389|NCT02549339|541817128|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
150185390|NCT02549339|541817127|FG000|12-month Follow-up|Lack of Efficacy|0|||
150100313|NCT00539838|541510785|FG001|Overall Study|Administrative|0|||
150100314|NCT00539838|541510786|FG002|Overall Study|Administrative|8|||
150100315|NCT02658890|541510792|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100316|NCT02658890|541510793|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100317|NCT02658890|541510794|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100318|NCT02658890|541510795|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100319|NCT02658890|541510796|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100320|NCT02658890|541510797|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100321|NCT02658890|541510798|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100322|NCT02658890|541510799|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100323|NCT02658890|541510800|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
150100324|NCT02658890|541510801|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100325|NCT02658890|541510802|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100326|NCT02658890|541510803|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100327|NCT02658890|541510804|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100328|NCT02658890|541510805|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100329|NCT02658890|541510806|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100330|NCT02658890|541510807|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100331|NCT02658890|541510808|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100332|NCT02658890|541510809|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100333|NCT02658890|541510810|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100334|NCT02658890|541510811|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100335|NCT02658890|541510812|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100336|NCT02658890|541510813|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100337|NCT02658890|541510814|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100338|NCT02658890|541510815|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100339|NCT02658890|541510816|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100340|NCT02658890|541510817|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100341|NCT02658890|541510818|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100342|NCT02658890|541510792|FG000|Treatment Phase|Adverse Event|0|||
150100343|NCT02658890|541510793|FG001|Treatment Phase|Adverse Event|1|||
150100344|NCT02658890|541510794|FG002|Treatment Phase|Adverse Event|2|||
150100345|NCT02658890|541510795|FG003|Treatment Phase|Adverse Event|2|||
150100346|NCT02658890|541510796|FG004|Treatment Phase|Adverse Event|1|||
150100347|NCT02658890|541510797|FG005|Treatment Phase|Adverse Event|0|||
150100348|NCT02658890|541510798|FG006|Treatment Phase|Adverse Event|0|||
150100349|NCT02658890|541510799|FG007|Treatment Phase|Adverse Event|2|||
150100350|NCT02658890|541510800|FG008|Treatment Phase|Adverse Event|1|||
150100351|NCT02658890|541510801|FG009|Treatment Phase|Adverse Event|2|||
150100352|NCT02658890|541510802|FG010|Treatment Phase|Adverse Event|3|||
150100353|NCT02658890|541510803|FG011|Treatment Phase|Adverse Event|0|||
150100354|NCT02658890|541510804|FG012|Treatment Phase|Adverse Event|1|||
150100355|NCT02658890|541510805|FG013|Treatment Phase|Adverse Event|4|||
150100356|NCT02658890|541510806|FG014|Treatment Phase|Adverse Event|0|||
150100357|NCT02658890|541510807|FG015|Treatment Phase|Adverse Event|0|||
150100358|NCT02658890|541510808|FG016|Treatment Phase|Adverse Event|0|||
150100359|NCT02658890|541510809|FG017|Treatment Phase|Adverse Event|0|||
150100360|NCT02658890|541510810|FG018|Treatment Phase|Adverse Event|5|||
150100361|NCT02658890|541510811|FG019|Treatment Phase|Adverse Event|1|||
150100362|NCT02658890|541510812|FG020|Treatment Phase|Adverse Event|3|||
150100363|NCT02658890|541510813|FG021|Treatment Phase|Adverse Event|0|||
150100364|NCT02658890|541510814|FG022|Treatment Phase|Adverse Event|5|||
150100365|NCT02658890|541510815|FG023|Treatment Phase|Adverse Event|0|||
150100366|NCT02658890|541510816|FG024|Treatment Phase|Adverse Event|0|||
150100367|NCT02658890|541510817|FG025|Treatment Phase|Adverse Event|2|||
150100368|NCT02658890|541510818|FG026|Treatment Phase|Adverse Event|1|||
150100369|NCT02658890|541510792|FG000|Treatment Phase|Death|0|||
150100370|NCT02658890|541510793|FG001|Treatment Phase|Death|0|||
150100371|NCT02658890|541510794|FG002|Treatment Phase|Death|0|||
150185391|NCT02549339|541817128|FG001|12-month Follow-up|Lack of Efficacy|2|||
150185392|NCT02549339|541817127|FG000|12-month Follow-up|Withdrawal by Subject|8|||
150185393|NCT02549339|541817128|FG001|12-month Follow-up|Withdrawal by Subject|3|||
150185394|NCT02549339|541817127|FG000|12-month Follow-up|Lost to Follow-up|1|||
150185395|NCT02549339|541817128|FG001|12-month Follow-up|Lost to Follow-up|3|||
150185396|NCT02549339|541817127|FG000|12-month Follow-up|Other|0|||
150185397|NCT02549339|541817128|FG001|12-month Follow-up|Other|3|||
150185398|NCT02728076|541817129|FG000|Overall Study|Physician Decision|4|||
150185399|NCT04820855|541817147|FG000|Overall Study|Lost to Follow-up|6|||
150185400|NCT04820855|541817148|FG001|Overall Study|Lost to Follow-up|9|||
150185401|NCT04838262|541817149|FG000|Overall Study|Withdrawal by Subject|9|||
150185402|NCT04838262|541817150|FG001|Overall Study|Withdrawal by Subject|4|||
150185403|NCT03526861|541817155|FG000|Initial Treatment Period|Not dosed|1|||
150185404|NCT03526861|541817156|FG001|Initial Treatment Period|Not dosed|1|||
150185405|NCT03526861|541817157|FG002|Initial Treatment Period|Not dosed|1|||
150185406|NCT03526861|541817158|FG003|Initial Treatment Period|Not dosed|0|||
150185407|NCT03526861|541817159|FG004|Initial Treatment Period|Not dosed|0|||
150185408|NCT03526861|541817160|FG005|Initial Treatment Period|Not dosed|0|||
150185409|NCT03526861|541817161|FG006|Initial Treatment Period|Not dosed|0|||
150185410|NCT03526861|541817162|FG007|Initial Treatment Period|Not dosed|0|||
150185411|NCT03526861|541817163|FG008|Initial Treatment Period|Not dosed|0|||
150185412|NCT03526861|541817155|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
150185413|NCT03526861|541817156|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
150100372|NCT02658890|541510795|FG003|Treatment Phase|Death|0|||
150100373|NCT02658890|541510796|FG004|Treatment Phase|Death|0|||
150100374|NCT02658890|541510797|FG005|Treatment Phase|Death|0|||
150100375|NCT02658890|541510798|FG006|Treatment Phase|Death|0|||
150100376|NCT02658890|541510799|FG007|Treatment Phase|Death|0|||
150100377|NCT02658890|541510800|FG008|Treatment Phase|Death|0|||
150100378|NCT02658890|541510801|FG009|Treatment Phase|Death|0|||
150100379|NCT02658890|541510802|FG010|Treatment Phase|Death|0|||
150100380|NCT02658890|541510803|FG011|Treatment Phase|Death|0|||
150100381|NCT02658890|541510804|FG012|Treatment Phase|Death|0|||
150100382|NCT02658890|541510805|FG013|Treatment Phase|Death|0|||
150100383|NCT02658890|541510806|FG014|Treatment Phase|Death|0|||
150100384|NCT02658890|541510807|FG015|Treatment Phase|Death|0|||
150100385|NCT02658890|541510808|FG016|Treatment Phase|Death|0|||
150100386|NCT02658890|541510809|FG017|Treatment Phase|Death|0|||
150100387|NCT02658890|541510810|FG018|Treatment Phase|Death|1|||
150100388|NCT02658890|541510811|FG019|Treatment Phase|Death|0|||
150100389|NCT02658890|541510812|FG020|Treatment Phase|Death|0|||
150100390|NCT02658890|541510813|FG021|Treatment Phase|Death|0|||
150100391|NCT02658890|541510814|FG022|Treatment Phase|Death|0|||
150100392|NCT02658890|541510815|FG023|Treatment Phase|Death|0|||
150100393|NCT02658890|541510816|FG024|Treatment Phase|Death|0|||
150100394|NCT02658890|541510817|FG025|Treatment Phase|Death|0|||
150100395|NCT02658890|541510818|FG026|Treatment Phase|Death|0|||
150100396|NCT02658890|541510792|FG000|Treatment Phase|Lost to Follow-up|0|||
150100397|NCT02658890|541510793|FG001|Treatment Phase|Lost to Follow-up|0|||
150100398|NCT02658890|541510794|FG002|Treatment Phase|Lost to Follow-up|0|||
150100399|NCT02658890|541510795|FG003|Treatment Phase|Lost to Follow-up|0|||
150100400|NCT02658890|541510796|FG004|Treatment Phase|Lost to Follow-up|0|||
150100401|NCT02658890|541510797|FG005|Treatment Phase|Lost to Follow-up|0|||
150100402|NCT02658890|541510798|FG006|Treatment Phase|Lost to Follow-up|1|||
150100403|NCT02658890|541510799|FG007|Treatment Phase|Lost to Follow-up|0|||
150100404|NCT02658890|541510800|FG008|Treatment Phase|Lost to Follow-up|0|||
150100405|NCT02658890|541510801|FG009|Treatment Phase|Lost to Follow-up|0|||
150100406|NCT02658890|541510802|FG010|Treatment Phase|Lost to Follow-up|0|||
150100407|NCT02658890|541510803|FG011|Treatment Phase|Lost to Follow-up|0|||
150100408|NCT02658890|541510804|FG012|Treatment Phase|Lost to Follow-up|0|||
150100409|NCT02658890|541510805|FG013|Treatment Phase|Lost to Follow-up|0|||
150100410|NCT02658890|541510806|FG014|Treatment Phase|Lost to Follow-up|0|||
150100411|NCT02658890|541510807|FG015|Treatment Phase|Lost to Follow-up|0|||
150100412|NCT02658890|541510808|FG016|Treatment Phase|Lost to Follow-up|0|||
150100413|NCT02658890|541510809|FG017|Treatment Phase|Lost to Follow-up|0|||
150100414|NCT02658890|541510810|FG018|Treatment Phase|Lost to Follow-up|0|||
150100415|NCT02658890|541510811|FG019|Treatment Phase|Lost to Follow-up|0|||
150100416|NCT02658890|541510812|FG020|Treatment Phase|Lost to Follow-up|0|||
150100417|NCT02658890|541510813|FG021|Treatment Phase|Lost to Follow-up|0|||
150100418|NCT02658890|541510814|FG022|Treatment Phase|Lost to Follow-up|0|||
150100419|NCT02658890|541510815|FG023|Treatment Phase|Lost to Follow-up|0|||
150100420|NCT02658890|541510816|FG024|Treatment Phase|Lost to Follow-up|0|||
150100421|NCT02658890|541510817|FG025|Treatment Phase|Lost to Follow-up|0|||
150100422|NCT02658890|541510818|FG026|Treatment Phase|Lost to Follow-up|0|||
150100423|NCT02658890|541510792|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
150100424|NCT02658890|541510793|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
150100425|NCT02658890|541510794|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
150100426|NCT02658890|541510795|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
150100427|NCT02658890|541510796|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
150100428|NCT02658890|541510797|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
150100429|NCT02658890|541510798|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
150100430|NCT02658890|541510799|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
150100431|NCT02658890|541510800|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
150100432|NCT02658890|541510801|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
150100433|NCT02658890|541510802|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
150100434|NCT02658890|541510803|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
150100435|NCT02658890|541510804|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
150100436|NCT02658890|541510805|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
150100437|NCT02658890|541510806|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
150100438|NCT02658890|541510807|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
150100439|NCT02658890|541510808|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
150100440|NCT02658890|541510809|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
150100441|NCT02658890|541510810|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
150100442|NCT02658890|541510811|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
150100443|NCT02658890|541510812|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
150100444|NCT02658890|541510813|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
150100445|NCT02658890|541510814|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
150100446|NCT02658890|541510815|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
150100447|NCT02658890|541510816|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
150100448|NCT02658890|541510817|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
150100449|NCT02658890|541510818|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
150100450|NCT02658890|541510792|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
150100451|NCT02658890|541510793|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
150100452|NCT02658890|541510794|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
150100453|NCT02658890|541510795|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
150100454|NCT02658890|541510796|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
150100455|NCT02658890|541510797|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
150100456|NCT02658890|541510798|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
150100457|NCT02658890|541510799|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
150100458|NCT02658890|541510800|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
150100459|NCT02658890|541510801|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
150100460|NCT02658890|541510802|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
150100461|NCT02658890|541510803|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
150100462|NCT02658890|541510804|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
150100463|NCT02658890|541510805|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
150100464|NCT02658890|541510806|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
150100465|NCT02658890|541510807|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
150100466|NCT02658890|541510808|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
150100467|NCT02658890|541510809|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
150100468|NCT02658890|541510810|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
150100469|NCT02658890|541510811|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
150100470|NCT02658890|541510812|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
150100471|NCT02658890|541510813|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
150100472|NCT02658890|541510814|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
150100473|NCT02658890|541510815|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
150100474|NCT02658890|541510816|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
150100475|NCT02658890|541510817|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
150100476|NCT02658890|541510818|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
150100477|NCT02658890|541510792|FG000|Treatment Phase|Other Reasons|0|||
150100478|NCT02658890|541510793|FG001|Treatment Phase|Other Reasons|0|||
150100479|NCT02658890|541510794|FG002|Treatment Phase|Other Reasons|0|||
150100480|NCT02658890|541510795|FG003|Treatment Phase|Other Reasons|0|||
150100481|NCT02658890|541510796|FG004|Treatment Phase|Other Reasons|0|||
150100482|NCT02658890|541510797|FG005|Treatment Phase|Other Reasons|0|||
150100483|NCT02658890|541510798|FG006|Treatment Phase|Other Reasons|1|||
150100484|NCT02658890|541510799|FG007|Treatment Phase|Other Reasons|0|||
150100485|NCT02658890|541510800|FG008|Treatment Phase|Other Reasons|1|||
150100486|NCT02658890|541510801|FG009|Treatment Phase|Other Reasons|0|||
150100487|NCT02658890|541510802|FG010|Treatment Phase|Other Reasons|0|||
150100488|NCT02658890|541510803|FG011|Treatment Phase|Other Reasons|0|||
150100489|NCT02658890|541510804|FG012|Treatment Phase|Other Reasons|0|||
150100490|NCT02658890|541510805|FG013|Treatment Phase|Other Reasons|2|||
150100491|NCT02658890|541510806|FG014|Treatment Phase|Other Reasons|0|||
150100492|NCT02658890|541510807|FG015|Treatment Phase|Other Reasons|0|||
150100493|NCT02658890|541510808|FG016|Treatment Phase|Other Reasons|0|||
150100494|NCT02658890|541510809|FG017|Treatment Phase|Other Reasons|0|||
150100495|NCT02658890|541510810|FG018|Treatment Phase|Other Reasons|1|||
150100496|NCT02658890|541510811|FG019|Treatment Phase|Other Reasons|0|||
150100497|NCT02658890|541510812|FG020|Treatment Phase|Other Reasons|0|||
150100498|NCT02658890|541510813|FG021|Treatment Phase|Other Reasons|0|||
150100499|NCT02658890|541510814|FG022|Treatment Phase|Other Reasons|0|||
150100500|NCT02658890|541510815|FG023|Treatment Phase|Other Reasons|0|||
150100501|NCT02658890|541510816|FG024|Treatment Phase|Other Reasons|1|||
150100502|NCT02658890|541510817|FG025|Treatment Phase|Other Reasons|0|||
150100503|NCT02658890|541510818|FG026|Treatment Phase|Other Reasons|1|||
150100504|NCT02658890|541510792|FG000|Treatment Phase|Progressive Disease|6|||
150100505|NCT02658890|541510793|FG001|Treatment Phase|Progressive Disease|7|||
150100506|NCT02658890|541510794|FG002|Treatment Phase|Progressive Disease|6|||
150100507|NCT02658890|541510795|FG003|Treatment Phase|Progressive Disease|12|||
150100508|NCT02658890|541510796|FG004|Treatment Phase|Progressive Disease|6|||
150100509|NCT02658890|541510797|FG005|Treatment Phase|Progressive Disease|18|||
150100510|NCT02658890|541510798|FG006|Treatment Phase|Progressive Disease|12|||
150100511|NCT02658890|541510799|FG007|Treatment Phase|Progressive Disease|19|||
150100512|NCT02658890|541510800|FG008|Treatment Phase|Progressive Disease|26|||
150100513|NCT02658890|541510801|FG009|Treatment Phase|Progressive Disease|8|||
150100514|NCT02658890|541510802|FG010|Treatment Phase|Progressive Disease|7|||
150100515|NCT02658890|541510803|FG011|Treatment Phase|Progressive Disease|9|||
150100516|NCT02658890|541510804|FG012|Treatment Phase|Progressive Disease|8|||
150100517|NCT02658890|541510805|FG013|Treatment Phase|Progressive Disease|29|||
150100518|NCT02658890|541510806|FG014|Treatment Phase|Progressive Disease|6|||
150100519|NCT02658890|541510807|FG015|Treatment Phase|Progressive Disease|2|||
150100520|NCT02658890|541510808|FG016|Treatment Phase|Progressive Disease|32|||
150100521|NCT02658890|541510809|FG017|Treatment Phase|Progressive Disease|14|||
150100522|NCT02658890|541510810|FG018|Treatment Phase|Progressive Disease|40|||
150100523|NCT02658890|541510811|FG019|Treatment Phase|Progressive Disease|32|||
150100524|NCT02658890|541510812|FG020|Treatment Phase|Progressive Disease|19|||
150100525|NCT02658890|541510813|FG021|Treatment Phase|Progressive Disease|30|||
150100526|NCT02658890|541510814|FG022|Treatment Phase|Progressive Disease|15|||
150100527|NCT02658890|541510815|FG023|Treatment Phase|Progressive Disease|0|||
150100528|NCT02658890|541510816|FG024|Treatment Phase|Progressive Disease|0|||
150100529|NCT02658890|541510817|FG025|Treatment Phase|Progressive Disease|14|||
150100530|NCT02658890|541510818|FG026|Treatment Phase|Progressive Disease|11|||
150100531|NCT02658890|541510792|FG000|Treatment Phase|Study Drug Toxicity|0|||
150100532|NCT02658890|541510793|FG001|Treatment Phase|Study Drug Toxicity|0|||
150100533|NCT02658890|541510794|FG002|Treatment Phase|Study Drug Toxicity|2|||
150100534|NCT02658890|541510795|FG003|Treatment Phase|Study Drug Toxicity|0|||
150100535|NCT02658890|541510796|FG004|Treatment Phase|Study Drug Toxicity|0|||
150100536|NCT02658890|541510797|FG005|Treatment Phase|Study Drug Toxicity|0|||
150100537|NCT02658890|541510798|FG006|Treatment Phase|Study Drug Toxicity|0|||
150100538|NCT02658890|541510799|FG007|Treatment Phase|Study Drug Toxicity|0|||
150100539|NCT02658890|541510800|FG008|Treatment Phase|Study Drug Toxicity|3|||
150100540|NCT02658890|541510801|FG009|Treatment Phase|Study Drug Toxicity|0|||
150100541|NCT02658890|541510802|FG010|Treatment Phase|Study Drug Toxicity|1|||
150100542|NCT02658890|541510803|FG011|Treatment Phase|Study Drug Toxicity|1|||
150100543|NCT02658890|541510804|FG012|Treatment Phase|Study Drug Toxicity|2|||
150100544|NCT02658890|541510805|FG013|Treatment Phase|Study Drug Toxicity|9|||
150100545|NCT02658890|541510806|FG014|Treatment Phase|Study Drug Toxicity|0|||
150100546|NCT02658890|541510807|FG015|Treatment Phase|Study Drug Toxicity|1|||
150100547|NCT02658890|541510808|FG016|Treatment Phase|Study Drug Toxicity|1|||
150100548|NCT02658890|541510809|FG017|Treatment Phase|Study Drug Toxicity|0|||
150100549|NCT02658890|541510810|FG018|Treatment Phase|Study Drug Toxicity|8|||
150100550|NCT02658890|541510811|FG019|Treatment Phase|Study Drug Toxicity|3|||
150100551|NCT02658890|541510812|FG020|Treatment Phase|Study Drug Toxicity|2|||
150100552|NCT02658890|541510813|FG021|Treatment Phase|Study Drug Toxicity|0|||
150100553|NCT02658890|541510814|FG022|Treatment Phase|Study Drug Toxicity|8|||
150100554|NCT02658890|541510815|FG023|Treatment Phase|Study Drug Toxicity|0|||
150100555|NCT02658890|541510816|FG024|Treatment Phase|Study Drug Toxicity|0|||
150100556|NCT02658890|541510817|FG025|Treatment Phase|Study Drug Toxicity|2|||
150100557|NCT02658890|541510818|FG026|Treatment Phase|Study Drug Toxicity|0|||
150100558|NCT02658890|541510792|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100559|NCT02658890|541510793|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100560|NCT02658890|541510794|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100561|NCT02658890|541510795|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
150100562|NCT02658890|541510796|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100563|NCT02658890|541510797|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100564|NCT02658890|541510798|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100565|NCT02658890|541510799|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100566|NCT02658890|541510800|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100567|NCT02658890|541510801|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
150100568|NCT02658890|541510802|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100569|NCT02658890|541510803|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100570|NCT02658890|541510804|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100571|NCT02658890|541510805|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100572|NCT02658890|541510806|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100573|NCT02658890|541510807|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100574|NCT02658890|541510808|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100575|NCT02658890|541510809|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100576|NCT02658890|541510810|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
150100577|NCT02658890|541510811|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100578|NCT02658890|541510812|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100579|NCT02658890|541510813|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100580|NCT02658890|541510814|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
150100581|NCT02658890|541510815|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100582|NCT02658890|541510816|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100583|NCT02658890|541510817|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100584|NCT02658890|541510818|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
150100585|NCT02658890|541510792|FG000|Treatment Phase|Withdrawal by Subject|0|||
150100586|NCT02658890|541510793|FG001|Treatment Phase|Withdrawal by Subject|1|||
150100587|NCT02658890|541510794|FG002|Treatment Phase|Withdrawal by Subject|0|||
150100588|NCT02658890|541510795|FG003|Treatment Phase|Withdrawal by Subject|0|||
150100589|NCT02658890|541510796|FG004|Treatment Phase|Withdrawal by Subject|0|||
150100590|NCT02658890|541510797|FG005|Treatment Phase|Withdrawal by Subject|0|||
150100591|NCT02658890|541510798|FG006|Treatment Phase|Withdrawal by Subject|1|||
150100592|NCT02658890|541510799|FG007|Treatment Phase|Withdrawal by Subject|0|||
150255264|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
150255265|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
150255266|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
150255267|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
150100593|NCT02658890|541510800|FG008|Treatment Phase|Withdrawal by Subject|0|||
150100594|NCT02658890|541510801|FG009|Treatment Phase|Withdrawal by Subject|1|||
150100595|NCT02658890|541510802|FG010|Treatment Phase|Withdrawal by Subject|0|||
150100596|NCT02658890|541510803|FG011|Treatment Phase|Withdrawal by Subject|0|||
150100597|NCT02658890|541510804|FG012|Treatment Phase|Withdrawal by Subject|1|||
150100598|NCT02658890|541510805|FG013|Treatment Phase|Withdrawal by Subject|3|||
150100599|NCT02658890|541510806|FG014|Treatment Phase|Withdrawal by Subject|0|||
150100600|NCT02658890|541510807|FG015|Treatment Phase|Withdrawal by Subject|0|||
150100601|NCT02658890|541510808|FG016|Treatment Phase|Withdrawal by Subject|1|||
150100602|NCT02658890|541510809|FG017|Treatment Phase|Withdrawal by Subject|0|||
150100603|NCT02658890|541510810|FG018|Treatment Phase|Withdrawal by Subject|4|||
150100604|NCT02658890|541510811|FG019|Treatment Phase|Withdrawal by Subject|3|||
150100605|NCT02658890|541510812|FG020|Treatment Phase|Withdrawal by Subject|0|||
150100606|NCT02658890|541510813|FG021|Treatment Phase|Withdrawal by Subject|4|||
150100607|NCT02658890|541510814|FG022|Treatment Phase|Withdrawal by Subject|1|||
150100608|NCT02658890|541510815|FG023|Treatment Phase|Withdrawal by Subject|1|||
150100609|NCT02658890|541510816|FG024|Treatment Phase|Withdrawal by Subject|0|||
150100610|NCT02658890|541510817|FG025|Treatment Phase|Withdrawal by Subject|0|||
150100611|NCT02658890|541510818|FG026|Treatment Phase|Withdrawal by Subject|0|||
150100612|NCT02474199|541510819|FG000|Overall Study|Lost to Follow-up|1|||
150100613|NCT02474199|541510820|FG001|Overall Study|Lost to Follow-up|0|||
150100614|NCT02474199|541510821|FG002|Overall Study|Lost to Follow-up|0|||
150100615|NCT02474199|541510822|FG003|Overall Study|Lost to Follow-up|0|||
150100616|NCT02474199|541510819|FG000|Overall Study|Withdrawal by Subject|1|||
150100617|NCT02474199|541510820|FG001|Overall Study|Withdrawal by Subject|2|||
150100618|NCT02474199|541510821|FG002|Overall Study|Withdrawal by Subject|0|||
150100619|NCT02474199|541510822|FG003|Overall Study|Withdrawal by Subject|1|||
150100620|NCT02474199|541510819|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
150100621|NCT02474199|541510820|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
150100622|NCT02474199|541510821|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
150100623|NCT02474199|541510822|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
150100624|NCT02474199|541510819|FG000|Overall Study|Did not meet eligibility criteria|0|||
150100625|NCT02474199|541510820|FG001|Overall Study|Did not meet eligibility criteria|0|||
150100626|NCT02474199|541510821|FG002|Overall Study|Did not meet eligibility criteria|2|||
150100627|NCT02474199|541510822|FG003|Overall Study|Did not meet eligibility criteria|2|||
150100628|NCT03090100|541510823|FG000|Overall Study|Adverse Event|9|||
150100629|NCT03090100|541510824|FG001|Overall Study|Adverse Event|11|||
150100630|NCT03090100|541510823|FG000|Overall Study|Pregnancy|1|||
150100631|NCT03090100|541510824|FG001|Overall Study|Pregnancy|1|||
150100632|NCT03090100|541510823|FG000|Overall Study|Lack of Efficacy|2|||
150100633|NCT03090100|541510824|FG001|Overall Study|Lack of Efficacy|7|||
150100634|NCT03090100|541510823|FG000|Overall Study|Lost to Follow-up|2|||
150100635|NCT03090100|541510824|FG001|Overall Study|Lost to Follow-up|2|||
150100636|NCT03090100|541510823|FG000|Overall Study|Withdrawal by Subject|7|||
150185414|NCT03526861|541817157|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
150100637|NCT03090100|541510824|FG001|Overall Study|Withdrawal by Subject|19|||
150100638|NCT03090100|541510823|FG000|Overall Study|Protocol Violation|2|||
150100639|NCT03090100|541510824|FG001|Overall Study|Protocol Violation|6|||
150185415|NCT03526861|541817158|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150100640|NCT03090100|541510823|FG000|Overall Study|Non-compliance|2|||
150100641|NCT03090100|541510824|FG001|Overall Study|Non-compliance|0|||
150100642|NCT03090100|541510823|FG000|Overall Study|Other|2|||
150100643|NCT03090100|541510824|FG001|Overall Study|Other|2|||
150100644|NCT04765358|541510829|FG000|Overall Study|Withdrawal by Subject|1|||
150100645|NCT02731729|541510830|FG000|Overall Study|Death|2|||
150100646|NCT02731729|541510831|FG001|Overall Study|Death|2|||
150100647|NCT02731729|541510830|FG000|Overall Study|Study terminated by Sponsor|6|||
150100648|NCT02731729|541510831|FG001|Overall Study|Study terminated by Sponsor|6|||
150100649|NCT02731729|541510830|FG000|Overall Study|Withdrawal by Subject|1|||
150100650|NCT02731729|541510831|FG001|Overall Study|Withdrawal by Subject|0|||
150100651|NCT00159588|541510832|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
150100652|NCT00159588|541510833|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
150100653|NCT00159588|541510834|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
150100654|NCT03446040|541510837|FG000|Overall Study|Disease progression|3|||
150100655|NCT03446040|541510838|FG001|Overall Study|Disease progression|3|||
150100656|NCT03446040|541510839|FG002|Overall Study|Disease progression|3|||
150100657|NCT03446040|541510840|FG003|Overall Study|Disease progression|4|||
150100658|NCT03446040|541510841|FG004|Overall Study|Disease progression|4|||
150100659|NCT03446040|541510842|FG005|Overall Study|Disease progression|6|||
150100660|NCT03446040|541510843|FG006|Overall Study|Disease progression|3|||
150100661|NCT03446040|541510844|FG007|Overall Study|Disease progression|4|||
150100662|NCT03446040|541510845|FG008|Overall Study|Disease progression|2|||
150100663|NCT03446040|541510846|FG009|Overall Study|Disease progression|4|||
150100664|NCT03446040|541510847|FG010|Overall Study|Disease progression|9|||
150100665|NCT03446040|541510848|FG011|Overall Study|Disease progression|3|||
150100666|NCT03446040|541510849|FG012|Overall Study|Disease progression|7|||
150100667|NCT03446040|541510850|FG013|Overall Study|Disease progression|7|||
150100668|NCT03446040|541510837|FG000|Overall Study|Study drug toxicity|0|||
150100669|NCT03446040|541510838|FG001|Overall Study|Study drug toxicity|0|||
150100670|NCT03446040|541510839|FG002|Overall Study|Study drug toxicity|0|||
150100671|NCT03446040|541510840|FG003|Overall Study|Study drug toxicity|0|||
150100672|NCT03446040|541510841|FG004|Overall Study|Study drug toxicity|0|||
150100673|NCT03446040|541510842|FG005|Overall Study|Study drug toxicity|0|||
150100674|NCT03446040|541510843|FG006|Overall Study|Study drug toxicity|0|||
150100675|NCT03446040|541510844|FG007|Overall Study|Study drug toxicity|0|||
150100676|NCT03446040|541510845|FG008|Overall Study|Study drug toxicity|1|||
150100677|NCT03446040|541510846|FG009|Overall Study|Study drug toxicity|0|||
150100678|NCT03446040|541510847|FG010|Overall Study|Study drug toxicity|0|||
150100679|NCT03446040|541510848|FG011|Overall Study|Study drug toxicity|0|||
150100680|NCT03446040|541510849|FG012|Overall Study|Study drug toxicity|0|||
150100681|NCT03446040|541510850|FG013|Overall Study|Study drug toxicity|0|||
150100682|NCT03446040|541510837|FG000|Overall Study|Adverse Event|0|||
150100683|NCT03446040|541510838|FG001|Overall Study|Adverse Event|0|||
150100684|NCT03446040|541510839|FG002|Overall Study|Adverse Event|0|||
150100685|NCT03446040|541510840|FG003|Overall Study|Adverse Event|0|||
150100686|NCT03446040|541510841|FG004|Overall Study|Adverse Event|0|||
150100687|NCT03446040|541510842|FG005|Overall Study|Adverse Event|2|||
150100688|NCT03446040|541510843|FG006|Overall Study|Adverse Event|0|||
150100689|NCT03446040|541510844|FG007|Overall Study|Adverse Event|0|||
150100690|NCT03446040|541510845|FG008|Overall Study|Adverse Event|1|||
150100691|NCT03446040|541510846|FG009|Overall Study|Adverse Event|0|||
150100692|NCT03446040|541510847|FG010|Overall Study|Adverse Event|0|||
150100693|NCT03446040|541510848|FG011|Overall Study|Adverse Event|0|||
150100694|NCT03446040|541510849|FG012|Overall Study|Adverse Event|0|||
150100695|NCT03446040|541510850|FG013|Overall Study|Adverse Event|0|||
150100696|NCT03446040|541510837|FG000|Overall Study|Death|0|||
150100697|NCT03446040|541510838|FG001|Overall Study|Death|0|||
150100698|NCT03446040|541510839|FG002|Overall Study|Death|0|||
150100699|NCT03446040|541510840|FG003|Overall Study|Death|0|||
150100700|NCT03446040|541510841|FG004|Overall Study|Death|0|||
150100701|NCT03446040|541510842|FG005|Overall Study|Death|0|||
150100702|NCT03446040|541510843|FG006|Overall Study|Death|0|||
150100703|NCT03446040|541510844|FG007|Overall Study|Death|0|||
150100704|NCT03446040|541510845|FG008|Overall Study|Death|0|||
150100705|NCT03446040|541510846|FG009|Overall Study|Death|0|||
150100706|NCT03446040|541510847|FG010|Overall Study|Death|1|||
150100707|NCT03446040|541510848|FG011|Overall Study|Death|0|||
150100708|NCT03446040|541510849|FG012|Overall Study|Death|0|||
150100709|NCT03446040|541510850|FG013|Overall Study|Death|2|||
150100710|NCT03446040|541510837|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
150100711|NCT03446040|541510838|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
150100712|NCT03446040|541510839|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
150100713|NCT03446040|541510840|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
150100714|NCT03446040|541510841|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
150100715|NCT03446040|541510842|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
150100716|NCT03446040|541510843|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
150100717|NCT03446040|541510844|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
150100718|NCT03446040|541510845|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
150100719|NCT03446040|541510846|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
150100720|NCT03446040|541510847|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
150100721|NCT03446040|541510848|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
150100722|NCT03446040|541510849|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
150100723|NCT03446040|541510850|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
150100724|NCT03446040|541510837|FG000|Overall Study|Participant withdrew consent|0|||
150100725|NCT03446040|541510838|FG001|Overall Study|Participant withdrew consent|0|||
150100726|NCT03446040|541510839|FG002|Overall Study|Participant withdrew consent|0|||
150100727|NCT03446040|541510840|FG003|Overall Study|Participant withdrew consent|0|||
150100728|NCT03446040|541510841|FG004|Overall Study|Participant withdrew consent|0|||
150100729|NCT03446040|541510842|FG005|Overall Study|Participant withdrew consent|1|||
150100730|NCT03446040|541510843|FG006|Overall Study|Participant withdrew consent|0|||
150100731|NCT03446040|541510844|FG007|Overall Study|Participant withdrew consent|1|||
150100732|NCT03446040|541510845|FG008|Overall Study|Participant withdrew consent|0|||
150100733|NCT03446040|541510846|FG009|Overall Study|Participant withdrew consent|0|||
150100734|NCT03446040|541510847|FG010|Overall Study|Participant withdrew consent|0|||
150100735|NCT03446040|541510848|FG011|Overall Study|Participant withdrew consent|0|||
150100736|NCT03446040|541510849|FG012|Overall Study|Participant withdrew consent|0|||
150100737|NCT03446040|541510850|FG013|Overall Study|Participant withdrew consent|0|||
150100738|NCT03446040|541510837|FG000|Overall Study|Not reported|0|||
150100739|NCT03446040|541510838|FG001|Overall Study|Not reported|0|||
150100740|NCT03446040|541510839|FG002|Overall Study|Not reported|1|||
150100741|NCT03446040|541510840|FG003|Overall Study|Not reported|0|||
150100742|NCT03446040|541510841|FG004|Overall Study|Not reported|0|||
150100743|NCT03446040|541510842|FG005|Overall Study|Not reported|0|||
150100744|NCT03446040|541510843|FG006|Overall Study|Not reported|0|||
150100745|NCT03446040|541510844|FG007|Overall Study|Not reported|0|||
150100746|NCT03446040|541510845|FG008|Overall Study|Not reported|0|||
150100747|NCT03446040|541510846|FG009|Overall Study|Not reported|0|||
150100748|NCT03446040|541510847|FG010|Overall Study|Not reported|0|||
150100749|NCT03446040|541510848|FG011|Overall Study|Not reported|0|||
150100750|NCT03446040|541510849|FG012|Overall Study|Not reported|0|||
150100751|NCT03446040|541510850|FG013|Overall Study|Not reported|0|||
150100752|NCT00605475|541510851|FG000|Overall Study|Abnormal Laboratory Values|0|||
150100753|NCT00605475|541510852|FG001|Overall Study|Abnormal Laboratory Values|0|||
150100754|NCT00605475|541510853|FG002|Overall Study|Abnormal Laboratory Values|0|||
150100755|NCT00605475|541510854|FG003|Overall Study|Abnormal Laboratory Values|0|||
150100756|NCT00605475|541510855|FG004|Overall Study|Abnormal Laboratory Values|0|||
150100757|NCT00605475|541510856|FG005|Overall Study|Abnormal Laboratory Values|0|||
150100758|NCT00605475|541510857|FG006|Overall Study|Abnormal Laboratory Values|0|||
150100759|NCT00605475|541510858|FG007|Overall Study|Abnormal Laboratory Values|0|||
150100760|NCT00605475|541510859|FG008|Overall Study|Abnormal Laboratory Values|1|||
150100761|NCT00605475|541510860|FG009|Overall Study|Abnormal Laboratory Values|0|||
150100762|NCT00605475|541510851|FG000|Overall Study|Administrative problems|0|||
150100763|NCT00605475|541510852|FG001|Overall Study|Administrative problems|0|||
150100764|NCT00605475|541510853|FG002|Overall Study|Administrative problems|0|||
150100765|NCT00605475|541510854|FG003|Overall Study|Administrative problems|0|||
150100766|NCT00605475|541510855|FG004|Overall Study|Administrative problems|0|||
150100767|NCT00605475|541510856|FG005|Overall Study|Administrative problems|0|||
150185416|NCT03526861|541817159|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185417|NCT03526861|541817160|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185418|NCT03526861|541817161|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185419|NCT03526861|541817162|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185420|NCT03526861|541817163|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150100768|NCT00605475|541510857|FG006|Overall Study|Administrative problems|1|||
150100769|NCT00605475|541510858|FG007|Overall Study|Administrative problems|0|||
150100770|NCT00605475|541510859|FG008|Overall Study|Administrative problems|0|||
150100771|NCT00605475|541510860|FG009|Overall Study|Administrative problems|0|||
150100772|NCT00605475|541510851|FG000|Overall Study|Lost to Follow-up|0|||
150100773|NCT00605475|541510852|FG001|Overall Study|Lost to Follow-up|0|||
150100774|NCT00605475|541510853|FG002|Overall Study|Lost to Follow-up|0|||
150100775|NCT00605475|541510854|FG003|Overall Study|Lost to Follow-up|0|||
150100776|NCT00605475|541510855|FG004|Overall Study|Lost to Follow-up|0|||
150100777|NCT00605475|541510856|FG005|Overall Study|Lost to Follow-up|0|||
150100778|NCT00605475|541510857|FG006|Overall Study|Lost to Follow-up|0|||
150100779|NCT00605475|541510858|FG007|Overall Study|Lost to Follow-up|0|||
150100780|NCT00605475|541510859|FG008|Overall Study|Lost to Follow-up|1|||
150100781|NCT00605475|541510860|FG009|Overall Study|Lost to Follow-up|1|||
150100782|NCT00605475|541510851|FG000|Overall Study|Protocol Violation|0|||
150100783|NCT00605475|541510852|FG001|Overall Study|Protocol Violation|0|||
150100784|NCT00605475|541510853|FG002|Overall Study|Protocol Violation|0|||
150100785|NCT00605475|541510854|FG003|Overall Study|Protocol Violation|0|||
150100786|NCT00605475|541510855|FG004|Overall Study|Protocol Violation|1|||
150100787|NCT00605475|541510856|FG005|Overall Study|Protocol Violation|0|||
150100788|NCT00605475|541510857|FG006|Overall Study|Protocol Violation|0|||
150100789|NCT00605475|541510858|FG007|Overall Study|Protocol Violation|0|||
150100790|NCT00605475|541510859|FG008|Overall Study|Protocol Violation|0|||
150100791|NCT00605475|541510860|FG009|Overall Study|Protocol Violation|0|||
150100792|NCT00605475|541510851|FG000|Overall Study|Withdrawal by Subject|0|||
150100793|NCT00605475|541510852|FG001|Overall Study|Withdrawal by Subject|0|||
150100794|NCT00605475|541510853|FG002|Overall Study|Withdrawal by Subject|0|||
150100795|NCT00605475|541510854|FG003|Overall Study|Withdrawal by Subject|0|||
150100796|NCT00605475|541510855|FG004|Overall Study|Withdrawal by Subject|0|||
150100797|NCT00605475|541510856|FG005|Overall Study|Withdrawal by Subject|2|||
150100798|NCT00605475|541510857|FG006|Overall Study|Withdrawal by Subject|0|||
150100799|NCT00605475|541510858|FG007|Overall Study|Withdrawal by Subject|0|||
150100800|NCT00605475|541510859|FG008|Overall Study|Withdrawal by Subject|0|||
150100801|NCT00605475|541510860|FG009|Overall Study|Withdrawal by Subject|1|||
150100802|NCT02596854|541510861|FG000|Overall Study|Withdrawn|8|||
150100803|NCT03897179|541510866|FG000|Overall Study|Withdrawal by Subject|1|||
150100804|NCT00704535|541510867|FG000|Overall Study|Adverse Event|2|||
150100805|NCT00704535|541510867|FG000|Overall Study|Death|2|||
150100806|NCT00704535|541510867|FG000|Overall Study|Lost to Follow-up|8|||
150100807|NCT00704535|541510867|FG000|Overall Study|Protocol Violation|10|||
150100808|NCT00704535|541510867|FG000|Overall Study|Completed status not on Case Report Form|124|||
150100809|NCT01480076|541510868|FG000|Overall Study|Run-in Failure|52|||
150100810|NCT01480076|541510868|FG000|Overall Study|Adverse Event|39|||
150100811|NCT01480076|541510868|FG000|Overall Study|Death|2|||
150100812|NCT01480076|541510868|FG000|Overall Study|Disease Progression|5|||
150100813|NCT01480076|541510868|FG000|Overall Study|Non-compliance With Study Protocol|15|||
150100814|NCT01480076|541510868|FG000|Overall Study|Withdrawal by Subject|105|||
150100815|NCT01480076|541510868|FG000|Overall Study|Lost to Follow-up|7|||
150100816|NCT01480076|541510868|FG000|Overall Study|Investigator Decision|13|||
150100817|NCT01480076|541510868|FG000|Overall Study|Other|52|||
150100818|NCT02503332|541510869|FG000|Overall Study|Adverse Event|17|||
150100819|NCT02503332|541510870|FG001|Overall Study|Adverse Event|5|||
150100820|NCT02503332|541510871|FG002|Overall Study|Adverse Event|3|||
150100821|NCT02503332|541510872|FG003|Overall Study|Adverse Event|1|||
150100822|NCT02503332|541510869|FG000|Overall Study|Investigator's Decision|5|||
150100823|NCT02503332|541510870|FG001|Overall Study|Investigator's Decision|1|||
150100824|NCT02503332|541510871|FG002|Overall Study|Investigator's Decision|0|||
150100825|NCT02503332|541510872|FG003|Overall Study|Investigator's Decision|0|||
150100826|NCT02503332|541510869|FG000|Overall Study|Sponsor's Decision|1|||
150100827|NCT02503332|541510870|FG001|Overall Study|Sponsor's Decision|0|||
150100828|NCT02503332|541510871|FG002|Overall Study|Sponsor's Decision|0|||
150100829|NCT02503332|541510872|FG003|Overall Study|Sponsor's Decision|1|||
150100830|NCT02503332|541510869|FG000|Overall Study|Subject Request|6|||
150100831|NCT02503332|541510870|FG001|Overall Study|Subject Request|5|||
150100832|NCT02503332|541510871|FG002|Overall Study|Subject Request|2|||
150100833|NCT02503332|541510872|FG003|Overall Study|Subject Request|1|||
150100834|NCT02503332|541510869|FG000|Overall Study|Death|0|||
150100835|NCT02503332|541510870|FG001|Overall Study|Death|2|||
150100836|NCT02503332|541510871|FG002|Overall Study|Death|2|||
150100837|NCT02503332|541510872|FG003|Overall Study|Death|0|||
150100838|NCT02503332|541510869|FG000|Overall Study|Other|5|||
150100839|NCT02503332|541510870|FG001|Overall Study|Other|6|||
150100840|NCT02503332|541510871|FG002|Overall Study|Other|1|||
150100841|NCT02503332|541510872|FG003|Overall Study|Other|1|||
150100842|NCT05694546|541510876|FG000|Overall Study|Lost to Follow-up|11|||
150100843|NCT02424383|541510877|FG000|Overall Study|Withdrawal by Subject|32|||
150100844|NCT02424383|541510877|FG000|Overall Study|Death|170|||
150100845|NCT02424383|541510877|FG000|Overall Study|Sponsor's decision|3|||
150100846|NCT02424383|541510877|FG000|Overall Study|Investigator's decision|44|||
150100847|NCT02424383|541510877|FG000|Overall Study|Lost to Follow-up|81|||
150100848|NCT02424383|541510877|FG000|Overall Study|Other|7|||
150100849|NCT02424383|541510877|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
150100850|NCT00325754|541510881|FG000|Overall Study|Adverse Event|4|||
150100851|NCT00325754|541510882|FG001|Overall Study|Adverse Event|1|||
150100852|NCT02290821|541510894|FG000|Overall Study|Withdrawal by Subject|1|||
150100853|NCT02290821|541510895|FG001|Overall Study|Withdrawal by Subject|1|||
150100854|NCT02290821|541510894|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
150100855|NCT02290821|541510895|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
150100856|NCT02290821|541510894|FG000|Overall Study|Lost to Follow-up|3|||
150100857|NCT02290821|541510895|FG001|Overall Study|Lost to Follow-up|2|||
150100858|NCT02438722|541510896|FG000|Overall Study|Adverse Event|12|||
150100859|NCT02438722|541510897|FG001|Overall Study|Adverse Event|9|||
150100860|NCT02438722|541510896|FG000|Overall Study|Refusal unrelated to AE|2|||
150100861|NCT02438722|541510897|FG001|Overall Study|Refusal unrelated to AE|5|||
150100862|NCT02438722|541510896|FG000|Overall Study|Disease progression/relapse|46|||
150100863|NCT02438722|541510897|FG001|Overall Study|Disease progression/relapse|51|||
150100864|NCT02438722|541510896|FG000|Overall Study|Death|0|||
150100865|NCT02438722|541510897|FG001|Overall Study|Death|3|||
150100866|NCT02438722|541510896|FG000|Overall Study|Physician Decision|2|||
150100867|NCT02438722|541510897|FG001|Overall Study|Physician Decision|2|||
150185421|NCT03526861|541817155|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
150185422|NCT03526861|541817156|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
150185423|NCT03526861|541817157|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
150100868|NCT02438722|541510896|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
150100869|NCT02438722|541510897|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
150100870|NCT02438722|541510896|FG000|Overall Study|Withdrawal by Subject|0|||
150100871|NCT02438722|541510897|FG001|Overall Study|Withdrawal by Subject|1|||
150100872|NCT02438722|541510896|FG000|Overall Study|On protocol treatment|15|||
150100873|NCT02438722|541510897|FG001|Overall Study|On protocol treatment|14|||
150100874|NCT02438722|541510896|FG000|Overall Study|Did not receive protocol treatment|5|||
150100875|NCT02438722|541510897|FG001|Overall Study|Did not receive protocol treatment|0|||
150100876|NCT01520363|541510901|FG000|Overall Study|Withdrawal by Subject|2|||
150100877|NCT01520363|541510902|FG001|Overall Study|Withdrawal by Subject|0|||
150100878|NCT04191382|541510904|FG000|Overall Study|Withdrawal by Subject|1|||
150100879|NCT04191382|541510905|FG001|Overall Study|Withdrawal by Subject|0|||
150100880|NCT04191382|541510906|FG002|Overall Study|Withdrawal by Subject|0|||
150100881|NCT05237206|541510907|FG000|Overall Study|screen failure-did not receive treatment|8|||
150100882|NCT05237206|541510907|FG000|Overall Study|did not receive treatment|3|||
150100883|NCT01476696|541510910|FG000|Overall Study|Sponsor decision|2|||
150100884|NCT01476696|541510911|FG001|Overall Study|Sponsor decision|1|||
150100885|NCT01476696|541510912|FG002|Overall Study|Sponsor decision|0|||
150100886|NCT01476696|541510910|FG000|Overall Study|Withdrawal by Subject|1|||
150100887|NCT01476696|541510911|FG001|Overall Study|Withdrawal by Subject|0|||
150100888|NCT01476696|541510912|FG002|Overall Study|Withdrawal by Subject|0|||
150100889|NCT00768144|541510916|FG000|Overall Study|Adverse Event|13|||
150100890|NCT00768144|541510916|FG000|Overall Study|Progressive Disease|21|||
150100891|NCT00768144|541510916|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
150100892|NCT00768144|541510916|FG000|Overall Study|Pt Withdrew Consent|1|||
150100893|NCT01150123|541510917|FG000|Overall Study|Withdrawal by Subject|1|||
150100894|NCT01150123|541510918|FG001|Overall Study|Withdrawal by Subject|1|||
150185424|NCT03526861|541817158|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185425|NCT03526861|541817159|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185426|NCT03526861|541817160|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185427|NCT03526861|541817161|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185428|NCT03526861|541817162|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185429|NCT03526861|541817163|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
150185430|NCT03526861|541817155|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185431|NCT03526861|541817156|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185432|NCT03526861|541817157|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185433|NCT03526861|541817158|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
150185434|NCT03526861|541817159|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
150185435|NCT03526861|541817160|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185436|NCT03526861|541817161|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
150100895|NCT01150123|541510919|FG002|Overall Study|Withdrawal by Subject|2|||
150185437|NCT03526861|541817162|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185438|NCT03526861|541817163|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185439|NCT03526861|541817155|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
150185440|NCT03526861|541817156|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
150185441|NCT03526861|541817157|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
150185442|NCT03526861|541817158|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
150185443|NCT03526861|541817159|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
150185444|NCT03526861|541817160|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
150185445|NCT03526861|541817161|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
150100896|NCT01150123|541510920|FG003|Overall Study|Withdrawal by Subject|1|||
150100897|NCT01150123|541510921|FG004|Overall Study|Withdrawal by Subject|1|||
150100898|NCT01150123|541510922|FG005|Overall Study|Withdrawal by Subject|1|||
150100899|NCT01150123|541510923|FG006|Overall Study|Withdrawal by Subject|0|||
150100900|NCT01150123|541510924|FG007|Overall Study|Withdrawal by Subject|3|||
150100901|NCT01150123|541510925|FG008|Overall Study|Withdrawal by Subject|2|||
150100902|NCT01150123|541510926|FG009|Overall Study|Withdrawal by Subject|0|||
150100903|NCT01150123|541510927|FG010|Overall Study|Withdrawal by Subject|1|||
150100904|NCT01150123|541510928|FG011|Overall Study|Withdrawal by Subject|0|||
150100905|NCT01150123|541510929|FG012|Overall Study|Withdrawal by Subject|1|||
150100906|NCT01150123|541510930|FG013|Overall Study|Withdrawal by Subject|0|||
150100907|NCT01150123|541510931|FG014|Overall Study|Withdrawal by Subject|0|||
150100908|NCT01150123|541510932|FG015|Overall Study|Withdrawal by Subject|1|||
150100909|NCT01150123|541510933|FG016|Overall Study|Withdrawal by Subject|0|||
150100910|NCT01150123|541510934|FG017|Overall Study|Withdrawal by Subject|1|||
150100911|NCT01150123|541510917|FG000|Overall Study|Lost to Follow-up|2|||
150100912|NCT01150123|541510918|FG001|Overall Study|Lost to Follow-up|1|||
150100913|NCT01150123|541510919|FG002|Overall Study|Lost to Follow-up|2|||
150100914|NCT01150123|541510920|FG003|Overall Study|Lost to Follow-up|2|||
150100915|NCT01150123|541510921|FG004|Overall Study|Lost to Follow-up|2|||
150100916|NCT01150123|541510922|FG005|Overall Study|Lost to Follow-up|5|||
150100917|NCT01150123|541510923|FG006|Overall Study|Lost to Follow-up|0|||
150100918|NCT01150123|541510924|FG007|Overall Study|Lost to Follow-up|0|||
150100919|NCT01150123|541510925|FG008|Overall Study|Lost to Follow-up|3|||
150100920|NCT01150123|541510926|FG009|Overall Study|Lost to Follow-up|1|||
150100921|NCT01150123|541510927|FG010|Overall Study|Lost to Follow-up|1|||
150100922|NCT01150123|541510928|FG011|Overall Study|Lost to Follow-up|1|||
150100923|NCT01150123|541510929|FG012|Overall Study|Lost to Follow-up|2|||
150100924|NCT01150123|541510930|FG013|Overall Study|Lost to Follow-up|0|||
150100925|NCT01150123|541510931|FG014|Overall Study|Lost to Follow-up|0|||
150100926|NCT01150123|541510932|FG015|Overall Study|Lost to Follow-up|0|||
150100927|NCT01150123|541510933|FG016|Overall Study|Lost to Follow-up|0|||
150100928|NCT01150123|541510934|FG017|Overall Study|Lost to Follow-up|0|||
150100929|NCT02347189|541510940|FG000|Overall Study|No implant attempted of study device|9|||
150100930|NCT02347189|541510940|FG000|Overall Study|No primary outcome data available|2|||
150100931|NCT00673179|541510942|FG000|Overall Study|Toxicity/Complications|3|||
150100932|NCT00673179|541510943|FG001|Overall Study|Toxicity/Complications|0|||
150100933|NCT01531387|541510946|FG000|Overall Study|Early termination of study|11|||
150100934|NCT01531387|541510947|FG001|Overall Study|Early termination of study|11|||
150100935|NCT04248933|541510948|FG000|Overall Study|Lost to Follow-up|9|||
150100936|NCT04248933|541510948|FG000|Overall Study|Withdrawal by Subject|2|||
150100937|NCT00578942|541510949|FG000|Overall Study|Lost to Follow-up|1|||
150100938|NCT00323115|541510958|FG000|Vaccine Administration|Adverse Event|1|||
150100939|NCT00323115|541510958|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
150100940|NCT03509675|541512489|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
150100941|NCT03509675|541512490|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
150100942|NCT03509675|541512489|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
150100943|NCT03509675|541512490|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
150100944|NCT03509675|541512489|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
150100945|NCT03509675|541512490|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
150100946|NCT03509675|541512489|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
150100947|NCT03509675|541512490|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
150100948|NCT03314584|541512494|FG000|Overall Study|Withdrawal by Subject|3|||
150100949|NCT03314584|541512495|FG001|Overall Study|Withdrawal by Subject|3|||
150100950|NCT03314584|541512494|FG000|Overall Study|Lost to Follow-up|4|||
150100951|NCT03314584|541512495|FG001|Overall Study|Lost to Follow-up|0|||
150100952|NCT06134817|541512496|FG000|Overall Study|Physician Departure - termination of study|1|||
150100953|NCT04343521|541512506|FG000|Overall Study|Adverse Event|0|||
150100954|NCT04343521|541512507|FG001|Overall Study|Adverse Event|2|||
150100955|NCT04343521|541512506|FG000|Overall Study|Death|1|||
150100956|NCT04343521|541512507|FG001|Overall Study|Death|2|||
150100957|NCT04343521|541512506|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
150100958|NCT04343521|541512507|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
150100959|NCT04343521|541512506|FG000|Overall Study|Withdrawal by Subject|70|||
150100960|NCT04343521|541512507|FG001|Overall Study|Withdrawal by Subject|95|||
150100961|NCT04343521|541512506|FG000|Overall Study|Withdrawal by study team|6|||
150100962|NCT04343521|541512507|FG001|Overall Study|Withdrawal by study team|12|||
150100963|NCT02532647|541512508|FG000|Overall Study|Did not receive trial medication|1|||
150100964|NCT02532647|541512509|FG001|Overall Study|Did not receive trial medication|0|||
150100965|NCT02532647|541512510|FG002|Overall Study|Did not receive trial medication|1|||
150100966|NCT02939560|541512511|FG000|Overall Study|Withdrawal by Subject|2|||
150100967|NCT02939560|541512511|FG000|Overall Study|Protocol Violation|1|||
150100968|NCT00634088|541512512|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
150100969|NCT00634088|541512513|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
150100970|NCT00634088|541512514|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
150100971|NCT00634088|541512515|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
150100972|NCT00634088|541512512|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
150100973|NCT00634088|541512513|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
150100974|NCT00634088|541512514|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
150100975|NCT00634088|541512515|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
150100976|NCT00634088|541512512|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
150100977|NCT00634088|541512513|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
150100978|NCT00634088|541512514|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
150100979|NCT00634088|541512515|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
150100980|NCT00634088|541512512|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
150100981|NCT00634088|541512513|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
150100982|NCT00634088|541512514|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
150100983|NCT00634088|541512515|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
150100984|NCT00634088|541512512|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
150100985|NCT00634088|541512513|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
150100986|NCT00634088|541512514|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
150100987|NCT00634088|541512515|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
150100988|NCT00634088|541512512|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
150100989|NCT00634088|541512513|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
150100990|NCT00634088|541512514|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
150100991|NCT00634088|541512515|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
150100992|NCT02439320|541512520|FG000|Overall Study|Adverse Event|0|||
150100993|NCT02439320|541512521|FG001|Overall Study|Adverse Event|2|||
150100994|NCT02439320|541512522|FG002|Overall Study|Adverse Event|0|||
150100995|NCT02439320|541512520|FG000|Overall Study|Lost to Follow-up|37|||
150100996|NCT02439320|541512521|FG001|Overall Study|Lost to Follow-up|34|||
150100997|NCT02439320|541512522|FG002|Overall Study|Lost to Follow-up|42|||
150100998|NCT02439320|541512520|FG000|Overall Study|Death|0|||
150100999|NCT02439320|541512521|FG001|Overall Study|Death|1|||
150101000|NCT02439320|541512522|FG002|Overall Study|Death|0|||
150101001|NCT02439320|541512520|FG000|Overall Study|Noncompliance with Protocol|10|||
150101002|NCT02439320|541512521|FG001|Overall Study|Noncompliance with Protocol|11|||
150101003|NCT02439320|541512522|FG002|Overall Study|Noncompliance with Protocol|7|||
150101004|NCT02439320|541512520|FG000|Overall Study|Pregnancy|0|||
150101005|NCT02439320|541512521|FG001|Overall Study|Pregnancy|1|||
150101006|NCT02439320|541512522|FG002|Overall Study|Pregnancy|1|||
150101007|NCT02439320|541512520|FG000|Overall Study|Withdrawal by Subject|12|||
150101008|NCT02439320|541512521|FG001|Overall Study|Withdrawal by Subject|16|||
150101009|NCT02439320|541512522|FG002|Overall Study|Withdrawal by Subject|14|||
150101010|NCT02439320|541512520|FG000|Overall Study|Physician Decision|2|||
150101011|NCT02439320|541512521|FG001|Overall Study|Physician Decision|1|||
150101012|NCT02439320|541512522|FG002|Overall Study|Physician Decision|0|||
150101013|NCT02439320|541512520|FG000|Overall Study|Sponsor Request|0|||
150101014|NCT02439320|541512521|FG001|Overall Study|Sponsor Request|2|||
150101015|NCT02439320|541512522|FG002|Overall Study|Sponsor Request|1|||
150101016|NCT02439320|541512520|FG000|Overall Study|Randomization Failure|35|||
150101017|NCT02439320|541512521|FG001|Overall Study|Randomization Failure|46|||
150101018|NCT02439320|541512522|FG002|Overall Study|Randomization Failure|34|||
150101019|NCT03343483|541512523|FG000|Overall Study|Death|0|||
150101020|NCT03343483|541512524|FG001|Overall Study|Death|3|||
150101021|NCT03343483|541512523|FG000|Overall Study|Lost to Follow-up|9|||
150101022|NCT03343483|541512524|FG001|Overall Study|Lost to Follow-up|13|||
150101023|NCT03343483|541512523|FG000|Overall Study|Withdrawal by Subject|8|||
150101024|NCT03343483|541512524|FG001|Overall Study|Withdrawal by Subject|17|||
150101025|NCT01251380|541512527|FG000|Overall Study|Other (Not otherwise specified)|12|||
150101026|NCT01251380|541512527|FG000|Overall Study|Withdrawal by Subject|6|||
150101027|NCT01251380|541512527|FG000|Overall Study|Lack of Efficacy|1|||
150101028|NCT01251380|541512527|FG000|Overall Study|Adverse Event|1|||
150101029|NCT01251380|541512527|FG000|Overall Study|Lost to Follow-up|2|||
150101030|NCT00600756|541512528|FG000|Analysis After 6 Months|Adverse Event|43|||
150101031|NCT00600756|541512529|FG001|Analysis After 6 Months|Adverse Event|33|||
150101032|NCT00600756|541512528|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
150101033|NCT00600756|541512529|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
150101034|NCT00600756|541512528|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
150101035|NCT00600756|541512529|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
150101036|NCT00600756|541512528|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
150101037|NCT00600756|541512529|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
150101038|NCT00600756|541512528|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
150101039|NCT00600756|541512529|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
150101040|NCT00600756|541512528|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
150101041|NCT00600756|541512529|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
150101042|NCT00600756|541512528|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
150101043|NCT00600756|541512529|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
150101044|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
150101045|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
150101046|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
150101047|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
150101048|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
150101049|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
150101050|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
150101051|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
150101052|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
150101053|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
150101054|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
150101055|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
150101056|NCT00600756|541512528|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
150101057|NCT00600756|541512529|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
150101058|NCT03261947|541512531|FG000|Overall Study|Death|10|||
150101059|NCT03261947|541512532|FG001|Overall Study|Death|13|||
150101060|NCT03261947|541512533|FG002|Overall Study|Death|17|||
150101061|NCT03261947|541512534|FG003|Overall Study|Death|12|||
150101062|NCT03261947|541512535|FG004|Overall Study|Death|8|||
150101063|NCT03261947|541512531|FG000|Overall Study|Lost to Follow-up|0|||
150101064|NCT03261947|541512532|FG001|Overall Study|Lost to Follow-up|0|||
150101065|NCT03261947|541512533|FG002|Overall Study|Lost to Follow-up|2|||
150101066|NCT03261947|541512534|FG003|Overall Study|Lost to Follow-up|1|||
150101067|NCT03261947|541512535|FG004|Overall Study|Lost to Follow-up|0|||
150101068|NCT03261947|541512531|FG000|Overall Study|Withdrawal by Subject|0|||
150101069|NCT03261947|541512532|FG001|Overall Study|Withdrawal by Subject|0|||
150101070|NCT03261947|541512533|FG002|Overall Study|Withdrawal by Subject|3|||
150101071|NCT03261947|541512534|FG003|Overall Study|Withdrawal by Subject|0|||
150101072|NCT03261947|541512535|FG004|Overall Study|Withdrawal by Subject|1|||
150101073|NCT03261947|541512531|FG000|Overall Study|Site Terminated by Sponsor|0|||
150101074|NCT03261947|541512532|FG001|Overall Study|Site Terminated by Sponsor|0|||
150101075|NCT03261947|541512533|FG002|Overall Study|Site Terminated by Sponsor|4|||
150101076|NCT03261947|541512534|FG003|Overall Study|Site Terminated by Sponsor|7|||
150101077|NCT03261947|541512535|FG004|Overall Study|Site Terminated by Sponsor|5|||
150101078|NCT03261947|541512531|FG000|Overall Study|Reason not Specified|2|||
150101079|NCT03261947|541512532|FG001|Overall Study|Reason not Specified|0|||
150101080|NCT03261947|541512533|FG002|Overall Study|Reason not Specified|4|||
150101081|NCT03261947|541512534|FG003|Overall Study|Reason not Specified|1|||
150101082|NCT03261947|541512535|FG004|Overall Study|Reason not Specified|3|||
150101083|NCT03969992|541512536|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
150101084|NCT03969992|541512537|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
150101085|NCT03969992|541512538|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
150101086|NCT03969992|541512536|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
150101087|NCT03969992|541512537|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
150101088|NCT03969992|541512538|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
150101089|NCT03969992|541512536|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
150101090|NCT03969992|541512537|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
150101091|NCT03969992|541512538|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
150101092|NCT03969992|541512536|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
150101093|NCT03969992|541512537|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
150101094|NCT03969992|541512538|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
150101095|NCT03969992|541512536|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
150101096|NCT03969992|541512537|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
150101097|NCT03969992|541512538|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
150101098|NCT02063737|541512539|FG000|Overall Study|Lost to Follow-up|11|||
150101099|NCT02063737|541512540|FG001|Overall Study|Lost to Follow-up|4|||
150101100|NCT00439556|541512541|FG000|Overall Study|Patient was taken off study for non-comp|0|||
150101101|NCT00439556|541512542|FG001|Overall Study|Patient was taken off study for non-comp|1|||
150101102|NCT00439556|541512543|FG002|Overall Study|Patient was taken off study for non-comp|0|||
150101103|NCT01324388|541512546|FG000|Part 1 of Study|Adverse Event|2|||
150101104|NCT01324388|541512547|FG001|Part 1 of Study|Adverse Event|0|||
150101105|NCT01324388|541512548|FG002|Part 1 of Study|Adverse Event|0|||
150101106|NCT01324388|541512549|FG003|Part 1 of Study|Adverse Event|0|||
150101107|NCT01324388|541512546|FG000|Part 1 of Study|Protocol Violation|1|||
150101108|NCT01324388|541512547|FG001|Part 1 of Study|Protocol Violation|2|||
150101109|NCT01324388|541512548|FG002|Part 1 of Study|Protocol Violation|0|||
150101110|NCT01324388|541512549|FG003|Part 1 of Study|Protocol Violation|0|||
150101111|NCT01324388|541512546|FG000|Part 1 of Study|Physician Decision|1|||
150101112|NCT01324388|541512547|FG001|Part 1 of Study|Physician Decision|0|||
150101113|NCT01324388|541512548|FG002|Part 1 of Study|Physician Decision|0|||
150101114|NCT01324388|541512549|FG003|Part 1 of Study|Physician Decision|0|||
150101115|NCT01324388|541512546|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
150101116|NCT01324388|541512547|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
150101117|NCT01324388|541512548|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
150101118|NCT01324388|541512549|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
150101119|NCT01324388|541512546|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
150101120|NCT01324388|541512547|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
150101121|NCT01324388|541512548|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
150101122|NCT01324388|541512549|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
150101123|NCT01405963|541512550|FG000|Overall Study|Moved Away|2|||
150101124|NCT01405963|541512551|FG001|Overall Study|Moved Away|0|||
150101125|NCT01405963|541512550|FG000|Overall Study|Adverse Event|0|||
150101126|NCT01405963|541512551|FG001|Overall Study|Adverse Event|1|||
150101127|NCT01405963|541512550|FG000|Overall Study|Lost to Follow-up|0|||
150101128|NCT01405963|541512551|FG001|Overall Study|Lost to Follow-up|1|||
150101129|NCT01498640|541512552|FG000|Overall Study|Lost to Follow-up|1|||
150101130|NCT01498640|541512552|FG000|Overall Study|Death|1|||
150101131|NCT01498640|541512552|FG000|Overall Study|Other|3|||
150101132|NCT01737047|541512553|FG000|Overall Study|Death|10|||
150101133|NCT01737047|541512554|FG001|Overall Study|Death|0|||
150101134|NCT01737047|541512555|FG002|Overall Study|Death|1|||
150101135|NCT01737047|541512553|FG000|Overall Study|Withdrawal by Subject|17|||
150101136|NCT01737047|541512554|FG001|Overall Study|Withdrawal by Subject|11|||
150101137|NCT01737047|541512555|FG002|Overall Study|Withdrawal by Subject|4|||
150101138|NCT00129129|541512556|FG000|Primary Phase|Adverse Event|2|||
150101139|NCT00129129|541512557|FG001|Primary Phase|Adverse Event|1|||
150101140|NCT00129129|541512558|FG002|Primary Phase|Adverse Event|0|||
150101141|NCT00129129|541512559|FG003|Primary Phase|Adverse Event|0|||
150101142|NCT00129129|541512560|FG004|Primary Phase|Adverse Event|0|||
150101143|NCT00129129|541512556|FG000|Primary Phase|Withdrawal by Subject|12|||
150101144|NCT00129129|541512557|FG001|Primary Phase|Withdrawal by Subject|10|||
150101145|NCT00129129|541512558|FG002|Primary Phase|Withdrawal by Subject|0|||
150101146|NCT00129129|541512559|FG003|Primary Phase|Withdrawal by Subject|0|||
150101147|NCT00129129|541512560|FG004|Primary Phase|Withdrawal by Subject|0|||
150101148|NCT00129129|541512556|FG000|Primary Phase|Migration from study area|1|||
150101149|NCT00129129|541512557|FG001|Primary Phase|Migration from study area|3|||
150101150|NCT00129129|541512558|FG002|Primary Phase|Migration from study area|0|||
150101151|NCT00129129|541512559|FG003|Primary Phase|Migration from study area|0|||
150101152|NCT00129129|541512560|FG004|Primary Phase|Migration from study area|0|||
150101153|NCT00129129|541512556|FG000|Primary Phase|Lost to Follow-up|8|||
150101154|NCT00129129|541512557|FG001|Primary Phase|Lost to Follow-up|6|||
150101155|NCT00129129|541512558|FG002|Primary Phase|Lost to Follow-up|0|||
150101156|NCT00129129|541512559|FG003|Primary Phase|Lost to Follow-up|0|||
150101157|NCT00129129|541512560|FG004|Primary Phase|Lost to Follow-up|0|||
150101158|NCT00129129|541512556|FG000|Primary Phase|Other|2|||
150101159|NCT00129129|541512557|FG001|Primary Phase|Other|5|||
150101160|NCT00129129|541512558|FG002|Primary Phase|Other|0|||
150101161|NCT00129129|541512559|FG003|Primary Phase|Other|0|||
150101162|NCT00129129|541512560|FG004|Primary Phase|Other|0|||
150101163|NCT00129129|541512556|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
150101164|NCT00129129|541512557|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
150101165|NCT00129129|541512558|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
150101166|NCT00129129|541512559|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
150101167|NCT00129129|541512560|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
150101168|NCT00129129|541512556|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
150101169|NCT00129129|541512557|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
150101170|NCT00129129|541512558|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
150101171|NCT00129129|541512559|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
150101172|NCT00129129|541512560|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
150101173|NCT00129129|541512556|FG000|Fourth Dose Phase|Migration from study area|0|||
150101174|NCT00129129|541512557|FG001|Fourth Dose Phase|Migration from study area|0|||
150101175|NCT00129129|541512558|FG002|Fourth Dose Phase|Migration from study area|0|||
150101176|NCT00129129|541512559|FG003|Fourth Dose Phase|Migration from study area|0|||
150101177|NCT00129129|541512560|FG004|Fourth Dose Phase|Migration from study area|2|||
150101178|NCT00129129|541512556|FG000|Fourth Dose Phase|Other|0|||
150101179|NCT00129129|541512557|FG001|Fourth Dose Phase|Other|0|||
150101180|NCT00129129|541512558|FG002|Fourth Dose Phase|Other|0|||
150101181|NCT00129129|541512559|FG003|Fourth Dose Phase|Other|1|||
150101182|NCT00129129|541512560|FG004|Fourth Dose Phase|Other|1|||
150101183|NCT00129129|541512556|FG000|Fourth Dose Phase|Protocol Violation|0|||
150101184|NCT00129129|541512557|FG001|Fourth Dose Phase|Protocol Violation|0|||
150101185|NCT00129129|541512558|FG002|Fourth Dose Phase|Protocol Violation|0|||
150101186|NCT00129129|541512559|FG003|Fourth Dose Phase|Protocol Violation|1|||
150101187|NCT00129129|541512560|FG004|Fourth Dose Phase|Protocol Violation|0|||
150101188|NCT02140567|541512562|FG000|Overall Study|Problems with recording equipment|6|||
150101189|NCT02802592|541512564|FG000|Overall Study|Study terminated due to loss of funding|4|||
150101190|NCT02882854|541512565|FG000|Overall Study|Lost to Follow-up|1|||
150101191|NCT02882854|541512566|FG001|Overall Study|Lost to Follow-up|2|||
150101192|NCT02882854|541512565|FG000|Overall Study|Physician Decision|0|||
150101193|NCT02882854|541512566|FG001|Overall Study|Physician Decision|1|||
150101194|NCT01358357|541512569|FG000|Open Label Phase|Adverse Event|0|||
150101195|NCT01358357|541512570|FG001|Open Label Phase|Adverse Event|0|||
150101196|NCT01358357|541512571|FG002|Open Label Phase|Adverse Event|59|||
150101197|NCT01358357|541512569|FG000|Open Label Phase|Lack of Efficacy|0|||
150101198|NCT01358357|541512570|FG001|Open Label Phase|Lack of Efficacy|0|||
150101199|NCT01358357|541512571|FG002|Open Label Phase|Lack of Efficacy|107|||
150101200|NCT01358357|541512569|FG000|Open Label Phase|Lost to Follow-up|0|||
150101201|NCT01358357|541512570|FG001|Open Label Phase|Lost to Follow-up|0|||
150101202|NCT01358357|541512571|FG002|Open Label Phase|Lost to Follow-up|76|||
150101203|NCT01358357|541512569|FG000|Open Label Phase|Protocol Violation|0|||
150101204|NCT01358357|541512570|FG001|Open Label Phase|Protocol Violation|0|||
150101205|NCT01358357|541512571|FG002|Open Label Phase|Protocol Violation|45|||
150101206|NCT01358357|541512569|FG000|Open Label Phase|Withdrawal by Subject|0|||
150101207|NCT01358357|541512570|FG001|Open Label Phase|Withdrawal by Subject|0|||
150101208|NCT01358357|541512571|FG002|Open Label Phase|Withdrawal by Subject|112|||
150101209|NCT01358357|541512569|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
150101210|NCT01358357|541512570|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
150101211|NCT01358357|541512571|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
150101212|NCT01358357|541512569|FG000|Open Label Phase|Terminated at study completion|0|||
150101213|NCT01358357|541512570|FG001|Open Label Phase|Terminated at study completion|0|||
150101214|NCT01358357|541512571|FG002|Open Label Phase|Terminated at study completion|5|||
150101215|NCT01358357|541512569|FG000|Open Label Phase|Mood episode|0|||
150101216|NCT01358357|541512570|FG001|Open Label Phase|Mood episode|0|||
150101217|NCT01358357|541512571|FG002|Open Label Phase|Mood episode|42|||
150101218|NCT01358357|541512569|FG000|Double-Blind Phase|Adverse Event|8|||
150101219|NCT01358357|541512570|FG001|Double-Blind Phase|Adverse Event|5|||
150101220|NCT01358357|541512571|FG002|Double-Blind Phase|Adverse Event|0|||
150101221|NCT01358357|541512569|FG000|Double-Blind Phase|Lost to Follow-up|5|||
150101222|NCT01358357|541512570|FG001|Double-Blind Phase|Lost to Follow-up|7|||
150101223|NCT01358357|541512571|FG002|Double-Blind Phase|Lost to Follow-up|0|||
150101224|NCT01358357|541512569|FG000|Double-Blind Phase|Protocol Violation|1|||
150101225|NCT01358357|541512570|FG001|Double-Blind Phase|Protocol Violation|11|||
150101226|NCT01358357|541512571|FG002|Double-Blind Phase|Protocol Violation|0|||
150101227|NCT01358357|541512569|FG000|Double-Blind Phase|Protocol Violation|16|||
150101228|NCT01358357|541512570|FG001|Double-Blind Phase|Protocol Violation|12|||
150101229|NCT01358357|541512571|FG002|Double-Blind Phase|Protocol Violation|0|||
150101230|NCT01358357|541512569|FG000|Double-Blind Phase|Terminated at study completion|2|||
150101231|NCT01358357|541512570|FG001|Double-Blind Phase|Terminated at study completion|0|||
150101232|NCT01358357|541512571|FG002|Double-Blind Phase|Terminated at study completion|0|||
150101233|NCT01358357|541512569|FG000|Double-Blind Phase|Recurrence of mood event|48|||
150101234|NCT01358357|541512570|FG001|Double-Blind Phase|Recurrence of mood event|64|||
150101235|NCT01358357|541512571|FG002|Double-Blind Phase|Recurrence of mood event|0|||
150101236|NCT01358357|541512569|FG000|Double-Blind Phase|Administrative|0|||
150101237|NCT01358357|541512570|FG001|Double-Blind Phase|Administrative|1|||
150101238|NCT01358357|541512571|FG002|Double-Blind Phase|Administrative|0|||
150101239|NCT01826487|541512572|FG000|Overall Study|Adverse Event|1|||
150101240|NCT01826487|541512573|FG001|Overall Study|Adverse Event|1|||
150101241|NCT01826487|541512572|FG000|Overall Study|Lost to Follow-up|1|||
150101242|NCT01826487|541512573|FG001|Overall Study|Lost to Follow-up|0|||
150101243|NCT01826487|541512572|FG000|Overall Study|Withdrawal by Subject|1|||
150101244|NCT01826487|541512573|FG001|Overall Study|Withdrawal by Subject|3|||
150101245|NCT01826487|541512572|FG000|Overall Study|Protocol Violation|1|||
150101246|NCT01826487|541512573|FG001|Overall Study|Protocol Violation|1|||
150101247|NCT02590939|541512574|FG000|Overall Study|Withdrawal by Subject|3|||
150101248|NCT02590939|541512575|FG001|Overall Study|Withdrawal by Subject|1|||
150101249|NCT02590939|541512574|FG000|Overall Study|Failed the nociceptive test|2|||
150101250|NCT02590939|541512575|FG001|Overall Study|Failed the nociceptive test|1|||
150101251|NCT02171260|541512582|FG000|Overall Study|Death|0|||
150101252|NCT02171260|541512583|FG001|Overall Study|Death|0|||
150101253|NCT02171260|541512584|FG002|Overall Study|Death|0|||
150101254|NCT02171260|541512585|FG003|Overall Study|Death|1|||
150101255|NCT02171260|541512582|FG000|Overall Study|Physician Decision|1|||
150101256|NCT02171260|541512583|FG001|Overall Study|Physician Decision|0|||
150101257|NCT02171260|541512584|FG002|Overall Study|Physician Decision|1|||
150101258|NCT02171260|541512585|FG003|Overall Study|Physician Decision|0|||
150101259|NCT02171260|541512582|FG000|Overall Study|Withdrawal by Subject|1|||
150101260|NCT02171260|541512583|FG001|Overall Study|Withdrawal by Subject|0|||
150101261|NCT02171260|541512584|FG002|Overall Study|Withdrawal by Subject|0|||
150101262|NCT02171260|541512585|FG003|Overall Study|Withdrawal by Subject|0|||
150101263|NCT02171260|541512582|FG000|Overall Study|Evidence of progressive disease|4|||
150101264|NCT02171260|541512583|FG001|Overall Study|Evidence of progressive disease|6|||
150101265|NCT02171260|541512584|FG002|Overall Study|Evidence of progressive disease|4|||
150101266|NCT02171260|541512585|FG003|Overall Study|Evidence of progressive disease|4|||
150101267|NCT00323492|541512586|FG000|Study Phase 1|Adverse Event|2|||
150101268|NCT00323492|541512587|FG001|Study Phase 1|Adverse Event|0|||
150101269|NCT00323492|541512588|FG002|Study Phase 1|Adverse Event|0|||
150101270|NCT00323492|541512586|FG000|Study Phase 2|Adverse Event|1|||
150101271|NCT00323492|541512587|FG001|Study Phase 2|Adverse Event|0|||
150101272|NCT00323492|541512588|FG002|Study Phase 2|Adverse Event|0|||
150101273|NCT00323492|541512586|FG000|Study Phase 2|Physician Decision|1|||
150101274|NCT00323492|541512587|FG001|Study Phase 2|Physician Decision|0|||
150101275|NCT00323492|541512588|FG002|Study Phase 2|Physician Decision|0|||
150101276|NCT00323492|541512586|FG000|Study Phase 2|Lost to Follow-up|1|||
150101277|NCT00323492|541512587|FG001|Study Phase 2|Lost to Follow-up|0|||
150101278|NCT00323492|541512588|FG002|Study Phase 2|Lost to Follow-up|0|||
150101279|NCT00323492|541512586|FG000|Study Phase 2|Withdrawal by Subject|0|||
150101280|NCT00323492|541512587|FG001|Study Phase 2|Withdrawal by Subject|1|||
150101281|NCT00323492|541512588|FG002|Study Phase 2|Withdrawal by Subject|0|||
150101282|NCT00323492|541512586|FG000|Study Phase 2|Noncompliance with study schedule|0|||
150101283|NCT00323492|541512587|FG001|Study Phase 2|Noncompliance with study schedule|0|||
150101284|NCT00323492|541512588|FG002|Study Phase 2|Noncompliance with study schedule|1|||
150101285|NCT00323492|541512586|FG000|Study Phase 2|Protocol Violation|1|||
150101286|NCT00323492|541512587|FG001|Study Phase 2|Protocol Violation|0|||
150101287|NCT00323492|541512588|FG002|Study Phase 2|Protocol Violation|0|||
150101288|NCT02486042|541512589|FG000|Overall Study|Physician Decision|1|||
150101289|NCT02486042|541512590|FG001|Overall Study|Physician Decision|7|||
150101290|NCT02486042|541512589|FG000|Overall Study|Hospital transfer|2|||
150101291|NCT02486042|541512590|FG001|Overall Study|Hospital transfer|2|||
150101292|NCT02486042|541512589|FG000|Overall Study|Withdrawal by Subject|0|||
150101293|NCT02486042|541512590|FG001|Overall Study|Withdrawal by Subject|2|||
150101294|NCT03320564|541512593|FG000|Overall Study|Protocol Violation|1|||
150101295|NCT00352846|541512594|FG000|Overall Study|Disease progression|0|||
150101296|NCT00352846|541512595|FG001|Overall Study|Disease progression|2|||
150101297|NCT00352846|541512594|FG000|Overall Study|Withdrawal by Subject|3|||
150101298|NCT00352846|541512595|FG001|Overall Study|Withdrawal by Subject|8|||
150101299|NCT00352846|541512594|FG000|Overall Study|Ineligible|3|||
150101300|NCT00352846|541512595|FG001|Overall Study|Ineligible|2|||
150101301|NCT00352846|541512594|FG000|Overall Study|Non-compliance|2|||
150101302|NCT00352846|541512595|FG001|Overall Study|Non-compliance|0|||
150101303|NCT00352846|541512594|FG000|Overall Study|Death|0|||
150101304|NCT00352846|541512595|FG001|Overall Study|Death|1|||
150101305|NCT01527682|541512596|FG000|Overall Study|Protocol Violation|8|||
150101306|NCT03979638|541512597|FG000|Period 1|Physician Decision|1|||
150101307|NCT03979638|541512598|FG001|Period 1|Physician Decision|1|||
150101308|NCT03979638|541512597|FG000|Period 1|Withdrawal by Subject|4|||
150101309|NCT03979638|541512598|FG001|Period 1|Withdrawal by Subject|3|||
150101310|NCT03979638|541512597|FG000|Period 1|Study terminated by Sponsor|1|||
150101311|NCT03979638|541512598|FG001|Period 1|Study terminated by Sponsor|3|||
150101312|NCT03979638|541512597|FG000|Period 1|Protocol Violation|1|||
150101313|NCT03979638|541512598|FG001|Period 1|Protocol Violation|0|||
150101314|NCT03979638|541512597|FG000|Period 2|Study terminated by Sponsor|1|||
150101315|NCT03979638|541512598|FG001|Period 2|Study terminated by Sponsor|1|||
150101316|NCT00600938|541512601|FG000|Core Study|Abnormal test procedure result(s)|3|||
150101317|NCT00600938|541512602|FG001|Core Study|Abnormal test procedure result(s)|2|||
150101318|NCT00600938|541512603|FG002|Core Study|Abnormal test procedure result(s)|0|||
150101319|NCT00600938|541512604|FG003|Core Study|Abnormal test procedure result(s)|0|||
150101320|NCT00600938|541512601|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
150101321|NCT00600938|541512602|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
150101322|NCT00600938|541512603|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
150101323|NCT00600938|541512604|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
150101324|NCT00600938|541512601|FG000|Core Study|Patient withdrew consent|7|||
150101325|NCT00600938|541512602|FG001|Core Study|Patient withdrew consent|12|||
150101326|NCT00600938|541512603|FG002|Core Study|Patient withdrew consent|0|||
150101327|NCT00600938|541512604|FG003|Core Study|Patient withdrew consent|0|||
150101328|NCT00600938|541512601|FG000|Core Study|Lost to Follow-up|3|||
150101329|NCT00600938|541512602|FG001|Core Study|Lost to Follow-up|2|||
150101330|NCT00600938|541512603|FG002|Core Study|Lost to Follow-up|0|||
150101331|NCT00600938|541512604|FG003|Core Study|Lost to Follow-up|0|||
150101332|NCT00600938|541512601|FG000|Core Study|Death|1|||
150101333|NCT00600938|541512602|FG001|Core Study|Death|1|||
150101334|NCT00600938|541512603|FG002|Core Study|Death|0|||
150101335|NCT00600938|541512604|FG003|Core Study|Death|0|||
150101336|NCT00600938|541512601|FG000|Core Study|Protocol Violation|1|||
150101337|NCT00600938|541512602|FG001|Core Study|Protocol Violation|2|||
150101338|NCT00600938|541512603|FG002|Core Study|Protocol Violation|0|||
150101339|NCT00600938|541512604|FG003|Core Study|Protocol Violation|0|||
150101340|NCT00600938|541512601|FG000|Extension Study|Adverse Event|1|||
150101341|NCT00600938|541512602|FG001|Extension Study|Adverse Event|0|||
150101342|NCT00600938|541512603|FG002|Extension Study|Adverse Event|2|||
150101343|NCT00600938|541512604|FG003|Extension Study|Adverse Event|0|||
150101344|NCT00600938|541512601|FG000|Extension Study|Abnormal test procedure results|0|||
150101345|NCT00600938|541512602|FG001|Extension Study|Abnormal test procedure results|1|||
150101346|NCT00600938|541512603|FG002|Extension Study|Abnormal test procedure results|1|||
150101347|NCT00600938|541512604|FG003|Extension Study|Abnormal test procedure results|1|||
150101348|NCT00600938|541512601|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
150101349|NCT00600938|541512602|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
150101350|NCT00600938|541512603|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
150101351|NCT00600938|541512604|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
150101352|NCT00600938|541512601|FG000|Extension Study|Withdrawal by Subject|2|||
150101353|NCT00600938|541512602|FG001|Extension Study|Withdrawal by Subject|2|||
150101354|NCT00600938|541512603|FG002|Extension Study|Withdrawal by Subject|3|||
150101355|NCT00600938|541512604|FG003|Extension Study|Withdrawal by Subject|0|||
150101356|NCT00600938|541512601|FG000|Extension Study|Lost to Follow-up|1|||
150101357|NCT00600938|541512602|FG001|Extension Study|Lost to Follow-up|1|||
150101358|NCT00600938|541512603|FG002|Extension Study|Lost to Follow-up|2|||
150101359|NCT00600938|541512604|FG003|Extension Study|Lost to Follow-up|0|||
150101360|NCT00600938|541512601|FG000|Extension Study|Death|1|||
150101361|NCT00600938|541512602|FG001|Extension Study|Death|0|||
150101362|NCT00600938|541512603|FG002|Extension Study|Death|0|||
150101363|NCT00600938|541512604|FG003|Extension Study|Death|0|||
150101364|NCT04220411|541512605|FG000|Overall Study|Adverse Event|0|||
150101365|NCT04220411|541512606|FG001|Overall Study|Adverse Event|0|||
150101366|NCT04220411|541512607|FG002|Overall Study|Adverse Event|0|||
150101367|NCT04220411|541512608|FG003|Overall Study|Adverse Event|1|||
150101368|NCT02680639|541512609|FG000|Screening Period|Screen Failure|7|||
150101369|NCT02680639|541512610|FG001|Screening Period|Screen Failure|0|||
150101370|NCT02680639|541512611|FG002|Screening Period|Screen Failure|0|||
150101371|NCT04837131|541512613|FG000|Overall Study|Death|1|||
150101372|NCT04837131|541512613|FG000|Overall Study|Withdrawal by Subject|1|||
150101373|NCT04837131|541512613|FG000|Overall Study|Adverse Event|1|||
150101374|NCT04837131|541512613|FG000|Overall Study|Protocol Violation|1|||
150101375|NCT02496533|541512614|FG000|Overall Study|Lack of data on outcome|3|||
150101376|NCT02496533|541512615|FG001|Overall Study|Lack of data on outcome|0|||
150101377|NCT02496533|541512614|FG000|Overall Study|Patient did not complete all measures|0|||
150101378|NCT02496533|541512615|FG001|Overall Study|Patient did not complete all measures|4|||
150101379|NCT02496533|541512614|FG000|Overall Study|Late for radiologic testing|0|||
150101380|NCT02496533|541512615|FG001|Overall Study|Late for radiologic testing|2|||
150101381|NCT03256552|541513790|FG000|Overall Study|Protocol Violation|1|||
150101382|NCT03256552|541513790|FG000|Overall Study|Physician Decision|1|||
150185446|NCT03526861|541817162|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
150101383|NCT03256552|541513790|FG000|Overall Study|Adverse Event|1|||
150101384|NCT03256552|541513790|FG000|Overall Study|Withdrawal by Subject|2|||
150101385|NCT02268409|541513793|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
150101386|NCT02268409|541513793|FG000|Overall Study|Death|1|||
150101387|NCT02268409|541513793|FG000|Overall Study|Lost to Follow-up|1|||
150101388|NCT02268409|541513793|FG000|Overall Study|Protocol Violation|3|||
150101389|NCT02268409|541513793|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
150101390|NCT02268409|541513793|FG000|Overall Study|Withdrawal by Subject|5|||
150101391|NCT05083442|541513794|FG000|Overall Study|Lost to Follow-up|1|||
150101392|NCT05083442|541513795|FG001|Overall Study|Lost to Follow-up|0|||
150101393|NCT05083442|541513794|FG000|Overall Study|Lack of Efficacy|0|||
150101394|NCT05083442|541513795|FG001|Overall Study|Lack of Efficacy|1|||
150185447|NCT03526861|541817163|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
150101395|NCT05083442|541513794|FG000|Overall Study|Withdrawal by Subject|1|||
150101396|NCT05083442|541513795|FG001|Overall Study|Withdrawal by Subject|3|||
150101397|NCT05083442|541513794|FG000|Overall Study|scheduling difficulties|1|||
150101398|NCT05083442|541513795|FG001|Overall Study|scheduling difficulties|2|||
150101399|NCT04865354|541513806|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
150101400|NCT04865354|541513807|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
150101401|NCT04865354|541513806|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
150101402|NCT04865354|541513807|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
150101403|NCT04865354|541513806|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
150101404|NCT04865354|541513807|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
150101405|NCT03873987|541513808|FG000|Overall Study|Adverse Event|1|||
150101406|NCT03873987|541513809|FG001|Overall Study|Adverse Event|0|||
150101407|NCT03873987|541513808|FG000|Overall Study|staff was unable to start a new IV line|1|||
150101408|NCT03873987|541513809|FG001|Overall Study|staff was unable to start a new IV line|0|||
150101409|NCT03873987|541513808|FG000|Overall Study|Lost to Follow-up|0|||
150101410|NCT03873987|541513809|FG001|Overall Study|Lost to Follow-up|1|||
150101411|NCT01465022|541513810|FG000|Overall Study|Lost to Follow-up|15|||
150101412|NCT01465022|541513811|FG001|Overall Study|Lost to Follow-up|14|||
150101413|NCT01465022|541513812|FG002|Overall Study|Lost to Follow-up|0|||
150101414|NCT01465022|541513810|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
150101415|NCT01465022|541513811|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
150101416|NCT01465022|541513812|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
150101417|NCT01465022|541513810|FG000|Overall Study|Not Randomized|0|||
150101418|NCT01465022|541513811|FG001|Overall Study|Not Randomized|0|||
150101419|NCT01465022|541513812|FG002|Overall Study|Not Randomized|70|||
150101420|NCT00004888|541513813|FG000|Overall Study|Adverse Event|5|||
150101421|NCT00004888|541513814|FG001|Overall Study|Adverse Event|10|||
150101422|NCT00004888|541513813|FG000|Overall Study|Withdrawal by Subject|0|||
150101423|NCT00004888|541513814|FG001|Overall Study|Withdrawal by Subject|3|||
150101424|NCT00004888|541513813|FG000|Overall Study|Physician Decision|1|||
150101425|NCT00004888|541513814|FG001|Overall Study|Physician Decision|1|||
150101426|NCT00004888|541513813|FG000|Overall Study|Progressive Disease|4|||
150101427|NCT00004888|541513814|FG001|Overall Study|Progressive Disease|9|||
150101428|NCT00004888|541513813|FG000|Overall Study|Death without progressive disease|0|||
150101429|NCT00004888|541513814|FG001|Overall Study|Death without progressive disease|1|||
150101430|NCT00004888|541513813|FG000|Overall Study|Toxic death|1|||
150101431|NCT00004888|541513814|FG001|Overall Study|Toxic death|0|||
150101432|NCT00136084|541513815|FG000|Overall Study|Death|12|||
150101433|NCT00136084|541513816|FG001|Overall Study|Death|5|||
150101434|NCT00136084|541513815|FG000|Overall Study|Unacceptable toxicity|8|||
150101435|NCT00136084|541513816|FG001|Overall Study|Unacceptable toxicity|11|||
150101436|NCT00136084|541513815|FG000|Overall Study|Relapse|20|||
150101437|NCT00136084|541513816|FG001|Overall Study|Relapse|23|||
150101438|NCT00136084|541513815|FG000|Overall Study|Lost to Follow-up|2|||
150101439|NCT00136084|541513816|FG001|Overall Study|Lost to Follow-up|0|||
150101440|NCT00136084|541513815|FG000|Overall Study|No Response|1|||
150101441|NCT00136084|541513816|FG001|Overall Study|No Response|2|||
150101442|NCT00136084|541513815|FG000|Overall Study|Withdrawal by Subject|5|||
150101443|NCT00136084|541513816|FG001|Overall Study|Withdrawal by Subject|1|||
150101444|NCT02579265|541513817|FG000|Overall Study|Weaned off earlier than 28 days|44|||
150101445|NCT02579265|541513818|FG001|Overall Study|Weaned off earlier than 28 days|43|||
150101446|NCT02579265|541513817|FG000|Overall Study|Adverse Event|2|||
150101447|NCT02579265|541513818|FG001|Overall Study|Adverse Event|0|||
150101448|NCT02579265|541513817|FG000|Overall Study|Any other reason not specified|0|||
150101449|NCT02579265|541513818|FG001|Overall Study|Any other reason not specified|2|||
150101450|NCT02579265|541513817|FG000|Overall Study|Withdrawal by Subject|2|||
150101451|NCT02579265|541513818|FG001|Overall Study|Withdrawal by Subject|0|||
150101452|NCT02579265|541513817|FG000|Overall Study|Physician Decision|1|||
150101453|NCT02579265|541513818|FG001|Overall Study|Physician Decision|0|||
150101454|NCT02579265|541513817|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
150101455|NCT02579265|541513818|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
150101456|NCT02174848|541513819|FG000|Overall Study|Adverse Event|2|||
150101457|NCT02174848|541513820|FG001|Overall Study|Adverse Event|1|||
150101458|NCT02174848|541513819|FG000|Overall Study|Withdrawal by Subject|3|||
150101459|NCT02174848|541513820|FG001|Overall Study|Withdrawal by Subject|3|||
150101460|NCT02174848|541513819|FG000|Overall Study|Lost to Follow-up|0|||
150101461|NCT02174848|541513820|FG001|Overall Study|Lost to Follow-up|1|||
150101462|NCT02174848|541513819|FG000|Overall Study|Worsening of disease|1|||
150101463|NCT02174848|541513820|FG001|Overall Study|Worsening of disease|1|||
150101464|NCT02174848|541513819|FG000|Overall Study|Unable to comply with study requirements|1|||
150101465|NCT02174848|541513820|FG001|Overall Study|Unable to comply with study requirements|0|||
150101466|NCT02520011|541513824|FG000|Overall Study|Adverse Event|0|||
150101467|NCT02520011|541513825|FG001|Overall Study|Adverse Event|1|||
150101468|NCT02520011|541513826|FG002|Overall Study|Adverse Event|2|||
150101469|NCT02520011|541513824|FG000|Overall Study|Death|0|||
150101470|NCT02520011|541513825|FG001|Overall Study|Death|8|||
150101471|NCT02520011|541513826|FG002|Overall Study|Death|1|||
150101472|NCT02520011|541513824|FG000|Overall Study|Lack of Efficacy|4|||
150101473|NCT02520011|541513825|FG001|Overall Study|Lack of Efficacy|26|||
150101474|NCT02520011|541513826|FG002|Overall Study|Lack of Efficacy|4|||
150101475|NCT02520011|541513824|FG000|Overall Study|Physician Decision|0|||
150101476|NCT02520011|541513825|FG001|Overall Study|Physician Decision|2|||
150101477|NCT02520011|541513826|FG002|Overall Study|Physician Decision|0|||
150101478|NCT02520011|541513824|FG000|Overall Study|Withdrawal by Subject|1|||
150101479|NCT02520011|541513825|FG001|Overall Study|Withdrawal by Subject|3|||
150101480|NCT02520011|541513826|FG002|Overall Study|Withdrawal by Subject|0|||
150101481|NCT02520011|541513824|FG000|Overall Study|Protocol Deviation|0|||
150101482|NCT02520011|541513825|FG001|Overall Study|Protocol Deviation|1|||
150101483|NCT02520011|541513826|FG002|Overall Study|Protocol Deviation|0|||
150101484|NCT02520011|541513824|FG000|Overall Study|Patient went to hospice|0|||
150101485|NCT02520011|541513825|FG001|Overall Study|Patient went to hospice|1|||
150101486|NCT02520011|541513826|FG002|Overall Study|Patient went to hospice|0|||
150101487|NCT02520011|541513824|FG000|Overall Study|Progressive disease following response|0|||
150101488|NCT02520011|541513825|FG001|Overall Study|Progressive disease following response|4|||
150101489|NCT02520011|541513826|FG002|Overall Study|Progressive disease following response|2|||
150101490|NCT00644969|541513827|FG000|Treatment Phase|Randomized, not treated|1|||
150101491|NCT00644969|541513828|FG001|Treatment Phase|Randomized, not treated|0|||
150101492|NCT00644969|541513827|FG000|Treatment Phase|Adverse Event|3|||
150101493|NCT00644969|541513828|FG001|Treatment Phase|Adverse Event|0|||
150101494|NCT00644969|541513827|FG000|Treatment Phase|Withdrawal by Subject|4|||
150101495|NCT00644969|541513828|FG001|Treatment Phase|Withdrawal by Subject|0|||
150101496|NCT00644969|541513827|FG000|Treatment Phase|Lost to Follow-up|2|||
150101497|NCT00644969|541513828|FG001|Treatment Phase|Lost to Follow-up|2|||
150101498|NCT00644969|541513827|FG000|Treatment Phase|Other|4|||
150101499|NCT00644969|541513828|FG001|Treatment Phase|Other|1|||
150101500|NCT00644969|541513827|FG000|Post Treatment Phase|Death|1|||
150101501|NCT00644969|541513828|FG001|Post Treatment Phase|Death|0|||
150101502|NCT00644969|541513827|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
150101503|NCT00644969|541513828|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
150101504|NCT00644969|541513827|FG000|Post Treatment Phase|Lost to Follow-up|4|||
150101505|NCT00644969|541513828|FG001|Post Treatment Phase|Lost to Follow-up|1|||
150101506|NCT00644969|541513827|FG000|Post Treatment Phase|Other|1|||
150101507|NCT00644969|541513828|FG001|Post Treatment Phase|Other|0|||
150101508|NCT05620576|541513829|FG000|Overall Study|Adverse Event|1|||
150101509|NCT05620576|541513830|FG001|Overall Study|Adverse Event|1|||
150101510|NCT05620576|541513829|FG000|Overall Study|Lost to Follow-up|3|||
150101511|NCT05620576|541513830|FG001|Overall Study|Lost to Follow-up|1|||
150101512|NCT05620576|541513829|FG000|Overall Study|Physician Decision|0|||
150101513|NCT05620576|541513830|FG001|Overall Study|Physician Decision|1|||
150101514|NCT05620576|541513829|FG000|Overall Study|Protocol Deviation|1|||
150101515|NCT05620576|541513830|FG001|Overall Study|Protocol Deviation|1|||
150101516|NCT05620576|541513829|FG000|Overall Study|Withdrawal by Subject|2|||
150101517|NCT05620576|541513830|FG001|Overall Study|Withdrawal by Subject|3|||
150101518|NCT03239470|541513831|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
150101519|NCT03239470|541513832|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
150101520|NCT01505608|541513849|FG000|Phase I|Lack of Efficacy|0|||
150101521|NCT01505608|541513850|FG001|Phase I|Lack of Efficacy|4|||
150101522|NCT01505608|541513849|FG000|Phase I|Adverse Event|0|||
150101523|NCT01505608|541513850|FG001|Phase I|Adverse Event|1|||
150101524|NCT01505608|541513849|FG000|Phase I|Withdrawal by Subject|0|||
150101525|NCT01505608|541513850|FG001|Phase I|Withdrawal by Subject|1|||
150101526|NCT01505608|541513849|FG000|Phase II|Lack of Efficacy|2|||
150101527|NCT01505608|541513850|FG001|Phase II|Lack of Efficacy|1|||
150101528|NCT01505608|541513849|FG000|Phase II|Protocol Violation|0|||
150101529|NCT01505608|541513850|FG001|Phase II|Protocol Violation|1|||
150101530|NCT01488097|541513851|FG000|Overall Study|Lost to Follow-up|1|||
150101531|NCT01577758|541513852|FG000|Dose Escalation Phase|Adverse Event|0|||
150101532|NCT01577758|541513853|FG001|Dose Escalation Phase|Adverse Event|0|||
150101533|NCT01577758|541513854|FG002|Dose Escalation Phase|Adverse Event|0|||
150101534|NCT01577758|541513855|FG003|Dose Escalation Phase|Adverse Event|0|||
150101535|NCT01577758|541513856|FG004|Dose Escalation Phase|Adverse Event|0|||
150101536|NCT01577758|541513857|FG005|Dose Escalation Phase|Adverse Event|2|||
150101537|NCT01577758|541513858|FG006|Dose Escalation Phase|Adverse Event|1|||
150101538|NCT01577758|541513859|FG007|Dose Escalation Phase|Adverse Event|0|||
150101539|NCT01577758|541513852|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
150101540|NCT01577758|541513853|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
150101541|NCT01577758|541513854|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
150101542|NCT01577758|541513855|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
150101543|NCT01577758|541513856|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
150101544|NCT01577758|541513857|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
150101545|NCT01577758|541513858|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
150101546|NCT01577758|541513859|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
150101547|NCT01577758|541513852|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
150101548|NCT01577758|541513853|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
150101549|NCT01577758|541513854|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
150101550|NCT01577758|541513855|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
150101551|NCT01577758|541513856|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
150101552|NCT01577758|541513857|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
150101553|NCT01577758|541513858|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
150101554|NCT01577758|541513859|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
150101555|NCT01577758|541513852|FG000|Dose Escalation Phase|Progression Disease|2|||
150101556|NCT01577758|541513853|FG001|Dose Escalation Phase|Progression Disease|2|||
150101557|NCT01577758|541513854|FG002|Dose Escalation Phase|Progression Disease|1|||
150101558|NCT01577758|541513855|FG003|Dose Escalation Phase|Progression Disease|2|||
150101559|NCT01577758|541513856|FG004|Dose Escalation Phase|Progression Disease|5|||
150101560|NCT01577758|541513857|FG005|Dose Escalation Phase|Progression Disease|0|||
150101561|NCT01577758|541513858|FG006|Dose Escalation Phase|Progression Disease|0|||
150101562|NCT01577758|541513859|FG007|Dose Escalation Phase|Progression Disease|0|||
150101563|NCT01577758|541513852|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101564|NCT01577758|541513853|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101565|NCT01577758|541513854|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101566|NCT01577758|541513855|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101567|NCT01577758|541513856|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101568|NCT01577758|541513857|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101569|NCT01577758|541513858|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
150101570|NCT01577758|541513859|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
150101571|NCT01577758|541513852|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101572|NCT01577758|541513853|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101573|NCT01577758|541513854|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101574|NCT01577758|541513855|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101575|NCT01577758|541513856|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101576|NCT01577758|541513857|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101577|NCT01577758|541513858|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
150101578|NCT01577758|541513859|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
150101579|NCT01577758|541513852|FG000|mCRC Expansion Phase|Progression Disease|0|||
150101580|NCT01577758|541513853|FG001|mCRC Expansion Phase|Progression Disease|0|||
150101581|NCT01577758|541513854|FG002|mCRC Expansion Phase|Progression Disease|0|||
150101582|NCT01577758|541513855|FG003|mCRC Expansion Phase|Progression Disease|0|||
150101583|NCT01577758|541513856|FG004|mCRC Expansion Phase|Progression Disease|0|||
150101584|NCT01577758|541513857|FG005|mCRC Expansion Phase|Progression Disease|0|||
150101585|NCT01577758|541513858|FG006|mCRC Expansion Phase|Progression Disease|0|||
150101586|NCT01577758|541513859|FG007|mCRC Expansion Phase|Progression Disease|19|||
150101587|NCT01293240|541513860|FG000|Overall Study|Noncompliance|2|||
150101588|NCT02404350|541513869|FG000|Overall Study|Adverse Event|2|||
150101589|NCT02404350|541513870|FG001|Overall Study|Adverse Event|2|||
150101590|NCT02404350|541513871|FG002|Overall Study|Adverse Event|3|||
150101591|NCT02404350|541513872|FG003|Overall Study|Adverse Event|9|||
150101592|NCT02404350|541513869|FG000|Overall Study|Lack of Efficacy|3|||
150101593|NCT02404350|541513870|FG001|Overall Study|Lack of Efficacy|1|||
150101594|NCT02404350|541513871|FG002|Overall Study|Lack of Efficacy|0|||
150101595|NCT02404350|541513872|FG003|Overall Study|Lack of Efficacy|3|||
150101596|NCT02404350|541513869|FG000|Overall Study|Lost to Follow-up|2|||
150101597|NCT02404350|541513870|FG001|Overall Study|Lost to Follow-up|0|||
150101598|NCT02404350|541513871|FG002|Overall Study|Lost to Follow-up|0|||
150101599|NCT02404350|541513872|FG003|Overall Study|Lost to Follow-up|1|||
150101600|NCT02404350|541513869|FG000|Overall Study|Physician Decision|1|||
150101601|NCT02404350|541513870|FG001|Overall Study|Physician Decision|0|||
150101602|NCT02404350|541513871|FG002|Overall Study|Physician Decision|0|||
150101603|NCT02404350|541513872|FG003|Overall Study|Physician Decision|2|||
150101604|NCT02404350|541513869|FG000|Overall Study|Pregnancy|0|||
150101605|NCT02404350|541513870|FG001|Overall Study|Pregnancy|0|||
150101606|NCT02404350|541513871|FG002|Overall Study|Pregnancy|0|||
150101607|NCT02404350|541513872|FG003|Overall Study|Pregnancy|1|||
150101608|NCT02404350|541513869|FG000|Overall Study|Withdrawal by Subject|7|||
150101609|NCT02404350|541513870|FG001|Overall Study|Withdrawal by Subject|3|||
150101610|NCT02404350|541513871|FG002|Overall Study|Withdrawal by Subject|3|||
150101611|NCT02404350|541513872|FG003|Overall Study|Withdrawal by Subject|19|||
150101612|NCT02404350|541513869|FG000|Overall Study|Due to Non-compliance with treatment|0|||
150101613|NCT02404350|541513870|FG001|Overall Study|Due to Non-compliance with treatment|0|||
150101614|NCT02404350|541513871|FG002|Overall Study|Due to Non-compliance with treatment|0|||
150101615|NCT02404350|541513872|FG003|Overall Study|Due to Non-compliance with treatment|1|||
150101616|NCT02404350|541513869|FG000|Overall Study|Due to Technical problems|0|||
150101617|NCT02404350|541513870|FG001|Overall Study|Due to Technical problems|0|||
150101618|NCT02404350|541513871|FG002|Overall Study|Due to Technical problems|0|||
150101619|NCT02404350|541513872|FG003|Overall Study|Due to Technical problems|1|||
150101620|NCT05389657|541513873|FG000|Overall Study|Lost to Follow-up|7|||
150101621|NCT05389657|541513874|FG001|Overall Study|Lost to Follow-up|8|||
150101622|NCT03089606|541513875|FG000|Overall Study|Progression after Cycle 1|1|||
150101623|NCT00335972|541513876|FG000|Overall Study|not given treatments|0|||
150101624|NCT00335972|541513877|FG001|Overall Study|not given treatments|3|||
150101625|NCT02039674|541513883|FG000|Overall Study|Adverse Event|0|||
150101626|NCT02039674|541513884|FG001|Overall Study|Adverse Event|0|||
150101627|NCT02039674|541513885|FG002|Overall Study|Adverse Event|0|||
150101628|NCT02039674|541513886|FG003|Overall Study|Adverse Event|1|||
150101629|NCT02039674|541513887|FG004|Overall Study|Adverse Event|0|||
150101630|NCT02039674|541513888|FG005|Overall Study|Adverse Event|0|||
150101631|NCT02039674|541513889|FG006|Overall Study|Adverse Event|0|||
150101632|NCT02039674|541513890|FG007|Overall Study|Adverse Event|0|||
150101633|NCT02039674|541513891|FG008|Overall Study|Adverse Event|2|||
150101634|NCT02039674|541513892|FG009|Overall Study|Adverse Event|1|||
150101635|NCT02039674|541513893|FG010|Overall Study|Adverse Event|0|||
150101636|NCT02039674|541513894|FG011|Overall Study|Adverse Event|2|||
150101637|NCT02039674|541513895|FG012|Overall Study|Adverse Event|3|||
150101638|NCT02039674|541513896|FG013|Overall Study|Adverse Event|1|||
150101639|NCT02039674|541513883|FG000|Overall Study|Death|2|||
150101640|NCT02039674|541513884|FG001|Overall Study|Death|0|||
150101641|NCT02039674|541513885|FG002|Overall Study|Death|2|||
150101642|NCT02039674|541513886|FG003|Overall Study|Death|3|||
150101643|NCT02039674|541513887|FG004|Overall Study|Death|0|||
150101644|NCT02039674|541513888|FG005|Overall Study|Death|0|||
150101645|NCT02039674|541513889|FG006|Overall Study|Death|1|||
150101646|NCT02039674|541513890|FG007|Overall Study|Death|0|||
150101647|NCT02039674|541513891|FG008|Overall Study|Death|2|||
150101648|NCT02039674|541513892|FG009|Overall Study|Death|0|||
150101649|NCT02039674|541513893|FG010|Overall Study|Death|1|||
150101650|NCT02039674|541513894|FG011|Overall Study|Death|3|||
150101651|NCT02039674|541513895|FG012|Overall Study|Death|2|||
150101652|NCT02039674|541513896|FG013|Overall Study|Death|8|||
150101653|NCT02039674|541513883|FG000|Overall Study|Excluded Medication|1|||
150101654|NCT02039674|541513884|FG001|Overall Study|Excluded Medication|1|||
150101655|NCT02039674|541513885|FG002|Overall Study|Excluded Medication|0|||
150101656|NCT02039674|541513886|FG003|Overall Study|Excluded Medication|1|||
150101657|NCT02039674|541513887|FG004|Overall Study|Excluded Medication|0|||
150101658|NCT02039674|541513888|FG005|Overall Study|Excluded Medication|1|||
150101659|NCT02039674|541513889|FG006|Overall Study|Excluded Medication|0|||
150101660|NCT02039674|541513890|FG007|Overall Study|Excluded Medication|0|||
150101661|NCT02039674|541513891|FG008|Overall Study|Excluded Medication|2|||
150101662|NCT02039674|541513892|FG009|Overall Study|Excluded Medication|3|||
150101663|NCT02039674|541513893|FG010|Overall Study|Excluded Medication|5|||
150101664|NCT02039674|541513894|FG011|Overall Study|Excluded Medication|6|||
150101665|NCT02039674|541513895|FG012|Overall Study|Excluded Medication|8|||
150101666|NCT02039674|541513896|FG013|Overall Study|Excluded Medication|3|||
150101667|NCT02039674|541513883|FG000|Overall Study|Lost to Follow-up|0|||
150101668|NCT02039674|541513884|FG001|Overall Study|Lost to Follow-up|0|||
150101669|NCT02039674|541513885|FG002|Overall Study|Lost to Follow-up|0|||
150101670|NCT02039674|541513886|FG003|Overall Study|Lost to Follow-up|0|||
150101671|NCT02039674|541513887|FG004|Overall Study|Lost to Follow-up|1|||
150101672|NCT02039674|541513888|FG005|Overall Study|Lost to Follow-up|1|||
150101673|NCT02039674|541513889|FG006|Overall Study|Lost to Follow-up|0|||
150101674|NCT02039674|541513890|FG007|Overall Study|Lost to Follow-up|0|||
150101675|NCT02039674|541513891|FG008|Overall Study|Lost to Follow-up|0|||
150101676|NCT02039674|541513892|FG009|Overall Study|Lost to Follow-up|0|||
150101677|NCT02039674|541513893|FG010|Overall Study|Lost to Follow-up|0|||
150101678|NCT02039674|541513894|FG011|Overall Study|Lost to Follow-up|2|||
150101679|NCT02039674|541513895|FG012|Overall Study|Lost to Follow-up|2|||
150101680|NCT02039674|541513896|FG013|Overall Study|Lost to Follow-up|1|||
150101681|NCT02039674|541513883|FG000|Overall Study|Physician Decision|0|||
150101682|NCT02039674|541513884|FG001|Overall Study|Physician Decision|0|||
150101683|NCT02039674|541513885|FG002|Overall Study|Physician Decision|0|||
150101684|NCT02039674|541513886|FG003|Overall Study|Physician Decision|0|||
150101685|NCT02039674|541513887|FG004|Overall Study|Physician Decision|0|||
150101686|NCT02039674|541513888|FG005|Overall Study|Physician Decision|0|||
150101687|NCT02039674|541513889|FG006|Overall Study|Physician Decision|0|||
150101688|NCT02039674|541513890|FG007|Overall Study|Physician Decision|0|||
150101689|NCT02039674|541513891|FG008|Overall Study|Physician Decision|0|||
150101690|NCT02039674|541513892|FG009|Overall Study|Physician Decision|0|||
150101691|NCT02039674|541513893|FG010|Overall Study|Physician Decision|0|||
150101692|NCT02039674|541513894|FG011|Overall Study|Physician Decision|1|||
150101693|NCT02039674|541513895|FG012|Overall Study|Physician Decision|1|||
150185448|NCT03526861|541817155|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185449|NCT03526861|541817156|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185450|NCT03526861|541817157|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185451|NCT03526861|541817158|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
150101694|NCT02039674|541513896|FG013|Overall Study|Physician Decision|0|||
150101695|NCT02039674|541513883|FG000|Overall Study|Progressive Disease|8|||
150101696|NCT02039674|541513884|FG001|Overall Study|Progressive Disease|8|||
150101697|NCT02039674|541513885|FG002|Overall Study|Progressive Disease|6|||
150101698|NCT02039674|541513886|FG003|Overall Study|Progressive Disease|7|||
150101699|NCT02039674|541513887|FG004|Overall Study|Progressive Disease|9|||
150101700|NCT02039674|541513888|FG005|Overall Study|Progressive Disease|10|||
150101701|NCT02039674|541513889|FG006|Overall Study|Progressive Disease|1|||
150101702|NCT02039674|541513890|FG007|Overall Study|Progressive Disease|3|||
150101703|NCT02039674|541513891|FG008|Overall Study|Progressive Disease|6|||
150101704|NCT02039674|541513892|FG009|Overall Study|Progressive Disease|4|||
150101705|NCT02039674|541513893|FG010|Overall Study|Progressive Disease|0|||
150101706|NCT02039674|541513894|FG011|Overall Study|Progressive Disease|34|||
150101707|NCT02039674|541513895|FG012|Overall Study|Progressive Disease|34|||
150101708|NCT02039674|541513896|FG013|Overall Study|Progressive Disease|18|||
150101709|NCT02039674|541513883|FG000|Overall Study|Withdrawal by Subject|1|||
150101710|NCT02039674|541513884|FG001|Overall Study|Withdrawal by Subject|2|||
150101711|NCT02039674|541513885|FG002|Overall Study|Withdrawal by Subject|3|||
150101712|NCT02039674|541513886|FG003|Overall Study|Withdrawal by Subject|0|||
150101713|NCT02039674|541513887|FG004|Overall Study|Withdrawal by Subject|1|||
150101714|NCT02039674|541513888|FG005|Overall Study|Withdrawal by Subject|0|||
150101715|NCT02039674|541513889|FG006|Overall Study|Withdrawal by Subject|0|||
150101716|NCT02039674|541513890|FG007|Overall Study|Withdrawal by Subject|0|||
150101717|NCT02039674|541513891|FG008|Overall Study|Withdrawal by Subject|0|||
150101718|NCT02039674|541513892|FG009|Overall Study|Withdrawal by Subject|1|||
150101719|NCT02039674|541513893|FG010|Overall Study|Withdrawal by Subject|1|||
150101720|NCT02039674|541513894|FG011|Overall Study|Withdrawal by Subject|4|||
150101721|NCT02039674|541513895|FG012|Overall Study|Withdrawal by Subject|6|||
150101722|NCT02039674|541513896|FG013|Overall Study|Withdrawal by Subject|2|||
150101723|NCT02039674|541513883|FG000|Overall Study|Clinical Progression|0|||
150101724|NCT02039674|541513884|FG001|Overall Study|Clinical Progression|0|||
150101725|NCT02039674|541513885|FG002|Overall Study|Clinical Progression|0|||
150101726|NCT02039674|541513886|FG003|Overall Study|Clinical Progression|0|||
150101727|NCT02039674|541513887|FG004|Overall Study|Clinical Progression|0|||
150101728|NCT02039674|541513888|FG005|Overall Study|Clinical Progression|0|||
150101729|NCT02039674|541513889|FG006|Overall Study|Clinical Progression|1|||
150101730|NCT02039674|541513890|FG007|Overall Study|Clinical Progression|0|||
150101731|NCT02039674|541513891|FG008|Overall Study|Clinical Progression|0|||
150101732|NCT02039674|541513892|FG009|Overall Study|Clinical Progression|0|||
150101733|NCT02039674|541513893|FG010|Overall Study|Clinical Progression|0|||
150101734|NCT02039674|541513894|FG011|Overall Study|Clinical Progression|0|||
150101735|NCT02039674|541513895|FG012|Overall Study|Clinical Progression|1|||
150101736|NCT02039674|541513896|FG013|Overall Study|Clinical Progression|0|||
150101737|NCT02039674|541513883|FG000|Overall Study|Sponsor Decision|1|||
150101738|NCT02039674|541513884|FG001|Overall Study|Sponsor Decision|1|||
150101739|NCT02039674|541513885|FG002|Overall Study|Sponsor Decision|1|||
150101740|NCT02039674|541513886|FG003|Overall Study|Sponsor Decision|1|||
150101741|NCT02039674|541513887|FG004|Overall Study|Sponsor Decision|1|||
150101742|NCT02039674|541513888|FG005|Overall Study|Sponsor Decision|0|||
150101743|NCT02039674|541513889|FG006|Overall Study|Sponsor Decision|0|||
150101744|NCT02039674|541513890|FG007|Overall Study|Sponsor Decision|0|||
150101745|NCT02039674|541513891|FG008|Overall Study|Sponsor Decision|0|||
150101746|NCT02039674|541513892|FG009|Overall Study|Sponsor Decision|3|||
150101747|NCT02039674|541513893|FG010|Overall Study|Sponsor Decision|0|||
150101748|NCT02039674|541513894|FG011|Overall Study|Sponsor Decision|8|||
150101749|NCT02039674|541513895|FG012|Overall Study|Sponsor Decision|5|||
150101750|NCT02039674|541513896|FG013|Overall Study|Sponsor Decision|0|||
150101751|NCT02039674|541513883|FG000|Overall Study|Other|0|||
150101752|NCT02039674|541513884|FG001|Overall Study|Other|0|||
150101753|NCT02039674|541513885|FG002|Overall Study|Other|0|||
150101754|NCT02039674|541513886|FG003|Overall Study|Other|0|||
150101755|NCT02039674|541513887|FG004|Overall Study|Other|0|||
150101756|NCT02039674|541513888|FG005|Overall Study|Other|0|||
150101757|NCT02039674|541513889|FG006|Overall Study|Other|0|||
150101758|NCT02039674|541513890|FG007|Overall Study|Other|0|||
150101759|NCT02039674|541513891|FG008|Overall Study|Other|0|||
150101760|NCT02039674|541513892|FG009|Overall Study|Other|0|||
150101761|NCT02039674|541513893|FG010|Overall Study|Other|0|||
150101762|NCT02039674|541513894|FG011|Overall Study|Other|0|||
150101763|NCT02039674|541513895|FG012|Overall Study|Other|1|||
150101764|NCT02039674|541513896|FG013|Overall Study|Other|0|||
150101765|NCT01408030|541513897|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
150101766|NCT01408030|541513898|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
150101767|NCT01408030|541513899|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
150101768|NCT01408030|541513900|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
150101769|NCT01408030|541513897|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
150101770|NCT01408030|541513898|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
150101771|NCT01408030|541513899|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
150101772|NCT01408030|541513900|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
150101773|NCT01408030|541513897|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
150101774|NCT01408030|541513898|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
150101775|NCT01408030|541513899|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
150101776|NCT01408030|541513900|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
150101777|NCT01408030|541513897|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
150101778|NCT01408030|541513898|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
150101779|NCT01408030|541513899|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
150101780|NCT01408030|541513900|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
150101781|NCT01408030|541513897|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
150101782|NCT01408030|541513898|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
150101783|NCT01408030|541513899|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
150101784|NCT01408030|541513900|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
150101785|NCT01408030|541513897|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
150101786|NCT01408030|541513898|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
150101787|NCT01408030|541513899|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
150101788|NCT01408030|541513900|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
150101789|NCT01408030|541513897|FG000|Observation Phase (Off Drug)|Other|1|||
150101790|NCT01408030|541513898|FG001|Observation Phase (Off Drug)|Other|1|||
150101791|NCT01408030|541513899|FG002|Observation Phase (Off Drug)|Other|1|||
150101792|NCT01408030|541513900|FG003|Observation Phase (Off Drug)|Other|1|||
150101793|NCT00108160|541513901|FG000|Overall Study|Lost to Follow-up|25|||
150101794|NCT00108160|541513902|FG001|Overall Study|Lost to Follow-up|12|||
150101795|NCT00108160|541513901|FG000|Overall Study|Death|1|||
150101796|NCT00108160|541513902|FG001|Overall Study|Death|2|||
150101797|NCT00108160|541513901|FG000|Overall Study|Withdrawal by Subject|4|||
150101798|NCT00108160|541513902|FG001|Overall Study|Withdrawal by Subject|2|||
150101799|NCT00108160|541513901|FG000|Overall Study|Protocol Violation|9|||
150101800|NCT00108160|541513902|FG001|Overall Study|Protocol Violation|5|||
150101801|NCT05045144|541513903|FG000|Overall Study|Lost to Follow-up|3|||
150101802|NCT05045144|541513904|FG001|Overall Study|Lost to Follow-up|2|||
150101803|NCT05045144|541513905|FG002|Overall Study|Lost to Follow-up|3|||
150101804|NCT05045144|541513906|FG003|Overall Study|Lost to Follow-up|5|||
150101805|NCT05045144|541513907|FG004|Overall Study|Lost to Follow-up|13|||
150101806|NCT05045144|541513903|FG000|Overall Study|Withdrawal by Subject|0|||
150101807|NCT05045144|541513904|FG001|Overall Study|Withdrawal by Subject|1|||
150101808|NCT05045144|541513905|FG002|Overall Study|Withdrawal by Subject|0|||
150101809|NCT05045144|541513906|FG003|Overall Study|Withdrawal by Subject|0|||
150101810|NCT05045144|541513907|FG004|Overall Study|Withdrawal by Subject|0|||
150101811|NCT05045144|541513903|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150101812|NCT05045144|541513904|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150101813|NCT05045144|541513905|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
150101814|NCT05045144|541513906|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150101815|NCT05045144|541513907|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
150101816|NCT02081079|541513908|FG000|Overall Study|Lack of Efficacy|3|||
150101817|NCT02081079|541513909|FG001|Overall Study|Lack of Efficacy|2|||
150101818|NCT02081079|541513908|FG000|Overall Study|Lost to Follow-up|1|||
150101819|NCT02081079|541513909|FG001|Overall Study|Lost to Follow-up|0|||
150101820|NCT00788827|541513918|FG000|Overall Study|Lack of Efficacy|2|||
150101821|NCT04668950|541513931|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
150101822|NCT04668950|541513932|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
150101823|NCT04668950|541513931|FG000|Overall Study|Could not confirm started study medication|15|||
150101824|NCT04668950|541513932|FG001|Overall Study|Could not confirm started study medication|15|||
150101825|NCT04668950|541513931|FG000|Overall Study|Could not confirm baseline status|6|||
150101826|NCT04668950|541513932|FG001|Overall Study|Could not confirm baseline status|2|||
150101827|NCT04668950|541513931|FG000|Overall Study|Drop out and did not start medication|15|||
150101828|NCT04668950|541513932|FG001|Overall Study|Drop out and did not start medication|17|||
150101829|NCT04668950|541513931|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
150101830|NCT04668950|541513932|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
150101831|NCT04668950|541513931|FG000|Overall Study|Other|2|||
150101832|NCT04668950|541513932|FG001|Overall Study|Other|4|||
150101833|NCT01342510|541513935|FG000|Overall Study|Protocol Violation|12|||
150101834|NCT01342510|541513936|FG001|Overall Study|Protocol Violation|6|||
150101835|NCT01342510|541513937|FG002|Overall Study|Protocol Violation|13|||
150101836|NCT01342510|541513938|FG003|Overall Study|Protocol Violation|11|||
150101837|NCT04365556|541513939|FG000|Overall Study|No longer eligible due to treatment plan|1|||
150101838|NCT04365556|541513940|FG001|Overall Study|No longer eligible due to treatment plan|0|||
150101839|NCT04365556|541513939|FG000|Overall Study|Lost to Follow-up|3|||
150101840|NCT04365556|541513940|FG001|Overall Study|Lost to Follow-up|2|||
150101841|NCT05756790|541513941|FG000|Overall Study|Withdrawal by Subject|1|||
150101842|NCT05756790|541513942|FG001|Overall Study|Withdrawal by Subject|1|||
150101843|NCT05756790|541513943|FG002|Overall Study|Withdrawal by Subject|1|||
150101844|NCT05756790|541513944|FG003|Overall Study|Withdrawal by Subject|1|||
150101845|NCT05756790|541513945|FG004|Overall Study|Withdrawal by Subject|0|||
150101846|NCT05756790|541513946|FG005|Overall Study|Withdrawal by Subject|0|||
150101847|NCT05756790|541513941|FG000|Overall Study|Protocol Violation|0|||
150101848|NCT05756790|541513942|FG001|Overall Study|Protocol Violation|0|||
150101849|NCT05756790|541513943|FG002|Overall Study|Protocol Violation|1|||
150101850|NCT05756790|541513944|FG003|Overall Study|Protocol Violation|1|||
150101851|NCT05756790|541513945|FG004|Overall Study|Protocol Violation|0|||
150101852|NCT05756790|541513946|FG005|Overall Study|Protocol Violation|0|||
150101853|NCT05756790|541513941|FG000|Overall Study|Ineligible|0|||
150101854|NCT05756790|541513942|FG001|Overall Study|Ineligible|0|||
150101855|NCT05756790|541513943|FG002|Overall Study|Ineligible|0|||
150101856|NCT05756790|541513944|FG003|Overall Study|Ineligible|0|||
150101857|NCT05756790|541513945|FG004|Overall Study|Ineligible|2|||
150101858|NCT05756790|541513946|FG005|Overall Study|Ineligible|2|||
150101859|NCT00502697|541515566|FG000|Overall Study|Withdrawal by Subject|3|||
150101860|NCT00502697|541515567|FG001|Overall Study|Withdrawal by Subject|1|||
150101861|NCT00502697|541515566|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
150101862|NCT00502697|541515567|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
150101863|NCT00502697|541515566|FG000|Overall Study|found not to meet eligibility criteria|3|||
150101864|NCT00502697|541515567|FG001|Overall Study|found not to meet eligibility criteria|4|||
150101865|NCT00502697|541515566|FG000|Overall Study|did not meet assignment criteria|4|||
150101866|NCT00502697|541515567|FG001|Overall Study|did not meet assignment criteria|2|||
150101867|NCT00589108|541515571|FG000|Overall Study|Lost to Follow-up|1|||
150101868|NCT00589108|541515572|FG001|Overall Study|Lost to Follow-up|1|||
150101869|NCT00589108|541515573|FG002|Overall Study|Lost to Follow-up|1|||
150101870|NCT00589108|541515571|FG000|Overall Study|Death|3|||
150101871|NCT00589108|541515572|FG001|Overall Study|Death|3|||
150101872|NCT00589108|541515573|FG002|Overall Study|Death|4|||
150101873|NCT00489853|541515580|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
150101874|NCT00489853|541515581|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
150101875|NCT00489853|541515582|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
150101876|NCT00489853|541515580|FG000|Wash-out Period 1|Adverse Event|0|||
150101877|NCT00489853|541515581|FG001|Wash-out Period 1|Adverse Event|1|||
150101878|NCT00489853|541515582|FG002|Wash-out Period 1|Adverse Event|1|||
150101879|NCT00489853|541515580|FG000|Wash-out Period 1|Protocol Violation|0|||
150101880|NCT00489853|541515581|FG001|Wash-out Period 1|Protocol Violation|1|||
150101881|NCT00489853|541515582|FG002|Wash-out Period 1|Protocol Violation|1|||
150101882|NCT00489853|541515580|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
150101883|NCT00489853|541515581|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
150101884|NCT00489853|541515582|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
150101885|NCT00489853|541515580|FG000|Wash-out Period 2|Adverse Event|1|||
150101886|NCT00489853|541515581|FG001|Wash-out Period 2|Adverse Event|1|||
150101887|NCT00489853|541515582|FG002|Wash-out Period 2|Adverse Event|0|||
150101888|NCT00489853|541515580|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
150101889|NCT00489853|541515581|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
150101890|NCT00489853|541515582|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
150101891|NCT00489853|541515580|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
150101892|NCT00489853|541515581|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
150101893|NCT00489853|541515582|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
150101894|NCT02449239|541515583|FG000|Induction Phase|Lack of Efficacy|64|||
150101895|NCT02449239|541515583|FG000|Induction Phase|Adverse Event|1|||
150101896|NCT02449239|541515583|FG000|Induction Phase|Lost to Follow-up|1|||
150101897|NCT02449239|541515583|FG000|Induction Phase|Protocol Violation|1|||
150101898|NCT02449239|541515583|FG000|Induction Phase|Physician Decision|1|||
150101899|NCT02449239|541515583|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
150101900|NCT02449239|541515583|FG000|Induction Phase|Withdrawal by Subject|1|||
150101901|NCT02449239|541515583|FG000|Maintenance Month 3|Lack of Efficacy|14|||
150101902|NCT02449239|541515583|FG000|Maintenance Month 6|Lack of Efficacy|10|||
150101903|NCT02449239|541515583|FG000|Maintenance Month 6|Adverse Event|2|||
150101904|NCT02449239|541515583|FG000|Maintenance Month 6|Physician Decision|1|||
150101905|NCT02449239|541515583|FG000|Maintenance Month 9|Lack of Efficacy|2|||
150101906|NCT02449239|541515583|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
150101907|NCT02449239|541515583|FG000|Maintenance Month 12|Lack of Efficacy|5|||
150101908|NCT02449239|541515583|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
150101909|NCT02449239|541515583|FG000|Maintenance Month 12|Subject moved from area|1|||
150101910|NCT02449239|541515583|FG000|Maintenance Month 15|Lack of Efficacy|1|||
150101911|NCT02449239|541515583|FG000|Maintenance Month 21|Lack of Efficacy|1|||
150101912|NCT02449239|541515583|FG000|Maintenance Month 21|Sponsor decision|1|||
150101913|NCT01023581|541515584|FG000|Overall Study|Adverse Event|4|||
150101914|NCT01023581|541515585|FG001|Overall Study|Adverse Event|4|||
150101915|NCT01023581|541515586|FG002|Overall Study|Adverse Event|7|||
150101916|NCT01023581|541515587|FG003|Overall Study|Adverse Event|3|||
150101917|NCT01023581|541515588|FG004|Overall Study|Adverse Event|2|||
150101918|NCT01023581|541515589|FG005|Overall Study|Adverse Event|5|||
150101919|NCT01023581|541515590|FG006|Overall Study|Adverse Event|11|||
150101920|NCT01023581|541515584|FG000|Overall Study|Major protocol deviation|2|||
150101921|NCT01023581|541515585|FG001|Overall Study|Major protocol deviation|0|||
150101922|NCT01023581|541515586|FG002|Overall Study|Major protocol deviation|3|||
150101923|NCT01023581|541515587|FG003|Overall Study|Major protocol deviation|0|||
150101924|NCT01023581|541515588|FG004|Overall Study|Major protocol deviation|0|||
150101925|NCT01023581|541515589|FG005|Overall Study|Major protocol deviation|0|||
150101926|NCT01023581|541515590|FG006|Overall Study|Major protocol deviation|0|||
150101927|NCT01023581|541515584|FG000|Overall Study|Lost to Follow-up|4|||
150101928|NCT01023581|541515585|FG001|Overall Study|Lost to Follow-up|8|||
150101929|NCT01023581|541515586|FG002|Overall Study|Lost to Follow-up|7|||
150101930|NCT01023581|541515587|FG003|Overall Study|Lost to Follow-up|2|||
150101931|NCT01023581|541515588|FG004|Overall Study|Lost to Follow-up|5|||
150101932|NCT01023581|541515589|FG005|Overall Study|Lost to Follow-up|2|||
150101933|NCT01023581|541515590|FG006|Overall Study|Lost to Follow-up|2|||
150101934|NCT01023581|541515584|FG000|Overall Study|Withdrawal by Subject|13|||
150101935|NCT01023581|541515585|FG001|Overall Study|Withdrawal by Subject|8|||
150101936|NCT01023581|541515586|FG002|Overall Study|Withdrawal by Subject|16|||
150101937|NCT01023581|541515587|FG003|Overall Study|Withdrawal by Subject|10|||
150101938|NCT01023581|541515588|FG004|Overall Study|Withdrawal by Subject|6|||
150101939|NCT01023581|541515589|FG005|Overall Study|Withdrawal by Subject|8|||
150101940|NCT01023581|541515590|FG006|Overall Study|Withdrawal by Subject|5|||
150101941|NCT01023581|541515584|FG000|Overall Study|Pregnancy|0|||
150101942|NCT01023581|541515585|FG001|Overall Study|Pregnancy|0|||
150101943|NCT01023581|541515586|FG002|Overall Study|Pregnancy|0|||
150101944|NCT01023581|541515587|FG003|Overall Study|Pregnancy|2|||
150101945|NCT01023581|541515588|FG004|Overall Study|Pregnancy|0|||
150101946|NCT01023581|541515589|FG005|Overall Study|Pregnancy|1|||
150101947|NCT01023581|541515590|FG006|Overall Study|Pregnancy|0|||
150101948|NCT01023581|541515584|FG000|Overall Study|Lack of Efficacy|9|||
150101949|NCT01023581|541515585|FG001|Overall Study|Lack of Efficacy|3|||
150185452|NCT03526861|541817159|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185453|NCT03526861|541817160|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185454|NCT03526861|541817161|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185455|NCT03526861|541817162|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150101950|NCT01023581|541515586|FG002|Overall Study|Lack of Efficacy|6|||
150101951|NCT01023581|541515587|FG003|Overall Study|Lack of Efficacy|2|||
150101952|NCT01023581|541515588|FG004|Overall Study|Lack of Efficacy|1|||
150101953|NCT01023581|541515589|FG005|Overall Study|Lack of Efficacy|2|||
150101954|NCT01023581|541515590|FG006|Overall Study|Lack of Efficacy|1|||
150101955|NCT01023581|541515584|FG000|Overall Study|Physician Decision|2|||
150101956|NCT01023581|541515585|FG001|Overall Study|Physician Decision|0|||
150101957|NCT01023581|541515586|FG002|Overall Study|Physician Decision|2|||
150101958|NCT01023581|541515587|FG003|Overall Study|Physician Decision|1|||
150101959|NCT01023581|541515588|FG004|Overall Study|Physician Decision|1|||
150101960|NCT01023581|541515589|FG005|Overall Study|Physician Decision|1|||
150101961|NCT01023581|541515590|FG006|Overall Study|Physician Decision|1|||
150101962|NCT01023581|541515584|FG000|Overall Study|Other|1|||
150101963|NCT01023581|541515585|FG001|Overall Study|Other|0|||
150101964|NCT01023581|541515586|FG002|Overall Study|Other|1|||
150101965|NCT01023581|541515587|FG003|Overall Study|Other|0|||
150101966|NCT01023581|541515588|FG004|Overall Study|Other|1|||
150101967|NCT01023581|541515589|FG005|Overall Study|Other|0|||
150101968|NCT01023581|541515590|FG006|Overall Study|Other|0|||
150101969|NCT01176292|541515594|FG000|Overall Study|Lost to Follow-up|2|||
150101970|NCT01176292|541515595|FG001|Overall Study|Lost to Follow-up|4|||
150101971|NCT01176292|541515594|FG000|Overall Study|Adverse Event|1|||
150101972|NCT01176292|541515595|FG001|Overall Study|Adverse Event|1|||
150101973|NCT01176292|541515594|FG000|Overall Study|Physician Decision|0|||
150101974|NCT01176292|541515595|FG001|Overall Study|Physician Decision|2|||
150101975|NCT01176292|541515594|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
150101976|NCT01176292|541515595|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
150101977|NCT01933048|541515596|FG000|Overall Study|Lost to Follow-up|15|||
150101978|NCT01933048|541515597|FG001|Overall Study|Lost to Follow-up|18|||
150101979|NCT01933048|541515596|FG000|Overall Study|personal reasons|1|||
150101980|NCT01933048|541515597|FG001|Overall Study|personal reasons|1|||
150101981|NCT01933048|541515596|FG000|Overall Study|Protocol Violation|7|||
150101982|NCT01933048|541515597|FG001|Overall Study|Protocol Violation|8|||
150101983|NCT01933048|541515596|FG000|Overall Study|Physician Decision|1|||
150101984|NCT01933048|541515597|FG001|Overall Study|Physician Decision|0|||
150101985|NCT01933048|541515596|FG000|Overall Study|unknown reasons|1|||
150101986|NCT01933048|541515597|FG001|Overall Study|unknown reasons|1|||
150101987|NCT02780804|541515598|FG000|Overall Study|Death|1|||
150101988|NCT02780804|541515599|FG001|Overall Study|Death|0|||
150101989|NCT02780804|541515600|FG002|Overall Study|Death|0|||
150101990|NCT02780804|541515598|FG000|Overall Study|Lack of Efficacy|5|||
150101991|NCT02780804|541515599|FG001|Overall Study|Lack of Efficacy|8|||
150101992|NCT02780804|541515600|FG002|Overall Study|Lack of Efficacy|4|||
150101993|NCT02780804|541515598|FG000|Overall Study|Physician Decision|0|||
150101994|NCT02780804|541515599|FG001|Overall Study|Physician Decision|0|||
150101995|NCT02780804|541515600|FG002|Overall Study|Physician Decision|2|||
150101996|NCT02780804|541515598|FG000|Overall Study|Withdrawal by Subject|0|||
150101997|NCT02780804|541515599|FG001|Overall Study|Withdrawal by Subject|1|||
150101998|NCT02780804|541515600|FG002|Overall Study|Withdrawal by Subject|0|||
150101999|NCT02476968|541515601|FG000|Overall Study|Other|0|||
150102000|NCT02476968|541515602|FG001|Overall Study|Other|2|||
150102001|NCT02476968|541515603|FG002|Overall Study|Other|0|||
150102002|NCT02476968|541515601|FG000|Overall Study|Lost to Follow-up|10|||
150102003|NCT02476968|541515602|FG001|Overall Study|Lost to Follow-up|0|||
150102004|NCT02476968|541515603|FG002|Overall Study|Lost to Follow-up|1|||
150102005|NCT02476968|541515601|FG000|Overall Study|Death|48|||
150102006|NCT02476968|541515602|FG001|Overall Study|Death|8|||
150102007|NCT02476968|541515603|FG002|Overall Study|Death|1|||
150102008|NCT02476968|541515601|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150102009|NCT02476968|541515602|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150102010|NCT02476968|541515603|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
150102011|NCT02476968|541515601|FG000|Overall Study|Patient decision|37|||
150102012|NCT02476968|541515602|FG001|Overall Study|Patient decision|8|||
150102013|NCT02476968|541515603|FG002|Overall Study|Patient decision|0|||
150102014|NCT01859507|541515604|FG000|Overall Study|left the country|4|||
150102015|NCT04476030|541515605|FG000|Overall Study|Withdrawal by Subject|20|||
150102016|NCT04476030|541515606|FG001|Overall Study|Withdrawal by Subject|16|||
150102017|NCT04476030|541515605|FG000|Overall Study|Adverse Event|10|||
150102018|NCT04476030|541515606|FG001|Overall Study|Adverse Event|11|||
150102019|NCT04476030|541515605|FG000|Overall Study|Lost to Follow-up|7|||
150102020|NCT04476030|541515606|FG001|Overall Study|Lost to Follow-up|4|||
150102021|NCT04476030|541515605|FG000|Overall Study|Physician Decision|1|||
150102022|NCT04476030|541515606|FG001|Overall Study|Physician Decision|1|||
150102023|NCT04476030|541515605|FG000|Overall Study|Protocol Deviation|2|||
150102024|NCT04476030|541515606|FG001|Overall Study|Protocol Deviation|0|||
150102025|NCT04476030|541515605|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
150102026|NCT04476030|541515606|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
150102027|NCT04476030|541515605|FG000|Overall Study|Randomized but not Dosed|2|||
150102028|NCT04476030|541515606|FG001|Overall Study|Randomized but not Dosed|8|||
150102029|NCT02404311|541515607|FG000|Part A: Month 0-18|Death|2|||
150102030|NCT02404311|541515608|FG001|Part A: Month 0-18|Death|0|||
150102031|NCT02404311|541515609|FG002|Part A: Month 0-18|Death|0|||
150102032|NCT02404311|541515610|FG003|Part A: Month 0-18|Death|0|||
150102033|NCT02404311|541515611|FG004|Part A: Month 0-18|Death|0|||
150102034|NCT02404311|541515607|FG000|Part A: Month 0-18|Physician Decision|1|||
150102035|NCT02404311|541515608|FG001|Part A: Month 0-18|Physician Decision|0|||
150102036|NCT02404311|541515609|FG002|Part A: Month 0-18|Physician Decision|0|||
150102037|NCT02404311|541515610|FG003|Part A: Month 0-18|Physician Decision|0|||
150102038|NCT02404311|541515611|FG004|Part A: Month 0-18|Physician Decision|0|||
150102039|NCT02404311|541515607|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
150102040|NCT02404311|541515608|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
150102041|NCT02404311|541515609|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
150102042|NCT02404311|541515610|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
150102043|NCT02404311|541515611|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
150102044|NCT02404311|541515607|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
150102045|NCT02404311|541515608|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
150102046|NCT02404311|541515609|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
150102047|NCT02404311|541515610|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
150102048|NCT02404311|541515611|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
150102049|NCT02404311|541515607|FG000|Part A: Month 0-18|HIV Infection|6|||
150102050|NCT02404311|541515608|FG001|Part A: Month 0-18|HIV Infection|2|||
150102051|NCT02404311|541515609|FG002|Part A: Month 0-18|HIV Infection|0|||
150102052|NCT02404311|541515610|FG003|Part A: Month 0-18|HIV Infection|0|||
150102053|NCT02404311|541515611|FG004|Part A: Month 0-18|HIV Infection|0|||
150102054|NCT02404311|541515607|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
150102055|NCT02404311|541515608|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
150102056|NCT02404311|541515609|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
150102057|NCT02404311|541515610|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
150102058|NCT02404311|541515611|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
150102059|NCT02256891|541515616|FG000|Overall Study|Death|0|||
150102060|NCT02256891|541515617|FG001|Overall Study|Death|2|||
150102061|NCT02256891|541515616|FG000|Overall Study|Lost to Follow-up|0|||
150102062|NCT02256891|541515617|FG001|Overall Study|Lost to Follow-up|3|||
150102063|NCT02256891|541515616|FG000|Overall Study|Physician Decision|7|||
150102064|NCT02256891|541515617|FG001|Overall Study|Physician Decision|3|||
150102065|NCT02256891|541515616|FG000|Overall Study|Screen Fail|5|||
150102066|NCT02256891|541515617|FG001|Overall Study|Screen Fail|4|||
150102067|NCT02256891|541515616|FG000|Overall Study|Equipment Malfunction|0|||
150102068|NCT02256891|541515617|FG001|Overall Study|Equipment Malfunction|1|||
150102069|NCT04171414|541515618|FG000|Overall Study|Death|1|||
150102070|NCT04171414|541515618|FG000|Overall Study|Withdrawal by Subject|1|||
150102071|NCT02586493|541515619|FG000|Overall Study|Adverse Event|4|||
150102072|NCT02586493|541515619|FG000|Overall Study|Protocol Violation|6|||
150102073|NCT02586493|541515619|FG000|Overall Study|Lost to Follow-up|1|||
150102074|NCT02586493|541515619|FG000|Overall Study|Withdrawal by Subject|1|||
150102075|NCT01589445|541515628|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
150102076|NCT01589445|541515628|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
150102077|NCT01589445|541515628|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
150102078|NCT01589445|541515628|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
150102079|NCT01589445|541515628|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
150102080|NCT01589445|541515628|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
150102081|NCT01589445|541515628|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
150102082|NCT01589445|541515628|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
150102083|NCT01589445|541515628|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
150102084|NCT01589445|541515628|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
150102085|NCT01990495|541515629|FG000|Overall Study|Physician Decision|5|||
150102086|NCT01990495|541515630|FG001|Overall Study|Physician Decision|4|||
150102087|NCT03412084|541515631|FG000|Overall Study|Withdrawal by Subject|2|||
150102088|NCT03412084|541515632|FG001|Overall Study|Withdrawal by Subject|0|||
150102089|NCT03412084|541515631|FG000|Overall Study|Participant moved|1|||
150102090|NCT03412084|541515632|FG001|Overall Study|Participant moved|0|||
150102091|NCT03412084|541515631|FG000|Overall Study|Lost to Follow-up|1|||
150102092|NCT03412084|541515632|FG001|Overall Study|Lost to Follow-up|1|||
150102093|NCT01928862|541515635|FG000|Overall Study|Lost to Follow-up|1|||
150102094|NCT01928862|541515636|FG001|Overall Study|Lost to Follow-up|0|||
150102095|NCT01928862|541515637|FG002|Overall Study|Lost to Follow-up|0|||
150102096|NCT01928862|541515638|FG003|Overall Study|Lost to Follow-up|0|||
150102097|NCT01928862|541515639|FG004|Overall Study|Lost to Follow-up|1|||
150102098|NCT01478321|541515641|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
150102099|NCT01478321|541515641|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
150102100|NCT01478321|541515641|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
150102101|NCT01478321|541515641|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
150102102|NCT01478321|541515641|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
150102103|NCT01478321|541515641|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
150102104|NCT01478321|541515641|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
150102105|NCT01478321|541515641|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
150102106|NCT00314574|541515645|FG000|Overall Study|Death|3|||
150102107|NCT00314574|541515646|FG001|Overall Study|Death|0|||
150102108|NCT00314574|541515645|FG000|Overall Study|Adverse Event|11|||
150102109|NCT00314574|541515646|FG001|Overall Study|Adverse Event|16|||
150102110|NCT00314574|541515645|FG000|Overall Study|Lost to Follow-up|19|||
150102111|NCT00314574|541515646|FG001|Overall Study|Lost to Follow-up|25|||
150102112|NCT00314574|541515645|FG000|Overall Study|Withdrawal by Subject|33|||
150102113|NCT00314574|541515646|FG001|Overall Study|Withdrawal by Subject|22|||
150102114|NCT00314574|541515645|FG000|Overall Study|Physician Decision|22|||
150102115|NCT00314574|541515646|FG001|Overall Study|Physician Decision|15|||
150102116|NCT00314574|541515645|FG000|Overall Study|Pregnancy|6|||
150102117|NCT00314574|541515646|FG001|Overall Study|Pregnancy|4|||
150102118|NCT00314574|541515645|FG000|Overall Study|Data unknown at database lock|0|||
150102119|NCT00314574|541515646|FG001|Overall Study|Data unknown at database lock|1|||
150102120|NCT02053753|541515651|FG000|Overall Study|Withdrawal by Subject|2|||
150102121|NCT02053753|541515652|FG001|Overall Study|Withdrawal by Subject|4|||
150102122|NCT02053753|541515651|FG000|Overall Study|Decision by Sponsor|1|||
150102123|NCT02053753|541515652|FG001|Overall Study|Decision by Sponsor|1|||
150102124|NCT02053753|541515651|FG000|Overall Study|Lost to Follow-up|4|||
150102125|NCT02053753|541515652|FG001|Overall Study|Lost to Follow-up|3|||
150102126|NCT02972632|541515657|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
150102127|NCT02972632|541515657|FG000|Overall Study|Lost to Follow-up|4|||
150102128|NCT02972632|541515657|FG000|Overall Study|Voluntary Withdrawal|10|||
150102129|NCT00337103|541515661|FG000|Overall Study|Progressive Disease|414|||
150102130|NCT00337103|541515662|FG001|Overall Study|Progressive Disease|410|||
150102131|NCT00337103|541515661|FG000|Overall Study|Adverse Event|45|||
150102132|NCT00337103|541515662|FG001|Overall Study|Adverse Event|59|||
150102133|NCT00337103|541515661|FG000|Overall Study|Subject Choice|34|||
150102134|NCT00337103|541515662|FG001|Overall Study|Subject Choice|27|||
150102135|NCT00337103|541515661|FG000|Overall Study|Clinical Progression|27|||
150102136|NCT00337103|541515662|FG001|Overall Study|Clinical Progression|24|||
150102137|NCT00337103|541515661|FG000|Overall Study|Physician Decision|15|||
150102138|NCT00337103|541515662|FG001|Overall Study|Physician Decision|14|||
150102139|NCT00337103|541515661|FG000|Overall Study|Withdrawal by Subject|8|||
150102140|NCT00337103|541515662|FG001|Overall Study|Withdrawal by Subject|5|||
150102141|NCT00337103|541515661|FG000|Overall Study|Other|5|||
150102142|NCT00337103|541515662|FG001|Overall Study|Other|6|||
150102143|NCT00337103|541515661|FG000|Overall Study|Entry Criteria Not Met|4|||
150102144|NCT00337103|541515662|FG001|Overall Study|Entry Criteria Not Met|1|||
150102145|NCT00337103|541515661|FG000|Overall Study|Lost to Follow-up|1|||
150102146|NCT00337103|541515662|FG001|Overall Study|Lost to Follow-up|2|||
150102147|NCT00337103|541515661|FG000|Overall Study|Death|1|||
150102148|NCT00337103|541515662|FG001|Overall Study|Death|0|||
150102149|NCT02016482|541515663|FG000|Period A|Adverse Event|3|||
150102150|NCT02016482|541515664|FG001|Period A|Adverse Event|5|||
150102151|NCT02016482|541515663|FG000|Period A|Withdrawal by Subject|3|||
150102152|NCT02016482|541515664|FG001|Period A|Withdrawal by Subject|4|||
150102153|NCT02016482|541515663|FG000|Period A|Lost to Follow-up|3|||
150102154|NCT02016482|541515664|FG001|Period A|Lost to Follow-up|3|||
150102155|NCT02016482|541515663|FG000|Period A|Lack of Efficacy|2|||
150102156|NCT02016482|541515664|FG001|Period A|Lack of Efficacy|1|||
150102157|NCT02016482|541515663|FG000|Period A|Other|3|||
150102158|NCT02016482|541515664|FG001|Period A|Other|0|||
150102159|NCT02016482|541515663|FG000|Period A|Protocol Violation|0|||
150102160|NCT02016482|541515664|FG001|Period A|Protocol Violation|1|||
150102161|NCT02016482|541515663|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
150102162|NCT02016482|541515664|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
150102163|NCT02016482|541515663|FG000|Period B|Withdrawal by Subject|1|||
150102164|NCT02016482|541515664|FG001|Period B|Withdrawal by Subject|1|||
150102165|NCT02016482|541515663|FG000|Period B|Lost to Follow-up|2|||
150102166|NCT02016482|541515664|FG001|Period B|Lost to Follow-up|0|||
150102167|NCT02016482|541515663|FG000|Period B|Lack of Efficacy|6|||
150102168|NCT02016482|541515664|FG001|Period B|Lack of Efficacy|4|||
150102169|NCT02016482|541515663|FG000|Period B|Other|4|||
150102170|NCT02016482|541515664|FG001|Period B|Other|0|||
150102171|NCT02016482|541515663|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
150102172|NCT02016482|541515664|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
150102173|NCT01289847|541515665|FG000|Overall Study|Patient could not comply with visits|1|||
150102174|NCT01774786|541515688|FG000|Overall Study|Death|300|||
150102175|NCT01774786|541515689|FG001|Overall Study|Death|319|||
150102176|NCT01774786|541515688|FG000|Overall Study|Lost to Follow-up|6|||
150102177|NCT01774786|541515689|FG001|Overall Study|Lost to Follow-up|7|||
150102178|NCT01774786|541515688|FG000|Overall Study|Withdrawal by Subject|18|||
150102179|NCT01774786|541515689|FG001|Overall Study|Withdrawal by Subject|14|||
150102180|NCT01774786|541515688|FG000|Overall Study|Physician Decision|2|||
150102181|NCT01774786|541515689|FG001|Overall Study|Physician Decision|0|||
150102182|NCT01774786|541515688|FG000|Overall Study|Non-compliance|0|||
150102183|NCT01774786|541515689|FG001|Overall Study|Non-compliance|1|||
150102184|NCT01774786|541515688|FG000|Overall Study|Reason Not Specified|2|||
150102185|NCT01774786|541515689|FG001|Overall Study|Reason Not Specified|5|||
150102186|NCT02268812|541515690|FG000|Overall Study|Adverse Event|8|||
150102187|NCT02268812|541515691|FG001|Overall Study|Adverse Event|26|||
150102188|NCT02268812|541515692|FG002|Overall Study|Adverse Event|7|||
150102189|NCT02268812|541515693|FG003|Overall Study|Adverse Event|10|||
150102190|NCT02268812|541515690|FG000|Overall Study|Protocol deviation|0|||
150102191|NCT02268812|541515691|FG001|Overall Study|Protocol deviation|0|||
150102192|NCT02268812|541515692|FG002|Overall Study|Protocol deviation|1|||
150102193|NCT02268812|541515693|FG003|Overall Study|Protocol deviation|0|||
150102194|NCT02268812|541515690|FG000|Overall Study|Withdrawal by Subject|0|||
150102195|NCT02268812|541515691|FG001|Overall Study|Withdrawal by Subject|1|||
150102196|NCT02268812|541515692|FG002|Overall Study|Withdrawal by Subject|0|||
150102197|NCT02268812|541515693|FG003|Overall Study|Withdrawal by Subject|0|||
150102198|NCT02268812|541515690|FG000|Overall Study|Physician Decision|3|||
150102199|NCT02268812|541515691|FG001|Overall Study|Physician Decision|1|||
150102200|NCT02268812|541515692|FG002|Overall Study|Physician Decision|0|||
150185456|NCT03526861|541817163|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185457|NCT03526861|541817155|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185458|NCT03526861|541817156|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185459|NCT03526861|541817157|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185460|NCT03526861|541817158|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185461|NCT03526861|541817159|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185462|NCT03526861|541817160|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185463|NCT03526861|541817161|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185464|NCT03526861|541817162|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
150185465|NCT03526861|541817163|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
150185466|NCT03526861|541817155|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185467|NCT03526861|541817156|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185468|NCT03526861|541817157|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185469|NCT03526861|541817158|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185470|NCT03526861|541817159|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185471|NCT03526861|541817160|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185472|NCT03526861|541817161|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185473|NCT03526861|541817162|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
150185474|NCT03526861|541817163|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
150185475|NCT03526861|541817155|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185476|NCT03526861|541817156|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185477|NCT03526861|541817157|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185478|NCT03526861|541817158|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185479|NCT03526861|541817159|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185480|NCT03526861|541817160|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185481|NCT03526861|541817161|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185482|NCT03526861|541817162|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
150185483|NCT03526861|541817163|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
150185484|NCT04382898|541817165|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
150185485|NCT04382898|541817166|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
150185486|NCT04382898|541817167|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
150185487|NCT04382898|541817168|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
150185488|NCT04382898|541817169|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
150185489|NCT04382898|541817165|FG000|Part 1: Dose Titration|Death|6|||
150185490|NCT04382898|541817166|FG001|Part 1: Dose Titration|Death|0|||
150185491|NCT04382898|541817167|FG002|Part 1: Dose Titration|Death|0|||
150185492|NCT04382898|541817168|FG003|Part 1: Dose Titration|Death|0|||
150185493|NCT04382898|541817169|FG004|Part 1: Dose Titration|Death|0|||
150185494|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150185495|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150185496|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
150185497|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150185498|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
150185499|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
150185500|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
150185501|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
150102201|NCT02268812|541515693|FG003|Overall Study|Physician Decision|1|||
150102202|NCT02268812|541515690|FG000|Overall Study|Other|5|||
150102203|NCT02268812|541515691|FG001|Overall Study|Other|4|||
150102204|NCT02268812|541515692|FG002|Overall Study|Other|1|||
150102205|NCT02268812|541515693|FG003|Overall Study|Other|3|||
150102206|NCT02385084|541515694|FG000|Period 2|Protocol Violation|0|||
150102207|NCT02385084|541515695|FG001|Period 2|Protocol Violation|0|||
150102208|NCT02385084|541515696|FG002|Period 2|Protocol Violation|1|||
150102209|NCT02385084|541515697|FG003|Period 2|Protocol Violation|0|||
150102210|NCT02385084|541515698|FG004|Period 2|Protocol Violation|0|||
150102211|NCT02385084|541515699|FG005|Period 2|Protocol Violation|0|||
150102212|NCT02268786|541515700|FG000|Overall Study|No Euploid Embryos available|42|||
150102213|NCT02268786|541515701|FG001|Overall Study|No Euploid Embryos available|0|||
150102214|NCT02268786|541515700|FG000|Overall Study|Withdrawal by Subject|7|||
150102215|NCT02268786|541515701|FG001|Overall Study|Withdrawal by Subject|14|||
150102216|NCT02268786|541515700|FG000|Overall Study|Thaw Failure|6|||
150102217|NCT02268786|541515701|FG001|Overall Study|Thaw Failure|4|||
150102218|NCT02268786|541515700|FG000|Overall Study|Protocol Violation|1|||
150102219|NCT02268786|541515701|FG001|Overall Study|Protocol Violation|0|||
150102220|NCT01062555|541515703|FG000|Phase 1|Death|10|||
150102221|NCT01062555|541515704|FG001|Phase 1|Death|17|||
150102222|NCT01062555|541515705|FG002|Phase 1|Death|0|||
150102223|NCT01062555|541515706|FG003|Phase 1|Death|0|||
150102224|NCT01062555|541515703|FG000|Phase 1|Graft Failure|12|||
150102225|NCT01062555|541515704|FG001|Phase 1|Graft Failure|8|||
150102226|NCT01062555|541515705|FG002|Phase 1|Graft Failure|0|||
150102227|NCT01062555|541515706|FG003|Phase 1|Graft Failure|0|||
150102228|NCT01062555|541515703|FG000|Phase 1|Withdrawal by Subject|1|||
150102229|NCT01062555|541515704|FG001|Phase 1|Withdrawal by Subject|1|||
150102230|NCT01062555|541515705|FG002|Phase 1|Withdrawal by Subject|0|||
150102231|NCT01062555|541515706|FG003|Phase 1|Withdrawal by Subject|0|||
150102232|NCT01062555|541515703|FG000|Phase 2|Death|0|||
150102233|NCT01062555|541515704|FG001|Phase 2|Death|0|||
150102234|NCT01062555|541515705|FG002|Phase 2|Death|8|||
150102235|NCT01062555|541515706|FG003|Phase 2|Death|3|||
150102236|NCT01062555|541515703|FG000|Phase 2|Graft failure|0|||
150102237|NCT01062555|541515704|FG001|Phase 2|Graft failure|0|||
150102238|NCT01062555|541515705|FG002|Phase 2|Graft failure|7|||
150102239|NCT01062555|541515706|FG003|Phase 2|Graft failure|4|||
150102240|NCT01062555|541515703|FG000|Phase 2|Withdrawal by Subject|0|||
150102241|NCT01062555|541515704|FG001|Phase 2|Withdrawal by Subject|0|||
150102242|NCT01062555|541515705|FG002|Phase 2|Withdrawal by Subject|0|||
150102243|NCT01062555|541515706|FG003|Phase 2|Withdrawal by Subject|7|||
150102244|NCT01062555|541515703|FG000|Phase 2|Protocol Violation|0|||
150102245|NCT01062555|541515704|FG001|Phase 2|Protocol Violation|0|||
150102246|NCT01062555|541515705|FG002|Phase 2|Protocol Violation|0|||
150102247|NCT01062555|541515706|FG003|Phase 2|Protocol Violation|3|||
150102248|NCT01062555|541515703|FG000|Phase 2|Physician Decision|0|||
150102249|NCT01062555|541515704|FG001|Phase 2|Physician Decision|0|||
150102250|NCT01062555|541515705|FG002|Phase 2|Physician Decision|0|||
150102251|NCT01062555|541515706|FG003|Phase 2|Physician Decision|17|||
150102252|NCT02968979|541515707|FG000|Overall Study|Protocol Violation|7|||
150102253|NCT02968979|541515707|FG000|Overall Study|Withdrawal by Subject|1|||
150102254|NCT00729183|541515708|FG000|Overall Study|Adverse Event|11|||
150102255|NCT00729183|541515709|FG001|Overall Study|Adverse Event|5|||
150102256|NCT00729183|541515708|FG000|Overall Study|Lack of Efficacy|0|||
150102257|NCT00729183|541515709|FG001|Overall Study|Lack of Efficacy|1|||
150102258|NCT00729183|541515708|FG000|Overall Study|Lost to Follow-up|3|||
150102259|NCT00729183|541515709|FG001|Overall Study|Lost to Follow-up|1|||
150102260|NCT00729183|541515708|FG000|Overall Study|Physician Decision|1|||
150102261|NCT00729183|541515709|FG001|Overall Study|Physician Decision|1|||
150102262|NCT00729183|541515708|FG000|Overall Study|Protocol Violation|1|||
150102263|NCT00729183|541515709|FG001|Overall Study|Protocol Violation|0|||
150102264|NCT00729183|541515708|FG000|Overall Study|Withdrawal by Subject|9|||
150102265|NCT00729183|541515709|FG001|Overall Study|Withdrawal by Subject|7|||
150102266|NCT01359254|541515710|FG000|Overall Study|Death|1|||
150102267|NCT01359254|541515711|FG001|Overall Study|Death|0|||
150102268|NCT01124643|541515712|FG000|Overall Study|Death|1|||
150102269|NCT02028988|541515713|FG000|Overall Study|Withdrawal by Subject|2|||
150102270|NCT02678676|541515716|FG000|Overall Study|Death|619|||
150102271|NCT02678676|541515717|FG001|Overall Study|Death|649|||
150102272|NCT02678676|541515716|FG000|Overall Study|Withdrawal by Subject|13|||
150102273|NCT02678676|541515717|FG001|Overall Study|Withdrawal by Subject|5|||
150102274|NCT02678676|541515716|FG000|Overall Study|Lost to Follow-up|171|||
150102275|NCT02678676|541515717|FG001|Overall Study|Lost to Follow-up|151|||
150102276|NCT02678676|541515716|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
150102277|NCT02678676|541515717|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
150102278|NCT02181556|541517314|FG000|Overall Study|Withdrawal by Subject|1|||
150102279|NCT00997503|541517315|FG000|Overall Study|Death|53|||
150102280|NCT00997503|541517315|FG000|Overall Study|Withdrawal by Subject|76|||
150102281|NCT00997503|541517315|FG000|Overall Study|Lost to Follow-up|33|||
150102282|NCT00997503|541517315|FG000|Overall Study|Adverse Event|3|||
150102283|NCT00997503|541517315|FG000|Overall Study|Physician Decision|10|||
150102284|NCT00997503|541517315|FG000|Overall Study|Missed 12-month follow-up|85|||
150102285|NCT00997503|541517315|FG000|Overall Study|Other reason|13|||
150102286|NCT00380393|541517316|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
150102287|NCT00380393|541517317|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
150102288|NCT00380393|541517316|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
150102289|NCT00380393|541517317|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
150102290|NCT00380393|541517316|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
150102291|NCT00380393|541517317|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
150102292|NCT00380393|541517316|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
150102293|NCT00380393|541517317|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
150102294|NCT00380393|541517316|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
150102295|NCT00380393|541517317|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
150102296|NCT00380393|541517316|FG000|Month 14|Withdrawal by Subject|9|||
150102297|NCT00380393|541517317|FG001|Month 14|Withdrawal by Subject|7|||
150185502|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
150185503|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
150185504|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Death|0|||
150185505|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Death|17|||
150185506|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Death|13|||
150185507|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Death|1|||
150185508|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Death|0|||
150185509|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
150185510|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
150185511|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
150185512|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
150185513|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
150185514|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
150185515|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
150185516|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
150185517|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
150185518|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
150185519|NCT04382898|541817165|FG000|Part 2: Dose Expansion|Other|0|||
150185520|NCT04382898|541817166|FG001|Part 2: Dose Expansion|Other|0|||
150185521|NCT04382898|541817167|FG002|Part 2: Dose Expansion|Other|1|||
150185522|NCT04382898|541817168|FG003|Part 2: Dose Expansion|Other|0|||
150185523|NCT04382898|541817169|FG004|Part 2: Dose Expansion|Other|0|||
150102298|NCT00380393|541517316|FG000|Month 14|Death|1|||
150102299|NCT00380393|541517317|FG001|Month 14|Death|0|||
150102300|NCT00380393|541517316|FG000|Month 14|Lost to Follow-up|0|||
150102301|NCT00380393|541517317|FG001|Month 14|Lost to Follow-up|1|||
150102302|NCT00380393|541517316|FG000|Month 14|Migrated/moved from study area|39|||
150102303|NCT00380393|541517317|FG001|Month 14|Migrated/moved from study area|42|||
150102304|NCT00380393|541517316|FG000|Month 14|Protocol Violation|2|||
150102305|NCT00380393|541517317|FG001|Month 14|Protocol Violation|0|||
150102306|NCT00380393|541517316|FG000|Month 14|Others|6|||
150102307|NCT00380393|541517317|FG001|Month 14|Others|6|||
150102308|NCT04920123|541517326|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
150102309|NCT04920123|541517327|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
150102310|NCT04920123|541517328|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
150102311|NCT00218296|541517334|FG000|Overall Study|Lost to Follow-up|9|||
150102312|NCT00218296|541517335|FG001|Overall Study|Lost to Follow-up|7|||
150102313|NCT00218296|541517334|FG000|Overall Study|Withdrawal by Subject|36|||
150102314|NCT00218296|541517335|FG001|Overall Study|Withdrawal by Subject|47|||
150102315|NCT00218296|541517334|FG000|Overall Study|Randomized but did not enter treatment|66|||
150102316|NCT00218296|541517335|FG001|Overall Study|Randomized but did not enter treatment|67|||
150102317|NCT00278954|541517350|FG000|Overall Study|Adverse Event|3|||
150102318|NCT00278954|541517350|FG000|Overall Study|Lost to Follow-up|1|||
150102319|NCT00278954|541517350|FG000|Overall Study|Withdrawal by Subject|1|||
150102320|NCT02211131|541517359|FG000|Overall Study|Death|26|||
150102321|NCT02211131|541517360|FG001|Overall Study|Death|16|||
150185524|NCT05956002|541817170|FG000|Treatment Period 3|Adverse Event|0|||
150185525|NCT05956002|541817171|FG001|Treatment Period 3|Adverse Event|0|||
150185526|NCT05956002|541817172|FG002|Treatment Period 3|Adverse Event|1|||
150185527|NCT05956002|541817173|FG003|Treatment Period 3|Adverse Event|0|||
150185528|NCT02307565|541817174|FG000|Overall Study|Adverse Event|3|||
150185529|NCT02307565|541817175|FG001|Overall Study|Adverse Event|2|||
150185530|NCT02307565|541817174|FG000|Overall Study|Withdrawal by Subject|2|||
150185531|NCT02307565|541817175|FG001|Overall Study|Withdrawal by Subject|2|||
150185532|NCT02323321|541817186|FG000|Overall Study|Re-Transplant|1|||
150185533|NCT02323321|541817186|FG000|Overall Study|Death|12|||
150185534|NCT02500758|541817187|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
150185535|NCT02500758|541817188|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
150185536|NCT02500758|541817187|FG000|Washout (1 Week)|Lost to Follow-up|2|||
150185537|NCT02500758|541817188|FG001|Washout (1 Week)|Lost to Follow-up|2|||
150185538|NCT02500758|541817187|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
150185539|NCT02500758|541817188|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
150185540|NCT02500758|541817187|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
150185541|NCT02500758|541817188|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
150185542|NCT02500758|541817187|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
150185543|NCT02500758|541817188|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
150185544|NCT02874534|541817190|FG000|Overall Study|Withdrawal by Subject|5|||
150185545|NCT02874534|541817191|FG001|Overall Study|Withdrawal by Subject|8|||
150185546|NCT02874534|541817190|FG000|Overall Study|Lost to Follow-up|2|||
150185547|NCT02874534|541817191|FG001|Overall Study|Lost to Follow-up|2|||
150185548|NCT02874534|541817190|FG000|Overall Study|Ongoing in study|1|||
150185549|NCT02874534|541817191|FG001|Overall Study|Ongoing in study|1|||
150185550|NCT02923180|541817192|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
150185551|NCT02923180|541817192|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
150185552|NCT05198310|541817193|FG000|Overall Study|Lost to Follow-up|0|||
150185553|NCT05198310|541817194|FG001|Overall Study|Lost to Follow-up|1|||
150185554|NCT05198310|541817195|FG002|Overall Study|Lost to Follow-up|0|||
150185555|NCT05198310|541817196|FG003|Overall Study|Lost to Follow-up|0|||
150185556|NCT05198310|541817197|FG004|Overall Study|Lost to Follow-up|0|||
150185557|NCT05198310|541817198|FG005|Overall Study|Lost to Follow-up|0|||
150185558|NCT05198310|541817199|FG006|Overall Study|Lost to Follow-up|0|||
150185559|NCT05198310|541817200|FG007|Overall Study|Lost to Follow-up|0|||
150185560|NCT05198310|541817193|FG000|Overall Study|Withdrawal by Subject|0|||
150185561|NCT05198310|541817194|FG001|Overall Study|Withdrawal by Subject|0|||
150185562|NCT05198310|541817195|FG002|Overall Study|Withdrawal by Subject|0|||
150185563|NCT05198310|541817196|FG003|Overall Study|Withdrawal by Subject|2|||
150185564|NCT05198310|541817197|FG004|Overall Study|Withdrawal by Subject|0|||
150185565|NCT05198310|541817198|FG005|Overall Study|Withdrawal by Subject|2|||
150185566|NCT05198310|541817199|FG006|Overall Study|Withdrawal by Subject|1|||
150185567|NCT05198310|541817200|FG007|Overall Study|Withdrawal by Subject|3|||
150185568|NCT04116736|541817203|FG000|Overall Study|Withdrew consent during study|3|||
150185569|NCT04116736|541817204|FG001|Overall Study|Withdrew consent during study|1|||
150185570|NCT04116736|541817203|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
150185571|NCT04116736|541817204|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
150185572|NCT04116736|541817203|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
150185573|NCT04116736|541817204|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
150185574|NCT04116736|541817203|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
150185575|NCT04116736|541817204|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
150185576|NCT04116736|541817203|FG000|Overall Study|Subject was enrolled in error|2|||
150185577|NCT04116736|541817204|FG001|Overall Study|Subject was enrolled in error|0|||
150185578|NCT04116736|541817203|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
150185579|NCT04116736|541817204|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
150185580|NCT04116736|541817203|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
150185581|NCT04116736|541817204|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
150185582|NCT04116736|541817203|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
150185583|NCT04116736|541817204|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
150185584|NCT04970654|541817211|FG000|Overall Study|Withdrawal by parents/guardian|1|||
150185585|NCT04970654|541817212|FG001|Overall Study|Withdrawal by parents/guardian|2|||
150185586|NCT04970654|541817211|FG000|Overall Study|Unclassified|2|||
150185587|NCT04970654|541817212|FG001|Overall Study|Unclassified|1|||
150185588|NCT04970654|541817211|FG000|Overall Study|Lost to Follow-up|1|||
150185589|NCT04970654|541817212|FG001|Overall Study|Lost to Follow-up|0|||
150185590|NCT04757610|541817213|FG000|Overall Study|Adverse Event|13|||
150185591|NCT04757610|541817214|FG001|Overall Study|Adverse Event|10|||
150185592|NCT04757610|541817215|FG002|Overall Study|Adverse Event|5|||
150185593|NCT04757610|541817213|FG000|Overall Study|Death|5|||
150185594|NCT04757610|541817214|FG001|Overall Study|Death|13|||
150185595|NCT04757610|541817215|FG002|Overall Study|Death|8|||
150102322|NCT02211131|541517359|FG000|Overall Study|Lost to Follow-up|4|||
150102323|NCT02211131|541517360|FG001|Overall Study|Lost to Follow-up|3|||
150102324|NCT02211131|541517359|FG000|Overall Study|Decision by Sponsor|1|||
150102325|NCT02211131|541517360|FG001|Overall Study|Decision by Sponsor|1|||
150102326|NCT02211131|541517359|FG000|Overall Study|Withdrawal by Subject|3|||
150102327|NCT02211131|541517360|FG001|Overall Study|Withdrawal by Subject|8|||
150102328|NCT05664490|541517361|FG000|Overall Study|Withdrawal by Subject|0|||
150102329|NCT05664490|541517362|FG001|Overall Study|Withdrawal by Subject|1|||
150102330|NCT05664490|541517361|FG000|Overall Study|Lost to Follow-up|14|||
150102331|NCT05664490|541517362|FG001|Overall Study|Lost to Follow-up|22|||
150102332|NCT05442554|541517363|FG000|Overall Study|Adverse Event|1|||
150102333|NCT00449956|541517371|FG000|Overall Study|Adverse Event|7|||
150102334|NCT00449956|541517372|FG001|Overall Study|Adverse Event|1|||
150102335|NCT00449956|541517373|FG002|Overall Study|Adverse Event|6|||
150102336|NCT00449956|541517371|FG000|Overall Study|Lack of Efficacy|0|||
150102337|NCT00449956|541517372|FG001|Overall Study|Lack of Efficacy|0|||
150102338|NCT00449956|541517373|FG002|Overall Study|Lack of Efficacy|1|||
150102339|NCT00449956|541517371|FG000|Overall Study|Protocol Violation|1|||
150102340|NCT00449956|541517372|FG001|Overall Study|Protocol Violation|1|||
150102341|NCT00449956|541517373|FG002|Overall Study|Protocol Violation|1|||
150102342|NCT00449956|541517371|FG000|Overall Study|Withdrawal by Subject|0|||
150102343|NCT00449956|541517372|FG001|Overall Study|Withdrawal by Subject|1|||
150102344|NCT00449956|541517373|FG002|Overall Study|Withdrawal by Subject|0|||
150102345|NCT00449956|541517371|FG000|Overall Study|Physician Decision|2|||
150102346|NCT00449956|541517372|FG001|Overall Study|Physician Decision|1|||
150102347|NCT00449956|541517373|FG002|Overall Study|Physician Decision|1|||
150102348|NCT01446965|541517378|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
150102349|NCT01446965|541517379|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
150102350|NCT01446965|541517378|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
150102351|NCT01446965|541517379|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
150102352|NCT04064294|541517380|FG000|Overall Study|Adverse Event|1|||
150102353|NCT04064294|541517381|FG001|Overall Study|Adverse Event|0|||
150102354|NCT04064294|541517382|FG002|Overall Study|Adverse Event|0|||
150102355|NCT03818516|541517391|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
150102356|NCT04372602|541517392|FG000|Overall Study|Withdrawal by Subject|1|||
150102357|NCT04372602|541517393|FG001|Overall Study|Withdrawal by Subject|1|||
150102358|NCT04372602|541517392|FG000|Overall Study|Adverse Event|0|||
150102359|NCT04372602|541517393|FG001|Overall Study|Adverse Event|1|||
150102360|NCT04372602|541517392|FG000|Overall Study|Transitioned to comfort care|0|||
150102361|NCT04372602|541517393|FG001|Overall Study|Transitioned to comfort care|1|||
150102362|NCT01085097|541517394|FG000|Overall Study|Adverse Event|0|||
150102363|NCT01085097|541517395|FG001|Overall Study|Adverse Event|0|||
150102364|NCT01085097|541517396|FG002|Overall Study|Adverse Event|2|||
150102365|NCT01085097|541517394|FG000|Overall Study|Treatment failure|2|||
150102366|NCT01085097|541517395|FG001|Overall Study|Treatment failure|0|||
150102367|NCT01085097|541517396|FG002|Overall Study|Treatment failure|0|||
150102368|NCT03742141|541517401|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
150102369|NCT00850395|541517406|FG000|Overall Study|Death|1|||
150102370|NCT00850395|541517406|FG000|Overall Study|Adverse Event|1|||
150102371|NCT00850395|541517406|FG000|Overall Study|Insufficient clinical response|3|||
150102372|NCT00850395|541517406|FG000|Overall Study|Other|5|||
150102373|NCT06049043|541517407|FG000|Overall Study|Lost to Follow-up|11|||
150102374|NCT06049043|541517408|FG001|Overall Study|Lost to Follow-up|9|||
150102375|NCT01354496|541517413|FG000|Period 1|Adverse Event|0|||
150102376|NCT01354496|541517414|FG001|Period 1|Adverse Event|0|||
150102377|NCT01354496|541517415|FG002|Period 1|Adverse Event|1|||
150102378|NCT01354496|541517416|FG003|Period 1|Adverse Event|0|||
150102379|NCT01354496|541517417|FG004|Period 1|Adverse Event|0|||
150102380|NCT01354496|541517418|FG005|Period 1|Adverse Event|0|||
150102381|NCT01354496|541517413|FG000|Period 1|Physician Decision|0|||
150102382|NCT01354496|541517414|FG001|Period 1|Physician Decision|0|||
150102383|NCT01354496|541517415|FG002|Period 1|Physician Decision|1|||
150102384|NCT01354496|541517416|FG003|Period 1|Physician Decision|0|||
150102385|NCT01354496|541517417|FG004|Period 1|Physician Decision|0|||
150102386|NCT01354496|541517418|FG005|Period 1|Physician Decision|0|||
150102387|NCT01354496|541517413|FG000|Period 2|Adverse Event|0|||
150102388|NCT01354496|541517414|FG001|Period 2|Adverse Event|0|||
150102389|NCT01354496|541517415|FG002|Period 2|Adverse Event|0|||
150102390|NCT01354496|541517416|FG003|Period 2|Adverse Event|1|||
150102391|NCT01354496|541517417|FG004|Period 2|Adverse Event|0|||
150102392|NCT01354496|541517418|FG005|Period 2|Adverse Event|0|||
150102393|NCT01354496|541517413|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
150102394|NCT01354496|541517414|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
150102395|NCT01354496|541517415|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
150102396|NCT01354496|541517416|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
150102397|NCT01354496|541517417|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
150102398|NCT01354496|541517418|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
150102399|NCT03774433|541517419|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
150102400|NCT01708174|541517420|FG000|Treatment Period|Withdrawal by Subject|1|||
150102401|NCT01708174|541517421|FG001|Treatment Period|Withdrawal by Subject|0|||
150102402|NCT01708174|541517422|FG002|Treatment Period|Withdrawal by Subject|0|||
150102403|NCT01708174|541517420|FG000|Treatment Period|Progressive disease|0|||
150102404|NCT01708174|541517421|FG001|Treatment Period|Progressive disease|1|||
150102405|NCT01708174|541517422|FG002|Treatment Period|Progressive disease|0|||
150102406|NCT01708174|541517420|FG000|Treatment Period|Death|0|||
150102407|NCT01708174|541517421|FG001|Treatment Period|Death|0|||
150102408|NCT01708174|541517422|FG002|Treatment Period|Death|1|||
150102409|NCT01708174|541517420|FG000|Treatment Period|Adverse Event|0|||
150102410|NCT01708174|541517421|FG001|Treatment Period|Adverse Event|1|||
150102411|NCT01708174|541517422|FG002|Treatment Period|Adverse Event|0|||
150102412|NCT01894152|541517423|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
150102413|NCT02741700|541517424|FG000|Overall Study|Lost to Follow-up|17|||
150102414|NCT02741700|541517425|FG001|Overall Study|Lost to Follow-up|8|||
150102415|NCT02741700|541517424|FG000|Overall Study|Withdrawal by Subject|2|||
150102416|NCT02741700|541517425|FG001|Overall Study|Withdrawal by Subject|5|||
150102417|NCT02741700|541517424|FG000|Overall Study|Physician Decision|3|||
150102418|NCT02741700|541517425|FG001|Overall Study|Physician Decision|0|||
150102419|NCT02741700|541517424|FG000|Overall Study|Moved out of State|0|||
150102420|NCT02741700|541517425|FG001|Overall Study|Moved out of State|1|||
150102421|NCT02741700|541517424|FG000|Overall Study|Death|4|||
150102422|NCT02741700|541517425|FG001|Overall Study|Death|5|||
150102423|NCT00923559|541517426|FG000|Overall Study|Lost to Follow-up|2|||
150102424|NCT00923559|541517427|FG001|Overall Study|Lost to Follow-up|3|||
150102425|NCT04544293|541517428|FG000|Double-blind|Adverse Event|2|||
150102426|NCT04544293|541517429|FG001|Double-blind|Adverse Event|1|||
150102427|NCT04544293|541517428|FG000|Double-blind|Pregnancy|0|||
150102428|NCT04544293|541517429|FG001|Double-blind|Pregnancy|1|||
150102429|NCT04544293|541517428|FG000|Double-blind|Lost to Follow-up|0|||
150102430|NCT04544293|541517429|FG001|Double-blind|Lost to Follow-up|1|||
150102431|NCT04544293|541517428|FG000|Open-Label Extension|Study ongoing|79|||
150102432|NCT04544293|541517429|FG001|Open-Label Extension|Study ongoing|81|||
150102433|NCT02965703|541517435|FG000|Overall Study|Withdrawal by Subject|6|||
150102434|NCT02965703|541517436|FG001|Overall Study|Withdrawal by Subject|3|||
150102435|NCT02965703|541517437|FG002|Overall Study|Withdrawal by Subject|1|||
150102436|NCT02965703|541517435|FG000|Overall Study|Protocol Violation|1|||
150185596|NCT04757610|541817213|FG000|Overall Study|Lack of Efficacy|1|||
150185597|NCT04757610|541817214|FG001|Overall Study|Lack of Efficacy|2|||
150185598|NCT04757610|541817215|FG002|Overall Study|Lack of Efficacy|3|||
150185599|NCT04757610|541817213|FG000|Overall Study|Lost to Follow-up|7|||
150185600|NCT04757610|541817214|FG001|Overall Study|Lost to Follow-up|2|||
150185601|NCT04757610|541817215|FG002|Overall Study|Lost to Follow-up|7|||
150185602|NCT04757610|541817213|FG000|Overall Study|Physician Decision|4|||
150185603|NCT04757610|541817214|FG001|Overall Study|Physician Decision|1|||
150185604|NCT04757610|541817215|FG002|Overall Study|Physician Decision|2|||
150185605|NCT04757610|541817213|FG000|Overall Study|Withdrawal by Subject|26|||
150185606|NCT04757610|541817214|FG001|Overall Study|Withdrawal by Subject|25|||
150185607|NCT04757610|541817215|FG002|Overall Study|Withdrawal by Subject|25|||
150185608|NCT04757610|541817213|FG000|Overall Study|Study Terminated by Sponsor|105|||
150185609|NCT04757610|541817214|FG001|Overall Study|Study Terminated by Sponsor|105|||
150185610|NCT04757610|541817215|FG002|Overall Study|Study Terminated by Sponsor|110|||
150185611|NCT04757610|541817213|FG000|Overall Study|Randomized in Error|1|||
150185612|NCT04757610|541817214|FG001|Overall Study|Randomized in Error|0|||
150102437|NCT02965703|541517436|FG001|Overall Study|Protocol Violation|0|||
150102438|NCT02965703|541517437|FG002|Overall Study|Protocol Violation|0|||
150185613|NCT04757610|541817215|FG002|Overall Study|Randomized in Error|0|||
150102439|NCT02965703|541517435|FG000|Overall Study|Adverse Event|1|||
150102440|NCT02965703|541517436|FG001|Overall Study|Adverse Event|1|||
150102441|NCT02965703|541517437|FG002|Overall Study|Adverse Event|0|||
150185614|NCT06450405|541817218|FG000|Overall Study|Study funding terminated.|0|||
150185615|NCT06450405|541817219|FG001|Overall Study|Study funding terminated.|2|||
150185616|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
150185617|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
150185618|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
150185619|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
150102442|NCT02965703|541517435|FG000|Overall Study|Lost to Follow-up|2|||
150102443|NCT02965703|541517436|FG001|Overall Study|Lost to Follow-up|1|||
150102444|NCT02965703|541517437|FG002|Overall Study|Lost to Follow-up|1|||
150102445|NCT01951157|541517439|FG000|Overall Study|Progressive Disease|12|||
150102446|NCT01951157|541517440|FG001|Overall Study|Progressive Disease|13|||
150102447|NCT01951157|541517441|FG002|Overall Study|Progressive Disease|10|||
150102448|NCT01951157|541517439|FG000|Overall Study|Treatment-unrelated AE|1|||
150102449|NCT01951157|541517440|FG001|Overall Study|Treatment-unrelated AE|0|||
150102450|NCT01951157|541517441|FG002|Overall Study|Treatment-unrelated AE|3|||
150102451|NCT01951157|541517439|FG000|Overall Study|Study Termination|0|||
150102452|NCT01951157|541517440|FG001|Overall Study|Study Termination|0|||
150102453|NCT01951157|541517441|FG002|Overall Study|Study Termination|1|||
150102454|NCT01951157|541517439|FG000|Overall Study|Physician Decision|5|||
150102455|NCT01951157|541517440|FG001|Overall Study|Physician Decision|3|||
150102456|NCT01951157|541517441|FG002|Overall Study|Physician Decision|2|||
150102457|NCT01951157|541517439|FG000|Overall Study|Non-treatmentrelated death|2|||
150102458|NCT01951157|541517440|FG001|Overall Study|Non-treatmentrelated death|2|||
150102459|NCT01951157|541517441|FG002|Overall Study|Non-treatmentrelated death|2|||
150102460|NCT01951157|541517439|FG000|Overall Study|No treated|0|||
150102461|NCT01951157|541517440|FG001|Overall Study|No treated|1|||
150102462|NCT01951157|541517441|FG002|Overall Study|No treated|0|||
150102463|NCT01951157|541517439|FG000|Overall Study|Treatment-related AE|2|||
150102464|NCT01951157|541517440|FG001|Overall Study|Treatment-related AE|0|||
150102465|NCT01951157|541517441|FG002|Overall Study|Treatment-related AE|4|||
150102466|NCT01951157|541517439|FG000|Overall Study|Consent withdrawn by subject|0|||
150102467|NCT01951157|541517440|FG001|Overall Study|Consent withdrawn by subject|1|||
150102468|NCT01951157|541517441|FG002|Overall Study|Consent withdrawn by subject|3|||
150102469|NCT01951157|541517439|FG000|Overall Study|Treatment-related death|0|||
150102470|NCT01951157|541517440|FG001|Overall Study|Treatment-related death|2|||
150102471|NCT01951157|541517441|FG002|Overall Study|Treatment-related death|0|||
150102472|NCT00744627|541517442|FG000|Overall Study|Adverse Event|6|||
150102473|NCT00744627|541517443|FG001|Overall Study|Adverse Event|9|||
150102474|NCT00744627|541517442|FG000|Overall Study|Lack of Efficacy|7|||
150102475|NCT00744627|541517443|FG001|Overall Study|Lack of Efficacy|3|||
150102476|NCT00744627|541517442|FG000|Overall Study|Noncompliance|0|||
150102477|NCT00744627|541517443|FG001|Overall Study|Noncompliance|1|||
150102478|NCT00744627|541517442|FG000|Overall Study|Protocol Deviations|0|||
150102479|NCT00744627|541517443|FG001|Overall Study|Protocol Deviations|2|||
150102480|NCT00744627|541517442|FG000|Overall Study|Voluntary Withdrawal|9|||
150102481|NCT00744627|541517443|FG001|Overall Study|Voluntary Withdrawal|6|||
150102482|NCT00744627|541517442|FG000|Overall Study|Lost to Follow-up|2|||
150102483|NCT00744627|541517443|FG001|Overall Study|Lost to Follow-up|1|||
150102484|NCT00744627|541517442|FG000|Overall Study|Other|1|||
150102485|NCT00744627|541517443|FG001|Overall Study|Other|0|||
150102486|NCT03560531|541517444|FG000|Overall Study|Death|4|||
150102487|NCT03560531|541517445|FG001|Overall Study|Death|1|||
150102488|NCT03560531|541517446|FG002|Overall Study|Death|1|||
150102489|NCT03560531|541517447|FG003|Overall Study|Death|2|||
150102490|NCT03560531|541517448|FG004|Overall Study|Death|6|||
150102491|NCT03560531|541517449|FG005|Overall Study|Death|1|||
150102492|NCT03560531|541517450|FG006|Overall Study|Death|4|||
150102493|NCT03560531|541517451|FG007|Overall Study|Death|8|||
150102494|NCT03560531|541517452|FG008|Overall Study|Death|1|||
150102495|NCT03560531|541517453|FG009|Overall Study|Death|3|||
150102496|NCT03560531|541517454|FG010|Overall Study|Death|2|||
150102497|NCT03560531|541517455|FG011|Overall Study|Death|0|||
150102498|NCT03560531|541517456|FG012|Overall Study|Death|4|||
150102499|NCT03560531|541517457|FG013|Overall Study|Death|1|||
150102500|NCT03560531|541517444|FG000|Overall Study|Lost to Follow-up|1|||
150102501|NCT03560531|541517445|FG001|Overall Study|Lost to Follow-up|1|||
150102502|NCT03560531|541517446|FG002|Overall Study|Lost to Follow-up|0|||
150102503|NCT03560531|541517447|FG003|Overall Study|Lost to Follow-up|0|||
150102504|NCT03560531|541517448|FG004|Overall Study|Lost to Follow-up|0|||
150102505|NCT03560531|541517449|FG005|Overall Study|Lost to Follow-up|0|||
150102506|NCT03560531|541517450|FG006|Overall Study|Lost to Follow-up|1|||
150102507|NCT03560531|541517451|FG007|Overall Study|Lost to Follow-up|0|||
150102508|NCT03560531|541517452|FG008|Overall Study|Lost to Follow-up|0|||
150102509|NCT03560531|541517453|FG009|Overall Study|Lost to Follow-up|0|||
150102510|NCT03560531|541517454|FG010|Overall Study|Lost to Follow-up|0|||
150102511|NCT03560531|541517455|FG011|Overall Study|Lost to Follow-up|0|||
150102512|NCT03560531|541517456|FG012|Overall Study|Lost to Follow-up|0|||
150102513|NCT03560531|541517457|FG013|Overall Study|Lost to Follow-up|0|||
150102514|NCT03560531|541517444|FG000|Overall Study|Withdrawal by Subject|1|||
150102515|NCT03560531|541517445|FG001|Overall Study|Withdrawal by Subject|0|||
150102516|NCT03560531|541517446|FG002|Overall Study|Withdrawal by Subject|0|||
150102517|NCT03560531|541517447|FG003|Overall Study|Withdrawal by Subject|0|||
150102518|NCT03560531|541517448|FG004|Overall Study|Withdrawal by Subject|0|||
150102519|NCT03560531|541517449|FG005|Overall Study|Withdrawal by Subject|0|||
150102520|NCT03560531|541517450|FG006|Overall Study|Withdrawal by Subject|0|||
150102521|NCT03560531|541517451|FG007|Overall Study|Withdrawal by Subject|3|||
150102522|NCT03560531|541517452|FG008|Overall Study|Withdrawal by Subject|2|||
150102523|NCT03560531|541517453|FG009|Overall Study|Withdrawal by Subject|0|||
150102524|NCT03560531|541517454|FG010|Overall Study|Withdrawal by Subject|0|||
150102525|NCT03560531|541517455|FG011|Overall Study|Withdrawal by Subject|0|||
150102526|NCT03560531|541517456|FG012|Overall Study|Withdrawal by Subject|2|||
150102527|NCT03560531|541517457|FG013|Overall Study|Withdrawal by Subject|0|||
150102528|NCT03560531|541517444|FG000|Overall Study|Study end per-protocol|1|||
150102529|NCT03560531|541517445|FG001|Overall Study|Study end per-protocol|1|||
150102530|NCT03560531|541517446|FG002|Overall Study|Study end per-protocol|2|||
150102531|NCT03560531|541517447|FG003|Overall Study|Study end per-protocol|0|||
150102532|NCT03560531|541517448|FG004|Overall Study|Study end per-protocol|1|||
150102533|NCT03560531|541517449|FG005|Overall Study|Study end per-protocol|0|||
150102534|NCT03560531|541517450|FG006|Overall Study|Study end per-protocol|0|||
150102535|NCT03560531|541517451|FG007|Overall Study|Study end per-protocol|0|||
150102536|NCT03560531|541517452|FG008|Overall Study|Study end per-protocol|0|||
150102537|NCT03560531|541517453|FG009|Overall Study|Study end per-protocol|0|||
150102538|NCT03560531|541517454|FG010|Overall Study|Study end per-protocol|0|||
150102539|NCT03560531|541517455|FG011|Overall Study|Study end per-protocol|0|||
150102540|NCT03560531|541517456|FG012|Overall Study|Study end per-protocol|0|||
150102541|NCT03560531|541517457|FG013|Overall Study|Study end per-protocol|0|||
150102542|NCT03560531|541517444|FG000|Overall Study|Early study termination by sponsor|9|||
150102543|NCT03560531|541517445|FG001|Overall Study|Early study termination by sponsor|0|||
150102544|NCT03560531|541517446|FG002|Overall Study|Early study termination by sponsor|0|||
150102545|NCT03560531|541517447|FG003|Overall Study|Early study termination by sponsor|4|||
150102546|NCT03560531|541517448|FG004|Overall Study|Early study termination by sponsor|8|||
150102547|NCT03560531|541517449|FG005|Overall Study|Early study termination by sponsor|2|||
150102548|NCT03560531|541517450|FG006|Overall Study|Early study termination by sponsor|5|||
150102549|NCT03560531|541517451|FG007|Overall Study|Early study termination by sponsor|64|||
150102550|NCT03560531|541517452|FG008|Overall Study|Early study termination by sponsor|7|||
150102551|NCT03560531|541517453|FG009|Overall Study|Early study termination by sponsor|2|||
150102552|NCT03560531|541517454|FG010|Overall Study|Early study termination by sponsor|16|||
150102553|NCT03560531|541517455|FG011|Overall Study|Early study termination by sponsor|2|||
150102554|NCT03560531|541517456|FG012|Overall Study|Early study termination by sponsor|6|||
150102555|NCT03560531|541517457|FG013|Overall Study|Early study termination by sponsor|2|||
150102556|NCT01471379|541517458|FG000|Overall Study|Adverse Event|1|||
150102557|NCT01471379|541517459|FG001|Overall Study|Adverse Event|0|||
150102558|NCT01471379|541517460|FG002|Overall Study|Adverse Event|0|||
150102559|NCT01471379|541517458|FG000|Overall Study|Study terminated|0|||
150102560|NCT01471379|541517459|FG001|Overall Study|Study terminated|1|||
150102561|NCT01471379|541517460|FG002|Overall Study|Study terminated|0|||
150102562|NCT01200797|541517461|FG000|Overall Study|symptomatic deterioration|2|||
150102563|NCT01200797|541517461|FG000|Overall Study|Adverse Event|4|||
150102564|NCT01200797|541517461|FG000|Overall Study|Disease Progression|13|||
150102565|NCT03745144|541517462|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
150102566|NCT03745144|541517463|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
150102567|NCT03745144|541517464|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
150102568|NCT03745144|541517462|FG000|Period 1|Other|0|||
150102569|NCT03745144|541517463|FG001|Period 1|Other|0|||
150102570|NCT03745144|541517464|FG002|Period 1|Other|1|||
150102571|NCT03608774|541517465|FG000|Overall Study|Lost to Follow-up|5|||
150102572|NCT03608774|541517466|FG001|Overall Study|Lost to Follow-up|5|||
150102573|NCT03608774|541517465|FG000|Overall Study|Withdrawal by Subject|1|||
150102574|NCT03608774|541517466|FG001|Overall Study|Withdrawal by Subject|0|||
150102575|NCT03608774|541517465|FG000|Overall Study|Protocol Violation|1|||
150102576|NCT03608774|541517466|FG001|Overall Study|Protocol Violation|0|||
150185620|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
150185621|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
150102577|NCT03608774|541517465|FG000|Overall Study|Not eligible at enrollment|0|||
150102578|NCT03608774|541517466|FG001|Overall Study|Not eligible at enrollment|1|||
150102579|NCT03608774|541517465|FG000|Overall Study|Health related event|0|||
150102580|NCT03608774|541517466|FG001|Overall Study|Health related event|1|||
150102581|NCT00642668|541517467|FG000|Overall Study|Lost to Follow-up|1|||
150102582|NCT00642668|541517467|FG000|Overall Study|Adverse Event|2|||
150102583|NCT00642668|541517467|FG000|Overall Study|Death|2|||
150102584|NCT00642668|541517467|FG000|Overall Study|Insufficient Therapeutic Response|1|||
150102585|NCT00642668|541517467|FG000|Overall Study|Failure to Return|1|||
150102586|NCT00642668|541517467|FG000|Overall Study|Dialysis Initiation|5|||
150102587|NCT00642668|541517467|FG000|Overall Study|Blood Transfusion|2|||
150102588|NCT01586819|541517468|FG000|Overall Study|Withdrawal by Subject|1|||
150102589|NCT01586819|541517469|FG001|Overall Study|Withdrawal by Subject|0|||
150102590|NCT01324349|541517480|FG000|Overall Study|Death|1|||
150102591|NCT01324349|541517481|FG001|Overall Study|Death|1|||
150102592|NCT01324349|541517480|FG000|Overall Study|Withdrawal by Subject|0|||
150102593|NCT01324349|541517481|FG001|Overall Study|Withdrawal by Subject|1|||
150102594|NCT00748215|541517482|FG000|Overall Study|Withdrawal by Subject|7|||
150102595|NCT00748215|541517483|FG001|Overall Study|Withdrawal by Subject|7|||
150102596|NCT00748215|541517482|FG000|Overall Study|Treatment change|2|||
150102597|NCT00748215|541517483|FG001|Overall Study|Treatment change|1|||
150102598|NCT00748215|541517482|FG000|Overall Study|Change in patient condition|0|||
150102599|NCT00748215|541517483|FG001|Overall Study|Change in patient condition|3|||
150102600|NCT00748215|541517482|FG000|Overall Study|Non-compliant|0|||
150102601|NCT00748215|541517483|FG001|Overall Study|Non-compliant|2|||
150102602|NCT00748215|541517482|FG000|Overall Study|Adverse Event|0|||
150102603|NCT00748215|541517483|FG001|Overall Study|Adverse Event|5|||
150102604|NCT00851799|541517484|FG000|Overall Study|Death|1|||
150102605|NCT00851799|541517485|FG001|Overall Study|Death|0|||
150102606|NCT00851799|541517486|FG002|Overall Study|Death|1|||
150102607|NCT00851799|541517484|FG000|Overall Study|Lost to Follow-up|5|||
150102608|NCT00851799|541517485|FG001|Overall Study|Lost to Follow-up|3|||
150102609|NCT00851799|541517486|FG002|Overall Study|Lost to Follow-up|10|||
150102610|NCT00851799|541517484|FG000|Overall Study|Not able to get to clinic|8|||
150102611|NCT00851799|541517485|FG001|Overall Study|Not able to get to clinic|5|||
150102612|NCT00851799|541517486|FG002|Overall Study|Not able to get to clinic|9|||
150102613|NCT00851799|541517484|FG000|Overall Study|Not willing to adhere to requirements|1|||
150102614|NCT00851799|541517485|FG001|Overall Study|Not willing to adhere to requirements|2|||
150102615|NCT00851799|541517486|FG002|Overall Study|Not willing to adhere to requirements|2|||
150102616|NCT00851799|541517484|FG000|Overall Study|Withdrew consent prior study completion|1|||
150102617|NCT00851799|541517485|FG001|Overall Study|Withdrew consent prior study completion|2|||
150102618|NCT00851799|541517486|FG002|Overall Study|Withdrew consent prior study completion|1|||
150102619|NCT00851799|541517484|FG000|Overall Study|Severe Debilitation|0|||
150102620|NCT00851799|541517485|FG001|Overall Study|Severe Debilitation|1|||
150102621|NCT00851799|541517486|FG002|Overall Study|Severe Debilitation|0|||
150102622|NCT00851799|541517484|FG000|Overall Study|Completed protocol due to pregnancy|0|||
150102623|NCT00851799|541517485|FG001|Overall Study|Completed protocol due to pregnancy|0|||
150102624|NCT00851799|541517486|FG002|Overall Study|Completed protocol due to pregnancy|1|||
150102625|NCT01449526|541517487|FG000|Overall Study|Lost to Follow-up|1|||
150102626|NCT01449526|541517488|FG001|Overall Study|Lost to Follow-up|2|||
150102627|NCT01449526|541517487|FG000|Overall Study|Withdrawal by Subject|1|||
150102628|NCT01449526|541517488|FG001|Overall Study|Withdrawal by Subject|1|||
150102629|NCT01449526|541517487|FG000|Overall Study|Symptoms/complaints|0|||
150102630|NCT01449526|541517488|FG001|Overall Study|Symptoms/complaints|1|||
150102631|NCT01449526|541517487|FG000|Overall Study|Lack of Motivation|0|||
150102632|NCT01449526|541517488|FG001|Overall Study|Lack of Motivation|1|||
150102633|NCT01449526|541517487|FG000|Overall Study|Cannot maintain visits|0|||
150102634|NCT01449526|541517488|FG001|Overall Study|Cannot maintain visits|1|||
150102635|NCT00244712|541517490|FG000|Overall Study|Adverse Event|20|||
150102636|NCT00244712|541517491|FG001|Overall Study|Adverse Event|21|||
150102637|NCT00244712|541517490|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
150102638|NCT00244712|541517491|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
150102639|NCT00244712|541517490|FG000|Overall Study|Lack of Compliance|10|||
150102640|NCT00244712|541517491|FG001|Overall Study|Lack of Compliance|11|||
150102641|NCT00244712|541517490|FG000|Overall Study|Lost to Follow-up|45|||
150102642|NCT00244712|541517491|FG001|Overall Study|Lost to Follow-up|52|||
150102643|NCT00244712|541517490|FG000|Overall Study|Withdrawal by Subject|13|||
150102644|NCT00244712|541517491|FG001|Overall Study|Withdrawal by Subject|23|||
150102645|NCT00244712|541517490|FG000|Overall Study|Protocol Violation, disease progression|13|||
150102646|NCT00244712|541517491|FG001|Overall Study|Protocol Violation, disease progression|11|||
150102647|NCT00427635|541518924|FG000|Treatment Phase|Withdrawal by Subject|1|||
150102648|NCT00427635|541518925|FG001|Treatment Phase|Withdrawal by Subject|0|||
150102649|NCT00427635|541518924|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
150102650|NCT00427635|541518925|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
150102651|NCT00838201|541518926|FG000|Overall Study|Investigator decision, or other reasons|2|||
150102652|NCT00838201|541518927|FG001|Overall Study|Investigator decision, or other reasons|3|||
150185622|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
150185623|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
150185624|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
150185625|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
150102653|NCT00838201|541518926|FG000|Overall Study|Noncompliance|0|||
150102654|NCT00838201|541518927|FG001|Overall Study|Noncompliance|1|||
150102655|NCT00838201|541518926|FG000|Overall Study|Administrative decision|1|||
150102656|NCT00838201|541518927|FG001|Overall Study|Administrative decision|2|||
150102657|NCT00838201|541518926|FG000|Overall Study|Disease progression|3|||
150102658|NCT00838201|541518927|FG001|Overall Study|Disease progression|3|||
150102659|NCT00838201|541518926|FG000|Overall Study|Consent withdrawn|16|||
150102660|NCT00838201|541518927|FG001|Overall Study|Consent withdrawn|19|||
150102661|NCT00838201|541518926|FG000|Overall Study|Lost to Follow-up|4|||
150102662|NCT00838201|541518927|FG001|Overall Study|Lost to Follow-up|3|||
150102663|NCT00838201|541518926|FG000|Overall Study|Adverse Event|5|||
150102664|NCT00838201|541518927|FG001|Overall Study|Adverse Event|9|||
150102665|NCT00838201|541518926|FG000|Overall Study|Death|11|||
150102666|NCT00838201|541518927|FG001|Overall Study|Death|13|||
150102667|NCT02558790|541518928|FG000|Overall Study|Lost to Follow-up|2|||
150102668|NCT02558790|541518928|FG000|Overall Study|Physician Decision|1|||
150102669|NCT02558790|541518928|FG000|Overall Study|Withdrawal by Subject|1|||
150102670|NCT02558790|541518928|FG000|Overall Study|Screen Fail|3|||
150102671|NCT02711800|541518936|FG000|Overall Study|Lost to Follow-up|1|||
150102672|NCT02711800|541518936|FG000|Overall Study|Withdrawal by Subject|1|||
150102673|NCT02023151|541518946|FG000|Overall Study|Lost to Follow-up|4|||
150102674|NCT03450707|541518947|FG000|Overall Study|Outside enrollment window|4|||
150102675|NCT03450707|541518948|FG001|Overall Study|Outside enrollment window|1|||
150102676|NCT03450707|541518947|FG000|Overall Study|Death|1|||
150102677|NCT03450707|541518948|FG001|Overall Study|Death|0|||
150102678|NCT03450707|541518947|FG000|Overall Study|Indication for thiamine|1|||
150102679|NCT03450707|541518948|FG001|Overall Study|Indication for thiamine|1|||
150102680|NCT03450707|541518947|FG000|Overall Study|Evidence of traumatic brain injury|1|||
150102681|NCT03450707|541518948|FG001|Overall Study|Evidence of traumatic brain injury|0|||
150102682|NCT03450707|541518947|FG000|Overall Study|Following commands|0|||
150102683|NCT03450707|541518948|FG001|Overall Study|Following commands|3|||
150102684|NCT03450707|541518947|FG000|Overall Study|Lactate < 3.5|0|||
150102685|NCT03450707|541518948|FG001|Overall Study|Lactate < 3.5|2|||
150102686|NCT03450707|541518947|FG000|Overall Study|Rearrest with ECMO|0|||
150102687|NCT03450707|541518948|FG001|Overall Study|Rearrest with ECMO|1|||
150102688|NCT03450707|541518947|FG000|Overall Study|Indication for thiamine + head CT results|0|||
150102689|NCT03450707|541518948|FG001|Overall Study|Indication for thiamine + head CT results|1|||
150102690|NCT03450707|541518947|FG000|Overall Study|Family/patient goals of care|0|||
150102691|NCT03450707|541518948|FG001|Overall Study|Family/patient goals of care|1|||
150102692|NCT00004412|541518949|FG000|Randomized Period|Moved to Crossover Period|3|||
150102693|NCT00004412|541518950|FG001|Randomized Period|Moved to Crossover Period|0|||
150102694|NCT00004412|541518951|FG002|Randomized Period|Moved to Crossover Period|0|||
150102695|NCT00481195|541518952|FG000|Overall Study|Adverse Event|16|||
150102696|NCT00481195|541518953|FG001|Overall Study|Adverse Event|11|||
150102697|NCT00481195|541518952|FG000|Overall Study|Lack of Efficacy|1|||
150102698|NCT00481195|541518953|FG001|Overall Study|Lack of Efficacy|3|||
150102699|NCT00481195|541518952|FG000|Overall Study|Lost to Follow-up|4|||
150102700|NCT00481195|541518953|FG001|Overall Study|Lost to Follow-up|6|||
150102701|NCT00481195|541518952|FG000|Overall Study|Physician Decision|3|||
150102702|NCT00481195|541518953|FG001|Overall Study|Physician Decision|1|||
150102703|NCT00481195|541518952|FG000|Overall Study|Protocol Violation|10|||
150102704|NCT00481195|541518953|FG001|Overall Study|Protocol Violation|7|||
150102705|NCT00481195|541518952|FG000|Overall Study|Withdrawal by Subject|3|||
150102706|NCT00481195|541518953|FG001|Overall Study|Withdrawal by Subject|9|||
150102707|NCT00481195|541518952|FG000|Overall Study|Miscellaneous|2|||
150102708|NCT00481195|541518953|FG001|Overall Study|Miscellaneous|2|||
150102709|NCT02932904|541518954|FG000|Overall Study|Reason not Specified|1|||
150102710|NCT02932904|541518955|FG001|Overall Study|Reason not Specified|0|||
150102711|NCT02932904|541518956|FG002|Overall Study|Reason not Specified|2|||
150102712|NCT02932904|541518957|FG003|Overall Study|Reason not Specified|2|||
150102713|NCT02932904|541518954|FG000|Overall Study|Noncompliance with Study Drug|2|||
150102714|NCT02932904|541518955|FG001|Overall Study|Noncompliance with Study Drug|3|||
150102715|NCT02932904|541518956|FG002|Overall Study|Noncompliance with Study Drug|3|||
150102716|NCT02932904|541518957|FG003|Overall Study|Noncompliance with Study Drug|4|||
150102717|NCT02932904|541518954|FG000|Overall Study|Pregnancy|0|||
150102718|NCT02932904|541518955|FG001|Overall Study|Pregnancy|1|||
150102719|NCT02932904|541518956|FG002|Overall Study|Pregnancy|1|||
150102720|NCT02932904|541518957|FG003|Overall Study|Pregnancy|0|||
150102721|NCT02932904|541518954|FG000|Overall Study|Study Termination|0|||
150102722|NCT02932904|541518955|FG001|Overall Study|Study Termination|1|||
150102723|NCT02932904|541518956|FG002|Overall Study|Study Termination|0|||
150102724|NCT02932904|541518957|FG003|Overall Study|Study Termination|0|||
150102725|NCT02932904|541518954|FG000|Overall Study|Voluntary Withdrawal|2|||
150102726|NCT02932904|541518955|FG001|Overall Study|Voluntary Withdrawal|1|||
150102727|NCT02932904|541518956|FG002|Overall Study|Voluntary Withdrawal|4|||
150102728|NCT02932904|541518957|FG003|Overall Study|Voluntary Withdrawal|2|||
150102729|NCT02932904|541518954|FG000|Overall Study|Lost to Follow-up|5|||
150102730|NCT02932904|541518955|FG001|Overall Study|Lost to Follow-up|3|||
150102731|NCT02932904|541518956|FG002|Overall Study|Lost to Follow-up|6|||
150102732|NCT02932904|541518957|FG003|Overall Study|Lost to Follow-up|0|||
150102733|NCT02932904|541518954|FG000|Overall Study|Significant Protocol Deviation|2|||
150102734|NCT02932904|541518955|FG001|Overall Study|Significant Protocol Deviation|3|||
150102735|NCT02932904|541518956|FG002|Overall Study|Significant Protocol Deviation|6|||
150102736|NCT02932904|541518957|FG003|Overall Study|Significant Protocol Deviation|1|||
150102737|NCT02932904|541518954|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
150102738|NCT02932904|541518955|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
150102739|NCT02932904|541518956|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
150185626|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
150185627|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
150102740|NCT02932904|541518957|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
150102741|NCT02932904|541518954|FG000|Overall Study|Randomized But Not Treated|1|||
150102742|NCT02932904|541518955|FG001|Overall Study|Randomized But Not Treated|1|||
150102743|NCT02932904|541518956|FG002|Overall Study|Randomized But Not Treated|0|||
150102744|NCT02932904|541518957|FG003|Overall Study|Randomized But Not Treated|2|||
150102745|NCT00006478|541518958|FG000|Overall Study|Vaccine could not be produced|1|||
150102746|NCT00006478|541518958|FG000|Overall Study|Physician Decision|6|||
150102747|NCT03161483|541518961|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
150102748|NCT03161483|541518962|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
150102749|NCT03161483|541518963|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
150102750|NCT03161483|541518964|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
150102751|NCT03161483|541518961|FG000|Treatment Period|Death|1|||
150102752|NCT03161483|541518962|FG001|Treatment Period|Death|0|||
150102753|NCT03161483|541518963|FG002|Treatment Period|Death|0|||
150102754|NCT03161483|541518964|FG003|Treatment Period|Death|0|||
150102755|NCT03161483|541518961|FG000|Treatment Period|Adverse Event|5|||
150102756|NCT03161483|541518962|FG001|Treatment Period|Adverse Event|2|||
150102757|NCT03161483|541518963|FG002|Treatment Period|Adverse Event|1|||
150102758|NCT03161483|541518964|FG003|Treatment Period|Adverse Event|11|||
150102759|NCT03161483|541518961|FG000|Treatment Period|Pregnancy|1|||
150102760|NCT03161483|541518962|FG001|Treatment Period|Pregnancy|0|||
150102761|NCT03161483|541518963|FG002|Treatment Period|Pregnancy|0|||
150102762|NCT03161483|541518964|FG003|Treatment Period|Pregnancy|0|||
150102763|NCT03161483|541518961|FG000|Treatment Period|Lack of Efficacy|0|||
150102764|NCT03161483|541518962|FG001|Treatment Period|Lack of Efficacy|0|||
150102765|NCT03161483|541518963|FG002|Treatment Period|Lack of Efficacy|0|||
150102766|NCT03161483|541518964|FG003|Treatment Period|Lack of Efficacy|1|||
150102767|NCT03161483|541518961|FG000|Treatment Period|Withdrawal by Subject|2|||
150102768|NCT03161483|541518962|FG001|Treatment Period|Withdrawal by Subject|5|||
150102769|NCT03161483|541518963|FG002|Treatment Period|Withdrawal by Subject|2|||
150102770|NCT03161483|541518964|FG003|Treatment Period|Withdrawal by Subject|6|||
150102771|NCT03161483|541518961|FG000|Treatment Period|Lost to Follow-up|0|||
150102772|NCT03161483|541518962|FG001|Treatment Period|Lost to Follow-up|0|||
150102773|NCT03161483|541518963|FG002|Treatment Period|Lost to Follow-up|0|||
150102774|NCT03161483|541518964|FG003|Treatment Period|Lost to Follow-up|1|||
150102775|NCT03161483|541518961|FG000|Treatment Period|Protocol Violation|0|||
150102776|NCT03161483|541518962|FG001|Treatment Period|Protocol Violation|0|||
150102777|NCT03161483|541518963|FG002|Treatment Period|Protocol Violation|0|||
150102778|NCT03161483|541518964|FG003|Treatment Period|Protocol Violation|1|||
150102779|NCT03161483|541518961|FG000|Treatment Period|Other reasons|1|||
150102780|NCT03161483|541518962|FG001|Treatment Period|Other reasons|1|||
150102781|NCT03161483|541518963|FG002|Treatment Period|Other reasons|0|||
150102782|NCT03161483|541518964|FG003|Treatment Period|Other reasons|0|||
150102783|NCT00805766|541518971|FG000|Screening Period|Adverse Event|1|||
150102784|NCT00805766|541518971|FG000|Screening Period|Lack of Efficacy|2|||
150102785|NCT00805766|541518971|FG000|Screening Period|Pregnancy|1|||
150102786|NCT00805766|541518971|FG000|Screening Period|Responder|2|||
150102787|NCT00805766|541518971|FG000|Increased Dose Period|Adverse Event|4|||
150102788|NCT00805766|541518971|FG000|Increased Dose Period|Lack of Efficacy|7|||
150102789|NCT00805766|541518971|FG000|Increased Dose Period|Pregnancy|1|||
150102790|NCT00805766|541518971|FG000|Increased Dose Period|Withdrawal by Subject|1|||
150102791|NCT00228917|541518976|FG000|Overall Study|Migrated/moved from study area|0|||
150102792|NCT00228917|541518977|FG001|Overall Study|Migrated/moved from study area|0|||
150102793|NCT00228917|541518978|FG002|Overall Study|Migrated/moved from study area|0|||
150102794|NCT00228917|541518979|FG003|Overall Study|Migrated/moved from study area|0|||
150102795|NCT00228917|541518980|FG004|Overall Study|Migrated/moved from study area|0|||
150185628|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
150185629|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
150185630|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
150102796|NCT00228917|541518981|FG005|Overall Study|Migrated/moved from study area|2|||
150102797|NCT00228917|541518982|FG006|Overall Study|Migrated/moved from study area|0|||
150102798|NCT00228917|541518983|FG007|Overall Study|Migrated/moved from study area|0|||
150102799|NCT00409617|541518984|FG000|Overall Study|Adverse Event|57|||
150102800|NCT00409617|541518984|FG000|Overall Study|Lack of Efficacy|54|||
150102801|NCT00409617|541518984|FG000|Overall Study|Lost to Follow-up|2|||
150102802|NCT00409617|541518984|FG000|Overall Study|Protocol Violation|24|||
150102803|NCT00409617|541518984|FG000|Overall Study|Withdrawal by Subject|8|||
150102804|NCT00409617|541518984|FG000|Overall Study|Administrative reasons|1|||
150102805|NCT00409617|541518984|FG000|Overall Study|Not described|14|||
150102806|NCT00149747|541518992|FG000|Overall Study|Death|1|||
150102807|NCT00149747|541518993|FG001|Overall Study|Death|0|||
150102808|NCT00149747|541518992|FG000|Overall Study|Withdrawal by Subject|3|||
150102809|NCT00149747|541518993|FG001|Overall Study|Withdrawal by Subject|3|||
150102810|NCT00694369|541518996|FG000|Overall Study|Adverse Event|0|||
150102811|NCT00694369|541518997|FG001|Overall Study|Adverse Event|1|||
150102812|NCT00694369|541518998|FG002|Overall Study|Adverse Event|0|||
150102813|NCT00694369|541518999|FG003|Overall Study|Adverse Event|1|||
150102814|NCT00694369|541519000|FG004|Overall Study|Adverse Event|3|||
150102815|NCT00694369|541518996|FG000|Overall Study|Lost to Follow-up|0|||
150102816|NCT00694369|541518997|FG001|Overall Study|Lost to Follow-up|0|||
150102817|NCT00694369|541518998|FG002|Overall Study|Lost to Follow-up|1|||
150102818|NCT00694369|541518999|FG003|Overall Study|Lost to Follow-up|1|||
150102819|NCT00694369|541519000|FG004|Overall Study|Lost to Follow-up|0|||
150102820|NCT00694369|541518996|FG000|Overall Study|Physician Decision|0|||
150102821|NCT00694369|541518997|FG001|Overall Study|Physician Decision|0|||
150102822|NCT00694369|541518998|FG002|Overall Study|Physician Decision|0|||
150102823|NCT00694369|541518999|FG003|Overall Study|Physician Decision|0|||
150102824|NCT00694369|541519000|FG004|Overall Study|Physician Decision|1|||
150102825|NCT00694369|541518996|FG000|Overall Study|Protocol Violation|0|||
150102826|NCT00694369|541518997|FG001|Overall Study|Protocol Violation|1|||
150102827|NCT00694369|541518998|FG002|Overall Study|Protocol Violation|0|||
150102828|NCT00694369|541518999|FG003|Overall Study|Protocol Violation|0|||
150102829|NCT00694369|541519000|FG004|Overall Study|Protocol Violation|0|||
150102830|NCT00694369|541518996|FG000|Overall Study|Withdrawal by Subject|1|||
150102831|NCT00694369|541518997|FG001|Overall Study|Withdrawal by Subject|1|||
150102832|NCT00694369|541518998|FG002|Overall Study|Withdrawal by Subject|1|||
150102833|NCT00694369|541518999|FG003|Overall Study|Withdrawal by Subject|1|||
150102834|NCT00694369|541519000|FG004|Overall Study|Withdrawal by Subject|2|||
150102835|NCT02871739|541519001|FG000|Overall Study|Lost to Follow-up|3|||
150102836|NCT02871739|541519002|FG001|Overall Study|Lost to Follow-up|2|||
150102837|NCT02871739|541519003|FG002|Overall Study|Lost to Follow-up|0|||
150102838|NCT02871739|541519004|FG003|Overall Study|Lost to Follow-up|2|||
150102839|NCT00594464|541519005|FG000|Overall Study|Withdrawal by Subject|1|||
150102840|NCT00594464|541519005|FG000|Overall Study|Delay in operation|2|||
150102841|NCT02907359|541519007|FG000|Overall Study|Death|234|||
150102842|NCT02907359|541519008|FG001|Overall Study|Death|117|||
150102843|NCT02907359|541519007|FG000|Overall Study|Withdrawal by Subject|6|||
150102844|NCT02907359|541519008|FG001|Overall Study|Withdrawal by Subject|11|||
150102845|NCT02907359|541519007|FG000|Overall Study|Lost to Follow-up|1|||
150102846|NCT02907359|541519008|FG001|Overall Study|Lost to Follow-up|0|||
150102847|NCT03131440|541519009|FG000|Overall Study|Withdrawal by Subject|1|||
150102848|NCT03131440|541519010|FG001|Overall Study|Withdrawal by Subject|3|||
150102849|NCT03131440|541519011|FG002|Overall Study|Withdrawal by Subject|0|||
150102850|NCT03131440|541519012|FG003|Overall Study|Withdrawal by Subject|0|||
150102851|NCT03131440|541519013|FG004|Overall Study|Withdrawal by Subject|1|||
150102852|NCT03131440|541519014|FG005|Overall Study|Withdrawal by Subject|0|||
150102853|NCT03131440|541519015|FG006|Overall Study|Withdrawal by Subject|0|||
150102854|NCT03131440|541519016|FG007|Overall Study|Withdrawal by Subject|1|||
150102855|NCT03131440|541519017|FG008|Overall Study|Withdrawal by Subject|1|||
150102856|NCT03131440|541519018|FG009|Overall Study|Withdrawal by Subject|1|||
150102857|NCT03131440|541519019|FG010|Overall Study|Withdrawal by Subject|0|||
150102858|NCT03131440|541519020|FG011|Overall Study|Withdrawal by Subject|1|||
150102859|NCT03131440|541519021|FG012|Overall Study|Withdrawal by Subject|1|||
150102860|NCT03131440|541519022|FG013|Overall Study|Withdrawal by Subject|0|||
150102861|NCT03131440|541519023|FG014|Overall Study|Withdrawal by Subject|1|||
150102862|NCT03131440|541519024|FG015|Overall Study|Withdrawal by Subject|0|||
150102863|NCT03131440|541519025|FG016|Overall Study|Withdrawal by Subject|0|||
150102864|NCT03131440|541519026|FG017|Overall Study|Withdrawal by Subject|0|||
150102865|NCT03131440|541519027|FG018|Overall Study|Withdrawal by Subject|1|||
150102866|NCT03131440|541519028|FG019|Overall Study|Withdrawal by Subject|0|||
150102867|NCT03131440|541519029|FG020|Overall Study|Withdrawal by Subject|1|||
150102868|NCT03131440|541519030|FG021|Overall Study|Withdrawal by Subject|1|||
150102869|NCT03131440|541519031|FG022|Overall Study|Withdrawal by Subject|1|||
150102870|NCT03131440|541519032|FG023|Overall Study|Withdrawal by Subject|0|||
150102871|NCT03131440|541519033|FG024|Overall Study|Withdrawal by Subject|0|||
150255268|NCT00700427|542070609|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
150102872|NCT03131440|541519034|FG025|Overall Study|Withdrawal by Subject|0|||
150102873|NCT03131440|541519035|FG026|Overall Study|Withdrawal by Subject|0|||
150102874|NCT03131440|541519036|FG027|Overall Study|Withdrawal by Subject|0|||
150102875|NCT03131440|541519037|FG028|Overall Study|Withdrawal by Subject|0|||
150102876|NCT03131440|541519038|FG029|Overall Study|Withdrawal by Subject|0|||
150102877|NCT03131440|541519039|FG030|Overall Study|Withdrawal by Subject|1|||
150102878|NCT03131440|541519040|FG031|Overall Study|Withdrawal by Subject|0|||
150102879|NCT03131440|541519009|FG000|Overall Study|Lost to Follow-up|0|||
150102880|NCT03131440|541519010|FG001|Overall Study|Lost to Follow-up|0|||
150102881|NCT03131440|541519011|FG002|Overall Study|Lost to Follow-up|0|||
150102882|NCT03131440|541519012|FG003|Overall Study|Lost to Follow-up|0|||
150102883|NCT03131440|541519013|FG004|Overall Study|Lost to Follow-up|0|||
150102884|NCT03131440|541519014|FG005|Overall Study|Lost to Follow-up|1|||
150102885|NCT03131440|541519015|FG006|Overall Study|Lost to Follow-up|0|||
150102886|NCT03131440|541519016|FG007|Overall Study|Lost to Follow-up|0|||
150102887|NCT03131440|541519017|FG008|Overall Study|Lost to Follow-up|0|||
150102888|NCT03131440|541519018|FG009|Overall Study|Lost to Follow-up|0|||
150102889|NCT03131440|541519019|FG010|Overall Study|Lost to Follow-up|0|||
150102890|NCT03131440|541519020|FG011|Overall Study|Lost to Follow-up|0|||
150102891|NCT03131440|541519021|FG012|Overall Study|Lost to Follow-up|0|||
150102892|NCT03131440|541519022|FG013|Overall Study|Lost to Follow-up|0|||
150102893|NCT03131440|541519023|FG014|Overall Study|Lost to Follow-up|0|||
150185631|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
150185632|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
150185633|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
150185634|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
150102894|NCT03131440|541519024|FG015|Overall Study|Lost to Follow-up|0|||
150102895|NCT03131440|541519025|FG016|Overall Study|Lost to Follow-up|0|||
150102896|NCT03131440|541519026|FG017|Overall Study|Lost to Follow-up|0|||
150102897|NCT03131440|541519027|FG018|Overall Study|Lost to Follow-up|0|||
150102898|NCT03131440|541519028|FG019|Overall Study|Lost to Follow-up|2|||
150102899|NCT03131440|541519029|FG020|Overall Study|Lost to Follow-up|1|||
150102900|NCT03131440|541519030|FG021|Overall Study|Lost to Follow-up|0|||
150102901|NCT03131440|541519031|FG022|Overall Study|Lost to Follow-up|1|||
150102902|NCT03131440|541519032|FG023|Overall Study|Lost to Follow-up|0|||
150102903|NCT03131440|541519033|FG024|Overall Study|Lost to Follow-up|1|||
150102904|NCT03131440|541519034|FG025|Overall Study|Lost to Follow-up|0|||
150102905|NCT03131440|541519035|FG026|Overall Study|Lost to Follow-up|0|||
150102906|NCT03131440|541519036|FG027|Overall Study|Lost to Follow-up|2|||
150102907|NCT03131440|541519037|FG028|Overall Study|Lost to Follow-up|0|||
150102908|NCT03131440|541519038|FG029|Overall Study|Lost to Follow-up|2|||
150102909|NCT03131440|541519039|FG030|Overall Study|Lost to Follow-up|0|||
150102910|NCT03131440|541519040|FG031|Overall Study|Lost to Follow-up|0|||
150102911|NCT03131440|541519009|FG000|Overall Study|Death|0|||
150102912|NCT03131440|541519010|FG001|Overall Study|Death|0|||
150102913|NCT03131440|541519011|FG002|Overall Study|Death|0|||
150102914|NCT03131440|541519012|FG003|Overall Study|Death|0|||
150102915|NCT03131440|541519013|FG004|Overall Study|Death|0|||
150102916|NCT03131440|541519014|FG005|Overall Study|Death|0|||
150102917|NCT03131440|541519015|FG006|Overall Study|Death|0|||
150102918|NCT03131440|541519016|FG007|Overall Study|Death|0|||
150102919|NCT03131440|541519017|FG008|Overall Study|Death|0|||
150102920|NCT03131440|541519018|FG009|Overall Study|Death|0|||
150102921|NCT03131440|541519019|FG010|Overall Study|Death|0|||
150102922|NCT03131440|541519020|FG011|Overall Study|Death|0|||
150102923|NCT03131440|541519021|FG012|Overall Study|Death|0|||
150102924|NCT03131440|541519022|FG013|Overall Study|Death|0|||
150102925|NCT03131440|541519023|FG014|Overall Study|Death|0|||
150102926|NCT03131440|541519024|FG015|Overall Study|Death|0|||
150102927|NCT03131440|541519025|FG016|Overall Study|Death|0|||
150102928|NCT03131440|541519026|FG017|Overall Study|Death|0|||
150102929|NCT03131440|541519027|FG018|Overall Study|Death|0|||
150102930|NCT03131440|541519028|FG019|Overall Study|Death|0|||
150102931|NCT03131440|541519029|FG020|Overall Study|Death|0|||
150102932|NCT03131440|541519030|FG021|Overall Study|Death|0|||
150102933|NCT03131440|541519031|FG022|Overall Study|Death|0|||
150102934|NCT03131440|541519032|FG023|Overall Study|Death|0|||
150102935|NCT03131440|541519033|FG024|Overall Study|Death|0|||
150102936|NCT03131440|541519034|FG025|Overall Study|Death|1|||
150102937|NCT03131440|541519035|FG026|Overall Study|Death|0|||
150102938|NCT03131440|541519036|FG027|Overall Study|Death|0|||
150102939|NCT03131440|541519037|FG028|Overall Study|Death|0|||
150102940|NCT03131440|541519038|FG029|Overall Study|Death|0|||
150102941|NCT03131440|541519039|FG030|Overall Study|Death|0|||
150102942|NCT03131440|541519040|FG031|Overall Study|Death|0|||
150185635|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
150185636|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
150185637|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
150185638|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
150185639|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
150185640|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
150185641|NCT05338086|541818832|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
150185642|NCT05338086|541818833|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
150185643|NCT05338086|541818834|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
150185644|NCT05338086|541818835|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
150185645|NCT05338086|541818836|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
150185646|NCT05338086|541818832|FG000|Transition Period (M12 to M18)|Death|0|||
150185647|NCT05338086|541818833|FG001|Transition Period (M12 to M18)|Death|0|||
150185648|NCT05338086|541818834|FG002|Transition Period (M12 to M18)|Death|1|||
150185649|NCT05338086|541818835|FG003|Transition Period (M12 to M18)|Death|0|||
150185650|NCT05338086|541818836|FG004|Transition Period (M12 to M18)|Death|0|||
150185651|NCT05338086|541818832|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
150185652|NCT05338086|541818833|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
150185653|NCT05338086|541818834|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
150185654|NCT05338086|541818835|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
150185655|NCT05338086|541818836|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
150185656|NCT05338086|541818832|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
150185657|NCT05338086|541818833|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
150185658|NCT05338086|541818834|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
150185659|NCT05338086|541818835|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
150185660|NCT05338086|541818836|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
150185661|NCT05338086|541818832|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
150185662|NCT05338086|541818833|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
150185663|NCT05338086|541818834|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
150185664|NCT05338086|541818835|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
150185665|NCT05338086|541818836|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
150185666|NCT03897686|541818846|FG000|Overall Study|Protocol Violation|1|||
150185667|NCT03897686|541818847|FG001|Overall Study|Protocol Violation|1|||
150185668|NCT03897686|541818846|FG000|Overall Study|Withdrawal by Subject|1|||
150185669|NCT03897686|541818847|FG001|Overall Study|Withdrawal by Subject|1|||
150185670|NCT04052516|541818848|FG000|Overall Study|Withdrawal by Subject|4|||
150185671|NCT04052516|541818849|FG001|Overall Study|Withdrawal by Subject|5|||
150185672|NCT04052516|541818850|FG002|Overall Study|Withdrawal by Subject|6|||
150185673|NCT04052516|541818848|FG000|Overall Study|Adverse Event|3|||
150185674|NCT04052516|541818849|FG001|Overall Study|Adverse Event|2|||
150185675|NCT04052516|541818850|FG002|Overall Study|Adverse Event|8|||
150185676|NCT04052516|541818848|FG000|Overall Study|Lost to Follow-up|2|||
150185677|NCT04052516|541818849|FG001|Overall Study|Lost to Follow-up|5|||
150185678|NCT04052516|541818850|FG002|Overall Study|Lost to Follow-up|3|||
150185679|NCT04052516|541818848|FG000|Overall Study|Protocol Violation|1|||
150185680|NCT04052516|541818849|FG001|Overall Study|Protocol Violation|1|||
150185681|NCT04052516|541818850|FG002|Overall Study|Protocol Violation|0|||
150185682|NCT04052516|541818848|FG000|Overall Study|Death|1|||
150185683|NCT04052516|541818849|FG001|Overall Study|Death|0|||
150185684|NCT04052516|541818850|FG002|Overall Study|Death|0|||
150185685|NCT04052516|541818848|FG000|Overall Study|Physician Decision|0|||
150185686|NCT04052516|541818849|FG001|Overall Study|Physician Decision|1|||
150185687|NCT04052516|541818850|FG002|Overall Study|Physician Decision|0|||
150185688|NCT04052516|541818848|FG000|Overall Study|Pregnancy|1|||
150185689|NCT04052516|541818849|FG001|Overall Study|Pregnancy|0|||
150185690|NCT04052516|541818850|FG002|Overall Study|Pregnancy|0|||
150185691|NCT04052516|541818848|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
150185692|NCT04052516|541818849|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
150185693|NCT04052516|541818850|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
150185694|NCT04052516|541818848|FG000|Overall Study|Reason not recorded|0|||
150185695|NCT04052516|541818849|FG001|Overall Study|Reason not recorded|1|||
150185696|NCT04052516|541818850|FG002|Overall Study|Reason not recorded|0|||
150185697|NCT03819686|541818852|FG000|Overall Study|Lost to Follow-up|2|||
150185698|NCT03819686|541818853|FG001|Overall Study|Lost to Follow-up|3|||
150185699|NCT05386355|541818854|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
150185700|NCT05386355|541818855|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
150185701|NCT05386355|541818856|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
150185702|NCT05386355|541818857|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
150185703|NCT06143670|541818858|FG000|Overall Study|Lost to Follow-up|0|||
150102943|NCT00746941|541519041|FG000|Overall Study|Death|2|||
150102944|NCT00746941|541519042|FG001|Overall Study|Death|0|||
150102945|NCT00746941|541519043|FG002|Overall Study|Death|0|||
150102946|NCT00746941|541519044|FG003|Overall Study|Death|6|||
150102947|NCT00746941|541519041|FG000|Overall Study|Physician Decision|0|||
150102948|NCT00746941|541519042|FG001|Overall Study|Physician Decision|0|||
150102949|NCT00746941|541519043|FG002|Overall Study|Physician Decision|2|||
150102950|NCT00746941|541519044|FG003|Overall Study|Physician Decision|0|||
150102951|NCT00746941|541519041|FG000|Overall Study|Withdrawal by Subject|3|||
150102952|NCT00746941|541519042|FG001|Overall Study|Withdrawal by Subject|0|||
150102953|NCT00746941|541519043|FG002|Overall Study|Withdrawal by Subject|0|||
150102954|NCT00746941|541519044|FG003|Overall Study|Withdrawal by Subject|2|||
150102955|NCT00746941|541519041|FG000|Overall Study|Other, reason not provided|2|||
150102956|NCT00746941|541519042|FG001|Overall Study|Other, reason not provided|4|||
150102957|NCT00746941|541519043|FG002|Overall Study|Other, reason not provided|0|||
150102958|NCT00746941|541519044|FG003|Overall Study|Other, reason not provided|4|||
150102959|NCT00746941|541519041|FG000|Overall Study|Adverse Event|0|||
150102960|NCT00746941|541519042|FG001|Overall Study|Adverse Event|0|||
150102961|NCT00746941|541519043|FG002|Overall Study|Adverse Event|0|||
150102962|NCT00746941|541519044|FG003|Overall Study|Adverse Event|1|||
150102963|NCT01524692|541519054|FG000|Overall Study|Withdrawal by Subject|3|||
150102964|NCT03190889|541519055|FG000|Overall Study|Lost to Follow-up|7|||
150102965|NCT03190889|541519056|FG001|Overall Study|Lost to Follow-up|7|||
150102966|NCT03190889|541519057|FG002|Overall Study|Lost to Follow-up|3|||
150102967|NCT03190889|541519055|FG000|Overall Study|Withdrawal by Subject|1|||
150102968|NCT03190889|541519056|FG001|Overall Study|Withdrawal by Subject|1|||
150102969|NCT03190889|541519057|FG002|Overall Study|Withdrawal by Subject|2|||
150102970|NCT03190889|541519055|FG000|Overall Study|Did not complete protocol|4|||
150102971|NCT03190889|541519056|FG001|Overall Study|Did not complete protocol|9|||
150102972|NCT03190889|541519057|FG002|Overall Study|Did not complete protocol|0|||
150102973|NCT03190889|541519055|FG000|Overall Study|COVID-19|1|||
150102974|NCT03190889|541519056|FG001|Overall Study|COVID-19|0|||
150102975|NCT03190889|541519057|FG002|Overall Study|COVID-19|2|||
150102976|NCT01709695|541519058|FG000|Overall Study|Withdrawal by Subject|1|||
150102977|NCT01709695|541519059|FG001|Overall Study|Withdrawal by Subject|1|||
150102978|NCT04007523|541519060|FG000|Overall Study|Withdrawal by Subject|0|||
150102979|NCT04007523|541519061|FG001|Overall Study|Withdrawal by Subject|1|||
150102980|NCT04007523|541519062|FG002|Overall Study|Withdrawal by Subject|1|||
150102981|NCT04007523|541519063|FG003|Overall Study|Withdrawal by Subject|0|||
150102982|NCT04007523|541519060|FG000|Overall Study|ICU Transfer|0|||
150102983|NCT04007523|541519061|FG001|Overall Study|ICU Transfer|1|||
150102984|NCT04007523|541519062|FG002|Overall Study|ICU Transfer|0|||
150102985|NCT04007523|541519063|FG003|Overall Study|ICU Transfer|0|||
150102986|NCT04007523|541519060|FG000|Overall Study|COVID hospital closure|0|||
150102987|NCT04007523|541519061|FG001|Overall Study|COVID hospital closure|0|||
150102988|NCT04007523|541519062|FG002|Overall Study|COVID hospital closure|1|||
150102989|NCT04007523|541519063|FG003|Overall Study|COVID hospital closure|2|||
150102990|NCT04007523|541519060|FG000|Overall Study|Surgery cancelled|0|||
150102991|NCT04007523|541519061|FG001|Overall Study|Surgery cancelled|0|||
150102992|NCT04007523|541519062|FG002|Overall Study|Surgery cancelled|1|||
150102993|NCT04007523|541519063|FG003|Overall Study|Surgery cancelled|1|||
150102994|NCT02818777|541519066|FG000|Overall Study|Adverse Event|3|||
150102995|NCT01418937|541519067|FG000|Overall Study|Lost to Follow-up|5|||
150102996|NCT01418937|541519067|FG000|Overall Study|Protocol Violation|1|||
150102997|NCT01418937|541519067|FG000|Overall Study|Pregnancy|1|||
150102998|NCT01418937|541519067|FG000|Overall Study|Withdrawal by Subject|1|||
150102999|NCT04059146|541519068|FG000|Overall Study|Withdrawal by Subject|0|||
150103000|NCT04059146|541519069|FG001|Overall Study|Withdrawal by Subject|1|||
150103001|NCT01623596|541519070|FG000|Overall Study|Abnormal laboratory values|2|||
150103002|NCT01623596|541519071|FG001|Overall Study|Abnormal laboratory values|0|||
150103003|NCT01623596|541519070|FG000|Overall Study|Administrative problems|9|||
150103004|NCT01623596|541519071|FG001|Overall Study|Administrative problems|13|||
150103005|NCT01623596|541519070|FG000|Overall Study|Adverse Event|20|||
150103006|NCT01623596|541519071|FG001|Overall Study|Adverse Event|29|||
150103007|NCT01623596|541519070|FG000|Overall Study|Death|0|||
150103008|NCT01623596|541519071|FG001|Overall Study|Death|2|||
150103009|NCT01623596|541519070|FG000|Overall Study|Lost to Follow-up|12|||
150103010|NCT01623596|541519071|FG001|Overall Study|Lost to Follow-up|16|||
150103011|NCT01623596|541519070|FG000|Overall Study|Withdrawal by Subject|13|||
150185704|NCT06143670|541818859|FG001|Overall Study|Lost to Follow-up|1|||
150185705|NCT06143670|541818858|FG000|Overall Study|Withdrawal by Subject|3|||
150103012|NCT01623596|541519071|FG001|Overall Study|Withdrawal by Subject|31|||
150103013|NCT01623596|541519070|FG000|Overall Study|Patient no longer requires study drug|1|||
150103014|NCT01623596|541519071|FG001|Overall Study|Patient no longer requires study drug|0|||
150103015|NCT01623596|541519070|FG000|Overall Study|Protocol Violation|0|||
150103016|NCT01623596|541519071|FG001|Overall Study|Protocol Violation|6|||
150103017|NCT01623596|541519070|FG000|Overall Study|Lack of Efficacy|5|||
150103018|NCT01623596|541519071|FG001|Overall Study|Lack of Efficacy|3|||
150103019|NCT00747435|541519072|FG000|Overall Study|Lost to Follow-up|2|||
150103020|NCT00747435|541519072|FG000|Overall Study|Withdrawal by Subject|3|||
150103021|NCT00747435|541519072|FG000|Overall Study|Still undergoing follow up|1|||
150103022|NCT00082433|541519082|FG000|Overall Study|Adverse Event|12|||
150103023|NCT00082433|541519083|FG001|Overall Study|Adverse Event|17|||
150103024|NCT00082433|541519082|FG000|Overall Study|Death|8|||
150103025|NCT00082433|541519083|FG001|Overall Study|Death|18|||
150103026|NCT00082433|541519082|FG000|Overall Study|Disease Progression/Relapse|270|||
150103027|NCT00082433|541519083|FG001|Overall Study|Disease Progression/Relapse|388|||
150103028|NCT00082433|541519082|FG000|Overall Study|Physician Decision|50|||
150103029|NCT00082433|541519083|FG001|Overall Study|Physician Decision|61|||
150103030|NCT00082433|541519082|FG000|Overall Study|Lost to Follow-up|1|||
150103031|NCT00082433|541519083|FG001|Overall Study|Lost to Follow-up|2|||
150103032|NCT00082433|541519082|FG000|Overall Study|Study Drug Toxicity|179|||
150103033|NCT00082433|541519083|FG001|Overall Study|Study Drug Toxicity|66|||
150103034|NCT00082433|541519082|FG000|Overall Study|Withdrawal by Subject|55|||
150103035|NCT00082433|541519083|FG001|Overall Study|Withdrawal by Subject|30|||
150103036|NCT00082433|541519082|FG000|Overall Study|Still On Treatment|2|||
150103037|NCT00082433|541519083|FG001|Overall Study|Still On Treatment|1|||
150103038|NCT00082433|541519082|FG000|Overall Study|Not Treated|12|||
150103039|NCT00082433|541519083|FG001|Overall Study|Not Treated|11|||
150103040|NCT00082433|541519082|FG000|Overall Study|Ineligible|2|||
150103041|NCT00082433|541519083|FG001|Overall Study|Ineligible|1|||
150103042|NCT00082433|541519082|FG000|Overall Study|Noncompliance|2|||
150103043|NCT00082433|541519083|FG001|Overall Study|Noncompliance|1|||
150103044|NCT00082433|541519082|FG000|Overall Study|New primary cancer|1|||
150103045|NCT00082433|541519083|FG001|Overall Study|New primary cancer|0|||
150103046|NCT00082433|541519082|FG000|Overall Study|Impending surgery|0|||
150103047|NCT00082433|541519083|FG001|Overall Study|Impending surgery|1|||
150103048|NCT01796197|541519084|FG000|Overall Study|Lost to Follow-up|1|||
150103049|NCT01796197|541519084|FG000|Overall Study|Lack of Efficacy|1|||
150103050|NCT03026257|541520929|FG000|Overall Study|Adverse Event|3|||
150103051|NCT03026257|541520930|FG001|Overall Study|Adverse Event|0|||
150103052|NCT03026257|541520931|FG002|Overall Study|Adverse Event|0|||
150103053|NCT03026257|541520932|FG003|Overall Study|Adverse Event|0|||
150103054|NCT03026257|541520933|FG004|Overall Study|Adverse Event|0|||
150103055|NCT03026257|541520934|FG005|Overall Study|Adverse Event|0|||
150103056|NCT03026257|541520929|FG000|Overall Study|Lost to Follow-up|1|||
150103057|NCT03026257|541520930|FG001|Overall Study|Lost to Follow-up|0|||
150103058|NCT03026257|541520931|FG002|Overall Study|Lost to Follow-up|0|||
150103059|NCT03026257|541520932|FG003|Overall Study|Lost to Follow-up|0|||
150103060|NCT03026257|541520933|FG004|Overall Study|Lost to Follow-up|0|||
150103061|NCT03026257|541520934|FG005|Overall Study|Lost to Follow-up|0|||
150103062|NCT03026257|541520929|FG000|Overall Study|Protocol Violation|1|||
150103063|NCT03026257|541520930|FG001|Overall Study|Protocol Violation|0|||
150103064|NCT03026257|541520931|FG002|Overall Study|Protocol Violation|0|||
150103065|NCT03026257|541520932|FG003|Overall Study|Protocol Violation|1|||
150103066|NCT03026257|541520933|FG004|Overall Study|Protocol Violation|1|||
150103067|NCT03026257|541520934|FG005|Overall Study|Protocol Violation|0|||
150103068|NCT03026257|541520929|FG000|Overall Study|Withdrawal by Subject|1|||
150103069|NCT03026257|541520930|FG001|Overall Study|Withdrawal by Subject|1|||
150103070|NCT03026257|541520931|FG002|Overall Study|Withdrawal by Subject|0|||
150103071|NCT03026257|541520932|FG003|Overall Study|Withdrawal by Subject|0|||
150103072|NCT03026257|541520933|FG004|Overall Study|Withdrawal by Subject|0|||
150103073|NCT03026257|541520934|FG005|Overall Study|Withdrawal by Subject|0|||
150103074|NCT04380857|541520935|FG000|Overall Study|Lost to Follow-up|3|||
150103075|NCT04380857|541520936|FG001|Overall Study|Lost to Follow-up|3|||
150103076|NCT02042924|541520940|FG000|Overall Study|Early Death|1|||
150103077|NCT04033003|541520941|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
150103078|NCT04033003|541520942|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
150103079|NCT04033003|541520941|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
150103080|NCT04033003|541520942|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
150103081|NCT04033003|541520941|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
150103082|NCT04033003|541520942|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
150103083|NCT04033003|541520941|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
150103084|NCT04033003|541520942|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
150103085|NCT04033003|541520941|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
150103086|NCT04033003|541520942|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
150103087|NCT04033003|541520941|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
150103088|NCT04033003|541520942|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
150103089|NCT04033003|541520941|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
150103090|NCT04033003|541520942|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
150103091|NCT04033003|541520941|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
150103092|NCT04033003|541520942|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
150103093|NCT04033003|541520941|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
150103094|NCT04033003|541520942|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
150103095|NCT04033003|541520941|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
150103096|NCT04033003|541520942|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
150103097|NCT04033003|541520941|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
150103098|NCT04033003|541520942|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
150103099|NCT04033003|541520941|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
150103100|NCT04033003|541520942|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
150103101|NCT04033003|541520941|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
150103102|NCT04033003|541520942|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
150103103|NCT02487394|541520943|FG000|Phase 1|Withdrawal by Subject|0|||
150103104|NCT02487394|541520944|FG001|Phase 1|Withdrawal by Subject|1|||
150103105|NCT01828034|541520949|FG000|Overall Study|Withdrawal by Subject|0|||
150103106|NCT01828034|541520950|FG001|Overall Study|Withdrawal by Subject|0|||
150103107|NCT01828034|541520951|FG002|Overall Study|Withdrawal by Subject|0|||
150103108|NCT01828034|541520952|FG003|Overall Study|Withdrawal by Subject|1|||
150103109|NCT01988571|541520953|FG000|Overall Study|Death|3|||
150103110|NCT01988571|541520954|FG001|Overall Study|Death|1|||
150103111|NCT01988571|541520953|FG000|Overall Study|Physician Decision|2|||
150103112|NCT01988571|541520954|FG001|Overall Study|Physician Decision|1|||
150103113|NCT01988571|541520953|FG000|Overall Study|Lost to Follow-up|3|||
150103114|NCT01988571|541520954|FG001|Overall Study|Lost to Follow-up|0|||
150103115|NCT01988571|541520953|FG000|Overall Study|Withdrawal by Subject|31|||
150103116|NCT01988571|541520954|FG001|Overall Study|Withdrawal by Subject|33|||
150103117|NCT03144180|541520959|FG000|Overall Study|STAT Delivery|1|||
150103118|NCT03144180|541520960|FG001|Overall Study|STAT Delivery|1|||
150103119|NCT03144180|541520959|FG000|Overall Study|Provider forgot to fill out forms|1|||
150103120|NCT03144180|541520960|FG001|Overall Study|Provider forgot to fill out forms|3|||
150103121|NCT03144180|541520959|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
150103122|NCT03144180|541520960|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
150103123|NCT03144180|541520959|FG000|Overall Study|Scrub tech removed tube cap|0|||
150103124|NCT03144180|541520960|FG001|Overall Study|Scrub tech removed tube cap|1|||
150103125|NCT03387813|541520963|FG000|Overall Study|Death|40|||
150103126|NCT03387813|541520964|FG001|Overall Study|Death|37|||
150103127|NCT03387813|541520965|FG002|Overall Study|Death|190|||
150103128|NCT03387813|541520963|FG000|Overall Study|Withdrawal by Subject|9|||
150103129|NCT03387813|541520964|FG001|Overall Study|Withdrawal by Subject|19|||
150103130|NCT03387813|541520965|FG002|Overall Study|Withdrawal by Subject|32|||
150103131|NCT03387813|541520963|FG000|Overall Study|Lost to Follow-up|3|||
150103132|NCT03387813|541520964|FG001|Overall Study|Lost to Follow-up|9|||
150103133|NCT03387813|541520965|FG002|Overall Study|Lost to Follow-up|15|||
150103134|NCT03387813|541520963|FG000|Overall Study|Non-Compliance|6|||
150103135|NCT03387813|541520964|FG001|Overall Study|Non-Compliance|6|||
150103136|NCT03387813|541520965|FG002|Overall Study|Non-Compliance|31|||
150103137|NCT03387813|541520963|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
150103138|NCT03387813|541520964|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
150103139|NCT03387813|541520965|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
150103140|NCT03792672|541520968|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
150103141|NCT03792672|541520969|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
150103142|NCT03792672|541520970|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
150103143|NCT03792672|541520971|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
150103144|NCT03792672|541520972|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
150103145|NCT03792672|541520973|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
150103146|NCT03792672|541520968|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
150103147|NCT03792672|541520969|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
150103148|NCT03792672|541520970|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
150103149|NCT03792672|541520971|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
150103150|NCT03792672|541520972|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
150103151|NCT03792672|541520973|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
150103152|NCT03792672|541520968|FG000|Treatment Period 4 (2 Days)|Other|1|||
150103153|NCT03792672|541520969|FG001|Treatment Period 4 (2 Days)|Other|0|||
150103154|NCT03792672|541520970|FG002|Treatment Period 4 (2 Days)|Other|0|||
150103155|NCT03792672|541520971|FG003|Treatment Period 4 (2 Days)|Other|0|||
150103156|NCT03792672|541520972|FG004|Treatment Period 4 (2 Days)|Other|0|||
150103157|NCT03792672|541520973|FG005|Treatment Period 4 (2 Days)|Other|0|||
150103158|NCT00453999|541520974|FG000|Overall Study|Adverse Event|1|||
150103159|NCT00453999|541520975|FG001|Overall Study|Adverse Event|2|||
150103160|NCT00453999|541520976|FG002|Overall Study|Adverse Event|1|||
150103161|NCT00453999|541520974|FG000|Overall Study|Lost to Follow-up|0|||
150103162|NCT00453999|541520975|FG001|Overall Study|Lost to Follow-up|1|||
150103163|NCT00453999|541520976|FG002|Overall Study|Lost to Follow-up|1|||
150103164|NCT00453999|541520974|FG000|Overall Study|Withdrawal by Subject|2|||
150103165|NCT00453999|541520975|FG001|Overall Study|Withdrawal by Subject|1|||
150103166|NCT00453999|541520976|FG002|Overall Study|Withdrawal by Subject|1|||
150103167|NCT00453999|541520974|FG000|Overall Study|Subject Request|2|||
150103168|NCT00453999|541520975|FG001|Overall Study|Subject Request|1|||
150103169|NCT00453999|541520976|FG002|Overall Study|Subject Request|0|||
150103170|NCT04238728|541520986|FG000|Overall Study|Withdrawal by Subject|1|||
150103171|NCT04238728|541520986|FG000|Overall Study|Lost to Follow-up|2|||
150103172|NCT01073865|541520988|FG000|Overall Study|Reasons other than below|19|||
150103173|NCT01073865|541520989|FG001|Overall Study|Reasons other than below|31|||
150103174|NCT01073865|541520988|FG000|Overall Study|Lost to Follow-up|1|||
150103175|NCT01073865|541520989|FG001|Overall Study|Lost to Follow-up|1|||
150103176|NCT01073865|541520988|FG000|Overall Study|Death|3|||
150103177|NCT01073865|541520989|FG001|Overall Study|Death|2|||
150103178|NCT01073865|541520988|FG000|Overall Study|Withdrawal by Subject|5|||
150103179|NCT01073865|541520989|FG001|Overall Study|Withdrawal by Subject|5|||
150103180|NCT00743652|541520990|FG000|Overall Study|Parent/Legal Guardian Request|3|||
150103181|NCT00743652|541520991|FG001|Overall Study|Parent/Legal Guardian Request|2|||
150103182|NCT00743652|541520992|FG002|Overall Study|Parent/Legal Guardian Request|2|||
150103183|NCT00743652|541520993|FG003|Overall Study|Parent/Legal Guardian Request|2|||
150103184|NCT00743652|541520994|FG004|Overall Study|Parent/Legal Guardian Request|0|||
150103185|NCT00743652|541520990|FG000|Overall Study|Adverse Event|3|||
150103186|NCT00743652|541520991|FG001|Overall Study|Adverse Event|0|||
150103187|NCT00743652|541520992|FG002|Overall Study|Adverse Event|0|||
150103188|NCT00743652|541520993|FG003|Overall Study|Adverse Event|0|||
150103189|NCT00743652|541520994|FG004|Overall Study|Adverse Event|0|||
150103190|NCT00743652|541520990|FG000|Overall Study|Death|2|||
150103191|NCT00743652|541520991|FG001|Overall Study|Death|0|||
150103192|NCT00743652|541520992|FG002|Overall Study|Death|0|||
150103193|NCT00743652|541520993|FG003|Overall Study|Death|0|||
150103194|NCT00743652|541520994|FG004|Overall Study|Death|0|||
150103195|NCT00743652|541520990|FG000|Overall Study|Investigator Request|0|||
150103196|NCT00743652|541520991|FG001|Overall Study|Investigator Request|0|||
150103197|NCT00743652|541520992|FG002|Overall Study|Investigator Request|0|||
150103198|NCT00743652|541520993|FG003|Overall Study|Investigator Request|2|||
150103199|NCT00743652|541520994|FG004|Overall Study|Investigator Request|0|||
150103200|NCT00743652|541520990|FG000|Overall Study|Other|1|||
150103201|NCT00743652|541520991|FG001|Overall Study|Other|1|||
150103202|NCT00743652|541520992|FG002|Overall Study|Other|0|||
150103203|NCT00743652|541520993|FG003|Overall Study|Other|0|||
150103204|NCT00743652|541520994|FG004|Overall Study|Other|0|||
150103205|NCT00743652|541520990|FG000|Overall Study|Lost to Follow-up|1|||
150103206|NCT00743652|541520991|FG001|Overall Study|Lost to Follow-up|0|||
150103207|NCT00743652|541520992|FG002|Overall Study|Lost to Follow-up|0|||
150103208|NCT00743652|541520993|FG003|Overall Study|Lost to Follow-up|0|||
150103209|NCT00743652|541520994|FG004|Overall Study|Lost to Follow-up|0|||
150103210|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
150103211|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
150103212|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
150103213|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
150103214|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
150103215|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
150103216|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
150103217|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
150103218|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
150103219|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
150103220|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
150103221|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
150103222|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
150103223|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
150103224|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
150103225|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
150103226|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
150103227|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
150103228|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
150103229|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
150103230|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
150103231|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
150103232|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
150103233|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
150103234|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
150103235|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
150103236|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
150103237|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
150103238|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
150103239|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
150103240|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
150103241|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
150103242|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
150103243|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
150103244|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
150103245|NCT03373383|541521000|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
150185706|NCT06143670|541818859|FG001|Overall Study|Withdrawal by Subject|0|||
150185707|NCT04842643|541818863|FG000|Overall Study|Physician Decision|1|||
150103246|NCT03373383|541521001|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
150103247|NCT03373383|541521002|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
150103248|NCT03373383|541521003|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
150103249|NCT03373383|541521004|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
150103250|NCT03373383|541521000|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
150103251|NCT03373383|541521001|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
150103252|NCT03373383|541521002|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
150103253|NCT03373383|541521003|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
150103254|NCT03373383|541521004|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
150103255|NCT02159521|541521005|FG000|Overall Study|Enrolled but not treated|3|||
150103256|NCT02159521|541521005|FG000|Overall Study|Withdrawal by Subject|7|||
150103257|NCT02159521|541521005|FG000|Overall Study|Lost to Follow-up|6|||
150103258|NCT02159521|541521005|FG000|Overall Study|Death|1|||
150103259|NCT02159521|541521005|FG000|Overall Study|Other than specified|1|||
150103260|NCT00907374|541521006|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
150103261|NCT00907374|541521007|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
150103262|NCT02136576|541521013|FG000|Overall Study|Lost to Follow-up|2|||
150103263|NCT02136576|541521014|FG001|Overall Study|Lost to Follow-up|0|||
150103264|NCT02136576|541521015|FG002|Overall Study|Lost to Follow-up|0|||
150103265|NCT02197806|541521016|FG000|Overall Study|Adverse Event|0|||
150103266|NCT02197806|541521017|FG001|Overall Study|Adverse Event|1|||
150103267|NCT02197806|541521018|FG002|Overall Study|Adverse Event|0|||
150103268|NCT02197806|541521019|FG003|Overall Study|Adverse Event|1|||
150103269|NCT00537381|541521021|FG000|Overall Study|Adverse Event|13|||
150103270|NCT00537381|541521022|FG001|Overall Study|Adverse Event|9|||
150103271|NCT00537381|541521021|FG000|Overall Study|Death|3|||
150103272|NCT00537381|541521022|FG001|Overall Study|Death|3|||
150103273|NCT00537381|541521021|FG000|Overall Study|Withdrawal by Subject|5|||
150103274|NCT00537381|541521022|FG001|Overall Study|Withdrawal by Subject|14|||
150103275|NCT00537381|541521021|FG000|Overall Study|Physician Decision|7|||
150103276|NCT00537381|541521022|FG001|Overall Study|Physician Decision|6|||
150103277|NCT00537381|541521021|FG000|Overall Study|Disease Progression|9|||
150103278|NCT00537381|541521022|FG001|Overall Study|Disease Progression|18|||
150103279|NCT00537381|541521021|FG000|Overall Study|Sponsor decision|14|||
150103280|NCT00537381|541521022|FG001|Overall Study|Sponsor decision|9|||
150103281|NCT00537381|541521021|FG000|Overall Study|Other|5|||
150103282|NCT00537381|541521022|FG001|Overall Study|Other|3|||
150103283|NCT00680901|541521023|FG000|Overall Study|Ongoing: On Study Treatment|1|||
150103284|NCT00680901|541521024|FG001|Overall Study|Ongoing: On Study Treatment|0|||
150103285|NCT00680901|541521023|FG000|Overall Study|Ongoing: In Follow Up|1|||
150103286|NCT00680901|541521024|FG001|Overall Study|Ongoing: In Follow Up|0|||
150103287|NCT00680901|541521023|FG000|Overall Study|Adverse Event|1|||
150103288|NCT00680901|541521024|FG001|Overall Study|Adverse Event|1|||
150103289|NCT00680901|541521023|FG000|Overall Study|Lost to Follow-up|3|||
150103290|NCT00680901|541521024|FG001|Overall Study|Lost to Follow-up|5|||
150103291|NCT00680901|541521023|FG000|Overall Study|Subject decided to withdraw from the study|4|||
150103292|NCT00680901|541521024|FG001|Overall Study|Subject decided to withdraw from the study|15|||
150103293|NCT00680901|541521023|FG000|Overall Study|Sponsor decision|1|||
150103294|NCT00680901|541521024|FG001|Overall Study|Sponsor decision|0|||
150103295|NCT00680901|541521023|FG000|Overall Study|Physician Decision|0|||
150103296|NCT00680901|541521024|FG001|Overall Study|Physician Decision|2|||
150103297|NCT00680901|541521023|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
150103298|NCT00680901|541521024|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
150103299|NCT00680901|541521023|FG000|Overall Study|Other protocol defined stopping criteria|17|||
150103300|NCT00680901|541521024|FG001|Overall Study|Other protocol defined stopping criteria|17|||
150103301|NCT00500292|541521031|FG000|Overall Study|Adverse Event|3|||
150103302|NCT00500292|541521032|FG001|Overall Study|Adverse Event|6|||
150103303|NCT00500292|541521033|FG002|Overall Study|Adverse Event|4|||
150103304|NCT00500292|541521031|FG000|Overall Study|Condition under investigation worsened|21|||
150103305|NCT00500292|541521032|FG001|Overall Study|Condition under investigation worsened|23|||
150103306|NCT00500292|541521033|FG002|Overall Study|Condition under investigation worsened|19|||
150103307|NCT00500292|541521031|FG000|Overall Study|Withdrawal by Subject|0|||
150103308|NCT00500292|541521032|FG001|Overall Study|Withdrawal by Subject|1|||
150103309|NCT00500292|541521033|FG002|Overall Study|Withdrawal by Subject|0|||
150103310|NCT00500292|541521031|FG000|Overall Study|Other|1|||
150103311|NCT00500292|541521032|FG001|Overall Study|Other|1|||
150103312|NCT00500292|541521033|FG002|Overall Study|Other|4|||
150103313|NCT03065244|541521034|FG000|Overall Study|Lost to Follow-up|1|||
150103314|NCT03065244|541521035|FG001|Overall Study|Lost to Follow-up|1|||
150103315|NCT03065244|541521034|FG000|Overall Study|Diagnosed with a different disease|1|||
150103316|NCT03065244|541521035|FG001|Overall Study|Diagnosed with a different disease|1|||
150103317|NCT03065244|541521034|FG000|Overall Study|Protocol Violation|0|||
150103318|NCT03065244|541521035|FG001|Overall Study|Protocol Violation|1|||
150103319|NCT03065244|541521034|FG000|Overall Study|Withdrawal by Subject|1|||
150103320|NCT03065244|541521035|FG001|Overall Study|Withdrawal by Subject|1|||
150103321|NCT03717480|541521036|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
150103322|NCT00075582|541521037|FG000|Overall Study|Adverse Event|3|||
150103323|NCT00075582|541521038|FG001|Overall Study|Adverse Event|1|||
150103324|NCT00075582|541521037|FG000|Overall Study|Lack of Efficacy|4|||
150103325|NCT00075582|541521038|FG001|Overall Study|Lack of Efficacy|8|||
150103326|NCT00075582|541521037|FG000|Overall Study|Physician Decision|5|||
150103327|NCT00075582|541521038|FG001|Overall Study|Physician Decision|8|||
150103328|NCT00075582|541521037|FG000|Overall Study|Withdrawal by Subject|2|||
150103329|NCT00075582|541521038|FG001|Overall Study|Withdrawal by Subject|2|||
150103330|NCT00075582|541521037|FG000|Overall Study|Ineligible for study|36|||
150103331|NCT00075582|541521038|FG001|Overall Study|Ineligible for study|16|||
150103332|NCT04809220|541521041|FG000|Overall Study|Adverse Event|4|||
150103333|NCT04809220|541521042|FG001|Overall Study|Adverse Event|0|||
150103334|NCT04809220|541521041|FG000|Overall Study|Death|1|||
150103335|NCT04809220|541521042|FG001|Overall Study|Death|0|||
150103336|NCT04809220|541521041|FG000|Overall Study|Lost to Follow-up|3|||
150103337|NCT04809220|541521042|FG001|Overall Study|Lost to Follow-up|0|||
150103338|NCT04809220|541521041|FG000|Overall Study|Physician Decision|0|||
150103339|NCT04809220|541521042|FG001|Overall Study|Physician Decision|1|||
150103340|NCT04809220|541521041|FG000|Overall Study|Withdrawal by Subject|9|||
150103341|NCT04809220|541521042|FG001|Overall Study|Withdrawal by Subject|5|||
150103342|NCT04809220|541521041|FG000|Overall Study|Due to long-term overseas business trips|1|||
150103343|NCT04809220|541521042|FG001|Overall Study|Due to long-term overseas business trips|0|||
150103344|NCT02120794|541521046|FG000|Overall Study|Withdrawal by Subject|43|||
150103345|NCT02120794|541521046|FG000|Overall Study|Adverse Event|10|||
150103346|NCT02120794|541521046|FG000|Overall Study|Physician Decision|4|||
150103347|NCT02120794|541521046|FG000|Overall Study|Due to insurance coverage|1|||
150103348|NCT00994240|541521049|FG000|Overall Study|Lost to Follow-up|3|||
150103349|NCT00994240|541521050|FG001|Overall Study|Lost to Follow-up|2|||
150103350|NCT00994240|541521049|FG000|Overall Study|Withdrawal by Subject|1|||
150103351|NCT00994240|541521050|FG001|Overall Study|Withdrawal by Subject|0|||
150103352|NCT00994240|541521049|FG000|Overall Study|study termination|2|||
150103353|NCT00994240|541521050|FG001|Overall Study|study termination|3|||
150103354|NCT04258605|541521051|FG000|Overall Study|Death|1|||
150103355|NCT04258605|541521052|FG001|Overall Study|Death|0|||
150103356|NCT04258605|541521051|FG000|Overall Study|Early study termination|21|||
150103357|NCT04258605|541521052|FG001|Overall Study|Early study termination|2|||
150103358|NCT00896337|541521057|FG000|Overall Study|Death|7|||
150103359|NCT00896337|541521057|FG000|Overall Study|Withdrawal by Subject|7|||
150103360|NCT00896337|541521057|FG000|Overall Study|Lost to Follow-up|11|||
150103361|NCT01177540|541521058|FG000|Overall Study|Adverse Event|1|||
150103362|NCT01177540|541521059|FG001|Overall Study|Adverse Event|0|||
150103363|NCT02910167|541521074|FG000|Overall Study|Adverse Event|1|||
150103364|NCT02910167|541521074|FG000|Overall Study|Lost to Follow-up|18|||
150103365|NCT00856908|541521092|FG000|Overall Study|Lost to Follow-up|1|||
150103366|NCT00856908|541521093|FG001|Overall Study|Lost to Follow-up|0|||
150103367|NCT01063595|541521094|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
150103368|NCT01063595|541521095|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
150103369|NCT01063595|541521094|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
150103370|NCT01063595|541521095|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
150103371|NCT01063595|541521094|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
150103372|NCT01063595|541521095|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
150103373|NCT01063595|541521094|FG000|First Intervention|Adverse Event|1|||
150103374|NCT01063595|541521095|FG001|First Intervention|Adverse Event|4|||
150103375|NCT01063595|541521094|FG000|First Intervention|Withdrawal by Subject|1|||
150103376|NCT01063595|541521095|FG001|First Intervention|Withdrawal by Subject|0|||
150103377|NCT01063595|541521094|FG000|First Intervention|Reason not Specified|0|||
150103378|NCT01063595|541521095|FG001|First Intervention|Reason not Specified|1|||
150103379|NCT01070316|541521098|FG000|Extension Phase|Lack of Efficacy|3|||
150103380|NCT01070316|541521098|FG000|Extension Phase|Withdrawal by Subject|1|||
150103381|NCT02013167|541521099|FG000|Overall Study|Withdrawal by Subject|15|||
150103382|NCT02013167|541521100|FG001|Overall Study|Withdrawal by Subject|14|||
150103383|NCT02013167|541521099|FG000|Overall Study|Sponsor Decision|1|||
150103384|NCT02013167|541521100|FG001|Overall Study|Sponsor Decision|3|||
150103385|NCT02013167|541521099|FG000|Overall Study|Lost to Follow-up|0|||
150103386|NCT02013167|541521100|FG001|Overall Study|Lost to Follow-up|1|||
150103387|NCT02013167|541521099|FG000|Overall Study|Death|85|||
150103388|NCT02013167|541521100|FG001|Overall Study|Death|160|||
150103389|NCT00026793|541521103|FG000|Overall Study|Death on study due to underlying disease|4|||
150103390|NCT00026793|541521103|FG000|Overall Study|Physician Decision|2|||
150103391|NCT00026793|541521103|FG000|Overall Study|Off study|2|||
150103392|NCT04151290|541521104|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
150103393|NCT04097821|541521107|FG000|Overall Study|Subject Decision|0|||
150103394|NCT04097821|541521108|FG001|Overall Study|Subject Decision|0|||
150103395|NCT04097821|541521109|FG002|Overall Study|Subject Decision|0|||
150185708|NCT04842643|541818863|FG000|Overall Study|Other|1|||
150185709|NCT01894061|541818864|FG000|Overall Study|Screen failure|1|||
150185710|NCT01894061|541818864|FG000|Overall Study|Withdrawal by Subject|1|||
150185711|NCT04173663|541818865|FG000|Overall Study|Withdrawal by Subject|1|||
150185712|NCT04173663|541818866|FG001|Overall Study|Withdrawal by Subject|6|||
150185713|NCT04173663|541818865|FG000|Overall Study|Lost to Follow-up|17|||
150185714|NCT04173663|541818866|FG001|Overall Study|Lost to Follow-up|24|||
150185715|NCT03089398|541818876|FG000|Overall Study|Death|4|||
150185716|NCT03089398|541818877|FG001|Overall Study|Death|9|||
150185717|NCT03089398|541818876|FG000|Overall Study|Lost to Follow-up|21|||
150185718|NCT03089398|541818877|FG001|Overall Study|Lost to Follow-up|30|||
150185719|NCT03089398|541818876|FG000|Overall Study|Withdrawal by Subject|2|||
150185720|NCT03089398|541818877|FG001|Overall Study|Withdrawal by Subject|2|||
150185721|NCT05439603|541818878|FG000|Overall Study|met withdrawal criteria|2|||
150185722|NCT03896516|541818884|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
150185723|NCT03896516|541818885|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
150185724|NCT03896516|541818884|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
150185725|NCT03896516|541818885|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
150185726|NCT03896516|541818884|FG000|Washout Period|Physician Decision|3|||
150185727|NCT03896516|541818885|FG001|Washout Period|Physician Decision|1|||
150185728|NCT03896516|541818884|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
150185729|NCT03896516|541818885|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
150185730|NCT05461131|541818886|FG000|Overall Study|Lost to Follow-up|0|||
150185731|NCT05461131|541818887|FG001|Overall Study|Lost to Follow-up|2|||
150185732|NCT04538417|541818894|FG000|Overall Study|Withdrawal by Subject|2|||
150185733|NCT04549168|541818899|FG000|Randomization Phase|Adverse Event|0|||
150185734|NCT04549168|541818900|FG001|Randomization Phase|Adverse Event|0|||
150185735|NCT04549168|541818901|FG002|Randomization Phase|Adverse Event|1|||
150185736|NCT04549168|541818899|FG000|Randomization Phase|Other|0|||
150185737|NCT04549168|541818900|FG001|Randomization Phase|Other|2|||
150185738|NCT04549168|541818901|FG002|Randomization Phase|Other|0|||
150185739|NCT04549168|541818899|FG000|Randomization Phase|Withdrawal by Subject|0|||
150185740|NCT04549168|541818900|FG001|Randomization Phase|Withdrawal by Subject|2|||
150185741|NCT04549168|541818901|FG002|Randomization Phase|Withdrawal by Subject|1|||
150185742|NCT02662062|541818903|FG000|Overall Study|Withdrawal by Subject|1|||
150185743|NCT02097420|541818904|FG000|Overall Study|Death|6|||
150185744|NCT02097420|541818904|FG000|Overall Study|Valve explanted|13|||
150185745|NCT02097420|541818904|FG000|Overall Study|Other Reason|1|||
150185746|NCT03393975|541818906|FG000|Urgent Treatment Period|Physician Decision|0|||
150185747|NCT03393975|541818907|FG001|Urgent Treatment Period|Physician Decision|0|||
150185748|NCT03393975|541818908|FG002|Urgent Treatment Period|Physician Decision|0|||
150185749|NCT03393975|541818909|FG003|Urgent Treatment Period|Physician Decision|1|||
150185750|NCT03393975|541818906|FG000|Prophylaxis Period 1|Reason not Specified|0|||
150185751|NCT03393975|541818907|FG001|Prophylaxis Period 1|Reason not Specified|1|||
150185752|NCT03393975|541818908|FG002|Prophylaxis Period 1|Reason not Specified|0|||
150185753|NCT03393975|541818909|FG003|Prophylaxis Period 1|Reason not Specified|0|||
150185754|NCT03393975|541818906|FG000|Prophylaxis Period 2|Reason not Specified|0|||
150185755|NCT03393975|541818907|FG001|Prophylaxis Period 2|Reason not Specified|1|||
150185756|NCT03393975|541818908|FG002|Prophylaxis Period 2|Reason not Specified|0|||
150185757|NCT03393975|541818909|FG003|Prophylaxis Period 2|Reason not Specified|0|||
150185758|NCT04936035|541818912|FG000|Overall Study|Adverse Event|0|||
150185759|NCT04936035|541818913|FG001|Overall Study|Adverse Event|1|||
150185760|NCT04936035|541818914|FG002|Overall Study|Adverse Event|0|||
150185761|NCT04936035|541818915|FG003|Overall Study|Adverse Event|0|||
150185762|NCT04936035|541818916|FG004|Overall Study|Adverse Event|0|||
150185763|NCT04936035|541818912|FG000|Overall Study|Death|0|||
150185764|NCT04936035|541818913|FG001|Overall Study|Death|0|||
150185765|NCT04936035|541818914|FG002|Overall Study|Death|0|||
150185766|NCT04936035|541818915|FG003|Overall Study|Death|1|||
150185767|NCT04936035|541818916|FG004|Overall Study|Death|0|||
150185768|NCT04936035|541818912|FG000|Overall Study|Lost to Follow-up|0|||
150185769|NCT04936035|541818913|FG001|Overall Study|Lost to Follow-up|1|||
150185770|NCT04936035|541818914|FG002|Overall Study|Lost to Follow-up|1|||
150185771|NCT04936035|541818915|FG003|Overall Study|Lost to Follow-up|2|||
150185772|NCT04936035|541818916|FG004|Overall Study|Lost to Follow-up|1|||
150185773|NCT04936035|541818912|FG000|Overall Study|Physician Decision|0|||
150185774|NCT04936035|541818913|FG001|Overall Study|Physician Decision|1|||
150185775|NCT04936035|541818914|FG002|Overall Study|Physician Decision|0|||
150185776|NCT04936035|541818915|FG003|Overall Study|Physician Decision|0|||
150185777|NCT04936035|541818916|FG004|Overall Study|Physician Decision|0|||
150185778|NCT04936035|541818912|FG000|Overall Study|Protocol Deviation|0|||
150185779|NCT04936035|541818913|FG001|Overall Study|Protocol Deviation|0|||
150185780|NCT04936035|541818914|FG002|Overall Study|Protocol Deviation|1|||
150185781|NCT04936035|541818915|FG003|Overall Study|Protocol Deviation|0|||
150185782|NCT04936035|541818916|FG004|Overall Study|Protocol Deviation|0|||
150185783|NCT04936035|541818912|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
150185784|NCT04936035|541818913|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
150185785|NCT04936035|541818914|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
150185786|NCT04936035|541818915|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
150185787|NCT04936035|541818916|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
150185788|NCT04936035|541818912|FG000|Overall Study|Reason Unknown|0|||
150185789|NCT04936035|541818913|FG001|Overall Study|Reason Unknown|0|||
150185790|NCT04936035|541818914|FG002|Overall Study|Reason Unknown|0|||
150185791|NCT04936035|541818915|FG003|Overall Study|Reason Unknown|0|||
150185792|NCT04936035|541818916|FG004|Overall Study|Reason Unknown|1|||
150185793|NCT04936035|541818912|FG000|Overall Study|Withdrawal by Subject|1|||
150185794|NCT04936035|541818913|FG001|Overall Study|Withdrawal by Subject|0|||
150185795|NCT04936035|541818914|FG002|Overall Study|Withdrawal by Subject|0|||
150185796|NCT04936035|541818915|FG003|Overall Study|Withdrawal by Subject|0|||
150185797|NCT04936035|541818916|FG004|Overall Study|Withdrawal by Subject|0|||
150185798|NCT04936035|541818912|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
150185799|NCT04936035|541818913|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
150185800|NCT04936035|541818914|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
150185801|NCT04936035|541818915|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
150185802|NCT04936035|541818916|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
150185803|NCT04936035|541818912|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
150185804|NCT04936035|541818913|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
150185805|NCT04936035|541818914|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
150185806|NCT04936035|541818915|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
150185807|NCT04936035|541818916|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
150185808|NCT04936035|541818912|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
150185809|NCT04936035|541818913|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
150185810|NCT04936035|541818914|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
150185811|NCT04936035|541818915|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
150185812|NCT04936035|541818916|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
150185813|NCT04401800|541818917|FG000|Overall Study|Death|17|||
150185814|NCT04401800|541818917|FG000|Overall Study|Lost to Follow-up|5|||
150185815|NCT04401800|541818917|FG000|Overall Study|Withdrawal by Subject|4|||
150185816|NCT01772472|541818922|FG000|Overall Study|Death|126|||
150185817|NCT01772472|541818923|FG001|Overall Study|Death|94|||
150185818|NCT01772472|541818922|FG000|Overall Study|Lost to Follow-up|51|||
150185819|NCT01772472|541818923|FG001|Overall Study|Lost to Follow-up|50|||
150185820|NCT01772472|541818922|FG000|Overall Study|Other|9|||
150185821|NCT01772472|541818923|FG001|Overall Study|Other|7|||
150185822|NCT01772472|541818922|FG000|Overall Study|Physician Decision|1|||
150185823|NCT01772472|541818923|FG001|Overall Study|Physician Decision|7|||
150185824|NCT01772472|541818922|FG000|Overall Study|Withdrawal by Subject|115|||
150185825|NCT01772472|541818923|FG001|Overall Study|Withdrawal by Subject|90|||
150185826|NCT01772472|541818922|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
150185827|NCT01772472|541818923|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
150185828|NCT04391894|541818924|FG000|Overall Study|Adverse Event|1|||
150185829|NCT04391894|541818925|FG001|Overall Study|Adverse Event|1|||
150185830|NCT04391894|541818926|FG002|Overall Study|Adverse Event|1|||
150185831|NCT04391894|541818927|FG003|Overall Study|Adverse Event|1|||
150185832|NCT04391894|541818928|FG004|Overall Study|Adverse Event|1|||
150185833|NCT04391894|541818924|FG000|Overall Study|Lost to Follow-up|1|||
150185834|NCT04391894|541818925|FG001|Overall Study|Lost to Follow-up|0|||
150185835|NCT04391894|541818926|FG002|Overall Study|Lost to Follow-up|0|||
150185836|NCT04391894|541818927|FG003|Overall Study|Lost to Follow-up|0|||
150185837|NCT04391894|541818928|FG004|Overall Study|Lost to Follow-up|0|||
150185838|NCT04391894|541818924|FG000|Overall Study|Protocol Violation|0|||
150185839|NCT04391894|541818925|FG001|Overall Study|Protocol Violation|0|||
150185840|NCT04391894|541818926|FG002|Overall Study|Protocol Violation|0|||
150185841|NCT04391894|541818927|FG003|Overall Study|Protocol Violation|1|||
150185842|NCT04391894|541818928|FG004|Overall Study|Protocol Violation|0|||
150185843|NCT04391894|541818924|FG000|Overall Study|Withdrawal by Subject|2|||
150185844|NCT04391894|541818925|FG001|Overall Study|Withdrawal by Subject|0|||
150185845|NCT04391894|541818926|FG002|Overall Study|Withdrawal by Subject|3|||
150185846|NCT04391894|541818927|FG003|Overall Study|Withdrawal by Subject|0|||
150185847|NCT04391894|541818928|FG004|Overall Study|Withdrawal by Subject|1|||
150185848|NCT04391894|541818924|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
150185849|NCT04391894|541818925|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
150185850|NCT04391894|541818926|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
150185851|NCT04391894|541818927|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
150185852|NCT04391894|541818928|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
150103396|NCT04097821|541521110|FG003|Overall Study|Subject Decision|1|||
150103397|NCT04097821|541521111|FG004|Overall Study|Subject Decision|2|||
150103398|NCT04097821|541521112|FG005|Overall Study|Subject Decision|2|||
150103399|NCT04097821|541521113|FG006|Overall Study|Subject Decision|0|||
150103400|NCT04097821|541521114|FG007|Overall Study|Subject Decision|1|||
150103401|NCT04097821|541521107|FG000|Overall Study|Death|0|||
150103402|NCT04097821|541521108|FG001|Overall Study|Death|0|||
150103403|NCT04097821|541521109|FG002|Overall Study|Death|3|||
150103404|NCT04097821|541521110|FG003|Overall Study|Death|1|||
150103405|NCT04097821|541521111|FG004|Overall Study|Death|0|||
150103406|NCT04097821|541521112|FG005|Overall Study|Death|0|||
150103407|NCT04097821|541521113|FG006|Overall Study|Death|0|||
150103408|NCT04097821|541521114|FG007|Overall Study|Death|0|||
150103409|NCT04097821|541521107|FG000|Overall Study|Physician Decision|1|||
150103410|NCT04097821|541521108|FG001|Overall Study|Physician Decision|2|||
150103411|NCT04097821|541521109|FG002|Overall Study|Physician Decision|0|||
150103412|NCT04097821|541521110|FG003|Overall Study|Physician Decision|0|||
150103413|NCT04097821|541521111|FG004|Overall Study|Physician Decision|0|||
150103414|NCT04097821|541521112|FG005|Overall Study|Physician Decision|0|||
150103415|NCT04097821|541521113|FG006|Overall Study|Physician Decision|0|||
150103416|NCT04097821|541521114|FG007|Overall Study|Physician Decision|0|||
150103417|NCT04097821|541521107|FG000|Overall Study|Adverse Event|0|||
150103418|NCT04097821|541521108|FG001|Overall Study|Adverse Event|0|||
150103419|NCT04097821|541521109|FG002|Overall Study|Adverse Event|1|||
150103420|NCT04097821|541521110|FG003|Overall Study|Adverse Event|1|||
150103421|NCT04097821|541521111|FG004|Overall Study|Adverse Event|0|||
150103422|NCT04097821|541521112|FG005|Overall Study|Adverse Event|0|||
150103423|NCT04097821|541521113|FG006|Overall Study|Adverse Event|0|||
150103424|NCT04097821|541521114|FG007|Overall Study|Adverse Event|0|||
150103425|NCT04097821|541521107|FG000|Overall Study|New Therapy For Study Indication|0|||
150103426|NCT04097821|541521108|FG001|Overall Study|New Therapy For Study Indication|0|||
150103427|NCT04097821|541521109|FG002|Overall Study|New Therapy For Study Indication|0|||
150103428|NCT04097821|541521110|FG003|Overall Study|New Therapy For Study Indication|0|||
150103429|NCT04097821|541521111|FG004|Overall Study|New Therapy For Study Indication|0|||
150103430|NCT04097821|541521112|FG005|Overall Study|New Therapy For Study Indication|0|||
150103431|NCT04097821|541521113|FG006|Overall Study|New Therapy For Study Indication|1|||
150103432|NCT04097821|541521114|FG007|Overall Study|New Therapy For Study Indication|0|||
150103433|NCT02776917|541521115|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
150103434|NCT00574405|541523008|FG000|Overall Study|Withdrawal by Subject|3|||
150103435|NCT00574405|541523009|FG001|Overall Study|Withdrawal by Subject|2|||
150103436|NCT01572038|541523013|FG000|Overall Study|Death|648|||
150103437|NCT01572038|541523013|FG000|Overall Study|Withdrawal by Subject|204|||
150103438|NCT01572038|541523013|FG000|Overall Study|Lost to Follow-up|81|||
150103439|NCT01572038|541523013|FG000|Overall Study|Physician Decision|20|||
150103440|NCT01572038|541523013|FG000|Overall Study|Patient Decision|14|||
150103441|NCT01572038|541523013|FG000|Overall Study|Progressive Disease|8|||
150103442|NCT01572038|541523013|FG000|Overall Study|Site Closed Before Completing Form|6|||
150103443|NCT01572038|541523013|FG000|Overall Study|Enrolled into Another Trial|3|||
150103444|NCT01572038|541523013|FG000|Overall Study|Participated in Another Trial|3|||
150103445|NCT01572038|541523013|FG000|Overall Study|Termination by Sponsor|2|||
150103446|NCT01572038|541523013|FG000|Overall Study|Patient Deterioration|1|||
150103447|NCT01572038|541523013|FG000|Overall Study|Sponsor Decision|1|||
150103448|NCT00394212|541523018|FG000|Overall Study|Lost to Follow-up|3|||
150103449|NCT00394212|541523019|FG001|Overall Study|Lost to Follow-up|0|||
150103450|NCT00394212|541523018|FG000|Overall Study|Withdrawal by Subject|4|||
150103451|NCT00394212|541523019|FG001|Overall Study|Withdrawal by Subject|1|||
150103452|NCT00588445|541523020|FG000|Overall Study|Protocol Violation|1|||
150103453|NCT00588445|541523020|FG000|Overall Study|Withdrawal by Subject|3|||
150103454|NCT00588445|541523020|FG000|Overall Study|Disease Progression|1|||
150103455|NCT00588445|541523020|FG000|Overall Study|Not Treated|10|||
150103456|NCT03240133|541523021|FG000|Overall Study|Withdrawal by Subject|0|||
150103457|NCT03240133|541523022|FG001|Overall Study|Withdrawal by Subject|1|||
150103458|NCT03240133|541523023|FG002|Overall Study|Withdrawal by Subject|0|||
150103459|NCT03240133|541523021|FG000|Overall Study|Adverse Event|1|||
150103460|NCT03240133|541523022|FG001|Overall Study|Adverse Event|1|||
150103461|NCT03240133|541523023|FG002|Overall Study|Adverse Event|0|||
150103462|NCT03240133|541523021|FG000|Overall Study|Rash|1|||
150103463|NCT03240133|541523022|FG001|Overall Study|Rash|0|||
150103464|NCT03240133|541523023|FG002|Overall Study|Rash|0|||
150103465|NCT03240133|541523021|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
150103466|NCT03240133|541523022|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
150103467|NCT03240133|541523023|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
150103468|NCT03240133|541523021|FG000|Overall Study|Intercurrent illness.|0|||
150103469|NCT03240133|541523022|FG001|Overall Study|Intercurrent illness.|1|||
150103470|NCT03240133|541523023|FG002|Overall Study|Intercurrent illness.|0|||
150103471|NCT03240133|541523021|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
150103472|NCT03240133|541523022|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
150185853|NCT00446225|541818932|FG000|Overall Study|Protocol Violation|1|||
150185854|NCT00446225|541818933|FG001|Overall Study|Protocol Violation|0|||
150185855|NCT04450342|541818934|FG000|Overall Study|Adverse Event|1|||
150185856|NCT04450342|541818935|FG001|Overall Study|Adverse Event|1|||
150185857|NCT04450342|541818936|FG002|Overall Study|Adverse Event|0|||
150103473|NCT03240133|541523023|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
150103474|NCT00116831|541523026|FG000|Overall Study|Adverse Event|14|||
150103475|NCT00116831|541523027|FG001|Overall Study|Adverse Event|16|||
150103476|NCT00116831|541523026|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
150103477|NCT00116831|541523027|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
150103478|NCT00116831|541523026|FG000|Overall Study|Lost to Follow-up|8|||
150103479|NCT00116831|541523027|FG001|Overall Study|Lost to Follow-up|6|||
150103480|NCT00116831|541523026|FG000|Overall Study|Protocol Violation|3|||
150103481|NCT00116831|541523027|FG001|Overall Study|Protocol Violation|6|||
150103482|NCT00116831|541523026|FG000|Overall Study|Hypoglycaemic events|1|||
150103483|NCT00116831|541523027|FG001|Overall Study|Hypoglycaemic events|0|||
150103484|NCT00116831|541523026|FG000|Overall Study|Low haemoglobin on screening|1|||
150103485|NCT00116831|541523027|FG001|Overall Study|Low haemoglobin on screening|0|||
150103486|NCT00116831|541523026|FG000|Overall Study|Withdrawn investigational product|1|||
150103487|NCT00116831|541523027|FG001|Overall Study|Withdrawn investigational product|0|||
150103488|NCT00116831|541523026|FG000|Overall Study|Withdrawal by Subject|32|||
150103489|NCT00116831|541523027|FG001|Overall Study|Withdrawal by Subject|32|||
150103490|NCT00116831|541523026|FG000|Overall Study|Insufficient therapeutic effect|0|||
150103491|NCT00116831|541523027|FG001|Overall Study|Insufficient therapeutic effect|1|||
150103492|NCT00116831|541523026|FG000|Overall Study|Missing data for participant|1|||
150103493|NCT00116831|541523027|FG001|Overall Study|Missing data for participant|0|||
150103494|NCT04904185|541523028|FG000|Overall Study|Expansion failure|1|||
150103495|NCT04904185|541523029|FG001|Overall Study|Expansion failure|0|||
150103496|NCT04904185|541523028|FG000|Overall Study|Late response on prior treatment|1|||
150103497|NCT04904185|541523029|FG001|Overall Study|Late response on prior treatment|0|||
150103498|NCT02945410|541523030|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150103499|NCT02945410|541523031|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
150103500|NCT02945410|541523032|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150103501|NCT02945410|541523033|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150103502|NCT02945410|541523034|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150103503|NCT02945410|541523035|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
150103504|NCT02945410|541523030|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
150103505|NCT02945410|541523031|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
150103506|NCT02945410|541523032|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
150103507|NCT02945410|541523033|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
150103508|NCT02945410|541523034|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
150103509|NCT02945410|541523035|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
150103510|NCT02945410|541523030|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
150103511|NCT02945410|541523031|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
150103512|NCT02945410|541523032|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
150103513|NCT02945410|541523033|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
150103514|NCT02945410|541523034|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
150103515|NCT02945410|541523035|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
150103516|NCT00110812|541523038|FG000|Main Study|Death|0|||
150103517|NCT00110812|541523039|FG001|Main Study|Death|0|||
150103518|NCT00110812|541523040|FG002|Main Study|Death|2|||
150103519|NCT00110812|541523038|FG000|Main Study|Withdrawal by Subject|0|||
150103520|NCT00110812|541523039|FG001|Main Study|Withdrawal by Subject|0|||
150103521|NCT00110812|541523040|FG002|Main Study|Withdrawal by Subject|1|||
150103522|NCT00110812|541523038|FG000|Main Study|Lost to Follow-up|8|||
150103523|NCT00110812|541523039|FG001|Main Study|Lost to Follow-up|11|||
150103524|NCT00110812|541523040|FG002|Main Study|Lost to Follow-up|10|||
150103525|NCT00110812|541523038|FG000|Extended Follow-up|Death|1|||
150185858|NCT04450342|541818934|FG000|Overall Study|Device not used|1|||
150185859|NCT04450342|541818935|FG001|Overall Study|Device not used|0|||
150185860|NCT04450342|541818936|FG002|Overall Study|Device not used|0|||
150185861|NCT04450342|541818934|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
150103526|NCT00110812|541523039|FG001|Extended Follow-up|Death|0|||
150103527|NCT00110812|541523040|FG002|Extended Follow-up|Death|3|||
150103528|NCT00110812|541523038|FG000|Extended Follow-up|Withdrawal by Subject|0|||
150103529|NCT00110812|541523039|FG001|Extended Follow-up|Withdrawal by Subject|1|||
150103530|NCT00110812|541523040|FG002|Extended Follow-up|Withdrawal by Subject|0|||
150103531|NCT00110812|541523038|FG000|Extended Follow-up|Lost to Follow-up|1|||
150103532|NCT00110812|541523039|FG001|Extended Follow-up|Lost to Follow-up|3|||
150103533|NCT00110812|541523040|FG002|Extended Follow-up|Lost to Follow-up|1|||
150185862|NCT04450342|541818935|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
150185863|NCT04450342|541818936|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
150185864|NCT04450342|541818934|FG000|Overall Study|Physician Decision|1|||
150185865|NCT04450342|541818935|FG001|Overall Study|Physician Decision|0|||
150185866|NCT04450342|541818936|FG002|Overall Study|Physician Decision|1|||
150185867|NCT04450342|541818934|FG000|Overall Study|Protocol Deviation|0|||
150185868|NCT04450342|541818935|FG001|Overall Study|Protocol Deviation|1|||
150185869|NCT04450342|541818936|FG002|Overall Study|Protocol Deviation|0|||
150103534|NCT04200248|541523043|FG000|Overall Study|Personal reasons|0|||
150103535|NCT04200248|541523044|FG001|Overall Study|Personal reasons|0|||
150103536|NCT04200248|541523045|FG002|Overall Study|Personal reasons|1|||
150103537|NCT04200248|541523043|FG000|Overall Study|Discontinued prior to treatment|3|||
150103538|NCT04200248|541523044|FG001|Overall Study|Discontinued prior to treatment|3|||
150103539|NCT04200248|541523045|FG002|Overall Study|Discontinued prior to treatment|2|||
150103540|NCT01454726|541523046|FG000|Overall Study|Withdrawal by Subject|0|||
150103541|NCT01454726|541523047|FG001|Overall Study|Withdrawal by Subject|1|||
150103542|NCT02919670|541523048|FG000|Overall Study|Only 17 participants met compliance|43|||
150103543|NCT02919670|541523049|FG001|Overall Study|Only 17 participants met compliance|39|||
150103544|NCT02118428|541523052|FG000|Overall Study|Physician Decision|0|||
150103545|NCT02118428|541523053|FG001|Overall Study|Physician Decision|1|||
150103546|NCT02118428|541523054|FG002|Overall Study|Physician Decision|0|||
150103547|NCT02118428|541523052|FG000|Overall Study|Withdrawal by Subject|2|||
150103548|NCT02118428|541523053|FG001|Overall Study|Withdrawal by Subject|2|||
150103549|NCT02118428|541523054|FG002|Overall Study|Withdrawal by Subject|0|||
150103550|NCT02118428|541523052|FG000|Overall Study|Death|7|||
150103551|NCT02118428|541523053|FG001|Overall Study|Death|5|||
150103552|NCT02118428|541523054|FG002|Overall Study|Death|0|||
150103553|NCT02118428|541523052|FG000|Overall Study|Lost to Follow-up|3|||
150103554|NCT02118428|541523053|FG001|Overall Study|Lost to Follow-up|1|||
150103555|NCT02118428|541523054|FG002|Overall Study|Lost to Follow-up|0|||
150103556|NCT02118428|541523052|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
150103557|NCT02118428|541523053|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
150103558|NCT02118428|541523054|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
150103559|NCT01714310|541523055|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
150103560|NCT01714310|541523056|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
150103561|NCT01714310|541523057|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
150103562|NCT01714310|541523055|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
150103563|NCT01714310|541523056|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
150103564|NCT01714310|541523057|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
150103565|NCT01714310|541523055|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
150103566|NCT01714310|541523056|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
150185870|NCT04450342|541818934|FG000|Overall Study|Reoperation|1|||
150185871|NCT04450342|541818935|FG001|Overall Study|Reoperation|1|||
150185872|NCT04450342|541818936|FG002|Overall Study|Reoperation|0|||
150185873|NCT04450342|541818934|FG000|Overall Study|Screen Failures|0|||
150185874|NCT04450342|541818935|FG001|Overall Study|Screen Failures|0|||
150185875|NCT04450342|541818936|FG002|Overall Study|Screen Failures|2|||
150185876|NCT04450342|541818934|FG000|Overall Study|Site Terminated by Sponsor|1|||
150185877|NCT04450342|541818935|FG001|Overall Study|Site Terminated by Sponsor|1|||
150185878|NCT04450342|541818936|FG002|Overall Study|Site Terminated by Sponsor|1|||
150185879|NCT04450342|541818934|FG000|Overall Study|Study Terminated by Sponsor|31|||
150185880|NCT04450342|541818935|FG001|Overall Study|Study Terminated by Sponsor|29|||
150185881|NCT04450342|541818936|FG002|Overall Study|Study Terminated by Sponsor|6|||
150185882|NCT04450342|541818934|FG000|Overall Study|Withdrawal by Subject|0|||
150185883|NCT04450342|541818935|FG001|Overall Study|Withdrawal by Subject|1|||
150185884|NCT04450342|541818936|FG002|Overall Study|Withdrawal by Subject|2|||
150185885|NCT05633407|541818937|FG000|Overall Study|Physician Decision|2|||
150185886|NCT05633407|541818938|FG001|Overall Study|Physician Decision|0|||
150185887|NCT05633407|541818937|FG000|Overall Study|Adverse Event|1|||
150185888|NCT05633407|541818938|FG001|Overall Study|Adverse Event|0|||
150185889|NCT05633407|541818937|FG000|Overall Study|Withdrawal by Subject|1|||
150185890|NCT05633407|541818938|FG001|Overall Study|Withdrawal by Subject|0|||
150185891|NCT05633407|541818937|FG000|Overall Study|Other|1|||
150185892|NCT05633407|541818938|FG001|Overall Study|Other|1|||
150185893|NCT00220740|541818941|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
150185894|NCT00220740|541818942|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
150185895|NCT00220740|541818941|FG000|Efficacy Period|Adverse Event|1|||
150103567|NCT01714310|541523057|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
150103568|NCT01714310|541523055|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
150103569|NCT01714310|541523056|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
150103570|NCT01714310|541523057|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
150103571|NCT01641367|541523058|FG000|Cohorts|Death|18|||
150103572|NCT01641367|541523059|FG001|Cohorts|Death|1|||
150185896|NCT00220740|541818942|FG001|Efficacy Period|Adverse Event|1|||
150185897|NCT00220740|541818941|FG000|Efficacy Period|Withdrawal by Subject|1|||
150185898|NCT00220740|541818942|FG001|Efficacy Period|Withdrawal by Subject|0|||
150185899|NCT00220740|541818941|FG000|Efficacy Period|Protocol Violation|1|||
150185900|NCT00220740|541818942|FG001|Efficacy Period|Protocol Violation|0|||
150185901|NCT00220740|541818941|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
150185902|NCT00220740|541818942|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
150185903|NCT01057433|541818943|FG000|Overall Study|Adverse Event|1|||
150185904|NCT03361748|541818944|FG000|Overall Study|Death|77|||
150185905|NCT03361748|541818944|FG000|Overall Study|Lost to Follow-up|4|||
150185906|NCT03361748|541818944|FG000|Overall Study|Withdrawal by Subject|20|||
150185907|NCT04774237|541818953|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
150185908|NCT04774237|541818954|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
150185909|NCT04774237|541818955|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
150185910|NCT04774237|541818956|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
150185911|NCT04774237|541818957|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
150185912|NCT04774237|541818958|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
150185913|NCT03747484|541820376|FG000|Overall Study|Lack of Efficacy|0|||
150185914|NCT03747484|541820377|FG001|Overall Study|Lack of Efficacy|1|||
150185915|NCT03747484|541820378|FG002|Overall Study|Lack of Efficacy|1|||
150185916|NCT03747484|541820379|FG003|Overall Study|Lack of Efficacy|2|||
150185917|NCT03747484|541820380|FG004|Overall Study|Lack of Efficacy|2|||
150185918|NCT03625882|541820382|FG000|Overall Study|Protocol Violation|3|||
150185919|NCT05058391|541820385|FG000|Overall Study|Adverse Event|1|||
150185920|NCT03833245|541820388|FG000|Overall Study|Death|0|||
150185921|NCT03833245|541820389|FG001|Overall Study|Death|1|||
150185922|NCT03775109|541820391|FG000|Overall Study|Adverse Event|1|||
150185923|NCT03775109|541820392|FG001|Overall Study|Adverse Event|0|||
150185924|NCT03775109|541820391|FG000|Overall Study|COVID-19 outbreak|2|||
150185925|NCT03775109|541820392|FG001|Overall Study|COVID-19 outbreak|0|||
150185926|NCT03775109|541820391|FG000|Overall Study|Lost to Follow-up|0|||
150185927|NCT03775109|541820392|FG001|Overall Study|Lost to Follow-up|2|||
150185928|NCT03775109|541820391|FG000|Overall Study|Withdrawal by Subject|1|||
150185929|NCT03775109|541820392|FG001|Overall Study|Withdrawal by Subject|1|||
150185930|NCT03775109|541820391|FG000|Overall Study|Death|0|||
150185931|NCT03775109|541820392|FG001|Overall Study|Death|1|||
150185932|NCT03775109|541820391|FG000|Overall Study|Lack of Efficacy|1|||
150185933|NCT03775109|541820392|FG001|Overall Study|Lack of Efficacy|0|||
150185934|NCT05110495|541820395|FG000|Overall Study|Lost to Follow-up|1|||
150185935|NCT05110495|541820395|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
150185936|NCT04402489|541820397|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
150185937|NCT04402489|541820398|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
150185938|NCT04402489|541820399|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
150185939|NCT04402489|541820400|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
150185940|NCT04402489|541820401|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
150185941|NCT04402489|541820397|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
150185942|NCT04402489|541820398|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
150185943|NCT04402489|541820399|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
150103573|NCT01641367|541523060|FG002|Cohorts|Death|2|||
150103574|NCT01641367|541523061|FG003|Cohorts|Death|0|||
150103575|NCT01641367|541523062|FG004|Cohorts|Death|1|||
150103576|NCT01641367|541523063|FG005|Cohorts|Death|1|||
150103577|NCT01641367|541523064|FG006|Cohorts|Death|0|||
150103578|NCT01641367|541523065|FG007|Cohorts|Death|0|||
150103579|NCT01641367|541523058|FG000|Cohorts|Lost to Follow-up|16|||
150103580|NCT01641367|541523059|FG001|Cohorts|Lost to Follow-up|0|||
150103581|NCT01641367|541523060|FG002|Cohorts|Lost to Follow-up|2|||
150103582|NCT01641367|541523061|FG003|Cohorts|Lost to Follow-up|0|||
150103583|NCT01641367|541523062|FG004|Cohorts|Lost to Follow-up|2|||
150103584|NCT01641367|541523063|FG005|Cohorts|Lost to Follow-up|0|||
150103585|NCT01641367|541523064|FG006|Cohorts|Lost to Follow-up|0|||
150103586|NCT01641367|541523065|FG007|Cohorts|Lost to Follow-up|0|||
150103587|NCT01641367|541523058|FG000|Randomized Adherence Intervention|Death|0|||
150103588|NCT01641367|541523059|FG001|Randomized Adherence Intervention|Death|0|||
150103589|NCT01641367|541523060|FG002|Randomized Adherence Intervention|Death|0|||
150185944|NCT04402489|541820400|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
150185945|NCT04402489|541820401|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
150185946|NCT04402489|541820397|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
150185947|NCT04402489|541820398|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
150185948|NCT04402489|541820399|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
150185949|NCT04402489|541820400|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
150185950|NCT04402489|541820401|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
150185951|NCT04402489|541820397|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
150185952|NCT04402489|541820398|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
150103590|NCT01641367|541523061|FG003|Randomized Adherence Intervention|Death|0|||
150103591|NCT01641367|541523062|FG004|Randomized Adherence Intervention|Death|0|||
150103592|NCT01641367|541523063|FG005|Randomized Adherence Intervention|Death|0|||
150103593|NCT01641367|541523064|FG006|Randomized Adherence Intervention|Death|11|||
150103594|NCT01641367|541523065|FG007|Randomized Adherence Intervention|Death|12|||
150103595|NCT01641367|541523058|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103596|NCT01641367|541523059|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103597|NCT01641367|541523060|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103598|NCT01641367|541523061|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103599|NCT01641367|541523062|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103600|NCT01641367|541523063|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
150103601|NCT01641367|541523064|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
150103602|NCT01641367|541523065|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
150103603|NCT00826267|541523066|FG000|Overall Study|Other Adverse Event|1|||
150103604|NCT00826267|541523067|FG001|Overall Study|Other Adverse Event|0|||
150103605|NCT00826267|541523068|FG002|Overall Study|Other Adverse Event|0|||
150103606|NCT01675882|541523071|FG000|Overall Study|Adverse Event|0|||
150103607|NCT01675882|541523072|FG001|Overall Study|Adverse Event|2|||
150103608|NCT01675882|541523073|FG002|Overall Study|Adverse Event|1|||
150103609|NCT01675882|541523074|FG003|Overall Study|Adverse Event|0|||
150103610|NCT01675882|541523071|FG000|Overall Study|Participant unwilling to continue|2|||
150103611|NCT01675882|541523072|FG001|Overall Study|Participant unwilling to continue|4|||
150103612|NCT01675882|541523073|FG002|Overall Study|Participant unwilling to continue|2|||
150103613|NCT01675882|541523074|FG003|Overall Study|Participant unwilling to continue|1|||
150103614|NCT01675882|541523071|FG000|Overall Study|Lost to Follow-up|0|||
150103615|NCT01675882|541523072|FG001|Overall Study|Lost to Follow-up|1|||
150103616|NCT01675882|541523073|FG002|Overall Study|Lost to Follow-up|0|||
150103617|NCT01675882|541523074|FG003|Overall Study|Lost to Follow-up|0|||
150103618|NCT01675882|541523071|FG000|Overall Study|Non-compliance|0|||
150103619|NCT01675882|541523072|FG001|Overall Study|Non-compliance|0|||
150103620|NCT01675882|541523073|FG002|Overall Study|Non-compliance|0|||
150103621|NCT01675882|541523074|FG003|Overall Study|Non-compliance|1|||
150103622|NCT00735371|541523075|FG000|Overall Study|Adverse Event|3|||
150103623|NCT00735371|541523076|FG001|Overall Study|Adverse Event|3|||
150103624|NCT00735371|541523077|FG002|Overall Study|Adverse Event|4|||
150103625|NCT00735371|541523078|FG003|Overall Study|Adverse Event|1|||
150103626|NCT00735371|541523075|FG000|Overall Study|Protocol Violation|2|||
150103627|NCT00735371|541523076|FG001|Overall Study|Protocol Violation|2|||
150103628|NCT00735371|541523077|FG002|Overall Study|Protocol Violation|0|||
150103629|NCT00735371|541523078|FG003|Overall Study|Protocol Violation|3|||
150103630|NCT00735371|541523075|FG000|Overall Study|Withdrawal by Subject|0|||
150103631|NCT00735371|541523076|FG001|Overall Study|Withdrawal by Subject|2|||
150103632|NCT00735371|541523077|FG002|Overall Study|Withdrawal by Subject|2|||
150103633|NCT00735371|541523078|FG003|Overall Study|Withdrawal by Subject|0|||
150103634|NCT00735371|541523075|FG000|Overall Study|Lost to Follow-up|1|||
150103635|NCT00735371|541523076|FG001|Overall Study|Lost to Follow-up|1|||
150103636|NCT00735371|541523077|FG002|Overall Study|Lost to Follow-up|3|||
150103637|NCT00735371|541523078|FG003|Overall Study|Lost to Follow-up|1|||
150103638|NCT00735371|541523075|FG000|Overall Study|Lack of Efficacy|4|||
150103639|NCT00735371|541523076|FG001|Overall Study|Lack of Efficacy|2|||
150103640|NCT00735371|541523077|FG002|Overall Study|Lack of Efficacy|0|||
150103641|NCT00735371|541523078|FG003|Overall Study|Lack of Efficacy|4|||
150103642|NCT00735371|541523075|FG000|Overall Study|Sponsor Decision|3|||
150103643|NCT00735371|541523076|FG001|Overall Study|Sponsor Decision|1|||
150103644|NCT00735371|541523077|FG002|Overall Study|Sponsor Decision|0|||
150103645|NCT00735371|541523078|FG003|Overall Study|Sponsor Decision|1|||
150103646|NCT00735371|541523075|FG000|Overall Study|Protocol Violation|0|||
150103647|NCT00735371|541523076|FG001|Overall Study|Protocol Violation|1|||
150103648|NCT00735371|541523077|FG002|Overall Study|Protocol Violation|2|||
150103649|NCT00735371|541523078|FG003|Overall Study|Protocol Violation|0|||
150103650|NCT00735371|541523075|FG000|Overall Study|Prior Vyvanse Exposure|1|||
150103651|NCT00735371|541523076|FG001|Overall Study|Prior Vyvanse Exposure|1|||
150103652|NCT00735371|541523077|FG002|Overall Study|Prior Vyvanse Exposure|0|||
150103653|NCT00735371|541523078|FG003|Overall Study|Prior Vyvanse Exposure|0|||
150103654|NCT00735371|541523075|FG000|Overall Study|Exclusion criteria|1|||
150103655|NCT00735371|541523076|FG001|Overall Study|Exclusion criteria|0|||
150103656|NCT00735371|541523077|FG002|Overall Study|Exclusion criteria|0|||
150103657|NCT00735371|541523078|FG003|Overall Study|Exclusion criteria|0|||
150103658|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
150103659|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
150103660|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
150103661|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
150103662|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
150103663|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
150103664|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
150103665|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
150103666|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
150103667|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
150103668|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
150103669|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
150103670|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
150103671|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
150103672|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
150103673|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Death|5|||
150103674|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Death|0|||
150103675|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Death|2|||
150103676|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Death|0|||
150103677|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Death|4|||
150103678|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
150103679|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
150103680|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
150103681|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
150103682|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
150103683|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
150103684|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
150103685|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
150103686|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
150103687|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
150103688|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
150103689|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
150103690|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
150103691|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
150103692|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
150103693|NCT01604343|541523079|FG000|Prior to W52 Administration(Through W52)|Other|15|||
150103694|NCT01604343|541523080|FG001|Prior to W52 Administration(Through W52)|Other|0|||
150103695|NCT01604343|541523081|FG002|Prior to W52 Administration(Through W52)|Other|10|||
150103696|NCT01604343|541523082|FG003|Prior to W52 Administration(Through W52)|Other|0|||
150103697|NCT01604343|541523083|FG004|Prior to W52 Administration(Through W52)|Other|6|||
150103698|NCT01604343|541523079|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
150103699|NCT01604343|541523080|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
150103700|NCT01604343|541523081|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
150103701|NCT01604343|541523082|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
150103702|NCT01604343|541523083|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
150103703|NCT01604343|541523079|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
150103704|NCT01604343|541523080|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
150103705|NCT01604343|541523081|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
150103706|NCT01604343|541523082|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
150103707|NCT01604343|541523083|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
150103708|NCT01604343|541523079|FG000|Week 52 to Week 104|Adverse Event|0|||
150103709|NCT01604343|541523080|FG001|Week 52 to Week 104|Adverse Event|12|||
150103710|NCT01604343|541523081|FG002|Week 52 to Week 104|Adverse Event|26|||
150185953|NCT04402489|541820399|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
150185954|NCT04402489|541820400|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
150185955|NCT04402489|541820401|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
150185956|NCT04402489|541820397|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
150185957|NCT04402489|541820398|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
150185958|NCT04402489|541820399|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
150185959|NCT04402489|541820400|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
150185960|NCT04402489|541820401|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
150185961|NCT04402489|541820397|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
150185962|NCT04402489|541820398|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
150185963|NCT04402489|541820399|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
150185964|NCT04402489|541820400|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
150185965|NCT04402489|541820401|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
150185966|NCT05418296|541820408|FG000|Overall Study|Withdrawal by Subject|4|||
150185967|NCT05418296|541820409|FG001|Overall Study|Withdrawal by Subject|1|||
150185968|NCT02682316|541820410|FG000|Overall Study|Benign Final Pathology|27|||
150185969|NCT02682316|541820411|FG001|Overall Study|Benign Final Pathology|26|||
150185970|NCT02682316|541820410|FG000|Overall Study|Reoperation before 30 days|7|||
150185971|NCT02682316|541820411|FG001|Overall Study|Reoperation before 30 days|6|||
150185972|NCT02682316|541820410|FG000|Overall Study|Ineligible|1|||
150185973|NCT02682316|541820411|FG001|Overall Study|Ineligible|0|||
150185974|NCT02682316|541820410|FG000|Overall Study|Death|1|||
150103711|NCT01604343|541523082|FG003|Week 52 to Week 104|Adverse Event|21|||
150103712|NCT01604343|541523083|FG004|Week 52 to Week 104|Adverse Event|27|||
150103713|NCT01604343|541523079|FG000|Week 52 to Week 104|Death|0|||
150103714|NCT01604343|541523080|FG001|Week 52 to Week 104|Death|4|||
150103715|NCT01604343|541523081|FG002|Week 52 to Week 104|Death|2|||
150103716|NCT01604343|541523082|FG003|Week 52 to Week 104|Death|5|||
150103717|NCT01604343|541523083|FG004|Week 52 to Week 104|Death|0|||
150103718|NCT01604343|541523079|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
150103719|NCT01604343|541523080|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
150103720|NCT01604343|541523081|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
150103721|NCT01604343|541523082|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
150103722|NCT01604343|541523083|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
150103723|NCT01604343|541523079|FG000|Week 52 to Week 104|Physician Decision|0|||
150103724|NCT01604343|541523080|FG001|Week 52 to Week 104|Physician Decision|1|||
150103725|NCT01604343|541523081|FG002|Week 52 to Week 104|Physician Decision|0|||
150103726|NCT01604343|541523082|FG003|Week 52 to Week 104|Physician Decision|0|||
150103727|NCT01604343|541523083|FG004|Week 52 to Week 104|Physician Decision|2|||
150103728|NCT01604343|541523079|FG000|Week 52 to Week 104|Pregnancy|0|||
150103729|NCT01604343|541523080|FG001|Week 52 to Week 104|Pregnancy|0|||
150103730|NCT01604343|541523081|FG002|Week 52 to Week 104|Pregnancy|1|||
150103731|NCT01604343|541523082|FG003|Week 52 to Week 104|Pregnancy|2|||
150103732|NCT01604343|541523083|FG004|Week 52 to Week 104|Pregnancy|1|||
150103733|NCT01604343|541523079|FG000|Week 52 to Week 104|Other|0|||
150103734|NCT01604343|541523080|FG001|Week 52 to Week 104|Other|11|||
150103735|NCT01604343|541523081|FG002|Week 52 to Week 104|Other|11|||
150103736|NCT01604343|541523082|FG003|Week 52 to Week 104|Other|6|||
150103737|NCT01604343|541523083|FG004|Week 52 to Week 104|Other|3|||
150103738|NCT01604343|541523079|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
150103739|NCT01604343|541523080|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
150103740|NCT01604343|541523081|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
150103741|NCT01604343|541523082|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
150103742|NCT01604343|541523083|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
150103743|NCT01604343|541523079|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
150103744|NCT01604343|541523080|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
150103745|NCT01604343|541523081|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
150103746|NCT01604343|541523082|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
150103747|NCT01604343|541523083|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
150103748|NCT01604343|541523079|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
150103749|NCT01604343|541523080|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
150103750|NCT01604343|541523081|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
150103751|NCT01604343|541523082|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
150103752|NCT01604343|541523083|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
150103753|NCT00850200|541523084|FG000|Overall Study|Physician Decision|2|||
150103754|NCT00850200|541523084|FG000|Overall Study|Did not recieve treatment|2|||
150103755|NCT00850200|541523084|FG000|Overall Study|Withdrawal by Subject|1|||
150103756|NCT00097721|541523085|FG000|Overall Study|Adverse Event|8|||
150103757|NCT00097721|541523086|FG001|Overall Study|Adverse Event|1|||
150103758|NCT00097721|541523085|FG000|Overall Study|Withdrawal by Subject|6|||
150103759|NCT00097721|541523086|FG001|Overall Study|Withdrawal by Subject|1|||
150103760|NCT00097721|541523085|FG000|Overall Study|Progressive Disease|55|||
150103761|NCT00097721|541523086|FG001|Overall Study|Progressive Disease|27|||
150103762|NCT00097721|541523085|FG000|Overall Study|Physician Decision|1|||
150103763|NCT00097721|541523086|FG001|Overall Study|Physician Decision|3|||
150103764|NCT00097721|541523085|FG000|Overall Study|Reason not given|1|||
150103765|NCT00097721|541523086|FG001|Overall Study|Reason not given|1|||
150103766|NCT02346136|541523092|FG000|Overall Study|Withdrawal by Subject|7|||
150103767|NCT02346136|541523093|FG001|Overall Study|Withdrawal by Subject|5|||
150103768|NCT02346136|541523092|FG000|Overall Study|Death|1|||
150103769|NCT02346136|541523093|FG001|Overall Study|Death|0|||
150103770|NCT02346136|541523092|FG000|Overall Study|Study termination|14|||
150103771|NCT02346136|541523093|FG001|Overall Study|Study termination|18|||
150103772|NCT02308735|541523094|FG000|Overall Study|Physician Decision|2|||
150103773|NCT02308735|541523095|FG001|Overall Study|Physician Decision|0|||
150103774|NCT02308735|541523096|FG002|Overall Study|Physician Decision|0|||
150103775|NCT02308735|541523097|FG003|Overall Study|Physician Decision|2|||
150103776|NCT01417481|541523109|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
150103777|NCT01417481|541523110|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
150103778|NCT00829296|541523116|FG000|Overall Study|Adverse Event|5|||
150103779|NCT00829296|541523117|FG001|Overall Study|Adverse Event|4|||
150103780|NCT01907828|541523118|FG000|Overall Study|Exclusion criteria not met|0|||
150103781|NCT01907828|541523119|FG001|Overall Study|Exclusion criteria not met|1|||
150103782|NCT01907828|541523118|FG000|Overall Study|Withdrawal by Subject|3|||
150103783|NCT01907828|541523119|FG001|Overall Study|Withdrawal by Subject|4|||
150103784|NCT01907828|541523118|FG000|Overall Study|Lost to Follow-up|3|||
150103785|NCT01907828|541523119|FG001|Overall Study|Lost to Follow-up|0|||
150103786|NCT01907828|541523118|FG000|Overall Study|Participant refused 24-month follow-up|1|||
150103787|NCT01907828|541523119|FG001|Overall Study|Participant refused 24-month follow-up|0|||
150103788|NCT01907828|541523118|FG000|Overall Study|Participant met exclusion criteria|0|||
150103789|NCT01907828|541523119|FG001|Overall Study|Participant met exclusion criteria|1|||
150103790|NCT04960228|541523124|FG000|Overall Study|Withdrawal by Subject|216|||
150103791|NCT04960228|541523125|FG001|Overall Study|Withdrawal by Subject|35|||
150103792|NCT04960228|541523124|FG000|Overall Study|Failed attention check|69|||
150103793|NCT04960228|541523125|FG001|Overall Study|Failed attention check|148|||
150103794|NCT04960228|541523124|FG000|Overall Study|Flagged for response quality by Dynata|3|||
150103795|NCT04960228|541523125|FG001|Overall Study|Flagged for response quality by Dynata|3|||
150103796|NCT03029624|541523126|FG000|Overall Study|Adverse Event|1|||
150103797|NCT03029624|541523126|FG000|Overall Study|Withdrawal by Subject|1|||
150103798|NCT03029624|541523126|FG000|Overall Study|Lack of Efficacy|1|||
150103799|NCT03029624|541523126|FG000|Overall Study|MRI need|2|||
150103800|NCT01364428|541523127|FG000|Overall Study|Adverse Event|1|||
150103801|NCT01364428|541523128|FG001|Overall Study|Adverse Event|2|||
150103802|NCT01364428|541523127|FG000|Overall Study|Protocol Violation|2|||
150103803|NCT01364428|541523128|FG001|Overall Study|Protocol Violation|0|||
150103804|NCT01364428|541523127|FG000|Overall Study|Withdrawal Criteria|14|||
150103805|NCT01364428|541523128|FG001|Overall Study|Withdrawal Criteria|10|||
150103806|NCT01364428|541523127|FG000|Overall Study|Other|3|||
150103807|NCT01364428|541523128|FG001|Overall Study|Other|3|||
150103808|NCT01987427|541523129|FG000|Overall Study|Adverse Event|4|||
150103809|NCT01987427|541523130|FG001|Overall Study|Adverse Event|2|||
150103810|NCT01987427|541523131|FG002|Overall Study|Adverse Event|8|||
150103811|NCT01987427|541523129|FG000|Overall Study|Lost to Follow-up|6|||
150103812|NCT01987427|541523130|FG001|Overall Study|Lost to Follow-up|6|||
150103813|NCT01987427|541523131|FG002|Overall Study|Lost to Follow-up|9|||
150103814|NCT01987427|541523129|FG000|Overall Study|Withdrawal by Subject|2|||
150103815|NCT01987427|541523130|FG001|Overall Study|Withdrawal by Subject|1|||
150103816|NCT01987427|541523131|FG002|Overall Study|Withdrawal by Subject|3|||
150103817|NCT01987427|541523129|FG000|Overall Study|Lack of Efficacy|1|||
150103818|NCT01987427|541523130|FG001|Overall Study|Lack of Efficacy|0|||
150103819|NCT01987427|541523131|FG002|Overall Study|Lack of Efficacy|0|||
150103820|NCT01987427|541523129|FG000|Overall Study|Other|1|||
150103821|NCT01987427|541523130|FG001|Overall Study|Other|1|||
150103822|NCT01987427|541523131|FG002|Overall Study|Other|0|||
150103823|NCT02547129|541523132|FG000|Overall Study|Difficulty with ongoing infection|1|||
150103824|NCT02547129|541523133|FG001|Overall Study|Difficulty with ongoing infection|0|||
150103825|NCT03925324|541523134|FG000|Overall Study|Death|1|||
150103826|NCT03925324|541523135|FG001|Overall Study|Death|1|||
150103827|NCT00794196|541523137|FG000|Overall Study|Lost to Follow-up|5|||
150103828|NCT00794196|541523138|FG001|Overall Study|Lost to Follow-up|23|||
150103829|NCT04414553|541523139|FG000|Overall Study|Lost to Follow-up|20|||
150103830|NCT02129803|541523143|FG000|Overall Study|Protocol Violation|4|||
150103831|NCT02129803|541523144|FG001|Overall Study|Protocol Violation|0|||
150103832|NCT02129803|541523143|FG000|Overall Study|Physician Decision|0|||
150103833|NCT02129803|541523144|FG001|Overall Study|Physician Decision|1|||
150103834|NCT02129803|541523143|FG000|Overall Study|Difficulty sleeping|1|||
150103835|NCT02129803|541523144|FG001|Overall Study|Difficulty sleeping|0|||
150103836|NCT02129803|541523143|FG000|Overall Study|Morning headache|0|||
150103837|NCT02129803|541523144|FG001|Overall Study|Morning headache|1|||
150103838|NCT02129803|541523143|FG000|Overall Study|Withdrawal by Subject|1|||
150103839|NCT02129803|541523144|FG001|Overall Study|Withdrawal by Subject|1|||
150103840|NCT02689258|541523145|FG000|Overall Study|Subject Non-Compliance|0|||
150103841|NCT02689258|541523146|FG001|Overall Study|Subject Non-Compliance|1|||
150103842|NCT02689258|541523147|FG002|Overall Study|Subject Non-Compliance|0|||
150103843|NCT02689258|541523148|FG003|Overall Study|Subject Non-Compliance|0|||
150103844|NCT02689258|541523149|FG004|Overall Study|Subject Non-Compliance|0|||
150103845|NCT02689258|541523150|FG005|Overall Study|Subject Non-Compliance|0|||
150103846|NCT02689258|541523151|FG006|Overall Study|Subject Non-Compliance|0|||
150103847|NCT02689258|541523152|FG007|Overall Study|Subject Non-Compliance|0|||
150103848|NCT02689258|541523153|FG008|Overall Study|Subject Non-Compliance|0|||
150103849|NCT02689258|541523154|FG009|Overall Study|Subject Non-Compliance|0|||
150103850|NCT02689258|541523155|FG010|Overall Study|Subject Non-Compliance|0|||
150103851|NCT02689258|541523156|FG011|Overall Study|Subject Non-Compliance|0|||
150103852|NCT02689258|541523145|FG000|Overall Study|Subject Refusal to Continue|0|||
150103853|NCT02689258|541523146|FG001|Overall Study|Subject Refusal to Continue|1|||
150103854|NCT02689258|541523147|FG002|Overall Study|Subject Refusal to Continue|0|||
150185975|NCT02682316|541820411|FG001|Overall Study|Death|0|||
150103855|NCT02689258|541523148|FG003|Overall Study|Subject Refusal to Continue|0|||
150103856|NCT02689258|541523149|FG004|Overall Study|Subject Refusal to Continue|0|||
150103857|NCT02689258|541523150|FG005|Overall Study|Subject Refusal to Continue|0|||
150103858|NCT02689258|541523151|FG006|Overall Study|Subject Refusal to Continue|0|||
150103859|NCT02689258|541523152|FG007|Overall Study|Subject Refusal to Continue|0|||
150103860|NCT02689258|541523153|FG008|Overall Study|Subject Refusal to Continue|1|||
150103861|NCT02689258|541523154|FG009|Overall Study|Subject Refusal to Continue|0|||
150185976|NCT02682316|541820410|FG000|Overall Study|Lost to Follow-up|7|||
150103862|NCT02689258|541523155|FG010|Overall Study|Subject Refusal to Continue|0|||
150103863|NCT02689258|541523156|FG011|Overall Study|Subject Refusal to Continue|1|||
150185977|NCT02682316|541820411|FG001|Overall Study|Lost to Follow-up|3|||
150103864|NCT02689258|541523145|FG000|Overall Study|Other|0|||
150103865|NCT02689258|541523146|FG001|Overall Study|Other|2|||
150103866|NCT02689258|541523147|FG002|Overall Study|Other|0|||
150103867|NCT02689258|541523148|FG003|Overall Study|Other|0|||
150103868|NCT02689258|541523149|FG004|Overall Study|Other|1|||
150103869|NCT02689258|541523150|FG005|Overall Study|Other|0|||
150103870|NCT02689258|541523151|FG006|Overall Study|Other|0|||
150103871|NCT02689258|541523152|FG007|Overall Study|Other|0|||
150103872|NCT02689258|541523153|FG008|Overall Study|Other|1|||
150103873|NCT02689258|541523154|FG009|Overall Study|Other|0|||
150103874|NCT02689258|541523155|FG010|Overall Study|Other|0|||
150103875|NCT02689258|541523156|FG011|Overall Study|Other|0|||
150103876|NCT04753164|541523158|FG000|Overall Study|Adverse Event|0|||
150103877|NCT04753164|541523159|FG001|Overall Study|Adverse Event|2|||
150103878|NCT04753164|541523158|FG000|Overall Study|Withdrawal by Subject|9|||
150103879|NCT04753164|541523159|FG001|Overall Study|Withdrawal by Subject|7|||
150103880|NCT04753164|541523158|FG000|Overall Study|Lost to Follow-up|6|||
150103881|NCT04753164|541523159|FG001|Overall Study|Lost to Follow-up|6|||
150103882|NCT04753164|541523158|FG000|Overall Study|Other|12|||
150103883|NCT04753164|541523159|FG001|Overall Study|Other|5|||
150103884|NCT01465464|541523161|FG000|Overall Study|Adverse Event|96|||
150103885|NCT01465464|541523162|FG001|Overall Study|Adverse Event|49|||
150103886|NCT01465464|541523161|FG000|Overall Study|Lack of Efficacy|139|||
150103887|NCT01465464|541523162|FG001|Overall Study|Lack of Efficacy|190|||
150103888|NCT01465464|541523161|FG000|Overall Study|Physician Decision|13|||
150103889|NCT01465464|541523162|FG001|Overall Study|Physician Decision|5|||
150103890|NCT01465464|541523161|FG000|Overall Study|Protocol Violation|1|||
150103891|NCT01465464|541523162|FG001|Overall Study|Protocol Violation|1|||
150103892|NCT01465464|541523161|FG000|Overall Study|Withdrawal by Subject|46|||
150103893|NCT01465464|541523162|FG001|Overall Study|Withdrawal by Subject|30|||
150103894|NCT01465464|541523161|FG000|Overall Study|Other|9|||
150103895|NCT01465464|541523162|FG001|Overall Study|Other|3|||
150103896|NCT01465464|541523161|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
150103897|NCT01465464|541523162|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
150103898|NCT00785486|541523168|FG000|Midazolam Alone|Withdrawal by Subject|1|||
150103899|NCT00775437|541523169|FG000|Overall Study|Loss of efficacy|2|||
150103900|NCT00775437|541523169|FG000|Overall Study|Withdrawal by Subject|3|||
150103901|NCT00775437|541523169|FG000|Overall Study|Lost to Follow-up|1|||
150103902|NCT04371380|541523170|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
150103903|NCT04371380|541523171|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
150103904|NCT04371380|541523172|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
150103905|NCT01132495|541523173|FG000|Overall Study|Various reasons|40|||
150103906|NCT01132495|541523174|FG001|Overall Study|Various reasons|38|||
150103907|NCT01132495|541523175|FG002|Overall Study|Various reasons|20|||
150103908|NCT01132495|541523176|FG003|Overall Study|Various reasons|12|||
150103909|NCT02276612|541523177|FG000|Overall Study|Death|1|||
150103910|NCT02276612|541523178|FG001|Overall Study|Death|0|||
150103911|NCT02276612|541523177|FG000|Overall Study|Pregnancy|1|||
150103912|NCT02276612|541523178|FG001|Overall Study|Pregnancy|0|||
150103913|NCT02276612|541523177|FG000|Overall Study|Withdrew Consent|1|||
150103914|NCT02276612|541523178|FG001|Overall Study|Withdrew Consent|0|||
150103915|NCT02276612|541523177|FG000|Overall Study|Lost to Follow-up|1|||
150103916|NCT02276612|541523178|FG001|Overall Study|Lost to Follow-up|0|||
150103917|NCT01077804|541523182|FG000|Overall Study|Unreachable|102|||
150103918|NCT01077804|541523182|FG000|Overall Study|Refused to continue|79|||
150103919|NCT01077804|541523182|FG000|Overall Study|Other|18|||
150103920|NCT02620046|541523183|FG000|Overall Study|Adverse Event|22|||
150103921|NCT02620046|541523184|FG001|Overall Study|Adverse Event|42|||
150103922|NCT02620046|541523183|FG000|Overall Study|Lost to Follow-up|4|||
150103923|NCT02620046|541523184|FG001|Overall Study|Lost to Follow-up|10|||
150103924|NCT02620046|541523183|FG000|Overall Study|Withdrawal by Subject|36|||
150103925|NCT02620046|541523184|FG001|Overall Study|Withdrawal by Subject|66|||
150103926|NCT02620046|541523183|FG000|Overall Study|Site Termination|3|||
150103927|NCT02620046|541523184|FG001|Overall Study|Site Termination|3|||
150103928|NCT02620046|541523183|FG000|Overall Study|Pregnancy|3|||
150103929|NCT02620046|541523184|FG001|Overall Study|Pregnancy|7|||
150103930|NCT02620046|541523183|FG000|Overall Study|Lack of Efficacy|81|||
150103931|NCT02620046|541523184|FG001|Overall Study|Lack of Efficacy|146|||
150103932|NCT02620046|541523183|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
150103933|NCT02620046|541523184|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
150103934|NCT02620046|541523183|FG000|Overall Study|Reason Not Specified|13|||
150103935|NCT02620046|541523184|FG001|Overall Study|Reason Not Specified|21|||
150103936|NCT02620046|541523183|FG000|Overall Study|Significant Protocol Deviation|0|||
150103937|NCT02620046|541523184|FG001|Overall Study|Significant Protocol Deviation|1|||
150103938|NCT00403273|541524860|FG000|Overall Study|Lost to Follow-up|3|||
150103939|NCT00403273|541524861|FG001|Overall Study|Lost to Follow-up|2|||
150103940|NCT00403273|541524860|FG000|Overall Study|Physician Decision|0|||
150103941|NCT00403273|541524861|FG001|Overall Study|Physician Decision|1|||
150103942|NCT00403273|541524860|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
150103943|NCT00403273|541524861|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
150103944|NCT01336738|541524863|FG000|Overall Study|Adverse Event|0|||
150103945|NCT01336738|541524864|FG001|Overall Study|Adverse Event|3|||
150103946|NCT01336738|541524865|FG002|Overall Study|Adverse Event|2|||
150103947|NCT01336738|541524866|FG003|Overall Study|Adverse Event|1|||
150103948|NCT01336738|541524867|FG004|Overall Study|Adverse Event|3|||
150103949|NCT01336738|541524863|FG000|Overall Study|Lost to Follow-up|2|||
150103950|NCT01336738|541524864|FG001|Overall Study|Lost to Follow-up|1|||
150103951|NCT01336738|541524865|FG002|Overall Study|Lost to Follow-up|2|||
150103952|NCT01336738|541524866|FG003|Overall Study|Lost to Follow-up|2|||
150103953|NCT01336738|541524867|FG004|Overall Study|Lost to Follow-up|2|||
150103954|NCT01336738|541524863|FG000|Overall Study|Did not meet entrance criteria|0|||
150103955|NCT01336738|541524864|FG001|Overall Study|Did not meet entrance criteria|1|||
150103956|NCT01336738|541524865|FG002|Overall Study|Did not meet entrance criteria|0|||
150103957|NCT01336738|541524866|FG003|Overall Study|Did not meet entrance criteria|0|||
150103958|NCT01336738|541524867|FG004|Overall Study|Did not meet entrance criteria|0|||
150103959|NCT01336738|541524863|FG000|Overall Study|Protocol Violation|0|||
150103960|NCT01336738|541524864|FG001|Overall Study|Protocol Violation|1|||
150103961|NCT01336738|541524865|FG002|Overall Study|Protocol Violation|0|||
150103962|NCT01336738|541524866|FG003|Overall Study|Protocol Violation|0|||
150103963|NCT01336738|541524867|FG004|Overall Study|Protocol Violation|0|||
150103964|NCT01336738|541524863|FG000|Overall Study|Withdrawal by Subject|2|||
150103965|NCT01336738|541524864|FG001|Overall Study|Withdrawal by Subject|0|||
150103966|NCT01336738|541524865|FG002|Overall Study|Withdrawal by Subject|2|||
150103967|NCT01336738|541524866|FG003|Overall Study|Withdrawal by Subject|1|||
150103968|NCT01336738|541524867|FG004|Overall Study|Withdrawal by Subject|1|||
150103969|NCT01336738|541524863|FG000|Overall Study|Other|3|||
150103970|NCT01336738|541524864|FG001|Overall Study|Other|3|||
150103971|NCT01336738|541524865|FG002|Overall Study|Other|2|||
150103972|NCT01336738|541524866|FG003|Overall Study|Other|3|||
150103973|NCT01336738|541524867|FG004|Overall Study|Other|4|||
150103974|NCT01083433|541524868|FG000|Overall Study|Lost to Follow-up|2|||
150103975|NCT01083433|541524869|FG001|Overall Study|Lost to Follow-up|1|||
150103976|NCT01083433|541524870|FG002|Overall Study|Lost to Follow-up|1|||
150103977|NCT01083433|541524868|FG000|Overall Study|Withdrawal by Subject|0|||
150103978|NCT01083433|541524869|FG001|Overall Study|Withdrawal by Subject|5|||
150103979|NCT01083433|541524870|FG002|Overall Study|Withdrawal by Subject|3|||
150103980|NCT01083433|541524868|FG000|Overall Study|Pregnancy|0|||
150103981|NCT01083433|541524869|FG001|Overall Study|Pregnancy|0|||
150103982|NCT01083433|541524870|FG002|Overall Study|Pregnancy|1|||
150103983|NCT03003520|541524872|FG000|Overall Study|Adverse Event|9|||
150103984|NCT03003520|541524873|FG001|Overall Study|Adverse Event|0|||
150103985|NCT03003520|541524872|FG000|Overall Study|Death|1|||
150103986|NCT03003520|541524873|FG001|Overall Study|Death|0|||
150103987|NCT03003520|541524872|FG000|Overall Study|Other reasons|4|||
150103988|NCT03003520|541524873|FG001|Overall Study|Other reasons|0|||
150103989|NCT03003520|541524872|FG000|Overall Study|Withdrawal by Subject|6|||
150103990|NCT03003520|541524873|FG001|Overall Study|Withdrawal by Subject|0|||
150103991|NCT03003520|541524872|FG000|Overall Study|Progressive disease|9|||
150103992|NCT03003520|541524873|FG001|Overall Study|Progressive disease|1|||
150103993|NCT01332149|541524874|FG000|Overall Study|Adverse Event|11|||
150103994|NCT01332149|541524875|FG001|Overall Study|Adverse Event|9|||
150103995|NCT01332149|541524874|FG000|Overall Study|Other unspecified|5|||
150103996|NCT01332149|541524875|FG001|Overall Study|Other unspecified|7|||
150103997|NCT01332149|541524874|FG000|Overall Study|Protocol Violation|1|||
150103998|NCT01332149|541524875|FG001|Overall Study|Protocol Violation|3|||
150103999|NCT01332149|541524874|FG000|Overall Study|Withdrawal by Subject|4|||
150104000|NCT01332149|541524875|FG001|Overall Study|Withdrawal by Subject|5|||
150104001|NCT01332149|541524874|FG000|Overall Study|Lost to Follow-up|1|||
150104002|NCT01332149|541524875|FG001|Overall Study|Lost to Follow-up|1|||
150104003|NCT01332149|541524874|FG000|Overall Study|Insufficient clinical response|4|||
150104004|NCT01332149|541524875|FG001|Overall Study|Insufficient clinical response|7|||
150104005|NCT01332149|541524874|FG000|Overall Study|Did not meet entrance criteria|3|||
150104006|NCT01332149|541524875|FG001|Overall Study|Did not meet entrance criteria|4|||
150104007|NCT01332149|541524874|FG000|Overall Study|Randomized but not treated|1|||
150104008|NCT01332149|541524875|FG001|Overall Study|Randomized but not treated|2|||
150104009|NCT04982029|541524876|FG000|Overall Study|Lost to Follow-up|2|||
150104010|NCT04982029|541524877|FG001|Overall Study|Lost to Follow-up|3|||
150104011|NCT03264404|541524878|FG000|Overall Study|Death|2|||
150104012|NCT03264404|541524878|FG000|Overall Study|Physician Decision|1|||
150104013|NCT03264404|541524878|FG000|Overall Study|Disease Progression|28|||
150104014|NCT03264404|541524878|FG000|Overall Study|Adverse Event|1|||
150104015|NCT03264404|541524878|FG000|Overall Study|Off study prior to treatment|2|||
150104016|NCT04615949|541524879|FG000|Overall Study|Withdrawal by Subject|2|||
150104017|NCT04615949|541524880|FG001|Overall Study|Withdrawal by Subject|4|||
150104018|NCT04615949|541524879|FG000|Overall Study|Lost to Follow-up|2|||
150104019|NCT04615949|541524880|FG001|Overall Study|Lost to Follow-up|2|||
150104020|NCT04615949|541524879|FG000|Overall Study|Death|0|||
150104021|NCT04615949|541524880|FG001|Overall Study|Death|2|||
150104022|NCT03036566|541524881|FG000|Overall Study|Lost to Follow-up|3|||
150104023|NCT05458856|541524882|FG000|Overall Study|Withdrawal by Subject|5|||
150104024|NCT05458856|541524882|FG000|Overall Study|Death|4|||
150104025|NCT05458856|541524882|FG000|Overall Study|Protocol Deviation|3|||
150104026|NCT05458856|541524882|FG000|Overall Study|Physician Decision|1|||
150104027|NCT01852292|541524883|FG000|Overall Study|Untreated - did not receive study drug|3|||
150104028|NCT01852292|541524884|FG001|Overall Study|Untreated - did not receive study drug|1|||
150104029|NCT01852292|541524883|FG000|Overall Study|Death|9|||
150104030|NCT01852292|541524884|FG001|Overall Study|Death|8|||
150104031|NCT01852292|541524883|FG000|Overall Study|Patient/guardian decision|8|||
150104032|NCT01852292|541524884|FG001|Overall Study|Patient/guardian decision|4|||
150104033|NCT01852292|541524883|FG000|Overall Study|Adverse Event|8|||
150104034|NCT01852292|541524884|FG001|Overall Study|Adverse Event|11|||
150104035|NCT01852292|541524883|FG000|Overall Study|Physician Decision|6|||
150104036|NCT01852292|541524884|FG001|Overall Study|Physician Decision|2|||
150104037|NCT01852292|541524883|FG000|Overall Study|Protocol Violation|2|||
150104038|NCT01852292|541524884|FG001|Overall Study|Protocol Violation|0|||
150104039|NCT01852292|541524883|FG000|Overall Study|Non-compliance with study treatment|1|||
150104040|NCT01852292|541524884|FG001|Overall Study|Non-compliance with study treatment|0|||
150104041|NCT01852292|541524883|FG000|Overall Study|Study terminated by Sponsor|0|||
150104042|NCT01852292|541524884|FG001|Overall Study|Study terminated by Sponsor|1|||
150104043|NCT01852292|541524883|FG000|Overall Study|Progressive disease|42|||
150104044|NCT01852292|541524884|FG001|Overall Study|Progressive disease|52|||
150104045|NCT02388737|541524886|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
150104046|NCT02388737|541524887|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
150104047|NCT02388737|541524888|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
150104048|NCT02388737|541524886|FG000|Overall Study|Major Protocol Deviation|18|||
150104049|NCT02388737|541524887|FG001|Overall Study|Major Protocol Deviation|25|||
150104050|NCT02388737|541524888|FG002|Overall Study|Major Protocol Deviation|22|||
150104051|NCT02388737|541524886|FG000|Overall Study|Lost to Follow-up|5|||
150104052|NCT02388737|541524887|FG001|Overall Study|Lost to Follow-up|1|||
150104053|NCT02388737|541524888|FG002|Overall Study|Lost to Follow-up|4|||
150104054|NCT02388737|541524886|FG000|Overall Study|Voluntary Withdrawal|10|||
150104055|NCT02388737|541524887|FG001|Overall Study|Voluntary Withdrawal|18|||
150104056|NCT02388737|541524888|FG002|Overall Study|Voluntary Withdrawal|17|||
150104057|NCT02388737|541524886|FG000|Overall Study|Lack of Efficacy|3|||
150104058|NCT02388737|541524887|FG001|Overall Study|Lack of Efficacy|0|||
150104059|NCT02388737|541524888|FG002|Overall Study|Lack of Efficacy|3|||
150104060|NCT02388737|541524886|FG000|Overall Study|Reason Not Specified|5|||
150104061|NCT02388737|541524887|FG001|Overall Study|Reason Not Specified|5|||
150104062|NCT02388737|541524888|FG002|Overall Study|Reason Not Specified|4|||
150104063|NCT01888497|541524889|FG000|Washout Period 1|Withdrawal by Subject|0|||
150104064|NCT01888497|541524890|FG001|Washout Period 1|Withdrawal by Subject|0|||
150104065|NCT01888497|541524891|FG002|Washout Period 1|Withdrawal by Subject|1|||
150104066|NCT01888497|541524892|FG003|Washout Period 1|Withdrawal by Subject|1|||
150104067|NCT01888497|541524889|FG000|Washout Period 2|Adverse Event|0|||
150104068|NCT01888497|541524890|FG001|Washout Period 2|Adverse Event|0|||
150104069|NCT01888497|541524891|FG002|Washout Period 2|Adverse Event|0|||
150104070|NCT01888497|541524892|FG003|Washout Period 2|Adverse Event|1|||
150104071|NCT01888497|541524889|FG000|Washout Period 2|Withdrawal by Subject|0|||
150104072|NCT01888497|541524890|FG001|Washout Period 2|Withdrawal by Subject|0|||
150104073|NCT01888497|541524891|FG002|Washout Period 2|Withdrawal by Subject|0|||
150104074|NCT01888497|541524892|FG003|Washout Period 2|Withdrawal by Subject|1|||
150104075|NCT04152447|541524893|FG000|Overall Study|Lost to Follow-up|1|||
150104076|NCT04152447|541524894|FG001|Overall Study|Lost to Follow-up|0|||
150104077|NCT04152447|541524893|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
150104078|NCT04152447|541524894|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
150104079|NCT04152447|541524893|FG000|Overall Study|Withdrawal by Subject|0|||
150104080|NCT04152447|541524894|FG001|Overall Study|Withdrawal by Subject|1|||
150104081|NCT04152447|541524893|FG000|Overall Study|Found ineligible after enrolling|1|||
150104082|NCT04152447|541524894|FG001|Overall Study|Found ineligible after enrolling|1|||
150104083|NCT04152447|541524893|FG000|Overall Study|Did not receive VR headset in time.|0|||
150104084|NCT04152447|541524894|FG001|Overall Study|Did not receive VR headset in time.|2|||
150104085|NCT04013191|541524895|FG000|Overall Study|Adverse Event|1|||
150104086|NCT04013191|541524896|FG001|Overall Study|Adverse Event|0|||
150104087|NCT03711162|541524905|FG000|Overall Study|Adverse Event|5|||
150104088|NCT03711162|541524906|FG001|Overall Study|Adverse Event|2|||
150104089|NCT03711162|541524907|FG002|Overall Study|Adverse Event|4|||
150104090|NCT03711162|541524905|FG000|Overall Study|Death|11|||
150104091|NCT03711162|541524906|FG001|Overall Study|Death|7|||
150104092|NCT03711162|541524907|FG002|Overall Study|Death|8|||
150104093|NCT03711162|541524905|FG000|Overall Study|Lost to Follow-up|1|||
150104094|NCT03711162|541524906|FG001|Overall Study|Lost to Follow-up|0|||
150104095|NCT03711162|541524907|FG002|Overall Study|Lost to Follow-up|1|||
150104096|NCT03711162|541524905|FG000|Overall Study|Study Terminated by Sponsor|139|||
150104097|NCT03711162|541524906|FG001|Overall Study|Study Terminated by Sponsor|152|||
150104098|NCT03711162|541524907|FG002|Overall Study|Study Terminated by Sponsor|146|||
150104099|NCT03711162|541524905|FG000|Overall Study|Withdrawal by Subject|17|||
150104100|NCT03711162|541524906|FG001|Overall Study|Withdrawal by Subject|10|||
150104101|NCT03711162|541524907|FG002|Overall Study|Withdrawal by Subject|10|||
150104102|NCT03711162|541524905|FG000|Overall Study|Miscellaneous|1|||
150104103|NCT03711162|541524906|FG001|Overall Study|Miscellaneous|2|||
150104104|NCT03711162|541524907|FG002|Overall Study|Miscellaneous|2|||
150104105|NCT03711162|541524905|FG000|Overall Study|Not Treated|1|||
150104106|NCT03711162|541524906|FG001|Overall Study|Not Treated|0|||
150104107|NCT03711162|541524907|FG002|Overall Study|Not Treated|1|||
150104108|NCT03711162|541524905|FG000|Overall Study|Physician Decision|0|||
150104109|NCT03711162|541524906|FG001|Overall Study|Physician Decision|2|||
150104110|NCT03711162|541524907|FG002|Overall Study|Physician Decision|0|||
150104111|NCT03711162|541524905|FG000|Overall Study|Lack of Efficacy|0|||
150104112|NCT03711162|541524906|FG001|Overall Study|Lack of Efficacy|0|||
150104113|NCT03711162|541524907|FG002|Overall Study|Lack of Efficacy|2|||
150104114|NCT03711162|541524905|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
150104115|NCT03711162|541524906|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
150104116|NCT03711162|541524907|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
150104117|NCT03034954|541524908|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
150104118|NCT03034954|541524909|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
150104119|NCT01275066|541524914|FG000|Overall Study|Withdrawal by Subject|0|||
150104120|NCT01275066|541524915|FG001|Overall Study|Withdrawal by Subject|0|||
150104121|NCT01275066|541524916|FG002|Overall Study|Withdrawal by Subject|1|||
150104122|NCT01275066|541524914|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
150104123|NCT01275066|541524915|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
150104124|NCT01275066|541524916|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
150104125|NCT01344369|541524917|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
150104126|NCT01344369|541524918|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
150104127|NCT01344369|541524917|FG000|Washout of 28 Days|Physician Decision|0|||
150104128|NCT01344369|541524918|FG001|Washout of 28 Days|Physician Decision|1|||
150104129|NCT01344369|541524917|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
150104130|NCT01344369|541524918|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
150104131|NCT01886833|541524919|FG000|Overall Study|IgA not available from both periods|204|||
150104132|NCT02342704|541524922|FG000|Overall Study|Physician Decision|0|||
150104133|NCT02342704|541524923|FG001|Overall Study|Physician Decision|3|||
150104134|NCT02342704|541524922|FG000|Overall Study|Sponsor Termination|49|||
150104135|NCT02342704|541524923|FG001|Overall Study|Sponsor Termination|43|||
150104136|NCT02342704|541524922|FG000|Overall Study|Other|0|||
150104137|NCT02342704|541524923|FG001|Overall Study|Other|1|||
150104138|NCT02342704|541524922|FG000|Overall Study|Withdrawal by Subject|1|||
150104139|NCT02342704|541524923|FG001|Overall Study|Withdrawal by Subject|0|||
150104140|NCT02342704|541524922|FG000|Overall Study|Lost to Follow-up|2|||
150104141|NCT02342704|541524923|FG001|Overall Study|Lost to Follow-up|1|||
150104142|NCT02342704|541524922|FG000|Overall Study|Adverse Event|1|||
150104143|NCT02342704|541524923|FG001|Overall Study|Adverse Event|3|||
150104144|NCT02871375|541524928|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
150104145|NCT02871375|541524929|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
150104146|NCT04327999|541524934|FG000|Overall Study|Protocol Violation|1|||
150104147|NCT02872116|541524937|FG000|Pre-Treatment|Disease Progression|0|||
150104148|NCT02872116|541524938|FG001|Pre-Treatment|Disease Progression|1|||
150104149|NCT02872116|541524939|FG002|Pre-Treatment|Disease Progression|0|||
150104150|NCT02872116|541524937|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
150104151|NCT02872116|541524938|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
150104152|NCT02872116|541524939|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
150104153|NCT02872116|541524937|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
150104154|NCT02872116|541524938|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
150104155|NCT02872116|541524939|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
150104156|NCT02872116|541524937|FG000|Pre-Treatment|Participant withdrew consent|2|||
150104157|NCT02872116|541524938|FG001|Pre-Treatment|Participant withdrew consent|20|||
150104158|NCT02872116|541524939|FG002|Pre-Treatment|Participant withdrew consent|3|||
150104159|NCT02872116|541524937|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
150104160|NCT02872116|541524938|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
150104161|NCT02872116|541524939|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
150104162|NCT02872116|541524937|FG000|Pre-Treatment|Other reasons|1|||
150104163|NCT02872116|541524938|FG001|Pre-Treatment|Other reasons|2|||
150104164|NCT02872116|541524939|FG002|Pre-Treatment|Other reasons|2|||
150104165|NCT02872116|541524937|FG000|Treatment|Death|121|||
150104166|NCT02872116|541524938|FG001|Treatment|Death|94|||
150104167|NCT02872116|541524939|FG002|Treatment|Death|68|||
150104168|NCT02872116|541524937|FG000|Treatment|Lost to Follow-up|5|||
150104169|NCT02872116|541524938|FG001|Treatment|Lost to Follow-up|7|||
150104170|NCT02872116|541524939|FG002|Treatment|Lost to Follow-up|3|||
150104171|NCT02872116|541524937|FG000|Treatment|Participant withdrew consent|20|||
150104172|NCT02872116|541524938|FG001|Treatment|Participant withdrew consent|40|||
150104173|NCT02872116|541524939|FG002|Treatment|Participant withdrew consent|8|||
150104174|NCT02872116|541524937|FG000|Treatment|Other reasons|13|||
150104175|NCT02872116|541524938|FG001|Treatment|Other reasons|12|||
150104176|NCT02872116|541524939|FG002|Treatment|Other reasons|5|||
150104177|NCT02319031|541524942|FG000|Treatment Period|Death|1|||
150104178|NCT02319031|541524943|FG001|Treatment Period|Death|0|||
150104179|NCT00696137|541524953|FG000|Overall Study|Withdrawal by Subject|2|||
150104180|NCT01183975|541524958|FG000|Overall Study|Lost to Follow-up|73|||
150104181|NCT03316885|541524959|FG000|Overall Study|Adverse Event|1|||
150104182|NCT03316885|541524959|FG000|Overall Study|Death|10|||
150104183|NCT03316885|541524959|FG000|Overall Study|Lost to Follow-up|4|||
150104184|NCT03316885|541524959|FG000|Overall Study|Withdrawal by Subject|9|||
150104185|NCT03316885|541524959|FG000|Overall Study|COVID related|8|||
150104186|NCT04180020|541524962|FG000|Overall Study|missed visit|18|||
150104187|NCT04180020|541524963|FG001|Overall Study|missed visit|16|||
150104188|NCT04180020|541524962|FG000|Overall Study|Death|2|||
150104189|NCT04180020|541524963|FG001|Overall Study|Death|3|||
150104190|NCT04180020|541524962|FG000|Overall Study|Withdrawal by Subject|1|||
150104191|NCT04180020|541524963|FG001|Overall Study|Withdrawal by Subject|5|||
150104192|NCT04180020|541524962|FG000|Overall Study|incarcerated|1|||
150104193|NCT04180020|541524963|FG001|Overall Study|incarcerated|1|||
150104194|NCT04180020|541524962|FG000|Overall Study|Physician Decision|0|||
150104195|NCT04180020|541524963|FG001|Overall Study|Physician Decision|2|||
150104196|NCT01640366|541524967|FG000|Overall Study|Withdrawal by Subject|1|||
150104197|NCT01640366|541524967|FG000|Overall Study|Protocol Violation|16|||
150104198|NCT01640366|541524967|FG000|Overall Study|Lost to Follow-up|5|||
150104199|NCT02739269|541524968|FG000|Overall Study|Protocol Violation|5|||
150104200|NCT02739269|541524969|FG001|Overall Study|Protocol Violation|0|||
150104201|NCT02739269|541524968|FG000|Overall Study|Cycle cancellation|2|||
150104202|NCT02739269|541524969|FG001|Overall Study|Cycle cancellation|2|||
150104203|NCT02739269|541524968|FG000|Overall Study|Withdrawal by Subject|0|||
150104204|NCT02739269|541524969|FG001|Overall Study|Withdrawal by Subject|2|||
150104205|NCT02244580|541524970|FG000|Overall Study|No cancer tissues available|241|||
150104206|NCT00405548|541524973|FG000|Overall Study|Cognitive Memory problems on study day|1|||
150104207|NCT00405548|541524974|FG001|Overall Study|Cognitive Memory problems on study day|0|||
150104208|NCT00405548|541524973|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
150104209|NCT00405548|541524974|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
150104210|NCT00405548|541524973|FG000|Overall Study|Unable to self-administer shots|1|||
150104211|NCT00405548|541524974|FG001|Overall Study|Unable to self-administer shots|0|||
150104212|NCT00405548|541524973|FG000|Overall Study|Venous access failed during study day|1|||
150104213|NCT00405548|541524974|FG001|Overall Study|Venous access failed during study day|0|||
150104214|NCT00405548|541524973|FG000|Overall Study|Withdrawal by Subject|1|||
150104215|NCT00405548|541524974|FG001|Overall Study|Withdrawal by Subject|0|||
150104216|NCT01228747|541524975|FG000|Overall Study|Adverse Event|8|||
150104217|NCT01228747|541524976|FG001|Overall Study|Adverse Event|4|||
150104218|NCT01228747|541524975|FG000|Overall Study|Lack of Efficacy|40|||
150104219|NCT01228747|541524976|FG001|Overall Study|Lack of Efficacy|27|||
150104220|NCT01228747|541524975|FG000|Overall Study|Protocol Violation|6|||
150104221|NCT01228747|541524976|FG001|Overall Study|Protocol Violation|5|||
150104222|NCT01228747|541524975|FG000|Overall Study|Lost to Follow-up|4|||
150104223|NCT01228747|541524976|FG001|Overall Study|Lost to Follow-up|3|||
150104224|NCT01228747|541524975|FG000|Overall Study|Withdrawal by Subject|5|||
150104225|NCT01228747|541524976|FG001|Overall Study|Withdrawal by Subject|1|||
150104226|NCT01228747|541524975|FG000|Overall Study|Other Reason|2|||
150104227|NCT01228747|541524976|FG001|Overall Study|Other Reason|5|||
150104228|NCT02036502|541524977|FG000|Part 1:Dose Determination/Escalation|Death|3|||
150104229|NCT02036502|541524978|FG001|Part 1:Dose Determination/Escalation|Death|2|||
150104230|NCT02036502|541524979|FG002|Part 1:Dose Determination/Escalation|Death|0|||
150104231|NCT02036502|541524980|FG003|Part 1:Dose Determination/Escalation|Death|0|||
150104232|NCT02036502|541524981|FG004|Part 1:Dose Determination/Escalation|Death|0|||
150104233|NCT02036502|541524982|FG005|Part 1:Dose Determination/Escalation|Death|0|||
150104234|NCT02036502|541524983|FG006|Part 1:Dose Determination/Escalation|Death|0|||
150104235|NCT02036502|541524984|FG007|Part 1:Dose Determination/Escalation|Death|0|||
150104236|NCT02036502|541524977|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
150104237|NCT02036502|541524978|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104238|NCT02036502|541524979|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104239|NCT02036502|541524980|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104240|NCT02036502|541524981|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104241|NCT02036502|541524982|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104242|NCT02036502|541524983|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104243|NCT02036502|541524984|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
150104244|NCT02036502|541524977|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104245|NCT02036502|541524978|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
150104246|NCT02036502|541524979|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104247|NCT02036502|541524980|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104248|NCT02036502|541524981|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104249|NCT02036502|541524982|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104250|NCT02036502|541524983|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104251|NCT02036502|541524984|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
150104252|NCT02036502|541524977|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
150104253|NCT02036502|541524978|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
150104254|NCT02036502|541524979|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
150104255|NCT02036502|541524980|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
150104256|NCT02036502|541524981|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
150104257|NCT02036502|541524982|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
150104258|NCT02036502|541524983|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
150104259|NCT02036502|541524984|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
150104260|NCT02036502|541524977|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
150104261|NCT02036502|541524978|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
150104262|NCT02036502|541524979|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
150104263|NCT02036502|541524980|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
150104264|NCT02036502|541524981|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
150104265|NCT02036502|541524982|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
150104266|NCT02036502|541524983|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
150104267|NCT02036502|541524984|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
150104268|NCT02036502|541524977|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104269|NCT02036502|541524978|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104270|NCT02036502|541524979|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
150104271|NCT02036502|541524980|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104272|NCT02036502|541524981|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104273|NCT02036502|541524982|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104274|NCT02036502|541524983|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104275|NCT02036502|541524984|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
150104276|NCT02036502|541524977|FG000|Part 2:Dose Confirmation|Death|0|||
150104277|NCT02036502|541524978|FG001|Part 2:Dose Confirmation|Death|0|||
150104278|NCT02036502|541524979|FG002|Part 2:Dose Confirmation|Death|1|||
150104279|NCT02036502|541524980|FG003|Part 2:Dose Confirmation|Death|0|||
150104280|NCT02036502|541524981|FG004|Part 2:Dose Confirmation|Death|0|||
150104281|NCT02036502|541524982|FG005|Part 2:Dose Confirmation|Death|0|||
150104282|NCT02036502|541524983|FG006|Part 2:Dose Confirmation|Death|0|||
150104283|NCT02036502|541524984|FG007|Part 2:Dose Confirmation|Death|0|||
150104284|NCT02036502|541524977|FG000|Part 2:Dose Confirmation|Not treated|0|||
150104285|NCT02036502|541524978|FG001|Part 2:Dose Confirmation|Not treated|0|||
150104286|NCT02036502|541524979|FG002|Part 2:Dose Confirmation|Not treated|0|||
150104287|NCT02036502|541524980|FG003|Part 2:Dose Confirmation|Not treated|1|||
150104288|NCT02036502|541524981|FG004|Part 2:Dose Confirmation|Not treated|0|||
150104289|NCT02036502|541524982|FG005|Part 2:Dose Confirmation|Not treated|0|||
150104290|NCT02036502|541524983|FG006|Part 2:Dose Confirmation|Not treated|0|||
150104291|NCT02036502|541524984|FG007|Part 2:Dose Confirmation|Not treated|0|||
150104292|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Adverse Event|0|||
150104293|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Adverse Event|0|||
150104294|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Adverse Event|0|||
150104295|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Adverse Event|0|||
150104296|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Adverse Event|0|||
150104297|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Adverse Event|4|||
150104298|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Adverse Event|0|||
150104299|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Adverse Event|2|||
150104300|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Death|0|||
150104301|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Death|0|||
150104302|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Death|0|||
150104303|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Death|0|||
150104304|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Death|0|||
150104305|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Death|24|||
150104306|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Death|0|||
150104307|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Death|3|||
150104308|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104309|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104310|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
150185978|NCT04630262|541820412|FG000|Overall Study|Intraoperative Screen Failure|5|||
150104311|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104312|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104313|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104314|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
150104315|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
150104316|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Physician Decision|0|||
150104317|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Physician Decision|0|||
150104318|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Physician Decision|0|||
150104319|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Physician Decision|0|||
150104320|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Physician Decision|0|||
150104321|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Physician Decision|1|||
150104322|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Physician Decision|0|||
150104323|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Physician Decision|0|||
150104324|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
150104325|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
150104326|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
150104327|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
150104328|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
150104329|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
150104330|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
150104331|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
150104332|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104333|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104334|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104335|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104336|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104337|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
150104338|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
150104339|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
150104340|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
150104341|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
150104342|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
150104343|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
150104344|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
150104345|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
150104346|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
150104347|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
150104348|NCT02036502|541524977|FG000|Part 3:Dose Expansion|Not Treated|0|||
150104349|NCT02036502|541524978|FG001|Part 3:Dose Expansion|Not Treated|0|||
150104350|NCT02036502|541524979|FG002|Part 3:Dose Expansion|Not Treated|0|||
150104351|NCT02036502|541524980|FG003|Part 3:Dose Expansion|Not Treated|0|||
150104352|NCT02036502|541524981|FG004|Part 3:Dose Expansion|Not Treated|0|||
150104353|NCT02036502|541524982|FG005|Part 3:Dose Expansion|Not Treated|2|||
150104354|NCT02036502|541524983|FG006|Part 3:Dose Expansion|Not Treated|0|||
150104355|NCT02036502|541524984|FG007|Part 3:Dose Expansion|Not Treated|0|||
150104356|NCT00811577|541524988|FG000|Overall Study|Lost to Follow-up|7|||
150104357|NCT00811577|541524989|FG001|Overall Study|Lost to Follow-up|1|||
150104358|NCT00811577|541524988|FG000|Overall Study|Withdrawal by Subject|3|||
150104359|NCT00811577|541524989|FG001|Overall Study|Withdrawal by Subject|0|||
150104360|NCT04251221|541524990|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
150104361|NCT04251221|541524991|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
150104362|NCT02357940|541524992|FG000|Overall Study|Adverse Event|0|||
150104363|NCT02357940|541524993|FG001|Overall Study|Adverse Event|1|||
150104364|NCT02357940|541524992|FG000|Overall Study|Investigator's judgement|0|||
150104365|NCT02357940|541524993|FG001|Overall Study|Investigator's judgement|1|||
150104366|NCT02442778|541524994|FG000|Overall Study|Adverse Event|2|||
150104367|NCT02442778|541524995|FG001|Overall Study|Adverse Event|6|||
150104368|NCT02442778|541524996|FG002|Overall Study|Adverse Event|6|||
150104369|NCT02442778|541524994|FG000|Overall Study|Death|0|||
150104370|NCT02442778|541524995|FG001|Overall Study|Death|2|||
150104371|NCT02442778|541524996|FG002|Overall Study|Death|0|||
150104372|NCT02442778|541524994|FG000|Overall Study|Lack of Efficacy|1|||
150185979|NCT04630262|541820412|FG000|Overall Study|Study terminated prematurely|71|||
150185980|NCT04630262|541820412|FG000|Overall Study|Withdrawal by Subject|2|||
150185981|NCT04630262|541820412|FG000|Overall Study|Physician Decision|2|||
150104373|NCT02442778|541524995|FG001|Overall Study|Lack of Efficacy|0|||
150104374|NCT02442778|541524996|FG002|Overall Study|Lack of Efficacy|0|||
150104375|NCT02442778|541524994|FG000|Overall Study|Lost to Follow-up|1|||
150185982|NCT01195831|541820413|FG000|Overall Study|Lost to Follow-up|2|||
150185983|NCT01195831|541820414|FG001|Overall Study|Lost to Follow-up|4|||
150104376|NCT02442778|541524995|FG001|Overall Study|Lost to Follow-up|1|||
150104377|NCT02442778|541524996|FG002|Overall Study|Lost to Follow-up|1|||
150104378|NCT02442778|541524994|FG000|Overall Study|Non-compliance with study drug|2|||
150104379|NCT02442778|541524995|FG001|Overall Study|Non-compliance with study drug|0|||
150104380|NCT02442778|541524996|FG002|Overall Study|Non-compliance with study drug|1|||
150104381|NCT02442778|541524994|FG000|Overall Study|Physician Decision|1|||
150104382|NCT02442778|541524995|FG001|Overall Study|Physician Decision|1|||
150104383|NCT02442778|541524996|FG002|Overall Study|Physician Decision|1|||
150104384|NCT02442778|541524994|FG000|Overall Study|Protocol Deviation|3|||
150104385|NCT02442778|541524995|FG001|Overall Study|Protocol Deviation|0|||
150104386|NCT02442778|541524996|FG002|Overall Study|Protocol Deviation|1|||
150104387|NCT02442778|541524994|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
150104388|NCT02442778|541524995|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
150104389|NCT02442778|541524996|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
150104390|NCT02442778|541524994|FG000|Overall Study|Withdrawal by Subject|4|||
150104391|NCT02442778|541524995|FG001|Overall Study|Withdrawal by Subject|4|||
150104392|NCT02442778|541524996|FG002|Overall Study|Withdrawal by Subject|3|||
150104393|NCT02442778|541524994|FG000|Overall Study|Reason not specified|1|||
150104394|NCT02442778|541524995|FG001|Overall Study|Reason not specified|4|||
150104395|NCT02442778|541524996|FG002|Overall Study|Reason not specified|0|||
150104396|NCT02641379|541524999|FG000|Overall Study|Exclusion criterion during screening|1|||
150104397|NCT02641379|541525000|FG001|Overall Study|Exclusion criterion during screening|0|||
150104398|NCT02641379|541525001|FG002|Overall Study|Exclusion criterion during screening|0|||
150104399|NCT02641379|541525002|FG003|Overall Study|Exclusion criterion during screening|1|||
150104400|NCT02641379|541525003|FG004|Overall Study|Exclusion criterion during screening|2|||
150104401|NCT02641379|541525004|FG005|Overall Study|Exclusion criterion during screening|0|||
150104402|NCT02641379|541525005|FG006|Overall Study|Exclusion criterion during screening|0|||
150104403|NCT02641379|541525006|FG007|Overall Study|Exclusion criterion during screening|0|||
150104404|NCT02641379|541525007|FG008|Overall Study|Exclusion criterion during screening|0|||
150104405|NCT02641379|541525008|FG009|Overall Study|Exclusion criterion during screening|0|||
150104406|NCT02641379|541525009|FG010|Overall Study|Exclusion criterion during screening|0|||
150104407|NCT02641379|541524999|FG000|Overall Study|Withdrawal of informed consent|0|||
150104408|NCT02641379|541525000|FG001|Overall Study|Withdrawal of informed consent|1|||
150104409|NCT02641379|541525001|FG002|Overall Study|Withdrawal of informed consent|0|||
150104410|NCT02641379|541525002|FG003|Overall Study|Withdrawal of informed consent|0|||
150104411|NCT02641379|541525003|FG004|Overall Study|Withdrawal of informed consent|0|||
150104412|NCT02641379|541525004|FG005|Overall Study|Withdrawal of informed consent|0|||
150104413|NCT02641379|541525005|FG006|Overall Study|Withdrawal of informed consent|0|||
150104414|NCT02641379|541525006|FG007|Overall Study|Withdrawal of informed consent|1|||
150104415|NCT02641379|541525007|FG008|Overall Study|Withdrawal of informed consent|0|||
150104416|NCT02641379|541525008|FG009|Overall Study|Withdrawal of informed consent|0|||
150104417|NCT02641379|541525009|FG010|Overall Study|Withdrawal of informed consent|0|||
150104418|NCT02641379|541524999|FG000|Overall Study|Adverse Event|7|||
150104419|NCT02641379|541525000|FG001|Overall Study|Adverse Event|8|||
150104420|NCT02641379|541525001|FG002|Overall Study|Adverse Event|2|||
150104421|NCT02641379|541525002|FG003|Overall Study|Adverse Event|2|||
150104422|NCT02641379|541525003|FG004|Overall Study|Adverse Event|5|||
150104423|NCT02641379|541525004|FG005|Overall Study|Adverse Event|1|||
150104424|NCT02641379|541525005|FG006|Overall Study|Adverse Event|5|||
150104425|NCT02641379|541525006|FG007|Overall Study|Adverse Event|0|||
150104426|NCT02641379|541525007|FG008|Overall Study|Adverse Event|1|||
150104427|NCT02641379|541525008|FG009|Overall Study|Adverse Event|1|||
150104428|NCT02641379|541525009|FG010|Overall Study|Adverse Event|5|||
150104429|NCT02641379|541524999|FG000|Overall Study|Lack of Efficacy|0|||
150104430|NCT02641379|541525000|FG001|Overall Study|Lack of Efficacy|0|||
150104431|NCT02641379|541525001|FG002|Overall Study|Lack of Efficacy|2|||
150104432|NCT02641379|541525002|FG003|Overall Study|Lack of Efficacy|0|||
150104433|NCT02641379|541525003|FG004|Overall Study|Lack of Efficacy|0|||
150104434|NCT02641379|541525004|FG005|Overall Study|Lack of Efficacy|2|||
150104435|NCT02641379|541525005|FG006|Overall Study|Lack of Efficacy|0|||
150104436|NCT02641379|541525006|FG007|Overall Study|Lack of Efficacy|5|||
150104437|NCT02641379|541525007|FG008|Overall Study|Lack of Efficacy|0|||
150104438|NCT02641379|541525008|FG009|Overall Study|Lack of Efficacy|0|||
150104439|NCT02641379|541525009|FG010|Overall Study|Lack of Efficacy|0|||
150104440|NCT02641379|541524999|FG000|Overall Study|Participant unable to attend study visit|4|||
150104441|NCT02641379|541525000|FG001|Overall Study|Participant unable to attend study visit|10|||
150104442|NCT02641379|541525001|FG002|Overall Study|Participant unable to attend study visit|1|||
150104443|NCT02641379|541525002|FG003|Overall Study|Participant unable to attend study visit|2|||
150104444|NCT02641379|541525003|FG004|Overall Study|Participant unable to attend study visit|5|||
150104445|NCT02641379|541525004|FG005|Overall Study|Participant unable to attend study visit|1|||
150104446|NCT02641379|541525005|FG006|Overall Study|Participant unable to attend study visit|1|||
150104447|NCT02641379|541525006|FG007|Overall Study|Participant unable to attend study visit|1|||
150104448|NCT02641379|541525007|FG008|Overall Study|Participant unable to attend study visit|0|||
150104449|NCT02641379|541525008|FG009|Overall Study|Participant unable to attend study visit|2|||
150104450|NCT02641379|541525009|FG010|Overall Study|Participant unable to attend study visit|0|||
150104451|NCT02641379|541524999|FG000|Overall Study|Participant's compliance|0|||
150104452|NCT02641379|541525000|FG001|Overall Study|Participant's compliance|1|||
150104453|NCT02641379|541525001|FG002|Overall Study|Participant's compliance|0|||
150104454|NCT02641379|541525002|FG003|Overall Study|Participant's compliance|1|||
150104455|NCT02641379|541525003|FG004|Overall Study|Participant's compliance|0|||
150104456|NCT02641379|541525004|FG005|Overall Study|Participant's compliance|2|||
150104457|NCT02641379|541525005|FG006|Overall Study|Participant's compliance|0|||
150104458|NCT02641379|541525006|FG007|Overall Study|Participant's compliance|0|||
150104459|NCT02641379|541525007|FG008|Overall Study|Participant's compliance|1|||
150104460|NCT02641379|541525008|FG009|Overall Study|Participant's compliance|1|||
150104461|NCT02641379|541525009|FG010|Overall Study|Participant's compliance|1|||
150185984|NCT01195831|541820413|FG000|Overall Study|Withdrawal by Subject|2|||
150185985|NCT01195831|541820414|FG001|Overall Study|Withdrawal by Subject|2|||
150185986|NCT01195831|541820413|FG000|Overall Study|Adverse Event|4|||
150185987|NCT01195831|541820414|FG001|Overall Study|Adverse Event|2|||
150185988|NCT01195831|541820413|FG000|Overall Study|Protocol Violation|0|||
150185989|NCT01195831|541820414|FG001|Overall Study|Protocol Violation|2|||
150185990|NCT04419168|541820415|FG000|Overall Study|Protocol Violation|1|||
150185991|NCT04419168|541820416|FG001|Overall Study|Protocol Violation|1|||
150185992|NCT04419168|541820415|FG000|Overall Study|Lost to Follow-up|7|||
150185993|NCT04419168|541820416|FG001|Overall Study|Lost to Follow-up|7|||
150185994|NCT04419168|541820415|FG000|Overall Study|Missed 6-month Visit|48|||
150185995|NCT04419168|541820416|FG001|Overall Study|Missed 6-month Visit|45|||
150185996|NCT03713086|541820420|FG000|Overall Study|Withdrawal by Subject|0|||
150185997|NCT03713086|541820421|FG001|Overall Study|Withdrawal by Subject|2|||
150185998|NCT03713086|541820422|FG002|Overall Study|Withdrawal by Subject|1|||
150185999|NCT03713086|541820423|FG003|Overall Study|Withdrawal by Subject|0|||
150186000|NCT03713086|541820420|FG000|Overall Study|Lost to Follow-up|0|||
150186001|NCT03713086|541820421|FG001|Overall Study|Lost to Follow-up|1|||
150186002|NCT03713086|541820422|FG002|Overall Study|Lost to Follow-up|0|||
150186003|NCT03713086|541820423|FG003|Overall Study|Lost to Follow-up|1|||
150186004|NCT05009251|541820424|FG000|Overall Study|Protocol Violation|100|||
150186005|NCT05009251|541820425|FG001|Overall Study|Protocol Violation|105|||
150186006|NCT05009251|541820426|FG002|Overall Study|Protocol Violation|119|||
150186007|NCT05009251|541820427|FG003|Overall Study|Protocol Violation|120|||
150186008|NCT05009251|541820428|FG004|Overall Study|Protocol Violation|119|||
150186009|NCT05009251|541820424|FG000|Overall Study|Death|25|||
150186010|NCT05009251|541820425|FG001|Overall Study|Death|22|||
150186011|NCT05009251|541820426|FG002|Overall Study|Death|24|||
150186012|NCT05009251|541820427|FG003|Overall Study|Death|19|||
150186013|NCT05009251|541820428|FG004|Overall Study|Death|15|||
150186014|NCT05374837|541820433|FG000|Overall Study|Lost to Follow-up|17|||
150186015|NCT05374837|541820434|FG001|Overall Study|Lost to Follow-up|18|||
150186016|NCT00676715|541820440|FG000|Treatment Period (TP)|Adverse Event|0|||
150186017|NCT00676715|541820441|FG001|Treatment Period (TP)|Adverse Event|3|||
150186018|NCT00676715|541820442|FG002|Treatment Period (TP)|Adverse Event|2|||
150186019|NCT00676715|541820443|FG003|Treatment Period (TP)|Adverse Event|2|||
150186020|NCT00676715|541820440|FG000|Treatment Period (TP)|Death|0|||
150186021|NCT00676715|541820441|FG001|Treatment Period (TP)|Death|0|||
150186022|NCT00676715|541820442|FG002|Treatment Period (TP)|Death|1|||
150186023|NCT00676715|541820443|FG003|Treatment Period (TP)|Death|0|||
150186024|NCT00676715|541820440|FG000|Treatment Period (TP)|Failure to return|1|||
150186025|NCT00676715|541820441|FG001|Treatment Period (TP)|Failure to return|0|||
150186026|NCT00676715|541820442|FG002|Treatment Period (TP)|Failure to return|0|||
150186027|NCT00676715|541820443|FG003|Treatment Period (TP)|Failure to return|0|||
150186028|NCT00676715|541820440|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
150186029|NCT00676715|541820441|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
150186030|NCT00676715|541820442|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
150186031|NCT00676715|541820443|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
150186032|NCT00676715|541820440|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
150186033|NCT00676715|541820441|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
150186034|NCT00676715|541820442|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
150186035|NCT00676715|541820443|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
150186036|NCT00676715|541820440|FG000|Treatment Period (TP)|Withdrew consent|3|||
150186037|NCT00676715|541820441|FG001|Treatment Period (TP)|Withdrew consent|3|||
150104462|NCT02641379|541524999|FG000|Overall Study|Participant cannot be reached|4|||
150104463|NCT02641379|541525000|FG001|Overall Study|Participant cannot be reached|4|||
150104464|NCT02641379|541525001|FG002|Overall Study|Participant cannot be reached|0|||
150186038|NCT00676715|541820442|FG002|Treatment Period (TP)|Withdrew consent|3|||
150186039|NCT00676715|541820443|FG003|Treatment Period (TP)|Withdrew consent|3|||
150186040|NCT00676715|541820440|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
150186041|NCT00676715|541820441|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
150186042|NCT00676715|541820442|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
150186043|NCT00676715|541820443|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
150186044|NCT00676715|541820440|FG000|Treatment Period (TP)|Administrative|0|||
150186045|NCT00676715|541820441|FG001|Treatment Period (TP)|Administrative|0|||
150186046|NCT00676715|541820442|FG002|Treatment Period (TP)|Administrative|0|||
150186047|NCT00676715|541820443|FG003|Treatment Period (TP)|Administrative|1|||
150186048|NCT00676715|541820440|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
150186049|NCT00676715|541820441|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
150186050|NCT00676715|541820442|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
150186051|NCT00676715|541820443|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
150186052|NCT00676715|541820440|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
150186053|NCT00676715|541820441|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
150186054|NCT00676715|541820442|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
150186055|NCT00676715|541820443|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
150186056|NCT00676715|541820440|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
150186057|NCT00676715|541820441|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
150186058|NCT00676715|541820442|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
150186059|NCT00676715|541820443|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
150186060|NCT00676715|541820440|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
150186061|NCT00676715|541820441|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
150186062|NCT00676715|541820442|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
150186063|NCT00676715|541820443|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
150186064|NCT00676715|541820440|FG000|Treatment-free Period (TFP)|Death|1|||
150186065|NCT00676715|541820441|FG001|Treatment-free Period (TFP)|Death|1|||
150186066|NCT00676715|541820442|FG002|Treatment-free Period (TFP)|Death|1|||
150186067|NCT00676715|541820443|FG003|Treatment-free Period (TFP)|Death|0|||
150186068|NCT00676715|541820440|FG000|Open Label Extension (OLE)|Reason not provided|3|||
150186069|NCT00676715|541820441|FG001|Open Label Extension (OLE)|Reason not provided|4|||
150186070|NCT00676715|541820442|FG002|Open Label Extension (OLE)|Reason not provided|1|||
150186071|NCT00676715|541820443|FG003|Open Label Extension (OLE)|Reason not provided|4|||
150186072|NCT00676715|541820440|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
150186073|NCT00676715|541820441|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
150186074|NCT00676715|541820442|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
150186075|NCT00676715|541820443|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
150186076|NCT00676715|541820440|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
150186077|NCT00676715|541820441|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
150186078|NCT00676715|541820442|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
150186079|NCT00676715|541820443|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
150186080|NCT00676715|541820440|FG000|Open Label Extension (OLE)|Adverse Event|0|||
150186081|NCT00676715|541820441|FG001|Open Label Extension (OLE)|Adverse Event|3|||
150186082|NCT00676715|541820442|FG002|Open Label Extension (OLE)|Adverse Event|1|||
150186083|NCT00676715|541820443|FG003|Open Label Extension (OLE)|Adverse Event|0|||
150186084|NCT00676715|541820440|FG000|Open Label Extension (OLE)|Death|2|||
150186085|NCT00676715|541820441|FG001|Open Label Extension (OLE)|Death|0|||
150186086|NCT00676715|541820442|FG002|Open Label Extension (OLE)|Death|2|||
150186087|NCT00676715|541820443|FG003|Open Label Extension (OLE)|Death|2|||
150186088|NCT04831281|541820447|FG000|Overall Study|Adverse Event|1|||
150186089|NCT04831281|541820448|FG001|Overall Study|Adverse Event|0|||
150186090|NCT04831281|541820449|FG002|Overall Study|Adverse Event|3|||
150186091|NCT04831281|541820447|FG000|Overall Study|Withdrawal by Subject|0|||
150186092|NCT04831281|541820448|FG001|Overall Study|Withdrawal by Subject|1|||
150186093|NCT04831281|541820449|FG002|Overall Study|Withdrawal by Subject|2|||
150186094|NCT04831281|541820447|FG000|Overall Study|Undetermined|1|||
150186095|NCT04831281|541820448|FG001|Overall Study|Undetermined|1|||
150186096|NCT04831281|541820449|FG002|Overall Study|Undetermined|0|||
150186097|NCT05249439|541820450|FG000|Overall Study|Withdrawal by Subject|2|||
150186098|NCT05249439|541820451|FG001|Overall Study|Withdrawal by Subject|5|||
150186099|NCT05249439|541820450|FG000|Overall Study|Physician Decision|3|||
150186100|NCT05249439|541820451|FG001|Overall Study|Physician Decision|1|||
150186101|NCT00616967|541820452|FG000|Overall Study|Withdrawal by Subject|0|||
150186102|NCT00616967|541820453|FG001|Overall Study|Withdrawal by Subject|0|||
150186103|NCT00616967|541820454|FG002|Overall Study|Withdrawal by Subject|1|||
150186104|NCT02910583|541820455|FG000|Overall Study|Death|7|||
150186105|NCT02910583|541820456|FG001|Overall Study|Death|3|||
150186106|NCT02910583|541820455|FG000|Overall Study|Lost to Follow-up|1|||
150186107|NCT02910583|541820456|FG001|Overall Study|Lost to Follow-up|0|||
150186108|NCT02910583|541820455|FG000|Overall Study|Withdrawal by Subject|12|||
150186109|NCT02910583|541820456|FG001|Overall Study|Withdrawal by Subject|8|||
150186110|NCT02910583|541820455|FG000|Overall Study|Other, Not Specified|6|||
150186111|NCT02910583|541820456|FG001|Overall Study|Other, Not Specified|3|||
150186112|NCT03161379|541820457|FG000|Overall Study|Withdrawal by Subject|4|||
150186113|NCT03161379|541820457|FG000|Overall Study|disease progression during chemotherapy|5|||
150186114|NCT03161379|541820457|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
150186115|NCT03161379|541820457|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
150186116|NCT05021640|541820459|FG000|Overall Study|Lost to Follow-up|0|||
150186117|NCT05021640|541820460|FG001|Overall Study|Lost to Follow-up|0|||
150186118|NCT05021640|541820461|FG002|Overall Study|Lost to Follow-up|0|||
150186119|NCT05021640|541820462|FG003|Overall Study|Lost to Follow-up|0|||
150186120|NCT05021640|541820463|FG004|Overall Study|Lost to Follow-up|1|||
150186121|NCT04088630|541820465|FG000|Overall Study|Lost to Follow-up|3|||
150186122|NCT04088630|541820466|FG001|Overall Study|Lost to Follow-up|2|||
150186123|NCT04088630|541820467|FG002|Overall Study|Lost to Follow-up|6|||
150186124|NCT04088630|541820465|FG000|Overall Study|Death|3|||
150186125|NCT04088630|541820466|FG001|Overall Study|Death|1|||
150186126|NCT04088630|541820467|FG002|Overall Study|Death|1|||
150186127|NCT04088630|541820465|FG000|Overall Study|Physician Decision|0|||
150186128|NCT04088630|541820466|FG001|Overall Study|Physician Decision|1|||
150186129|NCT04088630|541820467|FG002|Overall Study|Physician Decision|1|||
150186130|NCT03315754|541820468|FG000|Overall Study|COVID-19 complications leading to death|1|||
150186131|NCT03315754|541820468|FG000|Overall Study|insurance coverage issue|1|||
150186132|NCT02954341|541820469|FG000|Overall Study|Attempted Implant unsuccessful|5|||
150186133|NCT02954341|541820469|FG000|Overall Study|Death|90|||
150104465|NCT02641379|541525002|FG003|Overall Study|Participant cannot be reached|8|||
150104466|NCT02641379|541525003|FG004|Overall Study|Participant cannot be reached|2|||
150104467|NCT02641379|541525004|FG005|Overall Study|Participant cannot be reached|1|||
150104468|NCT02641379|541525005|FG006|Overall Study|Participant cannot be reached|0|||
150104469|NCT02641379|541525006|FG007|Overall Study|Participant cannot be reached|1|||
150104470|NCT02641379|541525007|FG008|Overall Study|Participant cannot be reached|0|||
150104471|NCT02641379|541525008|FG009|Overall Study|Participant cannot be reached|2|||
150104472|NCT02641379|541525009|FG010|Overall Study|Participant cannot be reached|1|||
150104473|NCT02641379|541524999|FG000|Overall Study|PCR positive at Week 24|15|||
150104474|NCT02641379|541525000|FG001|Overall Study|PCR positive at Week 24|21|||
150104475|NCT02641379|541525001|FG002|Overall Study|PCR positive at Week 24|62|||
150104476|NCT02641379|541525002|FG003|Overall Study|PCR positive at Week 24|0|||
150104477|NCT02641379|541525003|FG004|Overall Study|PCR positive at Week 24|0|||
150104478|NCT02641379|541525004|FG005|Overall Study|PCR positive at Week 24|6|||
150104479|NCT02641379|541525005|FG006|Overall Study|PCR positive at Week 24|3|||
150104480|NCT02641379|541525006|FG007|Overall Study|PCR positive at Week 24|8|||
150104481|NCT02641379|541525007|FG008|Overall Study|PCR positive at Week 24|0|||
150104482|NCT02641379|541525008|FG009|Overall Study|PCR positive at Week 24|1|||
150104483|NCT02641379|541525009|FG010|Overall Study|PCR positive at Week 24|0|||
150104484|NCT02641379|541524999|FG000|Overall Study|PCR positive at follow up 2|1|||
150104485|NCT02641379|541525000|FG001|Overall Study|PCR positive at follow up 2|0|||
150104486|NCT02641379|541525001|FG002|Overall Study|PCR positive at follow up 2|0|||
150104487|NCT02641379|541525002|FG003|Overall Study|PCR positive at follow up 2|0|||
150104488|NCT02641379|541525003|FG004|Overall Study|PCR positive at follow up 2|0|||
150104489|NCT02641379|541525004|FG005|Overall Study|PCR positive at follow up 2|0|||
150104490|NCT02641379|541525005|FG006|Overall Study|PCR positive at follow up 2|0|||
150104491|NCT02641379|541525006|FG007|Overall Study|PCR positive at follow up 2|0|||
150104492|NCT02641379|541525007|FG008|Overall Study|PCR positive at follow up 2|0|||
150104493|NCT02641379|541525008|FG009|Overall Study|PCR positive at follow up 2|0|||
150104494|NCT02641379|541525009|FG010|Overall Study|PCR positive at follow up 2|0|||
150104495|NCT02641379|541524999|FG000|Overall Study|Participant showed relapse|1|||
150104496|NCT02641379|541525000|FG001|Overall Study|Participant showed relapse|0|||
150104497|NCT02641379|541525001|FG002|Overall Study|Participant showed relapse|0|||
150104498|NCT02641379|541525002|FG003|Overall Study|Participant showed relapse|0|||
150104499|NCT02641379|541525003|FG004|Overall Study|Participant showed relapse|0|||
150104500|NCT02641379|541525004|FG005|Overall Study|Participant showed relapse|0|||
150104501|NCT02641379|541525005|FG006|Overall Study|Participant showed relapse|1|||
150104502|NCT02641379|541525006|FG007|Overall Study|Participant showed relapse|0|||
150104503|NCT02641379|541525007|FG008|Overall Study|Participant showed relapse|0|||
150104504|NCT02641379|541525008|FG009|Overall Study|Participant showed relapse|0|||
150104505|NCT02641379|541525009|FG010|Overall Study|Participant showed relapse|0|||
150104506|NCT02641379|541524999|FG000|Overall Study|Participant stopped study/treatment|1|||
150104507|NCT02641379|541525000|FG001|Overall Study|Participant stopped study/treatment|3|||
150104508|NCT02641379|541525001|FG002|Overall Study|Participant stopped study/treatment|1|||
150104509|NCT02641379|541525002|FG003|Overall Study|Participant stopped study/treatment|0|||
150104510|NCT02641379|541525003|FG004|Overall Study|Participant stopped study/treatment|0|||
150104511|NCT02641379|541525004|FG005|Overall Study|Participant stopped study/treatment|1|||
150104512|NCT02641379|541525005|FG006|Overall Study|Participant stopped study/treatment|2|||
150104513|NCT02641379|541525006|FG007|Overall Study|Participant stopped study/treatment|0|||
150104514|NCT02641379|541525007|FG008|Overall Study|Participant stopped study/treatment|1|||
150104515|NCT02641379|541525008|FG009|Overall Study|Participant stopped study/treatment|0|||
150104516|NCT02641379|541525009|FG010|Overall Study|Participant stopped study/treatment|0|||
150104517|NCT02641379|541524999|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
150186134|NCT02954341|541820469|FG000|Overall Study|Withdrawal by Subject|4|||
150186135|NCT02954341|541820469|FG000|Overall Study|Physician Decision|13|||
150186136|NCT02954341|541820469|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
150186137|NCT02954341|541820469|FG000|Overall Study|Not implanted due to physician's decision|1|||
150186138|NCT02954341|541820469|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
150186139|NCT04089371|541820473|FG000|Overall Study|Withdrawal by Subject|0|||
150186140|NCT04089371|541820474|FG001|Overall Study|Withdrawal by Subject|1|||
150186141|NCT04089371|541820473|FG000|Overall Study|Study terminated early|0|||
150186142|NCT04089371|541820474|FG001|Overall Study|Study terminated early|9|||
150186143|NCT05229120|541820475|FG000|Overall Study|Withdrawal by Subject|8|||
150186144|NCT03932682|541820478|FG000|Overall Study|Death|1|||
150186145|NCT03932682|541820479|FG001|Overall Study|Death|2|||
150186146|NCT03932682|541820478|FG000|Overall Study|Withdrawal by Subject|37|||
150186147|NCT03932682|541820479|FG001|Overall Study|Withdrawal by Subject|45|||
150186148|NCT03932682|541820478|FG000|Overall Study|Lost to Follow-up|19|||
150186149|NCT03932682|541820479|FG001|Overall Study|Lost to Follow-up|25|||
150186150|NCT03932682|541820478|FG000|Overall Study|Protocol Violation|0|||
150186151|NCT03932682|541820479|FG001|Overall Study|Protocol Violation|2|||
150186152|NCT03932682|541820478|FG000|Overall Study|Other|9|||
150186153|NCT03932682|541820479|FG001|Overall Study|Other|23|||
150186154|NCT00601900|541820480|FG000|Overall Study|Withdrawal by Subject|0|||
150186155|NCT00601900|541820481|FG001|Overall Study|Withdrawal by Subject|3|||
150186156|NCT04410042|541820482|FG000|Overall Study|Not Eligible|1|||
150186157|NCT04410042|541820483|FG001|Overall Study|Not Eligible|1|||
150186158|NCT01494662|541820484|FG000|Overall Study|Withdrawal by Subject|0|||
150186159|NCT01494662|541820485|FG001|Overall Study|Withdrawal by Subject|0|||
150186160|NCT01494662|541820486|FG002|Overall Study|Withdrawal by Subject|1|||
150186161|NCT01494662|541820487|FG003|Overall Study|Withdrawal by Subject|0|||
150186162|NCT01494662|541820488|FG004|Overall Study|Withdrawal by Subject|0|||
150186163|NCT01494662|541820489|FG005|Overall Study|Withdrawal by Subject|0|||
150186164|NCT01494662|541820490|FG006|Overall Study|Withdrawal by Subject|0|||
150104518|NCT02641379|541525000|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
150104519|NCT02641379|541525001|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
150104520|NCT02641379|541525002|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
150104521|NCT02641379|541525003|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
150104522|NCT02641379|541525004|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
150104523|NCT02641379|541525005|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
150104524|NCT02641379|541525006|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
150104525|NCT02641379|541525007|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
150104526|NCT02641379|541525008|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
150186165|NCT01494662|541820484|FG000|Overall Study|Physician Decision|0|||
150186166|NCT01494662|541820485|FG001|Overall Study|Physician Decision|0|||
150186167|NCT01494662|541820486|FG002|Overall Study|Physician Decision|1|||
150186168|NCT01494662|541820487|FG003|Overall Study|Physician Decision|0|||
150186169|NCT01494662|541820488|FG004|Overall Study|Physician Decision|0|||
150186170|NCT01494662|541820489|FG005|Overall Study|Physician Decision|0|||
150186171|NCT01494662|541820490|FG006|Overall Study|Physician Decision|0|||
150186172|NCT04072822|541820491|FG000|Treatment|Adverse Event|9|||
150186173|NCT04072822|541820492|FG001|Treatment|Adverse Event|5|||
150186174|NCT04072822|541820491|FG000|Treatment|Met Stopping Criteria|13|||
150186175|NCT04072822|541820492|FG001|Treatment|Met Stopping Criteria|24|||
150186176|NCT04072822|541820491|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
150186177|NCT04072822|541820492|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
150186178|NCT04072822|541820491|FG000|Treatment|Withdrawal by Subject|0|||
150186179|NCT04072822|541820492|FG001|Treatment|Withdrawal by Subject|2|||
150186180|NCT04072822|541820491|FG000|Treatment|Death|0|||
150186181|NCT04072822|541820492|FG001|Treatment|Death|2|||
150186182|NCT04072822|541820491|FG000|Treatment|Lost to Follow-up|11|||
150186183|NCT04072822|541820492|FG001|Treatment|Lost to Follow-up|3|||
150186184|NCT04072822|541820491|FG000|Treatment|Physician Decision|1|||
150186185|NCT04072822|541820492|FG001|Treatment|Physician Decision|0|||
150186186|NCT04072822|541820491|FG000|Treatment|Other|7|||
150186187|NCT04072822|541820492|FG001|Treatment|Other|9|||
150186188|NCT04072822|541820491|FG000|Follow-up|Withdrawal by Subject|1|||
150186189|NCT04072822|541820492|FG001|Follow-up|Withdrawal by Subject|0|||
150186190|NCT04072822|541820491|FG000|Follow-up|Lost to Follow-up|5|||
150186191|NCT04072822|541820492|FG001|Follow-up|Lost to Follow-up|4|||
150186192|NCT05268302|541820495|FG000|Overall Study|Death|0|||
150186193|NCT05268302|541820496|FG001|Overall Study|Death|1|||
150186194|NCT02811679|541820497|FG000|Overall Study|Adverse Event|1|||
150186195|NCT02811679|541820497|FG000|Overall Study|Lack of Efficacy|6|||
150186196|NCT02811679|541820497|FG000|Overall Study|Early study closure due to slow accrual|3|||
150104527|NCT02641379|541525009|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
150186197|NCT00753090|541822044|FG000|Overall Study|Withdrawal by Subject|10|||
150186198|NCT00753090|541822045|FG001|Overall Study|Withdrawal by Subject|10|||
150186199|NCT00753090|541822044|FG000|Overall Study|Death|17|||
150186200|NCT00753090|541822045|FG001|Overall Study|Death|6|||
150186201|NCT00753090|541822044|FG000|Overall Study|Study Prosthesis Removed|12|||
150104528|NCT02641379|541524999|FG000|Overall Study|Financial problems|0|||
150104529|NCT02641379|541525000|FG001|Overall Study|Financial problems|1|||
150104530|NCT02641379|541525001|FG002|Overall Study|Financial problems|0|||
150104531|NCT02641379|541525002|FG003|Overall Study|Financial problems|0|||
150104532|NCT02641379|541525003|FG004|Overall Study|Financial problems|0|||
150104533|NCT02641379|541525004|FG005|Overall Study|Financial problems|0|||
150104534|NCT02641379|541525005|FG006|Overall Study|Financial problems|0|||
150104535|NCT02641379|541525006|FG007|Overall Study|Financial problems|0|||
150104536|NCT02641379|541525007|FG008|Overall Study|Financial problems|0|||
150104537|NCT02641379|541525008|FG009|Overall Study|Financial problems|0|||
150104538|NCT02641379|541525009|FG010|Overall Study|Financial problems|0|||
150186202|NCT00753090|541822045|FG001|Overall Study|Study Prosthesis Removed|3|||
150186203|NCT00753090|541822044|FG000|Overall Study|Lost to Follow-up|2|||
150186204|NCT00753090|541822045|FG001|Overall Study|Lost to Follow-up|2|||
150186205|NCT00753090|541822044|FG000|Overall Study|Other|127|||
150186206|NCT00753090|541822045|FG001|Overall Study|Other|75|||
150186207|NCT05113966|541822048|FG000|Overall Study|Death|21|||
150186208|NCT05113966|541822048|FG000|Overall Study|Study Terminated by Sponsor|9|||
150186209|NCT03347383|541822054|FG000|Overall Study|Death|39|||
150186210|NCT03347383|541822054|FG000|Overall Study|Withdrawal by Subject|3|||
150186211|NCT03347383|541822054|FG000|Overall Study|Lost to Follow-up|9|||
150186212|NCT05691452|541822056|FG000|Overall Study|Withdrawal by Subject|1|||
150186213|NCT05691452|541822057|FG001|Overall Study|Withdrawal by Subject|1|||
150186214|NCT05691452|541822058|FG002|Overall Study|Withdrawal by Subject|0|||
150186215|NCT05691452|541822056|FG000|Overall Study|Physician Decision|1|||
150186216|NCT05691452|541822057|FG001|Overall Study|Physician Decision|0|||
150186217|NCT05691452|541822058|FG002|Overall Study|Physician Decision|0|||
150186218|NCT05691452|541822056|FG000|Overall Study|Lost to Follow-up|0|||
150186219|NCT05691452|541822057|FG001|Overall Study|Lost to Follow-up|0|||
150186220|NCT05691452|541822058|FG002|Overall Study|Lost to Follow-up|1|||
150186221|NCT05691452|541822056|FG000|Overall Study|Adverse Event|0|||
150186222|NCT05691452|541822057|FG001|Overall Study|Adverse Event|0|||
150186223|NCT05691452|541822058|FG002|Overall Study|Adverse Event|1|||
150186224|NCT05382936|541822076|FG000|Overall Study|Progressive Disease|3|||
150186225|NCT05382936|541822077|FG001|Overall Study|Progressive Disease|5|||
150186226|NCT05382936|541822078|FG002|Overall Study|Progressive Disease|2|||
150186227|NCT05382936|541822079|FG003|Overall Study|Progressive Disease|5|||
150186228|NCT05382936|541822076|FG000|Overall Study|Adverse Event|0|||
150186229|NCT05382936|541822077|FG001|Overall Study|Adverse Event|1|||
150186230|NCT05382936|541822078|FG002|Overall Study|Adverse Event|1|||
150186231|NCT05382936|541822079|FG003|Overall Study|Adverse Event|0|||
150186232|NCT05382936|541822076|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
150186233|NCT05382936|541822077|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
150186234|NCT05382936|541822078|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
150186235|NCT05382936|541822079|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
150186236|NCT05382936|541822076|FG000|Overall Study|Withdrawal by Subject|0|||
150186237|NCT05382936|541822077|FG001|Overall Study|Withdrawal by Subject|0|||
150186238|NCT05382936|541822078|FG002|Overall Study|Withdrawal by Subject|1|||
150186239|NCT05382936|541822079|FG003|Overall Study|Withdrawal by Subject|1|||
150186240|NCT03101904|541822082|FG000|Wash Out (10 Days)|Adverse Event|1|||
150186241|NCT03101904|541822083|FG001|Wash Out (10 Days)|Adverse Event|0|||
150186242|NCT03101904|541822082|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
150186243|NCT03101904|541822083|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
150186244|NCT04703322|541822085|FG000|Overall Study|Ongoing|8|||
150186245|NCT04703322|541822085|FG000|Overall Study|Withdrawal by Subject|1|||
150186246|NCT04638998|541822086|FG000|Overall Study|Withdrawal by Subject|1|||
150186247|NCT04638998|541822087|FG001|Overall Study|Withdrawal by Subject|3|||
150186248|NCT03988634|541822090|FG000|Double-Blind|Adverse Event|4|||
150186249|NCT03988634|541822091|FG001|Double-Blind|Adverse Event|0|||
150186250|NCT03988634|541822092|FG002|Double-Blind|Adverse Event|0|||
150186251|NCT03988634|541822090|FG000|Double-Blind|Death|18|||
150186252|NCT03988634|541822091|FG001|Double-Blind|Death|26|||
150186253|NCT03988634|541822092|FG002|Double-Blind|Death|0|||
150186254|NCT03988634|541822090|FG000|Double-Blind|Lost to Follow-up|6|||
150186255|NCT03988634|541822091|FG001|Double-Blind|Lost to Follow-up|7|||
150186256|NCT03988634|541822092|FG002|Double-Blind|Lost to Follow-up|0|||
150104539|NCT02641379|541524999|FG000|Overall Study|PCR positive at Week 68|0|||
150104540|NCT02641379|541525000|FG001|Overall Study|PCR positive at Week 68|1|||
150104541|NCT02641379|541525001|FG002|Overall Study|PCR positive at Week 68|0|||
150186257|NCT03988634|541822090|FG000|Double-Blind|Physician Decision|9|||
150186258|NCT03988634|541822091|FG001|Double-Blind|Physician Decision|5|||
150186259|NCT03988634|541822092|FG002|Double-Blind|Physician Decision|0|||
150186260|NCT03988634|541822090|FG000|Double-Blind|Subject decision|24|||
150186261|NCT03988634|541822091|FG001|Double-Blind|Subject decision|13|||
150186262|NCT03988634|541822092|FG002|Double-Blind|Subject decision|0|||
150186263|NCT03988634|541822090|FG000|Open-Label|Adverse Event|0|||
150186264|NCT03988634|541822091|FG001|Open-Label|Adverse Event|0|||
150186265|NCT03988634|541822092|FG002|Open-Label|Adverse Event|7|||
150186266|NCT03988634|541822090|FG000|Open-Label|Physician Decision|0|||
150104542|NCT02641379|541525002|FG003|Overall Study|PCR positive at Week 68|0|||
150104543|NCT02641379|541525003|FG004|Overall Study|PCR positive at Week 68|0|||
150104544|NCT02641379|541525004|FG005|Overall Study|PCR positive at Week 68|0|||
150104545|NCT02641379|541525005|FG006|Overall Study|PCR positive at Week 68|0|||
150104546|NCT02641379|541525006|FG007|Overall Study|PCR positive at Week 68|0|||
150104547|NCT02641379|541525007|FG008|Overall Study|PCR positive at Week 68|0|||
150104548|NCT02641379|541525008|FG009|Overall Study|PCR positive at Week 68|0|||
150104549|NCT02641379|541525009|FG010|Overall Study|PCR positive at Week 68|0|||
150104550|NCT02641379|541524999|FG000|Overall Study|PCR positive at Week 48|0|||
150104551|NCT02641379|541525000|FG001|Overall Study|PCR positive at Week 48|1|||
150104552|NCT02641379|541525001|FG002|Overall Study|PCR positive at Week 48|0|||
150104553|NCT02641379|541525002|FG003|Overall Study|PCR positive at Week 48|0|||
150104554|NCT02641379|541525003|FG004|Overall Study|PCR positive at Week 48|0|||
150104555|NCT02641379|541525004|FG005|Overall Study|PCR positive at Week 48|0|||
150104556|NCT02641379|541525005|FG006|Overall Study|PCR positive at Week 48|0|||
150104557|NCT02641379|541525006|FG007|Overall Study|PCR positive at Week 48|0|||
150104558|NCT02641379|541525007|FG008|Overall Study|PCR positive at Week 48|0|||
150104559|NCT02641379|541525008|FG009|Overall Study|PCR positive at Week 48|0|||
150104560|NCT02641379|541525009|FG010|Overall Study|PCR positive at Week 48|0|||
150104561|NCT02641379|541524999|FG000|Overall Study|PCR not performed at Week 12|0|||
150104562|NCT02641379|541525000|FG001|Overall Study|PCR not performed at Week 12|0|||
150104563|NCT02641379|541525001|FG002|Overall Study|PCR not performed at Week 12|1|||
150104564|NCT02641379|541525002|FG003|Overall Study|PCR not performed at Week 12|0|||
150104565|NCT02641379|541525003|FG004|Overall Study|PCR not performed at Week 12|0|||
150104566|NCT02641379|541525004|FG005|Overall Study|PCR not performed at Week 12|0|||
150104567|NCT02641379|541525005|FG006|Overall Study|PCR not performed at Week 12|0|||
150104568|NCT02641379|541525006|FG007|Overall Study|PCR not performed at Week 12|0|||
150104569|NCT02641379|541525007|FG008|Overall Study|PCR not performed at Week 12|0|||
150104570|NCT02641379|541525008|FG009|Overall Study|PCR not performed at Week 12|0|||
150104571|NCT02641379|541525009|FG010|Overall Study|PCR not performed at Week 12|0|||
150104572|NCT02641379|541524999|FG000|Overall Study|No PCR at baseline|0|||
150104573|NCT02641379|541525000|FG001|Overall Study|No PCR at baseline|0|||
150104574|NCT02641379|541525001|FG002|Overall Study|No PCR at baseline|1|||
150104575|NCT02641379|541525002|FG003|Overall Study|No PCR at baseline|0|||
150104576|NCT02641379|541525003|FG004|Overall Study|No PCR at baseline|0|||
150104577|NCT02641379|541525004|FG005|Overall Study|No PCR at baseline|0|||
150104578|NCT02641379|541525005|FG006|Overall Study|No PCR at baseline|0|||
150104579|NCT02641379|541525006|FG007|Overall Study|No PCR at baseline|0|||
150104580|NCT02641379|541525007|FG008|Overall Study|No PCR at baseline|0|||
150104581|NCT02641379|541525008|FG009|Overall Study|No PCR at baseline|0|||
150104582|NCT02641379|541525009|FG010|Overall Study|No PCR at baseline|0|||
150104583|NCT02641379|541524999|FG000|Overall Study|PCR positive at Week 28|0|||
150104584|NCT02641379|541525000|FG001|Overall Study|PCR positive at Week 28|0|||
150104585|NCT02641379|541525001|FG002|Overall Study|PCR positive at Week 28|1|||
150104586|NCT02641379|541525002|FG003|Overall Study|PCR positive at Week 28|0|||
150104587|NCT02641379|541525003|FG004|Overall Study|PCR positive at Week 28|0|||
150104588|NCT02641379|541525004|FG005|Overall Study|PCR positive at Week 28|0|||
150104589|NCT02641379|541525005|FG006|Overall Study|PCR positive at Week 28|0|||
150104590|NCT02641379|541525006|FG007|Overall Study|PCR positive at Week 28|0|||
150104591|NCT02641379|541525007|FG008|Overall Study|PCR positive at Week 28|0|||
150104592|NCT02641379|541525008|FG009|Overall Study|PCR positive at Week 28|0|||
150104593|NCT02641379|541525009|FG010|Overall Study|PCR positive at Week 28|0|||
150104594|NCT02641379|541524999|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
150104595|NCT02641379|541525000|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
150104596|NCT02641379|541525001|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
150104597|NCT02641379|541525002|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
150104598|NCT02641379|541525003|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
150104599|NCT02641379|541525004|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
150104600|NCT02641379|541525005|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
150104601|NCT02641379|541525006|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
150104602|NCT02641379|541525007|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
150104603|NCT02641379|541525008|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
150104604|NCT02641379|541525009|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
150104605|NCT02641379|541524999|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
150186267|NCT03988634|541822091|FG001|Open-Label|Physician Decision|0|||
150104606|NCT02641379|541525000|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
150104607|NCT02641379|541525001|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
150104608|NCT02641379|541525002|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
150104609|NCT02641379|541525003|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
150104610|NCT02641379|541525004|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
150104611|NCT02641379|541525005|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
150104612|NCT02641379|541525006|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
150104613|NCT02641379|541525007|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
150186268|NCT03988634|541822092|FG002|Open-Label|Physician Decision|1|||
150104614|NCT02641379|541525008|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
150104615|NCT02641379|541525009|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
150104616|NCT02641379|541524999|FG000|Overall Study|Baseline viral load unavailable|0|||
150104617|NCT02641379|541525000|FG001|Overall Study|Baseline viral load unavailable|0|||
150104618|NCT02641379|541525001|FG002|Overall Study|Baseline viral load unavailable|0|||
150104619|NCT02641379|541525002|FG003|Overall Study|Baseline viral load unavailable|1|||
150104620|NCT02641379|541525003|FG004|Overall Study|Baseline viral load unavailable|0|||
150104621|NCT02641379|541525004|FG005|Overall Study|Baseline viral load unavailable|0|||
150104622|NCT02641379|541525005|FG006|Overall Study|Baseline viral load unavailable|0|||
150104623|NCT02641379|541525006|FG007|Overall Study|Baseline viral load unavailable|0|||
150104624|NCT02641379|541525007|FG008|Overall Study|Baseline viral load unavailable|0|||
150104625|NCT02641379|541525008|FG009|Overall Study|Baseline viral load unavailable|0|||
150104626|NCT02641379|541525009|FG010|Overall Study|Baseline viral load unavailable|0|||
150104627|NCT02641379|541524999|FG000|Overall Study|Blood could not be drawn|0|||
150104628|NCT02641379|541525000|FG001|Overall Study|Blood could not be drawn|0|||
150104629|NCT02641379|541525001|FG002|Overall Study|Blood could not be drawn|0|||
150104630|NCT02641379|541525002|FG003|Overall Study|Blood could not be drawn|0|||
150104631|NCT02641379|541525003|FG004|Overall Study|Blood could not be drawn|1|||
150104632|NCT02641379|541525004|FG005|Overall Study|Blood could not be drawn|0|||
150104633|NCT02641379|541525005|FG006|Overall Study|Blood could not be drawn|0|||
150104634|NCT02641379|541525006|FG007|Overall Study|Blood could not be drawn|0|||
150104635|NCT02641379|541525007|FG008|Overall Study|Blood could not be drawn|0|||
150104636|NCT02641379|541525008|FG009|Overall Study|Blood could not be drawn|0|||
150104637|NCT02641379|541525009|FG010|Overall Study|Blood could not be drawn|0|||
150104638|NCT02641379|541524999|FG000|Overall Study|Protocol Violation|0|||
150104639|NCT02641379|541525000|FG001|Overall Study|Protocol Violation|0|||
150104640|NCT02641379|541525001|FG002|Overall Study|Protocol Violation|0|||
150104641|NCT02641379|541525002|FG003|Overall Study|Protocol Violation|0|||
150104642|NCT02641379|541525003|FG004|Overall Study|Protocol Violation|2|||
150104643|NCT02641379|541525004|FG005|Overall Study|Protocol Violation|0|||
150104644|NCT02641379|541525005|FG006|Overall Study|Protocol Violation|0|||
150104645|NCT02641379|541525006|FG007|Overall Study|Protocol Violation|0|||
150104646|NCT02641379|541525007|FG008|Overall Study|Protocol Violation|1|||
150104647|NCT02641379|541525008|FG009|Overall Study|Protocol Violation|0|||
150104648|NCT02641379|541525009|FG010|Overall Study|Protocol Violation|0|||
150104649|NCT02641379|541524999|FG000|Overall Study|Participation in sili rescue study|0|||
150104650|NCT02641379|541525000|FG001|Overall Study|Participation in sili rescue study|0|||
150104651|NCT02641379|541525001|FG002|Overall Study|Participation in sili rescue study|0|||
150104652|NCT02641379|541525002|FG003|Overall Study|Participation in sili rescue study|0|||
150104653|NCT02641379|541525003|FG004|Overall Study|Participation in sili rescue study|0|||
150104654|NCT02641379|541525004|FG005|Overall Study|Participation in sili rescue study|1|||
150104655|NCT02641379|541525005|FG006|Overall Study|Participation in sili rescue study|0|||
150104656|NCT02641379|541525006|FG007|Overall Study|Participation in sili rescue study|0|||
150104657|NCT02641379|541525007|FG008|Overall Study|Participation in sili rescue study|0|||
150104658|NCT02641379|541525008|FG009|Overall Study|Participation in sili rescue study|0|||
150104659|NCT02641379|541525009|FG010|Overall Study|Participation in sili rescue study|0|||
150104660|NCT02641379|541524999|FG000|Overall Study|Lost to Follow-up|0|||
150104661|NCT02641379|541525000|FG001|Overall Study|Lost to Follow-up|0|||
150104662|NCT02641379|541525001|FG002|Overall Study|Lost to Follow-up|0|||
150104663|NCT02641379|541525002|FG003|Overall Study|Lost to Follow-up|0|||
150104664|NCT02641379|541525003|FG004|Overall Study|Lost to Follow-up|0|||
150104665|NCT02641379|541525004|FG005|Overall Study|Lost to Follow-up|0|||
150104666|NCT02641379|541525005|FG006|Overall Study|Lost to Follow-up|0|||
150104667|NCT02641379|541525006|FG007|Overall Study|Lost to Follow-up|0|||
150104668|NCT02641379|541525007|FG008|Overall Study|Lost to Follow-up|1|||
150104669|NCT02641379|541525008|FG009|Overall Study|Lost to Follow-up|0|||
150104670|NCT02641379|541525009|FG010|Overall Study|Lost to Follow-up|0|||
150104671|NCT02641379|541524999|FG000|Overall Study|Source data not found|0|||
150104672|NCT02641379|541525000|FG001|Overall Study|Source data not found|0|||
150104673|NCT02641379|541525001|FG002|Overall Study|Source data not found|0|||
150104674|NCT02641379|541525002|FG003|Overall Study|Source data not found|0|||
150104675|NCT02641379|541525003|FG004|Overall Study|Source data not found|0|||
150104676|NCT02641379|541525004|FG005|Overall Study|Source data not found|1|||
150104677|NCT02641379|541525005|FG006|Overall Study|Source data not found|0|||
150104678|NCT02641379|541525006|FG007|Overall Study|Source data not found|0|||
150104679|NCT02641379|541525007|FG008|Overall Study|Source data not found|0|||
150104680|NCT02641379|541525008|FG009|Overall Study|Source data not found|0|||
150104681|NCT02641379|541525009|FG010|Overall Study|Source data not found|0|||
150104682|NCT02641379|541524999|FG000|Overall Study|Participant showed weight reduction|0|||
150104683|NCT02641379|541525000|FG001|Overall Study|Participant showed weight reduction|0|||
150186269|NCT03988634|541822090|FG000|Open-Label|Technical problems|0|||
150186270|NCT03988634|541822091|FG001|Open-Label|Technical problems|0|||
150186271|NCT03988634|541822092|FG002|Open-Label|Technical problems|1|||
150186272|NCT05406921|541822093|FG000|Overall Study|Withdrawal by Subject|25|||
150186273|NCT05406921|541822094|FG001|Overall Study|Withdrawal by Subject|0|||
150186274|NCT05406921|541822095|FG002|Overall Study|Withdrawal by Subject|25|||
150186275|NCT05406921|541822093|FG000|Overall Study|Protocol Violation|0|||
150186276|NCT05406921|541822094|FG001|Overall Study|Protocol Violation|12|||
150186277|NCT05406921|541822095|FG002|Overall Study|Protocol Violation|0|||
150186278|NCT04263311|541822100|FG000|Overall Study|Lost to Follow-up|1|||
150186279|NCT04263311|541822101|FG001|Overall Study|Lost to Follow-up|2|||
150186280|NCT04263311|541822102|FG002|Overall Study|Lost to Follow-up|0|||
150186281|NCT04263311|541822100|FG000|Overall Study|Health Issues|1|||
150186282|NCT04263311|541822101|FG001|Overall Study|Health Issues|0|||
150186283|NCT04263311|541822102|FG002|Overall Study|Health Issues|0|||
150186284|NCT04263311|541822100|FG000|Overall Study|Left the country|1|||
150186285|NCT04263311|541822101|FG001|Overall Study|Left the country|0|||
150186286|NCT04263311|541822102|FG002|Overall Study|Left the country|0|||
150186287|NCT04263311|541822100|FG000|Overall Study|Unable to maintain time commitment|1|||
150186288|NCT04263311|541822101|FG001|Overall Study|Unable to maintain time commitment|0|||
150186289|NCT04263311|541822102|FG002|Overall Study|Unable to maintain time commitment|0|||
150186290|NCT04263311|541822100|FG000|Overall Study|No longer interested|1|||
150186291|NCT04263311|541822101|FG001|Overall Study|No longer interested|0|||
150186292|NCT04263311|541822102|FG002|Overall Study|No longer interested|0|||
150186293|NCT04263311|541822100|FG000|Overall Study|Ineligible post consent|0|||
150186294|NCT04263311|541822101|FG001|Overall Study|Ineligible post consent|0|||
150186295|NCT04263311|541822102|FG002|Overall Study|Ineligible post consent|5|||
150186296|NCT03958955|541822103|FG000|Overall Study|Adverse Event|1|||
150186297|NCT04673929|541822104|FG000|Overall Study|Death|73|||
150186298|NCT04673929|541822104|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
150186299|NCT02927769|541822105|FG000|Induction Phase|Study drug toxicity|1|||
150186300|NCT02927769|541822106|FG001|Induction Phase|Study drug toxicity|1|||
150186301|NCT02927769|541822105|FG000|Induction Phase|Disease progression|0|||
150186302|NCT02927769|541822106|FG001|Induction Phase|Disease progression|1|||
150186303|NCT02927769|541822105|FG000|Intensification Phase|Study drug toxicity|1|||
150186304|NCT02927769|541822106|FG001|Intensification Phase|Study drug toxicity|0|||
150186305|NCT05082909|541822107|FG000|Overall Study|Protocol Violation|0|||
150186306|NCT05082909|541822108|FG001|Overall Study|Protocol Violation|0|||
150186307|NCT05082909|541822109|FG002|Overall Study|Protocol Violation|1|||
150186308|NCT05082909|541822110|FG003|Overall Study|Protocol Violation|0|||
150186309|NCT05082909|541822111|FG004|Overall Study|Protocol Violation|0|||
150186310|NCT05082909|541822112|FG005|Overall Study|Protocol Violation|0|||
150186311|NCT05227209|541822113|FG000|Overall Study|Adverse Event|11|||
150186312|NCT05227209|541822113|FG000|Overall Study|Lost to Follow-up|1|||
150186313|NCT05227209|541822113|FG000|Overall Study|Withdrawal by Subject|7|||
150186314|NCT05227209|541822113|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
150186315|NCT04024813|541822114|FG000|Overall Study|Study terminated by Sponsor|1|||
150186316|NCT04783935|541822127|FG000|Overall Study|Withdrawal by Subject|6|||
150186317|NCT04783935|541822127|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
150186318|NCT04783935|541822127|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
150186319|NCT04783935|541822127|FG000|Overall Study|Lost to Follow-up|3|||
150186320|NCT04783935|541822127|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
150186321|NCT06074523|541822133|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
150186322|NCT06074523|541822133|FG000|Overall Study|Withdrawal by Subject|1|||
150186323|NCT05524233|541822137|FG000|Overall Study|Lost to Follow-up|2|||
150186324|NCT05524233|541822137|FG000|Overall Study|Adverse Event|2|||
150186325|NCT05524233|541822137|FG000|Overall Study|Withdrawal by Subject|1|||
150186326|NCT05337748|541822144|FG000|Overall Study|Withdrawal by Subject|1|||
150186327|NCT05337748|541822145|FG001|Overall Study|Withdrawal by Subject|0|||
150186328|NCT05337748|541822144|FG000|Overall Study|Death|1|||
150186329|NCT05337748|541822145|FG001|Overall Study|Death|0|||
150186330|NCT02506959|541822146|FG000|Overall Study|Physician Decision|2|||
150186331|NCT02506959|541822147|FG001|Overall Study|Physician Decision|1|||
150186332|NCT03453619|541822150|FG000|Core Study (Part A)|Physician Decision|0|||
150186333|NCT03453619|541822151|FG001|Core Study (Part A)|Physician Decision|0|||
150186334|NCT03453619|541822152|FG002|Core Study (Part A)|Physician Decision|2|||
150186335|NCT03453619|541822153|FG003|Core Study (Part A)|Physician Decision|0|||
150186336|NCT03453619|541822150|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
150186337|NCT03453619|541822151|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
150186338|NCT03453619|541822152|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
150186339|NCT03453619|541822153|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
150186340|NCT03453619|541822150|FG000|Core Study (Part A)|Other|0|||
150186341|NCT03453619|541822151|FG001|Core Study (Part A)|Other|1|||
150186342|NCT03453619|541822152|FG002|Core Study (Part A)|Other|0|||
150186343|NCT03453619|541822153|FG003|Core Study (Part A)|Other|0|||
150186344|NCT03453619|541822150|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
150104684|NCT02641379|541525001|FG002|Overall Study|Participant showed weight reduction|0|||
150104685|NCT02641379|541525002|FG003|Overall Study|Participant showed weight reduction|0|||
150104686|NCT02641379|541525003|FG004|Overall Study|Participant showed weight reduction|0|||
150104687|NCT02641379|541525004|FG005|Overall Study|Participant showed weight reduction|0|||
150104688|NCT02641379|541525005|FG006|Overall Study|Participant showed weight reduction|0|||
150104689|NCT02641379|541525006|FG007|Overall Study|Participant showed weight reduction|1|||
150104690|NCT02641379|541525007|FG008|Overall Study|Participant showed weight reduction|0|||
150104691|NCT02641379|541525008|FG009|Overall Study|Participant showed weight reduction|0|||
150104692|NCT02641379|541525009|FG010|Overall Study|Participant showed weight reduction|0|||
150104693|NCT02641379|541524999|FG000|Overall Study|Non-response Week 12|0|||
150104694|NCT02641379|541525000|FG001|Overall Study|Non-response Week 12|0|||
150104695|NCT02641379|541525001|FG002|Overall Study|Non-response Week 12|0|||
150104696|NCT02641379|541525002|FG003|Overall Study|Non-response Week 12|0|||
150104697|NCT02641379|541525003|FG004|Overall Study|Non-response Week 12|0|||
150104698|NCT02641379|541525004|FG005|Overall Study|Non-response Week 12|0|||
150104699|NCT02641379|541525005|FG006|Overall Study|Non-response Week 12|0|||
150104700|NCT02641379|541525006|FG007|Overall Study|Non-response Week 12|1|||
150104701|NCT02641379|541525007|FG008|Overall Study|Non-response Week 12|0|||
150104702|NCT02641379|541525008|FG009|Overall Study|Non-response Week 12|0|||
150104703|NCT02641379|541525009|FG010|Overall Study|Non-response Week 12|0|||
150104704|NCT02641379|541524999|FG000|Overall Study|No 2 Log drop at Week 12|0|||
150104705|NCT02641379|541525000|FG001|Overall Study|No 2 Log drop at Week 12|0|||
150104706|NCT02641379|541525001|FG002|Overall Study|No 2 Log drop at Week 12|0|||
150104707|NCT02641379|541525002|FG003|Overall Study|No 2 Log drop at Week 12|0|||
150104708|NCT02641379|541525003|FG004|Overall Study|No 2 Log drop at Week 12|0|||
150104709|NCT02641379|541525004|FG005|Overall Study|No 2 Log drop at Week 12|0|||
150104710|NCT02641379|541525005|FG006|Overall Study|No 2 Log drop at Week 12|0|||
150104711|NCT02641379|541525006|FG007|Overall Study|No 2 Log drop at Week 12|0|||
150104712|NCT02641379|541525007|FG008|Overall Study|No 2 Log drop at Week 12|0|||
150104713|NCT02641379|541525008|FG009|Overall Study|No 2 Log drop at Week 12|0|||
150104714|NCT02641379|541525009|FG010|Overall Study|No 2 Log drop at Week 12|1|||
150104715|NCT02641379|541524999|FG000|Overall Study|Negative PCR result|0|||
150104716|NCT02641379|541525000|FG001|Overall Study|Negative PCR result|0|||
150104717|NCT02641379|541525001|FG002|Overall Study|Negative PCR result|0|||
150104718|NCT02641379|541525002|FG003|Overall Study|Negative PCR result|0|||
150104719|NCT02641379|541525003|FG004|Overall Study|Negative PCR result|0|||
150104720|NCT02641379|541525004|FG005|Overall Study|Negative PCR result|0|||
150104721|NCT02641379|541525005|FG006|Overall Study|Negative PCR result|0|||
150104722|NCT02641379|541525006|FG007|Overall Study|Negative PCR result|0|||
150104723|NCT02641379|541525007|FG008|Overall Study|Negative PCR result|0|||
150104724|NCT02641379|541525008|FG009|Overall Study|Negative PCR result|1|||
150104725|NCT02641379|541525009|FG010|Overall Study|Negative PCR result|0|||
150104726|NCT02641379|541524999|FG000|Overall Study|Participant's PCR high|0|||
150104727|NCT02641379|541525000|FG001|Overall Study|Participant's PCR high|0|||
150104728|NCT02641379|541525001|FG002|Overall Study|Participant's PCR high|0|||
150104729|NCT02641379|541525002|FG003|Overall Study|Participant's PCR high|0|||
150104730|NCT02641379|541525003|FG004|Overall Study|Participant's PCR high|0|||
150104731|NCT02641379|541525004|FG005|Overall Study|Participant's PCR high|0|||
150104732|NCT02641379|541525005|FG006|Overall Study|Participant's PCR high|0|||
150104733|NCT02641379|541525006|FG007|Overall Study|Participant's PCR high|1|||
150104734|NCT02641379|541525007|FG008|Overall Study|Participant's PCR high|0|||
150104735|NCT02641379|541525008|FG009|Overall Study|Participant's PCR high|0|||
150104736|NCT02641379|541525009|FG010|Overall Study|Participant's PCR high|0|||
150104737|NCT02641379|541524999|FG000|Overall Study|Participant treated after Week 24|0|||
150104738|NCT02641379|541525000|FG001|Overall Study|Participant treated after Week 24|0|||
150104739|NCT02641379|541525001|FG002|Overall Study|Participant treated after Week 24|0|||
150104740|NCT02641379|541525002|FG003|Overall Study|Participant treated after Week 24|0|||
150104741|NCT02641379|541525003|FG004|Overall Study|Participant treated after Week 24|0|||
150104742|NCT02641379|541525004|FG005|Overall Study|Participant treated after Week 24|0|||
150104743|NCT02641379|541525005|FG006|Overall Study|Participant treated after Week 24|0|||
150104744|NCT02641379|541525006|FG007|Overall Study|Participant treated after Week 24|0|||
150104745|NCT02641379|541525007|FG008|Overall Study|Participant treated after Week 24|1|||
150104746|NCT02641379|541525008|FG009|Overall Study|Participant treated after Week 24|0|||
150104747|NCT02641379|541525009|FG010|Overall Study|Participant treated after Week 24|0|||
150104748|NCT02641379|541524999|FG000|Overall Study|Missing PCR result at Week 8|0|||
150104749|NCT02641379|541525000|FG001|Overall Study|Missing PCR result at Week 8|0|||
150104750|NCT02641379|541525001|FG002|Overall Study|Missing PCR result at Week 8|0|||
150104751|NCT02641379|541525002|FG003|Overall Study|Missing PCR result at Week 8|0|||
150104752|NCT02641379|541525003|FG004|Overall Study|Missing PCR result at Week 8|0|||
150104753|NCT02641379|541525004|FG005|Overall Study|Missing PCR result at Week 8|0|||
150104754|NCT02641379|541525005|FG006|Overall Study|Missing PCR result at Week 8|0|||
150104755|NCT02641379|541525006|FG007|Overall Study|Missing PCR result at Week 8|0|||
150104756|NCT02641379|541525007|FG008|Overall Study|Missing PCR result at Week 8|0|||
150104757|NCT02641379|541525008|FG009|Overall Study|Missing PCR result at Week 8|1|||
150104758|NCT02641379|541525009|FG010|Overall Study|Missing PCR result at Week 8|0|||
150104759|NCT02641379|541524999|FG000|Overall Study|PCR positive|0|||
150104760|NCT02641379|541525000|FG001|Overall Study|PCR positive|0|||
150104761|NCT02641379|541525001|FG002|Overall Study|PCR positive|0|||
150104762|NCT02641379|541525002|FG003|Overall Study|PCR positive|0|||
150104763|NCT02641379|541525003|FG004|Overall Study|PCR positive|0|||
150104764|NCT02641379|541525004|FG005|Overall Study|PCR positive|0|||
150104765|NCT02641379|541525005|FG006|Overall Study|PCR positive|1|||
150104766|NCT02641379|541525006|FG007|Overall Study|PCR positive|0|||
150104767|NCT02641379|541525007|FG008|Overall Study|PCR positive|0|||
150104768|NCT02641379|541525008|FG009|Overall Study|PCR positive|0|||
150104769|NCT02641379|541525009|FG010|Overall Study|PCR positive|0|||
150104770|NCT01165138|541525010|FG000|Overall Study|Adverse Event|0|||
150104771|NCT01165138|541525011|FG001|Overall Study|Adverse Event|1|||
150104772|NCT01165138|541525012|FG002|Overall Study|Adverse Event|0|||
150104773|NCT01165138|541525013|FG003|Overall Study|Adverse Event|2|||
150104774|NCT01165138|541525010|FG000|Overall Study|Lack of Efficacy|0|||
150104775|NCT01165138|541525011|FG001|Overall Study|Lack of Efficacy|32|||
150104776|NCT01165138|541525012|FG002|Overall Study|Lack of Efficacy|6|||
150104777|NCT01165138|541525013|FG003|Overall Study|Lack of Efficacy|7|||
150104778|NCT01165138|541525010|FG000|Overall Study|Protocol Violation|0|||
150104779|NCT01165138|541525011|FG001|Overall Study|Protocol Violation|7|||
150104780|NCT01165138|541525012|FG002|Overall Study|Protocol Violation|0|||
150104781|NCT01165138|541525013|FG003|Overall Study|Protocol Violation|2|||
150104782|NCT01165138|541525010|FG000|Overall Study|Lost to Follow-up|0|||
150104783|NCT01165138|541525011|FG001|Overall Study|Lost to Follow-up|0|||
150104784|NCT01165138|541525012|FG002|Overall Study|Lost to Follow-up|1|||
150104785|NCT01165138|541525013|FG003|Overall Study|Lost to Follow-up|2|||
150104786|NCT01165138|541525010|FG000|Overall Study|Physician Decision|0|||
150104787|NCT01165138|541525011|FG001|Overall Study|Physician Decision|6|||
150104788|NCT01165138|541525012|FG002|Overall Study|Physician Decision|7|||
150104789|NCT01165138|541525013|FG003|Overall Study|Physician Decision|6|||
150104790|NCT01165138|541525010|FG000|Overall Study|Withdrawal by Subject|0|||
150104791|NCT01165138|541525011|FG001|Overall Study|Withdrawal by Subject|6|||
150104792|NCT01165138|541525012|FG002|Overall Study|Withdrawal by Subject|6|||
150104793|NCT01165138|541525013|FG003|Overall Study|Withdrawal by Subject|3|||
150104794|NCT04964128|541525014|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
150104795|NCT04964128|541525014|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
150104796|NCT01148511|541525015|FG000|Exposed to Study Drug|Protocol Violation|2|||
150104797|NCT01148511|541525016|FG001|Exposed to Study Drug|Protocol Violation|0|||
150104798|NCT01148511|541525017|FG002|Exposed to Study Drug|Protocol Violation|0|||
150104799|NCT01148511|541525015|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
150104800|NCT01148511|541525016|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
150104801|NCT01148511|541525017|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
150104802|NCT01148511|541525015|FG000|Randomized|Adverse Event|0|||
150104803|NCT01148511|541525016|FG001|Randomized|Adverse Event|1|||
150104804|NCT01148511|541525017|FG002|Randomized|Adverse Event|0|||
150104805|NCT01148511|541525015|FG000|Randomized|Protocol Violation|0|||
150104806|NCT01148511|541525016|FG001|Randomized|Protocol Violation|2|||
150104807|NCT01148511|541525017|FG002|Randomized|Protocol Violation|1|||
150186345|NCT03453619|541822151|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
150186346|NCT03453619|541822152|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
150186347|NCT03453619|541822153|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
150186348|NCT03453619|541822150|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
150186349|NCT03453619|541822151|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
150186350|NCT03453619|541822152|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
150104808|NCT01148511|541525015|FG000|Randomized|Lost to Follow-up|0|||
150104809|NCT01148511|541525016|FG001|Randomized|Lost to Follow-up|1|||
150104810|NCT01148511|541525017|FG002|Randomized|Lost to Follow-up|1|||
150104811|NCT01148511|541525015|FG000|Randomized|Consent withdrawal|0|||
150104812|NCT01148511|541525016|FG001|Randomized|Consent withdrawal|5|||
150104813|NCT01148511|541525017|FG002|Randomized|Consent withdrawal|3|||
150104814|NCT01148511|541525015|FG000|Randomized|Other|0|||
150104815|NCT01148511|541525016|FG001|Randomized|Other|1|||
150104816|NCT01148511|541525017|FG002|Randomized|Other|1|||
150104817|NCT01644175|541525020|FG000|Overall Study|Randomized But Not Treated|0|||
150104818|NCT01644175|541525021|FG001|Overall Study|Randomized But Not Treated|2|||
150104819|NCT01644175|541525020|FG000|Overall Study|Adverse Event|8|||
150104820|NCT01644175|541525021|FG001|Overall Study|Adverse Event|13|||
150186351|NCT03453619|541822153|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
150104821|NCT01644175|541525020|FG000|Overall Study|Death|1|||
150104822|NCT01644175|541525021|FG001|Overall Study|Death|2|||
150104823|NCT01644175|541525020|FG000|Overall Study|Poor compliance to protocol|9|||
150104824|NCT01644175|541525021|FG001|Overall Study|Poor compliance to protocol|10|||
150104825|NCT01644175|541525020|FG000|Overall Study|Physician Decision|1|||
150186352|NCT03453619|541822150|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
150186353|NCT03453619|541822151|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
150186354|NCT03453619|541822152|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
150186355|NCT03453619|541822153|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
150186356|NCT03453619|541822150|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
150186357|NCT03453619|541822151|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
150186358|NCT03453619|541822152|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
150186359|NCT03453619|541822153|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
150186360|NCT04321031|541822154|FG000|Overall Study|Adverse Event|0|||
150186361|NCT04321031|541822155|FG001|Overall Study|Adverse Event|2|||
150186362|NCT04321031|541822156|FG002|Overall Study|Adverse Event|2|||
150186363|NCT04321031|541822157|FG003|Overall Study|Adverse Event|2|||
150186364|NCT04321031|541822158|FG004|Overall Study|Adverse Event|2|||
150186365|NCT04321031|541822159|FG005|Overall Study|Adverse Event|2|||
150186366|NCT04321031|541822160|FG006|Overall Study|Adverse Event|0|||
150186367|NCT04321031|541822154|FG000|Overall Study|Lost to Follow-up|0|||
150186368|NCT04321031|541822155|FG001|Overall Study|Lost to Follow-up|0|||
150186369|NCT04321031|541822156|FG002|Overall Study|Lost to Follow-up|0|||
150186370|NCT04321031|541822157|FG003|Overall Study|Lost to Follow-up|1|||
150186371|NCT04321031|541822158|FG004|Overall Study|Lost to Follow-up|0|||
150186372|NCT04321031|541822159|FG005|Overall Study|Lost to Follow-up|2|||
150186373|NCT04321031|541822160|FG006|Overall Study|Lost to Follow-up|1|||
150186374|NCT04321031|541822154|FG000|Overall Study|Withdrawal by Subject|2|||
150186375|NCT04321031|541822155|FG001|Overall Study|Withdrawal by Subject|2|||
150186376|NCT04321031|541822156|FG002|Overall Study|Withdrawal by Subject|1|||
150186377|NCT04321031|541822157|FG003|Overall Study|Withdrawal by Subject|3|||
150186378|NCT04321031|541822158|FG004|Overall Study|Withdrawal by Subject|1|||
150186379|NCT04321031|541822159|FG005|Overall Study|Withdrawal by Subject|0|||
150186380|NCT04321031|541822160|FG006|Overall Study|Withdrawal by Subject|1|||
150186381|NCT04321031|541822154|FG000|Overall Study|Non-compliance with study drug|0|||
150186382|NCT04321031|541822155|FG001|Overall Study|Non-compliance with study drug|0|||
150186383|NCT04321031|541822156|FG002|Overall Study|Non-compliance with study drug|0|||
150186384|NCT04321031|541822157|FG003|Overall Study|Non-compliance with study drug|0|||
150186385|NCT04321031|541822158|FG004|Overall Study|Non-compliance with study drug|0|||
150186386|NCT04321031|541822159|FG005|Overall Study|Non-compliance with study drug|1|||
150186387|NCT04321031|541822160|FG006|Overall Study|Non-compliance with study drug|0|||
150186388|NCT04321031|541822154|FG000|Overall Study|Other|0|||
150186389|NCT04321031|541822155|FG001|Overall Study|Other|0|||
150186390|NCT04321031|541822156|FG002|Overall Study|Other|0|||
150186391|NCT04321031|541822157|FG003|Overall Study|Other|1|||
150186392|NCT04321031|541822158|FG004|Overall Study|Other|0|||
150186393|NCT04321031|541822159|FG005|Overall Study|Other|0|||
150186394|NCT04321031|541822160|FG006|Overall Study|Other|0|||
150186395|NCT02900924|541822161|FG000|Overall Study|Death|52|||
150186396|NCT02900924|541822161|FG000|Overall Study|Lost to Follow-up|4|||
150186397|NCT02900924|541822161|FG000|Overall Study|Withdrawal by Subject|20|||
150186398|NCT02900924|541822161|FG000|Overall Study|Missed Visit|33|||
150186399|NCT05536440|541822164|FG000|Overall Study|Adverse Event|0|||
150186400|NCT05536440|541822165|FG001|Overall Study|Adverse Event|0|||
150186401|NCT05536440|541822166|FG002|Overall Study|Adverse Event|0|||
150186402|NCT05536440|541822167|FG003|Overall Study|Adverse Event|0|||
150186403|NCT05536440|541822168|FG004|Overall Study|Adverse Event|0|||
150186404|NCT05536440|541822169|FG005|Overall Study|Adverse Event|0|||
150186405|NCT05536440|541822170|FG006|Overall Study|Adverse Event|0|||
150186406|NCT05536440|541822171|FG007|Overall Study|Adverse Event|0|||
150186407|NCT05536440|541822172|FG008|Overall Study|Adverse Event|1|||
150186408|NCT04812535|541822181|FG000|Overall Study|Withdrawal by Subject|0|||
150186409|NCT04812535|541822182|FG001|Overall Study|Withdrawal by Subject|0|||
150186410|NCT04812535|541822183|FG002|Overall Study|Withdrawal by Subject|0|||
150186411|NCT04812535|541822184|FG003|Overall Study|Withdrawal by Subject|1|||
150186412|NCT04812535|541822181|FG000|Overall Study|Death|7|||
150186413|NCT04812535|541822182|FG001|Overall Study|Death|2|||
150186414|NCT04812535|541822183|FG002|Overall Study|Death|4|||
150186415|NCT04812535|541822184|FG003|Overall Study|Death|1|||
150186416|NCT04812535|541822181|FG000|Overall Study|Due to premature study termination by sponsor|2|||
150186417|NCT04812535|541822182|FG001|Overall Study|Due to premature study termination by sponsor|0|||
150186418|NCT04812535|541822183|FG002|Overall Study|Due to premature study termination by sponsor|1|||
150186419|NCT04812535|541822184|FG003|Overall Study|Due to premature study termination by sponsor|3|||
150186420|NCT03436745|541822185|FG000|Overall Study|Ineligible|0|||
150186421|NCT03436745|541822186|FG001|Overall Study|Ineligible|0|||
150186422|NCT03436745|541822187|FG002|Overall Study|Ineligible|1|||
150186423|NCT00931710|541822190|FG000|Overall Study|Adverse Event|16|||
150186424|NCT00931710|541822191|FG001|Overall Study|Adverse Event|10|||
150186425|NCT00931710|541822190|FG000|Overall Study|Abnormal test procedure results|2|||
150186426|NCT00931710|541822191|FG001|Overall Study|Abnormal test procedure results|0|||
150186427|NCT00931710|541822190|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
150186428|NCT00931710|541822191|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
150186429|NCT00931710|541822190|FG000|Overall Study|Patient withdrew consent|4|||
150186430|NCT00931710|541822191|FG001|Overall Study|Patient withdrew consent|9|||
150186431|NCT00931710|541822190|FG000|Overall Study|Lost to Follow-up|6|||
150186432|NCT00931710|541822191|FG001|Overall Study|Lost to Follow-up|5|||
150186433|NCT00931710|541822190|FG000|Overall Study|Protocol deviation|1|||
150186434|NCT00931710|541822191|FG001|Overall Study|Protocol deviation|2|||
150186435|NCT03338790|541822195|FG000|Overall Study|Disease Progression|65|||
150186436|NCT03338790|541822196|FG001|Overall Study|Disease Progression|43|||
150186437|NCT03338790|541822197|FG002|Overall Study|Disease Progression|50|||
150186438|NCT03338790|541822198|FG003|Overall Study|Disease Progression|37|||
150186439|NCT03338790|541822195|FG000|Overall Study|Study Drug Toxicity|9|||
150186440|NCT03338790|541822196|FG001|Overall Study|Study Drug Toxicity|8|||
150186441|NCT03338790|541822197|FG002|Overall Study|Study Drug Toxicity|15|||
150186442|NCT03338790|541822198|FG003|Overall Study|Study Drug Toxicity|0|||
150186443|NCT03338790|541822195|FG000|Overall Study|Death|1|||
150186444|NCT03338790|541822196|FG001|Overall Study|Death|1|||
150186445|NCT03338790|541822197|FG002|Overall Study|Death|1|||
150186446|NCT03338790|541822198|FG003|Overall Study|Death|0|||
150186447|NCT03338790|541822195|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
150186448|NCT03338790|541822196|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
150186449|NCT03338790|541822197|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
150186450|NCT03338790|541822198|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
150186451|NCT03338790|541822195|FG000|Overall Study|Participant request to discontinue study treatment|3|||
150186452|NCT03338790|541822196|FG001|Overall Study|Participant request to discontinue study treatment|3|||
150186453|NCT03338790|541822197|FG002|Overall Study|Participant request to discontinue study treatment|2|||
150186454|NCT03338790|541822198|FG003|Overall Study|Participant request to discontinue study treatment|1|||
150186455|NCT03338790|541822195|FG000|Overall Study|Poor/non-compliance|0|||
150186456|NCT03338790|541822196|FG001|Overall Study|Poor/non-compliance|1|||
150186457|NCT03338790|541822197|FG002|Overall Study|Poor/non-compliance|0|||
150186458|NCT03338790|541822198|FG003|Overall Study|Poor/non-compliance|0|||
150186459|NCT03338790|541822195|FG000|Overall Study|Participant withdrew consent|1|||
150186460|NCT03338790|541822196|FG001|Overall Study|Participant withdrew consent|0|||
150186461|NCT03338790|541822197|FG002|Overall Study|Participant withdrew consent|1|||
150186462|NCT03338790|541822198|FG003|Overall Study|Participant withdrew consent|1|||
150186463|NCT03338790|541822195|FG000|Overall Study|Other reasons|0|||
150186464|NCT03338790|541822196|FG001|Overall Study|Other reasons|5|||
150186465|NCT03338790|541822197|FG002|Overall Study|Other reasons|0|||
150186466|NCT03338790|541822198|FG003|Overall Study|Other reasons|2|||
150186467|NCT03338790|541822195|FG000|Overall Study|Not reported|0|||
150186468|NCT03338790|541822196|FG001|Overall Study|Not reported|0|||
150186469|NCT03338790|541822197|FG002|Overall Study|Not reported|1|||
150186470|NCT03338790|541822198|FG003|Overall Study|Not reported|0|||
150186471|NCT03338790|541822195|FG000|Overall Study|Completed treatment period|1|||
150186472|NCT03338790|541822196|FG001|Overall Study|Completed treatment period|2|||
150186473|NCT03338790|541822197|FG002|Overall Study|Completed treatment period|0|||
150186474|NCT03338790|541822198|FG003|Overall Study|Completed treatment period|0|||
150186475|NCT05592418|541822199|FG000|Overall Study|Adverse Event|1|||
150186476|NCT05592418|541822200|FG001|Overall Study|Adverse Event|0|||
150186477|NCT05592418|541822199|FG000|Overall Study|Lost to Follow-up|1|||
150186478|NCT05592418|541822200|FG001|Overall Study|Lost to Follow-up|3|||
150186479|NCT05592418|541822199|FG000|Overall Study|Withdrawal by Subject|2|||
150186480|NCT05592418|541822200|FG001|Overall Study|Withdrawal by Subject|7|||
150186481|NCT05481320|541822203|FG000|Overall Study|Withdrawal by Subject|1|||
150186482|NCT05481320|541822204|FG001|Overall Study|Withdrawal by Subject|1|||
150186483|NCT05481320|541822203|FG000|Overall Study|Care recipent passed away|0|||
150186484|NCT05481320|541822204|FG001|Overall Study|Care recipent passed away|1|||
150186485|NCT05481320|541822203|FG000|Overall Study|Out-of-window assessment|0|||
150186486|NCT05481320|541822204|FG001|Overall Study|Out-of-window assessment|1|||
150186487|NCT05481320|541822203|FG000|Overall Study|No longer a primary caregiver|3|||
150186488|NCT05481320|541822204|FG001|Overall Study|No longer a primary caregiver|0|||
150186489|NCT05481320|541822203|FG000|Overall Study|Unable to contact|1|||
150186490|NCT05481320|541822204|FG001|Overall Study|Unable to contact|0|||
150186491|NCT04314895|541822206|FG000|Overall Study|Lost to Follow-up|1|||
150186492|NCT04314895|541822206|FG000|Overall Study|Death|10|||
150186493|NCT04314895|541822206|FG000|Overall Study|Physician Decision|2|||
150186494|NCT03930342|541822207|FG000|Overall Study|Lost to Follow-up|70|||
150104826|NCT01644175|541525021|FG001|Overall Study|Physician Decision|2|||
150104827|NCT01644175|541525020|FG000|Overall Study|Participant Moved|1|||
150104828|NCT01644175|541525021|FG001|Overall Study|Participant Moved|2|||
150104829|NCT01644175|541525020|FG000|Overall Study|Consent withdrawn by participant|3|||
150104830|NCT01644175|541525021|FG001|Overall Study|Consent withdrawn by participant|4|||
150104831|NCT01644175|541525020|FG000|Overall Study|Related to Autoinjector Administration|2|||
150104832|NCT01644175|541525021|FG001|Overall Study|Related to Autoinjector Administration|1|||
150104833|NCT01644175|541525020|FG000|Overall Study|Last visit outside protocol visit window|4|||
150104834|NCT01644175|541525021|FG001|Overall Study|Last visit outside protocol visit window|11|||
150104835|NCT01644175|541525020|FG000|Overall Study|Selection criteria finally not met|0|||
150104836|NCT01644175|541525021|FG001|Overall Study|Selection criteria finally not met|1|||
150104837|NCT01644175|541525020|FG000|Overall Study|Site closure|2|||
150104838|NCT01644175|541525021|FG001|Overall Study|Site closure|2|||
150104839|NCT01644175|541525020|FG000|Overall Study|Lost to Follow-up|1|||
150104840|NCT01644175|541525021|FG001|Overall Study|Lost to Follow-up|0|||
150104841|NCT01644175|541525020|FG000|Overall Study|Other than specified above|0|||
150104842|NCT01644175|541525021|FG001|Overall Study|Other than specified above|3|||
150104843|NCT00842348|541525028|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
150104844|NCT00842348|541525029|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
150104845|NCT00842348|541525028|FG000|Study 729|Disease progression/death|19|||
150104846|NCT00842348|541525029|FG001|Study 729|Disease progression/death|30|||
150104847|NCT00842348|541525028|FG000|Study 729|Adverse Event|1|||
150104848|NCT00842348|541525029|FG001|Study 729|Adverse Event|1|||
150104849|NCT00842348|541525028|FG000|Study 729|Protocol Violation|1|||
150104850|NCT00842348|541525029|FG001|Study 729|Protocol Violation|1|||
150104851|NCT00842348|541525028|FG000|Study 729|Withdrawal by Subject|2|||
150104852|NCT00842348|541525029|FG001|Study 729|Withdrawal by Subject|4|||
150104853|NCT00842348|541525028|FG000|Study 729|Due to Sponsor stopping the study|1|||
150104854|NCT00842348|541525029|FG001|Study 729|Due to Sponsor stopping the study|1|||
150104855|NCT00842348|541525028|FG000|Study 729|Due to non-availability of IP|0|||
150104856|NCT00842348|541525029|FG001|Study 729|Due to non-availability of IP|1|||
150104857|NCT00842348|541525028|FG000|Study 729|Sponsor's decision|1|||
150104858|NCT00842348|541525029|FG001|Study 729|Sponsor's decision|0|||
150104859|NCT00842348|541525028|FG000|Study 729|Surgical resection|1|||
150104860|NCT00842348|541525029|FG001|Study 729|Surgical resection|0|||
150104861|NCT01113879|541525032|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
150104862|NCT01113879|541525033|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
150104863|NCT00358527|541526987|FG000|Overall Study|Adverse Event|4|||
150104864|NCT00358527|541526988|FG001|Overall Study|Adverse Event|0|||
150104865|NCT00358527|541526987|FG000|Overall Study|Withdrawal by Subject|1|||
150104866|NCT00358527|541526988|FG001|Overall Study|Withdrawal by Subject|1|||
150104867|NCT00358527|541526987|FG000|Overall Study|Non-compliance with protocol|6|||
150104868|NCT00358527|541526988|FG001|Overall Study|Non-compliance with protocol|1|||
150104869|NCT00358527|541526987|FG000|Overall Study|Administrative|2|||
150104870|NCT00358527|541526988|FG001|Overall Study|Administrative|1|||
150104871|NCT00749463|541526989|FG000|Overall Study|Adverse Event|0|||
150104872|NCT00749463|541526990|FG001|Overall Study|Adverse Event|4|||
150104873|NCT00749463|541526991|FG002|Overall Study|Adverse Event|1|||
150104874|NCT00749463|541526989|FG000|Overall Study|Withdrawal by Subject|1|||
150104875|NCT00749463|541526990|FG001|Overall Study|Withdrawal by Subject|0|||
150104876|NCT00749463|541526991|FG002|Overall Study|Withdrawal by Subject|0|||
150104877|NCT00913744|541526994|FG000|Overall Study|Adverse Event|2|||
150104878|NCT00913744|541526995|FG001|Overall Study|Adverse Event|0|||
150104879|NCT00913744|541526994|FG000|Overall Study|Withdrawal by Subject|2|||
150104880|NCT00913744|541526995|FG001|Overall Study|Withdrawal by Subject|1|||
150104881|NCT00913744|541526994|FG000|Overall Study|Death|1|||
150104882|NCT00913744|541526995|FG001|Overall Study|Death|0|||
150104883|NCT00302003|541527000|FG000|Overall Study|Lack of Efficacy|62|||
150104884|NCT00302003|541527000|FG000|Overall Study|Lost to Follow-up|1|||
150104885|NCT00302003|541527000|FG000|Overall Study|Physician Decision|2|||
150104886|NCT00302003|541527000|FG000|Overall Study|Withdrawal by Subject|5|||
150104887|NCT00302003|541527000|FG000|Overall Study|Ineligible|9|||
150104888|NCT00302003|541527000|FG000|Overall Study|Protocol Violation|1|||
150104889|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
150104890|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
150104891|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
150104892|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
150104893|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
150104894|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
150186495|NCT03930342|541822208|FG001|Overall Study|Lost to Follow-up|77|||
150104895|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
150104896|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
150104897|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
150104898|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
150104899|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
150104900|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
150104901|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
150104902|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
150104903|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
150104904|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
150104905|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
150104906|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
150104907|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
150104908|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
150104909|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
150104910|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
150104911|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
150104912|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
150104913|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
150104914|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
150104915|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
150104916|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
150104917|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
150104918|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
150104919|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
150104920|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
150104921|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
150104922|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
150104923|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
150104924|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
150104925|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
150104926|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
150104927|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
150104928|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
150104929|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
150104930|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
150104931|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
150104932|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
150104933|NCT01218516|541527001|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
150104934|NCT01218516|541527002|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
150104935|NCT01218516|541527003|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
150104936|NCT01218516|541527004|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
150104937|NCT01539226|541527005|FG000|Overall Study|Withdrawal by Subject|24|||
150104938|NCT01539226|541527006|FG001|Overall Study|Withdrawal by Subject|54|||
150104939|NCT01539226|541527005|FG000|Overall Study|Lost to Follow-up|20|||
150104940|NCT01539226|541527006|FG001|Overall Study|Lost to Follow-up|54|||
150104941|NCT01539226|541527005|FG000|Overall Study|Death|1|||
150104942|NCT01539226|541527006|FG001|Overall Study|Death|2|||
150104943|NCT01539226|541527005|FG000|Overall Study|Adverse Event|2|||
150104944|NCT01539226|541527006|FG001|Overall Study|Adverse Event|0|||
150104945|NCT01539226|541527005|FG000|Overall Study|Pregnancy|13|||
150104946|NCT01539226|541527006|FG001|Overall Study|Pregnancy|29|||
150104947|NCT01539226|541527005|FG000|Overall Study|inappropriate enrollment|0|||
150104948|NCT01539226|541527006|FG001|Overall Study|inappropriate enrollment|1|||
150104949|NCT01539226|541527005|FG000|Overall Study|Multiple Reasons|3|||
150104950|NCT01539226|541527006|FG001|Overall Study|Multiple Reasons|1|||
150104951|NCT01539226|541527005|FG000|Overall Study|not HIV seroconversion-related|93|||
150104952|NCT01539226|541527006|FG001|Overall Study|not HIV seroconversion-related|176|||
150104953|NCT01539226|541527005|FG000|Overall Study|HIV seroconversion-related|55|||
150104954|NCT01539226|541527006|FG001|Overall Study|HIV seroconversion-related|80|||
150104955|NCT01539226|541527005|FG000|Overall Study|Non-compliance|6|||
150104956|NCT01539226|541527006|FG001|Overall Study|Non-compliance|8|||
150104957|NCT01632891|541527007|FG000|Overall Study|Lost to Follow-up|0|||
150104958|NCT01632891|541527008|FG001|Overall Study|Lost to Follow-up|1|||
150104959|NCT01632891|541527007|FG000|Overall Study|Withdrawal by Subject|1|||
150104960|NCT01632891|541527008|FG001|Overall Study|Withdrawal by Subject|0|||
150104961|NCT00782210|541527022|FG000|Overall Study|Adverse Event|21|||
150104962|NCT00782210|541527023|FG001|Overall Study|Adverse Event|17|||
150104963|NCT00782210|541527024|FG002|Overall Study|Adverse Event|16|||
150104964|NCT00782210|541527022|FG000|Overall Study|Lost to Follow-up|2|||
150104965|NCT00782210|541527023|FG001|Overall Study|Lost to Follow-up|1|||
150104966|NCT00782210|541527024|FG002|Overall Study|Lost to Follow-up|2|||
150104967|NCT00782210|541527022|FG000|Overall Study|Withdrawal by Subject|11|||
150104968|NCT00782210|541527023|FG001|Overall Study|Withdrawal by Subject|8|||
150104969|NCT00782210|541527024|FG002|Overall Study|Withdrawal by Subject|11|||
150104970|NCT00782210|541527022|FG000|Overall Study|Non compliance with protocol|0|||
150104971|NCT00782210|541527023|FG001|Overall Study|Non compliance with protocol|3|||
150104972|NCT00782210|541527024|FG002|Overall Study|Non compliance with protocol|2|||
150104973|NCT00782210|541527022|FG000|Overall Study|Lack of Efficacy|13|||
150104974|NCT00782210|541527023|FG001|Overall Study|Lack of Efficacy|4|||
150104975|NCT00782210|541527024|FG002|Overall Study|Lack of Efficacy|1|||
150104976|NCT00782210|541527022|FG000|Overall Study|Other reason not described above|3|||
150104977|NCT00782210|541527023|FG001|Overall Study|Other reason not described above|2|||
150104978|NCT00782210|541527024|FG002|Overall Study|Other reason not described above|3|||
150104979|NCT00436748|541527029|FG000|Overall Study|Ineligibility Determined|1|||
150104980|NCT00436748|541527030|FG001|Overall Study|Ineligibility Determined|1|||
150104981|NCT00436748|541527029|FG000|Overall Study|Adverse Event|0|||
150104982|NCT00436748|541527030|FG001|Overall Study|Adverse Event|2|||
150104983|NCT00436748|541527029|FG000|Overall Study|Consent Withdrawn|1|||
150104984|NCT00436748|541527030|FG001|Overall Study|Consent Withdrawn|4|||
150104985|NCT00436748|541527029|FG000|Overall Study|Administrative Decision|1|||
150104986|NCT00436748|541527030|FG001|Overall Study|Administrative Decision|0|||
150104987|NCT00436748|541527029|FG000|Overall Study|Lost to Follow-up|0|||
150104988|NCT00436748|541527030|FG001|Overall Study|Lost to Follow-up|1|||
150104989|NCT00436748|541527029|FG000|Overall Study|Protocol-specified Criteria|5|||
150104990|NCT00436748|541527030|FG001|Overall Study|Protocol-specified Criteria|4|||
150104991|NCT00436748|541527029|FG000|Overall Study|Other|3|||
150104992|NCT00436748|541527030|FG001|Overall Study|Other|0|||
150104993|NCT01610791|541527031|FG000|Overall Study|Lost to Follow-up|7|||
150104994|NCT01610791|541527031|FG000|Overall Study|Adverse Event|6|||
150104995|NCT01610791|541527031|FG000|Overall Study|Physician Decision|1|||
150104996|NCT01610791|541527031|FG000|Overall Study|Adverse event and Investigator decision|1|||
150104997|NCT01610791|541527031|FG000|Overall Study|Death|1|||
150104998|NCT01610791|541527031|FG000|Overall Study|Not determined|5|||
150104999|NCT02086110|541527045|FG000|Overall Study|Withdrawal by Subject|1|||
150105000|NCT02086110|541527046|FG001|Overall Study|Withdrawal by Subject|1|||
150105001|NCT01869192|541527047|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
150105002|NCT01869192|541527048|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
150105003|NCT01869192|541527047|FG000|Postoperative Chemotherapy|Physician Decision|0|||
150105004|NCT01869192|541527048|FG001|Postoperative Chemotherapy|Physician Decision|2|||
150105005|NCT01203072|541527049|FG000|Overall Study|Adverse Event|5|||
150105006|NCT01203072|541527050|FG001|Overall Study|Adverse Event|3|||
150105007|NCT01203072|541527051|FG002|Overall Study|Adverse Event|2|||
150105008|NCT01203072|541527052|FG003|Overall Study|Adverse Event|4|||
150105009|NCT01203072|541527053|FG004|Overall Study|Adverse Event|2|||
150105010|NCT01203072|541527049|FG000|Overall Study|Lack of Efficacy|1|||
150105011|NCT01203072|541527050|FG001|Overall Study|Lack of Efficacy|0|||
150105012|NCT01203072|541527051|FG002|Overall Study|Lack of Efficacy|0|||
150105013|NCT01203072|541527052|FG003|Overall Study|Lack of Efficacy|0|||
150105014|NCT01203072|541527053|FG004|Overall Study|Lack of Efficacy|0|||
150105015|NCT01203072|541527049|FG000|Overall Study|Lost to Follow-up|0|||
150105016|NCT01203072|541527050|FG001|Overall Study|Lost to Follow-up|1|||
150105017|NCT01203072|541527051|FG002|Overall Study|Lost to Follow-up|0|||
150105018|NCT01203072|541527052|FG003|Overall Study|Lost to Follow-up|0|||
150105019|NCT01203072|541527053|FG004|Overall Study|Lost to Follow-up|0|||
150105020|NCT01203072|541527049|FG000|Overall Study|Protocol Violation|2|||
150105021|NCT01203072|541527050|FG001|Overall Study|Protocol Violation|0|||
150105022|NCT01203072|541527051|FG002|Overall Study|Protocol Violation|0|||
150105023|NCT01203072|541527052|FG003|Overall Study|Protocol Violation|0|||
150105024|NCT01203072|541527053|FG004|Overall Study|Protocol Violation|1|||
150105025|NCT01203072|541527049|FG000|Overall Study|Withdrawal by Subject|2|||
150105026|NCT01203072|541527050|FG001|Overall Study|Withdrawal by Subject|2|||
150105027|NCT01203072|541527051|FG002|Overall Study|Withdrawal by Subject|1|||
150105028|NCT01203072|541527052|FG003|Overall Study|Withdrawal by Subject|2|||
150105029|NCT01203072|541527053|FG004|Overall Study|Withdrawal by Subject|3|||
150105030|NCT02272413|541527055|FG000|Randomized Through Treatment Start|Not treated|3|||
150105031|NCT02272413|541527056|FG001|Randomized Through Treatment Start|Not treated|5|||
150105032|NCT02272413|541527055|FG000|Pre-switch Period|Adverse Event|38|||
150105033|NCT02272413|541527056|FG001|Pre-switch Period|Adverse Event|37|||
150105034|NCT02272413|541527055|FG000|Pre-switch Period|Death|26|||
150105035|NCT02272413|541527056|FG001|Pre-switch Period|Death|26|||
150105036|NCT02272413|541527055|FG000|Pre-switch Period|Withdrawal by Subject|27|||
150105037|NCT02272413|541527056|FG001|Pre-switch Period|Withdrawal by Subject|15|||
150186496|NCT04521478|541823520|FG000|Overall Study|Protocol Violation|2|||
150186497|NCT04521478|541823521|FG001|Overall Study|Protocol Violation|0|||
150105038|NCT02272413|541527055|FG000|Pre-switch Period|Physician Decision|6|||
150105039|NCT02272413|541527056|FG001|Pre-switch Period|Physician Decision|18|||
150105040|NCT02272413|541527055|FG000|Pre-switch Period|Progressive disease|185|||
150105041|NCT02272413|541527056|FG001|Pre-switch Period|Progressive disease|173|||
150105042|NCT02272413|541527055|FG000|Pre-switch Period|Lost to Follow-up|0|||
150105043|NCT02272413|541527056|FG001|Pre-switch Period|Lost to Follow-up|2|||
150105044|NCT02272413|541527055|FG000|Pre-switch Period|Protocol Violation|1|||
150105045|NCT02272413|541527056|FG001|Pre-switch Period|Protocol Violation|0|||
150105046|NCT02272413|541527055|FG000|Pre-switch Period|Other than listed|10|||
150105047|NCT02272413|541527056|FG001|Pre-switch Period|Other than listed|11|||
150105048|NCT02272413|541527055|FG000|Post-switch Period|Adverse Event|4|||
150105049|NCT02272413|541527056|FG001|Post-switch Period|Adverse Event|4|||
150105050|NCT02272413|541527055|FG000|Post-switch Period|Death|3|||
150105051|NCT02272413|541527056|FG001|Post-switch Period|Death|2|||
150105052|NCT02272413|541527055|FG000|Post-switch Period|Withdrawal by Subject|1|||
150105053|NCT02272413|541527056|FG001|Post-switch Period|Withdrawal by Subject|2|||
150105054|NCT02272413|541527055|FG000|Post-switch Period|Physician Decision|1|||
150105055|NCT02272413|541527056|FG001|Post-switch Period|Physician Decision|1|||
150105056|NCT02272413|541527055|FG000|Post-switch Period|Progressive disease|21|||
150105057|NCT02272413|541527056|FG001|Post-switch Period|Progressive disease|21|||
150105058|NCT02272413|541527055|FG000|Post-switch Period|Study terminated by sponsor|8|||
150105059|NCT02272413|541527056|FG001|Post-switch Period|Study terminated by sponsor|11|||
150105060|NCT02272413|541527055|FG000|Post-switch Period|Other than listed|4|||
150105061|NCT02272413|541527056|FG001|Post-switch Period|Other than listed|5|||
150105062|NCT02126969|541527059|FG000|Overall Study|Withdrawal by Subject|1|||
150105063|NCT02126969|541527060|FG001|Overall Study|Withdrawal by Subject|2|||
150105064|NCT01533246|541527068|FG000|Overall Study|Adverse Event|1|||
150105065|NCT01533246|541527068|FG000|Overall Study|Withdrawal by Subject|1|||
150105066|NCT02286193|541527069|FG000|Overall Study|Referred: CRS unable to make contact|62|||
150105067|NCT02286193|541527069|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
150105068|NCT02286193|541527069|FG000|Overall Study|Referred: Declined service|38|||
150105069|NCT00354172|541527070|FG000|Overall Study|Did not receive transplant|1|||
150105070|NCT00423891|541527071|FG000|Enrolled|Withdrawal by Subject|0|||
150105071|NCT00423891|541527072|FG001|Enrolled|Withdrawal by Subject|0|||
150105072|NCT00423891|541527073|FG002|Enrolled|Withdrawal by Subject|1|||
150105073|NCT00423891|541527071|FG000|Enrolled|Lost to Follow-up|0|||
150105074|NCT00423891|541527072|FG001|Enrolled|Lost to Follow-up|0|||
150105075|NCT00423891|541527073|FG002|Enrolled|Lost to Follow-up|1|||
150105076|NCT00423891|541527071|FG000|Enrolled|No longer met criteria|11|||
150105077|NCT00423891|541527072|FG001|Enrolled|No longer met criteria|2|||
150105078|NCT00423891|541527073|FG002|Enrolled|No longer met criteria|1|||
150105079|NCT00423891|541527071|FG000|Treatment|Withdrawal by Subject|1|||
150105080|NCT00423891|541527072|FG001|Treatment|Withdrawal by Subject|0|||
150186498|NCT04521478|541823522|FG002|Overall Study|Protocol Violation|1|||
150186499|NCT04521478|541823523|FG003|Overall Study|Protocol Violation|0|||
150186500|NCT04521478|541823524|FG004|Overall Study|Protocol Violation|0|||
150186501|NCT04521478|541823525|FG005|Overall Study|Protocol Violation|0|||
150186502|NCT04521478|541823520|FG000|Overall Study|Technical Problems|0|||
150186503|NCT04521478|541823521|FG001|Overall Study|Technical Problems|0|||
150186504|NCT04521478|541823522|FG002|Overall Study|Technical Problems|0|||
150186505|NCT04521478|541823523|FG003|Overall Study|Technical Problems|1|||
150186506|NCT04521478|541823524|FG004|Overall Study|Technical Problems|0|||
150186507|NCT04521478|541823525|FG005|Overall Study|Technical Problems|0|||
150186508|NCT04521478|541823520|FG000|Overall Study|Burden of Study Procedures|1|||
150186509|NCT04521478|541823521|FG001|Overall Study|Burden of Study Procedures|0|||
150105081|NCT00423891|541527073|FG002|Treatment|Withdrawal by Subject|0|||
150105082|NCT00423891|541527071|FG000|Treatment|Lost to Follow-up|1|||
150105083|NCT00423891|541527072|FG001|Treatment|Lost to Follow-up|0|||
150105084|NCT00423891|541527073|FG002|Treatment|Lost to Follow-up|0|||
150105085|NCT00423891|541527071|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
150105086|NCT00423891|541527072|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
150105087|NCT00423891|541527073|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
150105088|NCT00423891|541527071|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
150105089|NCT00423891|541527072|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
150105090|NCT00423891|541527073|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
150105091|NCT04225923|541527078|FG000|Overall Study|Protocol Violation|1|||
150186510|NCT04521478|541823522|FG002|Overall Study|Burden of Study Procedures|0|||
150186511|NCT04521478|541823523|FG003|Overall Study|Burden of Study Procedures|1|||
150186512|NCT04521478|541823524|FG004|Overall Study|Burden of Study Procedures|0|||
150105092|NCT04225923|541527079|FG001|Overall Study|Protocol Violation|0|||
150105093|NCT04225923|541527080|FG002|Overall Study|Protocol Violation|1|||
150105094|NCT04225923|541527078|FG000|Overall Study|Withdrawal by Subject|4|||
150105095|NCT04225923|541527079|FG001|Overall Study|Withdrawal by Subject|1|||
150105096|NCT04225923|541527080|FG002|Overall Study|Withdrawal by Subject|3|||
150105097|NCT04225923|541527078|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
150105098|NCT04225923|541527079|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
150105099|NCT04225923|541527080|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
150105100|NCT00855309|541527081|FG000|Overall Study|patient never recieved drug|1|||
150105101|NCT00855309|541527082|FG001|Overall Study|patient never recieved drug|0|||
150105102|NCT01585766|541527083|FG000|Overall Study|Withdrawal by Subject|0|||
150105103|NCT01585766|541527084|FG001|Overall Study|Withdrawal by Subject|1|||
150105104|NCT01585766|541527085|FG002|Overall Study|Withdrawal by Subject|1|||
150105105|NCT01585766|541527086|FG003|Overall Study|Withdrawal by Subject|0|||
150105106|NCT01585766|541527087|FG004|Overall Study|Withdrawal by Subject|0|||
150105107|NCT01585766|541527088|FG005|Overall Study|Withdrawal by Subject|0|||
150105108|NCT01585766|541527083|FG000|Overall Study|Death|0|||
150105109|NCT01585766|541527084|FG001|Overall Study|Death|1|||
150105110|NCT01585766|541527085|FG002|Overall Study|Death|0|||
150105111|NCT01585766|541527086|FG003|Overall Study|Death|0|||
150105112|NCT01585766|541527087|FG004|Overall Study|Death|0|||
150105113|NCT01585766|541527088|FG005|Overall Study|Death|0|||
150105114|NCT01585766|541527083|FG000|Overall Study|Physician Decision|0|||
150105115|NCT01585766|541527084|FG001|Overall Study|Physician Decision|0|||
150105116|NCT01585766|541527085|FG002|Overall Study|Physician Decision|1|||
150186513|NCT04521478|541823525|FG005|Overall Study|Burden of Study Procedures|1|||
150186514|NCT04521478|541823520|FG000|Overall Study|Lack of Efficacy|0|||
150186515|NCT04521478|541823521|FG001|Overall Study|Lack of Efficacy|0|||
150186516|NCT04521478|541823522|FG002|Overall Study|Lack of Efficacy|0|||
150186517|NCT04521478|541823523|FG003|Overall Study|Lack of Efficacy|0|||
150186518|NCT04521478|541823524|FG004|Overall Study|Lack of Efficacy|1|||
150186519|NCT04521478|541823525|FG005|Overall Study|Lack of Efficacy|1|||
150186520|NCT04521478|541823520|FG000|Overall Study|Adverse Event|7|||
150186521|NCT04521478|541823521|FG001|Overall Study|Adverse Event|0|||
150186522|NCT04521478|541823522|FG002|Overall Study|Adverse Event|2|||
150186523|NCT04521478|541823523|FG003|Overall Study|Adverse Event|1|||
150186524|NCT04521478|541823524|FG004|Overall Study|Adverse Event|2|||
150186525|NCT04521478|541823525|FG005|Overall Study|Adverse Event|7|||
150186526|NCT04521478|541823520|FG000|Overall Study|No Reason Available|0|||
150186527|NCT04521478|541823521|FG001|Overall Study|No Reason Available|2|||
150186528|NCT04521478|541823522|FG002|Overall Study|No Reason Available|0|||
150186529|NCT04521478|541823523|FG003|Overall Study|No Reason Available|0|||
150186530|NCT04521478|541823524|FG004|Overall Study|No Reason Available|1|||
150186531|NCT04521478|541823525|FG005|Overall Study|No Reason Available|0|||
150186532|NCT04521478|541823520|FG000|Overall Study|Other than listed|3|||
150186533|NCT04521478|541823521|FG001|Overall Study|Other than listed|3|||
150186534|NCT04521478|541823522|FG002|Overall Study|Other than listed|3|||
150186535|NCT04521478|541823523|FG003|Overall Study|Other than listed|2|||
150186536|NCT04521478|541823524|FG004|Overall Study|Other than listed|3|||
150186537|NCT04521478|541823525|FG005|Overall Study|Other than listed|3|||
150186538|NCT04521478|541823520|FG000|Overall Study|Not treated|0|||
150186539|NCT04521478|541823521|FG001|Overall Study|Not treated|0|||
150186540|NCT04521478|541823522|FG002|Overall Study|Not treated|0|||
150186541|NCT04521478|541823523|FG003|Overall Study|Not treated|0|||
150186542|NCT04521478|541823524|FG004|Overall Study|Not treated|0|||
150105117|NCT01585766|541527086|FG003|Overall Study|Physician Decision|0|||
150105118|NCT01585766|541527087|FG004|Overall Study|Physician Decision|0|||
150105119|NCT01585766|541527088|FG005|Overall Study|Physician Decision|0|||
150105120|NCT04116710|541527089|FG000|Overall Study|Death|4|||
150105121|NCT04116710|541527090|FG001|Overall Study|Death|6|||
150105122|NCT04116710|541527091|FG002|Overall Study|Death|3|||
150105123|NCT04116710|541527092|FG003|Overall Study|Death|1|||
150105124|NCT04116710|541527089|FG000|Overall Study|Withdrawal by Subject|0|||
150105125|NCT04116710|541527090|FG001|Overall Study|Withdrawal by Subject|0|||
150105126|NCT04116710|541527091|FG002|Overall Study|Withdrawal by Subject|0|||
150105127|NCT04116710|541527092|FG003|Overall Study|Withdrawal by Subject|1|||
150186543|NCT04521478|541823525|FG005|Overall Study|Not treated|1|||
150186544|NCT05062265|541823526|FG000|Overall Study|Withdrawal by Subject|1|||
150186545|NCT05062265|541823527|FG001|Overall Study|Withdrawal by Subject|0|||
150105128|NCT01256593|541527095|FG000|Overall Study|Protocol Violation|26|||
150105129|NCT01256593|541527095|FG000|Overall Study|No Drug Administration Information|2|||
150186546|NCT03692676|541823530|FG000|Overall Study|exclude patients with prior use|4424|||
150186547|NCT03692676|541823531|FG001|Overall Study|exclude patients with prior use|24726|||
150186548|NCT03692676|541823532|FG002|Overall Study|exclude patients with prior use|0|||
150186549|NCT03692676|541823533|FG003|Overall Study|exclude patients with prior use|0|||
150186550|NCT03692676|541823530|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
150186551|NCT03692676|541823531|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
150186552|NCT03692676|541823532|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
150186553|NCT03692676|541823533|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
150186554|NCT03692676|541823530|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
150105130|NCT01256593|541527095|FG000|Overall Study|No Visit After Treatment|186|||
150105131|NCT00582933|541527096|FG000|Overall Study|Physician Decision|3|||
150105132|NCT01371656|541527097|FG000|Overall Study|Death|7|||
150105133|NCT01371656|541527098|FG001|Overall Study|Death|4|||
150105134|NCT01371656|541527097|FG000|Overall Study|Physician Decision|46|||
150105135|NCT01371656|541527098|FG001|Overall Study|Physician Decision|7|||
150105136|NCT01371656|541527097|FG000|Overall Study|Withdrawal by Subject|7|||
150105137|NCT01371656|541527098|FG001|Overall Study|Withdrawal by Subject|0|||
150105138|NCT01371656|541527097|FG000|Overall Study|Ineligible|4|||
150105139|NCT01371656|541527098|FG001|Overall Study|Ineligible|3|||
150105140|NCT04334460|541527104|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
150105141|NCT04334460|541527105|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
150105142|NCT04334460|541527104|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
150105143|NCT04334460|541527105|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
150105144|NCT02376166|541527110|FG000|Overall Study|Adverse Event|1|||
150105145|NCT02376166|541527110|FG000|Overall Study|Discontinued metformin early|2|||
150105146|NCT01068509|541527115|FG000|Overall Study|Death|0|||
150105147|NCT01068509|541527116|FG001|Overall Study|Death|0|||
150105148|NCT01068509|541527117|FG002|Overall Study|Death|1|||
150105149|NCT01068509|541527115|FG000|Overall Study|Disease Progression|5|||
150105150|NCT01068509|541527116|FG001|Overall Study|Disease Progression|20|||
150105151|NCT01068509|541527117|FG002|Overall Study|Disease Progression|18|||
150105152|NCT01068509|541527115|FG000|Overall Study|Lost to Follow-up|1|||
150105153|NCT01068509|541527116|FG001|Overall Study|Lost to Follow-up|0|||
150105154|NCT01068509|541527117|FG002|Overall Study|Lost to Follow-up|0|||
150105155|NCT01068509|541527115|FG000|Overall Study|Withdrew Consent|0|||
150105156|NCT01068509|541527116|FG001|Overall Study|Withdrew Consent|1|||
150105157|NCT01068509|541527117|FG002|Overall Study|Withdrew Consent|2|||
150105158|NCT01068509|541527115|FG000|Overall Study|Reason Not Specified|0|||
150105159|NCT01068509|541527116|FG001|Overall Study|Reason Not Specified|1|||
150105160|NCT01068509|541527117|FG002|Overall Study|Reason Not Specified|0|||
150105161|NCT01712256|541527133|FG000|Overall Study|Lost to Follow-up|1|||
150105162|NCT00962104|541527134|FG000|Overall Study|Adverse Event|10|||
150105163|NCT00962104|541527135|FG001|Overall Study|Adverse Event|3|||
150105164|NCT00962104|541527134|FG000|Overall Study|Entry Criteria Not Met|1|||
150105165|NCT00962104|541527135|FG001|Overall Study|Entry Criteria Not Met|2|||
150105166|NCT00962104|541527134|FG000|Overall Study|Lack of Efficacy|0|||
150105167|NCT00962104|541527135|FG001|Overall Study|Lack of Efficacy|1|||
150105168|NCT00962104|541527134|FG000|Overall Study|Lost to Follow-up|10|||
150105169|NCT00962104|541527135|FG001|Overall Study|Lost to Follow-up|4|||
150105170|NCT00962104|541527134|FG000|Overall Study|Physician Decision|1|||
150105171|NCT00962104|541527135|FG001|Overall Study|Physician Decision|0|||
150105172|NCT00962104|541527134|FG000|Overall Study|Protocol Violation|6|||
150105173|NCT00962104|541527135|FG001|Overall Study|Protocol Violation|8|||
150105174|NCT00962104|541527134|FG000|Overall Study|Sponsor Decision|0|||
150105175|NCT00962104|541527135|FG001|Overall Study|Sponsor Decision|1|||
150105176|NCT00962104|541527134|FG000|Overall Study|Withdrawal by Subject|10|||
150105177|NCT00962104|541527135|FG001|Overall Study|Withdrawal by Subject|6|||
150105178|NCT00962104|541527134|FG000|Overall Study|Other|2|||
150105179|NCT00962104|541527135|FG001|Overall Study|Other|0|||
150105180|NCT03913091|541527141|FG000|Overall Study|Lost to Follow-up|18|||
150105181|NCT03913091|541527142|FG001|Overall Study|Lost to Follow-up|11|||
150105182|NCT03913091|541527141|FG000|Overall Study|Required additional meds/surgery|1|||
150105183|NCT03913091|541527142|FG001|Overall Study|Required additional meds/surgery|2|||
150105184|NCT03913091|541527141|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
150105185|NCT03913091|541527142|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
150105186|NCT02196324|541527144|FG000|Overall Study|Withdrawal by Subject|8|||
150105187|NCT02196324|541527145|FG001|Overall Study|Withdrawal by Subject|4|||
150105188|NCT02196324|541527144|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
150105189|NCT02196324|541527145|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
150105190|NCT02196324|541527144|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
150105191|NCT02196324|541527145|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
150186555|NCT03692676|541823531|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
150186556|NCT03692676|541823532|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
150186557|NCT03692676|541823533|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
150186558|NCT03692676|541823530|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
150186559|NCT03692676|541823531|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
150186560|NCT03692676|541823532|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
150186561|NCT03692676|541823533|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
150186562|NCT03692676|541823530|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
150186563|NCT03692676|541823531|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
150186564|NCT03692676|541823532|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
150186565|NCT03692676|541823533|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
150186566|NCT03692676|541823530|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
150186567|NCT03692676|541823531|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
150186568|NCT03692676|541823532|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
150186569|NCT03692676|541823533|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
150186570|NCT03692676|541823530|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
150186571|NCT03692676|541823531|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
150186572|NCT03692676|541823532|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
150186573|NCT03692676|541823533|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
150186574|NCT03692676|541823530|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
150186575|NCT03692676|541823531|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
150186576|NCT03692676|541823532|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
150186577|NCT03692676|541823533|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
150186578|NCT03692676|541823530|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
150186579|NCT03692676|541823531|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
150186580|NCT03692676|541823532|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
150186581|NCT03692676|541823533|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
150186582|NCT03692676|541823530|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
150186583|NCT03692676|541823531|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
150186584|NCT03692676|541823532|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
150186585|NCT03692676|541823533|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
150186586|NCT03692676|541823530|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
150105192|NCT02196324|541527144|FG000|Overall Study|Other|1|||
150105193|NCT02196324|541527145|FG001|Overall Study|Other|0|||
150105194|NCT04243538|541527146|FG000|Overall Study|Withdrawal by Subject|0|||
150105195|NCT04243538|541527147|FG001|Overall Study|Withdrawal by Subject|2|||
150105196|NCT04243538|541527146|FG000|Overall Study|Lost to Follow-up|0|||
150105197|NCT04243538|541527147|FG001|Overall Study|Lost to Follow-up|3|||
150105198|NCT00655564|541527148|FG000|Overall Study|Adverse Event|1|||
150105199|NCT00655564|541527148|FG000|Overall Study|Lost to Follow-up|1|||
150105200|NCT00655564|541527148|FG000|Overall Study|Desired Alternate Therapy|1|||
150105201|NCT04536727|541527149|FG000|Overall Study|Lost to Follow-up|1|||
150105202|NCT04536727|541527150|FG001|Overall Study|Lost to Follow-up|1|||
150105203|NCT04536727|541527149|FG000|Overall Study|Death|0|||
150105204|NCT04536727|541527150|FG001|Overall Study|Death|1|||
150105205|NCT00344773|541527151|FG000|Overall Study|Adverse Event|2|||
150105206|NCT00344773|541527151|FG000|Overall Study|Objective Disease Progression|16|||
150105207|NCT00344773|541527151|FG000|Overall Study|Withdrawal by Subject|1|||
150105208|NCT00344773|541527151|FG000|Overall Study|Not Eligible for the study|2|||
150105209|NCT00500370|541527158|FG000|Overall Study|Adverse Event|9|||
150105210|NCT00500370|541527159|FG001|Overall Study|Adverse Event|3|||
150105211|NCT00500370|541527158|FG000|Overall Study|Lost to Follow-up|10|||
150105212|NCT00500370|541527159|FG001|Overall Study|Lost to Follow-up|10|||
150105213|NCT00500370|541527158|FG000|Overall Study|Protocol Violation|2|||
150105214|NCT00500370|541527159|FG001|Overall Study|Protocol Violation|4|||
150105215|NCT00500370|541527158|FG000|Overall Study|Sponsor Decision|2|||
150105216|NCT00500370|541527159|FG001|Overall Study|Sponsor Decision|0|||
150105217|NCT00500370|541527158|FG000|Overall Study|Subject Decision|10|||
150105218|NCT00500370|541527159|FG001|Overall Study|Subject Decision|17|||
150105219|NCT05627518|541527160|FG000|Treatment Period 1|Adverse Event|0|||
150105220|NCT05627518|541527161|FG001|Treatment Period 1|Adverse Event|0|||
150105221|NCT05627518|541527162|FG002|Treatment Period 1|Adverse Event|1|||
150105222|NCT05627518|541527163|FG003|Treatment Period 1|Adverse Event|0|||
150105223|NCT05627518|541527164|FG004|Treatment Period 1|Adverse Event|0|||
150105224|NCT05627518|541527165|FG005|Treatment Period 1|Adverse Event|0|||
150105225|NCT05627518|541527166|FG006|Treatment Period 1|Adverse Event|0|||
150105226|NCT05627518|541527167|FG007|Treatment Period 1|Adverse Event|1|||
150105227|NCT05627518|541527160|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150105228|NCT05627518|541527161|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150105229|NCT05627518|541527162|FG002|Treatment Period 1|Withdrawal by Subject|1|||
150105230|NCT05627518|541527163|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150105231|NCT05627518|541527164|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150105232|NCT05627518|541527165|FG005|Treatment Period 1|Withdrawal by Subject|1|||
150105233|NCT05627518|541527166|FG006|Treatment Period 1|Withdrawal by Subject|0|||
150105234|NCT05627518|541527167|FG007|Treatment Period 1|Withdrawal by Subject|0|||
150105235|NCT05627518|541527160|FG000|Treatment Period 1|Protocol Violation|0|||
150105236|NCT05627518|541527161|FG001|Treatment Period 1|Protocol Violation|0|||
150105237|NCT05627518|541527162|FG002|Treatment Period 1|Protocol Violation|0|||
150105238|NCT05627518|541527163|FG003|Treatment Period 1|Protocol Violation|0|||
150105239|NCT05627518|541527164|FG004|Treatment Period 1|Protocol Violation|0|||
150105240|NCT05627518|541527165|FG005|Treatment Period 1|Protocol Violation|0|||
150105241|NCT05627518|541527166|FG006|Treatment Period 1|Protocol Violation|6|||
150105242|NCT05627518|541527167|FG007|Treatment Period 1|Protocol Violation|6|||
150105243|NCT05627518|541527160|FG000|Treatment Period 2|Adverse Event|1|||
150105244|NCT05627518|541527161|FG001|Treatment Period 2|Adverse Event|0|||
150105245|NCT05627518|541527162|FG002|Treatment Period 2|Adverse Event|0|||
150105246|NCT05627518|541527163|FG003|Treatment Period 2|Adverse Event|0|||
150105247|NCT05627518|541527164|FG004|Treatment Period 2|Adverse Event|0|||
150105248|NCT05627518|541527165|FG005|Treatment Period 2|Adverse Event|0|||
150105249|NCT05627518|541527166|FG006|Treatment Period 2|Adverse Event|0|||
150105250|NCT05627518|541527167|FG007|Treatment Period 2|Adverse Event|0|||
150105251|NCT05627518|541527160|FG000|Treatment Period 2|Withdrawal by Subject|1|||
150105252|NCT05627518|541527161|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150105253|NCT05627518|541527162|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150105254|NCT05627518|541527163|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150105255|NCT05627518|541527164|FG004|Treatment Period 2|Withdrawal by Subject|0|||
150105256|NCT05627518|541527165|FG005|Treatment Period 2|Withdrawal by Subject|0|||
150105257|NCT05627518|541527166|FG006|Treatment Period 2|Withdrawal by Subject|0|||
150105258|NCT05627518|541527167|FG007|Treatment Period 2|Withdrawal by Subject|0|||
150105259|NCT02917031|541527168|FG000|Overall Study|Reason not specified|7|||
150105260|NCT02917031|541527169|FG001|Overall Study|Reason not specified|5|||
150105261|NCT02917031|541527170|FG002|Overall Study|Reason not specified|6|||
150105262|NCT02917031|541527168|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
150105263|NCT02917031|541527169|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
150105264|NCT02917031|541527170|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
150105265|NCT02917031|541527168|FG000|Overall Study|Withdrawal by Subject|3|||
150105266|NCT02917031|541527169|FG001|Overall Study|Withdrawal by Subject|3|||
150105267|NCT02917031|541527170|FG002|Overall Study|Withdrawal by Subject|0|||
150105268|NCT02917031|541527168|FG000|Overall Study|Physician Decision|1|||
150105269|NCT02917031|541527169|FG001|Overall Study|Physician Decision|0|||
150105270|NCT02917031|541527170|FG002|Overall Study|Physician Decision|0|||
150105271|NCT02917031|541527168|FG000|Overall Study|Adverse Event|4|||
150105272|NCT02917031|541527169|FG001|Overall Study|Adverse Event|1|||
150105273|NCT02917031|541527170|FG002|Overall Study|Adverse Event|5|||
150105274|NCT02917031|541527168|FG000|Overall Study|Death|2|||
150105275|NCT02917031|541527169|FG001|Overall Study|Death|3|||
150105276|NCT02917031|541527170|FG002|Overall Study|Death|4|||
150105277|NCT01581593|541528952|FG000|Overall Study|Withdrawal by Subject|1|||
150105278|NCT05308901|541528957|FG000|Overall Study|Death|6|||
150105279|NCT01914666|541528961|FG000|Treatment Period|Lack of Efficacy|0|||
150105280|NCT01914666|541528962|FG001|Treatment Period|Lack of Efficacy|0|||
150105281|NCT01914666|541528963|FG002|Treatment Period|Lack of Efficacy|2|||
150105282|NCT01914666|541528961|FG000|Treatment Period|Adverse Event|10|||
150105283|NCT01914666|541528962|FG001|Treatment Period|Adverse Event|4|||
150105284|NCT01914666|541528963|FG002|Treatment Period|Adverse Event|2|||
150105285|NCT01914666|541528961|FG000|Treatment Period|Withdrawal by Subject|3|||
150105286|NCT01914666|541528962|FG001|Treatment Period|Withdrawal by Subject|2|||
150105287|NCT01914666|541528963|FG002|Treatment Period|Withdrawal by Subject|2|||
150105288|NCT01914666|541528961|FG000|Treatment Period|Physician Decision|0|||
150105289|NCT01914666|541528962|FG001|Treatment Period|Physician Decision|0|||
150105290|NCT01914666|541528963|FG002|Treatment Period|Physician Decision|2|||
150105291|NCT02586012|541528964|FG000|Overall Study|Withdrawal by Subject|1|||
150105292|NCT02586012|541528965|FG001|Overall Study|Withdrawal by Subject|1|||
150186587|NCT03692676|541823531|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
150105293|NCT02586012|541528966|FG002|Overall Study|Withdrawal by Subject|0|||
150105294|NCT02586012|541528967|FG003|Overall Study|Withdrawal by Subject|1|||
150105295|NCT02586012|541528968|FG004|Overall Study|Withdrawal by Subject|0|||
150105296|NCT02586012|541528969|FG005|Overall Study|Withdrawal by Subject|2|||
150105297|NCT02586012|541528964|FG000|Overall Study|Protocol Violation|0|||
150105298|NCT02586012|541528965|FG001|Overall Study|Protocol Violation|0|||
150105299|NCT02586012|541528966|FG002|Overall Study|Protocol Violation|0|||
150105300|NCT02586012|541528967|FG003|Overall Study|Protocol Violation|0|||
150105301|NCT02586012|541528968|FG004|Overall Study|Protocol Violation|0|||
150105302|NCT02586012|541528969|FG005|Overall Study|Protocol Violation|1|||
150105303|NCT02586012|541528964|FG000|Overall Study|study terminated|0|||
150105304|NCT02586012|541528965|FG001|Overall Study|study terminated|2|||
150105305|NCT02586012|541528966|FG002|Overall Study|study terminated|1|||
150105306|NCT02586012|541528967|FG003|Overall Study|study terminated|1|||
150105307|NCT02586012|541528968|FG004|Overall Study|study terminated|1|||
150105308|NCT02586012|541528969|FG005|Overall Study|study terminated|0|||
150105309|NCT03252522|541528970|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
150105310|NCT03252522|541528971|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
150105311|NCT03252522|541528972|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
150105312|NCT03252522|541528970|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
150105313|NCT03252522|541528971|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
150105314|NCT03252522|541528972|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
150105315|NCT03252522|541528970|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
150105316|NCT03252522|541528971|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
150105317|NCT03252522|541528972|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
150105318|NCT03252522|541528970|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
150105319|NCT03252522|541528971|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
150105320|NCT03252522|541528972|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
150105321|NCT03252522|541528970|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
150105322|NCT03252522|541528971|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
150105323|NCT03252522|541528972|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
150105324|NCT03252522|541528970|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
150105325|NCT03252522|541528971|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
150105326|NCT03252522|541528972|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
150105327|NCT03252522|541528970|FG000|Phase 2: Open Label|Adverse Event|0|||
150105328|NCT03252522|541528971|FG001|Phase 2: Open Label|Adverse Event|0|||
150105329|NCT03252522|541528972|FG002|Phase 2: Open Label|Adverse Event|2|||
150105330|NCT03252522|541528970|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
150105331|NCT03252522|541528971|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
150105332|NCT03252522|541528972|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
150105333|NCT03299842|541528974|FG000|Overall Study|Caregiver withdrew consent|2|||
150105334|NCT03299842|541528974|FG000|Overall Study|Child would not keep the watch on|3|||
150105335|NCT00071812|541528975|FG000|24-Week Double-Blind Period|Adverse Event|2|||
150105336|NCT00071812|541528976|FG001|24-Week Double-Blind Period|Adverse Event|3|||
150105337|NCT00071812|541528977|FG002|24-Week Double-Blind Period|Adverse Event|4|||
150105338|NCT00071812|541528978|FG003|24-Week Double-Blind Period|Adverse Event|4|||
150105339|NCT00071812|541528975|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
150105340|NCT00071812|541528976|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
150105341|NCT00071812|541528977|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
150105342|NCT00071812|541528978|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
150105343|NCT00071812|541528975|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
150105344|NCT00071812|541528976|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
150105345|NCT00071812|541528977|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
150105346|NCT00071812|541528978|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
150105347|NCT00071812|541528975|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
150105348|NCT00071812|541528976|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
150105349|NCT00071812|541528977|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
150105350|NCT00071812|541528978|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
150105351|NCT00071812|541528975|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
150105352|NCT00071812|541528976|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
150105353|NCT00071812|541528977|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
150105354|NCT00071812|541528978|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
150105355|NCT00071812|541528975|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
150105356|NCT00071812|541528976|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
150105357|NCT00071812|541528977|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
150105358|NCT00071812|541528978|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
150105359|NCT00071812|541528975|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150105360|NCT00071812|541528976|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150105361|NCT00071812|541528977|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150105362|NCT00071812|541528978|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
150105363|NCT00071812|541528975|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150105364|NCT00071812|541528976|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150105365|NCT00071812|541528977|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150105366|NCT00071812|541528978|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
150105367|NCT00071812|541528975|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150105368|NCT00071812|541528976|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150105369|NCT00071812|541528977|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150105370|NCT00071812|541528978|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
150105371|NCT00071812|541528975|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
150105372|NCT00071812|541528976|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
150105373|NCT00071812|541528977|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
150105374|NCT00071812|541528978|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
150105375|NCT01816139|541528979|FG000|Overall Study|Adverse Event|6|||
150105376|NCT01816139|541528980|FG001|Overall Study|Adverse Event|8|||
150105377|NCT01816139|541528979|FG000|Overall Study|Lack of Efficacy|1|||
150105378|NCT01816139|541528980|FG001|Overall Study|Lack of Efficacy|2|||
150105379|NCT01816139|541528979|FG000|Overall Study|Lost to Follow-up|5|||
150105380|NCT01816139|541528980|FG001|Overall Study|Lost to Follow-up|3|||
150105381|NCT01816139|541528979|FG000|Overall Study|Withdrew Consent|6|||
150105382|NCT01816139|541528980|FG001|Overall Study|Withdrew Consent|4|||
150105383|NCT01816139|541528979|FG000|Overall Study|Protocol Violation|6|||
150105384|NCT01816139|541528980|FG001|Overall Study|Protocol Violation|3|||
150105385|NCT01816139|541528979|FG000|Overall Study|Reason not Specified|4|||
150105386|NCT01816139|541528980|FG001|Overall Study|Reason not Specified|2|||
150105387|NCT01940120|541528983|FG000|Overall Study|Death|40|||
150105388|NCT01940120|541528983|FG000|Overall Study|Withdrawal by Subject|8|||
150105389|NCT03277846|541528984|FG000|Overall Study|Inpatient stay too brief|12|||
150105390|NCT03277846|541528985|FG001|Overall Study|Inpatient stay too brief|11|||
150105391|NCT02554656|541528986|FG000|Overall Study|Protocol Violation|3|||
150105392|NCT03240575|541528987|FG000|Overall Study|Adverse Event|0|||
150105393|NCT03240575|541528988|FG001|Overall Study|Adverse Event|2|||
150105394|NCT03240575|541528989|FG002|Overall Study|Adverse Event|0|||
150105395|NCT03240575|541528990|FG003|Overall Study|Adverse Event|1|||
150105396|NCT03240575|541528987|FG000|Overall Study|Withdrawal by Subject|2|||
150105397|NCT03240575|541528988|FG001|Overall Study|Withdrawal by Subject|11|||
150105398|NCT03240575|541528989|FG002|Overall Study|Withdrawal by Subject|0|||
150105399|NCT03240575|541528990|FG003|Overall Study|Withdrawal by Subject|1|||
150105400|NCT03240575|541528987|FG000|Overall Study|Other|0|||
150105401|NCT03240575|541528988|FG001|Overall Study|Other|1|||
150105402|NCT03240575|541528989|FG002|Overall Study|Other|0|||
150105403|NCT03240575|541528990|FG003|Overall Study|Other|0|||
150105404|NCT03568942|541528997|FG000|Overall Study|Family emergency|1|||
150105405|NCT03568942|541528997|FG000|Overall Study|Lost to Follow-up|1|||
150105406|NCT02433834|541528998|FG000|Overall Study|Protocol-specified criteria|7|||
150105407|NCT02433834|541528998|FG000|Overall Study|Protocol Violation|3|||
150105408|NCT02433834|541528998|FG000|Overall Study|Lost to Follow-up|6|||
150105409|NCT02433834|541528998|FG000|Overall Study|Withdrawal by Subject|14|||
150105410|NCT02433834|541528998|FG000|Overall Study|Adverse Event|6|||
150105411|NCT02433834|541528998|FG000|Overall Study|Physician Decision|1|||
150105412|NCT00283439|541528999|FG000|Overall Study|Adverse Event|0|||
150105413|NCT00283439|541529000|FG001|Overall Study|Adverse Event|0|||
150105414|NCT00283439|541529001|FG002|Overall Study|Adverse Event|0|||
150105415|NCT00283439|541529002|FG003|Overall Study|Adverse Event|1|||
150105416|NCT00283439|541528999|FG000|Overall Study|Death|0|||
150105417|NCT00283439|541529000|FG001|Overall Study|Death|0|||
150105418|NCT00283439|541529001|FG002|Overall Study|Death|1|||
150105419|NCT00283439|541529002|FG003|Overall Study|Death|0|||
150105420|NCT00283439|541528999|FG000|Overall Study|Disease progression|0|||
150105421|NCT00283439|541529000|FG001|Overall Study|Disease progression|1|||
150105422|NCT00283439|541529001|FG002|Overall Study|Disease progression|0|||
150186588|NCT03692676|541823532|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
150105423|NCT00283439|541529002|FG003|Overall Study|Disease progression|0|||
150105424|NCT00283439|541528999|FG000|Overall Study|Requirement for alternative therapy|1|||
150105425|NCT00283439|541529000|FG001|Overall Study|Requirement for alternative therapy|2|||
150105426|NCT00283439|541529001|FG002|Overall Study|Requirement for alternative therapy|5|||
150105427|NCT00283439|541529002|FG003|Overall Study|Requirement for alternative therapy|2|||
150105428|NCT00283439|541528999|FG000|Overall Study|Stem cell transplant|6|||
150186589|NCT03692676|541823533|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
150186590|NCT03692676|541823530|FG000|Overall Study|Other|0|||
150186591|NCT03692676|541823531|FG001|Overall Study|Other|805|||
150186592|NCT03692676|541823532|FG002|Overall Study|Other|758|||
150186593|NCT03692676|541823533|FG003|Overall Study|Other|277|||
150186594|NCT03692676|541823530|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
150186595|NCT03692676|541823531|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
150186596|NCT03692676|541823532|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
150186597|NCT03692676|541823533|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
150186598|NCT01180634|541823534|FG000|Overall Study|Adverse Event|4|||
150186599|NCT01180634|541823535|FG001|Overall Study|Adverse Event|1|||
150186600|NCT01180634|541823534|FG000|Overall Study|Miscellaneous|2|||
150186601|NCT01180634|541823535|FG001|Overall Study|Miscellaneous|0|||
150186602|NCT01180634|541823534|FG000|Overall Study|Withdrawal by Subject|4|||
150186603|NCT01180634|541823535|FG001|Overall Study|Withdrawal by Subject|0|||
150186604|NCT03692611|541823536|FG000|Overall Study|Found to be ineligible postrandomization|3|||
150186605|NCT03692611|541823537|FG001|Overall Study|Found to be ineligible postrandomization|0|||
150186606|NCT04490915|541823539|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
150186607|NCT04490915|541823540|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
150186608|NCT04490915|541823539|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
150186609|NCT04490915|541823540|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
150186610|NCT04490915|541823539|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
150186611|NCT04490915|541823540|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
150186612|NCT04490915|541823539|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
150186613|NCT04490915|541823540|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
150186614|NCT04490915|541823539|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
150186615|NCT04490915|541823540|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
150186616|NCT04490915|541823539|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
150186617|NCT04490915|541823540|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
150186618|NCT04490915|541823539|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
150186619|NCT04490915|541823540|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
150186620|NCT06311084|541823541|FG000|Overall Study|Lost to Follow-up|14|||
150186621|NCT04725240|541823542|FG000|Overall Study|Adverse Event|2|||
150186622|NCT02312960|541823549|FG000|Overall Study|Death|24|||
150186623|NCT02312960|541823550|FG001|Overall Study|Death|32|||
150186624|NCT02312960|541823551|FG002|Overall Study|Death|25|||
150186625|NCT02312960|541823552|FG003|Overall Study|Death|11|||
150186626|NCT02312960|541823553|FG004|Overall Study|Death|5|||
150186627|NCT02312960|541823554|FG005|Overall Study|Death|5|||
150186628|NCT02312960|541823555|FG006|Overall Study|Death|8|||
150186629|NCT02312960|541823556|FG007|Overall Study|Death|5|||
150186630|NCT02312960|541823557|FG008|Overall Study|Death|7|||
150186631|NCT02312960|541823558|FG009|Overall Study|Death|3|||
150186632|NCT02312960|541823559|FG010|Overall Study|Death|3|||
150186633|NCT02312960|541823560|FG011|Overall Study|Death|1|||
150186634|NCT02312960|541823561|FG012|Overall Study|Death|25|||
150186635|NCT02312960|541823562|FG013|Overall Study|Death|19|||
150186636|NCT02312960|541823549|FG000|Overall Study|Missing|0|||
150186637|NCT02312960|541823550|FG001|Overall Study|Missing|0|||
150186638|NCT02312960|541823551|FG002|Overall Study|Missing|2|||
150186639|NCT02312960|541823552|FG003|Overall Study|Missing|0|||
150186640|NCT02312960|541823553|FG004|Overall Study|Missing|0|||
150186641|NCT02312960|541823554|FG005|Overall Study|Missing|0|||
150186642|NCT02312960|541823555|FG006|Overall Study|Missing|0|||
150186643|NCT02312960|541823556|FG007|Overall Study|Missing|0|||
150186644|NCT02312960|541823557|FG008|Overall Study|Missing|0|||
150186645|NCT02312960|541823558|FG009|Overall Study|Missing|0|||
150186646|NCT02312960|541823559|FG010|Overall Study|Missing|0|||
150186647|NCT02312960|541823560|FG011|Overall Study|Missing|0|||
150186648|NCT02312960|541823561|FG012|Overall Study|Missing|0|||
150186649|NCT02312960|541823562|FG013|Overall Study|Missing|0|||
150186650|NCT02312960|541823549|FG000|Overall Study|Lost to Follow-up|0|||
150186651|NCT02312960|541823550|FG001|Overall Study|Lost to Follow-up|0|||
150186652|NCT02312960|541823551|FG002|Overall Study|Lost to Follow-up|1|||
150186653|NCT02312960|541823552|FG003|Overall Study|Lost to Follow-up|0|||
150186654|NCT02312960|541823553|FG004|Overall Study|Lost to Follow-up|0|||
150186655|NCT02312960|541823554|FG005|Overall Study|Lost to Follow-up|0|||
150186656|NCT02312960|541823555|FG006|Overall Study|Lost to Follow-up|1|||
150186657|NCT02312960|541823556|FG007|Overall Study|Lost to Follow-up|1|||
150186658|NCT02312960|541823557|FG008|Overall Study|Lost to Follow-up|0|||
150186659|NCT02312960|541823558|FG009|Overall Study|Lost to Follow-up|1|||
150186660|NCT02312960|541823559|FG010|Overall Study|Lost to Follow-up|0|||
150186661|NCT02312960|541823560|FG011|Overall Study|Lost to Follow-up|0|||
150186662|NCT02312960|541823561|FG012|Overall Study|Lost to Follow-up|1|||
150186663|NCT02312960|541823562|FG013|Overall Study|Lost to Follow-up|0|||
150186664|NCT02312960|541823549|FG000|Overall Study|Withdrawal by Subject|1|||
150186665|NCT02312960|541823550|FG001|Overall Study|Withdrawal by Subject|2|||
150186666|NCT02312960|541823551|FG002|Overall Study|Withdrawal by Subject|0|||
150186667|NCT02312960|541823552|FG003|Overall Study|Withdrawal by Subject|0|||
150186668|NCT02312960|541823553|FG004|Overall Study|Withdrawal by Subject|1|||
150186669|NCT02312960|541823554|FG005|Overall Study|Withdrawal by Subject|0|||
150186670|NCT02312960|541823555|FG006|Overall Study|Withdrawal by Subject|1|||
150186671|NCT02312960|541823556|FG007|Overall Study|Withdrawal by Subject|2|||
150186672|NCT02312960|541823557|FG008|Overall Study|Withdrawal by Subject|2|||
150186673|NCT02312960|541823558|FG009|Overall Study|Withdrawal by Subject|3|||
150186674|NCT02312960|541823559|FG010|Overall Study|Withdrawal by Subject|0|||
150186675|NCT02312960|541823560|FG011|Overall Study|Withdrawal by Subject|0|||
150186676|NCT02312960|541823561|FG012|Overall Study|Withdrawal by Subject|2|||
150186677|NCT02312960|541823562|FG013|Overall Study|Withdrawal by Subject|0|||
150186678|NCT04060355|541823563|FG000|Overall Study|Lost to Follow-up|41|||
150186679|NCT01140880|541823564|FG000|Overall Study|Death|0|||
150186680|NCT01140880|541823565|FG001|Overall Study|Death|1|||
150186681|NCT01140880|541823564|FG000|Overall Study|Withdrawal by Subject|6|||
150186682|NCT01140880|541823565|FG001|Overall Study|Withdrawal by Subject|3|||
150186683|NCT01140880|541823564|FG000|Overall Study|Lost to Follow-up|8|||
150186684|NCT01140880|541823565|FG001|Overall Study|Lost to Follow-up|10|||
150186685|NCT01140880|541823564|FG000|Overall Study|Protocol Violation|0|||
150186686|NCT01140880|541823565|FG001|Overall Study|Protocol Violation|30|||
150186687|NCT02724878|541823566|FG000|Overall Study|Still on Active Therapy|15|||
150186688|NCT02724878|541823566|FG000|Overall Study|Disease Progression|31|||
150186689|NCT02724878|541823566|FG000|Overall Study|Toxicity|5|||
150186690|NCT02724878|541823566|FG000|Overall Study|Death|1|||
150105429|NCT00283439|541529000|FG001|Overall Study|Stem cell transplant|6|||
150105430|NCT00283439|541529001|FG002|Overall Study|Stem cell transplant|4|||
150105431|NCT00283439|541529002|FG003|Overall Study|Stem cell transplant|3|||
150105432|NCT00283439|541528999|FG000|Overall Study|Treatment discontinued|0|||
150105433|NCT00283439|541529000|FG001|Overall Study|Treatment discontinued|2|||
150105434|NCT00283439|541529001|FG002|Overall Study|Treatment discontinued|1|||
150105435|NCT00283439|541529002|FG003|Overall Study|Treatment discontinued|3|||
150105436|NCT00283439|541528999|FG000|Overall Study|Other|1|||
150105437|NCT00283439|541529000|FG001|Overall Study|Other|0|||
150105438|NCT00283439|541529001|FG002|Overall Study|Other|0|||
150105439|NCT00283439|541529002|FG003|Overall Study|Other|0|||
150105440|NCT05358821|541529005|FG000|Overall Study|Withdrawal by Subject|0|||
150105441|NCT05358821|541529006|FG001|Overall Study|Withdrawal by Subject|1|||
150105442|NCT05358821|541529007|FG002|Overall Study|Withdrawal by Subject|0|||
150105443|NCT05358821|541529005|FG000|Overall Study|Withdrawal of Consent|0|||
150105444|NCT05358821|541529006|FG001|Overall Study|Withdrawal of Consent|0|||
150105445|NCT05358821|541529007|FG002|Overall Study|Withdrawal of Consent|1|||
150105446|NCT00048542|541529009|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
150105447|NCT00048542|541529010|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
150105448|NCT00048542|541529011|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
150105449|NCT00048542|541529012|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
150105450|NCT00048542|541529013|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
150105451|NCT00048542|541529014|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
150105452|NCT00048542|541529015|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
150105453|NCT00048542|541529016|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
150105454|NCT00048542|541529009|FG000|Double-Blind Phase|Protocol Violation|0|||
150105455|NCT00048542|541529010|FG001|Double-Blind Phase|Protocol Violation|0|||
150105456|NCT00048542|541529011|FG002|Double-Blind Phase|Protocol Violation|1|||
150105457|NCT00048542|541529012|FG003|Double-Blind Phase|Protocol Violation|0|||
150105458|NCT00048542|541529013|FG004|Double-Blind Phase|Protocol Violation|0|||
150186691|NCT02724878|541823566|FG000|Overall Study|Withdrawal by Subject|4|||
150186692|NCT02724878|541823566|FG000|Overall Study|Lost to Follow-up|2|||
150186693|NCT02724878|541823566|FG000|Overall Study|Protocol Violation|1|||
150186694|NCT02724878|541823566|FG000|Overall Study|Ineligible for Study Drug|5|||
150186695|NCT02724878|541823566|FG000|Overall Study|not started|1|||
150186696|NCT03779204|541823567|FG000|Overall Study|Lost to Follow-up|2|||
150186697|NCT03779204|541823568|FG001|Overall Study|Lost to Follow-up|0|||
150186698|NCT04421378|541823569|FG000|Overall Study|Adverse Event|2|||
150105459|NCT00048542|541529014|FG005|Double-Blind Phase|Protocol Violation|0|||
150105460|NCT00048542|541529015|FG006|Double-Blind Phase|Protocol Violation|0|||
150105461|NCT00048542|541529016|FG007|Double-Blind Phase|Protocol Violation|0|||
150105462|NCT00048542|541529009|FG000|Double-Blind Phase|Sponsor request or decision|2|||
150186699|NCT04421378|541823570|FG001|Overall Study|Adverse Event|7|||
150186700|NCT04421378|541823571|FG002|Overall Study|Adverse Event|0|||
150186701|NCT04421378|541823572|FG003|Overall Study|Adverse Event|1|||
150186702|NCT04421378|541823573|FG004|Overall Study|Adverse Event|0|||
150186703|NCT04421378|541823569|FG000|Overall Study|Physician Decision|1|||
150186704|NCT04421378|541823570|FG001|Overall Study|Physician Decision|2|||
150186705|NCT04421378|541823571|FG002|Overall Study|Physician Decision|0|||
150186706|NCT04421378|541823572|FG003|Overall Study|Physician Decision|0|||
150186707|NCT04421378|541823573|FG004|Overall Study|Physician Decision|0|||
150186708|NCT04421378|541823569|FG000|Overall Study|Progressive Disease|16|||
150186709|NCT04421378|541823570|FG001|Overall Study|Progressive Disease|4|||
150186710|NCT04421378|541823571|FG002|Overall Study|Progressive Disease|18|||
150186711|NCT04421378|541823572|FG003|Overall Study|Progressive Disease|11|||
150186712|NCT04421378|541823573|FG004|Overall Study|Progressive Disease|3|||
150186713|NCT04421378|541823569|FG000|Overall Study|Study Terminated by Sponsor|0|||
150186714|NCT04421378|541823570|FG001|Overall Study|Study Terminated by Sponsor|1|||
150186715|NCT04421378|541823571|FG002|Overall Study|Study Terminated by Sponsor|1|||
150186716|NCT04421378|541823572|FG003|Overall Study|Study Terminated by Sponsor|0|||
150186717|NCT04421378|541823573|FG004|Overall Study|Study Terminated by Sponsor|0|||
150186718|NCT04421378|541823569|FG000|Overall Study|Withdrawal by Subject|3|||
150186719|NCT04421378|541823570|FG001|Overall Study|Withdrawal by Subject|1|||
150186720|NCT04421378|541823571|FG002|Overall Study|Withdrawal by Subject|0|||
150186721|NCT04421378|541823572|FG003|Overall Study|Withdrawal by Subject|2|||
150186722|NCT04421378|541823573|FG004|Overall Study|Withdrawal by Subject|0|||
150186723|NCT04421378|541823569|FG000|Overall Study|Other|1|||
150186724|NCT04421378|541823570|FG001|Overall Study|Other|0|||
150186725|NCT04421378|541823571|FG002|Overall Study|Other|0|||
150186726|NCT04421378|541823572|FG003|Overall Study|Other|0|||
150186727|NCT04421378|541823573|FG004|Overall Study|Other|0|||
150186728|NCT04258709|541823574|FG000|Overall Study|Lost to Follow-up|10|||
150186729|NCT04258709|541823575|FG001|Overall Study|Lost to Follow-up|4|||
150186730|NCT04258709|541823574|FG000|Overall Study|Withdrawal by Subject|1|||
150186731|NCT04258709|541823575|FG001|Overall Study|Withdrawal by Subject|0|||
150186732|NCT04258709|541823574|FG000|Overall Study|Fetal demise|0|||
150186733|NCT04258709|541823575|FG001|Overall Study|Fetal demise|1|||
150186734|NCT04258709|541823574|FG000|Overall Study|Protocol Violation|1|||
150186735|NCT04258709|541823575|FG001|Overall Study|Protocol Violation|1|||
150186736|NCT02592330|541823576|FG000|Overall Study|Withdrawal by Subject|1|||
150186737|NCT02592330|541823577|FG001|Overall Study|Withdrawal by Subject|0|||
150186738|NCT02592330|541823576|FG000|Overall Study|Failed Biopsy|1|||
150186739|NCT02592330|541823577|FG001|Overall Study|Failed Biopsy|0|||
150186740|NCT03090152|541823578|FG000|Overall Study|Withdrawal by Subject|0|||
150186741|NCT03090152|541823579|FG001|Overall Study|Withdrawal by Subject|2|||
150186742|NCT03090152|541823580|FG002|Overall Study|Withdrawal by Subject|1|||
150186743|NCT03090152|541823578|FG000|Overall Study|Surgery Canceled|1|||
150186744|NCT03090152|541823579|FG001|Overall Study|Surgery Canceled|0|||
150186745|NCT03090152|541823580|FG002|Overall Study|Surgery Canceled|0|||
150186746|NCT03090152|541823578|FG000|Overall Study|Epidural catheter could not be placed|0|||
150186747|NCT03090152|541823579|FG001|Overall Study|Epidural catheter could not be placed|2|||
150186748|NCT03090152|541823580|FG002|Overall Study|Epidural catheter could not be placed|0|||
150186749|NCT02807636|541823581|FG000|Overall Study|Lost to Follow-up|10|||
150186750|NCT02807636|541823582|FG001|Overall Study|Lost to Follow-up|13|||
150186751|NCT02807636|541823583|FG002|Overall Study|Lost to Follow-up|6|||
150186752|NCT02807636|541823581|FG000|Overall Study|Protocol Deviation|1|||
150186753|NCT02807636|541823582|FG001|Overall Study|Protocol Deviation|0|||
150105463|NCT00048542|541529010|FG001|Double-Blind Phase|Sponsor request or decision|0|||
150105464|NCT00048542|541529011|FG002|Double-Blind Phase|Sponsor request or decision|0|||
150105465|NCT00048542|541529012|FG003|Double-Blind Phase|Sponsor request or decision|0|||
150105466|NCT00048542|541529013|FG004|Double-Blind Phase|Sponsor request or decision|0|||
150105467|NCT00048542|541529014|FG005|Double-Blind Phase|Sponsor request or decision|0|||
150105468|NCT00048542|541529015|FG006|Double-Blind Phase|Sponsor request or decision|0|||
150105469|NCT00048542|541529016|FG007|Double-Blind Phase|Sponsor request or decision|0|||
150105470|NCT00048542|541529009|FG000|Double-Blind Phase|Randomized in error|1|||
150105471|NCT00048542|541529010|FG001|Double-Blind Phase|Randomized in error|0|||
150105472|NCT00048542|541529011|FG002|Double-Blind Phase|Randomized in error|0|||
150105473|NCT00048542|541529012|FG003|Double-Blind Phase|Randomized in error|0|||
150105474|NCT00048542|541529013|FG004|Double-Blind Phase|Randomized in error|0|||
150105475|NCT00048542|541529014|FG005|Double-Blind Phase|Randomized in error|0|||
150105476|NCT00048542|541529015|FG006|Double-Blind Phase|Randomized in error|0|||
150105477|NCT00048542|541529016|FG007|Double-Blind Phase|Randomized in error|0|||
150186754|NCT02807636|541823583|FG002|Overall Study|Protocol Deviation|0|||
150186755|NCT02807636|541823581|FG000|Overall Study|Symptomatic Deterioration|0|||
150186756|NCT02807636|541823582|FG001|Overall Study|Symptomatic Deterioration|1|||
150186757|NCT02807636|541823583|FG002|Overall Study|Symptomatic Deterioration|0|||
150186758|NCT02807636|541823581|FG000|Overall Study|Withdrawal by Subject|39|||
150186759|NCT02807636|541823582|FG001|Overall Study|Withdrawal by Subject|28|||
150186760|NCT02807636|541823583|FG002|Overall Study|Withdrawal by Subject|24|||
150186761|NCT02807636|541823581|FG000|Overall Study|Death|303|||
150186762|NCT02807636|541823582|FG001|Overall Study|Death|332|||
150186763|NCT02807636|541823583|FG002|Overall Study|Death|272|||
150186764|NCT02807636|541823581|FG000|Overall Study|Study Terminated By Sponsor|47|||
150186765|NCT02807636|541823582|FG001|Overall Study|Study Terminated By Sponsor|76|||
150105478|NCT00048542|541529009|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105479|NCT00048542|541529010|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105480|NCT00048542|541529011|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105481|NCT00048542|541529012|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105482|NCT00048542|541529013|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
150105483|NCT00048542|541529014|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
150105484|NCT00048542|541529015|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105485|NCT00048542|541529016|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
150105486|NCT00048542|541529009|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105487|NCT00048542|541529010|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105488|NCT00048542|541529011|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105489|NCT00048542|541529012|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105490|NCT00048542|541529013|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105491|NCT00048542|541529014|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
150105492|NCT00048542|541529015|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105493|NCT00048542|541529016|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
150105494|NCT00048542|541529009|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105495|NCT00048542|541529010|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105496|NCT00048542|541529011|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105497|NCT00048542|541529012|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105498|NCT00048542|541529013|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
150105499|NCT00048542|541529014|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
150105500|NCT00048542|541529015|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105501|NCT00048542|541529016|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
150105502|NCT00048542|541529009|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
150105503|NCT00048542|541529010|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
150105504|NCT00048542|541529011|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
150105505|NCT00048542|541529012|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
150105506|NCT00048542|541529013|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
150105507|NCT00048542|541529014|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
150105508|NCT00048542|541529015|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
150105509|NCT00048542|541529016|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
150105510|NCT00048542|541529009|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105511|NCT00048542|541529010|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105512|NCT00048542|541529011|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105513|NCT00048542|541529012|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105514|NCT00048542|541529013|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
150105515|NCT00048542|541529014|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
150105516|NCT00048542|541529015|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105517|NCT00048542|541529016|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
150105518|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105519|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105520|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105521|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105522|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105523|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
150105524|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
150105525|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
150105526|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105527|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105528|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105529|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105530|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105531|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
150105532|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
150105533|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
150105534|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105535|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105536|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105537|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105538|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105539|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
150105540|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
150105541|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
150105542|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105543|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105544|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105545|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105546|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105547|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
150105548|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
150105549|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
150105550|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105551|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105552|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105553|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105554|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105555|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
150105556|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
150105557|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
150105558|NCT00048542|541529009|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105559|NCT00048542|541529010|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105560|NCT00048542|541529011|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105561|NCT00048542|541529012|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105562|NCT00048542|541529013|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105563|NCT00048542|541529014|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
150105564|NCT00048542|541529015|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
150105565|NCT00048542|541529016|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
150105566|NCT02704364|541529018|FG000|Overall Study|Adverse Event|1|||
150105567|NCT02704364|541529019|FG001|Overall Study|Adverse Event|1|||
150105568|NCT02704364|541529020|FG002|Overall Study|Adverse Event|0|||
150105569|NCT02704364|541529018|FG000|Overall Study|Noncompliance with study drug|1|||
150105570|NCT02704364|541529019|FG001|Overall Study|Noncompliance with study drug|1|||
150105571|NCT02704364|541529020|FG002|Overall Study|Noncompliance with study drug|0|||
150105572|NCT02704364|541529018|FG000|Overall Study|Other|0|||
150105573|NCT02704364|541529019|FG001|Overall Study|Other|1|||
150105574|NCT02704364|541529020|FG002|Overall Study|Other|1|||
150105575|NCT04627064|541529022|FG000|Overall Study|Progressive disease|8|||
150105576|NCT04627064|541529023|FG001|Overall Study|Progressive disease|0|||
150105577|NCT04627064|541529022|FG000|Overall Study|Withdrawal by Subject|2|||
150105578|NCT04627064|541529023|FG001|Overall Study|Withdrawal by Subject|0|||
150105579|NCT04627064|541529022|FG000|Overall Study|Physician Decision|1|||
150105580|NCT04627064|541529023|FG001|Overall Study|Physician Decision|0|||
150105581|NCT04098458|541529026|FG000|Overall Study|Death|1|||
150105582|NCT04098458|541529026|FG000|Overall Study|did not meet study inclusion criteria|3|||
150105583|NCT00006489|541529027|FG000|Overall Study|Adverse Event|3|||
150105584|NCT00006489|541529028|FG001|Overall Study|Adverse Event|2|||
150105585|NCT00006489|541529029|FG002|Overall Study|Adverse Event|4|||
150105586|NCT00006489|541529030|FG003|Overall Study|Adverse Event|3|||
150105587|NCT00006489|541529027|FG000|Overall Study|Withdrawal by Subject|10|||
150105588|NCT00006489|541529028|FG001|Overall Study|Withdrawal by Subject|9|||
150105589|NCT00006489|541529029|FG002|Overall Study|Withdrawal by Subject|9|||
150105590|NCT00006489|541529030|FG003|Overall Study|Withdrawal by Subject|6|||
150105591|NCT00006489|541529027|FG000|Overall Study|Scheduling Conflict|0|||
150105592|NCT00006489|541529028|FG001|Overall Study|Scheduling Conflict|3|||
150105593|NCT00006489|541529029|FG002|Overall Study|Scheduling Conflict|2|||
150105594|NCT00006489|541529030|FG003|Overall Study|Scheduling Conflict|1|||
150105595|NCT00006489|541529027|FG000|Overall Study|Death|0|||
150105596|NCT00006489|541529028|FG001|Overall Study|Death|0|||
150105597|NCT00006489|541529029|FG002|Overall Study|Death|0|||
150105598|NCT00006489|541529030|FG003|Overall Study|Death|1|||
150105599|NCT00578175|541529031|FG000|Overall Study|Adverse Event|0|||
150105600|NCT00578175|541529032|FG001|Overall Study|Adverse Event|1|||
150105601|NCT00578175|541529033|FG002|Overall Study|Adverse Event|1|||
150105602|NCT00578175|541529031|FG000|Overall Study|Other reasons|70|||
150105603|NCT00578175|541529032|FG001|Overall Study|Other reasons|42|||
150105604|NCT00578175|541529033|FG002|Overall Study|Other reasons|23|||
150105605|NCT01232296|541529034|FG000|Overall Study|Adverse Event|24|||
150105606|NCT01232296|541529035|FG001|Overall Study|Adverse Event|12|||
150105607|NCT01232296|541529034|FG000|Overall Study|Physician Decision|1|||
150105608|NCT01232296|541529035|FG001|Overall Study|Physician Decision|1|||
150105609|NCT01232296|541529034|FG000|Overall Study|Progressive disease|43|||
150105610|NCT01232296|541529035|FG001|Overall Study|Progressive disease|61|||
150105611|NCT01232296|541529034|FG000|Overall Study|Study terminated by sponsor|0|||
150105612|NCT01232296|541529035|FG001|Overall Study|Study terminated by sponsor|1|||
150105613|NCT01232296|541529034|FG000|Overall Study|Technical problems|3|||
150105614|NCT01232296|541529035|FG001|Overall Study|Technical problems|0|||
150105615|NCT01232296|541529034|FG000|Overall Study|Subject/guardian decision|10|||
150105616|NCT01232296|541529035|FG001|Overall Study|Subject/guardian decision|2|||
150105617|NCT01232296|541529034|FG000|Overall Study|Death|1|||
150105618|NCT01232296|541529035|FG001|Overall Study|Death|6|||
150105619|NCT01461096|541529037|FG000|Overall Study|Death|3|||
150105620|NCT01461096|541529038|FG001|Overall Study|Death|6|||
150105621|NCT01461096|541529037|FG000|Overall Study|Severe debilitation, unable to continue|1|||
150105622|NCT01461096|541529038|FG001|Overall Study|Severe debilitation, unable to continue|1|||
150105623|NCT01461096|541529037|FG000|Overall Study|Subj not able to get to clinic|15|||
150105624|NCT01461096|541529038|FG001|Overall Study|Subj not able to get to clinic|13|||
150105625|NCT01461096|541529037|FG000|Overall Study|Site is closing|27|||
150105626|NCT01461096|541529038|FG001|Overall Study|Site is closing|30|||
150105627|NCT01461096|541529037|FG000|Overall Study|Withdrawal by Subject|5|||
150105628|NCT01461096|541529038|FG001|Overall Study|Withdrawal by Subject|3|||
150105629|NCT01461096|541529037|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
150105630|NCT01461096|541529038|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
150105631|NCT01461096|541529037|FG000|Overall Study|Lost to Follow-up|8|||
150105632|NCT01461096|541529038|FG001|Overall Study|Lost to Follow-up|4|||
150105633|NCT04889625|541529039|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
150105634|NCT04889625|541529040|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
150105635|NCT04889625|541529039|FG000|Period 1|Subject out of window|0|||
150105636|NCT04889625|541529040|FG001|Period 1|Subject out of window|1|||
150105637|NCT04889625|541529039|FG000|Period 1|Wrong add power dispensed|0|||
150105638|NCT04889625|541529040|FG001|Period 1|Wrong add power dispensed|1|||
150105639|NCT04889625|541529039|FG000|Period 1|Discontinued due to fitting guide error|1|||
150186766|NCT02807636|541823583|FG002|Overall Study|Study Terminated By Sponsor|60|||
150186767|NCT02807636|541823581|FG000|Overall Study|Physician Decision|0|||
150186768|NCT02807636|541823582|FG001|Overall Study|Physician Decision|1|||
150186769|NCT02807636|541823583|FG002|Overall Study|Physician Decision|0|||
150186770|NCT03175029|541823584|FG000|Overall Study|Withdrawal by Subject|2|||
150186771|NCT03175029|541823585|FG001|Overall Study|Withdrawal by Subject|1|||
150186772|NCT03175029|541823584|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
150186773|NCT03175029|541823585|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
150186774|NCT05633953|541823586|FG000|Overall Study|Adverse Event|7|||
150186775|NCT05633953|541823586|FG000|Overall Study|Death|30|||
150186776|NCT05633953|541823586|FG000|Overall Study|Lost to Follow-up|1|||
150186777|NCT05633953|541823586|FG000|Overall Study|Osilodrostat discontinued|4|||
150186778|NCT05633953|541823586|FG000|Overall Study|Physician Decision|1|||
150186779|NCT05633953|541823586|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
150186780|NCT05633953|541823586|FG000|Overall Study|Progressive disease|2|||
150186781|NCT02729311|541823587|FG000|Overall Study|Withdrawal by Subject|8|||
150186782|NCT02729311|541823588|FG001|Overall Study|Withdrawal by Subject|2|||
150186783|NCT04034251|541823589|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
150186784|NCT04034251|541823590|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
150186785|NCT04034251|541823591|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
150186786|NCT05034952|541823592|FG000|Overall Study|Adverse Event|1|||
150186787|NCT05034952|541823593|FG001|Overall Study|Adverse Event|0|||
150186788|NCT05034952|541823594|FG002|Overall Study|Adverse Event|0|||
150186789|NCT05034952|541823595|FG003|Overall Study|Adverse Event|0|||
150105640|NCT04889625|541529040|FG001|Period 1|Discontinued due to fitting guide error|1|||
150105641|NCT04889625|541529039|FG000|Period 2|Test article no longer available|1|||
150105642|NCT04889625|541529040|FG001|Period 2|Test article no longer available|0|||
150105643|NCT04889625|541529039|FG000|Period 2|Incorrect lens dispensed|1|||
150186790|NCT05034952|541823592|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
150105644|NCT04889625|541529040|FG001|Period 2|Incorrect lens dispensed|0|||
150105645|NCT04889625|541529039|FG000|Period 2|Wrong add power dispensed|0|||
150105646|NCT04889625|541529040|FG001|Period 2|Wrong add power dispensed|1|||
150105647|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
150105648|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
150105649|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
150105650|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
150105651|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
150105652|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
150105653|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
150105654|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
150105655|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
150105656|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
150105657|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
150105658|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
150105659|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
150105660|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
150105661|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
150105662|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
150105663|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
150105664|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
150105665|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Death|0|||
150105666|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Death|0|||
150105667|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Death|1|||
150105668|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Death|0|||
150105669|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Death|0|||
150105670|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Death|0|||
150105671|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Death|0|||
150105672|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Death|0|||
150105673|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Death|0|||
150105674|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
150105675|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
150105676|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
150105677|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105678|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105679|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105680|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105681|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105682|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
150105683|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
150105684|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
150105685|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
150105686|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105687|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105688|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105689|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105690|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105691|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
150105692|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
150105693|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
150105694|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
150105695|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
150105696|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
150105697|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
150105698|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
150105699|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
150105700|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
150105701|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
150105702|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
150105703|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
150105704|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
150105705|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
150105706|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
150105707|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
150105708|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
150105709|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
150105710|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
150105711|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
150105712|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
150105713|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150105714|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150186791|NCT05034952|541823593|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
150105715|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150105716|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150105717|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150105718|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
150105719|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105720|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
150105721|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105722|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105723|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105724|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105725|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105726|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105727|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
150105728|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
150105729|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
150105730|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
150105731|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
150105732|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
150105733|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
150105734|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
150105735|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
150105736|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
150105737|NCT00404352|541529052|FG000|Double Blind (up to 24 Month)|Other|0|||
150105738|NCT00404352|541529053|FG001|Double Blind (up to 24 Month)|Other|1|||
150105739|NCT00404352|541529054|FG002|Double Blind (up to 24 Month)|Other|0|||
150105740|NCT00404352|541529055|FG003|Double Blind (up to 24 Month)|Other|0|||
150105741|NCT00404352|541529056|FG004|Double Blind (up to 24 Month)|Other|0|||
150105742|NCT00404352|541529057|FG005|Double Blind (up to 24 Month)|Other|0|||
150105743|NCT00404352|541529058|FG006|Double Blind (up to 24 Month)|Other|0|||
150105744|NCT00404352|541529059|FG007|Double Blind (up to 24 Month)|Other|0|||
150105745|NCT00404352|541529060|FG008|Double Blind (up to 24 Month)|Other|0|||
150105746|NCT00404352|541529052|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
150105747|NCT00404352|541529053|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
150105748|NCT00404352|541529054|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
150105749|NCT00404352|541529055|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
150105750|NCT00404352|541529056|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
150105751|NCT00404352|541529057|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
150105752|NCT00404352|541529058|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
150105753|NCT00404352|541529059|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
150105754|NCT00404352|541529060|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
150105755|NCT00404352|541529052|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
150105756|NCT00404352|541529053|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
150105757|NCT00404352|541529054|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
150105758|NCT00404352|541529055|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
150105759|NCT00404352|541529056|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
150105760|NCT00404352|541529057|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
150105761|NCT00404352|541529058|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
150105762|NCT00404352|541529059|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
150105763|NCT00404352|541529060|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
150105764|NCT00404352|541529052|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105765|NCT00404352|541529053|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105766|NCT00404352|541529054|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105767|NCT00404352|541529055|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105768|NCT00404352|541529056|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
150105769|NCT00404352|541529057|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105770|NCT00404352|541529058|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105771|NCT00404352|541529059|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105772|NCT00404352|541529060|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
150105773|NCT00404352|541529052|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105774|NCT00404352|541529053|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105775|NCT00404352|541529054|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105776|NCT00404352|541529055|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105777|NCT00404352|541529056|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105778|NCT00404352|541529057|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
150105779|NCT00404352|541529058|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105780|NCT00404352|541529059|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105781|NCT00404352|541529060|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
150105782|NCT00404352|541529052|FG000|Open Label (up to 24 Month)|Disease progression|0|||
150105783|NCT00404352|541529053|FG001|Open Label (up to 24 Month)|Disease progression|0|||
150105784|NCT00404352|541529054|FG002|Open Label (up to 24 Month)|Disease progression|0|||
150105785|NCT00404352|541529055|FG003|Open Label (up to 24 Month)|Disease progression|1|||
150105786|NCT00404352|541529056|FG004|Open Label (up to 24 Month)|Disease progression|0|||
150105787|NCT00404352|541529057|FG005|Open Label (up to 24 Month)|Disease progression|0|||
150105788|NCT00404352|541529058|FG006|Open Label (up to 24 Month)|Disease progression|0|||
150105789|NCT00404352|541529059|FG007|Open Label (up to 24 Month)|Disease progression|0|||
150105790|NCT00404352|541529060|FG008|Open Label (up to 24 Month)|Disease progression|0|||
150105791|NCT00404352|541529052|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105792|NCT00404352|541529053|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105793|NCT00404352|541529054|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105794|NCT00404352|541529055|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105795|NCT00404352|541529056|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105796|NCT00404352|541529057|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105797|NCT00404352|541529058|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
150105798|NCT00404352|541529059|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
150105799|NCT00404352|541529060|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
150105800|NCT00404352|541529052|FG000|Open Label Extension (up to 36 Months)|Other|0|||
150105801|NCT00404352|541529053|FG001|Open Label Extension (up to 36 Months)|Other|0|||
150105802|NCT00404352|541529054|FG002|Open Label Extension (up to 36 Months)|Other|0|||
150105803|NCT00404352|541529055|FG003|Open Label Extension (up to 36 Months)|Other|0|||
150105804|NCT00404352|541529056|FG004|Open Label Extension (up to 36 Months)|Other|0|||
150105805|NCT00404352|541529057|FG005|Open Label Extension (up to 36 Months)|Other|0|||
150105806|NCT00404352|541529058|FG006|Open Label Extension (up to 36 Months)|Other|0|||
150105807|NCT00404352|541529059|FG007|Open Label Extension (up to 36 Months)|Other|0|||
150105808|NCT00404352|541529060|FG008|Open Label Extension (up to 36 Months)|Other|2|||
150105809|NCT01479621|541529061|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
150105810|NCT01479621|541529062|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105811|NCT01479621|541529063|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105812|NCT01479621|541529064|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105813|NCT01479621|541529065|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105814|NCT01479621|541529066|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105815|NCT01479621|541529067|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150105816|NCT01479621|541529061|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
150105817|NCT01479621|541529062|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105818|NCT01479621|541529063|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105819|NCT01479621|541529064|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105820|NCT01479621|541529065|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105821|NCT01479621|541529066|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105822|NCT01479621|541529067|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150105823|NCT01479621|541529061|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
150105824|NCT01479621|541529062|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105825|NCT01479621|541529063|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105826|NCT01479621|541529064|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105827|NCT01479621|541529065|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105828|NCT01479621|541529066|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105829|NCT01479621|541529067|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150105830|NCT01479621|541529061|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
150105831|NCT01479621|541529062|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105832|NCT01479621|541529063|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105833|NCT01479621|541529064|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105834|NCT01479621|541529065|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105835|NCT01479621|541529066|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105836|NCT01479621|541529067|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150105837|NCT01479621|541529061|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
150105838|NCT01479621|541529062|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105839|NCT01479621|541529063|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105840|NCT01479621|541529064|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105841|NCT01479621|541529065|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105842|NCT01479621|541529066|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105843|NCT01479621|541529067|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150105844|NCT01479621|541529061|FG000|Treatment Period|Adverse Event|0|||
150105845|NCT01479621|541529062|FG001|Treatment Period|Adverse Event|0|||
150105846|NCT01479621|541529063|FG002|Treatment Period|Adverse Event|0|||
150105847|NCT01479621|541529064|FG003|Treatment Period|Adverse Event|0|||
150186792|NCT05034952|541823594|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
150105848|NCT01479621|541529065|FG004|Treatment Period|Adverse Event|1|||
150105849|NCT01479621|541529066|FG005|Treatment Period|Adverse Event|2|||
150105850|NCT01479621|541529067|FG006|Treatment Period|Adverse Event|2|||
150105851|NCT01479621|541529061|FG000|Treatment Period|Withdrawal by Subject|0|||
150105852|NCT01479621|541529062|FG001|Treatment Period|Withdrawal by Subject|4|||
150105853|NCT01479621|541529063|FG002|Treatment Period|Withdrawal by Subject|2|||
150105854|NCT01479621|541529064|FG003|Treatment Period|Withdrawal by Subject|2|||
150105855|NCT01479621|541529065|FG004|Treatment Period|Withdrawal by Subject|5|||
150105856|NCT01479621|541529066|FG005|Treatment Period|Withdrawal by Subject|5|||
150105857|NCT01479621|541529067|FG006|Treatment Period|Withdrawal by Subject|1|||
150105858|NCT01479621|541529061|FG000|Treatment Period|Physician Decision|0|||
150105859|NCT01479621|541529062|FG001|Treatment Period|Physician Decision|0|||
150105860|NCT01479621|541529063|FG002|Treatment Period|Physician Decision|0|||
150105861|NCT01479621|541529064|FG003|Treatment Period|Physician Decision|0|||
150105862|NCT01479621|541529065|FG004|Treatment Period|Physician Decision|1|||
150105863|NCT01479621|541529066|FG005|Treatment Period|Physician Decision|1|||
150105864|NCT01479621|541529067|FG006|Treatment Period|Physician Decision|0|||
150105865|NCT01479621|541529061|FG000|Treatment Period|Non-compliance to study drug|0|||
150105866|NCT01479621|541529062|FG001|Treatment Period|Non-compliance to study drug|1|||
150105867|NCT01479621|541529063|FG002|Treatment Period|Non-compliance to study drug|0|||
150105868|NCT01479621|541529064|FG003|Treatment Period|Non-compliance to study drug|0|||
150105869|NCT01479621|541529065|FG004|Treatment Period|Non-compliance to study drug|0|||
150105870|NCT01479621|541529066|FG005|Treatment Period|Non-compliance to study drug|0|||
150105871|NCT01479621|541529067|FG006|Treatment Period|Non-compliance to study drug|1|||
150105872|NCT01479621|541529061|FG000|Treatment Period|Protocol Violation|0|||
150105873|NCT01479621|541529062|FG001|Treatment Period|Protocol Violation|9|||
150105874|NCT01479621|541529063|FG002|Treatment Period|Protocol Violation|6|||
150105875|NCT01479621|541529064|FG003|Treatment Period|Protocol Violation|5|||
150105876|NCT01479621|541529065|FG004|Treatment Period|Protocol Violation|2|||
150105877|NCT01479621|541529066|FG005|Treatment Period|Protocol Violation|10|||
150105878|NCT01479621|541529067|FG006|Treatment Period|Protocol Violation|6|||
150105879|NCT01479621|541529061|FG000|Treatment Period|Pregnancy|0|||
150105880|NCT01479621|541529062|FG001|Treatment Period|Pregnancy|0|||
150105881|NCT01479621|541529063|FG002|Treatment Period|Pregnancy|2|||
150105882|NCT01479621|541529064|FG003|Treatment Period|Pregnancy|0|||
150105883|NCT01479621|541529065|FG004|Treatment Period|Pregnancy|0|||
150105884|NCT01479621|541529066|FG005|Treatment Period|Pregnancy|0|||
150105885|NCT01479621|541529067|FG006|Treatment Period|Pregnancy|0|||
150105886|NCT01479621|541529061|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
150105887|NCT01479621|541529062|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
150105888|NCT01479621|541529063|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
150105889|NCT01479621|541529064|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
150105890|NCT01479621|541529065|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
150105891|NCT01479621|541529066|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
150105892|NCT01479621|541529067|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
150105893|NCT01479621|541529061|FG000|Treatment Period|Lost to Follow-up|0|||
150105894|NCT01479621|541529062|FG001|Treatment Period|Lost to Follow-up|0|||
150105895|NCT01479621|541529063|FG002|Treatment Period|Lost to Follow-up|1|||
150105896|NCT01479621|541529064|FG003|Treatment Period|Lost to Follow-up|0|||
150105897|NCT01479621|541529065|FG004|Treatment Period|Lost to Follow-up|2|||
150105898|NCT01479621|541529066|FG005|Treatment Period|Lost to Follow-up|2|||
150105899|NCT01479621|541529067|FG006|Treatment Period|Lost to Follow-up|1|||
150105900|NCT01479621|541529061|FG000|Treatment Period|Met stopping criteria|0|||
150105901|NCT01479621|541529062|FG001|Treatment Period|Met stopping criteria|8|||
150105902|NCT01479621|541529063|FG002|Treatment Period|Met stopping criteria|7|||
150105903|NCT01479621|541529064|FG003|Treatment Period|Met stopping criteria|4|||
150186793|NCT05034952|541823595|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
150186794|NCT05034952|541823592|FG000|Overall Study|Lost to Follow-up|1|||
150186795|NCT05034952|541823593|FG001|Overall Study|Lost to Follow-up|4|||
150105904|NCT01479621|541529065|FG004|Treatment Period|Met stopping criteria|9|||
150105905|NCT01479621|541529066|FG005|Treatment Period|Met stopping criteria|20|||
150105906|NCT01479621|541529067|FG006|Treatment Period|Met stopping criteria|6|||
150105907|NCT04370691|541529068|FG000|Overall Study|Pending visit|48|||
150186796|NCT05034952|541823594|FG002|Overall Study|Lost to Follow-up|3|||
150105908|NCT04370691|541529068|FG000|Overall Study|Have Not Reached Lower Window|15|||
150105909|NCT04370691|541529068|FG000|Overall Study|Termination|14|||
150105910|NCT04370691|541529068|FG000|Overall Study|Missed or Overdue|10|||
150105911|NCT00606892|541529076|FG000|First Intervention|Protocol Violation|1|||
150105912|NCT00606892|541529077|FG001|First Intervention|Protocol Violation|4|||
150186797|NCT05034952|541823595|FG003|Overall Study|Lost to Follow-up|3|||
150105913|NCT03554291|541529090|FG000|Overall Study|Death|2|||
150186798|NCT05034952|541823592|FG000|Overall Study|Other|0|||
150186799|NCT05034952|541823593|FG001|Overall Study|Other|0|||
150186800|NCT05034952|541823594|FG002|Overall Study|Other|0|||
150105914|NCT03554291|541529091|FG001|Overall Study|Death|1|||
150105915|NCT03554291|541529090|FG000|Overall Study|Lost to Follow-up|1|||
150105916|NCT03554291|541529091|FG001|Overall Study|Lost to Follow-up|0|||
150105917|NCT03554291|541529090|FG000|Overall Study|Withdrawal by Subject|1|||
150105918|NCT03554291|541529091|FG001|Overall Study|Withdrawal by Subject|0|||
150105919|NCT03554291|541529090|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
150105920|NCT03554291|541529091|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
150105921|NCT00329407|541529097|FG000|Overall Study|Withdrawal by Subject|1|||
150105922|NCT00978068|541529098|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
150105923|NCT00978068|541529099|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
150105924|NCT00978068|541529098|FG000|Overall Study|Death|1|||
150105925|NCT00978068|541529099|FG001|Overall Study|Death|2|||
150105926|NCT00978068|541529098|FG000|Overall Study|Lost to Follow-up|1|||
150105927|NCT00978068|541529099|FG001|Overall Study|Lost to Follow-up|2|||
150105928|NCT00978068|541529098|FG000|Overall Study|Physician Decision|0|||
150105929|NCT00978068|541529099|FG001|Overall Study|Physician Decision|1|||
150105930|NCT00978068|541529098|FG000|Overall Study|Unable to Comply with Study|0|||
150105931|NCT00978068|541529099|FG001|Overall Study|Unable to Comply with Study|2|||
150105932|NCT01398956|541529102|FG000|Overall Study|Withdrawal by Subject|4|||
150105933|NCT01398956|541529102|FG000|Overall Study|AE, non-serious non-fatal|4|||
150105934|NCT01398956|541529102|FG000|Overall Study|Withdrawal Criteria No.3|1|||
150105935|NCT01398956|541529102|FG000|Overall Study|Subject moved a long distance|1|||
150105936|NCT00451035|541529103|FG000|Overall Study|Disease progression|11|||
150105937|NCT00451035|541529103|FG000|Overall Study|Death|3|||
150105938|NCT00451035|541529103|FG000|Overall Study|New anti-neoplastic therapy|3|||
150105939|NCT03274986|541529104|FG000|Overall Study|Withdrawal by Subject|0|||
150105940|NCT03274986|541529105|FG001|Overall Study|Withdrawal by Subject|1|||
150105941|NCT03274986|541529104|FG000|Overall Study|Lost to Follow-up|0|||
150105942|NCT03274986|541529105|FG001|Overall Study|Lost to Follow-up|1|||
150105943|NCT03323658|541529106|FG000|Overall Study|Adverse Event|0|||
150105944|NCT03323658|541529107|FG001|Overall Study|Adverse Event|1|||
150105945|NCT03323658|541529108|FG002|Overall Study|Adverse Event|0|||
150105946|NCT00615056|541529109|FG000|Overall Study|Death|31|||
150105947|NCT00615056|541529110|FG001|Overall Study|Death|31|||
150105948|NCT00615056|541529111|FG002|Overall Study|Death|21|||
150105949|NCT00615056|541529112|FG003|Overall Study|Death|23|||
150105950|NCT00615056|541529109|FG000|Overall Study|Lost to Follow-up|1|||
150105951|NCT00615056|541529110|FG001|Overall Study|Lost to Follow-up|2|||
150105952|NCT00615056|541529111|FG002|Overall Study|Lost to Follow-up|4|||
150105953|NCT00615056|541529112|FG003|Overall Study|Lost to Follow-up|5|||
150105954|NCT00615056|541529109|FG000|Overall Study|Other|13|||
150105955|NCT00615056|541529110|FG001|Overall Study|Other|15|||
150105956|NCT00615056|541529111|FG002|Overall Study|Other|10|||
150105957|NCT00615056|541529112|FG003|Overall Study|Other|7|||
150105958|NCT00615056|541529109|FG000|Overall Study|Objective progression or relapse|0|||
150105959|NCT00615056|541529110|FG001|Overall Study|Objective progression or relapse|2|||
150105960|NCT00615056|541529111|FG002|Overall Study|Objective progression or relapse|0|||
150105961|NCT00615056|541529112|FG003|Overall Study|Objective progression or relapse|0|||
150105962|NCT00615056|541529109|FG000|Overall Study|Withdrawal by Subject|0|||
150105963|NCT00615056|541529110|FG001|Overall Study|Withdrawal by Subject|1|||
150105964|NCT00615056|541529111|FG002|Overall Study|Withdrawal by Subject|1|||
150105965|NCT00615056|541529112|FG003|Overall Study|Withdrawal by Subject|0|||
150105966|NCT00615056|541529109|FG000|Overall Study|Discontinued by Sponsor|1|||
150105967|NCT00615056|541529110|FG001|Overall Study|Discontinued by Sponsor|0|||
150105968|NCT00615056|541529111|FG002|Overall Study|Discontinued by Sponsor|0|||
150105969|NCT00615056|541529112|FG003|Overall Study|Discontinued by Sponsor|0|||
150105970|NCT00615056|541529109|FG000|Overall Study|Randomized but not treated|3|||
150105971|NCT00615056|541529110|FG001|Overall Study|Randomized but not treated|0|||
150105972|NCT00615056|541529111|FG002|Overall Study|Randomized but not treated|0|||
150105973|NCT00615056|541529112|FG003|Overall Study|Randomized but not treated|0|||
150105974|NCT01380184|541529114|FG000|Part 1 (19 Days)|Adverse Event|1|||
150105975|NCT01380184|541529114|FG000|Part 2|Adverse Event|5|||
150105976|NCT01380184|541529114|FG000|Part 2|Disease Progression|8|||
150105977|NCT01380184|541529114|FG000|Part 2|Lost to Follow-up|1|||
150105978|NCT03350503|541529115|FG000|Overall Study|Adverse Event|5|||
150105979|NCT03350503|541529115|FG000|Overall Study|Withdrawal by Subject|5|||
150105980|NCT03350503|541529115|FG000|Overall Study|Continuation impossible due to move|4|||
150105981|NCT03350503|541529115|FG000|Overall Study|Physician Decision|3|||
150105982|NCT04804813|541529123|FG000|Overall Study|Protocol Violation|2|||
150105983|NCT04804813|541529124|FG001|Overall Study|Protocol Violation|0|||
150105984|NCT04804813|541529123|FG000|Overall Study|Withdrawal by Subject|1|||
150105985|NCT04804813|541529124|FG001|Overall Study|Withdrawal by Subject|0|||
150105986|NCT00560950|541529125|FG000|Overall Study|Lost to Follow-up|1|||
150105987|NCT00560950|541529126|FG001|Overall Study|Lost to Follow-up|0|||
150105988|NCT02970968|541530664|FG000|Overall Study|Withdrawal by Subject|3|||
150105989|NCT02970968|541530665|FG001|Overall Study|Withdrawal by Subject|3|||
150105990|NCT02970968|541530664|FG000|Overall Study|Adverse Event|1|||
150105991|NCT02970968|541530665|FG001|Overall Study|Adverse Event|2|||
150105992|NCT02970968|541530664|FG000|Overall Study|Lost to Follow-up|1|||
150105993|NCT02970968|541530665|FG001|Overall Study|Lost to Follow-up|1|||
150105994|NCT02970968|541530664|FG000|Overall Study|Non-Compliance|0|||
150105995|NCT02970968|541530665|FG001|Overall Study|Non-Compliance|1|||
150105996|NCT02565381|541530666|FG000|Overall Study|Lost to Follow-up|1|||
150105997|NCT02565381|541530667|FG001|Overall Study|Lost to Follow-up|0|||
150105998|NCT02565381|541530668|FG002|Overall Study|Lost to Follow-up|1|||
150105999|NCT01904604|541530669|FG000|Overall Study|Withdrew before receiving dosing|0|||
150106000|NCT01904604|541530670|FG001|Overall Study|Withdrew before receiving dosing|1|||
150106001|NCT01904604|541530671|FG002|Overall Study|Withdrew before receiving dosing|0|||
150106002|NCT01904604|541530669|FG000|Overall Study|Non-compliance|1|||
150106003|NCT01904604|541530670|FG001|Overall Study|Non-compliance|0|||
150106004|NCT01904604|541530671|FG002|Overall Study|Non-compliance|0|||
150106005|NCT01904604|541530669|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
150106006|NCT01904604|541530670|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
150106007|NCT01904604|541530671|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
150106008|NCT01904604|541530669|FG000|Overall Study|Patch site reactions|1|||
150106009|NCT01904604|541530670|FG001|Overall Study|Patch site reactions|1|||
150106010|NCT01904604|541530671|FG002|Overall Study|Patch site reactions|0|||
150106011|NCT01904604|541530669|FG000|Overall Study|Increased syncope|0|||
150106012|NCT01904604|541530670|FG001|Overall Study|Increased syncope|1|||
150106013|NCT01904604|541530671|FG002|Overall Study|Increased syncope|0|||
150106014|NCT01904604|541530669|FG000|Overall Study|Unrelated illness|0|||
150106015|NCT01904604|541530670|FG001|Overall Study|Unrelated illness|1|||
150106016|NCT01904604|541530671|FG002|Overall Study|Unrelated illness|0|||
150106017|NCT01904604|541530669|FG000|Overall Study|Passed Week 52 OFC|1|||
150106018|NCT01904604|541530670|FG001|Overall Study|Passed Week 52 OFC|0|||
150106019|NCT01904604|541530671|FG002|Overall Study|Passed Week 52 OFC|0|||
150106020|NCT01904604|541530669|FG000|Overall Study|Withdrawal by Subject|1|||
150106021|NCT01904604|541530670|FG001|Overall Study|Withdrawal by Subject|2|||
150106022|NCT01904604|541530671|FG002|Overall Study|Withdrawal by Subject|0|||
150106023|NCT01904604|541530669|FG000|Overall Study|Participant Relocated|1|||
150106024|NCT01904604|541530670|FG001|Overall Study|Participant Relocated|1|||
150106025|NCT01904604|541530671|FG002|Overall Study|Participant Relocated|1|||
150106026|NCT01904604|541530669|FG000|Overall Study|Lost to Follow-up|0|||
150106027|NCT01904604|541530670|FG001|Overall Study|Lost to Follow-up|0|||
150106028|NCT01904604|541530671|FG002|Overall Study|Lost to Follow-up|1|||
150106029|NCT01945489|541530672|FG000|Cycle 1|Adverse Event|2|||
150106030|NCT01945489|541530673|FG001|Cycle 1|Adverse Event|0|||
150106031|NCT01945489|541530672|FG000|Cycle 1|Lost to Follow-up|4|||
150106032|NCT01945489|541530673|FG001|Cycle 1|Lost to Follow-up|0|||
150106033|NCT01945489|541530672|FG000|Cycle 1|Personal Reasons|4|||
150106034|NCT01945489|541530673|FG001|Cycle 1|Personal Reasons|2|||
150106035|NCT01945489|541530672|FG000|Cycle 1|Protocol Violation|0|||
150106036|NCT01945489|541530673|FG001|Cycle 1|Protocol Violation|1|||
150106037|NCT01945489|541530672|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
150106038|NCT01945489|541530673|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
150106039|NCT01945489|541530672|FG000|Cycle 2|Adverse Event|1|||
150106040|NCT01945489|541530673|FG001|Cycle 2|Adverse Event|0|||
150106041|NCT01945489|541530672|FG000|Cycle 2|Lost to Follow-up|0|||
150106042|NCT01945489|541530673|FG001|Cycle 2|Lost to Follow-up|1|||
150106043|NCT04144166|541530677|FG000|Overall Study|Discharged before study start|1|||
150106044|NCT04144166|541530677|FG000|Overall Study|Pregnancy|1|||
150106045|NCT04144166|541530677|FG000|Overall Study|Nail polish could not be removed from finger|1|||
150106046|NCT00697346|541530678|FG000|Overall Study|Adverse Event|4|||
150106047|NCT00697346|541530679|FG001|Overall Study|Adverse Event|5|||
150106048|NCT00697346|541530680|FG002|Overall Study|Adverse Event|0|||
150106049|NCT00697346|541530678|FG000|Overall Study|Progressive Disease|19|||
150106050|NCT00697346|541530679|FG001|Overall Study|Progressive Disease|18|||
150106051|NCT00697346|541530680|FG002|Overall Study|Progressive Disease|0|||
150106052|NCT00697346|541530678|FG000|Overall Study|Symptomatic Deterioration|0|||
150106053|NCT00697346|541530679|FG001|Overall Study|Symptomatic Deterioration|1|||
150106054|NCT00697346|541530680|FG002|Overall Study|Symptomatic Deterioration|0|||
150106055|NCT00697346|541530678|FG000|Overall Study|Withdrawal by Subject|2|||
150106056|NCT00697346|541530679|FG001|Overall Study|Withdrawal by Subject|2|||
150106057|NCT00697346|541530680|FG002|Overall Study|Withdrawal by Subject|0|||
150106058|NCT00697346|541530678|FG000|Overall Study|Reason not Specified|3|||
150106059|NCT00697346|541530679|FG001|Overall Study|Reason not Specified|0|||
150106060|NCT00697346|541530680|FG002|Overall Study|Reason not Specified|1|||
150106061|NCT03643562|541530681|FG000|Overall Study|Adverse Event|1|||
150106062|NCT03643562|541530682|FG001|Overall Study|Adverse Event|0|||
150106063|NCT03643562|541530681|FG000|Overall Study|Lack of Efficacy|0|||
150106064|NCT03643562|541530682|FG001|Overall Study|Lack of Efficacy|1|||
150106065|NCT03643562|541530681|FG000|Overall Study|Physician Decision|0|||
150106066|NCT03643562|541530682|FG001|Overall Study|Physician Decision|1|||
150106067|NCT03643562|541530681|FG000|Overall Study|Study Terminated by Sponsor|2|||
150106068|NCT03643562|541530682|FG001|Overall Study|Study Terminated by Sponsor|10|||
150106069|NCT03643562|541530681|FG000|Overall Study|Withdrawal by Subject|2|||
150106070|NCT03643562|541530682|FG001|Overall Study|Withdrawal by Subject|2|||
150106071|NCT03643562|541530681|FG000|Overall Study|Other than specified|3|||
150106072|NCT03643562|541530682|FG001|Overall Study|Other than specified|2|||
150106073|NCT04145895|541530683|FG000|Overall Study|Physician Decision|2|||
150106074|NCT04145895|541530684|FG001|Overall Study|Physician Decision|0|||
150106075|NCT04145895|541530683|FG000|Overall Study|Withdrawal by Subject|0|||
150106076|NCT04145895|541530684|FG001|Overall Study|Withdrawal by Subject|2|||
150106077|NCT01236755|541530685|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
150106078|NCT01236755|541530685|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
150106079|NCT01236755|541530685|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
150106080|NCT01236755|541530685|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
150106081|NCT01481116|541530686|FG000|Overall Study|Adverse Event|26|||
150106082|NCT01481116|541530687|FG001|Overall Study|Adverse Event|26|||
150106083|NCT01481116|541530688|FG002|Overall Study|Adverse Event|42|||
150106084|NCT01481116|541530686|FG000|Overall Study|Major Protocol Deviation|3|||
150106085|NCT01481116|541530687|FG001|Overall Study|Major Protocol Deviation|7|||
150106086|NCT01481116|541530688|FG002|Overall Study|Major Protocol Deviation|1|||
150106087|NCT01481116|541530686|FG000|Overall Study|Lost to Follow-up|8|||
150106088|NCT01481116|541530687|FG001|Overall Study|Lost to Follow-up|12|||
150106089|NCT01481116|541530688|FG002|Overall Study|Lost to Follow-up|11|||
150106090|NCT01481116|541530686|FG000|Overall Study|Withdrawal by Subject|37|||
150106091|NCT01481116|541530687|FG001|Overall Study|Withdrawal by Subject|33|||
150106092|NCT01481116|541530688|FG002|Overall Study|Withdrawal by Subject|37|||
150106093|NCT01481116|541530686|FG000|Overall Study|Study Termination|730|||
150106094|NCT01481116|541530687|FG001|Overall Study|Study Termination|729|||
150106095|NCT01481116|541530688|FG002|Overall Study|Study Termination|713|||
150106096|NCT01481116|541530686|FG000|Overall Study|Pregnancy|0|||
150106097|NCT01481116|541530687|FG001|Overall Study|Pregnancy|0|||
150106098|NCT01481116|541530688|FG002|Overall Study|Pregnancy|1|||
150106099|NCT01481116|541530686|FG000|Overall Study|Lack of Efficacy|3|||
150106100|NCT01481116|541530687|FG001|Overall Study|Lack of Efficacy|3|||
150106101|NCT01481116|541530688|FG002|Overall Study|Lack of Efficacy|1|||
150106102|NCT01481116|541530686|FG000|Overall Study|Contraindications|1|||
150106103|NCT01481116|541530687|FG001|Overall Study|Contraindications|1|||
150106104|NCT01481116|541530688|FG002|Overall Study|Contraindications|0|||
150106105|NCT01481116|541530686|FG000|Overall Study|Other|1|||
150106106|NCT01481116|541530687|FG001|Overall Study|Other|1|||
150106107|NCT01481116|541530688|FG002|Overall Study|Other|0|||
150106108|NCT01481116|541530686|FG000|Overall Study|Participant Started Taking Glipizide|1|||
150106109|NCT01481116|541530687|FG001|Overall Study|Participant Started Taking Glipizide|0|||
150106110|NCT01481116|541530688|FG002|Overall Study|Participant Started Taking Glipizide|0|||
150106111|NCT01481116|541530686|FG000|Overall Study|Participant Moved Out of Area|2|||
150106112|NCT01481116|541530687|FG001|Overall Study|Participant Moved Out of Area|0|||
150106113|NCT01481116|541530688|FG002|Overall Study|Participant Moved Out of Area|1|||
150106114|NCT01481116|541530686|FG000|Overall Study|Participant Moved Out of Country|1|||
150106115|NCT01481116|541530687|FG001|Overall Study|Participant Moved Out of Country|0|||
150106116|NCT01481116|541530688|FG002|Overall Study|Participant Moved Out of Country|1|||
150106117|NCT01481116|541530686|FG000|Overall Study|Investigator Decision|3|||
150106118|NCT01481116|541530687|FG001|Overall Study|Investigator Decision|2|||
150106119|NCT01481116|541530688|FG002|Overall Study|Investigator Decision|1|||
150106120|NCT01481116|541530686|FG000|Overall Study|Sponsor Decision|0|||
150106121|NCT01481116|541530687|FG001|Overall Study|Sponsor Decision|1|||
150106122|NCT01481116|541530688|FG002|Overall Study|Sponsor Decision|3|||
150106123|NCT01481116|541530686|FG000|Overall Study|Non-Compliant With Study Drug|0|||
150106124|NCT01481116|541530687|FG001|Overall Study|Non-Compliant With Study Drug|1|||
150106125|NCT01481116|541530688|FG002|Overall Study|Non-Compliant With Study Drug|1|||
150106126|NCT01481116|541530686|FG000|Overall Study|Investigator's Discretion|2|||
150106127|NCT01481116|541530687|FG001|Overall Study|Investigator's Discretion|0|||
150106128|NCT01481116|541530688|FG002|Overall Study|Investigator's Discretion|0|||
150106129|NCT01481116|541530686|FG000|Overall Study|Death|2|||
150106130|NCT01481116|541530687|FG001|Overall Study|Death|1|||
150106131|NCT01481116|541530688|FG002|Overall Study|Death|0|||
150106132|NCT01481116|541530686|FG000|Overall Study|Hypoglycemic Event|4|||
150106133|NCT01481116|541530687|FG001|Overall Study|Hypoglycemic Event|0|||
150106134|NCT01481116|541530688|FG002|Overall Study|Hypoglycemic Event|0|||
150106135|NCT00805935|541530689|FG000|Overall Study|Stimulation Failure|1|||
150106136|NCT00805935|541530690|FG001|Overall Study|Stimulation Failure|5|||
150106137|NCT00805935|541530691|FG002|Overall Study|Stimulation Failure|2|||
150106138|NCT00805935|541530692|FG003|Overall Study|Stimulation Failure|2|||
150106139|NCT00805935|541530689|FG000|Overall Study|Cycle cancelled|0|||
150106140|NCT00805935|541530690|FG001|Overall Study|Cycle cancelled|0|||
150106141|NCT00805935|541530691|FG002|Overall Study|Cycle cancelled|2|||
150106142|NCT00805935|541530692|FG003|Overall Study|Cycle cancelled|0|||
150106143|NCT00805935|541530689|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
150106144|NCT00805935|541530690|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
150106145|NCT00805935|541530691|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
150106146|NCT00805935|541530692|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
150106147|NCT00805935|541530689|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
150106148|NCT00805935|541530690|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
150106149|NCT00805935|541530691|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
150106150|NCT00805935|541530692|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
150106151|NCT00805935|541530689|FG000|Overall Study|Lost to Follow-up|1|||
150106152|NCT00805935|541530690|FG001|Overall Study|Lost to Follow-up|0|||
150106153|NCT00805935|541530691|FG002|Overall Study|Lost to Follow-up|0|||
150106154|NCT00805935|541530692|FG003|Overall Study|Lost to Follow-up|0|||
150106155|NCT00805935|541530689|FG000|Overall Study|No positive serum pregnancy|8|||
150106156|NCT00805935|541530690|FG001|Overall Study|No positive serum pregnancy|7|||
150106157|NCT00805935|541530691|FG002|Overall Study|No positive serum pregnancy|6|||
150106158|NCT00805935|541530692|FG003|Overall Study|No positive serum pregnancy|5|||
150106159|NCT00805935|541530689|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
150106160|NCT00805935|541530690|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
150106161|NCT00805935|541530691|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
150106162|NCT00805935|541530692|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
150106163|NCT00805935|541530689|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
150106164|NCT00805935|541530690|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
150106165|NCT00805935|541530691|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
150106166|NCT00805935|541530692|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
150106167|NCT00805935|541530689|FG000|Overall Study|Biochemical pregnancy|0|||
150106168|NCT00805935|541530690|FG001|Overall Study|Biochemical pregnancy|1|||
150106169|NCT00805935|541530691|FG002|Overall Study|Biochemical pregnancy|0|||
150106170|NCT00805935|541530692|FG003|Overall Study|Biochemical pregnancy|0|||
150106171|NCT00805935|541530689|FG000|Overall Study|Chemical pregnancy|0|||
150106172|NCT00805935|541530690|FG001|Overall Study|Chemical pregnancy|5|||
150106173|NCT00805935|541530691|FG002|Overall Study|Chemical pregnancy|3|||
150106174|NCT00805935|541530692|FG003|Overall Study|Chemical pregnancy|2|||
150106175|NCT00805935|541530689|FG000|Overall Study|Ectopic pregnancy|0|||
150186801|NCT05034952|541823595|FG003|Overall Study|Other|1|||
150186802|NCT02287610|541823596|FG000|Overall Study|Lost to Follow-up|3|||
150186803|NCT02287610|541823596|FG000|Overall Study|Withdrawal by Subject|8|||
150106176|NCT00805935|541530690|FG001|Overall Study|Ectopic pregnancy|0|||
150106177|NCT00805935|541530691|FG002|Overall Study|Ectopic pregnancy|1|||
150186804|NCT02287610|541823596|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
150106178|NCT00805935|541530692|FG003|Overall Study|Ectopic pregnancy|0|||
150106179|NCT00805935|541530689|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
150106180|NCT00805935|541530690|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
150106181|NCT00805935|541530691|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
150106182|NCT00805935|541530692|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
150106183|NCT02223767|541530697|FG000|Overall Study|Withdrawal by Subject|4|||
150106184|NCT02223767|541530698|FG001|Overall Study|Withdrawal by Subject|4|||
150106185|NCT00333229|541530700|FG000|Overall Study|Lack of Efficacy|0|||
150106186|NCT00333229|541530701|FG001|Overall Study|Lack of Efficacy|1|||
150106187|NCT00430092|541530709|FG000|Overall Study|Adverse Event|0|||
150106188|NCT00430092|541530710|FG001|Overall Study|Adverse Event|0|||
150106189|NCT00430092|541530711|FG002|Overall Study|Adverse Event|1|||
150106190|NCT00430092|541530709|FG000|Overall Study|Lack of Efficacy|5|||
150106191|NCT00430092|541530710|FG001|Overall Study|Lack of Efficacy|2|||
150106192|NCT00430092|541530711|FG002|Overall Study|Lack of Efficacy|54|||
150106193|NCT00430092|541530709|FG000|Overall Study|Lost to Follow-up|1|||
150106194|NCT00430092|541530710|FG001|Overall Study|Lost to Follow-up|0|||
150106195|NCT00430092|541530711|FG002|Overall Study|Lost to Follow-up|0|||
150106196|NCT00430092|541530709|FG000|Overall Study|Protocol Violation|0|||
150106197|NCT00430092|541530710|FG001|Overall Study|Protocol Violation|1|||
150106198|NCT00430092|541530711|FG002|Overall Study|Protocol Violation|1|||
150106199|NCT00430092|541530709|FG000|Overall Study|Withdrawal by Subject|0|||
150106200|NCT00430092|541530710|FG001|Overall Study|Withdrawal by Subject|1|||
150106201|NCT00430092|541530711|FG002|Overall Study|Withdrawal by Subject|1|||
150106202|NCT00654381|541530719|FG000|1st Stage|Adverse Event|3|||
150106203|NCT00654381|541530720|FG001|1st Stage|Adverse Event|3|||
150106204|NCT00654381|541530721|FG002|1st Stage|Adverse Event|3|||
150106205|NCT00654381|541530722|FG003|1st Stage|Adverse Event|3|||
150106206|NCT00654381|541530723|FG004|1st Stage|Adverse Event|2|||
150106207|NCT00654381|541530724|FG005|1st Stage|Adverse Event|1|||
150106208|NCT00654381|541530719|FG000|1st Stage|Withdrawal by Subject|0|||
150106209|NCT00654381|541530720|FG001|1st Stage|Withdrawal by Subject|0|||
150106210|NCT00654381|541530721|FG002|1st Stage|Withdrawal by Subject|0|||
150106211|NCT00654381|541530722|FG003|1st Stage|Withdrawal by Subject|1|||
150106212|NCT00654381|541530723|FG004|1st Stage|Withdrawal by Subject|0|||
150106213|NCT00654381|541530724|FG005|1st Stage|Withdrawal by Subject|1|||
150106214|NCT00654381|541530719|FG000|1st Stage|Investigator's decision|0|||
150106215|NCT00654381|541530720|FG001|1st Stage|Investigator's decision|0|||
150106216|NCT00654381|541530721|FG002|1st Stage|Investigator's decision|0|||
150106217|NCT00654381|541530722|FG003|1st Stage|Investigator's decision|1|||
150106218|NCT00654381|541530723|FG004|1st Stage|Investigator's decision|0|||
150106219|NCT00654381|541530724|FG005|1st Stage|Investigator's decision|0|||
150106220|NCT00654381|541530719|FG000|2nd Stage|Adverse Event|2|||
150106221|NCT00654381|541530720|FG001|2nd Stage|Adverse Event|0|||
150106222|NCT00654381|541530721|FG002|2nd Stage|Adverse Event|2|||
150106223|NCT00654381|541530722|FG003|2nd Stage|Adverse Event|3|||
150106224|NCT00654381|541530723|FG004|2nd Stage|Adverse Event|7|||
150106225|NCT00654381|541530724|FG005|2nd Stage|Adverse Event|2|||
150106226|NCT00654381|541530719|FG000|2nd Stage|Withdrawal by Subject|0|||
150106227|NCT00654381|541530720|FG001|2nd Stage|Withdrawal by Subject|0|||
150106228|NCT00654381|541530721|FG002|2nd Stage|Withdrawal by Subject|0|||
150106229|NCT00654381|541530722|FG003|2nd Stage|Withdrawal by Subject|0|||
150106230|NCT00654381|541530723|FG004|2nd Stage|Withdrawal by Subject|1|||
150106231|NCT00654381|541530724|FG005|2nd Stage|Withdrawal by Subject|1|||
150106232|NCT00654381|541530719|FG000|2nd Stage|Investigator's decision|0|||
150106233|NCT00654381|541530720|FG001|2nd Stage|Investigator's decision|0|||
150106234|NCT00654381|541530721|FG002|2nd Stage|Investigator's decision|1|||
150106235|NCT00654381|541530722|FG003|2nd Stage|Investigator's decision|1|||
150106236|NCT00654381|541530723|FG004|2nd Stage|Investigator's decision|0|||
150106237|NCT00654381|541530724|FG005|2nd Stage|Investigator's decision|0|||
150106238|NCT00654381|541530719|FG000|Extension Stage|Adverse Event|1|||
150106239|NCT00654381|541530720|FG001|Extension Stage|Adverse Event|2|||
150106240|NCT00654381|541530721|FG002|Extension Stage|Adverse Event|9|||
150106241|NCT00654381|541530722|FG003|Extension Stage|Adverse Event|7|||
150106242|NCT00654381|541530723|FG004|Extension Stage|Adverse Event|1|||
150106243|NCT00654381|541530724|FG005|Extension Stage|Adverse Event|1|||
150106244|NCT00654381|541530719|FG000|Extension Stage|Protocol Violation|0|||
150106245|NCT00654381|541530720|FG001|Extension Stage|Protocol Violation|0|||
150106246|NCT00654381|541530721|FG002|Extension Stage|Protocol Violation|0|||
150106247|NCT00654381|541530722|FG003|Extension Stage|Protocol Violation|1|||
150106248|NCT00654381|541530723|FG004|Extension Stage|Protocol Violation|0|||
150106249|NCT00654381|541530724|FG005|Extension Stage|Protocol Violation|0|||
150106250|NCT00654381|541530719|FG000|Extension Stage|Lack of Efficacy|0|||
150106251|NCT00654381|541530720|FG001|Extension Stage|Lack of Efficacy|0|||
150106252|NCT00654381|541530721|FG002|Extension Stage|Lack of Efficacy|1|||
150106253|NCT00654381|541530722|FG003|Extension Stage|Lack of Efficacy|0|||
150106254|NCT00654381|541530723|FG004|Extension Stage|Lack of Efficacy|0|||
150106255|NCT00654381|541530724|FG005|Extension Stage|Lack of Efficacy|0|||
150106256|NCT00654381|541530719|FG000|Extension Stage|Withdrawal by Subject|0|||
150106257|NCT00654381|541530720|FG001|Extension Stage|Withdrawal by Subject|0|||
150106258|NCT00654381|541530721|FG002|Extension Stage|Withdrawal by Subject|1|||
150186805|NCT00961571|541823597|FG000|Overall Study|Physician Decision|39|||
150106259|NCT00654381|541530722|FG003|Extension Stage|Withdrawal by Subject|1|||
150106260|NCT00654381|541530723|FG004|Extension Stage|Withdrawal by Subject|1|||
150106261|NCT00654381|541530724|FG005|Extension Stage|Withdrawal by Subject|1|||
150106262|NCT00654381|541530719|FG000|Extension Stage|Closure of the trial site|0|||
150106263|NCT00654381|541530720|FG001|Extension Stage|Closure of the trial site|0|||
150106264|NCT00654381|541530721|FG002|Extension Stage|Closure of the trial site|0|||
150106265|NCT00654381|541530722|FG003|Extension Stage|Closure of the trial site|0|||
150106266|NCT00654381|541530723|FG004|Extension Stage|Closure of the trial site|1|||
150106267|NCT00654381|541530724|FG005|Extension Stage|Closure of the trial site|1|||
150106268|NCT03100825|541530725|FG000|Overall Study|Participant/Guardian Decision|7|||
150106269|NCT03100825|541530725|FG000|Overall Study|Physician Decision|1|||
150106270|NCT00994448|541530727|FG000|Overall Study|Adverse Event|1|||
150106271|NCT00994448|541530728|FG001|Overall Study|Adverse Event|0|||
150106272|NCT00994448|541530727|FG000|Overall Study|Lost to Follow-up|5|||
150106273|NCT00994448|541530728|FG001|Overall Study|Lost to Follow-up|1|||
150106274|NCT00994448|541530727|FG000|Overall Study|Withdrawal by Subject|1|||
150106275|NCT00994448|541530728|FG001|Overall Study|Withdrawal by Subject|1|||
150106276|NCT00994448|541530727|FG000|Overall Study|Physician Decision|1|||
150106277|NCT00994448|541530728|FG001|Overall Study|Physician Decision|0|||
150106278|NCT04164901|541530731|FG000|Overall Study|Withdrawal by Subject|4|||
150106279|NCT04164901|541530732|FG001|Overall Study|Withdrawal by Subject|4|||
150106280|NCT00235872|541530733|FG000|Overall Study|Adverse Event|34|||
150106281|NCT00235872|541530733|FG000|Overall Study|Death|1|||
150106282|NCT00235872|541530733|FG000|Overall Study|Lost to Follow-up|1|||
150106283|NCT00235872|541530733|FG000|Overall Study|Withdrawal by Subject|50|||
150106284|NCT00235872|541530733|FG000|Overall Study|Administrative reason|61|||
150106285|NCT02852265|541530734|FG000|3-month Follow-up|Lost to Follow-up|1|||
150106286|NCT02852265|541530735|FG001|3-month Follow-up|Lost to Follow-up|1|||
150106287|NCT01800916|541530738|FG000|Test Period 1 (1 Week)|Convex product user|0|||
150106288|NCT01800916|541530739|FG001|Test Period 1 (1 Week)|Convex product user|0|||
150106289|NCT01800916|541530740|FG002|Test Period 1 (1 Week)|Convex product user|0|||
150106290|NCT01800916|541530741|FG003|Test Period 1 (1 Week)|Convex product user|1|||
150106291|NCT01800916|541530742|FG004|Test Period 1 (1 Week)|Convex product user|0|||
150106292|NCT01800916|541530743|FG005|Test Period 1 (1 Week)|Convex product user|0|||
150106293|NCT01800916|541530744|FG006|Test Period 1 (1 Week)|Convex product user|0|||
150106294|NCT01800916|541530745|FG007|Test Period 1 (1 Week)|Convex product user|0|||
150106295|NCT01800916|541530746|FG008|Test Period 1 (1 Week)|Convex product user|0|||
150106296|NCT01800916|541530738|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
150106297|NCT01800916|541530739|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
150106298|NCT01800916|541530740|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
150106299|NCT01800916|541530741|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
150106300|NCT01800916|541530742|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
150106301|NCT01800916|541530743|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
150106302|NCT01800916|541530744|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
150106303|NCT01800916|541530745|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
150106304|NCT01800916|541530746|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
150106305|NCT00937547|541530752|FG000|Overall Study|misdiagnosis|1|||
150106306|NCT00937547|541530753|FG001|Overall Study|misdiagnosis|6|||
150106307|NCT00937547|541530754|FG002|Overall Study|misdiagnosis|7|||
150106308|NCT01234467|541530755|FG000|Overall Study|Adverse Event|3|||
150106309|NCT01234467|541530755|FG000|Overall Study|Death|2|||
150106310|NCT01234467|541530755|FG000|Overall Study|Withdrawal by Subject|2|||
150106311|NCT01234467|541530755|FG000|Overall Study|Disease Progression|2|||
150106312|NCT01234467|541530755|FG000|Overall Study|Clinical deterioration|1|||
150106313|NCT01234467|541530755|FG000|Overall Study|Physician Decision|1|||
150106314|NCT01234467|541530755|FG000|Overall Study|Other complicating disease (stroke)|1|||
150106315|NCT00559962|541530756|FG000|Overall Study|Adverse Event|1|||
150106316|NCT00559962|541530757|FG001|Overall Study|Adverse Event|7|||
150106317|NCT00559962|541530758|FG002|Overall Study|Adverse Event|8|||
150106318|NCT00559962|541530759|FG003|Overall Study|Adverse Event|5|||
150106319|NCT00559962|541530760|FG004|Overall Study|Adverse Event|11|||
150106320|NCT00559962|541530761|FG005|Overall Study|Adverse Event|4|||
150106321|NCT00559962|541530762|FG006|Overall Study|Adverse Event|4|||
150106322|NCT00559962|541530763|FG007|Overall Study|Adverse Event|2|||
150106323|NCT00559962|541530756|FG000|Overall Study|Lost to Follow-up|0|||
150106324|NCT00559962|541530757|FG001|Overall Study|Lost to Follow-up|1|||
150106325|NCT00559962|541530758|FG002|Overall Study|Lost to Follow-up|0|||
150106326|NCT00559962|541530759|FG003|Overall Study|Lost to Follow-up|0|||
150106327|NCT00559962|541530760|FG004|Overall Study|Lost to Follow-up|0|||
150106328|NCT00559962|541530761|FG005|Overall Study|Lost to Follow-up|0|||
150106329|NCT00559962|541530762|FG006|Overall Study|Lost to Follow-up|0|||
150106330|NCT00559962|541530763|FG007|Overall Study|Lost to Follow-up|0|||
150106331|NCT00559962|541530756|FG000|Overall Study|Withdrawal by Subject|1|||
150106332|NCT00559962|541530757|FG001|Overall Study|Withdrawal by Subject|1|||
150106333|NCT00559962|541530758|FG002|Overall Study|Withdrawal by Subject|2|||
150106334|NCT00559962|541530759|FG003|Overall Study|Withdrawal by Subject|0|||
150106335|NCT00559962|541530760|FG004|Overall Study|Withdrawal by Subject|3|||
150106336|NCT00559962|541530761|FG005|Overall Study|Withdrawal by Subject|1|||
150106337|NCT00559962|541530762|FG006|Overall Study|Withdrawal by Subject|0|||
150186806|NCT05862870|541823598|FG000|Overall Study|Lost to Follow-up|3|||
150106338|NCT00559962|541530763|FG007|Overall Study|Withdrawal by Subject|2|||
150106339|NCT00559962|541530756|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
150106340|NCT00559962|541530757|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
150106341|NCT00559962|541530758|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
150106342|NCT00559962|541530759|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
150106343|NCT00559962|541530760|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
150106344|NCT00559962|541530761|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
150106345|NCT00559962|541530762|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
150106346|NCT00559962|541530763|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
150106347|NCT03047135|541530765|FG000|Overall Study|Still being treated|3|||
150106348|NCT03778931|541530768|FG000|Overall Study|Withdrawal by Subject|12|||
150106349|NCT03778931|541530769|FG001|Overall Study|Withdrawal by Subject|25|||
150106350|NCT03778931|541530768|FG000|Overall Study|Physician Decision|1|||
150106351|NCT03778931|541530769|FG001|Overall Study|Physician Decision|3|||
150106352|NCT03778931|541530768|FG000|Overall Study|Participant Noncompliance|1|||
150106353|NCT03778931|541530769|FG001|Overall Study|Participant Noncompliance|1|||
150106354|NCT03778931|541530768|FG000|Overall Study|Lost to Follow-up|4|||
150106355|NCT03778931|541530769|FG001|Overall Study|Lost to Follow-up|1|||
150106356|NCT03778931|541530768|FG000|Overall Study|Death|69|||
150106357|NCT03778931|541530769|FG001|Overall Study|Death|79|||
150106358|NCT02130765|541530774|FG000|Overall Study|Did not receive treatment|4|||
150106359|NCT02130765|541530775|FG001|Overall Study|Did not receive treatment|0|||
150106360|NCT02130765|541530776|FG002|Overall Study|Did not receive treatment|0|||
150106361|NCT02130765|541530777|FG003|Overall Study|Did not receive treatment|0|||
150106362|NCT01537783|541530783|FG000|Overall Study|Lost to Follow-up|11|||
150106363|NCT01537783|541530784|FG001|Overall Study|Lost to Follow-up|2|||
150106364|NCT03216850|541530785|FG000|Overall Study|Pre-analytical error|6|||
150106365|NCT01116232|541530786|FG000|Overall Study|Progressive diease|4|||
150106366|NCT00603746|541530787|FG000|Overall Study|Adverse Event|2|||
150106367|NCT00603746|541530788|FG001|Overall Study|Adverse Event|3|||
150106368|NCT00603746|541530789|FG002|Overall Study|Adverse Event|0|||
150106369|NCT00603746|541530790|FG003|Overall Study|Adverse Event|1|||
150106370|NCT00603746|541530791|FG004|Overall Study|Adverse Event|0|||
150106371|NCT00603746|541530792|FG005|Overall Study|Adverse Event|4|||
150106372|NCT00603746|541530787|FG000|Overall Study|Lack of Efficacy|34|||
150106373|NCT00603746|541530788|FG001|Overall Study|Lack of Efficacy|11|||
150106374|NCT00603746|541530789|FG002|Overall Study|Lack of Efficacy|6|||
150106375|NCT00603746|541530790|FG003|Overall Study|Lack of Efficacy|11|||
150106376|NCT00603746|541530791|FG004|Overall Study|Lack of Efficacy|12|||
150106377|NCT00603746|541530792|FG005|Overall Study|Lack of Efficacy|8|||
150106378|NCT00603746|541530787|FG000|Overall Study|Protocol Violation|0|||
150106379|NCT00603746|541530788|FG001|Overall Study|Protocol Violation|3|||
150106380|NCT00603746|541530789|FG002|Overall Study|Protocol Violation|1|||
150106381|NCT00603746|541530790|FG003|Overall Study|Protocol Violation|0|||
150106382|NCT00603746|541530791|FG004|Overall Study|Protocol Violation|1|||
150106383|NCT00603746|541530792|FG005|Overall Study|Protocol Violation|0|||
150106384|NCT00603746|541530787|FG000|Overall Study|Lost to Follow-up|0|||
150106385|NCT00603746|541530788|FG001|Overall Study|Lost to Follow-up|1|||
150106386|NCT00603746|541530789|FG002|Overall Study|Lost to Follow-up|1|||
150106387|NCT00603746|541530790|FG003|Overall Study|Lost to Follow-up|0|||
150106388|NCT00603746|541530791|FG004|Overall Study|Lost to Follow-up|0|||
150106389|NCT00603746|541530792|FG005|Overall Study|Lost to Follow-up|0|||
150106390|NCT00603746|541530787|FG000|Overall Study|Physician Decision|1|||
150106391|NCT00603746|541530788|FG001|Overall Study|Physician Decision|0|||
150106392|NCT00603746|541530789|FG002|Overall Study|Physician Decision|0|||
150106393|NCT00603746|541530790|FG003|Overall Study|Physician Decision|0|||
150106394|NCT00603746|541530791|FG004|Overall Study|Physician Decision|1|||
150106395|NCT00603746|541530792|FG005|Overall Study|Physician Decision|0|||
150106396|NCT00603746|541530787|FG000|Overall Study|Withdrawal by Subject|1|||
150106397|NCT00603746|541530788|FG001|Overall Study|Withdrawal by Subject|0|||
150106398|NCT00603746|541530789|FG002|Overall Study|Withdrawal by Subject|0|||
150106399|NCT00603746|541530790|FG003|Overall Study|Withdrawal by Subject|1|||
150106400|NCT00603746|541530791|FG004|Overall Study|Withdrawal by Subject|3|||
150106401|NCT00603746|541530792|FG005|Overall Study|Withdrawal by Subject|1|||
150106402|NCT01524627|541530797|FG000|Overall Study|Physician Decision|0|||
150106403|NCT01524627|541530798|FG001|Overall Study|Physician Decision|1|||
150106404|NCT01524627|541530797|FG000|Overall Study|Lost to Follow-up|1|||
150106405|NCT01524627|541530798|FG001|Overall Study|Lost to Follow-up|1|||
150106406|NCT00969553|541530799|FG000|Overall Study|Progressive disease (PD)|2|||
150106407|NCT00969553|541530800|FG001|Overall Study|Progressive disease (PD)|2|||
150106408|NCT00969553|541530801|FG002|Overall Study|Progressive disease (PD)|6|||
150106409|NCT00969553|541530802|FG003|Overall Study|Progressive disease (PD)|9|||
150106410|NCT00969553|541530803|FG004|Overall Study|Progressive disease (PD)|2|||
150106411|NCT00969553|541530804|FG005|Overall Study|Progressive disease (PD)|4|||
150106412|NCT00969553|541530805|FG006|Overall Study|Progressive disease (PD)|2|||
150106413|NCT00969553|541530806|FG007|Overall Study|Progressive disease (PD)|12|||
150106414|NCT00969553|541530807|FG008|Overall Study|Progressive disease (PD)|3|||
150106415|NCT00969553|541530799|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106416|NCT00969553|541530800|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106417|NCT00969553|541530801|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106418|NCT00969553|541530802|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106419|NCT00969553|541530803|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
150106420|NCT00969553|541530804|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106421|NCT00969553|541530805|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106422|NCT00969553|541530806|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106423|NCT00969553|541530807|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
150106424|NCT00969553|541530799|FG000|Overall Study|Other Adverse Event|0|||
150106425|NCT00969553|541530800|FG001|Overall Study|Other Adverse Event|0|||
150106426|NCT00969553|541530801|FG002|Overall Study|Other Adverse Event|0|||
150106427|NCT00969553|541530802|FG003|Overall Study|Other Adverse Event|1|||
150106428|NCT00969553|541530803|FG004|Overall Study|Other Adverse Event|0|||
150106429|NCT00969553|541530804|FG005|Overall Study|Other Adverse Event|0|||
150106430|NCT00969553|541530805|FG006|Overall Study|Other Adverse Event|1|||
150106431|NCT00969553|541530806|FG007|Overall Study|Other Adverse Event|0|||
150106432|NCT00969553|541530807|FG008|Overall Study|Other Adverse Event|0|||
150106433|NCT00969553|541530799|FG000|Overall Study|Refused cont. medication|1|||
150106434|NCT00969553|541530800|FG001|Overall Study|Refused cont. medication|1|||
150106435|NCT00969553|541530801|FG002|Overall Study|Refused cont. medication|0|||
150106436|NCT00969553|541530802|FG003|Overall Study|Refused cont. medication|2|||
150106437|NCT00969553|541530803|FG004|Overall Study|Refused cont. medication|0|||
150106438|NCT00969553|541530804|FG005|Overall Study|Refused cont. medication|0|||
150106439|NCT00969553|541530805|FG006|Overall Study|Refused cont. medication|0|||
150106440|NCT00969553|541530806|FG007|Overall Study|Refused cont. medication|1|||
150106441|NCT00969553|541530807|FG008|Overall Study|Refused cont. medication|0|||
150106442|NCT00969553|541530799|FG000|Overall Study|Not specified above|0|||
150106443|NCT00969553|541530800|FG001|Overall Study|Not specified above|0|||
150106444|NCT00969553|541530801|FG002|Overall Study|Not specified above|0|||
150106445|NCT00969553|541530802|FG003|Overall Study|Not specified above|4|||
150106446|NCT00969553|541530803|FG004|Overall Study|Not specified above|0|||
150106447|NCT00969553|541530804|FG005|Overall Study|Not specified above|0|||
150106448|NCT00969553|541530805|FG006|Overall Study|Not specified above|1|||
150106449|NCT00969553|541530806|FG007|Overall Study|Not specified above|1|||
150106450|NCT00969553|541530807|FG008|Overall Study|Not specified above|0|||
150106451|NCT04248816|541530811|FG000|Overall Study|Ineligible post-randomization|7|||
150106452|NCT04248816|541530812|FG001|Overall Study|Ineligible post-randomization|21|||
150106453|NCT04248816|541530813|FG002|Overall Study|Ineligible post-randomization|25|||
150106454|NCT02357147|541530814|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
150106455|NCT02357147|541530815|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
150106456|NCT02357147|541530814|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
150106457|NCT02357147|541530815|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
150106458|NCT02357147|541530814|FG000|Combination Treatment Phase|Investigator Discretion|1|||
150106459|NCT02357147|541530815|FG001|Combination Treatment Phase|Investigator Discretion|1|||
150106460|NCT02357147|541530814|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
150106461|NCT02357147|541530815|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
150106462|NCT02357147|541530814|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
150106463|NCT02357147|541530815|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
150106464|NCT02357147|541530814|FG000|Combination Treatment Phase|Adverse Event|12|||
150106465|NCT02357147|541530815|FG001|Combination Treatment Phase|Adverse Event|4|||
150106466|NCT02357147|541530814|FG000|Combination Treatment Phase|Death|1|||
150106467|NCT02357147|541530815|FG001|Combination Treatment Phase|Death|1|||
150106468|NCT02357147|541530814|FG000|Combination Treatment Phase|Sponsor Decision|0|||
150106469|NCT02357147|541530815|FG001|Combination Treatment Phase|Sponsor Decision|12|||
150106470|NCT02357147|541530814|FG000|Combination Treatment Phase|Other|1|||
150106471|NCT02357147|541530815|FG001|Combination Treatment Phase|Other|0|||
150106472|NCT02357147|541530814|FG000|Combination Treatment Phase|Not treated|0|||
150106473|NCT02357147|541530815|FG001|Combination Treatment Phase|Not treated|2|||
150106474|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
150106475|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
150106476|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
150106477|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
150106478|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
150106479|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
150106480|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Adverse Event|0|||
150106481|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Adverse Event|3|||
150106482|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
150106483|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
150106484|NCT02357147|541530814|FG000|Maintenance Treatment Phase|Not Treated|1|||
150106485|NCT02357147|541530815|FG001|Maintenance Treatment Phase|Not Treated|0|||
150106486|NCT03962543|541530818|FG000|Treatment Phase|Death|0|||
150106487|NCT03962543|541530819|FG001|Treatment Phase|Death|1|||
150106488|NCT03962543|541530818|FG000|Treatment Phase|Withdrawal by Subject|3|||
150106489|NCT03962543|541530819|FG001|Treatment Phase|Withdrawal by Subject|0|||
150106490|NCT03962543|541530818|FG000|Treatment Phase|Adverse Event|3|||
150106491|NCT03962543|541530819|FG001|Treatment Phase|Adverse Event|12|||
150186807|NCT04541706|541823599|FG000|Overall Study|Withdrawal by Subject|3|||
150186808|NCT04541706|541823599|FG000|Overall Study|Progressive disease|33|||
150186809|NCT04541706|541823599|FG000|Overall Study|Physician Decision|1|||
150186810|NCT04541706|541823599|FG000|Overall Study|Lost to Follow-up|2|||
150186811|NCT04541706|541823599|FG000|Overall Study|Death|5|||
150186812|NCT04541706|541823599|FG000|Overall Study|Adverse Event|1|||
150186813|NCT05323084|541823601|FG000|Period 2 - Washout|Lost to Follow-up|0|||
150186814|NCT05323084|541823602|FG001|Period 2 - Washout|Lost to Follow-up|1|||
150186815|NCT03846505|541823603|FG000|Treatment Phase|Withdrawal by Subject|9|||
150186816|NCT03846505|541823604|FG001|Treatment Phase|Withdrawal by Subject|11|||
150186817|NCT03846505|541823603|FG000|Treatment Phase|Lost to Follow-up|6|||
150186818|NCT03846505|541823604|FG001|Treatment Phase|Lost to Follow-up|2|||
150186819|NCT03846505|541823603|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
150186820|NCT03846505|541823604|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
150186821|NCT03846505|541823603|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
150186822|NCT03846505|541823604|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
150186823|NCT05319860|541823607|FG000|Overall Study|Death|1|||
150186824|NCT05319860|541823608|FG001|Overall Study|Death|1|||
150186825|NCT05319860|541823607|FG000|Overall Study|Lost to Follow-up|3|||
150186826|NCT05319860|541823608|FG001|Overall Study|Lost to Follow-up|1|||
150186827|NCT05319860|541823607|FG000|Overall Study|Withdrawal by Subject|1|||
150186828|NCT05319860|541823608|FG001|Overall Study|Withdrawal by Subject|7|||
150186829|NCT03941860|541823609|FG000|Overall Study|Withdrawal by Subject|0|||
150186830|NCT03941860|541823610|FG001|Overall Study|Withdrawal by Subject|1|||
150186831|NCT01361711|541823614|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
150186832|NCT01361711|541823614|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
150186833|NCT01361711|541823614|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
150186834|NCT01361711|541823614|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
150186835|NCT01361711|541823614|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
150186836|NCT01361711|541823614|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
150186837|NCT01361711|541823614|FG000|Completed Week 18 of Treatment|Other|9|||
150186838|NCT01361711|541823614|FG000|10 Year Follow-up|Still in follow-up|22|||
150186839|NCT01361711|541823614|FG000|10 Year Follow-up|Death|7|||
150186840|NCT01361711|541823614|FG000|10 Year Follow-up|Developed new cancer|1|||
150186841|NCT01361711|541823614|FG000|10 Year Follow-up|Lost to Follow-up|2|||
150186842|NCT01361711|541823614|FG000|10 Year Follow-up|New treatment started|6|||
150186843|NCT01361711|541823614|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
150186844|NCT01361711|541823614|FG000|10 Year Follow-up|Progressive Disease|1|||
150186845|NCT02596126|541823615|FG000|Overall Study|Lost to Follow-up|12|||
150186846|NCT02596126|541823616|FG001|Overall Study|Lost to Follow-up|21|||
150186847|NCT02596126|541823615|FG000|Overall Study|Protocol Violation|7|||
150186848|NCT02596126|541823616|FG001|Overall Study|Protocol Violation|9|||
150186849|NCT05792423|541823622|FG000|Overall Study|Withdrawal by Subject|2|||
150186850|NCT02471638|541823623|FG000|Overall Study|Early Term Withdrawal|10|||
150186851|NCT02187003|541825149|FG000|Overall Study|Adverse Event|2|||
150186852|NCT02187003|541825150|FG001|Overall Study|Adverse Event|0|||
150186853|NCT02187003|541825149|FG000|Overall Study|Lost to Follow-up|14|||
150186854|NCT02187003|541825150|FG001|Overall Study|Lost to Follow-up|10|||
150186855|NCT02187003|541825149|FG000|Overall Study|Withdrawal by Subject|3|||
150186856|NCT02187003|541825150|FG001|Overall Study|Withdrawal by Subject|7|||
150186857|NCT02187003|541825149|FG000|Overall Study|Protocol Violation|2|||
150186858|NCT02187003|541825150|FG001|Overall Study|Protocol Violation|4|||
150186859|NCT02187003|541825149|FG000|Overall Study|Other|5|||
150186860|NCT02187003|541825150|FG001|Overall Study|Other|5|||
150186861|NCT02187003|541825149|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150186862|NCT02187003|541825150|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
150186863|NCT05816551|541825151|FG000|Overall Study|Withdrawal by Subject|0|||
150186864|NCT05816551|541825152|FG001|Overall Study|Withdrawal by Subject|1|||
150186865|NCT05816551|541825151|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
150186866|NCT05816551|541825152|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
150186867|NCT04593472|541825155|FG000|Overall Study|Death|31|||
150186868|NCT04593472|541825156|FG001|Overall Study|Death|27|||
150186869|NCT04593472|541825155|FG000|Overall Study|Withdrawal by Subject|12|||
150186870|NCT04593472|541825156|FG001|Overall Study|Withdrawal by Subject|12|||
150186871|NCT04593472|541825155|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
150186872|NCT04593472|541825156|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
150186873|NCT04593472|541825155|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
150186874|NCT04593472|541825156|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
150186875|NCT04593472|541825155|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
150186876|NCT04593472|541825156|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
150186877|NCT04593472|541825155|FG000|Overall Study|Lost to Follow-up|0|||
150106492|NCT03962543|541530818|FG000|Treatment Phase|Lost to Follow-up|1|||
150106493|NCT03962543|541530819|FG001|Treatment Phase|Lost to Follow-up|2|||
150106494|NCT03962543|541530818|FG000|Treatment Phase|Radiographic PD|9|||
150106495|NCT03962543|541530819|FG001|Treatment Phase|Radiographic PD|3|||
150106496|NCT03962543|541530818|FG000|Treatment Phase|Participant Decision|3|||
150106497|NCT03962543|541530819|FG001|Treatment Phase|Participant Decision|8|||
150106498|NCT03962543|541530818|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
150106499|NCT03962543|541530819|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
150106500|NCT03962543|541530818|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
150106501|NCT03962543|541530819|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
150106502|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
150106503|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
150106504|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
150106505|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
150106506|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
150106507|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
150106508|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
150106509|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
150106510|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
150106511|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
150106512|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
150106513|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
150106514|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
150106515|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
150106516|NCT03962543|541530818|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
150106517|NCT03962543|541530819|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
150106518|NCT05168475|541532097|FG000|Period 1|Protocol Violation|1|||
150106519|NCT05168475|541532097|FG000|Period 1|IMP shortage|2|||
150106520|NCT05168475|541532097|FG000|Period 1|Not randomised|2|||
150106521|NCT05168475|541532097|FG000|Period 2|IMP shortage|1|||
150106522|NCT01589822|541532098|FG000|Overall Study|Withdrawal by Subject|1|||
150106523|NCT01589822|541532099|FG001|Overall Study|Withdrawal by Subject|2|||
150106524|NCT01589822|541532100|FG002|Overall Study|Withdrawal by Subject|0|||
150106525|NCT01589822|541532098|FG000|Overall Study|Death|1|||
150106526|NCT01589822|541532099|FG001|Overall Study|Death|0|||
150106527|NCT01589822|541532100|FG002|Overall Study|Death|0|||
150106528|NCT01589822|541532098|FG000|Overall Study|Missed 90 day visit|2|||
150106529|NCT01589822|541532099|FG001|Overall Study|Missed 90 day visit|1|||
150106530|NCT01589822|541532100|FG002|Overall Study|Missed 90 day visit|1|||
150106531|NCT04482179|541532101|FG000|Overall Study|Death|1|||
150106532|NCT04482179|541532102|FG001|Overall Study|Death|0|||
150106533|NCT04482179|541532101|FG000|Overall Study|Withdrawal by Subject|1|||
150106534|NCT04482179|541532102|FG001|Overall Study|Withdrawal by Subject|0|||
150106535|NCT01302964|541532103|FG000|Overall Study|Adverse Event|1|||
150106536|NCT01302964|541532104|FG001|Overall Study|Adverse Event|0|||
150106537|NCT04127786|541532107|FG000|Primary Series|Adverse Event|1|||
150106538|NCT04127786|541532108|FG001|Primary Series|Adverse Event|0|||
150106539|NCT04127786|541532109|FG002|Primary Series|Adverse Event|0|||
150106540|NCT04127786|541532110|FG003|Primary Series|Adverse Event|1|||
150106541|NCT04127786|541532111|FG004|Primary Series|Adverse Event|0|||
150106542|NCT04127786|541532112|FG005|Primary Series|Adverse Event|1|||
150106543|NCT04127786|541532107|FG000|Primary Series|Protocol Violation|5|||
150106544|NCT04127786|541532108|FG001|Primary Series|Protocol Violation|3|||
150106545|NCT04127786|541532109|FG002|Primary Series|Protocol Violation|4|||
150106546|NCT04127786|541532110|FG003|Primary Series|Protocol Violation|3|||
150106547|NCT04127786|541532111|FG004|Primary Series|Protocol Violation|2|||
150106548|NCT04127786|541532112|FG005|Primary Series|Protocol Violation|0|||
150106549|NCT04127786|541532107|FG000|Primary Series|Withdrawal by Subject|0|||
150106550|NCT04127786|541532108|FG001|Primary Series|Withdrawal by Subject|0|||
150106551|NCT04127786|541532109|FG002|Primary Series|Withdrawal by Subject|0|||
150106552|NCT04127786|541532110|FG003|Primary Series|Withdrawal by Subject|1|||
150106553|NCT04127786|541532111|FG004|Primary Series|Withdrawal by Subject|0|||
150106554|NCT04127786|541532112|FG005|Primary Series|Withdrawal by Subject|0|||
150106555|NCT04127786|541532107|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
150106556|NCT04127786|541532108|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
150106557|NCT04127786|541532109|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
150106558|NCT04127786|541532110|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
150106559|NCT04127786|541532111|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
150106560|NCT04127786|541532112|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
150186878|NCT04593472|541825156|FG001|Overall Study|Lost to Follow-up|2|||
150106561|NCT04127786|541532107|FG000|Booster Phase|Withdrawal by Subject|2|||
150106562|NCT04127786|541532108|FG001|Booster Phase|Withdrawal by Subject|0|||
150106563|NCT04127786|541532109|FG002|Booster Phase|Withdrawal by Subject|0|||
150186879|NCT04593472|541825155|FG000|Overall Study|Still collecting 24-month assessment|17|||
150106564|NCT04127786|541532110|FG003|Booster Phase|Withdrawal by Subject|0|||
150106565|NCT04127786|541532111|FG004|Booster Phase|Withdrawal by Subject|0|||
150106566|NCT04127786|541532112|FG005|Booster Phase|Withdrawal by Subject|0|||
150106567|NCT03569371|541532115|FG000|Overall Study|Lack of Efficacy|1|||
150106568|NCT03569371|541532115|FG000|Overall Study|Lost to Follow-up|1|||
150106569|NCT03569371|541532115|FG000|Overall Study|Adverse Event|1|||
150106570|NCT02347527|541532116|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
150106571|NCT02347527|541532117|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
150106572|NCT02347527|541532118|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
150106573|NCT02347527|541532119|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
150106574|NCT02347527|541532116|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
150106575|NCT02347527|541532117|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
150106576|NCT02347527|541532118|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
150106577|NCT02347527|541532119|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
150106578|NCT02347527|541532116|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
150106579|NCT02347527|541532117|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
150106580|NCT02347527|541532118|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
150106581|NCT02347527|541532119|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
150106582|NCT02347527|541532116|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
150106583|NCT02347527|541532117|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
150106584|NCT02347527|541532118|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
150106585|NCT02347527|541532119|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
150106586|NCT02347527|541532116|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
150106587|NCT02347527|541532117|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
150106588|NCT02347527|541532118|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
150106589|NCT02347527|541532119|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
150106590|NCT00596011|541532120|FG000|Overall Study|Withdrawal by Subject|2|||
150106591|NCT00596011|541532121|FG001|Overall Study|Withdrawal by Subject|3|||
150106592|NCT00596011|541532120|FG000|Overall Study|Adverse Event|11|||
150106593|NCT00596011|541532121|FG001|Overall Study|Adverse Event|7|||
150106594|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
150106595|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
150106596|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
150106597|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
150106598|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
150106599|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
150106600|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
150106601|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
150106602|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
150106603|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
150106604|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
150106605|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
150106606|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
150106607|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
150106608|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
150106609|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
150106610|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
150106611|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
150106612|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
150106613|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
150106614|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
150106615|NCT00934544|541532122|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
150106616|NCT00934544|541532123|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
150106617|NCT00934544|541532124|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
150106618|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
150106619|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
150106620|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
150106621|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
150106622|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
150106623|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
150106624|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
150186880|NCT04593472|541825156|FG001|Overall Study|Still collecting 24-month assessment|10|||
150186881|NCT04833777|541825159|FG000|Overall Study|Lost to Follow-up|1|||
150186882|NCT04833777|541825160|FG001|Overall Study|Lost to Follow-up|0|||
150186883|NCT03648840|541825162|FG000|First IV Infusion Session|Adverse Event|0|||
150186884|NCT03648840|541825163|FG001|First IV Infusion Session|Adverse Event|2|||
150186885|NCT03648840|541825162|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
150186886|NCT03648840|541825163|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
150186887|NCT03648840|541825162|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
150186888|NCT03648840|541825163|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
150186889|NCT03648840|541825162|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
150186890|NCT03648840|541825163|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
150186891|NCT05063994|541825166|FG000|Cortef Run-In|Withdrawal of Consent|1|||
150186892|NCT05063994|541825167|FG001|Cortef Run-In|Withdrawal of Consent|0|||
150186893|NCT05063994|541825168|FG002|Cortef Run-In|Withdrawal of Consent|0|||
150186894|NCT05063994|541825166|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
150186895|NCT05063994|541825167|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
150186896|NCT05063994|541825168|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
150186897|NCT05063994|541825166|FG000|Treatment|Physician Decision|0|||
150186898|NCT05063994|541825167|FG001|Treatment|Physician Decision|0|||
150186899|NCT05063994|541825168|FG002|Treatment|Physician Decision|1|||
150186900|NCT05063994|541825166|FG000|Treatment|Withdrawal by Subject|0|||
150186901|NCT05063994|541825167|FG001|Treatment|Withdrawal by Subject|0|||
150186902|NCT05063994|541825168|FG002|Treatment|Withdrawal by Subject|1|||
150186903|NCT05063994|541825166|FG000|Treatment|Withdrawal of Consent|0|||
150186904|NCT05063994|541825167|FG001|Treatment|Withdrawal of Consent|0|||
150186905|NCT05063994|541825168|FG002|Treatment|Withdrawal of Consent|1|||
150186906|NCT01331005|541825175|FG000|Overall Study|Lost to Follow-up|2|||
150186907|NCT01331005|541825176|FG001|Overall Study|Lost to Follow-up|1|||
150186908|NCT01331005|541825175|FG000|Overall Study|Withdrawal by Subject|2|||
150186909|NCT01331005|541825176|FG001|Overall Study|Withdrawal by Subject|3|||
150186910|NCT03016169|541825190|FG000|Overall Study|Lost to Follow-up|4|||
150186911|NCT03016169|541825190|FG000|Overall Study|Death|54|||
150186912|NCT03016169|541825190|FG000|Overall Study|Device Explant|11|||
150186913|NCT03016169|541825190|FG000|Overall Study|Withdrawal by Subject|19|||
150186914|NCT03016169|541825190|FG000|Overall Study|Other Reasons|1|||
150186915|NCT03131648|541825191|FG000|Initial Treatment Period|Not dosed|2|||
150106625|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
150106626|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
150106627|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
150106628|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
150106629|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
150106630|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
150106631|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
150106632|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
150106633|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
150106634|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
150106635|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
150106636|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
150106637|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
150106638|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
150106639|NCT00934544|541532122|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
150106640|NCT00934544|541532123|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
150106641|NCT00934544|541532124|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
150106642|NCT02643251|541532125|FG000|Overall Study|Adverse Event|3|||
150186916|NCT03131648|541825192|FG001|Initial Treatment Period|Not dosed|2|||
150186917|NCT03131648|541825193|FG002|Initial Treatment Period|Not dosed|0|||
150186918|NCT03131648|541825194|FG003|Initial Treatment Period|Not dosed|0|||
150186919|NCT03131648|541825195|FG004|Initial Treatment Period|Not dosed|0|||
150186920|NCT03131648|541825196|FG005|Initial Treatment Period|Not dosed|0|||
150106643|NCT02643251|541532126|FG001|Overall Study|Adverse Event|1|||
150106644|NCT02643251|541532125|FG000|Overall Study|Withdrawal by Subject|2|||
150186921|NCT03131648|541825197|FG006|Initial Treatment Period|Not dosed|0|||
150186922|NCT03131648|541825198|FG007|Initial Treatment Period|Not dosed|0|||
150186923|NCT03131648|541825191|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
150186924|NCT03131648|541825192|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
150186925|NCT03131648|541825193|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150186926|NCT03131648|541825194|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150186927|NCT03131648|541825195|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150186928|NCT03131648|541825196|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150186929|NCT03131648|541825197|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150106645|NCT02643251|541532126|FG001|Overall Study|Withdrawal by Subject|0|||
150106646|NCT02643251|541532125|FG000|Overall Study|Lost to Follow-up|4|||
150106647|NCT02643251|541532126|FG001|Overall Study|Lost to Follow-up|1|||
150106648|NCT02643251|541532125|FG000|Overall Study|Protocol Violation|1|||
150106649|NCT02643251|541532126|FG001|Overall Study|Protocol Violation|0|||
150106650|NCT02643251|541532125|FG000|Overall Study|PI Decision to terminate patient|1|||
150106651|NCT02643251|541532126|FG001|Overall Study|PI Decision to terminate patient|0|||
150106652|NCT00348556|541532129|FG000|Overall Study|Adverse Event|1|||
150106653|NCT00240071|541532130|FG000|Overall Study|Withdrawal by Subject|3|||
150106654|NCT01466270|541532131|FG000|Overall Study|Withdrawal by Subject|4|||
150106655|NCT01466270|541532132|FG001|Overall Study|Withdrawal by Subject|1|||
150106656|NCT01466270|541532131|FG000|Overall Study|Physician Decision|1|||
150106657|NCT01466270|541532132|FG001|Overall Study|Physician Decision|0|||
150106658|NCT01466270|541532131|FG000|Overall Study|Lost to Follow-up|1|||
150106659|NCT01466270|541532132|FG001|Overall Study|Lost to Follow-up|3|||
150106660|NCT01466270|541532131|FG000|Overall Study|Progression|1|||
150106661|NCT01466270|541532132|FG001|Overall Study|Progression|0|||
150106662|NCT01466270|541532131|FG000|Overall Study|Toxicity|4|||
150106663|NCT01466270|541532132|FG001|Overall Study|Toxicity|1|||
150106664|NCT01466270|541532131|FG000|Overall Study|Multiple|1|||
150106665|NCT01466270|541532132|FG001|Overall Study|Multiple|1|||
150106666|NCT01944059|541532133|FG000|Overall Study|Lost to Follow-up|1|||
150106667|NCT01944059|541532133|FG000|Overall Study|Physician Decision|3|||
150106668|NCT01944059|541532133|FG000|Overall Study|Withdrawal by Subject|1|||
150106669|NCT01944059|541532133|FG000|Overall Study|Adverse Event|2|||
150106670|NCT02821962|541532134|FG000|Overall Study|Lost to Follow-up|2|||
150106671|NCT02821962|541532135|FG001|Overall Study|Lost to Follow-up|0|||
150106672|NCT04206293|541532139|FG000|Overall Study|Consent withdrawal|1|||
150106673|NCT01400841|541532140|FG000|Initial Study Phase (6 Months)|Death|1|||
150106674|NCT01400841|541532140|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
150106675|NCT01631474|541532141|FG000|Overall Study|Lost to Follow-up|8|||
150106676|NCT01631474|541532142|FG001|Overall Study|Lost to Follow-up|5|||
150106677|NCT01631474|541532143|FG002|Overall Study|Lost to Follow-up|7|||
150106678|NCT01631474|541532144|FG003|Overall Study|Lost to Follow-up|5|||
150106679|NCT01631474|541532145|FG004|Overall Study|Lost to Follow-up|5|||
150106680|NCT01631474|541532141|FG000|Overall Study|Withdrawal by Subject|4|||
150106681|NCT01631474|541532142|FG001|Overall Study|Withdrawal by Subject|4|||
150106682|NCT01631474|541532143|FG002|Overall Study|Withdrawal by Subject|2|||
150106683|NCT01631474|541532144|FG003|Overall Study|Withdrawal by Subject|6|||
150106684|NCT01631474|541532145|FG004|Overall Study|Withdrawal by Subject|5|||
150106685|NCT01631474|541532141|FG000|Overall Study|Lack of Efficacy|2|||
150106686|NCT01631474|541532142|FG001|Overall Study|Lack of Efficacy|2|||
150106687|NCT01631474|541532143|FG002|Overall Study|Lack of Efficacy|0|||
150106688|NCT01631474|541532144|FG003|Overall Study|Lack of Efficacy|0|||
150106689|NCT01631474|541532145|FG004|Overall Study|Lack of Efficacy|2|||
150106690|NCT01631474|541532141|FG000|Overall Study|Noncompliance with Study Drug|0|||
150106691|NCT01631474|541532142|FG001|Overall Study|Noncompliance with Study Drug|0|||
150106692|NCT01631474|541532143|FG002|Overall Study|Noncompliance with Study Drug|0|||
150106693|NCT01631474|541532144|FG003|Overall Study|Noncompliance with Study Drug|0|||
150106694|NCT01631474|541532145|FG004|Overall Study|Noncompliance with Study Drug|1|||
150106695|NCT01631474|541532141|FG000|Overall Study|Adverse Event|0|||
150106696|NCT01631474|541532142|FG001|Overall Study|Adverse Event|1|||
150106697|NCT01631474|541532143|FG002|Overall Study|Adverse Event|0|||
150106698|NCT01631474|541532144|FG003|Overall Study|Adverse Event|0|||
150106699|NCT01631474|541532145|FG004|Overall Study|Adverse Event|0|||
150106700|NCT01467076|541532146|FG000|Overall Study|Lost to Follow-up|1|||
150106701|NCT01467076|541532147|FG001|Overall Study|Lost to Follow-up|0|||
150106702|NCT01467076|541532148|FG002|Overall Study|Lost to Follow-up|0|||
150106703|NCT05040152|541532150|FG000|Overall Study|Withdrawal by Subject|5|||
150106704|NCT05040152|541532151|FG001|Overall Study|Withdrawal by Subject|0|||
150106705|NCT05040152|541532150|FG000|Overall Study|Lost to Follow-up|0|||
150106706|NCT05040152|541532151|FG001|Overall Study|Lost to Follow-up|2|||
150106707|NCT04476017|541532155|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
150106708|NCT04476017|541532156|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
150106709|NCT02075840|541532157|FG000|Overall Study|Withdrawal by Subject|13|||
150106710|NCT02075840|541532158|FG001|Overall Study|Withdrawal by Subject|22|||
150106711|NCT02075840|541532157|FG000|Overall Study|Reason not specified|1|||
150106712|NCT02075840|541532158|FG001|Overall Study|Reason not specified|0|||
150106713|NCT02075840|541532157|FG000|Overall Study|Adverse Event|0|||
150106714|NCT02075840|541532158|FG001|Overall Study|Adverse Event|2|||
150106715|NCT02075840|541532157|FG000|Overall Study|Death|35|||
150106716|NCT02075840|541532158|FG001|Overall Study|Death|40|||
150106717|NCT02075840|541532157|FG000|Overall Study|Lost to Follow-up|3|||
150106718|NCT02075840|541532158|FG001|Overall Study|Lost to Follow-up|2|||
150106719|NCT02075840|541532157|FG000|Overall Study|Physician Decision|1|||
150106720|NCT02075840|541532158|FG001|Overall Study|Physician Decision|3|||
150106721|NCT02075840|541532157|FG000|Overall Study|Ongoing at CCOD|99|||
150106722|NCT02075840|541532158|FG001|Overall Study|Ongoing at CCOD|82|||
150106723|NCT03795610|541532160|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
150106724|NCT03795610|541532160|FG000|Overall Study|Withdrawal by Subject|1|||
150106725|NCT03795610|541532160|FG000|Overall Study|Screen Failure (Unknown)|1|||
150106726|NCT02775344|541532161|FG000|Overall Study|No ovarian cyst identified|3|||
150106727|NCT02775344|541532162|FG001|Overall Study|No ovarian cyst identified|2|||
150106728|NCT03909165|541532165|FG000|Overall Study|Physician Decision|0|||
150106729|NCT03909165|541532166|FG001|Overall Study|Physician Decision|1|||
150106730|NCT03909165|541532167|FG002|Overall Study|Physician Decision|0|||
150106731|NCT03909165|541532168|FG003|Overall Study|Physician Decision|0|||
150106732|NCT03909165|541532169|FG004|Overall Study|Physician Decision|0|||
150106733|NCT03909165|541532165|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150106734|NCT03909165|541532166|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150106735|NCT03909165|541532167|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150106736|NCT03909165|541532168|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
150106737|NCT03909165|541532169|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
150106738|NCT03909165|541532165|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
150106739|NCT03909165|541532166|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
150106740|NCT03909165|541532167|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
150106741|NCT03909165|541532168|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
150106742|NCT03909165|541532169|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
150106743|NCT03909165|541532165|FG000|Overall Study|Previous Drug Exposure|0|||
150106744|NCT03909165|541532166|FG001|Overall Study|Previous Drug Exposure|0|||
150106745|NCT03909165|541532167|FG002|Overall Study|Previous Drug Exposure|1|||
150106746|NCT03909165|541532168|FG003|Overall Study|Previous Drug Exposure|0|||
150106747|NCT03909165|541532169|FG004|Overall Study|Previous Drug Exposure|0|||
150106748|NCT03909165|541532165|FG000|Overall Study|Early Discharge|1|||
150106749|NCT03909165|541532166|FG001|Overall Study|Early Discharge|0|||
150106750|NCT03909165|541532167|FG002|Overall Study|Early Discharge|0|||
150106751|NCT03909165|541532168|FG003|Overall Study|Early Discharge|0|||
150106752|NCT03909165|541532169|FG004|Overall Study|Early Discharge|0|||
150106753|NCT00414661|541532170|FG000|Overall Study|Death|2|||
150106754|NCT00414661|541532171|FG001|Overall Study|Death|5|||
150106755|NCT00414661|541532172|FG002|Overall Study|Death|0|||
150106756|NCT00414661|541532173|FG003|Overall Study|Death|0|||
150106757|NCT00414661|541532170|FG000|Overall Study|Lost to Follow-up|1|||
150106758|NCT00414661|541532171|FG001|Overall Study|Lost to Follow-up|4|||
150106759|NCT00414661|541532172|FG002|Overall Study|Lost to Follow-up|0|||
150106760|NCT00414661|541532173|FG003|Overall Study|Lost to Follow-up|1|||
150106761|NCT00414661|541532170|FG000|Overall Study|Withdrawal by Subject|5|||
150106762|NCT00414661|541532171|FG001|Overall Study|Withdrawal by Subject|2|||
150106763|NCT00414661|541532172|FG002|Overall Study|Withdrawal by Subject|2|||
150106764|NCT00414661|541532173|FG003|Overall Study|Withdrawal by Subject|2|||
150106765|NCT00414661|541532170|FG000|Overall Study|Other|6|||
150106766|NCT00414661|541532171|FG001|Overall Study|Other|3|||
150106767|NCT00414661|541532172|FG002|Overall Study|Other|0|||
150106768|NCT00414661|541532173|FG003|Overall Study|Other|0|||
150106769|NCT00717769|541532182|FG000|Overall Study|Adverse Event|9|||
150106770|NCT00717769|541532183|FG001|Overall Study|Adverse Event|6|||
150106771|NCT00717769|541532184|FG002|Overall Study|Adverse Event|1|||
150106772|NCT00717769|541532182|FG000|Overall Study|Lack of compliance|0|||
150106773|NCT00717769|541532183|FG001|Overall Study|Lack of compliance|2|||
150106774|NCT00717769|541532184|FG002|Overall Study|Lack of compliance|0|||
150106775|NCT00717769|541532182|FG000|Overall Study|Lost to Follow-up|3|||
150106776|NCT00717769|541532183|FG001|Overall Study|Lost to Follow-up|4|||
150106777|NCT00717769|541532184|FG002|Overall Study|Lost to Follow-up|0|||
150106778|NCT00717769|541532182|FG000|Overall Study|Lack of Efficacy|1|||
150106779|NCT00717769|541532183|FG001|Overall Study|Lack of Efficacy|2|||
150106780|NCT00717769|541532184|FG002|Overall Study|Lack of Efficacy|0|||
150106781|NCT00717769|541532182|FG000|Overall Study|Protocol Violation|0|||
150106782|NCT00717769|541532183|FG001|Overall Study|Protocol Violation|2|||
150106783|NCT00717769|541532184|FG002|Overall Study|Protocol Violation|0|||
150106784|NCT00717769|541532182|FG000|Overall Study|Sponsor decision|1|||
150106785|NCT00717769|541532183|FG001|Overall Study|Sponsor decision|0|||
150106786|NCT00717769|541532184|FG002|Overall Study|Sponsor decision|10|||
150106787|NCT00717769|541532182|FG000|Overall Study|Withdrew consent|2|||
150106788|NCT00717769|541532183|FG001|Overall Study|Withdrew consent|2|||
150106789|NCT00717769|541532184|FG002|Overall Study|Withdrew consent|0|||
150106790|NCT02321462|541532186|FG000|Overall Study|Withdrawal by Subject|5|||
150106791|NCT02321462|541532187|FG001|Overall Study|Withdrawal by Subject|2|||
150106792|NCT02321462|541532186|FG000|Overall Study|Subject withdrawn before any treatment|1|||
150106793|NCT02321462|541532187|FG001|Overall Study|Subject withdrawn before any treatment|1|||
150106794|NCT00692770|541532198|FG000|Overall Study|Protocol Violation|2|||
150106795|NCT00692770|541532199|FG001|Overall Study|Protocol Violation|7|||
150106796|NCT00692770|541532198|FG000|Overall Study|Withdrawal by Subject|97|||
150106797|NCT00692770|541532199|FG001|Overall Study|Withdrawal by Subject|36|||
150106798|NCT00692770|541532198|FG000|Overall Study|Adverse Event|136|||
150106799|NCT00692770|541532199|FG001|Overall Study|Adverse Event|41|||
150106800|NCT00692770|541532198|FG000|Overall Study|Death|10|||
150106801|NCT00692770|541532199|FG001|Overall Study|Death|5|||
150186930|NCT03131648|541825198|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150186931|NCT03131648|541825191|FG000|Open-label Treatment|Discontinued IMP|0|||
150186932|NCT03131648|541825192|FG001|Open-label Treatment|Discontinued IMP|0|||
150186933|NCT03131648|541825193|FG002|Open-label Treatment|Discontinued IMP|0|||
150186934|NCT03131648|541825194|FG003|Open-label Treatment|Discontinued IMP|0|||
150186935|NCT03131648|541825195|FG004|Open-label Treatment|Discontinued IMP|0|||
150186936|NCT03131648|541825196|FG005|Open-label Treatment|Discontinued IMP|0|||
150186937|NCT03131648|541825197|FG006|Open-label Treatment|Discontinued IMP|112|||
150186938|NCT03131648|541825198|FG007|Open-label Treatment|Discontinued IMP|0|||
150186939|NCT03131648|541825191|FG000|Open-label Treatment|Completed Week 50|0|||
150186940|NCT03131648|541825192|FG001|Open-label Treatment|Completed Week 50|0|||
150186941|NCT03131648|541825193|FG002|Open-label Treatment|Completed Week 50|0|||
150186942|NCT03131648|541825194|FG003|Open-label Treatment|Completed Week 50|0|||
150186943|NCT03131648|541825195|FG004|Open-label Treatment|Completed Week 50|0|||
150186944|NCT03131648|541825196|FG005|Open-label Treatment|Completed Week 50|0|||
150186945|NCT03131648|541825197|FG006|Open-label Treatment|Completed Week 50|6|||
150186946|NCT03131648|541825198|FG007|Open-label Treatment|Completed Week 50|0|||
150186947|NCT03131648|541825191|FG000|Maintenance Treatment Period|Not dosed|0|||
150186948|NCT03131648|541825192|FG001|Maintenance Treatment Period|Not dosed|0|||
150186949|NCT03131648|541825193|FG002|Maintenance Treatment Period|Not dosed|3|||
150186950|NCT03131648|541825194|FG003|Maintenance Treatment Period|Not dosed|2|||
150186951|NCT03131648|541825195|FG004|Maintenance Treatment Period|Not dosed|1|||
150186952|NCT03131648|541825196|FG005|Maintenance Treatment Period|Not dosed|0|||
150186953|NCT03131648|541825197|FG006|Maintenance Treatment Period|Not dosed|0|||
150186954|NCT03131648|541825198|FG007|Maintenance Treatment Period|Not dosed|0|||
150186955|NCT03131648|541825191|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
150186956|NCT03131648|541825192|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
150186957|NCT03131648|541825193|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
150186958|NCT03131648|541825194|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
150186959|NCT03131648|541825195|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
150186960|NCT03131648|541825196|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
150186961|NCT03131648|541825197|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
150186962|NCT03131648|541825198|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
150186963|NCT03131648|541825191|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150186964|NCT03131648|541825192|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150186965|NCT03131648|541825193|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
150186966|NCT03131648|541825194|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
150186967|NCT03131648|541825195|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
150186968|NCT03131648|541825196|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
150186969|NCT03131648|541825197|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150186970|NCT03131648|541825198|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150186971|NCT03131648|541825191|FG000|Maintenance Treatment Period|Completed Week 50|0|||
150186972|NCT03131648|541825192|FG001|Maintenance Treatment Period|Completed Week 50|0|||
150186973|NCT03131648|541825193|FG002|Maintenance Treatment Period|Completed Week 50|0|||
150186974|NCT03131648|541825194|FG003|Maintenance Treatment Period|Completed Week 50|0|||
150186975|NCT03131648|541825195|FG004|Maintenance Treatment Period|Completed Week 50|1|||
150186976|NCT03131648|541825196|FG005|Maintenance Treatment Period|Completed Week 50|0|||
150186977|NCT03131648|541825197|FG006|Maintenance Treatment Period|Completed Week 50|0|||
150186978|NCT03131648|541825198|FG007|Maintenance Treatment Period|Completed Week 50|0|||
150186979|NCT03131648|541825191|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186980|NCT03131648|541825192|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186981|NCT03131648|541825193|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186982|NCT03131648|541825194|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186983|NCT03131648|541825195|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186984|NCT03131648|541825196|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186985|NCT03131648|541825197|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
150186986|NCT03131648|541825198|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
150186987|NCT04150718|541825206|FG000|Overall Study|Withdrawal by Subject|2|||
150186988|NCT04150718|541825207|FG001|Overall Study|Withdrawal by Subject|7|||
150186989|NCT04150718|541825208|FG002|Overall Study|Withdrawal by Subject|1|||
150186990|NCT04150718|541825206|FG000|Overall Study|Lost to Follow-up|1|||
150186991|NCT04150718|541825207|FG001|Overall Study|Lost to Follow-up|2|||
150186992|NCT04150718|541825208|FG002|Overall Study|Lost to Follow-up|0|||
150186993|NCT04150718|541825206|FG000|Overall Study|Ineligible|1|||
150186994|NCT04150718|541825207|FG001|Overall Study|Ineligible|0|||
150186995|NCT04150718|541825208|FG002|Overall Study|Ineligible|10|||
150186996|NCT05324124|541825213|FG000|Period 1|Withdrawal by Subject|1|||
150186997|NCT05324124|541825214|FG001|Period 1|Withdrawal by Subject|0|||
150186998|NCT05324124|541825213|FG000|Period 1|Physician Decision|0|||
150186999|NCT05324124|541825214|FG001|Period 1|Physician Decision|1|||
150187000|NCT04950660|541825215|FG000|Overall Study|Protocol Violation|4|||
150106802|NCT00692770|541532198|FG000|Overall Study|Lost to Follow-up|7|||
150106803|NCT00692770|541532199|FG001|Overall Study|Lost to Follow-up|3|||
150106804|NCT00692770|541532198|FG000|Overall Study|Non-compliant with study medication|11|||
150106805|NCT00692770|541532199|FG001|Overall Study|Non-compliant with study medication|5|||
150106806|NCT00692770|541532198|FG000|Overall Study|Progression by clinical judgment|2|||
150106807|NCT00692770|541532199|FG001|Overall Study|Progression by clinical judgment|3|||
150106808|NCT00692770|541532198|FG000|Overall Study|Physician decision not protocol driven|10|||
150106809|NCT00692770|541532199|FG001|Overall Study|Physician decision not protocol driven|14|||
150106810|NCT00692770|541532198|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
150106811|NCT00692770|541532199|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
150106812|NCT00692770|541532198|FG000|Overall Study|Protocol driven decision point|3|||
150106813|NCT00692770|541532199|FG001|Overall Study|Protocol driven decision point|7|||
150106814|NCT00692770|541532198|FG000|Overall Study|Completed all planned assessments|79|||
150106815|NCT00692770|541532199|FG001|Overall Study|Completed all planned assessments|101|||
150106816|NCT00692770|541532198|FG000|Overall Study|Radiological and clinical progression|8|||
150106817|NCT00692770|541532199|FG001|Overall Study|Radiological and clinical progression|8|||
150106818|NCT00692770|541532198|FG000|Overall Study|Clinical endpoint reached|16|||
150106819|NCT00692770|541532199|FG001|Overall Study|Clinical endpoint reached|43|||
150106820|NCT00692770|541532198|FG000|Overall Study|Study terminated by sponsor|2|||
150106821|NCT00692770|541532199|FG001|Overall Study|Study terminated by sponsor|2|||
150106822|NCT00692770|541532198|FG000|Overall Study|Randomized but not treated|3|||
150106823|NCT00692770|541532199|FG001|Overall Study|Randomized but not treated|4|||
150106824|NCT04327986|541532200|FG000|Overall Study|Physician Decision|2|||
150106825|NCT04327986|541532201|FG001|Overall Study|Physician Decision|0|||
150106826|NCT04327986|541532202|FG002|Overall Study|Physician Decision|0|||
150106827|NCT04327986|541532200|FG000|Overall Study|Death|1|||
150106828|NCT04327986|541532201|FG001|Overall Study|Death|0|||
150106829|NCT04327986|541532202|FG002|Overall Study|Death|0|||
150106830|NCT00834912|541532204|FG000|Treatment Period 1|Adverse Event|0|||
150106831|NCT00834912|541532205|FG001|Treatment Period 1|Adverse Event|1|||
150106832|NCT00834912|541532206|FG002|Treatment Period 1|Adverse Event|0|||
150106833|NCT00834912|541532207|FG003|Treatment Period 1|Adverse Event|1|||
150106834|NCT00834912|541532208|FG004|Treatment Period 1|Adverse Event|0|||
150106835|NCT00834912|541532209|FG005|Treatment Period 1|Adverse Event|0|||
150106836|NCT00834912|541532204|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150106837|NCT00834912|541532205|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150106838|NCT00834912|541532206|FG002|Treatment Period 2|Withdrawal by Subject|1|||
150106839|NCT00834912|541532207|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150106840|NCT00834912|541532208|FG004|Treatment Period 2|Withdrawal by Subject|1|||
150106841|NCT00834912|541532209|FG005|Treatment Period 2|Withdrawal by Subject|0|||
150106842|NCT03044197|541532210|FG000|Overall Study|Withdrawal by Subject|3|||
150106843|NCT03044197|541532211|FG001|Overall Study|Withdrawal by Subject|1|||
150106844|NCT03829046|541532214|FG000|Overall Study|Withdrawal by Subject|1|||
150106845|NCT03829046|541532215|FG001|Overall Study|Withdrawal by Subject|0|||
150106846|NCT00262067|541532216|FG000|Overall Study|Death|190|||
150106847|NCT00262067|541532217|FG001|Overall Study|Death|89|||
150106848|NCT00262067|541532218|FG002|Overall Study|Death|186|||
150106849|NCT00262067|541532219|FG003|Overall Study|Death|99|||
150106850|NCT00262067|541532216|FG000|Overall Study|Lost to Follow-up|5|||
150106851|NCT00262067|541532217|FG001|Overall Study|Lost to Follow-up|4|||
150106852|NCT00262067|541532218|FG002|Overall Study|Lost to Follow-up|7|||
150106853|NCT00262067|541532219|FG003|Overall Study|Lost to Follow-up|5|||
150106854|NCT00262067|541532216|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
150106855|NCT00262067|541532217|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
150106856|NCT00262067|541532218|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
150106857|NCT00262067|541532219|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
150106858|NCT00262067|541532216|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
150106859|NCT00262067|541532217|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
150106860|NCT00262067|541532218|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
150106861|NCT00262067|541532219|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
150106862|NCT01399593|541532223|FG000|Overall Study|Physician Decision|1|||
150106863|NCT01399593|541532224|FG001|Overall Study|Physician Decision|0|||
150106864|NCT01399593|541532223|FG000|Overall Study|Adverse Event|1|||
150106865|NCT01399593|541532224|FG001|Overall Study|Adverse Event|0|||
150187001|NCT04950660|541825216|FG001|Overall Study|Protocol Violation|2|||
150187002|NCT04950660|541825215|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
150187003|NCT04950660|541825216|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
150187004|NCT04950660|541825215|FG000|Overall Study|Withdrawal by Subject|0|||
150187005|NCT04950660|541825216|FG001|Overall Study|Withdrawal by Subject|1|||
150187006|NCT04950660|541825215|FG000|Overall Study|Hypotension|1|||
150187007|NCT04950660|541825216|FG001|Overall Study|Hypotension|0|||
150187008|NCT02437318|541825223|FG000|Overall Study|Progressive disease|207|||
150187009|NCT02437318|541825224|FG001|Overall Study|Progressive disease|240|||
150187010|NCT02437318|541825223|FG000|Overall Study|Subject/guardian decision|24|||
150187011|NCT02437318|541825224|FG001|Overall Study|Subject/guardian decision|11|||
150187012|NCT02437318|541825223|FG000|Overall Study|Physician Decision|29|||
150187013|NCT02437318|541825224|FG001|Overall Study|Physician Decision|22|||
150187014|NCT02437318|541825223|FG000|Overall Study|Adverse Event|14|||
150187015|NCT02437318|541825224|FG001|Overall Study|Adverse Event|4|||
150187016|NCT02437318|541825223|FG000|Overall Study|Death|4|||
150187017|NCT02437318|541825224|FG001|Overall Study|Death|4|||
150187018|NCT02437318|541825223|FG000|Overall Study|Protocol deviation|5|||
150187019|NCT02437318|541825224|FG001|Overall Study|Protocol deviation|7|||
150187020|NCT02437318|541825223|FG000|Overall Study|Sponsor decision|1|||
150187021|NCT02437318|541825224|FG001|Overall Study|Sponsor decision|0|||
150187022|NCT00512070|541825230|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
150187023|NCT00512070|541825231|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
150187024|NCT00512070|541825232|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
150187025|NCT00512070|541825230|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
150187026|NCT00512070|541825231|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
150187027|NCT00512070|541825232|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
150187028|NCT03143153|541825236|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
150187029|NCT03143153|541825237|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
150187030|NCT03143153|541825238|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
150187031|NCT03143153|541825236|FG000|Pre-Treatment|Participant withdrew consent|0|||
150187032|NCT03143153|541825237|FG001|Pre-Treatment|Participant withdrew consent|1|||
150187033|NCT03143153|541825238|FG002|Pre-Treatment|Participant withdrew consent|12|||
150187034|NCT03143153|541825236|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
150187035|NCT03143153|541825237|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
150187036|NCT03143153|541825238|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
150187037|NCT03143153|541825236|FG000|Pre-Treatment|Other Reasons|1|||
150187038|NCT03143153|541825237|FG001|Pre-Treatment|Other Reasons|2|||
150106866|NCT01399593|541532223|FG000|Overall Study|Death|1|||
150106867|NCT01399593|541532224|FG001|Overall Study|Death|1|||
150106868|NCT01399593|541532223|FG000|Overall Study|Transplantectomy|0|||
150106869|NCT01399593|541532224|FG001|Overall Study|Transplantectomy|1|||
150106870|NCT02849548|541532225|FG000|Overall Study|Lost to Follow-up|1|||
150106871|NCT02849548|541532226|FG001|Overall Study|Lost to Follow-up|2|||
150106872|NCT02849548|541532225|FG000|Overall Study|Protocol Violation|1|||
150106873|NCT02849548|541532226|FG001|Overall Study|Protocol Violation|0|||
150106874|NCT00714259|541532227|FG000|Overall Study|Death|2|||
150106875|NCT01140477|541534149|FG000|Overall Study|Lost to Follow-up|4|||
150106876|NCT01140477|541534150|FG001|Overall Study|Lost to Follow-up|0|||
150106877|NCT01140477|541534149|FG000|Overall Study|Withdrawal by Subject|1|||
150106878|NCT01140477|541534150|FG001|Overall Study|Withdrawal by Subject|4|||
150106879|NCT01140477|541534149|FG000|Overall Study|Surgical complication preventing implant|2|||
150106880|NCT01140477|541534150|FG001|Overall Study|Surgical complication preventing implant|0|||
150106881|NCT01140477|541534149|FG000|Overall Study|Death|1|||
150106882|NCT01140477|541534150|FG001|Overall Study|Death|1|||
150106883|NCT01140477|541534149|FG000|Overall Study|Subject explanted|0|||
150106884|NCT01140477|541534150|FG001|Overall Study|Subject explanted|1|||
150106885|NCT01982253|541534158|FG000|Overall Study|Withdrawal by Subject|1|||
150106886|NCT01982253|541534159|FG001|Overall Study|Withdrawal by Subject|0|||
150106887|NCT01982253|541534160|FG002|Overall Study|Withdrawal by Subject|0|||
150187039|NCT03143153|541825238|FG002|Pre-Treatment|Other Reasons|1|||
150187040|NCT03143153|541825236|FG000|Pre-Treatment|Disease Progression|1|||
150187041|NCT03143153|541825237|FG001|Pre-Treatment|Disease Progression|1|||
150187042|NCT03143153|541825238|FG002|Pre-Treatment|Disease Progression|2|||
150187043|NCT03143153|541825236|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
150187044|NCT03143153|541825237|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
150187045|NCT03143153|541825238|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
150187046|NCT03143153|541825236|FG000|Treatment|Disease progression|174|||
150187047|NCT03143153|541825237|FG001|Treatment|Disease progression|184|||
150187048|NCT03143153|541825238|FG002|Treatment|Disease progression|193|||
150106888|NCT01982253|541534158|FG000|Overall Study|Study terminated by sponsor|1|||
150106889|NCT01982253|541534159|FG001|Overall Study|Study terminated by sponsor|4|||
150106890|NCT01982253|541534160|FG002|Overall Study|Study terminated by sponsor|4|||
150106891|NCT03848845|541534161|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
150106892|NCT03848845|541534162|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
150187049|NCT03143153|541825236|FG000|Treatment|Study drug toxicity|59|||
150187050|NCT03143153|541825237|FG001|Treatment|Study drug toxicity|33|||
150187051|NCT03143153|541825238|FG002|Treatment|Study drug toxicity|40|||
150187052|NCT03143153|541825236|FG000|Treatment|Death|5|||
150187053|NCT03143153|541825237|FG001|Treatment|Death|3|||
150187054|NCT03143153|541825238|FG002|Treatment|Death|4|||
150187055|NCT03143153|541825236|FG000|Treatment|Adverse event unrelated to study drug|19|||
150187056|NCT03143153|541825237|FG001|Treatment|Adverse event unrelated to study drug|28|||
150187057|NCT03143153|541825238|FG002|Treatment|Adverse event unrelated to study drug|12|||
150187058|NCT03143153|541825236|FG000|Treatment|Participant request to discontinue study treatment|13|||
150187059|NCT03143153|541825237|FG001|Treatment|Participant request to discontinue study treatment|15|||
150187060|NCT03143153|541825238|FG002|Treatment|Participant request to discontinue study treatment|20|||
150187061|NCT03143153|541825236|FG000|Treatment|Participant withdrew consent|3|||
150187062|NCT03143153|541825237|FG001|Treatment|Participant withdrew consent|4|||
150187063|NCT03143153|541825238|FG002|Treatment|Participant withdrew consent|12|||
150187064|NCT03143153|541825236|FG000|Treatment|Pregnancy|1|||
150187065|NCT03143153|541825237|FG001|Treatment|Pregnancy|0|||
150187066|NCT03143153|541825238|FG002|Treatment|Pregnancy|0|||
150187067|NCT03143153|541825236|FG000|Treatment|Maximum clinical benefit|1|||
150187068|NCT03143153|541825237|FG001|Treatment|Maximum clinical benefit|3|||
150187069|NCT03143153|541825238|FG002|Treatment|Maximum clinical benefit|4|||
150187070|NCT03143153|541825236|FG000|Treatment|Completed treatment as per Protocol|13|||
150187071|NCT03143153|541825237|FG001|Treatment|Completed treatment as per Protocol|8|||
150187072|NCT03143153|541825238|FG002|Treatment|Completed treatment as per Protocol|0|||
150187073|NCT03143153|541825236|FG000|Treatment|Other reasons|12|||
150187074|NCT03143153|541825237|FG001|Treatment|Other reasons|7|||
150187075|NCT03143153|541825238|FG002|Treatment|Other reasons|15|||
150187076|NCT03143153|541825236|FG000|Treatment|Not reported|1|||
150187077|NCT03143153|541825237|FG001|Treatment|Not reported|0|||
150187078|NCT03143153|541825238|FG002|Treatment|Not reported|0|||
150187079|NCT04237298|541825239|FG000|Overall Study|Lost to Follow-up|4|||
150187080|NCT04237298|541825240|FG001|Overall Study|Lost to Follow-up|5|||
150187081|NCT02530671|541825241|FG000|Overall Study|Lost to Follow-up|2|||
150187082|NCT02530671|541825242|FG001|Overall Study|Lost to Follow-up|0|||
150187083|NCT02530671|541825241|FG000|Overall Study|Withdrawal by Subject|1|||
150187084|NCT02530671|541825242|FG001|Overall Study|Withdrawal by Subject|0|||
150187085|NCT01566695|541825256|FG000|Overall Study|Lack of Efficacy|1|||
150187086|NCT01566695|541825257|FG001|Overall Study|Lack of Efficacy|0|||
150187087|NCT01566695|541825256|FG000|Overall Study|Adverse Event|3|||
150187088|NCT01566695|541825257|FG001|Overall Study|Adverse Event|0|||
150187089|NCT01566695|541825256|FG000|Overall Study|Death|79|||
150187090|NCT01566695|541825257|FG001|Overall Study|Death|86|||
150187091|NCT01566695|541825256|FG000|Overall Study|Withdrawal by Subject|13|||
150106893|NCT03848845|541534163|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
150106894|NCT03848845|541534164|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
150106895|NCT03848845|541534161|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
150106896|NCT03848845|541534162|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
150106897|NCT03848845|541534163|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
150106898|NCT03848845|541534164|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
150106899|NCT03848845|541534161|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
150106900|NCT03848845|541534162|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
150106901|NCT03848845|541534163|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
150106902|NCT03848845|541534164|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
150106903|NCT03848845|541534161|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
150106904|NCT03848845|541534162|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
150106905|NCT03848845|541534163|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
150106906|NCT03848845|541534164|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
150106907|NCT02789176|541534165|FG000|Overall Study|Death|0|||
150106908|NCT02789176|541534166|FG001|Overall Study|Death|0|||
150106909|NCT02789176|541534167|FG002|Overall Study|Death|3|||
150187092|NCT01566695|541825257|FG001|Overall Study|Withdrawal by Subject|12|||
150187093|NCT01566695|541825256|FG000|Overall Study|Lost to Follow-up|0|||
150187094|NCT01566695|541825257|FG001|Overall Study|Lost to Follow-up|3|||
150187095|NCT01566695|541825256|FG000|Overall Study|Other reasons|11|||
150187096|NCT01566695|541825257|FG001|Overall Study|Other reasons|8|||
150187097|NCT03763708|541825259|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
150187098|NCT03763708|541825260|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187099|NCT03763708|541825261|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187100|NCT03763708|541825262|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187101|NCT03763708|541825263|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150106910|NCT02789176|541534168|FG003|Overall Study|Death|0|||
150106911|NCT02789176|541534165|FG000|Overall Study|Withdrawal by Subject|0|||
150106912|NCT02789176|541534166|FG001|Overall Study|Withdrawal by Subject|0|||
150187102|NCT03763708|541825264|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187103|NCT03763708|541825265|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150106913|NCT02789176|541534167|FG002|Overall Study|Withdrawal by Subject|1|||
150106914|NCT02789176|541534168|FG003|Overall Study|Withdrawal by Subject|0|||
150106915|NCT02789176|541534165|FG000|Overall Study|Lost to Follow-up|8|||
150187104|NCT03763708|541825266|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187105|NCT03763708|541825267|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
150187106|NCT03763708|541825259|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187107|NCT03763708|541825260|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187108|NCT03763708|541825261|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
150187109|NCT03763708|541825262|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187110|NCT03763708|541825263|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187111|NCT03763708|541825264|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187112|NCT03763708|541825265|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187113|NCT03763708|541825266|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187114|NCT03763708|541825267|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
150187115|NCT03763708|541825259|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187116|NCT03763708|541825260|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187117|NCT03763708|541825261|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187118|NCT03763708|541825262|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
150187119|NCT03763708|541825263|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187120|NCT03763708|541825264|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187121|NCT03763708|541825265|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187122|NCT03763708|541825266|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187123|NCT03763708|541825267|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
150187124|NCT03763708|541825259|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187125|NCT03763708|541825260|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187126|NCT03763708|541825261|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187127|NCT03763708|541825262|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187128|NCT03763708|541825263|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
150187129|NCT03763708|541825264|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187130|NCT03763708|541825265|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187131|NCT03763708|541825266|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187132|NCT03763708|541825267|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
150187133|NCT03763708|541825259|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187134|NCT03763708|541825260|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187135|NCT03763708|541825261|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187136|NCT03763708|541825262|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187137|NCT03763708|541825263|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187138|NCT03763708|541825264|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
150187139|NCT03763708|541825265|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187140|NCT03763708|541825266|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187141|NCT03763708|541825267|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
150187142|NCT03763708|541825259|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187143|NCT03763708|541825260|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187144|NCT03763708|541825261|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187145|NCT03763708|541825262|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187146|NCT03763708|541825263|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187147|NCT03763708|541825264|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187148|NCT03763708|541825265|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
150187149|NCT03763708|541825266|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187150|NCT03763708|541825267|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
150187151|NCT03763708|541825259|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
150187152|NCT03763708|541825260|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
150187153|NCT03763708|541825261|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
150187154|NCT03763708|541825262|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
150187155|NCT03763708|541825263|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
150187156|NCT03763708|541825264|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
150187157|NCT03763708|541825265|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
150187158|NCT03763708|541825266|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
150187159|NCT03763708|541825267|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
150187160|NCT03763708|541825259|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
150187161|NCT03763708|541825260|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
150106916|NCT02789176|541534166|FG001|Overall Study|Lost to Follow-up|2|||
150106917|NCT02789176|541534167|FG002|Overall Study|Lost to Follow-up|6|||
150106918|NCT02789176|541534168|FG003|Overall Study|Lost to Follow-up|1|||
150106919|NCT00192075|541534170|FG000|Overall Study|Disease Progression|23|||
150187162|NCT03763708|541825261|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
150187163|NCT03763708|541825262|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
150187164|NCT03763708|541825263|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
150106920|NCT00192075|541534171|FG001|Overall Study|Disease Progression|6|||
150106921|NCT00192075|541534170|FG000|Overall Study|Adverse Event|1|||
150106922|NCT00192075|541534171|FG001|Overall Study|Adverse Event|3|||
150106923|NCT00192075|541534170|FG000|Overall Study|Death|0|||
150106924|NCT00192075|541534171|FG001|Overall Study|Death|1|||
150106925|NCT00192075|541534170|FG000|Overall Study|Lack of Efficacy|0|||
150106926|NCT00192075|541534171|FG001|Overall Study|Lack of Efficacy|0|||
150106927|NCT00192075|541534170|FG000|Overall Study|Physician Decision|3|||
150106928|NCT00192075|541534171|FG001|Overall Study|Physician Decision|0|||
150106929|NCT00192075|541534170|FG000|Overall Study|Withdrawal by Subject|5|||
150106930|NCT00192075|541534171|FG001|Overall Study|Withdrawal by Subject|5|||
150106931|NCT00192075|541534170|FG000|Overall Study|Patient Non-Compliance|0|||
150106932|NCT00192075|541534171|FG001|Overall Study|Patient Non-Compliance|1|||
150106933|NCT00192075|541534170|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
150106934|NCT00192075|541534171|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
150106935|NCT00192075|541534170|FG000|Overall Study|Other|5|||
150106936|NCT00192075|541534171|FG001|Overall Study|Other|2|||
150106937|NCT00779675|541534172|FG000|Treatment Period|Adverse Event|87|||
150106938|NCT00779675|541534172|FG000|Treatment Period|Treatment Failure|80|||
150106939|NCT00779675|541534172|FG000|Treatment Period|Transferred to Another Study|38|||
150106940|NCT00779675|541534172|FG000|Treatment Period|Lost to Follow-up|23|||
150106941|NCT00779675|541534172|FG000|Treatment Period|Withdrawal by Subject|46|||
150106942|NCT00779675|541534172|FG000|Treatment Period|Protocol Violation|54|||
150106943|NCT00779675|541534172|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
150106944|NCT00779675|541534172|FG000|Treatment Period|Administrative|3|||
150106945|NCT00779675|541534172|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
150106946|NCT00779675|541534172|FG000|Extended Treatment Period|Protocol Violation|13|||
150106947|NCT00779675|541534172|FG000|Extended Treatment Period|Adverse Event|6|||
150106948|NCT00779675|541534172|FG000|Extended Treatment Period|Treatment Failure|11|||
150106949|NCT00779675|541534172|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
150106950|NCT00779675|541534172|FG000|Extended Treatment Period|Lost to Follow-up|6|||
150106951|NCT01956110|541534185|FG000|Overall Study|Protocol Violation|25|||
150106952|NCT01956110|541534186|FG001|Overall Study|Protocol Violation|11|||
150106953|NCT01956110|541534185|FG000|Overall Study|Adverse Event|9|||
150106954|NCT01956110|541534186|FG001|Overall Study|Adverse Event|10|||
150106955|NCT01956110|541534185|FG000|Overall Study|Personal reasons|1|||
150106956|NCT01956110|541534186|FG001|Overall Study|Personal reasons|1|||
150106957|NCT03325166|541534195|FG000|Overall Study|Adverse Event|1|||
150106958|NCT00910715|541534196|FG000|Overall Study|Lost to Follow-up|22|||
150106959|NCT00910715|541534197|FG001|Overall Study|Lost to Follow-up|26|||
150106960|NCT00910715|541534198|FG002|Overall Study|Lost to Follow-up|0|||
150106961|NCT00706966|541534199|FG000|Overall Study|Adverse Event|1|||
150106962|NCT03354429|541534200|FG000|Overall Study|Withdrawal by Subject|8|||
150106963|NCT03354429|541534201|FG001|Overall Study|Withdrawal by Subject|7|||
150106964|NCT03354429|541534200|FG000|Overall Study|Lost to Follow-up|1|||
150106965|NCT03354429|541534201|FG001|Overall Study|Lost to Follow-up|0|||
150106966|NCT05923229|541534206|FG000|Overall Study|Withdrawal by Subject|3|||
150106967|NCT05923229|541534207|FG001|Overall Study|Withdrawal by Subject|0|||
150106968|NCT05923229|541534206|FG000|Overall Study|Health related|2|||
150106969|NCT05923229|541534207|FG001|Overall Study|Health related|1|||
150106970|NCT05288556|541534208|FG000|Overall Study|Protocol Violation|1|||
150106971|NCT05288556|541534208|FG000|Overall Study|Withdrawal by Subject|1|||
150106972|NCT02465528|541534209|FG000|Overall Study|Progressive disease|0|||
150106973|NCT02465528|541534210|FG001|Overall Study|Progressive disease|2|||
150106974|NCT02465528|541534211|FG002|Overall Study|Progressive disease|9|||
150106975|NCT02465528|541534212|FG003|Overall Study|Progressive disease|4|||
150106976|NCT02465528|541534209|FG000|Overall Study|Study terminated by sponsor|1|||
150106977|NCT02465528|541534210|FG001|Overall Study|Study terminated by sponsor|2|||
150106978|NCT02465528|541534211|FG002|Overall Study|Study terminated by sponsor|0|||
150106979|NCT02465528|541534212|FG003|Overall Study|Study terminated by sponsor|0|||
150106980|NCT02465528|541534209|FG000|Overall Study|Withdrawal by Subject|0|||
150106981|NCT02465528|541534210|FG001|Overall Study|Withdrawal by Subject|0|||
150106982|NCT02465528|541534211|FG002|Overall Study|Withdrawal by Subject|2|||
150106983|NCT02465528|541534212|FG003|Overall Study|Withdrawal by Subject|0|||
150106984|NCT02465528|541534209|FG000|Overall Study|Adverse Event|0|||
150106985|NCT02465528|541534210|FG001|Overall Study|Adverse Event|0|||
150106986|NCT02465528|541534211|FG002|Overall Study|Adverse Event|0|||
150106987|NCT02465528|541534212|FG003|Overall Study|Adverse Event|1|||
150106988|NCT02465528|541534209|FG000|Overall Study|Physician Decision|0|||
150106989|NCT02465528|541534210|FG001|Overall Study|Physician Decision|0|||
150106990|NCT02465528|541534211|FG002|Overall Study|Physician Decision|1|||
150106991|NCT02465528|541534212|FG003|Overall Study|Physician Decision|0|||
150106992|NCT03752619|541534215|FG000|Overall Study|Lost to Follow-up|2|||
150106993|NCT03752619|541534216|FG001|Overall Study|Lost to Follow-up|1|||
150106994|NCT03752619|541534215|FG000|Overall Study|Withdrawal by Subject|1|||
150106995|NCT03752619|541534216|FG001|Overall Study|Withdrawal by Subject|1|||
150106996|NCT03752619|541534215|FG000|Overall Study|Adverse Event|0|||
150106997|NCT03752619|541534216|FG001|Overall Study|Adverse Event|1|||
150106998|NCT03907683|541534217|FG000|Overall Study|Pregnancy|1|||
150106999|NCT03907683|541534217|FG000|Overall Study|Withdrawal by Subject|1|||
150107000|NCT03400332|541534218|FG000|Pre-Treatment|Other reasons|0|||
150107001|NCT03400332|541534219|FG001|Pre-Treatment|Other reasons|0|||
150107002|NCT03400332|541534220|FG002|Pre-Treatment|Other reasons|0|||
150107003|NCT03400332|541534221|FG003|Pre-Treatment|Other reasons|0|||
150107004|NCT03400332|541534222|FG004|Pre-Treatment|Other reasons|0|||
150107005|NCT03400332|541534223|FG005|Pre-Treatment|Other reasons|0|||
150107006|NCT03400332|541534224|FG006|Pre-Treatment|Other reasons|0|||
150107007|NCT03400332|541534225|FG007|Pre-Treatment|Other reasons|0|||
150107008|NCT03400332|541534226|FG008|Pre-Treatment|Other reasons|1|||
150107009|NCT03400332|541534218|FG000|Pre-Treatment|No longer met study criteria|0|||
150107010|NCT03400332|541534219|FG001|Pre-Treatment|No longer met study criteria|0|||
150107011|NCT03400332|541534220|FG002|Pre-Treatment|No longer met study criteria|0|||
150107012|NCT03400332|541534221|FG003|Pre-Treatment|No longer met study criteria|0|||
150107013|NCT03400332|541534222|FG004|Pre-Treatment|No longer met study criteria|0|||
150107014|NCT03400332|541534223|FG005|Pre-Treatment|No longer met study criteria|0|||
150107015|NCT03400332|541534224|FG006|Pre-Treatment|No longer met study criteria|0|||
150107016|NCT03400332|541534225|FG007|Pre-Treatment|No longer met study criteria|0|||
150107017|NCT03400332|541534226|FG008|Pre-Treatment|No longer met study criteria|1|||
150107018|NCT03400332|541534218|FG000|Pre-Treatment|Withdrawal by Subject|0|||
150107019|NCT03400332|541534219|FG001|Pre-Treatment|Withdrawal by Subject|0|||
150107020|NCT03400332|541534220|FG002|Pre-Treatment|Withdrawal by Subject|0|||
150107021|NCT03400332|541534221|FG003|Pre-Treatment|Withdrawal by Subject|0|||
150107022|NCT03400332|541534222|FG004|Pre-Treatment|Withdrawal by Subject|0|||
150107023|NCT03400332|541534223|FG005|Pre-Treatment|Withdrawal by Subject|0|||
150107024|NCT03400332|541534224|FG006|Pre-Treatment|Withdrawal by Subject|0|||
150107025|NCT03400332|541534225|FG007|Pre-Treatment|Withdrawal by Subject|0|||
150107026|NCT03400332|541534226|FG008|Pre-Treatment|Withdrawal by Subject|1|||
150107027|NCT03400332|541534218|FG000|Treatment|Participant withdrew consent|2|||
150107028|NCT03400332|541534219|FG001|Treatment|Participant withdrew consent|2|||
150107029|NCT03400332|541534220|FG002|Treatment|Participant withdrew consent|0|||
150107030|NCT03400332|541534221|FG003|Treatment|Participant withdrew consent|0|||
150107031|NCT03400332|541534222|FG004|Treatment|Participant withdrew consent|3|||
150107032|NCT03400332|541534223|FG005|Treatment|Participant withdrew consent|3|||
150107033|NCT03400332|541534224|FG006|Treatment|Participant withdrew consent|1|||
150107034|NCT03400332|541534225|FG007|Treatment|Participant withdrew consent|1|||
150107035|NCT03400332|541534226|FG008|Treatment|Participant withdrew consent|1|||
150107036|NCT03400332|541534218|FG000|Treatment|Other reasons|0|||
150107037|NCT03400332|541534219|FG001|Treatment|Other reasons|1|||
150107038|NCT03400332|541534220|FG002|Treatment|Other reasons|1|||
150107039|NCT03400332|541534221|FG003|Treatment|Other reasons|0|||
150107040|NCT03400332|541534222|FG004|Treatment|Other reasons|3|||
150107041|NCT03400332|541534223|FG005|Treatment|Other reasons|1|||
150107042|NCT03400332|541534224|FG006|Treatment|Other reasons|2|||
150107043|NCT03400332|541534225|FG007|Treatment|Other reasons|0|||
150107044|NCT03400332|541534226|FG008|Treatment|Other reasons|1|||
150107045|NCT03400332|541534218|FG000|Treatment|Lost to Follow-up|0|||
150107046|NCT03400332|541534219|FG001|Treatment|Lost to Follow-up|1|||
150107047|NCT03400332|541534220|FG002|Treatment|Lost to Follow-up|0|||
150107048|NCT03400332|541534221|FG003|Treatment|Lost to Follow-up|0|||
150107049|NCT03400332|541534222|FG004|Treatment|Lost to Follow-up|0|||
150107050|NCT03400332|541534223|FG005|Treatment|Lost to Follow-up|0|||
150107051|NCT03400332|541534224|FG006|Treatment|Lost to Follow-up|0|||
150107052|NCT03400332|541534225|FG007|Treatment|Lost to Follow-up|0|||
150107053|NCT03400332|541534226|FG008|Treatment|Lost to Follow-up|0|||
150107054|NCT03400332|541534218|FG000|Treatment|Death|3|||
150107055|NCT03400332|541534219|FG001|Treatment|Death|1|||
150107056|NCT03400332|541534220|FG002|Treatment|Death|2|||
150107057|NCT03400332|541534221|FG003|Treatment|Death|3|||
150107058|NCT03400332|541534222|FG004|Treatment|Death|6|||
150107059|NCT03400332|541534223|FG005|Treatment|Death|2|||
150107060|NCT03400332|541534224|FG006|Treatment|Death|1|||
150107061|NCT03400332|541534225|FG007|Treatment|Death|3|||
150107062|NCT03400332|541534226|FG008|Treatment|Death|6|||
150107063|NCT02027844|541534227|FG000|Overall Study|Withdrawal by Subject|3|||
150107064|NCT02027844|541534228|FG001|Overall Study|Withdrawal by Subject|2|||
150107065|NCT02027844|541534229|FG002|Overall Study|Withdrawal by Subject|1|||
150107066|NCT02027844|541534227|FG000|Overall Study|Lost to Follow-up|0|||
150107067|NCT02027844|541534228|FG001|Overall Study|Lost to Follow-up|2|||
150107068|NCT02027844|541534229|FG002|Overall Study|Lost to Follow-up|1|||
150107069|NCT02027844|541534227|FG000|Overall Study|Protocol Violation|0|||
150107070|NCT02027844|541534228|FG001|Overall Study|Protocol Violation|2|||
150107071|NCT02027844|541534229|FG002|Overall Study|Protocol Violation|0|||
150107072|NCT02027844|541534227|FG000|Overall Study|Incomlete data|2|||
150107073|NCT02027844|541534228|FG001|Overall Study|Incomlete data|0|||
150107074|NCT02027844|541534229|FG002|Overall Study|Incomlete data|0|||
150107075|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
150107076|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
150107077|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Graft loss|1|||
150107078|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Graft loss|2|||
150107079|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Death|5|||
150107080|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Death|3|||
150107081|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
150107082|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
150107083|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
150107084|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
150107085|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
150107086|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
150107087|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
150107088|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
150107089|NCT00378014|541534230|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
150107090|NCT00378014|541534231|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
150107091|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
150107092|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
150107093|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Death|1|||
150107094|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Death|2|||
150107095|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
150107096|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
150107097|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
150107098|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
150107099|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
150107100|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
150107101|NCT00378014|541534230|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
150107102|NCT00378014|541534231|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
150107103|NCT03013543|541534235|FG000|Overall Study|Withdrawal by Subject|0|||
150107104|NCT03013543|541534236|FG001|Overall Study|Withdrawal by Subject|2|||
150107105|NCT03013543|541534237|FG002|Overall Study|Withdrawal by Subject|0|||
150107106|NCT03013543|541534238|FG003|Overall Study|Withdrawal by Subject|5|||
150107107|NCT03013543|541534239|FG004|Overall Study|Withdrawal by Subject|6|||
150107108|NCT03013543|541534240|FG005|Overall Study|Withdrawal by Subject|2|||
150107109|NCT03013543|541534241|FG006|Overall Study|Withdrawal by Subject|3|||
150107110|NCT03013543|541534242|FG007|Overall Study|Withdrawal by Subject|1|||
150107111|NCT03013543|541534243|FG008|Overall Study|Withdrawal by Subject|0|||
150107112|NCT03013543|541534244|FG009|Overall Study|Withdrawal by Subject|4|||
150107113|NCT03013543|541534235|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
150107114|NCT03013543|541534236|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
150107115|NCT03013543|541534237|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
150107116|NCT03013543|541534238|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
150107117|NCT03013543|541534239|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
150107118|NCT03013543|541534240|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
150107119|NCT03013543|541534241|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
150107120|NCT03013543|541534242|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
150107121|NCT03013543|541534243|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
150107122|NCT03013543|541534244|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
150107123|NCT03013543|541534235|FG000|Overall Study|Other|0|||
150107124|NCT03013543|541534236|FG001|Overall Study|Other|0|||
150107125|NCT03013543|541534237|FG002|Overall Study|Other|2|||
150107126|NCT03013543|541534238|FG003|Overall Study|Other|0|||
150107127|NCT03013543|541534239|FG004|Overall Study|Other|2|||
150107128|NCT03013543|541534240|FG005|Overall Study|Other|0|||
150107129|NCT03013543|541534241|FG006|Overall Study|Other|0|||
150107130|NCT03013543|541534242|FG007|Overall Study|Other|0|||
150107131|NCT03013543|541534243|FG008|Overall Study|Other|1|||
150107132|NCT03013543|541534244|FG009|Overall Study|Other|0|||
150107133|NCT03013543|541534235|FG000|Overall Study|Adverse Event|0|||
150107134|NCT03013543|541534236|FG001|Overall Study|Adverse Event|0|||
150107135|NCT03013543|541534237|FG002|Overall Study|Adverse Event|0|||
150107136|NCT03013543|541534238|FG003|Overall Study|Adverse Event|3|||
150107137|NCT03013543|541534239|FG004|Overall Study|Adverse Event|2|||
150107138|NCT03013543|541534240|FG005|Overall Study|Adverse Event|1|||
150107139|NCT03013543|541534241|FG006|Overall Study|Adverse Event|3|||
150107140|NCT03013543|541534242|FG007|Overall Study|Adverse Event|8|||
150107141|NCT03013543|541534243|FG008|Overall Study|Adverse Event|0|||
150107142|NCT03013543|541534244|FG009|Overall Study|Adverse Event|2|||
150107143|NCT03013543|541534235|FG000|Overall Study|Death|0|||
150107144|NCT03013543|541534236|FG001|Overall Study|Death|0|||
150107145|NCT03013543|541534237|FG002|Overall Study|Death|0|||
150107146|NCT03013543|541534238|FG003|Overall Study|Death|1|||
150107147|NCT03013543|541534239|FG004|Overall Study|Death|0|||
150107148|NCT03013543|541534240|FG005|Overall Study|Death|0|||
150107149|NCT03013543|541534241|FG006|Overall Study|Death|0|||
150107150|NCT03013543|541534242|FG007|Overall Study|Death|0|||
150107151|NCT03013543|541534243|FG008|Overall Study|Death|0|||
150107152|NCT03013543|541534244|FG009|Overall Study|Death|0|||
150107153|NCT03013543|541534235|FG000|Overall Study|Lack of Efficacy|0|||
150107154|NCT03013543|541534236|FG001|Overall Study|Lack of Efficacy|0|||
150107155|NCT03013543|541534237|FG002|Overall Study|Lack of Efficacy|0|||
150107156|NCT03013543|541534238|FG003|Overall Study|Lack of Efficacy|1|||
150107157|NCT03013543|541534239|FG004|Overall Study|Lack of Efficacy|0|||
150107158|NCT03013543|541534240|FG005|Overall Study|Lack of Efficacy|0|||
150107159|NCT03013543|541534241|FG006|Overall Study|Lack of Efficacy|0|||
150107160|NCT03013543|541534242|FG007|Overall Study|Lack of Efficacy|0|||
150107161|NCT03013543|541534243|FG008|Overall Study|Lack of Efficacy|0|||
150107162|NCT03013543|541534244|FG009|Overall Study|Lack of Efficacy|0|||
150107163|NCT03013543|541534235|FG000|Overall Study|Lost to Follow-up|0|||
150107164|NCT03013543|541534236|FG001|Overall Study|Lost to Follow-up|0|||
150107165|NCT03013543|541534237|FG002|Overall Study|Lost to Follow-up|0|||
150107166|NCT03013543|541534238|FG003|Overall Study|Lost to Follow-up|1|||
150107167|NCT03013543|541534239|FG004|Overall Study|Lost to Follow-up|0|||
150107168|NCT03013543|541534240|FG005|Overall Study|Lost to Follow-up|0|||
150107169|NCT03013543|541534241|FG006|Overall Study|Lost to Follow-up|1|||
150107170|NCT03013543|541534242|FG007|Overall Study|Lost to Follow-up|0|||
150107171|NCT03013543|541534243|FG008|Overall Study|Lost to Follow-up|0|||
150107172|NCT03013543|541534244|FG009|Overall Study|Lost to Follow-up|2|||
150107173|NCT03013543|541534235|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150107174|NCT03013543|541534236|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150107175|NCT03013543|541534237|FG002|Overall Study|Non-Compliance With Study Drug|0|||
150107176|NCT03013543|541534238|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150107177|NCT03013543|541534239|FG004|Overall Study|Non-Compliance With Study Drug|0|||
150107178|NCT03013543|541534240|FG005|Overall Study|Non-Compliance With Study Drug|0|||
150107179|NCT03013543|541534241|FG006|Overall Study|Non-Compliance With Study Drug|0|||
150107180|NCT03013543|541534242|FG007|Overall Study|Non-Compliance With Study Drug|0|||
150107181|NCT03013543|541534243|FG008|Overall Study|Non-Compliance With Study Drug|1|||
150107182|NCT03013543|541534244|FG009|Overall Study|Non-Compliance With Study Drug|0|||
150107183|NCT03013543|541534235|FG000|Overall Study|Physician Decision|0|||
150107184|NCT03013543|541534236|FG001|Overall Study|Physician Decision|0|||
150107185|NCT03013543|541534237|FG002|Overall Study|Physician Decision|0|||
150107186|NCT03013543|541534238|FG003|Overall Study|Physician Decision|0|||
150107187|NCT03013543|541534239|FG004|Overall Study|Physician Decision|1|||
150107188|NCT03013543|541534240|FG005|Overall Study|Physician Decision|0|||
150107189|NCT03013543|541534241|FG006|Overall Study|Physician Decision|0|||
150107190|NCT03013543|541534242|FG007|Overall Study|Physician Decision|0|||
150107191|NCT03013543|541534243|FG008|Overall Study|Physician Decision|0|||
150107192|NCT03013543|541534244|FG009|Overall Study|Physician Decision|0|||
150107193|NCT03013543|541534235|FG000|Overall Study|Protocol Violation|0|||
150107194|NCT03013543|541534236|FG001|Overall Study|Protocol Violation|0|||
150107195|NCT03013543|541534237|FG002|Overall Study|Protocol Violation|0|||
150107196|NCT03013543|541534238|FG003|Overall Study|Protocol Violation|0|||
150107197|NCT03013543|541534239|FG004|Overall Study|Protocol Violation|0|||
150107198|NCT03013543|541534240|FG005|Overall Study|Protocol Violation|0|||
150107199|NCT03013543|541534241|FG006|Overall Study|Protocol Violation|0|||
150107200|NCT03013543|541534242|FG007|Overall Study|Protocol Violation|0|||
150107201|NCT03013543|541534243|FG008|Overall Study|Protocol Violation|0|||
150107202|NCT03013543|541534244|FG009|Overall Study|Protocol Violation|1|||
150107203|NCT00323414|541534245|FG000|Overall Study|Withdrawal by Subject|0|||
150107204|NCT00323414|541534246|FG001|Overall Study|Withdrawal by Subject|1|||
150107205|NCT02552316|541534248|FG000|Overall Study|Withdrawal by Subject|1|||
150107206|NCT02552316|541534248|FG000|Overall Study|Withdrawal due to non-compliance|1|||
150107207|NCT02659020|541534249|FG000|Overall Study|Adverse Event|0|||
150107208|NCT02659020|541534250|FG001|Overall Study|Adverse Event|0|||
150107209|NCT02659020|541534251|FG002|Overall Study|Adverse Event|0|||
150107210|NCT02659020|541534252|FG003|Overall Study|Adverse Event|2|||
150107211|NCT02659020|541534253|FG004|Overall Study|Adverse Event|0|||
150107212|NCT02659020|541534254|FG005|Overall Study|Adverse Event|0|||
150107213|NCT02659020|541534255|FG006|Overall Study|Adverse Event|2|||
150107214|NCT02659020|541534249|FG000|Overall Study|Lost to Follow-up|1|||
150107215|NCT02659020|541534250|FG001|Overall Study|Lost to Follow-up|2|||
150107216|NCT02659020|541534251|FG002|Overall Study|Lost to Follow-up|1|||
150107217|NCT02659020|541534252|FG003|Overall Study|Lost to Follow-up|6|||
150107218|NCT02659020|541534253|FG004|Overall Study|Lost to Follow-up|1|||
150107219|NCT02659020|541534254|FG005|Overall Study|Lost to Follow-up|5|||
150107220|NCT02659020|541534255|FG006|Overall Study|Lost to Follow-up|0|||
150107221|NCT02659020|541534249|FG000|Overall Study|Physician Decision|0|||
150107222|NCT02659020|541534250|FG001|Overall Study|Physician Decision|0|||
150107223|NCT02659020|541534251|FG002|Overall Study|Physician Decision|0|||
150107224|NCT02659020|541534252|FG003|Overall Study|Physician Decision|1|||
150107225|NCT02659020|541534253|FG004|Overall Study|Physician Decision|1|||
150107226|NCT02659020|541534254|FG005|Overall Study|Physician Decision|0|||
150107227|NCT02659020|541534255|FG006|Overall Study|Physician Decision|1|||
150107228|NCT02659020|541534249|FG000|Overall Study|Withdrawal by Subject|2|||
150107229|NCT02659020|541534250|FG001|Overall Study|Withdrawal by Subject|1|||
150107230|NCT02659020|541534251|FG002|Overall Study|Withdrawal by Subject|0|||
150187165|NCT03763708|541825264|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
150187166|NCT03763708|541825265|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
150187167|NCT03763708|541825266|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
150187168|NCT03763708|541825267|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
150187169|NCT03763708|541825259|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
150187170|NCT03763708|541825260|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
150187171|NCT03763708|541825261|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
150187172|NCT03763708|541825262|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
150187173|NCT03763708|541825263|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
150187174|NCT03763708|541825264|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
150187175|NCT03763708|541825265|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
150187176|NCT03763708|541825266|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
150187177|NCT03763708|541825267|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
150187178|NCT01416831|541825268|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
150187179|NCT01416831|541825269|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
150187180|NCT05470400|541825270|FG000|Overall Study|Lost to Follow-up|0|||
150187181|NCT05470400|541825271|FG001|Overall Study|Lost to Follow-up|0|||
150187182|NCT05470400|541825272|FG002|Overall Study|Lost to Follow-up|0|||
150187183|NCT05470400|541825273|FG003|Overall Study|Lost to Follow-up|0|||
150187184|NCT05470400|541825274|FG004|Overall Study|Lost to Follow-up|0|||
150187185|NCT05470400|541825275|FG005|Overall Study|Lost to Follow-up|0|||
150187186|NCT05470400|541825276|FG006|Overall Study|Lost to Follow-up|0|||
150187187|NCT05470400|541825277|FG007|Overall Study|Lost to Follow-up|1|||
150187188|NCT05470400|541825270|FG000|Overall Study|Withdrawal by Subject|1|||
150187189|NCT05470400|541825271|FG001|Overall Study|Withdrawal by Subject|0|||
150187190|NCT05470400|541825272|FG002|Overall Study|Withdrawal by Subject|0|||
150187191|NCT05470400|541825273|FG003|Overall Study|Withdrawal by Subject|0|||
150187192|NCT05470400|541825274|FG004|Overall Study|Withdrawal by Subject|0|||
150187193|NCT05470400|541825275|FG005|Overall Study|Withdrawal by Subject|1|||
150187194|NCT05470400|541825276|FG006|Overall Study|Withdrawal by Subject|0|||
150187195|NCT05470400|541825277|FG007|Overall Study|Withdrawal by Subject|2|||
150187196|NCT04784559|541825278|FG000|Overall Study|Withdrawal by Subject|3|||
150187197|NCT04784559|541825279|FG001|Overall Study|Withdrawal by Subject|2|||
150187198|NCT04784559|541825280|FG002|Overall Study|Withdrawal by Subject|1|||
150187199|NCT04784559|541825278|FG000|Overall Study|Death|2|||
150187200|NCT04784559|541825279|FG001|Overall Study|Death|1|||
150187201|NCT04784559|541825280|FG002|Overall Study|Death|2|||
150187202|NCT04784559|541825278|FG000|Overall Study|Lost to Follow-up|0|||
150187203|NCT04784559|541825279|FG001|Overall Study|Lost to Follow-up|0|||
150187204|NCT04784559|541825280|FG002|Overall Study|Lost to Follow-up|2|||
150187205|NCT04784559|541825278|FG000|Overall Study|Participant worsened, PI decision|1|||
150187206|NCT04784559|541825279|FG001|Overall Study|Participant worsened, PI decision|0|||
150187207|NCT04784559|541825280|FG002|Overall Study|Participant worsened, PI decision|0|||
150187208|NCT04784559|541825278|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
150187209|NCT04784559|541825279|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
150187210|NCT04784559|541825280|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
150187211|NCT04784559|541825278|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
150187212|NCT04784559|541825279|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
150187213|NCT04784559|541825280|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
150187214|NCT04784559|541825278|FG000|Overall Study|Did not meet all inclusion criteria|0|||
150187215|NCT04784559|541825279|FG001|Overall Study|Did not meet all inclusion criteria|1|||
150187216|NCT04784559|541825280|FG002|Overall Study|Did not meet all inclusion criteria|0|||
150187217|NCT04784559|541825278|FG000|Overall Study|The participant was transferred to IRCU|0|||
150187218|NCT04784559|541825279|FG001|Overall Study|The participant was transferred to IRCU|1|||
150187219|NCT04784559|541825280|FG002|Overall Study|The participant was transferred to IRCU|0|||
150187220|NCT04784559|541825278|FG000|Overall Study|SAE|0|||
150187221|NCT04784559|541825279|FG001|Overall Study|SAE|1|||
150187222|NCT04784559|541825280|FG002|Overall Study|SAE|0|||
150187223|NCT04784559|541825278|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
150187224|NCT04784559|541825279|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
150187225|NCT04784559|541825280|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
150187226|NCT04294225|541825281|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
150187227|NCT04294225|541825281|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
150187228|NCT04294225|541825281|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
150187229|NCT04294225|541825281|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
150187230|NCT04294225|541825281|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
150187231|NCT04927065|541825285|FG000|First Booster|Adverse Event|1|||
150187232|NCT04927065|541825286|FG001|First Booster|Adverse Event|0|||
150187233|NCT04927065|541825287|FG002|First Booster|Adverse Event|0|||
150187234|NCT04927065|541825288|FG003|First Booster|Adverse Event|0|||
150187235|NCT04927065|541825289|FG004|First Booster|Adverse Event|0|||
150187236|NCT04927065|541825290|FG005|First Booster|Adverse Event|0|||
150187237|NCT04927065|541825291|FG006|First Booster|Adverse Event|0|||
150187238|NCT04927065|541825292|FG007|First Booster|Adverse Event|1|||
150107231|NCT02659020|541534252|FG003|Overall Study|Withdrawal by Subject|3|||
150107232|NCT02659020|541534253|FG004|Overall Study|Withdrawal by Subject|3|||
150107233|NCT02659020|541534254|FG005|Overall Study|Withdrawal by Subject|6|||
150107234|NCT02659020|541534255|FG006|Overall Study|Withdrawal by Subject|3|||
150107235|NCT02659020|541534249|FG000|Overall Study|Progressive Disease|0|||
150107236|NCT02659020|541534250|FG001|Overall Study|Progressive Disease|0|||
150107237|NCT02659020|541534251|FG002|Overall Study|Progressive Disease|0|||
150107238|NCT02659020|541534252|FG003|Overall Study|Progressive Disease|4|||
150107239|NCT02659020|541534253|FG004|Overall Study|Progressive Disease|1|||
150107240|NCT02659020|541534254|FG005|Overall Study|Progressive Disease|0|||
150107241|NCT02659020|541534255|FG006|Overall Study|Progressive Disease|2|||
150107242|NCT04382911|541534256|FG000|Overall Study|unable to be imaged prior to surgery|2|||
150107243|NCT01120210|541534262|FG000|MAIN INFUSION|Adverse Event|1|||
150107244|NCT01120210|541534263|FG001|MAIN INFUSION|Adverse Event|0|||
150107245|NCT01120210|541534262|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
150107246|NCT01120210|541534263|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
150107247|NCT01077960|541534272|FG000|Overall Study|Adverse Event|6|||
150107248|NCT01077960|541534272|FG000|Overall Study|Protocol Violation|3|||
150107249|NCT01077960|541534272|FG000|Overall Study|Lost to Follow-up|5|||
150107250|NCT01077960|541534272|FG000|Overall Study|Subject decision|1|||
150107251|NCT01077960|541534272|FG000|Overall Study|Reason unspecified|1|||
150107252|NCT05619692|541534273|FG000|Overall Study|Adverse Event|2|||
150107253|NCT05619692|541534274|FG001|Overall Study|Adverse Event|2|||
150107254|NCT05619692|541534273|FG000|Overall Study|Withdrawal by Participant|3|||
150107255|NCT05619692|541534274|FG001|Overall Study|Withdrawal by Participant|4|||
150107256|NCT05619692|541534273|FG000|Overall Study|Lost to Follow-up|2|||
150107257|NCT05619692|541534274|FG001|Overall Study|Lost to Follow-up|1|||
150107258|NCT05619692|541534273|FG000|Overall Study|Randomized but not treated|1|||
150107259|NCT05619692|541534274|FG001|Overall Study|Randomized but not treated|3|||
150107260|NCT04049760|541534276|FG000|Overall Study|Withdrawal by Subject|1|||
150107261|NCT02457598|541534277|FG000|Overall Study|Progressive Disease|2|||
150107262|NCT02457598|541534278|FG001|Overall Study|Progressive Disease|2|||
150107263|NCT02457598|541534279|FG002|Overall Study|Progressive Disease|1|||
150107264|NCT02457598|541534280|FG003|Overall Study|Progressive Disease|11|||
150107265|NCT02457598|541534281|FG004|Overall Study|Progressive Disease|7|||
150107266|NCT02457598|541534282|FG005|Overall Study|Progressive Disease|3|||
150107267|NCT02457598|541534283|FG006|Overall Study|Progressive Disease|2|||
150107268|NCT02457598|541534284|FG007|Overall Study|Progressive Disease|1|||
150107269|NCT02457598|541534285|FG008|Overall Study|Progressive Disease|1|||
150107270|NCT02457598|541534286|FG009|Overall Study|Progressive Disease|2|||
150107271|NCT02457598|541534287|FG010|Overall Study|Progressive Disease|45|||
150107272|NCT02457598|541534288|FG011|Overall Study|Progressive Disease|6|||
150107273|NCT02457598|541534289|FG012|Overall Study|Progressive Disease|2|||
150107274|NCT02457598|541534290|FG013|Overall Study|Progressive Disease|2|||
150107275|NCT02457598|541534291|FG014|Overall Study|Progressive Disease|10|||
150107276|NCT02457598|541534292|FG015|Overall Study|Progressive Disease|1|||
150107277|NCT02457598|541534293|FG016|Overall Study|Progressive Disease|1|||
150107278|NCT02457598|541534277|FG000|Overall Study|Investigator's Discretion|0|||
150107279|NCT02457598|541534278|FG001|Overall Study|Investigator's Discretion|2|||
150107280|NCT02457598|541534279|FG002|Overall Study|Investigator's Discretion|2|||
150107281|NCT02457598|541534280|FG003|Overall Study|Investigator's Discretion|2|||
150107282|NCT02457598|541534281|FG004|Overall Study|Investigator's Discretion|0|||
150107283|NCT02457598|541534282|FG005|Overall Study|Investigator's Discretion|0|||
150107284|NCT02457598|541534283|FG006|Overall Study|Investigator's Discretion|0|||
150107285|NCT02457598|541534284|FG007|Overall Study|Investigator's Discretion|1|||
150107286|NCT02457598|541534285|FG008|Overall Study|Investigator's Discretion|2|||
150107287|NCT02457598|541534286|FG009|Overall Study|Investigator's Discretion|0|||
150107288|NCT02457598|541534287|FG010|Overall Study|Investigator's Discretion|10|||
150107289|NCT02457598|541534288|FG011|Overall Study|Investigator's Discretion|2|||
150107290|NCT02457598|541534289|FG012|Overall Study|Investigator's Discretion|2|||
150107291|NCT02457598|541534290|FG013|Overall Study|Investigator's Discretion|1|||
150107292|NCT02457598|541534291|FG014|Overall Study|Investigator's Discretion|5|||
150107293|NCT02457598|541534292|FG015|Overall Study|Investigator's Discretion|0|||
150187239|NCT04927065|541825293|FG008|First Booster|Adverse Event|0|||
150107294|NCT02457598|541534293|FG016|Overall Study|Investigator's Discretion|0|||
150107295|NCT02457598|541534277|FG000|Overall Study|Study Terminated by Sponsor|0|||
150107296|NCT02457598|541534278|FG001|Overall Study|Study Terminated by Sponsor|1|||
150107297|NCT02457598|541534279|FG002|Overall Study|Study Terminated by Sponsor|0|||
150107298|NCT02457598|541534280|FG003|Overall Study|Study Terminated by Sponsor|4|||
150107299|NCT02457598|541534281|FG004|Overall Study|Study Terminated by Sponsor|1|||
150107300|NCT02457598|541534282|FG005|Overall Study|Study Terminated by Sponsor|0|||
150107301|NCT02457598|541534283|FG006|Overall Study|Study Terminated by Sponsor|1|||
150107302|NCT02457598|541534284|FG007|Overall Study|Study Terminated by Sponsor|0|||
150107303|NCT02457598|541534285|FG008|Overall Study|Study Terminated by Sponsor|0|||
150107304|NCT02457598|541534286|FG009|Overall Study|Study Terminated by Sponsor|0|||
150107305|NCT02457598|541534287|FG010|Overall Study|Study Terminated by Sponsor|4|||
150107306|NCT02457598|541534288|FG011|Overall Study|Study Terminated by Sponsor|0|||
150107307|NCT02457598|541534289|FG012|Overall Study|Study Terminated by Sponsor|1|||
150107308|NCT02457598|541534290|FG013|Overall Study|Study Terminated by Sponsor|0|||
150107309|NCT02457598|541534291|FG014|Overall Study|Study Terminated by Sponsor|8|||
150107310|NCT02457598|541534292|FG015|Overall Study|Study Terminated by Sponsor|1|||
150107311|NCT02457598|541534293|FG016|Overall Study|Study Terminated by Sponsor|0|||
150107312|NCT02457598|541534277|FG000|Overall Study|Adverse Event|0|||
150107313|NCT02457598|541534278|FG001|Overall Study|Adverse Event|1|||
150107314|NCT02457598|541534279|FG002|Overall Study|Adverse Event|1|||
150107315|NCT02457598|541534280|FG003|Overall Study|Adverse Event|4|||
150107316|NCT02457598|541534281|FG004|Overall Study|Adverse Event|1|||
150107317|NCT02457598|541534282|FG005|Overall Study|Adverse Event|0|||
150107318|NCT02457598|541534283|FG006|Overall Study|Adverse Event|0|||
150107319|NCT02457598|541534284|FG007|Overall Study|Adverse Event|1|||
150107320|NCT02457598|541534285|FG008|Overall Study|Adverse Event|0|||
150107321|NCT02457598|541534286|FG009|Overall Study|Adverse Event|1|||
150107322|NCT02457598|541534287|FG010|Overall Study|Adverse Event|6|||
150107323|NCT02457598|541534288|FG011|Overall Study|Adverse Event|0|||
150107324|NCT02457598|541534289|FG012|Overall Study|Adverse Event|0|||
150107325|NCT02457598|541534290|FG013|Overall Study|Adverse Event|1|||
150107326|NCT02457598|541534291|FG014|Overall Study|Adverse Event|2|||
150107327|NCT02457598|541534292|FG015|Overall Study|Adverse Event|0|||
150107328|NCT02457598|541534293|FG016|Overall Study|Adverse Event|0|||
150107329|NCT02457598|541534277|FG000|Overall Study|Death|0|||
150107330|NCT02457598|541534278|FG001|Overall Study|Death|0|||
150107331|NCT02457598|541534279|FG002|Overall Study|Death|0|||
150107332|NCT02457598|541534280|FG003|Overall Study|Death|3|||
150107333|NCT02457598|541534281|FG004|Overall Study|Death|0|||
150107334|NCT02457598|541534282|FG005|Overall Study|Death|1|||
150107335|NCT02457598|541534283|FG006|Overall Study|Death|0|||
150107336|NCT02457598|541534284|FG007|Overall Study|Death|0|||
150107337|NCT02457598|541534285|FG008|Overall Study|Death|0|||
150107338|NCT02457598|541534286|FG009|Overall Study|Death|0|||
150107339|NCT02457598|541534287|FG010|Overall Study|Death|3|||
150107340|NCT02457598|541534288|FG011|Overall Study|Death|0|||
150107341|NCT02457598|541534289|FG012|Overall Study|Death|0|||
150107342|NCT02457598|541534290|FG013|Overall Study|Death|1|||
150107343|NCT02457598|541534291|FG014|Overall Study|Death|2|||
150107344|NCT02457598|541534292|FG015|Overall Study|Death|0|||
150107345|NCT02457598|541534293|FG016|Overall Study|Death|1|||
150107346|NCT02457598|541534277|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107347|NCT02457598|541534278|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
150107348|NCT02457598|541534279|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107349|NCT02457598|541534280|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
150107350|NCT02457598|541534281|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107351|NCT02457598|541534282|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107352|NCT02457598|541534283|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107353|NCT02457598|541534284|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
150107354|NCT02457598|541534285|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107355|NCT02457598|541534286|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107356|NCT02457598|541534287|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
150107357|NCT02457598|541534288|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107358|NCT02457598|541534289|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107359|NCT02457598|541534290|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
150107360|NCT02457598|541534291|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
150107361|NCT02457598|541534292|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
150107362|NCT02457598|541534293|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
150107363|NCT02457598|541534277|FG000|Overall Study|Withdrew Consent|0|||
150107364|NCT02457598|541534278|FG001|Overall Study|Withdrew Consent|0|||
150107365|NCT02457598|541534279|FG002|Overall Study|Withdrew Consent|0|||
150107366|NCT02457598|541534280|FG003|Overall Study|Withdrew Consent|0|||
150107367|NCT02457598|541534281|FG004|Overall Study|Withdrew Consent|0|||
150187240|NCT04927065|541825294|FG009|First Booster|Adverse Event|0|||
150187241|NCT04927065|541825295|FG010|First Booster|Adverse Event|0|||
150107368|NCT02457598|541534282|FG005|Overall Study|Withdrew Consent|0|||
150107369|NCT02457598|541534283|FG006|Overall Study|Withdrew Consent|0|||
150107370|NCT02457598|541534284|FG007|Overall Study|Withdrew Consent|2|||
150107371|NCT02457598|541534285|FG008|Overall Study|Withdrew Consent|0|||
150107372|NCT02457598|541534286|FG009|Overall Study|Withdrew Consent|0|||
150107373|NCT02457598|541534287|FG010|Overall Study|Withdrew Consent|3|||
150107374|NCT02457598|541534288|FG011|Overall Study|Withdrew Consent|0|||
150107375|NCT02457598|541534289|FG012|Overall Study|Withdrew Consent|0|||
150107376|NCT02457598|541534290|FG013|Overall Study|Withdrew Consent|1|||
150107377|NCT02457598|541534291|FG014|Overall Study|Withdrew Consent|0|||
150107378|NCT02457598|541534292|FG015|Overall Study|Withdrew Consent|0|||
150107379|NCT02457598|541534293|FG016|Overall Study|Withdrew Consent|0|||
150107380|NCT02457598|541534277|FG000|Overall Study|Unacceptable Toxicity|0|||
150107381|NCT02457598|541534278|FG001|Overall Study|Unacceptable Toxicity|0|||
150107382|NCT02457598|541534279|FG002|Overall Study|Unacceptable Toxicity|0|||
150107383|NCT02457598|541534280|FG003|Overall Study|Unacceptable Toxicity|0|||
150187242|NCT04927065|541825296|FG011|First Booster|Adverse Event|0|||
150187243|NCT04927065|541825297|FG012|First Booster|Adverse Event|0|||
150187244|NCT04927065|541825298|FG013|First Booster|Adverse Event|0|||
150187245|NCT04927065|541825299|FG014|First Booster|Adverse Event|0|||
150187246|NCT04927065|541825300|FG015|First Booster|Adverse Event|0|||
150187247|NCT04927065|541825285|FG000|First Booster|Death|1|||
150187248|NCT04927065|541825286|FG001|First Booster|Death|0|||
150187249|NCT04927065|541825287|FG002|First Booster|Death|0|||
150187250|NCT04927065|541825288|FG003|First Booster|Death|1|||
150187251|NCT04927065|541825289|FG004|First Booster|Death|0|||
150187252|NCT04927065|541825290|FG005|First Booster|Death|1|||
150187253|NCT04927065|541825291|FG006|First Booster|Death|0|||
150187254|NCT04927065|541825292|FG007|First Booster|Death|0|||
150187255|NCT04927065|541825293|FG008|First Booster|Death|0|||
150187256|NCT04927065|541825294|FG009|First Booster|Death|0|||
150187257|NCT04927065|541825295|FG010|First Booster|Death|0|||
150187258|NCT04927065|541825296|FG011|First Booster|Death|0|||
150187259|NCT04927065|541825297|FG012|First Booster|Death|0|||
150187260|NCT04927065|541825298|FG013|First Booster|Death|0|||
150187261|NCT04927065|541825299|FG014|First Booster|Death|0|||
150187262|NCT04927065|541825300|FG015|First Booster|Death|0|||
150187263|NCT04927065|541825285|FG000|First Booster|Lost to Follow-up|8|||
150187264|NCT04927065|541825286|FG001|First Booster|Lost to Follow-up|20|||
150187265|NCT04927065|541825287|FG002|First Booster|Lost to Follow-up|0|||
150187266|NCT04927065|541825288|FG003|First Booster|Lost to Follow-up|11|||
150187267|NCT04927065|541825289|FG004|First Booster|Lost to Follow-up|43|||
150107384|NCT02457598|541534281|FG004|Overall Study|Unacceptable Toxicity|0|||
150107385|NCT02457598|541534282|FG005|Overall Study|Unacceptable Toxicity|0|||
150107386|NCT02457598|541534283|FG006|Overall Study|Unacceptable Toxicity|0|||
150107387|NCT02457598|541534284|FG007|Overall Study|Unacceptable Toxicity|0|||
150107388|NCT02457598|541534285|FG008|Overall Study|Unacceptable Toxicity|0|||
150107389|NCT02457598|541534286|FG009|Overall Study|Unacceptable Toxicity|0|||
150107390|NCT02457598|541534287|FG010|Overall Study|Unacceptable Toxicity|1|||
150107391|NCT02457598|541534288|FG011|Overall Study|Unacceptable Toxicity|0|||
150107392|NCT02457598|541534289|FG012|Overall Study|Unacceptable Toxicity|1|||
150107393|NCT02457598|541534290|FG013|Overall Study|Unacceptable Toxicity|1|||
150107394|NCT02457598|541534291|FG014|Overall Study|Unacceptable Toxicity|1|||
150107395|NCT02457598|541534292|FG015|Overall Study|Unacceptable Toxicity|0|||
150187268|NCT04927065|541825290|FG005|First Booster|Lost to Follow-up|30|||
150187269|NCT04927065|541825291|FG006|First Booster|Lost to Follow-up|28|||
150187270|NCT04927065|541825292|FG007|First Booster|Lost to Follow-up|23|||
150187271|NCT04927065|541825293|FG008|First Booster|Lost to Follow-up|4|||
150187272|NCT04927065|541825294|FG009|First Booster|Lost to Follow-up|15|||
150187273|NCT04927065|541825295|FG010|First Booster|Lost to Follow-up|0|||
150187274|NCT04927065|541825296|FG011|First Booster|Lost to Follow-up|0|||
150187275|NCT04927065|541825297|FG012|First Booster|Lost to Follow-up|0|||
150187276|NCT04927065|541825298|FG013|First Booster|Lost to Follow-up|0|||
150187277|NCT04927065|541825299|FG014|First Booster|Lost to Follow-up|0|||
150187278|NCT04927065|541825300|FG015|First Booster|Lost to Follow-up|0|||
150187279|NCT04927065|541825285|FG000|First Booster|Physician Decision|1|||
150187280|NCT04927065|541825286|FG001|First Booster|Physician Decision|0|||
150187281|NCT04927065|541825287|FG002|First Booster|Physician Decision|0|||
150187282|NCT04927065|541825288|FG003|First Booster|Physician Decision|3|||
150187283|NCT04927065|541825289|FG004|First Booster|Physician Decision|1|||
150187284|NCT04927065|541825290|FG005|First Booster|Physician Decision|1|||
150187285|NCT04927065|541825291|FG006|First Booster|Physician Decision|0|||
150187286|NCT04927065|541825292|FG007|First Booster|Physician Decision|3|||
150187287|NCT04927065|541825293|FG008|First Booster|Physician Decision|0|||
150187288|NCT04927065|541825294|FG009|First Booster|Physician Decision|0|||
150187289|NCT04927065|541825295|FG010|First Booster|Physician Decision|0|||
150187290|NCT04927065|541825296|FG011|First Booster|Physician Decision|0|||
150187291|NCT04927065|541825297|FG012|First Booster|Physician Decision|0|||
150187292|NCT04927065|541825298|FG013|First Booster|Physician Decision|0|||
150187293|NCT04927065|541825299|FG014|First Booster|Physician Decision|0|||
150187294|NCT04927065|541825300|FG015|First Booster|Physician Decision|0|||
150187295|NCT04927065|541825285|FG000|First Booster|Protocol Violation|4|||
150187296|NCT04927065|541825286|FG001|First Booster|Protocol Violation|4|||
150187297|NCT04927065|541825287|FG002|First Booster|Protocol Violation|0|||
150187298|NCT04927065|541825288|FG003|First Booster|Protocol Violation|3|||
150187299|NCT04927065|541825289|FG004|First Booster|Protocol Violation|0|||
150187300|NCT04927065|541825290|FG005|First Booster|Protocol Violation|0|||
150187301|NCT04927065|541825291|FG006|First Booster|Protocol Violation|0|||
150187302|NCT04927065|541825292|FG007|First Booster|Protocol Violation|2|||
150107396|NCT02457598|541534293|FG016|Overall Study|Unacceptable Toxicity|0|||
150107397|NCT02457598|541534277|FG000|Overall Study|Intercurrent Illness|0|||
150107398|NCT02457598|541534278|FG001|Overall Study|Intercurrent Illness|0|||
150107399|NCT02457598|541534279|FG002|Overall Study|Intercurrent Illness|0|||
150187303|NCT04927065|541825293|FG008|First Booster|Protocol Violation|0|||
150187304|NCT04927065|541825294|FG009|First Booster|Protocol Violation|0|||
150107400|NCT02457598|541534280|FG003|Overall Study|Intercurrent Illness|0|||
150107401|NCT02457598|541534281|FG004|Overall Study|Intercurrent Illness|0|||
150107402|NCT02457598|541534282|FG005|Overall Study|Intercurrent Illness|0|||
150107403|NCT02457598|541534283|FG006|Overall Study|Intercurrent Illness|0|||
150107404|NCT02457598|541534284|FG007|Overall Study|Intercurrent Illness|0|||
150107405|NCT02457598|541534285|FG008|Overall Study|Intercurrent Illness|0|||
150107406|NCT02457598|541534286|FG009|Overall Study|Intercurrent Illness|0|||
150107407|NCT02457598|541534287|FG010|Overall Study|Intercurrent Illness|1|||
150107408|NCT02457598|541534288|FG011|Overall Study|Intercurrent Illness|0|||
150107409|NCT02457598|541534289|FG012|Overall Study|Intercurrent Illness|0|||
150107410|NCT02457598|541534290|FG013|Overall Study|Intercurrent Illness|0|||
150107411|NCT02457598|541534291|FG014|Overall Study|Intercurrent Illness|0|||
150107412|NCT02457598|541534292|FG015|Overall Study|Intercurrent Illness|0|||
150107413|NCT02457598|541534293|FG016|Overall Study|Intercurrent Illness|0|||
150107414|NCT02457598|541534277|FG000|Overall Study|Protocol Violation|0|||
150107415|NCT02457598|541534278|FG001|Overall Study|Protocol Violation|0|||
150107416|NCT02457598|541534279|FG002|Overall Study|Protocol Violation|0|||
150107417|NCT02457598|541534280|FG003|Overall Study|Protocol Violation|0|||
150107418|NCT02457598|541534281|FG004|Overall Study|Protocol Violation|0|||
150107419|NCT02457598|541534282|FG005|Overall Study|Protocol Violation|0|||
150107420|NCT02457598|541534283|FG006|Overall Study|Protocol Violation|0|||
150107421|NCT02457598|541534284|FG007|Overall Study|Protocol Violation|0|||
150107422|NCT02457598|541534285|FG008|Overall Study|Protocol Violation|0|||
150107423|NCT02457598|541534286|FG009|Overall Study|Protocol Violation|0|||
150107424|NCT02457598|541534287|FG010|Overall Study|Protocol Violation|1|||
150107425|NCT02457598|541534288|FG011|Overall Study|Protocol Violation|0|||
150107426|NCT02457598|541534289|FG012|Overall Study|Protocol Violation|0|||
150107427|NCT02457598|541534290|FG013|Overall Study|Protocol Violation|0|||
150107428|NCT02457598|541534291|FG014|Overall Study|Protocol Violation|0|||
150107429|NCT02457598|541534292|FG015|Overall Study|Protocol Violation|0|||
150107430|NCT02457598|541534293|FG016|Overall Study|Protocol Violation|0|||
150107431|NCT03837899|541534294|FG000|Overall Study|Death|6|||
150107432|NCT03837899|541534295|FG001|Overall Study|Death|8|||
150107433|NCT03837899|541534296|FG002|Overall Study|Death|3|||
150107434|NCT03837899|541534297|FG003|Overall Study|Death|7|||
150107435|NCT03837899|541534298|FG004|Overall Study|Death|8|||
150107436|NCT03837899|541534299|FG005|Overall Study|Death|7|||
150107437|NCT03837899|541534294|FG000|Overall Study|Moved to post-trial access program|0|||
150107438|NCT03837899|541534295|FG001|Overall Study|Moved to post-trial access program|1|||
150107439|NCT03837899|541534296|FG002|Overall Study|Moved to post-trial access program|0|||
150107440|NCT03837899|541534297|FG003|Overall Study|Moved to post-trial access program|0|||
150107441|NCT03837899|541534298|FG004|Overall Study|Moved to post-trial access program|0|||
150107442|NCT03837899|541534299|FG005|Overall Study|Moved to post-trial access program|0|||
150107443|NCT03837899|541534294|FG000|Overall Study|Other|0|||
150107444|NCT03837899|541534295|FG001|Overall Study|Other|0|||
150107445|NCT03837899|541534296|FG002|Overall Study|Other|0|||
150107446|NCT03837899|541534297|FG003|Overall Study|Other|0|||
150107447|NCT03837899|541534298|FG004|Overall Study|Other|0|||
150107448|NCT03837899|541534299|FG005|Overall Study|Other|2|||
150107449|NCT03837899|541534294|FG000|Overall Study|Lost to Follow-up|0|||
150107450|NCT03837899|541534295|FG001|Overall Study|Lost to Follow-up|1|||
150107451|NCT03837899|541534296|FG002|Overall Study|Lost to Follow-up|0|||
150107452|NCT03837899|541534297|FG003|Overall Study|Lost to Follow-up|0|||
150107453|NCT03837899|541534298|FG004|Overall Study|Lost to Follow-up|0|||
150107454|NCT03837899|541534299|FG005|Overall Study|Lost to Follow-up|0|||
150107455|NCT03837899|541534294|FG000|Overall Study|Withdrawal by Subject|0|||
150107456|NCT03837899|541534295|FG001|Overall Study|Withdrawal by Subject|0|||
150107457|NCT03837899|541534296|FG002|Overall Study|Withdrawal by Subject|0|||
150107458|NCT03837899|541534297|FG003|Overall Study|Withdrawal by Subject|1|||
150107459|NCT03837899|541534298|FG004|Overall Study|Withdrawal by Subject|0|||
150107460|NCT03837899|541534299|FG005|Overall Study|Withdrawal by Subject|0|||
150107461|NCT03837899|541534294|FG000|Overall Study|Study specific discontinuation criteria|0|||
150107462|NCT03837899|541534295|FG001|Overall Study|Study specific discontinuation criteria|1|||
150107463|NCT03837899|541534296|FG002|Overall Study|Study specific discontinuation criteria|0|||
150107464|NCT03837899|541534297|FG003|Overall Study|Study specific discontinuation criteria|0|||
150107465|NCT03837899|541534298|FG004|Overall Study|Study specific discontinuation criteria|3|||
150107466|NCT03837899|541534299|FG005|Overall Study|Study specific discontinuation criteria|1|||
150107467|NCT00974571|541534300|FG000|Overall Study|Adverse Event|31|||
150107468|NCT00974571|541534301|FG001|Overall Study|Adverse Event|4|||
150107469|NCT00974571|541534302|FG002|Overall Study|Adverse Event|27|||
150107470|NCT00974571|541534300|FG000|Overall Study|Lack of Efficacy|3|||
150107471|NCT00974571|541534301|FG001|Overall Study|Lack of Efficacy|2|||
150107472|NCT00974571|541534302|FG002|Overall Study|Lack of Efficacy|9|||
150107473|NCT00974571|541534300|FG000|Overall Study|Lost to Follow-up|2|||
150107474|NCT00974571|541534301|FG001|Overall Study|Lost to Follow-up|1|||
150107475|NCT00974571|541534302|FG002|Overall Study|Lost to Follow-up|2|||
150107476|NCT00974571|541534300|FG000|Overall Study|Protocol Violation|13|||
150107477|NCT00974571|541534301|FG001|Overall Study|Protocol Violation|4|||
150107478|NCT00974571|541534302|FG002|Overall Study|Protocol Violation|18|||
150107479|NCT00974571|541534300|FG000|Overall Study|Withdrawal by Subject|14|||
150107480|NCT00974571|541534301|FG001|Overall Study|Withdrawal by Subject|5|||
150107481|NCT00974571|541534302|FG002|Overall Study|Withdrawal by Subject|16|||
150107482|NCT00974571|541534300|FG000|Overall Study|Patient Moved|1|||
150107483|NCT00974571|541534301|FG001|Overall Study|Patient Moved|0|||
150107484|NCT00974571|541534302|FG002|Overall Study|Patient Moved|1|||
150107485|NCT00974571|541534300|FG000|Overall Study|Other|4|||
150107486|NCT00974571|541534301|FG001|Overall Study|Other|0|||
150107487|NCT00974571|541534302|FG002|Overall Study|Other|10|||
150107488|NCT02703636|541534304|FG000|Overall Study|Adverse Event|14|||
150107489|NCT02703636|541534304|FG000|Overall Study|Study stopped by sponsor|1|||
150107490|NCT02703636|541534304|FG000|Overall Study|Withdrawal by Subject|1|||
150107491|NCT01554618|541534311|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
150107492|NCT01554618|541534312|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
150107493|NCT01554618|541534311|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
150107494|NCT01554618|541534312|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
150107495|NCT01554618|541534311|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
150107496|NCT01554618|541534312|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
150107497|NCT01554618|541534311|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
150107498|NCT01554618|541534312|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
150107499|NCT01554618|541534311|FG000|Open-Label Extension Period|Physician Decision|0|||
150107500|NCT01554618|541534312|FG001|Open-Label Extension Period|Physician Decision|1|||
150107501|NCT01554618|541534311|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
150107502|NCT01554618|541534312|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
150107503|NCT00477672|541534313|FG000|Overall Study|Adverse Event|3|||
150107504|NCT00477672|541534314|FG001|Overall Study|Adverse Event|5|||
150107505|NCT00477672|541534315|FG002|Overall Study|Adverse Event|6|||
150107506|NCT00477672|541534313|FG000|Overall Study|Death|0|||
150107507|NCT00477672|541534314|FG001|Overall Study|Death|1|||
150107508|NCT00477672|541534315|FG002|Overall Study|Death|0|||
150107509|NCT00477672|541534313|FG000|Overall Study|Disease progression|0|||
150107510|NCT00477672|541534314|FG001|Overall Study|Disease progression|1|||
150107511|NCT00477672|541534315|FG002|Overall Study|Disease progression|0|||
150107512|NCT00477672|541534313|FG000|Overall Study|Physician Decision|1|||
150107513|NCT00477672|541534314|FG001|Overall Study|Physician Decision|0|||
150107514|NCT00477672|541534315|FG002|Overall Study|Physician Decision|0|||
150107515|NCT00477672|541534313|FG000|Overall Study|Protocol noncompliance|0|||
150107516|NCT00477672|541534314|FG001|Overall Study|Protocol noncompliance|2|||
150107517|NCT00477672|541534315|FG002|Overall Study|Protocol noncompliance|0|||
150107518|NCT00477672|541534313|FG000|Overall Study|Consent withdrawn|2|||
150107519|NCT00477672|541534314|FG001|Overall Study|Consent withdrawn|5|||
150107520|NCT00477672|541534315|FG002|Overall Study|Consent withdrawn|10|||
150107521|NCT00477672|541534313|FG000|Overall Study|Discretion of Sponsor|1|||
150107522|NCT00477672|541534314|FG001|Overall Study|Discretion of Sponsor|2|||
150107523|NCT00477672|541534315|FG002|Overall Study|Discretion of Sponsor|0|||
150107524|NCT02722928|541534318|FG000|Overall Study|Standard CT was not as required per prot|5|||
150107525|NCT02722928|541534319|FG001|Overall Study|Standard CT was not as required per prot|13|||
150107526|NCT02722928|541534318|FG000|Overall Study|Required Intraoperative MRI|5|||
150107527|NCT02722928|541534319|FG001|Overall Study|Required Intraoperative MRI|7|||
150107528|NCT04011410|541534320|FG000|Overall Study|Withdrawal by Subject|1|||
150107529|NCT02275481|541534321|FG000|Overall Study|Death|2|||
150107530|NCT02275481|541534322|FG001|Overall Study|Death|1|||
150107531|NCT02275481|541534321|FG000|Overall Study|Lost to Follow-up|2|||
150107532|NCT02275481|541534322|FG001|Overall Study|Lost to Follow-up|0|||
150107533|NCT02275481|541534321|FG000|Overall Study|Withdrawal by Subject|3|||
150107534|NCT02275481|541534322|FG001|Overall Study|Withdrawal by Subject|0|||
150107535|NCT02275481|541534321|FG000|Overall Study|all other reasons combined|2|||
150107536|NCT02275481|541534322|FG001|Overall Study|all other reasons combined|1|||
150107537|NCT02275481|541534321|FG000|Overall Study|Physician Decision|0|||
150107538|NCT02275481|541534322|FG001|Overall Study|Physician Decision|1|||
150107539|NCT01215227|541534323|FG000|Overall Study|Adverse Event|11|||
150107540|NCT01215227|541534324|FG001|Overall Study|Adverse Event|11|||
150107541|NCT01215227|541534325|FG002|Overall Study|Adverse Event|4|||
150107542|NCT01215227|541534326|FG003|Overall Study|Adverse Event|8|||
150107543|NCT01215227|541534327|FG004|Overall Study|Adverse Event|7|||
150107544|NCT01215227|541534328|FG005|Overall Study|Adverse Event|6|||
150107545|NCT01215227|541534323|FG000|Overall Study|Treatment Failure|8|||
150107546|NCT01215227|541534324|FG001|Overall Study|Treatment Failure|4|||
150107547|NCT01215227|541534325|FG002|Overall Study|Treatment Failure|1|||
150107548|NCT01215227|541534326|FG003|Overall Study|Treatment Failure|5|||
150107549|NCT01215227|541534327|FG004|Overall Study|Treatment Failure|1|||
150107550|NCT01215227|541534328|FG005|Overall Study|Treatment Failure|1|||
150107551|NCT01215227|541534323|FG000|Overall Study|Lost to Follow-up|1|||
150107552|NCT01215227|541534324|FG001|Overall Study|Lost to Follow-up|4|||
150107553|NCT01215227|541534325|FG002|Overall Study|Lost to Follow-up|1|||
150107554|NCT01215227|541534326|FG003|Overall Study|Lost to Follow-up|1|||
150107555|NCT01215227|541534327|FG004|Overall Study|Lost to Follow-up|1|||
150187305|NCT04927065|541825295|FG010|First Booster|Protocol Violation|0|||
150187306|NCT04927065|541825296|FG011|First Booster|Protocol Violation|0|||
150187307|NCT04927065|541825297|FG012|First Booster|Protocol Violation|0|||
150187308|NCT04927065|541825298|FG013|First Booster|Protocol Violation|0|||
150187309|NCT04927065|541825299|FG014|First Booster|Protocol Violation|0|||
150187310|NCT04927065|541825300|FG015|First Booster|Protocol Violation|0|||
150187311|NCT04927065|541825285|FG000|First Booster|Withdrawal by Subject|8|||
150187312|NCT04927065|541825286|FG001|First Booster|Withdrawal by Subject|23|||
150187313|NCT04927065|541825287|FG002|First Booster|Withdrawal by Subject|0|||
150187314|NCT04927065|541825288|FG003|First Booster|Withdrawal by Subject|19|||
150187315|NCT04927065|541825289|FG004|First Booster|Withdrawal by Subject|20|||
150187316|NCT04927065|541825290|FG005|First Booster|Withdrawal by Subject|15|||
150187317|NCT04927065|541825291|FG006|First Booster|Withdrawal by Subject|6|||
150187318|NCT04927065|541825292|FG007|First Booster|Withdrawal by Subject|24|||
150187319|NCT04927065|541825293|FG008|First Booster|Withdrawal by Subject|0|||
150187320|NCT04927065|541825294|FG009|First Booster|Withdrawal by Subject|4|||
150187321|NCT04927065|541825295|FG010|First Booster|Withdrawal by Subject|0|||
150187322|NCT04927065|541825296|FG011|First Booster|Withdrawal by Subject|0|||
150187323|NCT04927065|541825297|FG012|First Booster|Withdrawal by Subject|0|||
150187324|NCT04927065|541825298|FG013|First Booster|Withdrawal by Subject|0|||
150187325|NCT04927065|541825299|FG014|First Booster|Withdrawal by Subject|0|||
150187326|NCT04927065|541825300|FG015|First Booster|Withdrawal by Subject|0|||
150187327|NCT04927065|541825285|FG000|First Booster|Other Than Specified|1|||
150187328|NCT04927065|541825286|FG001|First Booster|Other Than Specified|1|||
150187329|NCT04927065|541825287|FG002|First Booster|Other Than Specified|0|||
150187330|NCT04927065|541825288|FG003|First Booster|Other Than Specified|1|||
150187331|NCT04927065|541825289|FG004|First Booster|Other Than Specified|2|||
150187332|NCT04927065|541825290|FG005|First Booster|Other Than Specified|3|||
150187333|NCT04927065|541825291|FG006|First Booster|Other Than Specified|2|||
150187334|NCT04927065|541825292|FG007|First Booster|Other Than Specified|6|||
150187335|NCT04927065|541825293|FG008|First Booster|Other Than Specified|0|||
150187336|NCT04927065|541825294|FG009|First Booster|Other Than Specified|4|||
150187337|NCT04927065|541825295|FG010|First Booster|Other Than Specified|0|||
150187338|NCT04927065|541825296|FG011|First Booster|Other Than Specified|0|||
150187339|NCT04927065|541825297|FG012|First Booster|Other Than Specified|0|||
150187340|NCT04927065|541825298|FG013|First Booster|Other Than Specified|0|||
150187341|NCT04927065|541825299|FG014|First Booster|Other Than Specified|0|||
150187342|NCT04927065|541825300|FG015|First Booster|Other Than Specified|0|||
150187343|NCT04927065|541825285|FG000|Second Booster|Death|0|||
150187344|NCT04927065|541825286|FG001|Second Booster|Death|0|||
150187345|NCT04927065|541825287|FG002|Second Booster|Death|0|||
150187346|NCT04927065|541825288|FG003|Second Booster|Death|0|||
150187347|NCT04927065|541825289|FG004|Second Booster|Death|0|||
150187348|NCT04927065|541825290|FG005|Second Booster|Death|0|||
150187349|NCT04927065|541825291|FG006|Second Booster|Death|0|||
150187350|NCT04927065|541825292|FG007|Second Booster|Death|0|||
150187351|NCT04927065|541825293|FG008|Second Booster|Death|0|||
150187352|NCT04927065|541825294|FG009|Second Booster|Death|0|||
150187353|NCT04927065|541825295|FG010|Second Booster|Death|2|||
150187354|NCT04927065|541825296|FG011|Second Booster|Death|0|||
150187355|NCT04927065|541825297|FG012|Second Booster|Death|2|||
150187356|NCT04927065|541825298|FG013|Second Booster|Death|2|||
150187357|NCT04927065|541825299|FG014|Second Booster|Death|0|||
150187358|NCT04927065|541825300|FG015|Second Booster|Death|0|||
150187359|NCT04927065|541825285|FG000|Second Booster|Lost to Follow-up|0|||
150187360|NCT04927065|541825286|FG001|Second Booster|Lost to Follow-up|0|||
150187361|NCT04927065|541825287|FG002|Second Booster|Lost to Follow-up|3|||
150187362|NCT04927065|541825288|FG003|Second Booster|Lost to Follow-up|0|||
150187363|NCT04927065|541825289|FG004|Second Booster|Lost to Follow-up|0|||
150187364|NCT04927065|541825290|FG005|Second Booster|Lost to Follow-up|0|||
150187365|NCT04927065|541825291|FG006|Second Booster|Lost to Follow-up|0|||
150187366|NCT04927065|541825292|FG007|Second Booster|Lost to Follow-up|0|||
150187367|NCT04927065|541825293|FG008|Second Booster|Lost to Follow-up|0|||
150187368|NCT04927065|541825294|FG009|Second Booster|Lost to Follow-up|0|||
150187369|NCT04927065|541825295|FG010|Second Booster|Lost to Follow-up|14|||
150187370|NCT04927065|541825296|FG011|Second Booster|Lost to Follow-up|10|||
150187371|NCT04927065|541825297|FG012|Second Booster|Lost to Follow-up|13|||
150187372|NCT04927065|541825298|FG013|Second Booster|Lost to Follow-up|16|||
150187373|NCT04927065|541825299|FG014|Second Booster|Lost to Follow-up|0|||
150187374|NCT04927065|541825300|FG015|Second Booster|Lost to Follow-up|0|||
150187375|NCT04927065|541825285|FG000|Second Booster|Physician Decision|0|||
150187376|NCT04927065|541825286|FG001|Second Booster|Physician Decision|0|||
150187377|NCT04927065|541825287|FG002|Second Booster|Physician Decision|0|||
150187378|NCT04927065|541825288|FG003|Second Booster|Physician Decision|0|||
150187379|NCT04927065|541825289|FG004|Second Booster|Physician Decision|0|||
150187380|NCT04927065|541825290|FG005|Second Booster|Physician Decision|0|||
150187381|NCT04927065|541825291|FG006|Second Booster|Physician Decision|0|||
150187382|NCT04927065|541825292|FG007|Second Booster|Physician Decision|0|||
150187383|NCT04927065|541825293|FG008|Second Booster|Physician Decision|0|||
150187384|NCT04927065|541825294|FG009|Second Booster|Physician Decision|0|||
150187385|NCT04927065|541825295|FG010|Second Booster|Physician Decision|0|||
150187386|NCT04927065|541825296|FG011|Second Booster|Physician Decision|3|||
150187387|NCT04927065|541825297|FG012|Second Booster|Physician Decision|0|||
150187388|NCT04927065|541825298|FG013|Second Booster|Physician Decision|1|||
150187389|NCT04927065|541825299|FG014|Second Booster|Physician Decision|0|||
150187390|NCT04927065|541825300|FG015|Second Booster|Physician Decision|0|||
150187391|NCT04927065|541825285|FG000|Second Booster|Withdrawal by Subject|0|||
150187392|NCT04927065|541825286|FG001|Second Booster|Withdrawal by Subject|0|||
150107556|NCT01215227|541534328|FG005|Overall Study|Lost to Follow-up|2|||
150107557|NCT01215227|541534323|FG000|Overall Study|Subject Withdrew Consent|16|||
150107558|NCT01215227|541534324|FG001|Overall Study|Subject Withdrew Consent|20|||
150107559|NCT01215227|541534325|FG002|Overall Study|Subject Withdrew Consent|7|||
150107560|NCT01215227|541534326|FG003|Overall Study|Subject Withdrew Consent|10|||
150107561|NCT01215227|541534327|FG004|Overall Study|Subject Withdrew Consent|11|||
150107562|NCT01215227|541534328|FG005|Overall Study|Subject Withdrew Consent|8|||
150107563|NCT01215227|541534323|FG000|Overall Study|Non-Compliance With Protocol|2|||
150107564|NCT01215227|541534324|FG001|Overall Study|Non-Compliance With Protocol|6|||
150107565|NCT01215227|541534325|FG002|Overall Study|Non-Compliance With Protocol|1|||
150107566|NCT01215227|541534326|FG003|Overall Study|Non-Compliance With Protocol|0|||
150107567|NCT01215227|541534327|FG004|Overall Study|Non-Compliance With Protocol|0|||
150187393|NCT04927065|541825287|FG002|Second Booster|Withdrawal by Subject|4|||
150187394|NCT04927065|541825288|FG003|Second Booster|Withdrawal by Subject|0|||
150187395|NCT04927065|541825289|FG004|Second Booster|Withdrawal by Subject|0|||
150187396|NCT04927065|541825290|FG005|Second Booster|Withdrawal by Subject|0|||
150187397|NCT04927065|541825291|FG006|Second Booster|Withdrawal by Subject|0|||
150187398|NCT04927065|541825292|FG007|Second Booster|Withdrawal by Subject|0|||
150187399|NCT04927065|541825293|FG008|Second Booster|Withdrawal by Subject|0|||
150187400|NCT04927065|541825294|FG009|Second Booster|Withdrawal by Subject|0|||
150187401|NCT04927065|541825295|FG010|Second Booster|Withdrawal by Subject|3|||
150107568|NCT01215227|541534328|FG005|Overall Study|Non-Compliance With Protocol|0|||
150107569|NCT01215227|541534323|FG000|Overall Study|Administrative|83|||
150107570|NCT01215227|541534324|FG001|Overall Study|Administrative|73|||
150107571|NCT01215227|541534325|FG002|Overall Study|Administrative|42|||
150107572|NCT01215227|541534326|FG003|Overall Study|Administrative|24|||
150107573|NCT01215227|541534327|FG004|Overall Study|Administrative|28|||
150107574|NCT01215227|541534328|FG005|Overall Study|Administrative|40|||
150107575|NCT01215227|541534323|FG000|Overall Study|Missing Status|0|||
150107576|NCT01215227|541534324|FG001|Overall Study|Missing Status|1|||
150107577|NCT01215227|541534325|FG002|Overall Study|Missing Status|0|||
150107578|NCT01215227|541534326|FG003|Overall Study|Missing Status|0|||
150107579|NCT01215227|541534327|FG004|Overall Study|Missing Status|0|||
150107580|NCT01215227|541534328|FG005|Overall Study|Missing Status|0|||
150107581|NCT01215227|541534323|FG000|Overall Study|Randomized but not treated|0|||
150107582|NCT01215227|541534324|FG001|Overall Study|Randomized but not treated|0|||
150107583|NCT01215227|541534325|FG002|Overall Study|Randomized but not treated|1|||
150107584|NCT01215227|541534326|FG003|Overall Study|Randomized but not treated|1|||
150107585|NCT01215227|541534327|FG004|Overall Study|Randomized but not treated|0|||
150107586|NCT01215227|541534328|FG005|Overall Study|Randomized but not treated|1|||
150107587|NCT00256698|541534329|FG000|Overall Study|Withdrawal by Subject|7|||
150107588|NCT00256698|541534330|FG001|Overall Study|Withdrawal by Subject|7|||
150107589|NCT00256698|541534329|FG000|Overall Study|Adverse Event|13|||
150107590|NCT00256698|541534330|FG001|Overall Study|Adverse Event|6|||
150187402|NCT04927065|541825296|FG011|Second Booster|Withdrawal by Subject|16|||
150187403|NCT04927065|541825297|FG012|Second Booster|Withdrawal by Subject|13|||
150187404|NCT04927065|541825298|FG013|Second Booster|Withdrawal by Subject|9|||
150187405|NCT04927065|541825299|FG014|Second Booster|Withdrawal by Subject|0|||
150187406|NCT04927065|541825300|FG015|Second Booster|Withdrawal by Subject|0|||
150187407|NCT04927065|541825285|FG000|Second Booster|Other Than Specified|0|||
150187408|NCT04927065|541825286|FG001|Second Booster|Other Than Specified|0|||
150187409|NCT04927065|541825287|FG002|Second Booster|Other Than Specified|0|||
150187410|NCT04927065|541825288|FG003|Second Booster|Other Than Specified|0|||
150187411|NCT04927065|541825289|FG004|Second Booster|Other Than Specified|0|||
150187412|NCT04927065|541825290|FG005|Second Booster|Other Than Specified|0|||
150187413|NCT04927065|541825291|FG006|Second Booster|Other Than Specified|0|||
150107591|NCT00256698|541534329|FG000|Overall Study|Protocol Violation|6|||
150107592|NCT00256698|541534330|FG001|Overall Study|Protocol Violation|5|||
150107593|NCT00256698|541534329|FG000|Overall Study|Lost to Follow-up|1|||
150107594|NCT00256698|541534330|FG001|Overall Study|Lost to Follow-up|3|||
150107595|NCT00256698|541534329|FG000|Overall Study|disease progression|97|||
150107596|NCT00256698|541534330|FG001|Overall Study|disease progression|105|||
150107597|NCT00256698|541534329|FG000|Overall Study|still ongoing at data cut-off|41|||
150187414|NCT04927065|541825292|FG007|Second Booster|Other Than Specified|0|||
150187415|NCT04927065|541825293|FG008|Second Booster|Other Than Specified|0|||
150187416|NCT04927065|541825294|FG009|Second Booster|Other Than Specified|0|||
150187417|NCT04927065|541825295|FG010|Second Booster|Other Than Specified|1|||
150187418|NCT04927065|541825296|FG011|Second Booster|Other Than Specified|1|||
150187419|NCT04927065|541825297|FG012|Second Booster|Other Than Specified|4|||
150187420|NCT04927065|541825298|FG013|Second Booster|Other Than Specified|0|||
150187421|NCT04927065|541825299|FG014|Second Booster|Other Than Specified|0|||
150187422|NCT04927065|541825300|FG015|Second Booster|Other Than Specified|0|||
150187423|NCT04927065|541825285|FG000|Third Booster|Lost to Follow-up|0|||
150187424|NCT04927065|541825286|FG001|Third Booster|Lost to Follow-up|0|||
150187425|NCT04927065|541825287|FG002|Third Booster|Lost to Follow-up|0|||
150187426|NCT04927065|541825288|FG003|Third Booster|Lost to Follow-up|0|||
150187427|NCT04927065|541825289|FG004|Third Booster|Lost to Follow-up|0|||
150187428|NCT04927065|541825290|FG005|Third Booster|Lost to Follow-up|0|||
150187429|NCT04927065|541825291|FG006|Third Booster|Lost to Follow-up|0|||
150187430|NCT04927065|541825292|FG007|Third Booster|Lost to Follow-up|0|||
150187431|NCT04927065|541825293|FG008|Third Booster|Lost to Follow-up|0|||
150187432|NCT04927065|541825294|FG009|Third Booster|Lost to Follow-up|0|||
150187433|NCT04927065|541825295|FG010|Third Booster|Lost to Follow-up|0|||
150187434|NCT04927065|541825296|FG011|Third Booster|Lost to Follow-up|0|||
150187435|NCT04927065|541825297|FG012|Third Booster|Lost to Follow-up|0|||
150187436|NCT04927065|541825298|FG013|Third Booster|Lost to Follow-up|0|||
150187437|NCT04927065|541825299|FG014|Third Booster|Lost to Follow-up|0|||
150187438|NCT04927065|541825300|FG015|Third Booster|Lost to Follow-up|1|||
150187439|NCT04927065|541825285|FG000|Third Booster|Withdrawal by Subject|0|||
150187440|NCT04927065|541825286|FG001|Third Booster|Withdrawal by Subject|0|||
150187441|NCT04927065|541825287|FG002|Third Booster|Withdrawal by Subject|0|||
150187442|NCT04927065|541825288|FG003|Third Booster|Withdrawal by Subject|0|||
150187443|NCT04927065|541825289|FG004|Third Booster|Withdrawal by Subject|0|||
150187444|NCT04927065|541825290|FG005|Third Booster|Withdrawal by Subject|0|||
150187445|NCT04927065|541825291|FG006|Third Booster|Withdrawal by Subject|0|||
150187446|NCT04927065|541825292|FG007|Third Booster|Withdrawal by Subject|0|||
150187447|NCT04927065|541825293|FG008|Third Booster|Withdrawal by Subject|0|||
150187448|NCT04927065|541825294|FG009|Third Booster|Withdrawal by Subject|0|||
150187449|NCT04927065|541825295|FG010|Third Booster|Withdrawal by Subject|0|||
150187450|NCT04927065|541825296|FG011|Third Booster|Withdrawal by Subject|0|||
150187451|NCT04927065|541825297|FG012|Third Booster|Withdrawal by Subject|0|||
150187452|NCT04927065|541825298|FG013|Third Booster|Withdrawal by Subject|0|||
150187453|NCT04927065|541825299|FG014|Third Booster|Withdrawal by Subject|0|||
150187454|NCT04927065|541825300|FG015|Third Booster|Withdrawal by Subject|1|||
150187455|NCT03924986|541825301|FG000|Overall Study|Death|57|||
150187456|NCT03924986|541825302|FG001|Overall Study|Death|66|||
150187457|NCT03924986|541825301|FG000|Overall Study|Study Concluded by Sponsor|51|||
150187458|NCT03924986|541825302|FG001|Overall Study|Study Concluded by Sponsor|41|||
150187459|NCT03924986|541825301|FG000|Overall Study|Withdrawal by Subject|15|||
150187460|NCT03924986|541825302|FG001|Overall Study|Withdrawal by Subject|20|||
150187461|NCT03924986|541825301|FG000|Overall Study|Lost to Follow-up|7|||
150187462|NCT03924986|541825302|FG001|Overall Study|Lost to Follow-up|5|||
150187463|NCT03924986|541825301|FG000|Overall Study|Miscellaneous|1|||
150187464|NCT03924986|541825302|FG001|Overall Study|Miscellaneous|0|||
150187465|NCT04831216|541825310|FG000|Overall Study|Lost to Follow-up|32|||
150187466|NCT04739956|541825311|FG000|Overall Study|Withdrawal by Subject|1|||
150187467|NCT04739956|541825312|FG001|Overall Study|Withdrawal by Subject|1|||
150187468|NCT05371652|541825313|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
150187469|NCT05371652|541825313|FG000|Overall Study|Withdrawal by Subject|12|||
150187470|NCT05371652|541825313|FG000|Overall Study|Adverse Event|1|||
150187471|NCT05371652|541825313|FG000|Overall Study|Other|11|||
150187472|NCT03978871|541825314|FG000|Overall Study|Lost to Follow-up|11|||
150187473|NCT03978871|541825315|FG001|Overall Study|Lost to Follow-up|12|||
150187474|NCT04083235|541826977|FG000|Overall Study|Death|252|||
150187475|NCT04083235|541826978|FG001|Overall Study|Death|277|||
150187476|NCT04083235|541826977|FG000|Overall Study|Withdrawal by Subject|13|||
150187477|NCT04083235|541826978|FG001|Overall Study|Withdrawal by Subject|17|||
150187478|NCT04083235|541826977|FG000|Overall Study|Lost to Follow-up|1|||
150187479|NCT04083235|541826978|FG001|Overall Study|Lost to Follow-up|1|||
150187480|NCT04083235|541826977|FG000|Overall Study|Does not meet entry criteria|1|||
150187481|NCT04083235|541826978|FG001|Overall Study|Does not meet entry criteria|0|||
150187482|NCT04083235|541826977|FG000|Overall Study|Did not receive treatment|13|||
150187483|NCT04083235|541826978|FG001|Overall Study|Did not receive treatment|8|||
150187484|NCT04083235|541826977|FG000|Overall Study|Ongoing at the time of DCO|44|||
150187485|NCT04083235|541826978|FG001|Overall Study|Ongoing at the time of DCO|7|||
150187486|NCT00920621|541826979|FG000|Overall Study|Lost to Follow-up|16|||
150187487|NCT00920621|541826980|FG001|Overall Study|Lost to Follow-up|17|||
150187488|NCT00920621|541826981|FG002|Overall Study|Lost to Follow-up|19|||
150187489|NCT00920621|541826982|FG003|Overall Study|Lost to Follow-up|21|||
150187490|NCT00920621|541826979|FG000|Overall Study|Fetal/neonatal deaths|16|||
150187491|NCT00920621|541826980|FG001|Overall Study|Fetal/neonatal deaths|14|||
150187492|NCT00920621|541826981|FG002|Overall Study|Fetal/neonatal deaths|16|||
150187493|NCT00920621|541826982|FG003|Overall Study|Fetal/neonatal deaths|14|||
150187494|NCT00920621|541826979|FG000|Overall Study|Blood sample not collected|22|||
150187495|NCT00920621|541826980|FG001|Overall Study|Blood sample not collected|14|||
150187496|NCT00920621|541826981|FG002|Overall Study|Blood sample not collected|0|||
150187497|NCT00920621|541826982|FG003|Overall Study|Blood sample not collected|0|||
150187498|NCT01426425|541826983|FG000|Overall Study|Exited prior to EP study|22|||
150187499|NCT01426425|541826983|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
150187500|NCT01426425|541826983|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
150187501|NCT04956861|541826984|FG000|Overall Study|Withdrawal by Subject|4|||
150187502|NCT04956861|541826985|FG001|Overall Study|Withdrawal by Subject|4|||
150187503|NCT04956861|541826986|FG002|Overall Study|Withdrawal by Subject|2|||
150187504|NCT04956861|541826984|FG000|Overall Study|Physician Decision|4|||
150187505|NCT04956861|541826985|FG001|Overall Study|Physician Decision|5|||
150187506|NCT04956861|541826986|FG002|Overall Study|Physician Decision|1|||
150187507|NCT00170573|541826989|FG000|Overall Study|Violation of inclusion criteria|13|||
150187508|NCT04556656|541826990|FG000|Overall Study|Withdrawal by Subject|14|||
150187509|NCT04556656|541826991|FG001|Overall Study|Withdrawal by Subject|12|||
150187510|NCT04556656|541826990|FG000|Overall Study|Physician Decision|1|||
150187511|NCT04556656|541826991|FG001|Overall Study|Physician Decision|0|||
150187512|NCT04556656|541826990|FG000|Overall Study|Adverse Event|4|||
150187513|NCT04556656|541826991|FG001|Overall Study|Adverse Event|7|||
150187514|NCT04556656|541826990|FG000|Overall Study|Death|4|||
150187515|NCT04556656|541826991|FG001|Overall Study|Death|0|||
150187516|NCT04556656|541826990|FG000|Overall Study|Lost to Follow-up|3|||
150187517|NCT04556656|541826991|FG001|Overall Study|Lost to Follow-up|2|||
150187518|NCT04556656|541826990|FG000|Overall Study|Not further specified|2|||
150187519|NCT04556656|541826991|FG001|Overall Study|Not further specified|1|||
150187520|NCT05563246|541826999|FG000|Overall Study|Withdrawal by Subject|1|||
150187521|NCT05563246|541827000|FG001|Overall Study|Withdrawal by Subject|2|||
150187522|NCT05563246|541827001|FG002|Overall Study|Withdrawal by Subject|0|||
150187523|NCT05563246|541827002|FG003|Overall Study|Withdrawal by Subject|0|||
150187524|NCT05563246|541826999|FG000|Overall Study|Protocol Deviation|0|||
150187525|NCT05563246|541827000|FG001|Overall Study|Protocol Deviation|1|||
150187526|NCT05563246|541827001|FG002|Overall Study|Protocol Deviation|0|||
150187527|NCT05563246|541827002|FG003|Overall Study|Protocol Deviation|0|||
150187528|NCT05563246|541826999|FG000|Overall Study|Physician Decision|0|||
150187529|NCT05563246|541827000|FG001|Overall Study|Physician Decision|1|||
150187530|NCT05563246|541827001|FG002|Overall Study|Physician Decision|0|||
150187531|NCT05563246|541827002|FG003|Overall Study|Physician Decision|0|||
150187532|NCT05563246|541826999|FG000|Overall Study|Adverse Event|0|||
150187533|NCT05563246|541827000|FG001|Overall Study|Adverse Event|0|||
150187534|NCT05563246|541827001|FG002|Overall Study|Adverse Event|2|||
150187535|NCT05563246|541827002|FG003|Overall Study|Adverse Event|0|||
150187536|NCT05563246|541826999|FG000|Overall Study|Lost to Follow-up|0|||
150187537|NCT05563246|541827000|FG001|Overall Study|Lost to Follow-up|0|||
150187538|NCT05563246|541827001|FG002|Overall Study|Lost to Follow-up|1|||
150187539|NCT05563246|541827002|FG003|Overall Study|Lost to Follow-up|0|||
150187540|NCT03138512|541827007|FG000|Randomization|Participants withdrew consent|0|||
150187541|NCT03138512|541827008|FG001|Randomization|Participants withdrew consent|1|||
150187542|NCT03138512|541827009|FG002|Randomization|Participants withdrew consent|1|||
150187543|NCT03138512|541827010|FG003|Randomization|Participants withdrew consent|0|||
150187544|NCT03138512|541827011|FG004|Randomization|Participants withdrew consent|0|||
150187545|NCT03138512|541827007|FG000|Randomization|Participant no longer meets study criteria|0|||
150187546|NCT03138512|541827008|FG001|Randomization|Participant no longer meets study criteria|3|||
150187547|NCT03138512|541827009|FG002|Randomization|Participant no longer meets study criteria|1|||
150187548|NCT03138512|541827010|FG003|Randomization|Participant no longer meets study criteria|1|||
150187549|NCT03138512|541827011|FG004|Randomization|Participant no longer meets study criteria|3|||
150187550|NCT03138512|541827007|FG000|Randomization|Other reasons|1|||
150187551|NCT03138512|541827008|FG001|Randomization|Other reasons|0|||
150187552|NCT03138512|541827009|FG002|Randomization|Other reasons|0|||
150187553|NCT03138512|541827010|FG003|Randomization|Other reasons|0|||
150187554|NCT03138512|541827011|FG004|Randomization|Other reasons|0|||
150187555|NCT03138512|541827007|FG000|Treatment Part A|Disease recurrence|10|||
150187556|NCT03138512|541827008|FG001|Treatment Part A|Disease recurrence|20|||
150187557|NCT03138512|541827009|FG002|Treatment Part A|Disease recurrence|0|||
150187558|NCT03138512|541827010|FG003|Treatment Part A|Disease recurrence|0|||
150187559|NCT03138512|541827011|FG004|Treatment Part A|Disease recurrence|0|||
150187560|NCT03138512|541827007|FG000|Treatment Part A|Study Drug Toxicity|132|||
150187561|NCT03138512|541827008|FG001|Treatment Part A|Study Drug Toxicity|5|||
150187562|NCT03138512|541827009|FG002|Treatment Part A|Study Drug Toxicity|0|||
150187563|NCT03138512|541827010|FG003|Treatment Part A|Study Drug Toxicity|0|||
150187564|NCT03138512|541827011|FG004|Treatment Part A|Study Drug Toxicity|0|||
150187565|NCT03138512|541827007|FG000|Treatment Part A|Death|1|||
150187566|NCT03138512|541827008|FG001|Treatment Part A|Death|0|||
150187567|NCT03138512|541827009|FG002|Treatment Part A|Death|0|||
150187568|NCT03138512|541827010|FG003|Treatment Part A|Death|0|||
150187569|NCT03138512|541827011|FG004|Treatment Part A|Death|0|||
150187570|NCT03138512|541827007|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
150187571|NCT03138512|541827008|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
150187572|NCT03138512|541827009|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
150187573|NCT03138512|541827010|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
150187574|NCT03138512|541827011|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
150187575|NCT03138512|541827007|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
150187576|NCT03138512|541827008|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
150187577|NCT03138512|541827009|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
150187578|NCT03138512|541827010|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
150187579|NCT03138512|541827011|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
150187580|NCT03138512|541827007|FG000|Treatment Part A|Participant withdrew consent|2|||
150187581|NCT03138512|541827008|FG001|Treatment Part A|Participant withdrew consent|4|||
150187582|NCT03138512|541827009|FG002|Treatment Part A|Participant withdrew consent|0|||
150107598|NCT00256698|541534330|FG001|Overall Study|still ongoing at data cut-off|46|||
150107599|NCT00256698|541534329|FG000|Overall Study|withdrawn due to osteoporosis|1|||
150107600|NCT00256698|541534330|FG001|Overall Study|withdrawn due to osteoporosis|0|||
150107601|NCT00256698|541534329|FG000|Overall Study|Prematurely Discontinued|1|||
150107602|NCT00256698|541534330|FG001|Overall Study|Prematurely Discontinued|0|||
150107603|NCT02777125|541534331|FG000|Overall Study|Consent form violation|14|||
150107604|NCT02777125|541534332|FG001|Overall Study|Consent form violation|12|||
150107605|NCT02777125|541534331|FG000|Overall Study|Assent form violation|21|||
150107606|NCT02777125|541534332|FG001|Overall Study|Assent form violation|23|||
150107607|NCT02777125|541534331|FG000|Overall Study|Protocol Violation|8|||
150107608|NCT02777125|541534332|FG001|Overall Study|Protocol Violation|12|||
150107609|NCT00653224|541535951|FG000|Overall Study|Adverse Event|2|||
150107610|NCT00653224|541535952|FG001|Overall Study|Adverse Event|1|||
150107611|NCT00653224|541535951|FG000|Overall Study|Lack of Efficacy|1|||
150107612|NCT00653224|541535952|FG001|Overall Study|Lack of Efficacy|2|||
150107613|NCT00653224|541535951|FG000|Overall Study|Loss of efficacy|1|||
150107614|NCT00653224|541535952|FG001|Overall Study|Loss of efficacy|0|||
150107615|NCT00653224|541535951|FG000|Overall Study|Lost to Follow-up|1|||
150107616|NCT00653224|541535952|FG001|Overall Study|Lost to Follow-up|0|||
150107617|NCT00653224|541535951|FG000|Overall Study|Other|2|||
150107618|NCT00653224|541535952|FG001|Overall Study|Other|4|||
150107619|NCT02365636|541535954|FG000|Overall Study|Adverse Event|3|||
150107620|NCT02365636|541535955|FG001|Overall Study|Adverse Event|3|||
150107621|NCT02365636|541535956|FG002|Overall Study|Adverse Event|2|||
150107622|NCT02365636|541535954|FG000|Overall Study|Protocol Violation|1|||
150107623|NCT02365636|541535955|FG001|Overall Study|Protocol Violation|4|||
150107624|NCT02365636|541535956|FG002|Overall Study|Protocol Violation|0|||
150107625|NCT02365636|541535954|FG000|Overall Study|Lost to Follow-up|0|||
150107626|NCT02365636|541535955|FG001|Overall Study|Lost to Follow-up|0|||
150107627|NCT02365636|541535956|FG002|Overall Study|Lost to Follow-up|1|||
150107628|NCT02365636|541535954|FG000|Overall Study|Other|2|||
150107629|NCT02365636|541535955|FG001|Overall Study|Other|0|||
150107630|NCT02365636|541535956|FG002|Overall Study|Other|0|||
150107631|NCT00355238|541535957|FG000|Overall Study|Adverse event unrelated to study drug|2|||
150107632|NCT00355238|541535958|FG001|Overall Study|Adverse event unrelated to study drug|2|||
150107633|NCT00355238|541535959|FG002|Overall Study|Adverse event unrelated to study drug|0|||
150107634|NCT00355238|541535960|FG003|Overall Study|Adverse event unrelated to study drug|1|||
150107635|NCT00355238|541535957|FG000|Overall Study|Death|1|||
150107636|NCT00355238|541535958|FG001|Overall Study|Death|0|||
150107637|NCT00355238|541535959|FG002|Overall Study|Death|0|||
150107638|NCT00355238|541535960|FG003|Overall Study|Death|0|||
150107639|NCT00355238|541535957|FG000|Overall Study|Disease progression|37|||
150107640|NCT00355238|541535958|FG001|Overall Study|Disease progression|36|||
150107641|NCT00355238|541535959|FG002|Overall Study|Disease progression|16|||
150107642|NCT00355238|541535960|FG003|Overall Study|Disease progression|11|||
150107643|NCT00355238|541535957|FG000|Overall Study|Study drug toxicity|11|||
150107644|NCT00355238|541535958|FG001|Overall Study|Study drug toxicity|7|||
150107645|NCT00355238|541535959|FG002|Overall Study|Study drug toxicity|5|||
150187583|NCT03138512|541827010|FG003|Treatment Part A|Participant withdrew consent|0|||
150187584|NCT03138512|541827011|FG004|Treatment Part A|Participant withdrew consent|0|||
150187585|NCT03138512|541827007|FG000|Treatment Part A|Lost to Follow-up|0|||
150187586|NCT03138512|541827008|FG001|Treatment Part A|Lost to Follow-up|1|||
150187587|NCT03138512|541827009|FG002|Treatment Part A|Lost to Follow-up|0|||
150187588|NCT03138512|541827010|FG003|Treatment Part A|Lost to Follow-up|0|||
150187589|NCT03138512|541827011|FG004|Treatment Part A|Lost to Follow-up|0|||
150107646|NCT00355238|541535960|FG003|Overall Study|Study drug toxicity|2|||
150107647|NCT00355238|541535957|FG000|Overall Study|Participant withdrew consent|3|||
150107648|NCT00355238|541535958|FG001|Overall Study|Participant withdrew consent|1|||
150107649|NCT00355238|541535959|FG002|Overall Study|Participant withdrew consent|0|||
150187590|NCT03138512|541827007|FG000|Treatment Part A|Poor/non-compliance|1|||
150107650|NCT00355238|541535960|FG003|Overall Study|Participant withdrew consent|0|||
150107651|NCT00355238|541535957|FG000|Overall Study|Participant request to discontinue study treatment|1|||
150107652|NCT00355238|541535958|FG001|Overall Study|Participant request to discontinue study treatment|0|||
150107653|NCT00355238|541535959|FG002|Overall Study|Participant request to discontinue study treatment|1|||
150107654|NCT00355238|541535960|FG003|Overall Study|Participant request to discontinue study treatment|0|||
150107655|NCT01633944|541535961|FG000|Open-label Titration Phase|Adverse Event|109|||
150107656|NCT01633944|541535962|FG001|Open-label Titration Phase|Adverse Event|0|||
150107657|NCT01633944|541535963|FG002|Open-label Titration Phase|Adverse Event|0|||
150107658|NCT01633944|541535961|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
150107659|NCT01633944|541535962|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
150107660|NCT01633944|541535963|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
150107661|NCT01633944|541535961|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
150107662|NCT01633944|541535962|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
150107663|NCT01633944|541535963|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
150107664|NCT01633944|541535961|FG000|Open-label Titration Phase|Protocol Violation|24|||
150107665|NCT01633944|541535962|FG001|Open-label Titration Phase|Protocol Violation|0|||
150107666|NCT01633944|541535963|FG002|Open-label Titration Phase|Protocol Violation|0|||
150107667|NCT01633944|541535961|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
150107668|NCT01633944|541535962|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
150107669|NCT01633944|541535963|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
150107670|NCT01633944|541535961|FG000|Open-label Titration Phase|Other|68|||
150107671|NCT01633944|541535962|FG001|Open-label Titration Phase|Other|0|||
150107672|NCT01633944|541535963|FG002|Open-label Titration Phase|Other|0|||
150107673|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Adverse Event|0|||
150107674|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Adverse Event|13|||
150107675|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Adverse Event|7|||
150107676|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
150107677|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
150107678|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
150107679|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
150107680|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
150107681|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
150107682|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
150107683|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
150107684|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
150107685|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
150107686|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
150107687|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
150107688|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
150107689|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
150107690|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
150107691|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
150107692|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
150107693|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
150107694|NCT01633944|541535961|FG000|Double-blind Treatment Phase|Other|0|||
150107695|NCT01633944|541535962|FG001|Double-blind Treatment Phase|Other|7|||
150107696|NCT01633944|541535963|FG002|Double-blind Treatment Phase|Other|0|||
150107697|NCT00463060|541535967|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
150107698|NCT00463060|541535967|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
150107699|NCT00701129|541535968|FG000|Overall Study|Death|2|||
150107700|NCT02884089|541535969|FG000|Period 1|Dosing error|2|||
150107701|NCT02884089|541535970|FG001|Period 1|Dosing error|2|||
150107702|NCT02884089|541535971|FG002|Period 1|Dosing error|0|||
150107703|NCT02884089|541535972|FG003|Period 1|Dosing error|0|||
150107704|NCT02884089|541535969|FG000|Washout Period 1|Lost to Follow-up|0|||
150107705|NCT02884089|541535970|FG001|Washout Period 1|Lost to Follow-up|1|||
150107706|NCT02884089|541535971|FG002|Washout Period 1|Lost to Follow-up|0|||
150107707|NCT02884089|541535972|FG003|Washout Period 1|Lost to Follow-up|1|||
150107708|NCT02884089|541535969|FG000|Washout Period 1|Withdrawal by Subject|0|||
150107709|NCT02884089|541535970|FG001|Washout Period 1|Withdrawal by Subject|1|||
150107710|NCT02884089|541535971|FG002|Washout Period 1|Withdrawal by Subject|0|||
150107711|NCT02884089|541535972|FG003|Washout Period 1|Withdrawal by Subject|0|||
150107712|NCT02884089|541535969|FG000|Period 2|Adverse Event|1|||
150107713|NCT02884089|541535970|FG001|Period 2|Adverse Event|0|||
150107714|NCT02884089|541535971|FG002|Period 2|Adverse Event|0|||
150107715|NCT02884089|541535972|FG003|Period 2|Adverse Event|0|||
150107716|NCT02884089|541535969|FG000|Period 3|Withdrawal by Subject|0|||
150107717|NCT02884089|541535970|FG001|Period 3|Withdrawal by Subject|0|||
150107718|NCT02884089|541535971|FG002|Period 3|Withdrawal by Subject|1|||
150107719|NCT02884089|541535972|FG003|Period 3|Withdrawal by Subject|0|||
150187591|NCT03138512|541827008|FG001|Treatment Part A|Poor/non-compliance|0|||
150107720|NCT02884089|541535969|FG000|Washout Period 3|Withdrawal by Subject|0|||
150107721|NCT02884089|541535970|FG001|Washout Period 3|Withdrawal by Subject|0|||
150107722|NCT02884089|541535971|FG002|Washout Period 3|Withdrawal by Subject|1|||
150187592|NCT03138512|541827009|FG002|Treatment Part A|Poor/non-compliance|0|||
150187593|NCT03138512|541827010|FG003|Treatment Part A|Poor/non-compliance|0|||
150187594|NCT03138512|541827011|FG004|Treatment Part A|Poor/non-compliance|0|||
150187595|NCT03138512|541827007|FG000|Treatment Part A|Pregnancy|0|||
150187596|NCT03138512|541827008|FG001|Treatment Part A|Pregnancy|1|||
150187597|NCT03138512|541827009|FG002|Treatment Part A|Pregnancy|0|||
150187598|NCT03138512|541827010|FG003|Treatment Part A|Pregnancy|0|||
150187599|NCT03138512|541827011|FG004|Treatment Part A|Pregnancy|0|||
150187600|NCT03138512|541827007|FG000|Treatment Part A|Other reasons|11|||
150187601|NCT03138512|541827008|FG001|Treatment Part A|Other reasons|8|||
150187602|NCT03138512|541827009|FG002|Treatment Part A|Other reasons|0|||
150187603|NCT03138512|541827010|FG003|Treatment Part A|Other reasons|0|||
150187604|NCT03138512|541827011|FG004|Treatment Part A|Other reasons|0|||
150187605|NCT03138512|541827007|FG000|Treatment Part B|Disease recurrence|0|||
150187606|NCT03138512|541827008|FG001|Treatment Part B|Disease recurrence|0|||
150187607|NCT03138512|541827009|FG002|Treatment Part B|Disease recurrence|6|||
150187608|NCT03138512|541827010|FG003|Treatment Part B|Disease recurrence|12|||
150187609|NCT03138512|541827011|FG004|Treatment Part B|Disease recurrence|10|||
150187610|NCT03138512|541827007|FG000|Treatment Part B|Study drug toxicity|0|||
150187611|NCT03138512|541827008|FG001|Treatment Part B|Study drug toxicity|0|||
150187612|NCT03138512|541827009|FG002|Treatment Part B|Study drug toxicity|63|||
150187613|NCT03138512|541827010|FG003|Treatment Part B|Study drug toxicity|3|||
150187614|NCT03138512|541827011|FG004|Treatment Part B|Study drug toxicity|45|||
150187615|NCT03138512|541827007|FG000|Treatment Part B|Death|0|||
150187616|NCT03138512|541827008|FG001|Treatment Part B|Death|0|||
150187617|NCT03138512|541827009|FG002|Treatment Part B|Death|1|||
150187618|NCT03138512|541827010|FG003|Treatment Part B|Death|0|||
150187619|NCT03138512|541827011|FG004|Treatment Part B|Death|0|||
150187620|NCT03138512|541827007|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
150187621|NCT03138512|541827008|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
150187622|NCT03138512|541827009|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
150187623|NCT03138512|541827010|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
150187624|NCT03138512|541827011|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
150187625|NCT03138512|541827007|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
150187626|NCT03138512|541827008|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
150187627|NCT03138512|541827009|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
150187628|NCT03138512|541827010|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
150187629|NCT03138512|541827011|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
150187630|NCT03138512|541827007|FG000|Treatment Part B|Participant withdrew consent|0|||
150187631|NCT03138512|541827008|FG001|Treatment Part B|Participant withdrew consent|0|||
150187632|NCT03138512|541827009|FG002|Treatment Part B|Participant withdrew consent|1|||
150187633|NCT03138512|541827010|FG003|Treatment Part B|Participant withdrew consent|1|||
150187634|NCT03138512|541827011|FG004|Treatment Part B|Participant withdrew consent|2|||
150187635|NCT03138512|541827007|FG000|Treatment Part B|Lost to Follow-up|0|||
150187636|NCT03138512|541827008|FG001|Treatment Part B|Lost to Follow-up|0|||
150187637|NCT03138512|541827009|FG002|Treatment Part B|Lost to Follow-up|0|||
150187638|NCT03138512|541827010|FG003|Treatment Part B|Lost to Follow-up|1|||
150187639|NCT03138512|541827011|FG004|Treatment Part B|Lost to Follow-up|0|||
150187640|NCT03138512|541827007|FG000|Treatment Part B|Poor/non-compliance|0|||
150187641|NCT03138512|541827008|FG001|Treatment Part B|Poor/non-compliance|0|||
150187642|NCT03138512|541827009|FG002|Treatment Part B|Poor/non-compliance|1|||
150187643|NCT03138512|541827010|FG003|Treatment Part B|Poor/non-compliance|1|||
150187644|NCT03138512|541827011|FG004|Treatment Part B|Poor/non-compliance|1|||
150187645|NCT03138512|541827007|FG000|Treatment Part B|Other reasons|0|||
150187646|NCT03138512|541827008|FG001|Treatment Part B|Other reasons|0|||
150187647|NCT03138512|541827009|FG002|Treatment Part B|Other reasons|3|||
150187648|NCT03138512|541827010|FG003|Treatment Part B|Other reasons|1|||
150187649|NCT03138512|541827011|FG004|Treatment Part B|Other reasons|5|||
150187650|NCT04382404|541827013|FG000|Overall Study|Adverse Event|1|||
150187651|NCT04382404|541827013|FG000|Overall Study|Lost to Follow-up|2|||
150187652|NCT05687916|541827017|FG000|Overall Study|Adverse Event|1|||
150107723|NCT02884089|541535972|FG003|Washout Period 3|Withdrawal by Subject|0|||
150107724|NCT02884089|541535969|FG000|Washout Period 3|Lost to Follow-up|0|||
150107725|NCT02884089|541535970|FG001|Washout Period 3|Lost to Follow-up|0|||
150107726|NCT02884089|541535971|FG002|Washout Period 3|Lost to Follow-up|0|||
150107727|NCT02884089|541535972|FG003|Washout Period 3|Lost to Follow-up|1|||
150107728|NCT02884089|541535969|FG000|Period 4|Withdrawal by Subject|0|||
150107729|NCT02884089|541535970|FG001|Period 4|Withdrawal by Subject|1|||
150107730|NCT02884089|541535971|FG002|Period 4|Withdrawal by Subject|0|||
150107731|NCT02884089|541535972|FG003|Period 4|Withdrawal by Subject|0|||
150107732|NCT02884089|541535969|FG000|Period 4|Lost to Follow-up|1|||
150107733|NCT02884089|541535970|FG001|Period 4|Lost to Follow-up|0|||
150107734|NCT02884089|541535971|FG002|Period 4|Lost to Follow-up|0|||
150107735|NCT02884089|541535972|FG003|Period 4|Lost to Follow-up|0|||
150107736|NCT02884089|541535969|FG000|Follow-up Visit|Withdrawal by Subject|1|||
150107737|NCT02884089|541535970|FG001|Follow-up Visit|Withdrawal by Subject|0|||
150107738|NCT02884089|541535971|FG002|Follow-up Visit|Withdrawal by Subject|0|||
150107739|NCT02884089|541535972|FG003|Follow-up Visit|Withdrawal by Subject|1|||
150107740|NCT02624284|541535973|FG000|Overall Study|Withdrawal by Subject|3|||
150107741|NCT02624284|541535974|FG001|Overall Study|Withdrawal by Subject|6|||
150107742|NCT02624284|541535975|FG002|Overall Study|Withdrawal by Subject|3|||
150107743|NCT02624284|541535973|FG000|Overall Study|Protocol Violation|9|||
150107744|NCT02624284|541535974|FG001|Overall Study|Protocol Violation|10|||
150107745|NCT02624284|541535975|FG002|Overall Study|Protocol Violation|7|||
150107746|NCT02624284|541535973|FG000|Overall Study|Revealed exclusionary condition|2|||
150107747|NCT02624284|541535974|FG001|Overall Study|Revealed exclusionary condition|2|||
150107748|NCT02624284|541535975|FG002|Overall Study|Revealed exclusionary condition|0|||
150107749|NCT02624284|541535973|FG000|Overall Study|Adverse Event|0|||
150107750|NCT02624284|541535974|FG001|Overall Study|Adverse Event|0|||
150107751|NCT02624284|541535975|FG002|Overall Study|Adverse Event|1|||
150107752|NCT03064126|541535976|FG000|Overall Study|Death|40|||
150107753|NCT03064126|541535977|FG001|Overall Study|Death|16|||
150107754|NCT03064126|541535978|FG002|Overall Study|Death|4|||
150107755|NCT03064126|541535979|FG003|Overall Study|Death|2|||
150107756|NCT03064126|541535976|FG000|Overall Study|Withdrawal by Subject|17|||
150107757|NCT03064126|541535977|FG001|Overall Study|Withdrawal by Subject|9|||
150107758|NCT03064126|541535978|FG002|Overall Study|Withdrawal by Subject|0|||
150107759|NCT03064126|541535979|FG003|Overall Study|Withdrawal by Subject|2|||
150107760|NCT03064126|541535976|FG000|Overall Study|Lost to Follow-up|7|||
150107761|NCT03064126|541535977|FG001|Overall Study|Lost to Follow-up|3|||
150107762|NCT03064126|541535978|FG002|Overall Study|Lost to Follow-up|0|||
150107763|NCT03064126|541535979|FG003|Overall Study|Lost to Follow-up|0|||
150107764|NCT03064126|541535976|FG000|Overall Study|Adverse Event|2|||
150107765|NCT03064126|541535977|FG001|Overall Study|Adverse Event|0|||
150107766|NCT03064126|541535978|FG002|Overall Study|Adverse Event|0|||
150107767|NCT03064126|541535979|FG003|Overall Study|Adverse Event|0|||
150107768|NCT03064126|541535976|FG000|Overall Study|Physician Decision|3|||
150107769|NCT03064126|541535977|FG001|Overall Study|Physician Decision|0|||
150107770|NCT03064126|541535978|FG002|Overall Study|Physician Decision|0|||
150107771|NCT03064126|541535979|FG003|Overall Study|Physician Decision|0|||
150107772|NCT03064126|541535976|FG000|Overall Study|Other reason for early termination|3|||
150107773|NCT03064126|541535977|FG001|Overall Study|Other reason for early termination|2|||
150107774|NCT03064126|541535978|FG002|Overall Study|Other reason for early termination|0|||
150107775|NCT03064126|541535979|FG003|Overall Study|Other reason for early termination|0|||
150107776|NCT03064126|541535976|FG000|Overall Study|Missed Visit|3|||
150107777|NCT03064126|541535977|FG001|Overall Study|Missed Visit|1|||
150107778|NCT03064126|541535978|FG002|Overall Study|Missed Visit|0|||
150107779|NCT03064126|541535979|FG003|Overall Study|Missed Visit|0|||
150107780|NCT06034496|541535991|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
150107781|NCT06034496|541535992|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
150107782|NCT06034496|541535991|FG000|Overall Study|Withdrawal by Subject|5|||
150107783|NCT06034496|541535992|FG001|Overall Study|Withdrawal by Subject|4|||
150107784|NCT02018458|541535993|FG000|Overall Study|Death|4|||
150107785|NCT01428193|541535996|FG000|Overall Study|Physician Decision|1|||
150107786|NCT01428193|541535996|FG000|Overall Study|Elevated screening liver enzymes|1|||
150107787|NCT03762083|541535997|FG000|Overall Study|Withdrawal by Subject|2|||
150107788|NCT03762083|541535997|FG000|Overall Study|Physician Decision|1|||
150107789|NCT00727714|541536000|FG000|Overall Study|Lost to Follow-up|2|||
150107790|NCT00325234|541536003|FG000|Overall Study|Adverse Event|10|||
150107791|NCT00325234|541536004|FG001|Overall Study|Adverse Event|7|||
150107792|NCT00325234|541536003|FG000|Overall Study|Death due to Study Disease|1|||
150107793|NCT00325234|541536004|FG001|Overall Study|Death due to Study Disease|0|||
150107794|NCT00325234|541536003|FG000|Overall Study|Entry Criteria Not Met|1|||
150107795|NCT00325234|541536004|FG001|Overall Study|Entry Criteria Not Met|2|||
150187653|NCT05687916|541827018|FG001|Overall Study|Adverse Event|2|||
150187654|NCT05687916|541827019|FG002|Overall Study|Adverse Event|0|||
150187655|NCT05687916|541827017|FG000|Overall Study|Withdrawal by Subject|1|||
150187656|NCT05687916|541827018|FG001|Overall Study|Withdrawal by Subject|0|||
150187657|NCT05687916|541827019|FG002|Overall Study|Withdrawal by Subject|1|||
150187658|NCT05687916|541827017|FG000|Overall Study|Protocol Violation|0|||
150187659|NCT05687916|541827018|FG001|Overall Study|Protocol Violation|2|||
150187660|NCT05687916|541827019|FG002|Overall Study|Protocol Violation|1|||
150187661|NCT05687916|541827017|FG000|Overall Study|Reason not Specified|1|||
150187662|NCT05687916|541827018|FG001|Overall Study|Reason not Specified|0|||
150187663|NCT05687916|541827019|FG002|Overall Study|Reason not Specified|0|||
150187664|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
150187665|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
150187666|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
150187667|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187668|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187669|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187670|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187671|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187672|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187673|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187674|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187675|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187676|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
150187677|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
150187678|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
150187679|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187680|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187681|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187682|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187683|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187684|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187685|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187686|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187687|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187688|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187689|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
150187690|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
150187691|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
150187692|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187693|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187694|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187695|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187696|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187697|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187698|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187699|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187700|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187701|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187702|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
150187703|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
150187704|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
150187705|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187706|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187707|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187708|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187709|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187710|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187711|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187712|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150107796|NCT00325234|541536003|FG000|Overall Study|Subject Decision|6|||
150107797|NCT00325234|541536004|FG001|Overall Study|Subject Decision|8|||
150107798|NCT00325234|541536003|FG000|Overall Study|Physician Decision|17|||
150107799|NCT00325234|541536004|FG001|Overall Study|Physician Decision|12|||
150107800|NCT00325234|541536003|FG000|Overall Study|Progressive Disease|34|||
150107801|NCT00325234|541536004|FG001|Overall Study|Progressive Disease|37|||
150107802|NCT05179421|541536007|FG000|First Infusion Day|Adverse Event|1|||
150107803|NCT05179421|541536008|FG001|First Infusion Day|Adverse Event|0|||
150107804|NCT03746522|541536009|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
150107805|NCT03746522|541536010|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
150107806|NCT03746522|541536011|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
150107807|NCT03746522|541536009|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
150107808|NCT03746522|541536010|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
150107809|NCT03746522|541536011|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
150107810|NCT03746522|541536009|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
150107811|NCT03746522|541536010|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
150107812|NCT03746522|541536011|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
150107813|NCT03746522|541536009|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
150107814|NCT03746522|541536010|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
150107815|NCT03746522|541536011|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
150107816|NCT03746522|541536009|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
150107817|NCT03746522|541536010|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
150107818|NCT03746522|541536011|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
150107819|NCT01639040|541536012|FG000|Overall Study|Adverse Event|1|||
150107820|NCT01639040|541536013|FG001|Overall Study|Adverse Event|0|||
150107821|NCT00486265|541536017|FG000|Overall Study|Adverse Event|1|||
150107822|NCT00486265|541536017|FG000|Overall Study|Lack of Efficacy|8|||
150107823|NCT01452412|541536018|FG000|Overall Study|Withdrawal by Subject|15|||
150107824|NCT01452412|541536019|FG001|Overall Study|Withdrawal by Subject|11|||
150107825|NCT01452412|541536018|FG000|Overall Study|Adverse Event|4|||
150107826|NCT01452412|541536019|FG001|Overall Study|Adverse Event|3|||
150107827|NCT01452412|541536018|FG000|Overall Study|Lost to Follow-up|5|||
150107828|NCT01452412|541536019|FG001|Overall Study|Lost to Follow-up|3|||
150107829|NCT01452412|541536018|FG000|Overall Study|Death|1|||
150107830|NCT01452412|541536019|FG001|Overall Study|Death|0|||
150107831|NCT01452412|541536018|FG000|Overall Study|Initiated dialysis|1|||
150107832|NCT01452412|541536019|FG001|Overall Study|Initiated dialysis|0|||
150107833|NCT01452412|541536018|FG000|Overall Study|Other|2|||
150107834|NCT01452412|541536019|FG001|Overall Study|Other|0|||
150107835|NCT05132127|541536020|FG000|Overall Study|Adverse Event|1|||
150107836|NCT01403974|541536023|FG000|Overall Study|Progressive disease according to RECIST|3|||
150107837|NCT01403974|541536024|FG001|Overall Study|Progressive disease according to RECIST|3|||
150107838|NCT01403974|541536025|FG002|Overall Study|Progressive disease according to RECIST|2|||
150107839|NCT01403974|541536026|FG003|Overall Study|Progressive disease according to RECIST|3|||
150107840|NCT01403974|541536027|FG004|Overall Study|Progressive disease according to RECIST|3|||
150107841|NCT01403974|541536028|FG005|Overall Study|Progressive disease according to RECIST|2|||
150107842|NCT01403974|541536029|FG006|Overall Study|Progressive disease according to RECIST|3|||
150107843|NCT01403974|541536030|FG007|Overall Study|Progressive disease according to RECIST|2|||
150107844|NCT01403974|541536031|FG008|Overall Study|Progressive disease according to RECIST|6|||
150107845|NCT01403974|541536032|FG009|Overall Study|Progressive disease according to RECIST|2|||
150107846|NCT01403974|541536033|FG010|Overall Study|Progressive disease according to RECIST|3|||
150107847|NCT01403974|541536034|FG011|Overall Study|Progressive disease according to RECIST|2|||
150107848|NCT01403974|541536035|FG012|Overall Study|Progressive disease according to RECIST|2|||
150107849|NCT01403974|541536036|FG013|Overall Study|Progressive disease according to RECIST|3|||
150107850|NCT01403974|541536037|FG014|Overall Study|Progressive disease according to RECIST|1|||
150107851|NCT01403974|541536038|FG015|Overall Study|Progressive disease according to RECIST|8|||
150107852|NCT01403974|541536023|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
150107853|NCT01403974|541536024|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
150107854|NCT01403974|541536025|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
150107855|NCT01403974|541536026|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
150107856|NCT01403974|541536027|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
150107857|NCT01403974|541536028|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
150107858|NCT01403974|541536029|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
150107859|NCT01403974|541536030|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
150107860|NCT01403974|541536031|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
150107861|NCT01403974|541536032|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
150107862|NCT01403974|541536033|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
150107863|NCT01403974|541536034|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
150107864|NCT01403974|541536035|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
150107865|NCT01403974|541536036|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
150107866|NCT01403974|541536037|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
150107867|NCT01403974|541536038|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
150107868|NCT01403974|541536023|FG000|Overall Study|Refused to continue study medication|0|||
150107869|NCT01403974|541536024|FG001|Overall Study|Refused to continue study medication|0|||
150107870|NCT01403974|541536025|FG002|Overall Study|Refused to continue study medication|0|||
150107871|NCT01403974|541536026|FG003|Overall Study|Refused to continue study medication|0|||
150107872|NCT01403974|541536027|FG004|Overall Study|Refused to continue study medication|0|||
150107873|NCT01403974|541536028|FG005|Overall Study|Refused to continue study medication|1|||
150107874|NCT01403974|541536029|FG006|Overall Study|Refused to continue study medication|0|||
150107875|NCT01403974|541536030|FG007|Overall Study|Refused to continue study medication|0|||
150107876|NCT01403974|541536031|FG008|Overall Study|Refused to continue study medication|1|||
150107877|NCT01403974|541536032|FG009|Overall Study|Refused to continue study medication|0|||
150107878|NCT01403974|541536033|FG010|Overall Study|Refused to continue study medication|1|||
150107879|NCT01403974|541536034|FG011|Overall Study|Refused to continue study medication|0|||
150107880|NCT01403974|541536035|FG012|Overall Study|Refused to continue study medication|0|||
150107881|NCT01403974|541536036|FG013|Overall Study|Refused to continue study medication|0|||
150107882|NCT01403974|541536037|FG014|Overall Study|Refused to continue study medication|0|||
150107883|NCT01403974|541536038|FG015|Overall Study|Refused to continue study medication|4|||
150107884|NCT01403974|541536023|FG000|Overall Study|Adverse Event|0|||
150107885|NCT01403974|541536024|FG001|Overall Study|Adverse Event|0|||
150107886|NCT01403974|541536025|FG002|Overall Study|Adverse Event|1|||
150107887|NCT01403974|541536026|FG003|Overall Study|Adverse Event|0|||
150107888|NCT01403974|541536027|FG004|Overall Study|Adverse Event|0|||
150107889|NCT01403974|541536028|FG005|Overall Study|Adverse Event|0|||
150107890|NCT01403974|541536029|FG006|Overall Study|Adverse Event|0|||
150107891|NCT01403974|541536030|FG007|Overall Study|Adverse Event|1|||
150107892|NCT01403974|541536031|FG008|Overall Study|Adverse Event|0|||
150107893|NCT01403974|541536032|FG009|Overall Study|Adverse Event|0|||
150107894|NCT01403974|541536033|FG010|Overall Study|Adverse Event|0|||
150107895|NCT01403974|541536034|FG011|Overall Study|Adverse Event|0|||
150107896|NCT01403974|541536035|FG012|Overall Study|Adverse Event|1|||
150107897|NCT01403974|541536036|FG013|Overall Study|Adverse Event|0|||
150107898|NCT01403974|541536037|FG014|Overall Study|Adverse Event|0|||
150107899|NCT01403974|541536038|FG015|Overall Study|Adverse Event|0|||
150107900|NCT01403974|541536023|FG000|Overall Study|Other than specified|0|||
150107901|NCT01403974|541536024|FG001|Overall Study|Other than specified|0|||
150107902|NCT01403974|541536025|FG002|Overall Study|Other than specified|0|||
150107903|NCT01403974|541536026|FG003|Overall Study|Other than specified|0|||
150107904|NCT01403974|541536027|FG004|Overall Study|Other than specified|0|||
150107905|NCT01403974|541536028|FG005|Overall Study|Other than specified|0|||
150107906|NCT01403974|541536029|FG006|Overall Study|Other than specified|0|||
150107907|NCT01403974|541536030|FG007|Overall Study|Other than specified|0|||
150107908|NCT01403974|541536031|FG008|Overall Study|Other than specified|0|||
150107909|NCT01403974|541536032|FG009|Overall Study|Other than specified|1|||
150107910|NCT01403974|541536033|FG010|Overall Study|Other than specified|0|||
150107911|NCT01403974|541536034|FG011|Overall Study|Other than specified|1|||
150107912|NCT01403974|541536035|FG012|Overall Study|Other than specified|0|||
150107913|NCT01403974|541536036|FG013|Overall Study|Other than specified|0|||
150107914|NCT01403974|541536037|FG014|Overall Study|Other than specified|0|||
150107915|NCT01403974|541536038|FG015|Overall Study|Other than specified|0|||
150107916|NCT04697628|541536039|FG000|Overall Study|Withdrawal by Subject|17|||
150107917|NCT04697628|541536040|FG001|Overall Study|Withdrawal by Subject|23|||
150107918|NCT04697628|541536039|FG000|Overall Study|Lost to Follow-up|0|||
150107919|NCT04697628|541536040|FG001|Overall Study|Lost to Follow-up|4|||
150107920|NCT04697628|541536039|FG000|Overall Study|On-going in study|122|||
150107921|NCT04697628|541536040|FG001|Overall Study|On-going in study|91|||
150107922|NCT00393939|541536041|FG000|Overall Study|Protocol Violation|1|||
150107923|NCT00393939|541536042|FG001|Overall Study|Protocol Violation|1|||
150107924|NCT00393939|541536041|FG000|Overall Study|Lost to Follow-up|2|||
150107925|NCT00393939|541536042|FG001|Overall Study|Lost to Follow-up|4|||
150107926|NCT00393939|541536041|FG000|Overall Study|Death|10|||
150107927|NCT00393939|541536042|FG001|Overall Study|Death|4|||
150107928|NCT00393939|541536041|FG000|Overall Study|Sponsor|5|||
150107929|NCT00393939|541536042|FG001|Overall Study|Sponsor|13|||
150107930|NCT00393939|541536041|FG000|Overall Study|Objective progression or relapse|239|||
150107931|NCT00393939|541536042|FG001|Overall Study|Objective progression or relapse|223|||
150107932|NCT00393939|541536041|FG000|Overall Study|Withdrawal by Subject|2|||
150107933|NCT00393939|541536042|FG001|Overall Study|Withdrawal by Subject|7|||
150107934|NCT00393939|541536041|FG000|Overall Study|Other|37|||
150107935|NCT00393939|541536042|FG001|Overall Study|Other|45|||
150107936|NCT02385799|541536043|FG000|Overall Study|Lost to Follow-up|1|||
150107937|NCT02385799|541536044|FG001|Overall Study|Lost to Follow-up|2|||
150107938|NCT02385799|541536043|FG000|Overall Study|Adverse Event|4|||
150107939|NCT02385799|541536044|FG001|Overall Study|Adverse Event|2|||
150107940|NCT02385799|541536043|FG000|Overall Study|Withdrawal by Subject|0|||
150107941|NCT02385799|541536044|FG001|Overall Study|Withdrawal by Subject|4|||
150107942|NCT03995953|541536045|FG000|Overall Study|Death|3|||
150107943|NCT03995953|541536046|FG001|Overall Study|Death|0|||
150107944|NCT03995953|541536047|FG002|Overall Study|Death|3|||
150107945|NCT03995953|541536048|FG003|Overall Study|Death|0|||
150107946|NCT03995953|541536049|FG004|Overall Study|Death|3|||
150107947|NCT03995953|541536050|FG005|Overall Study|Death|0|||
150107948|NCT03995953|541536051|FG006|Overall Study|Death|0|||
150107949|NCT03995953|541536052|FG007|Overall Study|Death|0|||
150107950|NCT03995953|541536053|FG008|Overall Study|Death|1|||
150107951|NCT03995953|541536054|FG009|Overall Study|Death|0|||
150107952|NCT03995953|541536055|FG010|Overall Study|Death|0|||
150107953|NCT03995953|541536056|FG011|Overall Study|Death|0|||
150107954|NCT03995953|541536045|FG000|Overall Study|Lost to Follow-up|6|||
150107955|NCT03995953|541536046|FG001|Overall Study|Lost to Follow-up|54|||
150107956|NCT03995953|541536047|FG002|Overall Study|Lost to Follow-up|3|||
150107957|NCT03995953|541536048|FG003|Overall Study|Lost to Follow-up|32|||
150107958|NCT03995953|541536049|FG004|Overall Study|Lost to Follow-up|5|||
150107959|NCT03995953|541536050|FG005|Overall Study|Lost to Follow-up|44|||
150107960|NCT03995953|541536051|FG006|Overall Study|Lost to Follow-up|0|||
150107961|NCT03995953|541536052|FG007|Overall Study|Lost to Follow-up|31|||
150107962|NCT03995953|541536053|FG008|Overall Study|Lost to Follow-up|8|||
150107963|NCT03995953|541536054|FG009|Overall Study|Lost to Follow-up|36|||
150107964|NCT03995953|541536055|FG010|Overall Study|Lost to Follow-up|5|||
150107965|NCT03995953|541536056|FG011|Overall Study|Lost to Follow-up|41|||
150107966|NCT03995953|541536045|FG000|Overall Study|Withdrawal by Subject|4|||
150107967|NCT03995953|541536046|FG001|Overall Study|Withdrawal by Subject|0|||
150107968|NCT03995953|541536047|FG002|Overall Study|Withdrawal by Subject|1|||
150107969|NCT03995953|541536048|FG003|Overall Study|Withdrawal by Subject|0|||
150107970|NCT03995953|541536049|FG004|Overall Study|Withdrawal by Subject|1|||
150107971|NCT03995953|541536050|FG005|Overall Study|Withdrawal by Subject|0|||
150107972|NCT03995953|541536051|FG006|Overall Study|Withdrawal by Subject|1|||
150107973|NCT03995953|541536052|FG007|Overall Study|Withdrawal by Subject|0|||
150107974|NCT03995953|541536053|FG008|Overall Study|Withdrawal by Subject|3|||
150107975|NCT03995953|541536054|FG009|Overall Study|Withdrawal by Subject|0|||
150107976|NCT03995953|541536055|FG010|Overall Study|Withdrawal by Subject|3|||
150107977|NCT03995953|541536056|FG011|Overall Study|Withdrawal by Subject|0|||
150107978|NCT03995953|541536045|FG000|Overall Study|Health Issues|0|||
150107979|NCT03995953|541536046|FG001|Overall Study|Health Issues|0|||
150107980|NCT03995953|541536047|FG002|Overall Study|Health Issues|0|||
150107981|NCT03995953|541536048|FG003|Overall Study|Health Issues|0|||
150107982|NCT03995953|541536049|FG004|Overall Study|Health Issues|1|||
150107983|NCT03995953|541536050|FG005|Overall Study|Health Issues|0|||
150107984|NCT03995953|541536051|FG006|Overall Study|Health Issues|0|||
150107985|NCT03995953|541536052|FG007|Overall Study|Health Issues|0|||
150107986|NCT03995953|541536053|FG008|Overall Study|Health Issues|4|||
150107987|NCT03995953|541536054|FG009|Overall Study|Health Issues|0|||
150107988|NCT03995953|541536055|FG010|Overall Study|Health Issues|0|||
150107989|NCT03995953|541536056|FG011|Overall Study|Health Issues|0|||
150107990|NCT03995953|541536045|FG000|Overall Study|Relocated|11|||
150107991|NCT03995953|541536046|FG001|Overall Study|Relocated|0|||
150107992|NCT03995953|541536047|FG002|Overall Study|Relocated|16|||
150107993|NCT03995953|541536048|FG003|Overall Study|Relocated|0|||
150107994|NCT03995953|541536049|FG004|Overall Study|Relocated|14|||
150107995|NCT03995953|541536050|FG005|Overall Study|Relocated|0|||
150107996|NCT03995953|541536051|FG006|Overall Study|Relocated|16|||
150107997|NCT03995953|541536052|FG007|Overall Study|Relocated|0|||
150107998|NCT03995953|541536053|FG008|Overall Study|Relocated|14|||
150107999|NCT03995953|541536054|FG009|Overall Study|Relocated|0|||
150108000|NCT03995953|541536055|FG010|Overall Study|Relocated|15|||
150108001|NCT03995953|541536056|FG011|Overall Study|Relocated|0|||
150108002|NCT02388997|541536057|FG000|Overall Study|Adverse Event|1|||
150108003|NCT02388997|541536058|FG001|Overall Study|Adverse Event|2|||
150108004|NCT02388997|541536057|FG000|Overall Study|Withdrawal by Subject|2|||
150108005|NCT02388997|541536058|FG001|Overall Study|Withdrawal by Subject|1|||
150108006|NCT02388997|541536057|FG000|Overall Study|Lung function exclusion criteria|0|||
150108007|NCT02388997|541536058|FG001|Overall Study|Lung function exclusion criteria|2|||
150108008|NCT02388997|541536057|FG000|Overall Study|Tested positive for virus during run-in|0|||
150108009|NCT02388997|541536058|FG001|Overall Study|Tested positive for virus during run-in|1|||
150108010|NCT00006184|541536059|FG000|Overall Study|Death|1|||
150108011|NCT00006184|541536060|FG001|Overall Study|Death|0|||
150108012|NCT01110915|541536067|FG000|Overall Study|Death|2|||
150108013|NCT01110915|541536068|FG001|Overall Study|Death|1|||
150108014|NCT01110915|541536067|FG000|Overall Study|Lost to Follow-up|1|||
150187713|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150108015|NCT01110915|541536068|FG001|Overall Study|Lost to Follow-up|0|||
150108016|NCT01110915|541536067|FG000|Overall Study|Withdrawal by Subject|7|||
150108017|NCT01110915|541536068|FG001|Overall Study|Withdrawal by Subject|1|||
150108018|NCT02350309|541536076|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
150108019|NCT02350309|541536077|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
150108020|NCT02350309|541536078|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
150108021|NCT02350309|541536079|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
150108022|NCT02350309|541536080|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
150108023|NCT02350309|541536081|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
150108024|NCT02350309|541536076|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
150108025|NCT02350309|541536077|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
150108026|NCT02350309|541536078|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
150108027|NCT02350309|541536079|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
150108028|NCT02350309|541536080|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
150108029|NCT02350309|541536081|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
150108030|NCT01205165|541536082|FG000|Overall Study|Lost to Follow-up|2|||
150108031|NCT01838642|541536084|FG000|Overall Study|Died on study|1|||
150108032|NCT01557400|541536088|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
150108033|NCT01557400|541536088|FG000|Overall Study|Adverse Event|3|||
150108034|NCT01557400|541536088|FG000|Overall Study|Lost to Follow-up|5|||
150108035|NCT01557400|541536088|FG000|Overall Study|Withdrawal by Subject|9|||
150108036|NCT01393405|541536091|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
150108037|NCT01393405|541536092|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
150108038|NCT01393405|541536093|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
150108039|NCT01393405|541536091|FG000|Induction Period (week1-16)|Adverse Event|16|||
150108040|NCT01393405|541536092|FG001|Induction Period (week1-16)|Adverse Event|0|||
150108041|NCT01393405|541536093|FG002|Induction Period (week1-16)|Adverse Event|0|||
150108042|NCT01393405|541536091|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
150108043|NCT01393405|541536092|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
150108044|NCT01393405|541536093|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
150108045|NCT01393405|541536091|FG000|Maintenance Period Week|Lack of Efficacy|0|||
150108046|NCT01393405|541536092|FG001|Maintenance Period Week|Lack of Efficacy|22|||
150108047|NCT01393405|541536093|FG002|Maintenance Period Week|Lack of Efficacy|22|||
150108048|NCT01393405|541536091|FG000|Maintenance Period Week|Adverse Event|0|||
150108049|NCT01393405|541536092|FG001|Maintenance Period Week|Adverse Event|5|||
150108050|NCT01393405|541536093|FG002|Maintenance Period Week|Adverse Event|2|||
150108051|NCT01393405|541536091|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
150108052|NCT01393405|541536092|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
150108053|NCT01393405|541536093|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
150108054|NCT01393405|541536091|FG000|Maintenance Period Week|Lost to Follow-up|0|||
150108055|NCT01393405|541536092|FG001|Maintenance Period Week|Lost to Follow-up|1|||
150108056|NCT01393405|541536093|FG002|Maintenance Period Week|Lost to Follow-up|0|||
150108057|NCT02281552|541536100|FG000|Overall Study|Medication error|1|||
150108058|NCT02281552|541536101|FG001|Overall Study|Medication error|0|||
150108059|NCT02281552|541536100|FG000|Overall Study|Insufficient clinical response|0|||
150108060|NCT02281552|541536101|FG001|Overall Study|Insufficient clinical response|1|||
150108061|NCT02281552|541536100|FG000|Overall Study|Adverse Event|3|||
150108062|NCT02281552|541536101|FG001|Overall Study|Adverse Event|9|||
150108063|NCT01434290|541536102|FG000|Overall Study|Protocol Violation|6|||
150108064|NCT01434290|541536103|FG001|Overall Study|Protocol Violation|3|||
150108065|NCT01434290|541536102|FG000|Overall Study|No protocol treatment|2|||
150108066|NCT01434290|541536103|FG001|Overall Study|No protocol treatment|4|||
150108067|NCT01224639|541536104|FG000|Overall Study|Withdrawal by Subject|0|||
150108068|NCT01224639|541536105|FG001|Overall Study|Withdrawal by Subject|0|||
150108069|NCT01224639|541536106|FG002|Overall Study|Withdrawal by Subject|0|||
150108070|NCT01224639|541536107|FG003|Overall Study|Withdrawal by Subject|0|||
150108071|NCT01224639|541536108|FG004|Overall Study|Withdrawal by Subject|2|||
150108072|NCT01224639|541536109|FG005|Overall Study|Withdrawal by Subject|0|||
150108073|NCT01224639|541536110|FG006|Overall Study|Withdrawal by Subject|1|||
150108074|NCT01224639|541536111|FG007|Overall Study|Withdrawal by Subject|1|||
150108075|NCT01224639|541536104|FG000|Overall Study|Adverse Event|0|||
150108076|NCT01224639|541536105|FG001|Overall Study|Adverse Event|0|||
150108077|NCT01224639|541536106|FG002|Overall Study|Adverse Event|0|||
150108078|NCT01224639|541536107|FG003|Overall Study|Adverse Event|0|||
150108079|NCT01224639|541536108|FG004|Overall Study|Adverse Event|0|||
150108080|NCT01224639|541536109|FG005|Overall Study|Adverse Event|0|||
150108081|NCT01224639|541536110|FG006|Overall Study|Adverse Event|0|||
150108082|NCT01224639|541536111|FG007|Overall Study|Adverse Event|1|||
150108083|NCT04365699|541536112|FG000|Overall Study|Death|2|||
150108084|NCT04365699|541536113|FG001|Overall Study|Death|5|||
150108085|NCT04365699|541536114|FG002|Overall Study|Death|15|||
150108086|NCT03925727|541536116|FG000|Overall Study|Adverse Event|4|||
150108087|NCT03925727|541536117|FG001|Overall Study|Adverse Event|0|||
150108088|NCT03925727|541536118|FG002|Overall Study|Adverse Event|3|||
150108089|NCT03925727|541536116|FG000|Overall Study|Protocol Violation|1|||
150108090|NCT03925727|541536117|FG001|Overall Study|Protocol Violation|2|||
150108091|NCT03925727|541536118|FG002|Overall Study|Protocol Violation|2|||
150108092|NCT03925727|541536116|FG000|Overall Study|Withdrawal by Subject|3|||
150108093|NCT03925727|541536117|FG001|Overall Study|Withdrawal by Subject|2|||
150108094|NCT03925727|541536118|FG002|Overall Study|Withdrawal by Subject|4|||
150108095|NCT03925727|541536116|FG000|Overall Study|Administrative Reasons|3|||
150108096|NCT03925727|541536117|FG001|Overall Study|Administrative Reasons|1|||
150108097|NCT03925727|541536118|FG002|Overall Study|Administrative Reasons|2|||
150108098|NCT03925727|541536116|FG000|Overall Study|Randomized in error or Disqualified|8|||
150108099|NCT03925727|541536117|FG001|Overall Study|Randomized in error or Disqualified|1|||
150108100|NCT03925727|541536118|FG002|Overall Study|Randomized in error or Disqualified|7|||
150108101|NCT01574352|541536123|FG000|Overall Study|Withdrawal by Subject|6|||
150108102|NCT01574352|541536124|FG001|Overall Study|Withdrawal by Subject|13|||
150108103|NCT01574352|541536123|FG000|Overall Study|Injury in non-camp related sport|1|||
150108104|NCT01574352|541536124|FG001|Overall Study|Injury in non-camp related sport|0|||
150108105|NCT06425458|541536125|FG000|Overall Study|Removed by study team|2|||
150108106|NCT06425458|541536125|FG000|Overall Study|Lost to Follow-up|5|||
150108107|NCT03945981|541536128|FG000|Overall Study|Lost to Follow-up|12|||
150108108|NCT03945981|541536128|FG000|Overall Study|Physician Decision|4|||
150108109|NCT03945981|541536128|FG000|Overall Study|Withdrawal by Subject|6|||
150108110|NCT03945981|541536128|FG000|Overall Study|Protocol Violation|1|||
150108111|NCT04477304|541536132|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
150108112|NCT04477304|541536133|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
150108113|NCT01101841|541538322|FG000|Overall Study|Adverse Event|15|||
150108114|NCT01101841|541538323|FG001|Overall Study|Adverse Event|15|||
150108115|NCT01101841|541538322|FG000|Overall Study|Lost to Follow-up|9|||
150108116|NCT01101841|541538323|FG001|Overall Study|Lost to Follow-up|3|||
150108117|NCT01101841|541538322|FG000|Overall Study|Withdrawal by Subject|21|||
150108118|NCT01101841|541538323|FG001|Overall Study|Withdrawal by Subject|40|||
150108119|NCT01101841|541538322|FG000|Overall Study|Protocol Violation|1|||
150108120|NCT01101841|541538323|FG001|Overall Study|Protocol Violation|1|||
150108121|NCT01101841|541538322|FG000|Overall Study|Physician Decision|0|||
150108122|NCT01101841|541538323|FG001|Overall Study|Physician Decision|2|||
150108123|NCT01101841|541538322|FG000|Overall Study|Lack of Efficacy|0|||
150108124|NCT01101841|541538323|FG001|Overall Study|Lack of Efficacy|2|||
150108125|NCT01101841|541538322|FG000|Overall Study|Other|0|||
150108126|NCT01101841|541538323|FG001|Overall Study|Other|1|||
150108127|NCT01101841|541538322|FG000|Overall Study|Suicidality Tracking Scale|3|||
150108128|NCT01101841|541538323|FG001|Overall Study|Suicidality Tracking Scale|1|||
150108129|NCT01101841|541538322|FG000|Overall Study|Eligibility Criteria|1|||
150108130|NCT01101841|541538323|FG001|Overall Study|Eligibility Criteria|2|||
150108131|NCT03756558|541538326|FG000|Overall Study|Death|1|||
150108132|NCT03756558|541538326|FG000|Overall Study|Lost to Follow-up|2|||
150108133|NCT03756558|541538326|FG000|Overall Study|Withdrawal by Subject|2|||
150108134|NCT02896400|541538328|FG000|1 Month Follow-up|Lost to Follow-up|7|||
150108135|NCT02896400|541538329|FG001|1 Month Follow-up|Lost to Follow-up|7|||
150108136|NCT02896400|541538330|FG002|1 Month Follow-up|Lost to Follow-up|5|||
150108137|NCT02896400|541538331|FG003|1 Month Follow-up|Lost to Follow-up|8|||
150108138|NCT02896400|541538332|FG004|1 Month Follow-up|Lost to Follow-up|9|||
150108139|NCT02896400|541538333|FG005|1 Month Follow-up|Lost to Follow-up|6|||
150108140|NCT02896400|541538334|FG006|1 Month Follow-up|Lost to Follow-up|5|||
150108141|NCT02896400|541538335|FG007|1 Month Follow-up|Lost to Follow-up|6|||
150108142|NCT02896400|541538336|FG008|1 Month Follow-up|Lost to Follow-up|4|||
150108143|NCT02896400|541538337|FG009|1 Month Follow-up|Lost to Follow-up|7|||
150108144|NCT02896400|541538338|FG010|1 Month Follow-up|Lost to Follow-up|5|||
150108145|NCT02896400|541538339|FG011|1 Month Follow-up|Lost to Follow-up|5|||
150108146|NCT02896400|541538340|FG012|1 Month Follow-up|Lost to Follow-up|3|||
150108147|NCT02896400|541538341|FG013|1 Month Follow-up|Lost to Follow-up|4|||
150108148|NCT02896400|541538342|FG014|1 Month Follow-up|Lost to Follow-up|1|||
150108149|NCT02896400|541538343|FG015|1 Month Follow-up|Lost to Follow-up|2|||
150108150|NCT02896400|541538328|FG000|1 Month Follow-up|Death|0|||
150108151|NCT02896400|541538329|FG001|1 Month Follow-up|Death|0|||
150108152|NCT02896400|541538330|FG002|1 Month Follow-up|Death|0|||
150108153|NCT02896400|541538331|FG003|1 Month Follow-up|Death|0|||
150108154|NCT02896400|541538332|FG004|1 Month Follow-up|Death|0|||
150108155|NCT02896400|541538333|FG005|1 Month Follow-up|Death|0|||
150108156|NCT02896400|541538334|FG006|1 Month Follow-up|Death|0|||
150108157|NCT02896400|541538335|FG007|1 Month Follow-up|Death|0|||
150108158|NCT02896400|541538336|FG008|1 Month Follow-up|Death|0|||
150108159|NCT02896400|541538337|FG009|1 Month Follow-up|Death|0|||
150108160|NCT02896400|541538338|FG010|1 Month Follow-up|Death|0|||
150108161|NCT02896400|541538339|FG011|1 Month Follow-up|Death|0|||
150108162|NCT02896400|541538340|FG012|1 Month Follow-up|Death|0|||
150108163|NCT02896400|541538341|FG013|1 Month Follow-up|Death|0|||
150108164|NCT02896400|541538342|FG014|1 Month Follow-up|Death|0|||
150108165|NCT02896400|541538343|FG015|1 Month Follow-up|Death|1|||
150108166|NCT02896400|541538328|FG000|3 Month Follow-up|Lost to Follow-up|6|||
150108167|NCT02896400|541538329|FG001|3 Month Follow-up|Lost to Follow-up|3|||
150108168|NCT02896400|541538330|FG002|3 Month Follow-up|Lost to Follow-up|6|||
150108169|NCT02896400|541538331|FG003|3 Month Follow-up|Lost to Follow-up|11|||
150108170|NCT02896400|541538332|FG004|3 Month Follow-up|Lost to Follow-up|12|||
150108171|NCT02896400|541538333|FG005|3 Month Follow-up|Lost to Follow-up|6|||
150108172|NCT02896400|541538334|FG006|3 Month Follow-up|Lost to Follow-up|4|||
150108173|NCT02896400|541538335|FG007|3 Month Follow-up|Lost to Follow-up|3|||
150108174|NCT02896400|541538336|FG008|3 Month Follow-up|Lost to Follow-up|6|||
150108175|NCT02896400|541538337|FG009|3 Month Follow-up|Lost to Follow-up|5|||
150108176|NCT02896400|541538338|FG010|3 Month Follow-up|Lost to Follow-up|6|||
150108177|NCT02896400|541538339|FG011|3 Month Follow-up|Lost to Follow-up|6|||
150108178|NCT02896400|541538340|FG012|3 Month Follow-up|Lost to Follow-up|3|||
150108179|NCT02896400|541538341|FG013|3 Month Follow-up|Lost to Follow-up|5|||
150108180|NCT02896400|541538342|FG014|3 Month Follow-up|Lost to Follow-up|3|||
150108181|NCT02896400|541538343|FG015|3 Month Follow-up|Lost to Follow-up|2|||
150108182|NCT02896400|541538328|FG000|3 Month Follow-up|Death|0|||
150108183|NCT02896400|541538329|FG001|3 Month Follow-up|Death|0|||
150108184|NCT02896400|541538330|FG002|3 Month Follow-up|Death|0|||
150108185|NCT02896400|541538331|FG003|3 Month Follow-up|Death|0|||
150108186|NCT02896400|541538332|FG004|3 Month Follow-up|Death|0|||
150108187|NCT02896400|541538333|FG005|3 Month Follow-up|Death|0|||
150108188|NCT02896400|541538334|FG006|3 Month Follow-up|Death|0|||
150108189|NCT02896400|541538335|FG007|3 Month Follow-up|Death|0|||
150108190|NCT02896400|541538336|FG008|3 Month Follow-up|Death|0|||
150108191|NCT02896400|541538337|FG009|3 Month Follow-up|Death|0|||
150108192|NCT02896400|541538338|FG010|3 Month Follow-up|Death|0|||
150108193|NCT02896400|541538339|FG011|3 Month Follow-up|Death|0|||
150108194|NCT02896400|541538340|FG012|3 Month Follow-up|Death|0|||
150108195|NCT02896400|541538341|FG013|3 Month Follow-up|Death|1|||
150108196|NCT02896400|541538342|FG014|3 Month Follow-up|Death|1|||
150108197|NCT02896400|541538343|FG015|3 Month Follow-up|Death|0|||
150108198|NCT02896400|541538328|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108199|NCT02896400|541538329|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
150108200|NCT02896400|541538330|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108201|NCT02896400|541538331|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108202|NCT02896400|541538332|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
150108203|NCT02896400|541538333|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108204|NCT02896400|541538334|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
150108205|NCT02896400|541538335|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
150108206|NCT02896400|541538336|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108207|NCT02896400|541538337|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108208|NCT02896400|541538338|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
150108209|NCT02896400|541538339|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
150108210|NCT02896400|541538340|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108211|NCT02896400|541538341|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
150108212|NCT02896400|541538342|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
150108213|NCT02896400|541538343|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
150108214|NCT02896400|541538328|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
150108215|NCT02896400|541538329|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
150108216|NCT02896400|541538330|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
150108217|NCT02896400|541538331|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
150108218|NCT02896400|541538332|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
150108219|NCT02896400|541538333|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
150108220|NCT02896400|541538334|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
150108221|NCT02896400|541538335|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
150108222|NCT02896400|541538336|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
150108223|NCT02896400|541538337|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
150108224|NCT02896400|541538338|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
150108225|NCT02896400|541538339|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
150108226|NCT02896400|541538340|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
150108227|NCT02896400|541538341|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
150108228|NCT02896400|541538342|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
150108229|NCT02896400|541538343|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
150108230|NCT02984020|541538344|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
150108231|NCT02984020|541538344|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
150108232|NCT02984020|541538344|FG000|Overall Study|Other significant protocol violation|2|||
150108233|NCT01700179|541538345|FG000|Overall Study|Physician Decision|2|||
150108234|NCT01896895|541538346|FG000|Double-blind MP|Physician Decision|0|||
150108235|NCT01896895|541538347|FG001|Double-blind MP|Physician Decision|0|||
150108236|NCT01896895|541538348|FG002|Double-blind MP|Physician Decision|1|||
150108237|NCT01896895|541538349|FG003|Double-blind MP|Physician Decision|0|||
150108238|NCT01896895|541538346|FG000|Double-blind MP|Withdrawal by Subject|0|||
150108239|NCT01896895|541538347|FG001|Double-blind MP|Withdrawal by Subject|2|||
150108240|NCT01896895|541538348|FG002|Double-blind MP|Withdrawal by Subject|1|||
150108241|NCT01896895|541538349|FG003|Double-blind MP|Withdrawal by Subject|0|||
150108242|NCT01896895|541538346|FG000|Double-blind MP|Lost to Follow-up|1|||
150108243|NCT01896895|541538347|FG001|Double-blind MP|Lost to Follow-up|0|||
150108244|NCT01896895|541538348|FG002|Double-blind MP|Lost to Follow-up|1|||
150108245|NCT01896895|541538349|FG003|Double-blind MP|Lost to Follow-up|0|||
150108246|NCT00646204|541538352|FG000|Overall Study|Adverse Event|3|||
150108247|NCT00646204|541538353|FG001|Overall Study|Adverse Event|0|||
150108248|NCT00646204|541538352|FG000|Overall Study|Withdrawal by Subject|1|||
150108249|NCT00646204|541538353|FG001|Overall Study|Withdrawal by Subject|0|||
150108250|NCT00773175|541538357|FG000|Overall Study|Adverse Event|2|||
150108251|NCT00773175|541538358|FG001|Overall Study|Adverse Event|0|||
150108252|NCT00773175|541538357|FG000|Overall Study|Consent Withdrawn|0|||
150108253|NCT00773175|541538358|FG001|Overall Study|Consent Withdrawn|2|||
150108254|NCT05723770|541538359|FG000|Overall Study|Lost to Follow-up|4|||
150108255|NCT05723770|541538359|FG000|Overall Study|Withdrawal by Subject|2|||
150108256|NCT00640510|541538360|FG000|Overall Study|Lack of Efficacy|0|||
150108257|NCT00640510|541538361|FG001|Overall Study|Lack of Efficacy|1|||
150108258|NCT00640510|541538360|FG000|Overall Study|Protocol Violation|1|||
150108259|NCT00640510|541538361|FG001|Overall Study|Protocol Violation|0|||
150108260|NCT00640510|541538360|FG000|Overall Study|Physician Decision|0|||
150108261|NCT00640510|541538361|FG001|Overall Study|Physician Decision|1|||
150108262|NCT01440322|541538362|FG000|Overall Study|Discomfort|2|||
150108263|NCT01440322|541538363|FG001|Overall Study|Discomfort|0|||
150108264|NCT01440322|541538362|FG000|Overall Study|Biomicroscopy|1|||
150108265|NCT01440322|541538363|FG001|Overall Study|Biomicroscopy|0|||
150108266|NCT01440322|541538362|FG000|Overall Study|Symptoms and Problems|1|||
150108267|NCT01440322|541538363|FG001|Overall Study|Symptoms and Problems|0|||
150108268|NCT01440322|541538362|FG000|Overall Study|Unacceptable Subjective Vision|1|||
150108269|NCT01440322|541538363|FG001|Overall Study|Unacceptable Subjective Vision|0|||
150108270|NCT01440322|541538362|FG000|Overall Study|Other Product Related|1|||
150108271|NCT01440322|541538363|FG001|Overall Study|Other Product Related|0|||
150108272|NCT01440322|541538362|FG000|Overall Study|Unrelated Medical Problem|0|||
150108273|NCT01440322|541538363|FG001|Overall Study|Unrelated Medical Problem|1|||
150108274|NCT01440322|541538362|FG000|Overall Study|Other Non-Product Related|1|||
150108275|NCT01440322|541538363|FG001|Overall Study|Other Non-Product Related|0|||
150108276|NCT01454934|541538364|FG000|Overall Study|Clinical progression|28|||
150108277|NCT01454934|541538365|FG001|Overall Study|Clinical progression|25|||
150108278|NCT01454934|541538364|FG000|Overall Study|Other|6|||
150108279|NCT01454934|541538365|FG001|Overall Study|Other|17|||
150108280|NCT01454934|541538364|FG000|Overall Study|Adverse Event|28|||
150108281|NCT01454934|541538365|FG001|Overall Study|Adverse Event|24|||
150108282|NCT01454934|541538364|FG000|Overall Study|Withdrawn consent|2|||
150108283|NCT01454934|541538365|FG001|Overall Study|Withdrawn consent|5|||
150108284|NCT01454934|541538364|FG000|Overall Study|Withdrawal by Subject|11|||
150108285|NCT01454934|541538365|FG001|Overall Study|Withdrawal by Subject|15|||
150108286|NCT01454934|541538364|FG000|Overall Study|Disease progression|194|||
150108287|NCT01454934|541538365|FG001|Overall Study|Disease progression|181|||
150108288|NCT01454934|541538364|FG000|Overall Study|Lost to Follow-up|0|||
150108289|NCT01454934|541538365|FG001|Overall Study|Lost to Follow-up|1|||
150108290|NCT01454934|541538364|FG000|Overall Study|Not treated|1|||
150108291|NCT01454934|541538365|FG001|Overall Study|Not treated|2|||
150108292|NCT02412631|541538370|FG000|Overall Study|Adverse Event|1|||
150108293|NCT02412631|541538371|FG001|Overall Study|Adverse Event|2|||
150108294|NCT02412631|541538370|FG000|Overall Study|Lost to Follow-up|5|||
150108295|NCT02412631|541538371|FG001|Overall Study|Lost to Follow-up|9|||
150108296|NCT02412631|541538370|FG000|Overall Study|Withdrawal by Subject|9|||
150108297|NCT02412631|541538371|FG001|Overall Study|Withdrawal by Subject|3|||
150108298|NCT02412631|541538370|FG000|Overall Study|Early stop by FDA|5|||
150108299|NCT02412631|541538371|FG001|Overall Study|Early stop by FDA|2|||
150108300|NCT02412631|541538370|FG000|Overall Study|Unspecified reason|6|||
150108301|NCT02412631|541538371|FG001|Overall Study|Unspecified reason|8|||
150108302|NCT00770120|541538372|FG000|Overall Study|Progression|31|||
150108303|NCT00770120|541538372|FG000|Overall Study|Adverse Event|11|||
150108304|NCT00770120|541538372|FG000|Overall Study|Not Protocol Specified|11|||
150108305|NCT00770120|541538372|FG000|Overall Study|Death|3|||
150108306|NCT00770120|541538372|FG000|Overall Study|Withdrawal by Subject|2|||
150108307|NCT00770120|541538372|FG000|Overall Study|Ineligible|1|||
150108308|NCT00770120|541538372|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
150108309|NCT00770120|541538372|FG000|Overall Study|Reason under Review|1|||
150108310|NCT01782313|541538380|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
150108311|NCT01782313|541538380|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
150108312|NCT01782313|541538380|FG000|Treated Cycle 3|Progressive Disease|21|||
150108313|NCT01782313|541538380|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
150108314|NCT01782313|541538380|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
150108315|NCT01782313|541538380|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
150187714|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187715|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
150187716|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
150187717|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
150187718|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
150187719|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187720|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187721|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187722|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187723|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187724|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187725|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187726|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187727|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187728|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
150187729|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
150187730|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
150187731|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
150187732|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187733|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187734|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187735|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187736|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187737|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187738|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187739|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187740|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187741|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
150187742|NCT01261312|541827020|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
150187743|NCT01261312|541827021|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187744|NCT01261312|541827022|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
150187745|NCT01261312|541827023|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187746|NCT01261312|541827024|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187747|NCT01261312|541827025|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187748|NCT01261312|541827026|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187749|NCT01261312|541827027|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187750|NCT01261312|541827028|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187751|NCT01261312|541827029|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187752|NCT01261312|541827030|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187753|NCT01261312|541827031|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187754|NCT01261312|541827032|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
150187755|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187756|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187757|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187758|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
150187759|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
150187760|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
150187761|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187762|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187763|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187764|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187765|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187766|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187767|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
150187768|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187769|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187770|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187771|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187772|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
150187773|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
150187774|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187775|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187776|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187777|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187778|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187779|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187780|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
150187781|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187782|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187783|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187784|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187785|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
150187786|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
150187787|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187788|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187789|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187790|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187791|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187792|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187793|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
150187794|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187795|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187796|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187797|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
150187798|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
150187799|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
150187800|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187801|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187802|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187803|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187804|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187805|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187806|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
150187807|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187808|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187809|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187810|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187811|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187812|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
150187813|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187814|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187815|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187816|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187817|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187818|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187819|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
150187820|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187821|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187822|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187823|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
150187824|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
150187825|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
150187826|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187827|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187828|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187829|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187830|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187831|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187832|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
150187833|NCT01261312|541827020|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187834|NCT01261312|541827021|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187835|NCT01261312|541827022|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187836|NCT01261312|541827023|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
150187837|NCT01261312|541827024|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
150187838|NCT01261312|541827025|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
150187839|NCT01261312|541827026|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187840|NCT01261312|541827027|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187841|NCT01261312|541827028|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187842|NCT01261312|541827029|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187843|NCT01261312|541827030|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187844|NCT01261312|541827031|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150108316|NCT01782313|541538380|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
150108317|NCT01782313|541538380|FG000|Survival Follow up|Lost to Follow-up|1|||
150108318|NCT00958776|541538381|FG000|Overall Study|Adverse Event|0|||
150108319|NCT00958776|541538382|FG001|Overall Study|Adverse Event|1|||
150108320|NCT00958776|541538381|FG000|Overall Study|Physician Decision|1|||
150108321|NCT00958776|541538382|FG001|Overall Study|Physician Decision|0|||
150108322|NCT00958776|541538381|FG000|Overall Study|Lost to Follow-up|2|||
150108323|NCT00958776|541538382|FG001|Overall Study|Lost to Follow-up|6|||
150108324|NCT00958776|541538381|FG000|Overall Study|Withdrawal by Subject|7|||
150108325|NCT00958776|541538382|FG001|Overall Study|Withdrawal by Subject|16|||
150108326|NCT00958776|541538381|FG000|Overall Study|Protocol Violation|1|||
150108327|NCT00958776|541538382|FG001|Overall Study|Protocol Violation|1|||
150108328|NCT00958776|541538381|FG000|Overall Study|Death|2|||
150108329|NCT00958776|541538382|FG001|Overall Study|Death|1|||
150108330|NCT00958776|541538381|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
150108331|NCT00958776|541538382|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
150108332|NCT00958776|541538381|FG000|Overall Study|Missing|1|||
150108333|NCT00958776|541538382|FG001|Overall Study|Missing|1|||
150108334|NCT00480636|541538383|FG000|Overall Study|Death|12|||
150108335|NCT00480636|541538383|FG000|Overall Study|Lost to Follow-up|4|||
150108336|NCT00480636|541538383|FG000|Overall Study|Other|2|||
150108337|NCT00480636|541538383|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
150108338|NCT02583256|541538384|FG000|Overall Study|Withdrawal by Subject|0|||
150108339|NCT02583256|541538385|FG001|Overall Study|Withdrawal by Subject|1|||
150108340|NCT02583256|541538386|FG002|Overall Study|Withdrawal by Subject|1|||
150108341|NCT02583256|541538387|FG003|Overall Study|Withdrawal by Subject|0|||
150108342|NCT02583256|541538384|FG000|Overall Study|Lost to Follow-up|1|||
150108343|NCT02583256|541538385|FG001|Overall Study|Lost to Follow-up|1|||
150108344|NCT02583256|541538386|FG002|Overall Study|Lost to Follow-up|0|||
150108345|NCT02583256|541538387|FG003|Overall Study|Lost to Follow-up|1|||
150108346|NCT02583256|541538384|FG000|Overall Study|Administrative/Other|2|||
150108347|NCT02583256|541538385|FG001|Overall Study|Administrative/Other|0|||
150108348|NCT02583256|541538386|FG002|Overall Study|Administrative/Other|1|||
150108349|NCT02583256|541538387|FG003|Overall Study|Administrative/Other|2|||
150108350|NCT02506816|541538394|FG000|Overall Study|Adverse Event|3|||
150108351|NCT02177266|541538395|FG000|Overall Study|Adverse Event|0|||
150108352|NCT02177266|541538396|FG001|Overall Study|Adverse Event|1|||
150108353|NCT02177266|541538395|FG000|Overall Study|Withdrawal by Subject|1|||
150108354|NCT02177266|541538396|FG001|Overall Study|Withdrawal by Subject|0|||
150108355|NCT03019627|541538398|FG000|Overall Study|Adverse Event|8|||
150108356|NCT03019627|541538399|FG001|Overall Study|Adverse Event|0|||
150108357|NCT03019627|541538398|FG000|Overall Study|Unrelated to adverse event|1|||
150108358|NCT03019627|541538399|FG001|Overall Study|Unrelated to adverse event|3|||
150108359|NCT03019627|541538398|FG000|Overall Study|Lost to Follow-up|2|||
150108360|NCT03019627|541538399|FG001|Overall Study|Lost to Follow-up|1|||
150108361|NCT03019627|541538398|FG000|Overall Study|not compliance|2|||
150108362|NCT03019627|541538399|FG001|Overall Study|not compliance|2|||
150108363|NCT03019627|541538398|FG000|Overall Study|Other|2|||
150108364|NCT03019627|541538399|FG001|Overall Study|Other|2|||
150108365|NCT03364049|541538400|FG000|Overall Study|Death|6|||
150108366|NCT03364049|541538401|FG001|Overall Study|Death|4|||
150108367|NCT03364049|541538402|FG002|Overall Study|Death|5|||
150108368|NCT03364049|541538403|FG003|Overall Study|Death|14|||
150108369|NCT03364049|541538400|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
150108370|NCT03364049|541538401|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
150108371|NCT03364049|541538402|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
150108372|NCT03364049|541538403|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
150108373|NCT03364049|541538400|FG000|Overall Study|Withdrawal by Subject|0|||
150108374|NCT03364049|541538401|FG001|Overall Study|Withdrawal by Subject|1|||
150108375|NCT03364049|541538402|FG002|Overall Study|Withdrawal by Subject|1|||
150108376|NCT03364049|541538403|FG003|Overall Study|Withdrawal by Subject|1|||
150108377|NCT00546715|541538404|FG000|Overall Study|Withdrawal by Subject|0|||
150108378|NCT00546715|541538405|FG001|Overall Study|Withdrawal by Subject|1|||
150108379|NCT00546715|541538406|FG002|Overall Study|Withdrawal by Subject|0|||
150108380|NCT00546715|541538407|FG003|Overall Study|Withdrawal by Subject|0|||
150108381|NCT00418691|541538408|FG000|Overall Study|Lost to Follow-up|1|||
150108382|NCT00418691|541538409|FG001|Overall Study|Lost to Follow-up|2|||
150108383|NCT00418691|541538410|FG002|Overall Study|Lost to Follow-up|3|||
150108384|NCT00418691|541538408|FG000|Overall Study|Started new medication voiding entry|0|||
150108385|NCT00418691|541538409|FG001|Overall Study|Started new medication voiding entry|0|||
150108386|NCT00418691|541538410|FG002|Overall Study|Started new medication voiding entry|1|||
150108387|NCT00418691|541538408|FG000|Overall Study|Progressive Disease|1|||
150108388|NCT00418691|541538409|FG001|Overall Study|Progressive Disease|0|||
150108389|NCT00418691|541538410|FG002|Overall Study|Progressive Disease|1|||
150108390|NCT01802775|541538413|FG000|Overall Study|Death|0|||
150108391|NCT01802775|541538414|FG001|Overall Study|Death|3|||
150108392|NCT01802775|541538413|FG000|Overall Study|Reason not provided|0|||
150108393|NCT01802775|541538414|FG001|Overall Study|Reason not provided|1|||
150108394|NCT01802775|541538413|FG000|Overall Study|Physician Decision|1|||
150108395|NCT01802775|541538414|FG001|Overall Study|Physician Decision|0|||
150108396|NCT01802775|541538413|FG000|Overall Study|Adverse Event|1|||
150108397|NCT01802775|541538414|FG001|Overall Study|Adverse Event|1|||
150108398|NCT01802775|541538413|FG000|Overall Study|Withdrawal by Subject|3|||
150108399|NCT01802775|541538414|FG001|Overall Study|Withdrawal by Subject|5|||
150108400|NCT01802775|541538413|FG000|Overall Study|Lost to Follow-up|1|||
150187845|NCT01261312|541827032|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
150187846|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187847|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187848|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187849|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187850|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187851|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187852|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
150187853|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
150187854|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
150187855|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187856|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187857|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187858|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
150187859|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187860|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187861|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187862|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187863|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187864|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187865|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187866|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
150187867|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
150187868|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187869|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187870|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187871|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
150187872|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187873|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187874|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187875|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187876|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187877|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187878|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
150187879|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
150187880|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
150187881|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187882|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187883|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187884|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
150187885|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
150187886|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
150187887|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
150187888|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
150187889|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
150187890|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
150187891|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
150108401|NCT01802775|541538414|FG001|Overall Study|Lost to Follow-up|2|||
150108402|NCT01340976|541538415|FG000|Overall Study|Physician Decision|2|||
150108403|NCT01340976|541538416|FG001|Overall Study|Physician Decision|0|||
150108404|NCT01340976|541538417|FG002|Overall Study|Physician Decision|1|||
150108405|NCT01340976|541538418|FG003|Overall Study|Physician Decision|1|||
150108406|NCT01340976|541538419|FG004|Overall Study|Physician Decision|1|||
150108407|NCT01340976|541538420|FG005|Overall Study|Physician Decision|0|||
150187892|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
150108408|NCT01340976|541538415|FG000|Overall Study|Death|0|||
150187893|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
150187894|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
150187895|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
150187896|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
150187897|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
150187898|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187899|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187900|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187901|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187902|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187903|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187904|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
150187905|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
150187906|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
150187907|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187908|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187909|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187910|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
150187911|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187912|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187913|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187914|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187915|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187916|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187917|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
150187918|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
150187919|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
150187920|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187921|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187922|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187923|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
150187924|NCT01261312|541827020|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187925|NCT01261312|541827021|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187926|NCT01261312|541827022|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187927|NCT01261312|541827023|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187928|NCT01261312|541827024|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187929|NCT01261312|541827025|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187930|NCT01261312|541827026|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
150187931|NCT01261312|541827027|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
150187932|NCT01261312|541827028|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
150187933|NCT01261312|541827029|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187934|NCT01261312|541827030|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187935|NCT01261312|541827031|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187936|NCT01261312|541827032|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
150187937|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187938|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187939|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150108409|NCT01340976|541538416|FG001|Overall Study|Death|1|||
150108410|NCT01340976|541538417|FG002|Overall Study|Death|0|||
150108411|NCT01340976|541538418|FG003|Overall Study|Death|0|||
150108412|NCT01340976|541538419|FG004|Overall Study|Death|0|||
150108413|NCT01340976|541538420|FG005|Overall Study|Death|0|||
150108414|NCT01340976|541538415|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
150108415|NCT01340976|541538416|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
150108416|NCT01340976|541538417|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
150108417|NCT01340976|541538418|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
150108418|NCT01340976|541538419|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
150108419|NCT01340976|541538420|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
150108420|NCT01340976|541538415|FG000|Overall Study|Withdrawal by Subject|0|||
150108421|NCT01340976|541538416|FG001|Overall Study|Withdrawal by Subject|0|||
150108422|NCT01340976|541538417|FG002|Overall Study|Withdrawal by Subject|0|||
150108423|NCT01340976|541538418|FG003|Overall Study|Withdrawal by Subject|1|||
150108424|NCT01340976|541538419|FG004|Overall Study|Withdrawal by Subject|1|||
150108425|NCT01340976|541538420|FG005|Overall Study|Withdrawal by Subject|0|||
150108426|NCT01340976|541538415|FG000|Overall Study|Other anemia treatment|1|||
150108427|NCT01340976|541538416|FG001|Overall Study|Other anemia treatment|0|||
150108428|NCT01340976|541538417|FG002|Overall Study|Other anemia treatment|2|||
150108429|NCT01340976|541538418|FG003|Overall Study|Other anemia treatment|1|||
150108430|NCT01340976|541538419|FG004|Overall Study|Other anemia treatment|0|||
150108431|NCT01340976|541538420|FG005|Overall Study|Other anemia treatment|1|||
150108432|NCT01340976|541538415|FG000|Overall Study|Adverse Event|0|||
150108433|NCT01340976|541538416|FG001|Overall Study|Adverse Event|1|||
150108434|NCT01340976|541538417|FG002|Overall Study|Adverse Event|0|||
150108435|NCT01340976|541538418|FG003|Overall Study|Adverse Event|0|||
150108436|NCT01340976|541538419|FG004|Overall Study|Adverse Event|0|||
150108437|NCT01340976|541538420|FG005|Overall Study|Adverse Event|0|||
150108438|NCT02953821|541538421|FG000|Overall Study|Adverse Event|0|||
150108439|NCT02953821|541538422|FG001|Overall Study|Adverse Event|4|||
150108440|NCT02953821|541538421|FG000|Overall Study|Death|1|||
150108441|NCT02953821|541538422|FG001|Overall Study|Death|0|||
150108442|NCT02953821|541538421|FG000|Overall Study|Progressive Disease|5|||
150108443|NCT02953821|541538422|FG001|Overall Study|Progressive Disease|1|||
150108444|NCT02953821|541538421|FG000|Overall Study|Lost to Follow-up|2|||
150108445|NCT02953821|541538422|FG001|Overall Study|Lost to Follow-up|0|||
150108446|NCT02953821|541538421|FG000|Overall Study|Physician Decision|1|||
150108447|NCT02953821|541538422|FG001|Overall Study|Physician Decision|1|||
150108448|NCT02953821|541538421|FG000|Overall Study|Withdrawal by Subject|3|||
150108449|NCT02953821|541538422|FG001|Overall Study|Withdrawal by Subject|3|||
150108450|NCT02953821|541538421|FG000|Overall Study|Change of address|0|||
150108451|NCT02953821|541538422|FG001|Overall Study|Change of address|1|||
150108452|NCT02953821|541538421|FG000|Overall Study|Lack of Efficacy|1|||
150108453|NCT02953821|541538422|FG001|Overall Study|Lack of Efficacy|0|||
150108454|NCT02953821|541538421|FG000|Overall Study|Out of state for indeterminate time|0|||
150108455|NCT02953821|541538422|FG001|Overall Study|Out of state for indeterminate time|1|||
150108456|NCT02953821|541538421|FG000|Overall Study|No improvement|0|||
150108457|NCT02953821|541538422|FG001|Overall Study|No improvement|1|||
150108458|NCT02953821|541538421|FG000|Overall Study|Refused follow-up visit|2|||
150108459|NCT02953821|541538422|FG001|Overall Study|Refused follow-up visit|1|||
150108460|NCT02103478|541538423|FG000|Overall Study|Adverse Event|0|||
150108461|NCT02103478|541538424|FG001|Overall Study|Adverse Event|0|||
150108462|NCT02103478|541538425|FG002|Overall Study|Adverse Event|1|||
150108463|NCT02103478|541538426|FG003|Overall Study|Adverse Event|1|||
150108464|NCT02103478|541538427|FG004|Overall Study|Adverse Event|2|||
150108465|NCT02103478|541538428|FG005|Overall Study|Adverse Event|1|||
150108466|NCT02103478|541538429|FG006|Overall Study|Adverse Event|0|||
150108467|NCT02103478|541538430|FG007|Overall Study|Adverse Event|0|||
150108468|NCT02103478|541538431|FG008|Overall Study|Adverse Event|0|||
150108469|NCT02103478|541538423|FG000|Overall Study|Death|2|||
150108470|NCT02103478|541538424|FG001|Overall Study|Death|2|||
150108471|NCT02103478|541538425|FG002|Overall Study|Death|1|||
150108472|NCT02103478|541538426|FG003|Overall Study|Death|1|||
150187940|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150108473|NCT02103478|541538427|FG004|Overall Study|Death|5|||
150108474|NCT02103478|541538428|FG005|Overall Study|Death|15|||
150108475|NCT02103478|541538429|FG006|Overall Study|Death|14|||
150108476|NCT02103478|541538430|FG007|Overall Study|Death|10|||
150108477|NCT02103478|541538431|FG008|Overall Study|Death|11|||
150108478|NCT02103478|541538423|FG000|Overall Study|Progressive Disease|2|||
150108479|NCT02103478|541538424|FG001|Overall Study|Progressive Disease|1|||
150108480|NCT02103478|541538425|FG002|Overall Study|Progressive Disease|2|||
150108481|NCT02103478|541538426|FG003|Overall Study|Progressive Disease|0|||
150108482|NCT02103478|541538427|FG004|Overall Study|Progressive Disease|9|||
150108483|NCT02103478|541538428|FG005|Overall Study|Progressive Disease|1|||
150108484|NCT02103478|541538429|FG006|Overall Study|Progressive Disease|2|||
150108485|NCT02103478|541538430|FG007|Overall Study|Progressive Disease|0|||
150108486|NCT02103478|541538431|FG008|Overall Study|Progressive Disease|1|||
150108487|NCT02103478|541538423|FG000|Overall Study|Withdrawal by Subject|2|||
150108488|NCT02103478|541538424|FG001|Overall Study|Withdrawal by Subject|0|||
150108489|NCT02103478|541538425|FG002|Overall Study|Withdrawal by Subject|0|||
150108490|NCT02103478|541538426|FG003|Overall Study|Withdrawal by Subject|4|||
150108491|NCT02103478|541538427|FG004|Overall Study|Withdrawal by Subject|0|||
150108492|NCT02103478|541538428|FG005|Overall Study|Withdrawal by Subject|0|||
150108493|NCT02103478|541538429|FG006|Overall Study|Withdrawal by Subject|1|||
150108494|NCT02103478|541538430|FG007|Overall Study|Withdrawal by Subject|1|||
150108495|NCT02103478|541538431|FG008|Overall Study|Withdrawal by Subject|0|||
150108496|NCT02103478|541538423|FG000|Overall Study|Lost to Follow-up|0|||
150108497|NCT02103478|541538424|FG001|Overall Study|Lost to Follow-up|0|||
150108498|NCT02103478|541538425|FG002|Overall Study|Lost to Follow-up|0|||
150108499|NCT02103478|541538426|FG003|Overall Study|Lost to Follow-up|0|||
150108500|NCT02103478|541538427|FG004|Overall Study|Lost to Follow-up|0|||
150108501|NCT02103478|541538428|FG005|Overall Study|Lost to Follow-up|0|||
150108502|NCT02103478|541538429|FG006|Overall Study|Lost to Follow-up|0|||
150108503|NCT02103478|541538430|FG007|Overall Study|Lost to Follow-up|1|||
150108504|NCT02103478|541538431|FG008|Overall Study|Lost to Follow-up|0|||
150108505|NCT02103478|541538423|FG000|Overall Study|Other|1|||
150108506|NCT02103478|541538424|FG001|Overall Study|Other|3|||
150108507|NCT02103478|541538425|FG002|Overall Study|Other|2|||
150108508|NCT02103478|541538426|FG003|Overall Study|Other|0|||
150108509|NCT02103478|541538427|FG004|Overall Study|Other|3|||
150108510|NCT02103478|541538428|FG005|Overall Study|Other|8|||
150108511|NCT02103478|541538429|FG006|Overall Study|Other|8|||
150108512|NCT02103478|541538430|FG007|Overall Study|Other|4|||
150108513|NCT02103478|541538431|FG008|Overall Study|Other|2|||
150108514|NCT00723606|541538432|FG000|Overall Study|Adverse Event|2|||
150108515|NCT00723606|541538433|FG001|Overall Study|Adverse Event|5|||
150108516|NCT00723606|541538432|FG000|Overall Study|Other|2|||
150108517|NCT00723606|541538433|FG001|Overall Study|Other|0|||
150108518|NCT00723606|541538432|FG000|Overall Study|Withdrawal by Subject|0|||
150108519|NCT00723606|541538433|FG001|Overall Study|Withdrawal by Subject|2|||
150108520|NCT01096784|541538434|FG000|Overall Study|Withdrawal by Subject|2|||
150108521|NCT01096784|541538435|FG001|Overall Study|Withdrawal by Subject|1|||
150108522|NCT01096784|541538434|FG000|Overall Study|Adverse Event|11|||
150108523|NCT01096784|541538435|FG001|Overall Study|Adverse Event|9|||
150108524|NCT01096784|541538434|FG000|Overall Study|Protocol Deviation|2|||
150108525|NCT01096784|541538435|FG001|Overall Study|Protocol Deviation|2|||
150108526|NCT01096784|541538434|FG000|Overall Study|Administrative Decision|0|||
150108527|NCT01096784|541538435|FG001|Overall Study|Administrative Decision|1|||
150108528|NCT01096784|541538434|FG000|Overall Study|Other Unspecified|0|||
150108529|NCT01096784|541538435|FG001|Overall Study|Other Unspecified|1|||
150108530|NCT03761628|541538436|FG000|Overall Study|Withdrawal by Subject|3|||
150108531|NCT03761628|541538436|FG000|Overall Study|Physician Decision|1|||
150108532|NCT03761628|541538436|FG000|Overall Study|Pregnancy|1|||
150108533|NCT03761628|541538436|FG000|Overall Study|Lost to Follow-up|1|||
150108534|NCT00116558|541538437|FG000|Overall Study|Death|11|||
150108535|NCT00116558|541538438|FG001|Overall Study|Death|5|||
150108536|NCT00116558|541538439|FG002|Overall Study|Death|3|||
150108537|NCT00116558|541538437|FG000|Overall Study|Withdrawal by Subject|17|||
150108538|NCT00116558|541538438|FG001|Overall Study|Withdrawal by Subject|3|||
150108539|NCT00116558|541538439|FG002|Overall Study|Withdrawal by Subject|12|||
150108540|NCT00116558|541538437|FG000|Overall Study|disease progression|3|||
150108541|NCT00116558|541538438|FG001|Overall Study|disease progression|7|||
150108542|NCT00116558|541538439|FG002|Overall Study|disease progression|18|||
150108543|NCT00357370|541538440|FG000|Cohort 2|Lack of Efficacy|0|||
150108544|NCT00357370|541538441|FG001|Cohort 2|Lack of Efficacy|2|||
150108545|NCT00357370|541538442|FG002|Cohort 2|Lack of Efficacy|1|||
150108546|NCT00357370|541538440|FG000|Cohort 2|Adverse Event|1|||
150108547|NCT00357370|541538441|FG001|Cohort 2|Adverse Event|1|||
150108548|NCT00357370|541538442|FG002|Cohort 2|Adverse Event|1|||
150108549|NCT00357370|541538440|FG000|Cohort 2|Lost to Follow-up|0|||
150108550|NCT00357370|541538441|FG001|Cohort 2|Lost to Follow-up|1|||
149737499|NCT02601950|540170377|FG000|Overall Study|Participant refused further study treatment|0|||
150108551|NCT00357370|541538442|FG002|Cohort 2|Lost to Follow-up|0|||
150108552|NCT00357370|541538440|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
150108553|NCT00357370|541538441|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
150108554|NCT00357370|541538442|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
150108555|NCT00357370|541538440|FG000|Cohort 2|Withdrawal by Subject|0|||
150108556|NCT00357370|541538441|FG001|Cohort 2|Withdrawal by Subject|2|||
150108557|NCT00357370|541538442|FG002|Cohort 2|Withdrawal by Subject|0|||
150108558|NCT03491150|541538443|FG000|Overall Study|Adverse Event|1|||
150108559|NCT03491150|541538444|FG001|Overall Study|Adverse Event|0|||
150108560|NCT03491150|541538443|FG000|Overall Study|Study Terminated by Sponsor|74|||
150108561|NCT03491150|541538444|FG001|Overall Study|Study Terminated by Sponsor|70|||
150108562|NCT03491150|541538443|FG000|Overall Study|Other|0|||
150108563|NCT03491150|541538444|FG001|Overall Study|Other|1|||
150108564|NCT03491150|541538443|FG000|Overall Study|Withdrawal by Subject|1|||
150108565|NCT03491150|541538444|FG001|Overall Study|Withdrawal by Subject|2|||
150108566|NCT01143090|541538445|FG000|Overall Study|Lack of Efficacy|2|||
150108567|NCT01143090|541538445|FG000|Overall Study|Adverse Event|17|||
150108568|NCT01143090|541538445|FG000|Overall Study|Lost to Follow-up|9|||
150108569|NCT01143090|541538445|FG000|Overall Study|Protocol Violation|2|||
150108570|NCT01143090|541538445|FG000|Overall Study|Withdrawal by Subject|18|||
150108571|NCT01143090|541538445|FG000|Overall Study|Non-compliance with study drug|1|||
150108572|NCT01143090|541538445|FG000|Overall Study|Failure to meet eligibility criteria|1|||
150108573|NCT01143090|541538445|FG000|Overall Study|Administrative|1|||
150108574|NCT02644967|541538453|FG000|Overall Study|Death|26|||
150108575|NCT02644967|541538453|FG000|Overall Study|Physician Decision|1|||
150108576|NCT02644967|541538453|FG000|Overall Study|Withdrawal by Subject|2|||
150108577|NCT02644967|541538453|FG000|Overall Study|Protocol Violation|1|||
150108578|NCT02644967|541538453|FG000|Overall Study|Progressive Disease|1|||
150108579|NCT02644967|541538453|FG000|Overall Study|Study Terminated by Sponsor|4|||
150108580|NCT02287896|541538454|FG000|Second Injection Visit|Withdrawal by Subject|0|||
150108581|NCT02287896|541538455|FG001|Second Injection Visit|Withdrawal by Subject|1|||
150108582|NCT01494610|541538456|FG000|Period 1|Withdrawal by Subject|1|||
150108583|NCT01494610|541538457|FG001|Period 1|Withdrawal by Subject|1|||
150108584|NCT01494610|541538456|FG000|Period 3|Adverse Event|1|||
150108585|NCT01494610|541538457|FG001|Period 3|Adverse Event|0|||
150108586|NCT01494610|541538456|FG000|Period 3|Withdrawal by Subject|1|||
150108587|NCT01494610|541538457|FG001|Period 3|Withdrawal by Subject|0|||
150108588|NCT01494610|541538456|FG000|Period 4|Protocol Violation|1|||
150108589|NCT01494610|541538457|FG001|Period 4|Protocol Violation|0|||
150108590|NCT00547703|541538458|FG000|Overall Study|Lost to Follow-up|1|||
150108591|NCT00547703|541538459|FG001|Overall Study|Lost to Follow-up|0|||
150108592|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
150108593|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
150108594|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
150108595|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
150108596|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
150108597|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
150108598|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
150108599|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
150108600|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
150108601|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
150108602|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
150108603|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
150108604|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
150108605|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
150108606|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
150108607|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
150108608|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
150108609|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
150108610|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
150108611|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
150108612|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
150108613|NCT02161718|541538460|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
150108614|NCT02161718|541538461|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
150108615|NCT02161718|541538462|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
150108616|NCT02161718|541538460|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
150108617|NCT02161718|541538461|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
150108618|NCT02161718|541538462|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
150108619|NCT02161718|541538460|FG000|Post- Randomization Period|Lost to Follow-up|0|||
150108620|NCT02161718|541538461|FG001|Post- Randomization Period|Lost to Follow-up|9|||
150108621|NCT02161718|541538462|FG002|Post- Randomization Period|Lost to Follow-up|15|||
150108622|NCT02161718|541538460|FG000|Post- Randomization Period|Adverse Event|0|||
150108623|NCT02161718|541538461|FG001|Post- Randomization Period|Adverse Event|9|||
150108624|NCT02161718|541538462|FG002|Post- Randomization Period|Adverse Event|10|||
150108625|NCT02161718|541538460|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
150108626|NCT02161718|541538461|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
150108627|NCT02161718|541538462|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
150108628|NCT02161718|541538460|FG000|Post- Randomization Period|Physician Decision|0|||
150108629|NCT02161718|541538461|FG001|Post- Randomization Period|Physician Decision|2|||
150108630|NCT02161718|541538462|FG002|Post- Randomization Period|Physician Decision|4|||
150108631|NCT02161718|541538460|FG000|Post- Randomization Period|Protocol Violation|0|||
150108632|NCT02161718|541538461|FG001|Post- Randomization Period|Protocol Violation|2|||
150108633|NCT02161718|541538462|FG002|Post- Randomization Period|Protocol Violation|3|||
150108634|NCT02161718|541538460|FG000|Post- Randomization Period|Lack of Efficacy|0|||
150108635|NCT02161718|541538461|FG001|Post- Randomization Period|Lack of Efficacy|0|||
150108636|NCT02161718|541538462|FG002|Post- Randomization Period|Lack of Efficacy|1|||
150108637|NCT02161718|541538460|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
150187941|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187942|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187943|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187944|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187945|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
150187946|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
150187947|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
150187948|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
150187949|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
150187950|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187951|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187952|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187953|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187954|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187955|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187956|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187957|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187958|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187959|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
150187960|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
150187961|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
150187962|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
150187963|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187964|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187965|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187966|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187967|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187968|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187969|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187970|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187971|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
150187972|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
150187973|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
150187974|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
150187975|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
150187976|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187977|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187978|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187979|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187980|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187981|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187982|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187983|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187984|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
150187985|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
150187986|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
150187987|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
150187988|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
150187989|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187990|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187991|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187992|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187993|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187994|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187995|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187996|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187997|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
150187998|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
150187999|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
150188000|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
150108638|NCT02161718|541538461|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
150108639|NCT02161718|541538462|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
150108640|NCT02161718|541538460|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
150108641|NCT02161718|541538461|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
150108642|NCT02161718|541538462|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
150108643|NCT02161718|541538460|FG000|Post- Randomization Period|Relocation|0|||
150108644|NCT02161718|541538461|FG001|Post- Randomization Period|Relocation|3|||
150108645|NCT02161718|541538462|FG002|Post- Randomization Period|Relocation|0|||
150108646|NCT02948842|541538467|FG000|Overall Study|Withdrawal by Subject|4|||
150108647|NCT01256710|541538469|FG000|Overall Study|Death|449|||
150108648|NCT01256710|541538469|FG000|Overall Study|System Explant|67|||
150108649|NCT01256710|541538469|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
150108650|NCT01256710|541538469|FG000|Overall Study|Lost to Follow-up|67|||
150108651|NCT01256710|541538469|FG000|Overall Study|Withdrawal by Subject|29|||
150108652|NCT01256710|541538469|FG000|Overall Study|Physician Decision|9|||
150108653|NCT01256710|541538469|FG000|Overall Study|Subject Noncompliance|2|||
150108654|NCT01256710|541538469|FG000|Overall Study|Study Terminated by Sponsor|273|||
150108655|NCT02681302|541538472|FG000|Overall Study|Withdrawal by Subject|1|||
150108656|NCT02681302|541538473|FG001|Overall Study|Withdrawal by Subject|1|||
150108657|NCT02681302|541538474|FG002|Overall Study|Withdrawal by Subject|0|||
150108658|NCT02681302|541538475|FG003|Overall Study|Withdrawal by Subject|0|||
150108659|NCT02681302|541538476|FG004|Overall Study|Withdrawal by Subject|1|||
150108660|NCT02681302|541538477|FG005|Overall Study|Withdrawal by Subject|0|||
150108661|NCT02681302|541538472|FG000|Overall Study|Screen Failure|2|||
150108662|NCT02681302|541538473|FG001|Overall Study|Screen Failure|4|||
150108663|NCT02681302|541538474|FG002|Overall Study|Screen Failure|2|||
150108664|NCT02681302|541538475|FG003|Overall Study|Screen Failure|0|||
150108665|NCT02681302|541538476|FG004|Overall Study|Screen Failure|1|||
150108666|NCT02681302|541538477|FG005|Overall Study|Screen Failure|1|||
150108667|NCT02681302|541538472|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
150108668|NCT02681302|541538473|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
150108669|NCT02681302|541538474|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
150108670|NCT02681302|541538475|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
150108671|NCT02681302|541538476|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
150108672|NCT02681302|541538477|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
150108673|NCT01736696|541538478|FG000|Overall Study|Withdrawal by Subject|0|||
150108674|NCT01736696|541538479|FG001|Overall Study|Withdrawal by Subject|0|||
150108675|NCT01736696|541538480|FG002|Overall Study|Withdrawal by Subject|1|||
150108676|NCT01736696|541538481|FG003|Overall Study|Withdrawal by Subject|0|||
150108677|NCT01736696|541538482|FG004|Overall Study|Withdrawal by Subject|0|||
150108678|NCT01736696|541538483|FG005|Overall Study|Withdrawal by Subject|0|||
150108679|NCT01736696|541538484|FG006|Overall Study|Withdrawal by Subject|0|||
150108680|NCT00838565|541538485|FG000|Overall Study|Withdrawal by Subject|0|||
150108681|NCT00838565|541538486|FG001|Overall Study|Withdrawal by Subject|0|||
150108682|NCT00838565|541538487|FG002|Overall Study|Withdrawal by Subject|1|||
150108683|NCT00838565|541538488|FG003|Overall Study|Withdrawal by Subject|0|||
150108684|NCT00838565|541538489|FG004|Overall Study|Withdrawal by Subject|0|||
150108685|NCT00838565|541538490|FG005|Overall Study|Withdrawal by Subject|2|||
150108686|NCT00838565|541538485|FG000|Overall Study|Other|0|||
150108687|NCT00838565|541538486|FG001|Overall Study|Other|2|||
150108688|NCT00838565|541538487|FG002|Overall Study|Other|0|||
150108689|NCT00838565|541538488|FG003|Overall Study|Other|0|||
150108690|NCT00838565|541538489|FG004|Overall Study|Other|0|||
150108691|NCT00838565|541538490|FG005|Overall Study|Other|0|||
150108692|NCT00838565|541538485|FG000|Overall Study|Randomized but not Treated|0|||
150108693|NCT00838565|541538486|FG001|Overall Study|Randomized but not Treated|1|||
150108694|NCT00838565|541538487|FG002|Overall Study|Randomized but not Treated|0|||
150108695|NCT00838565|541538488|FG003|Overall Study|Randomized but not Treated|0|||
150108696|NCT00838565|541538489|FG004|Overall Study|Randomized but not Treated|0|||
150108697|NCT00838565|541538490|FG005|Overall Study|Randomized but not Treated|0|||
150108698|NCT00458484|541538491|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
150188001|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
150188002|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150108699|NCT00458484|541538492|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
150108700|NCT00458484|541538493|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
150108701|NCT00458484|541538494|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
150108702|NCT00458484|541538495|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
150108703|NCT00458484|541538496|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
150108704|NCT00458484|541538497|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
150108705|NCT03571516|541538498|FG000|Overall Study|Severe diarrhea|1|||
150108706|NCT03571516|541538499|FG001|Overall Study|Severe diarrhea|0|||
150188003|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188004|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188005|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188006|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188007|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188008|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188009|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188010|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
150188011|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
150188012|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
150188013|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
150188014|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
150188015|NCT01261312|541827020|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188016|NCT01261312|541827021|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188017|NCT01261312|541827022|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188018|NCT01261312|541827023|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188019|NCT01261312|541827024|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188020|NCT01261312|541827025|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188021|NCT01261312|541827026|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188022|NCT01261312|541827027|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188023|NCT01261312|541827028|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
150188024|NCT01261312|541827029|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
150188025|NCT01261312|541827030|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
150188026|NCT01261312|541827031|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
150188027|NCT01261312|541827032|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
150188028|NCT01809691|541827038|FG000|Overall Study|Currently on Treatment|192|||
150188029|NCT01809691|541827039|FG001|Overall Study|Currently on Treatment|100|||
150188030|NCT01809691|541827038|FG000|Overall Study|No Protocol Treatment|10|||
150188031|NCT01809691|541827039|FG001|Overall Study|No Protocol Treatment|11|||
150188032|NCT01809691|541827038|FG000|Overall Study|Adverse Event|80|||
150188033|NCT01809691|541827039|FG001|Overall Study|Adverse Event|21|||
150188034|NCT01809691|541827038|FG000|Overall Study|Disease Progression|226|||
150188035|NCT01809691|541827039|FG001|Overall Study|Disease Progression|372|||
150188036|NCT01809691|541827038|FG000|Overall Study|Death|26|||
150188037|NCT01809691|541827039|FG001|Overall Study|Death|13|||
150188038|NCT01809691|541827038|FG000|Overall Study|Participant Refusal|70|||
150188039|NCT01809691|541827039|FG001|Overall Study|Participant Refusal|72|||
150188040|NCT01809691|541827038|FG000|Overall Study|Other, Not Specified|34|||
150188041|NCT01809691|541827039|FG001|Overall Study|Other, Not Specified|52|||
150188042|NCT01580488|541827040|FG000|Overall Study|Withdrawal by Subject|1|||
150188043|NCT03336333|541827041|FG000|Overall Study|Remained on study at time of data cut-off|202|||
150188044|NCT03336333|541827042|FG001|Overall Study|Remained on study at time of data cut-off|219|||
150188045|NCT03336333|541827043|FG002|Overall Study|Remained on study at time of data cut-off|102|||
150188046|NCT03336333|541827041|FG000|Overall Study|Death|14|||
150188047|NCT03336333|541827042|FG001|Overall Study|Death|16|||
150188048|NCT03336333|541827043|FG002|Overall Study|Death|8|||
150188049|NCT03336333|541827041|FG000|Overall Study|Withdrawal by Subject|16|||
150188050|NCT03336333|541827042|FG001|Overall Study|Withdrawal by Subject|5|||
150188051|NCT03336333|541827043|FG002|Overall Study|Withdrawal by Subject|1|||
150188052|NCT03336333|541827041|FG000|Overall Study|Physician Decision|5|||
150188053|NCT03336333|541827042|FG001|Overall Study|Physician Decision|1|||
150188054|NCT03336333|541827043|FG002|Overall Study|Physician Decision|0|||
150188055|NCT03336333|541827041|FG000|Overall Study|Lost to Follow-up|1|||
150188056|NCT03336333|541827042|FG001|Overall Study|Lost to Follow-up|0|||
150188057|NCT03336333|541827043|FG002|Overall Study|Lost to Follow-up|0|||
150188058|NCT04588298|541827046|FG000|Overall Study|Adverse Event|0|||
150188059|NCT04588298|541827047|FG001|Overall Study|Adverse Event|0|||
150188060|NCT04588298|541827048|FG002|Overall Study|Adverse Event|1|||
150188061|NCT04588298|541827049|FG003|Overall Study|Adverse Event|0|||
150188062|NCT04588298|541827050|FG004|Overall Study|Adverse Event|2|||
150188063|NCT04588298|541827046|FG000|Overall Study|Withdrawal by Subject|1|||
150188064|NCT04588298|541827047|FG001|Overall Study|Withdrawal by Subject|0|||
150188065|NCT04588298|541827048|FG002|Overall Study|Withdrawal by Subject|0|||
150188066|NCT04588298|541827049|FG003|Overall Study|Withdrawal by Subject|1|||
150188067|NCT04588298|541827050|FG004|Overall Study|Withdrawal by Subject|0|||
150188068|NCT04021602|541827055|FG000|Overall Study|Lost to Follow-up|3|||
150188069|NCT04021602|541827056|FG001|Overall Study|Lost to Follow-up|3|||
150188070|NCT04021602|541827057|FG002|Overall Study|Lost to Follow-up|1|||
150188071|NCT04021602|541827055|FG000|Overall Study|Adverse Event|1|||
150188072|NCT04021602|541827056|FG001|Overall Study|Adverse Event|0|||
150188073|NCT04021602|541827057|FG002|Overall Study|Adverse Event|1|||
150188074|NCT02243709|541827058|FG000|Phase 1|Lost to Follow-up|0|||
150188075|NCT02243709|541827059|FG001|Phase 1|Lost to Follow-up|1|||
150188076|NCT02243709|541827058|FG000|Phase 1|Withdrawal by Subject|1|||
150108707|NCT03571516|541538498|FG000|Overall Study|Withdrawal by Subject|0|||
150108708|NCT03571516|541538499|FG001|Overall Study|Withdrawal by Subject|1|||
150108709|NCT01455012|541538500|FG000|Overall Study|Adverse Event|0|||
150108710|NCT01455012|541538501|FG001|Overall Study|Adverse Event|2|||
150108711|NCT01455012|541538500|FG000|Overall Study|Lack of Efficacy|6|||
150108712|NCT01455012|541538501|FG001|Overall Study|Lack of Efficacy|1|||
150108713|NCT01455012|541538500|FG000|Overall Study|Withdrawal by Subject|3|||
150108714|NCT01455012|541538501|FG001|Overall Study|Withdrawal by Subject|1|||
150108715|NCT01455012|541538500|FG000|Overall Study|Unknown reason|2|||
150108716|NCT01455012|541538501|FG001|Overall Study|Unknown reason|0|||
150108717|NCT02253810|541538503|FG000|Overall Study|Withdrawal by Subject|2|||
150108718|NCT02253810|541538504|FG001|Overall Study|Withdrawal by Subject|1|||
150108719|NCT02253810|541538503|FG000|Overall Study|Unknown concomitant procedure|3|||
150108720|NCT02253810|541538504|FG001|Overall Study|Unknown concomitant procedure|2|||
150108721|NCT00291668|541538506|FG000|Overall Study|Lack of Efficacy|1|||
150108722|NCT00291668|541538507|FG001|Overall Study|Lack of Efficacy|0|||
150108723|NCT00291668|541538508|FG002|Overall Study|Lack of Efficacy|0|||
150108724|NCT00291668|541538506|FG000|Overall Study|SAE, non-fatal|1|||
150108725|NCT00291668|541538507|FG001|Overall Study|SAE, non-fatal|1|||
150108726|NCT00291668|541538508|FG002|Overall Study|SAE, non-fatal|1|||
150108727|NCT00291668|541538506|FG000|Overall Study|AE, non-serious non-fatal|1|||
150108728|NCT00291668|541538507|FG001|Overall Study|AE, non-serious non-fatal|0|||
150108729|NCT00291668|541538508|FG002|Overall Study|AE, non-serious non-fatal|0|||
150108730|NCT00291668|541538506|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
150108731|NCT00291668|541538507|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
150108732|NCT00291668|541538508|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
150108733|NCT00313612|541538511|FG000|Overall Study|Patient never received treatment|0|||
150108734|NCT00313612|541538512|FG001|Overall Study|Patient never received treatment|1|||
150108735|NCT04656132|541538513|FG000|Overall Study|Lost to Follow-up|4|||
150108736|NCT04656132|541538513|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
150108737|NCT00245765|541538515|FG000|Overall Study|Adverse Event|1|||
150108738|NCT00245765|541538516|FG001|Overall Study|Adverse Event|1|||
150108739|NCT00245765|541538517|FG002|Overall Study|Adverse Event|0|||
150108740|NCT00245765|541538515|FG000|Overall Study|Lack of Efficacy|14|||
150108741|NCT00245765|541538516|FG001|Overall Study|Lack of Efficacy|7|||
150108742|NCT00245765|541538517|FG002|Overall Study|Lack of Efficacy|0|||
150108743|NCT00245765|541538515|FG000|Overall Study|Lost to Follow-up|1|||
150108744|NCT00245765|541538516|FG001|Overall Study|Lost to Follow-up|2|||
150108745|NCT00245765|541538517|FG002|Overall Study|Lost to Follow-up|0|||
150108746|NCT00245765|541538515|FG000|Overall Study|Withdrawal by Subject|1|||
150108747|NCT00245765|541538516|FG001|Overall Study|Withdrawal by Subject|0|||
150108748|NCT00245765|541538517|FG002|Overall Study|Withdrawal by Subject|3|||
150108749|NCT00245765|541538515|FG000|Overall Study|Other reason|2|||
150108750|NCT00245765|541538516|FG001|Overall Study|Other reason|0|||
150108751|NCT00245765|541538517|FG002|Overall Study|Other reason|1|||
150108752|NCT00245765|541538515|FG000|Overall Study|Other|13|||
150108753|NCT00245765|541538516|FG001|Overall Study|Other|4|||
150108754|NCT00245765|541538517|FG002|Overall Study|Other|4|||
150108755|NCT02283788|541538520|FG000|Overall Study|Adverse Event|1|||
150108756|NCT02283788|541538521|FG001|Overall Study|Adverse Event|3|||
150108757|NCT02283788|541538522|FG002|Overall Study|Adverse Event|5|||
150108758|NCT02283788|541538523|FG003|Overall Study|Adverse Event|1|||
150108759|NCT02283788|541538520|FG000|Overall Study|Withdrawal by Subject|0|||
150108760|NCT02283788|541538521|FG001|Overall Study|Withdrawal by Subject|1|||
150108761|NCT02283788|541538522|FG002|Overall Study|Withdrawal by Subject|0|||
150108762|NCT02283788|541538523|FG003|Overall Study|Withdrawal by Subject|1|||
150108763|NCT00634647|541540141|FG000|Overall Study|death on study|3|||
150108764|NCT00634647|541540141|FG000|Overall Study|refused further treatment|3|||
150108765|NCT00634647|541540141|FG000|Overall Study|declined to participate before treatment|1|||
150108766|NCT00667342|541540142|FG000|Overall Study|Protocol Violation|1|||
150108767|NCT00667342|541540143|FG001|Overall Study|Protocol Violation|0|||
150108768|NCT00667342|541540144|FG002|Overall Study|Protocol Violation|0|||
150108769|NCT00667342|541540142|FG000|Overall Study|Withdrawal by Subject|1|||
150108770|NCT00667342|541540143|FG001|Overall Study|Withdrawal by Subject|0|||
150108771|NCT00667342|541540144|FG002|Overall Study|Withdrawal by Subject|0|||
150108772|NCT00667342|541540142|FG000|Overall Study|Physician Decision|3|||
150108773|NCT00667342|541540143|FG001|Overall Study|Physician Decision|0|||
150108774|NCT00667342|541540144|FG002|Overall Study|Physician Decision|0|||
150108775|NCT00667342|541540142|FG000|Overall Study|Relapse or tumor progression|9|||
150108776|NCT00667342|541540143|FG001|Overall Study|Relapse or tumor progression|0|||
150108777|NCT00667342|541540144|FG002|Overall Study|Relapse or tumor progression|7|||
150108778|NCT00667342|541540142|FG000|Overall Study|Adverse Event|0|||
150108779|NCT00667342|541540143|FG001|Overall Study|Adverse Event|0|||
150108780|NCT00667342|541540144|FG002|Overall Study|Adverse Event|1|||
150108781|NCT00667342|541540142|FG000|Overall Study|Ineligible|0|||
150188077|NCT02243709|541827059|FG001|Phase 1|Withdrawal by Subject|0|||
150188078|NCT02243709|541827058|FG000|Phase 1|Protocol Violation|0|||
150188079|NCT02243709|541827059|FG001|Phase 1|Protocol Violation|1|||
150188080|NCT02243709|541827058|FG000|Phase 1|Adverse Event|0|||
150188081|NCT02243709|541827059|FG001|Phase 1|Adverse Event|1|||
150188082|NCT01748448|541827065|FG000|Treatment Period|Consent withdrawn by subject|1|||
150188083|NCT01748448|541827066|FG001|Treatment Period|Consent withdrawn by subject|0|||
150188084|NCT01748448|541827065|FG000|Treatment Period|Adverse Event|1|||
150188085|NCT01748448|541827066|FG001|Treatment Period|Adverse Event|0|||
150188086|NCT01748448|541827065|FG000|Treatment Period|Personal|0|||
150188087|NCT01748448|541827066|FG001|Treatment Period|Personal|1|||
150188088|NCT03699709|541827068|FG000|Overall Study|Death|1|||
150188089|NCT03699709|541827069|FG001|Overall Study|Death|2|||
150188090|NCT03699709|541827068|FG000|Overall Study|Lost to Follow-up|10|||
150188091|NCT03699709|541827069|FG001|Overall Study|Lost to Follow-up|3|||
150188092|NCT03699709|541827068|FG000|Overall Study|Withdrawal by Subject|5|||
150188093|NCT03699709|541827069|FG001|Overall Study|Withdrawal by Subject|0|||
150188094|NCT03699709|541827068|FG000|Overall Study|incarcerated|1|||
150188095|NCT03699709|541827069|FG001|Overall Study|incarcerated|0|||
150188096|NCT03699709|541827068|FG000|Overall Study|scheduled, but no show|0|||
150188097|NCT03699709|541827069|FG001|Overall Study|scheduled, but no show|1|||
150188098|NCT02907099|541827070|FG000|Overall Study|Adverse Event|1|||
150188099|NCT02907099|541827070|FG000|Overall Study|Withdrawal by Subject|2|||
150108782|NCT00667342|541540143|FG001|Overall Study|Ineligible|0|||
150108783|NCT00667342|541540144|FG002|Overall Study|Ineligible|1|||
150108784|NCT01207778|541540145|FG000|Overall Study|Lost to Follow-up|0|||
150108785|NCT01207778|541540146|FG001|Overall Study|Lost to Follow-up|3|||
150108786|NCT01207778|541540147|FG002|Overall Study|Lost to Follow-up|3|||
150108787|NCT01433263|541540148|FG000|Overall Study|Adverse Event|3|||
150108788|NCT01433263|541540149|FG001|Overall Study|Adverse Event|1|||
150108789|NCT01433263|541540148|FG000|Overall Study|Death|5|||
150108790|NCT01433263|541540149|FG001|Overall Study|Death|3|||
150108791|NCT01433263|541540148|FG000|Overall Study|Lost to Follow-up|0|||
150108792|NCT01433263|541540149|FG001|Overall Study|Lost to Follow-up|1|||
150108793|NCT01433263|541540148|FG000|Overall Study|Protocol Deviation|1|||
150108794|NCT01433263|541540149|FG001|Overall Study|Protocol Deviation|0|||
150108795|NCT01433263|541540148|FG000|Overall Study|Withdrawal by Subject|10|||
150108796|NCT01433263|541540149|FG001|Overall Study|Withdrawal by Subject|7|||
150108797|NCT04709237|541540151|FG000|Overall Study|Lost to Follow-up|1|||
150108798|NCT04709237|541540152|FG001|Overall Study|Lost to Follow-up|0|||
150108799|NCT04709237|541540153|FG002|Overall Study|Lost to Follow-up|0|||
150108800|NCT00503841|541540155|FG000|Overall Study|All screen failures|44|||
150108801|NCT01359592|541540160|FG000|Initial Registration|Adverse Event|1|||
150108802|NCT01359592|541540161|FG001|Initial Registration|Adverse Event|0|||
150108803|NCT01359592|541540162|FG002|Initial Registration|Adverse Event|0|||
150108804|NCT01359592|541540163|FG003|Initial Registration|Adverse Event|0|||
150108805|NCT01359592|541540160|FG000|Initial Registration|Death|1|||
150108806|NCT01359592|541540161|FG001|Initial Registration|Death|0|||
150108807|NCT01359592|541540162|FG002|Initial Registration|Death|0|||
150108808|NCT01359592|541540163|FG003|Initial Registration|Death|0|||
150108809|NCT01359592|541540160|FG000|Initial Registration|Other reason not protocol specified|1|||
150108810|NCT01359592|541540161|FG001|Initial Registration|Other reason not protocol specified|0|||
150108811|NCT01359592|541540162|FG002|Initial Registration|Other reason not protocol specified|0|||
150108812|NCT01359592|541540163|FG003|Initial Registration|Other reason not protocol specified|0|||
150108813|NCT01359592|541540160|FG000|Initial Registration|Ineligible|26|||
150108814|NCT01359592|541540161|FG001|Initial Registration|Ineligible|0|||
150108815|NCT01359592|541540162|FG002|Initial Registration|Ineligible|0|||
150108816|NCT01359592|541540163|FG003|Initial Registration|Ineligible|0|||
150108817|NCT01359592|541540160|FG000|PET-Directed Therapy|Adverse Event|0|||
150108818|NCT01359592|541540161|FG001|PET-Directed Therapy|Adverse Event|0|||
150108819|NCT01359592|541540162|FG002|PET-Directed Therapy|Adverse Event|1|||
150108820|NCT01359592|541540163|FG003|PET-Directed Therapy|Adverse Event|0|||
150108821|NCT01359592|541540160|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
150108822|NCT01359592|541540161|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
150108823|NCT01359592|541540162|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
150108824|NCT01359592|541540163|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
150108825|NCT01359592|541540160|FG000|PET-Directed Therapy|Ineligible|0|||
150108826|NCT01359592|541540161|FG001|PET-Directed Therapy|Ineligible|0|||
150108827|NCT01359592|541540162|FG002|PET-Directed Therapy|Ineligible|24|||
150108828|NCT01359592|541540163|FG003|PET-Directed Therapy|Ineligible|0|||
150108829|NCT00326612|541540166|FG000|Overall Study|They did not have a seizure requiring tx|129|||
150108830|NCT00326612|541540167|FG001|Overall Study|They did not have a seizure requiring tx|137|||
150108831|NCT00419562|541540168|FG000|Overall Study|Lost to Follow-up|12|||
150108832|NCT00419562|541540169|FG001|Overall Study|Lost to Follow-up|13|||
150188100|NCT02907099|541827070|FG000|Overall Study|Screen Fail|2|||
150188101|NCT02689284|541827071|FG000|Overall Study|Adverse Event|1|||
150108833|NCT00419562|541540168|FG000|Overall Study|Withdrawal by Subject|20|||
150108834|NCT00419562|541540169|FG001|Overall Study|Withdrawal by Subject|18|||
150108835|NCT00419562|541540168|FG000|Overall Study|Participant Institutionalized|1|||
150108836|NCT00419562|541540169|FG001|Overall Study|Participant Institutionalized|0|||
150108837|NCT01067352|541540180|FG000|Overall Study|Withdrawal by Subject|1|||
150108838|NCT01067352|541540181|FG001|Overall Study|Withdrawal by Subject|2|||
150108839|NCT01067352|541540182|FG002|Overall Study|Withdrawal by Subject|1|||
150108840|NCT01067352|541540180|FG000|Overall Study|Physician Decision|0|||
150108841|NCT01067352|541540181|FG001|Overall Study|Physician Decision|1|||
150108842|NCT01067352|541540182|FG002|Overall Study|Physician Decision|0|||
150108843|NCT02566759|541540183|FG000|All Parts|Withdrawal by Subject|0|||
150108844|NCT02566759|541540184|FG001|All Parts|Withdrawal by Subject|1|||
150108845|NCT02566759|541540185|FG002|All Parts|Withdrawal by Subject|0|||
150108846|NCT02566759|541540186|FG003|All Parts|Withdrawal by Subject|0|||
150108847|NCT02566759|541540187|FG004|All Parts|Withdrawal by Subject|0|||
150108848|NCT02566759|541540188|FG005|All Parts|Withdrawal by Subject|0|||
150108849|NCT02566759|541540189|FG006|All Parts|Withdrawal by Subject|0|||
150108850|NCT02566759|541540190|FG007|All Parts|Withdrawal by Subject|0|||
150108851|NCT02566759|541540191|FG008|All Parts|Withdrawal by Subject|0|||
150108852|NCT02566759|541540192|FG009|All Parts|Withdrawal by Subject|0|||
150108853|NCT02566759|541540193|FG010|All Parts|Withdrawal by Subject|0|||
150108854|NCT02566759|541540194|FG011|All Parts|Withdrawal by Subject|0|||
150108855|NCT02566759|541540195|FG012|All Parts|Withdrawal by Subject|0|||
150108856|NCT02566759|541540196|FG013|All Parts|Withdrawal by Subject|0|||
150108857|NCT02566759|541540197|FG014|All Parts|Withdrawal by Subject|0|||
150108858|NCT02566759|541540198|FG015|All Parts|Withdrawal by Subject|0|||
150108859|NCT02566759|541540199|FG016|All Parts|Withdrawal by Subject|0|||
150108860|NCT02566759|541540183|FG000|All Parts|Adverse Event|0|||
150108861|NCT02566759|541540184|FG001|All Parts|Adverse Event|0|||
150108862|NCT02566759|541540185|FG002|All Parts|Adverse Event|0|||
150108863|NCT02566759|541540186|FG003|All Parts|Adverse Event|0|||
150108864|NCT02566759|541540187|FG004|All Parts|Adverse Event|0|||
150108865|NCT02566759|541540188|FG005|All Parts|Adverse Event|0|||
150108866|NCT02566759|541540189|FG006|All Parts|Adverse Event|0|||
150108867|NCT02566759|541540190|FG007|All Parts|Adverse Event|0|||
150108868|NCT02566759|541540191|FG008|All Parts|Adverse Event|0|||
150108869|NCT02566759|541540192|FG009|All Parts|Adverse Event|0|||
150108870|NCT02566759|541540193|FG010|All Parts|Adverse Event|0|||
150108871|NCT02566759|541540194|FG011|All Parts|Adverse Event|0|||
150108872|NCT02566759|541540195|FG012|All Parts|Adverse Event|1|||
150108873|NCT02566759|541540196|FG013|All Parts|Adverse Event|3|||
150108874|NCT02566759|541540197|FG014|All Parts|Adverse Event|0|||
150108875|NCT02566759|541540198|FG015|All Parts|Adverse Event|0|||
150108876|NCT02566759|541540199|FG016|All Parts|Adverse Event|0|||
150108877|NCT02566759|541540183|FG000|All Parts|Other|0|||
150108878|NCT02566759|541540184|FG001|All Parts|Other|0|||
150108879|NCT02566759|541540185|FG002|All Parts|Other|0|||
150108880|NCT02566759|541540186|FG003|All Parts|Other|0|||
150108881|NCT02566759|541540187|FG004|All Parts|Other|0|||
150108882|NCT02566759|541540188|FG005|All Parts|Other|0|||
150108883|NCT02566759|541540189|FG006|All Parts|Other|0|||
150108884|NCT02566759|541540190|FG007|All Parts|Other|0|||
150108885|NCT02566759|541540191|FG008|All Parts|Other|0|||
150108886|NCT02566759|541540192|FG009|All Parts|Other|0|||
150108887|NCT02566759|541540193|FG010|All Parts|Other|0|||
150108888|NCT02566759|541540194|FG011|All Parts|Other|0|||
150108889|NCT02566759|541540195|FG012|All Parts|Other|0|||
150108890|NCT02566759|541540196|FG013|All Parts|Other|2|||
150108891|NCT02566759|541540197|FG014|All Parts|Other|0|||
150108892|NCT02566759|541540198|FG015|All Parts|Other|0|||
150108893|NCT02566759|541540199|FG016|All Parts|Other|0|||
150108894|NCT02566759|541540183|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108895|NCT02566759|541540184|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108896|NCT02566759|541540185|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108897|NCT02566759|541540186|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108898|NCT02566759|541540187|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108899|NCT02566759|541540188|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108900|NCT02566759|541540189|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108901|NCT02566759|541540190|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108902|NCT02566759|541540191|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108903|NCT02566759|541540192|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108904|NCT02566759|541540193|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108905|NCT02566759|541540194|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108906|NCT02566759|541540195|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108907|NCT02566759|541540196|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108908|NCT02566759|541540197|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108909|NCT02566759|541540198|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
150108910|NCT02566759|541540199|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
150108911|NCT00976898|541540200|FG000|Overall Study|Protocol Violation|1|||
150108912|NCT00976898|541540200|FG000|Overall Study|Adverse Event|1|||
150188102|NCT02689284|541827072|FG001|Overall Study|Adverse Event|8|||
150188103|NCT02689284|541827071|FG000|Overall Study|Death|0|||
150188104|NCT02689284|541827072|FG001|Overall Study|Death|1|||
150108913|NCT00976898|541540200|FG000|Overall Study|Physician Decision|1|||
150108914|NCT00976898|541540200|FG000|Overall Study|Liver Transplant|1|||
150188105|NCT02689284|541827071|FG000|Overall Study|Physician Decision|1|||
150188106|NCT02689284|541827072|FG001|Overall Study|Physician Decision|2|||
150188107|NCT02689284|541827071|FG000|Overall Study|Withdrawal by Subject|0|||
150188108|NCT02689284|541827072|FG001|Overall Study|Withdrawal by Subject|1|||
150188109|NCT02689284|541827071|FG000|Overall Study|progression of cancer|1|||
150188110|NCT02689284|541827072|FG001|Overall Study|progression of cancer|72|||
150188111|NCT02689284|541827071|FG000|Overall Study|decreased heart function|0|||
150188112|NCT02689284|541827072|FG001|Overall Study|decreased heart function|1|||
150188113|NCT02689284|541827071|FG000|Overall Study|concern for anemia|0|||
150188114|NCT02689284|541827072|FG001|Overall Study|concern for anemia|1|||
150188115|NCT02689284|541827071|FG000|Overall Study|no measurable cancer for evaluation|0|||
150188116|NCT02689284|541827072|FG001|Overall Study|no measurable cancer for evaluation|1|||
150188117|NCT05569252|541827073|FG000|Overall Study|Adverse event (central vision loss)|1|||
150188118|NCT05569252|541827074|FG001|Overall Study|Adverse event (central vision loss)|0|||
150188119|NCT05569252|541827075|FG002|Overall Study|Adverse event (central vision loss)|0|||
150188120|NCT05569252|541827076|FG003|Overall Study|Adverse event (central vision loss)|0|||
150188121|NCT03665597|541827077|FG000|Period 1|Adverse Event|1|||
150188122|NCT03665597|541827078|FG001|Period 1|Adverse Event|0|||
150188123|NCT03665597|541827079|FG002|Period 1|Adverse Event|0|||
150188124|NCT03665597|541827080|FG003|Period 1|Adverse Event|1|||
150188125|NCT03665597|541827081|FG004|Period 1|Adverse Event|0|||
150188126|NCT03665597|541827082|FG005|Period 1|Adverse Event|0|||
150188127|NCT03665597|541827083|FG006|Period 1|Adverse Event|0|||
150188128|NCT03665597|541827077|FG000|Period 1|Screen Failure|0|||
150188129|NCT03665597|541827078|FG001|Period 1|Screen Failure|0|||
150188130|NCT03665597|541827079|FG002|Period 1|Screen Failure|0|||
150188131|NCT03665597|541827080|FG003|Period 1|Screen Failure|1|||
150188132|NCT03665597|541827081|FG004|Period 1|Screen Failure|0|||
150188133|NCT03665597|541827082|FG005|Period 1|Screen Failure|0|||
150188134|NCT03665597|541827083|FG006|Period 1|Screen Failure|0|||
150188135|NCT03665597|541827077|FG000|Period 1|Death|0|||
150188136|NCT03665597|541827078|FG001|Period 1|Death|0|||
150188137|NCT03665597|541827079|FG002|Period 1|Death|0|||
150108915|NCT00976898|541540200|FG000|Overall Study|Progressive Disease|1|||
150108916|NCT05107128|541540201|FG000|Overall Study|Adverse Event|2|||
150108917|NCT05107128|541540202|FG001|Overall Study|Adverse Event|0|||
150108918|NCT05107128|541540201|FG000|Overall Study|Withdrawal by Subject|3|||
150108919|NCT05107128|541540202|FG001|Overall Study|Withdrawal by Subject|3|||
150108920|NCT05107128|541540201|FG000|Overall Study|Withdrawal of Consent|0|||
150108921|NCT05107128|541540202|FG001|Overall Study|Withdrawal of Consent|1|||
150108922|NCT05107128|541540201|FG000|Overall Study|Reason Not Specified|2|||
150108923|NCT05107128|541540202|FG001|Overall Study|Reason Not Specified|0|||
150108924|NCT05459129|541540205|FG000|Overall Study|Death|1|||
150108925|NCT05459129|541540206|FG001|Overall Study|Death|0|||
150108926|NCT05459129|541540205|FG000|Overall Study|Study Terminated By Sponsor|5|||
150108927|NCT05459129|541540206|FG001|Overall Study|Study Terminated By Sponsor|6|||
150108928|NCT04304001|541540207|FG000|Overall Study|Lost to Follow-up|13|||
150108929|NCT04304001|541540208|FG001|Overall Study|Lost to Follow-up|9|||
150108930|NCT04649151|541540211|FG000|Overall Study|Pregnancy|0|||
150188138|NCT03665597|541827080|FG003|Period 1|Death|0|||
150188139|NCT03665597|541827081|FG004|Period 1|Death|0|||
150188140|NCT03665597|541827082|FG005|Period 1|Death|0|||
150188141|NCT03665597|541827083|FG006|Period 1|Death|45|||
150188142|NCT03665597|541827077|FG000|Period 1|Withdrawal by Subject|0|||
150188143|NCT03665597|541827078|FG001|Period 1|Withdrawal by Subject|0|||
150188144|NCT03665597|541827079|FG002|Period 1|Withdrawal by Subject|0|||
150188145|NCT03665597|541827080|FG003|Period 1|Withdrawal by Subject|0|||
150188146|NCT03665597|541827081|FG004|Period 1|Withdrawal by Subject|0|||
150108931|NCT04649151|541540212|FG001|Overall Study|Pregnancy|0|||
150188147|NCT03665597|541827082|FG005|Period 1|Withdrawal by Subject|0|||
150188148|NCT03665597|541827083|FG006|Period 1|Withdrawal by Subject|5|||
150188149|NCT03665597|541827077|FG000|Period 2|Adverse Event|0|||
150188150|NCT03665597|541827078|FG001|Period 2|Adverse Event|0|||
150108932|NCT04649151|541540213|FG002|Overall Study|Pregnancy|0|||
150108933|NCT04649151|541540214|FG003|Overall Study|Pregnancy|0|||
150108934|NCT04649151|541540215|FG004|Overall Study|Pregnancy|3|||
150108935|NCT04649151|541540211|FG000|Overall Study|Physician Decision|10|||
150108936|NCT04649151|541540212|FG001|Overall Study|Physician Decision|0|||
150108937|NCT04649151|541540213|FG002|Overall Study|Physician Decision|0|||
150188151|NCT03665597|541827079|FG002|Period 2|Adverse Event|0|||
150188152|NCT03665597|541827080|FG003|Period 2|Adverse Event|0|||
150188153|NCT03665597|541827081|FG004|Period 2|Adverse Event|0|||
150188154|NCT03665597|541827082|FG005|Period 2|Adverse Event|1|||
150188155|NCT03665597|541827083|FG006|Period 2|Adverse Event|0|||
150188156|NCT03665597|541827077|FG000|Period 3|Adverse Event|0|||
150188157|NCT03665597|541827078|FG001|Period 3|Adverse Event|1|||
150188158|NCT03665597|541827079|FG002|Period 3|Adverse Event|0|||
150188159|NCT03665597|541827080|FG003|Period 3|Adverse Event|0|||
150188160|NCT03665597|541827081|FG004|Period 3|Adverse Event|0|||
150188161|NCT03665597|541827082|FG005|Period 3|Adverse Event|0|||
150188162|NCT03665597|541827083|FG006|Period 3|Adverse Event|0|||
150188163|NCT03665597|541827077|FG000|Period 3|Death|0|||
150188164|NCT03665597|541827078|FG001|Period 3|Death|0|||
150188165|NCT03665597|541827079|FG002|Period 3|Death|0|||
150188166|NCT03665597|541827080|FG003|Period 3|Death|0|||
150188167|NCT03665597|541827081|FG004|Period 3|Death|1|||
150188168|NCT03665597|541827082|FG005|Period 3|Death|0|||
150188169|NCT03665597|541827083|FG006|Period 3|Death|0|||
150188170|NCT03665597|541827077|FG000|Period 4|Adverse Event|2|||
150188171|NCT03665597|541827078|FG001|Period 4|Adverse Event|2|||
150188172|NCT03665597|541827079|FG002|Period 4|Adverse Event|2|||
150188173|NCT03665597|541827080|FG003|Period 4|Adverse Event|2|||
150188174|NCT03665597|541827081|FG004|Period 4|Adverse Event|1|||
150188175|NCT03665597|541827082|FG005|Period 4|Adverse Event|0|||
150188176|NCT03665597|541827083|FG006|Period 4|Adverse Event|0|||
150188177|NCT03665597|541827077|FG000|Period 4|Death|0|||
150188178|NCT03665597|541827078|FG001|Period 4|Death|0|||
150188179|NCT03665597|541827079|FG002|Period 4|Death|2|||
150188180|NCT03665597|541827080|FG003|Period 4|Death|0|||
150188181|NCT03665597|541827081|FG004|Period 4|Death|0|||
150188182|NCT03665597|541827082|FG005|Period 4|Death|0|||
150188183|NCT03665597|541827083|FG006|Period 4|Death|0|||
150188184|NCT03665597|541827077|FG000|Period 4|Physician Decision|1|||
150188185|NCT03665597|541827078|FG001|Period 4|Physician Decision|2|||
150188186|NCT03665597|541827079|FG002|Period 4|Physician Decision|0|||
150188187|NCT03665597|541827080|FG003|Period 4|Physician Decision|0|||
150188188|NCT03665597|541827081|FG004|Period 4|Physician Decision|0|||
150188189|NCT03665597|541827082|FG005|Period 4|Physician Decision|0|||
150188190|NCT03665597|541827083|FG006|Period 4|Physician Decision|0|||
150188191|NCT02913872|541827090|FG000|Overall Study|Withdrawal by Subject|1|||
150188192|NCT03519581|541827093|FG000|Overall Study|Lost to Follow-up|3|||
150188193|NCT03519581|541827094|FG001|Overall Study|Lost to Follow-up|2|||
150188194|NCT03519581|541827093|FG000|Overall Study|Adverse Event|5|||
150188195|NCT03519581|541827094|FG001|Overall Study|Adverse Event|2|||
150188196|NCT03519581|541827093|FG000|Overall Study|Withdrawal by Subject|2|||
150188197|NCT03519581|541827094|FG001|Overall Study|Withdrawal by Subject|0|||
150188198|NCT03519581|541827093|FG000|Overall Study|Change to insurance|2|||
150188199|NCT03519581|541827094|FG001|Overall Study|Change to insurance|1|||
150188200|NCT03519581|541827093|FG000|Overall Study|Other|2|||
150188201|NCT03519581|541827094|FG001|Overall Study|Other|4|||
150188202|NCT05516147|541827095|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
150188203|NCT03110315|541827096|FG000|Overall Study|Withdrawal by Subject|1|||
150188204|NCT03110315|541827097|FG001|Overall Study|Withdrawal by Subject|0|||
150188205|NCT03302494|541827101|FG000|Overall Study|Other|7|||
150188206|NCT03302494|541827102|FG001|Overall Study|Other|4|||
150188207|NCT03302494|541827103|FG002|Overall Study|Other|6|||
150188208|NCT03302494|541827101|FG000|Overall Study|Withdrawal by Subject|10|||
150188209|NCT03302494|541827102|FG001|Overall Study|Withdrawal by Subject|2|||
150188210|NCT03302494|541827103|FG002|Overall Study|Withdrawal by Subject|9|||
150188211|NCT03302494|541827101|FG000|Overall Study|Study Terminated by Sponsor|32|||
150188212|NCT03302494|541827102|FG001|Overall Study|Study Terminated by Sponsor|29|||
150188213|NCT03302494|541827103|FG002|Overall Study|Study Terminated by Sponsor|30|||
150188214|NCT03302494|541827101|FG000|Overall Study|Physician Decision|1|||
150188215|NCT03302494|541827102|FG001|Overall Study|Physician Decision|0|||
150188216|NCT03302494|541827103|FG002|Overall Study|Physician Decision|1|||
150188217|NCT03302494|541827101|FG000|Overall Study|Lost to Follow-up|1|||
150188218|NCT03302494|541827102|FG001|Overall Study|Lost to Follow-up|3|||
150188219|NCT03302494|541827103|FG002|Overall Study|Lost to Follow-up|3|||
150188220|NCT03302494|541827101|FG000|Overall Study|Death|13|||
150188221|NCT03302494|541827102|FG001|Overall Study|Death|11|||
150188222|NCT03302494|541827103|FG002|Overall Study|Death|4|||
150188223|NCT03302494|541827101|FG000|Overall Study|Adverse Event|1|||
150188224|NCT03302494|541827102|FG001|Overall Study|Adverse Event|2|||
150188225|NCT03302494|541827103|FG002|Overall Study|Adverse Event|0|||
150188226|NCT03302494|541827101|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
150188227|NCT03302494|541827102|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
150188228|NCT03302494|541827103|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
150188229|NCT05071807|541827106|FG000|Overall Study|Withdrawal by Subject|4|||
150188230|NCT05071807|541827107|FG001|Overall Study|Withdrawal by Subject|0|||
150188231|NCT05071807|541827106|FG000|Overall Study|Unrelated medical issues|3|||
150108938|NCT04649151|541540214|FG003|Overall Study|Physician Decision|1|||
150108939|NCT04649151|541540215|FG004|Overall Study|Physician Decision|1|||
150108940|NCT04649151|541540211|FG000|Overall Study|Protocol Deviation|25|||
150108941|NCT04649151|541540212|FG001|Overall Study|Protocol Deviation|3|||
150108942|NCT04649151|541540213|FG002|Overall Study|Protocol Deviation|0|||
150108943|NCT04649151|541540214|FG003|Overall Study|Protocol Deviation|0|||
150108944|NCT04649151|541540215|FG004|Overall Study|Protocol Deviation|0|||
150108945|NCT04649151|541540211|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
150108946|NCT04649151|541540212|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
150108947|NCT04649151|541540213|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
150108948|NCT04649151|541540214|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
150108949|NCT04649151|541540215|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
150108950|NCT04649151|541540211|FG000|Overall Study|Withdrawal by Subject|370|||
150108951|NCT04649151|541540212|FG001|Overall Study|Withdrawal by Subject|113|||
150108952|NCT04649151|541540213|FG002|Overall Study|Withdrawal by Subject|2|||
150108953|NCT04649151|541540214|FG003|Overall Study|Withdrawal by Subject|7|||
150108954|NCT04649151|541540215|FG004|Overall Study|Withdrawal by Subject|15|||
150108955|NCT04649151|541540211|FG000|Overall Study|Adverse Event|1|||
150108956|NCT04649151|541540212|FG001|Overall Study|Adverse Event|0|||
150108957|NCT04649151|541540213|FG002|Overall Study|Adverse Event|0|||
150108958|NCT04649151|541540214|FG003|Overall Study|Adverse Event|0|||
150108959|NCT04649151|541540215|FG004|Overall Study|Adverse Event|0|||
150108960|NCT04649151|541540211|FG000|Overall Study|Lost to Follow-up|256|||
150108961|NCT04649151|541540212|FG001|Overall Study|Lost to Follow-up|29|||
150108962|NCT04649151|541540213|FG002|Overall Study|Lost to Follow-up|10|||
150108963|NCT04649151|541540214|FG003|Overall Study|Lost to Follow-up|3|||
150108964|NCT04649151|541540215|FG004|Overall Study|Lost to Follow-up|6|||
150108965|NCT04649151|541540211|FG000|Overall Study|Other than specified|59|||
150108966|NCT04649151|541540212|FG001|Overall Study|Other than specified|294|||
150108967|NCT04649151|541540213|FG002|Overall Study|Other than specified|0|||
150108968|NCT04649151|541540214|FG003|Overall Study|Other than specified|0|||
150108969|NCT04649151|541540215|FG004|Overall Study|Other than specified|4|||
150108970|NCT04649151|541540211|FG000|Overall Study|Death|0|||
150108971|NCT04649151|541540212|FG001|Overall Study|Death|0|||
150108972|NCT04649151|541540213|FG002|Overall Study|Death|0|||
150108973|NCT04649151|541540214|FG003|Overall Study|Death|0|||
150108974|NCT04649151|541540215|FG004|Overall Study|Death|1|||
150108975|NCT02975934|541540216|FG000|Treatment Phase|Never initiated study drug|0|||
150108976|NCT02975934|541540217|FG001|Treatment Phase|Never initiated study drug|5|||
150108977|NCT02975934|541540218|FG002|Treatment Phase|Never initiated study drug|0|||
150108978|NCT03362502|541540220|FG000|Overall Study|Death|0|||
150108979|NCT03362502|541540221|FG001|Overall Study|Death|0|||
150108980|NCT03362502|541540222|FG002|Overall Study|Death|1|||
150108981|NCT00433654|541540227|FG000|Overall Study|Death|4|||
150108982|NCT00433654|541540228|FG001|Overall Study|Death|0|||
150108983|NCT00433654|541540227|FG000|Overall Study|Missed visit|6|||
150108984|NCT00433654|541540228|FG001|Overall Study|Missed visit|3|||
150108985|NCT00433654|541540227|FG000|Overall Study|Subject not yet due for visit|4|||
150108986|NCT00433654|541540228|FG001|Overall Study|Subject not yet due for visit|0|||
150108987|NCT00433654|541540227|FG000|Overall Study|Withdrawal by Subject|1|||
150108988|NCT00433654|541540228|FG001|Overall Study|Withdrawal by Subject|2|||
150108989|NCT03277261|541540256|FG000|Overall Study|Adverse Event|17|||
150108990|NCT03277261|541540257|FG001|Overall Study|Adverse Event|1|||
150108991|NCT03277261|541540256|FG000|Overall Study|Participant Withdrawal of Consent|6|||
150108992|NCT03277261|541540257|FG001|Overall Study|Participant Withdrawal of Consent|15|||
150108993|NCT03277261|541540256|FG000|Overall Study|Investigator / Sponsor Decision|4|||
150108994|NCT03277261|541540257|FG001|Overall Study|Investigator / Sponsor Decision|2|||
150108995|NCT03277261|541540256|FG000|Overall Study|Pregnancy|2|||
150108996|NCT03277261|541540257|FG001|Overall Study|Pregnancy|0|||
150188232|NCT05071807|541827107|FG001|Overall Study|Unrelated medical issues|0|||
150108997|NCT03277261|541540256|FG000|Overall Study|Lost to Follow-up|2|||
150108998|NCT03277261|541540257|FG001|Overall Study|Lost to Follow-up|2|||
150108999|NCT03277261|541540256|FG000|Overall Study|Lack of Efficacy|2|||
150109000|NCT03277261|541540257|FG001|Overall Study|Lack of Efficacy|2|||
150109001|NCT03277261|541540256|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
150109002|NCT03277261|541540257|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
150109003|NCT00499603|541540258|FG000|Overall Study|Adverse Event|0|||
150109004|NCT00499603|541540259|FG001|Overall Study|Adverse Event|1|||
150109005|NCT03323099|541540260|FG000|Overall Study|Withdrawal by Subject|6|||
150109006|NCT03323099|541540261|FG001|Overall Study|Withdrawal by Subject|12|||
150109007|NCT03323099|541540260|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
150109008|NCT03323099|541540261|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
150109009|NCT05220397|541540262|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
150188233|NCT05071807|541827106|FG000|Overall Study|Relocated|0|||
150188234|NCT05071807|541827107|FG001|Overall Study|Relocated|1|||
150188235|NCT04952909|541827108|FG000|Overall Study|Death|3|||
150188236|NCT05308004|541827110|FG000|Overall Study|Not seen by Palliative Care NP|0|||
150188237|NCT05308004|541827111|FG001|Overall Study|Not seen by Palliative Care NP|1|||
150188238|NCT04552223|541827118|FG000|Overall Study|Withdrawal by Subject|1|||
150188239|NCT04072380|541827119|FG000|Overall Study|Adverse Event|4|||
150188240|NCT04072380|541827120|FG001|Overall Study|Adverse Event|6|||
150188241|NCT04072380|541827121|FG002|Overall Study|Adverse Event|0|||
150188242|NCT04072380|541827119|FG000|Overall Study|Withdrawal by Subject|3|||
150188243|NCT04072380|541827120|FG001|Overall Study|Withdrawal by Subject|1|||
150188244|NCT04072380|541827121|FG002|Overall Study|Withdrawal by Subject|1|||
150188245|NCT04072380|541827119|FG000|Overall Study|Physician Decision|2|||
150188246|NCT04072380|541827120|FG001|Overall Study|Physician Decision|0|||
150188247|NCT04072380|541827121|FG002|Overall Study|Physician Decision|0|||
150188248|NCT04072380|541827119|FG000|Overall Study|Protocol Violation|0|||
150188249|NCT04072380|541827120|FG001|Overall Study|Protocol Violation|2|||
150109010|NCT05220397|541540263|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
150109011|NCT05220397|541540264|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
150109012|NCT05220397|541540265|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
150109013|NCT05220397|541540266|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
150109014|NCT02043015|541540267|FG000|Overall Study|Lost to Follow-up|4|||
150109015|NCT02043015|541540267|FG000|Overall Study|Withdrawal by Subject|4|||
150109016|NCT02043015|541540267|FG000|Overall Study|Removed once target enrollment reached|15|||
150109017|NCT02043015|541540267|FG000|Overall Study|Participant moved away from study city|4|||
150109018|NCT02043015|541540267|FG000|Overall Study|Incarceration|1|||
150109019|NCT00207142|541540273|FG000|Induction Phase|Adverse Event|9|||
150109020|NCT00207142|541540274|FG001|Induction Phase|Adverse Event|0|||
150109021|NCT00207142|541540275|FG002|Induction Phase|Adverse Event|0|||
150109022|NCT00207142|541540276|FG003|Induction Phase|Adverse Event|0|||
150109023|NCT00207142|541540273|FG000|Induction Phase|Death|1|||
150109024|NCT00207142|541540274|FG001|Induction Phase|Death|0|||
150109025|NCT00207142|541540275|FG002|Induction Phase|Death|0|||
150109026|NCT00207142|541540276|FG003|Induction Phase|Death|0|||
150109027|NCT00207142|541540273|FG000|Induction Phase|Lack of Efficacy|1|||
150109028|NCT00207142|541540274|FG001|Induction Phase|Lack of Efficacy|0|||
150109029|NCT00207142|541540275|FG002|Induction Phase|Lack of Efficacy|0|||
150109030|NCT00207142|541540276|FG003|Induction Phase|Lack of Efficacy|0|||
150109031|NCT00207142|541540273|FG000|Induction Phase|Lost to Follow-up|5|||
150109032|NCT00207142|541540274|FG001|Induction Phase|Lost to Follow-up|0|||
150109033|NCT00207142|541540275|FG002|Induction Phase|Lost to Follow-up|0|||
150109034|NCT00207142|541540276|FG003|Induction Phase|Lost to Follow-up|0|||
150109035|NCT00207142|541540273|FG000|Induction Phase|Physician Decision|2|||
150109036|NCT00207142|541540274|FG001|Induction Phase|Physician Decision|0|||
150109037|NCT00207142|541540275|FG002|Induction Phase|Physician Decision|0|||
150109038|NCT00207142|541540276|FG003|Induction Phase|Physician Decision|0|||
150109039|NCT00207142|541540273|FG000|Induction Phase|Poor/noncompliance|2|||
150109040|NCT00207142|541540274|FG001|Induction Phase|Poor/noncompliance|0|||
150109041|NCT00207142|541540275|FG002|Induction Phase|Poor/noncompliance|0|||
150109042|NCT00207142|541540276|FG003|Induction Phase|Poor/noncompliance|0|||
150109043|NCT00207142|541540273|FG000|Induction Phase|Pregnancy|1|||
150109044|NCT00207142|541540274|FG001|Induction Phase|Pregnancy|0|||
150109045|NCT00207142|541540275|FG002|Induction Phase|Pregnancy|0|||
150109046|NCT00207142|541540276|FG003|Induction Phase|Pregnancy|0|||
150109047|NCT00207142|541540273|FG000|Induction Phase|Subject no longer meets study criteria|3|||
150109048|NCT00207142|541540274|FG001|Induction Phase|Subject no longer meets study criteria|0|||
150109049|NCT00207142|541540275|FG002|Induction Phase|Subject no longer meets study criteria|0|||
150109050|NCT00207142|541540276|FG003|Induction Phase|Subject no longer meets study criteria|0|||
150109051|NCT00207142|541540273|FG000|Induction Phase|Withdrawal by Subject|4|||
150109052|NCT00207142|541540274|FG001|Induction Phase|Withdrawal by Subject|0|||
150109053|NCT00207142|541540275|FG002|Induction Phase|Withdrawal by Subject|0|||
150188250|NCT04072380|541827121|FG002|Overall Study|Protocol Violation|3|||
150188251|NCT04072380|541827119|FG000|Overall Study|Intercurrent Illness and Others|3|||
150188252|NCT04072380|541827120|FG001|Overall Study|Intercurrent Illness and Others|5|||
150109054|NCT00207142|541540276|FG003|Induction Phase|Withdrawal by Subject|0|||
150109055|NCT00207142|541540273|FG000|Induction Phase|Incarceration|1|||
150109056|NCT00207142|541540274|FG001|Induction Phase|Incarceration|0|||
150109057|NCT00207142|541540275|FG002|Induction Phase|Incarceration|0|||
150109058|NCT00207142|541540276|FG003|Induction Phase|Incarceration|0|||
150109059|NCT00207142|541540273|FG000|Induction Phase|Missing lab data|1|||
150109060|NCT00207142|541540274|FG001|Induction Phase|Missing lab data|0|||
150109061|NCT00207142|541540275|FG002|Induction Phase|Missing lab data|0|||
150109062|NCT00207142|541540276|FG003|Induction Phase|Missing lab data|0|||
150188253|NCT04072380|541827121|FG002|Overall Study|Intercurrent Illness and Others|6|||
150188254|NCT03468218|541827125|FG000|Overall Study|Adverse Event|5|||
150109063|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
150109064|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
150109065|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
150109066|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
150109067|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
150109068|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
150109069|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
150109070|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
150109071|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
150109072|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
150109073|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
150109074|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
150109075|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
150109076|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
150109077|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
150109078|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
150109079|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
150109080|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
150109081|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
150109082|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
150109083|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
150109084|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
150109085|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
150109086|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
150109087|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
150109088|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
150109089|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
150109090|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
150109091|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Death|0|||
150109092|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Death|0|||
150109093|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Death|0|||
150109094|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Death|1|||
150109095|NCT00207142|541540273|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
150109096|NCT00207142|541540274|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
150109097|NCT00207142|541540275|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
150109098|NCT00207142|541540276|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
150109099|NCT04958109|541540277|FG000|Overall Study|Withdrawal by Subject|0|||
150109100|NCT04958109|541540278|FG001|Overall Study|Withdrawal by Subject|1|||
150109101|NCT04958109|541540277|FG000|Overall Study|Lost to Follow-up|0|||
150109102|NCT04958109|541540278|FG001|Overall Study|Lost to Follow-up|1|||
150109103|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109104|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
150109105|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
150109106|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
150109107|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109108|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109109|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109110|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109111|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109112|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109113|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109114|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109115|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109116|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109117|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109118|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109119|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109120|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109121|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109122|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109123|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109124|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109125|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109126|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
150109127|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109128|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
150109129|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109130|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109131|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109132|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109133|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109134|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109135|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109136|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109137|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109138|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109139|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109140|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109141|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109142|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109143|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109144|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109145|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109146|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109147|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109148|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109149|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109150|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
150109151|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109152|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
150109153|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109154|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109155|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109156|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109157|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109158|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109159|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109160|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109161|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109162|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109163|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109164|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109165|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109166|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109167|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109168|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109169|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109170|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109171|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109172|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109173|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109174|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
150109175|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
150109176|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
150109177|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
150109178|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
150109179|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109180|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109181|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109182|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109183|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109184|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109185|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109186|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109187|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109188|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109189|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109190|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150188255|NCT03468218|541827125|FG000|Overall Study|Progressive Disease|16|||
150188256|NCT03468218|541827125|FG000|Overall Study|Death|1|||
150188257|NCT03468218|541827125|FG000|Overall Study|Alternate therapy|1|||
150188258|NCT03468218|541827125|FG000|Overall Study|Withdrawal by Subject|2|||
150188259|NCT01214616|541827126|FG000|Overall Study|Progressive disease|2|||
150188260|NCT01214616|541827127|FG001|Overall Study|Progressive disease|2|||
150188261|NCT01214616|541827128|FG002|Overall Study|Progressive disease|2|||
150188262|NCT01214616|541827129|FG003|Overall Study|Progressive disease|4|||
150188263|NCT01214616|541827126|FG000|Overall Study|Dose limiting toxicity|0|||
150188264|NCT01214616|541827127|FG001|Overall Study|Dose limiting toxicity|2|||
150188265|NCT01214616|541827128|FG002|Overall Study|Dose limiting toxicity|0|||
150188266|NCT01214616|541827129|FG003|Overall Study|Dose limiting toxicity|0|||
150188267|NCT01214616|541827126|FG000|Overall Study|Other adverse events|0|||
150188268|NCT01214616|541827127|FG001|Overall Study|Other adverse events|1|||
150188269|NCT01214616|541827128|FG002|Overall Study|Other adverse events|1|||
150188270|NCT01214616|541827129|FG003|Overall Study|Other adverse events|1|||
150188271|NCT01214616|541827126|FG000|Overall Study|Withdrawal by Subject|1|||
150188272|NCT01214616|541827127|FG001|Overall Study|Withdrawal by Subject|0|||
150188273|NCT01214616|541827128|FG002|Overall Study|Withdrawal by Subject|0|||
150188274|NCT01214616|541827129|FG003|Overall Study|Withdrawal by Subject|1|||
150188275|NCT03047928|541829118|FG000|Overall Study|Adverse Event|0|||
150188276|NCT03047928|541829119|FG001|Overall Study|Adverse Event|2|||
150188277|NCT03047928|541829120|FG002|Overall Study|Adverse Event|0|||
150188278|NCT03047928|541829118|FG000|Overall Study|Protocol Violation|0|||
150188279|NCT03047928|541829119|FG001|Overall Study|Protocol Violation|1|||
150188280|NCT03047928|541829120|FG002|Overall Study|Protocol Violation|0|||
150188281|NCT03047928|541829118|FG000|Overall Study|included in another protocol|0|||
150188282|NCT03047928|541829119|FG001|Overall Study|included in another protocol|1|||
150188283|NCT03047928|541829120|FG002|Overall Study|included in another protocol|0|||
150188284|NCT03281291|541829122|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
150188285|NCT03281291|541829123|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
150188286|NCT03281291|541829124|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
150188287|NCT03281291|541829125|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
150109191|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109192|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109193|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109194|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109195|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109196|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109197|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109198|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
150109199|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
150109200|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
150109201|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
150109202|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
150109203|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109204|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109205|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109206|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109207|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109208|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109209|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109210|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109211|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109212|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150188288|NCT03281291|541829126|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
150188289|NCT03281291|541829122|FG000|Overall Study|Protocol Deviation|2|||
150188290|NCT03281291|541829123|FG001|Overall Study|Protocol Deviation|0|||
150188291|NCT03281291|541829124|FG002|Overall Study|Protocol Deviation|1|||
150188292|NCT03281291|541829125|FG003|Overall Study|Protocol Deviation|2|||
150188293|NCT03281291|541829126|FG004|Overall Study|Protocol Deviation|1|||
150188294|NCT03281291|541829122|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
150188295|NCT03281291|541829123|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
150188296|NCT03281291|541829124|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
150188297|NCT03281291|541829125|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
150188298|NCT03281291|541829126|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
150188299|NCT03281291|541829122|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
150109213|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109214|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109215|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109216|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109217|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109218|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109219|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109220|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109221|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109222|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
150109223|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109224|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
150109225|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109226|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
150109227|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109228|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109229|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109230|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109231|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109232|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109233|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109234|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109235|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109236|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109237|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109238|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109239|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109240|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109241|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109242|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109243|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109244|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109245|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109246|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
150109247|NCT02346240|541540279|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109248|NCT02346240|541540280|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109249|NCT02346240|541540281|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
150109250|NCT02346240|541540282|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109251|NCT02346240|541540283|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109252|NCT02346240|541540284|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109253|NCT02346240|541540285|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109254|NCT02346240|541540286|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109255|NCT02346240|541540287|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109256|NCT02346240|541540288|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109257|NCT02346240|541540289|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109258|NCT02346240|541540290|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109259|NCT02346240|541540291|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109260|NCT02346240|541540292|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109261|NCT02346240|541540293|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109262|NCT02346240|541540294|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109263|NCT02346240|541540295|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109264|NCT02346240|541540296|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109265|NCT02346240|541540297|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109266|NCT02346240|541540298|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109267|NCT02346240|541540299|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150188300|NCT03281291|541829123|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
150188301|NCT03281291|541829124|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
150188302|NCT03281291|541829125|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
150188303|NCT03281291|541829126|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
150188304|NCT03281291|541829122|FG000|Overall Study|Lost to Follow-up|10|||
150188305|NCT03281291|541829123|FG001|Overall Study|Lost to Follow-up|10|||
150188306|NCT03281291|541829124|FG002|Overall Study|Lost to Follow-up|4|||
150188307|NCT03281291|541829125|FG003|Overall Study|Lost to Follow-up|6|||
150109268|NCT02346240|541540300|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109269|NCT02346240|541540301|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109270|NCT02346240|541540302|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
150109271|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109272|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109273|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109274|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109275|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109276|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109277|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109278|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
150109279|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
150109280|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109281|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109282|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109283|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109284|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
150109285|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
150109286|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
150109287|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
150109288|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109289|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109290|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109291|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109292|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109293|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109294|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
150109295|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109296|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109297|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109298|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109299|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109300|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109301|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109302|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109303|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109304|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109305|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109306|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109307|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109308|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
150109309|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109310|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
150109311|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109312|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109313|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109314|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150188308|NCT03281291|541829126|FG004|Overall Study|Lost to Follow-up|10|||
150109315|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109316|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109317|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109318|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
150109319|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109320|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109321|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109322|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109323|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109324|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109325|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109326|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109327|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109328|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109329|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109330|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109331|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109332|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109333|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
150109334|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109335|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109336|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109337|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109338|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109339|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109340|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109341|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109342|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
150109343|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109344|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109345|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109346|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109347|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109348|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109349|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109350|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109351|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109352|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109353|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109354|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
150109355|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109356|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
150109357|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
150109358|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
150109359|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
150109360|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109361|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109362|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109363|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109364|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109365|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109366|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
150109367|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109368|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109369|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109370|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109371|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109372|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109373|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109374|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109375|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150188309|NCT03281291|541829122|FG000|Overall Study|Other|0|||
150188310|NCT03281291|541829123|FG001|Overall Study|Other|2|||
150188311|NCT03281291|541829124|FG002|Overall Study|Other|0|||
150109376|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109377|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109378|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109379|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109380|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
150109381|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
150109382|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
150109383|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
150109384|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109385|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109386|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109387|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109388|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109389|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109390|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
150109391|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109392|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109393|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109394|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109395|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109396|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109397|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
150109398|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109399|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109400|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109401|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109402|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109403|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109404|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109405|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109406|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109407|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109408|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109409|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109410|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109411|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109412|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109413|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109414|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
150109415|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109416|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109417|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109418|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109419|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109420|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109421|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109422|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109423|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
150109424|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109425|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109426|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
150109427|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109428|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
150109429|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
150109430|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109431|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109432|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109433|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109434|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150188312|NCT03281291|541829125|FG003|Overall Study|Other|2|||
150188313|NCT03281291|541829126|FG004|Overall Study|Other|1|||
150188314|NCT02736409|541829127|FG000|Overall Study|Withdrawal by Subject|4|||
150188315|NCT02736409|541829128|FG001|Overall Study|Withdrawal by Subject|2|||
150188316|NCT02736409|541829129|FG002|Overall Study|Withdrawal by Subject|17|||
150188317|NCT02736409|541829130|FG003|Overall Study|Withdrawal by Subject|3|||
150188318|NCT02736409|541829127|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150188319|NCT02736409|541829128|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150188320|NCT02736409|541829129|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150188321|NCT02736409|541829130|FG003|Overall Study|Non-Compliance with Study Drug|1|||
150188322|NCT02736409|541829127|FG000|Overall Study|Adverse Event|0|||
150188323|NCT02736409|541829128|FG001|Overall Study|Adverse Event|1|||
150188324|NCT02736409|541829129|FG002|Overall Study|Adverse Event|5|||
150188325|NCT02736409|541829130|FG003|Overall Study|Adverse Event|4|||
150188326|NCT02736409|541829127|FG000|Overall Study|Other|0|||
150188327|NCT02736409|541829128|FG001|Overall Study|Other|0|||
150188328|NCT02736409|541829129|FG002|Overall Study|Other|1|||
150188329|NCT02736409|541829130|FG003|Overall Study|Other|1|||
150188330|NCT02736409|541829127|FG000|Overall Study|Pregnancy|0|||
150188331|NCT02736409|541829128|FG001|Overall Study|Pregnancy|0|||
150188332|NCT02736409|541829129|FG002|Overall Study|Pregnancy|1|||
150188333|NCT02736409|541829130|FG003|Overall Study|Pregnancy|0|||
150188334|NCT02736409|541829127|FG000|Overall Study|Lost to Follow-up|0|||
150188335|NCT02736409|541829128|FG001|Overall Study|Lost to Follow-up|0|||
150188336|NCT02736409|541829129|FG002|Overall Study|Lost to Follow-up|2|||
150188337|NCT02736409|541829130|FG003|Overall Study|Lost to Follow-up|1|||
150188338|NCT02736409|541829127|FG000|Overall Study|Physician Decision|0|||
150188339|NCT02736409|541829128|FG001|Overall Study|Physician Decision|0|||
150188340|NCT02736409|541829129|FG002|Overall Study|Physician Decision|0|||
150188341|NCT02736409|541829130|FG003|Overall Study|Physician Decision|2|||
150188342|NCT01415154|541829131|FG000|Overall Study|Lack of Efficacy|4|||
150188343|NCT01415154|541829132|FG001|Overall Study|Lack of Efficacy|5|||
150188344|NCT01415154|541829131|FG000|Overall Study|Withdrawal by Subject|7|||
150188345|NCT01415154|541829132|FG001|Overall Study|Withdrawal by Subject|8|||
150188346|NCT01415154|541829131|FG000|Overall Study|Lost to Follow-up|1|||
150188347|NCT01415154|541829132|FG001|Overall Study|Lost to Follow-up|4|||
150188348|NCT01415154|541829131|FG000|Overall Study|Protocol Violation|0|||
150188349|NCT01415154|541829132|FG001|Overall Study|Protocol Violation|1|||
150188350|NCT01415154|541829131|FG000|Overall Study|Satisfactory Response|0|||
150188351|NCT01415154|541829132|FG001|Overall Study|Satisfactory Response|1|||
150188352|NCT01415154|541829131|FG000|Overall Study|Adverse Event|1|||
150188353|NCT01415154|541829132|FG001|Overall Study|Adverse Event|1|||
150188354|NCT03126019|541829133|FG000|Overall Study|Death|5|||
150188355|NCT03126019|541829134|FG001|Overall Study|Death|27|||
150188356|NCT03126019|541829133|FG000|Overall Study|Lost to Follow-up|2|||
150188357|NCT03126019|541829134|FG001|Overall Study|Lost to Follow-up|4|||
150188358|NCT03126019|541829133|FG000|Overall Study|Withdrawal by Subject|1|||
150188359|NCT03126019|541829134|FG001|Overall Study|Withdrawal by Subject|9|||
150188360|NCT03126019|541829133|FG000|Overall Study|Physician Decision|1|||
150188361|NCT03126019|541829134|FG001|Overall Study|Physician Decision|0|||
150188362|NCT03126019|541829133|FG000|Overall Study|Transitioned to Rollover Study|0|||
150188363|NCT03126019|541829134|FG001|Overall Study|Transitioned to Rollover Study|11|||
150188364|NCT03126019|541829133|FG000|Overall Study|Did Not Return to Site for Care|0|||
150188365|NCT03126019|541829134|FG001|Overall Study|Did Not Return to Site for Care|1|||
150188366|NCT03126019|541829133|FG000|Overall Study|Site Closed|0|||
150188367|NCT03126019|541829134|FG001|Overall Study|Site Closed|1|||
150188368|NCT06283173|541829164|FG000|Overall Study|Did not show for first visit|10|||
150188369|NCT06283173|541829164|FG000|Overall Study|Lost to Follow-up|12|||
150109435|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109436|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109437|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109438|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
150109439|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109440|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109441|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109442|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109443|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109444|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109445|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109446|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150188370|NCT06283173|541829164|FG000|Overall Study|Physician Decision|7|||
150188371|NCT03332017|541829165|FG000|Overall Study|Lost to Follow-up|1|||
150188372|NCT03332017|541829166|FG001|Overall Study|Lost to Follow-up|2|||
150188373|NCT03332017|541829165|FG000|Overall Study|Death|17|||
150109447|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109448|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
150109449|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109450|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109451|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109452|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109453|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109454|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109455|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109456|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109457|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109458|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109459|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109460|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109461|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109462|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
150109463|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109464|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109465|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109466|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109467|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109468|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109469|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109470|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109471|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109472|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109473|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
150109474|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109475|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109476|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109477|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109478|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109479|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109480|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109481|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109482|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109483|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109484|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109485|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109486|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
150109487|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109488|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109489|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109490|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109491|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109492|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109493|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109494|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109495|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109496|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109497|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150188374|NCT03332017|541829166|FG001|Overall Study|Death|16|||
150188375|NCT03332017|541829165|FG000|Overall Study|Withdrawal by Subject|6|||
150188376|NCT03332017|541829166|FG001|Overall Study|Withdrawal by Subject|14|||
150188377|NCT03332017|541829165|FG000|Overall Study|Other|1|||
150188378|NCT03332017|541829166|FG001|Overall Study|Other|3|||
150188379|NCT03332017|541829165|FG000|Overall Study|Remained in Study (Ongoing)|47|||
150188380|NCT03332017|541829166|FG001|Overall Study|Remained in Study (Ongoing)|110|||
150188381|NCT03406871|541829170|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
150109498|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109499|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109500|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109501|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
150109502|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109503|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109504|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109505|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109506|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109507|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109508|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109509|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109510|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
150109511|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109512|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109513|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109514|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109515|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109516|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109517|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109518|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109519|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109520|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109521|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109522|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109523|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109524|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109525|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
150109526|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109527|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109528|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109529|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109530|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109531|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109532|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109533|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109534|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
150109535|NCT02346240|541540279|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109536|NCT02346240|541540280|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109537|NCT02346240|541540281|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109538|NCT02346240|541540282|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109539|NCT02346240|541540283|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150188382|NCT03406871|541829171|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
150188383|NCT03406871|541829172|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
150188384|NCT03406871|541829170|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
150188385|NCT03406871|541829171|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
150188386|NCT03406871|541829172|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
150188387|NCT03406871|541829170|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
150188388|NCT03406871|541829171|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
150188389|NCT03406871|541829172|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
150188390|NCT03406871|541829170|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
150188391|NCT03406871|541829171|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
150188392|NCT03406871|541829172|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
150188393|NCT03406871|541829170|FG000|Expansion Cohort(Final Analysis)|Death|0|||
150188394|NCT03406871|541829171|FG001|Expansion Cohort(Final Analysis)|Death|1|||
150188395|NCT03406871|541829172|FG002|Expansion Cohort(Final Analysis)|Death|0|||
150188396|NCT03406871|541829170|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
150188397|NCT03406871|541829171|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
150188398|NCT03406871|541829172|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
150188399|NCT02281955|541829181|FG000|Overall Study|Death|1|||
150188400|NCT03535272|541829187|FG000|Overall Study|Lost to Follow-up|71|||
150188401|NCT03535272|541829188|FG001|Overall Study|Lost to Follow-up|73|||
150188402|NCT03892616|541829191|FG000|Washout Period 2|Met discontinuation criterion|0|||
150188403|NCT03892616|541829192|FG001|Washout Period 2|Met discontinuation criterion|0|||
150188404|NCT03892616|541829193|FG002|Washout Period 2|Met discontinuation criterion|0|||
150188405|NCT03892616|541829194|FG003|Washout Period 2|Met discontinuation criterion|0|||
150188406|NCT03892616|541829195|FG004|Washout Period 2|Met discontinuation criterion|0|||
150188407|NCT03892616|541829196|FG005|Washout Period 2|Met discontinuation criterion|0|||
150188408|NCT03892616|541829197|FG006|Washout Period 2|Met discontinuation criterion|0|||
150188409|NCT03892616|541829198|FG007|Washout Period 2|Met discontinuation criterion|0|||
150188410|NCT03892616|541829199|FG008|Washout Period 2|Met discontinuation criterion|1|||
150188411|NCT03892616|541829200|FG009|Washout Period 2|Met discontinuation criterion|0|||
150188412|NCT03892616|541829201|FG010|Washout Period 2|Met discontinuation criterion|0|||
150188413|NCT03892616|541829202|FG011|Washout Period 2|Met discontinuation criterion|0|||
150188414|NCT04177823|541829205|FG000|Overall Study|Physician Decision|1|||
150188415|NCT04177823|541829205|FG000|Overall Study|Withdrawal by Subject|1|||
150188416|NCT04229992|541829206|FG000|Overall Study|Withdrawal by Subject|0|||
150188417|NCT04229992|541829207|FG001|Overall Study|Withdrawal by Subject|2|||
150188418|NCT04229992|541829208|FG002|Overall Study|Withdrawal by Subject|1|||
150188419|NCT04229992|541829209|FG003|Overall Study|Withdrawal by Subject|1|||
150188420|NCT04229992|541829206|FG000|Overall Study|Adverse Event|1|||
150188421|NCT04229992|541829207|FG001|Overall Study|Adverse Event|1|||
150188422|NCT04229992|541829208|FG002|Overall Study|Adverse Event|3|||
150188423|NCT04229992|541829209|FG003|Overall Study|Adverse Event|1|||
150188424|NCT04229992|541829206|FG000|Overall Study|Lost to Follow-up|0|||
150188425|NCT04229992|541829207|FG001|Overall Study|Lost to Follow-up|0|||
150188426|NCT04229992|541829208|FG002|Overall Study|Lost to Follow-up|0|||
150188427|NCT04229992|541829209|FG003|Overall Study|Lost to Follow-up|1|||
150188428|NCT04347161|541829210|FG000|Overall Study|Death|0|||
150188429|NCT04347161|541829211|FG001|Overall Study|Death|2|||
150188430|NCT04347161|541829210|FG000|Overall Study|Withdrawal by Subject|1|||
150188431|NCT04347161|541829211|FG001|Overall Study|Withdrawal by Subject|0|||
150188432|NCT04347161|541829210|FG000|Overall Study|Lost to Follow-up|0|||
150188433|NCT04347161|541829211|FG001|Overall Study|Lost to Follow-up|1|||
150188434|NCT04347161|541829210|FG000|Overall Study|No longer on study medication|1|||
150188435|NCT04347161|541829211|FG001|Overall Study|No longer on study medication|1|||
150188436|NCT04169373|541829212|FG000|Week 1 to Week 14|Adverse Event|1|||
150188437|NCT04169373|541829213|FG001|Week 1 to Week 14|Adverse Event|0|||
150188438|NCT04169373|541829214|FG002|Week 1 to Week 14|Adverse Event|1|||
150188439|NCT04169373|541829215|FG003|Week 1 to Week 14|Adverse Event|2|||
150188440|NCT04169373|541829212|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
150188441|NCT04169373|541829213|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
150188442|NCT04169373|541829214|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
150188443|NCT04169373|541829215|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
150188444|NCT04169373|541829212|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
150188445|NCT04169373|541829213|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
150188446|NCT04169373|541829214|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
150188447|NCT04169373|541829215|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
150188448|NCT04169373|541829212|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
150188449|NCT04169373|541829213|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
150255269|NCT00700427|542070610|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
150255270|NCT00700427|542070611|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
150255271|NCT00700427|542070612|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
150255272|NCT00700427|542070613|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
150109540|NCT02346240|541540284|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109541|NCT02346240|541540285|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109542|NCT02346240|541540286|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109543|NCT02346240|541540287|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109544|NCT02346240|541540288|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109545|NCT02346240|541540289|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109546|NCT02346240|541540290|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109547|NCT02346240|541540291|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109548|NCT02346240|541540292|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109549|NCT02346240|541540293|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
150109550|NCT02346240|541540294|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109551|NCT02346240|541540295|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109552|NCT02346240|541540296|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109553|NCT02346240|541540297|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109554|NCT02346240|541540298|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109555|NCT02346240|541540299|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109556|NCT02346240|541540300|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109557|NCT02346240|541540301|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109558|NCT02346240|541540302|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
150109559|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109560|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109561|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109562|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109563|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109564|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109565|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109566|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109567|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109568|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109569|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109570|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109571|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109572|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109573|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109574|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109575|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
150109576|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
150109577|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
150109578|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
150109579|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
150109580|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
150109581|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
150109582|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
150109583|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109584|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109585|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109586|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109587|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109588|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109589|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109590|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109591|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109592|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109593|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109594|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109595|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109596|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109597|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109598|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109599|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109600|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109601|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
150109602|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
150109603|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109604|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
150109605|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109606|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
150109607|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109608|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109609|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109610|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109611|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109612|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109613|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109614|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109615|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109616|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109617|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109618|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109619|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109620|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109621|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109622|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109623|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109624|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109625|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
150109626|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109627|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109628|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
150109629|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109630|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
150109631|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109632|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109633|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109634|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109635|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109636|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109637|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109638|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109639|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109640|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109641|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109642|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109643|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109644|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109645|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109646|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109647|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109648|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109649|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109650|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109651|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109652|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
150109653|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109654|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
150109655|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109656|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109657|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109658|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109659|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109660|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109661|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109662|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109663|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109664|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109665|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109666|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109667|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109668|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109669|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109670|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109671|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109672|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
150109673|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
150109674|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
150109675|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
150109676|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
150109677|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
150109678|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
150109679|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109680|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109681|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109682|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109683|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109684|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109685|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109686|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109687|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109688|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109689|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109690|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109691|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109692|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109693|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109694|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109695|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109696|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109697|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
150109698|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
150109699|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
150109700|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
150109701|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
150109702|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
150109703|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109704|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109705|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109706|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109707|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109708|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109709|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109710|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109711|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109712|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109713|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109714|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109715|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109716|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109717|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109718|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109719|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109720|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109721|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
150109722|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109723|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
150109724|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
150109725|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
150109726|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
150109727|NCT02346240|541540279|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109728|NCT02346240|541540280|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109729|NCT02346240|541540281|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109730|NCT02346240|541540282|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109731|NCT02346240|541540283|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109732|NCT02346240|541540284|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109733|NCT02346240|541540285|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109734|NCT02346240|541540286|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109735|NCT02346240|541540287|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109736|NCT02346240|541540288|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109737|NCT02346240|541540289|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109738|NCT02346240|541540290|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109739|NCT02346240|541540291|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109740|NCT02346240|541540292|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109741|NCT02346240|541540293|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109742|NCT02346240|541540294|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109743|NCT02346240|541540295|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109744|NCT02346240|541540296|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109745|NCT02346240|541540297|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
150109746|NCT02346240|541540298|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109747|NCT02346240|541540299|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109748|NCT02346240|541540300|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109749|NCT02346240|541540301|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109750|NCT02346240|541540302|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
150109751|NCT02942017|541540303|FG000|Overall Study|Adverse Event|0|||
150109752|NCT02942017|541540304|FG001|Overall Study|Adverse Event|1|||
150109753|NCT02942017|541540303|FG000|Overall Study|Withdrawal by Subject|0|||
150109754|NCT02942017|541540304|FG001|Overall Study|Withdrawal by Subject|1|||
150109755|NCT02942017|541540303|FG000|Overall Study|Lost to Follow-up|1|||
150109756|NCT02942017|541540304|FG001|Overall Study|Lost to Follow-up|1|||
150109757|NCT02942017|541540303|FG000|Overall Study|Randomized but not dosed|1|||
150109758|NCT02942017|541540304|FG001|Overall Study|Randomized but not dosed|3|||
150109759|NCT03417141|541540305|FG000|Overall Study|Withdrawal by Subject|1|||
150109760|NCT03417141|541540305|FG000|Overall Study|Protocol Violation|3|||
150109761|NCT03465878|541540308|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
150109762|NCT03465878|541540309|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
150109763|NCT03465878|541540310|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
150109764|NCT03465878|541540311|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
150109765|NCT03465878|541540308|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
150109766|NCT03465878|541540309|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
150109767|NCT03465878|541540310|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
150109768|NCT03465878|541540311|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
150109769|NCT03465878|541540308|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
150109770|NCT03465878|541540309|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
150109771|NCT03465878|541540310|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
150109772|NCT03465878|541540311|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
150109773|NCT04019041|541540312|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
150109774|NCT04019041|541540313|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
150109775|NCT04019041|541540314|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
150109776|NCT04019041|541540315|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150109777|NCT04019041|541540316|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150109778|NCT04019041|541540317|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150109779|NCT04019041|541540312|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
150109780|NCT04019041|541540313|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
150109781|NCT04019041|541540314|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
150109782|NCT04019041|541540315|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
150109783|NCT04019041|541540316|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
150109784|NCT04019041|541540317|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
150109785|NCT04019041|541540312|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
150188450|NCT04169373|541829214|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
150188451|NCT04169373|541829215|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
150188452|NCT04169373|541829212|FG000|Week 1 to Week 14|Other|1|||
150109786|NCT04019041|541540313|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
150109787|NCT04019041|541540314|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
150109788|NCT04019041|541540315|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150109789|NCT04019041|541540316|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150109790|NCT04019041|541540317|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150109791|NCT04019041|541540312|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
150109792|NCT04019041|541540313|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
150109793|NCT04019041|541540314|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
150109794|NCT04019041|541540315|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
150109795|NCT04019041|541540316|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
150109796|NCT04019041|541540317|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
150109797|NCT04019041|541540312|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150109798|NCT04019041|541540313|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150109799|NCT04019041|541540314|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150109800|NCT04019041|541540315|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
150109801|NCT04019041|541540316|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
150109802|NCT04019041|541540317|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
150109803|NCT04019041|541540312|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
150109804|NCT04019041|541540313|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
150109805|NCT04019041|541540314|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
150109806|NCT04019041|541540315|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
150109807|NCT04019041|541540316|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
150109808|NCT04019041|541540317|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
150109809|NCT04019041|541540312|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
150109810|NCT04019041|541540313|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
150109811|NCT04019041|541540314|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
150109812|NCT04019041|541540315|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
150109813|NCT04019041|541540316|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
150109814|NCT04019041|541540317|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
150109815|NCT04019041|541540312|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150109816|NCT04019041|541540313|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150109817|NCT04019041|541540314|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150109818|NCT04019041|541540315|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
150109819|NCT04019041|541540316|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
150109820|NCT04019041|541540317|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
150109821|NCT04019041|541540312|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150109822|NCT04019041|541540313|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150109823|NCT04019041|541540314|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150109824|NCT04019041|541540315|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150109825|NCT04019041|541540316|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
150109826|NCT04019041|541540317|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
150109827|NCT02540954|541540318|FG000|Overall Study|Physician Decision|3|||
150109828|NCT02540954|541540319|FG001|Overall Study|Physician Decision|1|||
150109829|NCT02540954|541540318|FG000|Overall Study|Withdrawal by Subject|6|||
150109830|NCT02540954|541540319|FG001|Overall Study|Withdrawal by Subject|5|||
150109831|NCT02540954|541540318|FG000|Overall Study|Lost to Follow-up|1|||
150109832|NCT02540954|541540319|FG001|Overall Study|Lost to Follow-up|1|||
150109833|NCT02540954|541540318|FG000|Overall Study|Adverse Event|4|||
150109834|NCT02540954|541540319|FG001|Overall Study|Adverse Event|2|||
150109835|NCT02540954|541540318|FG000|Overall Study|Death|0|||
150109836|NCT02540954|541540319|FG001|Overall Study|Death|3|||
150109837|NCT02540954|541540318|FG000|Overall Study|Treatment failure|1|||
150109838|NCT02540954|541540319|FG001|Overall Study|Treatment failure|0|||
150109839|NCT02540954|541540318|FG000|Overall Study|Other reason|4|||
150109840|NCT02540954|541540319|FG001|Overall Study|Other reason|2|||
150109841|NCT01393743|541540320|FG000|Core Study|Adverse Event|5|||
150109842|NCT01393743|541540321|FG001|Core Study|Adverse Event|9|||
150109843|NCT01393743|541540322|FG002|Core Study|Adverse Event|0|||
150109844|NCT01393743|541540320|FG000|Core Study|Lost to Follow-up|1|||
150109845|NCT01393743|541540321|FG001|Core Study|Lost to Follow-up|1|||
150109846|NCT01393743|541540322|FG002|Core Study|Lost to Follow-up|0|||
150109847|NCT01393743|541540320|FG000|Core Study|Participant's Choice|2|||
150109848|NCT01393743|541540321|FG001|Core Study|Participant's Choice|3|||
150109849|NCT01393743|541540322|FG002|Core Study|Participant's Choice|0|||
150109850|NCT01393743|541540320|FG000|Core Study|Inadequate therapeutic effect|2|||
150109851|NCT01393743|541540321|FG001|Core Study|Inadequate therapeutic effect|0|||
150109852|NCT01393743|541540322|FG002|Core Study|Inadequate therapeutic effect|0|||
150109853|NCT01393743|541540320|FG000|Extension Phase|Adverse Event|0|||
150109854|NCT01393743|541540321|FG001|Extension Phase|Adverse Event|0|||
150109855|NCT01393743|541540322|FG002|Extension Phase|Adverse Event|12|||
150109856|NCT01393743|541540320|FG000|Extension Phase|Lost to Follow-up|0|||
150109857|NCT01393743|541540321|FG001|Extension Phase|Lost to Follow-up|0|||
150109858|NCT01393743|541540322|FG002|Extension Phase|Lost to Follow-up|2|||
150109859|NCT01393743|541540320|FG000|Extension Phase|Participant choice|0|||
150109860|NCT01393743|541540321|FG001|Extension Phase|Participant choice|0|||
150109861|NCT01393743|541540322|FG002|Extension Phase|Participant choice|16|||
150109862|NCT01393743|541540320|FG000|Extension Phase|Inadequate therapeutic effect|0|||
150109863|NCT01393743|541540321|FG001|Extension Phase|Inadequate therapeutic effect|0|||
150109864|NCT01393743|541540322|FG002|Extension Phase|Inadequate therapeutic effect|7|||
150109865|NCT01393743|541540320|FG000|Extension Phase|Withdrawal by Subject|0|||
150109866|NCT01393743|541540321|FG001|Extension Phase|Withdrawal by Subject|0|||
150109867|NCT01393743|541540322|FG002|Extension Phase|Withdrawal by Subject|8|||
150109868|NCT01393743|541540320|FG000|Extension Phase|Pregnancy|0|||
150109869|NCT01393743|541540321|FG001|Extension Phase|Pregnancy|0|||
150109870|NCT01393743|541540322|FG002|Extension Phase|Pregnancy|1|||
150109871|NCT01393743|541540320|FG000|Extension Phase|Other|0|||
150109872|NCT01393743|541540321|FG001|Extension Phase|Other|0|||
150109873|NCT01393743|541540322|FG002|Extension Phase|Other|14|||
150109874|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
150109875|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
150109876|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
150109877|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
150109878|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
150109879|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
150109880|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
150109881|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
150109882|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
150109883|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
150109884|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
150109885|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
150109886|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
150109887|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
150109888|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
150109889|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
150109890|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
150109891|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
150109892|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
150109893|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
150109894|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Other|3|||
150109895|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Other|0|||
150109896|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Other|2|||
150109897|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Other|2|||
150109898|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Other|7|||
150109899|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150188453|NCT04169373|541829213|FG001|Week 1 to Week 14|Other|3|||
150188454|NCT04169373|541829214|FG002|Week 1 to Week 14|Other|3|||
150188455|NCT04169373|541829215|FG003|Week 1 to Week 14|Other|5|||
150188456|NCT04169373|541829212|FG000|Week 14 to Week 52|Adverse Event|1|||
150188457|NCT04169373|541829213|FG001|Week 14 to Week 52|Adverse Event|0|||
150188458|NCT04169373|541829214|FG002|Week 14 to Week 52|Adverse Event|0|||
150188459|NCT04169373|541829215|FG003|Week 14 to Week 52|Adverse Event|1|||
150188460|NCT04169373|541829212|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
150188461|NCT04169373|541829213|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
150188462|NCT04169373|541829214|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
150109900|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109901|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109902|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
150109903|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109904|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109905|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109906|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109907|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109908|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
150188463|NCT04169373|541829215|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
150109909|NCT00213148|541540323|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
150109910|NCT00213148|541540324|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
150109911|NCT00213148|541540325|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
150109912|NCT00213148|541540326|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
150109913|NCT00213148|541540327|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
150109914|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
150109915|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
150109916|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
150109917|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
150109918|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
150109919|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
150109920|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
150109921|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
150109922|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
150109923|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
150109924|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Other|2|||
150109925|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Other|1|||
150109926|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Other|2|||
150109927|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Other|8|||
150109928|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Other|7|||
150109929|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109930|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
150109931|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109932|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109933|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
150109934|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
150109935|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109936|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109937|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109938|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
150109939|NCT00213148|541540323|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
150109940|NCT00213148|541540324|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
150109941|NCT00213148|541540325|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
150109942|NCT00213148|541540326|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
150109943|NCT00213148|541540327|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
150109944|NCT00213148|541540323|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
150109945|NCT00213148|541540324|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
150109946|NCT00213148|541540325|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
150109947|NCT00213148|541540326|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
150109948|NCT00213148|541540327|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
150109949|NCT00213148|541540323|FG000|Cycle 3 (1 Month)|Other|0|||
150109950|NCT00213148|541540324|FG001|Cycle 3 (1 Month)|Other|0|||
150109951|NCT00213148|541540325|FG002|Cycle 3 (1 Month)|Other|1|||
150109952|NCT00213148|541540326|FG003|Cycle 3 (1 Month)|Other|1|||
150109953|NCT00213148|541540327|FG004|Cycle 3 (1 Month)|Other|0|||
150109954|NCT01723228|541540329|FG000|Overall Study|Adverse Event|2|||
150109955|NCT01723228|541540330|FG001|Overall Study|Adverse Event|6|||
150109956|NCT01723228|541540329|FG000|Overall Study|Withdrawal by Subject|2|||
150109957|NCT01723228|541540330|FG001|Overall Study|Withdrawal by Subject|1|||
150109958|NCT01723228|541540329|FG000|Overall Study|Protocol Violation|0|||
150109959|NCT01723228|541540330|FG001|Overall Study|Protocol Violation|2|||
150109960|NCT01723228|541540329|FG000|Overall Study|Lost to Follow-up|2|||
150109961|NCT01723228|541540330|FG001|Overall Study|Lost to Follow-up|1|||
150109962|NCT01723228|541540329|FG000|Overall Study|Other|2|||
150109963|NCT01723228|541540330|FG001|Overall Study|Other|1|||
150109964|NCT01806896|541540331|FG000|Overall Study|Adverse Event|2|||
150109965|NCT01806896|541540332|FG001|Overall Study|Adverse Event|0|||
150109966|NCT01806896|541540331|FG000|Overall Study|Other|1|||
150109967|NCT01806896|541540332|FG001|Overall Study|Other|0|||
150109968|NCT02434770|541540333|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
150109969|NCT02434770|541540334|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
150109970|NCT02434770|541540335|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
150109971|NCT02434770|541540333|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
150109972|NCT02434770|541540334|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
150109973|NCT02434770|541540335|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
150109974|NCT02434770|541540333|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
150109975|NCT02434770|541540334|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
150109976|NCT02434770|541540335|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
150109977|NCT02434770|541540333|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
150109978|NCT02434770|541540334|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
150109979|NCT02434770|541540335|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
150109980|NCT02434770|541540333|FG000|Week 1 to Week 18|Death|1|||
150109981|NCT02434770|541540334|FG001|Week 1 to Week 18|Death|0|||
150109982|NCT02434770|541540335|FG002|Week 1 to Week 18|Death|0|||
150109983|NCT02434770|541540333|FG000|Week 18 to Week|Lost to Follow-up|2|||
150109984|NCT02434770|541540334|FG001|Week 18 to Week|Lost to Follow-up|2|||
150188464|NCT04169373|541829212|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
150188465|NCT04169373|541829213|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
150188466|NCT04169373|541829214|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
150188467|NCT04169373|541829215|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
150188468|NCT04169373|541829212|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
150188469|NCT04169373|541829213|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
150188470|NCT04169373|541829214|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
150188471|NCT04169373|541829215|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
150188472|NCT04169373|541829212|FG000|Week 14 to Week 52|Other|4|||
150188473|NCT04169373|541829213|FG001|Week 14 to Week 52|Other|5|||
150188474|NCT04169373|541829214|FG002|Week 14 to Week 52|Other|4|||
150188475|NCT04169373|541829215|FG003|Week 14 to Week 52|Other|5|||
150188476|NCT04169373|541829212|FG000|Week 14 to Week 52|Ongoing|0|||
150188477|NCT04169373|541829213|FG001|Week 14 to Week 52|Ongoing|1|||
150188478|NCT04169373|541829214|FG002|Week 14 to Week 52|Ongoing|0|||
150188479|NCT04169373|541829215|FG003|Week 14 to Week 52|Ongoing|0|||
150188480|NCT04610892|541829216|FG000|Overall Study|Adverse Event|1|||
150188481|NCT04610892|541829217|FG001|Overall Study|Adverse Event|0|||
150188482|NCT04610892|541829218|FG002|Overall Study|Adverse Event|0|||
150188483|NCT04610892|541829219|FG003|Overall Study|Adverse Event|1|||
150188484|NCT04610892|541829220|FG004|Overall Study|Adverse Event|3|||
150188485|NCT04610892|541829216|FG000|Overall Study|Death|0|||
150188486|NCT04610892|541829217|FG001|Overall Study|Death|1|||
150188487|NCT04610892|541829218|FG002|Overall Study|Death|0|||
150188488|NCT04610892|541829219|FG003|Overall Study|Death|1|||
150188489|NCT04610892|541829220|FG004|Overall Study|Death|0|||
150188490|NCT04610892|541829216|FG000|Overall Study|Withdrawal by Subject|3|||
150188491|NCT04610892|541829217|FG001|Overall Study|Withdrawal by Subject|2|||
150109985|NCT02434770|541540335|FG002|Week 18 to Week|Lost to Follow-up|1|||
150109986|NCT02434770|541540333|FG000|Week 18 to Week|Withdrawal by Subject|0|||
150109987|NCT02434770|541540334|FG001|Week 18 to Week|Withdrawal by Subject|0|||
150109988|NCT02434770|541540335|FG002|Week 18 to Week|Withdrawal by Subject|2|||
150109989|NCT02434770|541540333|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
150109990|NCT02434770|541540334|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
150109991|NCT02434770|541540335|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
150109992|NCT03080961|541540336|FG000|Overall Study|Withdrawal by Subject|3|||
150109993|NCT00660348|541540337|FG000|Overall Study|Withdrawal by Subject|1|||
150109994|NCT00660348|541540338|FG001|Overall Study|Withdrawal by Subject|0|||
150109995|NCT01282424|541540344|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
150109996|NCT01282424|541540344|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
150109997|NCT01282424|541540344|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
150109998|NCT01282424|541540344|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
150109999|NCT01282424|541540344|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
150110000|NCT01282424|541540344|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
150110001|NCT01282424|541540344|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
150110002|NCT01282424|541540344|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
150110003|NCT02741115|541540345|FG000|Overall Study|Adverse Event|1|||
150110004|NCT02741115|541540346|FG001|Overall Study|Adverse Event|0|||
150110005|NCT02741115|541540345|FG000|Overall Study|Lost to Follow-up|7|||
150110006|NCT02741115|541540346|FG001|Overall Study|Lost to Follow-up|4|||
150188492|NCT04610892|541829218|FG002|Overall Study|Withdrawal by Subject|0|||
150188493|NCT04610892|541829219|FG003|Overall Study|Withdrawal by Subject|6|||
150188494|NCT04610892|541829220|FG004|Overall Study|Withdrawal by Subject|6|||
150188495|NCT04610892|541829216|FG000|Overall Study|Subjects who did not receive treatment|1|||
150188496|NCT04610892|541829217|FG001|Overall Study|Subjects who did not receive treatment|0|||
150188497|NCT04610892|541829218|FG002|Overall Study|Subjects who did not receive treatment|0|||
150188498|NCT04610892|541829219|FG003|Overall Study|Subjects who did not receive treatment|0|||
150188499|NCT04610892|541829220|FG004|Overall Study|Subjects who did not receive treatment|2|||
150188500|NCT05520190|541829221|FG000|Overall Study|Lost to Follow-up|7|||
150188501|NCT05520190|541829221|FG000|Overall Study|Withdrawal by Subject|2|||
150110007|NCT02741115|541540345|FG000|Overall Study|Withdrawal by Subject|4|||
150110008|NCT02741115|541540346|FG001|Overall Study|Withdrawal by Subject|2|||
150110009|NCT04602624|541540347|FG000|Overall Study|Protocol Deviation|1|||
150188502|NCT03683719|541829222|FG000|Overall Study|Lack of Efficacy|1|||
150110010|NCT04602624|541540347|FG000|Overall Study|Withdrawal by Participant|1|||
150110011|NCT02782949|541540348|FG000|Overall Study|Protocol Violation|1|||
150110012|NCT02782949|541540349|FG001|Overall Study|Protocol Violation|0|||
150110013|NCT02782949|541540348|FG000|Overall Study|Withdrawal by Subject|0|||
150110014|NCT02782949|541540349|FG001|Overall Study|Withdrawal by Subject|1|||
150110015|NCT03316872|541540350|FG000|Overall Study|Death|1|||
150110016|NCT03548584|541541792|FG000|Overall Study|Lost to Follow-up|0|||
150110017|NCT03548584|541541793|FG001|Overall Study|Lost to Follow-up|0|||
150110018|NCT03548584|541541794|FG002|Overall Study|Lost to Follow-up|1|||
150110019|NCT03548584|541541792|FG000|Overall Study|Adverse Event|1|||
150110020|NCT03548584|541541793|FG001|Overall Study|Adverse Event|11|||
150110021|NCT03548584|541541794|FG002|Overall Study|Adverse Event|5|||
150110022|NCT03548584|541541792|FG000|Overall Study|Site Terminated by Sponsor|1|||
150110023|NCT03548584|541541793|FG001|Overall Study|Site Terminated by Sponsor|3|||
150110024|NCT03548584|541541794|FG002|Overall Study|Site Terminated by Sponsor|2|||
150110025|NCT03548584|541541792|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
150110026|NCT03548584|541541793|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
150110027|NCT03548584|541541794|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
150110028|NCT03548584|541541792|FG000|Overall Study|Lack of Efficacy|0|||
150110029|NCT03548584|541541793|FG001|Overall Study|Lack of Efficacy|1|||
150110030|NCT03548584|541541794|FG002|Overall Study|Lack of Efficacy|0|||
150110031|NCT03548584|541541792|FG000|Overall Study|Non-compliance with Study Drug|0|||
150110032|NCT03548584|541541793|FG001|Overall Study|Non-compliance with Study Drug|1|||
150110033|NCT03548584|541541794|FG002|Overall Study|Non-compliance with Study Drug|0|||
150110034|NCT03548584|541541792|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
150110035|NCT03548584|541541793|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
150110036|NCT03548584|541541794|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
150110037|NCT00533949|541541795|FG000|Overall Study|Protocol Violation|12|||
150110038|NCT00533949|541541796|FG001|Overall Study|Protocol Violation|12|||
150110039|NCT00533949|541541797|FG002|Overall Study|Protocol Violation|9|||
150110040|NCT00533949|541541798|FG003|Overall Study|Protocol Violation|9|||
150110041|NCT00533949|541541795|FG000|Overall Study|Withdrawal by Subject|3|||
150110042|NCT00533949|541541796|FG001|Overall Study|Withdrawal by Subject|2|||
150110043|NCT00533949|541541797|FG002|Overall Study|Withdrawal by Subject|1|||
150110044|NCT00533949|541541798|FG003|Overall Study|Withdrawal by Subject|1|||
150110045|NCT00727194|541541799|FG000|Screening Period|Low QMG scores|0|||
150110046|NCT00727194|541541800|FG001|Screening Period|Low QMG scores|0|||
150110047|NCT00727194|541541801|FG002|Screening Period|Low QMG scores|6|||
150110048|NCT00727194|541541799|FG000|Screening Period|Lacked AChR antibodies|0|||
150110049|NCT00727194|541541800|FG001|Screening Period|Lacked AChR antibodies|0|||
150110050|NCT00727194|541541801|FG002|Screening Period|Lacked AChR antibodies|5|||
150110051|NCT00727194|541541799|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
150110052|NCT00727194|541541800|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
150110053|NCT00727194|541541801|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
150110054|NCT00727194|541541799|FG000|Screening Period|Severe infections|0|||
150110055|NCT00727194|541541800|FG001|Screening Period|Severe infections|0|||
150110056|NCT00727194|541541801|FG002|Screening Period|Severe infections|2|||
150110057|NCT00727194|541541799|FG000|Screening Period|History of thymoma|0|||
150110058|NCT00727194|541541800|FG001|Screening Period|History of thymoma|0|||
150110059|NCT00727194|541541801|FG002|Screening Period|History of thymoma|1|||
150110060|NCT00727194|541541799|FG000|Treatment Period 2|Lack of Efficacy|0|||
150110061|NCT00727194|541541800|FG001|Treatment Period 2|Lack of Efficacy|1|||
150110062|NCT00727194|541541801|FG002|Treatment Period 2|Lack of Efficacy|0|||
150110063|NCT04269161|541541802|FG000|Overall Study|Change of modality and no longer eligible|3|||
150110064|NCT04269161|541541803|FG001|Overall Study|Change of modality and no longer eligible|3|||
150110065|NCT04269161|541541802|FG000|Overall Study|Required procedure outside of NICU|1|||
150110066|NCT04269161|541541803|FG001|Overall Study|Required procedure outside of NICU|0|||
150110067|NCT04269161|541541802|FG000|Overall Study|Equipment issue|1|||
150110068|NCT04269161|541541803|FG001|Overall Study|Equipment issue|1|||
150110069|NCT01677195|541541804|FG000|Overall Study|Lost to Follow-up|14|||
150110070|NCT01677195|541541805|FG001|Overall Study|Lost to Follow-up|22|||
150110071|NCT01677195|541541806|FG002|Overall Study|Lost to Follow-up|22|||
150110072|NCT01677195|541541804|FG000|Overall Study|Withdrawal by Subject|1|||
150110073|NCT01677195|541541805|FG001|Overall Study|Withdrawal by Subject|0|||
150110074|NCT01677195|541541806|FG002|Overall Study|Withdrawal by Subject|1|||
150110075|NCT01677195|541541804|FG000|Overall Study|Adverse Event|6|||
150110076|NCT01677195|541541805|FG001|Overall Study|Adverse Event|4|||
150110077|NCT01677195|541541806|FG002|Overall Study|Adverse Event|1|||
150110078|NCT01677195|541541804|FG000|Overall Study|Physician Decision|1|||
150110079|NCT01677195|541541805|FG001|Overall Study|Physician Decision|2|||
150110080|NCT01677195|541541806|FG002|Overall Study|Physician Decision|2|||
150110081|NCT01677195|541541804|FG000|Overall Study|Pregnancy|0|||
150110082|NCT01677195|541541805|FG001|Overall Study|Pregnancy|1|||
150110083|NCT01677195|541541806|FG002|Overall Study|Pregnancy|0|||
150188503|NCT03683719|541829223|FG001|Overall Study|Lack of Efficacy|3|||
150110084|NCT01677195|541541804|FG000|Overall Study|Protocol Violation|7|||
150110085|NCT01677195|541541805|FG001|Overall Study|Protocol Violation|3|||
150110086|NCT01677195|541541806|FG002|Overall Study|Protocol Violation|4|||
150110087|NCT04368429|541541807|FG000|Overall Study|Adverse Event|1|||
150110088|NCT04368429|541541808|FG001|Overall Study|Adverse Event|0|||
150110089|NCT03633396|541541811|FG000|Overall Study|Withdrawal by Subject|4|||
150110090|NCT03633396|541541812|FG001|Overall Study|Withdrawal by Subject|4|||
150110091|NCT03633396|541541811|FG000|Overall Study|Adverse Event|1|||
150110092|NCT03633396|541541812|FG001|Overall Study|Adverse Event|1|||
150110093|NCT03633396|541541811|FG000|Overall Study|Lack of Efficacy|1|||
150110094|NCT03633396|541541812|FG001|Overall Study|Lack of Efficacy|0|||
150110095|NCT03633396|541541811|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
150110096|NCT03633396|541541812|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
150110097|NCT01012817|541541813|FG000|Overall Study|Withdrawal by Subject|0|||
150110098|NCT01012817|541541814|FG001|Overall Study|Withdrawal by Subject|0|||
150110099|NCT01012817|541541815|FG002|Overall Study|Withdrawal by Subject|0|||
150110100|NCT01012817|541541816|FG003|Overall Study|Withdrawal by Subject|1|||
150110101|NCT01012817|541541817|FG004|Overall Study|Withdrawal by Subject|0|||
150110102|NCT01012817|541541818|FG005|Overall Study|Withdrawal by Subject|0|||
150110103|NCT01012817|541541819|FG006|Overall Study|Withdrawal by Subject|0|||
150110104|NCT01012817|541541820|FG007|Overall Study|Withdrawal by Subject|1|||
150110105|NCT01012817|541541821|FG008|Overall Study|Withdrawal by Subject|0|||
150110106|NCT01012817|541541822|FG009|Overall Study|Withdrawal by Subject|0|||
150110107|NCT01012817|541541823|FG010|Overall Study|Withdrawal by Subject|1|||
150110108|NCT01012817|541541824|FG011|Overall Study|Withdrawal by Subject|1|||
150110109|NCT01012817|541541825|FG012|Overall Study|Withdrawal by Subject|0|||
150110110|NCT01012817|541541826|FG013|Overall Study|Withdrawal by Subject|1|||
150110111|NCT01012817|541541813|FG000|Overall Study|Adverse Event|0|||
150110112|NCT01012817|541541814|FG001|Overall Study|Adverse Event|0|||
150110113|NCT01012817|541541815|FG002|Overall Study|Adverse Event|0|||
150110114|NCT01012817|541541816|FG003|Overall Study|Adverse Event|0|||
150110115|NCT01012817|541541817|FG004|Overall Study|Adverse Event|0|||
150110116|NCT01012817|541541818|FG005|Overall Study|Adverse Event|1|||
150110117|NCT01012817|541541819|FG006|Overall Study|Adverse Event|0|||
150110118|NCT01012817|541541820|FG007|Overall Study|Adverse Event|0|||
150110119|NCT01012817|541541821|FG008|Overall Study|Adverse Event|0|||
150110120|NCT01012817|541541822|FG009|Overall Study|Adverse Event|0|||
150110121|NCT01012817|541541823|FG010|Overall Study|Adverse Event|1|||
150110122|NCT01012817|541541824|FG011|Overall Study|Adverse Event|0|||
150110123|NCT01012817|541541825|FG012|Overall Study|Adverse Event|0|||
150110124|NCT01012817|541541826|FG013|Overall Study|Adverse Event|1|||
150110125|NCT02143414|541541827|FG000|Induction|Adverse Event|1|||
150110126|NCT02143414|541541828|FG001|Induction|Adverse Event|2|||
150110127|NCT02143414|541541827|FG000|Induction|Death|1|||
150110128|NCT02143414|541541828|FG001|Induction|Death|2|||
150110129|NCT02143414|541541827|FG000|Induction|Patient refusal|1|||
150110130|NCT02143414|541541828|FG001|Induction|Patient refusal|1|||
150110131|NCT02143414|541541827|FG000|Induction|Refractory|1|||
150110132|NCT02143414|541541828|FG001|Induction|Refractory|0|||
150110133|NCT02143414|541541827|FG000|Induction|Began alternative treatment|1|||
150110134|NCT02143414|541541828|FG001|Induction|Began alternative treatment|0|||
150110135|NCT02143414|541541827|FG000|Induction|Ineligible for postremission|5|||
150110136|NCT02143414|541541828|FG001|Induction|Ineligible for postremission|1|||
150110137|NCT02143414|541541827|FG000|Post-remission|Adverse Event|0|||
150110138|NCT02143414|541541828|FG001|Post-remission|Adverse Event|2|||
150110139|NCT02143414|541541827|FG000|Post-remission|Disease progression/relapse|5|||
150110140|NCT02143414|541541828|FG001|Post-remission|Disease progression/relapse|0|||
150110141|NCT02143414|541541827|FG000|Maintenance|Adverse Event|4|||
150110142|NCT02143414|541541828|FG001|Maintenance|Adverse Event|6|||
150110143|NCT02143414|541541827|FG000|Maintenance|Disease progression/relapse|3|||
150110144|NCT02143414|541541828|FG001|Maintenance|Disease progression/relapse|2|||
150110145|NCT02143414|541541827|FG000|Maintenance|Patient refusal|2|||
150110146|NCT02143414|541541828|FG001|Maintenance|Patient refusal|1|||
150110147|NCT02143414|541541827|FG000|Maintenance|Physician Decision|1|||
150110148|NCT02143414|541541828|FG001|Maintenance|Physician Decision|0|||
150110149|NCT02143414|541541827|FG000|Maintenance|Death|0|||
150110150|NCT02143414|541541828|FG001|Maintenance|Death|1|||
150110151|NCT02143414|541541827|FG000|Maintenance|On protocol treatment|0|||
150110152|NCT02143414|541541828|FG001|Maintenance|On protocol treatment|6|||
150110153|NCT00110266|541541831|FG000|Overall Study|Adverse Event|27|||
150110154|NCT00110266|541541831|FG000|Overall Study|Abnormal laboratory value|15|||
150110155|NCT00110266|541541831|FG000|Overall Study|Withdrawal by Subject|16|||
150110156|NCT00110266|541541831|FG000|Overall Study|Death|17|||
150110157|NCT00110266|541541831|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150110158|NCT00110266|541541831|FG000|Overall Study|Participant condition no longer requires study drug|1|||
150110159|NCT00293384|541541834|FG000|Overall Study|Non-compliance|2|||
150110160|NCT00293384|541541834|FG000|Overall Study|Missed dosage/study drug|1|||
150110161|NCT00293384|541541834|FG000|Overall Study|Ineligible|2|||
150110162|NCT02610192|541541835|FG000|Overall Study|Received other treatment|8|||
150110163|NCT02610192|541541835|FG000|Overall Study|Physician Decision|1|||
150110164|NCT01344057|541541836|FG000|Overall Study|Premature Withdrawal|1|||
150110165|NCT00145509|541541837|FG000|Overall Study|Adverse Event|10|||
150110166|NCT00145509|541541838|FG001|Overall Study|Adverse Event|3|||
150110167|NCT00145509|541541837|FG000|Overall Study|Lack of Efficacy|3|||
150110168|NCT00145509|541541838|FG001|Overall Study|Lack of Efficacy|1|||
150110169|NCT00145509|541541837|FG000|Overall Study|Lost to Follow-up|5|||
150110170|NCT00145509|541541838|FG001|Overall Study|Lost to Follow-up|9|||
150110171|NCT00145509|541541837|FG000|Overall Study|Withdrew Consent|2|||
150110172|NCT00145509|541541838|FG001|Overall Study|Withdrew Consent|7|||
150110173|NCT00145509|541541837|FG000|Overall Study|Reason not provided|2|||
150110174|NCT00145509|541541838|FG001|Overall Study|Reason not provided|1|||
150110175|NCT00749775|541541839|FG000|Overall Study|Protocol Violation|24|||
150110176|NCT00749775|541541839|FG000|Overall Study|Lost to Follow-up|36|||
150110177|NCT00749775|541541839|FG000|Overall Study|No visit after first day of treatment|44|||
150110178|NCT00749775|541541839|FG000|Overall Study|No drug administration|3|||
150110179|NCT05044234|541541840|FG000|Overall Study|Lost to Follow-up|2|||
150110180|NCT05044234|541541841|FG001|Overall Study|Lost to Follow-up|1|||
150110181|NCT05044234|541541842|FG002|Overall Study|Lost to Follow-up|1|||
150110182|NCT05044234|541541843|FG003|Overall Study|Lost to Follow-up|2|||
150110183|NCT05044234|541541840|FG000|Overall Study|Withdrawal by Subject|6|||
150110184|NCT05044234|541541841|FG001|Overall Study|Withdrawal by Subject|4|||
150110185|NCT05044234|541541842|FG002|Overall Study|Withdrawal by Subject|5|||
150110186|NCT05044234|541541843|FG003|Overall Study|Withdrawal by Subject|8|||
150110187|NCT05044234|541541840|FG000|Overall Study|Study terminated by Sponsor|21|||
150110188|NCT05044234|541541841|FG001|Overall Study|Study terminated by Sponsor|21|||
150110189|NCT05044234|541541842|FG002|Overall Study|Study terminated by Sponsor|20|||
150110190|NCT05044234|541541843|FG003|Overall Study|Study terminated by Sponsor|14|||
150110191|NCT05044234|541541840|FG000|Overall Study|Other, not specified|0|||
150110192|NCT05044234|541541841|FG001|Overall Study|Other, not specified|0|||
150110193|NCT05044234|541541842|FG002|Overall Study|Other, not specified|1|||
150110194|NCT05044234|541541843|FG003|Overall Study|Other, not specified|2|||
150110195|NCT05044234|541541840|FG000|Overall Study|Delayed data entry|0|||
150110196|NCT05044234|541541841|FG001|Overall Study|Delayed data entry|0|||
150110197|NCT05044234|541541842|FG002|Overall Study|Delayed data entry|0|||
150110198|NCT05044234|541541843|FG003|Overall Study|Delayed data entry|1|||
150110199|NCT03912233|541541844|FG000|Overall Study|Adverse Event|1|||
150110200|NCT03912233|541541845|FG001|Overall Study|Adverse Event|0|||
150110201|NCT03912233|541541846|FG002|Overall Study|Adverse Event|0|||
150110202|NCT03912233|541541847|FG003|Overall Study|Adverse Event|0|||
150110203|NCT03912233|541541848|FG004|Overall Study|Adverse Event|0|||
150110204|NCT03912233|541541849|FG005|Overall Study|Adverse Event|0|||
150110205|NCT03912233|541541844|FG000|Overall Study|Physician Decision|1|||
150110206|NCT03912233|541541845|FG001|Overall Study|Physician Decision|0|||
150110207|NCT03912233|541541846|FG002|Overall Study|Physician Decision|0|||
150110208|NCT03912233|541541847|FG003|Overall Study|Physician Decision|0|||
150110209|NCT03912233|541541848|FG004|Overall Study|Physician Decision|0|||
150110210|NCT03912233|541541849|FG005|Overall Study|Physician Decision|0|||
150110211|NCT03912233|541541844|FG000|Overall Study|Other|0|||
150110212|NCT03912233|541541845|FG001|Overall Study|Other|0|||
150110213|NCT03912233|541541846|FG002|Overall Study|Other|0|||
150110214|NCT03912233|541541847|FG003|Overall Study|Other|0|||
150110215|NCT03912233|541541848|FG004|Overall Study|Other|7|||
150110216|NCT03912233|541541849|FG005|Overall Study|Other|12|||
150110217|NCT00326911|541541850|FG000|Overall Study|Hospitalization prior to treatment|0|||
150110218|NCT00326911|541541851|FG001|Overall Study|Hospitalization prior to treatment|1|||
150110219|NCT00326911|541541850|FG000|Overall Study|Physician decision prior to treatment|1|||
150110220|NCT00326911|541541851|FG001|Overall Study|Physician decision prior to treatment|0|||
150110221|NCT00326911|541541850|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
150110222|NCT00326911|541541851|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
150110223|NCT01023659|541541855|FG000|Overall Study|Lost to Follow-up|73|||
150110224|NCT01023659|541541856|FG001|Overall Study|Lost to Follow-up|228|||
150110225|NCT01023659|541541857|FG002|Overall Study|Lost to Follow-up|99|||
150110226|NCT04537806|541541859|FG000|Overall Study|Randomized but not treated|1|||
150110227|NCT04537806|541541860|FG001|Overall Study|Randomized but not treated|0|||
150110228|NCT04537806|541541859|FG000|Overall Study|Adverse Event|1|||
150110229|NCT04537806|541541860|FG001|Overall Study|Adverse Event|1|||
150110230|NCT03219333|541541865|FG000|Overall Study|Withdrawal by Subject|9|||
150110231|NCT03219333|541541866|FG001|Overall Study|Withdrawal by Subject|4|||
150110232|NCT03219333|541541865|FG000|Overall Study|Lost to Follow-up|1|||
150110233|NCT03219333|541541866|FG001|Overall Study|Lost to Follow-up|1|||
150110234|NCT03219333|541541865|FG000|Overall Study|Death|104|||
150110235|NCT03219333|541541866|FG001|Overall Study|Death|72|||
150188504|NCT03683719|541829224|FG002|Overall Study|Lack of Efficacy|4|||
150188505|NCT03683719|541829225|FG003|Overall Study|Lack of Efficacy|0|||
150188506|NCT03683719|541829226|FG004|Overall Study|Lack of Efficacy|4|||
150188507|NCT03683719|541829222|FG000|Overall Study|Adverse Event|6|||
150188508|NCT03683719|541829223|FG001|Overall Study|Adverse Event|6|||
150188509|NCT03683719|541829224|FG002|Overall Study|Adverse Event|0|||
150110236|NCT03219333|541541865|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
150110237|NCT03219333|541541866|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
150110238|NCT03219333|541541865|FG000|Overall Study|Other|2|||
150188510|NCT03683719|541829225|FG003|Overall Study|Adverse Event|1|||
150188511|NCT03683719|541829226|FG004|Overall Study|Adverse Event|3|||
150188512|NCT03683719|541829222|FG000|Overall Study|Withdrawal by Subject|4|||
150188513|NCT03683719|541829223|FG001|Overall Study|Withdrawal by Subject|4|||
150188514|NCT03683719|541829224|FG002|Overall Study|Withdrawal by Subject|3|||
150188515|NCT03683719|541829225|FG003|Overall Study|Withdrawal by Subject|5|||
150188516|NCT03683719|541829226|FG004|Overall Study|Withdrawal by Subject|5|||
150188517|NCT03683719|541829222|FG000|Overall Study|Lost to Follow-up|1|||
150188518|NCT03683719|541829223|FG001|Overall Study|Lost to Follow-up|0|||
150188519|NCT03683719|541829224|FG002|Overall Study|Lost to Follow-up|0|||
150188520|NCT03683719|541829225|FG003|Overall Study|Lost to Follow-up|1|||
150188521|NCT03683719|541829226|FG004|Overall Study|Lost to Follow-up|1|||
150188522|NCT03683719|541829222|FG000|Overall Study|Other personal reasons|0|||
150188523|NCT03683719|541829223|FG001|Overall Study|Other personal reasons|0|||
150188524|NCT03683719|541829224|FG002|Overall Study|Other personal reasons|1|||
150188525|NCT03683719|541829225|FG003|Overall Study|Other personal reasons|0|||
150188526|NCT03683719|541829226|FG004|Overall Study|Other personal reasons|1|||
150188527|NCT03232138|541829228|FG000|Overall Study|Physician Decision|1|||
150188528|NCT03232138|541829229|FG001|Overall Study|Physician Decision|0|||
150188529|NCT03232138|541829228|FG000|Overall Study|Adverse Event|2|||
150188530|NCT03232138|541829229|FG001|Overall Study|Adverse Event|0|||
150188531|NCT03232138|541829228|FG000|Overall Study|Withdrawal by Subject|1|||
150188532|NCT03232138|541829229|FG001|Overall Study|Withdrawal by Subject|2|||
150188533|NCT03920111|541829233|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
150188534|NCT03920111|541829234|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
150188535|NCT03920111|541829235|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
150188536|NCT05268393|541829236|FG000|Overall Study|Withdrawal by Subject|2|||
150188537|NCT05268393|541829237|FG001|Overall Study|Withdrawal by Subject|1|||
150188538|NCT05256706|541829238|FG000|Overall Study|Lost to Follow-up|9|||
150188539|NCT05256706|541829239|FG001|Overall Study|Lost to Follow-up|3|||
150188540|NCT05256706|541829238|FG000|Overall Study|Withdrawal by Subject|7|||
150188541|NCT05256706|541829239|FG001|Overall Study|Withdrawal by Subject|11|||
150188542|NCT05256706|541829238|FG000|Overall Study|Screen Failures|3|||
150110239|NCT03219333|541541866|FG001|Overall Study|Other|2|||
150110240|NCT01126541|541541867|FG000|Overall Study|Adverse Event|0|||
150110241|NCT01126541|541541868|FG001|Overall Study|Adverse Event|2|||
150110242|NCT01126541|541541869|FG002|Overall Study|Adverse Event|4|||
150110243|NCT01126541|541541867|FG000|Overall Study|Death|0|||
150110244|NCT01126541|541541868|FG001|Overall Study|Death|1|||
150110245|NCT01126541|541541869|FG002|Overall Study|Death|0|||
150110246|NCT01126541|541541867|FG000|Overall Study|Lack of Efficacy|6|||
150110247|NCT01126541|541541868|FG001|Overall Study|Lack of Efficacy|1|||
150110248|NCT01126541|541541869|FG002|Overall Study|Lack of Efficacy|11|||
150110249|NCT01126541|541541867|FG000|Overall Study|Lost to Follow-up|1|||
150188543|NCT05256706|541829239|FG001|Overall Study|Screen Failures|0|||
150188544|NCT03850678|541829243|FG000|Overall Study|Withdrawal by Subject|3|||
150188545|NCT03850678|541829244|FG001|Overall Study|Withdrawal by Subject|0|||
150188546|NCT03850678|541829243|FG000|Overall Study|Experimenter Error|1|||
150188547|NCT03850678|541829244|FG001|Overall Study|Experimenter Error|1|||
150188548|NCT03850678|541829243|FG000|Overall Study|Did Not Condition To Experiment|7|||
150188549|NCT03850678|541829244|FG001|Overall Study|Did Not Condition To Experiment|2|||
150188550|NCT03720795|541829248|FG000|Phase 1|Lost to Follow-up|4|||
150188551|NCT03720795|541829248|FG000|Phase 1|Withdrawal by Subject|6|||
150188552|NCT03720795|541829248|FG000|Phase 1|Protocol Violation|1|||
150188553|NCT03720795|541829248|FG000|Phase 1|Other|1|||
150188554|NCT03720795|541829248|FG000|Phase 2|Lost to Follow-up|5|||
150188555|NCT03720795|541829248|FG000|Phase 2|Withdrawal by Subject|10|||
150188556|NCT03720795|541829248|FG000|Phase 2|Protocol Violation|2|||
150188557|NCT03720795|541829248|FG000|3 Month Follow Up|Lost to Follow-up|2|||
150188558|NCT04322643|541829249|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
150188559|NCT05134233|541829250|FG000|Overall Study|Pregnancy|1|||
150188560|NCT05134233|541829250|FG000|Overall Study|MEP value too low|2|||
150188561|NCT05134233|541829250|FG000|Overall Study|Lost to Follow-up|1|||
150188562|NCT01573442|541829251|FG000|Overall Study|Cancels|9|||
150188563|NCT01573442|541829252|FG001|Overall Study|Cancels|10|||
150188564|NCT05710107|541829253|FG000|Overall Study|Withdrawal by Subject|1|||
150188565|NCT05710107|541829254|FG001|Overall Study|Withdrawal by Subject|1|||
150188566|NCT05710107|541829253|FG000|Overall Study|Lost to Follow-up|8|||
150188567|NCT05710107|541829254|FG001|Overall Study|Lost to Follow-up|9|||
150110250|NCT01126541|541541868|FG001|Overall Study|Lost to Follow-up|2|||
150110251|NCT01126541|541541869|FG002|Overall Study|Lost to Follow-up|2|||
150110252|NCT01126541|541541867|FG000|Overall Study|Withdrawal by Subject|2|||
150110253|NCT01126541|541541868|FG001|Overall Study|Withdrawal by Subject|5|||
150110254|NCT01126541|541541869|FG002|Overall Study|Withdrawal by Subject|6|||
150110255|NCT01126541|541541867|FG000|Overall Study|Protocol Violation|0|||
150110256|NCT01126541|541541868|FG001|Overall Study|Protocol Violation|0|||
150110257|NCT01126541|541541869|FG002|Overall Study|Protocol Violation|1|||
150110258|NCT01126541|541541867|FG000|Overall Study|Administrative reason or other|1|||
150110259|NCT01126541|541541868|FG001|Overall Study|Administrative reason or other|1|||
150110260|NCT01126541|541541869|FG002|Overall Study|Administrative reason or other|2|||
150110261|NCT04033159|541541870|FG000|Washout Period|Physician Decision|0|||
150110262|NCT04033159|541541871|FG001|Washout Period|Physician Decision|1|||
150110263|NCT04033159|541541872|FG002|Washout Period|Physician Decision|0|||
150110264|NCT04033159|541541870|FG000|Washout Period|Study terminated by Sponsor|0|||
150110265|NCT04033159|541541871|FG001|Washout Period|Study terminated by Sponsor|7|||
150110266|NCT04033159|541541872|FG002|Washout Period|Study terminated by Sponsor|0|||
150110267|NCT04033159|541541870|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
150110268|NCT04033159|541541871|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
150110269|NCT04033159|541541872|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
150110270|NCT01857063|541541875|FG000|Period 1 (7 Days)|Adverse Event|0|||
150110271|NCT01857063|541541876|FG001|Period 1 (7 Days)|Adverse Event|1|||
150110272|NCT01857063|541541875|FG000|Period 1 (7 Days)|Physician Decision|1|||
150110273|NCT01857063|541541876|FG001|Period 1 (7 Days)|Physician Decision|0|||
150110274|NCT01857063|541541875|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
150110275|NCT01857063|541541876|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
150110276|NCT01857063|541541875|FG000|Period 2 (7 Days)|Adverse Event|2|||
150110277|NCT01857063|541541876|FG001|Period 2 (7 Days)|Adverse Event|1|||
150110278|NCT01857063|541541875|FG000|Period 2 (7 Days)|Physician Decision|1|||
150110279|NCT01857063|541541876|FG001|Period 2 (7 Days)|Physician Decision|1|||
150110280|NCT01857063|541541875|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
150110281|NCT01857063|541541876|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
150110282|NCT00715793|541541879|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
150110283|NCT00715793|541541880|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
150110284|NCT00715793|541541879|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
150110285|NCT00715793|541541880|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
150110286|NCT00058825|541541881|FG000|Overall Study|Relapse|9|||
150110287|NCT00058825|541541881|FG000|Overall Study|Progressive Disease|5|||
150110288|NCT00058825|541541881|FG000|Overall Study|Graft Failure|5|||
150110289|NCT00058825|541541881|FG000|Overall Study|Death|3|||
150110290|NCT04115358|541541882|FG000|Overall Study|exfoliation|0|||
150110291|NCT04115358|541541883|FG001|Overall Study|exfoliation|0|||
150110292|NCT04115358|541541884|FG002|Overall Study|exfoliation|1|||
150110293|NCT04399161|541541885|FG000|Overall Study|Withdrawal by Subject|1|||
150110294|NCT04399161|541541886|FG001|Overall Study|Withdrawal by Subject|0|||
150110295|NCT04399161|541541887|FG002|Overall Study|Withdrawal by Subject|2|||
150110296|NCT04399161|541541885|FG000|Overall Study|Protocol Violation|1|||
150110297|NCT04399161|541541886|FG001|Overall Study|Protocol Violation|2|||
150110298|NCT04399161|541541887|FG002|Overall Study|Protocol Violation|0|||
150110299|NCT04552587|541541891|FG000|Overall Study|Lost to Follow-up|4|||
150110300|NCT01822132|541541892|FG000|Overall Study|Lost to Follow-up|4|||
150110301|NCT01822132|541541893|FG001|Overall Study|Lost to Follow-up|2|||
150110302|NCT04847674|541541894|FG000|Overall Study|Withdrawal by Subject|0|||
150110303|NCT04847674|541541895|FG001|Overall Study|Withdrawal by Subject|1|||
150110304|NCT04847674|541541896|FG002|Overall Study|Withdrawal by Subject|0|||
150110305|NCT04847674|541541894|FG000|Overall Study|Lost to Follow-up|0|||
150110306|NCT04847674|541541895|FG001|Overall Study|Lost to Follow-up|0|||
150110307|NCT04847674|541541896|FG002|Overall Study|Lost to Follow-up|2|||
150110308|NCT04847674|541541894|FG000|Overall Study|Other than specified|21|||
150110309|NCT04847674|541541895|FG001|Overall Study|Other than specified|20|||
150110310|NCT04847674|541541896|FG002|Overall Study|Other than specified|20|||
150110311|NCT03400033|541541897|FG000|Overall Study|Withdrawal by Subject|1|||
150110312|NCT03400033|541541898|FG001|Overall Study|Withdrawal by Subject|2|||
150110313|NCT01524770|541541903|FG000|First Intervention|Withdrawal by Subject|1|||
150110314|NCT01524770|541541904|FG001|First Intervention|Withdrawal by Subject|0|||
150110315|NCT01524770|541541903|FG000|First Intervention|Adverse Event|1|||
150110316|NCT01524770|541541904|FG001|First Intervention|Adverse Event|1|||
150110317|NCT01524770|541541903|FG000|First Intervention|Protocol Violation|1|||
150110318|NCT01524770|541541904|FG001|First Intervention|Protocol Violation|0|||
150110319|NCT00689481|541541906|FG000|Overall Study|Adverse Event|7|||
150188568|NCT05710107|541829253|FG000|Overall Study|Unable to place assigned block|2|||
150110320|NCT00689481|541541907|FG001|Overall Study|Adverse Event|1|||
150110321|NCT00689481|541541906|FG000|Overall Study|Lost to Follow-up|4|||
150110322|NCT00689481|541541907|FG001|Overall Study|Lost to Follow-up|3|||
150110323|NCT00689481|541541906|FG000|Overall Study|Lack of Efficacy|4|||
150110324|NCT00689481|541541907|FG001|Overall Study|Lack of Efficacy|3|||
150110325|NCT00689481|541541906|FG000|Overall Study|Non-compliance with study treatment|1|||
150110326|NCT00689481|541541907|FG001|Overall Study|Non-compliance with study treatment|1|||
150110327|NCT00689481|541541906|FG000|Overall Study|Withdrawal by Subject|8|||
150110328|NCT00689481|541541907|FG001|Overall Study|Withdrawal by Subject|4|||
150110329|NCT00689481|541541906|FG000|Overall Study|Excluded medication started during study|0|||
150110330|NCT00689481|541541907|FG001|Overall Study|Excluded medication started during study|1|||
150110331|NCT00689481|541541906|FG000|Overall Study|Subject early term, left on vacation|0|||
150110332|NCT00689481|541541907|FG001|Overall Study|Subject early term, left on vacation|1|||
150110333|NCT00528528|541541908|FG000|Overall Study|Lost to Follow-up|0|||
150110334|NCT00528528|541541909|FG001|Overall Study|Lost to Follow-up|0|||
150110335|NCT00528528|541541910|FG002|Overall Study|Lost to Follow-up|1|||
150110336|NCT00528528|541541911|FG003|Overall Study|Lost to Follow-up|1|||
150110337|NCT00528528|541541908|FG000|Overall Study|Ineligible to continue the trial|0|||
150110338|NCT00528528|541541909|FG001|Overall Study|Ineligible to continue the trial|0|||
150110339|NCT00528528|541541910|FG002|Overall Study|Ineligible to continue the trial|0|||
150110340|NCT00528528|541541911|FG003|Overall Study|Ineligible to continue the trial|1|||
150110341|NCT00528528|541541908|FG000|Overall Study|Other|0|||
150110342|NCT00528528|541541909|FG001|Overall Study|Other|1|||
150110343|NCT00528528|541541910|FG002|Overall Study|Other|0|||
150110344|NCT00528528|541541911|FG003|Overall Study|Other|0|||
150110345|NCT00528528|541541908|FG000|Overall Study|Withdrawal by Subject|3|||
150110346|NCT00528528|541541909|FG001|Overall Study|Withdrawal by Subject|2|||
150110347|NCT00528528|541541910|FG002|Overall Study|Withdrawal by Subject|1|||
150110348|NCT00528528|541541911|FG003|Overall Study|Withdrawal by Subject|1|||
150110349|NCT00528528|541541908|FG000|Overall Study|Ongoing participant|0|||
150110350|NCT00528528|541541909|FG001|Overall Study|Ongoing participant|0|||
150110351|NCT00528528|541541910|FG002|Overall Study|Ongoing participant|1|||
150110352|NCT00528528|541541911|FG003|Overall Study|Ongoing participant|0|||
150110353|NCT03508219|541541912|FG000|Overall Study|Death|2|||
150110354|NCT03508219|541541912|FG000|Overall Study|Withdrawal by Subject|1|||
150110355|NCT03508219|541541912|FG000|Overall Study|Lost to Follow-up|4|||
150110356|NCT03508219|541541912|FG000|Overall Study|Missed visit|2|||
150110357|NCT04466891|541541913|FG000|Overall Study|Death|60|||
150110358|NCT04466891|541541914|FG001|Overall Study|Death|6|||
150110359|NCT04466891|541541913|FG000|Overall Study|Withdrawal by Subject|8|||
150110360|NCT04466891|541541914|FG001|Overall Study|Withdrawal by Subject|1|||
150110361|NCT04466891|541541913|FG000|Overall Study|Study terminated by sponsor|5|||
150110362|NCT04466891|541541914|FG001|Overall Study|Study terminated by sponsor|0|||
150110363|NCT04466891|541541913|FG000|Overall Study|Lost to Follow-up|2|||
150110364|NCT04466891|541541914|FG001|Overall Study|Lost to Follow-up|0|||
150110365|NCT04466891|541541913|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
150110366|NCT04466891|541541914|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
150110367|NCT00445328|541541915|FG000|Overall Study|Death|0|||
150110368|NCT00445328|541541916|FG001|Overall Study|Death|1|||
150110369|NCT00445328|541541915|FG000|Overall Study|Adverse Event|0|||
150110370|NCT00445328|541541916|FG001|Overall Study|Adverse Event|3|||
150110371|NCT00445328|541541915|FG000|Overall Study|Other|0|||
150110372|NCT00445328|541541916|FG001|Overall Study|Other|2|||
150110373|NCT00445328|541541915|FG000|Overall Study|Withdrawal by Subject|2|||
150110374|NCT00445328|541541916|FG001|Overall Study|Withdrawal by Subject|0|||
150110375|NCT00445328|541541915|FG000|Overall Study|Protocol Violation|1|||
150110376|NCT00445328|541541916|FG001|Overall Study|Protocol Violation|0|||
150110377|NCT00316199|541541917|FG000|Overall Study|Adverse Event|2|||
150110378|NCT00316199|541541917|FG000|Overall Study|Death|8|||
150110379|NCT00316199|541541917|FG000|Overall Study|Lost to Follow-up|2|||
150110380|NCT04074317|541541921|FG000|Third Period|Withdrawal by Subject|0|||
150110381|NCT04074317|541541922|FG001|Third Period|Withdrawal by Subject|0|||
150110382|NCT04074317|541541923|FG002|Third Period|Withdrawal by Subject|0|||
150110383|NCT04074317|541541924|FG003|Third Period|Withdrawal by Subject|1|||
150110384|NCT04074317|541541925|FG004|Third Period|Withdrawal by Subject|0|||
150110385|NCT04074317|541541926|FG005|Third Period|Withdrawal by Subject|0|||
150110386|NCT03091192|541541927|FG000|Overall Study|Study terminated by sponsor|21|||
150110387|NCT03091192|541541928|FG001|Overall Study|Study terminated by sponsor|14|||
150110388|NCT03091192|541541927|FG000|Overall Study|Death|9|||
150110389|NCT03091192|541541928|FG001|Overall Study|Death|13|||
150110390|NCT03091192|541541927|FG000|Overall Study|Withdrawal by Subject|2|||
150110391|NCT03091192|541541928|FG001|Overall Study|Withdrawal by Subject|0|||
150110392|NCT03091192|541541927|FG000|Overall Study|Lost to Follow-up|1|||
150110393|NCT03091192|541541928|FG001|Overall Study|Lost to Follow-up|0|||
150110394|NCT06023394|541541929|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
150110395|NCT06023394|541541930|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
150110396|NCT06023394|541541929|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
150110397|NCT06023394|541541930|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
150110398|NCT06023394|541541929|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
150110399|NCT06023394|541541930|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
150110400|NCT06023394|541541929|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
150110401|NCT06023394|541541930|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
150110402|NCT02096835|541543317|FG000|Overall Study|Withdrawal by Subject|1|||
150110403|NCT02096835|541543318|FG001|Overall Study|Withdrawal by Subject|0|||
150110404|NCT02096835|541543319|FG002|Overall Study|Withdrawal by Subject|0|||
150110405|NCT02096835|541543317|FG000|Overall Study|converted to open procedures|1|||
150110406|NCT02096835|541543318|FG001|Overall Study|converted to open procedures|0|||
150110407|NCT02096835|541543319|FG002|Overall Study|converted to open procedures|0|||
150110408|NCT02096835|541543317|FG000|Overall Study|Lost to Follow-up|1|||
150110409|NCT02096835|541543318|FG001|Overall Study|Lost to Follow-up|0|||
150110410|NCT02096835|541543319|FG002|Overall Study|Lost to Follow-up|1|||
150110411|NCT00023673|541543321|FG000|Overall Study|Ineligible / no protocol treatment|0|||
150110412|NCT00023673|541543322|FG001|Overall Study|Ineligible / no protocol treatment|0|||
150110413|NCT00023673|541543323|FG002|Overall Study|Ineligible / no protocol treatment|0|||
150110414|NCT00023673|541543324|FG003|Overall Study|Ineligible / no protocol treatment|1|||
150110415|NCT00023673|541543321|FG000|Overall Study|Patient withdrew consent|0|||
150110416|NCT00023673|541543322|FG001|Overall Study|Patient withdrew consent|0|||
150110417|NCT00023673|541543323|FG002|Overall Study|Patient withdrew consent|0|||
150110418|NCT00023673|541543324|FG003|Overall Study|Patient withdrew consent|1|||
150110419|NCT02472756|541543325|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
150110420|NCT02472756|541543325|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
150110421|NCT02472756|541543325|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
150110422|NCT02472756|541543325|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
150110423|NCT02472756|541543325|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
150110424|NCT00978731|541543327|FG000|Overall Study|Death|4|||
150110425|NCT00978731|541543328|FG001|Overall Study|Death|1|||
150110426|NCT00978731|541543329|FG002|Overall Study|Death|1|||
150110427|NCT00978731|541543330|FG003|Overall Study|Death|0|||
150110428|NCT00978731|541543327|FG000|Overall Study|Lost to Follow-up|0|||
150110429|NCT00978731|541543328|FG001|Overall Study|Lost to Follow-up|0|||
150110430|NCT00978731|541543329|FG002|Overall Study|Lost to Follow-up|0|||
150110431|NCT00978731|541543330|FG003|Overall Study|Lost to Follow-up|1|||
150110432|NCT00978731|541543327|FG000|Overall Study|Adverse Event|5|||
150110433|NCT00978731|541543328|FG001|Overall Study|Adverse Event|2|||
150110434|NCT00978731|541543329|FG002|Overall Study|Adverse Event|0|||
150110435|NCT00978731|541543330|FG003|Overall Study|Adverse Event|0|||
150110436|NCT00978731|541543327|FG000|Overall Study|Participant's request|1|||
150110437|NCT00978731|541543328|FG001|Overall Study|Participant's request|0|||
150110438|NCT00978731|541543329|FG002|Overall Study|Participant's request|0|||
150110439|NCT00978731|541543330|FG003|Overall Study|Participant's request|0|||
150110440|NCT00978731|541543327|FG000|Overall Study|Administrative reason|3|||
150110441|NCT00978731|541543328|FG001|Overall Study|Administrative reason|3|||
150110442|NCT00978731|541543329|FG002|Overall Study|Administrative reason|1|||
150110443|NCT00978731|541543330|FG003|Overall Study|Administrative reason|0|||
150110444|NCT00978731|541543327|FG000|Overall Study|Deterioration without progression|0|||
150110445|NCT00978731|541543328|FG001|Overall Study|Deterioration without progression|1|||
150110446|NCT00978731|541543329|FG002|Overall Study|Deterioration without progression|0|||
150110447|NCT00978731|541543330|FG003|Overall Study|Deterioration without progression|0|||
150110448|NCT00978731|541543327|FG000|Overall Study|Disease progression/relapse|5|||
150110449|NCT00978731|541543328|FG001|Overall Study|Disease progression/relapse|4|||
150110450|NCT00978731|541543329|FG002|Overall Study|Disease progression/relapse|2|||
150110451|NCT00978731|541543330|FG003|Overall Study|Disease progression/relapse|2|||
150110452|NCT00978731|541543327|FG000|Overall Study|Study closure|3|||
150110453|NCT00978731|541543328|FG001|Overall Study|Study closure|4|||
150110454|NCT00978731|541543329|FG002|Overall Study|Study closure|1|||
150110455|NCT00978731|541543330|FG003|Overall Study|Study closure|1|||
150110456|NCT00978731|541543327|FG000|Overall Study|No response|1|||
150110457|NCT00978731|541543328|FG001|Overall Study|No response|0|||
150110458|NCT00978731|541543329|FG002|Overall Study|No response|0|||
150110459|NCT00978731|541543330|FG003|Overall Study|No response|0|||
150110460|NCT03107988|541543335|FG000|Overall Study|Adverse Event|0|||
150110461|NCT03107988|541543336|FG001|Overall Study|Adverse Event|0|||
150110462|NCT03107988|541543337|FG002|Overall Study|Adverse Event|0|||
150110463|NCT03107988|541543338|FG003|Overall Study|Adverse Event|1|||
150110464|NCT03107988|541543339|FG004|Overall Study|Adverse Event|0|||
150110465|NCT03107988|541543340|FG005|Overall Study|Adverse Event|1|||
150110466|NCT03107988|541543341|FG006|Overall Study|Adverse Event|0|||
150110467|NCT03107988|541543342|FG007|Overall Study|Adverse Event|1|||
150110468|NCT03107988|541543343|FG008|Overall Study|Adverse Event|0|||
150110469|NCT03107988|541543344|FG009|Overall Study|Adverse Event|0|||
150110470|NCT03107988|541543345|FG010|Overall Study|Adverse Event|0|||
150110471|NCT03107988|541543346|FG011|Overall Study|Adverse Event|0|||
150110472|NCT03107988|541543347|FG012|Overall Study|Adverse Event|0|||
150110473|NCT03107988|541543335|FG000|Overall Study|Disease Progression or Relapse|1|||
150110474|NCT03107988|541543336|FG001|Overall Study|Disease Progression or Relapse|2|||
150110475|NCT03107988|541543337|FG002|Overall Study|Disease Progression or Relapse|2|||
150110476|NCT03107988|541543338|FG003|Overall Study|Disease Progression or Relapse|5|||
150110477|NCT03107988|541543339|FG004|Overall Study|Disease Progression or Relapse|1|||
150110478|NCT03107988|541543340|FG005|Overall Study|Disease Progression or Relapse|1|||
150110479|NCT03107988|541543341|FG006|Overall Study|Disease Progression or Relapse|0|||
150110480|NCT03107988|541543342|FG007|Overall Study|Disease Progression or Relapse|0|||
150110481|NCT03107988|541543343|FG008|Overall Study|Disease Progression or Relapse|0|||
150110482|NCT03107988|541543344|FG009|Overall Study|Disease Progression or Relapse|1|||
150110483|NCT03107988|541543345|FG010|Overall Study|Disease Progression or Relapse|4|||
150110484|NCT03107988|541543346|FG011|Overall Study|Disease Progression or Relapse|0|||
150110485|NCT03107988|541543347|FG012|Overall Study|Disease Progression or Relapse|0|||
150110486|NCT03107988|541543335|FG000|Overall Study|Ineligible|0|||
150110487|NCT03107988|541543336|FG001|Overall Study|Ineligible|0|||
150110488|NCT03107988|541543337|FG002|Overall Study|Ineligible|0|||
150110489|NCT03107988|541543338|FG003|Overall Study|Ineligible|0|||
150110490|NCT03107988|541543339|FG004|Overall Study|Ineligible|0|||
150110491|NCT03107988|541543340|FG005|Overall Study|Ineligible|0|||
150110492|NCT03107988|541543341|FG006|Overall Study|Ineligible|0|||
150110493|NCT03107988|541543342|FG007|Overall Study|Ineligible|0|||
150110494|NCT03107988|541543343|FG008|Overall Study|Ineligible|1|||
150110495|NCT03107988|541543344|FG009|Overall Study|Ineligible|0|||
150110496|NCT03107988|541543345|FG010|Overall Study|Ineligible|0|||
150110497|NCT03107988|541543346|FG011|Overall Study|Ineligible|0|||
150110498|NCT03107988|541543347|FG012|Overall Study|Ineligible|0|||
150110499|NCT00548808|541543353|FG000|Overall Study|Lost to Follow-up|9|||
150110500|NCT00548808|541543354|FG001|Overall Study|Lost to Follow-up|3|||
150110501|NCT00548808|541543353|FG000|Overall Study|Protocol Violation|8|||
150110502|NCT00548808|541543354|FG001|Overall Study|Protocol Violation|8|||
150110503|NCT00548808|541543353|FG000|Overall Study|Withdrawal by Subject|8|||
150110504|NCT00548808|541543354|FG001|Overall Study|Withdrawal by Subject|4|||
150110505|NCT00548808|541543353|FG000|Overall Study|Physician Decision|6|||
150110506|NCT00548808|541543354|FG001|Overall Study|Physician Decision|3|||
150110507|NCT00548808|541543353|FG000|Overall Study|Adverse Event|4|||
150110508|NCT00548808|541543354|FG001|Overall Study|Adverse Event|5|||
150110509|NCT00548808|541543353|FG000|Overall Study|Death|2|||
150110510|NCT00548808|541543354|FG001|Overall Study|Death|0|||
150110511|NCT00548808|541543353|FG000|Overall Study|Entry Criteria Not Met|2|||
150110512|NCT00548808|541543354|FG001|Overall Study|Entry Criteria Not Met|2|||
150110513|NCT00548808|541543353|FG000|Overall Study|Lack of Efficacy|2|||
150110514|NCT00548808|541543354|FG001|Overall Study|Lack of Efficacy|0|||
150110515|NCT00548808|541543353|FG000|Overall Study|Sponsor Decision|1|||
150110516|NCT00548808|541543354|FG001|Overall Study|Sponsor Decision|1|||
150110517|NCT04300296|541543355|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
150110518|NCT04300296|541543356|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
150110519|NCT04300296|541543357|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
150110520|NCT04300296|541543358|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
150110521|NCT04300296|541543359|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
150110522|NCT04300296|541543360|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
150110523|NCT04300296|541543355|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
150110524|NCT04300296|541543356|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
150110525|NCT04300296|541543357|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
150110526|NCT04300296|541543358|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
150110527|NCT04300296|541543359|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
150110528|NCT04300296|541543360|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
150110529|NCT04300296|541543355|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
150110530|NCT04300296|541543356|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
150110531|NCT04300296|541543357|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
150110532|NCT04300296|541543358|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
150110533|NCT04300296|541543359|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
150110534|NCT04300296|541543360|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
150110535|NCT04300296|541543355|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
150110536|NCT04300296|541543356|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
150110537|NCT04300296|541543357|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
150110538|NCT04300296|541543358|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
150110539|NCT04300296|541543359|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
150110540|NCT04300296|541543360|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
150110541|NCT04300296|541543355|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
150110542|NCT04300296|541543356|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
150110543|NCT04300296|541543357|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
150110544|NCT04300296|541543358|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
150110545|NCT04300296|541543359|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
150110546|NCT04300296|541543360|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
150110547|NCT04300296|541543355|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
150110548|NCT04300296|541543356|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
150110549|NCT04300296|541543357|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
150110550|NCT04300296|541543358|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
150110551|NCT04300296|541543359|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
150110552|NCT04300296|541543360|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
150110553|NCT04300296|541543355|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
150110554|NCT04300296|541543356|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
150110555|NCT04300296|541543357|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
150110556|NCT04300296|541543358|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
150110557|NCT04300296|541543359|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
150110558|NCT04300296|541543360|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
150110559|NCT00279708|541543363|FG000|Overall Study|Withdrawal by Subject|2|||
150110560|NCT00279708|541543364|FG001|Overall Study|Withdrawal by Subject|3|||
150110561|NCT00279708|541543363|FG000|Overall Study|Adverse Event|1|||
150110562|NCT00279708|541543364|FG001|Overall Study|Adverse Event|1|||
150110563|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Adverse Event|9|||
150110564|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Adverse Event|2|||
150110565|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
150110566|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
150110567|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
150110568|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
150110569|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Physician Decision|1|||
150110570|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Physician Decision|1|||
150110571|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Pregnancy|2|||
150110572|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Pregnancy|0|||
150110573|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
150110574|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
150110575|NCT02896127|541543365|FG000|COMPLETED WEEK 52|Technical problems|1|||
150110576|NCT02896127|541543366|FG001|COMPLETED WEEK 52|Technical problems|0|||
150110577|NCT02896127|541543365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
150110578|NCT02896127|541543366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
150110579|NCT02896127|541543365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
150110580|NCT02896127|541543366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
150110581|NCT02896127|541543365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
150110582|NCT02896127|541543366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
150188569|NCT05710107|541829254|FG001|Overall Study|Unable to place assigned block|0|||
150188570|NCT05710107|541829253|FG000|Overall Study|Withdrawn by study team|0|||
150188571|NCT05710107|541829254|FG001|Overall Study|Withdrawn by study team|1|||
150110583|NCT02896127|541543365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
150110584|NCT02896127|541543366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
150110585|NCT02896127|541543365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
150110586|NCT02896127|541543366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
150110587|NCT02940691|541543367|FG000|Overall Study|Lost to Follow-up|5|||
150110588|NCT02940691|541543367|FG000|Overall Study|Incarceration|1|||
150188572|NCT04166773|541829255|FG000|Overall Study|Adverse Event|2|||
150188573|NCT04166773|541829256|FG001|Overall Study|Adverse Event|0|||
150110589|NCT02477020|541543370|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
150110590|NCT02477020|541543371|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
150110591|NCT02477020|541543370|FG000|Overall Study|Voluntary Withdrawal|7|||
150110592|NCT02477020|541543371|FG001|Overall Study|Voluntary Withdrawal|16|||
150110593|NCT02477020|541543370|FG000|Overall Study|Reason not Specified|3|||
150110594|NCT02477020|541543371|FG001|Overall Study|Reason not Specified|1|||
150110595|NCT02477020|541543370|FG000|Overall Study|Lack of Efficacy|14|||
150110596|NCT02477020|541543371|FG001|Overall Study|Lack of Efficacy|5|||
150110597|NCT00519649|541543372|FG000|Overall Study|Withdrawal by Subject|1|||
150110598|NCT01465802|541543373|FG000|Overall Study|Study terminated by sponsor|1|||
150110599|NCT01465802|541543374|FG001|Overall Study|Study terminated by sponsor|0|||
150110600|NCT01465802|541543375|FG002|Overall Study|Study terminated by sponsor|0|||
150110601|NCT01465802|541543376|FG003|Overall Study|Study terminated by sponsor|1|||
150110602|NCT01465802|541543377|FG004|Overall Study|Study terminated by sponsor|7|||
150110603|NCT01465802|541543373|FG000|Overall Study|Withdrawal by Subject|7|||
150110604|NCT01465802|541543374|FG001|Overall Study|Withdrawal by Subject|7|||
150110605|NCT01465802|541543375|FG002|Overall Study|Withdrawal by Subject|0|||
150110606|NCT01465802|541543376|FG003|Overall Study|Withdrawal by Subject|8|||
150110607|NCT01465802|541543377|FG004|Overall Study|Withdrawal by Subject|1|||
150110608|NCT01465802|541543373|FG000|Overall Study|Lost to Follow-up|1|||
150110609|NCT01465802|541543374|FG001|Overall Study|Lost to Follow-up|1|||
150110610|NCT01465802|541543375|FG002|Overall Study|Lost to Follow-up|0|||
150110611|NCT01465802|541543376|FG003|Overall Study|Lost to Follow-up|0|||
150110612|NCT01465802|541543377|FG004|Overall Study|Lost to Follow-up|0|||
150110613|NCT01465802|541543373|FG000|Overall Study|Reason not specified|9|||
150110614|NCT01465802|541543374|FG001|Overall Study|Reason not specified|4|||
150110615|NCT01465802|541543375|FG002|Overall Study|Reason not specified|0|||
150110616|NCT01465802|541543376|FG003|Overall Study|Reason not specified|10|||
150110617|NCT01465802|541543377|FG004|Overall Study|Reason not specified|2|||
150110618|NCT01465802|541543373|FG000|Overall Study|Death|15|||
150110619|NCT01465802|541543374|FG001|Overall Study|Death|12|||
150110620|NCT01465802|541543375|FG002|Overall Study|Death|0|||
150110621|NCT01465802|541543376|FG003|Overall Study|Death|10|||
150110622|NCT01465802|541543377|FG004|Overall Study|Death|2|||
150110623|NCT03852316|541543378|FG000|Overall Study|Protocol Violation|1|||
150110624|NCT03852316|541543378|FG000|Overall Study|Withdrawal by Subject|2|||
150110625|NCT03852316|541543378|FG000|Overall Study|Enrolled but Device not Utilized|1|||
150110626|NCT03592641|541543379|FG000|Overall Study|Withdrawal by Subject|1|||
150110627|NCT01470469|541543380|FG000|Overall Study|Withdrawal by Subject|4|||
150110628|NCT01470469|541543381|FG001|Overall Study|Withdrawal by Subject|6|||
150110629|NCT01470469|541543380|FG000|Overall Study|Lack of Efficacy|1|||
150110630|NCT01470469|541543381|FG001|Overall Study|Lack of Efficacy|7|||
150110631|NCT01470469|541543380|FG000|Overall Study|Adverse Event|0|||
150110632|NCT01470469|541543381|FG001|Overall Study|Adverse Event|7|||
150110633|NCT01470469|541543380|FG000|Overall Study|Lost to Follow-up|2|||
150110634|NCT01470469|541543381|FG001|Overall Study|Lost to Follow-up|2|||
150110635|NCT01470469|541543380|FG000|Overall Study|Protocol Violation|1|||
150110636|NCT01470469|541543381|FG001|Overall Study|Protocol Violation|1|||
150110637|NCT01470469|541543380|FG000|Overall Study|Other|2|||
150110638|NCT01470469|541543381|FG001|Overall Study|Other|1|||
150110639|NCT02504372|541543384|FG000|Overall Study|Death|136|||
150110640|NCT02504372|541543385|FG001|Overall Study|Death|154|||
150110641|NCT02504372|541543384|FG000|Overall Study|Lost to Follow-up|0|||
150110642|NCT02504372|541543385|FG001|Overall Study|Lost to Follow-up|2|||
150110643|NCT02504372|541543384|FG000|Overall Study|Withdrawal of consent|25|||
150110644|NCT02504372|541543385|FG001|Overall Study|Withdrawal of consent|16|||
150110645|NCT02504372|541543384|FG000|Overall Study|Participants ongoing|429|||
150110646|NCT02504372|541543385|FG001|Overall Study|Participants ongoing|415|||
150110647|NCT01502644|541543388|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
150110648|NCT01502644|541543389|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
150110649|NCT01502644|541543390|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
150110650|NCT01502644|541543391|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
150110651|NCT01502644|541543388|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
150110652|NCT01502644|541543389|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
150110653|NCT01502644|541543390|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
150110654|NCT01502644|541543391|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
150110655|NCT01502644|541543388|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
150110656|NCT01502644|541543389|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
150110657|NCT01502644|541543390|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
150110658|NCT01502644|541543391|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
150110659|NCT01502644|541543388|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
150110660|NCT01502644|541543389|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
150188574|NCT04166773|541829257|FG002|Overall Study|Adverse Event|2|||
150188575|NCT04166773|541829258|FG003|Overall Study|Adverse Event|1|||
150110661|NCT01502644|541543390|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
150110662|NCT01502644|541543391|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
150110663|NCT01502644|541543388|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
150110664|NCT01502644|541543389|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
150110665|NCT01502644|541543390|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
150110666|NCT01502644|541543391|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
150110667|NCT02052739|541543394|FG000|Overall Study|Withdrew due to Adverse Event|3|||
150110668|NCT02052739|541543395|FG001|Overall Study|Withdrew due to Adverse Event|0|||
150110669|NCT02052739|541543394|FG000|Overall Study|Participant Died|2|||
150110670|NCT02052739|541543395|FG001|Overall Study|Participant Died|1|||
150110671|NCT01526889|541543396|FG000|Treatment Period|Adverse Event|2|||
150110672|NCT01526889|541543397|FG001|Treatment Period|Adverse Event|0|||
150110673|NCT01526889|541543396|FG000|Treatment Extension Period|Administrative problems|1|||
150110674|NCT01526889|541543397|FG001|Treatment Extension Period|Administrative problems|0|||
150110675|NCT01573624|541543398|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
150110676|NCT01573624|541543399|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
150110677|NCT01573624|541543400|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
150110678|NCT01573624|541543401|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
150110679|NCT01573624|541543402|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
150110680|NCT01573624|541543403|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
150110681|NCT01573624|541543404|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
150110682|NCT01573624|541543398|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
150110683|NCT01573624|541543399|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
150110684|NCT01573624|541543400|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
150110685|NCT01573624|541543401|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
150110686|NCT01573624|541543402|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
150110687|NCT01573624|541543403|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
150110688|NCT01573624|541543404|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
150110689|NCT01573624|541543398|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
150110690|NCT01573624|541543399|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110691|NCT01573624|541543400|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110692|NCT01573624|541543401|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110693|NCT01573624|541543402|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110694|NCT01573624|541543403|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110695|NCT01573624|541543404|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
150110696|NCT01573624|541543398|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
150110697|NCT01573624|541543399|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150110698|NCT01573624|541543400|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
150110699|NCT01573624|541543401|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150110700|NCT01573624|541543402|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150110701|NCT01573624|541543403|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
150110702|NCT01573624|541543404|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
150110703|NCT01573624|541543398|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
150110704|NCT01573624|541543399|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
150110705|NCT01573624|541543400|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
150110706|NCT01573624|541543401|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
150110707|NCT01573624|541543402|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
150110708|NCT01573624|541543403|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
150110709|NCT01573624|541543404|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
150110710|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110711|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110712|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110713|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110714|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110715|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
150110716|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
150110717|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
150110718|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
150110719|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
150110720|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
150110721|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
150110722|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
150110723|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
150110724|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
150110725|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150110726|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
150110727|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
150110728|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150110729|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150110730|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
150110731|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110732|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110733|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110734|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110735|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110736|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
150110737|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
150110738|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150110739|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150110740|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150110741|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
150110742|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150110743|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
150110744|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
150110745|NCT01573624|541543398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110746|NCT01573624|541543399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110747|NCT01573624|541543400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110748|NCT01573624|541543401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110749|NCT01573624|541543402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110750|NCT01573624|541543403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110751|NCT01573624|541543404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110752|NCT01573624|541543398|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
150110753|NCT01573624|541543399|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
150110754|NCT01573624|541543400|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
150110755|NCT01573624|541543401|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
150110756|NCT01573624|541543402|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
150110757|NCT01573624|541543403|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
150110758|NCT01573624|541543404|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
150110759|NCT01573624|541543398|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
150110760|NCT01573624|541543399|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
150110761|NCT01573624|541543400|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
150110762|NCT01573624|541543401|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
150110763|NCT01573624|541543402|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
150110764|NCT01573624|541543403|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
150110765|NCT01573624|541543404|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
150110766|NCT01573624|541543398|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
150110767|NCT01573624|541543399|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110768|NCT01573624|541543400|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110769|NCT01573624|541543401|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110770|NCT01573624|541543402|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110771|NCT01573624|541543403|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110772|NCT01573624|541543404|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
150110773|NCT01573624|541543398|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
150110774|NCT01573624|541543399|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
150110775|NCT01573624|541543400|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
150110776|NCT01573624|541543401|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
150188576|NCT04166773|541829255|FG000|Overall Study|Lost to Follow-up|4|||
150188577|NCT04166773|541829256|FG001|Overall Study|Lost to Follow-up|2|||
150188578|NCT04166773|541829257|FG002|Overall Study|Lost to Follow-up|1|||
150188579|NCT04166773|541829258|FG003|Overall Study|Lost to Follow-up|3|||
150188580|NCT04166773|541829255|FG000|Overall Study|Physician Decision|0|||
150188581|NCT04166773|541829256|FG001|Overall Study|Physician Decision|0|||
150110777|NCT01573624|541543402|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
150110778|NCT01573624|541543403|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
150110779|NCT01573624|541543404|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
150110780|NCT01573624|541543398|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
150110781|NCT01573624|541543399|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110782|NCT01573624|541543400|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110783|NCT01573624|541543401|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110784|NCT01573624|541543402|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110785|NCT01573624|541543403|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110786|NCT01573624|541543404|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
150110787|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
150110788|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
150110789|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
150110790|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
150110791|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
150110792|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
150110793|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
150110794|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
150110795|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
150110796|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
150110797|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
150110798|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
150110799|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
150110800|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
150110801|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110802|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
150110803|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110804|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110805|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110806|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110807|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
150110808|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110809|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
150110810|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110811|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110812|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110813|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110814|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
150110815|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150110816|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150110817|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150110818|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150110819|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
150110820|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
150110821|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
150110822|NCT01573624|541543398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110823|NCT01573624|541543399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110824|NCT01573624|541543400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110825|NCT01573624|541543401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110826|NCT01573624|541543402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
150188582|NCT04166773|541829257|FG002|Overall Study|Physician Decision|0|||
150188583|NCT04166773|541829258|FG003|Overall Study|Physician Decision|1|||
150188584|NCT04166773|541829255|FG000|Overall Study|Withdrawal by Subject|1|||
150188585|NCT04166773|541829256|FG001|Overall Study|Withdrawal by Subject|1|||
150188586|NCT04166773|541829257|FG002|Overall Study|Withdrawal by Subject|2|||
150188587|NCT04166773|541829258|FG003|Overall Study|Withdrawal by Subject|5|||
150188588|NCT04763265|541829262|FG000|Overall Study|Adverse Event|1|||
150188589|NCT04763265|541829263|FG001|Overall Study|Adverse Event|0|||
150188590|NCT04763265|541829262|FG000|Overall Study|Lost to Follow-up|2|||
150188591|NCT04763265|541829263|FG001|Overall Study|Lost to Follow-up|4|||
150188592|NCT04763265|541829262|FG000|Overall Study|Withdrawal by Subject|0|||
150188593|NCT04763265|541829263|FG001|Overall Study|Withdrawal by Subject|1|||
150188594|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Other|0|||
150188595|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Other|0|||
150188596|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Other|0|||
150188597|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Other|0|||
150188598|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Other|0|||
150188599|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Other|0|||
150188600|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Other|0|||
150188601|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Other|0|||
150188602|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Other|0|||
150188603|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Other|0|||
150188604|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Other|1|||
150188605|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Other|1|||
150188606|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Other|1|||
150188607|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Other|0|||
150188608|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Other|3|||
150188609|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Other|1|||
150188610|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Other|1|||
150188611|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Other|0|||
150188612|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188613|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188614|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188615|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188616|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188617|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188618|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
150188619|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188620|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
150188621|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188622|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188623|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188624|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
150188625|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188626|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188627|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188628|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188629|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
150188630|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188631|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188632|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188633|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188634|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188635|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188636|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188637|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
150188638|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188639|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188640|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188641|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188642|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188643|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188644|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188645|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188646|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188647|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
150188648|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188649|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188650|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188651|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188652|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188653|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188654|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188655|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188656|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188657|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
150188658|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188659|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188660|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188661|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188662|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188663|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188664|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188665|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
150188666|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Death|0|||
150188667|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Death|0|||
150188668|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Death|0|||
150188669|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Death|0|||
150188670|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Death|0|||
150188671|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Death|0|||
150188672|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Death|0|||
150188673|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Death|0|||
150188674|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Death|0|||
150188675|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Death|1|||
150188676|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Death|0|||
150188677|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Death|1|||
150188678|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Death|0|||
150188679|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Death|1|||
150188680|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Death|0|||
150188681|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Death|0|||
150188682|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Death|2|||
150188683|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Death|0|||
150188684|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
150188685|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
150188686|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
150188687|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
150188688|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
150188689|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
150188690|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
150188691|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
150188692|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
150188693|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
150188694|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
150188695|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
150188696|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
150188697|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
150188698|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
150188699|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
150188700|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
150188701|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
150188702|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Adverse Event|0|||
150188703|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Adverse Event|0|||
150188704|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Adverse Event|0|||
150188705|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Adverse Event|0|||
150188706|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Adverse Event|0|||
150188707|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Adverse Event|0|||
150188708|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Adverse Event|2|||
150188709|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Adverse Event|0|||
150188710|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Adverse Event|0|||
150188711|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Adverse Event|0|||
150188712|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Adverse Event|1|||
150188713|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Adverse Event|2|||
150188714|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Adverse Event|0|||
150188715|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Adverse Event|1|||
150188716|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Adverse Event|0|||
150188717|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Adverse Event|0|||
150188718|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Adverse Event|1|||
150188719|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Adverse Event|0|||
150188720|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
150188721|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
150188722|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
150188723|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
150188724|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
150188725|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
150188726|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
150188727|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
150188728|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
150188729|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
150188730|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
150188731|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
150188732|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
150110827|NCT01573624|541543403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
150110828|NCT01573624|541543404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
150110829|NCT01573624|541543398|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
150110830|NCT01573624|541543399|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
150110831|NCT01573624|541543400|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
150110832|NCT01573624|541543401|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
150110833|NCT01573624|541543402|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
150110834|NCT01573624|541543403|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
150110835|NCT01573624|541543404|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
150110836|NCT01573624|541543398|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
150110837|NCT01573624|541543399|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
150110838|NCT01573624|541543400|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
150110839|NCT01573624|541543401|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
150110840|NCT01573624|541543402|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
150110841|NCT01573624|541543403|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
150110842|NCT01573624|541543404|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
150110843|NCT01573624|541543398|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
150110844|NCT01573624|541543399|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110845|NCT01573624|541543400|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110846|NCT01573624|541543401|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110847|NCT01573624|541543402|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110848|NCT01573624|541543403|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110849|NCT01573624|541543404|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
150110850|NCT01573624|541543398|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
150110851|NCT01573624|541543399|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
150110852|NCT01573624|541543400|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
150110853|NCT01573624|541543401|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
150110854|NCT01573624|541543402|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
150110855|NCT01573624|541543403|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
150110856|NCT01573624|541543404|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
150110857|NCT01573624|541543398|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
150110858|NCT01573624|541543399|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110859|NCT01573624|541543400|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110860|NCT01573624|541543401|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110861|NCT01573624|541543402|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110862|NCT01573624|541543403|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110863|NCT01573624|541543404|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
150110864|NCT05059600|541543405|FG000|Overall Study|Enrolled but not Treated|10|||
150110865|NCT02519712|541543408|FG000|Overall Study|Disease Relapse|1|||
150110866|NCT02519712|541543408|FG000|Overall Study|Disease Progression|1|||
150110867|NCT02519712|541543408|FG000|Overall Study|Accruals are donors|2|||
150110868|NCT00613509|541543409|FG000|Cycle 1|Adverse Event|2|||
150110869|NCT00613509|541543410|FG001|Cycle 1|Adverse Event|1|||
150110870|NCT00613509|541543409|FG000|Cycle 1|Disease Progression|2|||
150110871|NCT00613509|541543410|FG001|Cycle 1|Disease Progression|6|||
150110872|NCT00613509|541543409|FG000|Cycle 1|Unacceptable Toxicity|1|||
150110873|NCT00613509|541543410|FG001|Cycle 1|Unacceptable Toxicity|0|||
150110874|NCT00613509|541543409|FG000|Cycle 1|Other administrative reason|0|||
150110875|NCT00613509|541543410|FG001|Cycle 1|Other administrative reason|1|||
150110876|NCT00677807|541543413|FG000|Overall Study|Adverse Event|4|||
150110877|NCT00677807|541543414|FG001|Overall Study|Adverse Event|1|||
150110878|NCT00677807|541543415|FG002|Overall Study|Adverse Event|6|||
150110879|NCT00677807|541543413|FG000|Overall Study|Lack of Efficacy|0|||
150110880|NCT00677807|541543414|FG001|Overall Study|Lack of Efficacy|0|||
150110881|NCT00677807|541543415|FG002|Overall Study|Lack of Efficacy|2|||
150110882|NCT00677807|541543413|FG000|Overall Study|Participant no longer needs study drug|0|||
150110883|NCT00677807|541543414|FG001|Overall Study|Participant no longer needs study drug|0|||
150110884|NCT00677807|541543415|FG002|Overall Study|Participant no longer needs study drug|1|||
150110885|NCT00677807|541543413|FG000|Overall Study|Withdrawal by Subject|10|||
150110886|NCT00677807|541543414|FG001|Overall Study|Withdrawal by Subject|3|||
150110887|NCT00677807|541543415|FG002|Overall Study|Withdrawal by Subject|6|||
150110888|NCT00677807|541543413|FG000|Overall Study|Lost to Follow-up|2|||
150110889|NCT00677807|541543414|FG001|Overall Study|Lost to Follow-up|2|||
150110890|NCT00677807|541543415|FG002|Overall Study|Lost to Follow-up|2|||
150188733|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
150188734|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
150188735|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
150188736|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
150110891|NCT00677807|541543413|FG000|Overall Study|Administrative problems|1|||
150110892|NCT00677807|541543414|FG001|Overall Study|Administrative problems|1|||
150110893|NCT00677807|541543415|FG002|Overall Study|Administrative problems|2|||
150110894|NCT00677807|541543413|FG000|Overall Study|Death|0|||
150110895|NCT00677807|541543414|FG001|Overall Study|Death|1|||
150110896|NCT00677807|541543415|FG002|Overall Study|Death|1|||
150110897|NCT00677807|541543413|FG000|Overall Study|Protocol Deviation|1|||
150110898|NCT00677807|541543414|FG001|Overall Study|Protocol Deviation|3|||
150110899|NCT00677807|541543415|FG002|Overall Study|Protocol Deviation|0|||
150110900|NCT00314366|541543420|FG000|Overall Study|not treated due to patient medical condi|1|||
150110901|NCT00314366|541543421|FG001|Overall Study|not treated due to patient medical condi|0|||
150110902|NCT02167256|541543427|FG000|Overall Study|Adverse Event|13|||
150110903|NCT02167256|541543428|FG001|Overall Study|Adverse Event|6|||
150110904|NCT02167256|541543427|FG000|Overall Study|Withdrawal by Subject|4|||
150110905|NCT02167256|541543428|FG001|Overall Study|Withdrawal by Subject|4|||
150110906|NCT02167256|541543427|FG000|Overall Study|non-compliance|3|||
150110907|NCT02167256|541543428|FG001|Overall Study|non-compliance|0|||
150110908|NCT02167256|541543427|FG000|Overall Study|Study partner unable to participate|1|||
150110909|NCT02167256|541543428|FG001|Overall Study|Study partner unable to participate|0|||
150110910|NCT02469610|541543429|FG000|Overall Study|Death|1|||
150110911|NCT02469610|541543430|FG001|Overall Study|Death|0|||
150110912|NCT02469610|541543429|FG000|Overall Study|Lost to Follow-up|1|||
150110913|NCT02469610|541543430|FG001|Overall Study|Lost to Follow-up|0|||
150110914|NCT02469610|541543429|FG000|Overall Study|exclusion criteria|2|||
150110915|NCT02469610|541543430|FG001|Overall Study|exclusion criteria|1|||
150110916|NCT03467425|541543433|FG000|Overall Study|Adverse Event|9|||
150110917|NCT03467425|541543434|FG001|Overall Study|Adverse Event|9|||
150110918|NCT03467425|541543433|FG000|Overall Study|Lack of Efficacy|3|||
150110919|NCT03467425|541543434|FG001|Overall Study|Lack of Efficacy|1|||
150110920|NCT03467425|541543433|FG000|Overall Study|Protocol Violation|0|||
150110921|NCT03467425|541543434|FG001|Overall Study|Protocol Violation|1|||
150110922|NCT03467425|541543433|FG000|Overall Study|Lost to Follow-up|18|||
150110923|NCT03467425|541543434|FG001|Overall Study|Lost to Follow-up|25|||
150110924|NCT03467425|541543433|FG000|Overall Study|Physician Decision|2|||
150110925|NCT03467425|541543434|FG001|Overall Study|Physician Decision|1|||
150110926|NCT03467425|541543433|FG000|Overall Study|Withdrawal by Subject|15|||
150110927|NCT03467425|541543434|FG001|Overall Study|Withdrawal by Subject|17|||
150110928|NCT01864291|541543435|FG000|Overall Study|need for revision surgery|2|||
150110929|NCT01387607|541543442|FG000|Overall Study|Adverse Event|23|||
150110930|NCT01387607|541543443|FG001|Overall Study|Adverse Event|11|||
150110931|NCT01387607|541543442|FG000|Overall Study|Lack of Efficacy|8|||
150110932|NCT01387607|541543443|FG001|Overall Study|Lack of Efficacy|6|||
150110933|NCT01387607|541543442|FG000|Overall Study|Lost to Follow-up|2|||
150110934|NCT01387607|541543443|FG001|Overall Study|Lost to Follow-up|1|||
150110935|NCT01387607|541543442|FG000|Overall Study|No longer meets eligibility criteria|0|||
150110936|NCT01387607|541543443|FG001|Overall Study|No longer meets eligibility criteria|1|||
150110937|NCT01387607|541543442|FG000|Overall Study|Protocol Violation|1|||
150110938|NCT01387607|541543443|FG001|Overall Study|Protocol Violation|5|||
150110939|NCT01387607|541543442|FG000|Overall Study|Withdrawal by Subject|13|||
150110940|NCT01387607|541543443|FG001|Overall Study|Withdrawal by Subject|14|||
150110941|NCT01387607|541543442|FG000|Overall Study|Other|1|||
150188737|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
150188738|NCT03269136|541829267|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150110942|NCT01387607|541543443|FG001|Overall Study|Other|1|||
150110943|NCT01387607|541543442|FG000|Overall Study|Randomized, not treated|3|||
150110944|NCT01387607|541543443|FG001|Overall Study|Randomized, not treated|6|||
150110945|NCT00590954|541543447|FG000|Overall Study|Inevaluable|2|||
150110946|NCT02742103|541544538|FG000|Overall Study|Protocol Violation|1|||
150110947|NCT02742103|541544539|FG001|Overall Study|Protocol Violation|0|||
150110948|NCT02742103|541544538|FG000|Overall Study|Death|2|||
150110949|NCT02742103|541544539|FG001|Overall Study|Death|2|||
150110950|NCT02742103|541544538|FG000|Overall Study|Adverse Event|1|||
150110951|NCT02742103|541544539|FG001|Overall Study|Adverse Event|0|||
150110952|NCT02742103|541544538|FG000|Overall Study|Moved to another town|0|||
150110953|NCT02742103|541544539|FG001|Overall Study|Moved to another town|1|||
150110954|NCT02742103|541544538|FG000|Overall Study|Withdrawal by Subject|5|||
150188739|NCT03269136|541829268|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150110955|NCT02742103|541544539|FG001|Overall Study|Withdrawal by Subject|2|||
150110956|NCT04346615|541544542|FG000|Overall Study|Lost to Follow-up|0|||
150110957|NCT04346615|541544543|FG001|Overall Study|Lost to Follow-up|2|||
150188740|NCT03269136|541829269|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150110958|NCT04346615|541544542|FG000|Overall Study|Withdrawal by Subject|1|||
150110959|NCT04346615|541544543|FG001|Overall Study|Withdrawal by Subject|0|||
150110960|NCT04346615|541544542|FG000|Overall Study|Death|5|||
150110961|NCT04346615|541544543|FG001|Overall Study|Death|1|||
150110962|NCT04346615|541544542|FG000|Overall Study|Other|0|||
150110963|NCT04346615|541544543|FG001|Overall Study|Other|2|||
150110964|NCT04346615|541544542|FG000|Overall Study|Randomized not treated|1|||
150110965|NCT04346615|541544543|FG001|Overall Study|Randomized not treated|0|||
150110966|NCT02349711|541544549|FG000|Overall Study|Withdrawal by Subject|2|||
150110967|NCT02349711|541544550|FG001|Overall Study|Withdrawal by Subject|1|||
150110968|NCT02349711|541544549|FG000|Overall Study|Lost to Follow-up|1|||
150110969|NCT02349711|541544550|FG001|Overall Study|Lost to Follow-up|1|||
150110970|NCT01610700|541544551|FG000|Overall Study|Adverse Event|3|||
150110971|NCT01610700|541544552|FG001|Overall Study|Adverse Event|1|||
150110972|NCT01610700|541544551|FG000|Overall Study|Withdrawal by Subject|0|||
150110973|NCT01610700|541544552|FG001|Overall Study|Withdrawal by Subject|1|||
150110974|NCT01610700|541544551|FG000|Overall Study|subject took one dose of street cannabis|0|||
150110975|NCT01610700|541544552|FG001|Overall Study|subject took one dose of street cannabis|1|||
150110976|NCT02453594|541544553|FG000|Overall Study|Protocol Violation|0|||
150110977|NCT02453594|541544554|FG001|Overall Study|Protocol Violation|0|||
150110978|NCT02453594|541544555|FG002|Overall Study|Protocol Violation|1|||
150110979|NCT02453594|541544553|FG000|Overall Study|Cohort Was Closed|17|||
150110980|NCT02453594|541544554|FG001|Overall Study|Cohort Was Closed|21|||
150110981|NCT02453594|541544555|FG002|Overall Study|Cohort Was Closed|14|||
150110982|NCT02453594|541544553|FG000|Overall Study|Death|20|||
150110983|NCT02453594|541544554|FG001|Overall Study|Death|24|||
150110984|NCT02453594|541544555|FG002|Overall Study|Death|16|||
150110985|NCT02453594|541544553|FG000|Overall Study|Lost to Follow-up|6|||
150110986|NCT02453594|541544554|FG001|Overall Study|Lost to Follow-up|14|||
150110987|NCT02453594|541544555|FG002|Overall Study|Lost to Follow-up|2|||
150110988|NCT02453594|541544553|FG000|Overall Study|Physician Decision|2|||
150110989|NCT02453594|541544554|FG001|Overall Study|Physician Decision|4|||
150110990|NCT02453594|541544555|FG002|Overall Study|Physician Decision|0|||
150110991|NCT02453594|541544553|FG000|Overall Study|Site Terminated by Sponsor|1|||
150110992|NCT02453594|541544554|FG001|Overall Study|Site Terminated by Sponsor|0|||
150110993|NCT02453594|541544555|FG002|Overall Study|Site Terminated by Sponsor|1|||
150110994|NCT02453594|541544553|FG000|Overall Study|Transitioned to Extension Study|16|||
150110995|NCT02453594|541544554|FG001|Overall Study|Transitioned to Extension Study|9|||
150110996|NCT02453594|541544555|FG002|Overall Study|Transitioned to Extension Study|16|||
150110997|NCT02453594|541544553|FG000|Overall Study|Withdrawal by Subject|7|||
150110998|NCT02453594|541544554|FG001|Overall Study|Withdrawal by Subject|9|||
150110999|NCT02453594|541544555|FG002|Overall Study|Withdrawal by Subject|11|||
150111000|NCT02097134|541544556|FG000|Overall Study|Physician Decision|4|||
150111001|NCT02097134|541544556|FG000|Overall Study|Non-Protocol Therapy|1|||
150111002|NCT02097134|541544556|FG000|Overall Study|Progressive Disease|3|||
150111003|NCT02097134|541544556|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
150111004|NCT00501540|541544562|FG000|Overall Study|Death|5|||
150111005|NCT02331446|541544563|FG000|Overall Study|Lost to Follow-up|2|||
150111006|NCT02331446|541544564|FG001|Overall Study|Lost to Follow-up|1|||
150111007|NCT02331446|541544565|FG002|Overall Study|Lost to Follow-up|0|||
150111008|NCT02331446|541544566|FG003|Overall Study|Lost to Follow-up|1|||
150111009|NCT02331446|541544563|FG000|Overall Study|Personal Problem|2|||
150111010|NCT02331446|541544564|FG001|Overall Study|Personal Problem|0|||
150111011|NCT02331446|541544565|FG002|Overall Study|Personal Problem|0|||
150111012|NCT02331446|541544566|FG003|Overall Study|Personal Problem|0|||
150111013|NCT02331446|541544563|FG000|Overall Study|Disease|0|||
150111014|NCT02331446|541544564|FG001|Overall Study|Disease|2|||
150111015|NCT02331446|541544565|FG002|Overall Study|Disease|2|||
150111016|NCT02331446|541544566|FG003|Overall Study|Disease|1|||
150111017|NCT02331446|541544563|FG000|Overall Study|Physician Decision|0|||
150111018|NCT02331446|541544564|FG001|Overall Study|Physician Decision|1|||
150111019|NCT02331446|541544565|FG002|Overall Study|Physician Decision|0|||
150111020|NCT02331446|541544566|FG003|Overall Study|Physician Decision|1|||
150111021|NCT02331446|541544563|FG000|Overall Study|Lost before baseline analysis|0|||
150111022|NCT02331446|541544564|FG001|Overall Study|Lost before baseline analysis|1|||
150111023|NCT02331446|541544565|FG002|Overall Study|Lost before baseline analysis|1|||
150111024|NCT02331446|541544566|FG003|Overall Study|Lost before baseline analysis|0|||
150111025|NCT04879745|541544567|FG000|Overall Study|Lost to Follow-up|4|||
150111026|NCT04879745|541544568|FG001|Overall Study|Lost to Follow-up|1|||
150111027|NCT00120042|541544569|FG000|Overall Study|all completed protocl|0|||
150111028|NCT00120042|541544570|FG001|Overall Study|all completed protocl|0|||
150111029|NCT00120042|541544571|FG002|Overall Study|all completed protocl|0|||
150111030|NCT00796861|541544572|FG000|Overall Study|Withdrawal by Subject|2|||
150111031|NCT00796861|541544572|FG000|Overall Study|Death|2|||
150111032|NCT00529386|541544575|FG000|Overall Study|Lost to Follow-up|1|||
150111033|NCT04532112|541544576|FG000|Overall Study|Adverse Event|3|||
150111034|NCT04532112|541544577|FG001|Overall Study|Adverse Event|0|||
150111035|NCT01049919|541544579|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
150111036|NCT01049919|541544580|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
150111037|NCT01049919|541544579|FG000|Overall Study|Withdrawal by Subject|5|||
150111038|NCT01049919|541544580|FG001|Overall Study|Withdrawal by Subject|0|||
150111039|NCT01049919|541544579|FG000|Overall Study|Lost to Follow-up|6|||
150111040|NCT01049919|541544580|FG001|Overall Study|Lost to Follow-up|1|||
150111041|NCT01049919|541544579|FG000|Overall Study|Physician Decision|2|||
150111042|NCT01049919|541544580|FG001|Overall Study|Physician Decision|0|||
150111043|NCT01049919|541544579|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
150111044|NCT01049919|541544580|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
150111045|NCT01049919|541544579|FG000|Overall Study|Early study termination by sponsor.|2|||
150111046|NCT01049919|541544580|FG001|Overall Study|Early study termination by sponsor.|0|||
150111047|NCT02984995|541544581|FG000|Overall Study|Required stem cell transplant|13|||
150111048|NCT02984995|541544582|FG001|Overall Study|Required stem cell transplant|2|||
150111049|NCT02984995|541544581|FG000|Overall Study|Progressive disease|11|||
150111050|NCT02984995|541544582|FG001|Overall Study|Progressive disease|1|||
150111051|NCT02984995|541544581|FG000|Overall Study|Adverse Event|1|||
150111052|NCT02984995|541544582|FG001|Overall Study|Adverse Event|0|||
150111053|NCT03120013|541544584|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150111054|NCT03120013|541544585|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
150111055|NCT02152995|541544587|FG000|Overall Study|Withdrawal by Subject|1|||
150111056|NCT02152995|541544588|FG001|Overall Study|Withdrawal by Subject|0|||
150111057|NCT02098109|541544589|FG000|Overall Study|Protocol Violation|3|||
150111058|NCT02098109|541544590|FG001|Overall Study|Protocol Violation|0|||
150111059|NCT01565291|541544591|FG000|Overall Study|Withdrawal by Subject|1|||
150111060|NCT01565291|541544592|FG001|Overall Study|Withdrawal by Subject|0|||
150111061|NCT04907032|541544593|FG000|Overall Study|Withdrawal by Subject|7|||
150111062|NCT04907032|541544594|FG001|Overall Study|Withdrawal by Subject|1|||
150111063|NCT02705820|541544595|FG000|Overall Study|Death|2|||
150111064|NCT02705820|541544595|FG000|Overall Study|Disease Progression|34|||
150111065|NCT02705820|541544595|FG000|Overall Study|Clinical Deterioration|3|||
150111066|NCT02751983|541544596|FG000|Treatment|Stopped ACT, but Remained in study|2|||
150111067|NCT02751983|541544597|FG001|Treatment|Stopped ACT, but Remained in study|0|||
150111068|NCT02751983|541544596|FG000|Treatment|Discharged prior to beginning ACT|2|||
150111069|NCT02751983|541544597|FG001|Treatment|Discharged prior to beginning ACT|0|||
150111070|NCT02751983|541544596|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
150111071|NCT02751983|541544597|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
150111072|NCT02751983|541544596|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
150111073|NCT02751983|541544597|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
150111074|NCT02751983|541544596|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
150111075|NCT02751983|541544597|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
150111076|NCT00989833|541544598|FG000|Overall Study|Lost to Follow-up|0|||
150111077|NCT00989833|541544599|FG001|Overall Study|Lost to Follow-up|1|||
150111078|NCT00989833|541544600|FG002|Overall Study|Lost to Follow-up|0|||
150111079|NCT00989833|541544598|FG000|Overall Study|Protocol Violation|1|||
150111080|NCT00989833|541544599|FG001|Overall Study|Protocol Violation|2|||
150111081|NCT00989833|541544600|FG002|Overall Study|Protocol Violation|1|||
150111082|NCT00989833|541544598|FG000|Overall Study|Withdrawal by Subject|0|||
150111083|NCT00989833|541544599|FG001|Overall Study|Withdrawal by Subject|0|||
150111084|NCT00989833|541544600|FG002|Overall Study|Withdrawal by Subject|1|||
150111085|NCT00989833|541544598|FG000|Overall Study|Incorrectly randomized|1|||
150111086|NCT00989833|541544599|FG001|Overall Study|Incorrectly randomized|0|||
150111087|NCT00989833|541544600|FG002|Overall Study|Incorrectly randomized|0|||
150111088|NCT00414388|541544601|FG000|Overall Study|Adverse Event|1|||
150111089|NCT00025883|541544602|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
150111090|NCT00025883|541544602|FG000|Overall Study|no baseline data|1|||
150111091|NCT00025883|541544602|FG000|Overall Study|Death|1|||
150111092|NCT00025883|541544602|FG000|Overall Study|Adverse Event|1|||
150111093|NCT00025883|541544602|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
150111094|NCT00218543|541544603|FG000|Overall Study|Lost to Follow-up|8|||
150111095|NCT00218543|541544603|FG000|Overall Study|relocated|1|||
150111096|NCT00218543|541544603|FG000|Overall Study|Withdrawal by Subject|1|||
150111097|NCT00218543|541544603|FG000|Overall Study|Physician Decision|3|||
150111098|NCT00218543|541544603|FG000|Overall Study|Adverse Event|2|||
150111099|NCT02448875|541544604|FG000|Overall Study|Adverse Event|2|||
150111100|NCT02448875|541544605|FG001|Overall Study|Adverse Event|1|||
150111101|NCT02448875|541544606|FG002|Overall Study|Adverse Event|0|||
150111102|NCT02448875|541544604|FG000|Overall Study|Lost to Follow-up|1|||
150111103|NCT02448875|541544605|FG001|Overall Study|Lost to Follow-up|0|||
150111104|NCT02448875|541544606|FG002|Overall Study|Lost to Follow-up|0|||
150111105|NCT02448875|541544604|FG000|Overall Study|Investigator Decision|3|||
150111106|NCT02448875|541544605|FG001|Overall Study|Investigator Decision|0|||
150111107|NCT02448875|541544606|FG002|Overall Study|Investigator Decision|1|||
150111108|NCT02448875|541544604|FG000|Overall Study|Withdrawal by Subject|1|||
150111109|NCT02448875|541544605|FG001|Overall Study|Withdrawal by Subject|0|||
150111110|NCT02448875|541544606|FG002|Overall Study|Withdrawal by Subject|0|||
150111111|NCT01282216|541544607|FG000|Overall Study|Graft failure|0|||
150111112|NCT01282216|541544608|FG001|Overall Study|Graft failure|0|||
150111113|NCT01282216|541544609|FG002|Overall Study|Graft failure|3|||
150188741|NCT03269136|541829270|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188742|NCT03269136|541829271|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188743|NCT03269136|541829272|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188744|NCT03269136|541829273|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188745|NCT03269136|541829274|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188746|NCT03269136|541829275|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188747|NCT03269136|541829276|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188748|NCT03269136|541829277|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188749|NCT03269136|541829278|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188750|NCT03269136|541829279|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
150188751|NCT03269136|541829280|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
150188752|NCT03269136|541829281|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
150188753|NCT03269136|541829282|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188754|NCT03269136|541829283|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
150188755|NCT03269136|541829284|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
150188756|NCT03269136|541829267|FG000|Part 2A: Dose Expansion|Other|0|||
150188757|NCT03269136|541829268|FG001|Part 2A: Dose Expansion|Other|0|||
150188758|NCT03269136|541829269|FG002|Part 2A: Dose Expansion|Other|0|||
150188759|NCT03269136|541829270|FG003|Part 2A: Dose Expansion|Other|0|||
150188760|NCT03269136|541829271|FG004|Part 2A: Dose Expansion|Other|0|||
150188761|NCT03269136|541829272|FG005|Part 2A: Dose Expansion|Other|0|||
150188762|NCT03269136|541829273|FG006|Part 2A: Dose Expansion|Other|0|||
150188763|NCT03269136|541829274|FG007|Part 2A: Dose Expansion|Other|0|||
150188764|NCT03269136|541829275|FG008|Part 2A: Dose Expansion|Other|0|||
150188765|NCT03269136|541829276|FG009|Part 2A: Dose Expansion|Other|0|||
150188766|NCT03269136|541829277|FG010|Part 2A: Dose Expansion|Other|0|||
150188767|NCT03269136|541829278|FG011|Part 2A: Dose Expansion|Other|0|||
150188768|NCT03269136|541829279|FG012|Part 2A: Dose Expansion|Other|0|||
150188769|NCT03269136|541829280|FG013|Part 2A: Dose Expansion|Other|0|||
150188770|NCT03269136|541829281|FG014|Part 2A: Dose Expansion|Other|0|||
150188771|NCT03269136|541829282|FG015|Part 2A: Dose Expansion|Other|0|||
150188772|NCT03269136|541829283|FG016|Part 2A: Dose Expansion|Other|0|||
150188773|NCT03269136|541829284|FG017|Part 2A: Dose Expansion|Other|1|||
150188774|NCT03269136|541829267|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188775|NCT03269136|541829268|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188776|NCT03269136|541829269|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188777|NCT03269136|541829270|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188778|NCT03269136|541829271|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188779|NCT03269136|541829272|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188780|NCT03269136|541829273|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188781|NCT03269136|541829274|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188782|NCT03269136|541829275|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150111114|NCT01282216|541544610|FG003|Overall Study|Graft failure|2|||
150111115|NCT01282216|541544607|FG000|Overall Study|Physician Decision|0|||
150111116|NCT01282216|541544608|FG001|Overall Study|Physician Decision|0|||
150111117|NCT01282216|541544609|FG002|Overall Study|Physician Decision|11|||
150111118|NCT01282216|541544610|FG003|Overall Study|Physician Decision|0|||
150111119|NCT01282216|541544607|FG000|Overall Study|Relapse|0|||
150111120|NCT01282216|541544608|FG001|Overall Study|Relapse|0|||
150111121|NCT01282216|541544609|FG002|Overall Study|Relapse|17|||
150111122|NCT01282216|541544610|FG003|Overall Study|Relapse|6|||
150111123|NCT01282216|541544607|FG000|Overall Study|Death|0|||
150111124|NCT01282216|541544608|FG001|Overall Study|Death|0|||
150111125|NCT01282216|541544609|FG002|Overall Study|Death|2|||
150111126|NCT01282216|541544610|FG003|Overall Study|Death|0|||
150111127|NCT02908529|541544611|FG000|Overall Study|Lost to Follow-up|0|||
150111128|NCT02908529|541544612|FG001|Overall Study|Lost to Follow-up|2|||
150111129|NCT03337724|541544619|FG000|Overall Study|Reason not Specified|12|||
150111130|NCT03337724|541544620|FG001|Overall Study|Reason not Specified|21|||
150111131|NCT03337724|541544621|FG002|Overall Study|Reason not Specified|9|||
150111132|NCT03337724|541544622|FG003|Overall Study|Reason not Specified|9|||
150111133|NCT03337724|541544623|FG004|Overall Study|Reason not Specified|29|||
150111134|NCT03337724|541544619|FG000|Overall Study|Withdrawal by Subject|13|||
150188783|NCT03269136|541829276|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188784|NCT03269136|541829277|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188785|NCT03269136|541829278|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188786|NCT03269136|541829279|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150111135|NCT03337724|541544620|FG001|Overall Study|Withdrawal by Subject|15|||
150111136|NCT03337724|541544621|FG002|Overall Study|Withdrawal by Subject|4|||
150111137|NCT03337724|541544622|FG003|Overall Study|Withdrawal by Subject|15|||
150111138|NCT03337724|541544623|FG004|Overall Study|Withdrawal by Subject|6|||
150111139|NCT03337724|541544619|FG000|Overall Study|Protocol Deviation|0|||
150188787|NCT03269136|541829280|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150111140|NCT03337724|541544620|FG001|Overall Study|Protocol Deviation|1|||
150111141|NCT03337724|541544621|FG002|Overall Study|Protocol Deviation|1|||
150111142|NCT03337724|541544622|FG003|Overall Study|Protocol Deviation|1|||
150111143|NCT03337724|541544623|FG004|Overall Study|Protocol Deviation|0|||
150111144|NCT03337724|541544619|FG000|Overall Study|Adverse Event|1|||
150111145|NCT03337724|541544620|FG001|Overall Study|Adverse Event|1|||
150111146|NCT03337724|541544621|FG002|Overall Study|Adverse Event|0|||
150111147|NCT03337724|541544622|FG003|Overall Study|Adverse Event|1|||
150111148|NCT03337724|541544623|FG004|Overall Study|Adverse Event|0|||
150111149|NCT03337724|541544619|FG000|Overall Study|Death|40|||
150111150|NCT03337724|541544620|FG001|Overall Study|Death|89|||
150111151|NCT03337724|541544621|FG002|Overall Study|Death|43|||
150111152|NCT03337724|541544622|FG003|Overall Study|Death|76|||
150111153|NCT03337724|541544623|FG004|Overall Study|Death|50|||
150111154|NCT03337724|541544619|FG000|Overall Study|Lost to Follow-up|5|||
150111155|NCT03337724|541544620|FG001|Overall Study|Lost to Follow-up|5|||
150111156|NCT03337724|541544621|FG002|Overall Study|Lost to Follow-up|4|||
150111157|NCT03337724|541544622|FG003|Overall Study|Lost to Follow-up|7|||
150111158|NCT03337724|541544623|FG004|Overall Study|Lost to Follow-up|4|||
150111159|NCT03337724|541544619|FG000|Overall Study|Physician Decision|16|||
150111160|NCT03337724|541544620|FG001|Overall Study|Physician Decision|34|||
150111161|NCT03337724|541544621|FG002|Overall Study|Physician Decision|14|||
150111162|NCT03337724|541544622|FG003|Overall Study|Physician Decision|34|||
150111163|NCT03337724|541544623|FG004|Overall Study|Physician Decision|13|||
150111164|NCT03337724|541544619|FG000|Overall Study|Progressive Disease|0|||
150111165|NCT03337724|541544620|FG001|Overall Study|Progressive Disease|2|||
150111166|NCT03337724|541544621|FG002|Overall Study|Progressive Disease|1|||
150111167|NCT03337724|541544622|FG003|Overall Study|Progressive Disease|2|||
150111168|NCT03337724|541544623|FG004|Overall Study|Progressive Disease|0|||
150111169|NCT03337724|541544619|FG000|Overall Study|Symptomatic Deterioration|0|||
150111170|NCT03337724|541544620|FG001|Overall Study|Symptomatic Deterioration|0|||
150111171|NCT03337724|541544621|FG002|Overall Study|Symptomatic Deterioration|0|||
150111172|NCT03337724|541544622|FG003|Overall Study|Symptomatic Deterioration|1|||
150111173|NCT03337724|541544623|FG004|Overall Study|Symptomatic Deterioration|0|||
150111174|NCT00773097|541544624|FG000|Overall Study|Withdrawal by Subject|1|||
150111175|NCT00773097|541544624|FG000|Overall Study|Physician Decision|6|||
150111176|NCT03238911|541544632|FG000|Overall Study|Withdrawal by Subject|1|||
150111177|NCT03238911|541544633|FG001|Overall Study|Withdrawal by Subject|2|||
150111178|NCT03238911|541544632|FG000|Overall Study|Lost to Follow-up|2|||
150111179|NCT03238911|541544633|FG001|Overall Study|Lost to Follow-up|1|||
150111180|NCT02239536|541544634|FG000|Overall Study|Non-neoplastic polyp|23|||
150111181|NCT02239536|541544635|FG001|Overall Study|Non-neoplastic polyp|17|||
150111182|NCT01038778|541544636|FG000|Overall Study|Withdrawal by Subject|0|||
150111183|NCT01038778|541544637|FG001|Overall Study|Withdrawal by Subject|2|||
150111184|NCT01038778|541544638|FG002|Overall Study|Withdrawal by Subject|3|||
150111185|NCT05645432|541544639|FG000|Overall Study|Withdrawal by Subject|1|||
150111186|NCT03195478|541544640|FG000|Overall Study|Disease Progression|5|||
150111187|NCT03195478|541544641|FG001|Overall Study|Disease Progression|4|||
150111188|NCT03195478|541544642|FG002|Overall Study|Disease Progression|6|||
150111189|NCT03195478|541544643|FG003|Overall Study|Disease Progression|1|||
150111190|NCT03195478|541544640|FG000|Overall Study|Study Drug Toxicity|2|||
150111191|NCT03195478|541544641|FG001|Overall Study|Study Drug Toxicity|0|||
150111192|NCT03195478|541544642|FG002|Overall Study|Study Drug Toxicity|0|||
150111193|NCT03195478|541544643|FG003|Overall Study|Study Drug Toxicity|1|||
150111194|NCT03195478|541544640|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
150111195|NCT03195478|541544641|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
150111196|NCT03195478|541544642|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
150111197|NCT03195478|541544643|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
150111198|NCT03195478|541544640|FG000|Overall Study|Participant Withdrew Consent|1|||
150111199|NCT03195478|541544641|FG001|Overall Study|Participant Withdrew Consent|0|||
150111200|NCT03195478|541544642|FG002|Overall Study|Participant Withdrew Consent|0|||
150111201|NCT03195478|541544643|FG003|Overall Study|Participant Withdrew Consent|0|||
150111202|NCT03195478|541544640|FG000|Overall Study|Maximum Clinical benefit|0|||
150111203|NCT03195478|541544641|FG001|Overall Study|Maximum Clinical benefit|0|||
150111204|NCT03195478|541544642|FG002|Overall Study|Maximum Clinical benefit|1|||
150111205|NCT03195478|541544643|FG003|Overall Study|Maximum Clinical benefit|0|||
150111206|NCT03195478|541544640|FG000|Overall Study|Other Reasons|0|||
150111207|NCT03195478|541544641|FG001|Overall Study|Other Reasons|0|||
150111208|NCT03195478|541544642|FG002|Overall Study|Other Reasons|1|||
150111209|NCT03195478|541544643|FG003|Overall Study|Other Reasons|0|||
150111210|NCT03285646|541546490|FG000|Overall Study|Adverse Event|1|||
150111211|NCT03285646|541546491|FG001|Overall Study|Adverse Event|0|||
150111212|NCT03285646|541546490|FG000|Overall Study|Withdrawal by Subject|10|||
150111213|NCT03285646|541546491|FG001|Overall Study|Withdrawal by Subject|2|||
150111214|NCT03285646|541546490|FG000|Overall Study|Lost to Follow-up|2|||
150111215|NCT03285646|541546491|FG001|Overall Study|Lost to Follow-up|1|||
150111216|NCT03285646|541546490|FG000|Overall Study|Investigator/Sponsor Decision|0|||
150111217|NCT03285646|541546491|FG001|Overall Study|Investigator/Sponsor Decision|1|||
150111218|NCT02652624|541546496|FG000|Randomized Phase|Pregnancy|3|||
150111219|NCT02652624|541546497|FG001|Randomized Phase|Pregnancy|1|||
150111220|NCT02652624|541546496|FG000|Randomized Phase|Investigator's Discretion|0|||
150111221|NCT02652624|541546497|FG001|Randomized Phase|Investigator's Discretion|2|||
150111222|NCT02652624|541546496|FG000|Randomized Phase|Death|0|||
150111223|NCT02652624|541546497|FG001|Randomized Phase|Death|1|||
150111224|NCT02652624|541546496|FG000|Randomized Phase|Lost to Follow-up|0|||
150111225|NCT02652624|541546497|FG001|Randomized Phase|Lost to Follow-up|1|||
150111226|NCT02652624|541546496|FG000|Extension Phase|Lost to Follow-up|3|||
150111227|NCT02652624|541546497|FG001|Extension Phase|Lost to Follow-up|1|||
150111228|NCT02652624|541546496|FG000|Extension Phase|Pregnancy|1|||
150111229|NCT02652624|541546497|FG001|Extension Phase|Pregnancy|1|||
150111230|NCT02652624|541546496|FG000|Extension Phase|Adverse Event|0|||
150111231|NCT02652624|541546497|FG001|Extension Phase|Adverse Event|1|||
150111232|NCT02652624|541546496|FG000|Extension Phase|Withdrew Consent|0|||
150111233|NCT02652624|541546497|FG001|Extension Phase|Withdrew Consent|1|||
150111234|NCT01434823|541546498|FG000|Overall Study|Incomplete data in medical record|4|||
150111235|NCT01434823|541546499|FG001|Overall Study|Incomplete data in medical record|7|||
150111236|NCT04354831|541546504|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
150111237|NCT04354831|541546505|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
150111238|NCT01018264|541546506|FG000|Overall Study|Withdrawal by Subject|1|||
150111239|NCT01018264|541546507|FG001|Overall Study|Withdrawal by Subject|0|||
150111240|NCT01018264|541546506|FG000|Overall Study|Lost to Follow-up|0|||
150111241|NCT01018264|541546507|FG001|Overall Study|Lost to Follow-up|1|||
150111242|NCT00812929|541546508|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
150111243|NCT00812929|541546509|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
150111244|NCT00812929|541546510|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
150111245|NCT00812929|541546511|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
150111246|NCT00812929|541546512|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
150111247|NCT00812929|541546513|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
150111248|NCT00812929|541546514|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
150111249|NCT00812929|541546515|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
150111250|NCT00812929|541546516|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
150111251|NCT00812929|541546517|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
150111252|NCT00812929|541546508|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
150111253|NCT00812929|541546509|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
150111254|NCT00812929|541546510|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
150111255|NCT00812929|541546511|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
150111256|NCT00812929|541546512|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
150111257|NCT00812929|541546513|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
150111258|NCT00812929|541546514|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
150111259|NCT00812929|541546515|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
150111260|NCT00812929|541546516|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
150111261|NCT00812929|541546517|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
150111262|NCT00812929|541546508|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
150111263|NCT00812929|541546509|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
150111264|NCT00812929|541546510|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
150111265|NCT00812929|541546511|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
150111266|NCT00812929|541546512|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
150111267|NCT00812929|541546513|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
150111268|NCT00812929|541546514|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
150111269|NCT00812929|541546515|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
150111270|NCT00812929|541546516|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
150111271|NCT00812929|541546517|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
150111272|NCT04027686|541546518|FG000|Overall Study|Lost to Follow-up|2|||
150111273|NCT04027686|541546519|FG001|Overall Study|Lost to Follow-up|0|||
150111274|NCT04027686|541546518|FG000|Overall Study|Withdrawal by Subject|0|||
150111275|NCT04027686|541546519|FG001|Overall Study|Withdrawal by Subject|1|||
150111276|NCT03217136|541546521|FG000|Overall Study|Lost to Follow-up|2|||
150111277|NCT03217136|541546522|FG001|Overall Study|Lost to Follow-up|1|||
150111278|NCT03217136|541546521|FG000|Overall Study|Site Randomized Participant in Error|0|||
150111279|NCT03217136|541546522|FG001|Overall Study|Site Randomized Participant in Error|1|||
150111280|NCT03217136|541546521|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
150111281|NCT03217136|541546522|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
150111282|NCT03217136|541546521|FG000|Overall Study|Dispensing Error|1|||
150111283|NCT03217136|541546522|FG001|Overall Study|Dispensing Error|0|||
150111284|NCT03217136|541546521|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150111285|NCT03217136|541546522|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150111286|NCT03670810|541546523|FG000|Main Study|Adverse Event|37|||
150111287|NCT03670810|541546524|FG001|Main Study|Adverse Event|38|||
150111288|NCT03670810|541546525|FG002|Main Study|Adverse Event|3|||
150111289|NCT03670810|541546526|FG003|Main Study|Adverse Event|4|||
150111290|NCT03670810|541546527|FG004|Main Study|Adverse Event|4|||
150111291|NCT03670810|541546528|FG005|Main Study|Adverse Event|5|||
150111292|NCT03670810|541546529|FG006|Main Study|Adverse Event|0|||
150111293|NCT03670810|541546530|FG007|Main Study|Adverse Event|0|||
150111294|NCT03670810|541546531|FG008|Main Study|Adverse Event|0|||
150111295|NCT03670810|541546523|FG000|Main Study|Lack of Efficacy|8|||
150111296|NCT03670810|541546524|FG001|Main Study|Lack of Efficacy|9|||
150111297|NCT03670810|541546525|FG002|Main Study|Lack of Efficacy|3|||
150111298|NCT03670810|541546526|FG003|Main Study|Lack of Efficacy|4|||
150111299|NCT03670810|541546527|FG004|Main Study|Lack of Efficacy|0|||
150111300|NCT03670810|541546528|FG005|Main Study|Lack of Efficacy|0|||
150111301|NCT03670810|541546529|FG006|Main Study|Lack of Efficacy|0|||
150111302|NCT03670810|541546530|FG007|Main Study|Lack of Efficacy|0|||
150111303|NCT03670810|541546531|FG008|Main Study|Lack of Efficacy|0|||
150111304|NCT03670810|541546523|FG000|Main Study|Lost to Follow-up|9|||
150111305|NCT03670810|541546524|FG001|Main Study|Lost to Follow-up|7|||
150111306|NCT03670810|541546525|FG002|Main Study|Lost to Follow-up|4|||
150111307|NCT03670810|541546526|FG003|Main Study|Lost to Follow-up|6|||
150111308|NCT03670810|541546527|FG004|Main Study|Lost to Follow-up|1|||
150111309|NCT03670810|541546528|FG005|Main Study|Lost to Follow-up|0|||
150111310|NCT03670810|541546529|FG006|Main Study|Lost to Follow-up|0|||
150111311|NCT03670810|541546530|FG007|Main Study|Lost to Follow-up|0|||
150111312|NCT03670810|541546531|FG008|Main Study|Lost to Follow-up|0|||
150111313|NCT03670810|541546523|FG000|Main Study|Non-compliance with Study Drug|0|||
150111314|NCT03670810|541546524|FG001|Main Study|Non-compliance with Study Drug|2|||
150111315|NCT03670810|541546525|FG002|Main Study|Non-compliance with Study Drug|3|||
150111316|NCT03670810|541546526|FG003|Main Study|Non-compliance with Study Drug|0|||
150111317|NCT03670810|541546527|FG004|Main Study|Non-compliance with Study Drug|0|||
150111318|NCT03670810|541546528|FG005|Main Study|Non-compliance with Study Drug|0|||
150111319|NCT03670810|541546529|FG006|Main Study|Non-compliance with Study Drug|0|||
150111320|NCT03670810|541546530|FG007|Main Study|Non-compliance with Study Drug|1|||
150111321|NCT03670810|541546531|FG008|Main Study|Non-compliance with Study Drug|0|||
150111322|NCT03670810|541546523|FG000|Main Study|Physician Decision|3|||
150111323|NCT03670810|541546524|FG001|Main Study|Physician Decision|0|||
150111324|NCT03670810|541546525|FG002|Main Study|Physician Decision|1|||
150111325|NCT03670810|541546526|FG003|Main Study|Physician Decision|0|||
150111326|NCT03670810|541546527|FG004|Main Study|Physician Decision|0|||
150111327|NCT03670810|541546528|FG005|Main Study|Physician Decision|0|||
150111328|NCT03670810|541546529|FG006|Main Study|Physician Decision|1|||
150111329|NCT03670810|541546530|FG007|Main Study|Physician Decision|1|||
150111330|NCT03670810|541546531|FG008|Main Study|Physician Decision|0|||
150111331|NCT03670810|541546523|FG000|Main Study|Pregnancy|1|||
150111332|NCT03670810|541546524|FG001|Main Study|Pregnancy|2|||
150111333|NCT03670810|541546525|FG002|Main Study|Pregnancy|0|||
150111334|NCT03670810|541546526|FG003|Main Study|Pregnancy|0|||
150111335|NCT03670810|541546527|FG004|Main Study|Pregnancy|0|||
150111336|NCT03670810|541546528|FG005|Main Study|Pregnancy|0|||
150111337|NCT03670810|541546529|FG006|Main Study|Pregnancy|0|||
150111338|NCT03670810|541546530|FG007|Main Study|Pregnancy|0|||
150111339|NCT03670810|541546531|FG008|Main Study|Pregnancy|0|||
150111340|NCT03670810|541546523|FG000|Main Study|Protocol Deviation|2|||
150111341|NCT03670810|541546524|FG001|Main Study|Protocol Deviation|12|||
150111342|NCT03670810|541546525|FG002|Main Study|Protocol Deviation|8|||
150111343|NCT03670810|541546526|FG003|Main Study|Protocol Deviation|4|||
150111344|NCT03670810|541546527|FG004|Main Study|Protocol Deviation|0|||
150111345|NCT03670810|541546528|FG005|Main Study|Protocol Deviation|0|||
150111346|NCT03670810|541546529|FG006|Main Study|Protocol Deviation|0|||
150111347|NCT03670810|541546530|FG007|Main Study|Protocol Deviation|0|||
150111348|NCT03670810|541546531|FG008|Main Study|Protocol Deviation|0|||
150111349|NCT03670810|541546523|FG000|Main Study|Withdrawal by Subject|21|||
150111350|NCT03670810|541546524|FG001|Main Study|Withdrawal by Subject|21|||
150111351|NCT03670810|541546525|FG002|Main Study|Withdrawal by Subject|8|||
150111352|NCT03670810|541546526|FG003|Main Study|Withdrawal by Subject|9|||
150111353|NCT03670810|541546527|FG004|Main Study|Withdrawal by Subject|5|||
150111354|NCT03670810|541546528|FG005|Main Study|Withdrawal by Subject|2|||
150111355|NCT03670810|541546529|FG006|Main Study|Withdrawal by Subject|1|||
150111356|NCT03670810|541546530|FG007|Main Study|Withdrawal by Subject|1|||
150111357|NCT03670810|541546531|FG008|Main Study|Withdrawal by Subject|0|||
150111358|NCT03670810|541546523|FG000|Main Study|Participant did not want to take the three other treatments|1|||
150188788|NCT03269136|541829281|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150111359|NCT03670810|541546524|FG001|Main Study|Participant did not want to take the three other treatments|0|||
150111360|NCT03670810|541546525|FG002|Main Study|Participant did not want to take the three other treatments|0|||
150111361|NCT03670810|541546526|FG003|Main Study|Participant did not want to take the three other treatments|0|||
150111362|NCT03670810|541546527|FG004|Main Study|Participant did not want to take the three other treatments|0|||
150111363|NCT03670810|541546528|FG005|Main Study|Participant did not want to take the three other treatments|0|||
150188789|NCT03269136|541829282|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188790|NCT03269136|541829283|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
150188791|NCT03269136|541829284|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
150188792|NCT03269136|541829267|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
150188793|NCT03269136|541829268|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
150188794|NCT03269136|541829269|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
150188795|NCT03269136|541829270|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
150188796|NCT03269136|541829271|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
150188797|NCT03269136|541829272|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
150188798|NCT03269136|541829273|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
150188799|NCT03269136|541829274|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
150188800|NCT03269136|541829275|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
150188801|NCT03269136|541829276|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
150188802|NCT03269136|541829277|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
150188803|NCT03269136|541829278|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
150188804|NCT03269136|541829279|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
150188805|NCT03269136|541829280|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
150188806|NCT03269136|541829281|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
150188807|NCT03269136|541829282|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
150188808|NCT03269136|541829283|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
150188809|NCT03269136|541829284|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
150188810|NCT03269136|541829267|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
150188811|NCT03269136|541829268|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
150188812|NCT03269136|541829269|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
150188813|NCT03269136|541829270|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
150188814|NCT03269136|541829271|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
150188815|NCT03269136|541829272|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
150188816|NCT03269136|541829273|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
150188817|NCT03269136|541829274|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
150188818|NCT03269136|541829275|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
150188819|NCT03269136|541829276|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
150188820|NCT03269136|541829277|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
150188821|NCT03269136|541829278|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
150188822|NCT03269136|541829279|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
150188823|NCT03269136|541829280|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
150188824|NCT03269136|541829281|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
150188825|NCT03269136|541829282|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
150188826|NCT03269136|541829283|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
150188827|NCT03269136|541829284|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
150188828|NCT03269136|541829267|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
150188829|NCT03269136|541829268|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
150188830|NCT03269136|541829269|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
150188831|NCT03269136|541829270|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
150188832|NCT03269136|541829271|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
150188833|NCT03269136|541829272|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
150188834|NCT03269136|541829273|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
150188835|NCT03269136|541829274|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
150188836|NCT03269136|541829275|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
150188837|NCT03269136|541829276|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
150188838|NCT03269136|541829277|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
150188839|NCT03269136|541829278|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
150188840|NCT03269136|541829279|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
150188841|NCT03269136|541829280|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
150111364|NCT03670810|541546529|FG006|Main Study|Participant did not want to take the three other treatments|0|||
150111365|NCT03670810|541546530|FG007|Main Study|Participant did not want to take the three other treatments|0|||
150111366|NCT03670810|541546531|FG008|Main Study|Participant did not want to take the three other treatments|0|||
150111367|NCT03670810|541546523|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111368|NCT03670810|541546524|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
150111369|NCT03670810|541546525|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111370|NCT03670810|541546526|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150188842|NCT03269136|541829281|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
150188843|NCT03269136|541829282|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
150188844|NCT03269136|541829283|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
150188845|NCT03269136|541829284|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
150188846|NCT04856163|541829285|FG000|Overall Study|Lost to Follow-up|97|||
150188847|NCT04856163|541829286|FG001|Overall Study|Lost to Follow-up|100|||
150188848|NCT02515773|541829295|FG000|Overall Study|Withdrawal by Subject|12|||
150188849|NCT02515773|541829296|FG001|Overall Study|Withdrawal by Subject|2|||
150188850|NCT02515773|541829295|FG000|Overall Study|Lost to Follow-up|119|||
150188851|NCT02515773|541829296|FG001|Overall Study|Lost to Follow-up|126|||
150188852|NCT02515773|541829295|FG000|Overall Study|Discharged from Clinic Services|53|||
150188853|NCT02515773|541829296|FG001|Overall Study|Discharged from Clinic Services|84|||
150188854|NCT02515773|541829295|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
150188855|NCT02515773|541829296|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
150188856|NCT02515773|541829295|FG000|Overall Study|Follow-up at non-study site|8|||
150188857|NCT02515773|541829296|FG001|Overall Study|Follow-up at non-study site|16|||
150188858|NCT02515773|541829295|FG000|Overall Study|Moved from area|9|||
150188859|NCT02515773|541829296|FG001|Overall Study|Moved from area|14|||
150188860|NCT05434078|541829297|FG000|Overall Study|Lost to Follow-up|2|||
150188861|NCT05434078|541829298|FG001|Overall Study|Lost to Follow-up|1|||
150188862|NCT05434078|541829297|FG000|Overall Study|Withdrawal by Subject|1|||
150188863|NCT05434078|541829298|FG001|Overall Study|Withdrawal by Subject|0|||
150188864|NCT03033576|541829300|FG000|Overall Study|Ineligible|1|||
150188865|NCT03033576|541829301|FG001|Overall Study|Ineligible|1|||
150188866|NCT03033576|541829300|FG000|Overall Study|Adverse Event|4|||
150188867|NCT03033576|541829301|FG001|Overall Study|Adverse Event|20|||
150188868|NCT03033576|541829300|FG000|Overall Study|Progression/relapse|9|||
150188869|NCT03033576|541829301|FG001|Overall Study|Progression/relapse|36|||
150188870|NCT03033576|541829300|FG000|Overall Study|Death|1|||
150188871|NCT03033576|541829301|FG001|Overall Study|Death|1|||
150188872|NCT03033576|541829300|FG000|Overall Study|Patient refusal|1|||
150188873|NCT03033576|541829301|FG001|Overall Study|Patient refusal|6|||
150188874|NCT03033576|541829300|FG000|Overall Study|Other, unspecified reasons|0|||
150188875|NCT03033576|541829301|FG001|Overall Study|Other, unspecified reasons|4|||
150188876|NCT03033576|541829300|FG000|Overall Study|Currently on protocol therapy|0|||
150188877|NCT03033576|541829301|FG001|Overall Study|Currently on protocol therapy|2|||
150188878|NCT03557697|541829302|FG000|Overall Study|Withdrawal by Subject|2|||
150188879|NCT03557697|541829303|FG001|Overall Study|Withdrawal by Subject|4|||
150188880|NCT04390048|541831201|FG000|Overall Study|Withdrawal by Subject|1|||
150188881|NCT04390048|541831202|FG001|Overall Study|Withdrawal by Subject|3|||
150188882|NCT04005716|541831215|FG000|Overall Study|Death|175|||
150188883|NCT04005716|541831216|FG001|Overall Study|Death|196|||
150188884|NCT04005716|541831215|FG000|Overall Study|Withdrawal by Subject|1|||
150188885|NCT04005716|541831216|FG001|Overall Study|Withdrawal by Subject|6|||
150188886|NCT04005716|541831215|FG000|Overall Study|Lost to Follow-up|2|||
150188887|NCT04005716|541831216|FG001|Overall Study|Lost to Follow-up|2|||
150188888|NCT02783300|541831217|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188889|NCT02783300|541831218|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188890|NCT02783300|541831219|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188891|NCT02783300|541831220|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188892|NCT02783300|541831221|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188893|NCT02783300|541831222|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188894|NCT02783300|541831223|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
150188895|NCT02783300|541831224|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188896|NCT02783300|541831225|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188897|NCT02783300|541831226|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188898|NCT02783300|541831227|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188899|NCT02783300|541831228|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188900|NCT02783300|541831229|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188901|NCT02783300|541831230|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188902|NCT02783300|541831231|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188903|NCT02783300|541831232|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188904|NCT02783300|541831233|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188905|NCT02783300|541831234|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188906|NCT02783300|541831235|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188907|NCT02783300|541831236|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188908|NCT02783300|541831237|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188909|NCT02783300|541831238|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188910|NCT02783300|541831239|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188911|NCT02783300|541831240|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188912|NCT02783300|541831241|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188913|NCT02783300|541831242|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188914|NCT02783300|541831243|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
150188915|NCT02783300|541831217|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188916|NCT02783300|541831218|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188917|NCT02783300|541831219|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188918|NCT02783300|541831220|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
150188919|NCT02783300|541831221|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150111371|NCT03670810|541546527|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111372|NCT03670810|541546528|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111373|NCT03670810|541546529|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111374|NCT03670810|541546530|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111375|NCT03670810|541546531|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
150111376|NCT03670810|541546523|FG000|Main Study|Travel and Coronavirus issues|0|||
150111377|NCT03670810|541546524|FG001|Main Study|Travel and Coronavirus issues|0|||
150111378|NCT03670810|541546525|FG002|Main Study|Travel and Coronavirus issues|0|||
150111379|NCT03670810|541546526|FG003|Main Study|Travel and Coronavirus issues|1|||
150111380|NCT03670810|541546527|FG004|Main Study|Travel and Coronavirus issues|0|||
150111381|NCT03670810|541546528|FG005|Main Study|Travel and Coronavirus issues|0|||
150111382|NCT03670810|541546529|FG006|Main Study|Travel and Coronavirus issues|0|||
150111383|NCT03670810|541546530|FG007|Main Study|Travel and Coronavirus issues|0|||
150111384|NCT03670810|541546531|FG008|Main Study|Travel and Coronavirus issues|0|||
150111385|NCT03670810|541546523|FG000|Open Label Extension|Protocol Deviation|0|||
150111386|NCT03670810|541546524|FG001|Open Label Extension|Protocol Deviation|0|||
150111387|NCT03670810|541546525|FG002|Open Label Extension|Protocol Deviation|0|||
150111388|NCT03670810|541546526|FG003|Open Label Extension|Protocol Deviation|0|||
150111389|NCT03670810|541546527|FG004|Open Label Extension|Protocol Deviation|0|||
150111390|NCT03670810|541546528|FG005|Open Label Extension|Protocol Deviation|0|||
150111391|NCT03670810|541546529|FG006|Open Label Extension|Protocol Deviation|0|||
150111392|NCT03670810|541546530|FG007|Open Label Extension|Protocol Deviation|0|||
150111393|NCT03670810|541546531|FG008|Open Label Extension|Protocol Deviation|5|||
150111394|NCT03670810|541546523|FG000|Open Label Extension|Death|0|||
150111395|NCT03670810|541546524|FG001|Open Label Extension|Death|0|||
150111396|NCT03670810|541546525|FG002|Open Label Extension|Death|0|||
150111397|NCT03670810|541546526|FG003|Open Label Extension|Death|0|||
150111398|NCT03670810|541546527|FG004|Open Label Extension|Death|0|||
150111399|NCT03670810|541546528|FG005|Open Label Extension|Death|0|||
150111400|NCT03670810|541546529|FG006|Open Label Extension|Death|0|||
150111401|NCT03670810|541546530|FG007|Open Label Extension|Death|0|||
150111402|NCT03670810|541546531|FG008|Open Label Extension|Death|1|||
150111403|NCT03670810|541546523|FG000|Open Label Extension|COVID-19|0|||
150111404|NCT03670810|541546524|FG001|Open Label Extension|COVID-19|0|||
150111405|NCT03670810|541546525|FG002|Open Label Extension|COVID-19|0|||
150111406|NCT03670810|541546526|FG003|Open Label Extension|COVID-19|0|||
150111407|NCT03670810|541546527|FG004|Open Label Extension|COVID-19|0|||
150111408|NCT03670810|541546528|FG005|Open Label Extension|COVID-19|0|||
150111409|NCT03670810|541546529|FG006|Open Label Extension|COVID-19|0|||
150111410|NCT03670810|541546530|FG007|Open Label Extension|COVID-19|0|||
150111411|NCT03670810|541546531|FG008|Open Label Extension|COVID-19|1|||
150111412|NCT03670810|541546523|FG000|Open Label Extension|Lack of Efficacy|0|||
150111413|NCT03670810|541546524|FG001|Open Label Extension|Lack of Efficacy|0|||
150111414|NCT03670810|541546525|FG002|Open Label Extension|Lack of Efficacy|0|||
150111415|NCT03670810|541546526|FG003|Open Label Extension|Lack of Efficacy|0|||
150111416|NCT03670810|541546527|FG004|Open Label Extension|Lack of Efficacy|0|||
150111417|NCT03670810|541546528|FG005|Open Label Extension|Lack of Efficacy|0|||
150111418|NCT03670810|541546529|FG006|Open Label Extension|Lack of Efficacy|0|||
150111419|NCT03670810|541546530|FG007|Open Label Extension|Lack of Efficacy|0|||
150111420|NCT03670810|541546531|FG008|Open Label Extension|Lack of Efficacy|39|||
150111421|NCT03670810|541546523|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
150111422|NCT03670810|541546524|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
150111423|NCT03670810|541546525|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
150111424|NCT03670810|541546526|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
150111425|NCT03670810|541546527|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
150111426|NCT03670810|541546528|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
150111427|NCT03670810|541546529|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
150111428|NCT03670810|541546530|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
150111429|NCT03670810|541546531|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
150111430|NCT03670810|541546523|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111431|NCT03670810|541546524|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111432|NCT03670810|541546525|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111433|NCT03670810|541546526|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111434|NCT03670810|541546527|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111435|NCT03670810|541546528|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111436|NCT03670810|541546529|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111437|NCT03670810|541546530|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
150111438|NCT03670810|541546531|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
150111439|NCT03670810|541546523|FG000|Open Label Extension|Withdrawal by Subject|0|||
150111440|NCT03670810|541546524|FG001|Open Label Extension|Withdrawal by Subject|0|||
150111441|NCT03670810|541546525|FG002|Open Label Extension|Withdrawal by Subject|0|||
150111442|NCT03670810|541546526|FG003|Open Label Extension|Withdrawal by Subject|0|||
150111443|NCT03670810|541546527|FG004|Open Label Extension|Withdrawal by Subject|0|||
150111444|NCT03670810|541546528|FG005|Open Label Extension|Withdrawal by Subject|0|||
150111445|NCT03670810|541546529|FG006|Open Label Extension|Withdrawal by Subject|0|||
150111446|NCT03670810|541546530|FG007|Open Label Extension|Withdrawal by Subject|0|||
150111447|NCT03670810|541546531|FG008|Open Label Extension|Withdrawal by Subject|46|||
150111448|NCT03670810|541546523|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111449|NCT03670810|541546524|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111450|NCT03670810|541546525|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111451|NCT03670810|541546526|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111452|NCT03670810|541546527|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111453|NCT03670810|541546528|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111454|NCT03670810|541546529|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111455|NCT03670810|541546530|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
150111456|NCT03670810|541546531|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
150111457|NCT03670810|541546523|FG000|Open Label Extension|Physician Decision|0|||
150111458|NCT03670810|541546524|FG001|Open Label Extension|Physician Decision|0|||
150111459|NCT03670810|541546525|FG002|Open Label Extension|Physician Decision|0|||
150111460|NCT03670810|541546526|FG003|Open Label Extension|Physician Decision|0|||
150111461|NCT03670810|541546527|FG004|Open Label Extension|Physician Decision|0|||
150111462|NCT03670810|541546528|FG005|Open Label Extension|Physician Decision|0|||
150111463|NCT03670810|541546529|FG006|Open Label Extension|Physician Decision|0|||
150111464|NCT03670810|541546530|FG007|Open Label Extension|Physician Decision|0|||
150111465|NCT03670810|541546531|FG008|Open Label Extension|Physician Decision|2|||
150111466|NCT03670810|541546523|FG000|Open Label Extension|Non-compliance with study drug|0|||
150111467|NCT03670810|541546524|FG001|Open Label Extension|Non-compliance with study drug|0|||
150111468|NCT03670810|541546525|FG002|Open Label Extension|Non-compliance with study drug|0|||
150111469|NCT03670810|541546526|FG003|Open Label Extension|Non-compliance with study drug|0|||
150111470|NCT03670810|541546527|FG004|Open Label Extension|Non-compliance with study drug|0|||
150111471|NCT03670810|541546528|FG005|Open Label Extension|Non-compliance with study drug|0|||
150111472|NCT03670810|541546529|FG006|Open Label Extension|Non-compliance with study drug|0|||
150111473|NCT03670810|541546530|FG007|Open Label Extension|Non-compliance with study drug|0|||
150111474|NCT03670810|541546531|FG008|Open Label Extension|Non-compliance with study drug|5|||
150111475|NCT03670810|541546523|FG000|Open Label Extension|Pregnancy|0|||
150111476|NCT03670810|541546524|FG001|Open Label Extension|Pregnancy|0|||
150111477|NCT03670810|541546525|FG002|Open Label Extension|Pregnancy|0|||
150111478|NCT03670810|541546526|FG003|Open Label Extension|Pregnancy|0|||
150111479|NCT03670810|541546527|FG004|Open Label Extension|Pregnancy|0|||
150111480|NCT03670810|541546528|FG005|Open Label Extension|Pregnancy|0|||
150111481|NCT03670810|541546529|FG006|Open Label Extension|Pregnancy|0|||
150111482|NCT03670810|541546530|FG007|Open Label Extension|Pregnancy|0|||
150111483|NCT03670810|541546531|FG008|Open Label Extension|Pregnancy|3|||
150111484|NCT03670810|541546523|FG000|Open Label Extension|Adverse Event|0|||
150111485|NCT03670810|541546524|FG001|Open Label Extension|Adverse Event|0|||
150111486|NCT03670810|541546525|FG002|Open Label Extension|Adverse Event|0|||
150111487|NCT03670810|541546526|FG003|Open Label Extension|Adverse Event|0|||
150111488|NCT03670810|541546527|FG004|Open Label Extension|Adverse Event|0|||
150111489|NCT03670810|541546528|FG005|Open Label Extension|Adverse Event|0|||
150111490|NCT03670810|541546529|FG006|Open Label Extension|Adverse Event|0|||
150111491|NCT03670810|541546530|FG007|Open Label Extension|Adverse Event|0|||
150111492|NCT03670810|541546531|FG008|Open Label Extension|Adverse Event|24|||
150111493|NCT03670810|541546523|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
150111494|NCT03670810|541546524|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
150111495|NCT03670810|541546525|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
150111496|NCT03670810|541546526|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
150111497|NCT03670810|541546527|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
150111498|NCT03670810|541546528|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
150111499|NCT03670810|541546529|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
150111500|NCT03670810|541546530|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
150111501|NCT03670810|541546531|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
150111502|NCT03670810|541546523|FG000|Open Label Extension|Lost to Follow-up|0|||
150111503|NCT03670810|541546524|FG001|Open Label Extension|Lost to Follow-up|0|||
150111504|NCT03670810|541546525|FG002|Open Label Extension|Lost to Follow-up|0|||
150111505|NCT03670810|541546526|FG003|Open Label Extension|Lost to Follow-up|0|||
150111506|NCT03670810|541546527|FG004|Open Label Extension|Lost to Follow-up|0|||
150111507|NCT03670810|541546528|FG005|Open Label Extension|Lost to Follow-up|0|||
150111508|NCT03670810|541546529|FG006|Open Label Extension|Lost to Follow-up|0|||
150111509|NCT03670810|541546530|FG007|Open Label Extension|Lost to Follow-up|0|||
150111510|NCT03670810|541546531|FG008|Open Label Extension|Lost to Follow-up|23|||
150111511|NCT02939404|541546532|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
150111512|NCT02939404|541546533|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
150111513|NCT02939404|541546532|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
150111514|NCT02939404|541546533|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
150111515|NCT04182100|541546534|FG000|Overall Study|Adverse Event|1|||
150111516|NCT04182100|541546534|FG000|Overall Study|Withdrawal by Subject|1|||
150111517|NCT06640829|541546541|FG000|Overall Study|Withdrawal by Subject|1|||
150111518|NCT06640829|541546541|FG000|Overall Study|Lost to Follow-up|1|||
150111519|NCT01350128|541546542|FG000|Overall Study|Withdrawal by Subject|3|||
150111520|NCT01350128|541546542|FG000|Overall Study|Protocol discontinuation criteria|8|||
150111521|NCT01350128|541546542|FG000|Overall Study|Physician Decision|1|||
150111522|NCT01350128|541546542|FG000|Overall Study|Lost to Follow-up|2|||
150111523|NCT01859715|541546545|FG000|Overall Study|No 2nd VAS|16|||
150111524|NCT01859715|541546546|FG001|Overall Study|No 2nd VAS|8|||
150111525|NCT01859715|541546547|FG002|Overall Study|No 2nd VAS|23|||
150111526|NCT01252290|541546548|FG000|Overall Study|Withdrawal by Subject|1|||
150111527|NCT02075437|541546553|FG000|Overall Study|Withdrawal by Subject|5|||
150111528|NCT02075437|541546553|FG000|Overall Study|Lost to Follow-up|1|||
150111529|NCT04439240|541546554|FG000|Overall Study|Ineligible|2|||
150111530|NCT04439240|541546554|FG000|Overall Study|Never started treatment|2|||
150111531|NCT04439240|541546554|FG000|Overall Study|Adverse Event|12|||
150111532|NCT04439240|541546554|FG000|Overall Study|Death|2|||
150111533|NCT04439240|541546554|FG000|Overall Study|Disease progression|25|||
150111534|NCT04439240|541546554|FG000|Overall Study|Other diseases|2|||
150111535|NCT04439240|541546554|FG000|Overall Study|Withdrawal by Subject|3|||
150111536|NCT04439240|541546554|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
150111537|NCT04439240|541546554|FG000|Overall Study|Symptomatic decline|1|||
150111538|NCT04439240|541546554|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
150111539|NCT04439240|541546554|FG000|Overall Study|Clinical progression|1|||
150111540|NCT00813124|541546556|FG000|Overall Study|Death|2|||
150111541|NCT00813124|541546556|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
150111542|NCT00813124|541546556|FG000|Overall Study|Withdrawal by Subject|1|||
150111543|NCT00079274|541546557|FG000|Overall Study|Withdrawal by Subject|111|||
150111544|NCT00079274|541546558|FG001|Overall Study|Withdrawal by Subject|10|||
150111545|NCT00079274|541546559|FG002|Overall Study|Withdrawal by Subject|12|||
150111546|NCT00079274|541546560|FG003|Overall Study|Withdrawal by Subject|163|||
150111547|NCT00079274|541546561|FG004|Overall Study|Withdrawal by Subject|7|||
150111548|NCT00079274|541546562|FG005|Overall Study|Withdrawal by Subject|8|||
150111549|NCT00079274|541546563|FG006|Overall Study|Withdrawal by Subject|0|||
150111550|NCT00079274|541546557|FG000|Overall Study|Adverse Event|130|||
150111551|NCT00079274|541546558|FG001|Overall Study|Adverse Event|8|||
150111552|NCT00079274|541546559|FG002|Overall Study|Adverse Event|8|||
150111553|NCT00079274|541546560|FG003|Overall Study|Adverse Event|184|||
150111554|NCT00079274|541546561|FG004|Overall Study|Adverse Event|7|||
150111555|NCT00079274|541546562|FG005|Overall Study|Adverse Event|8|||
150111556|NCT00079274|541546563|FG006|Overall Study|Adverse Event|0|||
150111557|NCT00079274|541546557|FG000|Overall Study|Recurrence|21|||
150111558|NCT00079274|541546558|FG001|Overall Study|Recurrence|0|||
150188920|NCT02783300|541831222|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150111559|NCT00079274|541546559|FG002|Overall Study|Recurrence|1|||
150111560|NCT00079274|541546560|FG003|Overall Study|Recurrence|15|||
150111561|NCT00079274|541546561|FG004|Overall Study|Recurrence|0|||
150111562|NCT00079274|541546562|FG005|Overall Study|Recurrence|2|||
150111563|NCT00079274|541546563|FG006|Overall Study|Recurrence|0|||
150111564|NCT00079274|541546557|FG000|Overall Study|Alternate Treatment|6|||
150111565|NCT00079274|541546558|FG001|Overall Study|Alternate Treatment|1|||
150188921|NCT02783300|541831223|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188922|NCT02783300|541831224|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150111566|NCT00079274|541546559|FG002|Overall Study|Alternate Treatment|0|||
150111567|NCT00079274|541546560|FG003|Overall Study|Alternate Treatment|3|||
150111568|NCT00079274|541546561|FG004|Overall Study|Alternate Treatment|0|||
150111569|NCT00079274|541546562|FG005|Overall Study|Alternate Treatment|0|||
150111570|NCT00079274|541546563|FG006|Overall Study|Alternate Treatment|0|||
150111571|NCT00079274|541546557|FG000|Overall Study|Other Medical Problems|6|||
150111572|NCT00079274|541546558|FG001|Overall Study|Other Medical Problems|1|||
150111573|NCT00079274|541546559|FG002|Overall Study|Other Medical Problems|0|||
150111574|NCT00079274|541546560|FG003|Overall Study|Other Medical Problems|7|||
150111575|NCT00079274|541546561|FG004|Overall Study|Other Medical Problems|0|||
150111576|NCT00079274|541546562|FG005|Overall Study|Other Medical Problems|0|||
150111577|NCT00079274|541546563|FG006|Overall Study|Other Medical Problems|0|||
150111578|NCT00079274|541546557|FG000|Overall Study|Death|4|||
150111579|NCT00079274|541546558|FG001|Overall Study|Death|0|||
150111580|NCT00079274|541546559|FG002|Overall Study|Death|1|||
150111581|NCT00079274|541546560|FG003|Overall Study|Death|15|||
150111582|NCT00079274|541546561|FG004|Overall Study|Death|0|||
150111583|NCT00079274|541546562|FG005|Overall Study|Death|0|||
150111584|NCT00079274|541546563|FG006|Overall Study|Death|0|||
150111585|NCT00079274|541546557|FG000|Overall Study|Cytogenetic resistance|0|||
150111586|NCT00079274|541546558|FG001|Overall Study|Cytogenetic resistance|0|||
150111587|NCT00079274|541546559|FG002|Overall Study|Cytogenetic resistance|0|||
150111588|NCT00079274|541546560|FG003|Overall Study|Cytogenetic resistance|2|||
150111589|NCT00079274|541546561|FG004|Overall Study|Cytogenetic resistance|0|||
150111590|NCT00079274|541546562|FG005|Overall Study|Cytogenetic resistance|0|||
150111591|NCT00079274|541546563|FG006|Overall Study|Cytogenetic resistance|0|||
150111592|NCT00079274|541546557|FG000|Overall Study|Other|43|||
150111593|NCT00079274|541546558|FG001|Overall Study|Other|7|||
150111594|NCT00079274|541546559|FG002|Overall Study|Other|5|||
150111595|NCT00079274|541546560|FG003|Overall Study|Other|55|||
150111596|NCT00079274|541546561|FG004|Overall Study|Other|1|||
150111597|NCT00079274|541546562|FG005|Overall Study|Other|2|||
150111598|NCT00079274|541546563|FG006|Overall Study|Other|0|||
150188923|NCT02783300|541831225|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150111599|NCT00767676|541546564|FG000|Overall Study|Investigator error|54|||
150111600|NCT00617240|541546569|FG000|Overall Study|Lack of Efficacy|1|||
150111601|NCT00617240|541546570|FG001|Overall Study|Lack of Efficacy|0|||
150111602|NCT01611259|541546571|FG000|Overall Study|Physician Decision|1|||
150111603|NCT01611259|541546571|FG000|Overall Study|Lack of Efficacy|2|||
150111604|NCT01611259|541546571|FG000|Overall Study|Adverse Event|4|||
150111605|NCT01611259|541546571|FG000|Overall Study|Withdrawal by Subject|7|||
150111606|NCT04936685|541546572|FG000|Overall Study|Protocol Violation|1|||
150111607|NCT04936685|541546573|FG001|Overall Study|Protocol Violation|0|||
150111608|NCT01302392|541546574|FG000|Overall Study|Lost to Follow-up|1|||
150111609|NCT01302392|541546575|FG001|Overall Study|Lost to Follow-up|0|||
150111610|NCT01302392|541546574|FG000|Overall Study|Withdrawal by Subject|6|||
150111611|NCT01302392|541546575|FG001|Overall Study|Withdrawal by Subject|1|||
150111612|NCT03604692|541546579|FG000|Overall Study|Investigator's Decision|0|||
150111613|NCT03604692|541546580|FG001|Overall Study|Investigator's Decision|0|||
150111614|NCT03604692|541546581|FG002|Overall Study|Investigator's Decision|0|||
150111615|NCT03604692|541546582|FG003|Overall Study|Investigator's Decision|1|||
150111616|NCT03604692|541546583|FG004|Overall Study|Investigator's Decision|0|||
150111617|NCT03604692|541546584|FG005|Overall Study|Investigator's Decision|7|||
150111618|NCT03604692|541546579|FG000|Overall Study|Withdrawal by Subject|0|||
150111619|NCT03604692|541546580|FG001|Overall Study|Withdrawal by Subject|0|||
150111620|NCT03604692|541546581|FG002|Overall Study|Withdrawal by Subject|0|||
150111621|NCT03604692|541546582|FG003|Overall Study|Withdrawal by Subject|0|||
150111622|NCT03604692|541546583|FG004|Overall Study|Withdrawal by Subject|0|||
150111623|NCT03604692|541546584|FG005|Overall Study|Withdrawal by Subject|2|||
150111624|NCT03604692|541546579|FG000|Overall Study|Progressive Disease|1|||
150111625|NCT03604692|541546580|FG001|Overall Study|Progressive Disease|0|||
150111626|NCT03604692|541546581|FG002|Overall Study|Progressive Disease|1|||
150111627|NCT03604692|541546582|FG003|Overall Study|Progressive Disease|0|||
150111628|NCT03604692|541546583|FG004|Overall Study|Progressive Disease|3|||
150111629|NCT03604692|541546584|FG005|Overall Study|Progressive Disease|4|||
150111630|NCT03604692|541546579|FG000|Overall Study|Difficulty Coming into Site|0|||
150111631|NCT03604692|541546580|FG001|Overall Study|Difficulty Coming into Site|0|||
150111632|NCT03604692|541546581|FG002|Overall Study|Difficulty Coming into Site|0|||
150111633|NCT03604692|541546582|FG003|Overall Study|Difficulty Coming into Site|0|||
150111634|NCT03604692|541546583|FG004|Overall Study|Difficulty Coming into Site|0|||
150111635|NCT03604692|541546584|FG005|Overall Study|Difficulty Coming into Site|1|||
150111636|NCT03604692|541546579|FG000|Overall Study|Death|0|||
150111637|NCT03604692|541546580|FG001|Overall Study|Death|0|||
150111638|NCT03604692|541546581|FG002|Overall Study|Death|1|||
150111639|NCT03604692|541546582|FG003|Overall Study|Death|0|||
150111640|NCT03604692|541546583|FG004|Overall Study|Death|0|||
150111641|NCT03604692|541546584|FG005|Overall Study|Death|0|||
150111642|NCT03604692|541546579|FG000|Overall Study|Drug Intolerance|0|||
150111643|NCT03604692|541546580|FG001|Overall Study|Drug Intolerance|0|||
150111644|NCT03604692|541546581|FG002|Overall Study|Drug Intolerance|0|||
150111645|NCT03604692|541546582|FG003|Overall Study|Drug Intolerance|1|||
150111646|NCT03604692|541546583|FG004|Overall Study|Drug Intolerance|0|||
150111647|NCT03604692|541546584|FG005|Overall Study|Drug Intolerance|0|||
150111648|NCT03604692|541546579|FG000|Overall Study|Noncompliance with follow-up visit|0|||
150111649|NCT03604692|541546580|FG001|Overall Study|Noncompliance with follow-up visit|0|||
150111650|NCT03604692|541546581|FG002|Overall Study|Noncompliance with follow-up visit|0|||
150111651|NCT03604692|541546582|FG003|Overall Study|Noncompliance with follow-up visit|1|||
150111652|NCT03604692|541546583|FG004|Overall Study|Noncompliance with follow-up visit|0|||
150111653|NCT03604692|541546584|FG005|Overall Study|Noncompliance with follow-up visit|0|||
150111654|NCT03604692|541546579|FG000|Overall Study|Not Treated|0|||
150111655|NCT03604692|541546580|FG001|Overall Study|Not Treated|0|||
150111656|NCT03604692|541546581|FG002|Overall Study|Not Treated|0|||
150111657|NCT03604692|541546582|FG003|Overall Study|Not Treated|0|||
150111658|NCT03604692|541546583|FG004|Overall Study|Not Treated|1|||
150111659|NCT03604692|541546584|FG005|Overall Study|Not Treated|0|||
150111660|NCT00637195|541546585|FG000|Overall Study|Lost to Follow-up|1|||
150111661|NCT00637195|541546586|FG001|Overall Study|Lost to Follow-up|0|||
150111662|NCT00637195|541546585|FG000|Overall Study|Other|2|||
150111663|NCT00637195|541546586|FG001|Overall Study|Other|0|||
150111664|NCT00637195|541546585|FG000|Overall Study|Withdrawal by Subject|0|||
150111665|NCT00637195|541546586|FG001|Overall Study|Withdrawal by Subject|1|||
150111666|NCT00376168|541546589|FG000|Overall Study|Adverse Event|1|||
150111667|NCT00376168|541546590|FG001|Overall Study|Adverse Event|1|||
150111668|NCT00376168|541546589|FG000|Overall Study|Pregnancy|1|||
150111669|NCT00376168|541546590|FG001|Overall Study|Pregnancy|0|||
150111670|NCT01020019|541546591|FG000|Overall Study|Lost to Follow-up|21|||
150111671|NCT01020019|541546592|FG001|Overall Study|Lost to Follow-up|18|||
150111672|NCT01020019|541546591|FG000|Overall Study|Adverse Event|1|||
150111673|NCT01020019|541546592|FG001|Overall Study|Adverse Event|5|||
150111674|NCT01020019|541546591|FG000|Overall Study|not interested in treatment|4|||
150111675|NCT01020019|541546592|FG001|Overall Study|not interested in treatment|4|||
150111676|NCT01020019|541546591|FG000|Overall Study|moving|0|||
150111677|NCT01020019|541546592|FG001|Overall Study|moving|2|||
150111678|NCT05091528|541546593|FG000|Overall Study|Study Termination by Sponsor|0|||
150111679|NCT05091528|541546594|FG001|Overall Study|Study Termination by Sponsor|1|||
150111680|NCT05091528|541546595|FG002|Overall Study|Study Termination by Sponsor|0|||
150111681|NCT05091528|541546596|FG003|Overall Study|Study Termination by Sponsor|1|||
150111682|NCT02214121|541546597|FG000|Part A|Patient decision|2|||
150111683|NCT02214121|541546598|FG001|Part A|Patient decision|0|||
150111684|NCT02214121|541546599|FG002|Part A|Patient decision|0|||
150111685|NCT02214121|541546597|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
150111686|NCT02214121|541546598|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
150111687|NCT02214121|541546599|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
150111688|NCT02214121|541546597|FG000|Part A|Other|1|||
150111689|NCT02214121|541546598|FG001|Part A|Other|0|||
150111690|NCT02214121|541546599|FG002|Part A|Other|0|||
150111691|NCT02214121|541546597|FG000|Part B|Patient decision|0|||
150111692|NCT02214121|541546598|FG001|Part B|Patient decision|1|||
150111693|NCT02214121|541546599|FG002|Part B|Patient decision|0|||
150111694|NCT02214121|541546597|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
150111695|NCT02214121|541546598|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
150111696|NCT02214121|541546599|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
150111697|NCT02214121|541546597|FG000|Part B|Lost to Follow-up|0|||
150111698|NCT02214121|541546598|FG001|Part B|Lost to Follow-up|0|||
150111699|NCT02214121|541546599|FG002|Part B|Lost to Follow-up|1|||
150111700|NCT02375672|541546600|FG000|Overall Study|remain on follow up|20|||
150111701|NCT03921411|541546607|FG000|Overall Study|Withdrawal by Subject|1|||
150111702|NCT03921411|541546607|FG000|Overall Study|Protocol Deviation|2|||
150111703|NCT03921411|541546607|FG000|Overall Study|Enrolled, but never treated|2|||
150111704|NCT02114879|541546608|FG000|Overall Study|Withdrawal by Subject|9|||
150111705|NCT02114879|541546609|FG001|Overall Study|Withdrawal by Subject|5|||
150111706|NCT02114879|541546608|FG000|Overall Study|Death|6|||
150111707|NCT02114879|541546609|FG001|Overall Study|Death|11|||
150111708|NCT02114879|541546608|FG000|Overall Study|Lost to Follow-up|4|||
150111709|NCT02114879|541546609|FG001|Overall Study|Lost to Follow-up|6|||
150111710|NCT02114879|541546608|FG000|Overall Study|Physician Decision|0|||
150111711|NCT02114879|541546609|FG001|Overall Study|Physician Decision|2|||
150111712|NCT01541826|541546612|FG000|Overall Study|Lost to Follow-up|2|||
150111713|NCT01541826|541546613|FG001|Overall Study|Lost to Follow-up|3|||
150111714|NCT01541826|541546614|FG002|Overall Study|Lost to Follow-up|0|||
150111715|NCT01541826|541546612|FG000|Overall Study|Withdrawal by Subject|2|||
150111716|NCT01541826|541546613|FG001|Overall Study|Withdrawal by Subject|0|||
150111717|NCT01541826|541546614|FG002|Overall Study|Withdrawal by Subject|0|||
150111718|NCT01365273|541546616|FG000|Overall Study|Lost to Follow-up|1|||
150111719|NCT01365273|541546617|FG001|Overall Study|Lost to Follow-up|0|||
150111720|NCT01365273|541546616|FG000|Overall Study|Protocol Violation|0|||
150111721|NCT01365273|541546617|FG001|Overall Study|Protocol Violation|1|||
150111722|NCT01365273|541546616|FG000|Overall Study|Physician Decision|1|||
150111723|NCT01365273|541546617|FG001|Overall Study|Physician Decision|0|||
150111724|NCT01527292|541546631|FG000|Overall Study|Physician Decision|0|||
150111725|NCT01527292|541546632|FG001|Overall Study|Physician Decision|3|||
150111726|NCT00006916|541546633|FG000|Overall Study|Device not inserted|4|||
150111727|NCT00006916|541546633|FG000|Overall Study|Complication of device insertion|1|||
150111728|NCT00558103|541546634|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
150111729|NCT00558103|541546635|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
150111730|NCT00558103|541546636|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
150111731|NCT00558103|541546637|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
150111732|NCT00558103|541546638|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
150111733|NCT00558103|541546639|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
150111734|NCT00558103|541546634|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
150111735|NCT00558103|541546635|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
150111736|NCT00558103|541546636|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
150111737|NCT00558103|541546637|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
150111738|NCT00558103|541546638|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
150111739|NCT00558103|541546639|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
150111740|NCT00558103|541546634|FG000|Randomized Treatment Phase|Disease Progression|1|||
150111741|NCT00558103|541546635|FG001|Randomized Treatment Phase|Disease Progression|0|||
150111742|NCT00558103|541546636|FG002|Randomized Treatment Phase|Disease Progression|1|||
150111743|NCT00558103|541546637|FG003|Randomized Treatment Phase|Disease Progression|0|||
150111744|NCT00558103|541546638|FG004|Randomized Treatment Phase|Disease Progression|0|||
150111745|NCT00558103|541546639|FG005|Randomized Treatment Phase|Disease Progression|0|||
150111746|NCT00558103|541546634|FG000|Randomized Treatment Phase|Adverse Event|0|||
150111747|NCT00558103|541546635|FG001|Randomized Treatment Phase|Adverse Event|0|||
150111748|NCT00558103|541546636|FG002|Randomized Treatment Phase|Adverse Event|0|||
150111749|NCT00558103|541546637|FG003|Randomized Treatment Phase|Adverse Event|1|||
150111750|NCT00558103|541546638|FG004|Randomized Treatment Phase|Adverse Event|1|||
150111751|NCT00558103|541546639|FG005|Randomized Treatment Phase|Adverse Event|0|||
150111752|NCT00558103|541546634|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
150111753|NCT00558103|541546635|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
150111754|NCT00558103|541546636|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
150111755|NCT00558103|541546637|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
150111756|NCT00558103|541546638|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
150111757|NCT00558103|541546639|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
150111758|NCT00558103|541546634|FG000|Monotherapy Extension Phase|Disease Progression|0|||
150111759|NCT00558103|541546635|FG001|Monotherapy Extension Phase|Disease Progression|0|||
150111760|NCT00558103|541546636|FG002|Monotherapy Extension Phase|Disease Progression|0|||
150111761|NCT00558103|541546637|FG003|Monotherapy Extension Phase|Disease Progression|0|||
150111762|NCT00558103|541546638|FG004|Monotherapy Extension Phase|Disease Progression|0|||
150111763|NCT00558103|541546639|FG005|Monotherapy Extension Phase|Disease Progression|8|||
150111764|NCT03385239|541546642|FG000|Overall Study|Voluntary Withdrawal|2|||
150111765|NCT03385239|541546643|FG001|Overall Study|Voluntary Withdrawal|3|||
150111766|NCT03385239|541546644|FG002|Overall Study|Voluntary Withdrawal|2|||
150111767|NCT03385239|541546645|FG003|Overall Study|Voluntary Withdrawal|3|||
150111768|NCT03385239|541546646|FG004|Overall Study|Voluntary Withdrawal|0|||
150111769|NCT03385239|541546642|FG000|Overall Study|Adverse Event|0|||
150111770|NCT03385239|541546643|FG001|Overall Study|Adverse Event|0|||
150111771|NCT03385239|541546644|FG002|Overall Study|Adverse Event|1|||
150111772|NCT03385239|541546645|FG003|Overall Study|Adverse Event|0|||
150111773|NCT03385239|541546646|FG004|Overall Study|Adverse Event|0|||
150111774|NCT03385239|541546642|FG000|Overall Study|Other|0|||
150111775|NCT03385239|541546643|FG001|Overall Study|Other|0|||
150111776|NCT03385239|541546644|FG002|Overall Study|Other|0|||
150111777|NCT03385239|541546645|FG003|Overall Study|Other|1|||
150111778|NCT03385239|541546646|FG004|Overall Study|Other|0|||
150111779|NCT00308711|541546648|FG000|Overall Study|Withdrawal by Subject|1|||
150111780|NCT00308711|541546649|FG001|Overall Study|Withdrawal by Subject|0|||
150111781|NCT00308711|541546650|FG002|Overall Study|Withdrawal by Subject|1|||
150111782|NCT00308711|541546648|FG000|Overall Study|Protocol Violation|0|||
150111783|NCT00308711|541546649|FG001|Overall Study|Protocol Violation|1|||
150111784|NCT00308711|541546650|FG002|Overall Study|Protocol Violation|1|||
150111785|NCT00308711|541546648|FG000|Overall Study|Lost to Follow-up|0|||
150111786|NCT00308711|541546649|FG001|Overall Study|Lost to Follow-up|1|||
150111787|NCT00308711|541546650|FG002|Overall Study|Lost to Follow-up|0|||
150111788|NCT00308711|541546648|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
150111789|NCT00308711|541546649|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
150111790|NCT00308711|541546650|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
150111791|NCT00308711|541546648|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
150111792|NCT00308711|541546649|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
150111793|NCT00308711|541546650|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
150111794|NCT03139916|541546653|FG000|Overall Study|Withdrawal by Subject|2|||
150111795|NCT03139916|541546653|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
150111796|NCT01420081|541546654|FG000|Overall Study|Death|1|||
150111797|NCT01420081|541546655|FG001|Overall Study|Death|0|||
150111798|NCT01420081|541546656|FG002|Overall Study|Death|8|||
150111799|NCT01420081|541546657|FG003|Overall Study|Death|0|||
150111800|NCT01420081|541546658|FG004|Overall Study|Death|7|||
150111801|NCT01420081|541546659|FG005|Overall Study|Death|12|||
150111802|NCT01420081|541546660|FG006|Overall Study|Death|0|||
150111803|NCT01420081|541546661|FG007|Overall Study|Death|1|||
150111804|NCT01420081|541546662|FG008|Overall Study|Death|1|||
150111805|NCT01420081|541546654|FG000|Overall Study|Lost to Follow-up|0|||
150111806|NCT01420081|541546655|FG001|Overall Study|Lost to Follow-up|0|||
150111807|NCT01420081|541546656|FG002|Overall Study|Lost to Follow-up|0|||
150111808|NCT01420081|541546657|FG003|Overall Study|Lost to Follow-up|0|||
150111809|NCT01420081|541546658|FG004|Overall Study|Lost to Follow-up|1|||
150111810|NCT01420081|541546659|FG005|Overall Study|Lost to Follow-up|1|||
150111811|NCT01420081|541546660|FG006|Overall Study|Lost to Follow-up|0|||
150111812|NCT01420081|541546661|FG007|Overall Study|Lost to Follow-up|0|||
150111813|NCT01420081|541546662|FG008|Overall Study|Lost to Follow-up|0|||
150111814|NCT01420081|541546654|FG000|Overall Study|Study Terminated by Sponsor|2|||
150111815|NCT01420081|541546655|FG001|Overall Study|Study Terminated by Sponsor|1|||
150111816|NCT01420081|541546656|FG002|Overall Study|Study Terminated by Sponsor|1|||
150111817|NCT01420081|541546657|FG003|Overall Study|Study Terminated by Sponsor|3|||
150111818|NCT01420081|541546658|FG004|Overall Study|Study Terminated by Sponsor|11|||
150111819|NCT01420081|541546659|FG005|Overall Study|Study Terminated by Sponsor|7|||
150111820|NCT01420081|541546660|FG006|Overall Study|Study Terminated by Sponsor|3|||
150111821|NCT01420081|541546661|FG007|Overall Study|Study Terminated by Sponsor|2|||
150111822|NCT01420081|541546662|FG008|Overall Study|Study Terminated by Sponsor|2|||
150111823|NCT01420081|541546654|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
150111824|NCT01420081|541546655|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
150111825|NCT01420081|541546656|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
150111826|NCT01420081|541546657|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
150111827|NCT01420081|541546658|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
150111828|NCT01420081|541546659|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
150111829|NCT01420081|541546660|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
150111830|NCT01420081|541546661|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
150111831|NCT01420081|541546662|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
150111832|NCT01420081|541546654|FG000|Overall Study|Other Reasons|0|||
150111833|NCT01420081|541546655|FG001|Overall Study|Other Reasons|0|||
150111834|NCT01420081|541546656|FG002|Overall Study|Other Reasons|1|||
150111835|NCT01420081|541546657|FG003|Overall Study|Other Reasons|0|||
150111836|NCT01420081|541546658|FG004|Overall Study|Other Reasons|0|||
150111837|NCT01420081|541546659|FG005|Overall Study|Other Reasons|0|||
150111838|NCT01420081|541546660|FG006|Overall Study|Other Reasons|0|||
150111839|NCT01420081|541546661|FG007|Overall Study|Other Reasons|0|||
150111840|NCT01420081|541546662|FG008|Overall Study|Other Reasons|0|||
150111841|NCT02318693|541546664|FG000|Overall Study|Protocol Violation|0|||
150111842|NCT02318693|541546665|FG001|Overall Study|Protocol Violation|1|||
150111843|NCT00700011|541546666|FG000|Overall Study|Death|0|||
150111844|NCT00700011|541546667|FG001|Overall Study|Death|1|||
150111845|NCT00678561|541546668|FG000|Overall Study|Adverse Event|0|||
150111846|NCT00678561|541546669|FG001|Overall Study|Adverse Event|1|||
150188924|NCT02783300|541831226|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188925|NCT02783300|541831227|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150111847|NCT00678561|541546670|FG002|Overall Study|Adverse Event|1|||
150111848|NCT00678561|541546671|FG003|Overall Study|Adverse Event|0|||
150111849|NCT00678561|541546672|FG004|Overall Study|Adverse Event|1|||
150111850|NCT00678561|541546673|FG005|Overall Study|Adverse Event|0|||
150111851|NCT00678561|541546674|FG006|Overall Study|Adverse Event|0|||
150111852|NCT00678561|541546675|FG007|Overall Study|Adverse Event|0|||
150111853|NCT00678561|541546668|FG000|Overall Study|Protocol Violation|0|||
150111854|NCT00678561|541546669|FG001|Overall Study|Protocol Violation|0|||
150111855|NCT00678561|541546670|FG002|Overall Study|Protocol Violation|0|||
150111856|NCT00678561|541546671|FG003|Overall Study|Protocol Violation|0|||
150111857|NCT00678561|541546672|FG004|Overall Study|Protocol Violation|1|||
150111858|NCT00678561|541546673|FG005|Overall Study|Protocol Violation|1|||
150111859|NCT00678561|541546674|FG006|Overall Study|Protocol Violation|0|||
150111860|NCT00678561|541546675|FG007|Overall Study|Protocol Violation|0|||
150111861|NCT00678561|541546668|FG000|Overall Study|Withdrawal by Subject|0|||
150111862|NCT00678561|541546669|FG001|Overall Study|Withdrawal by Subject|0|||
150111863|NCT00678561|541546670|FG002|Overall Study|Withdrawal by Subject|0|||
150111864|NCT00678561|541546671|FG003|Overall Study|Withdrawal by Subject|0|||
150111865|NCT00678561|541546672|FG004|Overall Study|Withdrawal by Subject|0|||
150111866|NCT00678561|541546673|FG005|Overall Study|Withdrawal by Subject|0|||
150111867|NCT00678561|541546674|FG006|Overall Study|Withdrawal by Subject|0|||
150111868|NCT00678561|541546675|FG007|Overall Study|Withdrawal by Subject|1|||
150111869|NCT00004031|541546676|FG000|Overall Study|Adverse Event|5|||
150111870|NCT00004031|541546677|FG001|Overall Study|Adverse Event|0|||
150111871|NCT00004031|541546676|FG000|Overall Study|Refusal unrelated to adverse events|2|||
150111872|NCT00004031|541546677|FG001|Overall Study|Refusal unrelated to adverse events|11|||
150111873|NCT00004031|541546676|FG000|Overall Study|Progression/relapse|9|||
150111874|NCT00004031|541546677|FG001|Overall Study|Progression/relapse|4|||
150111875|NCT00004031|541546676|FG000|Overall Study|Death|3|||
150111876|NCT00004031|541546677|FG001|Overall Study|Death|1|||
150111877|NCT00004031|541546676|FG000|Overall Study|Other- not protocol specified|3|||
150111878|NCT00004031|541546677|FG001|Overall Study|Other- not protocol specified|3|||
150111879|NCT00004031|541546676|FG000|Overall Study|Reason under review|3|||
150111880|NCT00004031|541546677|FG001|Overall Study|Reason under review|2|||
150111881|NCT01451424|541546678|FG000|Overall Study|Withdrawal by Subject|1|||
150111882|NCT01451424|541546679|FG001|Overall Study|Withdrawal by Subject|1|||
150111883|NCT01451424|541546680|FG002|Overall Study|Withdrawal by Subject|0|||
150111884|NCT01451424|541546681|FG003|Overall Study|Withdrawal by Subject|2|||
150111885|NCT01451424|541546678|FG000|Overall Study|Lost to Follow-up|0|||
150111886|NCT01451424|541546679|FG001|Overall Study|Lost to Follow-up|1|||
150111887|NCT01451424|541546680|FG002|Overall Study|Lost to Follow-up|0|||
150111888|NCT01451424|541546681|FG003|Overall Study|Lost to Follow-up|1|||
150111889|NCT01451424|541546678|FG000|Overall Study|Physician Decision|0|||
150111890|NCT01451424|541546679|FG001|Overall Study|Physician Decision|0|||
150111891|NCT01451424|541546680|FG002|Overall Study|Physician Decision|1|||
150111892|NCT01451424|541546681|FG003|Overall Study|Physician Decision|1|||
150111893|NCT01451424|541546678|FG000|Overall Study|Adverse Event|0|||
150111894|NCT01451424|541546679|FG001|Overall Study|Adverse Event|0|||
150111895|NCT01451424|541546680|FG002|Overall Study|Adverse Event|0|||
150111896|NCT01451424|541546681|FG003|Overall Study|Adverse Event|1|||
150111897|NCT02920983|541546682|FG000|Dispense 1|Unacceptable Lens Fit|0|||
150111898|NCT02920983|541546683|FG001|Dispense 1|Unacceptable Lens Fit|0|||
150111899|NCT02920983|541546684|FG002|Dispense 1|Unacceptable Lens Fit|0|||
150111900|NCT02920983|541546685|FG003|Dispense 1|Unacceptable Lens Fit|0|||
150111901|NCT02920983|541546686|FG004|Dispense 1|Unacceptable Lens Fit|1|||
150111902|NCT02920983|541546687|FG005|Dispense 1|Unacceptable Lens Fit|0|||
150111903|NCT02920983|541546682|FG000|Dispense 2|Unscceptable lens fit|1|||
150111904|NCT02920983|541546683|FG001|Dispense 2|Unscceptable lens fit|0|||
150111905|NCT02920983|541546684|FG002|Dispense 2|Unscceptable lens fit|0|||
150111906|NCT02920983|541546685|FG003|Dispense 2|Unscceptable lens fit|0|||
150111907|NCT02920983|541546686|FG004|Dispense 2|Unscceptable lens fit|1|||
150111908|NCT02920983|541546687|FG005|Dispense 2|Unscceptable lens fit|0|||
150111909|NCT02920983|541546682|FG000|Dispense 3|Unacceptable Lens Fit|1|||
150111910|NCT02920983|541546683|FG001|Dispense 3|Unacceptable Lens Fit|1|||
150111911|NCT02920983|541546684|FG002|Dispense 3|Unacceptable Lens Fit|0|||
150111912|NCT02920983|541546685|FG003|Dispense 3|Unacceptable Lens Fit|0|||
150111913|NCT02920983|541546686|FG004|Dispense 3|Unacceptable Lens Fit|1|||
150111914|NCT02920983|541546687|FG005|Dispense 3|Unacceptable Lens Fit|0|||
150111915|NCT02553421|541546688|FG000|Overall Study|Lost to Follow-up|21|||
150111916|NCT02553421|541546689|FG001|Overall Study|Lost to Follow-up|1|||
150111917|NCT02553421|541546688|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
150111918|NCT02553421|541546689|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
150111919|NCT02553421|541546688|FG000|Overall Study|Improper Device Placement|3|||
150111920|NCT02553421|541546689|FG001|Overall Study|Improper Device Placement|0|||
150111921|NCT01105533|541548920|FG000|Overall Study|Death|0|||
150111922|NCT01105533|541548921|FG001|Overall Study|Death|0|||
150111923|NCT01105533|541548922|FG002|Overall Study|Death|0|||
150111924|NCT01105533|541548923|FG003|Overall Study|Death|0|||
150111925|NCT01105533|541548924|FG004|Overall Study|Death|1|||
150111926|NCT01105533|541548925|FG005|Overall Study|Death|0|||
150111927|NCT01105533|541548926|FG006|Overall Study|Death|0|||
150111928|NCT01105533|541548927|FG007|Overall Study|Death|0|||
150111929|NCT01105533|541548928|FG008|Overall Study|Death|0|||
150111930|NCT01105533|541548920|FG000|Overall Study|Lack of Efficacy|1|||
150111931|NCT01105533|541548921|FG001|Overall Study|Lack of Efficacy|1|||
150111932|NCT01105533|541548922|FG002|Overall Study|Lack of Efficacy|3|||
150111933|NCT01105533|541548923|FG003|Overall Study|Lack of Efficacy|3|||
150111934|NCT01105533|541548924|FG004|Overall Study|Lack of Efficacy|4|||
150111935|NCT01105533|541548925|FG005|Overall Study|Lack of Efficacy|5|||
150111936|NCT01105533|541548926|FG006|Overall Study|Lack of Efficacy|3|||
150111937|NCT01105533|541548927|FG007|Overall Study|Lack of Efficacy|2|||
150111938|NCT01105533|541548928|FG008|Overall Study|Lack of Efficacy|9|||
150111939|NCT01105533|541548920|FG000|Overall Study|Adverse Event|0|||
150111940|NCT01105533|541548921|FG001|Overall Study|Adverse Event|0|||
150111941|NCT01105533|541548922|FG002|Overall Study|Adverse Event|0|||
150111942|NCT01105533|541548923|FG003|Overall Study|Adverse Event|0|||
150111943|NCT01105533|541548924|FG004|Overall Study|Adverse Event|1|||
150111944|NCT01105533|541548925|FG005|Overall Study|Adverse Event|2|||
150111945|NCT01105533|541548926|FG006|Overall Study|Adverse Event|2|||
150111946|NCT01105533|541548927|FG007|Overall Study|Adverse Event|0|||
150111947|NCT01105533|541548928|FG008|Overall Study|Adverse Event|1|||
150111948|NCT01105533|541548920|FG000|Overall Study|Other|0|||
150111949|NCT01105533|541548921|FG001|Overall Study|Other|0|||
150111950|NCT01105533|541548922|FG002|Overall Study|Other|0|||
150111951|NCT01105533|541548923|FG003|Overall Study|Other|0|||
150111952|NCT01105533|541548924|FG004|Overall Study|Other|1|||
150111953|NCT01105533|541548925|FG005|Overall Study|Other|0|||
150111954|NCT01105533|541548926|FG006|Overall Study|Other|3|||
150111955|NCT01105533|541548927|FG007|Overall Study|Other|1|||
150111956|NCT01105533|541548928|FG008|Overall Study|Other|2|||
150111957|NCT01105533|541548920|FG000|Overall Study|Physician Decision|0|||
150111958|NCT01105533|541548921|FG001|Overall Study|Physician Decision|0|||
150111959|NCT01105533|541548922|FG002|Overall Study|Physician Decision|0|||
150111960|NCT01105533|541548923|FG003|Overall Study|Physician Decision|0|||
150111961|NCT01105533|541548924|FG004|Overall Study|Physician Decision|0|||
150111962|NCT01105533|541548925|FG005|Overall Study|Physician Decision|0|||
150111963|NCT01105533|541548926|FG006|Overall Study|Physician Decision|0|||
150111964|NCT01105533|541548927|FG007|Overall Study|Physician Decision|1|||
150111965|NCT01105533|541548928|FG008|Overall Study|Physician Decision|0|||
150111966|NCT01639001|541548934|FG000|Overall Study|Refused further follow-up|9|||
150111967|NCT01639001|541548935|FG001|Overall Study|Refused further follow-up|12|||
150111968|NCT01639001|541548934|FG000|Overall Study|Lost to Follow-up|3|||
150111969|NCT01639001|541548935|FG001|Overall Study|Lost to Follow-up|0|||
150111970|NCT01639001|541548934|FG000|Overall Study|Death|62|||
150111971|NCT01639001|541548935|FG001|Overall Study|Death|61|||
150111972|NCT01639001|541548934|FG000|Overall Study|Randomized but not treated|0|||
150111973|NCT01639001|541548935|FG001|Overall Study|Randomized but not treated|2|||
150111974|NCT01639001|541548934|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
150111975|NCT01639001|541548935|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
150111976|NCT00679341|541548937|FG000|Overall Study|Disease progression|42|||
150111977|NCT00679341|541548938|FG001|Overall Study|Disease progression|36|||
150111978|NCT00679341|541548937|FG000|Overall Study|Adverse Event|5|||
150111979|NCT00679341|541548938|FG001|Overall Study|Adverse Event|6|||
150111980|NCT00679341|541548937|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
150111981|NCT00679341|541548938|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
150111982|NCT00679341|541548937|FG000|Overall Study|Death|1|||
150111983|NCT00679341|541548938|FG001|Overall Study|Death|1|||
150111984|NCT00679341|541548937|FG000|Overall Study|Other|1|||
150188926|NCT02783300|541831228|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188927|NCT02783300|541831229|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188928|NCT02783300|541831230|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188929|NCT02783300|541831231|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188930|NCT02783300|541831232|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188931|NCT02783300|541831233|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188932|NCT02783300|541831234|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188933|NCT02783300|541831235|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188934|NCT02783300|541831236|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188935|NCT02783300|541831237|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188936|NCT02783300|541831238|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188937|NCT02783300|541831239|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188938|NCT02783300|541831240|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188939|NCT02783300|541831241|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188940|NCT02783300|541831242|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188941|NCT02783300|541831243|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
150188942|NCT02783300|541831217|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
150188943|NCT02783300|541831218|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
150188944|NCT02783300|541831219|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
150188945|NCT02783300|541831220|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
150111985|NCT00679341|541548938|FG001|Overall Study|Other|0|||
150111986|NCT00679341|541548937|FG000|Overall Study|Physician Decision|1|||
150111987|NCT00679341|541548938|FG001|Overall Study|Physician Decision|0|||
150111988|NCT00679341|541548937|FG000|Overall Study|Not treated|0|||
150111989|NCT00679341|541548938|FG001|Overall Study|Not treated|2|||
150111990|NCT00679341|541548937|FG000|Overall Study|Physician/patient decision to withdraw|0|||
150111991|NCT00679341|541548938|FG001|Overall Study|Physician/patient decision to withdraw|6|||
150111992|NCT02649972|541548939|FG000|Overall Study|Not treated|1|||
150111993|NCT00306592|541548940|FG000|Overall Study|Adverse Event|8|||
150111994|NCT00306592|541548941|FG001|Overall Study|Adverse Event|15|||
150111995|NCT00306592|541548940|FG000|Overall Study|Lost to Follow-up|1|||
150111996|NCT00306592|541548941|FG001|Overall Study|Lost to Follow-up|0|||
150111997|NCT00306592|541548940|FG000|Overall Study|Noncompliance|0|||
150111998|NCT00306592|541548941|FG001|Overall Study|Noncompliance|2|||
150111999|NCT00306592|541548940|FG000|Overall Study|Persistent Antibodies|6|||
150112000|NCT00306592|541548941|FG001|Overall Study|Persistent Antibodies|3|||
150112001|NCT00306592|541548940|FG000|Overall Study|Voluntary|10|||
150112002|NCT00306592|541548941|FG001|Overall Study|Voluntary|6|||
150112003|NCT00306592|541548940|FG000|Overall Study|Other|5|||
150112004|NCT00306592|541548941|FG001|Overall Study|Other|10|||
150112005|NCT00306592|541548940|FG000|Overall Study|Other|1|||
150112006|NCT00306592|541548941|FG001|Overall Study|Other|2|||
150112007|NCT00306592|541548940|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
150112008|NCT00306592|541548941|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
150112009|NCT04101526|541548942|FG000|Overall Study|Did not complete all sleep diary entries|0|||
150112010|NCT04101526|541548943|FG001|Overall Study|Did not complete all sleep diary entries|1|||
150112011|NCT00424372|541548944|FG000|Overall Study|Death|1|||
150112012|NCT00424372|541548944|FG000|Overall Study|Adverse Event|18|||
150112013|NCT00424372|541548944|FG000|Overall Study|Lack of Efficacy|6|||
150112014|NCT00424372|541548944|FG000|Overall Study|Withdrawal by Subject|4|||
150112015|NCT00424372|541548944|FG000|Overall Study|Protocol Violation|1|||
150112016|NCT00424372|541548944|FG000|Overall Study|Health deterioration|1|||
150112017|NCT02488629|541548945|FG000|Overall Study|Lack of Efficacy|3|||
150112018|NCT02488629|541548946|FG001|Overall Study|Lack of Efficacy|1|||
150112019|NCT02488629|541548947|FG002|Overall Study|Lack of Efficacy|0|||
150112020|NCT02488629|541548948|FG003|Overall Study|Lack of Efficacy|0|||
150112021|NCT02488629|541548945|FG000|Overall Study|Withdrawal by Subject|0|||
150112022|NCT02488629|541548946|FG001|Overall Study|Withdrawal by Subject|1|||
150112023|NCT02488629|541548947|FG002|Overall Study|Withdrawal by Subject|0|||
150112024|NCT02488629|541548948|FG003|Overall Study|Withdrawal by Subject|0|||
150112025|NCT00654628|541548949|FG000|6-week Active Treatment Period|Adverse Event|9|||
150112026|NCT00654628|541548949|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
150112027|NCT00654628|541548949|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
150112028|NCT00654628|541548949|FG000|6-week Active Treatment Period|Out of window period|1|||
150112029|NCT00654628|541548949|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
150112030|NCT00654628|541548949|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
150112031|NCT00912405|541548952|FG000|Overall Study|Lost to Follow-up|5|||
150112032|NCT00953329|541548953|FG000|Overall Study|Lack of Efficacy|1|||
150112033|NCT03160703|541548956|FG000|Overall Study|Withdrawal by Subject|0|||
150112034|NCT03160703|541548957|FG001|Overall Study|Withdrawal by Subject|0|||
150112035|NCT03160703|541548958|FG002|Overall Study|Withdrawal by Subject|0|||
150112036|NCT03160703|541548959|FG003|Overall Study|Withdrawal by Subject|1|||
150112037|NCT01358981|541548960|FG000|Period 1|Withdrawal by Subject|0|||
150112038|NCT01358981|541548961|FG001|Period 1|Withdrawal by Subject|0|||
150112039|NCT01358981|541548962|FG002|Period 1|Withdrawal by Subject|0|||
150112040|NCT01358981|541548963|FG003|Period 1|Withdrawal by Subject|1|||
150112041|NCT01358981|541548964|FG004|Period 1|Withdrawal by Subject|0|||
150112042|NCT01358981|541548965|FG005|Period 1|Withdrawal by Subject|0|||
150112043|NCT01358981|541548966|FG006|Period 1|Withdrawal by Subject|0|||
150112044|NCT01401530|541548971|FG000|Overall Study|Disease Progression|1|||
150112045|NCT01401530|541548972|FG001|Overall Study|Disease Progression|2|||
150112046|NCT01401530|541548973|FG002|Overall Study|Disease Progression|1|||
150112047|NCT01401530|541548971|FG000|Overall Study|Adverse Event|1|||
150112048|NCT01401530|541548972|FG001|Overall Study|Adverse Event|1|||
150112049|NCT01401530|541548973|FG002|Overall Study|Adverse Event|1|||
150112050|NCT01401530|541548971|FG000|Overall Study|Participant Choice|1|||
150112051|NCT01401530|541548972|FG001|Overall Study|Participant Choice|2|||
150112052|NCT01401530|541548973|FG002|Overall Study|Participant Choice|1|||
150112053|NCT01401530|541548971|FG000|Overall Study|Physician Decision|0|||
150112054|NCT01401530|541548972|FG001|Overall Study|Physician Decision|1|||
150112055|NCT01401530|541548973|FG002|Overall Study|Physician Decision|0|||
150112056|NCT00678691|541548974|FG000|Overall Study|Adverse Event|6|||
150112057|NCT00678691|541548975|FG001|Overall Study|Adverse Event|4|||
150112058|NCT02247349|541548981|FG000|Overall Study|Disease Progression|7|||
150112059|NCT02247349|541548982|FG001|Overall Study|Disease Progression|4|||
150112060|NCT02247349|541548983|FG002|Overall Study|Disease Progression|26|||
150112061|NCT02247349|541548984|FG003|Overall Study|Disease Progression|31|||
150112062|NCT02247349|541548985|FG004|Overall Study|Disease Progression|16|||
150112063|NCT02247349|541548986|FG005|Overall Study|Disease Progression|6|||
150112064|NCT02247349|541548981|FG000|Overall Study|Study drug toxicity|0|||
150112065|NCT02247349|541548982|FG001|Overall Study|Study drug toxicity|1|||
150112066|NCT02247349|541548983|FG002|Overall Study|Study drug toxicity|1|||
150112067|NCT02247349|541548984|FG003|Overall Study|Study drug toxicity|1|||
150112068|NCT02247349|541548985|FG004|Overall Study|Study drug toxicity|2|||
150112069|NCT02247349|541548986|FG005|Overall Study|Study drug toxicity|2|||
150112070|NCT02247349|541548981|FG000|Overall Study|Death|0|||
150112071|NCT02247349|541548982|FG001|Overall Study|Death|0|||
150112072|NCT02247349|541548983|FG002|Overall Study|Death|0|||
150112073|NCT02247349|541548984|FG003|Overall Study|Death|1|||
150112074|NCT02247349|541548985|FG004|Overall Study|Death|0|||
150112075|NCT02247349|541548986|FG005|Overall Study|Death|0|||
150112076|NCT02247349|541548981|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
150112077|NCT02247349|541548982|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
150112078|NCT02247349|541548983|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
150112079|NCT02247349|541548984|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
150112080|NCT02247349|541548985|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
150112081|NCT02247349|541548986|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
150112082|NCT02247349|541548981|FG000|Overall Study|Participant request to discontinue study treatment|0|||
150112083|NCT02247349|541548982|FG001|Overall Study|Participant request to discontinue study treatment|0|||
150112084|NCT02247349|541548983|FG002|Overall Study|Participant request to discontinue study treatment|1|||
150112085|NCT02247349|541548984|FG003|Overall Study|Participant request to discontinue study treatment|2|||
150112086|NCT02247349|541548985|FG004|Overall Study|Participant request to discontinue study treatment|1|||
150112087|NCT02247349|541548986|FG005|Overall Study|Participant request to discontinue study treatment|0|||
150112088|NCT02247349|541548981|FG000|Overall Study|Withdrawal by Subject|0|||
150112089|NCT02247349|541548982|FG001|Overall Study|Withdrawal by Subject|1|||
150112090|NCT02247349|541548983|FG002|Overall Study|Withdrawal by Subject|0|||
150112091|NCT02247349|541548984|FG003|Overall Study|Withdrawal by Subject|0|||
150112092|NCT02247349|541548985|FG004|Overall Study|Withdrawal by Subject|0|||
150112093|NCT02247349|541548986|FG005|Overall Study|Withdrawal by Subject|0|||
150112094|NCT02247349|541548981|FG000|Overall Study|Administrative reason by sponsor|0|||
150112095|NCT02247349|541548982|FG001|Overall Study|Administrative reason by sponsor|0|||
150112096|NCT02247349|541548983|FG002|Overall Study|Administrative reason by sponsor|0|||
150112097|NCT02247349|541548984|FG003|Overall Study|Administrative reason by sponsor|0|||
150112098|NCT02247349|541548985|FG004|Overall Study|Administrative reason by sponsor|1|||
150112099|NCT02247349|541548986|FG005|Overall Study|Administrative reason by sponsor|0|||
150112100|NCT02247349|541548981|FG000|Overall Study|Other reasons|0|||
150112101|NCT02247349|541548982|FG001|Overall Study|Other reasons|0|||
150112102|NCT02247349|541548983|FG002|Overall Study|Other reasons|1|||
150112103|NCT02247349|541548984|FG003|Overall Study|Other reasons|0|||
150112104|NCT02247349|541548985|FG004|Overall Study|Other reasons|0|||
150112105|NCT02247349|541548986|FG005|Overall Study|Other reasons|0|||
150112106|NCT03969212|541548987|FG000|Overall Study|Adverse Event|1|||
150112107|NCT03969212|541548988|FG001|Overall Study|Adverse Event|0|||
150112108|NCT03969212|541548989|FG002|Overall Study|Adverse Event|0|||
150112109|NCT03969212|541548990|FG003|Overall Study|Adverse Event|0|||
150112110|NCT03969212|541548987|FG000|Overall Study|Lost to Follow-up|2|||
150112111|NCT03969212|541548988|FG001|Overall Study|Lost to Follow-up|2|||
150112112|NCT03969212|541548989|FG002|Overall Study|Lost to Follow-up|2|||
150112113|NCT03969212|541548990|FG003|Overall Study|Lost to Follow-up|2|||
150112114|NCT03969212|541548987|FG000|Overall Study|Protocol Violation|0|||
150112115|NCT03969212|541548988|FG001|Overall Study|Protocol Violation|0|||
150112116|NCT03969212|541548989|FG002|Overall Study|Protocol Violation|0|||
150112117|NCT03969212|541548990|FG003|Overall Study|Protocol Violation|1|||
150112118|NCT03969212|541548987|FG000|Overall Study|Withdrawal by Subject|7|||
150112119|NCT03969212|541548988|FG001|Overall Study|Withdrawal by Subject|13|||
150112120|NCT03969212|541548989|FG002|Overall Study|Withdrawal by Subject|5|||
150112121|NCT03969212|541548990|FG003|Overall Study|Withdrawal by Subject|11|||
150112122|NCT03969212|541548987|FG000|Overall Study|Physician Decision|0|||
150112123|NCT03969212|541548988|FG001|Overall Study|Physician Decision|0|||
150112124|NCT03969212|541548989|FG002|Overall Study|Physician Decision|1|||
150112125|NCT03969212|541548990|FG003|Overall Study|Physician Decision|0|||
150112126|NCT03969212|541548987|FG000|Overall Study|Reason not Specified|22|||
150112127|NCT03969212|541548988|FG001|Overall Study|Reason not Specified|23|||
150112128|NCT03969212|541548989|FG002|Overall Study|Reason not Specified|28|||
150112129|NCT03969212|541548990|FG003|Overall Study|Reason not Specified|26|||
150112130|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
150112131|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
150112132|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
150112133|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
150112134|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
150112135|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
150112136|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
150112137|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
150112138|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
150112139|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
150112140|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
150112141|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
150112142|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
150112143|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
150112144|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
150112145|NCT00280566|541548994|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
150112146|NCT00280566|541548995|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
150112147|NCT00280566|541548996|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
150112148|NCT00280566|541548994|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
150112149|NCT00280566|541548995|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
150112150|NCT00280566|541548996|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
150112151|NCT00280566|541548994|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
150112152|NCT00280566|541548995|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
150112153|NCT00280566|541548996|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
150112154|NCT00280566|541548994|FG000|Period 2 Double Blind|Adverse Event|0|||
150112155|NCT00280566|541548995|FG001|Period 2 Double Blind|Adverse Event|11|||
150112156|NCT00280566|541548996|FG002|Period 2 Double Blind|Adverse Event|15|||
150112157|NCT00280566|541548994|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
150112158|NCT00280566|541548995|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
150112159|NCT00280566|541548996|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
150112160|NCT00280566|541548994|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
150112161|NCT00280566|541548995|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
150112162|NCT00280566|541548996|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
150112163|NCT00280566|541548994|FG000|Period 2 Double Blind|miscellaneous|0|||
150112164|NCT00280566|541548995|FG001|Period 2 Double Blind|miscellaneous|10|||
150112165|NCT00280566|541548996|FG002|Period 2 Double Blind|miscellaneous|5|||
150112166|NCT01147653|541548997|FG000|Year 2|Withdrawal by Subject|2|||
150112167|NCT01147653|541548998|FG001|Year 2|Withdrawal by Subject|3|||
150112168|NCT00353366|541548999|FG000|Overall Study|Adverse Event|8|||
150112169|NCT00353366|541548999|FG000|Overall Study|Protocol Violation|12|||
150112170|NCT00353366|541548999|FG000|Overall Study|Withdrawal by Subject|12|||
150112171|NCT00353366|541548999|FG000|Overall Study|Lost to Follow-up|92|||
150112172|NCT00353366|541548999|FG000|Overall Study|Other|19|||
150112173|NCT00259857|541549000|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
150112174|NCT00259857|541549001|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
150112175|NCT00259857|541549000|FG000|24 Months Treatment|Lost to Follow-up|0|||
150112176|NCT00259857|541549001|FG001|24 Months Treatment|Lost to Follow-up|3|||
150112177|NCT00670228|541549002|FG000|Overall Study|Adverse Event|1|||
150112178|NCT00670228|541549003|FG001|Overall Study|Adverse Event|0|||
150112179|NCT00670228|541549002|FG000|Overall Study|Death or MACE|0|||
150112180|NCT00670228|541549003|FG001|Overall Study|Death or MACE|1|||
150112181|NCT00670228|541549002|FG000|Overall Study|Not treated|2|||
150112182|NCT00670228|541549003|FG001|Overall Study|Not treated|2|||
150112183|NCT00670228|541549002|FG000|Overall Study|Not meeting the selection criteria|2|||
150112184|NCT00670228|541549003|FG001|Overall Study|Not meeting the selection criteria|0|||
150112185|NCT05267054|541549004|FG000|Overall Study|Death|13|||
150112186|NCT05267054|541549005|FG001|Overall Study|Death|14|||
150112187|NCT05267054|541549004|FG000|Overall Study|Study Ended by Sponsor|9|||
150112188|NCT05267054|541549005|FG001|Overall Study|Study Ended by Sponsor|13|||
150112189|NCT05267054|541549004|FG000|Overall Study|Lost to Follow-up|1|||
150112190|NCT05267054|541549005|FG001|Overall Study|Lost to Follow-up|1|||
150112191|NCT05267054|541549004|FG000|Overall Study|Withdrawal by Subject|1|||
150112192|NCT05267054|541549005|FG001|Overall Study|Withdrawal by Subject|1|||
150112193|NCT01552226|541549008|FG000|Overall Study|Withdrawal by Subject|4|||
150112194|NCT01552226|541549009|FG001|Overall Study|Withdrawal by Subject|4|||
150112195|NCT01469065|541549015|FG000|Overall Study|Lack of Efficacy|0|||
150112196|NCT01469065|541549016|FG001|Overall Study|Lack of Efficacy|0|||
150112197|NCT01469065|541549017|FG002|Overall Study|Lack of Efficacy|0|||
150112198|NCT01469065|541549018|FG003|Overall Study|Lack of Efficacy|0|||
150112199|NCT01469065|541549019|FG004|Overall Study|Lack of Efficacy|1|||
150112200|NCT01469065|541549015|FG000|Overall Study|Other|0|||
150112201|NCT01469065|541549016|FG001|Overall Study|Other|1|||
150112202|NCT01469065|541549017|FG002|Overall Study|Other|0|||
150112203|NCT01469065|541549018|FG003|Overall Study|Other|0|||
150112204|NCT01469065|541549019|FG004|Overall Study|Other|0|||
150112205|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
150112206|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
150112207|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
150112208|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
150112209|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
150112210|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
150112211|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
150112212|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
150112213|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
150112214|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
150112215|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
150112216|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
150112217|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
150112218|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
150112219|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
150112220|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
150112221|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
150112222|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
150112223|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
150112224|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
150112225|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
150112226|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
150112227|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
150112228|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
150112229|NCT04542070|541549020|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
150112230|NCT04542070|541549021|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
150112231|NCT04542070|541549022|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
150112232|NCT04542070|541549023|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
150112233|NCT04542070|541549020|FG000|Maintenance + Extension Period|Adverse Event|10|||
150112234|NCT04542070|541549021|FG001|Maintenance + Extension Period|Adverse Event|2|||
150112235|NCT04542070|541549022|FG002|Maintenance + Extension Period|Adverse Event|0|||
150112236|NCT04542070|541549023|FG003|Maintenance + Extension Period|Adverse Event|0|||
150188946|NCT02783300|541831221|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
150188947|NCT02783300|541831222|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
150188948|NCT02783300|541831223|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
150188949|NCT02783300|541831224|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
150188950|NCT02783300|541831225|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
150188951|NCT02783300|541831226|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
150188952|NCT02783300|541831227|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
150188953|NCT02783300|541831228|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
150188954|NCT02783300|541831229|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
150188955|NCT02783300|541831230|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
150188956|NCT02783300|541831231|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
150188957|NCT02783300|541831232|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
150188958|NCT02783300|541831233|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
150188959|NCT02783300|541831234|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
150188960|NCT02783300|541831235|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
150188961|NCT02783300|541831236|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
150188962|NCT02783300|541831237|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
150188963|NCT02783300|541831238|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
150188964|NCT02783300|541831239|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
150188965|NCT02783300|541831240|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
150188966|NCT02783300|541831241|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
150188967|NCT02783300|541831242|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
150188968|NCT02783300|541831243|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
150188969|NCT02783300|541831217|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188970|NCT02783300|541831218|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188971|NCT02783300|541831219|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188972|NCT02783300|541831220|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188973|NCT02783300|541831221|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188974|NCT02783300|541831222|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188975|NCT02783300|541831223|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
150188976|NCT02783300|541831224|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188977|NCT02783300|541831225|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188978|NCT02783300|541831226|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188979|NCT02783300|541831227|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188980|NCT02783300|541831228|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188981|NCT02783300|541831229|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
150188982|NCT02783300|541831230|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188983|NCT02783300|541831231|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188984|NCT02783300|541831232|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188985|NCT02783300|541831233|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188986|NCT02783300|541831234|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188987|NCT02783300|541831235|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188988|NCT02783300|541831236|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188989|NCT02783300|541831237|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188990|NCT02783300|541831238|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188991|NCT02783300|541831239|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188992|NCT02783300|541831240|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188993|NCT02783300|541831241|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188994|NCT02783300|541831242|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188995|NCT02783300|541831243|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
150188996|NCT02783300|541831217|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150188997|NCT02783300|541831218|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150188998|NCT02783300|541831219|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150188999|NCT02783300|541831220|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189000|NCT02783300|541831221|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
150189001|NCT02783300|541831222|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189002|NCT02783300|541831223|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
150189003|NCT02783300|541831224|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189004|NCT02783300|541831225|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189005|NCT02783300|541831226|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
150189006|NCT02783300|541831227|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189007|NCT02783300|541831228|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189008|NCT02783300|541831229|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
150189009|NCT02783300|541831230|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189010|NCT02783300|541831231|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189011|NCT02783300|541831232|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189012|NCT02783300|541831233|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189013|NCT02783300|541831234|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189014|NCT02783300|541831235|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189015|NCT02783300|541831236|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189016|NCT02783300|541831237|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189017|NCT02783300|541831238|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189018|NCT02783300|541831239|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189019|NCT02783300|541831240|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189020|NCT02783300|541831241|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189021|NCT02783300|541831242|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189022|NCT02783300|541831243|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
150189023|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189024|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189025|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189026|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150112237|NCT04542070|541549020|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
150112238|NCT04542070|541549021|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
150112239|NCT04542070|541549022|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
150112240|NCT04542070|541549023|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
150112241|NCT04542070|541549020|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
150112242|NCT04542070|541549021|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
150112243|NCT04542070|541549022|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
150112244|NCT04542070|541549023|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
150112245|NCT04542070|541549020|FG000|Maintenance + Extension Period|Physician Decision|1|||
150112246|NCT04542070|541549021|FG001|Maintenance + Extension Period|Physician Decision|1|||
150112247|NCT04542070|541549022|FG002|Maintenance + Extension Period|Physician Decision|0|||
150112248|NCT04542070|541549023|FG003|Maintenance + Extension Period|Physician Decision|0|||
150112249|NCT04542070|541549020|FG000|Maintenance + Extension Period|Protocol Violation|2|||
150112250|NCT04542070|541549021|FG001|Maintenance + Extension Period|Protocol Violation|5|||
150112251|NCT04542070|541549022|FG002|Maintenance + Extension Period|Protocol Violation|0|||
150112252|NCT04542070|541549023|FG003|Maintenance + Extension Period|Protocol Violation|0|||
150112253|NCT04542070|541549020|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
150112254|NCT04542070|541549021|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
150112255|NCT04542070|541549022|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
150112256|NCT04542070|541549023|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
150112257|NCT04542070|541549020|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
150112258|NCT04542070|541549021|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
150112259|NCT04542070|541549022|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
150112260|NCT04542070|541549023|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
150112261|NCT04542070|541549020|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
150112262|NCT04542070|541549021|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
150112263|NCT04542070|541549022|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
150112264|NCT04542070|541549023|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
150112265|NCT04542070|541549020|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
150112266|NCT04542070|541549021|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
150112267|NCT04542070|541549022|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
150112268|NCT04542070|541549023|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
150112269|NCT04542070|541549020|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
150112270|NCT04542070|541549021|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
150189027|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189028|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189029|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150112271|NCT04542070|541549022|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
150112272|NCT04542070|541549023|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
150112273|NCT04542070|541549020|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
150112274|NCT04542070|541549021|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
150112275|NCT04542070|541549022|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
150112276|NCT04542070|541549023|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
150112277|NCT04542070|541549020|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
150112278|NCT04542070|541549021|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
150112279|NCT04542070|541549022|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
150112280|NCT04542070|541549023|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
150112281|NCT01813019|541549027|FG000|Overall Study|Adverse Event|0|||
150112282|NCT01813019|541549028|FG001|Overall Study|Adverse Event|3|||
150112283|NCT01813019|541549027|FG000|Overall Study|Withdrawal by Subject|3|||
150112284|NCT01813019|541549028|FG001|Overall Study|Withdrawal by Subject|2|||
150112285|NCT01813019|541549027|FG000|Overall Study|administrative problems|2|||
150112286|NCT01813019|541549028|FG001|Overall Study|administrative problems|0|||
150112287|NCT01813019|541549027|FG000|Overall Study|Protocol Deviation|2|||
150112288|NCT01813019|541549028|FG001|Overall Study|Protocol Deviation|1|||
150112289|NCT01696032|541549029|FG000|Overall Study|Withdrawal by Subject|0|||
150112290|NCT01696032|541549030|FG001|Overall Study|Withdrawal by Subject|0|||
150112291|NCT01696032|541549031|FG002|Overall Study|Withdrawal by Subject|1|||
150112292|NCT01696032|541549032|FG003|Overall Study|Withdrawal by Subject|2|||
150112293|NCT01696032|541549029|FG000|Overall Study|Death|14|||
150112294|NCT01696032|541549030|FG001|Overall Study|Death|4|||
150112295|NCT01696032|541549031|FG002|Overall Study|Death|43|||
150112296|NCT01696032|541549032|FG003|Overall Study|Death|18|||
150112297|NCT01696032|541549029|FG000|Overall Study|Lost to Follow-up|0|||
150112298|NCT01696032|541549030|FG001|Overall Study|Lost to Follow-up|1|||
150112299|NCT01696032|541549031|FG002|Overall Study|Lost to Follow-up|0|||
150112300|NCT01696032|541549032|FG003|Overall Study|Lost to Follow-up|0|||
150112301|NCT01696032|541549029|FG000|Overall Study|Database lock|0|||
150112302|NCT01696032|541549030|FG001|Overall Study|Database lock|1|||
150112303|NCT01696032|541549031|FG002|Overall Study|Database lock|7|||
150112304|NCT01696032|541549032|FG003|Overall Study|Database lock|2|||
150112305|NCT02203591|541549035|FG000|Overall Study|Did not meet treatment day baseline|147|||
150112306|NCT02203591|541549036|FG001|Overall Study|Did not meet treatment day baseline|141|||
150112307|NCT02203591|541549037|FG002|Overall Study|Did not meet treatment day baseline|150|||
150112308|NCT02203591|541549038|FG003|Overall Study|Did not meet treatment day baseline|45|||
150112309|NCT02203591|541549039|FG004|Overall Study|Did not meet treatment day baseline|33|||
150112310|NCT02203591|541549040|FG005|Overall Study|Did not meet treatment day baseline|35|||
150112311|NCT02203591|541549041|FG006|Overall Study|Did not meet treatment day baseline|29|||
150112312|NCT02203591|541549042|FG007|Overall Study|Did not meet treatment day baseline|12|||
150112313|NCT02203591|541549035|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
150112314|NCT02203591|541549036|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
150112315|NCT02203591|541549037|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
150112316|NCT02203591|541549038|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
150112317|NCT02203591|541549039|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
150112318|NCT02203591|541549040|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
150112319|NCT02203591|541549041|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
150112320|NCT02203591|541549042|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
150112321|NCT03306264|541549045|FG000|Overall Study|Death|33|||
150112322|NCT03306264|541549046|FG001|Overall Study|Death|25|||
150112323|NCT03306264|541549047|FG002|Overall Study|Death|34|||
150112324|NCT03306264|541549048|FG003|Overall Study|Death|34|||
150112325|NCT03306264|541549045|FG000|Overall Study|Complete Consent Withdrawal|4|||
150112326|NCT03306264|541549046|FG001|Overall Study|Complete Consent Withdrawal|4|||
150112327|NCT03306264|541549047|FG002|Overall Study|Complete Consent Withdrawal|1|||
150112328|NCT03306264|541549048|FG003|Overall Study|Complete Consent Withdrawal|8|||
150112329|NCT03306264|541549045|FG000|Overall Study|Lost to Follow-up|1|||
150112330|NCT03306264|541549046|FG001|Overall Study|Lost to Follow-up|0|||
150112331|NCT03306264|541549047|FG002|Overall Study|Lost to Follow-up|1|||
150112332|NCT03306264|541549048|FG003|Overall Study|Lost to Follow-up|0|||
150112333|NCT03306264|541549045|FG000|Overall Study|Rollover to ASTX727-06|10|||
150112334|NCT03306264|541549046|FG001|Overall Study|Rollover to ASTX727-06|18|||
150112335|NCT03306264|541549047|FG002|Overall Study|Rollover to ASTX727-06|4|||
150112336|NCT03306264|541549048|FG003|Overall Study|Rollover to ASTX727-06|2|||
150112337|NCT03306264|541549045|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
150112338|NCT03306264|541549046|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
150112339|NCT03306264|541549047|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
150112340|NCT03306264|541549048|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
150112341|NCT02702401|541549057|FG000|Overall Study|Death|242|||
150112342|NCT02702401|541549058|FG001|Overall Study|Death|125|||
150189030|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189031|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189032|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189033|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189034|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189035|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189036|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189037|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189038|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
150189039|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189040|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
150189041|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
150189042|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
150189043|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189044|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189045|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189046|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189047|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
150189048|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150189049|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
150112343|NCT02702401|541549057|FG000|Overall Study|Withdrawal by Subject|15|||
150112344|NCT02702401|541549058|FG001|Overall Study|Withdrawal by Subject|5|||
150112345|NCT02702401|541549057|FG000|Overall Study|Sponsor Decision|19|||
150112346|NCT02702401|541549058|FG001|Overall Study|Sponsor Decision|3|||
150112347|NCT02702401|541549057|FG000|Overall Study|Physician Decision|1|||
150112348|NCT02702401|541549058|FG001|Overall Study|Physician Decision|2|||
150112349|NCT02702401|541549057|FG000|Overall Study|Lost to Follow-up|1|||
150112350|NCT02702401|541549058|FG001|Overall Study|Lost to Follow-up|0|||
150112351|NCT01462357|541549063|FG000|Overall Study|Death|0|||
150112352|NCT01462357|541549064|FG001|Overall Study|Death|0|||
150112353|NCT01462357|541549065|FG002|Overall Study|Death|1|||
150112354|NCT01462357|541549063|FG000|Overall Study|Withdrawal by Subject|3|||
150112355|NCT01462357|541549064|FG001|Overall Study|Withdrawal by Subject|11|||
150112356|NCT01462357|541549065|FG002|Overall Study|Withdrawal by Subject|3|||
150112357|NCT01462357|541549063|FG000|Overall Study|Migrated/moved from study area|2|||
150112358|NCT01462357|541549064|FG001|Overall Study|Migrated/moved from study area|3|||
150112359|NCT01462357|541549065|FG002|Overall Study|Migrated/moved from study area|1|||
150112360|NCT01462357|541549063|FG000|Overall Study|Lost to Follow-up|3|||
150112361|NCT01462357|541549064|FG001|Overall Study|Lost to Follow-up|5|||
150112362|NCT01462357|541549065|FG002|Overall Study|Lost to Follow-up|7|||
150112363|NCT04292730|541549066|FG000|Overall Study|Lost to Follow-up|8|||
150112364|NCT04292730|541549067|FG001|Overall Study|Lost to Follow-up|12|||
150112365|NCT04292730|541549068|FG002|Overall Study|Lost to Follow-up|12|||
150112366|NCT04292730|541549069|FG003|Overall Study|Lost to Follow-up|48|||
150112367|NCT04292730|541549066|FG000|Overall Study|Death|2|||
150112368|NCT04292730|541549067|FG001|Overall Study|Death|2|||
150112369|NCT04292730|541549068|FG002|Overall Study|Death|4|||
150112370|NCT04292730|541549069|FG003|Overall Study|Death|12|||
150112371|NCT04292730|541549066|FG000|Overall Study|Withdrew Consent|2|||
150112372|NCT04292730|541549067|FG001|Overall Study|Withdrew Consent|2|||
150112373|NCT04292730|541549068|FG002|Overall Study|Withdrew Consent|5|||
150112374|NCT04292730|541549069|FG003|Overall Study|Withdrew Consent|6|||
150112375|NCT04292730|541549066|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150112376|NCT04292730|541549067|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150112377|NCT04292730|541549068|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150112378|NCT04292730|541549069|FG003|Overall Study|Non-Compliance with Study Drug|0|||
150112379|NCT04292730|541549066|FG000|Overall Study|Protocol Violation|0|||
150112380|NCT04292730|541549067|FG001|Overall Study|Protocol Violation|0|||
150112381|NCT04292730|541549068|FG002|Overall Study|Protocol Violation|1|||
150112382|NCT04292730|541549069|FG003|Overall Study|Protocol Violation|0|||
150112383|NCT04292730|541549066|FG000|Overall Study|Randomized but not Treated|8|||
150189050|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189051|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189052|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189053|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150112384|NCT04292730|541549067|FG001|Overall Study|Randomized but not Treated|4|||
150112385|NCT04292730|541549068|FG002|Overall Study|Randomized but not Treated|0|||
150112386|NCT04292730|541549069|FG003|Overall Study|Randomized but not Treated|14|||
150112387|NCT01247090|541549072|FG000|Overall Study|Physician Decision|1|||
150112388|NCT01247090|541549073|FG001|Overall Study|Physician Decision|0|||
150112389|NCT01247090|541549074|FG002|Overall Study|Physician Decision|0|||
150112390|NCT01247090|541549072|FG000|Overall Study|Withdrawal by Subject|0|||
150112391|NCT01247090|541549073|FG001|Overall Study|Withdrawal by Subject|1|||
150112392|NCT01247090|541549074|FG002|Overall Study|Withdrawal by Subject|0|||
150112393|NCT01574703|541549075|FG000|Overall Study|Adverse Event|0|||
150112394|NCT01574703|541549076|FG001|Overall Study|Adverse Event|2|||
150112395|NCT01574703|541549077|FG002|Overall Study|Adverse Event|1|||
150112396|NCT01574703|541549078|FG003|Overall Study|Adverse Event|1|||
150112397|NCT01574703|541549075|FG000|Overall Study|Protocol Violation|0|||
150112398|NCT01574703|541549076|FG001|Overall Study|Protocol Violation|0|||
150112399|NCT01574703|541549077|FG002|Overall Study|Protocol Violation|0|||
150112400|NCT01574703|541549078|FG003|Overall Study|Protocol Violation|1|||
150112401|NCT01574703|541549075|FG000|Overall Study|Unspecified Reason|27|||
150112402|NCT01574703|541549076|FG001|Overall Study|Unspecified Reason|15|||
150112403|NCT01574703|541549077|FG002|Overall Study|Unspecified Reason|20|||
150112404|NCT01574703|541549078|FG003|Overall Study|Unspecified Reason|16|||
150112405|NCT01574703|541549075|FG000|Overall Study|Withdrawal by Subject|53|||
150112406|NCT01574703|541549076|FG001|Overall Study|Withdrawal by Subject|52|||
150112407|NCT01574703|541549077|FG002|Overall Study|Withdrawal by Subject|36|||
150112408|NCT01574703|541549078|FG003|Overall Study|Withdrawal by Subject|61|||
150112409|NCT01574703|541549075|FG000|Overall Study|Met Withdrawal Criteria|0|||
150112410|NCT01574703|541549076|FG001|Overall Study|Met Withdrawal Criteria|1|||
150112411|NCT01574703|541549077|FG002|Overall Study|Met Withdrawal Criteria|1|||
150112412|NCT01574703|541549078|FG003|Overall Study|Met Withdrawal Criteria|0|||
150112413|NCT01574703|541549075|FG000|Overall Study|Lost to Follow-up|43|||
150112414|NCT01574703|541549076|FG001|Overall Study|Lost to Follow-up|41|||
150112415|NCT01574703|541549077|FG002|Overall Study|Lost to Follow-up|46|||
150112416|NCT01574703|541549078|FG003|Overall Study|Lost to Follow-up|35|||
150112417|NCT01574703|541549075|FG000|Overall Study|Death|2|||
150112418|NCT01574703|541549076|FG001|Overall Study|Death|1|||
150112419|NCT01574703|541549077|FG002|Overall Study|Death|1|||
150112420|NCT01574703|541549078|FG003|Overall Study|Death|0|||
150112421|NCT04084769|541549082|FG000|Overall Study|Protocol Violation|1|||
150112422|NCT04084769|541549083|FG001|Overall Study|Protocol Violation|3|||
150112423|NCT04084769|541549084|FG002|Overall Study|Protocol Violation|0|||
150112424|NCT04084769|541549085|FG003|Overall Study|Protocol Violation|1|||
150112425|NCT04084769|541549082|FG000|Overall Study|Withdrawal by Subject|0|||
150112426|NCT04084769|541549083|FG001|Overall Study|Withdrawal by Subject|1|||
150112427|NCT04084769|541549084|FG002|Overall Study|Withdrawal by Subject|0|||
150112428|NCT04084769|541549085|FG003|Overall Study|Withdrawal by Subject|0|||
150112429|NCT04084769|541549082|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150112430|NCT04084769|541549083|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150112431|NCT04084769|541549084|FG002|Overall Study|Withdrawal by parent/guardian|0|||
150112432|NCT04084769|541549085|FG003|Overall Study|Withdrawal by parent/guardian|1|||
150112433|NCT04084769|541549082|FG000|Overall Study|Lost to Follow-up|2|||
150112434|NCT04084769|541549083|FG001|Overall Study|Lost to Follow-up|0|||
150112435|NCT04084769|541549084|FG002|Overall Study|Lost to Follow-up|0|||
150112436|NCT04084769|541549085|FG003|Overall Study|Lost to Follow-up|0|||
150112437|NCT03013491|541549086|FG000|Main Study|Death|2|||
150112438|NCT03013491|541549087|FG001|Main Study|Death|2|||
150112439|NCT03013491|541549088|FG002|Main Study|Death|5|||
150112440|NCT03013491|541549089|FG003|Main Study|Death|3|||
150112441|NCT03013491|541549090|FG004|Main Study|Death|9|||
150112442|NCT03013491|541549091|FG005|Main Study|Death|12|||
150112443|NCT03013491|541549092|FG006|Main Study|Death|3|||
150112444|NCT03013491|541549093|FG007|Main Study|Death|5|||
150112445|NCT03013491|541549094|FG008|Main Study|Death|1|||
150189054|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189055|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150112446|NCT03013491|541549095|FG009|Main Study|Death|2|||
150112447|NCT03013491|541549096|FG010|Main Study|Death|4|||
150112448|NCT03013491|541549097|FG011|Main Study|Death|1|||
150112449|NCT03013491|541549098|FG012|Main Study|Death|1|||
150112450|NCT03013491|541549099|FG013|Main Study|Death|4|||
150112451|NCT03013491|541549100|FG014|Main Study|Death|0|||
150112452|NCT03013491|541549101|FG015|Main Study|Death|3|||
150112453|NCT03013491|541549102|FG016|Main Study|Death|5|||
150112454|NCT03013491|541549103|FG017|Main Study|Death|1|||
150112455|NCT03013491|541549104|FG018|Main Study|Death|47|||
150112456|NCT03013491|541549086|FG000|Main Study|Lost to Follow-up|0|||
150112457|NCT03013491|541549087|FG001|Main Study|Lost to Follow-up|0|||
150112458|NCT03013491|541549088|FG002|Main Study|Lost to Follow-up|1|||
150112459|NCT03013491|541549089|FG003|Main Study|Lost to Follow-up|0|||
150112460|NCT03013491|541549090|FG004|Main Study|Lost to Follow-up|1|||
150112461|NCT03013491|541549091|FG005|Main Study|Lost to Follow-up|0|||
150112462|NCT03013491|541549092|FG006|Main Study|Lost to Follow-up|0|||
150255273|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
150112463|NCT03013491|541549093|FG007|Main Study|Lost to Follow-up|0|||
150112464|NCT03013491|541549094|FG008|Main Study|Lost to Follow-up|0|||
150112465|NCT03013491|541549095|FG009|Main Study|Lost to Follow-up|0|||
150112466|NCT03013491|541549096|FG010|Main Study|Lost to Follow-up|0|||
150112467|NCT03013491|541549097|FG011|Main Study|Lost to Follow-up|0|||
150112468|NCT03013491|541549098|FG012|Main Study|Lost to Follow-up|0|||
150112469|NCT03013491|541549099|FG013|Main Study|Lost to Follow-up|0|||
150112470|NCT03013491|541549100|FG014|Main Study|Lost to Follow-up|0|||
150112471|NCT03013491|541549101|FG015|Main Study|Lost to Follow-up|0|||
150112472|NCT03013491|541549102|FG016|Main Study|Lost to Follow-up|0|||
150112473|NCT03013491|541549103|FG017|Main Study|Lost to Follow-up|0|||
150112474|NCT03013491|541549104|FG018|Main Study|Lost to Follow-up|3|||
150112475|NCT03013491|541549086|FG000|Main Study|Termination of the study by Sponsor|0|||
150112476|NCT03013491|541549087|FG001|Main Study|Termination of the study by Sponsor|0|||
150112477|NCT03013491|541549088|FG002|Main Study|Termination of the study by Sponsor|2|||
150112478|NCT03013491|541549089|FG003|Main Study|Termination of the study by Sponsor|0|||
150112479|NCT03013491|541549090|FG004|Main Study|Termination of the study by Sponsor|1|||
150112480|NCT03013491|541549091|FG005|Main Study|Termination of the study by Sponsor|2|||
150112481|NCT03013491|541549092|FG006|Main Study|Termination of the study by Sponsor|0|||
150112482|NCT03013491|541549093|FG007|Main Study|Termination of the study by Sponsor|0|||
150112483|NCT03013491|541549094|FG008|Main Study|Termination of the study by Sponsor|1|||
150112484|NCT03013491|541549095|FG009|Main Study|Termination of the study by Sponsor|1|||
150112485|NCT03013491|541549096|FG010|Main Study|Termination of the study by Sponsor|1|||
150112486|NCT03013491|541549097|FG011|Main Study|Termination of the study by Sponsor|2|||
150112487|NCT03013491|541549098|FG012|Main Study|Termination of the study by Sponsor|0|||
150112488|NCT03013491|541549099|FG013|Main Study|Termination of the study by Sponsor|0|||
150112489|NCT03013491|541549100|FG014|Main Study|Termination of the study by Sponsor|0|||
150112490|NCT03013491|541549101|FG015|Main Study|Termination of the study by Sponsor|0|||
150112491|NCT03013491|541549102|FG016|Main Study|Termination of the study by Sponsor|0|||
150112492|NCT03013491|541549103|FG017|Main Study|Termination of the study by Sponsor|1|||
150112493|NCT03013491|541549104|FG018|Main Study|Termination of the study by Sponsor|13|||
150112494|NCT03013491|541549086|FG000|Main Study|Withdrawal by Subject|0|||
150112495|NCT03013491|541549087|FG001|Main Study|Withdrawal by Subject|0|||
150112496|NCT03013491|541549088|FG002|Main Study|Withdrawal by Subject|0|||
150112497|NCT03013491|541549089|FG003|Main Study|Withdrawal by Subject|4|||
150112498|NCT03013491|541549090|FG004|Main Study|Withdrawal by Subject|2|||
150112499|NCT03013491|541549091|FG005|Main Study|Withdrawal by Subject|1|||
150112500|NCT03013491|541549092|FG006|Main Study|Withdrawal by Subject|0|||
150112501|NCT03013491|541549093|FG007|Main Study|Withdrawal by Subject|0|||
150112502|NCT03013491|541549094|FG008|Main Study|Withdrawal by Subject|0|||
150112503|NCT03013491|541549095|FG009|Main Study|Withdrawal by Subject|0|||
150112504|NCT03013491|541549096|FG010|Main Study|Withdrawal by Subject|1|||
150112505|NCT03013491|541549097|FG011|Main Study|Withdrawal by Subject|2|||
150112506|NCT03013491|541549098|FG012|Main Study|Withdrawal by Subject|0|||
150112507|NCT03013491|541549099|FG013|Main Study|Withdrawal by Subject|2|||
150112508|NCT03013491|541549100|FG014|Main Study|Withdrawal by Subject|0|||
150112509|NCT03013491|541549101|FG015|Main Study|Withdrawal by Subject|0|||
150112510|NCT03013491|541549102|FG016|Main Study|Withdrawal by Subject|0|||
150112511|NCT03013491|541549103|FG017|Main Study|Withdrawal by Subject|0|||
150112512|NCT03013491|541549104|FG018|Main Study|Withdrawal by Subject|18|||
150112513|NCT03013491|541549086|FG000|Main Study|Disease progression|0|||
150112514|NCT03013491|541549087|FG001|Main Study|Disease progression|0|||
150112515|NCT03013491|541549088|FG002|Main Study|Disease progression|0|||
150112516|NCT03013491|541549089|FG003|Main Study|Disease progression|1|||
150112517|NCT03013491|541549090|FG004|Main Study|Disease progression|0|||
150112518|NCT03013491|541549091|FG005|Main Study|Disease progression|0|||
150112519|NCT03013491|541549092|FG006|Main Study|Disease progression|0|||
150112520|NCT03013491|541549093|FG007|Main Study|Disease progression|0|||
150112521|NCT03013491|541549094|FG008|Main Study|Disease progression|1|||
150112522|NCT03013491|541549095|FG009|Main Study|Disease progression|0|||
150112523|NCT03013491|541549096|FG010|Main Study|Disease progression|1|||
150112524|NCT03013491|541549097|FG011|Main Study|Disease progression|0|||
150112525|NCT03013491|541549098|FG012|Main Study|Disease progression|0|||
150112526|NCT03013491|541549099|FG013|Main Study|Disease progression|0|||
150112527|NCT03013491|541549100|FG014|Main Study|Disease progression|0|||
150112528|NCT03013491|541549101|FG015|Main Study|Disease progression|0|||
150112529|NCT03013491|541549102|FG016|Main Study|Disease progression|0|||
150112530|NCT03013491|541549103|FG017|Main Study|Disease progression|0|||
150112531|NCT03013491|541549104|FG018|Main Study|Disease progression|4|||
150112532|NCT03013491|541549086|FG000|Main Study|Symptomatic deterioration|0|||
150112533|NCT03013491|541549087|FG001|Main Study|Symptomatic deterioration|0|||
150112534|NCT03013491|541549088|FG002|Main Study|Symptomatic deterioration|0|||
150112535|NCT03013491|541549089|FG003|Main Study|Symptomatic deterioration|0|||
150112536|NCT03013491|541549090|FG004|Main Study|Symptomatic deterioration|0|||
150112537|NCT03013491|541549091|FG005|Main Study|Symptomatic deterioration|1|||
150112538|NCT03013491|541549092|FG006|Main Study|Symptomatic deterioration|0|||
150112539|NCT03013491|541549093|FG007|Main Study|Symptomatic deterioration|0|||
150112540|NCT03013491|541549094|FG008|Main Study|Symptomatic deterioration|0|||
150112541|NCT03013491|541549095|FG009|Main Study|Symptomatic deterioration|0|||
150112542|NCT03013491|541549096|FG010|Main Study|Symptomatic deterioration|0|||
150112543|NCT03013491|541549097|FG011|Main Study|Symptomatic deterioration|0|||
150112544|NCT03013491|541549098|FG012|Main Study|Symptomatic deterioration|0|||
150112545|NCT03013491|541549099|FG013|Main Study|Symptomatic deterioration|0|||
150112546|NCT03013491|541549100|FG014|Main Study|Symptomatic deterioration|0|||
150112547|NCT03013491|541549101|FG015|Main Study|Symptomatic deterioration|0|||
150112548|NCT03013491|541549102|FG016|Main Study|Symptomatic deterioration|0|||
150112549|NCT03013491|541549103|FG017|Main Study|Symptomatic deterioration|0|||
150112550|NCT03013491|541549104|FG018|Main Study|Symptomatic deterioration|0|||
150112551|NCT03013491|541549086|FG000|Main Study|Protocol version 8.0 approval|0|||
150112552|NCT03013491|541549087|FG001|Main Study|Protocol version 8.0 approval|0|||
150112553|NCT03013491|541549088|FG002|Main Study|Protocol version 8.0 approval|0|||
150112554|NCT03013491|541549089|FG003|Main Study|Protocol version 8.0 approval|0|||
150112555|NCT03013491|541549090|FG004|Main Study|Protocol version 8.0 approval|0|||
150112556|NCT03013491|541549091|FG005|Main Study|Protocol version 8.0 approval|0|||
150112557|NCT03013491|541549092|FG006|Main Study|Protocol version 8.0 approval|0|||
150112558|NCT03013491|541549093|FG007|Main Study|Protocol version 8.0 approval|0|||
150112559|NCT03013491|541549094|FG008|Main Study|Protocol version 8.0 approval|0|||
150112560|NCT03013491|541549095|FG009|Main Study|Protocol version 8.0 approval|0|||
150112561|NCT03013491|541549096|FG010|Main Study|Protocol version 8.0 approval|1|||
150112562|NCT03013491|541549097|FG011|Main Study|Protocol version 8.0 approval|0|||
150112563|NCT03013491|541549098|FG012|Main Study|Protocol version 8.0 approval|0|||
150112564|NCT03013491|541549099|FG013|Main Study|Protocol version 8.0 approval|0|||
150112565|NCT03013491|541549100|FG014|Main Study|Protocol version 8.0 approval|0|||
150112566|NCT03013491|541549101|FG015|Main Study|Protocol version 8.0 approval|0|||
150112567|NCT03013491|541549102|FG016|Main Study|Protocol version 8.0 approval|0|||
150112568|NCT03013491|541549103|FG017|Main Study|Protocol version 8.0 approval|0|||
150112569|NCT03013491|541549104|FG018|Main Study|Protocol version 8.0 approval|0|||
150112570|NCT03013491|541549086|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
150112571|NCT03013491|541549087|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
150112572|NCT03013491|541549088|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
150112573|NCT03013491|541549089|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
150112574|NCT03013491|541549090|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
150112575|NCT03013491|541549091|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
150112576|NCT03013491|541549092|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
150112577|NCT03013491|541549093|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
150112578|NCT03013491|541549094|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
150112579|NCT03013491|541549095|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
150112580|NCT03013491|541549096|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
150112581|NCT03013491|541549097|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
150112582|NCT03013491|541549098|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
150112583|NCT03013491|541549099|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
150112584|NCT03013491|541549100|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
150112585|NCT03013491|541549101|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
150112586|NCT03013491|541549102|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
150112587|NCT03013491|541549103|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
150112588|NCT03013491|541549104|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
150112589|NCT03013491|541549086|FG000|Main Study|Start of new anticancer therapy|0|||
150112590|NCT03013491|541549087|FG001|Main Study|Start of new anticancer therapy|0|||
150112591|NCT03013491|541549088|FG002|Main Study|Start of new anticancer therapy|0|||
150112592|NCT03013491|541549089|FG003|Main Study|Start of new anticancer therapy|0|||
150112593|NCT03013491|541549090|FG004|Main Study|Start of new anticancer therapy|0|||
150112594|NCT03013491|541549091|FG005|Main Study|Start of new anticancer therapy|0|||
150112595|NCT03013491|541549092|FG006|Main Study|Start of new anticancer therapy|0|||
150112596|NCT03013491|541549093|FG007|Main Study|Start of new anticancer therapy|0|||
150112597|NCT03013491|541549094|FG008|Main Study|Start of new anticancer therapy|0|||
150112598|NCT03013491|541549095|FG009|Main Study|Start of new anticancer therapy|0|||
150112599|NCT03013491|541549096|FG010|Main Study|Start of new anticancer therapy|0|||
150112600|NCT03013491|541549097|FG011|Main Study|Start of new anticancer therapy|0|||
150112601|NCT03013491|541549098|FG012|Main Study|Start of new anticancer therapy|0|||
150112602|NCT03013491|541549099|FG013|Main Study|Start of new anticancer therapy|0|||
150112603|NCT03013491|541549100|FG014|Main Study|Start of new anticancer therapy|0|||
150112604|NCT03013491|541549101|FG015|Main Study|Start of new anticancer therapy|0|||
150112605|NCT03013491|541549102|FG016|Main Study|Start of new anticancer therapy|0|||
150112606|NCT03013491|541549103|FG017|Main Study|Start of new anticancer therapy|0|||
150112607|NCT03013491|541549104|FG018|Main Study|Start of new anticancer therapy|2|||
150112608|NCT03013491|541549086|FG000|Long-term Extension|Disease progression|0|||
150112609|NCT03013491|541549087|FG001|Long-term Extension|Disease progression|0|||
150112610|NCT03013491|541549088|FG002|Long-term Extension|Disease progression|0|||
150112611|NCT03013491|541549089|FG003|Long-term Extension|Disease progression|1|||
150112612|NCT03013491|541549090|FG004|Long-term Extension|Disease progression|0|||
150112613|NCT03013491|541549091|FG005|Long-term Extension|Disease progression|0|||
150112614|NCT03013491|541549092|FG006|Long-term Extension|Disease progression|0|||
150112615|NCT03013491|541549093|FG007|Long-term Extension|Disease progression|0|||
150112616|NCT03013491|541549094|FG008|Long-term Extension|Disease progression|0|||
150112617|NCT03013491|541549095|FG009|Long-term Extension|Disease progression|0|||
150112618|NCT03013491|541549096|FG010|Long-term Extension|Disease progression|0|||
150112619|NCT03013491|541549097|FG011|Long-term Extension|Disease progression|0|||
150112620|NCT03013491|541549098|FG012|Long-term Extension|Disease progression|0|||
150112621|NCT03013491|541549099|FG013|Long-term Extension|Disease progression|0|||
150112622|NCT03013491|541549100|FG014|Long-term Extension|Disease progression|0|||
150112623|NCT03013491|541549101|FG015|Long-term Extension|Disease progression|0|||
150112624|NCT03013491|541549102|FG016|Long-term Extension|Disease progression|0|||
150112625|NCT03013491|541549103|FG017|Long-term Extension|Disease progression|0|||
150112626|NCT03013491|541549104|FG018|Long-term Extension|Disease progression|1|||
150112627|NCT03013491|541549086|FG000|Long-term Extension|Withdrawal by Subject|0|||
150112628|NCT03013491|541549087|FG001|Long-term Extension|Withdrawal by Subject|0|||
150112629|NCT03013491|541549088|FG002|Long-term Extension|Withdrawal by Subject|0|||
150112630|NCT03013491|541549089|FG003|Long-term Extension|Withdrawal by Subject|0|||
150112631|NCT03013491|541549090|FG004|Long-term Extension|Withdrawal by Subject|0|||
150112632|NCT03013491|541549091|FG005|Long-term Extension|Withdrawal by Subject|0|||
150112633|NCT03013491|541549092|FG006|Long-term Extension|Withdrawal by Subject|0|||
150112634|NCT03013491|541549093|FG007|Long-term Extension|Withdrawal by Subject|1|||
150112635|NCT03013491|541549094|FG008|Long-term Extension|Withdrawal by Subject|0|||
150112636|NCT03013491|541549095|FG009|Long-term Extension|Withdrawal by Subject|0|||
150112637|NCT03013491|541549096|FG010|Long-term Extension|Withdrawal by Subject|0|||
150112638|NCT03013491|541549097|FG011|Long-term Extension|Withdrawal by Subject|0|||
150112639|NCT03013491|541549098|FG012|Long-term Extension|Withdrawal by Subject|0|||
150112640|NCT03013491|541549099|FG013|Long-term Extension|Withdrawal by Subject|0|||
150112641|NCT03013491|541549100|FG014|Long-term Extension|Withdrawal by Subject|0|||
150112642|NCT03013491|541549101|FG015|Long-term Extension|Withdrawal by Subject|0|||
150112643|NCT03013491|541549102|FG016|Long-term Extension|Withdrawal by Subject|0|||
150112644|NCT03013491|541549103|FG017|Long-term Extension|Withdrawal by Subject|0|||
150112645|NCT03013491|541549104|FG018|Long-term Extension|Withdrawal by Subject|0|||
150112646|NCT03013491|541549086|FG000|Long-term Extension|Adverse Event|0|||
150112647|NCT03013491|541549087|FG001|Long-term Extension|Adverse Event|0|||
150112648|NCT03013491|541549088|FG002|Long-term Extension|Adverse Event|0|||
150112649|NCT03013491|541549089|FG003|Long-term Extension|Adverse Event|0|||
150112650|NCT03013491|541549090|FG004|Long-term Extension|Adverse Event|0|||
150112651|NCT03013491|541549091|FG005|Long-term Extension|Adverse Event|0|||
150112652|NCT03013491|541549092|FG006|Long-term Extension|Adverse Event|0|||
150112653|NCT03013491|541549093|FG007|Long-term Extension|Adverse Event|0|||
150112654|NCT03013491|541549094|FG008|Long-term Extension|Adverse Event|0|||
150112655|NCT03013491|541549095|FG009|Long-term Extension|Adverse Event|0|||
150112656|NCT03013491|541549096|FG010|Long-term Extension|Adverse Event|0|||
150112657|NCT03013491|541549097|FG011|Long-term Extension|Adverse Event|0|||
150112658|NCT03013491|541549098|FG012|Long-term Extension|Adverse Event|0|||
150112659|NCT03013491|541549099|FG013|Long-term Extension|Adverse Event|0|||
150112660|NCT03013491|541549100|FG014|Long-term Extension|Adverse Event|0|||
150112661|NCT03013491|541549101|FG015|Long-term Extension|Adverse Event|0|||
150112662|NCT03013491|541549102|FG016|Long-term Extension|Adverse Event|0|||
150112663|NCT03013491|541549103|FG017|Long-term Extension|Adverse Event|0|||
150112664|NCT03013491|541549104|FG018|Long-term Extension|Adverse Event|1|||
150112665|NCT03013491|541549086|FG000|Long-term Extension|Death|0|||
150112666|NCT03013491|541549087|FG001|Long-term Extension|Death|0|||
150112667|NCT03013491|541549088|FG002|Long-term Extension|Death|0|||
150189056|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150112668|NCT03013491|541549089|FG003|Long-term Extension|Death|0|||
150112669|NCT03013491|541549090|FG004|Long-term Extension|Death|0|||
150112670|NCT03013491|541549091|FG005|Long-term Extension|Death|0|||
150112671|NCT03013491|541549092|FG006|Long-term Extension|Death|0|||
150112672|NCT03013491|541549093|FG007|Long-term Extension|Death|0|||
150112673|NCT03013491|541549094|FG008|Long-term Extension|Death|0|||
150112674|NCT03013491|541549095|FG009|Long-term Extension|Death|0|||
150112675|NCT03013491|541549096|FG010|Long-term Extension|Death|0|||
150112676|NCT03013491|541549097|FG011|Long-term Extension|Death|0|||
150112677|NCT03013491|541549098|FG012|Long-term Extension|Death|0|||
150112678|NCT03013491|541549099|FG013|Long-term Extension|Death|0|||
150112679|NCT03013491|541549100|FG014|Long-term Extension|Death|0|||
150112680|NCT03013491|541549101|FG015|Long-term Extension|Death|0|||
150112681|NCT03013491|541549102|FG016|Long-term Extension|Death|0|||
150112682|NCT03013491|541549103|FG017|Long-term Extension|Death|0|||
150189057|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150112683|NCT03013491|541549104|FG018|Long-term Extension|Death|1|||
150112684|NCT04579679|541549107|FG000|Overall Study|New Antitumor Therapy|6|||
150112685|NCT04579679|541549108|FG001|Overall Study|New Antitumor Therapy|4|||
150112686|NCT04579679|541549109|FG002|Overall Study|New Antitumor Therapy|7|||
150112687|NCT04579679|541549110|FG003|Overall Study|New Antitumor Therapy|0|||
150112688|NCT04579679|541549107|FG000|Overall Study|Withdrawal of Consent|1|||
150112689|NCT04579679|541549108|FG001|Overall Study|Withdrawal of Consent|1|||
150112690|NCT04579679|541549109|FG002|Overall Study|Withdrawal of Consent|2|||
150112691|NCT04579679|541549110|FG003|Overall Study|Withdrawal of Consent|4|||
150112692|NCT04579679|541549107|FG000|Overall Study|Death|2|||
150112693|NCT04579679|541549108|FG001|Overall Study|Death|2|||
150112694|NCT04579679|541549109|FG002|Overall Study|Death|2|||
150112695|NCT04579679|541549110|FG003|Overall Study|Death|0|||
150112696|NCT04579679|541549107|FG000|Overall Study|Adverse Event|0|||
150112697|NCT04579679|541549108|FG001|Overall Study|Adverse Event|4|||
150112698|NCT04579679|541549109|FG002|Overall Study|Adverse Event|0|||
150112699|NCT04579679|541549110|FG003|Overall Study|Adverse Event|0|||
150112700|NCT04579679|541549107|FG000|Overall Study|Disease Progression|9|||
150112701|NCT04579679|541549108|FG001|Overall Study|Disease Progression|13|||
150112702|NCT04579679|541549109|FG002|Overall Study|Disease Progression|7|||
150112703|NCT04579679|541549110|FG003|Overall Study|Disease Progression|0|||
150112704|NCT04579679|541549107|FG000|Overall Study|Physician Decision|0|||
150112705|NCT04579679|541549108|FG001|Overall Study|Physician Decision|0|||
150112706|NCT04579679|541549109|FG002|Overall Study|Physician Decision|1|||
150112707|NCT04579679|541549110|FG003|Overall Study|Physician Decision|0|||
150112708|NCT04579679|541549107|FG000|Overall Study|Study Terminated by Sponsor|2|||
150112709|NCT04579679|541549108|FG001|Overall Study|Study Terminated by Sponsor|7|||
150112710|NCT04579679|541549109|FG002|Overall Study|Study Terminated by Sponsor|1|||
150112711|NCT04579679|541549110|FG003|Overall Study|Study Terminated by Sponsor|0|||
150112712|NCT04740034|541549116|FG000|Overall Study|Death|0|||
150112713|NCT04740034|541549117|FG001|Overall Study|Death|1|||
150112714|NCT04740034|541549118|FG002|Overall Study|Death|2|||
150112715|NCT04740034|541549119|FG003|Overall Study|Death|3|||
150112716|NCT04740034|541549120|FG004|Overall Study|Death|4|||
150112717|NCT04740034|541549121|FG005|Overall Study|Death|4|||
150112718|NCT04740034|541549122|FG006|Overall Study|Death|2|||
150112719|NCT04740034|541549123|FG007|Overall Study|Death|2|||
150112720|NCT04740034|541549124|FG008|Overall Study|Death|2|||
150112721|NCT04740034|541549125|FG009|Overall Study|Death|4|||
150112722|NCT04740034|541549126|FG010|Overall Study|Death|0|||
150112723|NCT04740034|541549116|FG000|Overall Study|Lost to Follow-up|0|||
150112724|NCT04740034|541549117|FG001|Overall Study|Lost to Follow-up|0|||
150112725|NCT04740034|541549118|FG002|Overall Study|Lost to Follow-up|0|||
150112726|NCT04740034|541549119|FG003|Overall Study|Lost to Follow-up|1|||
150112727|NCT04740034|541549120|FG004|Overall Study|Lost to Follow-up|2|||
150112728|NCT04740034|541549121|FG005|Overall Study|Lost to Follow-up|2|||
150112729|NCT04740034|541549122|FG006|Overall Study|Lost to Follow-up|0|||
150112730|NCT04740034|541549123|FG007|Overall Study|Lost to Follow-up|0|||
150112731|NCT04740034|541549124|FG008|Overall Study|Lost to Follow-up|0|||
150112732|NCT04740034|541549125|FG009|Overall Study|Lost to Follow-up|1|||
150112733|NCT04740034|541549126|FG010|Overall Study|Lost to Follow-up|0|||
150112734|NCT04740034|541549116|FG000|Overall Study|Withdrawal by Subject|1|||
150112735|NCT04740034|541549117|FG001|Overall Study|Withdrawal by Subject|0|||
150112736|NCT04740034|541549118|FG002|Overall Study|Withdrawal by Subject|0|||
150112737|NCT04740034|541549119|FG003|Overall Study|Withdrawal by Subject|0|||
150112738|NCT04740034|541549120|FG004|Overall Study|Withdrawal by Subject|0|||
150112739|NCT04740034|541549121|FG005|Overall Study|Withdrawal by Subject|0|||
150112740|NCT04740034|541549122|FG006|Overall Study|Withdrawal by Subject|0|||
150112741|NCT04740034|541549123|FG007|Overall Study|Withdrawal by Subject|1|||
150112742|NCT04740034|541549124|FG008|Overall Study|Withdrawal by Subject|0|||
150112743|NCT04740034|541549125|FG009|Overall Study|Withdrawal by Subject|1|||
150112744|NCT04740034|541549126|FG010|Overall Study|Withdrawal by Subject|0|||
150112745|NCT04740034|541549116|FG000|Overall Study|Decision by sponsor|0|||
150112746|NCT04740034|541549117|FG001|Overall Study|Decision by sponsor|0|||
150112747|NCT04740034|541549118|FG002|Overall Study|Decision by sponsor|1|||
150112748|NCT04740034|541549119|FG003|Overall Study|Decision by sponsor|0|||
150112749|NCT04740034|541549120|FG004|Overall Study|Decision by sponsor|0|||
150112750|NCT04740034|541549121|FG005|Overall Study|Decision by sponsor|0|||
150112751|NCT04740034|541549122|FG006|Overall Study|Decision by sponsor|1|||
150112752|NCT04740034|541549123|FG007|Overall Study|Decision by sponsor|2|||
150112753|NCT04740034|541549124|FG008|Overall Study|Decision by sponsor|1|||
150112754|NCT04740034|541549125|FG009|Overall Study|Decision by sponsor|1|||
150112755|NCT04740034|541549126|FG010|Overall Study|Decision by sponsor|2|||
150112756|NCT00991302|541550837|FG000|Overall Study|Death|0|||
150112757|NCT00991302|541550838|FG001|Overall Study|Death|1|||
150112758|NCT00991302|541550837|FG000|Overall Study|Lost to Follow-up|14|||
150112759|NCT00991302|541550838|FG001|Overall Study|Lost to Follow-up|12|||
150112760|NCT02383758|541550839|FG000|Overall Study|Withdrawal by Subject|0|||
150112761|NCT02383758|541550840|FG001|Overall Study|Withdrawal by Subject|2|||
150112762|NCT02573324|541550846|FG000|Overall Study|Withdrawal by Subject|26|||
150112763|NCT02573324|541550847|FG001|Overall Study|Withdrawal by Subject|23|||
150112764|NCT02573324|541550848|FG002|Overall Study|Withdrawal by Subject|3|||
150112765|NCT02573324|541550846|FG000|Overall Study|Lost to Follow-up|4|||
150189058|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189059|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189060|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189061|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189062|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189063|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189064|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189065|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189066|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
150189067|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189068|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
150189069|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
150189070|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189071|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189072|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189073|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189074|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189075|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189076|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
150189077|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189078|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189079|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189080|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189081|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189082|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189083|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189084|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189085|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189086|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189087|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189088|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189089|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189090|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189091|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189092|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189093|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
150189094|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189095|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
150189096|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
150189097|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
150189098|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189099|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189100|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189101|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189102|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189103|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
150189104|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189105|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189106|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189107|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189108|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189109|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189110|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150112766|NCT02573324|541550847|FG001|Overall Study|Lost to Follow-up|5|||
150112767|NCT02573324|541550848|FG002|Overall Study|Lost to Follow-up|0|||
150112768|NCT02573324|541550846|FG000|Overall Study|Study Terminated by Sponsor|107|||
150112769|NCT02573324|541550847|FG001|Overall Study|Study Terminated by Sponsor|89|||
150112770|NCT02573324|541550848|FG002|Overall Study|Study Terminated by Sponsor|2|||
150112771|NCT02573324|541550846|FG000|Overall Study|Death|182|||
150112772|NCT02573324|541550847|FG001|Overall Study|Death|200|||
150112773|NCT02573324|541550848|FG002|Overall Study|Death|1|||
150112774|NCT02573324|541550846|FG000|Overall Study|Other, Not Specified|20|||
150112775|NCT02573324|541550847|FG001|Overall Study|Other, Not Specified|27|||
150112776|NCT02573324|541550848|FG002|Overall Study|Other, Not Specified|0|||
150112777|NCT02573324|541550846|FG000|Overall Study|Unknown Reason|2|||
150112778|NCT02573324|541550847|FG001|Overall Study|Unknown Reason|0|||
150112779|NCT02573324|541550848|FG002|Overall Study|Unknown Reason|0|||
150112780|NCT03892889|541550849|FG000|Overall Study|Adverse Event|17|||
150112781|NCT03892889|541550849|FG000|Overall Study|Lack of Efficacy|1|||
150112782|NCT03892889|541550849|FG000|Overall Study|Lost to Follow-up|46|||
150112783|NCT03892889|541550849|FG000|Overall Study|Non-compliance with study drug|22|||
150112784|NCT03892889|541550849|FG000|Overall Study|Pregnancy|1|||
150112785|NCT03892889|541550849|FG000|Overall Study|Protocol Deviation|3|||
150112786|NCT03892889|541550849|FG000|Overall Study|Withdrawal by Subject|50|||
150112787|NCT03892889|541550849|FG000|Overall Study|Withdrawal by Caregiver|1|||
150112788|NCT03892889|541550849|FG000|Overall Study|Study Terminated by Sponsor|50|||
150112789|NCT03892889|541550849|FG000|Overall Study|Physician Decision|8|||
150112790|NCT03892889|541550849|FG000|Overall Study|Reason not Specified|5|||
150112791|NCT02066298|541550850|FG000|Overall Study|Lost to Follow-up|3|||
150112792|NCT02066298|541550851|FG001|Overall Study|Lost to Follow-up|2|||
150112793|NCT02066298|541550852|FG002|Overall Study|Lost to Follow-up|3|||
150112794|NCT02066298|541550853|FG003|Overall Study|Lost to Follow-up|2|||
150112795|NCT02066298|541550854|FG004|Overall Study|Lost to Follow-up|3|||
150112796|NCT02066298|541550855|FG005|Overall Study|Lost to Follow-up|4|||
150112797|NCT02066298|541550850|FG000|Overall Study|Withdrawal by Subject|6|||
150112798|NCT02066298|541550851|FG001|Overall Study|Withdrawal by Subject|6|||
150112799|NCT02066298|541550852|FG002|Overall Study|Withdrawal by Subject|6|||
150112800|NCT02066298|541550853|FG003|Overall Study|Withdrawal by Subject|4|||
150112801|NCT02066298|541550854|FG004|Overall Study|Withdrawal by Subject|5|||
150112802|NCT02066298|541550855|FG005|Overall Study|Withdrawal by Subject|8|||
150112803|NCT02066298|541550850|FG000|Overall Study|Physician Decision|0|||
150112804|NCT02066298|541550851|FG001|Overall Study|Physician Decision|0|||
150112805|NCT02066298|541550852|FG002|Overall Study|Physician Decision|1|||
150112806|NCT02066298|541550853|FG003|Overall Study|Physician Decision|0|||
150112807|NCT02066298|541550854|FG004|Overall Study|Physician Decision|1|||
150112808|NCT02066298|541550855|FG005|Overall Study|Physician Decision|0|||
150112809|NCT00630877|541550858|FG000|Overall Study|Adverse Event|11|||
150112810|NCT00630877|541550859|FG001|Overall Study|Adverse Event|8|||
150112811|NCT00630877|541550860|FG002|Overall Study|Adverse Event|7|||
150112812|NCT00630877|541550858|FG000|Overall Study|Withdrawal by Subject|3|||
150112813|NCT00630877|541550859|FG001|Overall Study|Withdrawal by Subject|4|||
150112814|NCT00630877|541550860|FG002|Overall Study|Withdrawal by Subject|0|||
150112815|NCT00630877|541550858|FG000|Overall Study|Lost to Follow-up|2|||
150112816|NCT00630877|541550859|FG001|Overall Study|Lost to Follow-up|0|||
150112817|NCT00630877|541550860|FG002|Overall Study|Lost to Follow-up|0|||
150112818|NCT00630877|541550858|FG000|Overall Study|Noncompliance|2|||
150112819|NCT00630877|541550859|FG001|Overall Study|Noncompliance|3|||
150112820|NCT00630877|541550860|FG002|Overall Study|Noncompliance|1|||
150112821|NCT00630877|541550858|FG000|Overall Study|Protocol violation|1|||
150112822|NCT00630877|541550859|FG001|Overall Study|Protocol violation|0|||
150112823|NCT00630877|541550860|FG002|Overall Study|Protocol violation|1|||
150112824|NCT00630877|541550858|FG000|Overall Study|Personal reasons|0|||
150112825|NCT00630877|541550859|FG001|Overall Study|Personal reasons|0|||
150112826|NCT00630877|541550860|FG002|Overall Study|Personal reasons|1|||
150112827|NCT02343458|541550864|FG000|Overall Study|Adverse Event|15|||
150112828|NCT02343458|541550865|FG001|Overall Study|Adverse Event|14|||
150112829|NCT02343458|541550866|FG002|Overall Study|Adverse Event|15|||
150112830|NCT02343458|541550867|FG003|Overall Study|Adverse Event|3|||
150112831|NCT02343458|541550864|FG000|Overall Study|Lack of Efficacy|3|||
150112832|NCT02343458|541550865|FG001|Overall Study|Lack of Efficacy|8|||
150112833|NCT02343458|541550866|FG002|Overall Study|Lack of Efficacy|4|||
150112834|NCT02343458|541550867|FG003|Overall Study|Lack of Efficacy|8|||
150112835|NCT02343458|541550864|FG000|Overall Study|Withdrawal by Subject|18|||
150112836|NCT02343458|541550865|FG001|Overall Study|Withdrawal by Subject|17|||
150112837|NCT02343458|541550866|FG002|Overall Study|Withdrawal by Subject|23|||
150112838|NCT02343458|541550867|FG003|Overall Study|Withdrawal by Subject|14|||
150112839|NCT02343458|541550864|FG000|Overall Study|Physician Decision|1|||
150112840|NCT02343458|541550865|FG001|Overall Study|Physician Decision|4|||
150112841|NCT02343458|541550866|FG002|Overall Study|Physician Decision|2|||
150112842|NCT02343458|541550867|FG003|Overall Study|Physician Decision|2|||
150112843|NCT02343458|541550864|FG000|Overall Study|Lost to Follow-up|5|||
150112844|NCT02343458|541550865|FG001|Overall Study|Lost to Follow-up|5|||
150112845|NCT02343458|541550866|FG002|Overall Study|Lost to Follow-up|3|||
150189111|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189112|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189113|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189114|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189115|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189116|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189117|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189118|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189119|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
150189120|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189121|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189122|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189123|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189124|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189125|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189126|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
150189127|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189128|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189129|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189130|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
150189131|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189132|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189133|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189134|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189135|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189136|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189137|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189138|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189139|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189140|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189141|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189142|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189143|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189144|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
150189145|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
150189146|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
150189147|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
150189148|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189149|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
150189150|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
150189151|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189152|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189153|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189154|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189155|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189156|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189157|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
150189158|NCT02783300|541831217|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189159|NCT02783300|541831218|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189160|NCT02783300|541831219|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189161|NCT02783300|541831220|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189162|NCT02783300|541831221|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150112846|NCT02343458|541550867|FG003|Overall Study|Lost to Follow-up|1|||
150112847|NCT02343458|541550864|FG000|Overall Study|Protocol Violation|2|||
150112848|NCT02343458|541550865|FG001|Overall Study|Protocol Violation|5|||
150112849|NCT02343458|541550866|FG002|Overall Study|Protocol Violation|2|||
150112850|NCT02343458|541550867|FG003|Overall Study|Protocol Violation|2|||
150112851|NCT02343458|541550864|FG000|Overall Study|Protocol Specified Criteria|17|||
150112852|NCT02343458|541550865|FG001|Overall Study|Protocol Specified Criteria|13|||
150112853|NCT02343458|541550866|FG002|Overall Study|Protocol Specified Criteria|14|||
150112854|NCT02343458|541550867|FG003|Overall Study|Protocol Specified Criteria|8|||
150189163|NCT02783300|541831222|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150112855|NCT01913041|541550873|FG000|Overall Study|Protocol Violation|35|||
150112856|NCT01913041|541550873|FG000|Overall Study|Withdrawal by Subject|3|||
150112857|NCT01913041|541550873|FG000|Overall Study|Physician Decision|1|||
150112858|NCT01513317|541550874|FG000|Overall Study|Withdrawal by Subject|15|||
150112859|NCT01513317|541550875|FG001|Overall Study|Withdrawal by Subject|4|||
150112860|NCT01513317|541550874|FG000|Overall Study|Death|1|||
150112861|NCT01513317|541550875|FG001|Overall Study|Death|1|||
150112862|NCT01513317|541550874|FG000|Overall Study|Study terminated by sponsor|18|||
150112863|NCT01513317|541550875|FG001|Overall Study|Study terminated by sponsor|18|||
150112864|NCT01513317|541550874|FG000|Overall Study|Other|0|||
150112865|NCT01513317|541550875|FG001|Overall Study|Other|1|||
150112866|NCT00182689|541550877|FG000|Overall Study|Adverse Event|8|||
150112867|NCT00182689|541550878|FG001|Overall Study|Adverse Event|11|||
150112868|NCT00182689|541550877|FG000|Overall Study|Withdrawal by Subject|2|||
150112869|NCT00182689|541550878|FG001|Overall Study|Withdrawal by Subject|2|||
150112870|NCT00182689|541550877|FG000|Overall Study|Progression|27|||
150112871|NCT00182689|541550878|FG001|Overall Study|Progression|29|||
150112872|NCT00182689|541550877|FG000|Overall Study|Death|1|||
150112873|NCT00182689|541550878|FG001|Overall Study|Death|0|||
150112874|NCT00182689|541550877|FG000|Overall Study|not protocol specified|0|||
150112875|NCT00182689|541550878|FG001|Overall Study|not protocol specified|3|||
150112876|NCT00182689|541550877|FG000|Overall Study|Ineligible|1|||
150112877|NCT00182689|541550878|FG001|Overall Study|Ineligible|4|||
150112878|NCT00182689|541550877|FG000|Overall Study|Never received treatment|1|||
150112879|NCT00182689|541550878|FG001|Overall Study|Never received treatment|0|||
150112880|NCT02564198|541550879|FG000|Overall Study|Withdrawal by Subject|2|||
150112881|NCT02564198|541550880|FG001|Overall Study|Withdrawal by Subject|4|||
150112882|NCT02564198|541550881|FG002|Overall Study|Withdrawal by Subject|0|||
150112883|NCT02564198|541550879|FG000|Overall Study|Adverse Event|0|||
150112884|NCT02564198|541550880|FG001|Overall Study|Adverse Event|1|||
150112885|NCT02564198|541550881|FG002|Overall Study|Adverse Event|0|||
150112886|NCT00659646|541550882|FG000|Overall Study|Protocol Violation|12|||
150112887|NCT00659646|541550883|FG001|Overall Study|Protocol Violation|8|||
150112888|NCT00659646|541550882|FG000|Overall Study|Adverse Event|1|||
150112889|NCT00659646|541550883|FG001|Overall Study|Adverse Event|0|||
150112890|NCT00659646|541550882|FG000|Overall Study|Lost to Follow-up|1|||
150112891|NCT00659646|541550883|FG001|Overall Study|Lost to Follow-up|0|||
150112892|NCT00659646|541550882|FG000|Overall Study|protocol noncompliance after randomized|1|||
150112893|NCT00659646|541550883|FG001|Overall Study|protocol noncompliance after randomized|0|||
150112894|NCT01640301|541550884|FG000|Overall Study|Death|0|||
150112895|NCT01640301|541550885|FG001|Overall Study|Death|8|||
150112896|NCT01969838|541550888|FG000|Double-blind Phase|Adverse Event|10|||
150112897|NCT01969838|541550889|FG001|Double-blind Phase|Adverse Event|4|||
150112898|NCT01969838|541550890|FG002|Double-blind Phase|Adverse Event|0|||
150112899|NCT01969838|541550891|FG003|Double-blind Phase|Adverse Event|0|||
150112900|NCT01969838|541550888|FG000|Double-blind Phase|Death|5|||
150112901|NCT01969838|541550889|FG001|Double-blind Phase|Death|2|||
150112902|NCT01969838|541550890|FG002|Double-blind Phase|Death|0|||
150112903|NCT01969838|541550891|FG003|Double-blind Phase|Death|0|||
150112904|NCT01969838|541550888|FG000|Double-blind Phase|Physician Decision|5|||
150112905|NCT01969838|541550889|FG001|Double-blind Phase|Physician Decision|1|||
150112906|NCT01969838|541550890|FG002|Double-blind Phase|Physician Decision|0|||
150112907|NCT01969838|541550891|FG003|Double-blind Phase|Physician Decision|0|||
150112908|NCT01969838|541550888|FG000|Double-blind Phase|Subject Decision|4|||
150112909|NCT01969838|541550889|FG001|Double-blind Phase|Subject Decision|2|||
150112910|NCT01969838|541550890|FG002|Double-blind Phase|Subject Decision|0|||
150112911|NCT01969838|541550891|FG003|Double-blind Phase|Subject Decision|0|||
150112912|NCT01969838|541550888|FG000|Double-blind Phase|Disease Progression|2|||
150112913|NCT01969838|541550889|FG001|Double-blind Phase|Disease Progression|0|||
150112914|NCT01969838|541550890|FG002|Double-blind Phase|Disease Progression|0|||
150112915|NCT01969838|541550891|FG003|Double-blind Phase|Disease Progression|0|||
150112916|NCT01969838|541550888|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
150112917|NCT01969838|541550889|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
150112918|NCT01969838|541550890|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
150112919|NCT01969838|541550891|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
150112920|NCT01969838|541550888|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
150112921|NCT01969838|541550889|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
150112922|NCT01969838|541550890|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
150112923|NCT01969838|541550891|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
150112924|NCT01969838|541550888|FG000|Open-label Phase|Adverse Event|0|||
150112925|NCT01969838|541550889|FG001|Open-label Phase|Adverse Event|0|||
150112926|NCT01969838|541550890|FG002|Open-label Phase|Adverse Event|37|||
150112927|NCT01969838|541550891|FG003|Open-label Phase|Adverse Event|49|||
150112928|NCT01969838|541550888|FG000|Open-label Phase|Disease Progression|0|||
150112929|NCT01969838|541550889|FG001|Open-label Phase|Disease Progression|0|||
150112930|NCT01969838|541550890|FG002|Open-label Phase|Disease Progression|26|||
150112931|NCT01969838|541550891|FG003|Open-label Phase|Disease Progression|27|||
150112932|NCT01969838|541550888|FG000|Open-label Phase|Lack of Efficacy|0|||
150112933|NCT01969838|541550889|FG001|Open-label Phase|Lack of Efficacy|0|||
150112934|NCT01969838|541550890|FG002|Open-label Phase|Lack of Efficacy|17|||
150112935|NCT01969838|541550891|FG003|Open-label Phase|Lack of Efficacy|19|||
150112936|NCT01969838|541550888|FG000|Open-label Phase|Subject Decision|0|||
150112937|NCT01969838|541550889|FG001|Open-label Phase|Subject Decision|0|||
150112938|NCT01969838|541550890|FG002|Open-label Phase|Subject Decision|14|||
150112939|NCT01969838|541550891|FG003|Open-label Phase|Subject Decision|15|||
150112940|NCT01969838|541550888|FG000|Open-label Phase|Death|0|||
150112941|NCT01969838|541550889|FG001|Open-label Phase|Death|0|||
150112942|NCT01969838|541550890|FG002|Open-label Phase|Death|13|||
150112943|NCT01969838|541550891|FG003|Open-label Phase|Death|11|||
150112944|NCT01969838|541550888|FG000|Open-label Phase|Physician Decision|0|||
150112945|NCT01969838|541550889|FG001|Open-label Phase|Physician Decision|0|||
150112946|NCT01969838|541550890|FG002|Open-label Phase|Physician Decision|9|||
150112947|NCT01969838|541550891|FG003|Open-label Phase|Physician Decision|14|||
150112948|NCT01969838|541550888|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
150112949|NCT01969838|541550889|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
150112950|NCT01969838|541550890|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
150112951|NCT01969838|541550891|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
150112952|NCT00408993|541550892|FG000|Overall Study|Adverse Event|15|||
150112953|NCT00408993|541550893|FG001|Overall Study|Adverse Event|4|||
150112954|NCT00408993|541550892|FG000|Overall Study|Protocol Violation|1|||
150112955|NCT00408993|541550893|FG001|Overall Study|Protocol Violation|6|||
150112956|NCT00408993|541550892|FG000|Overall Study|Lack of Efficacy|1|||
150112957|NCT00408993|541550893|FG001|Overall Study|Lack of Efficacy|4|||
150112958|NCT00408993|541550892|FG000|Overall Study|Withdrawal by Subject|2|||
150112959|NCT00408993|541550893|FG001|Overall Study|Withdrawal by Subject|3|||
150112960|NCT00298896|541550894|FG000|Overall Study|Death|3|||
150112961|NCT00298896|541550894|FG000|Overall Study|Physician Decision|2|||
150112962|NCT00298896|541550894|FG000|Overall Study|Intercurrent Illness|1|||
150112963|NCT00298896|541550894|FG000|Overall Study|Disease Progression|41|||
150112964|NCT00298896|541550894|FG000|Overall Study|Withdrawal by Subject|2|||
150112965|NCT00298896|541550894|FG000|Overall Study|Assigned to treatment in error|1|||
150112966|NCT02660359|541550895|FG000|Overall Study|Protocol Deviation|0|||
150112967|NCT02660359|541550896|FG001|Overall Study|Protocol Deviation|0|||
150112968|NCT02660359|541550897|FG002|Overall Study|Protocol Deviation|1|||
150112969|NCT02660359|541550895|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
150112970|NCT02660359|541550896|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
150112971|NCT02660359|541550897|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
150112972|NCT02660359|541550895|FG000|Overall Study|Lack of Efficacy|1|||
150112973|NCT02660359|541550896|FG001|Overall Study|Lack of Efficacy|1|||
150112974|NCT02660359|541550897|FG002|Overall Study|Lack of Efficacy|1|||
150112975|NCT02660359|541550895|FG000|Overall Study|Adverse Event|0|||
150112976|NCT02660359|541550896|FG001|Overall Study|Adverse Event|1|||
150112977|NCT02660359|541550897|FG002|Overall Study|Adverse Event|0|||
150112978|NCT02660359|541550895|FG000|Overall Study|Other|2|||
150112979|NCT02660359|541550896|FG001|Overall Study|Other|1|||
150112980|NCT02660359|541550897|FG002|Overall Study|Other|3|||
150112981|NCT02660359|541550895|FG000|Overall Study|Withdrawal by Subject|7|||
150112982|NCT02660359|541550896|FG001|Overall Study|Withdrawal by Subject|5|||
150112983|NCT02660359|541550897|FG002|Overall Study|Withdrawal by Subject|8|||
150112984|NCT02660359|541550895|FG000|Overall Study|Lost to Follow-up|3|||
150112985|NCT02660359|541550896|FG001|Overall Study|Lost to Follow-up|3|||
150112986|NCT02660359|541550897|FG002|Overall Study|Lost to Follow-up|0|||
150112987|NCT01797536|541550901|FG000|Overall Study|Adverse Event|0|||
150112988|NCT01797536|541550902|FG001|Overall Study|Adverse Event|1|||
150112989|NCT01797536|541550903|FG002|Overall Study|Adverse Event|0|||
150112990|NCT01797536|541550904|FG003|Overall Study|Adverse Event|0|||
150112991|NCT00844545|541550914|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
150112992|NCT00844545|541550914|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
150112993|NCT00844545|541550914|FG000|Extension Treatment Period|Adverse Event|2|||
150112994|NCT00844545|541550914|FG000|Post Treatment Period|Withdrawal by Subject|1|||
150112995|NCT02039427|541550915|FG000|Overall Study|Duration of surgery > 3h|1|||
150112996|NCT02039427|541550916|FG001|Overall Study|Duration of surgery > 3h|1|||
150112997|NCT02039427|541550917|FG002|Overall Study|Duration of surgery > 3h|0|||
150112998|NCT02039427|541550918|FG003|Overall Study|Duration of surgery > 3h|0|||
150112999|NCT02039427|541550915|FG000|Overall Study|Withdrawal on concent|0|||
150113000|NCT02039427|541550916|FG001|Overall Study|Withdrawal on concent|0|||
150113001|NCT02039427|541550917|FG002|Overall Study|Withdrawal on concent|0|||
150113002|NCT02039427|541550918|FG003|Overall Study|Withdrawal on concent|1|||
150113003|NCT02039427|541550915|FG000|Overall Study|Cancellation of surgery|0|||
150113004|NCT02039427|541550916|FG001|Overall Study|Cancellation of surgery|0|||
150113005|NCT02039427|541550917|FG002|Overall Study|Cancellation of surgery|1|||
150189164|NCT02783300|541831223|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150113006|NCT02039427|541550918|FG003|Overall Study|Cancellation of surgery|0|||
150113007|NCT02039427|541550915|FG000|Overall Study|Loss of follow - up|1|||
150113008|NCT02039427|541550916|FG001|Overall Study|Loss of follow - up|0|||
150113009|NCT02039427|541550917|FG002|Overall Study|Loss of follow - up|2|||
150113010|NCT02039427|541550918|FG003|Overall Study|Loss of follow - up|4|||
150113011|NCT02039427|541550915|FG000|Overall Study|Steroid Use|1|||
150113012|NCT02039427|541550916|FG001|Overall Study|Steroid Use|0|||
150113013|NCT02039427|541550917|FG002|Overall Study|Steroid Use|0|||
150113014|NCT02039427|541550918|FG003|Overall Study|Steroid Use|0|||
150113015|NCT01532687|541550923|FG000|Overall Study|Death|2|||
150113016|NCT01532687|541550924|FG001|Overall Study|Death|0|||
150113017|NCT01532687|541550923|FG000|Overall Study|Adverse Event|6|||
150113018|NCT01532687|541550924|FG001|Overall Study|Adverse Event|1|||
150113019|NCT01532687|541550923|FG000|Overall Study|Withdrawal by Subject|1|||
150113020|NCT01532687|541550924|FG001|Overall Study|Withdrawal by Subject|0|||
150113021|NCT01532687|541550923|FG000|Overall Study|Physician Decision|2|||
150113022|NCT01532687|541550924|FG001|Overall Study|Physician Decision|1|||
150113023|NCT01532687|541550923|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
150113024|NCT01532687|541550924|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
150113025|NCT00403455|541550925|FG000|Overall Study|Withdrawal by Subject|1|||
150113026|NCT00226941|541550932|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
150113027|NCT00226941|541550933|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
150113028|NCT00226941|541550934|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
150113029|NCT00226941|541550935|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
150113030|NCT00226941|541550932|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
150113031|NCT00226941|541550933|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
150113032|NCT00226941|541550934|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
150113033|NCT00226941|541550935|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
150113034|NCT01513291|541550936|FG000|Treatment Period|Adverse Event|8|||
150113035|NCT01513291|541550937|FG001|Treatment Period|Adverse Event|4|||
150113036|NCT01513291|541550938|FG002|Treatment Period|Adverse Event|0|||
150113037|NCT01513291|541550939|FG003|Treatment Period|Adverse Event|0|||
150113038|NCT01513291|541550940|FG004|Treatment Period|Adverse Event|0|||
150113039|NCT01513291|541550936|FG000|Treatment Period|Lack of Efficacy|3|||
150113040|NCT01513291|541550937|FG001|Treatment Period|Lack of Efficacy|0|||
150113041|NCT01513291|541550938|FG002|Treatment Period|Lack of Efficacy|0|||
150113042|NCT01513291|541550939|FG003|Treatment Period|Lack of Efficacy|0|||
150113043|NCT01513291|541550940|FG004|Treatment Period|Lack of Efficacy|0|||
150113044|NCT01513291|541550936|FG000|Treatment Period|Lost to Follow-up|2|||
150113045|NCT01513291|541550937|FG001|Treatment Period|Lost to Follow-up|3|||
150113046|NCT01513291|541550938|FG002|Treatment Period|Lost to Follow-up|0|||
150113047|NCT01513291|541550939|FG003|Treatment Period|Lost to Follow-up|0|||
150113048|NCT01513291|541550940|FG004|Treatment Period|Lost to Follow-up|0|||
150113049|NCT01513291|541550936|FG000|Treatment Period|Physician Decision|1|||
150113050|NCT01513291|541550937|FG001|Treatment Period|Physician Decision|0|||
150113051|NCT01513291|541550938|FG002|Treatment Period|Physician Decision|0|||
150113052|NCT01513291|541550939|FG003|Treatment Period|Physician Decision|0|||
150113053|NCT01513291|541550940|FG004|Treatment Period|Physician Decision|0|||
150113054|NCT01513291|541550936|FG000|Treatment Period|Protocol Violation|1|||
150113055|NCT01513291|541550937|FG001|Treatment Period|Protocol Violation|2|||
150113056|NCT01513291|541550938|FG002|Treatment Period|Protocol Violation|0|||
150113057|NCT01513291|541550939|FG003|Treatment Period|Protocol Violation|0|||
150113058|NCT01513291|541550940|FG004|Treatment Period|Protocol Violation|0|||
150113059|NCT01513291|541550936|FG000|Treatment Period|Withdrawal by Subject|8|||
150113060|NCT01513291|541550937|FG001|Treatment Period|Withdrawal by Subject|5|||
150113061|NCT01513291|541550938|FG002|Treatment Period|Withdrawal by Subject|0|||
150113062|NCT01513291|541550939|FG003|Treatment Period|Withdrawal by Subject|0|||
150113063|NCT01513291|541550940|FG004|Treatment Period|Withdrawal by Subject|0|||
150113064|NCT01513291|541550936|FG000|Treatment Period|Randomized not treated|0|||
150113065|NCT01513291|541550937|FG001|Treatment Period|Randomized not treated|2|||
150113066|NCT01513291|541550938|FG002|Treatment Period|Randomized not treated|0|||
150113067|NCT01513291|541550939|FG003|Treatment Period|Randomized not treated|0|||
150113068|NCT01513291|541550940|FG004|Treatment Period|Randomized not treated|0|||
150113069|NCT01513291|541550936|FG000|Run-out Period|Lost to Follow-up|0|||
150113070|NCT01513291|541550937|FG001|Run-out Period|Lost to Follow-up|0|||
150113071|NCT01513291|541550938|FG002|Run-out Period|Lost to Follow-up|0|||
150113072|NCT01513291|541550939|FG003|Run-out Period|Lost to Follow-up|1|||
150113073|NCT01513291|541550940|FG004|Run-out Period|Lost to Follow-up|0|||
150113074|NCT01513291|541550936|FG000|Run-out Period|Withdrawal by Subject|0|||
150113075|NCT01513291|541550937|FG001|Run-out Period|Withdrawal by Subject|0|||
150113076|NCT01513291|541550938|FG002|Run-out Period|Withdrawal by Subject|0|||
150113077|NCT01513291|541550939|FG003|Run-out Period|Withdrawal by Subject|1|||
150113078|NCT01513291|541550940|FG004|Run-out Period|Withdrawal by Subject|0|||
150113079|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
150113080|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
150113081|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
150113082|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
150113083|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
150113084|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
150113085|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
150113086|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
150113087|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
150113088|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
150113089|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
150113090|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
150113091|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
150113092|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
150113093|NCT03732638|541550941|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
150113094|NCT03732638|541550942|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
150113095|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
150113096|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
150113097|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
150113098|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
150113099|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
150113100|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
150113101|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
150113102|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
150113103|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
150113104|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
150113105|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
150113106|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
150113107|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
150113108|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
150113109|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
150113110|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
150113111|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
150113112|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
150113113|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
150113114|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
150113115|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
150189165|NCT02783300|541831224|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189166|NCT02783300|541831225|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189167|NCT02783300|541831226|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189168|NCT02783300|541831227|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189169|NCT02783300|541831228|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189170|NCT02783300|541831229|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189171|NCT02783300|541831230|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
150189172|NCT02783300|541831231|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
150189173|NCT02783300|541831232|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
150189174|NCT02783300|541831233|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
150189175|NCT02783300|541831234|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
150189176|NCT02783300|541831235|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
150189177|NCT02783300|541831236|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
150189178|NCT02783300|541831237|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
150189179|NCT02783300|541831238|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
150189180|NCT02783300|541831239|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
150189181|NCT02783300|541831240|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
150189182|NCT02783300|541831241|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
150189183|NCT02783300|541831242|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
150189184|NCT02783300|541831243|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
150189185|NCT02783300|541831217|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189186|NCT02783300|541831218|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189187|NCT02783300|541831219|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189188|NCT02783300|541831220|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150113116|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
150113117|NCT03732638|541550941|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
150113118|NCT03732638|541550942|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
150113119|NCT03732638|541550941|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
150113120|NCT03732638|541550942|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
150113121|NCT03732638|541550941|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
150113122|NCT03732638|541550942|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
150113123|NCT03732638|541550941|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
150113124|NCT03732638|541550942|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
150113125|NCT03732638|541550941|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
150113126|NCT03732638|541550942|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
150113127|NCT03728582|541550943|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
150113128|NCT03728582|541550944|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
150113129|NCT03728582|541550943|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
150113130|NCT03728582|541550944|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
150113131|NCT02732847|541550945|FG000|Overall Study|some filled early|42|||
150113132|NCT02732847|541550946|FG001|Overall Study|some filled early|42|||
150113133|NCT02738775|541550947|FG000|Overall Study|Withdrawal by Subject|0|||
150113134|NCT02738775|541550948|FG001|Overall Study|Withdrawal by Subject|1|||
150113135|NCT02738775|541550949|FG002|Overall Study|Withdrawal by Subject|0|||
150113136|NCT02738775|541550950|FG003|Overall Study|Withdrawal by Subject|0|||
150113137|NCT02738775|541550951|FG004|Overall Study|Withdrawal by Subject|0|||
150113138|NCT02738775|541550952|FG005|Overall Study|Withdrawal by Subject|0|||
150113139|NCT02738775|541550947|FG000|Overall Study|Adverse Event|0|||
150113140|NCT02738775|541550948|FG001|Overall Study|Adverse Event|0|||
150113141|NCT02738775|541550949|FG002|Overall Study|Adverse Event|0|||
150113142|NCT02738775|541550950|FG003|Overall Study|Adverse Event|1|||
150113143|NCT02738775|541550951|FG004|Overall Study|Adverse Event|0|||
150113144|NCT02738775|541550952|FG005|Overall Study|Adverse Event|0|||
150113145|NCT02738775|541550947|FG000|Overall Study|Pregnancy|0|||
150113146|NCT02738775|541550948|FG001|Overall Study|Pregnancy|1|||
150113147|NCT02738775|541550949|FG002|Overall Study|Pregnancy|0|||
150113148|NCT02738775|541550950|FG003|Overall Study|Pregnancy|0|||
150113149|NCT02738775|541550951|FG004|Overall Study|Pregnancy|0|||
150113150|NCT02738775|541550952|FG005|Overall Study|Pregnancy|0|||
150113151|NCT02738775|541550947|FG000|Overall Study|Missing|0|||
150113152|NCT02738775|541550948|FG001|Overall Study|Missing|0|||
150113153|NCT02738775|541550949|FG002|Overall Study|Missing|0|||
150113154|NCT02738775|541550950|FG003|Overall Study|Missing|0|||
150113155|NCT02738775|541550951|FG004|Overall Study|Missing|0|||
150113156|NCT02738775|541550952|FG005|Overall Study|Missing|1|||
150113157|NCT01785524|541550953|FG000|Overall Study|Withdrawal by Subject|2|||
150113158|NCT01785524|541550954|FG001|Overall Study|Withdrawal by Subject|2|||
150113159|NCT01060384|541550955|FG000|Overall Study|Withdrawal by Subject|0|||
150113160|NCT01060384|541550956|FG001|Overall Study|Withdrawal by Subject|1|||
150113161|NCT01060384|541550957|FG002|Overall Study|Withdrawal by Subject|0|||
150113162|NCT01060384|541550958|FG003|Overall Study|Withdrawal by Subject|0|||
150113163|NCT01060384|541550959|FG004|Overall Study|Withdrawal by Subject|0|||
150113164|NCT01060384|541550955|FG000|Overall Study|Death|0|||
150113165|NCT01060384|541550956|FG001|Overall Study|Death|0|||
150113166|NCT01060384|541550957|FG002|Overall Study|Death|0|||
150113167|NCT01060384|541550958|FG003|Overall Study|Death|0|||
150113168|NCT01060384|541550959|FG004|Overall Study|Death|1|||
150113169|NCT01060384|541550955|FG000|Overall Study|Intercurrent illness|0|||
150113170|NCT01060384|541550956|FG001|Overall Study|Intercurrent illness|0|||
150113171|NCT01060384|541550957|FG002|Overall Study|Intercurrent illness|0|||
150113172|NCT01060384|541550958|FG003|Overall Study|Intercurrent illness|0|||
150113173|NCT01060384|541550959|FG004|Overall Study|Intercurrent illness|1|||
150113174|NCT01263873|541550960|FG000|Overall Study|One provider unable to complete numbers|1|||
150113175|NCT01263873|541550961|FG001|Overall Study|One provider unable to complete numbers|1|||
150113176|NCT02664038|541550974|FG000|13 Week|Lost to Follow-up|7|||
150113177|NCT02664038|541550975|FG001|13 Week|Lost to Follow-up|14|||
150113178|NCT02664038|541550974|FG000|13 Week|Withdrawal by Subject|1|||
150113179|NCT02664038|541550975|FG001|13 Week|Withdrawal by Subject|0|||
150113180|NCT02664038|541550974|FG000|26 Week|Lost to Follow-up|5|||
150113181|NCT02664038|541550975|FG001|26 Week|Lost to Follow-up|4|||
150113182|NCT04456699|541550981|FG000|Overall Study|Death|48|||
150113183|NCT04456699|541550982|FG001|Overall Study|Death|50|||
150113184|NCT04456699|541550983|FG002|Overall Study|Death|52|||
150113185|NCT04456699|541550981|FG000|Overall Study|Physician Decision|0|||
150113186|NCT04456699|541550982|FG001|Overall Study|Physician Decision|0|||
150113187|NCT04456699|541550983|FG002|Overall Study|Physician Decision|2|||
150113188|NCT04456699|541550981|FG000|Overall Study|Sponsor Decision|55|||
150113189|NCT04456699|541550982|FG001|Overall Study|Sponsor Decision|61|||
150113190|NCT04456699|541550983|FG002|Overall Study|Sponsor Decision|50|||
150113191|NCT04456699|541550981|FG000|Overall Study|Withdrawal by Subject|8|||
150113192|NCT04456699|541550982|FG001|Overall Study|Withdrawal by Subject|4|||
150113193|NCT04456699|541550983|FG002|Overall Study|Withdrawal by Subject|5|||
150113194|NCT02410811|541550990|FG000|Overall Study|Withdrawal by Subject|0|||
150113195|NCT02410811|541550991|FG001|Overall Study|Withdrawal by Subject|0|||
150113196|NCT02410811|541550992|FG002|Overall Study|Withdrawal by Subject|1|||
150113197|NCT02410811|541550993|FG003|Overall Study|Withdrawal by Subject|0|||
150189189|NCT02783300|541831221|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189190|NCT02783300|541831222|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189191|NCT02783300|541831223|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189192|NCT02783300|541831224|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189193|NCT02783300|541831225|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189194|NCT02783300|541831226|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189195|NCT02783300|541831227|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189196|NCT02783300|541831228|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189197|NCT02783300|541831229|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189198|NCT02783300|541831230|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189199|NCT02783300|541831231|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189200|NCT02783300|541831232|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189201|NCT02783300|541831233|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189202|NCT02783300|541831234|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189203|NCT02783300|541831235|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189204|NCT02783300|541831236|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189205|NCT02783300|541831237|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189206|NCT02783300|541831238|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189207|NCT02783300|541831239|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189208|NCT02783300|541831240|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189209|NCT02783300|541831241|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189210|NCT02783300|541831242|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
150189211|NCT02783300|541831243|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
150189212|NCT02783300|541831217|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189213|NCT02783300|541831218|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189214|NCT02783300|541831219|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189215|NCT02783300|541831220|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189216|NCT02783300|541831221|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189217|NCT02783300|541831222|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189218|NCT02783300|541831223|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189219|NCT02783300|541831224|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189220|NCT02783300|541831225|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189221|NCT02783300|541831226|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189222|NCT02783300|541831227|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189223|NCT02783300|541831228|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189224|NCT02783300|541831229|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189225|NCT02783300|541831230|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189226|NCT02783300|541831231|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189227|NCT02783300|541831232|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189228|NCT02783300|541831233|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189229|NCT02783300|541831234|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189230|NCT02783300|541831235|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189231|NCT02783300|541831236|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189232|NCT02783300|541831237|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189233|NCT02783300|541831238|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189234|NCT02783300|541831239|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189235|NCT02783300|541831240|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189236|NCT02783300|541831241|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189237|NCT02783300|541831242|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
150189238|NCT02783300|541831243|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
150189239|NCT05178316|541831250|FG000|Overall Study|Adverse Event|5|||
150189240|NCT05178316|541831251|FG001|Overall Study|Adverse Event|4|||
150189241|NCT05178316|541831252|FG002|Overall Study|Adverse Event|9|||
150189242|NCT05178316|541831250|FG000|Overall Study|Enrolled in Error|1|||
150189243|NCT05178316|541831251|FG001|Overall Study|Enrolled in Error|2|||
150189244|NCT05178316|541831252|FG002|Overall Study|Enrolled in Error|1|||
150189245|NCT05178316|541831250|FG000|Overall Study|Lost to Follow-up|3|||
150189246|NCT05178316|541831251|FG001|Overall Study|Lost to Follow-up|15|||
150189247|NCT05178316|541831252|FG002|Overall Study|Lost to Follow-up|11|||
150189248|NCT05178316|541831250|FG000|Overall Study|Noncompliance|1|||
150189249|NCT05178316|541831251|FG001|Overall Study|Noncompliance|3|||
150189250|NCT05178316|541831252|FG002|Overall Study|Noncompliance|1|||
150189251|NCT05178316|541831250|FG000|Overall Study|Other|0|||
150189252|NCT05178316|541831251|FG001|Overall Study|Other|1|||
150189253|NCT05178316|541831252|FG002|Overall Study|Other|0|||
150189254|NCT05178316|541831250|FG000|Overall Study|Physician Decision|0|||
150189255|NCT05178316|541831251|FG001|Overall Study|Physician Decision|3|||
150189256|NCT05178316|541831252|FG002|Overall Study|Physician Decision|2|||
150113198|NCT01193556|541550994|FG000|Overall Study|Study termination|26|||
150113199|NCT01193556|541550995|FG001|Overall Study|Study termination|25|||
150113200|NCT01482767|541550997|FG000|Overall Study|Death|1|||
150113201|NCT01482767|541550998|FG001|Overall Study|Death|1|||
150113202|NCT01482767|541550997|FG000|Overall Study|Withdrawal by Subject|7|||
150113203|NCT01482767|541550998|FG001|Overall Study|Withdrawal by Subject|5|||
150113204|NCT01482767|541550997|FG000|Overall Study|Lost to Follow-up|12|||
150113205|NCT01482767|541550998|FG001|Overall Study|Lost to Follow-up|6|||
150113206|NCT01482767|541550997|FG000|Overall Study|Adverse Event|0|||
150113207|NCT01482767|541550998|FG001|Overall Study|Adverse Event|3|||
150113208|NCT01482767|541550997|FG000|Overall Study|Site closure|22|||
150113209|NCT01482767|541550998|FG001|Overall Study|Site closure|14|||
150113210|NCT01482767|541550997|FG000|Overall Study|Non-adherence to study requirements|4|||
150113211|NCT01482767|541550998|FG001|Overall Study|Non-adherence to study requirements|7|||
150113212|NCT01482767|541550997|FG000|Overall Study|Alternate HCV treatment|7|||
150113213|NCT01482767|541550998|FG001|Overall Study|Alternate HCV treatment|8|||
150113214|NCT01482767|541550997|FG000|Overall Study|Ineligible|0|||
150113215|NCT01482767|541550998|FG001|Overall Study|Ineligible|5|||
150113216|NCT01482767|541550997|FG000|Overall Study|Nurse error|1|||
150113217|NCT01482767|541550998|FG001|Overall Study|Nurse error|0|||
150113218|NCT02457325|541551012|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
150113219|NCT02457325|541551013|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
150113220|NCT01541930|541551014|FG000|Overall Study|Withdrawal by Subject|1|||
150113221|NCT01957475|541551015|FG000|Test Period 1|Withdrawal by Subject|1|||
150113222|NCT01957475|541551016|FG001|Test Period 1|Withdrawal by Subject|0|||
150113223|NCT01957475|541551015|FG000|Test Period 1|Other|1|||
150113224|NCT01957475|541551016|FG001|Test Period 1|Other|0|||
150113225|NCT01957475|541551015|FG000|Test Period 1|Lack of Efficacy|0|||
150113226|NCT01957475|541551016|FG001|Test Period 1|Lack of Efficacy|1|||
150113227|NCT01957475|541551015|FG000|Test Period 2|Adverse Event|1|||
150113228|NCT01957475|541551016|FG001|Test Period 2|Adverse Event|0|||
150113229|NCT03591575|541551017|FG000|Overall Study|Adverse Event|2|||
150113230|NCT03591575|541551018|FG001|Overall Study|Adverse Event|0|||
150113231|NCT03591575|541551017|FG000|Overall Study|Withdrawal by Subject|4|||
150113232|NCT03591575|541551018|FG001|Overall Study|Withdrawal by Subject|1|||
150113233|NCT00813358|541551021|FG000|Overall Study|Death|32|||
150113234|NCT00813358|541551021|FG000|Overall Study|Lost to Follow-up|12|||
150113235|NCT00813358|541551021|FG000|Overall Study|other endpoints|5|||
150113236|NCT00813358|541551021|FG000|Overall Study|Withdrawal by Subject|20|||
150113237|NCT04497987|541551022|FG000|Overall Study|Adverse Event|1|||
150113238|NCT04497987|541551023|FG001|Overall Study|Adverse Event|0|||
150113239|NCT04497987|541551022|FG000|Overall Study|Death|21|||
150113240|NCT04497987|541551023|FG001|Overall Study|Death|13|||
150113241|NCT04497987|541551022|FG000|Overall Study|Lost to Follow-up|19|||
150113242|NCT04497987|541551023|FG001|Overall Study|Lost to Follow-up|17|||
150113243|NCT04497987|541551022|FG000|Overall Study|Other - as reported by the investigator|22|||
150113244|NCT04497987|541551023|FG001|Overall Study|Other - as reported by the investigator|16|||
150113245|NCT04497987|541551022|FG000|Overall Study|Physician Decision|1|||
150113246|NCT04497987|541551023|FG001|Overall Study|Physician Decision|0|||
150113247|NCT04497987|541551022|FG000|Overall Study|Withdrawal by Subject|35|||
150113248|NCT04497987|541551023|FG001|Overall Study|Withdrawal by Subject|21|||
150113249|NCT03665038|541551024|FG000|Overall Study|Lost to Follow-up|0|||
150113250|NCT03665038|541551025|FG001|Overall Study|Lost to Follow-up|0|||
150113251|NCT03665038|541551026|FG002|Overall Study|Lost to Follow-up|1|||
150113252|NCT01660412|541551027|FG000|Overall Study|Protocol Violation|0|||
150113253|NCT01660412|541551028|FG001|Overall Study|Protocol Violation|3|||
150113254|NCT03551210|541551029|FG000|Overall Study|Adverse Event|5|||
150113255|NCT03551210|541551030|FG001|Overall Study|Adverse Event|6|||
150113256|NCT03551210|541551029|FG000|Overall Study|Withdrawal by Subject|1|||
150113257|NCT03551210|541551030|FG001|Overall Study|Withdrawal by Subject|7|||
150113258|NCT03551210|541551029|FG000|Overall Study|Needed in other antibiotic treatment|2|||
150113259|NCT03551210|541551030|FG001|Overall Study|Needed in other antibiotic treatment|5|||
150113260|NCT03551210|541551029|FG000|Overall Study|Lost to Follow-up|1|||
150113261|NCT03551210|541551030|FG001|Overall Study|Lost to Follow-up|1|||
150113262|NCT03551210|541551029|FG000|Overall Study|Absence of visit 4 and 5|1|||
150113263|NCT03551210|541551030|FG001|Overall Study|Absence of visit 4 and 5|0|||
150113264|NCT03551210|541551029|FG000|Overall Study|No drug for dispensing|0|||
150113265|NCT03551210|541551030|FG001|Overall Study|No drug for dispensing|1|||
150113266|NCT01709318|541552899|FG000|Overall Study|Adverse Event|3|||
150113267|NCT01709318|541552900|FG001|Overall Study|Adverse Event|4|||
150113268|NCT01709318|541552901|FG002|Overall Study|Adverse Event|2|||
150113269|NCT01709318|541552902|FG003|Overall Study|Adverse Event|2|||
150113270|NCT01709318|541552903|FG004|Overall Study|Adverse Event|0|||
150113271|NCT01709318|541552904|FG005|Overall Study|Adverse Event|1|||
150113272|NCT01709318|541552905|FG006|Overall Study|Adverse Event|2|||
150113273|NCT01709318|541552899|FG000|Overall Study|Lost to Follow-up|2|||
150113274|NCT01709318|541552900|FG001|Overall Study|Lost to Follow-up|0|||
150113275|NCT01709318|541552901|FG002|Overall Study|Lost to Follow-up|0|||
150113276|NCT01709318|541552902|FG003|Overall Study|Lost to Follow-up|0|||
150113277|NCT01709318|541552903|FG004|Overall Study|Lost to Follow-up|1|||
150113278|NCT01709318|541552904|FG005|Overall Study|Lost to Follow-up|1|||
150113279|NCT01709318|541552905|FG006|Overall Study|Lost to Follow-up|1|||
150113280|NCT01709318|541552899|FG000|Overall Study|Non-compliance with Study Drug|0|||
150113281|NCT01709318|541552900|FG001|Overall Study|Non-compliance with Study Drug|2|||
150113282|NCT01709318|541552901|FG002|Overall Study|Non-compliance with Study Drug|1|||
150113283|NCT01709318|541552902|FG003|Overall Study|Non-compliance with Study Drug|1|||
150113284|NCT01709318|541552903|FG004|Overall Study|Non-compliance with Study Drug|0|||
150113285|NCT01709318|541552904|FG005|Overall Study|Non-compliance with Study Drug|0|||
150113286|NCT01709318|541552905|FG006|Overall Study|Non-compliance with Study Drug|2|||
150113287|NCT01709318|541552899|FG000|Overall Study|Physician Decision|0|||
150113288|NCT01709318|541552900|FG001|Overall Study|Physician Decision|0|||
150113289|NCT01709318|541552901|FG002|Overall Study|Physician Decision|0|||
150113290|NCT01709318|541552902|FG003|Overall Study|Physician Decision|0|||
150113291|NCT01709318|541552903|FG004|Overall Study|Physician Decision|0|||
150113292|NCT01709318|541552904|FG005|Overall Study|Physician Decision|0|||
150113293|NCT01709318|541552905|FG006|Overall Study|Physician Decision|1|||
150113294|NCT01709318|541552899|FG000|Overall Study|Pregnancy|0|||
150113295|NCT01709318|541552900|FG001|Overall Study|Pregnancy|0|||
150113296|NCT01709318|541552901|FG002|Overall Study|Pregnancy|0|||
150113297|NCT01709318|541552902|FG003|Overall Study|Pregnancy|0|||
150113298|NCT01709318|541552903|FG004|Overall Study|Pregnancy|1|||
150113299|NCT01709318|541552904|FG005|Overall Study|Pregnancy|0|||
150113300|NCT01709318|541552905|FG006|Overall Study|Pregnancy|0|||
150113301|NCT01709318|541552899|FG000|Overall Study|Protocol Violation|0|||
150113302|NCT01709318|541552900|FG001|Overall Study|Protocol Violation|0|||
150113303|NCT01709318|541552901|FG002|Overall Study|Protocol Violation|0|||
150113304|NCT01709318|541552902|FG003|Overall Study|Protocol Violation|0|||
150113305|NCT01709318|541552903|FG004|Overall Study|Protocol Violation|2|||
150113306|NCT01709318|541552904|FG005|Overall Study|Protocol Violation|0|||
150113307|NCT01709318|541552905|FG006|Overall Study|Protocol Violation|1|||
150113308|NCT01709318|541552899|FG000|Overall Study|Technical Problems|1|||
150113309|NCT01709318|541552900|FG001|Overall Study|Technical Problems|0|||
150113310|NCT01709318|541552901|FG002|Overall Study|Technical Problems|0|||
150113311|NCT01709318|541552902|FG003|Overall Study|Technical Problems|0|||
150113312|NCT01709318|541552903|FG004|Overall Study|Technical Problems|0|||
150113313|NCT01709318|541552904|FG005|Overall Study|Technical Problems|0|||
150113314|NCT01709318|541552905|FG006|Overall Study|Technical Problems|0|||
150113315|NCT01709318|541552899|FG000|Overall Study|Withdrawal by Subject|3|||
150113316|NCT01709318|541552900|FG001|Overall Study|Withdrawal by Subject|0|||
150113317|NCT01709318|541552901|FG002|Overall Study|Withdrawal by Subject|3|||
150113318|NCT01709318|541552902|FG003|Overall Study|Withdrawal by Subject|3|||
150113319|NCT01709318|541552903|FG004|Overall Study|Withdrawal by Subject|0|||
150113320|NCT01709318|541552904|FG005|Overall Study|Withdrawal by Subject|2|||
150113321|NCT01709318|541552905|FG006|Overall Study|Withdrawal by Subject|4|||
150113322|NCT01709318|541552899|FG000|Overall Study|Other Protocol Specified Criteria|0|||
150113323|NCT01709318|541552900|FG001|Overall Study|Other Protocol Specified Criteria|1|||
150113324|NCT01709318|541552901|FG002|Overall Study|Other Protocol Specified Criteria|0|||
150113325|NCT01709318|541552902|FG003|Overall Study|Other Protocol Specified Criteria|0|||
150113326|NCT01709318|541552903|FG004|Overall Study|Other Protocol Specified Criteria|0|||
150113327|NCT01709318|541552904|FG005|Overall Study|Other Protocol Specified Criteria|0|||
150113328|NCT01709318|541552905|FG006|Overall Study|Other Protocol Specified Criteria|0|||
150113329|NCT03370341|541552906|FG000|Overall Study|Lost to Follow-up|0|||
150113330|NCT03370341|541552907|FG001|Overall Study|Lost to Follow-up|1|||
150113331|NCT01707004|541552908|FG000|Overall Study|Physician Decision|3|||
150113332|NCT00646958|541552909|FG000|Overall Study|Lack of Efficacy|1|||
150113333|NCT00646958|541552910|FG001|Overall Study|Lack of Efficacy|0|||
150113334|NCT00646958|541552911|FG002|Overall Study|Lack of Efficacy|0|||
150113335|NCT00646958|541552909|FG000|Overall Study|Adverse Event|4|||
150113336|NCT00646958|541552910|FG001|Overall Study|Adverse Event|0|||
150189257|NCT05178316|541831250|FG000|Overall Study|Protocol deviation|1|||
150189258|NCT05178316|541831251|FG001|Overall Study|Protocol deviation|0|||
150189259|NCT05178316|541831252|FG002|Overall Study|Protocol deviation|1|||
150113337|NCT00646958|541552911|FG002|Overall Study|Adverse Event|0|||
150113338|NCT00646958|541552909|FG000|Overall Study|Lost to Follow-up|1|||
150113339|NCT00646958|541552910|FG001|Overall Study|Lost to Follow-up|5|||
150113340|NCT00646958|541552911|FG002|Overall Study|Lost to Follow-up|7|||
150113341|NCT00646958|541552909|FG000|Overall Study|Protocol Violation|1|||
150113342|NCT00646958|541552910|FG001|Overall Study|Protocol Violation|1|||
150113343|NCT00646958|541552911|FG002|Overall Study|Protocol Violation|0|||
150113344|NCT00646958|541552909|FG000|Overall Study|Abnormal screening lab tests|1|||
150113345|NCT00646958|541552910|FG001|Overall Study|Abnormal screening lab tests|1|||
150113346|NCT00646958|541552911|FG002|Overall Study|Abnormal screening lab tests|0|||
150113347|NCT00646958|541552909|FG000|Overall Study|Withdrawal by Subject|1|||
150113348|NCT00646958|541552910|FG001|Overall Study|Withdrawal by Subject|2|||
150113349|NCT00646958|541552911|FG002|Overall Study|Withdrawal by Subject|0|||
150113350|NCT00646958|541552909|FG000|Overall Study|Did not receive study drug|2|||
150113351|NCT00646958|541552910|FG001|Overall Study|Did not receive study drug|0|||
150113352|NCT00646958|541552911|FG002|Overall Study|Did not receive study drug|2|||
150113353|NCT03085927|541552912|FG000|Overall Study|Withdrawal by Subject|1|||
150113354|NCT03085927|541552913|FG001|Overall Study|Withdrawal by Subject|4|||
150113355|NCT03085927|541552912|FG000|Overall Study|Lost to Follow-up|3|||
150113356|NCT03085927|541552913|FG001|Overall Study|Lost to Follow-up|1|||
150113357|NCT03085927|541552912|FG000|Overall Study|Death|1|||
150113358|NCT03085927|541552913|FG001|Overall Study|Death|0|||
150113359|NCT03085927|541552912|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
150113360|NCT03085927|541552913|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
150113361|NCT03085927|541552912|FG000|Overall Study|Dyad Became Ineligible|0|||
150113362|NCT03085927|541552913|FG001|Overall Study|Dyad Became Ineligible|1|||
150113363|NCT00941733|541552914|FG000|Overall Study|Death|24|||
150113364|NCT00941733|541552915|FG001|Overall Study|Death|10|||
150113365|NCT00941733|541552914|FG000|Overall Study|Withdrawal by Subject|14|||
150113366|NCT00941733|541552915|FG001|Overall Study|Withdrawal by Subject|6|||
150113367|NCT00941733|541552914|FG000|Overall Study|Adverse Event|20|||
150113368|NCT00941733|541552915|FG001|Overall Study|Adverse Event|4|||
150113369|NCT00941733|541552914|FG000|Overall Study|Lost to Follow-up|1|||
150113370|NCT00941733|541552915|FG001|Overall Study|Lost to Follow-up|2|||
150113371|NCT00941733|541552914|FG000|Overall Study|Protocol Violation|15|||
150113372|NCT00941733|541552915|FG001|Overall Study|Protocol Violation|6|||
150113373|NCT00194012|541552916|FG000|Randomized Phase|Lack of Efficacy|8|||
150113374|NCT00194012|541552917|FG001|Randomized Phase|Lack of Efficacy|18|||
150113375|NCT00194012|541552916|FG000|Randomized Phase|Study nonadherence|2|||
150113376|NCT00194012|541552917|FG001|Randomized Phase|Study nonadherence|1|||
150113377|NCT00194012|541552916|FG000|Randomized Phase|Withdrawal by Subject|3|||
150113378|NCT00194012|541552917|FG001|Randomized Phase|Withdrawal by Subject|3|||
150113379|NCT00194012|541552916|FG000|Randomized Phase|Adverse Event|2|||
150113380|NCT00194012|541552917|FG001|Randomized Phase|Adverse Event|1|||
150113381|NCT00194012|541552916|FG000|Randomized Phase|Participant reported having a rash|1|||
150113382|NCT00194012|541552917|FG001|Randomized Phase|Participant reported having a rash|0|||
150113383|NCT00194012|541552916|FG000|Randomized Phase|Emesis and enuresis|0|||
150113384|NCT00194012|541552917|FG001|Randomized Phase|Emesis and enuresis|1|||
150113385|NCT00194012|541552916|FG000|Randomized Phase|Oral/nasal twitching|0|||
150113386|NCT00194012|541552917|FG001|Randomized Phase|Oral/nasal twitching|1|||
150113387|NCT00194012|541552916|FG000|Open Label Extension (OLE)|Weight Gain|1|||
150113388|NCT00194012|541552917|FG001|Open Label Extension (OLE)|Weight Gain|0|||
150113389|NCT00194012|541552916|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
150113390|NCT00194012|541552917|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
150113391|NCT00194012|541552916|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
150113392|NCT00194012|541552917|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
150113393|NCT00194012|541552916|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
150113394|NCT00194012|541552917|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
150113395|NCT04260191|541552923|FG000|Overall Study|Decision by Sponsor|0|||
150113396|NCT04260191|541552924|FG001|Overall Study|Decision by Sponsor|1|||
150113397|NCT04260191|541552925|FG002|Overall Study|Decision by Sponsor|0|||
150113398|NCT04260191|541552923|FG000|Overall Study|Withdrawal by Subject|1|||
150113399|NCT04260191|541552924|FG001|Overall Study|Withdrawal by Subject|0|||
150113400|NCT04260191|541552925|FG002|Overall Study|Withdrawal by Subject|3|||
150113401|NCT04260191|541552923|FG000|Overall Study|Death|4|||
150113402|NCT04260191|541552924|FG001|Overall Study|Death|3|||
150113403|NCT04260191|541552925|FG002|Overall Study|Death|2|||
150113404|NCT01643473|541552926|FG000|Overall Study|Lost to Follow-up|1|||
150113405|NCT01643473|541552927|FG001|Overall Study|Lost to Follow-up|0|||
150113406|NCT01519518|541552929|FG000|Overall Study|Consent not available|7|||
150113407|NCT01519518|541552930|FG001|Overall Study|Consent not available|10|||
150113408|NCT02033889|541552931|FG000|Overall Study|Adverse Event|3|||
150113409|NCT02033889|541552932|FG001|Overall Study|Adverse Event|1|||
150113410|NCT02033889|541552933|FG002|Overall Study|Adverse Event|3|||
150113411|NCT02033889|541552931|FG000|Overall Study|Death|3|||
150113412|NCT02033889|541552932|FG001|Overall Study|Death|1|||
150113413|NCT02033889|541552933|FG002|Overall Study|Death|2|||
150113414|NCT02033889|541552931|FG000|Overall Study|Excluded Medication|1|||
150113415|NCT02033889|541552932|FG001|Overall Study|Excluded Medication|1|||
150113416|NCT02033889|541552933|FG002|Overall Study|Excluded Medication|0|||
150113417|NCT02033889|541552931|FG000|Overall Study|Lost to Follow-up|8|||
150113418|NCT02033889|541552932|FG001|Overall Study|Lost to Follow-up|5|||
150113419|NCT02033889|541552933|FG002|Overall Study|Lost to Follow-up|6|||
150113420|NCT02033889|541552931|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150113421|NCT02033889|541552932|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150113422|NCT02033889|541552933|FG002|Overall Study|Non-Compliance With Study Drug|0|||
150113423|NCT02033889|541552931|FG000|Overall Study|Physician Decision|0|||
150189260|NCT05178316|541831250|FG000|Overall Study|Sponsor decision|1|||
150189261|NCT05178316|541831251|FG001|Overall Study|Sponsor decision|0|||
150189262|NCT05178316|541831252|FG002|Overall Study|Sponsor decision|1|||
150189263|NCT05178316|541831250|FG000|Overall Study|Withdrawal by Subject|5|||
150189264|NCT05178316|541831251|FG001|Overall Study|Withdrawal by Subject|11|||
150189265|NCT05178316|541831252|FG002|Overall Study|Withdrawal by Subject|5|||
150189266|NCT03770273|541831253|FG000|Overall Study|Adverse Event|2|||
150189267|NCT03770273|541831254|FG001|Overall Study|Adverse Event|0|||
150189268|NCT03770273|541831253|FG000|Overall Study|Lost to Follow-up|1|||
150189269|NCT03770273|541831254|FG001|Overall Study|Lost to Follow-up|1|||
150189270|NCT00418886|541831255|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
150189271|NCT00418886|541831256|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
150189272|NCT00418886|541831255|FG000|Randomized Period|Death|122|||
150113424|NCT02033889|541552932|FG001|Overall Study|Physician Decision|1|||
150113425|NCT02033889|541552933|FG002|Overall Study|Physician Decision|1|||
150113426|NCT02033889|541552931|FG000|Overall Study|Participant moved|0|||
150113427|NCT02033889|541552932|FG001|Overall Study|Participant moved|1|||
150113428|NCT02033889|541552933|FG002|Overall Study|Participant moved|0|||
150113429|NCT02033889|541552931|FG000|Overall Study|Withdrawal by Subject|18|||
150113430|NCT02033889|541552932|FG001|Overall Study|Withdrawal by Subject|10|||
150113431|NCT02033889|541552933|FG002|Overall Study|Withdrawal by Subject|13|||
150113432|NCT03019536|541552934|FG000|Overall Study|Withdrawal by Subject|1|||
150113433|NCT03019536|541552935|FG001|Overall Study|Withdrawal by Subject|1|||
150113434|NCT03019536|541552936|FG002|Overall Study|Withdrawal by Subject|0|||
150113435|NCT03019536|541552934|FG000|Overall Study|Adverse Event|0|||
150113436|NCT03019536|541552935|FG001|Overall Study|Adverse Event|0|||
150113437|NCT03019536|541552936|FG002|Overall Study|Adverse Event|2|||
150113438|NCT01312909|541552937|FG000|Overall Study|Randomized but not treated|1|||
150113439|NCT01312909|541552938|FG001|Overall Study|Randomized but not treated|3|||
150113440|NCT01312909|541552939|FG002|Overall Study|Randomized but not treated|1|||
150113441|NCT01312909|541552937|FG000|Overall Study|Adverse Event|1|||
150113442|NCT01312909|541552938|FG001|Overall Study|Adverse Event|0|||
150113443|NCT01312909|541552939|FG002|Overall Study|Adverse Event|3|||
150113444|NCT01312909|541552937|FG000|Overall Study|Protocol Violation|2|||
150113445|NCT01312909|541552938|FG001|Overall Study|Protocol Violation|0|||
150113446|NCT01312909|541552939|FG002|Overall Study|Protocol Violation|2|||
150113447|NCT01312909|541552937|FG000|Overall Study|Other|9|||
150113448|NCT01312909|541552938|FG001|Overall Study|Other|6|||
150113449|NCT01312909|541552939|FG002|Overall Study|Other|11|||
150113450|NCT01312909|541552937|FG000|Overall Study|Withdrawal by Subject|8|||
150113451|NCT01312909|541552938|FG001|Overall Study|Withdrawal by Subject|10|||
150113452|NCT01312909|541552939|FG002|Overall Study|Withdrawal by Subject|7|||
150113453|NCT01312909|541552937|FG000|Overall Study|Lost to Follow-up|21|||
150113454|NCT01312909|541552938|FG001|Overall Study|Lost to Follow-up|17|||
150113455|NCT01312909|541552939|FG002|Overall Study|Lost to Follow-up|20|||
150113456|NCT01312909|541552937|FG000|Overall Study|Insufficient clinical response|0|||
150113457|NCT01312909|541552938|FG001|Overall Study|Insufficient clinical response|0|||
150113458|NCT01312909|541552939|FG002|Overall Study|Insufficient clinical response|1|||
150113459|NCT01312909|541552937|FG000|Overall Study|Entrance criteria not met|0|||
150113460|NCT01312909|541552938|FG001|Overall Study|Entrance criteria not met|0|||
150113461|NCT01312909|541552939|FG002|Overall Study|Entrance criteria not met|2|||
150113462|NCT02200042|541552942|FG000|Overall Study|Withdrawal by Subject|0|||
150113463|NCT02200042|541552943|FG001|Overall Study|Withdrawal by Subject|1|||
150113464|NCT02880371|541552944|FG000|Phase 1b|Lost to Follow-up|1|||
150113465|NCT02880371|541552945|FG001|Phase 1b|Lost to Follow-up|0|||
150189273|NCT00418886|541831256|FG001|Randomized Period|Death|147|||
150113466|NCT02880371|541552946|FG002|Phase 1b|Lost to Follow-up|0|||
150113467|NCT02880371|541552947|FG003|Phase 1b|Lost to Follow-up|0|||
150113468|NCT02880371|541552948|FG004|Phase 1b|Lost to Follow-up|0|||
150189274|NCT00418886|541831255|FG000|Randomized Period|Withdrawal by Subject|9|||
150189275|NCT00418886|541831256|FG001|Randomized Period|Withdrawal by Subject|10|||
150189276|NCT00418886|541831255|FG000|Randomized Period|Lost to Follow-up|4|||
150189277|NCT00418886|541831256|FG001|Randomized Period|Lost to Follow-up|6|||
150113469|NCT02880371|541552949|FG005|Phase 1b|Lost to Follow-up|0|||
150113470|NCT02880371|541552950|FG006|Phase 1b|Lost to Follow-up|0|||
150113471|NCT02880371|541552951|FG007|Phase 1b|Lost to Follow-up|0|||
150189278|NCT00418886|541831255|FG000|Randomized Period|withdrawn due to other reason|1|||
150189279|NCT00418886|541831256|FG001|Randomized Period|withdrawn due to other reason|0|||
150189280|NCT00418886|541831255|FG000|Randomized Period|randomised but no treatment received|0|||
150113472|NCT02880371|541552944|FG000|Phase 1b|Participants terminated by Sponsor|1|||
150113473|NCT02880371|541552945|FG001|Phase 1b|Participants terminated by Sponsor|0|||
150113474|NCT02880371|541552946|FG002|Phase 1b|Participants terminated by Sponsor|0|||
150113475|NCT02880371|541552947|FG003|Phase 1b|Participants terminated by Sponsor|0|||
150113476|NCT02880371|541552948|FG004|Phase 1b|Participants terminated by Sponsor|0|||
150189281|NCT00418886|541831256|FG001|Randomized Period|randomised but no treatment received|1|||
150189282|NCT04060654|541831257|FG000|Overall Study|Withdrawal by Subject|1|||
150189283|NCT04060654|541831257|FG000|Overall Study|Lost to Follow-up|5|||
150189284|NCT03707951|541831258|FG000|Overall Study|Lost to Follow-up|8|||
150189285|NCT03707951|541831259|FG001|Overall Study|Lost to Follow-up|17|||
150189286|NCT03707951|541831258|FG000|Overall Study|Withdrawal by Subject|6|||
150189287|NCT03707951|541831259|FG001|Overall Study|Withdrawal by Subject|6|||
150189288|NCT04533347|541831260|FG000|Overall Study|Adverse Event|1|||
150189289|NCT04533347|541831261|FG001|Overall Study|Adverse Event|2|||
150189290|NCT04533347|541831260|FG000|Overall Study|Lost to Follow-up|2|||
150189291|NCT04533347|541831261|FG001|Overall Study|Lost to Follow-up|0|||
150189292|NCT04533347|541831260|FG000|Overall Study|Withdrawal by Subject|1|||
150189293|NCT04533347|541831261|FG001|Overall Study|Withdrawal by Subject|0|||
150189294|NCT03907397|541831264|FG000|Overall Study|Lost to Follow-up|0|||
150189295|NCT03907397|541831265|FG001|Overall Study|Lost to Follow-up|1|||
150189296|NCT03907397|541831264|FG000|Overall Study|Physician Decision|2|||
150189297|NCT03907397|541831265|FG001|Overall Study|Physician Decision|1|||
150189298|NCT03907397|541831264|FG000|Overall Study|Withdrawal by Subject|5|||
150189299|NCT03907397|541831265|FG001|Overall Study|Withdrawal by Subject|4|||
150189300|NCT03907397|541831264|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
150189301|NCT03907397|541831265|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
150189302|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
150189303|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
150189304|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
150189305|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
150189306|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
150189307|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
150189308|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
150189309|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
150189310|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
150189311|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
150189312|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
150189313|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
150189314|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
150189315|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
150189316|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
150189317|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
150189318|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
150189319|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
150189320|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
150189321|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
150189322|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
150189323|NCT05369403|541831266|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
150189324|NCT05369403|541831267|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
150113477|NCT02880371|541552949|FG005|Phase 1b|Participants terminated by Sponsor|0|||
150113478|NCT02880371|541552950|FG006|Phase 1b|Participants terminated by Sponsor|0|||
150113479|NCT02880371|541552951|FG007|Phase 1b|Participants terminated by Sponsor|0|||
150113480|NCT02880371|541552944|FG000|Phase 1b|Withdrawal by Subject|0|||
150113481|NCT02880371|541552945|FG001|Phase 1b|Withdrawal by Subject|0|||
150113482|NCT02880371|541552946|FG002|Phase 1b|Withdrawal by Subject|1|||
150113483|NCT02880371|541552947|FG003|Phase 1b|Withdrawal by Subject|0|||
150113484|NCT02880371|541552948|FG004|Phase 1b|Withdrawal by Subject|0|||
150113485|NCT02880371|541552949|FG005|Phase 1b|Withdrawal by Subject|0|||
150113486|NCT02880371|541552950|FG006|Phase 1b|Withdrawal by Subject|0|||
150113487|NCT02880371|541552951|FG007|Phase 1b|Withdrawal by Subject|0|||
150113488|NCT02880371|541552944|FG000|Phase 1b|Death|4|||
150113489|NCT02880371|541552945|FG001|Phase 1b|Death|6|||
150189325|NCT05369403|541831268|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
150189326|NCT05369403|541831266|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
150189327|NCT05369403|541831267|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
150189328|NCT05369403|541831268|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
150113490|NCT02880371|541552946|FG002|Phase 1b|Death|5|||
150113491|NCT02880371|541552947|FG003|Phase 1b|Death|1|||
150189329|NCT05369403|541831266|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
150189330|NCT05369403|541831267|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
150189331|NCT05369403|541831268|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
150189332|NCT05369403|541831266|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
150113492|NCT02880371|541552948|FG004|Phase 1b|Death|0|||
150113493|NCT02880371|541552949|FG005|Phase 1b|Death|0|||
150113494|NCT02880371|541552950|FG006|Phase 1b|Death|0|||
150113495|NCT02880371|541552951|FG007|Phase 1b|Death|0|||
150113496|NCT02880371|541552944|FG000|Phase 1b|Enrolled but not Treated|0|||
150113497|NCT02880371|541552945|FG001|Phase 1b|Enrolled but not Treated|1|||
150113498|NCT02880371|541552946|FG002|Phase 1b|Enrolled but not Treated|0|||
150113499|NCT02880371|541552947|FG003|Phase 1b|Enrolled but not Treated|0|||
150113500|NCT02880371|541552948|FG004|Phase 1b|Enrolled but not Treated|0|||
150113501|NCT02880371|541552949|FG005|Phase 1b|Enrolled but not Treated|0|||
150113502|NCT02880371|541552950|FG006|Phase 1b|Enrolled but not Treated|0|||
150113503|NCT02880371|541552951|FG007|Phase 1b|Enrolled but not Treated|0|||
150113504|NCT02880371|541552944|FG000|Phase 2|Enrolled but not Treated|0|||
150113505|NCT02880371|541552945|FG001|Phase 2|Enrolled but not Treated|0|||
150113506|NCT02880371|541552946|FG002|Phase 2|Enrolled but not Treated|0|||
150113507|NCT02880371|541552947|FG003|Phase 2|Enrolled but not Treated|0|||
150113508|NCT02880371|541552948|FG004|Phase 2|Enrolled but not Treated|0|||
150113509|NCT02880371|541552949|FG005|Phase 2|Enrolled but not Treated|1|||
150113510|NCT02880371|541552950|FG006|Phase 2|Enrolled but not Treated|1|||
150113511|NCT02880371|541552951|FG007|Phase 2|Enrolled but not Treated|0|||
150113512|NCT02880371|541552944|FG000|Phase 2|Other|0|||
150113513|NCT02880371|541552945|FG001|Phase 2|Other|0|||
150113514|NCT02880371|541552946|FG002|Phase 2|Other|0|||
150113515|NCT02880371|541552947|FG003|Phase 2|Other|0|||
150113516|NCT02880371|541552948|FG004|Phase 2|Other|0|||
150113517|NCT02880371|541552949|FG005|Phase 2|Other|1|||
150113518|NCT02880371|541552950|FG006|Phase 2|Other|2|||
150113519|NCT02880371|541552951|FG007|Phase 2|Other|1|||
150113520|NCT02880371|541552944|FG000|Phase 2|Participants terminated by Sponsor|0|||
150113521|NCT02880371|541552945|FG001|Phase 2|Participants terminated by Sponsor|0|||
150113522|NCT02880371|541552946|FG002|Phase 2|Participants terminated by Sponsor|0|||
150113523|NCT02880371|541552947|FG003|Phase 2|Participants terminated by Sponsor|0|||
150113524|NCT02880371|541552948|FG004|Phase 2|Participants terminated by Sponsor|1|||
150113525|NCT02880371|541552949|FG005|Phase 2|Participants terminated by Sponsor|6|||
150113526|NCT02880371|541552950|FG006|Phase 2|Participants terminated by Sponsor|1|||
150113527|NCT02880371|541552951|FG007|Phase 2|Participants terminated by Sponsor|5|||
150113528|NCT02880371|541552944|FG000|Phase 2|Death|0|||
150113529|NCT02880371|541552945|FG001|Phase 2|Death|0|||
150113530|NCT02880371|541552946|FG002|Phase 2|Death|0|||
150113531|NCT02880371|541552947|FG003|Phase 2|Death|0|||
150113532|NCT02880371|541552948|FG004|Phase 2|Death|1|||
150113533|NCT02880371|541552949|FG005|Phase 2|Death|10|||
150113534|NCT02880371|541552950|FG006|Phase 2|Death|20|||
150113535|NCT02880371|541552951|FG007|Phase 2|Death|5|||
150113536|NCT02880371|541552944|FG000|Phase 2|Lost to Follow-up|0|||
150113537|NCT02880371|541552945|FG001|Phase 2|Lost to Follow-up|0|||
150113538|NCT02880371|541552946|FG002|Phase 2|Lost to Follow-up|0|||
150113539|NCT02880371|541552947|FG003|Phase 2|Lost to Follow-up|0|||
150113540|NCT02880371|541552948|FG004|Phase 2|Lost to Follow-up|0|||
150113541|NCT02880371|541552949|FG005|Phase 2|Lost to Follow-up|0|||
150113542|NCT02880371|541552950|FG006|Phase 2|Lost to Follow-up|3|||
150113543|NCT02880371|541552951|FG007|Phase 2|Lost to Follow-up|0|||
150113544|NCT02880371|541552944|FG000|Phase 2|Withdrawal by Subject|0|||
150113545|NCT02880371|541552945|FG001|Phase 2|Withdrawal by Subject|0|||
150113546|NCT02880371|541552946|FG002|Phase 2|Withdrawal by Subject|0|||
150113547|NCT02880371|541552947|FG003|Phase 2|Withdrawal by Subject|0|||
150113548|NCT02880371|541552948|FG004|Phase 2|Withdrawal by Subject|0|||
150113549|NCT02880371|541552949|FG005|Phase 2|Withdrawal by Subject|1|||
150113550|NCT02880371|541552950|FG006|Phase 2|Withdrawal by Subject|1|||
150113551|NCT02880371|541552951|FG007|Phase 2|Withdrawal by Subject|0|||
150113552|NCT02880371|541552944|FG000|Phase 2|End of Study page not completed by error|0|||
150113553|NCT02880371|541552945|FG001|Phase 2|End of Study page not completed by error|0|||
150113554|NCT02880371|541552946|FG002|Phase 2|End of Study page not completed by error|0|||
150113555|NCT02880371|541552947|FG003|Phase 2|End of Study page not completed by error|0|||
150113556|NCT02880371|541552948|FG004|Phase 2|End of Study page not completed by error|0|||
150113557|NCT02880371|541552949|FG005|Phase 2|End of Study page not completed by error|1|||
150113558|NCT02880371|541552950|FG006|Phase 2|End of Study page not completed by error|0|||
150113559|NCT02880371|541552951|FG007|Phase 2|End of Study page not completed by error|0|||
150113560|NCT03394391|541552952|FG000|Overall Study|Lost to Follow-up|1|||
150113561|NCT03394391|541552953|FG001|Overall Study|Lost to Follow-up|2|||
150113562|NCT04622254|541552954|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
150113563|NCT04622254|541552955|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
150113564|NCT04622254|541552956|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
150113565|NCT04622254|541552957|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
150113566|NCT04622254|541552958|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
150113567|NCT04622254|541552959|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
150113568|NCT04622254|541552954|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
150113569|NCT04622254|541552955|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
150113570|NCT04622254|541552956|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
150113571|NCT04622254|541552957|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
150113572|NCT04622254|541552958|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
150113573|NCT04622254|541552959|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
150113574|NCT04622254|541552954|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
150113575|NCT04622254|541552955|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
150113576|NCT04622254|541552956|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
150113577|NCT04622254|541552957|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
150113578|NCT04622254|541552958|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
150113579|NCT04622254|541552959|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
150113580|NCT04622254|541552954|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
150113581|NCT04622254|541552955|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
150113582|NCT04622254|541552956|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
150113583|NCT04622254|541552957|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
150113584|NCT04622254|541552958|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
150113585|NCT04622254|541552959|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
150113586|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
150113587|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
150113588|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
150113589|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
150113590|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
150113591|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
150113592|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
150113593|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
150113594|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
150113595|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
150113596|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
150113597|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
150113598|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
150113599|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
150113600|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
150113601|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
150113602|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
150113603|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
150113604|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
150113605|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
150113606|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
150113607|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
150113608|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
150113609|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
150113610|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
150113611|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
150113612|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
150113613|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
150113614|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
150113615|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
150113616|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
150113617|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
150113618|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
150113619|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
150113620|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
150113621|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
150113622|NCT04622254|541552954|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
150113623|NCT04622254|541552955|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
150113624|NCT04622254|541552956|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
150113625|NCT04622254|541552957|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
150113626|NCT04622254|541552958|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
150113627|NCT04622254|541552959|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
150113628|NCT00451282|541552962|FG000|Overall Study|Lost to Follow-up|6|||
150113629|NCT00451282|541552963|FG001|Overall Study|Lost to Follow-up|5|||
150113630|NCT00098839|541552964|FG000|Overall Study|Adverse Event|5|||
150113631|NCT00098839|541552965|FG001|Overall Study|Adverse Event|2|||
150113632|NCT00098839|541552964|FG000|Overall Study|Death|1|||
150113633|NCT00098839|541552965|FG001|Overall Study|Death|2|||
150113634|NCT00098839|541552964|FG000|Overall Study|Physician Decision|4|||
150113635|NCT00098839|541552965|FG001|Overall Study|Physician Decision|14|||
150113636|NCT00098839|541552964|FG000|Overall Study|Withdrawal by Subject|1|||
150113637|NCT00098839|541552965|FG001|Overall Study|Withdrawal by Subject|0|||
150113638|NCT00098839|541552964|FG000|Overall Study|Refusal of further protocol therapy|3|||
150113639|NCT00098839|541552965|FG001|Overall Study|Refusal of further protocol therapy|1|||
150113640|NCT00098839|541552964|FG000|Overall Study|Relapse|6|||
150113641|NCT00098839|541552965|FG001|Overall Study|Relapse|3|||
150113642|NCT00098839|541552964|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
150113643|NCT00098839|541552965|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
150113644|NCT00098839|541552964|FG000|Overall Study|Ineligible|2|||
150189333|NCT05369403|541831267|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
150189334|NCT05369403|541831268|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
150189335|NCT03792256|541831273|FG000|Overall Study|Death|0|||
150189336|NCT03792256|541831274|FG001|Overall Study|Death|1|||
150189337|NCT03792256|541831273|FG000|Overall Study|Lack of Efficacy|0|||
150189338|NCT03792256|541831274|FG001|Overall Study|Lack of Efficacy|1|||
150189339|NCT03792256|541831273|FG000|Overall Study|Withdrawal by Subject|0|||
150189340|NCT03792256|541831274|FG001|Overall Study|Withdrawal by Subject|1|||
150189341|NCT04760678|541831275|FG000|Overall Study|Death|13|||
150189342|NCT04760678|541831275|FG000|Overall Study|Lost to Follow-up|48|||
150189343|NCT04760678|541831275|FG000|Overall Study|Withdrawal by Subject|1|||
150189344|NCT05368103|541831276|FG000|Overall Study|Withdrawal by Subject|4|||
150189345|NCT05368103|541831276|FG000|Overall Study|Lost to Follow-up|1|||
150189346|NCT05368103|541831276|FG000|Overall Study|Lack of Efficacy|3|||
150189347|NCT03675282|541831279|FG000|Overall Study|Lost to Follow-up|4|||
150189348|NCT03675282|541831280|FG001|Overall Study|Lost to Follow-up|8|||
150189349|NCT03675282|541831281|FG002|Overall Study|Lost to Follow-up|1|||
150189350|NCT03675282|541831282|FG003|Overall Study|Lost to Follow-up|0|||
150189351|NCT03675282|541831283|FG004|Overall Study|Lost to Follow-up|2|||
150189352|NCT03675282|541831284|FG005|Overall Study|Lost to Follow-up|7|||
150189353|NCT03675282|541831279|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
150189354|NCT03675282|541831280|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
150189355|NCT03675282|541831281|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
150189356|NCT03675282|541831282|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
150189357|NCT03675282|541831283|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
150189358|NCT03675282|541831284|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
150189359|NCT03675282|541831279|FG000|Overall Study|Physician Decision|1|||
150189360|NCT03675282|541831280|FG001|Overall Study|Physician Decision|0|||
150189361|NCT03675282|541831281|FG002|Overall Study|Physician Decision|0|||
150189362|NCT03675282|541831282|FG003|Overall Study|Physician Decision|0|||
150189363|NCT03675282|541831283|FG004|Overall Study|Physician Decision|0|||
150189364|NCT03675282|541831284|FG005|Overall Study|Physician Decision|0|||
150189365|NCT05784662|541831285|FG000|Overall Study|Lost to Follow-up|21|||
150189366|NCT05784662|541831286|FG001|Overall Study|Lost to Follow-up|17|||
150189367|NCT03611621|541831287|FG000|Overall Study|Graft loss|3|||
150189368|NCT03611621|541831287|FG000|Overall Study|Death|3|||
150189369|NCT03611621|541831287|FG000|Overall Study|Lost to Follow-up|1|||
150189370|NCT05177848|541831292|FG000|Overall Study|Lost to Follow-up|1|||
150189371|NCT05177848|541831293|FG001|Overall Study|Lost to Follow-up|4|||
150189372|NCT05177848|541831292|FG000|Overall Study|Discontinued|2|||
150189373|NCT05177848|541831293|FG001|Overall Study|Discontinued|1|||
150189374|NCT03396926|541831295|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
150189375|NCT03396926|541831296|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
150189376|NCT02035787|541831297|FG000|Overall Study- 12 Months|Adverse Event|3|||
150189377|NCT02035787|541831298|FG001|Overall Study- 12 Months|Adverse Event|0|||
150189378|NCT02035787|541831297|FG000|Overall Study- 12 Months|Complete response|4|||
150189379|NCT02035787|541831298|FG001|Overall Study- 12 Months|Complete response|1|||
150189380|NCT02035787|541831297|FG000|Overall Study- 12 Months|Protocol Violation|1|||
150189381|NCT02035787|541831298|FG001|Overall Study- 12 Months|Protocol Violation|1|||
150189382|NCT06414213|541831299|FG000|Overall Study|Lost to Follow-up|1|||
150189383|NCT06414213|541831300|FG001|Overall Study|Lost to Follow-up|1|||
150189384|NCT06414213|541831301|FG002|Overall Study|Lost to Follow-up|3|||
150189385|NCT01997840|541831304|FG000|Overall Study|Lost to Follow-up|0|||
150189386|NCT01997840|541831305|FG001|Overall Study|Lost to Follow-up|0|||
150189387|NCT01997840|541831306|FG002|Overall Study|Lost to Follow-up|1|||
150189388|NCT01997840|541831307|FG003|Overall Study|Lost to Follow-up|0|||
150189389|NCT01997840|541831304|FG000|Overall Study|Withdrawal by participant|0|||
150189390|NCT01997840|541831305|FG001|Overall Study|Withdrawal by participant|0|||
150189391|NCT01997840|541831306|FG002|Overall Study|Withdrawal by participant|8|||
150189392|NCT01997840|541831307|FG003|Overall Study|Withdrawal by participant|1|||
150189393|NCT01997840|541831304|FG000|Overall Study|Physician Decision|0|||
150189394|NCT01997840|541831305|FG001|Overall Study|Physician Decision|0|||
150189395|NCT01997840|541831306|FG002|Overall Study|Physician Decision|3|||
150189396|NCT01997840|541831307|FG003|Overall Study|Physician Decision|0|||
150189397|NCT01997840|541831304|FG000|Overall Study|Progressive disease|3|||
150189398|NCT01997840|541831305|FG001|Overall Study|Progressive disease|4|||
150189399|NCT01997840|541831306|FG002|Overall Study|Progressive disease|57|||
150189400|NCT01997840|541831307|FG003|Overall Study|Progressive disease|8|||
150189401|NCT01997840|541831304|FG000|Overall Study|Other reasons|0|||
150189402|NCT01997840|541831305|FG001|Overall Study|Other reasons|0|||
150189403|NCT01997840|541831306|FG002|Overall Study|Other reasons|1|||
150189404|NCT01997840|541831307|FG003|Overall Study|Other reasons|0|||
150189405|NCT01997840|541831304|FG000|Overall Study|Adverse Event|0|||
150189406|NCT01997840|541831305|FG001|Overall Study|Adverse Event|0|||
150189407|NCT01997840|541831306|FG002|Overall Study|Adverse Event|15|||
150189408|NCT01997840|541831307|FG003|Overall Study|Adverse Event|2|||
150189409|NCT05486078|541831312|FG000|Overall Study|4 drop out and one withdrawn|5|||
150189410|NCT03150810|541831318|FG000|Overall Study|Death|4|||
150189411|NCT03150810|541831319|FG001|Overall Study|Death|8|||
150189412|NCT03150810|541831320|FG002|Overall Study|Death|7|||
150189413|NCT03150810|541831321|FG003|Overall Study|Death|2|||
150189414|NCT03150810|541831322|FG004|Overall Study|Death|2|||
150189415|NCT03150810|541831323|FG005|Overall Study|Death|10|||
150189416|NCT03150810|541831324|FG006|Overall Study|Death|8|||
150189417|NCT03150810|541831325|FG007|Overall Study|Death|6|||
150189418|NCT03150810|541831326|FG008|Overall Study|Death|18|||
150189419|NCT03150810|541831327|FG009|Overall Study|Death|3|||
150189420|NCT03150810|541831328|FG010|Overall Study|Death|19|||
150189421|NCT03150810|541831329|FG011|Overall Study|Death|1|||
150189422|NCT03150810|541831330|FG012|Overall Study|Death|19|||
150189423|NCT03150810|541831318|FG000|Overall Study|Withdrawal by Subject|0|||
150189424|NCT03150810|541831319|FG001|Overall Study|Withdrawal by Subject|1|||
150189425|NCT03150810|541831320|FG002|Overall Study|Withdrawal by Subject|1|||
150189426|NCT03150810|541831321|FG003|Overall Study|Withdrawal by Subject|1|||
150189427|NCT03150810|541831322|FG004|Overall Study|Withdrawal by Subject|0|||
150189428|NCT03150810|541831323|FG005|Overall Study|Withdrawal by Subject|0|||
150189429|NCT03150810|541831324|FG006|Overall Study|Withdrawal by Subject|2|||
150189430|NCT03150810|541831325|FG007|Overall Study|Withdrawal by Subject|0|||
150189431|NCT03150810|541831326|FG008|Overall Study|Withdrawal by Subject|2|||
150189432|NCT03150810|541831327|FG009|Overall Study|Withdrawal by Subject|0|||
150189433|NCT03150810|541831328|FG010|Overall Study|Withdrawal by Subject|1|||
150189434|NCT03150810|541831329|FG011|Overall Study|Withdrawal by Subject|0|||
150189435|NCT03150810|541831330|FG012|Overall Study|Withdrawal by Subject|1|||
150189436|NCT03150810|541831318|FG000|Overall Study|Sponsor Decision|0|||
150189437|NCT03150810|541831319|FG001|Overall Study|Sponsor Decision|2|||
150113645|NCT00098839|541552965|FG001|Overall Study|Ineligible|0|||
150113646|NCT03228680|541552967|FG000|Overall Study|Adverse Event|13|||
150113647|NCT03228680|541552968|FG001|Overall Study|Adverse Event|18|||
150113648|NCT03228680|541552967|FG000|Overall Study|Randomization failure|0|||
150113649|NCT03228680|541552968|FG001|Overall Study|Randomization failure|1|||
150113650|NCT03228680|541552967|FG000|Overall Study|Withdrawal by Subject|1|||
150113651|NCT03228680|541552968|FG001|Overall Study|Withdrawal by Subject|0|||
150113652|NCT03228680|541552967|FG000|Overall Study|Other|9|||
150113653|NCT03228680|541552968|FG001|Overall Study|Other|16|||
150113654|NCT02167035|541552969|FG000|Overall Study|Adverse Event|2|||
150113655|NCT02167035|541552970|FG001|Overall Study|Adverse Event|2|||
150189438|NCT03150810|541831320|FG002|Overall Study|Sponsor Decision|0|||
150189439|NCT03150810|541831321|FG003|Overall Study|Sponsor Decision|0|||
150189440|NCT03150810|541831322|FG004|Overall Study|Sponsor Decision|1|||
150189441|NCT03150810|541831323|FG005|Overall Study|Sponsor Decision|1|||
150189442|NCT03150810|541831324|FG006|Overall Study|Sponsor Decision|0|||
150189443|NCT03150810|541831325|FG007|Overall Study|Sponsor Decision|0|||
150189444|NCT03150810|541831326|FG008|Overall Study|Sponsor Decision|1|||
150189445|NCT03150810|541831327|FG009|Overall Study|Sponsor Decision|0|||
150189446|NCT03150810|541831328|FG010|Overall Study|Sponsor Decision|0|||
150189447|NCT03150810|541831329|FG011|Overall Study|Sponsor Decision|0|||
150189448|NCT03150810|541831330|FG012|Overall Study|Sponsor Decision|5|||
150189449|NCT03150810|541831318|FG000|Overall Study|Lost to Follow-up|0|||
150189450|NCT03150810|541831319|FG001|Overall Study|Lost to Follow-up|1|||
150189451|NCT03150810|541831320|FG002|Overall Study|Lost to Follow-up|1|||
150189452|NCT03150810|541831321|FG003|Overall Study|Lost to Follow-up|0|||
150189453|NCT03150810|541831322|FG004|Overall Study|Lost to Follow-up|0|||
150189454|NCT03150810|541831323|FG005|Overall Study|Lost to Follow-up|0|||
150189455|NCT03150810|541831324|FG006|Overall Study|Lost to Follow-up|1|||
150189456|NCT03150810|541831325|FG007|Overall Study|Lost to Follow-up|0|||
150113656|NCT02167035|541552969|FG000|Overall Study|Lost to Follow-up|3|||
150113657|NCT02167035|541552970|FG001|Overall Study|Lost to Follow-up|3|||
150113658|NCT02167035|541552969|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
150113659|NCT02167035|541552970|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
150189457|NCT03150810|541831326|FG008|Overall Study|Lost to Follow-up|0|||
150189458|NCT03150810|541831327|FG009|Overall Study|Lost to Follow-up|0|||
150189459|NCT03150810|541831328|FG010|Overall Study|Lost to Follow-up|1|||
150189460|NCT03150810|541831329|FG011|Overall Study|Lost to Follow-up|0|||
150189461|NCT03150810|541831330|FG012|Overall Study|Lost to Follow-up|0|||
150113660|NCT02148003|541552971|FG000|Overall Study|Failed inclusion criteria|1|||
150189462|NCT03150810|541831318|FG000|Overall Study|Physician Decision|0|||
150113661|NCT02148003|541552972|FG001|Overall Study|Failed inclusion criteria|0|||
150113662|NCT02148003|541552971|FG000|Overall Study|Met exclusion criteria|0|||
150113663|NCT02148003|541552972|FG001|Overall Study|Met exclusion criteria|1|||
150189463|NCT03150810|541831319|FG001|Overall Study|Physician Decision|0|||
150113664|NCT02148003|541552971|FG000|Overall Study|Withdrawal by Subject|0|||
150113665|NCT02148003|541552972|FG001|Overall Study|Withdrawal by Subject|1|||
150189464|NCT03150810|541831320|FG002|Overall Study|Physician Decision|0|||
150189465|NCT03150810|541831321|FG003|Overall Study|Physician Decision|0|||
150189466|NCT03150810|541831322|FG004|Overall Study|Physician Decision|0|||
150189467|NCT03150810|541831323|FG005|Overall Study|Physician Decision|1|||
150189468|NCT03150810|541831324|FG006|Overall Study|Physician Decision|1|||
150189469|NCT03150810|541831325|FG007|Overall Study|Physician Decision|0|||
150189470|NCT03150810|541831326|FG008|Overall Study|Physician Decision|0|||
150189471|NCT03150810|541831327|FG009|Overall Study|Physician Decision|0|||
150113666|NCT02489981|541552973|FG000|Overall Study|Adverse Event|21|||
150113667|NCT02489981|541552973|FG000|Overall Study|Insufficient effectiveness|16|||
150189472|NCT03150810|541831328|FG010|Overall Study|Physician Decision|0|||
150189473|NCT03150810|541831329|FG011|Overall Study|Physician Decision|0|||
150189474|NCT03150810|541831330|FG012|Overall Study|Physician Decision|0|||
150113668|NCT02489981|541552973|FG000|Overall Study|Improved|31|||
150113669|NCT02489981|541552973|FG000|Overall Study|Lost to Follow-up|31|||
150113670|NCT02489981|541552973|FG000|Overall Study|Other than listed|28|||
150113671|NCT03348904|541552976|FG000|Overall Study|Administrative reason by the sponsor|0|||
150113672|NCT03348904|541552977|FG001|Overall Study|Administrative reason by the sponsor|1|||
150113673|NCT03348904|541552978|FG002|Overall Study|Administrative reason by the sponsor|0|||
150113674|NCT00436280|541552979|FG000|Period 1: Induction|Adverse Event|8|||
150113675|NCT00436280|541552979|FG000|Period 1: Induction|Progressive Disease|12|||
150113676|NCT00436280|541552979|FG000|Period 1: Induction|Stable Disease|6|||
150113677|NCT00436280|541552979|FG000|Period 1: Induction|Withdrawal by Subject|1|||
150113678|NCT00436280|541552979|FG000|Period 1: Induction|Death|1|||
150113679|NCT00436280|541552979|FG000|Period 2: Consolidation|Adverse Event|1|||
150113680|NCT00436280|541552979|FG000|Period 2: Consolidation|Progressive Disease|10|||
150113681|NCT00436280|541552979|FG000|Period 2: Consolidation|Stable Disease|1|||
150113682|NCT00436280|541552979|FG000|Period 2: Consolidation|Physician Decision|2|||
150113683|NCT00436280|541552979|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
150113684|NCT00436280|541552979|FG000|Period 2: Consolidation|Death|1|||
150113685|NCT00436280|541552979|FG000|Period 3: Maintenance|Adverse Event|6|||
150113686|NCT00436280|541552979|FG000|Period 3: Maintenance|Progressive Disease|12|||
150113687|NCT00087568|541552981|FG000|Overall Study|Adverse Event|4|||
150113688|NCT00087568|541552982|FG001|Overall Study|Adverse Event|0|||
150113689|NCT00087568|541552981|FG000|Overall Study|Withdrawal by Subject|1|||
150113690|NCT00087568|541552982|FG001|Overall Study|Withdrawal by Subject|1|||
150113691|NCT00087568|541552981|FG000|Overall Study|Lost to Follow-up|1|||
150113692|NCT00087568|541552982|FG001|Overall Study|Lost to Follow-up|0|||
150113693|NCT00087568|541552981|FG000|Overall Study|Lack of Efficacy|24|||
150113694|NCT00087568|541552982|FG001|Overall Study|Lack of Efficacy|1|||
150113695|NCT01034397|541552983|FG000|Overall Study|Lack of compliance|0|||
150113696|NCT01034397|541552984|FG001|Overall Study|Lack of compliance|1|||
150113697|NCT01034397|541552983|FG000|Overall Study|Lack of Efficacy|3|||
150113698|NCT01034397|541552984|FG001|Overall Study|Lack of Efficacy|0|||
150113699|NCT01034397|541552983|FG000|Overall Study|Adverse Event|4|||
150113700|NCT01034397|541552984|FG001|Overall Study|Adverse Event|0|||
150113701|NCT01034397|541552983|FG000|Overall Study|Other|0|||
150113702|NCT01034397|541552984|FG001|Overall Study|Other|1|||
150113703|NCT00086580|541552989|FG000|Treatment Period|Disease progression|9|||
150113704|NCT00086580|541552990|FG001|Treatment Period|Disease progression|8|||
150113705|NCT00086580|541552989|FG000|Treatment Period|Unable to comply with protocol|3|||
150113706|NCT00086580|541552990|FG001|Treatment Period|Unable to comply with protocol|1|||
150113707|NCT00086580|541552989|FG000|Treatment Period|Withdrawal by Subject|7|||
150113708|NCT00086580|541552990|FG001|Treatment Period|Withdrawal by Subject|8|||
150113709|NCT00086580|541552989|FG000|Treatment Period|Physician Decision|13|||
150113710|NCT00086580|541552990|FG001|Treatment Period|Physician Decision|7|||
150113711|NCT00086580|541552989|FG000|Treatment Period|AE - not treatment related|7|||
150113712|NCT00086580|541552990|FG001|Treatment Period|AE - not treatment related|7|||
150113713|NCT00086580|541552989|FG000|Treatment Period|Toxicity - treatment related|15|||
150113714|NCT00086580|541552990|FG001|Treatment Period|Toxicity - treatment related|15|||
150113715|NCT00086580|541552989|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
150189475|NCT03150810|541831318|FG000|Overall Study|Site withdrawal from study|0|||
150189476|NCT03150810|541831319|FG001|Overall Study|Site withdrawal from study|1|||
150189477|NCT03150810|541831320|FG002|Overall Study|Site withdrawal from study|0|||
150113716|NCT00086580|541552990|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
150113717|NCT00086580|541552989|FG000|Treatment Period|Death|5|||
150189478|NCT03150810|541831321|FG003|Overall Study|Site withdrawal from study|0|||
150189479|NCT03150810|541831322|FG004|Overall Study|Site withdrawal from study|0|||
150189480|NCT03150810|541831323|FG005|Overall Study|Site withdrawal from study|0|||
150113718|NCT00086580|541552990|FG001|Treatment Period|Death|7|||
150113719|NCT00086580|541552989|FG000|Treatment Period|Other|5|||
150189481|NCT03150810|541831324|FG006|Overall Study|Site withdrawal from study|0|||
150189482|NCT03150810|541831325|FG007|Overall Study|Site withdrawal from study|0|||
150113720|NCT00086580|541552990|FG001|Treatment Period|Other|3|||
150113721|NCT00086580|541552989|FG000|Follow-up Period|Disease progression|72|||
150113722|NCT00086580|541552990|FG001|Follow-up Period|Disease progression|99|||
150189483|NCT03150810|541831326|FG008|Overall Study|Site withdrawal from study|0|||
150189484|NCT03150810|541831327|FG009|Overall Study|Site withdrawal from study|1|||
150189485|NCT03150810|541831328|FG010|Overall Study|Site withdrawal from study|1|||
150189486|NCT03150810|541831329|FG011|Overall Study|Site withdrawal from study|0|||
150189487|NCT03150810|541831330|FG012|Overall Study|Site withdrawal from study|0|||
150189488|NCT03150810|541831318|FG000|Overall Study|Hospice|0|||
150189489|NCT03150810|541831319|FG001|Overall Study|Hospice|0|||
150189490|NCT03150810|541831320|FG002|Overall Study|Hospice|0|||
150189491|NCT03150810|541831321|FG003|Overall Study|Hospice|0|||
150189492|NCT03150810|541831322|FG004|Overall Study|Hospice|0|||
150189493|NCT03150810|541831323|FG005|Overall Study|Hospice|1|||
150189494|NCT03150810|541831324|FG006|Overall Study|Hospice|0|||
150189495|NCT03150810|541831325|FG007|Overall Study|Hospice|0|||
150189496|NCT03150810|541831326|FG008|Overall Study|Hospice|0|||
150189497|NCT03150810|541831327|FG009|Overall Study|Hospice|0|||
150189498|NCT03150810|541831328|FG010|Overall Study|Hospice|0|||
150189499|NCT03150810|541831329|FG011|Overall Study|Hospice|0|||
150189500|NCT03150810|541831330|FG012|Overall Study|Hospice|0|||
150189501|NCT03150810|541831318|FG000|Overall Study|Participant relocated abroad.|0|||
150189502|NCT03150810|541831319|FG001|Overall Study|Participant relocated abroad.|0|||
150189503|NCT03150810|541831320|FG002|Overall Study|Participant relocated abroad.|0|||
150189504|NCT03150810|541831321|FG003|Overall Study|Participant relocated abroad.|0|||
150189505|NCT03150810|541831322|FG004|Overall Study|Participant relocated abroad.|0|||
150189506|NCT03150810|541831323|FG005|Overall Study|Participant relocated abroad.|1|||
150189507|NCT03150810|541831324|FG006|Overall Study|Participant relocated abroad.|0|||
150189508|NCT03150810|541831325|FG007|Overall Study|Participant relocated abroad.|0|||
150189509|NCT03150810|541831326|FG008|Overall Study|Participant relocated abroad.|0|||
150189510|NCT03150810|541831327|FG009|Overall Study|Participant relocated abroad.|0|||
150189511|NCT03150810|541831328|FG010|Overall Study|Participant relocated abroad.|0|||
150189512|NCT03150810|541831329|FG011|Overall Study|Participant relocated abroad.|0|||
150189513|NCT03150810|541831330|FG012|Overall Study|Participant relocated abroad.|0|||
150189514|NCT03150810|541831318|FG000|Overall Study|Transferred care to oncologist|0|||
150189515|NCT03150810|541831319|FG001|Overall Study|Transferred care to oncologist|0|||
150189516|NCT03150810|541831320|FG002|Overall Study|Transferred care to oncologist|0|||
150189517|NCT03150810|541831321|FG003|Overall Study|Transferred care to oncologist|0|||
150189518|NCT03150810|541831322|FG004|Overall Study|Transferred care to oncologist|0|||
150189519|NCT03150810|541831323|FG005|Overall Study|Transferred care to oncologist|0|||
150189520|NCT03150810|541831324|FG006|Overall Study|Transferred care to oncologist|2|||
150189521|NCT03150810|541831325|FG007|Overall Study|Transferred care to oncologist|0|||
150189522|NCT03150810|541831326|FG008|Overall Study|Transferred care to oncologist|0|||
150189523|NCT03150810|541831327|FG009|Overall Study|Transferred care to oncologist|0|||
150189524|NCT03150810|541831328|FG010|Overall Study|Transferred care to oncologist|0|||
150189525|NCT03150810|541831329|FG011|Overall Study|Transferred care to oncologist|0|||
150189526|NCT03150810|541831330|FG012|Overall Study|Transferred care to oncologist|0|||
150189527|NCT04526704|541831331|FG000|Overall Study|Adverse Event|1|||
150189528|NCT04526704|541831332|FG001|Overall Study|Adverse Event|0|||
150189529|NCT04526704|541831331|FG000|Overall Study|Physician Decision|1|||
150189530|NCT04526704|541831332|FG001|Overall Study|Physician Decision|0|||
150189531|NCT04526704|541831331|FG000|Overall Study|Withdrawal by Subject|2|||
150189532|NCT04526704|541831332|FG001|Overall Study|Withdrawal by Subject|0|||
150189533|NCT00881621|541831333|FG000|Overall Study|Physician Decision|34|||
150189534|NCT04359108|541831334|FG000|Overall Study|Withdrawal by Subject|1|||
150189535|NCT04359108|541831335|FG001|Overall Study|Withdrawal by Subject|0|||
150189536|NCT04359108|541831334|FG000|Overall Study|Unable or too feeble to walk independently|0|||
150189537|NCT04359108|541831335|FG001|Overall Study|Unable or too feeble to walk independently|2|||
150189538|NCT04359108|541831334|FG000|Overall Study|Argus II system stopped functioning|0|||
150189539|NCT04359108|541831335|FG001|Overall Study|Argus II system stopped functioning|1|||
150189540|NCT04359108|541831334|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
150189541|NCT04359108|541831335|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
150189542|NCT06393088|541831337|FG000|Overall Study|Withdrawal by Subject|0|||
150189543|NCT06393088|541831338|FG001|Overall Study|Withdrawal by Subject|2|||
150189544|NCT04176965|541831339|FG000|Overall Study|Death|1|||
150189545|NCT04176965|541831340|FG001|Overall Study|Death|2|||
150189546|NCT04176965|541831339|FG000|Overall Study|Lost to Follow-up|10|||
150189547|NCT04176965|541831340|FG001|Overall Study|Lost to Follow-up|2|||
150189548|NCT04176965|541831339|FG000|Overall Study|Withdrawal by Subject|6|||
150189549|NCT04176965|541831340|FG001|Overall Study|Withdrawal by Subject|1|||
150189550|NCT03903146|541831341|FG000|Overall Study|Lost to Follow-up|6|||
150189551|NCT03903146|541831342|FG001|Overall Study|Lost to Follow-up|4|||
150189552|NCT03903146|541831341|FG000|Overall Study|Withdrawal by Subject|0|||
150189553|NCT03903146|541831342|FG001|Overall Study|Withdrawal by Subject|1|||
150189554|NCT03652688|541831343|FG000|Baseline|Withdrawal by Subject|0|||
150189555|NCT03652688|541831344|FG001|Baseline|Withdrawal by Subject|3|||
150189556|NCT03652688|541831343|FG000|Follow-up|Lost to Follow-up|56|||
150189557|NCT03652688|541831344|FG001|Follow-up|Lost to Follow-up|54|||
150113723|NCT00086580|541552989|FG000|Follow-up Period|Unable to comply with protocol|5|||
150113724|NCT00086580|541552990|FG001|Follow-up Period|Unable to comply with protocol|0|||
150113725|NCT00086580|541552989|FG000|Follow-up Period|Withdrawal by Subject|6|||
150113726|NCT00086580|541552990|FG001|Follow-up Period|Withdrawal by Subject|6|||
150113727|NCT00086580|541552989|FG000|Follow-up Period|Physician Decision|0|||
150113728|NCT00086580|541552990|FG001|Follow-up Period|Physician Decision|1|||
150113729|NCT00086580|541552989|FG000|Follow-up Period|AE - not related|1|||
150113730|NCT00086580|541552990|FG001|Follow-up Period|AE - not related|0|||
150113731|NCT00086580|541552989|FG000|Follow-up Period|Death|13|||
150113732|NCT00086580|541552990|FG001|Follow-up Period|Death|7|||
150113733|NCT00086580|541552989|FG000|Follow-up Period|Other|7|||
150113734|NCT00086580|541552990|FG001|Follow-up Period|Other|6|||
150113735|NCT00086580|541552989|FG000|Observation Period|Unable to comply with protocol|1|||
150113736|NCT00086580|541552990|FG001|Observation Period|Unable to comply with protocol|1|||
150113737|NCT00086580|541552989|FG000|Observation Period|Withdrawal by Subject|4|||
150113738|NCT00086580|541552990|FG001|Observation Period|Withdrawal by Subject|2|||
150113739|NCT00086580|541552989|FG000|Observation Period|Death|33|||
150113740|NCT00086580|541552990|FG001|Observation Period|Death|55|||
150113741|NCT00086580|541552989|FG000|Observation Period|Other|8|||
150113742|NCT00086580|541552990|FG001|Observation Period|Other|7|||
150113743|NCT01632800|541552993|FG000|Overall Study|Subject did not fit in apparatus|1|||
150113744|NCT01000051|541552994|FG000|Overall Study|Withdrawal by Subject|1|||
150113745|NCT01000051|541552995|FG001|Overall Study|Withdrawal by Subject|1|||
150113746|NCT01000051|541552994|FG000|Overall Study|Disease Progression|1|||
150113747|NCT01000051|541552995|FG001|Overall Study|Disease Progression|0|||
150113748|NCT01000051|541552994|FG000|Overall Study|Serious noncompliance|1|||
150113749|NCT01000051|541552995|FG001|Overall Study|Serious noncompliance|0|||
150113750|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Adverse Event|41|||
150113751|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Adverse Event|24|||
150113752|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
150113753|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
150113754|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
150113755|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
150113756|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Physician Decision|0|||
150113757|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Physician Decision|6|||
150113758|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
150113759|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
150113760|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
150113761|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
150113762|NCT00673452|541552996|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
150113763|NCT00673452|541552997|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
150113764|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
150113765|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
150113766|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
150113767|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
150113768|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
150113769|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
150113770|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
150113771|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
150113772|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
150113773|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
150113774|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
150113775|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
150113776|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
150113777|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
150113778|NCT00673452|541552996|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
150113779|NCT00673452|541552997|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
150113780|NCT03495908|541553000|FG000|Overall Study|Withdrawal by Subject|3|||
150113781|NCT03495908|541553001|FG001|Overall Study|Withdrawal by Subject|1|||
150113782|NCT03495908|541553000|FG000|Overall Study|Lost to Follow-up|1|||
150113783|NCT03495908|541553001|FG001|Overall Study|Lost to Follow-up|4|||
150113784|NCT03495908|541553000|FG000|Overall Study|Adverse Event|0|||
150113785|NCT03495908|541553001|FG001|Overall Study|Adverse Event|2|||
150113786|NCT03495908|541553000|FG000|Overall Study|Death|1|||
150113787|NCT03495908|541553001|FG001|Overall Study|Death|0|||
150113788|NCT03495908|541553000|FG000|Overall Study|Physician Decision|5|||
150113789|NCT03495908|541553001|FG001|Overall Study|Physician Decision|4|||
150113790|NCT03495908|541553000|FG000|Overall Study|No documented reason|0|||
150113791|NCT03495908|541553001|FG001|Overall Study|No documented reason|2|||
150113792|NCT03049813|541553002|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
150113793|NCT03049813|541553003|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
150113794|NCT03049813|541553004|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
150113795|NCT03049813|541553005|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
150113796|NCT03049813|541553002|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
150113797|NCT03049813|541553003|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
150113798|NCT03049813|541553004|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
150113799|NCT03049813|541553005|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
150113800|NCT03049813|541553002|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
150113801|NCT03049813|541553003|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
150113802|NCT03049813|541553004|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
150113803|NCT03049813|541553005|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
150113804|NCT03049813|541553002|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
150113805|NCT03049813|541553003|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
150113806|NCT03049813|541553004|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
150113807|NCT03049813|541553005|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
150113808|NCT03025828|541553012|FG000|Overall Study|Lost to Follow-up|1|||
150113809|NCT00094653|541553013|FG000|Overall Study|Death|306|||
150113810|NCT00094653|541553014|FG001|Overall Study|Death|100|||
150113811|NCT00094653|541553015|FG002|Overall Study|Death|119|||
150113812|NCT00094653|541553013|FG000|Overall Study|Subject Withdrew Consent|10|||
150113813|NCT00094653|541553014|FG001|Overall Study|Subject Withdrew Consent|2|||
150113814|NCT00094653|541553015|FG002|Overall Study|Subject Withdrew Consent|3|||
150113815|NCT00094653|541553013|FG000|Overall Study|Other|2|||
150113816|NCT00094653|541553014|FG001|Overall Study|Other|2|||
150113817|NCT00094653|541553015|FG002|Overall Study|Other|2|||
150113818|NCT00094653|541553013|FG000|Overall Study|Lost to Follow-up|3|||
150113819|NCT00094653|541553014|FG001|Overall Study|Lost to Follow-up|2|||
150113820|NCT00094653|541553015|FG002|Overall Study|Lost to Follow-up|1|||
150113821|NCT00094653|541553013|FG000|Overall Study|Protocol Violation|0|||
150113822|NCT00094653|541553014|FG001|Overall Study|Protocol Violation|0|||
150113823|NCT00094653|541553015|FG002|Overall Study|Protocol Violation|1|||
150113824|NCT02143843|541553016|FG000|Overall Study|Adverse Event|8|||
150113825|NCT02143843|541553016|FG000|Overall Study|Lack of Efficacy|2|||
150113826|NCT02143843|541553016|FG000|Overall Study|Withdrawal by Subject|2|||
150113827|NCT00480779|541553017|FG000|Overall Study|Other|2|||
150113828|NCT00480779|541553018|FG001|Overall Study|Other|0|||
150113829|NCT00480779|541553017|FG000|Overall Study|Job and Health-related|0|||
150113830|NCT00480779|541553018|FG001|Overall Study|Job and Health-related|3|||
150113831|NCT00378703|541553023|FG000|Overall Study|Disease progression|59|||
150113832|NCT00378703|541553024|FG001|Overall Study|Disease progression|43|||
150113833|NCT00378703|541553025|FG002|Overall Study|Disease progression|48|||
150113834|NCT00378703|541553026|FG003|Overall Study|Disease progression|49|||
150113835|NCT00378703|541553023|FG000|Overall Study|Adverse Event|11|||
150113836|NCT00378703|541553024|FG001|Overall Study|Adverse Event|17|||
150113837|NCT00378703|541553025|FG002|Overall Study|Adverse Event|20|||
150113838|NCT00378703|541553026|FG003|Overall Study|Adverse Event|18|||
150113839|NCT00378703|541553023|FG000|Overall Study|Death|2|||
150113840|NCT00378703|541553024|FG001|Overall Study|Death|2|||
150113841|NCT00378703|541553025|FG002|Overall Study|Death|4|||
150113842|NCT00378703|541553026|FG003|Overall Study|Death|3|||
150113843|NCT00378703|541553023|FG000|Overall Study|Withdrawal by Subject|4|||
150113844|NCT00378703|541553024|FG001|Overall Study|Withdrawal by Subject|8|||
150113845|NCT00378703|541553025|FG002|Overall Study|Withdrawal by Subject|5|||
150113846|NCT00378703|541553026|FG003|Overall Study|Withdrawal by Subject|7|||
150113847|NCT00378703|541553023|FG000|Overall Study|Physician Decision|1|||
150113848|NCT00378703|541553024|FG001|Overall Study|Physician Decision|4|||
150113849|NCT00378703|541553025|FG002|Overall Study|Physician Decision|1|||
150113850|NCT00378703|541553026|FG003|Overall Study|Physician Decision|0|||
150113851|NCT00378703|541553023|FG000|Overall Study|Alternative therapy|4|||
150113852|NCT00378703|541553024|FG001|Overall Study|Alternative therapy|2|||
150113853|NCT00378703|541553025|FG002|Overall Study|Alternative therapy|0|||
150113854|NCT00378703|541553026|FG003|Overall Study|Alternative therapy|0|||
150113855|NCT00378703|541553023|FG000|Overall Study|Other complicated disease|0|||
150113856|NCT00378703|541553024|FG001|Overall Study|Other complicated disease|2|||
150113857|NCT00378703|541553025|FG002|Overall Study|Other complicated disease|2|||
150113858|NCT00378703|541553026|FG003|Overall Study|Other complicated disease|0|||
150113859|NCT00378703|541553023|FG000|Overall Study|Symptomatic deterioration|0|||
150113860|NCT00378703|541553024|FG001|Overall Study|Symptomatic deterioration|1|||
150113861|NCT00378703|541553025|FG002|Overall Study|Symptomatic deterioration|0|||
150113862|NCT00378703|541553026|FG003|Overall Study|Symptomatic deterioration|2|||
150113863|NCT00378703|541553023|FG000|Overall Study|Surgery|1|||
150113864|NCT00378703|541553024|FG001|Overall Study|Surgery|0|||
150113865|NCT00378703|541553025|FG002|Overall Study|Surgery|0|||
150113866|NCT00378703|541553026|FG003|Overall Study|Surgery|1|||
150113867|NCT00378703|541553023|FG000|Overall Study|Joint decision of physician and patient|1|||
150113868|NCT00378703|541553024|FG001|Overall Study|Joint decision of physician and patient|0|||
150113869|NCT00378703|541553025|FG002|Overall Study|Joint decision of physician and patient|0|||
150113870|NCT00378703|541553026|FG003|Overall Study|Joint decision of physician and patient|0|||
150113871|NCT00378703|541553023|FG000|Overall Study|Adverse events and progressive disease|0|||
150113872|NCT00378703|541553024|FG001|Overall Study|Adverse events and progressive disease|0|||
150113873|NCT00378703|541553025|FG002|Overall Study|Adverse events and progressive disease|0|||
150113874|NCT00378703|541553026|FG003|Overall Study|Adverse events and progressive disease|1|||
150113875|NCT00378703|541553023|FG000|Overall Study|Relocation|0|||
150113876|NCT00378703|541553024|FG001|Overall Study|Relocation|0|||
150113877|NCT00378703|541553025|FG002|Overall Study|Relocation|1|||
150113878|NCT00378703|541553026|FG003|Overall Study|Relocation|0|||
150113879|NCT00378703|541553023|FG000|Overall Study|Ineligible|4|||
150113880|NCT00378703|541553024|FG001|Overall Study|Ineligible|7|||
150113881|NCT00378703|541553025|FG002|Overall Study|Ineligible|7|||
150113882|NCT00378703|541553026|FG003|Overall Study|Ineligible|7|||
150113883|NCT00378703|541553023|FG000|Overall Study|Never started treatment|1|||
150113884|NCT00378703|541553024|FG001|Overall Study|Never started treatment|4|||
150113885|NCT00378703|541553025|FG002|Overall Study|Never started treatment|0|||
150113886|NCT00378703|541553026|FG003|Overall Study|Never started treatment|0|||
150113887|NCT00378703|541553023|FG000|Overall Study|Other|1|||
150113888|NCT00378703|541553024|FG001|Overall Study|Other|1|||
150113889|NCT00378703|541553025|FG002|Overall Study|Other|2|||
150113890|NCT00378703|541553026|FG003|Overall Study|Other|3|||
150113891|NCT03181542|541553028|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
150113892|NCT03181542|541553029|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
150113893|NCT00806546|541553037|FG000|Overall Study|Enrolled, not treated|35|||
150113894|NCT00806546|541553037|FG000|Overall Study|Lost to Follow-up|32|||
150113895|NCT00806546|541553037|FG000|Overall Study|Adverse Event|74|||
150113896|NCT00806546|541553037|FG000|Overall Study|Withdrawal by Subject|75|||
150113897|NCT00806546|541553037|FG000|Overall Study|Protocol Violation|49|||
150113898|NCT00806546|541553037|FG000|Overall Study|Various|42|||
150113899|NCT01466192|541553045|FG000|Overall Study|Physician Decision|1|||
150113900|NCT01466192|541553045|FG000|Overall Study|Withdrawal by Subject|3|||
150113901|NCT03265119|541553047|FG000|Overall Study|Adverse Event|2|||
150113902|NCT03265119|541553048|FG001|Overall Study|Adverse Event|1|||
150113903|NCT03265119|541553047|FG000|Overall Study|Lack of Efficacy|3|||
150113904|NCT03265119|541553048|FG001|Overall Study|Lack of Efficacy|0|||
150113905|NCT03265119|541553047|FG000|Overall Study|Protocol Violation|1|||
150113906|NCT03265119|541553048|FG001|Overall Study|Protocol Violation|2|||
150113907|NCT03265119|541553047|FG000|Overall Study|Withdrawal by Subject|2|||
150113908|NCT03265119|541553048|FG001|Overall Study|Withdrawal by Subject|4|||
150113909|NCT03265119|541553047|FG000|Overall Study|Lost to Follow-up|1|||
150113910|NCT03265119|541553048|FG001|Overall Study|Lost to Follow-up|0|||
150113911|NCT03265119|541553047|FG000|Overall Study|Lack of Compliance|1|||
150113912|NCT03265119|541553048|FG001|Overall Study|Lack of Compliance|0|||
150113913|NCT03890367|541553053|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150113914|NCT03890367|541553054|FG001|Overall Study|Withdrawal by parent/guardian|3|||
150113915|NCT03890367|541553055|FG002|Overall Study|Withdrawal by parent/guardian|0|||
150113916|NCT03890367|541553053|FG000|Overall Study|Protocol deviation|2|||
150113917|NCT03890367|541553054|FG001|Overall Study|Protocol deviation|2|||
150113918|NCT03890367|541553055|FG002|Overall Study|Protocol deviation|1|||
150113919|NCT03890367|541553053|FG000|Overall Study|Lost to Follow-up|1|||
150113920|NCT03890367|541553054|FG001|Overall Study|Lost to Follow-up|1|||
150113921|NCT03890367|541553055|FG002|Overall Study|Lost to Follow-up|0|||
150113922|NCT04524403|541555113|FG000|Overall Study|Withdrawal by Subject|10|||
150113923|NCT04524403|541555114|FG001|Overall Study|Withdrawal by Subject|3|||
150113924|NCT04524403|541555115|FG002|Overall Study|Withdrawal by Subject|8|||
150113925|NCT04524403|541555113|FG000|Overall Study|Lost to Follow-up|3|||
150113926|NCT04524403|541555114|FG001|Overall Study|Lost to Follow-up|4|||
150113927|NCT04524403|541555115|FG002|Overall Study|Lost to Follow-up|3|||
150113928|NCT04524403|541555113|FG000|Overall Study|Adverse Event|3|||
150113929|NCT04524403|541555114|FG001|Overall Study|Adverse Event|1|||
150113930|NCT04524403|541555115|FG002|Overall Study|Adverse Event|4|||
150113931|NCT04524403|541555113|FG000|Overall Study|Non-compliant with study drug|1|||
150113932|NCT04524403|541555114|FG001|Overall Study|Non-compliant with study drug|2|||
150113933|NCT04524403|541555115|FG002|Overall Study|Non-compliant with study drug|3|||
150113934|NCT04524403|541555113|FG000|Overall Study|Moved|0|||
150113935|NCT04524403|541555114|FG001|Overall Study|Moved|1|||
150113936|NCT04524403|541555115|FG002|Overall Study|Moved|0|||
150113937|NCT00600821|541555116|FG000|Overall Study|Death|45|||
150113938|NCT00600821|541555117|FG001|Overall Study|Death|46|||
150113939|NCT00600821|541555116|FG000|Overall Study|Lost to Follow-up|2|||
150113940|NCT00600821|541555117|FG001|Overall Study|Lost to Follow-up|2|||
150113941|NCT00600821|541555116|FG000|Overall Study|Withdrawal by Subject|1|||
150113942|NCT00600821|541555117|FG001|Overall Study|Withdrawal by Subject|1|||
150113943|NCT00600821|541555116|FG000|Overall Study|Terminated by sponsor|8|||
150113944|NCT00600821|541555117|FG001|Overall Study|Terminated by sponsor|6|||
150113945|NCT00600821|541555116|FG000|Overall Study|Objective progression or relapse|0|||
150113946|NCT00600821|541555117|FG001|Overall Study|Objective progression or relapse|1|||
150113947|NCT00600821|541555116|FG000|Overall Study|Randomized but not treated|0|||
150113948|NCT00600821|541555117|FG001|Overall Study|Randomized but not treated|1|||
150113949|NCT00600821|541555116|FG000|Overall Study|Other|2|||
150113950|NCT00600821|541555117|FG001|Overall Study|Other|3|||
150113951|NCT01607905|541555118|FG000|Overall Study|Withdrawal by participant|7|||
150113952|NCT01607905|541555119|FG001|Overall Study|Withdrawal by participant|2|||
150113953|NCT01607905|541555120|FG002|Overall Study|Withdrawal by participant|4|||
150113954|NCT01607905|541555121|FG003|Overall Study|Withdrawal by participant|6|||
150113955|NCT01607905|541555122|FG004|Overall Study|Withdrawal by participant|0|||
150113956|NCT01607905|541555123|FG005|Overall Study|Withdrawal by participant|4|||
150113957|NCT01607905|541555124|FG006|Overall Study|Withdrawal by participant|12|||
150113958|NCT01607905|541555118|FG000|Overall Study|Incidence or severity of AEs|5|||
150113959|NCT01607905|541555119|FG001|Overall Study|Incidence or severity of AEs|1|||
150113960|NCT01607905|541555120|FG002|Overall Study|Incidence or severity of AEs|1|||
150113961|NCT01607905|541555121|FG003|Overall Study|Incidence or severity of AEs|3|||
150113962|NCT01607905|541555122|FG004|Overall Study|Incidence or severity of AEs|0|||
150113963|NCT01607905|541555123|FG005|Overall Study|Incidence or severity of AEs|2|||
150113964|NCT01607905|541555124|FG006|Overall Study|Incidence or severity of AEs|8|||
150113965|NCT01607905|541555118|FG000|Overall Study|Disease progression|44|||
150113966|NCT01607905|541555119|FG001|Overall Study|Disease progression|16|||
150113967|NCT01607905|541555120|FG002|Overall Study|Disease progression|15|||
150113968|NCT01607905|541555121|FG003|Overall Study|Disease progression|11|||
150113969|NCT01607905|541555122|FG004|Overall Study|Disease progression|6|||
150113970|NCT01607905|541555123|FG005|Overall Study|Disease progression|7|||
150113971|NCT01607905|541555124|FG006|Overall Study|Disease progression|21|||
150113972|NCT01607905|541555118|FG000|Overall Study|Non-compliance with study procedures|0|||
150113973|NCT01607905|541555119|FG001|Overall Study|Non-compliance with study procedures|0|||
150113974|NCT01607905|541555120|FG002|Overall Study|Non-compliance with study procedures|0|||
150113975|NCT01607905|541555121|FG003|Overall Study|Non-compliance with study procedures|0|||
150113976|NCT01607905|541555122|FG004|Overall Study|Non-compliance with study procedures|0|||
150113977|NCT01607905|541555123|FG005|Overall Study|Non-compliance with study procedures|0|||
150113978|NCT01607905|541555124|FG006|Overall Study|Non-compliance with study procedures|1|||
150113979|NCT01607905|541555118|FG000|Overall Study|Death|1|||
150113980|NCT01607905|541555119|FG001|Overall Study|Death|1|||
150113981|NCT01607905|541555120|FG002|Overall Study|Death|1|||
150113982|NCT01607905|541555121|FG003|Overall Study|Death|1|||
150113983|NCT01607905|541555122|FG004|Overall Study|Death|0|||
150113984|NCT01607905|541555123|FG005|Overall Study|Death|0|||
150113985|NCT01607905|541555124|FG006|Overall Study|Death|3|||
150113986|NCT01607905|541555118|FG000|Overall Study|Other treatments become available|1|||
150113987|NCT01607905|541555119|FG001|Overall Study|Other treatments become available|0|||
150113988|NCT01607905|541555120|FG002|Overall Study|Other treatments become available|0|||
150113989|NCT01607905|541555121|FG003|Overall Study|Other treatments become available|0|||
150113990|NCT01607905|541555122|FG004|Overall Study|Other treatments become available|0|||
150113991|NCT01607905|541555123|FG005|Overall Study|Other treatments become available|0|||
150113992|NCT01607905|541555124|FG006|Overall Study|Other treatments become available|1|||
150113993|NCT01607905|541555118|FG000|Overall Study|Investigator discretion|0|||
150113994|NCT01607905|541555119|FG001|Overall Study|Investigator discretion|0|||
150113995|NCT01607905|541555120|FG002|Overall Study|Investigator discretion|0|||
150113996|NCT01607905|541555121|FG003|Overall Study|Investigator discretion|0|||
150113997|NCT01607905|541555122|FG004|Overall Study|Investigator discretion|0|||
150113998|NCT01607905|541555123|FG005|Overall Study|Investigator discretion|1|||
150113999|NCT01607905|541555124|FG006|Overall Study|Investigator discretion|0|||
150114000|NCT01607905|541555118|FG000|Overall Study|Other|1|||
150114001|NCT01607905|541555119|FG001|Overall Study|Other|0|||
150114002|NCT01607905|541555120|FG002|Overall Study|Other|0|||
150114003|NCT01607905|541555121|FG003|Overall Study|Other|0|||
150114004|NCT01607905|541555122|FG004|Overall Study|Other|0|||
150114005|NCT01607905|541555123|FG005|Overall Study|Other|0|||
150114006|NCT01607905|541555124|FG006|Overall Study|Other|1|||
150114007|NCT01607905|541555118|FG000|Overall Study|Randomized but not treated|1|||
150114008|NCT01607905|541555119|FG001|Overall Study|Randomized but not treated|0|||
150114009|NCT01607905|541555120|FG002|Overall Study|Randomized but not treated|0|||
150114010|NCT01607905|541555121|FG003|Overall Study|Randomized but not treated|0|||
150114011|NCT01607905|541555122|FG004|Overall Study|Randomized but not treated|1|||
150114012|NCT01607905|541555123|FG005|Overall Study|Randomized but not treated|1|||
150114013|NCT01607905|541555124|FG006|Overall Study|Randomized but not treated|0|||
150114014|NCT02602288|541555125|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
150114015|NCT02602288|541555126|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
150114016|NCT02602288|541555125|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
150114017|NCT02602288|541555126|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
150114018|NCT02602288|541555125|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
150114019|NCT02602288|541555126|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
150114020|NCT02602288|541555125|FG000|12 Month Follow-up|Lost to Follow-up|0|||
150114021|NCT02602288|541555126|FG001|12 Month Follow-up|Lost to Follow-up|4|||
150114022|NCT02602288|541555125|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
150114023|NCT02602288|541555126|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
150114024|NCT01310413|541555127|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
150114025|NCT01310413|541555128|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
150114026|NCT01310413|541555129|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
150114027|NCT01310413|541555130|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
150114028|NCT01310413|541555131|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
150114029|NCT01310413|541555132|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
150114030|NCT01310413|541555133|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
150114031|NCT01310413|541555127|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
150114032|NCT01310413|541555128|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
150114033|NCT01310413|541555129|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
150114034|NCT01310413|541555130|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
150114035|NCT01310413|541555131|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
150114036|NCT01310413|541555132|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
150114037|NCT01310413|541555133|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
150114038|NCT01310413|541555127|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
150114039|NCT01310413|541555128|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
150114040|NCT01310413|541555129|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
150114041|NCT01310413|541555130|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
150114042|NCT01310413|541555131|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
150114043|NCT01310413|541555132|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
150114044|NCT01310413|541555133|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
150114045|NCT01310413|541555127|FG000|Day 0 to Day 385|Other|1|||
150114046|NCT01310413|541555128|FG001|Day 0 to Day 385|Other|0|||
150114047|NCT01310413|541555129|FG002|Day 0 to Day 385|Other|3|||
150114048|NCT01310413|541555130|FG003|Day 0 to Day 385|Other|0|||
150114049|NCT01310413|541555131|FG004|Day 0 to Day 385|Other|0|||
150114050|NCT01310413|541555132|FG005|Day 0 to Day 385|Other|0|||
150114051|NCT01310413|541555133|FG006|Day 0 to Day 385|Other|0|||
150114052|NCT01310413|541555127|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114053|NCT01310413|541555128|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114054|NCT01310413|541555129|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114055|NCT01310413|541555130|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114056|NCT01310413|541555131|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114057|NCT01310413|541555132|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
150114058|NCT01310413|541555133|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
150114059|NCT01310413|541555127|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
150114060|NCT01310413|541555128|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
150114061|NCT01310413|541555129|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
150114062|NCT01310413|541555130|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
150114063|NCT01310413|541555131|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
150114064|NCT01310413|541555132|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
150114065|NCT01310413|541555133|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
150114066|NCT02564471|541555134|FG000|Overall Study|Adverse Event|1|||
150114067|NCT02564471|541555135|FG001|Overall Study|Adverse Event|0|||
150114068|NCT02564471|541555136|FG002|Overall Study|Adverse Event|0|||
150114069|NCT02564471|541555137|FG003|Overall Study|Adverse Event|0|||
150114070|NCT02564471|541555134|FG000|Overall Study|Withdrawal by Subject|2|||
150114071|NCT02564471|541555135|FG001|Overall Study|Withdrawal by Subject|1|||
150114072|NCT02564471|541555136|FG002|Overall Study|Withdrawal by Subject|3|||
150114073|NCT02564471|541555137|FG003|Overall Study|Withdrawal by Subject|0|||
150114074|NCT02564471|541555134|FG000|Overall Study|Lost to Follow-up|0|||
150114075|NCT02564471|541555135|FG001|Overall Study|Lost to Follow-up|2|||
150114076|NCT02564471|541555136|FG002|Overall Study|Lost to Follow-up|0|||
150114077|NCT02564471|541555137|FG003|Overall Study|Lost to Follow-up|0|||
150114078|NCT03586869|541555138|FG000|Overall Study|Progressive Disease|3|||
150114079|NCT04116229|541555139|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
150114080|NCT04116229|541555140|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
150114081|NCT04116229|541555139|FG000|Overall Study|Scheduling not possible.|0|||
150114082|NCT04116229|541555140|FG001|Overall Study|Scheduling not possible.|1|||
150114083|NCT02992899|541555145|FG000|Overall Study|Withdrawal by Subject|1|||
150114084|NCT02992899|541555146|FG001|Overall Study|Withdrawal by Subject|0|||
150114085|NCT02992899|541555145|FG000|Overall Study|Lost to Follow-up|1|||
150114086|NCT02992899|541555146|FG001|Overall Study|Lost to Follow-up|3|||
150114087|NCT01332305|541555147|FG000|Overall Study|Adverse Event|1|||
150114088|NCT01332305|541555148|FG001|Overall Study|Adverse Event|4|||
150114089|NCT01332305|541555149|FG002|Overall Study|Adverse Event|6|||
150114090|NCT01332305|541555150|FG003|Overall Study|Adverse Event|3|||
150114091|NCT01332305|541555151|FG004|Overall Study|Adverse Event|5|||
150114092|NCT01332305|541555147|FG000|Overall Study|Withdrawal by Subject|6|||
150114093|NCT01332305|541555148|FG001|Overall Study|Withdrawal by Subject|5|||
150114094|NCT01332305|541555149|FG002|Overall Study|Withdrawal by Subject|4|||
150114095|NCT01332305|541555150|FG003|Overall Study|Withdrawal by Subject|1|||
150114096|NCT01332305|541555151|FG004|Overall Study|Withdrawal by Subject|0|||
150114097|NCT01332305|541555147|FG000|Overall Study|Lost to Follow-up|0|||
150114098|NCT01332305|541555148|FG001|Overall Study|Lost to Follow-up|2|||
150114099|NCT01332305|541555149|FG002|Overall Study|Lost to Follow-up|3|||
150114100|NCT01332305|541555150|FG003|Overall Study|Lost to Follow-up|2|||
150114101|NCT01332305|541555151|FG004|Overall Study|Lost to Follow-up|3|||
150114102|NCT01332305|541555147|FG000|Overall Study|Protocol Violation|1|||
150114103|NCT01332305|541555148|FG001|Overall Study|Protocol Violation|2|||
150114104|NCT01332305|541555149|FG002|Overall Study|Protocol Violation|1|||
150114105|NCT01332305|541555150|FG003|Overall Study|Protocol Violation|0|||
150114106|NCT01332305|541555151|FG004|Overall Study|Protocol Violation|3|||
150114107|NCT01332305|541555147|FG000|Overall Study|Withdrawal by Sponsor|1|||
150114108|NCT01332305|541555148|FG001|Overall Study|Withdrawal by Sponsor|0|||
150114109|NCT01332305|541555149|FG002|Overall Study|Withdrawal by Sponsor|0|||
150114110|NCT01332305|541555150|FG003|Overall Study|Withdrawal by Sponsor|1|||
150114111|NCT01332305|541555151|FG004|Overall Study|Withdrawal by Sponsor|1|||
150114112|NCT01332305|541555147|FG000|Overall Study|Treatment Failure|1|||
150114113|NCT01332305|541555148|FG001|Overall Study|Treatment Failure|1|||
150114114|NCT01332305|541555149|FG002|Overall Study|Treatment Failure|0|||
150114115|NCT01332305|541555150|FG003|Overall Study|Treatment Failure|0|||
150114116|NCT01332305|541555151|FG004|Overall Study|Treatment Failure|0|||
150114117|NCT01332305|541555147|FG000|Overall Study|Physician Decision|0|||
150114118|NCT01332305|541555148|FG001|Overall Study|Physician Decision|0|||
150114119|NCT01332305|541555149|FG002|Overall Study|Physician Decision|0|||
150114120|NCT01332305|541555150|FG003|Overall Study|Physician Decision|1|||
150114121|NCT01332305|541555151|FG004|Overall Study|Physician Decision|0|||
150114122|NCT03192150|541555154|FG000|Overall Study|Adverse Event|14|||
150114123|NCT03192150|541555155|FG001|Overall Study|Adverse Event|12|||
150114124|NCT03192150|541555154|FG000|Overall Study|Lack of Efficacy|23|||
150114125|NCT03192150|541555155|FG001|Overall Study|Lack of Efficacy|30|||
150114126|NCT03192150|541555154|FG000|Overall Study|Lost to Follow-up|1|||
150114127|NCT03192150|541555155|FG001|Overall Study|Lost to Follow-up|1|||
150114128|NCT03192150|541555154|FG000|Overall Study|Withdrawal by Subject|4|||
150114129|NCT03192150|541555155|FG001|Overall Study|Withdrawal by Subject|2|||
150114130|NCT03192150|541555154|FG000|Overall Study|Protocol Violation|5|||
150114131|NCT03192150|541555155|FG001|Overall Study|Protocol Violation|2|||
150114132|NCT03192150|541555154|FG000|Overall Study|Surgery Canceled|6|||
150114133|NCT03192150|541555155|FG001|Overall Study|Surgery Canceled|2|||
150114134|NCT03192150|541555154|FG000|Overall Study|Other-Various Administrative Reasons|2|||
150114135|NCT03192150|541555155|FG001|Overall Study|Other-Various Administrative Reasons|5|||
150114136|NCT01430585|541555156|FG000|Overall Study|Death|1|||
150114137|NCT01430585|541555156|FG000|Overall Study|Objective Progression or Relapse|3|||
150114138|NCT01430585|541555156|FG000|Overall Study|Study Terminated by Sponsor|3|||
150114139|NCT01430585|541555156|FG000|Overall Study|Other|7|||
150114140|NCT00482391|541555157|FG000|Overall Study|Withdrawal by Subject|1|||
150114141|NCT00482391|541555157|FG000|Overall Study|Adverse Event|1|||
150114142|NCT00482391|541555157|FG000|Overall Study|Death|1|||
150114143|NCT01448850|541555158|FG000|Overall Study|Death|3|||
150114144|NCT01448850|541555159|FG001|Overall Study|Death|6|||
150114145|NCT01448850|541555158|FG000|Overall Study|Withdrawal by Subject|13|||
150114146|NCT01448850|541555159|FG001|Overall Study|Withdrawal by Subject|21|||
150114147|NCT01448850|541555158|FG000|Overall Study|Lost to Follow-up|3|||
150114148|NCT01448850|541555159|FG001|Overall Study|Lost to Follow-up|1|||
150114149|NCT01448850|541555158|FG000|Overall Study|Other|15|||
150114150|NCT01448850|541555159|FG001|Overall Study|Other|12|||
150114151|NCT00779766|541555160|FG000|Month 24|Serious Adverse Event|2|||
150114152|NCT00779766|541555161|FG001|Month 24|Serious Adverse Event|3|||
150114153|NCT00779766|541555160|FG000|Month 24|Adverse Event|3|||
150114154|NCT00779766|541555161|FG001|Month 24|Adverse Event|3|||
150114155|NCT00779766|541555160|FG000|Month 24|Protocol Violation|3|||
150114156|NCT00779766|541555161|FG001|Month 24|Protocol Violation|1|||
150114157|NCT00779766|541555160|FG000|Month 24|Withdrawal by Subject|159|||
150114158|NCT00779766|541555161|FG001|Month 24|Withdrawal by Subject|127|||
150114159|NCT00779766|541555160|FG000|Month 24|Migrated/moved from study area|138|||
150114160|NCT00779766|541555161|FG001|Month 24|Migrated/moved from study area|162|||
150114161|NCT00779766|541555160|FG000|Month 24|Lost to Follow-up|9|||
150114162|NCT00779766|541555161|FG001|Month 24|Lost to Follow-up|9|||
150114163|NCT00779766|541555160|FG000|Month 24|Other|18|||
150114164|NCT00779766|541555161|FG001|Month 24|Other|27|||
150114165|NCT00779766|541555160|FG000|Month 48|Withdrawal by Subject|68|||
150114166|NCT00779766|541555161|FG001|Month 48|Withdrawal by Subject|63|||
150114167|NCT00779766|541555160|FG000|Month 48|Migrated/moved from study area|76|||
150114168|NCT00779766|541555161|FG001|Month 48|Migrated/moved from study area|75|||
150114169|NCT00779766|541555160|FG000|Month 48|Lost to Follow-up|29|||
150114170|NCT00779766|541555161|FG001|Month 48|Lost to Follow-up|30|||
150114171|NCT00779766|541555160|FG000|Month 48|Other|1|||
150114172|NCT00779766|541555161|FG001|Month 48|Other|0|||
150114173|NCT00779766|541555160|FG000|Month 72|Withdrawal by Subject|55|||
150114174|NCT00779766|541555161|FG001|Month 72|Withdrawal by Subject|71|||
150114175|NCT00779766|541555160|FG000|Month 72|Migrated/moved from study area|124|||
150114176|NCT00779766|541555161|FG001|Month 72|Migrated/moved from study area|109|||
150114177|NCT00779766|541555160|FG000|Month 72|Lost to Follow-up|6|||
150114178|NCT00779766|541555161|FG001|Month 72|Lost to Follow-up|8|||
150114179|NCT00779766|541555160|FG000|Month 72|Other|0|||
150114180|NCT00779766|541555161|FG001|Month 72|Other|1|||
150114181|NCT01412424|541555166|FG000|Core Treatment Period|Treatment Failure|24|||
150114182|NCT01412424|541555166|FG000|Core Treatment Period|Adverse Event|21|||
150114183|NCT01412424|541555166|FG000|Core Treatment Period|Patient Request|5|||
150114184|NCT01412424|541555166|FG000|Core Treatment Period|Lost to Follow-up|2|||
150114185|NCT01412424|541555166|FG000|Core Treatment Period|Sponsor Request|1|||
150114186|NCT01412424|541555166|FG000|Extension Treatment Period|Adverse Event|2|||
150114187|NCT01412424|541555166|FG000|Extension Treatment Period|Treatment Failure|2|||
150114188|NCT01412424|541555166|FG000|Extension Treatment Period|Patient Request|2|||
150114189|NCT01274637|541555169|FG000|Overall Study|Withdrawal by Subject|0|||
150114190|NCT01274637|541555170|FG001|Overall Study|Withdrawal by Subject|1|||
150114191|NCT01274637|541555169|FG000|Overall Study|Lost to Follow-up|0|||
150114192|NCT01274637|541555170|FG001|Overall Study|Lost to Follow-up|1|||
150114193|NCT01824303|541555175|FG000|Randomized Study|Withdrawal by Subject|1|||
150114194|NCT01824303|541555176|FG001|Randomized Study|Withdrawal by Subject|1|||
150114195|NCT01824303|541555175|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
150114196|NCT01824303|541555176|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
150114197|NCT02606136|541555177|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
150114198|NCT02606136|541555177|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
150114199|NCT02606136|541555177|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
150114200|NCT02606136|541555177|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
150114201|NCT03296696|541555178|FG000|Overall Study|Started Other Antitumor Therapy|1|||
150114202|NCT03296696|541555179|FG001|Overall Study|Started Other Antitumor Therapy|2|||
150114203|NCT03296696|541555180|FG002|Overall Study|Started Other Antitumor Therapy|1|||
150114204|NCT03296696|541555181|FG003|Overall Study|Started Other Antitumor Therapy|2|||
150114205|NCT03296696|541555182|FG004|Overall Study|Started Other Antitumor Therapy|1|||
150114206|NCT03296696|541555183|FG005|Overall Study|Started Other Antitumor Therapy|1|||
150114207|NCT03296696|541555184|FG006|Overall Study|Started Other Antitumor Therapy|2|||
150114208|NCT03296696|541555185|FG007|Overall Study|Started Other Antitumor Therapy|3|||
150114209|NCT03296696|541555186|FG008|Overall Study|Started Other Antitumor Therapy|1|||
150114210|NCT03296696|541555187|FG009|Overall Study|Started Other Antitumor Therapy|0|||
150114211|NCT03296696|541555178|FG000|Overall Study|Death|0|||
150114212|NCT03296696|541555179|FG001|Overall Study|Death|1|||
150114213|NCT03296696|541555180|FG002|Overall Study|Death|1|||
150114214|NCT03296696|541555181|FG003|Overall Study|Death|2|||
150114215|NCT03296696|541555182|FG004|Overall Study|Death|2|||
150114216|NCT03296696|541555183|FG005|Overall Study|Death|3|||
150114217|NCT03296696|541555184|FG006|Overall Study|Death|1|||
150114218|NCT03296696|541555185|FG007|Overall Study|Death|2|||
150114219|NCT03296696|541555186|FG008|Overall Study|Death|0|||
150114220|NCT03296696|541555187|FG009|Overall Study|Death|0|||
150114221|NCT03296696|541555178|FG000|Overall Study|Withdrawal by Subject|0|||
150114222|NCT03296696|541555179|FG001|Overall Study|Withdrawal by Subject|0|||
150114223|NCT03296696|541555180|FG002|Overall Study|Withdrawal by Subject|1|||
150114224|NCT03296696|541555181|FG003|Overall Study|Withdrawal by Subject|0|||
150114225|NCT03296696|541555182|FG004|Overall Study|Withdrawal by Subject|1|||
150114226|NCT03296696|541555183|FG005|Overall Study|Withdrawal by Subject|0|||
150114227|NCT03296696|541555184|FG006|Overall Study|Withdrawal by Subject|0|||
150114228|NCT03296696|541555185|FG007|Overall Study|Withdrawal by Subject|0|||
150114229|NCT03296696|541555186|FG008|Overall Study|Withdrawal by Subject|0|||
150114230|NCT03296696|541555187|FG009|Overall Study|Withdrawal by Subject|1|||
150114231|NCT04694131|541555190|FG000|Overall Study|Withdrawal by Subject|7|||
150114232|NCT04694131|541555190|FG000|Overall Study|Screen Failure|1|||
150114233|NCT04694131|541555190|FG000|Overall Study|High stimulation threshold|3|||
150114234|NCT03235024|541555194|FG000|Overall Study|Adverse Event|2|||
150114235|NCT03235024|541555195|FG001|Overall Study|Adverse Event|2|||
150114236|NCT03235024|541555194|FG000|Overall Study|Death|1|||
150114237|NCT03235024|541555195|FG001|Overall Study|Death|0|||
150114238|NCT03235024|541555194|FG000|Overall Study|Lost to Follow-up|2|||
150114239|NCT03235024|541555195|FG001|Overall Study|Lost to Follow-up|5|||
150114240|NCT03235024|541555194|FG000|Overall Study|Protocol Violation|1|||
150114241|NCT03235024|541555195|FG001|Overall Study|Protocol Violation|0|||
150114242|NCT03235024|541555194|FG000|Overall Study|Withdrawal by Subject|0|||
150114243|NCT03235024|541555195|FG001|Overall Study|Withdrawal by Subject|3|||
150114244|NCT02357576|541555196|FG000|Treatment Period|Withdrawal by Subject|0|||
150114245|NCT02357576|541555197|FG001|Treatment Period|Withdrawal by Subject|1|||
150114246|NCT02357576|541555196|FG000|Treatment Period|Physician Decision|0|||
150114247|NCT02357576|541555197|FG001|Treatment Period|Physician Decision|1|||
150114248|NCT02357576|541555196|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
150114249|NCT02357576|541555197|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
150114250|NCT02357576|541555196|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
150114251|NCT02357576|541555197|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
150114252|NCT02357576|541555196|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
150114253|NCT02357576|541555197|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
150114254|NCT02357576|541555196|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
150114255|NCT02357576|541555197|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
150114256|NCT00261716|541555198|FG000|Overall Study|Withdrawal by Subject|6|||
150114257|NCT00261716|541555199|FG001|Overall Study|Withdrawal by Subject|8|||
150114258|NCT00261716|541555198|FG000|Overall Study|Lost to Follow-up|0|||
150114259|NCT00261716|541555199|FG001|Overall Study|Lost to Follow-up|2|||
150114260|NCT02047110|541555202|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
150114261|NCT02047110|541555203|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
150114262|NCT02047110|541555204|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
150114263|NCT02047110|541555205|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
150114264|NCT02047110|541555202|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
150114265|NCT02047110|541555203|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
150114266|NCT02047110|541555204|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
150114267|NCT02047110|541555205|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
150114268|NCT02047110|541555202|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
150114269|NCT02047110|541555203|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
150114270|NCT02047110|541555204|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
150114271|NCT02047110|541555205|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
150114272|NCT02047110|541555202|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
150114273|NCT02047110|541555203|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
150114274|NCT02047110|541555204|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
150114275|NCT02047110|541555205|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
150114276|NCT02047110|541555202|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
150114277|NCT02047110|541555203|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
150114278|NCT02047110|541555204|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
150114279|NCT02047110|541555205|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
150114280|NCT02047110|541555202|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
150114281|NCT02047110|541555203|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
150114282|NCT02047110|541555204|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
150114283|NCT02047110|541555205|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
150114284|NCT02047110|541555202|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
150114285|NCT02047110|541555203|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
150114286|NCT02047110|541555204|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
150114287|NCT02047110|541555205|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
150114288|NCT02047110|541555202|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
150114289|NCT02047110|541555203|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
150114290|NCT02047110|541555204|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
150114291|NCT02047110|541555205|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
150114292|NCT02047110|541555202|FG000|Escape Treatment Period|Adverse Event|1|||
150114293|NCT02047110|541555203|FG001|Escape Treatment Period|Adverse Event|2|||
150114294|NCT02047110|541555204|FG002|Escape Treatment Period|Adverse Event|2|||
150114295|NCT02047110|541555205|FG003|Escape Treatment Period|Adverse Event|0|||
150114296|NCT02047110|541555202|FG000|Escape Treatment Period|Other than specified|1|||
150114297|NCT02047110|541555203|FG001|Escape Treatment Period|Other than specified|2|||
150114298|NCT02047110|541555204|FG002|Escape Treatment Period|Other than specified|0|||
150114299|NCT02047110|541555205|FG003|Escape Treatment Period|Other than specified|1|||
150114300|NCT02047110|541555202|FG000|OLE Treatment Period|Other than specified|0|||
150114301|NCT02047110|541555203|FG001|OLE Treatment Period|Other than specified|0|||
150114302|NCT02047110|541555204|FG002|OLE Treatment Period|Other than specified|1|||
150114303|NCT02047110|541555205|FG003|OLE Treatment Period|Other than specified|0|||
150114304|NCT00705575|541555206|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150114305|NCT00705575|541555207|FG001|Overall Study|Abnormal laboratory value(s)|3|||
150114306|NCT00705575|541555206|FG000|Overall Study|Abnormal test procedure result(s)|2|||
150114307|NCT00705575|541555207|FG001|Overall Study|Abnormal test procedure result(s)|12|||
150114308|NCT00705575|541555206|FG000|Overall Study|Adverse Event|11|||
150114309|NCT00705575|541555207|FG001|Overall Study|Adverse Event|15|||
150114310|NCT00705575|541555206|FG000|Overall Study|Lost to Follow-up|3|||
150114311|NCT00705575|541555207|FG001|Overall Study|Lost to Follow-up|4|||
150114312|NCT00705575|541555206|FG000|Overall Study|Protocol Violation|2|||
150114313|NCT00705575|541555207|FG001|Overall Study|Protocol Violation|2|||
150114314|NCT00705575|541555206|FG000|Overall Study|Withdrawal by Subject|5|||
150114315|NCT00705575|541555207|FG001|Overall Study|Withdrawal by Subject|10|||
150114316|NCT01959581|541555209|FG000|Overall Study|Lost to Follow-up|5|||
150114317|NCT02802345|541555214|FG000|Overall Study|Not Treated|0|||
150114318|NCT02802345|541555215|FG001|Overall Study|Not Treated|1|||
150114319|NCT02802345|541555214|FG000|Overall Study|Adverse Event|28|||
150114320|NCT02802345|541555215|FG001|Overall Study|Adverse Event|20|||
150114321|NCT02802345|541555214|FG000|Overall Study|Withdrawal by Subject|3|||
150114322|NCT02802345|541555215|FG001|Overall Study|Withdrawal by Subject|3|||
150114323|NCT02802345|541555214|FG000|Overall Study|Protocol Violation|0|||
150114324|NCT02802345|541555215|FG001|Overall Study|Protocol Violation|1|||
150114325|NCT02802345|541555214|FG000|Overall Study|Other than listed|1|||
150114326|NCT02802345|541555215|FG001|Overall Study|Other than listed|5|||
150114327|NCT02075320|541555218|FG000|Overall Study|Withdrawal by Subject|2|||
150114328|NCT03773757|541555220|FG000|Overall Study|Withdrawal by Subject|2|||
150114329|NCT03773757|541555221|FG001|Overall Study|Withdrawal by Subject|4|||
150114330|NCT00057746|541555222|FG000|Overall Study|Withdrawal by Subject|0|||
150114331|NCT00057746|541555223|FG001|Overall Study|Withdrawal by Subject|0|||
150114332|NCT00057746|541555224|FG002|Overall Study|Withdrawal by Subject|1|||
150114333|NCT01109316|541555225|FG000|Study Period 1|Adverse Event|0|||
150114334|NCT01109316|541555226|FG001|Study Period 1|Adverse Event|0|||
150114335|NCT01109316|541555227|FG002|Study Period 1|Adverse Event|1|||
150114336|NCT01109316|541555228|FG003|Study Period 1|Adverse Event|0|||
150114337|NCT01109316|541555229|FG004|Study Period 1|Adverse Event|0|||
150114338|NCT01109316|541555230|FG005|Study Period 1|Adverse Event|0|||
150114339|NCT01109316|541555225|FG000|Study Period 1|Lost to Follow-up|0|||
150114340|NCT01109316|541555226|FG001|Study Period 1|Lost to Follow-up|0|||
150114341|NCT01109316|541555227|FG002|Study Period 1|Lost to Follow-up|1|||
150114342|NCT01109316|541555228|FG003|Study Period 1|Lost to Follow-up|1|||
150114343|NCT01109316|541555229|FG004|Study Period 1|Lost to Follow-up|0|||
150114344|NCT01109316|541555230|FG005|Study Period 1|Lost to Follow-up|0|||
150114345|NCT01109316|541555225|FG000|Study Period 1|Withdrawal by Subject|0|||
150114346|NCT01109316|541555226|FG001|Study Period 1|Withdrawal by Subject|0|||
150114347|NCT01109316|541555227|FG002|Study Period 1|Withdrawal by Subject|1|||
150114348|NCT01109316|541555228|FG003|Study Period 1|Withdrawal by Subject|0|||
150114349|NCT01109316|541555229|FG004|Study Period 1|Withdrawal by Subject|2|||
150114350|NCT01109316|541555230|FG005|Study Period 1|Withdrawal by Subject|0|||
150114351|NCT01109316|541555225|FG000|Study Period 1|Sponsor Decision|0|||
150114352|NCT01109316|541555226|FG001|Study Period 1|Sponsor Decision|0|||
150114353|NCT01109316|541555227|FG002|Study Period 1|Sponsor Decision|0|||
150114354|NCT01109316|541555228|FG003|Study Period 1|Sponsor Decision|0|||
150114355|NCT01109316|541555229|FG004|Study Period 1|Sponsor Decision|0|||
150114356|NCT01109316|541555230|FG005|Study Period 1|Sponsor Decision|2|||
150114357|NCT01109316|541555225|FG000|Study Period 2|Entry Criteria Not Met|0|||
150114358|NCT01109316|541555226|FG001|Study Period 2|Entry Criteria Not Met|1|||
150114359|NCT01109316|541555227|FG002|Study Period 2|Entry Criteria Not Met|0|||
150114360|NCT01109316|541555228|FG003|Study Period 2|Entry Criteria Not Met|0|||
150114361|NCT01109316|541555229|FG004|Study Period 2|Entry Criteria Not Met|0|||
150114362|NCT01109316|541555230|FG005|Study Period 2|Entry Criteria Not Met|0|||
150114363|NCT01109316|541555225|FG000|Study Period 2|Physician Decision|0|||
150114364|NCT01109316|541555226|FG001|Study Period 2|Physician Decision|0|||
150114365|NCT01109316|541555227|FG002|Study Period 2|Physician Decision|0|||
150114366|NCT01109316|541555228|FG003|Study Period 2|Physician Decision|1|||
150114367|NCT01109316|541555229|FG004|Study Period 2|Physician Decision|0|||
150114368|NCT01109316|541555230|FG005|Study Period 2|Physician Decision|0|||
150114369|NCT01109316|541555225|FG000|Study Period 2|Protocol Violation|1|||
150114370|NCT01109316|541555226|FG001|Study Period 2|Protocol Violation|0|||
150114371|NCT01109316|541555227|FG002|Study Period 2|Protocol Violation|0|||
150114372|NCT01109316|541555228|FG003|Study Period 2|Protocol Violation|0|||
150114373|NCT01109316|541555229|FG004|Study Period 2|Protocol Violation|0|||
150114374|NCT01109316|541555230|FG005|Study Period 2|Protocol Violation|0|||
150114375|NCT01109316|541555225|FG000|Study Period 2|Withdrawal by Subject|0|||
150114376|NCT01109316|541555226|FG001|Study Period 2|Withdrawal by Subject|0|||
150114377|NCT01109316|541555227|FG002|Study Period 2|Withdrawal by Subject|1|||
150114378|NCT01109316|541555228|FG003|Study Period 2|Withdrawal by Subject|0|||
150189558|NCT02949362|541831345|FG000|Retrospective Period|Inform consent not signed by participant|4|||
150114379|NCT01109316|541555229|FG004|Study Period 2|Withdrawal by Subject|0|||
150114380|NCT01109316|541555230|FG005|Study Period 2|Withdrawal by Subject|1|||
150114381|NCT01109316|541555225|FG000|Study Period 3|Lost to Follow-up|0|||
150114382|NCT01109316|541555226|FG001|Study Period 3|Lost to Follow-up|0|||
150114383|NCT01109316|541555227|FG002|Study Period 3|Lost to Follow-up|0|||
150114384|NCT01109316|541555228|FG003|Study Period 3|Lost to Follow-up|0|||
150114385|NCT01109316|541555229|FG004|Study Period 3|Lost to Follow-up|1|||
150114386|NCT01109316|541555230|FG005|Study Period 3|Lost to Follow-up|0|||
150114387|NCT01109316|541555225|FG000|Study Period 3|Withdrawal by Subject|1|||
150114388|NCT01109316|541555226|FG001|Study Period 3|Withdrawal by Subject|0|||
150114389|NCT01109316|541555227|FG002|Study Period 3|Withdrawal by Subject|0|||
150114390|NCT01109316|541555228|FG003|Study Period 3|Withdrawal by Subject|0|||
150114391|NCT01109316|541555229|FG004|Study Period 3|Withdrawal by Subject|1|||
150114392|NCT01109316|541555230|FG005|Study Period 3|Withdrawal by Subject|0|||
150114393|NCT03511560|541555239|FG000|Overall Study|Death|0|||
150114394|NCT03511560|541555240|FG001|Overall Study|Death|1|||
150114395|NCT03511560|541555239|FG000|Overall Study|Adverse Event|0|||
150114396|NCT03511560|541555240|FG001|Overall Study|Adverse Event|2|||
150114397|NCT03511560|541555239|FG000|Overall Study|Transplant cancelled|0|||
150114398|NCT03511560|541555240|FG001|Overall Study|Transplant cancelled|1|||
150114399|NCT03511560|541555239|FG000|Overall Study|Patient switched to another drug|1|||
150114400|NCT03511560|541555240|FG001|Overall Study|Patient switched to another drug|0|||
150114401|NCT02985736|541555245|FG000|Overall Study|Lost to Follow-up|3|||
150114402|NCT00382733|541555246|FG000|Overall Study|Withdrawal by Subject|0|||
150114403|NCT00382733|541555247|FG001|Overall Study|Withdrawal by Subject|1|||
150114404|NCT00382733|541555248|FG002|Overall Study|Withdrawal by Subject|0|||
150114405|NCT00382733|541555249|FG003|Overall Study|Withdrawal by Subject|0|||
150114406|NCT00382733|541555250|FG004|Overall Study|Withdrawal by Subject|0|||
150114407|NCT00179413|541555251|FG000|Overall Study|Adverse Event|38|||
150114408|NCT00179413|541555252|FG001|Overall Study|Adverse Event|20|||
150114409|NCT00179413|541555251|FG000|Overall Study|Withdrawal by Subject|87|||
150114410|NCT00179413|541555252|FG001|Overall Study|Withdrawal by Subject|95|||
150114411|NCT00550836|541555253|FG000|Overall Study|Withdrawal by Subject|3|||
150114412|NCT00550836|541555254|FG001|Overall Study|Withdrawal by Subject|9|||
150114413|NCT03075644|541555257|FG000|Overall Study|Withdrawal by Subject|1|||
150114414|NCT03075644|541555258|FG001|Overall Study|Withdrawal by Subject|1|||
150114415|NCT00439140|541555259|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
150114416|NCT00439140|541555260|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
150114417|NCT00439140|541555261|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
150114418|NCT00439140|541555259|FG000|Treatment Cycle 1|Personal reasons|0|||
150114419|NCT00439140|541555260|FG001|Treatment Cycle 1|Personal reasons|2|||
150114420|NCT00439140|541555261|FG002|Treatment Cycle 1|Personal reasons|0|||
150114421|NCT00439140|541555259|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
150114422|NCT00439140|541555260|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
150114423|NCT00439140|541555261|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
150114424|NCT00439140|541555259|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
150114425|NCT00439140|541555260|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
150114426|NCT00439140|541555261|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
150114427|NCT00439140|541555259|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
150114428|NCT00439140|541555260|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
150114429|NCT00439140|541555261|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
150114430|NCT01458171|541555262|FG000|Overall Study|Adverse Event|1|||
150114431|NCT00578565|541555266|FG000|Overall Study|Adverse Event|3|||
150114432|NCT01192152|541555267|FG000|Period 1|left prematurely (while on treatment B)|0|||
150114433|NCT01192152|541555268|FG001|Period 1|left prematurely (while on treatment B)|1|||
150114434|NCT01192152|541555267|FG000|Period 3|family emergency|1|||
150114435|NCT01192152|541555268|FG001|Period 3|family emergency|0|||
150114436|NCT00854581|541555272|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
150114437|NCT00854581|541555272|FG000|Induction (Up to Day 21)|Death|1|||
150114438|NCT00854581|541555272|FG000|Induction (Up to Day 21)|Physician Decision|1|||
150114439|NCT00854581|541555272|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
150114440|NCT01339390|541555273|FG000|Overall Study|Death|32|||
150114441|NCT01339390|541555274|FG001|Overall Study|Death|29|||
150114442|NCT01339390|541555273|FG000|Overall Study|Lost to Follow-up|125|||
150114443|NCT01339390|541555274|FG001|Overall Study|Lost to Follow-up|127|||
150114444|NCT02348489|541556862|FG000|Overall Study|Death|336|||
150114445|NCT02348489|541556863|FG001|Overall Study|Death|335|||
150114446|NCT02348489|541556862|FG000|Overall Study|Withdrawal by Subject|14|||
150114447|NCT02348489|541556863|FG001|Overall Study|Withdrawal by Subject|27|||
150114448|NCT02348489|541556862|FG000|Overall Study|Lost to Follow-up|3|||
150114449|NCT02348489|541556863|FG001|Overall Study|Lost to Follow-up|5|||
150114450|NCT01750268|541556864|FG000|Overall Study|Lost to Follow-up|0|||
150114451|NCT01750268|541556865|FG001|Overall Study|Lost to Follow-up|2|||
150114452|NCT01750268|541556864|FG000|Overall Study|Physician Decision|0|||
150114453|NCT01750268|541556865|FG001|Overall Study|Physician Decision|3|||
150114454|NCT01750268|541556864|FG000|Overall Study|Withdrawal by Subject|2|||
150114455|NCT01750268|541556865|FG001|Overall Study|Withdrawal by Subject|0|||
150114456|NCT01777997|541556868|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
150114457|NCT01777997|541556868|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
150114458|NCT01777997|541556868|FG000|Weeks 48 to 72/96 on ART|Death|1|||
150114459|NCT01777997|541556868|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
150114460|NCT01694706|541556869|FG000|Overall Study|Adverse Event|0|||
150114461|NCT01694706|541556870|FG001|Overall Study|Adverse Event|1|||
150114462|NCT01694706|541556871|FG002|Overall Study|Adverse Event|0|||
150114463|NCT01694706|541556869|FG000|Overall Study|other reason not defined above|1|||
150114464|NCT01694706|541556870|FG001|Overall Study|other reason not defined above|0|||
150114465|NCT01694706|541556871|FG002|Overall Study|other reason not defined above|0|||
150114466|NCT01923181|541556872|FG000|Overall Study|Protocol Violation|2|||
150114467|NCT01923181|541556873|FG001|Overall Study|Protocol Violation|2|||
150114468|NCT01923181|541556874|FG002|Overall Study|Protocol Violation|0|||
150114469|NCT01923181|541556875|FG003|Overall Study|Protocol Violation|2|||
150114470|NCT01923181|541556876|FG004|Overall Study|Protocol Violation|2|||
150114471|NCT01923181|541556877|FG005|Overall Study|Protocol Violation|1|||
150114472|NCT01923181|541556878|FG006|Overall Study|Protocol Violation|1|||
150114473|NCT01923181|541556879|FG007|Overall Study|Protocol Violation|2|||
150114474|NCT01923181|541556880|FG008|Overall Study|Protocol Violation|1|||
150114475|NCT01923181|541556872|FG000|Overall Study|Withdrawal by Subject|0|||
150114476|NCT01923181|541556873|FG001|Overall Study|Withdrawal by Subject|1|||
150114477|NCT01923181|541556874|FG002|Overall Study|Withdrawal by Subject|0|||
150114478|NCT01923181|541556875|FG003|Overall Study|Withdrawal by Subject|1|||
150114479|NCT01923181|541556876|FG004|Overall Study|Withdrawal by Subject|4|||
150114480|NCT01923181|541556877|FG005|Overall Study|Withdrawal by Subject|2|||
150114481|NCT01923181|541556878|FG006|Overall Study|Withdrawal by Subject|4|||
150114482|NCT01923181|541556879|FG007|Overall Study|Withdrawal by Subject|3|||
150114483|NCT01923181|541556880|FG008|Overall Study|Withdrawal by Subject|1|||
150114484|NCT01923181|541556872|FG000|Overall Study|Other|1|||
150114485|NCT01923181|541556873|FG001|Overall Study|Other|0|||
150114486|NCT01923181|541556874|FG002|Overall Study|Other|0|||
150114487|NCT01923181|541556875|FG003|Overall Study|Other|1|||
150114488|NCT01923181|541556876|FG004|Overall Study|Other|0|||
150114489|NCT01923181|541556877|FG005|Overall Study|Other|0|||
150114490|NCT01923181|541556878|FG006|Overall Study|Other|0|||
150114491|NCT01923181|541556879|FG007|Overall Study|Other|0|||
150114492|NCT01923181|541556880|FG008|Overall Study|Other|0|||
150114493|NCT01923181|541556872|FG000|Overall Study|Lost to Follow-up|0|||
150114494|NCT01923181|541556873|FG001|Overall Study|Lost to Follow-up|3|||
150114495|NCT01923181|541556874|FG002|Overall Study|Lost to Follow-up|2|||
150114496|NCT01923181|541556875|FG003|Overall Study|Lost to Follow-up|1|||
150114497|NCT01923181|541556876|FG004|Overall Study|Lost to Follow-up|2|||
150114498|NCT01923181|541556877|FG005|Overall Study|Lost to Follow-up|1|||
150114499|NCT01923181|541556878|FG006|Overall Study|Lost to Follow-up|3|||
150114500|NCT01923181|541556879|FG007|Overall Study|Lost to Follow-up|3|||
150114501|NCT01923181|541556880|FG008|Overall Study|Lost to Follow-up|1|||
150114502|NCT02944578|541556881|FG000|Overall Study|Physician Decision|1|||
150114503|NCT02944578|541556882|FG001|Overall Study|Physician Decision|0|||
150114504|NCT02932891|541556884|FG000|Overall Study|Lost to Follow-up|2|||
150114505|NCT02932891|541556884|FG000|Overall Study|HPA Suppress|2|||
150114506|NCT00577122|541556887|FG000|Overall Study|Adverse Event|0|||
150114507|NCT00577122|541556888|FG001|Overall Study|Adverse Event|2|||
150114508|NCT00577122|541556887|FG000|Overall Study|Progression, relapse during active trt|6|||
150114509|NCT00577122|541556888|FG001|Overall Study|Progression, relapse during active trt|8|||
150114510|NCT00577122|541556887|FG000|Overall Study|Prog, refract disease during active trt|8|||
150114511|NCT00577122|541556888|FG001|Overall Study|Prog, refract disease during active trt|5|||
150114512|NCT00577122|541556887|FG000|Overall Study|Alternative Therapy|0|||
150114513|NCT00577122|541556888|FG001|Overall Study|Alternative Therapy|1|||
150114514|NCT00440271|541556890|FG000|Overall Study|Protocol Violation|1|||
150114515|NCT00440271|541556891|FG001|Overall Study|Protocol Violation|1|||
150114516|NCT00440271|541556890|FG000|Overall Study|Adverse Event|0|||
150114517|NCT00440271|541556891|FG001|Overall Study|Adverse Event|1|||
150114518|NCT00440271|541556890|FG000|Overall Study|Lost to Follow-up|1|||
150114519|NCT00440271|541556891|FG001|Overall Study|Lost to Follow-up|0|||
150114520|NCT00440271|541556890|FG000|Overall Study|Withdrawal by Subject|0|||
150114521|NCT00440271|541556891|FG001|Overall Study|Withdrawal by Subject|2|||
150114522|NCT00440271|541556890|FG000|Overall Study|Lack of Efficacy|0|||
150114523|NCT00440271|541556891|FG001|Overall Study|Lack of Efficacy|1|||
150114524|NCT00440271|541556890|FG000|Overall Study|Due to closure of trial|8|||
150114525|NCT00440271|541556891|FG001|Overall Study|Due to closure of trial|10|||
150114526|NCT00440271|541556890|FG000|Overall Study|Other|2|||
150114527|NCT00440271|541556891|FG001|Overall Study|Other|0|||
150189559|NCT02949362|541831346|FG001|Retrospective Period|Inform consent not signed by participant|1|||
150189560|NCT02949362|541831347|FG002|Retrospective Period|Inform consent not signed by participant|0|||
150114528|NCT00456092|541556892|FG000|Extension Phase|Grade 2 or Greater AE|2|||
150114529|NCT00456092|541556893|FG001|Extension Phase|Grade 2 or Greater AE|2|||
150114530|NCT00456092|541556894|FG002|Extension Phase|Grade 2 or Greater AE|0|||
150189561|NCT02949362|541831348|FG003|Retrospective Period|Inform consent not signed by participant|0|||
150189562|NCT02949362|541831345|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
150114531|NCT00456092|541556895|FG003|Extension Phase|Grade 2 or Greater AE|0|||
150114532|NCT00456092|541556896|FG004|Extension Phase|Grade 2 or Greater AE|2|||
150114533|NCT00456092|541556892|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
150114534|NCT00456092|541556893|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
150114535|NCT00456092|541556894|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
150114536|NCT00456092|541556895|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
150114537|NCT00456092|541556896|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
150114538|NCT00456092|541556892|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
150114539|NCT00456092|541556893|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
150114540|NCT00456092|541556894|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
150114541|NCT00456092|541556895|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
150114542|NCT00456092|541556896|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
150114543|NCT00456092|541556892|FG000|Extension Phase|Withdrew Consent|2|||
150114544|NCT00456092|541556893|FG001|Extension Phase|Withdrew Consent|0|||
150114545|NCT00456092|541556894|FG002|Extension Phase|Withdrew Consent|0|||
150114546|NCT00456092|541556895|FG003|Extension Phase|Withdrew Consent|0|||
150114547|NCT00456092|541556896|FG004|Extension Phase|Withdrew Consent|0|||
150114548|NCT00456092|541556892|FG000|Extension Phase|Lost to Follow-up|1|||
150114549|NCT00456092|541556893|FG001|Extension Phase|Lost to Follow-up|1|||
150114550|NCT00456092|541556894|FG002|Extension Phase|Lost to Follow-up|0|||
150114551|NCT00456092|541556895|FG003|Extension Phase|Lost to Follow-up|0|||
150114552|NCT00456092|541556896|FG004|Extension Phase|Lost to Follow-up|1|||
150114553|NCT00456092|541556892|FG000|Extension Phase|Other|2|||
150114554|NCT00456092|541556893|FG001|Extension Phase|Other|0|||
150114555|NCT00456092|541556894|FG002|Extension Phase|Other|0|||
150114556|NCT00456092|541556895|FG003|Extension Phase|Other|1|||
150114557|NCT00456092|541556896|FG004|Extension Phase|Other|1|||
150114558|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
150114559|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
150114560|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
150114561|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
150114562|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
150114563|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
150114564|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
150114565|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
150114566|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
150114567|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
150114568|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
150114569|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
150114570|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
150114571|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
150114572|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
150114573|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
150114574|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
150114575|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
150114576|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
150114577|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
150114578|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
150114579|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
150114580|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
150114581|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
150114582|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
150114583|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
150114584|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
150114585|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
150114586|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
150114587|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
150114588|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
150114589|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
150114590|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
150114591|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
150114592|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
150114593|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
150114594|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
150114595|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
150114596|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
150114597|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
150114598|NCT00456092|541556892|FG000|Treatment Phase (12 Weeks)|Other|1|||
150114599|NCT00456092|541556893|FG001|Treatment Phase (12 Weeks)|Other|0|||
150114600|NCT00456092|541556894|FG002|Treatment Phase (12 Weeks)|Other|1|||
150114601|NCT00456092|541556895|FG003|Treatment Phase (12 Weeks)|Other|0|||
150114602|NCT00456092|541556896|FG004|Treatment Phase (12 Weeks)|Other|0|||
150114603|NCT01565993|541556911|FG000|Overall Study|Physician Decision|0|||
150114604|NCT01565993|541556912|FG001|Overall Study|Physician Decision|3|||
150189563|NCT02949362|541831346|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
150189564|NCT02949362|541831347|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
150114605|NCT04086472|541556913|FG000|Overall Study|Lost to Follow-up|1|||
150114606|NCT04086472|541556914|FG001|Overall Study|Lost to Follow-up|0|||
150114607|NCT04086472|541556915|FG002|Overall Study|Lost to Follow-up|0|||
150114608|NCT04086472|541556916|FG003|Overall Study|Lost to Follow-up|0|||
150114609|NCT04086472|541556917|FG004|Overall Study|Lost to Follow-up|1|||
150114610|NCT04086472|541556913|FG000|Overall Study|Physician Decision|0|||
150114611|NCT04086472|541556914|FG001|Overall Study|Physician Decision|1|||
150114612|NCT04086472|541556915|FG002|Overall Study|Physician Decision|1|||
150114613|NCT04086472|541556916|FG003|Overall Study|Physician Decision|0|||
150114614|NCT04086472|541556917|FG004|Overall Study|Physician Decision|0|||
150114615|NCT04086472|541556913|FG000|Overall Study|Withdrawal by Subject|1|||
150114616|NCT04086472|541556914|FG001|Overall Study|Withdrawal by Subject|1|||
150114617|NCT04086472|541556915|FG002|Overall Study|Withdrawal by Subject|1|||
150114618|NCT04086472|541556916|FG003|Overall Study|Withdrawal by Subject|0|||
150114619|NCT04086472|541556917|FG004|Overall Study|Withdrawal by Subject|0|||
150114620|NCT04086472|541556913|FG000|Overall Study|Various reasons|2|||
150114621|NCT04086472|541556914|FG001|Overall Study|Various reasons|0|||
150114622|NCT04086472|541556915|FG002|Overall Study|Various reasons|0|||
150114623|NCT04086472|541556916|FG003|Overall Study|Various reasons|3|||
150114624|NCT04086472|541556917|FG004|Overall Study|Various reasons|1|||
150114625|NCT02252081|541556918|FG000|Overall Study|Withdrawal by Subject|2|||
150114626|NCT02252081|541556919|FG001|Overall Study|Withdrawal by Subject|1|||
150114627|NCT02252081|541556918|FG000|Overall Study|Adverse Event|4|||
150114628|NCT02252081|541556919|FG001|Overall Study|Adverse Event|1|||
150114629|NCT02252081|541556918|FG000|Overall Study|non compliance & others|0|||
150114630|NCT02252081|541556919|FG001|Overall Study|non compliance & others|2|||
150114631|NCT00048724|541556925|FG000|Overall Study|Adverse Event|53|||
150114632|NCT00048724|541556926|FG001|Overall Study|Adverse Event|12|||
150114633|NCT00048724|541556925|FG000|Overall Study|Withdrawal by Subject|34|||
150114634|NCT00048724|541556926|FG001|Overall Study|Withdrawal by Subject|54|||
150114635|NCT00048724|541556925|FG000|Overall Study|Lost to Follow-up|5|||
150114636|NCT00048724|541556926|FG001|Overall Study|Lost to Follow-up|5|||
150114637|NCT00048724|541556925|FG000|Overall Study|Protocol-defined Clinical Event|17|||
150114638|NCT00048724|541556926|FG001|Overall Study|Protocol-defined Clinical Event|32|||
150114639|NCT00048724|541556925|FG000|Overall Study|Noncompliance With Protocol|4|||
150114640|NCT00048724|541556926|FG001|Overall Study|Noncompliance With Protocol|12|||
150114641|NCT00048724|541556925|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
150114642|NCT00048724|541556926|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
150114643|NCT00048724|541556925|FG000|Overall Study|Administrative|1|||
150114644|NCT00048724|541556926|FG001|Overall Study|Administrative|1|||
150114645|NCT01743092|541556927|FG000|Overall Study|Lost to Follow-up|14|||
150114646|NCT01743092|541556928|FG001|Overall Study|Lost to Follow-up|15|||
150114647|NCT02370888|541556931|FG000|Overall Study|disease progression|2|||
150114648|NCT02370888|541556931|FG000|Overall Study|did not meet chimerism criteria|6|||
150114649|NCT04574362|541556932|FG000|Overall Study|Other|0|||
150114650|NCT04574362|541556933|FG001|Overall Study|Other|5|||
150114651|NCT04574362|541556932|FG000|Overall Study|COVID-19|0|||
150114652|NCT04574362|541556933|FG001|Overall Study|COVID-19|1|||
150114653|NCT04574362|541556932|FG000|Overall Study|Adverse Event|1|||
150114654|NCT04574362|541556933|FG001|Overall Study|Adverse Event|1|||
150114655|NCT04574362|541556932|FG000|Overall Study|Withdrawal by Subject|2|||
150114656|NCT04574362|541556933|FG001|Overall Study|Withdrawal by Subject|4|||
150114657|NCT04574362|541556932|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
150114658|NCT04574362|541556933|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
150114659|NCT04574362|541556932|FG000|Overall Study|Participant refused to come to the hospital|1|||
150114660|NCT04574362|541556933|FG001|Overall Study|Participant refused to come to the hospital|0|||
150114661|NCT04574362|541556932|FG000|Overall Study|Participant refused the visit|1|||
150114662|NCT04574362|541556933|FG001|Overall Study|Participant refused the visit|0|||
150114663|NCT04574362|541556932|FG000|Overall Study|Participant quit early because of business trip|1|||
150114664|NCT04574362|541556933|FG001|Overall Study|Participant quit early because of business trip|0|||
150114665|NCT01600040|541556935|FG000|Overall Study|Withdrawal by Subject|1|||
150114666|NCT00642304|541556936|FG000|Overall Study|Adverse Event|1|||
150114667|NCT00642304|541556936|FG000|Overall Study|Death|1|||
150189565|NCT02949362|541831348|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
150114668|NCT00642304|541556936|FG000|Overall Study|Blood transfusion|2|||
150114669|NCT00642304|541556936|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
150114670|NCT00642304|541556936|FG000|Overall Study|Transplantation|1|||
150114671|NCT02579616|541556940|FG000|Overall Study|Participants did not receive treatment|3|||
150114672|NCT02178475|541556941|FG000|Overall Study|Withdrawal by Subject|7|||
150189566|NCT02949362|541831345|FG000|Prospective Period|Other|0|||
150114673|NCT02178475|541556941|FG000|Overall Study|Lost to Follow-up|10|||
150114674|NCT02178475|541556941|FG000|Overall Study|Death|13|||
150189567|NCT02949362|541831346|FG001|Prospective Period|Other|0|||
150114675|NCT02178475|541556941|FG000|Overall Study|Protocol-specified Criteria|99|||
150114676|NCT01490060|541556942|FG000|Cycle 1|Change of Treatment|0|||
150189568|NCT02949362|541831347|FG002|Prospective Period|Other|0|||
150114677|NCT01490060|541556943|FG001|Cycle 1|Change of Treatment|1|||
150114678|NCT01490060|541556944|FG002|Cycle 1|Change of Treatment|1|||
150114679|NCT01490060|541556945|FG003|Cycle 1|Change of Treatment|1|||
150114680|NCT01490060|541556942|FG000|Cycle 1|Insurance Denied|0|||
150114681|NCT01490060|541556943|FG001|Cycle 1|Insurance Denied|0|||
150114682|NCT01490060|541556944|FG002|Cycle 1|Insurance Denied|2|||
150114683|NCT01490060|541556945|FG003|Cycle 1|Insurance Denied|0|||
150114684|NCT01490060|541556942|FG000|Cycle 1|Withdrawal by Subject|0|||
150114685|NCT01490060|541556943|FG001|Cycle 1|Withdrawal by Subject|0|||
150114686|NCT01490060|541556944|FG002|Cycle 1|Withdrawal by Subject|0|||
150114687|NCT01490060|541556945|FG003|Cycle 1|Withdrawal by Subject|1|||
150114688|NCT01490060|541556942|FG000|Cycle 1|Treatment at Another Facility|0|||
150114689|NCT01490060|541556943|FG001|Cycle 1|Treatment at Another Facility|0|||
150114690|NCT01490060|541556944|FG002|Cycle 1|Treatment at Another Facility|0|||
150114691|NCT01490060|541556945|FG003|Cycle 1|Treatment at Another Facility|1|||
150114692|NCT01490060|541556942|FG000|Cycle 2|Change of Treatment|1|||
150114693|NCT01490060|541556943|FG001|Cycle 2|Change of Treatment|1|||
150114694|NCT01490060|541556944|FG002|Cycle 2|Change of Treatment|0|||
150114695|NCT01490060|541556945|FG003|Cycle 2|Change of Treatment|0|||
150114696|NCT01490060|541556942|FG000|Cycle 2|Non-Compliance|0|||
150114697|NCT01490060|541556943|FG001|Cycle 2|Non-Compliance|0|||
150114698|NCT01490060|541556944|FG002|Cycle 2|Non-Compliance|1|||
150114699|NCT01490060|541556945|FG003|Cycle 2|Non-Compliance|0|||
150114700|NCT01490060|541556942|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
150114701|NCT01490060|541556943|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
150114702|NCT01490060|541556944|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
150114703|NCT01490060|541556945|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
150114704|NCT03698773|541556956|FG000|Overall Study|Lost to Follow-up|2|||
150114705|NCT03698773|541556957|FG001|Overall Study|Lost to Follow-up|1|||
150114706|NCT02399085|541556958|FG000|Overall Study|Adverse Event|16|||
150114707|NCT02399085|541556958|FG000|Overall Study|Death|2|||
150114708|NCT02399085|541556958|FG000|Overall Study|Withdrawal by Subject|8|||
150114709|NCT02399085|541556958|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
150114710|NCT02399085|541556958|FG000|Overall Study|Physician Decision|5|||
150114711|NCT00699699|541556959|FG000|Overall Study|Adverse Event|36|||
150114712|NCT00699699|541556959|FG000|Overall Study|Individual different reasons|21|||
150114713|NCT02170727|541556960|FG000|Overall Study|Lost to Follow-up|1|||
150114714|NCT02170727|541556961|FG001|Overall Study|Lost to Follow-up|0|||
150114715|NCT02170727|541556960|FG000|Overall Study|Withdrawal by Subject|2|||
150114716|NCT02170727|541556961|FG001|Overall Study|Withdrawal by Subject|0|||
150114717|NCT00414050|541556964|FG000|Overall Study|Adverse Event|1|||
150114718|NCT00414050|541556965|FG001|Overall Study|Adverse Event|1|||
150114719|NCT00414050|541556966|FG002|Overall Study|Adverse Event|1|||
150114720|NCT00414050|541556967|FG003|Overall Study|Adverse Event|1|||
150114721|NCT00414050|541556964|FG000|Overall Study|Lost to Follow-up|2|||
150114722|NCT00414050|541556965|FG001|Overall Study|Lost to Follow-up|2|||
150114723|NCT00414050|541556966|FG002|Overall Study|Lost to Follow-up|1|||
150114724|NCT00414050|541556967|FG003|Overall Study|Lost to Follow-up|1|||
150114725|NCT00414050|541556964|FG000|Overall Study|Withdrawal by Subject|5|||
150114726|NCT00414050|541556965|FG001|Overall Study|Withdrawal by Subject|3|||
150114727|NCT00414050|541556966|FG002|Overall Study|Withdrawal by Subject|2|||
150114728|NCT00414050|541556967|FG003|Overall Study|Withdrawal by Subject|4|||
150114729|NCT00414050|541556964|FG000|Overall Study|Subject discontinued for other reason|1|||
150114730|NCT00414050|541556965|FG001|Overall Study|Subject discontinued for other reason|2|||
150114731|NCT00414050|541556966|FG002|Overall Study|Subject discontinued for other reason|2|||
150114732|NCT00414050|541556967|FG003|Overall Study|Subject discontinued for other reason|1|||
150114733|NCT00414050|541556964|FG000|Overall Study|Subject Moved|0|||
150114734|NCT00414050|541556965|FG001|Overall Study|Subject Moved|0|||
150114735|NCT00414050|541556966|FG002|Overall Study|Subject Moved|0|||
150114736|NCT00414050|541556967|FG003|Overall Study|Subject Moved|1|||
150114737|NCT00515827|541556968|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
150114738|NCT00515827|541556969|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
150114739|NCT00515827|541556968|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
150114740|NCT00515827|541556969|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
150114741|NCT03254134|541556970|FG000|Overall Study|Not eligible patients|599|||
150114742|NCT03254134|541556971|FG001|Overall Study|Not eligible patients|3630|||
150114743|NCT02563028|541556972|FG000|Overall Study|Lack of equipment|1|||
150114744|NCT02563028|541556972|FG000|Overall Study|Unable to elicit VEP post induction|1|||
150114745|NCT01009099|541556973|FG000|Overall Study|Lost to Follow-up|1|||
150114746|NCT01009099|541556974|FG001|Overall Study|Lost to Follow-up|0|||
150114747|NCT01009099|541556973|FG000|Overall Study|Physician Decision|3|||
150114748|NCT01009099|541556974|FG001|Overall Study|Physician Decision|2|||
150114749|NCT01009099|541556973|FG000|Overall Study|Withdrawal by Subject|1|||
150114750|NCT01009099|541556974|FG001|Overall Study|Withdrawal by Subject|1|||
150114751|NCT01009099|541556973|FG000|Overall Study|Death|0|||
150114752|NCT01009099|541556974|FG001|Overall Study|Death|1|||
150114753|NCT01856543|541556975|FG000|Overall Study|Treatment discontinued|6|||
150189569|NCT02949362|541831348|FG003|Prospective Period|Other|4|||
150114754|NCT01856543|541556976|FG001|Overall Study|Treatment discontinued|3|||
150114755|NCT01856543|541556975|FG000|Overall Study|Withdrawn before start|7|||
150114756|NCT01856543|541556976|FG001|Overall Study|Withdrawn before start|3|||
150114757|NCT00799617|541556981|FG000|Main Testosterone Trial|Randomized in error|1|||
150114758|NCT00799617|541556982|FG001|Main Testosterone Trial|Randomized in error|1|||
150114759|NCT00799617|541556981|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
150114760|NCT00799617|541556982|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
150114761|NCT00799617|541556981|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
150114762|NCT00799617|541556982|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
150114763|NCT00799617|541556981|FG000|Sexual Funtion Trial|No Baseline Data|4|||
150114764|NCT00799617|541556982|FG001|Sexual Funtion Trial|No Baseline Data|7|||
150114765|NCT00799617|541556981|FG000|Physical Function Trial|Lost to Follow-up|6|||
150114766|NCT00799617|541556982|FG001|Physical Function Trial|Lost to Follow-up|11|||
150114767|NCT00799617|541556981|FG000|Vitality Trial|Lost to Follow-up|7|||
150114768|NCT00799617|541556982|FG001|Vitality Trial|Lost to Follow-up|22|||
150114769|NCT00799617|541556981|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
150114770|NCT00799617|541556982|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
150114771|NCT00799617|541556981|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
150114772|NCT00799617|541556982|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
150114773|NCT00799617|541556981|FG000|Bone Trial|Month 12 scan not available|6|||
150114774|NCT00799617|541556982|FG001|Bone Trial|Month 12 scan not available|16|||
150114775|NCT00799617|541556981|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
150114776|NCT00799617|541556982|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
150114777|NCT00799617|541556981|FG000|Anemia Trial|Withdrawal by Subject|3|||
150114778|NCT00799617|541556982|FG001|Anemia Trial|Withdrawal by Subject|3|||
150114779|NCT04545515|541556983|FG000|Overall Study|Adverse Event|1|||
150114780|NCT04545515|541556983|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
150114781|NCT04545515|541556983|FG000|Overall Study|Commercial drug is available for participant|7|||
150114782|NCT01712984|541556984|FG000|Overall Study|Adverse Event|0|||
150114783|NCT01712984|541556985|FG001|Overall Study|Adverse Event|0|||
150114784|NCT01712984|541556986|FG002|Overall Study|Adverse Event|1|||
150114785|NCT01712984|541556984|FG000|Overall Study|Protocol Violation|2|||
150114786|NCT01712984|541556985|FG001|Overall Study|Protocol Violation|0|||
150114787|NCT01712984|541556986|FG002|Overall Study|Protocol Violation|1|||
150114788|NCT01712984|541556984|FG000|Overall Study|Lost to Follow-up|8|||
150114789|NCT01712984|541556985|FG001|Overall Study|Lost to Follow-up|10|||
150114790|NCT01712984|541556986|FG002|Overall Study|Lost to Follow-up|1|||
150114791|NCT01712984|541556984|FG000|Overall Study|Withdrawal by Subject|6|||
150114792|NCT01712984|541556985|FG001|Overall Study|Withdrawal by Subject|6|||
150114793|NCT01712984|541556986|FG002|Overall Study|Withdrawal by Subject|7|||
150114794|NCT02501096|541556987|FG000|Overall Study|Lost to Follow-up|0|||
150114795|NCT02501096|541556988|FG001|Overall Study|Lost to Follow-up|0|||
150114796|NCT02501096|541556989|FG002|Overall Study|Lost to Follow-up|0|||
150114797|NCT02501096|541556990|FG003|Overall Study|Lost to Follow-up|0|||
150114798|NCT02501096|541556991|FG004|Overall Study|Lost to Follow-up|1|||
150114799|NCT02501096|541556992|FG005|Overall Study|Lost to Follow-up|1|||
150114800|NCT02501096|541556993|FG006|Overall Study|Lost to Follow-up|3|||
150114801|NCT02501096|541556994|FG007|Overall Study|Lost to Follow-up|0|||
150114802|NCT02501096|541556995|FG008|Overall Study|Lost to Follow-up|0|||
150114803|NCT02501096|541556987|FG000|Overall Study|Withdrawal by Subject|1|||
150114804|NCT02501096|541556988|FG001|Overall Study|Withdrawal by Subject|0|||
150114805|NCT02501096|541556989|FG002|Overall Study|Withdrawal by Subject|7|||
150114806|NCT02501096|541556990|FG003|Overall Study|Withdrawal by Subject|13|||
150114807|NCT02501096|541556991|FG004|Overall Study|Withdrawal by Subject|2|||
150114808|NCT02501096|541556992|FG005|Overall Study|Withdrawal by Subject|2|||
150114809|NCT02501096|541556993|FG006|Overall Study|Withdrawal by Subject|2|||
150114810|NCT02501096|541556994|FG007|Overall Study|Withdrawal by Subject|3|||
150114811|NCT02501096|541556995|FG008|Overall Study|Withdrawal by Subject|0|||
150114812|NCT02501096|541556987|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
150114813|NCT02501096|541556988|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
150114814|NCT02501096|541556989|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
150114815|NCT02501096|541556990|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
150114816|NCT02501096|541556991|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
150114817|NCT02501096|541556992|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
150114818|NCT02501096|541556993|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
150114819|NCT02501096|541556994|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
150114820|NCT02501096|541556995|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
150114821|NCT02501096|541556987|FG000|Overall Study|Death|1|||
150114822|NCT02501096|541556988|FG001|Overall Study|Death|1|||
150114823|NCT02501096|541556989|FG002|Overall Study|Death|88|||
150114824|NCT02501096|541556990|FG003|Overall Study|Death|74|||
150114825|NCT02501096|541556991|FG004|Overall Study|Death|15|||
150114826|NCT02501096|541556992|FG005|Overall Study|Death|16|||
150114827|NCT02501096|541556993|FG006|Overall Study|Death|15|||
150114828|NCT02501096|541556994|FG007|Overall Study|Death|16|||
150114829|NCT02501096|541556995|FG008|Overall Study|Death|1|||
150114830|NCT01848990|541556996|FG000|Overall Study|Adverse Event|6|||
150114831|NCT01848990|541556997|FG001|Overall Study|Adverse Event|2|||
150114832|NCT01848990|541556998|FG002|Overall Study|Adverse Event|0|||
150114833|NCT01848990|541556996|FG000|Overall Study|Lost to Follow-up|6|||
150114834|NCT01848990|541556997|FG001|Overall Study|Lost to Follow-up|2|||
150114835|NCT01848990|541556998|FG002|Overall Study|Lost to Follow-up|2|||
150114836|NCT01848990|541556996|FG000|Overall Study|Protocol Violation|1|||
150114837|NCT01848990|541556997|FG001|Overall Study|Protocol Violation|1|||
150114838|NCT01848990|541556998|FG002|Overall Study|Protocol Violation|0|||
150114839|NCT01848990|541556996|FG000|Overall Study|Withdrawal by Subject|29|||
150114840|NCT01848990|541556997|FG001|Overall Study|Withdrawal by Subject|10|||
150114841|NCT01848990|541556998|FG002|Overall Study|Withdrawal by Subject|11|||
150114842|NCT01848990|541556996|FG000|Overall Study|Physician Decision|1|||
150114843|NCT01848990|541556997|FG001|Overall Study|Physician Decision|1|||
150114844|NCT01848990|541556998|FG002|Overall Study|Physician Decision|0|||
150114845|NCT01848990|541556996|FG000|Overall Study|Non Compliance|1|||
150114846|NCT01848990|541556997|FG001|Overall Study|Non Compliance|0|||
150114847|NCT01848990|541556998|FG002|Overall Study|Non Compliance|0|||
150114848|NCT01848990|541556996|FG000|Overall Study|Death|1|||
150114849|NCT01848990|541556997|FG001|Overall Study|Death|0|||
150114850|NCT01848990|541556998|FG002|Overall Study|Death|1|||
150114851|NCT01848990|541556996|FG000|Overall Study|Other|1|||
150114852|NCT01848990|541556997|FG001|Overall Study|Other|4|||
150114853|NCT01848990|541556998|FG002|Overall Study|Other|2|||
150114854|NCT00512096|541557001|FG000|Overall Study|Adverse Event|2|||
150114855|NCT00512096|541557001|FG000|Overall Study|Withdrawal by Subject|2|||
150114856|NCT00512096|541557001|FG000|Overall Study|Lack of Efficacy|3|||
150114857|NCT01069289|541557008|FG000|Overall Study|Withdrawal by Subject|15|||
150114858|NCT01069289|541557009|FG001|Overall Study|Withdrawal by Subject|26|||
150114859|NCT01069289|541557008|FG000|Overall Study|Adverse Event|21|||
150114860|NCT01069289|541557009|FG001|Overall Study|Adverse Event|28|||
150114861|NCT01069289|541557008|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
150114862|NCT01069289|541557009|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150114863|NCT01069289|541557008|FG000|Overall Study|Severe non-compliance to protocol|3|||
150114864|NCT01069289|541557009|FG001|Overall Study|Severe non-compliance to protocol|2|||
150114865|NCT01069289|541557008|FG000|Overall Study|Due to deteriorating health condition|1|||
150114866|NCT01069289|541557009|FG001|Overall Study|Due to deteriorating health condition|0|||
150114867|NCT00298038|541557010|FG000|Overall Study|Lost to Follow-up|0|||
150114868|NCT00298038|541557011|FG001|Overall Study|Lost to Follow-up|1|||
150114869|NCT00298038|541557010|FG000|Overall Study|Liver Transplant|0|||
150114870|NCT00298038|541557011|FG001|Overall Study|Liver Transplant|1|||
150114871|NCT00298038|541557010|FG000|Overall Study|Protocol Violation|1|||
150114872|NCT00298038|541557011|FG001|Overall Study|Protocol Violation|3|||
150114873|NCT00298038|541557010|FG000|Overall Study|Death|6|||
150114874|NCT00298038|541557011|FG001|Overall Study|Death|3|||
150114875|NCT00298038|541557010|FG000|Overall Study|Withdrawal by Subject|6|||
150114876|NCT00298038|541557011|FG001|Overall Study|Withdrawal by Subject|9|||
150114877|NCT00298038|541557010|FG000|Overall Study|Adverse Event|8|||
150114878|NCT00298038|541557011|FG001|Overall Study|Adverse Event|7|||
150114879|NCT00298038|541557010|FG000|Overall Study|Breakthrough overt HE episode|28|||
150114880|NCT00298038|541557011|FG001|Overall Study|Breakthrough overt HE episode|69|||
150114881|NCT00298038|541557010|FG000|Overall Study|Noncompliance|1|||
150114882|NCT00298038|541557011|FG001|Overall Study|Noncompliance|0|||
150114883|NCT00298038|541557010|FG000|Overall Study|Cocaine Abuse|1|||
150114884|NCT00298038|541557011|FG001|Overall Study|Cocaine Abuse|0|||
150114885|NCT00298038|541557010|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
150114886|NCT00298038|541557011|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
150114887|NCT02696096|541557012|FG000|Overall Study|ruled out at screening|1|||
150114888|NCT02696096|541557012|FG000|Overall Study|did not attend second fMRI|1|||
150189570|NCT04015167|541831349|FG000|Overall Study|Lost to Follow-up|40|||
150189571|NCT04015167|541831349|FG000|Overall Study|Adverse Event|5|||
150189572|NCT04015167|541831349|FG000|Overall Study|Withdrawal by Subject|2|||
150189573|NCT04015167|541831349|FG000|Overall Study|Subject went to jail|1|||
150189574|NCT05008835|541831351|FG000|Overall Study|Adverse Event|5|||
150189575|NCT05008835|541831352|FG001|Overall Study|Adverse Event|2|||
150189576|NCT05008835|541831353|FG002|Overall Study|Adverse Event|1|||
150189577|NCT05008835|541831351|FG000|Overall Study|Lack of Efficacy|0|||
150114889|NCT00827372|541558178|FG000|Overall Study|Adverse Event|5|||
150114890|NCT00827372|541558178|FG000|Overall Study|Lack of Efficacy|3|||
150114891|NCT02766608|541558182|FG000|Overall Study|Adverse Event|27|||
150114892|NCT02766608|541558183|FG001|Overall Study|Adverse Event|22|||
150114893|NCT02766608|541558184|FG002|Overall Study|Adverse Event|17|||
150114894|NCT02766608|541558185|FG003|Overall Study|Adverse Event|13|||
150114895|NCT02766608|541558186|FG004|Overall Study|Adverse Event|12|||
150114896|NCT02766608|541558182|FG000|Overall Study|Withdrawal by Subject|21|||
150114897|NCT02766608|541558183|FG001|Overall Study|Withdrawal by Subject|20|||
150114898|NCT02766608|541558184|FG002|Overall Study|Withdrawal by Subject|24|||
150114899|NCT02766608|541558185|FG003|Overall Study|Withdrawal by Subject|13|||
150114900|NCT02766608|541558186|FG004|Overall Study|Withdrawal by Subject|10|||
150114901|NCT02766608|541558182|FG000|Overall Study|Lack of Efficacy|16|||
150114902|NCT02766608|541558183|FG001|Overall Study|Lack of Efficacy|15|||
150114903|NCT02766608|541558184|FG002|Overall Study|Lack of Efficacy|32|||
150114904|NCT02766608|541558185|FG003|Overall Study|Lack of Efficacy|8|||
150114905|NCT02766608|541558186|FG004|Overall Study|Lack of Efficacy|2|||
150114906|NCT02766608|541558182|FG000|Overall Study|Lost to Follow-up|6|||
150114907|NCT02766608|541558183|FG001|Overall Study|Lost to Follow-up|3|||
150114908|NCT02766608|541558184|FG002|Overall Study|Lost to Follow-up|5|||
150114909|NCT02766608|541558185|FG003|Overall Study|Lost to Follow-up|2|||
150114910|NCT02766608|541558186|FG004|Overall Study|Lost to Follow-up|2|||
150114911|NCT02766608|541558182|FG000|Overall Study|Physician Decision|3|||
150114912|NCT02766608|541558183|FG001|Overall Study|Physician Decision|2|||
150114913|NCT02766608|541558184|FG002|Overall Study|Physician Decision|3|||
150114914|NCT02766608|541558185|FG003|Overall Study|Physician Decision|1|||
150114915|NCT02766608|541558186|FG004|Overall Study|Physician Decision|2|||
150114916|NCT02766608|541558182|FG000|Overall Study|Protocol disc criteria|3|||
150114917|NCT02766608|541558183|FG001|Overall Study|Protocol disc criteria|3|||
150114918|NCT02766608|541558184|FG002|Overall Study|Protocol disc criteria|4|||
150114919|NCT02766608|541558185|FG003|Overall Study|Protocol disc criteria|0|||
150114920|NCT02766608|541558186|FG004|Overall Study|Protocol disc criteria|0|||
150114921|NCT02766608|541558182|FG000|Overall Study|Protocol Violation|0|||
150114922|NCT02766608|541558183|FG001|Overall Study|Protocol Violation|4|||
150114923|NCT02766608|541558184|FG002|Overall Study|Protocol Violation|4|||
150114924|NCT02766608|541558185|FG003|Overall Study|Protocol Violation|0|||
150114925|NCT02766608|541558186|FG004|Overall Study|Protocol Violation|1|||
150114926|NCT02766608|541558182|FG000|Overall Study|Administrative Reasons|3|||
150114927|NCT02766608|541558183|FG001|Overall Study|Administrative Reasons|1|||
150114928|NCT02766608|541558184|FG002|Overall Study|Administrative Reasons|1|||
150114929|NCT02766608|541558185|FG003|Overall Study|Administrative Reasons|0|||
150114930|NCT02766608|541558186|FG004|Overall Study|Administrative Reasons|0|||
150114931|NCT01265953|541558189|FG000|Overall Study|Non compliance|5|||
150114932|NCT01265953|541558190|FG001|Overall Study|Non compliance|3|||
150114933|NCT02866682|541558193|FG000|Overall Study|Death|0|||
150114934|NCT02866682|541558194|FG001|Overall Study|Death|1|||
150114935|NCT02866682|541558193|FG000|Overall Study|Lost to Follow-up|0|||
150114936|NCT02866682|541558194|FG001|Overall Study|Lost to Follow-up|4|||
150114937|NCT02866682|541558193|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
150114938|NCT02866682|541558194|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
150114939|NCT02866682|541558193|FG000|Overall Study|Other|0|||
150114940|NCT02866682|541558194|FG001|Overall Study|Other|1|||
150114941|NCT00201006|541558195|FG000|Overall Study|Withdrawal by Subject|7|||
150114942|NCT00201006|541558196|FG001|Overall Study|Withdrawal by Subject|2|||
150114943|NCT00201006|541558197|FG002|Overall Study|Withdrawal by Subject|3|||
150114944|NCT00201006|541558195|FG000|Overall Study|Adverse Event|1|||
150114945|NCT00201006|541558196|FG001|Overall Study|Adverse Event|0|||
150114946|NCT00201006|541558197|FG002|Overall Study|Adverse Event|1|||
150114947|NCT00938431|541558204|FG000|Overall Study|Adverse Event|5|||
150114948|NCT00938431|541558205|FG001|Overall Study|Adverse Event|8|||
150114949|NCT00938431|541558206|FG002|Overall Study|Adverse Event|6|||
150114950|NCT00938431|541558204|FG000|Overall Study|Lack of Efficacy|0|||
150114951|NCT00938431|541558205|FG001|Overall Study|Lack of Efficacy|1|||
150114952|NCT00938431|541558206|FG002|Overall Study|Lack of Efficacy|0|||
150114953|NCT00938431|541558204|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
150114954|NCT00938431|541558205|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
150114955|NCT00938431|541558206|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
150114956|NCT00938431|541558204|FG000|Overall Study|Dosing compliance issue|0|||
150114957|NCT00938431|541558205|FG001|Overall Study|Dosing compliance issue|0|||
150114958|NCT00938431|541558206|FG002|Overall Study|Dosing compliance issue|1|||
150114959|NCT00938431|541558204|FG000|Overall Study|Reached maximum dose early|0|||
150114960|NCT00938431|541558205|FG001|Overall Study|Reached maximum dose early|0|||
150114961|NCT00938431|541558206|FG002|Overall Study|Reached maximum dose early|1|||
150114962|NCT02086591|541558207|FG000|Overall Study|Adverse Event|1|||
150114963|NCT02086591|541558207|FG000|Overall Study|Withdrawal by Subject|1|||
150114964|NCT02086591|541558207|FG000|Overall Study|protocol terminated|3|||
150114965|NCT03738865|541558210|FG000|Overall Study|Withdrawal by Subject|3|||
150114966|NCT03738865|541558211|FG001|Overall Study|Withdrawal by Subject|3|||
150114967|NCT03738865|541558210|FG000|Overall Study|Adverse Event|2|||
150114968|NCT03738865|541558211|FG001|Overall Study|Adverse Event|0|||
150114969|NCT03738865|541558210|FG000|Overall Study|Physician Decision|0|||
150114970|NCT03738865|541558211|FG001|Overall Study|Physician Decision|1|||
150114971|NCT02212730|541558212|FG000|Overall Study|Tumor not of the required cell histology|1|||
150114972|NCT02212730|541558213|FG001|Overall Study|Tumor not of the required cell histology|0|||
150114973|NCT02212730|541558212|FG000|Overall Study|Withdrawal by Subject|1|||
150114974|NCT02212730|541558213|FG001|Overall Study|Withdrawal by Subject|0|||
150114975|NCT02212730|541558212|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
150114976|NCT02212730|541558213|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
150114977|NCT02691455|541558214|FG000|Overall Study|Withdrawal by Subject|1|||
150114978|NCT02691455|541558215|FG001|Overall Study|Withdrawal by Subject|2|||
150114979|NCT02691455|541558214|FG000|Overall Study|Lost to Follow-up|15|||
150114980|NCT02691455|541558215|FG001|Overall Study|Lost to Follow-up|15|||
150114981|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150114982|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
150114983|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
150114984|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
150114985|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
150114986|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
150114987|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
150114988|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
150114989|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
150114990|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
150114991|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
150114992|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
150114993|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
150114994|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
150114995|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
150114996|NCT01257204|541558216|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
150114997|NCT01257204|541558217|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
150114998|NCT01257204|541558218|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
150114999|NCT01257204|541558216|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
150115000|NCT01257204|541558217|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
150115001|NCT01257204|541558218|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
150115002|NCT01257204|541558216|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
150115003|NCT01257204|541558217|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
150115004|NCT01257204|541558218|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
150115005|NCT01257204|541558216|FG000|Follow-up Period (up to Week 48)|Other|0|||
150115006|NCT01257204|541558217|FG001|Follow-up Period (up to Week 48)|Other|0|||
150115007|NCT01257204|541558218|FG002|Follow-up Period (up to Week 48)|Other|5|||
150115008|NCT02057757|541558219|FG000|Overall Study|Withdrawal by Subject|3|||
150115009|NCT02057757|541558220|FG001|Overall Study|Withdrawal by Subject|5|||
150115010|NCT02057757|541558219|FG000|Overall Study|Death|2|||
150115011|NCT02057757|541558220|FG001|Overall Study|Death|0|||
150115012|NCT02057757|541558219|FG000|Overall Study|Lost to Follow-up|8|||
150115013|NCT02057757|541558220|FG001|Overall Study|Lost to Follow-up|3|||
150115014|NCT02057757|541558219|FG000|Overall Study|Non-compliance|1|||
150115015|NCT02057757|541558220|FG001|Overall Study|Non-compliance|0|||
150115016|NCT00723801|541558222|FG000|Overall Study|Lost to Follow-up|1|||
150115017|NCT00723801|541558223|FG001|Overall Study|Lost to Follow-up|2|||
150115018|NCT00723801|541558222|FG000|Overall Study|Protocol Violation|2|||
150115019|NCT00723801|541558223|FG001|Overall Study|Protocol Violation|1|||
150115020|NCT02809976|541558224|FG000|Overall Study|Lost to Follow-up|1|||
150115021|NCT02809976|541558224|FG000|Overall Study|Withdrawal by Subject|1|||
150115022|NCT00211081|541558225|FG000|Overall Study|Withdrawal by Subject|2|||
150115023|NCT00113516|541558226|FG000|Part 1|Adverse Event|6|||
150115024|NCT00113516|541558227|FG001|Part 1|Adverse Event|0|||
150115025|NCT00113516|541558226|FG000|Part 1|Death|3|||
150115026|NCT00113516|541558227|FG001|Part 1|Death|0|||
150115027|NCT00113516|541558226|FG000|Part 1|Other|3|||
150115028|NCT00113516|541558227|FG001|Part 1|Other|0|||
150115029|NCT00113516|541558226|FG000|Part 1|Withdrawal by Subject|2|||
150115030|NCT00113516|541558227|FG001|Part 1|Withdrawal by Subject|0|||
150115031|NCT00113516|541558226|FG000|Part 1|Lack of Efficacy|2|||
150115032|NCT00113516|541558227|FG001|Part 1|Lack of Efficacy|0|||
150115033|NCT00113516|541558226|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
150115034|NCT00113516|541558227|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
150115035|NCT00113516|541558226|FG000|Part 1|Laboratory Abnormality|1|||
150115036|NCT00113516|541558227|FG001|Part 1|Laboratory Abnormality|0|||
150115037|NCT00113516|541558226|FG000|Part 1|Ongoing|1|||
150115038|NCT00113516|541558227|FG001|Part 1|Ongoing|0|||
150115039|NCT00113516|541558226|FG000|Part 1|Missing|65|||
150115040|NCT00113516|541558227|FG001|Part 1|Missing|0|||
150115041|NCT00113516|541558226|FG000|Part 2|Adverse Event|0|||
150115042|NCT00113516|541558227|FG001|Part 2|Adverse Event|16|||
150115043|NCT00113516|541558226|FG000|Part 2|Death|0|||
150115044|NCT00113516|541558227|FG001|Part 2|Death|5|||
150115045|NCT00113516|541558226|FG000|Part 2|Lack of Efficacy|0|||
150115046|NCT00113516|541558227|FG001|Part 2|Lack of Efficacy|37|||
150115047|NCT00113516|541558226|FG000|Part 2|Withdrawal by Subject|0|||
150115048|NCT00113516|541558227|FG001|Part 2|Withdrawal by Subject|3|||
150115049|NCT00113516|541558226|FG000|Part 2|Other|0|||
150115050|NCT00113516|541558227|FG001|Part 2|Other|3|||
150115051|NCT00113516|541558226|FG000|Part 2|Laboratory Abnormality|0|||
150115052|NCT00113516|541558227|FG001|Part 2|Laboratory Abnormality|1|||
150115053|NCT00113516|541558226|FG000|Part 2|Ongoing|0|||
150115054|NCT00113516|541558227|FG001|Part 2|Ongoing|1|||
150115055|NCT00047463|541558228|FG000|Overall Study|Withdrawal by Subject|0|||
150115056|NCT00047463|541558229|FG001|Overall Study|Withdrawal by Subject|3|||
150115057|NCT02104557|541558230|FG000|Overall Study|Adverse Event|24|||
150115058|NCT02104557|541558230|FG000|Overall Study|Lost to Follow-up|34|||
150115059|NCT02104557|541558230|FG000|Overall Study|Violated the usage and dosage|14|||
150115060|NCT02104557|541558230|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
150115061|NCT02104557|541558230|FG000|Overall Study|Administered Sayana prior to the contract|1|||
150115062|NCT02104557|541558230|FG000|Overall Study|Other|17|||
150115063|NCT02104557|541558230|FG000|Overall Study|Change to other contraception methods|5|||
150115064|NCT02104557|541558230|FG000|Overall Study|Discontinuation due to no pain|1|||
150115065|NCT02104557|541558230|FG000|Overall Study|Withdrawal consent|2|||
150115066|NCT02104557|541558230|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
150115067|NCT02104557|541558230|FG000|Overall Study|Discontinuation of contraception|9|||
150115068|NCT01559311|541558234|FG000|Overall Study|Protocol Violation|0|||
150115069|NCT01559311|541558235|FG001|Overall Study|Protocol Violation|0|||
150115070|NCT01559311|541558236|FG002|Overall Study|Protocol Violation|2|||
150115071|NCT01559311|541558234|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
150115072|NCT01559311|541558235|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
150115073|NCT01559311|541558236|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
150115074|NCT01559311|541558234|FG000|Overall Study|Withdrawal by Subject|2|||
150115075|NCT01559311|541558235|FG001|Overall Study|Withdrawal by Subject|1|||
150115076|NCT01559311|541558236|FG002|Overall Study|Withdrawal by Subject|0|||
150115077|NCT01559311|541558234|FG000|Overall Study|Death|0|||
150115078|NCT01559311|541558235|FG001|Overall Study|Death|2|||
150115079|NCT01559311|541558236|FG002|Overall Study|Death|3|||
150115080|NCT01559311|541558234|FG000|Overall Study|Lost to Follow-up|0|||
150115081|NCT01559311|541558235|FG001|Overall Study|Lost to Follow-up|3|||
150115082|NCT01559311|541558236|FG002|Overall Study|Lost to Follow-up|2|||
150115083|NCT01559311|541558234|FG000|Overall Study|Adverse Event|0|||
150115084|NCT01559311|541558235|FG001|Overall Study|Adverse Event|0|||
150115085|NCT01559311|541558236|FG002|Overall Study|Adverse Event|1|||
150115086|NCT05013905|541558237|FG000|Overall Study|Adverse Event|1|||
150115087|NCT05013905|541558237|FG000|Overall Study|Lack of Efficacy|1|||
150115088|NCT01849588|541558239|FG000|Overall Study|Lack of Efficacy|3|||
150115089|NCT01706250|541558243|FG000|Overall Study|Lost to Follow-up|2|||
150115090|NCT03286140|541558244|FG000|Overall Study|Withdrawal by Subject|10|||
150115091|NCT03286140|541558245|FG001|Overall Study|Withdrawal by Subject|5|||
150115092|NCT03286140|541558244|FG000|Overall Study|Lost to Follow-up|5|||
150115093|NCT03286140|541558245|FG001|Overall Study|Lost to Follow-up|10|||
150115094|NCT03286140|541558244|FG000|Overall Study|Failure to comply|0|||
150115095|NCT03286140|541558245|FG001|Overall Study|Failure to comply|1|||
150115096|NCT01826825|541558246|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
150115097|NCT01826825|541558247|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
150115098|NCT05402995|541558250|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
150115099|NCT05402995|541558251|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
150115100|NCT05402995|541558252|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
150115101|NCT05402995|541558253|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
150115102|NCT00205712|541558254|FG000|Overall Study|Lost to Follow-up|0|||
150115103|NCT00205712|541558255|FG001|Overall Study|Lost to Follow-up|1|||
150115104|NCT02188485|541558256|FG000|Overall Study|Withdrawal by Subject|2|||
150115105|NCT02188485|541558257|FG001|Overall Study|Withdrawal by Subject|1|||
150115106|NCT02188485|541558256|FG000|Overall Study|PI withdrew, lack of capacity|0|||
150115107|NCT02188485|541558257|FG001|Overall Study|PI withdrew, lack of capacity|2|||
150115108|NCT00096044|541558260|FG000|Overall Study|Withdrawal by Subject|9|||
150115109|NCT00096044|541558260|FG000|Overall Study|Adverse Event|21|||
150115110|NCT00096044|541558260|FG000|Overall Study|Disease Progression|4|||
150115111|NCT03149237|541558261|FG000|Overall Study|Withdrawal by Subject|4|||
150115112|NCT03149237|541558262|FG001|Overall Study|Withdrawal by Subject|5|||
150115113|NCT02442830|541558263|FG000|Overall Study|Technical Failure|0|||
150115114|NCT02442830|541558264|FG001|Overall Study|Technical Failure|1|||
150115115|NCT04587193|541558265|FG000|Overall Study|Screen failure after consent|3|||
150115116|NCT04587193|541558266|FG001|Overall Study|Screen failure after consent|0|||
150115117|NCT04587193|541558265|FG000|Overall Study|Device broke during study|3|||
150115118|NCT04587193|541558266|FG001|Overall Study|Device broke during study|2|||
150115119|NCT01552772|541558267|FG000|Overall Study|Lost to Follow-up|2|||
150115120|NCT01552772|541558267|FG000|Overall Study|Adverse Event|1|||
150115121|NCT01552772|541558267|FG000|Overall Study|Protocol Deviation|1|||
150115122|NCT03851016|541558270|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
150115123|NCT03851016|541558271|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
150115124|NCT03878134|541558272|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
150115125|NCT00853658|541558273|FG000|Overall Study|Death|713|||
150115126|NCT00853658|541558274|FG001|Overall Study|Death|768|||
150115127|NCT00853658|541558275|FG002|Overall Study|Death|753|||
150115128|NCT00853658|541558273|FG000|Overall Study|Lost to Follow-up|11|||
150115129|NCT00853658|541558274|FG001|Overall Study|Lost to Follow-up|6|||
150115130|NCT00853658|541558275|FG002|Overall Study|Lost to Follow-up|11|||
150115131|NCT00853658|541558273|FG000|Overall Study|H.A. Request|26|||
150115132|NCT00853658|541558274|FG001|Overall Study|H.A. Request|23|||
150115133|NCT00853658|541558275|FG002|Overall Study|H.A. Request|19|||
150115134|NCT00853658|541558273|FG000|Overall Study|IRB request|0|||
150115135|NCT00853658|541558274|FG001|Overall Study|IRB request|0|||
150115136|NCT00853658|541558275|FG002|Overall Study|IRB request|2|||
150115137|NCT00853658|541558273|FG000|Overall Study|Vital Status known (alive) at study end|2|||
150115138|NCT00853658|541558274|FG001|Overall Study|Vital Status known (alive) at study end|3|||
150115139|NCT00853658|541558275|FG002|Overall Study|Vital Status known (alive) at study end|3|||
150115140|NCT00853658|541558273|FG000|Overall Study|Vital Status unknown at study end|1|||
150115141|NCT00853658|541558274|FG001|Overall Study|Vital Status unknown at study end|1|||
150115142|NCT00853658|541558275|FG002|Overall Study|Vital Status unknown at study end|0|||
150115143|NCT00853658|541558273|FG000|Overall Study|Vital Status at study end N/A|8|||
150115144|NCT00853658|541558274|FG001|Overall Study|Vital Status at study end N/A|10|||
150115145|NCT00853658|541558275|FG002|Overall Study|Vital Status at study end N/A|10|||
150115146|NCT00853658|541558273|FG000|Overall Study|Patient's request|21|||
150115147|NCT00853658|541558274|FG001|Overall Study|Patient's request|17|||
150115148|NCT00853658|541558275|FG002|Overall Study|Patient's request|11|||
150115149|NCT00853658|541558273|FG000|Overall Study|Missing study completion information|5|||
150115150|NCT00853658|541558274|FG001|Overall Study|Missing study completion information|4|||
150115151|NCT00853658|541558275|FG002|Overall Study|Missing study completion information|6|||
150115152|NCT00586469|541558276|FG000|Overall Study|Adverse Event|0|||
150115153|NCT00586469|541558277|FG001|Overall Study|Adverse Event|1|||
150115154|NCT01227512|541558279|FG000|Overall Study|Physician Decision|6|||
150115155|NCT01227512|541558280|FG001|Overall Study|Physician Decision|6|||
150115156|NCT01227512|541558279|FG000|Overall Study|Adverse Event|4|||
150115157|NCT01227512|541558280|FG001|Overall Study|Adverse Event|3|||
150115158|NCT01227512|541558279|FG000|Overall Study|Withdrawal by Subject|3|||
150115159|NCT01227512|541558280|FG001|Overall Study|Withdrawal by Subject|0|||
150115160|NCT01227512|541558279|FG000|Overall Study|Participant met withdrawal criteria|0|||
150115161|NCT01227512|541558280|FG001|Overall Study|Participant met withdrawal criteria|1|||
150115162|NCT04055116|541558287|FG000|First Intervention|Physician Decision|2|||
150115163|NCT04055116|541558288|FG001|First Intervention|Physician Decision|7|||
150115164|NCT02774681|541558289|FG000|Treatment on Study|Progressive Disease|7|||
150115165|NCT02774681|541558289|FG000|Follow-Up for 3 Years|Death|11|||
150115166|NCT02774681|541558289|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
150115167|NCT02556710|541560155|FG000|Overall Study|Surgical treatment|3|||
150115168|NCT02556710|541560156|FG001|Overall Study|Surgical treatment|0|||
150115169|NCT02556710|541560155|FG000|Overall Study|Required proscribed pain medication|2|||
150115170|NCT02556710|541560156|FG001|Overall Study|Required proscribed pain medication|1|||
150115171|NCT02556710|541560155|FG000|Overall Study|Lack of Efficacy|1|||
150115172|NCT02556710|541560156|FG001|Overall Study|Lack of Efficacy|0|||
150115173|NCT02556710|541560155|FG000|Overall Study|Worsening osteoarthritis|1|||
150115174|NCT02556710|541560156|FG001|Overall Study|Worsening osteoarthritis|0|||
150115175|NCT02556710|541560155|FG000|Overall Study|Moved out of state|1|||
150115176|NCT02556710|541560156|FG001|Overall Study|Moved out of state|0|||
150189578|NCT05008835|541831352|FG001|Overall Study|Lack of Efficacy|0|||
150189579|NCT05008835|541831353|FG002|Overall Study|Lack of Efficacy|1|||
150115177|NCT02556710|541560155|FG000|Overall Study|Missing reason|3|||
150115178|NCT02556710|541560156|FG001|Overall Study|Missing reason|1|||
150115179|NCT02556710|541560155|FG000|Overall Study|Pain as lack of efficacy|0|||
150115180|NCT02556710|541560156|FG001|Overall Study|Pain as lack of efficacy|4|||
150115181|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
150115182|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
150115183|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
150115184|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
150115185|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
150115186|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
150115187|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
150115188|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
150115189|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
150115190|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
150115191|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
150115192|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
150115193|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
150115194|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
150115195|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
150115196|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
150115197|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
150115198|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
150115199|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
150115200|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
150115201|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
150115202|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
150115203|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
150115204|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
150115205|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
150115206|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
150115207|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
150115208|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
150115209|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
150115210|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
150115211|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
150115212|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
150115213|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
150115214|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
150115215|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
150115216|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
150115217|NCT02139644|541560157|FG000|Run-In Period (Pre-assignment)|Other|6|||
150115218|NCT02139644|541560158|FG001|Run-In Period (Pre-assignment)|Other|0|||
150115219|NCT02139644|541560159|FG002|Run-In Period (Pre-assignment)|Other|0|||
150115220|NCT02139644|541560160|FG003|Run-In Period (Pre-assignment)|Other|0|||
150115221|NCT02139644|541560161|FG004|Run-In Period (Pre-assignment)|Other|0|||
150115222|NCT02139644|541560162|FG005|Run-In Period (Pre-assignment)|Other|0|||
150115223|NCT02139644|541560157|FG000|Treatment Period|Adverse Event|0|||
150115224|NCT02139644|541560158|FG001|Treatment Period|Adverse Event|0|||
150115225|NCT02139644|541560159|FG002|Treatment Period|Adverse Event|3|||
150115226|NCT02139644|541560160|FG003|Treatment Period|Adverse Event|2|||
150115227|NCT02139644|541560161|FG004|Treatment Period|Adverse Event|1|||
150115228|NCT02139644|541560162|FG005|Treatment Period|Adverse Event|6|||
150115229|NCT02139644|541560157|FG000|Treatment Period|Withdrawal by Subject|0|||
150115230|NCT02139644|541560158|FG001|Treatment Period|Withdrawal by Subject|0|||
150115231|NCT02139644|541560159|FG002|Treatment Period|Withdrawal by Subject|2|||
150115232|NCT02139644|541560160|FG003|Treatment Period|Withdrawal by Subject|2|||
150115233|NCT02139644|541560161|FG004|Treatment Period|Withdrawal by Subject|3|||
150115234|NCT02139644|541560162|FG005|Treatment Period|Withdrawal by Subject|2|||
150115235|NCT02139644|541560157|FG000|Treatment Period|Non-compliance|0|||
150115236|NCT02139644|541560158|FG001|Treatment Period|Non-compliance|0|||
150115237|NCT02139644|541560159|FG002|Treatment Period|Non-compliance|0|||
150115238|NCT02139644|541560160|FG003|Treatment Period|Non-compliance|1|||
150115239|NCT02139644|541560161|FG004|Treatment Period|Non-compliance|0|||
150115240|NCT02139644|541560162|FG005|Treatment Period|Non-compliance|0|||
150115241|NCT02139644|541560157|FG000|Treatment Period|Protocol Violation|0|||
150115242|NCT02139644|541560158|FG001|Treatment Period|Protocol Violation|0|||
150115243|NCT02139644|541560159|FG002|Treatment Period|Protocol Violation|0|||
150115244|NCT02139644|541560160|FG003|Treatment Period|Protocol Violation|1|||
150115245|NCT02139644|541560161|FG004|Treatment Period|Protocol Violation|1|||
150115246|NCT02139644|541560162|FG005|Treatment Period|Protocol Violation|1|||
150115247|NCT02139644|541560157|FG000|Treatment Period|Disease progression|0|||
150115248|NCT02139644|541560158|FG001|Treatment Period|Disease progression|0|||
150115249|NCT02139644|541560159|FG002|Treatment Period|Disease progression|0|||
150115250|NCT02139644|541560160|FG003|Treatment Period|Disease progression|1|||
150115251|NCT02139644|541560161|FG004|Treatment Period|Disease progression|1|||
150115252|NCT02139644|541560162|FG005|Treatment Period|Disease progression|2|||
150115253|NCT02139644|541560157|FG000|Treatment Period|Lost to Follow-up|0|||
150115254|NCT02139644|541560158|FG001|Treatment Period|Lost to Follow-up|0|||
150115255|NCT02139644|541560159|FG002|Treatment Period|Lost to Follow-up|1|||
150115256|NCT02139644|541560160|FG003|Treatment Period|Lost to Follow-up|1|||
150115257|NCT02139644|541560161|FG004|Treatment Period|Lost to Follow-up|1|||
150115258|NCT02139644|541560162|FG005|Treatment Period|Lost to Follow-up|1|||
150115259|NCT02139644|541560157|FG000|Treatment Period|Lack of Efficacy|0|||
150115260|NCT02139644|541560158|FG001|Treatment Period|Lack of Efficacy|0|||
150115261|NCT02139644|541560159|FG002|Treatment Period|Lack of Efficacy|1|||
150115262|NCT02139644|541560160|FG003|Treatment Period|Lack of Efficacy|0|||
150115263|NCT02139644|541560161|FG004|Treatment Period|Lack of Efficacy|1|||
150115264|NCT02139644|541560162|FG005|Treatment Period|Lack of Efficacy|4|||
150115265|NCT02139644|541560157|FG000|Treatment Period|Other|0|||
150115266|NCT02139644|541560158|FG001|Treatment Period|Other|3|||
150115267|NCT02139644|541560159|FG002|Treatment Period|Other|1|||
150115268|NCT02139644|541560160|FG003|Treatment Period|Other|1|||
150115269|NCT02139644|541560161|FG004|Treatment Period|Other|0|||
150115270|NCT02139644|541560162|FG005|Treatment Period|Other|1|||
150115271|NCT01076400|541560167|FG000|Overall Study|Adverse Event|2|||
150115272|NCT01076400|541560168|FG001|Overall Study|Adverse Event|0|||
150115273|NCT01076400|541560169|FG002|Overall Study|Adverse Event|0|||
150115274|NCT01076400|541560167|FG000|Overall Study|Progressive Disease|5|||
150115275|NCT01076400|541560168|FG001|Overall Study|Progressive Disease|0|||
150115276|NCT01076400|541560169|FG002|Overall Study|Progressive Disease|0|||
150115277|NCT02080091|541560170|FG000|Overall Study|Study Terminated|22|||
150115278|NCT02080091|541560170|FG000|Overall Study|Death|1|||
150115279|NCT02080091|541560170|FG000|Overall Study|Withdrawal by Subject|1|||
150115280|NCT02080091|541560170|FG000|Overall Study|Other|1|||
150115281|NCT03143829|541560171|FG000|Overall Study|Withdrawal by Subject|2|||
150115282|NCT03143829|541560172|FG001|Overall Study|Withdrawal by Subject|5|||
150115283|NCT03143829|541560171|FG000|Overall Study|Lost to Follow-up|0|||
150115284|NCT03143829|541560172|FG001|Overall Study|Lost to Follow-up|2|||
150115285|NCT03143829|541560171|FG000|Overall Study|Death|1|||
150115286|NCT03143829|541560172|FG001|Overall Study|Death|1|||
150115287|NCT03143829|541560171|FG000|Overall Study|changed treatment, no longer eligible|2|||
150115288|NCT03143829|541560172|FG001|Overall Study|changed treatment, no longer eligible|2|||
150115289|NCT02391948|541560174|FG000|6-month Assessment|Death|0|||
150115290|NCT02391948|541560175|FG001|6-month Assessment|Death|0|||
150115291|NCT02391948|541560176|FG002|6-month Assessment|Death|0|||
150115292|NCT02391948|541560177|FG003|6-month Assessment|Death|0|||
150115293|NCT02391948|541560178|FG004|6-month Assessment|Death|1|||
150115294|NCT02391948|541560174|FG000|6-month Assessment|Withdrawal by Subject|0|||
150115295|NCT02391948|541560175|FG001|6-month Assessment|Withdrawal by Subject|0|||
150115296|NCT02391948|541560176|FG002|6-month Assessment|Withdrawal by Subject|1|||
150115297|NCT02391948|541560177|FG003|6-month Assessment|Withdrawal by Subject|2|||
150115298|NCT02391948|541560178|FG004|6-month Assessment|Withdrawal by Subject|0|||
150115299|NCT02391948|541560174|FG000|6-month Assessment|Lost to Follow-up|4|||
150115300|NCT02391948|541560175|FG001|6-month Assessment|Lost to Follow-up|5|||
150115301|NCT02391948|541560176|FG002|6-month Assessment|Lost to Follow-up|2|||
150115302|NCT02391948|541560177|FG003|6-month Assessment|Lost to Follow-up|3|||
150115303|NCT02391948|541560178|FG004|6-month Assessment|Lost to Follow-up|1|||
150115304|NCT02391948|541560174|FG000|6-month Assessment|Medical issue/illness|1|||
150115305|NCT02391948|541560175|FG001|6-month Assessment|Medical issue/illness|1|||
150115306|NCT02391948|541560176|FG002|6-month Assessment|Medical issue/illness|0|||
150115307|NCT02391948|541560177|FG003|6-month Assessment|Medical issue/illness|0|||
150115308|NCT02391948|541560178|FG004|6-month Assessment|Medical issue/illness|0|||
150115309|NCT02391948|541560174|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
150115310|NCT02391948|541560175|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
150115311|NCT02391948|541560176|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
150115312|NCT02391948|541560177|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
150115313|NCT02391948|541560178|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
150115314|NCT02391948|541560174|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
150115315|NCT02391948|541560175|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
150115316|NCT02391948|541560176|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
150115317|NCT02391948|541560177|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
150115318|NCT02391948|541560178|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
150115319|NCT02391948|541560174|FG000|12-month Assessment|Death|0|||
150115320|NCT02391948|541560175|FG001|12-month Assessment|Death|0|||
150115321|NCT02391948|541560176|FG002|12-month Assessment|Death|0|||
150115322|NCT02391948|541560177|FG003|12-month Assessment|Death|1|||
150115323|NCT02391948|541560178|FG004|12-month Assessment|Death|0|||
150115324|NCT02391948|541560174|FG000|12-month Assessment|Withdrawal by Subject|1|||
150115325|NCT02391948|541560175|FG001|12-month Assessment|Withdrawal by Subject|0|||
150115326|NCT02391948|541560176|FG002|12-month Assessment|Withdrawal by Subject|0|||
150115327|NCT02391948|541560177|FG003|12-month Assessment|Withdrawal by Subject|1|||
150115328|NCT02391948|541560178|FG004|12-month Assessment|Withdrawal by Subject|0|||
150115329|NCT02391948|541560174|FG000|12-month Assessment|Lost to Follow-up|5|||
150115330|NCT02391948|541560175|FG001|12-month Assessment|Lost to Follow-up|4|||
150115331|NCT02391948|541560176|FG002|12-month Assessment|Lost to Follow-up|4|||
150115332|NCT02391948|541560177|FG003|12-month Assessment|Lost to Follow-up|4|||
150115333|NCT02391948|541560178|FG004|12-month Assessment|Lost to Follow-up|5|||
150115334|NCT02391948|541560174|FG000|12-month Assessment|Medical issue/illness|0|||
150115335|NCT02391948|541560175|FG001|12-month Assessment|Medical issue/illness|1|||
150115336|NCT02391948|541560176|FG002|12-month Assessment|Medical issue/illness|0|||
150115337|NCT02391948|541560177|FG003|12-month Assessment|Medical issue/illness|1|||
150115338|NCT02391948|541560178|FG004|12-month Assessment|Medical issue/illness|0|||
150115339|NCT02391948|541560174|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
150115340|NCT02391948|541560175|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
150115341|NCT02391948|541560176|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
150115342|NCT02391948|541560177|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
150115343|NCT02391948|541560178|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
150115344|NCT02391948|541560174|FG000|18-month Assessment|Death|0|||
150115345|NCT02391948|541560175|FG001|18-month Assessment|Death|0|||
150115346|NCT02391948|541560176|FG002|18-month Assessment|Death|0|||
150115347|NCT02391948|541560177|FG003|18-month Assessment|Death|1|||
150115348|NCT02391948|541560178|FG004|18-month Assessment|Death|1|||
150115349|NCT02391948|541560174|FG000|18-month Assessment|Withdrawal by Subject|1|||
150115350|NCT02391948|541560175|FG001|18-month Assessment|Withdrawal by Subject|0|||
150115351|NCT02391948|541560176|FG002|18-month Assessment|Withdrawal by Subject|0|||
150115352|NCT02391948|541560177|FG003|18-month Assessment|Withdrawal by Subject|1|||
150115353|NCT02391948|541560178|FG004|18-month Assessment|Withdrawal by Subject|0|||
150115354|NCT02391948|541560174|FG000|18-month Assessment|Lost to Follow-up|2|||
150115355|NCT02391948|541560175|FG001|18-month Assessment|Lost to Follow-up|6|||
150115356|NCT02391948|541560176|FG002|18-month Assessment|Lost to Follow-up|2|||
150115357|NCT02391948|541560177|FG003|18-month Assessment|Lost to Follow-up|2|||
150115358|NCT02391948|541560178|FG004|18-month Assessment|Lost to Follow-up|3|||
150115359|NCT02391948|541560174|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
150115360|NCT02391948|541560175|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
150115361|NCT02391948|541560176|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
150115362|NCT02391948|541560177|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
150115363|NCT02391948|541560178|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
150115364|NCT02391948|541560174|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
150115365|NCT02391948|541560175|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
150115366|NCT02391948|541560176|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
150115367|NCT02391948|541560177|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
150115368|NCT02391948|541560178|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
150115369|NCT02391948|541560174|FG000|24-month Assessment|Death|0|||
150115370|NCT02391948|541560175|FG001|24-month Assessment|Death|0|||
150115371|NCT02391948|541560176|FG002|24-month Assessment|Death|0|||
150115372|NCT02391948|541560177|FG003|24-month Assessment|Death|0|||
150115373|NCT02391948|541560178|FG004|24-month Assessment|Death|1|||
150115374|NCT02391948|541560174|FG000|24-month Assessment|Withdrawal by Subject|1|||
150115375|NCT02391948|541560175|FG001|24-month Assessment|Withdrawal by Subject|1|||
150115376|NCT02391948|541560176|FG002|24-month Assessment|Withdrawal by Subject|0|||
150115377|NCT02391948|541560177|FG003|24-month Assessment|Withdrawal by Subject|0|||
150115378|NCT02391948|541560178|FG004|24-month Assessment|Withdrawal by Subject|1|||
150115379|NCT02391948|541560174|FG000|24-month Assessment|Lost to Follow-up|5|||
150115380|NCT02391948|541560175|FG001|24-month Assessment|Lost to Follow-up|4|||
150115381|NCT02391948|541560176|FG002|24-month Assessment|Lost to Follow-up|0|||
150115382|NCT02391948|541560177|FG003|24-month Assessment|Lost to Follow-up|0|||
150115383|NCT02391948|541560178|FG004|24-month Assessment|Lost to Follow-up|0|||
150115384|NCT02391948|541560174|FG000|24-month Assessment|Medical issue/illness|0|||
150115385|NCT02391948|541560175|FG001|24-month Assessment|Medical issue/illness|0|||
150115386|NCT02391948|541560176|FG002|24-month Assessment|Medical issue/illness|1|||
150115387|NCT02391948|541560177|FG003|24-month Assessment|Medical issue/illness|0|||
150115388|NCT02391948|541560178|FG004|24-month Assessment|Medical issue/illness|0|||
150115389|NCT02391948|541560174|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
150115390|NCT02391948|541560175|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
150115391|NCT02391948|541560176|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
150115392|NCT02391948|541560177|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
150115393|NCT02391948|541560178|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
150115394|NCT01529645|541560182|FG000|Overall Study|Lost to Follow-up|0|||
150115395|NCT01529645|541560183|FG001|Overall Study|Lost to Follow-up|1|||
150115396|NCT01529645|541560184|FG002|Overall Study|Lost to Follow-up|1|||
150115397|NCT01529645|541560185|FG003|Overall Study|Lost to Follow-up|1|||
150115398|NCT01529645|541560186|FG004|Overall Study|Lost to Follow-up|1|||
150115399|NCT01529645|541560187|FG005|Overall Study|Lost to Follow-up|0|||
150115400|NCT01529645|541560188|FG006|Overall Study|Lost to Follow-up|2|||
150115401|NCT01529645|541560189|FG007|Overall Study|Lost to Follow-up|0|||
150115402|NCT01529645|541560190|FG008|Overall Study|Lost to Follow-up|1|||
150115403|NCT01529645|541560191|FG009|Overall Study|Lost to Follow-up|0|||
150115404|NCT01529645|541560182|FG000|Overall Study|SAE - Premature contractions|0|||
150115405|NCT01529645|541560183|FG001|Overall Study|SAE - Premature contractions|0|||
150115406|NCT01529645|541560184|FG002|Overall Study|SAE - Premature contractions|1|||
150115407|NCT01529645|541560185|FG003|Overall Study|SAE - Premature contractions|0|||
150115408|NCT01529645|541560186|FG004|Overall Study|SAE - Premature contractions|0|||
150115409|NCT01529645|541560187|FG005|Overall Study|SAE - Premature contractions|0|||
150115410|NCT01529645|541560188|FG006|Overall Study|SAE - Premature contractions|0|||
150115411|NCT01529645|541560189|FG007|Overall Study|SAE - Premature contractions|0|||
150115412|NCT01529645|541560190|FG008|Overall Study|SAE - Premature contractions|0|||
150115413|NCT01529645|541560191|FG009|Overall Study|SAE - Premature contractions|0|||
150115414|NCT01529645|541560182|FG000|Overall Study|Withdrawal by Subject|2|||
150115415|NCT01529645|541560183|FG001|Overall Study|Withdrawal by Subject|0|||
150115416|NCT01529645|541560184|FG002|Overall Study|Withdrawal by Subject|0|||
150115417|NCT01529645|541560185|FG003|Overall Study|Withdrawal by Subject|1|||
150115418|NCT01529645|541560186|FG004|Overall Study|Withdrawal by Subject|1|||
150115419|NCT01529645|541560187|FG005|Overall Study|Withdrawal by Subject|1|||
150115420|NCT01529645|541560188|FG006|Overall Study|Withdrawal by Subject|0|||
150115421|NCT01529645|541560189|FG007|Overall Study|Withdrawal by Subject|0|||
150115422|NCT01529645|541560190|FG008|Overall Study|Withdrawal by Subject|0|||
150115423|NCT01529645|541560191|FG009|Overall Study|Withdrawal by Subject|0|||
150115424|NCT00274716|541560196|FG000|Phase A|Other non-reported reason|4|||
150115425|NCT00274716|541560197|FG001|Phase A|Other non-reported reason|2|||
150115426|NCT00274716|541560198|FG002|Phase A|Other non-reported reason|1|||
150115427|NCT00274716|541560199|FG003|Phase A|Other non-reported reason|2|||
150115428|NCT00274716|541560200|FG004|Phase A|Other non-reported reason|0|||
150115429|NCT00274716|541560201|FG005|Phase A|Other non-reported reason|1|||
150115430|NCT00274716|541560196|FG000|Phase A|Participant moved|0|||
150115431|NCT00274716|541560197|FG001|Phase A|Participant moved|0|||
150115432|NCT00274716|541560198|FG002|Phase A|Participant moved|1|||
150115433|NCT00274716|541560199|FG003|Phase A|Participant moved|0|||
150115434|NCT00274716|541560200|FG004|Phase A|Participant moved|0|||
150115435|NCT00274716|541560201|FG005|Phase A|Participant moved|1|||
150115436|NCT00274716|541560196|FG000|Phase A|Site Terminated|0|||
150115437|NCT00274716|541560197|FG001|Phase A|Site Terminated|0|||
150115438|NCT00274716|541560198|FG002|Phase A|Site Terminated|0|||
150115439|NCT00274716|541560199|FG003|Phase A|Site Terminated|1|||
150115440|NCT00274716|541560200|FG004|Phase A|Site Terminated|0|||
150115441|NCT00274716|541560201|FG005|Phase A|Site Terminated|0|||
150115442|NCT00274716|541560196|FG000|Phase A|Protocol Violation|1|||
150115443|NCT00274716|541560197|FG001|Phase A|Protocol Violation|0|||
150115444|NCT00274716|541560198|FG002|Phase A|Protocol Violation|0|||
150115445|NCT00274716|541560199|FG003|Phase A|Protocol Violation|1|||
150115446|NCT00274716|541560200|FG004|Phase A|Protocol Violation|0|||
150115447|NCT00274716|541560201|FG005|Phase A|Protocol Violation|0|||
150115448|NCT00274716|541560196|FG000|Phase A|Met criteria for discontinuation|1|||
150115449|NCT00274716|541560197|FG001|Phase A|Met criteria for discontinuation|1|||
150115450|NCT00274716|541560198|FG002|Phase A|Met criteria for discontinuation|0|||
150115451|NCT00274716|541560199|FG003|Phase A|Met criteria for discontinuation|0|||
150115452|NCT00274716|541560200|FG004|Phase A|Met criteria for discontinuation|0|||
150115453|NCT00274716|541560201|FG005|Phase A|Met criteria for discontinuation|0|||
150115454|NCT00274716|541560196|FG000|Phase A|Withdrawal by Subject|2|||
150115455|NCT00274716|541560197|FG001|Phase A|Withdrawal by Subject|2|||
150115456|NCT00274716|541560198|FG002|Phase A|Withdrawal by Subject|1|||
150115457|NCT00274716|541560199|FG003|Phase A|Withdrawal by Subject|3|||
150115458|NCT00274716|541560200|FG004|Phase A|Withdrawal by Subject|0|||
150115459|NCT00274716|541560201|FG005|Phase A|Withdrawal by Subject|1|||
150115460|NCT00274716|541560196|FG000|Phase A|Adverse Event|2|||
150115461|NCT00274716|541560197|FG001|Phase A|Adverse Event|3|||
150115462|NCT00274716|541560198|FG002|Phase A|Adverse Event|3|||
150115463|NCT00274716|541560199|FG003|Phase A|Adverse Event|0|||
150115464|NCT00274716|541560200|FG004|Phase A|Adverse Event|2|||
150115465|NCT00274716|541560201|FG005|Phase A|Adverse Event|0|||
150115466|NCT00274716|541560196|FG000|Phase A|Completed but did not enter Phase B|1|||
150115467|NCT00274716|541560197|FG001|Phase A|Completed but did not enter Phase B|2|||
150115468|NCT00274716|541560198|FG002|Phase A|Completed but did not enter Phase B|2|||
150115469|NCT00274716|541560199|FG003|Phase A|Completed but did not enter Phase B|2|||
150115470|NCT00274716|541560200|FG004|Phase A|Completed but did not enter Phase B|1|||
150115471|NCT00274716|541560201|FG005|Phase A|Completed but did not enter Phase B|1|||
150115472|NCT00274716|541560196|FG000|Phase B|Adverse Event|0|||
150115473|NCT00274716|541560197|FG001|Phase B|Adverse Event|0|||
150115474|NCT00274716|541560198|FG002|Phase B|Adverse Event|2|||
150115475|NCT00274716|541560199|FG003|Phase B|Adverse Event|0|||
150115476|NCT00274716|541560200|FG004|Phase B|Adverse Event|0|||
150115477|NCT00274716|541560201|FG005|Phase B|Adverse Event|1|||
150115478|NCT00274716|541560196|FG000|Phase B|Protocol Violation|0|||
150115479|NCT00274716|541560197|FG001|Phase B|Protocol Violation|2|||
150115480|NCT00274716|541560198|FG002|Phase B|Protocol Violation|0|||
150115481|NCT00274716|541560199|FG003|Phase B|Protocol Violation|0|||
150115482|NCT00274716|541560200|FG004|Phase B|Protocol Violation|0|||
150115483|NCT00274716|541560201|FG005|Phase B|Protocol Violation|0|||
150115484|NCT00274716|541560196|FG000|Phase B|Withdrawal by Subject|0|||
150115485|NCT00274716|541560197|FG001|Phase B|Withdrawal by Subject|1|||
150115486|NCT00274716|541560198|FG002|Phase B|Withdrawal by Subject|0|||
150115487|NCT00274716|541560199|FG003|Phase B|Withdrawal by Subject|0|||
150115488|NCT00274716|541560200|FG004|Phase B|Withdrawal by Subject|0|||
150115489|NCT00274716|541560201|FG005|Phase B|Withdrawal by Subject|0|||
150115490|NCT00274716|541560196|FG000|Phase B|Participant moved|1|||
150115491|NCT00274716|541560197|FG001|Phase B|Participant moved|0|||
150115492|NCT00274716|541560198|FG002|Phase B|Participant moved|0|||
150115493|NCT00274716|541560199|FG003|Phase B|Participant moved|0|||
150115494|NCT00274716|541560200|FG004|Phase B|Participant moved|0|||
150115495|NCT00274716|541560201|FG005|Phase B|Participant moved|0|||
150115496|NCT00274716|541560196|FG000|Phase B|Other non-reported reason|0|||
150115497|NCT00274716|541560197|FG001|Phase B|Other non-reported reason|0|||
150115498|NCT00274716|541560198|FG002|Phase B|Other non-reported reason|1|||
150115499|NCT00274716|541560199|FG003|Phase B|Other non-reported reason|1|||
150115500|NCT00274716|541560200|FG004|Phase B|Other non-reported reason|0|||
150115501|NCT00274716|541560201|FG005|Phase B|Other non-reported reason|0|||
150115502|NCT00274716|541560196|FG000|Phase B|Lost to Follow-up|0|||
150115503|NCT00274716|541560197|FG001|Phase B|Lost to Follow-up|1|||
150115504|NCT00274716|541560198|FG002|Phase B|Lost to Follow-up|0|||
150115505|NCT00274716|541560199|FG003|Phase B|Lost to Follow-up|0|||
150115506|NCT00274716|541560200|FG004|Phase B|Lost to Follow-up|0|||
150115507|NCT00274716|541560201|FG005|Phase B|Lost to Follow-up|0|||
150115508|NCT01602315|541560202|FG000|Overall Study|Protocol Violation|0|||
150115509|NCT01602315|541560203|FG001|Overall Study|Protocol Violation|0|||
150115510|NCT01602315|541560204|FG002|Overall Study|Protocol Violation|0|||
150115511|NCT01602315|541560205|FG003|Overall Study|Protocol Violation|0|||
150115512|NCT01602315|541560206|FG004|Overall Study|Protocol Violation|0|||
150115513|NCT01602315|541560207|FG005|Overall Study|Protocol Violation|1|||
150115514|NCT01602315|541560208|FG006|Overall Study|Protocol Violation|0|||
150115515|NCT01602315|541560202|FG000|Overall Study|Physician Decision|2|||
150115516|NCT01602315|541560203|FG001|Overall Study|Physician Decision|0|||
150115517|NCT01602315|541560204|FG002|Overall Study|Physician Decision|0|||
150115518|NCT01602315|541560205|FG003|Overall Study|Physician Decision|0|||
150115519|NCT01602315|541560206|FG004|Overall Study|Physician Decision|2|||
150115520|NCT01602315|541560207|FG005|Overall Study|Physician Decision|1|||
150115521|NCT01602315|541560208|FG006|Overall Study|Physician Decision|1|||
150115522|NCT01602315|541560202|FG000|Overall Study|Disease progression|6|||
150115523|NCT01602315|541560203|FG001|Overall Study|Disease progression|3|||
150115524|NCT01602315|541560204|FG002|Overall Study|Disease progression|10|||
150115525|NCT01602315|541560205|FG003|Overall Study|Disease progression|1|||
150115526|NCT01602315|541560206|FG004|Overall Study|Disease progression|41|||
150115527|NCT01602315|541560207|FG005|Overall Study|Disease progression|12|||
150115528|NCT01602315|541560208|FG006|Overall Study|Disease progression|15|||
150115529|NCT01602315|541560202|FG000|Overall Study|Death|1|||
150115530|NCT01602315|541560203|FG001|Overall Study|Death|1|||
150115531|NCT01602315|541560204|FG002|Overall Study|Death|1|||
150115532|NCT01602315|541560205|FG003|Overall Study|Death|1|||
150115533|NCT01602315|541560206|FG004|Overall Study|Death|7|||
150115534|NCT01602315|541560207|FG005|Overall Study|Death|2|||
150115535|NCT01602315|541560208|FG006|Overall Study|Death|2|||
150115536|NCT01602315|541560202|FG000|Overall Study|Withdrawal by Subject|2|||
150115537|NCT01602315|541560203|FG001|Overall Study|Withdrawal by Subject|0|||
150115538|NCT01602315|541560204|FG002|Overall Study|Withdrawal by Subject|2|||
150115539|NCT01602315|541560205|FG003|Overall Study|Withdrawal by Subject|0|||
150115540|NCT01602315|541560206|FG004|Overall Study|Withdrawal by Subject|6|||
150115541|NCT01602315|541560207|FG005|Overall Study|Withdrawal by Subject|0|||
150189580|NCT05008835|541831351|FG000|Overall Study|Study terminated by sponsor|0|||
150189581|NCT05008835|541831352|FG001|Overall Study|Study terminated by sponsor|0|||
150189582|NCT05008835|541831353|FG002|Overall Study|Study terminated by sponsor|1|||
150115542|NCT01602315|541560208|FG006|Overall Study|Withdrawal by Subject|1|||
150115543|NCT01602315|541560202|FG000|Overall Study|Adverse Event|5|||
150189583|NCT05008835|541831351|FG000|Overall Study|Not further specified|3|||
150189584|NCT05008835|541831352|FG001|Overall Study|Not further specified|2|||
150115544|NCT01602315|541560203|FG001|Overall Study|Adverse Event|1|||
150189585|NCT05008835|541831353|FG002|Overall Study|Not further specified|1|||
150115545|NCT01602315|541560204|FG002|Overall Study|Adverse Event|5|||
150115546|NCT01602315|541560205|FG003|Overall Study|Adverse Event|4|||
150115547|NCT01602315|541560206|FG004|Overall Study|Adverse Event|15|||
150115548|NCT01602315|541560207|FG005|Overall Study|Adverse Event|3|||
150115549|NCT01602315|541560208|FG006|Overall Study|Adverse Event|9|||
150115550|NCT01602315|541560202|FG000|Overall Study|Subject/guardian decision|0|||
150115551|NCT01602315|541560203|FG001|Overall Study|Subject/guardian decision|0|||
150115552|NCT01602315|541560204|FG002|Overall Study|Subject/guardian decision|0|||
150115553|NCT01602315|541560205|FG003|Overall Study|Subject/guardian decision|0|||
150115554|NCT01602315|541560206|FG004|Overall Study|Subject/guardian decision|0|||
150115555|NCT01602315|541560207|FG005|Overall Study|Subject/guardian decision|0|||
150115556|NCT01602315|541560208|FG006|Overall Study|Subject/guardian decision|1|||
150115557|NCT01602315|541560202|FG000|Overall Study|Cross-over patients to combo treatment|0|||
150115558|NCT01602315|541560203|FG001|Overall Study|Cross-over patients to combo treatment|0|||
150115559|NCT01602315|541560204|FG002|Overall Study|Cross-over patients to combo treatment|0|||
150115560|NCT01602315|541560205|FG003|Overall Study|Cross-over patients to combo treatment|0|||
150115561|NCT01602315|541560206|FG004|Overall Study|Cross-over patients to combo treatment|0|||
150115562|NCT01602315|541560207|FG005|Overall Study|Cross-over patients to combo treatment|16|||
150115563|NCT01602315|541560208|FG006|Overall Study|Cross-over patients to combo treatment|0|||
150115564|NCT04193202|541560209|FG000|Overall Study|Adverse Event|2|||
150115565|NCT04193202|541560210|FG001|Overall Study|Adverse Event|1|||
150115566|NCT04193202|541560209|FG000|Overall Study|Death|0|||
150115567|NCT04193202|541560210|FG001|Overall Study|Death|1|||
150115568|NCT04193202|541560209|FG000|Overall Study|Physician Decision|1|||
150115569|NCT04193202|541560210|FG001|Overall Study|Physician Decision|1|||
150115570|NCT04193202|541560209|FG000|Overall Study|Protocol Violation|2|||
150115571|NCT04193202|541560210|FG001|Overall Study|Protocol Violation|2|||
150115572|NCT04193202|541560209|FG000|Overall Study|Withdrawal by Subject|11|||
150115573|NCT04193202|541560210|FG001|Overall Study|Withdrawal by Subject|5|||
150115574|NCT00975975|541560217|FG000|Overall Study|Death|6|||
150115575|NCT00961259|541560218|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
150115576|NCT00961259|541560219|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
150115577|NCT00961259|541560220|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
150115578|NCT01252251|541560223|FG000|Overall Study|Withdrawal by Subject|1|||
150115579|NCT01324024|541560224|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
150115580|NCT01324024|541560225|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
150115581|NCT03755765|541560228|FG000|Overall Study|Withdrawal by Subject|2|||
150115582|NCT03755765|541560229|FG001|Overall Study|Withdrawal by Subject|4|||
150115583|NCT03755765|541560230|FG002|Overall Study|Withdrawal by Subject|4|||
150115584|NCT01158222|541560234|FG000|Overall Study|Not eligible for intermediate phase|17|||
150115585|NCT00111228|541560237|FG000|Overall Study|Withdrawal by Subject|5|||
150115586|NCT00111228|541560238|FG001|Overall Study|Withdrawal by Subject|1|||
150115587|NCT00111228|541560239|FG002|Overall Study|Withdrawal by Subject|0|||
150115588|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
150115589|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
150115590|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
150115591|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
150115592|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
150115593|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
150115594|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
150115595|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
150115596|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
150115597|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
150115598|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
150115599|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
150115600|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
150115601|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
150115602|NCT02464969|541560244|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
150115603|NCT02464969|541560245|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
150115604|NCT02464969|541560244|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
150115605|NCT02464969|541560245|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
150115606|NCT02464969|541560244|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
150115607|NCT02464969|541560245|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
150115608|NCT02464969|541560244|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
150115609|NCT02464969|541560245|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
150115610|NCT00724451|541560246|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
150115611|NCT00724451|541560246|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
150115612|NCT00724451|541560246|FG000|Overall Study|Not Eligible for Treatment|431|||
150115613|NCT00724451|541560246|FG000|Overall Study|Participant Refused Treatment|89|||
150115614|NCT00724451|541560246|FG000|Overall Study|Never Started Treatment|89|||
150115615|NCT00724451|541560246|FG000|Overall Study|Unknown; No Data Sources Available|9|||
150115616|NCT00724451|541560246|FG000|Overall Study|Physician Decision|116|||
150115617|NCT00724451|541560246|FG000|Overall Study|Withdrawal by Subject|45|||
150115618|NCT00724451|541560246|FG000|Overall Study|Investigator + Participant Decision|13|||
150115619|NCT01599650|541560247|FG000|Overall Study|Administrative issue|1|||
150115620|NCT01599650|541560248|FG001|Overall Study|Administrative issue|0|||
150115621|NCT01599650|541560249|FG002|Overall Study|Administrative issue|1|||
150115622|NCT01599650|541560247|FG000|Overall Study|Physician Decision|2|||
150115623|NCT01599650|541560248|FG001|Overall Study|Physician Decision|0|||
150115624|NCT01599650|541560249|FG002|Overall Study|Physician Decision|7|||
150115625|NCT01599650|541560247|FG000|Overall Study|Protocol Violation|0|||
150115626|NCT01599650|541560248|FG001|Overall Study|Protocol Violation|3|||
150115627|NCT01599650|541560249|FG002|Overall Study|Protocol Violation|0|||
150115628|NCT01599650|541560247|FG000|Overall Study|Death|2|||
150115629|NCT01599650|541560248|FG001|Overall Study|Death|1|||
150115630|NCT01599650|541560249|FG002|Overall Study|Death|2|||
150115631|NCT01599650|541560247|FG000|Overall Study|Lost to Follow-up|3|||
150115632|NCT01599650|541560248|FG001|Overall Study|Lost to Follow-up|3|||
150115633|NCT01599650|541560249|FG002|Overall Study|Lost to Follow-up|3|||
150115634|NCT01599650|541560247|FG000|Overall Study|Withdrawal by Subject|11|||
150115635|NCT01599650|541560248|FG001|Overall Study|Withdrawal by Subject|11|||
150115636|NCT01599650|541560249|FG002|Overall Study|Withdrawal by Subject|10|||
150115637|NCT01599650|541560247|FG000|Overall Study|Adverse Event|3|||
150115638|NCT01599650|541560248|FG001|Overall Study|Adverse Event|8|||
150115639|NCT01599650|541560249|FG002|Overall Study|Adverse Event|4|||
150115640|NCT00720876|541560250|FG000|Overall Study|found to be ineligible after starting tx|2|||
150115641|NCT03304379|541560251|FG000|Overall Study|Protocol Violation|8|||
150115642|NCT03304379|541560252|FG001|Overall Study|Protocol Violation|10|||
150115643|NCT03304379|541560253|FG002|Overall Study|Protocol Violation|5|||
150115644|NCT03304379|541560254|FG003|Overall Study|Protocol Violation|0|||
150115645|NCT03304379|541560255|FG004|Overall Study|Protocol Violation|2|||
150115646|NCT03304379|541560251|FG000|Overall Study|Adverse Event|4|||
150115647|NCT03304379|541560252|FG001|Overall Study|Adverse Event|20|||
150115648|NCT03304379|541560253|FG002|Overall Study|Adverse Event|17|||
150115649|NCT03304379|541560254|FG003|Overall Study|Adverse Event|1|||
150115650|NCT03304379|541560255|FG004|Overall Study|Adverse Event|0|||
150115651|NCT03304379|541560251|FG000|Overall Study|Lack of Efficacy|17|||
150115652|NCT03304379|541560252|FG001|Overall Study|Lack of Efficacy|16|||
150115653|NCT03304379|541560253|FG002|Overall Study|Lack of Efficacy|20|||
150115654|NCT03304379|541560254|FG003|Overall Study|Lack of Efficacy|0|||
150115655|NCT03304379|541560255|FG004|Overall Study|Lack of Efficacy|0|||
150115656|NCT03304379|541560251|FG000|Overall Study|Physician Decision|6|||
150115657|NCT03304379|541560252|FG001|Overall Study|Physician Decision|10|||
150115658|NCT03304379|541560253|FG002|Overall Study|Physician Decision|6|||
150115659|NCT03304379|541560254|FG003|Overall Study|Physician Decision|9|||
150115660|NCT03304379|541560255|FG004|Overall Study|Physician Decision|10|||
150115661|NCT03304379|541560251|FG000|Overall Study|Withdrawal by Subject|26|||
150115662|NCT03304379|541560252|FG001|Overall Study|Withdrawal by Subject|58|||
150115663|NCT03304379|541560253|FG002|Overall Study|Withdrawal by Subject|66|||
150115664|NCT03304379|541560254|FG003|Overall Study|Withdrawal by Subject|3|||
150115665|NCT03304379|541560255|FG004|Overall Study|Withdrawal by Subject|5|||
150115666|NCT03304379|541560251|FG000|Overall Study|Lost to Follow-up|8|||
150115667|NCT03304379|541560252|FG001|Overall Study|Lost to Follow-up|24|||
150115668|NCT03304379|541560253|FG002|Overall Study|Lost to Follow-up|35|||
150115669|NCT03304379|541560254|FG003|Overall Study|Lost to Follow-up|4|||
150115670|NCT03304379|541560255|FG004|Overall Study|Lost to Follow-up|0|||
150115671|NCT03304379|541560251|FG000|Overall Study|Death|1|||
150115672|NCT03304379|541560252|FG001|Overall Study|Death|2|||
150115673|NCT03304379|541560253|FG002|Overall Study|Death|0|||
150115674|NCT03304379|541560254|FG003|Overall Study|Death|0|||
150115675|NCT03304379|541560255|FG004|Overall Study|Death|0|||
150115676|NCT03304379|541560251|FG000|Overall Study|Other|0|||
150115677|NCT03304379|541560252|FG001|Overall Study|Other|1|||
150115678|NCT03304379|541560253|FG002|Overall Study|Other|0|||
150115679|NCT03304379|541560254|FG003|Overall Study|Other|0|||
150115680|NCT03304379|541560255|FG004|Overall Study|Other|0|||
150115681|NCT01649856|541560263|FG000|Overall Study|Withdrawal by Subject|14|||
150115682|NCT01649856|541560264|FG001|Overall Study|Withdrawal by Subject|14|||
150115683|NCT01649856|541560263|FG000|Overall Study|Protocol Violation|4|||
150115684|NCT01649856|541560264|FG001|Overall Study|Protocol Violation|4|||
150115685|NCT01649856|541560263|FG000|Overall Study|Treatment Failure|1|||
150115686|NCT01649856|541560264|FG001|Overall Study|Treatment Failure|1|||
150115687|NCT01649856|541560263|FG000|Overall Study|Death|69|||
150115688|NCT01649856|541560264|FG001|Overall Study|Death|34|||
150115689|NCT01649856|541560263|FG000|Overall Study|Stable or Progressed Disease|5|||
150115690|NCT01649856|541560264|FG001|Overall Study|Stable or Progressed Disease|3|||
150115691|NCT01649856|541560263|FG000|Overall Study|Lost to Follow-up|20|||
150115692|NCT01649856|541560264|FG001|Overall Study|Lost to Follow-up|16|||
150115693|NCT01649856|541560263|FG000|Overall Study|Lack of Compliance|6|||
150115694|NCT01649856|541560264|FG001|Overall Study|Lack of Compliance|1|||
150115695|NCT01649856|541560263|FG000|Overall Study|Other|20|||
150115696|NCT01649856|541560264|FG001|Overall Study|Other|5|||
150115697|NCT00179647|541560265|FG000|Overall Study|Adverse Event|294|||
150115698|NCT00179647|541560265|FG000|Overall Study|Lack of Efficacy|478|||
150115699|NCT00179647|541560265|FG000|Overall Study|Withdrawal by Subject|83|||
150115700|NCT00179647|541560265|FG000|Overall Study|Lost to Follow-up|4|||
150115701|NCT00179647|541560265|FG000|Overall Study|Death|94|||
150115702|NCT00179647|541560265|FG000|Overall Study|Other|960|||
150115703|NCT00622635|541560266|FG000|Treatment Period 1|Adverse Event|0|||
150115704|NCT00622635|541560267|FG001|Treatment Period 1|Adverse Event|0|||
150115705|NCT00622635|541560268|FG002|Treatment Period 1|Adverse Event|1|||
150115706|NCT00622635|541560269|FG003|Treatment Period 1|Adverse Event|0|||
150115707|NCT00622635|541560270|FG004|Treatment Period 1|Adverse Event|0|||
150115708|NCT00622635|541560271|FG005|Treatment Period 1|Adverse Event|0|||
150115709|NCT00622635|541560266|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150115710|NCT00622635|541560267|FG001|Treatment Period 1|Withdrawal by Subject|1|||
150115711|NCT00622635|541560268|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150115712|NCT00622635|541560269|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150115713|NCT00622635|541560270|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150115714|NCT00622635|541560271|FG005|Treatment Period 1|Withdrawal by Subject|0|||
150115715|NCT00622635|541560266|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
150115716|NCT00622635|541560267|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
150115717|NCT00622635|541560268|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
150115718|NCT00622635|541560269|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
150115719|NCT00622635|541560270|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
150115720|NCT00622635|541560271|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
150115721|NCT00622635|541560266|FG000|Treatment Period 2|Adverse Event|1|||
150115722|NCT00622635|541560267|FG001|Treatment Period 2|Adverse Event|0|||
150115723|NCT00622635|541560268|FG002|Treatment Period 2|Adverse Event|0|||
150115724|NCT00622635|541560269|FG003|Treatment Period 2|Adverse Event|0|||
150115725|NCT00622635|541560270|FG004|Treatment Period 2|Adverse Event|0|||
150115726|NCT00622635|541560271|FG005|Treatment Period 2|Adverse Event|0|||
150115727|NCT00622635|541560266|FG000|Treatment Period 3|Adverse Event|0|||
150115728|NCT00622635|541560267|FG001|Treatment Period 3|Adverse Event|0|||
150115729|NCT00622635|541560268|FG002|Treatment Period 3|Adverse Event|0|||
150115730|NCT00622635|541560269|FG003|Treatment Period 3|Adverse Event|2|||
150115731|NCT00622635|541560270|FG004|Treatment Period 3|Adverse Event|0|||
150115732|NCT00622635|541560271|FG005|Treatment Period 3|Adverse Event|0|||
150115733|NCT00622635|541560266|FG000|Treatment Period 3|Withdrawal by Subject|0|||
150115734|NCT00622635|541560267|FG001|Treatment Period 3|Withdrawal by Subject|0|||
150115735|NCT00622635|541560268|FG002|Treatment Period 3|Withdrawal by Subject|0|||
150115736|NCT00622635|541560269|FG003|Treatment Period 3|Withdrawal by Subject|1|||
150115737|NCT00622635|541560270|FG004|Treatment Period 3|Withdrawal by Subject|0|||
150115738|NCT00622635|541560271|FG005|Treatment Period 3|Withdrawal by Subject|0|||
150115739|NCT00281840|541560272|FG000|Overall Study|Adverse Event|12|||
150115740|NCT00281840|541560272|FG000|Overall Study|Physician Decision|6|||
150115741|NCT00281840|541560272|FG000|Overall Study|Withdrawal by Subject|3|||
150115742|NCT00281840|541560272|FG000|Overall Study|Disease Progression|2|||
150115743|NCT00281840|541560272|FG000|Overall Study|exceed maximum delay in treatment|1|||
150115744|NCT00281840|541560272|FG000|Overall Study|Complicating Disease|1|||
150115745|NCT00835406|541560273|FG000|Period: First Intervention|Adverse Event|0|||
150115746|NCT00835406|541560274|FG001|Period: First Intervention|Adverse Event|1|||
150115747|NCT00835406|541560273|FG000|Period: First Intervention|Withdrawal by Subject|2|||
150115748|NCT00835406|541560274|FG001|Period: First Intervention|Withdrawal by Subject|0|||
150115749|NCT00835406|541560273|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
150115750|NCT00835406|541560274|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
150115751|NCT02138214|541560277|FG000|Overall Study|Withdrawal by Subject|0|||
150115752|NCT02138214|541560278|FG001|Overall Study|Withdrawal by Subject|1|||
150115753|NCT02138214|541560279|FG002|Overall Study|Withdrawal by Subject|0|||
150115754|NCT02138214|541560277|FG000|Overall Study|Lost to Follow-up|0|||
150115755|NCT02138214|541560278|FG001|Overall Study|Lost to Follow-up|2|||
150115756|NCT02138214|541560279|FG002|Overall Study|Lost to Follow-up|4|||
150115757|NCT02138214|541560277|FG000|Overall Study|Screen Failure|0|||
150115758|NCT02138214|541560278|FG001|Overall Study|Screen Failure|1|||
150115759|NCT02138214|541560279|FG002|Overall Study|Screen Failure|0|||
150115760|NCT02185768|541560280|FG000|Overall Study|Patients were not treated|2|||
150115761|NCT02550652|541560288|FG000|Overall Study|Death|1|||
150115762|NCT02550652|541560289|FG001|Overall Study|Death|4|||
150115763|NCT02550652|541560288|FG000|Overall Study|Lack of Efficacy|1|||
150115764|NCT02550652|541560289|FG001|Overall Study|Lack of Efficacy|0|||
150115765|NCT02550652|541560288|FG000|Overall Study|Withdrawal by Subject|4|||
150115766|NCT02550652|541560289|FG001|Overall Study|Withdrawal by Subject|7|||
150115767|NCT02550652|541560288|FG000|Overall Study|Post Trial Access|1|||
150115768|NCT02550652|541560289|FG001|Overall Study|Post Trial Access|0|||
150115769|NCT02550652|541560288|FG000|Overall Study|Lost to Follow-up|1|||
150115770|NCT02550652|541560289|FG001|Overall Study|Lost to Follow-up|3|||
150115771|NCT02550652|541560288|FG000|Overall Study|Physician Decision|0|||
150115772|NCT02550652|541560289|FG001|Overall Study|Physician Decision|2|||
150115773|NCT02550652|541560288|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
150115774|NCT02550652|541560289|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
150115775|NCT03027466|541560290|FG000|Overall Study|Opting out of the app|1869|||
150115776|NCT03027466|541560291|FG001|Overall Study|Opting out of the app|1819|||
150115777|NCT03027466|541560292|FG002|Overall Study|Opting out of the app|1743|||
150115778|NCT03027466|541560293|FG003|Overall Study|Opting out of the app|1821|||
150115779|NCT02158039|541560294|FG000|Overall Study|Withdrawal by Subject|1|||
150115780|NCT02158039|541560294|FG000|Overall Study|Screen Failure|9|||
150115781|NCT03062891|541560306|FG000|Overall Study|Withdrawal by Subject|2|||
150115782|NCT03062891|541560307|FG001|Overall Study|Withdrawal by Subject|0|||
150115783|NCT03062891|541560306|FG000|Overall Study|Lost to Follow-up|50|||
150115784|NCT03062891|541560307|FG001|Overall Study|Lost to Follow-up|38|||
150115785|NCT01079234|541560313|FG000|Main: Week 0 to 26|Adverse Event|5|||
150115786|NCT01079234|541560314|FG001|Main: Week 0 to 26|Adverse Event|4|||
150115787|NCT01079234|541560315|FG002|Main: Week 0 to 26|Adverse Event|1|||
150115788|NCT01079234|541560316|FG003|Main: Week 0 to 26|Adverse Event|0|||
150115789|NCT01079234|541560313|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
150115790|NCT01079234|541560314|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
150115791|NCT01079234|541560315|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
150115792|NCT01079234|541560316|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
150115793|NCT01079234|541560313|FG000|Main: Week 0 to 26|Protocol Violation|6|||
150115794|NCT01079234|541560314|FG001|Main: Week 0 to 26|Protocol Violation|2|||
150115795|NCT01079234|541560315|FG002|Main: Week 0 to 26|Protocol Violation|4|||
150115796|NCT01079234|541560316|FG003|Main: Week 0 to 26|Protocol Violation|0|||
150115797|NCT01079234|541560313|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
150115798|NCT01079234|541560314|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
150115799|NCT01079234|541560315|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
150115800|NCT01079234|541560316|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
150115801|NCT01079234|541560313|FG000|Main: Week 0 to 26|Unclassified|7|||
150115802|NCT01079234|541560314|FG001|Main: Week 0 to 26|Unclassified|13|||
150115803|NCT01079234|541560315|FG002|Main: Week 0 to 26|Unclassified|4|||
150115804|NCT01079234|541560316|FG003|Main: Week 0 to 26|Unclassified|0|||
150115805|NCT01079234|541560313|FG000|Extension: Week 27 to 52|Adverse Event|0|||
150115806|NCT01079234|541560314|FG001|Extension: Week 27 to 52|Adverse Event|0|||
150115807|NCT01079234|541560315|FG002|Extension: Week 27 to 52|Adverse Event|1|||
150115808|NCT01079234|541560316|FG003|Extension: Week 27 to 52|Adverse Event|0|||
150115809|NCT01079234|541560313|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
150115810|NCT01079234|541560314|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
150115811|NCT01079234|541560315|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
150115812|NCT01079234|541560316|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
150115813|NCT01079234|541560313|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
150115814|NCT01079234|541560314|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
150115815|NCT01079234|541560315|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
150115816|NCT01079234|541560316|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
150115817|NCT01079234|541560313|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
150115818|NCT01079234|541560314|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
150115819|NCT01079234|541560315|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
150115820|NCT01079234|541560316|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
150115821|NCT01079234|541560313|FG000|Extension: Week 27 to 52|Unclassified|0|||
150115822|NCT01079234|541560314|FG001|Extension: Week 27 to 52|Unclassified|0|||
150115823|NCT01079234|541560315|FG002|Extension: Week 27 to 52|Unclassified|4|||
150115824|NCT01079234|541560316|FG003|Extension: Week 27 to 52|Unclassified|7|||
150115825|NCT03509948|541560326|FG000|Overall Study|Protocol Violation|0|||
150115826|NCT03509948|541560327|FG001|Overall Study|Protocol Violation|1|||
150115827|NCT03221257|541560328|FG000|Overall Study|Lost to Follow-up|0|||
150115828|NCT03221257|541560329|FG001|Overall Study|Lost to Follow-up|1|||
150115829|NCT03221257|541560328|FG000|Overall Study|Withdrawal by Subject|1|||
150115830|NCT03221257|541560329|FG001|Overall Study|Withdrawal by Subject|1|||
150115831|NCT02047604|541560330|FG000|Overall Study|Withdrawal by Subject|0|||
150115832|NCT02047604|541560331|FG001|Overall Study|Withdrawal by Subject|0|||
150115833|NCT02047604|541560332|FG002|Overall Study|Withdrawal by Subject|0|||
150115834|NCT02047604|541560333|FG003|Overall Study|Withdrawal by Subject|0|||
150115835|NCT02047604|541560334|FG004|Overall Study|Withdrawal by Subject|1|||
150115836|NCT02047604|541560335|FG005|Overall Study|Withdrawal by Subject|1|||
150115837|NCT02517905|541560336|FG000|Overall Study|Lost to Follow-up|4|||
150115838|NCT02517905|541560337|FG001|Overall Study|Lost to Follow-up|0|||
150115839|NCT02517905|541560336|FG000|Overall Study|Withdrawal by Subject|4|||
150115840|NCT02517905|541560337|FG001|Overall Study|Withdrawal by Subject|0|||
150115841|NCT02517905|541560336|FG000|Overall Study|Screen failure|2|||
150115842|NCT02517905|541560337|FG001|Overall Study|Screen failure|2|||
150115843|NCT01994395|541560340|FG000|Overall Study|Withdrawal by Subject|1|||
150115844|NCT01994395|541560341|FG001|Overall Study|Withdrawal by Subject|2|||
150115845|NCT01940705|541560345|FG000|Overall Study|Lost to Follow-up|1|||
150115846|NCT01940705|541560346|FG001|Overall Study|Lost to Follow-up|3|||
150115847|NCT01940705|541560347|FG002|Overall Study|Lost to Follow-up|2|||
150115848|NCT01940705|541560348|FG003|Overall Study|Lost to Follow-up|2|||
150115849|NCT01940705|541560345|FG000|Overall Study|Withdrawal by Subject|2|||
150115850|NCT01940705|541560346|FG001|Overall Study|Withdrawal by Subject|2|||
150115851|NCT01940705|541560347|FG002|Overall Study|Withdrawal by Subject|3|||
150115852|NCT01940705|541560348|FG003|Overall Study|Withdrawal by Subject|2|||
150115853|NCT01940705|541560345|FG000|Overall Study|Intervention not given|0|||
150115854|NCT01940705|541560346|FG001|Overall Study|Intervention not given|3|||
150115855|NCT01940705|541560347|FG002|Overall Study|Intervention not given|3|||
150115856|NCT01940705|541560348|FG003|Overall Study|Intervention not given|0|||
150115857|NCT01940705|541560345|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
150115858|NCT01940705|541560346|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
150115859|NCT01940705|541560347|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
150115860|NCT01940705|541560348|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
150115861|NCT00459134|541560349|FG000|Overall Study|Physician Decision|1|||
150115862|NCT00459134|541560350|FG001|Overall Study|Physician Decision|1|||
150115863|NCT00459134|541560349|FG000|Overall Study|Withdrawal by Subject|8|||
150115864|NCT00459134|541560350|FG001|Overall Study|Withdrawal by Subject|7|||
150115865|NCT00459134|541560349|FG000|Overall Study|Lost to Follow-up|6|||
150115866|NCT00459134|541560350|FG001|Overall Study|Lost to Follow-up|7|||
150115867|NCT00459134|541560349|FG000|Overall Study|Surgery|1|||
150115868|NCT00459134|541560350|FG001|Overall Study|Surgery|2|||
150115869|NCT00459134|541560349|FG000|Overall Study|Toxicity|4|||
150115870|NCT00459134|541560350|FG001|Overall Study|Toxicity|5|||
150115871|NCT00459134|541560349|FG000|Overall Study|Progression|1|||
150115872|NCT00459134|541560350|FG001|Overall Study|Progression|0|||
150115873|NCT00459134|541560349|FG000|Overall Study|Multiple Reasons|2|||
150115874|NCT00459134|541560350|FG001|Overall Study|Multiple Reasons|3|||
150115875|NCT00829621|541560351|FG000|Overall Study|Death|1|||
150115876|NCT00829621|541560352|FG001|Overall Study|Death|0|||
150115877|NCT00829621|541560351|FG000|Overall Study|Lost to Follow-up|3|||
150115878|NCT00829621|541560352|FG001|Overall Study|Lost to Follow-up|4|||
150115879|NCT01755416|541560353|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
150115880|NCT01755416|541560354|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
150115881|NCT01976845|541560355|FG000|Overall Study|Physician Decision|8|||
150115882|NCT01976845|541560356|FG001|Overall Study|Physician Decision|8|||
150115883|NCT01976845|541560357|FG002|Overall Study|Physician Decision|3|||
150115884|NCT00441337|541560363|FG000|Overall Study|Disease Progression|6|||
150115885|NCT00441337|541560364|FG001|Overall Study|Disease Progression|6|||
150115886|NCT00441337|541560365|FG002|Overall Study|Disease Progression|4|||
150115887|NCT00441337|541560366|FG003|Overall Study|Disease Progression|18|||
150115888|NCT00441337|541560363|FG000|Overall Study|Lost to Follow-up|0|||
150115889|NCT00441337|541560364|FG001|Overall Study|Lost to Follow-up|0|||
150115890|NCT00441337|541560365|FG002|Overall Study|Lost to Follow-up|0|||
150115891|NCT00441337|541560366|FG003|Overall Study|Lost to Follow-up|1|||
150115892|NCT00441337|541560363|FG000|Overall Study|Sponsor Decision|0|||
150115893|NCT00441337|541560364|FG001|Overall Study|Sponsor Decision|0|||
150115894|NCT00441337|541560365|FG002|Overall Study|Sponsor Decision|1|||
150115895|NCT00441337|541560366|FG003|Overall Study|Sponsor Decision|2|||
150115896|NCT00441337|541560363|FG000|Overall Study|Did not meet inclusion criteria|0|||
150115897|NCT00441337|541560364|FG001|Overall Study|Did not meet inclusion criteria|0|||
150115898|NCT00441337|541560365|FG002|Overall Study|Did not meet inclusion criteria|1|||
150115899|NCT00441337|541560366|FG003|Overall Study|Did not meet inclusion criteria|0|||
150115900|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
150115901|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
150115902|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
150189586|NCT04876118|541831354|FG000|Overall Study|Pregnancy|1|||
150189587|NCT04876118|541831354|FG000|Overall Study|Withdrawal by Subject|14|||
150189588|NCT05089734|541831357|FG000|Overall Study|Still on study|122|||
150189589|NCT05089734|541831358|FG001|Overall Study|Still on study|101|||
150189590|NCT05089734|541831357|FG000|Overall Study|Death|161|||
150189591|NCT05089734|541831358|FG001|Overall Study|Death|179|||
150189592|NCT05089734|541831357|FG000|Overall Study|Withdrew consent|11|||
150189593|NCT05089734|541831358|FG001|Overall Study|Withdrew consent|24|||
150189594|NCT05089734|541831357|FG000|Overall Study|Lost to Follow-up|5|||
150189595|NCT05089734|541831358|FG001|Overall Study|Lost to Follow-up|0|||
150115903|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Death|1|||
150115904|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Death|0|||
150115905|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Death|0|||
150115906|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
150115907|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
150115908|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
150115909|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
150115910|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
150189596|NCT05093829|541831359|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
150115911|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
150189597|NCT05093829|541831360|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
150115912|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
150115913|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
150115914|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
150115915|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
150115916|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
150115917|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
150115918|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
150115919|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
150115920|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
150115921|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
150115922|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
150115923|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
150115924|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
150115925|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
150115926|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
150115927|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
150115928|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
150115929|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
150115930|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
150115931|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
150115932|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
150115933|NCT03655236|541560367|FG000|Subject Disposition in Part 1 Period|Other|0|||
150115934|NCT03655236|541560368|FG001|Subject Disposition in Part 1 Period|Other|2|||
150115935|NCT03655236|541560369|FG002|Subject Disposition in Part 1 Period|Other|2|||
150115936|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
150115937|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
150115938|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
150115939|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
150115940|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
150115941|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
150115942|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
150115943|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
150115944|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
150115945|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
150115946|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
150115947|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
150115948|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
150115949|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
150115950|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
150115951|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
150115952|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
150115953|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
150115954|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
150115955|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
150115956|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
150115957|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
150115958|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
150115959|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
150115960|NCT03655236|541560367|FG000|Subject Disposition in Part 2 Period|Other|1|||
150115961|NCT03655236|541560368|FG001|Subject Disposition in Part 2 Period|Other|0|||
150115962|NCT03655236|541560369|FG002|Subject Disposition in Part 2 Period|Other|0|||
150115963|NCT03042312|541561696|FG000|Overall Study|Administrative Reason|1|||
150115964|NCT03042312|541561697|FG001|Overall Study|Administrative Reason|1|||
150115965|NCT03042312|541561696|FG000|Overall Study|Adverse Event|0|||
150115966|NCT03042312|541561697|FG001|Overall Study|Adverse Event|1|||
150115967|NCT03042312|541561696|FG000|Overall Study|Lost to Follow-up|1|||
150115968|NCT03042312|541561697|FG001|Overall Study|Lost to Follow-up|3|||
150115969|NCT03042312|541561696|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
150115970|NCT03042312|541561697|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
150115971|NCT03042312|541561696|FG000|Overall Study|Withdrawal by Subject|4|||
150115972|NCT03042312|541561697|FG001|Overall Study|Withdrawal by Subject|5|||
150115973|NCT04258839|541561700|FG000|Overall Study|Adverse Event|2|||
150115974|NCT04258839|541561701|FG001|Overall Study|Adverse Event|4|||
150115975|NCT04258839|541561700|FG000|Overall Study|Lack of Efficacy|0|||
150115976|NCT04258839|541561701|FG001|Overall Study|Lack of Efficacy|2|||
150115977|NCT04258839|541561700|FG000|Overall Study|Lost to Follow-up|2|||
150115978|NCT04258839|541561701|FG001|Overall Study|Lost to Follow-up|0|||
150115979|NCT04258839|541561700|FG000|Overall Study|Withdrawal by Subject|1|||
150115980|NCT04258839|541561701|FG001|Overall Study|Withdrawal by Subject|2|||
150115981|NCT04258839|541561700|FG000|Overall Study|Withdrawal by Caregiver|5|||
150115982|NCT04258839|541561701|FG001|Overall Study|Withdrawal by Caregiver|6|||
150115983|NCT04258839|541561700|FG000|Overall Study|Reason not Specified|0|||
150115984|NCT04258839|541561701|FG001|Overall Study|Reason not Specified|1|||
150115985|NCT02293005|541561702|FG000|Overall Study|Adverse Event|2|||
150115986|NCT02293005|541561702|FG000|Overall Study|Death|4|||
150115987|NCT02293005|541561702|FG000|Overall Study|Lost to Follow-up|1|||
150115988|NCT02293005|541561702|FG000|Overall Study|Withdrawal by Subject|2|||
150115989|NCT02293005|541561702|FG000|Overall Study|Progression|17|||
150115990|NCT01043874|541561704|FG000|Overall Study|Adverse Event|3|||
150115991|NCT01043874|541561704|FG000|Overall Study|Withdrawal by Subject|1|||
150115992|NCT01043874|541561704|FG000|Overall Study|Lack of Efficacy|1|||
150115993|NCT01043874|541561704|FG000|Overall Study|Administrative Problems|1|||
150115994|NCT02648698|541561707|FG000|Overall Study|Protocol Violation|1|||
150115995|NCT02648698|541561708|FG001|Overall Study|Protocol Violation|5|||
150115996|NCT00966940|541561709|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
150115997|NCT00966940|541561710|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
150115998|NCT00966940|541561709|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
150115999|NCT00966940|541561710|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
150116000|NCT01774903|541561711|FG000|Overall Study|Adverse Event|7|||
150116001|NCT01774903|541561711|FG000|Overall Study|Withdrawal by Subject|2|||
150116002|NCT01774903|541561711|FG000|Overall Study|Lack of Efficacy|1|||
150116003|NCT01774903|541561711|FG000|Overall Study|Ineligible to continue the trial|1|||
150116004|NCT00924950|541561712|FG000|Overall Study|Lost to Follow-up|2|||
150116005|NCT00982319|541561713|FG000|Overall Study|Surgery date change|1|||
150116006|NCT00982319|541561714|FG001|Overall Study|Surgery date change|0|||
150116007|NCT00982319|541561713|FG000|Overall Study|Preop values out of acceptable range|1|||
150116008|NCT00982319|541561714|FG001|Overall Study|Preop values out of acceptable range|1|||
150116009|NCT00982319|541561713|FG000|Overall Study|Pregnancy|0|||
150116010|NCT00982319|541561714|FG001|Overall Study|Pregnancy|1|||
150116011|NCT03603964|541561717|FG000|Overall Study|Death|9|||
150116012|NCT03603964|541561717|FG000|Overall Study|Withdrawal by participant|7|||
150116013|NCT03603964|541561717|FG000|Overall Study|Study terminated by Sponsor|19|||
150116014|NCT00563797|541561718|FG000|Overall Study|Lost to Follow-up|7|||
150116015|NCT00563797|541561719|FG001|Overall Study|Lost to Follow-up|2|||
150116016|NCT00530023|541561720|FG000|Overall Study|Withdrawal by Subject|0|||
150116017|NCT00530023|541561721|FG001|Overall Study|Withdrawal by Subject|1|||
150116018|NCT02863354|541561726|FG000|Year 1|Lost to Follow-up|1|||
150116019|NCT02863354|541561727|FG001|Year 1|Lost to Follow-up|1|||
150116020|NCT02863354|541561726|FG000|Year 1|Withdrawal by Subject|3|||
150116021|NCT02863354|541561727|FG001|Year 1|Withdrawal by Subject|0|||
150116022|NCT02863354|541561726|FG000|Year 1|Death|0|||
150116023|NCT02863354|541561727|FG001|Year 1|Death|1|||
150116024|NCT02863354|541561726|FG000|Year 2|Lost to Follow-up|2|||
150116025|NCT02863354|541561727|FG001|Year 2|Lost to Follow-up|2|||
150116026|NCT04632940|541561749|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
150189598|NCT05093829|541831361|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
150116027|NCT04632940|541561750|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
150116028|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
150116029|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
150116030|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
150116031|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
150116032|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
150116033|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
150116034|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
150116035|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
150116036|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
150116037|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
150116038|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Other than specified|0|||
150116039|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Other than specified|1|||
150116040|NCT04632940|541561749|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
150116041|NCT04632940|541561750|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
150116042|NCT02520531|541561757|FG000|Overall Study|Revision of study device components|2|||
150116043|NCT02520531|541561758|FG001|Overall Study|Revision of study device components|2|||
150116044|NCT02520531|541561757|FG000|Overall Study|Death|1|||
150116045|NCT02520531|541561758|FG001|Overall Study|Death|2|||
150116046|NCT02520531|541561757|FG000|Overall Study|Lost to Follow-up|1|||
150116047|NCT02520531|541561758|FG001|Overall Study|Lost to Follow-up|1|||
150116048|NCT02520531|541561757|FG000|Overall Study|Meet exclusion criterion|0|||
150116049|NCT02520531|541561758|FG001|Overall Study|Meet exclusion criterion|1|||
150116050|NCT02520531|541561757|FG000|Overall Study|Withdrawal by Subject|1|||
150116051|NCT02520531|541561758|FG001|Overall Study|Withdrawal by Subject|0|||
150116052|NCT02520531|541561757|FG000|Overall Study|Not study device|1|||
150116053|NCT02520531|541561758|FG001|Overall Study|Not study device|0|||
150116054|NCT01723904|541561761|FG000|Overall Study|Noncompliant|3|||
150116055|NCT01723904|541561761|FG000|Overall Study|Adverse Event|5|||
150116056|NCT01723904|541561761|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
150116057|NCT00887341|541561772|FG000|Overall Study|Refused treatment|1|||
150116058|NCT00887341|541561773|FG001|Overall Study|Refused treatment|0|||
150116059|NCT00887341|541561772|FG000|Overall Study|Withdrawal by Subject|1|||
150116060|NCT00887341|541561773|FG001|Overall Study|Withdrawal by Subject|1|||
150116061|NCT00887341|541561772|FG000|Overall Study|Adverse Event|0|||
150116062|NCT00887341|541561773|FG001|Overall Study|Adverse Event|1|||
150116063|NCT00887341|541561772|FG000|Overall Study|Lost to Follow-up|0|||
150116064|NCT00887341|541561773|FG001|Overall Study|Lost to Follow-up|1|||
150116065|NCT01752933|541561776|FG000|Treatment|Disease Progression|3|||
150116066|NCT01752933|541561777|FG001|Treatment|Disease Progression|29|||
150116067|NCT01752933|541561776|FG000|Treatment|Withdrawal by Subject|0|||
150116068|NCT01752933|541561777|FG001|Treatment|Withdrawal by Subject|5|||
150116069|NCT01752933|541561776|FG000|Treatment|Adverse Event|1|||
150116070|NCT01752933|541561777|FG001|Treatment|Adverse Event|4|||
150116071|NCT01752933|541561776|FG000|Treatment|Physician Decision|0|||
150116072|NCT01752933|541561777|FG001|Treatment|Physician Decision|3|||
150116073|NCT01752933|541561776|FG000|Treatment|Death|0|||
150116074|NCT01752933|541561777|FG001|Treatment|Death|2|||
150116075|NCT01752933|541561776|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
150116076|NCT01752933|541561777|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
150116077|NCT01752933|541561776|FG000|Treatment|Patient noncompliant|0|||
150116078|NCT01752933|541561777|FG001|Treatment|Patient noncompliant|1|||
150116079|NCT01752933|541561776|FG000|Treatment|Patient unable to travel to appointments|0|||
150116080|NCT01752933|541561777|FG001|Treatment|Patient unable to travel to appointments|1|||
150116081|NCT01752933|541561776|FG000|Overall Study and Follow-up|Death|4|||
150116082|NCT01752933|541561777|FG001|Overall Study and Follow-up|Death|34|||
150116083|NCT01752933|541561776|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
150116084|NCT01752933|541561777|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
150116085|NCT01752933|541561776|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
150116086|NCT01752933|541561777|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
150116087|NCT01752933|541561776|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
150116088|NCT01752933|541561777|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
150116089|NCT01591681|541561778|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
150116090|NCT01591681|541561778|FG000|Overall Study|Failed to use system during run-in|1|||
150116091|NCT02486406|541561786|FG000|Overall Study|Withdrew consent|1|||
150116092|NCT02486406|541561787|FG001|Overall Study|Withdrew consent|0|||
150116093|NCT02486406|541561788|FG002|Overall Study|Withdrew consent|0|||
150116094|NCT02486406|541561789|FG003|Overall Study|Withdrew consent|1|||
150116095|NCT02486406|541561786|FG000|Overall Study|Lost to Follow-up|1|||
150116096|NCT02486406|541561787|FG001|Overall Study|Lost to Follow-up|3|||
150116097|NCT02486406|541561788|FG002|Overall Study|Lost to Follow-up|1|||
150116098|NCT02486406|541561789|FG003|Overall Study|Lost to Follow-up|3|||
150116099|NCT02486406|541561786|FG000|Overall Study|Other, not specified|0|||
150116100|NCT02486406|541561787|FG001|Overall Study|Other, not specified|0|||
150116101|NCT02486406|541561788|FG002|Overall Study|Other, not specified|1|||
150116102|NCT02486406|541561789|FG003|Overall Study|Other, not specified|0|||
150116103|NCT01858194|541561790|FG000|Overall Study|Total Artificial Heart Implant|0|||
150116104|NCT01858194|541561791|FG001|Overall Study|Total Artificial Heart Implant|1|||
150116105|NCT01858194|541561790|FG000|Overall Study|Lost to Follow-up|0|||
150116106|NCT01858194|541561791|FG001|Overall Study|Lost to Follow-up|1|||
150116107|NCT00235989|541561792|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
150116108|NCT00235989|541561793|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
150116109|NCT00235989|541561794|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
150116110|NCT00235989|541561795|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
150116111|NCT00235989|541561796|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
150116112|NCT00235989|541561797|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
150116113|NCT00235989|541561792|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
150116114|NCT00235989|541561793|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
150116115|NCT00235989|541561794|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
150116116|NCT00235989|541561795|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
150116117|NCT00235989|541561796|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
150116118|NCT00235989|541561797|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
150116119|NCT00235989|541561792|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
150116120|NCT00235989|541561793|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
150116121|NCT00235989|541561794|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
150116122|NCT00235989|541561795|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
150116123|NCT00235989|541561796|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
150116124|NCT00235989|541561797|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
150116125|NCT00235989|541561792|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
150116126|NCT00235989|541561793|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
150116127|NCT00235989|541561794|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
150116128|NCT00235989|541561795|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
150116129|NCT00235989|541561796|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
150116130|NCT00235989|541561797|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
150116131|NCT00235989|541561792|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
150116132|NCT00235989|541561793|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
150116133|NCT00235989|541561794|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
150116134|NCT00235989|541561795|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
150116135|NCT00235989|541561796|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
150116136|NCT00235989|541561797|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
150116137|NCT00298831|541561810|FG000|Overall Study|Adverse Event|1|||
150116138|NCT00298831|541561810|FG000|Overall Study|Lost to Follow-up|3|||
150116139|NCT00298831|541561810|FG000|Overall Study|Withdrawal by Subject|1|||
150116140|NCT00298831|541561810|FG000|Overall Study|Participants did not receive treatment|27|||
150116141|NCT00437034|541561811|FG000|Overall Study|Adverse Event|1|||
150116142|NCT00437034|541561811|FG000|Overall Study|Disease progression during treatment|5|||
150116143|NCT01978184|541561813|FG000|Overall Study|Progressive disease|5|||
150116144|NCT01978184|541561814|FG001|Overall Study|Progressive disease|5|||
150116145|NCT01978184|541561813|FG000|Overall Study|Other than PDA|2|||
150116146|NCT01978184|541561814|FG001|Overall Study|Other than PDA|2|||
150116147|NCT01978184|541561813|FG000|Overall Study|Physician Decision|0|||
150116148|NCT01978184|541561814|FG001|Overall Study|Physician Decision|3|||
150116149|NCT01978184|541561813|FG000|Overall Study|Noncompliance|1|||
150116150|NCT01978184|541561814|FG001|Overall Study|Noncompliance|2|||
150116151|NCT01978184|541561813|FG000|Overall Study|Death|1|||
150116152|NCT01978184|541561814|FG001|Overall Study|Death|0|||
150116153|NCT01978184|541561813|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
150116154|NCT01978184|541561814|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
150116155|NCT03146650|541561817|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
150189599|NCT05093829|541831362|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
150116156|NCT03146650|541561817|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
150116157|NCT03146650|541561817|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
150116158|NCT03146650|541561817|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
150116159|NCT03146650|541561817|FG000|2 Year Follow-up|Death|11|||
150116160|NCT03146650|541561817|FG000|2 Year Follow-up|Still in follow-up|7|||
150189600|NCT05093829|541831363|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
150189601|NCT04353661|541833232|FG000|Overall Study|Protocol Violation|0|||
150189602|NCT04353661|541833233|FG001|Overall Study|Protocol Violation|0|||
150189603|NCT04353661|541833234|FG002|Overall Study|Protocol Violation|1|||
150189604|NCT04353661|541833232|FG000|Overall Study|Study termination by the Sponsor|1|||
150189605|NCT04353661|541833233|FG001|Overall Study|Study termination by the Sponsor|1|||
150116161|NCT03146650|541561817|FG000|2 Year Follow-up|Lost to Follow-up|1|||
150116162|NCT00931307|541561818|FG000|Overall Study|Lack of Efficacy|12|||
150116163|NCT00931307|541561818|FG000|Overall Study|Biomicroscopy|1|||
150116164|NCT00691210|541561821|FG000|Overall Study|Progression of Disease|0|||
150189606|NCT04353661|541833234|FG002|Overall Study|Study termination by the Sponsor|1|||
150189607|NCT02671903|541833235|FG000|Period 0 (Run-In)|Death|0|||
150189608|NCT02671903|541833236|FG001|Period 0 (Run-In)|Death|0|||
150189609|NCT02671903|541833237|FG002|Period 0 (Run-In)|Death|3|||
150189610|NCT02671903|541833235|FG000|Period 0 (Run-In)|Physician Decision|0|||
150189611|NCT02671903|541833236|FG001|Period 0 (Run-In)|Physician Decision|0|||
150189612|NCT02671903|541833237|FG002|Period 0 (Run-In)|Physician Decision|4|||
150189613|NCT02671903|541833235|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
150189614|NCT02671903|541833236|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
150189615|NCT02671903|541833237|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
150189616|NCT02671903|541833235|FG000|Period 0 (Run-In)|Protocol Violation|0|||
150189617|NCT02671903|541833236|FG001|Period 0 (Run-In)|Protocol Violation|0|||
150189618|NCT02671903|541833237|FG002|Period 0 (Run-In)|Protocol Violation|1|||
150189619|NCT02671903|541833235|FG000|Period 0 (Run-In)|Adverse Event|0|||
150189620|NCT02671903|541833236|FG001|Period 0 (Run-In)|Adverse Event|0|||
150189621|NCT02671903|541833237|FG002|Period 0 (Run-In)|Adverse Event|1|||
150189622|NCT02671903|541833235|FG000|Period 0 (Run-In)|Implantation Failure|0|||
150189623|NCT02671903|541833236|FG001|Period 0 (Run-In)|Implantation Failure|0|||
150189624|NCT02671903|541833237|FG002|Period 0 (Run-In)|Implantation Failure|2|||
150189625|NCT02671903|541833235|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
150189626|NCT02671903|541833236|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
150116165|NCT00691210|541561822|FG001|Overall Study|Progression of Disease|0|||
150116166|NCT00691210|541561823|FG002|Overall Study|Progression of Disease|0|||
150116167|NCT00691210|541561824|FG003|Overall Study|Progression of Disease|2|||
150116168|NCT00691210|541561825|FG004|Overall Study|Progression of Disease|0|||
150116169|NCT00691210|541561826|FG005|Overall Study|Progression of Disease|0|||
150116170|NCT00691210|541561827|FG006|Overall Study|Progression of Disease|0|||
150116171|NCT00691210|541561828|FG007|Overall Study|Progression of Disease|0|||
150116172|NCT00691210|541561821|FG000|Overall Study|Lack of Efficacy|0|||
150116173|NCT00691210|541561822|FG001|Overall Study|Lack of Efficacy|0|||
150116174|NCT00691210|541561823|FG002|Overall Study|Lack of Efficacy|0|||
150116175|NCT00691210|541561824|FG003|Overall Study|Lack of Efficacy|1|||
150116176|NCT00691210|541561825|FG004|Overall Study|Lack of Efficacy|0|||
150116177|NCT00691210|541561826|FG005|Overall Study|Lack of Efficacy|1|||
150116178|NCT00691210|541561827|FG006|Overall Study|Lack of Efficacy|0|||
150116179|NCT00691210|541561828|FG007|Overall Study|Lack of Efficacy|0|||
150116180|NCT01208233|541561832|FG000|Overall Study|Adverse Event|0|||
150116181|NCT01208233|541561833|FG001|Overall Study|Adverse Event|1|||
150116182|NCT01208233|541561834|FG002|Overall Study|Adverse Event|2|||
150116183|NCT01208233|541561835|FG003|Overall Study|Adverse Event|0|||
150116184|NCT01208233|541561836|FG004|Overall Study|Adverse Event|3|||
150116185|NCT01208233|541561837|FG005|Overall Study|Adverse Event|5|||
150116186|NCT01208233|541561832|FG000|Overall Study|Death|0|||
150116187|NCT01208233|541561833|FG001|Overall Study|Death|0|||
150116188|NCT01208233|541561834|FG002|Overall Study|Death|0|||
150116189|NCT01208233|541561835|FG003|Overall Study|Death|0|||
150116190|NCT01208233|541561836|FG004|Overall Study|Death|3|||
150116191|NCT01208233|541561837|FG005|Overall Study|Death|5|||
150116192|NCT01208233|541561832|FG000|Overall Study|Did not meet entrance criteria|2|||
150116193|NCT01208233|541561833|FG001|Overall Study|Did not meet entrance criteria|1|||
150116194|NCT01208233|541561834|FG002|Overall Study|Did not meet entrance criteria|1|||
150116195|NCT01208233|541561835|FG003|Overall Study|Did not meet entrance criteria|0|||
150116196|NCT01208233|541561836|FG004|Overall Study|Did not meet entrance criteria|1|||
150116197|NCT01208233|541561837|FG005|Overall Study|Did not meet entrance criteria|0|||
150116198|NCT01208233|541561832|FG000|Overall Study|Medication error without adverse event|0|||
150116199|NCT01208233|541561833|FG001|Overall Study|Medication error without adverse event|0|||
150116200|NCT01208233|541561834|FG002|Overall Study|Medication error without adverse event|0|||
150116201|NCT01208233|541561835|FG003|Overall Study|Medication error without adverse event|0|||
150116202|NCT01208233|541561836|FG004|Overall Study|Medication error without adverse event|0|||
150116203|NCT01208233|541561837|FG005|Overall Study|Medication error without adverse event|1|||
150116204|NCT01208233|541561832|FG000|Overall Study|Study terminated by sponsor|0|||
150116205|NCT01208233|541561833|FG001|Overall Study|Study terminated by sponsor|0|||
150116206|NCT01208233|541561834|FG002|Overall Study|Study terminated by sponsor|0|||
150116207|NCT01208233|541561835|FG003|Overall Study|Study terminated by sponsor|0|||
150116208|NCT01208233|541561836|FG004|Overall Study|Study terminated by sponsor|10|||
150189627|NCT02671903|541833237|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
150189628|NCT03376321|541833238|FG000|Overall Study|Other|5|||
150189629|NCT03376321|541833239|FG001|Overall Study|Other|1|||
150189630|NCT03376321|541833238|FG000|Overall Study|Withdrawal by Subject|8|||
150189631|NCT03376321|541833239|FG001|Overall Study|Withdrawal by Subject|14|||
150116209|NCT01208233|541561837|FG005|Overall Study|Study terminated by sponsor|7|||
150116210|NCT01208233|541561832|FG000|Overall Study|Protocol Violation|0|||
150116211|NCT01208233|541561833|FG001|Overall Study|Protocol Violation|0|||
150116212|NCT01208233|541561834|FG002|Overall Study|Protocol Violation|0|||
150116213|NCT01208233|541561835|FG003|Overall Study|Protocol Violation|0|||
150116214|NCT01208233|541561836|FG004|Overall Study|Protocol Violation|3|||
150116215|NCT01208233|541561837|FG005|Overall Study|Protocol Violation|0|||
150116216|NCT01208233|541561832|FG000|Overall Study|Other|2|||
150116217|NCT01208233|541561833|FG001|Overall Study|Other|1|||
150116218|NCT01208233|541561834|FG002|Overall Study|Other|0|||
150116219|NCT01208233|541561835|FG003|Overall Study|Other|0|||
150116220|NCT01208233|541561836|FG004|Overall Study|Other|0|||
150116221|NCT01208233|541561837|FG005|Overall Study|Other|1|||
150116222|NCT01208233|541561832|FG000|Overall Study|Withdrawal by Subject|1|||
150116223|NCT01208233|541561833|FG001|Overall Study|Withdrawal by Subject|0|||
150116224|NCT01208233|541561834|FG002|Overall Study|Withdrawal by Subject|1|||
150116225|NCT01208233|541561835|FG003|Overall Study|Withdrawal by Subject|1|||
150116226|NCT01208233|541561836|FG004|Overall Study|Withdrawal by Subject|4|||
150116227|NCT01208233|541561837|FG005|Overall Study|Withdrawal by Subject|2|||
150116228|NCT00983814|541561838|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
150116229|NCT00983814|541561839|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
150116230|NCT00983814|541561840|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
150116231|NCT00983814|541561838|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
150116232|NCT00983814|541561839|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
150116233|NCT00983814|541561840|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
150116234|NCT00983814|541561838|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
150116235|NCT00983814|541561839|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
150116236|NCT00983814|541561840|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
150116237|NCT00983814|541561838|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
150116238|NCT00983814|541561839|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
150116239|NCT00983814|541561840|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
150116240|NCT00983814|541561838|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
150116241|NCT00983814|541561839|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
150116242|NCT00983814|541561840|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
150116243|NCT01181895|541561841|FG000|Overall Study|Adverse Event|3|||
150116244|NCT01181895|541561842|FG001|Overall Study|Adverse Event|1|||
150116245|NCT01181895|541561843|FG002|Overall Study|Adverse Event|1|||
150116246|NCT01181895|541561841|FG000|Overall Study|Lack of Efficacy|8|||
150116247|NCT01181895|541561842|FG001|Overall Study|Lack of Efficacy|9|||
150116248|NCT01181895|541561843|FG002|Overall Study|Lack of Efficacy|9|||
150116249|NCT01181895|541561841|FG000|Overall Study|Protocol Violation|2|||
150116250|NCT01181895|541561842|FG001|Overall Study|Protocol Violation|1|||
150116251|NCT01181895|541561843|FG002|Overall Study|Protocol Violation|0|||
150116252|NCT01181895|541561841|FG000|Overall Study|Lost to Follow-up|0|||
150116253|NCT01181895|541561842|FG001|Overall Study|Lost to Follow-up|1|||
150116254|NCT01181895|541561843|FG002|Overall Study|Lost to Follow-up|2|||
150116255|NCT01181895|541561841|FG000|Overall Study|Investigator Discretion|1|||
150116256|NCT01181895|541561842|FG001|Overall Study|Investigator Discretion|2|||
150116257|NCT01181895|541561843|FG002|Overall Study|Investigator Discretion|1|||
150116258|NCT01181895|541561841|FG000|Overall Study|Withdrawal by Subject|3|||
150116259|NCT01181895|541561842|FG001|Overall Study|Withdrawal by Subject|0|||
150116260|NCT01181895|541561843|FG002|Overall Study|Withdrawal by Subject|5|||
150116261|NCT02707640|541561844|FG000|Overall Study|Adverse Event|4|||
150116262|NCT02707640|541561845|FG001|Overall Study|Adverse Event|2|||
150116263|NCT02707640|541561844|FG000|Overall Study|Death|1|||
150116264|NCT02707640|541561845|FG001|Overall Study|Death|2|||
150116265|NCT02707640|541561844|FG000|Overall Study|Physician Decision|2|||
150116266|NCT02707640|541561845|FG001|Overall Study|Physician Decision|0|||
150116267|NCT02707640|541561844|FG000|Overall Study|Withdrawal by Subject|0|||
150116268|NCT02707640|541561845|FG001|Overall Study|Withdrawal by Subject|1|||
150116269|NCT02707640|541561844|FG000|Overall Study|Participant's Personal Decision|1|||
150116270|NCT02707640|541561845|FG001|Overall Study|Participant's Personal Decision|2|||
150116271|NCT02707640|541561844|FG000|Overall Study|Sponsor Discretion|1|||
150116272|NCT02707640|541561845|FG001|Overall Study|Sponsor Discretion|0|||
150116273|NCT05789875|541561846|FG000|Overall Study|Lost to Follow-up|6|||
150116274|NCT00023452|541561847|FG000|Overall Study|Ineligible for Study|163|||
150116275|NCT00023452|541561848|FG001|Overall Study|Ineligible for Study|159|||
150116276|NCT00023452|541561847|FG000|Overall Study|Out of Window|129|||
150116277|NCT00023452|541561848|FG001|Overall Study|Out of Window|69|||
150116278|NCT00023452|541561847|FG000|Overall Study|Death|2|||
150116279|NCT00023452|541561848|FG001|Overall Study|Death|0|||
150116280|NCT00023452|541561847|FG000|Overall Study|Withdrawal by Subject|66|||
150116281|NCT00023452|541561848|FG001|Overall Study|Withdrawal by Subject|54|||
150116282|NCT00023452|541561847|FG000|Overall Study|Adverse Event|139|||
150116283|NCT00023452|541561848|FG001|Overall Study|Adverse Event|196|||
150116284|NCT00023452|541561847|FG000|Overall Study|Lost to Follow-up|293|||
150116285|NCT00023452|541561848|FG001|Overall Study|Lost to Follow-up|60|||
150116286|NCT00023452|541561847|FG000|Overall Study|Physician Decision|49|||
150116287|NCT00023452|541561848|FG001|Overall Study|Physician Decision|21|||
150116288|NCT00023452|541561847|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
150116289|NCT00023452|541561848|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
150116290|NCT00023452|541561847|FG000|Overall Study|Pregnant|53|||
150116291|NCT00023452|541561848|FG001|Overall Study|Pregnant|20|||
150189632|NCT03376321|541833238|FG000|Overall Study|Lost to Follow-up|1|||
150189633|NCT03376321|541833239|FG001|Overall Study|Lost to Follow-up|7|||
150189634|NCT03376321|541833238|FG000|Overall Study|Death|4|||
150189635|NCT03376321|541833239|FG001|Overall Study|Death|0|||
150189636|NCT03376321|541833238|FG000|Overall Study|Randomized, not treated|5|||
150189637|NCT03376321|541833239|FG001|Overall Study|Randomized, not treated|3|||
150189638|NCT02992925|541833240|FG000|Cohort 2|Physician Decision|0|||
150189639|NCT02992925|541833241|FG001|Cohort 2|Physician Decision|0|||
150189640|NCT02992925|541833242|FG002|Cohort 2|Physician Decision|1|||
150189641|NCT02992925|541833243|FG003|Cohort 2|Physician Decision|0|||
150189642|NCT02992925|541833240|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
150189643|NCT02992925|541833241|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
150189644|NCT02992925|541833242|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
150189645|NCT02992925|541833243|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
150189646|NCT02995434|541833244|FG000|Overall Study|Adverse Event|1|||
150189647|NCT02995434|541833245|FG001|Overall Study|Adverse Event|0|||
150189648|NCT02995434|541833244|FG000|Overall Study|Withdrawal by Subject|6|||
150189649|NCT02995434|541833245|FG001|Overall Study|Withdrawal by Subject|3|||
150189650|NCT05273749|541833246|FG000|Overall Study|Adverse Event|14|||
150189651|NCT05273749|541833247|FG001|Overall Study|Adverse Event|8|||
150189652|NCT05273749|541833246|FG000|Overall Study|Lack of Efficacy|2|||
150189653|NCT05273749|541833247|FG001|Overall Study|Lack of Efficacy|8|||
150189654|NCT05273749|541833246|FG000|Overall Study|Physician Decision|0|||
150189655|NCT05273749|541833247|FG001|Overall Study|Physician Decision|2|||
150189656|NCT05273749|541833246|FG000|Overall Study|Withdrawal by Subject|14|||
150189657|NCT05273749|541833247|FG001|Overall Study|Withdrawal by Subject|16|||
150189658|NCT05273749|541833246|FG000|Overall Study|Lost to Follow-up|10|||
150189659|NCT05273749|541833247|FG001|Overall Study|Lost to Follow-up|10|||
150189660|NCT05273749|541833246|FG000|Overall Study|Pregnancy|1|||
150189661|NCT05273749|541833247|FG001|Overall Study|Pregnancy|0|||
150189662|NCT05273749|541833246|FG000|Overall Study|Non-Compliance|3|||
150189663|NCT05273749|541833247|FG001|Overall Study|Non-Compliance|2|||
150189664|NCT05273749|541833246|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
150189665|NCT05273749|541833247|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
150189666|NCT00378105|541833251|FG000|Overall Study|Adverse Event|3|||
150189667|NCT00378105|541833252|FG001|Overall Study|Adverse Event|1|||
150189668|NCT00378105|541833251|FG000|Overall Study|Withdrawal by Subject|3|||
150189669|NCT00378105|541833252|FG001|Overall Study|Withdrawal by Subject|3|||
150189670|NCT00378105|541833251|FG000|Overall Study|Death|1|||
150189671|NCT00378105|541833252|FG001|Overall Study|Death|0|||
150189672|NCT00378105|541833251|FG000|Overall Study|Going to transplant|7|||
150189673|NCT00378105|541833252|FG001|Overall Study|Going to transplant|8|||
150189674|NCT00378105|541833251|FG000|Overall Study|Progressive disease|3|||
150189675|NCT00378105|541833252|FG001|Overall Study|Progressive disease|3|||
150189676|NCT00378105|541833251|FG000|Overall Study|remain on study|3|||
150189677|NCT00378105|541833252|FG001|Overall Study|remain on study|11|||
150189678|NCT00378105|541833251|FG000|Overall Study|Physician Decision|0|||
150189679|NCT00378105|541833252|FG001|Overall Study|Physician Decision|2|||
150189680|NCT00378105|541833251|FG000|Overall Study|Going non-protocol therapy|0|||
150189681|NCT00378105|541833252|FG001|Overall Study|Going non-protocol therapy|1|||
150189682|NCT00378105|541833251|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
150189683|NCT00378105|541833252|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
150189684|NCT03623321|541833253|FG000|Overall Study|Adverse Event|32|||
150189685|NCT03623321|541833253|FG000|Overall Study|Death|9|||
150189686|NCT03623321|541833253|FG000|Overall Study|Lack of Efficacy|9|||
150189687|NCT03623321|541833253|FG000|Overall Study|Lost to Follow-up|6|||
150189688|NCT03623321|541833253|FG000|Overall Study|Noncompliance with study drug|6|||
150189689|NCT03623321|541833253|FG000|Overall Study|Use of prohibited medication|3|||
150189690|NCT03623321|541833253|FG000|Overall Study|Physician Decision|5|||
150189691|NCT03623321|541833253|FG000|Overall Study|Protocol Violation|1|||
150189692|NCT03623321|541833253|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
150189693|NCT03623321|541833253|FG000|Overall Study|Not further specified|43|||
150189694|NCT04241068|541833256|FG000|Core Treatment Period|Adverse Event|91|||
150116292|NCT00023452|541561847|FG000|Overall Study|Other|204|||
150116293|NCT00023452|541561848|FG001|Overall Study|Other|69|||
150116294|NCT01818336|541563954|FG000|Overall Study|Declined retest visit|0|||
150116295|NCT01818336|541563955|FG001|Overall Study|Declined retest visit|11|||
150116296|NCT01818336|541563954|FG000|Overall Study|Lost to Follow-up|0|||
150116297|NCT01818336|541563955|FG001|Overall Study|Lost to Follow-up|1|||
150116298|NCT03328897|541563958|FG000|Randomized-treatment Epoch|Adverse Event|4|||
150116299|NCT03328897|541563959|FG001|Randomized-treatment Epoch|Adverse Event|1|||
150116300|NCT03328897|541563960|FG002|Randomized-treatment Epoch|Adverse Event|1|||
150116301|NCT03328897|541563958|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
150116302|NCT03328897|541563959|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
150116303|NCT03328897|541563960|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
150116304|NCT03328897|541563958|FG000|Randomized-treatment Epoch|Pregnancy|3|||
150116305|NCT03328897|541563959|FG001|Randomized-treatment Epoch|Pregnancy|0|||
150116306|NCT03328897|541563960|FG002|Randomized-treatment Epoch|Pregnancy|0|||
150116307|NCT03328897|541563958|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
150116308|NCT03328897|541563959|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
150116309|NCT03328897|541563960|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
150116310|NCT03328897|541563958|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
150116311|NCT03328897|541563959|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
150116312|NCT03328897|541563960|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
150116313|NCT03328897|541563958|FG000|Follow-up Epoch|Adverse Event|4|||
150116314|NCT03328897|541563959|FG001|Follow-up Epoch|Adverse Event|0|||
150116315|NCT03328897|541563960|FG002|Follow-up Epoch|Adverse Event|1|||
150116316|NCT03328897|541563958|FG000|Follow-up Epoch|Lack of Efficacy|1|||
150116317|NCT03328897|541563959|FG001|Follow-up Epoch|Lack of Efficacy|1|||
150116318|NCT03328897|541563960|FG002|Follow-up Epoch|Lack of Efficacy|1|||
150116319|NCT03328897|541563958|FG000|Follow-up Epoch|Lost to Follow-up|0|||
150116320|NCT03328897|541563959|FG001|Follow-up Epoch|Lost to Follow-up|1|||
150116321|NCT03328897|541563960|FG002|Follow-up Epoch|Lost to Follow-up|0|||
150116322|NCT03328897|541563958|FG000|Follow-up Epoch|Pregnancy|1|||
150116323|NCT03328897|541563959|FG001|Follow-up Epoch|Pregnancy|0|||
150116324|NCT03328897|541563960|FG002|Follow-up Epoch|Pregnancy|0|||
150116325|NCT03328897|541563958|FG000|Follow-up Epoch|Patient/guardian decision|2|||
150116326|NCT03328897|541563959|FG001|Follow-up Epoch|Patient/guardian decision|1|||
150116327|NCT03328897|541563960|FG002|Follow-up Epoch|Patient/guardian decision|0|||
150116328|NCT00608829|541563961|FG000|Overall Study|Death|6|||
150116329|NCT00608829|541563961|FG000|Overall Study|Withdrawal by Subject|4|||
150116330|NCT00608829|541563961|FG000|Overall Study|Subject refuses to follow up or return.|5|||
150116331|NCT02805257|541563962|FG000|Overall Study|Lost to Follow-up|7|||
150116332|NCT02805257|541563963|FG001|Overall Study|Lost to Follow-up|6|||
150116333|NCT02805257|541563962|FG000|Overall Study|Death|0|||
150116334|NCT02805257|541563963|FG001|Overall Study|Death|1|||
150116335|NCT00612066|541563964|FG000|Overall Study|Adverse Event|1|||
150116336|NCT00672477|541563965|FG000|Overall Study|Adverse Event|10|||
150116337|NCT00672477|541563966|FG001|Overall Study|Adverse Event|7|||
150116338|NCT00672477|541563965|FG000|Overall Study|Death|7|||
150116339|NCT00672477|541563966|FG001|Overall Study|Death|11|||
150116340|NCT00672477|541563965|FG000|Overall Study|Physician Decision|2|||
150116341|NCT00672477|541563966|FG001|Overall Study|Physician Decision|0|||
150116342|NCT00672477|541563965|FG000|Overall Study|Protocol Violation|1|||
150116343|NCT00672477|541563966|FG001|Overall Study|Protocol Violation|1|||
150116344|NCT00672477|541563965|FG000|Overall Study|Withdrawal by Subject|5|||
150116345|NCT00672477|541563966|FG001|Overall Study|Withdrawal by Subject|3|||
150116346|NCT00672477|541563965|FG000|Overall Study|Lack of Efficacy|1|||
150116347|NCT00672477|541563966|FG001|Overall Study|Lack of Efficacy|1|||
150116348|NCT00672477|541563965|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
150116349|NCT00672477|541563966|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
150116350|NCT03266588|541563967|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
150116351|NCT03266588|541563968|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
150116352|NCT03266588|541563969|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
150116353|NCT03266588|541563967|FG000|Observational Period|Withdrawal by Subject|44|||
150116354|NCT03266588|541563968|FG001|Observational Period|Withdrawal by Subject|22|||
150116355|NCT03266588|541563969|FG002|Observational Period|Withdrawal by Subject|13|||
150116356|NCT03266588|541563967|FG000|Observational Period|Non-compliance|18|||
150116357|NCT03266588|541563968|FG001|Observational Period|Non-compliance|12|||
150116358|NCT03266588|541563969|FG002|Observational Period|Non-compliance|10|||
150116359|NCT03266588|541563967|FG000|Observational Period|Lost to Follow-up|8|||
150116360|NCT03266588|541563968|FG001|Observational Period|Lost to Follow-up|12|||
150116361|NCT03266588|541563969|FG002|Observational Period|Lost to Follow-up|4|||
150116362|NCT03266588|541563967|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
150116363|NCT03266588|541563968|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
150116364|NCT03266588|541563969|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
150116365|NCT03266588|541563967|FG000|Observational Period|Protocol Deviation|1|||
150116366|NCT03266588|541563968|FG001|Observational Period|Protocol Deviation|0|||
150116367|NCT03266588|541563969|FG002|Observational Period|Protocol Deviation|0|||
150116368|NCT03266588|541563967|FG000|Observational Period|Other Reasons|3|||
150116369|NCT03266588|541563968|FG001|Observational Period|Other Reasons|0|||
150116370|NCT03266588|541563969|FG002|Observational Period|Other Reasons|1|||
150116371|NCT03266588|541563967|FG000|Long-term Treatment Period|Adverse Event|33|||
150116372|NCT03266588|541563968|FG001|Long-term Treatment Period|Adverse Event|17|||
150116373|NCT03266588|541563969|FG002|Long-term Treatment Period|Adverse Event|8|||
150116374|NCT03266588|541563967|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
150116375|NCT03266588|541563968|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
150116376|NCT03266588|541563969|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
150116377|NCT03266588|541563967|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
150116378|NCT03266588|541563968|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
150116379|NCT03266588|541563969|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
150116380|NCT03266588|541563967|FG000|Long-term Treatment Period|Non-Compliance|126|||
150116381|NCT03266588|541563968|FG001|Long-term Treatment Period|Non-Compliance|57|||
150116382|NCT03266588|541563969|FG002|Long-term Treatment Period|Non-Compliance|7|||
150116383|NCT03266588|541563967|FG000|Long-term Treatment Period|Pregnancy|11|||
150116384|NCT03266588|541563968|FG001|Long-term Treatment Period|Pregnancy|5|||
150116385|NCT03266588|541563969|FG002|Long-term Treatment Period|Pregnancy|0|||
150116386|NCT03266588|541563967|FG000|Long-term Treatment Period|Protocol Deviation|17|||
150116387|NCT03266588|541563968|FG001|Long-term Treatment Period|Protocol Deviation|10|||
150116388|NCT03266588|541563969|FG002|Long-term Treatment Period|Protocol Deviation|4|||
150116389|NCT03266588|541563967|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
150116390|NCT03266588|541563968|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
150116391|NCT03266588|541563969|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
150116392|NCT03266588|541563967|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
150116393|NCT03266588|541563968|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
150116394|NCT03266588|541563969|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
150116395|NCT03266588|541563967|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
150116396|NCT03266588|541563968|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
150116397|NCT03266588|541563969|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
150116398|NCT03266588|541563967|FG000|Long-term Treatment Period|Other Reasons|5|||
150116399|NCT03266588|541563968|FG001|Long-term Treatment Period|Other Reasons|0|||
150116400|NCT03266588|541563969|FG002|Long-term Treatment Period|Other Reasons|0|||
150116401|NCT03266588|541563967|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
150116402|NCT03266588|541563968|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
150116403|NCT03266588|541563969|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
150116404|NCT02886572|541563971|FG000|Overall Study|Death|8|||
150116405|NCT00009737|541563974|FG000|Overall Study|Adverse Event|112|||
150116406|NCT00009737|541563975|FG001|Overall Study|Adverse Event|75|||
150116407|NCT00009737|541563974|FG000|Overall Study|Death|4|||
150116408|NCT00009737|541563975|FG001|Overall Study|Death|6|||
150116409|NCT00009737|541563974|FG000|Overall Study|Lack of Efficacy|17|||
150116410|NCT00009737|541563975|FG001|Overall Study|Lack of Efficacy|15|||
150116411|NCT00009737|541563974|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
150116412|NCT00009737|541563975|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
150116413|NCT00009737|541563974|FG000|Overall Study|Other Protocol Violation|1|||
150116414|NCT00009737|541563975|FG001|Overall Study|Other Protocol Violation|0|||
150116415|NCT00009737|541563974|FG000|Overall Study|Refused Treatment|15|||
150116416|NCT00009737|541563975|FG001|Overall Study|Refused Treatment|16|||
150116417|NCT00009737|541563974|FG000|Overall Study|Lost to Follow-up|1|||
150116418|NCT00009737|541563975|FG001|Overall Study|Lost to Follow-up|1|||
150116419|NCT00009737|541563974|FG000|Overall Study|Administrative/Other Reasons|7|||
150116420|NCT00009737|541563975|FG001|Overall Study|Administrative/Other Reasons|1|||
150116421|NCT01163682|541563977|FG000|Overall Study|Lost to Follow-up|6|||
150116422|NCT01163682|541563978|FG001|Overall Study|Lost to Follow-up|9|||
150116423|NCT01931839|541563979|FG000|Overall Study|Death|0|||
150116424|NCT01931839|541563980|FG001|Overall Study|Death|1|||
150116425|NCT01931839|541563981|FG002|Overall Study|Death|2|||
150116426|NCT01931839|541563982|FG003|Overall Study|Death|0|||
150116427|NCT01931839|541563983|FG004|Overall Study|Death|0|||
150116428|NCT01931839|541563984|FG005|Overall Study|Death|0|||
150116429|NCT01931839|541563985|FG006|Overall Study|Death|0|||
150116430|NCT01931839|541563979|FG000|Overall Study|Physician Decision|1|||
150116431|NCT01931839|541563980|FG001|Overall Study|Physician Decision|0|||
150116432|NCT01931839|541563981|FG002|Overall Study|Physician Decision|1|||
150116433|NCT01931839|541563982|FG003|Overall Study|Physician Decision|0|||
150116434|NCT01931839|541563983|FG004|Overall Study|Physician Decision|0|||
150116435|NCT01931839|541563984|FG005|Overall Study|Physician Decision|0|||
150116436|NCT01931839|541563985|FG006|Overall Study|Physician Decision|1|||
150116437|NCT01931839|541563979|FG000|Overall Study|Withdrawal of consent|0|||
150189695|NCT04241068|541833256|FG000|Core Treatment Period|Change of Treatment|4|||
150189696|NCT04241068|541833256|FG000|Core Treatment Period|Consent Withdrawn|143|||
150189697|NCT04241068|541833256|FG000|Core Treatment Period|Death|26|||
150189698|NCT04241068|541833256|FG000|Core Treatment Period|Disease Progression|67|||
150189699|NCT04241068|541833256|FG000|Core Treatment Period|Investigator Decision|40|||
150189700|NCT04241068|541833256|FG000|Core Treatment Period|Loss of Capacity|9|||
150116438|NCT01931839|541563980|FG001|Overall Study|Withdrawal of consent|0|||
150116439|NCT01931839|541563981|FG002|Overall Study|Withdrawal of consent|0|||
150116440|NCT01931839|541563982|FG003|Overall Study|Withdrawal of consent|0|||
150116441|NCT01931839|541563983|FG004|Overall Study|Withdrawal of consent|1|||
150116442|NCT01931839|541563984|FG005|Overall Study|Withdrawal of consent|0|||
150116443|NCT01931839|541563985|FG006|Overall Study|Withdrawal of consent|0|||
150116444|NCT01931839|541563979|FG000|Overall Study|Adverse Event|9|||
150116445|NCT01931839|541563980|FG001|Overall Study|Adverse Event|4|||
150116446|NCT01931839|541563981|FG002|Overall Study|Adverse Event|1|||
150116447|NCT01931839|541563982|FG003|Overall Study|Adverse Event|3|||
150116448|NCT01931839|541563983|FG004|Overall Study|Adverse Event|0|||
150116449|NCT01931839|541563984|FG005|Overall Study|Adverse Event|0|||
150116450|NCT01931839|541563985|FG006|Overall Study|Adverse Event|1|||
150116451|NCT01931839|541563979|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
150116452|NCT01931839|541563980|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
150116453|NCT01931839|541563981|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
150116454|NCT01931839|541563982|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
150116455|NCT01931839|541563983|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
150116456|NCT01931839|541563984|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
150116457|NCT01931839|541563985|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
150116458|NCT01931839|541563979|FG000|Overall Study|Other non-compliance|15|||
150116459|NCT01931839|541563980|FG001|Overall Study|Other non-compliance|9|||
150116460|NCT01931839|541563981|FG002|Overall Study|Other non-compliance|12|||
150116461|NCT01931839|541563982|FG003|Overall Study|Other non-compliance|3|||
150116462|NCT01931839|541563983|FG004|Overall Study|Other non-compliance|0|||
150116463|NCT01931839|541563984|FG005|Overall Study|Other non-compliance|3|||
150116464|NCT01931839|541563985|FG006|Overall Study|Other non-compliance|0|||
150116465|NCT01931839|541563979|FG000|Overall Study|Lost to Follow-up|1|||
150116466|NCT01931839|541563980|FG001|Overall Study|Lost to Follow-up|2|||
150116467|NCT01931839|541563981|FG002|Overall Study|Lost to Follow-up|4|||
150116468|NCT01931839|541563982|FG003|Overall Study|Lost to Follow-up|5|||
150116469|NCT01931839|541563983|FG004|Overall Study|Lost to Follow-up|0|||
150116470|NCT01931839|541563984|FG005|Overall Study|Lost to Follow-up|0|||
150116471|NCT01931839|541563985|FG006|Overall Study|Lost to Follow-up|0|||
150116472|NCT01931839|541563979|FG000|Overall Study|Other|4|||
150116473|NCT01931839|541563980|FG001|Overall Study|Other|2|||
150116474|NCT01931839|541563981|FG002|Overall Study|Other|6|||
150116475|NCT01931839|541563982|FG003|Overall Study|Other|0|||
150116476|NCT01931839|541563983|FG004|Overall Study|Other|0|||
150116477|NCT01931839|541563984|FG005|Overall Study|Other|0|||
150116478|NCT01931839|541563985|FG006|Overall Study|Other|0|||
150116479|NCT03224468|541563986|FG000|Overall Study|Did not obtain MM card|53|||
150116480|NCT03224468|541563987|FG001|Overall Study|Did not obtain MM card|0|||
150116481|NCT03224468|541563986|FG000|Overall Study|Lost to Follow-up|4|||
150116482|NCT03224468|541563987|FG001|Overall Study|Lost to Follow-up|11|||
150116483|NCT03224468|541563986|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
150116484|NCT03224468|541563987|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
150116485|NCT01978119|541563988|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
150116486|NCT01978119|541563989|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
150116487|NCT01978119|541563988|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
150116488|NCT01978119|541563989|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
150116489|NCT01978119|541563988|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
150116490|NCT01978119|541563989|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
150189701|NCT04241068|541833256|FG000|Core Treatment Period|Lost to Follow-up|11|||
150189702|NCT04241068|541833256|FG000|Core Treatment Period|Relocation|4|||
150189703|NCT04241068|541833256|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
150189704|NCT04241068|541833256|FG000|Core Treatment Period|Study Visit Burden|40|||
150189705|NCT04241068|541833256|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
150116491|NCT00812812|541563990|FG000|Overall Study|Adverse Event|2|||
150116492|NCT00812812|541563991|FG001|Overall Study|Adverse Event|1|||
150116493|NCT00812812|541563990|FG000|Overall Study|Lack of Efficacy|1|||
150116494|NCT00812812|541563991|FG001|Overall Study|Lack of Efficacy|0|||
150116495|NCT00812812|541563990|FG000|Overall Study|Lost to Follow-up|0|||
150189706|NCT04241068|541833256|FG000|Core Treatment Period|Missing|2|||
150189707|NCT04241068|541833256|FG000|Core Treatment Period|Reason Not Specified|41|||
150189708|NCT04241068|541833256|FG000|LTE Period|Adverse Event|19|||
150116496|NCT00812812|541563991|FG001|Overall Study|Lost to Follow-up|1|||
150116497|NCT00812812|541563990|FG000|Overall Study|Withdrawal by Subject|0|||
150116498|NCT00812812|541563991|FG001|Overall Study|Withdrawal by Subject|2|||
150116499|NCT03095417|541563992|FG000|Overall Study|missed|1|||
150116500|NCT03095417|541563993|FG001|Overall Study|missed|2|||
150116501|NCT03095417|541563994|FG002|Overall Study|missed|0|||
150116502|NCT03095417|541563995|FG003|Overall Study|missed|1|||
150116503|NCT03095417|541563992|FG000|Overall Study|Lost to Follow-up|2|||
150116504|NCT03095417|541563993|FG001|Overall Study|Lost to Follow-up|2|||
150116505|NCT03095417|541563994|FG002|Overall Study|Lost to Follow-up|1|||
150116506|NCT03095417|541563995|FG003|Overall Study|Lost to Follow-up|0|||
150116507|NCT03095417|541563992|FG000|Overall Study|refusal|0|||
150116508|NCT03095417|541563993|FG001|Overall Study|refusal|1|||
150116509|NCT03095417|541563994|FG002|Overall Study|refusal|0|||
150116510|NCT03095417|541563995|FG003|Overall Study|refusal|1|||
150116511|NCT03095417|541563992|FG000|Overall Study|Withdrawal by Subject|8|||
150116512|NCT03095417|541563993|FG001|Overall Study|Withdrawal by Subject|2|||
150116513|NCT03095417|541563994|FG002|Overall Study|Withdrawal by Subject|5|||
150116514|NCT03095417|541563995|FG003|Overall Study|Withdrawal by Subject|4|||
150116515|NCT03095417|541563992|FG000|Overall Study|Physician Decision|1|||
150116516|NCT03095417|541563993|FG001|Overall Study|Physician Decision|2|||
150116517|NCT03095417|541563994|FG002|Overall Study|Physician Decision|2|||
150116518|NCT03095417|541563995|FG003|Overall Study|Physician Decision|2|||
150116519|NCT03095417|541563992|FG000|Overall Study|Death|1|||
150116520|NCT03095417|541563993|FG001|Overall Study|Death|2|||
150116521|NCT03095417|541563994|FG002|Overall Study|Death|1|||
150116522|NCT03095417|541563995|FG003|Overall Study|Death|3|||
150116523|NCT02571452|541563996|FG000|Overall Study Treatment|Protocol Violation|0|||
150116524|NCT02571452|541563997|FG001|Overall Study Treatment|Protocol Violation|1|||
150116525|NCT02571452|541563996|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
150116526|NCT02571452|541563997|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
150116527|NCT02571452|541563996|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
150116528|NCT02571452|541563997|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
150116529|NCT01877421|541563998|FG000|Phase 2|Lost to Follow-up|0|||
150116530|NCT01877421|541563999|FG001|Phase 2|Lost to Follow-up|0|||
150189709|NCT04241068|541833256|FG000|LTE Period|Change of Treatment|1|||
150189710|NCT04241068|541833256|FG000|LTE Period|Consent Withdrawn|71|||
150189711|NCT04241068|541833256|FG000|LTE Period|Death|8|||
150189712|NCT04241068|541833256|FG000|LTE Period|Disease Progression|11|||
150189713|NCT04241068|541833256|FG000|LTE Period|Investigator Decision|12|||
150189714|NCT04241068|541833256|FG000|LTE Period|Loss of Capacity|2|||
150189715|NCT04241068|541833256|FG000|LTE Period|Lost to Follow-up|7|||
150189716|NCT04241068|541833256|FG000|LTE Period|Relocation|6|||
150189717|NCT04241068|541833256|FG000|LTE Period|Site Terminated by Sponsor|26|||
150189718|NCT04241068|541833256|FG000|LTE Period|Study Terminated by Sponsor|276|||
150189719|NCT04241068|541833256|FG000|LTE Period|Study Visit Burden|10|||
150189720|NCT04241068|541833256|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
150189721|NCT04241068|541833256|FG000|LTE Period|Reason Not Specified|65|||
150189722|NCT01999075|541833258|FG000|Overall Study|Lost to Follow-up|0|||
150189723|NCT01999075|541833259|FG001|Overall Study|Lost to Follow-up|2|||
150189724|NCT01999075|541833258|FG000|Overall Study|Withdrawal by Subject|2|||
150189725|NCT01999075|541833259|FG001|Overall Study|Withdrawal by Subject|7|||
150189726|NCT01999075|541833258|FG000|Overall Study|Enrolled in drug trial|3|||
150189727|NCT01999075|541833259|FG001|Overall Study|Enrolled in drug trial|1|||
150116531|NCT01877421|541564000|FG002|Phase 2|Lost to Follow-up|0|||
150116532|NCT01877421|541564001|FG003|Phase 2|Lost to Follow-up|0|||
150116533|NCT01877421|541564002|FG004|Phase 2|Lost to Follow-up|0|||
150116534|NCT01877421|541564003|FG005|Phase 2|Lost to Follow-up|0|||
150116535|NCT01877421|541564004|FG006|Phase 2|Lost to Follow-up|1|||
150189728|NCT01999075|541833258|FG000|Overall Study|Became ineligible|0|||
150189729|NCT01999075|541833259|FG001|Overall Study|Became ineligible|2|||
150189730|NCT01413100|541833260|FG000|Overall Study|Withdrawal by Subject|1|||
150189731|NCT04562649|541833272|FG000|Overall Study|Withdrawal by Subject|11|||
150189732|NCT04562649|541833273|FG001|Overall Study|Withdrawal by Subject|8|||
150189733|NCT04562649|541833272|FG000|Overall Study|Lost to Follow-up|26|||
150189734|NCT04562649|541833273|FG001|Overall Study|Lost to Follow-up|20|||
150116536|NCT01877421|541564005|FG007|Phase 2|Lost to Follow-up|0|||
150116537|NCT01877421|541564006|FG008|Phase 2|Lost to Follow-up|0|||
150116538|NCT01877421|541564007|FG009|Phase 2|Lost to Follow-up|0|||
150116539|NCT01877421|541564008|FG010|Phase 2|Lost to Follow-up|0|||
150116540|NCT01877421|541564009|FG011|Phase 2|Lost to Follow-up|0|||
150116541|NCT01877421|541564010|FG012|Phase 2|Lost to Follow-up|0|||
150189735|NCT03056040|541833277|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
150116542|NCT01877421|541564011|FG013|Phase 2|Lost to Follow-up|0|||
150116543|NCT01877421|541564012|FG014|Phase 2|Lost to Follow-up|0|||
150116544|NCT01877421|541564013|FG015|Phase 2|Lost to Follow-up|0|||
150116545|NCT01877421|541564014|FG016|Phase 2|Lost to Follow-up|0|||
150116546|NCT01877421|541564015|FG017|Phase 2|Lost to Follow-up|0|||
150116547|NCT01877421|541563998|FG000|Phase 2|Withdrawal by Subject|0|||
150116548|NCT01877421|541563999|FG001|Phase 2|Withdrawal by Subject|0|||
150116549|NCT01877421|541564000|FG002|Phase 2|Withdrawal by Subject|0|||
150116550|NCT01877421|541564001|FG003|Phase 2|Withdrawal by Subject|0|||
150116551|NCT01877421|541564002|FG004|Phase 2|Withdrawal by Subject|0|||
150116552|NCT01877421|541564003|FG005|Phase 2|Withdrawal by Subject|0|||
150116553|NCT01877421|541564004|FG006|Phase 2|Withdrawal by Subject|0|||
150116554|NCT01877421|541564005|FG007|Phase 2|Withdrawal by Subject|0|||
150116555|NCT01877421|541564006|FG008|Phase 2|Withdrawal by Subject|1|||
150116556|NCT01877421|541564007|FG009|Phase 2|Withdrawal by Subject|0|||
150116557|NCT01877421|541564008|FG010|Phase 2|Withdrawal by Subject|1|||
150116558|NCT01877421|541564009|FG011|Phase 2|Withdrawal by Subject|0|||
150116559|NCT01877421|541564010|FG012|Phase 2|Withdrawal by Subject|1|||
150116560|NCT01877421|541564011|FG013|Phase 2|Withdrawal by Subject|0|||
150116561|NCT01877421|541564012|FG014|Phase 2|Withdrawal by Subject|0|||
150116562|NCT01877421|541564013|FG015|Phase 2|Withdrawal by Subject|1|||
150116563|NCT01877421|541564014|FG016|Phase 2|Withdrawal by Subject|0|||
150116564|NCT01877421|541564015|FG017|Phase 2|Withdrawal by Subject|0|||
150116565|NCT01877421|541563998|FG000|Phase 2|Protocol Violation|0|||
150116566|NCT01877421|541563999|FG001|Phase 2|Protocol Violation|0|||
150116567|NCT01877421|541564000|FG002|Phase 2|Protocol Violation|0|||
150116568|NCT01877421|541564001|FG003|Phase 2|Protocol Violation|0|||
150116569|NCT01877421|541564002|FG004|Phase 2|Protocol Violation|0|||
150116570|NCT01877421|541564003|FG005|Phase 2|Protocol Violation|0|||
150116571|NCT01877421|541564004|FG006|Phase 2|Protocol Violation|0|||
150116572|NCT01877421|541564005|FG007|Phase 2|Protocol Violation|0|||
150116573|NCT01877421|541564006|FG008|Phase 2|Protocol Violation|0|||
150116574|NCT01877421|541564007|FG009|Phase 2|Protocol Violation|0|||
150116575|NCT01877421|541564008|FG010|Phase 2|Protocol Violation|1|||
150116576|NCT01877421|541564009|FG011|Phase 2|Protocol Violation|0|||
150116577|NCT01877421|541564010|FG012|Phase 2|Protocol Violation|0|||
150116578|NCT01877421|541564011|FG013|Phase 2|Protocol Violation|0|||
150116579|NCT01877421|541564012|FG014|Phase 2|Protocol Violation|0|||
150116580|NCT01877421|541564013|FG015|Phase 2|Protocol Violation|0|||
150116581|NCT01877421|541564014|FG016|Phase 2|Protocol Violation|0|||
150116582|NCT01877421|541564015|FG017|Phase 2|Protocol Violation|0|||
150116583|NCT00908960|541564016|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
150116584|NCT00908960|541564017|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
150116585|NCT00908960|541564018|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
150116586|NCT01158924|541564020|FG000|Overall Study|Withdrawal by Subject|1|||
150116587|NCT01158924|541564021|FG001|Overall Study|Withdrawal by Subject|2|||
150116588|NCT01158924|541564020|FG000|Overall Study|Lost to Follow-up|0|||
150116589|NCT01158924|541564021|FG001|Overall Study|Lost to Follow-up|1|||
150116590|NCT03795922|541564022|FG000|Overall Study|Adverse Event|2|||
150116591|NCT03795922|541564023|FG001|Overall Study|Adverse Event|1|||
150116592|NCT03795922|541564022|FG000|Overall Study|Withdrawal by Subject|5|||
150116593|NCT03795922|541564023|FG001|Overall Study|Withdrawal by Subject|13|||
150116594|NCT03795922|541564022|FG000|Overall Study|Lost to Follow-up|2|||
150116595|NCT03795922|541564023|FG001|Overall Study|Lost to Follow-up|3|||
150116596|NCT03795922|541564022|FG000|Overall Study|Pregnancy|0|||
150116597|NCT03795922|541564023|FG001|Overall Study|Pregnancy|1|||
150116598|NCT03795922|541564022|FG000|Overall Study|Physician Decision|1|||
150116599|NCT03795922|541564023|FG001|Overall Study|Physician Decision|2|||
150116600|NCT03795922|541564022|FG000|Overall Study|Protocol Violation|0|||
150116601|NCT03795922|541564023|FG001|Overall Study|Protocol Violation|1|||
150116602|NCT03795922|541564022|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
150116603|NCT03795922|541564023|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
150116604|NCT01416805|541564028|FG000|Overall Study|Lost to Follow-up|4|||
150116605|NCT01416805|541564029|FG001|Overall Study|Lost to Follow-up|4|||
150116606|NCT00684424|541564032|FG000|Overall Study|Adverse Event|1|||
150116607|NCT00684424|541564032|FG000|Overall Study|Lost to Follow-up|2|||
150116608|NCT00684424|541564032|FG000|Overall Study|Other|2|||
150116609|NCT01071512|541564033|FG000|Overall Study|Adverse Event|1|||
150116610|NCT01071512|541564033|FG000|Overall Study|Development of antibodies to drug|2|||
150116611|NCT01071512|541564033|FG000|Overall Study|positive anti-JC virus antibody test|2|||
150116612|NCT00958880|541564041|FG000|Overall Study|Lost to Follow-up|2|||
150116613|NCT00958880|541564042|FG001|Overall Study|Lost to Follow-up|2|||
150116614|NCT01971346|541564043|FG000|Overall Study|Protocol Violation|3|||
150116615|NCT01971346|541564043|FG000|Overall Study|Lost to Follow-up|2|||
150116616|NCT01971346|541564043|FG000|Overall Study|Withdrawal by Subject|2|||
150116617|NCT01971346|541564043|FG000|Overall Study|Physician Decision|1|||
150116618|NCT04187196|541564046|FG000|Overall Study|Screen Failure|2|||
150116619|NCT04187196|541564047|FG001|Overall Study|Screen Failure|0|||
150116620|NCT01687166|541564048|FG000|Overall Study|Attempt subject|2|||
150116621|NCT01687166|541564049|FG001|Overall Study|Attempt subject|3|||
150116622|NCT01687166|541564050|FG002|Overall Study|Attempt subject|2|||
150116623|NCT01687166|541564051|FG003|Overall Study|Attempt subject|0|||
150116624|NCT01687166|541564048|FG000|Overall Study|Did not meet eligibility criteria|4|||
150116625|NCT01687166|541564049|FG001|Overall Study|Did not meet eligibility criteria|6|||
150116626|NCT01687166|541564050|FG002|Overall Study|Did not meet eligibility criteria|1|||
150116627|NCT01687166|541564051|FG003|Overall Study|Did not meet eligibility criteria|1|||
150116628|NCT01687166|541564048|FG000|Overall Study|Adverse Event|2|||
150116629|NCT01687166|541564049|FG001|Overall Study|Adverse Event|1|||
150116630|NCT01687166|541564050|FG002|Overall Study|Adverse Event|0|||
150116631|NCT01687166|541564051|FG003|Overall Study|Adverse Event|0|||
150116632|NCT01687166|541564048|FG000|Overall Study|Physician Decision|3|||
150116633|NCT01687166|541564049|FG001|Overall Study|Physician Decision|2|||
150116634|NCT01687166|541564050|FG002|Overall Study|Physician Decision|1|||
150116635|NCT01687166|541564051|FG003|Overall Study|Physician Decision|0|||
150116636|NCT01687166|541564048|FG000|Overall Study|Withdrawal by Subject|11|||
150116637|NCT01687166|541564049|FG001|Overall Study|Withdrawal by Subject|4|||
150116638|NCT01687166|541564050|FG002|Overall Study|Withdrawal by Subject|3|||
150116639|NCT01687166|541564051|FG003|Overall Study|Withdrawal by Subject|0|||
150116640|NCT01687166|541564048|FG000|Overall Study|Lost to Follow-up|2|||
150116641|NCT01687166|541564049|FG001|Overall Study|Lost to Follow-up|5|||
150116642|NCT01687166|541564050|FG002|Overall Study|Lost to Follow-up|1|||
150116643|NCT01687166|541564051|FG003|Overall Study|Lost to Follow-up|0|||
150116644|NCT01687166|541564048|FG000|Overall Study|Equipment/Device Availability|0|||
150116645|NCT01687166|541564049|FG001|Overall Study|Equipment/Device Availability|1|||
150116646|NCT01687166|541564050|FG002|Overall Study|Equipment/Device Availability|0|||
150116647|NCT01687166|541564051|FG003|Overall Study|Equipment/Device Availability|0|||
150116648|NCT01687166|541564048|FG000|Overall Study|Death|1|||
150116649|NCT01687166|541564049|FG001|Overall Study|Death|1|||
150116650|NCT01687166|541564050|FG002|Overall Study|Death|0|||
150116651|NCT01687166|541564051|FG003|Overall Study|Death|0|||
150116652|NCT01687166|541564048|FG000|Overall Study|Protocol Violation|1|||
150116653|NCT01687166|541564049|FG001|Overall Study|Protocol Violation|1|||
150116654|NCT01687166|541564050|FG002|Overall Study|Protocol Violation|1|||
150116655|NCT01687166|541564051|FG003|Overall Study|Protocol Violation|0|||
150116656|NCT01687166|541564048|FG000|Overall Study|Subject moved out of state|0|||
150116657|NCT01687166|541564049|FG001|Overall Study|Subject moved out of state|1|||
150116658|NCT01687166|541564050|FG002|Overall Study|Subject moved out of state|0|||
150116659|NCT01687166|541564051|FG003|Overall Study|Subject moved out of state|0|||
150116660|NCT01687166|541564048|FG000|Overall Study|Patient unable to be compliant|1|||
150116661|NCT01687166|541564049|FG001|Overall Study|Patient unable to be compliant|0|||
150116662|NCT01687166|541564050|FG002|Overall Study|Patient unable to be compliant|0|||
150116663|NCT01687166|541564051|FG003|Overall Study|Patient unable to be compliant|0|||
150116664|NCT01687166|541564048|FG000|Overall Study|Physician choice to use different device|1|||
150116665|NCT01687166|541564049|FG001|Overall Study|Physician choice to use different device|2|||
150116666|NCT01687166|541564050|FG002|Overall Study|Physician choice to use different device|4|||
150116667|NCT01687166|541564051|FG003|Overall Study|Physician choice to use different device|0|||
150116668|NCT01687166|541564048|FG000|Overall Study|Insurance|0|||
150116669|NCT01687166|541564049|FG001|Overall Study|Insurance|0|||
150116670|NCT01687166|541564050|FG002|Overall Study|Insurance|1|||
150116671|NCT01687166|541564051|FG003|Overall Study|Insurance|1|||
150116672|NCT02755831|541564052|FG000|Overall Study|Lost to Follow-up|3|||
150116673|NCT02755831|541564053|FG001|Overall Study|Lost to Follow-up|3|||
150116674|NCT02316717|541564054|FG000|Overall Study|Adverse Event|2|||
150116675|NCT02316717|541564055|FG001|Overall Study|Adverse Event|2|||
150116676|NCT02316717|541564056|FG002|Overall Study|Adverse Event|0|||
150116677|NCT02316717|541564054|FG000|Overall Study|Lost to Follow-up|1|||
150116678|NCT02316717|541564055|FG001|Overall Study|Lost to Follow-up|2|||
150116679|NCT02316717|541564056|FG002|Overall Study|Lost to Follow-up|1|||
150116680|NCT02316717|541564054|FG000|Overall Study|Non compliance|3|||
150116681|NCT02316717|541564055|FG001|Overall Study|Non compliance|1|||
150116682|NCT02316717|541564056|FG002|Overall Study|Non compliance|0|||
150116683|NCT02316717|541564054|FG000|Overall Study|Protocol Violation|2|||
150116684|NCT02316717|541564055|FG001|Overall Study|Protocol Violation|0|||
150116685|NCT02316717|541564056|FG002|Overall Study|Protocol Violation|0|||
150116686|NCT02316717|541564054|FG000|Overall Study|Withdrawal by Subject|2|||
150116687|NCT02316717|541564055|FG001|Overall Study|Withdrawal by Subject|1|||
150116688|NCT02316717|541564056|FG002|Overall Study|Withdrawal by Subject|1|||
150116689|NCT02316717|541564054|FG000|Overall Study|Death|0|||
150116690|NCT02316717|541564055|FG001|Overall Study|Death|0|||
150189736|NCT03056040|541833278|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
150189737|NCT03056040|541833277|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
150189738|NCT03056040|541833278|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
150189739|NCT03056040|541833277|FG000|Primary Evaluation Period|Pregnancy|0|||
150189740|NCT03056040|541833278|FG001|Primary Evaluation Period|Pregnancy|1|||
150189741|NCT03056040|541833277|FG000|Primary Evaluation Period|Randomized, not treated|1|||
150189742|NCT03056040|541833278|FG001|Primary Evaluation Period|Randomized, not treated|1|||
150189743|NCT03056040|541833277|FG000|Extension Period|Physician Decision|3|||
150189744|NCT03056040|541833278|FG001|Extension Period|Physician Decision|3|||
150189745|NCT03056040|541833277|FG000|Extension Period|Lost to Follow-up|0|||
150189746|NCT03056040|541833278|FG001|Extension Period|Lost to Follow-up|1|||
150189747|NCT03056040|541833277|FG000|Extension Period|Death|0|||
150189748|NCT03056040|541833278|FG001|Extension Period|Death|3|||
150189749|NCT03056040|541833277|FG000|Extension Period|Withdrawal by Subject|1|||
150189750|NCT03056040|541833278|FG001|Extension Period|Withdrawal by Subject|0|||
150189751|NCT03445988|541833281|FG000|Overall Study|Lost to Follow-up|14|||
150189752|NCT03445988|541833282|FG001|Overall Study|Lost to Follow-up|26|||
150189753|NCT03445988|541833283|FG002|Overall Study|Lost to Follow-up|27|||
150189754|NCT03445988|541833284|FG003|Overall Study|Lost to Follow-up|66|||
150189755|NCT03445988|541833281|FG000|Overall Study|Withdrawal by Subject|7|||
150189756|NCT03445988|541833282|FG001|Overall Study|Withdrawal by Subject|4|||
150189757|NCT03445988|541833283|FG002|Overall Study|Withdrawal by Subject|3|||
150189758|NCT03445988|541833284|FG003|Overall Study|Withdrawal by Subject|5|||
150189759|NCT03445988|541833281|FG000|Overall Study|Death (unrelated to study)|5|||
150189760|NCT03445988|541833282|FG001|Overall Study|Death (unrelated to study)|1|||
150189761|NCT03445988|541833283|FG002|Overall Study|Death (unrelated to study)|2|||
150189762|NCT03445988|541833284|FG003|Overall Study|Death (unrelated to study)|4|||
150189763|NCT04274764|541833288|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
150189764|NCT04274764|541833289|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
150189765|NCT03853746|541833307|FG000|Overall Study|Withdrawal by Subject|1|||
150189766|NCT00450658|541833308|FG000|Overall Study|Adverse Event|24|||
150189767|NCT00450658|541833309|FG001|Overall Study|Adverse Event|15|||
150189768|NCT00450658|541833308|FG000|Overall Study|Withdrawal by Subject|43|||
150189769|NCT00450658|541833309|FG001|Overall Study|Withdrawal by Subject|26|||
150189770|NCT00450658|541833308|FG000|Overall Study|Lost to Follow-up|22|||
150116691|NCT02316717|541564056|FG002|Overall Study|Death|1|||
150116692|NCT02316717|541564054|FG000|Overall Study|Physician Decision|0|||
150116693|NCT02316717|541564055|FG001|Overall Study|Physician Decision|1|||
150116694|NCT02316717|541564056|FG002|Overall Study|Physician Decision|0|||
150116695|NCT02316717|541564054|FG000|Overall Study|TBC|1|||
150116696|NCT02316717|541564055|FG001|Overall Study|TBC|0|||
150116697|NCT02316717|541564056|FG002|Overall Study|TBC|0|||
150116698|NCT00183872|541564057|FG000|Overall Study|Death|3|||
150116699|NCT00183872|541564057|FG000|Overall Study|Adverse Event|9|||
150116700|NCT00183872|541564057|FG000|Overall Study|Withdrawal by Subject|2|||
150116701|NCT00183872|541564057|FG000|Overall Study|Drug delayed more than 28 days|2|||
150116702|NCT01516879|541564058|FG000|Overall Study|Withdrawal by Subject|9|||
150116703|NCT01516879|541564059|FG001|Overall Study|Withdrawal by Subject|11|||
150116704|NCT01516879|541564058|FG000|Overall Study|Death|0|||
150116705|NCT01516879|541564059|FG001|Overall Study|Death|2|||
150116706|NCT01516879|541564058|FG000|Overall Study|Lost to Follow-up|2|||
150116707|NCT01516879|541564059|FG001|Overall Study|Lost to Follow-up|11|||
150189771|NCT00450658|541833309|FG001|Overall Study|Lost to Follow-up|5|||
150189772|NCT00450658|541833308|FG000|Overall Study|UGI ulcer|33|||
150189773|NCT00450658|541833309|FG001|Overall Study|UGI ulcer|34|||
150189774|NCT00450658|541833308|FG000|Overall Study|misc|21|||
150189775|NCT00450658|541833309|FG001|Overall Study|misc|10|||
150189776|NCT01084876|541833311|FG000|Main Study Treatment Period|Adverse Event|12|||
150189777|NCT01084876|541833312|FG001|Main Study Treatment Period|Adverse Event|7|||
150189778|NCT01084876|541833311|FG000|Main Study Treatment Period|Disease Progression|41|||
150189779|NCT01084876|541833312|FG001|Main Study Treatment Period|Disease Progression|24|||
150189780|NCT01084876|541833311|FG000|Main Study Treatment Period|Physician Decision|2|||
150189781|NCT01084876|541833312|FG001|Main Study Treatment Period|Physician Decision|0|||
150189782|NCT01084876|541833311|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
150116708|NCT01516879|541564058|FG000|Overall Study|Other|5|||
150116709|NCT01516879|541564059|FG001|Overall Study|Other|10|||
150116710|NCT01720069|541564060|FG000|Overall Study|Could not use e-diary correctly|0|||
150189783|NCT01084876|541833312|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
150189784|NCT01084876|541833311|FG000|Main Study Treatment Period|Other Reason|0|||
150189785|NCT01084876|541833312|FG001|Main Study Treatment Period|Other Reason|1|||
150189786|NCT01084876|541833311|FG000|Main Study Treatment Period|Other|0|||
150189787|NCT01084876|541833312|FG001|Main Study Treatment Period|Other|1|||
150189788|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
150189789|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
150116711|NCT01720069|541564061|FG001|Overall Study|Could not use e-diary correctly|1|||
150116712|NCT01720069|541564062|FG002|Overall Study|Could not use e-diary correctly|1|||
150116713|NCT01720069|541564060|FG000|Overall Study|Randomised without baseline values|0|||
150116714|NCT01720069|541564061|FG001|Overall Study|Randomised without baseline values|0|||
150116715|NCT01720069|541564062|FG002|Overall Study|Randomised without baseline values|1|||
150116716|NCT01720069|541564060|FG000|Overall Study|Adverse Event|0|||
150116717|NCT01720069|541564061|FG001|Overall Study|Adverse Event|0|||
150116718|NCT01720069|541564062|FG002|Overall Study|Adverse Event|1|||
150116719|NCT01720069|541564060|FG000|Overall Study|Lack of Efficacy|0|||
150116720|NCT01720069|541564061|FG001|Overall Study|Lack of Efficacy|4|||
150116721|NCT01720069|541564062|FG002|Overall Study|Lack of Efficacy|0|||
150116722|NCT01720069|541564060|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
150116723|NCT01720069|541564061|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
150116724|NCT01720069|541564062|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
150116725|NCT01720069|541564060|FG000|Overall Study|Withdrawal by Subject|0|||
150116726|NCT01720069|541564061|FG001|Overall Study|Withdrawal by Subject|2|||
150116727|NCT01720069|541564062|FG002|Overall Study|Withdrawal by Subject|1|||
150116728|NCT01720069|541564060|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
150116729|NCT01720069|541564061|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
150116730|NCT01720069|541564062|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
150116731|NCT01720069|541564060|FG000|Overall Study|Non-compliance on using e-diary|0|||
150116732|NCT01720069|541564061|FG001|Overall Study|Non-compliance on using e-diary|0|||
150116733|NCT01720069|541564062|FG002|Overall Study|Non-compliance on using e-diary|1|||
150116734|NCT01720069|541564060|FG000|Overall Study|Lost to Follow-up|0|||
150116735|NCT01720069|541564061|FG001|Overall Study|Lost to Follow-up|0|||
150116736|NCT01720069|541564062|FG002|Overall Study|Lost to Follow-up|1|||
150116737|NCT04568122|541564063|FG000|Overall Study|Lost to Follow-up|48|||
150116738|NCT04568122|541564064|FG001|Overall Study|Lost to Follow-up|44|||
150116739|NCT04568122|541564065|FG002|Overall Study|Lost to Follow-up|4|||
150116740|NCT04568122|541564066|FG003|Overall Study|Lost to Follow-up|0|||
150116741|NCT04568122|541564067|FG004|Overall Study|Lost to Follow-up|0|||
150116742|NCT00595582|541564070|FG000|Overall Study|Pilot study that PI terminated|2|||
150116743|NCT00595582|541564070|FG000|Overall Study|Lost to Follow-up|1|||
150116744|NCT00595582|541564070|FG000|Overall Study|Adverse Event|2|||
150116745|NCT00595582|541564070|FG000|Overall Study|Physician Decision|5|||
150116746|NCT02460224|541564072|FG000|Overall Study|Adverse Event|0|||
150116747|NCT02460224|541564073|FG001|Overall Study|Adverse Event|0|||
150116748|NCT02460224|541564074|FG002|Overall Study|Adverse Event|0|||
150116749|NCT02460224|541564075|FG003|Overall Study|Adverse Event|0|||
150116750|NCT02460224|541564076|FG004|Overall Study|Adverse Event|0|||
150116751|NCT02460224|541564077|FG005|Overall Study|Adverse Event|0|||
150116752|NCT02460224|541564078|FG006|Overall Study|Adverse Event|1|||
150116753|NCT02460224|541564079|FG007|Overall Study|Adverse Event|0|||
150116754|NCT02460224|541564080|FG008|Overall Study|Adverse Event|0|||
150116755|NCT02460224|541564081|FG009|Overall Study|Adverse Event|0|||
150116756|NCT02460224|541564082|FG010|Overall Study|Adverse Event|0|||
150116757|NCT02460224|541564083|FG011|Overall Study|Adverse Event|0|||
150116758|NCT02460224|541564084|FG012|Overall Study|Adverse Event|1|||
150116759|NCT02460224|541564085|FG013|Overall Study|Adverse Event|0|||
150116760|NCT02460224|541564086|FG014|Overall Study|Adverse Event|0|||
150116761|NCT02460224|541564087|FG015|Overall Study|Adverse Event|0|||
150116762|NCT02460224|541564088|FG016|Overall Study|Adverse Event|1|||
150116763|NCT02460224|541564089|FG017|Overall Study|Adverse Event|0|||
150116764|NCT02460224|541564090|FG018|Overall Study|Adverse Event|1|||
150116765|NCT02460224|541564091|FG019|Overall Study|Adverse Event|0|||
150116766|NCT02460224|541564092|FG020|Overall Study|Adverse Event|1|||
150116767|NCT02460224|541564093|FG021|Overall Study|Adverse Event|1|||
150116768|NCT02460224|541564094|FG022|Overall Study|Adverse Event|1|||
150116769|NCT02460224|541564095|FG023|Overall Study|Adverse Event|0|||
150116770|NCT02460224|541564096|FG024|Overall Study|Adverse Event|0|||
150116771|NCT02460224|541564097|FG025|Overall Study|Adverse Event|0|||
150116772|NCT02460224|541564098|FG026|Overall Study|Adverse Event|11|||
150116773|NCT02460224|541564099|FG027|Overall Study|Adverse Event|1|||
150116774|NCT02460224|541564100|FG028|Overall Study|Adverse Event|6|||
150116775|NCT02460224|541564072|FG000|Overall Study|Death|0|||
150116776|NCT02460224|541564073|FG001|Overall Study|Death|0|||
150116777|NCT02460224|541564074|FG002|Overall Study|Death|0|||
150116778|NCT02460224|541564075|FG003|Overall Study|Death|0|||
150116779|NCT02460224|541564076|FG004|Overall Study|Death|0|||
150116780|NCT02460224|541564077|FG005|Overall Study|Death|2|||
150116781|NCT02460224|541564078|FG006|Overall Study|Death|1|||
150116782|NCT02460224|541564079|FG007|Overall Study|Death|0|||
150116783|NCT02460224|541564080|FG008|Overall Study|Death|0|||
150116784|NCT02460224|541564081|FG009|Overall Study|Death|1|||
150116785|NCT02460224|541564082|FG010|Overall Study|Death|0|||
150116786|NCT02460224|541564083|FG011|Overall Study|Death|0|||
150116787|NCT02460224|541564084|FG012|Overall Study|Death|0|||
150116788|NCT02460224|541564085|FG013|Overall Study|Death|1|||
150116789|NCT02460224|541564086|FG014|Overall Study|Death|0|||
150116790|NCT02460224|541564087|FG015|Overall Study|Death|0|||
150116791|NCT02460224|541564088|FG016|Overall Study|Death|2|||
150116792|NCT02460224|541564089|FG017|Overall Study|Death|1|||
150116793|NCT02460224|541564090|FG018|Overall Study|Death|0|||
150116794|NCT02460224|541564091|FG019|Overall Study|Death|2|||
150116795|NCT02460224|541564092|FG020|Overall Study|Death|0|||
150116796|NCT02460224|541564093|FG021|Overall Study|Death|0|||
150116797|NCT02460224|541564094|FG022|Overall Study|Death|0|||
150116798|NCT02460224|541564095|FG023|Overall Study|Death|0|||
150116799|NCT02460224|541564096|FG024|Overall Study|Death|1|||
150116800|NCT02460224|541564097|FG025|Overall Study|Death|1|||
150116801|NCT02460224|541564098|FG026|Overall Study|Death|5|||
150116802|NCT02460224|541564099|FG027|Overall Study|Death|0|||
150116803|NCT02460224|541564100|FG028|Overall Study|Death|1|||
150116804|NCT02460224|541564072|FG000|Overall Study|Lost to Follow-up|0|||
150116805|NCT02460224|541564073|FG001|Overall Study|Lost to Follow-up|0|||
150116806|NCT02460224|541564074|FG002|Overall Study|Lost to Follow-up|0|||
150116807|NCT02460224|541564075|FG003|Overall Study|Lost to Follow-up|0|||
150116808|NCT02460224|541564076|FG004|Overall Study|Lost to Follow-up|0|||
150116809|NCT02460224|541564077|FG005|Overall Study|Lost to Follow-up|0|||
150116810|NCT02460224|541564078|FG006|Overall Study|Lost to Follow-up|0|||
150116811|NCT02460224|541564079|FG007|Overall Study|Lost to Follow-up|0|||
150116812|NCT02460224|541564080|FG008|Overall Study|Lost to Follow-up|0|||
150116813|NCT02460224|541564081|FG009|Overall Study|Lost to Follow-up|0|||
150116814|NCT02460224|541564082|FG010|Overall Study|Lost to Follow-up|0|||
150116815|NCT02460224|541564083|FG011|Overall Study|Lost to Follow-up|0|||
150116816|NCT02460224|541564084|FG012|Overall Study|Lost to Follow-up|0|||
150116817|NCT02460224|541564085|FG013|Overall Study|Lost to Follow-up|0|||
150116818|NCT02460224|541564086|FG014|Overall Study|Lost to Follow-up|0|||
150116819|NCT02460224|541564087|FG015|Overall Study|Lost to Follow-up|0|||
150116820|NCT02460224|541564088|FG016|Overall Study|Lost to Follow-up|0|||
150116821|NCT02460224|541564089|FG017|Overall Study|Lost to Follow-up|0|||
150116822|NCT02460224|541564090|FG018|Overall Study|Lost to Follow-up|0|||
150116823|NCT02460224|541564091|FG019|Overall Study|Lost to Follow-up|0|||
150116824|NCT02460224|541564092|FG020|Overall Study|Lost to Follow-up|0|||
150116825|NCT02460224|541564093|FG021|Overall Study|Lost to Follow-up|0|||
150116826|NCT02460224|541564094|FG022|Overall Study|Lost to Follow-up|1|||
150116827|NCT02460224|541564095|FG023|Overall Study|Lost to Follow-up|0|||
150116828|NCT02460224|541564096|FG024|Overall Study|Lost to Follow-up|0|||
150116829|NCT02460224|541564097|FG025|Overall Study|Lost to Follow-up|0|||
150116830|NCT02460224|541564098|FG026|Overall Study|Lost to Follow-up|0|||
150116831|NCT02460224|541564099|FG027|Overall Study|Lost to Follow-up|0|||
150116832|NCT02460224|541564100|FG028|Overall Study|Lost to Follow-up|0|||
150116833|NCT02460224|541564072|FG000|Overall Study|Physician Decision|0|||
150116834|NCT02460224|541564073|FG001|Overall Study|Physician Decision|1|||
150116835|NCT02460224|541564074|FG002|Overall Study|Physician Decision|0|||
150116836|NCT02460224|541564075|FG003|Overall Study|Physician Decision|0|||
150116837|NCT02460224|541564076|FG004|Overall Study|Physician Decision|1|||
150116838|NCT02460224|541564077|FG005|Overall Study|Physician Decision|0|||
150116839|NCT02460224|541564078|FG006|Overall Study|Physician Decision|0|||
150116840|NCT02460224|541564079|FG007|Overall Study|Physician Decision|1|||
150116841|NCT02460224|541564080|FG008|Overall Study|Physician Decision|0|||
150116842|NCT02460224|541564081|FG009|Overall Study|Physician Decision|0|||
150116843|NCT02460224|541564082|FG010|Overall Study|Physician Decision|0|||
150116844|NCT02460224|541564083|FG011|Overall Study|Physician Decision|1|||
150116845|NCT02460224|541564084|FG012|Overall Study|Physician Decision|0|||
150116846|NCT02460224|541564085|FG013|Overall Study|Physician Decision|1|||
150116847|NCT02460224|541564086|FG014|Overall Study|Physician Decision|0|||
150116848|NCT02460224|541564087|FG015|Overall Study|Physician Decision|0|||
150116849|NCT02460224|541564088|FG016|Overall Study|Physician Decision|2|||
150116850|NCT02460224|541564089|FG017|Overall Study|Physician Decision|1|||
150116851|NCT02460224|541564090|FG018|Overall Study|Physician Decision|1|||
150116852|NCT02460224|541564091|FG019|Overall Study|Physician Decision|2|||
150116853|NCT02460224|541564092|FG020|Overall Study|Physician Decision|1|||
150116854|NCT02460224|541564093|FG021|Overall Study|Physician Decision|1|||
150116855|NCT02460224|541564094|FG022|Overall Study|Physician Decision|0|||
150116856|NCT02460224|541564095|FG023|Overall Study|Physician Decision|0|||
150116857|NCT02460224|541564096|FG024|Overall Study|Physician Decision|1|||
150116858|NCT02460224|541564097|FG025|Overall Study|Physician Decision|0|||
150116859|NCT02460224|541564098|FG026|Overall Study|Physician Decision|14|||
150116860|NCT02460224|541564099|FG027|Overall Study|Physician Decision|1|||
150116861|NCT02460224|541564100|FG028|Overall Study|Physician Decision|6|||
150116862|NCT02460224|541564072|FG000|Overall Study|Progressive disease|15|||
150116863|NCT02460224|541564073|FG001|Overall Study|Progressive disease|11|||
150116864|NCT02460224|541564074|FG002|Overall Study|Progressive disease|5|||
150116865|NCT02460224|541564075|FG003|Overall Study|Progressive disease|6|||
150116866|NCT02460224|541564076|FG004|Overall Study|Progressive disease|3|||
150116867|NCT02460224|541564077|FG005|Overall Study|Progressive disease|26|||
150116868|NCT02460224|541564078|FG006|Overall Study|Progressive disease|28|||
150116869|NCT02460224|541564079|FG007|Overall Study|Progressive disease|4|||
150116870|NCT02460224|541564080|FG008|Overall Study|Progressive disease|5|||
150116871|NCT02460224|541564081|FG009|Overall Study|Progressive disease|9|||
150116872|NCT02460224|541564082|FG010|Overall Study|Progressive disease|5|||
150116873|NCT02460224|541564083|FG011|Overall Study|Progressive disease|4|||
150189790|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
150189791|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
150189792|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
150189793|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
150189794|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
150189795|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
150189796|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
150189797|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
150189798|NCT01084876|541833311|FG000|Treatment Period Beyond Cycle 8|Other|6|||
150189799|NCT01084876|541833312|FG001|Treatment Period Beyond Cycle 8|Other|9|||
150189800|NCT04727554|541833313|FG000|Overall Study|Lost to Follow-up|0|||
150189801|NCT04727554|541833314|FG001|Overall Study|Lost to Follow-up|1|||
150189802|NCT04727554|541833313|FG000|Overall Study|Death|2|||
150189803|NCT04727554|541833314|FG001|Overall Study|Death|6|||
150189804|NCT04727554|541833313|FG000|Overall Study|Withdrawal by Subject|1|||
150189805|NCT04727554|541833314|FG001|Overall Study|Withdrawal by Subject|0|||
150189806|NCT05763823|541833315|FG000|Overall Study|Death|6|||
150189807|NCT05763823|541833315|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150189808|NCT05763823|541833315|FG000|Overall Study|Withdrawal by Subject|6|||
150189809|NCT05311384|541833323|FG000|Overall Study|Uncontrolled health conditions|2|||
150116874|NCT02460224|541564084|FG012|Overall Study|Progressive disease|5|||
150116875|NCT02460224|541564085|FG013|Overall Study|Progressive disease|4|||
150116876|NCT02460224|541564086|FG014|Overall Study|Progressive disease|5|||
150116877|NCT02460224|541564087|FG015|Overall Study|Progressive disease|5|||
150116878|NCT02460224|541564088|FG016|Overall Study|Progressive disease|15|||
150116879|NCT02460224|541564089|FG017|Overall Study|Progressive disease|3|||
150116880|NCT02460224|541564090|FG018|Overall Study|Progressive disease|8|||
150116881|NCT02460224|541564091|FG019|Overall Study|Progressive disease|3|||
150116882|NCT02460224|541564092|FG020|Overall Study|Progressive disease|4|||
150116883|NCT02460224|541564093|FG021|Overall Study|Progressive disease|9|||
150116884|NCT02460224|541564094|FG022|Overall Study|Progressive disease|4|||
150116885|NCT02460224|541564095|FG023|Overall Study|Progressive disease|11|||
150116886|NCT02460224|541564096|FG024|Overall Study|Progressive disease|4|||
150116887|NCT02460224|541564097|FG025|Overall Study|Progressive disease|5|||
150116888|NCT02460224|541564098|FG026|Overall Study|Progressive disease|85|||
150116889|NCT02460224|541564099|FG027|Overall Study|Progressive disease|17|||
150116890|NCT02460224|541564100|FG028|Overall Study|Progressive disease|77|||
150116891|NCT02460224|541564072|FG000|Overall Study|Subject/guardian decision|2|||
150116892|NCT02460224|541564073|FG001|Overall Study|Subject/guardian decision|0|||
150116893|NCT02460224|541564074|FG002|Overall Study|Subject/guardian decision|1|||
150116894|NCT02460224|541564075|FG003|Overall Study|Subject/guardian decision|0|||
150116895|NCT02460224|541564076|FG004|Overall Study|Subject/guardian decision|2|||
150116896|NCT02460224|541564077|FG005|Overall Study|Subject/guardian decision|2|||
150116897|NCT02460224|541564078|FG006|Overall Study|Subject/guardian decision|0|||
150116898|NCT02460224|541564079|FG007|Overall Study|Subject/guardian decision|0|||
150116899|NCT02460224|541564080|FG008|Overall Study|Subject/guardian decision|1|||
150116900|NCT02460224|541564081|FG009|Overall Study|Subject/guardian decision|1|||
150116901|NCT02460224|541564082|FG010|Overall Study|Subject/guardian decision|0|||
150116902|NCT02460224|541564083|FG011|Overall Study|Subject/guardian decision|1|||
150116903|NCT02460224|541564084|FG012|Overall Study|Subject/guardian decision|0|||
150116904|NCT02460224|541564085|FG013|Overall Study|Subject/guardian decision|0|||
150116905|NCT02460224|541564086|FG014|Overall Study|Subject/guardian decision|0|||
150116906|NCT02460224|541564087|FG015|Overall Study|Subject/guardian decision|1|||
150116907|NCT02460224|541564088|FG016|Overall Study|Subject/guardian decision|0|||
150116908|NCT02460224|541564089|FG017|Overall Study|Subject/guardian decision|1|||
150116909|NCT02460224|541564090|FG018|Overall Study|Subject/guardian decision|2|||
150116910|NCT02460224|541564091|FG019|Overall Study|Subject/guardian decision|0|||
150116911|NCT02460224|541564092|FG020|Overall Study|Subject/guardian decision|0|||
150116912|NCT02460224|541564093|FG021|Overall Study|Subject/guardian decision|1|||
150116913|NCT02460224|541564094|FG022|Overall Study|Subject/guardian decision|0|||
150116914|NCT02460224|541564095|FG023|Overall Study|Subject/guardian decision|0|||
150189810|NCT05311384|541833323|FG000|Overall Study|Withdrawal by Subject|1|||
150189811|NCT02908477|541833328|FG000|Overall Study|Withdrawal by Subject|8|||
150189812|NCT02908477|541833329|FG001|Overall Study|Withdrawal by Subject|28|||
150189813|NCT02924272|541833330|FG000|Overall Study|Site Terminated by Sponsor|4|||
150116915|NCT02460224|541564096|FG024|Overall Study|Subject/guardian decision|0|||
150189814|NCT02924272|541833331|FG001|Overall Study|Site Terminated by Sponsor|1|||
150189815|NCT02924272|541833330|FG000|Overall Study|Withdrawal by Subject|2|||
150189816|NCT02924272|541833331|FG001|Overall Study|Withdrawal by Subject|0|||
150189817|NCT02924272|541833330|FG000|Overall Study|Adverse Event|3|||
150189818|NCT02924272|541833331|FG001|Overall Study|Adverse Event|0|||
150189819|NCT02924272|541833330|FG000|Overall Study|Progressive Disease|11|||
150189820|NCT02924272|541833331|FG001|Overall Study|Progressive Disease|8|||
150189821|NCT02924272|541833330|FG000|Overall Study|Clinical Deterioration|1|||
150189822|NCT02924272|541833331|FG001|Overall Study|Clinical Deterioration|0|||
150189823|NCT02924272|541833330|FG000|Overall Study|Death|1|||
150189824|NCT02924272|541833331|FG001|Overall Study|Death|0|||
150189825|NCT02924272|541833330|FG000|Overall Study|Reason Not Specified|1|||
150189826|NCT02924272|541833331|FG001|Overall Study|Reason Not Specified|0|||
150189827|NCT05116787|541833336|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
150189828|NCT05116787|541833337|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
150189829|NCT05116787|541833336|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
150189830|NCT05116787|541833337|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
150189831|NCT05116787|541833336|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
150189832|NCT05116787|541833337|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
150189833|NCT05116787|541833336|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
150189834|NCT05116787|541833337|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
150189835|NCT02737436|541833338|FG000|Washout Period|Lost to Follow-up|5|||
150189836|NCT02737436|541833339|FG001|Washout Period|Lost to Follow-up|11|||
150189837|NCT02737436|541833338|FG000|Data Analysis|Scanning data problems|5|||
150189838|NCT02737436|541833339|FG001|Data Analysis|Scanning data problems|8|||
150189839|NCT02919683|541833340|FG000|Post-Surgery Follow-Up|Death|2|||
150189840|NCT02919683|541833341|FG001|Post-Surgery Follow-Up|Death|2|||
150189841|NCT02919683|541833340|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
150189842|NCT02919683|541833341|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
150189843|NCT05551637|541833344|FG000|Overall Study|Lack of Efficacy|0|||
150189844|NCT05551637|541833345|FG001|Overall Study|Lack of Efficacy|6|||
150189845|NCT05551637|541833344|FG000|Overall Study|Lost to Follow-up|1|||
150189846|NCT05551637|541833345|FG001|Overall Study|Lost to Follow-up|1|||
150189847|NCT05179837|541833346|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
150189848|NCT05179837|541833346|FG000|Overall Study|Device malfunctioned|1|||
150189849|NCT05179837|541833346|FG000|Overall Study|Image quality too low|2|||
150189850|NCT03158129|541833347|FG000|Overall Study|Adverse Event|0|||
150189851|NCT03158129|541833348|FG001|Overall Study|Adverse Event|1|||
150189852|NCT03158129|541833349|FG002|Overall Study|Adverse Event|0|||
150189853|NCT03158129|541833350|FG003|Overall Study|Adverse Event|0|||
150189854|NCT03158129|541833347|FG000|Overall Study|Death|0|||
150189855|NCT03158129|541833348|FG001|Overall Study|Death|0|||
150189856|NCT03158129|541833349|FG002|Overall Study|Death|0|||
150189857|NCT03158129|541833350|FG003|Overall Study|Death|1|||
150189858|NCT03158129|541833347|FG000|Overall Study|High surgical risk|1|||
150189859|NCT03158129|541833348|FG001|Overall Study|High surgical risk|1|||
150189860|NCT03158129|541833349|FG002|Overall Study|High surgical risk|0|||
150189861|NCT03158129|541833350|FG003|Overall Study|High surgical risk|0|||
150189862|NCT03158129|541833347|FG000|Overall Study|Progression|1|||
150189863|NCT03158129|541833348|FG001|Overall Study|Progression|1|||
150189864|NCT03158129|541833349|FG002|Overall Study|Progression|0|||
150189865|NCT03158129|541833350|FG003|Overall Study|Progression|0|||
150189866|NCT03158129|541833347|FG000|Overall Study|Lack of resectability|0|||
150189867|NCT03158129|541833348|FG001|Overall Study|Lack of resectability|1|||
150189868|NCT03158129|541833349|FG002|Overall Study|Lack of resectability|0|||
150189869|NCT03158129|541833350|FG003|Overall Study|Lack of resectability|0|||
150189870|NCT03158129|541833347|FG000|Overall Study|Declined surgery|0|||
150189871|NCT03158129|541833348|FG001|Overall Study|Declined surgery|1|||
150189872|NCT03158129|541833349|FG002|Overall Study|Declined surgery|0|||
150189873|NCT03158129|541833350|FG003|Overall Study|Declined surgery|0|||
150189874|NCT03158129|541833347|FG000|Overall Study|No longer surgical candidate|0|||
150189875|NCT03158129|541833348|FG001|Overall Study|No longer surgical candidate|0|||
150189876|NCT03158129|541833349|FG002|Overall Study|No longer surgical candidate|0|||
150189877|NCT03158129|541833350|FG003|Overall Study|No longer surgical candidate|1|||
150189878|NCT03719443|541833351|FG000|Overall Study|Lost to Follow-up|0|||
150189879|NCT03719443|541833352|FG001|Overall Study|Lost to Follow-up|0|||
150189880|NCT03719443|541833353|FG002|Overall Study|Lost to Follow-up|1|||
150189881|NCT03719443|541833354|FG003|Overall Study|Lost to Follow-up|0|||
150189882|NCT03719443|541833355|FG004|Overall Study|Lost to Follow-up|1|||
150189883|NCT03719443|541833356|FG005|Overall Study|Lost to Follow-up|0|||
150189884|NCT03719443|541833357|FG006|Overall Study|Lost to Follow-up|1|||
150189885|NCT03719443|541833351|FG000|Overall Study|Withdrawal by Subject|0|||
150189886|NCT03719443|541833352|FG001|Overall Study|Withdrawal by Subject|0|||
150189887|NCT03719443|541833353|FG002|Overall Study|Withdrawal by Subject|1|||
150189888|NCT03719443|541833354|FG003|Overall Study|Withdrawal by Subject|0|||
150189889|NCT03719443|541833355|FG004|Overall Study|Withdrawal by Subject|0|||
150116916|NCT02460224|541564097|FG025|Overall Study|Subject/guardian decision|0|||
150116917|NCT02460224|541564098|FG026|Overall Study|Subject/guardian decision|6|||
150116918|NCT02460224|541564099|FG027|Overall Study|Subject/guardian decision|2|||
150116919|NCT02460224|541564100|FG028|Overall Study|Subject/guardian decision|3|||
150116920|NCT02797262|541564101|FG000|Overall Study|Withdrawal by Subject|5|||
150189890|NCT03719443|541833356|FG005|Overall Study|Withdrawal by Subject|0|||
150189891|NCT03719443|541833357|FG006|Overall Study|Withdrawal by Subject|0|||
150116921|NCT02797262|541564102|FG001|Overall Study|Withdrawal by Subject|1|||
150116922|NCT02797262|541564101|FG000|Overall Study|Lost to Follow-up|10|||
150116923|NCT02797262|541564102|FG001|Overall Study|Lost to Follow-up|7|||
150116924|NCT02797262|541564101|FG000|Overall Study|Death|1|||
150116925|NCT02797262|541564102|FG001|Overall Study|Death|2|||
150116926|NCT02797262|541564101|FG000|Overall Study|Adverse Event|1|||
150116927|NCT02797262|541564102|FG001|Overall Study|Adverse Event|0|||
150116928|NCT02797262|541564101|FG000|Overall Study|COVID-19|2|||
150116929|NCT02797262|541564102|FG001|Overall Study|COVID-19|1|||
150116930|NCT02797262|541564101|FG000|Overall Study|Out-of-country|1|||
150116931|NCT02797262|541564102|FG001|Overall Study|Out-of-country|0|||
150116932|NCT01600586|541564103|FG000|Overall Study|Physician Decision|3|||
150116933|NCT01600586|541564104|FG001|Overall Study|Physician Decision|3|||
150189892|NCT04782973|541833358|FG000|Overall Study|Withdrawal by Subject|5|||
150189893|NCT04782973|541833358|FG000|Overall Study|Protocol Violation|6|||
150189894|NCT04782973|541833358|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
150189895|NCT04924660|541833359|FG000|United States|Death|29|||
150189896|NCT04924660|541833360|FG001|United States|Death|32|||
150189897|NCT04924660|541833361|FG002|United States|Death|34|||
150189898|NCT04924660|541833362|FG003|United States|Death|25|||
150189899|NCT04924660|541833363|FG004|United States|Death|26|||
150189900|NCT04924660|541833364|FG005|United States|Death|23|||
150189901|NCT04924660|541833359|FG000|United States|Lost to Follow-up|15|||
150189902|NCT04924660|541833360|FG001|United States|Lost to Follow-up|10|||
150189903|NCT04924660|541833361|FG002|United States|Lost to Follow-up|13|||
150189904|NCT04924660|541833362|FG003|United States|Lost to Follow-up|5|||
150189905|NCT04924660|541833363|FG004|United States|Lost to Follow-up|19|||
150189906|NCT04924660|541833364|FG005|United States|Lost to Follow-up|20|||
150189907|NCT04924660|541833359|FG000|United States|Withdrawal by Subject|8|||
150189908|NCT04924660|541833360|FG001|United States|Withdrawal by Subject|3|||
150116934|NCT02460198|541564109|FG000|Overall Study|Adverse Event|1|||
150116935|NCT02460198|541564110|FG001|Overall Study|Adverse Event|3|||
150116936|NCT02460198|541564109|FG000|Overall Study|Death|36|||
150116937|NCT02460198|541564110|FG001|Overall Study|Death|28|||
150116938|NCT02460198|541564109|FG000|Overall Study|Lost to Follow-up|1|||
150116939|NCT02460198|541564110|FG001|Overall Study|Lost to Follow-up|1|||
150116940|NCT02460198|541564109|FG000|Overall Study|Transferred to Extension Study|15|||
150116941|NCT02460198|541564110|FG001|Overall Study|Transferred to Extension Study|15|||
150116942|NCT02460198|541564109|FG000|Overall Study|Withdrawal by Subject|2|||
150116943|NCT02460198|541564110|FG001|Overall Study|Withdrawal by Subject|4|||
150116944|NCT02460198|541564109|FG000|Overall Study|Site Terminated By Sponsor|0|||
150116945|NCT02460198|541564110|FG001|Overall Study|Site Terminated By Sponsor|1|||
150116946|NCT02460198|541564109|FG000|Overall Study|Did Not Continue on Extension Study|6|||
150116947|NCT02460198|541564110|FG001|Overall Study|Did Not Continue on Extension Study|11|||
150116948|NCT00965848|541564111|FG000|Overall Study|Protocol Violation|3|||
150116949|NCT00965848|541564112|FG001|Overall Study|Protocol Violation|0|||
150116950|NCT00965848|541564113|FG002|Overall Study|Protocol Violation|1|||
150116951|NCT00965848|541564111|FG000|Overall Study|Death|11|||
150116952|NCT00965848|541564112|FG001|Overall Study|Death|1|||
150116953|NCT00965848|541564113|FG002|Overall Study|Death|5|||
150116954|NCT00965848|541564111|FG000|Overall Study|Lost to Follow-up|0|||
150116955|NCT00965848|541564112|FG001|Overall Study|Lost to Follow-up|0|||
150189909|NCT04924660|541833361|FG002|United States|Withdrawal by Subject|3|||
150189910|NCT04924660|541833362|FG003|United States|Withdrawal by Subject|3|||
150189911|NCT04924660|541833363|FG004|United States|Withdrawal by Subject|8|||
150189912|NCT04924660|541833364|FG005|United States|Withdrawal by Subject|4|||
150189913|NCT04924660|541833359|FG000|Spain|Death|0|||
150189914|NCT04924660|541833360|FG001|Spain|Death|0|||
150189915|NCT04924660|541833361|FG002|Spain|Death|0|||
150189916|NCT04924660|541833362|FG003|Spain|Death|0|||
150189917|NCT04924660|541833363|FG004|Spain|Death|0|||
150116956|NCT00965848|541564113|FG002|Overall Study|Lost to Follow-up|1|||
150116957|NCT00965848|541564111|FG000|Overall Study|Withdrawal by Subject|1|||
150189918|NCT04924660|541833364|FG005|Spain|Death|2|||
150189919|NCT04924660|541833359|FG000|Spain|Lost to Follow-up|0|||
150189920|NCT04924660|541833360|FG001|Spain|Lost to Follow-up|0|||
150189921|NCT04924660|541833361|FG002|Spain|Lost to Follow-up|0|||
150189922|NCT04924660|541833362|FG003|Spain|Lost to Follow-up|0|||
150116958|NCT00965848|541564112|FG001|Overall Study|Withdrawal by Subject|0|||
150189923|NCT04924660|541833363|FG004|Spain|Lost to Follow-up|1|||
150189924|NCT04924660|541833364|FG005|Spain|Lost to Follow-up|0|||
150189925|NCT04924660|541833359|FG000|Brazil|Death|0|||
150189926|NCT04924660|541833360|FG001|Brazil|Death|0|||
150116959|NCT00965848|541564113|FG002|Overall Study|Withdrawal by Subject|0|||
150116960|NCT00965848|541564111|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
150116961|NCT00965848|541564112|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
150116962|NCT00965848|541564113|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
150116963|NCT00965848|541564111|FG000|Overall Study|Not Clinically Evaluable|7|||
150116964|NCT00965848|541564112|FG001|Overall Study|Not Clinically Evaluable|1|||
150116965|NCT00965848|541564113|FG002|Overall Study|Not Clinically Evaluable|1|||
150116966|NCT00965848|541564111|FG000|Overall Study|Other|5|||
150116967|NCT00965848|541564112|FG001|Overall Study|Other|0|||
150116968|NCT00965848|541564113|FG002|Overall Study|Other|1|||
150116969|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
150116970|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
150116971|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
150116972|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
150116973|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
150116974|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
150116975|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
150116976|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
150116977|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
150116978|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
150116979|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
150116980|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
150116981|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
150116982|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
150116983|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
150116984|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
150116985|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
150116986|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
150116987|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
150116988|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
150116989|NCT00813761|541564114|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
150116990|NCT00813761|541564115|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
150116991|NCT00813761|541564116|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
150116992|NCT00813761|541564117|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
150116993|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
150116994|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
150116995|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
150116996|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
150116997|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
150116998|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
150116999|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
150117000|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
150117001|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
150117002|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
150117003|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
150117004|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
150117005|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
150117006|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
150117007|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
150117008|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
150117009|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
150117010|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
150117011|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
150117012|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
150117013|NCT00813761|541564114|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
150117014|NCT00813761|541564115|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
150117015|NCT00813761|541564116|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
150117016|NCT00813761|541564117|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
150189927|NCT04924660|541833361|FG002|Brazil|Death|0|||
150189928|NCT04924660|541833362|FG003|Brazil|Death|0|||
150189929|NCT04924660|541833363|FG004|Brazil|Death|1|||
150117017|NCT00555438|541564120|FG000|10 Days Post-operative|Death|4|||
150117018|NCT00555438|541564120|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
150189930|NCT04924660|541833364|FG005|Brazil|Death|0|||
150189931|NCT04924660|541833359|FG000|Italy|Lost to Follow-up|0|||
150117019|NCT02758236|541564123|FG000|Overall Study|Investigator discretion|43|||
150117020|NCT02447991|541564124|FG000|Overall Study|Withdrawn by subject - no data|0|||
150189932|NCT04924660|541833360|FG001|Italy|Lost to Follow-up|0|||
150117021|NCT02447991|541564125|FG001|Overall Study|Withdrawn by subject - no data|2|||
150189933|NCT04924660|541833361|FG002|Italy|Lost to Follow-up|0|||
150189934|NCT04924660|541833362|FG003|Italy|Lost to Follow-up|0|||
150189935|NCT04924660|541833363|FG004|Italy|Lost to Follow-up|0|||
150189936|NCT04924660|541833364|FG005|Italy|Lost to Follow-up|1|||
150189937|NCT04924660|541833359|FG000|South Africa|Death|0|||
150189938|NCT04924660|541833360|FG001|South Africa|Death|0|||
150189939|NCT04924660|541833361|FG002|South Africa|Death|0|||
150189940|NCT04924660|541833362|FG003|South Africa|Death|0|||
150189941|NCT04924660|541833363|FG004|South Africa|Death|0|||
150189942|NCT04924660|541833364|FG005|South Africa|Death|1|||
150189943|NCT04924660|541833359|FG000|South Africa|Lost to Follow-up|0|||
150189944|NCT04924660|541833360|FG001|South Africa|Lost to Follow-up|0|||
150189945|NCT04924660|541833361|FG002|South Africa|Lost to Follow-up|0|||
150189946|NCT04924660|541833362|FG003|South Africa|Lost to Follow-up|0|||
150189947|NCT04924660|541833363|FG004|South Africa|Lost to Follow-up|0|||
150189948|NCT04924660|541833364|FG005|South Africa|Lost to Follow-up|1|||
150189949|NCT00554788|541833365|FG000|Overall Study|Adverse Event|0|||
150189950|NCT00554788|541833366|FG001|Overall Study|Adverse Event|1|||
150189951|NCT00554788|541833367|FG002|Overall Study|Adverse Event|2|||
150189952|NCT00554788|541833365|FG000|Overall Study|Lost to Follow-up|4|||
150189953|NCT00554788|541833366|FG001|Overall Study|Lost to Follow-up|3|||
150189954|NCT00554788|541833367|FG002|Overall Study|Lost to Follow-up|3|||
150189955|NCT00554788|541833365|FG000|Overall Study|Physician Decision|1|||
150189956|NCT00554788|541833366|FG001|Overall Study|Physician Decision|1|||
150189957|NCT00554788|541833367|FG002|Overall Study|Physician Decision|3|||
150189958|NCT00554788|541833365|FG000|Overall Study|Withdrawal by Subject|0|||
150189959|NCT00554788|541833366|FG001|Overall Study|Withdrawal by Subject|0|||
150189960|NCT00554788|541833367|FG002|Overall Study|Withdrawal by Subject|1|||
150189961|NCT00554788|541833365|FG000|Overall Study|Refusal of further protocol therapy|0|||
150189962|NCT00554788|541833366|FG001|Overall Study|Refusal of further protocol therapy|1|||
150189963|NCT00554788|541833367|FG002|Overall Study|Refusal of further protocol therapy|1|||
150189964|NCT00554788|541833365|FG000|Overall Study|Progressive disease|0|||
150189965|NCT00554788|541833366|FG001|Overall Study|Progressive disease|0|||
150189966|NCT00554788|541833367|FG002|Overall Study|Progressive disease|3|||
150189967|NCT00554788|541833365|FG000|Overall Study|Ineligible|2|||
150189968|NCT00554788|541833366|FG001|Overall Study|Ineligible|0|||
150189969|NCT00554788|541833367|FG002|Overall Study|Ineligible|1|||
150189970|NCT06491433|541833368|FG000|Overall Study|Protocol Violation|51|||
150189971|NCT06491433|541833368|FG000|Overall Study|consent withdrawal|2|||
150189972|NCT06491433|541833368|FG000|Overall Study|screen failure|1|||
150189973|NCT03721952|541833374|FG000|Overall Study|Lost to Follow-up|0|||
150189974|NCT03721952|541833375|FG001|Overall Study|Lost to Follow-up|0|||
150189975|NCT03721952|541833376|FG002|Overall Study|Lost to Follow-up|2|||
150189976|NCT03721952|541833377|FG003|Overall Study|Lost to Follow-up|0|||
150189977|NCT03721952|541833378|FG004|Overall Study|Lost to Follow-up|0|||
150189978|NCT03721952|541833374|FG000|Overall Study|Protocol Violation|0|||
150189979|NCT03721952|541833375|FG001|Overall Study|Protocol Violation|1|||
150189980|NCT03721952|541833376|FG002|Overall Study|Protocol Violation|0|||
150189981|NCT03721952|541833377|FG003|Overall Study|Protocol Violation|0|||
150189982|NCT03721952|541833378|FG004|Overall Study|Protocol Violation|0|||
150189983|NCT03721952|541833374|FG000|Overall Study|Withdrawal by Subject|1|||
150189984|NCT03721952|541833375|FG001|Overall Study|Withdrawal by Subject|0|||
150189985|NCT03721952|541833376|FG002|Overall Study|Withdrawal by Subject|40|||
150189986|NCT03721952|541833377|FG003|Overall Study|Withdrawal by Subject|28|||
150189987|NCT03721952|541833378|FG004|Overall Study|Withdrawal by Subject|0|||
150189988|NCT03476460|541833382|FG000|Overall Study|Withdrawal by Subject|3|||
150189989|NCT03476460|541833383|FG001|Overall Study|Withdrawal by Subject|2|||
150189990|NCT03476460|541833382|FG000|Overall Study|Non-compliance with treatment|3|||
150189991|NCT03476460|541833383|FG001|Overall Study|Non-compliance with treatment|0|||
150189992|NCT03476460|541833382|FG000|Overall Study|Missing laboratory tests|5|||
150189993|NCT03476460|541833383|FG001|Overall Study|Missing laboratory tests|5|||
150189994|NCT03476460|541833382|FG000|Overall Study|Adverse Event|0|||
150189995|NCT03476460|541833383|FG001|Overall Study|Adverse Event|1|||
150189996|NCT05184192|541833389|FG000|Overall Study|Lost to Follow-up|4|||
150189997|NCT05184192|541833390|FG001|Overall Study|Lost to Follow-up|7|||
150189998|NCT05184192|541833389|FG000|Overall Study|Adverse Event|1|||
150189999|NCT05184192|541833390|FG001|Overall Study|Adverse Event|4|||
150190000|NCT05184192|541833389|FG000|Overall Study|PI withdrawal|1|||
150190001|NCT05184192|541833390|FG001|Overall Study|PI withdrawal|2|||
150190002|NCT05184192|541833389|FG000|Overall Study|Withdrew due to adverse effect|1|||
150190003|NCT05184192|541833390|FG001|Overall Study|Withdrew due to adverse effect|0|||
150190004|NCT05184192|541833389|FG000|Overall Study|Medication schedule|1|||
150190005|NCT05184192|541833390|FG001|Overall Study|Medication schedule|0|||
150190006|NCT05184192|541833389|FG000|Overall Study|Concern for adverse effects|0|||
150190007|NCT05184192|541833390|FG001|Overall Study|Concern for adverse effects|4|||
150190008|NCT03640312|541833397|FG000|Overall Study|Lost to Follow-up|3|||
150190009|NCT03640312|541833398|FG001|Overall Study|Lost to Follow-up|6|||
150190010|NCT06037369|541833404|FG000|Overall Study|Lost to Follow-up|0|||
150190011|NCT06037369|541833405|FG001|Overall Study|Lost to Follow-up|1|||
150190012|NCT05603143|541833406|FG000|Overall Study|Withdrew consent|6|||
150190013|NCT05603143|541833407|FG001|Overall Study|Withdrew consent|2|||
150117022|NCT02447991|541564124|FG000|Overall Study|Withdrawn by Subject - with data|4|||
150117023|NCT02447991|541564125|FG001|Overall Study|Withdrawn by Subject - with data|4|||
150117024|NCT02447991|541564124|FG000|Overall Study|Lost to Follow-up - no data|3|||
150117025|NCT02447991|541564125|FG001|Overall Study|Lost to Follow-up - no data|6|||
150117026|NCT02447991|541564124|FG000|Overall Study|Lost to follow-up - with data|0|||
150117027|NCT02447991|541564125|FG001|Overall Study|Lost to follow-up - with data|3|||
150117028|NCT02447991|541564124|FG000|Overall Study|End of study - no treatment results|3|||
150117029|NCT02447991|541564125|FG001|Overall Study|End of study - no treatment results|6|||
150117030|NCT02447991|541564124|FG000|Overall Study|End of study - partial treatment results|0|||
150117031|NCT02447991|541564125|FG001|Overall Study|End of study - partial treatment results|9|||
150117032|NCT02770391|541564132|FG000|Overall Study|Lost to Follow-up|2|||
150117033|NCT02770391|541564132|FG000|Overall Study|Withdrawal by Subject|1|||
150117034|NCT02770391|541564132|FG000|Overall Study|Surgery delayed unevaluable|2|||
150117035|NCT02770391|541564132|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
150117036|NCT03333486|541564135|FG000|Overall Study|Withdrawal by Subject|1|||
150117037|NCT03333486|541564135|FG000|Overall Study|Lost to Follow-up|1|||
150117038|NCT00524134|541565631|FG000|Overall Study|Withdrawal by Subject|1|||
150117039|NCT00524134|541565631|FG000|Overall Study|Physician Decision|1|||
150117040|NCT01782131|541565635|FG000|Overall Study|Death|93|||
150117041|NCT01782131|541565636|FG001|Overall Study|Death|96|||
150117042|NCT01782131|541565635|FG000|Overall Study|Lost to Follow-up|1|||
150117043|NCT01782131|541565636|FG001|Overall Study|Lost to Follow-up|3|||
150117044|NCT01782131|541565635|FG000|Overall Study|Withdrawal by Subject|10|||
150117045|NCT01782131|541565636|FG001|Overall Study|Withdrawal by Subject|10|||
150117046|NCT01782131|541565635|FG000|Overall Study|Randomized but not treated|5|||
150117047|NCT01782131|541565636|FG001|Overall Study|Randomized but not treated|5|||
150117048|NCT01782131|541565635|FG000|Overall Study|Reason not provided|0|||
150117049|NCT01782131|541565636|FG001|Overall Study|Reason not provided|1|||
150117050|NCT01627249|541565637|FG000|Overall Study|Death|3|||
150117051|NCT01627249|541565638|FG001|Overall Study|Death|5|||
150117052|NCT01627249|541565639|FG002|Overall Study|Death|3|||
150117053|NCT01627249|541565637|FG000|Overall Study|Withdrawal by Subject|12|||
150117054|NCT01627249|541565638|FG001|Overall Study|Withdrawal by Subject|6|||
150117055|NCT01627249|541565639|FG002|Overall Study|Withdrawal by Subject|9|||
150117056|NCT01627249|541565637|FG000|Overall Study|Missed Visit|1|||
150117057|NCT01627249|541565638|FG001|Overall Study|Missed Visit|1|||
150117058|NCT01627249|541565639|FG002|Overall Study|Missed Visit|0|||
150117059|NCT00796718|541565640|FG000|Overall Study|Adverse Event|2|||
150117060|NCT00796718|541565640|FG000|Overall Study|Exclusion Criteria|1|||
150117061|NCT00796718|541565640|FG000|Overall Study|Lost to Follow-up|5|||
150117062|NCT00796718|541565640|FG000|Overall Study|Withdrawal by Informed Consent|1|||
150117063|NCT02627677|541565641|FG000|Overall Study|Adverse event (not progressive disease)|1|||
150117064|NCT02627677|541565642|FG001|Overall Study|Adverse event (not progressive disease)|4|||
150117065|NCT02627677|541565643|FG002|Overall Study|Adverse event (not progressive disease)|1|||
150117066|NCT02627677|541565641|FG000|Overall Study|Progressive disease|1|||
150117067|NCT02627677|541565642|FG001|Overall Study|Progressive disease|3|||
150117068|NCT02627677|541565643|FG002|Overall Study|Progressive disease|0|||
150117069|NCT02627677|541565641|FG000|Overall Study|Lack of Efficacy|1|||
150117070|NCT02627677|541565642|FG001|Overall Study|Lack of Efficacy|2|||
150117071|NCT02627677|541565643|FG002|Overall Study|Lack of Efficacy|0|||
150117072|NCT02627677|541565641|FG000|Overall Study|Lost to Follow-up|0|||
150117073|NCT02627677|541565642|FG001|Overall Study|Lost to Follow-up|0|||
150117074|NCT02627677|541565643|FG002|Overall Study|Lost to Follow-up|1|||
150117075|NCT02627677|541565641|FG000|Overall Study|Pregnancy|0|||
150117076|NCT02627677|541565642|FG001|Overall Study|Pregnancy|1|||
150117077|NCT02627677|541565643|FG002|Overall Study|Pregnancy|0|||
150117078|NCT02627677|541565641|FG000|Overall Study|Study Terminated by Sponsor|5|||
150117079|NCT02627677|541565642|FG001|Overall Study|Study Terminated by Sponsor|10|||
150117080|NCT02627677|541565643|FG002|Overall Study|Study Terminated by Sponsor|6|||
150117081|NCT02627677|541565641|FG000|Overall Study|Physician Decision|0|||
150117082|NCT02627677|541565642|FG001|Overall Study|Physician Decision|0|||
150117083|NCT02627677|541565643|FG002|Overall Study|Physician Decision|2|||
150117084|NCT02627677|541565641|FG000|Overall Study|Withdrawal by Subject|2|||
150117085|NCT02627677|541565642|FG001|Overall Study|Withdrawal by Subject|1|||
150117086|NCT02627677|541565643|FG002|Overall Study|Withdrawal by Subject|1|||
150117087|NCT02627677|541565641|FG000|Overall Study|Reason not Specified|0|||
150117088|NCT02627677|541565642|FG001|Overall Study|Reason not Specified|0|||
150117089|NCT02627677|541565643|FG002|Overall Study|Reason not Specified|1|||
150117090|NCT02627677|541565641|FG000|Overall Study|Randomized but not Treated|1|||
150117091|NCT02627677|541565642|FG001|Overall Study|Randomized but not Treated|0|||
150117092|NCT02627677|541565643|FG002|Overall Study|Randomized but not Treated|0|||
150117093|NCT00317772|541565644|FG000|Overall Study|Adverse Event|0|||
150117094|NCT00317772|541565645|FG001|Overall Study|Adverse Event|0|||
150117095|NCT00317772|541565646|FG002|Overall Study|Adverse Event|0|||
150117096|NCT00317772|541565647|FG003|Overall Study|Adverse Event|2|||
150117097|NCT00317772|541565644|FG000|Overall Study|Disease Progression|2|||
150117098|NCT00317772|541565645|FG001|Overall Study|Disease Progression|2|||
150117099|NCT00317772|541565646|FG002|Overall Study|Disease Progression|1|||
150117100|NCT00317772|541565647|FG003|Overall Study|Disease Progression|7|||
150117101|NCT03087591|541565651|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
150117102|NCT03087591|541565651|FG000|Overall Study|Withdrawal by Subject|1|||
150117103|NCT01073618|541565654|FG000|Overall Study|Death|208|||
150117104|NCT01073618|541565654|FG000|Overall Study|Adverse Event|19|||
150117105|NCT01073618|541565654|FG000|Overall Study|Other|80|||
150117106|NCT02696850|541565655|FG000|Overall Study|Withdrawal by Subject|3|||
150117107|NCT02696850|541565656|FG001|Overall Study|Withdrawal by Subject|3|||
150117108|NCT02696850|541565655|FG000|Overall Study|Lost to Follow-up|8|||
150117109|NCT02696850|541565656|FG001|Overall Study|Lost to Follow-up|5|||
150117110|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
150117111|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
150117112|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
150117113|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
150117114|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Death|235|||
150117115|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Death|167|||
150117116|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Death|1|||
150117117|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Death|0|||
150117118|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
150117119|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
150117120|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
150117121|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
150117122|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
150117123|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
150117124|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
150117125|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
150117126|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Other|1|||
150117127|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Other|2|||
150117128|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Other|0|||
150117129|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Other|0|||
150117130|NCT00673049|541565657|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
150117131|NCT00673049|541565658|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
150117132|NCT00673049|541565659|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
150117133|NCT00673049|541565660|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
150117134|NCT00673049|541565657|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
150117135|NCT00673049|541565658|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
150117136|NCT00673049|541565659|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
150117137|NCT00673049|541565660|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
150117138|NCT00673049|541565657|FG000|After Progression on Erlotinib|Death|0|||
150117139|NCT00673049|541565658|FG001|After Progression on Erlotinib|Death|0|||
150117140|NCT00673049|541565659|FG002|After Progression on Erlotinib|Death|0|||
150117141|NCT00673049|541565660|FG003|After Progression on Erlotinib|Death|71|||
150117142|NCT00673049|541565657|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
150117143|NCT00673049|541565658|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
150117144|NCT00673049|541565659|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
150117145|NCT00673049|541565660|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
150117146|NCT00673049|541565657|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
150117147|NCT00673049|541565658|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
150117148|NCT00673049|541565659|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
150117149|NCT00673049|541565660|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
150117150|NCT00673049|541565657|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
150117151|NCT00673049|541565658|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
150117152|NCT00673049|541565659|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
150117153|NCT00673049|541565660|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
150117154|NCT02621606|541565661|FG000|Overall Study|Withdrawal by Subject|0|||
150117155|NCT02621606|541565662|FG001|Overall Study|Withdrawal by Subject|1|||
150117156|NCT02621606|541565663|FG002|Overall Study|Withdrawal by Subject|0|||
150117157|NCT01175824|541565664|FG000|Overall Study|Adverse Event|2|||
150117158|NCT01175824|541565665|FG001|Overall Study|Adverse Event|1|||
150117159|NCT01175824|541565664|FG000|Overall Study|Lack of Efficacy|2|||
150117160|NCT01175824|541565665|FG001|Overall Study|Lack of Efficacy|0|||
150117161|NCT01175824|541565664|FG000|Overall Study|Lost to Follow-up|0|||
150117162|NCT01175824|541565665|FG001|Overall Study|Lost to Follow-up|1|||
150117163|NCT01175824|541565664|FG000|Overall Study|Physician Decision|0|||
150117164|NCT01175824|541565665|FG001|Overall Study|Physician Decision|4|||
150117165|NCT01175824|541565664|FG000|Overall Study|Protocol Violation|2|||
150117166|NCT01175824|541565665|FG001|Overall Study|Protocol Violation|5|||
150117167|NCT01175824|541565664|FG000|Overall Study|Withdrawal by Subject|3|||
150117168|NCT01175824|541565665|FG001|Overall Study|Withdrawal by Subject|7|||
150117169|NCT01175824|541565664|FG000|Overall Study|Sponsor Decision|1|||
150117170|NCT01175824|541565665|FG001|Overall Study|Sponsor Decision|0|||
150117171|NCT01175824|541565664|FG000|Overall Study|Entry Criteria Not Met|6|||
150117172|NCT01175824|541565665|FG001|Overall Study|Entry Criteria Not Met|4|||
150117173|NCT03455855|541565666|FG000|Overall Study|Lost to Follow-up|4|||
150117174|NCT03455855|541565667|FG001|Overall Study|Lost to Follow-up|2|||
150117175|NCT02979535|541565668|FG000|Overall Study|Non compliance with the protocol|78|||
150117176|NCT02979535|541565669|FG001|Overall Study|Non compliance with the protocol|82|||
150117177|NCT02979535|541565668|FG000|Overall Study|Consent withdrawn by participant|11|||
150117178|NCT02979535|541565669|FG001|Overall Study|Consent withdrawn by participant|18|||
150117179|NCT02979535|541565668|FG000|Overall Study|Lost to Follow-up|6|||
150117180|NCT02979535|541565669|FG001|Overall Study|Lost to Follow-up|1|||
150117181|NCT04820673|541565673|FG000|Overall Study|Adverse Event|6|||
150117182|NCT04820673|541565673|FG000|Overall Study|Due to Lack of Effectiveness|1|||
150117183|NCT04820673|541565673|FG000|Overall Study|Pregnancy|1|||
150117184|NCT04820673|541565673|FG000|Overall Study|Voluntary Withdrawal|20|||
150117185|NCT04820673|541565673|FG000|Overall Study|Lost to Follow-up|10|||
150117186|NCT00587587|541565674|FG000|Overall Study|Lost to Follow-up|6|||
150117187|NCT00587587|541565675|FG001|Overall Study|Lost to Follow-up|1|||
150117188|NCT01933334|541565684|FG000|Overall Study|Adverse Event|5|||
150117189|NCT01933334|541565685|FG001|Overall Study|Adverse Event|1|||
150117190|NCT01933334|541565684|FG000|Overall Study|Withdrawal by Subject|0|||
150117191|NCT01933334|541565685|FG001|Overall Study|Withdrawal by Subject|1|||
150117192|NCT00767000|541565686|FG000|54-week Study|Adverse Event|4|||
150117193|NCT00767000|541565687|FG001|54-week Study|Adverse Event|6|||
150117194|NCT00767000|541565688|FG002|54-week Study|Adverse Event|6|||
150117195|NCT00767000|541565689|FG003|54-week Study|Adverse Event|8|||
150117196|NCT00767000|541565690|FG004|54-week Study|Adverse Event|4|||
150117197|NCT00767000|541565686|FG000|54-week Study|Creaninine/creatinine clearance|2|||
150117198|NCT00767000|541565687|FG001|54-week Study|Creaninine/creatinine clearance|1|||
150117199|NCT00767000|541565688|FG002|54-week Study|Creaninine/creatinine clearance|2|||
150117200|NCT00767000|541565689|FG003|54-week Study|Creaninine/creatinine clearance|2|||
150117201|NCT00767000|541565690|FG004|54-week Study|Creaninine/creatinine clearance|4|||
150117202|NCT00767000|541565686|FG000|54-week Study|Hyperglycemia|0|||
150117203|NCT00767000|541565687|FG001|54-week Study|Hyperglycemia|0|||
150117204|NCT00767000|541565688|FG002|54-week Study|Hyperglycemia|1|||
150117205|NCT00767000|541565689|FG003|54-week Study|Hyperglycemia|0|||
150117206|NCT00767000|541565690|FG004|54-week Study|Hyperglycemia|1|||
150117207|NCT00767000|541565686|FG000|54-week Study|Hypoglycemia|0|||
150117208|NCT00767000|541565687|FG001|54-week Study|Hypoglycemia|1|||
150117209|NCT00767000|541565688|FG002|54-week Study|Hypoglycemia|0|||
150117210|NCT00767000|541565689|FG003|54-week Study|Hypoglycemia|0|||
150117211|NCT00767000|541565690|FG004|54-week Study|Hypoglycemia|0|||
150117212|NCT00767000|541565686|FG000|54-week Study|Interruption of study medication|0|||
150117213|NCT00767000|541565687|FG001|54-week Study|Interruption of study medication|0|||
150117214|NCT00767000|541565688|FG002|54-week Study|Interruption of study medication|1|||
150117215|NCT00767000|541565689|FG003|54-week Study|Interruption of study medication|0|||
150117216|NCT00767000|541565690|FG004|54-week Study|Interruption of study medication|0|||
150117217|NCT00767000|541565686|FG000|54-week Study|Lack of Efficacy|2|||
150117218|NCT00767000|541565687|FG001|54-week Study|Lack of Efficacy|0|||
150117219|NCT00767000|541565688|FG002|54-week Study|Lack of Efficacy|1|||
150117220|NCT00767000|541565689|FG003|54-week Study|Lack of Efficacy|0|||
150117221|NCT00767000|541565690|FG004|54-week Study|Lack of Efficacy|5|||
150117222|NCT00767000|541565686|FG000|54-week Study|Lost to Follow-up|4|||
150117223|NCT00767000|541565687|FG001|54-week Study|Lost to Follow-up|0|||
150117224|NCT00767000|541565688|FG002|54-week Study|Lost to Follow-up|1|||
150117225|NCT00767000|541565689|FG003|54-week Study|Lost to Follow-up|4|||
150117226|NCT00767000|541565690|FG004|54-week Study|Lost to Follow-up|2|||
150117227|NCT00767000|541565686|FG000|54-week Study|Physician Decision|4|||
150190014|NCT05603143|541833406|FG000|Overall Study|Randomized but never treated|0|||
150117228|NCT00767000|541565687|FG001|54-week Study|Physician Decision|0|||
150117229|NCT00767000|541565688|FG002|54-week Study|Physician Decision|1|||
150117230|NCT00767000|541565689|FG003|54-week Study|Physician Decision|1|||
150117231|NCT00767000|541565690|FG004|54-week Study|Physician Decision|1|||
150117232|NCT00767000|541565686|FG000|54-week Study|Progressive disease|0|||
150117233|NCT00767000|541565687|FG001|54-week Study|Progressive disease|0|||
150117234|NCT00767000|541565688|FG002|54-week Study|Progressive disease|1|||
150117235|NCT00767000|541565689|FG003|54-week Study|Progressive disease|0|||
150117236|NCT00767000|541565690|FG004|54-week Study|Progressive disease|0|||
150117237|NCT00767000|541565686|FG000|54-week Study|Protocol Violation|0|||
150117238|NCT00767000|541565687|FG001|54-week Study|Protocol Violation|0|||
150117239|NCT00767000|541565688|FG002|54-week Study|Protocol Violation|1|||
150117240|NCT00767000|541565689|FG003|54-week Study|Protocol Violation|2|||
150117241|NCT00767000|541565690|FG004|54-week Study|Protocol Violation|0|||
150117242|NCT00767000|541565686|FG000|54-week Study|Withdrawal by Subject|2|||
150117243|NCT00767000|541565687|FG001|54-week Study|Withdrawal by Subject|3|||
150117244|NCT00767000|541565688|FG002|54-week Study|Withdrawal by Subject|5|||
150117245|NCT00767000|541565689|FG003|54-week Study|Withdrawal by Subject|11|||
150117246|NCT00767000|541565690|FG004|54-week Study|Withdrawal by Subject|13|||
150117247|NCT00767000|541565686|FG000|54-week Study|Study terminated by sponsor|90|||
150117248|NCT00767000|541565687|FG001|54-week Study|Study terminated by sponsor|102|||
150117249|NCT00767000|541565688|FG002|54-week Study|Study terminated by sponsor|89|||
150117250|NCT00767000|541565689|FG003|54-week Study|Study terminated by sponsor|196|||
150117251|NCT00767000|541565690|FG004|54-week Study|Study terminated by sponsor|194|||
150117252|NCT00767000|541565686|FG000|54-week Study|Reason not reported|0|||
150117253|NCT00767000|541565687|FG001|54-week Study|Reason not reported|0|||
150117254|NCT00767000|541565688|FG002|54-week Study|Reason not reported|0|||
150117255|NCT00767000|541565689|FG003|54-week Study|Reason not reported|1|||
150117256|NCT00767000|541565690|FG004|54-week Study|Reason not reported|0|||
150117257|NCT00767000|541565686|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
150117258|NCT00767000|541565687|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
150117259|NCT00767000|541565688|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
150117260|NCT00767000|541565689|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
150117261|NCT00767000|541565690|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
150117262|NCT02039505|541565692|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
150117263|NCT02039505|541565693|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
150117264|NCT02039505|541565694|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
150117265|NCT02039505|541565695|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
150117266|NCT02039505|541565696|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
150117267|NCT02039505|541565697|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
150117268|NCT02039505|541565698|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
150117269|NCT02039505|541565692|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
150117270|NCT02039505|541565693|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
150117271|NCT02039505|541565694|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
150117272|NCT02039505|541565695|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
150117273|NCT02039505|541565696|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
150117274|NCT02039505|541565697|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
150117275|NCT02039505|541565698|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
150117276|NCT02039505|541565692|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
150117277|NCT02039505|541565693|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117278|NCT02039505|541565694|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117279|NCT02039505|541565695|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117280|NCT02039505|541565696|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117281|NCT02039505|541565697|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117282|NCT02039505|541565698|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
150117283|NCT02039505|541565692|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
150117284|NCT02039505|541565693|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
150190015|NCT05603143|541833407|FG001|Overall Study|Randomized but never treated|3|||
150190016|NCT05603143|541833406|FG000|Overall Study|Adverse Event|2|||
150190017|NCT05603143|541833407|FG001|Overall Study|Adverse Event|0|||
150190018|NCT05603143|541833406|FG000|Overall Study|Death|0|||
150117285|NCT02039505|541565694|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
150117286|NCT02039505|541565695|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
150117287|NCT02039505|541565696|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
150117288|NCT02039505|541565697|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
150117289|NCT02039505|541565698|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
150117290|NCT02039505|541565692|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
150117291|NCT02039505|541565693|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
150117292|NCT02039505|541565694|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
150117293|NCT02039505|541565695|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
150117294|NCT02039505|541565696|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
150117295|NCT02039505|541565697|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
150117296|NCT02039505|541565698|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
150117297|NCT02039505|541565692|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
150117298|NCT02039505|541565693|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
150117299|NCT02039505|541565694|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
150117300|NCT02039505|541565695|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
150117301|NCT02039505|541565696|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
150117302|NCT02039505|541565697|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
150117303|NCT02039505|541565698|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
150117304|NCT02039505|541565692|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117305|NCT02039505|541565693|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117306|NCT02039505|541565694|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117307|NCT02039505|541565695|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
150117308|NCT02039505|541565696|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117309|NCT02039505|541565697|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117310|NCT02039505|541565698|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
150117311|NCT02039505|541565692|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117312|NCT02039505|541565693|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117313|NCT02039505|541565694|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117314|NCT02039505|541565695|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117315|NCT02039505|541565696|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117316|NCT02039505|541565697|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
150117317|NCT02039505|541565698|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
150117318|NCT02039505|541565692|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117319|NCT02039505|541565693|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117320|NCT02039505|541565694|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117321|NCT02039505|541565695|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117322|NCT02039505|541565696|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117323|NCT02039505|541565697|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
150117324|NCT02039505|541565698|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
150117325|NCT02039505|541565692|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117326|NCT02039505|541565693|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117327|NCT02039505|541565694|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117328|NCT02039505|541565695|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117329|NCT02039505|541565696|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117330|NCT02039505|541565697|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
150117331|NCT02039505|541565698|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
150117332|NCT02039505|541565692|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117333|NCT02039505|541565693|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117334|NCT02039505|541565694|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117335|NCT02039505|541565695|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117336|NCT02039505|541565696|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117337|NCT02039505|541565697|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
150117338|NCT02039505|541565698|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
150117339|NCT01343082|541565701|FG000|The run-in Period|Not meeting criteria|3|||
150117340|NCT01343082|541565702|FG001|The run-in Period|Not meeting criteria|4|||
150117341|NCT01343082|541565703|FG002|The run-in Period|Not meeting criteria|5|||
150117342|NCT01343082|541565701|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
150117343|NCT01343082|541565702|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
150117344|NCT01343082|541565703|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
150117345|NCT01343082|541565701|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
150117346|NCT01343082|541565702|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
150190019|NCT05603143|541833407|FG001|Overall Study|Death|1|||
150190020|NCT05603143|541833406|FG000|Overall Study|Investigator's discretion|1|||
150190021|NCT05603143|541833407|FG001|Overall Study|Investigator's discretion|0|||
150190022|NCT05603143|541833406|FG000|Overall Study|Lost to Follow-up|0|||
150190023|NCT05603143|541833407|FG001|Overall Study|Lost to Follow-up|1|||
150190024|NCT05603143|541833406|FG000|Overall Study|Protocol Violation|0|||
150190025|NCT05603143|541833407|FG001|Overall Study|Protocol Violation|1|||
150190026|NCT05783102|541833408|FG000|Overall Study|Lost to Follow-up|1|||
150190027|NCT05783102|541833408|FG000|Overall Study|Withdrawal by Subject|2|||
150190028|NCT05179395|541833413|FG000|Overall Study|Lack of Efficacy|1|||
150190029|NCT00812461|541833414|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
150190030|NCT00812461|541833415|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
150190031|NCT00812461|541833414|FG000|All Treated Patients|Adverse Event|8|||
150190032|NCT00812461|541833415|FG001|All Treated Patients|Adverse Event|15|||
150190033|NCT00812461|541833414|FG000|All Treated Patients|Lack of Efficacy|13|||
150190034|NCT00812461|541833415|FG001|All Treated Patients|Lack of Efficacy|7|||
150190035|NCT00812461|541833414|FG000|All Treated Patients|Non-compliance|6|||
150190036|NCT00812461|541833415|FG001|All Treated Patients|Non-compliance|9|||
150190037|NCT00812461|541833414|FG000|All Treated Patients|Protocol Violation|36|||
150190038|NCT00812461|541833415|FG001|All Treated Patients|Protocol Violation|27|||
150190039|NCT00812461|541833414|FG000|All Treated Patients|Withdrawal by Subject|45|||
150190040|NCT00812461|541833415|FG001|All Treated Patients|Withdrawal by Subject|54|||
150190041|NCT00812461|541833414|FG000|All Treated Patients|Lost to Follow-up|11|||
150190042|NCT00812461|541833415|FG001|All Treated Patients|Lost to Follow-up|14|||
150190043|NCT00812461|541833414|FG000|All Treated Patients|Other Reason|13|||
150190044|NCT00812461|541833415|FG001|All Treated Patients|Other Reason|21|||
150190045|NCT05302596|541833416|FG000|Overall Study|Withdrawal by Subject|1|||
150190046|NCT05302596|541833417|FG001|Overall Study|Withdrawal by Subject|1|||
150190047|NCT00667251|541835415|FG000|Overall Study|Disease progression|232|||
150190048|NCT00667251|541835416|FG001|Overall Study|Disease progression|203|||
150190049|NCT00667251|541835415|FG000|Overall Study|Toxicity|44|||
150190050|NCT00667251|541835416|FG001|Overall Study|Toxicity|23|||
150190051|NCT00667251|541835415|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
150190052|NCT00667251|541835416|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
150190053|NCT00667251|541835415|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
150190054|NCT00667251|541835416|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
150190055|NCT00667251|541835415|FG000|Overall Study|Symptomatic progression|8|||
150190056|NCT00667251|541835416|FG001|Overall Study|Symptomatic progression|4|||
150190057|NCT00667251|541835415|FG000|Overall Study|Death|6|||
150190058|NCT00667251|541835416|FG001|Overall Study|Death|11|||
150190059|NCT00667251|541835415|FG000|Overall Study|Intercurrent illness|5|||
150190060|NCT00667251|541835416|FG001|Overall Study|Intercurrent illness|6|||
150190061|NCT00667251|541835415|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
150190062|NCT00667251|541835416|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
150190063|NCT00667251|541835415|FG000|Overall Study|Randomized not Treated|4|||
150190064|NCT00667251|541835416|FG001|Overall Study|Randomized not Treated|1|||
150190065|NCT02543281|541835422|FG000|Overall Study|Lost to Follow-up|0|||
150190066|NCT02543281|541835423|FG001|Overall Study|Lost to Follow-up|0|||
150190067|NCT02543281|541835424|FG002|Overall Study|Lost to Follow-up|1|||
150190068|NCT05247489|541835425|FG000|Overall Study|Lost to Follow-up|5|||
150190069|NCT05247489|541835426|FG001|Overall Study|Lost to Follow-up|1|||
150190070|NCT05247489|541835425|FG000|Overall Study|Withdrawal by Subject|6|||
150190071|NCT05247489|541835426|FG001|Overall Study|Withdrawal by Subject|7|||
150190072|NCT05247489|541835425|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
150190073|NCT05247489|541835426|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
150190074|NCT05247489|541835425|FG000|Overall Study|Left Country|1|||
150190075|NCT05247489|541835426|FG001|Overall Study|Left Country|0|||
150190076|NCT05247489|541835425|FG000|Overall Study|Noncompliance with Investigational Product|1|||
150190077|NCT05247489|541835426|FG001|Overall Study|Noncompliance with Investigational Product|0|||
150190078|NCT05247489|541835425|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
150190079|NCT05247489|541835426|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
150190080|NCT05215314|541835433|FG000|Overall Study|Lost to Follow-up|2|||
150190081|NCT05215314|541835434|FG001|Overall Study|Lost to Follow-up|2|||
150190082|NCT05215314|541835433|FG000|Overall Study|Withdrawal by Subject|2|||
150190083|NCT05215314|541835434|FG001|Overall Study|Withdrawal by Subject|0|||
150190084|NCT05215314|541835433|FG000|Overall Study|Physician Decision|1|||
150190085|NCT05215314|541835434|FG001|Overall Study|Physician Decision|0|||
150190086|NCT04179500|541835435|FG000|Treatment|Withdrawal by Subject|1|||
150190087|NCT04179500|541835435|FG000|Treatment|Adverse Event|2|||
150117347|NCT01343082|541565703|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
150117348|NCT01343082|541565701|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
150117349|NCT01343082|541565702|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
150117350|NCT01343082|541565703|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
150117351|NCT01343082|541565701|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
150117352|NCT01343082|541565702|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
150117353|NCT01343082|541565703|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
150190088|NCT04179500|541835435|FG000|Treatment|pyrazinamide resistance|1|||
150190089|NCT03366649|541835440|FG000|Overall Study|Failed preoperative screening|4|||
150190090|NCT03366649|541835441|FG001|Overall Study|Failed preoperative screening|0|||
150190091|NCT03366649|541835442|FG002|Overall Study|Failed preoperative screening|0|||
150190092|NCT03366649|541835440|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
150190093|NCT03366649|541835441|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
150190094|NCT03366649|541835442|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
150190095|NCT03673111|541835443|FG000|Overall Study|Protocol Violation|0|||
150190096|NCT03673111|541835444|FG001|Overall Study|Protocol Violation|0|||
150190097|NCT03673111|541835445|FG002|Overall Study|Protocol Violation|0|||
150190098|NCT03673111|541835446|FG003|Overall Study|Protocol Violation|0|||
150190099|NCT03673111|541835447|FG004|Overall Study|Protocol Violation|0|||
150190100|NCT03673111|541835448|FG005|Overall Study|Protocol Violation|0|||
150190101|NCT03673111|541835449|FG006|Overall Study|Protocol Violation|0|||
150190102|NCT03673111|541835450|FG007|Overall Study|Protocol Violation|0|||
150190103|NCT03673111|541835451|FG008|Overall Study|Protocol Violation|0|||
150190104|NCT03673111|541835452|FG009|Overall Study|Protocol Violation|0|||
150190105|NCT03673111|541835453|FG010|Overall Study|Protocol Violation|1|||
150190106|NCT03673111|541835454|FG011|Overall Study|Protocol Violation|0|||
150190107|NCT03673111|541835455|FG012|Overall Study|Protocol Violation|0|||
150190108|NCT03673111|541835456|FG013|Overall Study|Protocol Violation|0|||
150190109|NCT03673111|541835443|FG000|Overall Study|Adverse Event|1|||
150190110|NCT03673111|541835444|FG001|Overall Study|Adverse Event|0|||
150190111|NCT03673111|541835445|FG002|Overall Study|Adverse Event|0|||
150190112|NCT03673111|541835446|FG003|Overall Study|Adverse Event|0|||
150190113|NCT03673111|541835447|FG004|Overall Study|Adverse Event|0|||
150190114|NCT03673111|541835448|FG005|Overall Study|Adverse Event|0|||
150190115|NCT03673111|541835449|FG006|Overall Study|Adverse Event|0|||
150190116|NCT03673111|541835450|FG007|Overall Study|Adverse Event|0|||
150190117|NCT03673111|541835451|FG008|Overall Study|Adverse Event|0|||
150190118|NCT03673111|541835452|FG009|Overall Study|Adverse Event|0|||
150190119|NCT03673111|541835453|FG010|Overall Study|Adverse Event|0|||
150190120|NCT03673111|541835454|FG011|Overall Study|Adverse Event|0|||
150190121|NCT03673111|541835455|FG012|Overall Study|Adverse Event|0|||
150190122|NCT03673111|541835456|FG013|Overall Study|Adverse Event|0|||
150190123|NCT03792555|541835457|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
150190124|NCT03792555|541835458|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
150190125|NCT03792555|541835459|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
150190126|NCT03792555|541835457|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
150190127|NCT03792555|541835458|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
150190128|NCT03792555|541835459|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
150190129|NCT03792555|541835457|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
150190130|NCT03792555|541835458|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
150190131|NCT03792555|541835459|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
150190132|NCT04485039|541835460|FG000|TPOXX Only|Adverse Event|2|||
150190133|NCT04485039|541835460|FG000|TPOXX Only|Physician Decision|1|||
150190134|NCT04485039|541835460|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
150190135|NCT04485039|541835460|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
150190136|NCT01744782|541835461|FG000|Overall Study|Death|1|||
150190137|NCT02120456|541835463|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190138|NCT02120456|541835464|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190139|NCT02120456|541835465|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190140|NCT02120456|541835466|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190141|NCT02120456|541835467|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190142|NCT02120456|541835468|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190143|NCT02120456|541835469|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
150190144|NCT02120456|541835470|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190145|NCT02120456|541835471|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
150190146|NCT02120456|541835463|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190147|NCT02120456|541835464|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190148|NCT02120456|541835465|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190149|NCT02120456|541835466|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190150|NCT02120456|541835467|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190151|NCT02120456|541835468|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190152|NCT02120456|541835469|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
150190153|NCT02120456|541835470|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190154|NCT02120456|541835471|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
150190155|NCT02120456|541835463|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190156|NCT02120456|541835464|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190157|NCT02120456|541835465|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190158|NCT02120456|541835466|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150117354|NCT04265755|541565704|FG000|Overall Study|Withdrawal by Subject|39|||
150117355|NCT04265755|541565704|FG000|Overall Study|Decision by sponsor|2|||
150117356|NCT04265755|541565704|FG000|Overall Study|Lost to Follow-up|11|||
150117357|NCT04265755|541565704|FG000|Overall Study|Death|1|||
150117358|NCT03614793|541565708|FG000|Overall Study|Lost to Follow-up|1|||
150117359|NCT03614793|541565709|FG001|Overall Study|Lost to Follow-up|2|||
150117360|NCT03614793|541565708|FG000|Overall Study|Lack of Efficacy|0|||
150117361|NCT03614793|541565709|FG001|Overall Study|Lack of Efficacy|5|||
150117362|NCT03614793|541565708|FG000|Overall Study|Withdrawal by Subject|0|||
150117363|NCT03614793|541565709|FG001|Overall Study|Withdrawal by Subject|1|||
150117364|NCT03614793|541565708|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
150117365|NCT03614793|541565709|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
150117366|NCT02082522|541565710|FG000|Overall Study|Sponsor termination|5|||
150117367|NCT02082522|541565711|FG001|Overall Study|Sponsor termination|3|||
150117368|NCT02082522|541565710|FG000|Overall Study|Withdrawal by Subject|2|||
150117369|NCT02082522|541565711|FG001|Overall Study|Withdrawal by Subject|4|||
150117370|NCT02082522|541565710|FG000|Overall Study|Death|1|||
150117371|NCT02082522|541565711|FG001|Overall Study|Death|0|||
150117372|NCT02082522|541565710|FG000|Overall Study|Lost to Follow-up|1|||
150117373|NCT02082522|541565711|FG001|Overall Study|Lost to Follow-up|0|||
150117374|NCT02082522|541565710|FG000|Overall Study|Physician Decision|3|||
150117375|NCT02082522|541565711|FG001|Overall Study|Physician Decision|1|||
150117376|NCT02082522|541565710|FG000|Overall Study|Disease progression|2|||
150117377|NCT02082522|541565711|FG001|Overall Study|Disease progression|2|||
150117378|NCT02082522|541565710|FG000|Overall Study|Chemotherapy change|1|||
150117379|NCT02082522|541565711|FG001|Overall Study|Chemotherapy change|3|||
150117380|NCT01863446|541565712|FG000|Overall Study|Withdrawal by Subject|1|||
150117381|NCT01863446|541565713|FG001|Overall Study|Withdrawal by Subject|0|||
150117382|NCT01863446|541565714|FG002|Overall Study|Withdrawal by Subject|1|||
150117383|NCT01863446|541565715|FG003|Overall Study|Withdrawal by Subject|2|||
150117384|NCT01863446|541565712|FG000|Overall Study|Physician Decision|0|||
150117385|NCT01863446|541565713|FG001|Overall Study|Physician Decision|0|||
150117386|NCT01863446|541565714|FG002|Overall Study|Physician Decision|1|||
150117387|NCT01863446|541565715|FG003|Overall Study|Physician Decision|0|||
150117388|NCT00633984|541565716|FG000|Overall Study|Lost to Follow-up|0|||
150117389|NCT00633984|541565717|FG001|Overall Study|Lost to Follow-up|6|||
150117390|NCT00633984|541565716|FG000|Overall Study|Withdrawal by Subject|8|||
150117391|NCT00633984|541565717|FG001|Overall Study|Withdrawal by Subject|7|||
150117392|NCT00633984|541565716|FG000|Overall Study|Hospitalized|1|||
150117393|NCT00633984|541565717|FG001|Overall Study|Hospitalized|0|||
150117394|NCT02554773|541565718|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
150117395|NCT02554773|541565719|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
150117396|NCT02554773|541565718|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
150117397|NCT02554773|541565719|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
150117398|NCT02554773|541565718|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
150117399|NCT02554773|541565719|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
150117400|NCT02554773|541565718|FG000|Original Dose Regimen (SAS 1)|Death|1|||
150117401|NCT02554773|541565719|FG001|Original Dose Regimen (SAS 1)|Death|0|||
150117402|NCT02554773|541565718|FG000|Original Dose Regimen (SAS 1)|Other|4|||
150117403|NCT02554773|541565719|FG001|Original Dose Regimen (SAS 1)|Other|0|||
150117404|NCT02554773|541565718|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
150117405|NCT02554773|541565719|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
150117406|NCT02554773|541565718|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
150117407|NCT02554773|541565719|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
150117408|NCT02554773|541565718|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
150117409|NCT02554773|541565719|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
150117410|NCT02554773|541565718|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
150117411|NCT02554773|541565719|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
150117412|NCT02496884|541565720|FG000|Overall Study|Counted twice as enrolled|2|||
150117413|NCT02496884|541565721|FG001|Overall Study|Counted twice as enrolled|0|||
150117414|NCT02496884|541565722|FG002|Overall Study|Counted twice as enrolled|0|||
150117415|NCT02496884|541565723|FG003|Overall Study|Counted twice as enrolled|0|||
150117416|NCT02496884|541565720|FG000|Overall Study|Withdrawal by Subject|0|||
150117417|NCT02496884|541565721|FG001|Overall Study|Withdrawal by Subject|3|||
150117418|NCT02496884|541565722|FG002|Overall Study|Withdrawal by Subject|0|||
150117419|NCT02496884|541565723|FG003|Overall Study|Withdrawal by Subject|0|||
150117420|NCT00097591|541565724|FG000|Overall Study|Withdrawal of consent|342|||
150117421|NCT00097591|541565725|FG001|Overall Study|Withdrawal of consent|323|||
150117422|NCT00097591|541565724|FG000|Overall Study|Less than 6 months on study drug|9|||
150190159|NCT02120456|541835467|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150117423|NCT00097591|541565725|FG001|Overall Study|Less than 6 months on study drug|7|||
150117424|NCT00097591|541565724|FG000|Overall Study|Unable to attend termination visit|53|||
150117425|NCT00097591|541565725|FG001|Overall Study|Unable to attend termination visit|51|||
150117426|NCT00097591|541565724|FG000|Overall Study|Lost to follow up|6|||
150117427|NCT00097591|541565725|FG001|Overall Study|Lost to follow up|10|||
150117428|NCT00097591|541565724|FG000|Overall Study|Other|0|||
150117429|NCT00097591|541565725|FG001|Overall Study|Other|3|||
150117430|NCT01168999|541565730|FG000|Overall Study|Lost to Follow-up|2|||
150117431|NCT01168999|541565731|FG001|Overall Study|Lost to Follow-up|1|||
150117432|NCT01168999|541565732|FG002|Overall Study|Lost to Follow-up|0|||
150117433|NCT01168999|541565733|FG003|Overall Study|Lost to Follow-up|0|||
150117434|NCT04317586|541565734|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
150117435|NCT04317586|541565734|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
150117436|NCT01276327|541565737|FG000|Overall Study|Adverse Event|1|||
150117437|NCT01276327|541565738|FG001|Overall Study|Adverse Event|3|||
150117438|NCT01276327|541565737|FG000|Overall Study|Withdrawal by Subject|1|||
150117439|NCT01276327|541565738|FG001|Overall Study|Withdrawal by Subject|0|||
150117440|NCT00807092|541565739|FG000|Overall Study|Adverse Event|0|||
150117441|NCT00807092|541565740|FG001|Overall Study|Adverse Event|1|||
150117442|NCT00807092|541565739|FG000|Overall Study|Protocol Violation|0|||
150117443|NCT00807092|541565740|FG001|Overall Study|Protocol Violation|2|||
150117444|NCT00807092|541565739|FG000|Overall Study|Withdrawal by Subject|1|||
150117445|NCT00807092|541565740|FG001|Overall Study|Withdrawal by Subject|0|||
150117446|NCT00807092|541565739|FG000|Overall Study|CGMS data collection failed|0|||
150117447|NCT00807092|541565740|FG001|Overall Study|CGMS data collection failed|1|||
150117448|NCT01794949|541565741|FG000|Overall Study|Lost to Follow-up|1|||
150117449|NCT01794949|541565742|FG001|Overall Study|Lost to Follow-up|0|||
150117450|NCT03766646|541565743|FG000|Overall Study|Withdrawal by Subject|1|||
150117451|NCT03766646|541565744|FG001|Overall Study|Withdrawal by Subject|0|||
150117452|NCT03766646|541565743|FG000|Overall Study|Protocol Violation|0|||
150117453|NCT03766646|541565744|FG001|Overall Study|Protocol Violation|3|||
150117454|NCT04479618|541565752|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
150117455|NCT04479618|541565753|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
150117456|NCT04479618|541565754|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
150117457|NCT04479618|541565752|FG000|Overall Study|Lack of Efficacy|1|||
150117458|NCT04479618|541565753|FG001|Overall Study|Lack of Efficacy|0|||
150117459|NCT04479618|541565754|FG002|Overall Study|Lack of Efficacy|0|||
150117460|NCT04479618|541565752|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
150117461|NCT04479618|541565753|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
150117462|NCT04479618|541565754|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
150117463|NCT04479618|541565752|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
150117464|NCT04479618|541565753|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
150117465|NCT04479618|541565754|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
150117466|NCT04479618|541565752|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
150117467|NCT04479618|541565753|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
150117468|NCT04479618|541565754|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
150117469|NCT04479618|541565752|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
150117470|NCT04479618|541565753|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
150117471|NCT04479618|541565754|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
150117472|NCT01260922|541565758|FG000|First Intervention|Withdrawal by Subject|0|||
150117473|NCT01260922|541565759|FG001|First Intervention|Withdrawal by Subject|1|||
150117474|NCT01260922|541565758|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
150117475|NCT01260922|541565759|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
150117476|NCT01260922|541565758|FG000|Second Intervention|Emesis|0|||
150117477|NCT01260922|541565759|FG001|Second Intervention|Emesis|2|||
150117478|NCT03653429|541565764|FG000|Overall Study|Physician Decision|4|||
150117479|NCT03653429|541565765|FG001|Overall Study|Physician Decision|10|||
150117480|NCT01700946|541565766|FG000|Overall Study|Lost to Follow-up|1|||
150117481|NCT01700946|541565767|FG001|Overall Study|Lost to Follow-up|0|||
150117482|NCT01700946|541565766|FG000|Overall Study|Physician Decision|7|||
150117483|NCT01700946|541565767|FG001|Overall Study|Physician Decision|12|||
150117484|NCT01700946|541565766|FG000|Overall Study|Withdrawal by Subject|0|||
150117485|NCT01700946|541565767|FG001|Overall Study|Withdrawal by Subject|2|||
150117486|NCT01700946|541565766|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
150117487|NCT01700946|541565767|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
150117488|NCT01700946|541565766|FG000|Overall Study|Relapse|2|||
150117489|NCT01700946|541565767|FG001|Overall Study|Relapse|1|||
150117490|NCT01700946|541565766|FG000|Overall Study|Unacceptable toxicity|1|||
150117491|NCT01700946|541565767|FG001|Overall Study|Unacceptable toxicity|0|||
150117492|NCT02480621|541565770|FG000|Randomization|Withdrawal by Subject|1|||
150117493|NCT02480621|541565771|FG001|Randomization|Withdrawal by Subject|0|||
150117494|NCT02480621|541565770|FG000|Randomization|Surgeon did not give intervention|0|||
150117495|NCT02480621|541565771|FG001|Randomization|Surgeon did not give intervention|1|||
150117496|NCT02480621|541565770|FG000|Follow Up|Lost to Follow-up|4|||
150117497|NCT02480621|541565771|FG001|Follow Up|Lost to Follow-up|2|||
150117498|NCT02617589|541565772|FG000|Randomization|Request to Discontinue Study Treatment|1|||
150117499|NCT02617589|541565773|FG001|Randomization|Request to Discontinue Study Treatment|3|||
150117500|NCT02617589|541565772|FG000|Randomization|Participant Withdrew Consent|1|||
150117501|NCT02617589|541565773|FG001|Randomization|Participant Withdrew Consent|2|||
150117502|NCT02617589|541565772|FG000|Treatment|Other Reasons|3|||
150117503|NCT02617589|541565773|FG001|Treatment|Other Reasons|3|||
150117504|NCT02617589|541565772|FG000|Treatment|Poor/Non Compliance|1|||
150117505|NCT02617589|541565773|FG001|Treatment|Poor/Non Compliance|1|||
150117506|NCT02617589|541565772|FG000|Treatment|Maximum Clinical Benefit|0|||
150117507|NCT02617589|541565773|FG001|Treatment|Maximum Clinical Benefit|2|||
150117508|NCT02617589|541565772|FG000|Treatment|Participant Withdrew Consent|2|||
150117509|NCT02617589|541565773|FG001|Treatment|Participant Withdrew Consent|6|||
150117510|NCT02617589|541565772|FG000|Treatment|Participant Request to Discontinue|12|||
150117511|NCT02617589|541565773|FG001|Treatment|Participant Request to Discontinue|21|||
150117512|NCT02617589|541565772|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
150117513|NCT02617589|541565773|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
150117514|NCT02617589|541565772|FG000|Treatment|Death|1|||
150117515|NCT02617589|541565773|FG001|Treatment|Death|1|||
150117516|NCT02617589|541565772|FG000|Treatment|Study Drug Toxicity|27|||
150117517|NCT02617589|541565773|FG001|Treatment|Study Drug Toxicity|20|||
150117518|NCT02617589|541565772|FG000|Treatment|Disease Progression|216|||
150117519|NCT02617589|541565773|FG001|Treatment|Disease Progression|136|||
150117520|NCT01975389|541565774|FG000|Overall Study|Adverse Event|10|||
150117521|NCT01975389|541565775|FG001|Overall Study|Adverse Event|6|||
150117522|NCT01975389|541565774|FG000|Overall Study|Death|61|||
150117523|NCT01975389|541565775|FG001|Overall Study|Death|54|||
150117524|NCT01975389|541565774|FG000|Overall Study|Lost to Follow-up|81|||
150117525|NCT01975389|541565775|FG001|Overall Study|Lost to Follow-up|86|||
150117526|NCT01975389|541565774|FG000|Overall Study|Withdrawal by Subject|90|||
150117527|NCT01975389|541565775|FG001|Overall Study|Withdrawal by Subject|76|||
150117528|NCT01975389|541565774|FG000|Overall Study|Other|6|||
150117529|NCT01975389|541565775|FG001|Overall Study|Other|9|||
150117530|NCT01975389|541565774|FG000|Overall Study|Randomized, not treated|4|||
150117531|NCT01975389|541565775|FG001|Overall Study|Randomized, not treated|5|||
150117532|NCT01334866|541565782|FG000|Overall Study|Withdrawal by Subject|10|||
150117533|NCT01334866|541565782|FG000|Overall Study|Lost to Follow-up|3|||
150117534|NCT01334866|541565782|FG000|Overall Study|Physician Decision|3|||
150117535|NCT01334866|541565782|FG000|Overall Study|medically necessary prior to procedure|2|||
150117536|NCT01334866|541565782|FG000|Overall Study|medically necessary post-procedure|1|||
150117537|NCT02296112|541565785|FG000|Overall Study|Disease progression|7|||
150117538|NCT02296112|541565785|FG000|Overall Study|Toxicity|1|||
150117539|NCT02296112|541565785|FG000|Overall Study|Began an alternate therapy|1|||
150117540|NCT02052466|541565786|FG000|Overall Study|Withdrawal by Subject|1|||
150117541|NCT02052466|541565786|FG000|Overall Study|Acromial fracture|1|||
150117542|NCT00508742|541565787|FG000|Period 1: Infant Series|Adverse Event|5|||
150117543|NCT00508742|541565788|FG001|Period 1: Infant Series|Adverse Event|4|||
150117544|NCT00508742|541565787|FG000|Period 1: Infant Series|Protocol Violation|1|||
150117545|NCT00508742|541565788|FG001|Period 1: Infant Series|Protocol Violation|0|||
150117546|NCT00508742|541565787|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
150117547|NCT00508742|541565788|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
150117548|NCT00508742|541565787|FG000|Period 1: Infant Series|Physician Decision|1|||
150117549|NCT00508742|541565788|FG001|Period 1: Infant Series|Physician Decision|0|||
150117550|NCT00508742|541565787|FG000|Period 1: Infant Series|Other|4|||
150117551|NCT00508742|541565788|FG001|Period 1: Infant Series|Other|1|||
150117552|NCT00508742|541565787|FG000|Period 2: After Infant Series|Adverse Event|2|||
150117553|NCT00508742|541565788|FG001|Period 2: After Infant Series|Adverse Event|6|||
150117554|NCT00508742|541565787|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
150117555|NCT00508742|541565788|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
150117556|NCT00508742|541565787|FG000|Period 2: After Infant Series|Protocol Violation|1|||
150117557|NCT00508742|541565788|FG001|Period 2: After Infant Series|Protocol Violation|0|||
150117558|NCT00508742|541565787|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
150117559|NCT00508742|541565788|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
150117560|NCT00508742|541565787|FG000|Period 2: After Infant Series|Failed to Return|1|||
150117561|NCT00508742|541565788|FG001|Period 2: After Infant Series|Failed to Return|0|||
150117562|NCT00508742|541565787|FG000|Period 2: After Infant Series|Other|2|||
150117563|NCT00508742|541565788|FG001|Period 2: After Infant Series|Other|1|||
150117564|NCT00508742|541565787|FG000|Period 3: Toddler Dose|Adverse Event|1|||
150117565|NCT00508742|541565788|FG001|Period 3: Toddler Dose|Adverse Event|0|||
150117566|NCT00508742|541565787|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
150117567|NCT00508742|541565788|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
150117568|NCT00508742|541565787|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
150117569|NCT00508742|541565788|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
150117570|NCT00508742|541565787|FG000|Period 3: Toddler Dose|Other|5|||
150117571|NCT00508742|541565788|FG001|Period 3: Toddler Dose|Other|4|||
150117572|NCT03246529|541565794|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
150117573|NCT03246529|541565795|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
150117574|NCT03246529|541565796|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
150117575|NCT03246529|541565794|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
150117576|NCT03246529|541565795|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
150117577|NCT03246529|541565796|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
150117578|NCT03246529|541565794|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
150117579|NCT03246529|541565795|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
150117580|NCT03246529|541565796|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
150117581|NCT03246529|541565794|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
150117582|NCT03246529|541565795|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
150117583|NCT03246529|541565796|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
150117584|NCT03246529|541565794|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
150117585|NCT03246529|541565795|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
150117586|NCT03246529|541565796|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
150117587|NCT03246529|541565794|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
150117588|NCT03246529|541565795|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
150117589|NCT03246529|541565796|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
150117590|NCT03246529|541565794|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
150117591|NCT03246529|541565795|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
150117592|NCT03246529|541565796|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
150117593|NCT03246529|541565794|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
150117594|NCT03246529|541565795|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
150117595|NCT03246529|541565796|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
150117596|NCT03246529|541565794|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
150117597|NCT03246529|541565795|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
150117598|NCT03246529|541565796|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
150117599|NCT03136068|541567677|FG000|Overall Study|Lost to Follow-up|1|||
150117600|NCT03136068|541567678|FG001|Overall Study|Lost to Follow-up|1|||
150117601|NCT03136068|541567677|FG000|Overall Study|Protocol Violation|1|||
150117602|NCT03136068|541567678|FG001|Overall Study|Protocol Violation|0|||
150117603|NCT01071395|541567679|FG000|Overall Study|Withdrawal by Subject|2|||
150117604|NCT01071395|541567680|FG001|Overall Study|Withdrawal by Subject|1|||
150117605|NCT01071395|541567679|FG000|Overall Study|Adverse Event|3|||
150117606|NCT01071395|541567680|FG001|Overall Study|Adverse Event|1|||
150117607|NCT01337089|541567683|FG000|Overall Study|Adverse Event|237|||
150117608|NCT01337089|541567683|FG000|Overall Study|Withdrawal by Subject|129|||
150117609|NCT01337089|541567683|FG000|Overall Study|Withdrawal by Investigator|33|||
150117610|NCT01337089|541567683|FG000|Overall Study|Met Withdrawal Criteria|3|||
150117611|NCT01337089|541567683|FG000|Overall Study|Lost to Follow-up|2|||
150117612|NCT04419493|541567684|FG000|Wash-out After Period 1|Adverse Event|1|||
150117613|NCT04419493|541567685|FG001|Wash-out After Period 1|Adverse Event|2|||
150117614|NCT04419493|541567686|FG002|Wash-out After Period 1|Adverse Event|1|||
150117615|NCT04419493|541567687|FG003|Wash-out After Period 1|Adverse Event|0|||
150117616|NCT01040871|541567688|FG000|Overall Study|Adverse Event|6|||
150117617|NCT01040871|541567689|FG001|Overall Study|Adverse Event|2|||
150117618|NCT01040871|541567688|FG000|Overall Study|Withdrawal by Subject|2|||
150117619|NCT01040871|541567689|FG001|Overall Study|Withdrawal by Subject|0|||
150117620|NCT01040871|541567688|FG000|Overall Study|Death|1|||
150117621|NCT01040871|541567689|FG001|Overall Study|Death|3|||
150117622|NCT01040871|541567688|FG000|Overall Study|Lack of Efficacy|1|||
150117623|NCT01040871|541567689|FG001|Overall Study|Lack of Efficacy|1|||
150117624|NCT01040871|541567688|FG000|Overall Study|drug supply issue|1|||
150117625|NCT01040871|541567689|FG001|Overall Study|drug supply issue|0|||
150117626|NCT01040871|541567688|FG000|Overall Study|Randomized and Not Treated|2|||
150117627|NCT01040871|541567689|FG001|Overall Study|Randomized and Not Treated|1|||
150117628|NCT02044510|541567692|FG000|Overall Study|Adverse Event|1|||
150117629|NCT02044510|541567693|FG001|Overall Study|Adverse Event|2|||
150117630|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
150117631|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
150117632|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
150117633|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150117634|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150117635|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150117636|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150117637|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150190160|NCT02120456|541835468|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190161|NCT02120456|541835469|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190162|NCT02120456|541835470|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
150190163|NCT02120456|541835471|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
150190164|NCT05192200|541835472|FG000|Treatment Period|Other|1|||
150190165|NCT05192200|541835472|FG000|Treatment Period|Lack of Efficacy|1|||
150190166|NCT05192200|541835472|FG000|Treatment Period|Withdrawal by Subject|1|||
150190167|NCT05192200|541835472|FG000|Follow-up|Withdrawal by Subject|1|||
150190168|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Physician Decision|1|||
150190169|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Physician Decision|0|||
150190170|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
150190171|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
150190172|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
150190173|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
150190174|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Pregnancy|0|||
150190175|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Pregnancy|2|||
150190176|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
150190177|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
150190178|NCT01785719|541835473|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
150190179|NCT01785719|541835474|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
150190180|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
150190181|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
150190182|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
150190183|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
150190184|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
150190185|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
150190186|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
150190187|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
150190188|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
150190189|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
150190190|NCT01785719|541835473|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
150190191|NCT01785719|541835474|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
150190192|NCT01785719|541835473|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
150117638|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
150117639|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
150117640|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
150117641|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
150117642|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117643|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117644|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117645|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117646|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117647|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
150117648|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117649|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
150117650|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
150117651|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117652|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117653|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117654|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117655|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117656|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
150117657|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
150117658|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
150117659|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
150117660|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150117661|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150117662|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150190193|NCT01785719|541835474|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
150190194|NCT01785719|541835473|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
150190195|NCT01785719|541835474|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
150190196|NCT01785719|541835473|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
150190197|NCT01785719|541835474|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
150190198|NCT03443323|541835475|FG000|Overall Study|Lost to Follow-up|2|||
150190199|NCT03443323|541835476|FG001|Overall Study|Lost to Follow-up|2|||
150190200|NCT03443323|541835475|FG000|Overall Study|PI withdrawal|1|||
150117663|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150117664|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150117665|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
150117666|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117667|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
150117668|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117669|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117670|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117671|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117672|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117673|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117674|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
150117675|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
150117676|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117677|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117678|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117679|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117680|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117681|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117682|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117683|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150117684|NCT01172938|541567695|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117685|NCT01172938|541567696|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
150117686|NCT01172938|541567697|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
150117687|NCT01172938|541567698|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117688|NCT01172938|541567699|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117689|NCT01172938|541567700|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117690|NCT01172938|541567701|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117691|NCT01172938|541567702|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117692|NCT01172938|541567703|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
150117693|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
150117694|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
150117695|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
150117696|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
150117697|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
150117698|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
150117699|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
150117700|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
150117701|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
150117702|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
150117703|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
150117704|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
150117705|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
150117706|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
150117707|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
150117708|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
150117709|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
150117710|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
150117711|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117712|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117713|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
150117714|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117715|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117716|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117717|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117718|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117719|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
150117720|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
150117721|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
150117722|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
150190201|NCT03443323|541835476|FG001|Overall Study|PI withdrawal|0|||
150190202|NCT04492007|541835477|FG000|Overall Study|Lost to Follow-up|1|||
150190203|NCT04492007|541835478|FG001|Overall Study|Lost to Follow-up|1|||
150190204|NCT04492007|541835479|FG002|Overall Study|Lost to Follow-up|2|||
150117723|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
150117724|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
150117725|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
150117726|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
150117727|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
150117728|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
150117729|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117730|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
150117731|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
150117732|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
150117733|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117734|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117735|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117736|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117737|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
150117738|NCT01172938|541567695|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117739|NCT01172938|541567696|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117740|NCT01172938|541567697|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117741|NCT01172938|541567698|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117742|NCT01172938|541567699|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117743|NCT01172938|541567700|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
150117744|NCT01172938|541567701|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
150117745|NCT01172938|541567702|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117746|NCT01172938|541567703|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
150117747|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
150117748|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
150117749|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
150117750|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
150117751|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
150117752|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
150117753|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
150117754|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
150117755|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
150117756|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117757|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
150117758|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
150117759|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117760|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117761|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117762|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117763|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
150117764|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
150117765|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117766|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117767|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
150117768|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117769|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117770|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117771|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117772|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117773|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
150117774|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
150117775|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
150117776|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
150117777|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
150117778|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
150117779|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
150117780|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
150117781|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
150117782|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
150117783|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150190205|NCT04492007|541835480|FG003|Overall Study|Lost to Follow-up|2|||
150190206|NCT04492007|541835477|FG000|Overall Study|Protocol Violation|1|||
150190207|NCT04492007|541835478|FG001|Overall Study|Protocol Violation|1|||
150190208|NCT04492007|541835479|FG002|Overall Study|Protocol Violation|1|||
150190209|NCT04492007|541835480|FG003|Overall Study|Protocol Violation|1|||
150190210|NCT04492007|541835477|FG000|Overall Study|Withdrawal by Subject|0|||
150190211|NCT04492007|541835478|FG001|Overall Study|Withdrawal by Subject|0|||
150190212|NCT04492007|541835479|FG002|Overall Study|Withdrawal by Subject|1|||
150190213|NCT04492007|541835480|FG003|Overall Study|Withdrawal by Subject|1|||
150190214|NCT04887129|541835483|FG000|Overall Study|Lost to Follow-up|0|||
150190215|NCT04887129|541835484|FG001|Overall Study|Lost to Follow-up|24|||
150190216|NCT04887129|541835483|FG000|Overall Study|Withdrawal by Subject|9|||
150190217|NCT04887129|541835484|FG001|Overall Study|Withdrawal by Subject|57|||
150190218|NCT04887129|541835483|FG000|Overall Study|Other|2|||
150190219|NCT04887129|541835484|FG001|Overall Study|Other|9|||
150190220|NCT04896476|541835486|FG000|Overall Study|Withdrawal by Subject|1|||
150190221|NCT04896476|541835486|FG000|Overall Study|Lost to Follow-up|2|||
150190222|NCT03476187|541835487|FG000|Overall Study|Protocol Violation|7|||
150190223|NCT03476187|541835487|FG000|Overall Study|Physician Decision|5|||
150190224|NCT05948670|541835489|FG000|Overall Study|Protocol Violation|6|||
150190225|NCT05948670|541835490|FG001|Overall Study|Protocol Violation|8|||
150190226|NCT05948670|541835489|FG000|Overall Study|Withdrawal by Subject|0|||
150190227|NCT05948670|541835490|FG001|Overall Study|Withdrawal by Subject|1|||
150190228|NCT02724631|541835505|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
150190229|NCT05076708|541835506|FG000|Overall Study|Withdrawal by Subject|4|||
150190230|NCT05076708|541835506|FG000|Overall Study|Lost to study during switch phase|8|||
150190231|NCT04971395|541835507|FG000|Overall Study|Withdrawal by Subject|0|||
150190232|NCT04971395|541835508|FG001|Overall Study|Withdrawal by Subject|1|||
150190233|NCT04971395|541835509|FG002|Overall Study|Withdrawal by Subject|0|||
150190234|NCT05051124|541835515|FG000|Overall Study|Lost to Follow-up|2|||
150190235|NCT05051124|541835515|FG000|Overall Study|Withdrawal by Subject|1|||
150190236|NCT05051124|541835515|FG000|Overall Study|Residential relocation|2|||
150190237|NCT05051124|541835515|FG000|Overall Study|Death|1|||
150190238|NCT06205407|541835520|FG000|Period 2|Withdrawal by Subject|0|||
150190239|NCT06205407|541835521|FG001|Period 2|Withdrawal by Subject|1|||
150190240|NCT06205407|541835520|FG000|Period 2|Adverse Event|2|||
150190241|NCT06205407|541835521|FG001|Period 2|Adverse Event|1|||
150190242|NCT02936752|541835522|FG000|Overall Study|Death|2|||
150190243|NCT02936752|541835523|FG001|Overall Study|Death|1|||
150190244|NCT02936752|541835522|FG000|Overall Study|Physician Decision|4|||
150190245|NCT02936752|541835523|FG001|Overall Study|Physician Decision|0|||
150190246|NCT02936752|541835522|FG000|Overall Study|Withdrawal by Subject|0|||
150190247|NCT02936752|541835523|FG001|Overall Study|Withdrawal by Subject|2|||
150190248|NCT05894577|541835524|FG000|Overall Study|No receipt of study drug|14|||
150190249|NCT05894577|541835525|FG001|Overall Study|No receipt of study drug|13|||
150190250|NCT05894577|541835524|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
150190251|NCT05894577|541835525|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
150117784|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117785|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
150117786|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117787|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117788|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117789|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117790|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117791|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
150117792|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150117793|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
150117794|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
150117795|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150117796|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150190252|NCT05894577|541835524|FG000|Overall Study|Screen Fail|2|||
150190253|NCT05894577|541835525|FG001|Overall Study|Screen Fail|0|||
150190254|NCT05894577|541835524|FG000|Overall Study|Study drug recall|86|||
150190255|NCT05894577|541835525|FG001|Overall Study|Study drug recall|63|||
150190256|NCT03197662|541835533|FG000|Overall Study|Withdrawn by family|0|||
150190257|NCT03197662|541835534|FG001|Overall Study|Withdrawn by family|2|||
150190258|NCT05292365|541835535|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
150190259|NCT05292365|541835536|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
150190260|NCT05292365|541835537|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
150190261|NCT05292365|541835538|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
150190262|NCT04495894|541835545|FG000|Overall Study|Withdrawal by Subject|2|||
150190263|NCT04495894|541835546|FG001|Overall Study|Withdrawal by Subject|0|||
150190264|NCT04495894|541835547|FG002|Overall Study|Withdrawal by Subject|2|||
150190265|NCT04495894|541835548|FG003|Overall Study|Withdrawal by Subject|3|||
150190266|NCT04495894|541835545|FG000|Overall Study|Early termination|0|||
150190267|NCT04495894|541835546|FG001|Overall Study|Early termination|0|||
150190268|NCT04495894|541835547|FG002|Overall Study|Early termination|3|||
150190269|NCT04495894|541835548|FG003|Overall Study|Early termination|0|||
150190270|NCT03364647|541835549|FG000|Overall Study|Withdrawal by Subject|3|||
150190271|NCT03364647|541835550|FG001|Overall Study|Withdrawal by Subject|1|||
150190272|NCT01000961|541835551|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
150190273|NCT01000961|541835552|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
150190274|NCT01000961|541835551|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
150190275|NCT01000961|541835552|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
150190276|NCT05746455|541835555|FG000|Overall Study|Discharged from Clinical Service|1|||
150190277|NCT05746455|541835555|FG000|Overall Study|Lost to Follow-up|1|||
150190278|NCT03307343|541835556|FG000|Overall Study|Withdrawal by Subject|1|||
150190279|NCT03307343|541835557|FG001|Overall Study|Withdrawal by Subject|2|||
150190280|NCT03307343|541835556|FG000|Overall Study|Pregnancy|0|||
150190281|NCT03307343|541835557|FG001|Overall Study|Pregnancy|2|||
150190282|NCT03307343|541835556|FG000|Overall Study|Physician Decision|1|||
150190283|NCT03307343|541835557|FG001|Overall Study|Physician Decision|0|||
150190284|NCT03307343|541835556|FG000|Overall Study|Lost to Follow-up|0|||
150190285|NCT03307343|541835557|FG001|Overall Study|Lost to Follow-up|2|||
150190286|NCT03447470|541835559|FG000|Overall Study|Death|0|||
150190287|NCT03447470|541835560|FG001|Overall Study|Death|1|||
150190288|NCT03447470|541835561|FG002|Overall Study|Death|3|||
150190289|NCT03447470|541835562|FG003|Overall Study|Death|0|||
150190290|NCT03447470|541835563|FG004|Overall Study|Death|1|||
150190291|NCT03447470|541835564|FG005|Overall Study|Death|0|||
150190292|NCT03447470|541835565|FG006|Overall Study|Death|3|||
150190293|NCT03447470|541835566|FG007|Overall Study|Death|3|||
150190294|NCT03447470|541835567|FG008|Overall Study|Death|1|||
150190295|NCT03447470|541835559|FG000|Overall Study|Withdrawal by Subject|1|||
150190296|NCT03447470|541835560|FG001|Overall Study|Withdrawal by Subject|0|||
150117797|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150117798|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150117799|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
150117800|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
150117801|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117802|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
150117803|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117804|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117805|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117806|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117807|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117808|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
150117809|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
150117810|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117811|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
150117812|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117813|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117814|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117815|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117816|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117817|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117818|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
150117819|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117820|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150190297|NCT03447470|541835561|FG002|Overall Study|Withdrawal by Subject|0|||
150190298|NCT03447470|541835562|FG003|Overall Study|Withdrawal by Subject|0|||
150190299|NCT03447470|541835563|FG004|Overall Study|Withdrawal by Subject|1|||
150190300|NCT03447470|541835564|FG005|Overall Study|Withdrawal by Subject|0|||
150190301|NCT03447470|541835565|FG006|Overall Study|Withdrawal by Subject|1|||
150190302|NCT03447470|541835566|FG007|Overall Study|Withdrawal by Subject|1|||
150190303|NCT03447470|541835567|FG008|Overall Study|Withdrawal by Subject|3|||
150190304|NCT03447470|541835559|FG000|Overall Study|Treatment discontinued|3|||
150117821|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117822|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150190305|NCT03447470|541835560|FG001|Overall Study|Treatment discontinued|2|||
150190306|NCT03447470|541835561|FG002|Overall Study|Treatment discontinued|4|||
150190307|NCT03447470|541835562|FG003|Overall Study|Treatment discontinued|6|||
150190308|NCT03447470|541835563|FG004|Overall Study|Treatment discontinued|2|||
150190309|NCT03447470|541835564|FG005|Overall Study|Treatment discontinued|1|||
150190310|NCT03447470|541835565|FG006|Overall Study|Treatment discontinued|2|||
150190311|NCT03447470|541835566|FG007|Overall Study|Treatment discontinued|4|||
150190312|NCT03447470|541835567|FG008|Overall Study|Treatment discontinued|3|||
150117823|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117824|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117825|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117826|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
150117827|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
150117828|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
150117829|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
150117830|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
150117831|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
150117832|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
150117833|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
150117834|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
150117835|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
150117836|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
150117837|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
150117838|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
150117839|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
150117840|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
150117841|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
150117842|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
150117843|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
150117844|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
150117845|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
150117846|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117847|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117848|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117849|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117850|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117851|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117852|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117853|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
150117854|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
150117855|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117856|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
150117857|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117858|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117859|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117860|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117861|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117862|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117863|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
150117864|NCT01172938|541567695|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117865|NCT01172938|541567696|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117866|NCT01172938|541567697|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
150117867|NCT01172938|541567698|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117868|NCT01172938|541567699|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117869|NCT01172938|541567700|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117870|NCT01172938|541567701|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117871|NCT01172938|541567702|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117872|NCT01172938|541567703|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
150117873|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117874|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
150117875|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
150117876|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117877|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117878|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117879|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117880|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
150117881|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
150117882|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
150117883|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
150117884|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
150117885|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
150117886|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
150117887|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
150190313|NCT04592549|541835568|FG000|Overall Study|Withdrawal by Subject|0|||
150190314|NCT04592549|541835569|FG001|Overall Study|Withdrawal by Subject|1|||
150190315|NCT04592549|541835570|FG002|Overall Study|Withdrawal by Subject|0|||
150190316|NCT04592549|541835571|FG003|Overall Study|Withdrawal by Subject|1|||
150190317|NCT04592549|541835572|FG004|Overall Study|Withdrawal by Subject|1|||
150190318|NCT04592549|541835573|FG005|Overall Study|Withdrawal by Subject|0|||
150190319|NCT04592549|541835568|FG000|Overall Study|Lost to Follow-up|2|||
150190320|NCT04592549|541835569|FG001|Overall Study|Lost to Follow-up|0|||
150190321|NCT04592549|541835570|FG002|Overall Study|Lost to Follow-up|0|||
150190322|NCT04592549|541835571|FG003|Overall Study|Lost to Follow-up|1|||
150190323|NCT04592549|541835572|FG004|Overall Study|Lost to Follow-up|1|||
150190324|NCT04592549|541835573|FG005|Overall Study|Lost to Follow-up|1|||
150190325|NCT04295798|541835574|FG000|Overall Study|Lost to Follow-up|1|||
150190326|NCT04624633|541835577|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
150190327|NCT04624633|541835578|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
150190328|NCT04624633|541835577|FG000|Overall Study|Death|1|||
150190329|NCT04624633|541835578|FG001|Overall Study|Death|0|||
150190330|NCT01959425|541835579|FG000|Overall Study|Withdrawal by Subject|5|||
150190331|NCT01959425|541835580|FG001|Overall Study|Withdrawal by Subject|4|||
150190332|NCT01959425|541835579|FG000|Overall Study|Lost to Follow-up|1|||
150190333|NCT01959425|541835580|FG001|Overall Study|Lost to Follow-up|0|||
150190334|NCT01959425|541835579|FG000|Overall Study|Discontinued Subjects|6|||
150190335|NCT01959425|541835580|FG001|Overall Study|Discontinued Subjects|4|||
150190336|NCT01902173|541835586|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
150190337|NCT01902173|541835587|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
150190338|NCT01902173|541835588|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
150190339|NCT01902173|541835589|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
150190340|NCT01902173|541835590|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
150190341|NCT01902173|541835591|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
150190342|NCT01902173|541835586|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
150190343|NCT01902173|541835587|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
150190344|NCT01902173|541835588|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
150190345|NCT01902173|541835589|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
150190346|NCT01902173|541835590|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
150190347|NCT01902173|541835591|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
150190348|NCT01902173|541835586|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
150190349|NCT01902173|541835587|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
150190350|NCT01902173|541835588|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
150190351|NCT01902173|541835589|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
150190352|NCT01902173|541835590|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
150190353|NCT01902173|541835591|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
150117888|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
150117889|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
150117890|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
150117891|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
150117892|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
150117893|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
150117894|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
150117895|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
150117896|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
150117897|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
150117898|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
150117899|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
150117900|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117901|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117902|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
150117903|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150190354|NCT01902173|541835586|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
150190355|NCT01902173|541835587|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
150190356|NCT01902173|541835588|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
150190357|NCT01902173|541835589|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
150190358|NCT01902173|541835590|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
150190359|NCT01902173|541835591|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
150190360|NCT01902173|541835586|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
150190361|NCT01902173|541835587|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
150190362|NCT01902173|541835588|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
150190363|NCT01902173|541835589|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
150190364|NCT01902173|541835590|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
150190365|NCT01902173|541835591|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
150190366|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
150190367|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
150190368|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
150190369|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
150190370|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
150190371|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
150190372|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
150190373|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
150190374|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
150190375|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
150190376|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
150190377|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
150190378|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
150190379|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
150190380|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
150190381|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
150190382|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
150190383|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
150190384|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
150190385|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
150190386|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
150190387|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
150190388|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
150190389|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
150190390|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
150190391|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
150190392|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
150190393|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
150190394|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
150190395|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
150190396|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
150190397|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
150190398|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
150190399|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
150190400|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
150190401|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
150190402|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
150190403|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
150190404|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
150190405|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
150190406|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
150190407|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
150117904|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117905|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117906|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117907|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
150117908|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
150117909|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117910|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117911|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117912|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117913|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117914|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117915|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117916|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
150117917|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
150117918|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150117919|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150117920|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
150117921|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150117922|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150117923|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150117924|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
150190408|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
150117925|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
150117926|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
150117927|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117928|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117929|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
150117930|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117931|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117932|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117933|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117934|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117935|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
150117936|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117937|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
150117938|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117939|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117940|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117941|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117942|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117943|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
150117944|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
150117945|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117946|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
150117947|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
150117948|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117949|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117950|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117951|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117952|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
150117953|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
150117954|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117955|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117956|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
150117957|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117958|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117959|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117960|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117961|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117962|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
150117963|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117964|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117965|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
150117966|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117967|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117968|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117969|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117970|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117971|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
150117972|NCT01172938|541567695|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117973|NCT01172938|541567696|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117974|NCT01172938|541567697|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117975|NCT01172938|541567698|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117976|NCT01172938|541567699|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117977|NCT01172938|541567700|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117978|NCT01172938|541567701|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117979|NCT01172938|541567702|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
150117980|NCT01172938|541567703|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
150117981|NCT01033747|541567704|FG000|Overall Study|Adverse Event|9|||
150117982|NCT01033747|541567705|FG001|Overall Study|Adverse Event|4|||
150117983|NCT01033747|541567704|FG000|Overall Study|Abnormal Laboratory Value|1|||
150117984|NCT01033747|541567705|FG001|Overall Study|Abnormal Laboratory Value|0|||
150117985|NCT01033747|541567704|FG000|Overall Study|Abnormal test procedure|0|||
150117986|NCT01033747|541567705|FG001|Overall Study|Abnormal test procedure|1|||
150117987|NCT01033747|541567704|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
150117988|NCT01033747|541567705|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
150117989|NCT01033747|541567704|FG000|Overall Study|Protocol Violation|1|||
150117990|NCT01033747|541567705|FG001|Overall Study|Protocol Violation|0|||
150117991|NCT01033747|541567704|FG000|Overall Study|Withdrawal by Subject|9|||
150117992|NCT01033747|541567705|FG001|Overall Study|Withdrawal by Subject|6|||
150117993|NCT01033747|541567704|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
150117994|NCT01033747|541567705|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
150117995|NCT01033747|541567704|FG000|Overall Study|Stopped at end of Extension 1|2|||
150117996|NCT01033747|541567705|FG001|Overall Study|Stopped at end of Extension 1|0|||
150117997|NCT00003498|541567706|FG000|Overall Study|Not evaluable.|4|||
150117998|NCT02956629|541567707|FG000|Overall Study|Adverse Event|0|||
150117999|NCT02956629|541567708|FG001|Overall Study|Adverse Event|0|||
150118000|NCT02956629|541567709|FG002|Overall Study|Adverse Event|1|||
150118001|NCT02956629|541567710|FG003|Overall Study|Adverse Event|0|||
150118002|NCT02956629|541567711|FG004|Overall Study|Adverse Event|0|||
150118003|NCT02956629|541567712|FG005|Overall Study|Adverse Event|0|||
150118004|NCT02956629|541567707|FG000|Overall Study|Lost to Follow-up|2|||
150118005|NCT02956629|541567708|FG001|Overall Study|Lost to Follow-up|5|||
150118006|NCT02956629|541567709|FG002|Overall Study|Lost to Follow-up|3|||
150118007|NCT02956629|541567710|FG003|Overall Study|Lost to Follow-up|1|||
150118008|NCT02956629|541567711|FG004|Overall Study|Lost to Follow-up|0|||
150118009|NCT02956629|541567712|FG005|Overall Study|Lost to Follow-up|1|||
150118010|NCT02956629|541567707|FG000|Overall Study|Withdrawal by Subject|3|||
150118011|NCT02956629|541567708|FG001|Overall Study|Withdrawal by Subject|1|||
150118012|NCT02956629|541567709|FG002|Overall Study|Withdrawal by Subject|0|||
150118013|NCT02956629|541567710|FG003|Overall Study|Withdrawal by Subject|0|||
150118014|NCT02956629|541567711|FG004|Overall Study|Withdrawal by Subject|0|||
150118015|NCT02956629|541567712|FG005|Overall Study|Withdrawal by Subject|0|||
150118016|NCT04713748|541567725|FG000|Overall Study|Not enough kits allocated|35|||
150118017|NCT00406029|541567730|FG000|Overall Study|Adverse Event|12|||
150118018|NCT00406029|541567731|FG001|Overall Study|Adverse Event|2|||
150118019|NCT00406029|541567732|FG002|Overall Study|Adverse Event|5|||
150118020|NCT00406029|541567733|FG003|Overall Study|Adverse Event|10|||
150118021|NCT00406029|541567734|FG004|Overall Study|Adverse Event|7|||
150118022|NCT00406029|541567730|FG000|Overall Study|Withdrawal by Subject|3|||
150118023|NCT00406029|541567731|FG001|Overall Study|Withdrawal by Subject|4|||
150118024|NCT00406029|541567732|FG002|Overall Study|Withdrawal by Subject|2|||
150118025|NCT00406029|541567733|FG003|Overall Study|Withdrawal by Subject|2|||
150118026|NCT00406029|541567734|FG004|Overall Study|Withdrawal by Subject|0|||
150118027|NCT00406029|541567730|FG000|Overall Study|Protocol Violation|1|||
150118028|NCT00406029|541567731|FG001|Overall Study|Protocol Violation|2|||
150118029|NCT00406029|541567732|FG002|Overall Study|Protocol Violation|0|||
150118030|NCT00406029|541567733|FG003|Overall Study|Protocol Violation|2|||
150118031|NCT00406029|541567734|FG004|Overall Study|Protocol Violation|0|||
150118032|NCT00406029|541567730|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
150118033|NCT00406029|541567731|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
150118034|NCT00406029|541567732|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
150118035|NCT00406029|541567733|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
150118036|NCT00406029|541567734|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
150118037|NCT00406029|541567730|FG000|Overall Study|Randomized in Error|0|||
150118038|NCT00406029|541567731|FG001|Overall Study|Randomized in Error|0|||
150118039|NCT00406029|541567732|FG002|Overall Study|Randomized in Error|2|||
150118040|NCT00406029|541567733|FG003|Overall Study|Randomized in Error|3|||
150118041|NCT00406029|541567734|FG004|Overall Study|Randomized in Error|1|||
150118042|NCT01557946|541567735|FG000|Overall Study|Adverse Event|3|||
150118043|NCT01557946|541567736|FG001|Overall Study|Adverse Event|0|||
150118044|NCT04067141|541567737|FG000|First Intervention|Withdrawal by Subject|0|||
150118045|NCT04067141|541567738|FG001|First Intervention|Withdrawal by Subject|1|||
150118046|NCT04067141|541567737|FG000|Second Intervention|Adverse Event|0|||
150118047|NCT04067141|541567738|FG001|Second Intervention|Adverse Event|2|||
150118048|NCT01831089|541567741|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
150190409|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
150190410|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
150190411|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
150190412|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
150190413|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
150190414|NCT01902173|541835586|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
150190415|NCT01902173|541835587|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
150190416|NCT01902173|541835588|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
150190417|NCT01902173|541835589|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
150190418|NCT01902173|541835590|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
150190419|NCT01902173|541835591|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
150118049|NCT01831089|541567742|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
150118050|NCT01831089|541567743|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
150118051|NCT01831089|541567744|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
150118052|NCT01831089|541567745|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
150118053|NCT01831089|541567746|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
150118054|NCT01831089|541567741|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
150118055|NCT01831089|541567742|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
150118056|NCT01831089|541567743|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
150118057|NCT01831089|541567744|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
150118058|NCT01831089|541567745|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
150118059|NCT01831089|541567746|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
150118060|NCT01831089|541567741|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
150118061|NCT01831089|541567742|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
150118062|NCT01831089|541567743|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
150118063|NCT01831089|541567744|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
150118064|NCT01831089|541567745|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
150118065|NCT01831089|541567746|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
150118066|NCT01831089|541567741|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
150118067|NCT01831089|541567742|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
150118068|NCT01831089|541567743|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
150118069|NCT01831089|541567744|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
150118070|NCT01831089|541567745|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
150118071|NCT01831089|541567746|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
150118072|NCT01831089|541567741|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
150118073|NCT01831089|541567742|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
150118074|NCT01831089|541567743|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
150118075|NCT01831089|541567744|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
150118076|NCT01831089|541567745|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
150118077|NCT01831089|541567746|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
150118078|NCT01831089|541567741|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
150118079|NCT01831089|541567742|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
150118080|NCT01831089|541567743|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
150118081|NCT01831089|541567744|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
150118082|NCT01831089|541567745|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
150118083|NCT01831089|541567746|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
150118084|NCT01831089|541567741|FG000|Cohort III: Dose Level 3|Global end of study|0|||
150118085|NCT01831089|541567742|FG001|Cohort III: Dose Level 3|Global end of study|0|||
150118086|NCT01831089|541567743|FG002|Cohort III: Dose Level 3|Global end of study|1|||
150118087|NCT01831089|541567744|FG003|Cohort III: Dose Level 3|Global end of study|0|||
150118088|NCT01831089|541567745|FG004|Cohort III: Dose Level 3|Global end of study|0|||
150118089|NCT01831089|541567746|FG005|Cohort III: Dose Level 3|Global end of study|0|||
150118090|NCT01831089|541567741|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
150118091|NCT01831089|541567742|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
150118092|NCT01831089|541567743|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
150118093|NCT01831089|541567744|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
150118094|NCT01831089|541567745|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
150118095|NCT01831089|541567746|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
150118096|NCT01831089|541567741|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
150118097|NCT01831089|541567742|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
150118098|NCT01831089|541567743|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
150118099|NCT01831089|541567744|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
150118100|NCT01831089|541567745|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
150118101|NCT01831089|541567746|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
150118102|NCT01831089|541567741|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
150118103|NCT01831089|541567742|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
150118104|NCT01831089|541567743|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
150118105|NCT01831089|541567744|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
150118106|NCT01831089|541567745|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
150118107|NCT01831089|541567746|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
150118108|NCT01831089|541567741|FG000|Cohort V: Dose Level 5|Death|0|||
150118109|NCT01831089|541567742|FG001|Cohort V: Dose Level 5|Death|0|||
150118110|NCT01831089|541567743|FG002|Cohort V: Dose Level 5|Death|0|||
150118111|NCT01831089|541567744|FG003|Cohort V: Dose Level 5|Death|0|||
150118112|NCT01831089|541567745|FG004|Cohort V: Dose Level 5|Death|1|||
150118113|NCT01831089|541567746|FG005|Cohort V: Dose Level 5|Death|0|||
150118114|NCT01831089|541567741|FG000|Cohort V: Dose Level 5|Global end of study|0|||
150118115|NCT01831089|541567742|FG001|Cohort V: Dose Level 5|Global end of study|0|||
150118116|NCT01831089|541567743|FG002|Cohort V: Dose Level 5|Global end of study|0|||
150118117|NCT01831089|541567744|FG003|Cohort V: Dose Level 5|Global end of study|0|||
150118118|NCT01831089|541567745|FG004|Cohort V: Dose Level 5|Global end of study|2|||
150118119|NCT01831089|541567746|FG005|Cohort V: Dose Level 5|Global end of study|0|||
150118120|NCT01831089|541567741|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
150118121|NCT01831089|541567742|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
150118122|NCT01831089|541567743|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
150118123|NCT01831089|541567744|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
150118124|NCT01831089|541567745|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
150190420|NCT01824394|541835592|FG000|Overall Study|Early Termination|1|||
150190421|NCT01824394|541835593|FG001|Overall Study|Early Termination|1|||
150190422|NCT01824394|541835594|FG002|Overall Study|Early Termination|3|||
150190423|NCT01824394|541835592|FG000|Overall Study|Withdrawn due to Study Termination|91|||
150190424|NCT01824394|541835593|FG001|Overall Study|Withdrawn due to Study Termination|83|||
150190425|NCT01824394|541835594|FG002|Overall Study|Withdrawn due to Study Termination|41|||
150190426|NCT01824394|541835592|FG000|Overall Study|Lost to Follow-up|0|||
150190427|NCT01824394|541835593|FG001|Overall Study|Lost to Follow-up|9|||
150190428|NCT01824394|541835594|FG002|Overall Study|Lost to Follow-up|3|||
150190429|NCT01824394|541835592|FG000|Overall Study|Death|3|||
150190430|NCT01824394|541835593|FG001|Overall Study|Death|2|||
150190431|NCT01824394|541835594|FG002|Overall Study|Death|4|||
150190432|NCT01824394|541835592|FG000|Overall Study|Discontinued Subjects|1|||
150190433|NCT01824394|541835593|FG001|Overall Study|Discontinued Subjects|1|||
150190434|NCT01824394|541835594|FG002|Overall Study|Discontinued Subjects|2|||
150190435|NCT01824394|541835592|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
150190436|NCT01824394|541835593|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
150190437|NCT01824394|541835594|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
150190438|NCT05364671|541835595|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
150190439|NCT05364671|541835596|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
150190440|NCT05364671|541835595|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
150190441|NCT05364671|541835596|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
150118125|NCT01831089|541567746|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
150190442|NCT05364671|541835595|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
150190443|NCT05364671|541835596|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
150118126|NCT01831089|541567741|FG000|Cohort B: Arm B|Progressive disease|0|||
150118127|NCT01831089|541567742|FG001|Cohort B: Arm B|Progressive disease|0|||
150118128|NCT01831089|541567743|FG002|Cohort B: Arm B|Progressive disease|0|||
150118129|NCT01831089|541567744|FG003|Cohort B: Arm B|Progressive disease|0|||
150118130|NCT01831089|541567745|FG004|Cohort B: Arm B|Progressive disease|0|||
150118131|NCT01831089|541567746|FG005|Cohort B: Arm B|Progressive disease|8|||
150118132|NCT01831089|541567741|FG000|Cohort B: Arm B|Physician Decision|0|||
150118133|NCT01831089|541567742|FG001|Cohort B: Arm B|Physician Decision|0|||
150118134|NCT01831089|541567743|FG002|Cohort B: Arm B|Physician Decision|0|||
150118135|NCT01831089|541567744|FG003|Cohort B: Arm B|Physician Decision|0|||
150118136|NCT01831089|541567745|FG004|Cohort B: Arm B|Physician Decision|0|||
150118137|NCT01831089|541567746|FG005|Cohort B: Arm B|Physician Decision|2|||
150118138|NCT01831089|541567741|FG000|Cohort B: Arm B|Never treated|0|||
150118139|NCT01831089|541567742|FG001|Cohort B: Arm B|Never treated|0|||
150118140|NCT01831089|541567743|FG002|Cohort B: Arm B|Never treated|0|||
150118141|NCT01831089|541567744|FG003|Cohort B: Arm B|Never treated|0|||
150118142|NCT01831089|541567745|FG004|Cohort B: Arm B|Never treated|0|||
150118143|NCT01831089|541567746|FG005|Cohort B: Arm B|Never treated|2|||
150118144|NCT01831089|541567741|FG000|Cohort B: Arm B|Adverse Event|0|||
150118145|NCT01831089|541567742|FG001|Cohort B: Arm B|Adverse Event|0|||
150118146|NCT01831089|541567743|FG002|Cohort B: Arm B|Adverse Event|0|||
150118147|NCT01831089|541567744|FG003|Cohort B: Arm B|Adverse Event|0|||
150118148|NCT01831089|541567745|FG004|Cohort B: Arm B|Adverse Event|0|||
150118149|NCT01831089|541567746|FG005|Cohort B: Arm B|Adverse Event|1|||
150118150|NCT01831089|541567741|FG000|Cohort B: Arm B|Global end of study|0|||
150118151|NCT01831089|541567742|FG001|Cohort B: Arm B|Global end of study|0|||
150118152|NCT01831089|541567743|FG002|Cohort B: Arm B|Global end of study|0|||
150118153|NCT01831089|541567744|FG003|Cohort B: Arm B|Global end of study|0|||
150118154|NCT01831089|541567745|FG004|Cohort B: Arm B|Global end of study|0|||
150118155|NCT01831089|541567746|FG005|Cohort B: Arm B|Global end of study|1|||
150118156|NCT00889421|541567747|FG000|Overall Study|Lack of Efficacy|3|||
150118157|NCT01958918|541567748|FG000|Overall Study|Death|1|||
150118158|NCT01958918|541567749|FG001|Overall Study|Death|3|||
150118159|NCT01958918|541567748|FG000|Overall Study|Lost to Follow-up|4|||
150118160|NCT01958918|541567749|FG001|Overall Study|Lost to Follow-up|7|||
150118161|NCT01958918|541567748|FG000|Overall Study|Withdrawal by Subject|13|||
150190444|NCT05364671|541835595|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
150190445|NCT05364671|541835596|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
150190446|NCT05364671|541835595|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
150190447|NCT05364671|541835596|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
150190448|NCT03382652|541835597|FG000|Overall Study|Lost to Follow-up|6|||
150118162|NCT01958918|541567749|FG001|Overall Study|Withdrawal by Subject|8|||
150118163|NCT01958918|541567748|FG000|Overall Study|Lack of Efficacy|13|||
150118164|NCT01958918|541567749|FG001|Overall Study|Lack of Efficacy|10|||
150118165|NCT01958918|541567748|FG000|Overall Study|Adverse Event|12|||
150118166|NCT01958918|541567749|FG001|Overall Study|Adverse Event|12|||
150118167|NCT01958918|541567748|FG000|Overall Study|administrative problems|0|||
150118168|NCT01958918|541567749|FG001|Overall Study|administrative problems|2|||
150118169|NCT02114892|541567753|FG000|Overall Study|Lost to Follow-up|1|||
150118170|NCT02114892|541567754|FG001|Overall Study|Lost to Follow-up|2|||
150118171|NCT02013765|541567758|FG000|Overall Study|Trial was terminated by sponsor|1|||
150118172|NCT00659269|541567763|FG000|Overall Study|Physician Decision|1|||
150118173|NCT00659269|541567764|FG001|Overall Study|Physician Decision|1|||
150118174|NCT00718042|541567766|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
150118175|NCT00718042|541567767|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
150118176|NCT00718042|541567768|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
150118177|NCT00718042|541567769|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
150118178|NCT00718042|541567770|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
150118179|NCT00718042|541567771|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
150118180|NCT00718042|541567766|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
150118181|NCT00718042|541567767|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
150118182|NCT00718042|541567768|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
150118183|NCT00718042|541567769|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
150118184|NCT00718042|541567770|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
150118185|NCT00718042|541567771|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
150118186|NCT00718042|541567766|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
150118187|NCT00718042|541567767|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
150118188|NCT00718042|541567768|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
150118189|NCT00718042|541567769|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
150118190|NCT00718042|541567770|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
150118191|NCT00718042|541567771|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
150118192|NCT00718042|541567766|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
150118193|NCT00718042|541567767|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
150118194|NCT00718042|541567768|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
150118195|NCT00718042|541567769|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
150118196|NCT00718042|541567770|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
150118197|NCT00718042|541567771|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
150118198|NCT00718042|541567766|FG000|Donor Follow-up|Lost to Follow-up|13|||
150118199|NCT00718042|541567767|FG001|Donor Follow-up|Lost to Follow-up|0|||
150118200|NCT00718042|541567768|FG002|Donor Follow-up|Lost to Follow-up|0|||
150118201|NCT00718042|541567769|FG003|Donor Follow-up|Lost to Follow-up|0|||
150118202|NCT00718042|541567770|FG004|Donor Follow-up|Lost to Follow-up|19|||
150118203|NCT00718042|541567771|FG005|Donor Follow-up|Lost to Follow-up|0|||
150118204|NCT04327934|541567772|FG000|Overall Study|Did not qualify|7|||
150118205|NCT04327934|541567773|FG001|Overall Study|Did not qualify|4|||
150118206|NCT04327934|541567772|FG000|Overall Study|Physician Decision|0|||
150118207|NCT04327934|541567773|FG001|Overall Study|Physician Decision|1|||
150118208|NCT02443298|541567774|FG000|Overall Study|Adverse Event|3|||
150118209|NCT02443298|541567775|FG001|Overall Study|Adverse Event|3|||
150118210|NCT02443298|541567774|FG000|Overall Study|Withdrawal by Subject|1|||
150118211|NCT02443298|541567775|FG001|Overall Study|Withdrawal by Subject|2|||
150118212|NCT01047683|541567776|FG000|Overall Study|Adverse Event|3|||
150118213|NCT01047683|541567777|FG001|Overall Study|Adverse Event|1|||
150118214|NCT01047683|541567778|FG002|Overall Study|Adverse Event|0|||
150118215|NCT01047683|541567776|FG000|Overall Study|Withdrew Consent|1|||
150118216|NCT01047683|541567777|FG001|Overall Study|Withdrew Consent|4|||
150118217|NCT01047683|541567778|FG002|Overall Study|Withdrew Consent|2|||
150118218|NCT01047683|541567776|FG000|Overall Study|Lost to Follow-up|0|||
150118219|NCT01047683|541567777|FG001|Overall Study|Lost to Follow-up|1|||
150118220|NCT01047683|541567778|FG002|Overall Study|Lost to Follow-up|0|||
150118221|NCT01047683|541567776|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
150118222|NCT01047683|541567777|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
150118223|NCT01047683|541567778|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
150118224|NCT02822794|541567791|FG000|Overall Study|Withdrew Consent|1|||
150118225|NCT02822794|541567792|FG001|Overall Study|Withdrew Consent|0|||
150118226|NCT04788147|541567793|FG000|Overall Study|Screen Failure|3|||
150118227|NCT04788147|541567794|FG001|Overall Study|Screen Failure|10|||
150118228|NCT04788147|541567793|FG000|Overall Study|Incomplete RMRS image session|2|||
150190449|NCT03382652|541835597|FG000|Overall Study|Death|4|||
150118229|NCT04788147|541567794|FG001|Overall Study|Incomplete RMRS image session|0|||
150118230|NCT00781326|541567799|FG000|Phase I|Adverse Event|1|||
150118231|NCT00781326|541567799|FG000|Phase I|Withdrawal by Subject|1|||
150118232|NCT00781326|541567799|FG000|Phase I|Physician Decision|2|||
150118233|NCT03732248|541567800|FG000|Overall Study|Withdrawal by Subject|1|||
150118234|NCT03732248|541567801|FG001|Overall Study|Withdrawal by Subject|0|||
150118235|NCT05101252|541567802|FG000|Overall Study|Unsatisfactory Test Article|1|||
150118236|NCT05101252|541567803|FG001|Overall Study|Unsatisfactory Test Article|0|||
150118237|NCT05101252|541567802|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150118238|NCT05101252|541567803|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
150118239|NCT05101252|541567802|FG000|Overall Study|Withdrew Consent during study|0|||
150118240|NCT05101252|541567803|FG001|Overall Study|Withdrew Consent during study|1|||
150190450|NCT03382652|541835597|FG000|Overall Study|Revision|5|||
150118241|NCT05101252|541567802|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
150118242|NCT05101252|541567803|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
150118243|NCT01243944|541567804|FG000|Overall Study|Adverse Event|15|||
150118244|NCT01243944|541567805|FG001|Overall Study|Adverse Event|13|||
150118245|NCT01243944|541567804|FG000|Overall Study|Lost to Follow-up|2|||
150118246|NCT01243944|541567805|FG001|Overall Study|Lost to Follow-up|1|||
150118247|NCT01243944|541567804|FG000|Overall Study|Physician Decision|2|||
150118248|NCT01243944|541567805|FG001|Overall Study|Physician Decision|7|||
150118249|NCT01243944|541567804|FG000|Overall Study|Disease progression|12|||
150118250|NCT01243944|541567805|FG001|Overall Study|Disease progression|11|||
150118251|NCT01243944|541567804|FG000|Overall Study|Protocol deviation|1|||
150118252|NCT01243944|541567805|FG001|Overall Study|Protocol deviation|1|||
150118253|NCT01243944|541567804|FG000|Overall Study|Participant decision|10|||
150118254|NCT01243944|541567805|FG001|Overall Study|Participant decision|15|||
150118255|NCT01243944|541567804|FG000|Overall Study|Death|2|||
150118256|NCT01243944|541567805|FG001|Overall Study|Death|3|||
150118257|NCT01243944|541567804|FG000|Overall Study|Non-compliance with study treatment|1|||
150118258|NCT01243944|541567805|FG001|Overall Study|Non-compliance with study treatment|0|||
150118259|NCT01731171|541567816|FG000|Overall Study|Withdrawal by Subject|4|||
150118260|NCT01731171|541567817|FG001|Overall Study|Withdrawal by Subject|1|||
150118261|NCT01731171|541567816|FG000|Overall Study|Lost to Follow-up|3|||
150118262|NCT01731171|541567817|FG001|Overall Study|Lost to Follow-up|2|||
150118263|NCT01731171|541567816|FG000|Overall Study|Moved out of Area|0|||
150118264|NCT01731171|541567817|FG001|Overall Study|Moved out of Area|2|||
150118265|NCT01731171|541567816|FG000|Overall Study|Terminated for Lack of Adherence|0|||
150118266|NCT01731171|541567817|FG001|Overall Study|Terminated for Lack of Adherence|1|||
150118267|NCT01731171|541567816|FG000|Overall Study|Terminated for Safety Reasons|0|||
150118268|NCT01731171|541567817|FG001|Overall Study|Terminated for Safety Reasons|1|||
150118269|NCT00403546|541567820|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
150118270|NCT00403546|541567821|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
150118271|NCT00403546|541567822|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
150118272|NCT00403546|541567820|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
150118273|NCT00403546|541567821|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
150118274|NCT00403546|541567822|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
150118275|NCT00403546|541567820|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
150118276|NCT00403546|541567821|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
150118277|NCT00403546|541567822|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
150118278|NCT00403546|541567820|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
150118279|NCT00403546|541567821|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
150118280|NCT00403546|541567822|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
150118281|NCT00403546|541567820|FG000|Screening Phase|Screening Failure|22|||
150118282|NCT00403546|541567821|FG001|Screening Phase|Screening Failure|0|||
150118283|NCT00403546|541567822|FG002|Screening Phase|Screening Failure|0|||
150118284|NCT00403546|541567820|FG000|Screening Phase|Adverse Event|1|||
150118285|NCT00403546|541567821|FG001|Screening Phase|Adverse Event|0|||
150118286|NCT00403546|541567822|FG002|Screening Phase|Adverse Event|0|||
150118287|NCT00403546|541567820|FG000|Screening Phase|Terminated Prior to Randomization|5|||
150118288|NCT00403546|541567821|FG001|Screening Phase|Terminated Prior to Randomization|0|||
150118289|NCT00403546|541567822|FG002|Screening Phase|Terminated Prior to Randomization|0|||
150118290|NCT00403546|541567820|FG000|Randomized Trial|Early Terminations|0|||
150118291|NCT00403546|541567821|FG001|Randomized Trial|Early Terminations|17|||
150118292|NCT00403546|541567822|FG002|Randomized Trial|Early Terminations|16|||
150118293|NCT02604589|541567826|FG000|Overall Study|catheter dislodgement|0|||
150118294|NCT02604589|541567827|FG001|Overall Study|catheter dislodgement|0|||
150118295|NCT02604589|541567828|FG002|Overall Study|catheter dislodgement|1|||
150118296|NCT00793910|541567831|FG000|Overall Study|discarded study pills|0|||
150118297|NCT00793910|541567832|FG001|Overall Study|discarded study pills|1|||
150118298|NCT00793910|541567831|FG000|Overall Study|did not pick up medications|1|||
150118299|NCT00793910|541567832|FG001|Overall Study|did not pick up medications|1|||
150118300|NCT00793910|541567831|FG000|Overall Study|ineligible based on entry criteria|2|||
150118301|NCT00793910|541567832|FG001|Overall Study|ineligible based on entry criteria|3|||
150118302|NCT00793910|541567831|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
150118303|NCT00793910|541567832|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
150118304|NCT00793910|541567831|FG000|Overall Study|Withdrawal by Subject|0|||
150118305|NCT00793910|541567832|FG001|Overall Study|Withdrawal by Subject|1|||
150118306|NCT05061446|541567840|FG000|Overall Study|Adverse Event|2|||
150118307|NCT05061446|541567841|FG001|Overall Study|Adverse Event|0|||
150118308|NCT05061446|541567842|FG002|Overall Study|Adverse Event|0|||
150118309|NCT05061446|541567840|FG000|Overall Study|Participant no longer available due to personal reason|0|||
150118310|NCT05061446|541567841|FG001|Overall Study|Participant no longer available due to personal reason|1|||
150118311|NCT05061446|541567842|FG002|Overall Study|Participant no longer available due to personal reason|0|||
150118312|NCT03056690|541567843|FG000|Overall Study|Adverse Event|3|||
150118313|NCT03056690|541567844|FG001|Overall Study|Adverse Event|2|||
150190451|NCT03382652|541835597|FG000|Overall Study|Patient withdrew|3|||
150190452|NCT03382652|541835597|FG000|Overall Study|Other reasons|21|||
150190453|NCT04810650|541835599|FG000|Overall Study|Disenrolled in error|0|||
150190454|NCT04810650|541835600|FG001|Overall Study|Disenrolled in error|0|||
150190455|NCT04810650|541835601|FG002|Overall Study|Disenrolled in error|0|||
150190456|NCT04810650|541835602|FG003|Overall Study|Disenrolled in error|0|||
150190457|NCT04810650|541835603|FG004|Overall Study|Disenrolled in error|0|||
150190458|NCT04810650|541835604|FG005|Overall Study|Disenrolled in error|0|||
150190459|NCT04810650|541835605|FG006|Overall Study|Disenrolled in error|0|||
150190460|NCT04810650|541835606|FG007|Overall Study|Disenrolled in error|0|||
150190461|NCT04810650|541835607|FG008|Overall Study|Disenrolled in error|1|||
150190462|NCT04810650|541835608|FG009|Overall Study|Disenrolled in error|0|||
150190463|NCT04810650|541835609|FG010|Overall Study|Disenrolled in error|0|||
150190464|NCT04810650|541835610|FG011|Overall Study|Disenrolled in error|0|||
150190465|NCT04810650|541835611|FG012|Overall Study|Disenrolled in error|0|||
150190466|NCT04810650|541835612|FG013|Overall Study|Disenrolled in error|0|||
150190467|NCT04810650|541835599|FG000|Overall Study|Death|0|||
150190468|NCT04810650|541835600|FG001|Overall Study|Death|0|||
150190469|NCT04810650|541835601|FG002|Overall Study|Death|0|||
150190470|NCT04810650|541835602|FG003|Overall Study|Death|0|||
150190471|NCT04810650|541835603|FG004|Overall Study|Death|0|||
150190472|NCT04810650|541835604|FG005|Overall Study|Death|0|||
150190473|NCT04810650|541835605|FG006|Overall Study|Death|2|||
150190474|NCT04810650|541835606|FG007|Overall Study|Death|2|||
150190475|NCT04810650|541835607|FG008|Overall Study|Death|0|||
150190476|NCT04810650|541835608|FG009|Overall Study|Death|1|||
150190477|NCT04810650|541835609|FG010|Overall Study|Death|0|||
150190478|NCT04810650|541835610|FG011|Overall Study|Death|0|||
150190479|NCT04810650|541835611|FG012|Overall Study|Death|2|||
150190480|NCT04810650|541835612|FG013|Overall Study|Death|1|||
150190481|NCT04810650|541835599|FG000|Overall Study|Moved/transferred care|0|||
150190482|NCT04810650|541835600|FG001|Overall Study|Moved/transferred care|0|||
150190483|NCT04810650|541835601|FG002|Overall Study|Moved/transferred care|0|||
150190484|NCT04810650|541835602|FG003|Overall Study|Moved/transferred care|0|||
150190485|NCT04810650|541835603|FG004|Overall Study|Moved/transferred care|0|||
150190486|NCT04810650|541835604|FG005|Overall Study|Moved/transferred care|0|||
150190487|NCT04810650|541835605|FG006|Overall Study|Moved/transferred care|0|||
150190488|NCT04810650|541835606|FG007|Overall Study|Moved/transferred care|1|||
150190489|NCT04810650|541835607|FG008|Overall Study|Moved/transferred care|12|||
150190490|NCT04810650|541835608|FG009|Overall Study|Moved/transferred care|10|||
150190491|NCT04810650|541835609|FG010|Overall Study|Moved/transferred care|0|||
150190492|NCT04810650|541835610|FG011|Overall Study|Moved/transferred care|0|||
150190493|NCT04810650|541835611|FG012|Overall Study|Moved/transferred care|0|||
150190494|NCT04810650|541835612|FG013|Overall Study|Moved/transferred care|0|||
150190495|NCT04810650|541835599|FG000|Overall Study|Lost to Follow-up|15|||
150190496|NCT04810650|541835600|FG001|Overall Study|Lost to Follow-up|12|||
150190497|NCT04810650|541835601|FG002|Overall Study|Lost to Follow-up|7|||
150190498|NCT04810650|541835602|FG003|Overall Study|Lost to Follow-up|9|||
150190499|NCT04810650|541835603|FG004|Overall Study|Lost to Follow-up|10|||
150118314|NCT03056690|541567843|FG000|Overall Study|Lack of Efficacy|1|||
150118315|NCT03056690|541567844|FG001|Overall Study|Lack of Efficacy|2|||
150118316|NCT03056690|541567843|FG000|Overall Study|Lost to Follow-up|3|||
150118317|NCT03056690|541567844|FG001|Overall Study|Lost to Follow-up|2|||
150118318|NCT03056690|541567843|FG000|Overall Study|Protocol Violation|2|||
150118319|NCT03056690|541567844|FG001|Overall Study|Protocol Violation|2|||
150118320|NCT03056690|541567843|FG000|Overall Study|Withdrawal by Subject|3|||
150118321|NCT03056690|541567844|FG001|Overall Study|Withdrawal by Subject|6|||
150118322|NCT03056690|541567843|FG000|Overall Study|Non-compliance with Study Drug|1|||
150118323|NCT03056690|541567844|FG001|Overall Study|Non-compliance with Study Drug|0|||
150118324|NCT03056690|541567843|FG000|Overall Study|Miscellaneous|1|||
150190500|NCT04810650|541835604|FG005|Overall Study|Lost to Follow-up|6|||
150190501|NCT04810650|541835605|FG006|Overall Study|Lost to Follow-up|0|||
150190502|NCT04810650|541835606|FG007|Overall Study|Lost to Follow-up|0|||
150190503|NCT04810650|541835607|FG008|Overall Study|Lost to Follow-up|0|||
150190504|NCT04810650|541835608|FG009|Overall Study|Lost to Follow-up|0|||
150190505|NCT04810650|541835609|FG010|Overall Study|Lost to Follow-up|1|||
150190506|NCT04810650|541835610|FG011|Overall Study|Lost to Follow-up|0|||
150190507|NCT04810650|541835611|FG012|Overall Study|Lost to Follow-up|3|||
150190508|NCT04810650|541835612|FG013|Overall Study|Lost to Follow-up|9|||
150190509|NCT04810650|541835599|FG000|Overall Study|Participant declined|0|||
150190510|NCT04810650|541835600|FG001|Overall Study|Participant declined|0|||
150190511|NCT04810650|541835601|FG002|Overall Study|Participant declined|0|||
150190512|NCT04810650|541835602|FG003|Overall Study|Participant declined|0|||
150190513|NCT04810650|541835603|FG004|Overall Study|Participant declined|0|||
150190514|NCT04810650|541835604|FG005|Overall Study|Participant declined|0|||
150190515|NCT04810650|541835605|FG006|Overall Study|Participant declined|0|||
150190516|NCT04810650|541835606|FG007|Overall Study|Participant declined|0|||
150190517|NCT04810650|541835607|FG008|Overall Study|Participant declined|0|||
150190518|NCT04810650|541835608|FG009|Overall Study|Participant declined|0|||
150190519|NCT04810650|541835609|FG010|Overall Study|Participant declined|2|||
150190520|NCT04810650|541835610|FG011|Overall Study|Participant declined|0|||
150190521|NCT04810650|541835611|FG012|Overall Study|Participant declined|0|||
150190522|NCT04810650|541835612|FG013|Overall Study|Participant declined|0|||
150190523|NCT05794243|541835613|FG000|Overall Study|Withdrawal by Subject|1|||
150190524|NCT05794243|541835614|FG001|Overall Study|Withdrawal by Subject|0|||
150190525|NCT05794243|541835615|FG002|Overall Study|Withdrawal by Subject|1|||
150190526|NCT05794243|541835613|FG000|Overall Study|Physician Decision|0|||
150190527|NCT05794243|541835614|FG001|Overall Study|Physician Decision|3|||
150118325|NCT03056690|541567844|FG001|Overall Study|Miscellaneous|2|||
150118326|NCT02610140|541567849|FG000|Randomization and Treatment Period|Radiological progression|23|||
150118327|NCT02610140|541567850|FG001|Randomization and Treatment Period|Radiological progression|15|||
150118328|NCT02610140|541567849|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
150118329|NCT02610140|541567850|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
150118330|NCT02610140|541567849|FG000|Randomization and Treatment Period|Protocol Violation|1|||
150118331|NCT02610140|541567850|FG001|Randomization and Treatment Period|Protocol Violation|0|||
150118332|NCT02610140|541567849|FG000|Randomization and Treatment Period|Physician Decision|0|||
150118333|NCT02610140|541567850|FG001|Randomization and Treatment Period|Physician Decision|1|||
150118334|NCT02610140|541567849|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
150118335|NCT02610140|541567850|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
150118336|NCT02610140|541567849|FG000|Randomization and Treatment Period|Death|7|||
150118337|NCT02610140|541567850|FG001|Randomization and Treatment Period|Death|1|||
150118338|NCT02610140|541567849|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
150118339|NCT02610140|541567850|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
150118340|NCT02610140|541567849|FG000|Randomization and Treatment Period|Adverse Event|44|||
150118341|NCT02610140|541567850|FG001|Randomization and Treatment Period|Adverse Event|13|||
150118342|NCT02610140|541567849|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
150118343|NCT02610140|541567850|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
150118344|NCT02610140|541567849|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
150118345|NCT02610140|541567850|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
150118346|NCT02610140|541567849|FG000|Randomization and Treatment Period|Not treated|3|||
150118347|NCT02610140|541567850|FG001|Randomization and Treatment Period|Not treated|10|||
150118348|NCT02610140|541567849|FG000|Safety Follow-up|Other|0|||
150118349|NCT02610140|541567850|FG001|Safety Follow-up|Other|2|||
150118350|NCT02610140|541567849|FG000|Safety Follow-up|Lost to Follow-up|1|||
150118351|NCT02610140|541567850|FG001|Safety Follow-up|Lost to Follow-up|0|||
150118352|NCT02610140|541567849|FG000|Safety Follow-up|No follow-up|5|||
150118353|NCT02610140|541567850|FG001|Safety Follow-up|No follow-up|3|||
150118354|NCT02610140|541567849|FG000|Safety Follow-up|Death|12|||
150118355|NCT02610140|541567850|FG001|Safety Follow-up|Death|2|||
150118356|NCT02610140|541567849|FG000|Safety Follow-up|Deterioration of general conditions|15|||
150118357|NCT02610140|541567850|FG001|Safety Follow-up|Deterioration of general conditions|5|||
150118358|NCT02610140|541567849|FG000|Safety Follow-up|Withdrawal by Subject|12|||
150118359|NCT02610140|541567850|FG001|Safety Follow-up|Withdrawal by Subject|12|||
150118360|NCT02610140|541567849|FG000|Active Follow-up|Progressive disease - radiological|30|||
150118361|NCT02610140|541567850|FG001|Active Follow-up|Progressive disease - radiological|22|||
150118362|NCT02610140|541567849|FG000|Active Follow-up|Death|8|||
150118363|NCT02610140|541567850|FG001|Active Follow-up|Death|1|||
150118364|NCT02610140|541567849|FG000|Active Follow-up|Withdrawal by Subject|4|||
150118365|NCT02610140|541567850|FG001|Active Follow-up|Withdrawal by Subject|0|||
150118366|NCT02610140|541567849|FG000|Active Follow-up|Progressive disease - clinical|1|||
150190528|NCT05794243|541835615|FG002|Overall Study|Physician Decision|1|||
150190529|NCT02761057|541835619|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
150118367|NCT02610140|541567850|FG001|Active Follow-up|Progressive disease - clinical|2|||
150118368|NCT02610140|541567849|FG000|Active Follow-up|Deterioration of general conditions|1|||
150190530|NCT02761057|541835620|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
150190531|NCT02761057|541835621|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
150190532|NCT02761057|541835622|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
150190533|NCT02761057|541835619|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
150118369|NCT02610140|541567850|FG001|Active Follow-up|Deterioration of general conditions|0|||
150118370|NCT02610140|541567849|FG000|Active Follow-up|Ongoing but not completed|4|||
150118371|NCT02610140|541567850|FG001|Active Follow-up|Ongoing but not completed|1|||
150118372|NCT02610140|541567849|FG000|Long-term Follow-up|Death|86|||
150118373|NCT02610140|541567850|FG001|Long-term Follow-up|Death|44|||
150118374|NCT02610140|541567849|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
150118375|NCT02610140|541567850|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
150118376|NCT02610140|541567849|FG000|Long-term Follow-up|Lost to Follow-up|1|||
150118377|NCT02610140|541567850|FG001|Long-term Follow-up|Lost to Follow-up|2|||
150118378|NCT02610140|541567849|FG000|Long-term Follow-up|Ongoing but not completed|30|||
150118379|NCT02610140|541567850|FG001|Long-term Follow-up|Ongoing but not completed|17|||
150118380|NCT00861341|541567851|FG000|Overall Study|Withdrawal by Subject|2|||
150118381|NCT02127307|541567852|FG000|Overall Study|Protocol Violation|36|||
150118382|NCT02127307|541567852|FG000|Overall Study|Lost to Follow-up|2|||
150118383|NCT02127307|541567852|FG000|Overall Study|Death|101|||
150118384|NCT02127307|541567852|FG000|Overall Study|Other than specified above|169|||
150118385|NCT01312961|541567854|FG000|Overall Study|Adverse Event|3|||
150118386|NCT01312961|541567855|FG001|Overall Study|Adverse Event|3|||
150118387|NCT01312961|541567854|FG000|Overall Study|Lack of Efficacy|11|||
150118388|NCT01312961|541567855|FG001|Overall Study|Lack of Efficacy|1|||
150118389|NCT01312961|541567854|FG000|Overall Study|Poor compliance to protocol|1|||
150118390|NCT01312961|541567855|FG001|Overall Study|Poor compliance to protocol|0|||
150118391|NCT01312961|541567854|FG000|Overall Study|Other than specified above|2|||
150118392|NCT01312961|541567855|FG001|Overall Study|Other than specified above|3|||
150118393|NCT01337297|541567861|FG000|Overall Study|They entered to single anodal tDCS|4|||
150118394|NCT01337297|541567862|FG001|Overall Study|They entered to single anodal tDCS|3|||
150118395|NCT01337297|541567861|FG000|Overall Study|Lost to Follow-up|1|||
150118396|NCT01337297|541567862|FG001|Overall Study|Lost to Follow-up|3|||
150118397|NCT02778204|541567863|FG000|Overall Study|Adverse Event|1|||
150118398|NCT02778204|541567864|FG001|Overall Study|Adverse Event|0|||
150118399|NCT02778204|541567865|FG002|Overall Study|Adverse Event|0|||
150118400|NCT02778204|541567866|FG003|Overall Study|Adverse Event|0|||
150118401|NCT02778204|541567863|FG000|Overall Study|Withdrawal by Subject|0|||
150118402|NCT02778204|541567864|FG001|Overall Study|Withdrawal by Subject|0|||
150118403|NCT02778204|541567865|FG002|Overall Study|Withdrawal by Subject|1|||
150118404|NCT02778204|541567866|FG003|Overall Study|Withdrawal by Subject|2|||
150118405|NCT02778204|541567863|FG000|Overall Study|Lost to Follow-up|1|||
150118406|NCT02778204|541567864|FG001|Overall Study|Lost to Follow-up|0|||
150118407|NCT02778204|541567865|FG002|Overall Study|Lost to Follow-up|2|||
150118408|NCT02778204|541567866|FG003|Overall Study|Lost to Follow-up|1|||
150118409|NCT02778204|541567863|FG000|Overall Study|Protocol Violation|0|||
150118410|NCT02778204|541567864|FG001|Overall Study|Protocol Violation|0|||
150118411|NCT02778204|541567865|FG002|Overall Study|Protocol Violation|1|||
150118412|NCT02778204|541567866|FG003|Overall Study|Protocol Violation|0|||
150118413|NCT02778204|541567863|FG000|Overall Study|Eligibility Violation|0|||
150118414|NCT02778204|541567864|FG001|Overall Study|Eligibility Violation|0|||
150118415|NCT02778204|541567865|FG002|Overall Study|Eligibility Violation|0|||
150118416|NCT02778204|541567866|FG003|Overall Study|Eligibility Violation|1|||
150118417|NCT04122443|541567867|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
150118418|NCT04122443|541567868|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
150118419|NCT04122443|541567869|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
150118420|NCT04122443|541567867|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
150118421|NCT04122443|541567868|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
150118422|NCT04122443|541567869|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
150118423|NCT00432380|541569832|FG000|Overall Study|Migrated/moved from study area|3|||
150118424|NCT00432380|541569833|FG001|Overall Study|Migrated/moved from study area|4|||
150118425|NCT00432380|541569834|FG002|Overall Study|Migrated/moved from study area|1|||
150118426|NCT00432380|541569832|FG000|Overall Study|Adverse Event|1|||
150118427|NCT00432380|541569833|FG001|Overall Study|Adverse Event|0|||
150118428|NCT00432380|541569834|FG002|Overall Study|Adverse Event|0|||
150118429|NCT03422003|541569838|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
150118430|NCT03422003|541569839|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
150118431|NCT03422003|541569838|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
150118432|NCT03422003|541569839|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
150190534|NCT02761057|541835620|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
150190535|NCT02761057|541835621|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
150190536|NCT02761057|541835622|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
150190537|NCT02761057|541835619|FG000|Overall Study|Currently On Study Treatment|0|||
150190538|NCT02761057|541835620|FG001|Overall Study|Currently On Study Treatment|3|||
150190539|NCT02761057|541835621|FG002|Overall Study|Currently On Study Treatment|0|||
150190540|NCT02761057|541835622|FG003|Overall Study|Currently On Study Treatment|0|||
150190541|NCT02761057|541835619|FG000|Overall Study|Adverse Event|11|||
150190542|NCT02761057|541835620|FG001|Overall Study|Adverse Event|9|||
150190543|NCT02761057|541835621|FG002|Overall Study|Adverse Event|5|||
150190544|NCT02761057|541835622|FG003|Overall Study|Adverse Event|3|||
150190545|NCT02761057|541835619|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
150190546|NCT02761057|541835620|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
150190547|NCT02761057|541835621|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
150190548|NCT02761057|541835622|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
150190549|NCT02761057|541835619|FG000|Overall Study|Progression/Relapse|29|||
150190550|NCT02761057|541835620|FG001|Overall Study|Progression/Relapse|27|||
150190551|NCT02761057|541835621|FG002|Overall Study|Progression/Relapse|20|||
150190552|NCT02761057|541835622|FG003|Overall Study|Progression/Relapse|23|||
150190553|NCT02761057|541835619|FG000|Overall Study|Death|2|||
150190554|NCT02761057|541835620|FG001|Overall Study|Death|2|||
150190555|NCT02761057|541835621|FG002|Overall Study|Death|1|||
150190556|NCT02761057|541835622|FG003|Overall Study|Death|1|||
150190557|NCT02761057|541835619|FG000|Overall Study|Other - Not Protocol Specified|2|||
150190558|NCT02761057|541835620|FG001|Overall Study|Other - Not Protocol Specified|1|||
150190559|NCT02761057|541835621|FG002|Overall Study|Other - Not Protocol Specified|2|||
150190560|NCT02761057|541835622|FG003|Overall Study|Other - Not Protocol Specified|0|||
150190561|NCT04505904|541835625|FG000|Overall Study|Withdrawal by Subject|1|||
150190562|NCT04505904|541835626|FG001|Overall Study|Withdrawal by Subject|2|||
150190563|NCT04505904|541835627|FG002|Overall Study|Withdrawal by Subject|0|||
150190564|NCT04505904|541835628|FG003|Overall Study|Withdrawal by Subject|0|||
150190565|NCT04505904|541835625|FG000|Overall Study|Physician Decision|1|||
150190566|NCT04505904|541835626|FG001|Overall Study|Physician Decision|0|||
150190567|NCT04505904|541835627|FG002|Overall Study|Physician Decision|0|||
150190568|NCT04505904|541835628|FG003|Overall Study|Physician Decision|0|||
150190569|NCT04505904|541835625|FG000|Overall Study|Adverse Event|0|||
150190570|NCT04505904|541835626|FG001|Overall Study|Adverse Event|1|||
150190571|NCT04505904|541835627|FG002|Overall Study|Adverse Event|0|||
150190572|NCT04505904|541835628|FG003|Overall Study|Adverse Event|0|||
150190573|NCT04277442|541835631|FG000|Overall Study|Death|1|||
150190574|NCT05084508|541835632|FG000|Overall Study|Lost to Follow-up|6|||
150190575|NCT05084508|541835633|FG001|Overall Study|Lost to Follow-up|3|||
150190576|NCT05084508|541835634|FG002|Overall Study|Lost to Follow-up|7|||
150190577|NCT05084508|541835635|FG003|Overall Study|Lost to Follow-up|3|||
150190578|NCT05084508|541835632|FG000|Overall Study|Withdrawal by Subject|0|||
150190579|NCT05084508|541835633|FG001|Overall Study|Withdrawal by Subject|2|||
150190580|NCT05084508|541835634|FG002|Overall Study|Withdrawal by Subject|3|||
150190581|NCT05084508|541835635|FG003|Overall Study|Withdrawal by Subject|1|||
150190582|NCT05084508|541835632|FG000|Overall Study|Other|0|||
150190583|NCT05084508|541835633|FG001|Overall Study|Other|0|||
150190584|NCT05084508|541835634|FG002|Overall Study|Other|0|||
150190585|NCT05084508|541835635|FG003|Overall Study|Other|1|||
150190586|NCT05609760|541835643|FG000|Overall Study|Lost to Follow-up|0|||
150190587|NCT05609760|541835644|FG001|Overall Study|Lost to Follow-up|1|||
150190588|NCT05609760|541835643|FG000|Overall Study|Withdrawal by Subject|1|||
150190589|NCT05609760|541835644|FG001|Overall Study|Withdrawal by Subject|0|||
150190590|NCT03396588|541835645|FG000|Overall Study|Physician Decision|2|||
150190591|NCT03396588|541835646|FG001|Overall Study|Physician Decision|3|||
150190592|NCT05351554|541835648|FG000|Overall Study|Study terminated by sponsor|1|||
150190593|NCT04806594|541837465|FG000|Overall Study|Withdrawal by Subject|2|||
150190594|NCT04806594|541837465|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
150190595|NCT03457142|541837469|FG000|Overall Study|Death|1|||
150190596|NCT04977947|541837473|FG000|Overall Study|Lost to Follow-up|1|||
150190597|NCT04977947|541837474|FG001|Overall Study|Lost to Follow-up|1|||
150190598|NCT02921230|541837475|FG000|Overall Study|Withdrawal by Subject|20|||
150190599|NCT02921230|541837476|FG001|Overall Study|Withdrawal by Subject|8|||
150190600|NCT02921230|541837475|FG000|Overall Study|Death|12|||
150190601|NCT02921230|541837476|FG001|Overall Study|Death|3|||
150190602|NCT02921230|541837475|FG000|Overall Study|Protocol Violation|17|||
150190603|NCT02921230|541837476|FG001|Overall Study|Protocol Violation|6|||
150190604|NCT02921230|541837475|FG000|Overall Study|Early completion|5|||
150190605|NCT02921230|541837476|FG001|Overall Study|Early completion|1|||
150190606|NCT02921230|541837475|FG000|Overall Study|Pending data entry|1|||
150190607|NCT02921230|541837476|FG001|Overall Study|Pending data entry|0|||
150190608|NCT04142788|541837479|FG000|Overall Study|Trial terminated prematurely|2|||
150190609|NCT04142788|541837480|FG001|Overall Study|Trial terminated prematurely|2|||
150190610|NCT01396278|541837481|FG000|Overall Study|Adverse Event|0|||
150190611|NCT01396278|541837482|FG001|Overall Study|Adverse Event|0|||
150190612|NCT01396278|541837483|FG002|Overall Study|Adverse Event|0|||
150190613|NCT01396278|541837484|FG003|Overall Study|Adverse Event|2|||
150190614|NCT01396278|541837485|FG004|Overall Study|Adverse Event|0|||
150190615|NCT01396278|541837481|FG000|Overall Study|Withdraw due to trial termination|2|||
150190616|NCT01396278|541837482|FG001|Overall Study|Withdraw due to trial termination|1|||
150190617|NCT01396278|541837483|FG002|Overall Study|Withdraw due to trial termination|1|||
150190618|NCT01396278|541837484|FG003|Overall Study|Withdraw due to trial termination|0|||
150190619|NCT01396278|541837485|FG004|Overall Study|Withdraw due to trial termination|2|||
150190620|NCT00999804|541837488|FG000|Overall Study|Lack of Efficacy|9|||
150190621|NCT00999804|541837489|FG001|Overall Study|Lack of Efficacy|2|||
150190622|NCT00999804|541837488|FG000|Overall Study|Adverse Event|4|||
150190623|NCT00999804|541837489|FG001|Overall Study|Adverse Event|3|||
150190624|NCT00999804|541837488|FG000|Overall Study|Withdrawal by Subject|4|||
150190625|NCT00999804|541837489|FG001|Overall Study|Withdrawal by Subject|0|||
150190626|NCT00999804|541837488|FG000|Overall Study|Death|1|||
150190627|NCT00999804|541837489|FG001|Overall Study|Death|0|||
150190628|NCT00999804|541837488|FG000|Overall Study|Ineligible|3|||
150190629|NCT00999804|541837489|FG001|Overall Study|Ineligible|0|||
150190630|NCT05653427|541837491|FG000|Overall Study|Study Terminated by Sponsor|13|||
150190631|NCT04256941|541837495|FG000|Overall Study|Withdrawal by Subject|0|||
150190632|NCT04256941|541837496|FG001|Overall Study|Withdrawal by Subject|1|||
150190633|NCT04256941|541837495|FG000|Overall Study|Death|1|||
150190634|NCT04256941|541837496|FG001|Overall Study|Death|0|||
150190635|NCT04256941|541837495|FG000|Overall Study|Disease Progession|0|||
150190636|NCT04256941|541837496|FG001|Overall Study|Disease Progession|2|||
150190637|NCT05590403|541837509|FG000|Overall Study|Lost to Follow-up|13|||
150190638|NCT05590403|541837510|FG001|Overall Study|Lost to Follow-up|1|||
150190639|NCT05590403|541837511|FG002|Overall Study|Lost to Follow-up|7|||
150190640|NCT05590403|541837512|FG003|Overall Study|Lost to Follow-up|3|||
150190641|NCT05590403|541837513|FG004|Overall Study|Lost to Follow-up|4|||
150190642|NCT05590403|541837509|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
150190643|NCT05590403|541837510|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
150190644|NCT05590403|541837511|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
150190645|NCT05590403|541837512|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
150190646|NCT05590403|541837513|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
150190647|NCT05590403|541837509|FG000|Overall Study|Other|2|||
150190648|NCT05590403|541837510|FG001|Overall Study|Other|0|||
150190649|NCT05590403|541837511|FG002|Overall Study|Other|2|||
150190650|NCT05590403|541837512|FG003|Overall Study|Other|2|||
150190651|NCT05590403|541837513|FG004|Overall Study|Other|0|||
150190652|NCT05590403|541837509|FG000|Overall Study|Migrated / moved from the study area|1|||
150190653|NCT05590403|541837510|FG001|Overall Study|Migrated / moved from the study area|1|||
150190654|NCT05590403|541837511|FG002|Overall Study|Migrated / moved from the study area|0|||
150190655|NCT05590403|541837512|FG003|Overall Study|Migrated / moved from the study area|3|||
150190656|NCT05590403|541837513|FG004|Overall Study|Migrated / moved from the study area|1|||
150190657|NCT05590403|541837509|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
150190658|NCT05590403|541837510|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
150190659|NCT05590403|541837511|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
150190660|NCT05590403|541837512|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
150190661|NCT05590403|541837513|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
150190662|NCT04717492|541837519|FG000|Overall Study|Withdrawal by Subject|2|||
150190663|NCT04717492|541837520|FG001|Overall Study|Withdrawal by Subject|13|||
150190664|NCT04717492|541837519|FG000|Overall Study|Lost to Follow-up|2|||
150190665|NCT04717492|541837520|FG001|Overall Study|Lost to Follow-up|9|||
150190666|NCT03575897|541837521|FG000|Overall Study|Lost to Follow-up|12|||
150190667|NCT03575897|541837522|FG001|Overall Study|Lost to Follow-up|13|||
150190668|NCT03829410|541837524|FG000|Overall Study|Adverse Event|1|||
150190669|NCT03829410|541837525|FG001|Overall Study|Adverse Event|0|||
150190670|NCT03829410|541837526|FG002|Overall Study|Adverse Event|1|||
150190671|NCT03829410|541837527|FG003|Overall Study|Adverse Event|4|||
150190672|NCT03829410|541837524|FG000|Overall Study|Physician Decision|0|||
150190673|NCT03829410|541837525|FG001|Overall Study|Physician Decision|0|||
150190674|NCT03829410|541837526|FG002|Overall Study|Physician Decision|0|||
150190675|NCT03829410|541837527|FG003|Overall Study|Physician Decision|2|||
150118433|NCT01404312|541569840|FG000|Overall Study|Death|21|||
150118434|NCT01404312|541569841|FG001|Overall Study|Death|27|||
150118435|NCT01404312|541569840|FG000|Overall Study|Withdrawal by Subject|15|||
150118436|NCT01404312|541569841|FG001|Overall Study|Withdrawal by Subject|18|||
150118437|NCT01404312|541569840|FG000|Overall Study|Participant Unable to get to clinic|93|||
150118438|NCT01404312|541569841|FG001|Overall Study|Participant Unable to get to clinic|103|||
150118439|NCT01404312|541569840|FG000|Overall Study|Lost to Follow-up|115|||
150118440|NCT01404312|541569841|FG001|Overall Study|Lost to Follow-up|111|||
150118441|NCT01404312|541569840|FG000|Overall Study|Site closed|22|||
150118442|NCT01404312|541569841|FG001|Overall Study|Site closed|21|||
150118443|NCT01404312|541569840|FG000|Overall Study|Participant not willing to adhere to req|31|||
150118444|NCT01404312|541569841|FG001|Overall Study|Participant not willing to adhere to req|29|||
150118445|NCT01404312|541569840|FG000|Overall Study|Severe debilitation, unable to continue|1|||
150118446|NCT01404312|541569841|FG001|Overall Study|Severe debilitation, unable to continue|2|||
150118447|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Adverse Event|5|||
150118448|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Adverse Event|8|||
150118449|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Adverse Event|4|||
150118450|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Adverse Event|8|||
150118451|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
150118452|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
150118453|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
150118454|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
150118455|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
150118456|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
150118457|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
150118458|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
150118459|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Physician Decision|1|||
150118460|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Physician Decision|0|||
150118461|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Physician Decision|0|||
150118462|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Physician Decision|0|||
150118463|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
150118464|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
150118465|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
150118466|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
150118467|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Pregnancy|0|||
150118468|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Pregnancy|1|||
150118469|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Pregnancy|0|||
150118470|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Pregnancy|0|||
150118471|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
150118472|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
150118473|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
150118474|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
150118475|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Death|0|||
150118476|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Death|1|||
150118477|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Death|0|||
150118478|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Death|0|||
150118479|NCT00071487|541569844|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
150118480|NCT00071487|541569845|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
150118481|NCT00071487|541569846|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
150118482|NCT00071487|541569847|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
150118483|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
150118484|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
150118485|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
150118486|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
150118487|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150118488|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150118489|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
150118490|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
150118491|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150118492|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150118493|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
150118494|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
150118495|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
150118496|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
150118497|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
150118498|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
150118499|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150190676|NCT03829410|541837524|FG000|Overall Study|Disease Progressing|3|||
150118500|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150118501|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
150118502|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
150118503|NCT00071487|541569844|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
150118504|NCT00071487|541569845|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
150118505|NCT00071487|541569846|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
150118506|NCT00071487|541569847|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
150118507|NCT00581945|541569852|FG000|Overall Study|Adverse Event|4|||
150118508|NCT00581945|541569853|FG001|Overall Study|Adverse Event|4|||
150118509|NCT00581945|541569852|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150118510|NCT00581945|541569853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150118511|NCT00581945|541569852|FG000|Overall Study|Withdrawal by Subject|2|||
150118512|NCT00581945|541569853|FG001|Overall Study|Withdrawal by Subject|6|||
150118513|NCT00581945|541569852|FG000|Overall Study|Death|1|||
150118514|NCT00581945|541569853|FG001|Overall Study|Death|0|||
150118515|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
150118516|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
150118517|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
150118518|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Death|1|||
150118519|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
150118520|NCT02840877|541569854|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
150118521|NCT02840877|541569854|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
150118522|NCT02840877|541569854|FG000|12 Weeks to 6 Months|Treatment failure|1|||
150118523|NCT02840877|541569854|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
150118524|NCT02840877|541569854|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
150118525|NCT02840877|541569854|FG000|12 Weeks to 6 Months|Death|1|||
150118526|NCT02840877|541569854|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
150118527|NCT02840877|541569854|FG000|6 Months to 18 Months|Treatment failure|7|||
150118528|NCT02840877|541569854|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
150118529|NCT02840877|541569854|FG000|6 Months to 18 Months|Moved/transferred out|6|||
150118530|NCT02840877|541569854|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
150118531|NCT02840877|541569854|FG000|6 Months to 18 Months|Death|4|||
150118532|NCT02840877|541569854|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
150118533|NCT02840877|541569854|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
150118534|NCT02840877|541569854|FG000|6 Months to 18 Months|Still in study.|14|||
150118535|NCT03003676|541569855|FG000|Overall Study|Lack of Efficacy|5|||
150118536|NCT03003676|541569856|FG001|Overall Study|Lack of Efficacy|7|||
150118537|NCT03003676|541569855|FG000|Overall Study|Withdrawal by Subject|0|||
150118538|NCT03003676|541569856|FG001|Overall Study|Withdrawal by Subject|1|||
150118539|NCT03003676|541569855|FG000|Overall Study|Hepatitis B infection|1|||
150118540|NCT03003676|541569856|FG001|Overall Study|Hepatitis B infection|0|||
150118541|NCT00803023|541569863|FG000|Overall Study|Adverse Event|5|||
150118542|NCT00803023|541569864|FG001|Overall Study|Adverse Event|4|||
150118543|NCT00803023|541569865|FG002|Overall Study|Adverse Event|8|||
150118544|NCT00803023|541569866|FG003|Overall Study|Adverse Event|6|||
150118545|NCT00803023|541569863|FG000|Overall Study|Withdrawal by Subject|0|||
150118546|NCT00803023|541569864|FG001|Overall Study|Withdrawal by Subject|2|||
150118547|NCT00803023|541569865|FG002|Overall Study|Withdrawal by Subject|0|||
150118548|NCT00803023|541569866|FG003|Overall Study|Withdrawal by Subject|0|||
150118549|NCT00803023|541569863|FG000|Overall Study|Lost to Follow-up|0|||
150118550|NCT00803023|541569864|FG001|Overall Study|Lost to Follow-up|1|||
150118551|NCT00803023|541569865|FG002|Overall Study|Lost to Follow-up|2|||
150118552|NCT00803023|541569866|FG003|Overall Study|Lost to Follow-up|1|||
150118553|NCT00803023|541569863|FG000|Overall Study|Lack of Efficacy|0|||
150118554|NCT00803023|541569864|FG001|Overall Study|Lack of Efficacy|1|||
150118555|NCT00803023|541569865|FG002|Overall Study|Lack of Efficacy|1|||
150118556|NCT00803023|541569866|FG003|Overall Study|Lack of Efficacy|1|||
150118557|NCT02647658|541569871|FG000|Overall Study|Consent refusal|15|||
150118558|NCT02647658|541569872|FG001|Overall Study|Consent refusal|24|||
150118559|NCT01542528|541569873|FG000|Overall Study|Lost to Follow-up|2|||
150118560|NCT01542528|541569874|FG001|Overall Study|Lost to Follow-up|1|||
150118561|NCT01542528|541569873|FG000|Overall Study|Physician Decision|1|||
150118562|NCT01542528|541569874|FG001|Overall Study|Physician Decision|0|||
150118563|NCT01542528|541569873|FG000|Overall Study|Withdrawal by Subject|9|||
150118564|NCT01542528|541569874|FG001|Overall Study|Withdrawal by Subject|6|||
150118565|NCT05282004|541569875|FG000|Overall Study|Adverse Event|2|||
150118566|NCT04808609|541569876|FG000|Overall Study|Lost to Follow-up|0|||
150118567|NCT04808609|541569877|FG001|Overall Study|Lost to Follow-up|2|||
150118568|NCT04808609|541569876|FG000|Overall Study|Administrative Withdrawal|0|||
150118569|NCT04808609|541569877|FG001|Overall Study|Administrative Withdrawal|1|||
150118570|NCT01993719|541569879|FG000|First Drug Administration|Not treated|1|||
150118571|NCT01993719|541569880|FG001|First Drug Administration|Not treated|0|||
150118572|NCT01993719|541569881|FG002|First Drug Administration|Not treated|0|||
150118573|NCT01993719|541569882|FG003|First Drug Administration|Not treated|0|||
150118574|NCT01993719|541569883|FG004|First Drug Administration|Not treated|0|||
150118575|NCT04382326|541569886|FG000|Overall Study|Adverse Event, not serious|1|||
150118576|NCT04382326|541569887|FG001|Overall Study|Adverse Event, not serious|2|||
150118577|NCT04382326|541569886|FG000|Overall Study|Other|1|||
150118578|NCT04382326|541569887|FG001|Overall Study|Other|0|||
150118579|NCT04382326|541569886|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
150118580|NCT04382326|541569887|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
150118581|NCT04382326|541569886|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
150118582|NCT04382326|541569887|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
150118583|NCT04382326|541569886|FG000|Overall Study|Protocol Violation|29|||
150118584|NCT04382326|541569887|FG001|Overall Study|Protocol Violation|23|||
150118585|NCT04382326|541569886|FG000|Overall Study|Physician Decision|0|||
150118586|NCT04382326|541569887|FG001|Overall Study|Physician Decision|1|||
150118587|NCT04382326|541569886|FG000|Overall Study|Lost to Follow-up|48|||
150118588|NCT04382326|541569887|FG001|Overall Study|Lost to Follow-up|63|||
150118589|NCT04382326|541569886|FG000|Overall Study|Adverse Event, non-fatal|1|||
150118590|NCT04382326|541569887|FG001|Overall Study|Adverse Event, non-fatal|1|||
150118591|NCT02461589|541569893|FG000|Overall Study|Withdrawal by Subject|5|||
150118592|NCT02461589|541569894|FG001|Overall Study|Withdrawal by Subject|1|||
150118593|NCT02461589|541569895|FG002|Overall Study|Withdrawal by Subject|3|||
150118594|NCT02461589|541569896|FG003|Overall Study|Withdrawal by Subject|2|||
150118595|NCT02461589|541569897|FG004|Overall Study|Withdrawal by Subject|1|||
150118596|NCT02461589|541569898|FG005|Overall Study|Withdrawal by Subject|2|||
150118597|NCT02461589|541569899|FG006|Overall Study|Withdrawal by Subject|1|||
150118598|NCT02461589|541569900|FG007|Overall Study|Withdrawal by Subject|3|||
150118599|NCT02461589|541569901|FG008|Overall Study|Withdrawal by Subject|3|||
150118600|NCT02461589|541569902|FG009|Overall Study|Withdrawal by Subject|1|||
150118601|NCT02461589|541569893|FG000|Overall Study|Lost to Follow-up|0|||
150118602|NCT02461589|541569894|FG001|Overall Study|Lost to Follow-up|0|||
150118603|NCT02461589|541569895|FG002|Overall Study|Lost to Follow-up|2|||
150118604|NCT02461589|541569896|FG003|Overall Study|Lost to Follow-up|3|||
150118605|NCT02461589|541569897|FG004|Overall Study|Lost to Follow-up|1|||
150118606|NCT02461589|541569898|FG005|Overall Study|Lost to Follow-up|1|||
150118607|NCT02461589|541569899|FG006|Overall Study|Lost to Follow-up|3|||
150118608|NCT02461589|541569900|FG007|Overall Study|Lost to Follow-up|1|||
150118609|NCT02461589|541569901|FG008|Overall Study|Lost to Follow-up|3|||
150118610|NCT02461589|541569902|FG009|Overall Study|Lost to Follow-up|1|||
150118611|NCT02461589|541569893|FG000|Overall Study|Death|0|||
150118612|NCT02461589|541569894|FG001|Overall Study|Death|0|||
150118613|NCT02461589|541569895|FG002|Overall Study|Death|0|||
150118614|NCT02461589|541569896|FG003|Overall Study|Death|0|||
150118615|NCT02461589|541569897|FG004|Overall Study|Death|0|||
150118616|NCT02461589|541569898|FG005|Overall Study|Death|0|||
150118617|NCT02461589|541569899|FG006|Overall Study|Death|0|||
150118618|NCT02461589|541569900|FG007|Overall Study|Death|1|||
150118619|NCT02461589|541569901|FG008|Overall Study|Death|0|||
150118620|NCT02461589|541569902|FG009|Overall Study|Death|0|||
150118621|NCT02461589|541569893|FG000|Overall Study|Unclassified|0|||
150118622|NCT02461589|541569894|FG001|Overall Study|Unclassified|0|||
150118623|NCT02461589|541569895|FG002|Overall Study|Unclassified|0|||
150118624|NCT02461589|541569896|FG003|Overall Study|Unclassified|0|||
150118625|NCT02461589|541569897|FG004|Overall Study|Unclassified|0|||
150118626|NCT02461589|541569898|FG005|Overall Study|Unclassified|0|||
150118627|NCT02461589|541569899|FG006|Overall Study|Unclassified|1|||
150118628|NCT02461589|541569900|FG007|Overall Study|Unclassified|0|||
150118629|NCT02461589|541569901|FG008|Overall Study|Unclassified|0|||
150118630|NCT02461589|541569902|FG009|Overall Study|Unclassified|2|||
150118631|NCT02461589|541569893|FG000|Overall Study|Missing follow-up information|1|||
150118632|NCT02461589|541569894|FG001|Overall Study|Missing follow-up information|1|||
150118633|NCT02461589|541569895|FG002|Overall Study|Missing follow-up information|0|||
150118634|NCT02461589|541569896|FG003|Overall Study|Missing follow-up information|0|||
150118635|NCT02461589|541569897|FG004|Overall Study|Missing follow-up information|0|||
150118636|NCT02461589|541569898|FG005|Overall Study|Missing follow-up information|0|||
150118637|NCT02461589|541569899|FG006|Overall Study|Missing follow-up information|1|||
150118638|NCT02461589|541569900|FG007|Overall Study|Missing follow-up information|0|||
150118639|NCT02461589|541569901|FG008|Overall Study|Missing follow-up information|0|||
150118640|NCT02461589|541569902|FG009|Overall Study|Missing follow-up information|0|||
150118641|NCT02461589|541569893|FG000|Overall Study|Withdrawal from trial before exposure|0|||
150118642|NCT02461589|541569894|FG001|Overall Study|Withdrawal from trial before exposure|0|||
150118643|NCT02461589|541569895|FG002|Overall Study|Withdrawal from trial before exposure|0|||
150118644|NCT02461589|541569896|FG003|Overall Study|Withdrawal from trial before exposure|0|||
150118645|NCT02461589|541569897|FG004|Overall Study|Withdrawal from trial before exposure|0|||
150118646|NCT02461589|541569898|FG005|Overall Study|Withdrawal from trial before exposure|0|||
150118647|NCT02461589|541569899|FG006|Overall Study|Withdrawal from trial before exposure|0|||
150118648|NCT02461589|541569900|FG007|Overall Study|Withdrawal from trial before exposure|0|||
150118649|NCT02461589|541569901|FG008|Overall Study|Withdrawal from trial before exposure|0|||
150190677|NCT03829410|541837525|FG001|Overall Study|Disease Progressing|4|||
150190678|NCT03829410|541837526|FG002|Overall Study|Disease Progressing|2|||
150190679|NCT03829410|541837527|FG003|Overall Study|Disease Progressing|31|||
150190680|NCT03829410|541837524|FG000|Overall Study|Miscellaneous|2|||
150190681|NCT03829410|541837525|FG001|Overall Study|Miscellaneous|4|||
150190682|NCT03829410|541837526|FG002|Overall Study|Miscellaneous|3|||
150190683|NCT03829410|541837527|FG003|Overall Study|Miscellaneous|10|||
150190684|NCT02577835|541837528|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
150190685|NCT04749615|541837529|FG000|Overall Study|Lost to Follow-up|6|||
150190686|NCT04749615|541837530|FG001|Overall Study|Lost to Follow-up|10|||
150190687|NCT03611491|541837531|FG000|Overall Study|Lost to Follow-up|1|||
150190688|NCT04676022|541837532|FG000|Overall Study|Screen Failure/|1|||
150190689|NCT04676022|541837533|FG001|Overall Study|Screen Failure/|1|||
150190690|NCT04676022|541837534|FG002|Overall Study|Screen Failure/|85|||
150190691|NCT04676022|541837532|FG000|Overall Study|Lost to Follow-up|1|||
150190692|NCT04676022|541837533|FG001|Overall Study|Lost to Follow-up|1|||
150118650|NCT02461589|541569902|FG009|Overall Study|Withdrawal from trial before exposure|1|||
150118651|NCT01038921|541569903|FG000|Overall Study|Withdrawal by Subject|1|||
150118652|NCT01038921|541569904|FG001|Overall Study|Withdrawal by Subject|0|||
150118653|NCT01038921|541569903|FG000|Overall Study|Physician Decision|1|||
150118654|NCT01038921|541569904|FG001|Overall Study|Physician Decision|0|||
150118655|NCT01709227|541569905|FG000|Overall Study|Physician Decision|1|||
150118656|NCT01709227|541569906|FG001|Overall Study|Physician Decision|0|||
150118657|NCT01709227|541569905|FG000|Overall Study|Pleural Peritoneal communication|0|||
150118658|NCT01709227|541569906|FG001|Overall Study|Pleural Peritoneal communication|9|||
150118659|NCT03295201|541569909|FG000|Overall Study|Lost to Follow-up|1|||
150118660|NCT03295201|541569910|FG001|Overall Study|Lost to Follow-up|1|||
150118661|NCT03295201|541569909|FG000|Overall Study|Hospital admission|0|||
150118662|NCT03295201|541569910|FG001|Overall Study|Hospital admission|1|||
150118663|NCT00572572|541569911|FG000|Overall Study|Withdrawal by Subject|3|||
150118664|NCT00572572|541569912|FG001|Overall Study|Withdrawal by Subject|6|||
150118665|NCT02828111|541569913|FG000|Overall Study|Withdrawal by Subject|0|||
150118666|NCT02828111|541569914|FG001|Overall Study|Withdrawal by Subject|0|||
150118667|NCT02828111|541569915|FG002|Overall Study|Withdrawal by Subject|2|||
150118668|NCT02828111|541569916|FG003|Overall Study|Withdrawal by Subject|0|||
150118669|NCT02828111|541569917|FG004|Overall Study|Withdrawal by Subject|0|||
150118670|NCT02828111|541569913|FG000|Overall Study|Lost to Follow-up|0|||
150118671|NCT02828111|541569914|FG001|Overall Study|Lost to Follow-up|0|||
150118672|NCT02828111|541569915|FG002|Overall Study|Lost to Follow-up|0|||
150118673|NCT02828111|541569916|FG003|Overall Study|Lost to Follow-up|1|||
150118674|NCT02828111|541569917|FG004|Overall Study|Lost to Follow-up|1|||
150118675|NCT04096560|541569918|FG000|Overall Study|Reason not Specified|1|||
150118676|NCT04096560|541569919|FG001|Overall Study|Reason not Specified|0|||
150118677|NCT04096560|541569920|FG002|Overall Study|Reason not Specified|0|||
150118678|NCT04096560|541569921|FG003|Overall Study|Reason not Specified|0|||
150118679|NCT04096560|541569922|FG004|Overall Study|Reason not Specified|1|||
150118680|NCT04096560|541569923|FG005|Overall Study|Reason not Specified|1|||
150118681|NCT04096560|541569924|FG006|Overall Study|Reason not Specified|1|||
150118682|NCT04096560|541569925|FG007|Overall Study|Reason not Specified|0|||
150190693|NCT04676022|541837534|FG002|Overall Study|Lost to Follow-up|0|||
150190694|NCT04676022|541837532|FG000|Overall Study|Adverse Event|2|||
150190695|NCT04676022|541837533|FG001|Overall Study|Adverse Event|0|||
150190696|NCT04676022|541837534|FG002|Overall Study|Adverse Event|1|||
150190697|NCT04676022|541837532|FG000|Overall Study|Physician Decision|2|||
150118683|NCT04096560|541569918|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118684|NCT04096560|541569919|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118685|NCT04096560|541569920|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118686|NCT04096560|541569921|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118687|NCT04096560|541569922|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118688|NCT04096560|541569923|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
150118689|NCT04096560|541569924|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
150190698|NCT04676022|541837533|FG001|Overall Study|Physician Decision|0|||
150190699|NCT04676022|541837534|FG002|Overall Study|Physician Decision|1|||
150190700|NCT04676022|541837532|FG000|Overall Study|Withdrawal by Subject|3|||
150190701|NCT04676022|541837533|FG001|Overall Study|Withdrawal by Subject|1|||
150190702|NCT04676022|541837534|FG002|Overall Study|Withdrawal by Subject|6|||
150190703|NCT04676022|541837532|FG000|Overall Study|Will not move forward with permanent implant|6|||
150190704|NCT04676022|541837533|FG001|Overall Study|Will not move forward with permanent implant|0|||
150190705|NCT04676022|541837534|FG002|Overall Study|Will not move forward with permanent implant|0|||
150190706|NCT04676022|541837532|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
150190707|NCT04676022|541837533|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
150190708|NCT04676022|541837534|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
150190709|NCT02274662|541837550|FG000|Overall Study|Death|1|||
150190710|NCT02274662|541837550|FG000|Overall Study|Lost to Follow-up|3|||
150190711|NCT03194217|541837551|FG000|Overall Study|Adverse Event|0|||
150190712|NCT03194217|541837552|FG001|Overall Study|Adverse Event|2|||
150190713|NCT03194217|541837553|FG002|Overall Study|Adverse Event|3|||
150190714|NCT03194217|541837554|FG003|Overall Study|Adverse Event|3|||
150190715|NCT03194217|541837551|FG000|Overall Study|Failure to meet randomisation criteria|0|||
150190716|NCT03194217|541837552|FG001|Overall Study|Failure to meet randomisation criteria|0|||
150190717|NCT03194217|541837553|FG002|Overall Study|Failure to meet randomisation criteria|0|||
150190718|NCT03194217|541837554|FG003|Overall Study|Failure to meet randomisation criteria|1|||
150190719|NCT03194217|541837551|FG000|Overall Study|Other|0|||
150190720|NCT03194217|541837552|FG001|Overall Study|Other|1|||
150190721|NCT03194217|541837553|FG002|Overall Study|Other|1|||
150190722|NCT03194217|541837554|FG003|Overall Study|Other|0|||
150190723|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
150190724|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
150190725|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
150190726|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
150190727|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
150190728|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
150190729|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
150190730|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190731|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
150190732|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190733|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190734|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190735|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190736|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
150190737|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
150190738|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
150190739|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
150190740|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
150190741|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
150190742|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
150190743|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
150190744|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
150190745|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150190746|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150190747|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150118690|NCT04096560|541569925|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
150118691|NCT04096560|541569918|FG000|Overall Study|Study Terminated by Sponsor|0|||
150118692|NCT04096560|541569919|FG001|Overall Study|Study Terminated by Sponsor|0|||
150118693|NCT04096560|541569920|FG002|Overall Study|Study Terminated by Sponsor|0|||
150118694|NCT04096560|541569921|FG003|Overall Study|Study Terminated by Sponsor|5|||
150118695|NCT04096560|541569922|FG004|Overall Study|Study Terminated by Sponsor|6|||
150118696|NCT04096560|541569923|FG005|Overall Study|Study Terminated by Sponsor|4|||
150118697|NCT04096560|541569924|FG006|Overall Study|Study Terminated by Sponsor|6|||
150118698|NCT04096560|541569925|FG007|Overall Study|Study Terminated by Sponsor|1|||
150118699|NCT04096560|541569918|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150118700|NCT04096560|541569919|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150190748|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150118701|NCT04096560|541569920|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150118702|NCT04096560|541569921|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150190749|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150118703|NCT04096560|541569922|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150118704|NCT04096560|541569923|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150190750|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
150190751|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190752|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
150190753|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190754|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190755|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190756|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190757|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
150190758|NCT02962895|541837555|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190759|NCT02962895|541837556|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190760|NCT02962895|541837557|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190761|NCT02962895|541837558|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
150190762|NCT02962895|541837559|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190763|NCT02962895|541837560|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190764|NCT02962895|541837561|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
150190765|NCT02962895|541837555|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190766|NCT02962895|541837556|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190767|NCT02962895|541837557|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190768|NCT02962895|541837558|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190769|NCT02962895|541837559|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190770|NCT02962895|541837560|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
150190771|NCT02962895|541837561|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
150190772|NCT02962895|541837555|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
150190773|NCT02962895|541837556|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
150190774|NCT02962895|541837557|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
150190775|NCT02962895|541837558|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
150190776|NCT02962895|541837559|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
150190777|NCT02962895|541837560|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
150190778|NCT02962895|541837561|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
150190779|NCT02962895|541837555|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190780|NCT02962895|541837556|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190781|NCT02962895|541837557|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190782|NCT02962895|541837558|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190783|NCT02962895|541837559|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190784|NCT02962895|541837560|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
150190785|NCT02962895|541837561|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
150190786|NCT02962895|541837555|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190787|NCT02962895|541837556|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
150190788|NCT02962895|541837557|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190789|NCT02962895|541837558|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190790|NCT02962895|541837559|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190791|NCT02962895|541837560|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190792|NCT02962895|541837561|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
150190793|NCT02962895|541837555|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190794|NCT02962895|541837556|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190795|NCT02962895|541837557|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190796|NCT02962895|541837558|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190797|NCT02962895|541837559|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
150190798|NCT02962895|541837560|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190799|NCT02962895|541837561|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
150190800|NCT02962895|541837555|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190801|NCT02962895|541837556|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190802|NCT02962895|541837557|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190803|NCT02962895|541837558|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190804|NCT02962895|541837559|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
150190805|NCT02962895|541837560|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190806|NCT02962895|541837561|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
150190807|NCT02962895|541837555|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
150190808|NCT02962895|541837556|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
150190809|NCT02962895|541837557|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
150190810|NCT02962895|541837558|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
150190811|NCT02962895|541837559|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
150190812|NCT02962895|541837560|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
150190813|NCT02962895|541837561|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
150190814|NCT02962895|541837555|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
150190815|NCT02962895|541837556|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
150190816|NCT02962895|541837557|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
150190817|NCT02962895|541837558|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
150190818|NCT02962895|541837559|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
150190819|NCT02962895|541837560|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
150190820|NCT02962895|541837561|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
150190821|NCT05282173|541837570|FG000|Overall Study|Missed|3|||
150190822|NCT05282173|541837571|FG001|Overall Study|Missed|2|||
150190823|NCT05282173|541837572|FG002|Overall Study|Missed|4|||
150190824|NCT03134196|541837573|FG000|Overall Study|Death|2|||
150190825|NCT03134196|541837574|FG001|Overall Study|Death|1|||
150190826|NCT03134196|541837573|FG000|Overall Study|Lost to Follow-up|13|||
150190827|NCT03134196|541837574|FG001|Overall Study|Lost to Follow-up|15|||
150190828|NCT03134196|541837573|FG000|Overall Study|Physician Decision|0|||
150190829|NCT03134196|541837574|FG001|Overall Study|Physician Decision|1|||
150190830|NCT03134196|541837573|FG000|Overall Study|Withdrawal by Subject|19|||
150190831|NCT03134196|541837574|FG001|Overall Study|Withdrawal by Subject|12|||
150190832|NCT03134196|541837573|FG000|Overall Study|Site Unable to Contact Participant|2|||
150190833|NCT03134196|541837574|FG001|Overall Study|Site Unable to Contact Participant|0|||
150190834|NCT03134196|541837573|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
150190835|NCT03134196|541837574|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
150190836|NCT03134196|541837573|FG000|Overall Study|Scheduling Conflict|1|||
150190837|NCT03134196|541837574|FG001|Overall Study|Scheduling Conflict|0|||
150190838|NCT01798498|541837594|FG000|Overall Study|Lost to Follow-up|1|||
150190839|NCT03896789|541837595|FG000|Baseline|Lost to Follow-up|1|||
150190840|NCT03896789|541837596|FG001|Baseline|Lost to Follow-up|2|||
150190841|NCT03896789|541837595|FG000|Baseline|Death|3|||
150190842|NCT03896789|541837596|FG001|Baseline|Death|6|||
150190843|NCT03896789|541837595|FG000|Post-Randomization|Lost to Follow-up|12|||
150190844|NCT03896789|541837596|FG001|Post-Randomization|Lost to Follow-up|11|||
150190845|NCT03896789|541837595|FG000|Post-Randomization|Death|12|||
150190846|NCT03896789|541837596|FG001|Post-Randomization|Death|13|||
150190847|NCT04927364|541837600|FG000|Overall Study|Withdrawal by Subject|3|||
150190848|NCT04927364|541837600|FG000|Overall Study|Unable to complete preassessment MRI|1|||
150190849|NCT05087992|541837601|FG000|Overall Study|Adverse Event|0|||
150190850|NCT05087992|541837602|FG001|Overall Study|Adverse Event|1|||
150190851|NCT05087992|541837603|FG002|Overall Study|Adverse Event|0|||
150190852|NCT05087992|541837601|FG000|Overall Study|Withdrawal by Subject|2|||
150190853|NCT05087992|541837602|FG001|Overall Study|Withdrawal by Subject|0|||
150190854|NCT05087992|541837603|FG002|Overall Study|Withdrawal by Subject|0|||
150190855|NCT05087992|541837601|FG000|Overall Study|clinical disease progression|3|||
150190856|NCT05087992|541837602|FG001|Overall Study|clinical disease progression|1|||
150190857|NCT05087992|541837603|FG002|Overall Study|clinical disease progression|0|||
150190858|NCT05087992|541837601|FG000|Overall Study|objective disease progression|4|||
150190859|NCT05087992|541837602|FG001|Overall Study|objective disease progression|1|||
150190860|NCT05087992|541837603|FG002|Overall Study|objective disease progression|0|||
150118705|NCT04096560|541569924|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
150118706|NCT04096560|541569925|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
150118707|NCT00534352|541569926|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
150118708|NCT00534352|541569926|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
150118709|NCT00534352|541569926|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
150118710|NCT00534352|541569926|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
150118711|NCT00534352|541569926|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
150118712|NCT00534352|541569926|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
150118713|NCT00833924|541569931|FG000|Overall Study|Death|21|||
150190861|NCT04625283|541837607|FG000|Overall Study|post randomization exclusion|28|||
150190862|NCT04625283|541837608|FG001|Overall Study|post randomization exclusion|20|||
150190863|NCT05020249|541837609|FG000|Overall Study|Protocol Violation|1|||
150190864|NCT05020249|541837610|FG001|Overall Study|Protocol Violation|0|||
150190865|NCT03536754|541837613|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
150190866|NCT03536754|541837614|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
150190867|NCT03536754|541837615|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
150190868|NCT03536754|541837616|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
150190869|NCT03536754|541837617|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
150190870|NCT03536754|541837613|FG000|Open Label Extension|Other|0|||
150190871|NCT03536754|541837614|FG001|Open Label Extension|Other|0|||
150190872|NCT03536754|541837615|FG002|Open Label Extension|Other|0|||
150190873|NCT03536754|541837616|FG003|Open Label Extension|Other|0|||
150190874|NCT03536754|541837617|FG004|Open Label Extension|Other|1|||
150118714|NCT00833924|541569931|FG000|Overall Study|Conversion|2|||
150190875|NCT00686335|541837620|FG000|Run-in Period|Adverse Event|1|||
150190876|NCT00686335|541837620|FG000|Run-in Period|asthma exacerbation|1|||
150190877|NCT00686335|541837620|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
150118715|NCT00833924|541569931|FG000|Overall Study|Lost to Follow-up|2|||
150118716|NCT00833924|541569931|FG000|Overall Study|Withdrawal by Subject|13|||
150118717|NCT00833924|541569931|FG000|Overall Study|In study follow-up|71|||
150118718|NCT01485861|541569932|FG000|Phase Ib|Death|1|||
150118719|NCT01485861|541569933|FG001|Phase Ib|Death|0|||
150118720|NCT01485861|541569934|FG002|Phase Ib|Death|0|||
150118721|NCT01485861|541569935|FG003|Phase Ib|Death|0|||
150118722|NCT01485861|541569936|FG004|Phase Ib|Death|0|||
150118723|NCT01485861|541569937|FG005|Phase Ib|Death|0|||
150118724|NCT01485861|541569932|FG000|Phase Ib|Physician Decision|1|||
150118725|NCT01485861|541569933|FG001|Phase Ib|Physician Decision|1|||
150118726|NCT01485861|541569934|FG002|Phase Ib|Physician Decision|0|||
150118727|NCT01485861|541569935|FG003|Phase Ib|Physician Decision|0|||
150118728|NCT01485861|541569936|FG004|Phase Ib|Physician Decision|0|||
150118729|NCT01485861|541569937|FG005|Phase Ib|Physician Decision|0|||
150118730|NCT01485861|541569932|FG000|Phase Ib|Adverse Event|0|||
150118731|NCT01485861|541569933|FG001|Phase Ib|Adverse Event|4|||
150118732|NCT01485861|541569934|FG002|Phase Ib|Adverse Event|0|||
150118733|NCT01485861|541569935|FG003|Phase Ib|Adverse Event|0|||
150118734|NCT01485861|541569936|FG004|Phase Ib|Adverse Event|0|||
150118735|NCT01485861|541569937|FG005|Phase Ib|Adverse Event|0|||
150118736|NCT01485861|541569932|FG000|Phase Ib|Progression of disease|5|||
150118737|NCT01485861|541569933|FG001|Phase Ib|Progression of disease|0|||
150118738|NCT01485861|541569934|FG002|Phase Ib|Progression of disease|0|||
150118739|NCT01485861|541569935|FG003|Phase Ib|Progression of disease|0|||
150118740|NCT01485861|541569936|FG004|Phase Ib|Progression of disease|0|||
150118741|NCT01485861|541569937|FG005|Phase Ib|Progression of disease|0|||
150118742|NCT01485861|541569932|FG000|Phase Ib|Other|3|||
150118743|NCT01485861|541569933|FG001|Phase Ib|Other|0|||
150118744|NCT01485861|541569934|FG002|Phase Ib|Other|0|||
150118745|NCT01485861|541569935|FG003|Phase Ib|Other|0|||
150118746|NCT01485861|541569936|FG004|Phase Ib|Other|0|||
150118747|NCT01485861|541569937|FG005|Phase Ib|Other|0|||
150118748|NCT01485861|541569932|FG000|Phase Ib|Withdrawal by Subject|4|||
150118749|NCT01485861|541569933|FG001|Phase Ib|Withdrawal by Subject|1|||
150118750|NCT01485861|541569934|FG002|Phase Ib|Withdrawal by Subject|0|||
150118751|NCT01485861|541569935|FG003|Phase Ib|Withdrawal by Subject|0|||
150118752|NCT01485861|541569936|FG004|Phase Ib|Withdrawal by Subject|0|||
150118753|NCT01485861|541569937|FG005|Phase Ib|Withdrawal by Subject|0|||
150118754|NCT01485861|541569932|FG000|Phase II|Death|0|||
150118755|NCT01485861|541569933|FG001|Phase II|Death|0|||
150118756|NCT01485861|541569934|FG002|Phase II|Death|67|||
150118757|NCT01485861|541569935|FG003|Phase II|Death|71|||
150118758|NCT01485861|541569936|FG004|Phase II|Death|68|||
150118759|NCT01485861|541569937|FG005|Phase II|Death|0|||
150118760|NCT01485861|541569932|FG000|Phase II|Progression of Disease|0|||
150118761|NCT01485861|541569933|FG001|Phase II|Progression of Disease|0|||
150118762|NCT01485861|541569934|FG002|Phase II|Progression of Disease|1|||
150118763|NCT01485861|541569935|FG003|Phase II|Progression of Disease|0|||
150118764|NCT01485861|541569936|FG004|Phase II|Progression of Disease|0|||
150118765|NCT01485861|541569937|FG005|Phase II|Progression of Disease|0|||
150118766|NCT01485861|541569932|FG000|Phase II|Other|0|||
150118767|NCT01485861|541569933|FG001|Phase II|Other|0|||
150118768|NCT01485861|541569934|FG002|Phase II|Other|0|||
150118769|NCT01485861|541569935|FG003|Phase II|Other|1|||
150118770|NCT01485861|541569936|FG004|Phase II|Other|0|||
150118771|NCT01485861|541569937|FG005|Phase II|Other|0|||
150118772|NCT01485861|541569932|FG000|Phase II|Withdrawal by Subject|0|||
150118773|NCT01485861|541569933|FG001|Phase II|Withdrawal by Subject|0|||
150118774|NCT01485861|541569934|FG002|Phase II|Withdrawal by Subject|6|||
150118775|NCT01485861|541569935|FG003|Phase II|Withdrawal by Subject|3|||
150118776|NCT01485861|541569936|FG004|Phase II|Withdrawal by Subject|4|||
150118777|NCT01485861|541569937|FG005|Phase II|Withdrawal by Subject|0|||
150118778|NCT01485861|541569932|FG000|Phase II|Lost to Follow-up|0|||
150118779|NCT01485861|541569933|FG001|Phase II|Lost to Follow-up|0|||
150118780|NCT01485861|541569934|FG002|Phase II|Lost to Follow-up|2|||
150118781|NCT01485861|541569935|FG003|Phase II|Lost to Follow-up|3|||
150118782|NCT01485861|541569936|FG004|Phase II|Lost to Follow-up|5|||
150118783|NCT01485861|541569937|FG005|Phase II|Lost to Follow-up|0|||
150118784|NCT01485861|541569932|FG000|Phase II|Study Ended|0|||
150118785|NCT01485861|541569933|FG001|Phase II|Study Ended|0|||
150118786|NCT01485861|541569934|FG002|Phase II|Study Ended|7|||
150118787|NCT01485861|541569935|FG003|Phase II|Study Ended|8|||
150118788|NCT01485861|541569936|FG004|Phase II|Study Ended|6|||
150118789|NCT01485861|541569937|FG005|Phase II|Study Ended|0|||
150118790|NCT01485861|541569932|FG000|Safety Phase|Death|0|||
150118791|NCT01485861|541569933|FG001|Safety Phase|Death|0|||
150118792|NCT01485861|541569934|FG002|Safety Phase|Death|0|||
150118793|NCT01485861|541569935|FG003|Safety Phase|Death|0|||
150118794|NCT01485861|541569936|FG004|Safety Phase|Death|0|||
150118795|NCT01485861|541569937|FG005|Safety Phase|Death|2|||
150118796|NCT01485861|541569932|FG000|Safety Phase|Adverse Event|0|||
150118797|NCT01485861|541569933|FG001|Safety Phase|Adverse Event|0|||
150118798|NCT01485861|541569934|FG002|Safety Phase|Adverse Event|0|||
150118799|NCT01485861|541569935|FG003|Safety Phase|Adverse Event|0|||
150118800|NCT01485861|541569936|FG004|Safety Phase|Adverse Event|0|||
150118801|NCT01485861|541569937|FG005|Safety Phase|Adverse Event|1|||
150190878|NCT03524612|541837621|FG000|Overall Study|Lack of Efficacy|10|||
150190879|NCT03524612|541837621|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
150190880|NCT03524612|541837621|FG000|Overall Study|Adverse Event|10|||
150190881|NCT03524612|541837621|FG000|Overall Study|Withdrawal by Subject|7|||
150190882|NCT03524612|541837621|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
150190883|NCT03524612|541837621|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
150190884|NCT03524612|541837621|FG000|Overall Study|New therapy for study indication|6|||
150190885|NCT03524612|541837621|FG000|Overall Study|Death|3|||
150190886|NCT03524612|541837621|FG000|Overall Study|Lost to Follow-up|2|||
150190887|NCT03524612|541837621|FG000|Overall Study|Protocol Violation|1|||
150190888|NCT02727699|541839915|FG000|Overall Study|Adverse Event|2|||
150190889|NCT02727699|541839916|FG001|Overall Study|Adverse Event|0|||
150190890|NCT02727699|541839915|FG000|Overall Study|Withdrawal by Subject|5|||
150190891|NCT02727699|541839916|FG001|Overall Study|Withdrawal by Subject|3|||
150190892|NCT02727699|541839915|FG000|Overall Study|Protocol Violation|0|||
150190893|NCT02727699|541839916|FG001|Overall Study|Protocol Violation|1|||
150190894|NCT02727699|541839915|FG000|Overall Study|Physician Decision|0|||
150190895|NCT02727699|541839916|FG001|Overall Study|Physician Decision|1|||
150190896|NCT02727699|541839915|FG000|Overall Study|Lost to Follow-up|1|||
150190897|NCT02727699|541839916|FG001|Overall Study|Lost to Follow-up|0|||
150190898|NCT02727699|541839915|FG000|Overall Study|Sponsor Decision|1|||
150190899|NCT02727699|541839916|FG001|Overall Study|Sponsor Decision|0|||
150190900|NCT04318548|541839926|FG000|Overall Study|Adverse Event|0|||
150190901|NCT04318548|541839927|FG001|Overall Study|Adverse Event|0|||
150190902|NCT04318548|541839928|FG002|Overall Study|Adverse Event|1|||
150190903|NCT04318548|541839926|FG000|Overall Study|Lost to Follow-up|6|||
150190904|NCT04318548|541839927|FG001|Overall Study|Lost to Follow-up|13|||
150190905|NCT04318548|541839928|FG002|Overall Study|Lost to Follow-up|9|||
150190906|NCT04318548|541839926|FG000|Overall Study|Protocol Violation|1|||
150190907|NCT04318548|541839927|FG001|Overall Study|Protocol Violation|0|||
150190908|NCT04318548|541839928|FG002|Overall Study|Protocol Violation|2|||
150190909|NCT04318548|541839926|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
150190910|NCT04318548|541839927|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
150190911|NCT04318548|541839928|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
150190912|NCT04318548|541839926|FG000|Overall Study|Migrated / moved from the study area|0|||
150190913|NCT04318548|541839927|FG001|Overall Study|Migrated / moved from the study area|0|||
150190914|NCT04318548|541839928|FG002|Overall Study|Migrated / moved from the study area|1|||
150190915|NCT04318548|541839926|FG000|Overall Study|Other|1|||
150190916|NCT04318548|541839927|FG001|Overall Study|Other|2|||
150190917|NCT04318548|541839928|FG002|Overall Study|Other|3|||
150190918|NCT04029688|541839933|FG000|Overall Study|Death|8|||
150190919|NCT04029688|541839934|FG001|Overall Study|Death|3|||
150190920|NCT04029688|541839935|FG002|Overall Study|Death|6|||
150190921|NCT04029688|541839936|FG003|Overall Study|Death|2|||
150190922|NCT04029688|541839937|FG004|Overall Study|Death|5|||
150190923|NCT04029688|541839938|FG005|Overall Study|Death|0|||
150190924|NCT04029688|541839939|FG006|Overall Study|Death|2|||
150190925|NCT04029688|541839940|FG007|Overall Study|Death|3|||
150190926|NCT04029688|541839933|FG000|Overall Study|Study Terminated by Sponsor|0|||
150190927|NCT04029688|541839934|FG001|Overall Study|Study Terminated by Sponsor|0|||
150190928|NCT04029688|541839935|FG002|Overall Study|Study Terminated by Sponsor|0|||
150190929|NCT04029688|541839936|FG003|Overall Study|Study Terminated by Sponsor|0|||
150190930|NCT04029688|541839937|FG004|Overall Study|Study Terminated by Sponsor|1|||
150190931|NCT04029688|541839938|FG005|Overall Study|Study Terminated by Sponsor|3|||
150190932|NCT04029688|541839939|FG006|Overall Study|Study Terminated by Sponsor|1|||
150190933|NCT04029688|541839940|FG007|Overall Study|Study Terminated by Sponsor|3|||
150190934|NCT04029688|541839933|FG000|Overall Study|Withdrawal by Subject|0|||
150118802|NCT01485861|541569932|FG000|Safety Phase|Other|0|||
150118803|NCT01485861|541569933|FG001|Safety Phase|Other|0|||
150190935|NCT04029688|541839934|FG001|Overall Study|Withdrawal by Subject|0|||
150118804|NCT01485861|541569934|FG002|Safety Phase|Other|0|||
150118805|NCT01485861|541569935|FG003|Safety Phase|Other|0|||
150118806|NCT01485861|541569936|FG004|Safety Phase|Other|0|||
150118807|NCT01485861|541569937|FG005|Safety Phase|Other|5|||
150118808|NCT01485861|541569932|FG000|Safety Phase|Progression of Disease|0|||
150118809|NCT01485861|541569933|FG001|Safety Phase|Progression of Disease|0|||
150118810|NCT01485861|541569934|FG002|Safety Phase|Progression of Disease|0|||
150190936|NCT04029688|541839935|FG002|Overall Study|Withdrawal by Subject|0|||
150190937|NCT04029688|541839936|FG003|Overall Study|Withdrawal by Subject|1|||
150190938|NCT04029688|541839937|FG004|Overall Study|Withdrawal by Subject|0|||
150190939|NCT04029688|541839938|FG005|Overall Study|Withdrawal by Subject|0|||
150190940|NCT04029688|541839939|FG006|Overall Study|Withdrawal by Subject|0|||
150190941|NCT04029688|541839940|FG007|Overall Study|Withdrawal by Subject|0|||
150190942|NCT05875142|541839941|FG000|Overall Study|Lost to Follow-up|0|||
150190943|NCT05875142|541839942|FG001|Overall Study|Lost to Follow-up|1|||
150190944|NCT05875142|541839943|FG002|Overall Study|Lost to Follow-up|1|||
150190945|NCT03436290|541839944|FG000|Overall Study|Post-randomization Exclusion|1|||
150190946|NCT03436290|541839945|FG001|Overall Study|Post-randomization Exclusion|0|||
150190947|NCT03436290|541839944|FG000|Overall Study|Death|6|||
150190948|NCT03436290|541839945|FG001|Overall Study|Death|0|||
150190949|NCT03436290|541839944|FG000|Overall Study|Withdrawal by Subject|4|||
150190950|NCT03436290|541839945|FG001|Overall Study|Withdrawal by Subject|0|||
150190951|NCT03436290|541839944|FG000|Overall Study|Protocol Violation|30|||
150190952|NCT03436290|541839945|FG001|Overall Study|Protocol Violation|0|||
150190953|NCT02677298|541839946|FG000|Double Blind Phase|Adverse Event|2|||
150190954|NCT02677298|541839947|FG001|Double Blind Phase|Adverse Event|1|||
150190955|NCT02677298|541839948|FG002|Double Blind Phase|Adverse Event|0|||
150190956|NCT02677298|541839946|FG000|Double Blind Phase|Physician Decision|5|||
150190957|NCT02677298|541839947|FG001|Double Blind Phase|Physician Decision|0|||
150190958|NCT02677298|541839948|FG002|Double Blind Phase|Physician Decision|0|||
150190959|NCT02677298|541839946|FG000|Double Blind Phase|Lost to Follow-up|11|||
150190960|NCT02677298|541839947|FG001|Double Blind Phase|Lost to Follow-up|7|||
150190961|NCT02677298|541839948|FG002|Double Blind Phase|Lost to Follow-up|0|||
150190962|NCT02677298|541839946|FG000|Double Blind Phase|Withdrawal by Subject|11|||
150190963|NCT02677298|541839947|FG001|Double Blind Phase|Withdrawal by Subject|8|||
150190964|NCT02677298|541839948|FG002|Double Blind Phase|Withdrawal by Subject|0|||
150190965|NCT02677298|541839946|FG000|Double Blind Phase|No study drug available at site|0|||
150190966|NCT02677298|541839947|FG001|Double Blind Phase|No study drug available at site|1|||
150190967|NCT02677298|541839948|FG002|Double Blind Phase|No study drug available at site|0|||
150190968|NCT02677298|541839946|FG000|Open Label Phase|Adverse Event|0|||
150190969|NCT02677298|541839947|FG001|Open Label Phase|Adverse Event|0|||
150190970|NCT02677298|541839948|FG002|Open Label Phase|Adverse Event|4|||
150190971|NCT02677298|541839946|FG000|Open Label Phase|Physician Decision|0|||
150190972|NCT02677298|541839947|FG001|Open Label Phase|Physician Decision|0|||
150190973|NCT02677298|541839948|FG002|Open Label Phase|Physician Decision|1|||
150190974|NCT02677298|541839946|FG000|Open Label Phase|Lost to Follow-up|0|||
150190975|NCT02677298|541839947|FG001|Open Label Phase|Lost to Follow-up|0|||
150190976|NCT02677298|541839948|FG002|Open Label Phase|Lost to Follow-up|17|||
150190977|NCT02677298|541839946|FG000|Open Label Phase|Withdrawal by Subject|0|||
150190978|NCT02677298|541839947|FG001|Open Label Phase|Withdrawal by Subject|0|||
150190979|NCT02677298|541839948|FG002|Open Label Phase|Withdrawal by Subject|38|||
150190980|NCT03988608|541839949|FG000|Overall Study|Adverse Event|1|||
150190981|NCT03988608|541839949|FG000|Overall Study|Lost to Follow-up|1|||
150190982|NCT03988608|541839949|FG000|Overall Study|Withdrawal by Subject|3|||
150190983|NCT03988608|541839949|FG000|Overall Study|Death|1|||
150190984|NCT03338933|541839954|FG000|Screening Visit|Lost to Follow-up|1|||
150190985|NCT03338933|541839955|FG001|Screening Visit|Lost to Follow-up|3|||
150190986|NCT03338933|541839956|FG002|Screening Visit|Lost to Follow-up|1|||
150190987|NCT03338933|541839957|FG003|Screening Visit|Lost to Follow-up|4|||
150190988|NCT03338933|541839954|FG000|Screening Visit|Screen fail after consent|2|||
150190989|NCT03338933|541839955|FG001|Screening Visit|Screen fail after consent|7|||
150190990|NCT03338933|541839956|FG002|Screening Visit|Screen fail after consent|1|||
150190991|NCT03338933|541839957|FG003|Screening Visit|Screen fail after consent|4|||
150190992|NCT03338933|541839954|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
150190993|NCT03338933|541839955|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
150190994|NCT03338933|541839956|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
150190995|NCT03338933|541839957|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
150190996|NCT03338933|541839954|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
150190997|NCT03338933|541839955|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
150190998|NCT03338933|541839956|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
150190999|NCT03338933|541839957|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
150191000|NCT03338933|541839954|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
150191001|NCT03338933|541839955|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
150191002|NCT03338933|541839956|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
150191003|NCT03338933|541839957|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
150191004|NCT04764448|541839960|FG000|Overall Study|Study terminated by sponsor|2|||
150191005|NCT04764448|541839961|FG001|Overall Study|Study terminated by sponsor|2|||
150191006|NCT04764448|541839962|FG002|Overall Study|Study terminated by sponsor|5|||
150191007|NCT04764448|541839960|FG000|Overall Study|Withdrawal by Subject|3|||
150191008|NCT04764448|541839961|FG001|Overall Study|Withdrawal by Subject|3|||
150191009|NCT04764448|541839962|FG002|Overall Study|Withdrawal by Subject|1|||
150191010|NCT03812679|541839963|FG000|Overall Study|Adverse Event|2|||
150191011|NCT03812679|541839963|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
150191012|NCT03812679|541839963|FG000|Overall Study|Renal transplant|1|||
150191013|NCT03812679|541839963|FG000|Overall Study|Withdrawal by Subject|1|||
150191014|NCT03812679|541839963|FG000|Overall Study|Termination of study|2|||
150191015|NCT03812679|541839963|FG000|Overall Study|Water device replacement|1|||
150191016|NCT05028634|541839964|FG000|Overall Study|Withdrawal by Subject|0|||
150191017|NCT05028634|541839965|FG001|Overall Study|Withdrawal by Subject|1|||
150191018|NCT03891667|541839970|FG000|Overall Study|Physician Decision|1|||
150191019|NCT03891667|541839971|FG001|Overall Study|Physician Decision|1|||
150191020|NCT03891667|541839970|FG000|Overall Study|COVID related pause|1|||
150191021|NCT03891667|541839971|FG001|Overall Study|COVID related pause|0|||
150191022|NCT03891667|541839970|FG000|Overall Study|Withdrawal by Subject|0|||
150191023|NCT03891667|541839971|FG001|Overall Study|Withdrawal by Subject|1|||
150191024|NCT03891667|541839970|FG000|Overall Study|Adverse Event|0|||
150191025|NCT03891667|541839971|FG001|Overall Study|Adverse Event|1|||
150191026|NCT05659537|541839974|FG000|Overall Study|Adverse Event|5|||
150191027|NCT05659537|541839974|FG000|Overall Study|Lost to Follow-up|4|||
150191028|NCT05659537|541839974|FG000|Overall Study|Withdrawal by Subject|13|||
150191029|NCT05659537|541839974|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
150191030|NCT05659537|541839974|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
150191031|NCT05659537|541839974|FG000|Overall Study|Participant was suffering from anaemia|1|||
150191032|NCT03771417|541839975|FG000|Overall Study|Withdrawal by Subject|1|||
150191033|NCT03771417|541839976|FG001|Overall Study|Withdrawal by Subject|0|||
150191034|NCT03771417|541839977|FG002|Overall Study|Withdrawal by Subject|0|||
150191035|NCT03771417|541839975|FG000|Overall Study|Covid-19 Shutdown|0|||
150191036|NCT03771417|541839976|FG001|Overall Study|Covid-19 Shutdown|1|||
150191037|NCT03771417|541839977|FG002|Overall Study|Covid-19 Shutdown|0|||
150191038|NCT04456517|541839978|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
150191039|NCT04456517|541839979|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
150191040|NCT03766009|541839980|FG000|Usual Care|Death|0|||
150191041|NCT03766009|541839981|FG001|Usual Care|Death|0|||
150191042|NCT03766009|541839982|FG002|Usual Care|Death|0|||
150191043|NCT03766009|541839983|FG003|Usual Care|Death|1|||
150191044|NCT03766009|541839984|FG004|Usual Care|Death|0|||
150191045|NCT03766009|541839985|FG005|Usual Care|Death|0|||
150191046|NCT03766009|541839980|FG000|Usual Care|Lost to Follow-up|0|||
150191047|NCT03766009|541839981|FG001|Usual Care|Lost to Follow-up|0|||
150191048|NCT03766009|541839982|FG002|Usual Care|Lost to Follow-up|0|||
150191049|NCT03766009|541839983|FG003|Usual Care|Lost to Follow-up|1|||
150191050|NCT03766009|541839984|FG004|Usual Care|Lost to Follow-up|0|||
150191051|NCT03766009|541839985|FG005|Usual Care|Lost to Follow-up|0|||
150191052|NCT03766009|541839980|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
150191053|NCT03766009|541839981|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
150191054|NCT03766009|541839982|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
150191055|NCT03766009|541839983|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
150191056|NCT03766009|541839984|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
150191057|NCT03766009|541839985|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
150191058|NCT03766009|541839980|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
150191059|NCT03766009|541839981|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
150191060|NCT03766009|541839982|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
150191061|NCT03766009|541839983|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
150191062|NCT03766009|541839984|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
150191063|NCT03766009|541839985|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
150191064|NCT03766009|541839980|FG000|Usual Care|No treatment or declined surgery|0|||
150191065|NCT03766009|541839981|FG001|Usual Care|No treatment or declined surgery|0|||
150191066|NCT03766009|541839982|FG002|Usual Care|No treatment or declined surgery|0|||
150191067|NCT03766009|541839983|FG003|Usual Care|No treatment or declined surgery|2|||
150191068|NCT03766009|541839984|FG004|Usual Care|No treatment or declined surgery|0|||
150191069|NCT03766009|541839985|FG005|Usual Care|No treatment or declined surgery|0|||
150191070|NCT03766009|541839980|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
150191071|NCT03766009|541839981|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
150191072|NCT03766009|541839982|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
150191073|NCT03766009|541839983|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
150191074|NCT03766009|541839984|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
150191075|NCT03766009|541839985|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
150118811|NCT01485861|541569935|FG003|Safety Phase|Progression of Disease|0|||
150118812|NCT01485861|541569936|FG004|Safety Phase|Progression of Disease|0|||
150118813|NCT01485861|541569937|FG005|Safety Phase|Progression of Disease|9|||
150118814|NCT01485861|541569932|FG000|Safety Phase|Withdrawal by Subject|0|||
150118815|NCT01485861|541569933|FG001|Safety Phase|Withdrawal by Subject|0|||
150118816|NCT01485861|541569934|FG002|Safety Phase|Withdrawal by Subject|0|||
150118817|NCT01485861|541569935|FG003|Safety Phase|Withdrawal by Subject|0|||
150118818|NCT01485861|541569936|FG004|Safety Phase|Withdrawal by Subject|0|||
150118819|NCT01485861|541569937|FG005|Safety Phase|Withdrawal by Subject|6|||
150118820|NCT01485861|541569932|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
150118821|NCT01485861|541569933|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
150118822|NCT01485861|541569934|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
150118823|NCT01485861|541569935|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
150118824|NCT01485861|541569936|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
150118825|NCT01485861|541569937|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
150118826|NCT02266381|541569940|FG000|Overall Study|Physician Decision|3|||
150118827|NCT02266381|541569941|FG001|Overall Study|Physician Decision|5|||
150118828|NCT02266381|541569942|FG002|Overall Study|Physician Decision|4|||
150118829|NCT00096941|541569943|FG000|Overall Study|disease progression|3|||
150118830|NCT02401672|541569944|FG000|Overall Study|Withdrawal by Subject|1|||
150118831|NCT02401672|541569945|FG001|Overall Study|Withdrawal by Subject|3|||
150118832|NCT04796610|541569946|FG000|Overall Study|Withdrawal by Subject|1|||
150118833|NCT04796610|541569947|FG001|Overall Study|Withdrawal by Subject|0|||
150118834|NCT04796610|541569948|FG002|Overall Study|Withdrawal by Subject|0|||
150118835|NCT04796610|541569949|FG003|Overall Study|Withdrawal by Subject|0|||
150118836|NCT04796610|541569946|FG000|Overall Study|Lost to Follow-up|2|||
150118837|NCT04796610|541569947|FG001|Overall Study|Lost to Follow-up|0|||
150118838|NCT04796610|541569948|FG002|Overall Study|Lost to Follow-up|1|||
150118839|NCT04796610|541569949|FG003|Overall Study|Lost to Follow-up|1|||
150118840|NCT01459796|541569950|FG000|Overall Study|Non compliance with protocol|2|||
150118841|NCT01459796|541569951|FG001|Overall Study|Non compliance with protocol|4|||
150118842|NCT01459796|541569950|FG000|Overall Study|Adverse Event|5|||
150118843|NCT01459796|541569951|FG001|Overall Study|Adverse Event|5|||
150118844|NCT01459796|541569950|FG000|Overall Study|Withdrawal by Subject|6|||
150118845|NCT01459796|541569951|FG001|Overall Study|Withdrawal by Subject|3|||
150118846|NCT01459796|541569950|FG000|Overall Study|Lost to Follow-up|5|||
150118847|NCT01459796|541569951|FG001|Overall Study|Lost to Follow-up|4|||
150118848|NCT01459796|541569950|FG000|Overall Study|Reason unspecified|1|||
150118849|NCT01459796|541569951|FG001|Overall Study|Reason unspecified|2|||
150118850|NCT01459796|541569950|FG000|Overall Study|Decision by the sponsor|75|||
150118851|NCT01459796|541569951|FG001|Overall Study|Decision by the sponsor|108|||
150118852|NCT00733824|541569952|FG000|Phase I|Withdrawal by Subject|1|||
150118853|NCT00733824|541569953|FG001|Phase I|Withdrawal by Subject|0|||
150118854|NCT00733824|541569954|FG002|Phase I|Withdrawal by Subject|0|||
150118855|NCT00733824|541569955|FG003|Phase I|Withdrawal by Subject|0|||
150118856|NCT00733824|541569956|FG004|Phase I|Withdrawal by Subject|0|||
150118857|NCT00701051|541569957|FG000|Screening|Failed Screening|40|||
150118858|NCT00701051|541569958|FG001|Screening|Failed Screening|0|||
150118859|NCT00701051|541569959|FG002|Screening|Failed Screening|0|||
150118860|NCT00701051|541569957|FG000|Screening|Time conflicts|19|||
150118861|NCT00701051|541569958|FG001|Screening|Time conflicts|0|||
150118862|NCT00701051|541569959|FG002|Screening|Time conflicts|0|||
150118863|NCT00701051|541569957|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
150118864|NCT00701051|541569958|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
150118865|NCT00701051|541569959|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
150118866|NCT01410110|541569961|FG000|Overall Study|Withdrawal by Subject|4|||
150118867|NCT01410110|541569962|FG001|Overall Study|Withdrawal by Subject|2|||
150118868|NCT03634579|541569963|FG000|Overall Study|study termination|9|||
150118869|NCT04111497|541569964|FG000|Overall Study|relapse of primary disease|1|||
150118870|NCT04111497|541569964|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
150118871|NCT05857527|541569967|FG000|Overall Study|Withdrawal by Subject|0|||
150118872|NCT05857527|541569968|FG001|Overall Study|Withdrawal by Subject|1|||
150118873|NCT02799082|541569969|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
150118874|NCT02799082|541569970|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
150118875|NCT02799082|541569969|FG000|Overall Study|Protocol Violation|0|||
150118876|NCT02799082|541569970|FG001|Overall Study|Protocol Violation|1|||
150118877|NCT02543346|541569971|FG000|Second Priming Visit|Withdrawal by Subject|0|||
150118878|NCT02543346|541569972|FG001|Second Priming Visit|Withdrawal by Subject|2|||
150118879|NCT02543346|541569973|FG002|Second Priming Visit|Withdrawal by Subject|2|||
150118880|NCT02543346|541569974|FG003|Second Priming Visit|Withdrawal by Subject|2|||
150118881|NCT02543346|541569971|FG000|Second Priming Visit|Adverse Event|1|||
150118882|NCT02543346|541569972|FG001|Second Priming Visit|Adverse Event|0|||
150191076|NCT03766009|541839980|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
150191077|NCT03766009|541839981|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
150118883|NCT02543346|541569973|FG002|Second Priming Visit|Adverse Event|0|||
150118884|NCT02543346|541569974|FG003|Second Priming Visit|Adverse Event|0|||
150118885|NCT01072201|541569980|FG000|Overall Study|Lost to Follow-up|0|||
150118886|NCT01072201|541569981|FG001|Overall Study|Lost to Follow-up|1|||
150118887|NCT00360334|541569982|FG000|Overall Study|Adverse Event|7|||
150118888|NCT00360334|541569983|FG001|Overall Study|Adverse Event|4|||
150118889|NCT00360334|541569982|FG000|Overall Study|Protocol Violation|1|||
150118890|NCT00360334|541569983|FG001|Overall Study|Protocol Violation|1|||
150118891|NCT00360334|541569982|FG000|Overall Study|Physician Decision|2|||
150118892|NCT00360334|541569983|FG001|Overall Study|Physician Decision|3|||
150118893|NCT00360334|541569982|FG000|Overall Study|Lack of Efficacy|0|||
150118894|NCT00360334|541569983|FG001|Overall Study|Lack of Efficacy|1|||
150118895|NCT00360334|541569982|FG000|Overall Study|Entry criterion not met|1|||
150118896|NCT00360334|541569983|FG001|Overall Study|Entry criterion not met|2|||
150118897|NCT00360334|541569982|FG000|Overall Study|Subject decision|8|||
150118898|NCT00360334|541569983|FG001|Overall Study|Subject decision|2|||
150118899|NCT01916304|541569984|FG000|Overall Study|Screening failure|17|||
150118900|NCT01898793|541569985|FG000|Overall Study|Death|2|||
150118901|NCT01898793|541569986|FG001|Overall Study|Death|1|||
150118902|NCT01898793|541569987|FG002|Overall Study|Death|4|||
150118903|NCT01898793|541569988|FG003|Overall Study|Death|0|||
150118904|NCT01898793|541569989|FG004|Overall Study|Death|0|||
150118905|NCT01898793|541569990|FG005|Overall Study|Death|0|||
150118906|NCT01898793|541569991|FG006|Overall Study|Death|0|||
150118907|NCT04666441|541569992|FG000|Overall Study|Lost to Follow-up|1|||
150118908|NCT04666441|541569993|FG001|Overall Study|Lost to Follow-up|4|||
150118909|NCT04666441|541569994|FG002|Overall Study|Lost to Follow-up|1|||
150118910|NCT04666441|541569995|FG003|Overall Study|Lost to Follow-up|3|||
150118911|NCT04666441|541569996|FG004|Overall Study|Lost to Follow-up|0|||
150118912|NCT04666441|541569997|FG005|Overall Study|Lost to Follow-up|2|||
150118913|NCT04666441|541569998|FG006|Overall Study|Lost to Follow-up|2|||
150118914|NCT04666441|541569999|FG007|Overall Study|Lost to Follow-up|2|||
150118915|NCT04666441|541569992|FG000|Overall Study|Subject Decision|1|||
150118916|NCT04666441|541569993|FG001|Overall Study|Subject Decision|1|||
150118917|NCT04666441|541569994|FG002|Overall Study|Subject Decision|3|||
150118918|NCT04666441|541569995|FG003|Overall Study|Subject Decision|1|||
150118919|NCT04666441|541569996|FG004|Overall Study|Subject Decision|0|||
150118920|NCT04666441|541569997|FG005|Overall Study|Subject Decision|1|||
150118921|NCT04666441|541569998|FG006|Overall Study|Subject Decision|3|||
150118922|NCT04666441|541569999|FG007|Overall Study|Subject Decision|2|||
150118923|NCT00766415|541570000|FG000|Overall Study|Withdrawal by Subject|0|||
150118924|NCT00766415|541570001|FG001|Overall Study|Withdrawal by Subject|1|||
150118925|NCT01114516|541570002|FG000|Overall Study|Lost to Follow-up|2|||
150118926|NCT01114516|541570003|FG001|Overall Study|Lost to Follow-up|1|||
150118927|NCT00061048|541570004|FG000|Overall Study|Adverse Event|2|||
150118928|NCT00061048|541570004|FG000|Overall Study|disease progression|20|||
150118929|NCT01632579|541570005|FG000|Washout Period|Adverse Event|1|||
150118930|NCT01632579|541570006|FG001|Washout Period|Adverse Event|0|||
150118931|NCT01632579|541570007|FG002|Washout Period|Adverse Event|0|||
150118932|NCT01632579|541570008|FG003|Washout Period|Adverse Event|0|||
150118933|NCT01632579|541570009|FG004|Washout Period|Adverse Event|0|||
150118934|NCT01632579|541570010|FG005|Washout Period|Adverse Event|0|||
150118935|NCT01632579|541570011|FG006|Washout Period|Adverse Event|0|||
150118936|NCT01632579|541570012|FG007|Washout Period|Adverse Event|0|||
150118937|NCT01632579|541570013|FG008|Washout Period|Adverse Event|0|||
150118938|NCT01632579|541570005|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
150118939|NCT01632579|541570006|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
150118940|NCT01632579|541570007|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
150118941|NCT01632579|541570008|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
150118942|NCT01632579|541570009|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
150118943|NCT01632579|541570010|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
150118944|NCT01632579|541570011|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
150118945|NCT01632579|541570012|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
150118946|NCT01632579|541570013|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
150118947|NCT03779841|541570014|FG000|Randomized Population|Did Not Receive Treatment|3|||
150118948|NCT03779841|541570015|FG001|Randomized Population|Did Not Receive Treatment|1|||
150118949|NCT03779841|541570016|FG002|Randomized Population|Did Not Receive Treatment|0|||
150118950|NCT03779841|541570014|FG000|Treated (Safety) Population|Adverse Event|1|||
150118951|NCT03779841|541570015|FG001|Treated (Safety) Population|Adverse Event|1|||
150118952|NCT03779841|541570016|FG002|Treated (Safety) Population|Adverse Event|0|||
150118953|NCT03779841|541570014|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
150191078|NCT03766009|541839982|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
150191079|NCT03766009|541839983|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
150191080|NCT03766009|541839984|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
150191081|NCT03766009|541839985|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
150191082|NCT03766009|541839980|FG000|Usual Care|Ineligible|0|||
150118954|NCT03779841|541570015|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
150118955|NCT03779841|541570016|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
150118956|NCT03779841|541570014|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
150118957|NCT03779841|541570015|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
150118958|NCT03779841|541570016|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
150118959|NCT03779841|541570014|FG000|Treated (Safety) Population|Death|1|||
150118960|NCT03779841|541570015|FG001|Treated (Safety) Population|Death|0|||
150118961|NCT03779841|541570016|FG002|Treated (Safety) Population|Death|2|||
150118962|NCT00898677|541570017|FG000|Overall Study|Adverse Event|0|||
150118963|NCT00898677|541570018|FG001|Overall Study|Adverse Event|0|||
150118964|NCT00898677|541570019|FG002|Overall Study|Adverse Event|1|||
150118965|NCT00898677|541570020|FG003|Overall Study|Adverse Event|0|||
150118966|NCT00898677|541570017|FG000|Overall Study|Lost to Follow-up|0|||
150118967|NCT00898677|541570018|FG001|Overall Study|Lost to Follow-up|0|||
150118968|NCT00898677|541570019|FG002|Overall Study|Lost to Follow-up|2|||
150118969|NCT00898677|541570020|FG003|Overall Study|Lost to Follow-up|0|||
150118970|NCT00898677|541570017|FG000|Overall Study|Protocol Violation|1|||
150118971|NCT00898677|541570018|FG001|Overall Study|Protocol Violation|1|||
150118972|NCT00898677|541570019|FG002|Overall Study|Protocol Violation|2|||
150118973|NCT00898677|541570020|FG003|Overall Study|Protocol Violation|0|||
150118974|NCT00898677|541570017|FG000|Overall Study|Withdrawal by Subject|0|||
150118975|NCT00898677|541570018|FG001|Overall Study|Withdrawal by Subject|0|||
150118976|NCT00898677|541570019|FG002|Overall Study|Withdrawal by Subject|0|||
150118977|NCT00898677|541570020|FG003|Overall Study|Withdrawal by Subject|1|||
150118978|NCT00898677|541570017|FG000|Overall Study|Not Treated: Adverse Event|0|||
150118979|NCT00898677|541570018|FG001|Overall Study|Not Treated: Adverse Event|2|||
150118980|NCT00898677|541570019|FG002|Overall Study|Not Treated: Adverse Event|1|||
150118981|NCT00898677|541570020|FG003|Overall Study|Not Treated: Adverse Event|0|||
150118982|NCT00898677|541570017|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
150118983|NCT00898677|541570018|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
150118984|NCT00898677|541570019|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
150118985|NCT00898677|541570020|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
150118986|NCT00898677|541570017|FG000|Overall Study|Not Treated: Pregnancy|0|||
150118987|NCT00898677|541570018|FG001|Overall Study|Not Treated: Pregnancy|0|||
150118988|NCT00898677|541570019|FG002|Overall Study|Not Treated: Pregnancy|1|||
150118989|NCT00898677|541570020|FG003|Overall Study|Not Treated: Pregnancy|0|||
150118990|NCT00898677|541570017|FG000|Overall Study|Not Treated: Protocol Violation|2|||
150118991|NCT00898677|541570018|FG001|Overall Study|Not Treated: Protocol Violation|0|||
150118992|NCT00898677|541570019|FG002|Overall Study|Not Treated: Protocol Violation|2|||
150118993|NCT00898677|541570020|FG003|Overall Study|Not Treated: Protocol Violation|0|||
150118994|NCT00898677|541570017|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
150118995|NCT00898677|541570018|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
150118996|NCT00898677|541570019|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
150118997|NCT00898677|541570020|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
150118998|NCT00898677|541570017|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
150118999|NCT00898677|541570018|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
150119000|NCT00898677|541570019|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
150119001|NCT00898677|541570020|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
150119002|NCT00898677|541570017|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
150119003|NCT00898677|541570018|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
150119004|NCT00898677|541570019|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
150119005|NCT00898677|541570020|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
150119006|NCT00898677|541570017|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
150119007|NCT00898677|541570018|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
150119008|NCT00898677|541570019|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
150119009|NCT00898677|541570020|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
150119010|NCT00898677|541570017|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
150119011|NCT00898677|541570018|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
150119012|NCT00898677|541570019|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
150119013|NCT00898677|541570020|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
150119014|NCT00898677|541570017|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
150191083|NCT03766009|541839981|FG001|Usual Care|Ineligible|1|||
150119015|NCT00898677|541570018|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
150119016|NCT00898677|541570019|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
150119017|NCT00898677|541570020|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
150119018|NCT00898677|541570017|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
150119019|NCT00898677|541570018|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
150119020|NCT00898677|541570019|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
150119021|NCT00898677|541570020|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
150119022|NCT00836875|541570023|FG000|Overall Study|Death|3|||
150119023|NCT00836875|541570024|FG001|Overall Study|Death|2|||
150119024|NCT00836875|541570023|FG000|Overall Study|Withdrawal by Subject|0|||
150119025|NCT00836875|541570024|FG001|Overall Study|Withdrawal by Subject|1|||
150119026|NCT06748040|541570025|FG000|Overall Study|Death|3|||
150119027|NCT06748040|541570026|FG001|Overall Study|Death|4|||
150119028|NCT06748040|541570025|FG000|Overall Study|Lost to Follow-up|134|||
150119029|NCT06748040|541570026|FG001|Overall Study|Lost to Follow-up|132|||
150119030|NCT06748040|541570025|FG000|Overall Study|Withdrawal by Subject|3|||
150119031|NCT06748040|541570026|FG001|Overall Study|Withdrawal by Subject|5|||
150119032|NCT03794089|541571856|FG000|Overall Study|Lost to Follow-up|4|||
150119033|NCT03794089|541571857|FG001|Overall Study|Lost to Follow-up|1|||
150119034|NCT03794089|541571856|FG000|Overall Study|Withdrawal by Subject|2|||
150119035|NCT03794089|541571857|FG001|Overall Study|Withdrawal by Subject|0|||
150119036|NCT00116805|541571858|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
150119037|NCT00116805|541571859|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
150119038|NCT00116805|541571858|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
150119039|NCT00116805|541571859|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
150119040|NCT00116805|541571858|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
150119041|NCT00116805|541571859|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
150119042|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
150119043|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
150119044|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
150119045|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
150119046|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
150119047|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
150119048|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
150119049|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
150119050|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
150119051|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
150119052|NCT00116805|541571858|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
150119053|NCT00116805|541571859|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
150119054|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
150119055|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
150119056|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
150119057|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
150119058|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
150119059|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
150119060|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
150191084|NCT03766009|541839982|FG002|Usual Care|Ineligible|0|||
150119061|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
150191085|NCT03766009|541839983|FG003|Usual Care|Ineligible|0|||
150191086|NCT03766009|541839984|FG004|Usual Care|Ineligible|0|||
150191087|NCT03766009|541839985|FG005|Usual Care|Ineligible|0|||
150191088|NCT03766009|541839980|FG000|Usual Care|Other: Staff turnover|0|||
150191089|NCT03766009|541839981|FG001|Usual Care|Other: Staff turnover|0|||
150191090|NCT03766009|541839982|FG002|Usual Care|Other: Staff turnover|0|||
150191091|NCT03766009|541839983|FG003|Usual Care|Other: Staff turnover|0|||
150191092|NCT03766009|541839984|FG004|Usual Care|Other: Staff turnover|0|||
150191093|NCT03766009|541839985|FG005|Usual Care|Other: Staff turnover|2|||
150191094|NCT02975882|541839990|FG000|Overall Study|Adverse Event|1|||
150191095|NCT02975882|541839991|FG001|Overall Study|Adverse Event|2|||
150191096|NCT02975882|541839992|FG002|Overall Study|Adverse Event|1|||
150191097|NCT02975882|541839993|FG003|Overall Study|Adverse Event|1|||
150191098|NCT02975882|541839990|FG000|Overall Study|Death|0|||
150191099|NCT02975882|541839991|FG001|Overall Study|Death|1|||
150191100|NCT02975882|541839992|FG002|Overall Study|Death|0|||
150191101|NCT02975882|541839993|FG003|Overall Study|Death|0|||
150191102|NCT02975882|541839990|FG000|Overall Study|Lack of Efficacy|3|||
150191103|NCT02975882|541839991|FG001|Overall Study|Lack of Efficacy|7|||
150191104|NCT02975882|541839992|FG002|Overall Study|Lack of Efficacy|4|||
150191105|NCT02975882|541839993|FG003|Overall Study|Lack of Efficacy|3|||
150191106|NCT02975882|541839990|FG000|Overall Study|Physician Decision|0|||
150191107|NCT02975882|541839991|FG001|Overall Study|Physician Decision|2|||
150191108|NCT02975882|541839992|FG002|Overall Study|Physician Decision|4|||
150191109|NCT02975882|541839993|FG003|Overall Study|Physician Decision|2|||
150191110|NCT02975882|541839990|FG000|Overall Study|Ineligible|0|||
150191111|NCT02975882|541839991|FG001|Overall Study|Ineligible|1|||
150191112|NCT02975882|541839992|FG002|Overall Study|Ineligible|0|||
150191113|NCT02975882|541839993|FG003|Overall Study|Ineligible|0|||
150191114|NCT03936322|541839994|FG000|Overall Study|Lost to Follow-up|1|||
150191115|NCT03936322|541839994|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
150191116|NCT01160211|541839995|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
150191117|NCT01160211|541839996|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
150191118|NCT01160211|541839997|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
150191119|NCT01160211|541839995|FG000|Overall Study|Lost to Follow-up|4|||
150191120|NCT01160211|541839996|FG001|Overall Study|Lost to Follow-up|8|||
150191121|NCT01160211|541839997|FG002|Overall Study|Lost to Follow-up|4|||
150191122|NCT01160211|541839995|FG000|Overall Study|Physician Decision|1|||
150191123|NCT01160211|541839996|FG001|Overall Study|Physician Decision|0|||
150191124|NCT01160211|541839997|FG002|Overall Study|Physician Decision|0|||
150191125|NCT01160211|541839995|FG000|Overall Study|Withdrawal by Subject|4|||
150191126|NCT01160211|541839996|FG001|Overall Study|Withdrawal by Subject|2|||
150191127|NCT01160211|541839997|FG002|Overall Study|Withdrawal by Subject|2|||
150191128|NCT01160211|541839995|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
150191129|NCT01160211|541839996|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
150191130|NCT01160211|541839997|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
150191131|NCT02734290|541839998|FG000|Overall Study|Adverse Event|1|||
150191132|NCT02734290|541839999|FG001|Overall Study|Adverse Event|0|||
150191133|NCT02734290|541839998|FG000|Overall Study|Death|1|||
150191134|NCT02734290|541839999|FG001|Overall Study|Death|0|||
150191135|NCT05119023|541840001|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
150191136|NCT05119023|541840001|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
150191137|NCT05119023|541840001|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
150191138|NCT04806451|541840004|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
150191139|NCT04806451|541840005|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
150191140|NCT04806451|541840004|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
150191141|NCT04806451|541840005|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
150191142|NCT04806451|541840004|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
150191143|NCT04806451|541840005|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
150191144|NCT04064164|541840022|FG000|Overall Study|Withdrawal by Subject|8|||
150191145|NCT04064164|541840023|FG001|Overall Study|Withdrawal by Subject|8|||
150191146|NCT04719390|541840024|FG000|Overall Study|Withdrawal by Subject|1|||
150191147|NCT06190691|541840025|FG000|Overall Study|Adverse Event|2|||
150191148|NCT06190691|541840026|FG001|Overall Study|Adverse Event|0|||
150191149|NCT06190691|541840027|FG002|Overall Study|Adverse Event|0|||
150191150|NCT06190691|541840028|FG003|Overall Study|Adverse Event|0|||
150191151|NCT02023866|541840030|FG000|Overall Study|Non-compliance|2|||
150191152|NCT02023866|541840030|FG000|Overall Study|Adverse Event|3|||
150191153|NCT02023866|541840030|FG000|Overall Study|Withdrawal by Subject|1|||
150191154|NCT03016754|541840031|FG000|Overall Study|Death|5|||
150191155|NCT03016754|541840032|FG001|Overall Study|Death|4|||
150191156|NCT03016754|541840033|FG002|Overall Study|Death|5|||
150191157|NCT03016754|541840034|FG003|Overall Study|Death|1|||
150191158|NCT03016754|541840031|FG000|Overall Study|Lost to Follow-up|23|||
150191159|NCT03016754|541840032|FG001|Overall Study|Lost to Follow-up|17|||
150191160|NCT03016754|541840033|FG002|Overall Study|Lost to Follow-up|4|||
150191161|NCT03016754|541840034|FG003|Overall Study|Lost to Follow-up|2|||
150191162|NCT03016754|541840031|FG000|Overall Study|Withdrawal by Subject|6|||
150191163|NCT03016754|541840032|FG001|Overall Study|Withdrawal by Subject|6|||
150191164|NCT03016754|541840033|FG002|Overall Study|Withdrawal by Subject|2|||
150191165|NCT03016754|541840034|FG003|Overall Study|Withdrawal by Subject|2|||
150191166|NCT03016754|541840031|FG000|Overall Study|Other/Unknown|2|||
150191167|NCT03016754|541840032|FG001|Overall Study|Other/Unknown|4|||
150191168|NCT03016754|541840033|FG002|Overall Study|Other/Unknown|2|||
150191169|NCT03016754|541840034|FG003|Overall Study|Other/Unknown|1|||
150191170|NCT03016754|541840031|FG000|Overall Study|Protocol Violation|0|||
150191171|NCT03016754|541840032|FG001|Overall Study|Protocol Violation|0|||
150191172|NCT03016754|541840033|FG002|Overall Study|Protocol Violation|0|||
150191173|NCT03016754|541840034|FG003|Overall Study|Protocol Violation|4|||
150191174|NCT03839940|541840035|FG000|Overall Study|Withdrawal by Subject|3|||
150191175|NCT03839940|541840036|FG001|Overall Study|Withdrawal by Subject|0|||
150191176|NCT03839940|541840035|FG000|Overall Study|Protocol Violation|0|||
150191177|NCT03839940|541840036|FG001|Overall Study|Protocol Violation|1|||
150191178|NCT03839940|541840035|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
150191179|NCT03839940|541840036|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
150191180|NCT04683744|541840037|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
150191181|NCT04683744|541840038|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
150191182|NCT04683744|541840039|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
150191183|NCT01606215|541840043|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
150191184|NCT01606215|541840044|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
150191185|NCT03524118|541840048|FG000|Overall Study|Lost to Follow-up|0|||
150191186|NCT03524118|541840049|FG001|Overall Study|Lost to Follow-up|0|||
150191187|NCT03524118|541840050|FG002|Overall Study|Lost to Follow-up|0|||
150191188|NCT03524118|541840051|FG003|Overall Study|Lost to Follow-up|0|||
150191189|NCT03524118|541840052|FG004|Overall Study|Lost to Follow-up|1|||
150191190|NCT03524118|541840053|FG005|Overall Study|Lost to Follow-up|0|||
150191191|NCT03524118|541840048|FG000|Overall Study|Other|0|||
150191192|NCT03524118|541840049|FG001|Overall Study|Other|1|||
150191193|NCT03524118|541840050|FG002|Overall Study|Other|0|||
150191194|NCT03524118|541840051|FG003|Overall Study|Other|0|||
150191195|NCT03524118|541840052|FG004|Overall Study|Other|1|||
150191196|NCT03524118|541840053|FG005|Overall Study|Other|1|||
150191197|NCT03524118|541840048|FG000|Overall Study|Physician Decision|0|||
150191198|NCT03524118|541840049|FG001|Overall Study|Physician Decision|0|||
150191199|NCT03524118|541840050|FG002|Overall Study|Physician Decision|0|||
150191200|NCT03524118|541840051|FG003|Overall Study|Physician Decision|0|||
150191201|NCT03524118|541840052|FG004|Overall Study|Physician Decision|1|||
150191202|NCT03524118|541840053|FG005|Overall Study|Physician Decision|0|||
150191203|NCT03524118|541840048|FG000|Overall Study|Protocol Violation|0|||
150191204|NCT03524118|541840049|FG001|Overall Study|Protocol Violation|0|||
150191205|NCT03524118|541840050|FG002|Overall Study|Protocol Violation|1|||
150191206|NCT03524118|541840051|FG003|Overall Study|Protocol Violation|0|||
150191207|NCT03524118|541840052|FG004|Overall Study|Protocol Violation|1|||
150191208|NCT03524118|541840053|FG005|Overall Study|Protocol Violation|0|||
150191209|NCT03524118|541840048|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150191210|NCT03524118|541840049|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150191211|NCT03524118|541840050|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
150191212|NCT03524118|541840051|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
150191213|NCT03524118|541840052|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
150191214|NCT03524118|541840053|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
150191215|NCT04316871|541840060|FG000|Overall Study|Protocol Violation|2|||
150191216|NCT04316871|541840061|FG001|Overall Study|Protocol Violation|2|||
150191217|NCT04316871|541840062|FG002|Overall Study|Protocol Violation|2|||
150191218|NCT04316871|541840063|FG003|Overall Study|Protocol Violation|2|||
150191219|NCT04650269|541840064|FG000|Overall Study|Death|3|||
150191220|NCT04650269|541840064|FG000|Overall Study|Lost to Follow-up|6|||
150191221|NCT01437709|541840065|FG000|Overall Study|Adverse Event|0|||
150191222|NCT01437709|541840066|FG001|Overall Study|Adverse Event|1|||
150191223|NCT01437709|541840067|FG002|Overall Study|Adverse Event|0|||
150191224|NCT01437709|541840065|FG000|Overall Study|Pt trasnferred care|0|||
150191225|NCT01437709|541840066|FG001|Overall Study|Pt trasnferred care|1|||
150191226|NCT01437709|541840067|FG002|Overall Study|Pt trasnferred care|0|||
150191227|NCT04091750|541840068|FG000|Overall Study|Adverse Event|4|||
150191228|NCT04091750|541840068|FG000|Overall Study|Withdrawal by Subject|1|||
150191229|NCT04473222|541840069|FG000|Overall Study|Lost to Follow-up|13|||
150191230|NCT04473222|541840070|FG001|Overall Study|Lost to Follow-up|13|||
150191231|NCT04473222|541840069|FG000|Overall Study|Withdrawal by Subject|0|||
150191232|NCT04473222|541840070|FG001|Overall Study|Withdrawal by Subject|1|||
150191233|NCT04473222|541840069|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
150191234|NCT04473222|541840070|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
150191235|NCT02919306|541840071|FG000|Overall Study|Withdrawal by Subject|1|||
150191236|NCT02919306|541840072|FG001|Overall Study|Withdrawal by Subject|0|||
150191237|NCT02919306|541840071|FG000|Overall Study|Protocol Violation|1|||
150191238|NCT02919306|541840072|FG001|Overall Study|Protocol Violation|0|||
150191239|NCT03560609|541840073|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
150191240|NCT03560609|541840074|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
150191241|NCT04293055|541840075|FG000|Overall Study|Lost to Follow-up|1|||
150191242|NCT04293055|541840076|FG001|Overall Study|Lost to Follow-up|1|||
150191243|NCT04293055|541840075|FG000|Overall Study|Did not trigger randomization|6|||
150191244|NCT04293055|541840076|FG001|Overall Study|Did not trigger randomization|5|||
150191245|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
150191246|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
150191247|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
150191248|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
150191249|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
150191250|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
150191251|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
150191252|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
150191253|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
150191254|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
150191255|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
150191256|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
150191257|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
150191258|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
150191259|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
150191260|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
150191261|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
150191262|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
150191263|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191264|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
150191265|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
150191266|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191267|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191268|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
150191269|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191270|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191271|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
150191272|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
150191273|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
150191274|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
150191275|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
150191276|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
150191277|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
150191278|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
150191279|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
150191280|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
150191281|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
150191282|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
150191283|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
150191284|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
150191285|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
150191286|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
150191287|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
150191288|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
150191289|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
150191290|NCT01369355|541840086|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
150191291|NCT01369355|541840087|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
150191292|NCT01369355|541840088|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
150191293|NCT01369355|541840089|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
150191294|NCT01369355|541840090|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
150191295|NCT01369355|541840091|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
150191296|NCT01369355|541840092|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
150191297|NCT01369355|541840093|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
150191298|NCT01369355|541840094|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
150191299|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191300|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191301|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191302|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191303|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191304|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
150191305|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
150191306|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
150191307|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
150191308|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Death|0|||
150191309|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Death|0|||
150191310|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Death|0|||
150191311|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Death|0|||
150191312|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Death|0|||
150191313|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Death|0|||
150191314|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Death|0|||
150191315|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Death|1|||
150191316|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Death|3|||
150191317|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191318|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191319|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191320|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191321|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191322|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
150191323|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
150191324|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
150191325|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
150191326|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191327|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191328|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191329|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191330|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191331|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191332|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
150191333|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
150191334|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
150191335|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191336|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191337|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191338|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191339|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191340|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
150191341|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
150191342|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
150191343|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
150191344|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191345|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191346|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191347|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191348|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191349|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
150191350|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
150191351|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
150191352|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
150191353|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150191354|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150191355|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150191356|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150191357|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150119062|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
150119063|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
150119064|NCT00116805|541571858|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
150119065|NCT00116805|541571859|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
150119066|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
150119067|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
150119068|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
150119069|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
150119070|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
150119071|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
150119072|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
150119073|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
150119074|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
150119075|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
150119076|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
150119077|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
150119078|NCT00116805|541571858|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
150119079|NCT00116805|541571859|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
150119080|NCT00116805|541571858|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
150119081|NCT00116805|541571859|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
150119082|NCT00116805|541571858|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
150119083|NCT00116805|541571859|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
150119084|NCT00116805|541571858|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
150119085|NCT00116805|541571859|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
150119086|NCT00116805|541571858|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
150119087|NCT00116805|541571859|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
150119088|NCT00116805|541571858|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
150119089|NCT00116805|541571859|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
150119090|NCT00116805|541571858|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
150119091|NCT00116805|541571859|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
150119092|NCT00116805|541571858|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
150119093|NCT00116805|541571859|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
150119094|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
150119095|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
150119096|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
150119097|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
150119098|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
150119099|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
150119100|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
150119101|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
150119102|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
150119103|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
150119104|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
150119105|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
150119106|NCT00116805|541571858|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
150119107|NCT00116805|541571859|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
150119108|NCT00116805|541571858|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
150119109|NCT00116805|541571859|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
150119110|NCT00116805|541571858|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
150119111|NCT00116805|541571859|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
150119112|NCT00116805|541571858|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
150119113|NCT00116805|541571859|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
150119114|NCT00116805|541571858|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
150119115|NCT00116805|541571859|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
150191358|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
150191359|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
150191360|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
150191361|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
150191362|NCT01369355|541840086|FG000|Long-term Extension (Week 44-272)|Other|0|||
150191363|NCT01369355|541840087|FG001|Long-term Extension (Week 44-272)|Other|0|||
150191364|NCT01369355|541840088|FG002|Long-term Extension (Week 44-272)|Other|0|||
150191365|NCT01369355|541840089|FG003|Long-term Extension (Week 44-272)|Other|0|||
150191366|NCT01369355|541840090|FG004|Long-term Extension (Week 44-272)|Other|0|||
150191367|NCT01369355|541840091|FG005|Long-term Extension (Week 44-272)|Other|0|||
150191368|NCT01369355|541840092|FG006|Long-term Extension (Week 44-272)|Other|110|||
150191369|NCT01369355|541840093|FG007|Long-term Extension (Week 44-272)|Other|9|||
150191370|NCT01369355|541840094|FG008|Long-term Extension (Week 44-272)|Other|17|||
150191371|NCT02319759|541840097|FG000|Week 0 - 16|Lack of Efficacy|1|||
150191372|NCT02319759|541840098|FG001|Week 0 - 16|Lack of Efficacy|0|||
150191373|NCT02319759|541840099|FG002|Week 0 - 16|Lack of Efficacy|0|||
150191374|NCT02319759|541840100|FG003|Week 0 - 16|Lack of Efficacy|0|||
150191375|NCT02319759|541840101|FG004|Week 0 - 16|Lack of Efficacy|0|||
150191376|NCT02319759|541840097|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
150119116|NCT00116805|541571858|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
150119117|NCT00116805|541571859|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
150119118|NCT00116805|541571858|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
150119119|NCT00116805|541571859|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
150119120|NCT00116805|541571858|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
150119121|NCT00116805|541571859|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
150119122|NCT00116805|541571858|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
150119123|NCT00116805|541571859|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
150119124|NCT00116805|541571858|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
150119125|NCT00116805|541571859|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
150119126|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
150119127|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
150119128|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
150119129|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
150119130|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Adverse Event|5|||
150119131|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Adverse Event|3|||
150119132|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Adverse Event|4|||
150119133|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Adverse Event|10|||
150119134|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
150119135|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
150119136|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
150119137|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
150119138|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
150119139|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
150119140|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
150119141|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
150119142|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Pregnancy|5|||
150119143|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Pregnancy|0|||
150119144|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Pregnancy|3|||
150119145|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Pregnancy|2|||
150119146|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Non-compliance|1|||
150119147|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Non-compliance|4|||
150191377|NCT02319759|541840098|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
150191378|NCT02319759|541840099|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
150191379|NCT02319759|541840100|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
150119148|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Non-compliance|0|||
150119149|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Non-compliance|3|||
150191380|NCT02319759|541840101|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
150191381|NCT02319759|541840097|FG000|Week 16 - 24|Lack of Efficacy|1|||
150119150|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Other|0|||
150119151|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Other|3|||
150119152|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Other|3|||
150119153|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Other|1|||
150119154|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
150119155|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
150119156|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
150119157|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
150119158|NCT01760954|541571860|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
150119159|NCT01760954|541571861|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
150119160|NCT01760954|541571862|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
150119161|NCT01760954|541571863|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
150191382|NCT02319759|541840098|FG001|Week 16 - 24|Lack of Efficacy|0|||
150191383|NCT02319759|541840099|FG002|Week 16 - 24|Lack of Efficacy|1|||
150191384|NCT02319759|541840100|FG003|Week 16 - 24|Lack of Efficacy|0|||
150191385|NCT02319759|541840101|FG004|Week 16 - 24|Lack of Efficacy|0|||
150191386|NCT02319759|541840097|FG000|Week 16 - 24|Lost to Follow-up|1|||
150191387|NCT02319759|541840098|FG001|Week 16 - 24|Lost to Follow-up|0|||
150191388|NCT02319759|541840099|FG002|Week 16 - 24|Lost to Follow-up|0|||
150191389|NCT02319759|541840100|FG003|Week 16 - 24|Lost to Follow-up|0|||
150191390|NCT02319759|541840101|FG004|Week 16 - 24|Lost to Follow-up|0|||
150191391|NCT02319759|541840097|FG000|Week 16 - 24|Withdrawal by Subject|0|||
150191392|NCT02319759|541840098|FG001|Week 16 - 24|Withdrawal by Subject|0|||
150191393|NCT02319759|541840099|FG002|Week 16 - 24|Withdrawal by Subject|2|||
150191394|NCT02319759|541840100|FG003|Week 16 - 24|Withdrawal by Subject|0|||
150191395|NCT02319759|541840101|FG004|Week 16 - 24|Withdrawal by Subject|0|||
150191396|NCT02319759|541840097|FG000|Week 24 - 56|Adverse Event|0|||
150191397|NCT02319759|541840098|FG001|Week 24 - 56|Adverse Event|0|||
150191398|NCT02319759|541840099|FG002|Week 24 - 56|Adverse Event|2|||
150191399|NCT02319759|541840100|FG003|Week 24 - 56|Adverse Event|0|||
150191400|NCT02319759|541840101|FG004|Week 24 - 56|Adverse Event|0|||
150191401|NCT02319759|541840097|FG000|Week 24 - 56|Lack of Efficacy|0|||
150191402|NCT02319759|541840098|FG001|Week 24 - 56|Lack of Efficacy|0|||
150191403|NCT02319759|541840099|FG002|Week 24 - 56|Lack of Efficacy|0|||
150191404|NCT02319759|541840100|FG003|Week 24 - 56|Lack of Efficacy|2|||
150191405|NCT02319759|541840101|FG004|Week 24 - 56|Lack of Efficacy|1|||
150191406|NCT02319759|541840097|FG000|Week 24 - 56|Withdrawal by Subject|0|||
150191407|NCT02319759|541840098|FG001|Week 24 - 56|Withdrawal by Subject|1|||
150191408|NCT02319759|541840099|FG002|Week 24 - 56|Withdrawal by Subject|0|||
150191409|NCT02319759|541840100|FG003|Week 24 - 56|Withdrawal by Subject|0|||
150191410|NCT02319759|541840101|FG004|Week 24 - 56|Withdrawal by Subject|0|||
150191411|NCT02319759|541840097|FG000|Week 24 - 56|Lost to Follow-up|0|||
150191412|NCT02319759|541840098|FG001|Week 24 - 56|Lost to Follow-up|0|||
150191413|NCT02319759|541840099|FG002|Week 24 - 56|Lost to Follow-up|0|||
150191414|NCT02319759|541840100|FG003|Week 24 - 56|Lost to Follow-up|0|||
150191415|NCT02319759|541840101|FG004|Week 24 - 56|Lost to Follow-up|1|||
150191416|NCT06424236|541840102|FG000|Overall Study|Adverse Event|0|||
150191417|NCT06424236|541840103|FG001|Overall Study|Adverse Event|1|||
150191418|NCT06424236|541840104|FG002|Overall Study|Adverse Event|0|||
150191419|NCT06424236|541840102|FG000|Overall Study|Withdrawal by Subject|3|||
150191420|NCT06424236|541840103|FG001|Overall Study|Withdrawal by Subject|1|||
150191421|NCT06424236|541840104|FG002|Overall Study|Withdrawal by Subject|2|||
150191422|NCT06424236|541840102|FG000|Overall Study|Physician Decision|0|||
150191423|NCT06424236|541840103|FG001|Overall Study|Physician Decision|1|||
150191424|NCT06424236|541840104|FG002|Overall Study|Physician Decision|0|||
150191425|NCT06424236|541840102|FG000|Overall Study|Study Terminated by Sponsor|11|||
150191426|NCT06424236|541840103|FG001|Overall Study|Study Terminated by Sponsor|20|||
150191427|NCT06424236|541840104|FG002|Overall Study|Study Terminated by Sponsor|16|||
150191428|NCT06424236|541840102|FG000|Overall Study|Lost to Follow-up|0|||
150191429|NCT06424236|541840103|FG001|Overall Study|Lost to Follow-up|1|||
150191430|NCT06424236|541840104|FG002|Overall Study|Lost to Follow-up|0|||
150191431|NCT06424236|541840102|FG000|Overall Study|Disease Progression|0|||
150191432|NCT06424236|541840103|FG001|Overall Study|Disease Progression|1|||
150191433|NCT06424236|541840104|FG002|Overall Study|Disease Progression|2|||
150191434|NCT06424236|541840102|FG000|Overall Study|Other|0|||
150191435|NCT06424236|541840103|FG001|Overall Study|Other|0|||
150191436|NCT06424236|541840104|FG002|Overall Study|Other|1|||
150191437|NCT02262728|541840106|FG000|Follow-up Phase (3 Years)|Death|0|||
150191438|NCT02262728|541840107|FG001|Follow-up Phase (3 Years)|Death|1|||
150191439|NCT02262728|541840106|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
150191440|NCT02262728|541840107|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
150191441|NCT02262728|541840106|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
150191442|NCT02262728|541840107|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
150191443|NCT02619838|541840108|FG000|Overall Study|Lost to Follow-up|9|||
150191444|NCT02619838|541840108|FG000|Overall Study|Withdrawal by Subject|15|||
150191445|NCT00227344|541840109|FG000|Overall Study|study terminated early|12|||
150191446|NCT00227344|541840110|FG001|Overall Study|study terminated early|5|||
150191447|NCT02677805|541840111|FG000|Double Blind Phase|Lost to Follow-up|8|||
150191448|NCT02677805|541840112|FG001|Double Blind Phase|Lost to Follow-up|3|||
150191449|NCT02677805|541840113|FG002|Double Blind Phase|Lost to Follow-up|0|||
150191450|NCT02677805|541840111|FG000|Double Blind Phase|Withdrawal by Subject|5|||
150191451|NCT02677805|541840112|FG001|Double Blind Phase|Withdrawal by Subject|2|||
150119162|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
150119163|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
150119164|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
150119165|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
150119166|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
150119167|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
150119168|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
150119169|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
150119170|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
150119171|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
150119172|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
150119173|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
150119174|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
150119175|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
150119176|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
150119177|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
150119178|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
150119179|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
150119180|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
150119181|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
150119182|NCT01760954|541571860|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
150119183|NCT01760954|541571861|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
150119184|NCT01760954|541571862|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
150119185|NCT01760954|541571863|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
150119186|NCT01159938|541571864|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
150119187|NCT01159938|541571865|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
150119188|NCT01159938|541571866|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
150119189|NCT01159938|541571867|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
150119190|NCT01159938|541571868|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
150119191|NCT02032901|541571874|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
150119192|NCT02032901|541571875|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
150119193|NCT02032901|541571874|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
150119194|NCT02032901|541571875|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
150119195|NCT00982020|541571876|FG000|Overall Study|Adverse Event|19|||
150119196|NCT00982020|541571877|FG001|Overall Study|Adverse Event|15|||
150119197|NCT00982020|541571876|FG000|Overall Study|Withdrawal by Subject|11|||
150119198|NCT00982020|541571877|FG001|Overall Study|Withdrawal by Subject|14|||
150119199|NCT00982020|541571876|FG000|Overall Study|Lost to Follow-up|5|||
150119200|NCT00982020|541571877|FG001|Overall Study|Lost to Follow-up|11|||
150119201|NCT00982020|541571876|FG000|Overall Study|Lack of Efficacy|10|||
150119202|NCT00982020|541571877|FG001|Overall Study|Lack of Efficacy|4|||
150119203|NCT00982020|541571876|FG000|Overall Study|Parent/Caregiver Decision|5|||
150119204|NCT00982020|541571877|FG001|Overall Study|Parent/Caregiver Decision|5|||
150119205|NCT00982020|541571876|FG000|Overall Study|Treatment Non-compliance|3|||
150119206|NCT00982020|541571877|FG001|Overall Study|Treatment Non-compliance|6|||
150119207|NCT00982020|541571876|FG000|Overall Study|Physician Decision|2|||
150119208|NCT00982020|541571877|FG001|Overall Study|Physician Decision|5|||
150119209|NCT00982020|541571876|FG000|Overall Study|Entry Criteria Not Met|2|||
150119210|NCT00982020|541571877|FG001|Overall Study|Entry Criteria Not Met|1|||
150119211|NCT00982020|541571876|FG000|Overall Study|Protocol Violation|0|||
150119212|NCT00982020|541571877|FG001|Overall Study|Protocol Violation|2|||
150119213|NCT00982020|541571876|FG000|Overall Study|Clinical Relapse|0|||
150119214|NCT00982020|541571877|FG001|Overall Study|Clinical Relapse|1|||
150119215|NCT01722331|541571878|FG000|Part 1|Adverse Event|5|||
150119216|NCT01722331|541571879|FG001|Part 1|Adverse Event|0|||
150119217|NCT01722331|541571880|FG002|Part 1|Adverse Event|0|||
150119218|NCT01722331|541571881|FG003|Part 1|Adverse Event|0|||
150119219|NCT01722331|541571882|FG004|Part 1|Adverse Event|0|||
150119220|NCT01722331|541571883|FG005|Part 1|Adverse Event|0|||
150119221|NCT01722331|541571884|FG006|Part 1|Adverse Event|0|||
150119222|NCT01722331|541571878|FG000|Part 1|Lack of Efficacy|0|||
150119223|NCT01722331|541571879|FG001|Part 1|Lack of Efficacy|0|||
150119224|NCT01722331|541571880|FG002|Part 1|Lack of Efficacy|1|||
150119225|NCT01722331|541571881|FG003|Part 1|Lack of Efficacy|0|||
150119226|NCT01722331|541571882|FG004|Part 1|Lack of Efficacy|2|||
150119227|NCT01722331|541571883|FG005|Part 1|Lack of Efficacy|0|||
150119228|NCT01722331|541571884|FG006|Part 1|Lack of Efficacy|0|||
150119229|NCT01722331|541571878|FG000|Part 1|Lost to Follow-up|1|||
150119230|NCT01722331|541571879|FG001|Part 1|Lost to Follow-up|0|||
150119231|NCT01722331|541571880|FG002|Part 1|Lost to Follow-up|2|||
150119232|NCT01722331|541571881|FG003|Part 1|Lost to Follow-up|0|||
150191452|NCT02677805|541840113|FG002|Double Blind Phase|Withdrawal by Subject|0|||
150191453|NCT02677805|541840111|FG000|Open Label Phase|Lost to Follow-up|0|||
150191454|NCT02677805|541840112|FG001|Open Label Phase|Lost to Follow-up|0|||
150191455|NCT02677805|541840113|FG002|Open Label Phase|Lost to Follow-up|10|||
150191456|NCT02677805|541840111|FG000|Open Label Phase|Withdrawal by Subject|0|||
150191457|NCT02677805|541840112|FG001|Open Label Phase|Withdrawal by Subject|0|||
150191458|NCT02677805|541840113|FG002|Open Label Phase|Withdrawal by Subject|6|||
150191459|NCT04111536|541840114|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
150191460|NCT04111536|541840115|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
150191461|NCT04111536|541840114|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
150191462|NCT04111536|541840115|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
150191463|NCT04111536|541840114|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
150191464|NCT04111536|541840115|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
150191465|NCT04111536|541840114|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
150191466|NCT04111536|541840115|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
150191467|NCT04187833|541840116|FG000|Overall Study|Withdrawal by Subject|1|||
150191468|NCT04171999|541840117|FG000|Overall Study|deemed ineligible after randomization|2|||
150191469|NCT04171999|541840118|FG001|Overall Study|deemed ineligible after randomization|1|||
150191470|NCT04282148|541840119|FG000|Overall Study|Death|7|||
150191471|NCT04282148|541840119|FG000|Overall Study|Withdrawal by Subject|1|||
150191472|NCT04282148|541840119|FG000|Overall Study|Physician Decision|1|||
150191473|NCT04130438|541842579|FG000|Overall Study|Lost to Follow-up|0|||
150191474|NCT04130438|541842580|FG001|Overall Study|Lost to Follow-up|0|||
150191475|NCT04130438|541842581|FG002|Overall Study|Lost to Follow-up|1|||
150191476|NCT04515576|541842583|FG000|Overall Study|Withdrawal by Subject|0|||
150119233|NCT01722331|541571882|FG004|Part 1|Lost to Follow-up|1|||
150119234|NCT01722331|541571883|FG005|Part 1|Lost to Follow-up|0|||
150119235|NCT01722331|541571884|FG006|Part 1|Lost to Follow-up|0|||
150119236|NCT01722331|541571878|FG000|Part 1|Physician Decision|0|||
150119237|NCT01722331|541571879|FG001|Part 1|Physician Decision|0|||
150119238|NCT01722331|541571880|FG002|Part 1|Physician Decision|3|||
150119239|NCT01722331|541571881|FG003|Part 1|Physician Decision|0|||
150119240|NCT01722331|541571882|FG004|Part 1|Physician Decision|1|||
150119241|NCT01722331|541571883|FG005|Part 1|Physician Decision|0|||
150119242|NCT01722331|541571884|FG006|Part 1|Physician Decision|0|||
150119243|NCT01722331|541571878|FG000|Part 1|Pregnancy|1|||
150119244|NCT01722331|541571879|FG001|Part 1|Pregnancy|0|||
150119245|NCT01722331|541571880|FG002|Part 1|Pregnancy|0|||
150119246|NCT01722331|541571881|FG003|Part 1|Pregnancy|0|||
150119247|NCT01722331|541571882|FG004|Part 1|Pregnancy|0|||
150119248|NCT01722331|541571883|FG005|Part 1|Pregnancy|0|||
150119249|NCT01722331|541571884|FG006|Part 1|Pregnancy|0|||
150119250|NCT01722331|541571878|FG000|Part 1|Progressive Disease|0|||
150119251|NCT01722331|541571879|FG001|Part 1|Progressive Disease|0|||
150119252|NCT01722331|541571880|FG002|Part 1|Progressive Disease|0|||
150119253|NCT01722331|541571881|FG003|Part 1|Progressive Disease|0|||
150119254|NCT01722331|541571882|FG004|Part 1|Progressive Disease|1|||
150119255|NCT01722331|541571883|FG005|Part 1|Progressive Disease|0|||
150119256|NCT01722331|541571884|FG006|Part 1|Progressive Disease|0|||
150119257|NCT01722331|541571878|FG000|Part 1|Protocol Violation|1|||
150119258|NCT01722331|541571879|FG001|Part 1|Protocol Violation|0|||
150119259|NCT01722331|541571880|FG002|Part 1|Protocol Violation|0|||
150119260|NCT01722331|541571881|FG003|Part 1|Protocol Violation|0|||
150119261|NCT01722331|541571882|FG004|Part 1|Protocol Violation|1|||
150119262|NCT01722331|541571883|FG005|Part 1|Protocol Violation|0|||
150119263|NCT01722331|541571884|FG006|Part 1|Protocol Violation|0|||
150119264|NCT01722331|541571878|FG000|Part 1|Withdrawal by Subject|2|||
150119265|NCT01722331|541571879|FG001|Part 1|Withdrawal by Subject|0|||
150191477|NCT04515576|541842584|FG001|Overall Study|Withdrawal by Subject|0|||
150191478|NCT04515576|541842585|FG002|Overall Study|Withdrawal by Subject|0|||
150191479|NCT04515576|541842586|FG003|Overall Study|Withdrawal by Subject|0|||
150191480|NCT04515576|541842587|FG004|Overall Study|Withdrawal by Subject|0|||
150191481|NCT04515576|541842588|FG005|Overall Study|Withdrawal by Subject|1|||
150191482|NCT02140554|541842589|FG000|Overall Study|Withdrawal of consent|1|||
150191483|NCT02140554|541842590|FG001|Overall Study|Withdrawal of consent|0|||
150191484|NCT02140554|541842591|FG002|Overall Study|Withdrawal of consent|4|||
150191485|NCT02140554|541842589|FG000|Overall Study|Physician Decision|1|||
150191486|NCT02140554|541842590|FG001|Overall Study|Physician Decision|0|||
150191487|NCT02140554|541842591|FG002|Overall Study|Physician Decision|2|||
150191488|NCT02140554|541842589|FG000|Overall Study|Death|0|||
150191489|NCT02140554|541842590|FG001|Overall Study|Death|0|||
150191490|NCT02140554|541842591|FG002|Overall Study|Death|1|||
150191491|NCT02140554|541842589|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
150191492|NCT02140554|541842590|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
150191493|NCT02140554|541842591|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
150119266|NCT01722331|541571880|FG002|Part 1|Withdrawal by Subject|3|||
150119267|NCT01722331|541571881|FG003|Part 1|Withdrawal by Subject|0|||
150119268|NCT01722331|541571882|FG004|Part 1|Withdrawal by Subject|3|||
150119269|NCT01722331|541571883|FG005|Part 1|Withdrawal by Subject|0|||
150119270|NCT01722331|541571884|FG006|Part 1|Withdrawal by Subject|0|||
150191494|NCT03953508|541842593|FG000|Baseline|Lost to Follow-up|3|||
150191495|NCT03953508|541842594|FG001|Baseline|Lost to Follow-up|2|||
150191496|NCT03953508|541842593|FG000|6-month Follow-up|Lost to Follow-up|62|||
150191497|NCT03953508|541842594|FG001|6-month Follow-up|Lost to Follow-up|70|||
150191498|NCT02100813|541842595|FG000|Overall Study|Adverse Event|0|||
150191499|NCT02100813|541842596|FG001|Overall Study|Adverse Event|0|||
150191500|NCT02100813|541842597|FG002|Overall Study|Adverse Event|0|||
150191501|NCT02100813|541842598|FG003|Overall Study|Adverse Event|0|||
150191502|NCT02100813|541842599|FG004|Overall Study|Adverse Event|0|||
150191503|NCT02100813|541842600|FG005|Overall Study|Adverse Event|0|||
150191504|NCT02100813|541842601|FG006|Overall Study|Adverse Event|0|||
150191505|NCT02100813|541842602|FG007|Overall Study|Adverse Event|1|||
150191506|NCT05835336|541842607|FG000|Overall Study|Withdrawal by Subject|5|||
150191507|NCT05835336|541842607|FG000|Overall Study|Did not complete the personalization process|3|||
150191508|NCT04489771|541842608|FG000|Overall Study|Death|27|||
150191509|NCT04489771|541842609|FG001|Overall Study|Death|25|||
150191510|NCT04489771|541842608|FG000|Overall Study|Withdrawal by Subject|1|||
150191511|NCT04489771|541842609|FG001|Overall Study|Withdrawal by Subject|0|||
150191512|NCT04489771|541842608|FG000|Overall Study|Participants Ongoing in Study|50|||
150191513|NCT04489771|541842609|FG001|Overall Study|Participants Ongoing in Study|51|||
150191514|NCT04509674|541842610|FG000|Overall Study|Not treated|33|||
150191515|NCT04509674|541842611|FG001|Overall Study|Not treated|26|||
150191516|NCT04509674|541842610|FG000|Overall Study|Protocol Violation|9|||
150191517|NCT04509674|541842611|FG001|Overall Study|Protocol Violation|10|||
150191518|NCT04509674|541842610|FG000|Overall Study|Lost to Follow-up|31|||
150191519|NCT04509674|541842611|FG001|Overall Study|Lost to Follow-up|39|||
150191520|NCT04509674|541842610|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
150191521|NCT04509674|541842611|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
150191522|NCT04509674|541842610|FG000|Overall Study|Adverse event, serious fatal event|11|||
150191523|NCT04509674|541842611|FG001|Overall Study|Adverse event, serious fatal event|4|||
150191524|NCT04509674|541842610|FG000|Overall Study|Adverse event, non-fatal event|107|||
150119271|NCT01722331|541571878|FG000|Part 2|Adverse Event|3|||
150119272|NCT01722331|541571879|FG001|Part 2|Adverse Event|0|||
150119273|NCT01722331|541571880|FG002|Part 2|Adverse Event|0|||
150119274|NCT01722331|541571881|FG003|Part 2|Adverse Event|0|||
150119275|NCT01722331|541571882|FG004|Part 2|Adverse Event|0|||
150119276|NCT01722331|541571883|FG005|Part 2|Adverse Event|1|||
150119277|NCT01722331|541571884|FG006|Part 2|Adverse Event|0|||
150119278|NCT01722331|541571878|FG000|Part 2|Lack of Efficacy|3|||
150119279|NCT01722331|541571879|FG001|Part 2|Lack of Efficacy|0|||
150119280|NCT01722331|541571880|FG002|Part 2|Lack of Efficacy|11|||
150119281|NCT01722331|541571881|FG003|Part 2|Lack of Efficacy|0|||
150119282|NCT01722331|541571882|FG004|Part 2|Lack of Efficacy|0|||
150119283|NCT01722331|541571883|FG005|Part 2|Lack of Efficacy|3|||
150119284|NCT01722331|541571884|FG006|Part 2|Lack of Efficacy|3|||
150119285|NCT01722331|541571878|FG000|Part 2|Lost to Follow-up|0|||
150119286|NCT01722331|541571879|FG001|Part 2|Lost to Follow-up|0|||
150119287|NCT01722331|541571880|FG002|Part 2|Lost to Follow-up|3|||
150119288|NCT01722331|541571881|FG003|Part 2|Lost to Follow-up|0|||
150119289|NCT01722331|541571882|FG004|Part 2|Lost to Follow-up|0|||
150119290|NCT01722331|541571883|FG005|Part 2|Lost to Follow-up|1|||
150119291|NCT01722331|541571884|FG006|Part 2|Lost to Follow-up|1|||
150119292|NCT01722331|541571878|FG000|Part 2|Non-Compliance with Study Drug|1|||
150119293|NCT01722331|541571879|FG001|Part 2|Non-Compliance with Study Drug|0|||
150191525|NCT04509674|541842611|FG001|Overall Study|Adverse event, non-fatal event|118|||
150191526|NCT04509674|541842610|FG000|Overall Study|Other reason than listed|106|||
150191527|NCT04509674|541842611|FG001|Overall Study|Other reason than listed|95|||
150191528|NCT04059484|541842614|FG000|Overall Study|Adverse Event|2|||
150191529|NCT04059484|541842615|FG001|Overall Study|Adverse Event|5|||
150191530|NCT04059484|541842614|FG000|Overall Study|Withdrawal by Subject|5|||
150191531|NCT04059484|541842615|FG001|Overall Study|Withdrawal by Subject|3|||
150191532|NCT04059484|541842614|FG000|Overall Study|Progressive disease|112|||
150191533|NCT04059484|541842615|FG001|Overall Study|Progressive disease|112|||
150191534|NCT04059484|541842614|FG000|Overall Study|Other|8|||
150191535|NCT04059484|541842615|FG001|Overall Study|Other|3|||
150119294|NCT01722331|541571880|FG002|Part 2|Non-Compliance with Study Drug|1|||
150191536|NCT04059484|541842614|FG000|Overall Study|Ongoing|20|||
150191537|NCT04059484|541842615|FG001|Overall Study|Ongoing|20|||
150191538|NCT04185298|541842617|FG000|Overall Study|Lost to Follow-up|1|||
150191539|NCT04185298|541842618|FG001|Overall Study|Lost to Follow-up|3|||
150191540|NCT04185298|541842617|FG000|Overall Study|Withdrawal by Subject|0|||
150119295|NCT01722331|541571881|FG003|Part 2|Non-Compliance with Study Drug|0|||
150191541|NCT04185298|541842618|FG001|Overall Study|Withdrawal by Subject|3|||
150191542|NCT03339713|541842619|FG000|Overall Study|Lost to Follow-up|2|||
150191543|NCT03339713|541842620|FG001|Overall Study|Lost to Follow-up|1|||
150119296|NCT01722331|541571882|FG004|Part 2|Non-Compliance with Study Drug|0|||
150119297|NCT01722331|541571883|FG005|Part 2|Non-Compliance with Study Drug|0|||
150119298|NCT01722331|541571884|FG006|Part 2|Non-Compliance with Study Drug|0|||
150119299|NCT01722331|541571878|FG000|Part 2|Physician Decision|0|||
150119300|NCT01722331|541571879|FG001|Part 2|Physician Decision|0|||
150191544|NCT03339713|541842619|FG000|Overall Study|Protocol Violation|1|||
150191545|NCT03339713|541842620|FG001|Overall Study|Protocol Violation|0|||
150191546|NCT03339713|541842619|FG000|Overall Study|Withdrawal by Subject|1|||
150191547|NCT03339713|541842620|FG001|Overall Study|Withdrawal by Subject|1|||
150191548|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
150191549|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
150191550|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
150191551|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
150191552|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
150191553|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
150191554|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
150191555|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
150191556|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
150191557|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
150191558|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
150191559|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
150191560|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
150191561|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
150191562|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
150191563|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
150191564|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
150191565|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
150191566|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
150191567|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
150191568|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
150191569|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
150191570|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
150191571|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
150191572|NCT01715285|541842623|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
150191573|NCT01715285|541842624|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
150191574|NCT01715285|541842625|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
150191575|NCT01715285|541842623|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
150191576|NCT01715285|541842624|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
150191577|NCT01715285|541842625|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
150191578|NCT01715285|541842623|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
150191579|NCT01715285|541842624|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
150191580|NCT01715285|541842625|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
150191581|NCT01715285|541842623|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
150191582|NCT01715285|541842624|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
150191583|NCT01715285|541842625|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
150191584|NCT01715285|541842623|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
150191585|NCT01715285|541842624|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
150191586|NCT01715285|541842625|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
150191587|NCT01715285|541842623|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
150191588|NCT01715285|541842624|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
150119301|NCT01722331|541571880|FG002|Part 2|Physician Decision|2|||
150119302|NCT01722331|541571881|FG003|Part 2|Physician Decision|0|||
150119303|NCT01722331|541571882|FG004|Part 2|Physician Decision|0|||
150119304|NCT01722331|541571883|FG005|Part 2|Physician Decision|0|||
150119305|NCT01722331|541571884|FG006|Part 2|Physician Decision|0|||
150119306|NCT01722331|541571878|FG000|Part 2|Pregnancy|0|||
150119307|NCT01722331|541571879|FG001|Part 2|Pregnancy|0|||
150119308|NCT01722331|541571880|FG002|Part 2|Pregnancy|0|||
150119309|NCT01722331|541571881|FG003|Part 2|Pregnancy|0|||
150119310|NCT01722331|541571882|FG004|Part 2|Pregnancy|0|||
150119311|NCT01722331|541571883|FG005|Part 2|Pregnancy|1|||
150119312|NCT01722331|541571884|FG006|Part 2|Pregnancy|0|||
150119313|NCT01722331|541571878|FG000|Part 2|Progressive Disease|0|||
150119314|NCT01722331|541571879|FG001|Part 2|Progressive Disease|0|||
150119315|NCT01722331|541571880|FG002|Part 2|Progressive Disease|1|||
150191589|NCT01715285|541842625|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
150119316|NCT01722331|541571881|FG003|Part 2|Progressive Disease|0|||
150119317|NCT01722331|541571882|FG004|Part 2|Progressive Disease|0|||
150119318|NCT01722331|541571883|FG005|Part 2|Progressive Disease|0|||
150119319|NCT01722331|541571884|FG006|Part 2|Progressive Disease|0|||
150119320|NCT01722331|541571878|FG000|Part 2|Protocol Violation|1|||
150119321|NCT01722331|541571879|FG001|Part 2|Protocol Violation|0|||
150119322|NCT01722331|541571880|FG002|Part 2|Protocol Violation|0|||
150119323|NCT01722331|541571881|FG003|Part 2|Protocol Violation|0|||
150119324|NCT01722331|541571882|FG004|Part 2|Protocol Violation|0|||
150119325|NCT01722331|541571883|FG005|Part 2|Protocol Violation|0|||
150119326|NCT01722331|541571884|FG006|Part 2|Protocol Violation|0|||
150191590|NCT01987895|541842626|FG000|Overall Study|Withdrawal by Subject|12|||
150191591|NCT01987895|541842627|FG001|Overall Study|Withdrawal by Subject|7|||
150119327|NCT01722331|541571878|FG000|Part 2|Withdrawal by Subject|5|||
150119328|NCT01722331|541571879|FG001|Part 2|Withdrawal by Subject|0|||
150119329|NCT01722331|541571880|FG002|Part 2|Withdrawal by Subject|3|||
150119330|NCT01722331|541571881|FG003|Part 2|Withdrawal by Subject|0|||
150119331|NCT01722331|541571882|FG004|Part 2|Withdrawal by Subject|0|||
150119332|NCT01722331|541571883|FG005|Part 2|Withdrawal by Subject|2|||
150119333|NCT01722331|541571884|FG006|Part 2|Withdrawal by Subject|2|||
150119334|NCT01722331|541571878|FG000|Part 2|Other Protocol Specified Criteria|6|||
150119335|NCT01722331|541571879|FG001|Part 2|Other Protocol Specified Criteria|0|||
150119336|NCT01722331|541571880|FG002|Part 2|Other Protocol Specified Criteria|10|||
150119337|NCT01722331|541571881|FG003|Part 2|Other Protocol Specified Criteria|0|||
150119338|NCT01722331|541571882|FG004|Part 2|Other Protocol Specified Criteria|0|||
150119339|NCT01722331|541571883|FG005|Part 2|Other Protocol Specified Criteria|2|||
150119340|NCT01722331|541571884|FG006|Part 2|Other Protocol Specified Criteria|1|||
150119341|NCT01722331|541571878|FG000|Part 3|Adverse Event|2|||
150119342|NCT01722331|541571879|FG001|Part 3|Adverse Event|2|||
150119343|NCT01722331|541571880|FG002|Part 3|Adverse Event|0|||
150119344|NCT01722331|541571881|FG003|Part 3|Adverse Event|1|||
150119345|NCT01722331|541571882|FG004|Part 3|Adverse Event|0|||
150119346|NCT01722331|541571883|FG005|Part 3|Adverse Event|0|||
150119347|NCT01722331|541571884|FG006|Part 3|Adverse Event|0|||
150119348|NCT01722331|541571878|FG000|Part 3|Death|1|||
150119349|NCT01722331|541571879|FG001|Part 3|Death|0|||
150119350|NCT01722331|541571880|FG002|Part 3|Death|0|||
150119351|NCT01722331|541571881|FG003|Part 3|Death|0|||
150119352|NCT01722331|541571882|FG004|Part 3|Death|0|||
150119353|NCT01722331|541571883|FG005|Part 3|Death|0|||
150119354|NCT01722331|541571884|FG006|Part 3|Death|0|||
150119355|NCT01722331|541571878|FG000|Part 3|Lack of Efficacy|1|||
150119356|NCT01722331|541571879|FG001|Part 3|Lack of Efficacy|0|||
150119357|NCT01722331|541571880|FG002|Part 3|Lack of Efficacy|0|||
150119358|NCT01722331|541571881|FG003|Part 3|Lack of Efficacy|0|||
150119359|NCT01722331|541571882|FG004|Part 3|Lack of Efficacy|0|||
150119360|NCT01722331|541571883|FG005|Part 3|Lack of Efficacy|0|||
150119361|NCT01722331|541571884|FG006|Part 3|Lack of Efficacy|0|||
150119362|NCT01722331|541571878|FG000|Part 3|Lost to Follow-up|3|||
150119363|NCT01722331|541571879|FG001|Part 3|Lost to Follow-up|4|||
150119364|NCT01722331|541571880|FG002|Part 3|Lost to Follow-up|0|||
150119365|NCT01722331|541571881|FG003|Part 3|Lost to Follow-up|0|||
150119366|NCT01722331|541571882|FG004|Part 3|Lost to Follow-up|0|||
150119367|NCT01722331|541571883|FG005|Part 3|Lost to Follow-up|1|||
150119368|NCT01722331|541571884|FG006|Part 3|Lost to Follow-up|0|||
150119369|NCT01722331|541571878|FG000|Part 3|Non-Compliance with Study Drug|0|||
150119370|NCT01722331|541571879|FG001|Part 3|Non-Compliance with Study Drug|1|||
150119371|NCT01722331|541571880|FG002|Part 3|Non-Compliance with Study Drug|0|||
150119372|NCT01722331|541571881|FG003|Part 3|Non-Compliance with Study Drug|0|||
150119373|NCT01722331|541571882|FG004|Part 3|Non-Compliance with Study Drug|0|||
150119374|NCT01722331|541571883|FG005|Part 3|Non-Compliance with Study Drug|0|||
150119375|NCT01722331|541571884|FG006|Part 3|Non-Compliance with Study Drug|0|||
150119376|NCT01722331|541571878|FG000|Part 3|Physician Decision|1|||
150119377|NCT01722331|541571879|FG001|Part 3|Physician Decision|1|||
150119378|NCT01722331|541571880|FG002|Part 3|Physician Decision|0|||
150119379|NCT01722331|541571881|FG003|Part 3|Physician Decision|0|||
150119380|NCT01722331|541571882|FG004|Part 3|Physician Decision|0|||
150119381|NCT01722331|541571883|FG005|Part 3|Physician Decision|0|||
150119382|NCT01722331|541571884|FG006|Part 3|Physician Decision|1|||
150119383|NCT01722331|541571878|FG000|Part 3|Protocol Violation|2|||
150119384|NCT01722331|541571879|FG001|Part 3|Protocol Violation|1|||
150119385|NCT01722331|541571880|FG002|Part 3|Protocol Violation|0|||
150119386|NCT01722331|541571881|FG003|Part 3|Protocol Violation|0|||
150119387|NCT01722331|541571882|FG004|Part 3|Protocol Violation|0|||
150119388|NCT01722331|541571883|FG005|Part 3|Protocol Violation|0|||
150119389|NCT01722331|541571884|FG006|Part 3|Protocol Violation|0|||
150119390|NCT01722331|541571878|FG000|Part 3|Withdrawal by Subject|4|||
150119391|NCT01722331|541571879|FG001|Part 3|Withdrawal by Subject|7|||
150119392|NCT01722331|541571880|FG002|Part 3|Withdrawal by Subject|0|||
150119393|NCT01722331|541571881|FG003|Part 3|Withdrawal by Subject|0|||
150119394|NCT01722331|541571882|FG004|Part 3|Withdrawal by Subject|0|||
150119395|NCT01722331|541571883|FG005|Part 3|Withdrawal by Subject|2|||
150119396|NCT01722331|541571884|FG006|Part 3|Withdrawal by Subject|1|||
150119397|NCT01722331|541571878|FG000|Part 3|Other Protocol Specified Criteria|1|||
150119398|NCT01722331|541571879|FG001|Part 3|Other Protocol Specified Criteria|1|||
150119399|NCT01722331|541571880|FG002|Part 3|Other Protocol Specified Criteria|0|||
150119400|NCT01722331|541571881|FG003|Part 3|Other Protocol Specified Criteria|0|||
150119401|NCT01722331|541571882|FG004|Part 3|Other Protocol Specified Criteria|0|||
150119402|NCT01722331|541571883|FG005|Part 3|Other Protocol Specified Criteria|0|||
150119403|NCT01722331|541571884|FG006|Part 3|Other Protocol Specified Criteria|0|||
150119404|NCT00353704|541571897|FG000|Overall Study|Protocol Violation|3|||
150119405|NCT00353704|541571898|FG001|Overall Study|Protocol Violation|1|||
150119406|NCT02525133|541571899|FG000|Overall Study|Adverse Event|0|||
150119407|NCT02525133|541571900|FG001|Overall Study|Adverse Event|1|||
150119408|NCT02525133|541571899|FG000|Overall Study|Death|0|||
150119409|NCT02525133|541571900|FG001|Overall Study|Death|1|||
150119410|NCT02525133|541571899|FG000|Overall Study|did not meet randomization criteria|1|||
150119411|NCT02525133|541571900|FG001|Overall Study|did not meet randomization criteria|0|||
150119412|NCT02525133|541571899|FG000|Overall Study|Lost to Follow-up|5|||
150119413|NCT02525133|541571900|FG001|Overall Study|Lost to Follow-up|1|||
150119414|NCT02525133|541571899|FG000|Overall Study|randomized not enrolled|3|||
150119415|NCT02525133|541571900|FG001|Overall Study|randomized not enrolled|0|||
150119416|NCT02525133|541571899|FG000|Overall Study|Withdrawal by Subject|1|||
150119417|NCT02525133|541571900|FG001|Overall Study|Withdrawal by Subject|0|||
150119418|NCT01154166|541571901|FG000|Overall Study|Adverse Event|14|||
150119419|NCT01154166|541571902|FG001|Overall Study|Adverse Event|9|||
150119420|NCT01154166|541571901|FG000|Overall Study|Lost to Follow-up|1|||
150119421|NCT01154166|541571902|FG001|Overall Study|Lost to Follow-up|1|||
150119422|NCT01154166|541571901|FG000|Overall Study|Protocol Violation|4|||
150119423|NCT01154166|541571902|FG001|Overall Study|Protocol Violation|1|||
150119424|NCT01154166|541571901|FG000|Overall Study|Withdrawal by Subject|10|||
150119425|NCT01154166|541571902|FG001|Overall Study|Withdrawal by Subject|1|||
150119426|NCT01154166|541571901|FG000|Overall Study|Lack of Efficacy|3|||
150119427|NCT01154166|541571902|FG001|Overall Study|Lack of Efficacy|0|||
150191592|NCT01987895|541842626|FG000|Overall Study|Physician Decision|8|||
150191593|NCT01987895|541842627|FG001|Overall Study|Physician Decision|10|||
150191594|NCT01987895|541842626|FG000|Overall Study|Death|7|||
150191595|NCT01987895|541842627|FG001|Overall Study|Death|7|||
150191596|NCT01987895|541842626|FG000|Overall Study|Lost to Follow-up|3|||
150191597|NCT01987895|541842627|FG001|Overall Study|Lost to Follow-up|5|||
150191598|NCT01987895|541842626|FG000|Overall Study|randomized before giving IC|0|||
150191599|NCT01987895|541842627|FG001|Overall Study|randomized before giving IC|1|||
150191600|NCT05780437|541842628|FG000|Overall Study|Withdrawal by Subject|22|||
150191601|NCT05780437|541842629|FG001|Overall Study|Withdrawal by Subject|16|||
150191602|NCT05006872|541842630|FG000|Overall Study|Lost to Follow-up|37|||
150191603|NCT05006872|541842631|FG001|Overall Study|Lost to Follow-up|31|||
150191604|NCT02573493|541842637|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
150191605|NCT02573493|541842638|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
150191606|NCT02573493|541842639|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
150191607|NCT02573493|541842640|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
150191608|NCT04971681|541842641|FG000|Followup|Lost to Follow-up|1|||
150191609|NCT04971681|541842642|FG001|Followup|Lost to Follow-up|0|||
150191610|NCT04350463|541842650|FG000|Overall Study|Other reason|0|||
150191611|NCT04350463|541842651|FG001|Overall Study|Other reason|0|||
150191612|NCT04350463|541842652|FG002|Overall Study|Other reason|0|||
150191613|NCT04350463|541842653|FG003|Overall Study|Other reason|1|||
150191614|NCT04350463|541842650|FG000|Overall Study|Lost to Follow-up|0|||
150191615|NCT04350463|541842651|FG001|Overall Study|Lost to Follow-up|0|||
150191616|NCT04350463|541842652|FG002|Overall Study|Lost to Follow-up|0|||
150191617|NCT04350463|541842653|FG003|Overall Study|Lost to Follow-up|2|||
150191618|NCT04350463|541842650|FG000|Overall Study|Withdrawal by Subject|4|||
150191619|NCT04350463|541842651|FG001|Overall Study|Withdrawal by Subject|0|||
150191620|NCT04350463|541842652|FG002|Overall Study|Withdrawal by Subject|1|||
150191621|NCT04350463|541842653|FG003|Overall Study|Withdrawal by Subject|4|||
150191622|NCT04350463|541842650|FG000|Overall Study|Adverse Event|0|||
150191623|NCT04350463|541842651|FG001|Overall Study|Adverse Event|0|||
150191624|NCT04350463|541842652|FG002|Overall Study|Adverse Event|0|||
150191625|NCT04350463|541842653|FG003|Overall Study|Adverse Event|2|||
150191626|NCT04350463|541842650|FG000|Overall Study|Death|27|||
150191627|NCT04350463|541842651|FG001|Overall Study|Death|2|||
150191628|NCT04350463|541842652|FG002|Overall Study|Death|13|||
150191629|NCT04350463|541842653|FG003|Overall Study|Death|26|||
150191630|NCT04652700|541842654|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
150191631|NCT04652700|541842655|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
150191632|NCT04652700|541842654|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
150191633|NCT04652700|541842655|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
150191634|NCT04652700|541842654|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
150191635|NCT04652700|541842655|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
150119428|NCT01154166|541571901|FG000|Overall Study|Disease Progression|1|||
150191636|NCT04652700|541842654|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
150191637|NCT04652700|541842655|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
150119429|NCT01154166|541571902|FG001|Overall Study|Disease Progression|0|||
150119430|NCT01154166|541571901|FG000|Overall Study|Poor Compliance|1|||
150119431|NCT01154166|541571902|FG001|Overall Study|Poor Compliance|0|||
150119432|NCT01375049|541571903|FG000|Overall Study|Adverse Event|2|||
150191638|NCT04652700|541842654|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
150119433|NCT01375049|541571903|FG000|Overall Study|Lost to Follow-up|1|||
150119434|NCT01375049|541571903|FG000|Overall Study|Withdrawal by Subject|2|||
150119435|NCT01375049|541571903|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
150119436|NCT01575561|541571904|FG000|Overall Study|Adverse Event|9|||
150119437|NCT01575561|541571904|FG000|Overall Study|Lack of Efficacy|8|||
150119438|NCT01575561|541571904|FG000|Overall Study|Lost to Follow-up|6|||
150119439|NCT01575561|541571904|FG000|Overall Study|Protocol Violation|4|||
150119440|NCT01575561|541571904|FG000|Overall Study|Withdrawal by Subject|11|||
150119441|NCT01575561|541571904|FG000|Overall Study|administration|1|||
150119442|NCT02530619|541571914|FG000|Registered for Study|Withdrawal by Subject|2|||
150119443|NCT02530619|541571914|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
150119444|NCT02530619|541571914|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
150119445|NCT02530619|541571914|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
150119446|NCT02530619|541571914|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
150119447|NCT02530619|541571914|FG000|Follow-up Period (6 Months)|Death|4|||
150119448|NCT02530619|541571914|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
150119449|NCT02530619|541571914|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
150119450|NCT01854554|541571924|FG000|Overall Study|Denial of Insurance Coverage|12|||
150119451|NCT01854554|541571925|FG001|Overall Study|Denial of Insurance Coverage|0|||
150119452|NCT01854554|541571924|FG000|Overall Study|Decided to get treatment locally|1|||
150119453|NCT01854554|541571925|FG001|Overall Study|Decided to get treatment locally|5|||
150119454|NCT01854554|541571924|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
150119455|NCT01854554|541571925|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
150119456|NCT01854554|541571924|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
150119457|NCT01854554|541571925|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
150119458|NCT01854554|541571924|FG000|Overall Study|Progression|0|||
150119459|NCT01854554|541571925|FG001|Overall Study|Progression|1|||
150119460|NCT01854554|541571924|FG000|Overall Study|Lost to Follow-up|0|||
150119461|NCT01854554|541571925|FG001|Overall Study|Lost to Follow-up|1|||
150119462|NCT02819726|541571926|FG000|Part A (All Participants)|Lost to Follow-up|0|||
150119463|NCT02819726|541571927|FG001|Part A (All Participants)|Lost to Follow-up|1|||
150119464|NCT02819726|541571928|FG002|Part A (All Participants)|Lost to Follow-up|0|||
150119465|NCT02819726|541571929|FG003|Part A (All Participants)|Lost to Follow-up|0|||
150119466|NCT02819726|541571926|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
150119467|NCT02819726|541571927|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
150119468|NCT02819726|541571928|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
150119469|NCT02819726|541571929|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
150119470|NCT02819726|541571926|FG000|Part A (All Participants)|Protocol non-compliance|3|||
150119471|NCT02819726|541571927|FG001|Part A (All Participants)|Protocol non-compliance|4|||
150119472|NCT02819726|541571928|FG002|Part A (All Participants)|Protocol non-compliance|5|||
150119473|NCT02819726|541571929|FG003|Part A (All Participants)|Protocol non-compliance|0|||
150119474|NCT02819726|541571926|FG000|Part B (All Participants)|Lost to Follow-up|1|||
150119475|NCT02819726|541571927|FG001|Part B (All Participants)|Lost to Follow-up|1|||
150119476|NCT02819726|541571928|FG002|Part B (All Participants)|Lost to Follow-up|2|||
150119477|NCT02819726|541571929|FG003|Part B (All Participants)|Lost to Follow-up|2|||
150119478|NCT02819726|541571926|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
150119479|NCT02819726|541571927|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
150119480|NCT02819726|541571928|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
150119481|NCT02819726|541571929|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
150119482|NCT02819726|541571926|FG000|Part B (All Participants)|Protocol non-compliance|0|||
150119483|NCT02819726|541571927|FG001|Part B (All Participants)|Protocol non-compliance|0|||
150119484|NCT02819726|541571928|FG002|Part B (All Participants)|Protocol non-compliance|1|||
150119485|NCT02819726|541571929|FG003|Part B (All Participants)|Protocol non-compliance|0|||
150119486|NCT00359762|541571930|FG000|Period II|Adverse Event|17|||
150119487|NCT00359762|541571931|FG001|Period II|Adverse Event|0|||
150119488|NCT00359762|541571932|FG002|Period II|Adverse Event|0|||
150119489|NCT00359762|541571933|FG003|Period II|Adverse Event|0|||
150119490|NCT00359762|541571934|FG004|Period II|Adverse Event|49|||
150119491|NCT00359762|541571930|FG000|Period II|Protocol Violation|18|||
150119492|NCT00359762|541571931|FG001|Period II|Protocol Violation|0|||
150119493|NCT00359762|541571932|FG002|Period II|Protocol Violation|0|||
150119494|NCT00359762|541571933|FG003|Period II|Protocol Violation|0|||
150119495|NCT00359762|541571934|FG004|Period II|Protocol Violation|11|||
150119496|NCT00359762|541571930|FG000|Period II|Physician Decision|17|||
150119497|NCT00359762|541571931|FG001|Period II|Physician Decision|0|||
150119498|NCT00359762|541571932|FG002|Period II|Physician Decision|0|||
150119499|NCT00359762|541571933|FG003|Period II|Physician Decision|0|||
150119500|NCT00359762|541571934|FG004|Period II|Physician Decision|23|||
150119501|NCT00359762|541571930|FG000|Period II|Death|2|||
150119502|NCT00359762|541571931|FG001|Period II|Death|0|||
150119503|NCT00359762|541571932|FG002|Period II|Death|0|||
150119504|NCT00359762|541571933|FG003|Period II|Death|0|||
150119505|NCT00359762|541571934|FG004|Period II|Death|4|||
150119506|NCT00359762|541571930|FG000|Period II|Lack of Efficacy|11|||
150119507|NCT00359762|541571931|FG001|Period II|Lack of Efficacy|0|||
150119508|NCT00359762|541571932|FG002|Period II|Lack of Efficacy|0|||
150119509|NCT00359762|541571933|FG003|Period II|Lack of Efficacy|0|||
150119510|NCT00359762|541571934|FG004|Period II|Lack of Efficacy|8|||
150119511|NCT00359762|541571930|FG000|Period II|Lost to follow up|5|||
150119512|NCT00359762|541571931|FG001|Period II|Lost to follow up|0|||
150119513|NCT00359762|541571932|FG002|Period II|Lost to follow up|0|||
150119514|NCT00359762|541571933|FG003|Period II|Lost to follow up|0|||
150119515|NCT00359762|541571934|FG004|Period II|Lost to follow up|5|||
150119516|NCT00359762|541571930|FG000|Period II|Entry Criteria Not Met|8|||
150119517|NCT00359762|541571931|FG001|Period II|Entry Criteria Not Met|0|||
150119518|NCT00359762|541571932|FG002|Period II|Entry Criteria Not Met|0|||
150119519|NCT00359762|541571933|FG003|Period II|Entry Criteria Not Met|0|||
150119520|NCT00359762|541571934|FG004|Period II|Entry Criteria Not Met|4|||
150119521|NCT00359762|541571930|FG000|Period II|Subject Decision|50|||
150119522|NCT00359762|541571931|FG001|Period II|Subject Decision|0|||
150119523|NCT00359762|541571932|FG002|Period II|Subject Decision|0|||
150119524|NCT00359762|541571933|FG003|Period II|Subject Decision|0|||
150119525|NCT00359762|541571934|FG004|Period II|Subject Decision|70|||
150119526|NCT00359762|541571930|FG000|Period III|Protocol Violation|0|||
150119527|NCT00359762|541571931|FG001|Period III|Protocol Violation|5|||
150119528|NCT00359762|541571932|FG002|Period III|Protocol Violation|3|||
150119529|NCT00359762|541571933|FG003|Period III|Protocol Violation|8|||
150119530|NCT00359762|541571934|FG004|Period III|Protocol Violation|0|||
150119531|NCT00359762|541571930|FG000|Period III|Adverse Event|0|||
150119532|NCT00359762|541571931|FG001|Period III|Adverse Event|3|||
150119533|NCT00359762|541571932|FG002|Period III|Adverse Event|4|||
150119534|NCT00359762|541571933|FG003|Period III|Adverse Event|10|||
150119535|NCT00359762|541571934|FG004|Period III|Adverse Event|0|||
150119536|NCT00359762|541571930|FG000|Period III|Physician Decision|0|||
150119537|NCT00359762|541571931|FG001|Period III|Physician Decision|5|||
150119538|NCT00359762|541571932|FG002|Period III|Physician Decision|9|||
150119539|NCT00359762|541571933|FG003|Period III|Physician Decision|15|||
150119540|NCT00359762|541571934|FG004|Period III|Physician Decision|0|||
150119541|NCT00359762|541571930|FG000|Period III|Lack of Efficacy|0|||
150119542|NCT00359762|541571931|FG001|Period III|Lack of Efficacy|7|||
150119543|NCT00359762|541571932|FG002|Period III|Lack of Efficacy|5|||
150119544|NCT00359762|541571933|FG003|Period III|Lack of Efficacy|9|||
150119545|NCT00359762|541571934|FG004|Period III|Lack of Efficacy|0|||
150119546|NCT00359762|541571930|FG000|Period III|Lost to follow up|0|||
150119547|NCT00359762|541571931|FG001|Period III|Lost to follow up|1|||
150119548|NCT00359762|541571932|FG002|Period III|Lost to follow up|1|||
150119549|NCT00359762|541571933|FG003|Period III|Lost to follow up|2|||
150119550|NCT00359762|541571934|FG004|Period III|Lost to follow up|0|||
150119551|NCT00359762|541571930|FG000|Period III|Entry Criteria Not Met|0|||
150119552|NCT00359762|541571931|FG001|Period III|Entry Criteria Not Met|1|||
150119553|NCT00359762|541571932|FG002|Period III|Entry Criteria Not Met|0|||
150119554|NCT00359762|541571933|FG003|Period III|Entry Criteria Not Met|1|||
150119555|NCT00359762|541571934|FG004|Period III|Entry Criteria Not Met|0|||
150119556|NCT00359762|541571930|FG000|Period III|Subject Decision|0|||
150119557|NCT00359762|541571931|FG001|Period III|Subject Decision|7|||
150119558|NCT00359762|541571932|FG002|Period III|Subject Decision|8|||
150119559|NCT00359762|541571933|FG003|Period III|Subject Decision|20|||
150119560|NCT00359762|541571934|FG004|Period III|Subject Decision|0|||
150119561|NCT02613481|541571937|FG000|Overall Study|Lost to Follow-up|7|||
150119562|NCT02613481|541571937|FG000|Overall Study|Withdrawal by Subject|2|||
150119563|NCT01762761|541571938|FG000|Overall Study|Adverse Event|15|||
150119564|NCT01762761|541571939|FG001|Overall Study|Adverse Event|17|||
150119565|NCT01762761|541571938|FG000|Overall Study|Lack of Efficacy|9|||
150119566|NCT01762761|541571939|FG001|Overall Study|Lack of Efficacy|25|||
150119567|NCT01762761|541571938|FG000|Overall Study|Protocol Violation|1|||
150119568|NCT01762761|541571939|FG001|Overall Study|Protocol Violation|1|||
150119569|NCT01762761|541571938|FG000|Overall Study|Study closed/terminated|0|||
150119570|NCT01762761|541571939|FG001|Overall Study|Study closed/terminated|2|||
150119571|NCT01762761|541571938|FG000|Overall Study|Lost to Follow-up|3|||
150119572|NCT01762761|541571939|FG001|Overall Study|Lost to Follow-up|6|||
150119573|NCT01762761|541571938|FG000|Overall Study|Physician Decision|4|||
150119574|NCT01762761|541571939|FG001|Overall Study|Physician Decision|6|||
150119575|NCT01762761|541571938|FG000|Overall Study|Withdrawal by Subject|7|||
150119576|NCT01762761|541571939|FG001|Overall Study|Withdrawal by Subject|8|||
150119577|NCT02317575|541571940|FG000|Period 1|Difficulty with venous cannulation|0|||
150119578|NCT02317575|541571941|FG001|Period 1|Difficulty with venous cannulation|1|||
150119579|NCT02317575|541571942|FG002|Period 1|Difficulty with venous cannulation|0|||
150119580|NCT02317575|541571943|FG003|Period 1|Difficulty with venous cannulation|0|||
150119581|NCT02317575|541571944|FG004|Period 1|Difficulty with venous cannulation|0|||
150119582|NCT02317575|541571940|FG000|Period 1|Withdrawal by Subject|1|||
150119583|NCT02317575|541571941|FG001|Period 1|Withdrawal by Subject|0|||
150119584|NCT02317575|541571942|FG002|Period 1|Withdrawal by Subject|0|||
150119585|NCT02317575|541571943|FG003|Period 1|Withdrawal by Subject|0|||
150119586|NCT02317575|541571944|FG004|Period 1|Withdrawal by Subject|0|||
150119587|NCT03465540|541571945|FG000|Overall Study|Withdrawal by Subject|0|||
150119588|NCT03465540|541571946|FG001|Overall Study|Withdrawal by Subject|0|||
150119589|NCT03465540|541571947|FG002|Overall Study|Withdrawal by Subject|1|||
150119590|NCT03465540|541571948|FG003|Overall Study|Withdrawal by Subject|1|||
150119591|NCT03465540|541571949|FG004|Overall Study|Withdrawal by Subject|1|||
150119592|NCT03465540|541571950|FG005|Overall Study|Withdrawal by Subject|0|||
150119593|NCT03465540|541571945|FG000|Overall Study|Lost to Follow-up|0|||
150119594|NCT03465540|541571946|FG001|Overall Study|Lost to Follow-up|1|||
150119595|NCT03465540|541571947|FG002|Overall Study|Lost to Follow-up|0|||
150119596|NCT03465540|541571948|FG003|Overall Study|Lost to Follow-up|0|||
150119597|NCT03465540|541571949|FG004|Overall Study|Lost to Follow-up|1|||
150119598|NCT03465540|541571950|FG005|Overall Study|Lost to Follow-up|0|||
150119599|NCT03465540|541571945|FG000|Overall Study|Death|1|||
150119600|NCT03465540|541571946|FG001|Overall Study|Death|1|||
150119601|NCT03465540|541571947|FG002|Overall Study|Death|0|||
150119602|NCT03465540|541571948|FG003|Overall Study|Death|2|||
150119603|NCT03465540|541571949|FG004|Overall Study|Death|0|||
150119604|NCT03465540|541571950|FG005|Overall Study|Death|2|||
150119605|NCT03465540|541571945|FG000|Overall Study|Protocol specified criteria|0|||
150119606|NCT03465540|541571946|FG001|Overall Study|Protocol specified criteria|2|||
150119607|NCT03465540|541571947|FG002|Overall Study|Protocol specified criteria|2|||
150119608|NCT03465540|541571948|FG003|Overall Study|Protocol specified criteria|0|||
150119609|NCT03465540|541571949|FG004|Overall Study|Protocol specified criteria|2|||
150119610|NCT03465540|541571950|FG005|Overall Study|Protocol specified criteria|0|||
150119611|NCT01592708|541571955|FG000|Overall Study|Protocol Violation|3|||
150119612|NCT01592708|541571956|FG001|Overall Study|Protocol Violation|0|||
150119613|NCT02141516|541571957|FG000|Overall Study|Adverse Event|0|||
150119614|NCT02141516|541571958|FG001|Overall Study|Adverse Event|1|||
150119615|NCT02141516|541571959|FG002|Overall Study|Adverse Event|0|||
150119616|NCT02141516|541571957|FG000|Overall Study|Lost to Follow-up|0|||
150119617|NCT02141516|541571958|FG001|Overall Study|Lost to Follow-up|1|||
150119618|NCT02141516|541571959|FG002|Overall Study|Lost to Follow-up|0|||
150119619|NCT02141516|541571957|FG000|Overall Study|Other|0|||
150119620|NCT02141516|541571958|FG001|Overall Study|Other|3|||
150119621|NCT02141516|541571959|FG002|Overall Study|Other|0|||
150119622|NCT03169153|541571960|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
150119623|NCT03169153|541571961|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
150119624|NCT03169153|541571960|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
150119625|NCT03169153|541571961|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
150119626|NCT03169153|541571960|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
150119627|NCT03169153|541571961|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
150119628|NCT03169153|541571960|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
150119629|NCT03169153|541571961|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
150119630|NCT01603875|541571965|FG000|Overall Study|Preexisting rabies antibody|3|||
150119631|NCT01603875|541571966|FG001|Overall Study|Preexisting rabies antibody|4|||
150119632|NCT01603875|541571967|FG002|Overall Study|Preexisting rabies antibody|3|||
150119633|NCT01603875|541571965|FG000|Overall Study|Lost to Follow-up|4|||
150119634|NCT01603875|541571966|FG001|Overall Study|Lost to Follow-up|3|||
150119635|NCT01603875|541571967|FG002|Overall Study|Lost to Follow-up|6|||
150119636|NCT01603875|541571965|FG000|Overall Study|Protocol Violation|0|||
150119637|NCT01603875|541571966|FG001|Overall Study|Protocol Violation|1|||
150119638|NCT01603875|541571967|FG002|Overall Study|Protocol Violation|0|||
150119639|NCT01652716|541571968|FG000|Overall Study|Loss of glucose control|1|||
150119640|NCT01652716|541571969|FG001|Overall Study|Loss of glucose control|0|||
150119641|NCT01652716|541571968|FG000|Overall Study|Administrative|0|||
150119642|NCT01652716|541571969|FG001|Overall Study|Administrative|2|||
150119643|NCT01652716|541571968|FG000|Overall Study|Investigator decision|1|||
150119644|NCT01652716|541571969|FG001|Overall Study|Investigator decision|4|||
150119645|NCT01652716|541571968|FG000|Overall Study|Lost to Follow-up|12|||
150119646|NCT01652716|541571969|FG001|Overall Study|Lost to Follow-up|11|||
150119647|NCT01652716|541571968|FG000|Overall Study|Protocol Violation|2|||
150119648|NCT01652716|541571969|FG001|Overall Study|Protocol Violation|1|||
150119649|NCT01652716|541571968|FG000|Overall Study|Adverse Event|7|||
150119650|NCT01652716|541571969|FG001|Overall Study|Adverse Event|10|||
150119651|NCT01652716|541571968|FG000|Overall Study|Withdrawal by Subject|33|||
150119652|NCT01652716|541571969|FG001|Overall Study|Withdrawal by Subject|18|||
150119653|NCT04028388|541571977|FG000|Overall Study|Evaluations missing|3|||
150119654|NCT04028388|541571978|FG001|Overall Study|Evaluations missing|6|||
150119655|NCT04028388|541571977|FG000|Overall Study|Not started|2|||
150119656|NCT04028388|541571978|FG001|Overall Study|Not started|0|||
150119657|NCT02752048|541571987|FG000|Overall Study|Withdrawal by Subject|0|||
150119658|NCT02752048|541571988|FG001|Overall Study|Withdrawal by Subject|0|||
150119659|NCT02752048|541571989|FG002|Overall Study|Withdrawal by Subject|3|||
150119660|NCT01312467|541571990|FG000|Overall Study|Adverse Event|4|||
150119661|NCT01312467|541571990|FG000|Overall Study|Lost to Follow-up|1|||
150119662|NCT01312467|541571990|FG000|Overall Study|Withdrawal by Subject|2|||
150119663|NCT01312467|541571990|FG000|Overall Study|Deported to country of origin|1|||
150119664|NCT01312467|541571990|FG000|Overall Study|Another medical condition|1|||
150119665|NCT01312467|541571990|FG000|Overall Study|Ineligible|4|||
150119666|NCT00132769|541571991|FG000|Overall Study|Withdrawal by Subject|1|||
150119667|NCT00132769|541571992|FG001|Overall Study|Withdrawal by Subject|3|||
150119668|NCT00132769|541571991|FG000|Overall Study|Lack of Efficacy|7|||
150119669|NCT00132769|541571992|FG001|Overall Study|Lack of Efficacy|6|||
150119670|NCT00132769|541571991|FG000|Overall Study|Adverse Event|2|||
150119671|NCT00132769|541571992|FG001|Overall Study|Adverse Event|1|||
150119672|NCT00132769|541571991|FG000|Overall Study|Protocol Violation|1|||
150119673|NCT00132769|541571992|FG001|Overall Study|Protocol Violation|1|||
150119674|NCT01431508|541571993|FG000|Overall Study|Lack of Efficacy|1|||
150119675|NCT01431508|541571993|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
150119676|NCT00129259|541571994|FG000|Overall Study|Lost to Follow-up|1|||
150119677|NCT00129259|541571995|FG001|Overall Study|Lost to Follow-up|1|||
150119678|NCT00129259|541571994|FG000|Overall Study|Withdrawal by Subject|2|||
150119679|NCT00129259|541571995|FG001|Overall Study|Withdrawal by Subject|1|||
150119680|NCT00129259|541571994|FG000|Overall Study|Only available minimal phone assessments|0|||
150119681|NCT00129259|541571995|FG001|Overall Study|Only available minimal phone assessments|1|||
150119682|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119683|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119684|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119685|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119686|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
150119687|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119688|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119689|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
150119690|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
150119691|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119692|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
150119693|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
150119694|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119695|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119696|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119697|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
150119698|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
150119699|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
150119700|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
150119701|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
150119702|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
150119703|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
150119704|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
150119705|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
150119706|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
150119707|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
150119708|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
150119709|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
150119710|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
150119711|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
150119712|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
150119713|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
150119714|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119715|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119716|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119717|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119718|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119719|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
150119720|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
150119721|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119722|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119723|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
150119724|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
150119725|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
150119726|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119727|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119728|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119729|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
150119730|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119731|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119732|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119733|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150191639|NCT04652700|541842655|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
150191640|NCT04652700|541842654|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
150191641|NCT04652700|541842655|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
150119734|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119735|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
150191642|NCT04652700|541842654|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
150191643|NCT04652700|541842655|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
150119736|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119737|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119738|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119739|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119740|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119741|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
150119742|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119743|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119744|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119745|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
150119746|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119747|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119748|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119749|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119750|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119751|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
150119752|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119753|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119754|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119755|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119756|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119757|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119758|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119759|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119760|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119761|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
150119762|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119763|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119764|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119765|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119766|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119767|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119768|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119769|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119770|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
150119771|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119772|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119773|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119774|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119775|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119776|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119777|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
150119778|NCT01609556|541571999|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
150119779|NCT01609556|541572000|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119780|NCT01609556|541572001|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119781|NCT01609556|541572002|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119782|NCT01609556|541572003|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119783|NCT01609556|541572004|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
150119784|NCT01609556|541572005|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150191644|NCT04652700|541842654|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
150191645|NCT04652700|541842655|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
150191646|NCT04652700|541842654|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
150191647|NCT04652700|541842655|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
150191648|NCT04209465|541842659|FG000|Overall Study|Adverse Event|0|||
150191649|NCT04209465|541842660|FG001|Overall Study|Adverse Event|0|||
150191650|NCT04209465|541842661|FG002|Overall Study|Adverse Event|0|||
150191651|NCT04209465|541842662|FG003|Overall Study|Adverse Event|0|||
150191652|NCT04209465|541842663|FG004|Overall Study|Adverse Event|0|||
150119785|NCT01609556|541572006|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119786|NCT01609556|541572007|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119787|NCT01609556|541572008|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119788|NCT01609556|541572009|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
150119789|NCT01609556|541572010|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119790|NCT01609556|541572011|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119791|NCT01609556|541572012|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119792|NCT01609556|541572013|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119793|NCT01609556|541572014|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
150119794|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119795|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119796|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119797|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119798|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119799|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119800|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119801|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119802|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119803|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119804|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119805|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
150119806|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
150119807|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
150119808|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
150119809|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
150119810|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119811|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119812|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119813|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119814|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119815|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119816|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119817|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119818|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119819|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119820|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119821|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
150119822|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
150119823|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
150119824|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
150119825|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
150119826|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119827|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119828|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119829|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119830|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119831|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119832|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119833|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119834|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119835|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119836|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119837|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
150119838|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
150119839|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
150119840|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
150119841|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
150119842|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119843|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119844|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119845|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119846|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119847|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119848|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150191653|NCT04209465|541842664|FG005|Overall Study|Adverse Event|1|||
150119849|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119850|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119851|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119852|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119853|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119854|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
150119855|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119856|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119857|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
150119858|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119859|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119860|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119861|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119862|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119863|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119864|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119865|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119866|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119867|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119868|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119869|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
150119870|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
150119871|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
150119872|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
150119873|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
150119874|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119875|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119876|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119877|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119878|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119879|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119880|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119881|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119882|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119883|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119884|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119885|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119886|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119887|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119888|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
150119889|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
150119890|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119891|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119892|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119893|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119894|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119895|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119896|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119897|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119898|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119899|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119900|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119901|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119902|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
150119903|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
150119904|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
150119905|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
150119906|NCT01609556|541571999|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119907|NCT01609556|541572000|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119908|NCT01609556|541572001|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119909|NCT01609556|541572002|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119910|NCT01609556|541572003|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119911|NCT01609556|541572004|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119912|NCT01609556|541572005|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119913|NCT01609556|541572006|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119914|NCT01609556|541572007|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119915|NCT01609556|541572008|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150191654|NCT04209465|541842665|FG006|Overall Study|Adverse Event|0|||
150191655|NCT04209465|541842666|FG007|Overall Study|Adverse Event|0|||
150191656|NCT04209465|541842667|FG008|Overall Study|Adverse Event|1|||
150191657|NCT04209465|541842668|FG009|Overall Study|Adverse Event|0|||
150191658|NCT04209465|541842669|FG010|Overall Study|Adverse Event|2|||
150191659|NCT04209465|541842670|FG011|Overall Study|Adverse Event|1|||
150191660|NCT04209465|541842671|FG012|Overall Study|Adverse Event|1|||
150191661|NCT04209465|541842659|FG000|Overall Study|Death|1|||
150191662|NCT04209465|541842660|FG001|Overall Study|Death|0|||
150191663|NCT04209465|541842661|FG002|Overall Study|Death|0|||
150191664|NCT04209465|541842662|FG003|Overall Study|Death|0|||
150191665|NCT04209465|541842663|FG004|Overall Study|Death|2|||
150191666|NCT04209465|541842664|FG005|Overall Study|Death|7|||
150191667|NCT04209465|541842665|FG006|Overall Study|Death|2|||
150191668|NCT04209465|541842666|FG007|Overall Study|Death|2|||
150191669|NCT04209465|541842667|FG008|Overall Study|Death|1|||
150191670|NCT04209465|541842668|FG009|Overall Study|Death|1|||
150191671|NCT04209465|541842669|FG010|Overall Study|Death|1|||
150191672|NCT04209465|541842670|FG011|Overall Study|Death|0|||
150191673|NCT04209465|541842671|FG012|Overall Study|Death|10|||
150191674|NCT04209465|541842659|FG000|Overall Study|Physician Decision|0|||
150191675|NCT04209465|541842660|FG001|Overall Study|Physician Decision|1|||
150191676|NCT04209465|541842661|FG002|Overall Study|Physician Decision|0|||
150191677|NCT04209465|541842662|FG003|Overall Study|Physician Decision|0|||
150191678|NCT04209465|541842663|FG004|Overall Study|Physician Decision|0|||
150191679|NCT04209465|541842664|FG005|Overall Study|Physician Decision|0|||
150191680|NCT04209465|541842665|FG006|Overall Study|Physician Decision|0|||
150191681|NCT04209465|541842666|FG007|Overall Study|Physician Decision|0|||
150191682|NCT04209465|541842667|FG008|Overall Study|Physician Decision|0|||
150191683|NCT04209465|541842668|FG009|Overall Study|Physician Decision|0|||
150191684|NCT04209465|541842669|FG010|Overall Study|Physician Decision|0|||
150191685|NCT04209465|541842670|FG011|Overall Study|Physician Decision|0|||
150191686|NCT04209465|541842671|FG012|Overall Study|Physician Decision|0|||
150191687|NCT04209465|541842659|FG000|Overall Study|Progressive Disease|0|||
150191688|NCT04209465|541842660|FG001|Overall Study|Progressive Disease|0|||
150191689|NCT04209465|541842661|FG002|Overall Study|Progressive Disease|1|||
150191690|NCT04209465|541842662|FG003|Overall Study|Progressive Disease|2|||
150191691|NCT04209465|541842663|FG004|Overall Study|Progressive Disease|8|||
150191692|NCT04209465|541842664|FG005|Overall Study|Progressive Disease|5|||
150191693|NCT04209465|541842665|FG006|Overall Study|Progressive Disease|3|||
150191694|NCT04209465|541842666|FG007|Overall Study|Progressive Disease|4|||
150191695|NCT04209465|541842667|FG008|Overall Study|Progressive Disease|1|||
150191696|NCT04209465|541842668|FG009|Overall Study|Progressive Disease|3|||
150191697|NCT04209465|541842669|FG010|Overall Study|Progressive Disease|2|||
150191698|NCT04209465|541842670|FG011|Overall Study|Progressive Disease|1|||
150191699|NCT04209465|541842671|FG012|Overall Study|Progressive Disease|0|||
150191700|NCT04209465|541842659|FG000|Overall Study|Withdrawal by Subject|0|||
150191701|NCT04209465|541842660|FG001|Overall Study|Withdrawal by Subject|0|||
150191702|NCT04209465|541842661|FG002|Overall Study|Withdrawal by Subject|0|||
150191703|NCT04209465|541842662|FG003|Overall Study|Withdrawal by Subject|0|||
150191704|NCT04209465|541842663|FG004|Overall Study|Withdrawal by Subject|0|||
150191705|NCT04209465|541842664|FG005|Overall Study|Withdrawal by Subject|1|||
150191706|NCT04209465|541842665|FG006|Overall Study|Withdrawal by Subject|2|||
150191707|NCT04209465|541842666|FG007|Overall Study|Withdrawal by Subject|0|||
150191708|NCT04209465|541842667|FG008|Overall Study|Withdrawal by Subject|1|||
150191709|NCT04209465|541842668|FG009|Overall Study|Withdrawal by Subject|0|||
150191710|NCT04209465|541842669|FG010|Overall Study|Withdrawal by Subject|0|||
150191711|NCT04209465|541842670|FG011|Overall Study|Withdrawal by Subject|2|||
150191712|NCT04209465|541842671|FG012|Overall Study|Withdrawal by Subject|2|||
150191713|NCT04209465|541842659|FG000|Overall Study|Lost to Follow-up|0|||
150191714|NCT04209465|541842660|FG001|Overall Study|Lost to Follow-up|0|||
150191715|NCT04209465|541842661|FG002|Overall Study|Lost to Follow-up|0|||
150191716|NCT04209465|541842662|FG003|Overall Study|Lost to Follow-up|0|||
150191717|NCT04209465|541842663|FG004|Overall Study|Lost to Follow-up|0|||
150191718|NCT04209465|541842664|FG005|Overall Study|Lost to Follow-up|1|||
150191719|NCT04209465|541842665|FG006|Overall Study|Lost to Follow-up|0|||
150191720|NCT04209465|541842666|FG007|Overall Study|Lost to Follow-up|0|||
150191721|NCT04209465|541842667|FG008|Overall Study|Lost to Follow-up|1|||
150191722|NCT04209465|541842668|FG009|Overall Study|Lost to Follow-up|0|||
150191723|NCT04209465|541842669|FG010|Overall Study|Lost to Follow-up|0|||
150191724|NCT04209465|541842670|FG011|Overall Study|Lost to Follow-up|1|||
150191725|NCT04209465|541842671|FG012|Overall Study|Lost to Follow-up|0|||
150191726|NCT04209465|541842659|FG000|Overall Study|Started new therapy|0|||
150191727|NCT04209465|541842660|FG001|Overall Study|Started new therapy|0|||
150191728|NCT04209465|541842661|FG002|Overall Study|Started new therapy|0|||
150191729|NCT04209465|541842662|FG003|Overall Study|Started new therapy|0|||
150191730|NCT04209465|541842663|FG004|Overall Study|Started new therapy|0|||
150191731|NCT04209465|541842664|FG005|Overall Study|Started new therapy|1|||
150191732|NCT04209465|541842665|FG006|Overall Study|Started new therapy|0|||
150191733|NCT04209465|541842666|FG007|Overall Study|Started new therapy|0|||
150191734|NCT04209465|541842667|FG008|Overall Study|Started new therapy|0|||
150119916|NCT01609556|541572009|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119917|NCT01609556|541572010|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119918|NCT01609556|541572011|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
150119919|NCT01609556|541572012|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119920|NCT01609556|541572013|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150191735|NCT04209465|541842668|FG009|Overall Study|Started new therapy|0|||
150191736|NCT04209465|541842669|FG010|Overall Study|Started new therapy|0|||
150191737|NCT04209465|541842670|FG011|Overall Study|Started new therapy|0|||
150191738|NCT04209465|541842671|FG012|Overall Study|Started new therapy|0|||
150191739|NCT04209465|541842659|FG000|Overall Study|Study terminated early by sponsor|0|||
150191740|NCT04209465|541842660|FG001|Overall Study|Study terminated early by sponsor|0|||
150191741|NCT04209465|541842661|FG002|Overall Study|Study terminated early by sponsor|0|||
150191742|NCT04209465|541842662|FG003|Overall Study|Study terminated early by sponsor|0|||
150191743|NCT04209465|541842663|FG004|Overall Study|Study terminated early by sponsor|0|||
150191744|NCT04209465|541842664|FG005|Overall Study|Study terminated early by sponsor|0|||
150191745|NCT04209465|541842665|FG006|Overall Study|Study terminated early by sponsor|3|||
150191746|NCT04209465|541842666|FG007|Overall Study|Study terminated early by sponsor|0|||
150191747|NCT04209465|541842667|FG008|Overall Study|Study terminated early by sponsor|0|||
150191748|NCT04209465|541842668|FG009|Overall Study|Study terminated early by sponsor|0|||
150191749|NCT04209465|541842669|FG010|Overall Study|Study terminated early by sponsor|0|||
150191750|NCT04209465|541842670|FG011|Overall Study|Study terminated early by sponsor|0|||
150191751|NCT04209465|541842671|FG012|Overall Study|Study terminated early by sponsor|3|||
150191752|NCT04209465|541842659|FG000|Overall Study|Other|0|||
150191753|NCT04209465|541842660|FG001|Overall Study|Other|0|||
150191754|NCT04209465|541842661|FG002|Overall Study|Other|0|||
150191755|NCT04209465|541842662|FG003|Overall Study|Other|0|||
150191756|NCT04209465|541842663|FG004|Overall Study|Other|0|||
150191757|NCT04209465|541842664|FG005|Overall Study|Other|0|||
150191758|NCT04209465|541842665|FG006|Overall Study|Other|0|||
150191759|NCT04209465|541842666|FG007|Overall Study|Other|0|||
150191760|NCT04209465|541842667|FG008|Overall Study|Other|1|||
150191761|NCT04209465|541842668|FG009|Overall Study|Other|0|||
150191762|NCT04209465|541842669|FG010|Overall Study|Other|0|||
150191763|NCT04209465|541842670|FG011|Overall Study|Other|0|||
150191764|NCT04209465|541842671|FG012|Overall Study|Other|0|||
150191765|NCT03097549|541842672|FG000|Overall Study|Withdrawal by Subject|1|||
150191766|NCT03097549|541842673|FG001|Overall Study|Withdrawal by Subject|0|||
150191767|NCT03097549|541842672|FG000|Overall Study|Lost to Follow-up|1|||
150191768|NCT03097549|541842673|FG001|Overall Study|Lost to Follow-up|0|||
150191769|NCT05647304|541842674|FG000|Overall Study|Withdrawal by Subject|1|||
150191770|NCT05647304|541842675|FG001|Overall Study|Withdrawal by Subject|0|||
150191771|NCT03544281|541842676|FG000|Main Study Phase|Death|3|||
150191772|NCT03544281|541842677|FG001|Main Study Phase|Death|2|||
150191773|NCT03544281|541842678|FG002|Main Study Phase|Death|6|||
150191774|NCT03544281|541842679|FG003|Main Study Phase|Death|8|||
150191775|NCT03544281|541842680|FG004|Main Study Phase|Death|4|||
150191776|NCT03544281|541842681|FG005|Main Study Phase|Death|2|||
150191777|NCT03544281|541842682|FG006|Main Study Phase|Death|4|||
150191778|NCT03544281|541842683|FG007|Main Study Phase|Death|5|||
150191779|NCT03544281|541842684|FG008|Main Study Phase|Death|5|||
150191780|NCT03544281|541842685|FG009|Main Study Phase|Death|8|||
150191781|NCT03544281|541842686|FG010|Main Study Phase|Death|6|||
150191782|NCT03544281|541842687|FG011|Main Study Phase|Death|4|||
150191783|NCT03544281|541842688|FG012|Main Study Phase|Death|0|||
150191784|NCT03544281|541842689|FG013|Main Study Phase|Death|0|||
150191785|NCT03544281|541842690|FG014|Main Study Phase|Death|0|||
150191786|NCT03544281|541842691|FG015|Main Study Phase|Death|0|||
150191787|NCT03544281|541842692|FG016|Main Study Phase|Death|0|||
150191788|NCT03544281|541842693|FG017|Main Study Phase|Death|0|||
150191789|NCT03544281|541842694|FG018|Main Study Phase|Death|0|||
150191790|NCT03544281|541842695|FG019|Main Study Phase|Death|0|||
150191791|NCT03544281|541842696|FG020|Main Study Phase|Death|0|||
150191792|NCT03544281|541842697|FG021|Main Study Phase|Death|0|||
150191793|NCT03544281|541842676|FG000|Main Study Phase|Lost to Follow-up|0|||
150191794|NCT03544281|541842677|FG001|Main Study Phase|Lost to Follow-up|0|||
150191795|NCT03544281|541842678|FG002|Main Study Phase|Lost to Follow-up|0|||
150191796|NCT03544281|541842679|FG003|Main Study Phase|Lost to Follow-up|0|||
150191797|NCT03544281|541842680|FG004|Main Study Phase|Lost to Follow-up|0|||
150191798|NCT03544281|541842681|FG005|Main Study Phase|Lost to Follow-up|0|||
150191799|NCT03544281|541842682|FG006|Main Study Phase|Lost to Follow-up|0|||
150191800|NCT03544281|541842683|FG007|Main Study Phase|Lost to Follow-up|0|||
150191801|NCT03544281|541842684|FG008|Main Study Phase|Lost to Follow-up|0|||
150191802|NCT03544281|541842685|FG009|Main Study Phase|Lost to Follow-up|0|||
150191803|NCT03544281|541842686|FG010|Main Study Phase|Lost to Follow-up|1|||
150191804|NCT03544281|541842687|FG011|Main Study Phase|Lost to Follow-up|0|||
150191805|NCT03544281|541842688|FG012|Main Study Phase|Lost to Follow-up|0|||
150191806|NCT03544281|541842689|FG013|Main Study Phase|Lost to Follow-up|0|||
150191807|NCT03544281|541842690|FG014|Main Study Phase|Lost to Follow-up|0|||
150191808|NCT03544281|541842691|FG015|Main Study Phase|Lost to Follow-up|0|||
150191809|NCT03544281|541842692|FG016|Main Study Phase|Lost to Follow-up|0|||
150191810|NCT03544281|541842693|FG017|Main Study Phase|Lost to Follow-up|0|||
150191811|NCT03544281|541842694|FG018|Main Study Phase|Lost to Follow-up|0|||
150191812|NCT03544281|541842695|FG019|Main Study Phase|Lost to Follow-up|0|||
150191813|NCT03544281|541842696|FG020|Main Study Phase|Lost to Follow-up|0|||
150191814|NCT03544281|541842697|FG021|Main Study Phase|Lost to Follow-up|0|||
150119921|NCT01609556|541572014|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
150119922|NCT02199691|541572017|FG000|Overall Study|Protocol Violation|3|||
150119923|NCT02199691|541572018|FG001|Overall Study|Protocol Violation|3|||
150119924|NCT02199691|541572019|FG002|Overall Study|Protocol Violation|6|||
150119925|NCT02199691|541572020|FG003|Overall Study|Protocol Violation|7|||
150119926|NCT02199691|541572017|FG000|Overall Study|Withdrawal by Subject|5|||
150119927|NCT02199691|541572018|FG001|Overall Study|Withdrawal by Subject|3|||
150119928|NCT02199691|541572019|FG002|Overall Study|Withdrawal by Subject|12|||
150119929|NCT02199691|541572020|FG003|Overall Study|Withdrawal by Subject|13|||
150119930|NCT02199691|541572017|FG000|Overall Study|Lost to Follow-up|2|||
150119931|NCT02199691|541572018|FG001|Overall Study|Lost to Follow-up|1|||
150119932|NCT02199691|541572019|FG002|Overall Study|Lost to Follow-up|9|||
150119933|NCT02199691|541572020|FG003|Overall Study|Lost to Follow-up|10|||
150119934|NCT00774995|541572024|FG000|Overall Study|Protocol Violation|0|||
150119935|NCT00774995|541572025|FG001|Overall Study|Protocol Violation|0|||
150119936|NCT00774995|541572026|FG002|Overall Study|Protocol Violation|1|||
150119937|NCT00774995|541572027|FG003|Overall Study|Protocol Violation|0|||
150119938|NCT01209624|541572033|FG000|Overall Study|Death|2|||
150119939|NCT01209624|541572033|FG000|Overall Study|Adverse Event|13|||
150119940|NCT01209624|541572033|FG000|Overall Study|Lack of Efficacy|17|||
150119941|NCT01209624|541572033|FG000|Overall Study|Lost to Follow-up|290|||
150119942|NCT01209624|541572033|FG000|Overall Study|Other|4|||
150119943|NCT03403634|541572038|FG000|Overall Study|Disease progression|3|||
150119944|NCT03403634|541572038|FG000|Overall Study|Did not meet eligibility criteria|4|||
150119945|NCT03964454|541572039|FG000|Overall Study|Lost to Follow-up|13|||
150119946|NCT03964454|541572040|FG001|Overall Study|Lost to Follow-up|7|||
150119947|NCT03964454|541572039|FG000|Overall Study|Withdrawal by Subject|4|||
150119948|NCT03964454|541572040|FG001|Overall Study|Withdrawal by Subject|11|||
150119949|NCT01539291|541573901|FG000|Study GS-US-312-0116|Adverse Event|9|||
150119950|NCT01539291|541573902|FG001|Study GS-US-312-0116|Adverse Event|0|||
150119951|NCT01539291|541573903|FG002|Study GS-US-312-0116|Adverse Event|0|||
150119952|NCT01539291|541573904|FG003|Study GS-US-312-0116|Adverse Event|0|||
150119953|NCT01539291|541573901|FG000|Study GS-US-312-0116|Physician Decision|1|||
150119954|NCT01539291|541573902|FG001|Study GS-US-312-0116|Physician Decision|0|||
150119955|NCT01539291|541573903|FG002|Study GS-US-312-0116|Physician Decision|0|||
150119956|NCT01539291|541573904|FG003|Study GS-US-312-0116|Physician Decision|0|||
150119957|NCT01539291|541573901|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
150119958|NCT01539291|541573902|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
150119959|NCT01539291|541573903|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
150119960|NCT01539291|541573904|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
150119961|NCT01539291|541573901|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
150119962|NCT01539291|541573902|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
150119963|NCT01539291|541573903|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
150119964|NCT01539291|541573904|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
150119965|NCT01539291|541573901|FG000|Study GS-US-312-0116|Other|1|||
150119966|NCT01539291|541573902|FG001|Study GS-US-312-0116|Other|0|||
150119967|NCT01539291|541573903|FG002|Study GS-US-312-0116|Other|0|||
150119968|NCT01539291|541573904|FG003|Study GS-US-312-0116|Other|0|||
150119969|NCT01539291|541573901|FG000|Study GS-US-312-0117|Adverse Event|22|||
150119970|NCT01539291|541573902|FG001|Study GS-US-312-0117|Adverse Event|1|||
150119971|NCT01539291|541573903|FG002|Study GS-US-312-0117|Adverse Event|9|||
150119972|NCT01539291|541573904|FG003|Study GS-US-312-0117|Adverse Event|12|||
150119973|NCT01539291|541573901|FG000|Study GS-US-312-0117|Physician Decision|9|||
150191815|NCT03544281|541842676|FG000|Main Study Phase|Physician Decision|0|||
150119974|NCT01539291|541573902|FG001|Study GS-US-312-0117|Physician Decision|0|||
150119975|NCT01539291|541573903|FG002|Study GS-US-312-0117|Physician Decision|6|||
150119976|NCT01539291|541573904|FG003|Study GS-US-312-0117|Physician Decision|4|||
150119977|NCT01539291|541573901|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
150119978|NCT01539291|541573902|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
150119979|NCT01539291|541573903|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
150119980|NCT01539291|541573904|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
150119981|NCT01539291|541573901|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
150119982|NCT01539291|541573902|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
150119983|NCT01539291|541573903|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
150119984|NCT01539291|541573904|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
150119985|NCT01539291|541573901|FG000|Study GS-US-312-0117|Other|2|||
150119986|NCT01539291|541573902|FG001|Study GS-US-312-0117|Other|1|||
150119987|NCT01539291|541573903|FG002|Study GS-US-312-0117|Other|1|||
150119988|NCT01539291|541573904|FG003|Study GS-US-312-0117|Other|1|||
150119989|NCT04450264|541573905|FG000|Overall Study|Incomplete survey|13|||
150119990|NCT04450264|541573906|FG001|Overall Study|Incomplete survey|19|||
150119991|NCT03985423|541573911|FG000|Overall Study|Adverse Event|1|||
150119992|NCT03985423|541573911|FG000|Overall Study|Death|2|||
150119993|NCT03985423|541573911|FG000|Overall Study|Physician Decision|1|||
150119994|NCT03985423|541573911|FG000|Overall Study|Withdrawal by Subject|2|||
150119995|NCT03985423|541573911|FG000|Overall Study|Lack of insurance and citizenship|1|||
150119996|NCT01045447|541573922|FG000|Overall Study|Adverse Event|0|||
150119997|NCT01045447|541573923|FG001|Overall Study|Adverse Event|1|||
150119998|NCT01045447|541573922|FG000|Overall Study|Lack of Efficacy|3|||
150119999|NCT01045447|541573923|FG001|Overall Study|Lack of Efficacy|1|||
150120000|NCT01045447|541573922|FG000|Overall Study|Protocol Violation|6|||
150120001|NCT01045447|541573923|FG001|Overall Study|Protocol Violation|3|||
150120002|NCT01045447|541573922|FG000|Overall Study|Withdrawal Criteria|10|||
150120003|NCT01045447|541573923|FG001|Overall Study|Withdrawal Criteria|10|||
150120004|NCT01045447|541573922|FG000|Overall Study|Unclassified|17|||
150120005|NCT01045447|541573923|FG001|Overall Study|Unclassified|13|||
150120006|NCT00129987|541573924|FG000|1st Educational Session|Withdrawal by Subject|141|||
150120007|NCT00129987|541573925|FG001|1st Educational Session|Withdrawal by Subject|109|||
150120008|NCT00129987|541573924|FG000|1 Year|Withdrawal by Subject|32|||
150120009|NCT00129987|541573925|FG001|1 Year|Withdrawal by Subject|21|||
150120010|NCT02318329|541573926|FG000|Overall Study|Progressive Disease|2|||
150120011|NCT02318329|541573927|FG001|Overall Study|Progressive Disease|3|||
150120012|NCT02318329|541573928|FG002|Overall Study|Progressive Disease|2|||
150120013|NCT02318329|541573929|FG003|Overall Study|Progressive Disease|3|||
150120014|NCT02318329|541573930|FG004|Overall Study|Progressive Disease|3|||
150120015|NCT02318329|541573931|FG005|Overall Study|Progressive Disease|3|||
150120016|NCT02318329|541573932|FG006|Overall Study|Progressive Disease|1|||
150120017|NCT02318329|541573933|FG007|Overall Study|Progressive Disease|1|||
150120018|NCT02318329|541573934|FG008|Overall Study|Progressive Disease|5|||
150120019|NCT02318329|541573935|FG009|Overall Study|Progressive Disease|39|||
150120020|NCT02318329|541573926|FG000|Overall Study|Death|0|||
150120021|NCT02318329|541573927|FG001|Overall Study|Death|0|||
150120022|NCT02318329|541573928|FG002|Overall Study|Death|0|||
150120023|NCT02318329|541573929|FG003|Overall Study|Death|0|||
150120024|NCT02318329|541573930|FG004|Overall Study|Death|0|||
150120025|NCT02318329|541573931|FG005|Overall Study|Death|0|||
150120026|NCT02318329|541573932|FG006|Overall Study|Death|0|||
150120027|NCT02318329|541573933|FG007|Overall Study|Death|0|||
150120028|NCT02318329|541573934|FG008|Overall Study|Death|0|||
150120029|NCT02318329|541573935|FG009|Overall Study|Death|5|||
150120030|NCT02318329|541573926|FG000|Overall Study|Lost to Follow-up|0|||
150120031|NCT02318329|541573927|FG001|Overall Study|Lost to Follow-up|0|||
150120032|NCT02318329|541573928|FG002|Overall Study|Lost to Follow-up|0|||
150120033|NCT02318329|541573929|FG003|Overall Study|Lost to Follow-up|0|||
150120034|NCT02318329|541573930|FG004|Overall Study|Lost to Follow-up|0|||
150120035|NCT02318329|541573931|FG005|Overall Study|Lost to Follow-up|0|||
150120036|NCT02318329|541573932|FG006|Overall Study|Lost to Follow-up|0|||
150120037|NCT02318329|541573933|FG007|Overall Study|Lost to Follow-up|0|||
150120038|NCT02318329|541573934|FG008|Overall Study|Lost to Follow-up|0|||
150120039|NCT02318329|541573935|FG009|Overall Study|Lost to Follow-up|1|||
150120040|NCT02318329|541573926|FG000|Overall Study|Withdrawal by Subject|0|||
150120041|NCT02318329|541573927|FG001|Overall Study|Withdrawal by Subject|0|||
150120042|NCT02318329|541573928|FG002|Overall Study|Withdrawal by Subject|0|||
150120043|NCT02318329|541573929|FG003|Overall Study|Withdrawal by Subject|0|||
150120044|NCT02318329|541573930|FG004|Overall Study|Withdrawal by Subject|0|||
150120045|NCT02318329|541573931|FG005|Overall Study|Withdrawal by Subject|0|||
150120046|NCT02318329|541573932|FG006|Overall Study|Withdrawal by Subject|0|||
150120047|NCT02318329|541573933|FG007|Overall Study|Withdrawal by Subject|0|||
150120048|NCT02318329|541573934|FG008|Overall Study|Withdrawal by Subject|0|||
150120049|NCT02318329|541573935|FG009|Overall Study|Withdrawal by Subject|6|||
150120050|NCT02318329|541573926|FG000|Overall Study|Other|1|||
150120051|NCT02318329|541573927|FG001|Overall Study|Other|1|||
150120052|NCT02318329|541573928|FG002|Overall Study|Other|1|||
150120053|NCT02318329|541573929|FG003|Overall Study|Other|0|||
150120054|NCT02318329|541573930|FG004|Overall Study|Other|0|||
150191816|NCT03544281|541842677|FG001|Main Study Phase|Physician Decision|0|||
150191817|NCT03544281|541842678|FG002|Main Study Phase|Physician Decision|0|||
150191818|NCT03544281|541842679|FG003|Main Study Phase|Physician Decision|0|||
150191819|NCT03544281|541842680|FG004|Main Study Phase|Physician Decision|0|||
150191820|NCT03544281|541842681|FG005|Main Study Phase|Physician Decision|0|||
150191821|NCT03544281|541842682|FG006|Main Study Phase|Physician Decision|0|||
150191822|NCT03544281|541842683|FG007|Main Study Phase|Physician Decision|1|||
150191823|NCT03544281|541842684|FG008|Main Study Phase|Physician Decision|0|||
150191824|NCT03544281|541842685|FG009|Main Study Phase|Physician Decision|0|||
150191825|NCT03544281|541842686|FG010|Main Study Phase|Physician Decision|0|||
150191826|NCT03544281|541842687|FG011|Main Study Phase|Physician Decision|0|||
150191827|NCT03544281|541842688|FG012|Main Study Phase|Physician Decision|0|||
150191828|NCT03544281|541842689|FG013|Main Study Phase|Physician Decision|0|||
150191829|NCT03544281|541842690|FG014|Main Study Phase|Physician Decision|0|||
150191830|NCT03544281|541842691|FG015|Main Study Phase|Physician Decision|0|||
150191831|NCT03544281|541842692|FG016|Main Study Phase|Physician Decision|0|||
150191832|NCT03544281|541842693|FG017|Main Study Phase|Physician Decision|0|||
150191833|NCT03544281|541842694|FG018|Main Study Phase|Physician Decision|0|||
150191834|NCT03544281|541842695|FG019|Main Study Phase|Physician Decision|0|||
150191835|NCT03544281|541842696|FG020|Main Study Phase|Physician Decision|0|||
150191836|NCT03544281|541842697|FG021|Main Study Phase|Physician Decision|0|||
150191837|NCT03544281|541842676|FG000|Main Study Phase|Withdrawal by Subject|2|||
150191838|NCT03544281|541842677|FG001|Main Study Phase|Withdrawal by Subject|0|||
150191839|NCT03544281|541842678|FG002|Main Study Phase|Withdrawal by Subject|1|||
150191840|NCT03544281|541842679|FG003|Main Study Phase|Withdrawal by Subject|2|||
150191841|NCT03544281|541842680|FG004|Main Study Phase|Withdrawal by Subject|0|||
150191842|NCT03544281|541842681|FG005|Main Study Phase|Withdrawal by Subject|0|||
150191843|NCT03544281|541842682|FG006|Main Study Phase|Withdrawal by Subject|0|||
150191844|NCT03544281|541842683|FG007|Main Study Phase|Withdrawal by Subject|0|||
150191845|NCT03544281|541842684|FG008|Main Study Phase|Withdrawal by Subject|2|||
150191846|NCT03544281|541842685|FG009|Main Study Phase|Withdrawal by Subject|3|||
150191847|NCT03544281|541842686|FG010|Main Study Phase|Withdrawal by Subject|0|||
150191848|NCT03544281|541842687|FG011|Main Study Phase|Withdrawal by Subject|4|||
150191849|NCT03544281|541842688|FG012|Main Study Phase|Withdrawal by Subject|0|||
150191850|NCT03544281|541842689|FG013|Main Study Phase|Withdrawal by Subject|0|||
150191851|NCT03544281|541842690|FG014|Main Study Phase|Withdrawal by Subject|0|||
150191852|NCT03544281|541842691|FG015|Main Study Phase|Withdrawal by Subject|0|||
150191853|NCT03544281|541842692|FG016|Main Study Phase|Withdrawal by Subject|0|||
150191854|NCT03544281|541842693|FG017|Main Study Phase|Withdrawal by Subject|0|||
150191855|NCT03544281|541842694|FG018|Main Study Phase|Withdrawal by Subject|0|||
150191856|NCT03544281|541842695|FG019|Main Study Phase|Withdrawal by Subject|0|||
150191857|NCT03544281|541842696|FG020|Main Study Phase|Withdrawal by Subject|0|||
150191858|NCT03544281|541842697|FG021|Main Study Phase|Withdrawal by Subject|0|||
150191859|NCT03544281|541842676|FG000|Main Study Phase|Ongoing|3|||
150191860|NCT03544281|541842677|FG001|Main Study Phase|Ongoing|1|||
150191861|NCT03544281|541842678|FG002|Main Study Phase|Ongoing|2|||
150191862|NCT03544281|541842679|FG003|Main Study Phase|Ongoing|4|||
150191863|NCT03544281|541842680|FG004|Main Study Phase|Ongoing|2|||
150191864|NCT03544281|541842681|FG005|Main Study Phase|Ongoing|4|||
150191865|NCT03544281|541842682|FG006|Main Study Phase|Ongoing|4|||
150191866|NCT03544281|541842683|FG007|Main Study Phase|Ongoing|0|||
150191867|NCT03544281|541842684|FG008|Main Study Phase|Ongoing|2|||
150191868|NCT03544281|541842685|FG009|Main Study Phase|Ongoing|2|||
150191869|NCT03544281|541842686|FG010|Main Study Phase|Ongoing|1|||
150191870|NCT03544281|541842687|FG011|Main Study Phase|Ongoing|0|||
150191871|NCT03544281|541842688|FG012|Main Study Phase|Ongoing|0|||
150191872|NCT03544281|541842689|FG013|Main Study Phase|Ongoing|0|||
150191873|NCT03544281|541842690|FG014|Main Study Phase|Ongoing|0|||
150191874|NCT03544281|541842691|FG015|Main Study Phase|Ongoing|0|||
150191875|NCT03544281|541842692|FG016|Main Study Phase|Ongoing|0|||
150191876|NCT03544281|541842693|FG017|Main Study Phase|Ongoing|0|||
150191877|NCT03544281|541842694|FG018|Main Study Phase|Ongoing|0|||
150191878|NCT03544281|541842695|FG019|Main Study Phase|Ongoing|0|||
150191879|NCT03544281|541842696|FG020|Main Study Phase|Ongoing|0|||
150191880|NCT03544281|541842697|FG021|Main Study Phase|Ongoing|0|||
150191881|NCT03544281|541842676|FG000|Main Study Phase|Investigator Site Closed|0|||
150191882|NCT03544281|541842677|FG001|Main Study Phase|Investigator Site Closed|0|||
150191883|NCT03544281|541842678|FG002|Main Study Phase|Investigator Site Closed|0|||
150191884|NCT03544281|541842679|FG003|Main Study Phase|Investigator Site Closed|0|||
150191885|NCT03544281|541842680|FG004|Main Study Phase|Investigator Site Closed|0|||
150191886|NCT03544281|541842681|FG005|Main Study Phase|Investigator Site Closed|0|||
150191887|NCT03544281|541842682|FG006|Main Study Phase|Investigator Site Closed|0|||
150191888|NCT03544281|541842683|FG007|Main Study Phase|Investigator Site Closed|0|||
150191889|NCT03544281|541842684|FG008|Main Study Phase|Investigator Site Closed|0|||
150191890|NCT03544281|541842685|FG009|Main Study Phase|Investigator Site Closed|1|||
150191891|NCT03544281|541842686|FG010|Main Study Phase|Investigator Site Closed|0|||
150191892|NCT03544281|541842687|FG011|Main Study Phase|Investigator Site Closed|0|||
150191893|NCT03544281|541842688|FG012|Main Study Phase|Investigator Site Closed|0|||
150191894|NCT03544281|541842689|FG013|Main Study Phase|Investigator Site Closed|0|||
150191895|NCT03544281|541842690|FG014|Main Study Phase|Investigator Site Closed|0|||
150191896|NCT03544281|541842691|FG015|Main Study Phase|Investigator Site Closed|0|||
150191897|NCT03544281|541842692|FG016|Main Study Phase|Investigator Site Closed|0|||
150191898|NCT03544281|541842693|FG017|Main Study Phase|Investigator Site Closed|0|||
150191899|NCT03544281|541842694|FG018|Main Study Phase|Investigator Site Closed|0|||
150191900|NCT03544281|541842695|FG019|Main Study Phase|Investigator Site Closed|0|||
150191901|NCT03544281|541842696|FG020|Main Study Phase|Investigator Site Closed|0|||
150191902|NCT03544281|541842697|FG021|Main Study Phase|Investigator Site Closed|0|||
150191903|NCT03544281|541842676|FG000|Main Study Phase|Did not receive study treatment|0|||
150191904|NCT03544281|541842677|FG001|Main Study Phase|Did not receive study treatment|0|||
150191905|NCT03544281|541842678|FG002|Main Study Phase|Did not receive study treatment|0|||
150191906|NCT03544281|541842679|FG003|Main Study Phase|Did not receive study treatment|0|||
150191907|NCT03544281|541842680|FG004|Main Study Phase|Did not receive study treatment|0|||
150191908|NCT03544281|541842681|FG005|Main Study Phase|Did not receive study treatment|0|||
150191909|NCT03544281|541842682|FG006|Main Study Phase|Did not receive study treatment|1|||
150191910|NCT03544281|541842683|FG007|Main Study Phase|Did not receive study treatment|0|||
150191911|NCT03544281|541842684|FG008|Main Study Phase|Did not receive study treatment|0|||
150191912|NCT03544281|541842685|FG009|Main Study Phase|Did not receive study treatment|0|||
150191913|NCT03544281|541842686|FG010|Main Study Phase|Did not receive study treatment|0|||
150191914|NCT03544281|541842687|FG011|Main Study Phase|Did not receive study treatment|0|||
150191915|NCT03544281|541842688|FG012|Main Study Phase|Did not receive study treatment|0|||
150191916|NCT03544281|541842689|FG013|Main Study Phase|Did not receive study treatment|0|||
150191917|NCT03544281|541842690|FG014|Main Study Phase|Did not receive study treatment|0|||
150191918|NCT03544281|541842691|FG015|Main Study Phase|Did not receive study treatment|0|||
150191919|NCT03544281|541842692|FG016|Main Study Phase|Did not receive study treatment|0|||
150191920|NCT03544281|541842693|FG017|Main Study Phase|Did not receive study treatment|0|||
150191921|NCT03544281|541842694|FG018|Main Study Phase|Did not receive study treatment|0|||
150191922|NCT03544281|541842695|FG019|Main Study Phase|Did not receive study treatment|0|||
150191923|NCT03544281|541842696|FG020|Main Study Phase|Did not receive study treatment|0|||
150191924|NCT03544281|541842697|FG021|Main Study Phase|Did not receive study treatment|0|||
150191925|NCT03544281|541842676|FG000|PACT Phase|Adverse Event|0|||
150191926|NCT03544281|541842677|FG001|PACT Phase|Adverse Event|0|||
150191927|NCT03544281|541842678|FG002|PACT Phase|Adverse Event|0|||
150191928|NCT03544281|541842679|FG003|PACT Phase|Adverse Event|0|||
150191929|NCT03544281|541842680|FG004|PACT Phase|Adverse Event|0|||
150191930|NCT03544281|541842681|FG005|PACT Phase|Adverse Event|0|||
150191931|NCT03544281|541842682|FG006|PACT Phase|Adverse Event|0|||
150191932|NCT03544281|541842683|FG007|PACT Phase|Adverse Event|0|||
150191933|NCT03544281|541842684|FG008|PACT Phase|Adverse Event|0|||
150191934|NCT03544281|541842685|FG009|PACT Phase|Adverse Event|0|||
150191935|NCT03544281|541842686|FG010|PACT Phase|Adverse Event|0|||
150191936|NCT03544281|541842687|FG011|PACT Phase|Adverse Event|0|||
150191937|NCT03544281|541842688|FG012|PACT Phase|Adverse Event|1|||
150191938|NCT03544281|541842689|FG013|PACT Phase|Adverse Event|0|||
150191939|NCT03544281|541842690|FG014|PACT Phase|Adverse Event|0|||
150191940|NCT03544281|541842691|FG015|PACT Phase|Adverse Event|0|||
150191941|NCT03544281|541842692|FG016|PACT Phase|Adverse Event|0|||
150191942|NCT03544281|541842693|FG017|PACT Phase|Adverse Event|1|||
150191943|NCT03544281|541842694|FG018|PACT Phase|Adverse Event|1|||
150191944|NCT03544281|541842695|FG019|PACT Phase|Adverse Event|0|||
150191945|NCT03544281|541842696|FG020|PACT Phase|Adverse Event|0|||
150191946|NCT03544281|541842697|FG021|PACT Phase|Adverse Event|0|||
150191947|NCT03092518|541842698|FG000|Overall Study|Ineligible|2|||
150191948|NCT02547987|541842701|FG000|Overall Study|Withdrawal by Subject|1|||
150191949|NCT02547987|541842701|FG000|Overall Study|Adverse Event|2|||
150191950|NCT02146378|541842702|FG000|Overall Study|No information of administration|2|||
150191951|NCT04973254|541842711|FG000|Overall Study|Not adherent|0|||
150191952|NCT04973254|541842712|FG001|Overall Study|Not adherent|1|||
150191953|NCT04973254|541842713|FG002|Overall Study|Not adherent|0|||
150191954|NCT05089019|541842717|FG000|Period 1|Withdrawal by Subject|0|||
150191955|NCT05089019|541842718|FG001|Period 1|Withdrawal by Subject|1|||
150191956|NCT05089019|541842717|FG000|Washout Period|Adverse Event|3|||
150191957|NCT05089019|541842718|FG001|Washout Period|Adverse Event|4|||
150191958|NCT05089019|541842717|FG000|Washout Period|Lost to Follow-up|1|||
150191959|NCT05089019|541842718|FG001|Washout Period|Lost to Follow-up|0|||
150191960|NCT05089019|541842717|FG000|Washout Period|Physician Decision|2|||
150191961|NCT05089019|541842718|FG001|Washout Period|Physician Decision|0|||
150191962|NCT05089019|541842717|FG000|Washout Period|Withdrawal by Subject|6|||
150191963|NCT05089019|541842718|FG001|Washout Period|Withdrawal by Subject|3|||
150191964|NCT05089019|541842717|FG000|Period 2|Adverse Event|4|||
150191965|NCT05089019|541842718|FG001|Period 2|Adverse Event|2|||
150191966|NCT05089019|541842717|FG000|Period 2|Lost to Follow-up|1|||
150191967|NCT05089019|541842718|FG001|Period 2|Lost to Follow-up|0|||
150191968|NCT05089019|541842717|FG000|Period 2|Withdrawal by Subject|0|||
150191969|NCT05089019|541842718|FG001|Period 2|Withdrawal by Subject|1|||
150191970|NCT05170009|541842719|FG000|Overall Study|Physician Decision|0|||
150120055|NCT02318329|541573931|FG005|Overall Study|Other|0|||
150120056|NCT02318329|541573932|FG006|Overall Study|Other|0|||
150120057|NCT02318329|541573933|FG007|Overall Study|Other|0|||
150120058|NCT02318329|541573934|FG008|Overall Study|Other|1|||
150120059|NCT02318329|541573935|FG009|Overall Study|Other|1|||
150120060|NCT00466193|541573940|FG000|Overall Study|Adverse Event|0|||
150120061|NCT00466193|541573941|FG001|Overall Study|Adverse Event|1|||
150120062|NCT00466193|541573940|FG000|Overall Study|Lost to Follow-up|2|||
150120063|NCT00466193|541573941|FG001|Overall Study|Lost to Follow-up|4|||
150120064|NCT00466193|541573940|FG000|Overall Study|Physician Decision|1|||
150120065|NCT00466193|541573941|FG001|Overall Study|Physician Decision|0|||
150120066|NCT00466193|541573940|FG000|Overall Study|Protocol Violation|1|||
150120067|NCT00466193|541573941|FG001|Overall Study|Protocol Violation|1|||
150120068|NCT00466193|541573940|FG000|Overall Study|Withdrawal by Subject|7|||
150120069|NCT00466193|541573941|FG001|Overall Study|Withdrawal by Subject|2|||
150120070|NCT00466193|541573940|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
150120071|NCT00466193|541573941|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
150120072|NCT01181921|541573943|FG000|Overall Study|Lost to Follow-up|1|||
150120073|NCT01992536|541573944|FG000|Overall Study|Administrative Reason|0|||
150120074|NCT01992536|541573945|FG001|Overall Study|Administrative Reason|0|||
150120075|NCT01992536|541573946|FG002|Overall Study|Administrative Reason|0|||
150120076|NCT01992536|541573947|FG003|Overall Study|Administrative Reason|0|||
150120077|NCT01992536|541573948|FG004|Overall Study|Administrative Reason|0|||
150120078|NCT01992536|541573949|FG005|Overall Study|Administrative Reason|0|||
150120079|NCT01992536|541573950|FG006|Overall Study|Administrative Reason|7|||
150120080|NCT01992536|541573951|FG007|Overall Study|Administrative Reason|0|||
150120081|NCT01992536|541573952|FG008|Overall Study|Administrative Reason|0|||
150120082|NCT01992536|541573953|FG009|Overall Study|Administrative Reason|0|||
150120083|NCT01992536|541573944|FG000|Overall Study|Lost to Follow-up|4|||
150120084|NCT01992536|541573945|FG001|Overall Study|Lost to Follow-up|2|||
150120085|NCT01992536|541573946|FG002|Overall Study|Lost to Follow-up|1|||
150120086|NCT01992536|541573947|FG003|Overall Study|Lost to Follow-up|0|||
150120087|NCT01992536|541573948|FG004|Overall Study|Lost to Follow-up|0|||
150120088|NCT01992536|541573949|FG005|Overall Study|Lost to Follow-up|1|||
150120089|NCT01992536|541573950|FG006|Overall Study|Lost to Follow-up|0|||
150120090|NCT01992536|541573951|FG007|Overall Study|Lost to Follow-up|0|||
150120091|NCT01992536|541573952|FG008|Overall Study|Lost to Follow-up|1|||
150120092|NCT01992536|541573953|FG009|Overall Study|Lost to Follow-up|1|||
150120093|NCT01992536|541573944|FG000|Overall Study|Withdrawal by Subject|0|||
150120094|NCT01992536|541573945|FG001|Overall Study|Withdrawal by Subject|1|||
150120095|NCT01992536|541573946|FG002|Overall Study|Withdrawal by Subject|0|||
150120096|NCT01992536|541573947|FG003|Overall Study|Withdrawal by Subject|2|||
150120097|NCT01992536|541573948|FG004|Overall Study|Withdrawal by Subject|0|||
150120098|NCT01992536|541573949|FG005|Overall Study|Withdrawal by Subject|0|||
150120099|NCT01992536|541573950|FG006|Overall Study|Withdrawal by Subject|0|||
150120100|NCT01992536|541573951|FG007|Overall Study|Withdrawal by Subject|0|||
150120101|NCT01992536|541573952|FG008|Overall Study|Withdrawal by Subject|0|||
150120102|NCT01992536|541573953|FG009|Overall Study|Withdrawal by Subject|0|||
150120103|NCT03669081|541573954|FG000|Overall Study|Data could not be validated|1|||
150120104|NCT03669081|541573955|FG001|Overall Study|Data could not be validated|1|||
150120105|NCT00389324|541573956|FG000|Run-In Phase|Adverse Event|1|||
150120106|NCT00389324|541573956|FG000|Run-In Phase|Lost to Follow-up|1|||
150120107|NCT00389324|541573956|FG000|Run-In Phase|Withdrawal by Subject|1|||
150120108|NCT00389324|541573956|FG000|Subcutaneous Phase|Adverse Event|2|||
150120109|NCT00389324|541573956|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
150120110|NCT00389324|541573956|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
150120111|NCT00389324|541573956|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
150120112|NCT02519504|541573957|FG000|Overall Study|Protocol Violation|6|||
150120113|NCT02519504|541573958|FG001|Overall Study|Protocol Violation|5|||
150120114|NCT02519504|541573957|FG000|Overall Study|Ineligible for direct testing|12|||
150120115|NCT02519504|541573958|FG001|Overall Study|Ineligible for direct testing|12|||
150120116|NCT02519504|541573957|FG000|Overall Study|Did not participate in direct testing|95|||
150120117|NCT02519504|541573958|FG001|Overall Study|Did not participate in direct testing|86|||
150120118|NCT02548962|541573959|FG000|Overall Study|Withdrawal by Subject|1|||
150120119|NCT02548962|541573960|FG001|Overall Study|Withdrawal by Subject|0|||
150120120|NCT04831736|541573961|FG000|Overall Study|Withdrawal by Subject|0|||
150120121|NCT04831736|541573962|FG001|Overall Study|Withdrawal by Subject|1|||
150120122|NCT03551938|541573965|FG000|3-Month Follow Up|Lost to Follow-up|39|||
150120123|NCT03551938|541573966|FG001|3-Month Follow Up|Lost to Follow-up|38|||
150120124|NCT03551938|541573965|FG000|6-Month Follow Up|Lost to Follow-up|46|||
150120125|NCT03551938|541573966|FG001|6-Month Follow Up|Lost to Follow-up|42|||
150120126|NCT03551938|541573965|FG000|9-Month Follow Up|Lost to Follow-up|44|||
150120127|NCT03551938|541573966|FG001|9-Month Follow Up|Lost to Follow-up|43|||
150120128|NCT01925183|541573967|FG000|Overall Study|Adverse Event|1|||
150120129|NCT01925183|541573968|FG001|Overall Study|Adverse Event|0|||
150120130|NCT01046110|541573969|FG000|Overall Study|Adverse Event|9|||
150120131|NCT01046110|541573970|FG001|Overall Study|Adverse Event|2|||
150120132|NCT01046110|541573969|FG000|Overall Study|Lack of Efficacy|0|||
150120133|NCT01046110|541573970|FG001|Overall Study|Lack of Efficacy|1|||
150120134|NCT01046110|541573969|FG000|Overall Study|Protocol Violation|7|||
150120135|NCT01046110|541573970|FG001|Overall Study|Protocol Violation|12|||
150120136|NCT01046110|541573969|FG000|Overall Study|Withdrawal Criteria|3|||
150120137|NCT01046110|541573970|FG001|Overall Study|Withdrawal Criteria|5|||
150120138|NCT01046110|541573969|FG000|Overall Study|Unclassified|36|||
150120139|NCT01046110|541573970|FG001|Overall Study|Unclassified|35|||
150120140|NCT02159482|541573973|FG000|Overall Study|Withdrawal by Subject|2|||
150120141|NCT02159482|541573973|FG000|Overall Study|Physician Decision|3|||
150120142|NCT01233817|541573974|FG000|Overall Study|Lost to Follow-up|1|||
150120143|NCT01233817|541573974|FG000|Overall Study|Withdrawal by Subject|2|||
150120144|NCT01854827|541573977|FG000|Overall Study|Death|1|||
150120145|NCT00736996|541573978|FG000|Overall Study|Lost to Follow-up|1|||
150120146|NCT00736996|541573979|FG001|Overall Study|Lost to Follow-up|9|||
150120147|NCT00736996|541573980|FG002|Overall Study|Lost to Follow-up|2|||
150120148|NCT02667912|541573981|FG000|Overall Study|Death|3|||
150120149|NCT02667912|541573982|FG001|Overall Study|Death|1|||
150120150|NCT02667912|541573981|FG000|Overall Study|Withdrawal by Subject|1|||
150120151|NCT02667912|541573982|FG001|Overall Study|Withdrawal by Subject|2|||
150120152|NCT02667912|541573981|FG000|Overall Study|Withdrawal by Subject|1|||
150120153|NCT02667912|541573982|FG001|Overall Study|Withdrawal by Subject|0|||
150120154|NCT04443218|541573983|FG000|Overall Study|Exited study for other reasons|9|||
150120155|NCT04443218|541573983|FG000|Overall Study|Withdrawal by Subject|1|||
150120156|NCT04443218|541573983|FG000|Overall Study|Lost to Follow-up|4|||
150120157|NCT04443218|541573983|FG000|Overall Study|Death|19|||
150120158|NCT02660944|541573984|FG000|Overall Study|Adverse Event|3|||
150120159|NCT02660944|541573985|FG001|Overall Study|Adverse Event|4|||
150120160|NCT02660944|541573984|FG000|Overall Study|Physician Decision|3|||
150120161|NCT02660944|541573985|FG001|Overall Study|Physician Decision|1|||
150120162|NCT02660944|541573984|FG000|Overall Study|Withdrawal by Subject|5|||
150120163|NCT02660944|541573985|FG001|Overall Study|Withdrawal by Subject|3|||
150120164|NCT02660944|541573984|FG000|Overall Study|Lost to Follow-up|4|||
150120165|NCT02660944|541573985|FG001|Overall Study|Lost to Follow-up|1|||
150120166|NCT02660944|541573984|FG000|Overall Study|Subject schedule|0|||
150120167|NCT02660944|541573985|FG001|Overall Study|Subject schedule|1|||
150120168|NCT02660944|541573984|FG000|Overall Study|Exclusion criteria met|2|||
150120169|NCT02660944|541573985|FG001|Overall Study|Exclusion criteria met|0|||
150120170|NCT02843568|541573986|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
150120171|NCT02843568|541573987|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
150120172|NCT02843568|541573986|FG000|Overall Study|Death|3|||
150120173|NCT02843568|541573987|FG001|Overall Study|Death|3|||
150120174|NCT02843568|541573986|FG000|Overall Study|Withdrawal by Subject|1|||
150120175|NCT02843568|541573987|FG001|Overall Study|Withdrawal by Subject|1|||
150120176|NCT02843568|541573986|FG000|Overall Study|Lost to Follow-up|2|||
150120177|NCT02843568|541573987|FG001|Overall Study|Lost to Follow-up|0|||
150120178|NCT03586999|541573988|FG000|Overall Study|Lack of Efficacy|2|||
150120179|NCT02059148|541573999|FG000|Treatment 1|Protocol Violation|0|||
150120180|NCT02059148|541574000|FG001|Treatment 1|Protocol Violation|0|||
150120181|NCT02059148|541574001|FG002|Treatment 1|Protocol Violation|0|||
150120182|NCT02059148|541574002|FG003|Treatment 1|Protocol Violation|0|||
150120183|NCT02059148|541574003|FG004|Treatment 1|Protocol Violation|0|||
150120184|NCT02059148|541574004|FG005|Treatment 1|Protocol Violation|1|||
150120185|NCT01525082|541574005|FG000|Overall Study|Death|1|||
150120186|NCT03880578|541574007|FG000|Overall Study|Withdrawal by Subject|0|||
150120187|NCT03880578|541574008|FG001|Overall Study|Withdrawal by Subject|3|||
150120188|NCT03880578|541574009|FG002|Overall Study|Withdrawal by Subject|1|||
150120189|NCT03880578|541574007|FG000|Overall Study|Death|0|||
150120190|NCT03880578|541574008|FG001|Overall Study|Death|1|||
150120191|NCT03880578|541574009|FG002|Overall Study|Death|0|||
150120192|NCT04934670|541574010|FG000|Overall Study|Death|4|||
150120193|NCT04934670|541574011|FG001|Overall Study|Death|0|||
150120194|NCT04934670|541574010|FG000|Overall Study|Lost to Follow-up|1|||
150120195|NCT04934670|541574011|FG001|Overall Study|Lost to Follow-up|4|||
150120196|NCT02328326|541574016|FG000|Overall Study|Withdrawal by Subject|10|||
150120197|NCT02328326|541574017|FG001|Overall Study|Withdrawal by Subject|3|||
150120198|NCT02328326|541574016|FG000|Overall Study|Death|2|||
150120199|NCT02328326|541574017|FG001|Overall Study|Death|1|||
150120200|NCT02328326|541574016|FG000|Overall Study|Lost to Follow-up|10|||
150120201|NCT02328326|541574017|FG001|Overall Study|Lost to Follow-up|4|||
150120202|NCT01748994|541574019|FG000|Overall Study|Lost to Follow-up|8|||
150120203|NCT01748994|541574020|FG001|Overall Study|Lost to Follow-up|6|||
150120204|NCT03433456|541574021|FG000|Overall Study|Death|1|||
150120205|NCT03433456|541574022|FG001|Overall Study|Death|1|||
150120206|NCT03433456|541574021|FG000|Overall Study|Lost to Follow-up|14|||
150120207|NCT03433456|541574022|FG001|Overall Study|Lost to Follow-up|11|||
150120208|NCT03433456|541574021|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
150120209|NCT03433456|541574022|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
150120210|NCT04496258|541574023|FG000|Overall Study|Withdrawal by Subject|2|||
150191971|NCT05170009|541842720|FG001|Overall Study|Physician Decision|1|||
150191972|NCT04925986|541842721|FG000|Overall Study|Death|0|||
150191973|NCT04925986|541842722|FG001|Overall Study|Death|0|||
150191974|NCT04925986|541842723|FG002|Overall Study|Death|2|||
150191975|NCT04925986|541842724|FG003|Overall Study|Death|0|||
150191976|NCT04925986|541842721|FG000|Overall Study|Lack of Efficacy|1|||
150191977|NCT04925986|541842722|FG001|Overall Study|Lack of Efficacy|2|||
150191978|NCT04925986|541842723|FG002|Overall Study|Lack of Efficacy|0|||
150191979|NCT04925986|541842724|FG003|Overall Study|Lack of Efficacy|1|||
150191980|NCT04925986|541842721|FG000|Overall Study|Withdrawal by Subject|0|||
150191981|NCT04925986|541842722|FG001|Overall Study|Withdrawal by Subject|0|||
150191982|NCT04925986|541842723|FG002|Overall Study|Withdrawal by Subject|1|||
150191983|NCT04925986|541842724|FG003|Overall Study|Withdrawal by Subject|2|||
150191984|NCT06181760|541842725|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
150191985|NCT06181760|541842726|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
150191986|NCT06181760|541842727|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
150191987|NCT06181760|541842728|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
150191988|NCT04629716|541842730|FG000|Overall Study|Lost to Follow-up|7|||
150191989|NCT04629716|541842731|FG001|Overall Study|Lost to Follow-up|3|||
150191990|NCT04770532|541842732|FG000|Overall Study|Withdrawal by Subject|0|||
150191991|NCT04770532|541842733|FG001|Overall Study|Withdrawal by Subject|3|||
150191992|NCT04770532|541842732|FG000|Overall Study|Physician Decision|1|||
150191993|NCT04770532|541842733|FG001|Overall Study|Physician Decision|0|||
150191994|NCT04770532|541842732|FG000|Overall Study|Death|2|||
150191995|NCT04770532|541842733|FG001|Overall Study|Death|2|||
150191996|NCT05457647|541842735|FG000|Overall Study|Lost to Follow-up|3|||
150191997|NCT04938492|541842736|FG000|Overall Study|Lost to Follow-up|17|||
150191998|NCT04938492|541842737|FG001|Overall Study|Lost to Follow-up|18|||
150191999|NCT03865498|541842740|FG000|Overall Study|Lack of Efficacy|12|||
150192000|NCT03865498|541842741|FG001|Overall Study|Lack of Efficacy|11|||
150192001|NCT03865498|541842740|FG000|Overall Study|Lost to Follow-up|125|||
150192002|NCT03865498|541842741|FG001|Overall Study|Lost to Follow-up|133|||
150192003|NCT03865498|541842740|FG000|Overall Study|Withdrawal by Subject|2|||
150192004|NCT03865498|541842741|FG001|Overall Study|Withdrawal by Subject|4|||
150192005|NCT01648023|541842746|FG000|Overall Study|Screen Fail Post Randomization|1|||
150192006|NCT01648023|541842747|FG001|Overall Study|Screen Fail Post Randomization|2|||
150192007|NCT05296525|541842750|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
150192008|NCT05296525|541842751|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
150192009|NCT05296525|541842752|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
150192010|NCT05296525|541842753|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
150192011|NCT04137289|541842754|FG000|Overall Study|Death|0|||
150192012|NCT04137289|541842755|FG001|Overall Study|Death|0|||
150192013|NCT04137289|541842756|FG002|Overall Study|Death|0|||
150192014|NCT04137289|541842757|FG003|Overall Study|Death|0|||
150192015|NCT04137289|541842758|FG004|Overall Study|Death|0|||
150192016|NCT04137289|541842759|FG005|Overall Study|Death|0|||
150192017|NCT04137289|541842760|FG006|Overall Study|Death|1|||
150192018|NCT04137289|541842761|FG007|Overall Study|Death|0|||
150192019|NCT04137289|541842762|FG008|Overall Study|Death|0|||
150192020|NCT04137289|541842754|FG000|Overall Study|Clinical disease progression|0|||
150192021|NCT04137289|541842755|FG001|Overall Study|Clinical disease progression|0|||
150192022|NCT04137289|541842756|FG002|Overall Study|Clinical disease progression|0|||
150192023|NCT04137289|541842757|FG003|Overall Study|Clinical disease progression|4|||
150120211|NCT04496258|541574024|FG001|Overall Study|Withdrawal by Subject|1|||
150120212|NCT03251924|541574025|FG000|Overall Study|Disease Progression|6|||
150120213|NCT03251924|541574026|FG001|Overall Study|Disease Progression|6|||
150120214|NCT03251924|541574027|FG002|Overall Study|Disease Progression|7|||
150120215|NCT03251924|541574028|FG003|Overall Study|Disease Progression|8|||
150120216|NCT03251924|541574029|FG004|Overall Study|Disease Progression|8|||
150120217|NCT03251924|541574030|FG005|Overall Study|Disease Progression|7|||
150120218|NCT03251924|541574031|FG006|Overall Study|Disease Progression|6|||
150120219|NCT03251924|541574032|FG007|Overall Study|Disease Progression|10|||
150120220|NCT03251924|541574033|FG008|Overall Study|Disease Progression|6|||
150120221|NCT03251924|541574025|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
150120222|NCT03251924|541574026|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
150120223|NCT03251924|541574027|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
150120224|NCT03251924|541574028|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
150120225|NCT03251924|541574029|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
150120226|NCT03251924|541574030|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
150120227|NCT03251924|541574031|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
150120228|NCT03251924|541574032|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
150120229|NCT03251924|541574033|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
150120230|NCT03251924|541574025|FG000|Overall Study|Death|0|||
150120231|NCT03251924|541574026|FG001|Overall Study|Death|1|||
150120232|NCT03251924|541574027|FG002|Overall Study|Death|0|||
150120233|NCT03251924|541574028|FG003|Overall Study|Death|1|||
150120234|NCT03251924|541574029|FG004|Overall Study|Death|1|||
150120235|NCT03251924|541574030|FG005|Overall Study|Death|1|||
150120236|NCT03251924|541574031|FG006|Overall Study|Death|0|||
150120237|NCT03251924|541574032|FG007|Overall Study|Death|0|||
150120238|NCT03251924|541574033|FG008|Overall Study|Death|0|||
150120239|NCT03251924|541574025|FG000|Overall Study|Study Drug Toxicity|0|||
150120240|NCT03251924|541574026|FG001|Overall Study|Study Drug Toxicity|0|||
150120241|NCT03251924|541574027|FG002|Overall Study|Study Drug Toxicity|0|||
150120242|NCT03251924|541574028|FG003|Overall Study|Study Drug Toxicity|1|||
150120243|NCT03251924|541574029|FG004|Overall Study|Study Drug Toxicity|0|||
150120244|NCT03251924|541574030|FG005|Overall Study|Study Drug Toxicity|0|||
150120245|NCT03251924|541574031|FG006|Overall Study|Study Drug Toxicity|0|||
150120246|NCT03251924|541574032|FG007|Overall Study|Study Drug Toxicity|0|||
150120247|NCT03251924|541574033|FG008|Overall Study|Study Drug Toxicity|1|||
150120248|NCT03251924|541574025|FG000|Overall Study|Other Reasons|0|||
150120249|NCT03251924|541574026|FG001|Overall Study|Other Reasons|0|||
150120250|NCT03251924|541574027|FG002|Overall Study|Other Reasons|0|||
150120251|NCT03251924|541574028|FG003|Overall Study|Other Reasons|0|||
150120252|NCT03251924|541574029|FG004|Overall Study|Other Reasons|0|||
150120253|NCT03251924|541574030|FG005|Overall Study|Other Reasons|0|||
150120254|NCT03251924|541574031|FG006|Overall Study|Other Reasons|0|||
150120255|NCT03251924|541574032|FG007|Overall Study|Other Reasons|0|||
150120256|NCT03251924|541574033|FG008|Overall Study|Other Reasons|1|||
150120257|NCT03251924|541574025|FG000|Overall Study|Participant request to discontinue study treatment|0|||
150120258|NCT03251924|541574026|FG001|Overall Study|Participant request to discontinue study treatment|0|||
150120259|NCT03251924|541574027|FG002|Overall Study|Participant request to discontinue study treatment|0|||
150120260|NCT03251924|541574028|FG003|Overall Study|Participant request to discontinue study treatment|0|||
150120261|NCT03251924|541574029|FG004|Overall Study|Participant request to discontinue study treatment|0|||
150120262|NCT03251924|541574030|FG005|Overall Study|Participant request to discontinue study treatment|0|||
150120263|NCT03251924|541574031|FG006|Overall Study|Participant request to discontinue study treatment|0|||
150120264|NCT03251924|541574032|FG007|Overall Study|Participant request to discontinue study treatment|1|||
150120265|NCT03251924|541574033|FG008|Overall Study|Participant request to discontinue study treatment|0|||
150120266|NCT00153101|541574034|FG000|Overall Study|Lost to Follow-up|14|||
150120267|NCT00153101|541574035|FG001|Overall Study|Lost to Follow-up|14|||
150120268|NCT00153101|541574036|FG002|Overall Study|Lost to Follow-up|12|||
150120269|NCT00153101|541574037|FG003|Overall Study|Lost to Follow-up|5|||
150120270|NCT00153101|541574038|FG004|Overall Study|Lost to Follow-up|5|||
150120271|NCT00153101|541574034|FG000|Overall Study|Withdrawal by Subject|3|||
150120272|NCT00153101|541574035|FG001|Overall Study|Withdrawal by Subject|4|||
150192024|NCT04137289|541842758|FG004|Overall Study|Clinical disease progression|4|||
150192025|NCT04137289|541842759|FG005|Overall Study|Clinical disease progression|2|||
150120273|NCT00153101|541574036|FG002|Overall Study|Withdrawal by Subject|3|||
150120274|NCT00153101|541574037|FG003|Overall Study|Withdrawal by Subject|3|||
150120275|NCT00153101|541574038|FG004|Overall Study|Withdrawal by Subject|5|||
150120276|NCT01440946|541574043|FG000|Overall Study|Lost to Follow-up|1|||
150120277|NCT01440946|541574044|FG001|Overall Study|Lost to Follow-up|1|||
150120278|NCT01440946|541574043|FG000|Overall Study|Physician Decision|1|||
150120279|NCT01440946|541574044|FG001|Overall Study|Physician Decision|0|||
150120280|NCT03299192|541574045|FG000|Overall Study|Fell before classes started|1|||
150120281|NCT03299192|541574046|FG001|Overall Study|Fell before classes started|0|||
150120282|NCT03299192|541574047|FG002|Overall Study|Fell before classes started|0|||
150120283|NCT03299192|541574045|FG000|Overall Study|Other|0|||
150120284|NCT03299192|541574046|FG001|Overall Study|Other|2|||
150120285|NCT03299192|541574047|FG002|Overall Study|Other|1|||
150120286|NCT00983580|541574049|FG000|Overall Study|Cancel Prior to treatment|1|||
150120287|NCT00983580|541574050|FG001|Overall Study|Cancel Prior to treatment|3|||
150120288|NCT00983580|541574049|FG000|Overall Study|Protocol Violation|1|||
150120289|NCT00983580|541574050|FG001|Overall Study|Protocol Violation|1|||
150120290|NCT00983580|541574049|FG000|Overall Study|Ineligible|3|||
150120291|NCT00983580|541574050|FG001|Overall Study|Ineligible|0|||
150120292|NCT04382612|541574056|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
150120293|NCT01328002|541574057|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
150120294|NCT01328002|541574058|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
150120295|NCT01328002|541574057|FG000|Open-Label Period|Adverse Event|8|||
150120296|NCT01328002|541574058|FG001|Open-Label Period|Adverse Event|0|||
150120297|NCT01328002|541574057|FG000|Open-Label Period|Lack of Efficacy|3|||
150120298|NCT01328002|541574058|FG001|Open-Label Period|Lack of Efficacy|0|||
150120299|NCT01328002|541574057|FG000|Open-Label Period|Protocol Violation|2|||
150120300|NCT01328002|541574058|FG001|Open-Label Period|Protocol Violation|0|||
150120301|NCT01328002|541574057|FG000|Open-Label Period|Withdrawal by Subject|9|||
150120302|NCT01328002|541574058|FG001|Open-Label Period|Withdrawal by Subject|0|||
150120303|NCT01328002|541574057|FG000|Open-Label Period|Lost to Follow-up|6|||
150120304|NCT01328002|541574058|FG001|Open-Label Period|Lost to Follow-up|0|||
150120305|NCT01328002|541574057|FG000|Open-Label Period|Other Reason|2|||
150120306|NCT01328002|541574058|FG001|Open-Label Period|Other Reason|0|||
150120307|NCT01328002|541574057|FG000|Double-Blind Period|Adverse Event|1|||
150120308|NCT01328002|541574058|FG001|Double-Blind Period|Adverse Event|0|||
150120309|NCT01328002|541574057|FG000|Double-Blind Period|Lack of Efficacy|1|||
150120310|NCT01328002|541574058|FG001|Double-Blind Period|Lack of Efficacy|0|||
150120311|NCT03149328|541574059|FG000|Overall Study|Withdrawal by Subject|30|||
150120312|NCT03149328|541574060|FG001|Overall Study|Withdrawal by Subject|26|||
150120313|NCT03149328|541574059|FG000|Overall Study|Changed Dialysis Modality|18|||
150120314|NCT03149328|541574060|FG001|Overall Study|Changed Dialysis Modality|1|||
150120315|NCT03149328|541574059|FG000|Overall Study|Transplant|9|||
150120316|NCT03149328|541574060|FG001|Overall Study|Transplant|1|||
150120317|NCT03149328|541574059|FG000|Overall Study|Lost to Follow-up|25|||
150120318|NCT03149328|541574060|FG001|Overall Study|Lost to Follow-up|16|||
150120319|NCT03149328|541574059|FG000|Overall Study|Left Study Site|1|||
150120320|NCT03149328|541574060|FG001|Overall Study|Left Study Site|2|||
150120321|NCT03149328|541574059|FG000|Overall Study|Language Barrier|1|||
150120322|NCT03149328|541574060|FG001|Overall Study|Language Barrier|0|||
150120323|NCT01306617|541574064|FG000|Overall Study|Adverse Event|1|||
150120324|NCT01306617|541574065|FG001|Overall Study|Adverse Event|0|||
150120325|NCT01306617|541574066|FG002|Overall Study|Adverse Event|0|||
150120326|NCT01306617|541574064|FG000|Overall Study|Virologic Failure|0|||
150120327|NCT01306617|541574065|FG001|Overall Study|Virologic Failure|0|||
150120328|NCT01306617|541574066|FG002|Overall Study|Virologic Failure|5|||
150120329|NCT01306617|541574064|FG000|Overall Study|Non-compliance|0|||
150120330|NCT01306617|541574065|FG001|Overall Study|Non-compliance|1|||
150120331|NCT01306617|541574066|FG002|Overall Study|Non-compliance|0|||
150120332|NCT01578551|541574067|FG000|Overall Study|Adverse Event|1|||
150120333|NCT01578551|541574068|FG001|Overall Study|Adverse Event|0|||
150120334|NCT05204134|541574070|FG000|Overall Study|Withdrawal by Subject|3|||
150120335|NCT05204134|541574070|FG000|Overall Study|Physician Decision|1|||
150120336|NCT02788175|541574071|FG000|Overall Study|Protocol Violation|3|||
150120337|NCT02788175|541574071|FG000|Overall Study|Withdrawal by Subject|4|||
150120338|NCT02788175|541574071|FG000|Overall Study|Ineligible prior to study agent|6|||
150120339|NCT00162136|541574072|FG000|Overall Study|Adverse Event|1|||
150120340|NCT00162136|541574072|FG000|Overall Study|Death|1|||
150120341|NCT00162136|541574072|FG000|Overall Study|Disease Progression/Relapse|23|||
150120342|NCT00162136|541574072|FG000|Overall Study|Investigator Request|5|||
150120343|NCT00162136|541574072|FG000|Overall Study|Study Drug Toxicity|4|||
150120344|NCT00162136|541574072|FG000|Overall Study|Withdrawal by Subject|1|||
150120345|NCT00818441|541574073|FG000|Overall Study|Death|69|||
150120346|NCT00818441|541574074|FG001|Overall Study|Death|26|||
150120347|NCT00818441|541574073|FG000|Overall Study|Other|5|||
150120348|NCT00818441|541574074|FG001|Overall Study|Other|0|||
150120349|NCT00818441|541574073|FG000|Overall Study|Lost to Follow-up|2|||
150120350|NCT00818441|541574074|FG001|Overall Study|Lost to Follow-up|1|||
150120351|NCT00818441|541574073|FG000|Overall Study|Withdrawal by Subject|2|||
150120352|NCT00818441|541574074|FG001|Overall Study|Withdrawal by Subject|0|||
150120353|NCT00818441|541574073|FG000|Overall Study|Adverse Event|0|||
150120354|NCT00818441|541574074|FG001|Overall Study|Adverse Event|1|||
150120355|NCT00818441|541574073|FG000|Overall Study|Study terminated by sponsor|11|||
150120356|NCT00818441|541574074|FG001|Overall Study|Study terminated by sponsor|2|||
150120357|NCT03320070|541575518|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
150120358|NCT03320070|541575519|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
150120359|NCT03320070|541575518|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
150120360|NCT03320070|541575519|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
150120361|NCT03320070|541575518|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
150120362|NCT03320070|541575519|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
150120363|NCT03320070|541575518|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
150120364|NCT03320070|541575519|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
150120365|NCT03320070|541575518|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
150120366|NCT03320070|541575519|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
150120367|NCT03320070|541575518|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
150120368|NCT03320070|541575519|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
150120369|NCT01075321|541575524|FG000|Overall Study|Withdrawal by Subject|0|||
150120370|NCT01075321|541575525|FG001|Overall Study|Withdrawal by Subject|0|||
150120371|NCT01075321|541575526|FG002|Overall Study|Withdrawal by Subject|1|||
150120372|NCT01075321|541575527|FG003|Overall Study|Withdrawal by Subject|1|||
150120373|NCT01075321|541575524|FG000|Overall Study|Protocol Violation|0|||
150120374|NCT01075321|541575525|FG001|Overall Study|Protocol Violation|0|||
150120375|NCT01075321|541575526|FG002|Overall Study|Protocol Violation|1|||
150120376|NCT01075321|541575527|FG003|Overall Study|Protocol Violation|0|||
150120377|NCT01075321|541575524|FG000|Overall Study|Treatment Incomplete due to progression|1|||
150120378|NCT01075321|541575525|FG001|Overall Study|Treatment Incomplete due to progression|0|||
150120379|NCT01075321|541575526|FG002|Overall Study|Treatment Incomplete due to progression|0|||
150120380|NCT01075321|541575527|FG003|Overall Study|Treatment Incomplete due to progression|0|||
150120381|NCT01075321|541575524|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
150120382|NCT01075321|541575525|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
150120383|NCT01075321|541575526|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
150120384|NCT01075321|541575527|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
150120385|NCT00262834|541575528|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
150120386|NCT00262834|541575529|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
150120387|NCT00003457|541575532|FG000|Overall Study|Not evaluable|9|||
150120388|NCT02246998|541575533|FG000|Overall Study|Adverse Event|0|||
150120389|NCT02246998|541575534|FG001|Overall Study|Adverse Event|1|||
150120390|NCT02246998|541575535|FG002|Overall Study|Adverse Event|1|||
150120391|NCT02246998|541575536|FG003|Overall Study|Adverse Event|0|||
150120392|NCT02246998|541575533|FG000|Overall Study|Lost to Follow-up|1|||
150120393|NCT02246998|541575534|FG001|Overall Study|Lost to Follow-up|0|||
150120394|NCT02246998|541575535|FG002|Overall Study|Lost to Follow-up|0|||
150120395|NCT02246998|541575536|FG003|Overall Study|Lost to Follow-up|1|||
150120396|NCT02246998|541575533|FG000|Overall Study|Randomized but Never Dosed|1|||
150120397|NCT02246998|541575534|FG001|Overall Study|Randomized but Never Dosed|2|||
150120398|NCT02246998|541575535|FG002|Overall Study|Randomized but Never Dosed|2|||
150120399|NCT02246998|541575536|FG003|Overall Study|Randomized but Never Dosed|1|||
150120400|NCT02473614|541575537|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
150120401|NCT02473614|541575538|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
150120402|NCT01075074|541575539|FG000|Overall Study|Surgeon changed to open incisional case|1|||
150120403|NCT01075074|541575540|FG001|Overall Study|Surgeon changed to open incisional case|2|||
150120404|NCT01075074|541575541|FG002|Overall Study|Surgeon changed to open incisional case|2|||
150120405|NCT02416791|541575542|FG000|6 Months|Lost to Follow-up|0|||
150120406|NCT02416791|541575543|FG001|6 Months|Lost to Follow-up|0|||
150120407|NCT02416791|541575544|FG002|6 Months|Lost to Follow-up|1|||
150120408|NCT01054729|541575545|FG000|Overall Study|Randomized but Not Treated|0|||
150120409|NCT01054729|541575546|FG001|Overall Study|Randomized but Not Treated|1|||
150120410|NCT01054729|541575547|FG002|Overall Study|Randomized but Not Treated|0|||
150120411|NCT01054729|541575548|FG003|Overall Study|Randomized but Not Treated|0|||
150120412|NCT01054729|541575545|FG000|Overall Study|Adverse Event|1|||
150120413|NCT01054729|541575546|FG001|Overall Study|Adverse Event|1|||
150120414|NCT01054729|541575547|FG002|Overall Study|Adverse Event|2|||
150120415|NCT01054729|541575548|FG003|Overall Study|Adverse Event|1|||
150192026|NCT04137289|541842760|FG006|Overall Study|Clinical disease progression|5|||
150192027|NCT04137289|541842761|FG007|Overall Study|Clinical disease progression|1|||
150192028|NCT04137289|541842762|FG008|Overall Study|Clinical disease progression|0|||
150192029|NCT04137289|541842754|FG000|Overall Study|Lost to Follow-up|0|||
150192030|NCT04137289|541842755|FG001|Overall Study|Lost to Follow-up|0|||
150192031|NCT04137289|541842756|FG002|Overall Study|Lost to Follow-up|0|||
150192032|NCT04137289|541842757|FG003|Overall Study|Lost to Follow-up|1|||
150192033|NCT04137289|541842758|FG004|Overall Study|Lost to Follow-up|0|||
150192034|NCT04137289|541842759|FG005|Overall Study|Lost to Follow-up|0|||
150192035|NCT04137289|541842760|FG006|Overall Study|Lost to Follow-up|0|||
150192036|NCT04137289|541842761|FG007|Overall Study|Lost to Follow-up|0|||
150192037|NCT04137289|541842762|FG008|Overall Study|Lost to Follow-up|0|||
150120416|NCT01054729|541575545|FG000|Overall Study|Withdrawal by Subject|1|||
150120417|NCT01054729|541575546|FG001|Overall Study|Withdrawal by Subject|0|||
150120418|NCT01054729|541575547|FG002|Overall Study|Withdrawal by Subject|1|||
150120419|NCT01054729|541575548|FG003|Overall Study|Withdrawal by Subject|0|||
150120420|NCT01054729|541575545|FG000|Overall Study|Lost to Follow-up|0|||
150120421|NCT01054729|541575546|FG001|Overall Study|Lost to Follow-up|1|||
150120422|NCT01054729|541575547|FG002|Overall Study|Lost to Follow-up|0|||
150120423|NCT01054729|541575548|FG003|Overall Study|Lost to Follow-up|0|||
150120424|NCT01054729|541575545|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
150120425|NCT01054729|541575546|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
150120426|NCT01054729|541575547|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
150120427|NCT01054729|541575548|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
150120428|NCT01054729|541575545|FG000|Overall Study|Non-responder|1|||
150120429|NCT01054729|541575546|FG001|Overall Study|Non-responder|0|||
150120430|NCT01054729|541575547|FG002|Overall Study|Non-responder|1|||
150120431|NCT01054729|541575548|FG003|Overall Study|Non-responder|1|||
150120432|NCT01054729|541575545|FG000|Overall Study|PEG/RBV Non-responder|1|||
150120433|NCT01054729|541575546|FG001|Overall Study|PEG/RBV Non-responder|0|||
150120434|NCT01054729|541575547|FG002|Overall Study|PEG/RBV Non-responder|1|||
150120435|NCT01054729|541575548|FG003|Overall Study|PEG/RBV Non-responder|0|||
150120436|NCT01054729|541575545|FG000|Overall Study|Personal/Obligations|0|||
150120437|NCT01054729|541575546|FG001|Overall Study|Personal/Obligations|1|||
150120438|NCT01054729|541575547|FG002|Overall Study|Personal/Obligations|0|||
150120439|NCT01054729|541575548|FG003|Overall Study|Personal/Obligations|0|||
150120440|NCT01054729|541575545|FG000|Overall Study|Subject moved|0|||
150120441|NCT01054729|541575546|FG001|Overall Study|Subject moved|0|||
150120442|NCT01054729|541575547|FG002|Overall Study|Subject moved|1|||
150120443|NCT01054729|541575548|FG003|Overall Study|Subject moved|0|||
150120444|NCT01054729|541575545|FG000|Overall Study|Lack of Efficacy|0|||
150120445|NCT01054729|541575546|FG001|Overall Study|Lack of Efficacy|0|||
150120446|NCT01054729|541575547|FG002|Overall Study|Lack of Efficacy|0|||
150120447|NCT01054729|541575548|FG003|Overall Study|Lack of Efficacy|1|||
150120448|NCT00844194|541575549|FG000|Overall Study|Adverse Event|17|||
150120449|NCT00844194|541575550|FG001|Overall Study|Adverse Event|5|||
150120450|NCT00844194|541575549|FG000|Overall Study|Protocol Violation|1|||
150120451|NCT00844194|541575550|FG001|Overall Study|Protocol Violation|1|||
150120452|NCT00844194|541575549|FG000|Overall Study|Lost to Follow-up|1|||
150120453|NCT00844194|541575550|FG001|Overall Study|Lost to Follow-up|1|||
150120454|NCT00844194|541575549|FG000|Overall Study|Withdrawal by Subject|2|||
150120455|NCT00844194|541575550|FG001|Overall Study|Withdrawal by Subject|1|||
150120456|NCT00844194|541575549|FG000|Overall Study|Lack of Efficacy|3|||
150120457|NCT00844194|541575550|FG001|Overall Study|Lack of Efficacy|0|||
150120458|NCT00844194|541575549|FG000|Overall Study|Other reason (not specified)|1|||
150120459|NCT00844194|541575550|FG001|Overall Study|Other reason (not specified)|0|||
150120460|NCT00562159|541575551|FG000|Overall Study|Adverse Event|11|||
150120461|NCT00562159|541575552|FG001|Overall Study|Adverse Event|8|||
150120462|NCT00562159|541575551|FG000|Overall Study|Lost to Follow-up|5|||
150192038|NCT04137289|541842754|FG000|Overall Study|Adverse Event|0|||
150120463|NCT00562159|541575552|FG001|Overall Study|Lost to Follow-up|4|||
150120464|NCT00562159|541575551|FG000|Overall Study|Withdrawal by Subject|9|||
150120465|NCT00562159|541575552|FG001|Overall Study|Withdrawal by Subject|8|||
150120466|NCT00562159|541575551|FG000|Overall Study|Protocol Violation|12|||
150120467|NCT00562159|541575552|FG001|Overall Study|Protocol Violation|12|||
150120468|NCT00562159|541575551|FG000|Overall Study|Did not meet protocol eligibility|1|||
150120469|NCT00562159|541575552|FG001|Overall Study|Did not meet protocol eligibility|1|||
150120470|NCT01659021|541575560|FG000|Main Study|Adverse Event|2|||
150120471|NCT01659021|541575561|FG001|Main Study|Adverse Event|3|||
150120472|NCT01659021|541575560|FG000|Main Study|Lost to Follow-up|1|||
150120473|NCT01659021|541575561|FG001|Main Study|Lost to Follow-up|0|||
150120474|NCT01659021|541575560|FG000|Main Study|Unknown Reasons|2|||
150120475|NCT01659021|541575561|FG001|Main Study|Unknown Reasons|1|||
150120476|NCT01659021|541575560|FG000|Main Study|Physician Decision|34|||
150192039|NCT04137289|541842755|FG001|Overall Study|Adverse Event|0|||
150192040|NCT04137289|541842756|FG002|Overall Study|Adverse Event|1|||
150192041|NCT04137289|541842757|FG003|Overall Study|Adverse Event|0|||
150192042|NCT04137289|541842758|FG004|Overall Study|Adverse Event|0|||
150192043|NCT04137289|541842759|FG005|Overall Study|Adverse Event|1|||
150192044|NCT04137289|541842760|FG006|Overall Study|Adverse Event|0|||
150192045|NCT04137289|541842761|FG007|Overall Study|Adverse Event|0|||
150192046|NCT04137289|541842762|FG008|Overall Study|Adverse Event|0|||
150192047|NCT04137289|541842754|FG000|Overall Study|Lack of clinical benefit|0|||
150192048|NCT04137289|541842755|FG001|Overall Study|Lack of clinical benefit|0|||
150192049|NCT04137289|541842756|FG002|Overall Study|Lack of clinical benefit|0|||
150192050|NCT04137289|541842757|FG003|Overall Study|Lack of clinical benefit|0|||
150192051|NCT04137289|541842758|FG004|Overall Study|Lack of clinical benefit|0|||
150192052|NCT04137289|541842759|FG005|Overall Study|Lack of clinical benefit|0|||
150192053|NCT04137289|541842760|FG006|Overall Study|Lack of clinical benefit|0|||
150192054|NCT04137289|541842761|FG007|Overall Study|Lack of clinical benefit|0|||
150192055|NCT04137289|541842762|FG008|Overall Study|Lack of clinical benefit|1|||
150192056|NCT04137289|541842754|FG000|Overall Study|Objective disease progression|1|||
150192057|NCT04137289|541842755|FG001|Overall Study|Objective disease progression|1|||
150192058|NCT04137289|541842756|FG002|Overall Study|Objective disease progression|6|||
150192059|NCT04137289|541842757|FG003|Overall Study|Objective disease progression|18|||
150192060|NCT04137289|541842758|FG004|Overall Study|Objective disease progression|12|||
150192061|NCT04137289|541842759|FG005|Overall Study|Objective disease progression|20|||
150192062|NCT04137289|541842760|FG006|Overall Study|Objective disease progression|18|||
150192063|NCT04137289|541842761|FG007|Overall Study|Objective disease progression|7|||
150192064|NCT04137289|541842762|FG008|Overall Study|Objective disease progression|6|||
150192065|NCT02547363|541842765|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
150192066|NCT02547363|541842766|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
150192067|NCT02547363|541842765|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
150192068|NCT02547363|541842766|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
150192069|NCT02547363|541842765|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
150192070|NCT02547363|541842766|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
150192071|NCT02547363|541842765|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
150192072|NCT02547363|541842766|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
150192073|NCT02547363|541842765|FG000|12-month Follow-up|Withdrawal by Subject|4|||
150192074|NCT02547363|541842766|FG001|12-month Follow-up|Withdrawal by Subject|3|||
150192075|NCT02547363|541842765|FG000|12-month Follow-up|Lost to Follow-up|4|||
150192076|NCT02547363|541842766|FG001|12-month Follow-up|Lost to Follow-up|1|||
150192077|NCT02547363|541842765|FG000|12-month Follow-up|Lack of Efficacy|1|||
150192078|NCT02547363|541842766|FG001|12-month Follow-up|Lack of Efficacy|1|||
150192079|NCT02547363|541842765|FG000|12-month Follow-up|Other|1|||
150192080|NCT02547363|541842766|FG001|12-month Follow-up|Other|0|||
150192081|NCT03931174|541842767|FG000|Providers|Staff left organization|26|||
150192082|NCT03931174|541842768|FG001|Providers|Staff left organization|25|||
150192083|NCT03931174|541842767|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
150192084|NCT03931174|541842768|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
150192085|NCT03931174|541842767|FG000|Providers|Lost to Follow-up|4|||
150192086|NCT03931174|541842768|FG001|Providers|Lost to Follow-up|4|||
150192087|NCT03931174|541842767|FG000|Patients|Post-consent screening failure|1|||
150192088|NCT03931174|541842768|FG001|Patients|Post-consent screening failure|1|||
150192089|NCT03931174|541842767|FG000|Patients|Death|1|||
150192090|NCT03931174|541842768|FG001|Patients|Death|1|||
150192091|NCT03931174|541842767|FG000|Patients|Lost to Follow-up|60|||
150192092|NCT03931174|541842768|FG001|Patients|Lost to Follow-up|89|||
150192093|NCT05386030|541842769|FG000|Overall Study|Death|1|||
150192094|NCT05386030|541842770|FG001|Overall Study|Death|0|||
150192095|NCT05386030|541842769|FG000|Overall Study|Physician Decision|2|||
150192096|NCT05386030|541842770|FG001|Overall Study|Physician Decision|1|||
150192097|NCT05386030|541842769|FG000|Overall Study|Lost to Follow-up|19|||
150192098|NCT05386030|541842770|FG001|Overall Study|Lost to Follow-up|7|||
150192099|NCT05386030|541842769|FG000|Overall Study|Withdrawal by Subject|20|||
150192100|NCT05386030|541842770|FG001|Overall Study|Withdrawal by Subject|10|||
150192101|NCT05386030|541842769|FG000|Overall Study|Eligibility criteria violation|1|||
150192102|NCT05386030|541842770|FG001|Overall Study|Eligibility criteria violation|1|||
150192103|NCT05386030|541842769|FG000|Overall Study|Personal Reasons|1|||
150192104|NCT05386030|541842770|FG001|Overall Study|Personal Reasons|0|||
150192105|NCT05228457|541842771|FG000|Overall Study|Withdrawal by Subject|1|||
150192106|NCT05228457|541842772|FG001|Overall Study|Withdrawal by Subject|1|||
150192107|NCT03213691|541842777|FG000|Overall Study|Adverse Event|2|||
150192108|NCT03213691|541842777|FG000|Overall Study|Death|3|||
150192109|NCT03213691|541842777|FG000|Overall Study|Physician Decision|1|||
150192110|NCT03213691|541842777|FG000|Overall Study|Progressive Disease|14|||
150192111|NCT03213691|541842777|FG000|Overall Study|Ineligible|1|||
150192112|NCT03161028|541842778|FG000|Overall Study|Withdrawal by Subject|6|||
150192113|NCT03161028|541842779|FG001|Overall Study|Withdrawal by Subject|4|||
150192114|NCT03161028|541842778|FG000|Overall Study|Adverse Event|5|||
150192115|NCT03161028|541842779|FG001|Overall Study|Adverse Event|1|||
150192116|NCT03161028|541842778|FG000|Overall Study|Study drug side effects|2|||
150192117|NCT03161028|541842779|FG001|Overall Study|Study drug side effects|2|||
150192118|NCT03161028|541842778|FG000|Overall Study|Administrative PD/UP|4|||
150192119|NCT03161028|541842779|FG001|Overall Study|Administrative PD/UP|2|||
150192120|NCT03161028|541842778|FG000|Overall Study|Lost to Follow-up|2|||
150192121|NCT03161028|541842779|FG001|Overall Study|Lost to Follow-up|0|||
150192122|NCT03161028|541842778|FG000|Overall Study|Unable to comply with procedures|1|||
150192123|NCT03161028|541842779|FG001|Overall Study|Unable to comply with procedures|1|||
150192124|NCT03492216|541842782|FG000|Overall Study|Death|1|||
150192125|NCT03492216|541842783|FG001|Overall Study|Death|0|||
150192126|NCT03492216|541842784|FG002|Overall Study|Death|4|||
150192127|NCT03492216|541842785|FG003|Overall Study|Death|0|||
150192128|NCT03492216|541842782|FG000|Overall Study|Withdrawal by Subject|5|||
150192129|NCT03492216|541842783|FG001|Overall Study|Withdrawal by Subject|3|||
150192130|NCT03492216|541842784|FG002|Overall Study|Withdrawal by Subject|1|||
150192131|NCT03492216|541842785|FG003|Overall Study|Withdrawal by Subject|1|||
150192132|NCT03492216|541842782|FG000|Overall Study|Lost to Follow-up|9|||
150192133|NCT03492216|541842783|FG001|Overall Study|Lost to Follow-up|2|||
150192134|NCT03492216|541842784|FG002|Overall Study|Lost to Follow-up|7|||
150192135|NCT03492216|541842785|FG003|Overall Study|Lost to Follow-up|8|||
150192136|NCT03492216|541842782|FG000|Overall Study|Moved|5|||
150192137|NCT03492216|541842783|FG001|Overall Study|Moved|3|||
150192138|NCT03492216|541842784|FG002|Overall Study|Moved|3|||
150192139|NCT03492216|541842785|FG003|Overall Study|Moved|5|||
150192140|NCT03492216|541842782|FG000|Overall Study|Too ill|0|||
150192141|NCT03492216|541842783|FG001|Overall Study|Too ill|1|||
150192142|NCT03492216|541842784|FG002|Overall Study|Too ill|0|||
150192143|NCT03492216|541842785|FG003|Overall Study|Too ill|0|||
150192144|NCT03492216|541842782|FG000|Overall Study|Incarcerated|0|||
150192145|NCT03492216|541842783|FG001|Overall Study|Incarcerated|0|||
150192146|NCT03492216|541842784|FG002|Overall Study|Incarcerated|2|||
150192147|NCT03492216|541842785|FG003|Overall Study|Incarcerated|0|||
150192148|NCT00736723|541842786|FG000|Overall Study|Withdrawal by Subject|4|||
150192149|NCT00736723|541842787|FG001|Overall Study|Withdrawal by Subject|3|||
150192150|NCT01799265|541842790|FG000|Overall Study|Lost to Follow-up|1|||
150192151|NCT01799265|541842791|FG001|Overall Study|Lost to Follow-up|0|||
150192152|NCT01799265|541842790|FG000|Overall Study|Protocol Violation|2|||
150192153|NCT01799265|541842791|FG001|Overall Study|Protocol Violation|1|||
150192154|NCT01799265|541842790|FG000|Overall Study|inadequate sleep study|0|||
150192155|NCT01799265|541842791|FG001|Overall Study|inadequate sleep study|2|||
150192156|NCT05030233|541842795|FG000|Overall Study|withdrawn for transfer|1|||
150192157|NCT05030233|541842796|FG001|Overall Study|withdrawn for transfer|0|||
150192158|NCT04728347|541844823|FG000|Overall Study|Sponsor decision|0|||
150192159|NCT04728347|541844824|FG001|Overall Study|Sponsor decision|0|||
150120477|NCT01659021|541575561|FG001|Main Study|Physician Decision|16|||
150120478|NCT01659021|541575560|FG000|Main Study|Withdrawal by Subject|19|||
150120479|NCT01659021|541575561|FG001|Main Study|Withdrawal by Subject|16|||
150120480|NCT01659021|541575560|FG000|Main Study|Study Terminated by Sponsor|16|||
150120481|NCT01659021|541575561|FG001|Main Study|Study Terminated by Sponsor|1|||
150120482|NCT01659021|541575560|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
150120483|NCT01659021|541575561|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
150120484|NCT01659021|541575560|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
150120485|NCT01659021|541575561|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
150120486|NCT01114646|541575565|FG000|Overall Study|Withdrawal by Subject|3|||
150120487|NCT01114646|541575566|FG001|Overall Study|Withdrawal by Subject|2|||
150120488|NCT00575588|541575575|FG000|Overall Study|Adverse Event|11|||
150120489|NCT00575588|541575576|FG001|Overall Study|Adverse Event|13|||
150120490|NCT00575588|541575575|FG000|Overall Study|Withdrawal by Subject|27|||
150120491|NCT00575588|541575576|FG001|Overall Study|Withdrawal by Subject|31|||
150120492|NCT00575588|541575575|FG000|Overall Study|Lost to Follow-up|1|||
150120493|NCT00575588|541575576|FG001|Overall Study|Lost to Follow-up|3|||
150120494|NCT00575588|541575575|FG000|Overall Study|Death|4|||
150192160|NCT04728347|541844825|FG002|Overall Study|Sponsor decision|1|||
150192161|NCT04728347|541844826|FG003|Overall Study|Sponsor decision|0|||
150192162|NCT01186367|541844828|FG000|Overall Study|Lost to Follow-up|7|||
150192163|NCT01186367|541844829|FG001|Overall Study|Lost to Follow-up|4|||
150192164|NCT01186367|541844830|FG002|Overall Study|Lost to Follow-up|7|||
150192165|NCT01186367|541844828|FG000|Overall Study|Did not receive study treatment|0|||
150192166|NCT01186367|541844829|FG001|Overall Study|Did not receive study treatment|1|||
150120495|NCT00575588|541575576|FG001|Overall Study|Death|2|||
150192167|NCT01186367|541844830|FG002|Overall Study|Did not receive study treatment|0|||
150192168|NCT02105766|541844832|FG000|Overall Study|Physician Decision|1|||
150192169|NCT02105766|541844833|FG001|Overall Study|Physician Decision|1|||
150192170|NCT02105766|541844834|FG002|Overall Study|Physician Decision|0|||
150192171|NCT02105766|541844832|FG000|Overall Study|Lost to Follow-up|2|||
150192172|NCT02105766|541844833|FG001|Overall Study|Lost to Follow-up|0|||
150192173|NCT02105766|541844834|FG002|Overall Study|Lost to Follow-up|0|||
150192174|NCT02105766|541844832|FG000|Overall Study|Death|1|||
150192175|NCT02105766|541844833|FG001|Overall Study|Death|1|||
150192176|NCT02105766|541844834|FG002|Overall Study|Death|0|||
150192177|NCT03867500|541844835|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
150192178|NCT02985957|541844837|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150192179|NCT02985957|541844838|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150192180|NCT02985957|541844839|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150192181|NCT02985957|541844840|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150192182|NCT02985957|541844841|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
150192183|NCT02985957|541844842|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150192184|NCT02985957|541844843|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
150120496|NCT00575588|541575575|FG000|Overall Study|Incorrect enrollment|8|||
150120497|NCT00575588|541575576|FG001|Overall Study|Incorrect enrollment|4|||
150120498|NCT00575588|541575575|FG000|Overall Study|Study specific discontinuation criteria|203|||
150120499|NCT00575588|541575576|FG001|Overall Study|Study specific discontinuation criteria|218|||
150120500|NCT00575588|541575575|FG000|Overall Study|Severe non-compliance to protocol|5|||
150120501|NCT00575588|541575576|FG001|Overall Study|Severe non-compliance to protocol|7|||
150120502|NCT00575588|541575575|FG000|Overall Study|Safety reasons|2|||
150120503|NCT00575588|541575576|FG001|Overall Study|Safety reasons|1|||
150120504|NCT00575588|541575575|FG000|Overall Study|Elevated triglyceride|1|||
150120505|NCT00575588|541575576|FG001|Overall Study|Elevated triglyceride|0|||
150120506|NCT00575588|541575575|FG000|Overall Study|Patient moved|1|||
150120507|NCT00575588|541575576|FG001|Overall Study|Patient moved|3|||
150120508|NCT00575588|541575575|FG000|Overall Study|Impossible to determine HbA1c|0|||
150120509|NCT00575588|541575576|FG001|Overall Study|Impossible to determine HbA1c|1|||
150120510|NCT01430130|541575577|FG000|Overall Study|Lost to Follow-up|1|||
150120511|NCT01430130|541575577|FG000|Overall Study|Infection on Control Side of Incision|1|||
150120512|NCT03525834|541575578|FG000|Overall Study|Progressive disease|1|||
150120513|NCT00614939|541575584|FG000|Overall Study|Withdrawal by Subject|10|||
150120514|NCT00614939|541575585|FG001|Overall Study|Withdrawal by Subject|17|||
150120515|NCT00614939|541575584|FG000|Overall Study|Study specific discontinuation criteris|13|||
150120516|NCT00614939|541575585|FG001|Overall Study|Study specific discontinuation criteris|16|||
150120517|NCT00614939|541575584|FG000|Overall Study|Adverse Event|2|||
150120518|NCT00614939|541575585|FG001|Overall Study|Adverse Event|5|||
150120519|NCT00614939|541575584|FG000|Overall Study|Incorrect enrollment|1|||
150120520|NCT00614939|541575585|FG001|Overall Study|Incorrect enrollment|2|||
150120521|NCT00614939|541575584|FG000|Overall Study|Death|4|||
150120522|NCT00614939|541575585|FG001|Overall Study|Death|3|||
150120523|NCT00614939|541575584|FG000|Overall Study|Poor/non-compliance|4|||
150120524|NCT00614939|541575585|FG001|Overall Study|Poor/non-compliance|0|||
150120525|NCT00614939|541575584|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
150120526|NCT00614939|541575585|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
150120527|NCT00840970|541575586|FG000|Overall Study|Adverse Event|0|||
150120528|NCT00840970|541575587|FG001|Overall Study|Adverse Event|0|||
150120529|NCT00840970|541575588|FG002|Overall Study|Adverse Event|1|||
150120530|NCT00504829|541575589|FG000|Overall Study|Protocol Violation|6|||
150120531|NCT00504829|541575590|FG001|Overall Study|Protocol Violation|4|||
150120532|NCT00504829|541575591|FG002|Overall Study|Protocol Violation|10|||
150120533|NCT02673697|541575596|FG000|Overall Study|Adverse Event|2|||
150120534|NCT02673697|541575597|FG001|Overall Study|Adverse Event|0|||
150120535|NCT02673697|541575596|FG000|Overall Study|Death|32|||
150120536|NCT02673697|541575597|FG001|Overall Study|Death|24|||
150120537|NCT02673697|541575596|FG000|Overall Study|Lost to Follow-up|5|||
150120538|NCT02673697|541575597|FG001|Overall Study|Lost to Follow-up|2|||
150120539|NCT02673697|541575596|FG000|Overall Study|Physician Decision|2|||
150120540|NCT02673697|541575597|FG001|Overall Study|Physician Decision|1|||
150120541|NCT02673697|541575596|FG000|Overall Study|Withdrawal by Subject|10|||
150192185|NCT02985957|541844837|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
150192186|NCT02985957|541844838|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
150120542|NCT02673697|541575597|FG001|Overall Study|Withdrawal by Subject|7|||
150120543|NCT02673697|541575596|FG000|Overall Study|Change subj medical status|1|||
150120544|NCT02673697|541575597|FG001|Overall Study|Change subj medical status|2|||
150120545|NCT02673697|541575596|FG000|Overall Study|Explant|10|||
150120546|NCT02673697|541575597|FG001|Overall Study|Explant|5|||
150120547|NCT02673697|541575596|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
150192187|NCT02985957|541844839|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
150192188|NCT02985957|541844840|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
150192189|NCT02985957|541844841|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
150120548|NCT02673697|541575597|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
150120549|NCT00437489|541575598|FG000|Overall Study|Study terminated by sponsor|23|||
150120550|NCT00437489|541575599|FG001|Overall Study|Study terminated by sponsor|21|||
150120551|NCT00437489|541575598|FG000|Overall Study|Lost to Follow-up|0|||
150120552|NCT00437489|541575599|FG001|Overall Study|Lost to Follow-up|1|||
150120553|NCT03321981|541575601|FG000|Overall Study|Progressive Disease (PD)|15|||
150120554|NCT03321981|541575602|FG001|Overall Study|Progressive Disease (PD)|30|||
150120555|NCT03321981|541575603|FG002|Overall Study|Progressive Disease (PD)|47|||
150120556|NCT03321981|541575601|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
150120557|NCT03321981|541575602|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
150120558|NCT03321981|541575603|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
150120559|NCT03321981|541575601|FG000|Overall Study|Adverse Event|0|||
150120560|NCT03321981|541575602|FG001|Overall Study|Adverse Event|0|||
150120561|NCT03321981|541575603|FG002|Overall Study|Adverse Event|2|||
150120562|NCT03321981|541575601|FG000|Overall Study|symptomatic deterioration|0|||
150120563|NCT03321981|541575602|FG001|Overall Study|symptomatic deterioration|1|||
150120564|NCT03321981|541575603|FG002|Overall Study|symptomatic deterioration|1|||
150120565|NCT03321981|541575601|FG000|Overall Study|Lack of compliance|0|||
150120566|NCT03321981|541575602|FG001|Overall Study|Lack of compliance|1|||
150120567|NCT03321981|541575603|FG002|Overall Study|Lack of compliance|0|||
150120568|NCT03321981|541575601|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
150120569|NCT03321981|541575602|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
150120570|NCT03321981|541575603|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
150120571|NCT03321981|541575601|FG000|Overall Study|Death|0|||
150120572|NCT03321981|541575602|FG001|Overall Study|Death|1|||
150120573|NCT03321981|541575603|FG002|Overall Study|Death|0|||
150120574|NCT03321981|541575601|FG000|Overall Study|Subject withdrawal of investigational product|0|||
150120575|NCT03321981|541575602|FG001|Overall Study|Subject withdrawal of investigational product|1|||
150120576|NCT03321981|541575603|FG002|Overall Study|Subject withdrawal of investigational product|0|||
150120577|NCT03321981|541575601|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
150120578|NCT03321981|541575602|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
150120579|NCT03321981|541575603|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
150120580|NCT03321981|541575601|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
150120581|NCT03321981|541575602|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
150120582|NCT03321981|541575603|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
150120583|NCT03321019|541575604|FG000|Overall Study|Withdrawal by Subject|0|||
150120584|NCT03321019|541575605|FG001|Overall Study|Withdrawal by Subject|6|||
150120585|NCT03321019|541575604|FG000|Overall Study|Lost to Follow-up|0|||
150120586|NCT03321019|541575605|FG001|Overall Study|Lost to Follow-up|22|||
150120587|NCT02056301|541575610|FG000|Overall Study|Protocol Violation|1|||
150120588|NCT02056301|541575611|FG001|Overall Study|Protocol Violation|2|||
150120589|NCT02056301|541575610|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
150120590|NCT02056301|541575611|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
150120591|NCT02056301|541575610|FG000|Overall Study|Withdrawal by Subject|0|||
150120592|NCT02056301|541575611|FG001|Overall Study|Withdrawal by Subject|1|||
150120593|NCT02056301|541575610|FG000|Overall Study|Issues with epidural|0|||
150120594|NCT02056301|541575611|FG001|Overall Study|Issues with epidural|3|||
150120595|NCT02209324|541575612|FG000|Overall Study|Adverse Event|2|||
150120596|NCT02209324|541575612|FG000|Overall Study|Lack of Efficacy|1|||
150120597|NCT02209324|541575612|FG000|Overall Study|Lost to Follow-up|1|||
150120598|NCT02209324|541575612|FG000|Overall Study|Physician Decision|3|||
150120599|NCT02209324|541575612|FG000|Overall Study|Protocol Violation|14|||
150120600|NCT02209324|541575612|FG000|Overall Study|Withdrawal by Subject|8|||
150120601|NCT02209324|541575612|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
150120602|NCT02209324|541575612|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
150120603|NCT02209324|541575612|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
150120604|NCT03105362|541575613|FG000|Overall Study|Withdrawal by Subject|1|||
150120605|NCT03105362|541575613|FG000|Overall Study|Lost to Follow-up|1|||
150120606|NCT01198600|541575618|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
150120607|NCT01198600|541575619|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
150120608|NCT01198600|541575620|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
150120609|NCT01198600|541575621|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
150120610|NCT01198600|541575618|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
150120611|NCT01198600|541575619|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
150120612|NCT01198600|541575620|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
150120613|NCT01198600|541575621|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
150120614|NCT01198600|541575618|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
150120615|NCT01198600|541575619|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
150120616|NCT01198600|541575620|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
150120617|NCT01198600|541575621|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
150120618|NCT01198600|541575618|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
150120619|NCT01198600|541575619|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
150120620|NCT01198600|541575620|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
150120621|NCT01198600|541575621|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
150120622|NCT01198600|541575618|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
150120623|NCT01198600|541575619|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
150120624|NCT01198600|541575620|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
150120625|NCT01198600|541575621|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
150120626|NCT01198600|541575618|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
150120627|NCT01198600|541575619|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
150120628|NCT01198600|541575620|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
150120629|NCT01198600|541575621|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
150120630|NCT01198600|541575618|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
150120631|NCT01198600|541575619|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
150120632|NCT01198600|541575620|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
150120633|NCT01198600|541575621|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
150120634|NCT01785602|541575622|FG000|Overall Study|Withdrawal by Subject|2|||
150120635|NCT01785602|541575623|FG001|Overall Study|Withdrawal by Subject|0|||
150120636|NCT01785602|541575622|FG000|Overall Study|Lost to Follow-up|1|||
150120637|NCT01785602|541575623|FG001|Overall Study|Lost to Follow-up|1|||
150120638|NCT01785602|541575622|FG000|Overall Study|Adverse Event|3|||
150120639|NCT01785602|541575623|FG001|Overall Study|Adverse Event|5|||
150120640|NCT01785602|541575622|FG000|Overall Study|Administrative problems|7|||
150120641|NCT01785602|541575623|FG001|Overall Study|Administrative problems|3|||
150120642|NCT04177108|541575625|FG000|Overall Study|Withdrawal by Subject|4|||
150120643|NCT04177108|541575626|FG001|Overall Study|Withdrawal by Subject|8|||
150120644|NCT04177108|541575627|FG002|Overall Study|Withdrawal by Subject|9|||
150120645|NCT04177108|541575628|FG003|Overall Study|Withdrawal by Subject|11|||
150120646|NCT04177108|541575629|FG004|Overall Study|Withdrawal by Subject|13|||
150120647|NCT04177108|541575625|FG000|Overall Study|Physician Decision|23|||
150120648|NCT04177108|541575626|FG001|Overall Study|Physician Decision|15|||
150120649|NCT04177108|541575627|FG002|Overall Study|Physician Decision|18|||
150120650|NCT04177108|541575628|FG003|Overall Study|Physician Decision|29|||
150120651|NCT04177108|541575629|FG004|Overall Study|Physician Decision|23|||
150120652|NCT04177108|541575625|FG000|Overall Study|Reason Not Specified|0|||
150120653|NCT04177108|541575626|FG001|Overall Study|Reason Not Specified|1|||
150120654|NCT04177108|541575627|FG002|Overall Study|Reason Not Specified|0|||
150120655|NCT04177108|541575628|FG003|Overall Study|Reason Not Specified|0|||
150120656|NCT04177108|541575629|FG004|Overall Study|Reason Not Specified|2|||
150120657|NCT04177108|541575625|FG000|Overall Study|Lost to Follow-up|0|||
150120658|NCT04177108|541575626|FG001|Overall Study|Lost to Follow-up|0|||
150120659|NCT04177108|541575627|FG002|Overall Study|Lost to Follow-up|1|||
150120660|NCT04177108|541575628|FG003|Overall Study|Lost to Follow-up|1|||
150120661|NCT04177108|541575629|FG004|Overall Study|Lost to Follow-up|1|||
150120662|NCT04177108|541575625|FG000|Overall Study|Death|16|||
150120663|NCT04177108|541575626|FG001|Overall Study|Death|19|||
150120664|NCT04177108|541575627|FG002|Overall Study|Death|13|||
150120665|NCT04177108|541575628|FG003|Overall Study|Death|17|||
150120666|NCT04177108|541575629|FG004|Overall Study|Death|18|||
150120667|NCT02041429|541575632|FG000|Overall Study|Progressive Disease|2|||
150120668|NCT02041429|541575633|FG001|Overall Study|Progressive Disease|2|||
150120669|NCT02041429|541575634|FG002|Overall Study|Progressive Disease|3|||
150120670|NCT02041429|541575635|FG003|Overall Study|Progressive Disease|2|||
150120671|NCT02041429|541575632|FG000|Overall Study|Toxicity|0|||
150120672|NCT02041429|541575633|FG001|Overall Study|Toxicity|1|||
150120673|NCT02041429|541575634|FG002|Overall Study|Toxicity|4|||
150120674|NCT02041429|541575635|FG003|Overall Study|Toxicity|2|||
150120675|NCT02041429|541575632|FG000|Overall Study|Withdrawal by Subject|0|||
150120676|NCT02041429|541575633|FG001|Overall Study|Withdrawal by Subject|1|||
150120677|NCT02041429|541575634|FG002|Overall Study|Withdrawal by Subject|0|||
150120678|NCT02041429|541575635|FG003|Overall Study|Withdrawal by Subject|0|||
150120679|NCT02041429|541575632|FG000|Overall Study|On Maintenance Therapy|1|||
150120680|NCT02041429|541575633|FG001|Overall Study|On Maintenance Therapy|0|||
150192190|NCT02985957|541844842|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
150120681|NCT02041429|541575634|FG002|Overall Study|On Maintenance Therapy|0|||
150120682|NCT02041429|541575635|FG003|Overall Study|On Maintenance Therapy|2|||
150120683|NCT01427712|541575636|FG000|Overall Study|Transfer to a different hospital|2|||
150120684|NCT01427712|541575636|FG000|Overall Study|Lost to Follow-up|1|||
150192191|NCT02985957|541844843|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
150120685|NCT01427712|541575636|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
150120686|NCT01427712|541575636|FG000|Overall Study|Failure to visit|1|||
150120687|NCT00784043|541575637|FG000|Overall Study|Withdrawal by Subject|8|||
150120688|NCT00784043|541575638|FG001|Overall Study|Withdrawal by Subject|5|||
150120689|NCT00784043|541575637|FG000|Overall Study|Protocol Terminated|23|||
150120690|NCT00784043|541575638|FG001|Overall Study|Protocol Terminated|1|||
150120691|NCT01143259|541575639|FG000|Overall Study|Withdrawal by Subject|3|||
150120692|NCT01143259|541575640|FG001|Overall Study|Withdrawal by Subject|2|||
150120693|NCT01143259|541575639|FG000|Overall Study|Protocol Violation|13|||
150120694|NCT01143259|541575640|FG001|Overall Study|Protocol Violation|9|||
150120695|NCT01143259|541575639|FG000|Overall Study|Screen Failure|7|||
150120696|NCT01143259|541575640|FG001|Overall Study|Screen Failure|9|||
150120697|NCT03791398|541575641|FG000|Overall Study|Progression of Disease Under Study|2|||
150120698|NCT03791398|541575642|FG001|Overall Study|Progression of Disease Under Study|0|||
150120699|NCT03791398|541575643|FG002|Overall Study|Progression of Disease Under Study|0|||
150120700|NCT00766376|541575646|FG000|Overall Study|Withdrawal by Subject|27|||
150120701|NCT02207829|541575647|FG000|Overall Study|Adverse Event|10|||
150120702|NCT02207829|541575648|FG001|Overall Study|Adverse Event|9|||
150120703|NCT02207829|541575647|FG000|Overall Study|Lack of Efficacy|7|||
150120704|NCT02207829|541575648|FG001|Overall Study|Lack of Efficacy|5|||
150120705|NCT02207829|541575647|FG000|Overall Study|Lost to Follow-up|2|||
150120706|NCT02207829|541575648|FG001|Overall Study|Lost to Follow-up|2|||
150120707|NCT02207829|541575647|FG000|Overall Study|Protocol deviation|5|||
150120708|NCT02207829|541575648|FG001|Overall Study|Protocol deviation|4|||
150120709|NCT02207829|541575647|FG000|Overall Study|Withdrew consent|18|||
150120710|NCT02207829|541575648|FG001|Overall Study|Withdrew consent|14|||
150120711|NCT00101101|541575649|FG000|Overall Study|never received vaccine|20|||
150120712|NCT01800903|541575650|FG000|Second Test Period|unable to catheterise|1|||
150120713|NCT01800903|541575651|FG001|Second Test Period|unable to catheterise|0|||
150120714|NCT01800903|541575652|FG002|Second Test Period|unable to catheterise|0|||
150120715|NCT01800903|541575653|FG003|Second Test Period|unable to catheterise|0|||
150120716|NCT01800903|541575654|FG004|Second Test Period|unable to catheterise|0|||
150120717|NCT01800903|541575655|FG005|Second Test Period|unable to catheterise|0|||
150120718|NCT00852397|541575657|FG000|Overall Study|Adverse Event|4|||
150120719|NCT00852397|541575658|FG001|Overall Study|Adverse Event|6|||
150120720|NCT00852397|541575659|FG002|Overall Study|Adverse Event|4|||
150120721|NCT00852397|541575657|FG000|Overall Study|Death|0|||
150120722|NCT00852397|541575658|FG001|Overall Study|Death|0|||
150120723|NCT00852397|541575659|FG002|Overall Study|Death|1|||
150120724|NCT00852397|541575657|FG000|Overall Study|Withdrawal by Subject|4|||
150120725|NCT00852397|541575658|FG001|Overall Study|Withdrawal by Subject|1|||
150120726|NCT00852397|541575659|FG002|Overall Study|Withdrawal by Subject|2|||
150120727|NCT00852397|541575657|FG000|Overall Study|Study terminated by sponsor|2|||
150120728|NCT00852397|541575658|FG001|Overall Study|Study terminated by sponsor|1|||
150120729|NCT00852397|541575659|FG002|Overall Study|Study terminated by sponsor|6|||
150120730|NCT00852397|541575657|FG000|Overall Study|Difficulty in study site visit|1|||
150120731|NCT00852397|541575658|FG001|Overall Study|Difficulty in study site visit|0|||
150120732|NCT00852397|541575659|FG002|Overall Study|Difficulty in study site visit|0|||
150120733|NCT00852397|541575657|FG000|Overall Study|Protocol Violation|0|||
150120734|NCT00852397|541575658|FG001|Overall Study|Protocol Violation|0|||
150120735|NCT00852397|541575659|FG002|Overall Study|Protocol Violation|1|||
150120736|NCT01968434|541575665|FG000|Overall Study|Lost to Follow-up|3|||
150120737|NCT01968434|541575666|FG001|Overall Study|Lost to Follow-up|6|||
150120738|NCT00428610|541575667|FG000|Overall Study|Death Due to Adverse Event|3|||
150120739|NCT00428610|541575668|FG001|Overall Study|Death Due to Adverse Event|0|||
150120740|NCT00428610|541575669|FG002|Overall Study|Death Due to Adverse Event|5|||
150120741|NCT00428610|541575667|FG000|Overall Study|Death Due to Progressive Disease|0|||
150120742|NCT00428610|541575668|FG001|Overall Study|Death Due to Progressive Disease|0|||
150120743|NCT00428610|541575669|FG002|Overall Study|Death Due to Progressive Disease|2|||
150120744|NCT00428610|541575667|FG000|Overall Study|Adverse Event|2|||
150120745|NCT00428610|541575668|FG001|Overall Study|Adverse Event|3|||
150120746|NCT00428610|541575669|FG002|Overall Study|Adverse Event|2|||
150120747|NCT00428610|541575667|FG000|Overall Study|Investigator Decision|2|||
150120748|NCT00428610|541575668|FG001|Overall Study|Investigator Decision|1|||
150120749|NCT00428610|541575669|FG002|Overall Study|Investigator Decision|1|||
150120750|NCT00428610|541575667|FG000|Overall Study|Progressive Disease|42|||
150120751|NCT00428610|541575668|FG001|Overall Study|Progressive Disease|14|||
150120752|NCT00428610|541575669|FG002|Overall Study|Progressive Disease|22|||
150120753|NCT00428610|541575667|FG000|Overall Study|Withdrawal by Subject|4|||
150120754|NCT00428610|541575668|FG001|Overall Study|Withdrawal by Subject|0|||
150120755|NCT00428610|541575669|FG002|Overall Study|Withdrawal by Subject|0|||
150120756|NCT02280044|541577676|FG000|Overall Study|Planned alternate|0|||
150120757|NCT02280044|541577677|FG001|Overall Study|Planned alternate|2|||
150120758|NCT02105116|541577678|FG000|Overall Study|not eligible for step 2 of trial|5|||
150120759|NCT02105116|541577678|FG000|Overall Study|Death|1|||
150120760|NCT04837482|541577679|FG000|Period 2|Withdrawal by Subject|0|||
150120761|NCT04837482|541577680|FG001|Period 2|Withdrawal by Subject|1|||
150120762|NCT00987467|541577681|FG000|Overall Study|Lost to Follow-up|2|||
150120763|NCT02646423|541577682|FG000|Overall Study|Adverse Event|5|||
150120764|NCT02646423|541577683|FG001|Overall Study|Adverse Event|7|||
150120765|NCT02646423|541577682|FG000|Overall Study|Ineligible|2|||
150120766|NCT02646423|541577683|FG001|Overall Study|Ineligible|1|||
150120767|NCT00086346|541577684|FG000|Randomization|Did not receive test article|4|||
150120768|NCT00086346|541577685|FG001|Randomization|Did not receive test article|4|||
150120769|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Adverse Event|94|||
150120770|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Adverse Event|11|||
150120771|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
150120772|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
150120773|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
150120774|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
150120775|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
150120776|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
150120777|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
150120778|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
150120779|NCT00086346|541577684|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
150120780|NCT00086346|541577685|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
150120781|NCT02352493|541577689|FG000|Overall Study|Pregnancy|0|||
150120782|NCT02352493|541577690|FG001|Overall Study|Pregnancy|0|||
150120783|NCT02352493|541577691|FG002|Overall Study|Pregnancy|0|||
150120784|NCT02352493|541577692|FG003|Overall Study|Pregnancy|0|||
150120785|NCT02352493|541577693|FG004|Overall Study|Pregnancy|0|||
150120786|NCT02352493|541577694|FG005|Overall Study|Pregnancy|0|||
150120787|NCT02352493|541577695|FG006|Overall Study|Pregnancy|1|||
150120788|NCT02352493|541577696|FG007|Overall Study|Pregnancy|0|||
150120789|NCT02352493|541577697|FG008|Overall Study|Pregnancy|1|||
150120790|NCT02352493|541577698|FG009|Overall Study|Pregnancy|0|||
150120791|NCT02352493|541577699|FG010|Overall Study|Pregnancy|0|||
150120792|NCT02352493|541577700|FG011|Overall Study|Pregnancy|0|||
150120793|NCT02352493|541577701|FG012|Overall Study|Pregnancy|0|||
150120794|NCT02352493|541577702|FG013|Overall Study|Pregnancy|0|||
150120795|NCT02352493|541577703|FG014|Overall Study|Pregnancy|0|||
150120796|NCT02352493|541577704|FG015|Overall Study|Pregnancy|0|||
150120797|NCT02352493|541577705|FG016|Overall Study|Pregnancy|0|||
150120798|NCT02352493|541577706|FG017|Overall Study|Pregnancy|0|||
150120799|NCT02352493|541577689|FG000|Overall Study|Withdrawal by Subject|0|||
150120800|NCT02352493|541577690|FG001|Overall Study|Withdrawal by Subject|0|||
150120801|NCT02352493|541577691|FG002|Overall Study|Withdrawal by Subject|0|||
150120802|NCT02352493|541577692|FG003|Overall Study|Withdrawal by Subject|0|||
150120803|NCT02352493|541577693|FG004|Overall Study|Withdrawal by Subject|0|||
150120804|NCT02352493|541577694|FG005|Overall Study|Withdrawal by Subject|0|||
150120805|NCT02352493|541577695|FG006|Overall Study|Withdrawal by Subject|0|||
150120806|NCT02352493|541577696|FG007|Overall Study|Withdrawal by Subject|0|||
150120807|NCT02352493|541577697|FG008|Overall Study|Withdrawal by Subject|1|||
150120808|NCT02352493|541577698|FG009|Overall Study|Withdrawal by Subject|0|||
150120809|NCT02352493|541577699|FG010|Overall Study|Withdrawal by Subject|0|||
150120810|NCT02352493|541577700|FG011|Overall Study|Withdrawal by Subject|0|||
150120811|NCT02352493|541577701|FG012|Overall Study|Withdrawal by Subject|0|||
150120812|NCT02352493|541577702|FG013|Overall Study|Withdrawal by Subject|0|||
150120813|NCT02352493|541577703|FG014|Overall Study|Withdrawal by Subject|1|||
150120814|NCT02352493|541577704|FG015|Overall Study|Withdrawal by Subject|0|||
150120815|NCT02352493|541577705|FG016|Overall Study|Withdrawal by Subject|0|||
150120816|NCT02352493|541577706|FG017|Overall Study|Withdrawal by Subject|0|||
150120817|NCT02352493|541577689|FG000|Overall Study|Lost to Follow-up|0|||
150120818|NCT02352493|541577690|FG001|Overall Study|Lost to Follow-up|0|||
150120819|NCT02352493|541577691|FG002|Overall Study|Lost to Follow-up|0|||
150120820|NCT02352493|541577692|FG003|Overall Study|Lost to Follow-up|0|||
150120821|NCT02352493|541577693|FG004|Overall Study|Lost to Follow-up|0|||
150120822|NCT02352493|541577694|FG005|Overall Study|Lost to Follow-up|0|||
150120823|NCT02352493|541577695|FG006|Overall Study|Lost to Follow-up|0|||
150120824|NCT02352493|541577696|FG007|Overall Study|Lost to Follow-up|0|||
150120825|NCT02352493|541577697|FG008|Overall Study|Lost to Follow-up|0|||
150120826|NCT02352493|541577698|FG009|Overall Study|Lost to Follow-up|1|||
150120827|NCT02352493|541577699|FG010|Overall Study|Lost to Follow-up|0|||
150120828|NCT02352493|541577700|FG011|Overall Study|Lost to Follow-up|0|||
150120829|NCT02352493|541577701|FG012|Overall Study|Lost to Follow-up|1|||
150120830|NCT02352493|541577702|FG013|Overall Study|Lost to Follow-up|2|||
150120831|NCT02352493|541577703|FG014|Overall Study|Lost to Follow-up|0|||
150120832|NCT02352493|541577704|FG015|Overall Study|Lost to Follow-up|0|||
150120833|NCT02352493|541577705|FG016|Overall Study|Lost to Follow-up|0|||
150120834|NCT02352493|541577706|FG017|Overall Study|Lost to Follow-up|0|||
150120835|NCT02162810|541577707|FG000|Overall Study|Protocol Violation|1|||
150120836|NCT02162810|541577708|FG001|Overall Study|Protocol Violation|0|||
150120837|NCT02162810|541577707|FG000|Overall Study|patients did not report compliance|4|||
150120838|NCT02162810|541577708|FG001|Overall Study|patients did not report compliance|1|||
150120839|NCT02546544|541577713|FG000|Overall Study|Disease Progression|14|||
150120840|NCT02546544|541577713|FG000|Overall Study|Adverse Event|1|||
150120841|NCT02546544|541577713|FG000|Overall Study|Withdrawal by Subject|1|||
150120842|NCT01921348|541577714|FG000|Overall Study|Withdrawal by Subject|1|||
150120843|NCT01921348|541577715|FG001|Overall Study|Withdrawal by Subject|0|||
150120844|NCT01921348|541577714|FG000|Overall Study|Lost to Follow-up|0|||
150120845|NCT01921348|541577715|FG001|Overall Study|Lost to Follow-up|2|||
150120846|NCT02223390|541577716|FG000|Overall Study|Lost to Follow-up|9|||
150120847|NCT02223390|541577717|FG001|Overall Study|Lost to Follow-up|4|||
150120848|NCT01465334|541577718|FG000|Overall Study|Disease Progression|1|||
150120849|NCT01465334|541577719|FG001|Overall Study|Disease Progression|0|||
150120850|NCT01465334|541577718|FG000|Overall Study|Adverse Event|1|||
150120851|NCT01465334|541577719|FG001|Overall Study|Adverse Event|0|||
150120852|NCT01465334|541577718|FG000|Overall Study|Richter's transformation|0|||
150120853|NCT01465334|541577719|FG001|Overall Study|Richter's transformation|3|||
150120854|NCT01465334|541577718|FG000|Overall Study|Refractory Disease|0|||
150120855|NCT01465334|541577719|FG001|Overall Study|Refractory Disease|3|||
150120856|NCT00795600|541577724|FG000|Overall Study|Adverse Event|1|||
150120857|NCT00795600|541577725|FG001|Overall Study|Adverse Event|1|||
150120858|NCT00795600|541577724|FG000|Overall Study|Protocol Violation|1|||
150120859|NCT00795600|541577725|FG001|Overall Study|Protocol Violation|2|||
150120860|NCT00795600|541577724|FG000|Overall Study|Withdrawal by Subject|1|||
150120861|NCT00795600|541577725|FG001|Overall Study|Withdrawal by Subject|0|||
150120862|NCT00795600|541577724|FG000|Overall Study|Unclassified|1|||
150120863|NCT00795600|541577725|FG001|Overall Study|Unclassified|1|||
150120864|NCT03936244|541577726|FG000|Overall Study|Lost to Follow-up|5|||
150120865|NCT03936244|541577727|FG001|Overall Study|Lost to Follow-up|1|||
150120866|NCT03936244|541577726|FG000|Overall Study|Physician Decision|7|||
150120867|NCT03936244|541577727|FG001|Overall Study|Physician Decision|3|||
150120868|NCT01248884|541577728|FG000|Overall Study|Withdrawal by Subject|1|||
150120869|NCT01248884|541577729|FG001|Overall Study|Withdrawal by Subject|3|||
150120870|NCT01248884|541577730|FG002|Overall Study|Withdrawal by Subject|1|||
150120871|NCT01248884|541577728|FG000|Overall Study|Adverse Event|1|||
150120872|NCT01248884|541577729|FG001|Overall Study|Adverse Event|0|||
150120873|NCT01248884|541577730|FG002|Overall Study|Adverse Event|0|||
150120874|NCT01202773|541577731|FG000|Overall Study|Adverse Event|4|||
150120875|NCT01202773|541577732|FG001|Overall Study|Adverse Event|5|||
150120876|NCT01202773|541577733|FG002|Overall Study|Adverse Event|5|||
150120877|NCT01202773|541577731|FG000|Overall Study|Lack of Efficacy|5|||
150120878|NCT01202773|541577732|FG001|Overall Study|Lack of Efficacy|4|||
150120879|NCT01202773|541577733|FG002|Overall Study|Lack of Efficacy|9|||
150120880|NCT01202773|541577731|FG000|Overall Study|Entry Criteria Not Met|2|||
150120881|NCT01202773|541577732|FG001|Overall Study|Entry Criteria Not Met|0|||
150120882|NCT01202773|541577733|FG002|Overall Study|Entry Criteria Not Met|1|||
150120883|NCT01202773|541577731|FG000|Overall Study|Lost to Follow-up|1|||
150120884|NCT01202773|541577732|FG001|Overall Study|Lost to Follow-up|2|||
150120885|NCT01202773|541577733|FG002|Overall Study|Lost to Follow-up|2|||
150120886|NCT01202773|541577731|FG000|Overall Study|Withdrawal by Subject|13|||
150120887|NCT01202773|541577732|FG001|Overall Study|Withdrawal by Subject|6|||
150120888|NCT01202773|541577733|FG002|Overall Study|Withdrawal by Subject|5|||
150120889|NCT01202773|541577731|FG000|Overall Study|Physician Decision|2|||
150120890|NCT01202773|541577732|FG001|Overall Study|Physician Decision|0|||
150120891|NCT01202773|541577733|FG002|Overall Study|Physician Decision|0|||
150120892|NCT01202773|541577731|FG000|Overall Study|Protocol Violation|11|||
150120893|NCT01202773|541577732|FG001|Overall Study|Protocol Violation|6|||
150120894|NCT01202773|541577733|FG002|Overall Study|Protocol Violation|10|||
150120895|NCT01202773|541577731|FG000|Overall Study|Sponsor Decision|19|||
150120896|NCT01202773|541577732|FG001|Overall Study|Sponsor Decision|20|||
150120897|NCT01202773|541577733|FG002|Overall Study|Sponsor Decision|23|||
150120898|NCT00462384|541577734|FG000|Overall Study|Adverse Event|2|||
150120899|NCT00462384|541577734|FG000|Overall Study|Death|2|||
150120900|NCT00462384|541577734|FG000|Overall Study|Withdrawal by Subject|1|||
150120901|NCT00462384|541577734|FG000|Overall Study|Other|4|||
150192192|NCT02985957|541844837|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150192193|NCT02985957|541844838|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150120902|NCT01131312|541577735|FG000|Overall Study|Lost to Follow-up|425|||
150120903|NCT01131312|541577736|FG001|Overall Study|Lost to Follow-up|229|||
150120904|NCT01131312|541577737|FG002|Overall Study|Lost to Follow-up|351|||
150120905|NCT03879798|541577750|FG000|Overall Study|Adverse Event|0|||
150120906|NCT03879798|541577751|FG001|Overall Study|Adverse Event|0|||
150120907|NCT03879798|541577752|FG002|Overall Study|Adverse Event|0|||
150120908|NCT03879798|541577753|FG003|Overall Study|Adverse Event|0|||
150120909|NCT03879798|541577754|FG004|Overall Study|Adverse Event|0|||
150120910|NCT03879798|541577755|FG005|Overall Study|Adverse Event|1|||
150120911|NCT03879798|541577750|FG000|Overall Study|Lack of Efficacy|0|||
150120912|NCT03879798|541577751|FG001|Overall Study|Lack of Efficacy|0|||
150120913|NCT03879798|541577752|FG002|Overall Study|Lack of Efficacy|0|||
150120914|NCT03879798|541577753|FG003|Overall Study|Lack of Efficacy|0|||
150120915|NCT03879798|541577754|FG004|Overall Study|Lack of Efficacy|0|||
150120916|NCT03879798|541577755|FG005|Overall Study|Lack of Efficacy|1|||
150120917|NCT03879798|541577750|FG000|Overall Study|Withdrawal by Subject|0|||
150120918|NCT03879798|541577751|FG001|Overall Study|Withdrawal by Subject|0|||
150120919|NCT03879798|541577752|FG002|Overall Study|Withdrawal by Subject|0|||
150120920|NCT03879798|541577753|FG003|Overall Study|Withdrawal by Subject|0|||
150120921|NCT03879798|541577754|FG004|Overall Study|Withdrawal by Subject|0|||
150120922|NCT03879798|541577755|FG005|Overall Study|Withdrawal by Subject|1|||
150120923|NCT01343407|541577756|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
150120924|NCT01343407|541577757|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
150120925|NCT01343407|541577758|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
150120926|NCT01343407|541577759|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
150120927|NCT01343407|541577760|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
150120928|NCT01343407|541577761|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
150120929|NCT01343407|541577756|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
150120930|NCT01343407|541577757|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
150120931|NCT01343407|541577758|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
150120932|NCT01343407|541577759|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
150120933|NCT01343407|541577760|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
150120934|NCT01343407|541577761|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
150120935|NCT04079933|541577763|FG000|Overall Study|Withdrawal by Subject|3|||
150120936|NCT04079933|541577764|FG001|Overall Study|Withdrawal by Subject|4|||
150120937|NCT04079933|541577763|FG000|Overall Study|Lost to Follow-up|0|||
150120938|NCT04079933|541577764|FG001|Overall Study|Lost to Follow-up|1|||
150120939|NCT01986829|541577765|FG000|Overall Study|Death|1|||
150120940|NCT02504866|541577766|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
150120941|NCT02504866|541577767|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
150120942|NCT02504866|541577768|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
150120943|NCT01229436|541577769|FG000|Overall Study|Withdrawal by Subject|2|||
150120944|NCT01229436|541577769|FG000|Overall Study|Lost to Follow-up|3|||
150120945|NCT01775137|541577770|FG000|Overall Study|Death|1|||
150120946|NCT01775137|541577770|FG000|Overall Study|Protocol deviation|2|||
150120947|NCT01775137|541577770|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150120948|NCT01775137|541577770|FG000|Overall Study|Adverse Event|1|||
150120949|NCT01775137|541577770|FG000|Overall Study|Withdrawal by participants|5|||
150120950|NCT03231371|541577772|FG000|Overall Study|Withdrawal by Subject|1|||
150120951|NCT03231371|541577772|FG000|Overall Study|chose or were ineligible to have MRI|12|||
150120952|NCT00022516|541577780|FG000|Overall Study|Adverse Event|0|||
150120953|NCT00022516|541577781|FG001|Overall Study|Adverse Event|59|||
150120954|NCT00022516|541577780|FG000|Overall Study|Lack of Efficacy|0|||
150120955|NCT00022516|541577781|FG001|Overall Study|Lack of Efficacy|27|||
150120956|NCT00022516|541577780|FG000|Overall Study|Physician Decision|0|||
150120957|NCT00022516|541577781|FG001|Overall Study|Physician Decision|1|||
150120958|NCT00022516|541577780|FG000|Overall Study|Protocol Violation|1|||
150120959|NCT00022516|541577781|FG001|Overall Study|Protocol Violation|3|||
150120960|NCT00022516|541577780|FG000|Overall Study|Withdrawal by Subject|2|||
150120961|NCT00022516|541577781|FG001|Overall Study|Withdrawal by Subject|113|||
150120962|NCT00022516|541577780|FG000|Overall Study|Incomplete documentation|0|||
150120963|NCT00022516|541577781|FG001|Overall Study|Incomplete documentation|27|||
150120964|NCT03067441|541577782|FG000|Overall Study|Withdrawal by Subject|16|||
150120965|NCT03067441|541577783|FG001|Overall Study|Withdrawal by Subject|34|||
150120966|NCT03067441|541577782|FG000|Overall Study|Lost to Follow-up|7|||
150120967|NCT03067441|541577783|FG001|Overall Study|Lost to Follow-up|5|||
150120968|NCT03067441|541577782|FG000|Overall Study|Adverse Event|7|||
150120969|NCT03067441|541577783|FG001|Overall Study|Adverse Event|14|||
150120970|NCT03067441|541577782|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
150120971|NCT03067441|541577783|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
150120972|NCT03067441|541577782|FG000|Overall Study|Physician Decision|1|||
150120973|NCT03067441|541577783|FG001|Overall Study|Physician Decision|3|||
150120974|NCT03067441|541577782|FG000|Overall Study|Other|1|||
150120975|NCT03067441|541577783|FG001|Overall Study|Other|1|||
150120976|NCT01985126|541577793|FG000|Overall Study|Death|15|||
150120977|NCT01985126|541577794|FG001|Overall Study|Death|69|||
150120978|NCT01985126|541577793|FG000|Overall Study|Lost to Follow-up|0|||
150120979|NCT01985126|541577794|FG001|Overall Study|Lost to Follow-up|8|||
150120980|NCT01985126|541577793|FG000|Overall Study|Study Terminated By Sponsor|1|||
150120981|NCT01985126|541577794|FG001|Overall Study|Study Terminated By Sponsor|22|||
150120982|NCT01985126|541577793|FG000|Overall Study|Withdrawal by Subject|2|||
150120983|NCT01985126|541577794|FG001|Overall Study|Withdrawal by Subject|7|||
150120984|NCT05799495|541577797|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
150192194|NCT02985957|541844839|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150192195|NCT02985957|541844840|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150192196|NCT02985957|541844841|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150192197|NCT02985957|541844842|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
150192198|NCT02985957|541844843|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
150192199|NCT02985957|541844837|FG000|Treatment Period|Death|0|||
150192200|NCT02985957|541844838|FG001|Treatment Period|Death|0|||
150192201|NCT02985957|541844839|FG002|Treatment Period|Death|0|||
150192202|NCT02985957|541844840|FG003|Treatment Period|Death|0|||
150192203|NCT02985957|541844841|FG004|Treatment Period|Death|1|||
150192204|NCT02985957|541844842|FG005|Treatment Period|Death|0|||
150192205|NCT02985957|541844843|FG006|Treatment Period|Death|0|||
150192206|NCT02985957|541844837|FG000|Treatment Period|Participant withdrew consent|0|||
150192207|NCT02985957|541844838|FG001|Treatment Period|Participant withdrew consent|0|||
150192208|NCT02985957|541844839|FG002|Treatment Period|Participant withdrew consent|0|||
150192209|NCT02985957|541844840|FG003|Treatment Period|Participant withdrew consent|1|||
150192210|NCT02985957|541844841|FG004|Treatment Period|Participant withdrew consent|3|||
150192211|NCT02985957|541844842|FG005|Treatment Period|Participant withdrew consent|0|||
150192212|NCT02985957|541844843|FG006|Treatment Period|Participant withdrew consent|1|||
150192213|NCT02985957|541844837|FG000|Treatment Period|Lost to Follow-up|0|||
150192214|NCT02985957|541844838|FG001|Treatment Period|Lost to Follow-up|0|||
150192215|NCT02985957|541844839|FG002|Treatment Period|Lost to Follow-up|0|||
150192216|NCT02985957|541844840|FG003|Treatment Period|Lost to Follow-up|0|||
150192217|NCT02985957|541844841|FG004|Treatment Period|Lost to Follow-up|1|||
150192218|NCT02985957|541844842|FG005|Treatment Period|Lost to Follow-up|0|||
150192219|NCT02985957|541844843|FG006|Treatment Period|Lost to Follow-up|0|||
150192220|NCT02985957|541844837|FG000|Treatment Period|Other reasons|0|||
150192221|NCT02985957|541844838|FG001|Treatment Period|Other reasons|0|||
150192222|NCT02985957|541844839|FG002|Treatment Period|Other reasons|1|||
150192223|NCT02985957|541844840|FG003|Treatment Period|Other reasons|3|||
150192224|NCT02985957|541844841|FG004|Treatment Period|Other reasons|6|||
150192225|NCT02985957|541844842|FG005|Treatment Period|Other reasons|0|||
150192226|NCT02985957|541844843|FG006|Treatment Period|Other reasons|1|||
150192227|NCT02985957|541844837|FG000|Treatment Period|Not reported|0|||
150192228|NCT02985957|541844838|FG001|Treatment Period|Not reported|1|||
150192229|NCT02985957|541844839|FG002|Treatment Period|Not reported|2|||
150192230|NCT02985957|541844840|FG003|Treatment Period|Not reported|5|||
150192231|NCT02985957|541844841|FG004|Treatment Period|Not reported|0|||
150192232|NCT02985957|541844842|FG005|Treatment Period|Not reported|0|||
150192233|NCT02985957|541844843|FG006|Treatment Period|Not reported|0|||
150192234|NCT02985957|541844837|FG000|Treatment Period|Maximum clinical benefit|0|||
150192235|NCT02985957|541844838|FG001|Treatment Period|Maximum clinical benefit|0|||
150192236|NCT02985957|541844839|FG002|Treatment Period|Maximum clinical benefit|1|||
150192237|NCT02985957|541844840|FG003|Treatment Period|Maximum clinical benefit|1|||
150192238|NCT02985957|541844841|FG004|Treatment Period|Maximum clinical benefit|0|||
150192239|NCT02985957|541844842|FG005|Treatment Period|Maximum clinical benefit|0|||
150192240|NCT02985957|541844843|FG006|Treatment Period|Maximum clinical benefit|2|||
150192241|NCT02985957|541844837|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
150192242|NCT02985957|541844838|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
150192243|NCT02985957|541844839|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
150192244|NCT02985957|541844840|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
150192245|NCT02985957|541844841|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
150192246|NCT02985957|541844842|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
150192247|NCT02985957|541844843|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
150192248|NCT02985957|541844837|FG000|Treatment Period|Study drug toxicity|1|||
150192249|NCT02985957|541844838|FG001|Treatment Period|Study drug toxicity|23|||
150192250|NCT02985957|541844839|FG002|Treatment Period|Study drug toxicity|20|||
150192251|NCT02985957|541844840|FG003|Treatment Period|Study drug toxicity|11|||
150192252|NCT02985957|541844841|FG004|Treatment Period|Study drug toxicity|19|||
150192253|NCT02985957|541844842|FG005|Treatment Period|Study drug toxicity|3|||
150192254|NCT02985957|541844843|FG006|Treatment Period|Study drug toxicity|5|||
150192255|NCT02985957|541844837|FG000|Treatment Period|Disease progression|0|||
150192256|NCT02985957|541844838|FG001|Treatment Period|Disease progression|16|||
150192257|NCT02985957|541844839|FG002|Treatment Period|Disease progression|20|||
150192258|NCT02985957|541844840|FG003|Treatment Period|Disease progression|39|||
150192259|NCT02985957|541844841|FG004|Treatment Period|Disease progression|29|||
150192260|NCT02985957|541844842|FG005|Treatment Period|Disease progression|11|||
150192261|NCT02985957|541844843|FG006|Treatment Period|Disease progression|28|||
150192262|NCT02985957|541844837|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
150192263|NCT02985957|541844838|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
150192264|NCT02985957|541844839|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
150192265|NCT02985957|541844840|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
150192266|NCT02985957|541844841|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
150192267|NCT02985957|541844842|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
150192268|NCT02985957|541844843|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
150192269|NCT02985957|541844837|FG000|Treatment Period|Poor/Non-Compliance|0|||
150192270|NCT02985957|541844838|FG001|Treatment Period|Poor/Non-Compliance|0|||
150192271|NCT02985957|541844839|FG002|Treatment Period|Poor/Non-Compliance|0|||
150192272|NCT02985957|541844840|FG003|Treatment Period|Poor/Non-Compliance|0|||
150192273|NCT02985957|541844841|FG004|Treatment Period|Poor/Non-Compliance|1|||
150192274|NCT02985957|541844842|FG005|Treatment Period|Poor/Non-Compliance|1|||
150120985|NCT05799495|541577798|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
150120986|NCT05799495|541577799|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
150192275|NCT02985957|541844843|FG006|Treatment Period|Poor/Non-Compliance|0|||
150192276|NCT02985957|541844837|FG000|Treatment Period|Continuing in Treatment Period|0|||
150192277|NCT02985957|541844838|FG001|Treatment Period|Continuing in Treatment Period|1|||
150192278|NCT02985957|541844839|FG002|Treatment Period|Continuing in Treatment Period|0|||
150192279|NCT02985957|541844840|FG003|Treatment Period|Continuing in Treatment Period|4|||
150192280|NCT02985957|541844841|FG004|Treatment Period|Continuing in Treatment Period|4|||
150192281|NCT02985957|541844842|FG005|Treatment Period|Continuing in Treatment Period|0|||
150192282|NCT02985957|541844843|FG006|Treatment Period|Continuing in Treatment Period|0|||
150192283|NCT04342494|541844844|FG000|Overall Study|Questionnaire partially completed|1|||
150120987|NCT05799495|541577800|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
150120988|NCT05799495|541577797|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
150120989|NCT05799495|541577798|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
150120990|NCT05799495|541577799|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
150120991|NCT05799495|541577800|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
150120992|NCT05799495|541577797|FG000|Treatment (Up to 5 Days)|Other|0|||
150120993|NCT05799495|541577798|FG001|Treatment (Up to 5 Days)|Other|1|||
150120994|NCT05799495|541577799|FG002|Treatment (Up to 5 Days)|Other|0|||
150120995|NCT05799495|541577800|FG003|Treatment (Up to 5 Days)|Other|0|||
150120996|NCT05799495|541577797|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
150120997|NCT05799495|541577798|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
150120998|NCT05799495|541577799|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
150120999|NCT05799495|541577800|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
150121000|NCT05799495|541577797|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
150121001|NCT05799495|541577798|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
150121002|NCT05799495|541577799|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
150121003|NCT05799495|541577800|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
150121004|NCT05799495|541577797|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
150121005|NCT05799495|541577798|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
150121006|NCT05799495|541577799|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
150121007|NCT05799495|541577800|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
150121008|NCT03694548|541577804|FG000|Part A Survey|Protocol Violation|3|||
150121009|NCT03694548|541577805|FG001|Part A Survey|Protocol Violation|3|||
150121010|NCT03694548|541577806|FG002|Part A Survey|Protocol Violation|0|||
150121011|NCT03694548|541577804|FG000|Part B Yoga Program|Protocol Violation|0|||
150121012|NCT03694548|541577805|FG001|Part B Yoga Program|Protocol Violation|0|||
150121013|NCT03694548|541577806|FG002|Part B Yoga Program|Protocol Violation|3|||
150121014|NCT03694548|541577804|FG000|Part B Yoga Program|Did not attend intervention|0|||
150121015|NCT03694548|541577805|FG001|Part B Yoga Program|Did not attend intervention|0|||
150121016|NCT03694548|541577806|FG002|Part B Yoga Program|Did not attend intervention|8|||
150121017|NCT00439777|541577807|FG000|Treatment Period|Death|29|||
150121018|NCT00439777|541577808|FG001|Treatment Period|Death|21|||
150192284|NCT04342494|541844845|FG001|Overall Study|Questionnaire partially completed|0|||
150192285|NCT04342494|541844846|FG002|Overall Study|Questionnaire partially completed|2|||
150192286|NCT04342494|541844847|FG003|Overall Study|Questionnaire partially completed|0|||
150192287|NCT04342494|541844848|FG004|Overall Study|Questionnaire partially completed|1|||
150192288|NCT04342494|541844844|FG000|Overall Study|Lost to Follow-up|49|||
150192289|NCT04342494|541844845|FG001|Overall Study|Lost to Follow-up|38|||
150192290|NCT04342494|541844846|FG002|Overall Study|Lost to Follow-up|34|||
150192291|NCT04342494|541844847|FG003|Overall Study|Lost to Follow-up|34|||
150192292|NCT04342494|541844848|FG004|Overall Study|Lost to Follow-up|35|||
150192293|NCT05409183|541844850|FG000|Complete Study|Adverse Event|1|||
150121019|NCT00439777|541577807|FG000|Treatment Period|Study terminated by sponsor|125|||
150121020|NCT00439777|541577808|FG001|Treatment Period|Study terminated by sponsor|132|||
150121021|NCT00439777|541577807|FG000|Treatment Period|Site closed by investigator|0|||
150192294|NCT05409183|541844851|FG001|Complete Study|Adverse Event|2|||
150192295|NCT05409183|541844850|FG000|Complete Study|Withdrawal by Subject|3|||
150192296|NCT05409183|541844851|FG001|Complete Study|Withdrawal by Subject|0|||
150121022|NCT00439777|541577808|FG001|Treatment Period|Site closed by investigator|1|||
150192297|NCT04292223|541844857|FG000|Overall Study|Adverse Event|1|||
150192298|NCT04292223|541844857|FG000|Overall Study|Lost to Follow-up|1|||
150192299|NCT04292223|541844857|FG000|Overall Study|Noncompliance with study drug|2|||
150192300|NCT04292223|541844857|FG000|Overall Study|Patient moved out of the state|1|||
150192301|NCT00753545|541844858|FG000|Overall Study|Death|98|||
150192302|NCT00753545|541844859|FG001|Overall Study|Death|112|||
150192303|NCT00753545|541844858|FG000|Overall Study|Lost to Follow-up|2|||
150192304|NCT00753545|541844859|FG001|Overall Study|Lost to Follow-up|3|||
150192305|NCT00753545|541844858|FG000|Overall Study|Protocol Violation|1|||
150192306|NCT00753545|541844859|FG001|Overall Study|Protocol Violation|0|||
150192307|NCT00753545|541844858|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
150192308|NCT00753545|541844859|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
150192309|NCT02485938|541844860|FG000|Overall Study|Withdrawal of consent|2|||
150192310|NCT02485938|541844861|FG001|Overall Study|Withdrawal of consent|0|||
150192311|NCT04633122|541844862|FG000|Overall Study|Remained on treatment|19|||
150192312|NCT04633122|541844863|FG001|Overall Study|Remained on treatment|14|||
150121023|NCT00439777|541577807|FG000|Treatment Period|Did not take study treatment|7|||
150121024|NCT00439777|541577808|FG001|Treatment Period|Did not take study treatment|8|||
150121025|NCT00439777|541577807|FG000|Treatment Period|Adverse Event|111|||
150121026|NCT00439777|541577808|FG001|Treatment Period|Adverse Event|92|||
150121027|NCT00439777|541577807|FG000|Treatment Period|Protocol Violation|23|||
150121028|NCT00439777|541577808|FG001|Treatment Period|Protocol Violation|30|||
150121029|NCT00439777|541577807|FG000|Treatment Period|Withdrawal by Subject|66|||
150121030|NCT00439777|541577808|FG001|Treatment Period|Withdrawal by Subject|118|||
150121031|NCT00439777|541577807|FG000|Treatment Period|Lack of Efficacy|1|||
150121032|NCT00439777|541577808|FG001|Treatment Period|Lack of Efficacy|4|||
150121033|NCT00439777|541577807|FG000|Treatment Period|Lost to Follow-up|8|||
150121034|NCT00439777|541577808|FG001|Treatment Period|Lost to Follow-up|10|||
150121035|NCT00439777|541577807|FG000|Treatment Period|Protocol driven decision point|1|||
150121036|NCT00439777|541577808|FG001|Treatment Period|Protocol driven decision point|3|||
150121037|NCT00439777|541577807|FG000|Treatment Period|Physician Decision|7|||
150121038|NCT00439777|541577808|FG001|Treatment Period|Physician Decision|18|||
150121039|NCT00439777|541577807|FG000|Treatment Period|Clinical endpoint reached|26|||
150121040|NCT00439777|541577808|FG001|Treatment Period|Clinical endpoint reached|13|||
150121041|NCT00439777|541577807|FG000|Treatment Period|Technical problems|3|||
150121042|NCT00439777|541577808|FG001|Treatment Period|Technical problems|1|||
150121043|NCT00439777|541577807|FG000|Treatment Period|Participant convenience|12|||
150121044|NCT00439777|541577808|FG001|Treatment Period|Participant convenience|8|||
150121045|NCT00439777|541577807|FG000|Observational Period|Protocol Violation|0|||
150121046|NCT00439777|541577808|FG001|Observational Period|Protocol Violation|2|||
150121047|NCT00439777|541577807|FG000|Observational Period|Withdrawal by Subject|9|||
150121048|NCT00439777|541577808|FG001|Observational Period|Withdrawal by Subject|5|||
150121049|NCT00439777|541577807|FG000|Observational Period|Lost to Follow-up|1|||
150121050|NCT00439777|541577808|FG001|Observational Period|Lost to Follow-up|11|||
150121051|NCT00439777|541577807|FG000|Observational Period|Death|27|||
150121052|NCT00439777|541577808|FG001|Observational Period|Death|20|||
150121053|NCT00439777|541577807|FG000|Observational Period|Study terminated by sponsor|3|||
150121054|NCT00439777|541577808|FG001|Observational Period|Study terminated by sponsor|1|||
150121055|NCT00439777|541577807|FG000|Observational Period|Protocol driven decision point|0|||
150121056|NCT00439777|541577808|FG001|Observational Period|Protocol driven decision point|1|||
150121057|NCT00439777|541577807|FG000|Observational Period|Lack of Efficacy|1|||
150121058|NCT00439777|541577808|FG001|Observational Period|Lack of Efficacy|0|||
150192313|NCT04633122|541844862|FG000|Overall Study|Survival follow-up stopped|22|||
150192314|NCT04633122|541844863|FG001|Overall Study|Survival follow-up stopped|25|||
150192315|NCT04799899|541844864|FG000|Overall Study|Lost to Follow-up|2|||
150192316|NCT04799899|541844865|FG001|Overall Study|Lost to Follow-up|4|||
150192317|NCT04019873|541844866|FG000|Overall Study|Discontinued from the treatment|1|||
150192318|NCT04019873|541844867|FG001|Overall Study|Discontinued from the treatment|39|||
150192319|NCT04019873|541844868|FG002|Overall Study|Discontinued from the treatment|2|||
150192320|NCT01842542|541844869|FG000|Overall Study|Withdrawal by Subject|2|||
150192321|NCT01842542|541844869|FG000|Overall Study|Lack of Efficacy|1|||
150192322|NCT01842542|541844869|FG000|Overall Study|Protocol Non-compliance|2|||
150192323|NCT01842542|541844869|FG000|Overall Study|Lost to Follow-up|1|||
150192324|NCT01098812|541844870|FG000|Overall Study|Death|2|||
150192325|NCT01098812|541844871|FG001|Overall Study|Death|0|||
150192326|NCT01098812|541844872|FG002|Overall Study|Death|1|||
150121059|NCT00439777|541577807|FG000|Observational Period|Technical problems|0|||
150121060|NCT00439777|541577808|FG001|Observational Period|Technical problems|1|||
150121061|NCT00661492|541577809|FG000|Overall Study|Adverse Event|16|||
150121062|NCT00661492|541577810|FG001|Overall Study|Adverse Event|13|||
150121063|NCT00661492|541577809|FG000|Overall Study|Disease Progression|44|||
150192327|NCT01098812|541844870|FG000|Overall Study|Lost to Follow-up|0|||
150121064|NCT00661492|541577810|FG001|Overall Study|Disease Progression|14|||
150121065|NCT00661492|541577809|FG000|Overall Study|Patient Request|6|||
150121066|NCT00661492|541577810|FG001|Overall Study|Patient Request|1|||
150121067|NCT00661492|541577809|FG000|Overall Study|Investigator Request|1|||
150121068|NCT00661492|541577810|FG001|Overall Study|Investigator Request|0|||
150121069|NCT00661492|541577809|FG000|Overall Study|Lost to Follow-up|0|||
150121070|NCT00661492|541577810|FG001|Overall Study|Lost to Follow-up|1|||
150121071|NCT00661492|541577809|FG000|Overall Study|Other|1|||
150121072|NCT00661492|541577810|FG001|Overall Study|Other|0|||
150121073|NCT01024387|541577811|FG000|Overall Study|Radiographic Progression|29|||
150121074|NCT01024387|541577811|FG000|Overall Study|Symptomatic Progression|10|||
150121075|NCT01024387|541577811|FG000|Overall Study|Physician Decision|5|||
150121076|NCT01024387|541577811|FG000|Overall Study|Withdrawal by Subject|5|||
150121077|NCT01024387|541577811|FG000|Overall Study|Death|2|||
150121078|NCT01024387|541577811|FG000|Overall Study|Prolonged Treatment Delay|1|||
150121079|NCT01024387|541577811|FG000|Overall Study|Adverse Event|3|||
150121080|NCT01024387|541577811|FG000|Overall Study|Other|5|||
150121081|NCT03855189|541577812|FG000|Overall Study|Adverse Event|5|||
150121082|NCT03855189|541577813|FG001|Overall Study|Adverse Event|2|||
150121083|NCT03855189|541577814|FG002|Overall Study|Adverse Event|4|||
150121084|NCT03855189|541577812|FG000|Overall Study|Treatment Failure|1|||
150121085|NCT03855189|541577813|FG001|Overall Study|Treatment Failure|1|||
150121086|NCT03855189|541577814|FG002|Overall Study|Treatment Failure|2|||
150121087|NCT03855189|541577812|FG000|Overall Study|Noncompliance with Protocol|0|||
150121088|NCT03855189|541577813|FG001|Overall Study|Noncompliance with Protocol|1|||
150121089|NCT03855189|541577814|FG002|Overall Study|Noncompliance with Protocol|0|||
150121090|NCT03855189|541577812|FG000|Overall Study|Did Not Return|4|||
150121091|NCT03855189|541577813|FG001|Overall Study|Did Not Return|3|||
150121092|NCT03855189|541577814|FG002|Overall Study|Did Not Return|0|||
150121093|NCT00099983|541577815|FG000|Overall Study|Lost to Follow-up|2|||
150121094|NCT00099983|541577816|FG001|Overall Study|Lost to Follow-up|3|||
150121095|NCT00099983|541577815|FG000|Overall Study|Missing Source Documents|14|||
150121096|NCT00099983|541577816|FG001|Overall Study|Missing Source Documents|15|||
150121097|NCT00099983|541577815|FG000|Overall Study|Withdrawal by Subject|3|||
150121098|NCT00099983|541577816|FG001|Overall Study|Withdrawal by Subject|2|||
150121099|NCT00099983|541577815|FG000|Overall Study|Adverse Event|1|||
150121100|NCT00099983|541577816|FG001|Overall Study|Adverse Event|1|||
150121101|NCT00099983|541577815|FG000|Overall Study|Lack of Efficacy|0|||
150121102|NCT00099983|541577816|FG001|Overall Study|Lack of Efficacy|1|||
150121103|NCT00099983|541577815|FG000|Overall Study|Unable to return for appointments|1|||
150121104|NCT00099983|541577816|FG001|Overall Study|Unable to return for appointments|1|||
150121105|NCT00099983|541577815|FG000|Overall Study|Moved|1|||
150121106|NCT00099983|541577816|FG001|Overall Study|Moved|0|||
150121107|NCT00099983|541577815|FG000|Overall Study|Other psychiatric problem|1|||
150121108|NCT00099983|541577816|FG001|Overall Study|Other psychiatric problem|0|||
150121109|NCT00099983|541577815|FG000|Overall Study|Incarcerated|0|||
150121110|NCT00099983|541577816|FG001|Overall Study|Incarcerated|1|||
150121111|NCT00099983|541577815|FG000|Overall Study|Intolerant of burden of visits|0|||
150121112|NCT00099983|541577816|FG001|Overall Study|Intolerant of burden of visits|1|||
150121113|NCT00099983|541577815|FG000|Overall Study|Other issue|1|||
150121114|NCT00099983|541577816|FG001|Overall Study|Other issue|0|||
150121115|NCT02641080|541577817|FG000|Overall Study|Physician Decision|2|||
150121116|NCT02641080|541577818|FG001|Overall Study|Physician Decision|0|||
150121117|NCT02641080|541577817|FG000|Overall Study|Withdrawal by Subject|0|||
150121118|NCT02641080|541577818|FG001|Overall Study|Withdrawal by Subject|1|||
150121119|NCT02641080|541577817|FG000|Overall Study|Rehab Center denied use of pumps|0|||
150121120|NCT02641080|541577818|FG001|Overall Study|Rehab Center denied use of pumps|3|||
150121121|NCT02641080|541577817|FG000|Overall Study|Lost to Follow-up|0|||
150121122|NCT02641080|541577818|FG001|Overall Study|Lost to Follow-up|3|||
150121123|NCT00803634|541577819|FG000|Overall Study|Withdrew Consent|1|||
150121124|NCT00803634|541577820|FG001|Overall Study|Withdrew Consent|0|||
150121125|NCT00803634|541577819|FG000|Overall Study|Lost to Follow-up|2|||
150121126|NCT00803634|541577820|FG001|Overall Study|Lost to Follow-up|3|||
150121127|NCT00803634|541577819|FG000|Overall Study|Death|3|||
150121128|NCT00803634|541577820|FG001|Overall Study|Death|2|||
150121129|NCT03835533|541577821|FG000|Overall Study|Death|5|||
150121130|NCT03835533|541577822|FG001|Overall Study|Death|10|||
150121131|NCT03835533|541577823|FG002|Overall Study|Death|9|||
150121132|NCT03835533|541577821|FG000|Overall Study|Withdrawal by Subject|2|||
150121133|NCT03835533|541577822|FG001|Overall Study|Withdrawal by Subject|2|||
150121134|NCT03835533|541577823|FG002|Overall Study|Withdrawal by Subject|2|||
150121135|NCT03835533|541577821|FG000|Overall Study|Lost to Follow-up|1|||
150121136|NCT03835533|541577822|FG001|Overall Study|Lost to Follow-up|0|||
150121137|NCT03835533|541577823|FG002|Overall Study|Lost to Follow-up|0|||
150121138|NCT01418209|541577827|FG000|Overall Study|Withdrawal by Subject|1|||
150121139|NCT01418209|541577828|FG001|Overall Study|Withdrawal by Subject|0|||
150121140|NCT01418209|541577829|FG002|Overall Study|Withdrawal by Subject|1|||
150121141|NCT01418209|541577827|FG000|Overall Study|Did not provide hot flash diary data|1|||
150121142|NCT01418209|541577828|FG001|Overall Study|Did not provide hot flash diary data|3|||
150121143|NCT01418209|541577829|FG002|Overall Study|Did not provide hot flash diary data|3|||
150121144|NCT01110239|541577832|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
150121145|NCT01110239|541577833|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
150121146|NCT01110239|541577834|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
150121147|NCT01110239|541577835|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
150121148|NCT01110239|541577832|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
150121149|NCT01110239|541577833|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
150121150|NCT01110239|541577834|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
150121151|NCT01110239|541577835|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
150121152|NCT00080223|541577836|FG000|Overall Study|Adverse Event|23|||
150121153|NCT00080223|541577836|FG000|Overall Study|Death|21|||
150121154|NCT00080223|541577836|FG000|Overall Study|Withdrawal by Subject|13|||
150121155|NCT00080223|541577836|FG000|Overall Study|Lung Transplantation|9|||
150121156|NCT00080223|541577836|FG000|Overall Study|Non-compliance With Study Treatment|7|||
150121157|NCT00080223|541577836|FG000|Overall Study|Participant unwilling to continue|2|||
150121158|NCT00080223|541577836|FG000|Overall Study|Physician Decision|1|||
150121159|NCT03099382|541577843|FG000|Overall Study|Protocol Violation|2|||
150121160|NCT03099382|541577844|FG001|Overall Study|Protocol Violation|3|||
150121161|NCT00499369|541577845|FG000|Overall Study|Adverse Event|2|||
150121162|NCT00499369|541577846|FG001|Overall Study|Adverse Event|2|||
150121163|NCT00499369|541577847|FG002|Overall Study|Adverse Event|3|||
150121164|NCT00499369|541577848|FG003|Overall Study|Adverse Event|1|||
150121165|NCT00499369|541577849|FG004|Overall Study|Adverse Event|2|||
150121166|NCT00499369|541577845|FG000|Overall Study|Withdrawal by Subject|0|||
150121167|NCT00499369|541577846|FG001|Overall Study|Withdrawal by Subject|1|||
150121168|NCT00499369|541577847|FG002|Overall Study|Withdrawal by Subject|1|||
150121169|NCT00499369|541577848|FG003|Overall Study|Withdrawal by Subject|0|||
150121170|NCT00499369|541577849|FG004|Overall Study|Withdrawal by Subject|0|||
150121171|NCT00499369|541577845|FG000|Overall Study|Progression|10|||
150121172|NCT00499369|541577846|FG001|Overall Study|Progression|12|||
150121173|NCT00499369|541577847|FG002|Overall Study|Progression|9|||
150121174|NCT00499369|541577848|FG003|Overall Study|Progression|6|||
150121175|NCT00499369|541577849|FG004|Overall Study|Progression|10|||
150121176|NCT00499369|541577845|FG000|Overall Study|Death|0|||
150121177|NCT00499369|541577846|FG001|Overall Study|Death|1|||
150121178|NCT00499369|541577847|FG002|Overall Study|Death|0|||
150121179|NCT00499369|541577848|FG003|Overall Study|Death|0|||
150121180|NCT00499369|541577849|FG004|Overall Study|Death|0|||
150121181|NCT00499369|541577845|FG000|Overall Study|Not protocol specified|2|||
150121182|NCT00499369|541577846|FG001|Overall Study|Not protocol specified|0|||
150121183|NCT00499369|541577847|FG002|Overall Study|Not protocol specified|3|||
150121184|NCT00499369|541577848|FG003|Overall Study|Not protocol specified|1|||
150121185|NCT00499369|541577849|FG004|Overall Study|Not protocol specified|0|||
150121186|NCT00499369|541577845|FG000|Overall Study|Ineligible|2|||
150121187|NCT00499369|541577846|FG001|Overall Study|Ineligible|2|||
150121188|NCT00499369|541577847|FG002|Overall Study|Ineligible|1|||
150121189|NCT00499369|541577848|FG003|Overall Study|Ineligible|1|||
150121190|NCT00499369|541577849|FG004|Overall Study|Ineligible|0|||
150121191|NCT01898195|541577851|FG000|Smoking Abstinence|Did not have good measurements|35|||
150121192|NCT01898195|541577852|FG001|Smoking Abstinence|Did not have good measurements|38|||
150121193|NCT01898195|541577853|FG002|Smoking Abstinence|Did not have good measurements|36|||
150121194|NCT01802411|541577854|FG000|Overall Study|Death|2|||
150121195|NCT01802411|541577855|FG001|Overall Study|Death|1|||
150121196|NCT01802411|541577854|FG000|Overall Study|Adverse Event|2|||
150121197|NCT01802411|541577855|FG001|Overall Study|Adverse Event|7|||
150121198|NCT01802411|541577854|FG000|Overall Study|Lack of Efficacy|8|||
150121199|NCT01802411|541577855|FG001|Overall Study|Lack of Efficacy|10|||
150121200|NCT01802411|541577854|FG000|Overall Study|Withdrawal by Subject|0|||
150121201|NCT01802411|541577855|FG001|Overall Study|Withdrawal by Subject|2|||
150192328|NCT01098812|541844871|FG001|Overall Study|Lost to Follow-up|1|||
150192329|NCT01098812|541844872|FG002|Overall Study|Lost to Follow-up|0|||
150192330|NCT04908722|541844873|FG000|Overall Study|Protocol deviation|1|||
150192331|NCT04908722|541844874|FG001|Overall Study|Protocol deviation|0|||
150192332|NCT04908722|541844875|FG002|Overall Study|Protocol deviation|0|||
150192333|NCT04908722|541844876|FG003|Overall Study|Protocol deviation|0|||
150192334|NCT04908722|541844877|FG004|Overall Study|Protocol deviation|0|||
150192335|NCT04908722|541844878|FG005|Overall Study|Protocol deviation|1|||
150192336|NCT04908722|541844873|FG000|Overall Study|Lost to Follow-up|33|||
150192337|NCT04908722|541844874|FG001|Overall Study|Lost to Follow-up|33|||
150192338|NCT04908722|541844875|FG002|Overall Study|Lost to Follow-up|36|||
150192339|NCT04908722|541844876|FG003|Overall Study|Lost to Follow-up|30|||
150192340|NCT04908722|541844877|FG004|Overall Study|Lost to Follow-up|32|||
150192341|NCT04908722|541844878|FG005|Overall Study|Lost to Follow-up|34|||
150192342|NCT04908722|541844873|FG000|Overall Study|Physician Decision|1|||
150192343|NCT04908722|541844874|FG001|Overall Study|Physician Decision|1|||
150192344|NCT04908722|541844875|FG002|Overall Study|Physician Decision|1|||
150192345|NCT04908722|541844876|FG003|Overall Study|Physician Decision|2|||
150192346|NCT04908722|541844877|FG004|Overall Study|Physician Decision|0|||
150192347|NCT04908722|541844878|FG005|Overall Study|Physician Decision|0|||
150192348|NCT04908722|541844873|FG000|Overall Study|Death|1|||
150192349|NCT04908722|541844874|FG001|Overall Study|Death|0|||
150192350|NCT04908722|541844875|FG002|Overall Study|Death|0|||
150192351|NCT04908722|541844876|FG003|Overall Study|Death|0|||
150192352|NCT04908722|541844877|FG004|Overall Study|Death|0|||
150192353|NCT04908722|541844878|FG005|Overall Study|Death|1|||
150192354|NCT04908722|541844873|FG000|Overall Study|Withdrawal by Subject|12|||
150192355|NCT04908722|541844874|FG001|Overall Study|Withdrawal by Subject|8|||
150192356|NCT04908722|541844875|FG002|Overall Study|Withdrawal by Subject|7|||
150192357|NCT04908722|541844876|FG003|Overall Study|Withdrawal by Subject|6|||
150192358|NCT04908722|541844877|FG004|Overall Study|Withdrawal by Subject|12|||
150192359|NCT04908722|541844878|FG005|Overall Study|Withdrawal by Subject|14|||
150192360|NCT04908722|541844873|FG000|Overall Study|Other|3|||
150192361|NCT04908722|541844874|FG001|Overall Study|Other|1|||
150192362|NCT04908722|541844875|FG002|Overall Study|Other|3|||
150192363|NCT04908722|541844876|FG003|Overall Study|Other|2|||
150192364|NCT04908722|541844877|FG004|Overall Study|Other|4|||
150192365|NCT04908722|541844878|FG005|Overall Study|Other|1|||
150192366|NCT04908722|541844873|FG000|Overall Study|Initiated prohibited medication|0|||
150192367|NCT04908722|541844874|FG001|Overall Study|Initiated prohibited medication|0|||
150121202|NCT01802411|541577854|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
150121203|NCT01802411|541577855|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
150121204|NCT01802411|541577854|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
150121205|NCT01802411|541577855|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
150121206|NCT01802411|541577854|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
150121207|NCT01802411|541577855|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
150121208|NCT03930745|541577856|FG000|Overall Study|Lost to Follow-up|10|||
150121209|NCT03930745|541577857|FG001|Overall Study|Lost to Follow-up|5|||
150121210|NCT03930745|541577856|FG000|Overall Study|Withdrawal by Subject|1|||
150121211|NCT03930745|541577857|FG001|Overall Study|Withdrawal by Subject|2|||
150121212|NCT03930745|541577856|FG000|Overall Study|Protocol Violation|2|||
150121213|NCT03930745|541577857|FG001|Overall Study|Protocol Violation|2|||
150121214|NCT03930745|541577856|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
150121215|NCT03930745|541577857|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
150121216|NCT03930745|541577856|FG000|Overall Study|Adverse Event|0|||
150121217|NCT03930745|541577857|FG001|Overall Study|Adverse Event|1|||
150121218|NCT03930745|541577856|FG000|Overall Study|Pregnancy|0|||
150121219|NCT03930745|541577857|FG001|Overall Study|Pregnancy|1|||
150121220|NCT01337245|541577858|FG000|Overall Study|Lost to Follow-up|1|||
150121221|NCT04095858|541577861|FG000|Overall Study|Death|1|||
150121222|NCT04095858|541577862|FG001|Overall Study|Death|0|||
150121223|NCT04095858|541577861|FG000|Overall Study|Study terminated by Sponsor|2|||
150121224|NCT04095858|541577862|FG001|Overall Study|Study terminated by Sponsor|4|||
150121225|NCT02055352|541580042|FG000|Overall Study|Adverse Event|0|||
150121226|NCT02055352|541580043|FG001|Overall Study|Adverse Event|1|||
150121227|NCT02055352|541580042|FG000|Overall Study|Non-eligible|0|||
150121228|NCT02055352|541580043|FG001|Overall Study|Non-eligible|1|||
150121229|NCT02055352|541580042|FG000|Overall Study|Poor compliance|1|||
150121230|NCT02055352|541580043|FG001|Overall Study|Poor compliance|1|||
150192368|NCT04908722|541844875|FG002|Overall Study|Initiated prohibited medication|0|||
150192369|NCT04908722|541844876|FG003|Overall Study|Initiated prohibited medication|1|||
150121231|NCT02055352|541580042|FG000|Overall Study|Death|1|||
150121232|NCT02055352|541580043|FG001|Overall Study|Death|2|||
150121233|NCT02055352|541580042|FG000|Overall Study|Patient decision|1|||
150121234|NCT02055352|541580043|FG001|Overall Study|Patient decision|1|||
150121235|NCT02055352|541580042|FG000|Overall Study|Use of prohibited treatment|0|||
150192370|NCT04908722|541844877|FG004|Overall Study|Initiated prohibited medication|0|||
150121236|NCT02055352|541580043|FG001|Overall Study|Use of prohibited treatment|3|||
150121237|NCT02055352|541580042|FG000|Overall Study|AE, study drug would be detrimental|1|||
150121238|NCT02055352|541580043|FG001|Overall Study|AE, study drug would be detrimental|3|||
150121239|NCT02055352|541580042|FG000|Overall Study|Withdrawal of informed consent|1|||
150121240|NCT02055352|541580043|FG001|Overall Study|Withdrawal of informed consent|0|||
150121241|NCT02055352|541580042|FG000|Overall Study|Reason unknown|1|||
150121242|NCT02055352|541580043|FG001|Overall Study|Reason unknown|5|||
150121243|NCT05349617|541580046|FG000|Overall Study|Death|1|||
150121244|NCT05349617|541580047|FG001|Overall Study|Death|1|||
150121245|NCT05349617|541580046|FG000|Overall Study|Lost to Follow-up|3|||
150121246|NCT05349617|541580047|FG001|Overall Study|Lost to Follow-up|8|||
150192371|NCT04908722|541844878|FG005|Overall Study|Initiated prohibited medication|1|||
150192372|NCT04908722|541844873|FG000|Overall Study|Randomized but not vaccinated|3|||
150121247|NCT05349617|541580046|FG000|Overall Study|Withdrawal by Subject|2|||
150121248|NCT05349617|541580047|FG001|Overall Study|Withdrawal by Subject|10|||
150121249|NCT00993447|541580051|FG000|Overall Study|Withdrawal by Subject|23|||
150192373|NCT04908722|541844874|FG001|Overall Study|Randomized but not vaccinated|1|||
150192374|NCT04908722|541844875|FG002|Overall Study|Randomized but not vaccinated|2|||
150192375|NCT04908722|541844876|FG003|Overall Study|Randomized but not vaccinated|2|||
150192376|NCT04908722|541844877|FG004|Overall Study|Randomized but not vaccinated|3|||
150192377|NCT04908722|541844878|FG005|Overall Study|Randomized but not vaccinated|4|||
150192378|NCT04858321|541844885|FG000|Overall Study|Withdrawal by Subject|3|||
150192379|NCT04537715|541844900|FG000|Overall Study|Death|3|||
150192380|NCT04537715|541844901|FG001|Overall Study|Death|1|||
150192381|NCT04537715|541844900|FG000|Overall Study|Withdrawal by Subject|3|||
150192382|NCT04537715|541844901|FG001|Overall Study|Withdrawal by Subject|1|||
150192383|NCT04537715|541844900|FG000|Overall Study|Other|4|||
150192384|NCT04537715|541844901|FG001|Overall Study|Other|3|||
150192385|NCT04537715|541844900|FG000|Overall Study|Progressive disease|1|||
150192386|NCT04537715|541844901|FG001|Overall Study|Progressive disease|0|||
150192387|NCT04623671|541844904|FG000|Overall Study|Adverse Event|0|||
150192388|NCT04623671|541844905|FG001|Overall Study|Adverse Event|1|||
150192389|NCT04623671|541844904|FG000|Overall Study|Lost to Follow-up|2|||
150192390|NCT04623671|541844905|FG001|Overall Study|Lost to Follow-up|1|||
150192391|NCT04623671|541844904|FG000|Overall Study|Death|5|||
150192392|NCT04623671|541844905|FG001|Overall Study|Death|5|||
150192393|NCT03448107|541844906|FG000|Overall Study|Lost to Follow-up|229|||
150192394|NCT03448107|541844907|FG001|Overall Study|Lost to Follow-up|258|||
150192395|NCT04025554|541844908|FG000|Overall Study|Adverse Event|3|||
150192396|NCT03115476|541844909|FG000|LP0084-1369|Death|1|||
150192397|NCT03115476|541844910|FG001|LP0084-1369|Death|0|||
150192398|NCT03115476|541844911|FG002|LP0084-1369|Death|2|||
150192399|NCT03115476|541844909|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
150192400|NCT03115476|541844910|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
150192401|NCT03115476|541844911|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
150192402|NCT05257486|541844915|FG000|Overall Study|Protocol Violation|3|||
150192403|NCT02310646|541844916|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
150192404|NCT02310646|541844917|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
150192405|NCT02310646|541844916|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
150192406|NCT02310646|541844917|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
150192407|NCT04700163|541844918|FG000|Overall Study|Lost to Follow-up|0|||
150192408|NCT04700163|541844919|FG001|Overall Study|Lost to Follow-up|0|||
150192409|NCT04700163|541844920|FG002|Overall Study|Lost to Follow-up|0|||
150192410|NCT04700163|541844921|FG003|Overall Study|Lost to Follow-up|0|||
150192411|NCT04700163|541844922|FG004|Overall Study|Lost to Follow-up|0|||
150192412|NCT04700163|541844923|FG005|Overall Study|Lost to Follow-up|1|||
150192413|NCT00613106|541844924|FG000|Overall Study|Adverse Event|3|||
150192414|NCT00613106|541844925|FG001|Overall Study|Adverse Event|1|||
150192415|NCT00613106|541844924|FG000|Overall Study|Withdrawal by Subject|6|||
150192416|NCT00613106|541844925|FG001|Overall Study|Withdrawal by Subject|3|||
150192417|NCT00613106|541844924|FG000|Overall Study|Lost to Follow-up|7|||
150192418|NCT00613106|541844925|FG001|Overall Study|Lost to Follow-up|2|||
150192419|NCT00613106|541844924|FG000|Overall Study|misc|4|||
150192420|NCT00613106|541844925|FG001|Overall Study|misc|3|||
150192421|NCT05543629|541844932|FG000|Overall Study|Death|1|||
150192422|NCT05543629|541844933|FG001|Overall Study|Death|0|||
150192423|NCT05543629|541844934|FG002|Overall Study|Death|1|||
150192424|NCT05543629|541844935|FG003|Overall Study|Death|0|||
150192425|NCT05543629|541844936|FG004|Overall Study|Death|0|||
150192426|NCT05543629|541844937|FG005|Overall Study|Death|1|||
150192427|NCT05543629|541844938|FG006|Overall Study|Death|2|||
150192428|NCT05543629|541844939|FG007|Overall Study|Death|2|||
150192429|NCT05543629|541844932|FG000|Overall Study|Other Reasons|0|||
150192430|NCT05543629|541844933|FG001|Overall Study|Other Reasons|0|||
150192431|NCT05543629|541844934|FG002|Overall Study|Other Reasons|0|||
150192432|NCT05543629|541844935|FG003|Overall Study|Other Reasons|0|||
150192433|NCT05543629|541844936|FG004|Overall Study|Other Reasons|1|||
150192434|NCT05543629|541844937|FG005|Overall Study|Other Reasons|0|||
150192435|NCT05543629|541844938|FG006|Overall Study|Other Reasons|0|||
150192436|NCT05543629|541844939|FG007|Overall Study|Other Reasons|0|||
150192437|NCT05543629|541844932|FG000|Overall Study|Physician Decision|0|||
150192438|NCT05543629|541844933|FG001|Overall Study|Physician Decision|0|||
150192439|NCT05543629|541844934|FG002|Overall Study|Physician Decision|3|||
150192440|NCT05543629|541844935|FG003|Overall Study|Physician Decision|0|||
150192441|NCT05543629|541844936|FG004|Overall Study|Physician Decision|0|||
150192442|NCT05543629|541844937|FG005|Overall Study|Physician Decision|0|||
150192443|NCT05543629|541844938|FG006|Overall Study|Physician Decision|1|||
150192444|NCT05543629|541844939|FG007|Overall Study|Physician Decision|0|||
150192445|NCT05543629|541844932|FG000|Overall Study|Study terminated by Sponsor|1|||
150192446|NCT05543629|541844933|FG001|Overall Study|Study terminated by Sponsor|0|||
150192447|NCT05543629|541844934|FG002|Overall Study|Study terminated by Sponsor|0|||
150192448|NCT05543629|541844935|FG003|Overall Study|Study terminated by Sponsor|1|||
150192449|NCT05543629|541844936|FG004|Overall Study|Study terminated by Sponsor|0|||
150192450|NCT05543629|541844937|FG005|Overall Study|Study terminated by Sponsor|4|||
150192451|NCT05543629|541844938|FG006|Overall Study|Study terminated by Sponsor|1|||
150192452|NCT05543629|541844939|FG007|Overall Study|Study terminated by Sponsor|0|||
150192453|NCT05543629|541844932|FG000|Overall Study|Withdrawal by Subject|1|||
150192454|NCT05543629|541844933|FG001|Overall Study|Withdrawal by Subject|1|||
150192455|NCT05543629|541844934|FG002|Overall Study|Withdrawal by Subject|0|||
150192456|NCT05543629|541844935|FG003|Overall Study|Withdrawal by Subject|2|||
150192457|NCT05543629|541844936|FG004|Overall Study|Withdrawal by Subject|1|||
150192458|NCT05543629|541844937|FG005|Overall Study|Withdrawal by Subject|1|||
150192459|NCT05543629|541844938|FG006|Overall Study|Withdrawal by Subject|1|||
150192460|NCT05543629|541844939|FG007|Overall Study|Withdrawal by Subject|1|||
150192461|NCT05543629|541844932|FG000|Overall Study|Not Reported|2|||
150192462|NCT05543629|541844933|FG001|Overall Study|Not Reported|2|||
150192463|NCT05543629|541844934|FG002|Overall Study|Not Reported|0|||
150192464|NCT05543629|541844935|FG003|Overall Study|Not Reported|0|||
150192465|NCT05543629|541844936|FG004|Overall Study|Not Reported|1|||
150192466|NCT05543629|541844937|FG005|Overall Study|Not Reported|1|||
150192467|NCT05543629|541844938|FG006|Overall Study|Not Reported|3|||
150192468|NCT05543629|541844939|FG007|Overall Study|Not Reported|0|||
150192469|NCT03313076|541844940|FG000|Overall Study|Withdrawal by Subject|2|||
150192470|NCT03313076|541844941|FG001|Overall Study|Withdrawal by Subject|0|||
150192471|NCT03313076|541844942|FG002|Overall Study|Withdrawal by Subject|0|||
150192472|NCT03313076|541844943|FG003|Overall Study|Withdrawal by Subject|0|||
150192473|NCT03313076|541844940|FG000|Overall Study|Lost to Follow-up|0|||
150192474|NCT03313076|541844941|FG001|Overall Study|Lost to Follow-up|2|||
150192475|NCT03313076|541844942|FG002|Overall Study|Lost to Follow-up|2|||
150192476|NCT03313076|541844943|FG003|Overall Study|Lost to Follow-up|2|||
150192477|NCT05869383|541844944|FG000|Overall Study|Withdrawal by Subject|2|||
150192478|NCT05869383|541844945|FG001|Overall Study|Withdrawal by Subject|0|||
150192479|NCT04307355|541844950|FG000|Overall Study|Non-Compliance|3|||
150192480|NCT04307355|541844951|FG001|Overall Study|Non-Compliance|3|||
150192481|NCT04307355|541844952|FG002|Overall Study|Non-Compliance|0|||
150192482|NCT04065841|541844953|FG000|Overall Study|Adverse Event|4|||
150192483|NCT04065841|541844954|FG001|Overall Study|Adverse Event|2|||
150192484|NCT04065841|541844955|FG002|Overall Study|Adverse Event|10|||
150192485|NCT04065841|541844956|FG003|Overall Study|Adverse Event|1|||
150192486|NCT04065841|541844953|FG000|Overall Study|Lost to Follow-up|1|||
150192487|NCT04065841|541844954|FG001|Overall Study|Lost to Follow-up|2|||
150192488|NCT04065841|541844955|FG002|Overall Study|Lost to Follow-up|2|||
150192489|NCT04065841|541844956|FG003|Overall Study|Lost to Follow-up|2|||
150192490|NCT04065841|541844953|FG000|Overall Study|Physician Decision|1|||
150192491|NCT04065841|541844954|FG001|Overall Study|Physician Decision|0|||
150192492|NCT04065841|541844955|FG002|Overall Study|Physician Decision|0|||
150192493|NCT04065841|541844956|FG003|Overall Study|Physician Decision|0|||
150192494|NCT04065841|541844953|FG000|Overall Study|Protocol Violation|0|||
150192495|NCT04065841|541844954|FG001|Overall Study|Protocol Violation|1|||
150192496|NCT04065841|541844955|FG002|Overall Study|Protocol Violation|0|||
150192497|NCT04065841|541844956|FG003|Overall Study|Protocol Violation|0|||
150192498|NCT04065841|541844953|FG000|Overall Study|Study terminated by Sponsor|22|||
150192499|NCT04065841|541844954|FG001|Overall Study|Study terminated by Sponsor|16|||
150192500|NCT04065841|541844955|FG002|Overall Study|Study terminated by Sponsor|28|||
150192501|NCT04065841|541844956|FG003|Overall Study|Study terminated by Sponsor|17|||
150192502|NCT04065841|541844953|FG000|Overall Study|Withdrawal by Subject|1|||
150192503|NCT04065841|541844954|FG001|Overall Study|Withdrawal by Subject|1|||
150192504|NCT04065841|541844955|FG002|Overall Study|Withdrawal by Subject|2|||
150192505|NCT04065841|541844956|FG003|Overall Study|Withdrawal by Subject|0|||
150192506|NCT01420237|541844959|FG000|Overall Study|Death|13|||
150192507|NCT01420237|541844959|FG000|Overall Study|Withdrawal by Subject|41|||
150192508|NCT01420237|541844959|FG000|Overall Study|Lost to Follow-up|32|||
150192509|NCT01420237|541844959|FG000|Overall Study|Adverse Event|10|||
150192510|NCT01420237|541844959|FG000|Overall Study|Investigative Site Termination|43|||
150192511|NCT01420237|541844959|FG000|Overall Study|Censored because study device not implanted|21|||
150192512|NCT01420237|541844959|FG000|Overall Study|Censored because surgery not performed|2|||
150192513|NCT01420237|541844959|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
150192514|NCT01420237|541844959|FG000|Overall Study|Sponsor terminated study early|127|||
150192515|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
150192516|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
150192517|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
150192518|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
150192519|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
150192520|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
150192521|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
150192522|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
150192523|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
150192524|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
150192525|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
150192526|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
150192527|NCT04338061|541844960|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
150192528|NCT04338061|541844961|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
150192529|NCT04338061|541844960|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
150192530|NCT04338061|541844961|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
150192531|NCT04338061|541844960|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
150192532|NCT04338061|541844961|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
150192533|NCT04338061|541844960|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
150192534|NCT04338061|541844961|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
150192535|NCT04338061|541844960|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
150192536|NCT04338061|541844961|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
150192537|NCT04338061|541844960|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
150192538|NCT04338061|541844961|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
150192539|NCT04492722|541844963|FG000|Overall Study|Adverse Event|7|||
150192540|NCT04492722|541844964|FG001|Overall Study|Adverse Event|2|||
150192541|NCT04492722|541844965|FG002|Overall Study|Adverse Event|3|||
150192542|NCT04492722|541844966|FG003|Overall Study|Adverse Event|0|||
150192543|NCT04492722|541844963|FG000|Overall Study|Death|0|||
150192544|NCT04492722|541844964|FG001|Overall Study|Death|0|||
150192545|NCT04492722|541844965|FG002|Overall Study|Death|0|||
150192546|NCT04492722|541844966|FG003|Overall Study|Death|1|||
150192547|NCT04492722|541844963|FG000|Overall Study|Lost to Follow-up|0|||
150192548|NCT04492722|541844964|FG001|Overall Study|Lost to Follow-up|1|||
150192549|NCT04492722|541844965|FG002|Overall Study|Lost to Follow-up|0|||
150192550|NCT04492722|541844966|FG003|Overall Study|Lost to Follow-up|1|||
150192551|NCT04492722|541844963|FG000|Overall Study|Physician Decision|0|||
150192552|NCT04492722|541844964|FG001|Overall Study|Physician Decision|3|||
150192553|NCT04492722|541844965|FG002|Overall Study|Physician Decision|1|||
150192554|NCT04492722|541844966|FG003|Overall Study|Physician Decision|1|||
150192555|NCT04492722|541844963|FG000|Overall Study|Withdrawal by Subject|6|||
150192556|NCT04492722|541844964|FG001|Overall Study|Withdrawal by Subject|6|||
150192557|NCT04492722|541844965|FG002|Overall Study|Withdrawal by Subject|0|||
150192558|NCT04492722|541844966|FG003|Overall Study|Withdrawal by Subject|3|||
150192559|NCT04492722|541844963|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
150192560|NCT04492722|541844964|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
150192561|NCT04492722|541844965|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
150192562|NCT04492722|541844966|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
150192563|NCT04492722|541844963|FG000|Overall Study|Due to Covid-19 pandemic|7|||
150192564|NCT04492722|541844964|FG001|Overall Study|Due to Covid-19 pandemic|3|||
150192565|NCT04492722|541844965|FG002|Overall Study|Due to Covid-19 pandemic|7|||
150192566|NCT04492722|541844966|FG003|Overall Study|Due to Covid-19 pandemic|6|||
150192567|NCT04492722|541844963|FG000|Overall Study|Failure to meet randomisation criteria|2|||
150192568|NCT04492722|541844964|FG001|Overall Study|Failure to meet randomisation criteria|3|||
150192569|NCT04492722|541844965|FG002|Overall Study|Failure to meet randomisation criteria|4|||
150192570|NCT04492722|541844966|FG003|Overall Study|Failure to meet randomisation criteria|2|||
150192571|NCT04492722|541844963|FG000|Overall Study|Early termination from the study|54|||
150192572|NCT04492722|541844964|FG001|Overall Study|Early termination from the study|51|||
150192573|NCT04492722|541844965|FG002|Overall Study|Early termination from the study|50|||
150192574|NCT04492722|541844966|FG003|Overall Study|Early termination from the study|50|||
150192575|NCT04492722|541844963|FG000|Overall Study|Missing|3|||
150192576|NCT04492722|541844964|FG001|Overall Study|Missing|0|||
150192577|NCT04492722|541844965|FG002|Overall Study|Missing|0|||
150192578|NCT04492722|541844966|FG003|Overall Study|Missing|5|||
150121250|NCT00993447|541580052|FG001|Overall Study|Withdrawal by Subject|8|||
150121251|NCT00993447|541580051|FG000|Overall Study|Protocol Violation|12|||
150121252|NCT00993447|541580052|FG001|Overall Study|Protocol Violation|8|||
150121253|NCT00993447|541580051|FG000|Overall Study|Lost to Follow-up|1|||
150121254|NCT00993447|541580052|FG001|Overall Study|Lost to Follow-up|3|||
150121255|NCT00993447|541580051|FG000|Overall Study|Adverse Event|1|||
150121256|NCT00993447|541580052|FG001|Overall Study|Adverse Event|0|||
150121257|NCT00970502|541580055|FG000|Overall Study|Withdrawal by Subject|1|||
150121258|NCT01863680|541580056|FG000|Overall Study|Adverse Event|17|||
150121259|NCT01863680|541580056|FG000|Overall Study|Risk of OHSS|17|||
150121260|NCT01863680|541580056|FG000|Overall Study|Spontaneous pregnancy|2|||
150121261|NCT01863680|541580056|FG000|Overall Study|Withdrawal by Subject|1|||
150121262|NCT01863680|541580056|FG000|Overall Study|Did not undergo IVF/ET|14|||
150121263|NCT01863680|541580056|FG000|Overall Study|Other|6|||
150121264|NCT00566228|541580057|FG000|Overall Study|Withdrawal by Subject|1|||
150121265|NCT00566228|541580058|FG001|Overall Study|Withdrawal by Subject|0|||
150121266|NCT00566228|541580057|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
150121267|NCT00566228|541580058|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
150121268|NCT00566228|541580057|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
150121269|NCT00566228|541580058|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
150121270|NCT00566228|541580057|FG000|Overall Study|progressed before infusion could occur|0|||
150121271|NCT00566228|541580058|FG001|Overall Study|progressed before infusion could occur|1|||
150121272|NCT02041195|541580061|FG000|Overall Study|Adverse Event|1|||
150121273|NCT02041195|541580062|FG001|Overall Study|Adverse Event|2|||
150121274|NCT02041195|541580063|FG002|Overall Study|Adverse Event|0|||
150121275|NCT02041195|541580064|FG003|Overall Study|Adverse Event|0|||
150121276|NCT02041195|541580065|FG004|Overall Study|Adverse Event|0|||
150121277|NCT02041195|541580066|FG005|Overall Study|Adverse Event|0|||
150121278|NCT02041195|541580067|FG006|Overall Study|Adverse Event|3|||
150121279|NCT02041195|541580068|FG007|Overall Study|Adverse Event|0|||
150121280|NCT02041195|541580061|FG000|Overall Study|Withdrawal by Subject|1|||
150121281|NCT02041195|541580062|FG001|Overall Study|Withdrawal by Subject|0|||
150121282|NCT02041195|541580063|FG002|Overall Study|Withdrawal by Subject|0|||
150121283|NCT02041195|541580064|FG003|Overall Study|Withdrawal by Subject|0|||
150121284|NCT02041195|541580065|FG004|Overall Study|Withdrawal by Subject|0|||
150121285|NCT02041195|541580066|FG005|Overall Study|Withdrawal by Subject|0|||
150121286|NCT02041195|541580067|FG006|Overall Study|Withdrawal by Subject|4|||
150121287|NCT02041195|541580068|FG007|Overall Study|Withdrawal by Subject|3|||
150121288|NCT02041195|541580061|FG000|Overall Study|Unable to comply with study visits|0|||
150121289|NCT02041195|541580062|FG001|Overall Study|Unable to comply with study visits|1|||
150121290|NCT02041195|541580063|FG002|Overall Study|Unable to comply with study visits|0|||
150121291|NCT02041195|541580064|FG003|Overall Study|Unable to comply with study visits|0|||
150121292|NCT02041195|541580065|FG004|Overall Study|Unable to comply with study visits|1|||
150121293|NCT02041195|541580066|FG005|Overall Study|Unable to comply with study visits|0|||
150121294|NCT02041195|541580067|FG006|Overall Study|Unable to comply with study visits|0|||
150121295|NCT02041195|541580068|FG007|Overall Study|Unable to comply with study visits|0|||
150121296|NCT02707055|541580069|FG000|Phase 1|Withdrawal by Subject|1|||
150121297|NCT02707055|541580070|FG001|Phase 1|Withdrawal by Subject|2|||
150121298|NCT02707055|541580069|FG000|Phase 1|Physician Decision|0|||
150121299|NCT02707055|541580070|FG001|Phase 1|Physician Decision|1|||
150121300|NCT02707055|541580069|FG000|Phase 2|Adverse Event|1|||
150121301|NCT02707055|541580070|FG001|Phase 2|Adverse Event|2|||
150121302|NCT03564496|541580071|FG000|Overall Study|Withdrawal by Subject|1|||
150121303|NCT03564496|541580072|FG001|Overall Study|Withdrawal by Subject|1|||
150121304|NCT03564496|541580073|FG002|Overall Study|Withdrawal by Subject|0|||
150121305|NCT03564496|541580071|FG000|Overall Study|Screen failure|0|||
150121306|NCT03564496|541580072|FG001|Overall Study|Screen failure|3|||
150121307|NCT03564496|541580073|FG002|Overall Study|Screen failure|0|||
150121308|NCT00674986|541580074|FG000|Overall Study|Adverse Event|2|||
150121309|NCT00674986|541580075|FG001|Overall Study|Adverse Event|1|||
150121310|NCT00674986|541580074|FG000|Overall Study|Subject withdrew consent|12|||
150121311|NCT00674986|541580075|FG001|Overall Study|Subject withdrew consent|19|||
150192579|NCT04492722|541844963|FG000|Overall Study|Participants who did not receive treatment|0|||
150121312|NCT00674986|541580074|FG000|Overall Study|Lost to Follow-up|25|||
150121313|NCT00674986|541580075|FG001|Overall Study|Lost to Follow-up|53|||
150121314|NCT00674986|541580074|FG000|Overall Study|Other reasons|4|||
150121315|NCT00674986|541580075|FG001|Overall Study|Other reasons|8|||
150121316|NCT01880424|541580076|FG000|Overall Study|Adverse Event|7|||
150121317|NCT01880424|541580077|FG001|Overall Study|Adverse Event|6|||
150121318|NCT01880424|541580076|FG000|Overall Study|Lack of Efficacy|1|||
150121319|NCT01880424|541580077|FG001|Overall Study|Lack of Efficacy|4|||
150121320|NCT01880424|541580076|FG000|Overall Study|Lost to Follow-up|3|||
150121321|NCT01880424|541580077|FG001|Overall Study|Lost to Follow-up|2|||
150121322|NCT01880424|541580076|FG000|Overall Study|Protocol Violation|11|||
150121323|NCT01880424|541580077|FG001|Overall Study|Protocol Violation|13|||
150121324|NCT01880424|541580076|FG000|Overall Study|Withdrawal by Subject|10|||
150121325|NCT01880424|541580077|FG001|Overall Study|Withdrawal by Subject|30|||
150121326|NCT01880424|541580076|FG000|Overall Study|Other|1|||
150121327|NCT01880424|541580077|FG001|Overall Study|Other|0|||
150121328|NCT03521635|541580080|FG000|Overall Study|Adverse Event|1|||
150121329|NCT03521635|541580081|FG001|Overall Study|Adverse Event|1|||
150121330|NCT03521635|541580080|FG000|Overall Study|Refused to complete study visit|1|||
150121331|NCT03521635|541580081|FG001|Overall Study|Refused to complete study visit|0|||
150121332|NCT03521635|541580080|FG000|Overall Study|Refused to continue trial medication|2|||
150121333|NCT03521635|541580081|FG001|Overall Study|Refused to continue trial medication|2|||
150121334|NCT03521635|541580080|FG000|Overall Study|Lost to Follow-up|0|||
150121335|NCT03521635|541580081|FG001|Overall Study|Lost to Follow-up|1|||
150121336|NCT03521635|541580080|FG000|Overall Study|Meet exclusion criteria|0|||
150121337|NCT03521635|541580081|FG001|Overall Study|Meet exclusion criteria|1|||
150121338|NCT03521635|541580080|FG000|Overall Study|Patient not taken study medicine|0|||
150121339|NCT03521635|541580081|FG001|Overall Study|Patient not taken study medicine|1|||
150121340|NCT00902304|541580084|FG000|Overall Study|Adverse Event|4|||
150121341|NCT00902304|541580085|FG001|Overall Study|Adverse Event|10|||
150121342|NCT00902304|541580086|FG002|Overall Study|Adverse Event|25|||
150121343|NCT00902304|541580084|FG000|Overall Study|Investigator discretion|3|||
150121344|NCT00902304|541580085|FG001|Overall Study|Investigator discretion|5|||
150121345|NCT00902304|541580086|FG002|Overall Study|Investigator discretion|13|||
150121346|NCT00902304|541580084|FG000|Overall Study|Lost to Follow-up|7|||
150121347|NCT00902304|541580085|FG001|Overall Study|Lost to Follow-up|7|||
150121348|NCT00902304|541580086|FG002|Overall Study|Lost to Follow-up|7|||
150121349|NCT00902304|541580084|FG000|Overall Study|Protocol Violation|9|||
150121350|NCT00902304|541580085|FG001|Overall Study|Protocol Violation|18|||
150121351|NCT00902304|541580086|FG002|Overall Study|Protocol Violation|20|||
150121352|NCT00902304|541580084|FG000|Overall Study|Withdrawal by Subject|32|||
150121353|NCT00902304|541580085|FG001|Overall Study|Withdrawal by Subject|22|||
150121354|NCT00902304|541580086|FG002|Overall Study|Withdrawal by Subject|43|||
150121355|NCT00902304|541580084|FG000|Overall Study|includes pregnancy|3|||
150121356|NCT00902304|541580085|FG001|Overall Study|includes pregnancy|9|||
150121357|NCT00902304|541580086|FG002|Overall Study|includes pregnancy|2|||
150121358|NCT02492100|541580087|FG000|Overall Study|Death|1|||
150121359|NCT05706506|541580088|FG000|Overall Study|Adverse Event|1|||
150121360|NCT05706506|541580088|FG000|Overall Study|Withdrawal by Subject|4|||
150121361|NCT05706506|541580088|FG000|Overall Study|Lost to Follow-up|2|||
150121362|NCT05706506|541580088|FG000|Overall Study|Inadvertent Enrolment|12|||
150121363|NCT05706506|541580088|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
150121364|NCT05706506|541580088|FG000|Overall Study|Participant Moved Out of State|1|||
150121365|NCT02807948|541580092|FG000|Overall Study|Physician Decision|1|||
150121366|NCT02807948|541580093|FG001|Overall Study|Physician Decision|0|||
150121367|NCT01303627|541580094|FG000|Overall Study|the failure while performing URS|0|||
150121368|NCT01303627|541580095|FG001|Overall Study|the failure while performing URS|1|||
150121369|NCT01175382|541580101|FG000|Overall Study|Lost to Follow-up|4|||
150121370|NCT01175382|541580102|FG001|Overall Study|Lost to Follow-up|3|||
150121371|NCT01175382|541580103|FG002|Overall Study|Lost to Follow-up|1|||
150121372|NCT01175382|541580101|FG000|Overall Study|Physician Decision|0|||
150121373|NCT01175382|541580102|FG001|Overall Study|Physician Decision|1|||
150121374|NCT01175382|541580103|FG002|Overall Study|Physician Decision|0|||
150121375|NCT01175382|541580101|FG000|Overall Study|Withdrawal by Subject|0|||
150121376|NCT01175382|541580102|FG001|Overall Study|Withdrawal by Subject|0|||
150121377|NCT01175382|541580103|FG002|Overall Study|Withdrawal by Subject|1|||
150121378|NCT01175382|541580101|FG000|Overall Study|No longer having problem|1|||
150121379|NCT01175382|541580102|FG001|Overall Study|No longer having problem|0|||
150121380|NCT01175382|541580103|FG002|Overall Study|No longer having problem|1|||
150121381|NCT01175382|541580101|FG000|Overall Study|Unable/unwilling to attend visits|3|||
150121382|NCT01175382|541580102|FG001|Overall Study|Unable/unwilling to attend visits|1|||
150121383|NCT01175382|541580103|FG002|Overall Study|Unable/unwilling to attend visits|2|||
150192580|NCT04492722|541844964|FG001|Overall Study|Participants who did not receive treatment|1|||
150192581|NCT04492722|541844965|FG002|Overall Study|Participants who did not receive treatment|4|||
150192582|NCT04492722|541844966|FG003|Overall Study|Participants who did not receive treatment|0|||
150192583|NCT04074759|541844967|FG000|Overall Study|Withdrawal by Subject|0|||
150192584|NCT04074759|541844968|FG001|Overall Study|Withdrawal by Subject|0|||
150192585|NCT04074759|541844969|FG002|Overall Study|Withdrawal by Subject|0|||
150192586|NCT04074759|541844970|FG003|Overall Study|Withdrawal by Subject|0|||
150192587|NCT04074759|541844971|FG004|Overall Study|Withdrawal by Subject|0|||
150192588|NCT04074759|541844972|FG005|Overall Study|Withdrawal by Subject|2|||
150121384|NCT01175382|541580101|FG000|Overall Study|Unwilling to follow protocol|0|||
150121385|NCT01175382|541580102|FG001|Overall Study|Unwilling to follow protocol|1|||
150121386|NCT01175382|541580103|FG002|Overall Study|Unwilling to follow protocol|0|||
150121387|NCT01175382|541580101|FG000|Overall Study|Unable to tolerate study meds|0|||
150121388|NCT01175382|541580102|FG001|Overall Study|Unable to tolerate study meds|1|||
150121389|NCT01175382|541580103|FG002|Overall Study|Unable to tolerate study meds|1|||
150121390|NCT02511431|541580110|FG000|Treatment|Lost to Follow-up|0|||
150121391|NCT02511431|541580111|FG001|Treatment|Lost to Follow-up|0|||
150121392|NCT02511431|541580112|FG002|Treatment|Lost to Follow-up|1|||
150121393|NCT02511431|541580113|FG003|Treatment|Lost to Follow-up|0|||
150121394|NCT02511431|541580114|FG004|Treatment|Lost to Follow-up|0|||
150121395|NCT02511431|541580115|FG005|Treatment|Lost to Follow-up|1|||
150121396|NCT01751568|541580117|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
150121397|NCT01751568|541580118|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
150121398|NCT01751568|541580119|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
150121399|NCT03447769|541580120|FG000|Overall Study|Progressive disease|138|||
150121400|NCT03447769|541580121|FG001|Overall Study|Progressive disease|148|||
150121401|NCT03447769|541580120|FG000|Overall Study|Study terminated by Sponsor|60|||
150121402|NCT03447769|541580121|FG001|Overall Study|Study terminated by Sponsor|44|||
150121403|NCT03447769|541580120|FG000|Overall Study|Adverse Event|34|||
150121404|NCT03447769|541580121|FG001|Overall Study|Adverse Event|31|||
150121405|NCT03447769|541580120|FG000|Overall Study|Patient decision|27|||
150121406|NCT03447769|541580121|FG001|Overall Study|Patient decision|27|||
150192589|NCT04074759|541844973|FG006|Overall Study|Withdrawal by Subject|0|||
150121407|NCT03447769|541580120|FG000|Overall Study|Protocol deviation|4|||
150192590|NCT04074759|541844974|FG007|Overall Study|Withdrawal by Subject|2|||
150192591|NCT04074759|541844975|FG008|Overall Study|Withdrawal by Subject|1|||
150121408|NCT03447769|541580121|FG001|Overall Study|Protocol deviation|6|||
150121409|NCT03447769|541580120|FG000|Overall Study|Death|2|||
150121410|NCT03447769|541580121|FG001|Overall Study|Death|7|||
150121411|NCT03447769|541580120|FG000|Overall Study|Technical problems|1|||
150121412|NCT03447769|541580121|FG001|Overall Study|Technical problems|0|||
150121413|NCT03447769|541580120|FG000|Overall Study|Lost to Follow-up|0|||
150121414|NCT03447769|541580121|FG001|Overall Study|Lost to Follow-up|1|||
150121415|NCT03447769|541580120|FG000|Overall Study|Physician Decision|13|||
150121416|NCT03447769|541580121|FG001|Overall Study|Physician Decision|5|||
150121417|NCT03264989|541580123|FG000|Overall Study|Lost to Follow-up|1|||
150121418|NCT03264989|541580124|FG001|Overall Study|Lost to Follow-up|0|||
150121419|NCT03264989|541580123|FG000|Overall Study|New Therapy for study Indication|1|||
150121420|NCT03264989|541580124|FG001|Overall Study|New Therapy for study Indication|0|||
150121421|NCT03264989|541580123|FG000|Overall Study|Protocol Violation|0|||
150121422|NCT03264989|541580124|FG001|Overall Study|Protocol Violation|1|||
150121423|NCT03264989|541580123|FG000|Overall Study|Patient decision|13|||
150121424|NCT03264989|541580124|FG001|Overall Study|Patient decision|0|||
150121425|NCT03264989|541580123|FG000|Overall Study|Physician Decision|6|||
150121426|NCT03264989|541580124|FG001|Overall Study|Physician Decision|4|||
150121427|NCT03264989|541580123|FG000|Overall Study|Adverse Event|2|||
150121428|NCT03264989|541580124|FG001|Overall Study|Adverse Event|1|||
150121429|NCT03264989|541580123|FG000|Overall Study|Death|1|||
150121430|NCT03264989|541580124|FG001|Overall Study|Death|1|||
150121431|NCT03264989|541580123|FG000|Overall Study|Pregnancy|2|||
150121432|NCT03264989|541580124|FG001|Overall Study|Pregnancy|0|||
150121433|NCT03264989|541580123|FG000|Overall Study|End of Study|19|||
150121434|NCT03264989|541580124|FG001|Overall Study|End of Study|5|||
150121435|NCT00797667|541580125|FG000|Overall Study|Lack of Efficacy|0|||
150121436|NCT00797667|541580126|FG001|Overall Study|Lack of Efficacy|1|||
150121437|NCT00797667|541580127|FG002|Overall Study|Lack of Efficacy|0|||
150121438|NCT00797667|541580125|FG000|Overall Study|Lost to Follow-up|8|||
150121439|NCT00797667|541580126|FG001|Overall Study|Lost to Follow-up|12|||
150121440|NCT00797667|541580127|FG002|Overall Study|Lost to Follow-up|2|||
150121441|NCT00797667|541580125|FG000|Overall Study|Physician Decision|3|||
150121442|NCT00797667|541580126|FG001|Overall Study|Physician Decision|1|||
150121443|NCT00797667|541580127|FG002|Overall Study|Physician Decision|0|||
150121444|NCT00797667|541580125|FG000|Overall Study|Pregnancy|2|||
150121445|NCT00797667|541580126|FG001|Overall Study|Pregnancy|0|||
150121446|NCT00797667|541580127|FG002|Overall Study|Pregnancy|0|||
150121447|NCT00797667|541580125|FG000|Overall Study|Protocol Violation|2|||
150121448|NCT00797667|541580126|FG001|Overall Study|Protocol Violation|7|||
150121449|NCT00797667|541580127|FG002|Overall Study|Protocol Violation|0|||
150121450|NCT00797667|541580125|FG000|Overall Study|Study Terminated by Sponsor|217|||
150121451|NCT00797667|541580126|FG001|Overall Study|Study Terminated by Sponsor|216|||
150121452|NCT00797667|541580127|FG002|Overall Study|Study Terminated by Sponsor|115|||
150121453|NCT00797667|541580125|FG000|Overall Study|Withdrawal by Subject|9|||
150121454|NCT00797667|541580126|FG001|Overall Study|Withdrawal by Subject|14|||
150121455|NCT00797667|541580127|FG002|Overall Study|Withdrawal by Subject|2|||
150121456|NCT00797667|541580125|FG000|Overall Study|Adverse Event|19|||
150121457|NCT00797667|541580126|FG001|Overall Study|Adverse Event|8|||
150121458|NCT00797667|541580127|FG002|Overall Study|Adverse Event|8|||
150121459|NCT03029208|541580128|FG000|Overall Study|Withdrawal by Subject|2|||
150121460|NCT03029208|541580129|FG001|Overall Study|Withdrawal by Subject|3|||
150121461|NCT03029208|541580128|FG000|Overall Study|Lost to Follow-up|0|||
150121462|NCT03029208|541580129|FG001|Overall Study|Lost to Follow-up|1|||
150121463|NCT03207750|541580132|FG000|Overall Study|Adverse Event|3|||
150121464|NCT03207750|541580133|FG001|Overall Study|Adverse Event|2|||
150121465|NCT03207750|541580132|FG000|Overall Study|Lost to Follow-up|21|||
150121466|NCT03207750|541580133|FG001|Overall Study|Lost to Follow-up|29|||
150121467|NCT03207750|541580132|FG000|Overall Study|Protocol Violation|0|||
150121468|NCT03207750|541580133|FG001|Overall Study|Protocol Violation|1|||
150121469|NCT03207750|541580132|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
150121470|NCT03207750|541580133|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
150121471|NCT03207750|541580132|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
150121472|NCT03207750|541580133|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
150121473|NCT03207750|541580132|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
150121474|NCT03207750|541580133|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
150121475|NCT03207750|541580132|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
150121476|NCT03207750|541580133|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
150121477|NCT03207750|541580132|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
150121478|NCT03207750|541580133|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
150121479|NCT02334748|541580134|FG000|Overall Study|Adverse Event|1|||
150121480|NCT02334748|541580134|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
150121481|NCT02334748|541580134|FG000|Overall Study|Patient no longer required study drug|2|||
150121482|NCT02334748|541580134|FG000|Overall Study|Lack of Efficacy|4|||
150121483|NCT02493361|541580135|FG000|Overall Study|Withdrawal by Subject|3|||
150121484|NCT03893448|541580138|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
150121485|NCT03893448|541580139|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
150121486|NCT03893448|541580138|FG000|Overall Study|Physician Decision|8|||
150121487|NCT03893448|541580139|FG001|Overall Study|Physician Decision|14|||
150121488|NCT03893448|541580138|FG000|Overall Study|Lost to Follow-up|34|||
150121489|NCT03893448|541580139|FG001|Overall Study|Lost to Follow-up|27|||
150121490|NCT03893448|541580138|FG000|Overall Study|Death|1|||
150121491|NCT03893448|541580139|FG001|Overall Study|Death|0|||
150121492|NCT01568047|541580146|FG000|Overall Study|Ineligibility|1|||
150121493|NCT01568047|541580147|FG001|Overall Study|Ineligibility|0|||
150121494|NCT01568047|541580148|FG002|Overall Study|Ineligibility|0|||
150121495|NCT01568047|541580149|FG003|Overall Study|Ineligibility|0|||
150121496|NCT01568047|541580146|FG000|Overall Study|Withdrawal by Subject|0|||
150121497|NCT01568047|541580147|FG001|Overall Study|Withdrawal by Subject|1|||
150121498|NCT01568047|541580148|FG002|Overall Study|Withdrawal by Subject|0|||
150121499|NCT01568047|541580149|FG003|Overall Study|Withdrawal by Subject|0|||
150121500|NCT01568047|541580146|FG000|Overall Study|Adverse Event|0|||
150121501|NCT01568047|541580147|FG001|Overall Study|Adverse Event|0|||
150121502|NCT01568047|541580148|FG002|Overall Study|Adverse Event|1|||
150121503|NCT01568047|541580149|FG003|Overall Study|Adverse Event|1|||
150121504|NCT00817089|541580150|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
150121505|NCT00817089|541580151|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
150121506|NCT00817089|541580152|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
150121507|NCT00817089|541580153|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
150121508|NCT00817089|541580150|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
150121509|NCT00817089|541580151|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
150121510|NCT00817089|541580152|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
150121511|NCT00817089|541580153|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
150121512|NCT03783923|541580154|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
150121513|NCT03783923|541580155|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
150121514|NCT03783923|541580154|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
150121515|NCT03783923|541580155|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
150121516|NCT03783923|541580154|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
150121517|NCT03783923|541580155|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
150121518|NCT03783923|541580154|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
150121519|NCT03783923|541580155|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
150121520|NCT03783923|541580154|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
150121521|NCT03783923|541580155|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
150121522|NCT00856583|541580159|FG000|Overall Study|Lack of Efficacy|389|||
150121523|NCT00856583|541580160|FG001|Overall Study|Lack of Efficacy|377|||
150121524|NCT00856583|541580159|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
150121525|NCT00856583|541580160|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
150121526|NCT00856583|541580159|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
150121527|NCT00856583|541580160|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
150121528|NCT00856583|541580159|FG000|Overall Study|Non-compliance|305|||
150121529|NCT00856583|541580160|FG001|Overall Study|Non-compliance|262|||
150121530|NCT00856583|541580159|FG000|Overall Study|Withdrawal by Subject|1092|||
150121531|NCT00856583|541580160|FG001|Overall Study|Withdrawal by Subject|919|||
150192592|NCT04074759|541844976|FG009|Overall Study|Withdrawal by Subject|2|||
150192593|NCT04074759|541844977|FG010|Overall Study|Withdrawal by Subject|9|||
150192594|NCT04074759|541844978|FG011|Overall Study|Withdrawal by Subject|2|||
150192595|NCT04074759|541844979|FG012|Overall Study|Withdrawal by Subject|1|||
150121532|NCT00856583|541580159|FG000|Overall Study|Physician Decision|59|||
150121533|NCT00856583|541580160|FG001|Overall Study|Physician Decision|82|||
150121534|NCT00856583|541580159|FG000|Overall Study|Pregnancy|14|||
150121535|NCT00856583|541580160|FG001|Overall Study|Pregnancy|5|||
150121536|NCT00856583|541580159|FG000|Overall Study|Other|92|||
150192596|NCT04074759|541844980|FG013|Overall Study|Withdrawal by Subject|3|||
150192597|NCT04074759|541844981|FG014|Overall Study|Withdrawal by Subject|2|||
150121537|NCT00856583|541580160|FG001|Overall Study|Other|104|||
150121538|NCT00856583|541580159|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
150121539|NCT00856583|541580160|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
150121540|NCT01944046|541580161|FG000|Randomized to DB|Adverse Event|5|||
150121541|NCT01944046|541580162|FG001|Randomized to DB|Adverse Event|2|||
150121542|NCT01944046|541580161|FG000|Randomized to DB|Clinical Worsening|3|||
150121543|NCT01944046|541580162|FG001|Randomized to DB|Clinical Worsening|2|||
150121544|NCT01944046|541580161|FG000|Randomized to DB|Lost to Follow-up|3|||
150121545|NCT01944046|541580162|FG001|Randomized to DB|Lost to Follow-up|3|||
150121546|NCT01944046|541580161|FG000|Randomized to DB|Withdrawal by Subject|2|||
150121547|NCT01944046|541580162|FG001|Randomized to DB|Withdrawal by Subject|4|||
150121548|NCT01944046|541580161|FG000|Randomized to DB|Physician Decision|1|||
150121549|NCT01944046|541580162|FG001|Randomized to DB|Physician Decision|2|||
150121550|NCT01944046|541580161|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
150121551|NCT01944046|541580162|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
150121552|NCT01944046|541580161|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
150121553|NCT01944046|541580162|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
150121554|NCT01944046|541580161|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
150121555|NCT01944046|541580162|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
150121556|NCT01944046|541580161|FG000|Open Label Eligible and Consented|Adverse Event|6|||
150121557|NCT01944046|541580162|FG001|Open Label Eligible and Consented|Adverse Event|1|||
150121558|NCT01944046|541580161|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
150121559|NCT01944046|541580162|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
150121560|NCT01944046|541580161|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
150121561|NCT01944046|541580162|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
150121562|NCT01767116|541580169|FG000|Overall Study|Lost to Follow-up|2|||
150121563|NCT01767116|541580170|FG001|Overall Study|Lost to Follow-up|2|||
150121564|NCT04307186|541580171|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
150121565|NCT04307186|541580171|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
150121566|NCT04307186|541580171|FG000|Washout 3-14 Days|Progressive disease|1|||
150121567|NCT04307186|541580171|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
150121568|NCT04307186|541580171|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
150121569|NCT03238001|541580177|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
150121570|NCT03238001|541580177|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
150121571|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
150121572|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
150121573|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
150121574|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
150121575|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
150121576|NCT03238001|541580177|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
150121577|NCT01866709|541580181|FG000|Overall Study|Adverse Event|1|||
150121578|NCT01866709|541580182|FG001|Overall Study|Adverse Event|0|||
150121579|NCT00499889|541580183|FG000|Overall Study|Infection prior to treatment|1|||
150121580|NCT00345397|541580184|FG000|Overall Study|Death|1|||
150121581|NCT03191903|541580188|FG000|Overall Study|Withdrawal by Subject|6|||
150121582|NCT03191903|541580189|FG001|Overall Study|Withdrawal by Subject|5|||
150121583|NCT03191903|541580190|FG002|Overall Study|Withdrawal by Subject|4|||
150121584|NCT03191903|541580188|FG000|Overall Study|Adverse Event|1|||
150121585|NCT03191903|541580189|FG001|Overall Study|Adverse Event|0|||
150121586|NCT03191903|541580190|FG002|Overall Study|Adverse Event|0|||
150121587|NCT00503685|541580191|FG000|Overall Study|Adverse Event|0|||
150121588|NCT00503685|541580192|FG001|Overall Study|Adverse Event|0|||
150121589|NCT00503685|541580193|FG002|Overall Study|Adverse Event|2|||
150121590|NCT00503685|541580191|FG000|Overall Study|Withdrawal by Subject|0|||
150121591|NCT00503685|541580192|FG001|Overall Study|Withdrawal by Subject|1|||
150121592|NCT00503685|541580193|FG002|Overall Study|Withdrawal by Subject|0|||
150121593|NCT00503685|541580191|FG000|Overall Study|Protocol Violation|0|||
150121594|NCT00503685|541580192|FG001|Overall Study|Protocol Violation|1|||
150121595|NCT00503685|541580193|FG002|Overall Study|Protocol Violation|0|||
150121596|NCT00503685|541580191|FG000|Overall Study|Eligibility Criteria Not Met|0|||
150121597|NCT00503685|541580192|FG001|Overall Study|Eligibility Criteria Not Met|1|||
150121598|NCT00503685|541580193|FG002|Overall Study|Eligibility Criteria Not Met|0|||
150121599|NCT00927927|541580194|FG000|Overall Study|Withdrawal by Subject|0|||
150121600|NCT00927927|541580195|FG001|Overall Study|Withdrawal by Subject|0|||
150121601|NCT00927927|541580196|FG002|Overall Study|Withdrawal by Subject|0|||
150121602|NCT00927927|541580197|FG003|Overall Study|Withdrawal by Subject|0|||
150121603|NCT00927927|541580198|FG004|Overall Study|Withdrawal by Subject|0|||
150121604|NCT00927927|541580199|FG005|Overall Study|Withdrawal by Subject|0|||
150121605|NCT00927927|541580200|FG006|Overall Study|Withdrawal by Subject|0|||
150121606|NCT00927927|541580201|FG007|Overall Study|Withdrawal by Subject|2|||
150121607|NCT00927927|541580202|FG008|Overall Study|Withdrawal by Subject|0|||
150121608|NCT00927927|541580203|FG009|Overall Study|Withdrawal by Subject|0|||
150121609|NCT00927927|541580204|FG010|Overall Study|Withdrawal by Subject|0|||
150121610|NCT00927927|541580205|FG011|Overall Study|Withdrawal by Subject|2|||
150121611|NCT00927927|541580206|FG012|Overall Study|Withdrawal by Subject|0|||
150121612|NCT00927927|541580207|FG013|Overall Study|Withdrawal by Subject|0|||
150121613|NCT00927927|541580208|FG014|Overall Study|Withdrawal by Subject|0|||
150121614|NCT03135522|541580217|FG000|Overall Study|Adverse Event|1|||
150121615|NCT03135522|541580218|FG001|Overall Study|Adverse Event|0|||
150121616|NCT01344460|541580219|FG000|Overall Study|Withdrawal by Subject|1|||
150121617|NCT01344460|541580219|FG000|Overall Study|Lost to Follow-up|2|||
150121618|NCT03483623|541580232|FG000|Overall Study|43 complete sets achieved|1|||
150121619|NCT00560833|541580233|FG000|Overall Study|Adverse Event|16|||
150121620|NCT00560833|541580234|FG001|Overall Study|Adverse Event|10|||
150121621|NCT00560833|541580235|FG002|Overall Study|Adverse Event|25|||
150121622|NCT00560833|541580236|FG003|Overall Study|Adverse Event|23|||
150121623|NCT00560833|541580237|FG004|Overall Study|Adverse Event|35|||
150121624|NCT00560833|541580233|FG000|Overall Study|Lost to Follow-up|0|||
150121625|NCT00560833|541580234|FG001|Overall Study|Lost to Follow-up|0|||
150121626|NCT00560833|541580235|FG002|Overall Study|Lost to Follow-up|1|||
150121627|NCT00560833|541580236|FG003|Overall Study|Lost to Follow-up|0|||
150121628|NCT00560833|541580237|FG004|Overall Study|Lost to Follow-up|0|||
150121629|NCT00560833|541580233|FG000|Overall Study|Lack of Efficacy|22|||
150121630|NCT00560833|541580234|FG001|Overall Study|Lack of Efficacy|9|||
150121631|NCT00560833|541580235|FG002|Overall Study|Lack of Efficacy|6|||
150121632|NCT00560833|541580236|FG003|Overall Study|Lack of Efficacy|4|||
150121633|NCT00560833|541580237|FG004|Overall Study|Lack of Efficacy|4|||
150121634|NCT00560833|541580233|FG000|Overall Study|Participant uncooperative|5|||
150192598|NCT04074759|541844982|FG015|Overall Study|Withdrawal by Subject|0|||
150192599|NCT04074759|541844983|FG016|Overall Study|Withdrawal by Subject|0|||
150192600|NCT04074759|541844984|FG017|Overall Study|Withdrawal by Subject|3|||
150121635|NCT00560833|541580234|FG001|Overall Study|Participant uncooperative|5|||
150121636|NCT00560833|541580235|FG002|Overall Study|Participant uncooperative|4|||
150121637|NCT00560833|541580236|FG003|Overall Study|Participant uncooperative|4|||
150192601|NCT04074759|541844985|FG018|Overall Study|Withdrawal by Subject|1|||
150192602|NCT04074759|541844967|FG000|Overall Study|Death|1|||
150192603|NCT04074759|541844968|FG001|Overall Study|Death|0|||
150192604|NCT04074759|541844969|FG002|Overall Study|Death|1|||
150192605|NCT04074759|541844970|FG003|Overall Study|Death|1|||
150192606|NCT04074759|541844971|FG004|Overall Study|Death|2|||
150192607|NCT04074759|541844972|FG005|Overall Study|Death|0|||
150192608|NCT04074759|541844973|FG006|Overall Study|Death|1|||
150192609|NCT04074759|541844974|FG007|Overall Study|Death|0|||
150192610|NCT04074759|541844975|FG008|Overall Study|Death|3|||
150192611|NCT04074759|541844976|FG009|Overall Study|Death|2|||
150192612|NCT04074759|541844977|FG010|Overall Study|Death|4|||
150192613|NCT04074759|541844978|FG011|Overall Study|Death|1|||
150192614|NCT04074759|541844979|FG012|Overall Study|Death|0|||
150192615|NCT04074759|541844980|FG013|Overall Study|Death|2|||
150192616|NCT04074759|541844981|FG014|Overall Study|Death|1|||
150192617|NCT04074759|541844982|FG015|Overall Study|Death|0|||
150192618|NCT04074759|541844983|FG016|Overall Study|Death|1|||
150192619|NCT04074759|541844984|FG017|Overall Study|Death|0|||
150192620|NCT04074759|541844985|FG018|Overall Study|Death|1|||
150192621|NCT04074759|541844967|FG000|Overall Study|Lost to Follow-up|0|||
150192622|NCT04074759|541844968|FG001|Overall Study|Lost to Follow-up|0|||
150192623|NCT04074759|541844969|FG002|Overall Study|Lost to Follow-up|0|||
150192624|NCT04074759|541844970|FG003|Overall Study|Lost to Follow-up|0|||
150192625|NCT04074759|541844971|FG004|Overall Study|Lost to Follow-up|0|||
150192626|NCT04074759|541844972|FG005|Overall Study|Lost to Follow-up|0|||
150192627|NCT04074759|541844973|FG006|Overall Study|Lost to Follow-up|0|||
150192628|NCT04074759|541844974|FG007|Overall Study|Lost to Follow-up|0|||
150192629|NCT04074759|541844975|FG008|Overall Study|Lost to Follow-up|0|||
150192630|NCT04074759|541844976|FG009|Overall Study|Lost to Follow-up|0|||
150192631|NCT04074759|541844977|FG010|Overall Study|Lost to Follow-up|1|||
150192632|NCT04074759|541844978|FG011|Overall Study|Lost to Follow-up|0|||
150192633|NCT04074759|541844979|FG012|Overall Study|Lost to Follow-up|0|||
150192634|NCT04074759|541844980|FG013|Overall Study|Lost to Follow-up|0|||
150192635|NCT04074759|541844981|FG014|Overall Study|Lost to Follow-up|0|||
150192636|NCT04074759|541844982|FG015|Overall Study|Lost to Follow-up|0|||
150192637|NCT04074759|541844983|FG016|Overall Study|Lost to Follow-up|1|||
150192638|NCT04074759|541844984|FG017|Overall Study|Lost to Follow-up|0|||
150192639|NCT04074759|541844985|FG018|Overall Study|Lost to Follow-up|1|||
150192640|NCT04074759|541844967|FG000|Overall Study|Other|0|||
150192641|NCT04074759|541844968|FG001|Overall Study|Other|1|||
150192642|NCT04074759|541844969|FG002|Overall Study|Other|1|||
150121638|NCT00560833|541580237|FG004|Overall Study|Participant uncooperative|2|||
150121639|NCT00560833|541580233|FG000|Overall Study|Other|1|||
150192643|NCT04074759|541844970|FG003|Overall Study|Other|0|||
150192644|NCT04074759|541844971|FG004|Overall Study|Other|2|||
150192645|NCT04074759|541844972|FG005|Overall Study|Other|1|||
150192646|NCT04074759|541844973|FG006|Overall Study|Other|2|||
150121640|NCT00560833|541580234|FG001|Overall Study|Other|1|||
150121641|NCT00560833|541580235|FG002|Overall Study|Other|3|||
150121642|NCT00560833|541580236|FG003|Overall Study|Other|0|||
150121643|NCT00560833|541580237|FG004|Overall Study|Other|0|||
150121644|NCT00560833|541580233|FG000|Overall Study|Never received drug|0|||
150121645|NCT00560833|541580234|FG001|Overall Study|Never received drug|1|||
150121646|NCT00560833|541580235|FG002|Overall Study|Never received drug|0|||
150121647|NCT00560833|541580236|FG003|Overall Study|Never received drug|0|||
150121648|NCT00560833|541580237|FG004|Overall Study|Never received drug|1|||
150121649|NCT01059617|541580240|FG000|Overall Study|Other|7|||
150121650|NCT01059617|541580241|FG001|Overall Study|Other|1|||
150121651|NCT01059617|541580242|FG002|Overall Study|Other|8|||
150121652|NCT01059617|541580243|FG003|Overall Study|Other|6|||
150121653|NCT00612313|541580246|FG000|Overall Study|Withdrawal by Subject|6|||
150121654|NCT00612313|541580247|FG001|Overall Study|Withdrawal by Subject|9|||
150121655|NCT00612313|541580246|FG000|Overall Study|Lost to Follow-up|11|||
150121656|NCT00612313|541580247|FG001|Overall Study|Lost to Follow-up|4|||
150121657|NCT03864614|541580251|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
150121658|NCT03864614|541580252|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
150121659|NCT03864614|541580253|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
150121660|NCT03864614|541580254|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
150121661|NCT03864614|541580251|FG000|Overall Study|Withdrawal by Subject|72|||
150121662|NCT03864614|541580252|FG001|Overall Study|Withdrawal by Subject|100|||
150121663|NCT03864614|541580253|FG002|Overall Study|Withdrawal by Subject|1|||
150121664|NCT03864614|541580254|FG003|Overall Study|Withdrawal by Subject|21|||
150121665|NCT03864614|541580251|FG000|Overall Study|Lost to Follow-up|45|||
150121666|NCT03864614|541580252|FG001|Overall Study|Lost to Follow-up|54|||
150121667|NCT03864614|541580253|FG002|Overall Study|Lost to Follow-up|0|||
150121668|NCT03864614|541580254|FG003|Overall Study|Lost to Follow-up|9|||
150121669|NCT03864614|541580251|FG000|Overall Study|Adverse Event|42|||
150121670|NCT03864614|541580252|FG001|Overall Study|Adverse Event|30|||
150121671|NCT03864614|541580253|FG002|Overall Study|Adverse Event|1|||
150121672|NCT03864614|541580254|FG003|Overall Study|Adverse Event|9|||
150121673|NCT03864614|541580251|FG000|Overall Study|Protocol Deviation|6|||
150121674|NCT03864614|541580252|FG001|Overall Study|Protocol Deviation|26|||
150121675|NCT03864614|541580253|FG002|Overall Study|Protocol Deviation|0|||
150121676|NCT03864614|541580254|FG003|Overall Study|Protocol Deviation|1|||
150121677|NCT03864614|541580251|FG000|Overall Study|Physician Decision|7|||
150121678|NCT03864614|541580252|FG001|Overall Study|Physician Decision|10|||
150121679|NCT03864614|541580253|FG002|Overall Study|Physician Decision|1|||
150121680|NCT03864614|541580254|FG003|Overall Study|Physician Decision|5|||
150121681|NCT03864614|541580251|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
150121682|NCT03864614|541580252|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
150121683|NCT03864614|541580253|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
150121684|NCT03864614|541580254|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
150121685|NCT03864614|541580251|FG000|Overall Study|Sponsor Decision|1|||
150121686|NCT03864614|541580252|FG001|Overall Study|Sponsor Decision|2|||
150121687|NCT03864614|541580253|FG002|Overall Study|Sponsor Decision|0|||
150121688|NCT03864614|541580254|FG003|Overall Study|Sponsor Decision|0|||
150121689|NCT03864614|541580251|FG000|Overall Study|Pregnancy|0|||
150121690|NCT03864614|541580252|FG001|Overall Study|Pregnancy|1|||
150121691|NCT03864614|541580253|FG002|Overall Study|Pregnancy|0|||
150121692|NCT03864614|541580254|FG003|Overall Study|Pregnancy|0|||
150121693|NCT03864614|541580251|FG000|Overall Study|Other|7|||
150121694|NCT03864614|541580252|FG001|Overall Study|Other|9|||
150121695|NCT03864614|541580253|FG002|Overall Study|Other|1|||
150121696|NCT03864614|541580254|FG003|Overall Study|Other|4|||
150121697|NCT03864614|541580251|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
150121698|NCT03864614|541580252|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
150192647|NCT04074759|541844974|FG007|Overall Study|Other|1|||
150192648|NCT04074759|541844975|FG008|Overall Study|Other|1|||
150192649|NCT04074759|541844976|FG009|Overall Study|Other|4|||
150192650|NCT04074759|541844977|FG010|Overall Study|Other|4|||
150192651|NCT04074759|541844978|FG011|Overall Study|Other|2|||
150192652|NCT04074759|541844979|FG012|Overall Study|Other|0|||
150192653|NCT04074759|541844980|FG013|Overall Study|Other|0|||
150192654|NCT04074759|541844981|FG014|Overall Study|Other|0|||
150192655|NCT04074759|541844982|FG015|Overall Study|Other|1|||
150192656|NCT04074759|541844983|FG016|Overall Study|Other|0|||
150192657|NCT04074759|541844984|FG017|Overall Study|Other|0|||
150192658|NCT04074759|541844985|FG018|Overall Study|Other|0|||
150192659|NCT04074759|541844967|FG000|Overall Study|Missing end of study status|0|||
150192660|NCT04074759|541844968|FG001|Overall Study|Missing end of study status|0|||
150192661|NCT04074759|541844969|FG002|Overall Study|Missing end of study status|0|||
150192662|NCT04074759|541844970|FG003|Overall Study|Missing end of study status|0|||
150192663|NCT04074759|541844971|FG004|Overall Study|Missing end of study status|0|||
150192664|NCT04074759|541844972|FG005|Overall Study|Missing end of study status|0|||
150192665|NCT04074759|541844973|FG006|Overall Study|Missing end of study status|0|||
150192666|NCT04074759|541844974|FG007|Overall Study|Missing end of study status|0|||
150192667|NCT04074759|541844975|FG008|Overall Study|Missing end of study status|0|||
150192668|NCT04074759|541844976|FG009|Overall Study|Missing end of study status|0|||
150192669|NCT04074759|541844977|FG010|Overall Study|Missing end of study status|2|||
150192670|NCT04074759|541844978|FG011|Overall Study|Missing end of study status|0|||
150192671|NCT04074759|541844979|FG012|Overall Study|Missing end of study status|0|||
150192672|NCT04074759|541844980|FG013|Overall Study|Missing end of study status|0|||
150192673|NCT04074759|541844981|FG014|Overall Study|Missing end of study status|0|||
150192674|NCT04074759|541844982|FG015|Overall Study|Missing end of study status|0|||
150192675|NCT04074759|541844983|FG016|Overall Study|Missing end of study status|1|||
150192676|NCT04074759|541844984|FG017|Overall Study|Missing end of study status|0|||
150192677|NCT04074759|541844985|FG018|Overall Study|Missing end of study status|0|||
150192678|NCT03631784|541844987|FG000|Overall Study|Participants Ongoing|1|||
150192679|NCT03631784|541844988|FG001|Overall Study|Participants Ongoing|0|||
150192680|NCT03631784|541844987|FG000|Overall Study|Withdrawal by Subject|3|||
150192681|NCT03631784|541844988|FG001|Overall Study|Withdrawal by Subject|3|||
150192682|NCT03631784|541844987|FG000|Overall Study|Sponsor's Decision|36|||
150192683|NCT03631784|541844988|FG001|Overall Study|Sponsor's Decision|52|||
150192684|NCT03631784|541844987|FG000|Overall Study|Lost to Follow-up|1|||
150192685|NCT03631784|541844988|FG001|Overall Study|Lost to Follow-up|0|||
150192686|NCT03631784|541844987|FG000|Overall Study|Death|71|||
150192687|NCT03631784|541844988|FG001|Overall Study|Death|49|||
150192688|NCT05329220|541844989|FG000|Active Trial Period|Adverse Event|0|||
150192689|NCT05329220|541844990|FG001|Active Trial Period|Adverse Event|0|||
150192690|NCT05329220|541844991|FG002|Active Trial Period|Adverse Event|0|||
150192691|NCT05329220|541844992|FG003|Active Trial Period|Adverse Event|0|||
150192692|NCT05329220|541844993|FG004|Active Trial Period|Adverse Event|1|||
150192693|NCT05329220|541844994|FG005|Active Trial Period|Adverse Event|0|||
150192694|NCT05329220|541844989|FG000|Active Trial Period|Lost to Follow-up|0|||
150192695|NCT05329220|541844990|FG001|Active Trial Period|Lost to Follow-up|0|||
150192696|NCT05329220|541844991|FG002|Active Trial Period|Lost to Follow-up|0|||
150192697|NCT05329220|541844992|FG003|Active Trial Period|Lost to Follow-up|0|||
150192698|NCT05329220|541844993|FG004|Active Trial Period|Lost to Follow-up|32|||
150192699|NCT05329220|541844994|FG005|Active Trial Period|Lost to Follow-up|28|||
150192700|NCT05329220|541844989|FG000|Active Trial Period|Physician Decision|0|||
150192701|NCT05329220|541844990|FG001|Active Trial Period|Physician Decision|0|||
150192702|NCT05329220|541844991|FG002|Active Trial Period|Physician Decision|0|||
150192703|NCT05329220|541844992|FG003|Active Trial Period|Physician Decision|0|||
150192704|NCT05329220|541844993|FG004|Active Trial Period|Physician Decision|2|||
150192705|NCT05329220|541844994|FG005|Active Trial Period|Physician Decision|0|||
150192706|NCT05329220|541844989|FG000|Active Trial Period|Protocol Violation|0|||
150192707|NCT05329220|541844990|FG001|Active Trial Period|Protocol Violation|0|||
150192708|NCT05329220|541844991|FG002|Active Trial Period|Protocol Violation|0|||
150192709|NCT05329220|541844992|FG003|Active Trial Period|Protocol Violation|0|||
150192710|NCT05329220|541844993|FG004|Active Trial Period|Protocol Violation|1|||
150192711|NCT05329220|541844994|FG005|Active Trial Period|Protocol Violation|3|||
150192712|NCT05329220|541844989|FG000|Active Trial Period|Withdrawal by Subject|0|||
150192713|NCT05329220|541844990|FG001|Active Trial Period|Withdrawal by Subject|0|||
150192714|NCT05329220|541844991|FG002|Active Trial Period|Withdrawal by Subject|0|||
150192715|NCT05329220|541844992|FG003|Active Trial Period|Withdrawal by Subject|1|||
150192716|NCT05329220|541844993|FG004|Active Trial Period|Withdrawal by Subject|12|||
150192717|NCT05329220|541844994|FG005|Active Trial Period|Withdrawal by Subject|13|||
150192718|NCT05329220|541844989|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
150192719|NCT05329220|541844990|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
150192720|NCT05329220|541844991|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
150192721|NCT05329220|541844992|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
150255274|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
150121699|NCT03864614|541580253|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
150121700|NCT03864614|541580254|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
150121701|NCT00136955|541582094|FG000|Overall Study|Adverse Event|8|||
150121702|NCT00136955|541582094|FG000|Overall Study|Lost to Follow-up|1|||
150121703|NCT00136955|541582094|FG000|Overall Study|Withdrawal by Subject|2|||
150121704|NCT00136955|541582094|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
150121705|NCT02239510|541582095|FG000|Overall Study|Lost to Follow-up|2|||
150121706|NCT02239510|541582096|FG001|Overall Study|Lost to Follow-up|1|||
150121707|NCT00074282|541582100|FG000|Step 1|Adverse Event|32|||
150121708|NCT00074282|541582101|FG001|Step 1|Adverse Event|0|||
150121709|NCT00074282|541582102|FG002|Step 1|Adverse Event|0|||
150121710|NCT00074282|541582100|FG000|Step 1|Death|6|||
150121711|NCT00074282|541582101|FG001|Step 1|Death|0|||
150121712|NCT00074282|541582102|FG002|Step 1|Death|0|||
150121713|NCT00074282|541582100|FG000|Step 1|Withdrawal by Subject|7|||
150121714|NCT00074282|541582101|FG001|Step 1|Withdrawal by Subject|0|||
150121715|NCT00074282|541582102|FG002|Step 1|Withdrawal by Subject|0|||
150121716|NCT00074282|541582100|FG000|Step 1|Disease progression|2|||
150121717|NCT00074282|541582101|FG001|Step 1|Disease progression|0|||
150121718|NCT00074282|541582102|FG002|Step 1|Disease progression|0|||
150121719|NCT00074282|541582100|FG000|Step 1|Alternative therapy|2|||
150121720|NCT00074282|541582101|FG001|Step 1|Alternative therapy|0|||
150121721|NCT00074282|541582102|FG002|Step 1|Alternative therapy|0|||
150121722|NCT00074282|541582100|FG000|Step 1|Other complicating disease|2|||
150121723|NCT00074282|541582101|FG001|Step 1|Other complicating disease|0|||
150121724|NCT00074282|541582102|FG002|Step 1|Other complicating disease|0|||
150121725|NCT00074282|541582100|FG000|Step 1|Physician Decision|1|||
150121726|NCT00074282|541582101|FG001|Step 1|Physician Decision|0|||
150121727|NCT00074282|541582102|FG002|Step 1|Physician Decision|0|||
150121728|NCT00074282|541582100|FG000|Step 1|Ineligible|4|||
150121729|NCT00074282|541582101|FG001|Step 1|Ineligible|0|||
150121730|NCT00074282|541582102|FG002|Step 1|Ineligible|0|||
150121731|NCT00074282|541582100|FG000|Step 1|Never started treatment|2|||
150121732|NCT00074282|541582101|FG001|Step 1|Never started treatment|0|||
150121733|NCT00074282|541582102|FG002|Step 1|Never started treatment|0|||
150121734|NCT00074282|541582100|FG000|Step 2|Adverse Event|0|||
150121735|NCT00074282|541582101|FG001|Step 2|Adverse Event|2|||
150121736|NCT00074282|541582102|FG002|Step 2|Adverse Event|12|||
150121737|NCT00074282|541582100|FG000|Step 2|Disease progression|0|||
150121738|NCT00074282|541582101|FG001|Step 2|Disease progression|0|||
150121739|NCT00074282|541582102|FG002|Step 2|Disease progression|5|||
150121740|NCT00074282|541582100|FG000|Step 2|Death|0|||
150121741|NCT00074282|541582101|FG001|Step 2|Death|0|||
150121742|NCT00074282|541582102|FG002|Step 2|Death|3|||
150121743|NCT00074282|541582100|FG000|Step 2|Withdrawal by Subject|0|||
150121744|NCT00074282|541582101|FG001|Step 2|Withdrawal by Subject|0|||
150121745|NCT00074282|541582102|FG002|Step 2|Withdrawal by Subject|2|||
150121746|NCT00074282|541582100|FG000|Step 2|Physician Decision|0|||
150121747|NCT00074282|541582101|FG001|Step 2|Physician Decision|0|||
150121748|NCT00074282|541582102|FG002|Step 2|Physician Decision|1|||
150121749|NCT00074282|541582100|FG000|Step 2|Ineligible|0|||
150121750|NCT00074282|541582101|FG001|Step 2|Ineligible|0|||
150121751|NCT00074282|541582102|FG002|Step 2|Ineligible|1|||
150121752|NCT00464542|541582103|FG000|Pre-treatment|Withdrawal by Subject|2|||
150121753|NCT01773226|541582105|FG000|Overall Study|Withdrawal by Subject|1|||
150121754|NCT04401579|541582106|FG000|Overall Study|Death|23|||
150121755|NCT04401579|541582107|FG001|Overall Study|Death|36|||
150121756|NCT04401579|541582106|FG000|Overall Study|Lost to Follow-up|40|||
150121757|NCT04401579|541582107|FG001|Overall Study|Lost to Follow-up|41|||
150121758|NCT04401579|541582106|FG000|Overall Study|Withdrawal by Subject|8|||
150121759|NCT04401579|541582107|FG001|Overall Study|Withdrawal by Subject|16|||
150121760|NCT04401579|541582106|FG000|Overall Study|Physician Decision|1|||
150121761|NCT04401579|541582107|FG001|Overall Study|Physician Decision|2|||
150121762|NCT04401579|541582106|FG000|Overall Study|Became ineligible after enrollment|1|||
150121763|NCT04401579|541582107|FG001|Overall Study|Became ineligible after enrollment|1|||
150121764|NCT04401579|541582106|FG000|Overall Study|Enrolled but treatment not administered|7|||
150121765|NCT04401579|541582107|FG001|Overall Study|Enrolled but treatment not administered|9|||
150121766|NCT04401579|541582106|FG000|Overall Study|Adverse Event|2|||
150121767|NCT04401579|541582107|FG001|Overall Study|Adverse Event|1|||
150121768|NCT04401579|541582106|FG000|Overall Study|Scheduling error|1|||
150121769|NCT04401579|541582107|FG001|Overall Study|Scheduling error|2|||
150121770|NCT04401579|541582106|FG000|Overall Study|Transferred to another hospital|1|||
150255275|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
150121771|NCT04401579|541582107|FG001|Overall Study|Transferred to another hospital|2|||
150121772|NCT00489970|541582108|FG000|Persistence Year 9|Lost to Follow-up|2|||
150121773|NCT00489970|541582109|FG001|Persistence Year 9|Lost to Follow-up|2|||
150121774|NCT00489970|541582110|FG002|Persistence Year 9|Lost to Follow-up|3|||
150121775|NCT00489970|541582108|FG000|Persistence Year 9|Other|1|||
150121776|NCT00489970|541582109|FG001|Persistence Year 9|Other|0|||
150121777|NCT00489970|541582110|FG002|Persistence Year 9|Other|2|||
150121778|NCT01438411|541582111|FG000|Overall Study|Adverse Event|8|||
150121779|NCT01438411|541582111|FG000|Overall Study|Lost to Follow-up|1|||
150121780|NCT01438411|541582111|FG000|Overall Study|Lack of Efficacy|1|||
150121781|NCT01438411|541582111|FG000|Overall Study|Withdrawal by Subject|3|||
150121782|NCT00618514|541582112|FG000|Overall Study|Lost to Follow-up|11|||
150121783|NCT00618514|541582113|FG001|Overall Study|Lost to Follow-up|12|||
150121784|NCT00618514|541582114|FG002|Overall Study|Lost to Follow-up|4|||
150121785|NCT02053350|541582119|FG000|Overall Study|Withdrawal by Subject|1|||
150121786|NCT02053350|541582119|FG000|Overall Study|Adverse Event|4|||
150121787|NCT02244944|541582120|FG000|Overall Study|Withdrawal by Subject|1|||
150121788|NCT02244944|541582120|FG000|Overall Study|Study Terminated|1|||
150121789|NCT01747772|541582121|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
150121790|NCT01928719|541582124|FG000|Overall Study|Lost to Follow-up|26|||
150121791|NCT01928719|541582125|FG001|Overall Study|Lost to Follow-up|11|||
150121792|NCT01928719|541582124|FG000|Overall Study|Withdrawal by Subject|22|||
150121793|NCT01928719|541582125|FG001|Overall Study|Withdrawal by Subject|7|||
150121794|NCT01928719|541582124|FG000|Overall Study|Protocol Violation|3|||
150121795|NCT01928719|541582125|FG001|Overall Study|Protocol Violation|1|||
150121796|NCT01928719|541582124|FG000|Overall Study|Adverse Event|1|||
150121797|NCT01928719|541582125|FG001|Overall Study|Adverse Event|0|||
150121798|NCT03832010|541582126|FG000|Overall Study|Withdrawal by Subject|2|||
150121799|NCT03832010|541582127|FG001|Overall Study|Withdrawal by Subject|1|||
150121800|NCT03832010|541582128|FG002|Overall Study|Withdrawal by Subject|0|||
150121801|NCT03832010|541582126|FG000|Overall Study|Lost to Follow-up|2|||
150121802|NCT03832010|541582127|FG001|Overall Study|Lost to Follow-up|1|||
150121803|NCT03832010|541582128|FG002|Overall Study|Lost to Follow-up|1|||
150121804|NCT04495374|541582132|FG000|Overall Study|Protocol Violation|2|||
150121805|NCT04495374|541582133|FG001|Overall Study|Protocol Violation|1|||
150121806|NCT03727750|541582134|FG000|Overall Study|Death|45|||
150121807|NCT03727750|541582134|FG000|Overall Study|Withdrawal by Subject|2|||
150121808|NCT03727750|541582134|FG000|Overall Study|Lost to Follow-up|1|||
150121809|NCT03727750|541582134|FG000|Overall Study|Other|1|||
150121810|NCT01054820|541582137|FG000|Overall Study|Withdrawal by Subject|2|||
150121811|NCT00321919|541582138|FG000|Overall Study|Adverse Event|17|||
150121812|NCT00321919|541582139|FG001|Overall Study|Adverse Event|10|||
150121813|NCT00321919|541582138|FG000|Overall Study|Death|21|||
150121814|NCT00321919|541582139|FG001|Overall Study|Death|17|||
150121815|NCT00321919|541582138|FG000|Overall Study|Insufficient Therapeutic Response|1|||
150121816|NCT00321919|541582139|FG001|Overall Study|Insufficient Therapeutic Response|0|||
150121817|NCT00321919|541582138|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
150121818|NCT00321919|541582139|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
150121819|NCT00321919|541582138|FG000|Overall Study|Refused Treatment|23|||
150121820|NCT00321919|541582139|FG001|Overall Study|Refused Treatment|14|||
150121821|NCT00321919|541582138|FG000|Overall Study|Other Protocol Violation|2|||
150121822|NCT00321919|541582139|FG001|Overall Study|Other Protocol Violation|3|||
150121823|NCT00321919|541582138|FG000|Overall Study|Failure to Return|3|||
150121824|NCT00321919|541582139|FG001|Overall Study|Failure to Return|1|||
150121825|NCT00321919|541582138|FG000|Overall Study|Other withdrawal reason|7|||
150121826|NCT00321919|541582139|FG001|Overall Study|Other withdrawal reason|6|||
150121827|NCT02624804|541582140|FG000|Overall Study|Screen Failure|5|||
150121828|NCT02590354|541582141|FG000|Phase 1|Active hepatitis B or C infection|1|||
150121829|NCT02590354|541582141|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
150121830|NCT02590354|541582141|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
150121831|NCT02590354|541582141|FG000|Phase 1|Subject does not want to participate|20|||
150121832|NCT02590354|541582141|FG000|Phase 1|Lost to Follow-up|1|||
150121833|NCT02590354|541582141|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
150121834|NCT00996996|541582142|FG000|Overall Study|Progressive Disease|10|||
150121835|NCT00996996|541582142|FG000|Overall Study|Non-compliance|8|||
150121836|NCT00996996|541582142|FG000|Overall Study|Lost to Follow-up|9|||
150121837|NCT00996996|541582142|FG000|Overall Study|Death|5|||
150121838|NCT00996996|541582142|FG000|Overall Study|Did Not Receive Study Medications|1|||
150121839|NCT00760929|541582143|FG000|Overall Study|Adverse Event|2|||
150121840|NCT00760929|541582144|FG001|Overall Study|Adverse Event|0|||
150121841|NCT00760929|541582145|FG002|Overall Study|Adverse Event|6|||
150121842|NCT00760929|541582146|FG003|Overall Study|Adverse Event|10|||
150121843|NCT00760929|541582143|FG000|Overall Study|Lack of Efficacy|0|||
150121844|NCT00760929|541582144|FG001|Overall Study|Lack of Efficacy|2|||
150121845|NCT00760929|541582145|FG002|Overall Study|Lack of Efficacy|1|||
150121846|NCT00760929|541582146|FG003|Overall Study|Lack of Efficacy|0|||
150121847|NCT00760929|541582143|FG000|Overall Study|Withdrawal by Subject|1|||
150121848|NCT00760929|541582144|FG001|Overall Study|Withdrawal by Subject|0|||
150121849|NCT00760929|541582145|FG002|Overall Study|Withdrawal by Subject|9|||
150121850|NCT00760929|541582146|FG003|Overall Study|Withdrawal by Subject|1|||
150121851|NCT00760929|541582143|FG000|Overall Study|Lost to Follow-up|0|||
150121852|NCT00760929|541582144|FG001|Overall Study|Lost to Follow-up|0|||
150121853|NCT00760929|541582145|FG002|Overall Study|Lost to Follow-up|1|||
150121854|NCT00760929|541582146|FG003|Overall Study|Lost to Follow-up|0|||
150121855|NCT00760929|541582143|FG000|Overall Study|Progression of Disease|21|||
150121856|NCT00760929|541582144|FG001|Overall Study|Progression of Disease|26|||
150121857|NCT00760929|541582145|FG002|Overall Study|Progression of Disease|38|||
150121858|NCT00760929|541582146|FG003|Overall Study|Progression of Disease|42|||
150121859|NCT00760929|541582143|FG000|Overall Study|Other|2|||
150121860|NCT00760929|541582144|FG001|Overall Study|Other|0|||
150121861|NCT00760929|541582145|FG002|Overall Study|Other|2|||
150121862|NCT00760929|541582146|FG003|Overall Study|Other|1|||
150121863|NCT00760929|541582143|FG000|Overall Study|Death|0|||
150121864|NCT00760929|541582144|FG001|Overall Study|Death|0|||
150121865|NCT00760929|541582145|FG002|Overall Study|Death|1|||
150121866|NCT00760929|541582146|FG003|Overall Study|Death|0|||
150121867|NCT00760929|541582143|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
150121868|NCT00760929|541582144|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
150121869|NCT00760929|541582145|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
150121870|NCT00760929|541582146|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
150121871|NCT01666002|541582147|FG000|Overall Study|Lost to Follow-up|5|||
150121872|NCT01666002|541582148|FG001|Overall Study|Lost to Follow-up|0|||
150121873|NCT01255358|541582168|FG000|Overall Study|Adverse Event|2|||
150121874|NCT01255358|541582168|FG000|Overall Study|Protocol Violation|2|||
150121875|NCT03950739|541582169|FG000|Treatment Phase|Adverse Event|2|||
150121876|NCT03950739|541582169|FG000|Optional Extension Phase|Death|1|||
150121877|NCT03950739|541582169|FG000|Optional Extension Phase|Progressive Disease|5|||
150121878|NCT03950739|541582169|FG000|Optional Extension Phase|Adverse Event|7|||
150121879|NCT03950739|541582169|FG000|Optional Extension Phase|Lost to Follow-up|2|||
150121880|NCT03950739|541582169|FG000|Optional Extension Phase|Site Closure|2|||
150121881|NCT03950739|541582169|FG000|Optional Extension Phase|Pregnancy|1|||
150121882|NCT03625570|541582170|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
150121883|NCT03625570|541582171|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
150121884|NCT03625570|541582170|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
150121885|NCT03625570|541582171|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
150121886|NCT03625570|541582170|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
150121887|NCT03625570|541582171|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
150121888|NCT01343056|541582174|FG000|Overall Study|Lost to Follow-up|7|||
150121889|NCT01343056|541582175|FG001|Overall Study|Lost to Follow-up|5|||
150121890|NCT01343056|541582176|FG002|Overall Study|Lost to Follow-up|3|||
150121891|NCT01343056|541582177|FG003|Overall Study|Lost to Follow-up|9|||
150121892|NCT00345579|541582178|FG000|Overall Study|Adverse Event|9|||
150121893|NCT00345579|541582179|FG001|Overall Study|Adverse Event|6|||
150121894|NCT00345579|541582178|FG000|Overall Study|Protocol Violation|14|||
150121895|NCT00345579|541582179|FG001|Overall Study|Protocol Violation|5|||
150121896|NCT00345579|541582178|FG000|Overall Study|Withdrawal by Subject|50|||
150121897|NCT00345579|541582179|FG001|Overall Study|Withdrawal by Subject|17|||
150121898|NCT00345579|541582178|FG000|Overall Study|Lost to Follow-up|82|||
150121899|NCT00345579|541582179|FG001|Overall Study|Lost to Follow-up|36|||
150121900|NCT00345579|541582178|FG000|Overall Study|Other|9|||
150121901|NCT00345579|541582179|FG001|Overall Study|Other|1|||
150121902|NCT01732835|541582180|FG000|6-month Primary Endpoint|Did not receive device|19|||
150121903|NCT01732835|541582180|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
150121904|NCT01732835|541582180|FG000|6-month Primary Endpoint|Adverse Event|3|||
150121905|NCT01732835|541582180|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
150121906|NCT01732835|541582180|FG000|2-year Extended Follow-up|Adverse Event|3|||
150121907|NCT01732835|541582180|FG000|2-year Extended Follow-up|Death|1|||
150121908|NCT01046643|541582181|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
150121909|NCT01046643|541582182|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
150121910|NCT01046643|541582183|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
150121911|NCT01046643|541582184|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
150121912|NCT01175668|541582191|FG000|Overall Study|Withdrawal by Subject|2|||
150121913|NCT01175668|541582192|FG001|Overall Study|Withdrawal by Subject|0|||
150121914|NCT02937545|541582193|FG000|Overall Study|Withdrawal by Subject|1|||
150121915|NCT02937545|541582194|FG001|Overall Study|Withdrawal by Subject|2|||
150121916|NCT02937545|541582195|FG002|Overall Study|Withdrawal by Subject|6|||
150121917|NCT02937545|541582196|FG003|Overall Study|Withdrawal by Subject|7|||
150121918|NCT02937545|541582193|FG000|Overall Study|Lost to Follow-up|1|||
150121919|NCT02937545|541582194|FG001|Overall Study|Lost to Follow-up|0|||
150121920|NCT02937545|541582195|FG002|Overall Study|Lost to Follow-up|0|||
150121921|NCT02937545|541582196|FG003|Overall Study|Lost to Follow-up|0|||
150121922|NCT02007577|541582199|FG000|Overall Study|Adverse Event|1|||
150121923|NCT02007577|541582200|FG001|Overall Study|Adverse Event|0|||
150121924|NCT02007577|541582199|FG000|Overall Study|Withdrawal by Subject|0|||
150121925|NCT02007577|541582200|FG001|Overall Study|Withdrawal by Subject|1|||
150121926|NCT02504294|541582201|FG000|Overall Study|Adverse Event|15|||
150121927|NCT02504294|541582202|FG001|Overall Study|Adverse Event|12|||
150121928|NCT02504294|541582201|FG000|Overall Study|Withdrawal by Subject|7|||
150121929|NCT02504294|541582202|FG001|Overall Study|Withdrawal by Subject|1|||
150121930|NCT02504294|541582201|FG000|Overall Study|Protocol Violation|27|||
150192722|NCT05329220|541844993|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
150192723|NCT05329220|541844994|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
150192724|NCT05329220|541844989|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
150192725|NCT05329220|541844990|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
150192726|NCT05329220|541844991|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
150192727|NCT05329220|541844992|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
150192728|NCT05329220|541844993|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
150192729|NCT05329220|541844994|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
150192730|NCT05329220|541844989|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
150192731|NCT05329220|541844990|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
150192732|NCT05329220|541844991|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
150192733|NCT05329220|541844992|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
150192734|NCT05329220|541844993|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
150192735|NCT05329220|541844994|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
150192736|NCT05329220|541844989|FG000|Follow-up Period|Adverse Event|0|||
150192737|NCT05329220|541844990|FG001|Follow-up Period|Adverse Event|0|||
150192738|NCT05329220|541844991|FG002|Follow-up Period|Adverse Event|0|||
150192739|NCT05329220|541844992|FG003|Follow-up Period|Adverse Event|0|||
150192740|NCT05329220|541844993|FG004|Follow-up Period|Adverse Event|2|||
150192741|NCT05329220|541844994|FG005|Follow-up Period|Adverse Event|1|||
150192742|NCT05329220|541844989|FG000|Follow-up Period|Death|0|||
150192743|NCT05329220|541844990|FG001|Follow-up Period|Death|0|||
150192744|NCT05329220|541844991|FG002|Follow-up Period|Death|1|||
150192745|NCT05329220|541844992|FG003|Follow-up Period|Death|1|||
150192746|NCT05329220|541844993|FG004|Follow-up Period|Death|0|||
150192747|NCT05329220|541844994|FG005|Follow-up Period|Death|1|||
150121931|NCT02504294|541582202|FG001|Overall Study|Protocol Violation|26|||
150121932|NCT02504294|541582201|FG000|Overall Study|Physician Decision|1|||
150121933|NCT02504294|541582202|FG001|Overall Study|Physician Decision|2|||
150121934|NCT02504294|541582201|FG000|Overall Study|Lost to Follow-up|6|||
150121935|NCT02504294|541582202|FG001|Overall Study|Lost to Follow-up|7|||
150121936|NCT00144339|541582203|FG000|Overall Study|Adverse Event|746|||
150121937|NCT00144339|541582204|FG001|Overall Study|Adverse Event|627|||
150121938|NCT00144339|541582203|FG000|Overall Study|Protocol Violation|75|||
150121939|NCT00144339|541582204|FG001|Overall Study|Protocol Violation|48|||
150121940|NCT00144339|541582203|FG000|Overall Study|Withdrawal by Subject|403|||
150121941|NCT00144339|541582204|FG001|Overall Study|Withdrawal by Subject|300|||
150121942|NCT00144339|541582203|FG000|Overall Study|Lost to Follow-up|76|||
150121943|NCT00144339|541582204|FG001|Overall Study|Lost to Follow-up|64|||
150121944|NCT00144339|541582203|FG000|Overall Study|Other|58|||
150121945|NCT00144339|541582204|FG001|Overall Study|Other|60|||
150121946|NCT00305058|541582205|FG000|Overall Study|Participant too young|1|||
150121947|NCT00305058|541582206|FG001|Overall Study|Participant too young|0|||
150121948|NCT00305058|541582205|FG000|Overall Study|Missing data collection instrument|3|||
150121949|NCT00305058|541582206|FG001|Overall Study|Missing data collection instrument|2|||
150121950|NCT00305058|541582205|FG000|Overall Study|Missing outcome data|3|||
150121951|NCT00305058|541582206|FG001|Overall Study|Missing outcome data|2|||
150121952|NCT04102501|541582207|FG000|Overall Study|Withdrawal by Subject|7|||
150121953|NCT04102501|541582208|FG001|Overall Study|Withdrawal by Subject|9|||
150121954|NCT04102501|541582207|FG000|Overall Study|Adverse Event|1|||
150121955|NCT04102501|541582208|FG001|Overall Study|Adverse Event|3|||
150121956|NCT02338362|541582210|FG000|Overall Study|Withdrawal by Subject|1|||
150121957|NCT02338362|541582211|FG001|Overall Study|Withdrawal by Subject|1|||
150121958|NCT01669343|541582212|FG000|Part A: All Patients|Withdrawal by Subject|7|||
150121959|NCT01669343|541582212|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
150121960|NCT01669343|541582212|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
150121961|NCT01669343|541582212|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
150121962|NCT01669343|541582212|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
150121963|NCT02371369|541582213|FG000|Part 1|Physician Decision|0|||
150121964|NCT02371369|541582214|FG001|Part 1|Physician Decision|3|||
150121965|NCT02371369|541582213|FG000|Part 1|Adverse Event|8|||
150121966|NCT02371369|541582214|FG001|Part 1|Adverse Event|0|||
150121967|NCT02371369|541582213|FG000|Part 1|Withdrawal by Subject|1|||
150121968|NCT02371369|541582214|FG001|Part 1|Withdrawal by Subject|6|||
150121969|NCT02371369|541582213|FG000|Part 1|Disease progression|0|||
150121970|NCT02371369|541582214|FG001|Part 1|Disease progression|1|||
150121971|NCT02371369|541582213|FG000|Part 1|Protocol Violation|0|||
150121972|NCT02371369|541582214|FG001|Part 1|Protocol Violation|1|||
150121973|NCT02371369|541582213|FG000|Part 2|Adverse Event|6|||
150121974|NCT02371369|541582214|FG001|Part 2|Adverse Event|5|||
150121975|NCT02371369|541582213|FG000|Part 2|Withdrawal by Subject|16|||
150121976|NCT02371369|541582214|FG001|Part 2|Withdrawal by Subject|6|||
150121977|NCT02371369|541582213|FG000|Part 2|Investigator decision|1|||
150121978|NCT02371369|541582214|FG001|Part 2|Investigator decision|2|||
150121979|NCT02371369|541582213|FG000|Part 2|Death|0|||
150121980|NCT02371369|541582214|FG001|Part 2|Death|1|||
150121981|NCT02371369|541582213|FG000|Part 2|Disease progression|1|||
150121982|NCT02371369|541582214|FG001|Part 2|Disease progression|0|||
150121983|NCT02371369|541582213|FG000|Part 2|Subject Noncompliance|1|||
150121984|NCT02371369|541582214|FG001|Part 2|Subject Noncompliance|0|||
150121985|NCT02371369|541582213|FG000|Part 2|Lost to Follow-up|1|||
150121986|NCT02371369|541582214|FG001|Part 2|Lost to Follow-up|1|||
150121987|NCT02371369|541582213|FG000|Part 2|Subject transitioned to commercial supply|6|||
150121988|NCT02371369|541582214|FG001|Part 2|Subject transitioned to commercial supply|4|||
150121989|NCT02371369|541582213|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
150121990|NCT02371369|541582214|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
150121991|NCT02371369|541582213|FG000|Part 2|Surgical resection of tumor|1|||
150121992|NCT02371369|541582214|FG001|Part 2|Surgical resection of tumor|1|||
150121993|NCT02371369|541582213|FG000|Part 2|Other|0|||
150121994|NCT02371369|541582214|FG001|Part 2|Other|1|||
150121995|NCT06281548|541582215|FG000|Overall Study|Lost to Follow-up|3|||
150121996|NCT01618838|541582216|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
150121997|NCT01587651|541582217|FG000|Overall Study|Adverse Event|0|||
150121998|NCT01587651|541582218|FG001|Overall Study|Adverse Event|1|||
150121999|NCT01587651|541582219|FG002|Overall Study|Adverse Event|0|||
150122000|NCT01587651|541582217|FG000|Overall Study|Protocol Violation|0|||
150122001|NCT01587651|541582218|FG001|Overall Study|Protocol Violation|1|||
150122002|NCT01587651|541582219|FG002|Overall Study|Protocol Violation|1|||
150122003|NCT01587651|541582217|FG000|Overall Study|Withdrawal by Subject|0|||
150122004|NCT01587651|541582218|FG001|Overall Study|Withdrawal by Subject|1|||
150122005|NCT01587651|541582219|FG002|Overall Study|Withdrawal by Subject|0|||
150122006|NCT00586105|541582220|FG000|Overall Study|Adverse Event|4|||
150122007|NCT00586105|541582220|FG000|Overall Study|Death|2|||
150122008|NCT00586105|541582220|FG000|Overall Study|Protocol Violation|1|||
150122009|NCT00586105|541582220|FG000|Overall Study|Withdrawal by Subject|3|||
150122010|NCT00586105|541582220|FG000|Overall Study|Disease progression|19|||
150122011|NCT00586105|541582220|FG000|Overall Study|Switched to commercial drug|9|||
150122012|NCT00586105|541582220|FG000|Overall Study|Reason not reported|1|||
150122013|NCT03864900|541582229|FG000|Overall Study|Withdrawal by Subject|1|||
150122014|NCT03864900|541582230|FG001|Overall Study|Withdrawal by Subject|1|||
150122015|NCT03864900|541582229|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
150122016|NCT03864900|541582230|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
150122017|NCT02308033|541582231|FG000|Overall Study|Normal Gram stain at Baseline|13|||
150122018|NCT02308033|541582232|FG001|Overall Study|Normal Gram stain at Baseline|10|||
150122019|NCT02308033|541582231|FG000|Overall Study|Positive for STD at Baseline|7|||
150122020|NCT02308033|541582232|FG001|Overall Study|Positive for STD at Baseline|4|||
150122021|NCT02308033|541582231|FG000|Overall Study|Lost to Follow-up|6|||
150122022|NCT02308033|541582232|FG001|Overall Study|Lost to Follow-up|5|||
150122023|NCT03285477|541582236|FG000|Treatment and Response Assessment Period|Death|1|||
150122024|NCT03285477|541582237|FG001|Treatment and Response Assessment Period|Death|0|||
150122025|NCT03285477|541582236|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
150122026|NCT03285477|541582237|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
150122027|NCT03285477|541582236|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
150122028|NCT03285477|541582237|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
150122029|NCT03285477|541582236|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
150122030|NCT03285477|541582237|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
150122031|NCT03285477|541582236|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
150122032|NCT03285477|541582237|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
150122033|NCT03283670|541582238|FG000|Placebo Gas|Withdrawal by Subject|2|||
150122034|NCT03283670|541582238|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
150122035|NCT03283670|541582238|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
150122036|NCT01165281|541582239|FG000|Overall Study|Adverse Event|12|||
150122037|NCT01165281|541582240|FG001|Overall Study|Adverse Event|14|||
150122038|NCT01165281|541582239|FG000|Overall Study|Death|3|||
150122039|NCT01165281|541582240|FG001|Overall Study|Death|4|||
150122040|NCT01165281|541582239|FG000|Overall Study|Lack of Efficacy|4|||
150122041|NCT01165281|541582240|FG001|Overall Study|Lack of Efficacy|1|||
150122042|NCT01165281|541582239|FG000|Overall Study|Lost to Follow-up|0|||
150122043|NCT01165281|541582240|FG001|Overall Study|Lost to Follow-up|1|||
150122044|NCT01165281|541582239|FG000|Overall Study|Physician Decision|8|||
150122045|NCT01165281|541582240|FG001|Overall Study|Physician Decision|1|||
150122046|NCT01165281|541582239|FG000|Overall Study|Protocol Violation|6|||
150122047|NCT01165281|541582240|FG001|Overall Study|Protocol Violation|5|||
150122048|NCT01165281|541582239|FG000|Overall Study|Withdrawal by Subject|8|||
150122049|NCT01165281|541582240|FG001|Overall Study|Withdrawal by Subject|7|||
150122050|NCT01165281|541582239|FG000|Overall Study|Noncompliance with Study Drug|1|||
150122051|NCT01165281|541582240|FG001|Overall Study|Noncompliance with Study Drug|4|||
150122052|NCT01165281|541582239|FG000|Overall Study|Progressive Disease|10|||
150122053|NCT01165281|541582240|FG001|Overall Study|Progressive Disease|14|||
150122054|NCT01165281|541582239|FG000|Overall Study|Other|6|||
150122055|NCT01165281|541582240|FG001|Overall Study|Other|0|||
150122056|NCT01307501|541582241|FG000|Overall Study|Treatment Failure|1|||
150122057|NCT01307501|541582241|FG000|Overall Study|Death|20|||
150122058|NCT01307501|541582241|FG000|Overall Study|Lost to Follow-up|1|||
150122059|NCT01307501|541582241|FG000|Overall Study|Starting Hospice|1|||
150122060|NCT03859323|541584632|FG000|Overall Study|Lost to Follow-up|0|||
150122061|NCT03859323|541584633|FG001|Overall Study|Lost to Follow-up|0|||
150122062|NCT03859323|541584634|FG002|Overall Study|Lost to Follow-up|0|||
150122063|NCT03859323|541584635|FG003|Overall Study|Lost to Follow-up|0|||
150122064|NCT03859323|541584636|FG004|Overall Study|Lost to Follow-up|0|||
150122065|NCT03859323|541584637|FG005|Overall Study|Lost to Follow-up|0|||
150122066|NCT03859323|541584638|FG006|Overall Study|Lost to Follow-up|1|||
150122067|NCT03859323|541584639|FG007|Overall Study|Lost to Follow-up|0|||
150122068|NCT03859323|541584640|FG008|Overall Study|Lost to Follow-up|0|||
150122069|NCT03859323|541584641|FG009|Overall Study|Lost to Follow-up|0|||
150122070|NCT03859323|541584642|FG010|Overall Study|Lost to Follow-up|0|||
150122071|NCT03859323|541584643|FG011|Overall Study|Lost to Follow-up|0|||
150122072|NCT03859323|541584644|FG012|Overall Study|Lost to Follow-up|0|||
150122073|NCT03859323|541584632|FG000|Overall Study|Withdrawal by Subject|0|||
150122074|NCT03859323|541584633|FG001|Overall Study|Withdrawal by Subject|0|||
150122075|NCT03859323|541584634|FG002|Overall Study|Withdrawal by Subject|1|||
150122076|NCT03859323|541584635|FG003|Overall Study|Withdrawal by Subject|0|||
150122077|NCT03859323|541584636|FG004|Overall Study|Withdrawal by Subject|0|||
150122078|NCT03859323|541584637|FG005|Overall Study|Withdrawal by Subject|1|||
150122079|NCT03859323|541584638|FG006|Overall Study|Withdrawal by Subject|0|||
150122080|NCT03859323|541584639|FG007|Overall Study|Withdrawal by Subject|0|||
150122081|NCT03859323|541584640|FG008|Overall Study|Withdrawal by Subject|0|||
150122082|NCT03859323|541584641|FG009|Overall Study|Withdrawal by Subject|1|||
150122083|NCT03859323|541584642|FG010|Overall Study|Withdrawal by Subject|1|||
150122084|NCT03859323|541584643|FG011|Overall Study|Withdrawal by Subject|2|||
150122085|NCT03859323|541584644|FG012|Overall Study|Withdrawal by Subject|1|||
150122086|NCT03859323|541584632|FG000|Overall Study|Pregnancy|0|||
150122087|NCT03859323|541584633|FG001|Overall Study|Pregnancy|0|||
150122088|NCT03859323|541584634|FG002|Overall Study|Pregnancy|0|||
150122089|NCT03859323|541584635|FG003|Overall Study|Pregnancy|0|||
150122090|NCT03859323|541584636|FG004|Overall Study|Pregnancy|0|||
150122091|NCT03859323|541584637|FG005|Overall Study|Pregnancy|0|||
150122092|NCT03859323|541584638|FG006|Overall Study|Pregnancy|0|||
150122093|NCT03859323|541584639|FG007|Overall Study|Pregnancy|0|||
150122094|NCT03859323|541584640|FG008|Overall Study|Pregnancy|0|||
150122095|NCT03859323|541584641|FG009|Overall Study|Pregnancy|1|||
150122096|NCT03859323|541584642|FG010|Overall Study|Pregnancy|0|||
150122097|NCT03859323|541584643|FG011|Overall Study|Pregnancy|0|||
150122098|NCT03859323|541584644|FG012|Overall Study|Pregnancy|0|||
150122099|NCT01682460|541584646|FG000|Overall Study|Withdrawal by Subject|2|||
150122100|NCT01682460|541584646|FG000|Overall Study|Did not meet inclusion criteria|2|||
150122101|NCT03811912|541584649|FG000|Overall Study|Withdrew Consent|4|||
150122102|NCT03811912|541584650|FG001|Overall Study|Withdrew Consent|2|||
150122103|NCT03586648|541584651|FG000|Period 1|Withdrawal by Subject|0|||
150122104|NCT03586648|541584652|FG001|Period 1|Withdrawal by Subject|1|||
150122105|NCT03586648|541584651|FG000|Period 1|Lost to Follow-up|1|||
150122106|NCT03586648|541584652|FG001|Period 1|Lost to Follow-up|1|||
150122107|NCT03586648|541584651|FG000|Period 1|Adverse Event|1|||
150122108|NCT03586648|541584652|FG001|Period 1|Adverse Event|0|||
150122109|NCT03586648|541584651|FG000|Period 1|Study related symptoms or complaints|2|||
150122110|NCT03586648|541584652|FG001|Period 1|Study related symptoms or complaints|1|||
150122111|NCT03586648|541584651|FG000|Period 1|Physician Decision|0|||
150122112|NCT03586648|541584652|FG001|Period 1|Physician Decision|1|||
150122113|NCT03586648|541584651|FG000|Period 2|Adverse Event|1|||
150122114|NCT03586648|541584652|FG001|Period 2|Adverse Event|0|||
150122115|NCT02099838|541584653|FG000|Overall Study|Death|1|||
150122116|NCT02099838|541584654|FG001|Overall Study|Death|0|||
150122117|NCT02099838|541584653|FG000|Overall Study|Lost to Follow-up|3|||
150122118|NCT02099838|541584654|FG001|Overall Study|Lost to Follow-up|1|||
150122119|NCT02099838|541584653|FG000|Overall Study|Withdrawal by Subject|0|||
150122120|NCT02099838|541584654|FG001|Overall Study|Withdrawal by Subject|1|||
150122121|NCT01227889|541584655|FG000|Randomized Phase (RP)|Adverse Event|13|||
150122122|NCT01227889|541584656|FG001|Randomized Phase (RP)|Adverse Event|0|||
150122123|NCT01227889|541584655|FG000|Randomized Phase (RP)|Physician Decision|13|||
150122124|NCT01227889|541584656|FG001|Randomized Phase (RP)|Physician Decision|5|||
150122125|NCT01227889|541584655|FG000|Randomized Phase (RP)|Progressive Disease|135|||
150122126|NCT01227889|541584656|FG001|Randomized Phase (RP)|Progressive Disease|52|||
150122127|NCT01227889|541584655|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
150122128|NCT01227889|541584656|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
150122129|NCT01227889|541584655|FG000|Randomized Phase (RP)|Missing|1|||
150122130|NCT01227889|541584656|FG001|Randomized Phase (RP)|Missing|3|||
150122131|NCT01227889|541584655|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
150122132|NCT01227889|541584656|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
150122133|NCT01227889|541584655|FG000|Crossover Phase|Adverse Event|0|||
150122134|NCT01227889|541584656|FG001|Crossover Phase|Adverse Event|1|||
150122135|NCT01227889|541584655|FG000|Crossover Phase|Physician Decision|0|||
150122136|NCT01227889|541584656|FG001|Crossover Phase|Physician Decision|3|||
150122137|NCT01227889|541584655|FG000|Crossover Phase|Progressive Disease|0|||
150122138|NCT01227889|541584656|FG001|Crossover Phase|Progressive Disease|31|||
150122139|NCT01227889|541584655|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
150122140|NCT01227889|541584656|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
150122141|NCT01227889|541584655|FG000|Crossover Phase|Withdrawal by Subject|0|||
150122142|NCT01227889|541584656|FG001|Crossover Phase|Withdrawal by Subject|1|||
150122143|NCT04121962|541584657|FG000|Overall Study|Lost to Follow-up|42|||
150122144|NCT04121962|541584658|FG001|Overall Study|Lost to Follow-up|39|||
150122145|NCT00774787|541584659|FG000|Overall Study|Lost to Follow-up|1|||
150122146|NCT02019719|541584660|FG000|Overall Study|Adverse Event|1|||
150122147|NCT02019719|541584661|FG001|Overall Study|Adverse Event|0|||
150122148|NCT02019719|541584662|FG002|Overall Study|Adverse Event|0|||
150122149|NCT02019719|541584663|FG003|Overall Study|Adverse Event|1|||
150122150|NCT02019719|541584664|FG004|Overall Study|Adverse Event|1|||
150122151|NCT02019719|541584660|FG000|Overall Study|Protocol Violation|1|||
150122152|NCT02019719|541584661|FG001|Overall Study|Protocol Violation|1|||
150122153|NCT02019719|541584662|FG002|Overall Study|Protocol Violation|0|||
150122154|NCT02019719|541584663|FG003|Overall Study|Protocol Violation|0|||
150122155|NCT02019719|541584664|FG004|Overall Study|Protocol Violation|0|||
150122156|NCT02019719|541584660|FG000|Overall Study|Protocol defined stopping criteria|2|||
150122157|NCT02019719|541584661|FG001|Overall Study|Protocol defined stopping criteria|0|||
150122158|NCT02019719|541584662|FG002|Overall Study|Protocol defined stopping criteria|0|||
150122159|NCT02019719|541584663|FG003|Overall Study|Protocol defined stopping criteria|1|||
150122160|NCT02019719|541584664|FG004|Overall Study|Protocol defined stopping criteria|1|||
150122161|NCT02019719|541584660|FG000|Overall Study|Physician Decision|2|||
150122162|NCT02019719|541584661|FG001|Overall Study|Physician Decision|0|||
150122163|NCT02019719|541584662|FG002|Overall Study|Physician Decision|0|||
150122164|NCT02019719|541584663|FG003|Overall Study|Physician Decision|0|||
150122165|NCT02019719|541584664|FG004|Overall Study|Physician Decision|0|||
150122166|NCT04535037|541584665|FG000|Overall Study|Protocol Violation|1|||
150122167|NCT04535037|541584666|FG001|Overall Study|Protocol Violation|0|||
150122168|NCT04535037|541584665|FG000|Overall Study|Withdrawal by Subject|8|||
150122169|NCT04535037|541584666|FG001|Overall Study|Withdrawal by Subject|9|||
150122170|NCT04535037|541584665|FG000|Overall Study|Migrated / moved from the study area|1|||
150122171|NCT04535037|541584666|FG001|Overall Study|Migrated / moved from the study area|4|||
150122172|NCT04535037|541584665|FG000|Overall Study|Other|2|||
150122173|NCT04535037|541584666|FG001|Overall Study|Other|5|||
150122174|NCT02731131|541584668|FG000|Overall Study|Psychiatric Disorder|0|||
150122175|NCT02731131|541584669|FG001|Overall Study|Psychiatric Disorder|1|||
150122176|NCT02731131|541584668|FG000|Overall Study|Refused Therapy|0|||
150122177|NCT02731131|541584669|FG001|Overall Study|Refused Therapy|1|||
150122178|NCT02348216|541584674|FG000|Overall Study|Death|5|||
150122179|NCT02348216|541584675|FG001|Overall Study|Death|53|||
150122180|NCT02348216|541584676|FG002|Overall Study|Death|11|||
150122181|NCT02348216|541584677|FG003|Overall Study|Death|20|||
150122182|NCT02348216|541584678|FG004|Overall Study|Death|16|||
150122183|NCT02348216|541584679|FG005|Overall Study|Death|32|||
150122184|NCT02348216|541584680|FG006|Overall Study|Death|17|||
150122185|NCT02348216|541584674|FG000|Overall Study|Full consent withdrawal|0|||
150122186|NCT02348216|541584675|FG001|Overall Study|Full consent withdrawal|0|||
150122187|NCT02348216|541584676|FG002|Overall Study|Full consent withdrawal|0|||
150122188|NCT02348216|541584677|FG003|Overall Study|Full consent withdrawal|1|||
150122189|NCT02348216|541584678|FG004|Overall Study|Full consent withdrawal|3|||
150122190|NCT02348216|541584679|FG005|Overall Study|Full consent withdrawal|0|||
150122191|NCT02348216|541584680|FG006|Overall Study|Full consent withdrawal|3|||
150122192|NCT02348216|541584674|FG000|Overall Study|Lost to Follow-up|0|||
150122193|NCT02348216|541584675|FG001|Overall Study|Lost to Follow-up|5|||
150122194|NCT02348216|541584676|FG002|Overall Study|Lost to Follow-up|2|||
150122195|NCT02348216|541584677|FG003|Overall Study|Lost to Follow-up|0|||
150122196|NCT02348216|541584678|FG004|Overall Study|Lost to Follow-up|1|||
150122197|NCT02348216|541584679|FG005|Overall Study|Lost to Follow-up|1|||
150122198|NCT02348216|541584680|FG006|Overall Study|Lost to Follow-up|1|||
150122199|NCT02348216|541584674|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
150122200|NCT02348216|541584675|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
150122201|NCT02348216|541584676|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
150122202|NCT02348216|541584677|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
150122203|NCT02348216|541584678|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
150122204|NCT02348216|541584679|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
150122205|NCT02348216|541584680|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
150122206|NCT02348216|541584674|FG000|Overall Study|Reason not specified|2|||
150122207|NCT02348216|541584675|FG001|Overall Study|Reason not specified|19|||
150122208|NCT02348216|541584676|FG002|Overall Study|Reason not specified|11|||
150122209|NCT02348216|541584677|FG003|Overall Study|Reason not specified|17|||
150122210|NCT02348216|541584678|FG004|Overall Study|Reason not specified|21|||
150122211|NCT02348216|541584679|FG005|Overall Study|Reason not specified|17|||
150122212|NCT02348216|541584680|FG006|Overall Study|Reason not specified|19|||
150122213|NCT01055639|541584681|FG000|Overall Study|Adverse Event|0|||
150122214|NCT01055639|541584682|FG001|Overall Study|Adverse Event|1|||
150122215|NCT01055639|541584681|FG000|Overall Study|Lack of Efficacy|0|||
150122216|NCT01055639|541584682|FG001|Overall Study|Lack of Efficacy|1|||
150122217|NCT01055639|541584681|FG000|Overall Study|Lost to Follow-up|8|||
150122218|NCT01055639|541584682|FG001|Overall Study|Lost to Follow-up|11|||
150122219|NCT01055639|541584681|FG000|Overall Study|Protocol Violation|5|||
150122220|NCT01055639|541584682|FG001|Overall Study|Protocol Violation|5|||
150122221|NCT01055639|541584681|FG000|Overall Study|Withdrawal by Subject|8|||
150122222|NCT01055639|541584682|FG001|Overall Study|Withdrawal by Subject|11|||
150122223|NCT00765245|541584683|FG000|Overall Study|disease progression|3|||
150122224|NCT00765245|541584684|FG001|Overall Study|disease progression|2|||
150122225|NCT00765245|541584683|FG000|Overall Study|Withdrawal by Subject|3|||
150122226|NCT00765245|541584684|FG001|Overall Study|Withdrawal by Subject|0|||
150122227|NCT00765245|541584683|FG000|Overall Study|Adverse Event|5|||
150122228|NCT00765245|541584684|FG001|Overall Study|Adverse Event|0|||
150122229|NCT00765245|541584683|FG000|Overall Study|Physician Decision|1|||
150122230|NCT00765245|541584684|FG001|Overall Study|Physician Decision|0|||
150122231|NCT00765245|541584683|FG000|Overall Study|Death|1|||
150122232|NCT00765245|541584684|FG001|Overall Study|Death|0|||
150122233|NCT01197950|541584686|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
150122234|NCT01197950|541584687|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
150122235|NCT01197950|541584688|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
150122236|NCT02553330|541584689|FG000|Overall Study|Study Terminated by Sponsor|2|||
150122237|NCT02553330|541584690|FG001|Overall Study|Study Terminated by Sponsor|13|||
150122238|NCT02553330|541584691|FG002|Overall Study|Study Terminated by Sponsor|12|||
150122239|NCT02553330|541584689|FG000|Overall Study|Withdrawal by Subject|3|||
150122240|NCT02553330|541584690|FG001|Overall Study|Withdrawal by Subject|19|||
150122241|NCT02553330|541584691|FG002|Overall Study|Withdrawal by Subject|21|||
150122242|NCT02553330|541584689|FG000|Overall Study|Other|0|||
150122243|NCT02553330|541584690|FG001|Overall Study|Other|1|||
150122244|NCT02553330|541584691|FG002|Overall Study|Other|0|||
150122245|NCT02553330|541584689|FG000|Overall Study|Non compliance to study treatment|0|||
150122246|NCT02553330|541584690|FG001|Overall Study|Non compliance to study treatment|1|||
150122247|NCT02553330|541584691|FG002|Overall Study|Non compliance to study treatment|0|||
150122248|NCT02553330|541584689|FG000|Overall Study|Adverse Event|0|||
150122249|NCT02553330|541584690|FG001|Overall Study|Adverse Event|1|||
150122250|NCT02553330|541584691|FG002|Overall Study|Adverse Event|0|||
150122251|NCT02553330|541584689|FG000|Overall Study|Lost to Follow-up|0|||
150122252|NCT02553330|541584690|FG001|Overall Study|Lost to Follow-up|4|||
150122253|NCT02553330|541584691|FG002|Overall Study|Lost to Follow-up|4|||
150122254|NCT02896855|541584692|FG000|Overall Study|Death|50|||
150122255|NCT02896855|541584693|FG001|Overall Study|Death|40|||
150122256|NCT02896855|541584692|FG000|Overall Study|Lost to Follow-up|15|||
150122257|NCT02896855|541584693|FG001|Overall Study|Lost to Follow-up|9|||
150122258|NCT02896855|541584692|FG000|Overall Study|Withdrawal by Subject|7|||
150122259|NCT02896855|541584693|FG001|Overall Study|Withdrawal by Subject|4|||
150122260|NCT02169674|541584694|FG000|Overall Study|Withdrawal by Subject|2|||
150122261|NCT02169674|541584695|FG001|Overall Study|Withdrawal by Subject|1|||
150122262|NCT02169674|541584694|FG000|Overall Study|Seroprotected|30|||
150122263|NCT02169674|541584695|FG001|Overall Study|Seroprotected|76|||
150122264|NCT02169674|541584694|FG000|Overall Study|Lost to Follow-up|0|||
150122265|NCT02169674|541584695|FG001|Overall Study|Lost to Follow-up|1|||
150122266|NCT02265705|541584698|FG000|Treatment Period Week 0-24|Adverse Event|3|||
150122267|NCT02265705|541584699|FG001|Treatment Period Week 0-24|Adverse Event|2|||
150122268|NCT02265705|541584700|FG002|Treatment Period Week 0-24|Adverse Event|0|||
150122269|NCT02265705|541584701|FG003|Treatment Period Week 0-24|Adverse Event|0|||
150122270|NCT02265705|541584702|FG004|Treatment Period Week 0-24|Adverse Event|0|||
150122271|NCT02265705|541584703|FG005|Treatment Period Week 0-24|Adverse Event|0|||
150122272|NCT02265705|541584704|FG006|Treatment Period Week 0-24|Adverse Event|0|||
150122273|NCT02265705|541584698|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
150122274|NCT02265705|541584699|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
150122275|NCT02265705|541584700|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
150122276|NCT02265705|541584701|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
150122277|NCT02265705|541584702|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
150122278|NCT02265705|541584703|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
150122279|NCT02265705|541584704|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
150122280|NCT02265705|541584698|FG000|Treatment Period Week 0-24|Physician Decision|1|||
150122281|NCT02265705|541584699|FG001|Treatment Period Week 0-24|Physician Decision|0|||
150122282|NCT02265705|541584700|FG002|Treatment Period Week 0-24|Physician Decision|0|||
150122283|NCT02265705|541584701|FG003|Treatment Period Week 0-24|Physician Decision|0|||
150122284|NCT02265705|541584702|FG004|Treatment Period Week 0-24|Physician Decision|0|||
150122285|NCT02265705|541584703|FG005|Treatment Period Week 0-24|Physician Decision|0|||
150122286|NCT02265705|541584704|FG006|Treatment Period Week 0-24|Physician Decision|0|||
150192748|NCT05329220|541844989|FG000|Follow-up Period|Lost to Follow-up|0|||
150192749|NCT05329220|541844990|FG001|Follow-up Period|Lost to Follow-up|1|||
150192750|NCT05329220|541844991|FG002|Follow-up Period|Lost to Follow-up|2|||
150192751|NCT05329220|541844992|FG003|Follow-up Period|Lost to Follow-up|2|||
150192752|NCT05329220|541844993|FG004|Follow-up Period|Lost to Follow-up|113|||
150192753|NCT05329220|541844994|FG005|Follow-up Period|Lost to Follow-up|89|||
150192754|NCT05329220|541844989|FG000|Follow-up Period|Physician Decision|0|||
150192755|NCT05329220|541844990|FG001|Follow-up Period|Physician Decision|0|||
150192756|NCT05329220|541844991|FG002|Follow-up Period|Physician Decision|0|||
150192757|NCT05329220|541844992|FG003|Follow-up Period|Physician Decision|0|||
150122287|NCT02265705|541584698|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
150122288|NCT02265705|541584699|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
150122289|NCT02265705|541584700|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
150122290|NCT02265705|541584701|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
150122291|NCT02265705|541584702|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
150122292|NCT02265705|541584703|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
150122293|NCT02265705|541584704|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
150122294|NCT02265705|541584698|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122295|NCT02265705|541584699|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
150122296|NCT02265705|541584700|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122297|NCT02265705|541584701|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122298|NCT02265705|541584702|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122299|NCT02265705|541584703|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122300|NCT02265705|541584704|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
150122301|NCT02265705|541584698|FG000|Rescue Period|Withdrawal by Subject|0|||
150122302|NCT02265705|541584699|FG001|Rescue Period|Withdrawal by Subject|0|||
150122303|NCT02265705|541584700|FG002|Rescue Period|Withdrawal by Subject|1|||
150122304|NCT02265705|541584701|FG003|Rescue Period|Withdrawal by Subject|0|||
150122305|NCT02265705|541584702|FG004|Rescue Period|Withdrawal by Subject|0|||
150122306|NCT02265705|541584703|FG005|Rescue Period|Withdrawal by Subject|0|||
150122307|NCT02265705|541584704|FG006|Rescue Period|Withdrawal by Subject|0|||
150122308|NCT02265705|541584698|FG000|Rescue Period|Death|0|||
150122309|NCT02265705|541584699|FG001|Rescue Period|Death|0|||
150122310|NCT02265705|541584700|FG002|Rescue Period|Death|1|||
150122311|NCT02265705|541584701|FG003|Rescue Period|Death|0|||
150122312|NCT02265705|541584702|FG004|Rescue Period|Death|0|||
150122313|NCT02265705|541584703|FG005|Rescue Period|Death|0|||
150122314|NCT02265705|541584704|FG006|Rescue Period|Death|0|||
150122315|NCT02265705|541584698|FG000|Rescue Period|Lack of Efficacy|0|||
150122316|NCT02265705|541584699|FG001|Rescue Period|Lack of Efficacy|0|||
150122317|NCT02265705|541584700|FG002|Rescue Period|Lack of Efficacy|1|||
150122318|NCT02265705|541584701|FG003|Rescue Period|Lack of Efficacy|0|||
150122319|NCT02265705|541584702|FG004|Rescue Period|Lack of Efficacy|0|||
150192758|NCT05329220|541844993|FG004|Follow-up Period|Physician Decision|2|||
150192759|NCT05329220|541844994|FG005|Follow-up Period|Physician Decision|2|||
150192760|NCT05329220|541844989|FG000|Follow-up Period|Protocol Violation|0|||
150192761|NCT05329220|541844990|FG001|Follow-up Period|Protocol Violation|0|||
150192762|NCT05329220|541844991|FG002|Follow-up Period|Protocol Violation|0|||
150192763|NCT05329220|541844992|FG003|Follow-up Period|Protocol Violation|0|||
150122320|NCT02265705|541584703|FG005|Rescue Period|Lack of Efficacy|0|||
150122321|NCT02265705|541584704|FG006|Rescue Period|Lack of Efficacy|0|||
150122322|NCT02265705|541584698|FG000|Open Label Period|Adverse Event|0|||
150122323|NCT02265705|541584699|FG001|Open Label Period|Adverse Event|0|||
150122324|NCT02265705|541584700|FG002|Open Label Period|Adverse Event|0|||
150192764|NCT05329220|541844993|FG004|Follow-up Period|Protocol Violation|0|||
150192765|NCT05329220|541844994|FG005|Follow-up Period|Protocol Violation|1|||
150192766|NCT05329220|541844989|FG000|Follow-up Period|Withdrawal by Subject|0|||
150192767|NCT05329220|541844990|FG001|Follow-up Period|Withdrawal by Subject|0|||
150122325|NCT02265705|541584701|FG003|Open Label Period|Adverse Event|2|||
150122326|NCT02265705|541584702|FG004|Open Label Period|Adverse Event|2|||
150122327|NCT02265705|541584703|FG005|Open Label Period|Adverse Event|0|||
150122328|NCT02265705|541584704|FG006|Open Label Period|Adverse Event|0|||
150122329|NCT02265705|541584698|FG000|Open Label Period|Physician Decision|0|||
150122330|NCT02265705|541584699|FG001|Open Label Period|Physician Decision|0|||
150122331|NCT02265705|541584700|FG002|Open Label Period|Physician Decision|0|||
150122332|NCT02265705|541584701|FG003|Open Label Period|Physician Decision|0|||
150122333|NCT02265705|541584702|FG004|Open Label Period|Physician Decision|1|||
150122334|NCT02265705|541584703|FG005|Open Label Period|Physician Decision|0|||
150122335|NCT02265705|541584704|FG006|Open Label Period|Physician Decision|0|||
150122336|NCT02265705|541584698|FG000|Open Label Period|Withdrawal by Subject|0|||
150122337|NCT02265705|541584699|FG001|Open Label Period|Withdrawal by Subject|0|||
150122338|NCT02265705|541584700|FG002|Open Label Period|Withdrawal by Subject|0|||
150122339|NCT02265705|541584701|FG003|Open Label Period|Withdrawal by Subject|0|||
150122340|NCT02265705|541584702|FG004|Open Label Period|Withdrawal by Subject|2|||
150122341|NCT02265705|541584703|FG005|Open Label Period|Withdrawal by Subject|0|||
150122342|NCT02265705|541584704|FG006|Open Label Period|Withdrawal by Subject|0|||
150122343|NCT02265705|541584698|FG000|Follow-up Period|Sponsor Decision|0|||
150122344|NCT02265705|541584699|FG001|Follow-up Period|Sponsor Decision|0|||
150122345|NCT02265705|541584700|FG002|Follow-up Period|Sponsor Decision|0|||
150122346|NCT02265705|541584701|FG003|Follow-up Period|Sponsor Decision|0|||
150122347|NCT02265705|541584702|FG004|Follow-up Period|Sponsor Decision|0|||
150122348|NCT02265705|541584703|FG005|Follow-up Period|Sponsor Decision|1|||
150122349|NCT02265705|541584704|FG006|Follow-up Period|Sponsor Decision|6|||
150122350|NCT02265705|541584698|FG000|Follow-up Period|Adverse Event|0|||
150122351|NCT02265705|541584699|FG001|Follow-up Period|Adverse Event|0|||
150122352|NCT02265705|541584700|FG002|Follow-up Period|Adverse Event|0|||
150122353|NCT02265705|541584701|FG003|Follow-up Period|Adverse Event|0|||
150122354|NCT02265705|541584702|FG004|Follow-up Period|Adverse Event|0|||
150122355|NCT02265705|541584703|FG005|Follow-up Period|Adverse Event|0|||
150122356|NCT02265705|541584704|FG006|Follow-up Period|Adverse Event|3|||
150122357|NCT02265705|541584698|FG000|Follow-up Period|Physician Decision|0|||
150122358|NCT02265705|541584699|FG001|Follow-up Period|Physician Decision|0|||
150122359|NCT02265705|541584700|FG002|Follow-up Period|Physician Decision|0|||
150122360|NCT02265705|541584701|FG003|Follow-up Period|Physician Decision|0|||
150122361|NCT02265705|541584702|FG004|Follow-up Period|Physician Decision|0|||
150122362|NCT02265705|541584703|FG005|Follow-up Period|Physician Decision|0|||
150122363|NCT02265705|541584704|FG006|Follow-up Period|Physician Decision|1|||
150122364|NCT02265705|541584698|FG000|Follow-up Period|Withdrawal by Subject|0|||
150122365|NCT02265705|541584699|FG001|Follow-up Period|Withdrawal by Subject|0|||
150122366|NCT02265705|541584700|FG002|Follow-up Period|Withdrawal by Subject|0|||
150122367|NCT02265705|541584701|FG003|Follow-up Period|Withdrawal by Subject|0|||
150122368|NCT02265705|541584702|FG004|Follow-up Period|Withdrawal by Subject|0|||
150122369|NCT02265705|541584703|FG005|Follow-up Period|Withdrawal by Subject|0|||
150122370|NCT02265705|541584704|FG006|Follow-up Period|Withdrawal by Subject|1|||
150122371|NCT00346034|541584706|FG000|Overall Study|Adverse Event|34|||
150122372|NCT00346034|541584706|FG000|Overall Study|Lack of Efficacy|8|||
150122373|NCT00346034|541584706|FG000|Overall Study|Withdrawal by Subject|13|||
150122374|NCT00346034|541584706|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
150122375|NCT00346034|541584706|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
150122376|NCT04000165|541584707|FG000|Overall Study|Physician Decision|1|||
150122377|NCT04000165|541584707|FG000|Overall Study|Withdrawal by Subject|1|||
150122378|NCT00941603|541584711|FG000|Overall Study|Adverse Event|10|||
150122379|NCT00941603|541584712|FG001|Overall Study|Adverse Event|15|||
150122380|NCT00941603|541584713|FG002|Overall Study|Adverse Event|5|||
150122381|NCT00941603|541584714|FG003|Overall Study|Adverse Event|1|||
150122382|NCT00941603|541584715|FG004|Overall Study|Adverse Event|4|||
150122383|NCT00941603|541584716|FG005|Overall Study|Adverse Event|0|||
150122384|NCT00941603|541584711|FG000|Overall Study|Lost to Follow-up|0|||
150122385|NCT00941603|541584712|FG001|Overall Study|Lost to Follow-up|0|||
150122386|NCT00941603|541584713|FG002|Overall Study|Lost to Follow-up|0|||
150122387|NCT00941603|541584714|FG003|Overall Study|Lost to Follow-up|1|||
150122388|NCT00941603|541584715|FG004|Overall Study|Lost to Follow-up|0|||
150122389|NCT00941603|541584716|FG005|Overall Study|Lost to Follow-up|2|||
150122390|NCT00941603|541584711|FG000|Overall Study|Withdrawal by Subject|0|||
150122391|NCT00941603|541584712|FG001|Overall Study|Withdrawal by Subject|0|||
150122392|NCT00941603|541584713|FG002|Overall Study|Withdrawal by Subject|0|||
150122393|NCT00941603|541584714|FG003|Overall Study|Withdrawal by Subject|2|||
150122394|NCT00941603|541584715|FG004|Overall Study|Withdrawal by Subject|0|||
150122395|NCT00941603|541584716|FG005|Overall Study|Withdrawal by Subject|1|||
150122396|NCT00941603|541584711|FG000|Overall Study|Protocol Violation|0|||
150122397|NCT00941603|541584712|FG001|Overall Study|Protocol Violation|1|||
150122398|NCT00941603|541584713|FG002|Overall Study|Protocol Violation|0|||
150122399|NCT00941603|541584714|FG003|Overall Study|Protocol Violation|0|||
150122400|NCT00941603|541584715|FG004|Overall Study|Protocol Violation|0|||
150122401|NCT00941603|541584716|FG005|Overall Study|Protocol Violation|0|||
150122402|NCT00941603|541584711|FG000|Overall Study|Did not meet protocol eligibility|1|||
150122403|NCT00941603|541584712|FG001|Overall Study|Did not meet protocol eligibility|0|||
150122404|NCT00941603|541584713|FG002|Overall Study|Did not meet protocol eligibility|0|||
150122405|NCT00941603|541584714|FG003|Overall Study|Did not meet protocol eligibility|0|||
150122406|NCT00941603|541584715|FG004|Overall Study|Did not meet protocol eligibility|0|||
150122407|NCT00941603|541584716|FG005|Overall Study|Did not meet protocol eligibility|0|||
150122408|NCT02079805|541584717|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
150122409|NCT02079805|541584718|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
150122410|NCT02079805|541584717|FG000|Overall Study|Voluntary Withdrawal|0|||
150122411|NCT02079805|541584718|FG001|Overall Study|Voluntary Withdrawal|1|||
150122412|NCT01753193|541584719|FG000|Overall Study|Withdrawal by Subject|23|||
150122413|NCT01753193|541584719|FG000|Overall Study|Lost to Follow-up|6|||
150122414|NCT01753193|541584719|FG000|Overall Study|Death|1|||
150122415|NCT01753193|541584719|FG000|Overall Study|Other|16|||
150122416|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
150122417|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
150122418|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
150122419|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
150122420|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
150122421|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
150122422|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
150122423|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
150122424|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
150122425|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
150122426|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
150122427|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
150122428|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
150122429|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
150122430|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
150122431|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
150122432|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
150122433|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
150122434|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
150122435|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
150122436|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
150122437|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
150122438|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
150122439|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
150122440|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
150122441|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
150122442|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
150122443|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
150122444|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
150122445|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
150122446|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
150122447|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
150122448|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
150122449|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
150122450|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
150122451|NCT00383435|541584720|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
150122452|NCT00383435|541584721|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
150122453|NCT00383435|541584722|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
150122454|NCT00383435|541584723|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
150122455|NCT00383435|541584724|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
150122456|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
150122457|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
150122458|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
150122459|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
150122460|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
150122461|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
150122462|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
150122463|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
150122464|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
150122465|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
150122466|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
150122467|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
150122468|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
150122469|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
150122470|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
150122471|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
150122472|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
150122473|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
150122474|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
150122475|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
150122476|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
150122477|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
150122478|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
150122479|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
150122480|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
150122481|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
150122482|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
150122483|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
150122484|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
150122485|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
150122486|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
150122487|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
150122488|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
150122489|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
150122490|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
150122491|NCT00383435|541584720|FG000|26-Week Treatment Safety Extension|Administrative|1|||
150122492|NCT00383435|541584721|FG001|26-Week Treatment Safety Extension|Administrative|1|||
150122493|NCT00383435|541584722|FG002|26-Week Treatment Safety Extension|Administrative|0|||
150122494|NCT00383435|541584723|FG003|26-Week Treatment Safety Extension|Administrative|1|||
150122495|NCT00383435|541584724|FG004|26-Week Treatment Safety Extension|Administrative|0|||
150122496|NCT00583557|541584725|FG000|Overall Study|Withdrawal by Subject|18|||
150122497|NCT00583557|541584725|FG000|Overall Study|Adverse Event|9|||
150122498|NCT00583557|541584725|FG000|Overall Study|Lack of Efficacy|31|||
150122499|NCT00583557|541584725|FG000|Overall Study|Lack of Compliance|5|||
150122500|NCT00583557|541584725|FG000|Overall Study|Other|5|||
150122501|NCT00583557|541584725|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
150122502|NCT02682264|541584726|FG000|Overall Study|Withdrawal by Subject|56|||
150122503|NCT02682264|541584727|FG001|Overall Study|Withdrawal by Subject|45|||
150122504|NCT02682264|541584726|FG000|Overall Study|Lost to Follow-up|49|||
150122505|NCT02682264|541584727|FG001|Overall Study|Lost to Follow-up|41|||
150122506|NCT02682264|541584726|FG000|Overall Study|Lack of Efficacy|14|||
150122507|NCT02682264|541584727|FG001|Overall Study|Lack of Efficacy|16|||
150122508|NCT02682264|541584726|FG000|Overall Study|Withdrawal by Parent|6|||
150122509|NCT02682264|541584727|FG001|Overall Study|Withdrawal by Parent|7|||
150122510|NCT02682264|541584726|FG000|Overall Study|Adverse Event|9|||
150122511|NCT02682264|541584727|FG001|Overall Study|Adverse Event|0|||
150122512|NCT02682264|541584726|FG000|Overall Study|Noncompliance with study drug|1|||
150122513|NCT02682264|541584727|FG001|Overall Study|Noncompliance with study drug|4|||
150122514|NCT02682264|541584726|FG000|Overall Study|Pregnancy|1|||
150122515|NCT02682264|541584727|FG001|Overall Study|Pregnancy|2|||
150122516|NCT02682264|541584726|FG000|Overall Study|Recovery|1|||
150122517|NCT02682264|541584727|FG001|Overall Study|Recovery|2|||
150122518|NCT02682264|541584726|FG000|Overall Study|Progressive Disease|1|||
150122519|NCT02682264|541584727|FG001|Overall Study|Progressive Disease|0|||
150122520|NCT02682264|541584726|FG000|Overall Study|Technical Problems|0|||
150122521|NCT02682264|541584727|FG001|Overall Study|Technical Problems|1|||
150122522|NCT02682264|541584726|FG000|Overall Study|Moved abroad and unable to continue|0|||
150122523|NCT02682264|541584727|FG001|Overall Study|Moved abroad and unable to continue|3|||
150122524|NCT02682264|541584726|FG000|Overall Study|Stopped test article application|0|||
150122525|NCT02682264|541584727|FG001|Overall Study|Stopped test article application|1|||
150122526|NCT02347761|541584728|FG000|All Collected|Death|1|||
150122527|NCT02347761|541584729|FG001|All Collected|Death|0|||
150122528|NCT02347761|541584730|FG002|All Collected|Death|0|||
150122529|NCT02347761|541584728|FG000|All Collected|Lost to Follow-up|3|||
150122530|NCT02347761|541584729|FG001|All Collected|Lost to Follow-up|2|||
150122531|NCT02347761|541584730|FG002|All Collected|Lost to Follow-up|3|||
150122532|NCT02347761|541584728|FG000|All Collected|Withdrawal by Subject|11|||
150122533|NCT02347761|541584729|FG001|All Collected|Withdrawal by Subject|11|||
150122534|NCT02347761|541584730|FG002|All Collected|Withdrawal by Subject|22|||
150122535|NCT02347761|541584728|FG000|All Collected|invetigator disretion|2|||
150122536|NCT02347761|541584729|FG001|All Collected|invetigator disretion|0|||
150122537|NCT02347761|541584730|FG002|All Collected|invetigator disretion|0|||
150122538|NCT02347761|541584728|FG000|All Collected|instillation site pain|0|||
150122539|NCT02347761|541584729|FG001|All Collected|instillation site pain|0|||
150122540|NCT02347761|541584730|FG002|All Collected|instillation site pain|1|||
150122541|NCT02347761|541584728|FG000|All Collected|exacerbation of COPD|0|||
150122542|NCT02347761|541584729|FG001|All Collected|exacerbation of COPD|0|||
150122543|NCT02347761|541584730|FG002|All Collected|exacerbation of COPD|1|||
150122544|NCT02347761|541584728|FG000|All Collected|moved/travel|0|||
150122545|NCT02347761|541584729|FG001|All Collected|moved/travel|1|||
150122546|NCT02347761|541584730|FG002|All Collected|moved/travel|0|||
150122547|NCT02347761|541584728|FG000|On Study Treatment|Lack of Efficacy|2|||
150122548|NCT02347761|541584729|FG001|On Study Treatment|Lack of Efficacy|3|||
150122549|NCT02347761|541584730|FG002|On Study Treatment|Lack of Efficacy|4|||
150122550|NCT02347761|541584728|FG000|On Study Treatment|non-compliance with study medication|0|||
150122551|NCT02347761|541584729|FG001|On Study Treatment|non-compliance with study medication|0|||
150122552|NCT02347761|541584730|FG002|On Study Treatment|non-compliance with study medication|2|||
150122553|NCT02347761|541584728|FG000|On Study Treatment|Withdrawal by Subject|7|||
150122554|NCT02347761|541584729|FG001|On Study Treatment|Withdrawal by Subject|3|||
150122555|NCT02347761|541584730|FG002|On Study Treatment|Withdrawal by Subject|5|||
150122556|NCT02347761|541584728|FG000|On Study Treatment|move/travel|2|||
150122557|NCT02347761|541584729|FG001|On Study Treatment|move/travel|6|||
150122558|NCT02347761|541584730|FG002|On Study Treatment|move/travel|5|||
150122559|NCT02347761|541584728|FG000|On Study Treatment|dissastisfaction with device|2|||
150122560|NCT02347761|541584729|FG001|On Study Treatment|dissastisfaction with device|1|||
150122561|NCT02347761|541584730|FG002|On Study Treatment|dissastisfaction with device|4|||
150122562|NCT02347761|541584728|FG000|On Study Treatment|Lost to Follow-up|2|||
150122563|NCT02347761|541584729|FG001|On Study Treatment|Lost to Follow-up|1|||
150122564|NCT02347761|541584730|FG002|On Study Treatment|Lost to Follow-up|1|||
150122565|NCT02347761|541584728|FG000|On Study Treatment|investigator discretion|2|||
150122566|NCT02347761|541584729|FG001|On Study Treatment|investigator discretion|0|||
150122567|NCT02347761|541584730|FG002|On Study Treatment|investigator discretion|0|||
150122568|NCT02347761|541584728|FG000|On Study Treatment|durg not working|0|||
150122569|NCT02347761|541584729|FG001|On Study Treatment|durg not working|1|||
150122570|NCT02347761|541584730|FG002|On Study Treatment|durg not working|1|||
150122571|NCT02347761|541584728|FG000|On Study Treatment|Adverse Event|10|||
150122572|NCT02347761|541584729|FG001|On Study Treatment|Adverse Event|8|||
150122573|NCT02347761|541584730|FG002|On Study Treatment|Adverse Event|20|||
150122574|NCT00874029|541584731|FG000|Overall Study|Withdrawal by Subject|10|||
150122575|NCT00874029|541584731|FG000|Overall Study|Pregnancy|4|||
150122576|NCT00874029|541584731|FG000|Overall Study|Physician Decision|1|||
150122577|NCT00874029|541584731|FG000|Overall Study|Adverse Event|1|||
150122578|NCT00874029|541584731|FG000|Overall Study|Lost to Follow-up|5|||
150122579|NCT02252211|541584743|FG000|Overall Study|Adverse Event|0|||
150122580|NCT02252211|541584744|FG001|Overall Study|Adverse Event|1|||
150122581|NCT02252211|541584745|FG002|Overall Study|Adverse Event|0|||
150122582|NCT02252211|541584743|FG000|Overall Study|Progressive disease|3|||
150122583|NCT02252211|541584744|FG001|Overall Study|Progressive disease|2|||
150122584|NCT02252211|541584745|FG002|Overall Study|Progressive disease|0|||
150122585|NCT02252211|541584743|FG000|Overall Study|Withdrawal by Subject|1|||
150122586|NCT02252211|541584744|FG001|Overall Study|Withdrawal by Subject|0|||
150122587|NCT02252211|541584745|FG002|Overall Study|Withdrawal by Subject|0|||
150122588|NCT02252211|541584743|FG000|Overall Study|Serious Adverse Event During Screening|1|||
150122589|NCT02252211|541584744|FG001|Overall Study|Serious Adverse Event During Screening|0|||
150122590|NCT02252211|541584745|FG002|Overall Study|Serious Adverse Event During Screening|1|||
150122591|NCT00968669|541584747|FG000|Overall Study|Lost to Follow-up|5|||
150122592|NCT00968669|541584748|FG001|Overall Study|Lost to Follow-up|2|||
150122593|NCT00968669|541584749|FG002|Overall Study|Lost to Follow-up|1|||
150122594|NCT00968669|541584750|FG003|Overall Study|Lost to Follow-up|4|||
150122595|NCT00968669|541584747|FG000|Overall Study|Withdrawal by Subject|9|||
150122596|NCT00968669|541584748|FG001|Overall Study|Withdrawal by Subject|7|||
150122597|NCT00968669|541584749|FG002|Overall Study|Withdrawal by Subject|5|||
150122598|NCT00968669|541584750|FG003|Overall Study|Withdrawal by Subject|3|||
150122599|NCT00968669|541584747|FG000|Overall Study|Pregnancy|0|||
150122600|NCT00968669|541584748|FG001|Overall Study|Pregnancy|0|||
150122601|NCT00968669|541584749|FG002|Overall Study|Pregnancy|2|||
150122602|NCT00968669|541584750|FG003|Overall Study|Pregnancy|0|||
150122603|NCT00968669|541584747|FG000|Overall Study|AE|1|||
150122604|NCT00968669|541584748|FG001|Overall Study|AE|0|||
150122605|NCT00968669|541584749|FG002|Overall Study|AE|0|||
150122606|NCT00968669|541584750|FG003|Overall Study|AE|0|||
150122607|NCT00968669|541584747|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
150122608|NCT00968669|541584748|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
150122609|NCT00968669|541584749|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
150122610|NCT00968669|541584750|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
150122611|NCT00968669|541584747|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
150122612|NCT00968669|541584748|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
150122613|NCT00968669|541584749|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
150122614|NCT00968669|541584750|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
150122615|NCT00968669|541584747|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
150122616|NCT00968669|541584748|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
150122617|NCT00968669|541584749|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
150122618|NCT00968669|541584750|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
150122619|NCT00968669|541584747|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
150122620|NCT00968669|541584748|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
150122621|NCT00968669|541584749|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
150122622|NCT00968669|541584750|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
150122623|NCT00968669|541584747|FG000|Overall Study|EARLY WITHDRAWAL|0|||
150122624|NCT00968669|541584748|FG001|Overall Study|EARLY WITHDRAWAL|1|||
150122625|NCT00968669|541584749|FG002|Overall Study|EARLY WITHDRAWAL|0|||
150122626|NCT00968669|541584750|FG003|Overall Study|EARLY WITHDRAWAL|0|||
150122627|NCT00968669|541584747|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
150122628|NCT00968669|541584748|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
150122629|NCT00968669|541584749|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
150122630|NCT00968669|541584750|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
150122631|NCT00968669|541584747|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
150122632|NCT00968669|541584748|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
150122633|NCT00968669|541584749|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
150122634|NCT00968669|541584750|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
150122635|NCT00968669|541584747|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
150122636|NCT00968669|541584748|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
150122637|NCT00968669|541584749|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
150122638|NCT00968669|541584750|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
150122639|NCT00968669|541584747|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
150122640|NCT00968669|541584748|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
150122641|NCT00968669|541584749|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
150122642|NCT00968669|541584750|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
150122643|NCT00968669|541584747|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
150122644|NCT00968669|541584748|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
150122645|NCT00968669|541584749|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
150122646|NCT00968669|541584750|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
150122647|NCT00968669|541584747|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
150122648|NCT00968669|541584748|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
150122649|NCT00968669|541584749|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
150122650|NCT00968669|541584750|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
150122651|NCT00968669|541584747|FG000|Overall Study|SPONSOR DECISION|0|||
150122652|NCT00968669|541584748|FG001|Overall Study|SPONSOR DECISION|1|||
150122653|NCT00968669|541584749|FG002|Overall Study|SPONSOR DECISION|0|||
150122654|NCT00968669|541584750|FG003|Overall Study|SPONSOR DECISION|0|||
150122655|NCT00968669|541584747|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
150122656|NCT00968669|541584748|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
150122657|NCT00968669|541584749|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
150122658|NCT00968669|541584750|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
150192768|NCT05329220|541844991|FG002|Follow-up Period|Withdrawal by Subject|1|||
150192769|NCT05329220|541844992|FG003|Follow-up Period|Withdrawal by Subject|1|||
150192770|NCT05329220|541844993|FG004|Follow-up Period|Withdrawal by Subject|34|||
150122659|NCT00968669|541584747|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
150122660|NCT00968669|541584748|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
150122661|NCT00968669|541584749|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
150122662|NCT00968669|541584750|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
150122663|NCT00968669|541584747|FG000|Overall Study|SUBJECT INCARCERATED|0|||
150122664|NCT00968669|541584748|FG001|Overall Study|SUBJECT INCARCERATED|1|||
150122665|NCT00968669|541584749|FG002|Overall Study|SUBJECT INCARCERATED|0|||
150122666|NCT00968669|541584750|FG003|Overall Study|SUBJECT INCARCERATED|0|||
150122667|NCT00968669|541584747|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
150122668|NCT00968669|541584748|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
150122669|NCT00968669|541584749|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
150122670|NCT00968669|541584750|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
150122671|NCT00968669|541584747|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
150122672|NCT00968669|541584748|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
150192771|NCT05329220|541844994|FG005|Follow-up Period|Withdrawal by Subject|35|||
150192772|NCT05329220|541844989|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
150192773|NCT05329220|541844990|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
150192774|NCT05329220|541844991|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
150192775|NCT05329220|541844992|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
150192776|NCT05329220|541844993|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
150192777|NCT05329220|541844994|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
150192778|NCT05329220|541844989|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
150192779|NCT05329220|541844990|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
150192780|NCT05329220|541844991|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
150192781|NCT05329220|541844992|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
150192782|NCT05329220|541844993|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
150192783|NCT05329220|541844994|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
150192784|NCT05329220|541844989|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
150192785|NCT05329220|541844990|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
150192786|NCT05329220|541844991|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
150192787|NCT05329220|541844992|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
150192788|NCT05329220|541844993|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
150192789|NCT05329220|541844994|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
150192790|NCT05329220|541844989|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
150192791|NCT05329220|541844990|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
150192792|NCT05329220|541844991|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
150192793|NCT05329220|541844992|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
150192794|NCT05329220|541844993|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
150192795|NCT05329220|541844994|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
150192796|NCT05329220|541844989|FG000|Follow-up Period|EARLY TERMINATION|0|||
150192797|NCT05329220|541844990|FG001|Follow-up Period|EARLY TERMINATION|0|||
150192798|NCT05329220|541844991|FG002|Follow-up Period|EARLY TERMINATION|0|||
150192799|NCT05329220|541844992|FG003|Follow-up Period|EARLY TERMINATION|0|||
150192800|NCT05329220|541844993|FG004|Follow-up Period|EARLY TERMINATION|0|||
150192801|NCT05329220|541844994|FG005|Follow-up Period|EARLY TERMINATION|1|||
150192802|NCT05329220|541844989|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
150192803|NCT05329220|541844990|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
150192804|NCT05329220|541844991|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
150192805|NCT05329220|541844992|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
150192806|NCT05329220|541844993|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
150192807|NCT05329220|541844994|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
150192808|NCT05329220|541844989|FG000|Follow-up Period|DROPPED|0|||
150192809|NCT05329220|541844990|FG001|Follow-up Period|DROPPED|0|||
150192810|NCT05329220|541844991|FG002|Follow-up Period|DROPPED|0|||
150192811|NCT05329220|541844992|FG003|Follow-up Period|DROPPED|0|||
150192812|NCT05329220|541844993|FG004|Follow-up Period|DROPPED|0|||
150192813|NCT05329220|541844994|FG005|Follow-up Period|DROPPED|1|||
150192814|NCT05329220|541844989|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
150192815|NCT05329220|541844990|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
150192816|NCT05329220|541844991|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
150192817|NCT05329220|541844992|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
150192818|NCT05329220|541844993|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
150192819|NCT05329220|541844994|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
150192820|NCT02465268|541844996|FG000|Overall Study|Withdrawal by Subject|4|||
150192821|NCT02465268|541844997|FG001|Overall Study|Withdrawal by Subject|3|||
150192822|NCT02465268|541844998|FG002|Overall Study|Withdrawal by Subject|1|||
150192823|NCT02465268|541844996|FG000|Overall Study|Not evaluable per protocol criteria|3|||
150192824|NCT02465268|541844997|FG001|Overall Study|Not evaluable per protocol criteria|2|||
150192825|NCT02465268|541844998|FG002|Overall Study|Not evaluable per protocol criteria|1|||
150192826|NCT02465268|541844996|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
150192827|NCT02465268|541844997|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
150122673|NCT00968669|541584749|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
150122674|NCT00968669|541584750|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
150122675|NCT01953926|541584751|FG000|Overall Study|Withdrawal by Subject|23|||
150122676|NCT01953926|541584752|FG001|Overall Study|Withdrawal by Subject|3|||
150122677|NCT01953926|541584753|FG002|Overall Study|Withdrawal by Subject|3|||
150122678|NCT01953926|541584754|FG003|Overall Study|Withdrawal by Subject|5|||
150122679|NCT01953926|541584755|FG004|Overall Study|Withdrawal by Subject|6|||
150122680|NCT01953926|541584756|FG005|Overall Study|Withdrawal by Subject|0|||
150122681|NCT01953926|541584757|FG006|Overall Study|Withdrawal by Subject|1|||
150122682|NCT01953926|541584751|FG000|Overall Study|Physician Decision|1|||
150122683|NCT01953926|541584752|FG001|Overall Study|Physician Decision|0|||
150122684|NCT01953926|541584753|FG002|Overall Study|Physician Decision|0|||
150122685|NCT01953926|541584754|FG003|Overall Study|Physician Decision|0|||
150122686|NCT01953926|541584755|FG004|Overall Study|Physician Decision|2|||
150122687|NCT01953926|541584756|FG005|Overall Study|Physician Decision|0|||
150122688|NCT01953926|541584757|FG006|Overall Study|Physician Decision|0|||
150122689|NCT01953926|541584751|FG000|Overall Study|Lost to Follow-up|18|||
150122690|NCT01953926|541584752|FG001|Overall Study|Lost to Follow-up|3|||
150122691|NCT01953926|541584753|FG002|Overall Study|Lost to Follow-up|0|||
150122692|NCT01953926|541584754|FG003|Overall Study|Lost to Follow-up|5|||
150122693|NCT01953926|541584755|FG004|Overall Study|Lost to Follow-up|3|||
150122694|NCT01953926|541584756|FG005|Overall Study|Lost to Follow-up|0|||
150122695|NCT01953926|541584757|FG006|Overall Study|Lost to Follow-up|0|||
150122696|NCT01953926|541584751|FG000|Overall Study|Protocol Violation|1|||
150122697|NCT01953926|541584752|FG001|Overall Study|Protocol Violation|0|||
150122698|NCT01953926|541584753|FG002|Overall Study|Protocol Violation|0|||
150122699|NCT01953926|541584754|FG003|Overall Study|Protocol Violation|0|||
150122700|NCT01953926|541584755|FG004|Overall Study|Protocol Violation|0|||
150122701|NCT01953926|541584756|FG005|Overall Study|Protocol Violation|0|||
150122702|NCT01953926|541584757|FG006|Overall Study|Protocol Violation|0|||
150122703|NCT01953926|541584751|FG000|Overall Study|Other, Disease progression|2|||
150122704|NCT01953926|541584752|FG001|Overall Study|Other, Disease progression|1|||
150122705|NCT01953926|541584753|FG002|Overall Study|Other, Disease progression|0|||
150122706|NCT01953926|541584754|FG003|Overall Study|Other, Disease progression|0|||
150122707|NCT01953926|541584755|FG004|Overall Study|Other, Disease progression|1|||
150122708|NCT01953926|541584756|FG005|Overall Study|Other, Disease progression|0|||
150122709|NCT01953926|541584757|FG006|Overall Study|Other, Disease progression|0|||
150122710|NCT01953926|541584751|FG000|Overall Study|Discontinuation of study by sponsor|41|||
150122711|NCT01953926|541584752|FG001|Overall Study|Discontinuation of study by sponsor|7|||
150122712|NCT01953926|541584753|FG002|Overall Study|Discontinuation of study by sponsor|5|||
150122713|NCT01953926|541584754|FG003|Overall Study|Discontinuation of study by sponsor|12|||
150122714|NCT01953926|541584755|FG004|Overall Study|Discontinuation of study by sponsor|46|||
150122715|NCT01953926|541584756|FG005|Overall Study|Discontinuation of study by sponsor|5|||
150122716|NCT01953926|541584757|FG006|Overall Study|Discontinuation of study by sponsor|6|||
150122717|NCT01953926|541584751|FG000|Overall Study|Not Treated|1|||
150122718|NCT01953926|541584752|FG001|Overall Study|Not Treated|0|||
150122719|NCT01953926|541584753|FG002|Overall Study|Not Treated|1|||
150122720|NCT01953926|541584754|FG003|Overall Study|Not Treated|0|||
150122721|NCT01953926|541584755|FG004|Overall Study|Not Treated|0|||
150122722|NCT01953926|541584756|FG005|Overall Study|Not Treated|0|||
150192828|NCT02465268|541844998|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
150192829|NCT02465268|541844996|FG000|Overall Study|Study drug did not pass QA/QC|1|||
150192830|NCT02465268|541844997|FG001|Overall Study|Study drug did not pass QA/QC|0|||
150192831|NCT02465268|541844998|FG002|Overall Study|Study drug did not pass QA/QC|0|||
150192832|NCT02465268|541844996|FG000|Overall Study|Adverse Event|0|||
150192833|NCT02465268|541844997|FG001|Overall Study|Adverse Event|1|||
150192834|NCT02465268|541844998|FG002|Overall Study|Adverse Event|0|||
150192835|NCT02465268|541844996|FG000|Overall Study|Physician Decision|0|||
150192836|NCT02465268|541844997|FG001|Overall Study|Physician Decision|1|||
150192837|NCT02465268|541844998|FG002|Overall Study|Physician Decision|0|||
150192838|NCT03322267|541844999|FG000|Overall Study|Lack of Efficacy|11|||
150192839|NCT03322267|541844999|FG000|Overall Study|Adverse Event|1|||
150192840|NCT03322267|541844999|FG000|Overall Study|Withdrawal by Subject|2|||
150192841|NCT05792085|541845000|FG000|Overall Study|Death|0|||
150192842|NCT05792085|541845001|FG001|Overall Study|Death|0|||
150192843|NCT05792085|541845002|FG002|Overall Study|Death|0|||
150122723|NCT01953926|541584757|FG006|Overall Study|Not Treated|0|||
150122724|NCT01949480|541584764|FG000|Overall Study|Physician Decision|5|||
150122725|NCT01949480|541584765|FG001|Overall Study|Physician Decision|8|||
150122726|NCT04798586|541584767|FG000|Overall Study|Death|2|||
150122727|NCT00142909|541584780|FG000|Randomization|Various Reasons|7|||
150122728|NCT00142909|541584781|FG001|Randomization|Various Reasons|10|||
150122729|NCT00142909|541584780|FG000|Medications Begin|Protocol Violation|2|||
150122730|NCT00142909|541584781|FG001|Medications Begin|Protocol Violation|0|||
150122731|NCT00142909|541584780|FG000|Medications Begin|Withdrawal by Subject|5|||
150122732|NCT00142909|541584781|FG001|Medications Begin|Withdrawal by Subject|3|||
150122733|NCT00142909|541584780|FG000|Medications Begin|Withdrawal by Subject|2|||
150122734|NCT00142909|541584781|FG001|Medications Begin|Withdrawal by Subject|0|||
150122735|NCT01870843|541584785|FG000|Overall Study|Adverse Event|10|||
150122736|NCT01870843|541584785|FG000|Overall Study|Lost to Follow-up|24|||
150122737|NCT01870843|541584785|FG000|Overall Study|Death|1|||
150122738|NCT01870843|541584785|FG000|Overall Study|Withdrawal by Subject|18|||
150122739|NCT03325712|541584786|FG000|Overall Study|Protocol Violation|0|||
150122740|NCT03325712|541584787|FG001|Overall Study|Protocol Violation|0|||
150122741|NCT03325712|541584788|FG002|Overall Study|Protocol Violation|0|||
150122742|NCT03325712|541584789|FG003|Overall Study|Protocol Violation|0|||
150122743|NCT03325712|541584790|FG004|Overall Study|Protocol Violation|1|||
150122744|NCT03325712|541584791|FG005|Overall Study|Protocol Violation|0|||
150122745|NCT03325712|541584792|FG006|Overall Study|Protocol Violation|0|||
150122746|NCT03325712|541584793|FG007|Overall Study|Protocol Violation|0|||
150122747|NCT03325712|541584786|FG000|Overall Study|Adverse Event|0|||
150122748|NCT03325712|541584787|FG001|Overall Study|Adverse Event|0|||
150122749|NCT03325712|541584788|FG002|Overall Study|Adverse Event|0|||
150122750|NCT03325712|541584789|FG003|Overall Study|Adverse Event|0|||
150122751|NCT03325712|541584790|FG004|Overall Study|Adverse Event|1|||
150122752|NCT03325712|541584791|FG005|Overall Study|Adverse Event|0|||
150122753|NCT03325712|541584792|FG006|Overall Study|Adverse Event|0|||
150122754|NCT03325712|541584793|FG007|Overall Study|Adverse Event|0|||
150122755|NCT02265237|541584794|FG000|As Treated (Overall Study)|Adverse Event|1|||
150122756|NCT02265237|541584795|FG001|As Treated (Overall Study)|Adverse Event|1|||
150122757|NCT02265237|541584796|FG002|As Treated (Overall Study)|Adverse Event|0|||
150122758|NCT02265237|541584797|FG003|As Treated (Overall Study)|Adverse Event|0|||
150122759|NCT02265237|541584794|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
150122760|NCT02265237|541584795|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
150122761|NCT02265237|541584796|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
150192844|NCT05792085|541845003|FG003|Overall Study|Death|0|||
150192845|NCT05792085|541845004|FG004|Overall Study|Death|1|||
150192846|NCT04797897|541845007|FG000|Overall Study|Study Termination by Sponsor|1|||
150192847|NCT04797897|541845008|FG001|Overall Study|Study Termination by Sponsor|1|||
150192848|NCT03084536|541845010|FG000|Overall Study|Determined to be ineligible|0|||
150192849|NCT03084536|541845011|FG001|Overall Study|Determined to be ineligible|0|||
150192850|NCT03084536|541845012|FG002|Overall Study|Determined to be ineligible|16|||
150122762|NCT02265237|541584797|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
150122763|NCT02265237|541584794|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
150122764|NCT02265237|541584795|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
150122765|NCT02265237|541584796|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
150192851|NCT03084536|541845010|FG000|Overall Study|Withdrawal by Subject|0|||
150192852|NCT03084536|541845011|FG001|Overall Study|Withdrawal by Subject|0|||
150192853|NCT03084536|541845012|FG002|Overall Study|Withdrawal by Subject|4|||
150192854|NCT03084536|541845010|FG000|Overall Study|Physician Decision|0|||
150192855|NCT03084536|541845011|FG001|Overall Study|Physician Decision|0|||
150192856|NCT03084536|541845012|FG002|Overall Study|Physician Decision|3|||
150122766|NCT02265237|541584797|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
150122767|NCT02265237|541584794|FG000|As Treated (Overall Study)|Other|2|||
150122768|NCT02265237|541584795|FG001|As Treated (Overall Study)|Other|0|||
150122769|NCT02265237|541584796|FG002|As Treated (Overall Study)|Other|3|||
150122770|NCT02265237|541584797|FG003|As Treated (Overall Study)|Other|1|||
150122771|NCT01178853|541584799|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
150122772|NCT01178853|541584800|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
150122773|NCT01178853|541584799|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
150122774|NCT01178853|541584800|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
150122775|NCT01178853|541584799|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
150122776|NCT01178853|541584800|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
150122777|NCT01178853|541584799|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
150122778|NCT01178853|541584800|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
150122779|NCT01178853|541584799|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
150122780|NCT01178853|541584800|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
150122781|NCT03550313|541584801|FG000|Overall Study|Adverse Event|0|||
150122782|NCT03550313|541584802|FG001|Overall Study|Adverse Event|1|||
150122783|NCT03550313|541584803|FG002|Overall Study|Adverse Event|0|||
150122784|NCT03550313|541584801|FG000|Overall Study|Lost to Follow-up|5|||
150122785|NCT03550313|541584802|FG001|Overall Study|Lost to Follow-up|7|||
150122786|NCT03550313|541584803|FG002|Overall Study|Lost to Follow-up|12|||
150122787|NCT03550313|541584801|FG000|Overall Study|Study terminated by sponsor|44|||
150122788|NCT03550313|541584802|FG001|Overall Study|Study terminated by sponsor|37|||
150122789|NCT03550313|541584803|FG002|Overall Study|Study terminated by sponsor|48|||
150122790|NCT03550313|541584801|FG000|Overall Study|No longer met eligibility criteria|3|||
150122791|NCT03550313|541584802|FG001|Overall Study|No longer met eligibility criteria|5|||
150122792|NCT03550313|541584803|FG002|Overall Study|No longer met eligibility criteria|6|||
150122793|NCT03550313|541584801|FG000|Overall Study|Withdrawal by parent/guardian|20|||
150122794|NCT03550313|541584802|FG001|Overall Study|Withdrawal by parent/guardian|18|||
150122795|NCT03550313|541584803|FG002|Overall Study|Withdrawal by parent/guardian|26|||
150122796|NCT03550313|541584801|FG000|Overall Study|Other|4|||
150122797|NCT03550313|541584802|FG001|Overall Study|Other|2|||
150122798|NCT03550313|541584803|FG002|Overall Study|Other|2|||
150122799|NCT03550313|541584801|FG000|Overall Study|Randomized but not vaccinated|3|||
150122800|NCT03550313|541584802|FG001|Overall Study|Randomized but not vaccinated|23|||
150122801|NCT03550313|541584803|FG002|Overall Study|Randomized but not vaccinated|2|||
150122802|NCT03550313|541584801|FG000|Overall Study|Sites terminated due to quality issues|18|||
150122803|NCT03550313|541584802|FG001|Overall Study|Sites terminated due to quality issues|17|||
150122804|NCT03550313|541584803|FG002|Overall Study|Sites terminated due to quality issues|18|||
150122805|NCT00839072|541584804|FG000|First Intervention Period|Withdrawal by Subject|1|||
150122806|NCT00839072|541584805|FG001|First Intervention Period|Withdrawal by Subject|0|||
150122807|NCT00839072|541584804|FG000|First Intervention Period|Adverse Event|1|||
150122808|NCT00839072|541584805|FG001|First Intervention Period|Adverse Event|1|||
150122809|NCT00839072|541584804|FG000|Second Intervention Period|Withdrawal by Subject|1|||
150122810|NCT00839072|541584805|FG001|Second Intervention Period|Withdrawal by Subject|0|||
150122811|NCT01297062|541584806|FG000|Overall Study|Adverse Event|2|||
150122812|NCT01297062|541584807|FG001|Overall Study|Adverse Event|0|||
150122813|NCT01297062|541584808|FG002|Overall Study|Adverse Event|1|||
150122814|NCT01297062|541584809|FG003|Overall Study|Adverse Event|0|||
150122815|NCT01297062|541584810|FG004|Overall Study|Adverse Event|0|||
150122816|NCT01297062|541584811|FG005|Overall Study|Adverse Event|0|||
150122817|NCT01297062|541584812|FG006|Overall Study|Adverse Event|0|||
150122818|NCT01297062|541584806|FG000|Overall Study|Physician Decision|1|||
150122819|NCT01297062|541584807|FG001|Overall Study|Physician Decision|0|||
150122820|NCT01297062|541584808|FG002|Overall Study|Physician Decision|1|||
150122821|NCT01297062|541584809|FG003|Overall Study|Physician Decision|0|||
150122822|NCT01297062|541584810|FG004|Overall Study|Physician Decision|0|||
150122823|NCT01297062|541584811|FG005|Overall Study|Physician Decision|0|||
150122824|NCT01297062|541584812|FG006|Overall Study|Physician Decision|6|||
150122825|NCT01297062|541584806|FG000|Overall Study|Protocol Violation|0|||
150122826|NCT01297062|541584807|FG001|Overall Study|Protocol Violation|0|||
150122827|NCT01297062|541584808|FG002|Overall Study|Protocol Violation|0|||
150122828|NCT01297062|541584809|FG003|Overall Study|Protocol Violation|0|||
150122829|NCT01297062|541584810|FG004|Overall Study|Protocol Violation|1|||
150122830|NCT01297062|541584811|FG005|Overall Study|Protocol Violation|0|||
150122831|NCT01297062|541584812|FG006|Overall Study|Protocol Violation|0|||
150122832|NCT01297062|541584806|FG000|Overall Study|Subject Decision|1|||
150122833|NCT01297062|541584807|FG001|Overall Study|Subject Decision|1|||
150192857|NCT03084536|541845010|FG000|Overall Study|Death|0|||
150192858|NCT03084536|541845011|FG001|Overall Study|Death|0|||
150192859|NCT03084536|541845012|FG002|Overall Study|Death|1|||
150192860|NCT03084536|541845010|FG000|Overall Study|Lost to Follow-up|0|||
150192861|NCT03084536|541845011|FG001|Overall Study|Lost to Follow-up|0|||
150192862|NCT03084536|541845012|FG002|Overall Study|Lost to Follow-up|1|||
150122834|NCT01297062|541584808|FG002|Overall Study|Subject Decision|0|||
150122835|NCT01297062|541584809|FG003|Overall Study|Subject Decision|1|||
150122836|NCT01297062|541584810|FG004|Overall Study|Subject Decision|1|||
150122837|NCT01297062|541584811|FG005|Overall Study|Subject Decision|1|||
150122838|NCT01297062|541584812|FG006|Overall Study|Subject Decision|2|||
150122839|NCT01682837|541584813|FG000|Baseline|Withdrawal by Subject|5|||
150122840|NCT04782323|541584814|FG000|Overall Study|Death|1|||
150122841|NCT04782323|541584815|FG001|Overall Study|Death|0|||
150122842|NCT04782323|541584816|FG002|Overall Study|Death|0|||
150122843|NCT04782323|541584817|FG003|Overall Study|Death|0|||
150122844|NCT04782323|541584818|FG004|Overall Study|Death|1|||
150122845|NCT04782323|541584819|FG005|Overall Study|Death|1|||
150122846|NCT04782323|541584820|FG006|Overall Study|Death|1|||
150122847|NCT04782323|541584821|FG007|Overall Study|Death|0|||
150122848|NCT04782323|541584814|FG000|Overall Study|Withdrawal by Subject|0|||
150122849|NCT04782323|541584815|FG001|Overall Study|Withdrawal by Subject|0|||
150122850|NCT04782323|541584816|FG002|Overall Study|Withdrawal by Subject|1|||
150122851|NCT04782323|541584817|FG003|Overall Study|Withdrawal by Subject|0|||
150122852|NCT04782323|541584818|FG004|Overall Study|Withdrawal by Subject|0|||
150122853|NCT04782323|541584819|FG005|Overall Study|Withdrawal by Subject|1|||
150122854|NCT04782323|541584820|FG006|Overall Study|Withdrawal by Subject|0|||
150122855|NCT04782323|541584821|FG007|Overall Study|Withdrawal by Subject|1|||
150122856|NCT04782323|541584814|FG000|Overall Study|Lost to Follow-up|0|||
150122857|NCT04782323|541584815|FG001|Overall Study|Lost to Follow-up|1|||
150122858|NCT04782323|541584816|FG002|Overall Study|Lost to Follow-up|1|||
150122859|NCT04782323|541584817|FG003|Overall Study|Lost to Follow-up|0|||
150122860|NCT04782323|541584818|FG004|Overall Study|Lost to Follow-up|0|||
150122861|NCT04782323|541584819|FG005|Overall Study|Lost to Follow-up|1|||
150122862|NCT04782323|541584820|FG006|Overall Study|Lost to Follow-up|1|||
150122863|NCT04782323|541584821|FG007|Overall Study|Lost to Follow-up|2|||
150122864|NCT04782323|541584814|FG000|Overall Study|randomization in error|1|||
150122865|NCT04782323|541584815|FG001|Overall Study|randomization in error|0|||
150122866|NCT04782323|541584816|FG002|Overall Study|randomization in error|0|||
150122867|NCT04782323|541584817|FG003|Overall Study|randomization in error|0|||
150122868|NCT04782323|541584818|FG004|Overall Study|randomization in error|0|||
150122869|NCT04782323|541584819|FG005|Overall Study|randomization in error|0|||
150122870|NCT04782323|541584820|FG006|Overall Study|randomization in error|0|||
150122871|NCT04782323|541584821|FG007|Overall Study|randomization in error|0|||
150122872|NCT04369469|541584822|FG000|Overall Study|Lost to Follow-up|2|||
150122873|NCT04369469|541584823|FG001|Overall Study|Lost to Follow-up|4|||
150122874|NCT04369469|541584822|FG000|Overall Study|Physician Decision|2|||
150122875|NCT04369469|541584823|FG001|Overall Study|Physician Decision|1|||
150122876|NCT04369469|541584822|FG000|Overall Study|Withdrawal by Subject|2|||
150122877|NCT04369469|541584823|FG001|Overall Study|Withdrawal by Subject|3|||
150122878|NCT04369469|541584822|FG000|Overall Study|Adverse Event|1|||
150122879|NCT04369469|541584823|FG001|Overall Study|Adverse Event|0|||
150122880|NCT04369469|541584822|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
150122881|NCT04369469|541584823|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
150122882|NCT04369469|541584822|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
150122883|NCT04369469|541584823|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
150122884|NCT04369469|541584822|FG000|Overall Study|Unable to Provide Consent|0|||
150122885|NCT04369469|541584823|FG001|Overall Study|Unable to Provide Consent|1|||
150122886|NCT02863991|541584824|FG000|Overall Study|Death|0|||
150122887|NCT02863991|541584825|FG001|Overall Study|Death|3|||
150122888|NCT02863991|541584824|FG000|Overall Study|Lack of Efficacy|0|||
150122889|NCT02863991|541584825|FG001|Overall Study|Lack of Efficacy|1|||
150122890|NCT02863991|541584824|FG000|Overall Study|Study Terminated|2|||
150122891|NCT02863991|541584825|FG001|Overall Study|Study Terminated|8|||
150122892|NCT00364858|541584830|FG000|Overall Study|Adverse Event|1|||
150192863|NCT03084536|541845010|FG000|Overall Study|Protocol Violation|0|||
150122893|NCT00364858|541584831|FG001|Overall Study|Adverse Event|5|||
150122894|NCT00364858|541584830|FG000|Overall Study|Withdrawal by Subject|1|||
150122895|NCT00364858|541584831|FG001|Overall Study|Withdrawal by Subject|1|||
150122896|NCT00364858|541584830|FG000|Overall Study|Pregnancy|1|||
150122897|NCT00364858|541584831|FG001|Overall Study|Pregnancy|1|||
150122898|NCT00364858|541584830|FG000|Overall Study|Clinical failure|2|||
150192864|NCT03084536|541845011|FG001|Overall Study|Protocol Violation|0|||
150192865|NCT03084536|541845012|FG002|Overall Study|Protocol Violation|1|||
150122899|NCT00364858|541584831|FG001|Overall Study|Clinical failure|13|||
150122900|NCT00364858|541584830|FG000|Overall Study|Discontinuation at baseline|1|||
150122901|NCT00364858|541584831|FG001|Overall Study|Discontinuation at baseline|0|||
150122902|NCT00364858|541584830|FG000|Overall Study|Non-compliant|1|||
150122903|NCT00364858|541584831|FG001|Overall Study|Non-compliant|0|||
150122904|NCT00364858|541584830|FG000|Overall Study|Return to Q2 regimen|0|||
150122905|NCT00364858|541584831|FG001|Overall Study|Return to Q2 regimen|1|||
150122906|NCT00364858|541584830|FG000|Overall Study|Clinical baseline issue|0|||
150122907|NCT00364858|541584831|FG001|Overall Study|Clinical baseline issue|1|||
150122908|NCT00558285|541584832|FG000|Overall Study|Adverse Event|1|||
150122909|NCT00558285|541584833|FG001|Overall Study|Adverse Event|1|||
150122910|NCT00558285|541584834|FG002|Overall Study|Adverse Event|4|||
150122911|NCT00558285|541584835|FG003|Overall Study|Adverse Event|1|||
150122912|NCT00558285|541584836|FG004|Overall Study|Adverse Event|2|||
150122913|NCT00558285|541584832|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150122914|NCT00558285|541584833|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150122915|NCT00558285|541584834|FG002|Overall Study|Abnormal test procedure result(s)|0|||
150122916|NCT00558285|541584835|FG003|Overall Study|Abnormal test procedure result(s)|0|||
150122917|NCT00558285|541584836|FG004|Overall Study|Abnormal test procedure result(s)|0|||
150122918|NCT00558285|541584832|FG000|Overall Study|Subject withdrew consent|2|||
150122919|NCT00558285|541584833|FG001|Overall Study|Subject withdrew consent|0|||
150122920|NCT00558285|541584834|FG002|Overall Study|Subject withdrew consent|1|||
150122921|NCT00558285|541584835|FG003|Overall Study|Subject withdrew consent|1|||
150122922|NCT00558285|541584836|FG004|Overall Study|Subject withdrew consent|1|||
150122923|NCT00558285|541584832|FG000|Overall Study|Lost to Follow-up|1|||
150122924|NCT00558285|541584833|FG001|Overall Study|Lost to Follow-up|1|||
150122925|NCT00558285|541584834|FG002|Overall Study|Lost to Follow-up|0|||
150122926|NCT00558285|541584835|FG003|Overall Study|Lost to Follow-up|0|||
150122927|NCT00558285|541584836|FG004|Overall Study|Lost to Follow-up|0|||
150122928|NCT00558285|541584832|FG000|Overall Study|Administrative problems|0|||
150122929|NCT00558285|541584833|FG001|Overall Study|Administrative problems|0|||
150122930|NCT00558285|541584834|FG002|Overall Study|Administrative problems|0|||
150122931|NCT00558285|541584835|FG003|Overall Study|Administrative problems|1|||
150122932|NCT00558285|541584836|FG004|Overall Study|Administrative problems|1|||
150122933|NCT00558285|541584832|FG000|Overall Study|Protocol deviation|1|||
150122934|NCT00558285|541584833|FG001|Overall Study|Protocol deviation|1|||
150122935|NCT00558285|541584834|FG002|Overall Study|Protocol deviation|0|||
150122936|NCT00558285|541584835|FG003|Overall Study|Protocol deviation|1|||
150122937|NCT00558285|541584836|FG004|Overall Study|Protocol deviation|0|||
150122938|NCT02345512|541584843|FG000|Overall Study|Adverse Event|1|||
150122939|NCT02345512|541584843|FG000|Overall Study|Withdrawal by Subject|1|||
150122940|NCT01660906|541584844|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
150122941|NCT03478891|541584847|FG000|Overall Study|Enrolled, but product never administered|0|||
150122942|NCT03478891|541584848|FG001|Overall Study|Enrolled, but product never administered|0|||
150122943|NCT03478891|541584849|FG002|Overall Study|Enrolled, but product never administered|1|||
150122944|NCT03478891|541584847|FG000|Overall Study|Moved from area|0|||
150122945|NCT03478891|541584848|FG001|Overall Study|Moved from area|0|||
150122946|NCT03478891|541584849|FG002|Overall Study|Moved from area|1|||
150122947|NCT03478891|541584847|FG000|Overall Study|Lost to Follow-up|1|||
150122948|NCT03478891|541584848|FG001|Overall Study|Lost to Follow-up|0|||
150122949|NCT03478891|541584849|FG002|Overall Study|Lost to Follow-up|1|||
150122950|NCT03823651|541584850|FG000|Overall Study|Death|5|||
150122951|NCT03823651|541584851|FG001|Overall Study|Death|0|||
150122952|NCT03823651|541584850|FG000|Overall Study|Physician Decision|1|||
150122953|NCT03823651|541584851|FG001|Overall Study|Physician Decision|0|||
150122954|NCT03823651|541584850|FG000|Overall Study|Caregiver to patient who died|0|||
150122955|NCT03823651|541584851|FG001|Overall Study|Caregiver to patient who died|5|||
150122956|NCT03823651|541584850|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
150122957|NCT03823651|541584851|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
150122958|NCT01850004|541584852|FG000|Overall Study|Poor/Non-compliance|1|||
150122959|NCT01850004|541584852|FG000|Overall Study|Participant Withdrew Consent|9|||
150122960|NCT01850004|541584852|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
150122961|NCT01850004|541584852|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
150122962|NCT01850004|541584852|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
150122963|NCT01850004|541584852|FG000|Overall Study|Other Reasons|2|||
150122964|NCT01850004|541584852|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
150122965|NCT01850004|541584852|FG000|Overall Study|Maximum Clinical Benefit|4|||
150122966|NCT04827576|541586675|FG000|Overall Study|Death|5|||
150192866|NCT03084536|541845010|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
150122967|NCT04827576|541586676|FG001|Overall Study|Death|17|||
150122968|NCT04827576|541586677|FG002|Overall Study|Death|17|||
150122969|NCT04827576|541586678|FG003|Overall Study|Death|32|||
150122970|NCT04827576|541586675|FG000|Overall Study|Study Terminated by Sponsor|2|||
150122971|NCT04827576|541586676|FG001|Overall Study|Study Terminated by Sponsor|9|||
150122972|NCT04827576|541586677|FG002|Overall Study|Study Terminated by Sponsor|7|||
150122973|NCT04827576|541586678|FG003|Overall Study|Study Terminated by Sponsor|5|||
150122974|NCT04827576|541586675|FG000|Overall Study|Investigator's Discretion|1|||
150122975|NCT04827576|541586676|FG001|Overall Study|Investigator's Discretion|0|||
150122976|NCT04827576|541586677|FG002|Overall Study|Investigator's Discretion|2|||
150192867|NCT03084536|541845011|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
150122977|NCT04827576|541586678|FG003|Overall Study|Investigator's Discretion|5|||
150122978|NCT04827576|541586675|FG000|Overall Study|Withdrew Consent|0|||
150122979|NCT04827576|541586676|FG001|Overall Study|Withdrew Consent|3|||
150122980|NCT04827576|541586677|FG002|Overall Study|Withdrew Consent|0|||
150122981|NCT04827576|541586678|FG003|Overall Study|Withdrew Consent|0|||
150122982|NCT04827576|541586675|FG000|Overall Study|Lost to Follow-up|1|||
150122983|NCT04827576|541586676|FG001|Overall Study|Lost to Follow-up|0|||
150192868|NCT03084536|541845012|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
150192869|NCT00506519|541846639|FG000|Overall Study|Death|4|||
150192870|NCT00506519|541846640|FG001|Overall Study|Death|6|||
150192871|NCT00506519|541846641|FG002|Overall Study|Death|0|||
150122984|NCT04827576|541586677|FG002|Overall Study|Lost to Follow-up|0|||
150122985|NCT04827576|541586678|FG003|Overall Study|Lost to Follow-up|0|||
150122986|NCT04745169|541586679|FG000|Overall Study|Kidney transplantation|1|||
150122987|NCT04745169|541586679|FG000|Overall Study|Participant health problems|3|||
150122988|NCT04745169|541586679|FG000|Overall Study|Physician Decision|2|||
150122989|NCT00724282|541586681|FG000|Overall Study|Withdrawal by Subject|3|||
150122990|NCT00724282|541586681|FG000|Overall Study|Physician Decision|1|||
150122991|NCT02367911|541586688|FG000|Overall Study|Withdrawal by Subject|3|||
150122992|NCT02367911|541586689|FG001|Overall Study|Withdrawal by Subject|2|||
150122993|NCT02367911|541586688|FG000|Overall Study|Lost to Follow-up|2|||
150122994|NCT02367911|541586689|FG001|Overall Study|Lost to Follow-up|2|||
150122995|NCT00263666|541586690|FG000|Overall Study|Adverse Event|6|||
150122996|NCT00263666|541586691|FG001|Overall Study|Adverse Event|8|||
150122997|NCT00263666|541586690|FG000|Overall Study|Lost to Follow-up|1|||
150122998|NCT00263666|541586691|FG001|Overall Study|Lost to Follow-up|2|||
150122999|NCT00263666|541586690|FG000|Overall Study|Withdrawal by Subject|0|||
150123000|NCT00263666|541586691|FG001|Overall Study|Withdrawal by Subject|1|||
150123001|NCT00896168|541586692|FG000|Overall Study|Adverse Event|4|||
150123002|NCT00896168|541586693|FG001|Overall Study|Adverse Event|7|||
150123003|NCT00896168|541586692|FG000|Overall Study|Treatment failure|8|||
150123004|NCT00896168|541586693|FG001|Overall Study|Treatment failure|10|||
150123005|NCT00896168|541586692|FG000|Overall Study|Lost to Follow-up|1|||
150123006|NCT00896168|541586693|FG001|Overall Study|Lost to Follow-up|1|||
150123007|NCT00896168|541586692|FG000|Overall Study|Other|1|||
150123008|NCT00896168|541586693|FG001|Overall Study|Other|1|||
150123009|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
150123010|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
150123011|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
150123012|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
150123013|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
150123014|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
150123015|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
150123016|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
150123017|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
150123018|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
150123019|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
150123020|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
150123021|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
150123022|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
150123023|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
150123024|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
150123025|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
150192872|NCT00506519|541846639|FG000|Overall Study|Adverse Event|1|||
150192873|NCT00506519|541846640|FG001|Overall Study|Adverse Event|0|||
150192874|NCT00506519|541846641|FG002|Overall Study|Adverse Event|0|||
150192875|NCT03452579|541846650|FG000|Overall Study|Death|0|||
150192876|NCT03452579|541846651|FG001|Overall Study|Death|1|||
150192877|NCT03452579|541846650|FG000|Overall Study|Withdrawal by Subject|2|||
150123026|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
150123027|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
150123028|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
150123029|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
150123030|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
150192878|NCT03452579|541846651|FG001|Overall Study|Withdrawal by Subject|0|||
150192879|NCT03452579|541846650|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
150123031|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
150192880|NCT03452579|541846651|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
150123032|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
150192881|NCT03452579|541846650|FG000|Overall Study|Physician Decision|1|||
150192882|NCT03452579|541846651|FG001|Overall Study|Physician Decision|1|||
150123033|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123034|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123035|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123036|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123037|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123038|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123039|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123040|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123041|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123042|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123043|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123044|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123045|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123046|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123047|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123048|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
150123049|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123050|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123051|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
150123052|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
150123053|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
150123054|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150192883|NCT03452579|541846650|FG000|Overall Study|Adverse Event|1|||
150192884|NCT03452579|541846651|FG001|Overall Study|Adverse Event|4|||
150192885|NCT03474679|541846652|FG000|Overall Study|Death|7|||
150192886|NCT03474679|541846652|FG000|Overall Study|Withdrawal by Subject|1|||
150123055|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123056|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150192887|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
150192888|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
150192889|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
150192890|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
150192891|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
150192892|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
150192893|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Death|6|||
150192894|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Death|0|||
150192895|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Death|0|||
150192896|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
150192897|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
150192898|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
150192899|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
150192900|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
150192901|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
150192902|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
150192903|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
150192904|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
150192905|NCT01539083|541846657|FG000|Before Randomization (VCD Induction)|Other|5|||
150192906|NCT01539083|541846658|FG001|Before Randomization (VCD Induction)|Other|0|||
150192907|NCT01539083|541846659|FG002|Before Randomization (VCD Induction)|Other|0|||
150123057|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123058|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123059|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123060|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123061|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123062|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123063|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123064|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123065|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123066|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123067|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123068|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
150123069|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
150123070|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
150123071|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
150123072|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
150123073|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
150123074|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
150123075|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
150123076|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
150123077|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
150123078|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
150123079|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
150123080|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
150123081|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
150123082|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
150123083|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
150123084|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
150123085|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
150123086|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
150123087|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
150123088|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
150123089|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
150123090|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123091|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
150192908|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
150192909|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
150192910|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
150192911|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Other|0|||
150123092|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123093|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123094|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123095|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123096|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123097|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123098|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123099|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123100|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123101|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123102|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123103|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123104|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123105|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123106|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123107|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123108|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
150123109|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
150123110|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
150123111|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123112|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
150123113|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
150123114|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123115|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123116|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123117|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123118|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123119|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123120|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123121|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123122|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123123|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123124|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123125|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123126|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123127|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123128|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
150123129|NCT01490632|541586694|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123130|NCT01490632|541586695|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123131|NCT01490632|541586696|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123132|NCT01490632|541586697|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123133|NCT01490632|541586698|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
150123134|NCT01490632|541586699|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123135|NCT01490632|541586700|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123136|NCT01490632|541586701|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123137|NCT01490632|541586702|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123138|NCT01490632|541586703|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123139|NCT01490632|541586704|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123140|NCT01490632|541586705|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123141|NCT01490632|541586706|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123142|NCT01490632|541586707|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123143|NCT01490632|541586708|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123144|NCT01490632|541586709|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123145|NCT01490632|541586710|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123146|NCT01490632|541586711|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123147|NCT01490632|541586712|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123148|NCT01490632|541586713|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
150123149|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123150|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123151|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123152|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123153|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123154|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
150123155|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
150123156|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123157|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123158|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
150123159|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
150123160|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
150123161|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123162|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123163|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123164|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123165|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123166|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123167|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123168|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
150123169|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123170|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123171|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123172|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123173|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123174|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123175|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
150123176|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123177|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
150123178|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
150123179|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
150123180|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123181|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123182|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123183|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123184|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123185|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123186|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123187|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123188|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
150123189|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123190|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123191|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123192|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123193|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123194|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123195|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
150123196|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123197|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123198|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
150123199|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123200|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123201|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123202|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123203|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123204|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123205|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123206|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123207|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123208|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
150123209|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123210|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123211|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123212|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123213|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123214|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123215|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
150123216|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123217|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123218|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123219|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123220|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123221|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123222|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123223|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123224|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123225|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123226|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123227|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123228|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
150123229|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123230|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123231|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123232|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123233|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123234|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
150123235|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123236|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123237|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123238|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123239|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123240|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123241|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123242|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123243|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123244|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123245|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123246|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123247|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123248|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
150123249|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123250|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123251|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123252|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123253|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123254|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123255|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
150123256|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123257|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
150123258|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123259|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
150123260|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
150123261|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123262|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123263|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123264|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123265|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150192912|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Other|1|||
150123266|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123267|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123268|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
150123269|NCT01490632|541586694|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123270|NCT01490632|541586695|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123271|NCT01490632|541586696|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123272|NCT01490632|541586697|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123273|NCT01490632|541586698|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123274|NCT01490632|541586699|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
150123275|NCT01490632|541586700|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
150123276|NCT01490632|541586701|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
150123277|NCT01490632|541586702|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
150123278|NCT01490632|541586703|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
150123279|NCT01490632|541586704|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
150123280|NCT01490632|541586705|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
150123281|NCT01490632|541586706|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123282|NCT01490632|541586707|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123283|NCT01490632|541586708|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123284|NCT01490632|541586709|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123285|NCT01490632|541586710|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123286|NCT01490632|541586711|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123287|NCT01490632|541586712|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123288|NCT01490632|541586713|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
150123289|NCT01490632|541586694|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123290|NCT01490632|541586695|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123291|NCT01490632|541586696|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123292|NCT01490632|541586697|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123293|NCT01490632|541586698|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123294|NCT01490632|541586699|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123295|NCT01490632|541586700|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123296|NCT01490632|541586701|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123297|NCT01490632|541586702|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123298|NCT01490632|541586703|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123299|NCT01490632|541586704|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123300|NCT01490632|541586705|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123301|NCT01490632|541586706|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123302|NCT01490632|541586707|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123303|NCT01490632|541586708|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
150123304|NCT01490632|541586709|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
150123305|NCT01490632|541586710|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123306|NCT01490632|541586711|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123307|NCT01490632|541586712|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123308|NCT01490632|541586713|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
150123309|NCT01490632|541586694|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123310|NCT01490632|541586695|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123311|NCT01490632|541586696|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123312|NCT01490632|541586697|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123313|NCT01490632|541586698|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123314|NCT01490632|541586699|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123315|NCT01490632|541586700|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150192913|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Other|1|||
150123316|NCT01490632|541586701|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123317|NCT01490632|541586702|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123318|NCT01490632|541586703|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123319|NCT01490632|541586704|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123320|NCT01490632|541586705|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123321|NCT01490632|541586706|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123322|NCT01490632|541586707|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
150123323|NCT01490632|541586708|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123324|NCT01490632|541586709|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123325|NCT01490632|541586710|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123326|NCT01490632|541586711|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123327|NCT01490632|541586712|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123328|NCT01490632|541586713|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
150123329|NCT01490632|541586694|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123330|NCT01490632|541586695|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123331|NCT01490632|541586696|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123332|NCT01490632|541586697|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123333|NCT01490632|541586698|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123334|NCT01490632|541586699|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123335|NCT01490632|541586700|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123336|NCT01490632|541586701|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123337|NCT01490632|541586702|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123338|NCT01490632|541586703|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123339|NCT01490632|541586704|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123340|NCT01490632|541586705|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123341|NCT01490632|541586706|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123342|NCT01490632|541586707|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123343|NCT01490632|541586708|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
150123344|NCT01490632|541586709|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
150123345|NCT01490632|541586710|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123346|NCT01490632|541586711|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123347|NCT01490632|541586712|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123348|NCT01490632|541586713|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
150123349|NCT01490632|541586694|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123350|NCT01490632|541586695|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123351|NCT01490632|541586696|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123352|NCT01490632|541586697|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123353|NCT01490632|541586698|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123354|NCT01490632|541586699|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123355|NCT01490632|541586700|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123356|NCT01490632|541586701|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123357|NCT01490632|541586702|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123358|NCT01490632|541586703|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123359|NCT01490632|541586704|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123360|NCT01490632|541586705|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123361|NCT01490632|541586706|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
150123362|NCT01490632|541586707|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
150123363|NCT01490632|541586708|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
150123364|NCT01490632|541586709|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
150123365|NCT01490632|541586710|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123366|NCT01490632|541586711|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123367|NCT01490632|541586712|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123368|NCT01490632|541586713|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
150123369|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
150123370|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
150123371|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
150123372|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
150123373|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
150123374|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
150123375|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
150123376|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
150123377|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
150123378|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
150123379|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
150123380|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
150123381|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
150123382|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
150123383|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
150123384|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
150123385|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
150123386|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
150123387|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
150123388|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
150123389|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Death|0|||
150123390|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Death|0|||
150123391|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Death|0|||
150123392|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Death|0|||
150123393|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Death|0|||
150123394|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Death|0|||
150123395|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Death|0|||
150123396|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Death|0|||
150123397|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Death|0|||
150123398|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Death|0|||
150123399|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Death|0|||
150123400|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Death|0|||
150123401|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Death|0|||
150123402|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Death|0|||
150123403|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Death|0|||
150123404|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Death|0|||
150123405|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Death|0|||
150123406|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Death|0|||
150123407|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Death|1|||
150123408|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Death|0|||
150123409|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123410|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123411|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150192914|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
150192915|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
150192916|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
150192917|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
150192918|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
150192919|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
150192920|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
150192921|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
150192922|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
150192923|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
150192924|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
150192925|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
150192926|NCT01539083|541846657|FG000|After Randomization (TP and VTP)|Death|0|||
150192927|NCT01539083|541846658|FG001|After Randomization (TP and VTP)|Death|6|||
150192928|NCT01539083|541846659|FG002|After Randomization (TP and VTP)|Death|11|||
150123412|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150192929|NCT05499377|541846660|FG000|Overall Study|Withdrawal by Subject|2|||
150192930|NCT05499377|541846661|FG001|Overall Study|Withdrawal by Subject|0|||
150192931|NCT05499377|541846660|FG000|Overall Study|Physician Decision|1|||
150192932|NCT05499377|541846661|FG001|Overall Study|Physician Decision|0|||
150123413|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123414|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123415|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123416|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123417|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150192933|NCT04149704|541846662|FG000|Three Month Follow-up|Death|2|||
150123418|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123419|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123420|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123421|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123422|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123423|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150192934|NCT04149704|541846663|FG001|Three Month Follow-up|Death|0|||
150192935|NCT04149704|541846664|FG002|Three Month Follow-up|Death|0|||
150192936|NCT04149704|541846665|FG003|Three Month Follow-up|Death|0|||
150192937|NCT04149704|541846662|FG000|Three Month Follow-up|Lost to Follow-up|1|||
150192938|NCT04149704|541846663|FG001|Three Month Follow-up|Lost to Follow-up|4|||
150192939|NCT04149704|541846664|FG002|Three Month Follow-up|Lost to Follow-up|5|||
150192940|NCT04149704|541846665|FG003|Three Month Follow-up|Lost to Follow-up|5|||
150192941|NCT04149704|541846662|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
150192942|NCT04149704|541846663|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
150192943|NCT04149704|541846664|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
150192944|NCT04149704|541846665|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
150192945|NCT04149704|541846662|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
150192946|NCT04149704|541846663|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
150192947|NCT04149704|541846664|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
150192948|NCT04149704|541846665|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
150192949|NCT04332926|541846666|FG000|Overall Study|Withdrawal by Subject|6|||
150192950|NCT04332926|541846666|FG000|Overall Study|Physician Decision|6|||
150192951|NCT04376502|541846671|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
150192952|NCT04632992|541846672|FG000|Overall Study|Adverse Event|0|||
150192953|NCT04632992|541846673|FG001|Overall Study|Adverse Event|0|||
150192954|NCT04632992|541846674|FG002|Overall Study|Adverse Event|0|||
150192955|NCT04632992|541846675|FG003|Overall Study|Adverse Event|0|||
150192956|NCT04632992|541846676|FG004|Overall Study|Adverse Event|0|||
150192957|NCT04632992|541846677|FG005|Overall Study|Adverse Event|0|||
150192958|NCT04632992|541846678|FG006|Overall Study|Adverse Event|0|||
150192959|NCT04632992|541846679|FG007|Overall Study|Adverse Event|0|||
150192960|NCT04632992|541846680|FG008|Overall Study|Adverse Event|0|||
150192961|NCT04632992|541846681|FG009|Overall Study|Adverse Event|0|||
150192962|NCT04632992|541846682|FG010|Overall Study|Adverse Event|0|||
150192963|NCT04632992|541846683|FG011|Overall Study|Adverse Event|0|||
150192964|NCT04632992|541846684|FG012|Overall Study|Adverse Event|1|||
150192965|NCT04632992|541846685|FG013|Overall Study|Adverse Event|0|||
150192966|NCT04632992|541846672|FG000|Overall Study|Death|17|||
150192967|NCT04632992|541846673|FG001|Overall Study|Death|1|||
150192968|NCT04632992|541846674|FG002|Overall Study|Death|14|||
150192969|NCT04632992|541846675|FG003|Overall Study|Death|14|||
150192970|NCT04632992|541846676|FG004|Overall Study|Death|13|||
150192971|NCT04632992|541846677|FG005|Overall Study|Death|6|||
150192972|NCT04632992|541846678|FG006|Overall Study|Death|7|||
150192973|NCT04632992|541846679|FG007|Overall Study|Death|12|||
150192974|NCT04632992|541846680|FG008|Overall Study|Death|15|||
150192975|NCT04632992|541846681|FG009|Overall Study|Death|20|||
150192976|NCT04632992|541846682|FG010|Overall Study|Death|8|||
150192977|NCT04632992|541846683|FG011|Overall Study|Death|2|||
150192978|NCT04632992|541846684|FG012|Overall Study|Death|10|||
150192979|NCT04632992|541846685|FG013|Overall Study|Death|1|||
150192980|NCT04632992|541846672|FG000|Overall Study|Lost to Follow-up|1|||
150192981|NCT04632992|541846673|FG001|Overall Study|Lost to Follow-up|0|||
150192982|NCT04632992|541846674|FG002|Overall Study|Lost to Follow-up|1|||
150192983|NCT04632992|541846675|FG003|Overall Study|Lost to Follow-up|0|||
150192984|NCT04632992|541846676|FG004|Overall Study|Lost to Follow-up|2|||
150192985|NCT04632992|541846677|FG005|Overall Study|Lost to Follow-up|0|||
150123424|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123425|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
150123426|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
150123427|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
150123428|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
150123429|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123430|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123431|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123432|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123433|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123434|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123435|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123436|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150192986|NCT04632992|541846678|FG006|Overall Study|Lost to Follow-up|1|||
150192987|NCT04632992|541846679|FG007|Overall Study|Lost to Follow-up|1|||
150192988|NCT04632992|541846680|FG008|Overall Study|Lost to Follow-up|1|||
150192989|NCT04632992|541846681|FG009|Overall Study|Lost to Follow-up|1|||
150192990|NCT04632992|541846682|FG010|Overall Study|Lost to Follow-up|2|||
150192991|NCT04632992|541846683|FG011|Overall Study|Lost to Follow-up|0|||
150123437|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150192992|NCT04632992|541846684|FG012|Overall Study|Lost to Follow-up|0|||
150192993|NCT04632992|541846685|FG013|Overall Study|Lost to Follow-up|0|||
150123438|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150192994|NCT04632992|541846672|FG000|Overall Study|Reason not Specified|2|||
150192995|NCT04632992|541846673|FG001|Overall Study|Reason not Specified|0|||
150192996|NCT04632992|541846674|FG002|Overall Study|Reason not Specified|1|||
150192997|NCT04632992|541846675|FG003|Overall Study|Reason not Specified|1|||
150123439|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123440|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123441|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123442|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123443|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123444|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123445|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123446|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123447|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
150123448|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
150123449|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
150123450|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
150123451|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
150123452|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
150123453|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
150123454|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
150123455|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
150123456|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
150123457|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
150123458|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
150123459|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
150123460|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
150123461|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
150123462|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
150123463|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
150123464|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
150123465|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
150123466|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
150123467|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
150123468|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
150123469|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
150123470|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
150123471|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
150123472|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
150123473|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
150123474|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
150123475|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
150123476|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
150123477|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
150123478|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
150123479|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
150123480|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
150123481|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
150123482|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
150123483|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
150123484|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
150123485|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
150123486|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
150123487|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
150123488|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
150123489|NCT01490632|541586694|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123490|NCT01490632|541586695|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123491|NCT01490632|541586696|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123492|NCT01490632|541586697|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123493|NCT01490632|541586698|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123494|NCT01490632|541586699|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123495|NCT01490632|541586700|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123496|NCT01490632|541586701|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123497|NCT01490632|541586702|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123498|NCT01490632|541586703|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150192998|NCT04632992|541846676|FG004|Overall Study|Reason not Specified|0|||
150123499|NCT01490632|541586704|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123500|NCT01490632|541586705|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123501|NCT01490632|541586706|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123502|NCT01490632|541586707|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123503|NCT01490632|541586708|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123504|NCT01490632|541586709|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123505|NCT01490632|541586710|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
150123506|NCT01490632|541586711|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
150123507|NCT01490632|541586712|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
150123508|NCT01490632|541586713|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
150123509|NCT00352365|541586714|FG000|Induction Therapy|Adverse Event|7|||
150123510|NCT00352365|541586714|FG000|Induction Therapy|Progression/Relapse|8|||
150123511|NCT00352365|541586714|FG000|Induction Therapy|Death|7|||
150123512|NCT00352365|541586714|FG000|Induction Therapy|Not protocol specified|1|||
150123513|NCT00352365|541586714|FG000|Induction Therapy|Not eligible|3|||
150123514|NCT00352365|541586714|FG000|Induction Therapy|Death before starting protocol therapy|1|||
150123515|NCT00352365|541586714|FG000|Maintenance Therapy|Progression/Relapse|3|||
150123516|NCT00352365|541586714|FG000|Maintenance Therapy|Death|2|||
150123517|NCT00352365|541586714|FG000|Maintenance Therapy|Not protocol specified|3|||
150123518|NCT00352365|541586714|FG000|Maintenance Therapy|Not eligible|4|||
150123519|NCT02811861|541586715|FG000|Overall Study|Radiological Disease Progression|123|||
150123520|NCT02811861|541586716|FG001|Overall Study|Radiological Disease Progression|97|||
150123521|NCT02811861|541586717|FG002|Overall Study|Radiological Disease Progression|174|||
150123522|NCT02811861|541586715|FG000|Overall Study|Clinical Disease Progression|20|||
150123523|NCT02811861|541586716|FG001|Overall Study|Clinical Disease Progression|19|||
150123524|NCT02811861|541586717|FG002|Overall Study|Clinical Disease Progression|22|||
150123525|NCT02811861|541586715|FG000|Overall Study|Adverse Event|63|||
150123526|NCT02811861|541586716|FG001|Overall Study|Adverse Event|60|||
150123527|NCT02811861|541586717|FG002|Overall Study|Adverse Event|41|||
150123528|NCT02811861|541586715|FG000|Overall Study|Lost to Follow-up|0|||
150123529|NCT02811861|541586716|FG001|Overall Study|Lost to Follow-up|0|||
150123530|NCT02811861|541586717|FG002|Overall Study|Lost to Follow-up|1|||
150123531|NCT02811861|541586715|FG000|Overall Study|Subject Choice|29|||
150123532|NCT02811861|541586716|FG001|Overall Study|Subject Choice|17|||
150123533|NCT02811861|541586717|FG002|Overall Study|Subject Choice|23|||
150123534|NCT02811861|541586715|FG000|Overall Study|Withdrawal by Subject|4|||
150123535|NCT02811861|541586716|FG001|Overall Study|Withdrawal by Subject|4|||
150123536|NCT02811861|541586717|FG002|Overall Study|Withdrawal by Subject|9|||
150123537|NCT02811861|541586715|FG000|Overall Study|Other|4|||
150123538|NCT02811861|541586716|FG001|Overall Study|Other|13|||
150123539|NCT02811861|541586717|FG002|Overall Study|Other|3|||
150123540|NCT02811861|541586715|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
150123541|NCT02811861|541586716|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
150123542|NCT02811861|541586717|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
150123543|NCT02811861|541586715|FG000|Overall Study|Randomized but not treated|2|||
150123544|NCT02811861|541586716|FG001|Overall Study|Randomized but not treated|3|||
150123545|NCT02811861|541586717|FG002|Overall Study|Randomized but not treated|17|||
150123546|NCT04743908|541586718|FG000|Overall Study|Death|1|||
150123547|NCT04743908|541586719|FG001|Overall Study|Death|0|||
150123548|NCT04743908|541586718|FG000|Overall Study|Lost to Follow-up|181|||
150123549|NCT04743908|541586719|FG001|Overall Study|Lost to Follow-up|180|||
150123550|NCT04743908|541586718|FG000|Overall Study|Withdrawal by Subject|1|||
150123551|NCT04743908|541586719|FG001|Overall Study|Withdrawal by Subject|2|||
150123552|NCT00512135|541586720|FG000|Overall Study|Not Treated|5|||
150123553|NCT00512135|541586720|FG000|Overall Study|Lack of Efficacy|2|||
150123554|NCT00512135|541586720|FG000|Overall Study|Adverse Event|6|||
150123555|NCT00512135|541586720|FG000|Overall Study|Withdrawal by Subject|22|||
150123556|NCT00512135|541586720|FG000|Overall Study|Lost to Follow-up|27|||
150123557|NCT00512135|541586720|FG000|Overall Study|Other|22|||
150123558|NCT03422250|541586721|FG000|Intervention|Adverse Event|0|||
150123559|NCT03422250|541586722|FG001|Intervention|Adverse Event|1|||
150123560|NCT03422250|541586723|FG002|Intervention|Adverse Event|0|||
150123561|NCT03422250|541586724|FG003|Intervention|Adverse Event|1|||
150123562|NCT03422250|541586721|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
150123563|NCT03422250|541586722|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
150123564|NCT03422250|541586723|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
150123565|NCT03422250|541586724|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
150123566|NCT03422250|541586721|FG000|Follow-up|Withdrawal by Subject|0|||
150123567|NCT03422250|541586722|FG001|Follow-up|Withdrawal by Subject|0|||
150123568|NCT03422250|541586723|FG002|Follow-up|Withdrawal by Subject|0|||
150123569|NCT03422250|541586724|FG003|Follow-up|Withdrawal by Subject|1|||
150123570|NCT03422250|541586721|FG000|Follow-up|Adverse Event|0|||
150123571|NCT03422250|541586722|FG001|Follow-up|Adverse Event|0|||
150123572|NCT03422250|541586723|FG002|Follow-up|Adverse Event|0|||
150123573|NCT03422250|541586724|FG003|Follow-up|Adverse Event|1|||
150123574|NCT00377819|541586727|FG000|Overall Study|Adverse Event|2|||
150123575|NCT00377819|541586728|FG001|Overall Study|Adverse Event|3|||
150123576|NCT00377819|541586727|FG000|Overall Study|Withdrawal by Subject|10|||
150123577|NCT00377819|541586728|FG001|Overall Study|Withdrawal by Subject|4|||
150123578|NCT00377819|541586727|FG000|Overall Study|Death|0|||
150123579|NCT00377819|541586728|FG001|Overall Study|Death|1|||
150123580|NCT00377819|541586727|FG000|Overall Study|Lost to Follow-up|0|||
150123581|NCT00377819|541586728|FG001|Overall Study|Lost to Follow-up|1|||
150123582|NCT00377819|541586727|FG000|Overall Study|Protocol Violation|1|||
150123583|NCT00377819|541586728|FG001|Overall Study|Protocol Violation|1|||
150123584|NCT00467870|541586735|FG000|Overall Study|Adverse Event|13|||
150123585|NCT00467870|541586736|FG001|Overall Study|Adverse Event|9|||
150123586|NCT00467870|541586737|FG002|Overall Study|Adverse Event|1|||
150123587|NCT00467870|541586738|FG003|Overall Study|Adverse Event|15|||
150123588|NCT00467870|541586739|FG004|Overall Study|Adverse Event|15|||
150123589|NCT00467870|541586740|FG005|Overall Study|Adverse Event|1|||
150123590|NCT00467870|541586735|FG000|Overall Study|Protocol Violation|2|||
150123591|NCT00467870|541586736|FG001|Overall Study|Protocol Violation|1|||
150123592|NCT00467870|541586737|FG002|Overall Study|Protocol Violation|1|||
150123593|NCT00467870|541586738|FG003|Overall Study|Protocol Violation|2|||
150123594|NCT00467870|541586739|FG004|Overall Study|Protocol Violation|0|||
150123595|NCT00467870|541586740|FG005|Overall Study|Protocol Violation|0|||
150123596|NCT00467870|541586735|FG000|Overall Study|Withdrawal by Subject|14|||
150123597|NCT00467870|541586736|FG001|Overall Study|Withdrawal by Subject|21|||
150123598|NCT00467870|541586737|FG002|Overall Study|Withdrawal by Subject|0|||
150123599|NCT00467870|541586738|FG003|Overall Study|Withdrawal by Subject|9|||
150123600|NCT00467870|541586739|FG004|Overall Study|Withdrawal by Subject|10|||
150123601|NCT00467870|541586740|FG005|Overall Study|Withdrawal by Subject|1|||
150123602|NCT00467870|541586735|FG000|Overall Study|Lost to Follow-up|5|||
150123603|NCT00467870|541586736|FG001|Overall Study|Lost to Follow-up|3|||
150123604|NCT00467870|541586737|FG002|Overall Study|Lost to Follow-up|1|||
150123605|NCT00467870|541586738|FG003|Overall Study|Lost to Follow-up|1|||
150123606|NCT00467870|541586739|FG004|Overall Study|Lost to Follow-up|3|||
150123607|NCT00467870|541586740|FG005|Overall Study|Lost to Follow-up|0|||
150123608|NCT00467870|541586735|FG000|Overall Study|Subject Non-compliance|3|||
150123609|NCT00467870|541586736|FG001|Overall Study|Subject Non-compliance|4|||
150123610|NCT00467870|541586737|FG002|Overall Study|Subject Non-compliance|0|||
150123611|NCT00467870|541586738|FG003|Overall Study|Subject Non-compliance|1|||
150123612|NCT00467870|541586739|FG004|Overall Study|Subject Non-compliance|5|||
150123613|NCT00467870|541586740|FG005|Overall Study|Subject Non-compliance|0|||
150123614|NCT00467870|541586735|FG000|Overall Study|Other/Unknown|8|||
150123615|NCT00467870|541586736|FG001|Overall Study|Other/Unknown|5|||
150123616|NCT00467870|541586737|FG002|Overall Study|Other/Unknown|1|||
150123617|NCT00467870|541586738|FG003|Overall Study|Other/Unknown|5|||
150123618|NCT00467870|541586739|FG004|Overall Study|Other/Unknown|4|||
150123619|NCT00467870|541586740|FG005|Overall Study|Other/Unknown|0|||
150123620|NCT01917526|541586741|FG000|Overall Study|Protocol Violation|1|||
150123621|NCT01917526|541586742|FG001|Overall Study|Protocol Violation|1|||
150123622|NCT02261363|541586743|FG000|Overall Study|Lost to Follow-up|21|||
150123623|NCT01517802|541586744|FG000|Overall Study|Death|1|||
150123624|NCT03268811|541586750|FG000|Overall Study|Adverse Event|0|||
150123625|NCT03268811|541586751|FG001|Overall Study|Adverse Event|1|||
150123626|NCT02031276|541586752|FG000|Period 1 Double-blind IV|Adverse Event|6|||
150123627|NCT02031276|541586753|FG001|Period 1 Double-blind IV|Adverse Event|5|||
150123628|NCT02031276|541586754|FG002|Period 1 Double-blind IV|Adverse Event|1|||
150123629|NCT02031276|541586752|FG000|Period 1 Double-blind IV|Other|0|||
150123630|NCT02031276|541586753|FG001|Period 1 Double-blind IV|Other|1|||
150123631|NCT02031276|541586754|FG002|Period 1 Double-blind IV|Other|0|||
150123632|NCT02031276|541586752|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
150123633|NCT02031276|541586753|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
150123634|NCT02031276|541586754|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
150123635|NCT02031276|541586752|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
150123636|NCT02031276|541586753|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
150123637|NCT02031276|541586754|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
150123638|NCT02031276|541586752|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
150123639|NCT02031276|541586753|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
150123640|NCT02031276|541586754|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
150123641|NCT02031276|541586752|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
150123642|NCT02031276|541586753|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
150123643|NCT02031276|541586754|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
150123644|NCT02031276|541586752|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
150123645|NCT02031276|541586753|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
150123646|NCT02031276|541586754|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
150123647|NCT02031276|541586752|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
150123648|NCT02031276|541586753|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
150123649|NCT02031276|541586754|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
150123650|NCT02031276|541586752|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
150123651|NCT02031276|541586753|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
150123652|NCT02031276|541586754|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
150123653|NCT01148810|541586755|FG000|Overall Study|Adverse Event|0|||
150123654|NCT01148810|541586756|FG001|Overall Study|Adverse Event|2|||
150123655|NCT01148810|541586755|FG000|Overall Study|Lack of Efficacy|0|||
150123656|NCT01148810|541586756|FG001|Overall Study|Lack of Efficacy|1|||
150123657|NCT01148810|541586755|FG000|Overall Study|Withdrawal by Subject|0|||
150123658|NCT01148810|541586756|FG001|Overall Study|Withdrawal by Subject|2|||
150123659|NCT01148810|541586755|FG000|Overall Study|Protocol Violation|1|||
150123660|NCT01148810|541586756|FG001|Overall Study|Protocol Violation|0|||
150123661|NCT02417246|541586764|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
150123662|NCT02417246|541586765|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
150123663|NCT02417246|541586764|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
150123664|NCT02417246|541586765|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
150123665|NCT02417246|541586764|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
150123666|NCT02417246|541586765|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
150123667|NCT02417246|541586764|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
150123668|NCT02417246|541586765|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
150123669|NCT04408469|541586769|FG000|Overall Study|Lost to Follow-up|6|||
150123670|NCT04408469|541586770|FG001|Overall Study|Lost to Follow-up|9|||
150123671|NCT04408469|541586769|FG000|Overall Study|Withdrawal by Subject|6|||
150123672|NCT04408469|541586770|FG001|Overall Study|Withdrawal by Subject|1|||
150123673|NCT04408469|541586769|FG000|Overall Study|Dismissal due to ineligibility|0|||
150123674|NCT04408469|541586770|FG001|Overall Study|Dismissal due to ineligibility|1|||
150123675|NCT04321460|541586771|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
150123676|NCT04321460|541586772|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
150123677|NCT01308749|541586773|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
150123678|NCT01308749|541586774|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
150123679|NCT01308749|541586773|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
150123680|NCT01308749|541586774|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
150123681|NCT01308749|541586773|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
150123682|NCT01308749|541586774|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
150123683|NCT01205685|541586779|FG000|Overall Study|Disease Progression|10|||
150123684|NCT01205685|541586779|FG000|Overall Study|Withdrawal by Subject|1|||
150123685|NCT03058679|541586780|FG000|Baseline to Week 6|Lost to Follow-up|3|||
150123686|NCT03058679|541586781|FG001|Baseline to Week 6|Lost to Follow-up|2|||
150123687|NCT03058679|541586780|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
150123688|NCT03058679|541586781|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
150123689|NCT03058679|541586780|FG000|Baseline to Week 6|Adverse Event|6|||
150123690|NCT03058679|541586781|FG001|Baseline to Week 6|Adverse Event|6|||
150123691|NCT03058679|541586780|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
150123692|NCT03058679|541586781|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
150123693|NCT03058679|541586780|FG000|Baseline to Week 6|Difficulty following the diet|0|||
150123694|NCT03058679|541586781|FG001|Baseline to Week 6|Difficulty following the diet|2|||
150123695|NCT03058679|541586780|FG000|Baseline to Week 6|Physician Decision|1|||
150123696|NCT03058679|541586781|FG001|Baseline to Week 6|Physician Decision|0|||
150123697|NCT03058679|541586780|FG000|Week 6 to Week 12|Change in medication|5|||
150123698|NCT03058679|541586781|FG001|Week 6 to Week 12|Change in medication|7|||
150123699|NCT03058679|541586780|FG000|Week 6 to Week 12|Adverse Event|4|||
150123700|NCT03058679|541586781|FG001|Week 6 to Week 12|Adverse Event|3|||
150123701|NCT03058679|541586780|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
150123702|NCT03058679|541586781|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
150123703|NCT03058679|541586780|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
150123704|NCT03058679|541586781|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
150123705|NCT00574080|541586782|FG000|Overall Study|Death|10|||
150123706|NCT00574080|541586783|FG001|Overall Study|Death|10|||
150123707|NCT00784810|541586788|FG000|Overall Study|Adverse Event|32|||
150123708|NCT00784810|541586789|FG001|Overall Study|Adverse Event|20|||
150123709|NCT00784810|541586788|FG000|Overall Study|Lack of Efficacy|14|||
150123710|NCT00784810|541586789|FG001|Overall Study|Lack of Efficacy|11|||
150123711|NCT00784810|541586788|FG000|Overall Study|Withdrawal by Subject|11|||
150123712|NCT00784810|541586789|FG001|Overall Study|Withdrawal by Subject|9|||
150123713|NCT00784810|541586788|FG000|Overall Study|Administrative|5|||
150123714|NCT00784810|541586789|FG001|Overall Study|Administrative|8|||
150123715|NCT00784810|541586788|FG000|Overall Study|Lost to Follow-up|1|||
150123716|NCT00784810|541586789|FG001|Overall Study|Lost to Follow-up|1|||
150123717|NCT04137380|541586790|FG000|Overall Study|Physician Decision|0|||
150123718|NCT04137380|541586791|FG001|Overall Study|Physician Decision|0|||
150123719|NCT04137380|541586792|FG002|Overall Study|Physician Decision|0|||
150123720|NCT04137380|541586793|FG003|Overall Study|Physician Decision|1|||
150123721|NCT04137380|541586794|FG004|Overall Study|Physician Decision|0|||
150123722|NCT04137380|541586795|FG005|Overall Study|Physician Decision|0|||
150123723|NCT04137380|541586796|FG006|Overall Study|Physician Decision|0|||
150123724|NCT06027216|541586797|FG000|Overall Study|Did not qualify|8|||
150123725|NCT03646513|541586801|FG000|Overall Study|Premature study termination|4|||
150123726|NCT00968617|541586805|FG000|Overall Study|Study terminated by sponsor|6|||
150123727|NCT04433767|541586806|FG000|Overall Study|Adverse Event|1|||
150123728|NCT00288587|541586810|FG000|Overall Study|Death|4|||
150123729|NCT00288587|541586811|FG001|Overall Study|Death|4|||
150123730|NCT00288587|541586810|FG000|Overall Study|Transplant|0|||
150123731|NCT00288587|541586811|FG001|Overall Study|Transplant|3|||
150123732|NCT00288587|541586810|FG000|Overall Study|Adverse Event|0|||
150123733|NCT00288587|541586811|FG001|Overall Study|Adverse Event|1|||
150123734|NCT00288587|541586810|FG000|Overall Study|Physician Decision|0|||
150123735|NCT00288587|541586811|FG001|Overall Study|Physician Decision|2|||
150123736|NCT00288587|541586810|FG000|Overall Study|Severe Aortic Stenosis|1|||
150123737|NCT00288587|541586811|FG001|Overall Study|Severe Aortic Stenosis|0|||
150123738|NCT01434602|541586812|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
150123739|NCT01434602|541586813|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
150123740|NCT01434602|541586814|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
150123741|NCT01434602|541586815|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
150123742|NCT01434602|541586816|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
150123743|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
150123744|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
150123745|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
150123746|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
150123747|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
150123748|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
150123749|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
150123750|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
150123751|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
150123752|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
150123753|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
150123754|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
150123755|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
150123756|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
150123757|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
150123758|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
150123759|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
150123760|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
150123761|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
150123762|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
150123763|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
150123764|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
150123765|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
150123766|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
150123767|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
150123768|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
150123769|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
150123770|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
150123771|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
150123772|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
150123773|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
150123774|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
150123775|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
150123776|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
150123777|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
150123778|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
150123779|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
150123780|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
150123781|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
150123782|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
150123783|NCT01434602|541586812|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
150123784|NCT01434602|541586813|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
150123785|NCT01434602|541586814|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
150123786|NCT01434602|541586815|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
150123787|NCT01434602|541586816|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
150123788|NCT01764945|541586822|FG000|Overall Study|Adverse Event|0|||
150123789|NCT01764945|541586823|FG001|Overall Study|Adverse Event|1|||
150123790|NCT01764945|541586824|FG002|Overall Study|Adverse Event|0|||
150123791|NCT01764945|541586825|FG003|Overall Study|Adverse Event|0|||
150123792|NCT01764945|541586826|FG004|Overall Study|Adverse Event|0|||
150123793|NCT01764945|541586827|FG005|Overall Study|Adverse Event|0|||
150123794|NCT01764945|541586828|FG006|Overall Study|Adverse Event|1|||
150123795|NCT01764945|541586829|FG007|Overall Study|Adverse Event|0|||
150123796|NCT05077267|541586831|FG000|Treatment Period|Lost to Follow-up|0|||
150123797|NCT05077267|541586832|FG001|Treatment Period|Lost to Follow-up|1|||
150123798|NCT05077267|541586833|FG002|Treatment Period|Lost to Follow-up|0|||
150123799|NCT05077267|541586831|FG000|Treatment Period|Withdrawal by Subject|0|||
150123800|NCT05077267|541586832|FG001|Treatment Period|Withdrawal by Subject|1|||
150123801|NCT05077267|541586833|FG002|Treatment Period|Withdrawal by Subject|0|||
150123802|NCT05077267|541586831|FG000|Follow-up Period|Lost to Follow-up|0|||
150123803|NCT05077267|541586832|FG001|Follow-up Period|Lost to Follow-up|5|||
150123804|NCT05077267|541586833|FG002|Follow-up Period|Lost to Follow-up|7|||
150123805|NCT05077267|541586831|FG000|Follow-up Period|Withdrawal by Subject|0|||
150123806|NCT05077267|541586832|FG001|Follow-up Period|Withdrawal by Subject|2|||
150123807|NCT05077267|541586833|FG002|Follow-up Period|Withdrawal by Subject|5|||
150123808|NCT05077267|541586831|FG000|Follow-up Period|Study terminated by sponsor|0|||
150123809|NCT05077267|541586832|FG001|Follow-up Period|Study terminated by sponsor|27|||
150123810|NCT05077267|541586833|FG002|Follow-up Period|Study terminated by sponsor|23|||
150123811|NCT05077267|541586831|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
150123812|NCT05077267|541586832|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
150123813|NCT05077267|541586833|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
150123814|NCT05077267|541586831|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
150123815|NCT05077267|541586832|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
150123816|NCT05077267|541586833|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
150123817|NCT01136291|541586842|FG000|Overall Study|Lost to Follow-up|1|||
150123818|NCT01136291|541586843|FG001|Overall Study|Lost to Follow-up|1|||
150123819|NCT03165045|541586848|FG000|Visit 1|No registration after visit 1|9|||
150123820|NCT03165045|541586848|FG000|Visit 1|No treatment documented|10|||
150123821|NCT03165045|541586848|FG000|Visit 1|No visit 1|10|||
150123822|NCT03165045|541586848|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
150123823|NCT03165045|541586848|FG000|Visit 2|No available total CCQ score at all|29|||
150123824|NCT03165045|541586848|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
150123825|NCT00759109|541586849|FG000|Overall Study|Adverse Event|17|||
150123826|NCT00759109|541586850|FG001|Overall Study|Adverse Event|12|||
150123827|NCT00759109|541586849|FG000|Overall Study|Inability to comply|1|||
150123828|NCT00759109|541586850|FG001|Overall Study|Inability to comply|1|||
150123829|NCT00759109|541586849|FG000|Overall Study|Withdrawal by Subject|9|||
150123830|NCT00759109|541586850|FG001|Overall Study|Withdrawal by Subject|5|||
150123831|NCT00759109|541586849|FG000|Overall Study|Death|4|||
150123832|NCT00759109|541586850|FG001|Overall Study|Death|3|||
150123833|NCT00759109|541586849|FG000|Overall Study|Lost to Follow-up|4|||
150123834|NCT00759109|541586850|FG001|Overall Study|Lost to Follow-up|6|||
150123835|NCT00759109|541586849|FG000|Overall Study|Started new therapy|2|||
150123836|NCT00759109|541586850|FG001|Overall Study|Started new therapy|6|||
150123837|NCT00759109|541586849|FG000|Overall Study|HCV RNA negative|1|||
150123838|NCT00759109|541586850|FG001|Overall Study|HCV RNA negative|0|||
150123839|NCT00759109|541586849|FG000|Overall Study|Participant moved to a different city|0|||
150123840|NCT00759109|541586850|FG001|Overall Study|Participant moved to a different city|1|||
150123841|NCT00759109|541586849|FG000|Overall Study|Participant had a liver transplant|0|||
150123842|NCT00759109|541586850|FG001|Overall Study|Participant had a liver transplant|1|||
150123843|NCT00759109|541586849|FG000|Overall Study|Lost during study|1|||
150123844|NCT00759109|541586850|FG001|Overall Study|Lost during study|0|||
150123845|NCT01827904|541586851|FG000|Main Study|Withdrawal by Subject|1|||
150123846|NCT01827904|541586852|FG001|Main Study|Withdrawal by Subject|0|||
150123847|NCT01827904|541586853|FG002|Main Study|Withdrawal by Subject|0|||
150123848|NCT01827904|541586851|FG000|Main Study|Adverse Event|1|||
150123849|NCT01827904|541586852|FG001|Main Study|Adverse Event|0|||
150123850|NCT01827904|541586853|FG002|Main Study|Adverse Event|0|||
150123851|NCT01827904|541586851|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
150123852|NCT01827904|541586852|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
150123853|NCT01827904|541586853|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
150123854|NCT01827904|541586851|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
150123855|NCT01827904|541586852|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
150123856|NCT01827904|541586853|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
150123857|NCT01827904|541586851|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
150123858|NCT01827904|541586852|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
150123859|NCT01827904|541586853|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
150123860|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
150123861|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
150123862|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
150123863|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
150123864|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
150123865|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
150123866|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
150123867|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
150123868|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
150123869|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
150123870|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
150123871|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
150123872|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Physician Decision|1|||
150123873|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Physician Decision|0|||
150123874|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Physician Decision|0|||
150123875|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
150123876|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
150123877|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
150123878|NCT01827904|541586851|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
150123879|NCT01827904|541586852|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
150123880|NCT01827904|541586853|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
150123881|NCT01660763|541586856|FG000|Overall Study|Lack of Efficacy|45|||
150123882|NCT01660763|541586857|FG001|Overall Study|Lack of Efficacy|50|||
150123883|NCT01660763|541586856|FG000|Overall Study|Adverse Event|22|||
150123884|NCT01660763|541586857|FG001|Overall Study|Adverse Event|7|||
150123885|NCT01660763|541586856|FG000|Overall Study|Protocol Violation|1|||
150123886|NCT01660763|541586857|FG001|Overall Study|Protocol Violation|0|||
150123887|NCT01660763|541586856|FG000|Overall Study|Withdrawal by Subject|4|||
150123888|NCT01660763|541586857|FG001|Overall Study|Withdrawal by Subject|0|||
150123889|NCT01660763|541586856|FG000|Overall Study|Patient ready for early discharge|28|||
150123890|NCT01660763|541586857|FG001|Overall Study|Patient ready for early discharge|4|||
150123891|NCT01910519|541586858|FG000|Overall Study|Withdrawal by Subject|2|||
150123892|NCT01910519|541586859|FG001|Overall Study|Withdrawal by Subject|0|||
150123893|NCT01910519|541586858|FG000|Overall Study|Adverse Event|2|||
150123894|NCT01910519|541586859|FG001|Overall Study|Adverse Event|0|||
150123895|NCT04266028|541586860|FG000|Overall Study|Adverse Event|0|||
150123896|NCT04266028|541586861|FG001|Overall Study|Adverse Event|0|||
150123897|NCT04266028|541586862|FG002|Overall Study|Adverse Event|1|||
150123898|NCT04266028|541586863|FG003|Overall Study|Adverse Event|0|||
150123899|NCT04266028|541586864|FG004|Overall Study|Adverse Event|1|||
150123900|NCT04266028|541586865|FG005|Overall Study|Adverse Event|0|||
150123901|NCT04266028|541586866|FG006|Overall Study|Adverse Event|2|||
150123902|NCT04266028|541586867|FG007|Overall Study|Adverse Event|0|||
150123903|NCT04266028|541586860|FG000|Overall Study|temporary halt of the study|0|||
150123904|NCT04266028|541586861|FG001|Overall Study|temporary halt of the study|0|||
150123905|NCT04266028|541586862|FG002|Overall Study|temporary halt of the study|0|||
150123906|NCT04266028|541586863|FG003|Overall Study|temporary halt of the study|0|||
150123907|NCT04266028|541586864|FG004|Overall Study|temporary halt of the study|0|||
150123908|NCT04266028|541586865|FG005|Overall Study|temporary halt of the study|0|||
150123909|NCT04266028|541586866|FG006|Overall Study|temporary halt of the study|2|||
150123910|NCT04266028|541586867|FG007|Overall Study|temporary halt of the study|1|||
150123911|NCT04266028|541586860|FG000|Overall Study|Onset of birch pollen season|0|||
150123912|NCT04266028|541586861|FG001|Overall Study|Onset of birch pollen season|0|||
150123913|NCT04266028|541586862|FG002|Overall Study|Onset of birch pollen season|0|||
150123914|NCT04266028|541586863|FG003|Overall Study|Onset of birch pollen season|0|||
150123915|NCT04266028|541586864|FG004|Overall Study|Onset of birch pollen season|1|||
150123916|NCT04266028|541586865|FG005|Overall Study|Onset of birch pollen season|0|||
150123917|NCT04266028|541586866|FG006|Overall Study|Onset of birch pollen season|0|||
150123918|NCT04266028|541586867|FG007|Overall Study|Onset of birch pollen season|0|||
150123919|NCT00380068|541586869|FG000|Overall Study|Adverse Event|40|||
150123920|NCT00380068|541586869|FG000|Overall Study|Withdrawal by Subject|10|||
150192999|NCT04632992|541846677|FG005|Overall Study|Reason not Specified|0|||
150193000|NCT04632992|541846678|FG006|Overall Study|Reason not Specified|0|||
150193001|NCT04632992|541846679|FG007|Overall Study|Reason not Specified|0|||
150123921|NCT00380068|541586869|FG000|Overall Study|Not compliant|6|||
150123922|NCT00380068|541586869|FG000|Overall Study|Lost to Follow-up|1|||
150123923|NCT00380068|541586869|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
150123924|NCT00380068|541586869|FG000|Overall Study|Lung transplant|3|||
150123925|NCT00380068|541586869|FG000|Overall Study|Physician Decision|2|||
150123926|NCT00380068|541586869|FG000|Overall Study|Partipant moved away|1|||
150193002|NCT04632992|541846680|FG008|Overall Study|Reason not Specified|0|||
150123927|NCT00380068|541586869|FG000|Overall Study|Lack of Efficacy|5|||
150123928|NCT02720484|541586876|FG000|Treatment on Study|Adverse Event|1|||
150123929|NCT02720484|541586876|FG000|Treatment on Study|Withdrawal by Subject|1|||
150123930|NCT02720484|541586876|FG000|Treatment on Study|Progressive Disease|4|||
150123931|NCT02720484|541586876|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
150123932|NCT02720484|541586876|FG000|Follow Up for 2 Years|Death|3|||
150123933|NCT02720484|541586876|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
150123934|NCT05070897|541586877|FG000|Overall Study|Protocol Violation|123|||
150123935|NCT05070897|541586878|FG001|Overall Study|Protocol Violation|68|||
150123936|NCT01617629|541586879|FG000|Overall Study|Death|2|||
150123937|NCT01617629|541586879|FG000|Overall Study|Investigator's Clinical Judgement|1|||
150123938|NCT01617629|541586879|FG000|Overall Study|Reason Not Specified|1|||
150123939|NCT01617629|541586879|FG000|Overall Study|Participant Withdrew Consent|2|||
150123940|NCT02715765|541586880|FG000|Overall Study|Study Termination|3|||
150123941|NCT02715765|541586881|FG001|Overall Study|Study Termination|0|||
150123942|NCT02715765|541586882|FG002|Overall Study|Study Termination|0|||
150123943|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
150123944|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
150123945|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
150123946|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
150123947|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
150123948|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
150123949|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
150123950|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
150123951|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
150123952|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
150123953|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
150123954|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
150123955|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
150123956|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
150123957|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
150123958|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
150123959|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
150123960|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
150123961|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
150123962|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
150123963|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
150123964|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
150123965|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
150123966|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
150123967|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
150123968|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
150123969|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
150123970|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
150123971|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
150123972|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
150123973|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
150123974|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
150123975|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
150123976|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
150123977|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
150123978|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
150123979|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
150123980|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
150123981|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
150123982|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
150123983|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
150123984|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
150123985|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
150123986|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
150123987|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
150123988|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
150123989|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
150123990|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
150193003|NCT04632992|541846681|FG009|Overall Study|Reason not Specified|0|||
150123991|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
150123992|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
150123993|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
150123994|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
150123995|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
150123996|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
150123997|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
150123998|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
150123999|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
150124000|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
150124001|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
150124002|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
150124003|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
150124004|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
150124005|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
150124006|NCT01884350|541586883|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
150124007|NCT01884350|541586884|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
150124008|NCT01884350|541586885|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
150124009|NCT00363766|541586890|FG000|Overall Study|Progressive Disease|15|||
150124010|NCT00363766|541586891|FG001|Overall Study|Progressive Disease|9|||
150124011|NCT00363766|541586890|FG000|Overall Study|Adverse Event|10|||
150124012|NCT00363766|541586891|FG001|Overall Study|Adverse Event|2|||
150124013|NCT00363766|541586890|FG000|Overall Study|Disease Related Death|1|||
150124014|NCT00363766|541586891|FG001|Overall Study|Disease Related Death|3|||
150124015|NCT00363766|541586890|FG000|Overall Study|Not Disease Related Death|3|||
150124016|NCT00363766|541586891|FG001|Overall Study|Not Disease Related Death|4|||
150124017|NCT00363766|541586890|FG000|Overall Study|Withdrawal by Subject|2|||
150124018|NCT00363766|541586891|FG001|Overall Study|Withdrawal by Subject|0|||
150124019|NCT00363766|541586890|FG000|Overall Study|Physician Decision|1|||
150124020|NCT00363766|541586891|FG001|Overall Study|Physician Decision|2|||
150124021|NCT04295564|541588852|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
150124022|NCT04295564|541588853|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
150124023|NCT04537923|541588854|FG000|Overall Study|Adverse Event|2|||
150124024|NCT04537923|541588855|FG001|Overall Study|Adverse Event|1|||
150124025|NCT04537923|541588856|FG002|Overall Study|Adverse Event|2|||
150124026|NCT04537923|541588857|FG003|Overall Study|Adverse Event|4|||
150124027|NCT04537923|541588854|FG000|Overall Study|Death|3|||
150124028|NCT04537923|541588855|FG001|Overall Study|Death|3|||
150124029|NCT04537923|541588856|FG002|Overall Study|Death|1|||
150124030|NCT04537923|541588857|FG003|Overall Study|Death|11|||
150124031|NCT04537923|541588854|FG000|Overall Study|Lost to Follow-up|1|||
150124032|NCT04537923|541588855|FG001|Overall Study|Lost to Follow-up|2|||
150124033|NCT04537923|541588856|FG002|Overall Study|Lost to Follow-up|1|||
150124034|NCT04537923|541588857|FG003|Overall Study|Lost to Follow-up|6|||
150124035|NCT04537923|541588854|FG000|Overall Study|Physician Decision|1|||
150124036|NCT04537923|541588855|FG001|Overall Study|Physician Decision|0|||
150124037|NCT04537923|541588856|FG002|Overall Study|Physician Decision|2|||
150124038|NCT04537923|541588857|FG003|Overall Study|Physician Decision|5|||
150124039|NCT04537923|541588854|FG000|Overall Study|Pregnancy|1|||
150124040|NCT04537923|541588855|FG001|Overall Study|Pregnancy|0|||
150124041|NCT04537923|541588856|FG002|Overall Study|Pregnancy|0|||
150124042|NCT04537923|541588857|FG003|Overall Study|Pregnancy|0|||
150124043|NCT04537923|541588854|FG000|Overall Study|Withdrawal by Subject|4|||
150124044|NCT04537923|541588855|FG001|Overall Study|Withdrawal by Subject|4|||
150124045|NCT04537923|541588856|FG002|Overall Study|Withdrawal by Subject|4|||
150124046|NCT04537923|541588857|FG003|Overall Study|Withdrawal by Subject|58|||
150124047|NCT04537923|541588854|FG000|Overall Study|Missed study visits|2|||
150124048|NCT04537923|541588855|FG001|Overall Study|Missed study visits|0|||
150124049|NCT04537923|541588856|FG002|Overall Study|Missed study visits|0|||
150124050|NCT04537923|541588857|FG003|Overall Study|Missed study visits|3|||
150124051|NCT04537923|541588854|FG000|Overall Study|Sponsor's decision|0|||
150124052|NCT04537923|541588855|FG001|Overall Study|Sponsor's decision|0|||
150124053|NCT04537923|541588856|FG002|Overall Study|Sponsor's decision|1|||
150124054|NCT04537923|541588857|FG003|Overall Study|Sponsor's decision|1|||
150124055|NCT04537923|541588854|FG000|Overall Study|Safety reasons|1|||
150124056|NCT04537923|541588855|FG001|Overall Study|Safety reasons|0|||
150124057|NCT04537923|541588856|FG002|Overall Study|Safety reasons|0|||
150124058|NCT04537923|541588857|FG003|Overall Study|Safety reasons|0|||
150124059|NCT01261611|541588858|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
150124060|NCT01261611|541588859|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
150124061|NCT01261611|541588860|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
150124062|NCT01261611|541588858|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
150124063|NCT01261611|541588859|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
150124064|NCT01261611|541588860|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
150124065|NCT01261611|541588858|FG000|Treatment Cycle 1|Adverse Event|0|||
150124066|NCT01261611|541588859|FG001|Treatment Cycle 1|Adverse Event|1|||
150124067|NCT01261611|541588860|FG002|Treatment Cycle 1|Adverse Event|0|||
150124068|NCT01261611|541588858|FG000|Treatment Cycle 1|Protocol Violation|0|||
150124069|NCT01261611|541588859|FG001|Treatment Cycle 1|Protocol Violation|0|||
150124070|NCT01261611|541588860|FG002|Treatment Cycle 1|Protocol Violation|2|||
150124071|NCT01261611|541588858|FG000|Treatment Cycle 2|Completed study|4|||
150124072|NCT01261611|541588859|FG001|Treatment Cycle 2|Completed study|0|||
150124073|NCT01261611|541588860|FG002|Treatment Cycle 2|Completed study|0|||
150124074|NCT01261611|541588858|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
150124075|NCT01261611|541588859|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
150124076|NCT01261611|541588860|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
150124077|NCT01261611|541588858|FG000|Treatment Cycle 2|Adverse Event|1|||
150124078|NCT01261611|541588859|FG001|Treatment Cycle 2|Adverse Event|0|||
150124079|NCT01261611|541588860|FG002|Treatment Cycle 2|Adverse Event|0|||
150124080|NCT01261611|541588858|FG000|Treatment Cycle 2|Protocol Violation|2|||
150124081|NCT01261611|541588859|FG001|Treatment Cycle 2|Protocol Violation|0|||
150124082|NCT01261611|541588860|FG002|Treatment Cycle 2|Protocol Violation|0|||
150124083|NCT01261611|541588858|FG000|Treatment Cycle 2|Not otherwise specified|2|||
150124084|NCT01261611|541588859|FG001|Treatment Cycle 2|Not otherwise specified|0|||
150124085|NCT01261611|541588860|FG002|Treatment Cycle 2|Not otherwise specified|0|||
150124086|NCT01261611|541588858|FG000|Treatment Cycle 3|Completed study|24|||
150124087|NCT01261611|541588859|FG001|Treatment Cycle 3|Completed study|0|||
150124088|NCT01261611|541588860|FG002|Treatment Cycle 3|Completed study|0|||
150124089|NCT01261611|541588858|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
150124090|NCT01261611|541588859|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
150124091|NCT01261611|541588860|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
150124092|NCT01261611|541588858|FG000|Treatment Cycle 3|Adverse Event|1|||
150124093|NCT01261611|541588859|FG001|Treatment Cycle 3|Adverse Event|0|||
150124094|NCT01261611|541588860|FG002|Treatment Cycle 3|Adverse Event|0|||
150124095|NCT01261611|541588858|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
150124096|NCT01261611|541588859|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
150124097|NCT01261611|541588860|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
150124098|NCT01261611|541588858|FG000|Treatment Cycle 4|Completed study|87|||
150124099|NCT01261611|541588859|FG001|Treatment Cycle 4|Completed study|0|||
150124100|NCT01261611|541588860|FG002|Treatment Cycle 4|Completed study|0|||
150124101|NCT01261611|541588858|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
150124102|NCT01261611|541588859|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
150124103|NCT01261611|541588860|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
150124104|NCT01261611|541588858|FG000|Treatment Cycle 4|Adverse Event|1|||
150124105|NCT01261611|541588859|FG001|Treatment Cycle 4|Adverse Event|0|||
150124106|NCT01261611|541588860|FG002|Treatment Cycle 4|Adverse Event|0|||
150124107|NCT01261611|541588858|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
150124108|NCT01261611|541588859|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
150124109|NCT01261611|541588860|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
150124110|NCT01261611|541588858|FG000|Treatment Cycle 4|Not otherwise specified|3|||
150124111|NCT01261611|541588859|FG001|Treatment Cycle 4|Not otherwise specified|0|||
150124112|NCT01261611|541588860|FG002|Treatment Cycle 4|Not otherwise specified|0|||
150124113|NCT01261611|541588858|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
150124114|NCT01261611|541588859|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
150124115|NCT01261611|541588860|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
150124116|NCT01261611|541588858|FG000|Treatment Cycle 5|Adverse Event|1|||
150124117|NCT01261611|541588859|FG001|Treatment Cycle 5|Adverse Event|0|||
150124118|NCT01261611|541588860|FG002|Treatment Cycle 5|Adverse Event|0|||
150124119|NCT01261611|541588858|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
150124120|NCT01261611|541588859|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
150124121|NCT01261611|541588860|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
150124122|NCT02527798|541588861|FG000|Overall Study|Physician Decision|1|||
150124123|NCT02527798|541588862|FG001|Overall Study|Physician Decision|0|||
150124124|NCT02527798|541588863|FG002|Overall Study|Physician Decision|1|||
150124125|NCT02527798|541588864|FG003|Overall Study|Physician Decision|1|||
150124126|NCT02527798|541588865|FG004|Overall Study|Physician Decision|0|||
150124127|NCT02527798|541588866|FG005|Overall Study|Physician Decision|0|||
150124128|NCT02527798|541588861|FG000|Overall Study|Death|0|||
150124129|NCT02527798|541588862|FG001|Overall Study|Death|0|||
150124130|NCT02527798|541588863|FG002|Overall Study|Death|1|||
150124131|NCT02527798|541588864|FG003|Overall Study|Death|0|||
150124132|NCT02527798|541588865|FG004|Overall Study|Death|0|||
150124133|NCT02527798|541588866|FG005|Overall Study|Death|0|||
150124134|NCT02527798|541588861|FG000|Overall Study|Withdrawal by Subject|0|||
150193004|NCT04632992|541846682|FG010|Overall Study|Reason not Specified|1|||
150124135|NCT02527798|541588862|FG001|Overall Study|Withdrawal by Subject|1|||
150124136|NCT02527798|541588863|FG002|Overall Study|Withdrawal by Subject|2|||
150124137|NCT02527798|541588864|FG003|Overall Study|Withdrawal by Subject|0|||
150124138|NCT02527798|541588865|FG004|Overall Study|Withdrawal by Subject|0|||
150124139|NCT02527798|541588866|FG005|Overall Study|Withdrawal by Subject|0|||
150124140|NCT02527798|541588861|FG000|Overall Study|Reason undisclosed|1|||
150124141|NCT02527798|541588862|FG001|Overall Study|Reason undisclosed|0|||
150124142|NCT02527798|541588863|FG002|Overall Study|Reason undisclosed|1|||
150124143|NCT02527798|541588864|FG003|Overall Study|Reason undisclosed|0|||
150124144|NCT02527798|541588865|FG004|Overall Study|Reason undisclosed|0|||
150124145|NCT02527798|541588866|FG005|Overall Study|Reason undisclosed|0|||
150124146|NCT02527798|541588861|FG000|Overall Study|Did not receive intervention|1|||
150124147|NCT02527798|541588862|FG001|Overall Study|Did not receive intervention|1|||
150124148|NCT02527798|541588863|FG002|Overall Study|Did not receive intervention|0|||
150124149|NCT02527798|541588864|FG003|Overall Study|Did not receive intervention|0|||
150124150|NCT02527798|541588865|FG004|Overall Study|Did not receive intervention|0|||
150124151|NCT02527798|541588866|FG005|Overall Study|Did not receive intervention|0|||
150124152|NCT01808690|541588868|FG000|Overall Study|Withdrawal by Subject|1|||
150124153|NCT01808690|541588869|FG001|Overall Study|Withdrawal by Subject|2|||
150124154|NCT02395120|541588870|FG000|Overall Study|Missed follow-up dental exam|57|||
150124155|NCT02395120|541588871|FG001|Overall Study|Missed follow-up dental exam|62|||
150124156|NCT02395120|541588872|FG002|Overall Study|Missed follow-up dental exam|6|||
150124157|NCT02395120|541588873|FG003|Overall Study|Missed follow-up dental exam|6|||
150124158|NCT02395120|541588874|FG004|Overall Study|Missed follow-up dental exam|51|||
150124159|NCT00377234|541588875|FG000|Overall Study|Adverse Event|14|||
150124160|NCT00377234|541588876|FG001|Overall Study|Adverse Event|17|||
150124161|NCT00377234|541588875|FG000|Overall Study|Withdrawal by Subject|11|||
150124162|NCT00377234|541588876|FG001|Overall Study|Withdrawal by Subject|9|||
150124163|NCT00377234|541588875|FG000|Overall Study|Lost to Follow-up|4|||
150124164|NCT00377234|541588876|FG001|Overall Study|Lost to Follow-up|2|||
150124165|NCT00377234|541588875|FG000|Overall Study|Administrative|2|||
150124166|NCT00377234|541588876|FG001|Overall Study|Administrative|1|||
150124167|NCT00377234|541588875|FG000|Overall Study|Not assigned|3|||
150124168|NCT00377234|541588876|FG001|Overall Study|Not assigned|2|||
150124169|NCT00626522|541588878|FG000|Overall Study|Protocol Violation|0|||
150124170|NCT00626522|541588879|FG001|Overall Study|Protocol Violation|0|||
150124171|NCT00626522|541588880|FG002|Overall Study|Protocol Violation|0|||
150124172|NCT00626522|541588881|FG003|Overall Study|Protocol Violation|0|||
150124173|NCT00626522|541588882|FG004|Overall Study|Protocol Violation|1|||
150124174|NCT00626522|541588883|FG005|Overall Study|Protocol Violation|0|||
150124175|NCT00626522|541588878|FG000|Overall Study|Adverse Event|2|||
150124176|NCT00626522|541588879|FG001|Overall Study|Adverse Event|1|||
150124177|NCT00626522|541588880|FG002|Overall Study|Adverse Event|2|||
150124178|NCT00626522|541588881|FG003|Overall Study|Adverse Event|0|||
150124179|NCT00626522|541588882|FG004|Overall Study|Adverse Event|1|||
150124180|NCT00626522|541588883|FG005|Overall Study|Adverse Event|1|||
150124181|NCT00626522|541588878|FG000|Overall Study|Withdrawal by Subject|2|||
150124182|NCT00626522|541588879|FG001|Overall Study|Withdrawal by Subject|5|||
150124183|NCT00626522|541588880|FG002|Overall Study|Withdrawal by Subject|5|||
150124184|NCT00626522|541588881|FG003|Overall Study|Withdrawal by Subject|0|||
150124185|NCT00626522|541588882|FG004|Overall Study|Withdrawal by Subject|4|||
150124186|NCT00626522|541588883|FG005|Overall Study|Withdrawal by Subject|1|||
150124187|NCT00626522|541588878|FG000|Overall Study|COPD exacerbation|0|||
150124188|NCT00626522|541588879|FG001|Overall Study|COPD exacerbation|0|||
150124189|NCT00626522|541588880|FG002|Overall Study|COPD exacerbation|0|||
150124190|NCT00626522|541588881|FG003|Overall Study|COPD exacerbation|1|||
150124191|NCT00626522|541588882|FG004|Overall Study|COPD exacerbation|1|||
150124192|NCT00626522|541588883|FG005|Overall Study|COPD exacerbation|0|||
150124193|NCT00626522|541588878|FG000|Overall Study|Lost to Follow-up|0|||
150124194|NCT00626522|541588879|FG001|Overall Study|Lost to Follow-up|1|||
150124195|NCT00626522|541588880|FG002|Overall Study|Lost to Follow-up|0|||
150124196|NCT00626522|541588881|FG003|Overall Study|Lost to Follow-up|0|||
150124197|NCT00626522|541588882|FG004|Overall Study|Lost to Follow-up|0|||
150124198|NCT00626522|541588883|FG005|Overall Study|Lost to Follow-up|0|||
150124199|NCT00626522|541588878|FG000|Overall Study|Inconsistent reason reported|1|||
150124200|NCT00626522|541588879|FG001|Overall Study|Inconsistent reason reported|0|||
150124201|NCT00626522|541588880|FG002|Overall Study|Inconsistent reason reported|0|||
150124202|NCT00626522|541588881|FG003|Overall Study|Inconsistent reason reported|0|||
150124203|NCT00626522|541588882|FG004|Overall Study|Inconsistent reason reported|0|||
150124204|NCT00626522|541588883|FG005|Overall Study|Inconsistent reason reported|0|||
149737500|NCT02601950|540170378|FG001|Overall Study|Participant refused further study treatment|1|||
150124205|NCT00626522|541588878|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
150124206|NCT00626522|541588879|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
150124207|NCT00626522|541588880|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
150124208|NCT00626522|541588881|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
150124209|NCT00626522|541588882|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
150124210|NCT00626522|541588883|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
150124211|NCT01159691|541588884|FG000|Overall Study|Lost to Follow-up|2|||
150124212|NCT01159691|541588884|FG000|Overall Study|Unknown reasons|1|||
150124213|NCT01159691|541588884|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
150124214|NCT01159691|541588884|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
150193005|NCT04632992|541846683|FG011|Overall Study|Reason not Specified|0|||
150193006|NCT04632992|541846684|FG012|Overall Study|Reason not Specified|0|||
150193007|NCT04632992|541846685|FG013|Overall Study|Reason not Specified|0|||
150193008|NCT04632992|541846672|FG000|Overall Study|Physician Decision|0|||
150193009|NCT04632992|541846673|FG001|Overall Study|Physician Decision|0|||
150193010|NCT04632992|541846674|FG002|Overall Study|Physician Decision|0|||
150193011|NCT04632992|541846675|FG003|Overall Study|Physician Decision|2|||
150193012|NCT04632992|541846676|FG004|Overall Study|Physician Decision|1|||
150193013|NCT04632992|541846677|FG005|Overall Study|Physician Decision|0|||
150193014|NCT04632992|541846678|FG006|Overall Study|Physician Decision|0|||
150193015|NCT04632992|541846679|FG007|Overall Study|Physician Decision|0|||
150193016|NCT04632992|541846680|FG008|Overall Study|Physician Decision|0|||
150193017|NCT04632992|541846681|FG009|Overall Study|Physician Decision|0|||
150193018|NCT04632992|541846682|FG010|Overall Study|Physician Decision|0|||
150193019|NCT04632992|541846683|FG011|Overall Study|Physician Decision|0|||
150193020|NCT04632992|541846684|FG012|Overall Study|Physician Decision|3|||
150193021|NCT04632992|541846685|FG013|Overall Study|Physician Decision|0|||
150193022|NCT04632992|541846672|FG000|Overall Study|Progressive Disease|0|||
150193023|NCT04632992|541846673|FG001|Overall Study|Progressive Disease|0|||
150193024|NCT04632992|541846674|FG002|Overall Study|Progressive Disease|0|||
150193025|NCT04632992|541846675|FG003|Overall Study|Progressive Disease|0|||
150193026|NCT04632992|541846676|FG004|Overall Study|Progressive Disease|1|||
150193027|NCT04632992|541846677|FG005|Overall Study|Progressive Disease|0|||
150193028|NCT04632992|541846678|FG006|Overall Study|Progressive Disease|0|||
150193029|NCT04632992|541846679|FG007|Overall Study|Progressive Disease|0|||
150193030|NCT04632992|541846680|FG008|Overall Study|Progressive Disease|0|||
150193031|NCT04632992|541846681|FG009|Overall Study|Progressive Disease|1|||
150193032|NCT04632992|541846682|FG010|Overall Study|Progressive Disease|1|||
150124215|NCT01159691|541588884|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
150124216|NCT01159691|541588884|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
150124217|NCT01159691|541588884|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
150124218|NCT01159691|541588884|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
150124219|NCT05732454|541588886|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
150124220|NCT05732454|541588887|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
150124221|NCT05732454|541588886|FG000|Part 1: DB Period|Adverse Event|1|||
150124222|NCT05732454|541588887|FG001|Part 1: DB Period|Adverse Event|0|||
150124223|NCT05732454|541588886|FG000|Part 1: DB Period|Lost to Follow-up|1|||
150124224|NCT05732454|541588887|FG001|Part 1: DB Period|Lost to Follow-up|0|||
150124225|NCT05732454|541588886|FG000|Part 1: DB Period|Protocol Violation|0|||
150124226|NCT05732454|541588887|FG001|Part 1: DB Period|Protocol Violation|1|||
150124227|NCT05732454|541588886|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
150124228|NCT05732454|541588887|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
150124229|NCT05732454|541588886|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
150124230|NCT05732454|541588887|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
150124231|NCT05732454|541588886|FG000|Part 1: OLE Period|Adverse Event|0|||
150124232|NCT05732454|541588887|FG001|Part 1: OLE Period|Adverse Event|1|||
150124233|NCT05732454|541588886|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
150124234|NCT05732454|541588887|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
150124235|NCT01153633|541588888|FG000|Overall Study|Protocol Violation|1|||
150124236|NCT01153633|541588889|FG001|Overall Study|Protocol Violation|1|||
150124237|NCT01153633|541588888|FG000|Overall Study|Therapeutic failure|3|||
150124238|NCT01153633|541588889|FG001|Overall Study|Therapeutic failure|3|||
150124239|NCT00384085|541588890|FG000|Overall Study|Adverse Event|5|||
150124240|NCT00384085|541588891|FG001|Overall Study|Adverse Event|5|||
150124241|NCT00384085|541588892|FG002|Overall Study|Adverse Event|4|||
150124242|NCT00384085|541588890|FG000|Overall Study|Lack of Efficacy|0|||
150124243|NCT00384085|541588891|FG001|Overall Study|Lack of Efficacy|3|||
150124244|NCT00384085|541588892|FG002|Overall Study|Lack of Efficacy|2|||
150124245|NCT00384085|541588890|FG000|Overall Study|No longer Requires Study Treatment|1|||
150124246|NCT00384085|541588891|FG001|Overall Study|No longer Requires Study Treatment|0|||
150124247|NCT00384085|541588892|FG002|Overall Study|No longer Requires Study Treatment|1|||
150124248|NCT00384085|541588890|FG000|Overall Study|Protocol Violation|2|||
150124249|NCT00384085|541588891|FG001|Overall Study|Protocol Violation|2|||
150124250|NCT00384085|541588892|FG002|Overall Study|Protocol Violation|2|||
150124251|NCT00384085|541588890|FG000|Overall Study|Lost to Follow-up|9|||
150124252|NCT00384085|541588891|FG001|Overall Study|Lost to Follow-up|9|||
150124253|NCT00384085|541588892|FG002|Overall Study|Lost to Follow-up|10|||
150124254|NCT00384085|541588890|FG000|Overall Study|Progressive Disease|0|||
150124255|NCT00384085|541588891|FG001|Overall Study|Progressive Disease|1|||
150124256|NCT00384085|541588892|FG002|Overall Study|Progressive Disease|0|||
150124257|NCT00384085|541588890|FG000|Overall Study|Withdrawal by Subject|14|||
150124258|NCT00384085|541588891|FG001|Overall Study|Withdrawal by Subject|19|||
150124259|NCT00384085|541588892|FG002|Overall Study|Withdrawal by Subject|29|||
150124260|NCT00384085|541588890|FG000|Overall Study|Patient non-compliant|4|||
150124261|NCT00384085|541588891|FG001|Overall Study|Patient non-compliant|4|||
150124262|NCT00384085|541588892|FG002|Overall Study|Patient non-compliant|5|||
150124263|NCT00384085|541588890|FG000|Overall Study|Physician Decision|1|||
150124264|NCT00384085|541588891|FG001|Overall Study|Physician Decision|0|||
150124265|NCT00384085|541588892|FG002|Overall Study|Physician Decision|0|||
150124266|NCT00384085|541588890|FG000|Overall Study|Loss of site personnel|1|||
150124267|NCT00384085|541588891|FG001|Overall Study|Loss of site personnel|0|||
150124268|NCT00384085|541588892|FG002|Overall Study|Loss of site personnel|1|||
150124269|NCT00384085|541588890|FG000|Overall Study|Sponsor decision|1|||
150124270|NCT00384085|541588891|FG001|Overall Study|Sponsor decision|2|||
150124271|NCT00384085|541588892|FG002|Overall Study|Sponsor decision|1|||
150124272|NCT00384085|541588890|FG000|Overall Study|Patient moved|1|||
150124273|NCT00384085|541588891|FG001|Overall Study|Patient moved|0|||
150124274|NCT00384085|541588892|FG002|Overall Study|Patient moved|1|||
150124275|NCT00384085|541588890|FG000|Overall Study|Patient required surgery|0|||
150124276|NCT00384085|541588891|FG001|Overall Study|Patient required surgery|1|||
150124277|NCT00384085|541588892|FG002|Overall Study|Patient required surgery|0|||
150124278|NCT03725982|541588895|FG000|First Intervention|Withdrawal by Subject|0|||
150124279|NCT03725982|541588896|FG001|First Intervention|Withdrawal by Subject|1|||
150124280|NCT03725982|541588895|FG000|First Intervention|Physician Decision|1|||
150124281|NCT03725982|541588896|FG001|First Intervention|Physician Decision|1|||
150124282|NCT01944631|541588900|FG000|Overall Study|Adverse Event|1|||
150124283|NCT01944631|541588901|FG001|Overall Study|Adverse Event|0|||
150124284|NCT01944631|541588900|FG000|Overall Study|Lost to Follow-up|3|||
150124285|NCT01944631|541588901|FG001|Overall Study|Lost to Follow-up|1|||
150193033|NCT04632992|541846683|FG011|Overall Study|Progressive Disease|0|||
150193034|NCT04632992|541846684|FG012|Overall Study|Progressive Disease|2|||
150193035|NCT04632992|541846685|FG013|Overall Study|Progressive Disease|0|||
150193036|NCT04632992|541846672|FG000|Overall Study|Withdrawal by Subject|4|||
150193037|NCT04632992|541846673|FG001|Overall Study|Withdrawal by Subject|1|||
150193038|NCT04632992|541846674|FG002|Overall Study|Withdrawal by Subject|5|||
150193039|NCT04632992|541846675|FG003|Overall Study|Withdrawal by Subject|4|||
150193040|NCT04632992|541846676|FG004|Overall Study|Withdrawal by Subject|3|||
150193041|NCT04632992|541846677|FG005|Overall Study|Withdrawal by Subject|3|||
150193042|NCT04632992|541846678|FG006|Overall Study|Withdrawal by Subject|0|||
150193043|NCT04632992|541846679|FG007|Overall Study|Withdrawal by Subject|5|||
150193044|NCT04632992|541846680|FG008|Overall Study|Withdrawal by Subject|0|||
150193045|NCT04632992|541846681|FG009|Overall Study|Withdrawal by Subject|2|||
150193046|NCT04632992|541846682|FG010|Overall Study|Withdrawal by Subject|8|||
150193047|NCT04632992|541846683|FG011|Overall Study|Withdrawal by Subject|0|||
150193048|NCT04632992|541846684|FG012|Overall Study|Withdrawal by Subject|1|||
150193049|NCT04632992|541846685|FG013|Overall Study|Withdrawal by Subject|1|||
150193050|NCT02268253|541846686|FG000|Stage 1|Withdrawal by Subject|1|||
150193051|NCT02268253|541846687|FG001|Stage 1|Withdrawal by Subject|0|||
150193052|NCT02268253|541846688|FG002|Stage 1|Withdrawal by Subject|0|||
150193053|NCT02268253|541846689|FG003|Stage 1|Withdrawal by Subject|0|||
150193054|NCT02268253|541846690|FG004|Stage 1|Withdrawal by Subject|0|||
150193055|NCT02268253|541846691|FG005|Stage 1|Withdrawal by Subject|0|||
150193056|NCT02268253|541846692|FG006|Stage 1|Withdrawal by Subject|0|||
150193057|NCT02268253|541846686|FG000|Stage 1|Death|0|||
150193058|NCT02268253|541846687|FG001|Stage 1|Death|2|||
150193059|NCT02268253|541846688|FG002|Stage 1|Death|2|||
150193060|NCT02268253|541846689|FG003|Stage 1|Death|2|||
150193061|NCT02268253|541846690|FG004|Stage 1|Death|1|||
150193062|NCT02268253|541846691|FG005|Stage 1|Death|1|||
150193063|NCT02268253|541846692|FG006|Stage 1|Death|0|||
150193064|NCT02268253|541846686|FG000|Stage 2|Disease Recurrence/ Progression|0|||
150193065|NCT02268253|541846687|FG001|Stage 2|Disease Recurrence/ Progression|0|||
150193066|NCT02268253|541846688|FG002|Stage 2|Disease Recurrence/ Progression|1|||
150193067|NCT02268253|541846689|FG003|Stage 2|Disease Recurrence/ Progression|0|||
150193068|NCT02268253|541846690|FG004|Stage 2|Disease Recurrence/ Progression|0|||
150193069|NCT02268253|541846691|FG005|Stage 2|Disease Recurrence/ Progression|0|||
150193070|NCT02268253|541846692|FG006|Stage 2|Disease Recurrence/ Progression|0|||
150193071|NCT02268253|541846686|FG000|Stage 2|Withdrawal by Subject|0|||
150193072|NCT02268253|541846687|FG001|Stage 2|Withdrawal by Subject|0|||
150193073|NCT02268253|541846688|FG002|Stage 2|Withdrawal by Subject|2|||
150193074|NCT02268253|541846689|FG003|Stage 2|Withdrawal by Subject|0|||
150193075|NCT02268253|541846690|FG004|Stage 2|Withdrawal by Subject|0|||
150193076|NCT02268253|541846691|FG005|Stage 2|Withdrawal by Subject|2|||
150193077|NCT02268253|541846692|FG006|Stage 2|Withdrawal by Subject|0|||
150193078|NCT02268253|541846686|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
150193079|NCT02268253|541846687|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
150193080|NCT02268253|541846688|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
150193081|NCT02268253|541846689|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
150193082|NCT02268253|541846690|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
150193083|NCT02268253|541846691|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
150193084|NCT02268253|541846692|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
150193085|NCT02268253|541846686|FG000|Stage 2|Death|0|||
150193086|NCT02268253|541846687|FG001|Stage 2|Death|0|||
150193087|NCT02268253|541846688|FG002|Stage 2|Death|19|||
150193088|NCT02268253|541846689|FG003|Stage 2|Death|0|||
150193089|NCT02268253|541846690|FG004|Stage 2|Death|0|||
150193090|NCT02268253|541846691|FG005|Stage 2|Death|20|||
150193091|NCT02268253|541846692|FG006|Stage 2|Death|1|||
150193092|NCT02268253|541846686|FG000|Stage 2|Lost to Follow-up|0|||
150193093|NCT02268253|541846687|FG001|Stage 2|Lost to Follow-up|0|||
150193094|NCT02268253|541846688|FG002|Stage 2|Lost to Follow-up|0|||
150193095|NCT02268253|541846689|FG003|Stage 2|Lost to Follow-up|0|||
150193096|NCT02268253|541846690|FG004|Stage 2|Lost to Follow-up|0|||
150193097|NCT02268253|541846691|FG005|Stage 2|Lost to Follow-up|4|||
150193098|NCT02268253|541846692|FG006|Stage 2|Lost to Follow-up|0|||
150193099|NCT02268253|541846686|FG000|Stage 2|Transferred to Hospice|0|||
150193100|NCT02268253|541846687|FG001|Stage 2|Transferred to Hospice|0|||
150193101|NCT02268253|541846688|FG002|Stage 2|Transferred to Hospice|0|||
150193102|NCT02268253|541846689|FG003|Stage 2|Transferred to Hospice|0|||
150193103|NCT02268253|541846690|FG004|Stage 2|Transferred to Hospice|0|||
150193104|NCT02268253|541846691|FG005|Stage 2|Transferred to Hospice|2|||
150193105|NCT02268253|541846692|FG006|Stage 2|Transferred to Hospice|0|||
150193106|NCT02268253|541846686|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
150193107|NCT02268253|541846687|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
150193108|NCT02268253|541846688|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
150193109|NCT02268253|541846689|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
150193110|NCT02268253|541846690|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
150193111|NCT02268253|541846691|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
150193112|NCT02268253|541846692|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
150124286|NCT01944631|541588900|FG000|Overall Study|Withdrawal by Subject|0|||
150124287|NCT01944631|541588901|FG001|Overall Study|Withdrawal by Subject|1|||
150124288|NCT00838110|541588902|FG000|Overall Study|Death|0|||
150124289|NCT00838110|541588903|FG001|Overall Study|Death|0|||
150124290|NCT00838110|541588904|FG002|Overall Study|Death|1|||
150124291|NCT00838110|541588905|FG003|Overall Study|Death|2|||
150124292|NCT00838110|541588902|FG000|Overall Study|Adverse Event|11|||
150124293|NCT00838110|541588903|FG001|Overall Study|Adverse Event|10|||
150124294|NCT00838110|541588904|FG002|Overall Study|Adverse Event|8|||
150124295|NCT00838110|541588905|FG003|Overall Study|Adverse Event|7|||
150124296|NCT00838110|541588902|FG000|Overall Study|Withdrawal by Subject|5|||
150124297|NCT00838110|541588903|FG001|Overall Study|Withdrawal by Subject|6|||
150124298|NCT00838110|541588904|FG002|Overall Study|Withdrawal by Subject|3|||
150124299|NCT00838110|541588905|FG003|Overall Study|Withdrawal by Subject|4|||
150124300|NCT00838110|541588902|FG000|Overall Study|Other|3|||
150124301|NCT00838110|541588903|FG001|Overall Study|Other|3|||
150124302|NCT00838110|541588904|FG002|Overall Study|Other|3|||
150124303|NCT00838110|541588905|FG003|Overall Study|Other|2|||
150124304|NCT00838110|541588902|FG000|Overall Study|Protocol Violation|0|||
150124305|NCT00838110|541588903|FG001|Overall Study|Protocol Violation|2|||
150124306|NCT00838110|541588904|FG002|Overall Study|Protocol Violation|1|||
150124307|NCT00838110|541588905|FG003|Overall Study|Protocol Violation|1|||
150124308|NCT00838110|541588902|FG000|Overall Study|Lost to Follow-up|3|||
150124309|NCT00838110|541588903|FG001|Overall Study|Lost to Follow-up|0|||
150124310|NCT00838110|541588904|FG002|Overall Study|Lost to Follow-up|0|||
150124311|NCT00838110|541588905|FG003|Overall Study|Lost to Follow-up|0|||
150124312|NCT00838110|541588902|FG000|Overall Study|Did not meet eligibility criteria|0|||
150124313|NCT00838110|541588903|FG001|Overall Study|Did not meet eligibility criteria|0|||
150124314|NCT00838110|541588904|FG002|Overall Study|Did not meet eligibility criteria|1|||
150124315|NCT00838110|541588905|FG003|Overall Study|Did not meet eligibility criteria|2|||
150124316|NCT00838110|541588902|FG000|Overall Study|Randomized but not treated|0|||
150124317|NCT00838110|541588903|FG001|Overall Study|Randomized but not treated|1|||
150124318|NCT00838110|541588904|FG002|Overall Study|Randomized but not treated|0|||
150124319|NCT00838110|541588905|FG003|Overall Study|Randomized but not treated|0|||
150124320|NCT01003899|541588906|FG000|Overall Study|Other Adverse Event|8|||
150124321|NCT01003899|541588906|FG000|Overall Study|Not entered|4|||
150124322|NCT01003899|541588906|FG000|Overall Study|Not treated|1|||
150124323|NCT01003899|541588906|FG000|Overall Study|Progressive disease|34|||
150124324|NCT01262651|541588907|FG000|Overall Study|Adverse Event|40|||
150124325|NCT01262651|541588908|FG001|Overall Study|Adverse Event|35|||
150124326|NCT01262651|541588907|FG000|Overall Study|Withdrawal by Subject|15|||
150124327|NCT01262651|541588908|FG001|Overall Study|Withdrawal by Subject|11|||
150124328|NCT01262651|541588907|FG000|Overall Study|Withdrawal by Investigator|2|||
150124329|NCT01262651|541588908|FG001|Overall Study|Withdrawal by Investigator|2|||
150124330|NCT01262651|541588907|FG000|Overall Study|Met Withdrawal Criteria|1|||
150124331|NCT01262651|541588908|FG001|Overall Study|Met Withdrawal Criteria|0|||
150124332|NCT04969783|541588912|FG000|Overall Study|Lost to Follow-up|2|||
150124333|NCT04969783|541588913|FG001|Overall Study|Lost to Follow-up|0|||
150124334|NCT04969783|541588912|FG000|Overall Study|Withdrawal by Subject|4|||
150124335|NCT04969783|541588913|FG001|Overall Study|Withdrawal by Subject|0|||
150124336|NCT04969783|541588912|FG000|Overall Study|Physician Decision|6|||
150124337|NCT04969783|541588913|FG001|Overall Study|Physician Decision|0|||
150124338|NCT02489500|541588914|FG000|Overall Study|Death|1|||
150124339|NCT02489500|541588915|FG001|Overall Study|Death|1|||
150124340|NCT03489304|541588916|FG000|Overall Study|Lost to Follow-up|4|||
150124341|NCT02239679|541588917|FG000|Overall Study|Lost to Follow-up|1|||
150124342|NCT02239679|541588918|FG001|Overall Study|Lost to Follow-up|0|||
150124343|NCT02239679|541588919|FG002|Overall Study|Lost to Follow-up|0|||
150124344|NCT02239679|541588917|FG000|Overall Study|Withdrawal by Subject|2|||
150124345|NCT02239679|541588918|FG001|Overall Study|Withdrawal by Subject|3|||
150124346|NCT02239679|541588919|FG002|Overall Study|Withdrawal by Subject|1|||
150124347|NCT02605954|541588921|FG000|Overall Study|Adverse Event|5|||
150193113|NCT02268253|541846686|FG000|Stage 3A|Withdrawal by Subject|0|||
150124348|NCT02605954|541588922|FG001|Overall Study|Adverse Event|1|||
150124349|NCT02605954|541588921|FG000|Overall Study|Investigator's Discretion|1|||
150124350|NCT02605954|541588922|FG001|Overall Study|Investigator's Discretion|0|||
150124351|NCT02605954|541588921|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150124352|NCT02605954|541588922|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150193114|NCT02268253|541846687|FG001|Stage 3A|Withdrawal by Subject|0|||
150124353|NCT02605954|541588921|FG000|Overall Study|Withdrew Consent|2|||
150124354|NCT02605954|541588922|FG001|Overall Study|Withdrew Consent|2|||
150124355|NCT02605954|541588921|FG000|Overall Study|Lost to Follow-up|3|||
150124356|NCT02605954|541588922|FG001|Overall Study|Lost to Follow-up|0|||
150124357|NCT02605954|541588921|FG000|Overall Study|Randomized but not treated|0|||
150193115|NCT02268253|541846688|FG002|Stage 3A|Withdrawal by Subject|2|||
150193116|NCT02268253|541846689|FG003|Stage 3A|Withdrawal by Subject|0|||
150193117|NCT02268253|541846690|FG004|Stage 3A|Withdrawal by Subject|0|||
150124358|NCT02605954|541588922|FG001|Overall Study|Randomized but not treated|1|||
150124359|NCT00599326|541588925|FG000|Overall Study|Lost to Follow-up|1|||
150124360|NCT00599326|541588925|FG000|Overall Study|Noncompliant|1|||
150124361|NCT03434119|541588926|FG000|Overall Study|Randomized but not treated|1|||
150124362|NCT03434119|541588927|FG001|Overall Study|Randomized but not treated|0|||
150124363|NCT03434119|541588926|FG000|Overall Study|Adverse Event|1|||
150124364|NCT03434119|541588927|FG001|Overall Study|Adverse Event|0|||
150124365|NCT03434119|541588926|FG000|Overall Study|Poor Compliance to Protocol|0|||
150124366|NCT03434119|541588927|FG001|Overall Study|Poor Compliance to Protocol|1|||
150124367|NCT03434119|541588926|FG000|Overall Study|Study Terminated by Sponsor|91|||
150124368|NCT03434119|541588927|FG001|Overall Study|Study Terminated by Sponsor|102|||
150124369|NCT03434119|541588926|FG000|Overall Study|Withdrawal by Subject|7|||
150124370|NCT03434119|541588927|FG001|Overall Study|Withdrawal by Subject|5|||
150124371|NCT03434119|541588926|FG000|Overall Study|Other than specified|7|||
150124372|NCT03434119|541588927|FG001|Overall Study|Other than specified|5|||
150124373|NCT00779246|541588932|FG000|Overall Study|Missing sufficient data for analysis|33|||
150124374|NCT00779246|541588933|FG001|Overall Study|Missing sufficient data for analysis|53|||
150124375|NCT00148343|541588934|FG000|Overall Study|Withdrawal by Subject|12|||
150124376|NCT00148343|541588935|FG001|Overall Study|Withdrawal by Subject|7|||
150124377|NCT00148343|541588934|FG000|Overall Study|Physician Decision|3|||
150124378|NCT00148343|541588935|FG001|Overall Study|Physician Decision|4|||
150124379|NCT03579459|541588936|FG000|Overall Study|Adverse Event|7|||
150124380|NCT03579459|541588937|FG001|Overall Study|Adverse Event|6|||
150124381|NCT03579459|541588938|FG002|Overall Study|Adverse Event|2|||
150124382|NCT03579459|541588939|FG003|Overall Study|Adverse Event|6|||
150124383|NCT03579459|541588936|FG000|Overall Study|Death|1|||
150124384|NCT03579459|541588937|FG001|Overall Study|Death|0|||
150124385|NCT03579459|541588938|FG002|Overall Study|Death|1|||
150124386|NCT03579459|541588939|FG003|Overall Study|Death|2|||
150124387|NCT03579459|541588936|FG000|Overall Study|Lost to Follow-up|6|||
150124388|NCT03579459|541588937|FG001|Overall Study|Lost to Follow-up|2|||
150124389|NCT03579459|541588938|FG002|Overall Study|Lost to Follow-up|4|||
150124390|NCT03579459|541588939|FG003|Overall Study|Lost to Follow-up|1|||
150124391|NCT03579459|541588936|FG000|Overall Study|Physician Decision|0|||
150124392|NCT03579459|541588937|FG001|Overall Study|Physician Decision|1|||
150124393|NCT03579459|541588938|FG002|Overall Study|Physician Decision|0|||
150124394|NCT03579459|541588939|FG003|Overall Study|Physician Decision|1|||
150124395|NCT03579459|541588936|FG000|Overall Study|Protocol Violation|1|||
150124396|NCT03579459|541588937|FG001|Overall Study|Protocol Violation|2|||
150124397|NCT03579459|541588938|FG002|Overall Study|Protocol Violation|3|||
150124398|NCT03579459|541588939|FG003|Overall Study|Protocol Violation|5|||
150124399|NCT03579459|541588936|FG000|Overall Study|Withdrawal by Subject|12|||
150124400|NCT03579459|541588937|FG001|Overall Study|Withdrawal by Subject|8|||
150124401|NCT03579459|541588938|FG002|Overall Study|Withdrawal by Subject|11|||
150124402|NCT03579459|541588939|FG003|Overall Study|Withdrawal by Subject|8|||
150124403|NCT03579459|541588936|FG000|Overall Study|Medication error without associated adverse event|2|||
150124404|NCT03579459|541588937|FG001|Overall Study|Medication error without associated adverse event|1|||
150124405|NCT03579459|541588938|FG002|Overall Study|Medication error without associated adverse event|1|||
150124406|NCT03579459|541588939|FG003|Overall Study|Medication error without associated adverse event|0|||
150124407|NCT03579459|541588936|FG000|Overall Study|Other|0|||
150124408|NCT03579459|541588937|FG001|Overall Study|Other|1|||
150124409|NCT03579459|541588938|FG002|Overall Study|Other|1|||
150124410|NCT03579459|541588939|FG003|Overall Study|Other|0|||
150124411|NCT03579459|541588936|FG000|Overall Study|Randomized not vaccinated|0|||
150124412|NCT03579459|541588937|FG001|Overall Study|Randomized not vaccinated|2|||
150124413|NCT03579459|541588938|FG002|Overall Study|Randomized not vaccinated|0|||
150124414|NCT03579459|541588939|FG003|Overall Study|Randomized not vaccinated|1|||
150124415|NCT02844946|541588943|FG000|Overall Study|Lost to Follow-up|7|||
150124416|NCT02844946|541588944|FG001|Overall Study|Lost to Follow-up|0|||
150124417|NCT02806986|541588945|FG000|Treatment Stage 1|Adverse Event|1|||
150124418|NCT02806986|541588945|FG000|Treatment Stage 2|Adverse Event|3|||
150124419|NCT02806986|541588945|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
150124420|NCT00407537|541588946|FG000|Overall Study|Death|5|||
150124421|NCT00407537|541588947|FG001|Overall Study|Death|2|||
150124422|NCT00407537|541588946|FG000|Overall Study|Adverse Event|36|||
150124423|NCT00407537|541588947|FG001|Overall Study|Adverse Event|0|||
150124424|NCT00407537|541588946|FG000|Overall Study|Lost to Follow-up|12|||
150124425|NCT00407537|541588947|FG001|Overall Study|Lost to Follow-up|19|||
150124426|NCT00407537|541588946|FG000|Overall Study|Other|6|||
150124427|NCT00407537|541588947|FG001|Overall Study|Other|7|||
150124428|NCT00407537|541588946|FG000|Overall Study|Withdrawal by Subject|34|||
150124429|NCT00407537|541588947|FG001|Overall Study|Withdrawal by Subject|16|||
150124430|NCT01380327|541588948|FG000|Overall Study|Lost to Follow-up|0|||
150124431|NCT01380327|541588949|FG001|Overall Study|Lost to Follow-up|1|||
150124432|NCT01380327|541588950|FG002|Overall Study|Lost to Follow-up|1|||
150124433|NCT01380327|541588948|FG000|Overall Study|Protocol Violation|3|||
150124434|NCT01380327|541588949|FG001|Overall Study|Protocol Violation|2|||
150124435|NCT01380327|541588950|FG002|Overall Study|Protocol Violation|3|||
150124436|NCT01380327|541588948|FG000|Overall Study|Withdrawal by Subject|0|||
150124437|NCT01380327|541588949|FG001|Overall Study|Withdrawal by Subject|0|||
150124438|NCT01380327|541588950|FG002|Overall Study|Withdrawal by Subject|1|||
150124439|NCT01380327|541588948|FG000|Overall Study|Housing situation precluded ability to k|0|||
150124440|NCT01380327|541588949|FG001|Overall Study|Housing situation precluded ability to k|0|||
150124441|NCT01380327|541588950|FG002|Overall Study|Housing situation precluded ability to k|1|||
150124442|NCT01380327|541588948|FG000|Overall Study|Questionable onset of epilepsy|0|||
150124443|NCT01380327|541588949|FG001|Overall Study|Questionable onset of epilepsy|0|||
150124444|NCT01380327|541588950|FG002|Overall Study|Questionable onset of epilepsy|1|||
150124445|NCT05046795|541588951|FG000|Overall Study|Adverse Event|13|||
150124446|NCT05046795|541588952|FG001|Overall Study|Adverse Event|15|||
150124447|NCT05046795|541588951|FG000|Overall Study|Withdrawal by Subject|4|||
150124448|NCT05046795|541588952|FG001|Overall Study|Withdrawal by Subject|7|||
150124449|NCT05046795|541588951|FG000|Overall Study|Physician Decision|1|||
150124450|NCT05046795|541588952|FG001|Overall Study|Physician Decision|2|||
150124451|NCT05046795|541588951|FG000|Overall Study|Protocol Violation|1|||
150124452|NCT05046795|541588952|FG001|Overall Study|Protocol Violation|2|||
150124453|NCT05046795|541588951|FG000|Overall Study|Death|1|||
150124454|NCT05046795|541588952|FG001|Overall Study|Death|0|||
150124455|NCT05046795|541588951|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
150124456|NCT05046795|541588952|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
150124457|NCT01127178|541588953|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
150124458|NCT01127178|541588954|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
150124459|NCT01127178|541588953|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
150124460|NCT01127178|541588954|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
150124461|NCT01127178|541588953|FG000|Dose Escalation: Treatment Phase|Other|2|||
150124462|NCT01127178|541588954|FG001|Dose Escalation: Treatment Phase|Other|0|||
150124463|NCT01127178|541588953|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
150124464|NCT01127178|541588954|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
150124465|NCT01127178|541588953|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
150124466|NCT01127178|541588954|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
150124467|NCT01127178|541588953|FG000|Dose Escalation: Extension Phase|Other|1|||
150124468|NCT01127178|541588954|FG001|Dose Escalation: Extension Phase|Other|0|||
150124469|NCT05348681|541588955|FG000|Overall Study|Study terminated by Sponsor|8|||
150124470|NCT05348681|541588956|FG001|Overall Study|Study terminated by Sponsor|3|||
150124471|NCT05348681|541588955|FG000|Overall Study|Withdrawal by Subject|1|||
150124472|NCT05348681|541588956|FG001|Overall Study|Withdrawal by Subject|1|||
150124473|NCT05348681|541588955|FG000|Overall Study|Lost to Follow-up|1|||
150124474|NCT05348681|541588956|FG001|Overall Study|Lost to Follow-up|1|||
150124475|NCT05348681|541588955|FG000|Overall Study|Adverse Event|1|||
150124476|NCT05348681|541588956|FG001|Overall Study|Adverse Event|0|||
150124477|NCT05348681|541588955|FG000|Overall Study|Other|2|||
150124478|NCT05348681|541588956|FG001|Overall Study|Other|1|||
150124479|NCT01040130|541588957|FG000|Overall Study|Adverse Event|1|||
150124480|NCT01040130|541588958|FG001|Overall Study|Adverse Event|1|||
150124481|NCT01040130|541588959|FG002|Overall Study|Adverse Event|0|||
150124482|NCT01040130|541588960|FG003|Overall Study|Adverse Event|5|||
150124483|NCT01040130|541588961|FG004|Overall Study|Adverse Event|0|||
150124484|NCT01040130|541588962|FG005|Overall Study|Adverse Event|3|||
150124485|NCT01040130|541588957|FG000|Overall Study|Protocol Violation|0|||
150124486|NCT01040130|541588958|FG001|Overall Study|Protocol Violation|0|||
150124487|NCT01040130|541588959|FG002|Overall Study|Protocol Violation|2|||
150124488|NCT01040130|541588960|FG003|Overall Study|Protocol Violation|0|||
150124489|NCT01040130|541588961|FG004|Overall Study|Protocol Violation|0|||
150124490|NCT01040130|541588962|FG005|Overall Study|Protocol Violation|0|||
150124491|NCT01040130|541588957|FG000|Overall Study|Withdrawal by Subject|0|||
150124492|NCT01040130|541588958|FG001|Overall Study|Withdrawal by Subject|2|||
150124493|NCT01040130|541588959|FG002|Overall Study|Withdrawal by Subject|0|||
150124494|NCT01040130|541588960|FG003|Overall Study|Withdrawal by Subject|0|||
150124495|NCT01040130|541588961|FG004|Overall Study|Withdrawal by Subject|0|||
150124496|NCT01040130|541588962|FG005|Overall Study|Withdrawal by Subject|1|||
150124497|NCT01040130|541588957|FG000|Overall Study|Other reasons not listed above|2|||
150124498|NCT01040130|541588958|FG001|Overall Study|Other reasons not listed above|0|||
150124499|NCT01040130|541588959|FG002|Overall Study|Other reasons not listed above|0|||
150124500|NCT01040130|541588960|FG003|Overall Study|Other reasons not listed above|0|||
150124501|NCT01040130|541588961|FG004|Overall Study|Other reasons not listed above|0|||
150124502|NCT01040130|541588962|FG005|Overall Study|Other reasons not listed above|0|||
150124503|NCT00782340|541588963|FG000|Open Label Titration|Adverse Event|12|||
150124504|NCT00782340|541588964|FG001|Open Label Titration|Adverse Event|0|||
150124505|NCT00782340|541588965|FG002|Open Label Titration|Adverse Event|0|||
150124506|NCT00782340|541588963|FG000|Open Label Titration|Treatment failure|50|||
150124507|NCT00782340|541588964|FG001|Open Label Titration|Treatment failure|0|||
150124508|NCT00782340|541588965|FG002|Open Label Titration|Treatment failure|0|||
150124509|NCT00782340|541588963|FG000|Open Label Titration|Protocol Violation|5|||
150124510|NCT00782340|541588964|FG001|Open Label Titration|Protocol Violation|0|||
150124511|NCT00782340|541588965|FG002|Open Label Titration|Protocol Violation|0|||
150124512|NCT00782340|541588963|FG000|Open Label Titration|Withdrawal by Subject|5|||
150124513|NCT00782340|541588964|FG001|Open Label Titration|Withdrawal by Subject|0|||
150124514|NCT00782340|541588965|FG002|Open Label Titration|Withdrawal by Subject|0|||
150124515|NCT00782340|541588963|FG000|Open Label Titration|Enrollment capped|16|||
150124516|NCT00782340|541588964|FG001|Open Label Titration|Enrollment capped|0|||
150124517|NCT00782340|541588965|FG002|Open Label Titration|Enrollment capped|0|||
150124518|NCT00782340|541588963|FG000|Open Label Titration|Did not meet responder criteria|2|||
150124519|NCT00782340|541588964|FG001|Open Label Titration|Did not meet responder criteria|0|||
150124520|NCT00782340|541588965|FG002|Open Label Titration|Did not meet responder criteria|0|||
150124521|NCT00782340|541588963|FG000|Open Label Titration|Lost to Follow-up|5|||
150124522|NCT00782340|541588964|FG001|Open Label Titration|Lost to Follow-up|0|||
150124523|NCT00782340|541588965|FG002|Open Label Titration|Lost to Follow-up|0|||
150124524|NCT00782340|541588963|FG000|Open Label Titration|Randomized in error|6|||
150124525|NCT00782340|541588964|FG001|Open Label Titration|Randomized in error|0|||
150124526|NCT00782340|541588965|FG002|Open Label Titration|Randomized in error|0|||
150124527|NCT02952924|541588968|FG000|Overall Study|Protocol Violation|0|||
150124528|NCT02952924|541588969|FG001|Overall Study|Protocol Violation|0|||
150124529|NCT02952924|541588970|FG002|Overall Study|Protocol Violation|0|||
150124530|NCT02952924|541588971|FG003|Overall Study|Protocol Violation|0|||
150124531|NCT02952924|541588972|FG004|Overall Study|Protocol Violation|0|||
150124532|NCT02952924|541588973|FG005|Overall Study|Protocol Violation|0|||
150124533|NCT02952924|541588974|FG006|Overall Study|Protocol Violation|0|||
150124534|NCT02952924|541588975|FG007|Overall Study|Protocol Violation|0|||
150124535|NCT02952924|541588976|FG008|Overall Study|Protocol Violation|0|||
150124536|NCT02952924|541588977|FG009|Overall Study|Protocol Violation|0|||
150124537|NCT02952924|541588978|FG010|Overall Study|Protocol Violation|0|||
150124538|NCT02952924|541588979|FG011|Overall Study|Protocol Violation|0|||
150124539|NCT02952924|541588980|FG012|Overall Study|Protocol Violation|0|||
150124540|NCT02952924|541588981|FG013|Overall Study|Protocol Violation|0|||
150124541|NCT02952924|541588982|FG014|Overall Study|Protocol Violation|0|||
150124542|NCT02952924|541588983|FG015|Overall Study|Protocol Violation|0|||
150124543|NCT02952924|541588984|FG016|Overall Study|Protocol Violation|0|||
150124544|NCT02952924|541588985|FG017|Overall Study|Protocol Violation|0|||
150124545|NCT02952924|541588986|FG018|Overall Study|Protocol Violation|0|||
150124546|NCT02952924|541588987|FG019|Overall Study|Protocol Violation|1|||
150124547|NCT02952924|541588988|FG020|Overall Study|Protocol Violation|0|||
150124548|NCT02952924|541588989|FG021|Overall Study|Protocol Violation|0|||
150124549|NCT02952924|541588968|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
150124550|NCT02952924|541588969|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
150124551|NCT02952924|541588970|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
150124552|NCT02952924|541588971|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
150124553|NCT02952924|541588972|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
150124554|NCT02952924|541588973|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
150124555|NCT02952924|541588974|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
150124556|NCT02952924|541588975|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
150124557|NCT02952924|541588976|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
150124558|NCT02952924|541588977|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
150124559|NCT02952924|541588978|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
150124560|NCT02952924|541588979|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
150124561|NCT02952924|541588980|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
150124562|NCT02952924|541588981|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
150124563|NCT02952924|541588982|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
150124564|NCT02952924|541588983|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
150124565|NCT02952924|541588984|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
150124566|NCT02952924|541588985|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
150124567|NCT02952924|541588986|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
150124568|NCT02952924|541588987|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
150124569|NCT02952924|541588988|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
150124570|NCT02952924|541588989|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
150124571|NCT02952924|541588968|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124572|NCT02952924|541588969|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124573|NCT02952924|541588970|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124574|NCT02952924|541588971|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124575|NCT02952924|541588972|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124576|NCT02952924|541588973|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124577|NCT02952924|541588974|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124578|NCT02952924|541588975|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124579|NCT02952924|541588976|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124580|NCT02952924|541588977|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124581|NCT02952924|541588978|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124582|NCT02952924|541588979|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124583|NCT02952924|541588980|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124584|NCT02952924|541588981|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124585|NCT02952924|541588982|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124586|NCT02952924|541588983|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124587|NCT02952924|541588984|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124588|NCT02952924|541588985|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124589|NCT02952924|541588986|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124590|NCT02952924|541588987|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124591|NCT02952924|541588988|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
150124592|NCT02952924|541588989|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
150124593|NCT02952924|541588968|FG000|Overall Study|Noncompliance with study drug|0|||
150124594|NCT02952924|541588969|FG001|Overall Study|Noncompliance with study drug|0|||
150124595|NCT02952924|541588970|FG002|Overall Study|Noncompliance with study drug|0|||
150124596|NCT02952924|541588971|FG003|Overall Study|Noncompliance with study drug|0|||
150124597|NCT02952924|541588972|FG004|Overall Study|Noncompliance with study drug|0|||
150124598|NCT02952924|541588973|FG005|Overall Study|Noncompliance with study drug|0|||
150124599|NCT02952924|541588974|FG006|Overall Study|Noncompliance with study drug|0|||
150124600|NCT02952924|541588975|FG007|Overall Study|Noncompliance with study drug|0|||
150124601|NCT02952924|541588976|FG008|Overall Study|Noncompliance with study drug|0|||
150124602|NCT02952924|541588977|FG009|Overall Study|Noncompliance with study drug|0|||
150124603|NCT02952924|541588978|FG010|Overall Study|Noncompliance with study drug|0|||
150124604|NCT02952924|541588979|FG011|Overall Study|Noncompliance with study drug|0|||
150124605|NCT02952924|541588980|FG012|Overall Study|Noncompliance with study drug|0|||
150124606|NCT02952924|541588981|FG013|Overall Study|Noncompliance with study drug|0|||
150124607|NCT02952924|541588982|FG014|Overall Study|Noncompliance with study drug|0|||
150124608|NCT02952924|541588983|FG015|Overall Study|Noncompliance with study drug|0|||
150124609|NCT02952924|541588984|FG016|Overall Study|Noncompliance with study drug|0|||
150124610|NCT02952924|541588985|FG017|Overall Study|Noncompliance with study drug|0|||
150124611|NCT02952924|541588986|FG018|Overall Study|Noncompliance with study drug|0|||
150124612|NCT02952924|541588987|FG019|Overall Study|Noncompliance with study drug|0|||
150124613|NCT02952924|541588988|FG020|Overall Study|Noncompliance with study drug|0|||
150124614|NCT02952924|541588989|FG021|Overall Study|Noncompliance with study drug|1|||
150124615|NCT01226745|541588990|FG000|Overall Study|Did not complete schedule of assessments|8|||
150124616|NCT01226745|541588991|FG001|Overall Study|Did not complete schedule of assessments|3|||
150124617|NCT01226745|541588992|FG002|Overall Study|Did not complete schedule of assessments|6|||
150124618|NCT01226745|541588993|FG003|Overall Study|Did not complete schedule of assessments|0|||
150124619|NCT01226745|541588994|FG004|Overall Study|Did not complete schedule of assessments|0|||
150124620|NCT01226745|541588995|FG005|Overall Study|Did not complete schedule of assessments|1|||
150124621|NCT01226745|541588990|FG000|Overall Study|Lost to Follow-up|2|||
150124622|NCT01226745|541588991|FG001|Overall Study|Lost to Follow-up|6|||
150124623|NCT01226745|541588992|FG002|Overall Study|Lost to Follow-up|6|||
150124624|NCT01226745|541588993|FG003|Overall Study|Lost to Follow-up|1|||
150124625|NCT01226745|541588994|FG004|Overall Study|Lost to Follow-up|1|||
150124626|NCT01226745|541588995|FG005|Overall Study|Lost to Follow-up|2|||
150124627|NCT01226745|541588990|FG000|Overall Study|Death|1|||
150124628|NCT01226745|541588991|FG001|Overall Study|Death|0|||
150124629|NCT01226745|541588992|FG002|Overall Study|Death|0|||
150124630|NCT01226745|541588993|FG003|Overall Study|Death|0|||
150124631|NCT01226745|541588994|FG004|Overall Study|Death|0|||
150124632|NCT01226745|541588995|FG005|Overall Study|Death|1|||
150124633|NCT01226745|541588990|FG000|Overall Study|Other|6|||
150124634|NCT01226745|541588991|FG001|Overall Study|Other|7|||
150124635|NCT01226745|541588992|FG002|Overall Study|Other|8|||
150124636|NCT01226745|541588993|FG003|Overall Study|Other|4|||
150124637|NCT01226745|541588994|FG004|Overall Study|Other|3|||
150124638|NCT01226745|541588995|FG005|Overall Study|Other|1|||
150124639|NCT01435577|541588996|FG000|Overall Study|Adverse Event|10|||
150124640|NCT01435577|541588997|FG001|Overall Study|Adverse Event|0|||
150124641|NCT01435577|541588996|FG000|Overall Study|Lack of Efficacy|7|||
150124642|NCT01435577|541588997|FG001|Overall Study|Lack of Efficacy|51|||
150124643|NCT01435577|541588996|FG000|Overall Study|Alternative treatment started|0|||
150124644|NCT01435577|541588997|FG001|Overall Study|Alternative treatment started|1|||
150124645|NCT01458574|541588998|FG000|Overall Study|Adverse Event|5|||
150124646|NCT01458574|541588999|FG001|Overall Study|Adverse Event|9|||
150124647|NCT01458574|541589000|FG002|Overall Study|Adverse Event|7|||
150124648|NCT01458574|541588998|FG000|Overall Study|Lack of Efficacy|70|||
150124649|NCT01458574|541588999|FG001|Overall Study|Lack of Efficacy|53|||
150124650|NCT01458574|541589000|FG002|Overall Study|Lack of Efficacy|132|||
150124651|NCT01458574|541588998|FG000|Overall Study|Lost to Follow-up|3|||
150124652|NCT01458574|541588999|FG001|Overall Study|Lost to Follow-up|2|||
150124653|NCT01458574|541589000|FG002|Overall Study|Lost to Follow-up|1|||
150124654|NCT01458574|541588998|FG000|Overall Study|Pregnancy|1|||
150124655|NCT01458574|541588999|FG001|Overall Study|Pregnancy|1|||
150124656|NCT01458574|541589000|FG002|Overall Study|Pregnancy|0|||
150124657|NCT01458574|541588998|FG000|Overall Study|Protocol Violation|0|||
150124658|NCT01458574|541588999|FG001|Overall Study|Protocol Violation|1|||
150124659|NCT01458574|541589000|FG002|Overall Study|Protocol Violation|0|||
150124660|NCT01458574|541588998|FG000|Overall Study|Withdrawal by Subject|6|||
150124661|NCT01458574|541588999|FG001|Overall Study|Withdrawal by Subject|3|||
150124662|NCT01458574|541589000|FG002|Overall Study|Withdrawal by Subject|5|||
150124663|NCT01458574|541588998|FG000|Overall Study|Other|2|||
150124664|NCT01458574|541588999|FG001|Overall Study|Other|1|||
150124665|NCT01458574|541589000|FG002|Overall Study|Other|0|||
150124666|NCT01458574|541588998|FG000|Overall Study|Randomized but not treated|0|||
150124667|NCT01458574|541588999|FG001|Overall Study|Randomized but not treated|1|||
150124668|NCT01458574|541589000|FG002|Overall Study|Randomized but not treated|0|||
150124669|NCT02125786|541589001|FG000|Overall Study|Still in Follow-up|3|||
150124670|NCT02125786|541589001|FG000|Overall Study|Screen Failure|2|||
150124671|NCT02125786|541589001|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
150124672|NCT02125786|541589001|FG000|Overall Study|Progressive Disease|44|||
150124673|NCT02125786|541589001|FG000|Overall Study|Death|8|||
150124674|NCT04964089|541589004|FG000|Overall Study|Adverse Event|8|||
150124675|NCT04964089|541589005|FG001|Overall Study|Adverse Event|6|||
150124676|NCT04964089|541589004|FG000|Overall Study|Non-compliance with study schedule|1|||
150124677|NCT04964089|541589005|FG001|Overall Study|Non-compliance with study schedule|0|||
150124678|NCT04964089|541589004|FG000|Overall Study|Withdrawal by Subject|6|||
150124679|NCT04964089|541589005|FG001|Overall Study|Withdrawal by Subject|5|||
150124680|NCT04964089|541589004|FG000|Overall Study|Lost to Follow-up|1|||
150124681|NCT04964089|541589005|FG001|Overall Study|Lost to Follow-up|1|||
150124682|NCT04964089|541589004|FG000|Overall Study|Progressive disease|4|||
150124683|NCT04964089|541589005|FG001|Overall Study|Progressive disease|0|||
150193118|NCT02268253|541846691|FG005|Stage 3A|Withdrawal by Subject|0|||
150124684|NCT04964089|541589004|FG000|Overall Study|Physician Decision|1|||
150124685|NCT04964089|541589005|FG001|Overall Study|Physician Decision|0|||
150124686|NCT04964089|541589004|FG000|Overall Study|Participant did not want to continue study treatment|1|||
150124687|NCT04964089|541589005|FG001|Overall Study|Participant did not want to continue study treatment|0|||
150124688|NCT04964089|541589004|FG000|Overall Study|Participant moved to different state|1|||
150124689|NCT04964089|541589005|FG001|Overall Study|Participant moved to different state|0|||
150124690|NCT04964089|541589004|FG000|Overall Study|Participant decided to discontinue|0|||
150124691|NCT04964089|541589005|FG001|Overall Study|Participant decided to discontinue|1|||
150124692|NCT01365494|541589008|FG000|Overall Study|Adverse Event|1|||
150124693|NCT01365494|541589009|FG001|Overall Study|Adverse Event|0|||
150124694|NCT01365494|541589008|FG000|Overall Study|Withdrawal by Subject|0|||
150124695|NCT01365494|541589009|FG001|Overall Study|Withdrawal by Subject|1|||
150124696|NCT01365494|541589008|FG000|Overall Study|Lost to Follow-up|1|||
150124697|NCT01365494|541589009|FG001|Overall Study|Lost to Follow-up|2|||
150124698|NCT01664078|541589010|FG000|Overall Study|Death|9|||
150124699|NCT01664078|541589010|FG000|Overall Study|Withdrawal by Subject|4|||
150124700|NCT01664078|541589010|FG000|Overall Study|Lost to Follow-up|2|||
150124701|NCT01664078|541589010|FG000|Overall Study|missed 5 year visit|1|||
150124702|NCT01664078|541589010|FG000|Overall Study|Other|53|||
150124703|NCT03351049|541589011|FG000|Overall Study|Withdrawal|26|||
150124704|NCT03351049|541589012|FG001|Overall Study|Withdrawal|22|||
150124705|NCT02838017|541589019|FG000|Overall Study|Lost to Follow-up|14|||
150124706|NCT02838017|541589020|FG001|Overall Study|Lost to Follow-up|11|||
150124707|NCT05350449|541589021|FG000|Overall Study|Withdrawal by Subject|4|||
150124708|NCT05350449|541589022|FG001|Overall Study|Withdrawal by Subject|8|||
150124709|NCT03581305|541590747|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
150124710|NCT03581305|541590748|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
150124711|NCT03581305|541590747|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
150124712|NCT03581305|541590748|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
150124713|NCT03581305|541590747|FG000|Serotonergic Study|Withdrawal by Subject|5|||
150124714|NCT03581305|541590748|FG001|Serotonergic Study|Withdrawal by Subject|1|||
150124715|NCT01798927|541590749|FG000|Overall Study|Withdrawal by Subject|1|||
150124716|NCT03822533|541590755|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
150193119|NCT02268253|541846692|FG006|Stage 3A|Withdrawal by Subject|0|||
150193120|NCT02268253|541846686|FG000|Stage 3A|Physician Decision|0|||
150193121|NCT02268253|541846687|FG001|Stage 3A|Physician Decision|0|||
150193122|NCT02268253|541846688|FG002|Stage 3A|Physician Decision|2|||
150193123|NCT02268253|541846689|FG003|Stage 3A|Physician Decision|0|||
150193124|NCT02268253|541846690|FG004|Stage 3A|Physician Decision|0|||
150193125|NCT02268253|541846691|FG005|Stage 3A|Physician Decision|0|||
150193126|NCT02268253|541846692|FG006|Stage 3A|Physician Decision|0|||
150193127|NCT02268253|541846686|FG000|Stage 3A|Study Terminated by Sponsor|0|||
150193128|NCT02268253|541846687|FG001|Stage 3A|Study Terminated by Sponsor|0|||
150124717|NCT03822533|541590756|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
150124718|NCT03822533|541590755|FG000|3 Month Follow-up|Lost to Follow-up|2|||
150124719|NCT03822533|541590756|FG001|3 Month Follow-up|Lost to Follow-up|2|||
150124720|NCT03822533|541590755|FG000|6 Month Follow-up|Lost to Follow-up|3|||
150124721|NCT03822533|541590756|FG001|6 Month Follow-up|Lost to Follow-up|0|||
150124722|NCT03822533|541590755|FG000|12 Month Follow-up|Lost to Follow-up|2|||
150124723|NCT03822533|541590756|FG001|12 Month Follow-up|Lost to Follow-up|3|||
150124724|NCT03822533|541590755|FG000|12 Month Follow-up|Pregnancy|0|||
150124725|NCT03822533|541590756|FG001|12 Month Follow-up|Pregnancy|1|||
150124726|NCT03822533|541590755|FG000|12 Month Follow-up|Surgery|2|||
150124727|NCT03822533|541590756|FG001|12 Month Follow-up|Surgery|0|||
150124728|NCT03822533|541590755|FG000|12 Month Follow-up|Wrong address|1|||
150124729|NCT03822533|541590756|FG001|12 Month Follow-up|Wrong address|0|||
150124730|NCT03822533|541590755|FG000|12 Month Follow-up|No symptoms|1|||
150124731|NCT03822533|541590756|FG001|12 Month Follow-up|No symptoms|0|||
150124732|NCT03822533|541590755|FG000|12 Month Follow-up|Changed primary care center|0|||
150124733|NCT03822533|541590756|FG001|12 Month Follow-up|Changed primary care center|1|||
150124734|NCT02863926|541590757|FG000|Overall Study|Physician Decision|1|||
150124735|NCT02863926|541590758|FG001|Overall Study|Physician Decision|0|||
150124736|NCT02863926|541590757|FG000|Overall Study|Lost to Follow-up|1|||
150124737|NCT02863926|541590758|FG001|Overall Study|Lost to Follow-up|1|||
150124738|NCT02301143|541590761|FG000|Induction Period|Enrolled But Not Treated|1|||
150124739|NCT02301143|541590762|FG001|Induction Period|Enrolled But Not Treated|0|||
150124740|NCT02301143|541590761|FG000|Induction Period|Death|1|||
150124741|NCT02301143|541590762|FG001|Induction Period|Death|0|||
150124742|NCT02301143|541590761|FG000|Induction Period|Adverse Event|22|||
150124743|NCT02301143|541590762|FG001|Induction Period|Adverse Event|0|||
150124744|NCT02301143|541590761|FG000|Induction Period|Progressive Disease|8|||
150124745|NCT02301143|541590762|FG001|Induction Period|Progressive Disease|0|||
150124746|NCT02301143|541590761|FG000|Induction Period|Withdrawal by Subject|3|||
150124747|NCT02301143|541590762|FG001|Induction Period|Withdrawal by Subject|0|||
150124748|NCT02301143|541590761|FG000|Induction Period|Noncompliance with Study Drug|1|||
150124749|NCT02301143|541590762|FG001|Induction Period|Noncompliance with Study Drug|0|||
150124750|NCT02301143|541590761|FG000|Induction Period|Physician Decision|4|||
150124751|NCT02301143|541590762|FG001|Induction Period|Physician Decision|0|||
150124752|NCT02301143|541590761|FG000|Induction Period|Symptomatic Deterioration|2|||
150124753|NCT02301143|541590762|FG001|Induction Period|Symptomatic Deterioration|0|||
150124754|NCT02301143|541590761|FG000|Induction Period|Protocol Violation|2|||
150124755|NCT02301143|541590762|FG001|Induction Period|Protocol Violation|0|||
150124756|NCT02301143|541590761|FG000|Induction Period|Other|1|||
150124757|NCT02301143|541590762|FG001|Induction Period|Other|0|||
150124758|NCT02301143|541590761|FG000|Investigator's Choice|Adverse Event|0|||
150124759|NCT02301143|541590762|FG001|Investigator's Choice|Adverse Event|3|||
150124760|NCT02301143|541590761|FG000|Investigator's Choice|Progressive Disease|0|||
150124761|NCT02301143|541590762|FG001|Investigator's Choice|Progressive Disease|3|||
150124762|NCT02301143|541590761|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
150124763|NCT02301143|541590762|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
150124764|NCT02301143|541590761|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
150124765|NCT02301143|541590762|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
150124766|NCT02301143|541590761|FG000|Investigator's Choice|Other|0|||
150124767|NCT02301143|541590762|FG001|Investigator's Choice|Other|1|||
150124768|NCT02301143|541590761|FG000|Investigator's Choice|Unresectable Surgery|0|||
150124769|NCT02301143|541590762|FG001|Investigator's Choice|Unresectable Surgery|1|||
150124770|NCT03214367|541590763|FG000|Lead-in Period|Withdrawal by Subject|50|||
150124771|NCT03214367|541590764|FG001|Lead-in Period|Withdrawal by Subject|0|||
150124772|NCT03214367|541590765|FG002|Lead-in Period|Withdrawal by Subject|0|||
150124773|NCT03214367|541590766|FG003|Lead-in Period|Withdrawal by Subject|0|||
150124774|NCT03214367|541590767|FG004|Lead-in Period|Withdrawal by Subject|2|||
150124775|NCT03214367|541590768|FG005|Lead-in Period|Withdrawal by Subject|0|||
150124776|NCT03214367|541590769|FG006|Lead-in Period|Withdrawal by Subject|0|||
150124777|NCT03214367|541590770|FG007|Lead-in Period|Withdrawal by Subject|0|||
150124778|NCT03214367|541590763|FG000|Lead-in Period|Adverse Event|3|||
150124779|NCT03214367|541590764|FG001|Lead-in Period|Adverse Event|0|||
150124780|NCT03214367|541590765|FG002|Lead-in Period|Adverse Event|0|||
150124781|NCT03214367|541590766|FG003|Lead-in Period|Adverse Event|0|||
150124782|NCT03214367|541590767|FG004|Lead-in Period|Adverse Event|0|||
150124783|NCT03214367|541590768|FG005|Lead-in Period|Adverse Event|0|||
150124784|NCT03214367|541590769|FG006|Lead-in Period|Adverse Event|0|||
150124785|NCT03214367|541590770|FG007|Lead-in Period|Adverse Event|0|||
150124786|NCT03214367|541590763|FG000|Lead-in Period|Lost to Follow-up|12|||
150124787|NCT03214367|541590764|FG001|Lead-in Period|Lost to Follow-up|0|||
150193129|NCT02268253|541846688|FG002|Stage 3A|Study Terminated by Sponsor|2|||
150124788|NCT03214367|541590765|FG002|Lead-in Period|Lost to Follow-up|0|||
150124789|NCT03214367|541590766|FG003|Lead-in Period|Lost to Follow-up|0|||
150124790|NCT03214367|541590767|FG004|Lead-in Period|Lost to Follow-up|0|||
150124791|NCT03214367|541590768|FG005|Lead-in Period|Lost to Follow-up|0|||
150124792|NCT03214367|541590769|FG006|Lead-in Period|Lost to Follow-up|0|||
150124793|NCT03214367|541590770|FG007|Lead-in Period|Lost to Follow-up|0|||
150124794|NCT03214367|541590763|FG000|Lead-in Period|Sponsor Decision|11|||
150124795|NCT03214367|541590764|FG001|Lead-in Period|Sponsor Decision|0|||
150124796|NCT03214367|541590765|FG002|Lead-in Period|Sponsor Decision|0|||
150124797|NCT03214367|541590766|FG003|Lead-in Period|Sponsor Decision|0|||
150124798|NCT03214367|541590767|FG004|Lead-in Period|Sponsor Decision|0|||
150124799|NCT03214367|541590768|FG005|Lead-in Period|Sponsor Decision|0|||
150124800|NCT03214367|541590769|FG006|Lead-in Period|Sponsor Decision|0|||
150124801|NCT03214367|541590770|FG007|Lead-in Period|Sponsor Decision|0|||
150124802|NCT03214367|541590763|FG000|Lead-in Period|Physician Decision|12|||
150124803|NCT03214367|541590764|FG001|Lead-in Period|Physician Decision|0|||
150124804|NCT03214367|541590765|FG002|Lead-in Period|Physician Decision|0|||
150124805|NCT03214367|541590766|FG003|Lead-in Period|Physician Decision|0|||
150124806|NCT03214367|541590767|FG004|Lead-in Period|Physician Decision|0|||
150124807|NCT03214367|541590768|FG005|Lead-in Period|Physician Decision|0|||
150124808|NCT03214367|541590769|FG006|Lead-in Period|Physician Decision|0|||
150124809|NCT03214367|541590770|FG007|Lead-in Period|Physician Decision|0|||
150124810|NCT03214367|541590763|FG000|Lead-in Period|Protocol Violation|5|||
150124811|NCT03214367|541590764|FG001|Lead-in Period|Protocol Violation|0|||
150124812|NCT03214367|541590765|FG002|Lead-in Period|Protocol Violation|0|||
150124813|NCT03214367|541590766|FG003|Lead-in Period|Protocol Violation|0|||
150124814|NCT03214367|541590767|FG004|Lead-in Period|Protocol Violation|0|||
150124815|NCT03214367|541590768|FG005|Lead-in Period|Protocol Violation|0|||
150124816|NCT03214367|541590769|FG006|Lead-in Period|Protocol Violation|0|||
150124817|NCT03214367|541590770|FG007|Lead-in Period|Protocol Violation|0|||
150124818|NCT03214367|541590763|FG000|Lead-in Period|Treatment Interruption|1|||
150124819|NCT03214367|541590764|FG001|Lead-in Period|Treatment Interruption|0|||
150124820|NCT03214367|541590765|FG002|Lead-in Period|Treatment Interruption|0|||
150124821|NCT03214367|541590766|FG003|Lead-in Period|Treatment Interruption|0|||
150124822|NCT03214367|541590767|FG004|Lead-in Period|Treatment Interruption|0|||
150124823|NCT03214367|541590768|FG005|Lead-in Period|Treatment Interruption|0|||
150124824|NCT03214367|541590769|FG006|Lead-in Period|Treatment Interruption|0|||
150124825|NCT03214367|541590770|FG007|Lead-in Period|Treatment Interruption|0|||
150124826|NCT03214367|541590763|FG000|Treatment Period|Adverse Event|0|||
150124827|NCT03214367|541590764|FG001|Treatment Period|Adverse Event|1|||
150124828|NCT03214367|541590765|FG002|Treatment Period|Adverse Event|4|||
150124829|NCT03214367|541590766|FG003|Treatment Period|Adverse Event|2|||
150124830|NCT03214367|541590767|FG004|Treatment Period|Adverse Event|0|||
150124831|NCT03214367|541590768|FG005|Treatment Period|Adverse Event|0|||
150124832|NCT03214367|541590769|FG006|Treatment Period|Adverse Event|0|||
150124833|NCT03214367|541590770|FG007|Treatment Period|Adverse Event|0|||
150124834|NCT03214367|541590763|FG000|Treatment Period|Death|0|||
150124835|NCT03214367|541590764|FG001|Treatment Period|Death|1|||
150124836|NCT03214367|541590765|FG002|Treatment Period|Death|1|||
150124837|NCT03214367|541590766|FG003|Treatment Period|Death|1|||
150124838|NCT03214367|541590767|FG004|Treatment Period|Death|0|||
150124839|NCT03214367|541590768|FG005|Treatment Period|Death|0|||
150124840|NCT03214367|541590769|FG006|Treatment Period|Death|0|||
150124841|NCT03214367|541590770|FG007|Treatment Period|Death|0|||
150124842|NCT03214367|541590763|FG000|Treatment Period|Lost to Follow-up|0|||
150124843|NCT03214367|541590764|FG001|Treatment Period|Lost to Follow-up|5|||
150124844|NCT03214367|541590765|FG002|Treatment Period|Lost to Follow-up|3|||
150124845|NCT03214367|541590766|FG003|Treatment Period|Lost to Follow-up|2|||
150124846|NCT03214367|541590767|FG004|Treatment Period|Lost to Follow-up|0|||
150124847|NCT03214367|541590768|FG005|Treatment Period|Lost to Follow-up|2|||
150124848|NCT03214367|541590769|FG006|Treatment Period|Lost to Follow-up|1|||
150124849|NCT03214367|541590770|FG007|Treatment Period|Lost to Follow-up|0|||
150124850|NCT03214367|541590763|FG000|Treatment Period|Sponsor Decision|0|||
150124851|NCT03214367|541590764|FG001|Treatment Period|Sponsor Decision|3|||
150124852|NCT03214367|541590765|FG002|Treatment Period|Sponsor Decision|0|||
150124853|NCT03214367|541590766|FG003|Treatment Period|Sponsor Decision|0|||
150124854|NCT03214367|541590767|FG004|Treatment Period|Sponsor Decision|0|||
150124855|NCT03214367|541590768|FG005|Treatment Period|Sponsor Decision|0|||
150124856|NCT03214367|541590769|FG006|Treatment Period|Sponsor Decision|0|||
150124857|NCT03214367|541590770|FG007|Treatment Period|Sponsor Decision|0|||
150124858|NCT03214367|541590763|FG000|Treatment Period|Physician Decision|0|||
150124859|NCT03214367|541590764|FG001|Treatment Period|Physician Decision|1|||
150124860|NCT03214367|541590765|FG002|Treatment Period|Physician Decision|2|||
150124861|NCT03214367|541590766|FG003|Treatment Period|Physician Decision|0|||
150124862|NCT03214367|541590767|FG004|Treatment Period|Physician Decision|0|||
150124863|NCT03214367|541590768|FG005|Treatment Period|Physician Decision|0|||
150124864|NCT03214367|541590769|FG006|Treatment Period|Physician Decision|0|||
150124865|NCT03214367|541590770|FG007|Treatment Period|Physician Decision|0|||
150124866|NCT03214367|541590763|FG000|Treatment Period|Protocol Violation|0|||
150124867|NCT03214367|541590764|FG001|Treatment Period|Protocol Violation|3|||
150124868|NCT03214367|541590765|FG002|Treatment Period|Protocol Violation|0|||
150124869|NCT03214367|541590766|FG003|Treatment Period|Protocol Violation|0|||
150124870|NCT03214367|541590767|FG004|Treatment Period|Protocol Violation|0|||
150124871|NCT03214367|541590768|FG005|Treatment Period|Protocol Violation|0|||
150124872|NCT03214367|541590769|FG006|Treatment Period|Protocol Violation|0|||
150124873|NCT03214367|541590770|FG007|Treatment Period|Protocol Violation|0|||
150124874|NCT03214367|541590763|FG000|Treatment Period|Withdrawal by Subject|0|||
150124875|NCT03214367|541590764|FG001|Treatment Period|Withdrawal by Subject|20|||
150124876|NCT03214367|541590765|FG002|Treatment Period|Withdrawal by Subject|23|||
150124877|NCT03214367|541590766|FG003|Treatment Period|Withdrawal by Subject|14|||
150124878|NCT03214367|541590767|FG004|Treatment Period|Withdrawal by Subject|0|||
150124879|NCT03214367|541590768|FG005|Treatment Period|Withdrawal by Subject|1|||
150124880|NCT03214367|541590769|FG006|Treatment Period|Withdrawal by Subject|1|||
150124881|NCT03214367|541590770|FG007|Treatment Period|Withdrawal by Subject|1|||
150124882|NCT03555396|541590771|FG000|Overall Study|Death|3|||
150124883|NCT03555396|541590772|FG001|Overall Study|Death|1|||
150124884|NCT03555396|541590771|FG000|Overall Study|Lost to Follow-up|0|||
150124885|NCT03555396|541590772|FG001|Overall Study|Lost to Follow-up|2|||
150124886|NCT04726709|541590776|FG000|Overall Study|Withdrawal by Subject|2|||
150124887|NCT04726709|541590777|FG001|Overall Study|Withdrawal by Subject|2|||
150124888|NCT01286779|541590779|FG000|Overall Study|Withdrawal by Subject|9|||
150124889|NCT01286779|541590779|FG000|Overall Study|Protocol Violation|5|||
150124890|NCT01286779|541590779|FG000|Overall Study|Physician Decision|2|||
150124891|NCT01286779|541590779|FG000|Overall Study|Participant had scheduled surgery|1|||
150124892|NCT01286779|541590779|FG000|Overall Study|Participant moved to another country|1|||
150124893|NCT01286779|541590779|FG000|Overall Study|Discontinued by sponsor|1|||
150124894|NCT04827212|541590780|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
150124895|NCT04827212|541590781|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
150124896|NCT04827212|541590780|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
150124897|NCT04827212|541590781|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
150124898|NCT04360824|541590782|FG000|Overall Study|Withdrawal by Subject|2|||
150124899|NCT04360824|541590783|FG001|Overall Study|Withdrawal by Subject|1|||
150124900|NCT04360824|541590782|FG000|Overall Study|Did not receive assigned treatment|1|||
150124901|NCT04360824|541590783|FG001|Overall Study|Did not receive assigned treatment|3|||
150124902|NCT00304070|541590784|FG000|Overall Study|Death|0|||
150124903|NCT00304070|541590785|FG001|Overall Study|Death|0|||
150124904|NCT00304070|541590786|FG002|Overall Study|Death|3|||
150124905|NCT00304070|541590784|FG000|Overall Study|Lost to Follow-up|0|||
150124906|NCT00304070|541590785|FG001|Overall Study|Lost to Follow-up|0|||
150124907|NCT00304070|541590786|FG002|Overall Study|Lost to Follow-up|1|||
150124908|NCT00304070|541590784|FG000|Overall Study|Physician Decision|0|||
150124909|NCT00304070|541590785|FG001|Overall Study|Physician Decision|0|||
150124910|NCT00304070|541590786|FG002|Overall Study|Physician Decision|3|||
150124911|NCT00304070|541590784|FG000|Overall Study|Withdrawal by Subject|0|||
150124912|NCT00304070|541590785|FG001|Overall Study|Withdrawal by Subject|0|||
150124913|NCT00304070|541590786|FG002|Overall Study|Withdrawal by Subject|1|||
150124914|NCT00304070|541590784|FG000|Overall Study|Progressive Disease|3|||
150124915|NCT00304070|541590785|FG001|Overall Study|Progressive Disease|7|||
150124916|NCT00304070|541590786|FG002|Overall Study|Progressive Disease|4|||
150124917|NCT00320216|541590787|FG000|Overall Study|Adverse Event|0|||
150124918|NCT00320216|541590788|FG001|Overall Study|Adverse Event|6|||
150124919|NCT00320216|541590789|FG002|Overall Study|Adverse Event|0|||
150124920|NCT00320216|541590790|FG003|Overall Study|Adverse Event|2|||
150124921|NCT00320216|541590791|FG004|Overall Study|Adverse Event|2|||
150124922|NCT00320216|541590787|FG000|Overall Study|Lack of Efficacy|6|||
150124923|NCT00320216|541590788|FG001|Overall Study|Lack of Efficacy|2|||
150124924|NCT00320216|541590789|FG002|Overall Study|Lack of Efficacy|1|||
150124925|NCT00320216|541590790|FG003|Overall Study|Lack of Efficacy|0|||
150124926|NCT00320216|541590791|FG004|Overall Study|Lack of Efficacy|1|||
150124927|NCT00320216|541590787|FG000|Overall Study|Lost to Follow-up|3|||
150124928|NCT00320216|541590788|FG001|Overall Study|Lost to Follow-up|0|||
150124929|NCT00320216|541590789|FG002|Overall Study|Lost to Follow-up|0|||
150124930|NCT00320216|541590790|FG003|Overall Study|Lost to Follow-up|0|||
150124931|NCT00320216|541590791|FG004|Overall Study|Lost to Follow-up|0|||
150124932|NCT00320216|541590787|FG000|Overall Study|Other|7|||
150124933|NCT00320216|541590788|FG001|Overall Study|Other|2|||
150124934|NCT00320216|541590789|FG002|Overall Study|Other|5|||
150124935|NCT00320216|541590790|FG003|Overall Study|Other|1|||
150124936|NCT00320216|541590791|FG004|Overall Study|Other|3|||
150124937|NCT00377676|541590792|FG000|Overall Study|Adverse Event|498|||
150124938|NCT00377676|541590793|FG001|Overall Study|Adverse Event|107|||
150124939|NCT00377676|541590792|FG000|Overall Study|Protocol Violation|33|||
150124940|NCT00377676|541590793|FG001|Overall Study|Protocol Violation|27|||
150124941|NCT00377676|541590792|FG000|Overall Study|Death|5|||
150124942|NCT00377676|541590793|FG001|Overall Study|Death|2|||
150124943|NCT00377676|541590792|FG000|Overall Study|Withdrawal by Subject|187|||
150124944|NCT00377676|541590793|FG001|Overall Study|Withdrawal by Subject|72|||
150124945|NCT00377676|541590792|FG000|Overall Study|Lost to Follow-up|120|||
150124946|NCT00377676|541590793|FG001|Overall Study|Lost to Follow-up|56|||
150124947|NCT00377676|541590792|FG000|Overall Study|Other|118|||
150124948|NCT00377676|541590793|FG001|Overall Study|Other|58|||
150124949|NCT02528214|541590801|FG000|Overall Study|Protocol Violation|0|||
150124950|NCT02528214|541590802|FG001|Overall Study|Protocol Violation|1|||
150124951|NCT02528214|541590801|FG000|Overall Study|Adverse Event|0|||
150124952|NCT02528214|541590802|FG001|Overall Study|Adverse Event|1|||
150124953|NCT02528214|541590801|FG000|Overall Study|Other than specified above|0|||
150124954|NCT02528214|541590802|FG001|Overall Study|Other than specified above|1|||
150124955|NCT02384759|541590803|FG000|Overall Study|Patients not treated|3|||
150124956|NCT02384759|541590804|FG001|Overall Study|Patients not treated|2|||
150124957|NCT01605617|541590805|FG000|First Intervention|Adverse Event|0|||
150124958|NCT01605617|541590806|FG001|First Intervention|Adverse Event|1|||
150124959|NCT01605617|541590805|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
150124960|NCT01605617|541590806|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
150124961|NCT02014116|541590808|FG000|Overall Study|Progressive Disease|3|||
150124962|NCT02014116|541590809|FG001|Overall Study|Progressive Disease|4|||
150124963|NCT02014116|541590810|FG002|Overall Study|Progressive Disease|2|||
150124964|NCT02014116|541590811|FG003|Overall Study|Progressive Disease|6|||
150124965|NCT02014116|541590812|FG004|Overall Study|Progressive Disease|1|||
150124966|NCT02014116|541590813|FG005|Overall Study|Progressive Disease|13|||
150124967|NCT02014116|541590814|FG006|Overall Study|Progressive Disease|1|||
150124968|NCT02014116|541590815|FG007|Overall Study|Progressive Disease|3|||
150124969|NCT02014116|541590816|FG008|Overall Study|Progressive Disease|7|||
150124970|NCT02014116|541590808|FG000|Overall Study|Adverse Event|0|||
150124971|NCT02014116|541590809|FG001|Overall Study|Adverse Event|0|||
150124972|NCT02014116|541590810|FG002|Overall Study|Adverse Event|0|||
150124973|NCT02014116|541590811|FG003|Overall Study|Adverse Event|0|||
150124974|NCT02014116|541590812|FG004|Overall Study|Adverse Event|1|||
150124975|NCT02014116|541590813|FG005|Overall Study|Adverse Event|0|||
150124976|NCT02014116|541590814|FG006|Overall Study|Adverse Event|0|||
150124977|NCT02014116|541590815|FG007|Overall Study|Adverse Event|1|||
150124978|NCT02014116|541590816|FG008|Overall Study|Adverse Event|0|||
150124979|NCT02014116|541590808|FG000|Overall Study|Lost to Follow-up|0|||
150124980|NCT02014116|541590809|FG001|Overall Study|Lost to Follow-up|0|||
150124981|NCT02014116|541590810|FG002|Overall Study|Lost to Follow-up|0|||
150124982|NCT02014116|541590811|FG003|Overall Study|Lost to Follow-up|0|||
150124983|NCT02014116|541590812|FG004|Overall Study|Lost to Follow-up|0|||
150124984|NCT02014116|541590813|FG005|Overall Study|Lost to Follow-up|1|||
150124985|NCT02014116|541590814|FG006|Overall Study|Lost to Follow-up|0|||
150124986|NCT02014116|541590815|FG007|Overall Study|Lost to Follow-up|0|||
150124987|NCT02014116|541590816|FG008|Overall Study|Lost to Follow-up|1|||
150124988|NCT02014116|541590808|FG000|Overall Study|Death|0|||
150124989|NCT02014116|541590809|FG001|Overall Study|Death|0|||
150124990|NCT02014116|541590810|FG002|Overall Study|Death|0|||
150124991|NCT02014116|541590811|FG003|Overall Study|Death|0|||
150124992|NCT02014116|541590812|FG004|Overall Study|Death|0|||
150124993|NCT02014116|541590813|FG005|Overall Study|Death|0|||
150124994|NCT02014116|541590814|FG006|Overall Study|Death|0|||
150124995|NCT02014116|541590815|FG007|Overall Study|Death|1|||
150124996|NCT02014116|541590816|FG008|Overall Study|Death|1|||
150124997|NCT02014116|541590808|FG000|Overall Study|Withdrawal by Subject|0|||
150124998|NCT02014116|541590809|FG001|Overall Study|Withdrawal by Subject|0|||
150124999|NCT02014116|541590810|FG002|Overall Study|Withdrawal by Subject|1|||
150125000|NCT02014116|541590811|FG003|Overall Study|Withdrawal by Subject|1|||
150125001|NCT02014116|541590812|FG004|Overall Study|Withdrawal by Subject|0|||
150125002|NCT02014116|541590813|FG005|Overall Study|Withdrawal by Subject|1|||
150125003|NCT02014116|541590814|FG006|Overall Study|Withdrawal by Subject|0|||
150125004|NCT02014116|541590815|FG007|Overall Study|Withdrawal by Subject|0|||
150125005|NCT02014116|541590816|FG008|Overall Study|Withdrawal by Subject|0|||
150125006|NCT02014116|541590808|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
150125007|NCT02014116|541590809|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
150125008|NCT02014116|541590810|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
150125009|NCT02014116|541590811|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
150125010|NCT02014116|541590812|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
150125011|NCT02014116|541590813|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
150125012|NCT02014116|541590814|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
150125013|NCT02014116|541590815|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
150125014|NCT02014116|541590816|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
150125015|NCT02014116|541590808|FG000|Overall Study|Physician Decision|0|||
150125016|NCT02014116|541590809|FG001|Overall Study|Physician Decision|0|||
150125017|NCT02014116|541590810|FG002|Overall Study|Physician Decision|0|||
150125018|NCT02014116|541590811|FG003|Overall Study|Physician Decision|0|||
150125019|NCT02014116|541590812|FG004|Overall Study|Physician Decision|0|||
150125020|NCT02014116|541590813|FG005|Overall Study|Physician Decision|0|||
150125021|NCT02014116|541590814|FG006|Overall Study|Physician Decision|0|||
150125022|NCT02014116|541590815|FG007|Overall Study|Physician Decision|0|||
150125023|NCT02014116|541590816|FG008|Overall Study|Physician Decision|1|||
150125024|NCT00121238|541590817|FG000|Overall Study|disease progression before intervention|1|||
150125025|NCT00121238|541590817|FG000|Overall Study|Protocol Violation|2|||
150125026|NCT01540851|541590818|FG000|Overall Study|Lost to Follow-up|14|||
150125027|NCT01540851|541590819|FG001|Overall Study|Lost to Follow-up|15|||
150125028|NCT01540851|541590818|FG000|Overall Study|Withdrawal by Subject|7|||
150125029|NCT01540851|541590819|FG001|Overall Study|Withdrawal by Subject|3|||
150125030|NCT00325468|541590820|FG000|Overall Study|Adverse Event|1|||
150125031|NCT00325468|541590821|FG001|Overall Study|Adverse Event|1|||
150125032|NCT00325468|541590822|FG002|Overall Study|Adverse Event|0|||
150125033|NCT00325468|541590823|FG003|Overall Study|Adverse Event|5|||
150125034|NCT00325468|541590824|FG004|Overall Study|Adverse Event|1|||
150125035|NCT00325468|541590820|FG000|Overall Study|Death|2|||
150125036|NCT00325468|541590821|FG001|Overall Study|Death|0|||
150125037|NCT00325468|541590822|FG002|Overall Study|Death|2|||
150125038|NCT00325468|541590823|FG003|Overall Study|Death|4|||
150125039|NCT00325468|541590824|FG004|Overall Study|Death|0|||
150125040|NCT00325468|541590820|FG000|Overall Study|Lost to Follow-up|0|||
150125041|NCT00325468|541590821|FG001|Overall Study|Lost to Follow-up|0|||
150125042|NCT00325468|541590822|FG002|Overall Study|Lost to Follow-up|1|||
150125043|NCT00325468|541590823|FG003|Overall Study|Lost to Follow-up|2|||
150125044|NCT00325468|541590824|FG004|Overall Study|Lost to Follow-up|2|||
150125045|NCT00325468|541590820|FG000|Overall Study|Physician Decision|1|||
150125046|NCT00325468|541590821|FG001|Overall Study|Physician Decision|1|||
150125047|NCT00325468|541590822|FG002|Overall Study|Physician Decision|0|||
150125048|NCT00325468|541590823|FG003|Overall Study|Physician Decision|1|||
150125049|NCT00325468|541590824|FG004|Overall Study|Physician Decision|0|||
150125050|NCT00325468|541590820|FG000|Overall Study|Withdrawal by Subject|3|||
150125051|NCT00325468|541590821|FG001|Overall Study|Withdrawal by Subject|1|||
150125052|NCT00325468|541590822|FG002|Overall Study|Withdrawal by Subject|0|||
150125053|NCT00325468|541590823|FG003|Overall Study|Withdrawal by Subject|14|||
150125054|NCT00325468|541590824|FG004|Overall Study|Withdrawal by Subject|4|||
150125055|NCT00325468|541590820|FG000|Overall Study|site closure etc|4|||
150125056|NCT00325468|541590821|FG001|Overall Study|site closure etc|2|||
150125057|NCT00325468|541590822|FG002|Overall Study|site closure etc|1|||
150125058|NCT00325468|541590823|FG003|Overall Study|site closure etc|8|||
150125059|NCT00325468|541590824|FG004|Overall Study|site closure etc|1|||
150125060|NCT03593655|541590825|FG000|First Product Use Period|Withdrawal by Subject|1|||
150125061|NCT03593655|541590826|FG001|First Product Use Period|Withdrawal by Subject|1|||
150125062|NCT03593655|541590825|FG000|First Product Use Period|Lost to Follow-up|1|||
150125063|NCT03593655|541590826|FG001|First Product Use Period|Lost to Follow-up|3|||
150125064|NCT03593655|541590825|FG000|Second Product Use Period|Withdrawal by Subject|1|||
150193130|NCT02268253|541846689|FG003|Stage 3A|Study Terminated by Sponsor|0|||
150193131|NCT02268253|541846690|FG004|Stage 3A|Study Terminated by Sponsor|0|||
150193132|NCT02268253|541846691|FG005|Stage 3A|Study Terminated by Sponsor|0|||
150193133|NCT02268253|541846692|FG006|Stage 3A|Study Terminated by Sponsor|0|||
150193134|NCT02268253|541846686|FG000|Stage 3A|Lost to Follow-up|0|||
150193135|NCT02268253|541846687|FG001|Stage 3A|Lost to Follow-up|0|||
150193136|NCT02268253|541846688|FG002|Stage 3A|Lost to Follow-up|1|||
150193137|NCT02268253|541846689|FG003|Stage 3A|Lost to Follow-up|0|||
150193138|NCT02268253|541846690|FG004|Stage 3A|Lost to Follow-up|0|||
150193139|NCT02268253|541846691|FG005|Stage 3A|Lost to Follow-up|0|||
150193140|NCT02268253|541846692|FG006|Stage 3A|Lost to Follow-up|0|||
150193141|NCT02268253|541846686|FG000|Stage 3A|Death|0|||
150193142|NCT02268253|541846687|FG001|Stage 3A|Death|0|||
150193143|NCT02268253|541846688|FG002|Stage 3A|Death|5|||
150193144|NCT02268253|541846689|FG003|Stage 3A|Death|0|||
150193145|NCT02268253|541846690|FG004|Stage 3A|Death|0|||
150193146|NCT02268253|541846691|FG005|Stage 3A|Death|0|||
150193147|NCT02268253|541846692|FG006|Stage 3A|Death|0|||
150193148|NCT05714761|541846693|FG000|Overall Study|Lost to Follow-up|3|||
150193149|NCT05714761|541846693|FG000|Overall Study|Withdrawal by Subject|3|||
150193150|NCT05714761|541846693|FG000|Overall Study|unblinding of sensor data|1|||
150193151|NCT05714761|541846693|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
150193152|NCT05714761|541846693|FG000|Overall Study|did not return second CGM sensor|4|||
150193153|NCT02547233|541846696|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
150193154|NCT02547233|541846697|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
150193155|NCT02547233|541846696|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
150193156|NCT02547233|541846697|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
150193157|NCT02547233|541846696|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
150193158|NCT02547233|541846697|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
150193159|NCT02547233|541846696|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
150193160|NCT02547233|541846697|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
150193161|NCT02547233|541846696|FG000|12-month Follow-up|Withdrawal by Subject|10|||
150193162|NCT02547233|541846697|FG001|12-month Follow-up|Withdrawal by Subject|10|||
150193163|NCT02547233|541846696|FG000|12-month Follow-up|Lost to Follow-up|3|||
150193164|NCT02547233|541846697|FG001|12-month Follow-up|Lost to Follow-up|3|||
150193165|NCT02547233|541846696|FG000|12-month Follow-up|Lack of Efficacy|1|||
150193166|NCT02547233|541846697|FG001|12-month Follow-up|Lack of Efficacy|2|||
150193167|NCT02547233|541846696|FG000|12-month Follow-up|Protocol Violation|0|||
150193168|NCT02547233|541846697|FG001|12-month Follow-up|Protocol Violation|1|||
150193169|NCT02547233|541846696|FG000|12-month Follow-up|Other|0|||
150193170|NCT02547233|541846697|FG001|12-month Follow-up|Other|1|||
150193171|NCT06019559|541846699|FG000|Overall Study|Withdrawal by Subject|7|||
150193172|NCT06019559|541846700|FG001|Overall Study|Withdrawal by Subject|6|||
150193173|NCT06019559|541846701|FG002|Overall Study|Withdrawal by Subject|5|||
150193174|NCT06019559|541846699|FG000|Overall Study|Lost to Follow-up|2|||
150193175|NCT06019559|541846700|FG001|Overall Study|Lost to Follow-up|0|||
150193176|NCT06019559|541846701|FG002|Overall Study|Lost to Follow-up|3|||
150193177|NCT05949788|541846702|FG000|Overall Study|severe birth deformity|2|||
150193178|NCT05949788|541846703|FG001|Overall Study|severe birth deformity|7|||
150193179|NCT05949788|541846702|FG000|Overall Study|twin-twin transfusion syndrome|2|||
150193180|NCT05949788|541846703|FG001|Overall Study|twin-twin transfusion syndrome|7|||
150193181|NCT05949788|541846702|FG000|Overall Study|neonatal hemolytic disease|3|||
150193182|NCT05949788|541846703|FG001|Overall Study|neonatal hemolytic disease|8|||
150193183|NCT05949788|541846702|FG000|Overall Study|death within 14 days after birth|2|||
150193184|NCT05949788|541846703|FG001|Overall Study|death within 14 days after birth|6|||
150193185|NCT05949788|541846702|FG000|Overall Study|transfer to another hospital|2|||
150193186|NCT05949788|541846703|FG001|Overall Study|transfer to another hospital|6|||
150193187|NCT05213390|541846704|FG000|Overall Study|Withdrawal by Subject|2|||
150193188|NCT05213390|541846704|FG000|Overall Study|Lost to Follow-up|12|||
150193189|NCT05213390|541846704|FG000|Overall Study|Protocol Violation|9|||
150193190|NCT01824537|541846705|FG000|Overall Study|Lost to Follow-up|78|||
150193191|NCT01824537|541846706|FG001|Overall Study|Lost to Follow-up|87|||
150193192|NCT06215521|541846708|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
150193193|NCT06215521|541846709|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
150193194|NCT06215521|541846710|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
150193195|NCT06215521|541846711|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
150193196|NCT06215521|541846712|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
150193197|NCT06215521|541846713|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
150193198|NCT04096040|541846714|FG000|Overall Study|Protocol Violation|12|||
150193199|NCT04096040|541846714|FG000|Overall Study|Non-compliant site|4|||
150193200|NCT03603600|541846717|FG000|Overall Study|Withdrawal by Subject|5|||
150193201|NCT03603600|541846718|FG001|Overall Study|Withdrawal by Subject|7|||
150125065|NCT03593655|541590826|FG001|Second Product Use Period|Withdrawal by Subject|1|||
150125066|NCT03593655|541590825|FG000|Second Product Use Period|Lost to Follow-up|1|||
150125067|NCT03593655|541590826|FG001|Second Product Use Period|Lost to Follow-up|0|||
150125068|NCT03593655|541590825|FG000|Third Product Use Period|Lost to Follow-up|1|||
150125069|NCT03593655|541590826|FG001|Third Product Use Period|Lost to Follow-up|2|||
150125070|NCT03593655|541590825|FG000|Third Product Use Period|Physician Decision|0|||
150125071|NCT03593655|541590826|FG001|Third Product Use Period|Physician Decision|1|||
150125072|NCT03593655|541590825|FG000|Third Product Use Period|Withdrawal by Subject|0|||
150125073|NCT03593655|541590826|FG001|Third Product Use Period|Withdrawal by Subject|1|||
150125074|NCT03732209|541590827|FG000|Overall Study|Lost to Follow-up|4|||
150125075|NCT03732209|541590828|FG001|Overall Study|Lost to Follow-up|4|||
150125076|NCT03732209|541590827|FG000|Overall Study|Withdrawal by Subject|8|||
150125077|NCT03732209|541590828|FG001|Overall Study|Withdrawal by Subject|9|||
150125078|NCT00413413|541590831|FG000|Single-Blind|Adverse Event|0|||
150125079|NCT00413413|541590832|FG001|Single-Blind|Adverse Event|9|||
150125080|NCT00413413|541590833|FG002|Single-Blind|Adverse Event|0|||
150125081|NCT00413413|541590831|FG000|Single-Blind|Lack of Efficacy|0|||
150125082|NCT00413413|541590832|FG001|Single-Blind|Lack of Efficacy|5|||
150125083|NCT00413413|541590833|FG002|Single-Blind|Lack of Efficacy|0|||
150125084|NCT00413413|541590831|FG000|Single-Blind|Subject no longer requires study drug|0|||
150125085|NCT00413413|541590832|FG001|Single-Blind|Subject no longer requires study drug|151|||
150125086|NCT00413413|541590833|FG002|Single-Blind|Subject no longer requires study drug|0|||
150125087|NCT00413413|541590831|FG000|Single-Blind|Protocol Violation|0|||
150125088|NCT00413413|541590832|FG001|Single-Blind|Protocol Violation|16|||
150125089|NCT00413413|541590833|FG002|Single-Blind|Protocol Violation|0|||
150125090|NCT00413413|541590831|FG000|Single-Blind|Withdrawal by Subject|0|||
150125091|NCT00413413|541590832|FG001|Single-Blind|Withdrawal by Subject|27|||
150125092|NCT00413413|541590833|FG002|Single-Blind|Withdrawal by Subject|0|||
150125093|NCT00413413|541590831|FG000|Single-Blind|Lost to Follow-up|0|||
150125094|NCT00413413|541590832|FG001|Single-Blind|Lost to Follow-up|8|||
150125095|NCT00413413|541590833|FG002|Single-Blind|Lost to Follow-up|0|||
150125096|NCT00413413|541590831|FG000|Double-Blind|Adverse Event|6|||
150125097|NCT00413413|541590832|FG001|Double-Blind|Adverse Event|0|||
150125098|NCT00413413|541590833|FG002|Double-Blind|Adverse Event|5|||
150125099|NCT00413413|541590831|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
150125100|NCT00413413|541590832|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
150125101|NCT00413413|541590833|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
150125102|NCT00413413|541590831|FG000|Double-Blind|Protocol deviation|1|||
150125103|NCT00413413|541590832|FG001|Double-Blind|Protocol deviation|2|||
150125104|NCT00413413|541590833|FG002|Double-Blind|Protocol deviation|1|||
150125105|NCT00413413|541590831|FG000|Double-Blind|Subject withdrew consent|4|||
150125106|NCT00413413|541590832|FG001|Double-Blind|Subject withdrew consent|6|||
150125107|NCT00413413|541590833|FG002|Double-Blind|Subject withdrew consent|9|||
150125108|NCT00413413|541590831|FG000|Double-Blind|Lost to Follow-up|3|||
150125109|NCT00413413|541590832|FG001|Double-Blind|Lost to Follow-up|4|||
150125110|NCT00413413|541590833|FG002|Double-Blind|Lost to Follow-up|2|||
150125111|NCT00553267|541590842|FG000|Overall Study|Adverse Event|8|||
150125112|NCT00553267|541590843|FG001|Overall Study|Adverse Event|10|||
150125113|NCT00553267|541590844|FG002|Overall Study|Adverse Event|5|||
150125114|NCT00553267|541590842|FG000|Overall Study|Non compliant with protocol|3|||
150125115|NCT00553267|541590843|FG001|Overall Study|Non compliant with protocol|3|||
150125116|NCT00553267|541590844|FG002|Overall Study|Non compliant with protocol|2|||
150125117|NCT00553267|541590842|FG000|Overall Study|Lost to Follow-up|0|||
150125118|NCT00553267|541590843|FG001|Overall Study|Lost to Follow-up|0|||
150125119|NCT00553267|541590844|FG002|Overall Study|Lost to Follow-up|1|||
150125120|NCT00553267|541590842|FG000|Overall Study|Consent withdrawn|2|||
150125121|NCT00553267|541590843|FG001|Overall Study|Consent withdrawn|3|||
150125122|NCT00553267|541590844|FG002|Overall Study|Consent withdrawn|1|||
150125123|NCT00553267|541590842|FG000|Overall Study|Specified category|1|||
150125124|NCT00553267|541590843|FG001|Overall Study|Specified category|2|||
150125125|NCT00553267|541590844|FG002|Overall Study|Specified category|1|||
150125126|NCT04389840|541590845|FG000|Overall Study|Adverse Event|0|||
150125127|NCT04389840|541590846|FG001|Overall Study|Adverse Event|0|||
150125128|NCT04389840|541590847|FG002|Overall Study|Adverse Event|0|||
150125129|NCT04389840|541590848|FG003|Overall Study|Adverse Event|1|||
150125130|NCT04389840|541590849|FG004|Overall Study|Adverse Event|0|||
150125131|NCT04389840|541590850|FG005|Overall Study|Adverse Event|0|||
150125132|NCT04389840|541590845|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
150125133|NCT04389840|541590846|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
150125134|NCT04389840|541590847|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
150125135|NCT04389840|541590848|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
150193202|NCT03603600|541846717|FG000|Overall Study|Lost to Follow-up|2|||
150125136|NCT04389840|541590849|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
150125137|NCT04389840|541590850|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
150125138|NCT04389840|541590845|FG000|Overall Study|Death|0|||
150125139|NCT04389840|541590846|FG001|Overall Study|Death|1|||
150125140|NCT04389840|541590847|FG002|Overall Study|Death|0|||
150125141|NCT04389840|541590848|FG003|Overall Study|Death|0|||
150125142|NCT04389840|541590849|FG004|Overall Study|Death|0|||
150125143|NCT04389840|541590850|FG005|Overall Study|Death|0|||
150125144|NCT00096135|541590856|FG000|Overall Study|Physician Decision|20|||
150125145|NCT00096135|541590857|FG001|Overall Study|Physician Decision|4|||
150125146|NCT00096135|541590856|FG000|Overall Study|Refusal of further protocol therapy|4|||
150125147|NCT00096135|541590857|FG001|Overall Study|Refusal of further protocol therapy|1|||
150125148|NCT00096135|541590856|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
150125149|NCT00096135|541590857|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
150125150|NCT00096135|541590856|FG000|Overall Study|Other, specify|15|||
150125151|NCT00096135|541590857|FG001|Overall Study|Other, specify|3|||
150125152|NCT00096135|541590856|FG000|Overall Study|Ineligible|2|||
150125153|NCT00096135|541590857|FG001|Overall Study|Ineligible|0|||
150125154|NCT02365467|541590858|FG000|Overall Study|Death|3|||
150125155|NCT00709722|541590859|FG000|Overall Study|Adverse Event|1|||
150125156|NCT02043782|541590860|FG000|Period 1|Adverse Event|0|||
150125157|NCT02043782|541590861|FG001|Period 1|Adverse Event|0|||
150125158|NCT02043782|541590862|FG002|Period 1|Adverse Event|1|||
150125159|NCT02043782|541590863|FG003|Period 1|Adverse Event|0|||
150125160|NCT02043782|541590864|FG004|Period 1|Adverse Event|0|||
150125161|NCT02043782|541590865|FG005|Period 1|Adverse Event|0|||
150125162|NCT04667117|541590866|FG000|Investigational Period|Lost to Follow-up|0|||
150125163|NCT04667117|541590867|FG001|Investigational Period|Lost to Follow-up|0|||
150125164|NCT04667117|541590868|FG002|Investigational Period|Lost to Follow-up|1|||
150125165|NCT04667117|541590866|FG000|Investigational Period|Protocol Deviation|0|||
150125166|NCT04667117|541590867|FG001|Investigational Period|Protocol Deviation|1|||
150125167|NCT04667117|541590868|FG002|Investigational Period|Protocol Deviation|0|||
150125168|NCT04667117|541590866|FG000|Extension Period|Lost to Follow-up|1|||
150125169|NCT04667117|541590867|FG001|Extension Period|Lost to Follow-up|0|||
150125170|NCT04667117|541590868|FG002|Extension Period|Lost to Follow-up|0|||
150125171|NCT01306162|541590869|FG000|Period 1|Adverse Event|0|||
150125172|NCT01306162|541590870|FG001|Period 1|Adverse Event|0|||
150125173|NCT01306162|541590871|FG002|Period 1|Adverse Event|0|||
150125174|NCT01306162|541590872|FG003|Period 1|Adverse Event|1|||
150125175|NCT01306162|541590869|FG000|Washout 1|Non-compliance to protocol|0|||
150125176|NCT01306162|541590870|FG001|Washout 1|Non-compliance to protocol|1|||
150125177|NCT01306162|541590871|FG002|Washout 1|Non-compliance to protocol|0|||
150125178|NCT01306162|541590872|FG003|Washout 1|Non-compliance to protocol|0|||
150125179|NCT02232893|541590877|FG000|Overall Study|Withdrawal by Subject|4|||
150125180|NCT02232893|541590878|FG001|Overall Study|Withdrawal by Subject|1|||
150125181|NCT02232893|541590877|FG000|Overall Study|Adverse Event|0|||
150125182|NCT02232893|541590878|FG001|Overall Study|Adverse Event|1|||
150125183|NCT02232893|541590877|FG000|Overall Study|Sponsor request early termination|0|||
150125184|NCT02232893|541590878|FG001|Overall Study|Sponsor request early termination|1|||
150125185|NCT02232893|541590877|FG000|Overall Study|Developed exclusion criteria|0|||
150125186|NCT02232893|541590878|FG001|Overall Study|Developed exclusion criteria|1|||
150125187|NCT02232893|541590877|FG000|Overall Study|Other|0|||
150125188|NCT02232893|541590878|FG001|Overall Study|Other|3|||
150125189|NCT01090453|541590881|FG000|Overall Study|Withdrawal by Subject|1|||
150125190|NCT01090453|541590882|FG001|Overall Study|Withdrawal by Subject|2|||
150125191|NCT01090453|541590881|FG000|Overall Study|Lost to Follow-up|7|||
150125192|NCT01090453|541590882|FG001|Overall Study|Lost to Follow-up|7|||
150193203|NCT03603600|541846718|FG001|Overall Study|Lost to Follow-up|3|||
150193204|NCT03603600|541846717|FG000|Overall Study|Death|3|||
150193205|NCT03603600|541846718|FG001|Overall Study|Death|1|||
150193206|NCT03603600|541846717|FG000|Overall Study|Physician Decision|2|||
150193207|NCT03603600|541846718|FG001|Overall Study|Physician Decision|1|||
150193208|NCT03603600|541846717|FG000|Overall Study|Other reason|1|||
150193209|NCT03603600|541846718|FG001|Overall Study|Other reason|0|||
150193210|NCT04044768|541846719|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
150193211|NCT04044768|541846720|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
150193212|NCT03808818|541846725|FG000|Overall Study|Death|6|||
150193213|NCT03808818|541846726|FG001|Overall Study|Death|6|||
150193214|NCT03808818|541846725|FG000|Overall Study|Withdrawal by Subject|7|||
150193215|NCT03808818|541846726|FG001|Overall Study|Withdrawal by Subject|18|||
150125193|NCT01090453|541590881|FG000|Overall Study|Non serious AEs|1|||
150125194|NCT01090453|541590882|FG001|Overall Study|Non serious AEs|0|||
150125195|NCT01090453|541590881|FG000|Overall Study|Protocol Violation|2|||
150125196|NCT01090453|541590882|FG001|Overall Study|Protocol Violation|0|||
150193216|NCT03808818|541846725|FG000|Overall Study|Lost to Follow-up|31|||
150193217|NCT03808818|541846726|FG001|Overall Study|Lost to Follow-up|33|||
150193218|NCT03858634|541846727|FG000|Overall Study|Withdrawal by Subject|1|||
150125197|NCT01090453|541590881|FG000|Overall Study|Other|2|||
150125198|NCT01090453|541590882|FG001|Overall Study|Other|4|||
150125199|NCT01090453|541590881|FG000|Overall Study|Eligibility Criteria|0|||
150125200|NCT01090453|541590882|FG001|Overall Study|Eligibility Criteria|1|||
150125201|NCT03867734|541590884|FG000|Overall Study|Lost to Follow-up|2|||
150125202|NCT03832192|541590890|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
150125203|NCT03832192|541590891|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
150125204|NCT02663128|541590892|FG000|Period 2|Physician Decision|0|||
150125205|NCT02663128|541590893|FG001|Period 2|Physician Decision|0|||
150125206|NCT02663128|541590894|FG002|Period 2|Physician Decision|0|||
150125207|NCT02663128|541590895|FG003|Period 2|Physician Decision|0|||
150125208|NCT02663128|541590896|FG004|Period 2|Physician Decision|1|||
150125209|NCT02663128|541590897|FG005|Period 2|Physician Decision|0|||
150125210|NCT01663636|541590900|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
150125211|NCT01663636|541590901|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
150125212|NCT03832946|541590902|FG000|Overall Study|Adverse Event|3|||
150125213|NCT03832946|541590903|FG001|Overall Study|Adverse Event|1|||
150125214|NCT03832946|541590902|FG000|Overall Study|Lost to Follow-up|1|||
150125215|NCT03832946|541590903|FG001|Overall Study|Lost to Follow-up|0|||
150193219|NCT03858634|541846728|FG001|Overall Study|Withdrawal by Subject|0|||
150193220|NCT03858634|541846727|FG000|Overall Study|Adverse Event|1|||
150193221|NCT03858634|541846728|FG001|Overall Study|Adverse Event|0|||
150125216|NCT03832946|541590902|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
150125217|NCT03832946|541590903|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
150125218|NCT03832946|541590902|FG000|Overall Study|Lack of Efficacy|1|||
150125219|NCT03832946|541590903|FG001|Overall Study|Lack of Efficacy|0|||
150125220|NCT03832946|541590902|FG000|Overall Study|Withdrawal by Subject|12|||
150125221|NCT03832946|541590903|FG001|Overall Study|Withdrawal by Subject|9|||
150125222|NCT01692197|541590905|FG000|Overall Study|Failed Screening|3|||
150125223|NCT02120924|541590906|FG000|Overall Study|Lack of Efficacy|1|||
150125224|NCT02120924|541590907|FG001|Overall Study|Lack of Efficacy|2|||
150125225|NCT02120924|541590908|FG002|Overall Study|Lack of Efficacy|3|||
150125226|NCT02120924|541590906|FG000|Overall Study|Adverse Event|0|||
150125227|NCT02120924|541590907|FG001|Overall Study|Adverse Event|1|||
150125228|NCT02120924|541590908|FG002|Overall Study|Adverse Event|3|||
150125229|NCT02120924|541590906|FG000|Overall Study|Withdrawal by Subject|16|||
150125230|NCT02120924|541590907|FG001|Overall Study|Withdrawal by Subject|20|||
150125231|NCT02120924|541590908|FG002|Overall Study|Withdrawal by Subject|8|||
150125232|NCT02120924|541590906|FG000|Overall Study|Lost to Follow-up|14|||
150125233|NCT02120924|541590907|FG001|Overall Study|Lost to Follow-up|14|||
150125234|NCT02120924|541590908|FG002|Overall Study|Lost to Follow-up|11|||
150125235|NCT02120924|541590906|FG000|Overall Study|Pregnancy|2|||
150125236|NCT02120924|541590907|FG001|Overall Study|Pregnancy|0|||
150125237|NCT02120924|541590908|FG002|Overall Study|Pregnancy|0|||
150125238|NCT02120924|541590906|FG000|Overall Study|Protocol Violation|3|||
150125239|NCT02120924|541590907|FG001|Overall Study|Protocol Violation|7|||
150125240|NCT02120924|541590908|FG002|Overall Study|Protocol Violation|2|||
150125241|NCT02120924|541590906|FG000|Overall Study|Physician Decision|0|||
150125242|NCT02120924|541590907|FG001|Overall Study|Physician Decision|1|||
150125243|NCT02120924|541590908|FG002|Overall Study|Physician Decision|1|||
150125244|NCT02120924|541590906|FG000|Overall Study|Death|1|||
150125245|NCT02120924|541590907|FG001|Overall Study|Death|0|||
150125246|NCT02120924|541590908|FG002|Overall Study|Death|0|||
150125247|NCT02120924|541590906|FG000|Overall Study|Compliance with IP|5|||
150125248|NCT02120924|541590907|FG001|Overall Study|Compliance with IP|1|||
150125249|NCT02120924|541590908|FG002|Overall Study|Compliance with IP|1|||
150125250|NCT03588572|541590911|FG000|Visitation 1|Lack of Efficacy|1|||
150125251|NCT03588572|541590912|FG001|Visitation 1|Lack of Efficacy|1|||
150125252|NCT03588572|541590911|FG000|Visitation 2|Lost to Follow-up|1|||
150125253|NCT03588572|541590912|FG001|Visitation 2|Lost to Follow-up|1|||
150125254|NCT03588572|541590911|FG000|Visitation 2|Lack of Efficacy|0|||
150125255|NCT03588572|541590912|FG001|Visitation 2|Lack of Efficacy|1|||
150125256|NCT03588572|541590911|FG000|Visitation 2|Withdrawal by Subject|1|||
150125257|NCT03588572|541590912|FG001|Visitation 2|Withdrawal by Subject|0|||
150125258|NCT03588572|541590911|FG000|Visitation 3|Lost to Follow-up|1|||
150125259|NCT03588572|541590912|FG001|Visitation 3|Lost to Follow-up|1|||
150125260|NCT03588572|541590911|FG000|Visitation 3|Physician Decision|1|||
150125261|NCT03588572|541590912|FG001|Visitation 3|Physician Decision|1|||
150125262|NCT03588572|541590911|FG000|Visitation 3|Withdrawal by Subject|1|||
150125263|NCT03588572|541590912|FG001|Visitation 3|Withdrawal by Subject|0|||
150125264|NCT02730819|541590918|FG000|Overall Study|Lost to Follow-up|9|||
150125265|NCT02121847|541590919|FG000|Overall Study|Administrative Reasons|1|||
150125266|NCT02121847|541590919|FG000|Overall Study|Adverse Event|2|||
150125267|NCT02663817|541590920|FG000|Overall Study|Screen failure|2|||
150125268|NCT01410448|541590927|FG000|Overall Study|No conversion to everolimus|0|||
150125269|NCT01410448|541590928|FG001|Overall Study|No conversion to everolimus|24|||
150125270|NCT01410448|541590927|FG000|Overall Study|Graft loss|4|||
150125271|NCT01410448|541590928|FG001|Overall Study|Graft loss|1|||
150125272|NCT01410448|541590927|FG000|Overall Study|Administrative issues|2|||
150125273|NCT01410448|541590928|FG001|Overall Study|Administrative issues|1|||
150125274|NCT01410448|541590927|FG000|Overall Study|Lost to Follow-up|1|||
150125275|NCT01410448|541590928|FG001|Overall Study|Lost to Follow-up|0|||
150125276|NCT01410448|541590927|FG000|Overall Study|Withdrawal by Subject|3|||
150125277|NCT01410448|541590928|FG001|Overall Study|Withdrawal by Subject|2|||
150125278|NCT01410448|541590927|FG000|Overall Study|Protocol Violation|0|||
150125279|NCT01410448|541590928|FG001|Overall Study|Protocol Violation|4|||
150125280|NCT01410448|541590927|FG000|Overall Study|Death|2|||
150125281|NCT01410448|541590928|FG001|Overall Study|Death|3|||
150125282|NCT01308580|541590929|FG000|Overall Study|Lost to Follow-up|12|||
150125283|NCT01308580|541590930|FG001|Overall Study|Lost to Follow-up|7|||
150125284|NCT02535065|541590931|FG000|Overall Study|Death|13|||
150125285|NCT02535065|541590931|FG000|Overall Study|Lost to Follow-up|1|||
150125286|NCT02535065|541590931|FG000|Overall Study|Withdrawal by Subject|6|||
150125287|NCT03712917|541590932|FG000|Overall Study|Pregnancy|0|||
150125288|NCT03712917|541590933|FG001|Overall Study|Pregnancy|0|||
150125289|NCT03712917|541590934|FG002|Overall Study|Pregnancy|1|||
150125290|NCT03712917|541590932|FG000|Overall Study|Adverse Event|0|||
150125291|NCT03712917|541590933|FG001|Overall Study|Adverse Event|4|||
150125292|NCT03712917|541590934|FG002|Overall Study|Adverse Event|3|||
150125293|NCT03712917|541590932|FG000|Overall Study|Lost to Follow-up|9|||
150125294|NCT03712917|541590933|FG001|Overall Study|Lost to Follow-up|4|||
150125295|NCT03712917|541590934|FG002|Overall Study|Lost to Follow-up|5|||
150125296|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
150125297|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
150125298|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
150125299|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
150125300|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
150125301|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
150125302|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
150125303|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
150125304|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
150125305|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
150125306|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
150125307|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
150125308|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
150125309|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
150125310|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
150125311|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
150125312|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
150125313|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
150125314|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
150125315|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
150125316|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
150125317|NCT01781572|541590935|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
150125318|NCT01781572|541590936|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
150125319|NCT01781572|541590937|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
150125320|NCT01781572|541590935|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
150125321|NCT01781572|541590936|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
150125322|NCT01781572|541590937|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
150125323|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
150125324|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
150125325|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
150125326|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
150125327|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
150125328|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
150125329|NCT01781572|541590935|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
150125330|NCT01781572|541590936|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
150125331|NCT01781572|541590937|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
150125332|NCT01781572|541590935|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
150125333|NCT01781572|541590936|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
150125334|NCT01781572|541590937|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
150125335|NCT01781572|541590935|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
150125336|NCT01781572|541590936|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
150125337|NCT01781572|541590937|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
150125338|NCT01781572|541590935|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
150125339|NCT01781572|541590936|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
150125340|NCT01781572|541590937|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
150125341|NCT01781572|541590935|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
150125342|NCT01781572|541590936|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
150125343|NCT01781572|541590937|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
150125344|NCT01781572|541590935|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
150125345|NCT01781572|541590936|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
150125346|NCT01781572|541590937|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
150125347|NCT01781572|541590935|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
150125348|NCT01781572|541590936|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
150125349|NCT01781572|541590937|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
150125350|NCT01438541|541590938|FG000|Overall Study|Physician Decision|1|||
150125351|NCT01438541|541590938|FG000|Overall Study|Withdrawal by Subject|1|||
150125352|NCT01438541|541590938|FG000|Overall Study|discharge from the hospital|5|||
150125353|NCT02091167|541590939|FG000|Overall Study|Lost to Follow-up|0|||
150125354|NCT02091167|541590940|FG001|Overall Study|Lost to Follow-up|2|||
150125355|NCT00791765|541593174|FG000|Weeks 1 to 12|Adverse Event|0|||
150125356|NCT00791765|541593175|FG001|Weeks 1 to 12|Adverse Event|1|||
150125357|NCT00791765|541593174|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
150125358|NCT00791765|541593175|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
150125359|NCT00791765|541593174|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
150125360|NCT00791765|541593175|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
150125361|NCT00791765|541593174|FG000|Weeks 1 to 12|Physician Decision|1|||
150125362|NCT00791765|541593175|FG001|Weeks 1 to 12|Physician Decision|0|||
150125363|NCT00791765|541593174|FG000|Weeks 1 to 12|Disease progression|3|||
150125364|NCT00791765|541593175|FG001|Weeks 1 to 12|Disease progression|0|||
150125365|NCT00791765|541593174|FG000|Weeks 1 to 12|Ineligibility determined|0|||
150125366|NCT00791765|541593175|FG001|Weeks 1 to 12|Ineligibility determined|3|||
150125367|NCT00791765|541593174|FG000|Weeks 13 to 24|Protocol deviation|2|||
150125368|NCT00791765|541593175|FG001|Weeks 13 to 24|Protocol deviation|0|||
150125369|NCT00791765|541593174|FG000|Weeks 13 to 24|Adverse Event|0|||
150125370|NCT00791765|541593175|FG001|Weeks 13 to 24|Adverse Event|3|||
150125371|NCT00791765|541593174|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
150125372|NCT00791765|541593175|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
150125373|NCT00791765|541593174|FG000|Weeks 13 to 24|Disease progression|0|||
150125374|NCT00791765|541593175|FG001|Weeks 13 to 24|Disease progression|1|||
150125375|NCT00791765|541593174|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
150125376|NCT00791765|541593175|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
150125377|NCT00791765|541593174|FG000|Weeks 13 to 24|Other|0|||
150125378|NCT00791765|541593175|FG001|Weeks 13 to 24|Other|1|||
150125379|NCT00924287|541593177|FG000|Overall Study|Death|1|||
150125380|NCT01625897|541593184|FG000|Overall Study|Adverse Event|27|||
150125381|NCT01625897|541593185|FG001|Overall Study|Adverse Event|10|||
150125382|NCT01625897|541593184|FG000|Overall Study|Physician Decision|0|||
150125383|NCT01625897|541593185|FG001|Overall Study|Physician Decision|1|||
150125384|NCT01625897|541593184|FG000|Overall Study|Withdrawal by Subject|25|||
150125385|NCT01625897|541593185|FG001|Overall Study|Withdrawal by Subject|3|||
150125386|NCT00156065|541593186|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
150125387|NCT00156065|541593187|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
150125388|NCT00156065|541593188|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
150125389|NCT00156065|541593186|FG000|Overall Study|Adverse Event|8|||
150125390|NCT00156065|541593187|FG001|Overall Study|Adverse Event|11|||
150125391|NCT00156065|541593188|FG002|Overall Study|Adverse Event|4|||
150125392|NCT00156065|541593186|FG000|Overall Study|Lack of Efficacy|2|||
150125393|NCT00156065|541593187|FG001|Overall Study|Lack of Efficacy|9|||
150125394|NCT00156065|541593188|FG002|Overall Study|Lack of Efficacy|3|||
150125395|NCT00156065|541593186|FG000|Overall Study|Withdrawal by Subject|13|||
150125396|NCT00156065|541593187|FG001|Overall Study|Withdrawal by Subject|26|||
150125397|NCT00156065|541593188|FG002|Overall Study|Withdrawal by Subject|16|||
150125398|NCT00156065|541593186|FG000|Overall Study|Lost to Follow-up|5|||
150125399|NCT00156065|541593187|FG001|Overall Study|Lost to Follow-up|7|||
150125400|NCT00156065|541593188|FG002|Overall Study|Lost to Follow-up|1|||
150125401|NCT00156065|541593186|FG000|Overall Study|Other|2|||
150125402|NCT00156065|541593187|FG001|Overall Study|Other|9|||
150125403|NCT00156065|541593188|FG002|Overall Study|Other|3|||
150125404|NCT01432366|541593189|FG000|Overall Study|Non-Responder|7|||
150125405|NCT01432366|541593189|FG000|Overall Study|Adverse Event|8|||
150125406|NCT01432366|541593189|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
150125407|NCT01432366|541593189|FG000|Overall Study|Pregnancy|1|||
150125408|NCT01432366|541593189|FG000|Overall Study|Lost to Follow-up|13|||
150125409|NCT01432366|541593189|FG000|Overall Study|Lack of Efficacy|1|||
150125410|NCT01432366|541593189|FG000|Overall Study|Site Closed|20|||
150125411|NCT01432366|541593189|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
150125412|NCT01432366|541593189|FG000|Overall Study|Other|14|||
150125413|NCT02891187|541593190|FG000|Overall Study|Lost to Follow-up|1|||
150125414|NCT02891187|541593191|FG001|Overall Study|Lost to Follow-up|2|||
150125415|NCT04546581|541593192|FG000|Overall Study|Adverse Event|9|||
150125416|NCT04546581|541593193|FG001|Overall Study|Adverse Event|3|||
150125417|NCT04546581|541593192|FG000|Overall Study|Physician Decision|0|||
150125418|NCT04546581|541593193|FG001|Overall Study|Physician Decision|1|||
150125419|NCT04546581|541593192|FG000|Overall Study|Protocol Violation|1|||
150125420|NCT04546581|541593193|FG001|Overall Study|Protocol Violation|2|||
150125421|NCT04546581|541593192|FG000|Overall Study|Withdrawal by Subject|3|||
150125422|NCT04546581|541593193|FG001|Overall Study|Withdrawal by Subject|7|||
150125423|NCT02526693|541593194|FG000|Overall Study|Physician Decision|3|||
150125424|NCT02526693|541593195|FG001|Overall Study|Physician Decision|1|||
150125425|NCT01275625|541593196|FG000|Overall Study|Death|1|||
150125426|NCT01275625|541593196|FG000|Overall Study|Lack of Efficacy|2|||
150125427|NCT01275625|541593196|FG000|Overall Study|Lost to Follow-up|1|||
150125428|NCT01275625|541593196|FG000|Overall Study|Withdrawal by Subject|3|||
150125429|NCT01275625|541593196|FG000|Overall Study|Protocol Violation|1|||
150125430|NCT01275625|541593196|FG000|Overall Study|Adverse Event|4|||
150125431|NCT01275625|541593196|FG000|Overall Study|Other|1|||
150125432|NCT01585103|541593198|FG000|Overall Study|Unable to swallow Cytosponge|6|||
150125433|NCT01349569|541593199|FG000|Overall Study|Lack of Efficacy|4|||
150125434|NCT00328510|541593203|FG000|Overall Study|Gag disorder, could not use frame|4|||
150125435|NCT00328510|541593204|FG001|Overall Study|Gag disorder, could not use frame|0|||
150125436|NCT00328510|541593203|FG000|Overall Study|Dentition problems, could not use frame|1|||
150193222|NCT03858634|541846727|FG000|Overall Study|Lost to Follow-up|0|||
150193223|NCT03858634|541846728|FG001|Overall Study|Lost to Follow-up|1|||
150193224|NCT03858634|541846727|FG000|Overall Study|Other, Not Specified|1|||
150193225|NCT03858634|541846728|FG001|Overall Study|Other, Not Specified|1|||
150193226|NCT05415722|541846729|FG000|Overall Study|Lost to Follow-up|0|||
150193227|NCT05415722|541846730|FG001|Overall Study|Lost to Follow-up|2|||
150193228|NCT05415722|541846731|FG002|Overall Study|Lost to Follow-up|0|||
150193229|NCT05415722|541846732|FG003|Overall Study|Lost to Follow-up|1|||
150193230|NCT05415722|541846733|FG004|Overall Study|Lost to Follow-up|0|||
150193231|NCT05415722|541846734|FG005|Overall Study|Lost to Follow-up|0|||
150193232|NCT05415722|541846735|FG006|Overall Study|Lost to Follow-up|1|||
150193233|NCT05415722|541846729|FG000|Overall Study|Physician Decision|0|||
150193234|NCT05415722|541846730|FG001|Overall Study|Physician Decision|0|||
150193235|NCT05415722|541846731|FG002|Overall Study|Physician Decision|0|||
150193236|NCT05415722|541846732|FG003|Overall Study|Physician Decision|1|||
150193237|NCT05415722|541846733|FG004|Overall Study|Physician Decision|0|||
150193238|NCT05415722|541846734|FG005|Overall Study|Physician Decision|0|||
150193239|NCT05415722|541846735|FG006|Overall Study|Physician Decision|1|||
150193240|NCT05415722|541846729|FG000|Overall Study|Protocol Violation|0|||
150193241|NCT05415722|541846730|FG001|Overall Study|Protocol Violation|0|||
150193242|NCT05415722|541846731|FG002|Overall Study|Protocol Violation|0|||
150193243|NCT05415722|541846732|FG003|Overall Study|Protocol Violation|1|||
150193244|NCT05415722|541846733|FG004|Overall Study|Protocol Violation|0|||
150193245|NCT05415722|541846734|FG005|Overall Study|Protocol Violation|0|||
150193246|NCT05415722|541846735|FG006|Overall Study|Protocol Violation|0|||
150193247|NCT05415722|541846729|FG000|Overall Study|Sponsor Discretion|0|||
150193248|NCT05415722|541846730|FG001|Overall Study|Sponsor Discretion|0|||
150193249|NCT05415722|541846731|FG002|Overall Study|Sponsor Discretion|0|||
150193250|NCT05415722|541846732|FG003|Overall Study|Sponsor Discretion|0|||
150193251|NCT05415722|541846733|FG004|Overall Study|Sponsor Discretion|1|||
150193252|NCT05415722|541846734|FG005|Overall Study|Sponsor Discretion|1|||
150193253|NCT05415722|541846735|FG006|Overall Study|Sponsor Discretion|0|||
150193254|NCT05415722|541846729|FG000|Overall Study|Withdrawal by Subject|0|||
150193255|NCT05415722|541846730|FG001|Overall Study|Withdrawal by Subject|1|||
150125437|NCT00328510|541593204|FG001|Overall Study|Dentition problems, could not use frame|0|||
150125438|NCT00328510|541593203|FG000|Overall Study|Withdrawal by Subject|4|||
150125439|NCT00328510|541593204|FG001|Overall Study|Withdrawal by Subject|2|||
150125440|NCT00328510|541593203|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
150125441|NCT00328510|541593204|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
150125442|NCT00328510|541593203|FG000|Overall Study|Treatment changed to a single fraction|1|||
150125443|NCT00328510|541593204|FG001|Overall Study|Treatment changed to a single fraction|1|||
150125444|NCT01412944|541593205|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
150125445|NCT01412944|541593206|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
150125446|NCT01412944|541593207|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
150125447|NCT01412944|541593208|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
150125448|NCT01412944|541593209|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
150125449|NCT01412944|541593210|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
150125450|NCT01412944|541593205|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
150125451|NCT01412944|541593206|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
150125452|NCT01412944|541593207|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
150125453|NCT01412944|541593208|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
150125454|NCT01412944|541593209|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
150125455|NCT01412944|541593210|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
150193256|NCT05415722|541846731|FG002|Overall Study|Withdrawal by Subject|0|||
150193257|NCT05415722|541846732|FG003|Overall Study|Withdrawal by Subject|1|||
150125456|NCT01412944|541593205|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
150125457|NCT01412944|541593206|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
150125458|NCT01412944|541593207|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
150125459|NCT01412944|541593208|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
150125460|NCT01412944|541593209|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
150193258|NCT05415722|541846733|FG004|Overall Study|Withdrawal by Subject|1|||
150193259|NCT05415722|541846734|FG005|Overall Study|Withdrawal by Subject|0|||
150193260|NCT05415722|541846735|FG006|Overall Study|Withdrawal by Subject|1|||
150193261|NCT02683447|541846740|FG000|Overall Study|Lost to Follow-up|2|||
150193262|NCT04542317|541846744|FG000|Overall Study|Care recipients passed away|18|||
150193263|NCT04542317|541846745|FG001|Overall Study|Care recipients passed away|13|||
150193264|NCT04542317|541846744|FG000|Overall Study|No longer a primary caregiver|5|||
150193265|NCT04542317|541846745|FG001|Overall Study|No longer a primary caregiver|1|||
150193266|NCT04542317|541846744|FG000|Overall Study|Withdrawal by Subject|4|||
150125461|NCT01412944|541593210|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
150125462|NCT01412944|541593205|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
150125463|NCT01412944|541593206|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
150125464|NCT01412944|541593207|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
150125465|NCT01412944|541593208|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
150125466|NCT01412944|541593209|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
150125467|NCT01412944|541593210|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
150125468|NCT01412944|541593205|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
150125469|NCT01412944|541593206|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
150125470|NCT01412944|541593207|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
150125471|NCT01412944|541593208|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
150125472|NCT01412944|541593209|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
150125473|NCT01412944|541593210|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
150125474|NCT01412944|541593205|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
150125475|NCT01412944|541593206|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
150125476|NCT01412944|541593207|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
150125477|NCT01412944|541593208|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
150125478|NCT01412944|541593209|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
150125479|NCT01412944|541593210|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
150125480|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125481|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125482|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
150125483|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
150125484|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
150125485|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125486|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Adverse Event|0|||
150125487|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Adverse Event|0|||
150125488|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Adverse Event|0|||
150125489|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Adverse Event|0|||
150125490|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Adverse Event|1|||
150125491|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Adverse Event|0|||
150125492|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
150125493|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
150125494|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
150125495|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
150125496|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
150125497|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
150125498|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125499|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125500|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125501|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125502|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125503|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
150125504|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125505|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125506|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125507|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125508|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
150125509|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125510|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
150125511|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
150125512|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125513|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125514|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125515|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
150125516|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
150125517|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
150125518|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
150125519|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
150125520|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
150125521|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
150125522|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125523|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
150125524|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125525|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125526|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
150193267|NCT04542317|541846745|FG001|Overall Study|Withdrawal by Subject|2|||
150125527|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
150125528|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125529|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
150125530|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
150193268|NCT04542317|541846744|FG000|Overall Study|Caregivers passed away|0|||
150125531|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125532|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125533|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
150125534|NCT01412944|541593205|FG000|Entire: IV + Maintenance|Adverse Event|0|||
150125535|NCT01412944|541593206|FG001|Entire: IV + Maintenance|Adverse Event|1|||
150125536|NCT01412944|541593207|FG002|Entire: IV + Maintenance|Adverse Event|0|||
150125537|NCT01412944|541593208|FG003|Entire: IV + Maintenance|Adverse Event|0|||
150125538|NCT01412944|541593209|FG004|Entire: IV + Maintenance|Adverse Event|0|||
150125539|NCT01412944|541593210|FG005|Entire: IV + Maintenance|Adverse Event|0|||
150125540|NCT01990950|541593211|FG000|Overall Study|Death|3|||
150125541|NCT01990950|541593211|FG000|Overall Study|Lost to Follow-up|2|||
150125542|NCT01990950|541593211|FG000|Overall Study|Withdrawal by Subject|6|||
150125543|NCT03508843|541593213|FG000|Overall Study|Withdrawal by Subject|1|||
150125544|NCT03508843|541593213|FG000|Overall Study|technical difficulties|2|||
150125545|NCT02536508|541593214|FG000|Overall Study|Withdrawal by Subject|18|||
150125546|NCT02536508|541593215|FG001|Overall Study|Withdrawal by Subject|13|||
150125547|NCT02536508|541593216|FG002|Overall Study|Withdrawal by Subject|7|||
150125548|NCT02536508|541593214|FG000|Overall Study|Adverse Event|14|||
150125549|NCT02536508|541593215|FG001|Overall Study|Adverse Event|13|||
150125550|NCT02536508|541593216|FG002|Overall Study|Adverse Event|6|||
150125551|NCT02536508|541593214|FG000|Overall Study|Lost to Follow-up|12|||
150125552|NCT02536508|541593215|FG001|Overall Study|Lost to Follow-up|4|||
150125553|NCT02536508|541593216|FG002|Overall Study|Lost to Follow-up|0|||
150125554|NCT02536508|541593214|FG000|Overall Study|Lack of Efficacy|3|||
150125555|NCT02536508|541593215|FG001|Overall Study|Lack of Efficacy|5|||
150125556|NCT02536508|541593216|FG002|Overall Study|Lack of Efficacy|4|||
150125557|NCT02536508|541593214|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
150125558|NCT02536508|541593215|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
150125559|NCT02536508|541593216|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
150125560|NCT02536508|541593214|FG000|Overall Study|Physician Decision|0|||
150125561|NCT02536508|541593215|FG001|Overall Study|Physician Decision|4|||
150125562|NCT02536508|541593216|FG002|Overall Study|Physician Decision|2|||
150125563|NCT02536508|541593214|FG000|Overall Study|Major Protocol Deviation|2|||
150125564|NCT02536508|541593215|FG001|Overall Study|Major Protocol Deviation|2|||
150125565|NCT02536508|541593216|FG002|Overall Study|Major Protocol Deviation|2|||
150125566|NCT02536508|541593214|FG000|Overall Study|Administrative Reasons|0|||
150125567|NCT02536508|541593215|FG001|Overall Study|Administrative Reasons|1|||
150125568|NCT02536508|541593216|FG002|Overall Study|Administrative Reasons|0|||
150125569|NCT03073603|541593218|FG000|Overall Study|Noncompliance|3|||
150125570|NCT03073603|541593219|FG001|Overall Study|Noncompliance|1|||
150125571|NCT03073603|541593218|FG000|Overall Study|Adverse Event|5|||
150125572|NCT03073603|541593219|FG001|Overall Study|Adverse Event|3|||
150125573|NCT03073603|541593218|FG000|Overall Study|Physician Decision|1|||
150125574|NCT03073603|541593219|FG001|Overall Study|Physician Decision|2|||
150125575|NCT03073603|541593218|FG000|Overall Study|Required treatment not allowed by protocol|1|||
150125576|NCT03073603|541593219|FG001|Overall Study|Required treatment not allowed by protocol|0|||
150125577|NCT03073603|541593218|FG000|Overall Study|Financial or insurance-related|8|||
150125578|NCT03073603|541593219|FG001|Overall Study|Financial or insurance-related|0|||
150125579|NCT03073603|541593218|FG000|Overall Study|Withdrawal by Subject|0|||
150125580|NCT03073603|541593219|FG001|Overall Study|Withdrawal by Subject|1|||
150125581|NCT03073603|541593218|FG000|Overall Study|Discontinued DMT|4|||
150125582|NCT03073603|541593219|FG001|Overall Study|Discontinued DMT|0|||
150125583|NCT03073603|541593218|FG000|Overall Study|Restarted DMT|0|||
150125584|NCT03073603|541593219|FG001|Overall Study|Restarted DMT|1|||
150125585|NCT00823719|541593222|FG000|Overall Study|Adverse Event|1|||
150125586|NCT00823719|541593223|FG001|Overall Study|Adverse Event|2|||
150125587|NCT00823719|541593222|FG000|Overall Study|Physician Decision|1|||
150125588|NCT00823719|541593223|FG001|Overall Study|Physician Decision|4|||
150125589|NCT00823719|541593222|FG000|Overall Study|Withdrawal by Subject|0|||
150125590|NCT00823719|541593223|FG001|Overall Study|Withdrawal by Subject|1|||
150125591|NCT00823719|541593222|FG000|Overall Study|Disease Progression|4|||
150125592|NCT00823719|541593223|FG001|Overall Study|Disease Progression|4|||
150125593|NCT04757649|541593225|FG000|Overall Study|Withdrawal by Subject|1|||
150125594|NCT04757649|541593225|FG000|Overall Study|Adverse Event|1|||
150125595|NCT02862106|541593232|FG000|Overall Study|Adverse Event|4|||
150125596|NCT02862106|541593233|FG001|Overall Study|Adverse Event|0|||
150125597|NCT02862106|541593232|FG000|Overall Study|Protocol Violation|16|||
150125598|NCT02862106|541593233|FG001|Overall Study|Protocol Violation|1|||
150125599|NCT02862106|541593232|FG000|Overall Study|Lost to Follow-up|15|||
150125600|NCT02862106|541593233|FG001|Overall Study|Lost to Follow-up|5|||
150125601|NCT02862106|541593232|FG000|Overall Study|Withdrawal by Subject|2|||
150125602|NCT02862106|541593233|FG001|Overall Study|Withdrawal by Subject|0|||
150125603|NCT02862106|541593232|FG000|Overall Study|Subjects moved to other city|1|||
150125604|NCT02862106|541593233|FG001|Overall Study|Subjects moved to other city|0|||
150125605|NCT04969250|541593238|FG000|Overall Study|Protocol Violation|0|||
150125606|NCT04969250|541593239|FG001|Overall Study|Protocol Violation|2|||
150125607|NCT04969250|541593240|FG002|Overall Study|Protocol Violation|3|||
150125608|NCT04969250|541593241|FG003|Overall Study|Protocol Violation|8|||
150125609|NCT04969250|541593238|FG000|Overall Study|Withdrawal by Subject|0|||
150125610|NCT04969250|541593239|FG001|Overall Study|Withdrawal by Subject|1|||
150125611|NCT04969250|541593240|FG002|Overall Study|Withdrawal by Subject|0|||
150125612|NCT04969250|541593241|FG003|Overall Study|Withdrawal by Subject|0|||
150125613|NCT03305016|541593242|FG000|Overall Study|Withdrawal by Subject|2|||
150125614|NCT00563784|541593243|FG000|Overall Study|Withdrawal by Subject|2|||
150125615|NCT00563784|541593243|FG000|Overall Study|Screen Failures|20|||
150125616|NCT02119416|541593244|FG000|Overall Study|Protocol Violation|1|||
150125617|NCT02119416|541593245|FG001|Overall Study|Protocol Violation|1|||
150125618|NCT02119416|541593246|FG002|Overall Study|Protocol Violation|1|||
150125619|NCT02119416|541593244|FG000|Overall Study|wrong pubertal stage|1|||
150125620|NCT02119416|541593245|FG001|Overall Study|wrong pubertal stage|0|||
150125621|NCT02119416|541593246|FG002|Overall Study|wrong pubertal stage|1|||
150125622|NCT02278328|541593247|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
150125623|NCT02278328|541593248|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
150125624|NCT02278328|541593249|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
150125625|NCT02278328|541593247|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
150125626|NCT02278328|541593248|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
150125627|NCT02278328|541593249|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
150125628|NCT02278328|541593247|FG000|Neuropsych Screening|incomplete consent|0|||
150125629|NCT02278328|541593248|FG001|Neuropsych Screening|incomplete consent|0|||
150125630|NCT02278328|541593249|FG002|Neuropsych Screening|incomplete consent|2|||
150125631|NCT03834779|541593250|FG000|Overall Study|Death|1|||
150125632|NCT03834779|541593251|FG001|Overall Study|Death|2|||
150125633|NCT03834779|541593250|FG000|Overall Study|Lost to Follow-up|6|||
150125634|NCT03834779|541593251|FG001|Overall Study|Lost to Follow-up|4|||
150125635|NCT03043664|541593256|FG000|Overall Study|Lost to Follow-up|1|||
150125636|NCT00093145|541593257|FG000|Overall Study|Unacceptable Toxicity Only|2|||
150125637|NCT00093145|541593257|FG000|Overall Study|Physician Decision|5|||
150125638|NCT00093145|541593257|FG000|Overall Study|Withdrawal by Subject|9|||
150125639|NCT00093145|541593257|FG000|Overall Study|Other|1|||
150125640|NCT01310036|541593258|FG000|Overall Study|Administrative/other|10|||
150125641|NCT01310036|541593258|FG000|Overall Study|Withdrew Consent|11|||
150125642|NCT01310036|541593258|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
150125643|NCT01310036|541593258|FG000|Overall Study|Progression of Disease|164|||
150125644|NCT01310036|541593258|FG000|Overall Study|Death|1|||
150125645|NCT01310036|541593258|FG000|Overall Study|Adverse event or intercurrent illness|12|||
150125646|NCT03359096|541593259|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
150125647|NCT03359096|541593260|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
150125648|NCT03359096|541593259|FG000|First Intervention (4 Weeks)|Death|1|||
150125649|NCT03359096|541593260|FG001|First Intervention (4 Weeks)|Death|0|||
150125650|NCT03359096|541593259|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
150125651|NCT03359096|541593260|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
150125652|NCT00833989|541593261|FG000|Overall Study|Physician Decision|0|||
150125653|NCT00833989|541593262|FG001|Overall Study|Physician Decision|0|||
150125654|NCT00833989|541593263|FG002|Overall Study|Physician Decision|0|||
150125655|NCT00833989|541593264|FG003|Overall Study|Physician Decision|1|||
150125656|NCT00833989|541593261|FG000|Overall Study|Withdrawal by Subject|3|||
150125657|NCT00833989|541593262|FG001|Overall Study|Withdrawal by Subject|0|||
150125658|NCT00833989|541593263|FG002|Overall Study|Withdrawal by Subject|1|||
150125659|NCT00833989|541593264|FG003|Overall Study|Withdrawal by Subject|1|||
150125660|NCT02310750|541593265|FG000|HP Period 1|Lost to Follow-up|0|||
150125661|NCT02310750|541593266|FG001|HP Period 1|Lost to Follow-up|0|||
150125662|NCT02310750|541593267|FG002|HP Period 1|Lost to Follow-up|0|||
150125663|NCT02310750|541593268|FG003|HP Period 1|Lost to Follow-up|0|||
150125664|NCT02310750|541593269|FG004|HP Period 1|Lost to Follow-up|0|||
150193269|NCT04542317|541846745|FG001|Overall Study|Caregivers passed away|2|||
150125665|NCT02310750|541593270|FG005|HP Period 1|Lost to Follow-up|0|||
150125666|NCT02310750|541593271|FG006|HP Period 1|Lost to Follow-up|1|||
150125667|NCT02310750|541593272|FG007|HP Period 1|Lost to Follow-up|0|||
150125668|NCT02310750|541593273|FG008|HP Period 1|Lost to Follow-up|0|||
150125669|NCT02310750|541593274|FG009|HP Period 1|Lost to Follow-up|0|||
150125670|NCT02310750|541593275|FG010|HP Period 1|Lost to Follow-up|0|||
150193270|NCT03021096|541846748|FG000|Overall Study|Lost to Follow-up|4|||
150193271|NCT03021096|541846748|FG000|Overall Study|Protocol Violation|2|||
150193272|NCT03848065|541846751|FG000|Overall Study|Death|0|||
150193273|NCT03848065|541846752|FG001|Overall Study|Death|1|||
150193274|NCT03848065|541846753|FG002|Overall Study|Death|0|||
150193275|NCT03848065|541846751|FG000|Overall Study|Lost to Follow-up|0|||
150193276|NCT03848065|541846752|FG001|Overall Study|Lost to Follow-up|0|||
150193277|NCT03848065|541846753|FG002|Overall Study|Lost to Follow-up|1|||
150193278|NCT03848065|541846751|FG000|Overall Study|Physician Decision|0|||
150193279|NCT03848065|541846752|FG001|Overall Study|Physician Decision|0|||
150193280|NCT03848065|541846753|FG002|Overall Study|Physician Decision|1|||
150193281|NCT04137367|541846759|FG000|Overall Study|Lost to Follow-up|8|||
150193282|NCT04137367|541846760|FG001|Overall Study|Lost to Follow-up|6|||
150193283|NCT04137367|541846761|FG002|Overall Study|Lost to Follow-up|4|||
150193284|NCT05144009|541846762|FG000|Overall Study|Lost to Follow-up|0|||
150193285|NCT05144009|541846763|FG001|Overall Study|Lost to Follow-up|1|||
150193286|NCT05144009|541846762|FG000|Overall Study|Study Termination by the Sponsor|11|||
150193287|NCT05144009|541846763|FG001|Overall Study|Study Termination by the Sponsor|11|||
150193288|NCT05144009|541846762|FG000|Overall Study|Disease Progression|1|||
150193289|NCT05144009|541846763|FG001|Overall Study|Disease Progression|0|||
150193290|NCT05144009|541846762|FG000|Overall Study|Participant Decision|0|||
150193291|NCT05144009|541846763|FG001|Overall Study|Participant Decision|2|||
150193292|NCT05144009|541846762|FG000|Overall Study|Death|5|||
150193293|NCT05144009|541846763|FG001|Overall Study|Death|10|||
150193294|NCT03270501|541846764|FG000|Overall Study|Screen failure|6|||
150193295|NCT03270501|541846764|FG000|Overall Study|Lost to Follow-up|2|||
150193296|NCT03270501|541846764|FG000|Overall Study|Adverse Event|1|||
150193297|NCT00764751|541846767|FG000|Overall Study|Adverse Event|1|||
150193298|NCT00764751|541846768|FG001|Overall Study|Adverse Event|1|||
150193299|NCT00764751|541846767|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
150193300|NCT00764751|541846768|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
150193301|NCT01175356|541846780|FG000|Overall Study|Death|1|||
150193302|NCT01175356|541846780|FG000|Overall Study|Lack of Efficacy|12|||
150193303|NCT01175356|541846780|FG000|Overall Study|Lost to Follow-up|1|||
150193304|NCT01175356|541846780|FG000|Overall Study|Physician Decision|23|||
150193305|NCT01175356|541846780|FG000|Overall Study|Ineligible|1|||
150193306|NCT01175356|541846780|FG000|Overall Study|Treatment Slot Not Available|18|||
150193307|NCT01175356|541846780|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
150193308|NCT01175356|541846780|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
150193309|NCT01175356|541846780|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
150193310|NCT01175356|541846780|FG000|Overall Study|Inadequate stem cell for transplant|1|||
150193311|NCT01175356|541846780|FG000|Overall Study|Initiation other tx prior to completion|9|||
150125671|NCT02310750|541593276|FG011|HP Period 1|Lost to Follow-up|0|||
150125672|NCT02310750|541593277|FG012|HP Period 1|Lost to Follow-up|0|||
150125673|NCT02310750|541593278|FG013|HP Period 1|Lost to Follow-up|0|||
150125674|NCT02310750|541593279|FG014|HP Period 1|Lost to Follow-up|0|||
150125675|NCT02310750|541593280|FG015|HP Period 1|Lost to Follow-up|0|||
150125676|NCT02310750|541593265|FG000|HP Period 1|Withdrawal by Subject|1|||
150125677|NCT02310750|541593266|FG001|HP Period 1|Withdrawal by Subject|0|||
150125678|NCT02310750|541593267|FG002|HP Period 1|Withdrawal by Subject|0|||
150125679|NCT02310750|541593268|FG003|HP Period 1|Withdrawal by Subject|1|||
150125680|NCT02310750|541593269|FG004|HP Period 1|Withdrawal by Subject|0|||
150125681|NCT02310750|541593270|FG005|HP Period 1|Withdrawal by Subject|0|||
150125682|NCT02310750|541593271|FG006|HP Period 1|Withdrawal by Subject|0|||
150125683|NCT02310750|541593272|FG007|HP Period 1|Withdrawal by Subject|0|||
150125684|NCT02310750|541593273|FG008|HP Period 1|Withdrawal by Subject|0|||
150125685|NCT02310750|541593274|FG009|HP Period 1|Withdrawal by Subject|0|||
150125686|NCT02310750|541593275|FG010|HP Period 1|Withdrawal by Subject|0|||
150125687|NCT02310750|541593276|FG011|HP Period 1|Withdrawal by Subject|0|||
150125688|NCT02310750|541593277|FG012|HP Period 1|Withdrawal by Subject|0|||
150125689|NCT02310750|541593278|FG013|HP Period 1|Withdrawal by Subject|0|||
150125690|NCT02310750|541593279|FG014|HP Period 1|Withdrawal by Subject|0|||
150125691|NCT02310750|541593280|FG015|HP Period 1|Withdrawal by Subject|0|||
150125692|NCT02310750|541593265|FG000|HP Washout 1|Lost to Follow-up|0|||
150125693|NCT02310750|541593266|FG001|HP Washout 1|Lost to Follow-up|0|||
150125694|NCT02310750|541593267|FG002|HP Washout 1|Lost to Follow-up|1|||
150125695|NCT02310750|541593268|FG003|HP Washout 1|Lost to Follow-up|1|||
150125696|NCT02310750|541593269|FG004|HP Washout 1|Lost to Follow-up|2|||
150125697|NCT02310750|541593270|FG005|HP Washout 1|Lost to Follow-up|2|||
150125698|NCT02310750|541593271|FG006|HP Washout 1|Lost to Follow-up|3|||
150125699|NCT02310750|541593272|FG007|HP Washout 1|Lost to Follow-up|0|||
150125700|NCT02310750|541593273|FG008|HP Washout 1|Lost to Follow-up|0|||
150125701|NCT02310750|541593274|FG009|HP Washout 1|Lost to Follow-up|0|||
150125702|NCT02310750|541593275|FG010|HP Washout 1|Lost to Follow-up|0|||
150125703|NCT02310750|541593276|FG011|HP Washout 1|Lost to Follow-up|0|||
150125704|NCT02310750|541593277|FG012|HP Washout 1|Lost to Follow-up|0|||
150125705|NCT02310750|541593278|FG013|HP Washout 1|Lost to Follow-up|0|||
150125706|NCT02310750|541593279|FG014|HP Washout 1|Lost to Follow-up|0|||
150125707|NCT02310750|541593280|FG015|HP Washout 1|Lost to Follow-up|0|||
150125708|NCT02310750|541593265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125709|NCT02310750|541593266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125710|NCT02310750|541593267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150193312|NCT00324805|541846781|FG000|Overall Study|Adverse Event|62|||
150193313|NCT00324805|541846782|FG001|Overall Study|Adverse Event|203|||
150193314|NCT00324805|541846781|FG000|Overall Study|Progression|7|||
150193315|NCT00324805|541846782|FG001|Overall Study|Progression|35|||
150193316|NCT00324805|541846781|FG000|Overall Study|Withdrawal by Subject|51|||
150193317|NCT00324805|541846782|FG001|Overall Study|Withdrawal by Subject|174|||
150193318|NCT00324805|541846781|FG000|Overall Study|Death|6|||
150193319|NCT00324805|541846782|FG001|Overall Study|Death|9|||
150193320|NCT00324805|541846781|FG000|Overall Study|Alternative therapy|4|||
150193321|NCT00324805|541846782|FG001|Overall Study|Alternative therapy|8|||
150193322|NCT00324805|541846781|FG000|Overall Study|Other complicating disease|1|||
150193323|NCT00324805|541846782|FG001|Overall Study|Other complicating disease|9|||
150193324|NCT00324805|541846781|FG000|Overall Study|Other reasons|7|||
150193325|NCT00324805|541846782|FG001|Overall Study|Other reasons|26|||
150193326|NCT00324805|541846781|FG000|Overall Study|Other|0|||
150193327|NCT00324805|541846782|FG001|Overall Study|Other|2|||
150193328|NCT00324805|541846781|FG000|Overall Study|Did not start therapy|12|||
150193329|NCT00324805|541846782|FG001|Overall Study|Did not start therapy|17|||
150193330|NCT05977530|541846784|FG000|Overall Study|Withdrawal by Subject|1|||
150193331|NCT05977530|541846784|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
150193332|NCT04719832|541846787|FG000|Overall Study|Adverse Event|2|||
150193333|NCT04719832|541846788|FG001|Overall Study|Adverse Event|0|||
150193334|NCT04719832|541846787|FG000|Overall Study|Lack of Efficacy|2|||
150193335|NCT04719832|541846788|FG001|Overall Study|Lack of Efficacy|4|||
150193336|NCT04719832|541846787|FG000|Overall Study|Lost to Follow-up|0|||
150193337|NCT04719832|541846788|FG001|Overall Study|Lost to Follow-up|2|||
150193338|NCT04719832|541846787|FG000|Overall Study|Physician Decision|0|||
150193339|NCT04719832|541846788|FG001|Overall Study|Physician Decision|1|||
150193340|NCT04719832|541846787|FG000|Overall Study|Pregnancy|1|||
150193341|NCT04719832|541846788|FG001|Overall Study|Pregnancy|1|||
150125711|NCT02310750|541593268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
150125712|NCT02310750|541593269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125713|NCT02310750|541593270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
150125714|NCT02310750|541593271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125715|NCT02310750|541593272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150193342|NCT04719832|541846787|FG000|Overall Study|Withdrawal by Subject|5|||
150193343|NCT04719832|541846788|FG001|Overall Study|Withdrawal by Subject|5|||
150193344|NCT04719832|541846787|FG000|Overall Study|Randomized, not treated|0|||
150193345|NCT04719832|541846788|FG001|Overall Study|Randomized, not treated|2|||
150125716|NCT02310750|541593273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
150125717|NCT02310750|541593274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
150125718|NCT02310750|541593275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125719|NCT02310750|541593276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125720|NCT02310750|541593277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125721|NCT02310750|541593278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125722|NCT02310750|541593279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125723|NCT02310750|541593280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
150125724|NCT02310750|541593265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125725|NCT02310750|541593266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125726|NCT02310750|541593267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125727|NCT02310750|541593268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125728|NCT02310750|541593269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125729|NCT02310750|541593270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125730|NCT02310750|541593271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125731|NCT02310750|541593272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125732|NCT02310750|541593273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125733|NCT02310750|541593274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
150125734|NCT02310750|541593275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125735|NCT02310750|541593276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125736|NCT02310750|541593277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125737|NCT02310750|541593278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125738|NCT02310750|541593279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125739|NCT02310750|541593280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
150125740|NCT02310750|541593265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125741|NCT02310750|541593266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125742|NCT02310750|541593267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125743|NCT02310750|541593268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125744|NCT02310750|541593269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125745|NCT02310750|541593270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125746|NCT02310750|541593271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125747|NCT02310750|541593272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
150125748|NCT02310750|541593273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
150125749|NCT02310750|541593274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
150125750|NCT02310750|541593275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125751|NCT02310750|541593276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125752|NCT02310750|541593277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125753|NCT02310750|541593278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125754|NCT02310750|541593279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125755|NCT02310750|541593280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
150125756|NCT02310750|541593265|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125757|NCT02310750|541593266|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125758|NCT02310750|541593267|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125759|NCT02310750|541593268|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125760|NCT02310750|541593269|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125761|NCT02310750|541593270|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125762|NCT02310750|541593271|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125763|NCT02310750|541593272|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
150125764|NCT02310750|541593273|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
150125765|NCT02310750|541593274|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150193346|NCT04719832|541846787|FG000|Overall Study|GCP violations|4|||
150193347|NCT04719832|541846788|FG001|Overall Study|GCP violations|7|||
150193348|NCT05192109|541846793|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
150193349|NCT05192109|541846794|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
150193350|NCT05192109|541846795|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
150193351|NCT05192109|541846796|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
150193352|NCT05192109|541846793|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
150193353|NCT05192109|541846794|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
150193354|NCT05192109|541846795|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
150193355|NCT05192109|541846796|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
150193356|NCT04515849|541846797|FG000|Overall Study|Adverse Event|0|||
150193357|NCT04515849|541846798|FG001|Overall Study|Adverse Event|0|||
150193358|NCT04515849|541846799|FG002|Overall Study|Adverse Event|0|||
150193359|NCT04515849|541846800|FG003|Overall Study|Adverse Event|1|||
150193360|NCT04515849|541846801|FG004|Overall Study|Adverse Event|2|||
150193361|NCT04515849|541846797|FG000|Overall Study|Death|2|||
150193362|NCT04515849|541846798|FG001|Overall Study|Death|0|||
150193363|NCT04515849|541846799|FG002|Overall Study|Death|0|||
150193364|NCT04515849|541846800|FG003|Overall Study|Death|0|||
150193365|NCT04515849|541846801|FG004|Overall Study|Death|0|||
150193366|NCT04515849|541846797|FG000|Overall Study|Other:family emergency|0|||
150193367|NCT04515849|541846798|FG001|Overall Study|Other:family emergency|0|||
150193368|NCT04515849|541846799|FG002|Overall Study|Other:family emergency|0|||
150193369|NCT04515849|541846800|FG003|Overall Study|Other:family emergency|1|||
150193370|NCT04515849|541846801|FG004|Overall Study|Other:family emergency|0|||
150193371|NCT04515849|541846797|FG000|Overall Study|Other:randomised by error|0|||
150193372|NCT04515849|541846798|FG001|Overall Study|Other:randomised by error|1|||
150193373|NCT04515849|541846799|FG002|Overall Study|Other:randomised by error|0|||
150193374|NCT04515849|541846800|FG003|Overall Study|Other:randomised by error|0|||
150193375|NCT04515849|541846801|FG004|Overall Study|Other:randomised by error|0|||
150193376|NCT04515849|541846797|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
150193377|NCT04515849|541846798|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
150193378|NCT04515849|541846799|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
150193379|NCT04515849|541846800|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
150193380|NCT04515849|541846801|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
150193381|NCT04515849|541846797|FG000|Overall Study|Physician Decision|0|||
150193382|NCT04515849|541846798|FG001|Overall Study|Physician Decision|1|||
150193383|NCT04515849|541846799|FG002|Overall Study|Physician Decision|0|||
150193384|NCT04515849|541846800|FG003|Overall Study|Physician Decision|0|||
150193385|NCT04515849|541846801|FG004|Overall Study|Physician Decision|0|||
150193386|NCT04515849|541846797|FG000|Overall Study|Withdrawal by Subject|1|||
150193387|NCT04515849|541846798|FG001|Overall Study|Withdrawal by Subject|2|||
150193388|NCT04515849|541846799|FG002|Overall Study|Withdrawal by Subject|1|||
150193389|NCT04515849|541846800|FG003|Overall Study|Withdrawal by Subject|0|||
150193390|NCT04515849|541846801|FG004|Overall Study|Withdrawal by Subject|0|||
150193391|NCT04049643|541846807|FG000|Overall Study|Lack of Efficacy|1|||
150193392|NCT04049643|541846808|FG001|Overall Study|Lack of Efficacy|1|||
150193393|NCT04049643|541846809|FG002|Overall Study|Lack of Efficacy|0|||
150193394|NCT04049643|541846807|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
150193395|NCT04049643|541846808|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
150193396|NCT04049643|541846809|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
150193397|NCT04437615|541846810|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
150193398|NCT02696707|541848593|FG000|Per Protocol Population|Physician Decision|2|||
150193399|NCT02696707|541848594|FG001|Per Protocol Population|Physician Decision|1|||
150125766|NCT02310750|541593275|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125767|NCT02310750|541593276|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125768|NCT02310750|541593277|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125769|NCT02310750|541593278|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125770|NCT02310750|541593279|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125771|NCT02310750|541593280|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
150125772|NCT02310750|541593265|FG000|HP Washout 2|Lost to Follow-up|0|||
150125773|NCT02310750|541593266|FG001|HP Washout 2|Lost to Follow-up|0|||
150125774|NCT02310750|541593267|FG002|HP Washout 2|Lost to Follow-up|0|||
150125775|NCT02310750|541593268|FG003|HP Washout 2|Lost to Follow-up|0|||
150125776|NCT02310750|541593269|FG004|HP Washout 2|Lost to Follow-up|1|||
150125777|NCT02310750|541593270|FG005|HP Washout 2|Lost to Follow-up|0|||
150125778|NCT02310750|541593271|FG006|HP Washout 2|Lost to Follow-up|7|||
150125779|NCT02310750|541593272|FG007|HP Washout 2|Lost to Follow-up|0|||
150125780|NCT02310750|541593273|FG008|HP Washout 2|Lost to Follow-up|0|||
150125781|NCT02310750|541593274|FG009|HP Washout 2|Lost to Follow-up|0|||
150125782|NCT02310750|541593275|FG010|HP Washout 2|Lost to Follow-up|0|||
150125783|NCT02310750|541593276|FG011|HP Washout 2|Lost to Follow-up|0|||
150125784|NCT02310750|541593277|FG012|HP Washout 2|Lost to Follow-up|0|||
150125785|NCT02310750|541593278|FG013|HP Washout 2|Lost to Follow-up|0|||
150125786|NCT02310750|541593279|FG014|HP Washout 2|Lost to Follow-up|0|||
150125787|NCT02310750|541593280|FG015|HP Washout 2|Lost to Follow-up|0|||
150125788|NCT01934218|541593284|FG000|Double-blind Phase|Adverse Event|8|||
150125789|NCT01934218|541593285|FG001|Double-blind Phase|Adverse Event|8|||
150125790|NCT01934218|541593284|FG000|Double-blind Phase|Lack of Efficacy|6|||
150125791|NCT01934218|541593285|FG001|Double-blind Phase|Lack of Efficacy|7|||
150125792|NCT01934218|541593284|FG000|Double-blind Phase|Lost to Follow-up|7|||
150125793|NCT01934218|541593285|FG001|Double-blind Phase|Lost to Follow-up|14|||
150125794|NCT01934218|541593284|FG000|Double-blind Phase|Physician Decision|1|||
150125795|NCT01934218|541593285|FG001|Double-blind Phase|Physician Decision|2|||
150125796|NCT01934218|541593284|FG000|Double-blind Phase|Protocol Violation|4|||
150125797|NCT01934218|541593285|FG001|Double-blind Phase|Protocol Violation|0|||
150125798|NCT01934218|541593284|FG000|Double-blind Phase|Withdrawal by Subject|16|||
150125799|NCT01934218|541593285|FG001|Double-blind Phase|Withdrawal by Subject|13|||
150125800|NCT01934218|541593284|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
150125801|NCT01934218|541593285|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
150125802|NCT01934218|541593284|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
150125803|NCT01934218|541593285|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
150125804|NCT01934218|541593284|FG000|Open-Label Phase|Adverse Event|2|||
150125805|NCT01934218|541593285|FG001|Open-Label Phase|Adverse Event|4|||
150125806|NCT01934218|541593284|FG000|Open-Label Phase|Lack of Efficacy|1|||
150125807|NCT01934218|541593285|FG001|Open-Label Phase|Lack of Efficacy|4|||
150125808|NCT01934218|541593284|FG000|Open-Label Phase|Lost to Follow-up|4|||
150125809|NCT01934218|541593285|FG001|Open-Label Phase|Lost to Follow-up|2|||
150125810|NCT01934218|541593284|FG000|Open-Label Phase|Physician Decision|1|||
150125811|NCT01934218|541593285|FG001|Open-Label Phase|Physician Decision|0|||
150125812|NCT01934218|541593284|FG000|Open-Label Phase|Protocol Violation|1|||
150125813|NCT01934218|541593285|FG001|Open-Label Phase|Protocol Violation|0|||
150125814|NCT01934218|541593284|FG000|Open-Label Phase|Withdrawal by Subject|13|||
150125815|NCT01934218|541593285|FG001|Open-Label Phase|Withdrawal by Subject|11|||
150125816|NCT01934218|541593284|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
150125817|NCT01934218|541593285|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
150125818|NCT01934218|541593284|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
150125819|NCT01934218|541593285|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
150125820|NCT03538626|541593286|FG000|Overall Study|Withdrawal by Subject|0|||
150125821|NCT03538626|541593287|FG001|Overall Study|Withdrawal by Subject|1|||
150125822|NCT03538626|541593288|FG002|Overall Study|Withdrawal by Subject|0|||
150125823|NCT03538626|541593289|FG003|Overall Study|Withdrawal by Subject|0|||
150125824|NCT03538626|541593290|FG004|Overall Study|Withdrawal by Subject|0|||
150125825|NCT03538626|541593291|FG005|Overall Study|Withdrawal by Subject|0|||
150125826|NCT03538626|541593292|FG006|Overall Study|Withdrawal by Subject|0|||
150125827|NCT03538626|541593293|FG007|Overall Study|Withdrawal by Subject|0|||
150125828|NCT03538626|541593286|FG000|Overall Study|Lost to Follow-up|0|||
150125829|NCT03538626|541593287|FG001|Overall Study|Lost to Follow-up|0|||
150125830|NCT03538626|541593288|FG002|Overall Study|Lost to Follow-up|0|||
150125831|NCT03538626|541593289|FG003|Overall Study|Lost to Follow-up|0|||
150125832|NCT03538626|541593290|FG004|Overall Study|Lost to Follow-up|0|||
150125833|NCT03538626|541593291|FG005|Overall Study|Lost to Follow-up|0|||
150125834|NCT03538626|541593292|FG006|Overall Study|Lost to Follow-up|1|||
150125835|NCT03538626|541593293|FG007|Overall Study|Lost to Follow-up|0|||
150125836|NCT02911948|541593300|FG000|Overall Study|Protocol Violation|0|||
150125837|NCT02911948|541593301|FG001|Overall Study|Protocol Violation|1|||
150125838|NCT02911948|541593300|FG000|Overall Study|Withdrawal by Subject|0|||
150125839|NCT02911948|541593301|FG001|Overall Study|Withdrawal by Subject|2|||
150125840|NCT02911948|541593300|FG000|Overall Study|Lack of Efficacy|0|||
150125841|NCT02911948|541593301|FG001|Overall Study|Lack of Efficacy|1|||
150125842|NCT02911948|541593300|FG000|Overall Study|Unclassified|0|||
150125843|NCT02911948|541593301|FG001|Overall Study|Unclassified|3|||
150125844|NCT00522275|541593302|FG000|Overall Study|Adverse Event|35|||
150125845|NCT00522275|541593302|FG000|Overall Study|Lack of Efficacy|80|||
150125846|NCT00522275|541593302|FG000|Overall Study|Subject withdrew consent|16|||
150125847|NCT00522275|541593302|FG000|Overall Study|Protocol deviation|1|||
150125848|NCT00522275|541593302|FG000|Overall Study|Unsatisfactory compliance|11|||
150125849|NCT00522275|541593302|FG000|Overall Study|Lost to Follow-up|8|||
150125850|NCT00522275|541593302|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
150125851|NCT00522275|541593302|FG000|Overall Study|Other: Subject is pregnant|2|||
150125852|NCT00522275|541593302|FG000|Overall Study|Other: Subject relocated|2|||
150125853|NCT00522275|541593302|FG000|Overall Study|Other: Subject arrested|1|||
150125854|NCT00522275|541593302|FG000|Overall Study|Other: Site / clinic closed|4|||
150125855|NCT00522275|541593302|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
150125856|NCT00522275|541593302|FG000|Overall Study|Other: Sponsor request|2|||
150125857|NCT00522275|541593302|FG000|Overall Study|Other: Subject ran out of medication|1|||
150125858|NCT00522275|541593302|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
150125859|NCT03965052|541593303|FG000|Overall Study|Protocol Violation|1|||
150125860|NCT03965052|541593304|FG001|Overall Study|Protocol Violation|0|||
150125861|NCT04323436|541593305|FG000|Overall Study|Adverse Event|7|||
150125862|NCT04323436|541593306|FG001|Overall Study|Adverse Event|0|||
150125863|NCT04323436|541593307|FG002|Overall Study|Adverse Event|0|||
150125864|NCT04323436|541593305|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
150125865|NCT04323436|541593306|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
150125866|NCT04323436|541593307|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
150193400|NCT02696707|541848593|FG000|Per Protocol Population|Participant Decision|0|||
150125867|NCT04323436|541593305|FG000|Overall Study|Death|1|||
150125868|NCT04323436|541593306|FG001|Overall Study|Death|0|||
150125869|NCT04323436|541593307|FG002|Overall Study|Death|0|||
150125870|NCT04323436|541593305|FG000|Overall Study|Physician Decision|2|||
150125871|NCT04323436|541593306|FG001|Overall Study|Physician Decision|0|||
150125872|NCT04323436|541593307|FG002|Overall Study|Physician Decision|0|||
150125873|NCT04323436|541593305|FG000|Overall Study|Progressive disease|10|||
150125874|NCT04323436|541593306|FG001|Overall Study|Progressive disease|0|||
150125875|NCT04323436|541593307|FG002|Overall Study|Progressive disease|0|||
150125876|NCT04323436|541593305|FG000|Overall Study|Subject decision|3|||
150125877|NCT04323436|541593306|FG001|Overall Study|Subject decision|0|||
150125878|NCT04323436|541593307|FG002|Overall Study|Subject decision|0|||
150125879|NCT03021187|541593308|FG000|Overall Study|Death|0|||
150125880|NCT03021187|541593309|FG001|Overall Study|Death|0|||
150125881|NCT03021187|541593310|FG002|Overall Study|Death|3|||
150125882|NCT03021187|541593311|FG003|Overall Study|Death|0|||
150125883|NCT03021187|541593308|FG000|Overall Study|Withdrawal by Subject|0|||
150125884|NCT03021187|541593309|FG001|Overall Study|Withdrawal by Subject|6|||
150125885|NCT03021187|541593310|FG002|Overall Study|Withdrawal by Subject|2|||
150125886|NCT03021187|541593311|FG003|Overall Study|Withdrawal by Subject|5|||
150125887|NCT03021187|541593308|FG000|Overall Study|Lost to Follow-up|10|||
150125888|NCT03021187|541593309|FG001|Overall Study|Lost to Follow-up|3|||
150125889|NCT03021187|541593310|FG002|Overall Study|Lost to Follow-up|1|||
150125890|NCT03021187|541593311|FG003|Overall Study|Lost to Follow-up|4|||
150125891|NCT03394924|541593312|FG000|Overall Study|Adverse Event|0|||
150125892|NCT03394924|541593313|FG001|Overall Study|Adverse Event|5|||
150125893|NCT03394924|541593314|FG002|Overall Study|Adverse Event|0|||
150125894|NCT03394924|541593312|FG000|Overall Study|Withdrawal by Subject|2|||
150125895|NCT03394924|541593313|FG001|Overall Study|Withdrawal by Subject|0|||
150125896|NCT03394924|541593314|FG002|Overall Study|Withdrawal by Subject|0|||
150125897|NCT03394924|541593312|FG000|Overall Study|Lost to Follow-up|0|||
150125898|NCT03394924|541593313|FG001|Overall Study|Lost to Follow-up|1|||
150125899|NCT03394924|541593314|FG002|Overall Study|Lost to Follow-up|0|||
150125900|NCT03394924|541593312|FG000|Overall Study|Did not meet all inclusion criteria|1|||
150125901|NCT03394924|541593313|FG001|Overall Study|Did not meet all inclusion criteria|0|||
150125902|NCT03394924|541593314|FG002|Overall Study|Did not meet all inclusion criteria|0|||
150125903|NCT02276482|541593317|FG000|Overall Study|Adverse Event|1|||
150125904|NCT02276482|541593318|FG001|Overall Study|Adverse Event|0|||
150125905|NCT02276482|541593317|FG000|Overall Study|Withdrawal by Subject|1|||
150125906|NCT02276482|541593318|FG001|Overall Study|Withdrawal by Subject|0|||
150125907|NCT02276482|541593317|FG000|Overall Study|Gram-negative infection|1|||
150125908|NCT02276482|541593318|FG001|Overall Study|Gram-negative infection|0|||
150125909|NCT02276482|541593317|FG000|Overall Study|Reason not specified|0|||
150125910|NCT02276482|541593318|FG001|Overall Study|Reason not specified|1|||
150125911|NCT02005471|541593321|FG000|Main Study|Adverse Event|0|||
150125912|NCT02005471|541593322|FG001|Main Study|Adverse Event|1|||
150125913|NCT02005471|541593323|FG002|Main Study|Adverse Event|0|||
150125914|NCT02005471|541593324|FG003|Main Study|Adverse Event|0|||
150125915|NCT02005471|541593321|FG000|Main Study|Death|83|||
150125916|NCT02005471|541593322|FG001|Main Study|Death|52|||
150125917|NCT02005471|541593323|FG002|Main Study|Death|0|||
150125918|NCT02005471|541593324|FG003|Main Study|Death|0|||
150125919|NCT02005471|541593321|FG000|Main Study|Lost to Follow-up|4|||
150125920|NCT02005471|541593322|FG001|Main Study|Lost to Follow-up|5|||
150125921|NCT02005471|541593323|FG002|Main Study|Lost to Follow-up|0|||
150125922|NCT02005471|541593324|FG003|Main Study|Lost to Follow-up|0|||
150125923|NCT02005471|541593321|FG000|Main Study|Physician Decision|3|||
150125924|NCT02005471|541593322|FG001|Main Study|Physician Decision|1|||
150125925|NCT02005471|541593323|FG002|Main Study|Physician Decision|0|||
150125926|NCT02005471|541593324|FG003|Main Study|Physician Decision|0|||
150125927|NCT02005471|541593321|FG000|Main Study|Withdrawal by Subject|26|||
150125928|NCT02005471|541593322|FG001|Main Study|Withdrawal by Subject|11|||
150125929|NCT02005471|541593323|FG002|Main Study|Withdrawal by Subject|0|||
150125930|NCT02005471|541593324|FG003|Main Study|Withdrawal by Subject|0|||
150125931|NCT02005471|541593321|FG000|Main Study|Reason not Specified|0|||
150193401|NCT02696707|541848594|FG001|Per Protocol Population|Participant Decision|2|||
150193402|NCT02696707|541848593|FG000|Completed Study as Planned|Reason = LVEF|2|||
150125932|NCT02005471|541593322|FG001|Main Study|Reason not Specified|6|||
150125933|NCT02005471|541593323|FG002|Main Study|Reason not Specified|0|||
150125934|NCT02005471|541593324|FG003|Main Study|Reason not Specified|0|||
150125935|NCT02005471|541593321|FG000|Main Study|Randomized but not Dosed|8|||
150125936|NCT02005471|541593322|FG001|Main Study|Randomized but not Dosed|0|||
150125937|NCT02005471|541593323|FG002|Main Study|Randomized but not Dosed|0|||
150125938|NCT02005471|541593324|FG003|Main Study|Randomized but not Dosed|0|||
150125939|NCT02005471|541593321|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
150125940|NCT02005471|541593322|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
150125941|NCT02005471|541593323|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
150125942|NCT02005471|541593324|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
150125943|NCT02005471|541593321|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
150125944|NCT02005471|541593322|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
150125945|NCT02005471|541593323|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
150125946|NCT02005471|541593324|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
150125947|NCT02005471|541593321|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
150125948|NCT02005471|541593322|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
150125949|NCT02005471|541593323|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
150125950|NCT02005471|541593324|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
150125951|NCT00627705|541593326|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
150125952|NCT00627705|541593327|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
150125953|NCT00627705|541593326|FG000|Overall Study|Adverse Event|1|||
150125954|NCT00627705|541593327|FG001|Overall Study|Adverse Event|0|||
150125955|NCT00627705|541593326|FG000|Overall Study|Withdrawal by Subject|0|||
150125956|NCT00627705|541593327|FG001|Overall Study|Withdrawal by Subject|2|||
150125957|NCT00627705|541593326|FG000|Overall Study|Lost to Follow-up|0|||
150125958|NCT00627705|541593327|FG001|Overall Study|Lost to Follow-up|1|||
150125959|NCT03096782|541593330|FG000|Overall Study|Death|1|||
150125960|NCT03096782|541593330|FG000|Overall Study|Participant Relapsed|1|||
150125961|NCT03156023|541593331|FG000|Overall Study|Withdrawal by Subject|1|||
150125962|NCT03156023|541593332|FG001|Overall Study|Withdrawal by Subject|0|||
150125963|NCT03156023|541593333|FG002|Overall Study|Withdrawal by Subject|2|||
150125964|NCT03156023|541593334|FG003|Overall Study|Withdrawal by Subject|1|||
150125965|NCT03156023|541593335|FG004|Overall Study|Withdrawal by Subject|1|||
150125966|NCT03156023|541593331|FG000|Overall Study|Lost to Follow-up|0|||
150125967|NCT03156023|541593332|FG001|Overall Study|Lost to Follow-up|0|||
150125968|NCT03156023|541593333|FG002|Overall Study|Lost to Follow-up|0|||
150125969|NCT03156023|541593334|FG003|Overall Study|Lost to Follow-up|0|||
150125970|NCT03156023|541593335|FG004|Overall Study|Lost to Follow-up|1|||
150125971|NCT05819749|541593336|FG000|Overall Study|Lost to Follow-up|1|||
150125972|NCT00932893|541593341|FG000|Overall Study|Death|115|||
150125973|NCT00932893|541593342|FG001|Overall Study|Death|24|||
150125974|NCT00932893|541593341|FG000|Overall Study|Lost to Follow-up|8|||
150125975|NCT00932893|541593342|FG001|Overall Study|Lost to Follow-up|0|||
150125976|NCT00932893|541593341|FG000|Overall Study|Withdrawal by Subject|5|||
150125977|NCT00932893|541593342|FG001|Overall Study|Withdrawal by Subject|2|||
150125978|NCT00932893|541593341|FG000|Overall Study|Other|5|||
150125979|NCT00932893|541593342|FG001|Overall Study|Other|144|||
150125980|NCT02062632|541595473|FG000|Overall Study|No treatment data|1|||
150125981|NCT04579757|541595476|FG000|Overall Study|Adverse Event|0|||
150125982|NCT04579757|541595477|FG001|Overall Study|Adverse Event|0|||
150125983|NCT04579757|541595478|FG002|Overall Study|Adverse Event|0|||
150125984|NCT04579757|541595479|FG003|Overall Study|Adverse Event|2|||
150125985|NCT04579757|541595480|FG004|Overall Study|Adverse Event|1|||
150125986|NCT04579757|541595481|FG005|Overall Study|Adverse Event|1|||
150125987|NCT04579757|541595482|FG006|Overall Study|Adverse Event|0|||
150125988|NCT04579757|541595483|FG007|Overall Study|Adverse Event|0|||
150125989|NCT04579757|541595484|FG008|Overall Study|Adverse Event|0|||
150125990|NCT04579757|541595476|FG000|Overall Study|Death|4|||
150125991|NCT04579757|541595477|FG001|Overall Study|Death|1|||
150125992|NCT04579757|541595478|FG002|Overall Study|Death|14|||
150125993|NCT04579757|541595479|FG003|Overall Study|Death|3|||
150125994|NCT04579757|541595480|FG004|Overall Study|Death|2|||
150125995|NCT04579757|541595481|FG005|Overall Study|Death|7|||
150125996|NCT04579757|541595482|FG006|Overall Study|Death|0|||
150125997|NCT04579757|541595483|FG007|Overall Study|Death|1|||
150125998|NCT04579757|541595484|FG008|Overall Study|Death|3|||
150125999|NCT04579757|541595476|FG000|Overall Study|Physician Decision|0|||
150126000|NCT04579757|541595477|FG001|Overall Study|Physician Decision|0|||
150126001|NCT04579757|541595478|FG002|Overall Study|Physician Decision|0|||
150126002|NCT04579757|541595479|FG003|Overall Study|Physician Decision|2|||
150126003|NCT04579757|541595480|FG004|Overall Study|Physician Decision|1|||
150126004|NCT04579757|541595481|FG005|Overall Study|Physician Decision|1|||
150126005|NCT04579757|541595482|FG006|Overall Study|Physician Decision|1|||
150126006|NCT04579757|541595483|FG007|Overall Study|Physician Decision|0|||
150126007|NCT04579757|541595484|FG008|Overall Study|Physician Decision|0|||
150126008|NCT04579757|541595476|FG000|Overall Study|Study Terminated By Sponsor|0|||
150126009|NCT04579757|541595477|FG001|Overall Study|Study Terminated By Sponsor|0|||
150126010|NCT04579757|541595478|FG002|Overall Study|Study Terminated By Sponsor|0|||
150126011|NCT04579757|541595479|FG003|Overall Study|Study Terminated By Sponsor|0|||
150126012|NCT04579757|541595480|FG004|Overall Study|Study Terminated By Sponsor|2|||
150126013|NCT04579757|541595481|FG005|Overall Study|Study Terminated By Sponsor|0|||
150126014|NCT04579757|541595482|FG006|Overall Study|Study Terminated By Sponsor|0|||
150126015|NCT04579757|541595483|FG007|Overall Study|Study Terminated By Sponsor|2|||
150126016|NCT04579757|541595484|FG008|Overall Study|Study Terminated By Sponsor|0|||
150126017|NCT04579757|541595476|FG000|Overall Study|Withdrawal by Subject|1|||
150126018|NCT04579757|541595477|FG001|Overall Study|Withdrawal by Subject|1|||
150126019|NCT04579757|541595478|FG002|Overall Study|Withdrawal by Subject|0|||
150126020|NCT04579757|541595479|FG003|Overall Study|Withdrawal by Subject|0|||
150126021|NCT04579757|541595480|FG004|Overall Study|Withdrawal by Subject|2|||
150126022|NCT04579757|541595481|FG005|Overall Study|Withdrawal by Subject|1|||
150126023|NCT04579757|541595482|FG006|Overall Study|Withdrawal by Subject|0|||
150126024|NCT04579757|541595483|FG007|Overall Study|Withdrawal by Subject|3|||
150126025|NCT04579757|541595484|FG008|Overall Study|Withdrawal by Subject|0|||
150126026|NCT04579757|541595476|FG000|Overall Study|Radiological or Clinical PD|1|||
150126027|NCT04579757|541595477|FG001|Overall Study|Radiological or Clinical PD|4|||
150126028|NCT04579757|541595478|FG002|Overall Study|Radiological or Clinical PD|1|||
150126029|NCT04579757|541595479|FG003|Overall Study|Radiological or Clinical PD|3|||
150126030|NCT04579757|541595480|FG004|Overall Study|Radiological or Clinical PD|9|||
150126031|NCT04579757|541595481|FG005|Overall Study|Radiological or Clinical PD|4|||
150126032|NCT04579757|541595482|FG006|Overall Study|Radiological or Clinical PD|2|||
150126033|NCT04579757|541595483|FG007|Overall Study|Radiological or Clinical PD|2|||
150126034|NCT04579757|541595484|FG008|Overall Study|Radiological or Clinical PD|0|||
150126035|NCT04579757|541595476|FG000|Overall Study|Start of New Therapy|0|||
150126036|NCT04579757|541595477|FG001|Overall Study|Start of New Therapy|0|||
150126037|NCT04579757|541595478|FG002|Overall Study|Start of New Therapy|0|||
150126038|NCT04579757|541595479|FG003|Overall Study|Start of New Therapy|0|||
150126039|NCT04579757|541595480|FG004|Overall Study|Start of New Therapy|2|||
150126040|NCT04579757|541595481|FG005|Overall Study|Start of New Therapy|1|||
150126041|NCT04579757|541595482|FG006|Overall Study|Start of New Therapy|0|||
150126042|NCT04579757|541595483|FG007|Overall Study|Start of New Therapy|0|||
150126043|NCT04579757|541595484|FG008|Overall Study|Start of New Therapy|0|||
150126044|NCT02332720|541595485|FG000|Part A and Part B|Lost to Follow-up|1|||
150126045|NCT02332720|541595486|FG001|Part A and Part B|Lost to Follow-up|0|||
150126046|NCT02332720|541595487|FG002|Part A and Part B|Lost to Follow-up|0|||
150126047|NCT02332720|541595488|FG003|Part A and Part B|Lost to Follow-up|0|||
150126048|NCT02332720|541595489|FG004|Part A and Part B|Lost to Follow-up|0|||
150126049|NCT02332720|541595490|FG005|Part A and Part B|Lost to Follow-up|2|||
150126050|NCT02332720|541595491|FG006|Part A and Part B|Lost to Follow-up|1|||
150126051|NCT02332720|541595492|FG007|Part A and Part B|Lost to Follow-up|1|||
150126052|NCT02332720|541595493|FG008|Part A and Part B|Lost to Follow-up|0|||
150126053|NCT02332720|541595494|FG009|Part A and Part B|Lost to Follow-up|0|||
150126054|NCT02332720|541595495|FG010|Part A and Part B|Lost to Follow-up|0|||
150126055|NCT02332720|541595496|FG011|Part A and Part B|Lost to Follow-up|0|||
150126056|NCT02332720|541595497|FG012|Part A and Part B|Lost to Follow-up|0|||
150126057|NCT02332720|541595498|FG013|Part A and Part B|Lost to Follow-up|0|||
150126058|NCT02332720|541595499|FG014|Part A and Part B|Lost to Follow-up|0|||
150126059|NCT02332720|541595500|FG015|Part A and Part B|Lost to Follow-up|1|||
150126060|NCT02332720|541595501|FG016|Part A and Part B|Lost to Follow-up|0|||
150126061|NCT02332720|541595502|FG017|Part A and Part B|Lost to Follow-up|0|||
150126062|NCT02332720|541595503|FG018|Part A and Part B|Lost to Follow-up|0|||
150126063|NCT02332720|541595504|FG019|Part A and Part B|Lost to Follow-up|0|||
150126064|NCT02332720|541595505|FG020|Part A and Part B|Lost to Follow-up|0|||
150126065|NCT02332720|541595506|FG021|Part A and Part B|Lost to Follow-up|0|||
150126066|NCT02332720|541595507|FG022|Part A and Part B|Lost to Follow-up|0|||
150126067|NCT02332720|541595485|FG000|Part A and Part B|Adverse Event|0|||
150126068|NCT02332720|541595486|FG001|Part A and Part B|Adverse Event|0|||
150126069|NCT02332720|541595487|FG002|Part A and Part B|Adverse Event|0|||
150126070|NCT02332720|541595488|FG003|Part A and Part B|Adverse Event|0|||
150126071|NCT02332720|541595489|FG004|Part A and Part B|Adverse Event|0|||
150126072|NCT02332720|541595490|FG005|Part A and Part B|Adverse Event|0|||
150126073|NCT02332720|541595491|FG006|Part A and Part B|Adverse Event|0|||
150126074|NCT02332720|541595492|FG007|Part A and Part B|Adverse Event|0|||
150126075|NCT02332720|541595493|FG008|Part A and Part B|Adverse Event|0|||
150126076|NCT02332720|541595494|FG009|Part A and Part B|Adverse Event|0|||
150126077|NCT02332720|541595495|FG010|Part A and Part B|Adverse Event|0|||
150126078|NCT02332720|541595496|FG011|Part A and Part B|Adverse Event|0|||
150126079|NCT02332720|541595497|FG012|Part A and Part B|Adverse Event|0|||
150126080|NCT02332720|541595498|FG013|Part A and Part B|Adverse Event|0|||
150193403|NCT02696707|541848594|FG001|Completed Study as Planned|Reason = LVEF|2|||
150193404|NCT02696707|541848593|FG000|Completed Study as Planned|Protocol Violation|2|||
150193405|NCT02696707|541848594|FG001|Completed Study as Planned|Protocol Violation|6|||
150193406|NCT02696707|541848593|FG000|Completed Study as Planned|Metastatic disease|3|||
150193407|NCT02696707|541848594|FG001|Completed Study as Planned|Metastatic disease|0|||
150193408|NCT02696707|541848593|FG000|Completed Study as Planned|Location|1|||
150193409|NCT02696707|541848594|FG001|Completed Study as Planned|Location|1|||
150193410|NCT06181227|541848604|FG000|Overall Study|Study terminated by sponsor|7|||
150193411|NCT06181227|541848605|FG001|Overall Study|Study terminated by sponsor|9|||
150193412|NCT06516705|541848610|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
150193413|NCT06516705|541848611|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
150193414|NCT06516705|541848610|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
150193415|NCT06516705|541848611|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
150193416|NCT06516705|541848610|FG000|T3 ( 3 Month After Education)|covid-19|1|||
150193417|NCT06516705|541848611|FG001|T3 ( 3 Month After Education)|covid-19|2|||
150193418|NCT06516705|541848610|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
150193419|NCT06516705|541848611|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
150193420|NCT06516705|541848610|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
150193421|NCT06516705|541848611|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
150193422|NCT06516705|541848610|FG000|T4 ( 6 Month After Education)|covid-19|3|||
150193423|NCT06516705|541848611|FG001|T4 ( 6 Month After Education)|covid-19|2|||
150193424|NCT06516705|541848610|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
150193425|NCT06516705|541848611|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
150193426|NCT05453773|541848612|FG000|Overall Study|Withdrawal by Subject|3|||
150193427|NCT05453773|541848612|FG000|Overall Study|Lost to Follow-up|3|||
150193428|NCT05453773|541848612|FG000|Overall Study|Difficult Blood Draw|3|||
150193429|NCT03241745|541848615|FG000|Overall Study|Adverse Event|7|||
150193430|NCT03241745|541848615|FG000|Overall Study|Death|1|||
150193431|NCT03241745|541848615|FG000|Overall Study|Withdrawal by Subject|5|||
150193432|NCT03241745|541848615|FG000|Overall Study|Treatment delay >28 days|2|||
150193433|NCT03241745|541848615|FG000|Overall Study|Lack of Efficacy|14|||
150193434|NCT00470704|541848616|FG000|Overall Study|Withdrawal by Subject|4|||
150193435|NCT00470704|541848617|FG001|Overall Study|Withdrawal by Subject|3|||
150193436|NCT00470704|541848616|FG000|Overall Study|Relapse/Progression|37|||
150193437|NCT00470704|541848617|FG001|Overall Study|Relapse/Progression|42|||
150193438|NCT00470704|541848616|FG000|Overall Study|toxicity|0|||
150193439|NCT00470704|541848617|FG001|Overall Study|toxicity|1|||
150193440|NCT02561247|541848622|FG000|Overall Study|Protocol Violation|1|||
150193441|NCT02561247|541848622|FG000|Overall Study|Withdrawal by Subject|1|||
150193442|NCT02561247|541848622|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
150193443|NCT04963270|541848624|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
150193444|NCT04963270|541848625|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
150193445|NCT04963270|541848626|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
150193446|NCT04963270|541848627|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
150193447|NCT04963270|541848624|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150193448|NCT04963270|541848625|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
150193449|NCT04963270|541848626|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150193450|NCT04963270|541848627|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
150193451|NCT04963270|541848624|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
150193452|NCT04963270|541848625|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150193453|NCT04963270|541848626|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150193454|NCT04963270|541848627|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
150193455|NCT04963270|541848624|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
150193456|NCT04963270|541848625|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
150193457|NCT04963270|541848626|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
150193458|NCT04963270|541848627|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
150193459|NCT04963270|541848624|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
150193460|NCT04963270|541848625|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
150193461|NCT04963270|541848626|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
150193462|NCT04963270|541848627|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
150126081|NCT02332720|541595499|FG014|Part A and Part B|Adverse Event|0|||
150126082|NCT02332720|541595500|FG015|Part A and Part B|Adverse Event|0|||
150126083|NCT02332720|541595501|FG016|Part A and Part B|Adverse Event|0|||
150126084|NCT02332720|541595502|FG017|Part A and Part B|Adverse Event|1|||
150126085|NCT02332720|541595503|FG018|Part A and Part B|Adverse Event|0|||
150126086|NCT02332720|541595504|FG019|Part A and Part B|Adverse Event|0|||
150126087|NCT02332720|541595505|FG020|Part A and Part B|Adverse Event|0|||
150126088|NCT02332720|541595506|FG021|Part A and Part B|Adverse Event|0|||
150126089|NCT02332720|541595507|FG022|Part A and Part B|Adverse Event|0|||
150126090|NCT02332720|541595485|FG000|Part A and Part B|Physician Decision|0|||
150126091|NCT02332720|541595486|FG001|Part A and Part B|Physician Decision|0|||
150126092|NCT02332720|541595487|FG002|Part A and Part B|Physician Decision|0|||
150126093|NCT02332720|541595488|FG003|Part A and Part B|Physician Decision|0|||
150126094|NCT02332720|541595489|FG004|Part A and Part B|Physician Decision|0|||
150126095|NCT02332720|541595490|FG005|Part A and Part B|Physician Decision|0|||
150126096|NCT02332720|541595491|FG006|Part A and Part B|Physician Decision|0|||
150126097|NCT02332720|541595492|FG007|Part A and Part B|Physician Decision|0|||
150126098|NCT02332720|541595493|FG008|Part A and Part B|Physician Decision|0|||
150126099|NCT02332720|541595494|FG009|Part A and Part B|Physician Decision|0|||
150126100|NCT02332720|541595495|FG010|Part A and Part B|Physician Decision|0|||
150126101|NCT02332720|541595496|FG011|Part A and Part B|Physician Decision|0|||
150126102|NCT02332720|541595497|FG012|Part A and Part B|Physician Decision|0|||
150126103|NCT02332720|541595498|FG013|Part A and Part B|Physician Decision|0|||
150126104|NCT02332720|541595499|FG014|Part A and Part B|Physician Decision|0|||
150126105|NCT02332720|541595500|FG015|Part A and Part B|Physician Decision|0|||
150126106|NCT02332720|541595501|FG016|Part A and Part B|Physician Decision|0|||
150126107|NCT02332720|541595502|FG017|Part A and Part B|Physician Decision|0|||
150126108|NCT02332720|541595503|FG018|Part A and Part B|Physician Decision|1|||
150126109|NCT02332720|541595504|FG019|Part A and Part B|Physician Decision|0|||
150126110|NCT02332720|541595505|FG020|Part A and Part B|Physician Decision|0|||
150126111|NCT02332720|541595506|FG021|Part A and Part B|Physician Decision|0|||
150126112|NCT02332720|541595507|FG022|Part A and Part B|Physician Decision|0|||
150126113|NCT02332720|541595485|FG000|Part A and Part B|Withdrawal by Subject|0|||
150126114|NCT02332720|541595486|FG001|Part A and Part B|Withdrawal by Subject|0|||
150126115|NCT02332720|541595487|FG002|Part A and Part B|Withdrawal by Subject|0|||
150126116|NCT02332720|541595488|FG003|Part A and Part B|Withdrawal by Subject|0|||
150126117|NCT02332720|541595489|FG004|Part A and Part B|Withdrawal by Subject|0|||
150126118|NCT02332720|541595490|FG005|Part A and Part B|Withdrawal by Subject|1|||
150126119|NCT02332720|541595491|FG006|Part A and Part B|Withdrawal by Subject|0|||
150126120|NCT02332720|541595492|FG007|Part A and Part B|Withdrawal by Subject|0|||
150126121|NCT02332720|541595493|FG008|Part A and Part B|Withdrawal by Subject|0|||
150126122|NCT02332720|541595494|FG009|Part A and Part B|Withdrawal by Subject|0|||
150126123|NCT02332720|541595495|FG010|Part A and Part B|Withdrawal by Subject|0|||
150126124|NCT02332720|541595496|FG011|Part A and Part B|Withdrawal by Subject|0|||
150126125|NCT02332720|541595497|FG012|Part A and Part B|Withdrawal by Subject|0|||
150126126|NCT02332720|541595498|FG013|Part A and Part B|Withdrawal by Subject|0|||
150126127|NCT02332720|541595499|FG014|Part A and Part B|Withdrawal by Subject|0|||
150126128|NCT02332720|541595500|FG015|Part A and Part B|Withdrawal by Subject|0|||
150126129|NCT02332720|541595501|FG016|Part A and Part B|Withdrawal by Subject|0|||
150126130|NCT02332720|541595502|FG017|Part A and Part B|Withdrawal by Subject|0|||
150126131|NCT02332720|541595503|FG018|Part A and Part B|Withdrawal by Subject|0|||
150126132|NCT02332720|541595504|FG019|Part A and Part B|Withdrawal by Subject|1|||
150126133|NCT02332720|541595505|FG020|Part A and Part B|Withdrawal by Subject|0|||
150126134|NCT02332720|541595506|FG021|Part A and Part B|Withdrawal by Subject|0|||
150126135|NCT02332720|541595507|FG022|Part A and Part B|Withdrawal by Subject|0|||
150126136|NCT02207816|541595508|FG000|Overall Study|Serious Adverse Event|0|||
150126137|NCT02207816|541595509|FG001|Overall Study|Serious Adverse Event|5|||
150126138|NCT02207816|541595510|FG002|Overall Study|Serious Adverse Event|2|||
150126139|NCT02207816|541595508|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
150126140|NCT02207816|541595509|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
150126141|NCT02207816|541595510|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
150126142|NCT02207816|541595508|FG000|Overall Study|Withdrawal by Subject|4|||
150126143|NCT02207816|541595509|FG001|Overall Study|Withdrawal by Subject|9|||
150126144|NCT02207816|541595510|FG002|Overall Study|Withdrawal by Subject|7|||
150126145|NCT02207816|541595508|FG000|Overall Study|Migrated/Moved From Study Area|41|||
150126146|NCT02207816|541595509|FG001|Overall Study|Migrated/Moved From Study Area|60|||
150126147|NCT02207816|541595510|FG002|Overall Study|Migrated/Moved From Study Area|51|||
150126148|NCT02207816|541595508|FG000|Overall Study|Lost to Follow-up|3|||
150126149|NCT02207816|541595509|FG001|Overall Study|Lost to Follow-up|9|||
150126150|NCT02207816|541595510|FG002|Overall Study|Lost to Follow-up|1|||
150126151|NCT02207816|541595508|FG000|Overall Study|Other|1|||
150126152|NCT02207816|541595509|FG001|Overall Study|Other|2|||
150126153|NCT02207816|541595510|FG002|Overall Study|Other|4|||
150126154|NCT02349295|541595512|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
150126155|NCT02349295|541595513|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
150126156|NCT02349295|541595514|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
150126157|NCT02349295|541595515|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126158|NCT02349295|541595516|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126159|NCT02349295|541595517|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126160|NCT02349295|541595518|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126161|NCT02349295|541595519|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126162|NCT02349295|541595520|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126163|NCT02349295|541595521|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126164|NCT02349295|541595522|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126165|NCT02349295|541595523|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126166|NCT02349295|541595524|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126167|NCT02349295|541595525|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
150126168|NCT02349295|541595512|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
150126169|NCT02349295|541595513|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
150126170|NCT02349295|541595514|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
150126171|NCT02349295|541595515|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126172|NCT02349295|541595516|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126173|NCT02349295|541595517|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126174|NCT02349295|541595518|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126175|NCT02349295|541595519|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126176|NCT02349295|541595520|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126177|NCT02349295|541595521|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126178|NCT02349295|541595522|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126179|NCT02349295|541595523|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126180|NCT02349295|541595524|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126181|NCT02349295|541595525|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
150126182|NCT02349295|541595512|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
150126183|NCT02349295|541595513|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
150126184|NCT02349295|541595514|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
150126185|NCT02349295|541595515|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126186|NCT02349295|541595516|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126187|NCT02349295|541595517|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126188|NCT02349295|541595518|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126189|NCT02349295|541595519|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126190|NCT02349295|541595520|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126191|NCT02349295|541595521|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126192|NCT02349295|541595522|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126193|NCT02349295|541595523|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126194|NCT02349295|541595524|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126195|NCT02349295|541595525|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
150126196|NCT02349295|541595512|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
150126197|NCT02349295|541595513|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
150126198|NCT02349295|541595514|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
150126199|NCT02349295|541595515|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126200|NCT02349295|541595516|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126201|NCT02349295|541595517|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126202|NCT02349295|541595518|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126203|NCT02349295|541595519|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126204|NCT02349295|541595520|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126205|NCT02349295|541595521|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126206|NCT02349295|541595522|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126207|NCT02349295|541595523|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150193463|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
150193464|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
150126208|NCT02349295|541595524|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150126209|NCT02349295|541595525|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
150193465|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
150193466|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
150193467|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
150193468|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
150193469|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
150193470|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
150193471|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
150193472|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
150193473|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
150193474|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
150193475|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
150193476|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
150193477|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
150193478|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
150193479|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
150193480|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
150193481|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
150193482|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
150193483|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
150193484|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
150193485|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
150193486|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
150193487|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
150193488|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
150193489|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
150193490|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
150193491|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
150193492|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
150193493|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
150193494|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
150193495|NCT04963270|541848624|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
150193496|NCT04963270|541848625|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
150193497|NCT04963270|541848626|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
150193498|NCT04963270|541848627|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
150193499|NCT04802967|541848628|FG000|Part B|Withdrawal by Subject|0|||
150193500|NCT04802967|541848629|FG001|Part B|Withdrawal by Subject|0|||
150193501|NCT04802967|541848630|FG002|Part B|Withdrawal by Subject|0|||
150193502|NCT04802967|541848631|FG003|Part B|Withdrawal by Subject|0|||
150193503|NCT04802967|541848632|FG004|Part B|Withdrawal by Subject|0|||
150193504|NCT04802967|541848633|FG005|Part B|Withdrawal by Subject|1|||
150193505|NCT04802967|541848634|FG006|Part B|Withdrawal by Subject|0|||
150193506|NCT04802967|541848635|FG007|Part B|Withdrawal by Subject|0|||
150193507|NCT04802967|541848636|FG008|Part B|Withdrawal by Subject|0|||
150193508|NCT04802967|541848637|FG009|Part B|Withdrawal by Subject|0|||
150193509|NCT02979327|541848644|FG000|First Intervention|Protocol Violation|1|||
150193510|NCT02979327|541848645|FG001|First Intervention|Protocol Violation|0|||
150193511|NCT01073566|541848646|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
150193512|NCT01073566|541848647|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
150193513|NCT05672069|541848665|FG000|Overall Study|Implant removal|1|||
150193514|NCT05672069|541848665|FG000|Overall Study|Lost to Follow-up|2|||
150193515|NCT05362487|541848666|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
150193516|NCT02191618|541848667|FG000|Overall Study|Withdrawal by Subject|3|||
150193517|NCT02191618|541848667|FG000|Overall Study|Missed Visit|4|||
150193518|NCT03031470|541848669|FG000|Overall Study|Adverse Event|3|||
150193519|NCT03031470|541848670|FG001|Overall Study|Adverse Event|0|||
150193520|NCT03031470|541848669|FG000|Overall Study|Death|3|||
150193521|NCT03031470|541848670|FG001|Overall Study|Death|1|||
150193522|NCT03031470|541848669|FG000|Overall Study|Lost to Follow-up|1|||
150193523|NCT03031470|541848670|FG001|Overall Study|Lost to Follow-up|1|||
150193524|NCT03031470|541848669|FG000|Overall Study|Withdrawal by Subject|1|||
150193525|NCT03031470|541848670|FG001|Overall Study|Withdrawal by Subject|0|||
150193526|NCT03031470|541848669|FG000|Overall Study|Protocol entry criteria not met|0|||
150193527|NCT03031470|541848670|FG001|Overall Study|Protocol entry criteria not met|1|||
150193528|NCT03031470|541848669|FG000|Overall Study|Cancel the operation|0|||
150193529|NCT03031470|541848670|FG001|Overall Study|Cancel the operation|1|||
150193530|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
150193531|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
150193532|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
150193533|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
150193534|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
150193535|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
150193536|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
150193537|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
150193538|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
150193539|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
150193540|NCT03461276|541848671|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
150193541|NCT03461276|541848672|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
150193542|NCT03461276|541848671|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
150193543|NCT03461276|541848672|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
150193544|NCT03461276|541848671|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
150193545|NCT03461276|541848672|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
150193546|NCT03461276|541848671|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
150193547|NCT03461276|541848672|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
150193548|NCT03461276|541848671|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
150193549|NCT03461276|541848672|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
150193550|NCT01943409|541848673|FG000|Overall Study|resumed oral/entral|24|||
150193551|NCT01943409|541848674|FG001|Overall Study|resumed oral/entral|20|||
150193552|NCT01943409|541848673|FG000|Overall Study|Protocol Violation|14|||
150193553|NCT01943409|541848674|FG001|Overall Study|Protocol Violation|24|||
150193554|NCT01943409|541848673|FG000|Overall Study|Death|3|||
150193555|NCT01943409|541848674|FG001|Overall Study|Death|1|||
150193556|NCT01943409|541848673|FG000|Overall Study|Withdrawal by Subject|4|||
150193557|NCT01943409|541848674|FG001|Overall Study|Withdrawal by Subject|3|||
150193558|NCT02489903|541848675|FG000|Screening|Screen Failure|24|||
150193559|NCT02489903|541848676|FG001|Screening|Screen Failure|0|||
150193560|NCT02489903|541848677|FG002|Screening|Screen Failure|0|||
150193561|NCT02489903|541848678|FG003|Screening|Screen Failure|8|||
150193562|NCT02489903|541848675|FG000|Randomized and Received Treatment|Protocol Violation|0|||
150193563|NCT02489903|541848676|FG001|Randomized and Received Treatment|Protocol Violation|1|||
150193564|NCT02489903|541848677|FG002|Randomized and Received Treatment|Protocol Violation|0|||
150193565|NCT02489903|541848678|FG003|Randomized and Received Treatment|Protocol Violation|0|||
150193566|NCT02489903|541848675|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
150193567|NCT02489903|541848676|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
150193568|NCT02489903|541848677|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
150193569|NCT02489903|541848678|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
150193570|NCT02489903|541848675|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
150193571|NCT02489903|541848676|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
150193572|NCT02489903|541848677|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
150193573|NCT02489903|541848678|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
150193574|NCT02489903|541848675|FG000|Randomized and Received Treatment|Death|10|||
150193575|NCT02489903|541848676|FG001|Randomized and Received Treatment|Death|1|||
150193576|NCT02489903|541848677|FG002|Randomized and Received Treatment|Death|0|||
150193577|NCT02489903|541848678|FG003|Randomized and Received Treatment|Death|0|||
150193578|NCT01802788|541848679|FG000|Overall Study|Withdrawal by Subject|102|||
150193579|NCT01802788|541848680|FG001|Overall Study|Withdrawal by Subject|5|||
150193580|NCT01802788|541848679|FG000|Overall Study|Death|382|||
150193581|NCT01802788|541848680|FG001|Overall Study|Death|18|||
150193582|NCT01802788|541848679|FG000|Overall Study|Lost to Follow-up|31|||
150193583|NCT01802788|541848680|FG001|Overall Study|Lost to Follow-up|2|||
150193584|NCT01802788|541848679|FG000|Overall Study|Physician Decision|3|||
150193585|NCT01802788|541848680|FG001|Overall Study|Physician Decision|0|||
150193586|NCT01802788|541848679|FG000|Overall Study|Patient Non-Compliance|1|||
150193587|NCT01802788|541848680|FG001|Overall Study|Patient Non-Compliance|0|||
150193588|NCT01802788|541848679|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
150193589|NCT01802788|541848680|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
150193590|NCT01802788|541848679|FG000|Overall Study|Other Reasons|19|||
150193591|NCT01802788|541848680|FG001|Overall Study|Other Reasons|0|||
150193592|NCT03496168|541848681|FG000|Overall Study|Other Reasons|1|||
150193593|NCT03496168|541848681|FG000|Overall Study|Adverse Event|1|||
150193594|NCT02043678|541848684|FG000|Overall Study|Never treated|11|||
150193595|NCT02043678|541848685|FG001|Overall Study|Never treated|9|||
150193596|NCT02043678|541848684|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
150193597|NCT02043678|541848685|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
150193598|NCT02043678|541848684|FG000|Overall Study|AE without clinical PD|54|||
150193599|NCT02043678|541848685|FG001|Overall Study|AE without clinical PD|36|||
150193600|NCT02043678|541848684|FG000|Overall Study|Lost to Follow-up|1|||
150193601|NCT02043678|541848685|FG001|Overall Study|Lost to Follow-up|1|||
150193602|NCT02043678|541848684|FG000|Overall Study|Other|10|||
150126210|NCT02349295|541595512|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126211|NCT02349295|541595513|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
150126212|NCT02349295|541595514|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
150126213|NCT02349295|541595515|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126214|NCT02349295|541595516|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126215|NCT02349295|541595517|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126216|NCT02349295|541595518|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126217|NCT02349295|541595519|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126218|NCT02349295|541595520|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126219|NCT02349295|541595521|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126220|NCT02349295|541595522|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126221|NCT02349295|541595523|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126222|NCT02349295|541595524|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126223|NCT02349295|541595525|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
150126224|NCT02349295|541595512|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
150126225|NCT02349295|541595513|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
150126226|NCT02349295|541595514|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
150126227|NCT02349295|541595515|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
150126228|NCT02349295|541595516|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
150126229|NCT02349295|541595517|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
150126230|NCT02349295|541595518|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
150126231|NCT02349295|541595519|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
150126232|NCT02349295|541595520|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
150126233|NCT02349295|541595521|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
150126234|NCT02349295|541595522|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
150126235|NCT02349295|541595523|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
150126236|NCT02349295|541595524|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
150126237|NCT02349295|541595525|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
150126238|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126239|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126240|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126241|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126242|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126243|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126244|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126245|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
150126246|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
150126247|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
150126248|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
150126249|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126250|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126251|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
150126252|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126253|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126254|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126255|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126256|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126257|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126258|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126259|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
150126260|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
150126261|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
150126262|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
150126263|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126264|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126265|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
150126266|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126267|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126268|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126269|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126270|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126271|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126272|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126273|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
150126274|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126275|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
150193603|NCT02043678|541848685|FG001|Overall Study|Other|14|||
150193604|NCT02043678|541848684|FG000|Overall Study|Clinical PD|114|||
150193605|NCT02043678|541848685|FG001|Overall Study|Clinical PD|148|||
150193606|NCT02043678|541848684|FG000|Overall Study|Radiological PD|100|||
150193607|NCT02043678|541848685|FG001|Overall Study|Radiological PD|90|||
150193608|NCT02043678|541848684|FG000|Overall Study|Protocol-driven decision point|59|||
150193609|NCT02043678|541848685|FG001|Overall Study|Protocol-driven decision point|58|||
150193610|NCT02043678|541848684|FG000|Overall Study|Withdrawal by Subject|16|||
150193611|NCT02043678|541848685|FG001|Overall Study|Withdrawal by Subject|20|||
150193612|NCT02043678|541848684|FG000|Overall Study|Protocol Violation|1|||
150193613|NCT02043678|541848685|FG001|Overall Study|Protocol Violation|0|||
150193614|NCT02043678|541848684|FG000|Overall Study|Deterioration of general conditions|1|||
150193615|NCT02043678|541848685|FG001|Overall Study|Deterioration of general conditions|1|||
150193616|NCT02043678|541848684|FG000|Overall Study|Logistical difficulties|2|||
150193617|NCT02043678|541848685|FG001|Overall Study|Logistical difficulties|0|||
150193618|NCT02043678|541848684|FG000|Overall Study|Non-compliance with study drug|3|||
150193619|NCT02043678|541848685|FG001|Overall Study|Non-compliance with study drug|1|||
150193620|NCT02043678|541848684|FG000|Overall Study|Physician Decision|4|||
150193621|NCT02043678|541848685|FG001|Overall Study|Physician Decision|3|||
150193622|NCT02043678|541848684|FG000|Overall Study|Subject decision|0|||
150193623|NCT02043678|541848685|FG001|Overall Study|Subject decision|1|||
150193624|NCT02043678|541848684|FG000|Overall Study|Switching to other therapy|3|||
150193625|NCT02043678|541848685|FG001|Overall Study|Switching to other therapy|2|||
150193626|NCT02043678|541848684|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
150193627|NCT02043678|541848685|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
150193628|NCT02043678|541848684|FG000|Overall Study|Missing|1|||
150193629|NCT02043678|541848685|FG001|Overall Study|Missing|0|||
150193630|NCT02043678|541848684|FG000|Overall Study|Adverse Event|0|||
150193631|NCT02043678|541848685|FG001|Overall Study|Adverse Event|1|||
150193632|NCT03216057|541848686|FG000|Overall Study|Lost to Follow-up|2|||
150193633|NCT03216057|541848687|FG001|Overall Study|Lost to Follow-up|2|||
150193634|NCT04568603|541848688|FG000|Overall Study|Physician Decision|1|||
150193635|NCT04564742|541848689|FG000|Overall Study|Lost to Follow-up|1|||
150193636|NCT04564742|541848690|FG001|Overall Study|Lost to Follow-up|0|||
150193637|NCT04564742|541848689|FG000|Overall Study|Consent Withdrawal|4|||
150193638|NCT04564742|541848690|FG001|Overall Study|Consent Withdrawal|4|||
150193639|NCT05269667|541848699|FG000|Overall Study|Study Terminated by Sponsor|4|||
150193640|NCT04948697|541848705|FG000|Overall Study|Progressive disease|27|||
150193641|NCT04948697|541848706|FG001|Overall Study|Progressive disease|18|||
150193642|NCT04948697|541848705|FG000|Overall Study|Adverse Event|14|||
150193643|NCT04948697|541848706|FG001|Overall Study|Adverse Event|4|||
150193644|NCT04948697|541848705|FG000|Overall Study|Participant moved to long term extension study|7|||
150193645|NCT04948697|541848706|FG001|Overall Study|Participant moved to long term extension study|4|||
150193646|NCT04948697|541848705|FG000|Overall Study|Withdrawal by Subject|10|||
150193647|NCT04948697|541848706|FG001|Overall Study|Withdrawal by Subject|0|||
150193648|NCT04948697|541848705|FG000|Overall Study|Closed by Sponsor|3|||
150193649|NCT04948697|541848706|FG001|Overall Study|Closed by Sponsor|2|||
150193650|NCT04948697|541848705|FG000|Overall Study|Physician Decision|0|||
150193651|NCT04948697|541848706|FG001|Overall Study|Physician Decision|2|||
150193652|NCT04948697|541848705|FG000|Overall Study|Lost to Follow-up|0|||
150193653|NCT04948697|541848706|FG001|Overall Study|Lost to Follow-up|1|||
150193654|NCT04948697|541848705|FG000|Overall Study|Other-Miscellaneous|1|||
150193655|NCT04948697|541848706|FG001|Overall Study|Other-Miscellaneous|0|||
150193656|NCT04948697|541848705|FG000|Overall Study|Randomized but not treated|0|||
150193657|NCT04948697|541848706|FG001|Overall Study|Randomized but not treated|1|||
150193658|NCT04599062|541848708|FG000|Overall Study|Physician Decision|1|||
150193659|NCT04599062|541848709|FG001|Overall Study|Physician Decision|0|||
150193660|NCT04032704|541848710|FG000|Part A|Withdrawal by Subject|0|||
150193661|NCT04032704|541848711|FG001|Part A|Withdrawal by Subject|0|||
150193662|NCT04032704|541848712|FG002|Part A|Withdrawal by Subject|3|||
150193663|NCT04032704|541848713|FG003|Part A|Withdrawal by Subject|0|||
150193664|NCT04032704|541848714|FG004|Part A|Withdrawal by Subject|1|||
150193665|NCT04032704|541848715|FG005|Part A|Withdrawal by Subject|7|||
150193666|NCT04032704|541848716|FG006|Part A|Withdrawal by Subject|0|||
150193667|NCT04032704|541848717|FG007|Part A|Withdrawal by Subject|0|||
150193668|NCT04032704|541848718|FG008|Part A|Withdrawal by Subject|0|||
150193669|NCT04032704|541848719|FG009|Part A|Withdrawal by Subject|0|||
150193670|NCT04032704|541848720|FG010|Part A|Withdrawal by Subject|0|||
150193671|NCT04032704|541848721|FG011|Part A|Withdrawal by Subject|0|||
150193672|NCT04032704|541848722|FG012|Part A|Withdrawal by Subject|0|||
150193673|NCT04032704|541848723|FG013|Part A|Withdrawal by Subject|0|||
150193674|NCT04032704|541848724|FG014|Part A|Withdrawal by Subject|0|||
150193675|NCT04032704|541848725|FG015|Part A|Withdrawal by Subject|0|||
150193676|NCT04032704|541848726|FG016|Part A|Withdrawal by Subject|0|||
150193677|NCT04032704|541848727|FG017|Part A|Withdrawal by Subject|0|||
150193678|NCT04032704|541848710|FG000|Part A|Lost to Follow-up|1|||
150193679|NCT04032704|541848711|FG001|Part A|Lost to Follow-up|0|||
150193680|NCT04032704|541848712|FG002|Part A|Lost to Follow-up|0|||
150126276|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126277|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126278|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126279|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
150126280|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
150126281|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
150126282|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
150126283|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
150126284|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
150126285|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
150126286|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
150126287|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
150126288|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
150126289|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
150126290|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
150126291|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
150126292|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
150126293|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
150126294|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126295|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126296|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126297|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126298|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126299|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126300|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126301|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
150126302|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
150126303|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
150126304|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
150126305|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126306|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126307|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
150126308|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126309|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126310|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126311|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126312|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126313|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126314|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126315|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
150126316|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
150126317|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126318|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126319|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126320|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126321|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
150126322|NCT02349295|541595512|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126323|NCT02349295|541595513|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126324|NCT02349295|541595514|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126325|NCT02349295|541595515|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126326|NCT02349295|541595516|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126327|NCT02349295|541595517|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126328|NCT02349295|541595518|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126329|NCT02349295|541595519|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
150126330|NCT02349295|541595520|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
150126331|NCT02349295|541595521|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126332|NCT02349295|541595522|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150193681|NCT04032704|541848713|FG003|Part A|Lost to Follow-up|0|||
150126333|NCT02349295|541595523|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126334|NCT02349295|541595524|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126335|NCT02349295|541595525|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
150126336|NCT02349295|541595512|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126337|NCT02349295|541595513|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126338|NCT02349295|541595514|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126339|NCT02349295|541595515|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126340|NCT02349295|541595516|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126341|NCT02349295|541595517|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126342|NCT02349295|541595518|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126343|NCT02349295|541595519|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126344|NCT02349295|541595520|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126345|NCT02349295|541595521|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126346|NCT02349295|541595522|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
150126347|NCT02349295|541595523|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
150126348|NCT02349295|541595524|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
150126349|NCT02349295|541595525|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
150126350|NCT02349295|541595512|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126351|NCT02349295|541595513|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126352|NCT02349295|541595514|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126353|NCT02349295|541595515|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126354|NCT02349295|541595516|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126355|NCT02349295|541595517|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126356|NCT02349295|541595518|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126357|NCT02349295|541595519|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126358|NCT02349295|541595520|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126359|NCT02349295|541595521|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126360|NCT02349295|541595522|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126361|NCT02349295|541595523|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
150126362|NCT02349295|541595524|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
150126363|NCT02349295|541595525|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
150126364|NCT02349295|541595512|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126365|NCT02349295|541595513|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126366|NCT02349295|541595514|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126367|NCT02349295|541595515|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126368|NCT02349295|541595516|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126369|NCT02349295|541595517|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126370|NCT02349295|541595518|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126371|NCT02349295|541595519|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126372|NCT02349295|541595520|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126373|NCT02349295|541595521|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126374|NCT02349295|541595522|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126375|NCT02349295|541595523|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
150126376|NCT02349295|541595524|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
150126377|NCT02349295|541595525|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
150126378|NCT02349295|541595512|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126379|NCT02349295|541595513|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126380|NCT02349295|541595514|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126381|NCT02349295|541595515|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126382|NCT02349295|541595516|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126383|NCT02349295|541595517|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126384|NCT02349295|541595518|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126385|NCT02349295|541595519|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150193682|NCT04032704|541848714|FG004|Part A|Lost to Follow-up|0|||
150193683|NCT04032704|541848715|FG005|Part A|Lost to Follow-up|0|||
150193684|NCT04032704|541848716|FG006|Part A|Lost to Follow-up|0|||
150193685|NCT04032704|541848717|FG007|Part A|Lost to Follow-up|0|||
150193686|NCT04032704|541848718|FG008|Part A|Lost to Follow-up|0|||
150193687|NCT04032704|541848719|FG009|Part A|Lost to Follow-up|0|||
150193688|NCT04032704|541848720|FG010|Part A|Lost to Follow-up|0|||
150193689|NCT04032704|541848721|FG011|Part A|Lost to Follow-up|0|||
150193690|NCT04032704|541848722|FG012|Part A|Lost to Follow-up|0|||
150193691|NCT04032704|541848723|FG013|Part A|Lost to Follow-up|0|||
150193692|NCT04032704|541848724|FG014|Part A|Lost to Follow-up|0|||
150193693|NCT04032704|541848725|FG015|Part A|Lost to Follow-up|0|||
150193694|NCT04032704|541848726|FG016|Part A|Lost to Follow-up|0|||
150193695|NCT04032704|541848727|FG017|Part A|Lost to Follow-up|0|||
150193696|NCT04032704|541848710|FG000|Part A|Death|9|||
150193697|NCT04032704|541848711|FG001|Part A|Death|2|||
150193698|NCT04032704|541848712|FG002|Part A|Death|10|||
150193699|NCT04032704|541848713|FG003|Part A|Death|7|||
150193700|NCT04032704|541848714|FG004|Part A|Death|4|||
150193701|NCT04032704|541848715|FG005|Part A|Death|5|||
150193702|NCT04032704|541848716|FG006|Part A|Death|0|||
150193703|NCT04032704|541848717|FG007|Part A|Death|0|||
150193704|NCT04032704|541848718|FG008|Part A|Death|0|||
150193705|NCT04032704|541848719|FG009|Part A|Death|0|||
150193706|NCT04032704|541848720|FG010|Part A|Death|0|||
150193707|NCT04032704|541848721|FG011|Part A|Death|0|||
150193708|NCT04032704|541848722|FG012|Part A|Death|0|||
150193709|NCT04032704|541848723|FG013|Part A|Death|0|||
150193710|NCT04032704|541848724|FG014|Part A|Death|0|||
150193711|NCT04032704|541848725|FG015|Part A|Death|0|||
150193712|NCT04032704|541848726|FG016|Part A|Death|0|||
150193713|NCT04032704|541848727|FG017|Part A|Death|0|||
150193714|NCT04032704|541848710|FG000|Part B|Other|0|||
150193715|NCT04032704|541848711|FG001|Part B|Other|0|||
150193716|NCT04032704|541848712|FG002|Part B|Other|0|||
150193717|NCT04032704|541848713|FG003|Part B|Other|0|||
150193718|NCT04032704|541848714|FG004|Part B|Other|0|||
150193719|NCT04032704|541848715|FG005|Part B|Other|0|||
150193720|NCT04032704|541848716|FG006|Part B|Other|0|||
150193721|NCT04032704|541848717|FG007|Part B|Other|1|||
150193722|NCT04032704|541848718|FG008|Part B|Other|2|||
150193723|NCT04032704|541848719|FG009|Part B|Other|1|||
150193724|NCT04032704|541848720|FG010|Part B|Other|1|||
150193725|NCT04032704|541848721|FG011|Part B|Other|1|||
150193726|NCT04032704|541848722|FG012|Part B|Other|5|||
150193727|NCT04032704|541848723|FG013|Part B|Other|13|||
150193728|NCT04032704|541848724|FG014|Part B|Other|0|||
150193729|NCT04032704|541848725|FG015|Part B|Other|0|||
150193730|NCT04032704|541848726|FG016|Part B|Other|0|||
150193731|NCT04032704|541848727|FG017|Part B|Other|0|||
150193732|NCT04032704|541848710|FG000|Part B|Study termination by Sponsor|0|||
150193733|NCT04032704|541848711|FG001|Part B|Study termination by Sponsor|0|||
150193734|NCT04032704|541848712|FG002|Part B|Study termination by Sponsor|0|||
150193735|NCT04032704|541848713|FG003|Part B|Study termination by Sponsor|0|||
150193736|NCT04032704|541848714|FG004|Part B|Study termination by Sponsor|0|||
150193737|NCT04032704|541848715|FG005|Part B|Study termination by Sponsor|0|||
150193738|NCT04032704|541848716|FG006|Part B|Study termination by Sponsor|0|||
150193739|NCT04032704|541848717|FG007|Part B|Study termination by Sponsor|0|||
150193740|NCT04032704|541848718|FG008|Part B|Study termination by Sponsor|1|||
150193741|NCT04032704|541848719|FG009|Part B|Study termination by Sponsor|0|||
150193742|NCT04032704|541848720|FG010|Part B|Study termination by Sponsor|0|||
150193743|NCT04032704|541848721|FG011|Part B|Study termination by Sponsor|0|||
150193744|NCT04032704|541848722|FG012|Part B|Study termination by Sponsor|0|||
150193745|NCT04032704|541848723|FG013|Part B|Study termination by Sponsor|0|||
150193746|NCT04032704|541848724|FG014|Part B|Study termination by Sponsor|0|||
150193747|NCT04032704|541848725|FG015|Part B|Study termination by Sponsor|0|||
150193748|NCT04032704|541848726|FG016|Part B|Study termination by Sponsor|0|||
150193749|NCT04032704|541848727|FG017|Part B|Study termination by Sponsor|0|||
150193750|NCT04032704|541848710|FG000|Part B|Withdrawal by Subject|0|||
150193751|NCT04032704|541848711|FG001|Part B|Withdrawal by Subject|0|||
150193752|NCT04032704|541848712|FG002|Part B|Withdrawal by Subject|0|||
150193753|NCT04032704|541848713|FG003|Part B|Withdrawal by Subject|0|||
150193754|NCT04032704|541848714|FG004|Part B|Withdrawal by Subject|0|||
150193755|NCT04032704|541848715|FG005|Part B|Withdrawal by Subject|0|||
150193756|NCT04032704|541848716|FG006|Part B|Withdrawal by Subject|3|||
150193757|NCT04032704|541848717|FG007|Part B|Withdrawal by Subject|2|||
150193758|NCT04032704|541848718|FG008|Part B|Withdrawal by Subject|2|||
150193759|NCT04032704|541848719|FG009|Part B|Withdrawal by Subject|1|||
150193760|NCT04032704|541848720|FG010|Part B|Withdrawal by Subject|4|||
150193761|NCT04032704|541848721|FG011|Part B|Withdrawal by Subject|6|||
150193762|NCT04032704|541848722|FG012|Part B|Withdrawal by Subject|2|||
150193763|NCT04032704|541848723|FG013|Part B|Withdrawal by Subject|1|||
150193764|NCT04032704|541848724|FG014|Part B|Withdrawal by Subject|0|||
150193765|NCT04032704|541848725|FG015|Part B|Withdrawal by Subject|1|||
150193766|NCT04032704|541848726|FG016|Part B|Withdrawal by Subject|0|||
150193767|NCT04032704|541848727|FG017|Part B|Withdrawal by Subject|0|||
150193768|NCT04032704|541848710|FG000|Part B|Lost to Follow-up|0|||
150193769|NCT04032704|541848711|FG001|Part B|Lost to Follow-up|0|||
150193770|NCT04032704|541848712|FG002|Part B|Lost to Follow-up|0|||
150193771|NCT04032704|541848713|FG003|Part B|Lost to Follow-up|0|||
150193772|NCT04032704|541848714|FG004|Part B|Lost to Follow-up|0|||
150193773|NCT04032704|541848715|FG005|Part B|Lost to Follow-up|0|||
150193774|NCT04032704|541848716|FG006|Part B|Lost to Follow-up|0|||
150193775|NCT04032704|541848717|FG007|Part B|Lost to Follow-up|0|||
150193776|NCT04032704|541848718|FG008|Part B|Lost to Follow-up|0|||
150193777|NCT04032704|541848719|FG009|Part B|Lost to Follow-up|0|||
150193778|NCT04032704|541848720|FG010|Part B|Lost to Follow-up|0|||
150193779|NCT04032704|541848721|FG011|Part B|Lost to Follow-up|1|||
150193780|NCT04032704|541848722|FG012|Part B|Lost to Follow-up|0|||
150193781|NCT04032704|541848723|FG013|Part B|Lost to Follow-up|0|||
150193782|NCT04032704|541848724|FG014|Part B|Lost to Follow-up|0|||
150193783|NCT04032704|541848725|FG015|Part B|Lost to Follow-up|0|||
150193784|NCT04032704|541848726|FG016|Part B|Lost to Follow-up|0|||
150193785|NCT04032704|541848727|FG017|Part B|Lost to Follow-up|0|||
150193786|NCT04032704|541848710|FG000|Part B|Death|0|||
150193787|NCT04032704|541848711|FG001|Part B|Death|0|||
150193788|NCT04032704|541848712|FG002|Part B|Death|0|||
150193789|NCT04032704|541848713|FG003|Part B|Death|0|||
150193790|NCT04032704|541848714|FG004|Part B|Death|0|||
150193791|NCT04032704|541848715|FG005|Part B|Death|0|||
150193792|NCT04032704|541848716|FG006|Part B|Death|13|||
150193793|NCT04032704|541848717|FG007|Part B|Death|13|||
150193794|NCT04032704|541848718|FG008|Part B|Death|14|||
150193795|NCT04032704|541848719|FG009|Part B|Death|12|||
150193796|NCT04032704|541848720|FG010|Part B|Death|12|||
150193797|NCT04032704|541848721|FG011|Part B|Death|13|||
150193798|NCT04032704|541848722|FG012|Part B|Death|7|||
150193799|NCT04032704|541848723|FG013|Part B|Death|17|||
150193800|NCT04032704|541848724|FG014|Part B|Death|2|||
150193801|NCT04032704|541848725|FG015|Part B|Death|1|||
150193802|NCT04032704|541848726|FG016|Part B|Death|2|||
150193803|NCT04032704|541848727|FG017|Part B|Death|2|||
150193804|NCT02993159|541848728|FG000|Overall Study|Withdrawal by Subject|1|||
150193805|NCT02993159|541848729|FG001|Overall Study|Withdrawal by Subject|3|||
150193806|NCT02993159|541848728|FG000|Overall Study|Protocol Violation|1|||
150193807|NCT02993159|541848729|FG001|Overall Study|Protocol Violation|0|||
150193808|NCT02993159|541848728|FG000|Overall Study|Opted out of surgery|2|||
150193809|NCT02993159|541848729|FG001|Overall Study|Opted out of surgery|0|||
150193810|NCT02993159|541848728|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
150193811|NCT02993159|541848729|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
150193812|NCT02993159|541848728|FG000|Overall Study|Physician Decision|0|||
150193813|NCT02993159|541848729|FG001|Overall Study|Physician Decision|1|||
150193814|NCT04992520|541848730|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
150193815|NCT04992520|541848731|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
150193816|NCT04992520|541848732|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
150193817|NCT04992520|541848733|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
150193818|NCT04992520|541848734|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
150193819|NCT04992520|541848735|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
150193820|NCT04992520|541848730|FG000|Part A: First Challenge|Non-compliance|0|||
150193821|NCT04992520|541848731|FG001|Part A: First Challenge|Non-compliance|0|||
150193822|NCT04992520|541848732|FG002|Part A: First Challenge|Non-compliance|0|||
150193823|NCT04992520|541848733|FG003|Part A: First Challenge|Non-compliance|1|||
150193824|NCT04992520|541848734|FG004|Part A: First Challenge|Non-compliance|0|||
150193825|NCT04992520|541848735|FG005|Part A: First Challenge|Non-compliance|0|||
150193826|NCT04992520|541848730|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
150126386|NCT02349295|541595520|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126387|NCT02349295|541595521|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126388|NCT02349295|541595522|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126389|NCT02349295|541595523|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
150126390|NCT02349295|541595524|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126391|NCT02349295|541595525|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
150126392|NCT02349295|541595512|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126393|NCT02349295|541595513|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126394|NCT02349295|541595514|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126395|NCT02349295|541595515|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126396|NCT02349295|541595516|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126397|NCT02349295|541595517|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126398|NCT02349295|541595518|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126399|NCT02349295|541595519|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126400|NCT02349295|541595520|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126401|NCT02349295|541595521|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126402|NCT02349295|541595522|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126403|NCT02349295|541595523|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
150126404|NCT02349295|541595524|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126405|NCT02349295|541595525|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
150126406|NCT06111742|541595526|FG000|Overall Study|Did not receive intervention|1|||
150126407|NCT06111742|541595527|FG001|Overall Study|Did not receive intervention|0|||
150126408|NCT06111742|541595528|FG002|Overall Study|Did not receive intervention|0|||
150126409|NCT06111742|541595526|FG000|Overall Study|Withdrawal by Subject|2|||
150126410|NCT06111742|541595527|FG001|Overall Study|Withdrawal by Subject|0|||
150126411|NCT06111742|541595528|FG002|Overall Study|Withdrawal by Subject|0|||
150126412|NCT01914926|541595529|FG000|Overall Study|Adverse Event|1|||
150126413|NCT01914926|541595530|FG001|Overall Study|Adverse Event|0|||
150126414|NCT01914926|541595529|FG000|Overall Study|uncooperative, agitated and removed|0|||
150126415|NCT01914926|541595530|FG001|Overall Study|uncooperative, agitated and removed|1|||
150126416|NCT04717596|541595531|FG000|Overall Study|Withdrawal by Subject|4|||
150126417|NCT02473952|541595532|FG000|Overall Study|Adverse Event|2|||
150126418|NCT02473952|541595533|FG001|Overall Study|Adverse Event|2|||
150126419|NCT02473952|541595532|FG000|Overall Study|Withdrawal by Subject|0|||
150126420|NCT02473952|541595533|FG001|Overall Study|Withdrawal by Subject|6|||
150126421|NCT00237744|541595535|FG000|Overall Study|Withdrawal by Subject|3|||
150126422|NCT00237744|541595536|FG001|Overall Study|Withdrawal by Subject|1|||
150126423|NCT00237744|541595537|FG002|Overall Study|Withdrawal by Subject|0|||
150126424|NCT03204279|541595538|FG000|Overall Study|Withdrawal by Subject|0|||
150126425|NCT03204279|541595539|FG001|Overall Study|Withdrawal by Subject|1|||
150126426|NCT01064739|541595540|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
150126427|NCT04258020|541595543|FG000|Overall Study|Withdrawal by Subject|1|||
150126428|NCT04258020|541595544|FG001|Overall Study|Withdrawal by Subject|0|||
150126429|NCT02097472|541595545|FG000|Received Vaccination 2|Adverse Event|0|||
150126430|NCT02097472|541595546|FG001|Received Vaccination 2|Adverse Event|0|||
150126431|NCT02097472|541595547|FG002|Received Vaccination 2|Adverse Event|0|||
150126432|NCT02097472|541595548|FG003|Received Vaccination 2|Adverse Event|0|||
150126433|NCT02097472|541595549|FG004|Received Vaccination 2|Adverse Event|0|||
150126434|NCT02097472|541595550|FG005|Received Vaccination 2|Adverse Event|0|||
150126435|NCT02097472|541595551|FG006|Received Vaccination 2|Adverse Event|1|||
150126436|NCT02097472|541595552|FG007|Received Vaccination 2|Adverse Event|0|||
150126437|NCT04004611|541595553|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126438|NCT04004611|541595554|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126439|NCT04004611|541595555|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126440|NCT04004611|541595556|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126441|NCT04004611|541595557|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126442|NCT04004611|541595558|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126443|NCT04004611|541595559|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126444|NCT04004611|541595560|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
150126445|NCT04004611|541595561|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
150126446|NCT04004611|541595553|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126447|NCT04004611|541595554|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126448|NCT04004611|541595555|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126449|NCT04004611|541595556|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126450|NCT04004611|541595557|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126451|NCT04004611|541595558|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
150126452|NCT04004611|541595559|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
150126453|NCT04004611|541595560|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
150126454|NCT04004611|541595561|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
150126455|NCT04004611|541595553|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150193827|NCT04992520|541848731|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
150193828|NCT04992520|541848732|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
150193829|NCT04992520|541848733|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
150193830|NCT04992520|541848734|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
150193831|NCT04992520|541848735|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
150193832|NCT04992520|541848730|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
150193833|NCT04992520|541848731|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
150193834|NCT04992520|541848732|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
150193835|NCT04992520|541848733|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
150193836|NCT04992520|541848734|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
150193837|NCT04992520|541848735|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
150193838|NCT05281562|541848737|FG000|Overall Study|Ineligible patient|1|||
150193839|NCT05281562|541848738|FG001|Overall Study|Ineligible patient|0|||
150193840|NCT03058289|541848745|FG000|Overall Study|Radiographic Deterioration|0|||
150193841|NCT03058289|541848746|FG001|Overall Study|Radiographic Deterioration|3|||
150193842|NCT03058289|541848747|FG002|Overall Study|Radiographic Deterioration|1|||
150193843|NCT03058289|541848748|FG003|Overall Study|Radiographic Deterioration|2|||
150193844|NCT03058289|541848749|FG004|Overall Study|Radiographic Deterioration|6|||
150193845|NCT03058289|541848750|FG005|Overall Study|Radiographic Deterioration|3|||
150193846|NCT03058289|541848751|FG006|Overall Study|Radiographic Deterioration|0|||
150193847|NCT03058289|541848752|FG007|Overall Study|Radiographic Deterioration|4|||
150193848|NCT03058289|541848753|FG008|Overall Study|Radiographic Deterioration|2|||
150193849|NCT03058289|541848745|FG000|Overall Study|Adverse Event|2|||
150193850|NCT03058289|541848746|FG001|Overall Study|Adverse Event|0|||
150193851|NCT03058289|541848747|FG002|Overall Study|Adverse Event|1|||
150193852|NCT03058289|541848748|FG003|Overall Study|Adverse Event|3|||
150193853|NCT03058289|541848749|FG004|Overall Study|Adverse Event|1|||
150193854|NCT03058289|541848750|FG005|Overall Study|Adverse Event|0|||
150193855|NCT03058289|541848751|FG006|Overall Study|Adverse Event|1|||
150193856|NCT03058289|541848752|FG007|Overall Study|Adverse Event|3|||
150193857|NCT03058289|541848753|FG008|Overall Study|Adverse Event|0|||
150193858|NCT03058289|541848745|FG000|Overall Study|Withdrawal by Subject|0|||
150193859|NCT03058289|541848746|FG001|Overall Study|Withdrawal by Subject|0|||
150193860|NCT03058289|541848747|FG002|Overall Study|Withdrawal by Subject|0|||
150193861|NCT03058289|541848748|FG003|Overall Study|Withdrawal by Subject|2|||
150193862|NCT03058289|541848749|FG004|Overall Study|Withdrawal by Subject|0|||
150193863|NCT03058289|541848750|FG005|Overall Study|Withdrawal by Subject|2|||
150193864|NCT03058289|541848751|FG006|Overall Study|Withdrawal by Subject|0|||
150193865|NCT03058289|541848752|FG007|Overall Study|Withdrawal by Subject|4|||
150193866|NCT03058289|541848753|FG008|Overall Study|Withdrawal by Subject|1|||
150193867|NCT03058289|541848745|FG000|Overall Study|Physician Decision|1|||
150193868|NCT03058289|541848746|FG001|Overall Study|Physician Decision|0|||
150193869|NCT03058289|541848747|FG002|Overall Study|Physician Decision|0|||
150193870|NCT03058289|541848748|FG003|Overall Study|Physician Decision|2|||
150193871|NCT03058289|541848749|FG004|Overall Study|Physician Decision|1|||
150193872|NCT03058289|541848750|FG005|Overall Study|Physician Decision|0|||
150193873|NCT03058289|541848751|FG006|Overall Study|Physician Decision|2|||
150193874|NCT03058289|541848752|FG007|Overall Study|Physician Decision|3|||
150193875|NCT03058289|541848753|FG008|Overall Study|Physician Decision|0|||
150193876|NCT03058289|541848745|FG000|Overall Study|Clinical Deterioration|2|||
150193877|NCT03058289|541848746|FG001|Overall Study|Clinical Deterioration|0|||
150193878|NCT03058289|541848747|FG002|Overall Study|Clinical Deterioration|0|||
150193879|NCT03058289|541848748|FG003|Overall Study|Clinical Deterioration|2|||
150193880|NCT03058289|541848749|FG004|Overall Study|Clinical Deterioration|1|||
150193881|NCT03058289|541848750|FG005|Overall Study|Clinical Deterioration|1|||
150193882|NCT03058289|541848751|FG006|Overall Study|Clinical Deterioration|0|||
150193883|NCT03058289|541848752|FG007|Overall Study|Clinical Deterioration|3|||
150193884|NCT03058289|541848753|FG008|Overall Study|Clinical Deterioration|2|||
150193885|NCT03058289|541848745|FG000|Overall Study|Lost to Follow-up|0|||
150193886|NCT03058289|541848746|FG001|Overall Study|Lost to Follow-up|0|||
150193887|NCT03058289|541848747|FG002|Overall Study|Lost to Follow-up|0|||
150193888|NCT03058289|541848748|FG003|Overall Study|Lost to Follow-up|0|||
150193889|NCT03058289|541848749|FG004|Overall Study|Lost to Follow-up|1|||
150193890|NCT03058289|541848750|FG005|Overall Study|Lost to Follow-up|0|||
150193891|NCT03058289|541848751|FG006|Overall Study|Lost to Follow-up|0|||
150193892|NCT03058289|541848752|FG007|Overall Study|Lost to Follow-up|0|||
150193893|NCT03058289|541848753|FG008|Overall Study|Lost to Follow-up|0|||
150193894|NCT03058289|541848745|FG000|Overall Study|Refused Further Treatment|0|||
150193895|NCT03058289|541848746|FG001|Overall Study|Refused Further Treatment|0|||
150193896|NCT03058289|541848747|FG002|Overall Study|Refused Further Treatment|1|||
150193897|NCT03058289|541848748|FG003|Overall Study|Refused Further Treatment|0|||
150193898|NCT03058289|541848749|FG004|Overall Study|Refused Further Treatment|1|||
150193899|NCT03058289|541848750|FG005|Overall Study|Refused Further Treatment|0|||
150193900|NCT03058289|541848751|FG006|Overall Study|Refused Further Treatment|0|||
150193901|NCT03058289|541848752|FG007|Overall Study|Refused Further Treatment|0|||
150193902|NCT03058289|541848753|FG008|Overall Study|Refused Further Treatment|0|||
150193903|NCT03058289|541848745|FG000|Overall Study|Rapid Progression of Disease|0|||
150193904|NCT03058289|541848746|FG001|Overall Study|Rapid Progression of Disease|0|||
150193905|NCT03058289|541848747|FG002|Overall Study|Rapid Progression of Disease|0|||
150193906|NCT03058289|541848748|FG003|Overall Study|Rapid Progression of Disease|1|||
150193907|NCT03058289|541848749|FG004|Overall Study|Rapid Progression of Disease|0|||
150193908|NCT03058289|541848750|FG005|Overall Study|Rapid Progression of Disease|0|||
150193909|NCT03058289|541848751|FG006|Overall Study|Rapid Progression of Disease|0|||
150193910|NCT03058289|541848752|FG007|Overall Study|Rapid Progression of Disease|0|||
150193911|NCT03058289|541848753|FG008|Overall Study|Rapid Progression of Disease|0|||
150193912|NCT03869866|541850930|FG000|Overall Study|Protocol Violation|1|||
150193913|NCT03869866|541850930|FG000|Overall Study|Withdrawal by Subject|3|||
150193914|NCT05579899|541850931|FG000|Overall Study|Lost to Follow-up|3|||
150193915|NCT05579899|541850932|FG001|Overall Study|Lost to Follow-up|1|||
150193916|NCT05579899|541850931|FG000|Overall Study|Adverse Event|0|||
150193917|NCT05579899|541850932|FG001|Overall Study|Adverse Event|3|||
150193918|NCT05579899|541850931|FG000|Overall Study|Pregnancy|0|||
150193919|NCT05579899|541850932|FG001|Overall Study|Pregnancy|1|||
150193920|NCT05579899|541850931|FG000|Overall Study|Withdrawal by Subject|0|||
150193921|NCT05579899|541850932|FG001|Overall Study|Withdrawal by Subject|3|||
150193922|NCT03023410|541850933|FG000|Overall Study|study termination|0|||
150193923|NCT03023410|541850934|FG001|Overall Study|study termination|1|||
150193924|NCT03379675|541850937|FG000|Overall Study|Lost to Follow-up|0|||
150193925|NCT03379675|541850938|FG001|Overall Study|Lost to Follow-up|1|||
150193926|NCT03379675|541850939|FG002|Overall Study|Lost to Follow-up|0|||
150193927|NCT03379675|541850937|FG000|Overall Study|Adverse Event|2|||
150193928|NCT03379675|541850938|FG001|Overall Study|Adverse Event|0|||
150193929|NCT03379675|541850939|FG002|Overall Study|Adverse Event|0|||
150193930|NCT03379675|541850937|FG000|Overall Study|Withdrawal by Subject|2|||
150193931|NCT03379675|541850938|FG001|Overall Study|Withdrawal by Subject|1|||
150193932|NCT03379675|541850939|FG002|Overall Study|Withdrawal by Subject|2|||
150193933|NCT05540665|541850942|FG000|Overall Study|Study terminated by sponsor|6|||
150193934|NCT05540665|541850943|FG001|Overall Study|Study terminated by sponsor|6|||
150193935|NCT05540665|541850944|FG002|Overall Study|Study terminated by sponsor|7|||
150193936|NCT03381196|541850945|FG000|Overall Study|Withdrawal by Subject|7|||
150193937|NCT03381196|541850946|FG001|Overall Study|Withdrawal by Subject|7|||
150193938|NCT03381196|541850945|FG000|Overall Study|Other|0|||
150193939|NCT03381196|541850946|FG001|Overall Study|Other|1|||
150193940|NCT03381196|541850945|FG000|Overall Study|Lost to Follow-up|5|||
150193941|NCT03381196|541850946|FG001|Overall Study|Lost to Follow-up|4|||
150193942|NCT03381196|541850945|FG000|Overall Study|Death|0|||
150193943|NCT03381196|541850946|FG001|Overall Study|Death|1|||
150193944|NCT03381196|541850945|FG000|Overall Study|Adverse Event|1|||
150193945|NCT03381196|541850946|FG001|Overall Study|Adverse Event|0|||
150193946|NCT03381196|541850945|FG000|Overall Study|Randomized, not treated|3|||
150193947|NCT03381196|541850946|FG001|Overall Study|Randomized, not treated|6|||
150193948|NCT02675751|541850947|FG000|Overall Study|Lost to Follow-up|16|||
150193949|NCT03628924|541850948|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
150193950|NCT03628924|541850949|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193951|NCT03628924|541850950|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193952|NCT03628924|541850951|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193953|NCT03628924|541850952|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193954|NCT03628924|541850953|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193955|NCT03628924|541850954|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
150193956|NCT03628924|541850948|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193957|NCT03628924|541850949|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193958|NCT03628924|541850950|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
150193959|NCT03628924|541850951|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193960|NCT03628924|541850952|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193961|NCT03628924|541850953|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193962|NCT03628924|541850954|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
150193963|NCT03628924|541850948|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
150193964|NCT03628924|541850949|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
150193965|NCT03628924|541850950|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
150193966|NCT03628924|541850951|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
150193967|NCT03628924|541850952|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
150193968|NCT03628924|541850953|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
150193969|NCT03628924|541850954|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
150193970|NCT03628924|541850948|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193971|NCT03628924|541850949|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
150193972|NCT03628924|541850950|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193973|NCT03628924|541850951|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193974|NCT03628924|541850952|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193975|NCT03628924|541850953|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193976|NCT03628924|541850954|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150193977|NCT03628924|541850948|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
150193978|NCT03628924|541850949|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
150193979|NCT03628924|541850950|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
150193980|NCT03628924|541850951|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
150193981|NCT03628924|541850952|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
150193982|NCT03628924|541850953|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
150193983|NCT03628924|541850954|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
150193984|NCT03628924|541850948|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
150193985|NCT03628924|541850949|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
150193986|NCT03628924|541850950|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
150193987|NCT03628924|541850951|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
150193988|NCT03628924|541850952|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
150193989|NCT03628924|541850953|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
150193990|NCT03628924|541850954|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
150193991|NCT03628924|541850948|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
150193992|NCT03628924|541850949|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
150193993|NCT03628924|541850950|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
150193994|NCT03628924|541850951|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
150193995|NCT03628924|541850952|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
150193996|NCT03628924|541850953|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
150193997|NCT03628924|541850954|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
150193998|NCT03628924|541850948|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
150193999|NCT03628924|541850949|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
150194000|NCT03628924|541850950|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
150194001|NCT03628924|541850951|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
150194002|NCT03628924|541850952|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
150194003|NCT03628924|541850953|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
150194004|NCT03628924|541850954|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
150194005|NCT03628924|541850948|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
150194006|NCT03628924|541850949|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
150194007|NCT03628924|541850950|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
150194008|NCT03628924|541850951|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
150194009|NCT03628924|541850952|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
150194010|NCT03628924|541850953|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
150194011|NCT03628924|541850954|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
150194012|NCT03628924|541850948|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
150194013|NCT03628924|541850949|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
150194014|NCT03628924|541850950|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
150194015|NCT03628924|541850951|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
150194016|NCT03628924|541850952|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
150194017|NCT03628924|541850953|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
150194018|NCT03628924|541850954|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
150194019|NCT05126433|541850960|FG000|Overall Study|Withdrawal by Subject|3|||
150194020|NCT05126433|541850961|FG001|Overall Study|Withdrawal by Subject|0|||
150194021|NCT05126433|541850962|FG002|Overall Study|Withdrawal by Subject|4|||
150194022|NCT05126433|541850960|FG000|Overall Study|Death|9|||
150194023|NCT05126433|541850961|FG001|Overall Study|Death|3|||
150194024|NCT05126433|541850962|FG002|Overall Study|Death|5|||
150194025|NCT05126433|541850960|FG000|Overall Study|Study Terminated by sponsor|0|||
150194026|NCT05126433|541850961|FG001|Overall Study|Study Terminated by sponsor|1|||
150194027|NCT05126433|541850962|FG002|Overall Study|Study Terminated by sponsor|2|||
150194028|NCT05126433|541850960|FG000|Overall Study|Progressive Disease|1|||
150194029|NCT05126433|541850961|FG001|Overall Study|Progressive Disease|4|||
150194030|NCT05126433|541850962|FG002|Overall Study|Progressive Disease|3|||
150194031|NCT05126433|541850960|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
150194032|NCT05126433|541850961|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
150194033|NCT05126433|541850962|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
150194034|NCT03907878|541850963|FG000|Treatment Period|Withdrawal by Subject|5|||
150194035|NCT03907878|541850963|FG000|Treatment Period|Adverse Event|4|||
150194036|NCT03907878|541850963|FG000|Treatment Period|Lack of Efficacy|1|||
150194037|NCT03907878|541850963|FG000|Treatment Period|Protocol Violation|1|||
150194038|NCT03907878|541850963|FG000|Follow-up Period|Adverse Event|3|||
150194039|NCT03907878|541850963|FG000|Follow-up Period|Withdrawal by Subject|3|||
150194040|NCT03904147|541850968|FG000|Overall Study|Death|15|||
150194041|NCT03904147|541850969|FG001|Overall Study|Death|13|||
150194042|NCT03904147|541850970|FG002|Overall Study|Death|15|||
150194043|NCT03904147|541850968|FG000|Overall Study|Withdrawal by Subject|7|||
150194044|NCT03904147|541850969|FG001|Overall Study|Withdrawal by Subject|12|||
150194045|NCT03904147|541850970|FG002|Overall Study|Withdrawal by Subject|1|||
150194046|NCT03904147|541850968|FG000|Overall Study|1Y visit completed after 365 days|1|||
150194047|NCT03904147|541850969|FG001|Overall Study|1Y visit completed after 365 days|1|||
150194048|NCT03904147|541850970|FG002|Overall Study|1Y visit completed after 365 days|0|||
150194049|NCT05270408|541850973|FG000|Started Treatment|Withdrawal by Subject|0|||
150194050|NCT05270408|541850974|FG001|Started Treatment|Withdrawal by Subject|0|||
150194051|NCT05270408|541850975|FG002|Started Treatment|Withdrawal by Subject|3|||
150194052|NCT05270408|541850973|FG000|Started Treatment|Adverse Event|0|||
150194053|NCT05270408|541850974|FG001|Started Treatment|Adverse Event|0|||
150194054|NCT05270408|541850975|FG002|Started Treatment|Adverse Event|1|||
150194055|NCT05270408|541850973|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
150194056|NCT05270408|541850974|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
150194057|NCT05270408|541850975|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
150194058|NCT03768505|541850976|FG000|Overall Study|sponsor decision|76|||
150194059|NCT03768505|541850976|FG000|Overall Study|Death|35|||
150194060|NCT03768505|541850976|FG000|Overall Study|Other -Various|30|||
150194061|NCT03768505|541850976|FG000|Overall Study|Withdrawal by Subject|22|||
150194062|NCT03768505|541850976|FG000|Overall Study|Lost to Follow-up|6|||
150194063|NCT02815566|541850978|FG000|Overall Study|Adverse Event|1|||
150194064|NCT02815566|541850979|FG001|Overall Study|Adverse Event|1|||
150194065|NCT02815566|541850978|FG000|Overall Study|Withdrawal by Subject|1|||
150194066|NCT02815566|541850979|FG001|Overall Study|Withdrawal by Subject|0|||
150194067|NCT02815566|541850978|FG000|Overall Study|Lost to Follow-up|0|||
150194068|NCT02815566|541850979|FG001|Overall Study|Lost to Follow-up|1|||
150194069|NCT02861300|541850982|FG000|Overall Study|Death|0|||
150194070|NCT02861300|541850983|FG001|Overall Study|Death|0|||
150194071|NCT02861300|541850984|FG002|Overall Study|Death|0|||
150194072|NCT02861300|541850985|FG003|Overall Study|Death|0|||
150194073|NCT02861300|541850986|FG004|Overall Study|Death|0|||
150194074|NCT02861300|541850987|FG005|Overall Study|Death|0|||
150194075|NCT02861300|541850988|FG006|Overall Study|Death|24|||
150194076|NCT02861300|541850982|FG000|Overall Study|Delay in treatment|0|||
150194077|NCT02861300|541850983|FG001|Overall Study|Delay in treatment|0|||
150194078|NCT02861300|541850984|FG002|Overall Study|Delay in treatment|0|||
150194079|NCT02861300|541850985|FG003|Overall Study|Delay in treatment|0|||
150194080|NCT02861300|541850986|FG004|Overall Study|Delay in treatment|0|||
150194081|NCT02861300|541850987|FG005|Overall Study|Delay in treatment|1|||
150194082|NCT02861300|541850988|FG006|Overall Study|Delay in treatment|0|||
150194083|NCT02861300|541850982|FG000|Overall Study|Disease Progression|0|||
150194084|NCT02861300|541850983|FG001|Overall Study|Disease Progression|1|||
150194085|NCT02861300|541850984|FG002|Overall Study|Disease Progression|0|||
150194086|NCT02861300|541850985|FG003|Overall Study|Disease Progression|0|||
150194087|NCT02861300|541850986|FG004|Overall Study|Disease Progression|0|||
150194088|NCT02861300|541850987|FG005|Overall Study|Disease Progression|0|||
150194089|NCT02861300|541850988|FG006|Overall Study|Disease Progression|2|||
150194090|NCT02861300|541850982|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
150194091|NCT02861300|541850983|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
150194092|NCT02861300|541850984|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
150194093|NCT02861300|541850985|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
150194094|NCT02861300|541850986|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
150194095|NCT02861300|541850987|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
150194096|NCT02861300|541850988|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
150194097|NCT02861300|541850982|FG000|Overall Study|Clinical Complications|0|||
150194098|NCT02861300|541850983|FG001|Overall Study|Clinical Complications|0|||
150194099|NCT02861300|541850984|FG002|Overall Study|Clinical Complications|0|||
150194100|NCT02861300|541850985|FG003|Overall Study|Clinical Complications|0|||
150194101|NCT02861300|541850986|FG004|Overall Study|Clinical Complications|0|||
150194102|NCT02861300|541850987|FG005|Overall Study|Clinical Complications|0|||
150194103|NCT02861300|541850988|FG006|Overall Study|Clinical Complications|1|||
150194104|NCT05034328|541850991|FG000|Overall Study|Protocol Violation|1|||
150194105|NCT05034328|541850992|FG001|Overall Study|Protocol Violation|0|||
150194106|NCT05034328|541850991|FG000|Overall Study|Lost to Follow-up|0|||
150194107|NCT05034328|541850992|FG001|Overall Study|Lost to Follow-up|10|||
150194108|NCT02969707|541850997|FG000|Overall Study|Withdrawal by Subject|6|||
150194109|NCT02969707|541850998|FG001|Overall Study|Withdrawal by Subject|5|||
150194110|NCT02969707|541850997|FG000|Overall Study|Severe anxiety|0|||
150194111|NCT02969707|541850998|FG001|Overall Study|Severe anxiety|1|||
150194112|NCT02969707|541850997|FG000|Overall Study|Positive toxicology screen|0|||
150194113|NCT02969707|541850998|FG001|Overall Study|Positive toxicology screen|2|||
150194114|NCT02969707|541850997|FG000|Overall Study|Claustrophobia|2|||
150194115|NCT02969707|541850998|FG001|Overall Study|Claustrophobia|2|||
150194116|NCT02969707|541850997|FG000|Overall Study|Non-compliance|1|||
150194117|NCT02969707|541850998|FG001|Overall Study|Non-compliance|2|||
150194118|NCT05201079|541850999|FG000|Overall Study|Adverse Event|7|||
150194119|NCT05201079|541851000|FG001|Overall Study|Adverse Event|11|||
150194120|NCT05201079|541850999|FG000|Overall Study|Death|1|||
150194121|NCT05201079|541851000|FG001|Overall Study|Death|1|||
150194122|NCT05201079|541850999|FG000|Overall Study|Lack of Efficacy|0|||
150194123|NCT05201079|541851000|FG001|Overall Study|Lack of Efficacy|2|||
150194124|NCT05201079|541850999|FG000|Overall Study|Lost to Follow-up|0|||
150194125|NCT05201079|541851000|FG001|Overall Study|Lost to Follow-up|1|||
150194126|NCT05201079|541850999|FG000|Overall Study|Physician Decision|1|||
150194127|NCT05201079|541851000|FG001|Overall Study|Physician Decision|1|||
150194128|NCT05201079|541850999|FG000|Overall Study|Protocol Violation|1|||
150194129|NCT05201079|541851000|FG001|Overall Study|Protocol Violation|0|||
150194130|NCT05201079|541850999|FG000|Overall Study|Withdrawal by Subject|1|||
150194131|NCT05201079|541851000|FG001|Overall Study|Withdrawal by Subject|0|||
150194132|NCT05201079|541850999|FG000|Overall Study|Forbidden medication|9|||
150194133|NCT05201079|541851000|FG001|Overall Study|Forbidden medication|5|||
150194134|NCT05201079|541850999|FG000|Overall Study|Transfer to another hospital|0|||
150194135|NCT05201079|541851000|FG001|Overall Study|Transfer to another hospital|1|||
150194136|NCT05201079|541850999|FG000|Overall Study|Clinical condition|1|||
150194137|NCT05201079|541851000|FG001|Overall Study|Clinical condition|0|||
150194138|NCT05201079|541850999|FG000|Overall Study|SAE and sepsis|1|||
150194139|NCT05201079|541851000|FG001|Overall Study|SAE and sepsis|0|||
150194140|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
150194141|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
150194142|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
150194143|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
150194144|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
150194145|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
150194146|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
150194147|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
150194148|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
150194149|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
150194150|NCT04103580|541851003|FG000|Phase 1 Active Caregiving|Other|3|||
150194151|NCT04103580|541851004|FG001|Phase 1 Active Caregiving|Other|3|||
150194152|NCT04103580|541851003|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
150194153|NCT04103580|541851004|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
150194154|NCT04103580|541851003|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
150194155|NCT04103580|541851004|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
150194156|NCT04103580|541851003|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
150194157|NCT04103580|541851004|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
150194158|NCT04103580|541851003|FG000|Phase 2 Bereavement|Other|8|||
150194159|NCT04103580|541851004|FG001|Phase 2 Bereavement|Other|6|||
150194160|NCT04145440|541851005|FG000|Overall Study|Physician Decision|3|||
150194161|NCT04145440|541851006|FG001|Overall Study|Physician Decision|0|||
150194162|NCT04145440|541851005|FG000|Overall Study|Use of prohibited therapy|2|||
150194163|NCT04145440|541851006|FG001|Overall Study|Use of prohibited therapy|3|||
150194164|NCT04436276|541851011|FG000|Overall Study|Adverse Event|0|||
150194165|NCT04436276|541851012|FG001|Overall Study|Adverse Event|0|||
150194166|NCT04436276|541851013|FG002|Overall Study|Adverse Event|0|||
150194167|NCT04436276|541851014|FG003|Overall Study|Adverse Event|0|||
150194168|NCT04436276|541851015|FG004|Overall Study|Adverse Event|0|||
150194169|NCT04436276|541851016|FG005|Overall Study|Adverse Event|0|||
150194170|NCT04436276|541851017|FG006|Overall Study|Adverse Event|0|||
150194171|NCT04436276|541851018|FG007|Overall Study|Adverse Event|0|||
150194172|NCT04436276|541851019|FG008|Overall Study|Adverse Event|0|||
150194173|NCT04436276|541851020|FG009|Overall Study|Adverse Event|0|||
150194174|NCT04436276|541851021|FG010|Overall Study|Adverse Event|0|||
150194175|NCT04436276|541851022|FG011|Overall Study|Adverse Event|0|||
150194176|NCT04436276|541851023|FG012|Overall Study|Adverse Event|0|||
150194177|NCT04436276|541851024|FG013|Overall Study|Adverse Event|0|||
150194178|NCT04436276|541851025|FG014|Overall Study|Adverse Event|0|||
150194179|NCT04436276|541851026|FG015|Overall Study|Adverse Event|0|||
150194180|NCT04436276|541851027|FG016|Overall Study|Adverse Event|1|||
150194181|NCT04436276|541851028|FG017|Overall Study|Adverse Event|0|||
150194182|NCT04436276|541851029|FG018|Overall Study|Adverse Event|0|||
150194183|NCT04436276|541851030|FG019|Overall Study|Adverse Event|0|||
150194184|NCT04436276|541851031|FG020|Overall Study|Adverse Event|0|||
150194185|NCT04436276|541851032|FG021|Overall Study|Adverse Event|0|||
150194186|NCT04436276|541851033|FG022|Overall Study|Adverse Event|0|||
150194187|NCT04436276|541851011|FG000|Overall Study|Death|0|||
150194188|NCT04436276|541851012|FG001|Overall Study|Death|0|||
150194189|NCT04436276|541851013|FG002|Overall Study|Death|0|||
150194190|NCT04436276|541851014|FG003|Overall Study|Death|0|||
150194191|NCT04436276|541851015|FG004|Overall Study|Death|0|||
150194192|NCT04436276|541851016|FG005|Overall Study|Death|0|||
150194193|NCT04436276|541851017|FG006|Overall Study|Death|0|||
150194194|NCT04436276|541851018|FG007|Overall Study|Death|0|||
150194195|NCT04436276|541851019|FG008|Overall Study|Death|0|||
150194196|NCT04436276|541851020|FG009|Overall Study|Death|0|||
150194197|NCT04436276|541851021|FG010|Overall Study|Death|0|||
150194198|NCT04436276|541851022|FG011|Overall Study|Death|0|||
150194199|NCT04436276|541851023|FG012|Overall Study|Death|1|||
150194200|NCT04436276|541851024|FG013|Overall Study|Death|0|||
150194201|NCT04436276|541851025|FG014|Overall Study|Death|1|||
150194202|NCT04436276|541851026|FG015|Overall Study|Death|0|||
150194203|NCT04436276|541851027|FG016|Overall Study|Death|0|||
150194204|NCT04436276|541851028|FG017|Overall Study|Death|0|||
150194205|NCT04436276|541851029|FG018|Overall Study|Death|0|||
150194206|NCT04436276|541851030|FG019|Overall Study|Death|2|||
150194207|NCT04436276|541851031|FG020|Overall Study|Death|0|||
150194208|NCT04436276|541851032|FG021|Overall Study|Death|1|||
150194209|NCT04436276|541851033|FG022|Overall Study|Death|0|||
150194210|NCT04436276|541851011|FG000|Overall Study|Lost to Follow-up|0|||
150194211|NCT04436276|541851012|FG001|Overall Study|Lost to Follow-up|2|||
150194212|NCT04436276|541851013|FG002|Overall Study|Lost to Follow-up|2|||
150194213|NCT04436276|541851014|FG003|Overall Study|Lost to Follow-up|1|||
150194214|NCT04436276|541851015|FG004|Overall Study|Lost to Follow-up|4|||
150194215|NCT04436276|541851016|FG005|Overall Study|Lost to Follow-up|1|||
150194216|NCT04436276|541851017|FG006|Overall Study|Lost to Follow-up|0|||
150194217|NCT04436276|541851018|FG007|Overall Study|Lost to Follow-up|0|||
150194218|NCT04436276|541851019|FG008|Overall Study|Lost to Follow-up|1|||
150194219|NCT04436276|541851020|FG009|Overall Study|Lost to Follow-up|0|||
150194220|NCT04436276|541851021|FG010|Overall Study|Lost to Follow-up|5|||
150194221|NCT04436276|541851022|FG011|Overall Study|Lost to Follow-up|5|||
150194222|NCT04436276|541851023|FG012|Overall Study|Lost to Follow-up|4|||
150194223|NCT04436276|541851024|FG013|Overall Study|Lost to Follow-up|1|||
150194224|NCT04436276|541851025|FG014|Overall Study|Lost to Follow-up|7|||
150194225|NCT04436276|541851026|FG015|Overall Study|Lost to Follow-up|7|||
150194226|NCT04436276|541851027|FG016|Overall Study|Lost to Follow-up|1|||
150194227|NCT04436276|541851028|FG017|Overall Study|Lost to Follow-up|0|||
150194228|NCT04436276|541851029|FG018|Overall Study|Lost to Follow-up|1|||
150194229|NCT04436276|541851030|FG019|Overall Study|Lost to Follow-up|1|||
150194230|NCT04436276|541851031|FG020|Overall Study|Lost to Follow-up|2|||
150194231|NCT04436276|541851032|FG021|Overall Study|Lost to Follow-up|1|||
150194232|NCT04436276|541851033|FG022|Overall Study|Lost to Follow-up|1|||
150194233|NCT04436276|541851011|FG000|Overall Study|Physician Decision|1|||
150194234|NCT04436276|541851012|FG001|Overall Study|Physician Decision|0|||
150194235|NCT04436276|541851013|FG002|Overall Study|Physician Decision|2|||
150194236|NCT04436276|541851014|FG003|Overall Study|Physician Decision|1|||
150194237|NCT04436276|541851015|FG004|Overall Study|Physician Decision|0|||
150194238|NCT04436276|541851016|FG005|Overall Study|Physician Decision|0|||
150194239|NCT04436276|541851017|FG006|Overall Study|Physician Decision|0|||
150194240|NCT04436276|541851018|FG007|Overall Study|Physician Decision|0|||
150194241|NCT04436276|541851019|FG008|Overall Study|Physician Decision|0|||
150194242|NCT04436276|541851020|FG009|Overall Study|Physician Decision|0|||
150194243|NCT04436276|541851021|FG010|Overall Study|Physician Decision|0|||
150194244|NCT04436276|541851022|FG011|Overall Study|Physician Decision|1|||
150194245|NCT04436276|541851023|FG012|Overall Study|Physician Decision|2|||
150194246|NCT04436276|541851024|FG013|Overall Study|Physician Decision|0|||
150194247|NCT04436276|541851025|FG014|Overall Study|Physician Decision|0|||
150194248|NCT04436276|541851026|FG015|Overall Study|Physician Decision|0|||
150194249|NCT04436276|541851027|FG016|Overall Study|Physician Decision|0|||
150194250|NCT04436276|541851028|FG017|Overall Study|Physician Decision|0|||
150194251|NCT04436276|541851029|FG018|Overall Study|Physician Decision|0|||
150194252|NCT04436276|541851030|FG019|Overall Study|Physician Decision|0|||
150194253|NCT04436276|541851031|FG020|Overall Study|Physician Decision|1|||
150194254|NCT04436276|541851032|FG021|Overall Study|Physician Decision|2|||
150194255|NCT04436276|541851033|FG022|Overall Study|Physician Decision|0|||
150194256|NCT04436276|541851011|FG000|Overall Study|Protocol Violation|0|||
150194257|NCT04436276|541851012|FG001|Overall Study|Protocol Violation|0|||
150194258|NCT04436276|541851013|FG002|Overall Study|Protocol Violation|0|||
150194259|NCT04436276|541851014|FG003|Overall Study|Protocol Violation|0|||
150194260|NCT04436276|541851015|FG004|Overall Study|Protocol Violation|0|||
150194261|NCT04436276|541851016|FG005|Overall Study|Protocol Violation|0|||
150194262|NCT04436276|541851017|FG006|Overall Study|Protocol Violation|0|||
150194263|NCT04436276|541851018|FG007|Overall Study|Protocol Violation|0|||
150194264|NCT04436276|541851019|FG008|Overall Study|Protocol Violation|0|||
150194265|NCT04436276|541851020|FG009|Overall Study|Protocol Violation|0|||
150194266|NCT04436276|541851021|FG010|Overall Study|Protocol Violation|0|||
150194267|NCT04436276|541851022|FG011|Overall Study|Protocol Violation|0|||
150194268|NCT04436276|541851023|FG012|Overall Study|Protocol Violation|0|||
150194269|NCT04436276|541851024|FG013|Overall Study|Protocol Violation|1|||
150194270|NCT04436276|541851025|FG014|Overall Study|Protocol Violation|0|||
150194271|NCT04436276|541851026|FG015|Overall Study|Protocol Violation|1|||
150194272|NCT04436276|541851027|FG016|Overall Study|Protocol Violation|0|||
150194273|NCT04436276|541851028|FG017|Overall Study|Protocol Violation|0|||
150194274|NCT04436276|541851029|FG018|Overall Study|Protocol Violation|0|||
150194275|NCT04436276|541851030|FG019|Overall Study|Protocol Violation|0|||
150194276|NCT04436276|541851031|FG020|Overall Study|Protocol Violation|0|||
150194277|NCT04436276|541851032|FG021|Overall Study|Protocol Violation|0|||
150194278|NCT04436276|541851033|FG022|Overall Study|Protocol Violation|0|||
150194279|NCT04436276|541851011|FG000|Overall Study|Withdrawal by Subject|25|||
150194280|NCT04436276|541851012|FG001|Overall Study|Withdrawal by Subject|22|||
150194281|NCT04436276|541851013|FG002|Overall Study|Withdrawal by Subject|24|||
150194282|NCT04436276|541851014|FG003|Overall Study|Withdrawal by Subject|23|||
150194283|NCT04436276|541851015|FG004|Overall Study|Withdrawal by Subject|14|||
150194284|NCT04436276|541851016|FG005|Overall Study|Withdrawal by Subject|0|||
150194285|NCT04436276|541851017|FG006|Overall Study|Withdrawal by Subject|0|||
150194286|NCT04436276|541851018|FG007|Overall Study|Withdrawal by Subject|1|||
150194287|NCT04436276|541851019|FG008|Overall Study|Withdrawal by Subject|0|||
150194288|NCT04436276|541851020|FG009|Overall Study|Withdrawal by Subject|1|||
150194289|NCT04436276|541851021|FG010|Overall Study|Withdrawal by Subject|17|||
150194290|NCT04436276|541851022|FG011|Overall Study|Withdrawal by Subject|7|||
150194291|NCT04436276|541851023|FG012|Overall Study|Withdrawal by Subject|10|||
150194292|NCT04436276|541851024|FG013|Overall Study|Withdrawal by Subject|6|||
150194293|NCT04436276|541851025|FG014|Overall Study|Withdrawal by Subject|20|||
150194294|NCT04436276|541851026|FG015|Overall Study|Withdrawal by Subject|6|||
150194295|NCT04436276|541851027|FG016|Overall Study|Withdrawal by Subject|11|||
150194296|NCT04436276|541851028|FG017|Overall Study|Withdrawal by Subject|4|||
150194297|NCT04436276|541851029|FG018|Overall Study|Withdrawal by Subject|14|||
150194298|NCT04436276|541851030|FG019|Overall Study|Withdrawal by Subject|24|||
150194299|NCT04436276|541851031|FG020|Overall Study|Withdrawal by Subject|24|||
150194300|NCT04436276|541851032|FG021|Overall Study|Withdrawal by Subject|16|||
150194301|NCT04436276|541851033|FG022|Overall Study|Withdrawal by Subject|14|||
150194302|NCT04436276|541851011|FG000|Overall Study|Other|3|||
150194303|NCT04436276|541851012|FG001|Overall Study|Other|2|||
150194304|NCT04436276|541851013|FG002|Overall Study|Other|5|||
150194305|NCT04436276|541851014|FG003|Overall Study|Other|9|||
150194306|NCT04436276|541851015|FG004|Overall Study|Other|23|||
150194307|NCT04436276|541851016|FG005|Overall Study|Other|1|||
150194308|NCT04436276|541851017|FG006|Overall Study|Other|0|||
150194309|NCT04436276|541851018|FG007|Overall Study|Other|0|||
150194310|NCT04436276|541851019|FG008|Overall Study|Other|0|||
150194311|NCT04436276|541851020|FG009|Overall Study|Other|0|||
150194312|NCT04436276|541851021|FG010|Overall Study|Other|3|||
150194313|NCT04436276|541851022|FG011|Overall Study|Other|1|||
150194314|NCT04436276|541851023|FG012|Overall Study|Other|1|||
150194315|NCT04436276|541851024|FG013|Overall Study|Other|2|||
150194316|NCT04436276|541851025|FG014|Overall Study|Other|3|||
150194317|NCT04436276|541851026|FG015|Overall Study|Other|0|||
150194318|NCT04436276|541851027|FG016|Overall Study|Other|0|||
150194319|NCT04436276|541851028|FG017|Overall Study|Other|6|||
150194320|NCT04436276|541851029|FG018|Overall Study|Other|1|||
150194321|NCT04436276|541851030|FG019|Overall Study|Other|0|||
150194322|NCT04436276|541851031|FG020|Overall Study|Other|2|||
150194323|NCT04436276|541851032|FG021|Overall Study|Other|2|||
150194324|NCT04436276|541851033|FG022|Overall Study|Other|60|||
150194325|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
150194326|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
150194327|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
150194328|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
150194329|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
150194330|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
150194331|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
150194332|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
150194333|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
150194334|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
150194335|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
150194336|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
150194337|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
150194338|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
150194339|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
150194340|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
150194341|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
150194342|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
150194343|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
150194344|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
150194345|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
150194346|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
150194347|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
150194348|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
150194349|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
150194350|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
150194351|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
150194352|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
150194353|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
150194354|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
150194355|NCT03852472|541851035|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
150194356|NCT03852472|541851036|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
150194357|NCT03852472|541851037|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
150194358|NCT03852472|541851038|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
150194359|NCT03852472|541851039|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
150194360|NCT03852472|541851035|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
150194361|NCT03852472|541851036|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
150194362|NCT03852472|541851037|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
150194363|NCT03852472|541851038|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
150194364|NCT03852472|541851039|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
150194365|NCT03852472|541851035|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
150194366|NCT03852472|541851036|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
150194367|NCT03852472|541851037|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
150194368|NCT03852472|541851038|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
150194369|NCT03852472|541851039|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
150194370|NCT03852472|541851035|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
150194371|NCT03852472|541851036|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
150194372|NCT03852472|541851037|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
150194373|NCT03852472|541851038|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
150194374|NCT03852472|541851039|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
150194375|NCT03852472|541851035|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
150194376|NCT03852472|541851036|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
150194377|NCT03852472|541851037|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
150194378|NCT03852472|541851038|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
150194379|NCT03852472|541851039|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
150194380|NCT03852472|541851035|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
150194381|NCT03852472|541851036|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
150194382|NCT03852472|541851037|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
150194383|NCT03852472|541851038|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
150194384|NCT03852472|541851039|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
150194385|NCT03852472|541851035|FG000|Period 2 - Week 44|Adverse Event|0|||
150194386|NCT03852472|541851036|FG001|Period 2 - Week 44|Adverse Event|3|||
150194387|NCT03852472|541851037|FG002|Period 2 - Week 44|Adverse Event|1|||
150194388|NCT03852472|541851038|FG003|Period 2 - Week 44|Adverse Event|2|||
150194389|NCT03852472|541851039|FG004|Period 2 - Week 44|Adverse Event|2|||
150194390|NCT03852472|541851035|FG000|Period 2 - Week 44|COVID-19 Related|0|||
150194391|NCT03852472|541851036|FG001|Period 2 - Week 44|COVID-19 Related|0|||
150194392|NCT03852472|541851037|FG002|Period 2 - Week 44|COVID-19 Related|0|||
150194393|NCT03852472|541851038|FG003|Period 2 - Week 44|COVID-19 Related|1|||
150194394|NCT03852472|541851039|FG004|Period 2 - Week 44|COVID-19 Related|0|||
150194395|NCT03852472|541851035|FG000|Period 2 - Week 44|Reason not stated|0|||
150194396|NCT03852472|541851036|FG001|Period 2 - Week 44|Reason not stated|0|||
150194397|NCT03852472|541851037|FG002|Period 2 - Week 44|Reason not stated|0|||
150194398|NCT03852472|541851038|FG003|Period 2 - Week 44|Reason not stated|0|||
150194399|NCT03852472|541851039|FG004|Period 2 - Week 44|Reason not stated|1|||
150194400|NCT01919554|541851040|FG000|Overall Study|Withdrawal by Subject|0|||
150194401|NCT01919554|541851041|FG001|Overall Study|Withdrawal by Subject|0|||
150194402|NCT01919554|541851042|FG002|Overall Study|Withdrawal by Subject|1|||
150194403|NCT01919554|541851043|FG003|Overall Study|Withdrawal by Subject|1|||
150194404|NCT06457802|541851044|FG000|Overall Study|Early termination of study prior to participant completion|2|||
150194405|NCT06457802|541851045|FG001|Overall Study|Early termination of study prior to participant completion|2|||
150194406|NCT04524442|541851047|FG000|Overall Study|Subject Decision|1|||
150194407|NCT04898673|541851057|FG000|Overall Study|Screenfail|1|||
150194408|NCT04898673|541851058|FG001|Overall Study|Screenfail|0|||
150194409|NCT01544114|541851064|FG000|Overall Study|Withdrawal by Subject|0|||
150194410|NCT01544114|541851065|FG001|Overall Study|Withdrawal by Subject|0|||
150194411|NCT01544114|541851066|FG002|Overall Study|Withdrawal by Subject|3|||
150194412|NCT01544114|541851064|FG000|Overall Study|Lost to Follow-up|0|||
150194413|NCT01544114|541851065|FG001|Overall Study|Lost to Follow-up|2|||
150194414|NCT01544114|541851066|FG002|Overall Study|Lost to Follow-up|0|||
150194415|NCT01544114|541851064|FG000|Overall Study|Adverse Event|1|||
150194416|NCT01544114|541851065|FG001|Overall Study|Adverse Event|1|||
150194417|NCT01544114|541851066|FG002|Overall Study|Adverse Event|2|||
150194418|NCT01544114|541851064|FG000|Overall Study|Protocol Violation|0|||
150194419|NCT01544114|541851065|FG001|Overall Study|Protocol Violation|1|||
150194420|NCT01544114|541851066|FG002|Overall Study|Protocol Violation|0|||
150194421|NCT05526430|541851069|FG000|Overall Study|Withdrawal by Subject|0|||
150194422|NCT05526430|541851070|FG001|Overall Study|Withdrawal by Subject|2|||
150194423|NCT05526430|541851071|FG002|Overall Study|Withdrawal by Subject|0|||
150194424|NCT05526430|541851072|FG003|Overall Study|Withdrawal by Subject|0|||
150194425|NCT03085810|541851073|FG000|Main Study|Withdrawal by Subject|77|||
150194426|NCT03085810|541851074|FG001|Main Study|Withdrawal by Subject|0|||
150194427|NCT03085810|541851075|FG002|Main Study|Withdrawal by Subject|0|||
150194428|NCT03085810|541851073|FG000|Main Study|Terminated By Sponsor|14|||
150194429|NCT03085810|541851074|FG001|Main Study|Terminated By Sponsor|0|||
150194430|NCT03085810|541851075|FG002|Main Study|Terminated By Sponsor|0|||
150194431|NCT03085810|541851073|FG000|Main Study|Protocol Violation|15|||
150194432|NCT03085810|541851074|FG001|Main Study|Protocol Violation|0|||
150194433|NCT03085810|541851075|FG002|Main Study|Protocol Violation|0|||
150194434|NCT03085810|541851073|FG000|Main Study|Physician Decision|13|||
150194435|NCT03085810|541851074|FG001|Main Study|Physician Decision|0|||
150194436|NCT03085810|541851075|FG002|Main Study|Physician Decision|0|||
150194437|NCT03085810|541851073|FG000|Main Study|Lost to Follow-up|17|||
150194438|NCT03085810|541851074|FG001|Main Study|Lost to Follow-up|0|||
150194439|NCT03085810|541851075|FG002|Main Study|Lost to Follow-up|0|||
150194440|NCT03085810|541851073|FG000|Main Study|Adverse Event|25|||
150194441|NCT03085810|541851074|FG001|Main Study|Adverse Event|0|||
150194442|NCT03085810|541851075|FG002|Main Study|Adverse Event|0|||
150194443|NCT03085810|541851073|FG000|Main Study|Pregnancy|7|||
150194444|NCT03085810|541851074|FG001|Main Study|Pregnancy|0|||
150194445|NCT03085810|541851075|FG002|Main Study|Pregnancy|0|||
150194446|NCT03085810|541851073|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
150194447|NCT03085810|541851074|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
150194448|NCT03085810|541851075|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
150194449|NCT03085810|541851073|FG000|Main Study|Lack of Efficacy|10|||
150194450|NCT03085810|541851074|FG001|Main Study|Lack of Efficacy|0|||
150194451|NCT03085810|541851075|FG002|Main Study|Lack of Efficacy|0|||
150194452|NCT03085810|541851073|FG000|Main Study|Death|12|||
150194453|NCT03085810|541851074|FG001|Main Study|Death|0|||
150194454|NCT03085810|541851075|FG002|Main Study|Death|0|||
150194455|NCT03085810|541851073|FG000|Main Study|Disease progression|1|||
150194456|NCT03085810|541851074|FG001|Main Study|Disease progression|0|||
150194457|NCT03085810|541851075|FG002|Main Study|Disease progression|0|||
150194458|NCT03085810|541851073|FG000|Main Study|Site Closure|3|||
150194459|NCT03085810|541851074|FG001|Main Study|Site Closure|0|||
150194460|NCT03085810|541851075|FG002|Main Study|Site Closure|0|||
150194461|NCT03085810|541851073|FG000|Main Study|Planned pregnancy|17|||
150194462|NCT03085810|541851074|FG001|Main Study|Planned pregnancy|0|||
150194463|NCT03085810|541851075|FG002|Main Study|Planned pregnancy|0|||
150194464|NCT03085810|541851073|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
150194465|NCT03085810|541851074|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
150194466|NCT03085810|541851075|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
150194467|NCT03085810|541851073|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
150194468|NCT03085810|541851074|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
150194469|NCT03085810|541851075|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
150194470|NCT03085810|541851073|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
150194471|NCT03085810|541851074|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
150194472|NCT03085810|541851075|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
150194473|NCT03085810|541851073|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
150194474|NCT03085810|541851074|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
150194475|NCT03085810|541851075|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
150194476|NCT02601313|541851076|FG000|Overall Study|Death|2|||
150194477|NCT02601313|541851077|FG001|Overall Study|Death|41|||
150194478|NCT02601313|541851078|FG002|Overall Study|Death|6|||
150194479|NCT02601313|541851076|FG000|Overall Study|Enrolled but never treated|0|||
150194480|NCT02601313|541851077|FG001|Overall Study|Enrolled but never treated|6|||
150194481|NCT02601313|541851078|FG002|Overall Study|Enrolled but never treated|3|||
150194482|NCT02601313|541851076|FG000|Overall Study|Enrolled, did not initiate AC|4|||
150194483|NCT02601313|541851077|FG001|Overall Study|Enrolled, did not initiate AC|0|||
150194484|NCT02601313|541851078|FG002|Overall Study|Enrolled, did not initiate AC|0|||
150194485|NCT02601313|541851076|FG000|Overall Study|Full consent withdrawal|0|||
150194486|NCT02601313|541851077|FG001|Overall Study|Full consent withdrawal|3|||
150194487|NCT02601313|541851078|FG002|Overall Study|Full consent withdrawal|2|||
150194488|NCT02601313|541851076|FG000|Overall Study|Lost to Follow-up|0|||
150194489|NCT02601313|541851077|FG001|Overall Study|Lost to Follow-up|1|||
150194490|NCT02601313|541851078|FG002|Overall Study|Lost to Follow-up|1|||
150194491|NCT03800654|541851079|FG000|Overall Study|Time constraints|3|||
150194492|NCT03800654|541851080|FG001|Overall Study|Time constraints|3|||
150194493|NCT03800654|541851081|FG002|Overall Study|Time constraints|3|||
150194494|NCT03800654|541851079|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
150194495|NCT03800654|541851080|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
150194496|NCT03800654|541851081|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
150194497|NCT03800654|541851079|FG000|Overall Study|Lost to Follow-up|2|||
150194498|NCT03800654|541851080|FG001|Overall Study|Lost to Follow-up|1|||
150194499|NCT03800654|541851081|FG002|Overall Study|Lost to Follow-up|6|||
150194500|NCT03800654|541851079|FG000|Overall Study|Medical Health Issue|0|||
150194501|NCT03800654|541851080|FG001|Overall Study|Medical Health Issue|0|||
150194502|NCT03800654|541851081|FG002|Overall Study|Medical Health Issue|1|||
150194503|NCT03800654|541851079|FG000|Overall Study|Personal Issues|0|||
150194504|NCT03800654|541851080|FG001|Overall Study|Personal Issues|2|||
150194505|NCT03800654|541851081|FG002|Overall Study|Personal Issues|0|||
150194506|NCT03800654|541851079|FG000|Overall Study|Protocol Violation|0|||
150194507|NCT03800654|541851080|FG001|Overall Study|Protocol Violation|1|||
150194508|NCT03800654|541851081|FG002|Overall Study|Protocol Violation|0|||
150194509|NCT03459729|541851082|FG000|Overall Study|Physician Decision|2|||
150194510|NCT06182033|541851083|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
150194511|NCT06182033|541851084|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
150194512|NCT06182033|541851083|FG000|Overall Study|Target child relocation|1|||
150194513|NCT06182033|541851084|FG001|Overall Study|Target child relocation|1|||
150194514|NCT06182033|541851083|FG000|Overall Study|Withdrawal by Subject|1|||
150194515|NCT06182033|541851084|FG001|Overall Study|Withdrawal by Subject|0|||
150194516|NCT05704543|541851085|FG000|Overall Study|Withdrawal by Subject|1|||
150194517|NCT05704543|541851086|FG001|Overall Study|Withdrawal by Subject|1|||
150194518|NCT05704543|541851087|FG002|Overall Study|Withdrawal by Subject|0|||
150194519|NCT05704543|541851088|FG003|Overall Study|Withdrawal by Subject|2|||
150194520|NCT05704543|541851085|FG000|Overall Study|Lost to Follow-up|1|||
150194521|NCT05704543|541851086|FG001|Overall Study|Lost to Follow-up|2|||
150194522|NCT05704543|541851087|FG002|Overall Study|Lost to Follow-up|0|||
150194523|NCT05704543|541851088|FG003|Overall Study|Lost to Follow-up|0|||
150194524|NCT04830800|541851094|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
150194525|NCT04830800|541851095|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
150194526|NCT04830800|541851096|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
150194527|NCT04830800|541851097|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
150194528|NCT04830800|541851098|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
150194529|NCT02626533|541851099|FG000|Overall Study|Protocol Violation|14|||
150194530|NCT02626533|541851099|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
150194531|NCT02626533|541851099|FG000|Overall Study|Withdrawal by Subject|1|||
150194532|NCT03701763|541851100|FG000|Placebo-controlled Phase|Adverse Event|1|||
150194533|NCT03701763|541851101|FG001|Placebo-controlled Phase|Adverse Event|5|||
150194534|NCT03701763|541851102|FG002|Placebo-controlled Phase|Adverse Event|0|||
150194535|NCT03701763|541851103|FG003|Placebo-controlled Phase|Adverse Event|0|||
150194536|NCT03701763|541851100|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
150194537|NCT03701763|541851101|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
150194538|NCT03701763|541851102|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
150194539|NCT03701763|541851103|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
150194540|NCT03701763|541851100|FG000|Placebo-controlled Phase|Miscellaneous|2|||
150194541|NCT03701763|541851101|FG001|Placebo-controlled Phase|Miscellaneous|0|||
150194542|NCT03701763|541851102|FG002|Placebo-controlled Phase|Miscellaneous|0|||
150194543|NCT03701763|541851103|FG003|Placebo-controlled Phase|Miscellaneous|0|||
150194544|NCT03701763|541851100|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
150194545|NCT03701763|541851101|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
150194546|NCT03701763|541851102|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
150194547|NCT03701763|541851103|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
150194548|NCT03701763|541851100|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
150194549|NCT03701763|541851101|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
150194550|NCT03701763|541851102|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
150194551|NCT03701763|541851103|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
150194552|NCT03701763|541851100|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
150194553|NCT03701763|541851101|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
150194554|NCT03701763|541851102|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
150194555|NCT03701763|541851103|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
150194556|NCT03701763|541851100|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
150194557|NCT03701763|541851101|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
150126456|NCT04004611|541595554|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126457|NCT04004611|541595555|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150194558|NCT03701763|541851102|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
150194559|NCT03701763|541851103|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
150194560|NCT03701763|541851100|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
150194561|NCT03701763|541851101|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
150194562|NCT03701763|541851102|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
150194563|NCT03701763|541851103|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
150194564|NCT03701763|541851100|FG000|Apremilast Extension Phase|Adverse Event|0|||
150194565|NCT03701763|541851101|FG001|Apremilast Extension Phase|Adverse Event|0|||
150194566|NCT03701763|541851102|FG002|Apremilast Extension Phase|Adverse Event|3|||
150194567|NCT03701763|541851103|FG003|Apremilast Extension Phase|Adverse Event|1|||
150194568|NCT03701763|541851100|FG000|Apremilast Extension Phase|Miscellaneous|0|||
150194569|NCT03701763|541851101|FG001|Apremilast Extension Phase|Miscellaneous|0|||
150194570|NCT03701763|541851102|FG002|Apremilast Extension Phase|Miscellaneous|2|||
150194571|NCT03701763|541851103|FG003|Apremilast Extension Phase|Miscellaneous|1|||
150194572|NCT03701763|541851100|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
150126458|NCT04004611|541595556|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126459|NCT04004611|541595557|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
150126460|NCT04004611|541595558|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126461|NCT04004611|541595559|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126462|NCT04004611|541595560|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126463|NCT04004611|541595561|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
150126464|NCT04004611|541595553|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
150126465|NCT04004611|541595554|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
150126466|NCT04004611|541595555|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
150126467|NCT04004611|541595556|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
150126468|NCT04004611|541595557|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
150126469|NCT04004611|541595558|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
150126470|NCT04004611|541595559|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
150126471|NCT04004611|541595560|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
150126472|NCT04004611|541595561|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
150126473|NCT04004611|541595553|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
150126474|NCT04004611|541595554|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126475|NCT04004611|541595555|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
150126476|NCT04004611|541595556|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126477|NCT04004611|541595557|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126478|NCT04004611|541595558|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126479|NCT04004611|541595559|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126480|NCT04004611|541595560|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126481|NCT04004611|541595561|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
150126482|NCT04004611|541595553|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126483|NCT04004611|541595554|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
150126484|NCT04004611|541595555|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126485|NCT04004611|541595556|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126486|NCT04004611|541595557|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126487|NCT04004611|541595558|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126488|NCT04004611|541595559|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126489|NCT04004611|541595560|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150194573|NCT03701763|541851101|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
150194574|NCT03701763|541851102|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
150194575|NCT03701763|541851103|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
150194576|NCT03701763|541851100|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
150194577|NCT03701763|541851101|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
150194578|NCT03701763|541851102|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
150194579|NCT03701763|541851103|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
150194580|NCT03701763|541851100|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
150194581|NCT03701763|541851101|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
150194582|NCT03701763|541851102|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
150194583|NCT03701763|541851103|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
150194584|NCT03701763|541851100|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
150194585|NCT03701763|541851101|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
150194586|NCT03701763|541851102|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
150194587|NCT03701763|541851103|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
150194588|NCT03701763|541851100|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
150194589|NCT03701763|541851101|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
150194590|NCT03701763|541851102|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
150194591|NCT03701763|541851103|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
150126490|NCT04004611|541595561|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
150126491|NCT00130533|541595567|FG000|Overall Study|Withdrawal by Subject|33|||
150126492|NCT00130533|541595568|FG001|Overall Study|Withdrawal by Subject|6|||
150126493|NCT00130533|541595567|FG000|Overall Study|Adverse Event|34|||
150126494|NCT00130533|541595568|FG001|Overall Study|Adverse Event|1|||
150126495|NCT00130533|541595567|FG000|Overall Study|Disease relapse|9|||
150126496|NCT00130533|541595568|FG001|Overall Study|Disease relapse|13|||
150126497|NCT00130533|541595567|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
150126498|NCT00130533|541595568|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
150126499|NCT00130533|541595567|FG000|Overall Study|Death|4|||
150126500|NCT00130533|541595568|FG001|Overall Study|Death|2|||
150126501|NCT00130533|541595567|FG000|Overall Study|Protocol Violation|5|||
150126502|NCT00130533|541595568|FG001|Overall Study|Protocol Violation|1|||
150126503|NCT00130533|541595567|FG000|Overall Study|Lost to Follow-up|1|||
150126504|NCT00130533|541595568|FG001|Overall Study|Lost to Follow-up|1|||
150126505|NCT00130533|541595567|FG000|Overall Study|Sponsor´s decision|2|||
150126506|NCT00130533|541595568|FG001|Overall Study|Sponsor´s decision|0|||
150126507|NCT00130533|541595567|FG000|Overall Study|Second Primary Malignancy|0|||
150126508|NCT00130533|541595568|FG001|Overall Study|Second Primary Malignancy|1|||
150126509|NCT00130533|541595567|FG000|Overall Study|Other|12|||
150126510|NCT00130533|541595568|FG001|Overall Study|Other|5|||
150126511|NCT01059565|541595569|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
150126512|NCT01059565|541595570|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
150126513|NCT01059565|541595569|FG000|24-Week Randomized Phase|Adverse Event|5|||
150126514|NCT01059565|541595570|FG001|24-Week Randomized Phase|Adverse Event|0|||
150126515|NCT01059565|541595569|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
150126516|NCT01059565|541595570|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
150126517|NCT01059565|541595569|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
150126518|NCT01059565|541595570|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
150126519|NCT01059565|541595569|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
150126520|NCT01059565|541595570|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
150126521|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Adverse Event|2|||
150126522|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Adverse Event|0|||
150126523|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
150126524|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
150126525|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
150126526|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
150126527|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
150126528|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
150126529|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
150126530|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
150126531|NCT01059565|541595569|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
150126532|NCT01059565|541595570|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
150126533|NCT03927950|541595577|FG000|Overall Study|Adverse Event|9|||
150126534|NCT03263429|541595578|FG000|Overall Study|Withdrawal by Subject|0|||
150126535|NCT03263429|541595579|FG001|Overall Study|Withdrawal by Subject|1|||
150126536|NCT03263429|541595580|FG002|Overall Study|Withdrawal by Subject|0|||
150126537|NCT03263429|541595578|FG000|Overall Study|Follow-Up Period Completed|0|||
150126538|NCT03263429|541595579|FG001|Overall Study|Follow-Up Period Completed|2|||
150126539|NCT03263429|541595580|FG002|Overall Study|Follow-Up Period Completed|0|||
150126540|NCT03263429|541595578|FG000|Overall Study|Death|3|||
150126541|NCT03263429|541595579|FG001|Overall Study|Death|5|||
150126542|NCT03263429|541595580|FG002|Overall Study|Death|16|||
150126543|NCT03263429|541595578|FG000|Overall Study|Participant unable to return|0|||
150126544|NCT03263429|541595579|FG001|Overall Study|Participant unable to return|0|||
150126545|NCT03263429|541595580|FG002|Overall Study|Participant unable to return|1|||
150126546|NCT03263429|541595578|FG000|Overall Study|Study Closed|0|||
150126547|NCT03263429|541595579|FG001|Overall Study|Study Closed|0|||
150126548|NCT03263429|541595580|FG002|Overall Study|Study Closed|1|||
150126549|NCT02864082|541595581|FG000|Overall Study|Adverse Event|1|||
150126550|NCT02864082|541595582|FG001|Overall Study|Adverse Event|1|||
150126551|NCT02864082|541595581|FG000|Overall Study|Lost to Follow-up|0|||
150126552|NCT02864082|541595582|FG001|Overall Study|Lost to Follow-up|1|||
150126553|NCT02864082|541595581|FG000|Overall Study|Withdrawal by Subject|2|||
150126554|NCT02864082|541595582|FG001|Overall Study|Withdrawal by Subject|2|||
150126555|NCT04139317|541595583|FG000|Overall Study|Adverse Event|10|||
150126556|NCT04139317|541595584|FG001|Overall Study|Adverse Event|2|||
150126557|NCT04139317|541595583|FG000|Overall Study|Death|6|||
150126558|NCT04139317|541595584|FG001|Overall Study|Death|4|||
150194592|NCT03701763|541851100|FG000|14-Week Observational Follow-up Phase|Other|0|||
150126559|NCT04139317|541595583|FG000|Overall Study|Lost to Follow-up|1|||
150126560|NCT04139317|541595584|FG001|Overall Study|Lost to Follow-up|0|||
150194593|NCT03701763|541851101|FG001|14-Week Observational Follow-up Phase|Other|0|||
150194594|NCT03701763|541851102|FG002|14-Week Observational Follow-up Phase|Other|1|||
150194595|NCT03701763|541851103|FG003|14-Week Observational Follow-up Phase|Other|0|||
150194596|NCT03701763|541851100|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
150194597|NCT03701763|541851101|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
150194598|NCT03701763|541851102|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
150194599|NCT03701763|541851103|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
150194600|NCT03701763|541851100|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
150194601|NCT03701763|541851101|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
150194602|NCT03701763|541851102|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
150194603|NCT03701763|541851103|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
150194604|NCT05576155|541851106|FG000|Overall Study|Withdrawal by Subject|1|||
150194605|NCT05576155|541851107|FG001|Overall Study|Withdrawal by Subject|1|||
150194606|NCT04081103|541851110|FG000|Overall Study|Adverse Event|1|||
150194607|NCT04081103|541851111|FG001|Overall Study|Adverse Event|1|||
150194608|NCT04081103|541851112|FG002|Overall Study|Adverse Event|1|||
150194609|NCT04081103|541851110|FG000|Overall Study|Physician Decision|0|||
150194610|NCT04081103|541851111|FG001|Overall Study|Physician Decision|0|||
150194611|NCT04081103|541851112|FG002|Overall Study|Physician Decision|1|||
150194612|NCT03365882|541851117|FG000|Randomization|Still Receiving Protocol Treatment|2|||
150194613|NCT03365882|541851118|FG001|Randomization|Still Receiving Protocol Treatment|0|||
150194614|NCT03365882|541851117|FG000|Randomization|Adverse Event|1|||
150194615|NCT03365882|541851118|FG001|Randomization|Adverse Event|2|||
150194616|NCT03365882|541851117|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
150194617|NCT03365882|541851118|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
150194618|NCT03365882|541851117|FG000|Randomization|Progression/Relapse|21|||
150194619|NCT03365882|541851118|FG001|Randomization|Progression/Relapse|3|||
150194620|NCT03365882|541851117|FG000|Randomization|Death|1|||
150194621|NCT03365882|541851118|FG001|Randomization|Death|0|||
150194622|NCT03365882|541851117|FG000|Randomization|Other - Not Protocol Specified|1|||
150194623|NCT03365882|541851118|FG001|Randomization|Other - Not Protocol Specified|1|||
150194624|NCT03365882|541851117|FG000|Randomization|Major Protocol Deviation|0|||
150194625|NCT03365882|541851118|FG001|Randomization|Major Protocol Deviation|1|||
150194626|NCT03365882|541851117|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
150194627|NCT03365882|541851118|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
150194628|NCT03365882|541851117|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
150194629|NCT03365882|541851118|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
150194630|NCT03365882|541851117|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
150194631|NCT03365882|541851118|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
150194632|NCT03365882|541851117|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
150194633|NCT03365882|541851118|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
150194634|NCT04828005|541851119|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
150194635|NCT04828005|541851120|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
150194636|NCT04828005|541851121|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
150194637|NCT04828005|541851122|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
150194638|NCT04828005|541851119|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
150194639|NCT04828005|541851120|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
150194640|NCT04828005|541851121|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
150194641|NCT04828005|541851122|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
150194642|NCT04828005|541851119|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
150194643|NCT04828005|541851120|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
150194644|NCT04828005|541851121|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
150194645|NCT04828005|541851122|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
150194646|NCT04828005|541851119|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
150194647|NCT04828005|541851120|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
150194648|NCT04828005|541851121|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
150194649|NCT04828005|541851122|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
150194650|NCT04828005|541851119|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
150194651|NCT04828005|541851120|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
150194652|NCT04828005|541851121|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
150194653|NCT04828005|541851122|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
150194654|NCT04828005|541851119|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
150194655|NCT04828005|541851120|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
150194656|NCT04828005|541851121|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
150194657|NCT04828005|541851122|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
150194658|NCT04828005|541851119|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
150194659|NCT04828005|541851120|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
150194660|NCT04828005|541851121|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
150194661|NCT04828005|541851122|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
150194662|NCT04828005|541851119|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
150194663|NCT04828005|541851120|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
150194664|NCT04828005|541851121|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
150194665|NCT04828005|541851122|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
150194666|NCT04828005|541851119|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
150126561|NCT04139317|541595583|FG000|Overall Study|Physician Decision|3|||
150126562|NCT04139317|541595584|FG001|Overall Study|Physician Decision|1|||
150126563|NCT04139317|541595583|FG000|Overall Study|Progressive Disease|19|||
150126564|NCT04139317|541595584|FG001|Overall Study|Progressive Disease|9|||
150126565|NCT04139317|541595583|FG000|Overall Study|Subject Decision|2|||
150126566|NCT04139317|541595584|FG001|Overall Study|Subject Decision|2|||
150126567|NCT03621696|541595585|FG000|Overall Study|Not eligible|0|||
150126568|NCT03621696|541595586|FG001|Overall Study|Not eligible|0|||
150126569|NCT03621696|541595587|FG002|Overall Study|Not eligible|0|||
150126570|NCT03621696|541595588|FG003|Overall Study|Not eligible|5|||
150126571|NCT03621696|541595585|FG000|Overall Study|Withdrawal by Subject|1|||
150126572|NCT03621696|541595586|FG001|Overall Study|Withdrawal by Subject|1|||
150126573|NCT03621696|541595587|FG002|Overall Study|Withdrawal by Subject|1|||
150126574|NCT03621696|541595588|FG003|Overall Study|Withdrawal by Subject|0|||
150126575|NCT03621696|541595585|FG000|Overall Study|Physician Decision|0|||
150126576|NCT03621696|541595586|FG001|Overall Study|Physician Decision|0|||
150126577|NCT03621696|541595587|FG002|Overall Study|Physician Decision|1|||
150126578|NCT03621696|541595588|FG003|Overall Study|Physician Decision|0|||
150126579|NCT01618864|541595591|FG000|Overall Study|Withdrawal by Subject|2|||
150126580|NCT01618864|541595591|FG000|Overall Study|Lost to Follow-up|2|||
150126581|NCT01109992|541595592|FG000|Overall Study|Withdrawal by Subject|0|||
150126582|NCT01109992|541595593|FG001|Overall Study|Withdrawal by Subject|1|||
150126583|NCT01109992|541595592|FG000|Overall Study|Movement during rest scan.|0|||
150126584|NCT01109992|541595593|FG001|Overall Study|Movement during rest scan.|1|||
150126585|NCT00690755|541595594|FG000|Overall Study|Physician Decision|2|||
150126586|NCT00690755|541595595|FG001|Overall Study|Physician Decision|0|||
150126587|NCT00690755|541595596|FG002|Overall Study|Physician Decision|46|||
150126588|NCT00690755|541595597|FG003|Overall Study|Physician Decision|5|||
150126589|NCT00690755|541595598|FG004|Overall Study|Physician Decision|0|||
150126590|NCT00690755|541595599|FG005|Overall Study|Physician Decision|4|||
150126591|NCT00690755|541595600|FG006|Overall Study|Physician Decision|0|||
150126592|NCT04287920|541595601|FG000|Overall Study|Lost to Follow-up|1|||
150126593|NCT04287920|541595602|FG001|Overall Study|Lost to Follow-up|1|||
150126594|NCT04287920|541595601|FG000|Overall Study|Withdrawal by Subject|0|||
150126595|NCT04287920|541595602|FG001|Overall Study|Withdrawal by Subject|3|||
150126596|NCT03585244|541595605|FG000|Overall Study|Withdrawal by Subject|15|||
150126597|NCT03273946|541595609|FG000|Overall Study|Withdrawal by Subject|5|||
150126598|NCT03273946|541595609|FG000|Overall Study|Unwillingness of the guardian|1|||
150126599|NCT03273946|541595609|FG000|Overall Study|Participant refused to use the drug|2|||
150126600|NCT03273946|541595609|FG000|Overall Study|Participant relative refused to use drug|1|||
150126601|NCT01220557|541595610|FG000|Overall Study|Lost to Follow-up|5|||
150126602|NCT01220557|541595611|FG001|Overall Study|Lost to Follow-up|3|||
150126603|NCT01220557|541595610|FG000|Overall Study|attended less than 6 lessons|1|||
150126604|NCT01220557|541595611|FG001|Overall Study|attended less than 6 lessons|2|||
150126605|NCT02199028|541595616|FG000|Week 1|Adverse Event|1|||
150126606|NCT02199028|541595617|FG001|Week 1|Adverse Event|0|||
150126607|NCT02199028|541595616|FG000|Week 3|Adverse Event|1|||
150126608|NCT02199028|541595617|FG001|Week 3|Adverse Event|0|||
150126609|NCT01881126|541595618|FG000|Overall Study|Non-compliance|1|||
150126610|NCT01881126|541595619|FG001|Overall Study|Non-compliance|1|||
150126611|NCT01881126|541595618|FG000|Overall Study|Adverse Event|0|||
150126612|NCT01881126|541595619|FG001|Overall Study|Adverse Event|1|||
150126613|NCT05045625|541595622|FG000|Overall Study|Lost to Follow-up|3|||
150126614|NCT00718718|541595623|FG000|Prior to Week 12|Adverse Event|0|||
150126615|NCT00718718|541595624|FG001|Prior to Week 12|Adverse Event|0|||
150126616|NCT00718718|541595625|FG002|Prior to Week 12|Adverse Event|0|||
150126617|NCT00718718|541595626|FG003|Prior to Week 12|Adverse Event|0|||
150126618|NCT00718718|541595627|FG004|Prior to Week 12|Adverse Event|0|||
150126619|NCT00718718|541595628|FG005|Prior to Week 12|Adverse Event|0|||
150126620|NCT00718718|541595629|FG006|Prior to Week 12|Adverse Event|0|||
150126621|NCT00718718|541595630|FG007|Prior to Week 12|Adverse Event|1|||
150126622|NCT00718718|541595631|FG008|Prior to Week 12|Adverse Event|1|||
150126623|NCT00718718|541595632|FG009|Prior to Week 12|Adverse Event|0|||
150126624|NCT00718718|541595623|FG000|Prior to Week 12|Withdrawal by Subject|0|||
150126625|NCT00718718|541595624|FG001|Prior to Week 12|Withdrawal by Subject|0|||
150126626|NCT00718718|541595625|FG002|Prior to Week 12|Withdrawal by Subject|0|||
150126627|NCT00718718|541595626|FG003|Prior to Week 12|Withdrawal by Subject|0|||
150126628|NCT00718718|541595627|FG004|Prior to Week 12|Withdrawal by Subject|3|||
150194667|NCT04828005|541851120|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
150194668|NCT04828005|541851121|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
150194669|NCT04828005|541851122|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
150194670|NCT03287817|541852734|FG000|Overall Study|Progressive disease|4|||
150194671|NCT03287817|541852735|FG001|Overall Study|Progressive disease|2|||
150194672|NCT03287817|541852736|FG002|Overall Study|Progressive disease|3|||
150194673|NCT03287817|541852737|FG003|Overall Study|Progressive disease|10|||
150194674|NCT03287817|541852738|FG004|Overall Study|Progressive disease|8|||
150126629|NCT00718718|541595628|FG005|Prior to Week 12|Withdrawal by Subject|0|||
150126630|NCT00718718|541595629|FG006|Prior to Week 12|Withdrawal by Subject|1|||
150126631|NCT00718718|541595630|FG007|Prior to Week 12|Withdrawal by Subject|1|||
150126632|NCT00718718|541595631|FG008|Prior to Week 12|Withdrawal by Subject|1|||
150126633|NCT00718718|541595632|FG009|Prior to Week 12|Withdrawal by Subject|0|||
150126634|NCT00718718|541595623|FG000|Prior to Week 12|Other|1|||
150126635|NCT00718718|541595624|FG001|Prior to Week 12|Other|0|||
150126636|NCT00718718|541595625|FG002|Prior to Week 12|Other|1|||
150126637|NCT00718718|541595626|FG003|Prior to Week 12|Other|0|||
150126638|NCT00718718|541595627|FG004|Prior to Week 12|Other|0|||
150126639|NCT00718718|541595628|FG005|Prior to Week 12|Other|0|||
150126640|NCT00718718|541595629|FG006|Prior to Week 12|Other|0|||
150126641|NCT00718718|541595630|FG007|Prior to Week 12|Other|0|||
150126642|NCT00718718|541595631|FG008|Prior to Week 12|Other|0|||
150126643|NCT00718718|541595632|FG009|Prior to Week 12|Other|0|||
150126644|NCT00718718|541595623|FG000|Week 12 to End of Study|Adverse Event|0|||
150126645|NCT00718718|541595624|FG001|Week 12 to End of Study|Adverse Event|0|||
150126646|NCT00718718|541595625|FG002|Week 12 to End of Study|Adverse Event|0|||
150126647|NCT00718718|541595626|FG003|Week 12 to End of Study|Adverse Event|0|||
150126648|NCT00718718|541595627|FG004|Week 12 to End of Study|Adverse Event|0|||
150126649|NCT00718718|541595628|FG005|Week 12 to End of Study|Adverse Event|0|||
150126650|NCT00718718|541595629|FG006|Week 12 to End of Study|Adverse Event|0|||
150126651|NCT00718718|541595630|FG007|Week 12 to End of Study|Adverse Event|1|||
150126652|NCT00718718|541595631|FG008|Week 12 to End of Study|Adverse Event|0|||
150126653|NCT00718718|541595632|FG009|Week 12 to End of Study|Adverse Event|0|||
150126654|NCT00718718|541595623|FG000|Week 12 to End of Study|Death|0|||
150126655|NCT00718718|541595624|FG001|Week 12 to End of Study|Death|0|||
150126656|NCT00718718|541595625|FG002|Week 12 to End of Study|Death|0|||
150126657|NCT00718718|541595626|FG003|Week 12 to End of Study|Death|0|||
150126658|NCT00718718|541595627|FG004|Week 12 to End of Study|Death|0|||
150126659|NCT00718718|541595628|FG005|Week 12 to End of Study|Death|1|||
150126660|NCT00718718|541595629|FG006|Week 12 to End of Study|Death|0|||
150126661|NCT00718718|541595630|FG007|Week 12 to End of Study|Death|0|||
150126662|NCT00718718|541595631|FG008|Week 12 to End of Study|Death|0|||
150126663|NCT00718718|541595632|FG009|Week 12 to End of Study|Death|0|||
150126664|NCT00718718|541595623|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
150126665|NCT00718718|541595624|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
150126666|NCT00718718|541595625|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
150126667|NCT00718718|541595626|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
150126668|NCT00718718|541595627|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
150126669|NCT00718718|541595628|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
150126670|NCT00718718|541595629|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
150126671|NCT00718718|541595630|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
150194675|NCT03287817|541852734|FG000|Overall Study|Death|0|||
150194676|NCT03287817|541852735|FG001|Overall Study|Death|0|||
150194677|NCT03287817|541852736|FG002|Overall Study|Death|2|||
150126672|NCT00718718|541595631|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
150194678|NCT03287817|541852737|FG003|Overall Study|Death|3|||
150194679|NCT03287817|541852738|FG004|Overall Study|Death|4|||
150126673|NCT00718718|541595632|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
150126674|NCT00718718|541595623|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
150126675|NCT00718718|541595624|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
150126676|NCT00718718|541595625|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
150126677|NCT00718718|541595626|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
150194680|NCT03287817|541852734|FG000|Overall Study|Physician Decision|0|||
150194681|NCT03287817|541852735|FG001|Overall Study|Physician Decision|0|||
150194682|NCT03287817|541852736|FG002|Overall Study|Physician Decision|0|||
150194683|NCT03287817|541852737|FG003|Overall Study|Physician Decision|1|||
150194684|NCT03287817|541852738|FG004|Overall Study|Physician Decision|0|||
150194685|NCT03287817|541852734|FG000|Overall Study|Withdrawal by Subject|0|||
150194686|NCT03287817|541852735|FG001|Overall Study|Withdrawal by Subject|0|||
150194687|NCT03287817|541852736|FG002|Overall Study|Withdrawal by Subject|0|||
150194688|NCT03287817|541852737|FG003|Overall Study|Withdrawal by Subject|0|||
150194689|NCT03287817|541852738|FG004|Overall Study|Withdrawal by Subject|4|||
150194690|NCT05251909|541852739|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
150194691|NCT05251909|541852740|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
150194692|NCT05543915|541852741|FG000|Overall Study|Lost to Follow-up|0|||
150194693|NCT05543915|541852742|FG001|Overall Study|Lost to Follow-up|1|||
150194694|NCT04987320|541852744|FG000|Overall Study|Withdrawal by Subject|0|||
150194695|NCT04987320|541852745|FG001|Overall Study|Withdrawal by Subject|1|||
150194696|NCT00085735|541852746|FG000|Overall Study|Adverse Event|1|||
150194697|NCT00085735|541852747|FG001|Overall Study|Adverse Event|0|||
150194698|NCT00085735|541852748|FG002|Overall Study|Adverse Event|0|||
150194699|NCT00085735|541852749|FG003|Overall Study|Adverse Event|0|||
150194700|NCT00085735|541852750|FG004|Overall Study|Adverse Event|0|||
150194701|NCT00085735|541852751|FG005|Overall Study|Adverse Event|0|||
150194702|NCT00085735|541852746|FG000|Overall Study|Lack of Efficacy|2|||
150194703|NCT00085735|541852747|FG001|Overall Study|Lack of Efficacy|4|||
150194704|NCT00085735|541852748|FG002|Overall Study|Lack of Efficacy|6|||
150194705|NCT00085735|541852749|FG003|Overall Study|Lack of Efficacy|3|||
150194706|NCT00085735|541852750|FG004|Overall Study|Lack of Efficacy|4|||
150194707|NCT00085735|541852751|FG005|Overall Study|Lack of Efficacy|3|||
150194708|NCT00085735|541852746|FG000|Overall Study|Lost to Follow-up|0|||
150194709|NCT00085735|541852747|FG001|Overall Study|Lost to Follow-up|1|||
150194710|NCT00085735|541852748|FG002|Overall Study|Lost to Follow-up|0|||
150194711|NCT00085735|541852749|FG003|Overall Study|Lost to Follow-up|0|||
150194712|NCT00085735|541852750|FG004|Overall Study|Lost to Follow-up|1|||
150194713|NCT00085735|541852751|FG005|Overall Study|Lost to Follow-up|0|||
150194714|NCT00085735|541852746|FG000|Overall Study|Physician Decision|2|||
150194715|NCT00085735|541852747|FG001|Overall Study|Physician Decision|3|||
150194716|NCT00085735|541852748|FG002|Overall Study|Physician Decision|2|||
150194717|NCT00085735|541852749|FG003|Overall Study|Physician Decision|3|||
150194718|NCT00085735|541852750|FG004|Overall Study|Physician Decision|11|||
150194719|NCT00085735|541852751|FG005|Overall Study|Physician Decision|8|||
150194720|NCT00085735|541852746|FG000|Overall Study|Protocol Violation|1|||
150194721|NCT00085735|541852747|FG001|Overall Study|Protocol Violation|0|||
150194722|NCT00085735|541852748|FG002|Overall Study|Protocol Violation|0|||
150194723|NCT00085735|541852749|FG003|Overall Study|Protocol Violation|0|||
150194724|NCT00085735|541852750|FG004|Overall Study|Protocol Violation|0|||
150194725|NCT00085735|541852751|FG005|Overall Study|Protocol Violation|0|||
150194726|NCT00085735|541852746|FG000|Overall Study|Withdrawal by Subject|1|||
150194727|NCT00085735|541852747|FG001|Overall Study|Withdrawal by Subject|0|||
150194728|NCT00085735|541852748|FG002|Overall Study|Withdrawal by Subject|4|||
150194729|NCT00085735|541852749|FG003|Overall Study|Withdrawal by Subject|5|||
150194730|NCT00085735|541852750|FG004|Overall Study|Withdrawal by Subject|7|||
150194731|NCT00085735|541852751|FG005|Overall Study|Withdrawal by Subject|8|||
150194732|NCT00085735|541852746|FG000|Overall Study|Patient ineligible|1|||
150194733|NCT00085735|541852747|FG001|Overall Study|Patient ineligible|0|||
150194734|NCT00085735|541852748|FG002|Overall Study|Patient ineligible|3|||
150194735|NCT00085735|541852749|FG003|Overall Study|Patient ineligible|7|||
150194736|NCT00085735|541852750|FG004|Overall Study|Patient ineligible|17|||
150194737|NCT00085735|541852751|FG005|Overall Study|Patient ineligible|8|||
150194738|NCT00085735|541852746|FG000|Overall Study|Excess residual disease|2|||
150194739|NCT00085735|541852747|FG001|Overall Study|Excess residual disease|2|||
150194740|NCT00085735|541852748|FG002|Overall Study|Excess residual disease|1|||
150194741|NCT00085735|541852749|FG003|Overall Study|Excess residual disease|1|||
150194742|NCT00085735|541852750|FG004|Overall Study|Excess residual disease|1|||
150194743|NCT00085735|541852751|FG005|Overall Study|Excess residual disease|4|||
150194744|NCT00085735|541852746|FG000|Overall Study|Reason not documented|1|||
150194745|NCT00085735|541852747|FG001|Overall Study|Reason not documented|0|||
150194746|NCT00085735|541852748|FG002|Overall Study|Reason not documented|1|||
150194747|NCT00085735|541852749|FG003|Overall Study|Reason not documented|0|||
150194748|NCT00085735|541852750|FG004|Overall Study|Reason not documented|1|||
150194749|NCT00085735|541852751|FG005|Overall Study|Reason not documented|0|||
150194750|NCT00085735|541852746|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
150194751|NCT00085735|541852747|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
150194752|NCT00085735|541852748|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
150194753|NCT00085735|541852749|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
150194754|NCT00085735|541852750|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
150194755|NCT00085735|541852751|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
150194756|NCT01824875|541852752|FG000|Overall Study|Disease progression|22|||
150194757|NCT01824875|541852753|FG001|Overall Study|Disease progression|15|||
150194758|NCT01824875|541852752|FG000|Overall Study|Withdrawal by Subject|5|||
150194759|NCT01824875|541852753|FG001|Overall Study|Withdrawal by Subject|4|||
150194760|NCT01824875|541852752|FG000|Overall Study|Adverse Event|4|||
150194761|NCT01824875|541852753|FG001|Overall Study|Adverse Event|10|||
150194762|NCT01824875|541852752|FG000|Overall Study|Alternative therapy|3|||
150194763|NCT01824875|541852753|FG001|Overall Study|Alternative therapy|0|||
150194764|NCT01824875|541852752|FG000|Overall Study|Complicating disease|1|||
150194765|NCT01824875|541852753|FG001|Overall Study|Complicating disease|0|||
150194766|NCT01824875|541852752|FG000|Overall Study|Physician Decision|0|||
150194767|NCT01824875|541852753|FG001|Overall Study|Physician Decision|1|||
150194768|NCT01824875|541852752|FG000|Overall Study|Non-compliance|1|||
150194769|NCT01824875|541852753|FG001|Overall Study|Non-compliance|1|||
150194770|NCT01824875|541852752|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
150194771|NCT01824875|541852753|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
150194772|NCT01824875|541852752|FG000|Overall Study|Administrative issues|0|||
150194773|NCT01824875|541852753|FG001|Overall Study|Administrative issues|2|||
150194774|NCT01824875|541852752|FG000|Overall Study|Ineligible or never started treatment|9|||
150194775|NCT01824875|541852753|FG001|Overall Study|Ineligible or never started treatment|5|||
150194776|NCT01824875|541852752|FG000|Overall Study|Other|0|||
150194777|NCT01824875|541852753|FG001|Overall Study|Other|2|||
150194778|NCT04195698|541852756|FG000|Overall Study|Adverse Event|4|||
150194779|NCT04195698|541852757|FG001|Overall Study|Adverse Event|11|||
150194780|NCT04195698|541852756|FG000|Overall Study|Withdrawal by Subject|9|||
150194781|NCT04195698|541852757|FG001|Overall Study|Withdrawal by Subject|10|||
150194782|NCT04195698|541852756|FG000|Overall Study|Lost to Follow-up|5|||
150194783|NCT04195698|541852757|FG001|Overall Study|Lost to Follow-up|4|||
150194784|NCT04195698|541852756|FG000|Overall Study|Lack of Efficacy|2|||
150194785|NCT04195698|541852757|FG001|Overall Study|Lack of Efficacy|10|||
150194786|NCT04195698|541852756|FG000|Overall Study|Other|5|||
150194787|NCT04195698|541852757|FG001|Overall Study|Other|4|||
150194788|NCT00433329|541852758|FG000|Overall Study|Adverse Event|9|||
150194789|NCT00433329|541852758|FG000|Overall Study|Death|4|||
150194790|NCT00433329|541852758|FG000|Overall Study|Withdrew consent|3|||
150194791|NCT00433329|541852758|FG000|Overall Study|Discontinued sildenafil|2|||
150194792|NCT00433329|541852758|FG000|Overall Study|Moved out of state|1|||
150194793|NCT00433329|541852758|FG000|Overall Study|Lost to Follow-up|1|||
150194794|NCT00433329|541852758|FG000|Overall Study|Physician Decision|1|||
150194795|NCT05459688|541852759|FG000|Overall Study|Lost to Follow-up|6|||
150194796|NCT05459688|541852759|FG000|Overall Study|Physician Decision|1|||
150194797|NCT05459688|541852759|FG000|Overall Study|Withdrawal by Subject|19|||
150194798|NCT05459688|541852759|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
150194799|NCT01129102|541852760|FG000|Overall Study|No study drug treatment|2|||
150194800|NCT01129102|541852761|FG001|Overall Study|No study drug treatment|3|||
150194801|NCT01129102|541852762|FG002|Overall Study|No study drug treatment|1|||
150194802|NCT01129102|541852760|FG000|Overall Study|Withdrawal by Subject|2|||
150194803|NCT01129102|541852761|FG001|Overall Study|Withdrawal by Subject|0|||
150194804|NCT01129102|541852762|FG002|Overall Study|Withdrawal by Subject|3|||
150194805|NCT01129102|541852760|FG000|Overall Study|Protocol Violation|0|||
150194806|NCT01129102|541852761|FG001|Overall Study|Protocol Violation|1|||
150194807|NCT01129102|541852762|FG002|Overall Study|Protocol Violation|1|||
150194808|NCT01129102|541852760|FG000|Overall Study|Pregnancy|0|||
150194809|NCT01129102|541852761|FG001|Overall Study|Pregnancy|0|||
150194810|NCT01129102|541852762|FG002|Overall Study|Pregnancy|1|||
150194811|NCT01129102|541852760|FG000|Overall Study|Adverse Event|2|||
150194812|NCT01129102|541852761|FG001|Overall Study|Adverse Event|2|||
150194813|NCT01129102|541852762|FG002|Overall Study|Adverse Event|1|||
150194814|NCT01129102|541852760|FG000|Overall Study|Lost to Follow-up|2|||
150194815|NCT01129102|541852761|FG001|Overall Study|Lost to Follow-up|0|||
150194816|NCT01129102|541852762|FG002|Overall Study|Lost to Follow-up|0|||
150194817|NCT02817776|541852763|FG000|Overall Study|Excluded|33|||
150194818|NCT02817776|541852763|FG000|Overall Study|Lost to Follow-up|20|||
150194819|NCT02817776|541852763|FG000|Overall Study|Withdrawal by Subject|33|||
150194820|NCT02817776|541852763|FG000|Overall Study|Death|2|||
150194821|NCT03462030|541852766|FG000|Overall Study|Withdrawal by Subject|1|||
150194822|NCT03462030|541852767|FG001|Overall Study|Withdrawal by Subject|1|||
150194823|NCT03371381|541852768|FG000|Overall Study|Death|5|||
150194824|NCT03371381|541852768|FG000|Overall Study|Study terminated by sponsor|3|||
150194825|NCT03371381|541852768|FG000|Overall Study|Other|4|||
150194826|NCT02359890|541852770|FG000|Overall Study|Not meeting eligibility|4|||
150194827|NCT02359890|541852770|FG000|Overall Study|Never treated with study catheter|6|||
150194828|NCT03133546|541852780|FG000|Overall Study|Death|46|||
150194829|NCT03133546|541852781|FG001|Overall Study|Death|43|||
150194830|NCT03133546|541852780|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
150194831|NCT03133546|541852781|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
150194832|NCT01501955|541852785|FG000|Overall Study|Withdrawal by Subject|1|||
150194833|NCT01501955|541852786|FG001|Overall Study|Withdrawal by Subject|0|||
150194834|NCT01501955|541852785|FG000|Overall Study|Adverse Event|1|||
150194835|NCT01501955|541852786|FG001|Overall Study|Adverse Event|3|||
150194836|NCT05399459|541852788|FG000|Overall Study|Randomized but not treated|29|||
150194837|NCT05399459|541852789|FG001|Overall Study|Randomized but not treated|30|||
150194838|NCT05399459|541852790|FG002|Overall Study|Randomized but not treated|38|||
150194839|NCT05399459|541852788|FG000|Overall Study|Lost to Follow-up|1|||
150194840|NCT05399459|541852789|FG001|Overall Study|Lost to Follow-up|0|||
150194841|NCT05399459|541852790|FG002|Overall Study|Lost to Follow-up|0|||
150194842|NCT03625167|541852794|FG000|Overall Study|Protocol Violation|5|||
150194843|NCT02231164|541852795|FG000|Overall Study|Adverse Event|1|||
150194844|NCT02231164|541852796|FG001|Overall Study|Adverse Event|1|||
150194845|NCT02231164|541852795|FG000|Overall Study|Lack of Efficacy|4|||
150194846|NCT02231164|541852796|FG001|Overall Study|Lack of Efficacy|3|||
150194847|NCT02231164|541852795|FG000|Overall Study|Withdrawal by Subject|1|||
150194848|NCT02231164|541852796|FG001|Overall Study|Withdrawal by Subject|2|||
150194849|NCT06103188|541852797|FG000|Overall Study|Lost to Follow-up|1|||
150194850|NCT06103188|541852798|FG001|Overall Study|Lost to Follow-up|6|||
150194851|NCT06103188|541852799|FG002|Overall Study|Lost to Follow-up|4|||
150194852|NCT03020199|541852810|FG000|Treatment Period|Adverse Event|0|||
150194853|NCT03020199|541852811|FG001|Treatment Period|Adverse Event|2|||
150194854|NCT03020199|541852810|FG000|Treatment Period|Lack of Efficacy|1|||
150194855|NCT03020199|541852811|FG001|Treatment Period|Lack of Efficacy|6|||
150194856|NCT03020199|541852810|FG000|Treatment Period|Lost to Follow-up|1|||
150194857|NCT03020199|541852811|FG001|Treatment Period|Lost to Follow-up|6|||
150194858|NCT03020199|541852810|FG000|Treatment Period|Physician Decision|0|||
150194859|NCT03020199|541852811|FG001|Treatment Period|Physician Decision|1|||
150194860|NCT03020199|541852810|FG000|Treatment Period|Subject/guardian decision|8|||
150194861|NCT03020199|541852811|FG001|Treatment Period|Subject/guardian decision|15|||
150194862|NCT03020199|541852810|FG000|Treatment Period|Subjects not treated|3|||
150194863|NCT03020199|541852811|FG001|Treatment Period|Subjects not treated|4|||
150194864|NCT03020199|541852810|FG000|Follow-up Period|Disease relapse|32|||
150194865|NCT03020199|541852811|FG001|Follow-up Period|Disease relapse|7|||
150194866|NCT03020199|541852810|FG000|Follow-up Period|Lack of Efficacy|1|||
150194867|NCT03020199|541852811|FG001|Follow-up Period|Lack of Efficacy|2|||
150194868|NCT03020199|541852810|FG000|Follow-up Period|Lost to Follow-up|4|||
150194869|NCT03020199|541852811|FG001|Follow-up Period|Lost to Follow-up|6|||
150194870|NCT03020199|541852810|FG000|Follow-up Period|Physician Decision|2|||
150194871|NCT03020199|541852811|FG001|Follow-up Period|Physician Decision|2|||
150194872|NCT03020199|541852810|FG000|Follow-up Period|Protocol Violation|1|||
150194873|NCT03020199|541852811|FG001|Follow-up Period|Protocol Violation|2|||
150194874|NCT03020199|541852810|FG000|Follow-up Period|Study terminated by Sponsor|6|||
150194875|NCT03020199|541852811|FG001|Follow-up Period|Study terminated by Sponsor|3|||
150194876|NCT03020199|541852810|FG000|Follow-up Period|Subject/guardian decision|14|||
150194877|NCT03020199|541852811|FG001|Follow-up Period|Subject/guardian decision|9|||
150194878|NCT05583578|541852812|FG000|Overall Study|Withdrawal by Subject|2|||
150194879|NCT05583578|541852813|FG001|Overall Study|Withdrawal by Subject|0|||
150194880|NCT04313972|541852814|FG000|Overall Study|Withdrawal by Subject|0|||
150194881|NCT04313972|541852815|FG001|Overall Study|Withdrawal by Subject|1|||
150194882|NCT05877976|541852816|FG000|Overall Study|Lost to Follow-up|31|||
150194883|NCT04314713|541852818|FG000|Overall Study|Lost to Follow-up|0|||
150194884|NCT04314713|541852819|FG001|Overall Study|Lost to Follow-up|0|||
150194885|NCT04314713|541852820|FG002|Overall Study|Lost to Follow-up|0|||
150194886|NCT04314713|541852821|FG003|Overall Study|Lost to Follow-up|1|||
150194887|NCT04314713|541852822|FG004|Overall Study|Lost to Follow-up|0|||
150194888|NCT04314713|541852823|FG005|Overall Study|Lost to Follow-up|0|||
150194889|NCT00248287|541852824|FG000|Overall Study|Adverse Event|11|||
150194890|NCT00248287|541852825|FG001|Overall Study|Adverse Event|10|||
150194891|NCT00248287|541852824|FG000|Overall Study|Death|1|||
150194892|NCT00248287|541852825|FG001|Overall Study|Death|0|||
150194893|NCT00248287|541852824|FG000|Overall Study|Lost to Follow-up|0|||
150194894|NCT00248287|541852825|FG001|Overall Study|Lost to Follow-up|1|||
150194895|NCT00248287|541852824|FG000|Overall Study|Investigator Request|4|||
150194896|NCT00248287|541852825|FG001|Overall Study|Investigator Request|3|||
150194897|NCT00248287|541852824|FG000|Overall Study|Patient Request|5|||
150194898|NCT00248287|541852825|FG001|Overall Study|Patient Request|3|||
150194899|NCT00248287|541852824|FG000|Overall Study|Other|3|||
150194900|NCT00248287|541852825|FG001|Overall Study|Other|2|||
150194901|NCT02714257|541852838|FG000|Overall Study|Withdrawal by Subject|6|||
150194902|NCT02714257|541852839|FG001|Overall Study|Withdrawal by Subject|11|||
150194903|NCT02714257|541852838|FG000|Overall Study|Death|3|||
150194904|NCT02714257|541852839|FG001|Overall Study|Death|4|||
150194905|NCT02714257|541852838|FG000|Overall Study|Lost to Follow-up|1|||
150126678|NCT00718718|541595627|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
150126679|NCT00718718|541595628|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
150126680|NCT00718718|541595629|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
150126681|NCT00718718|541595630|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
150126682|NCT00718718|541595631|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
150126683|NCT00718718|541595632|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
150126684|NCT00718718|541595623|FG000|Week 12 to End of Study|Other|0|||
150126685|NCT00718718|541595624|FG001|Week 12 to End of Study|Other|1|||
150126686|NCT00718718|541595625|FG002|Week 12 to End of Study|Other|0|||
150126687|NCT00718718|541595626|FG003|Week 12 to End of Study|Other|1|||
150126688|NCT00718718|541595627|FG004|Week 12 to End of Study|Other|0|||
150126689|NCT00718718|541595628|FG005|Week 12 to End of Study|Other|0|||
150126690|NCT00718718|541595629|FG006|Week 12 to End of Study|Other|1|||
150126691|NCT00718718|541595630|FG007|Week 12 to End of Study|Other|0|||
150126692|NCT00718718|541595631|FG008|Week 12 to End of Study|Other|0|||
150126693|NCT00718718|541595632|FG009|Week 12 to End of Study|Other|0|||
150126694|NCT03277313|541595637|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
150126695|NCT03277313|541595638|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
150126696|NCT03277313|541595637|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
150126697|NCT03277313|541595638|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
150126698|NCT03277313|541595637|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
150126699|NCT03277313|541595638|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
150126700|NCT03277313|541595637|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
150126701|NCT03277313|541595638|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
150126702|NCT03277313|541595637|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
150194906|NCT02714257|541852839|FG001|Overall Study|Lost to Follow-up|6|||
150194907|NCT04568486|541852846|FG000|Overall Study|Withdrawal by Subject|26|||
150194908|NCT04568486|541852846|FG000|Overall Study|Lost to Follow-up|7|||
150194909|NCT04248725|541852847|FG000|Post-Treatment|Lost to Follow-up|6|||
150126703|NCT03277313|541595638|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
150126704|NCT01218438|541595642|FG000|Epoch 1|Physician Decision|2|||
150126705|NCT01218438|541595642|FG000|Epoch 1|Adverse Event|1|||
150126706|NCT01218438|541595642|FG000|Epoch 3|Withdrawal by Subject|3|||
150194910|NCT04248725|541852848|FG001|Post-Treatment|Lost to Follow-up|5|||
150194911|NCT04248725|541852847|FG000|6-Month Follow Up|Lost to Follow-up|9|||
150194912|NCT04248725|541852848|FG001|6-Month Follow Up|Lost to Follow-up|8|||
150194913|NCT01210807|541852849|FG000|Overall Study|Lost to Follow-up|1|||
150194914|NCT01210807|541852850|FG001|Overall Study|Lost to Follow-up|2|||
150194915|NCT01210807|541852849|FG000|Overall Study|Not implanted bilaterally|2|||
150194916|NCT01210807|541852850|FG001|Overall Study|Not implanted bilaterally|1|||
150194917|NCT03656510|541852853|FG000|Overall Study|Lost to Follow-up|1|||
150194918|NCT03656510|541852854|FG001|Overall Study|Lost to Follow-up|0|||
150194919|NCT03656510|541852855|FG002|Overall Study|Lost to Follow-up|0|||
150194920|NCT03656510|541852856|FG003|Overall Study|Lost to Follow-up|0|||
150194921|NCT03656510|541852857|FG004|Overall Study|Lost to Follow-up|0|||
150194922|NCT03656510|541852858|FG005|Overall Study|Lost to Follow-up|0|||
150194923|NCT03656510|541852853|FG000|Overall Study|Withdrawal by Subject|1|||
150194924|NCT03656510|541852854|FG001|Overall Study|Withdrawal by Subject|1|||
150194925|NCT03656510|541852855|FG002|Overall Study|Withdrawal by Subject|0|||
150194926|NCT03656510|541852856|FG003|Overall Study|Withdrawal by Subject|1|||
150194927|NCT03656510|541852857|FG004|Overall Study|Withdrawal by Subject|0|||
150194928|NCT03656510|541852858|FG005|Overall Study|Withdrawal by Subject|0|||
150194929|NCT04880863|541852868|FG000|Overall Study|Adverse Event|1|||
150194930|NCT04880863|541852868|FG000|Overall Study|Patient decision|2|||
150194931|NCT04880863|541852868|FG000|Overall Study|Confirmed Disease Progression|15|||
150194932|NCT04880863|541852868|FG000|Overall Study|Death|3|||
150194933|NCT04880863|541852868|FG000|Overall Study|Physician Decision|4|||
150194934|NCT04880863|541852868|FG000|Overall Study|Unconfirmed Disease Progression|4|||
150194935|NCT04880863|541852868|FG000|Overall Study|Withdrawal by Subject|2|||
150194936|NCT04880863|541852868|FG000|Overall Study|Study discontinuation by the sponsor|4|||
150194937|NCT04880863|541852868|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
150194938|NCT04880863|541852868|FG000|Overall Study|Not received study drug NAP|2|||
150194939|NCT05239455|541852869|FG000|Overall Study|Adverse Event|1|||
150194940|NCT05239455|541852869|FG000|Overall Study|Sponsor Decision|5|||
150194941|NCT05239455|541852869|FG000|Overall Study|Incomplete Blood Collection|1|||
150194942|NCT03785964|541852878|FG000|Overall Study|Adverse Event|14|||
150194943|NCT03785964|541852879|FG001|Overall Study|Adverse Event|1|||
150194944|NCT03785964|541852878|FG000|Overall Study|Unqualified Clinical Progression|1|||
150194945|NCT03785964|541852879|FG001|Overall Study|Unqualified Clinical Progression|1|||
150194946|NCT03785964|541852878|FG000|Overall Study|Participant non-compliance|1|||
150194947|NCT03785964|541852879|FG001|Overall Study|Participant non-compliance|1|||
150194948|NCT03785964|541852878|FG000|Overall Study|Not treated|1|||
150194949|NCT03785964|541852879|FG001|Overall Study|Not treated|0|||
150194950|NCT03785964|541852878|FG000|Overall Study|Other reason|5|||
150194951|NCT03785964|541852879|FG001|Overall Study|Other reason|11|||
150194952|NCT03785964|541852878|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
150194953|NCT03785964|541852879|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
150194954|NCT05070728|541852880|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
150194955|NCT05070728|541852881|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
150194956|NCT02151981|541852882|FG000|Overall Study|Death|184|||
150194957|NCT02151981|541852883|FG001|Overall Study|Death|88|||
150194958|NCT02151981|541852882|FG000|Overall Study|Lost to Follow-up|7|||
150194959|NCT02151981|541852883|FG001|Overall Study|Lost to Follow-up|1|||
150194960|NCT02151981|541852882|FG000|Overall Study|Withdrawal by Subject|27|||
150194961|NCT02151981|541852883|FG001|Overall Study|Withdrawal by Subject|21|||
150194962|NCT02151981|541852882|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150194963|NCT02151981|541852883|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
150194964|NCT02151981|541852882|FG000|Overall Study|Other reasons|1|||
150194965|NCT02151981|541852883|FG001|Overall Study|Other reasons|2|||
150194966|NCT02276885|541854370|FG000|Overall Study|Withdrawal by Subject|2|||
150194967|NCT02276885|541854371|FG001|Overall Study|Withdrawal by Subject|0|||
150194968|NCT02276885|541854370|FG000|Overall Study|Lost to Follow-up|5|||
150194969|NCT02276885|541854371|FG001|Overall Study|Lost to Follow-up|2|||
150194970|NCT01574274|541854372|FG000|Overall Study|Ineligible|0|||
150194971|NCT01574274|541854373|FG001|Overall Study|Ineligible|1|||
150194972|NCT01574274|541854372|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
150194973|NCT01574274|541854373|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
150194974|NCT01574274|541854372|FG000|Overall Study|Ph+ B-ALL|3|||
150194975|NCT01574274|541854373|FG001|Overall Study|Ph+ B-ALL|4|||
150194976|NCT01574274|541854372|FG000|Overall Study|Induction Death|2|||
150194977|NCT01574274|541854373|FG001|Overall Study|Induction Death|0|||
150194978|NCT01574274|541854372|FG000|Overall Study|Induction Failure|4|||
150194979|NCT01574274|541854373|FG001|Overall Study|Induction Failure|1|||
150194980|NCT01574274|541854372|FG000|Overall Study|Adverse Event|16|||
150194981|NCT01574274|541854373|FG001|Overall Study|Adverse Event|13|||
150194982|NCT01574274|541854372|FG000|Overall Study|Remission Death|1|||
150194983|NCT01574274|541854373|FG001|Overall Study|Remission Death|0|||
150194984|NCT01574274|541854372|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
150194985|NCT01574274|541854373|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
150194986|NCT01574274|541854372|FG000|Overall Study|Other, unknown|3|||
150194987|NCT01574274|541854373|FG001|Overall Study|Other, unknown|2|||
150194988|NCT04676763|541854375|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
150194989|NCT04676763|541854376|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
150194990|NCT04676763|541854377|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
150194991|NCT04676763|541854375|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
150194992|NCT04676763|541854376|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
150194993|NCT04676763|541854377|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
150194994|NCT04676763|541854375|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
150194995|NCT04676763|541854376|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
150194996|NCT04676763|541854377|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
150194997|NCT01593917|541854387|FG000|Overall Study|Death|67|||
150194998|NCT01593917|541854387|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
150194999|NCT01593917|541854387|FG000|Overall Study|Withdrawal by Subject|23|||
150195000|NCT01593917|541854387|FG000|Overall Study|Lost to Follow-up|12|||
150195001|NCT01593917|541854387|FG000|Overall Study|Protocol Violation|5|||
150195002|NCT01593917|541854387|FG000|Overall Study|Physician Decision|3|||
150195003|NCT04663737|541854388|FG000|Overall Study|Withdrawal by Subject|2|||
150195004|NCT04663737|541854389|FG001|Overall Study|Withdrawal by Subject|0|||
150195005|NCT04016662|541854390|FG000|Run-In Phase|Death|1|||
150195006|NCT04016662|541854390|FG000|Run-In Phase|Withdrawal by Subject|11|||
150195007|NCT04016662|541854390|FG000|Run-In Phase|Not meeting screening eligibility|9|||
150195008|NCT04016662|541854390|FG000|Run-In Phase|Physician Decision|3|||
150195009|NCT04016662|541854390|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
150195010|NCT04016662|541854390|FG000|PLGS (12 Weeks)|Death|1|||
150195011|NCT04016662|541854390|FG000|SAP (12 Weeks)|Death|1|||
150195012|NCT04499924|541854391|FG000|Overall Study|Study termination by sponsor|4|||
150195013|NCT04499924|541854392|FG001|Overall Study|Study termination by sponsor|6|||
150195014|NCT04499924|541854391|FG000|Overall Study|Withdrawal by Subject|1|||
150195015|NCT04499924|541854392|FG001|Overall Study|Withdrawal by Subject|3|||
150195016|NCT02841579|541854400|FG000|Overall Study|Death|1|||
150195017|NCT02841579|541854400|FG000|Overall Study|Adverse Event|1|||
150195018|NCT02841579|541854400|FG000|Overall Study|Lack of Efficacy|9|||
150195019|NCT03011333|541854403|FG000|Overall Study|Lost to Follow-up|0|||
150195020|NCT03011333|541854404|FG001|Overall Study|Lost to Follow-up|1|||
150195021|NCT03011333|541854405|FG002|Overall Study|Lost to Follow-up|0|||
150195022|NCT03011333|541854406|FG003|Overall Study|Lost to Follow-up|1|||
150195023|NCT03011333|541854407|FG004|Overall Study|Lost to Follow-up|4|||
150195024|NCT03011333|541854408|FG005|Overall Study|Lost to Follow-up|4|||
150195025|NCT03011333|541854409|FG006|Overall Study|Lost to Follow-up|5|||
150195026|NCT02998268|541854410|FG000|Overall Study|Adverse Event|0|||
150195027|NCT02998268|541854411|FG001|Overall Study|Adverse Event|2|||
150195028|NCT02998268|541854410|FG000|Overall Study|Withdrawal by Subject|0|||
150195029|NCT02998268|541854411|FG001|Overall Study|Withdrawal by Subject|1|||
150195030|NCT04225273|541854412|FG000|Overall Study|Lost to Follow-up|3|||
150195031|NCT03652389|541854413|FG000|Overall Study|Lost to Follow-up|1|||
150195032|NCT03652389|541854414|FG001|Overall Study|Lost to Follow-up|5|||
150195033|NCT03652389|541854413|FG000|Overall Study|Withdrawal by Subject|5|||
150195034|NCT03652389|541854414|FG001|Overall Study|Withdrawal by Subject|1|||
150195035|NCT03652389|541854413|FG000|Overall Study|New diagnosis|2|||
150195036|NCT03652389|541854414|FG001|Overall Study|New diagnosis|0|||
150195037|NCT04413708|541854415|FG000|Overall Study|Lost to Follow-up|1|||
150195038|NCT04413708|541854416|FG001|Overall Study|Lost to Follow-up|2|||
150195039|NCT03974178|541854418|FG000|Overall Study|Death|0|||
150195040|NCT03974178|541854419|FG001|Overall Study|Death|1|||
150195041|NCT03899259|541854423|FG000|Overall Study|Adverse Event|5|||
150195042|NCT03899259|541854424|FG001|Overall Study|Adverse Event|4|||
150195043|NCT03899259|541854425|FG002|Overall Study|Adverse Event|6|||
150195044|NCT03899259|541854423|FG000|Overall Study|Lack of Efficacy|5|||
150195045|NCT03899259|541854424|FG001|Overall Study|Lack of Efficacy|0|||
150195046|NCT03899259|541854425|FG002|Overall Study|Lack of Efficacy|2|||
150195047|NCT03899259|541854423|FG000|Overall Study|Pregnancy|3|||
150195048|NCT03899259|541854424|FG001|Overall Study|Pregnancy|0|||
150126707|NCT01218438|541595642|FG000|Epoch 3|Adverse Event|1|||
150126708|NCT01218438|541595642|FG000|Epoch 4|Physician Decision|1|||
150126709|NCT01218438|541595642|FG000|Epoch 4|Withdrawal by Subject|2|||
150126710|NCT00045110|541595644|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
150126711|NCT00045110|541595645|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
150126712|NCT00045110|541595646|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
150126713|NCT00045110|541595644|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
150126714|NCT00045110|541595645|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
150126715|NCT00045110|541595646|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
150126716|NCT00045110|541595644|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
150126717|NCT00045110|541595645|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
150195049|NCT03899259|541854425|FG002|Overall Study|Pregnancy|1|||
150195050|NCT03899259|541854423|FG000|Overall Study|Physician Decision|0|||
150195051|NCT03899259|541854424|FG001|Overall Study|Physician Decision|1|||
150195052|NCT03899259|541854425|FG002|Overall Study|Physician Decision|0|||
150195053|NCT03899259|541854423|FG000|Overall Study|Protocol Deviation|1|||
150195054|NCT03899259|541854424|FG001|Overall Study|Protocol Deviation|1|||
150195055|NCT03899259|541854425|FG002|Overall Study|Protocol Deviation|1|||
150195056|NCT03899259|541854423|FG000|Overall Study|Withdrawal by Subject|8|||
150195057|NCT03899259|541854424|FG001|Overall Study|Withdrawal by Subject|10|||
150195058|NCT03899259|541854425|FG002|Overall Study|Withdrawal by Subject|12|||
150195059|NCT03899259|541854423|FG000|Overall Study|Lost to Follow-up|5|||
150195060|NCT03899259|541854424|FG001|Overall Study|Lost to Follow-up|6|||
150195061|NCT03899259|541854425|FG002|Overall Study|Lost to Follow-up|2|||
150195062|NCT03899259|541854423|FG000|Overall Study|Lack of Adherence|1|||
150195063|NCT03899259|541854424|FG001|Overall Study|Lack of Adherence|0|||
150195064|NCT03899259|541854425|FG002|Overall Study|Lack of Adherence|0|||
150195065|NCT03899259|541854423|FG000|Overall Study|Screen Failure|1|||
150195066|NCT03899259|541854424|FG001|Overall Study|Screen Failure|0|||
150195067|NCT03899259|541854425|FG002|Overall Study|Screen Failure|0|||
150195068|NCT03899259|541854423|FG000|Overall Study|Ongoing Study Participation|127|||
150195069|NCT03899259|541854424|FG001|Overall Study|Ongoing Study Participation|134|||
150195070|NCT03899259|541854425|FG002|Overall Study|Ongoing Study Participation|210|||
150195071|NCT01152450|541854426|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
150195072|NCT01152450|541854427|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
150195073|NCT01152450|541854428|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
150195074|NCT01152450|541854429|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
150195075|NCT01152450|541854430|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
150195076|NCT01152450|541854431|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
150195077|NCT01152450|541854426|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
150195078|NCT01152450|541854427|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
150195079|NCT01152450|541854428|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
150195080|NCT01152450|541854429|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
150195081|NCT01152450|541854430|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
150195082|NCT01152450|541854431|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
150195083|NCT01152450|541854426|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
150195084|NCT01152450|541854427|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
150195085|NCT01152450|541854428|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
150195086|NCT01152450|541854429|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
150195087|NCT01152450|541854430|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
150195088|NCT01152450|541854431|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
150195089|NCT05670587|541854432|FG000|Overall Study|Withdrawal by Subject|3|||
150195090|NCT01733316|541854436|FG000|RP103 Phase|Non-compliance|1|||
150195091|NCT01733316|541854436|FG000|Long Term Extension Phase|Adverse Event|1|||
150195092|NCT01733316|541854436|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
150195093|NCT01733316|541854436|FG000|Long Term Extension Phase|Sponsor Decision|2|||
150195094|NCT02305888|541854445|FG000|Overall Study|Lost to Follow-up|0|||
150195095|NCT02305888|541854446|FG001|Overall Study|Lost to Follow-up|0|||
150195096|NCT02305888|541854447|FG002|Overall Study|Lost to Follow-up|1|||
150195097|NCT02305888|541854445|FG000|Overall Study|Adverse Event|0|||
150195098|NCT02305888|541854446|FG001|Overall Study|Adverse Event|1|||
150195099|NCT02305888|541854447|FG002|Overall Study|Adverse Event|0|||
150195100|NCT05139810|541854448|FG000|Overall Study|Voluntary Withdrawal|2|||
150195101|NCT05139810|541854449|FG001|Overall Study|Voluntary Withdrawal|1|||
150195102|NCT05139810|541854450|FG002|Overall Study|Voluntary Withdrawal|0|||
150195103|NCT05139810|541854448|FG000|Overall Study|Pregnancy|1|||
150195104|NCT05139810|541854449|FG001|Overall Study|Pregnancy|0|||
150195105|NCT05139810|541854450|FG002|Overall Study|Pregnancy|0|||
150195106|NCT05139810|541854448|FG000|Overall Study|Roll Over to CS7|19|||
150195107|NCT05139810|541854449|FG001|Overall Study|Roll Over to CS7|44|||
150195108|NCT05139810|541854450|FG002|Overall Study|Roll Over to CS7|20|||
150195109|NCT04914676|541854455|FG000|Overall Study|Study termination|3|||
150195110|NCT04914676|541854456|FG001|Overall Study|Study termination|0|||
150195111|NCT03024437|541854457|FG000|Overall Study|Adverse Event|0|||
150195112|NCT03024437|541854458|FG001|Overall Study|Adverse Event|1|||
150195113|NCT03024437|541854459|FG002|Overall Study|Adverse Event|3|||
150195114|NCT03024437|541854460|FG003|Overall Study|Adverse Event|5|||
150195115|NCT03024437|541854461|FG004|Overall Study|Adverse Event|0|||
150195116|NCT03024437|541854457|FG000|Overall Study|Physician Decision|1|||
150195117|NCT03024437|541854458|FG001|Overall Study|Physician Decision|0|||
150195118|NCT03024437|541854459|FG002|Overall Study|Physician Decision|0|||
150195119|NCT03024437|541854460|FG003|Overall Study|Physician Decision|1|||
150195120|NCT03024437|541854461|FG004|Overall Study|Physician Decision|0|||
150195121|NCT03024437|541854457|FG000|Overall Study|Disease progression, relapse|1|||
150126718|NCT00045110|541595646|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
150126719|NCT03662750|541595647|FG000|Overall Study|Withdrawal by Subject|1|||
150126720|NCT01983293|541598229|FG000|Overall Study|Withdrawal by Subject|29|||
150126721|NCT01983293|541598230|FG001|Overall Study|Withdrawal by Subject|15|||
150126722|NCT01983293|541598229|FG000|Overall Study|Missing 12-month visit|3|||
150126723|NCT01983293|541598230|FG001|Overall Study|Missing 12-month visit|3|||
150126724|NCT01983293|541598229|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
150126725|NCT01983293|541598230|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
150126726|NCT03147248|541598231|FG000|Overall Study|Adverse Event|0|||
150126727|NCT03147248|541598232|FG001|Overall Study|Adverse Event|2|||
150126728|NCT03147248|541598233|FG002|Overall Study|Adverse Event|2|||
150126729|NCT03147248|541598234|FG003|Overall Study|Adverse Event|2|||
150126730|NCT03147248|541598235|FG004|Overall Study|Adverse Event|6|||
150126731|NCT03147248|541598236|FG005|Overall Study|Adverse Event|11|||
150126732|NCT03147248|541598231|FG000|Overall Study|Disease progression|1|||
150126733|NCT03147248|541598232|FG001|Overall Study|Disease progression|0|||
150126734|NCT03147248|541598233|FG002|Overall Study|Disease progression|0|||
150126735|NCT03147248|541598234|FG003|Overall Study|Disease progression|0|||
150126736|NCT03147248|541598235|FG004|Overall Study|Disease progression|0|||
150126737|NCT03147248|541598236|FG005|Overall Study|Disease progression|2|||
150126738|NCT03147248|541598231|FG000|Overall Study|Withdrawal by Subject|0|||
150126739|NCT03147248|541598232|FG001|Overall Study|Withdrawal by Subject|0|||
150126740|NCT03147248|541598233|FG002|Overall Study|Withdrawal by Subject|0|||
150126741|NCT03147248|541598234|FG003|Overall Study|Withdrawal by Subject|0|||
150126742|NCT03147248|541598235|FG004|Overall Study|Withdrawal by Subject|12|||
150126743|NCT03147248|541598236|FG005|Overall Study|Withdrawal by Subject|9|||
150126744|NCT03147248|541598231|FG000|Overall Study|Protocol Violation|0|||
150126745|NCT03147248|541598232|FG001|Overall Study|Protocol Violation|0|||
150126746|NCT03147248|541598233|FG002|Overall Study|Protocol Violation|0|||
150126747|NCT03147248|541598234|FG003|Overall Study|Protocol Violation|0|||
150126748|NCT03147248|541598235|FG004|Overall Study|Protocol Violation|2|||
150126749|NCT03147248|541598236|FG005|Overall Study|Protocol Violation|0|||
150126750|NCT03147248|541598231|FG000|Overall Study|Lost to Follow-up|0|||
150126751|NCT03147248|541598232|FG001|Overall Study|Lost to Follow-up|0|||
150126752|NCT03147248|541598233|FG002|Overall Study|Lost to Follow-up|0|||
150126753|NCT03147248|541598234|FG003|Overall Study|Lost to Follow-up|0|||
150126754|NCT03147248|541598235|FG004|Overall Study|Lost to Follow-up|2|||
150126755|NCT03147248|541598236|FG005|Overall Study|Lost to Follow-up|0|||
150126756|NCT03147248|541598231|FG000|Overall Study|Pregnancy|0|||
150126757|NCT03147248|541598232|FG001|Overall Study|Pregnancy|0|||
150126758|NCT03147248|541598233|FG002|Overall Study|Pregnancy|0|||
150126759|NCT03147248|541598234|FG003|Overall Study|Pregnancy|0|||
150126760|NCT03147248|541598235|FG004|Overall Study|Pregnancy|1|||
150126761|NCT03147248|541598236|FG005|Overall Study|Pregnancy|0|||
150126762|NCT03147248|541598231|FG000|Overall Study|Death|0|||
150126763|NCT03147248|541598232|FG001|Overall Study|Death|0|||
150126764|NCT03147248|541598233|FG002|Overall Study|Death|0|||
150126765|NCT03147248|541598234|FG003|Overall Study|Death|0|||
150126766|NCT03147248|541598235|FG004|Overall Study|Death|0|||
150126767|NCT03147248|541598236|FG005|Overall Study|Death|4|||
150126768|NCT03147248|541598231|FG000|Overall Study|Physician Decision|0|||
150126769|NCT03147248|541598232|FG001|Overall Study|Physician Decision|0|||
150126770|NCT03147248|541598233|FG002|Overall Study|Physician Decision|0|||
150126771|NCT03147248|541598234|FG003|Overall Study|Physician Decision|0|||
150126772|NCT03147248|541598235|FG004|Overall Study|Physician Decision|2|||
150126773|NCT03147248|541598236|FG005|Overall Study|Physician Decision|4|||
150126774|NCT03147248|541598231|FG000|Overall Study|Prolonged Dosing Interval|0|||
150126775|NCT03147248|541598232|FG001|Overall Study|Prolonged Dosing Interval|0|||
150126776|NCT03147248|541598233|FG002|Overall Study|Prolonged Dosing Interval|0|||
150126777|NCT03147248|541598234|FG003|Overall Study|Prolonged Dosing Interval|0|||
150195122|NCT03024437|541854458|FG001|Overall Study|Disease progression, relapse|0|||
150126778|NCT03147248|541598235|FG004|Overall Study|Prolonged Dosing Interval|1|||
150126779|NCT03147248|541598236|FG005|Overall Study|Prolonged Dosing Interval|1|||
150126780|NCT03750552|541598237|FG000|Overall Study|Adverse Event|5|||
150126781|NCT03750552|541598238|FG001|Overall Study|Adverse Event|1|||
150126782|NCT03750552|541598237|FG000|Overall Study|Withdrawal by Subject|1|||
150126783|NCT03750552|541598238|FG001|Overall Study|Withdrawal by Subject|1|||
150126784|NCT03750552|541598237|FG000|Overall Study|Other|2|||
150195123|NCT03024437|541854459|FG002|Overall Study|Disease progression, relapse|0|||
150126785|NCT03750552|541598238|FG001|Overall Study|Other|0|||
150126786|NCT00773968|541598239|FG000|Overall Study|Adverse Event|2|||
150126787|NCT00773968|541598239|FG000|Overall Study|Death|1|||
150126788|NCT00773968|541598239|FG000|Overall Study|Failure to Return|2|||
150126789|NCT00773968|541598239|FG000|Overall Study|Lack of Efficacy|3|||
150126790|NCT00773968|541598239|FG000|Overall Study|Protocol Violation|1|||
150126791|NCT00773968|541598239|FG000|Overall Study|Withdrawal by Subject|11|||
150126792|NCT00773968|541598239|FG000|Overall Study|Screen Failure|17|||
150126793|NCT00773968|541598239|FG000|Overall Study|Other|8|||
150195124|NCT03024437|541854460|FG003|Overall Study|Disease progression, relapse|3|||
150195125|NCT03024437|541854461|FG004|Overall Study|Disease progression, relapse|0|||
150195126|NCT03024437|541854457|FG000|Overall Study|Disease progression, refractory disease|4|||
150195127|NCT03024437|541854458|FG001|Overall Study|Disease progression, refractory disease|4|||
150195128|NCT03024437|541854459|FG002|Overall Study|Disease progression, refractory disease|2|||
150195129|NCT03024437|541854460|FG003|Overall Study|Disease progression, refractory disease|2|||
150195130|NCT03024437|541854461|FG004|Overall Study|Disease progression, refractory disease|1|||
150195131|NCT03024437|541854457|FG000|Overall Study|Newly diagnosed cancer|0|||
150195132|NCT03024437|541854458|FG001|Overall Study|Newly diagnosed cancer|0|||
150195133|NCT03024437|541854459|FG002|Overall Study|Newly diagnosed cancer|0|||
150195134|NCT03024437|541854460|FG003|Overall Study|Newly diagnosed cancer|1|||
150195135|NCT03024437|541854461|FG004|Overall Study|Newly diagnosed cancer|0|||
150195136|NCT03024437|541854457|FG000|Overall Study|Moved out of state|0|||
150195137|NCT03024437|541854458|FG001|Overall Study|Moved out of state|1|||
150195138|NCT03024437|541854459|FG002|Overall Study|Moved out of state|0|||
150195139|NCT03024437|541854460|FG003|Overall Study|Moved out of state|0|||
150195140|NCT03024437|541854461|FG004|Overall Study|Moved out of state|0|||
150195141|NCT03024437|541854457|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
150195142|NCT03024437|541854458|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
150195143|NCT03024437|541854459|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
150195144|NCT03024437|541854460|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
150195145|NCT03024437|541854461|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
150126794|NCT02008890|541598248|FG000|Period 1|Withdrawal by Subject|7|||
150126795|NCT02008890|541598249|FG001|Period 1|Withdrawal by Subject|7|||
150126796|NCT02008890|541598250|FG002|Period 1|Withdrawal by Subject|5|||
150126797|NCT02008890|541598251|FG003|Period 1|Withdrawal by Subject|0|||
150126798|NCT02008890|541598252|FG004|Period 1|Withdrawal by Subject|0|||
150126799|NCT02008890|541598248|FG000|Period 1|Pregnancy|1|||
150126800|NCT02008890|541598249|FG001|Period 1|Pregnancy|0|||
150126801|NCT02008890|541598250|FG002|Period 1|Pregnancy|0|||
150195146|NCT05546411|541854462|FG000|Overall Study|Progressive Disease|1|||
150195147|NCT05546411|541854463|FG001|Overall Study|Progressive Disease|0|||
150195148|NCT05546411|541854462|FG000|Overall Study|Adverse Event|0|||
150195149|NCT05546411|541854463|FG001|Overall Study|Adverse Event|1|||
150195150|NCT05546411|541854462|FG000|Overall Study|Metastatic disease|1|||
150195151|NCT05546411|541854463|FG001|Overall Study|Metastatic disease|0|||
150195152|NCT02606422|541854464|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
150195153|NCT02606422|541854465|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
150195154|NCT02606422|541854464|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
150195155|NCT02606422|541854465|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
150195156|NCT02606422|541854464|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
150195157|NCT02606422|541854465|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
150195158|NCT02606422|541854464|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
150195159|NCT02606422|541854465|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
150195160|NCT04625465|541854466|FG000|Overall Study|Lost to Follow-up|2|||
150195161|NCT04625465|541854467|FG001|Overall Study|Lost to Follow-up|2|||
150195162|NCT04625465|541854468|FG002|Overall Study|Lost to Follow-up|1|||
150195163|NCT04625465|541854469|FG003|Overall Study|Lost to Follow-up|0|||
150195164|NCT04625465|541854470|FG004|Overall Study|Lost to Follow-up|0|||
150195165|NCT04625465|541854471|FG005|Overall Study|Lost to Follow-up|2|||
150195166|NCT04625465|541854472|FG006|Overall Study|Lost to Follow-up|0|||
150195167|NCT04625465|541854473|FG007|Overall Study|Lost to Follow-up|0|||
150195168|NCT04625465|541854466|FG000|Overall Study|Death|1|||
150195169|NCT04625465|541854467|FG001|Overall Study|Death|0|||
150195170|NCT04625465|541854468|FG002|Overall Study|Death|0|||
150195171|NCT04625465|541854469|FG003|Overall Study|Death|0|||
150195172|NCT04625465|541854470|FG004|Overall Study|Death|0|||
150126802|NCT02008890|541598251|FG003|Period 1|Pregnancy|0|||
150126803|NCT02008890|541598252|FG004|Period 1|Pregnancy|0|||
150126804|NCT02008890|541598248|FG000|Period 1|Physician Decision|1|||
150126805|NCT02008890|541598249|FG001|Period 1|Physician Decision|0|||
150195173|NCT04625465|541854471|FG005|Overall Study|Death|0|||
150195174|NCT04625465|541854472|FG006|Overall Study|Death|0|||
150195175|NCT04625465|541854473|FG007|Overall Study|Death|0|||
150195176|NCT04625465|541854466|FG000|Overall Study|Withdrawal by Subject|1|||
150195177|NCT04625465|541854467|FG001|Overall Study|Withdrawal by Subject|0|||
150195178|NCT04625465|541854468|FG002|Overall Study|Withdrawal by Subject|4|||
150195179|NCT04625465|541854469|FG003|Overall Study|Withdrawal by Subject|4|||
150195180|NCT04625465|541854470|FG004|Overall Study|Withdrawal by Subject|4|||
150195181|NCT04625465|541854471|FG005|Overall Study|Withdrawal by Subject|0|||
150195182|NCT04625465|541854472|FG006|Overall Study|Withdrawal by Subject|0|||
150195183|NCT04625465|541854473|FG007|Overall Study|Withdrawal by Subject|0|||
150195184|NCT05566639|541854481|FG000|Overall Study|Adverse Event|1|||
150195185|NCT05566639|541854482|FG001|Overall Study|Adverse Event|1|||
150126806|NCT02008890|541598250|FG002|Period 1|Physician Decision|1|||
150195186|NCT05566639|541854481|FG000|Overall Study|Serious Adverse Event|1|||
150195187|NCT05566639|541854482|FG001|Overall Study|Serious Adverse Event|3|||
150195188|NCT05566639|541854481|FG000|Overall Study|Death|44|||
150195189|NCT05566639|541854482|FG001|Overall Study|Death|45|||
150195190|NCT05566639|541854481|FG000|Overall Study|Lost to Follow-up|467|||
150195191|NCT05566639|541854482|FG001|Overall Study|Lost to Follow-up|461|||
150195192|NCT05566639|541854481|FG000|Overall Study|Physician Decision|45|||
150195193|NCT05566639|541854482|FG001|Overall Study|Physician Decision|44|||
150195194|NCT05566639|541854481|FG000|Overall Study|Protocol Deviation|4|||
150195195|NCT05566639|541854482|FG001|Overall Study|Protocol Deviation|4|||
150195196|NCT05566639|541854481|FG000|Overall Study|Withdrawal by Subject|277|||
150195197|NCT05566639|541854482|FG001|Overall Study|Withdrawal by Subject|271|||
150195198|NCT05566639|541854481|FG000|Overall Study|Other Than Specified|52|||
150195199|NCT05566639|541854482|FG001|Overall Study|Other Than Specified|64|||
150195200|NCT04054193|541854491|FG000|Cycle 1|Physician Decision|1|||
150195201|NCT04054193|541854491|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
150195202|NCT04054193|541854491|FG000|Cycle 1|Allocated but not treated|3|||
150195203|NCT04054193|541854491|FG000|Cycles 2-3|Physician Decision|2|||
150195204|NCT04054193|541854491|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
150195205|NCT04054193|541854491|FG000|Cycles 2-3|Various reasons|17|||
150195206|NCT02966873|541854492|FG000|Overall Study|Lost to Follow-up|16|||
150195207|NCT02966873|541854493|FG001|Overall Study|Lost to Follow-up|15|||
150195208|NCT04753697|541854494|FG000|Induction Phase|Withdrawal by Subject|12|||
150195209|NCT04753697|541854495|FG001|Induction Phase|Withdrawal by Subject|5|||
150195210|NCT04753697|541854496|FG002|Induction Phase|Withdrawal by Subject|6|||
150195211|NCT04753697|541854494|FG000|Induction Phase|Physician Decision|1|||
150195212|NCT04753697|541854495|FG001|Induction Phase|Physician Decision|0|||
150195213|NCT04753697|541854496|FG002|Induction Phase|Physician Decision|0|||
150195214|NCT04753697|541854494|FG000|Induction Phase|Lost to Follow-up|2|||
150195215|NCT04753697|541854495|FG001|Induction Phase|Lost to Follow-up|2|||
150195216|NCT04753697|541854496|FG002|Induction Phase|Lost to Follow-up|1|||
150195217|NCT04753697|541854494|FG000|Induction Phase|Lack of Efficacy|1|||
150195218|NCT04753697|541854495|FG001|Induction Phase|Lack of Efficacy|0|||
150195219|NCT04753697|541854496|FG002|Induction Phase|Lack of Efficacy|0|||
150195220|NCT04753697|541854494|FG000|Maintenance Phase|Physician Decision|0|||
150195221|NCT04753697|541854495|FG001|Maintenance Phase|Physician Decision|0|||
150195222|NCT04753697|541854496|FG002|Maintenance Phase|Physician Decision|1|||
150195223|NCT04753697|541854494|FG000|Maintenance Phase|Withdrawal by Subject|3|||
150195224|NCT04753697|541854495|FG001|Maintenance Phase|Withdrawal by Subject|4|||
150195225|NCT04753697|541854496|FG002|Maintenance Phase|Withdrawal by Subject|6|||
150195226|NCT04753697|541854494|FG000|Maintenance Phase|Lost to Follow-up|2|||
150195227|NCT04753697|541854495|FG001|Maintenance Phase|Lost to Follow-up|2|||
150195228|NCT04753697|541854496|FG002|Maintenance Phase|Lost to Follow-up|0|||
150195229|NCT04753697|541854494|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
150195230|NCT04753697|541854495|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
150195231|NCT04753697|541854496|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
150195232|NCT04753697|541854494|FG000|Maintenance Phase|Adverse Event|0|||
150195233|NCT04753697|541854495|FG001|Maintenance Phase|Adverse Event|1|||
150195234|NCT04753697|541854496|FG002|Maintenance Phase|Adverse Event|1|||
150195235|NCT04753697|541854494|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
150195236|NCT04753697|541854495|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
150195237|NCT04753697|541854496|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
150195238|NCT04200456|541854497|FG000|Overall Study|Physician Decision|0|||
150195239|NCT04200456|541854498|FG001|Overall Study|Physician Decision|1|||
150195240|NCT04200456|541854497|FG000|Overall Study|Withdrawal by Subject|2|||
150195241|NCT04200456|541854498|FG001|Overall Study|Withdrawal by Subject|2|||
150195242|NCT04200456|541854497|FG000|Overall Study|Lack of Efficacy|1|||
150195243|NCT04200456|541854498|FG001|Overall Study|Lack of Efficacy|1|||
150195244|NCT04200456|541854497|FG000|Overall Study|Adverse event, non-fatal|0|||
150195245|NCT04200456|541854498|FG001|Overall Study|Adverse event, non-fatal|1|||
150195246|NCT04200456|541854497|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
150195247|NCT04200456|541854498|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
150195248|NCT05446168|541854499|FG000|Overall Study|Physician Decision|0|||
150195249|NCT05446168|541854500|FG001|Overall Study|Physician Decision|1|||
150195250|NCT03257410|541856474|FG000|Overall Study|Adverse Event|2|||
150195251|NCT03257410|541856475|FG001|Overall Study|Adverse Event|3|||
150195252|NCT03257410|541856474|FG000|Overall Study|Protocol Violation|1|||
150195253|NCT03257410|541856475|FG001|Overall Study|Protocol Violation|2|||
150195254|NCT03257410|541856474|FG000|Overall Study|Lost to Follow-up|1|||
150195255|NCT03257410|541856475|FG001|Overall Study|Lost to Follow-up|0|||
150195256|NCT03257410|541856474|FG000|Overall Study|Withdrawal by Subject|1|||
150195257|NCT03257410|541856475|FG001|Overall Study|Withdrawal by Subject|2|||
150195258|NCT03257410|541856474|FG000|Overall Study|Physician Decision|1|||
150195259|NCT03257410|541856475|FG001|Overall Study|Physician Decision|1|||
150195260|NCT03257410|541856474|FG000|Overall Study|Renal transplantation|2|||
150195261|NCT03257410|541856475|FG001|Overall Study|Renal transplantation|0|||
150195262|NCT03257410|541856474|FG000|Overall Study|Switch to peritoneal dialysis|1|||
150195263|NCT03257410|541856475|FG001|Overall Study|Switch to peritoneal dialysis|0|||
150195264|NCT03257410|541856474|FG000|Overall Study|Death|3|||
150195265|NCT03257410|541856475|FG001|Overall Study|Death|2|||
150195266|NCT03257410|541856474|FG000|Overall Study|Change to another dialysis center|2|||
150195267|NCT03257410|541856475|FG001|Overall Study|Change to another dialysis center|2|||
150195268|NCT03257410|541856474|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
150195269|NCT03257410|541856475|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
150195270|NCT03257410|541856474|FG000|Overall Study|Miscellaneous|2|||
150195271|NCT03257410|541856475|FG001|Overall Study|Miscellaneous|2|||
150195272|NCT03257410|541856474|FG000|Overall Study|Other|0|||
150195273|NCT03257410|541856475|FG001|Overall Study|Other|1|||
150195274|NCT02598388|541856476|FG000|Overall Study|Lost to Follow-up|1|||
150195275|NCT02598388|541856477|FG001|Overall Study|Lost to Follow-up|0|||
150195276|NCT02598388|541856478|FG002|Overall Study|Lost to Follow-up|1|||
150195277|NCT02598388|541856479|FG003|Overall Study|Lost to Follow-up|0|||
150195278|NCT02598388|541856480|FG004|Overall Study|Lost to Follow-up|5|||
150195279|NCT02598388|541856481|FG005|Overall Study|Lost to Follow-up|1|||
150195280|NCT02598388|541856482|FG006|Overall Study|Lost to Follow-up|2|||
150195281|NCT02598388|541856483|FG007|Overall Study|Lost to Follow-up|1|||
150195282|NCT02598388|541856484|FG008|Overall Study|Lost to Follow-up|0|||
150195283|NCT02598388|541856485|FG009|Overall Study|Lost to Follow-up|0|||
150195284|NCT02598388|541856486|FG010|Overall Study|Lost to Follow-up|1|||
150195285|NCT02598388|541856487|FG011|Overall Study|Lost to Follow-up|0|||
150195286|NCT02598388|541856476|FG000|Overall Study|Withdrawal by Subject|0|||
150195287|NCT02598388|541856477|FG001|Overall Study|Withdrawal by Subject|0|||
150195288|NCT02598388|541856478|FG002|Overall Study|Withdrawal by Subject|0|||
150195289|NCT02598388|541856479|FG003|Overall Study|Withdrawal by Subject|0|||
150195290|NCT02598388|541856480|FG004|Overall Study|Withdrawal by Subject|2|||
150195291|NCT02598388|541856481|FG005|Overall Study|Withdrawal by Subject|0|||
150195292|NCT02598388|541856482|FG006|Overall Study|Withdrawal by Subject|2|||
150195293|NCT02598388|541856483|FG007|Overall Study|Withdrawal by Subject|0|||
150195294|NCT02598388|541856484|FG008|Overall Study|Withdrawal by Subject|0|||
150195295|NCT02598388|541856485|FG009|Overall Study|Withdrawal by Subject|1|||
150195296|NCT02598388|541856486|FG010|Overall Study|Withdrawal by Subject|0|||
150195297|NCT02598388|541856487|FG011|Overall Study|Withdrawal by Subject|0|||
150195298|NCT02598388|541856476|FG000|Overall Study|Other|0|||
150195299|NCT02598388|541856477|FG001|Overall Study|Other|0|||
150195300|NCT02598388|541856478|FG002|Overall Study|Other|1|||
150195301|NCT02598388|541856479|FG003|Overall Study|Other|0|||
150195302|NCT02598388|541856480|FG004|Overall Study|Other|3|||
150195303|NCT02598388|541856481|FG005|Overall Study|Other|0|||
150195304|NCT02598388|541856482|FG006|Overall Study|Other|1|||
150195305|NCT02598388|541856483|FG007|Overall Study|Other|0|||
150195306|NCT02598388|541856484|FG008|Overall Study|Other|0|||
150195307|NCT02598388|541856485|FG009|Overall Study|Other|0|||
150195308|NCT02598388|541856486|FG010|Overall Study|Other|0|||
150195309|NCT02598388|541856487|FG011|Overall Study|Other|0|||
150195310|NCT05256017|541856490|FG000|Treatment Period|Withdrawal by Subject|1|||
150195311|NCT05256017|541856491|FG001|Treatment Period|Withdrawal by Subject|1|||
150195312|NCT05256017|541856490|FG000|Follow-up|Lost to Follow-up|7|||
150195313|NCT05256017|541856491|FG001|Follow-up|Lost to Follow-up|1|||
150195314|NCT05256017|541856490|FG000|Follow-up|Withdrawal by Subject|1|||
150126807|NCT02008890|541598251|FG003|Period 1|Physician Decision|0|||
150126808|NCT02008890|541598252|FG004|Period 1|Physician Decision|0|||
150126809|NCT02008890|541598248|FG000|Period 1|Adverse Event|6|||
150126810|NCT02008890|541598249|FG001|Period 1|Adverse Event|8|||
150126811|NCT02008890|541598250|FG002|Period 1|Adverse Event|6|||
150126812|NCT02008890|541598251|FG003|Period 1|Adverse Event|0|||
150126813|NCT02008890|541598252|FG004|Period 1|Adverse Event|0|||
150126814|NCT02008890|541598248|FG000|Period 2|Adverse Event|12|||
150126815|NCT02008890|541598249|FG001|Period 2|Adverse Event|7|||
150126816|NCT02008890|541598250|FG002|Period 2|Adverse Event|0|||
150126817|NCT02008890|541598251|FG003|Period 2|Adverse Event|5|||
150126818|NCT02008890|541598252|FG004|Period 2|Adverse Event|5|||
150126819|NCT02008890|541598248|FG000|Period 2|Withdrawal by Subject|11|||
150126820|NCT02008890|541598249|FG001|Period 2|Withdrawal by Subject|8|||
150126821|NCT02008890|541598250|FG002|Period 2|Withdrawal by Subject|0|||
150126822|NCT02008890|541598251|FG003|Period 2|Withdrawal by Subject|7|||
150126823|NCT02008890|541598252|FG004|Period 2|Withdrawal by Subject|2|||
150126824|NCT02008890|541598248|FG000|Period 2|Physician Decision|4|||
150126825|NCT02008890|541598249|FG001|Period 2|Physician Decision|0|||
150126826|NCT02008890|541598250|FG002|Period 2|Physician Decision|0|||
150126827|NCT02008890|541598251|FG003|Period 2|Physician Decision|2|||
150126828|NCT02008890|541598252|FG004|Period 2|Physician Decision|1|||
150126829|NCT02008890|541598248|FG000|Period 2|Lost to Follow-up|0|||
150126830|NCT02008890|541598249|FG001|Period 2|Lost to Follow-up|0|||
150126831|NCT02008890|541598250|FG002|Period 2|Lost to Follow-up|1|||
150126832|NCT02008890|541598251|FG003|Period 2|Lost to Follow-up|0|||
150126833|NCT02008890|541598252|FG004|Period 2|Lost to Follow-up|0|||
150126834|NCT02008890|541598248|FG000|Extension Period|Withdrawal by Subject|3|||
150126835|NCT02008890|541598249|FG001|Extension Period|Withdrawal by Subject|2|||
150126836|NCT02008890|541598250|FG002|Extension Period|Withdrawal by Subject|0|||
150126837|NCT02008890|541598251|FG003|Extension Period|Withdrawal by Subject|4|||
150126838|NCT02008890|541598252|FG004|Extension Period|Withdrawal by Subject|2|||
150126839|NCT02008890|541598248|FG000|Extension Period|Lost to Follow-up|1|||
150126840|NCT02008890|541598249|FG001|Extension Period|Lost to Follow-up|0|||
150126841|NCT02008890|541598250|FG002|Extension Period|Lost to Follow-up|0|||
150126842|NCT02008890|541598251|FG003|Extension Period|Lost to Follow-up|0|||
150126843|NCT02008890|541598252|FG004|Extension Period|Lost to Follow-up|0|||
150126844|NCT02008890|541598248|FG000|Extension Period|Adverse Event|1|||
150126845|NCT02008890|541598249|FG001|Extension Period|Adverse Event|3|||
150126846|NCT02008890|541598250|FG002|Extension Period|Adverse Event|0|||
150126847|NCT02008890|541598251|FG003|Extension Period|Adverse Event|0|||
150126848|NCT02008890|541598252|FG004|Extension Period|Adverse Event|2|||
150126849|NCT02522494|541598253|FG000|Overall Study|Lost to Follow-up|6|||
150126850|NCT02522494|541598254|FG001|Overall Study|Lost to Follow-up|2|||
150126851|NCT02522494|541598253|FG000|Overall Study|Withdrawal by Subject|1|||
150126852|NCT02522494|541598254|FG001|Overall Study|Withdrawal by Subject|0|||
150126853|NCT02522494|541598253|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
150126854|NCT02522494|541598254|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
150126855|NCT02522494|541598253|FG000|Overall Study|Participant did not watch the video|1|||
150126856|NCT02522494|541598254|FG001|Overall Study|Participant did not watch the video|0|||
150126857|NCT02522494|541598253|FG000|Overall Study|Death|0|||
150126858|NCT02522494|541598254|FG001|Overall Study|Death|1|||
150126859|NCT03240588|541598255|FG000|Overall Study|Death|3|||
150126860|NCT03240588|541598256|FG001|Overall Study|Death|0|||
150126861|NCT03240588|541598257|FG002|Overall Study|Death|0|||
150126862|NCT03240588|541598255|FG000|Overall Study|Adverse Event|5|||
150126863|NCT03240588|541598256|FG001|Overall Study|Adverse Event|4|||
150126864|NCT03240588|541598257|FG002|Overall Study|Adverse Event|0|||
150126865|NCT03240588|541598255|FG000|Overall Study|Lost to Follow-up|9|||
150126866|NCT03240588|541598256|FG001|Overall Study|Lost to Follow-up|4|||
150126867|NCT03240588|541598257|FG002|Overall Study|Lost to Follow-up|0|||
150126868|NCT03240588|541598255|FG000|Overall Study|Physician Decision|3|||
150126869|NCT03240588|541598256|FG001|Overall Study|Physician Decision|2|||
150126870|NCT03240588|541598257|FG002|Overall Study|Physician Decision|0|||
150126871|NCT03240588|541598255|FG000|Overall Study|Did not meet eligibility criteria|0|||
150126872|NCT03240588|541598256|FG001|Overall Study|Did not meet eligibility criteria|6|||
150126873|NCT03240588|541598257|FG002|Overall Study|Did not meet eligibility criteria|0|||
150126874|NCT03240588|541598255|FG000|Overall Study|No longer meets protocol criteria|12|||
150126875|NCT03240588|541598256|FG001|Overall Study|No longer meets protocol criteria|7|||
150126876|NCT03240588|541598257|FG002|Overall Study|No longer meets protocol criteria|0|||
150126877|NCT03240588|541598255|FG000|Overall Study|Withdrawal by Subject|60|||
150126878|NCT03240588|541598256|FG001|Overall Study|Withdrawal by Subject|52|||
150126879|NCT03240588|541598257|FG002|Overall Study|Withdrawal by Subject|7|||
150126880|NCT03240588|541598255|FG000|Overall Study|Other, additional details not available.|0|||
150126881|NCT03240588|541598256|FG001|Overall Study|Other, additional details not available.|12|||
150126882|NCT03240588|541598257|FG002|Overall Study|Other, additional details not available.|1|||
150195315|NCT05256017|541856491|FG001|Follow-up|Withdrawal by Subject|0|||
150126883|NCT03240588|541598255|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
150126884|NCT03240588|541598256|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
150126885|NCT03240588|541598257|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
150126886|NCT03240588|541598255|FG000|Overall Study|Closure of study|55|||
150126887|NCT03240588|541598256|FG001|Overall Study|Closure of study|3|||
150126888|NCT03240588|541598257|FG002|Overall Study|Closure of study|0|||
150126889|NCT03240588|541598255|FG000|Overall Study|Subject non-compliance|23|||
150126890|NCT03240588|541598256|FG001|Overall Study|Subject non-compliance|2|||
150126891|NCT03240588|541598257|FG002|Overall Study|Subject non-compliance|1|||
150126892|NCT03240588|541598255|FG000|Overall Study|Device Deficiency|1|||
150126893|NCT03240588|541598256|FG001|Overall Study|Device Deficiency|0|||
150126894|NCT03240588|541598257|FG002|Overall Study|Device Deficiency|0|||
150126895|NCT03240588|541598255|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
150126896|NCT03240588|541598256|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
150126897|NCT03240588|541598257|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
150126898|NCT02091726|541598259|FG000|Overall Study|Lost to Follow-up|6|||
150126899|NCT02047045|541598269|FG000|Baseline|Withdrawal by Subject|3|||
150126900|NCT02047045|541598270|FG001|Baseline|Withdrawal by Subject|2|||
150126901|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
150126902|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
150126903|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
150126904|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
150126905|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
150126906|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
150126907|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
150126908|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
150126909|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
150126910|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
150126911|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
150126912|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
150126913|NCT02047045|541598269|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
150126914|NCT02047045|541598270|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
150126915|NCT02047045|541598269|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
150126916|NCT02047045|541598270|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
150126917|NCT04066114|541598271|FG000|Overall Study|Adverse Event|1|||
150126918|NCT04066114|541598272|FG001|Overall Study|Adverse Event|0|||
150126919|NCT04066114|541598273|FG002|Overall Study|Adverse Event|0|||
150126920|NCT04066114|541598271|FG000|Overall Study|Withdrawal by Subject|1|||
150126921|NCT04066114|541598272|FG001|Overall Study|Withdrawal by Subject|0|||
150126922|NCT04066114|541598273|FG002|Overall Study|Withdrawal by Subject|0|||
150126923|NCT04066114|541598271|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
150126924|NCT04066114|541598272|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
150126925|NCT04066114|541598273|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
150126926|NCT00856856|541598275|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
150126927|NCT00856856|541598275|FG000|4-year Clinical Follow-up|Missed visit|1|||
150126928|NCT00434057|541598278|FG000|Overall Study|Withdrawal by Subject|1|||
150126929|NCT00455195|541598279|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
150126930|NCT00455195|541598280|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
150126931|NCT00455195|541598279|FG000|Double-blind Study AGLU02704|Death|1|||
150126932|NCT00455195|541598280|FG001|Double-blind Study AGLU02704|Death|0|||
150126933|NCT00455195|541598279|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
150126934|NCT00455195|541598280|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
150126935|NCT00455195|541598279|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
150126936|NCT00455195|541598280|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
150126937|NCT02117570|541598281|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
150126938|NCT02117570|541598282|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
150126939|NCT02117570|541598283|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
150126940|NCT02117570|541598281|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
150126941|NCT02117570|541598282|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
150126942|NCT02117570|541598283|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
150126943|NCT02117570|541598281|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
150126944|NCT02117570|541598282|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
150126945|NCT02117570|541598283|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
150126946|NCT02117570|541598281|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
150126947|NCT02117570|541598282|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
150126948|NCT02117570|541598283|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
150126949|NCT02117570|541598281|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
150126950|NCT02117570|541598282|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
150126951|NCT02117570|541598283|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
150126952|NCT02117570|541598281|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
150126953|NCT02117570|541598282|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
150126954|NCT02117570|541598283|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
150126955|NCT02117570|541598281|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
150126956|NCT02117570|541598282|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
150126957|NCT02117570|541598283|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
150126958|NCT02148250|541598284|FG000|Screening|Withdrawal by Subject|5|||
150126959|NCT02148250|541598285|FG001|Screening|Withdrawal by Subject|0|||
150126960|NCT00922428|541598288|FG000|Overall Study|retrospective/extremely implausible data|2|||
150126961|NCT00922428|541598288|FG000|Overall Study|no medication use or questionable use|13|||
150126962|NCT03701555|541598300|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
150126963|NCT03701555|541598301|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
150126964|NCT03701555|541598302|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
150126965|NCT03701555|541598303|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
150126966|NCT03701555|541598304|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
150126967|NCT03701555|541598305|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
150126968|NCT03701555|541598306|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
150126969|NCT03701555|541598307|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
150126970|NCT03701555|541598308|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
150126971|NCT03701555|541598309|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
150126972|NCT03701555|541598310|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
150126973|NCT03701555|541598311|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
150126974|NCT03701555|541598312|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
150126975|NCT03701555|541598313|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
150126976|NCT03701555|541598314|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
150126977|NCT03701555|541598315|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
150126978|NCT03701555|541598316|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
150126979|NCT03701555|541598317|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
150126980|NCT03701555|541598318|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
150126981|NCT03701555|541598319|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
150126982|NCT03701555|541598320|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
150126983|NCT03701555|541598321|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
150126984|NCT03701555|541598322|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
150126985|NCT03701555|541598323|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
150126986|NCT03701555|541598324|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
150126987|NCT03701555|541598325|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
150126988|NCT03701555|541598326|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
150126989|NCT03701555|541598327|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
150126990|NCT03701555|541598328|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
150126991|NCT03701555|541598329|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
150126992|NCT03701555|541598330|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
150126993|NCT03701555|541598331|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
150126994|NCT03701555|541598332|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
150126995|NCT03701555|541598333|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
150126996|NCT03701555|541598334|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
150126997|NCT03701555|541598335|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
150126998|NCT03701555|541598300|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
150126999|NCT03701555|541598301|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
150127000|NCT03701555|541598302|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
150127001|NCT03701555|541598303|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
150127002|NCT03701555|541598304|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
150127003|NCT03701555|541598305|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
150127004|NCT03701555|541598306|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
150127005|NCT03701555|541598307|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
150127006|NCT03701555|541598308|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
150127007|NCT03701555|541598309|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
150127008|NCT03701555|541598310|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
150127009|NCT03701555|541598311|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
150127010|NCT03701555|541598312|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
150127011|NCT03701555|541598313|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
150127012|NCT03701555|541598314|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
150127013|NCT03701555|541598315|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
150127014|NCT03701555|541598316|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
150127015|NCT03701555|541598317|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
150127016|NCT03701555|541598318|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
150127017|NCT03701555|541598319|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
150127018|NCT03701555|541598320|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
150127019|NCT03701555|541598321|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
150127020|NCT03701555|541598322|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
150127021|NCT03701555|541598323|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
150127022|NCT03701555|541598324|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
150127023|NCT03701555|541598325|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
150127024|NCT03701555|541598326|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
150127025|NCT03701555|541598327|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
150127026|NCT03701555|541598328|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
150127027|NCT03701555|541598329|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
150127028|NCT03701555|541598330|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
150127029|NCT03701555|541598331|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
150127030|NCT03701555|541598332|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
150127031|NCT03701555|541598333|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
150127032|NCT03701555|541598334|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
150127033|NCT03701555|541598335|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
150127034|NCT03701555|541598300|FG000|Part 2 (Day 1)|Other|0|||
150127035|NCT03701555|541598301|FG001|Part 2 (Day 1)|Other|0|||
150127036|NCT03701555|541598302|FG002|Part 2 (Day 1)|Other|0|||
150127037|NCT03701555|541598303|FG003|Part 2 (Day 1)|Other|0|||
150127038|NCT03701555|541598304|FG004|Part 2 (Day 1)|Other|0|||
150127039|NCT03701555|541598305|FG005|Part 2 (Day 1)|Other|0|||
150127040|NCT03701555|541598306|FG006|Part 2 (Day 1)|Other|0|||
150127041|NCT03701555|541598307|FG007|Part 2 (Day 1)|Other|0|||
150127042|NCT03701555|541598308|FG008|Part 2 (Day 1)|Other|0|||
150127043|NCT03701555|541598309|FG009|Part 2 (Day 1)|Other|0|||
150127044|NCT03701555|541598310|FG010|Part 2 (Day 1)|Other|3|||
150127045|NCT03701555|541598311|FG011|Part 2 (Day 1)|Other|1|||
150127046|NCT03701555|541598312|FG012|Part 2 (Day 1)|Other|0|||
150127047|NCT03701555|541598313|FG013|Part 2 (Day 1)|Other|1|||
150127048|NCT03701555|541598314|FG014|Part 2 (Day 1)|Other|0|||
150127049|NCT03701555|541598315|FG015|Part 2 (Day 1)|Other|2|||
150127050|NCT03701555|541598316|FG016|Part 2 (Day 1)|Other|2|||
150127051|NCT03701555|541598317|FG017|Part 2 (Day 1)|Other|0|||
150127052|NCT03701555|541598318|FG018|Part 2 (Day 1)|Other|0|||
150127053|NCT03701555|541598319|FG019|Part 2 (Day 1)|Other|0|||
150127054|NCT03701555|541598320|FG020|Part 2 (Day 1)|Other|0|||
150127055|NCT03701555|541598321|FG021|Part 2 (Day 1)|Other|0|||
150127056|NCT03701555|541598322|FG022|Part 2 (Day 1)|Other|0|||
150127057|NCT03701555|541598323|FG023|Part 2 (Day 1)|Other|0|||
150127058|NCT03701555|541598324|FG024|Part 2 (Day 1)|Other|0|||
150127059|NCT03701555|541598325|FG025|Part 2 (Day 1)|Other|0|||
150127060|NCT03701555|541598326|FG026|Part 2 (Day 1)|Other|0|||
150127061|NCT03701555|541598327|FG027|Part 2 (Day 1)|Other|0|||
150127062|NCT03701555|541598328|FG028|Part 2 (Day 1)|Other|0|||
150127063|NCT03701555|541598329|FG029|Part 2 (Day 1)|Other|0|||
150127064|NCT03701555|541598330|FG030|Part 2 (Day 1)|Other|0|||
150127065|NCT03701555|541598331|FG031|Part 2 (Day 1)|Other|0|||
150127066|NCT03701555|541598332|FG032|Part 2 (Day 1)|Other|0|||
150127067|NCT03701555|541598333|FG033|Part 2 (Day 1)|Other|0|||
150127068|NCT03701555|541598334|FG034|Part 2 (Day 1)|Other|0|||
150127069|NCT03701555|541598335|FG035|Part 2 (Day 1)|Other|0|||
150127070|NCT03701555|541598300|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
150127071|NCT03701555|541598301|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
150127072|NCT03701555|541598302|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
150127073|NCT03701555|541598303|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
150127074|NCT03701555|541598304|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
150127075|NCT03701555|541598305|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
150127076|NCT03701555|541598306|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
150127077|NCT03701555|541598307|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
150127078|NCT03701555|541598308|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
150127079|NCT03701555|541598309|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
150127080|NCT03701555|541598310|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
150127081|NCT03701555|541598311|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
150127082|NCT03701555|541598312|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
150127083|NCT03701555|541598313|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
150127084|NCT03701555|541598314|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
150127085|NCT03701555|541598315|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
150127086|NCT03701555|541598316|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
150127087|NCT03701555|541598317|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
150127088|NCT03701555|541598318|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
150127089|NCT03701555|541598319|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
150127090|NCT03701555|541598320|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
150127091|NCT03701555|541598321|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
150127092|NCT03701555|541598322|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
150127093|NCT03701555|541598323|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
150127094|NCT03701555|541598324|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
150127095|NCT03701555|541598325|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
150127096|NCT03701555|541598326|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
150127097|NCT03701555|541598327|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
150127098|NCT03701555|541598328|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
150127099|NCT03701555|541598329|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
150127100|NCT03701555|541598330|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
150127101|NCT03701555|541598331|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
150127102|NCT03701555|541598332|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
150127103|NCT03701555|541598333|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
150127104|NCT03701555|541598334|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
150127105|NCT03701555|541598335|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
150127106|NCT03701555|541598300|FG000|Part 3 (Day 1)|Subject Decision|0|||
150127107|NCT03701555|541598301|FG001|Part 3 (Day 1)|Subject Decision|0|||
150127108|NCT03701555|541598302|FG002|Part 3 (Day 1)|Subject Decision|0|||
150127109|NCT03701555|541598303|FG003|Part 3 (Day 1)|Subject Decision|0|||
150127110|NCT03701555|541598304|FG004|Part 3 (Day 1)|Subject Decision|0|||
150127111|NCT03701555|541598305|FG005|Part 3 (Day 1)|Subject Decision|0|||
150127112|NCT03701555|541598306|FG006|Part 3 (Day 1)|Subject Decision|0|||
150127113|NCT03701555|541598307|FG007|Part 3 (Day 1)|Subject Decision|0|||
150127114|NCT03701555|541598308|FG008|Part 3 (Day 1)|Subject Decision|0|||
150127115|NCT03701555|541598309|FG009|Part 3 (Day 1)|Subject Decision|0|||
150127116|NCT03701555|541598310|FG010|Part 3 (Day 1)|Subject Decision|0|||
150127117|NCT03701555|541598311|FG011|Part 3 (Day 1)|Subject Decision|0|||
150127118|NCT03701555|541598312|FG012|Part 3 (Day 1)|Subject Decision|0|||
150127119|NCT03701555|541598313|FG013|Part 3 (Day 1)|Subject Decision|0|||
150127120|NCT03701555|541598314|FG014|Part 3 (Day 1)|Subject Decision|0|||
150127121|NCT03701555|541598315|FG015|Part 3 (Day 1)|Subject Decision|0|||
150127122|NCT03701555|541598316|FG016|Part 3 (Day 1)|Subject Decision|0|||
150127123|NCT03701555|541598317|FG017|Part 3 (Day 1)|Subject Decision|0|||
150127124|NCT03701555|541598318|FG018|Part 3 (Day 1)|Subject Decision|0|||
150127125|NCT03701555|541598319|FG019|Part 3 (Day 1)|Subject Decision|0|||
150127126|NCT03701555|541598320|FG020|Part 3 (Day 1)|Subject Decision|0|||
150127127|NCT03701555|541598321|FG021|Part 3 (Day 1)|Subject Decision|0|||
150127128|NCT03701555|541598322|FG022|Part 3 (Day 1)|Subject Decision|0|||
150127129|NCT03701555|541598323|FG023|Part 3 (Day 1)|Subject Decision|0|||
150127130|NCT03701555|541598324|FG024|Part 3 (Day 1)|Subject Decision|0|||
150127131|NCT03701555|541598325|FG025|Part 3 (Day 1)|Subject Decision|0|||
150127132|NCT03701555|541598326|FG026|Part 3 (Day 1)|Subject Decision|1|||
150127133|NCT03701555|541598327|FG027|Part 3 (Day 1)|Subject Decision|0|||
150127134|NCT03701555|541598328|FG028|Part 3 (Day 1)|Subject Decision|0|||
150127135|NCT03701555|541598329|FG029|Part 3 (Day 1)|Subject Decision|0|||
150127136|NCT03701555|541598330|FG030|Part 3 (Day 1)|Subject Decision|0|||
150127137|NCT03701555|541598331|FG031|Part 3 (Day 1)|Subject Decision|2|||
150127138|NCT03701555|541598332|FG032|Part 3 (Day 1)|Subject Decision|1|||
150127139|NCT03701555|541598333|FG033|Part 3 (Day 1)|Subject Decision|1|||
150127140|NCT03701555|541598334|FG034|Part 3 (Day 1)|Subject Decision|0|||
150127141|NCT03701555|541598335|FG035|Part 3 (Day 1)|Subject Decision|0|||
150127142|NCT03701555|541598300|FG000|Part 3 (Day 1)|Other|0|||
150127143|NCT03701555|541598301|FG001|Part 3 (Day 1)|Other|0|||
150127144|NCT03701555|541598302|FG002|Part 3 (Day 1)|Other|0|||
150127145|NCT03701555|541598303|FG003|Part 3 (Day 1)|Other|0|||
150127146|NCT03701555|541598304|FG004|Part 3 (Day 1)|Other|0|||
150127147|NCT03701555|541598305|FG005|Part 3 (Day 1)|Other|0|||
150127148|NCT03701555|541598306|FG006|Part 3 (Day 1)|Other|0|||
150127149|NCT03701555|541598307|FG007|Part 3 (Day 1)|Other|0|||
150127150|NCT03701555|541598308|FG008|Part 3 (Day 1)|Other|0|||
150127151|NCT03701555|541598309|FG009|Part 3 (Day 1)|Other|0|||
150127152|NCT03701555|541598310|FG010|Part 3 (Day 1)|Other|0|||
150127153|NCT03701555|541598311|FG011|Part 3 (Day 1)|Other|0|||
150127154|NCT03701555|541598312|FG012|Part 3 (Day 1)|Other|0|||
150127155|NCT03701555|541598313|FG013|Part 3 (Day 1)|Other|0|||
150127156|NCT03701555|541598314|FG014|Part 3 (Day 1)|Other|0|||
150127157|NCT03701555|541598315|FG015|Part 3 (Day 1)|Other|0|||
150127158|NCT03701555|541598316|FG016|Part 3 (Day 1)|Other|0|||
150127159|NCT03701555|541598317|FG017|Part 3 (Day 1)|Other|0|||
150127160|NCT03701555|541598318|FG018|Part 3 (Day 1)|Other|0|||
150127161|NCT03701555|541598319|FG019|Part 3 (Day 1)|Other|0|||
150127162|NCT03701555|541598320|FG020|Part 3 (Day 1)|Other|0|||
150127163|NCT03701555|541598321|FG021|Part 3 (Day 1)|Other|0|||
150127164|NCT03701555|541598322|FG022|Part 3 (Day 1)|Other|0|||
150127165|NCT03701555|541598323|FG023|Part 3 (Day 1)|Other|0|||
150127166|NCT03701555|541598324|FG024|Part 3 (Day 1)|Other|1|||
150127167|NCT03701555|541598325|FG025|Part 3 (Day 1)|Other|1|||
150127168|NCT03701555|541598326|FG026|Part 3 (Day 1)|Other|0|||
150127169|NCT03701555|541598327|FG027|Part 3 (Day 1)|Other|0|||
150127170|NCT03701555|541598328|FG028|Part 3 (Day 1)|Other|0|||
150127171|NCT03701555|541598329|FG029|Part 3 (Day 1)|Other|1|||
150127172|NCT03701555|541598330|FG030|Part 3 (Day 1)|Other|1|||
150127173|NCT03701555|541598331|FG031|Part 3 (Day 1)|Other|0|||
150127174|NCT03701555|541598332|FG032|Part 3 (Day 1)|Other|1|||
150127175|NCT03701555|541598333|FG033|Part 3 (Day 1)|Other|1|||
150127176|NCT03701555|541598334|FG034|Part 3 (Day 1)|Other|0|||
150127177|NCT03701555|541598335|FG035|Part 3 (Day 1)|Other|0|||
150127178|NCT02508311|541598341|FG000|Overall Study|Withdrawal by Subject|1|||
150127179|NCT02508311|541598342|FG001|Overall Study|Withdrawal by Subject|0|||
150127180|NCT02370602|541598343|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
150127181|NCT02370602|541598344|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
150127182|NCT02370602|541598345|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
150127183|NCT02370602|541598346|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
150127184|NCT02370602|541598347|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
150127185|NCT02370602|541598348|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
150127186|NCT03349710|541598349|FG000|Treatment Period|Death|0|||
150127187|NCT03349710|541598350|FG001|Treatment Period|Death|0|||
150127188|NCT03349710|541598351|FG002|Treatment Period|Death|1|||
150127189|NCT03349710|541598352|FG003|Treatment Period|Death|0|||
150127190|NCT03349710|541598349|FG000|Treatment Period|Disease Progression|0|||
150127191|NCT03349710|541598350|FG001|Treatment Period|Disease Progression|2|||
150127192|NCT03349710|541598351|FG002|Treatment Period|Disease Progression|0|||
150127193|NCT03349710|541598352|FG003|Treatment Period|Disease Progression|1|||
150127194|NCT03349710|541598349|FG000|Treatment Period|Study Drug Toxicity|1|||
150127195|NCT03349710|541598350|FG001|Treatment Period|Study Drug Toxicity|0|||
150127196|NCT03349710|541598351|FG002|Treatment Period|Study Drug Toxicity|1|||
150127197|NCT03349710|541598352|FG003|Treatment Period|Study Drug Toxicity|1|||
150127198|NCT03349710|541598349|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
150127199|NCT03349710|541598350|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
150127200|NCT03349710|541598351|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
150127201|NCT03349710|541598352|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
150127202|NCT03349710|541598349|FG000|Treatment Period|admin reason by sponsor|0|||
150127203|NCT03349710|541598350|FG001|Treatment Period|admin reason by sponsor|7|||
150127204|NCT03349710|541598351|FG002|Treatment Period|admin reason by sponsor|0|||
150127205|NCT03349710|541598352|FG003|Treatment Period|admin reason by sponsor|19|||
150127206|NCT03349710|541598349|FG000|Treatment Period|Other Reason|2|||
150127207|NCT03349710|541598350|FG001|Treatment Period|Other Reason|0|||
150127208|NCT03349710|541598351|FG002|Treatment Period|Other Reason|2|||
150127209|NCT03349710|541598352|FG003|Treatment Period|Other Reason|1|||
150127210|NCT03349710|541598349|FG000|Treatment Period|completed|6|||
150127211|NCT03349710|541598350|FG001|Treatment Period|completed|0|||
150127212|NCT03349710|541598351|FG002|Treatment Period|completed|18|||
150127213|NCT03349710|541598352|FG003|Treatment Period|completed|1|||
150127214|NCT03349710|541598349|FG000|Treatment Period|participant request to discontinue|0|||
150127215|NCT03349710|541598350|FG001|Treatment Period|participant request to discontinue|0|||
150127216|NCT03349710|541598351|FG002|Treatment Period|participant request to discontinue|4|||
150127217|NCT03349710|541598352|FG003|Treatment Period|participant request to discontinue|0|||
150127218|NCT03349710|541598349|FG000|Treatment Period|participant withdrew consent|1|||
150127219|NCT03349710|541598350|FG001|Treatment Period|participant withdrew consent|0|||
150127220|NCT03349710|541598351|FG002|Treatment Period|participant withdrew consent|0|||
150195316|NCT05256017|541856490|FG000|Follow-up|Death|0|||
150127221|NCT03349710|541598352|FG003|Treatment Period|participant withdrew consent|0|||
150127222|NCT04955639|541598355|FG000|Overall Study|Withdrawal by Subject|2|||
150127223|NCT04955639|541598356|FG001|Overall Study|Withdrawal by Subject|2|||
150127224|NCT04955639|541598355|FG000|Overall Study|Week 26 survey not completed|2|||
150127225|NCT04955639|541598356|FG001|Overall Study|Week 26 survey not completed|2|||
150127226|NCT04447404|541598357|FG000|Overall Study|Death|2|||
150127227|NCT04447404|541598358|FG001|Overall Study|Death|0|||
150127228|NCT01369342|541598361|FG000|Overall Study|Withdrawal by Subject|7|||
150127229|NCT01369342|541598362|FG001|Overall Study|Withdrawal by Subject|7|||
150127230|NCT01369342|541598363|FG002|Overall Study|Withdrawal by Subject|2|||
150127231|NCT01369342|541598361|FG000|Overall Study|Lost to Follow-up|5|||
150127232|NCT01369342|541598362|FG001|Overall Study|Lost to Follow-up|2|||
150127233|NCT01369342|541598363|FG002|Overall Study|Lost to Follow-up|1|||
150127234|NCT01369342|541598361|FG000|Overall Study|Not Treated|1|||
150127235|NCT01369342|541598362|FG001|Overall Study|Not Treated|0|||
150127236|NCT01369342|541598363|FG002|Overall Study|Not Treated|0|||
150127237|NCT04723576|541598364|FG000|Overall Study|Withdrawal by Subject|2133|||
150127238|NCT04723576|541598365|FG001|Overall Study|Withdrawal by Subject|3234|||
150127239|NCT00454051|541598369|FG000|Overall Study|Adverse Event|1|||
150127240|NCT00454051|541598370|FG001|Overall Study|Adverse Event|2|||
150127241|NCT00454051|541598369|FG000|Overall Study|Withdrawal by Subject|1|||
150127242|NCT00454051|541598370|FG001|Overall Study|Withdrawal by Subject|0|||
150127243|NCT00454051|541598369|FG000|Overall Study|Protocol Violation|1|||
150127244|NCT00454051|541598370|FG001|Overall Study|Protocol Violation|1|||
150127245|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
150127246|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
150127247|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
150127248|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
150127249|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
150127250|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
150127251|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
150127252|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
150127253|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
150127254|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
150127255|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
150127256|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
150127257|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
150127258|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
150127259|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
150127260|NCT01571362|541598371|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
150127261|NCT01571362|541598372|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
150127262|NCT01571362|541598373|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
150127263|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
150127264|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
150127265|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
150127266|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
150127267|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
150127268|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
150127269|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Adverse Event|0|||
150127270|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Adverse Event|9|||
150127271|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Adverse Event|14|||
150127272|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150127273|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
150127274|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
150127275|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
150127276|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
150127277|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
150127278|NCT01571362|541598371|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
150127279|NCT01571362|541598372|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
150127280|NCT01571362|541598373|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
150127281|NCT03966157|541598374|FG000|Overall Study|Physician Decision|1|||
150127282|NCT03966157|541598375|FG001|Overall Study|Physician Decision|0|||
150127283|NCT01519206|541598376|FG000|Overall Study|Lost to Follow-up|3|||
150127284|NCT01519206|541598376|FG000|Overall Study|Missed Visit|2|||
150127285|NCT01491854|541598377|FG000|Overall Study|mainly due to premature termination|93|||
150127286|NCT01491854|541598377|FG000|Overall Study|Death|1|||
150127287|NCT01491854|541598377|FG000|Overall Study|Withdrawal by Subject|3|||
150127288|NCT01491854|541598377|FG000|Overall Study|Lost to Follow-up|33|||
150127289|NCT01026974|541598378|FG000|Overall Study|Withdrawal by Subject|0|||
150127290|NCT01026974|541598379|FG001|Overall Study|Withdrawal by Subject|1|||
150127291|NCT01026974|541598380|FG002|Overall Study|Withdrawal by Subject|7|||
150127292|NCT01026974|541598381|FG003|Overall Study|Withdrawal by Subject|2|||
150127293|NCT01026974|541598378|FG000|Overall Study|Lost to Follow-up|1|||
150127294|NCT01026974|541598379|FG001|Overall Study|Lost to Follow-up|1|||
150127295|NCT01026974|541598380|FG002|Overall Study|Lost to Follow-up|4|||
150127296|NCT01026974|541598381|FG003|Overall Study|Lost to Follow-up|0|||
150127297|NCT01026974|541598378|FG000|Overall Study|Adverse Event|0|||
150127298|NCT01026974|541598379|FG001|Overall Study|Adverse Event|0|||
150127299|NCT01026974|541598380|FG002|Overall Study|Adverse Event|0|||
150127300|NCT01026974|541598381|FG003|Overall Study|Adverse Event|1|||
150127301|NCT01026974|541598378|FG000|Overall Study|Inappropriate enrollment|0|||
150127302|NCT01026974|541598379|FG001|Overall Study|Inappropriate enrollment|0|||
150127303|NCT01026974|541598380|FG002|Overall Study|Inappropriate enrollment|1|||
150127304|NCT01026974|541598381|FG003|Overall Study|Inappropriate enrollment|0|||
150127305|NCT03579563|541598384|FG000|Overall Study|Lost to Follow-up|0|||
150127306|NCT03579563|541598385|FG001|Overall Study|Lost to Follow-up|0|||
150127307|NCT03579563|541598386|FG002|Overall Study|Lost to Follow-up|0|||
150127308|NCT03579563|541598387|FG003|Overall Study|Lost to Follow-up|0|||
150127309|NCT03579563|541598388|FG004|Overall Study|Lost to Follow-up|1|||
150127310|NCT03579563|541598389|FG005|Overall Study|Lost to Follow-up|0|||
150127311|NCT03579563|541598384|FG000|Overall Study|Lack of Efficacy|1|||
150127312|NCT03579563|541598385|FG001|Overall Study|Lack of Efficacy|1|||
150127313|NCT03579563|541598386|FG002|Overall Study|Lack of Efficacy|4|||
150127314|NCT03579563|541598387|FG003|Overall Study|Lack of Efficacy|1|||
150127315|NCT03579563|541598388|FG004|Overall Study|Lack of Efficacy|2|||
150127316|NCT03579563|541598389|FG005|Overall Study|Lack of Efficacy|3|||
150127317|NCT03579563|541598384|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
150127318|NCT03579563|541598385|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
150127319|NCT03579563|541598386|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
150127320|NCT03579563|541598387|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
150127321|NCT03579563|541598388|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
150127322|NCT03579563|541598389|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
150127323|NCT03579563|541598384|FG000|Overall Study|Time/distance concern|0|||
150127324|NCT03579563|541598385|FG001|Overall Study|Time/distance concern|0|||
150127325|NCT03579563|541598386|FG002|Overall Study|Time/distance concern|1|||
150127326|NCT03579563|541598387|FG003|Overall Study|Time/distance concern|0|||
150127327|NCT03579563|541598388|FG004|Overall Study|Time/distance concern|0|||
150127328|NCT03579563|541598389|FG005|Overall Study|Time/distance concern|1|||
150127329|NCT03579563|541598384|FG000|Overall Study|COVID shutdown|2|||
150127330|NCT03579563|541598385|FG001|Overall Study|COVID shutdown|3|||
150127331|NCT03579563|541598386|FG002|Overall Study|COVID shutdown|4|||
150127332|NCT03579563|541598387|FG003|Overall Study|COVID shutdown|3|||
150127333|NCT03579563|541598388|FG004|Overall Study|COVID shutdown|1|||
150127334|NCT03579563|541598389|FG005|Overall Study|COVID shutdown|2|||
150127335|NCT03579563|541598384|FG000|Overall Study|Protocol administration error|1|||
150127336|NCT03579563|541598385|FG001|Overall Study|Protocol administration error|0|||
150127337|NCT03579563|541598386|FG002|Overall Study|Protocol administration error|1|||
150127338|NCT03579563|541598387|FG003|Overall Study|Protocol administration error|0|||
150127339|NCT03579563|541598388|FG004|Overall Study|Protocol administration error|1|||
150127340|NCT03579563|541598389|FG005|Overall Study|Protocol administration error|5|||
150127341|NCT05177770|541598390|FG000|Overall Study|Death|4|||
150127342|NCT05177770|541598390|FG000|Overall Study|Withdrawal by Subject|1|||
150127343|NCT05177770|541598390|FG000|Overall Study|Adverse Event prior to dosing|1|||
150127344|NCT00214136|541598393|FG000|Overall Study|Death|5|||
150127345|NCT02105948|541598394|FG000|Overall Study|Adverse Event|10|||
150127346|NCT02105948|541598395|FG001|Overall Study|Adverse Event|7|||
150127347|NCT02105948|541598396|FG002|Overall Study|Adverse Event|11|||
150127348|NCT02105948|541598397|FG003|Overall Study|Adverse Event|11|||
150127349|NCT02105948|541598394|FG000|Overall Study|Lack of Efficacy|0|||
150127350|NCT02105948|541598395|FG001|Overall Study|Lack of Efficacy|1|||
150127351|NCT02105948|541598396|FG002|Overall Study|Lack of Efficacy|3|||
150127352|NCT02105948|541598397|FG003|Overall Study|Lack of Efficacy|2|||
150127353|NCT02105948|541598394|FG000|Overall Study|Lost to Follow-up|0|||
150127354|NCT02105948|541598395|FG001|Overall Study|Lost to Follow-up|0|||
150127355|NCT02105948|541598396|FG002|Overall Study|Lost to Follow-up|2|||
150127356|NCT02105948|541598397|FG003|Overall Study|Lost to Follow-up|1|||
150127357|NCT02105948|541598394|FG000|Overall Study|Physician Decision|2|||
150127358|NCT02105948|541598395|FG001|Overall Study|Physician Decision|2|||
150127359|NCT02105948|541598396|FG002|Overall Study|Physician Decision|2|||
150127360|NCT02105948|541598397|FG003|Overall Study|Physician Decision|2|||
150127361|NCT02105948|541598394|FG000|Overall Study|Withdrawal by Subject|15|||
150127362|NCT02105948|541598395|FG001|Overall Study|Withdrawal by Subject|10|||
150127363|NCT02105948|541598396|FG002|Overall Study|Withdrawal by Subject|10|||
150127364|NCT02105948|541598397|FG003|Overall Study|Withdrawal by Subject|11|||
150127365|NCT04072159|541598401|FG000|Overall Study|Lost to Follow-up|6|||
150127366|NCT04072159|541598402|FG001|Overall Study|Lost to Follow-up|6|||
150127367|NCT04072159|541598401|FG000|Overall Study|Withdrawal by Subject|2|||
150127368|NCT04072159|541598402|FG001|Overall Study|Withdrawal by Subject|0|||
150127369|NCT00695669|541598405|FG000|Overall Study|Adverse Event|0|||
150127370|NCT00695669|541598406|FG001|Overall Study|Adverse Event|0|||
150127371|NCT00695669|541598407|FG002|Overall Study|Adverse Event|2|||
150127372|NCT00695669|541598408|FG003|Overall Study|Adverse Event|0|||
150127373|NCT00695669|541598405|FG000|Overall Study|Lost to Follow-up|4|||
150127374|NCT00695669|541598406|FG001|Overall Study|Lost to Follow-up|4|||
150127375|NCT00695669|541598407|FG002|Overall Study|Lost to Follow-up|1|||
150127376|NCT00695669|541598408|FG003|Overall Study|Lost to Follow-up|4|||
150127377|NCT01196975|541598411|FG000|Overall Study|Adverse Event|2|||
150127378|NCT01196975|541598412|FG001|Overall Study|Adverse Event|2|||
150127379|NCT01196975|541598413|FG002|Overall Study|Adverse Event|0|||
150127380|NCT01196975|541598414|FG003|Overall Study|Adverse Event|0|||
150127381|NCT01196975|541598415|FG004|Overall Study|Adverse Event|2|||
150127382|NCT01196975|541598411|FG000|Overall Study|Withdrawal by Subject|2|||
150127383|NCT01196975|541598412|FG001|Overall Study|Withdrawal by Subject|1|||
150127384|NCT01196975|541598413|FG002|Overall Study|Withdrawal by Subject|0|||
150127385|NCT01196975|541598414|FG003|Overall Study|Withdrawal by Subject|1|||
150127386|NCT01196975|541598415|FG004|Overall Study|Withdrawal by Subject|0|||
150127387|NCT01196975|541598411|FG000|Overall Study|Lost to Follow-up|11|||
150127388|NCT01196975|541598412|FG001|Overall Study|Lost to Follow-up|6|||
150127389|NCT01196975|541598413|FG002|Overall Study|Lost to Follow-up|5|||
150127390|NCT01196975|541598414|FG003|Overall Study|Lost to Follow-up|5|||
150127391|NCT01196975|541598415|FG004|Overall Study|Lost to Follow-up|11|||
150127392|NCT03738150|541598416|FG000|Base Study|Withdrawal by Subject|1|||
150127393|NCT03738150|541598416|FG000|Extension Study|Withdrawal by Subject|1|||
150127394|NCT01462344|541598419|FG000|Overall Study|Withdrawal by Subject|245|||
150127395|NCT01462344|541598420|FG001|Overall Study|Withdrawal by Subject|226|||
150127396|NCT01462344|541598419|FG000|Overall Study|Adverse Event|24|||
150127397|NCT01462344|541598420|FG001|Overall Study|Adverse Event|23|||
150127398|NCT01462344|541598419|FG000|Overall Study|Asthma Exacerbation|34|||
150127399|NCT01462344|541598420|FG001|Overall Study|Asthma Exacerbation|35|||
150127400|NCT01462344|541598419|FG000|Overall Study|Lack of Efficacy|5|||
150127401|NCT01462344|541598420|FG001|Overall Study|Lack of Efficacy|6|||
150127402|NCT01462344|541598419|FG000|Overall Study|Protocol Violation|68|||
150127403|NCT01462344|541598420|FG001|Overall Study|Protocol Violation|53|||
150127404|NCT01462344|541598419|FG000|Overall Study|Lost to Follow-up|7|||
150127405|NCT01462344|541598420|FG001|Overall Study|Lost to Follow-up|7|||
150127406|NCT00253864|541598424|FG000|Overall Study|Lost to Follow-up|5|||
150127407|NCT00253864|541598425|FG001|Overall Study|Lost to Follow-up|8|||
150127408|NCT00360529|541598429|FG000|Overall Study|Adverse Event|10|||
150127409|NCT00360529|541598430|FG001|Overall Study|Adverse Event|23|||
150127410|NCT00360529|541598431|FG002|Overall Study|Adverse Event|33|||
150127411|NCT00360529|541598429|FG000|Overall Study|Protocol Violation|3|||
150127412|NCT00360529|541598430|FG001|Overall Study|Protocol Violation|3|||
150127413|NCT00360529|541598431|FG002|Overall Study|Protocol Violation|11|||
150127414|NCT00360529|541598429|FG000|Overall Study|Lost to Follow-up|14|||
150127415|NCT00360529|541598430|FG001|Overall Study|Lost to Follow-up|10|||
150127416|NCT00360529|541598431|FG002|Overall Study|Lost to Follow-up|13|||
150127417|NCT00360529|541598429|FG000|Overall Study|Withdrawal by Subject|22|||
150127418|NCT00360529|541598430|FG001|Overall Study|Withdrawal by Subject|14|||
150127419|NCT00360529|541598431|FG002|Overall Study|Withdrawal by Subject|18|||
150127420|NCT00360529|541598429|FG000|Overall Study|Lack of Efficacy|8|||
150127421|NCT00360529|541598430|FG001|Overall Study|Lack of Efficacy|6|||
150127422|NCT00360529|541598431|FG002|Overall Study|Lack of Efficacy|5|||
150127423|NCT00360529|541598429|FG000|Overall Study|Reason discontinued not explained above|4|||
150127424|NCT00360529|541598430|FG001|Overall Study|Reason discontinued not explained above|9|||
150127425|NCT00360529|541598431|FG002|Overall Study|Reason discontinued not explained above|11|||
150127426|NCT00110617|541598435|FG000|Overall Study|Adverse Event|2|||
150127427|NCT00110617|541598436|FG001|Overall Study|Adverse Event|4|||
150127428|NCT00110617|541598435|FG000|Overall Study|Abnormal Laboratory Value|4|||
150127429|NCT00110617|541598436|FG001|Overall Study|Abnormal Laboratory Value|2|||
150127430|NCT00110617|541598435|FG000|Overall Study|Lack of Efficacy|1|||
150127431|NCT00110617|541598436|FG001|Overall Study|Lack of Efficacy|0|||
150127432|NCT00110617|541598435|FG000|Overall Study|Patient no longer requires study drug|1|||
150127433|NCT00110617|541598436|FG001|Overall Study|Patient no longer requires study drug|0|||
150127434|NCT00110617|541598435|FG000|Overall Study|Protocol Violation|5|||
150127435|NCT00110617|541598436|FG001|Overall Study|Protocol Violation|0|||
150127436|NCT00110617|541598435|FG000|Overall Study|Withdrawal by Subject|10|||
150127437|NCT00110617|541598436|FG001|Overall Study|Withdrawal by Subject|4|||
150127438|NCT00110617|541598435|FG000|Overall Study|Lost to Follow-up|9|||
150127439|NCT00110617|541598436|FG001|Overall Study|Lost to Follow-up|1|||
150127440|NCT00110617|541598435|FG000|Overall Study|Administrative problems|6|||
150127441|NCT00110617|541598436|FG001|Overall Study|Administrative problems|5|||
150127442|NCT00110617|541598435|FG000|Overall Study|Death|1|||
150127443|NCT00110617|541598436|FG001|Overall Study|Death|1|||
150127444|NCT00110617|541598435|FG000|Overall Study|Did not receive study drug|0|||
150127445|NCT00110617|541598436|FG001|Overall Study|Did not receive study drug|12|||
150127446|NCT04764396|541598437|FG000|Overall Study|Physician Decision|1|||
150127447|NCT04764396|541598438|FG001|Overall Study|Physician Decision|0|||
150127448|NCT03230916|541598440|FG000|Overall Study|Withdrawal by Subject|0|||
150127449|NCT03230916|541598441|FG001|Overall Study|Withdrawal by Subject|0|||
150127450|NCT03230916|541598442|FG002|Overall Study|Withdrawal by Subject|0|||
150127451|NCT03230916|541598443|FG003|Overall Study|Withdrawal by Subject|0|||
150127452|NCT03230916|541598444|FG004|Overall Study|Withdrawal by Subject|0|||
150127453|NCT03230916|541598445|FG005|Overall Study|Withdrawal by Subject|1|||
150127454|NCT03230916|541598446|FG006|Overall Study|Withdrawal by Subject|0|||
150127455|NCT03230916|541598447|FG007|Overall Study|Withdrawal by Subject|0|||
150127456|NCT03230916|541598448|FG008|Overall Study|Withdrawal by Subject|0|||
150127457|NCT03230916|541598449|FG009|Overall Study|Withdrawal by Subject|0|||
150127458|NCT03230916|541598450|FG010|Overall Study|Withdrawal by Subject|0|||
150127459|NCT01128413|541598452|FG000|Overall Study|Withdrawal by Subject|1|||
150127460|NCT01128413|541598453|FG001|Overall Study|Withdrawal by Subject|0|||
150127461|NCT01128413|541598452|FG000|Overall Study|NICOM Monitor Problems|2|||
150127462|NCT01128413|541598453|FG001|Overall Study|NICOM Monitor Problems|1|||
150127463|NCT01128413|541598452|FG000|Overall Study|Pt made DNR|1|||
150127464|NCT01128413|541598453|FG001|Overall Study|Pt made DNR|0|||
150127465|NCT00722761|541598454|FG000|Overall Study|Lost to Follow-up|1|||
150127466|NCT00722761|541598455|FG001|Overall Study|Lost to Follow-up|4|||
150127467|NCT00722761|541598454|FG000|Overall Study|Withdrawal by Subject|5|||
150127468|NCT00722761|541598455|FG001|Overall Study|Withdrawal by Subject|2|||
150127469|NCT00660010|541598459|FG000|Overall Study|Withdrawal by Subject|2|||
150127470|NCT00660010|541598459|FG000|Overall Study|Lost to Follow-up|3|||
150127471|NCT00660010|541598459|FG000|Overall Study|Adverse Event|1|||
150127472|NCT00660010|541598459|FG000|Overall Study|Noncompliance with visit schedule|3|||
150127473|NCT03069482|541600366|FG000|Overall Study|Lost to Follow-up|0|||
150127474|NCT03069482|541600367|FG001|Overall Study|Lost to Follow-up|1|||
150127475|NCT03069482|541600366|FG000|Overall Study|Physician Decision|1|||
150127476|NCT03069482|541600367|FG001|Overall Study|Physician Decision|0|||
150127477|NCT05912400|541600373|FG000|Overall Study|Lost to Follow-up|1|||
150127478|NCT05912400|541600374|FG001|Overall Study|Lost to Follow-up|0|||
150127479|NCT05912400|541600373|FG000|Overall Study|Physician Decision|6|||
150127480|NCT05912400|541600374|FG001|Overall Study|Physician Decision|0|||
150127481|NCT05912400|541600373|FG000|Overall Study|Withdrawal by Subject|1|||
150127482|NCT05912400|541600374|FG001|Overall Study|Withdrawal by Subject|0|||
150127483|NCT01843192|541600375|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
150127484|NCT01843192|541600376|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
150127485|NCT01843192|541600377|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
150127486|NCT01259713|541600382|FG000|Overall Study|Adverse Event|54|||
150127487|NCT01259713|541600383|FG001|Overall Study|Adverse Event|23|||
150127488|NCT01259713|541600382|FG000|Overall Study|Death Not Related to IFI|8|||
150195317|NCT05256017|541856491|FG001|Follow-up|Death|1|||
150127489|NCT01259713|541600383|FG001|Overall Study|Death Not Related to IFI|1|||
150127490|NCT01259713|541600382|FG000|Overall Study|Investigators Discretion|14|||
150127491|NCT01259713|541600383|FG001|Overall Study|Investigators Discretion|6|||
150127492|NCT01259713|541600382|FG000|Overall Study|Lack of Efficacy|2|||
150127493|NCT01259713|541600383|FG001|Overall Study|Lack of Efficacy|0|||
150127494|NCT01259713|541600382|FG000|Overall Study|Protocol Violation|5|||
150127495|NCT01259713|541600383|FG001|Overall Study|Protocol Violation|4|||
150127496|NCT01259713|541600382|FG000|Overall Study|Subject Withdrew Consent|12|||
150127497|NCT01259713|541600383|FG001|Overall Study|Subject Withdrew Consent|7|||
150127498|NCT03461003|541600384|FG000|Overall Study|Lost to Follow-up|2|||
150127499|NCT03461003|541600385|FG001|Overall Study|Lost to Follow-up|2|||
150127500|NCT03461003|541600384|FG000|Overall Study|Withdrawal by Subject|3|||
150127501|NCT03461003|541600385|FG001|Overall Study|Withdrawal by Subject|1|||
150127502|NCT00620750|541600386|FG000|Overall Study|Lost to Follow-up|25|||
150127503|NCT00765843|541600388|FG000|Overall Study|Lost to Follow-up|1|||
150127504|NCT00765843|541600389|FG001|Overall Study|Lost to Follow-up|3|||
150127505|NCT00765843|541600390|FG002|Overall Study|Lost to Follow-up|2|||
150127506|NCT00765843|541600388|FG000|Overall Study|did not return to receive intervention|0|||
150127507|NCT00765843|541600389|FG001|Overall Study|did not return to receive intervention|1|||
150127508|NCT00765843|541600390|FG002|Overall Study|did not return to receive intervention|0|||
150127509|NCT00765843|541600388|FG000|Overall Study|Adverse Event|0|||
150127510|NCT00765843|541600389|FG001|Overall Study|Adverse Event|0|||
150127511|NCT00765843|541600390|FG002|Overall Study|Adverse Event|1|||
150127512|NCT02564523|541600393|FG000|Overall Study|Withdrawal by Subject|3|||
150127513|NCT02564523|541600394|FG001|Overall Study|Withdrawal by Subject|0|||
150127514|NCT02564523|541600395|FG002|Overall Study|Withdrawal by Subject|1|||
150127515|NCT02564523|541600396|FG003|Overall Study|Withdrawal by Subject|0|||
150127516|NCT02564523|541600397|FG004|Overall Study|Withdrawal by Subject|1|||
150127517|NCT02564523|541600398|FG005|Overall Study|Withdrawal by Subject|0|||
150127518|NCT02564523|541600399|FG006|Overall Study|Withdrawal by Subject|1|||
150127519|NCT02564523|541600400|FG007|Overall Study|Withdrawal by Subject|0|||
150127520|NCT02564523|541600401|FG008|Overall Study|Withdrawal by Subject|0|||
150127521|NCT02564523|541600402|FG009|Overall Study|Withdrawal by Subject|0|||
150127522|NCT02564523|541600403|FG010|Overall Study|Withdrawal by Subject|1|||
150127523|NCT02564523|541600404|FG011|Overall Study|Withdrawal by Subject|0|||
150127524|NCT02564523|541600405|FG012|Overall Study|Withdrawal by Subject|1|||
150127525|NCT02564523|541600406|FG013|Overall Study|Withdrawal by Subject|0|||
150127526|NCT02564523|541600407|FG014|Overall Study|Withdrawal by Subject|0|||
150127527|NCT02564523|541600408|FG015|Overall Study|Withdrawal by Subject|0|||
150127528|NCT02564523|541600409|FG016|Overall Study|Withdrawal by Subject|0|||
150127529|NCT02564523|541600410|FG017|Overall Study|Withdrawal by Subject|0|||
150127530|NCT02564523|541600393|FG000|Overall Study|Adverse Event|0|||
150127531|NCT02564523|541600394|FG001|Overall Study|Adverse Event|0|||
150127532|NCT02564523|541600395|FG002|Overall Study|Adverse Event|0|||
150127533|NCT02564523|541600396|FG003|Overall Study|Adverse Event|0|||
150127534|NCT02564523|541600397|FG004|Overall Study|Adverse Event|0|||
150127535|NCT02564523|541600398|FG005|Overall Study|Adverse Event|0|||
150127536|NCT02564523|541600399|FG006|Overall Study|Adverse Event|0|||
150127537|NCT02564523|541600400|FG007|Overall Study|Adverse Event|0|||
150127538|NCT02564523|541600401|FG008|Overall Study|Adverse Event|0|||
150127539|NCT02564523|541600402|FG009|Overall Study|Adverse Event|0|||
150127540|NCT02564523|541600403|FG010|Overall Study|Adverse Event|0|||
150127541|NCT02564523|541600404|FG011|Overall Study|Adverse Event|0|||
150127542|NCT02564523|541600405|FG012|Overall Study|Adverse Event|0|||
150127543|NCT02564523|541600406|FG013|Overall Study|Adverse Event|0|||
150127544|NCT02564523|541600407|FG014|Overall Study|Adverse Event|0|||
150127545|NCT02564523|541600408|FG015|Overall Study|Adverse Event|0|||
150127546|NCT02564523|541600409|FG016|Overall Study|Adverse Event|0|||
150127547|NCT02564523|541600410|FG017|Overall Study|Adverse Event|1|||
150127548|NCT02564523|541600393|FG000|Overall Study|Death|0|||
150127549|NCT02564523|541600394|FG001|Overall Study|Death|0|||
150127550|NCT02564523|541600395|FG002|Overall Study|Death|0|||
150127551|NCT02564523|541600396|FG003|Overall Study|Death|0|||
150127552|NCT02564523|541600397|FG004|Overall Study|Death|0|||
150127553|NCT02564523|541600398|FG005|Overall Study|Death|0|||
150127554|NCT02564523|541600399|FG006|Overall Study|Death|1|||
150127555|NCT02564523|541600400|FG007|Overall Study|Death|0|||
150127556|NCT02564523|541600401|FG008|Overall Study|Death|0|||
150127557|NCT02564523|541600402|FG009|Overall Study|Death|0|||
150127558|NCT02564523|541600403|FG010|Overall Study|Death|1|||
150127559|NCT02564523|541600404|FG011|Overall Study|Death|0|||
150127560|NCT02564523|541600405|FG012|Overall Study|Death|0|||
150127561|NCT02564523|541600406|FG013|Overall Study|Death|0|||
150127562|NCT02564523|541600407|FG014|Overall Study|Death|0|||
150127563|NCT02564523|541600408|FG015|Overall Study|Death|0|||
150127564|NCT02564523|541600409|FG016|Overall Study|Death|0|||
150127565|NCT02564523|541600410|FG017|Overall Study|Death|0|||
150127566|NCT02564523|541600393|FG000|Overall Study|Lost to Follow-up|2|||
150127567|NCT02564523|541600394|FG001|Overall Study|Lost to Follow-up|1|||
150127568|NCT02564523|541600395|FG002|Overall Study|Lost to Follow-up|4|||
150127569|NCT02564523|541600396|FG003|Overall Study|Lost to Follow-up|0|||
150127570|NCT02564523|541600397|FG004|Overall Study|Lost to Follow-up|1|||
150127571|NCT02564523|541600398|FG005|Overall Study|Lost to Follow-up|0|||
150127572|NCT02564523|541600399|FG006|Overall Study|Lost to Follow-up|1|||
150127573|NCT02564523|541600400|FG007|Overall Study|Lost to Follow-up|0|||
150127574|NCT02564523|541600401|FG008|Overall Study|Lost to Follow-up|0|||
150127575|NCT02564523|541600402|FG009|Overall Study|Lost to Follow-up|0|||
150127576|NCT02564523|541600403|FG010|Overall Study|Lost to Follow-up|0|||
150127577|NCT02564523|541600404|FG011|Overall Study|Lost to Follow-up|1|||
150127578|NCT02564523|541600405|FG012|Overall Study|Lost to Follow-up|1|||
150127579|NCT02564523|541600406|FG013|Overall Study|Lost to Follow-up|0|||
150127580|NCT02564523|541600407|FG014|Overall Study|Lost to Follow-up|0|||
150127581|NCT02564523|541600408|FG015|Overall Study|Lost to Follow-up|0|||
150127582|NCT02564523|541600409|FG016|Overall Study|Lost to Follow-up|0|||
150127583|NCT02564523|541600410|FG017|Overall Study|Lost to Follow-up|0|||
150127584|NCT02564523|541600393|FG000|Overall Study|Physician Decision|0|||
150127585|NCT02564523|541600394|FG001|Overall Study|Physician Decision|0|||
150127586|NCT02564523|541600395|FG002|Overall Study|Physician Decision|0|||
150127587|NCT02564523|541600396|FG003|Overall Study|Physician Decision|0|||
150127588|NCT02564523|541600397|FG004|Overall Study|Physician Decision|1|||
150127589|NCT02564523|541600398|FG005|Overall Study|Physician Decision|0|||
150127590|NCT02564523|541600399|FG006|Overall Study|Physician Decision|0|||
150127591|NCT02564523|541600400|FG007|Overall Study|Physician Decision|0|||
150127592|NCT02564523|541600401|FG008|Overall Study|Physician Decision|0|||
150127593|NCT02564523|541600402|FG009|Overall Study|Physician Decision|0|||
150127594|NCT02564523|541600403|FG010|Overall Study|Physician Decision|1|||
150127595|NCT02564523|541600404|FG011|Overall Study|Physician Decision|0|||
150127596|NCT02564523|541600405|FG012|Overall Study|Physician Decision|0|||
150127597|NCT02564523|541600406|FG013|Overall Study|Physician Decision|0|||
150127598|NCT02564523|541600407|FG014|Overall Study|Physician Decision|0|||
150127599|NCT02564523|541600408|FG015|Overall Study|Physician Decision|0|||
150127600|NCT02564523|541600409|FG016|Overall Study|Physician Decision|0|||
150127601|NCT02564523|541600410|FG017|Overall Study|Physician Decision|0|||
150127602|NCT02564523|541600393|FG000|Overall Study|Protocol Violation|2|||
150127603|NCT02564523|541600394|FG001|Overall Study|Protocol Violation|2|||
150127604|NCT02564523|541600395|FG002|Overall Study|Protocol Violation|5|||
150127605|NCT02564523|541600396|FG003|Overall Study|Protocol Violation|0|||
150127606|NCT02564523|541600397|FG004|Overall Study|Protocol Violation|1|||
150127607|NCT02564523|541600398|FG005|Overall Study|Protocol Violation|0|||
150127608|NCT02564523|541600399|FG006|Overall Study|Protocol Violation|0|||
150127609|NCT02564523|541600400|FG007|Overall Study|Protocol Violation|0|||
150127610|NCT02564523|541600401|FG008|Overall Study|Protocol Violation|0|||
150127611|NCT02564523|541600402|FG009|Overall Study|Protocol Violation|0|||
150127612|NCT02564523|541600403|FG010|Overall Study|Protocol Violation|0|||
150127613|NCT02564523|541600404|FG011|Overall Study|Protocol Violation|0|||
150127614|NCT02564523|541600405|FG012|Overall Study|Protocol Violation|0|||
150127615|NCT02564523|541600406|FG013|Overall Study|Protocol Violation|0|||
150127616|NCT02564523|541600407|FG014|Overall Study|Protocol Violation|0|||
150127617|NCT02564523|541600408|FG015|Overall Study|Protocol Violation|0|||
150127618|NCT02564523|541600409|FG016|Overall Study|Protocol Violation|0|||
150127619|NCT02564523|541600410|FG017|Overall Study|Protocol Violation|0|||
150127620|NCT02564523|541600393|FG000|Overall Study|Other|3|||
150127621|NCT02564523|541600394|FG001|Overall Study|Other|0|||
150127622|NCT02564523|541600395|FG002|Overall Study|Other|0|||
150127623|NCT02564523|541600396|FG003|Overall Study|Other|1|||
150127624|NCT02564523|541600397|FG004|Overall Study|Other|0|||
150127625|NCT02564523|541600398|FG005|Overall Study|Other|0|||
150127626|NCT02564523|541600399|FG006|Overall Study|Other|0|||
150127627|NCT02564523|541600400|FG007|Overall Study|Other|0|||
150127628|NCT02564523|541600401|FG008|Overall Study|Other|0|||
150127629|NCT02564523|541600402|FG009|Overall Study|Other|0|||
150127630|NCT02564523|541600403|FG010|Overall Study|Other|0|||
150127631|NCT02564523|541600404|FG011|Overall Study|Other|0|||
150127632|NCT02564523|541600405|FG012|Overall Study|Other|0|||
150127633|NCT02564523|541600406|FG013|Overall Study|Other|0|||
150127634|NCT02564523|541600407|FG014|Overall Study|Other|0|||
150127635|NCT02564523|541600408|FG015|Overall Study|Other|0|||
150127636|NCT02564523|541600409|FG016|Overall Study|Other|0|||
150127637|NCT02564523|541600410|FG017|Overall Study|Other|0|||
150127638|NCT00448539|541600413|FG000|Overall Study|Medication non-compliance|4|||
150127639|NCT00448539|541600414|FG001|Overall Study|Medication non-compliance|1|||
150127640|NCT00448539|541600413|FG000|Overall Study|Protocol Violation|1|||
150127641|NCT00448539|541600414|FG001|Overall Study|Protocol Violation|0|||
150127642|NCT00448539|541600413|FG000|Overall Study|Request of the investigator or sponsor|67|||
150127643|NCT00448539|541600414|FG001|Overall Study|Request of the investigator or sponsor|54|||
150127644|NCT00448539|541600413|FG000|Overall Study|Withdrawal by Subject|20|||
150127645|NCT00448539|541600414|FG001|Overall Study|Withdrawal by Subject|24|||
150127646|NCT00448539|541600413|FG000|Overall Study|Diary non-compliance|1|||
150127647|NCT00448539|541600414|FG001|Overall Study|Diary non-compliance|0|||
150127648|NCT00448539|541600413|FG000|Overall Study|Adverse Event|9|||
150127649|NCT00448539|541600414|FG001|Overall Study|Adverse Event|26|||
150127650|NCT00448539|541600413|FG000|Overall Study|Lack of Efficacy|27|||
150127651|NCT00448539|541600414|FG001|Overall Study|Lack of Efficacy|40|||
150127652|NCT00448539|541600413|FG000|Overall Study|Miscellaneous|2|||
150127653|NCT00448539|541600414|FG001|Overall Study|Miscellaneous|1|||
150127654|NCT00448539|541600413|FG000|Overall Study|Change of meds|2|||
150127655|NCT00448539|541600414|FG001|Overall Study|Change of meds|3|||
150127656|NCT00448539|541600413|FG000|Overall Study|Lost to Follow-up|1|||
150127657|NCT00448539|541600414|FG001|Overall Study|Lost to Follow-up|3|||
150127658|NCT04862143|541600415|FG000|Overall Study|Adverse Event|1|||
150127659|NCT04862143|541600415|FG000|Overall Study|Study terminated by sponsor|1|||
150127660|NCT02103439|541600416|FG000|Overall Study|Adverse Event|0|||
150127661|NCT02103439|541600417|FG001|Overall Study|Adverse Event|2|||
150127662|NCT02103439|541600416|FG000|Overall Study|Withdrawal by Subject|3|||
150127663|NCT02103439|541600417|FG001|Overall Study|Withdrawal by Subject|1|||
150127664|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
150127665|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
150127666|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
150127667|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
150127668|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
150127669|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
150127670|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
150127671|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
150127672|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
150127673|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
150127674|NCT00695903|541600418|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
150127675|NCT00695903|541600419|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
150127676|NCT00695903|541600418|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
150127677|NCT00695903|541600419|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
150127678|NCT00695903|541600418|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
150127679|NCT00695903|541600419|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
150127680|NCT00695903|541600418|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
150127681|NCT00695903|541600419|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
150127682|NCT02696317|541600420|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
150127683|NCT02696317|541600421|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
150127684|NCT02696317|541600420|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
150127685|NCT02696317|541600421|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
150127686|NCT01343368|541600422|FG000|Overall Study|Death|1|||
150127687|NCT01343368|541600423|FG001|Overall Study|Death|0|||
150127688|NCT01343368|541600422|FG000|Overall Study|Lost to Follow-up|1|||
150127689|NCT01343368|541600423|FG001|Overall Study|Lost to Follow-up|0|||
150127690|NCT01816594|541600427|FG000|Overall Study|Local Progress|0|||
150127691|NCT01816594|541600428|FG001|Overall Study|Local Progress|2|||
150127692|NCT01816594|541600427|FG000|Overall Study|Adverse Event|9|||
150127693|NCT01816594|541600428|FG001|Overall Study|Adverse Event|0|||
150127694|NCT01816594|541600427|FG000|Overall Study|Withdrawal by Subject|1|||
150127695|NCT01816594|541600428|FG001|Overall Study|Withdrawal by Subject|0|||
150127696|NCT01816594|541600427|FG000|Overall Study|Physician Decision|1|||
150127697|NCT01816594|541600428|FG001|Overall Study|Physician Decision|0|||
150127698|NCT00413153|541600429|FG000|Overall Study|Withdrawal by Subject|1|||
150127699|NCT00413153|541600430|FG001|Overall Study|Withdrawal by Subject|1|||
150127700|NCT00413153|541600429|FG000|Overall Study|Adverse Event|1|||
150127701|NCT00413153|541600430|FG001|Overall Study|Adverse Event|0|||
150127702|NCT03117738|541600431|FG000|Overall Study|Withdrawal by Subject|3|||
150127703|NCT03117738|541600432|FG001|Overall Study|Withdrawal by Subject|1|||
150127704|NCT03117738|541600431|FG000|Overall Study|Lost to Follow-up|1|||
150127705|NCT03117738|541600432|FG001|Overall Study|Lost to Follow-up|4|||
150127706|NCT01669629|541600433|FG000|Period 1|protocol deviation|1|||
150127707|NCT01669629|541600434|FG001|Period 1|protocol deviation|2|||
150127708|NCT01221597|541600435|FG000|Overall Study|Adverse Event|4|||
150127709|NCT01221597|541600436|FG001|Overall Study|Adverse Event|1|||
150127710|NCT01221597|541600435|FG000|Overall Study|Withdrawal by Subject|20|||
150127711|NCT01221597|541600436|FG001|Overall Study|Withdrawal by Subject|6|||
150127712|NCT01221597|541600435|FG000|Overall Study|Lost to Follow-up|6|||
150127713|NCT01221597|541600436|FG001|Overall Study|Lost to Follow-up|5|||
150127714|NCT01221597|541600435|FG000|Overall Study|Protocol Violation|1|||
150127715|NCT01221597|541600436|FG001|Overall Study|Protocol Violation|0|||
150127716|NCT01221597|541600435|FG000|Overall Study|Other|3|||
150127717|NCT01221597|541600436|FG001|Overall Study|Other|4|||
150127718|NCT01221597|541600435|FG000|Overall Study|Death|2|||
150127719|NCT01221597|541600436|FG001|Overall Study|Death|0|||
150127720|NCT04420689|541600438|FG000|Overall Study|COVID-19 related hospitalization|0|||
150127721|NCT04420689|541600439|FG001|Overall Study|COVID-19 related hospitalization|0|||
150127722|NCT04420689|541600440|FG002|Overall Study|COVID-19 related hospitalization|0|||
150127723|NCT04420689|541600441|FG003|Overall Study|COVID-19 related hospitalization|0|||
150127724|NCT04420689|541600442|FG004|Overall Study|COVID-19 related hospitalization|1|||
150127725|NCT04420689|541600443|FG005|Overall Study|COVID-19 related hospitalization|0|||
150127726|NCT04420689|541600444|FG006|Overall Study|COVID-19 related hospitalization|0|||
150127727|NCT04420689|541600438|FG000|Overall Study|Physician Decision|0|||
150127728|NCT04420689|541600439|FG001|Overall Study|Physician Decision|0|||
150127729|NCT04420689|541600440|FG002|Overall Study|Physician Decision|0|||
150127730|NCT04420689|541600441|FG003|Overall Study|Physician Decision|0|||
150127731|NCT04420689|541600442|FG004|Overall Study|Physician Decision|0|||
150127732|NCT04420689|541600443|FG005|Overall Study|Physician Decision|1|||
150127733|NCT04420689|541600444|FG006|Overall Study|Physician Decision|0|||
150127734|NCT01292928|541600450|FG000|Overall Study|Death|8|||
150127735|NCT01292928|541600450|FG000|Overall Study|Withdrawal by Subject|8|||
150127736|NCT01292928|541600450|FG000|Overall Study|Lost to Follow-up|6|||
150127737|NCT01292928|541600450|FG000|Overall Study|Physician Decision|2|||
150127738|NCT04530448|541600451|FG000|Overall Study|Physician Decision|3|||
150127739|NCT04530448|541600452|FG001|Overall Study|Physician Decision|0|||
150127740|NCT03638141|541600463|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
150127741|NCT03759873|541600464|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
150127742|NCT03759873|541600465|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
150127743|NCT03759873|541600466|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
150127744|NCT03759873|541600467|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
150127745|NCT03759873|541600464|FG000|Overall Study|Moved outside eligible area|0|||
150127746|NCT03759873|541600465|FG001|Overall Study|Moved outside eligible area|2|||
150127747|NCT03759873|541600466|FG002|Overall Study|Moved outside eligible area|0|||
150127748|NCT03759873|541600467|FG003|Overall Study|Moved outside eligible area|0|||
150127749|NCT03759873|541600464|FG000|Overall Study|Withdrawal by Subject|0|||
150127750|NCT03759873|541600465|FG001|Overall Study|Withdrawal by Subject|0|||
150127751|NCT03759873|541600466|FG002|Overall Study|Withdrawal by Subject|1|||
150127752|NCT03759873|541600467|FG003|Overall Study|Withdrawal by Subject|0|||
150127753|NCT04420221|541600468|FG000|Overall Study|Withdrawal by Subject|0|||
150127754|NCT04420221|541600469|FG001|Overall Study|Withdrawal by Subject|0|||
150127755|NCT04420221|541600470|FG002|Overall Study|Withdrawal by Subject|0|||
150127756|NCT04420221|541600471|FG003|Overall Study|Withdrawal by Subject|0|||
150127757|NCT04420221|541600472|FG004|Overall Study|Withdrawal by Subject|0|||
150127758|NCT04420221|541600473|FG005|Overall Study|Withdrawal by Subject|20|||
150127759|NCT04420221|541600474|FG006|Overall Study|Withdrawal by Subject|5|||
150127760|NCT04420221|541600468|FG000|Overall Study|Other|0|||
150127761|NCT04420221|541600469|FG001|Overall Study|Other|0|||
150127762|NCT04420221|541600470|FG002|Overall Study|Other|0|||
150127763|NCT04420221|541600471|FG003|Overall Study|Other|0|||
150127764|NCT04420221|541600472|FG004|Overall Study|Other|0|||
150127765|NCT04420221|541600473|FG005|Overall Study|Other|1|||
150127766|NCT04420221|541600474|FG006|Overall Study|Other|1|||
150127767|NCT04420221|541600468|FG000|Overall Study|Lost to Follow-up|0|||
150127768|NCT04420221|541600469|FG001|Overall Study|Lost to Follow-up|0|||
150127769|NCT04420221|541600470|FG002|Overall Study|Lost to Follow-up|0|||
150127770|NCT04420221|541600471|FG003|Overall Study|Lost to Follow-up|0|||
150127771|NCT04420221|541600472|FG004|Overall Study|Lost to Follow-up|0|||
150127772|NCT04420221|541600473|FG005|Overall Study|Lost to Follow-up|3|||
150127773|NCT04420221|541600474|FG006|Overall Study|Lost to Follow-up|2|||
150127774|NCT04420221|541600468|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
150127775|NCT04420221|541600469|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
150127776|NCT04420221|541600470|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
150127777|NCT04420221|541600471|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
150127778|NCT04420221|541600472|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
150127779|NCT04420221|541600473|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
150127780|NCT04420221|541600474|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
150127781|NCT00511004|541600475|FG000|Overall Study|Lost to Follow-up|0|||
150127782|NCT00511004|541600476|FG001|Overall Study|Lost to Follow-up|0|||
150127783|NCT00511004|541600477|FG002|Overall Study|Lost to Follow-up|4|||
150127784|NCT00990652|541600478|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
150127785|NCT00990652|541600478|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
150127786|NCT02384954|541600488|FG000|Phase 1|Progressive Disease|2|||
150127787|NCT02384954|541600489|FG001|Phase 1|Progressive Disease|0|||
150127788|NCT02384954|541600490|FG002|Phase 1|Progressive Disease|1|||
150127789|NCT02384954|541600491|FG003|Phase 1|Progressive Disease|1|||
150127790|NCT02384954|541600492|FG004|Phase 1|Progressive Disease|0|||
150127791|NCT02384954|541600493|FG005|Phase 1|Progressive Disease|0|||
150127792|NCT02384954|541600494|FG006|Phase 1|Progressive Disease|0|||
150127793|NCT02384954|541600495|FG007|Phase 1|Progressive Disease|0|||
150127794|NCT02384954|541600496|FG008|Phase 1|Progressive Disease|0|||
150127795|NCT02384954|541600488|FG000|Phase 1|Adverse Event|0|||
150127796|NCT02384954|541600489|FG001|Phase 1|Adverse Event|0|||
150127797|NCT02384954|541600490|FG002|Phase 1|Adverse Event|1|||
150127798|NCT02384954|541600491|FG003|Phase 1|Adverse Event|0|||
150127799|NCT02384954|541600492|FG004|Phase 1|Adverse Event|0|||
150127800|NCT02384954|541600493|FG005|Phase 1|Adverse Event|0|||
150127801|NCT02384954|541600494|FG006|Phase 1|Adverse Event|0|||
150127802|NCT02384954|541600495|FG007|Phase 1|Adverse Event|0|||
150127803|NCT02384954|541600496|FG008|Phase 1|Adverse Event|0|||
150127804|NCT02384954|541600488|FG000|Phase 2|Progressive Disease|0|||
150127805|NCT02384954|541600489|FG001|Phase 2|Progressive Disease|0|||
150127806|NCT02384954|541600490|FG002|Phase 2|Progressive Disease|0|||
150127807|NCT02384954|541600491|FG003|Phase 2|Progressive Disease|0|||
150127808|NCT02384954|541600492|FG004|Phase 2|Progressive Disease|0|||
150127809|NCT02384954|541600493|FG005|Phase 2|Progressive Disease|0|||
150127810|NCT02384954|541600494|FG006|Phase 2|Progressive Disease|0|||
150127811|NCT02384954|541600495|FG007|Phase 2|Progressive Disease|1|||
150127812|NCT02384954|541600496|FG008|Phase 2|Progressive Disease|2|||
150127813|NCT02384954|541600488|FG000|Phase 2|Adverse Event|0|||
150127814|NCT02384954|541600489|FG001|Phase 2|Adverse Event|0|||
150127815|NCT02384954|541600490|FG002|Phase 2|Adverse Event|0|||
150127816|NCT02384954|541600491|FG003|Phase 2|Adverse Event|0|||
150127817|NCT02384954|541600492|FG004|Phase 2|Adverse Event|0|||
150127818|NCT02384954|541600493|FG005|Phase 2|Adverse Event|0|||
150127819|NCT02384954|541600494|FG006|Phase 2|Adverse Event|0|||
150127820|NCT02384954|541600495|FG007|Phase 2|Adverse Event|1|||
150127821|NCT02384954|541600496|FG008|Phase 2|Adverse Event|1|||
150127822|NCT02384954|541600488|FG000|Phase 2|Failure to meet continuation criteria|0|||
150127823|NCT02384954|541600489|FG001|Phase 2|Failure to meet continuation criteria|0|||
150127824|NCT02384954|541600490|FG002|Phase 2|Failure to meet continuation criteria|0|||
150127825|NCT02384954|541600491|FG003|Phase 2|Failure to meet continuation criteria|0|||
150127826|NCT02384954|541600492|FG004|Phase 2|Failure to meet continuation criteria|0|||
150127827|NCT02384954|541600493|FG005|Phase 2|Failure to meet continuation criteria|0|||
150127828|NCT02384954|541600494|FG006|Phase 2|Failure to meet continuation criteria|0|||
150127829|NCT02384954|541600495|FG007|Phase 2|Failure to meet continuation criteria|1|||
150127830|NCT02384954|541600496|FG008|Phase 2|Failure to meet continuation criteria|0|||
150127831|NCT02372396|541600497|FG000|Overall Study|Lost to Follow-up|7|||
150127832|NCT02372396|541600498|FG001|Overall Study|Lost to Follow-up|9|||
150127833|NCT04313634|541600499|FG000|Overall Study|Adverse Event|2|||
150127834|NCT04313634|541600500|FG001|Overall Study|Adverse Event|2|||
150127835|NCT04313634|541600501|FG002|Overall Study|Adverse Event|0|||
150127836|NCT04313634|541600499|FG000|Overall Study|Withdrawal by Subject|1|||
150127837|NCT04313634|541600500|FG001|Overall Study|Withdrawal by Subject|0|||
150127838|NCT04313634|541600501|FG002|Overall Study|Withdrawal by Subject|1|||
150127839|NCT04313634|541600499|FG000|Overall Study|Protocol Violation|0|||
150127840|NCT04313634|541600500|FG001|Overall Study|Protocol Violation|0|||
150127841|NCT04313634|541600501|FG002|Overall Study|Protocol Violation|1|||
150127842|NCT00047879|541600508|FG000|Overall Study|Progressive disease|4|||
150127843|NCT00047879|541600509|FG001|Overall Study|Progressive disease|3|||
150127844|NCT04558346|541600522|FG000|Overall Study|Withdrawal by Subject|2|||
150127845|NCT04558346|541600523|FG001|Overall Study|Withdrawal by Subject|0|||
150127846|NCT04558346|541600522|FG000|Overall Study|Lost to Follow-up|0|||
150127847|NCT04558346|541600523|FG001|Overall Study|Lost to Follow-up|1|||
150127848|NCT04558346|541600522|FG000|Overall Study|Adverse Event|0|||
150127849|NCT04558346|541600523|FG001|Overall Study|Adverse Event|1|||
150127850|NCT03086447|541600524|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
150195318|NCT03854227|541856494|FG000|Overall Study|Adverse Event|0|||
150127851|NCT03086447|541600525|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
150127852|NCT03086447|541600524|FG000|Overall Study|Lost Lens|2|||
150127853|NCT03086447|541600525|FG001|Overall Study|Lost Lens|5|||
150127854|NCT03086447|541600524|FG000|Overall Study|Product quality complaint|0|||
150127855|NCT03086447|541600525|FG001|Overall Study|Product quality complaint|1|||
150127856|NCT03086447|541600524|FG000|Overall Study|Lens Damage|1|||
150127857|NCT03086447|541600525|FG001|Overall Study|Lens Damage|6|||
150127858|NCT03086447|541600524|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
150127859|NCT03086447|541600525|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
150127860|NCT03086447|541600524|FG000|Overall Study|Test Article No Longer Available|1|||
150127861|NCT03086447|541600525|FG001|Overall Study|Test Article No Longer Available|0|||
150127862|NCT03086447|541600524|FG000|Overall Study|Protocol Violation|2|||
150127863|NCT03086447|541600525|FG001|Overall Study|Protocol Violation|4|||
150127864|NCT03086447|541600524|FG000|Overall Study|Lost to Follow-up|0|||
150127865|NCT03086447|541600525|FG001|Overall Study|Lost to Follow-up|1|||
150127866|NCT03086447|541600524|FG000|Overall Study|Adverse Event|3|||
150127867|NCT03086447|541600525|FG001|Overall Study|Adverse Event|0|||
150127868|NCT03086447|541600524|FG000|Overall Study|Lens Discomfort|2|||
150127869|NCT03086447|541600525|FG001|Overall Study|Lens Discomfort|1|||
150127870|NCT00809757|541600526|FG000|Overall Study|Adverse Event|2|||
150127871|NCT00809757|541600527|FG001|Overall Study|Adverse Event|3|||
150127872|NCT00809757|541600528|FG002|Overall Study|Adverse Event|3|||
150127873|NCT00809757|541600526|FG000|Overall Study|Lost to Follow-up|0|||
150127874|NCT00809757|541600527|FG001|Overall Study|Lost to Follow-up|0|||
150127875|NCT00809757|541600528|FG002|Overall Study|Lost to Follow-up|1|||
150127876|NCT00809757|541600526|FG000|Overall Study|Protocol Violation|1|||
150127877|NCT00809757|541600527|FG001|Overall Study|Protocol Violation|1|||
150127878|NCT00809757|541600528|FG002|Overall Study|Protocol Violation|1|||
150127879|NCT00809757|541600526|FG000|Overall Study|Withdrawal by Subject|2|||
150127880|NCT00809757|541600527|FG001|Overall Study|Withdrawal by Subject|1|||
150127881|NCT00809757|541600528|FG002|Overall Study|Withdrawal by Subject|3|||
150127882|NCT00809757|541600526|FG000|Overall Study|Subject Uncooperative|1|||
150127883|NCT00809757|541600527|FG001|Overall Study|Subject Uncooperative|0|||
150127884|NCT00809757|541600528|FG002|Overall Study|Subject Uncooperative|2|||
150127885|NCT00809757|541600526|FG000|Overall Study|Noncompliance with Medication|0|||
150127886|NCT00809757|541600527|FG001|Overall Study|Noncompliance with Medication|0|||
150127887|NCT00809757|541600528|FG002|Overall Study|Noncompliance with Medication|1|||
150127888|NCT00659334|541600529|FG000|Overall Study|Screen Failure|8|||
150127889|NCT00659334|541600530|FG001|Overall Study|Screen Failure|5|||
150127890|NCT00659334|541600531|FG002|Overall Study|Screen Failure|0|||
150127891|NCT00659334|541600532|FG003|Overall Study|Screen Failure|0|||
150127892|NCT00659334|541600533|FG004|Overall Study|Screen Failure|0|||
150127893|NCT00659334|541600534|FG005|Overall Study|Screen Failure|0|||
150127894|NCT00659334|541600535|FG006|Overall Study|Screen Failure|1|||
150127895|NCT01174342|541600536|FG000|Overall Study|Conversion to cesarean section|4|||
150127896|NCT01218646|541600539|FG000|Overall Study|Adverse Event|0|||
150127897|NCT01218646|541600540|FG001|Overall Study|Adverse Event|0|||
150127898|NCT01218646|541600541|FG002|Overall Study|Adverse Event|1|||
150127899|NCT01218646|541600542|FG003|Overall Study|Adverse Event|0|||
150127900|NCT01218646|541600539|FG000|Overall Study|Lost to Follow-up|1|||
150127901|NCT01218646|541600540|FG001|Overall Study|Lost to Follow-up|0|||
150127902|NCT01218646|541600541|FG002|Overall Study|Lost to Follow-up|0|||
150127903|NCT01218646|541600542|FG003|Overall Study|Lost to Follow-up|0|||
150127904|NCT01218646|541600539|FG000|Overall Study|Protocol Violation|0|||
150127905|NCT01218646|541600540|FG001|Overall Study|Protocol Violation|0|||
150127906|NCT01218646|541600541|FG002|Overall Study|Protocol Violation|1|||
150127907|NCT01218646|541600542|FG003|Overall Study|Protocol Violation|1|||
150127908|NCT02693665|541600543|FG000|Overall Study|Death|3|||
150127909|NCT02693665|541600544|FG001|Overall Study|Death|2|||
150127910|NCT02693665|541600543|FG000|Overall Study|Lost to Follow-up|7|||
150127911|NCT02693665|541600544|FG001|Overall Study|Lost to Follow-up|3|||
150127912|NCT02693665|541600543|FG000|Overall Study|Protocol Violation|1|||
150127913|NCT02693665|541600544|FG001|Overall Study|Protocol Violation|0|||
150127914|NCT02693665|541600543|FG000|Overall Study|Withdrawal by Subject|2|||
150127915|NCT02693665|541600544|FG001|Overall Study|Withdrawal by Subject|0|||
150127916|NCT02693665|541600543|FG000|Overall Study|patient wanted to leave it behind|1|||
150127917|NCT02693665|541600544|FG001|Overall Study|patient wanted to leave it behind|0|||
150127918|NCT02693665|541600543|FG000|Overall Study|anxiety|1|||
150127919|NCT02693665|541600544|FG001|Overall Study|anxiety|0|||
150127920|NCT02693665|541600543|FG000|Overall Study|family issues|1|||
150127921|NCT02693665|541600544|FG001|Overall Study|family issues|0|||
150127922|NCT02693665|541600543|FG000|Overall Study|no reason given|1|||
150127923|NCT02693665|541600544|FG001|Overall Study|no reason given|0|||
150127924|NCT02075593|541600545|FG000|Overall Study|Withdrawal by Subject|1|||
150127925|NCT02010060|541600546|FG000|Overall Study|Lost to Follow-up|1|||
150127926|NCT02010060|541600547|FG001|Overall Study|Lost to Follow-up|2|||
150127927|NCT02010060|541600548|FG002|Overall Study|Lost to Follow-up|2|||
150127928|NCT02010060|541600546|FG000|Overall Study|Injury|0|||
150127929|NCT02010060|541600547|FG001|Overall Study|Injury|1|||
150127930|NCT02010060|541600548|FG002|Overall Study|Injury|0|||
150127931|NCT04414696|541600549|FG000|3-month Follow up|Withdrawal by Subject|1|||
150127932|NCT04414696|541600550|FG001|3-month Follow up|Withdrawal by Subject|0|||
150127933|NCT04414696|541600549|FG000|3-month Follow up|Lost to Follow-up|22|||
150127934|NCT04414696|541600550|FG001|3-month Follow up|Lost to Follow-up|23|||
150127935|NCT04414696|541600549|FG000|6-month Follow up|Withdrawal by Subject|1|||
150127936|NCT04414696|541600550|FG001|6-month Follow up|Withdrawal by Subject|2|||
150127937|NCT04414696|541600549|FG000|6-month Follow up|Lost to Follow-up|5|||
150127938|NCT04414696|541600550|FG001|6-month Follow up|Lost to Follow-up|2|||
150127939|NCT00726752|541600551|FG000|Overall Study|Lack of Efficacy|6|||
150127940|NCT00844857|541602917|FG000|Overall Study|Adverse Event|24|||
150127941|NCT00844857|541602918|FG001|Overall Study|Adverse Event|5|||
150127942|NCT00844857|541602917|FG000|Overall Study|Sponsor Decision|1|||
150127943|NCT00844857|541602918|FG001|Overall Study|Sponsor Decision|1|||
150127944|NCT00844857|541602917|FG000|Overall Study|Physician Decision|2|||
150127945|NCT00844857|541602918|FG001|Overall Study|Physician Decision|0|||
150127946|NCT00844857|541602917|FG000|Overall Study|Parent/Caregiver Decision|6|||
150127947|NCT00844857|541602918|FG001|Overall Study|Parent/Caregiver Decision|2|||
150127948|NCT00844857|541602917|FG000|Overall Study|Withdrawal by Subject|8|||
150127949|NCT00844857|541602918|FG001|Overall Study|Withdrawal by Subject|7|||
150127950|NCT00844857|541602917|FG000|Overall Study|Protocol Violation|6|||
150127951|NCT00844857|541602918|FG001|Overall Study|Protocol Violation|0|||
150127952|NCT00844857|541602917|FG000|Overall Study|Lack of Efficacy|5|||
150127953|NCT00844857|541602918|FG001|Overall Study|Lack of Efficacy|5|||
150127954|NCT00844857|541602917|FG000|Overall Study|Clinical Relapse|0|||
150127955|NCT00844857|541602918|FG001|Overall Study|Clinical Relapse|1|||
150127956|NCT00844857|541602917|FG000|Overall Study|Entry Criteria Not Met|0|||
150127957|NCT00844857|541602918|FG001|Overall Study|Entry Criteria Not Met|1|||
150127958|NCT00844857|541602917|FG000|Overall Study|Lost to Follow-up|2|||
150127959|NCT00844857|541602918|FG001|Overall Study|Lost to Follow-up|3|||
150127960|NCT00844857|541602917|FG000|Overall Study|Did Not Take Study Drug|3|||
150127961|NCT00844857|541602918|FG001|Overall Study|Did Not Take Study Drug|1|||
150127962|NCT00844857|541602917|FG000|Overall Study|Good Clinical Practice Violations|21|||
150127963|NCT00844857|541602918|FG001|Overall Study|Good Clinical Practice Violations|11|||
150127964|NCT00570674|541602919|FG000|Overall Study|Withdrawal by Subject|0|||
150127965|NCT00570674|541602920|FG001|Overall Study|Withdrawal by Subject|0|||
150127966|NCT00570674|541602921|FG002|Overall Study|Withdrawal by Subject|1|||
150127967|NCT00570674|541602922|FG003|Overall Study|Withdrawal by Subject|0|||
150127968|NCT00570674|541602923|FG004|Overall Study|Withdrawal by Subject|0|||
150127969|NCT00570674|541602924|FG005|Overall Study|Withdrawal by Subject|0|||
150127970|NCT00570674|541602925|FG006|Overall Study|Withdrawal by Subject|0|||
150127971|NCT01912612|541602932|FG000|Overall Study|Adverse Event|4|||
150127972|NCT01912612|541602933|FG001|Overall Study|Adverse Event|0|||
150127973|NCT01912612|541602934|FG002|Overall Study|Adverse Event|0|||
150127974|NCT01912612|541602932|FG000|Overall Study|Withdrew consent|1|||
150127975|NCT01912612|541602933|FG001|Overall Study|Withdrew consent|0|||
150127976|NCT01912612|541602934|FG002|Overall Study|Withdrew consent|0|||
150127977|NCT01912612|541602932|FG000|Overall Study|Study design change|0|||
150127978|NCT01912612|541602933|FG001|Overall Study|Study design change|0|||
150127979|NCT01912612|541602934|FG002|Overall Study|Study design change|3|||
150127980|NCT01588184|541602935|FG000|Overall Study|Death|1|||
150127981|NCT01588184|541602936|FG001|Overall Study|Death|0|||
150127982|NCT01588184|541602937|FG002|Overall Study|Death|0|||
150127983|NCT01588184|541602938|FG003|Overall Study|Death|1|||
150127984|NCT01588184|541602939|FG004|Overall Study|Death|1|||
150127985|NCT01588184|541602940|FG005|Overall Study|Death|1|||
150127986|NCT01588184|541602935|FG000|Overall Study|Withdrawal by Subject|2|||
150127987|NCT01588184|541602936|FG001|Overall Study|Withdrawal by Subject|4|||
150127988|NCT01588184|541602937|FG002|Overall Study|Withdrawal by Subject|0|||
150127989|NCT01588184|541602938|FG003|Overall Study|Withdrawal by Subject|1|||
150127990|NCT01588184|541602939|FG004|Overall Study|Withdrawal by Subject|0|||
150127991|NCT01588184|541602940|FG005|Overall Study|Withdrawal by Subject|0|||
150127992|NCT01588184|541602935|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
150127993|NCT01588184|541602936|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
150127994|NCT01588184|541602937|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
150127995|NCT01588184|541602938|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
150127996|NCT01588184|541602939|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
150127997|NCT01588184|541602940|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
150127998|NCT01588184|541602935|FG000|Overall Study|multiple reasons|0|||
150127999|NCT01588184|541602936|FG001|Overall Study|multiple reasons|3|||
150128000|NCT01588184|541602937|FG002|Overall Study|multiple reasons|0|||
150128001|NCT01588184|541602938|FG003|Overall Study|multiple reasons|1|||
150128002|NCT01588184|541602939|FG004|Overall Study|multiple reasons|0|||
150128003|NCT01588184|541602940|FG005|Overall Study|multiple reasons|0|||
150128004|NCT00907153|541602941|FG000|Overall Study|Lost to Follow-up|1|||
150128005|NCT00907153|541602942|FG001|Overall Study|Lost to Follow-up|1|||
150128006|NCT00907153|541602941|FG000|Overall Study|Withdrawal by Subject|1|||
150128007|NCT00907153|541602942|FG001|Overall Study|Withdrawal by Subject|3|||
150128008|NCT02120027|541602945|FG000|Overall Study|Adverse Event|4|||
150128009|NCT02120027|541602946|FG001|Overall Study|Adverse Event|5|||
150128010|NCT02120027|541602945|FG000|Overall Study|Lack of Efficacy|3|||
150128011|NCT02120027|541602946|FG001|Overall Study|Lack of Efficacy|5|||
150128012|NCT02120027|541602945|FG000|Overall Study|Lost to Follow-up|5|||
150128013|NCT02120027|541602946|FG001|Overall Study|Lost to Follow-up|13|||
150128014|NCT02120027|541602945|FG000|Overall Study|Other|4|||
150128015|NCT02120027|541602946|FG001|Overall Study|Other|0|||
150128016|NCT02120027|541602945|FG000|Overall Study|Physician Decision|4|||
150128017|NCT02120027|541602946|FG001|Overall Study|Physician Decision|3|||
150128018|NCT02120027|541602945|FG000|Overall Study|Protocol Violation|18|||
150128019|NCT02120027|541602946|FG001|Overall Study|Protocol Violation|21|||
150128020|NCT02120027|541602945|FG000|Overall Study|Study terminated by Sponsor|45|||
150128021|NCT02120027|541602946|FG001|Overall Study|Study terminated by Sponsor|47|||
150128022|NCT02120027|541602945|FG000|Overall Study|Withdrawal by Subject|33|||
150128023|NCT02120027|541602946|FG001|Overall Study|Withdrawal by Subject|25|||
150128024|NCT03393000|541602951|FG000|Overall Study|Death|11|||
150128025|NCT03393000|541602951|FG000|Overall Study|Withdrawal by Subject|2|||
150128026|NCT03393000|541602951|FG000|Overall Study|Physician Decision|1|||
150128027|NCT01773070|541602952|FG000|Overall Study|Withdrawal by Subject|24|||
150128028|NCT01773070|541602952|FG000|Overall Study|Lost to Follow-up|39|||
150128029|NCT01773070|541602952|FG000|Overall Study|Other|15|||
150128030|NCT01773070|541602952|FG000|Overall Study|Death (unrelated to study procedures)|3|||
150128031|NCT01471054|541602953|FG000|Overall Study|Study terminated prematurely|4|||
150128032|NCT01471054|541602954|FG001|Overall Study|Study terminated prematurely|0|||
150128033|NCT01559844|541602955|FG000|Overall Study|Consent Withdrawn|7|||
150128034|NCT01559844|541602955|FG000|Overall Study|Death|5|||
150128035|NCT01559844|541602955|FG000|Overall Study|Efficacy Failure|10|||
150128036|NCT01559844|541602955|FG000|Overall Study|No Longer A Transplant Candidate|3|||
150128037|NCT02181803|541602956|FG000|Overall Study|Withdrawal by Subject|0|||
150128038|NCT02181803|541602957|FG001|Overall Study|Withdrawal by Subject|2|||
150128039|NCT02181803|541602958|FG002|Overall Study|Withdrawal by Subject|0|||
150128040|NCT02181803|541602959|FG003|Overall Study|Withdrawal by Subject|0|||
150128041|NCT02181803|541602960|FG004|Overall Study|Withdrawal by Subject|0|||
150128042|NCT02181803|541602961|FG005|Overall Study|Withdrawal by Subject|0|||
150128043|NCT02181803|541602962|FG006|Overall Study|Withdrawal by Subject|0|||
150128044|NCT02181803|541602963|FG007|Overall Study|Withdrawal by Subject|0|||
150128045|NCT02181803|541602964|FG008|Overall Study|Withdrawal by Subject|0|||
150128046|NCT02181803|541602956|FG000|Overall Study|Physician Decision|0|||
150128047|NCT02181803|541602957|FG001|Overall Study|Physician Decision|0|||
150128048|NCT02181803|541602958|FG002|Overall Study|Physician Decision|0|||
150128049|NCT02181803|541602959|FG003|Overall Study|Physician Decision|1|||
150128050|NCT02181803|541602960|FG004|Overall Study|Physician Decision|0|||
150128051|NCT02181803|541602961|FG005|Overall Study|Physician Decision|0|||
150128052|NCT02181803|541602962|FG006|Overall Study|Physician Decision|0|||
150128053|NCT02181803|541602963|FG007|Overall Study|Physician Decision|1|||
150128054|NCT02181803|541602964|FG008|Overall Study|Physician Decision|0|||
150128055|NCT02181803|541602956|FG000|Overall Study|Adverse Event|0|||
150128056|NCT02181803|541602957|FG001|Overall Study|Adverse Event|2|||
150128057|NCT02181803|541602958|FG002|Overall Study|Adverse Event|0|||
150128058|NCT02181803|541602959|FG003|Overall Study|Adverse Event|1|||
150128059|NCT02181803|541602960|FG004|Overall Study|Adverse Event|0|||
150128060|NCT02181803|541602961|FG005|Overall Study|Adverse Event|0|||
150128061|NCT02181803|541602962|FG006|Overall Study|Adverse Event|1|||
150128062|NCT02181803|541602963|FG007|Overall Study|Adverse Event|0|||
150128063|NCT02181803|541602964|FG008|Overall Study|Adverse Event|0|||
150128064|NCT00951041|541602965|FG000|Overall Study|Withdrawal by Subject|1|||
150128065|NCT00951041|541602966|FG001|Overall Study|Withdrawal by Subject|1|||
150128066|NCT00951041|541602965|FG000|Overall Study|Lost to Follow-up|1|||
150128067|NCT00951041|541602966|FG001|Overall Study|Lost to Follow-up|0|||
150128068|NCT00951041|541602965|FG000|Overall Study|Other|3|||
150128069|NCT00951041|541602966|FG001|Overall Study|Other|0|||
150128070|NCT02388724|541602968|FG000|Overall Study|Reason not Specified|0|||
150128071|NCT02388724|541602969|FG001|Overall Study|Reason not Specified|1|||
150128072|NCT02388724|541602968|FG000|Overall Study|Major Protocol Deviation|3|||
150128073|NCT02388724|541602969|FG001|Overall Study|Major Protocol Deviation|3|||
150128074|NCT02388724|541602968|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
150128075|NCT02388724|541602969|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
150128076|NCT02388724|541602968|FG000|Overall Study|Voluntary Withdrawal|6|||
150128077|NCT02388724|541602969|FG001|Overall Study|Voluntary Withdrawal|5|||
150128078|NCT02388724|541602968|FG000|Overall Study|Randomized but not Treated|0|||
150128079|NCT02388724|541602969|FG001|Overall Study|Randomized but not Treated|2|||
150128080|NCT01217073|541602972|FG000|Base Period|Adverse Event|1|||
150128081|NCT01217073|541602973|FG001|Base Period|Adverse Event|0|||
150128082|NCT01217073|541602974|FG002|Base Period|Adverse Event|1|||
150128083|NCT01217073|541602975|FG003|Base Period|Adverse Event|0|||
150128084|NCT01217073|541602976|FG004|Base Period|Adverse Event|4|||
150128085|NCT01217073|541602977|FG005|Base Period|Adverse Event|1|||
150128086|NCT01217073|541602978|FG006|Base Period|Adverse Event|0|||
150128087|NCT01217073|541602979|FG007|Base Period|Adverse Event|0|||
150128088|NCT01217073|541602972|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
150128089|NCT01217073|541602973|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128090|NCT01217073|541602974|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128091|NCT01217073|541602975|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128092|NCT01217073|541602976|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128093|NCT01217073|541602977|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128094|NCT01217073|541602978|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128095|NCT01217073|541602979|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
150128096|NCT01217073|541602972|FG000|Base Period|Excluded medication|0|||
150128097|NCT01217073|541602973|FG001|Base Period|Excluded medication|0|||
150128098|NCT01217073|541602974|FG002|Base Period|Excluded medication|0|||
150128099|NCT01217073|541602975|FG003|Base Period|Excluded medication|0|||
150128100|NCT01217073|541602976|FG004|Base Period|Excluded medication|1|||
150128101|NCT01217073|541602977|FG005|Base Period|Excluded medication|0|||
150128102|NCT01217073|541602978|FG006|Base Period|Excluded medication|0|||
150128103|NCT01217073|541602979|FG007|Base Period|Excluded medication|0|||
150128104|NCT01217073|541602972|FG000|Base Period|Lack of Efficacy|0|||
150128105|NCT01217073|541602973|FG001|Base Period|Lack of Efficacy|0|||
150128106|NCT01217073|541602974|FG002|Base Period|Lack of Efficacy|0|||
150128107|NCT01217073|541602975|FG003|Base Period|Lack of Efficacy|0|||
150128108|NCT01217073|541602976|FG004|Base Period|Lack of Efficacy|0|||
150128109|NCT01217073|541602977|FG005|Base Period|Lack of Efficacy|1|||
150128110|NCT01217073|541602978|FG006|Base Period|Lack of Efficacy|0|||
150128111|NCT01217073|541602979|FG007|Base Period|Lack of Efficacy|0|||
150128112|NCT01217073|541602972|FG000|Base Period|Lost to Follow-up|0|||
150128113|NCT01217073|541602973|FG001|Base Period|Lost to Follow-up|0|||
150128114|NCT01217073|541602974|FG002|Base Period|Lost to Follow-up|1|||
150128115|NCT01217073|541602975|FG003|Base Period|Lost to Follow-up|1|||
150128116|NCT01217073|541602976|FG004|Base Period|Lost to Follow-up|3|||
150128117|NCT01217073|541602977|FG005|Base Period|Lost to Follow-up|0|||
150128118|NCT01217073|541602978|FG006|Base Period|Lost to Follow-up|0|||
150128119|NCT01217073|541602979|FG007|Base Period|Lost to Follow-up|0|||
150128120|NCT01217073|541602972|FG000|Base Period|Physician Decision|0|||
150128121|NCT01217073|541602973|FG001|Base Period|Physician Decision|0|||
150128122|NCT01217073|541602974|FG002|Base Period|Physician Decision|0|||
150128123|NCT01217073|541602975|FG003|Base Period|Physician Decision|0|||
150128124|NCT01217073|541602976|FG004|Base Period|Physician Decision|1|||
150128125|NCT01217073|541602977|FG005|Base Period|Physician Decision|0|||
150128126|NCT01217073|541602978|FG006|Base Period|Physician Decision|0|||
150128127|NCT01217073|541602979|FG007|Base Period|Physician Decision|0|||
150128128|NCT01217073|541602972|FG000|Base Period|Protocol Violation|1|||
150128129|NCT01217073|541602973|FG001|Base Period|Protocol Violation|0|||
150128130|NCT01217073|541602974|FG002|Base Period|Protocol Violation|0|||
150128131|NCT01217073|541602975|FG003|Base Period|Protocol Violation|0|||
150128132|NCT01217073|541602976|FG004|Base Period|Protocol Violation|1|||
150128133|NCT01217073|541602977|FG005|Base Period|Protocol Violation|2|||
150128134|NCT01217073|541602978|FG006|Base Period|Protocol Violation|0|||
150128135|NCT01217073|541602979|FG007|Base Period|Protocol Violation|0|||
150128136|NCT01217073|541602972|FG000|Base Period|Withdrawal by Subject|4|||
150128137|NCT01217073|541602973|FG001|Base Period|Withdrawal by Subject|5|||
150128138|NCT01217073|541602974|FG002|Base Period|Withdrawal by Subject|5|||
150128139|NCT01217073|541602975|FG003|Base Period|Withdrawal by Subject|1|||
150128140|NCT01217073|541602976|FG004|Base Period|Withdrawal by Subject|5|||
150128141|NCT01217073|541602977|FG005|Base Period|Withdrawal by Subject|5|||
150128142|NCT01217073|541602978|FG006|Base Period|Withdrawal by Subject|0|||
150128143|NCT01217073|541602979|FG007|Base Period|Withdrawal by Subject|0|||
150128144|NCT01217073|541602972|FG000|Extension Period|Adverse Event|0|||
150128145|NCT01217073|541602973|FG001|Extension Period|Adverse Event|0|||
150128146|NCT01217073|541602974|FG002|Extension Period|Adverse Event|0|||
150128147|NCT01217073|541602975|FG003|Extension Period|Adverse Event|0|||
150128148|NCT01217073|541602976|FG004|Extension Period|Adverse Event|0|||
150128149|NCT01217073|541602977|FG005|Extension Period|Adverse Event|0|||
150128150|NCT01217073|541602978|FG006|Extension Period|Adverse Event|19|||
150128151|NCT01217073|541602979|FG007|Extension Period|Adverse Event|5|||
150128152|NCT01217073|541602972|FG000|Extension Period|ALT/AST|0|||
150128153|NCT01217073|541602973|FG001|Extension Period|ALT/AST|0|||
150128154|NCT01217073|541602974|FG002|Extension Period|ALT/AST|0|||
150128155|NCT01217073|541602975|FG003|Extension Period|ALT/AST|0|||
150128156|NCT01217073|541602976|FG004|Extension Period|ALT/AST|0|||
150128157|NCT01217073|541602977|FG005|Extension Period|ALT/AST|0|||
150128158|NCT01217073|541602978|FG006|Extension Period|ALT/AST|2|||
150128159|NCT01217073|541602979|FG007|Extension Period|ALT/AST|0|||
150128160|NCT01217073|541602972|FG000|Extension Period|Contraindication to study medication|0|||
150128161|NCT01217073|541602973|FG001|Extension Period|Contraindication to study medication|0|||
150128162|NCT01217073|541602974|FG002|Extension Period|Contraindication to study medication|0|||
150128163|NCT01217073|541602975|FG003|Extension Period|Contraindication to study medication|0|||
150128164|NCT01217073|541602976|FG004|Extension Period|Contraindication to study medication|0|||
150128165|NCT01217073|541602977|FG005|Extension Period|Contraindication to study medication|0|||
150128166|NCT01217073|541602978|FG006|Extension Period|Contraindication to study medication|1|||
150128167|NCT01217073|541602979|FG007|Extension Period|Contraindication to study medication|0|||
150128168|NCT01217073|541602972|FG000|Extension Period|Creatinine/eGFR|0|||
150128169|NCT01217073|541602973|FG001|Extension Period|Creatinine/eGFR|0|||
150128170|NCT01217073|541602974|FG002|Extension Period|Creatinine/eGFR|0|||
150128171|NCT01217073|541602975|FG003|Extension Period|Creatinine/eGFR|0|||
150128172|NCT01217073|541602976|FG004|Extension Period|Creatinine/eGFR|0|||
150128173|NCT01217073|541602977|FG005|Extension Period|Creatinine/eGFR|0|||
150128174|NCT01217073|541602978|FG006|Extension Period|Creatinine/eGFR|11|||
150128175|NCT01217073|541602979|FG007|Extension Period|Creatinine/eGFR|1|||
150128176|NCT01217073|541602972|FG000|Extension Period|Death|0|||
150128177|NCT01217073|541602973|FG001|Extension Period|Death|0|||
150128178|NCT01217073|541602974|FG002|Extension Period|Death|0|||
150128179|NCT01217073|541602975|FG003|Extension Period|Death|0|||
150128180|NCT01217073|541602976|FG004|Extension Period|Death|0|||
150128181|NCT01217073|541602977|FG005|Extension Period|Death|0|||
150128182|NCT01217073|541602978|FG006|Extension Period|Death|1|||
150128183|NCT01217073|541602979|FG007|Extension Period|Death|0|||
150128184|NCT01217073|541602972|FG000|Extension Period|Excluded medication|0|||
150128185|NCT01217073|541602973|FG001|Extension Period|Excluded medication|0|||
150128186|NCT01217073|541602974|FG002|Extension Period|Excluded medication|0|||
150128187|NCT01217073|541602975|FG003|Extension Period|Excluded medication|0|||
150128188|NCT01217073|541602976|FG004|Extension Period|Excluded medication|0|||
150128189|NCT01217073|541602977|FG005|Extension Period|Excluded medication|0|||
150128190|NCT01217073|541602978|FG006|Extension Period|Excluded medication|2|||
150128191|NCT01217073|541602979|FG007|Extension Period|Excluded medication|0|||
150128192|NCT01217073|541602972|FG000|Extension Period|Lack of Efficacy|0|||
150128193|NCT01217073|541602973|FG001|Extension Period|Lack of Efficacy|0|||
150128194|NCT01217073|541602974|FG002|Extension Period|Lack of Efficacy|0|||
150128195|NCT01217073|541602975|FG003|Extension Period|Lack of Efficacy|0|||
150128196|NCT01217073|541602976|FG004|Extension Period|Lack of Efficacy|0|||
150128197|NCT01217073|541602977|FG005|Extension Period|Lack of Efficacy|0|||
150128198|NCT01217073|541602978|FG006|Extension Period|Lack of Efficacy|3|||
150128199|NCT01217073|541602979|FG007|Extension Period|Lack of Efficacy|0|||
150128200|NCT01217073|541602972|FG000|Extension Period|Lost to Follow-up|0|||
150128201|NCT01217073|541602973|FG001|Extension Period|Lost to Follow-up|0|||
150128202|NCT01217073|541602974|FG002|Extension Period|Lost to Follow-up|0|||
150128203|NCT01217073|541602975|FG003|Extension Period|Lost to Follow-up|0|||
150128204|NCT01217073|541602976|FG004|Extension Period|Lost to Follow-up|0|||
150128205|NCT01217073|541602977|FG005|Extension Period|Lost to Follow-up|0|||
150128206|NCT01217073|541602978|FG006|Extension Period|Lost to Follow-up|9|||
150128207|NCT01217073|541602979|FG007|Extension Period|Lost to Follow-up|1|||
150128208|NCT01217073|541602972|FG000|Extension Period|Non-compliance with study drug|0|||
150128209|NCT01217073|541602973|FG001|Extension Period|Non-compliance with study drug|0|||
150128210|NCT01217073|541602974|FG002|Extension Period|Non-compliance with study drug|0|||
150128211|NCT01217073|541602975|FG003|Extension Period|Non-compliance with study drug|0|||
150128212|NCT01217073|541602976|FG004|Extension Period|Non-compliance with study drug|0|||
150128213|NCT01217073|541602977|FG005|Extension Period|Non-compliance with study drug|0|||
150128214|NCT01217073|541602978|FG006|Extension Period|Non-compliance with study drug|0|||
150128215|NCT01217073|541602979|FG007|Extension Period|Non-compliance with study drug|1|||
150128216|NCT01217073|541602972|FG000|Extension Period|Physician Decision|0|||
150128217|NCT01217073|541602973|FG001|Extension Period|Physician Decision|0|||
150128218|NCT01217073|541602974|FG002|Extension Period|Physician Decision|0|||
150128219|NCT01217073|541602975|FG003|Extension Period|Physician Decision|0|||
150128220|NCT01217073|541602976|FG004|Extension Period|Physician Decision|0|||
150128221|NCT01217073|541602977|FG005|Extension Period|Physician Decision|0|||
150128222|NCT01217073|541602978|FG006|Extension Period|Physician Decision|4|||
150128223|NCT01217073|541602979|FG007|Extension Period|Physician Decision|1|||
150128224|NCT01217073|541602972|FG000|Extension Period|Protocol Violation|0|||
150128225|NCT01217073|541602973|FG001|Extension Period|Protocol Violation|0|||
150128226|NCT01217073|541602974|FG002|Extension Period|Protocol Violation|0|||
150128227|NCT01217073|541602975|FG003|Extension Period|Protocol Violation|0|||
150128228|NCT01217073|541602976|FG004|Extension Period|Protocol Violation|0|||
150128229|NCT01217073|541602977|FG005|Extension Period|Protocol Violation|0|||
150128230|NCT01217073|541602978|FG006|Extension Period|Protocol Violation|2|||
150128231|NCT01217073|541602979|FG007|Extension Period|Protocol Violation|1|||
150128232|NCT01217073|541602972|FG000|Extension Period|Site discontinued study participation|0|||
150128233|NCT01217073|541602973|FG001|Extension Period|Site discontinued study participation|0|||
150128234|NCT01217073|541602974|FG002|Extension Period|Site discontinued study participation|0|||
150128235|NCT01217073|541602975|FG003|Extension Period|Site discontinued study participation|0|||
150128236|NCT01217073|541602976|FG004|Extension Period|Site discontinued study participation|0|||
150128237|NCT01217073|541602977|FG005|Extension Period|Site discontinued study participation|0|||
150128238|NCT01217073|541602978|FG006|Extension Period|Site discontinued study participation|7|||
150128239|NCT01217073|541602979|FG007|Extension Period|Site discontinued study participation|2|||
150128240|NCT01217073|541602972|FG000|Extension Period|Withdrawal by Subject|0|||
150128241|NCT01217073|541602973|FG001|Extension Period|Withdrawal by Subject|0|||
150128242|NCT01217073|541602974|FG002|Extension Period|Withdrawal by Subject|0|||
150128243|NCT01217073|541602975|FG003|Extension Period|Withdrawal by Subject|0|||
150128244|NCT01217073|541602976|FG004|Extension Period|Withdrawal by Subject|0|||
150128245|NCT01217073|541602977|FG005|Extension Period|Withdrawal by Subject|0|||
150128246|NCT01217073|541602978|FG006|Extension Period|Withdrawal by Subject|30|||
150128247|NCT01217073|541602979|FG007|Extension Period|Withdrawal by Subject|8|||
150128248|NCT04477187|541602980|FG000|Overall Study|Lost to Follow-up|2|||
150128249|NCT02460991|541602981|FG000|Overall Study|Withdrawal by Subject|0|||
150128250|NCT02460991|541602982|FG001|Overall Study|Withdrawal by Subject|2|||
150128251|NCT01296568|541602985|FG000|Continued Access Phase|Lost to Follow-up|1|||
150128252|NCT01296568|541602985|FG000|Continued Access Phase|Withdrawal by Subject|1|||
150128253|NCT01296568|541602985|FG000|Continued Access Phase|Disease Progression|1|||
150128254|NCT00321854|541602986|FG000|Overall Study|Adverse Event|41|||
150128255|NCT00321854|541602987|FG001|Overall Study|Adverse Event|43|||
150128256|NCT00321854|541602986|FG000|Overall Study|Lack of Efficacy|9|||
150128257|NCT00321854|541602987|FG001|Overall Study|Lack of Efficacy|14|||
150128258|NCT00321854|541602986|FG000|Overall Study|Protocol Violation|6|||
150128259|NCT00321854|541602987|FG001|Overall Study|Protocol Violation|5|||
150128260|NCT00321854|541602986|FG000|Overall Study|Lost to Follow-up|0|||
150128261|NCT00321854|541602987|FG001|Overall Study|Lost to Follow-up|2|||
150128262|NCT00321854|541602986|FG000|Overall Study|Withdrawal by Subject|6|||
150128263|NCT00321854|541602987|FG001|Overall Study|Withdrawal by Subject|17|||
150128264|NCT00321854|541602986|FG000|Overall Study|Other|1|||
150128265|NCT00321854|541602987|FG001|Overall Study|Other|1|||
150128266|NCT03905655|541602988|FG000|Overall Study|Adverse Event|1|||
150128267|NCT03905655|541602989|FG001|Overall Study|Adverse Event|0|||
150128268|NCT03905655|541602990|FG002|Overall Study|Adverse Event|1|||
150128269|NCT03905655|541602991|FG003|Overall Study|Adverse Event|1|||
150128270|NCT02566031|541602992|FG000|Overall Study|Patient/guardian decision|14|||
150128271|NCT02566031|541602993|FG001|Overall Study|Patient/guardian decision|7|||
150128272|NCT02566031|541602992|FG000|Overall Study|Protocol deviation|2|||
150128273|NCT02566031|541602993|FG001|Overall Study|Protocol deviation|3|||
150128274|NCT02566031|541602992|FG000|Overall Study|Adverse Event|3|||
150128275|NCT02566031|541602993|FG001|Overall Study|Adverse Event|1|||
150128276|NCT02566031|541602992|FG000|Overall Study|Lost to Follow-up|1|||
150128277|NCT02566031|541602993|FG001|Overall Study|Lost to Follow-up|1|||
150128278|NCT02277106|541602994|FG000|Stage 2|Adverse Event|0|||
150128279|NCT02277106|541602995|FG001|Stage 2|Adverse Event|0|||
150128280|NCT02277106|541602996|FG002|Stage 2|Adverse Event|1|||
150128281|NCT03280121|541603001|FG000|Overall Study|Physician Decision|1|||
150128282|NCT03280121|541603001|FG000|Overall Study|Lost to Follow-up|1|||
150128283|NCT03280121|541603001|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
150128284|NCT03996473|541603007|FG000|Treatment Assignment|Withdrawal by Subject|1|||
150128285|NCT03996473|541603007|FG000|Treatment Assignment|Progressive disease|6|||
150128286|NCT03996473|541603007|FG000|Treatment Assignment|Study drug never administered|1|||
150128287|NCT03996473|541603007|FG000|Active Follow-up|Death|1|||
150128288|NCT03996473|541603007|FG000|Long-term Follow-up|Death|5|||
150128289|NCT04349553|541603011|FG000|Overall Study|Withdrawal by Subject|1|||
150128290|NCT04349553|541603012|FG001|Overall Study|Withdrawal by Subject|0|||
150128291|NCT04349553|541603013|FG002|Overall Study|Withdrawal by Subject|1|||
150128292|NCT04349553|541603014|FG003|Overall Study|Withdrawal by Subject|0|||
150128293|NCT03526250|541603015|FG000|Overall Study|Adverse Event|4|||
150128294|NCT03526250|541603015|FG000|Overall Study|Progressive Disease|16|||
150128295|NCT03526250|541603015|FG000|Overall Study|No Treatment|3|||
150128296|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
150128297|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
150128298|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
150128299|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
150128300|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
150128301|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
150128302|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
150128303|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
150128304|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
150128305|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
150128306|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
150128307|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
150128308|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
150128309|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
150128310|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
150128311|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
150128312|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
150128313|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
150128314|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
150128315|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
150128316|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
150128317|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
150128318|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
150128319|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
150128320|NCT01715805|541603016|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
150128321|NCT01715805|541603017|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
150128322|NCT01715805|541603018|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
150128323|NCT01715805|541603019|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
150128324|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
150128325|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
150128326|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
150128327|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
150128328|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
150128329|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
150128330|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
150128331|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
150128332|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
150128333|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
150128334|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
150128335|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
150128336|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
150128337|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
150128338|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
150128339|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
150128340|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
150128341|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
150128342|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
150128343|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
150128344|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
150128345|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
150128346|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
150128347|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
150128348|NCT01715805|541603016|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
150128349|NCT01715805|541603017|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
150128350|NCT01715805|541603018|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
150128351|NCT01715805|541603019|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
150128352|NCT02219932|541603022|FG000|Overall Study|Other|5|||
150128353|NCT02219932|541603023|FG001|Overall Study|Other|11|||
150128354|NCT02219932|541603022|FG000|Overall Study|Death|1|||
150128355|NCT02219932|541603023|FG001|Overall Study|Death|1|||
150128356|NCT02219932|541603022|FG000|Overall Study|Investigator Decision|0|||
150128357|NCT02219932|541603023|FG001|Overall Study|Investigator Decision|1|||
150128358|NCT02219932|541603022|FG000|Overall Study|Consent Withdrawn|11|||
150128359|NCT02219932|541603023|FG001|Overall Study|Consent Withdrawn|7|||
150128360|NCT02219932|541603022|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
150128361|NCT02219932|541603023|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
150128362|NCT02219932|541603022|FG000|Overall Study|Protocol Violation|10|||
150128363|NCT02219932|541603023|FG001|Overall Study|Protocol Violation|6|||
150128364|NCT02219932|541603022|FG000|Overall Study|Pregnancy|1|||
150128365|NCT02219932|541603023|FG001|Overall Study|Pregnancy|0|||
150128366|NCT02219932|541603022|FG000|Overall Study|Lost to Follow-up|4|||
150128367|NCT02219932|541603023|FG001|Overall Study|Lost to Follow-up|2|||
150128368|NCT02219932|541603022|FG000|Overall Study|Adverse Event|23|||
150128369|NCT02219932|541603023|FG001|Overall Study|Adverse Event|21|||
150128370|NCT01672801|541603030|FG000|Overall Study|Screen Failure|0|||
150128371|NCT01672801|541603031|FG001|Overall Study|Screen Failure|1|||
150128372|NCT06476366|541603032|FG000|Overall Study|Lost to Follow-up|1|||
150128373|NCT06476366|541603033|FG001|Overall Study|Lost to Follow-up|3|||
150128374|NCT06476366|541603032|FG000|Overall Study|Adverse Event|1|||
150128375|NCT06476366|541603033|FG001|Overall Study|Adverse Event|0|||
150128376|NCT01272934|541603050|FG000|Overall Study|Adverse Event|0|||
150128377|NCT01272934|541603051|FG001|Overall Study|Adverse Event|1|||
150128378|NCT01272934|541603050|FG000|Overall Study|Abnormal Laboratory Value|0|||
150128379|NCT01272934|541603051|FG001|Overall Study|Abnormal Laboratory Value|1|||
150128380|NCT03449030|541603052|FG000|Overall Study|Withdrawal by Subject|0|||
150128381|NCT03449030|541603053|FG001|Overall Study|Withdrawal by Subject|0|||
150128382|NCT03449030|541603054|FG002|Overall Study|Withdrawal by Subject|0|||
150128383|NCT03449030|541603055|FG003|Overall Study|Withdrawal by Subject|1|||
150128384|NCT03449030|541603056|FG004|Overall Study|Withdrawal by Subject|1|||
150128385|NCT03449030|541603057|FG005|Overall Study|Withdrawal by Subject|1|||
150128386|NCT03449030|541603058|FG006|Overall Study|Withdrawal by Subject|1|||
150128387|NCT03449030|541603059|FG007|Overall Study|Withdrawal by Subject|2|||
150128388|NCT03449030|541603060|FG008|Overall Study|Withdrawal by Subject|0|||
150128389|NCT03449030|541603061|FG009|Overall Study|Withdrawal by Subject|0|||
150128390|NCT03449030|541603052|FG000|Overall Study|Symptomatic Deterioration|0|||
150128391|NCT03449030|541603053|FG001|Overall Study|Symptomatic Deterioration|1|||
150128392|NCT03449030|541603054|FG002|Overall Study|Symptomatic Deterioration|0|||
150128393|NCT03449030|541603055|FG003|Overall Study|Symptomatic Deterioration|0|||
150128394|NCT03449030|541603056|FG004|Overall Study|Symptomatic Deterioration|0|||
150128395|NCT03449030|541603057|FG005|Overall Study|Symptomatic Deterioration|1|||
150128396|NCT03449030|541603058|FG006|Overall Study|Symptomatic Deterioration|1|||
150128397|NCT03449030|541603059|FG007|Overall Study|Symptomatic Deterioration|0|||
150128398|NCT03449030|541603060|FG008|Overall Study|Symptomatic Deterioration|2|||
150128399|NCT03449030|541603061|FG009|Overall Study|Symptomatic Deterioration|0|||
150128400|NCT03449030|541603052|FG000|Overall Study|Progressive Disease|1|||
150128401|NCT03449030|541603053|FG001|Overall Study|Progressive Disease|0|||
150128402|NCT03449030|541603054|FG002|Overall Study|Progressive Disease|1|||
150128403|NCT03449030|541603055|FG003|Overall Study|Progressive Disease|4|||
150128404|NCT03449030|541603056|FG004|Overall Study|Progressive Disease|5|||
150128405|NCT03449030|541603057|FG005|Overall Study|Progressive Disease|3|||
150128406|NCT03449030|541603058|FG006|Overall Study|Progressive Disease|0|||
150128407|NCT03449030|541603059|FG007|Overall Study|Progressive Disease|1|||
150128408|NCT03449030|541603060|FG008|Overall Study|Progressive Disease|1|||
150128409|NCT03449030|541603061|FG009|Overall Study|Progressive Disease|1|||
150128410|NCT03449030|541603052|FG000|Overall Study|Adverse Event|0|||
150128411|NCT03449030|541603053|FG001|Overall Study|Adverse Event|0|||
150128412|NCT03449030|541603054|FG002|Overall Study|Adverse Event|0|||
150128413|NCT03449030|541603055|FG003|Overall Study|Adverse Event|0|||
150128414|NCT03449030|541603056|FG004|Overall Study|Adverse Event|0|||
150128415|NCT03449030|541603057|FG005|Overall Study|Adverse Event|2|||
150128416|NCT03449030|541603058|FG006|Overall Study|Adverse Event|0|||
150128417|NCT03449030|541603059|FG007|Overall Study|Adverse Event|0|||
150128418|NCT03449030|541603060|FG008|Overall Study|Adverse Event|0|||
150128419|NCT03449030|541603061|FG009|Overall Study|Adverse Event|0|||
150128420|NCT03449030|541603052|FG000|Overall Study|Death|0|||
150128421|NCT03449030|541603053|FG001|Overall Study|Death|0|||
150128422|NCT03449030|541603054|FG002|Overall Study|Death|0|||
150128423|NCT03449030|541603055|FG003|Overall Study|Death|0|||
150128424|NCT03449030|541603056|FG004|Overall Study|Death|1|||
150128425|NCT03449030|541603057|FG005|Overall Study|Death|0|||
150128426|NCT03449030|541603058|FG006|Overall Study|Death|0|||
150128427|NCT03449030|541603059|FG007|Overall Study|Death|0|||
150128428|NCT03449030|541603060|FG008|Overall Study|Death|0|||
150128429|NCT03449030|541603061|FG009|Overall Study|Death|0|||
150128430|NCT03595904|541603065|FG000|Overall Study|Protocol Violation|3|||
150128431|NCT03595904|541603066|FG001|Overall Study|Protocol Violation|1|||
150128432|NCT03595904|541603065|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
150128433|NCT03595904|541603066|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
150128434|NCT03595904|541603065|FG000|Overall Study|Insurance complications|1|||
150128435|NCT03595904|541603066|FG001|Overall Study|Insurance complications|0|||
150128436|NCT03595904|541603065|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
150128437|NCT03595904|541603066|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
150128438|NCT01581281|541603067|FG000|Overall Study|Early Study Closure|15|||
150128439|NCT01581281|541603068|FG001|Overall Study|Early Study Closure|6|||
150128440|NCT01581281|541603069|FG002|Overall Study|Early Study Closure|12|||
150128441|NCT00700401|541603075|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
150128442|NCT00700401|541603075|FG000|Overall Study|Adverse Event|5|||
150128443|NCT00700401|541603075|FG000|Overall Study|Refused Treatment|2|||
150128444|NCT00700401|541603075|FG000|Overall Study|Lost to Follow-up|1|||
150128445|NCT00700401|541603075|FG000|Overall Study|Treatment never started|1|||
150128446|NCT00700401|541603075|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
150128447|NCT00700401|541603075|FG000|Overall Study|Withdrawal by Subject|2|||
150128448|NCT01650259|541603076|FG000|Overall Study|Improvement|105|||
150128449|NCT01650259|541603077|FG001|Overall Study|Improvement|0|||
150128450|NCT01650259|541603076|FG000|Overall Study|Adverse Event|127|||
150128451|NCT01650259|541603077|FG001|Overall Study|Adverse Event|0|||
150128452|NCT01650259|541603076|FG000|Overall Study|Lack of Efficacy|143|||
150128453|NCT01650259|541603077|FG001|Overall Study|Lack of Efficacy|0|||
150128454|NCT01650259|541603076|FG000|Overall Study|Lost to Follow-up|435|||
150128455|NCT01650259|541603077|FG001|Overall Study|Lost to Follow-up|0|||
150128456|NCT01650259|541603076|FG000|Overall Study|Patients had no visit after entry|70|||
150128457|NCT01650259|541603077|FG001|Overall Study|Patients had no visit after entry|0|||
150128458|NCT01650259|541603076|FG000|Overall Study|CRF not collected|98|||
150128459|NCT01650259|541603077|FG001|Overall Study|CRF not collected|82|||
150128460|NCT01650259|541603076|FG000|Overall Study|Not treated|1|||
150128461|NCT01650259|541603077|FG001|Overall Study|Not treated|7|||
150128462|NCT01650259|541603076|FG000|Overall Study|Other than listed|64|||
150128463|NCT01650259|541603077|FG001|Overall Study|Other than listed|146|||
150128464|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
150128465|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
150128466|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
150128467|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
150128468|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
150128469|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
150128470|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
150128471|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
150128472|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
150128473|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
150128474|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
150128475|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
150128476|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
150128477|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
150128478|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
150128479|NCT00355082|541603083|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
150128480|NCT00355082|541603084|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
150128481|NCT00355082|541603085|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
150128482|NCT00355082|541603083|FG000|Continuation Phase|Adverse Event|2|||
150128483|NCT00355082|541603084|FG001|Continuation Phase|Adverse Event|0|||
150128484|NCT00355082|541603085|FG002|Continuation Phase|Adverse Event|1|||
150128485|NCT00355082|541603083|FG000|Continuation Phase|Lost to Follow-up|2|||
150128486|NCT00355082|541603084|FG001|Continuation Phase|Lost to Follow-up|0|||
150128487|NCT00355082|541603085|FG002|Continuation Phase|Lost to Follow-up|1|||
150128488|NCT00355082|541603083|FG000|Continuation Phase|Protocol Violation|1|||
150128489|NCT00355082|541603084|FG001|Continuation Phase|Protocol Violation|0|||
150128490|NCT00355082|541603085|FG002|Continuation Phase|Protocol Violation|1|||
150128491|NCT00355082|541603083|FG000|Continuation Phase|Withdrawal by Subject|4|||
150128492|NCT00355082|541603084|FG001|Continuation Phase|Withdrawal by Subject|0|||
150128493|NCT00355082|541603085|FG002|Continuation Phase|Withdrawal by Subject|0|||
150128494|NCT00355082|541603083|FG000|Continuation Phase|Lack of Efficacy|5|||
150128495|NCT00355082|541603084|FG001|Continuation Phase|Lack of Efficacy|0|||
150128496|NCT00355082|541603085|FG002|Continuation Phase|Lack of Efficacy|0|||
150128497|NCT00355082|541603083|FG000|Continuation Phase|Site Closed by Sponsor|8|||
150128498|NCT00355082|541603084|FG001|Continuation Phase|Site Closed by Sponsor|0|||
150128499|NCT00355082|541603085|FG002|Continuation Phase|Site Closed by Sponsor|0|||
150128500|NCT00355082|541603083|FG000|Continuation Phase|Scheduling Error|1|||
150128501|NCT00355082|541603084|FG001|Continuation Phase|Scheduling Error|0|||
150128502|NCT00355082|541603085|FG002|Continuation Phase|Scheduling Error|0|||
150128503|NCT00355082|541603083|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
150128504|NCT00355082|541603084|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
150128505|NCT00355082|541603085|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
150128506|NCT02576067|541603086|FG000|Overall Study|Death|0|||
150128507|NCT02576067|541603087|FG001|Overall Study|Death|1|||
150128508|NCT02576067|541603086|FG000|Overall Study|Lack of Efficacy|1|||
150128509|NCT02576067|541603087|FG001|Overall Study|Lack of Efficacy|0|||
150128510|NCT02576067|541603086|FG000|Overall Study|Lost to Follow-up|11|||
150128511|NCT02576067|541603087|FG001|Overall Study|Lost to Follow-up|0|||
150128512|NCT02576067|541603086|FG000|Overall Study|Withdrawal by Subject|11|||
150128513|NCT02576067|541603087|FG001|Overall Study|Withdrawal by Subject|2|||
150128514|NCT02576067|541603086|FG000|Overall Study|study closure of main CIRT trial)|0|||
150128515|NCT02576067|541603087|FG001|Overall Study|study closure of main CIRT trial)|8|||
150128516|NCT02576067|541603086|FG000|Overall Study|not randomized, failed run-in|7|||
150128517|NCT02576067|541603087|FG001|Overall Study|not randomized, failed run-in|0|||
150128518|NCT02576067|541603086|FG000|Overall Study|screen failure/ re-enrolled|0|||
150128519|NCT02576067|541603087|FG001|Overall Study|screen failure/ re-enrolled|25|||
150128520|NCT02576067|541603086|FG000|Overall Study|Physician Decision|4|||
150128521|NCT02576067|541603087|FG001|Overall Study|Physician Decision|0|||
150128522|NCT03570619|541603090|FG000|Overall Study|Adverse Event|2|||
150128523|NCT03570619|541603091|FG001|Overall Study|Adverse Event|0|||
150128524|NCT03570619|541603092|FG002|Overall Study|Adverse Event|1|||
150128525|NCT03570619|541603090|FG000|Overall Study|new diagnosis of new malignancy|1|||
150128526|NCT03570619|541603091|FG001|Overall Study|new diagnosis of new malignancy|0|||
150128527|NCT03570619|541603092|FG002|Overall Study|new diagnosis of new malignancy|0|||
150128528|NCT03570619|541603090|FG000|Overall Study|Physician Decision|1|||
150128529|NCT03570619|541603091|FG001|Overall Study|Physician Decision|1|||
150128530|NCT03570619|541603092|FG002|Overall Study|Physician Decision|0|||
150128531|NCT03570619|541603090|FG000|Overall Study|Withdrawal by Subject|0|||
150128532|NCT03570619|541603091|FG001|Overall Study|Withdrawal by Subject|2|||
150128533|NCT03570619|541603092|FG002|Overall Study|Withdrawal by Subject|0|||
150128534|NCT01808313|541603095|FG000|Overall Study|Adverse Event|5|||
150128535|NCT01808313|541603095|FG000|Overall Study|Protocol Violation|2|||
150128536|NCT01808313|541603095|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
150128537|NCT01808313|541603095|FG000|Overall Study|Lost to Follow-up|1|||
150128538|NCT01808313|541603095|FG000|Overall Study|Physician Decision|1|||
150128539|NCT04656847|541603098|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
150128540|NCT03301051|541603099|FG000|Overall Study|Adverse Event|0|||
150128541|NCT03301051|541603100|FG001|Overall Study|Adverse Event|4|||
150128542|NCT03301051|541603099|FG000|Overall Study|Withdrawal by Subject|59|||
150128543|NCT03301051|541603100|FG001|Overall Study|Withdrawal by Subject|65|||
150128544|NCT03301051|541603099|FG000|Overall Study|Lost to Follow-up|263|||
150128545|NCT03301051|541603100|FG001|Overall Study|Lost to Follow-up|282|||
150128546|NCT03301051|541603099|FG000|Overall Study|Protocol Violation|1|||
150128547|NCT03301051|541603100|FG001|Overall Study|Protocol Violation|3|||
150128548|NCT03301051|541603099|FG000|Overall Study|Physician Decision|1|||
150128549|NCT03301051|541603100|FG001|Overall Study|Physician Decision|3|||
150128550|NCT03301051|541603099|FG000|Overall Study|Death|1|||
150128551|NCT03301051|541603100|FG001|Overall Study|Death|1|||
150128552|NCT03301051|541603099|FG000|Overall Study|Miscellaneous|8|||
150128553|NCT03301051|541603100|FG001|Overall Study|Miscellaneous|4|||
150128554|NCT03301051|541603099|FG000|Overall Study|Randomized, not vaccinated|13|||
150128555|NCT03301051|541603100|FG001|Overall Study|Randomized, not vaccinated|10|||
150128556|NCT01358526|541603106|FG000|Open-label Titration Period|Adverse Event|95|||
150128557|NCT01358526|541603107|FG001|Open-label Titration Period|Adverse Event|0|||
150128558|NCT01358526|541603108|FG002|Open-label Titration Period|Adverse Event|0|||
150128559|NCT01358526|541603106|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
150128560|NCT01358526|541603107|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
150128561|NCT01358526|541603108|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
150128562|NCT01358526|541603106|FG000|Open-label Titration Period|Lost to Follow-up|25|||
150128563|NCT01358526|541603107|FG001|Open-label Titration Period|Lost to Follow-up|0|||
150128564|NCT01358526|541603108|FG002|Open-label Titration Period|Lost to Follow-up|0|||
150128565|NCT01358526|541603106|FG000|Open-label Titration Period|Lack of Efficacy|107|||
150128566|NCT01358526|541603107|FG001|Open-label Titration Period|Lack of Efficacy|0|||
150128567|NCT01358526|541603108|FG002|Open-label Titration Period|Lack of Efficacy|0|||
150128568|NCT01358526|541603106|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
150128569|NCT01358526|541603107|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
150128570|NCT01358526|541603108|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
150128571|NCT01358526|541603106|FG000|Open-label Titration Period|Administrative|8|||
150128572|NCT01358526|541603107|FG001|Open-label Titration Period|Administrative|0|||
150128573|NCT01358526|541603108|FG002|Open-label Titration Period|Administrative|0|||
150128574|NCT01358526|541603106|FG000|Open-label Titration Period|Did not qualify|178|||
150128575|NCT01358526|541603107|FG001|Open-label Titration Period|Did not qualify|0|||
150128576|NCT01358526|541603108|FG002|Open-label Titration Period|Did not qualify|0|||
150128577|NCT01358526|541603106|FG000|Double-blind Phase|Adverse Event|0|||
150128578|NCT01358526|541603107|FG001|Double-blind Phase|Adverse Event|24|||
150128579|NCT01358526|541603108|FG002|Double-blind Phase|Adverse Event|23|||
150128580|NCT01358526|541603106|FG000|Double-blind Phase|Withdrawal by Subject|0|||
150128581|NCT01358526|541603107|FG001|Double-blind Phase|Withdrawal by Subject|10|||
150128582|NCT01358526|541603108|FG002|Double-blind Phase|Withdrawal by Subject|8|||
150128583|NCT01358526|541603106|FG000|Double-blind Phase|Lost to Follow-up|0|||
150128584|NCT01358526|541603107|FG001|Double-blind Phase|Lost to Follow-up|4|||
150128585|NCT01358526|541603108|FG002|Double-blind Phase|Lost to Follow-up|1|||
150128586|NCT01358526|541603106|FG000|Double-blind Phase|Lack of Efficacy|0|||
150128587|NCT01358526|541603107|FG001|Double-blind Phase|Lack of Efficacy|31|||
150128588|NCT01358526|541603108|FG002|Double-blind Phase|Lack of Efficacy|73|||
150128589|NCT01358526|541603106|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
150128590|NCT01358526|541603107|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
150128591|NCT01358526|541603108|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
150128592|NCT01358526|541603106|FG000|Double-blind Phase|Administrative|0|||
150128593|NCT01358526|541603107|FG001|Double-blind Phase|Administrative|6|||
150128594|NCT01358526|541603108|FG002|Double-blind Phase|Administrative|10|||
150128595|NCT00724971|541603111|FG000|Overall Study|Adverse Event|5|||
150128596|NCT00724971|541603111|FG000|Overall Study|Withdrawal by Subject|1|||
150128597|NCT01003249|541603112|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
150128598|NCT01003249|541603113|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
150128599|NCT01003249|541603112|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
150128600|NCT01003249|541603113|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
150128601|NCT01003249|541603112|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
150128602|NCT01003249|541603113|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
150128603|NCT01003249|541603112|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
150128604|NCT01003249|541603113|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
150128605|NCT01962974|541603114|FG000|Overall Study|Study termination|7|||
150128606|NCT02132611|541603119|FG000|Overall Study|Death|2|||
150128607|NCT02298192|541603120|FG000|Overall Study|Unclassified|3|||
150128608|NCT02298192|541603121|FG001|Overall Study|Unclassified|2|||
150128609|NCT02298192|541603120|FG000|Overall Study|Withdrawal criteria|2|||
150128610|NCT02298192|541603121|FG001|Overall Study|Withdrawal criteria|0|||
150128611|NCT02298192|541603120|FG000|Overall Study|Withdrawal by Subject|6|||
150128612|NCT02298192|541603121|FG001|Overall Study|Withdrawal by Subject|1|||
150128613|NCT02298192|541603120|FG000|Overall Study|Lost to Follow-up|2|||
150128614|NCT02298192|541603121|FG001|Overall Study|Lost to Follow-up|1|||
150128615|NCT02298192|541603120|FG000|Overall Study|Adverse Event|6|||
150128616|NCT02298192|541603121|FG001|Overall Study|Adverse Event|2|||
150128617|NCT06167031|541603125|FG000|Overall Study|Lost to Follow-up|5|||
150128618|NCT06167031|541603126|FG001|Overall Study|Lost to Follow-up|1|||
150128619|NCT02979639|541605638|FG000|Overall Study|Withdrawal based on medical judgement|1|||
150128620|NCT02979639|541605638|FG000|Overall Study|Lost to Follow-up|8|||
150128621|NCT02979639|541605638|FG000|Overall Study|Withdrawal by Subject|3|||
150128622|NCT02979639|541605638|FG000|Overall Study|Adverse Event|2|||
150128623|NCT01877408|541605642|FG000|Overall Study|Lost to Follow-up|0|||
150128624|NCT01877408|541605643|FG001|Overall Study|Lost to Follow-up|2|||
150128625|NCT02621931|541605646|FG000|Overall Study|Death|0|||
150128626|NCT02621931|541605647|FG001|Overall Study|Death|1|||
150128627|NCT02621931|541605648|FG002|Overall Study|Death|0|||
150128628|NCT02621931|541605646|FG000|Overall Study|Adverse Event|8|||
150128629|NCT02621931|541605647|FG001|Overall Study|Adverse Event|5|||
150128630|NCT02621931|541605648|FG002|Overall Study|Adverse Event|7|||
150128631|NCT02621931|541605646|FG000|Overall Study|Withdrawal by Subject|12|||
150128632|NCT02621931|541605647|FG001|Overall Study|Withdrawal by Subject|10|||
150128633|NCT02621931|541605648|FG002|Overall Study|Withdrawal by Subject|11|||
150128634|NCT02621931|541605646|FG000|Overall Study|Protocol Violation|2|||
150128635|NCT02621931|541605647|FG001|Overall Study|Protocol Violation|2|||
150128636|NCT02621931|541605648|FG002|Overall Study|Protocol Violation|2|||
150128637|NCT02621931|541605646|FG000|Overall Study|Pregnancy|2|||
150128638|NCT02621931|541605647|FG001|Overall Study|Pregnancy|0|||
150128639|NCT02621931|541605648|FG002|Overall Study|Pregnancy|0|||
150128640|NCT02621931|541605646|FG000|Overall Study|Noncompliance to study procedures|0|||
150128641|NCT02621931|541605647|FG001|Overall Study|Noncompliance to study procedures|1|||
150128642|NCT02621931|541605648|FG002|Overall Study|Noncompliance to study procedures|2|||
150128643|NCT02621931|541605646|FG000|Overall Study|Lost to Follow-up|8|||
150128644|NCT02621931|541605647|FG001|Overall Study|Lost to Follow-up|7|||
150128645|NCT02621931|541605648|FG002|Overall Study|Lost to Follow-up|10|||
150128646|NCT02621931|541605646|FG000|Overall Study|Lack of Efficacy|0|||
150128647|NCT02621931|541605647|FG001|Overall Study|Lack of Efficacy|0|||
150128648|NCT02621931|541605648|FG002|Overall Study|Lack of Efficacy|1|||
150128649|NCT02621931|541605646|FG000|Overall Study|Other|1|||
150128650|NCT02621931|541605647|FG001|Overall Study|Other|1|||
150128651|NCT02621931|541605648|FG002|Overall Study|Other|3|||
150128652|NCT00920426|541605649|FG000|ITZ111451|Adverse Event|1|||
150128653|NCT00920426|541605650|FG001|ITZ111451|Adverse Event|0|||
150128654|NCT00920426|541605651|FG002|ITZ111451|Adverse Event|0|||
150128655|NCT00920426|541605652|FG003|ITZ111451|Adverse Event|0|||
150128656|NCT01292603|541605653|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
150128657|NCT01292603|541605654|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
150128658|NCT01292603|541605655|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
150128659|NCT01292603|541605656|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
150128660|NCT01292603|541605657|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
150128661|NCT01292603|541605658|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
150128662|NCT01292603|541605653|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
150128663|NCT01292603|541605654|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
150128664|NCT01292603|541605655|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
150128665|NCT01292603|541605656|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
150128666|NCT01292603|541605657|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
150128667|NCT01292603|541605658|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
150128668|NCT01292603|541605653|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
150128669|NCT01292603|541605654|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
150128670|NCT01292603|541605655|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
150128671|NCT01292603|541605656|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
150128672|NCT01292603|541605657|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
150128673|NCT01292603|541605658|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
150128674|NCT01292603|541605653|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
150128675|NCT01292603|541605654|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
150128676|NCT01292603|541605655|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
150128677|NCT01292603|541605656|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
150128678|NCT01292603|541605657|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
150128679|NCT01292603|541605658|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
150128680|NCT01292603|541605653|FG000|Part 1: Regular Follow-Up Period|Death|3|||
150128681|NCT01292603|541605654|FG001|Part 1: Regular Follow-Up Period|Death|1|||
150128682|NCT01292603|541605655|FG002|Part 1: Regular Follow-Up Period|Death|3|||
150128683|NCT01292603|541605656|FG003|Part 1: Regular Follow-Up Period|Death|1|||
150128684|NCT01292603|541605657|FG004|Part 1: Regular Follow-Up Period|Death|0|||
150128685|NCT01292603|541605658|FG005|Part 1: Regular Follow-Up Period|Death|0|||
150128686|NCT01292603|541605653|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
150128687|NCT01292603|541605654|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
150128688|NCT01292603|541605655|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
150128689|NCT01292603|541605656|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
150128690|NCT01292603|541605657|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
150128691|NCT01292603|541605658|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
150128692|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Death|0|||
150128693|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Death|0|||
150128694|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Death|0|||
150128695|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Death|0|||
150128696|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Death|1|||
150128697|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Death|0|||
150128698|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
150128699|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
150128700|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
150128701|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
150128702|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
150128703|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
150128704|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
150128705|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
150128706|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
150128707|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
150128708|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
150128709|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
150128710|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
150128711|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
150128712|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
150128713|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
150128714|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
150128715|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
150128716|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
150128717|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
150128718|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
150128719|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
150128720|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
150128721|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
150128722|NCT01292603|541605653|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
150128723|NCT01292603|541605654|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
150128724|NCT01292603|541605655|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
150128725|NCT01292603|541605656|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
150128726|NCT01292603|541605657|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
150128727|NCT01292603|541605658|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
150128728|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Death|0|||
150128729|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Death|0|||
150128730|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Death|0|||
150128731|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Death|0|||
150128732|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Death|6|||
150128733|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Death|3|||
150128734|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
150128735|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
150128736|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
150128737|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
150128738|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
150128739|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
150128740|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
150128741|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
150128742|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
150128743|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
150128744|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
150128745|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
150128746|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
150128747|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
150128748|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
150128749|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
150128750|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
150128751|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
150128752|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
150128753|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
150128754|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
150128755|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
150128756|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
150128757|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
150128758|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
150128759|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
150128760|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
150128761|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
150128762|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
150128763|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
150128764|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
150128765|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
150128766|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
150128767|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
150128768|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
150128769|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
150128770|NCT01292603|541605653|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
150128771|NCT01292603|541605654|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
150128772|NCT01292603|541605655|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
150128773|NCT01292603|541605656|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
150128774|NCT01292603|541605657|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
150128775|NCT01292603|541605658|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
150128776|NCT01292603|541605653|FG000|Overall Survival Status|Death|3|||
150128777|NCT01292603|541605654|FG001|Overall Survival Status|Death|1|||
150128778|NCT01292603|541605655|FG002|Overall Survival Status|Death|3|||
150128779|NCT01292603|541605656|FG003|Overall Survival Status|Death|1|||
150128780|NCT01292603|541605657|FG004|Overall Survival Status|Death|16|||
150128781|NCT01292603|541605658|FG005|Overall Survival Status|Death|10|||
150128782|NCT03870763|541605661|FG000|Overall Study|Study terminated by sponsor|0|||
150128783|NCT03870763|541605662|FG001|Overall Study|Study terminated by sponsor|2|||
150128784|NCT03870763|541605663|FG002|Overall Study|Study terminated by sponsor|0|||
150128785|NCT03870763|541605661|FG000|Overall Study|Withdrawal by Subject|0|||
150128786|NCT03870763|541605662|FG001|Overall Study|Withdrawal by Subject|1|||
150128787|NCT03870763|541605663|FG002|Overall Study|Withdrawal by Subject|0|||
150128788|NCT03870763|541605661|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
150128789|NCT03870763|541605662|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
150128790|NCT03870763|541605663|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
150128791|NCT03031938|541605671|FG000|Overall Study|Death|1|||
150128792|NCT03031938|541605672|FG001|Overall Study|Death|0|||
150128793|NCT02479412|541605673|FG000|Overall Study|Adverse Event|0|||
150128794|NCT02479412|541605674|FG001|Overall Study|Adverse Event|0|||
150128795|NCT02479412|541605675|FG002|Overall Study|Adverse Event|1|||
150128796|NCT02479412|541605676|FG003|Overall Study|Adverse Event|0|||
150128797|NCT02479412|541605677|FG004|Overall Study|Adverse Event|0|||
150128798|NCT02479412|541605678|FG005|Overall Study|Adverse Event|0|||
150128799|NCT02479412|541605679|FG006|Overall Study|Adverse Event|0|||
150128800|NCT02479412|541605680|FG007|Overall Study|Adverse Event|0|||
150128801|NCT02479412|541605681|FG008|Overall Study|Adverse Event|0|||
150128802|NCT02479412|541605673|FG000|Overall Study|Study-specific withdrawal criteria|0|||
150128803|NCT02479412|541605674|FG001|Overall Study|Study-specific withdrawal criteria|0|||
150128804|NCT02479412|541605675|FG002|Overall Study|Study-specific withdrawal criteria|1|||
150128805|NCT02479412|541605676|FG003|Overall Study|Study-specific withdrawal criteria|1|||
150128806|NCT02479412|541605677|FG004|Overall Study|Study-specific withdrawal criteria|0|||
150128807|NCT02479412|541605678|FG005|Overall Study|Study-specific withdrawal criteria|0|||
150128808|NCT02479412|541605679|FG006|Overall Study|Study-specific withdrawal criteria|0|||
150128809|NCT02479412|541605680|FG007|Overall Study|Study-specific withdrawal criteria|1|||
150128810|NCT02479412|541605681|FG008|Overall Study|Study-specific withdrawal criteria|1|||
150128811|NCT02479412|541605673|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
150128812|NCT02479412|541605674|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
150128813|NCT02479412|541605675|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
150128814|NCT02479412|541605676|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
150128815|NCT02479412|541605677|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
150128816|NCT02479412|541605678|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
150128817|NCT02479412|541605679|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
150128818|NCT02479412|541605680|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
150128819|NCT02479412|541605681|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
150128820|NCT02732938|541605683|FG000|Overall Study|Death|0|||
150128821|NCT02732938|541605684|FG001|Overall Study|Death|11|||
150128822|NCT02732938|541605685|FG002|Overall Study|Death|0|||
150128823|NCT02732938|541605683|FG000|Overall Study|Randomized but did not receive treatment|0|||
150128824|NCT02732938|541605684|FG001|Overall Study|Randomized but did not receive treatment|1|||
150128825|NCT02732938|541605685|FG002|Overall Study|Randomized but did not receive treatment|0|||
150128826|NCT02732938|541605683|FG000|Overall Study|Refused further follow-up|1|||
150128827|NCT02732938|541605684|FG001|Overall Study|Refused further follow-up|0|||
150128828|NCT02732938|541605685|FG002|Overall Study|Refused further follow-up|0|||
150128829|NCT02732938|541605683|FG000|Overall Study|Study terminated by sponsor|3|||
150128830|NCT02732938|541605684|FG001|Overall Study|Study terminated by sponsor|6|||
150128831|NCT02732938|541605685|FG002|Overall Study|Study terminated by sponsor|0|||
150128832|NCT01613248|541605686|FG000|Overall Study|Adverse Event|0|||
150128833|NCT01613248|541605687|FG001|Overall Study|Adverse Event|0|||
150128834|NCT01613248|541605688|FG002|Overall Study|Adverse Event|0|||
150128835|NCT01613248|541605689|FG003|Overall Study|Adverse Event|1|||
150128836|NCT01613248|541605690|FG004|Overall Study|Adverse Event|0|||
150128837|NCT01613248|541605691|FG005|Overall Study|Adverse Event|0|||
150128838|NCT01613248|541605686|FG000|Overall Study|Withdrawal by Subject|3|||
150128839|NCT01613248|541605687|FG001|Overall Study|Withdrawal by Subject|2|||
150128840|NCT01613248|541605688|FG002|Overall Study|Withdrawal by Subject|2|||
150128841|NCT01613248|541605689|FG003|Overall Study|Withdrawal by Subject|5|||
150128842|NCT01613248|541605690|FG004|Overall Study|Withdrawal by Subject|0|||
150128843|NCT01613248|541605691|FG005|Overall Study|Withdrawal by Subject|1|||
150128844|NCT01613248|541605686|FG000|Overall Study|Lost to Follow-up|5|||
150128845|NCT01613248|541605687|FG001|Overall Study|Lost to Follow-up|7|||
150128846|NCT01613248|541605688|FG002|Overall Study|Lost to Follow-up|4|||
150128847|NCT01613248|541605689|FG003|Overall Study|Lost to Follow-up|8|||
150128848|NCT01613248|541605690|FG004|Overall Study|Lost to Follow-up|4|||
150128849|NCT01613248|541605691|FG005|Overall Study|Lost to Follow-up|2|||
150128850|NCT01613248|541605686|FG000|Overall Study|Study Terminated by Sponsor|4|||
150128851|NCT01613248|541605687|FG001|Overall Study|Study Terminated by Sponsor|6|||
150128852|NCT01613248|541605688|FG002|Overall Study|Study Terminated by Sponsor|8|||
150128853|NCT01613248|541605689|FG003|Overall Study|Study Terminated by Sponsor|8|||
150128854|NCT01613248|541605690|FG004|Overall Study|Study Terminated by Sponsor|9|||
150128855|NCT01613248|541605691|FG005|Overall Study|Study Terminated by Sponsor|11|||
150128856|NCT01613248|541605686|FG000|Overall Study|Physician Decision|8|||
150128857|NCT01613248|541605687|FG001|Overall Study|Physician Decision|8|||
150128858|NCT01613248|541605688|FG002|Overall Study|Physician Decision|9|||
150128859|NCT01613248|541605689|FG003|Overall Study|Physician Decision|4|||
150128860|NCT01613248|541605690|FG004|Overall Study|Physician Decision|7|||
150128861|NCT01613248|541605691|FG005|Overall Study|Physician Decision|6|||
150128862|NCT01613248|541605686|FG000|Overall Study|Lack of Qualifying Event|9|||
150128863|NCT01613248|541605687|FG001|Overall Study|Lack of Qualifying Event|11|||
150128864|NCT01613248|541605688|FG002|Overall Study|Lack of Qualifying Event|10|||
150128865|NCT01613248|541605689|FG003|Overall Study|Lack of Qualifying Event|11|||
150128866|NCT01613248|541605690|FG004|Overall Study|Lack of Qualifying Event|15|||
150128867|NCT01613248|541605691|FG005|Overall Study|Lack of Qualifying Event|18|||
150128868|NCT01613248|541605686|FG000|Overall Study|Pregnancy|0|||
150128869|NCT01613248|541605687|FG001|Overall Study|Pregnancy|0|||
150128870|NCT01613248|541605688|FG002|Overall Study|Pregnancy|0|||
150128871|NCT01613248|541605689|FG003|Overall Study|Pregnancy|1|||
150128872|NCT01613248|541605690|FG004|Overall Study|Pregnancy|0|||
150128873|NCT01613248|541605691|FG005|Overall Study|Pregnancy|0|||
150128874|NCT06116591|541605701|FG000|Overall Study|No longer met eligibility criteria|0|||
150128875|NCT06116591|541605702|FG001|Overall Study|No longer met eligibility criteria|1|||
150128876|NCT06116591|541605701|FG000|Overall Study|Other: Change in life situation|0|||
150128877|NCT06116591|541605702|FG001|Overall Study|Other: Change in life situation|1|||
150128878|NCT05585307|541605703|FG000|Overall Study|Lost to Follow-up|0|||
150128879|NCT05585307|541605704|FG001|Overall Study|Lost to Follow-up|0|||
150128880|NCT05585307|541605705|FG002|Overall Study|Lost to Follow-up|0|||
150128881|NCT05585307|541605706|FG003|Overall Study|Lost to Follow-up|0|||
150128882|NCT05585307|541605707|FG004|Overall Study|Lost to Follow-up|0|||
150128883|NCT05585307|541605708|FG005|Overall Study|Lost to Follow-up|0|||
150128884|NCT05585307|541605709|FG006|Overall Study|Lost to Follow-up|1|||
150128885|NCT05585307|541605710|FG007|Overall Study|Lost to Follow-up|0|||
150128886|NCT02647359|541605711|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
150128887|NCT02647359|541605712|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
150128888|NCT02647359|541605711|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
150128889|NCT02647359|541605712|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
150128890|NCT02647359|541605711|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
150128891|NCT02647359|541605712|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
150128892|NCT02647359|541605711|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
150128893|NCT02647359|541605712|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
150128894|NCT02647359|541605711|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
150128895|NCT02647359|541605712|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
150128896|NCT02647359|541605711|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
150128897|NCT02647359|541605712|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
150128898|NCT04642638|541605713|FG000|Overall Study|Withdrawal by Subject|23|||
150128899|NCT04642638|541605714|FG001|Overall Study|Withdrawal by Subject|29|||
150128900|NCT04642638|541605715|FG002|Overall Study|Withdrawal by Subject|9|||
150128901|NCT04642638|541605716|FG003|Overall Study|Withdrawal by Subject|7|||
150128902|NCT04642638|541605717|FG004|Overall Study|Withdrawal by Subject|61|||
150128903|NCT04642638|541605718|FG005|Overall Study|Withdrawal by Subject|27|||
150128904|NCT04642638|541605713|FG000|Overall Study|Lost to Follow-up|17|||
150128905|NCT04642638|541605714|FG001|Overall Study|Lost to Follow-up|18|||
150128906|NCT04642638|541605715|FG002|Overall Study|Lost to Follow-up|5|||
150128907|NCT04642638|541605716|FG003|Overall Study|Lost to Follow-up|5|||
150128908|NCT04642638|541605717|FG004|Overall Study|Lost to Follow-up|6|||
150128909|NCT04642638|541605718|FG005|Overall Study|Lost to Follow-up|3|||
150128910|NCT04642638|541605713|FG000|Overall Study|Adverse Event|0|||
150128911|NCT04642638|541605714|FG001|Overall Study|Adverse Event|0|||
150128912|NCT04642638|541605715|FG002|Overall Study|Adverse Event|1|||
150128913|NCT04642638|541605716|FG003|Overall Study|Adverse Event|0|||
150128914|NCT04642638|541605717|FG004|Overall Study|Adverse Event|10|||
150128915|NCT04642638|541605718|FG005|Overall Study|Adverse Event|3|||
150128916|NCT04642638|541605713|FG000|Overall Study|Reason Not Specified|1|||
150128917|NCT04642638|541605714|FG001|Overall Study|Reason Not Specified|4|||
150128918|NCT04642638|541605715|FG002|Overall Study|Reason Not Specified|0|||
150128919|NCT04642638|541605716|FG003|Overall Study|Reason Not Specified|0|||
150128920|NCT04642638|541605717|FG004|Overall Study|Reason Not Specified|38|||
150128921|NCT04642638|541605718|FG005|Overall Study|Reason Not Specified|16|||
150128922|NCT04642638|541605713|FG000|Overall Study|Physician Decision|0|||
150128923|NCT04642638|541605714|FG001|Overall Study|Physician Decision|0|||
150128924|NCT04642638|541605715|FG002|Overall Study|Physician Decision|0|||
150128925|NCT04642638|541605716|FG003|Overall Study|Physician Decision|0|||
150128926|NCT04642638|541605717|FG004|Overall Study|Physician Decision|2|||
150128927|NCT04642638|541605718|FG005|Overall Study|Physician Decision|1|||
150128928|NCT04642638|541605713|FG000|Overall Study|Protocol Deviation|0|||
150128929|NCT04642638|541605714|FG001|Overall Study|Protocol Deviation|0|||
150128930|NCT04642638|541605715|FG002|Overall Study|Protocol Deviation|0|||
150128931|NCT04642638|541605716|FG003|Overall Study|Protocol Deviation|0|||
150128932|NCT04642638|541605717|FG004|Overall Study|Protocol Deviation|1|||
150128933|NCT04642638|541605718|FG005|Overall Study|Protocol Deviation|3|||
150128934|NCT04642638|541605713|FG000|Overall Study|Study Terminated|0|||
150128935|NCT04642638|541605714|FG001|Overall Study|Study Terminated|0|||
150128936|NCT04642638|541605715|FG002|Overall Study|Study Terminated|0|||
150128937|NCT04642638|541605716|FG003|Overall Study|Study Terminated|0|||
150128938|NCT04642638|541605717|FG004|Overall Study|Study Terminated|484|||
150128939|NCT04642638|541605718|FG005|Overall Study|Study Terminated|250|||
150128940|NCT04642638|541605713|FG000|Overall Study|Pregnancy|0|||
150128941|NCT04642638|541605714|FG001|Overall Study|Pregnancy|0|||
150128942|NCT04642638|541605715|FG002|Overall Study|Pregnancy|0|||
150128943|NCT04642638|541605716|FG003|Overall Study|Pregnancy|0|||
150128944|NCT04642638|541605717|FG004|Overall Study|Pregnancy|1|||
150128945|NCT04642638|541605718|FG005|Overall Study|Pregnancy|0|||
150128946|NCT00319098|541605719|FG000|Overall Study|Serious adverse event|3|||
150128947|NCT00319098|541605720|FG001|Overall Study|Serious adverse event|0|||
150128948|NCT00319098|541605719|FG000|Overall Study|Adverse Event|20|||
150128949|NCT00319098|541605720|FG001|Overall Study|Adverse Event|1|||
150128950|NCT00319098|541605719|FG000|Overall Study|Withdrawal by Subject|37|||
150128951|NCT00319098|541605720|FG001|Overall Study|Withdrawal by Subject|8|||
150128952|NCT00319098|541605719|FG000|Overall Study|Migrated/moved from study area|2|||
150128953|NCT00319098|541605720|FG001|Overall Study|Migrated/moved from study area|1|||
150128954|NCT00319098|541605719|FG000|Overall Study|Lost to Follow-up|37|||
150128955|NCT00319098|541605720|FG001|Overall Study|Lost to Follow-up|13|||
150128956|NCT00319098|541605719|FG000|Overall Study|Others|33|||
150128957|NCT00319098|541605720|FG001|Overall Study|Others|8|||
150128958|NCT00319098|541605719|FG000|Overall Study|Protocol Violation|3|||
150128959|NCT00319098|541605720|FG001|Overall Study|Protocol Violation|1|||
150128960|NCT00965523|541605721|FG000|Study 221|Progressive Disease|4|||
150128961|NCT00965523|541605721|FG000|Study 221|Physician Decision|3|||
150128962|NCT00965523|541605721|FG000|Study 224|Progressive Disease|5|||
150128963|NCT00965523|541605721|FG000|Study 224|Physician Decision|1|||
150128964|NCT02415400|541605722|FG000|Overall Study|Adverse Event|0|||
150128965|NCT02415400|541605723|FG001|Overall Study|Adverse Event|1|||
150128966|NCT02415400|541605724|FG002|Overall Study|Adverse Event|1|||
150128967|NCT02415400|541605725|FG003|Overall Study|Adverse Event|2|||
150128968|NCT02415400|541605722|FG000|Overall Study|Participant request to stop therapy|4|||
150128969|NCT02415400|541605723|FG001|Overall Study|Participant request to stop therapy|3|||
150128970|NCT02415400|541605724|FG002|Overall Study|Participant request to stop therapy|8|||
150128971|NCT02415400|541605725|FG003|Overall Study|Participant request to stop therapy|6|||
150128972|NCT02415400|541605722|FG000|Overall Study|Participant withdrew consent|14|||
150128973|NCT02415400|541605723|FG001|Overall Study|Participant withdrew consent|12|||
150128974|NCT02415400|541605724|FG002|Overall Study|Participant withdrew consent|30|||
150128975|NCT02415400|541605725|FG003|Overall Study|Participant withdrew consent|21|||
150128976|NCT02415400|541605722|FG000|Overall Study|Death|39|||
150128977|NCT02415400|541605723|FG001|Overall Study|Death|41|||
150128978|NCT02415400|541605724|FG002|Overall Study|Death|35|||
150128979|NCT02415400|541605725|FG003|Overall Study|Death|42|||
150128980|NCT02415400|541605722|FG000|Overall Study|Lost to Follow-up|3|||
150128981|NCT02415400|541605723|FG001|Overall Study|Lost to Follow-up|3|||
150128982|NCT02415400|541605724|FG002|Overall Study|Lost to Follow-up|2|||
150128983|NCT02415400|541605725|FG003|Overall Study|Lost to Follow-up|5|||
150128984|NCT02415400|541605722|FG000|Overall Study|Poor/Non-Compliance|0|||
150128985|NCT02415400|541605723|FG001|Overall Study|Poor/Non-Compliance|1|||
150128986|NCT02415400|541605724|FG002|Overall Study|Poor/Non-Compliance|3|||
150128987|NCT02415400|541605725|FG003|Overall Study|Poor/Non-Compliance|4|||
150128988|NCT02415400|541605722|FG000|Overall Study|Participant no longer meets criteria|2|||
150128989|NCT02415400|541605723|FG001|Overall Study|Participant no longer meets criteria|0|||
150128990|NCT02415400|541605724|FG002|Overall Study|Participant no longer meets criteria|0|||
150128991|NCT02415400|541605725|FG003|Overall Study|Participant no longer meets criteria|1|||
150128992|NCT02415400|541605722|FG000|Overall Study|Participant doesn't answer phone|1|||
150128993|NCT02415400|541605723|FG001|Overall Study|Participant doesn't answer phone|0|||
150128994|NCT02415400|541605724|FG002|Overall Study|Participant doesn't answer phone|0|||
150128995|NCT02415400|541605725|FG003|Overall Study|Participant doesn't answer phone|0|||
150128996|NCT02415400|541605722|FG000|Overall Study|Participant wanted home visits|1|||
150128997|NCT02415400|541605723|FG001|Overall Study|Participant wanted home visits|0|||
150128998|NCT02415400|541605724|FG002|Overall Study|Participant wanted home visits|0|||
150128999|NCT02415400|541605725|FG003|Overall Study|Participant wanted home visits|0|||
150129000|NCT02415400|541605722|FG000|Overall Study|Randomized in error|2|||
150129001|NCT02415400|541605723|FG001|Overall Study|Randomized in error|0|||
150129002|NCT02415400|541605724|FG002|Overall Study|Randomized in error|0|||
150129003|NCT02415400|541605725|FG003|Overall Study|Randomized in error|0|||
150129004|NCT02415400|541605722|FG000|Overall Study|No study drug on site|0|||
150129005|NCT02415400|541605723|FG001|Overall Study|No study drug on site|1|||
150129006|NCT02415400|541605724|FG002|Overall Study|No study drug on site|0|||
150129007|NCT02415400|541605725|FG003|Overall Study|No study drug on site|0|||
150129008|NCT02415400|541605722|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
150129009|NCT02415400|541605723|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
150129010|NCT02415400|541605724|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
150129011|NCT02415400|541605725|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
150129012|NCT02415400|541605722|FG000|Overall Study|Coagulation values cannot be set|0|||
150129013|NCT02415400|541605723|FG001|Overall Study|Coagulation values cannot be set|0|||
150129014|NCT02415400|541605724|FG002|Overall Study|Coagulation values cannot be set|1|||
150129015|NCT02415400|541605725|FG003|Overall Study|Coagulation values cannot be set|0|||
150129016|NCT02415400|541605722|FG000|Overall Study|State regulations prevent participation|0|||
150129017|NCT02415400|541605723|FG001|Overall Study|State regulations prevent participation|0|||
150129018|NCT02415400|541605724|FG002|Overall Study|State regulations prevent participation|1|||
150129019|NCT02415400|541605725|FG003|Overall Study|State regulations prevent participation|0|||
150129020|NCT02415400|541605722|FG000|Overall Study|Poor treatment monitoring|0|||
150129021|NCT02415400|541605723|FG001|Overall Study|Poor treatment monitoring|0|||
150129022|NCT02415400|541605724|FG002|Overall Study|Poor treatment monitoring|1|||
150129023|NCT02415400|541605725|FG003|Overall Study|Poor treatment monitoring|0|||
150129024|NCT02415400|541605722|FG000|Overall Study|Participant in jail|0|||
150129025|NCT02415400|541605723|FG001|Overall Study|Participant in jail|0|||
150129026|NCT02415400|541605724|FG002|Overall Study|Participant in jail|1|||
150129027|NCT02415400|541605725|FG003|Overall Study|Participant in jail|0|||
150129028|NCT02415400|541605722|FG000|Overall Study|Investigator decision|0|||
150129029|NCT02415400|541605723|FG001|Overall Study|Investigator decision|0|||
150129030|NCT02415400|541605724|FG002|Overall Study|Investigator decision|1|||
150129031|NCT02415400|541605725|FG003|Overall Study|Investigator decision|1|||
150129032|NCT02415400|541605722|FG000|Overall Study|Site closure; participant won't transfer|0|||
150129033|NCT02415400|541605723|FG001|Overall Study|Site closure; participant won't transfer|0|||
150129034|NCT02415400|541605724|FG002|Overall Study|Site closure; participant won't transfer|0|||
150129035|NCT02415400|541605725|FG003|Overall Study|Site closure; participant won't transfer|1|||
150129036|NCT02270450|541605726|FG000|Overall Study|Refusal unrelated to adverse event|3|||
150129037|NCT02270450|541605727|FG001|Overall Study|Refusal unrelated to adverse event|1|||
150129038|NCT02270450|541605728|FG002|Overall Study|Refusal unrelated to adverse event|5|||
150129039|NCT02270450|541605729|FG003|Overall Study|Refusal unrelated to adverse event|14|||
150129040|NCT02270450|541605726|FG000|Overall Study|Progression/relapse|1|||
150129041|NCT02270450|541605727|FG001|Overall Study|Progression/relapse|2|||
150129042|NCT02270450|541605728|FG002|Overall Study|Progression/relapse|4|||
150129043|NCT02270450|541605729|FG003|Overall Study|Progression/relapse|9|||
150129044|NCT02270450|541605726|FG000|Overall Study|Death|19|||
150129045|NCT02270450|541605727|FG001|Overall Study|Death|19|||
150129046|NCT02270450|541605728|FG002|Overall Study|Death|31|||
150129047|NCT02270450|541605729|FG003|Overall Study|Death|59|||
150129048|NCT02363738|541605730|FG000|Overall Study|Adverse Event|5|||
150129049|NCT02363738|541605731|FG001|Overall Study|Adverse Event|2|||
150129050|NCT02363738|541605730|FG000|Overall Study|Lack of Efficacy|1|||
150129051|NCT02363738|541605731|FG001|Overall Study|Lack of Efficacy|2|||
150129052|NCT02363738|541605730|FG000|Overall Study|Lost to Follow-up|2|||
150129053|NCT02363738|541605731|FG001|Overall Study|Lost to Follow-up|1|||
150129054|NCT02187991|541605735|FG000|Overall Study|Adverse Event|13|||
150129055|NCT02187991|541605736|FG001|Overall Study|Adverse Event|14|||
150129056|NCT02187991|541605737|FG002|Overall Study|Adverse Event|3|||
150129057|NCT02187991|541605738|FG003|Overall Study|Adverse Event|2|||
150129058|NCT02187991|541605735|FG000|Overall Study|Withdrawal by Subject|9|||
150129059|NCT02187991|541605736|FG001|Overall Study|Withdrawal by Subject|6|||
150129060|NCT02187991|541605737|FG002|Overall Study|Withdrawal by Subject|3|||
150129061|NCT02187991|541605738|FG003|Overall Study|Withdrawal by Subject|2|||
150129062|NCT02187991|541605735|FG000|Overall Study|Physician Decision|4|||
150129063|NCT02187991|541605736|FG001|Overall Study|Physician Decision|4|||
150129064|NCT02187991|541605737|FG002|Overall Study|Physician Decision|0|||
150129065|NCT02187991|541605738|FG003|Overall Study|Physician Decision|2|||
150129066|NCT02187991|541605735|FG000|Overall Study|Other, unrelated complication|7|||
150129067|NCT02187991|541605736|FG001|Overall Study|Other, unrelated complication|1|||
150129068|NCT02187991|541605737|FG002|Overall Study|Other, unrelated complication|1|||
150129069|NCT02187991|541605738|FG003|Overall Study|Other, unrelated complication|2|||
150129070|NCT02187991|541605735|FG000|Overall Study|Death|1|||
150129071|NCT02187991|541605736|FG001|Overall Study|Death|3|||
150129072|NCT02187991|541605737|FG002|Overall Study|Death|0|||
150129073|NCT02187991|541605738|FG003|Overall Study|Death|0|||
150129074|NCT01392560|541605739|FG000|Overall Study|Adverse Event|2|||
150129075|NCT01392560|541605739|FG000|Overall Study|not entered|8|||
150195319|NCT03854227|541856495|FG001|Overall Study|Adverse Event|0|||
150129076|NCT01392560|541605739|FG000|Overall Study|discontinued during placebo run-in|2|||
150129077|NCT02081846|541605740|FG000|Overall Study|Withdrawal by Subject|1|||
150129078|NCT02081846|541605741|FG001|Overall Study|Withdrawal by Subject|0|||
150129079|NCT02081846|541605740|FG000|Overall Study|invalid consent|1|||
150129080|NCT02081846|541605741|FG001|Overall Study|invalid consent|0|||
150129081|NCT01939028|541605744|FG000|Overall Study|Withdrawal by Subject|5|||
150129082|NCT01939028|541605744|FG000|Overall Study|Physician Decision|7|||
150129083|NCT03282227|541605745|FG000|Overall Study|Exposure Goals Achieved|60|||
150129084|NCT03282227|541605745|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
150129085|NCT03282227|541605745|FG000|Overall Study|Adverse Event|15|||
150129086|NCT03282227|541605745|FG000|Overall Study|Lost to Follow-up|21|||
150129087|NCT03282227|541605745|FG000|Overall Study|Withdrawal by Subject|20|||
150129088|NCT03282227|541605745|FG000|Overall Study|Lack of Efficacy|12|||
150129089|NCT03282227|541605745|FG000|Overall Study|Sponsor decision|3|||
150129090|NCT03282227|541605745|FG000|Overall Study|Physician Decision|2|||
150129091|NCT03282227|541605745|FG000|Overall Study|Pregnancy|2|||
150129092|NCT03282227|541605745|FG000|Overall Study|Other|1|||
150129093|NCT00295750|541605752|FG000|Overall Study|Adverse Event|19|||
150129094|NCT00295750|541605753|FG001|Overall Study|Adverse Event|15|||
150129095|NCT00295750|541605754|FG002|Overall Study|Adverse Event|12|||
150129096|NCT00295750|541605752|FG000|Overall Study|Lack of Efficacy|1|||
150129097|NCT00295750|541605753|FG001|Overall Study|Lack of Efficacy|1|||
150129098|NCT00295750|541605754|FG002|Overall Study|Lack of Efficacy|0|||
150129099|NCT00295750|541605752|FG000|Overall Study|Lost to Follow-up|1|||
150129100|NCT00295750|541605753|FG001|Overall Study|Lost to Follow-up|4|||
150129101|NCT00295750|541605754|FG002|Overall Study|Lost to Follow-up|1|||
150129102|NCT00295750|541605752|FG000|Overall Study|Taking prohibited therapy|2|||
150129103|NCT00295750|541605753|FG001|Overall Study|Taking prohibited therapy|3|||
150129104|NCT00295750|541605754|FG002|Overall Study|Taking prohibited therapy|2|||
150129105|NCT00295750|541605752|FG000|Overall Study|Administrative errors|2|||
150129106|NCT00295750|541605753|FG001|Overall Study|Administrative errors|4|||
150129107|NCT00295750|541605754|FG002|Overall Study|Administrative errors|5|||
150129108|NCT00295750|541605752|FG000|Overall Study|Trial drug errors|1|||
150129109|NCT00295750|541605753|FG001|Overall Study|Trial drug errors|1|||
150129110|NCT00295750|541605754|FG002|Overall Study|Trial drug errors|0|||
150129111|NCT00295750|541605752|FG000|Overall Study|Disease progression|2|||
150129112|NCT00295750|541605753|FG001|Overall Study|Disease progression|1|||
150129113|NCT00295750|541605754|FG002|Overall Study|Disease progression|0|||
150129114|NCT00295750|541605752|FG000|Overall Study|Personal reasons|0|||
150129115|NCT00295750|541605753|FG001|Overall Study|Personal reasons|1|||
150129116|NCT00295750|541605754|FG002|Overall Study|Personal reasons|0|||
150129117|NCT00295750|541605752|FG000|Overall Study|Randomized but never received trial drug|4|||
150129118|NCT00295750|541605753|FG001|Overall Study|Randomized but never received trial drug|3|||
150129119|NCT00295750|541605754|FG002|Overall Study|Randomized but never received trial drug|3|||
150129120|NCT00295750|541605752|FG000|Overall Study|Withdrawal by Subject|9|||
150129121|NCT00295750|541605753|FG001|Overall Study|Withdrawal by Subject|4|||
150129122|NCT00295750|541605754|FG002|Overall Study|Withdrawal by Subject|7|||
150129123|NCT00295750|541605752|FG000|Overall Study|Protocol Violation|2|||
150129124|NCT00295750|541605753|FG001|Overall Study|Protocol Violation|4|||
150129125|NCT00295750|541605754|FG002|Overall Study|Protocol Violation|2|||
150129126|NCT00322348|541605755|FG000|Overall Study|Adverse Event|0|||
150129127|NCT00322348|541605756|FG001|Overall Study|Adverse Event|1|||
150129128|NCT00322348|541605755|FG000|Overall Study|Withdrawal by Subject|1|||
150129129|NCT00322348|541605756|FG001|Overall Study|Withdrawal by Subject|4|||
150129130|NCT00322348|541605755|FG000|Overall Study|Lost to Follow-up|1|||
150129131|NCT00322348|541605756|FG001|Overall Study|Lost to Follow-up|0|||
150129132|NCT00322348|541605755|FG000|Overall Study|Death|0|||
150129133|NCT00322348|541605756|FG001|Overall Study|Death|2|||
150129134|NCT00322348|541605755|FG000|Overall Study|Disease Progression|30|||
150129135|NCT00322348|541605756|FG001|Overall Study|Disease Progression|25|||
150129136|NCT00322348|541605755|FG000|Overall Study|Reasons not specified|5|||
150129137|NCT00322348|541605756|FG001|Overall Study|Reasons not specified|1|||
150129138|NCT00989287|541605761|FG000|Overall Study|Adverse Event|1|||
150129139|NCT00989287|541605762|FG001|Overall Study|Adverse Event|0|||
150129140|NCT00989287|541605761|FG000|Overall Study|Lost to Follow-up|0|||
150129141|NCT00989287|541605762|FG001|Overall Study|Lost to Follow-up|1|||
150129142|NCT01857531|541605776|FG000|Overall Study|Withdrawal by Subject|4|||
150129143|NCT04598152|541605788|FG000|Overall Study|Lost to Follow-up|0|||
150129144|NCT04598152|541605789|FG001|Overall Study|Lost to Follow-up|1|||
150129145|NCT00435370|541605791|FG000|Overall Study|Adverse Event|8|||
150129146|NCT00435370|541605792|FG001|Overall Study|Adverse Event|8|||
150129147|NCT00435370|541605791|FG000|Overall Study|Withdrawal by Subject|10|||
150129148|NCT00435370|541605792|FG001|Overall Study|Withdrawal by Subject|10|||
150129149|NCT00435370|541605791|FG000|Overall Study|Antipsychotic medication changed|4|||
150129150|NCT00435370|541605792|FG001|Overall Study|Antipsychotic medication changed|2|||
150129151|NCT01965834|541605793|FG000|Overall Study|Lack of Efficacy|4|||
150129152|NCT03943095|541605796|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
150129153|NCT03943095|541605797|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
150129154|NCT03943095|541605796|FG000|Overall Study|Withdrawal by Subject|1|||
150129155|NCT03943095|541605797|FG001|Overall Study|Withdrawal by Subject|0|||
150129156|NCT03674177|541605798|FG000|Overall Study|Lost to Follow-up|2|||
150129157|NCT03674177|541605799|FG001|Overall Study|Lost to Follow-up|1|||
150129158|NCT03674177|541605800|FG002|Overall Study|Lost to Follow-up|0|||
150129159|NCT03674177|541605801|FG003|Overall Study|Lost to Follow-up|2|||
150129160|NCT03387852|541605802|FG000|Overall Study|Adverse event (AE)|3|||
150129161|NCT03387852|541605803|FG001|Overall Study|Adverse event (AE)|0|||
150129162|NCT03387852|541605804|FG002|Overall Study|Adverse event (AE)|2|||
150129163|NCT03387852|541605805|FG003|Overall Study|Adverse event (AE)|0|||
150129164|NCT03387852|541605802|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
150129165|NCT03387852|541605803|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
150129166|NCT03387852|541605804|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
150129167|NCT03387852|541605805|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
150129168|NCT03387852|541605802|FG000|Overall Study|Withdrawal by participant|1|||
150129169|NCT03387852|541605803|FG001|Overall Study|Withdrawal by participant|1|||
150129170|NCT03387852|541605804|FG002|Overall Study|Withdrawal by participant|3|||
150129171|NCT03387852|541605805|FG003|Overall Study|Withdrawal by participant|2|||
150129172|NCT03387852|541605802|FG000|Overall Study|Other- Unspecified|1|||
150129173|NCT03387852|541605803|FG001|Overall Study|Other- Unspecified|1|||
150129174|NCT03387852|541605804|FG002|Overall Study|Other- Unspecified|2|||
150129175|NCT03387852|541605805|FG003|Overall Study|Other- Unspecified|1|||
150129176|NCT03387852|541605802|FG000|Overall Study|Poor compliance to protocol|0|||
150129177|NCT03387852|541605803|FG001|Overall Study|Poor compliance to protocol|0|||
150129178|NCT03387852|541605804|FG002|Overall Study|Poor compliance to protocol|0|||
150129179|NCT03387852|541605805|FG003|Overall Study|Poor compliance to protocol|1|||
150129180|NCT03387852|541605802|FG000|Overall Study|Randomized and not treated|0|||
150129181|NCT03387852|541605803|FG001|Overall Study|Randomized and not treated|0|||
150129182|NCT03387852|541605804|FG002|Overall Study|Randomized and not treated|0|||
150129183|NCT03387852|541605805|FG003|Overall Study|Randomized and not treated|1|||
150129184|NCT02194621|541605806|FG000|Overall Study|6 withdrew prior to randomization|2|||
150129185|NCT02194621|541605807|FG001|Overall Study|6 withdrew prior to randomization|2|||
150129186|NCT02194621|541605808|FG002|Overall Study|6 withdrew prior to randomization|2|||
150129187|NCT02194621|541605806|FG000|Overall Study|Withdrawal by Subject|4|||
150129188|NCT02194621|541605807|FG001|Overall Study|Withdrawal by Subject|4|||
150129189|NCT02194621|541605808|FG002|Overall Study|Withdrawal by Subject|7|||
150129190|NCT02493127|541605816|FG000|Overall Study|Lost to Follow-up|1|||
150129191|NCT02493127|541605817|FG001|Overall Study|Lost to Follow-up|1|||
150129192|NCT02763384|541605818|FG000|Overall Study|Physician Decision|1|||
150129193|NCT02763384|541605818|FG000|Overall Study|Rapid decline - went on hospice|1|||
150129194|NCT00714168|541605819|FG000|Overall Study|Pregnancy|5|||
150129195|NCT00714168|541605820|FG001|Overall Study|Pregnancy|4|||
150129196|NCT00714168|541605819|FG000|Overall Study|Lost to Follow-up|32|||
150129197|NCT00714168|541605820|FG001|Overall Study|Lost to Follow-up|50|||
150129198|NCT00714168|541605819|FG000|Overall Study|Relocation|4|||
150129199|NCT00714168|541605820|FG001|Overall Study|Relocation|3|||
150129200|NCT00714168|541605819|FG000|Overall Study|Non-study medical condition|3|||
150129201|NCT00714168|541605820|FG001|Overall Study|Non-study medical condition|2|||
150129202|NCT04988308|541605822|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
150129203|NCT04988308|541605823|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
150129204|NCT04988308|541605824|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
150129205|NCT04988308|541605825|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150129206|NCT04988308|541605826|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150129207|NCT04988308|541605827|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
150129208|NCT04988308|541605822|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
150129209|NCT04988308|541605823|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
150129210|NCT04988308|541605824|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
150129211|NCT04988308|541605825|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
150129212|NCT04988308|541605826|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
150129213|NCT04988308|541605827|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
150129214|NCT04988308|541605822|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
150129215|NCT04988308|541605823|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
150129216|NCT04988308|541605824|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
150129217|NCT04988308|541605825|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
150129218|NCT04988308|541605826|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
150129219|NCT04988308|541605827|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
150129220|NCT04988308|541605822|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
150129221|NCT04988308|541605823|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
150129222|NCT04988308|541605824|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
150129223|NCT04988308|541605825|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150129224|NCT04988308|541605826|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150129225|NCT04988308|541605827|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
150129226|NCT04988308|541605822|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
150129227|NCT04988308|541605823|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
150129228|NCT04988308|541605824|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
150129229|NCT04988308|541605825|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
150129230|NCT04988308|541605826|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
150129231|NCT04988308|541605827|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
150129232|NCT04988308|541605822|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150129233|NCT04988308|541605823|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150129234|NCT04988308|541605824|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
150129235|NCT04988308|541605825|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
150129236|NCT04988308|541605826|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
150129237|NCT04988308|541605827|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
150129238|NCT04988308|541605822|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150129239|NCT04988308|541605823|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150129240|NCT04988308|541605824|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
150129241|NCT04988308|541605825|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
150129242|NCT04988308|541605826|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
150129243|NCT04988308|541605827|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
150129244|NCT04988308|541605822|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150129245|NCT04988308|541605823|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150129246|NCT04988308|541605824|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
150129247|NCT04988308|541605825|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
150129248|NCT04988308|541605826|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
150129249|NCT04988308|541605827|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
150129250|NCT04988308|541605822|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
150129251|NCT04988308|541605823|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
150129252|NCT04988308|541605824|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
150129253|NCT04988308|541605825|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
150129254|NCT04988308|541605826|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
150129255|NCT04988308|541605827|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
150129256|NCT02096900|541605828|FG000|Overall Study|Did not receive medication|3|||
150129257|NCT02096900|541605829|FG001|Overall Study|Did not receive medication|1|||
150129258|NCT02096900|541605828|FG000|Overall Study|Surgery cancelled- medication received|1|||
150129259|NCT02096900|541605829|FG001|Overall Study|Surgery cancelled- medication received|1|||
150129260|NCT03034577|541605837|FG000|Overall Study|Withdrawal by Subject|6|||
150129261|NCT03034577|541605838|FG001|Overall Study|Withdrawal by Subject|9|||
150129262|NCT03034577|541605837|FG000|Overall Study|Lost to Follow-up|25|||
150129263|NCT03034577|541605838|FG001|Overall Study|Lost to Follow-up|26|||
150129264|NCT04177758|541605841|FG000|Overall Study|Lost to Follow-up|19|||
150129265|NCT04177758|541605842|FG001|Overall Study|Lost to Follow-up|11|||
150129266|NCT02625623|541605843|FG000|Overall Study|Participants randomized but not treated|9|||
150129267|NCT02625623|541605844|FG001|Overall Study|Participants randomized but not treated|1|||
150129268|NCT00744653|541605845|FG000|Overall Study|antineoplastic treatment|11|||
150129269|NCT00744653|541605845|FG000|Overall Study|Death|1|||
150129270|NCT00744653|541605845|FG000|Overall Study|Lost to Follow-up|1|||
150129271|NCT00744653|541605845|FG000|Overall Study|Physician Decision|3|||
150129272|NCT00808808|541605849|FG000|Overall Study|Vaccinated; survey not completed|131|||
150129273|NCT00808808|541605850|FG001|Overall Study|Vaccinated; survey not completed|169|||
150129274|NCT00808808|541605851|FG002|Overall Study|Vaccinated; survey not completed|302|||
150129275|NCT00808808|541605849|FG000|Overall Study|Employee was not vaccinated.|2686|||
150129276|NCT00808808|541605850|FG001|Overall Study|Employee was not vaccinated.|2268|||
150129277|NCT00808808|541605851|FG002|Overall Study|Employee was not vaccinated.|2255|||
150129278|NCT02352948|541605855|FG000|Overall Study|Death|47|||
150129279|NCT02352948|541605856|FG001|Overall Study|Death|48|||
150129280|NCT02352948|541605857|FG002|Overall Study|Death|114|||
150129281|NCT02352948|541605858|FG003|Overall Study|Death|74|||
150129282|NCT02352948|541605859|FG004|Overall Study|Death|77|||
150129283|NCT02352948|541605860|FG005|Overall Study|Death|44|||
150129284|NCT02352948|541605855|FG000|Overall Study|Lost to Follow-up|1|||
150129285|NCT02352948|541605856|FG001|Overall Study|Lost to Follow-up|0|||
150129286|NCT02352948|541605857|FG002|Overall Study|Lost to Follow-up|2|||
150129287|NCT02352948|541605858|FG003|Overall Study|Lost to Follow-up|1|||
150129288|NCT02352948|541605859|FG004|Overall Study|Lost to Follow-up|2|||
150129289|NCT02352948|541605860|FG005|Overall Study|Lost to Follow-up|1|||
150129290|NCT02352948|541605855|FG000|Overall Study|Withdrawal by Subject|1|||
150129291|NCT02352948|541605856|FG001|Overall Study|Withdrawal by Subject|10|||
150129292|NCT02352948|541605857|FG002|Overall Study|Withdrawal by Subject|11|||
150129293|NCT02352948|541605858|FG003|Overall Study|Withdrawal by Subject|23|||
150129294|NCT02352948|541605859|FG004|Overall Study|Withdrawal by Subject|9|||
150129295|NCT02352948|541605860|FG005|Overall Study|Withdrawal by Subject|4|||
150129296|NCT02352948|541605855|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150129297|NCT02352948|541605856|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
150129298|NCT02352948|541605857|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
150129299|NCT02352948|541605858|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
150129300|NCT02352948|541605859|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
150129301|NCT02352948|541605860|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
150129302|NCT02352948|541605855|FG000|Overall Study|Other|0|||
150129303|NCT02352948|541605856|FG001|Overall Study|Other|0|||
150129304|NCT02352948|541605857|FG002|Overall Study|Other|2|||
150129305|NCT02352948|541605858|FG003|Overall Study|Other|0|||
150129306|NCT02352948|541605859|FG004|Overall Study|Other|0|||
150129307|NCT02352948|541605860|FG005|Overall Study|Other|0|||
150129308|NCT00679939|541605861|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
150129309|NCT00679939|541605862|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
150129310|NCT00679939|541605861|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
150129311|NCT00679939|541605862|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
150129312|NCT00679939|541605861|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
150129313|NCT00679939|541605862|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
150129314|NCT00679939|541605861|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
150129315|NCT00679939|541605862|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
150129316|NCT00679939|541605861|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
150129317|NCT00679939|541605862|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
150129318|NCT00679939|541605861|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
150129319|NCT00679939|541605862|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
150129320|NCT00679939|541605861|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
150129321|NCT00679939|541605862|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
150129322|NCT00679939|541605861|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
150129323|NCT00679939|541605862|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
150129324|NCT00679939|541605861|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
150129325|NCT00679939|541605862|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
150129326|NCT00679939|541605861|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
150129327|NCT00679939|541605862|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
150129328|NCT02653482|541605864|FG000|Overall Study|Death|1|||
150129329|NCT02653482|541605865|FG001|Overall Study|Death|1|||
150129330|NCT04657211|541605866|FG000|Overall Study|Withdrawal by Subject|21|||
150129331|NCT04657211|541605866|FG000|Overall Study|Lost to Follow-up|113|||
150129332|NCT04657211|541605866|FG000|Overall Study|Death|47|||
150129333|NCT04657211|541605866|FG000|Overall Study|Transfer to another institution|21|||
150129334|NCT04657211|541605866|FG000|Overall Study|Other|29|||
150129335|NCT06273774|541605868|FG000|Overall Study|Participant was out of state.|0|||
150129336|NCT06273774|541605869|FG001|Overall Study|Participant was out of state.|0|||
150129337|NCT06273774|541605870|FG002|Overall Study|Participant was out of state.|0|||
150129338|NCT06273774|541605871|FG003|Overall Study|Participant was out of state.|0|||
150129339|NCT06273774|541605872|FG004|Overall Study|Participant was out of state.|0|||
150129340|NCT06273774|541605873|FG005|Overall Study|Participant was out of state.|1|||
150129341|NCT06273774|541605868|FG000|Overall Study|Lost to Follow-up|0|||
150129342|NCT06273774|541605869|FG001|Overall Study|Lost to Follow-up|0|||
150129343|NCT06273774|541605870|FG002|Overall Study|Lost to Follow-up|0|||
150129344|NCT06273774|541605871|FG003|Overall Study|Lost to Follow-up|0|||
150129345|NCT06273774|541605872|FG004|Overall Study|Lost to Follow-up|1|||
150129346|NCT06273774|541605873|FG005|Overall Study|Lost to Follow-up|0|||
150129347|NCT02985866|541607451|FG000|Overall Study|Poor CGM data|1|||
150129348|NCT02985866|541607452|FG001|Overall Study|Poor CGM data|1|||
150129349|NCT01949311|541607453|FG000|Overall Study|Lost to Follow-up|73|||
150129350|NCT01949311|541607453|FG000|Overall Study|Terminated by Sponsor|708|||
150129351|NCT01949311|541607453|FG000|Overall Study|Withdrawal by Subject|375|||
150129352|NCT01949311|541607453|FG000|Overall Study|Lack of Efficacy|50|||
150129353|NCT01949311|541607453|FG000|Overall Study|Protocol Deviation|34|||
150129354|NCT01949311|541607453|FG000|Overall Study|Pregnancy|20|||
150129355|NCT01949311|541607453|FG000|Overall Study|Physician Decision|9|||
150129356|NCT01949311|541607453|FG000|Overall Study|Other|4|||
150129357|NCT01949311|541607453|FG000|Overall Study|Adverse Event|107|||
150129358|NCT02338154|541607454|FG000|Overall Study|Death|46|||
150129359|NCT02338154|541607454|FG000|Overall Study|Valve Implant Failure|17|||
150129360|NCT02338154|541607454|FG000|Overall Study|Valve Explant|11|||
150129361|NCT02338154|541607454|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
150129362|NCT02338154|541607454|FG000|Overall Study|Lost to Follow-up|8|||
150129363|NCT02338154|541607454|FG000|Overall Study|Other Reason|3|||
150129364|NCT02338154|541607454|FG000|Overall Study|Patients Without Exit Form|47|||
150129365|NCT02338154|541607454|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
150129366|NCT04279314|541607457|FG000|Overall Study|Adverse Event|55|||
150129367|NCT04279314|541607457|FG000|Overall Study|Withdrawal by Subject|5|||
150129368|NCT04279314|541607457|FG000|Overall Study|Lack of Efficacy|5|||
150129369|NCT04279314|541607457|FG000|Overall Study|Protocol Violation|3|||
150129370|NCT04279314|541607457|FG000|Overall Study|Other (not COVID-19 related)|2|||
150129371|NCT03166618|541607462|FG000|Overall Study|Study was Terminated|0|||
150129372|NCT03166618|541607463|FG001|Overall Study|Study was Terminated|1|||
150129373|NCT03137303|541607465|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
150129374|NCT03137303|541607466|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
150129375|NCT03137303|541607465|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
150129376|NCT03137303|541607466|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
150129377|NCT03137303|541607465|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
150129378|NCT03137303|541607466|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
150129379|NCT03137303|541607465|FG000|T3: 9-month Follow-up|Death|1|||
150129380|NCT03137303|541607466|FG001|T3: 9-month Follow-up|Death|0|||
150129381|NCT03137303|541607465|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
150129382|NCT03137303|541607466|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
150129383|NCT03137303|541607465|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
150129384|NCT03137303|541607466|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
150129385|NCT03137303|541607465|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
150129386|NCT03137303|541607466|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
150129387|NCT03561090|541607467|FG000|Overall Study|Adverse Event|11|||
150129388|NCT03561090|541607468|FG001|Overall Study|Adverse Event|7|||
150129389|NCT03561090|541607467|FG000|Overall Study|Non-Compliance With Study Drug|2|||
150129390|NCT03561090|541607468|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150129391|NCT03561090|541607467|FG000|Overall Study|Protocol Violation|2|||
150129392|NCT03561090|541607468|FG001|Overall Study|Protocol Violation|2|||
150129393|NCT03561090|541607467|FG000|Overall Study|Withdrawal by Subject|7|||
150129394|NCT03561090|541607468|FG001|Overall Study|Withdrawal by Subject|7|||
150129395|NCT03561090|541607467|FG000|Overall Study|Lost to Follow-up|7|||
150129396|NCT03561090|541607468|FG001|Overall Study|Lost to Follow-up|2|||
150129397|NCT03561090|541607467|FG000|Overall Study|Study Terminated by Sponsor|10|||
150129398|NCT03561090|541607468|FG001|Overall Study|Study Terminated by Sponsor|15|||
150129399|NCT03561090|541607467|FG000|Overall Study|Randomized by Mistake|1|||
150129400|NCT03561090|541607468|FG001|Overall Study|Randomized by Mistake|1|||
150129401|NCT03561090|541607467|FG000|Overall Study|Other Not Specified|0|||
150129402|NCT03561090|541607468|FG001|Overall Study|Other Not Specified|2|||
150129403|NCT04402866|541607486|FG000|Overall Study|Discontinued Prior to Treatment|0|||
150129404|NCT04402866|541607487|FG001|Overall Study|Discontinued Prior to Treatment|0|||
150129405|NCT04402866|541607488|FG002|Overall Study|Discontinued Prior to Treatment|0|||
150129406|NCT04402866|541607489|FG003|Overall Study|Discontinued Prior to Treatment|0|||
150129407|NCT04402866|541607490|FG004|Overall Study|Discontinued Prior to Treatment|2|||
150129408|NCT04402866|541607491|FG005|Overall Study|Discontinued Prior to Treatment|3|||
150129409|NCT04402866|541607486|FG000|Overall Study|Adverse Event|2|||
150129410|NCT04402866|541607487|FG001|Overall Study|Adverse Event|1|||
150129411|NCT04402866|541607488|FG002|Overall Study|Adverse Event|0|||
150129412|NCT04402866|541607489|FG003|Overall Study|Adverse Event|0|||
150129413|NCT04402866|541607490|FG004|Overall Study|Adverse Event|13|||
150129414|NCT04402866|541607491|FG005|Overall Study|Adverse Event|8|||
150129415|NCT04402866|541607486|FG000|Overall Study|Miscellaneous|0|||
150129416|NCT04402866|541607487|FG001|Overall Study|Miscellaneous|0|||
150129417|NCT04402866|541607488|FG002|Overall Study|Miscellaneous|1|||
150129418|NCT04402866|541607489|FG003|Overall Study|Miscellaneous|0|||
150129419|NCT04402866|541607490|FG004|Overall Study|Miscellaneous|0|||
150129420|NCT04402866|541607491|FG005|Overall Study|Miscellaneous|0|||
150129421|NCT04402866|541607486|FG000|Overall Study|Lost to Follow-up|0|||
150129422|NCT04402866|541607487|FG001|Overall Study|Lost to Follow-up|0|||
150129423|NCT04402866|541607488|FG002|Overall Study|Lost to Follow-up|0|||
150129424|NCT04402866|541607489|FG003|Overall Study|Lost to Follow-up|0|||
150129425|NCT04402866|541607490|FG004|Overall Study|Lost to Follow-up|0|||
150129426|NCT04402866|541607491|FG005|Overall Study|Lost to Follow-up|1|||
150129427|NCT04402866|541607486|FG000|Overall Study|Withdrawal by Subject|0|||
150129428|NCT04402866|541607487|FG001|Overall Study|Withdrawal by Subject|0|||
150129429|NCT04402866|541607488|FG002|Overall Study|Withdrawal by Subject|0|||
150129430|NCT04402866|541607489|FG003|Overall Study|Withdrawal by Subject|0|||
150129431|NCT04402866|541607490|FG004|Overall Study|Withdrawal by Subject|0|||
150129432|NCT04402866|541607491|FG005|Overall Study|Withdrawal by Subject|2|||
150129433|NCT03667053|541607492|FG000|Overall Study|Withdrawal by Subject|1|||
150129434|NCT03667053|541607493|FG001|Overall Study|Withdrawal by Subject|0|||
150129435|NCT03667053|541607494|FG002|Overall Study|Withdrawal by Subject|0|||
150129436|NCT00515502|541607495|FG000|Treatment Period 1|Adverse Event|0|||
150129437|NCT00515502|541607496|FG001|Treatment Period 1|Adverse Event|0|||
150129438|NCT00515502|541607497|FG002|Treatment Period 1|Adverse Event|0|||
150129439|NCT00515502|541607498|FG003|Treatment Period 1|Adverse Event|0|||
150129440|NCT00515502|541607499|FG004|Treatment Period 1|Adverse Event|0|||
150129441|NCT00515502|541607500|FG005|Treatment Period 1|Adverse Event|0|||
150129442|NCT00515502|541607501|FG006|Treatment Period 1|Adverse Event|1|||
150129443|NCT00515502|541607502|FG007|Treatment Period 1|Adverse Event|0|||
150129444|NCT00515502|541607503|FG008|Treatment Period 1|Adverse Event|1|||
150129445|NCT00515502|541607504|FG009|Treatment Period 1|Adverse Event|0|||
150129446|NCT00515502|541607505|FG010|Treatment Period 1|Adverse Event|0|||
150129447|NCT00515502|541607506|FG011|Treatment Period 1|Adverse Event|1|||
150129448|NCT00515502|541607495|FG000|Treatment Period 2|Adverse Event|0|||
150129449|NCT00515502|541607496|FG001|Treatment Period 2|Adverse Event|1|||
150129450|NCT00515502|541607497|FG002|Treatment Period 2|Adverse Event|0|||
150129451|NCT00515502|541607498|FG003|Treatment Period 2|Adverse Event|0|||
150129452|NCT00515502|541607499|FG004|Treatment Period 2|Adverse Event|0|||
150129453|NCT00515502|541607500|FG005|Treatment Period 2|Adverse Event|0|||
150129454|NCT00515502|541607501|FG006|Treatment Period 2|Adverse Event|0|||
150129455|NCT00515502|541607502|FG007|Treatment Period 2|Adverse Event|0|||
150129456|NCT00515502|541607503|FG008|Treatment Period 2|Adverse Event|0|||
150129457|NCT00515502|541607504|FG009|Treatment Period 2|Adverse Event|0|||
150129458|NCT00515502|541607505|FG010|Treatment Period 2|Adverse Event|0|||
150129459|NCT00515502|541607506|FG011|Treatment Period 2|Adverse Event|0|||
150129460|NCT03647501|541607507|FG000|Overall Study|Lost to Follow-up|1|||
150129461|NCT03647501|541607508|FG001|Overall Study|Lost to Follow-up|1|||
150129462|NCT03647501|541607507|FG000|Overall Study|Withdrawal by Subject|0|||
150129463|NCT03647501|541607508|FG001|Overall Study|Withdrawal by Subject|1|||
150129464|NCT03152526|541607513|FG000|Overall Study|Withdrawal by Subject|0|||
150129465|NCT03152526|541607514|FG001|Overall Study|Withdrawal by Subject|1|||
150129466|NCT02807558|541607515|FG000|Overall Study|Consent withdrawn by participant|4|||
150129467|NCT02807558|541607516|FG001|Overall Study|Consent withdrawn by participant|0|||
150129468|NCT02807558|541607517|FG002|Overall Study|Consent withdrawn by participant|4|||
150129469|NCT02807558|541607518|FG003|Overall Study|Consent withdrawn by participant|2|||
150129470|NCT02807558|541607519|FG004|Overall Study|Consent withdrawn by participant|1|||
150129471|NCT02807558|541607520|FG005|Overall Study|Consent withdrawn by participant|0|||
150129472|NCT02807558|541607515|FG000|Overall Study|Non-compliance with Study Drug|0|||
150129473|NCT02807558|541607516|FG001|Overall Study|Non-compliance with Study Drug|0|||
150129474|NCT02807558|541607517|FG002|Overall Study|Non-compliance with Study Drug|1|||
150129475|NCT02807558|541607518|FG003|Overall Study|Non-compliance with Study Drug|0|||
150129476|NCT02807558|541607519|FG004|Overall Study|Non-compliance with Study Drug|0|||
150129477|NCT02807558|541607520|FG005|Overall Study|Non-compliance with Study Drug|0|||
150129478|NCT02807558|541607515|FG000|Overall Study|Adverse Event|0|||
150129479|NCT02807558|541607516|FG001|Overall Study|Adverse Event|0|||
150129480|NCT02807558|541607517|FG002|Overall Study|Adverse Event|9|||
150129481|NCT02807558|541607518|FG003|Overall Study|Adverse Event|0|||
150129482|NCT02807558|541607519|FG004|Overall Study|Adverse Event|0|||
150129483|NCT02807558|541607520|FG005|Overall Study|Adverse Event|0|||
150129484|NCT02807558|541607515|FG000|Overall Study|Death|23|||
150129485|NCT02807558|541607516|FG001|Overall Study|Death|2|||
150129486|NCT02807558|541607517|FG002|Overall Study|Death|3|||
150129487|NCT02807558|541607518|FG003|Overall Study|Death|43|||
150129488|NCT02807558|541607519|FG004|Overall Study|Death|24|||
150129489|NCT02807558|541607520|FG005|Overall Study|Death|15|||
150129490|NCT02807558|541607515|FG000|Overall Study|Progressive Disease|0|||
150129491|NCT02807558|541607516|FG001|Overall Study|Progressive Disease|0|||
150129492|NCT02807558|541607517|FG002|Overall Study|Progressive Disease|1|||
150129493|NCT02807558|541607518|FG003|Overall Study|Progressive Disease|0|||
150129494|NCT02807558|541607519|FG004|Overall Study|Progressive Disease|0|||
150129495|NCT02807558|541607520|FG005|Overall Study|Progressive Disease|0|||
150129496|NCT02807558|541607515|FG000|Overall Study|Other than specified|1|||
150129497|NCT02807558|541607516|FG001|Overall Study|Other than specified|0|||
150129498|NCT02807558|541607517|FG002|Overall Study|Other than specified|2|||
150129499|NCT02807558|541607518|FG003|Overall Study|Other than specified|0|||
150129500|NCT02807558|541607519|FG004|Overall Study|Other than specified|1|||
150129501|NCT02807558|541607520|FG005|Overall Study|Other than specified|1|||
150129502|NCT02807558|541607515|FG000|Overall Study|Lack of Efficacy|0|||
150129503|NCT02807558|541607516|FG001|Overall Study|Lack of Efficacy|0|||
150129504|NCT02807558|541607517|FG002|Overall Study|Lack of Efficacy|9|||
150129505|NCT02807558|541607518|FG003|Overall Study|Lack of Efficacy|0|||
150129506|NCT02807558|541607519|FG004|Overall Study|Lack of Efficacy|0|||
150129507|NCT02807558|541607520|FG005|Overall Study|Lack of Efficacy|0|||
150129508|NCT01362140|541607521|FG000|Overall Study|Noncompliance|1|||
150129509|NCT01362140|541607522|FG001|Overall Study|Noncompliance|0|||
150129510|NCT01362140|541607521|FG000|Overall Study|Adverse Event|2|||
150129511|NCT01362140|541607522|FG001|Overall Study|Adverse Event|2|||
150129512|NCT01362140|541607521|FG000|Overall Study|Withdrawal by Subject|3|||
150129513|NCT01362140|541607522|FG001|Overall Study|Withdrawal by Subject|3|||
150129514|NCT01362140|541607521|FG000|Overall Study|Administrative Decision|0|||
150129515|NCT01362140|541607522|FG001|Overall Study|Administrative Decision|1|||
150129516|NCT01362140|541607521|FG000|Overall Study|Death|2|||
150129517|NCT01362140|541607522|FG001|Overall Study|Death|1|||
150129518|NCT01362140|541607521|FG000|Overall Study|Other|1|||
150129519|NCT01362140|541607522|FG001|Overall Study|Other|1|||
150129520|NCT01362140|541607521|FG000|Overall Study|Protocol-specified Criteria|1|||
150129521|NCT01362140|541607522|FG001|Overall Study|Protocol-specified Criteria|2|||
150129522|NCT01362140|541607521|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
150129523|NCT01362140|541607522|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
150129524|NCT01910129|541607523|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
150129525|NCT01910129|541607524|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
150129526|NCT01910129|541607525|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
150129527|NCT01910129|541607523|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
150129528|NCT01910129|541607524|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
150129529|NCT01910129|541607525|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
150129530|NCT02491671|541607527|FG000|Overall Study|Adverse Event|6|||
150129531|NCT02491671|541607528|FG001|Overall Study|Adverse Event|8|||
150129532|NCT02491671|541607527|FG000|Overall Study|Death|0|||
150129533|NCT02491671|541607528|FG001|Overall Study|Death|2|||
150129534|NCT02491671|541607527|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
150129535|NCT02491671|541607528|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
150129536|NCT00535730|541607529|FG000|Overall Study|Adverse Event|1|||
150129537|NCT00535730|541607530|FG001|Overall Study|Adverse Event|1|||
150129538|NCT00535730|541607529|FG000|Overall Study|Lost to Follow-up|0|||
150129539|NCT00535730|541607530|FG001|Overall Study|Lost to Follow-up|1|||
150129540|NCT00535730|541607529|FG000|Overall Study|Physician Decision|0|||
150129541|NCT00535730|541607530|FG001|Overall Study|Physician Decision|1|||
150129542|NCT00535730|541607529|FG000|Overall Study|Protocol Violation|1|||
150129543|NCT00535730|541607530|FG001|Overall Study|Protocol Violation|0|||
150129544|NCT00535730|541607529|FG000|Overall Study|Withdrawal by Subject|0|||
150129545|NCT00535730|541607530|FG001|Overall Study|Withdrawal by Subject|4|||
150129546|NCT00936858|541607531|FG000|Overall Study|Death|3|||
150129547|NCT00936858|541607531|FG000|Overall Study|Progression|29|||
150129548|NCT00936858|541607531|FG000|Overall Study|Withdrawal by Subject|5|||
150129549|NCT00936858|541607531|FG000|Overall Study|Adverse Event|1|||
150129550|NCT00936858|541607531|FG000|Overall Study|Physician Decision|7|||
150129551|NCT00936858|541607531|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
150129552|NCT00936858|541607531|FG000|Overall Study|Lost to Follow-up|1|||
150129553|NCT00584727|541607539|FG000|First Intervention|Discontinuation|0|||
150129554|NCT00584727|541607540|FG001|First Intervention|Discontinuation|0|||
150129555|NCT00584727|541607541|FG002|First Intervention|Discontinuation|1|||
150129556|NCT00584727|541607542|FG003|First Intervention|Discontinuation|0|||
150129557|NCT00584727|541607543|FG004|First Intervention|Discontinuation|0|||
150129558|NCT00584727|541607544|FG005|First Intervention|Discontinuation|0|||
150129559|NCT00584727|541607539|FG000|Third Intervention|Protocol Violation|0|||
150129560|NCT00584727|541607540|FG001|Third Intervention|Protocol Violation|0|||
150129561|NCT00584727|541607541|FG002|Third Intervention|Protocol Violation|1|||
150129562|NCT00584727|541607542|FG003|Third Intervention|Protocol Violation|0|||
150129563|NCT00584727|541607543|FG004|Third Intervention|Protocol Violation|4|||
150129564|NCT00584727|541607544|FG005|Third Intervention|Protocol Violation|2|||
150129565|NCT00729833|541607547|FG000|Overall Study|Death|5|||
150129566|NCT00729833|541607548|FG001|Overall Study|Death|1|||
150129567|NCT00729833|541607549|FG002|Overall Study|Death|3|||
150129568|NCT00729833|541607550|FG003|Overall Study|Death|5|||
150129569|NCT00729833|541607547|FG000|Overall Study|Study Terminated by Sponsor|0|||
150129570|NCT00729833|541607548|FG001|Overall Study|Study Terminated by Sponsor|0|||
150129571|NCT00729833|541607549|FG002|Overall Study|Study Terminated by Sponsor|1|||
150129572|NCT00729833|541607550|FG003|Overall Study|Study Terminated by Sponsor|0|||
150129573|NCT00729833|541607547|FG000|Overall Study|Lost to Follow-up|1|||
150129574|NCT00729833|541607548|FG001|Overall Study|Lost to Follow-up|0|||
150129575|NCT00729833|541607549|FG002|Overall Study|Lost to Follow-up|0|||
150129576|NCT00729833|541607550|FG003|Overall Study|Lost to Follow-up|0|||
150129577|NCT00729833|541607547|FG000|Overall Study|Withdrawal by Subject|3|||
150129578|NCT00729833|541607548|FG001|Overall Study|Withdrawal by Subject|1|||
150129579|NCT00729833|541607549|FG002|Overall Study|Withdrawal by Subject|3|||
150129580|NCT00729833|541607550|FG003|Overall Study|Withdrawal by Subject|0|||
150129581|NCT00729833|541607547|FG000|Overall Study|Unspecified Reasons|11|||
150129582|NCT00729833|541607548|FG001|Overall Study|Unspecified Reasons|5|||
150129583|NCT00729833|541607549|FG002|Overall Study|Unspecified Reasons|5|||
150129584|NCT00729833|541607550|FG003|Overall Study|Unspecified Reasons|1|||
150129585|NCT00092131|541607551|FG000|Treatment Period I|Adverse Event|1|||
150129586|NCT00092131|541607552|FG001|Treatment Period I|Adverse Event|0|||
150129587|NCT00092131|541607551|FG000|Treatment Period II|Adverse Event|0|||
150129588|NCT00092131|541607552|FG001|Treatment Period II|Adverse Event|1|||
150129589|NCT02341417|541607553|FG000|Overall Study|Withdrawal by Subject|0|||
150129590|NCT02341417|541607554|FG001|Overall Study|Withdrawal by Subject|2|||
150129591|NCT02341417|541607555|FG002|Overall Study|Withdrawal by Subject|0|||
150129592|NCT02341417|541607553|FG000|Overall Study|Decision by sponsor|2|||
150129593|NCT02341417|541607554|FG001|Overall Study|Decision by sponsor|0|||
150129594|NCT02341417|541607555|FG002|Overall Study|Decision by sponsor|0|||
150129595|NCT02341417|541607553|FG000|Overall Study|Death|0|||
150129596|NCT02341417|541607554|FG001|Overall Study|Death|0|||
150129597|NCT02341417|541607555|FG002|Overall Study|Death|1|||
150129598|NCT04773587|541607556|FG000|Overall Study|Lost to Follow-up|11|||
150129599|NCT04773587|541607557|FG001|Overall Study|Lost to Follow-up|3|||
150129600|NCT04773587|541607556|FG000|Overall Study|Adverse Event|6|||
150129601|NCT04773587|541607557|FG001|Overall Study|Adverse Event|3|||
150129602|NCT04773587|541607556|FG000|Overall Study|Lack of Efficacy|5|||
150129603|NCT04773587|541607557|FG001|Overall Study|Lack of Efficacy|2|||
150129604|NCT04773587|541607556|FG000|Overall Study|Withdrawal by Subject|4|||
150129605|NCT04773587|541607557|FG001|Overall Study|Withdrawal by Subject|5|||
150129606|NCT04773587|541607556|FG000|Overall Study|Noncompliance|1|||
150129607|NCT04773587|541607557|FG001|Overall Study|Noncompliance|0|||
150129608|NCT04773587|541607556|FG000|Overall Study|Protocol Violation|1|||
150129609|NCT04773587|541607557|FG001|Overall Study|Protocol Violation|0|||
150129610|NCT04773587|541607556|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
150129611|NCT04773587|541607557|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
150129612|NCT02372409|541607558|FG000|Overall Study|Lost to Follow-up|1|||
150129613|NCT02372409|541607559|FG001|Overall Study|Lost to Follow-up|0|||
150129614|NCT02372409|541607558|FG000|Overall Study|Disease progression|1|||
150129615|NCT02372409|541607559|FG001|Overall Study|Disease progression|1|||
150129616|NCT00622167|541607560|FG000|Overall Study|Did not meet angiographic criteria|20|||
150129617|NCT02820623|541607561|FG000|Overall Study|Withdrawal by Subject|1|||
150129618|NCT02820623|541607562|FG001|Overall Study|Withdrawal by Subject|3|||
150129619|NCT02820623|541607563|FG002|Overall Study|Withdrawal by Subject|3|||
150129620|NCT02820623|541607561|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
150129621|NCT02820623|541607562|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
150129622|NCT02820623|541607563|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
150129623|NCT02820623|541607561|FG000|Overall Study|Therapist unable to enroll clients|1|||
150129624|NCT02820623|541607562|FG001|Overall Study|Therapist unable to enroll clients|1|||
150129625|NCT02820623|541607563|FG002|Overall Study|Therapist unable to enroll clients|3|||
150129626|NCT02820623|541607561|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
150129627|NCT02820623|541607562|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
150129628|NCT02820623|541607563|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
150129629|NCT01954017|541607566|FG000|Overall Study|Adverse Event|0|||
150129630|NCT01954017|541607567|FG001|Overall Study|Adverse Event|0|||
150129631|NCT01954017|541607568|FG002|Overall Study|Adverse Event|1|||
150129632|NCT01954017|541607566|FG000|Overall Study|Death|2|||
150129633|NCT01954017|541607567|FG001|Overall Study|Death|1|||
150129634|NCT01954017|541607568|FG002|Overall Study|Death|1|||
150129635|NCT01954017|541607566|FG000|Overall Study|Withdrawal by Subject|0|||
150129636|NCT01954017|541607567|FG001|Overall Study|Withdrawal by Subject|1|||
150129637|NCT01954017|541607568|FG002|Overall Study|Withdrawal by Subject|0|||
150129638|NCT01954017|541607566|FG000|Overall Study|Protocol Violation|0|||
150129639|NCT01954017|541607567|FG001|Overall Study|Protocol Violation|3|||
150129640|NCT01954017|541607568|FG002|Overall Study|Protocol Violation|2|||
150129641|NCT01954017|541607566|FG000|Overall Study|Necrotizing enterocolitis|1|||
150129642|NCT01954017|541607567|FG001|Overall Study|Necrotizing enterocolitis|0|||
150129643|NCT01954017|541607568|FG002|Overall Study|Necrotizing enterocolitis|1|||
150129644|NCT01954017|541607566|FG000|Overall Study|Enteral intake stopped >7 days|0|||
150129645|NCT01954017|541607567|FG001|Overall Study|Enteral intake stopped >7 days|1|||
150129646|NCT01954017|541607568|FG002|Overall Study|Enteral intake stopped >7 days|1|||
150129647|NCT01954017|541607566|FG000|Overall Study|All other reasons|2|||
150129648|NCT01954017|541607567|FG001|Overall Study|All other reasons|2|||
150129649|NCT01954017|541607568|FG002|Overall Study|All other reasons|7|||
150129650|NCT03346759|541607569|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
150129651|NCT03346759|541607570|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
150129652|NCT03346759|541607569|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
150129653|NCT03346759|541607570|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
150129654|NCT03346759|541607569|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
150129655|NCT03346759|541607570|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
150129656|NCT03826667|541607575|FG000|Overall Study|Protocol deviation|21|||
150129657|NCT01453595|541607580|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
150129658|NCT01453595|541607581|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
150129659|NCT01453595|541607582|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
150129660|NCT03077724|541607583|FG000|Overall Study|Lost to Follow-up|5|||
150129661|NCT03077724|541607584|FG001|Overall Study|Lost to Follow-up|1|||
150129662|NCT03077724|541607583|FG000|Overall Study|Withdrawal by Subject|3|||
150129663|NCT03077724|541607584|FG001|Overall Study|Withdrawal by Subject|1|||
150129664|NCT02313428|541607585|FG000|Overall Study|Lost to Follow-up|1|||
150129665|NCT02313428|541607586|FG001|Overall Study|Lost to Follow-up|1|||
150129666|NCT05374421|541607587|FG000|Overall Study|Withdrawal by Subject|3|||
150129667|NCT05374421|541607588|FG001|Overall Study|Withdrawal by Subject|4|||
150129668|NCT04370054|541607589|FG000|Treatment Phase|Lost to Follow-up|1|||
150129669|NCT04370054|541607589|FG000|Treatment Phase|Withdrawal by Subject|1|||
150129670|NCT04370054|541607589|FG000|Follow-Up Phase|Ongoing|75|||
150129671|NCT00593567|541609830|FG000|Overall Study|Adverse Event|2|||
150129672|NCT00593567|541609831|FG001|Overall Study|Adverse Event|0|||
150129673|NCT00593567|541609830|FG000|Overall Study|Physician Decision|2|||
150129674|NCT00593567|541609831|FG001|Overall Study|Physician Decision|0|||
150129675|NCT00593567|541609830|FG000|Overall Study|Protocol Violation|13|||
150129676|NCT00593567|541609831|FG001|Overall Study|Protocol Violation|7|||
150129677|NCT00593567|541609830|FG000|Overall Study|Lack of Efficacy|2|||
150129678|NCT00593567|541609831|FG001|Overall Study|Lack of Efficacy|1|||
150129679|NCT00593567|541609830|FG000|Overall Study|Withdrawal by Subject|1|||
150129680|NCT00593567|541609831|FG001|Overall Study|Withdrawal by Subject|2|||
150129681|NCT00590902|541609837|FG000|Overall Study|Death|1|||
150129682|NCT00785291|541609838|FG000|Overall Study|Never began treatment|8|||
150129683|NCT00785291|541609839|FG001|Overall Study|Never began treatment|4|||
150129684|NCT00785291|541609840|FG002|Overall Study|Never began treatment|4|||
150129685|NCT00785291|541609838|FG000|Overall Study|Adverse Event|39|||
150129686|NCT00785291|541609839|FG001|Overall Study|Adverse Event|70|||
150129687|NCT00785291|541609840|FG002|Overall Study|Adverse Event|56|||
150129688|NCT00785291|541609838|FG000|Overall Study|Death|7|||
150129689|NCT00785291|541609839|FG001|Overall Study|Death|4|||
150129690|NCT00785291|541609840|FG002|Overall Study|Death|3|||
150129691|NCT00785291|541609838|FG000|Overall Study|Withdrawal by Subject|35|||
150129692|NCT00785291|541609839|FG001|Overall Study|Withdrawal by Subject|36|||
150129693|NCT00785291|541609840|FG002|Overall Study|Withdrawal by Subject|17|||
150129694|NCT00785291|541609838|FG000|Overall Study|Alternative Therapy|12|||
150129695|NCT00785291|541609839|FG001|Overall Study|Alternative Therapy|6|||
150129696|NCT00785291|541609840|FG002|Overall Study|Alternative Therapy|7|||
150129697|NCT00785291|541609838|FG000|Overall Study|Complicating illness|6|||
150129698|NCT00785291|541609839|FG001|Overall Study|Complicating illness|4|||
150129699|NCT00785291|541609840|FG002|Overall Study|Complicating illness|4|||
150129700|NCT00785291|541609838|FG000|Overall Study|Other Medical Reasons|29|||
150129701|NCT00785291|541609839|FG001|Overall Study|Other Medical Reasons|25|||
150129702|NCT00785291|541609840|FG002|Overall Study|Other Medical Reasons|15|||
150129703|NCT02119260|541609841|FG000|Overall Study|Adverse Event|1|||
150129704|NCT02119260|541609842|FG001|Overall Study|Adverse Event|0|||
150129705|NCT02119260|541609843|FG002|Overall Study|Adverse Event|0|||
150129706|NCT02119260|541609844|FG003|Overall Study|Adverse Event|0|||
150129707|NCT02119260|541609845|FG004|Overall Study|Adverse Event|0|||
150129708|NCT02119260|541609846|FG005|Overall Study|Adverse Event|0|||
150129709|NCT02119260|541609847|FG006|Overall Study|Adverse Event|0|||
150129710|NCT02119260|541609841|FG000|Overall Study|Withdrew consent|0|||
150129711|NCT02119260|541609842|FG001|Overall Study|Withdrew consent|1|||
150129712|NCT02119260|541609843|FG002|Overall Study|Withdrew consent|1|||
150129713|NCT02119260|541609844|FG003|Overall Study|Withdrew consent|0|||
150129714|NCT02119260|541609845|FG004|Overall Study|Withdrew consent|0|||
150129715|NCT02119260|541609846|FG005|Overall Study|Withdrew consent|0|||
150129716|NCT02119260|541609847|FG006|Overall Study|Withdrew consent|0|||
150129717|NCT02057874|541609849|FG000|Overall Study|participant did not return for scan|1|||
150129718|NCT01738984|541609852|FG000|Overall Study|Pregnancy|4|||
150129719|NCT01738984|541609853|FG001|Overall Study|Pregnancy|0|||
150129720|NCT01738984|541609852|FG000|Overall Study|Withdrawal by Subject|1|||
150129721|NCT01738984|541609853|FG001|Overall Study|Withdrawal by Subject|0|||
150129722|NCT01738984|541609852|FG000|Overall Study|Lost to Follow-up|59|||
150129723|NCT01738984|541609853|FG001|Overall Study|Lost to Follow-up|39|||
150129724|NCT03912259|541609856|FG000|Overall Study|Adverse Event (AE)|2|||
150129725|NCT03912259|541609857|FG001|Overall Study|Adverse Event (AE)|4|||
150129726|NCT03912259|541609856|FG000|Overall Study|Lack of Efficacy|4|||
150129727|NCT03912259|541609857|FG001|Overall Study|Lack of Efficacy|1|||
150129728|NCT03912259|541609856|FG000|Overall Study|Withdrawal by Subject|11|||
150129729|NCT03912259|541609857|FG001|Overall Study|Withdrawal by Subject|1|||
150129730|NCT00360308|541609858|FG000|Overall Study|Adverse Event|15|||
150129731|NCT00360308|541609859|FG001|Overall Study|Adverse Event|14|||
150129732|NCT00360308|541609860|FG002|Overall Study|Adverse Event|25|||
150129733|NCT00360308|541609858|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
150129734|NCT00360308|541609859|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
150129735|NCT00360308|541609860|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
150129736|NCT00360308|541609858|FG000|Overall Study|Protocol Violation|2|||
150129737|NCT00360308|541609859|FG001|Overall Study|Protocol Violation|1|||
150129738|NCT00360308|541609860|FG002|Overall Study|Protocol Violation|2|||
150129739|NCT00360308|541609858|FG000|Overall Study|Withdrawal by Subject|11|||
150129740|NCT00360308|541609859|FG001|Overall Study|Withdrawal by Subject|7|||
150129741|NCT00360308|541609860|FG002|Overall Study|Withdrawal by Subject|14|||
150129742|NCT00360308|541609858|FG000|Overall Study|Lack of Efficacy|3|||
150129743|NCT00360308|541609859|FG001|Overall Study|Lack of Efficacy|0|||
150129744|NCT00360308|541609860|FG002|Overall Study|Lack of Efficacy|2|||
150129745|NCT00360308|541609858|FG000|Overall Study|Other|2|||
150129746|NCT00360308|541609859|FG001|Overall Study|Other|1|||
150129747|NCT00360308|541609860|FG002|Overall Study|Other|1|||
150129748|NCT00360308|541609858|FG000|Overall Study|Study termination by sponsor|43|||
150129749|NCT00360308|541609859|FG001|Overall Study|Study termination by sponsor|55|||
150129750|NCT00360308|541609860|FG002|Overall Study|Study termination by sponsor|44|||
150129751|NCT04786444|541609861|FG000|Overall Study|Withdrawal by Subject|4|||
150129752|NCT04786444|541609862|FG001|Overall Study|Withdrawal by Subject|7|||
150129753|NCT04786444|541609863|FG002|Overall Study|Withdrawal by Subject|2|||
150129754|NCT04786444|541609861|FG000|Overall Study|Lost to Follow-up|11|||
150129755|NCT04786444|541609862|FG001|Overall Study|Lost to Follow-up|9|||
150129756|NCT04786444|541609863|FG002|Overall Study|Lost to Follow-up|10|||
150129757|NCT04786444|541609861|FG000|Overall Study|Subject would like to become pregnant|0|||
150129758|NCT04786444|541609862|FG001|Overall Study|Subject would like to become pregnant|1|||
150129759|NCT04786444|541609863|FG002|Overall Study|Subject would like to become pregnant|0|||
150129760|NCT01433354|541609866|FG000|Overall Study|Adverse Event|6|||
150129761|NCT01433354|541609866|FG000|Overall Study|Lost to Follow-up|1|||
150129762|NCT01433354|541609866|FG000|Overall Study|Administrative problems|90|||
150129763|NCT01433354|541609866|FG000|Overall Study|Protocol Violation|2|||
150129764|NCT01433354|541609866|FG000|Overall Study|Lack of Efficacy|17|||
150129765|NCT01433354|541609866|FG000|Overall Study|Subject Withdrew Consent|3|||
150129766|NCT02015676|541609875|FG000|Overall Study|Adverse Event|2|||
150129767|NCT02015676|541609876|FG001|Overall Study|Adverse Event|18|||
150129768|NCT02015676|541609877|FG002|Overall Study|Adverse Event|0|||
150129769|NCT02015676|541609875|FG000|Overall Study|Lack of Efficacy|2|||
150129770|NCT02015676|541609876|FG001|Overall Study|Lack of Efficacy|4|||
150129771|NCT02015676|541609877|FG002|Overall Study|Lack of Efficacy|0|||
150129772|NCT02015676|541609875|FG000|Overall Study|Protocol Violation|1|||
150129773|NCT02015676|541609876|FG001|Overall Study|Protocol Violation|0|||
150129774|NCT02015676|541609877|FG002|Overall Study|Protocol Violation|0|||
150129775|NCT02015676|541609875|FG000|Overall Study|Withdrawal by Subject|1|||
150129776|NCT02015676|541609876|FG001|Overall Study|Withdrawal by Subject|7|||
150129777|NCT02015676|541609877|FG002|Overall Study|Withdrawal by Subject|1|||
150129778|NCT02015676|541609875|FG000|Overall Study|Administrative reasons|0|||
150129779|NCT02015676|541609876|FG001|Overall Study|Administrative reasons|3|||
150129780|NCT02015676|541609877|FG002|Overall Study|Administrative reasons|1|||
150129781|NCT02015676|541609875|FG000|Overall Study|Death|0|||
150129782|NCT02015676|541609876|FG001|Overall Study|Death|1|||
150129783|NCT02015676|541609877|FG002|Overall Study|Death|0|||
150129784|NCT02015676|541609875|FG000|Overall Study|Disease progression|3|||
150129785|NCT02015676|541609876|FG001|Overall Study|Disease progression|1|||
150129786|NCT02015676|541609877|FG002|Overall Study|Disease progression|1|||
150129787|NCT01618162|541609878|FG000|Overall Study|Protocol Violation|13|||
150129788|NCT01618162|541609879|FG001|Overall Study|Protocol Violation|10|||
150129789|NCT01618162|541609878|FG000|Overall Study|Adverse Event|9|||
150129790|NCT01618162|541609879|FG001|Overall Study|Adverse Event|2|||
150129791|NCT01618162|541609878|FG000|Overall Study|Withdrawal Criteria|2|||
150129792|NCT01618162|541609879|FG001|Overall Study|Withdrawal Criteria|10|||
150129793|NCT01618162|541609878|FG000|Overall Study|Unclassified|14|||
150129794|NCT01618162|541609879|FG001|Overall Study|Unclassified|13|||
150129795|NCT04794803|541609880|FG000|Overall Study|Death|1|||
150129796|NCT04794803|541609881|FG001|Overall Study|Death|3|||
150129797|NCT04794803|541609880|FG000|Overall Study|Lost to Follow-up|2|||
150129798|NCT04794803|541609881|FG001|Overall Study|Lost to Follow-up|2|||
150129799|NCT04794803|541609880|FG000|Overall Study|Withdrawal by Subject|1|||
150129800|NCT04794803|541609881|FG001|Overall Study|Withdrawal by Subject|0|||
150129801|NCT04794803|541609880|FG000|Overall Study|Physician Decision|1|||
150129802|NCT04794803|541609881|FG001|Overall Study|Physician Decision|1|||
150129803|NCT04794803|541609880|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
150129804|NCT04794803|541609881|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
150129805|NCT04794803|541609880|FG000|Overall Study|Refused to continue the treatment|1|||
150129806|NCT04794803|541609881|FG001|Overall Study|Refused to continue the treatment|0|||
150129807|NCT04794803|541609880|FG000|Overall Study|Patient admitted to ICU|0|||
150129808|NCT04794803|541609881|FG001|Overall Study|Patient admitted to ICU|1|||
150129809|NCT00476476|541609882|FG000|Overall Study|Adverse Event|2|||
150129810|NCT00476476|541609883|FG001|Overall Study|Adverse Event|7|||
150129811|NCT00476476|541609882|FG000|Overall Study|Progressive Disease|0|||
150129812|NCT00476476|541609883|FG001|Overall Study|Progressive Disease|17|||
150129813|NCT00971048|541609889|FG000|Overall Study|Protocol Violation|1|||
150129814|NCT00971048|541609890|FG001|Overall Study|Protocol Violation|2|||
150129815|NCT00971048|541609891|FG002|Overall Study|Protocol Violation|0|||
150129816|NCT00971048|541609892|FG003|Overall Study|Protocol Violation|1|||
150129817|NCT00971048|541609889|FG000|Overall Study|Adverse Event|0|||
150129818|NCT00971048|541609890|FG001|Overall Study|Adverse Event|0|||
150129819|NCT00971048|541609891|FG002|Overall Study|Adverse Event|1|||
150129820|NCT00971048|541609892|FG003|Overall Study|Adverse Event|0|||
150129821|NCT00971048|541609889|FG000|Overall Study|Physician Decision|0|||
150129822|NCT00971048|541609890|FG001|Overall Study|Physician Decision|0|||
150129823|NCT00971048|541609891|FG002|Overall Study|Physician Decision|0|||
150129824|NCT00971048|541609892|FG003|Overall Study|Physician Decision|1|||
150129825|NCT03321396|541609896|FG000|Overall Study|Physician Decision|1|||
150129826|NCT02633137|541609904|FG000|Overall Study|Adverse Event|1|||
150129827|NCT02633137|541609904|FG000|Overall Study|Lack of Efficacy|2|||
150129828|NCT02633137|541609904|FG000|Overall Study|Withdrawal by Subject|1|||
150129829|NCT04307004|541609905|FG000|Randomization 1|Withdrawal by Subject|25|||
150129830|NCT04307004|541609906|FG001|Randomization 1|Withdrawal by Subject|26|||
150129831|NCT04307004|541609907|FG002|Randomization 1|Withdrawal by Subject|0|||
150129832|NCT04307004|541609908|FG003|Randomization 1|Withdrawal by Subject|0|||
150129833|NCT04307004|541609905|FG000|Randomization 2|Withdrawal by Subject|0|||
150129834|NCT04307004|541609906|FG001|Randomization 2|Withdrawal by Subject|0|||
150129835|NCT04307004|541609907|FG002|Randomization 2|Withdrawal by Subject|28|||
150129836|NCT04307004|541609908|FG003|Randomization 2|Withdrawal by Subject|23|||
150129837|NCT05545072|541609909|FG000|Overall Study|Lost to Follow-up|1|||
150129838|NCT05545072|541609910|FG001|Overall Study|Lost to Follow-up|0|||
150129839|NCT05545072|541609909|FG000|Overall Study|Study ended prematurely due to funding|2|||
150129840|NCT05545072|541609910|FG001|Overall Study|Study ended prematurely due to funding|2|||
150129841|NCT02395042|541609911|FG000|Treatment 1 Period|Adverse Event|1|||
150129842|NCT02395042|541609912|FG001|Treatment 1 Period|Adverse Event|3|||
150129843|NCT02395042|541609913|FG002|Treatment 1 Period|Adverse Event|1|||
150129844|NCT02395042|541609911|FG000|Treatment 1 Period|Lack of Efficacy|1|||
150129845|NCT02395042|541609912|FG001|Treatment 1 Period|Lack of Efficacy|1|||
150129846|NCT02395042|541609913|FG002|Treatment 1 Period|Lack of Efficacy|0|||
150129847|NCT02395042|541609911|FG000|Treatment 1 Period|Lost to Follow-up|1|||
150129848|NCT02395042|541609912|FG001|Treatment 1 Period|Lost to Follow-up|0|||
150129849|NCT02395042|541609913|FG002|Treatment 1 Period|Lost to Follow-up|0|||
150129850|NCT02395042|541609911|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
150129851|NCT02395042|541609912|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
150129852|NCT02395042|541609913|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
150129853|NCT02395042|541609911|FG000|Treatment 2 Period|Lack of Efficacy|1|||
150129854|NCT02395042|541609912|FG001|Treatment 2 Period|Lack of Efficacy|1|||
150129855|NCT02395042|541609913|FG002|Treatment 2 Period|Lack of Efficacy|0|||
150129856|NCT01324271|541609914|FG000|Overall Study|Lost to Follow-up|3|||
150129857|NCT01324271|541609915|FG001|Overall Study|Lost to Follow-up|0|||
150129858|NCT01324271|541609914|FG000|Overall Study|Physician Decision|1|||
150129859|NCT01324271|541609915|FG001|Overall Study|Physician Decision|0|||
150129860|NCT01972841|541609916|FG000|Overall Study|Randomized but Never Received Treatment|2|||
150129861|NCT01972841|541609917|FG001|Overall Study|Randomized but Never Received Treatment|5|||
150129862|NCT01972841|541609918|FG002|Overall Study|Randomized but Never Received Treatment|4|||
150129863|NCT01972841|541609919|FG003|Overall Study|Randomized but Never Received Treatment|2|||
150129864|NCT01972841|541609920|FG004|Overall Study|Randomized but Never Received Treatment|6|||
150129865|NCT01972841|541609921|FG005|Overall Study|Randomized but Never Received Treatment|13|||
150129866|NCT01972841|541609916|FG000|Overall Study|Adverse Event|13|||
150129867|NCT01972841|541609917|FG001|Overall Study|Adverse Event|8|||
150129868|NCT01972841|541609918|FG002|Overall Study|Adverse Event|12|||
150129869|NCT01972841|541609919|FG003|Overall Study|Adverse Event|9|||
150129870|NCT01972841|541609920|FG004|Overall Study|Adverse Event|21|||
150129871|NCT01972841|541609921|FG005|Overall Study|Adverse Event|26|||
150129872|NCT01972841|541609916|FG000|Overall Study|Lack of Efficacy|1|||
150129873|NCT01972841|541609917|FG001|Overall Study|Lack of Efficacy|0|||
150129874|NCT01972841|541609918|FG002|Overall Study|Lack of Efficacy|0|||
150129875|NCT01972841|541609919|FG003|Overall Study|Lack of Efficacy|2|||
150129876|NCT01972841|541609920|FG004|Overall Study|Lack of Efficacy|4|||
150129877|NCT01972841|541609921|FG005|Overall Study|Lack of Efficacy|1|||
150129878|NCT01972841|541609916|FG000|Overall Study|Lost to Follow-up|4|||
150129879|NCT01972841|541609917|FG001|Overall Study|Lost to Follow-up|2|||
150129880|NCT01972841|541609918|FG002|Overall Study|Lost to Follow-up|4|||
150129881|NCT01972841|541609919|FG003|Overall Study|Lost to Follow-up|2|||
150129882|NCT01972841|541609920|FG004|Overall Study|Lost to Follow-up|9|||
150129883|NCT01972841|541609921|FG005|Overall Study|Lost to Follow-up|3|||
150129884|NCT01972841|541609916|FG000|Overall Study|Protocol Violation|2|||
150129885|NCT01972841|541609917|FG001|Overall Study|Protocol Violation|2|||
150129886|NCT01972841|541609918|FG002|Overall Study|Protocol Violation|3|||
150129887|NCT01972841|541609919|FG003|Overall Study|Protocol Violation|5|||
150129888|NCT01972841|541609920|FG004|Overall Study|Protocol Violation|9|||
150129889|NCT01972841|541609921|FG005|Overall Study|Protocol Violation|4|||
150129890|NCT01972841|541609916|FG000|Overall Study|Withdrawal by participants|21|||
150129891|NCT01972841|541609917|FG001|Overall Study|Withdrawal by participants|27|||
150129892|NCT01972841|541609918|FG002|Overall Study|Withdrawal by participants|23|||
150129893|NCT01972841|541609919|FG003|Overall Study|Withdrawal by participants|16|||
150129894|NCT01972841|541609920|FG004|Overall Study|Withdrawal by participants|33|||
150129895|NCT01972841|541609921|FG005|Overall Study|Withdrawal by participants|34|||
150129896|NCT01972841|541609916|FG000|Overall Study|Miscellaneous|0|||
150129897|NCT01972841|541609917|FG001|Overall Study|Miscellaneous|0|||
150129898|NCT01972841|541609918|FG002|Overall Study|Miscellaneous|4|||
150129899|NCT01972841|541609919|FG003|Overall Study|Miscellaneous|1|||
150129900|NCT01972841|541609920|FG004|Overall Study|Miscellaneous|0|||
150129901|NCT01972841|541609921|FG005|Overall Study|Miscellaneous|4|||
150129902|NCT01972841|541609916|FG000|Overall Study|Did not have end of treatment page|0|||
150129903|NCT01972841|541609917|FG001|Overall Study|Did not have end of treatment page|0|||
150129904|NCT01972841|541609918|FG002|Overall Study|Did not have end of treatment page|0|||
150129905|NCT01972841|541609919|FG003|Overall Study|Did not have end of treatment page|0|||
150129906|NCT01972841|541609920|FG004|Overall Study|Did not have end of treatment page|1|||
150129907|NCT01972841|541609921|FG005|Overall Study|Did not have end of treatment page|0|||
150129908|NCT01869491|541609926|FG000|Overall Study|Adverse Event|3|||
150129909|NCT01869491|541609927|FG001|Overall Study|Adverse Event|5|||
150129910|NCT01869491|541609926|FG000|Overall Study|Lack of Efficacy|0|||
150129911|NCT01869491|541609927|FG001|Overall Study|Lack of Efficacy|3|||
150129912|NCT01869491|541609926|FG000|Overall Study|Withdrawal by Subject|6|||
150129913|NCT01869491|541609927|FG001|Overall Study|Withdrawal by Subject|7|||
150129914|NCT01869491|541609926|FG000|Overall Study|Lost to Follow-up|11|||
150129915|NCT01869491|541609927|FG001|Overall Study|Lost to Follow-up|9|||
150129916|NCT01869491|541609926|FG000|Overall Study|No further need of investigational product|1|||
150129917|NCT01869491|541609927|FG001|Overall Study|No further need of investigational product|0|||
150129918|NCT01270347|541609928|FG000|Core Phase|Adverse Event|1|||
150129919|NCT01270347|541609929|FG001|Core Phase|Adverse Event|6|||
150129920|NCT01270347|541609928|FG000|Core Phase|Withdrawal by Subject|1|||
150129921|NCT01270347|541609929|FG001|Core Phase|Withdrawal by Subject|2|||
150129922|NCT01270347|541609928|FG000|Core Phase|Lost to Follow-up|0|||
150129923|NCT01270347|541609929|FG001|Core Phase|Lost to Follow-up|1|||
150129924|NCT01270347|541609928|FG000|Core Phase|Miscellaneous|8|||
150129925|NCT01270347|541609929|FG001|Core Phase|Miscellaneous|14|||
150129926|NCT01270347|541609928|FG000|Extension Phase|Adverse Event|1|||
150129927|NCT01270347|541609929|FG001|Extension Phase|Adverse Event|3|||
150129928|NCT01270347|541609928|FG000|Extension Phase|Withdrawal by Subject|3|||
150129929|NCT01270347|541609929|FG001|Extension Phase|Withdrawal by Subject|4|||
150129930|NCT01270347|541609928|FG000|Extension Phase|Miscellaneous|2|||
150129931|NCT01270347|541609929|FG001|Extension Phase|Miscellaneous|2|||
150129932|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
150129933|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
150129934|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
150129935|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
150129936|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
150129937|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
150129938|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
150129939|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
150129940|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
150129941|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
150129942|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
150129943|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
150129944|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
150129945|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
150129946|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
150129947|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
150129948|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
150129949|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
150129950|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
150129951|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
150129952|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
150129953|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
150129954|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
150129955|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
150129956|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
150129957|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
150129958|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
150129959|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
150129960|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
150129961|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
150129962|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
150129963|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
150129964|NCT04818346|541609930|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
150129965|NCT04818346|541609931|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
150195320|NCT03854227|541856496|FG002|Overall Study|Adverse Event|0|||
150129966|NCT04818346|541609932|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
150129967|NCT04818346|541609933|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
150129968|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
150129969|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
150129970|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
150129971|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
150129972|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
150129973|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
150129974|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
150129975|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
150129976|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
150129977|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
150129978|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
150129979|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
150129980|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
150129981|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
150129982|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
150129983|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
150129984|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
150129985|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
150129986|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
150129987|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
150129988|NCT04818346|541609930|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
150129989|NCT04818346|541609931|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
150129990|NCT04818346|541609932|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
150129991|NCT04818346|541609933|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
150129992|NCT05553808|541609934|FG000|Overall Study|Death|25|||
150129993|NCT05553808|541609935|FG001|Overall Study|Death|62|||
150129994|NCT05553808|541609934|FG000|Overall Study|Site Closed|6|||
150129995|NCT05553808|541609935|FG001|Overall Study|Site Closed|6|||
150129996|NCT05553808|541609934|FG000|Overall Study|Lost to Follow-up|1|||
150129997|NCT05553808|541609935|FG001|Overall Study|Lost to Follow-up|0|||
150129998|NCT05553808|541609934|FG000|Overall Study|Withdrawal by Subject|3|||
150129999|NCT05553808|541609935|FG001|Overall Study|Withdrawal by Subject|2|||
150130000|NCT02273141|541609936|FG000|Overall Study|Adverse Event|0|||
150130001|NCT02273141|541609937|FG001|Overall Study|Adverse Event|1|||
150130002|NCT02273141|541609936|FG000|Overall Study|Lost to Follow-up|1|||
150130003|NCT02273141|541609937|FG001|Overall Study|Lost to Follow-up|3|||
150130004|NCT02273141|541609936|FG000|Overall Study|Withdrawal by Subject|10|||
150130005|NCT02273141|541609937|FG001|Overall Study|Withdrawal by Subject|15|||
150130006|NCT02273141|541609936|FG000|Overall Study|Various|6|||
150130007|NCT02273141|541609937|FG001|Overall Study|Various|6|||
150130008|NCT00492284|541609938|FG000|Overall Study|Adverse Event|0|||
150130009|NCT00492284|541609939|FG001|Overall Study|Adverse Event|1|||
150130010|NCT00492284|541609940|FG002|Overall Study|Adverse Event|1|||
150130011|NCT00492284|541609941|FG003|Overall Study|Adverse Event|2|||
150130012|NCT00492284|541609938|FG000|Overall Study|Lost to Follow-up|0|||
150130013|NCT00492284|541609939|FG001|Overall Study|Lost to Follow-up|0|||
150130014|NCT00492284|541609940|FG002|Overall Study|Lost to Follow-up|3|||
150130015|NCT00492284|541609941|FG003|Overall Study|Lost to Follow-up|1|||
150130016|NCT00492284|541609938|FG000|Overall Study|Death|0|||
150130017|NCT00492284|541609939|FG001|Overall Study|Death|3|||
150130018|NCT00492284|541609940|FG002|Overall Study|Death|2|||
150130019|NCT00492284|541609941|FG003|Overall Study|Death|5|||
150130020|NCT00492284|541609938|FG000|Overall Study|Withdrawal by Subject|1|||
150130021|NCT00492284|541609939|FG001|Overall Study|Withdrawal by Subject|0|||
150130022|NCT00492284|541609940|FG002|Overall Study|Withdrawal by Subject|0|||
150130023|NCT00492284|541609941|FG003|Overall Study|Withdrawal by Subject|2|||
150130024|NCT02734212|541609942|FG000|Overall Study|Lost to Follow-up|5|||
150130025|NCT02734212|541609943|FG001|Overall Study|Lost to Follow-up|10|||
150130026|NCT04313881|541609944|FG000|Overall Study|Death|138|||
150130027|NCT04313881|541609945|FG001|Overall Study|Death|126|||
150130028|NCT04313881|541609944|FG000|Overall Study|Study terminated by sponsor|108|||
150130029|NCT04313881|541609945|FG001|Overall Study|Study terminated by sponsor|129|||
150130030|NCT04313881|541609944|FG000|Overall Study|Consent withdrawn|19|||
150130031|NCT04313881|541609945|FG001|Overall Study|Consent withdrawn|15|||
150130032|NCT04313881|541609944|FG000|Overall Study|Reason not Specified|3|||
150130033|NCT04313881|541609945|FG001|Overall Study|Reason not Specified|1|||
150130034|NCT00727272|541609946|FG000|Washout Period A|Adverse Event|0|||
150130035|NCT00727272|541609947|FG001|Washout Period A|Adverse Event|0|||
150130036|NCT00727272|541609948|FG002|Washout Period A|Adverse Event|1|||
150130037|NCT00727272|541609946|FG000|Washout Period B|Withdrawal by Subject|0|||
150130038|NCT00727272|541609947|FG001|Washout Period B|Withdrawal by Subject|0|||
150130039|NCT00727272|541609948|FG002|Washout Period B|Withdrawal by Subject|1|||
150130040|NCT00651664|541609949|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
150130041|NCT00651664|541609950|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
150130042|NCT00651664|541609951|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
150130043|NCT00651664|541609952|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
150130044|NCT00651664|541609953|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
150130045|NCT00651664|541609954|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
150130046|NCT00651664|541609955|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
150130047|NCT00651664|541609956|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
150130048|NCT00651664|541609957|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
150130049|NCT00651664|541609958|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
150130050|NCT00651664|541609949|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130051|NCT00651664|541609950|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130052|NCT00651664|541609951|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130053|NCT00651664|541609952|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130054|NCT00651664|541609953|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
150130055|NCT00651664|541609954|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
150130056|NCT00651664|541609955|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130057|NCT00651664|541609956|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
150130058|NCT00651664|541609957|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
150130059|NCT00651664|541609958|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
150130060|NCT00651664|541609949|FG000|Overall Study|Progressive Disease|3|||
150130061|NCT00651664|541609950|FG001|Overall Study|Progressive Disease|3|||
150130062|NCT00651664|541609951|FG002|Overall Study|Progressive Disease|3|||
150130063|NCT00651664|541609952|FG003|Overall Study|Progressive Disease|12|||
150130064|NCT00651664|541609953|FG004|Overall Study|Progressive Disease|4|||
150130065|NCT00651664|541609954|FG005|Overall Study|Progressive Disease|1|||
150130066|NCT00651664|541609955|FG006|Overall Study|Progressive Disease|3|||
150130067|NCT00651664|541609956|FG007|Overall Study|Progressive Disease|6|||
150130068|NCT00651664|541609957|FG008|Overall Study|Progressive Disease|5|||
150130069|NCT00651664|541609958|FG009|Overall Study|Progressive Disease|5|||
150130070|NCT00651664|541609949|FG000|Overall Study|Patient Declined Further Treatment|0|||
150130071|NCT00651664|541609950|FG001|Overall Study|Patient Declined Further Treatment|0|||
150130072|NCT00651664|541609951|FG002|Overall Study|Patient Declined Further Treatment|0|||
150130073|NCT00651664|541609952|FG003|Overall Study|Patient Declined Further Treatment|1|||
150130074|NCT00651664|541609953|FG004|Overall Study|Patient Declined Further Treatment|1|||
150130075|NCT00651664|541609954|FG005|Overall Study|Patient Declined Further Treatment|1|||
150130076|NCT00651664|541609955|FG006|Overall Study|Patient Declined Further Treatment|0|||
150130077|NCT00651664|541609956|FG007|Overall Study|Patient Declined Further Treatment|0|||
150130078|NCT00651664|541609957|FG008|Overall Study|Patient Declined Further Treatment|0|||
150130079|NCT00651664|541609958|FG009|Overall Study|Patient Declined Further Treatment|1|||
150130080|NCT00651664|541609949|FG000|Overall Study|Symptomatic Deterioration|0|||
150130081|NCT00651664|541609950|FG001|Overall Study|Symptomatic Deterioration|0|||
150130082|NCT00651664|541609951|FG002|Overall Study|Symptomatic Deterioration|0|||
150130083|NCT00651664|541609952|FG003|Overall Study|Symptomatic Deterioration|1|||
150130084|NCT00651664|541609953|FG004|Overall Study|Symptomatic Deterioration|0|||
150130085|NCT00651664|541609954|FG005|Overall Study|Symptomatic Deterioration|0|||
150130086|NCT00651664|541609955|FG006|Overall Study|Symptomatic Deterioration|1|||
150130087|NCT00651664|541609956|FG007|Overall Study|Symptomatic Deterioration|0|||
150130088|NCT00651664|541609957|FG008|Overall Study|Symptomatic Deterioration|1|||
150130089|NCT00651664|541609958|FG009|Overall Study|Symptomatic Deterioration|0|||
150130090|NCT00651664|541609949|FG000|Overall Study|Reason not Specified|0|||
150130091|NCT00651664|541609950|FG001|Overall Study|Reason not Specified|0|||
150130092|NCT00651664|541609951|FG002|Overall Study|Reason not Specified|0|||
150130093|NCT00651664|541609952|FG003|Overall Study|Reason not Specified|0|||
150130094|NCT00651664|541609953|FG004|Overall Study|Reason not Specified|0|||
150130095|NCT00651664|541609954|FG005|Overall Study|Reason not Specified|0|||
150130096|NCT00651664|541609955|FG006|Overall Study|Reason not Specified|1|||
150130097|NCT00651664|541609956|FG007|Overall Study|Reason not Specified|0|||
150130098|NCT00651664|541609957|FG008|Overall Study|Reason not Specified|0|||
150130099|NCT00651664|541609958|FG009|Overall Study|Reason not Specified|0|||
150130100|NCT00688636|541609959|FG000|Overall Study|Adverse Event|2|||
150130101|NCT00688636|541609960|FG001|Overall Study|Adverse Event|1|||
150130102|NCT01572727|541609961|FG000|Overall Study|Adverse Event|43|||
150130103|NCT01572727|541609962|FG001|Overall Study|Adverse Event|15|||
150130104|NCT01572727|541609961|FG000|Overall Study|Lost to Follow-up|1|||
150130105|NCT01572727|541609962|FG001|Overall Study|Lost to Follow-up|1|||
150130106|NCT01572727|541609961|FG000|Overall Study|Physician Decision|23|||
150130107|NCT01572727|541609962|FG001|Overall Study|Physician Decision|9|||
150130108|NCT01572727|541609961|FG000|Overall Study|Progressive disease|59|||
150130109|NCT01572727|541609962|FG001|Overall Study|Progressive disease|82|||
150130110|NCT01572727|541609961|FG000|Overall Study|Protocol Violation|0|||
150130111|NCT01572727|541609962|FG001|Overall Study|Protocol Violation|1|||
150130112|NCT01572727|541609961|FG000|Overall Study|Study terminated by sponsor|61|||
150130113|NCT01572727|541609962|FG001|Overall Study|Study terminated by sponsor|83|||
150130114|NCT01572727|541609961|FG000|Overall Study|Parent/guardian decision|14|||
150130115|NCT01572727|541609962|FG001|Overall Study|Parent/guardian decision|9|||
150130116|NCT01572727|541609961|FG000|Overall Study|Death|2|||
150130117|NCT01572727|541609962|FG001|Overall Study|Death|2|||
150130118|NCT01572727|541609961|FG000|Overall Study|Untreated|4|||
150130119|NCT01572727|541609962|FG001|Overall Study|Untreated|7|||
150130120|NCT04053764|541609963|FG000|Overall Study|Withdrawal by Subject|6|||
150130121|NCT04053764|541609964|FG001|Overall Study|Withdrawal by Subject|2|||
150130122|NCT04053764|541609963|FG000|Overall Study|Physician Decision|2|||
150130123|NCT04053764|541609964|FG001|Overall Study|Physician Decision|1|||
150130124|NCT04053764|541609963|FG000|Overall Study|Adverse Event|1|||
150130125|NCT04053764|541609964|FG001|Overall Study|Adverse Event|0|||
150130126|NCT04053764|541609963|FG000|Overall Study|Pregnancy|1|||
150130127|NCT04053764|541609964|FG001|Overall Study|Pregnancy|0|||
150130128|NCT04732286|541609965|FG000|Overall Study|Progressive Disease|2|||
150130129|NCT04732286|541609965|FG000|Overall Study|Physician Decision|1|||
150130130|NCT04732286|541609965|FG000|Overall Study|Study Terminated by Sponsor|31|||
150130131|NCT04732286|541609965|FG000|Overall Study|Withdrawal by Subject|10|||
150130132|NCT04732286|541609965|FG000|Overall Study|Non-compliance With Study Drug|1|||
150130133|NCT04732286|541609965|FG000|Overall Study|Lost to Follow-up|4|||
150130134|NCT04732286|541609965|FG000|Overall Study|Death|51|||
150130135|NCT01474681|541609966|FG000|Overall Study|Death|0|||
150130136|NCT01474681|541609967|FG001|Overall Study|Death|3|||
150130137|NCT01474681|541609968|FG002|Overall Study|Death|2|||
150130138|NCT01474681|541609969|FG003|Overall Study|Death|6|||
150130139|NCT02195986|541609972|FG000|Overall Study|Adverse Event|3|||
150130140|NCT02195986|541609973|FG001|Overall Study|Adverse Event|0|||
150130141|NCT02195986|541609974|FG002|Overall Study|Adverse Event|0|||
150130142|NCT02195986|541609972|FG000|Overall Study|Withdrawal by Subject|0|||
150130143|NCT02195986|541609973|FG001|Overall Study|Withdrawal by Subject|3|||
150130144|NCT02195986|541609974|FG002|Overall Study|Withdrawal by Subject|0|||
150130145|NCT02195986|541609972|FG000|Overall Study|Family Emergency|0|||
150130146|NCT02195986|541609973|FG001|Overall Study|Family Emergency|0|||
150130147|NCT02195986|541609974|FG002|Overall Study|Family Emergency|1|||
150130148|NCT02195986|541609972|FG000|Overall Study|Protocol Violation|0|||
150130149|NCT02195986|541609973|FG001|Overall Study|Protocol Violation|1|||
150130150|NCT02195986|541609974|FG002|Overall Study|Protocol Violation|1|||
150130151|NCT02195986|541609972|FG000|Overall Study|Non-compliance|0|||
150130152|NCT02195986|541609973|FG001|Overall Study|Non-compliance|1|||
150130153|NCT02195986|541609974|FG002|Overall Study|Non-compliance|0|||
150130154|NCT02834780|541609977|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
150130155|NCT02834780|541609978|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
150130156|NCT02834780|541609979|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
150130157|NCT02834780|541609980|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
150130158|NCT02834780|541609981|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
150130159|NCT02834780|541609982|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
150130160|NCT02834780|541609983|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
150130161|NCT02834780|541609984|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
150130162|NCT02834780|541609985|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
150130163|NCT02834780|541609986|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
150130164|NCT02834780|541609987|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
150130165|NCT02834780|541609988|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
150130166|NCT02834780|541609989|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
150130167|NCT02834780|541609977|FG000|Overall Study|Withdrawal by Subject|0|||
150130168|NCT02834780|541609978|FG001|Overall Study|Withdrawal by Subject|0|||
150130169|NCT02834780|541609979|FG002|Overall Study|Withdrawal by Subject|1|||
150130170|NCT02834780|541609980|FG003|Overall Study|Withdrawal by Subject|0|||
150130171|NCT02834780|541609981|FG004|Overall Study|Withdrawal by Subject|0|||
150130172|NCT02834780|541609982|FG005|Overall Study|Withdrawal by Subject|0|||
150130173|NCT02834780|541609983|FG006|Overall Study|Withdrawal by Subject|0|||
150130174|NCT02834780|541609984|FG007|Overall Study|Withdrawal by Subject|0|||
150130175|NCT02834780|541609985|FG008|Overall Study|Withdrawal by Subject|0|||
150130176|NCT02834780|541609986|FG009|Overall Study|Withdrawal by Subject|0|||
150130177|NCT02834780|541609987|FG010|Overall Study|Withdrawal by Subject|1|||
150130178|NCT02834780|541609988|FG011|Overall Study|Withdrawal by Subject|0|||
150130179|NCT02834780|541609989|FG012|Overall Study|Withdrawal by Subject|0|||
150130180|NCT02834780|541609977|FG000|Overall Study|Adverse Event|0|||
150130181|NCT02834780|541609978|FG001|Overall Study|Adverse Event|0|||
150130182|NCT02834780|541609979|FG002|Overall Study|Adverse Event|0|||
150130183|NCT02834780|541609980|FG003|Overall Study|Adverse Event|0|||
150130184|NCT02834780|541609981|FG004|Overall Study|Adverse Event|1|||
150130185|NCT02834780|541609982|FG005|Overall Study|Adverse Event|0|||
150130186|NCT02834780|541609983|FG006|Overall Study|Adverse Event|1|||
150130187|NCT02834780|541609984|FG007|Overall Study|Adverse Event|1|||
150195321|NCT03854227|541856497|FG003|Overall Study|Adverse Event|1|||
150195322|NCT03854227|541856498|FG004|Overall Study|Adverse Event|0|||
150195323|NCT03854227|541856499|FG005|Overall Study|Adverse Event|0|||
150195324|NCT03854227|541856500|FG006|Overall Study|Adverse Event|1|||
150195325|NCT03854227|541856501|FG007|Overall Study|Adverse Event|0|||
150195326|NCT03854227|541856502|FG008|Overall Study|Adverse Event|0|||
150195327|NCT03854227|541856503|FG009|Overall Study|Adverse Event|3|||
150195328|NCT03854227|541856504|FG010|Overall Study|Adverse Event|0|||
150195329|NCT03854227|541856505|FG011|Overall Study|Adverse Event|1|||
150195330|NCT03854227|541856494|FG000|Overall Study|Death|0|||
150195331|NCT03854227|541856495|FG001|Overall Study|Death|0|||
150195332|NCT03854227|541856496|FG002|Overall Study|Death|0|||
150195333|NCT03854227|541856497|FG003|Overall Study|Death|0|||
150195334|NCT03854227|541856498|FG004|Overall Study|Death|0|||
150195335|NCT03854227|541856499|FG005|Overall Study|Death|1|||
150195336|NCT03854227|541856500|FG006|Overall Study|Death|0|||
150195337|NCT03854227|541856501|FG007|Overall Study|Death|0|||
150195338|NCT03854227|541856502|FG008|Overall Study|Death|0|||
150195339|NCT03854227|541856503|FG009|Overall Study|Death|1|||
150195340|NCT03854227|541856504|FG010|Overall Study|Death|0|||
150195341|NCT03854227|541856505|FG011|Overall Study|Death|1|||
150195342|NCT03854227|541856494|FG000|Overall Study|Physician Decision|0|||
150195343|NCT03854227|541856495|FG001|Overall Study|Physician Decision|0|||
150195344|NCT03854227|541856496|FG002|Overall Study|Physician Decision|0|||
150195345|NCT03854227|541856497|FG003|Overall Study|Physician Decision|0|||
150195346|NCT03854227|541856498|FG004|Overall Study|Physician Decision|0|||
150195347|NCT03854227|541856499|FG005|Overall Study|Physician Decision|1|||
150195348|NCT03854227|541856500|FG006|Overall Study|Physician Decision|0|||
150195349|NCT03854227|541856501|FG007|Overall Study|Physician Decision|0|||
150195350|NCT03854227|541856502|FG008|Overall Study|Physician Decision|1|||
150195351|NCT03854227|541856503|FG009|Overall Study|Physician Decision|1|||
150195352|NCT03854227|541856504|FG010|Overall Study|Physician Decision|0|||
150195353|NCT03854227|541856505|FG011|Overall Study|Physician Decision|1|||
150195354|NCT03854227|541856494|FG000|Overall Study|Progressive disease|1|||
150195355|NCT03854227|541856495|FG001|Overall Study|Progressive disease|1|||
150195356|NCT03854227|541856496|FG002|Overall Study|Progressive disease|1|||
150195357|NCT03854227|541856497|FG003|Overall Study|Progressive disease|2|||
150130188|NCT02834780|541609985|FG008|Overall Study|Adverse Event|0|||
150195358|NCT03854227|541856498|FG004|Overall Study|Progressive disease|3|||
150195359|NCT03854227|541856499|FG005|Overall Study|Progressive disease|1|||
150195360|NCT03854227|541856500|FG006|Overall Study|Progressive disease|2|||
150195361|NCT03854227|541856501|FG007|Overall Study|Progressive disease|5|||
150195362|NCT03854227|541856502|FG008|Overall Study|Progressive disease|2|||
150195363|NCT03854227|541856503|FG009|Overall Study|Progressive disease|5|||
150195364|NCT03854227|541856504|FG010|Overall Study|Progressive disease|1|||
150195365|NCT03854227|541856505|FG011|Overall Study|Progressive disease|6|||
150195366|NCT03854227|541856494|FG000|Overall Study|Study terminated by sponsor|0|||
150195367|NCT03854227|541856495|FG001|Overall Study|Study terminated by sponsor|0|||
150195368|NCT03854227|541856496|FG002|Overall Study|Study terminated by sponsor|0|||
150195369|NCT03854227|541856497|FG003|Overall Study|Study terminated by sponsor|0|||
150195370|NCT03854227|541856498|FG004|Overall Study|Study terminated by sponsor|0|||
150195371|NCT03854227|541856499|FG005|Overall Study|Study terminated by sponsor|0|||
150195372|NCT03854227|541856500|FG006|Overall Study|Study terminated by sponsor|0|||
150195373|NCT03854227|541856501|FG007|Overall Study|Study terminated by sponsor|0|||
150195374|NCT03854227|541856502|FG008|Overall Study|Study terminated by sponsor|0|||
150195375|NCT03854227|541856503|FG009|Overall Study|Study terminated by sponsor|1|||
150195376|NCT03854227|541856504|FG010|Overall Study|Study terminated by sponsor|0|||
150195377|NCT03854227|541856505|FG011|Overall Study|Study terminated by sponsor|0|||
150195378|NCT03854227|541856494|FG000|Overall Study|Withdrawal by Subject|0|||
150195379|NCT03854227|541856495|FG001|Overall Study|Withdrawal by Subject|0|||
150195380|NCT03854227|541856496|FG002|Overall Study|Withdrawal by Subject|1|||
150195381|NCT03854227|541856497|FG003|Overall Study|Withdrawal by Subject|0|||
150195382|NCT03854227|541856498|FG004|Overall Study|Withdrawal by Subject|0|||
150195383|NCT03854227|541856499|FG005|Overall Study|Withdrawal by Subject|0|||
150195384|NCT03854227|541856500|FG006|Overall Study|Withdrawal by Subject|0|||
150195385|NCT03854227|541856501|FG007|Overall Study|Withdrawal by Subject|0|||
150195386|NCT03854227|541856502|FG008|Overall Study|Withdrawal by Subject|0|||
150195387|NCT03854227|541856503|FG009|Overall Study|Withdrawal by Subject|1|||
150195388|NCT03854227|541856504|FG010|Overall Study|Withdrawal by Subject|1|||
150195389|NCT03854227|541856505|FG011|Overall Study|Withdrawal by Subject|0|||
150195390|NCT03854227|541856494|FG000|Overall Study|Disease relapse|0|||
150195391|NCT03854227|541856495|FG001|Overall Study|Disease relapse|0|||
150195392|NCT03854227|541856496|FG002|Overall Study|Disease relapse|0|||
150195393|NCT03854227|541856497|FG003|Overall Study|Disease relapse|0|||
150195394|NCT03854227|541856498|FG004|Overall Study|Disease relapse|0|||
150195395|NCT03854227|541856499|FG005|Overall Study|Disease relapse|0|||
150195396|NCT03854227|541856500|FG006|Overall Study|Disease relapse|0|||
150195397|NCT03854227|541856501|FG007|Overall Study|Disease relapse|0|||
150195398|NCT03854227|541856502|FG008|Overall Study|Disease relapse|1|||
150195399|NCT03854227|541856503|FG009|Overall Study|Disease relapse|0|||
150195400|NCT03854227|541856504|FG010|Overall Study|Disease relapse|0|||
150195401|NCT03854227|541856505|FG011|Overall Study|Disease relapse|0|||
150195402|NCT03854227|541856494|FG000|Overall Study|Global deterioration of health status|0|||
150195403|NCT03854227|541856495|FG001|Overall Study|Global deterioration of health status|0|||
150195404|NCT03854227|541856496|FG002|Overall Study|Global deterioration of health status|0|||
150195405|NCT03854227|541856497|FG003|Overall Study|Global deterioration of health status|0|||
150195406|NCT03854227|541856498|FG004|Overall Study|Global deterioration of health status|0|||
150195407|NCT03854227|541856499|FG005|Overall Study|Global deterioration of health status|1|||
150195408|NCT03854227|541856500|FG006|Overall Study|Global deterioration of health status|0|||
150195409|NCT03854227|541856501|FG007|Overall Study|Global deterioration of health status|1|||
150195410|NCT03854227|541856502|FG008|Overall Study|Global deterioration of health status|0|||
150195411|NCT03854227|541856503|FG009|Overall Study|Global deterioration of health status|0|||
150195412|NCT03854227|541856504|FG010|Overall Study|Global deterioration of health status|0|||
150195413|NCT03854227|541856505|FG011|Overall Study|Global deterioration of health status|0|||
150195414|NCT03854227|541856494|FG000|Overall Study|Refused further treatment|0|||
150195415|NCT03854227|541856495|FG001|Overall Study|Refused further treatment|0|||
150195416|NCT03854227|541856496|FG002|Overall Study|Refused further treatment|0|||
150195417|NCT03854227|541856497|FG003|Overall Study|Refused further treatment|0|||
150195418|NCT03854227|541856498|FG004|Overall Study|Refused further treatment|0|||
150195419|NCT03854227|541856499|FG005|Overall Study|Refused further treatment|0|||
150195420|NCT03854227|541856500|FG006|Overall Study|Refused further treatment|0|||
150195421|NCT03854227|541856501|FG007|Overall Study|Refused further treatment|0|||
150195422|NCT03854227|541856502|FG008|Overall Study|Refused further treatment|0|||
150195423|NCT03854227|541856503|FG009|Overall Study|Refused further treatment|1|||
150195424|NCT03854227|541856504|FG010|Overall Study|Refused further treatment|0|||
150195425|NCT03854227|541856505|FG011|Overall Study|Refused further treatment|1|||
150195426|NCT03854227|541856494|FG000|Overall Study|Other|0|||
150195427|NCT03854227|541856495|FG001|Overall Study|Other|0|||
150195428|NCT03854227|541856496|FG002|Overall Study|Other|0|||
150195429|NCT03854227|541856497|FG003|Overall Study|Other|0|||
150195430|NCT03854227|541856498|FG004|Overall Study|Other|0|||
150195431|NCT03854227|541856499|FG005|Overall Study|Other|0|||
150195432|NCT03854227|541856500|FG006|Overall Study|Other|0|||
150195433|NCT03854227|541856501|FG007|Overall Study|Other|0|||
150195434|NCT03854227|541856502|FG008|Overall Study|Other|1|||
150195435|NCT03854227|541856503|FG009|Overall Study|Other|1|||
150195436|NCT03854227|541856504|FG010|Overall Study|Other|0|||
150195437|NCT03854227|541856505|FG011|Overall Study|Other|0|||
150195438|NCT03668236|541856506|FG000|90-day Follow-up|Withdrawal by Subject|3|||
150195439|NCT03668236|541856507|FG001|90-day Follow-up|Withdrawal by Subject|2|||
150195440|NCT03668236|541856506|FG000|90-day Follow-up|Lost to Follow-up|3|||
150195441|NCT03668236|541856507|FG001|90-day Follow-up|Lost to Follow-up|1|||
150195442|NCT03668236|541856506|FG000|Baseline Characteristics|Lost to Follow-up|9|||
150195443|NCT03668236|541856507|FG001|Baseline Characteristics|Lost to Follow-up|5|||
150195444|NCT03668236|541856506|FG000|1-year Follow-up|Withdrawal by Subject|17|||
150195445|NCT03668236|541856507|FG001|1-year Follow-up|Withdrawal by Subject|15|||
150195446|NCT06132282|541856508|FG000|Overall Study|Lost to Follow-up|31|||
150195447|NCT03748953|541856509|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
150195448|NCT03748953|541856510|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
150195449|NCT03748953|541856509|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
150195450|NCT03748953|541856510|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
150195451|NCT03748953|541856509|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
150195452|NCT03748953|541856510|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
150195453|NCT03748953|541856509|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
150195454|NCT03748953|541856510|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
150195455|NCT03748953|541856509|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
150195456|NCT03748953|541856510|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
150195457|NCT04119843|541856513|FG000|Overall Study|Adverse Event|3|||
150195458|NCT04119843|541856513|FG000|Overall Study|Death|1|||
150195459|NCT04233216|541856515|FG000|Overall Study|Lost to Follow-up|1|||
150195460|NCT04233216|541856516|FG001|Overall Study|Lost to Follow-up|0|||
150195461|NCT04233216|541856517|FG002|Overall Study|Lost to Follow-up|2|||
150195462|NCT04233216|541856518|FG003|Overall Study|Lost to Follow-up|0|||
150195463|NCT04233216|541856515|FG000|Overall Study|Physician Decision|0|||
150195464|NCT04233216|541856516|FG001|Overall Study|Physician Decision|3|||
150195465|NCT04233216|541856517|FG002|Overall Study|Physician Decision|0|||
150195466|NCT04233216|541856518|FG003|Overall Study|Physician Decision|2|||
150195467|NCT04233216|541856515|FG000|Overall Study|Withdrawal by Subject|0|||
150195468|NCT04233216|541856516|FG001|Overall Study|Withdrawal by Subject|2|||
150195469|NCT04233216|541856517|FG002|Overall Study|Withdrawal by Subject|1|||
150195470|NCT04233216|541856518|FG003|Overall Study|Withdrawal by Subject|0|||
150195471|NCT04231149|541856519|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
150195472|NCT04231149|541856520|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
150195473|NCT04231149|541856521|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
150195474|NCT04231149|541856522|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
150195475|NCT04231149|541856523|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
150195476|NCT03252847|541856524|FG000|Overall Study|Withdrawal by Subject|0|||
150195477|NCT03252847|541856525|FG001|Overall Study|Withdrawal by Subject|0|||
150195478|NCT03252847|541856526|FG002|Overall Study|Withdrawal by Subject|1|||
150195479|NCT03252847|541856527|FG003|Overall Study|Withdrawal by Subject|0|||
150195480|NCT03252847|541856528|FG004|Overall Study|Withdrawal by Subject|0|||
150195481|NCT03252847|541856529|FG005|Overall Study|Withdrawal by Subject|0|||
150195482|NCT03252847|541856530|FG006|Overall Study|Withdrawal by Subject|0|||
150195483|NCT03252847|541856524|FG000|Overall Study|Other: Patient decision|0|||
150195484|NCT03252847|541856525|FG001|Overall Study|Other: Patient decision|0|||
150195485|NCT03252847|541856526|FG002|Overall Study|Other: Patient decision|0|||
150195486|NCT03252847|541856527|FG003|Overall Study|Other: Patient decision|0|||
150195487|NCT03252847|541856528|FG004|Overall Study|Other: Patient decision|1|||
150195488|NCT03252847|541856529|FG005|Overall Study|Other: Patient decision|0|||
150195489|NCT03252847|541856530|FG006|Overall Study|Other: Patient decision|0|||
150195490|NCT05808257|541856533|FG000|Overall Study|Lost to Follow-up|8|||
150195491|NCT05808257|541856534|FG001|Overall Study|Lost to Follow-up|8|||
150195492|NCT04042233|541856535|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
150195493|NCT04042233|541856536|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
150195494|NCT04042233|541856535|FG000|Overall Study|Protocol Violation|0|||
150130189|NCT02834780|541609986|FG009|Overall Study|Adverse Event|2|||
150130190|NCT02834780|541609987|FG010|Overall Study|Adverse Event|0|||
150130191|NCT02834780|541609988|FG011|Overall Study|Adverse Event|3|||
150130192|NCT02834780|541609989|FG012|Overall Study|Adverse Event|2|||
150130193|NCT02834780|541609977|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130194|NCT02834780|541609978|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
150130195|NCT02834780|541609979|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
150130196|NCT02834780|541609980|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130197|NCT02834780|541609981|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130198|NCT02834780|541609982|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130199|NCT02834780|541609983|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130200|NCT02834780|541609984|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
150130201|NCT02834780|541609985|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
150130202|NCT02834780|541609986|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
150130203|NCT02834780|541609987|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
150130204|NCT02834780|541609988|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
150130205|NCT02834780|541609989|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
150130206|NCT02834780|541609977|FG000|Overall Study|Other|1|||
150130207|NCT02834780|541609978|FG001|Overall Study|Other|0|||
150130208|NCT02834780|541609979|FG002|Overall Study|Other|1|||
150130209|NCT02834780|541609980|FG003|Overall Study|Other|2|||
150130210|NCT02834780|541609981|FG004|Overall Study|Other|0|||
150130211|NCT02834780|541609982|FG005|Overall Study|Other|0|||
150130212|NCT02834780|541609983|FG006|Overall Study|Other|0|||
150130213|NCT02834780|541609984|FG007|Overall Study|Other|0|||
150130214|NCT02834780|541609985|FG008|Overall Study|Other|0|||
150130215|NCT02834780|541609986|FG009|Overall Study|Other|0|||
150130216|NCT02834780|541609987|FG010|Overall Study|Other|0|||
150130217|NCT02834780|541609988|FG011|Overall Study|Other|0|||
150130218|NCT02834780|541609989|FG012|Overall Study|Other|1|||
150130219|NCT03150056|541609990|FG000|Overall Study|Withdrawal by Subject|0|||
150130220|NCT03150056|541609991|FG001|Overall Study|Withdrawal by Subject|0|||
150130221|NCT03150056|541609992|FG002|Overall Study|Withdrawal by Subject|0|||
150130222|NCT03150056|541609993|FG003|Overall Study|Withdrawal by Subject|0|||
150130223|NCT03150056|541609994|FG004|Overall Study|Withdrawal by Subject|0|||
150130224|NCT03150056|541609995|FG005|Overall Study|Withdrawal by Subject|2|||
150130225|NCT03150056|541609990|FG000|Overall Study|Study terminated by Sponsor|1|||
150130226|NCT03150056|541609991|FG001|Overall Study|Study terminated by Sponsor|3|||
150130227|NCT03150056|541609992|FG002|Overall Study|Study terminated by Sponsor|1|||
150130228|NCT03150056|541609993|FG003|Overall Study|Study terminated by Sponsor|1|||
150130229|NCT03150056|541609994|FG004|Overall Study|Study terminated by Sponsor|5|||
150130230|NCT03150056|541609995|FG005|Overall Study|Study terminated by Sponsor|6|||
150130231|NCT03150056|541609990|FG000|Overall Study|Death|9|||
150130232|NCT03150056|541609991|FG001|Overall Study|Death|2|||
150130233|NCT03150056|541609992|FG002|Overall Study|Death|2|||
150130234|NCT03150056|541609993|FG003|Overall Study|Death|7|||
150130235|NCT03150056|541609994|FG004|Overall Study|Death|8|||
150130236|NCT03150056|541609995|FG005|Overall Study|Death|10|||
150130237|NCT02251990|541610005|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
150130238|NCT02251990|541610006|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
150130239|NCT02251990|541610005|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
150130240|NCT02251990|541610006|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
150130241|NCT02251990|541610005|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
150130242|NCT02251990|541610006|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
150130243|NCT02251990|541610005|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
150130244|NCT02251990|541610006|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
150130245|NCT02251990|541610005|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
150130246|NCT02251990|541610006|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
150130247|NCT02251990|541610005|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
150130248|NCT02251990|541610006|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
150130249|NCT03265600|541610007|FG000|Overall Study|Lost to Follow-up|17|||
150130250|NCT03265600|541610008|FG001|Overall Study|Lost to Follow-up|5|||
150130251|NCT03265600|541610007|FG000|Overall Study|Withdrawal by Subject|4|||
150130252|NCT03265600|541610008|FG001|Overall Study|Withdrawal by Subject|2|||
150130253|NCT03265600|541610007|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
150130254|NCT03265600|541610008|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
150130255|NCT02293538|541610009|FG000|Overall Study|Adverse Event|0|||
150130256|NCT02293538|541610010|FG001|Overall Study|Adverse Event|1|||
150130257|NCT02293538|541610009|FG000|Overall Study|Lost to Follow-up|1|||
150130258|NCT02293538|541610010|FG001|Overall Study|Lost to Follow-up|0|||
150130259|NCT02293538|541610009|FG000|Overall Study|Withdrawal by Subject|0|||
150130260|NCT02293538|541610010|FG001|Overall Study|Withdrawal by Subject|1|||
150130261|NCT02269670|541610015|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
150130262|NCT01962493|541610018|FG000|Overall Study|Adverse Event|1|||
150130263|NCT01962493|541610019|FG001|Overall Study|Adverse Event|2|||
150130264|NCT01962493|541610018|FG000|Overall Study|Protocol Violation|0|||
150130265|NCT01962493|541610019|FG001|Overall Study|Protocol Violation|1|||
150130266|NCT01962493|541610018|FG000|Overall Study|Withdrawal by Subject|4|||
150130267|NCT01962493|541610019|FG001|Overall Study|Withdrawal by Subject|2|||
150130268|NCT00003508|541611453|FG000|Overall Study|Not evaluable|5|||
150130269|NCT02160314|541611454|FG000|Overall Study|Adverse Event|0|||
150130270|NCT02160314|541611455|FG001|Overall Study|Adverse Event|6|||
150130271|NCT02160314|541611454|FG000|Overall Study|Protocol Violation|0|||
150130272|NCT02160314|541611455|FG001|Overall Study|Protocol Violation|4|||
150130273|NCT02160314|541611454|FG000|Overall Study|Withdrawal by Subject|1|||
150130274|NCT02160314|541611455|FG001|Overall Study|Withdrawal by Subject|2|||
150130275|NCT02160314|541611454|FG000|Overall Study|Lost to Follow-up|0|||
150130276|NCT02160314|541611455|FG001|Overall Study|Lost to Follow-up|1|||
150130277|NCT03576768|541611456|FG000|Overall Study|Lost to Follow-up|3|||
150130278|NCT03576768|541611457|FG001|Overall Study|Lost to Follow-up|3|||
150130279|NCT03576768|541611458|FG002|Overall Study|Lost to Follow-up|0|||
150130280|NCT03576768|541611459|FG003|Overall Study|Lost to Follow-up|0|||
150130281|NCT02925455|541611463|FG000|Overall Study|Withdrawal by Subject|2|||
150130282|NCT02925455|541611464|FG001|Overall Study|Withdrawal by Subject|0|||
150130283|NCT01514448|541611465|FG000|Overall Study|Death|7|||
150130284|NCT01514448|541611466|FG001|Overall Study|Death|8|||
150130285|NCT01514448|541611465|FG000|Overall Study|Withdrawal by Subject|2|||
150130286|NCT01514448|541611466|FG001|Overall Study|Withdrawal by Subject|0|||
150130287|NCT01514448|541611465|FG000|Overall Study|Lost to Follow-up|2|||
150130288|NCT01514448|541611466|FG001|Overall Study|Lost to Follow-up|0|||
150130289|NCT01514448|541611465|FG000|Overall Study|New Cancer Therapy|1|||
150130290|NCT01514448|541611466|FG001|Overall Study|New Cancer Therapy|0|||
150130291|NCT02314624|541611467|FG000|Overall Study|No participating patient|16|||
150130292|NCT02314624|541611468|FG001|Overall Study|No participating patient|13|||
150130293|NCT02314624|541611467|FG000|Overall Study|Participant withdrew|7|||
150130294|NCT02314624|541611468|FG001|Overall Study|Participant withdrew|2|||
150130295|NCT02314624|541611467|FG000|Overall Study|Lost to Follow-up|2|||
150130296|NCT02314624|541611468|FG001|Overall Study|Lost to Follow-up|5|||
150130297|NCT02314624|541611467|FG000|Overall Study|Dropped/Excluded by PI|6|||
150130298|NCT02314624|541611468|FG001|Overall Study|Dropped/Excluded by PI|6|||
150130299|NCT01925950|541611473|FG000|Part 2|Withdrawal by Subject|1|||
150130300|NCT01925950|541611474|FG001|Part 2|Withdrawal by Subject|0|||
150130301|NCT03162224|541611475|FG000|Overall Study|Death|4|||
150130302|NCT03162224|541611476|FG001|Overall Study|Death|5|||
150130303|NCT03162224|541611477|FG002|Overall Study|Death|8|||
150130304|NCT03162224|541611475|FG000|Overall Study|Withdrawal by Subject|1|||
150130305|NCT03162224|541611476|FG001|Overall Study|Withdrawal by Subject|0|||
150130306|NCT03162224|541611477|FG002|Overall Study|Withdrawal by Subject|1|||
150130307|NCT03162224|541611475|FG000|Overall Study|Lost to Follow-up|0|||
150130308|NCT03162224|541611476|FG001|Overall Study|Lost to Follow-up|1|||
150130309|NCT03162224|541611477|FG002|Overall Study|Lost to Follow-up|0|||
150130310|NCT03162224|541611475|FG000|Overall Study|Other|6|||
150130311|NCT03162224|541611476|FG001|Overall Study|Other|2|||
150130312|NCT03162224|541611477|FG002|Overall Study|Other|1|||
150130313|NCT00725452|541611478|FG000|Overall Study|Adverse Event|3|||
150130314|NCT00725452|541611478|FG000|Overall Study|Lack of Efficacy|2|||
150130315|NCT00725452|541611478|FG000|Overall Study|Reason not specified|1|||
150130316|NCT00725452|541611478|FG000|Overall Study|Physician Decision|1|||
150130317|NCT00725452|541611478|FG000|Overall Study|Withdrawal by Subject|3|||
150130318|NCT00725452|541611478|FG000|Overall Study|Lost to Follow-up|1|||
150130319|NCT02723864|541611480|FG000|Overall Study|Refused further treatment|1|||
150130320|NCT02723864|541611481|FG001|Overall Study|Refused further treatment|0|||
150130321|NCT02723864|541611482|FG002|Overall Study|Refused further treatment|0|||
150130322|NCT02723864|541611483|FG003|Overall Study|Refused further treatment|0|||
150195495|NCT04042233|541856536|FG001|Overall Study|Protocol Violation|2|||
150195496|NCT05477186|541856559|FG000|Overall Study|Vaccine not administered|0|||
150195497|NCT05477186|541856560|FG001|Overall Study|Vaccine not administered|2|||
150195498|NCT05477186|541856561|FG002|Overall Study|Vaccine not administered|1|||
150195499|NCT05477186|541856562|FG003|Overall Study|Vaccine not administered|0|||
150195500|NCT05477186|541856563|FG004|Overall Study|Vaccine not administered|1|||
150195501|NCT05477186|541856564|FG005|Overall Study|Vaccine not administered|0|||
150195502|NCT05477186|541856565|FG006|Overall Study|Vaccine not administered|0|||
150195503|NCT05477186|541856559|FG000|Overall Study|Withdrawal by Subject|1|||
150195504|NCT05477186|541856560|FG001|Overall Study|Withdrawal by Subject|0|||
150130323|NCT02723864|541611484|FG004|Overall Study|Refused further treatment|1|||
150130324|NCT02723864|541611485|FG005|Overall Study|Refused further treatment|2|||
150130325|NCT02723864|541611486|FG006|Overall Study|Refused further treatment|0|||
150130326|NCT02723864|541611480|FG000|Overall Study|Exceed treatment hold time|0|||
150130327|NCT02723864|541611481|FG001|Overall Study|Exceed treatment hold time|1|||
150130328|NCT02723864|541611482|FG002|Overall Study|Exceed treatment hold time|0|||
150130329|NCT02723864|541611483|FG003|Overall Study|Exceed treatment hold time|0|||
150130330|NCT02723864|541611484|FG004|Overall Study|Exceed treatment hold time|0|||
150130331|NCT02723864|541611485|FG005|Overall Study|Exceed treatment hold time|0|||
150130332|NCT02723864|541611486|FG006|Overall Study|Exceed treatment hold time|0|||
150130333|NCT02723864|541611480|FG000|Overall Study|Clinical progression|0|||
150130334|NCT02723864|541611481|FG001|Overall Study|Clinical progression|0|||
150130335|NCT02723864|541611482|FG002|Overall Study|Clinical progression|1|||
150130336|NCT02723864|541611483|FG003|Overall Study|Clinical progression|0|||
150130337|NCT02723864|541611484|FG004|Overall Study|Clinical progression|0|||
150130338|NCT02723864|541611485|FG005|Overall Study|Clinical progression|3|||
150130339|NCT02723864|541611486|FG006|Overall Study|Clinical progression|1|||
150130340|NCT02723864|541611480|FG000|Overall Study|Physician Decision|0|||
150130341|NCT02723864|541611481|FG001|Overall Study|Physician Decision|0|||
150130342|NCT02723864|541611482|FG002|Overall Study|Physician Decision|0|||
150130343|NCT02723864|541611483|FG003|Overall Study|Physician Decision|0|||
150130344|NCT02723864|541611484|FG004|Overall Study|Physician Decision|0|||
150130345|NCT02723864|541611485|FG005|Overall Study|Physician Decision|0|||
150130346|NCT02723864|541611486|FG006|Overall Study|Physician Decision|1|||
150130347|NCT02723864|541611480|FG000|Overall Study|Changes in patient condition|0|||
150130348|NCT02723864|541611481|FG001|Overall Study|Changes in patient condition|0|||
150130349|NCT02723864|541611482|FG002|Overall Study|Changes in patient condition|0|||
150130350|NCT02723864|541611483|FG003|Overall Study|Changes in patient condition|0|||
150130351|NCT02723864|541611484|FG004|Overall Study|Changes in patient condition|0|||
150130352|NCT02723864|541611485|FG005|Overall Study|Changes in patient condition|1|||
150130353|NCT02723864|541611486|FG006|Overall Study|Changes in patient condition|0|||
150130354|NCT02723864|541611480|FG000|Overall Study|Patient choice|0|||
150130355|NCT02723864|541611481|FG001|Overall Study|Patient choice|0|||
150130356|NCT02723864|541611482|FG002|Overall Study|Patient choice|0|||
150130357|NCT02723864|541611483|FG003|Overall Study|Patient choice|0|||
150130358|NCT02723864|541611484|FG004|Overall Study|Patient choice|0|||
150130359|NCT02723864|541611485|FG005|Overall Study|Patient choice|1|||
150130360|NCT02723864|541611486|FG006|Overall Study|Patient choice|0|||
150130361|NCT02723864|541611480|FG000|Overall Study|Adverse Event|0|||
150130362|NCT02723864|541611481|FG001|Overall Study|Adverse Event|0|||
150130363|NCT02723864|541611482|FG002|Overall Study|Adverse Event|0|||
150130364|NCT02723864|541611483|FG003|Overall Study|Adverse Event|0|||
150130365|NCT02723864|541611484|FG004|Overall Study|Adverse Event|0|||
150130366|NCT02723864|541611485|FG005|Overall Study|Adverse Event|1|||
150130367|NCT02723864|541611486|FG006|Overall Study|Adverse Event|0|||
150130368|NCT02723864|541611480|FG000|Overall Study|Started new treatment|0|||
150130369|NCT02723864|541611481|FG001|Overall Study|Started new treatment|0|||
150130370|NCT02723864|541611482|FG002|Overall Study|Started new treatment|0|||
150130371|NCT02723864|541611483|FG003|Overall Study|Started new treatment|0|||
150130372|NCT02723864|541611484|FG004|Overall Study|Started new treatment|0|||
150130373|NCT02723864|541611485|FG005|Overall Study|Started new treatment|1|||
150130374|NCT02723864|541611486|FG006|Overall Study|Started new treatment|0|||
150130375|NCT02723864|541611480|FG000|Overall Study|Switched to alternative treatment|0|||
150130376|NCT02723864|541611481|FG001|Overall Study|Switched to alternative treatment|0|||
150130377|NCT02723864|541611482|FG002|Overall Study|Switched to alternative treatment|0|||
150130378|NCT02723864|541611483|FG003|Overall Study|Switched to alternative treatment|0|||
150130379|NCT02723864|541611484|FG004|Overall Study|Switched to alternative treatment|0|||
150130380|NCT02723864|541611485|FG005|Overall Study|Switched to alternative treatment|1|||
150130381|NCT02723864|541611486|FG006|Overall Study|Switched to alternative treatment|0|||
150130382|NCT02723864|541611480|FG000|Overall Study|Late determination of ineligibility|0|||
150130383|NCT02723864|541611481|FG001|Overall Study|Late determination of ineligibility|0|||
150130384|NCT02723864|541611482|FG002|Overall Study|Late determination of ineligibility|0|||
150130385|NCT02723864|541611483|FG003|Overall Study|Late determination of ineligibility|0|||
150130386|NCT02723864|541611484|FG004|Overall Study|Late determination of ineligibility|0|||
150130387|NCT02723864|541611485|FG005|Overall Study|Late determination of ineligibility|1|||
150130388|NCT02723864|541611486|FG006|Overall Study|Late determination of ineligibility|0|||
150130389|NCT00713648|541611489|FG000|Overall Study|Adverse Event|1|||
150130390|NCT00713648|541611489|FG000|Overall Study|Unclassified|2|||
150130391|NCT00713648|541611489|FG000|Overall Study|According to Protocol|2|||
150130392|NCT00713648|541611489|FG000|Overall Study|Development of antibodies|3|||
150130393|NCT00082173|541611490|FG000|Overall Study|Withdrawal by Subject|3|||
150130394|NCT00082173|541611491|FG001|Overall Study|Withdrawal by Subject|5|||
150130395|NCT00082173|541611490|FG000|Overall Study|Lost to Follow-up|1|||
150130396|NCT00082173|541611491|FG001|Overall Study|Lost to Follow-up|0|||
150130397|NCT00082173|541611490|FG000|Overall Study|Adverse Event|1|||
150130398|NCT00082173|541611491|FG001|Overall Study|Adverse Event|0|||
150130399|NCT00082173|541611490|FG000|Overall Study|Culture negative or resistant at baselin|5|||
150130400|NCT00082173|541611491|FG001|Overall Study|Culture negative or resistant at baselin|6|||
150130401|NCT01733732|541611492|FG000|Overall Study|Adverse Event|1|||
150130402|NCT01733732|541611493|FG001|Overall Study|Adverse Event|0|||
150130403|NCT01733732|541611492|FG000|Overall Study|Did not attend all study visits|1|||
150130404|NCT01733732|541611493|FG001|Overall Study|Did not attend all study visits|0|||
150130405|NCT00464815|541611496|FG000|Overall Study|Withdrawal by Subject|6|||
150130406|NCT00464815|541611497|FG001|Overall Study|Withdrawal by Subject|3|||
150130407|NCT02633800|541611500|FG000|Overall Study|Death|3|||
150130408|NCT02633800|541611501|FG001|Overall Study|Death|3|||
150130409|NCT02633800|541611500|FG000|Overall Study|Reason not provided|1|||
150130410|NCT02633800|541611501|FG001|Overall Study|Reason not provided|0|||
150130411|NCT02633800|541611500|FG000|Overall Study|Radiologic(al) progression|23|||
150130412|NCT02633800|541611501|FG001|Overall Study|Radiologic(al) progression|23|||
150130413|NCT02633800|541611500|FG000|Overall Study|Clinical progression|3|||
150130414|NCT02633800|541611501|FG001|Overall Study|Clinical progression|6|||
150130415|NCT02633800|541611500|FG000|Overall Study|Study terminated by sponsor|6|||
150130416|NCT02633800|541611501|FG001|Overall Study|Study terminated by sponsor|5|||
150130417|NCT02633800|541611500|FG000|Overall Study|Adverse event, non-fatal|7|||
150130418|NCT02633800|541611501|FG001|Overall Study|Adverse event, non-fatal|2|||
150130419|NCT02633800|541611500|FG000|Overall Study|Withdrawal by Subject|0|||
150130420|NCT02633800|541611501|FG001|Overall Study|Withdrawal by Subject|3|||
150130421|NCT02633800|541611500|FG000|Overall Study|Patient Request|1|||
150130422|NCT02633800|541611501|FG001|Overall Study|Patient Request|1|||
150130423|NCT00254982|541611506|FG000|Overall Study|Other|2|||
150130424|NCT00254982|541611507|FG001|Overall Study|Other|1|||
150130425|NCT00254982|541611506|FG000|Overall Study|Lack of Efficacy|5|||
150130426|NCT00254982|541611507|FG001|Overall Study|Lack of Efficacy|3|||
150130427|NCT00254982|541611506|FG000|Overall Study|Lost to Follow-up|5|||
150130428|NCT00254982|541611507|FG001|Overall Study|Lost to Follow-up|3|||
150130429|NCT00254982|541611506|FG000|Overall Study|Adverse Event|18|||
150130430|NCT00254982|541611507|FG001|Overall Study|Adverse Event|16|||
150130431|NCT00254982|541611506|FG000|Overall Study|Withdrawal by Subject|1|||
150130432|NCT00254982|541611507|FG001|Overall Study|Withdrawal by Subject|1|||
150130433|NCT00254982|541611506|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
150130434|NCT00254982|541611507|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
150130435|NCT00254982|541611506|FG000|Overall Study|Protocol deviation|1|||
150130436|NCT00254982|541611507|FG001|Overall Study|Protocol deviation|1|||
150130437|NCT00254982|541611506|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
150130438|NCT00254982|541611507|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
150130439|NCT00254982|541611506|FG000|Overall Study|Malignancy|0|||
150130440|NCT00254982|541611507|FG001|Overall Study|Malignancy|2|||
150130441|NCT00254982|541611506|FG000|Overall Study|Opportunistic infection|1|||
150130442|NCT00254982|541611507|FG001|Overall Study|Opportunistic infection|0|||
150130443|NCT00254982|541611506|FG000|Overall Study|Abnormal liver function tests|2|||
150130444|NCT00254982|541611507|FG001|Overall Study|Abnormal liver function tests|1|||
150130445|NCT01654549|541611517|FG000|Overall Study|H.pylori eradication not successful|0|||
150130446|NCT01654549|541611518|FG001|Overall Study|H.pylori eradication not successful|1|||
150130447|NCT00937924|541611519|FG000|Overall Study|Lost to Follow-up|44|||
150130448|NCT00937924|541611520|FG001|Overall Study|Lost to Follow-up|44|||
150130449|NCT00937924|541611521|FG002|Overall Study|Lost to Follow-up|41|||
150130450|NCT04969198|541611531|FG000|Overall Study|Withdrawal by Subject|20|||
150130451|NCT04969198|541611531|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
150130452|NCT04969198|541611531|FG000|Overall Study|Lost to Follow-up|20|||
150130453|NCT04391023|541611532|FG000|Overall Study|Withdrawal by Subject|2|||
150130454|NCT04391023|541611533|FG001|Overall Study|Withdrawal by Subject|2|||
150130455|NCT02189798|541611535|FG000|Extended Use Phase|Withdrawal by Subject|0|||
150130456|NCT02189798|541611536|FG001|Extended Use Phase|Withdrawal by Subject|4|||
150130457|NCT02189798|541611535|FG000|Extended Use Phase|Physician Decision|1|||
150130458|NCT02189798|541611536|FG001|Extended Use Phase|Physician Decision|0|||
150130459|NCT02189798|541611535|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
150130460|NCT02189798|541611536|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
150130461|NCT02189798|541611535|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
150130462|NCT02189798|541611536|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
150130463|NCT02189798|541611535|FG000|Extended Use Phase|Travel Issues|2|||
150130464|NCT02189798|541611536|FG001|Extended Use Phase|Travel Issues|1|||
150130465|NCT02189798|541611535|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
150130466|NCT02189798|541611536|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
150130467|NCT00529399|541611541|FG000|Overall Study|Lost to Follow-up|1|||
150130468|NCT00529399|541611542|FG001|Overall Study|Lost to Follow-up|0|||
150130469|NCT00529399|541611543|FG002|Overall Study|Lost to Follow-up|1|||
150130470|NCT00529399|541611541|FG000|Overall Study|Withdrawal by Subject|1|||
150130471|NCT00529399|541611542|FG001|Overall Study|Withdrawal by Subject|0|||
150130472|NCT00529399|541611543|FG002|Overall Study|Withdrawal by Subject|1|||
150130473|NCT00529399|541611541|FG000|Overall Study|Non-compliant|0|||
150195505|NCT05477186|541856561|FG002|Overall Study|Withdrawal by Subject|0|||
150195506|NCT05477186|541856562|FG003|Overall Study|Withdrawal by Subject|0|||
150195507|NCT05477186|541856563|FG004|Overall Study|Withdrawal by Subject|0|||
150195508|NCT05477186|541856564|FG005|Overall Study|Withdrawal by Subject|1|||
150195509|NCT05477186|541856565|FG006|Overall Study|Withdrawal by Subject|0|||
150195510|NCT05477186|541856559|FG000|Overall Study|Lost to Follow-up|1|||
150195511|NCT05477186|541856560|FG001|Overall Study|Lost to Follow-up|0|||
150195512|NCT05477186|541856561|FG002|Overall Study|Lost to Follow-up|2|||
150195513|NCT05477186|541856562|FG003|Overall Study|Lost to Follow-up|1|||
150195514|NCT05477186|541856563|FG004|Overall Study|Lost to Follow-up|1|||
150195515|NCT05477186|541856564|FG005|Overall Study|Lost to Follow-up|0|||
150195516|NCT05477186|541856565|FG006|Overall Study|Lost to Follow-up|2|||
150195517|NCT05496231|541856566|FG000|Overall Study|Adverse Event|1|||
150195518|NCT05496231|541856567|FG001|Overall Study|Adverse Event|1|||
150195519|NCT05496231|541856568|FG002|Overall Study|Adverse Event|0|||
150195520|NCT05496231|541856569|FG003|Overall Study|Adverse Event|4|||
150195521|NCT05496231|541856566|FG000|Overall Study|Withdrawal by Subject|5|||
150195522|NCT05496231|541856567|FG001|Overall Study|Withdrawal by Subject|5|||
150195523|NCT05496231|541856568|FG002|Overall Study|Withdrawal by Subject|4|||
150195524|NCT05496231|541856569|FG003|Overall Study|Withdrawal by Subject|11|||
150195525|NCT05496231|541856566|FG000|Overall Study|Migrated/moved from the study area|3|||
150195526|NCT05496231|541856567|FG001|Overall Study|Migrated/moved from the study area|5|||
150195527|NCT05496231|541856568|FG002|Overall Study|Migrated/moved from the study area|3|||
150195528|NCT05496231|541856569|FG003|Overall Study|Migrated/moved from the study area|3|||
150195529|NCT05496231|541856566|FG000|Overall Study|Lost to Follow-up|13|||
150195530|NCT05496231|541856567|FG001|Overall Study|Lost to Follow-up|6|||
150195531|NCT05496231|541856568|FG002|Overall Study|Lost to Follow-up|11|||
150195532|NCT05496231|541856569|FG003|Overall Study|Lost to Follow-up|6|||
150195533|NCT05496231|541856566|FG000|Overall Study|Other|9|||
150195534|NCT05496231|541856567|FG001|Overall Study|Other|7|||
150195535|NCT05496231|541856568|FG002|Overall Study|Other|7|||
150195536|NCT05496231|541856569|FG003|Overall Study|Other|8|||
150195537|NCT03819153|541856574|FG000|Overall Study|Withdrawal by Subject|20|||
150195538|NCT03819153|541856575|FG001|Overall Study|Withdrawal by Subject|28|||
150195539|NCT03819153|541856574|FG000|Overall Study|Lost to Follow-up|23|||
150195540|NCT03819153|541856575|FG001|Overall Study|Lost to Follow-up|30|||
150195541|NCT04508309|541856581|FG000|Overall Study|Death|0|||
150195542|NCT04508309|541856582|FG001|Overall Study|Death|0|||
150195543|NCT04508309|541856583|FG002|Overall Study|Death|0|||
150195544|NCT04508309|541856584|FG003|Overall Study|Death|0|||
150195545|NCT04508309|541856585|FG004|Overall Study|Death|1|||
150195546|NCT04508309|541856581|FG000|Overall Study|Lost to Follow-up|0|||
150195547|NCT04508309|541856582|FG001|Overall Study|Lost to Follow-up|0|||
150195548|NCT04508309|541856583|FG002|Overall Study|Lost to Follow-up|1|||
150195549|NCT04508309|541856584|FG003|Overall Study|Lost to Follow-up|1|||
150195550|NCT04508309|541856585|FG004|Overall Study|Lost to Follow-up|0|||
150195551|NCT04508309|541856581|FG000|Overall Study|Withdrawal by Subject|0|||
150195552|NCT04508309|541856582|FG001|Overall Study|Withdrawal by Subject|0|||
150195553|NCT04508309|541856583|FG002|Overall Study|Withdrawal by Subject|0|||
150195554|NCT04508309|541856584|FG003|Overall Study|Withdrawal by Subject|0|||
150195555|NCT04508309|541856585|FG004|Overall Study|Withdrawal by Subject|1|||
150195556|NCT05940194|541856586|FG000|Overall Study|Adverse Event|0|||
150195557|NCT05940194|541856587|FG001|Overall Study|Adverse Event|1|||
150195558|NCT05940194|541856588|FG002|Overall Study|Adverse Event|0|||
150195559|NCT05940194|541856586|FG000|Overall Study|Migrated/Moved from the study area|2|||
150195560|NCT05940194|541856587|FG001|Overall Study|Migrated/Moved from the study area|2|||
150195561|NCT05940194|541856588|FG002|Overall Study|Migrated/Moved from the study area|4|||
150195562|NCT03240016|541856591|FG000|Overall Study|Adverse Event|9|||
150195563|NCT03240016|541856591|FG000|Overall Study|Withdrawal by Subject|7|||
150195564|NCT03240016|541856591|FG000|Overall Study|Death|1|||
150195565|NCT03240016|541856591|FG000|Overall Study|Physician Decision|2|||
150195566|NCT05200403|541856592|FG000|Overall Study|Withdrawal by Subject|4|||
150195567|NCT05200403|541856593|FG001|Overall Study|Withdrawal by Subject|2|||
150195568|NCT05200403|541856594|FG002|Overall Study|Withdrawal by Subject|6|||
150195569|NCT03235544|541856597|FG000|Overall Study|Death|11|||
150195570|NCT03235544|541856598|FG001|Overall Study|Death|31|||
150195571|NCT03235544|541856599|FG002|Overall Study|Death|19|||
150195572|NCT03235544|541856600|FG003|Overall Study|Death|34|||
150195573|NCT03235544|541856597|FG000|Overall Study|Lost to Follow-up|0|||
150195574|NCT03235544|541856598|FG001|Overall Study|Lost to Follow-up|1|||
150195575|NCT03235544|541856599|FG002|Overall Study|Lost to Follow-up|1|||
150195576|NCT03235544|541856600|FG003|Overall Study|Lost to Follow-up|1|||
150195577|NCT03235544|541856597|FG000|Overall Study|Withdrawal by Subject|0|||
150195578|NCT03235544|541856598|FG001|Overall Study|Withdrawal by Subject|3|||
150195579|NCT03235544|541856599|FG002|Overall Study|Withdrawal by Subject|1|||
150195580|NCT03235544|541856600|FG003|Overall Study|Withdrawal by Subject|5|||
150195581|NCT03235544|541856597|FG000|Overall Study|Disease Progression|0|||
150195582|NCT03235544|541856598|FG001|Overall Study|Disease Progression|1|||
150195583|NCT03235544|541856599|FG002|Overall Study|Disease Progression|0|||
150130474|NCT00529399|541611542|FG001|Overall Study|Non-compliant|1|||
150130475|NCT00529399|541611543|FG002|Overall Study|Non-compliant|0|||
150130476|NCT03695172|541611544|FG000|Overall Study|Withdrawal by Subject|1|||
150130477|NCT03695172|541611545|FG001|Overall Study|Withdrawal by Subject|1|||
150130478|NCT03695172|541611546|FG002|Overall Study|Withdrawal by Subject|0|||
150130479|NCT01483924|541611565|FG000|Overall Study|Withdrawal by Subject|2|||
150130480|NCT01483924|541611566|FG001|Overall Study|Withdrawal by Subject|0|||
150130481|NCT01483924|541611567|FG002|Overall Study|Withdrawal by Subject|0|||
150130482|NCT01483924|541611568|FG003|Overall Study|Withdrawal by Subject|1|||
150130483|NCT01483924|541611569|FG004|Overall Study|Withdrawal by Subject|1|||
150130484|NCT01483924|541611565|FG000|Overall Study|Adverse Event|0|||
150130485|NCT01483924|541611566|FG001|Overall Study|Adverse Event|0|||
150130486|NCT01483924|541611567|FG002|Overall Study|Adverse Event|1|||
150130487|NCT01483924|541611568|FG003|Overall Study|Adverse Event|1|||
150130488|NCT01483924|541611569|FG004|Overall Study|Adverse Event|0|||
150130489|NCT01483924|541611565|FG000|Overall Study|Non-compliance|0|||
150130490|NCT01483924|541611566|FG001|Overall Study|Non-compliance|0|||
150130491|NCT01483924|541611567|FG002|Overall Study|Non-compliance|0|||
150130492|NCT01483924|541611568|FG003|Overall Study|Non-compliance|1|||
150130493|NCT01483924|541611569|FG004|Overall Study|Non-compliance|1|||
150130494|NCT01483924|541611565|FG000|Overall Study|Sponsor concern over ECG result|0|||
150130495|NCT01483924|541611566|FG001|Overall Study|Sponsor concern over ECG result|0|||
150130496|NCT01483924|541611567|FG002|Overall Study|Sponsor concern over ECG result|0|||
150130497|NCT01483924|541611568|FG003|Overall Study|Sponsor concern over ECG result|1|||
150130498|NCT01483924|541611569|FG004|Overall Study|Sponsor concern over ECG result|0|||
150130499|NCT00003298|541611570|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
150130500|NCT00003298|541611570|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
150130501|NCT00003298|541611570|FG000|Surgery|Unresectable at surgery|3|||
150130502|NCT00003298|541611570|FG000|Surgery|Progression before surgery|2|||
150130503|NCT00003298|541611570|FG000|Surgery|Unevaluable and off study|2|||
150130504|NCT00003298|541611570|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
150130505|NCT00003298|541611570|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
150130506|NCT00003298|541611570|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
150130507|NCT00003298|541611570|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
150130508|NCT00003298|541611570|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
150130509|NCT00003298|541611570|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
150130510|NCT00003298|541611570|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
150130511|NCT00003298|541611570|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
150130512|NCT00003298|541611570|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
150130513|NCT00003298|541611570|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
150130514|NCT00335322|541611571|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
150130515|NCT00335322|541611572|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
150130516|NCT00335322|541611573|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
150130517|NCT04330638|541611578|FG000|Overall Study|Adverse Event|9|||
150130518|NCT04330638|541611579|FG001|Overall Study|Adverse Event|10|||
150130519|NCT04330638|541611580|FG002|Overall Study|Adverse Event|15|||
150130520|NCT04330638|541611581|FG003|Overall Study|Adverse Event|6|||
150130521|NCT04330638|541611582|FG004|Overall Study|Adverse Event|10|||
150130522|NCT04330638|541611583|FG005|Overall Study|Adverse Event|5|||
150130523|NCT04330638|541611578|FG000|Overall Study|Other|2|||
150130524|NCT04330638|541611579|FG001|Overall Study|Other|2|||
150130525|NCT04330638|541611580|FG002|Overall Study|Other|5|||
150130526|NCT04330638|541611581|FG003|Overall Study|Other|1|||
150130527|NCT04330638|541611582|FG004|Overall Study|Other|3|||
150130528|NCT04330638|541611583|FG005|Overall Study|Other|2|||
150130529|NCT04330638|541611578|FG000|Overall Study|Withdrawal by Subject|4|||
150130530|NCT04330638|541611579|FG001|Overall Study|Withdrawal by Subject|0|||
150130531|NCT04330638|541611580|FG002|Overall Study|Withdrawal by Subject|0|||
150130532|NCT04330638|541611581|FG003|Overall Study|Withdrawal by Subject|0|||
150130533|NCT04330638|541611582|FG004|Overall Study|Withdrawal by Subject|0|||
150130534|NCT04330638|541611583|FG005|Overall Study|Withdrawal by Subject|0|||
150130535|NCT04330638|541611578|FG000|Overall Study|Lost to Follow-up|3|||
150130536|NCT04330638|541611579|FG001|Overall Study|Lost to Follow-up|2|||
150130537|NCT04330638|541611580|FG002|Overall Study|Lost to Follow-up|3|||
150130538|NCT04330638|541611581|FG003|Overall Study|Lost to Follow-up|2|||
150130539|NCT04330638|541611582|FG004|Overall Study|Lost to Follow-up|3|||
150130540|NCT04330638|541611583|FG005|Overall Study|Lost to Follow-up|0|||
150130541|NCT01041638|541611587|FG000|Overall Study|Adverse Event|4|||
150130542|NCT01041638|541611587|FG000|Overall Study|Death|1|||
150130543|NCT01041638|541611587|FG000|Overall Study|Lack of Efficacy|7|||
150130544|NCT01041638|541611587|FG000|Overall Study|Physician Decision|4|||
150130545|NCT01041638|541611587|FG000|Overall Study|Withdrawal by Subject|11|||
150130546|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
150130547|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
150130548|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
150130549|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
150130550|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
150130551|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
150130552|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
150130553|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
150130554|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
150130555|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
150130556|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
150130557|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
150130558|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
150130559|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
150130560|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
150130561|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150130562|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150130563|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
150130564|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150130565|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
150130566|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
150130567|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
150130568|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
150130569|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
150130570|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
150130571|NCT03152552|541611588|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
150130572|NCT03152552|541611589|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
150130573|NCT03152552|541611590|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
150130574|NCT03152552|541611591|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
150130575|NCT03152552|541611592|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
150130576|NCT03152552|541611588|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
150130577|NCT03152552|541611589|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
150130578|NCT03152552|541611590|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
150130579|NCT03152552|541611591|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
150130580|NCT03152552|541611592|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
150130581|NCT04084314|541611595|FG000|Overall Study|Subject/guardian decision|91|||
150130582|NCT04084314|541611595|FG000|Overall Study|Adverse Event|24|||
150130583|NCT04084314|541611595|FG000|Overall Study|Lost to Follow-up|19|||
150130584|NCT04084314|541611595|FG000|Overall Study|New therapy for study indication|9|||
150130585|NCT04084314|541611595|FG000|Overall Study|Pregnancy|9|||
150130586|NCT04084314|541611595|FG000|Overall Study|Withdrawal of informed consent|8|||
150130587|NCT04084314|541611595|FG000|Overall Study|Physician Decision|4|||
150130588|NCT04084314|541611595|FG000|Overall Study|Protocol Deviation|3|||
150130589|NCT03336619|541611596|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
150130590|NCT03336619|541611597|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
150130591|NCT03336619|541611596|FG000|Overall Study|Withdrawal by Subject|17|||
150130592|NCT03336619|541611597|FG001|Overall Study|Withdrawal by Subject|16|||
150130593|NCT03336619|541611596|FG000|Overall Study|Adverse Event|2|||
150130594|NCT03336619|541611597|FG001|Overall Study|Adverse Event|5|||
150130595|NCT03336619|541611596|FG000|Overall Study|Physician Decision|3|||
150130596|NCT03336619|541611597|FG001|Overall Study|Physician Decision|0|||
150130597|NCT01300546|541611598|FG000|Overall Study|Withdrawal by Subject|1|||
150130598|NCT01300546|541611599|FG001|Overall Study|Withdrawal by Subject|0|||
150130599|NCT01300546|541611598|FG000|Overall Study|Lost to Follow-up|0|||
150130600|NCT01300546|541611599|FG001|Overall Study|Lost to Follow-up|2|||
150130601|NCT01300546|541611598|FG000|Overall Study|Lack of Efficacy|0|||
150130602|NCT01300546|541611599|FG001|Overall Study|Lack of Efficacy|3|||
150130603|NCT01300546|541611598|FG000|Overall Study|Adverse Event|0|||
150130604|NCT01300546|541611599|FG001|Overall Study|Adverse Event|1|||
150130605|NCT01864564|541611608|FG000|Overall Study|Lost to Follow-up|17|||
150130606|NCT01864564|541611609|FG001|Overall Study|Lost to Follow-up|23|||
150130607|NCT01864564|541611608|FG000|Overall Study|Withdrawal by Subject|20|||
150130608|NCT01864564|541611609|FG001|Overall Study|Withdrawal by Subject|11|||
150130609|NCT01864564|541611608|FG000|Overall Study|Protocol Violation|0|||
150130610|NCT01864564|541611609|FG001|Overall Study|Protocol Violation|27|||
150130611|NCT01864564|541611608|FG000|Overall Study|not reported|0|||
150130612|NCT01864564|541611609|FG001|Overall Study|not reported|34|||
150130613|NCT00710424|541611612|FG000|Overall Study|Adverse Event|30|||
150130614|NCT00710424|541611613|FG001|Overall Study|Adverse Event|12|||
150130615|NCT00710424|541611612|FG000|Overall Study|Lack of Efficacy|4|||
150130616|NCT00710424|541611613|FG001|Overall Study|Lack of Efficacy|5|||
150130617|NCT00710424|541611612|FG000|Overall Study|Withdrawal by Subject|5|||
150130618|NCT00710424|541611613|FG001|Overall Study|Withdrawal by Subject|3|||
150130619|NCT00710424|541611612|FG000|Overall Study|Lost to Follow-up|0|||
150130620|NCT00710424|541611613|FG001|Overall Study|Lost to Follow-up|1|||
150130621|NCT00710424|541611612|FG000|Overall Study|Refused medication, no side effects|1|||
150195584|NCT03235544|541856600|FG003|Overall Study|Disease Progression|2|||
150195585|NCT03235544|541856597|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
150195586|NCT03235544|541856598|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
150195587|NCT03235544|541856599|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
150195588|NCT03235544|541856600|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
150195589|NCT03235544|541856597|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
150195590|NCT03235544|541856598|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
150195591|NCT03235544|541856599|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
150195592|NCT03235544|541856600|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
150195593|NCT00950742|541856601|FG000|Overall Study|Other Adverse Event|1|||
150195594|NCT00950742|541856602|FG001|Overall Study|Other Adverse Event|0|||
150195595|NCT00950742|541856601|FG000|Overall Study|Withdrawal by Subject|3|||
150195596|NCT00950742|541856602|FG001|Overall Study|Withdrawal by Subject|0|||
150195597|NCT00950742|541856601|FG000|Overall Study|Progressive Disease|6|||
150195598|NCT00950742|541856602|FG001|Overall Study|Progressive Disease|2|||
150195599|NCT00950742|541856601|FG000|Overall Study|Dose limiting toxicity|6|||
150195600|NCT00950742|541856602|FG001|Overall Study|Dose limiting toxicity|0|||
150195601|NCT05436262|541856606|FG000|Pre-Randomization|Withdrawal by Subject|1|||
150195602|NCT05436262|541856607|FG001|Pre-Randomization|Withdrawal by Subject|0|||
150195603|NCT05436262|541856608|FG002|Pre-Randomization|Withdrawal by Subject|0|||
150195604|NCT05436262|541856606|FG000|Randomization|Withdrawal by Subject|0|||
150130622|NCT00710424|541611613|FG001|Overall Study|Refused medication, no side effects|0|||
150130623|NCT00710424|541611612|FG000|Overall Study|Non-compliance with stable analgesia|1|||
150130624|NCT00710424|541611613|FG001|Overall Study|Non-compliance with stable analgesia|0|||
150130625|NCT00710424|541611612|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
150130626|NCT00710424|541611613|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
150130627|NCT00710424|541611612|FG000|Overall Study|Subject thought medication changed|1|||
150130628|NCT00710424|541611613|FG001|Overall Study|Subject thought medication changed|0|||
150130629|NCT00710424|541611612|FG000|Overall Study|Ceased treatment due to travel|1|||
150130630|NCT00710424|541611613|FG001|Overall Study|Ceased treatment due to travel|0|||
150130631|NCT00710424|541611612|FG000|Overall Study|Subject preferred paracetamol|0|||
150130632|NCT00710424|541611613|FG001|Overall Study|Subject preferred paracetamol|1|||
150130633|NCT00710424|541611612|FG000|Overall Study|Felt good so stopped treatment|0|||
150130634|NCT00710424|541611613|FG001|Overall Study|Felt good so stopped treatment|1|||
150130635|NCT01986881|541613320|FG000|Overall Study|Death|228|||
150130636|NCT01986881|541613321|FG001|Overall Study|Death|233|||
150130637|NCT01986881|541613322|FG002|Overall Study|Death|247|||
150130638|NCT01986881|541613320|FG000|Overall Study|Lost to Follow-up|51|||
150130639|NCT01986881|541613321|FG001|Overall Study|Lost to Follow-up|44|||
150130640|NCT01986881|541613322|FG002|Overall Study|Lost to Follow-up|55|||
150130641|NCT01986881|541613320|FG000|Overall Study|Physician Decision|7|||
150130642|NCT01986881|541613321|FG001|Overall Study|Physician Decision|4|||
150130643|NCT01986881|541613322|FG002|Overall Study|Physician Decision|6|||
150130644|NCT01986881|541613320|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
150130645|NCT01986881|541613321|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
150130646|NCT01986881|541613322|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
150130647|NCT01986881|541613320|FG000|Overall Study|Withdrawal by Subject|41|||
150130648|NCT01986881|541613321|FG001|Overall Study|Withdrawal by Subject|60|||
150130649|NCT01986881|541613322|FG002|Overall Study|Withdrawal by Subject|45|||
150130650|NCT01986881|541613320|FG000|Overall Study|Subject Moved|0|||
150130651|NCT01986881|541613321|FG001|Overall Study|Subject Moved|1|||
150130652|NCT01986881|541613322|FG002|Overall Study|Subject Moved|0|||
150130653|NCT01986881|541613320|FG000|Overall Study|Other|1|||
150130654|NCT01986881|541613321|FG001|Overall Study|Other|2|||
150130655|NCT01986881|541613322|FG002|Overall Study|Other|2|||
150130656|NCT00955357|541613329|FG000|Titration Phase|Adverse Event|9|||
150130657|NCT00955357|541613330|FG001|Titration Phase|Adverse Event|46|||
150130658|NCT00955357|541613329|FG000|Titration Phase|Lack of Efficacy|0|||
150130659|NCT00955357|541613330|FG001|Titration Phase|Lack of Efficacy|2|||
150130660|NCT00955357|541613329|FG000|Titration Phase|Protocol Violation|3|||
150130661|NCT00955357|541613330|FG001|Titration Phase|Protocol Violation|7|||
150130662|NCT00955357|541613329|FG000|Titration Phase|Lost to Follow-up|1|||
150130663|NCT00955357|541613330|FG001|Titration Phase|Lost to Follow-up|3|||
150130664|NCT00955357|541613329|FG000|Titration Phase|Withdrawal by Subject|3|||
150130665|NCT00955357|541613330|FG001|Titration Phase|Withdrawal by Subject|5|||
150130666|NCT00955357|541613329|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
150130667|NCT00955357|541613330|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
150130668|NCT00955357|541613329|FG000|Titration Phase|Study medication not tolerated|0|||
150130669|NCT00955357|541613330|FG001|Titration Phase|Study medication not tolerated|1|||
150130670|NCT00955357|541613329|FG000|Titration Phase|Non compliance to study procedures|0|||
150130671|NCT00955357|541613330|FG001|Titration Phase|Non compliance to study procedures|1|||
150130672|NCT00955357|541613329|FG000|Maintenance Phase|Adverse Event|3|||
150130673|NCT00955357|541613330|FG001|Maintenance Phase|Adverse Event|23|||
150130674|NCT00955357|541613329|FG000|Maintenance Phase|Lack of Efficacy|0|||
150195605|NCT05436262|541856607|FG001|Randomization|Withdrawal by Subject|1|||
150195606|NCT05436262|541856608|FG002|Randomization|Withdrawal by Subject|0|||
150195607|NCT03463044|541856612|FG000|Overall Study|Lost to Follow-up|0|||
150195608|NCT03463044|541856613|FG001|Overall Study|Lost to Follow-up|0|||
150195609|NCT03463044|541856614|FG002|Overall Study|Lost to Follow-up|0|||
150195610|NCT03463044|541856615|FG003|Overall Study|Lost to Follow-up|0|||
150195611|NCT03463044|541856616|FG004|Overall Study|Lost to Follow-up|0|||
150195612|NCT03463044|541856617|FG005|Overall Study|Lost to Follow-up|0|||
150195613|NCT03463044|541856618|FG006|Overall Study|Lost to Follow-up|0|||
150195614|NCT03463044|541856619|FG007|Overall Study|Lost to Follow-up|1|||
150195615|NCT03463044|541856620|FG008|Overall Study|Lost to Follow-up|0|||
150195616|NCT04471246|541856621|FG000|Overall Study|Lost to Follow-up|2|||
150195617|NCT04471246|541856622|FG001|Overall Study|Lost to Follow-up|2|||
150195618|NCT05764525|541856623|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
150195619|NCT05764525|541856624|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
150195620|NCT05764525|541856623|FG000|Overall Study|Withdrawal by Subject|4|||
150195621|NCT05764525|541856624|FG001|Overall Study|Withdrawal by Subject|8|||
150195622|NCT05764525|541856623|FG000|Overall Study|Physician Decision|1|||
150195623|NCT05764525|541856624|FG001|Overall Study|Physician Decision|0|||
150195624|NCT03334630|541856625|FG000|Overall Study|Withdrawal by Subject|7|||
150195625|NCT03334630|541856626|FG001|Overall Study|Withdrawal by Subject|7|||
150195626|NCT03334630|541856625|FG000|Overall Study|Lost to Follow-up|3|||
150195627|NCT03334630|541856626|FG001|Overall Study|Lost to Follow-up|1|||
150195628|NCT03334630|541856625|FG000|Overall Study|Adverse Event|0|||
150195629|NCT03334630|541856626|FG001|Overall Study|Adverse Event|1|||
150195630|NCT03334630|541856625|FG000|Overall Study|Physician Decision|1|||
150195631|NCT03334630|541856626|FG001|Overall Study|Physician Decision|1|||
150195632|NCT03334630|541856625|FG000|Overall Study|Enrollment closed|2|||
150195633|NCT03334630|541856626|FG001|Overall Study|Enrollment closed|1|||
150195634|NCT03334630|541856625|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
150195635|NCT03334630|541856626|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
150195636|NCT03334630|541856625|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
150195637|NCT03334630|541856626|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
150195638|NCT05907174|541856636|FG000|3-Month Assessment|Withdrawal by Subject|0|||
150195639|NCT05907174|541856637|FG001|3-Month Assessment|Withdrawal by Subject|0|||
150195640|NCT05907174|541856638|FG002|3-Month Assessment|Withdrawal by Subject|0|||
150195641|NCT05907174|541856639|FG003|3-Month Assessment|Withdrawal by Subject|1|||
150195642|NCT05907174|541856636|FG000|3-Month Assessment|Lost to Follow-up|1|||
150195643|NCT05907174|541856637|FG001|3-Month Assessment|Lost to Follow-up|1|||
150195644|NCT05907174|541856638|FG002|3-Month Assessment|Lost to Follow-up|1|||
150195645|NCT05907174|541856639|FG003|3-Month Assessment|Lost to Follow-up|1|||
150195646|NCT05907174|541856636|FG000|6-Month Assessment|Death|0|||
150195647|NCT05907174|541856637|FG001|6-Month Assessment|Death|0|||
150195648|NCT05907174|541856638|FG002|6-Month Assessment|Death|3|||
150195649|NCT05907174|541856639|FG003|6-Month Assessment|Death|0|||
150195650|NCT05907174|541856636|FG000|6-Month Assessment|Withdrawal by Subject|0|||
150195651|NCT05907174|541856637|FG001|6-Month Assessment|Withdrawal by Subject|0|||
150195652|NCT05907174|541856638|FG002|6-Month Assessment|Withdrawal by Subject|1|||
150195653|NCT05907174|541856639|FG003|6-Month Assessment|Withdrawal by Subject|1|||
150195654|NCT05907174|541856636|FG000|6-Month Assessment|Lost to Follow-up|0|||
150195655|NCT05907174|541856637|FG001|6-Month Assessment|Lost to Follow-up|1|||
150195656|NCT05907174|541856638|FG002|6-Month Assessment|Lost to Follow-up|1|||
150195657|NCT05907174|541856639|FG003|6-Month Assessment|Lost to Follow-up|1|||
150195658|NCT04498390|541856640|FG000|Overall Study|Adverse Event|0|||
150195659|NCT04498390|541856641|FG001|Overall Study|Adverse Event|0|||
150195660|NCT04498390|541856642|FG002|Overall Study|Adverse Event|1|||
150195661|NCT04498390|541856643|FG003|Overall Study|Adverse Event|0|||
150195662|NCT04498390|541856644|FG004|Overall Study|Adverse Event|0|||
150195663|NCT04498390|541856640|FG000|Overall Study|Withdrawal by Subject|0|||
150195664|NCT04498390|541856641|FG001|Overall Study|Withdrawal by Subject|0|||
150195665|NCT04498390|541856642|FG002|Overall Study|Withdrawal by Subject|0|||
150195666|NCT04498390|541856643|FG003|Overall Study|Withdrawal by Subject|1|||
150195667|NCT04498390|541856644|FG004|Overall Study|Withdrawal by Subject|0|||
150195668|NCT05093842|541856649|FG000|Overall Study|Pregnancy loss|1|||
150195669|NCT05093842|541856650|FG001|Overall Study|Pregnancy loss|1|||
150195670|NCT05093842|541856649|FG000|Overall Study|Lost to Follow-up|6|||
150195671|NCT05093842|541856650|FG001|Overall Study|Lost to Follow-up|0|||
150195672|NCT05093842|541856649|FG000|Overall Study|Physician Decision|0|||
150195673|NCT05093842|541856650|FG001|Overall Study|Physician Decision|1|||
150195674|NCT03910478|541856651|FG000|Overall Study|Death|13|||
150195675|NCT03910478|541856652|FG001|Overall Study|Death|6|||
150195676|NCT03910478|541856651|FG000|Overall Study|Withdrawal by Subject|23|||
150195677|NCT03910478|541856652|FG001|Overall Study|Withdrawal by Subject|2|||
150195678|NCT03910478|541856651|FG000|Overall Study|Physician Decision|5|||
150195679|NCT03910478|541856652|FG001|Overall Study|Physician Decision|0|||
150195680|NCT03910478|541856651|FG000|Overall Study|Protocol Violation|1|||
150195681|NCT03910478|541856652|FG001|Overall Study|Protocol Violation|0|||
150195682|NCT03910478|541856651|FG000|Overall Study|Failure to meet continuation criteria|2|||
150195683|NCT03910478|541856652|FG001|Overall Study|Failure to meet continuation criteria|0|||
150195684|NCT03910478|541856651|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
150195685|NCT03910478|541856652|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
150195686|NCT03987022|541856657|FG000|Overall Study|Lost to Follow-up|2|||
150195687|NCT03987022|541856658|FG001|Overall Study|Lost to Follow-up|2|||
150195688|NCT03987022|541856657|FG000|Overall Study|Withdrawal by Subject|1|||
150195689|NCT03987022|541856658|FG001|Overall Study|Withdrawal by Subject|0|||
150195690|NCT03478956|541856659|FG000|Randomized Treatment Period|Adverse Event|1|||
150195691|NCT03478956|541856660|FG001|Randomized Treatment Period|Adverse Event|0|||
150195692|NCT03478956|541856661|FG002|Randomized Treatment Period|Adverse Event|0|||
150195693|NCT03478956|541856662|FG003|Randomized Treatment Period|Adverse Event|0|||
150195694|NCT03478956|541856659|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
150195695|NCT03478956|541856660|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
150195696|NCT03478956|541856661|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
150195697|NCT03478956|541856662|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
150195698|NCT03478956|541856659|FG000|Open Label Extension Period|Adverse Event|0|||
150195699|NCT03478956|541856660|FG001|Open Label Extension Period|Adverse Event|0|||
150195700|NCT03478956|541856661|FG002|Open Label Extension Period|Adverse Event|4|||
150195701|NCT03478956|541856662|FG003|Open Label Extension Period|Adverse Event|0|||
150195702|NCT03478956|541856659|FG000|Open Label Extension Period|Lack of Efficacy|0|||
150195703|NCT03478956|541856660|FG001|Open Label Extension Period|Lack of Efficacy|0|||
150195704|NCT03478956|541856661|FG002|Open Label Extension Period|Lack of Efficacy|8|||
150195705|NCT03478956|541856662|FG003|Open Label Extension Period|Lack of Efficacy|0|||
150195706|NCT03478956|541856659|FG000|Open Label Extension Period|Reason Not Provided|0|||
150195707|NCT03478956|541856660|FG001|Open Label Extension Period|Reason Not Provided|0|||
150195708|NCT03478956|541856661|FG002|Open Label Extension Period|Reason Not Provided|1|||
150195709|NCT03478956|541856662|FG003|Open Label Extension Period|Reason Not Provided|0|||
150195710|NCT03478956|541856659|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
150195711|NCT03478956|541856660|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
150195712|NCT03478956|541856661|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
150195713|NCT03478956|541856662|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
150195714|NCT03478956|541856659|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
150195715|NCT03478956|541856660|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
150195716|NCT03478956|541856661|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
150195717|NCT03478956|541856662|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
150195718|NCT03478956|541856659|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
150195719|NCT03478956|541856660|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
150195720|NCT03478956|541856661|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
150195721|NCT03478956|541856662|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
150195722|NCT04858451|541858707|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
150195723|NCT04858451|541858708|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195724|NCT04858451|541858709|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195725|NCT04858451|541858710|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195726|NCT04858451|541858711|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195727|NCT04858451|541858712|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195728|NCT04858451|541858713|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195729|NCT04858451|541858714|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195730|NCT04858451|541858715|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
150195731|NCT04858451|541858707|FG000|Part 2|Discontinued|0|||
150195732|NCT04858451|541858708|FG001|Part 2|Discontinued|0|||
150195733|NCT04858451|541858709|FG002|Part 2|Discontinued|0|||
150195734|NCT04858451|541858710|FG003|Part 2|Discontinued|0|||
150195735|NCT04858451|541858711|FG004|Part 2|Discontinued|0|||
150195736|NCT04858451|541858712|FG005|Part 2|Discontinued|0|||
150195737|NCT04858451|541858713|FG006|Part 2|Discontinued|0|||
150195738|NCT04858451|541858714|FG007|Part 2|Discontinued|0|||
150195739|NCT04858451|541858715|FG008|Part 2|Discontinued|63|||
150195740|NCT03314454|541858716|FG000|Overall Study|Protocol Violation|1|||
150195741|NCT04298983|541858719|FG000|Overall Study|Adverse Event|4|||
150195742|NCT04298983|541858719|FG000|Overall Study|Lack of Efficacy|3|||
150195743|NCT04907851|541858720|FG000|Overall Study|Consent withdrawn|1|||
150195744|NCT04907851|541858721|FG001|Overall Study|Consent withdrawn|2|||
150195745|NCT04907851|541858722|FG002|Overall Study|Consent withdrawn|0|||
150195746|NCT04907851|541858720|FG000|Overall Study|Death|5|||
150195747|NCT04907851|541858721|FG001|Overall Study|Death|15|||
150195748|NCT04907851|541858722|FG002|Overall Study|Death|10|||
150195749|NCT01456949|541858726|FG000|Enrollment|PI death- incomplete data|6|||
150195750|NCT01456949|541858726|FG000|Enrollment|Death|1|||
150195751|NCT01456949|541858726|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
150195752|NCT01456949|541858726|FG000|Enrollment|Physician Decision|10|||
150195753|NCT01456949|541858726|FG000|Enrollment|Withdrawal by Subject|7|||
150195754|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
150195755|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
150195756|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
150195757|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
150195758|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
150195759|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
150195760|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
150195761|NCT01456949|541858726|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
150195762|NCT03710603|541858727|FG000|Overall Study|Adverse Event|1|||
150195763|NCT03710603|541858728|FG001|Overall Study|Adverse Event|0|||
150195764|NCT03710603|541858727|FG000|Overall Study|Death|44|||
150195765|NCT03710603|541858728|FG001|Overall Study|Death|34|||
150195766|NCT03710603|541858727|FG000|Overall Study|Lost to Follow-up|3|||
150195767|NCT03710603|541858728|FG001|Overall Study|Lost to Follow-up|5|||
150195768|NCT03710603|541858727|FG000|Overall Study|Withdrawal by Subject|11|||
150195769|NCT03710603|541858728|FG001|Overall Study|Withdrawal by Subject|10|||
150195770|NCT05002088|541858731|FG000|Overall Study|Withdrawal by Subject|9|||
150195771|NCT05002088|541858732|FG001|Overall Study|Withdrawal by Subject|0|||
150195772|NCT05002088|541858731|FG000|Overall Study|Lost to Follow-up|0|||
150195773|NCT05002088|541858732|FG001|Overall Study|Lost to Follow-up|1|||
150195774|NCT05002088|541858731|FG000|Overall Study|Death|16|||
150195775|NCT05002088|541858732|FG001|Overall Study|Death|2|||
150195776|NCT05002088|541858731|FG000|Overall Study|Protocol Violation|25|||
150195777|NCT05002088|541858732|FG001|Overall Study|Protocol Violation|7|||
150195778|NCT04068181|541858734|FG000|Overall Study|Death|17|||
150195779|NCT04068181|541858735|FG001|Overall Study|Death|12|||
150195780|NCT04068181|541858736|FG002|Overall Study|Death|4|||
150195781|NCT04068181|541858737|FG003|Overall Study|Death|7|||
150195782|NCT04068181|541858734|FG000|Overall Study|Lost to Follow-up|1|||
150195783|NCT04068181|541858735|FG001|Overall Study|Lost to Follow-up|0|||
150195784|NCT04068181|541858736|FG002|Overall Study|Lost to Follow-up|0|||
150195785|NCT04068181|541858737|FG003|Overall Study|Lost to Follow-up|0|||
150195786|NCT04068181|541858734|FG000|Overall Study|Withdrawal of consent from study|3|||
150195787|NCT04068181|541858735|FG001|Overall Study|Withdrawal of consent from study|0|||
150195788|NCT04068181|541858736|FG002|Overall Study|Withdrawal of consent from study|0|||
150195789|NCT04068181|541858737|FG003|Overall Study|Withdrawal of consent from study|0|||
150195790|NCT02723591|541858738|FG000|Overall Study|Adverse Event|48|||
150195791|NCT02723591|541858739|FG001|Overall Study|Adverse Event|40|||
150195792|NCT02723591|541858738|FG000|Overall Study|Death|2|||
150195793|NCT02723591|541858739|FG001|Overall Study|Death|2|||
150195794|NCT02723591|541858738|FG000|Overall Study|Lack of Efficacy|4|||
150195795|NCT02723591|541858739|FG001|Overall Study|Lack of Efficacy|3|||
150195796|NCT02723591|541858738|FG000|Overall Study|Lost to Follow-up|1|||
150195797|NCT02723591|541858739|FG001|Overall Study|Lost to Follow-up|7|||
150195798|NCT02723591|541858738|FG000|Overall Study|Protocol Violation|20|||
150195799|NCT02723591|541858739|FG001|Overall Study|Protocol Violation|23|||
150195800|NCT02723591|541858738|FG000|Overall Study|Withdrawal by Subject|4|||
150195801|NCT02723591|541858739|FG001|Overall Study|Withdrawal by Subject|8|||
150195802|NCT02723591|541858738|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
150195803|NCT02723591|541858739|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
150195804|NCT02723591|541858738|FG000|Overall Study|Miscellaneous|5|||
150195805|NCT02723591|541858739|FG001|Overall Study|Miscellaneous|6|||
150195806|NCT03599661|541858741|FG000|Overall Study|Lost to Follow-up|9|||
150195807|NCT04117347|541858742|FG000|Overall Study|Adverse Event|0|||
150195808|NCT04117347|541858743|FG001|Overall Study|Adverse Event|0|||
150195809|NCT04117347|541858744|FG002|Overall Study|Adverse Event|1|||
150195810|NCT04117347|541858742|FG000|Overall Study|No time for study|0|||
150195811|NCT04117347|541858743|FG001|Overall Study|No time for study|2|||
150195812|NCT04117347|541858744|FG002|Overall Study|No time for study|0|||
150195813|NCT04117347|541858742|FG000|Overall Study|Family emergency|1|||
150195814|NCT04117347|541858743|FG001|Overall Study|Family emergency|0|||
150195815|NCT04117347|541858744|FG002|Overall Study|Family emergency|0|||
150195816|NCT03691935|541858745|FG000|Overall Study|Physician Decision|2|||
150195817|NCT03691935|541858746|FG001|Overall Study|Physician Decision|1|||
150195818|NCT03691935|541858745|FG000|Overall Study|Adverse Event|3|||
150195819|NCT03691935|541858746|FG001|Overall Study|Adverse Event|0|||
150195820|NCT03511664|541858747|FG000|Overall Study|Death|457|||
150195821|NCT03511664|541858748|FG001|Overall Study|Death|201|||
150195822|NCT03511664|541858749|FG002|Overall Study|Death|21|||
150195823|NCT03511664|541858747|FG000|Overall Study|Withdrew consent|40|||
150195824|NCT03511664|541858748|FG001|Overall Study|Withdrew consent|63|||
150195825|NCT03511664|541858749|FG002|Overall Study|Withdrew consent|3|||
150195826|NCT03511664|541858747|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
150195827|NCT03511664|541858748|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
150195828|NCT03511664|541858749|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
150195829|NCT03511664|541858747|FG000|Overall Study|Lost to Follow-up|8|||
150195830|NCT03511664|541858748|FG001|Overall Study|Lost to Follow-up|5|||
150195831|NCT03511664|541858749|FG002|Overall Study|Lost to Follow-up|0|||
150195832|NCT03511664|541858747|FG000|Overall Study|Physician Decision|2|||
150195833|NCT03511664|541858748|FG001|Overall Study|Physician Decision|1|||
150195834|NCT03511664|541858749|FG002|Overall Study|Physician Decision|0|||
150195835|NCT03511664|541858747|FG000|Overall Study|Patient non-compliance|1|||
150195836|NCT03511664|541858748|FG001|Overall Study|Patient non-compliance|0|||
150195837|NCT03511664|541858749|FG002|Overall Study|Patient non-compliance|0|||
150195838|NCT01946789|541858750|FG000|Overall Study|Death|0|||
150195839|NCT01946789|541858751|FG001|Overall Study|Death|2|||
150195840|NCT01946789|541858752|FG002|Overall Study|Death|1|||
150195841|NCT01946789|541858753|FG003|Overall Study|Death|1|||
150195842|NCT01946789|541858754|FG004|Overall Study|Death|1|||
150195843|NCT01946789|541858755|FG005|Overall Study|Death|1|||
150195844|NCT01946789|541858756|FG006|Overall Study|Death|3|||
150195845|NCT01946789|541858757|FG007|Overall Study|Death|1|||
150195846|NCT01946789|541858758|FG008|Overall Study|Death|2|||
150195847|NCT01946789|541858750|FG000|Overall Study|Progressive Disease|0|||
150195848|NCT01946789|541858751|FG001|Overall Study|Progressive Disease|0|||
150195849|NCT01946789|541858752|FG002|Overall Study|Progressive Disease|1|||
150195850|NCT01946789|541858753|FG003|Overall Study|Progressive Disease|0|||
150195851|NCT01946789|541858754|FG004|Overall Study|Progressive Disease|0|||
150195852|NCT01946789|541858755|FG005|Overall Study|Progressive Disease|2|||
150195853|NCT01946789|541858756|FG006|Overall Study|Progressive Disease|0|||
150195854|NCT01946789|541858757|FG007|Overall Study|Progressive Disease|0|||
150195855|NCT01946789|541858758|FG008|Overall Study|Progressive Disease|0|||
150195856|NCT01946789|541858750|FG000|Overall Study|Withdrawal by Subject|0|||
150195857|NCT01946789|541858751|FG001|Overall Study|Withdrawal by Subject|0|||
150195858|NCT01946789|541858752|FG002|Overall Study|Withdrawal by Subject|0|||
150195859|NCT01946789|541858753|FG003|Overall Study|Withdrawal by Subject|2|||
150195860|NCT01946789|541858754|FG004|Overall Study|Withdrawal by Subject|1|||
150195861|NCT01946789|541858755|FG005|Overall Study|Withdrawal by Subject|0|||
150195862|NCT01946789|541858756|FG006|Overall Study|Withdrawal by Subject|1|||
150195863|NCT01946789|541858757|FG007|Overall Study|Withdrawal by Subject|0|||
150195864|NCT01946789|541858758|FG008|Overall Study|Withdrawal by Subject|0|||
150195865|NCT03905798|541858763|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
150195866|NCT05374798|541858764|FG000|Overall Study|Lost to Follow-up|2|||
150195867|NCT05374798|541858764|FG000|Overall Study|Withdrawal by Subject|2|||
150195868|NCT05374798|541858764|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
150195869|NCT06473662|541858765|FG000|Overall Study|Withdrawal by Subject|1|||
150195870|NCT06473662|541858766|FG001|Overall Study|Withdrawal by Subject|6|||
150195871|NCT06473662|541858767|FG002|Overall Study|Withdrawal by Subject|5|||
150195872|NCT06473662|541858765|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
150195873|NCT06473662|541858766|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
150195874|NCT06473662|541858767|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
150195875|NCT06473662|541858765|FG000|Overall Study|Starting HbA1c below 7%|0|||
150195876|NCT06473662|541858766|FG001|Overall Study|Starting HbA1c below 7%|1|||
150195877|NCT06473662|541858767|FG002|Overall Study|Starting HbA1c below 7%|1|||
150195878|NCT06473662|541858765|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
150195879|NCT06473662|541858766|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
150195880|NCT06473662|541858767|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
150195881|NCT06473662|541858765|FG000|Overall Study|Did not take medication|2|||
150195882|NCT06473662|541858766|FG001|Overall Study|Did not take medication|3|||
150195883|NCT06473662|541858767|FG002|Overall Study|Did not take medication|2|||
150195884|NCT05485779|541858770|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195885|NCT05485779|541858771|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195886|NCT05485779|541858772|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195887|NCT05485779|541858773|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195888|NCT05485779|541858774|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195889|NCT05485779|541858775|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195890|NCT05485779|541858776|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195891|NCT05485779|541858777|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
150195892|NCT05485779|541858778|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
150195893|NCT05485779|541858779|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195894|NCT05485779|541858780|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
150195895|NCT05485779|541858770|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195896|NCT05485779|541858771|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195897|NCT05485779|541858772|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195898|NCT05485779|541858773|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195899|NCT05485779|541858774|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195900|NCT05485779|541858775|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195901|NCT05485779|541858776|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195902|NCT05485779|541858777|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195903|NCT05485779|541858778|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195904|NCT05485779|541858779|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
150195905|NCT05485779|541858780|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
150195906|NCT05485779|541858770|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195907|NCT05485779|541858771|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195908|NCT05485779|541858772|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195909|NCT05485779|541858773|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
150195910|NCT05485779|541858774|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195911|NCT05485779|541858775|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195912|NCT05485779|541858776|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195913|NCT05485779|541858777|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195914|NCT05485779|541858778|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195915|NCT05485779|541858779|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195916|NCT05485779|541858780|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
150195917|NCT03030261|541858783|FG000|Overall Study|Still receiving continuation therapy|5|||
150195918|NCT04079218|541858784|FG000|Overall Study|Death|1|||
150195919|NCT04079218|541858785|FG001|Overall Study|Death|0|||
150195920|NCT04079218|541858784|FG000|Overall Study|Withdrawal by Subject|3|||
150195921|NCT04079218|541858785|FG001|Overall Study|Withdrawal by Subject|0|||
150195922|NCT04079218|541858784|FG000|Overall Study|Physician Decision|4|||
150195923|NCT04079218|541858785|FG001|Overall Study|Physician Decision|0|||
150195924|NCT04079218|541858784|FG000|Overall Study|Lost to Follow-up|0|||
150195925|NCT04079218|541858785|FG001|Overall Study|Lost to Follow-up|1|||
150195926|NCT01275677|541858793|FG000|Overall Study|Not at risk for recurrence.|1|||
150195927|NCT01275677|541858794|FG001|Overall Study|Not at risk for recurrence.|1|||
150195928|NCT01275677|541858793|FG000|Overall Study|No follow-up|26|||
150195929|NCT01275677|541858794|FG001|Overall Study|No follow-up|37|||
150195930|NCT01275677|541858793|FG000|Overall Study|No clinical follow up.|1|||
150195931|NCT01275677|541858794|FG001|Overall Study|No clinical follow up.|4|||
150195932|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
150195933|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
150195934|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
150195935|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
150195936|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
150195937|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
150195938|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
150195939|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
150195940|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
150195941|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
150195942|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
150195943|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
150195944|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
150195945|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
150195946|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
150195947|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
150195948|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
150195949|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
150195950|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
150195951|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
150195952|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
150195953|NCT04800211|541858797|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
150195954|NCT04800211|541858798|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
150195955|NCT04800211|541858799|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
150195956|NCT04800211|541858797|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
150195957|NCT04800211|541858798|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
150195958|NCT04800211|541858799|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
150195959|NCT04800211|541858797|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
150195960|NCT04800211|541858798|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
150195961|NCT04800211|541858799|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
150195962|NCT04800211|541858797|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
150195963|NCT04800211|541858798|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
150195964|NCT04800211|541858799|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
150195965|NCT05170841|541858800|FG000|Single Dose Phase|Adverse Event|1|||
150195966|NCT05170841|541858801|FG001|Single Dose Phase|Adverse Event|2|||
150195967|NCT05170841|541858802|FG002|Single Dose Phase|Adverse Event|0|||
150195968|NCT05170841|541858803|FG003|Single Dose Phase|Adverse Event|2|||
150195969|NCT05170841|541858800|FG000|Multiple Dose Phase|Adverse Event|1|||
150195970|NCT05170841|541858801|FG001|Multiple Dose Phase|Adverse Event|2|||
150195971|NCT05170841|541858802|FG002|Multiple Dose Phase|Adverse Event|1|||
150195972|NCT05170841|541858803|FG003|Multiple Dose Phase|Adverse Event|4|||
150195973|NCT05170841|541858800|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
150195974|NCT05170841|541858801|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
150195975|NCT05170841|541858802|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
150195976|NCT05170841|541858803|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
150195977|NCT02733159|541858813|FG000|Overall Study|Adverse Event|1|||
150195978|NCT02733159|541858813|FG000|Overall Study|Lack of disease progression|1|||
150195979|NCT03088878|541858823|FG000|Overall Study|Adverse Event|0|||
150195980|NCT03088878|541858824|FG001|Overall Study|Adverse Event|0|||
150195981|NCT03088878|541858825|FG002|Overall Study|Adverse Event|0|||
150195982|NCT03088878|541858826|FG003|Overall Study|Adverse Event|0|||
150195983|NCT03088878|541858827|FG004|Overall Study|Adverse Event|4|||
150195984|NCT03088878|541858828|FG005|Overall Study|Adverse Event|2|||
150195985|NCT03088878|541858829|FG006|Overall Study|Adverse Event|1|||
150195986|NCT03088878|541858830|FG007|Overall Study|Adverse Event|0|||
150195987|NCT03088878|541858831|FG008|Overall Study|Adverse Event|0|||
150195988|NCT03088878|541858832|FG009|Overall Study|Adverse Event|0|||
150195989|NCT03088878|541858833|FG010|Overall Study|Adverse Event|0|||
150195990|NCT03088878|541858834|FG011|Overall Study|Adverse Event|0|||
150195991|NCT03088878|541858835|FG012|Overall Study|Adverse Event|5|||
150195992|NCT03088878|541858836|FG013|Overall Study|Adverse Event|3|||
150195993|NCT03088878|541858823|FG000|Overall Study|Clinical Progression|0|||
150195994|NCT03088878|541858824|FG001|Overall Study|Clinical Progression|0|||
150195995|NCT03088878|541858825|FG002|Overall Study|Clinical Progression|0|||
150195996|NCT03088878|541858826|FG003|Overall Study|Clinical Progression|0|||
150195997|NCT03088878|541858827|FG004|Overall Study|Clinical Progression|2|||
150195998|NCT03088878|541858828|FG005|Overall Study|Clinical Progression|0|||
150195999|NCT03088878|541858829|FG006|Overall Study|Clinical Progression|0|||
150196000|NCT03088878|541858830|FG007|Overall Study|Clinical Progression|0|||
150196001|NCT03088878|541858831|FG008|Overall Study|Clinical Progression|0|||
150196002|NCT03088878|541858832|FG009|Overall Study|Clinical Progression|0|||
150196003|NCT03088878|541858833|FG010|Overall Study|Clinical Progression|0|||
150196004|NCT03088878|541858834|FG011|Overall Study|Clinical Progression|0|||
150196005|NCT03088878|541858835|FG012|Overall Study|Clinical Progression|0|||
150196006|NCT03088878|541858836|FG013|Overall Study|Clinical Progression|0|||
150196007|NCT03088878|541858823|FG000|Overall Study|Death|0|||
150196008|NCT03088878|541858824|FG001|Overall Study|Death|0|||
150196009|NCT03088878|541858825|FG002|Overall Study|Death|0|||
150196010|NCT03088878|541858826|FG003|Overall Study|Death|0|||
150196011|NCT03088878|541858827|FG004|Overall Study|Death|2|||
150196012|NCT03088878|541858828|FG005|Overall Study|Death|0|||
150196013|NCT03088878|541858829|FG006|Overall Study|Death|0|||
150196014|NCT03088878|541858830|FG007|Overall Study|Death|0|||
150196015|NCT03088878|541858831|FG008|Overall Study|Death|0|||
150196016|NCT03088878|541858832|FG009|Overall Study|Death|0|||
150196017|NCT03088878|541858833|FG010|Overall Study|Death|0|||
150196018|NCT03088878|541858834|FG011|Overall Study|Death|1|||
150196019|NCT03088878|541858835|FG012|Overall Study|Death|0|||
150196020|NCT03088878|541858836|FG013|Overall Study|Death|0|||
150196021|NCT03088878|541858823|FG000|Overall Study|Disease Progression|1|||
150196022|NCT03088878|541858824|FG001|Overall Study|Disease Progression|2|||
150196023|NCT03088878|541858825|FG002|Overall Study|Disease Progression|3|||
150196024|NCT03088878|541858826|FG003|Overall Study|Disease Progression|0|||
150196025|NCT03088878|541858827|FG004|Overall Study|Disease Progression|3|||
150196026|NCT03088878|541858828|FG005|Overall Study|Disease Progression|0|||
150196027|NCT03088878|541858829|FG006|Overall Study|Disease Progression|0|||
150196028|NCT03088878|541858830|FG007|Overall Study|Disease Progression|0|||
150196029|NCT03088878|541858831|FG008|Overall Study|Disease Progression|0|||
150196030|NCT03088878|541858832|FG009|Overall Study|Disease Progression|0|||
150196031|NCT03088878|541858833|FG010|Overall Study|Disease Progression|0|||
150196032|NCT03088878|541858834|FG011|Overall Study|Disease Progression|0|||
150196033|NCT03088878|541858835|FG012|Overall Study|Disease Progression|1|||
150196034|NCT03088878|541858836|FG013|Overall Study|Disease Progression|1|||
150196035|NCT03088878|541858823|FG000|Overall Study|Initiation of Alternative Treatment|0|||
150196036|NCT03088878|541858824|FG001|Overall Study|Initiation of Alternative Treatment|0|||
150196037|NCT03088878|541858825|FG002|Overall Study|Initiation of Alternative Treatment|0|||
150196038|NCT03088878|541858826|FG003|Overall Study|Initiation of Alternative Treatment|1|||
150196039|NCT03088878|541858827|FG004|Overall Study|Initiation of Alternative Treatment|0|||
150196040|NCT03088878|541858828|FG005|Overall Study|Initiation of Alternative Treatment|0|||
150196041|NCT03088878|541858829|FG006|Overall Study|Initiation of Alternative Treatment|0|||
150196042|NCT03088878|541858830|FG007|Overall Study|Initiation of Alternative Treatment|1|||
150196043|NCT03088878|541858831|FG008|Overall Study|Initiation of Alternative Treatment|1|||
150196044|NCT03088878|541858832|FG009|Overall Study|Initiation of Alternative Treatment|0|||
150196045|NCT03088878|541858833|FG010|Overall Study|Initiation of Alternative Treatment|0|||
150196046|NCT03088878|541858834|FG011|Overall Study|Initiation of Alternative Treatment|0|||
150196047|NCT03088878|541858835|FG012|Overall Study|Initiation of Alternative Treatment|0|||
150196048|NCT03088878|541858836|FG013|Overall Study|Initiation of Alternative Treatment|0|||
150196049|NCT03088878|541858823|FG000|Overall Study|Withdrawal by Subject|0|||
150196050|NCT03088878|541858824|FG001|Overall Study|Withdrawal by Subject|0|||
150196051|NCT03088878|541858825|FG002|Overall Study|Withdrawal by Subject|0|||
150196052|NCT03088878|541858826|FG003|Overall Study|Withdrawal by Subject|1|||
150196053|NCT03088878|541858827|FG004|Overall Study|Withdrawal by Subject|4|||
150196054|NCT03088878|541858828|FG005|Overall Study|Withdrawal by Subject|1|||
150196055|NCT03088878|541858829|FG006|Overall Study|Withdrawal by Subject|1|||
150196056|NCT03088878|541858830|FG007|Overall Study|Withdrawal by Subject|0|||
150196057|NCT03088878|541858831|FG008|Overall Study|Withdrawal by Subject|1|||
150196058|NCT03088878|541858832|FG009|Overall Study|Withdrawal by Subject|2|||
150196059|NCT03088878|541858833|FG010|Overall Study|Withdrawal by Subject|0|||
150196060|NCT03088878|541858834|FG011|Overall Study|Withdrawal by Subject|2|||
150196061|NCT03088878|541858835|FG012|Overall Study|Withdrawal by Subject|1|||
150196062|NCT03088878|541858836|FG013|Overall Study|Withdrawal by Subject|0|||
150196063|NCT03088878|541858823|FG000|Overall Study|Terminated by Sponsor|2|||
150196064|NCT03088878|541858824|FG001|Overall Study|Terminated by Sponsor|1|||
150196065|NCT03088878|541858825|FG002|Overall Study|Terminated by Sponsor|0|||
150196066|NCT03088878|541858826|FG003|Overall Study|Terminated by Sponsor|1|||
150196067|NCT03088878|541858827|FG004|Overall Study|Terminated by Sponsor|6|||
150196068|NCT03088878|541858828|FG005|Overall Study|Terminated by Sponsor|0|||
150196069|NCT03088878|541858829|FG006|Overall Study|Terminated by Sponsor|0|||
150196070|NCT03088878|541858830|FG007|Overall Study|Terminated by Sponsor|0|||
150196071|NCT03088878|541858831|FG008|Overall Study|Terminated by Sponsor|0|||
150196072|NCT03088878|541858832|FG009|Overall Study|Terminated by Sponsor|0|||
150130675|NCT00955357|541613330|FG001|Maintenance Phase|Lack of Efficacy|4|||
150130676|NCT00955357|541613329|FG000|Maintenance Phase|Protocol Violation|2|||
150130677|NCT00955357|541613330|FG001|Maintenance Phase|Protocol Violation|6|||
150130678|NCT00955357|541613329|FG000|Maintenance Phase|Lost to Follow-up|2|||
150130679|NCT00955357|541613330|FG001|Maintenance Phase|Lost to Follow-up|7|||
150130680|NCT00955357|541613329|FG000|Maintenance Phase|Withdrawal by Subject|4|||
150130681|NCT00955357|541613330|FG001|Maintenance Phase|Withdrawal by Subject|4|||
150130682|NCT00955357|541613329|FG000|Maintenance Phase|Patient moving out of area|0|||
150130683|NCT00955357|541613330|FG001|Maintenance Phase|Patient moving out of area|1|||
150130684|NCT00955357|541613329|FG000|Maintenance Phase|Non compliance to study procedures|1|||
150130685|NCT00955357|541613330|FG001|Maintenance Phase|Non compliance to study procedures|0|||
150130686|NCT01258608|541613331|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
150130687|NCT01258608|541613332|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
150130688|NCT01258608|541613331|FG000|Overall Study|Clinical progression|1|||
150130689|NCT01258608|541613332|FG001|Overall Study|Clinical progression|0|||
150130690|NCT01258608|541613331|FG000|Overall Study|Sponsor decision|0|||
150130691|NCT01258608|541613332|FG001|Overall Study|Sponsor decision|1|||
150130692|NCT01258608|541613331|FG000|Overall Study|Physician Decision|6|||
150130693|NCT01258608|541613332|FG001|Overall Study|Physician Decision|1|||
150130694|NCT01258608|541613331|FG000|Overall Study|Lost to Follow-up|0|||
150130695|NCT01258608|541613332|FG001|Overall Study|Lost to Follow-up|1|||
150130696|NCT01258608|541613331|FG000|Overall Study|Lack of compliance|1|||
150130697|NCT01258608|541613332|FG001|Overall Study|Lack of compliance|0|||
150130698|NCT01258608|541613331|FG000|Overall Study|Lack of Efficacy|0|||
150130699|NCT01258608|541613332|FG001|Overall Study|Lack of Efficacy|1|||
150130700|NCT01258608|541613331|FG000|Overall Study|Adverse Event|6|||
150130701|NCT01258608|541613332|FG001|Overall Study|Adverse Event|10|||
150130702|NCT01258608|541613331|FG000|Overall Study|Withdrawal by Subject|6|||
150130703|NCT01258608|541613332|FG001|Overall Study|Withdrawal by Subject|5|||
150130704|NCT04205630|541613333|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
150130705|NCT04205630|541613333|FG000|Overall Study|Disease clinical progression|7|||
150130706|NCT04205630|541613333|FG000|Overall Study|Withdrawal by Subject|2|||
150130707|NCT04205630|541613333|FG000|Overall Study|Adverse Event|17|||
150130708|NCT04205630|541613333|FG000|Overall Study|Other|1|||
150130709|NCT02943408|541613339|FG000|Overall Study|Lost to Follow-up|7|||
150130710|NCT02943408|541613340|FG001|Overall Study|Lost to Follow-up|1|||
150130711|NCT02943408|541613339|FG000|Overall Study|Withdrawal by Subject|0|||
150130712|NCT02943408|541613340|FG001|Overall Study|Withdrawal by Subject|1|||
150130713|NCT01621126|541613343|FG000|Overall Study|Physician Decision|6|||
150130714|NCT00886340|541613344|FG000|Overall Study|Withdrawal by Subject|0|||
150130715|NCT00886340|541613345|FG001|Overall Study|Withdrawal by Subject|7|||
150130716|NCT03224182|541613346|FG000|Overall Study|Study Drug Not Instilled|6|||
150130717|NCT03224182|541613347|FG001|Overall Study|Study Drug Not Instilled|1|||
150130718|NCT03224182|541613346|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
150130719|NCT03224182|541613347|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
150130720|NCT03224182|541613346|FG000|Overall Study|Withdrew of Consent|4|||
150130721|NCT03224182|541613347|FG001|Overall Study|Withdrew of Consent|2|||
150130722|NCT03224182|541613346|FG000|Overall Study|Investigator Decision|3|||
150130723|NCT03224182|541613347|FG001|Overall Study|Investigator Decision|1|||
150130724|NCT03224182|541613346|FG000|Overall Study|Sponsor Decision|26|||
150130725|NCT03224182|541613347|FG001|Overall Study|Sponsor Decision|12|||
150130726|NCT03224182|541613346|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
150130727|NCT03224182|541613347|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
150130728|NCT03224182|541613346|FG000|Overall Study|Lost to Follow-up|1|||
150130729|NCT03224182|541613347|FG001|Overall Study|Lost to Follow-up|0|||
150130730|NCT03224182|541613346|FG000|Overall Study|Participant Had Recurrence|11|||
150130731|NCT03224182|541613347|FG001|Overall Study|Participant Had Recurrence|5|||
150130732|NCT03224182|541613346|FG000|Overall Study|Death|0|||
150130733|NCT03224182|541613347|FG001|Overall Study|Death|1|||
150130734|NCT03224182|541613346|FG000|Overall Study|Reason not Specified|3|||
150130735|NCT03224182|541613347|FG001|Overall Study|Reason not Specified|3|||
150130736|NCT03224182|541613346|FG000|Overall Study|Other|1|||
150130737|NCT03224182|541613347|FG001|Overall Study|Other|0|||
150130738|NCT02481310|541613348|FG000|Follow up|Still in follow up|0|||
150130739|NCT02481310|541613349|FG001|Follow up|Still in follow up|3|||
150130740|NCT02481310|541613350|FG002|Follow up|Still in follow up|0|||
150130741|NCT00643916|541613352|FG000|Overall Study|Protocol Violation|0|||
150130742|NCT00643916|541613353|FG001|Overall Study|Protocol Violation|1|||
150130743|NCT00643916|541613354|FG002|Overall Study|Protocol Violation|1|||
150130744|NCT00643916|541613355|FG003|Overall Study|Protocol Violation|1|||
150130745|NCT00643916|541613356|FG004|Overall Study|Protocol Violation|0|||
150130746|NCT00643916|541613357|FG005|Overall Study|Protocol Violation|0|||
150130747|NCT00643916|541613352|FG000|Overall Study|Lost to Follow-up|0|||
150130748|NCT00643916|541613353|FG001|Overall Study|Lost to Follow-up|1|||
150130749|NCT00643916|541613354|FG002|Overall Study|Lost to Follow-up|0|||
150130750|NCT00643916|541613355|FG003|Overall Study|Lost to Follow-up|0|||
150130751|NCT00643916|541613356|FG004|Overall Study|Lost to Follow-up|0|||
150130752|NCT00643916|541613357|FG005|Overall Study|Lost to Follow-up|0|||
150130753|NCT00643916|541613352|FG000|Overall Study|Withdrawal by Subject|2|||
150130754|NCT00643916|541613353|FG001|Overall Study|Withdrawal by Subject|2|||
150130755|NCT00643916|541613354|FG002|Overall Study|Withdrawal by Subject|2|||
150130756|NCT00643916|541613355|FG003|Overall Study|Withdrawal by Subject|1|||
150130757|NCT00643916|541613356|FG004|Overall Study|Withdrawal by Subject|0|||
150196073|NCT03088878|541858833|FG010|Overall Study|Terminated by Sponsor|3|||
150196074|NCT03088878|541858834|FG011|Overall Study|Terminated by Sponsor|13|||
150196075|NCT03088878|541858835|FG012|Overall Study|Terminated by Sponsor|2|||
150196076|NCT03088878|541858836|FG013|Overall Study|Terminated by Sponsor|1|||
150196077|NCT03088878|541858823|FG000|Overall Study|Completed 2 years of Treatment|0|||
150196078|NCT03088878|541858824|FG001|Overall Study|Completed 2 years of Treatment|0|||
150196079|NCT03088878|541858825|FG002|Overall Study|Completed 2 years of Treatment|0|||
150196080|NCT03088878|541858826|FG003|Overall Study|Completed 2 years of Treatment|0|||
150196081|NCT03088878|541858827|FG004|Overall Study|Completed 2 years of Treatment|0|||
150196082|NCT03088878|541858828|FG005|Overall Study|Completed 2 years of Treatment|0|||
150196083|NCT03088878|541858829|FG006|Overall Study|Completed 2 years of Treatment|1|||
150196084|NCT03088878|541858830|FG007|Overall Study|Completed 2 years of Treatment|0|||
150196085|NCT03088878|541858831|FG008|Overall Study|Completed 2 years of Treatment|0|||
150196086|NCT03088878|541858832|FG009|Overall Study|Completed 2 years of Treatment|1|||
150196087|NCT03088878|541858833|FG010|Overall Study|Completed 2 years of Treatment|0|||
150196088|NCT03088878|541858834|FG011|Overall Study|Completed 2 years of Treatment|0|||
150196089|NCT03088878|541858835|FG012|Overall Study|Completed 2 years of Treatment|8|||
150196090|NCT03088878|541858836|FG013|Overall Study|Completed 2 years of Treatment|3|||
150196091|NCT03088878|541858823|FG000|Overall Study|Physician Decision|0|||
150196092|NCT03088878|541858824|FG001|Overall Study|Physician Decision|0|||
150196093|NCT03088878|541858825|FG002|Overall Study|Physician Decision|0|||
150196094|NCT03088878|541858826|FG003|Overall Study|Physician Decision|0|||
150196095|NCT03088878|541858827|FG004|Overall Study|Physician Decision|0|||
150196096|NCT03088878|541858828|FG005|Overall Study|Physician Decision|0|||
150196097|NCT03088878|541858829|FG006|Overall Study|Physician Decision|0|||
150196098|NCT03088878|541858830|FG007|Overall Study|Physician Decision|2|||
150196099|NCT03088878|541858831|FG008|Overall Study|Physician Decision|1|||
150196100|NCT03088878|541858832|FG009|Overall Study|Physician Decision|0|||
150196101|NCT03088878|541858833|FG010|Overall Study|Physician Decision|0|||
150196102|NCT03088878|541858834|FG011|Overall Study|Physician Decision|0|||
150196103|NCT03088878|541858835|FG012|Overall Study|Physician Decision|0|||
150196104|NCT03088878|541858836|FG013|Overall Study|Physician Decision|1|||
150196105|NCT03088878|541858823|FG000|Overall Study|COVID Related noncompliance|0|||
150196106|NCT03088878|541858824|FG001|Overall Study|COVID Related noncompliance|0|||
150196107|NCT03088878|541858825|FG002|Overall Study|COVID Related noncompliance|0|||
150196108|NCT03088878|541858826|FG003|Overall Study|COVID Related noncompliance|0|||
150196109|NCT03088878|541858827|FG004|Overall Study|COVID Related noncompliance|0|||
150196110|NCT03088878|541858828|FG005|Overall Study|COVID Related noncompliance|0|||
150196111|NCT03088878|541858829|FG006|Overall Study|COVID Related noncompliance|0|||
150196112|NCT03088878|541858830|FG007|Overall Study|COVID Related noncompliance|0|||
150196113|NCT03088878|541858831|FG008|Overall Study|COVID Related noncompliance|0|||
150196114|NCT03088878|541858832|FG009|Overall Study|COVID Related noncompliance|0|||
150196115|NCT03088878|541858833|FG010|Overall Study|COVID Related noncompliance|0|||
150196116|NCT03088878|541858834|FG011|Overall Study|COVID Related noncompliance|0|||
150196117|NCT03088878|541858835|FG012|Overall Study|COVID Related noncompliance|0|||
150196118|NCT03088878|541858836|FG013|Overall Study|COVID Related noncompliance|1|||
150196119|NCT03088878|541858823|FG000|Overall Study|Drug or Study Noncompliance|0|||
150196120|NCT03088878|541858824|FG001|Overall Study|Drug or Study Noncompliance|0|||
150196121|NCT03088878|541858825|FG002|Overall Study|Drug or Study Noncompliance|0|||
150196122|NCT03088878|541858826|FG003|Overall Study|Drug or Study Noncompliance|0|||
150196123|NCT03088878|541858827|FG004|Overall Study|Drug or Study Noncompliance|0|||
150196124|NCT03088878|541858828|FG005|Overall Study|Drug or Study Noncompliance|0|||
150196125|NCT03088878|541858829|FG006|Overall Study|Drug or Study Noncompliance|0|||
150196126|NCT03088878|541858830|FG007|Overall Study|Drug or Study Noncompliance|0|||
150196127|NCT03088878|541858831|FG008|Overall Study|Drug or Study Noncompliance|0|||
150196128|NCT03088878|541858832|FG009|Overall Study|Drug or Study Noncompliance|0|||
150196129|NCT03088878|541858833|FG010|Overall Study|Drug or Study Noncompliance|0|||
150196130|NCT03088878|541858834|FG011|Overall Study|Drug or Study Noncompliance|0|||
150196131|NCT03088878|541858835|FG012|Overall Study|Drug or Study Noncompliance|1|||
150196132|NCT03088878|541858836|FG013|Overall Study|Drug or Study Noncompliance|0|||
150196133|NCT02724969|541858837|FG000|Overall Study|Lost to Follow-up|12|||
150196134|NCT02724969|541858838|FG001|Overall Study|Lost to Follow-up|6|||
150196135|NCT02724969|541858837|FG000|Overall Study|Withdrawal by Subject|3|||
150196136|NCT02724969|541858838|FG001|Overall Study|Withdrawal by Subject|3|||
150196137|NCT02724969|541858837|FG000|Overall Study|Infant demise|0|||
150196138|NCT02724969|541858838|FG001|Overall Study|Infant demise|2|||
150196139|NCT05216406|541858839|FG000|Overall Study|Lost to Follow-up|8|||
150196140|NCT05216406|541858840|FG001|Overall Study|Lost to Follow-up|9|||
150196141|NCT04690582|541858843|FG000|Overall Study|Withdrawal by Subject|6|||
150196142|NCT04690582|541858844|FG001|Overall Study|Withdrawal by Subject|4|||
150196143|NCT04270942|541858845|FG000|Overall Study|Death|1|||
150196144|NCT04797195|541858852|FG000|Overall Study|Death|8|||
150196145|NCT04797195|541858853|FG001|Overall Study|Death|15|||
150196146|NCT04797195|541858852|FG000|Overall Study|Change from PD|15|||
150196147|NCT04797195|541858853|FG001|Overall Study|Change from PD|15|||
150196148|NCT04797195|541858852|FG000|Overall Study|Withdrawal by Subject|3|||
150196149|NCT04797195|541858853|FG001|Overall Study|Withdrawal by Subject|2|||
150196150|NCT04577963|541858855|FG000|Part 2|Death|0|||
150196151|NCT04577963|541858856|FG001|Part 2|Death|1|||
150196152|NCT04577963|541858857|FG002|Part 2|Death|8|||
150196153|NCT04577963|541858858|FG003|Part 2|Death|0|||
150196154|NCT04577963|541858859|FG004|Part 2|Death|20|||
150196155|NCT04577963|541858855|FG000|Part 2|Lost to Follow-up|0|||
150196156|NCT04577963|541858856|FG001|Part 2|Lost to Follow-up|0|||
150196157|NCT04577963|541858857|FG002|Part 2|Lost to Follow-up|0|||
150196158|NCT04577963|541858858|FG003|Part 2|Lost to Follow-up|0|||
150196159|NCT04577963|541858859|FG004|Part 2|Lost to Follow-up|2|||
150196160|NCT04577963|541858855|FG000|Part 2|Withdrawal by Subject|0|||
150196161|NCT04577963|541858856|FG001|Part 2|Withdrawal by Subject|0|||
150196162|NCT04577963|541858857|FG002|Part 2|Withdrawal by Subject|0|||
150196163|NCT04577963|541858858|FG003|Part 2|Withdrawal by Subject|0|||
150196164|NCT04577963|541858859|FG004|Part 2|Withdrawal by Subject|10|||
150196165|NCT04577963|541858855|FG000|Part 2|Progressive disease|0|||
150196166|NCT04577963|541858856|FG001|Part 2|Progressive disease|0|||
150196167|NCT04577963|541858857|FG002|Part 2|Progressive disease|0|||
150196168|NCT04577963|541858858|FG003|Part 2|Progressive disease|0|||
150196169|NCT04577963|541858859|FG004|Part 2|Progressive disease|2|||
150196170|NCT04577963|541858855|FG000|Part 2|Investigator decision|0|||
150196171|NCT04577963|541858856|FG001|Part 2|Investigator decision|0|||
150196172|NCT04577963|541858857|FG002|Part 2|Investigator decision|0|||
150196173|NCT04577963|541858858|FG003|Part 2|Investigator decision|0|||
150130758|NCT00643916|541613357|FG005|Overall Study|Withdrawal by Subject|1|||
150130759|NCT00643916|541613352|FG000|Overall Study|Not Vaccinated|2|||
150130760|NCT00643916|541613353|FG001|Overall Study|Not Vaccinated|2|||
150130761|NCT00643916|541613354|FG002|Overall Study|Not Vaccinated|3|||
150130762|NCT00643916|541613355|FG003|Overall Study|Not Vaccinated|0|||
150130763|NCT00643916|541613356|FG004|Overall Study|Not Vaccinated|2|||
150130764|NCT00643916|541613357|FG005|Overall Study|Not Vaccinated|0|||
150130765|NCT00686166|541613364|FG000|Overall Study|Adverse Event|7|||
150130766|NCT00686166|541613364|FG000|Overall Study|Withdrawal by Subject|1|||
150130767|NCT00686166|541613364|FG000|Overall Study|Progression/Relapse|1|||
150130768|NCT00686166|541613364|FG000|Overall Study|Death|1|||
150130769|NCT00686166|541613364|FG000|Overall Study|Not Protocol Specified|1|||
150130770|NCT00686166|541613364|FG000|Overall Study|Ineligible|5|||
150130771|NCT00686166|541613364|FG000|Overall Study|Did not begin protocol therapy|4|||
150130772|NCT01549613|541613365|FG000|Overall Study|Lost to Follow-up|11|||
150130773|NCT01549613|541613366|FG001|Overall Study|Lost to Follow-up|11|||
150130774|NCT02131272|541613367|FG000|Overall Study|Withdrawal by parent|0|||
150130775|NCT02131272|541613368|FG001|Overall Study|Withdrawal by parent|1|||
150130776|NCT02131272|541613367|FG000|Overall Study|Withdrawal by Subject|0|||
150130777|NCT02131272|541613368|FG001|Overall Study|Withdrawal by Subject|1|||
150130778|NCT02131272|541613367|FG000|Overall Study|Withdrawal Criteria|1|||
150130779|NCT02131272|541613368|FG001|Overall Study|Withdrawal Criteria|0|||
150130780|NCT00381940|541613369|FG000|Overall Study|Lack of Efficacy|3|||
150130781|NCT00381940|541613369|FG000|Overall Study|Protocol Violation|1|||
150130782|NCT00381940|541613369|FG000|Overall Study|Ineligible|1|||
150130783|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
150130784|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
150130785|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
150130786|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
150130787|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
150130788|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
150130789|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
150130790|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
150130791|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
150130792|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
150130793|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
150130794|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
150130795|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
150130796|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
150130797|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
150130798|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
150130799|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
150130800|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
150130801|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
150130802|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
150130803|NCT04162769|541613370|FG000|Double-blind Treatment (12-Week)|Other|0|||
150130804|NCT04162769|541613371|FG001|Double-blind Treatment (12-Week)|Other|1|||
150130805|NCT04162769|541613372|FG002|Double-blind Treatment (12-Week)|Other|1|||
150130806|NCT04162769|541613373|FG003|Double-blind Treatment (12-Week)|Other|0|||
150130807|NCT04162769|541613370|FG000|OLE Period (52-Week)|Adverse Event|0|||
150130808|NCT04162769|541613371|FG001|OLE Period (52-Week)|Adverse Event|0|||
150130809|NCT04162769|541613372|FG002|OLE Period (52-Week)|Adverse Event|0|||
150130810|NCT04162769|541613373|FG003|OLE Period (52-Week)|Adverse Event|5|||
150130811|NCT04162769|541613370|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
150130812|NCT04162769|541613371|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
150130813|NCT04162769|541613372|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
150130814|NCT04162769|541613373|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
150130815|NCT04162769|541613370|FG000|OLE Period (52-Week)|Physician Decision|0|||
150130816|NCT04162769|541613371|FG001|OLE Period (52-Week)|Physician Decision|0|||
150130817|NCT04162769|541613372|FG002|OLE Period (52-Week)|Physician Decision|0|||
150130818|NCT04162769|541613373|FG003|OLE Period (52-Week)|Physician Decision|1|||
150130819|NCT04162769|541613370|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
150130820|NCT04162769|541613371|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
150130821|NCT04162769|541613372|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
150130822|NCT04162769|541613373|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
150130823|NCT04162769|541613370|FG000|OLE Period (52-Week)|Protocol deviation|0|||
150130824|NCT04162769|541613371|FG001|OLE Period (52-Week)|Protocol deviation|0|||
150130825|NCT04162769|541613372|FG002|OLE Period (52-Week)|Protocol deviation|0|||
150130826|NCT04162769|541613373|FG003|OLE Period (52-Week)|Protocol deviation|2|||
150130827|NCT02163733|541613374|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
150130828|NCT02163733|541613375|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
150130829|NCT02163733|541613376|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
150130830|NCT02163733|541613374|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
150130831|NCT02163733|541613375|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
150130832|NCT02163733|541613376|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
150130833|NCT00746590|541613377|FG000|Overall Study|Death|1|||
150130834|NCT02794285|541613380|FG000|Overall Study|Adverse Event|11|||
150130835|NCT02794285|541613381|FG001|Overall Study|Adverse Event|4|||
150130836|NCT02794285|541613382|FG002|Overall Study|Adverse Event|5|||
150130837|NCT02794285|541613383|FG003|Overall Study|Adverse Event|8|||
150196174|NCT04577963|541858859|FG004|Part 2|Investigator decision|1|||
150196175|NCT04577963|541858855|FG000|Part 2|Sponsor terminated study|0|||
150196176|NCT04577963|541858856|FG001|Part 2|Sponsor terminated study|0|||
150196177|NCT04577963|541858857|FG002|Part 2|Sponsor terminated study|3|||
150196178|NCT04577963|541858858|FG003|Part 2|Sponsor terminated study|1|||
150196179|NCT04577963|541858859|FG004|Part 2|Sponsor terminated study|4|||
150196180|NCT02709161|541858860|FG000|Overall Study|Withdrawal by Subject|1|||
150196181|NCT02709161|541858861|FG001|Overall Study|Withdrawal by Subject|0|||
150196182|NCT05167864|541858864|FG000|Overall Study|Lost to Follow-up|7|||
150196183|NCT05167864|541858865|FG001|Overall Study|Lost to Follow-up|6|||
150196184|NCT05167864|541858866|FG002|Overall Study|Lost to Follow-up|7|||
150196185|NCT05167864|541858867|FG003|Overall Study|Lost to Follow-up|9|||
150196186|NCT04059185|541858870|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
150196187|NCT04059185|541858871|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
150196188|NCT04059185|541858872|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
150196189|NCT04059185|541858870|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
150196190|NCT04059185|541858871|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
150196191|NCT04059185|541858872|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
150196192|NCT04059185|541858870|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
150196193|NCT04059185|541858871|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
150196194|NCT04059185|541858872|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
150196195|NCT04059185|541858870|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
150196196|NCT04059185|541858871|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
150196197|NCT04059185|541858872|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
150196198|NCT04059185|541858870|FG000|Longitudinal Assessment-Adults Only|Death|4|||
150196199|NCT04059185|541858871|FG001|Longitudinal Assessment-Adults Only|Death|4|||
150196200|NCT04059185|541858872|FG002|Longitudinal Assessment-Adults Only|Death|3|||
150196201|NCT05623228|541858882|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
150196202|NCT05623228|541858883|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196203|NCT05623228|541858884|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196204|NCT05623228|541858885|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196205|NCT05623228|541858886|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196206|NCT05623228|541858887|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196207|NCT05623228|541858888|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196208|NCT05623228|541858889|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
150196209|NCT05623228|541858882|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
150196210|NCT05623228|541858883|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
150196211|NCT05623228|541858884|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
150196212|NCT05623228|541858885|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
150196213|NCT05623228|541858886|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
150196214|NCT05623228|541858887|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
150130838|NCT02794285|541613380|FG000|Overall Study|Condition Under Investigation Improved|1|||
150196215|NCT05623228|541858888|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
150196216|NCT05623228|541858889|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
150196217|NCT03056573|541858895|FG000|Overall Study|Death|2|||
150196218|NCT03056573|541858896|FG001|Overall Study|Death|4|||
150196219|NCT03056573|541858895|FG000|Overall Study|Withdrawal by Subject|2|||
150196220|NCT03056573|541858896|FG001|Overall Study|Withdrawal by Subject|0|||
150196221|NCT03056573|541858895|FG000|Overall Study|Lost to Follow-up|1|||
150196222|NCT03056573|541858896|FG001|Overall Study|Lost to Follow-up|1|||
150196223|NCT02823145|541858897|FG000|Enrollment|Other|1|||
150196224|NCT02823145|541858898|FG001|Enrollment|Other|0|||
150196225|NCT02823145|541858897|FG000|Treatment|Adverse Event|0|||
150196226|NCT02823145|541858898|FG001|Treatment|Adverse Event|11|||
150196227|NCT02823145|541858897|FG000|Treatment|Death|0|||
150196228|NCT02823145|541858898|FG001|Treatment|Death|3|||
150196229|NCT02823145|541858897|FG000|Treatment|Family Decision|0|||
150196230|NCT02823145|541858898|FG001|Treatment|Family Decision|1|||
150196231|NCT02823145|541858897|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
150196232|NCT02823145|541858898|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
150196233|NCT02823145|541858897|FG000|Treatment|Lack of Efficacy|0|||
150196234|NCT02823145|541858898|FG001|Treatment|Lack of Efficacy|48|||
150196235|NCT02823145|541858897|FG000|Treatment|Non-Compliance With E-Diary|0|||
150196236|NCT02823145|541858898|FG001|Treatment|Non-Compliance With E-Diary|1|||
150196237|NCT02823145|541858897|FG000|Treatment|Physician Decision|0|||
150196238|NCT02823145|541858898|FG001|Treatment|Physician Decision|2|||
150196239|NCT02823145|541858897|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
150196240|NCT02823145|541858898|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
150196241|NCT02823145|541858897|FG000|Treatment|Subject needed to take prohibited medication|0|||
150196242|NCT02823145|541858898|FG001|Treatment|Subject needed to take prohibited medication|1|||
150196243|NCT02823145|541858897|FG000|Treatment|Subject transferred to direct access programme|0|||
150196244|NCT02823145|541858898|FG001|Treatment|Subject transferred to direct access programme|1|||
150196245|NCT02823145|541858897|FG000|Treatment|Switching to commercially available drug|0|||
150196246|NCT02823145|541858898|FG001|Treatment|Switching to commercially available drug|11|||
150196247|NCT02823145|541858897|FG000|Treatment|Transitioned to commercial supply of medication|0|||
150196248|NCT02823145|541858898|FG001|Treatment|Transitioned to commercial supply of medication|1|||
150196249|NCT02823145|541858897|FG000|Treatment|Withdrawal By Caregiver|0|||
150196250|NCT02823145|541858898|FG001|Treatment|Withdrawal By Caregiver|1|||
150196251|NCT02823145|541858897|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
150196252|NCT02823145|541858898|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
150196253|NCT02823145|541858897|FG000|Treatment|Withdrawal by Subject|0|||
150196254|NCT02823145|541858898|FG001|Treatment|Withdrawal by Subject|16|||
150196255|NCT02823145|541858897|FG000|Treatment|Reason unknown|0|||
150196256|NCT02823145|541858898|FG001|Treatment|Reason unknown|1|||
150196257|NCT04741776|541858899|FG000|Overall Study|Withdrawal by Subject|7|||
150196258|NCT04741776|541858900|FG001|Overall Study|Withdrawal by Subject|10|||
150196259|NCT04741776|541858901|FG002|Overall Study|Withdrawal by Subject|10|||
150196260|NCT04741776|541858902|FG003|Overall Study|Withdrawal by Subject|17|||
150196261|NCT04741776|541858899|FG000|Overall Study|Death|0|||
150196262|NCT04741776|541858900|FG001|Overall Study|Death|0|||
150196263|NCT04741776|541858901|FG002|Overall Study|Death|1|||
150196264|NCT04741776|541858902|FG003|Overall Study|Death|0|||
150196265|NCT02116530|541860998|FG000|Overall Study|Withdrawal by Subject|1|||
150196266|NCT02116530|541860999|FG001|Overall Study|Withdrawal by Subject|2|||
150196267|NCT02116530|541860998|FG000|Overall Study|Adverse Event|4|||
150196268|NCT02116530|541860999|FG001|Overall Study|Adverse Event|0|||
150196269|NCT02116530|541860998|FG000|Overall Study|Physician Decision|1|||
150196270|NCT02116530|541860999|FG001|Overall Study|Physician Decision|0|||
150196271|NCT02116530|541860998|FG000|Overall Study|Lost to Follow-up|1|||
150196272|NCT02116530|541860999|FG001|Overall Study|Lost to Follow-up|0|||
150196273|NCT02116530|541860998|FG000|Overall Study|Other Medical Problems|2|||
150196274|NCT02116530|541860999|FG001|Overall Study|Other Medical Problems|2|||
150196275|NCT03766685|541861000|FG000|Overall Study|Lost to Follow-up|1|||
150196276|NCT03766685|541861001|FG001|Overall Study|Lost to Follow-up|1|||
150196277|NCT03766685|541861002|FG002|Overall Study|Lost to Follow-up|0|||
150196278|NCT03766685|541861003|FG003|Overall Study|Lost to Follow-up|0|||
150196279|NCT03766685|541861000|FG000|Overall Study|Adverse Event, not fatal|0|||
150196280|NCT03766685|541861001|FG001|Overall Study|Adverse Event, not fatal|1|||
150196281|NCT03766685|541861002|FG002|Overall Study|Adverse Event, not fatal|0|||
150196282|NCT03766685|541861003|FG003|Overall Study|Adverse Event, not fatal|1|||
150196283|NCT03766685|541861000|FG000|Overall Study|Withdrawal by Subject|0|||
150196284|NCT03766685|541861001|FG001|Overall Study|Withdrawal by Subject|2|||
150196285|NCT03766685|541861002|FG002|Overall Study|Withdrawal by Subject|0|||
150196286|NCT03766685|541861003|FG003|Overall Study|Withdrawal by Subject|0|||
150196287|NCT03766685|541861000|FG000|Overall Study|Protocol Violation|0|||
150196288|NCT03766685|541861001|FG001|Overall Study|Protocol Violation|1|||
150196289|NCT03766685|541861002|FG002|Overall Study|Protocol Violation|0|||
150196290|NCT03766685|541861003|FG003|Overall Study|Protocol Violation|0|||
150196291|NCT03766685|541861000|FG000|Overall Study|Non-compliance|0|||
150130839|NCT02794285|541613381|FG001|Overall Study|Condition Under Investigation Improved|0|||
150130840|NCT02794285|541613382|FG002|Overall Study|Condition Under Investigation Improved|0|||
150130841|NCT02794285|541613383|FG003|Overall Study|Condition Under Investigation Improved|0|||
150130842|NCT02794285|541613380|FG000|Overall Study|Condition Under Investigation Worsened|0|||
150130843|NCT02794285|541613381|FG001|Overall Study|Condition Under Investigation Worsened|2|||
150130844|NCT02794285|541613382|FG002|Overall Study|Condition Under Investigation Worsened|1|||
150130845|NCT02794285|541613383|FG003|Overall Study|Condition Under Investigation Worsened|0|||
150130846|NCT02794285|541613380|FG000|Overall Study|Death|2|||
150130847|NCT02794285|541613381|FG001|Overall Study|Death|1|||
150130848|NCT02794285|541613382|FG002|Overall Study|Death|2|||
150130849|NCT02794285|541613383|FG003|Overall Study|Death|0|||
150130850|NCT02794285|541613380|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
150130851|NCT02794285|541613381|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
150130852|NCT02794285|541613382|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
150130853|NCT02794285|541613383|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
150130854|NCT02794285|541613380|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
150130855|NCT02794285|541613381|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
150130856|NCT02794285|541613382|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
150130857|NCT02794285|541613383|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
150130858|NCT02794285|541613380|FG000|Overall Study|Lack of Efficacy|10|||
150130859|NCT02794285|541613381|FG001|Overall Study|Lack of Efficacy|6|||
150130860|NCT02794285|541613382|FG002|Overall Study|Lack of Efficacy|3|||
150130861|NCT02794285|541613383|FG003|Overall Study|Lack of Efficacy|3|||
150130862|NCT02794285|541613380|FG000|Overall Study|Lost to Follow-up|5|||
150130863|NCT02794285|541613381|FG001|Overall Study|Lost to Follow-up|6|||
150130864|NCT02794285|541613382|FG002|Overall Study|Lost to Follow-up|3|||
150130865|NCT02794285|541613383|FG003|Overall Study|Lost to Follow-up|1|||
150130866|NCT02794285|541613380|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
150130867|NCT02794285|541613381|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
150130868|NCT02794285|541613382|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
150130869|NCT02794285|541613383|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
150130870|NCT02794285|541613380|FG000|Overall Study|Withdrawal by Subject|38|||
150130871|NCT02794285|541613381|FG001|Overall Study|Withdrawal by Subject|29|||
150130872|NCT02794285|541613382|FG002|Overall Study|Withdrawal by Subject|20|||
150130873|NCT02794285|541613383|FG003|Overall Study|Withdrawal by Subject|12|||
150130874|NCT02794285|541613380|FG000|Overall Study|Missing|1|||
150130875|NCT02794285|541613381|FG001|Overall Study|Missing|0|||
150130876|NCT02794285|541613382|FG002|Overall Study|Missing|0|||
150130877|NCT02794285|541613383|FG003|Overall Study|Missing|0|||
150130878|NCT02794285|541613380|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
150130879|NCT02794285|541613381|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
150130880|NCT02794285|541613382|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
150130881|NCT02794285|541613383|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
150130882|NCT02794285|541613380|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
150130883|NCT02794285|541613381|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
150130884|NCT02794285|541613382|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
150130885|NCT02794285|541613383|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
150130886|NCT04052204|541613384|FG000|Overall Study|Death|1|||
150130887|NCT04052204|541613385|FG001|Overall Study|Death|0|||
150130888|NCT04052204|541613386|FG002|Overall Study|Death|0|||
150130889|NCT04052204|541613384|FG000|Overall Study|Progressive disease|1|||
150130890|NCT04052204|541613385|FG001|Overall Study|Progressive disease|0|||
150130891|NCT04052204|541613386|FG002|Overall Study|Progressive disease|0|||
150130892|NCT04052204|541613384|FG000|Overall Study|Other|1|||
150130893|NCT04052204|541613385|FG001|Overall Study|Other|0|||
150130894|NCT04052204|541613386|FG002|Overall Study|Other|0|||
150130895|NCT04124926|541613402|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
150130896|NCT04124926|541613403|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
150130897|NCT04124926|541613404|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
150130898|NCT04124926|541613405|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
150130899|NCT04124926|541613406|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
150130900|NCT04124926|541613402|FG000|Healing Phase|Protocol Violation|0|||
150130901|NCT04124926|541613403|FG001|Healing Phase|Protocol Violation|1|||
150130902|NCT04124926|541613404|FG002|Healing Phase|Protocol Violation|0|||
150130903|NCT04124926|541613405|FG003|Healing Phase|Protocol Violation|0|||
150130904|NCT04124926|541613406|FG004|Healing Phase|Protocol Violation|0|||
150130905|NCT04124926|541613402|FG000|Healing Phase|Lost to Follow-up|5|||
150130906|NCT04124926|541613403|FG001|Healing Phase|Lost to Follow-up|4|||
150130907|NCT04124926|541613404|FG002|Healing Phase|Lost to Follow-up|0|||
150130908|NCT04124926|541613405|FG003|Healing Phase|Lost to Follow-up|0|||
150130909|NCT04124926|541613406|FG004|Healing Phase|Lost to Follow-up|0|||
150130910|NCT04124926|541613402|FG000|Healing Phase|Voluntary Withdrawal|10|||
150130911|NCT04124926|541613403|FG001|Healing Phase|Voluntary Withdrawal|7|||
150130912|NCT04124926|541613404|FG002|Healing Phase|Voluntary Withdrawal|0|||
150130913|NCT04124926|541613405|FG003|Healing Phase|Voluntary Withdrawal|0|||
150130914|NCT04124926|541613406|FG004|Healing Phase|Voluntary Withdrawal|0|||
150130915|NCT04124926|541613402|FG000|Healing Phase|Withdrawal of Consent|5|||
150130916|NCT04124926|541613403|FG001|Healing Phase|Withdrawal of Consent|3|||
150130917|NCT04124926|541613404|FG002|Healing Phase|Withdrawal of Consent|0|||
150130918|NCT04124926|541613405|FG003|Healing Phase|Withdrawal of Consent|0|||
150130919|NCT04124926|541613406|FG004|Healing Phase|Withdrawal of Consent|0|||
150130920|NCT04124926|541613402|FG000|Healing Phase|Miscellaneous|8|||
150130921|NCT04124926|541613403|FG001|Healing Phase|Miscellaneous|7|||
150130922|NCT04124926|541613404|FG002|Healing Phase|Miscellaneous|0|||
150130923|NCT04124926|541613405|FG003|Healing Phase|Miscellaneous|0|||
150130924|NCT04124926|541613406|FG004|Healing Phase|Miscellaneous|0|||
150130925|NCT04124926|541613402|FG000|Healing Phase|Randomized but not Treated|0|||
150130926|NCT04124926|541613403|FG001|Healing Phase|Randomized but not Treated|3|||
150130927|NCT04124926|541613404|FG002|Healing Phase|Randomized but not Treated|0|||
150130928|NCT04124926|541613405|FG003|Healing Phase|Randomized but not Treated|0|||
150130929|NCT04124926|541613406|FG004|Healing Phase|Randomized but not Treated|0|||
150130930|NCT04124926|541613402|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
150130931|NCT04124926|541613403|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
150130932|NCT04124926|541613404|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
150130933|NCT04124926|541613405|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
150130934|NCT04124926|541613406|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
150130935|NCT04124926|541613402|FG000|Maintenance Phase|Protocol Violation|0|||
150130936|NCT04124926|541613403|FG001|Maintenance Phase|Protocol Violation|0|||
150130937|NCT04124926|541613404|FG002|Maintenance Phase|Protocol Violation|3|||
150130938|NCT04124926|541613405|FG003|Maintenance Phase|Protocol Violation|0|||
150130939|NCT04124926|541613406|FG004|Maintenance Phase|Protocol Violation|0|||
150130940|NCT04124926|541613402|FG000|Maintenance Phase|Lost to Follow-up|0|||
150130941|NCT04124926|541613403|FG001|Maintenance Phase|Lost to Follow-up|0|||
150130942|NCT04124926|541613404|FG002|Maintenance Phase|Lost to Follow-up|7|||
150130943|NCT04124926|541613405|FG003|Maintenance Phase|Lost to Follow-up|8|||
150130944|NCT04124926|541613406|FG004|Maintenance Phase|Lost to Follow-up|9|||
150130945|NCT04124926|541613402|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
150130946|NCT04124926|541613403|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
150130947|NCT04124926|541613404|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
150130948|NCT04124926|541613405|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
150130949|NCT04124926|541613406|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
150130950|NCT04124926|541613402|FG000|Maintenance Phase|Pregnancy|0|||
150130951|NCT04124926|541613403|FG001|Maintenance Phase|Pregnancy|0|||
150130952|NCT04124926|541613404|FG002|Maintenance Phase|Pregnancy|0|||
150130953|NCT04124926|541613405|FG003|Maintenance Phase|Pregnancy|1|||
150130954|NCT04124926|541613406|FG004|Maintenance Phase|Pregnancy|0|||
150130955|NCT04124926|541613402|FG000|Maintenance Phase|Lack of Efficacy|0|||
150130956|NCT04124926|541613403|FG001|Maintenance Phase|Lack of Efficacy|0|||
150130957|NCT04124926|541613404|FG002|Maintenance Phase|Lack of Efficacy|0|||
150130958|NCT04124926|541613405|FG003|Maintenance Phase|Lack of Efficacy|0|||
150130959|NCT04124926|541613406|FG004|Maintenance Phase|Lack of Efficacy|1|||
150130960|NCT04124926|541613402|FG000|Maintenance Phase|Withdrawal of Consent|0|||
150130961|NCT04124926|541613403|FG001|Maintenance Phase|Withdrawal of Consent|0|||
150130962|NCT04124926|541613404|FG002|Maintenance Phase|Withdrawal of Consent|5|||
150130963|NCT04124926|541613405|FG003|Maintenance Phase|Withdrawal of Consent|5|||
150130964|NCT04124926|541613406|FG004|Maintenance Phase|Withdrawal of Consent|5|||
150130965|NCT04124926|541613402|FG000|Maintenance Phase|Miscellaneous|0|||
150130966|NCT04124926|541613403|FG001|Maintenance Phase|Miscellaneous|0|||
150130967|NCT04124926|541613404|FG002|Maintenance Phase|Miscellaneous|1|||
150130968|NCT04124926|541613405|FG003|Maintenance Phase|Miscellaneous|2|||
150130969|NCT04124926|541613406|FG004|Maintenance Phase|Miscellaneous|4|||
150130970|NCT04124926|541613402|FG000|Maintenance Phase|Randomized but not Treated|0|||
150130971|NCT04124926|541613403|FG001|Maintenance Phase|Randomized but not Treated|0|||
150130972|NCT04124926|541613404|FG002|Maintenance Phase|Randomized but not Treated|2|||
150130973|NCT04124926|541613405|FG003|Maintenance Phase|Randomized but not Treated|2|||
150130974|NCT04124926|541613406|FG004|Maintenance Phase|Randomized but not Treated|0|||
150130975|NCT02013622|541613412|FG000|Overall Study|Lost to Follow-up|10|||
150130976|NCT02013622|541613412|FG000|Overall Study|Adverse Event|3|||
150130977|NCT02013622|541613412|FG000|Overall Study|Met Withdrawal Criteria|3|||
150130978|NCT02013622|541613412|FG000|Overall Study|Withdrawal by Subject|6|||
150130979|NCT02013622|541613412|FG000|Overall Study|Protocol Deviation|1|||
150130980|NCT02013622|541613412|FG000|Overall Study|Lack of Efficacy|1|||
150130981|NCT03644186|541613415|FG000|Overall Study|Withdrawal by Subject|1|||
150130982|NCT03644186|541613416|FG001|Overall Study|Withdrawal by Subject|1|||
150130983|NCT02701985|541613419|FG000|Overall Study|Withdrawal by Subject|1|||
150130984|NCT02701985|541613420|FG001|Overall Study|Withdrawal by Subject|1|||
150130985|NCT02701985|541613419|FG000|Overall Study|Lost to Follow-up|1|||
150130986|NCT02701985|541613420|FG001|Overall Study|Lost to Follow-up|0|||
150130987|NCT02701985|541613419|FG000|Overall Study|Death|1|||
150196292|NCT03766685|541861001|FG001|Overall Study|Non-compliance|2|||
150196293|NCT03766685|541861002|FG002|Overall Study|Non-compliance|0|||
150196294|NCT03766685|541861003|FG003|Overall Study|Non-compliance|0|||
150196295|NCT02927236|541861006|FG000|Characterization Phase|Physician Decision|0|||
150196296|NCT02927236|541861007|FG001|Characterization Phase|Physician Decision|3|||
150196297|NCT02927236|541861008|FG002|Characterization Phase|Physician Decision|0|||
150196298|NCT02927236|541861009|FG003|Characterization Phase|Physician Decision|2|||
150196299|NCT02927236|541861006|FG000|Characterization Phase|Lost to Follow-up|0|||
150196300|NCT02927236|541861007|FG001|Characterization Phase|Lost to Follow-up|0|||
150196301|NCT02927236|541861008|FG002|Characterization Phase|Lost to Follow-up|0|||
150196302|NCT02927236|541861009|FG003|Characterization Phase|Lost to Follow-up|3|||
150196303|NCT02927236|541861006|FG000|Characterization Phase|Withdrawal by Subject|1|||
150196304|NCT02927236|541861007|FG001|Characterization Phase|Withdrawal by Subject|0|||
150196305|NCT02927236|541861008|FG002|Characterization Phase|Withdrawal by Subject|0|||
150196306|NCT02927236|541861009|FG003|Characterization Phase|Withdrawal by Subject|1|||
150196307|NCT02927236|541861006|FG000|Treatment Phase|Adverse Event|1|||
150196308|NCT02927236|541861007|FG001|Treatment Phase|Adverse Event|0|||
150196309|NCT02927236|541861008|FG002|Treatment Phase|Adverse Event|1|||
150196310|NCT02927236|541861009|FG003|Treatment Phase|Adverse Event|1|||
150196311|NCT02927236|541861006|FG000|Treatment Phase|Protocol Violation|3|||
150196312|NCT02927236|541861007|FG001|Treatment Phase|Protocol Violation|0|||
150196313|NCT02927236|541861008|FG002|Treatment Phase|Protocol Violation|0|||
150196314|NCT02927236|541861009|FG003|Treatment Phase|Protocol Violation|1|||
150196315|NCT02927236|541861006|FG000|Treatment Phase|Lost to Follow-up|1|||
150196316|NCT02927236|541861007|FG001|Treatment Phase|Lost to Follow-up|0|||
150196317|NCT02927236|541861008|FG002|Treatment Phase|Lost to Follow-up|0|||
150196318|NCT02927236|541861009|FG003|Treatment Phase|Lost to Follow-up|0|||
150196319|NCT02927236|541861006|FG000|Follow-up Phase|Lost to Follow-up|1|||
150196320|NCT02927236|541861007|FG001|Follow-up Phase|Lost to Follow-up|0|||
150196321|NCT02927236|541861008|FG002|Follow-up Phase|Lost to Follow-up|1|||
150196322|NCT02927236|541861009|FG003|Follow-up Phase|Lost to Follow-up|0|||
150196323|NCT05297565|541861010|FG000|Overall Study|Other Reasons|0|||
150196324|NCT05297565|541861011|FG001|Overall Study|Other Reasons|1|||
150196325|NCT05297565|541861010|FG000|Overall Study|Physician Decision|0|||
150196326|NCT05297565|541861011|FG001|Overall Study|Physician Decision|1|||
150196327|NCT05297565|541861010|FG000|Overall Study|Disease recurrence|1|||
150196328|NCT05297565|541861011|FG001|Overall Study|Disease recurrence|0|||
150196329|NCT05299723|541861013|FG000|Overall Study|Withdrawal by Subject|0|||
150196330|NCT05299723|541861014|FG001|Overall Study|Withdrawal by Subject|2|||
150196331|NCT05299723|541861015|FG002|Overall Study|Withdrawal by Subject|0|||
150196332|NCT01959607|541861016|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
150196333|NCT01959607|541861017|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
150196334|NCT01959607|541861018|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
150196335|NCT01959607|541861019|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
150196336|NCT03913442|541861020|FG000|Overall Study|Adverse Event|0|||
150196337|NCT03913442|541861021|FG001|Overall Study|Adverse Event|3|||
150196338|NCT03913442|541861020|FG000|Overall Study|Withdrawal by Subject|5|||
150196339|NCT03913442|541861021|FG001|Overall Study|Withdrawal by Subject|5|||
150196340|NCT03913442|541861020|FG000|Overall Study|Terminations|2|||
150196341|NCT03913442|541861021|FG001|Overall Study|Terminations|1|||
150196342|NCT03913442|541861020|FG000|Overall Study|Lost to Follow-up|2|||
150196343|NCT03913442|541861021|FG001|Overall Study|Lost to Follow-up|2|||
150196344|NCT03952338|541861022|FG000|Overall Study|Lost to Follow-up|11|||
150196345|NCT03952338|541861023|FG001|Overall Study|Lost to Follow-up|17|||
150196346|NCT03952338|541861022|FG000|Overall Study|Withdrawal by Subject|1|||
150196347|NCT03952338|541861023|FG001|Overall Study|Withdrawal by Subject|1|||
150196348|NCT03952338|541861022|FG000|Overall Study|Protocol Violation|1|||
150196349|NCT03952338|541861023|FG001|Overall Study|Protocol Violation|0|||
150196350|NCT04811040|541861024|FG000|Overall Study|Lost to Follow-up|2|||
150196351|NCT04811040|541861025|FG001|Overall Study|Lost to Follow-up|0|||
150196352|NCT04811040|541861026|FG002|Overall Study|Lost to Follow-up|0|||
150196353|NCT04811040|541861027|FG003|Overall Study|Lost to Follow-up|0|||
150196354|NCT04811040|541861024|FG000|Overall Study|Withdrew consent|1|||
150196355|NCT04811040|541861025|FG001|Overall Study|Withdrew consent|1|||
150196356|NCT04811040|541861026|FG002|Overall Study|Withdrew consent|0|||
150196357|NCT04811040|541861027|FG003|Overall Study|Withdrew consent|0|||
150196358|NCT05274074|541861028|FG000|Overall Study|Lost to Follow-up|2|||
150196359|NCT05274074|541861029|FG001|Overall Study|Lost to Follow-up|3|||
150196360|NCT05274074|541861028|FG000|Overall Study|Withdrawal by Subject|1|||
150196361|NCT05274074|541861029|FG001|Overall Study|Withdrawal by Subject|2|||
150196362|NCT05194956|541861030|FG000|Washout Period|Withdrawal by Subject|0|||
150196363|NCT05194956|541861031|FG001|Washout Period|Withdrawal by Subject|2|||
150196364|NCT01828099|541861040|FG000|Treatment Period|Adverse Event|24|||
150196365|NCT01828099|541861041|FG001|Treatment Period|Adverse Event|23|||
150196366|NCT01828099|541861040|FG000|Treatment Period|Death|10|||
150196367|NCT01828099|541861041|FG001|Treatment Period|Death|12|||
150196368|NCT01828099|541861040|FG000|Treatment Period|Lost to Follow-up|2|||
150196369|NCT01828099|541861041|FG001|Treatment Period|Lost to Follow-up|1|||
150196370|NCT01828099|541861040|FG000|Treatment Period|Non-compliance with study treatment|1|||
150196371|NCT01828099|541861041|FG001|Treatment Period|Non-compliance with study treatment|0|||
150196372|NCT01828099|541861040|FG000|Treatment Period|Physician Decision|17|||
150196373|NCT01828099|541861041|FG001|Treatment Period|Physician Decision|16|||
150196374|NCT01828099|541861040|FG000|Treatment Period|Progressive disease|99|||
150196375|NCT01828099|541861041|FG001|Treatment Period|Progressive disease|107|||
150196376|NCT01828099|541861040|FG000|Treatment Period|Subject/guardian decision|22|||
150196377|NCT01828099|541861041|FG001|Treatment Period|Subject/guardian decision|26|||
150196378|NCT01828099|541861040|FG000|Treatment Period|Study terminated by Sponsor|13|||
150196379|NCT01828099|541861041|FG001|Treatment Period|Study terminated by Sponsor|1|||
150196380|NCT01828099|541861040|FG000|Treatment Period|Protocol deviation|1|||
150196381|NCT01828099|541861041|FG001|Treatment Period|Protocol deviation|0|||
150196382|NCT01828099|541861040|FG000|Treatment Period|No longer requires treatment|0|||
150196383|NCT01828099|541861041|FG001|Treatment Period|No longer requires treatment|1|||
150196384|NCT01828099|541861040|FG000|Extension-treatment Phase|Adverse Event|0|||
150196385|NCT01828099|541861041|FG001|Extension-treatment Phase|Adverse Event|17|||
150196386|NCT01828099|541861040|FG000|Extension-treatment Phase|Death|0|||
150196387|NCT01828099|541861041|FG001|Extension-treatment Phase|Death|11|||
150196388|NCT01828099|541861040|FG000|Extension-treatment Phase|Physician Decision|0|||
150196389|NCT01828099|541861041|FG001|Extension-treatment Phase|Physician Decision|5|||
150196390|NCT01828099|541861040|FG000|Extension-treatment Phase|Progressive disease|0|||
150196391|NCT01828099|541861041|FG001|Extension-treatment Phase|Progressive disease|54|||
150196392|NCT01828099|541861040|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
150196393|NCT01828099|541861041|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
150196394|NCT01828099|541861040|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
150196395|NCT01828099|541861041|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
150196396|NCT05934942|541861046|FG000|Run-in Period|Not treated|1|||
150196397|NCT05934942|541861046|FG000|Run-in Period|Withdrawal by Subject|1|||
150196398|NCT05645757|541861061|FG000|Overall Study|Enrolled but treatment not administered|0|||
150130988|NCT02701985|541613420|FG001|Overall Study|Death|0|||
150130989|NCT02701985|541613419|FG000|Overall Study|Adverse Event|0|||
150130990|NCT02701985|541613420|FG001|Overall Study|Adverse Event|5|||
150130991|NCT04009291|541613421|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
150130992|NCT04009291|541613422|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
150130993|NCT04009291|541613423|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
150130994|NCT04009291|541613424|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
150130995|NCT04009291|541613425|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
150130996|NCT04009291|541613421|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
150130997|NCT04009291|541613422|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
150130998|NCT04009291|541613423|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
150130999|NCT04009291|541613424|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
150131000|NCT04009291|541613425|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
150131001|NCT02085408|541613426|FG000|Step 1: Induction|Disease Progression|19|||
150131002|NCT02085408|541613427|FG001|Step 1: Induction|Disease Progression|19|||
150131003|NCT02085408|541613426|FG000|Step 1: Induction|Adverse Event|18|||
150131004|NCT02085408|541613427|FG001|Step 1: Induction|Adverse Event|17|||
150131005|NCT02085408|541613426|FG000|Step 1: Induction|Death|33|||
150131006|NCT02085408|541613427|FG001|Step 1: Induction|Death|30|||
150131007|NCT02085408|541613426|FG000|Step 1: Induction|Withdrawal by Subject|16|||
150131008|NCT02085408|541613427|FG001|Step 1: Induction|Withdrawal by Subject|8|||
150131009|NCT02085408|541613426|FG000|Step 1: Induction|Alternative Therapy|15|||
150131010|NCT02085408|541613427|FG001|Step 1: Induction|Alternative Therapy|19|||
150131011|NCT02085408|541613426|FG000|Step 1: Induction|Complicating Disease|2|||
150131012|NCT02085408|541613427|FG001|Step 1: Induction|Complicating Disease|3|||
150131013|NCT02085408|541613426|FG000|Step 1: Induction|Other|27|||
150131014|NCT02085408|541613427|FG001|Step 1: Induction|Other|39|||
150196399|NCT05645757|541861062|FG001|Overall Study|Enrolled but treatment not administered|0|||
150196400|NCT05645757|541861063|FG002|Overall Study|Enrolled but treatment not administered|0|||
150196401|NCT05645757|541861064|FG003|Overall Study|Enrolled but treatment not administered|0|||
150131015|NCT02085408|541613426|FG000|Step 1: Induction|Never started treatment|6|||
150131016|NCT02085408|541613427|FG001|Step 1: Induction|Never started treatment|4|||
150131017|NCT02085408|541613426|FG000|Step 2: Consolidation|Disease Progression|5|||
150131018|NCT02085408|541613427|FG001|Step 2: Consolidation|Disease Progression|20|||
150131019|NCT02085408|541613426|FG000|Step 2: Consolidation|Adverse Event|9|||
150131020|NCT02085408|541613427|FG001|Step 2: Consolidation|Adverse Event|8|||
150131021|NCT02085408|541613426|FG000|Step 2: Consolidation|Death|4|||
150131022|NCT02085408|541613427|FG001|Step 2: Consolidation|Death|3|||
150131023|NCT02085408|541613426|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
150131024|NCT02085408|541613427|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
150131025|NCT02085408|541613426|FG000|Step 2: Consolidation|Alternative Therapy|9|||
150131026|NCT02085408|541613427|FG001|Step 2: Consolidation|Alternative Therapy|3|||
150131027|NCT02085408|541613426|FG000|Step 2: Consolidation|Complicating Disease|0|||
150131028|NCT02085408|541613427|FG001|Step 2: Consolidation|Complicating Disease|2|||
150131029|NCT02085408|541613426|FG000|Step 2: Consolidation|Other|6|||
150131030|NCT02085408|541613427|FG001|Step 2: Consolidation|Other|6|||
150131031|NCT02085408|541613426|FG000|Step 2: Consolidation|Never started treatment|4|||
150131032|NCT02085408|541613427|FG001|Step 2: Consolidation|Never started treatment|3|||
150131033|NCT02085408|541613426|FG000|Step 3: Maintenance|Disease Progression|13|||
150131034|NCT02085408|541613427|FG001|Step 3: Maintenance|Disease Progression|11|||
150131035|NCT02085408|541613426|FG000|Step 3: Maintenance|Adverse Event|2|||
150131036|NCT02085408|541613427|FG001|Step 3: Maintenance|Adverse Event|4|||
150131037|NCT02085408|541613426|FG000|Step 3: Maintenance|Death|1|||
150131038|NCT02085408|541613427|FG001|Step 3: Maintenance|Death|2|||
150131039|NCT02085408|541613426|FG000|Step 3: Maintenance|Alternative Therapy|1|||
150131040|NCT02085408|541613427|FG001|Step 3: Maintenance|Alternative Therapy|1|||
150131041|NCT02085408|541613426|FG000|Step 3: Maintenance|Complicating Disease|0|||
150131042|NCT02085408|541613427|FG001|Step 3: Maintenance|Complicating Disease|1|||
150131043|NCT02085408|541613426|FG000|Step 3: Maintenance|Other|3|||
150131044|NCT02085408|541613427|FG001|Step 3: Maintenance|Other|2|||
150131045|NCT02085408|541613426|FG000|Step 3: Maintenance|Never started treatment|5|||
150131046|NCT02085408|541613427|FG001|Step 3: Maintenance|Never started treatment|1|||
150131047|NCT01556438|541613429|FG000|Overall Study|Adverse Event|4|||
150131048|NCT01556438|541613430|FG001|Overall Study|Adverse Event|2|||
150131049|NCT01556438|541613429|FG000|Overall Study|Sponsor Decision|0|||
150131050|NCT01556438|541613430|FG001|Overall Study|Sponsor Decision|2|||
150131051|NCT01556438|541613429|FG000|Overall Study|Progressive Disease|0|||
150131052|NCT01556438|541613430|FG001|Overall Study|Progressive Disease|6|||
150131053|NCT01556438|541613429|FG000|Overall Study|Death|0|||
150131054|NCT01556438|541613430|FG001|Overall Study|Death|1|||
150131055|NCT01506193|541613433|FG000|Overall Study|Protocol Violation|1|||
150131056|NCT01506193|541613434|FG001|Overall Study|Protocol Violation|0|||
150131057|NCT01506193|541613435|FG002|Overall Study|Protocol Violation|1|||
150131058|NCT01506193|541613433|FG000|Overall Study|Migrated/moved from study area|0|||
150131059|NCT01506193|541613434|FG001|Overall Study|Migrated/moved from study area|0|||
150131060|NCT01506193|541613435|FG002|Overall Study|Migrated/moved from study area|1|||
150131061|NCT01506193|541613433|FG000|Overall Study|Adverse event, non-fatal|0|||
150131062|NCT01506193|541613434|FG001|Overall Study|Adverse event, non-fatal|0|||
150131063|NCT01506193|541613435|FG002|Overall Study|Adverse event, non-fatal|1|||
150131064|NCT01506193|541613433|FG000|Overall Study|Withdrawal by Subject|5|||
150131065|NCT01506193|541613434|FG001|Overall Study|Withdrawal by Subject|1|||
150131066|NCT01506193|541613435|FG002|Overall Study|Withdrawal by Subject|8|||
150131067|NCT01506193|541613433|FG000|Overall Study|Lost to Follow-up|8|||
150131068|NCT01506193|541613434|FG001|Overall Study|Lost to Follow-up|3|||
150131069|NCT01506193|541613435|FG002|Overall Study|Lost to Follow-up|3|||
150131070|NCT01388816|541613436|FG000|Overall Study|Adverse Event|0|||
150131071|NCT01388816|541613437|FG001|Overall Study|Adverse Event|2|||
150131072|NCT01388816|541613438|FG002|Overall Study|Adverse Event|0|||
150131073|NCT01388816|541613439|FG003|Overall Study|Adverse Event|0|||
150131074|NCT01388816|541613436|FG000|Overall Study|Lost to Follow-up|0|||
150131075|NCT01388816|541613437|FG001|Overall Study|Lost to Follow-up|1|||
150131076|NCT01388816|541613438|FG002|Overall Study|Lost to Follow-up|0|||
150196402|NCT05645757|541861065|FG004|Overall Study|Enrolled but treatment not administered|1|||
150131077|NCT01388816|541613439|FG003|Overall Study|Lost to Follow-up|0|||
150131078|NCT01388816|541613436|FG000|Overall Study|Withdrawal by Subject|2|||
150131079|NCT01388816|541613437|FG001|Overall Study|Withdrawal by Subject|1|||
150131080|NCT01388816|541613438|FG002|Overall Study|Withdrawal by Subject|1|||
150131081|NCT01388816|541613439|FG003|Overall Study|Withdrawal by Subject|0|||
150131082|NCT01388816|541613436|FG000|Overall Study|Protocol Violation|0|||
150131083|NCT01388816|541613437|FG001|Overall Study|Protocol Violation|0|||
150131084|NCT01388816|541613438|FG002|Overall Study|Protocol Violation|2|||
150131085|NCT01388816|541613439|FG003|Overall Study|Protocol Violation|0|||
150131086|NCT03206203|541613440|FG000|Treatment|Death|38|||
150131087|NCT03206203|541613441|FG001|Treatment|Death|26|||
150131088|NCT03206203|541613442|FG002|Treatment|Death|0|||
150131089|NCT03206203|541613440|FG000|Treatment|Withdrawal by Subject|1|||
150131090|NCT03206203|541613441|FG001|Treatment|Withdrawal by Subject|0|||
150196403|NCT05645757|541861066|FG005|Overall Study|Enrolled but treatment not administered|1|||
150131091|NCT03206203|541613442|FG002|Treatment|Withdrawal by Subject|0|||
150131092|NCT03206203|541613440|FG000|Treatment|Lost to Follow-up|4|||
150131093|NCT03206203|541613441|FG001|Treatment|Lost to Follow-up|0|||
150131094|NCT03206203|541613442|FG002|Treatment|Lost to Follow-up|0|||
150131095|NCT03206203|541613440|FG000|Treatment|N/A in Follow-Up|8|||
150131096|NCT03206203|541613441|FG001|Treatment|N/A in Follow-Up|1|||
150131097|NCT03206203|541613442|FG002|Treatment|N/A in Follow-Up|0|||
150131098|NCT03206203|541613440|FG000|Treatment|Disease progression|0|||
150131099|NCT03206203|541613441|FG001|Treatment|Disease progression|1|||
150131100|NCT03206203|541613442|FG002|Treatment|Disease progression|0|||
150131101|NCT03206203|541613440|FG000|Treatment|Refused follow-up|0|||
150131102|NCT03206203|541613441|FG001|Treatment|Refused follow-up|1|||
150131103|NCT03206203|541613442|FG002|Treatment|Refused follow-up|0|||
150131104|NCT03206203|541613440|FG000|Treatment|Cross over to Arm 1|0|||
150131105|NCT03206203|541613441|FG001|Treatment|Cross over to Arm 1|19|||
150131106|NCT03206203|541613442|FG002|Treatment|Cross over to Arm 1|0|||
150131107|NCT03206203|541613440|FG000|Optional Cross-Over|Death|0|||
150131108|NCT03206203|541613441|FG001|Optional Cross-Over|Death|0|||
150131109|NCT03206203|541613442|FG002|Optional Cross-Over|Death|14|||
150131110|NCT03206203|541613440|FG000|Optional Cross-Over|Refused follow-up|0|||
150131111|NCT03206203|541613441|FG001|Optional Cross-Over|Refused follow-up|0|||
150131112|NCT03206203|541613442|FG002|Optional Cross-Over|Refused follow-up|2|||
150131113|NCT01687257|541613452|FG000|Overall Study|Efficacy Failure|6|||
150131114|NCT01687257|541613453|FG001|Overall Study|Efficacy Failure|0|||
150131115|NCT01687257|541613454|FG002|Overall Study|Efficacy Failure|5|||
150131116|NCT01687257|541613452|FG000|Overall Study|Subject Withdrew Consent|1|||
150131117|NCT01687257|541613453|FG001|Overall Study|Subject Withdrew Consent|1|||
150131118|NCT01687257|541613454|FG002|Overall Study|Subject Withdrew Consent|1|||
150131119|NCT01687257|541613452|FG000|Overall Study|Adverse Event|1|||
150131120|NCT01687257|541613453|FG001|Overall Study|Adverse Event|0|||
150131121|NCT01687257|541613454|FG002|Overall Study|Adverse Event|0|||
150131122|NCT01687257|541613452|FG000|Overall Study|Investigator's Discretion|0|||
150131123|NCT01687257|541613453|FG001|Overall Study|Investigator's Discretion|3|||
150131124|NCT01687257|541613454|FG002|Overall Study|Investigator's Discretion|0|||
150131125|NCT03776136|541613455|FG000|Overall Study|Death|85|||
150131126|NCT03776136|541613455|FG000|Overall Study|Withdrawal by Subject|3|||
150131127|NCT03776136|541613455|FG000|Overall Study|Sponsor Decision|15|||
150131128|NCT05245864|541613462|FG000|Overall Study|Withdrawal by Subject|1|||
150131129|NCT05245864|541613463|FG001|Overall Study|Withdrawal by Subject|1|||
150131130|NCT00160680|541615097|FG000|Overall Study|Adverse Event|0|||
150131131|NCT00160680|541615098|FG001|Overall Study|Adverse Event|1|||
150131132|NCT00160680|541615097|FG000|Overall Study|Lack of Efficacy|2|||
150131133|NCT00160680|541615098|FG001|Overall Study|Lack of Efficacy|1|||
150131134|NCT00160680|541615097|FG000|Overall Study|Lost to Follow-up|3|||
150131135|NCT00160680|541615098|FG001|Overall Study|Lost to Follow-up|2|||
150131136|NCT00160680|541615097|FG000|Overall Study|Withdrawal by Subject|4|||
150131137|NCT00160680|541615098|FG001|Overall Study|Withdrawal by Subject|9|||
150131138|NCT00985725|541615099|FG000|Overall Study|Adverse Event|4|||
150131139|NCT00985725|541615100|FG001|Overall Study|Adverse Event|1|||
150131140|NCT00985725|541615099|FG000|Overall Study|Protocol Violation|1|||
150131141|NCT00985725|541615100|FG001|Overall Study|Protocol Violation|3|||
150131142|NCT00985725|541615099|FG000|Overall Study|Withdrawal by Subject|4|||
150131143|NCT00985725|541615100|FG001|Overall Study|Withdrawal by Subject|4|||
150131144|NCT00985725|541615099|FG000|Overall Study|Lost to Follow-up|1|||
150131145|NCT00985725|541615100|FG001|Overall Study|Lost to Follow-up|1|||
150131146|NCT00985725|541615099|FG000|Overall Study|Lack of Efficacy|0|||
150131147|NCT00985725|541615100|FG001|Overall Study|Lack of Efficacy|1|||
150131148|NCT00985725|541615099|FG000|Overall Study|Non-compliance|1|||
150131149|NCT00985725|541615100|FG001|Overall Study|Non-compliance|2|||
150131150|NCT00985725|541615099|FG000|Overall Study|Out-of-window visits|0|||
150131151|NCT00985725|541615100|FG001|Overall Study|Out-of-window visits|1|||
150131152|NCT02216123|541615101|FG000|Overall Study|Lost to Follow-up|4|||
150131153|NCT02216123|541615102|FG001|Overall Study|Lost to Follow-up|2|||
150131154|NCT02216123|541615101|FG000|Overall Study|Withdrawal by Subject|2|||
150131155|NCT02216123|541615102|FG001|Overall Study|Withdrawal by Subject|0|||
150131156|NCT05159622|541615103|FG000|Overall Study|Lost to Follow-up|4|||
150131157|NCT05159622|541615104|FG001|Overall Study|Lost to Follow-up|5|||
150131158|NCT03643952|541615105|FG000|Overall Study|Lack of Efficacy|1|||
150131159|NCT01358968|541615106|FG000|Period 2|Adverse Event|0|||
150131160|NCT01358968|541615107|FG001|Period 2|Adverse Event|1|||
150131161|NCT01358968|541615108|FG002|Period 2|Adverse Event|0|||
150131162|NCT01358968|541615109|FG003|Period 2|Adverse Event|0|||
150131163|NCT01358968|541615106|FG000|Continued Access Phase|Progression of Disease|0|||
150131164|NCT01358968|541615107|FG001|Continued Access Phase|Progression of Disease|0|||
150131165|NCT01358968|541615108|FG002|Continued Access Phase|Progression of Disease|8|||
150131166|NCT01358968|541615109|FG003|Continued Access Phase|Progression of Disease|4|||
150131167|NCT01358968|541615106|FG000|Continued Access Phase|Protocol Violation|0|||
150131168|NCT01358968|541615107|FG001|Continued Access Phase|Protocol Violation|0|||
150131169|NCT01358968|541615108|FG002|Continued Access Phase|Protocol Violation|0|||
150131170|NCT01358968|541615109|FG003|Continued Access Phase|Protocol Violation|2|||
150131171|NCT01358968|541615106|FG000|Continued Access Phase|Withdrawal by Subject|0|||
150131172|NCT01358968|541615107|FG001|Continued Access Phase|Withdrawal by Subject|0|||
150131173|NCT01358968|541615108|FG002|Continued Access Phase|Withdrawal by Subject|3|||
150131174|NCT01358968|541615109|FG003|Continued Access Phase|Withdrawal by Subject|0|||
150131175|NCT01358968|541615106|FG000|Continued Access Phase|Death|0|||
150131176|NCT01358968|541615107|FG001|Continued Access Phase|Death|0|||
150131177|NCT01358968|541615108|FG002|Continued Access Phase|Death|1|||
150131178|NCT01358968|541615109|FG003|Continued Access Phase|Death|1|||
150131179|NCT00487162|541615110|FG000|Overall Study|Adverse Event|0|||
150131180|NCT00487162|541615111|FG001|Overall Study|Adverse Event|1|||
150131181|NCT00487162|541615110|FG000|Overall Study|Physician Decision|0|||
150131182|NCT00487162|541615111|FG001|Overall Study|Physician Decision|1|||
150131183|NCT00487162|541615110|FG000|Overall Study|Withdrawal by Subject|2|||
150131184|NCT00487162|541615111|FG001|Overall Study|Withdrawal by Subject|3|||
150131185|NCT00815295|541615112|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
150131186|NCT00815295|541615113|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
150131187|NCT00815295|541615114|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
150131188|NCT03252587|541615115|FG000|Overall Study|Adverse Event|3|||
150131189|NCT03252587|541615116|FG001|Overall Study|Adverse Event|8|||
150131190|NCT03252587|541615117|FG002|Overall Study|Adverse Event|6|||
150131191|NCT03252587|541615118|FG003|Overall Study|Adverse Event|12|||
150131192|NCT03252587|541615115|FG000|Overall Study|Lack of Efficacy|7|||
150131193|NCT03252587|541615116|FG001|Overall Study|Lack of Efficacy|2|||
150131194|NCT03252587|541615117|FG002|Overall Study|Lack of Efficacy|2|||
150131195|NCT03252587|541615118|FG003|Overall Study|Lack of Efficacy|4|||
150131196|NCT03252587|541615115|FG000|Overall Study|Lost to Follow-up|2|||
150131197|NCT03252587|541615116|FG001|Overall Study|Lost to Follow-up|0|||
150131198|NCT03252587|541615117|FG002|Overall Study|Lost to Follow-up|0|||
150131199|NCT03252587|541615118|FG003|Overall Study|Lost to Follow-up|2|||
150131200|NCT03252587|541615115|FG000|Overall Study|Pregnancy|2|||
150131201|NCT03252587|541615116|FG001|Overall Study|Pregnancy|1|||
150131202|NCT03252587|541615117|FG002|Overall Study|Pregnancy|0|||
150131203|NCT03252587|541615118|FG003|Overall Study|Pregnancy|1|||
150131204|NCT03252587|541615115|FG000|Overall Study|Withdrawal by Subject|8|||
150131205|NCT03252587|541615116|FG001|Overall Study|Withdrawal by Subject|4|||
150131206|NCT03252587|541615117|FG002|Overall Study|Withdrawal by Subject|4|||
150131207|NCT03252587|541615118|FG003|Overall Study|Withdrawal by Subject|4|||
150131208|NCT03252587|541615115|FG000|Overall Study|Other Reasons|2|||
150131209|NCT03252587|541615116|FG001|Overall Study|Other Reasons|5|||
150131210|NCT03252587|541615117|FG002|Overall Study|Other Reasons|5|||
150131211|NCT03252587|541615118|FG003|Overall Study|Other Reasons|4|||
150131212|NCT05130970|541615122|FG000|Overall Study|Adverse Event|1|||
150131213|NCT05130970|541615123|FG001|Overall Study|Adverse Event|1|||
150131214|NCT05130970|541615122|FG000|Overall Study|Death|0|||
150131215|NCT05130970|541615123|FG001|Overall Study|Death|1|||
150131216|NCT05130970|541615122|FG000|Overall Study|Lost to Follow-up|0|||
150131217|NCT05130970|541615123|FG001|Overall Study|Lost to Follow-up|1|||
150131218|NCT05130970|541615122|FG000|Overall Study|Physician Decision|0|||
150131219|NCT05130970|541615123|FG001|Overall Study|Physician Decision|1|||
150131220|NCT05130970|541615122|FG000|Overall Study|Withdrawal by Subject|1|||
150131221|NCT05130970|541615123|FG001|Overall Study|Withdrawal by Subject|1|||
150131222|NCT01640808|541615124|FG000|Overall Study|Unable to continue dynamic CT|14|||
150131223|NCT01640808|541615125|FG001|Overall Study|Unable to continue dynamic CT|4|||
150131224|NCT01640808|541615124|FG000|Overall Study|Withdrawal by Subject|12|||
150131225|NCT01640808|541615125|FG001|Overall Study|Withdrawal by Subject|4|||
150131226|NCT01640808|541615124|FG000|Overall Study|Lost to Follow-up|4|||
150131227|NCT01640808|541615125|FG001|Overall Study|Lost to Follow-up|0|||
150131228|NCT01640808|541615124|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
150131229|NCT01640808|541615125|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
150131230|NCT01640808|541615124|FG000|Overall Study|Administration of anticancer drugs|2|||
150131231|NCT01640808|541615125|FG001|Overall Study|Administration of anticancer drugs|1|||
150131232|NCT01640808|541615124|FG000|Overall Study|Physician Decision|19|||
150131233|NCT01640808|541615125|FG001|Overall Study|Physician Decision|5|||
150131234|NCT01640808|541615124|FG000|Overall Study|Randomized but not treated|4|||
150131235|NCT01640808|541615125|FG001|Overall Study|Randomized but not treated|2|||
150131236|NCT03896035|541615126|FG000|Overall Study|Lost to Follow-up|2|||
150131237|NCT03896035|541615127|FG001|Overall Study|Lost to Follow-up|6|||
150131238|NCT03896035|541615126|FG000|Overall Study|Withdrawal by Subject|0|||
150131239|NCT03896035|541615127|FG001|Overall Study|Withdrawal by Subject|1|||
150131240|NCT03896035|541615126|FG000|Overall Study|Health/family health issues during COVID|0|||
150131241|NCT03896035|541615127|FG001|Overall Study|Health/family health issues during COVID|4|||
150131242|NCT00743366|541615128|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
150131243|NCT00743366|541615129|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
150131244|NCT03998618|541615130|FG000|Overall Study|Death|7|||
150131245|NCT03998618|541615131|FG001|Overall Study|Death|11|||
150131246|NCT03998618|541615130|FG000|Overall Study|hospice enrollment|3|||
150131247|NCT03998618|541615131|FG001|Overall Study|hospice enrollment|3|||
150131248|NCT03998618|541615130|FG000|Overall Study|Not feeling well/health problems|3|||
150131249|NCT03998618|541615131|FG001|Overall Study|Not feeling well/health problems|5|||
150131250|NCT03998618|541615130|FG000|Overall Study|Lost to Follow-up|6|||
150131251|NCT03998618|541615131|FG001|Overall Study|Lost to Follow-up|6|||
150131252|NCT03998618|541615130|FG000|Overall Study|Withdrawal by Subject|0|||
150131253|NCT03998618|541615131|FG001|Overall Study|Withdrawal by Subject|4|||
150131254|NCT02308748|541615132|FG000|Period 1|Withdrawal by Subject|0|||
150131255|NCT02308748|541615133|FG001|Period 1|Withdrawal by Subject|0|||
150131256|NCT02308748|541615134|FG002|Period 1|Withdrawal by Subject|1|||
150131257|NCT02308748|541615135|FG003|Period 1|Withdrawal by Subject|0|||
150131258|NCT02308748|541615136|FG004|Period 1|Withdrawal by Subject|0|||
150131259|NCT02308748|541615137|FG005|Period 1|Withdrawal by Subject|0|||
150131260|NCT02308748|541615138|FG006|Period 1|Withdrawal by Subject|0|||
150131261|NCT02308748|541615139|FG007|Period 1|Withdrawal by Subject|0|||
150131262|NCT02308748|541615140|FG008|Period 1|Withdrawal by Subject|0|||
150131263|NCT02308748|541615141|FG009|Period 1|Withdrawal by Subject|0|||
150131264|NCT02308748|541615132|FG000|Period 2|Adverse Event|0|||
150131265|NCT02308748|541615133|FG001|Period 2|Adverse Event|0|||
150131266|NCT02308748|541615134|FG002|Period 2|Adverse Event|0|||
150131267|NCT02308748|541615135|FG003|Period 2|Adverse Event|0|||
150131268|NCT02308748|541615136|FG004|Period 2|Adverse Event|0|||
150131269|NCT02308748|541615137|FG005|Period 2|Adverse Event|0|||
150131270|NCT02308748|541615138|FG006|Period 2|Adverse Event|0|||
150131271|NCT02308748|541615139|FG007|Period 2|Adverse Event|1|||
150131272|NCT02308748|541615140|FG008|Period 2|Adverse Event|0|||
150131273|NCT02308748|541615141|FG009|Period 2|Adverse Event|0|||
150131274|NCT02308748|541615132|FG000|Period 3|Protocol Violation|0|||
150131275|NCT02308748|541615133|FG001|Period 3|Protocol Violation|0|||
150131276|NCT02308748|541615134|FG002|Period 3|Protocol Violation|0|||
150131277|NCT02308748|541615135|FG003|Period 3|Protocol Violation|0|||
150131278|NCT02308748|541615136|FG004|Period 3|Protocol Violation|0|||
150131279|NCT02308748|541615137|FG005|Period 3|Protocol Violation|0|||
150131280|NCT02308748|541615138|FG006|Period 3|Protocol Violation|0|||
150131281|NCT02308748|541615139|FG007|Period 3|Protocol Violation|0|||
150131282|NCT02308748|541615140|FG008|Period 3|Protocol Violation|0|||
150131283|NCT02308748|541615141|FG009|Period 3|Protocol Violation|1|||
150131284|NCT02308748|541615132|FG000|Period 5|Adverse Event|1|||
150131285|NCT02308748|541615133|FG001|Period 5|Adverse Event|0|||
150131286|NCT02308748|541615134|FG002|Period 5|Adverse Event|0|||
150131287|NCT02308748|541615135|FG003|Period 5|Adverse Event|0|||
150131288|NCT02308748|541615136|FG004|Period 5|Adverse Event|0|||
150131289|NCT02308748|541615137|FG005|Period 5|Adverse Event|0|||
150131290|NCT02308748|541615138|FG006|Period 5|Adverse Event|0|||
150131291|NCT02308748|541615139|FG007|Period 5|Adverse Event|0|||
150131292|NCT02308748|541615140|FG008|Period 5|Adverse Event|1|||
150131293|NCT02308748|541615141|FG009|Period 5|Adverse Event|0|||
150131294|NCT00675766|541615142|FG000|Overall Study|Lost to Follow-up|6|||
150131295|NCT00675766|541615143|FG001|Overall Study|Lost to Follow-up|5|||
150131296|NCT00675766|541615144|FG002|Overall Study|Lost to Follow-up|21|||
150131297|NCT00675766|541615145|FG003|Overall Study|Lost to Follow-up|26|||
150131298|NCT01749982|541615146|FG000|Overall Study|Physician Decision|0|||
150131299|NCT01749982|541615147|FG001|Overall Study|Physician Decision|0|||
150131300|NCT01749982|541615148|FG002|Overall Study|Physician Decision|0|||
150131301|NCT01749982|541615149|FG003|Overall Study|Physician Decision|1|||
150131302|NCT01749982|541615146|FG000|Overall Study|Lost to Follow-up|0|||
150131303|NCT01749982|541615147|FG001|Overall Study|Lost to Follow-up|0|||
150131304|NCT01749982|541615148|FG002|Overall Study|Lost to Follow-up|0|||
150131305|NCT01749982|541615149|FG003|Overall Study|Lost to Follow-up|1|||
150131306|NCT01749982|541615146|FG000|Overall Study|Withdrawal by Subject|0|||
150131307|NCT01749982|541615147|FG001|Overall Study|Withdrawal by Subject|0|||
150131308|NCT01749982|541615148|FG002|Overall Study|Withdrawal by Subject|0|||
150131309|NCT01749982|541615149|FG003|Overall Study|Withdrawal by Subject|1|||
150131310|NCT01988779|541615151|FG000|Overall Study|Withdrawal by Subject|2|||
150131311|NCT01988779|541615152|FG001|Overall Study|Withdrawal by Subject|2|||
150131312|NCT01988779|541615151|FG000|Overall Study|Protocol Violation|1|||
150131313|NCT01988779|541615152|FG001|Overall Study|Protocol Violation|0|||
150131314|NCT00377403|541615153|FG000|Overall Study|Unable to contact for telephone intervie|4|||
150131315|NCT00377403|541615154|FG001|Overall Study|Unable to contact for telephone intervie|7|||
150131316|NCT00417079|541615156|FG000|Overall Study|Disease progression|267|||
150131317|NCT00417079|541615157|FG001|Overall Study|Disease progression|180|||
150131318|NCT00417079|541615156|FG000|Overall Study|Adverse Event|32|||
150131319|NCT00417079|541615157|FG001|Overall Study|Adverse Event|67|||
150131320|NCT00417079|541615156|FG000|Overall Study|Non-compliance to protocol|0|||
150131321|NCT00417079|541615157|FG001|Overall Study|Non-compliance to protocol|1|||
150131322|NCT00417079|541615156|FG000|Overall Study|Lost to Follow-up|2|||
150131323|NCT00417079|541615157|FG001|Overall Study|Lost to Follow-up|0|||
150131324|NCT00417079|541615156|FG000|Overall Study|Withdrawal by Subject|17|||
150131325|NCT00417079|541615157|FG001|Overall Study|Withdrawal by Subject|8|||
150131326|NCT00417079|541615156|FG000|Overall Study|Not treated|6|||
150131327|NCT00417079|541615157|FG001|Overall Study|Not treated|7|||
150131328|NCT00417079|541615156|FG000|Overall Study|Screened failure|2|||
150131329|NCT00417079|541615157|FG001|Overall Study|Screened failure|1|||
150131330|NCT00417079|541615156|FG000|Overall Study|Investigator's decision|1|||
150131331|NCT00417079|541615157|FG001|Overall Study|Investigator's decision|4|||
150131332|NCT00417079|541615156|FG000|Overall Study|Non-confirmed Disease progression|1|||
150131333|NCT00417079|541615157|FG001|Overall Study|Non-confirmed Disease progression|1|||
150131334|NCT00417079|541615156|FG000|Overall Study|Clinical deterioration|1|||
150131335|NCT00417079|541615157|FG001|Overall Study|Clinical deterioration|0|||
150131336|NCT00417079|541615156|FG000|Overall Study|Screening error|2|||
150131337|NCT00417079|541615157|FG001|Overall Study|Screening error|1|||
150131338|NCT00417079|541615156|FG000|Overall Study|Withdrawal by subject's family|0|||
150131339|NCT00417079|541615157|FG001|Overall Study|Withdrawal by subject's family|1|||
150131340|NCT00417079|541615156|FG000|Overall Study|Patient unable to come to the clinic|0|||
150131341|NCT00417079|541615157|FG001|Overall Study|Patient unable to come to the clinic|1|||
150131342|NCT00417079|541615156|FG000|Overall Study|abnormal liver function tests|0|||
150131343|NCT00417079|541615157|FG001|Overall Study|abnormal liver function tests|1|||
150131344|NCT01922076|541615160|FG000|Overall Study|Adverse Event|0|||
150131345|NCT01922076|541615161|FG001|Overall Study|Adverse Event|0|||
150131346|NCT01922076|541615162|FG002|Overall Study|Adverse Event|0|||
150131347|NCT01922076|541615163|FG003|Overall Study|Adverse Event|0|||
150131348|NCT01922076|541615164|FG004|Overall Study|Adverse Event|1|||
150131349|NCT01922076|541615165|FG005|Overall Study|Adverse Event|0|||
150131350|NCT01922076|541615166|FG006|Overall Study|Adverse Event|0|||
150131351|NCT01922076|541615160|FG000|Overall Study|Physician Decision|0|||
150131352|NCT01922076|541615161|FG001|Overall Study|Physician Decision|0|||
150131353|NCT01922076|541615162|FG002|Overall Study|Physician Decision|1|||
150131354|NCT01922076|541615163|FG003|Overall Study|Physician Decision|0|||
150131355|NCT01922076|541615164|FG004|Overall Study|Physician Decision|0|||
150131356|NCT01922076|541615165|FG005|Overall Study|Physician Decision|0|||
150131357|NCT01922076|541615166|FG006|Overall Study|Physician Decision|0|||
150131358|NCT01922076|541615160|FG000|Overall Study|Withdrawal by Subject|0|||
150131359|NCT01922076|541615161|FG001|Overall Study|Withdrawal by Subject|0|||
150131360|NCT01922076|541615162|FG002|Overall Study|Withdrawal by Subject|0|||
150131361|NCT01922076|541615163|FG003|Overall Study|Withdrawal by Subject|1|||
150131362|NCT01922076|541615164|FG004|Overall Study|Withdrawal by Subject|0|||
150131363|NCT01922076|541615165|FG005|Overall Study|Withdrawal by Subject|1|||
150131364|NCT01922076|541615166|FG006|Overall Study|Withdrawal by Subject|1|||
150131365|NCT01022762|541615167|FG000|Overall Study|Adverse Event|3|||
150131366|NCT01022762|541615168|FG001|Overall Study|Adverse Event|1|||
150131367|NCT01022762|541615167|FG000|Overall Study|Lack of Efficacy|0|||
150131368|NCT01022762|541615168|FG001|Overall Study|Lack of Efficacy|1|||
150131369|NCT01022762|541615167|FG000|Overall Study|Protocol Violation|7|||
150131370|NCT01022762|541615168|FG001|Overall Study|Protocol Violation|6|||
150131371|NCT01022762|541615167|FG000|Overall Study|Unclassified|12|||
150131372|NCT01022762|541615168|FG001|Overall Study|Unclassified|20|||
150131373|NCT00802074|541615169|FG000|Overall Study|Adverse Event|1|||
150131374|NCT00802074|541615170|FG001|Overall Study|Adverse Event|1|||
150131375|NCT00802074|541615171|FG002|Overall Study|Adverse Event|1|||
150131376|NCT00802074|541615172|FG003|Overall Study|Adverse Event|0|||
150131377|NCT00802074|541615173|FG004|Overall Study|Adverse Event|0|||
150131378|NCT00802074|541615174|FG005|Overall Study|Adverse Event|0|||
150131379|NCT00802074|541615169|FG000|Overall Study|Withdrawal by Subject|1|||
150131380|NCT00802074|541615170|FG001|Overall Study|Withdrawal by Subject|0|||
150131381|NCT00802074|541615171|FG002|Overall Study|Withdrawal by Subject|0|||
150131382|NCT00802074|541615172|FG003|Overall Study|Withdrawal by Subject|0|||
150131383|NCT00802074|541615173|FG004|Overall Study|Withdrawal by Subject|0|||
150131384|NCT00802074|541615174|FG005|Overall Study|Withdrawal by Subject|0|||
150131385|NCT00827918|541615175|FG000|Overall Study|Adverse Event|4|||
150131386|NCT00827918|541615176|FG001|Overall Study|Adverse Event|0|||
150131387|NCT00827918|541615177|FG002|Overall Study|Adverse Event|0|||
150131388|NCT00827918|541615175|FG000|Overall Study|Lack of Efficacy|16|||
150131389|NCT00827918|541615176|FG001|Overall Study|Lack of Efficacy|4|||
150131390|NCT00827918|541615177|FG002|Overall Study|Lack of Efficacy|15|||
150131391|NCT00827918|541615175|FG000|Overall Study|Physician Decision|1|||
150131392|NCT00827918|541615176|FG001|Overall Study|Physician Decision|0|||
150131393|NCT00827918|541615177|FG002|Overall Study|Physician Decision|0|||
150131394|NCT00827918|541615175|FG000|Overall Study|Pregnancy|0|||
150131395|NCT00827918|541615176|FG001|Overall Study|Pregnancy|1|||
150131396|NCT00827918|541615177|FG002|Overall Study|Pregnancy|0|||
150131397|NCT00827918|541615175|FG000|Overall Study|Progressive Disease|1|||
150131398|NCT00827918|541615176|FG001|Overall Study|Progressive Disease|1|||
150131399|NCT00827918|541615177|FG002|Overall Study|Progressive Disease|0|||
150131400|NCT00827918|541615175|FG000|Overall Study|Protocol Violation|0|||
150131401|NCT00827918|541615176|FG001|Overall Study|Protocol Violation|1|||
150131402|NCT00827918|541615177|FG002|Overall Study|Protocol Violation|0|||
150131403|NCT00827918|541615175|FG000|Overall Study|Withdrawal by Subject|6|||
150131404|NCT00827918|541615176|FG001|Overall Study|Withdrawal by Subject|2|||
150131405|NCT00827918|541615177|FG002|Overall Study|Withdrawal by Subject|6|||
150131406|NCT03743038|541615180|FG000|Overall Study|Physician Decision|1|||
150131407|NCT01565707|541615181|FG000|Overall Study|Adverse Event|1|||
150131408|NCT01565707|541615182|FG001|Overall Study|Adverse Event|6|||
150131409|NCT01565707|541615183|FG002|Overall Study|Adverse Event|2|||
150131410|NCT01565707|541615184|FG003|Overall Study|Adverse Event|1|||
150131411|NCT01565707|541615181|FG000|Overall Study|Lost to Follow-up|1|||
150131412|NCT01565707|541615182|FG001|Overall Study|Lost to Follow-up|0|||
150131413|NCT01565707|541615183|FG002|Overall Study|Lost to Follow-up|0|||
150131414|NCT01565707|541615184|FG003|Overall Study|Lost to Follow-up|0|||
150131415|NCT01565707|541615181|FG000|Overall Study|Protocol Violation|1|||
150131416|NCT01565707|541615182|FG001|Overall Study|Protocol Violation|0|||
150131417|NCT01565707|541615183|FG002|Overall Study|Protocol Violation|0|||
150131418|NCT01565707|541615184|FG003|Overall Study|Protocol Violation|1|||
150131419|NCT01565707|541615181|FG000|Overall Study|Withdrawal by Subject|3|||
150131420|NCT01565707|541615182|FG001|Overall Study|Withdrawal by Subject|1|||
150131421|NCT01565707|541615183|FG002|Overall Study|Withdrawal by Subject|1|||
150131422|NCT01565707|541615184|FG003|Overall Study|Withdrawal by Subject|1|||
150131423|NCT01565707|541615181|FG000|Overall Study|Randomized but not evaluable|2|||
150131424|NCT01565707|541615182|FG001|Overall Study|Randomized but not evaluable|0|||
150131425|NCT01565707|541615183|FG002|Overall Study|Randomized but not evaluable|0|||
150131426|NCT01565707|541615184|FG003|Overall Study|Randomized but not evaluable|0|||
150131427|NCT01565707|541615181|FG000|Overall Study|Miscellaneous|1|||
150131428|NCT01565707|541615182|FG001|Overall Study|Miscellaneous|1|||
150131429|NCT01565707|541615183|FG002|Overall Study|Miscellaneous|0|||
150131430|NCT01565707|541615184|FG003|Overall Study|Miscellaneous|2|||
150131431|NCT05207813|541615185|FG000|Overall Study|Lost to Follow-up|2|||
150131432|NCT00617344|541615186|FG000|Overall Study|Serious adverse event|1|||
150131433|NCT00617344|541615187|FG001|Overall Study|Serious adverse event|0|||
150131434|NCT00617344|541615188|FG002|Overall Study|Serious adverse event|0|||
150131435|NCT00617344|541615186|FG000|Overall Study|Other Adverse Event|1|||
150131436|NCT00617344|541615187|FG001|Overall Study|Other Adverse Event|1|||
150131437|NCT00617344|541615188|FG002|Overall Study|Other Adverse Event|0|||
150131438|NCT00617344|541615186|FG000|Overall Study|Protocol Violation|10|||
150131439|NCT00617344|541615187|FG001|Overall Study|Protocol Violation|8|||
150131440|NCT00617344|541615188|FG002|Overall Study|Protocol Violation|5|||
150131441|NCT00617344|541615186|FG000|Overall Study|Lost to Follow-up|5|||
150131442|NCT00617344|541615187|FG001|Overall Study|Lost to Follow-up|4|||
150131443|NCT00617344|541615188|FG002|Overall Study|Lost to Follow-up|1|||
150131444|NCT00617344|541615186|FG000|Overall Study|Withdrawal by Subject|8|||
150131445|NCT00617344|541615187|FG001|Overall Study|Withdrawal by Subject|9|||
150131446|NCT00617344|541615188|FG002|Overall Study|Withdrawal by Subject|2|||
150131447|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
150131448|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
150131449|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
150131450|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
150131451|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
150131452|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
150131453|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
150131454|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
150131455|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
150131456|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
150131457|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
150131458|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
150131459|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
150131460|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
150131461|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
150131462|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
150131463|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
150131464|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
150131465|NCT00833638|541615190|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
150131466|NCT00833638|541615191|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
150131467|NCT00833638|541615192|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
150131468|NCT00833638|541615190|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
150131469|NCT00833638|541615191|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
150131470|NCT00833638|541615192|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
150131471|NCT00833638|541615190|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
150131472|NCT00833638|541615191|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
150131473|NCT00833638|541615192|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
150131474|NCT00490646|541615193|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
150131475|NCT00490646|541615194|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
150131476|NCT00490646|541615193|FG000|Overall Study|Never Treated (had an adverse event)|1|||
150131477|NCT00490646|541615194|FG001|Overall Study|Never Treated (had an adverse event)|0|||
150131478|NCT00490646|541615193|FG000|Overall Study|Never Treated (withdrew consent)|0|||
150131479|NCT00490646|541615194|FG001|Overall Study|Never Treated (withdrew consent)|1|||
150131480|NCT01178086|541615195|FG000|Overall Study|Participant refusal|7|||
150131481|NCT01178086|541615195|FG000|Overall Study|Physician Decision|44|||
150131482|NCT01178086|541615195|FG000|Overall Study|Switch to other CLL therapy|113|||
150131483|NCT01178086|541615195|FG000|Overall Study|Death|59|||
150131484|NCT01178086|541615195|FG000|Overall Study|Other unspecified|89|||
150131485|NCT01178086|541615195|FG000|Overall Study|Excluded from EAS|20|||
150131486|NCT02137369|541615196|FG000|Overall Study|Withdrawal by Subject|3|||
150131487|NCT02137369|541615197|FG001|Overall Study|Withdrawal by Subject|2|||
150131488|NCT02137369|541615196|FG000|Overall Study|Adverse Event|2|||
150131489|NCT02137369|541615197|FG001|Overall Study|Adverse Event|0|||
150131490|NCT02137369|541615196|FG000|Overall Study|Lost to Follow-up|1|||
150131491|NCT02137369|541615197|FG001|Overall Study|Lost to Follow-up|0|||
150131492|NCT02137369|541615196|FG000|Overall Study|Moved away|2|||
150131493|NCT02137369|541615197|FG001|Overall Study|Moved away|0|||
150131494|NCT01400503|541615199|FG000|Overall Study|Withdrawal by Subject|1|||
150131495|NCT01400503|541615199|FG000|Overall Study|Study Terminated by Sponsor|58|||
150131496|NCT01400503|541615199|FG000|Overall Study|Other|1|||
150131497|NCT00983073|541615200|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
150131498|NCT00983073|541615200|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
150131499|NCT00983073|541615200|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
150131500|NCT00983073|541615200|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
150131501|NCT00983073|541615200|FG000|Titration and Optimal Dose Period|Other reason|4|||
150131502|NCT00983073|541615200|FG000|Maintenance Period|Adverse Event|5|||
150131503|NCT00983073|541615200|FG000|Maintenance Period|Withdrawal by Subject|2|||
150131504|NCT00983073|541615200|FG000|Maintenance Period|Lack of Efficacy|2|||
150131505|NCT00983073|541615200|FG000|Maintenance Period|Other Reason|7|||
150131506|NCT01669122|541615203|FG000|Period I|Lost to Follow-up|1|||
150131507|NCT01669122|541615203|FG000|Washout Period II|Protocol Violation|2|||
150131508|NCT03762473|541615206|FG000|Overall Study|Death|1|||
150131509|NCT03762473|541615207|FG001|Overall Study|Death|0|||
150131510|NCT02962908|541615208|FG000|Overall Study|Lost to Follow-up|0|||
150131511|NCT02962908|541615209|FG001|Overall Study|Lost to Follow-up|3|||
150131512|NCT02962908|541615210|FG002|Overall Study|Lost to Follow-up|0|||
150131513|NCT02962908|541615211|FG003|Overall Study|Lost to Follow-up|1|||
150131514|NCT02962908|541615208|FG000|Overall Study|Withdrawal by Subject|0|||
150131515|NCT02962908|541615209|FG001|Overall Study|Withdrawal by Subject|3|||
150131516|NCT02962908|541615210|FG002|Overall Study|Withdrawal by Subject|0|||
150131517|NCT02962908|541615211|FG003|Overall Study|Withdrawal by Subject|2|||
150131518|NCT02962908|541615208|FG000|Overall Study|Protocol Violation|0|||
150131519|NCT02962908|541615209|FG001|Overall Study|Protocol Violation|1|||
150131520|NCT02962908|541615210|FG002|Overall Study|Protocol Violation|0|||
150131521|NCT02962908|541615211|FG003|Overall Study|Protocol Violation|0|||
150131522|NCT02962908|541615208|FG000|Overall Study|Physician Decision|0|||
150131523|NCT02962908|541615209|FG001|Overall Study|Physician Decision|1|||
150131524|NCT02962908|541615210|FG002|Overall Study|Physician Decision|0|||
150131525|NCT02962908|541615211|FG003|Overall Study|Physician Decision|0|||
150131526|NCT03543254|541615212|FG000|Overall Study|Lost to Follow-up|1|||
150131527|NCT02077166|541615213|FG000|Overall Study|Death|6|||
150131528|NCT02077166|541615214|FG001|Overall Study|Death|7|||
150131529|NCT02077166|541615215|FG002|Overall Study|Death|5|||
150131530|NCT02077166|541615216|FG003|Overall Study|Death|6|||
150131531|NCT02077166|541615217|FG004|Overall Study|Death|4|||
150131532|NCT02077166|541615218|FG005|Overall Study|Death|32|||
150131533|NCT02077166|541615219|FG006|Overall Study|Death|22|||
150131534|NCT02077166|541615213|FG000|Overall Study|Study Closure by Sponsor|3|||
150131535|NCT02077166|541615214|FG001|Overall Study|Study Closure by Sponsor|0|||
150131536|NCT02077166|541615215|FG002|Overall Study|Study Closure by Sponsor|2|||
150131537|NCT02077166|541615216|FG003|Overall Study|Study Closure by Sponsor|2|||
150131538|NCT02077166|541615217|FG004|Overall Study|Study Closure by Sponsor|2|||
150131539|NCT02077166|541615218|FG005|Overall Study|Study Closure by Sponsor|12|||
150131540|NCT02077166|541615219|FG006|Overall Study|Study Closure by Sponsor|4|||
150131541|NCT02077166|541615213|FG000|Overall Study|Lost to Follow-up|0|||
150131542|NCT02077166|541615214|FG001|Overall Study|Lost to Follow-up|0|||
150131543|NCT02077166|541615215|FG002|Overall Study|Lost to Follow-up|0|||
150131544|NCT02077166|541615216|FG003|Overall Study|Lost to Follow-up|0|||
150131545|NCT02077166|541615217|FG004|Overall Study|Lost to Follow-up|0|||
150131546|NCT02077166|541615218|FG005|Overall Study|Lost to Follow-up|1|||
150131547|NCT02077166|541615219|FG006|Overall Study|Lost to Follow-up|0|||
150131548|NCT02077166|541615213|FG000|Overall Study|Withdrawal by Subject|3|||
150131549|NCT02077166|541615214|FG001|Overall Study|Withdrawal by Subject|0|||
150196404|NCT05645757|541861067|FG006|Overall Study|Enrolled but treatment not administered|0|||
150196405|NCT05645757|541861068|FG007|Overall Study|Enrolled but treatment not administered|0|||
150196406|NCT03924635|541861069|FG000|Overall Study|Withdrawal by Subject|2|||
150196407|NCT03924635|541861070|FG001|Overall Study|Withdrawal by Subject|4|||
150196408|NCT00539591|541861071|FG000|Overall Study|Toxicity|3|||
150196409|NCT00539591|541861072|FG001|Overall Study|Toxicity|0|||
150196410|NCT00539591|541861073|FG002|Overall Study|Toxicity|0|||
150196411|NCT00539591|541861071|FG000|Overall Study|Disease progression|2|||
150196412|NCT00539591|541861072|FG001|Overall Study|Disease progression|2|||
150196413|NCT00539591|541861073|FG002|Overall Study|Disease progression|3|||
150196414|NCT04362254|541861074|FG000|Overall Study|Adverse Event|1|||
150196415|NCT04362254|541861074|FG000|Overall Study|Protocol Violation|1|||
150196416|NCT04362254|541861074|FG000|Overall Study|Due to early termination of the trial|10|||
150196417|NCT04568434|541861075|FG000|Overall Study|Voluntary Withdrawal|0|||
150196418|NCT04568434|541861076|FG001|Overall Study|Voluntary Withdrawal|1|||
150196419|NCT04568434|541861077|FG002|Overall Study|Voluntary Withdrawal|1|||
150196420|NCT04568434|541861075|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
150196421|NCT04568434|541861076|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
150196422|NCT04568434|541861077|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
150196423|NCT04568434|541861075|FG000|Overall Study|Investigator Judgement|1|||
150196424|NCT04568434|541861076|FG001|Overall Study|Investigator Judgement|0|||
150196425|NCT04568434|541861077|FG002|Overall Study|Investigator Judgement|0|||
150196426|NCT05469464|541861078|FG000|Overall Study|Withdrawal by Subject|8|||
150196427|NCT05469464|541861079|FG001|Overall Study|Withdrawal by Subject|7|||
150196428|NCT05469464|541861080|FG002|Overall Study|Withdrawal by Subject|4|||
150196429|NCT05469464|541861081|FG003|Overall Study|Withdrawal by Subject|5|||
150196430|NCT05469464|541861078|FG000|Overall Study|Adverse Event|8|||
150196431|NCT05469464|541861079|FG001|Overall Study|Adverse Event|14|||
150196432|NCT05469464|541861080|FG002|Overall Study|Adverse Event|13|||
150196433|NCT05469464|541861081|FG003|Overall Study|Adverse Event|2|||
150196434|NCT05469464|541861078|FG000|Overall Study|Lost to Follow-up|2|||
150196435|NCT05469464|541861079|FG001|Overall Study|Lost to Follow-up|5|||
150196436|NCT05469464|541861080|FG002|Overall Study|Lost to Follow-up|3|||
150196437|NCT05469464|541861081|FG003|Overall Study|Lost to Follow-up|3|||
150196438|NCT05469464|541861078|FG000|Overall Study|Lack of Efficacy|4|||
150196439|NCT05469464|541861079|FG001|Overall Study|Lack of Efficacy|1|||
150131550|NCT02077166|541615215|FG002|Overall Study|Withdrawal by Subject|1|||
150131551|NCT02077166|541615216|FG003|Overall Study|Withdrawal by Subject|1|||
150131552|NCT02077166|541615217|FG004|Overall Study|Withdrawal by Subject|1|||
150131553|NCT02077166|541615218|FG005|Overall Study|Withdrawal by Subject|3|||
150131554|NCT02077166|541615219|FG006|Overall Study|Withdrawal by Subject|0|||
150196440|NCT05469464|541861080|FG002|Overall Study|Lack of Efficacy|2|||
150196441|NCT05469464|541861081|FG003|Overall Study|Lack of Efficacy|2|||
150196442|NCT05469464|541861078|FG000|Overall Study|Physician Decision|0|||
150196443|NCT05469464|541861079|FG001|Overall Study|Physician Decision|0|||
150131555|NCT02077166|541615213|FG000|Overall Study|Other, Not Specified|0|||
150131556|NCT02077166|541615214|FG001|Overall Study|Other, Not Specified|0|||
150131557|NCT02077166|541615215|FG002|Overall Study|Other, Not Specified|1|||
150131558|NCT02077166|541615216|FG003|Overall Study|Other, Not Specified|0|||
150131559|NCT02077166|541615217|FG004|Overall Study|Other, Not Specified|1|||
150131560|NCT02077166|541615218|FG005|Overall Study|Other, Not Specified|7|||
150131561|NCT02077166|541615219|FG006|Overall Study|Other, Not Specified|8|||
150131562|NCT01261338|541615220|FG000|Overall Study|Withdrawal by Subject|3|||
150131563|NCT01261338|541615221|FG001|Overall Study|Withdrawal by Subject|2|||
150131564|NCT03519854|541615222|FG000|Overall Study|Technical Error|0|||
150131565|NCT03519854|541615223|FG001|Overall Study|Technical Error|0|||
150131566|NCT03519854|541615224|FG002|Overall Study|Technical Error|1|||
150131567|NCT03519854|541615225|FG003|Overall Study|Technical Error|0|||
150131568|NCT03519854|541615226|FG004|Overall Study|Technical Error|0|||
150131569|NCT03519854|541615227|FG005|Overall Study|Technical Error|0|||
150131570|NCT03519854|541615228|FG006|Overall Study|Technical Error|0|||
150131571|NCT03519854|541615229|FG007|Overall Study|Technical Error|0|||
150131572|NCT03519854|541615230|FG008|Overall Study|Technical Error|0|||
150131573|NCT03519854|541615231|FG009|Overall Study|Technical Error|0|||
150131574|NCT03519854|541615232|FG010|Overall Study|Technical Error|0|||
150131575|NCT03519854|541615233|FG011|Overall Study|Technical Error|0|||
150131576|NCT03519854|541615234|FG012|Overall Study|Technical Error|0|||
150131577|NCT03519854|541615235|FG013|Overall Study|Technical Error|0|||
150131578|NCT03519854|541615236|FG014|Overall Study|Technical Error|0|||
150131579|NCT03519854|541615237|FG015|Overall Study|Technical Error|0|||
150131580|NCT03519854|541615238|FG016|Overall Study|Technical Error|0|||
150131581|NCT03519854|541615239|FG017|Overall Study|Technical Error|0|||
150131582|NCT00234065|541615240|FG000|Overall Study|Adverse Event|268|||
150131583|NCT00234065|541615241|FG001|Overall Study|Adverse Event|166|||
150131584|NCT00234065|541615240|FG000|Overall Study|Withdrawal by Subject|73|||
150131585|NCT00234065|541615241|FG001|Overall Study|Withdrawal by Subject|56|||
150131586|NCT00234065|541615240|FG000|Overall Study|Physician Decision|23|||
150131587|NCT00234065|541615241|FG001|Overall Study|Physician Decision|22|||
150131588|NCT00234065|541615240|FG000|Overall Study|Not Classified|111|||
150131589|NCT00234065|541615241|FG001|Overall Study|Not Classified|112|||
150131590|NCT00126438|541615242|FG000|Overall Study|Withdrawal due to adverse event|1|||
150131591|NCT00126438|541615243|FG001|Overall Study|Withdrawal due to adverse event|0|||
150131592|NCT00126438|541615242|FG000|Overall Study|Lost to Follow-up|22|||
150131593|NCT00126438|541615243|FG001|Overall Study|Lost to Follow-up|0|||
150131594|NCT00126438|541615242|FG000|Overall Study|Protocol Violation|8|||
150131595|NCT00126438|541615243|FG001|Overall Study|Protocol Violation|8|||
150131596|NCT00126438|541615242|FG000|Overall Study|Withdrawal by Subject|3|||
150131597|NCT00126438|541615243|FG001|Overall Study|Withdrawal by Subject|2|||
150131598|NCT05132699|541615247|FG000|Overall Study|Withdrawal by Subject|3|||
150131599|NCT05132699|541615248|FG001|Overall Study|Withdrawal by Subject|0|||
150131600|NCT02899728|541615249|FG000|Overall Study|Withdrawal by Subject|1|||
150131601|NCT02899728|541615250|FG001|Overall Study|Withdrawal by Subject|1|||
150131602|NCT05557942|541615251|FG000|Overall Study|Death|0|||
150131603|NCT05557942|541615252|FG001|Overall Study|Death|0|||
150131604|NCT05557942|541615253|FG002|Overall Study|Death|0|||
150131605|NCT05557942|541615254|FG003|Overall Study|Death|2|||
150131606|NCT05557942|541615255|FG004|Overall Study|Death|1|||
150131607|NCT05557942|541615256|FG005|Overall Study|Death|1|||
150131608|NCT05557942|541615251|FG000|Overall Study|Physician Decision|1|||
150196444|NCT05469464|541861080|FG002|Overall Study|Physician Decision|0|||
150131609|NCT05557942|541615252|FG001|Overall Study|Physician Decision|1|||
150131610|NCT05557942|541615253|FG002|Overall Study|Physician Decision|2|||
150131611|NCT05557942|541615254|FG003|Overall Study|Physician Decision|3|||
150196445|NCT05469464|541861081|FG003|Overall Study|Physician Decision|1|||
150131612|NCT05557942|541615255|FG004|Overall Study|Physician Decision|0|||
150131613|NCT05557942|541615256|FG005|Overall Study|Physician Decision|2|||
150196446|NCT04707625|541861084|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
150196447|NCT04826471|541861085|FG000|Overall Study|Lost to Follow-up|2|||
150196448|NCT04826471|541861085|FG000|Overall Study|Protocol Violation|3|||
150196449|NCT04826471|541861085|FG000|Overall Study|Withdrawal by Subject|1|||
150196450|NCT05293171|541861086|FG000|Washout 5 to 7 Days|Adverse Event|1|||
150196451|NCT05293171|541861087|FG001|Washout 5 to 7 Days|Adverse Event|1|||
150196452|NCT05293171|541861088|FG002|Washout 5 to 7 Days|Adverse Event|0|||
150196453|NCT05293171|541861089|FG003|Washout 5 to 7 Days|Adverse Event|0|||
150196454|NCT05293171|541861090|FG004|Washout 5 to 7 Days|Adverse Event|0|||
150196455|NCT05293171|541861091|FG005|Washout 5 to 7 Days|Adverse Event|0|||
150196456|NCT05293171|541861092|FG006|Washout 5 to 7 Days|Adverse Event|0|||
150196457|NCT05293171|541861093|FG007|Washout 5 to 7 Days|Adverse Event|0|||
150196458|NCT05293171|541861094|FG008|Washout 5 to 7 Days|Adverse Event|0|||
150196459|NCT05293171|541861095|FG009|Washout 5 to 7 Days|Adverse Event|0|||
150196460|NCT05293171|541861096|FG010|Washout 5 to 7 Days|Adverse Event|0|||
150196461|NCT05293171|541861097|FG011|Washout 5 to 7 Days|Adverse Event|0|||
150196462|NCT05293171|541861086|FG000|Washout 5 to 7 Days|Adverse Event|0|||
150196463|NCT05293171|541861087|FG001|Washout 5 to 7 Days|Adverse Event|0|||
150196464|NCT05293171|541861088|FG002|Washout 5 to 7 Days|Adverse Event|0|||
150196465|NCT05293171|541861089|FG003|Washout 5 to 7 Days|Adverse Event|0|||
150196466|NCT05293171|541861090|FG004|Washout 5 to 7 Days|Adverse Event|0|||
150196467|NCT05293171|541861091|FG005|Washout 5 to 7 Days|Adverse Event|1|||
150196468|NCT05293171|541861092|FG006|Washout 5 to 7 Days|Adverse Event|0|||
150196469|NCT05293171|541861093|FG007|Washout 5 to 7 Days|Adverse Event|0|||
150196470|NCT05293171|541861094|FG008|Washout 5 to 7 Days|Adverse Event|0|||
150196471|NCT05293171|541861095|FG009|Washout 5 to 7 Days|Adverse Event|0|||
150196472|NCT05293171|541861096|FG010|Washout 5 to 7 Days|Adverse Event|0|||
150196473|NCT05293171|541861097|FG011|Washout 5 to 7 Days|Adverse Event|0|||
150196474|NCT02052882|541861098|FG000|Overall Study|Not treated|11|||
150196475|NCT02052882|541861098|FG000|Overall Study|Protocol Violation|1|||
150196476|NCT02052882|541861098|FG000|Overall Study|Inadequate testing|1|||
150196477|NCT03734679|541861107|FG000|Overall Study|Missed Visit|1|||
150196478|NCT02240238|541861118|FG000|Phase 1|Adverse Event|0|||
150196479|NCT02240238|541861119|FG001|Phase 1|Adverse Event|0|||
150196480|NCT02240238|541861120|FG002|Phase 1|Adverse Event|0|||
150196481|NCT02240238|541861121|FG003|Phase 1|Adverse Event|0|||
150196482|NCT02240238|541861122|FG004|Phase 1|Adverse Event|0|||
150196483|NCT02240238|541861123|FG005|Phase 1|Adverse Event|0|||
150196484|NCT02240238|541861124|FG006|Phase 1|Adverse Event|3|||
150196485|NCT02240238|541861125|FG007|Phase 1|Adverse Event|1|||
150196486|NCT02240238|541861126|FG008|Phase 1|Adverse Event|0|||
150196487|NCT02240238|541861127|FG009|Phase 1|Adverse Event|0|||
150196488|NCT02240238|541861128|FG010|Phase 1|Adverse Event|0|||
150196489|NCT02240238|541861129|FG011|Phase 1|Adverse Event|0|||
150196490|NCT02240238|541861118|FG000|Phase 1|Death|0|||
150196491|NCT02240238|541861119|FG001|Phase 1|Death|0|||
150196492|NCT02240238|541861120|FG002|Phase 1|Death|0|||
150196493|NCT02240238|541861121|FG003|Phase 1|Death|0|||
150196494|NCT02240238|541861122|FG004|Phase 1|Death|0|||
150196495|NCT02240238|541861123|FG005|Phase 1|Death|1|||
150196496|NCT02240238|541861124|FG006|Phase 1|Death|0|||
150196497|NCT02240238|541861125|FG007|Phase 1|Death|0|||
150196498|NCT02240238|541861126|FG008|Phase 1|Death|0|||
150196499|NCT02240238|541861127|FG009|Phase 1|Death|0|||
150196500|NCT02240238|541861128|FG010|Phase 1|Death|0|||
150196501|NCT02240238|541861129|FG011|Phase 1|Death|0|||
150196502|NCT02240238|541861118|FG000|Phase 1|Sponsor termination|0|||
150196503|NCT02240238|541861119|FG001|Phase 1|Sponsor termination|0|||
150196504|NCT02240238|541861120|FG002|Phase 1|Sponsor termination|0|||
150196505|NCT02240238|541861121|FG003|Phase 1|Sponsor termination|0|||
150196506|NCT02240238|541861122|FG004|Phase 1|Sponsor termination|0|||
150196507|NCT02240238|541861123|FG005|Phase 1|Sponsor termination|1|||
150196508|NCT02240238|541861124|FG006|Phase 1|Sponsor termination|0|||
150196509|NCT02240238|541861125|FG007|Phase 1|Sponsor termination|0|||
150196510|NCT02240238|541861126|FG008|Phase 1|Sponsor termination|0|||
150196511|NCT02240238|541861127|FG009|Phase 1|Sponsor termination|0|||
150196512|NCT02240238|541861128|FG010|Phase 1|Sponsor termination|0|||
150196513|NCT02240238|541861129|FG011|Phase 1|Sponsor termination|0|||
150196514|NCT02240238|541861118|FG000|Phase 1|Withdrawal by Subject|0|||
150196515|NCT02240238|541861119|FG001|Phase 1|Withdrawal by Subject|0|||
150196516|NCT02240238|541861120|FG002|Phase 1|Withdrawal by Subject|0|||
150196517|NCT02240238|541861121|FG003|Phase 1|Withdrawal by Subject|0|||
150196518|NCT02240238|541861122|FG004|Phase 1|Withdrawal by Subject|0|||
150196519|NCT02240238|541861123|FG005|Phase 1|Withdrawal by Subject|2|||
150196520|NCT02240238|541861124|FG006|Phase 1|Withdrawal by Subject|0|||
150196521|NCT02240238|541861125|FG007|Phase 1|Withdrawal by Subject|0|||
150196522|NCT02240238|541861126|FG008|Phase 1|Withdrawal by Subject|0|||
150196523|NCT02240238|541861127|FG009|Phase 1|Withdrawal by Subject|0|||
150196524|NCT02240238|541861128|FG010|Phase 1|Withdrawal by Subject|0|||
150196525|NCT02240238|541861129|FG011|Phase 1|Withdrawal by Subject|0|||
150131614|NCT05557942|541615251|FG000|Overall Study|Study terminated by sponsor|17|||
150131615|NCT05557942|541615252|FG001|Overall Study|Study terminated by sponsor|17|||
150131616|NCT05557942|541615253|FG002|Overall Study|Study terminated by sponsor|14|||
150131617|NCT05557942|541615254|FG003|Overall Study|Study terminated by sponsor|40|||
150131618|NCT05557942|541615255|FG004|Overall Study|Study terminated by sponsor|45|||
150131619|NCT05557942|541615256|FG005|Overall Study|Study terminated by sponsor|37|||
150131620|NCT05557942|541615251|FG000|Overall Study|Protocol Violation|0|||
150131621|NCT05557942|541615252|FG001|Overall Study|Protocol Violation|0|||
150131622|NCT05557942|541615253|FG002|Overall Study|Protocol Violation|0|||
150131623|NCT05557942|541615254|FG003|Overall Study|Protocol Violation|0|||
150131624|NCT05557942|541615255|FG004|Overall Study|Protocol Violation|0|||
150131625|NCT05557942|541615256|FG005|Overall Study|Protocol Violation|1|||
150131626|NCT05557942|541615251|FG000|Overall Study|Withdrawal by Subject|0|||
150131627|NCT05557942|541615252|FG001|Overall Study|Withdrawal by Subject|0|||
150131628|NCT05557942|541615253|FG002|Overall Study|Withdrawal by Subject|0|||
150131629|NCT05557942|541615254|FG003|Overall Study|Withdrawal by Subject|0|||
150131630|NCT05557942|541615255|FG004|Overall Study|Withdrawal by Subject|2|||
150131631|NCT05557942|541615256|FG005|Overall Study|Withdrawal by Subject|0|||
150131632|NCT00127608|541615257|FG000|Overall Study|VZV DNA negative|1|||
150131633|NCT01329029|541615260|FG000|Overall Study|Withdrawal by Subject|117|||
150131634|NCT01329029|541615261|FG001|Overall Study|Withdrawal by Subject|87|||
150131635|NCT01329029|541615260|FG000|Overall Study|Adverse Event|82|||
150131636|NCT01329029|541615261|FG001|Overall Study|Adverse Event|29|||
150131637|NCT01329029|541615260|FG000|Overall Study|Death|16|||
150131638|NCT01329029|541615261|FG001|Overall Study|Death|19|||
150131639|NCT01329029|541615260|FG000|Overall Study|Other|14|||
150131640|NCT01329029|541615261|FG001|Overall Study|Other|20|||
150131641|NCT01329029|541615260|FG000|Overall Study|COPD Exacerbation|11|||
150131642|NCT01329029|541615261|FG001|Overall Study|COPD Exacerbation|18|||
150131643|NCT01329029|541615260|FG000|Overall Study|Physician Decision|16|||
150131644|NCT01329029|541615261|FG001|Overall Study|Physician Decision|13|||
150131645|NCT01329029|541615260|FG000|Overall Study|Lost to Follow-up|8|||
150131646|NCT01329029|541615261|FG001|Overall Study|Lost to Follow-up|5|||
150131647|NCT01329029|541615260|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
150131648|NCT01329029|541615261|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
150131649|NCT00680407|541615270|FG000|Overall Study|Lost to Follow-up|3|||
150131650|NCT00680407|541615271|FG001|Overall Study|Lost to Follow-up|3|||
150131651|NCT00680407|541615272|FG002|Overall Study|Lost to Follow-up|1|||
150131652|NCT00680407|541615270|FG000|Overall Study|Withdrawal by Subject|5|||
150131653|NCT00680407|541615271|FG001|Overall Study|Withdrawal by Subject|2|||
150131654|NCT00680407|541615272|FG002|Overall Study|Withdrawal by Subject|2|||
150131655|NCT00447057|541617623|FG000|Overall Study|Adverse Event|4|||
150131656|NCT00447057|541617624|FG001|Overall Study|Adverse Event|10|||
150131657|NCT00447057|541617625|FG002|Overall Study|Adverse Event|0|||
150131658|NCT00447057|541617626|FG003|Overall Study|Adverse Event|3|||
150131659|NCT00447057|541617623|FG000|Overall Study|Death due to study disease|6|||
150131660|NCT00447057|541617624|FG001|Overall Study|Death due to study disease|4|||
150131661|NCT00447057|541617625|FG002|Overall Study|Death due to study disease|1|||
150131662|NCT00447057|541617626|FG003|Overall Study|Death due to study disease|1|||
150131663|NCT00447057|541617623|FG000|Overall Study|Lost to Follow-up|0|||
150131664|NCT00447057|541617624|FG001|Overall Study|Lost to Follow-up|1|||
150131665|NCT00447057|541617625|FG002|Overall Study|Lost to Follow-up|0|||
150131666|NCT00447057|541617626|FG003|Overall Study|Lost to Follow-up|0|||
150131667|NCT00447057|541617623|FG000|Overall Study|Entry criteria not met|1|||
150131668|NCT00447057|541617624|FG001|Overall Study|Entry criteria not met|1|||
150131669|NCT00447057|541617625|FG002|Overall Study|Entry criteria not met|0|||
150131670|NCT00447057|541617626|FG003|Overall Study|Entry criteria not met|0|||
150131671|NCT00447057|541617623|FG000|Overall Study|Protocol Violation|0|||
150131672|NCT00447057|541617624|FG001|Overall Study|Protocol Violation|1|||
150131673|NCT00447057|541617625|FG002|Overall Study|Protocol Violation|0|||
150131674|NCT00447057|541617626|FG003|Overall Study|Protocol Violation|0|||
150131675|NCT00447057|541617623|FG000|Overall Study|Withdrawal by Subject|4|||
150131676|NCT00447057|541617624|FG001|Overall Study|Withdrawal by Subject|5|||
150131677|NCT00447057|541617625|FG002|Overall Study|Withdrawal by Subject|1|||
150131678|NCT00447057|541617626|FG003|Overall Study|Withdrawal by Subject|1|||
150131679|NCT00447057|541617623|FG000|Overall Study|Physician Decision|9|||
150131680|NCT00447057|541617624|FG001|Overall Study|Physician Decision|6|||
150131681|NCT00447057|541617625|FG002|Overall Study|Physician Decision|3|||
150131682|NCT00447057|541617626|FG003|Overall Study|Physician Decision|1|||
150131683|NCT00447057|541617623|FG000|Overall Study|Sponsor decision|1|||
150131684|NCT00447057|541617624|FG001|Overall Study|Sponsor decision|1|||
150131685|NCT00447057|541617625|FG002|Overall Study|Sponsor decision|0|||
150131686|NCT00447057|541617626|FG003|Overall Study|Sponsor decision|0|||
150131687|NCT00447057|541617623|FG000|Overall Study|Progressive disease|58|||
150131688|NCT00447057|541617624|FG001|Overall Study|Progressive disease|43|||
150131689|NCT00447057|541617625|FG002|Overall Study|Progressive disease|13|||
150131690|NCT00447057|541617626|FG003|Overall Study|Progressive disease|18|||
150131691|NCT00447057|541617623|FG000|Overall Study|Death due to adverse event|0|||
150196526|NCT02240238|541861118|FG000|Phase 1|Physician Decision|0|||
150131692|NCT00447057|541617624|FG001|Overall Study|Death due to adverse event|0|||
150131693|NCT00447057|541617625|FG002|Overall Study|Death due to adverse event|1|||
150131694|NCT00447057|541617626|FG003|Overall Study|Death due to adverse event|2|||
150131695|NCT00447057|541617623|FG000|Overall Study|Death, study drug related|0|||
150131696|NCT00447057|541617624|FG001|Overall Study|Death, study drug related|1|||
150131697|NCT00447057|541617625|FG002|Overall Study|Death, study drug related|0|||
150131698|NCT00447057|541617626|FG003|Overall Study|Death, study drug related|0|||
150131699|NCT00440531|541617627|FG000|Overall Study|Adverse Event|1|||
150131700|NCT00440531|541617628|FG001|Overall Study|Adverse Event|0|||
150131701|NCT00440531|541617629|FG002|Overall Study|Adverse Event|2|||
150131702|NCT00440531|541617627|FG000|Overall Study|Withdrawal by Subject|2|||
150131703|NCT00440531|541617628|FG001|Overall Study|Withdrawal by Subject|0|||
150131704|NCT00440531|541617629|FG002|Overall Study|Withdrawal by Subject|0|||
150131705|NCT00440531|541617627|FG000|Overall Study|Protocol Violation|1|||
150131706|NCT00440531|541617628|FG001|Overall Study|Protocol Violation|2|||
150131707|NCT00440531|541617629|FG002|Overall Study|Protocol Violation|0|||
150131708|NCT00440531|541617627|FG000|Overall Study|Lost to Follow-up|4|||
150131709|NCT00440531|541617628|FG001|Overall Study|Lost to Follow-up|3|||
150131710|NCT00440531|541617629|FG002|Overall Study|Lost to Follow-up|5|||
150131711|NCT00440531|541617627|FG000|Overall Study|see pre-assignment details|2|||
150131712|NCT00440531|541617628|FG001|Overall Study|see pre-assignment details|0|||
150131713|NCT00440531|541617629|FG002|Overall Study|see pre-assignment details|0|||
150131714|NCT00677833|541617632|FG000|Overall Study|Withdrawal by Subject|4|||
150131715|NCT00677833|541617633|FG001|Overall Study|Withdrawal by Subject|0|||
150131716|NCT00677833|541617634|FG002|Overall Study|Withdrawal by Subject|1|||
150131717|NCT00677833|541617635|FG003|Overall Study|Withdrawal by Subject|3|||
150131718|NCT00677833|541617632|FG000|Overall Study|Lost to Follow-up|0|||
150131719|NCT00677833|541617633|FG001|Overall Study|Lost to Follow-up|0|||
150131720|NCT00677833|541617634|FG002|Overall Study|Lost to Follow-up|1|||
150131721|NCT00677833|541617635|FG003|Overall Study|Lost to Follow-up|0|||
150131722|NCT02606279|541617636|FG000|Overall Study|Lost to Follow-up|0|||
150131723|NCT02606279|541617637|FG001|Overall Study|Lost to Follow-up|1|||
150131724|NCT02184611|541617640|FG000|Overall Study|Lack of Efficacy|11|||
150131725|NCT02184611|541617641|FG001|Overall Study|Lack of Efficacy|15|||
150131726|NCT02184611|541617640|FG000|Overall Study|Withdrawal by Subject|5|||
150131727|NCT02184611|541617641|FG001|Overall Study|Withdrawal by Subject|6|||
150131728|NCT02184611|541617640|FG000|Overall Study|Adverse Event|4|||
150131729|NCT02184611|541617641|FG001|Overall Study|Adverse Event|5|||
150131730|NCT02184611|541617640|FG000|Overall Study|Protocol Violation|1|||
150131731|NCT02184611|541617641|FG001|Overall Study|Protocol Violation|1|||
150131732|NCT02184611|541617640|FG000|Overall Study|Protocol defined stopping criteria|0|||
150131733|NCT02184611|541617641|FG001|Overall Study|Protocol defined stopping criteria|1|||
150131734|NCT04493216|541617642|FG000|Overall Study|Study terminated by sponsor|30|||
150131735|NCT04493216|541617643|FG001|Overall Study|Study terminated by sponsor|33|||
150131736|NCT04493216|541617644|FG002|Overall Study|Study terminated by sponsor|28|||
150131737|NCT04493216|541617645|FG003|Overall Study|Study terminated by sponsor|27|||
150131738|NCT04493216|541617642|FG000|Overall Study|Withdrawal by Subject|2|||
150131739|NCT04493216|541617643|FG001|Overall Study|Withdrawal by Subject|1|||
150131740|NCT04493216|541617644|FG002|Overall Study|Withdrawal by Subject|1|||
150131741|NCT04493216|541617645|FG003|Overall Study|Withdrawal by Subject|2|||
150131742|NCT04493216|541617642|FG000|Overall Study|Protocol Violation|1|||
150131743|NCT04493216|541617643|FG001|Overall Study|Protocol Violation|2|||
150131744|NCT04493216|541617644|FG002|Overall Study|Protocol Violation|0|||
150131745|NCT04493216|541617645|FG003|Overall Study|Protocol Violation|2|||
150131746|NCT04493216|541617642|FG000|Overall Study|Physician Decision|0|||
150131747|NCT04493216|541617643|FG001|Overall Study|Physician Decision|0|||
150131748|NCT04493216|541617644|FG002|Overall Study|Physician Decision|1|||
150131749|NCT04493216|541617645|FG003|Overall Study|Physician Decision|0|||
150131750|NCT04493216|541617642|FG000|Overall Study|Lost to Follow-up|2|||
150131751|NCT04493216|541617643|FG001|Overall Study|Lost to Follow-up|1|||
150131752|NCT04493216|541617644|FG002|Overall Study|Lost to Follow-up|0|||
150131753|NCT04493216|541617645|FG003|Overall Study|Lost to Follow-up|1|||
150131754|NCT04493216|541617642|FG000|Overall Study|Adverse Event|1|||
150131755|NCT04493216|541617643|FG001|Overall Study|Adverse Event|4|||
150131756|NCT04493216|541617644|FG002|Overall Study|Adverse Event|5|||
150131757|NCT04493216|541617645|FG003|Overall Study|Adverse Event|2|||
150131758|NCT04493216|541617642|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
150131759|NCT04493216|541617643|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
150196527|NCT02240238|541861119|FG001|Phase 1|Physician Decision|0|||
150131760|NCT04493216|541617644|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
150131761|NCT04493216|541617645|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
150131762|NCT03151005|541617651|FG000|Overall Study|Lost to Follow-up|5|||
150131763|NCT03151005|541617652|FG001|Overall Study|Lost to Follow-up|5|||
150131764|NCT03318523|541617653|FG000|PC Period: Up to Year 1|Adverse Event|1|||
150131765|NCT03318523|541617654|FG001|PC Period: Up to Year 1|Adverse Event|0|||
150131766|NCT03318523|541617655|FG002|PC Period: Up to Year 1|Adverse Event|2|||
150131767|NCT03318523|541617656|FG003|PC Period: Up to Year 1|Adverse Event|0|||
150131768|NCT03318523|541617657|FG004|PC Period: Up to Year 1|Adverse Event|0|||
150131769|NCT03318523|541617658|FG005|PC Period: Up to Year 1|Adverse Event|0|||
150131770|NCT03318523|541617659|FG006|PC Period: Up to Year 1|Adverse Event|0|||
150131771|NCT03318523|541617660|FG007|PC Period: Up to Year 1|Adverse Event|0|||
150131772|NCT03318523|541617661|FG008|PC Period: Up to Year 1|Adverse Event|0|||
150131773|NCT03318523|541617662|FG009|PC Period: Up to Year 1|Adverse Event|0|||
150131774|NCT03318523|541617653|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
150131775|NCT03318523|541617654|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
150131776|NCT03318523|541617655|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131777|NCT03318523|541617656|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
150131778|NCT03318523|541617657|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131779|NCT03318523|541617658|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131780|NCT03318523|541617659|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131781|NCT03318523|541617660|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131782|NCT03318523|541617661|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131783|NCT03318523|541617662|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
150131784|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131785|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131786|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131787|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131788|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
150131789|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131790|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131791|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
150131792|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
150131793|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
150131794|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131795|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131796|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131797|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131798|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
150131799|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131800|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
150131801|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
150131802|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
150131803|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
150131804|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131805|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131806|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131807|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131808|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131809|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
150131810|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131811|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131812|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131813|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
150131814|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131815|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131816|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131817|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131818|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131819|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131820|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131821|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131822|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
150131823|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
150131824|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
150131825|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
150131826|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
150131827|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
150131828|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
150131829|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
150131830|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
150131831|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
150131832|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
150131833|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
150131834|NCT03318523|541617653|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131835|NCT03318523|541617654|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131836|NCT03318523|541617655|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131837|NCT03318523|541617656|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131838|NCT03318523|541617657|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
150131839|NCT03318523|541617658|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131840|NCT03318523|541617659|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131841|NCT03318523|541617660|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
150131842|NCT03318523|541617661|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
150131843|NCT03318523|541617662|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
150131844|NCT03232983|541617665|FG000|Period 1|Physician Decision|0|||
150131845|NCT03232983|541617666|FG001|Period 1|Physician Decision|0|||
150131846|NCT03232983|541617667|FG002|Period 1|Physician Decision|1|||
150131847|NCT03232983|541617668|FG003|Period 1|Physician Decision|0|||
150196528|NCT02240238|541861120|FG002|Phase 1|Physician Decision|0|||
150196529|NCT02240238|541861121|FG003|Phase 1|Physician Decision|0|||
150196530|NCT02240238|541861122|FG004|Phase 1|Physician Decision|0|||
150196531|NCT02240238|541861123|FG005|Phase 1|Physician Decision|2|||
150196532|NCT02240238|541861124|FG006|Phase 1|Physician Decision|0|||
150196533|NCT02240238|541861125|FG007|Phase 1|Physician Decision|0|||
150196534|NCT02240238|541861126|FG008|Phase 1|Physician Decision|0|||
150196535|NCT02240238|541861127|FG009|Phase 1|Physician Decision|0|||
150196536|NCT02240238|541861128|FG010|Phase 1|Physician Decision|0|||
150196537|NCT02240238|541861129|FG011|Phase 1|Physician Decision|0|||
150196538|NCT02240238|541861118|FG000|Phase 2|Adverse Event|0|||
150196539|NCT02240238|541861119|FG001|Phase 2|Adverse Event|0|||
150196540|NCT02240238|541861120|FG002|Phase 2|Adverse Event|0|||
150196541|NCT02240238|541861121|FG003|Phase 2|Adverse Event|0|||
150196542|NCT02240238|541861122|FG004|Phase 2|Adverse Event|0|||
150196543|NCT02240238|541861123|FG005|Phase 2|Adverse Event|0|||
150196544|NCT02240238|541861124|FG006|Phase 2|Adverse Event|0|||
150196545|NCT02240238|541861125|FG007|Phase 2|Adverse Event|0|||
150196546|NCT02240238|541861126|FG008|Phase 2|Adverse Event|0|||
150196547|NCT02240238|541861127|FG009|Phase 2|Adverse Event|7|||
150196548|NCT02240238|541861128|FG010|Phase 2|Adverse Event|14|||
150196549|NCT02240238|541861129|FG011|Phase 2|Adverse Event|2|||
150196550|NCT02240238|541861118|FG000|Phase 2|Death|0|||
150196551|NCT02240238|541861119|FG001|Phase 2|Death|0|||
150196552|NCT02240238|541861120|FG002|Phase 2|Death|0|||
150196553|NCT02240238|541861121|FG003|Phase 2|Death|0|||
150196554|NCT02240238|541861122|FG004|Phase 2|Death|0|||
150196555|NCT02240238|541861123|FG005|Phase 2|Death|0|||
150196556|NCT02240238|541861124|FG006|Phase 2|Death|0|||
150196557|NCT02240238|541861125|FG007|Phase 2|Death|0|||
150196558|NCT02240238|541861126|FG008|Phase 2|Death|0|||
150196559|NCT02240238|541861127|FG009|Phase 2|Death|3|||
150196560|NCT02240238|541861128|FG010|Phase 2|Death|2|||
150196561|NCT02240238|541861129|FG011|Phase 2|Death|1|||
150196562|NCT02240238|541861118|FG000|Phase 2|Disease progression|0|||
150196563|NCT02240238|541861119|FG001|Phase 2|Disease progression|0|||
150196564|NCT02240238|541861120|FG002|Phase 2|Disease progression|0|||
150196565|NCT02240238|541861121|FG003|Phase 2|Disease progression|0|||
150196566|NCT02240238|541861122|FG004|Phase 2|Disease progression|0|||
150196567|NCT02240238|541861123|FG005|Phase 2|Disease progression|0|||
150196568|NCT02240238|541861124|FG006|Phase 2|Disease progression|0|||
150196569|NCT02240238|541861125|FG007|Phase 2|Disease progression|0|||
150196570|NCT02240238|541861126|FG008|Phase 2|Disease progression|0|||
150196571|NCT02240238|541861127|FG009|Phase 2|Disease progression|5|||
150196572|NCT02240238|541861128|FG010|Phase 2|Disease progression|11|||
150196573|NCT02240238|541861129|FG011|Phase 2|Disease progression|1|||
150196574|NCT02240238|541861118|FG000|Phase 2|Withdrawal by Subject|0|||
150196575|NCT02240238|541861119|FG001|Phase 2|Withdrawal by Subject|0|||
150196576|NCT02240238|541861120|FG002|Phase 2|Withdrawal by Subject|0|||
150131848|NCT03232983|541617665|FG000|Washout Period 2|Physician Decision|0|||
150131849|NCT03232983|541617666|FG001|Washout Period 2|Physician Decision|0|||
150131850|NCT03232983|541617667|FG002|Washout Period 2|Physician Decision|1|||
150131851|NCT03232983|541617668|FG003|Washout Period 2|Physician Decision|0|||
150131852|NCT03232983|541617665|FG000|Washout Period 2|Withdrawal by Subject|0|||
150131853|NCT03232983|541617666|FG001|Washout Period 2|Withdrawal by Subject|0|||
150131854|NCT03232983|541617667|FG002|Washout Period 2|Withdrawal by Subject|0|||
150131855|NCT03232983|541617668|FG003|Washout Period 2|Withdrawal by Subject|1|||
150131856|NCT03232983|541617665|FG000|Period 4|Withdrawal by Subject|1|||
150131857|NCT03232983|541617666|FG001|Period 4|Withdrawal by Subject|0|||
150131858|NCT03232983|541617667|FG002|Period 4|Withdrawal by Subject|0|||
150131859|NCT03232983|541617668|FG003|Period 4|Withdrawal by Subject|0|||
150131860|NCT01615328|541617669|FG000|Overall Study|Lost to Follow-up|3|||
150131861|NCT01615328|541617670|FG001|Overall Study|Lost to Follow-up|5|||
150131862|NCT02261493|541617671|FG000|Overall Study|Noncompliance|0|||
150131863|NCT02261493|541617672|FG001|Overall Study|Noncompliance|0|||
150131864|NCT02261493|541617673|FG002|Overall Study|Noncompliance|2|||
150131865|NCT02261493|541617671|FG000|Overall Study|Physician Decision|0|||
150131866|NCT02261493|541617672|FG001|Overall Study|Physician Decision|1|||
150131867|NCT02261493|541617673|FG002|Overall Study|Physician Decision|0|||
150131868|NCT02261493|541617671|FG000|Overall Study|Undisclosed alcohol abuse|0|||
150131869|NCT02261493|541617672|FG001|Overall Study|Undisclosed alcohol abuse|1|||
150131870|NCT02261493|541617673|FG002|Overall Study|Undisclosed alcohol abuse|0|||
150131871|NCT02261493|541617671|FG000|Overall Study|Protocol Violation|1|||
150131872|NCT02261493|541617672|FG001|Overall Study|Protocol Violation|0|||
150131873|NCT02261493|541617673|FG002|Overall Study|Protocol Violation|0|||
150131874|NCT02261493|541617671|FG000|Overall Study|Personal Reasons|14|||
150131875|NCT02261493|541617672|FG001|Overall Study|Personal Reasons|14|||
150131876|NCT02261493|541617673|FG002|Overall Study|Personal Reasons|16|||
150131877|NCT02261493|541617671|FG000|Overall Study|Lost to Follow-up|14|||
150131878|NCT02261493|541617672|FG001|Overall Study|Lost to Follow-up|27|||
150131879|NCT02261493|541617673|FG002|Overall Study|Lost to Follow-up|8|||
150131880|NCT02261493|541617671|FG000|Overall Study|Pregnancy|1|||
150131881|NCT02261493|541617672|FG001|Overall Study|Pregnancy|2|||
150131882|NCT02261493|541617673|FG002|Overall Study|Pregnancy|0|||
150131883|NCT02261493|541617671|FG000|Overall Study|Lack of Efficacy|0|||
150131884|NCT02261493|541617672|FG001|Overall Study|Lack of Efficacy|1|||
150131885|NCT02261493|541617673|FG002|Overall Study|Lack of Efficacy|0|||
150131886|NCT02261493|541617671|FG000|Overall Study|Adverse Event|0|||
150131887|NCT02261493|541617672|FG001|Overall Study|Adverse Event|1|||
150131888|NCT02261493|541617673|FG002|Overall Study|Adverse Event|0|||
150131889|NCT01597050|541617674|FG000|Overall Study|Withdrawal by Subject|1|||
150131890|NCT01597050|541617675|FG001|Overall Study|Withdrawal by Subject|0|||
150131891|NCT00483184|541617676|FG000|Overall Study|Withdrawal by Subject|2|||
150131892|NCT00483184|541617677|FG001|Overall Study|Withdrawal by Subject|2|||
150131893|NCT00483184|541617678|FG002|Overall Study|Withdrawal by Subject|0|||
150131894|NCT00483184|541617676|FG000|Overall Study|Lost to Follow-up|1|||
150131895|NCT00483184|541617677|FG001|Overall Study|Lost to Follow-up|0|||
150131896|NCT00483184|541617678|FG002|Overall Study|Lost to Follow-up|0|||
150131897|NCT00483184|541617676|FG000|Overall Study|Adverse Event|1|||
150131898|NCT00483184|541617677|FG001|Overall Study|Adverse Event|2|||
150131899|NCT00483184|541617678|FG002|Overall Study|Adverse Event|2|||
150131900|NCT00483184|541617676|FG000|Overall Study|Protocol Violation|1|||
150131901|NCT00483184|541617677|FG001|Overall Study|Protocol Violation|0|||
150131902|NCT00483184|541617678|FG002|Overall Study|Protocol Violation|1|||
150131903|NCT02065336|541617682|FG000|Extension Phase|Study Terminated by Sponsor|0|||
150131904|NCT02065336|541617683|FG001|Extension Phase|Study Terminated by Sponsor|0|||
150131905|NCT02065336|541617684|FG002|Extension Phase|Study Terminated by Sponsor|0|||
150131906|NCT02065336|541617685|FG003|Extension Phase|Study Terminated by Sponsor|0|||
150131907|NCT02065336|541617686|FG004|Extension Phase|Study Terminated by Sponsor|0|||
150131908|NCT02065336|541617687|FG005|Extension Phase|Study Terminated by Sponsor|0|||
150131909|NCT02065336|541617688|FG006|Extension Phase|Study Terminated by Sponsor|0|||
150131910|NCT02065336|541617689|FG007|Extension Phase|Study Terminated by Sponsor|0|||
150131911|NCT02065336|541617690|FG008|Extension Phase|Study Terminated by Sponsor|2|||
150131912|NCT02065336|541617691|FG009|Extension Phase|Study Terminated by Sponsor|8|||
150131913|NCT02192502|541617696|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
150131914|NCT02192502|541617697|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
150196577|NCT02240238|541861121|FG003|Phase 2|Withdrawal by Subject|0|||
150196578|NCT02240238|541861122|FG004|Phase 2|Withdrawal by Subject|0|||
150196579|NCT02240238|541861123|FG005|Phase 2|Withdrawal by Subject|0|||
150196580|NCT02240238|541861124|FG006|Phase 2|Withdrawal by Subject|0|||
150196581|NCT02240238|541861125|FG007|Phase 2|Withdrawal by Subject|0|||
150196582|NCT02240238|541861126|FG008|Phase 2|Withdrawal by Subject|0|||
150196583|NCT02240238|541861127|FG009|Phase 2|Withdrawal by Subject|1|||
150196584|NCT02240238|541861128|FG010|Phase 2|Withdrawal by Subject|1|||
150196585|NCT02240238|541861129|FG011|Phase 2|Withdrawal by Subject|0|||
150196586|NCT02240238|541861118|FG000|Phase 2|Physician Decision|0|||
150196587|NCT02240238|541861119|FG001|Phase 2|Physician Decision|0|||
150196588|NCT02240238|541861120|FG002|Phase 2|Physician Decision|0|||
150196589|NCT02240238|541861121|FG003|Phase 2|Physician Decision|0|||
150196590|NCT02240238|541861122|FG004|Phase 2|Physician Decision|0|||
150196591|NCT02240238|541861123|FG005|Phase 2|Physician Decision|0|||
150196592|NCT02240238|541861124|FG006|Phase 2|Physician Decision|0|||
150196593|NCT02240238|541861125|FG007|Phase 2|Physician Decision|0|||
150196594|NCT02240238|541861126|FG008|Phase 2|Physician Decision|0|||
150196595|NCT02240238|541861127|FG009|Phase 2|Physician Decision|1|||
150196596|NCT02240238|541861128|FG010|Phase 2|Physician Decision|3|||
150196597|NCT02240238|541861129|FG011|Phase 2|Physician Decision|0|||
150196598|NCT02240238|541861118|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196599|NCT02240238|541861119|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196600|NCT02240238|541861120|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196601|NCT02240238|541861121|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196602|NCT02240238|541861122|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196603|NCT02240238|541861123|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196604|NCT02240238|541861124|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196605|NCT02240238|541861125|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196606|NCT02240238|541861126|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196607|NCT02240238|541861127|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
150196608|NCT02240238|541861128|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196609|NCT02240238|541861129|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
150196610|NCT02240238|541861118|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196611|NCT02240238|541861119|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196612|NCT02240238|541861120|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196613|NCT02240238|541861121|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196614|NCT02240238|541861122|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196615|NCT02240238|541861123|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196616|NCT02240238|541861124|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196617|NCT02240238|541861125|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196618|NCT02240238|541861126|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196619|NCT02240238|541861127|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
150196620|NCT02240238|541861128|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196621|NCT02240238|541861129|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
150196622|NCT02240238|541861118|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196623|NCT02240238|541861119|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196624|NCT02240238|541861120|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196625|NCT02240238|541861121|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196626|NCT02240238|541861122|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196627|NCT02240238|541861123|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196628|NCT02240238|541861124|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196629|NCT02240238|541861125|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196630|NCT02240238|541861126|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196631|NCT02240238|541861127|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196632|NCT02240238|541861128|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
150196633|NCT02240238|541861129|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
150196634|NCT02240238|541861118|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196635|NCT02240238|541861119|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196636|NCT02240238|541861120|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196637|NCT02240238|541861121|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196638|NCT02240238|541861122|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196639|NCT02240238|541861123|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196640|NCT02240238|541861124|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196641|NCT02240238|541861125|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196642|NCT02240238|541861126|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196643|NCT02240238|541861127|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196644|NCT02240238|541861128|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
150196645|NCT02240238|541861129|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
150196646|NCT02240238|541861118|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150131915|NCT02192502|541617696|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
150131916|NCT02192502|541617697|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
150131917|NCT02192502|541617696|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
150131918|NCT02192502|541617697|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
150131919|NCT01381692|541617698|FG000|Overall Study|Adverse Event|1|||
150131920|NCT01381692|541617699|FG001|Overall Study|Adverse Event|0|||
150131921|NCT01381692|541617700|FG002|Overall Study|Adverse Event|0|||
150131922|NCT01381692|541617701|FG003|Overall Study|Adverse Event|0|||
150131923|NCT01381692|541617702|FG004|Overall Study|Adverse Event|0|||
150131924|NCT01381692|541617703|FG005|Overall Study|Adverse Event|0|||
150131925|NCT04575467|541617704|FG000|Overall Study|Adverse Event|0|||
150131926|NCT04575467|541617705|FG001|Overall Study|Adverse Event|1|||
150131927|NCT04575467|541617706|FG002|Overall Study|Adverse Event|0|||
150131928|NCT04575467|541617707|FG003|Overall Study|Adverse Event|0|||
150131929|NCT01994954|541617708|FG000|Overall Study|Death|1|||
150131930|NCT01994954|541617709|FG001|Overall Study|Death|0|||
150131931|NCT01994954|541617708|FG000|Overall Study|Withdrawal by Subject|9|||
150131932|NCT01994954|541617709|FG001|Overall Study|Withdrawal by Subject|14|||
150131933|NCT01994954|541617708|FG000|Overall Study|Physician Decision|2|||
150131934|NCT01994954|541617709|FG001|Overall Study|Physician Decision|2|||
150131935|NCT01994954|541617708|FG000|Overall Study|Lost to Follow-up|8|||
150131936|NCT01994954|541617709|FG001|Overall Study|Lost to Follow-up|10|||
150131937|NCT01994954|541617708|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
150131938|NCT01994954|541617709|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
150131939|NCT00449176|541617710|FG000|Overall Study|Withdrawal by Subject|39|||
150131940|NCT00449176|541617711|FG001|Overall Study|Withdrawal by Subject|43|||
150131941|NCT00449176|541617712|FG002|Overall Study|Withdrawal by Subject|59|||
150131942|NCT00449176|541617710|FG000|Overall Study|Lost to Follow-up|13|||
150131943|NCT00449176|541617711|FG001|Overall Study|Lost to Follow-up|8|||
150131944|NCT00449176|541617712|FG002|Overall Study|Lost to Follow-up|12|||
150131945|NCT00449176|541617710|FG000|Overall Study|Adverse Event|51|||
150131946|NCT00449176|541617711|FG001|Overall Study|Adverse Event|107|||
150131947|NCT00449176|541617712|FG002|Overall Study|Adverse Event|15|||
150131948|NCT00449176|541617710|FG000|Overall Study|Lack of Efficacy|13|||
150131949|NCT00449176|541617711|FG001|Overall Study|Lack of Efficacy|7|||
150131950|NCT00449176|541617712|FG002|Overall Study|Lack of Efficacy|50|||
150131951|NCT00449176|541617710|FG000|Overall Study|Study drug non-compliant|14|||
150131952|NCT00449176|541617711|FG001|Overall Study|Study drug non-compliant|11|||
150131953|NCT00449176|541617712|FG002|Overall Study|Study drug non-compliant|11|||
150131954|NCT00449176|541617710|FG000|Overall Study|all other|22|||
150131955|NCT00449176|541617711|FG001|Overall Study|all other|19|||
150131956|NCT00449176|541617712|FG002|Overall Study|all other|20|||
150131957|NCT02576678|541617713|FG000|Overall Study|Adverse Event|0|||
150131958|NCT02576678|541617714|FG001|Overall Study|Adverse Event|0|||
150131959|NCT02576678|541617715|FG002|Overall Study|Adverse Event|2|||
150131960|NCT02576678|541617713|FG000|Overall Study|Withdrawal by Subject|3|||
150131961|NCT02576678|541617714|FG001|Overall Study|Withdrawal by Subject|1|||
150131962|NCT02576678|541617715|FG002|Overall Study|Withdrawal by Subject|2|||
150131963|NCT02576678|541617713|FG000|Overall Study|Lost to Follow-up|0|||
150131964|NCT02576678|541617714|FG001|Overall Study|Lost to Follow-up|0|||
150131965|NCT02576678|541617715|FG002|Overall Study|Lost to Follow-up|1|||
150131966|NCT02576678|541617713|FG000|Overall Study|Miscellaneous|2|||
150131967|NCT02576678|541617714|FG001|Overall Study|Miscellaneous|0|||
150131968|NCT02576678|541617715|FG002|Overall Study|Miscellaneous|0|||
150131969|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
150131970|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
150131971|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|disease progression|58|||
150131972|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|disease progression|47|||
150131973|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Death|3|||
150131974|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Death|6|||
150196647|NCT02240238|541861119|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196648|NCT02240238|541861120|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196649|NCT02240238|541861121|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196650|NCT02240238|541861122|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196651|NCT02240238|541861123|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196652|NCT02240238|541861124|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196653|NCT02240238|541861125|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196654|NCT02240238|541861126|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196655|NCT02240238|541861127|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196656|NCT02240238|541861128|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
150196657|NCT02240238|541861129|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
150196658|NCT02240238|541861118|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196659|NCT02240238|541861119|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196660|NCT02240238|541861120|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196661|NCT02240238|541861121|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196662|NCT02240238|541861122|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196663|NCT02240238|541861123|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196664|NCT02240238|541861124|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196665|NCT02240238|541861125|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196666|NCT02240238|541861126|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196667|NCT02240238|541861127|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196668|NCT02240238|541861128|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
150196669|NCT02240238|541861129|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
150196670|NCT02240238|541861118|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196671|NCT02240238|541861119|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196672|NCT02240238|541861120|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196673|NCT02240238|541861121|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196674|NCT02240238|541861122|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196675|NCT02240238|541861123|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196676|NCT02240238|541861124|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196677|NCT02240238|541861125|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196678|NCT02240238|541861126|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196679|NCT02240238|541861127|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196680|NCT02240238|541861128|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
150196681|NCT02240238|541861129|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
150196682|NCT02240238|541861118|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196683|NCT02240238|541861119|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196684|NCT02240238|541861120|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196685|NCT02240238|541861121|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196686|NCT02240238|541861122|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196687|NCT02240238|541861123|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196688|NCT02240238|541861124|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196689|NCT02240238|541861125|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196690|NCT02240238|541861126|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196691|NCT02240238|541861127|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196692|NCT02240238|541861128|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
150196693|NCT02240238|541861129|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
150196694|NCT01346540|541861141|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
150196695|NCT01346540|541861142|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
150196696|NCT01346540|541861141|FG000|Overall Study|Adverse Event|0|||
150196697|NCT01346540|541861142|FG001|Overall Study|Adverse Event|4|||
150196698|NCT03362476|541861146|FG000|Overall Study|Withdrawal by Subject|0|||
150196699|NCT03362476|541861147|FG001|Overall Study|Withdrawal by Subject|1|||
150196700|NCT01236781|541861155|FG000|Overall Study|Ineligible|2|||
150196701|NCT01236781|541861156|FG001|Overall Study|Ineligible|1|||
150196702|NCT01236781|541861155|FG000|Overall Study|Did not complete study imaging|5|||
150196703|NCT01236781|541861156|FG001|Overall Study|Did not complete study imaging|0|||
150196704|NCT04587453|541861157|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
150196705|NCT04587453|541861158|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
150196706|NCT04737330|541861159|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
150196707|NCT04737330|541861160|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
150196708|NCT04737330|541861159|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
150196709|NCT04737330|541861160|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
150196710|NCT04737330|541861159|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
150196711|NCT04737330|541861160|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
150196712|NCT04737330|541861159|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
150196713|NCT04737330|541861160|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
150196714|NCT04737330|541861159|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
150196715|NCT04737330|541861160|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
150196716|NCT04737330|541861159|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
150196717|NCT04737330|541861160|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
150196718|NCT02852655|541861164|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
150196719|NCT02852655|541861165|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
150196720|NCT02852655|541861166|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
150196721|NCT02852655|541861164|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
150196722|NCT02852655|541861165|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
150196723|NCT02852655|541861166|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
150196724|NCT02852655|541861164|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
150196725|NCT02852655|541861165|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
150196726|NCT02852655|541861166|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
150196727|NCT02852655|541861164|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
150196728|NCT02852655|541861165|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
150196729|NCT02852655|541861166|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
150196730|NCT02852655|541861164|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
150196731|NCT02852655|541861165|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
150196732|NCT02852655|541861166|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
150196733|NCT02852655|541861164|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
150196734|NCT02852655|541861165|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
150196735|NCT02852655|541861166|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
150196736|NCT02852655|541861164|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
150196737|NCT02852655|541861165|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
150196738|NCT02852655|541861166|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
150196739|NCT02852655|541861164|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
150196740|NCT02852655|541861165|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
150196741|NCT02852655|541861166|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
150196742|NCT02852655|541861164|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
150196743|NCT02852655|541861165|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
150196744|NCT02852655|541861166|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
150196745|NCT00323856|541861167|FG000|Overall Study|Withdrawal by Subject|1|||
150196746|NCT00323856|541861167|FG000|Overall Study|Was uncooperative and noncompliant|1|||
150196747|NCT00323856|541861167|FG000|Overall Study|Reason not specified|1|||
150196748|NCT00323856|541861167|FG000|Overall Study|Missing|2|||
150196749|NCT05309291|541861168|FG000|Overall Study|Adverse Event|0|||
150196750|NCT05309291|541861169|FG001|Overall Study|Adverse Event|1|||
150196751|NCT05209152|541861170|FG000|Overall Study|Sponsor decision|1|||
150196752|NCT05209152|541861171|FG001|Overall Study|Sponsor decision|2|||
150196753|NCT05209152|541861170|FG000|Overall Study|Death|3|||
150196754|NCT05209152|541861171|FG001|Overall Study|Death|1|||
150196755|NCT05292391|541861174|FG000|Overall Study|Lost to Follow-up|0|||
150196756|NCT05292391|541861175|FG001|Overall Study|Lost to Follow-up|0|||
150196757|NCT05292391|541861176|FG002|Overall Study|Lost to Follow-up|0|||
150196758|NCT05292391|541861177|FG003|Overall Study|Lost to Follow-up|1|||
150196759|NCT05292391|541861178|FG004|Overall Study|Lost to Follow-up|0|||
150196760|NCT03221426|541861182|FG000|Overall Study|Ongoing in study|212|||
150196761|NCT03221426|541861183|FG001|Overall Study|Ongoing in study|193|||
150196762|NCT03221426|541861184|FG002|Overall Study|Ongoing in study|61|||
150196763|NCT03221426|541861185|FG003|Overall Study|Ongoing in study|55|||
150196764|NCT03221426|541861182|FG000|Overall Study|Withdrawal by Subject|12|||
150196765|NCT03221426|541861183|FG001|Overall Study|Withdrawal by Subject|4|||
150196766|NCT03221426|541861184|FG002|Overall Study|Withdrawal by Subject|2|||
150196767|NCT03221426|541861185|FG003|Overall Study|Withdrawal by Subject|3|||
150196768|NCT03221426|541861182|FG000|Overall Study|Lost to Follow-up|4|||
150196769|NCT03221426|541861183|FG001|Overall Study|Lost to Follow-up|1|||
150196770|NCT03221426|541861184|FG002|Overall Study|Lost to Follow-up|1|||
150196771|NCT03221426|541861185|FG003|Overall Study|Lost to Follow-up|0|||
150196772|NCT03221426|541861182|FG000|Overall Study|Death|174|||
150196773|NCT03221426|541861183|FG001|Overall Study|Death|204|||
150196774|NCT03221426|541861184|FG002|Overall Study|Death|36|||
150196775|NCT03221426|541861185|FG003|Overall Study|Death|45|||
150196776|NCT04171141|541862962|FG000|Overall Study|Adverse Event|0|||
150196777|NCT04171141|541862963|FG001|Overall Study|Adverse Event|0|||
150196778|NCT04171141|541862964|FG002|Overall Study|Adverse Event|2|||
150196779|NCT04171141|541862965|FG003|Overall Study|Adverse Event|0|||
150196780|NCT04171141|541862966|FG004|Overall Study|Adverse Event|0|||
150196781|NCT04171141|541862967|FG005|Overall Study|Adverse Event|0|||
150196782|NCT04171141|541862968|FG006|Overall Study|Adverse Event|0|||
150196783|NCT04171141|541862969|FG007|Overall Study|Adverse Event|0|||
150196784|NCT04171141|541862970|FG008|Overall Study|Adverse Event|0|||
150196785|NCT04171141|541862971|FG009|Overall Study|Adverse Event|0|||
150196786|NCT04171141|541862972|FG010|Overall Study|Adverse Event|0|||
150196787|NCT04171141|541862973|FG011|Overall Study|Adverse Event|0|||
150196788|NCT04171141|541862974|FG012|Overall Study|Adverse Event|0|||
150196789|NCT04171141|541862975|FG013|Overall Study|Adverse Event|2|||
150196790|NCT04171141|541862976|FG014|Overall Study|Adverse Event|0|||
150196791|NCT04171141|541862977|FG015|Overall Study|Adverse Event|0|||
150196792|NCT04171141|541862962|FG000|Overall Study|Physician Decision|0|||
150196793|NCT04171141|541862963|FG001|Overall Study|Physician Decision|0|||
150196794|NCT04171141|541862964|FG002|Overall Study|Physician Decision|0|||
150196795|NCT04171141|541862965|FG003|Overall Study|Physician Decision|0|||
150196796|NCT04171141|541862966|FG004|Overall Study|Physician Decision|1|||
150196797|NCT04171141|541862967|FG005|Overall Study|Physician Decision|0|||
150196798|NCT04171141|541862968|FG006|Overall Study|Physician Decision|0|||
150196799|NCT04171141|541862969|FG007|Overall Study|Physician Decision|0|||
150196800|NCT04171141|541862970|FG008|Overall Study|Physician Decision|0|||
150196801|NCT04171141|541862971|FG009|Overall Study|Physician Decision|0|||
150196802|NCT04171141|541862972|FG010|Overall Study|Physician Decision|0|||
150196803|NCT04171141|541862973|FG011|Overall Study|Physician Decision|0|||
150196804|NCT04171141|541862974|FG012|Overall Study|Physician Decision|0|||
150196805|NCT04171141|541862975|FG013|Overall Study|Physician Decision|0|||
150196806|NCT04171141|541862976|FG014|Overall Study|Physician Decision|0|||
150196807|NCT04171141|541862977|FG015|Overall Study|Physician Decision|1|||
150196808|NCT04171141|541862962|FG000|Overall Study|Progressive disease|2|||
150196809|NCT04171141|541862963|FG001|Overall Study|Progressive disease|3|||
150196810|NCT04171141|541862964|FG002|Overall Study|Progressive disease|4|||
150196811|NCT04171141|541862965|FG003|Overall Study|Progressive disease|7|||
150196812|NCT04171141|541862966|FG004|Overall Study|Progressive disease|1|||
150196813|NCT04171141|541862967|FG005|Overall Study|Progressive disease|8|||
150196814|NCT04171141|541862968|FG006|Overall Study|Progressive disease|4|||
150196815|NCT04171141|541862969|FG007|Overall Study|Progressive disease|6|||
150196816|NCT04171141|541862970|FG008|Overall Study|Progressive disease|7|||
150196817|NCT04171141|541862971|FG009|Overall Study|Progressive disease|3|||
150196818|NCT04171141|541862972|FG010|Overall Study|Progressive disease|4|||
150196819|NCT04171141|541862973|FG011|Overall Study|Progressive disease|3|||
150196820|NCT04171141|541862974|FG012|Overall Study|Progressive disease|4|||
150196821|NCT04171141|541862975|FG013|Overall Study|Progressive disease|2|||
150196822|NCT04171141|541862976|FG014|Overall Study|Progressive disease|4|||
150196823|NCT04171141|541862977|FG015|Overall Study|Progressive disease|1|||
150196824|NCT04171141|541862962|FG000|Overall Study|Withdrawal by Subject|0|||
150196825|NCT04171141|541862963|FG001|Overall Study|Withdrawal by Subject|0|||
150196826|NCT04171141|541862964|FG002|Overall Study|Withdrawal by Subject|0|||
150196827|NCT04171141|541862965|FG003|Overall Study|Withdrawal by Subject|1|||
150196828|NCT04171141|541862966|FG004|Overall Study|Withdrawal by Subject|0|||
150196829|NCT04171141|541862967|FG005|Overall Study|Withdrawal by Subject|0|||
150196830|NCT04171141|541862968|FG006|Overall Study|Withdrawal by Subject|1|||
150196831|NCT04171141|541862969|FG007|Overall Study|Withdrawal by Subject|0|||
150196832|NCT04171141|541862970|FG008|Overall Study|Withdrawal by Subject|0|||
150196833|NCT04171141|541862971|FG009|Overall Study|Withdrawal by Subject|1|||
150196834|NCT04171141|541862972|FG010|Overall Study|Withdrawal by Subject|0|||
150196835|NCT04171141|541862973|FG011|Overall Study|Withdrawal by Subject|0|||
150196836|NCT04171141|541862974|FG012|Overall Study|Withdrawal by Subject|0|||
150196837|NCT04171141|541862975|FG013|Overall Study|Withdrawal by Subject|0|||
150196838|NCT04171141|541862976|FG014|Overall Study|Withdrawal by Subject|0|||
150196839|NCT04171141|541862977|FG015|Overall Study|Withdrawal by Subject|0|||
150196840|NCT04171141|541862962|FG000|Overall Study|Global deterioration of health status|0|||
150196841|NCT04171141|541862963|FG001|Overall Study|Global deterioration of health status|0|||
150196842|NCT04171141|541862964|FG002|Overall Study|Global deterioration of health status|0|||
150196843|NCT04171141|541862965|FG003|Overall Study|Global deterioration of health status|1|||
150196844|NCT04171141|541862966|FG004|Overall Study|Global deterioration of health status|0|||
150196845|NCT04171141|541862967|FG005|Overall Study|Global deterioration of health status|2|||
150196846|NCT04171141|541862968|FG006|Overall Study|Global deterioration of health status|1|||
150196847|NCT04171141|541862969|FG007|Overall Study|Global deterioration of health status|0|||
150196848|NCT04171141|541862970|FG008|Overall Study|Global deterioration of health status|1|||
150196849|NCT04171141|541862971|FG009|Overall Study|Global deterioration of health status|0|||
150131975|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
150131976|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
150131977|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
150131978|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
150131979|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
150131980|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
150131981|NCT02472964|541617716|FG000|Part 1 (up to Week 24)|Other|2|||
150131982|NCT02472964|541617717|FG001|Part 1 (up to Week 24)|Other|1|||
150131983|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
150131984|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
150131985|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
150131986|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
150131987|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Death|0|||
150131988|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Death|1|||
150131989|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
150131990|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
150131991|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
150131992|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
150131993|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
150131994|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
150131995|NCT02472964|541617716|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
150131996|NCT02472964|541617717|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
150131997|NCT01454583|541617720|FG000|1st Year|Lost to Follow-up|1057|||
150131998|NCT01454583|541617721|FG001|1st Year|Lost to Follow-up|318|||
150131999|NCT01454583|541617722|FG002|1st Year|Lost to Follow-up|180|||
150132000|NCT01454583|541617720|FG000|2nd Year|Lost to Follow-up|3965|||
150132001|NCT01454583|541617721|FG001|2nd Year|Lost to Follow-up|1049|||
150132002|NCT01454583|541617722|FG002|2nd Year|Lost to Follow-up|737|||
150132003|NCT01454583|541617720|FG000|3rd Year|Lost to Follow-up|1959|||
150132004|NCT01454583|541617721|FG001|3rd Year|Lost to Follow-up|512|||
150132005|NCT01454583|541617722|FG002|3rd Year|Lost to Follow-up|297|||
150132006|NCT01967732|541617725|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
150132007|NCT01967732|541617726|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
150132008|NCT01967732|541617727|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
150132009|NCT01967732|541617728|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
150132010|NCT01967732|541617725|FG000|First Intervention (Day 1)|Poor venous access|0|||
150132011|NCT01967732|541617726|FG001|First Intervention (Day 1)|Poor venous access|1|||
150132012|NCT01967732|541617727|FG002|First Intervention (Day 1)|Poor venous access|0|||
150132013|NCT01967732|541617728|FG003|First Intervention (Day 1)|Poor venous access|0|||
150132014|NCT04403698|541617730|FG000|Overall Study|Adverse Event|1|||
150132015|NCT04403698|541617731|FG001|Overall Study|Adverse Event|1|||
150132016|NCT04403698|541617730|FG000|Overall Study|Lost to Follow-up|1|||
150132017|NCT04403698|541617731|FG001|Overall Study|Lost to Follow-up|0|||
150132018|NCT04403698|541617730|FG000|Overall Study|Protocol Violation|0|||
150132019|NCT04403698|541617731|FG001|Overall Study|Protocol Violation|1|||
150132020|NCT00977665|541617732|FG000|Overall Study|Withdrawal by Subject|1|||
150132021|NCT00977665|541617733|FG001|Overall Study|Withdrawal by Subject|3|||
150132022|NCT00977665|541617732|FG000|Overall Study|Physician Decision|2|||
150132023|NCT00977665|541617733|FG001|Overall Study|Physician Decision|1|||
150132024|NCT00977665|541617732|FG000|Overall Study|Sponsor requested withdrawal|0|||
150132025|NCT00977665|541617733|FG001|Overall Study|Sponsor requested withdrawal|1|||
150132026|NCT00977665|541617732|FG000|Overall Study|Lost to Follow-up|1|||
150132027|NCT00977665|541617733|FG001|Overall Study|Lost to Follow-up|0|||
150132028|NCT00977665|541617732|FG000|Overall Study|Death|3|||
150132029|NCT00977665|541617733|FG001|Overall Study|Death|2|||
150132030|NCT00977665|541617732|FG000|Overall Study|Adverse Event|14|||
150132031|NCT00977665|541617733|FG001|Overall Study|Adverse Event|7|||
150132032|NCT00977665|541617732|FG000|Overall Study|Treatment failure|0|||
150132033|NCT00977665|541617733|FG001|Overall Study|Treatment failure|1|||
150132034|NCT01018394|541617736|FG000|Overall Study|Withdrawal by Subject|5|||
150132035|NCT01018394|541617737|FG001|Overall Study|Withdrawal by Subject|5|||
150132036|NCT01018394|541617736|FG000|Overall Study|Lost to Follow-up|4|||
150132037|NCT01018394|541617737|FG001|Overall Study|Lost to Follow-up|3|||
150132038|NCT03792126|541617738|FG000|Overall Study|Adverse Event|1|||
150132039|NCT03792126|541617739|FG001|Overall Study|Adverse Event|2|||
150132040|NCT03792126|541617738|FG000|Overall Study|Death|0|||
150132041|NCT03792126|541617739|FG001|Overall Study|Death|1|||
150132042|NCT03792126|541617738|FG000|Overall Study|Lost to Follow-up|1|||
150132043|NCT03792126|541617739|FG001|Overall Study|Lost to Follow-up|0|||
150132044|NCT03792126|541617738|FG000|Overall Study|Withdrawal by Subject|0|||
150132045|NCT03792126|541617739|FG001|Overall Study|Withdrawal by Subject|1|||
150132046|NCT03792126|541617738|FG000|Overall Study|COVID-19 Restrictions|1|||
150196850|NCT04171141|541862972|FG010|Overall Study|Global deterioration of health status|0|||
150196851|NCT04171141|541862973|FG011|Overall Study|Global deterioration of health status|0|||
150196852|NCT04171141|541862974|FG012|Overall Study|Global deterioration of health status|0|||
150196853|NCT04171141|541862975|FG013|Overall Study|Global deterioration of health status|0|||
150196854|NCT04171141|541862976|FG014|Overall Study|Global deterioration of health status|1|||
150196855|NCT04171141|541862977|FG015|Overall Study|Global deterioration of health status|1|||
150196856|NCT03663569|541862980|FG000|Overall Study|Discontinuation of study|11|||
150196857|NCT03663569|541862980|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
150196858|NCT03663569|541862980|FG000|Overall Study|Deceased patient|6|||
150196859|NCT03663569|541862980|FG000|Overall Study|Lost to Follow-up|18|||
150196860|NCT03663569|541862980|FG000|Overall Study|Withdrawal of consent|5|||
150196861|NCT03663569|541862980|FG000|Overall Study|Patient's request|11|||
150196862|NCT03663569|541862980|FG000|Overall Study|Adverse Event|4|||
150196863|NCT03663569|541862980|FG000|Overall Study|Not come to second visit|3|||
150196864|NCT03663569|541862980|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
150196865|NCT03663569|541862980|FG000|Overall Study|Serious adverse event|1|||
150196866|NCT04979442|541862981|FG000|Overall Study|Death|43|||
150196867|NCT04979442|541862982|FG001|Overall Study|Death|30|||
150196868|NCT04979442|541862981|FG000|Overall Study|Withdrawal by Subject|8|||
150196869|NCT04979442|541862982|FG001|Overall Study|Withdrawal by Subject|13|||
150196870|NCT04979442|541862981|FG000|Overall Study|Physician Decision|1|||
150196871|NCT04979442|541862982|FG001|Overall Study|Physician Decision|1|||
150196872|NCT04979442|541862981|FG000|Overall Study|Lost to Follow-up|0|||
150196873|NCT04979442|541862982|FG001|Overall Study|Lost to Follow-up|2|||
150196874|NCT04979442|541862981|FG000|Overall Study|do not want to continue|0|||
150196875|NCT04979442|541862982|FG001|Overall Study|do not want to continue|1|||
150196876|NCT04005794|541862984|FG000|Overall Study|Lost to Follow-up|0|||
150196877|NCT04005794|541862985|FG001|Overall Study|Lost to Follow-up|4|||
150196878|NCT04005794|541862986|FG002|Overall Study|Lost to Follow-up|0|||
150196879|NCT00104676|541862990|FG000|Overall Study|Death|3|||
150196880|NCT00104676|541862991|FG001|Overall Study|Death|2|||
150196881|NCT00104676|541862990|FG000|Overall Study|Withdrawal by Subject|0|||
150196882|NCT00104676|541862991|FG001|Overall Study|Withdrawal by Subject|2|||
150196883|NCT00104676|541862990|FG000|Overall Study|treatment interruption|4|||
150196884|NCT00104676|541862991|FG001|Overall Study|treatment interruption|10|||
150196885|NCT05622812|541862992|FG000|Overall Study|Withdrawal by Subject|1|||
150196886|NCT05622812|541862993|FG001|Overall Study|Withdrawal by Subject|4|||
150196887|NCT05622812|541862992|FG000|Overall Study|Lost to Follow-up|2|||
150196888|NCT05622812|541862993|FG001|Overall Study|Lost to Follow-up|1|||
150196889|NCT06232590|541862997|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
150196890|NCT06232590|541862998|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
150196891|NCT02433379|541862999|FG000|Overall Study|Screen Failures|55|||
150196892|NCT02433379|541862999|FG000|Overall Study|Death|57|||
150196893|NCT02433379|541862999|FG000|Overall Study|Total Withdrawals|209|||
150196894|NCT00592852|541863000|FG000|Overall Study|Non-compliance|1|||
150196895|NCT00592852|541863000|FG000|Overall Study|Adverse Event|3|||
150196896|NCT00592852|541863000|FG000|Overall Study|Found ineligible|1|||
150196897|NCT00592852|541863000|FG000|Overall Study|Withdrawal by Subject|1|||
150196898|NCT04770402|541863015|FG000|Overall Study|Lost to Follow-up|1|||
150196899|NCT04770402|541863016|FG001|Overall Study|Lost to Follow-up|2|||
150196900|NCT04770402|541863015|FG000|Overall Study|Non-compliance|1|||
150196901|NCT04770402|541863016|FG001|Overall Study|Non-compliance|0|||
150196902|NCT04770402|541863015|FG000|Overall Study|Withdrawal by Subject|0|||
150196903|NCT04770402|541863016|FG001|Overall Study|Withdrawal by Subject|1|||
150196904|NCT02589795|541863017|FG000|Overall Study|Lost to Follow-up|1|||
150196905|NCT02589795|541863018|FG001|Overall Study|Lost to Follow-up|0|||
150196906|NCT02589795|541863019|FG002|Overall Study|Lost to Follow-up|0|||
150196907|NCT02589795|541863017|FG000|Overall Study|Withdrawal by Subject|0|||
150196908|NCT02589795|541863018|FG001|Overall Study|Withdrawal by Subject|0|||
150196909|NCT02589795|541863019|FG002|Overall Study|Withdrawal by Subject|2|||
150196910|NCT02589795|541863017|FG000|Overall Study|Protocol Violation|0|||
150196911|NCT02589795|541863018|FG001|Overall Study|Protocol Violation|0|||
150196912|NCT02589795|541863019|FG002|Overall Study|Protocol Violation|1|||
150196913|NCT04909801|541863022|FG000|Overall Study|Lack of Efficacy|2|||
150196914|NCT04909801|541863023|FG001|Overall Study|Lack of Efficacy|1|||
150196915|NCT04909801|541863022|FG000|Overall Study|Adverse Event|1|||
150196916|NCT04909801|541863023|FG001|Overall Study|Adverse Event|2|||
150196917|NCT04909801|541863022|FG000|Overall Study|Participant request to discontinue study treatment|1|||
150132047|NCT03792126|541617739|FG001|Overall Study|COVID-19 Restrictions|3|||
150132048|NCT03792126|541617738|FG000|Overall Study|Symptoms resolved|0|||
150132049|NCT03792126|541617739|FG001|Overall Study|Symptoms resolved|3|||
150132050|NCT00683644|541617740|FG000|Overall Study|Withdrawal by Subject|4|||
150132051|NCT00683644|541617741|FG001|Overall Study|Withdrawal by Subject|2|||
150132052|NCT00683644|541617740|FG000|Overall Study|Lost to Follow-up|1|||
150132053|NCT00683644|541617741|FG001|Overall Study|Lost to Follow-up|4|||
150132054|NCT00683644|541617740|FG000|Overall Study|Adverse Event|1|||
150132055|NCT00683644|541617741|FG001|Overall Study|Adverse Event|2|||
150132056|NCT00683644|541617740|FG000|Overall Study|Low copper, other health problems,|7|||
150132057|NCT00683644|541617741|FG001|Overall Study|Low copper, other health problems,|6|||
150132058|NCT04322682|541617742|FG000|Overall Study|Withdrawal by Subject|33|||
150132059|NCT04322682|541617743|FG001|Overall Study|Withdrawal by Subject|47|||
150132060|NCT04322682|541617742|FG000|Overall Study|Death|5|||
150132061|NCT04322682|541617743|FG001|Overall Study|Death|9|||
150132062|NCT04322682|541617742|FG000|Overall Study|Lost to Follow-up|4|||
150132063|NCT04322682|541617743|FG001|Overall Study|Lost to Follow-up|8|||
150132064|NCT04322682|541617742|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
150132065|NCT04322682|541617743|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
150132066|NCT04123067|541617745|FG000|Overall Study|Lost to Follow-up|0|||
150132067|NCT04123067|541617746|FG001|Overall Study|Lost to Follow-up|1|||
150132068|NCT02238379|541617747|FG000|Overall Study|Lost to Follow-up|1|||
150132069|NCT02238379|541617748|FG001|Overall Study|Lost to Follow-up|0|||
150132070|NCT00441090|541617749|FG000|Overall Study|Adverse Event|0|||
150132071|NCT00441090|541617750|FG001|Overall Study|Adverse Event|1|||
150132072|NCT00441090|541617751|FG002|Overall Study|Adverse Event|1|||
150132073|NCT00441090|541617752|FG003|Overall Study|Adverse Event|0|||
150132074|NCT00441090|541617753|FG004|Overall Study|Adverse Event|0|||
150132075|NCT00441090|541617749|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
150132076|NCT00441090|541617750|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
150132077|NCT00441090|541617751|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
150132078|NCT00441090|541617752|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
150132079|NCT00441090|541617753|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
150132080|NCT00441090|541617749|FG000|Overall Study|Withdrawal by Subject|1|||
150132081|NCT00441090|541617750|FG001|Overall Study|Withdrawal by Subject|0|||
150132082|NCT00441090|541617751|FG002|Overall Study|Withdrawal by Subject|1|||
150132083|NCT00441090|541617752|FG003|Overall Study|Withdrawal by Subject|0|||
150132084|NCT00441090|541617753|FG004|Overall Study|Withdrawal by Subject|0|||
150132085|NCT00441090|541617749|FG000|Overall Study|Lack of Efficacy|1|||
150132086|NCT00441090|541617750|FG001|Overall Study|Lack of Efficacy|0|||
150132087|NCT00441090|541617751|FG002|Overall Study|Lack of Efficacy|0|||
150132088|NCT00441090|541617752|FG003|Overall Study|Lack of Efficacy|0|||
150132089|NCT00441090|541617753|FG004|Overall Study|Lack of Efficacy|0|||
150132090|NCT01441102|541617754|FG000|Overall Study|Adverse Event|1|||
150132091|NCT01441102|541617754|FG000|Overall Study|Withdrawal by Subject|2|||
150132092|NCT03085485|541617755|FG000|Overall Study|Death|1|||
150132093|NCT03085485|541617756|FG001|Overall Study|Death|0|||
150132094|NCT03085485|541617755|FG000|Overall Study|Lost to Follow-up|1|||
150132095|NCT03085485|541617756|FG001|Overall Study|Lost to Follow-up|0|||
150132096|NCT00605280|541617757|FG000|Year 1|Protocol Violation|0|||
150132097|NCT00605280|541617758|FG001|Year 1|Protocol Violation|0|||
150132098|NCT00605280|541617759|FG002|Year 1|Protocol Violation|0|||
150132099|NCT00605280|541617760|FG003|Year 1|Protocol Violation|1|||
150132100|NCT00605280|541617757|FG000|Year 1|Adverse Event|3|||
150132101|NCT00605280|541617758|FG001|Year 1|Adverse Event|1|||
150132102|NCT00605280|541617759|FG002|Year 1|Adverse Event|1|||
150132103|NCT00605280|541617760|FG003|Year 1|Adverse Event|5|||
150132104|NCT00605280|541617757|FG000|Year 1|Physician Decision|7|||
150132105|NCT00605280|541617758|FG001|Year 1|Physician Decision|4|||
150132106|NCT00605280|541617759|FG002|Year 1|Physician Decision|0|||
150132107|NCT00605280|541617760|FG003|Year 1|Physician Decision|6|||
150132108|NCT00605280|541617757|FG000|Year 1|Withdrawal by Subject|2|||
150196918|NCT04909801|541863023|FG001|Overall Study|Participant request to discontinue study treatment|2|||
150196919|NCT04909801|541863022|FG000|Overall Study|Withdrawal by Subject|2|||
150196920|NCT04909801|541863023|FG001|Overall Study|Withdrawal by Subject|1|||
150196921|NCT04909801|541863022|FG000|Overall Study|other reasons|1|||
150196922|NCT04909801|541863023|FG001|Overall Study|other reasons|1|||
150196923|NCT02505984|541863024|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
150196924|NCT02505984|541863025|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
150196925|NCT02505984|541863024|FG000|Overall Study|Unreliable self-report data|1|||
150196926|NCT02505984|541863025|FG001|Overall Study|Unreliable self-report data|0|||
150196927|NCT02505984|541863024|FG000|Overall Study|Study blind opened during assessment|0|||
150196928|NCT02505984|541863025|FG001|Overall Study|Study blind opened during assessment|1|||
150196929|NCT02505984|541863024|FG000|Overall Study|Noncompliance with study protocol|0|||
150196930|NCT02505984|541863025|FG001|Overall Study|Noncompliance with study protocol|1|||
150196931|NCT03687086|541863026|FG000|Overall Study|Withdrawal by Subject|3|||
150196932|NCT03687086|541863027|FG001|Overall Study|Withdrawal by Subject|4|||
150196933|NCT03687086|541863026|FG000|Overall Study|Lost to Follow-up|1|||
150196934|NCT03687086|541863027|FG001|Overall Study|Lost to Follow-up|1|||
150196935|NCT03687086|541863026|FG000|Overall Study|Death|1|||
150196936|NCT03687086|541863027|FG001|Overall Study|Death|0|||
150196937|NCT03687086|541863026|FG000|Overall Study|Incomplete assessment|0|||
150196938|NCT03687086|541863027|FG001|Overall Study|Incomplete assessment|2|||
150196939|NCT00321048|541863028|FG000|Overall Study|Withdrawal by Subject|6|||
150196940|NCT00321048|541863029|FG001|Overall Study|Withdrawal by Subject|8|||
150196941|NCT02038777|541863030|FG000|Overall Study|Death|0|||
150196942|NCT02038777|541863031|FG001|Overall Study|Death|2|||
150196943|NCT02038777|541863032|FG002|Overall Study|Death|0|||
150196944|NCT02038777|541863033|FG003|Overall Study|Death|1|||
150196945|NCT02038777|541863034|FG004|Overall Study|Death|2|||
150196946|NCT02038777|541863035|FG005|Overall Study|Death|4|||
150196947|NCT02038777|541863036|FG006|Overall Study|Death|0|||
150196948|NCT02038777|541863037|FG007|Overall Study|Death|11|||
150196949|NCT02038777|541863030|FG000|Overall Study|Lost to Follow-up|0|||
150196950|NCT02038777|541863031|FG001|Overall Study|Lost to Follow-up|0|||
150196951|NCT02038777|541863032|FG002|Overall Study|Lost to Follow-up|0|||
150196952|NCT02038777|541863033|FG003|Overall Study|Lost to Follow-up|1|||
150196953|NCT02038777|541863034|FG004|Overall Study|Lost to Follow-up|0|||
150196954|NCT02038777|541863035|FG005|Overall Study|Lost to Follow-up|0|||
150196955|NCT02038777|541863036|FG006|Overall Study|Lost to Follow-up|0|||
150196956|NCT02038777|541863037|FG007|Overall Study|Lost to Follow-up|0|||
150196957|NCT02038777|541863030|FG000|Overall Study|Other|0|||
150196958|NCT02038777|541863031|FG001|Overall Study|Other|1|||
150196959|NCT02038777|541863032|FG002|Overall Study|Other|0|||
150196960|NCT02038777|541863033|FG003|Overall Study|Other|2|||
150196961|NCT02038777|541863034|FG004|Overall Study|Other|1|||
150196962|NCT02038777|541863035|FG005|Overall Study|Other|0|||
150196963|NCT02038777|541863036|FG006|Overall Study|Other|0|||
150196964|NCT02038777|541863037|FG007|Overall Study|Other|0|||
150196965|NCT02038777|541863030|FG000|Overall Study|Randomized but not treated|0|||
150196966|NCT02038777|541863031|FG001|Overall Study|Randomized but not treated|1|||
150196967|NCT02038777|541863032|FG002|Overall Study|Randomized but not treated|0|||
150196968|NCT02038777|541863033|FG003|Overall Study|Randomized but not treated|0|||
150196969|NCT02038777|541863034|FG004|Overall Study|Randomized but not treated|0|||
150196970|NCT02038777|541863035|FG005|Overall Study|Randomized but not treated|0|||
150196971|NCT02038777|541863036|FG006|Overall Study|Randomized but not treated|0|||
150196972|NCT02038777|541863037|FG007|Overall Study|Randomized but not treated|0|||
150196973|NCT02038777|541863030|FG000|Overall Study|Started Chemotherapy|1|||
150196974|NCT02038777|541863031|FG001|Overall Study|Started Chemotherapy|0|||
150196975|NCT02038777|541863032|FG002|Overall Study|Started Chemotherapy|3|||
150196976|NCT02038777|541863033|FG003|Overall Study|Started Chemotherapy|0|||
150132109|NCT00605280|541617758|FG001|Year 1|Withdrawal by Subject|4|||
150132110|NCT00605280|541617759|FG002|Year 1|Withdrawal by Subject|0|||
150132111|NCT00605280|541617760|FG003|Year 1|Withdrawal by Subject|4|||
150132112|NCT00605280|541617757|FG000|Year 1|Other|2|||
150132113|NCT00605280|541617758|FG001|Year 1|Other|1|||
150132114|NCT00605280|541617759|FG002|Year 1|Other|0|||
150132115|NCT00605280|541617760|FG003|Year 1|Other|1|||
150132116|NCT00605280|541617757|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
150132117|NCT00605280|541617758|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
150132118|NCT00605280|541617759|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
150132119|NCT00605280|541617760|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
150132120|NCT00605280|541617757|FG000|Year 2|Adverse Event|4|||
150132121|NCT00605280|541617758|FG001|Year 2|Adverse Event|0|||
150196977|NCT02038777|541863034|FG004|Overall Study|Started Chemotherapy|0|||
150196978|NCT02038777|541863035|FG005|Overall Study|Started Chemotherapy|0|||
150196979|NCT02038777|541863036|FG006|Overall Study|Started Chemotherapy|0|||
150196980|NCT02038777|541863037|FG007|Overall Study|Started Chemotherapy|0|||
150196981|NCT02038777|541863030|FG000|Overall Study|participation terminated by sponsor|0|||
150196982|NCT02038777|541863031|FG001|Overall Study|participation terminated by sponsor|0|||
150196983|NCT02038777|541863032|FG002|Overall Study|participation terminated by sponsor|0|||
150196984|NCT02038777|541863033|FG003|Overall Study|participation terminated by sponsor|0|||
150196985|NCT02038777|541863034|FG004|Overall Study|participation terminated by sponsor|0|||
150196986|NCT02038777|541863035|FG005|Overall Study|participation terminated by sponsor|0|||
150196987|NCT02038777|541863036|FG006|Overall Study|participation terminated by sponsor|1|||
150196988|NCT02038777|541863037|FG007|Overall Study|participation terminated by sponsor|1|||
150196989|NCT04299464|541863038|FG000|Overall Study|Adverse Event|1|||
150196990|NCT04299464|541863039|FG001|Overall Study|Adverse Event|0|||
150196991|NCT04299464|541863040|FG002|Overall Study|Adverse Event|2|||
150196992|NCT04299464|541863038|FG000|Overall Study|Non-compliance with Study Drug|1|||
150196993|NCT04299464|541863039|FG001|Overall Study|Non-compliance with Study Drug|0|||
150196994|NCT04299464|541863040|FG002|Overall Study|Non-compliance with Study Drug|0|||
150196995|NCT04299464|541863038|FG000|Overall Study|Reason not Specified|0|||
150196996|NCT04299464|541863039|FG001|Overall Study|Reason not Specified|1|||
150196997|NCT04299464|541863040|FG002|Overall Study|Reason not Specified|3|||
150196998|NCT04299464|541863038|FG000|Overall Study|Physician Decision|0|||
150196999|NCT04299464|541863039|FG001|Overall Study|Physician Decision|1|||
150197000|NCT04299464|541863040|FG002|Overall Study|Physician Decision|1|||
150197001|NCT04299464|541863038|FG000|Overall Study|Withdrawal by Subject|0|||
150197002|NCT04299464|541863039|FG001|Overall Study|Withdrawal by Subject|2|||
150197003|NCT04299464|541863040|FG002|Overall Study|Withdrawal by Subject|1|||
150197004|NCT04971109|541863050|FG000|Overall Study|Adverse Event|4|||
150197005|NCT04971109|541863051|FG001|Overall Study|Adverse Event|3|||
150197006|NCT04971109|541863050|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
150197007|NCT04971109|541863051|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
150197008|NCT04971109|541863050|FG000|Overall Study|Lost to Follow-up|8|||
150197009|NCT04971109|541863051|FG001|Overall Study|Lost to Follow-up|2|||
150197010|NCT04971109|541863050|FG000|Overall Study|Physician Decision|5|||
150197011|NCT04971109|541863051|FG001|Overall Study|Physician Decision|0|||
150197012|NCT04971109|541863050|FG000|Overall Study|Protocol Violation|0|||
150197013|NCT04971109|541863051|FG001|Overall Study|Protocol Violation|1|||
150197014|NCT04971109|541863050|FG000|Overall Study|Withdrawal by Subject|18|||
150197015|NCT04971109|541863051|FG001|Overall Study|Withdrawal by Subject|3|||
150197016|NCT04971109|541863050|FG000|Overall Study|Subject was randomized in error|1|||
150197017|NCT04971109|541863051|FG001|Overall Study|Subject was randomized in error|0|||
150197018|NCT05123586|541863058|FG000|Overall Study|Physician Decision|1|||
150197019|NCT05123586|541863059|FG001|Overall Study|Physician Decision|1|||
150197020|NCT05123586|541863058|FG000|Overall Study|Withdrawal by Subject|0|||
150197021|NCT05123586|541863059|FG001|Overall Study|Withdrawal by Subject|3|||
150197022|NCT06122194|541863071|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
150197023|NCT06122194|541863072|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
150197024|NCT06122194|541863073|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
150197025|NCT06122194|541863074|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
150197026|NCT04314778|541863075|FG000|Overall Study|Lost to Follow-up|5|||
150197027|NCT04314778|541863076|FG001|Overall Study|Lost to Follow-up|3|||
150197028|NCT05218096|541863077|FG000|Primary Evaluation|Withdrawal by Subject|0|||
150197029|NCT05218096|541863078|FG001|Primary Evaluation|Withdrawal by Subject|0|||
150197030|NCT05218096|541863079|FG002|Primary Evaluation|Withdrawal by Subject|2|||
150197031|NCT05218096|541863080|FG003|Primary Evaluation|Withdrawal by Subject|0|||
150197032|NCT05218096|541863081|FG004|Primary Evaluation|Withdrawal by Subject|0|||
150197033|NCT05218096|541863077|FG000|Primary Evaluation|Physician Decision|1|||
150197034|NCT05218096|541863078|FG001|Primary Evaluation|Physician Decision|0|||
150197035|NCT05218096|541863079|FG002|Primary Evaluation|Physician Decision|0|||
150197036|NCT05218096|541863080|FG003|Primary Evaluation|Physician Decision|0|||
150197037|NCT05218096|541863081|FG004|Primary Evaluation|Physician Decision|0|||
150197038|NCT05218096|541863077|FG000|Extended Treatment|Clinical Deterioration|1|||
150197039|NCT05218096|541863078|FG001|Extended Treatment|Clinical Deterioration|1|||
150197040|NCT05218096|541863079|FG002|Extended Treatment|Clinical Deterioration|0|||
150197041|NCT05218096|541863080|FG003|Extended Treatment|Clinical Deterioration|0|||
150197042|NCT05218096|541863081|FG004|Extended Treatment|Clinical Deterioration|0|||
150197043|NCT05218096|541863077|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
150197044|NCT05218096|541863078|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
150197045|NCT05218096|541863079|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
150197046|NCT05218096|541863080|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
150197047|NCT05218096|541863081|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
150197048|NCT05218096|541863077|FG000|Extended Treatment|Withdrawal by Subject|1|||
150197049|NCT05218096|541863078|FG001|Extended Treatment|Withdrawal by Subject|3|||
150197050|NCT05218096|541863079|FG002|Extended Treatment|Withdrawal by Subject|0|||
150197051|NCT05218096|541863080|FG003|Extended Treatment|Withdrawal by Subject|2|||
150197052|NCT05218096|541863081|FG004|Extended Treatment|Withdrawal by Subject|2|||
150197053|NCT05218096|541863077|FG000|Extended Treatment|Lack of Efficacy|3|||
150197054|NCT05218096|541863078|FG001|Extended Treatment|Lack of Efficacy|0|||
150132122|NCT00605280|541617759|FG002|Year 2|Adverse Event|2|||
150132123|NCT00605280|541617760|FG003|Year 2|Adverse Event|4|||
150132124|NCT00605280|541617757|FG000|Year 2|Physician Decision|11|||
150132125|NCT00605280|541617758|FG001|Year 2|Physician Decision|6|||
150132126|NCT00605280|541617759|FG002|Year 2|Physician Decision|4|||
150132127|NCT00605280|541617760|FG003|Year 2|Physician Decision|11|||
150132128|NCT00605280|541617757|FG000|Year 2|Withdrawal by Subject|4|||
150132129|NCT00605280|541617758|FG001|Year 2|Withdrawal by Subject|0|||
150132130|NCT00605280|541617759|FG002|Year 2|Withdrawal by Subject|0|||
150132131|NCT00605280|541617760|FG003|Year 2|Withdrawal by Subject|4|||
150132132|NCT00605280|541617757|FG000|Year 2|Other|1|||
150132133|NCT00605280|541617758|FG001|Year 2|Other|0|||
150132134|NCT00605280|541617759|FG002|Year 2|Other|0|||
150132135|NCT00605280|541617760|FG003|Year 2|Other|1|||
150132136|NCT00605280|541617757|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
150132137|NCT00605280|541617758|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
150132138|NCT00605280|541617759|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
150132139|NCT00605280|541617760|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
150132140|NCT00605280|541617757|FG000|Year 3 Extension|Adverse Event|2|||
150132141|NCT00605280|541617758|FG001|Year 3 Extension|Adverse Event|0|||
150132142|NCT00605280|541617759|FG002|Year 3 Extension|Adverse Event|0|||
150132143|NCT00605280|541617760|FG003|Year 3 Extension|Adverse Event|2|||
150132144|NCT00605280|541617757|FG000|Year 3 Extension|Physician Decision|0|||
150132145|NCT00605280|541617758|FG001|Year 3 Extension|Physician Decision|0|||
150132146|NCT00605280|541617759|FG002|Year 3 Extension|Physician Decision|0|||
150132147|NCT00605280|541617760|FG003|Year 3 Extension|Physician Decision|2|||
150132148|NCT00605280|541617757|FG000|Year 3 Extension|Withdrawal by Subject|2|||
150132149|NCT00605280|541617758|FG001|Year 3 Extension|Withdrawal by Subject|0|||
150132150|NCT00605280|541617759|FG002|Year 3 Extension|Withdrawal by Subject|0|||
150132151|NCT00605280|541617760|FG003|Year 3 Extension|Withdrawal by Subject|5|||
150132152|NCT00605280|541617757|FG000|Year 3 Extension|Other|2|||
150132153|NCT00605280|541617758|FG001|Year 3 Extension|Other|0|||
150132154|NCT00605280|541617759|FG002|Year 3 Extension|Other|0|||
150132155|NCT00605280|541617760|FG003|Year 3 Extension|Other|0|||
150132156|NCT00605280|541617757|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
150132157|NCT00605280|541617758|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
150132158|NCT00605280|541617759|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
150132159|NCT00605280|541617760|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
150132160|NCT01302119|541617761|FG000|Overall Study|Withdrawal by Subject|30|||
150132161|NCT01302119|541617762|FG001|Overall Study|Withdrawal by Subject|20|||
150132162|NCT01302119|541617761|FG000|Overall Study|Lost to Follow-up|10|||
150132163|NCT01302119|541617762|FG001|Overall Study|Lost to Follow-up|4|||
150132164|NCT01302119|541617761|FG000|Overall Study|Adverse Event|2|||
150132165|NCT01302119|541617762|FG001|Overall Study|Adverse Event|1|||
150132166|NCT01302119|541617761|FG000|Overall Study|Non-compliance|4|||
150132167|NCT01302119|541617762|FG001|Overall Study|Non-compliance|2|||
150132168|NCT01302119|541617761|FG000|Overall Study|Non-specific|4|||
150132169|NCT01302119|541617762|FG001|Overall Study|Non-specific|1|||
150132170|NCT01775904|541617766|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
150132171|NCT01775904|541617766|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
150132172|NCT00518115|541617767|FG000|Overall Study|Adverse Event|6|||
150132173|NCT00518115|541617768|FG001|Overall Study|Adverse Event|1|||
150132174|NCT00518115|541617769|FG002|Overall Study|Adverse Event|5|||
150132175|NCT00518115|541617770|FG003|Overall Study|Adverse Event|6|||
150132176|NCT00518115|541617771|FG004|Overall Study|Adverse Event|5|||
150132177|NCT00518115|541617772|FG005|Overall Study|Adverse Event|5|||
150132178|NCT00518115|541617773|FG006|Overall Study|Adverse Event|5|||
150132179|NCT00518115|541617774|FG007|Overall Study|Adverse Event|10|||
150132180|NCT00518115|541617775|FG008|Overall Study|Adverse Event|2|||
150132181|NCT00518115|541617776|FG009|Overall Study|Adverse Event|9|||
150132182|NCT00518115|541617767|FG000|Overall Study|Lost to Follow-up|0|||
150132183|NCT00518115|541617768|FG001|Overall Study|Lost to Follow-up|0|||
150132184|NCT00518115|541617769|FG002|Overall Study|Lost to Follow-up|2|||
150132185|NCT00518115|541617770|FG003|Overall Study|Lost to Follow-up|3|||
150132186|NCT00518115|541617771|FG004|Overall Study|Lost to Follow-up|1|||
150132187|NCT00518115|541617772|FG005|Overall Study|Lost to Follow-up|3|||
150132188|NCT00518115|541617773|FG006|Overall Study|Lost to Follow-up|0|||
150132189|NCT00518115|541617774|FG007|Overall Study|Lost to Follow-up|1|||
150132190|NCT00518115|541617775|FG008|Overall Study|Lost to Follow-up|1|||
150132191|NCT00518115|541617776|FG009|Overall Study|Lost to Follow-up|1|||
150132192|NCT00518115|541617767|FG000|Overall Study|Protocol Violation|1|||
150132193|NCT00518115|541617768|FG001|Overall Study|Protocol Violation|3|||
150132194|NCT00518115|541617769|FG002|Overall Study|Protocol Violation|1|||
150132195|NCT00518115|541617770|FG003|Overall Study|Protocol Violation|0|||
150132196|NCT00518115|541617771|FG004|Overall Study|Protocol Violation|0|||
150132197|NCT00518115|541617772|FG005|Overall Study|Protocol Violation|0|||
150132198|NCT00518115|541617773|FG006|Overall Study|Protocol Violation|0|||
150132199|NCT00518115|541617774|FG007|Overall Study|Protocol Violation|0|||
150132200|NCT00518115|541617775|FG008|Overall Study|Protocol Violation|0|||
150132201|NCT00518115|541617776|FG009|Overall Study|Protocol Violation|0|||
150132202|NCT00518115|541617767|FG000|Overall Study|Withdrawal by Subject|1|||
150132203|NCT00518115|541617768|FG001|Overall Study|Withdrawal by Subject|1|||
150132204|NCT00518115|541617769|FG002|Overall Study|Withdrawal by Subject|5|||
150132205|NCT00518115|541617770|FG003|Overall Study|Withdrawal by Subject|0|||
150132206|NCT00518115|541617771|FG004|Overall Study|Withdrawal by Subject|2|||
150132207|NCT00518115|541617772|FG005|Overall Study|Withdrawal by Subject|1|||
150132208|NCT00518115|541617773|FG006|Overall Study|Withdrawal by Subject|0|||
150132209|NCT00518115|541617774|FG007|Overall Study|Withdrawal by Subject|2|||
150132210|NCT00518115|541617775|FG008|Overall Study|Withdrawal by Subject|1|||
150132211|NCT00518115|541617776|FG009|Overall Study|Withdrawal by Subject|3|||
150132212|NCT00518115|541617767|FG000|Overall Study|Lack of Efficacy|1|||
150132213|NCT00518115|541617768|FG001|Overall Study|Lack of Efficacy|0|||
150132214|NCT00518115|541617769|FG002|Overall Study|Lack of Efficacy|1|||
150132215|NCT00518115|541617770|FG003|Overall Study|Lack of Efficacy|1|||
150132216|NCT00518115|541617771|FG004|Overall Study|Lack of Efficacy|0|||
150197055|NCT05218096|541863079|FG002|Extended Treatment|Lack of Efficacy|0|||
150197056|NCT05218096|541863080|FG003|Extended Treatment|Lack of Efficacy|0|||
150197057|NCT05218096|541863081|FG004|Extended Treatment|Lack of Efficacy|0|||
150197058|NCT05218096|541863077|FG000|Extended Treatment|Physician Decision|0|||
150197059|NCT05218096|541863078|FG001|Extended Treatment|Physician Decision|1|||
150197060|NCT05218096|541863079|FG002|Extended Treatment|Physician Decision|0|||
150197061|NCT05218096|541863080|FG003|Extended Treatment|Physician Decision|0|||
150197062|NCT05218096|541863081|FG004|Extended Treatment|Physician Decision|0|||
150197063|NCT05218096|541863077|FG000|Open-label Extension|Adverse Event|1|||
150197064|NCT05218096|541863078|FG001|Open-label Extension|Adverse Event|0|||
150197065|NCT05218096|541863079|FG002|Open-label Extension|Adverse Event|0|||
150197066|NCT05218096|541863080|FG003|Open-label Extension|Adverse Event|0|||
150197067|NCT05218096|541863081|FG004|Open-label Extension|Adverse Event|1|||
150197068|NCT05218096|541863077|FG000|Open-label Extension|Pregnancy|0|||
150197069|NCT05218096|541863078|FG001|Open-label Extension|Pregnancy|0|||
150197070|NCT05218096|541863079|FG002|Open-label Extension|Pregnancy|0|||
150197071|NCT05218096|541863080|FG003|Open-label Extension|Pregnancy|0|||
150197072|NCT05218096|541863081|FG004|Open-label Extension|Pregnancy|1|||
150197073|NCT05218096|541863077|FG000|Open-label Extension|Lack of Efficacy|1|||
150197074|NCT05218096|541863078|FG001|Open-label Extension|Lack of Efficacy|2|||
150197075|NCT05218096|541863079|FG002|Open-label Extension|Lack of Efficacy|0|||
150197076|NCT05218096|541863080|FG003|Open-label Extension|Lack of Efficacy|0|||
150197077|NCT05218096|541863081|FG004|Open-label Extension|Lack of Efficacy|0|||
150197078|NCT05218096|541863077|FG000|Open-label Extension|Lost to Follow-up|1|||
150197079|NCT05218096|541863078|FG001|Open-label Extension|Lost to Follow-up|0|||
150197080|NCT05218096|541863079|FG002|Open-label Extension|Lost to Follow-up|0|||
150132217|NCT00518115|541617772|FG005|Overall Study|Lack of Efficacy|0|||
150132218|NCT00518115|541617773|FG006|Overall Study|Lack of Efficacy|0|||
150132219|NCT00518115|541617774|FG007|Overall Study|Lack of Efficacy|1|||
150132220|NCT00518115|541617775|FG008|Overall Study|Lack of Efficacy|0|||
150132221|NCT00518115|541617776|FG009|Overall Study|Lack of Efficacy|0|||
150132222|NCT00518115|541617767|FG000|Overall Study|Non-Compliance|1|||
150132223|NCT00518115|541617768|FG001|Overall Study|Non-Compliance|0|||
150132224|NCT00518115|541617769|FG002|Overall Study|Non-Compliance|1|||
150132225|NCT00518115|541617770|FG003|Overall Study|Non-Compliance|0|||
150132226|NCT00518115|541617771|FG004|Overall Study|Non-Compliance|1|||
150132227|NCT00518115|541617772|FG005|Overall Study|Non-Compliance|1|||
150132228|NCT00518115|541617773|FG006|Overall Study|Non-Compliance|1|||
150132229|NCT00518115|541617774|FG007|Overall Study|Non-Compliance|1|||
150132230|NCT00518115|541617775|FG008|Overall Study|Non-Compliance|0|||
150132231|NCT00518115|541617776|FG009|Overall Study|Non-Compliance|1|||
150132232|NCT00518115|541617767|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
150132233|NCT00518115|541617768|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
150132234|NCT00518115|541617769|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132235|NCT00518115|541617770|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132236|NCT00518115|541617771|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132237|NCT00518115|541617772|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
150132238|NCT00518115|541617773|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132239|NCT00518115|541617774|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132240|NCT00518115|541617775|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132241|NCT00518115|541617776|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
150132242|NCT00518115|541617767|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
150132243|NCT00518115|541617768|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132244|NCT00518115|541617769|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132245|NCT00518115|541617770|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132246|NCT00518115|541617771|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132247|NCT00518115|541617772|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132248|NCT00518115|541617773|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132249|NCT00518115|541617774|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132250|NCT00518115|541617775|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132251|NCT00518115|541617776|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
150132252|NCT00518115|541617767|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132253|NCT00518115|541617768|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132254|NCT00518115|541617769|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
150132255|NCT00518115|541617770|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132256|NCT00518115|541617771|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132257|NCT00518115|541617772|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132258|NCT00518115|541617773|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132259|NCT00518115|541617774|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132260|NCT00518115|541617775|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
150132261|NCT00518115|541617776|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
150132262|NCT00518115|541617767|FG000|Overall Study|Wrong Monotherapy Administered|0|||
150132263|NCT00518115|541617768|FG001|Overall Study|Wrong Monotherapy Administered|0|||
150132264|NCT00518115|541617769|FG002|Overall Study|Wrong Monotherapy Administered|1|||
150132265|NCT00518115|541617770|FG003|Overall Study|Wrong Monotherapy Administered|0|||
150132266|NCT00518115|541617771|FG004|Overall Study|Wrong Monotherapy Administered|0|||
150132267|NCT00518115|541617772|FG005|Overall Study|Wrong Monotherapy Administered|0|||
150132268|NCT00518115|541617773|FG006|Overall Study|Wrong Monotherapy Administered|1|||
150132269|NCT00518115|541617774|FG007|Overall Study|Wrong Monotherapy Administered|0|||
150132270|NCT00518115|541617775|FG008|Overall Study|Wrong Monotherapy Administered|0|||
150132271|NCT00518115|541617776|FG009|Overall Study|Wrong Monotherapy Administered|0|||
150132272|NCT00518115|541617767|FG000|Overall Study|Violation of Exclusion Criteria|0|||
150132273|NCT00518115|541617768|FG001|Overall Study|Violation of Exclusion Criteria|0|||
150132274|NCT00518115|541617769|FG002|Overall Study|Violation of Exclusion Criteria|0|||
150132275|NCT00518115|541617770|FG003|Overall Study|Violation of Exclusion Criteria|1|||
150132276|NCT00518115|541617771|FG004|Overall Study|Violation of Exclusion Criteria|0|||
150132277|NCT00518115|541617772|FG005|Overall Study|Violation of Exclusion Criteria|0|||
150132278|NCT00518115|541617773|FG006|Overall Study|Violation of Exclusion Criteria|1|||
150132279|NCT00518115|541617774|FG007|Overall Study|Violation of Exclusion Criteria|0|||
150132280|NCT00518115|541617775|FG008|Overall Study|Violation of Exclusion Criteria|0|||
150132281|NCT00518115|541617776|FG009|Overall Study|Violation of Exclusion Criteria|0|||
150132282|NCT00518115|541617767|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
150132283|NCT00518115|541617768|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
150132284|NCT00518115|541617769|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
150132285|NCT00518115|541617770|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
150132286|NCT00518115|541617771|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
150132287|NCT00518115|541617772|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
150132288|NCT00518115|541617773|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
150132289|NCT00518115|541617774|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
150132290|NCT00518115|541617775|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
150132291|NCT00518115|541617776|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
150132292|NCT00518115|541617767|FG000|Overall Study|Withdrew Consent|0|||
150132293|NCT00518115|541617768|FG001|Overall Study|Withdrew Consent|0|||
150197081|NCT05218096|541863080|FG003|Open-label Extension|Lost to Follow-up|0|||
150197082|NCT05218096|541863081|FG004|Open-label Extension|Lost to Follow-up|0|||
150197083|NCT05218096|541863077|FG000|Open-label Extension|Death|0|||
150197084|NCT05218096|541863078|FG001|Open-label Extension|Death|0|||
150197085|NCT05218096|541863079|FG002|Open-label Extension|Death|0|||
150197086|NCT05218096|541863080|FG003|Open-label Extension|Death|1|||
150197087|NCT05218096|541863081|FG004|Open-label Extension|Death|0|||
150197088|NCT05218096|541863077|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
150197089|NCT05218096|541863078|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
150197090|NCT05218096|541863079|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
150197091|NCT05218096|541863080|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
150197092|NCT05218096|541863081|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
150197093|NCT03571581|541863082|FG000|Overall Study|Death|2|||
150197094|NCT03571581|541863082|FG000|Overall Study|Withdrawal by Subject|2|||
150197095|NCT01309672|541863083|FG000|Overall Study|Lack of Efficacy|20|||
150197096|NCT01309672|541863083|FG000|Overall Study|Other|9|||
150197097|NCT01309672|541863083|FG000|Overall Study|Adverse Event|5|||
150197098|NCT01309672|541863083|FG000|Overall Study|Withdrawal by Subject|3|||
150197099|NCT04141891|541863085|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
150197100|NCT04141891|541863086|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
150197101|NCT04141891|541863085|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
150197102|NCT04141891|541863086|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
150197103|NCT04141891|541863085|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
150197104|NCT04141891|541863086|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
150197105|NCT04141891|541863085|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
150197106|NCT04141891|541863086|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
150197107|NCT04141891|541863085|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
150197108|NCT04141891|541863086|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
150197109|NCT04141891|541863085|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
150197110|NCT04141891|541863086|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
150197111|NCT04141891|541863085|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
150197112|NCT04141891|541863086|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
150197113|NCT04141891|541863085|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
150197114|NCT04141891|541863086|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
150197115|NCT04141891|541863085|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
150197116|NCT04141891|541863086|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
150197117|NCT04141891|541863085|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
150197118|NCT04141891|541863086|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
150197119|NCT04141891|541863085|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
150197120|NCT04141891|541863086|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
150197121|NCT04141891|541863085|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
150197122|NCT04141891|541863086|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
150197123|NCT04141891|541863085|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
150197124|NCT04141891|541863086|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
150197125|NCT04141891|541863085|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
150197126|NCT04141891|541863086|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
150197127|NCT03295721|541863091|FG000|Overall Study|Adverse Event|1|||
150197128|NCT03295721|541863092|FG001|Overall Study|Adverse Event|0|||
150197129|NCT03295721|541863093|FG002|Overall Study|Adverse Event|0|||
150197130|NCT03295721|541863091|FG000|Overall Study|Lost to Follow-up|1|||
150197131|NCT03295721|541863092|FG001|Overall Study|Lost to Follow-up|1|||
150197132|NCT03295721|541863093|FG002|Overall Study|Lost to Follow-up|1|||
150197133|NCT03295721|541863091|FG000|Overall Study|Withdrawal by Subject|1|||
150197134|NCT03295721|541863092|FG001|Overall Study|Withdrawal by Subject|0|||
150197135|NCT03295721|541863093|FG002|Overall Study|Withdrawal by Subject|1|||
150197136|NCT03295721|541863091|FG000|Overall Study|Death|0|||
150197137|NCT03295721|541863092|FG001|Overall Study|Death|0|||
150197138|NCT03295721|541863093|FG002|Overall Study|Death|1|||
150197139|NCT01651403|541863094|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
150197140|NCT01651403|541863095|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
150197141|NCT01651403|541863094|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
150197142|NCT01651403|541863095|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
150197143|NCT01651403|541863094|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
150197144|NCT01651403|541863095|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
150197145|NCT01651403|541863094|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
150197146|NCT01651403|541863095|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
150197147|NCT01651403|541863094|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
150197148|NCT01651403|541863095|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
150197149|NCT01651403|541863094|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
150197150|NCT01651403|541863095|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
150197151|NCT05090683|541863096|FG000|Overall Study|Lost to Follow-up|10|||
150197152|NCT05090683|541863097|FG001|Overall Study|Lost to Follow-up|2|||
150197153|NCT05090683|541863096|FG000|Overall Study|Withdrawal by Subject|15|||
150197154|NCT05090683|541863097|FG001|Overall Study|Withdrawal by Subject|0|||
150197155|NCT04032847|541863098|FG000|Overall Study|Study termination by sponsor|8|||
150197156|NCT04032847|541863099|FG001|Overall Study|Study termination by sponsor|0|||
150197157|NCT04032847|541863100|FG002|Overall Study|Study termination by sponsor|4|||
150197158|NCT04032847|541863098|FG000|Overall Study|Death|12|||
150197159|NCT04032847|541863099|FG001|Overall Study|Death|0|||
150197160|NCT04032847|541863100|FG002|Overall Study|Death|0|||
150197161|NCT04032847|541863098|FG000|Overall Study|Progressive disease|2|||
150197162|NCT04032847|541863099|FG001|Overall Study|Progressive disease|0|||
150197163|NCT04032847|541863100|FG002|Overall Study|Progressive disease|1|||
150197164|NCT03213665|541863101|FG000|Overall Study|Adverse Event|1|||
150197165|NCT03213665|541863101|FG000|Overall Study|Physician Decision|2|||
150197166|NCT03213665|541863101|FG000|Overall Study|Withdrawal by Subject|3|||
150197167|NCT03213665|541863101|FG000|Overall Study|Progressive Disease|13|||
150197168|NCT03325985|541863102|FG000|Overall Study|Lost to Follow-up|122|||
150197169|NCT03325985|541863103|FG001|Overall Study|Lost to Follow-up|26|||
150197170|NCT03325985|541863104|FG002|Overall Study|Lost to Follow-up|141|||
150197171|NCT03325985|541863105|FG003|Overall Study|Lost to Follow-up|28|||
150197172|NCT03325985|541863102|FG000|Overall Study|Death|99|||
150197173|NCT03325985|541863103|FG001|Overall Study|Death|36|||
150197174|NCT03325985|541863104|FG002|Overall Study|Death|94|||
150197175|NCT03325985|541863105|FG003|Overall Study|Death|32|||
150197176|NCT03034356|541863106|FG000|Baseline|Lost to Follow-up|2|||
150197177|NCT03034356|541863107|FG001|Baseline|Lost to Follow-up|4|||
150197178|NCT03034356|541863106|FG000|Baseline|Withdrawal by Subject|2|||
150197179|NCT03034356|541863107|FG001|Baseline|Withdrawal by Subject|0|||
150197180|NCT03034356|541863106|FG000|Baseline|Physician Decision|0|||
150197181|NCT03034356|541863107|FG001|Baseline|Physician Decision|1|||
150197182|NCT03034356|541863106|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
150197183|NCT03034356|541863107|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
150197184|NCT03034356|541863106|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
150197185|NCT03034356|541863107|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
150197186|NCT03034356|541863106|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
150197187|NCT03034356|541863107|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
150197188|NCT03034356|541863106|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
150197189|NCT03034356|541863107|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
150197190|NCT02684227|541863108|FG000|Overall Study|Adverse Event|1|||
150197191|NCT02684227|541863109|FG001|Overall Study|Adverse Event|7|||
150197192|NCT02684227|541863108|FG000|Overall Study|Death|0|||
150197193|NCT02684227|541863109|FG001|Overall Study|Death|2|||
150197194|NCT02684227|541863108|FG000|Overall Study|Withdrawal by Subject|0|||
150197195|NCT02684227|541863109|FG001|Overall Study|Withdrawal by Subject|1|||
150197196|NCT02684227|541863108|FG000|Overall Study|Progressive Disease|0|||
150197197|NCT02684227|541863109|FG001|Overall Study|Progressive Disease|2|||
150197198|NCT05104463|541863110|FG000|Overall Study|Adverse Event|1|||
150197199|NCT05104463|541863111|FG001|Overall Study|Adverse Event|1|||
150197200|NCT05104463|541863110|FG000|Overall Study|Lost to Follow-up|1|||
150197201|NCT05104463|541863111|FG001|Overall Study|Lost to Follow-up|1|||
150197202|NCT05104463|541863110|FG000|Overall Study|Physician Decision|1|||
150197203|NCT05104463|541863111|FG001|Overall Study|Physician Decision|0|||
150197204|NCT05104463|541863110|FG000|Overall Study|Protocol Violation|0|||
150197205|NCT05104463|541863111|FG001|Overall Study|Protocol Violation|2|||
150197206|NCT05104463|541863110|FG000|Overall Study|Withdrawal by Subject|1|||
150197207|NCT05104463|541863111|FG001|Overall Study|Withdrawal by Subject|1|||
150197208|NCT05267470|541863112|FG000|Overall Study|Decision by sponsor|0|||
150197209|NCT05267470|541863113|FG001|Overall Study|Decision by sponsor|3|||
150197210|NCT05267470|541863114|FG002|Overall Study|Decision by sponsor|19|||
150197211|NCT05267470|541863115|FG003|Overall Study|Decision by sponsor|7|||
150197212|NCT05267470|541863116|FG004|Overall Study|Decision by sponsor|3|||
150197213|NCT05267470|541863112|FG000|Overall Study|Withdrawal by Subject|1|||
150197214|NCT05267470|541863113|FG001|Overall Study|Withdrawal by Subject|1|||
150197215|NCT05267470|541863114|FG002|Overall Study|Withdrawal by Subject|2|||
150197216|NCT05267470|541863115|FG003|Overall Study|Withdrawal by Subject|2|||
150197217|NCT05267470|541863116|FG004|Overall Study|Withdrawal by Subject|0|||
150197218|NCT05267470|541863112|FG000|Overall Study|Death|3|||
150197219|NCT05267470|541863113|FG001|Overall Study|Death|5|||
150197220|NCT05267470|541863114|FG002|Overall Study|Death|8|||
150197221|NCT05267470|541863115|FG003|Overall Study|Death|18|||
150197222|NCT05267470|541863116|FG004|Overall Study|Death|1|||
150197223|NCT05267470|541863112|FG000|Overall Study|Lost to Follow-up|0|||
150197224|NCT05267470|541863113|FG001|Overall Study|Lost to Follow-up|0|||
150197225|NCT05267470|541863114|FG002|Overall Study|Lost to Follow-up|0|||
150197226|NCT05267470|541863115|FG003|Overall Study|Lost to Follow-up|1|||
150197227|NCT05267470|541863116|FG004|Overall Study|Lost to Follow-up|0|||
150197228|NCT04428203|541863119|FG000|Overall Study|Adverse Event|1|||
150197229|NCT04428203|541863120|FG001|Overall Study|Adverse Event|0|||
150197230|NCT04428203|541863121|FG002|Overall Study|Adverse Event|0|||
150197231|NCT04428203|541863119|FG000|Overall Study|Withdrawal by Subject|1|||
150197232|NCT04428203|541863120|FG001|Overall Study|Withdrawal by Subject|0|||
150197233|NCT04428203|541863121|FG002|Overall Study|Withdrawal by Subject|1|||
150197234|NCT04086121|541863132|FG000|Overall Study|Other than listed|8|||
150197235|NCT04086121|541863132|FG000|Overall Study|Withdrawal by Subject|3|||
150197236|NCT04086121|541863132|FG000|Overall Study|Lost to Follow-up|2|||
150197237|NCT04086121|541863132|FG000|Overall Study|Adverse Event|1|||
150197238|NCT04857723|541863133|FG000|Overall Study|Withdrawal by Subject|2|||
150197239|NCT02844465|541864677|FG000|Overall Study|Screen Failure|36|||
150197240|NCT02844465|541864677|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
150197241|NCT02844465|541864677|FG000|Overall Study|Withdrawal by Subject|5|||
150197242|NCT02844465|541864677|FG000|Overall Study|Lost to Follow-up|1|||
150197243|NCT02844465|541864677|FG000|Overall Study|Retreatment|1|||
150197244|NCT05029622|541864681|FG000|Overall Study|Lost to Follow-up|1|||
150197245|NCT05671653|541864682|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
150197246|NCT05671653|541864683|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
150197247|NCT05671653|541864684|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
150197248|NCT05671653|541864685|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
150197249|NCT05671653|541864686|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
150197250|NCT05671653|541864687|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
150197251|NCT05671653|541864688|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
150197252|NCT05671653|541864689|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
150197253|NCT05671653|541864690|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
150197254|NCT05671653|541864691|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
150197255|NCT05671653|541864692|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
150197256|NCT05671653|541864693|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
150197257|NCT05671653|541864694|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
150197258|NCT05671653|541864682|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197259|NCT05671653|541864683|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197260|NCT05671653|541864684|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197261|NCT05671653|541864685|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197262|NCT05671653|541864686|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197263|NCT05671653|541864687|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
150197264|NCT05671653|541864688|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197265|NCT05671653|541864689|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197266|NCT05671653|541864690|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197267|NCT05671653|541864691|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197268|NCT05671653|541864692|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197269|NCT05671653|541864693|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150132294|NCT00518115|541617769|FG002|Overall Study|Withdrew Consent|0|||
150132295|NCT00518115|541617770|FG003|Overall Study|Withdrew Consent|0|||
150132296|NCT00518115|541617771|FG004|Overall Study|Withdrew Consent|0|||
150132297|NCT00518115|541617772|FG005|Overall Study|Withdrew Consent|1|||
150132298|NCT00518115|541617773|FG006|Overall Study|Withdrew Consent|0|||
150132299|NCT00518115|541617774|FG007|Overall Study|Withdrew Consent|0|||
150132300|NCT00518115|541617775|FG008|Overall Study|Withdrew Consent|0|||
150132301|NCT00518115|541617776|FG009|Overall Study|Withdrew Consent|0|||
150132302|NCT00518115|541617767|FG000|Overall Study|Moved Out of State|0|||
150132303|NCT00518115|541617768|FG001|Overall Study|Moved Out of State|0|||
150132304|NCT00518115|541617769|FG002|Overall Study|Moved Out of State|0|||
150132305|NCT00518115|541617770|FG003|Overall Study|Moved Out of State|0|||
150132306|NCT00518115|541617771|FG004|Overall Study|Moved Out of State|0|||
150132307|NCT00518115|541617772|FG005|Overall Study|Moved Out of State|0|||
150132308|NCT00518115|541617773|FG006|Overall Study|Moved Out of State|0|||
150197270|NCT05671653|541864694|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
150197271|NCT05671653|541864682|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197272|NCT05671653|541864683|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197273|NCT05671653|541864684|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150132309|NCT00518115|541617774|FG007|Overall Study|Moved Out of State|0|||
150132310|NCT00518115|541617775|FG008|Overall Study|Moved Out of State|0|||
150132311|NCT00518115|541617776|FG009|Overall Study|Moved Out of State|1|||
150132312|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
150132313|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
150132314|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
150132315|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
150132316|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
150132317|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
150132318|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
150132319|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
150132320|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
150132321|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
150132322|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
150132323|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
150132324|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
150132325|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
150132326|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
150132327|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
150132328|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
150132329|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
150132330|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
150132331|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
150132332|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
150132333|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
150132334|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
150132335|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
150132336|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
150132337|NCT01662310|541617780|FG000|Run-In or Stabilization Phase|Other|1|||
150132338|NCT01662310|541617781|FG001|Run-In or Stabilization Phase|Other|0|||
150132339|NCT01662310|541617782|FG002|Run-In or Stabilization Phase|Other|0|||
150132340|NCT01662310|541617783|FG003|Run-In or Stabilization Phase|Other|0|||
150132341|NCT01662310|541617784|FG004|Run-In or Stabilization Phase|Other|0|||
150132342|NCT01662310|541617780|FG000|Double-Blind Phase|Adverse Event|0|||
150132343|NCT01662310|541617781|FG001|Double-Blind Phase|Adverse Event|0|||
150132344|NCT01662310|541617782|FG002|Double-Blind Phase|Adverse Event|1|||
150132345|NCT01662310|541617783|FG003|Double-Blind Phase|Adverse Event|0|||
150132346|NCT01662310|541617784|FG004|Double-Blind Phase|Adverse Event|0|||
150132347|NCT01662310|541617780|FG000|Double-Blind Phase|Lost to Follow-up|0|||
150132348|NCT01662310|541617781|FG001|Double-Blind Phase|Lost to Follow-up|3|||
150132349|NCT01662310|541617782|FG002|Double-Blind Phase|Lost to Follow-up|0|||
150132350|NCT01662310|541617783|FG003|Double-Blind Phase|Lost to Follow-up|0|||
150132351|NCT01662310|541617784|FG004|Double-Blind Phase|Lost to Follow-up|0|||
150132352|NCT01662310|541617780|FG000|Double-Blind Phase|Pregnancy|0|||
150132353|NCT01662310|541617781|FG001|Double-Blind Phase|Pregnancy|2|||
150132354|NCT01662310|541617782|FG002|Double-Blind Phase|Pregnancy|0|||
150132355|NCT01662310|541617783|FG003|Double-Blind Phase|Pregnancy|0|||
150132356|NCT01662310|541617784|FG004|Double-Blind Phase|Pregnancy|0|||
150132357|NCT01662310|541617780|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
150132358|NCT01662310|541617781|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
150132359|NCT01662310|541617782|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
150132360|NCT01662310|541617783|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
150132361|NCT01662310|541617784|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
150132362|NCT01662310|541617780|FG000|Double-Blind Phase|Other|0|||
150132363|NCT01662310|541617781|FG001|Double-Blind Phase|Other|0|||
150132364|NCT01662310|541617782|FG002|Double-Blind Phase|Other|1|||
150132365|NCT01662310|541617783|FG003|Double-Blind Phase|Other|0|||
150132366|NCT01662310|541617784|FG004|Double-Blind Phase|Other|0|||
150132367|NCT01662310|541617780|FG000|Double-Blind Phase|Randomized but not treated|0|||
150132368|NCT01662310|541617781|FG001|Double-Blind Phase|Randomized but not treated|1|||
150132369|NCT01662310|541617782|FG002|Double-Blind Phase|Randomized but not treated|0|||
150132370|NCT01662310|541617783|FG003|Double-Blind Phase|Randomized but not treated|0|||
150132371|NCT01662310|541617784|FG004|Double-Blind Phase|Randomized but not treated|0|||
150132372|NCT01662310|541617780|FG000|Open-Label Extension Phase|Adverse Event|0|||
150132373|NCT01662310|541617781|FG001|Open-Label Extension Phase|Adverse Event|0|||
150132374|NCT01662310|541617782|FG002|Open-Label Extension Phase|Adverse Event|0|||
150132375|NCT01662310|541617783|FG003|Open-Label Extension Phase|Adverse Event|3|||
150132376|NCT01662310|541617784|FG004|Open-Label Extension Phase|Adverse Event|0|||
150132377|NCT01662310|541617780|FG000|Open-Label Extension Phase|Death|0|||
150132378|NCT01662310|541617781|FG001|Open-Label Extension Phase|Death|0|||
150197274|NCT05671653|541864685|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197275|NCT05671653|541864686|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150132379|NCT01662310|541617782|FG002|Open-Label Extension Phase|Death|0|||
150132380|NCT01662310|541617783|FG003|Open-Label Extension Phase|Death|1|||
150132381|NCT01662310|541617784|FG004|Open-Label Extension Phase|Death|0|||
150132382|NCT01662310|541617780|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
150132383|NCT01662310|541617781|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
150197276|NCT05671653|541864687|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
150197277|NCT05671653|541864688|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197278|NCT05671653|541864689|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197279|NCT05671653|541864690|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197280|NCT05671653|541864691|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197281|NCT05671653|541864692|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197282|NCT05671653|541864693|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197283|NCT05671653|541864694|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
150197284|NCT05671653|541864682|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197285|NCT05671653|541864683|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197286|NCT05671653|541864684|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197287|NCT05671653|541864685|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197288|NCT05671653|541864686|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197289|NCT05671653|541864687|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197290|NCT05671653|541864688|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197291|NCT05671653|541864689|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197292|NCT05671653|541864690|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
150197293|NCT05671653|541864691|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197294|NCT05671653|541864692|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197295|NCT05671653|541864693|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197296|NCT05671653|541864694|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
150197297|NCT05671653|541864682|FG000|Cohort 2 Period 2|Adverse Event|0|||
150197298|NCT05671653|541864683|FG001|Cohort 2 Period 2|Adverse Event|0|||
150197299|NCT05671653|541864684|FG002|Cohort 2 Period 2|Adverse Event|0|||
150197300|NCT05671653|541864685|FG003|Cohort 2 Period 2|Adverse Event|0|||
150197301|NCT05671653|541864686|FG004|Cohort 2 Period 2|Adverse Event|0|||
150197302|NCT05671653|541864687|FG005|Cohort 2 Period 2|Adverse Event|0|||
150197303|NCT05671653|541864688|FG006|Cohort 2 Period 2|Adverse Event|0|||
150197304|NCT05671653|541864689|FG007|Cohort 2 Period 2|Adverse Event|0|||
150197305|NCT05671653|541864690|FG008|Cohort 2 Period 2|Adverse Event|0|||
150197306|NCT05671653|541864691|FG009|Cohort 2 Period 2|Adverse Event|0|||
150197307|NCT05671653|541864692|FG010|Cohort 2 Period 2|Adverse Event|1|||
150197308|NCT05671653|541864693|FG011|Cohort 2 Period 2|Adverse Event|0|||
150197309|NCT05671653|541864694|FG012|Cohort 2 Period 2|Adverse Event|0|||
150197310|NCT05671653|541864682|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
150197311|NCT05671653|541864683|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
150197312|NCT05671653|541864684|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
150197313|NCT05671653|541864685|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
150197314|NCT05671653|541864686|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
150197315|NCT05671653|541864687|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
150197316|NCT05671653|541864688|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
150197317|NCT05671653|541864689|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
150197318|NCT05671653|541864690|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
150197319|NCT05671653|541864691|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
150197320|NCT05671653|541864692|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
150197321|NCT05671653|541864693|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
150197322|NCT05671653|541864694|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
150197323|NCT05671653|541864682|FG000|Cohort 2 Period 2|Pregnancy|0|||
150197324|NCT05671653|541864683|FG001|Cohort 2 Period 2|Pregnancy|0|||
150197325|NCT05671653|541864684|FG002|Cohort 2 Period 2|Pregnancy|0|||
150197326|NCT05671653|541864685|FG003|Cohort 2 Period 2|Pregnancy|0|||
150197327|NCT05671653|541864686|FG004|Cohort 2 Period 2|Pregnancy|0|||
150197328|NCT05671653|541864687|FG005|Cohort 2 Period 2|Pregnancy|0|||
150197329|NCT05671653|541864688|FG006|Cohort 2 Period 2|Pregnancy|0|||
150197330|NCT05671653|541864689|FG007|Cohort 2 Period 2|Pregnancy|0|||
150197331|NCT05671653|541864690|FG008|Cohort 2 Period 2|Pregnancy|0|||
150197332|NCT05671653|541864691|FG009|Cohort 2 Period 2|Pregnancy|0|||
150197333|NCT05671653|541864692|FG010|Cohort 2 Period 2|Pregnancy|1|||
150197334|NCT05671653|541864693|FG011|Cohort 2 Period 2|Pregnancy|0|||
150197335|NCT05671653|541864694|FG012|Cohort 2 Period 2|Pregnancy|0|||
150197336|NCT05671653|541864682|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197337|NCT05671653|541864683|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197338|NCT05671653|541864684|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197339|NCT05671653|541864685|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197340|NCT05671653|541864686|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197341|NCT05671653|541864687|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197342|NCT05671653|541864688|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197343|NCT05671653|541864689|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197344|NCT05671653|541864690|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197345|NCT05671653|541864691|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197346|NCT05671653|541864692|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
150197347|NCT05671653|541864693|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197348|NCT05671653|541864694|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
150197349|NCT05671653|541864682|FG000|Cohort 2 Period 2|Other|0|||
150197350|NCT05671653|541864683|FG001|Cohort 2 Period 2|Other|0|||
150197351|NCT05671653|541864684|FG002|Cohort 2 Period 2|Other|0|||
150197352|NCT05671653|541864685|FG003|Cohort 2 Period 2|Other|0|||
150197353|NCT05671653|541864686|FG004|Cohort 2 Period 2|Other|0|||
150197354|NCT05671653|541864687|FG005|Cohort 2 Period 2|Other|0|||
150197355|NCT05671653|541864688|FG006|Cohort 2 Period 2|Other|0|||
150197356|NCT05671653|541864689|FG007|Cohort 2 Period 2|Other|0|||
150197357|NCT05671653|541864690|FG008|Cohort 2 Period 2|Other|0|||
150197358|NCT05671653|541864691|FG009|Cohort 2 Period 2|Other|0|||
150197359|NCT05671653|541864692|FG010|Cohort 2 Period 2|Other|1|||
150197360|NCT05671653|541864693|FG011|Cohort 2 Period 2|Other|0|||
150197361|NCT05671653|541864694|FG012|Cohort 2 Period 2|Other|0|||
150197362|NCT05671653|541864682|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197363|NCT05671653|541864683|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197364|NCT05671653|541864684|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197365|NCT05671653|541864685|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197366|NCT05671653|541864686|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197367|NCT05671653|541864687|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197368|NCT05671653|541864688|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197369|NCT05671653|541864689|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197370|NCT05671653|541864690|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197371|NCT05671653|541864691|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197372|NCT05671653|541864692|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197373|NCT05671653|541864693|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
150197374|NCT05671653|541864694|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
150197375|NCT01197378|541864698|FG000|Overall Study|Adverse Event|3|||
150197376|NCT01197378|541864698|FG000|Overall Study|Withdrawal by Subject|1|||
150197377|NCT01197378|541864698|FG000|Overall Study|Physician Decision|1|||
150197378|NCT01197378|541864698|FG000|Overall Study|Other|2|||
150197379|NCT02460458|541864702|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
150197380|NCT02460458|541864702|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
150197381|NCT02460458|541864702|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
150197382|NCT02460458|541864702|FG000|First Prospective Phase|Lost to Follow-up|84|||
150197383|NCT02460458|541864702|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
150197384|NCT00696111|541864703|FG000|Overall Study|Withdrawal by Subject|17|||
150197385|NCT05299073|541864704|FG000|Overall Study|Withdrawal by Subject|0|||
150197386|NCT05299073|541864705|FG001|Overall Study|Withdrawal by Subject|0|||
150197387|NCT05299073|541864706|FG002|Overall Study|Withdrawal by Subject|1|||
150197388|NCT05299073|541864704|FG000|Overall Study|Adverse Event|0|||
150197389|NCT05299073|541864705|FG001|Overall Study|Adverse Event|1|||
150197390|NCT05299073|541864706|FG002|Overall Study|Adverse Event|0|||
150197391|NCT05299073|541864704|FG000|Overall Study|Lost to Follow-up|0|||
150197392|NCT05299073|541864705|FG001|Overall Study|Lost to Follow-up|1|||
150197393|NCT05299073|541864706|FG002|Overall Study|Lost to Follow-up|0|||
150197394|NCT04850898|541864707|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
150197395|NCT04850898|541864708|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
150197396|NCT04550221|541864709|FG000|Overall Study|Lost to Follow-up|0|||
150197397|NCT04550221|541864710|FG001|Overall Study|Lost to Follow-up|4|||
150197398|NCT04550221|541864709|FG000|Overall Study|Withdrawn|3|||
150197399|NCT04550221|541864710|FG001|Overall Study|Withdrawn|0|||
150197400|NCT04550221|541864709|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
150197401|NCT04550221|541864710|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
150197402|NCT02593773|541864718|FG000|Overall Study|Voluntary Withdrawal|3|||
150197403|NCT02593773|541864718|FG000|Overall Study|Study Terminated by Sponsor|31|||
150197404|NCT02593773|541864718|FG000|Overall Study|Death|1|||
150197405|NCT04447040|541864720|FG000|Overall Study|Lost to Follow-up|2|||
150197406|NCT04447040|541864721|FG001|Overall Study|Lost to Follow-up|1|||
150197407|NCT04447040|541864722|FG002|Overall Study|Lost to Follow-up|3|||
150197408|NCT04447040|541864723|FG003|Overall Study|Lost to Follow-up|3|||
150197409|NCT04447040|541864724|FG004|Overall Study|Lost to Follow-up|1|||
150197410|NCT04447040|541864725|FG005|Overall Study|Lost to Follow-up|3|||
150197411|NCT04447040|541864720|FG000|Overall Study|Withdrawal by Subject|0|||
150197412|NCT04447040|541864721|FG001|Overall Study|Withdrawal by Subject|1|||
150197413|NCT04447040|541864722|FG002|Overall Study|Withdrawal by Subject|1|||
150197414|NCT04447040|541864723|FG003|Overall Study|Withdrawal by Subject|1|||
150197415|NCT04447040|541864724|FG004|Overall Study|Withdrawal by Subject|0|||
150197416|NCT04447040|541864725|FG005|Overall Study|Withdrawal by Subject|0|||
150197417|NCT01208662|541864726|FG000|Induction and Consolidation|Disease Progression|23|||
150197418|NCT01208662|541864727|FG001|Induction and Consolidation|Disease Progression|13|||
150197419|NCT01208662|541864728|FG002|Induction and Consolidation|Disease Progression|0|||
150197420|NCT01208662|541864726|FG000|Induction and Consolidation|Adverse Event|16|||
150197421|NCT01208662|541864727|FG001|Induction and Consolidation|Adverse Event|18|||
150197422|NCT01208662|541864728|FG002|Induction and Consolidation|Adverse Event|2|||
150197423|NCT01208662|541864726|FG000|Induction and Consolidation|MD or Participant Decision|16|||
150197424|NCT01208662|541864727|FG001|Induction and Consolidation|MD or Participant Decision|34|||
150197425|NCT01208662|541864728|FG002|Induction and Consolidation|MD or Participant Decision|4|||
150197426|NCT01208662|541864726|FG000|Induction and Consolidation|Death|1|||
150197427|NCT01208662|541864727|FG001|Induction and Consolidation|Death|3|||
150197428|NCT01208662|541864728|FG002|Induction and Consolidation|Death|1|||
150197429|NCT01208662|541864726|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
150132384|NCT01662310|541617782|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
150132385|NCT01662310|541617783|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
150132386|NCT01662310|541617784|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
150132387|NCT01662310|541617780|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
150132388|NCT01662310|541617781|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
150132389|NCT01662310|541617782|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
150132390|NCT01662310|541617783|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
150132391|NCT01662310|541617784|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
150132392|NCT01662310|541617780|FG000|Open-Label Extension Phase|Pregnancy|0|||
150132393|NCT01662310|541617781|FG001|Open-Label Extension Phase|Pregnancy|0|||
150197430|NCT01208662|541864727|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
150197431|NCT01208662|541864728|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
150197432|NCT01208662|541864726|FG000|Maintenance|Disease Progression|156|||
150197433|NCT01208662|541864727|FG001|Maintenance|Disease Progression|102|||
150197434|NCT01208662|541864728|FG002|Maintenance|Disease Progression|0|||
150197435|NCT01208662|541864726|FG000|Maintenance|Adverse Event|12|||
150197436|NCT01208662|541864727|FG001|Maintenance|Adverse Event|28|||
150197437|NCT01208662|541864728|FG002|Maintenance|Adverse Event|0|||
150197438|NCT01208662|541864726|FG000|Maintenance|MD or Participant Decision|24|||
150197439|NCT01208662|541864727|FG001|Maintenance|MD or Participant Decision|36|||
150197440|NCT01208662|541864728|FG002|Maintenance|MD or Participant Decision|0|||
150197441|NCT01208662|541864726|FG000|Maintenance|Death|0|||
150197442|NCT01208662|541864727|FG001|Maintenance|Death|3|||
150197443|NCT01208662|541864728|FG002|Maintenance|Death|0|||
150197444|NCT01208662|541864726|FG000|Maintenance|Discontinued for other reasons|21|||
150197445|NCT01208662|541864727|FG001|Maintenance|Discontinued for other reasons|31|||
150197446|NCT01208662|541864728|FG002|Maintenance|Discontinued for other reasons|0|||
150197447|NCT01208662|541864726|FG000|Maintenance|Still on Treatment|78|||
150197448|NCT01208662|541864727|FG001|Maintenance|Still on Treatment|89|||
150197449|NCT01208662|541864728|FG002|Maintenance|Still on Treatment|0|||
150197450|NCT04076618|541864729|FG000|Overall Study|Lost to Follow-up|2|||
150197451|NCT04076618|541864730|FG001|Overall Study|Lost to Follow-up|1|||
150197452|NCT04076618|541864731|FG002|Overall Study|Lost to Follow-up|3|||
150197453|NCT04076618|541864729|FG000|Overall Study|Withdrawal by Subject|3|||
150197454|NCT04076618|541864730|FG001|Overall Study|Withdrawal by Subject|1|||
150197455|NCT04076618|541864731|FG002|Overall Study|Withdrawal by Subject|2|||
150197456|NCT04076618|541864729|FG000|Overall Study|Relocated out of state|0|||
150197457|NCT04076618|541864730|FG001|Overall Study|Relocated out of state|2|||
150197458|NCT04076618|541864731|FG002|Overall Study|Relocated out of state|0|||
150197459|NCT04076618|541864729|FG000|Overall Study|COVID concerns|0|||
150197460|NCT04076618|541864730|FG001|Overall Study|COVID concerns|1|||
150197461|NCT04076618|541864731|FG002|Overall Study|COVID concerns|0|||
150197462|NCT04076618|541864729|FG000|Overall Study|Adverse Event|0|||
150197463|NCT04076618|541864730|FG001|Overall Study|Adverse Event|0|||
150197464|NCT04076618|541864731|FG002|Overall Study|Adverse Event|2|||
150197465|NCT01928394|541864732|FG000|Treatment Period|Disease progression|17|||
150197466|NCT01928394|541864733|FG001|Treatment Period|Disease progression|2|||
150197467|NCT01928394|541864734|FG002|Treatment Period|Disease progression|12|||
150132394|NCT01662310|541617782|FG002|Open-Label Extension Phase|Pregnancy|0|||
150132395|NCT01662310|541617783|FG003|Open-Label Extension Phase|Pregnancy|1|||
150132396|NCT01662310|541617784|FG004|Open-Label Extension Phase|Pregnancy|0|||
150132397|NCT01662310|541617780|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
150132398|NCT01662310|541617781|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
150132399|NCT01662310|541617782|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
150132400|NCT01662310|541617783|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
150132401|NCT01662310|541617784|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
150132402|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
150132403|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
150132404|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
150132405|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132406|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132407|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132408|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132409|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132410|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
150132411|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
150132412|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
150132413|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
150132414|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132415|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132416|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132417|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132418|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132419|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
150132420|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
150132421|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
150132422|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
150132423|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132424|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132425|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132426|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132427|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132428|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
150132429|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
150132430|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132431|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
150132432|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132433|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132434|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132435|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132436|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132437|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
150132438|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132439|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132440|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
150132441|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132442|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132443|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132444|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132445|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132446|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
150132447|NCT01212770|541617785|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
150132448|NCT01212770|541617786|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
150132449|NCT01212770|541617787|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
150132450|NCT01212770|541617788|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132451|NCT01212770|541617789|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132452|NCT01212770|541617790|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132453|NCT01212770|541617791|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132454|NCT01212770|541617792|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132455|NCT01212770|541617793|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
150132456|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
150132457|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
150197468|NCT01928394|541864735|FG003|Treatment Period|Disease progression|48|||
150197469|NCT01928394|541864736|FG004|Treatment Period|Disease progression|3|||
150132458|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
150132459|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
150132460|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
150132461|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
150132462|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
150132463|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
150132464|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
150132465|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
150132466|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
150132467|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
150132468|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
150132469|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
150132470|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
150132471|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
150132472|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
150132473|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
150132474|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
150132475|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
150132476|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
150132477|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
150132478|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
150132479|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
150132480|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
150132481|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
150132482|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
150132483|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132484|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132485|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
150132486|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132487|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132488|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132489|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132490|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132491|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
150132492|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132493|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132494|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132495|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
150132496|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132497|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132498|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132499|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132500|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
150132501|NCT01212770|541617785|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132502|NCT01212770|541617786|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132503|NCT01212770|541617787|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
150132504|NCT01212770|541617788|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
150132505|NCT01212770|541617789|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132506|NCT01212770|541617790|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132507|NCT01212770|541617791|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132508|NCT01212770|541617792|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132509|NCT01212770|541617793|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
150132510|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132511|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
150132512|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
150132513|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132514|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132515|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132516|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132517|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
150132518|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
150197470|NCT01928394|541864737|FG005|Treatment Period|Disease progression|25|||
150197471|NCT01928394|541864738|FG006|Treatment Period|Disease progression|38|||
150197472|NCT01928394|541864739|FG007|Treatment Period|Disease progression|16|||
150197473|NCT01928394|541864740|FG008|Treatment Period|Disease progression|3|||
150197474|NCT01928394|541864741|FG009|Treatment Period|Disease progression|11|||
150197475|NCT01928394|541864742|FG010|Treatment Period|Disease progression|22|||
150197476|NCT01928394|541864743|FG011|Treatment Period|Disease progression|73|||
150197477|NCT01928394|541864744|FG012|Treatment Period|Disease progression|38|||
150197478|NCT01928394|541864745|FG013|Treatment Period|Disease progression|118|||
150197479|NCT01928394|541864746|FG014|Treatment Period|Disease progression|59|||
150197480|NCT01928394|541864747|FG015|Treatment Period|Disease progression|1|||
150197481|NCT01928394|541864748|FG016|Treatment Period|Disease progression|43|||
150197482|NCT01928394|541864749|FG017|Treatment Period|Disease progression|56|||
150197483|NCT01928394|541864750|FG018|Treatment Period|Disease progression|50|||
150197484|NCT01928394|541864751|FG019|Treatment Period|Disease progression|71|||
150197485|NCT01928394|541864752|FG020|Treatment Period|Disease progression|30|||
150197486|NCT01928394|541864753|FG021|Treatment Period|Disease progression|31|||
150197487|NCT01928394|541864754|FG022|Treatment Period|Disease progression|31|||
150197488|NCT01928394|541864732|FG000|Treatment Period|Study drug toxicity|1|||
150197489|NCT01928394|541864733|FG001|Treatment Period|Study drug toxicity|1|||
150197490|NCT01928394|541864734|FG002|Treatment Period|Study drug toxicity|3|||
150132519|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
150132520|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
150132521|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
150132522|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
150132523|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
150132524|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
150132525|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
150132526|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
150132527|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
150132528|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132529|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
150132530|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132531|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132532|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132533|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132534|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132535|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132536|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
150132537|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150132538|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
150132539|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
150132540|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150132541|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150132542|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150132543|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
150132544|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
150132545|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
150132546|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
150132547|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
150132548|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
150132549|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
150132550|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
150132551|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
150132552|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
150132553|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
150132554|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
150132555|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132556|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
150132557|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
150132558|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132559|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132560|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132561|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132562|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150132563|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
150132564|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
150197491|NCT01928394|541864735|FG003|Treatment Period|Study drug toxicity|3|||
150197492|NCT01928394|541864736|FG004|Treatment Period|Study drug toxicity|0|||
150197493|NCT01928394|541864737|FG005|Treatment Period|Study drug toxicity|9|||
150197494|NCT01928394|541864738|FG006|Treatment Period|Study drug toxicity|7|||
150197495|NCT01928394|541864739|FG007|Treatment Period|Study drug toxicity|1|||
150197496|NCT01928394|541864740|FG008|Treatment Period|Study drug toxicity|0|||
150197497|NCT01928394|541864741|FG009|Treatment Period|Study drug toxicity|5|||
150197498|NCT01928394|541864742|FG010|Treatment Period|Study drug toxicity|2|||
150197499|NCT01928394|541864743|FG011|Treatment Period|Study drug toxicity|3|||
150197500|NCT01928394|541864744|FG012|Treatment Period|Study drug toxicity|7|||
150197501|NCT01928394|541864745|FG013|Treatment Period|Study drug toxicity|5|||
150197502|NCT01928394|541864746|FG014|Treatment Period|Study drug toxicity|12|||
150197503|NCT01928394|541864747|FG015|Treatment Period|Study drug toxicity|0|||
150197504|NCT01928394|541864748|FG016|Treatment Period|Study drug toxicity|3|||
150197505|NCT01928394|541864749|FG017|Treatment Period|Study drug toxicity|3|||
150197506|NCT01928394|541864750|FG018|Treatment Period|Study drug toxicity|12|||
150197507|NCT01928394|541864751|FG019|Treatment Period|Study drug toxicity|15|||
150197508|NCT01928394|541864752|FG020|Treatment Period|Study drug toxicity|4|||
150197509|NCT01928394|541864753|FG021|Treatment Period|Study drug toxicity|7|||
150132565|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
150132566|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
150132567|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
150132568|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
150132569|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
150132570|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
150132571|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
150132572|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
150132573|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
150132574|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
150132575|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
150132576|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
150132577|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
150132578|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
150132579|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
150132580|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
150132581|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
150132582|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150132583|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
150132584|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
150132585|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150132586|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150132587|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150132588|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
150132589|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
150132590|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
150132591|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150197510|NCT01928394|541864754|FG022|Treatment Period|Study drug toxicity|4|||
150197511|NCT01928394|541864732|FG000|Treatment Period|AE unrelated to study drug|0|||
150197512|NCT01928394|541864733|FG001|Treatment Period|AE unrelated to study drug|0|||
150197513|NCT01928394|541864734|FG002|Treatment Period|AE unrelated to study drug|2|||
150197514|NCT01928394|541864735|FG003|Treatment Period|AE unrelated to study drug|3|||
150197515|NCT01928394|541864736|FG004|Treatment Period|AE unrelated to study drug|0|||
150197516|NCT01928394|541864737|FG005|Treatment Period|AE unrelated to study drug|5|||
150197517|NCT01928394|541864738|FG006|Treatment Period|AE unrelated to study drug|1|||
150197518|NCT01928394|541864739|FG007|Treatment Period|AE unrelated to study drug|0|||
150197519|NCT01928394|541864740|FG008|Treatment Period|AE unrelated to study drug|0|||
150197520|NCT01928394|541864741|FG009|Treatment Period|AE unrelated to study drug|2|||
150197521|NCT01928394|541864742|FG010|Treatment Period|AE unrelated to study drug|0|||
150197522|NCT01928394|541864743|FG011|Treatment Period|AE unrelated to study drug|12|||
150197523|NCT01928394|541864744|FG012|Treatment Period|AE unrelated to study drug|6|||
150197524|NCT01928394|541864745|FG013|Treatment Period|AE unrelated to study drug|13|||
150197525|NCT01928394|541864746|FG014|Treatment Period|AE unrelated to study drug|6|||
150197526|NCT01928394|541864747|FG015|Treatment Period|AE unrelated to study drug|1|||
150197527|NCT01928394|541864748|FG016|Treatment Period|AE unrelated to study drug|1|||
150197528|NCT01928394|541864749|FG017|Treatment Period|AE unrelated to study drug|6|||
150197529|NCT01928394|541864750|FG018|Treatment Period|AE unrelated to study drug|3|||
150197530|NCT01928394|541864751|FG019|Treatment Period|AE unrelated to study drug|5|||
150197531|NCT01928394|541864752|FG020|Treatment Period|AE unrelated to study drug|1|||
150132592|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
150132593|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132594|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132595|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132596|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132597|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132598|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132599|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
150132600|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132601|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132602|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132603|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132604|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132605|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132606|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132607|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
150132608|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
150132609|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
150132610|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
150132611|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
150132612|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
150132613|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
150132614|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
150132615|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
150132616|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
150132617|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
150132618|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132619|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
150132620|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
150132621|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132622|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132623|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132624|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132625|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
150132626|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
150132627|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132628|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
150132629|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
150132630|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132631|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132632|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132633|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132634|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
150132635|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
150132636|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132637|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
150132638|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
150132639|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132640|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132641|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132642|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132643|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
150132644|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
150132645|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132646|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
150132647|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
150132648|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132649|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132650|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132651|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132652|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132653|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
150132654|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132655|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132656|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
150197532|NCT01928394|541864753|FG021|Treatment Period|AE unrelated to study drug|1|||
150197533|NCT01928394|541864754|FG022|Treatment Period|AE unrelated to study drug|0|||
150197534|NCT01928394|541864732|FG000|Treatment Period|Participant request to stop therapy|0|||
150197535|NCT01928394|541864733|FG001|Treatment Period|Participant request to stop therapy|0|||
150197536|NCT01928394|541864734|FG002|Treatment Period|Participant request to stop therapy|0|||
150197537|NCT01928394|541864735|FG003|Treatment Period|Participant request to stop therapy|0|||
150197538|NCT01928394|541864736|FG004|Treatment Period|Participant request to stop therapy|0|||
150197539|NCT01928394|541864737|FG005|Treatment Period|Participant request to stop therapy|3|||
150197540|NCT01928394|541864738|FG006|Treatment Period|Participant request to stop therapy|3|||
150197541|NCT01928394|541864739|FG007|Treatment Period|Participant request to stop therapy|0|||
150197542|NCT01928394|541864740|FG008|Treatment Period|Participant request to stop therapy|0|||
150197543|NCT01928394|541864741|FG009|Treatment Period|Participant request to stop therapy|0|||
150197544|NCT01928394|541864742|FG010|Treatment Period|Participant request to stop therapy|3|||
150197545|NCT01928394|541864743|FG011|Treatment Period|Participant request to stop therapy|2|||
150197546|NCT01928394|541864744|FG012|Treatment Period|Participant request to stop therapy|1|||
150197547|NCT01928394|541864745|FG013|Treatment Period|Participant request to stop therapy|2|||
150197548|NCT01928394|541864746|FG014|Treatment Period|Participant request to stop therapy|4|||
150197549|NCT01928394|541864747|FG015|Treatment Period|Participant request to stop therapy|0|||
150197550|NCT01928394|541864748|FG016|Treatment Period|Participant request to stop therapy|1|||
150197551|NCT01928394|541864749|FG017|Treatment Period|Participant request to stop therapy|3|||
150197552|NCT01928394|541864750|FG018|Treatment Period|Participant request to stop therapy|1|||
150197553|NCT01928394|541864751|FG019|Treatment Period|Participant request to stop therapy|1|||
150197554|NCT01928394|541864752|FG020|Treatment Period|Participant request to stop therapy|3|||
150197555|NCT01928394|541864753|FG021|Treatment Period|Participant request to stop therapy|1|||
150197556|NCT01928394|541864754|FG022|Treatment Period|Participant request to stop therapy|3|||
150197557|NCT01928394|541864732|FG000|Treatment Period|Participant withdrew consent|0|||
150197558|NCT01928394|541864733|FG001|Treatment Period|Participant withdrew consent|0|||
150197559|NCT01928394|541864734|FG002|Treatment Period|Participant withdrew consent|1|||
150197560|NCT01928394|541864735|FG003|Treatment Period|Participant withdrew consent|1|||
150197561|NCT01928394|541864736|FG004|Treatment Period|Participant withdrew consent|0|||
150197562|NCT01928394|541864737|FG005|Treatment Period|Participant withdrew consent|1|||
150197563|NCT01928394|541864738|FG006|Treatment Period|Participant withdrew consent|0|||
150197564|NCT01928394|541864739|FG007|Treatment Period|Participant withdrew consent|1|||
150197565|NCT01928394|541864740|FG008|Treatment Period|Participant withdrew consent|0|||
150197566|NCT01928394|541864741|FG009|Treatment Period|Participant withdrew consent|0|||
150197567|NCT01928394|541864742|FG010|Treatment Period|Participant withdrew consent|1|||
150197568|NCT01928394|541864743|FG011|Treatment Period|Participant withdrew consent|1|||
150197569|NCT01928394|541864744|FG012|Treatment Period|Participant withdrew consent|1|||
150197570|NCT01928394|541864745|FG013|Treatment Period|Participant withdrew consent|0|||
150197571|NCT01928394|541864746|FG014|Treatment Period|Participant withdrew consent|2|||
150197572|NCT01928394|541864747|FG015|Treatment Period|Participant withdrew consent|0|||
150197573|NCT01928394|541864748|FG016|Treatment Period|Participant withdrew consent|2|||
150197574|NCT01928394|541864749|FG017|Treatment Period|Participant withdrew consent|1|||
150197575|NCT01928394|541864750|FG018|Treatment Period|Participant withdrew consent|1|||
150197576|NCT01928394|541864751|FG019|Treatment Period|Participant withdrew consent|1|||
150197577|NCT01928394|541864752|FG020|Treatment Period|Participant withdrew consent|0|||
150197578|NCT01928394|541864753|FG021|Treatment Period|Participant withdrew consent|2|||
150197579|NCT01928394|541864754|FG022|Treatment Period|Participant withdrew consent|0|||
150197580|NCT01928394|541864732|FG000|Treatment Period|Poor/non-compliance|0|||
150197581|NCT01928394|541864733|FG001|Treatment Period|Poor/non-compliance|0|||
150197582|NCT01928394|541864734|FG002|Treatment Period|Poor/non-compliance|0|||
150197583|NCT01928394|541864735|FG003|Treatment Period|Poor/non-compliance|1|||
150197584|NCT01928394|541864736|FG004|Treatment Period|Poor/non-compliance|0|||
150197585|NCT01928394|541864737|FG005|Treatment Period|Poor/non-compliance|0|||
150197586|NCT01928394|541864738|FG006|Treatment Period|Poor/non-compliance|0|||
150197587|NCT01928394|541864739|FG007|Treatment Period|Poor/non-compliance|0|||
150197588|NCT01928394|541864740|FG008|Treatment Period|Poor/non-compliance|0|||
150197589|NCT01928394|541864741|FG009|Treatment Period|Poor/non-compliance|0|||
150197590|NCT01928394|541864742|FG010|Treatment Period|Poor/non-compliance|0|||
150197591|NCT01928394|541864743|FG011|Treatment Period|Poor/non-compliance|0|||
150197592|NCT01928394|541864744|FG012|Treatment Period|Poor/non-compliance|1|||
150197593|NCT01928394|541864745|FG013|Treatment Period|Poor/non-compliance|0|||
150197594|NCT01928394|541864746|FG014|Treatment Period|Poor/non-compliance|1|||
150197595|NCT01928394|541864747|FG015|Treatment Period|Poor/non-compliance|0|||
150197596|NCT01928394|541864748|FG016|Treatment Period|Poor/non-compliance|0|||
150197597|NCT01928394|541864749|FG017|Treatment Period|Poor/non-compliance|1|||
150197598|NCT01928394|541864750|FG018|Treatment Period|Poor/non-compliance|0|||
150197599|NCT01928394|541864751|FG019|Treatment Period|Poor/non-compliance|1|||
150197600|NCT01928394|541864752|FG020|Treatment Period|Poor/non-compliance|0|||
150197601|NCT01928394|541864753|FG021|Treatment Period|Poor/non-compliance|0|||
150197602|NCT01928394|541864754|FG022|Treatment Period|Poor/non-compliance|0|||
150197603|NCT01928394|541864732|FG000|Treatment Period|other reason|0|||
150197604|NCT01928394|541864733|FG001|Treatment Period|other reason|0|||
150197605|NCT01928394|541864734|FG002|Treatment Period|other reason|0|||
150197606|NCT01928394|541864735|FG003|Treatment Period|other reason|0|||
150197607|NCT01928394|541864736|FG004|Treatment Period|other reason|0|||
150197608|NCT01928394|541864737|FG005|Treatment Period|other reason|0|||
150197609|NCT01928394|541864738|FG006|Treatment Period|other reason|0|||
150197610|NCT01928394|541864739|FG007|Treatment Period|other reason|0|||
150197611|NCT01928394|541864740|FG008|Treatment Period|other reason|0|||
150197612|NCT01928394|541864741|FG009|Treatment Period|other reason|0|||
150197613|NCT01928394|541864742|FG010|Treatment Period|other reason|1|||
150197614|NCT01928394|541864743|FG011|Treatment Period|other reason|1|||
150197615|NCT01928394|541864744|FG012|Treatment Period|other reason|1|||
150197616|NCT01928394|541864745|FG013|Treatment Period|other reason|0|||
150197617|NCT01928394|541864746|FG014|Treatment Period|other reason|1|||
150197618|NCT01928394|541864747|FG015|Treatment Period|other reason|0|||
150197619|NCT01928394|541864748|FG016|Treatment Period|other reason|0|||
150197620|NCT01928394|541864749|FG017|Treatment Period|other reason|0|||
150197621|NCT01928394|541864750|FG018|Treatment Period|other reason|2|||
150197622|NCT01928394|541864751|FG019|Treatment Period|other reason|2|||
150197623|NCT01928394|541864752|FG020|Treatment Period|other reason|0|||
150197624|NCT01928394|541864753|FG021|Treatment Period|other reason|0|||
150197625|NCT01928394|541864754|FG022|Treatment Period|other reason|0|||
150197626|NCT01928394|541864732|FG000|Treatment Period|Maximum clinical benefit|0|||
150197627|NCT01928394|541864733|FG001|Treatment Period|Maximum clinical benefit|0|||
150197628|NCT01928394|541864734|FG002|Treatment Period|Maximum clinical benefit|0|||
150197629|NCT01928394|541864735|FG003|Treatment Period|Maximum clinical benefit|0|||
150197630|NCT01928394|541864736|FG004|Treatment Period|Maximum clinical benefit|0|||
150197631|NCT01928394|541864737|FG005|Treatment Period|Maximum clinical benefit|0|||
150197632|NCT01928394|541864738|FG006|Treatment Period|Maximum clinical benefit|0|||
150197633|NCT01928394|541864739|FG007|Treatment Period|Maximum clinical benefit|0|||
150197634|NCT01928394|541864740|FG008|Treatment Period|Maximum clinical benefit|0|||
150197635|NCT01928394|541864741|FG009|Treatment Period|Maximum clinical benefit|0|||
150197636|NCT01928394|541864742|FG010|Treatment Period|Maximum clinical benefit|1|||
150197637|NCT01928394|541864743|FG011|Treatment Period|Maximum clinical benefit|1|||
150197638|NCT01928394|541864744|FG012|Treatment Period|Maximum clinical benefit|0|||
150197639|NCT01928394|541864745|FG013|Treatment Period|Maximum clinical benefit|0|||
150197640|NCT01928394|541864746|FG014|Treatment Period|Maximum clinical benefit|1|||
150197641|NCT01928394|541864747|FG015|Treatment Period|Maximum clinical benefit|0|||
150197642|NCT01928394|541864748|FG016|Treatment Period|Maximum clinical benefit|0|||
150197643|NCT01928394|541864749|FG017|Treatment Period|Maximum clinical benefit|1|||
150197644|NCT01928394|541864750|FG018|Treatment Period|Maximum clinical benefit|1|||
150197645|NCT01928394|541864751|FG019|Treatment Period|Maximum clinical benefit|0|||
150197646|NCT01928394|541864752|FG020|Treatment Period|Maximum clinical benefit|2|||
150197647|NCT01928394|541864753|FG021|Treatment Period|Maximum clinical benefit|0|||
150197648|NCT01928394|541864754|FG022|Treatment Period|Maximum clinical benefit|0|||
150197649|NCT01928394|541864732|FG000|Treatment Period|Lost to Follow-up|0|||
150197650|NCT01928394|541864733|FG001|Treatment Period|Lost to Follow-up|0|||
150197651|NCT01928394|541864734|FG002|Treatment Period|Lost to Follow-up|0|||
150197652|NCT01928394|541864735|FG003|Treatment Period|Lost to Follow-up|0|||
150197653|NCT01928394|541864736|FG004|Treatment Period|Lost to Follow-up|0|||
150197654|NCT01928394|541864737|FG005|Treatment Period|Lost to Follow-up|0|||
150197655|NCT01928394|541864738|FG006|Treatment Period|Lost to Follow-up|0|||
150197656|NCT01928394|541864739|FG007|Treatment Period|Lost to Follow-up|0|||
150197657|NCT01928394|541864740|FG008|Treatment Period|Lost to Follow-up|0|||
150197658|NCT01928394|541864741|FG009|Treatment Period|Lost to Follow-up|0|||
150197659|NCT01928394|541864742|FG010|Treatment Period|Lost to Follow-up|0|||
150197660|NCT01928394|541864743|FG011|Treatment Period|Lost to Follow-up|0|||
150197661|NCT01928394|541864744|FG012|Treatment Period|Lost to Follow-up|0|||
150197662|NCT01928394|541864745|FG013|Treatment Period|Lost to Follow-up|0|||
150197663|NCT01928394|541864746|FG014|Treatment Period|Lost to Follow-up|0|||
150197664|NCT01928394|541864747|FG015|Treatment Period|Lost to Follow-up|0|||
150197665|NCT01928394|541864748|FG016|Treatment Period|Lost to Follow-up|0|||
150197666|NCT01928394|541864749|FG017|Treatment Period|Lost to Follow-up|0|||
150197667|NCT01928394|541864750|FG018|Treatment Period|Lost to Follow-up|0|||
150197668|NCT01928394|541864751|FG019|Treatment Period|Lost to Follow-up|0|||
150197669|NCT01928394|541864752|FG020|Treatment Period|Lost to Follow-up|0|||
150197670|NCT01928394|541864753|FG021|Treatment Period|Lost to Follow-up|0|||
150197671|NCT01928394|541864754|FG022|Treatment Period|Lost to Follow-up|1|||
150197672|NCT01928394|541864732|FG000|Treatment Period|Death|0|||
150197673|NCT01928394|541864733|FG001|Treatment Period|Death|0|||
150197674|NCT01928394|541864734|FG002|Treatment Period|Death|0|||
150197675|NCT01928394|541864735|FG003|Treatment Period|Death|0|||
150197676|NCT01928394|541864736|FG004|Treatment Period|Death|0|||
150197677|NCT01928394|541864737|FG005|Treatment Period|Death|0|||
150197678|NCT01928394|541864738|FG006|Treatment Period|Death|0|||
150197679|NCT01928394|541864739|FG007|Treatment Period|Death|0|||
150197680|NCT01928394|541864740|FG008|Treatment Period|Death|0|||
150197681|NCT01928394|541864741|FG009|Treatment Period|Death|0|||
150197682|NCT01928394|541864742|FG010|Treatment Period|Death|0|||
150197683|NCT01928394|541864743|FG011|Treatment Period|Death|0|||
150197684|NCT01928394|541864744|FG012|Treatment Period|Death|0|||
150197685|NCT01928394|541864745|FG013|Treatment Period|Death|1|||
150197686|NCT01928394|541864746|FG014|Treatment Period|Death|2|||
150197687|NCT01928394|541864747|FG015|Treatment Period|Death|0|||
150197688|NCT01928394|541864748|FG016|Treatment Period|Death|0|||
150197689|NCT01928394|541864749|FG017|Treatment Period|Death|0|||
150132657|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132658|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132659|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132660|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132661|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132662|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
150132663|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132664|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
150132665|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132666|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132667|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132668|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132669|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132670|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
150132671|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
150132672|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
150197690|NCT01928394|541864750|FG018|Treatment Period|Death|0|||
150197691|NCT01928394|541864751|FG019|Treatment Period|Death|0|||
150197692|NCT01928394|541864752|FG020|Treatment Period|Death|0|||
150132673|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
150197693|NCT01928394|541864753|FG021|Treatment Period|Death|0|||
150197694|NCT01928394|541864754|FG022|Treatment Period|Death|0|||
150197695|NCT01928394|541864732|FG000|Follow-up Period|Participant withdrew consent|3|||
150197696|NCT01928394|541864733|FG001|Follow-up Period|Participant withdrew consent|0|||
150197697|NCT01928394|541864734|FG002|Follow-up Period|Participant withdrew consent|1|||
150197698|NCT01928394|541864735|FG003|Follow-up Period|Participant withdrew consent|4|||
150197699|NCT01928394|541864736|FG004|Follow-up Period|Participant withdrew consent|0|||
150197700|NCT01928394|541864737|FG005|Follow-up Period|Participant withdrew consent|2|||
150197701|NCT01928394|541864738|FG006|Follow-up Period|Participant withdrew consent|5|||
150197702|NCT01928394|541864739|FG007|Follow-up Period|Participant withdrew consent|1|||
150197703|NCT01928394|541864740|FG008|Follow-up Period|Participant withdrew consent|0|||
150197704|NCT01928394|541864741|FG009|Follow-up Period|Participant withdrew consent|0|||
150197705|NCT01928394|541864742|FG010|Follow-up Period|Participant withdrew consent|5|||
150197706|NCT01928394|541864743|FG011|Follow-up Period|Participant withdrew consent|8|||
150197707|NCT01928394|541864744|FG012|Follow-up Period|Participant withdrew consent|2|||
150197708|NCT01928394|541864745|FG013|Follow-up Period|Participant withdrew consent|12|||
150197709|NCT01928394|541864746|FG014|Follow-up Period|Participant withdrew consent|7|||
150197710|NCT01928394|541864747|FG015|Follow-up Period|Participant withdrew consent|0|||
150197711|NCT01928394|541864748|FG016|Follow-up Period|Participant withdrew consent|5|||
150197712|NCT01928394|541864749|FG017|Follow-up Period|Participant withdrew consent|3|||
150197713|NCT01928394|541864750|FG018|Follow-up Period|Participant withdrew consent|2|||
150197714|NCT01928394|541864751|FG019|Follow-up Period|Participant withdrew consent|7|||
150197715|NCT01928394|541864752|FG020|Follow-up Period|Participant withdrew consent|4|||
150197716|NCT01928394|541864753|FG021|Follow-up Period|Participant withdrew consent|6|||
150197717|NCT01928394|541864754|FG022|Follow-up Period|Participant withdrew consent|2|||
150197718|NCT01928394|541864732|FG000|Follow-up Period|Death|0|||
150197719|NCT01928394|541864733|FG001|Follow-up Period|Death|0|||
150197720|NCT01928394|541864734|FG002|Follow-up Period|Death|2|||
150197721|NCT01928394|541864735|FG003|Follow-up Period|Death|6|||
150197722|NCT01928394|541864736|FG004|Follow-up Period|Death|0|||
150197723|NCT01928394|541864737|FG005|Follow-up Period|Death|6|||
150197724|NCT01928394|541864738|FG006|Follow-up Period|Death|6|||
150197725|NCT01928394|541864739|FG007|Follow-up Period|Death|2|||
150197726|NCT01928394|541864740|FG008|Follow-up Period|Death|1|||
150197727|NCT01928394|541864741|FG009|Follow-up Period|Death|2|||
150197728|NCT01928394|541864742|FG010|Follow-up Period|Death|4|||
150197729|NCT01928394|541864743|FG011|Follow-up Period|Death|12|||
150197730|NCT01928394|541864744|FG012|Follow-up Period|Death|11|||
150197731|NCT01928394|541864745|FG013|Follow-up Period|Death|25|||
150197732|NCT01928394|541864746|FG014|Follow-up Period|Death|18|||
150197733|NCT01928394|541864747|FG015|Follow-up Period|Death|0|||
150197734|NCT01928394|541864748|FG016|Follow-up Period|Death|6|||
150197735|NCT01928394|541864749|FG017|Follow-up Period|Death|5|||
150197736|NCT01928394|541864750|FG018|Follow-up Period|Death|13|||
150197737|NCT01928394|541864751|FG019|Follow-up Period|Death|13|||
150197738|NCT01928394|541864752|FG020|Follow-up Period|Death|5|||
150197739|NCT01928394|541864753|FG021|Follow-up Period|Death|3|||
150197740|NCT01928394|541864754|FG022|Follow-up Period|Death|2|||
150197741|NCT01928394|541864732|FG000|Follow-up Period|other reason|0|||
150197742|NCT01928394|541864733|FG001|Follow-up Period|other reason|0|||
150197743|NCT01928394|541864734|FG002|Follow-up Period|other reason|0|||
150197744|NCT01928394|541864735|FG003|Follow-up Period|other reason|0|||
150197745|NCT01928394|541864736|FG004|Follow-up Period|other reason|0|||
150197746|NCT01928394|541864737|FG005|Follow-up Period|other reason|0|||
150197747|NCT01928394|541864738|FG006|Follow-up Period|other reason|1|||
150197748|NCT01928394|541864739|FG007|Follow-up Period|other reason|3|||
150197749|NCT01928394|541864740|FG008|Follow-up Period|other reason|0|||
150197750|NCT01928394|541864741|FG009|Follow-up Period|other reason|0|||
150197751|NCT01928394|541864742|FG010|Follow-up Period|other reason|2|||
150197752|NCT01928394|541864743|FG011|Follow-up Period|other reason|1|||
150197753|NCT01928394|541864744|FG012|Follow-up Period|other reason|0|||
150197754|NCT01928394|541864745|FG013|Follow-up Period|other reason|1|||
150197755|NCT01928394|541864746|FG014|Follow-up Period|other reason|4|||
150197756|NCT01928394|541864747|FG015|Follow-up Period|other reason|0|||
150197757|NCT01928394|541864748|FG016|Follow-up Period|other reason|2|||
150197758|NCT01928394|541864749|FG017|Follow-up Period|other reason|0|||
150197759|NCT01928394|541864750|FG018|Follow-up Period|other reason|1|||
150197760|NCT01928394|541864751|FG019|Follow-up Period|other reason|1|||
150197761|NCT01928394|541864752|FG020|Follow-up Period|other reason|0|||
150197762|NCT01928394|541864753|FG021|Follow-up Period|other reason|0|||
150197763|NCT01928394|541864754|FG022|Follow-up Period|other reason|1|||
150197764|NCT01928394|541864732|FG000|Follow-up Period|Lost to Follow-up|0|||
150197765|NCT01928394|541864733|FG001|Follow-up Period|Lost to Follow-up|0|||
150197766|NCT01928394|541864734|FG002|Follow-up Period|Lost to Follow-up|0|||
150197767|NCT01928394|541864735|FG003|Follow-up Period|Lost to Follow-up|0|||
150197768|NCT01928394|541864736|FG004|Follow-up Period|Lost to Follow-up|0|||
150197769|NCT01928394|541864737|FG005|Follow-up Period|Lost to Follow-up|0|||
150197770|NCT01928394|541864738|FG006|Follow-up Period|Lost to Follow-up|0|||
150197771|NCT01928394|541864739|FG007|Follow-up Period|Lost to Follow-up|0|||
150197772|NCT01928394|541864740|FG008|Follow-up Period|Lost to Follow-up|0|||
150197773|NCT01928394|541864741|FG009|Follow-up Period|Lost to Follow-up|0|||
150197774|NCT01928394|541864742|FG010|Follow-up Period|Lost to Follow-up|0|||
150197775|NCT01928394|541864743|FG011|Follow-up Period|Lost to Follow-up|1|||
150197776|NCT01928394|541864744|FG012|Follow-up Period|Lost to Follow-up|1|||
150197777|NCT01928394|541864745|FG013|Follow-up Period|Lost to Follow-up|0|||
150197778|NCT01928394|541864746|FG014|Follow-up Period|Lost to Follow-up|1|||
150197779|NCT01928394|541864747|FG015|Follow-up Period|Lost to Follow-up|0|||
150197780|NCT01928394|541864748|FG016|Follow-up Period|Lost to Follow-up|1|||
150197781|NCT01928394|541864749|FG017|Follow-up Period|Lost to Follow-up|0|||
150197782|NCT01928394|541864750|FG018|Follow-up Period|Lost to Follow-up|0|||
150197783|NCT01928394|541864751|FG019|Follow-up Period|Lost to Follow-up|0|||
150197784|NCT01928394|541864752|FG020|Follow-up Period|Lost to Follow-up|0|||
150197785|NCT01928394|541864753|FG021|Follow-up Period|Lost to Follow-up|0|||
150197786|NCT01928394|541864754|FG022|Follow-up Period|Lost to Follow-up|1|||
150197787|NCT03209973|541864755|FG000|Overall Study|Withdrawal by Subject|7|||
150197788|NCT03209973|541864755|FG000|Overall Study|Lost to Follow-up|2|||
150197789|NCT03209973|541864755|FG000|Overall Study|Death|8|||
150197790|NCT03209973|541864755|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
150197791|NCT03209973|541864755|FG000|Overall Study|Sponsor Decision|18|||
150197792|NCT03209973|541864755|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
150197793|NCT03209973|541864755|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
150197794|NCT04066205|541864756|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
150197795|NCT04066205|541864757|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
150197796|NCT04066205|541864756|FG000|T2 Immediate Post-Intervention|did not respond|5|||
150197797|NCT04066205|541864757|FG001|T2 Immediate Post-Intervention|did not respond|3|||
150197798|NCT03249090|541864761|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
150197799|NCT03249090|541864762|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
150197800|NCT03249090|541864761|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
150197801|NCT03249090|541864762|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
150197802|NCT03249090|541864761|FG000|3 Month Time Point|Voluntary withdrawal|6|||
150197803|NCT03249090|541864762|FG001|3 Month Time Point|Voluntary withdrawal|3|||
150197804|NCT03249090|541864761|FG000|3 Month Time Point|Changed oncology practice|4|||
150197805|NCT03249090|541864762|FG001|3 Month Time Point|Changed oncology practice|2|||
150197806|NCT03249090|541864761|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
150197807|NCT03249090|541864762|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
150197808|NCT03249090|541864761|FG000|12 Month Time Point|Voluntary withdrawal|35|||
150197809|NCT03249090|541864762|FG001|12 Month Time Point|Voluntary withdrawal|4|||
150197810|NCT03249090|541864761|FG000|12 Month Time Point|Changed oncology practice|20|||
150197811|NCT03249090|541864762|FG001|12 Month Time Point|Changed oncology practice|9|||
150197812|NCT04359654|541864766|FG000|Overall Study|Withdrawal by Subject|1|||
150197813|NCT04359654|541864767|FG001|Overall Study|Withdrawal by Subject|0|||
150197814|NCT04359654|541864766|FG000|Overall Study|Adverse Event|0|||
150197815|NCT04359654|541864767|FG001|Overall Study|Adverse Event|1|||
150197816|NCT04024020|541864770|FG000|Overall Study|Withdrawal by Subject|2|||
150197817|NCT04024020|541864771|FG001|Overall Study|Withdrawal by Subject|2|||
150197818|NCT05863156|541864778|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
150197819|NCT05863156|541864779|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
150197820|NCT05863156|541864780|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
150197821|NCT03672916|541864782|FG000|Overall Study|Death|6|||
150197822|NCT03672916|541864782|FG000|Overall Study|Lost to Follow-up|29|||
150197823|NCT03672916|541864782|FG000|Overall Study|Adverse Event|6|||
150197824|NCT03672916|541864782|FG000|Overall Study|Withdrawal by Subject|11|||
150197825|NCT03513302|541864785|FG000|First Intervention (14 Days)|Screen failure|15|||
150197826|NCT03513302|541864786|FG001|First Intervention (14 Days)|Screen failure|16|||
150197827|NCT05256654|541864787|FG000|Overall Study|Adverse Event|0|||
150197828|NCT05256654|541864788|FG001|Overall Study|Adverse Event|0|||
150197829|NCT05256654|541864789|FG002|Overall Study|Adverse Event|1|||
150197830|NCT05256654|541864790|FG003|Overall Study|Adverse Event|0|||
150197831|NCT05256654|541864787|FG000|Overall Study|Lost to Follow-up|0|||
150197832|NCT05256654|541864788|FG001|Overall Study|Lost to Follow-up|0|||
150197833|NCT05256654|541864789|FG002|Overall Study|Lost to Follow-up|0|||
150197834|NCT05256654|541864790|FG003|Overall Study|Lost to Follow-up|1|||
150197835|NCT05256654|541864787|FG000|Overall Study|Withdrawal by Subject|1|||
150197836|NCT05256654|541864788|FG001|Overall Study|Withdrawal by Subject|2|||
150197837|NCT05256654|541864789|FG002|Overall Study|Withdrawal by Subject|1|||
150197838|NCT05256654|541864790|FG003|Overall Study|Withdrawal by Subject|3|||
150197839|NCT05256654|541864787|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
150197840|NCT05256654|541864788|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
150197841|NCT05256654|541864789|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
150197842|NCT05256654|541864790|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
150197843|NCT05256654|541864787|FG000|Overall Study|Other|0|||
150197844|NCT05256654|541864788|FG001|Overall Study|Other|0|||
150197845|NCT05256654|541864789|FG002|Overall Study|Other|0|||
150197846|NCT05256654|541864790|FG003|Overall Study|Other|1|||
150197847|NCT04862416|541864795|FG000|Overall Study|Withdrawal by Subject|0|||
150197848|NCT04862416|541864796|FG001|Overall Study|Withdrawal by Subject|1|||
150197849|NCT04862416|541864797|FG002|Overall Study|Withdrawal by Subject|0|||
150197850|NCT04862416|541864798|FG003|Overall Study|Withdrawal by Subject|1|||
150197851|NCT04862416|541864799|FG004|Overall Study|Withdrawal by Subject|0|||
150197852|NCT04862416|541864800|FG005|Overall Study|Withdrawal by Subject|0|||
150197853|NCT04862416|541864801|FG006|Overall Study|Withdrawal by Subject|0|||
150197854|NCT04862416|541864802|FG007|Overall Study|Withdrawal by Subject|0|||
150197855|NCT00746096|541864803|FG000|Overall Study|Adverse Event|1|||
150197856|NCT00746096|541864804|FG001|Overall Study|Adverse Event|0|||
150197857|NCT00746096|541864803|FG000|Overall Study|Withdrawal by Subject|5|||
150197858|NCT00746096|541864804|FG001|Overall Study|Withdrawal by Subject|1|||
150197859|NCT00746096|541864803|FG000|Overall Study|Lost to Follow-up|2|||
150197860|NCT00746096|541864804|FG001|Overall Study|Lost to Follow-up|1|||
150197861|NCT00746096|541864803|FG000|Overall Study|Protocol Violation|1|||
150197862|NCT00746096|541864804|FG001|Overall Study|Protocol Violation|0|||
150197863|NCT00746096|541864803|FG000|Overall Study|No study drug treatment|1|||
150197864|NCT00746096|541864804|FG001|Overall Study|No study drug treatment|1|||
150197865|NCT04295512|541864809|FG000|Overall Study|Lack of family response to schedule assessment|0|||
150197866|NCT04295512|541864810|FG001|Overall Study|Lack of family response to schedule assessment|0|||
150197867|NCT04295512|541864811|FG002|Overall Study|Lack of family response to schedule assessment|0|||
150197868|NCT04295512|541864812|FG003|Overall Study|Lack of family response to schedule assessment|2|||
150197869|NCT04295512|541864809|FG000|Overall Study|Therapist did not refer eligible family|7|||
150197870|NCT04295512|541864810|FG001|Overall Study|Therapist did not refer eligible family|7|||
150197871|NCT04295512|541864811|FG002|Overall Study|Therapist did not refer eligible family|0|||
150197872|NCT04295512|541864812|FG003|Overall Study|Therapist did not refer eligible family|0|||
150197873|NCT05207956|541864820|FG000|Overall Study|Lost to follow up|1|||
150197874|NCT05207956|541864821|FG001|Overall Study|Lost to follow up|2|||
150197875|NCT01009788|541864824|FG000|Overall Study|Withdrawal by Subject|1|||
150197876|NCT01009788|541864825|FG001|Overall Study|Withdrawal by Subject|0|||
150197877|NCT03626220|541864827|FG000|Overall Study|Withdrawal by Subject|2|||
150197878|NCT03626220|541864828|FG001|Overall Study|Withdrawal by Subject|0|||
150197879|NCT05565820|541864835|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
150197880|NCT05565820|541864836|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
150197881|NCT05565820|541864835|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
150197882|NCT05565820|541864836|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
150197883|NCT05828017|541864838|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
150197884|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
150197885|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
150197886|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
150197887|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
150197888|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
150197889|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
150197890|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
150197891|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
150132674|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
150132675|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
150132676|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
150132677|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
150132678|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
150132679|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
150132680|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
150132681|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132682|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132683|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
150132684|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132685|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132686|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132687|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132688|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132689|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
150132690|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132691|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132692|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
150132693|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132694|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132695|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132696|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132697|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
150132698|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
150132699|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132700|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132701|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
150132702|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132703|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132704|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132705|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132706|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132707|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
150132708|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132709|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
150132710|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
150132711|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132712|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132713|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132714|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132715|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
150132716|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
150132717|NCT01212770|541617785|FG000|Long-term Safety Phase (Year 5)|Death|0|||
150132718|NCT01212770|541617786|FG001|Long-term Safety Phase (Year 5)|Death|0|||
150132719|NCT01212770|541617787|FG002|Long-term Safety Phase (Year 5)|Death|0|||
150132720|NCT01212770|541617788|FG003|Long-term Safety Phase (Year 5)|Death|0|||
150132721|NCT01212770|541617789|FG004|Long-term Safety Phase (Year 5)|Death|0|||
150132722|NCT01212770|541617790|FG005|Long-term Safety Phase (Year 5)|Death|0|||
150132723|NCT01212770|541617791|FG006|Long-term Safety Phase (Year 5)|Death|0|||
150132724|NCT01212770|541617792|FG007|Long-term Safety Phase (Year 5)|Death|1|||
150132725|NCT01212770|541617793|FG008|Long-term Safety Phase (Year 5)|Death|0|||
150132726|NCT00829387|541617796|FG000|Overall Study|Withdrawal by Subject|2|||
150132727|NCT00829387|541617797|FG001|Overall Study|Withdrawal by Subject|3|||
150132728|NCT00829387|541617796|FG000|Overall Study|Disqualified by PI|1|||
150132729|NCT00829387|541617797|FG001|Overall Study|Disqualified by PI|0|||
150132730|NCT00707031|541617805|FG000|Overall Study|Adverse Event|45|||
150132731|NCT00707031|541617806|FG001|Overall Study|Adverse Event|45|||
150132732|NCT00707031|541617805|FG000|Overall Study|Lack of Efficacy|19|||
150132733|NCT00707031|541617806|FG001|Overall Study|Lack of Efficacy|6|||
150132734|NCT00707031|541617805|FG000|Overall Study|Lost to Follow-up|2|||
150132735|NCT00707031|541617806|FG001|Overall Study|Lost to Follow-up|1|||
150132736|NCT00707031|541617805|FG000|Overall Study|Protocol Violation|1|||
150132737|NCT00707031|541617806|FG001|Overall Study|Protocol Violation|0|||
150132738|NCT00707031|541617805|FG000|Overall Study|Withdrawal by Subject|7|||
150132739|NCT00707031|541617806|FG001|Overall Study|Withdrawal by Subject|8|||
150132740|NCT00707031|541617805|FG000|Overall Study|Poor Compliance to Protocol|7|||
150132741|NCT00707031|541617806|FG001|Overall Study|Poor Compliance to Protocol|13|||
150132742|NCT00707031|541617805|FG000|Overall Study|Familial or Personal Reasons|12|||
150132743|NCT00707031|541617806|FG001|Overall Study|Familial or Personal Reasons|15|||
150132744|NCT00707031|541617805|FG000|Overall Study|Serious Noncompliance|2|||
150132745|NCT00707031|541617806|FG001|Overall Study|Serious Noncompliance|3|||
150132746|NCT00707031|541617805|FG000|Overall Study|Sponsor Decision|9|||
150132747|NCT00707031|541617806|FG001|Overall Study|Sponsor Decision|8|||
150132748|NCT02747238|541617807|FG000|Overall Study|Lack of Efficacy|0|||
150132749|NCT02747238|541617808|FG001|Overall Study|Lack of Efficacy|1|||
150132750|NCT02747238|541617807|FG000|Overall Study|Data lost|3|||
150132751|NCT02747238|541617808|FG001|Overall Study|Data lost|5|||
150132752|NCT00541450|541617809|FG000|Phase A|Adverse Event|3|||
150132753|NCT00541450|541617810|FG001|Phase A|Adverse Event|0|||
150132754|NCT00541450|541617809|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
150132755|NCT00541450|541617810|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
150132756|NCT00541450|541617809|FG000|Phase A|Hyperglycemia|0|||
150132757|NCT00541450|541617810|FG001|Phase A|Hyperglycemia|1|||
150132758|NCT00541450|541617809|FG000|Phase A|Lost to Follow-up|6|||
150132759|NCT00541450|541617810|FG001|Phase A|Lost to Follow-up|4|||
150132760|NCT00541450|541617809|FG000|Phase A|Physician Decision|2|||
150132761|NCT00541450|541617810|FG001|Phase A|Physician Decision|0|||
150132762|NCT00541450|541617809|FG000|Phase A|Protocol Violation|2|||
150132763|NCT00541450|541617810|FG001|Phase A|Protocol Violation|3|||
150132764|NCT00541450|541617809|FG000|Phase A|Withdrawal by Subject|7|||
150132765|NCT00541450|541617810|FG001|Phase A|Withdrawal by Subject|7|||
150132766|NCT00541450|541617809|FG000|Phase B|Adverse Event|6|||
150132767|NCT00541450|541617810|FG001|Phase B|Adverse Event|6|||
150132768|NCT00541450|541617809|FG000|Phase B|Hyperglycemia|10|||
150132769|NCT00541450|541617810|FG001|Phase B|Hyperglycemia|9|||
150132770|NCT00541450|541617809|FG000|Phase B|Lost to Follow-up|6|||
150132771|NCT00541450|541617810|FG001|Phase B|Lost to Follow-up|4|||
150132772|NCT00541450|541617809|FG000|Phase B|Physician Decision|4|||
150132773|NCT00541450|541617810|FG001|Phase B|Physician Decision|2|||
150132774|NCT00541450|541617809|FG000|Phase B|Pregnancy|0|||
150132775|NCT00541450|541617810|FG001|Phase B|Pregnancy|1|||
150132776|NCT00541450|541617809|FG000|Phase B|Protocol Violation|3|||
150132777|NCT00541450|541617810|FG001|Phase B|Protocol Violation|3|||
150132778|NCT00541450|541617809|FG000|Phase B|Withdrawal by Subject|8|||
150132779|NCT00541450|541617810|FG001|Phase B|Withdrawal by Subject|6|||
150132780|NCT02626780|541617814|FG000|Overall Study|Withdrawal by Subject|3|||
150132781|NCT04304833|541617815|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
150132782|NCT04304833|541617816|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
150132783|NCT01951625|541617817|FG000|Treatment Period|Protocol Violation|2|||
150132784|NCT01951625|541617818|FG001|Treatment Period|Protocol Violation|0|||
150132785|NCT01951625|541617819|FG002|Treatment Period|Protocol Violation|1|||
150132786|NCT01951625|541617820|FG003|Treatment Period|Protocol Violation|3|||
150132787|NCT01951625|541617821|FG004|Treatment Period|Protocol Violation|2|||
150132788|NCT01951625|541617817|FG000|Treatment Period|Physician Decision|0|||
150132789|NCT01951625|541617818|FG001|Treatment Period|Physician Decision|0|||
150132790|NCT01951625|541617819|FG002|Treatment Period|Physician Decision|0|||
150132791|NCT01951625|541617820|FG003|Treatment Period|Physician Decision|0|||
150132792|NCT01951625|541617821|FG004|Treatment Period|Physician Decision|1|||
150132793|NCT01951625|541617817|FG000|Treatment Period|Protocol driven decision point|0|||
150132794|NCT01951625|541617818|FG001|Treatment Period|Protocol driven decision point|5|||
150132795|NCT01951625|541617819|FG002|Treatment Period|Protocol driven decision point|0|||
150132796|NCT01951625|541617820|FG003|Treatment Period|Protocol driven decision point|2|||
150132797|NCT01951625|541617821|FG004|Treatment Period|Protocol driven decision point|1|||
150132798|NCT01951625|541617817|FG000|Treatment Period|Non compliance with study drug|1|||
150132799|NCT01951625|541617818|FG001|Treatment Period|Non compliance with study drug|2|||
150132800|NCT01951625|541617819|FG002|Treatment Period|Non compliance with study drug|2|||
150132801|NCT01951625|541617820|FG003|Treatment Period|Non compliance with study drug|0|||
150132802|NCT01951625|541617821|FG004|Treatment Period|Non compliance with study drug|0|||
150132803|NCT01951625|541617817|FG000|Treatment Period|Death|3|||
150132804|NCT01951625|541617818|FG001|Treatment Period|Death|2|||
150132805|NCT01951625|541617819|FG002|Treatment Period|Death|2|||
150132806|NCT01951625|541617820|FG003|Treatment Period|Death|1|||
150132807|NCT01951625|541617821|FG004|Treatment Period|Death|2|||
150132808|NCT01951625|541617817|FG000|Treatment Period|Adverse Event|7|||
150132809|NCT01951625|541617818|FG001|Treatment Period|Adverse Event|10|||
150132810|NCT01951625|541617819|FG002|Treatment Period|Adverse Event|9|||
150132811|NCT01951625|541617820|FG003|Treatment Period|Adverse Event|8|||
150132812|NCT01951625|541617821|FG004|Treatment Period|Adverse Event|8|||
150132813|NCT01951625|541617817|FG000|Treatment Period|Withdrawal by Subject|5|||
150132814|NCT01951625|541617818|FG001|Treatment Period|Withdrawal by Subject|2|||
150132815|NCT01951625|541617819|FG002|Treatment Period|Withdrawal by Subject|1|||
150132816|NCT01951625|541617820|FG003|Treatment Period|Withdrawal by Subject|7|||
150132817|NCT01951625|541617821|FG004|Treatment Period|Withdrawal by Subject|3|||
150132818|NCT01951625|541617817|FG000|Treatment Period|Lost to Follow-up|1|||
150132819|NCT01951625|541617818|FG001|Treatment Period|Lost to Follow-up|0|||
150132820|NCT01951625|541617819|FG002|Treatment Period|Lost to Follow-up|0|||
150132821|NCT01951625|541617820|FG003|Treatment Period|Lost to Follow-up|1|||
150132822|NCT01951625|541617821|FG004|Treatment Period|Lost to Follow-up|0|||
150132823|NCT01951625|541617817|FG000|Follow Up Period|Non-compliance with study drug|1|||
150132824|NCT01951625|541617818|FG001|Follow Up Period|Non-compliance with study drug|0|||
150132825|NCT01951625|541617819|FG002|Follow Up Period|Non-compliance with study drug|0|||
150132826|NCT01951625|541617820|FG003|Follow Up Period|Non-compliance with study drug|0|||
150132827|NCT01951625|541617821|FG004|Follow Up Period|Non-compliance with study drug|0|||
150132828|NCT01951625|541617817|FG000|Follow Up Period|Death|1|||
150132829|NCT01951625|541617818|FG001|Follow Up Period|Death|3|||
150132830|NCT01951625|541617819|FG002|Follow Up Period|Death|2|||
150132831|NCT01951625|541617820|FG003|Follow Up Period|Death|2|||
150132832|NCT01951625|541617821|FG004|Follow Up Period|Death|1|||
150132833|NCT01951625|541617817|FG000|Follow Up Period|Logistical difficulties|1|||
150132834|NCT01951625|541617818|FG001|Follow Up Period|Logistical difficulties|2|||
150132835|NCT01951625|541617819|FG002|Follow Up Period|Logistical difficulties|0|||
150132836|NCT01951625|541617820|FG003|Follow Up Period|Logistical difficulties|0|||
150132837|NCT01951625|541617821|FG004|Follow Up Period|Logistical difficulties|0|||
150132838|NCT01951625|541617817|FG000|Follow Up Period|Adverse Event|0|||
150132839|NCT01951625|541617818|FG001|Follow Up Period|Adverse Event|3|||
150132840|NCT01951625|541617819|FG002|Follow Up Period|Adverse Event|2|||
150132841|NCT01951625|541617820|FG003|Follow Up Period|Adverse Event|3|||
150132842|NCT01951625|541617821|FG004|Follow Up Period|Adverse Event|5|||
150132843|NCT01951625|541617817|FG000|Follow Up Period|Withdrawal by Subject|4|||
150132844|NCT01951625|541617818|FG001|Follow Up Period|Withdrawal by Subject|1|||
150132845|NCT01951625|541617819|FG002|Follow Up Period|Withdrawal by Subject|0|||
150132846|NCT01951625|541617820|FG003|Follow Up Period|Withdrawal by Subject|5|||
150132847|NCT01951625|541617821|FG004|Follow Up Period|Withdrawal by Subject|3|||
150132848|NCT01951625|541617817|FG000|Follow Up Period|Lost to Follow-up|1|||
150132849|NCT01951625|541617818|FG001|Follow Up Period|Lost to Follow-up|0|||
150132850|NCT01951625|541617819|FG002|Follow Up Period|Lost to Follow-up|0|||
150132851|NCT01951625|541617820|FG003|Follow Up Period|Lost to Follow-up|1|||
150132852|NCT01951625|541617821|FG004|Follow Up Period|Lost to Follow-up|1|||
150132853|NCT00613951|541617824|FG000|Overall Study|Adverse Event|1|||
150132854|NCT00613951|541617825|FG001|Overall Study|Adverse Event|0|||
150132855|NCT00613951|541617826|FG002|Overall Study|Adverse Event|1|||
150132856|NCT00613951|541617824|FG000|Overall Study|Lack of Efficacy|0|||
150132857|NCT00613951|541617825|FG001|Overall Study|Lack of Efficacy|1|||
150132858|NCT00613951|541617826|FG002|Overall Study|Lack of Efficacy|1|||
150132859|NCT00613951|541617824|FG000|Overall Study|Protocol Violation|1|||
150132860|NCT00613951|541617825|FG001|Overall Study|Protocol Violation|1|||
150132861|NCT00613951|541617826|FG002|Overall Study|Protocol Violation|1|||
150132862|NCT00613951|541617824|FG000|Overall Study|Unclassified|5|||
150132863|NCT00613951|541617825|FG001|Overall Study|Unclassified|3|||
150132864|NCT00613951|541617826|FG002|Overall Study|Unclassified|2|||
150132865|NCT00655980|541617828|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
150132866|NCT00655980|541617829|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
150132867|NCT00655980|541617830|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
150197892|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
150197893|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
150197894|NCT02361216|541864839|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
150197895|NCT02361216|541864840|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
150197896|NCT05809453|541866269|FG000|Overall Study|Withdrawal by Subject|1|||
150197897|NCT05809453|541866270|FG001|Overall Study|Withdrawal by Subject|0|||
150197898|NCT05809453|541866271|FG002|Overall Study|Withdrawal by Subject|0|||
150197899|NCT05809453|541866272|FG003|Overall Study|Withdrawal by Subject|0|||
150197900|NCT03916185|541866277|FG000|Overall Study|Lost to Follow-up|0|||
150197901|NCT03916185|541866278|FG001|Overall Study|Lost to Follow-up|1|||
150197902|NCT03916185|541866279|FG002|Overall Study|Lost to Follow-up|0|||
150197903|NCT03916185|541866280|FG003|Overall Study|Lost to Follow-up|0|||
150197904|NCT03916185|541866277|FG000|Overall Study|Moved|1|||
150197905|NCT03916185|541866278|FG001|Overall Study|Moved|0|||
150197906|NCT03916185|541866279|FG002|Overall Study|Moved|0|||
150197907|NCT03916185|541866280|FG003|Overall Study|Moved|1|||
150197908|NCT03916185|541866277|FG000|Overall Study|Not Able to Get to Clinic|1|||
150197909|NCT03916185|541866278|FG001|Overall Study|Not Able to Get to Clinic|0|||
150197910|NCT03916185|541866279|FG002|Overall Study|Not Able to Get to Clinic|0|||
150197911|NCT03916185|541866280|FG003|Overall Study|Not Able to Get to Clinic|0|||
150197912|NCT05370040|541866284|FG000|Overall Study|Lost to Follow-up|0|||
150197913|NCT05370040|541866285|FG001|Overall Study|Lost to Follow-up|0|||
150197914|NCT05370040|541866286|FG002|Overall Study|Lost to Follow-up|1|||
150197915|NCT05370040|541866287|FG003|Overall Study|Lost to Follow-up|0|||
150197916|NCT05370040|541866288|FG004|Overall Study|Lost to Follow-up|1|||
150197917|NCT05370040|541866289|FG005|Overall Study|Lost to Follow-up|0|||
150197918|NCT04778397|541866291|FG000|Overall Study|Death|59|||
150197919|NCT04778397|541866292|FG001|Overall Study|Death|54|||
150197920|NCT04778397|541866293|FG002|Overall Study|Death|11|||
150197921|NCT04778397|541866294|FG003|Overall Study|Death|9|||
150197922|NCT04778397|541866291|FG000|Overall Study|Study Terminated by Sponsor|34|||
150197923|NCT04778397|541866292|FG001|Overall Study|Study Terminated by Sponsor|42|||
150197924|NCT04778397|541866293|FG002|Overall Study|Study Terminated by Sponsor|15|||
150197925|NCT04778397|541866294|FG003|Overall Study|Study Terminated by Sponsor|12|||
150197926|NCT04778397|541866291|FG000|Overall Study|Withdrew Consent|5|||
150197927|NCT04778397|541866292|FG001|Overall Study|Withdrew Consent|4|||
150197928|NCT04778397|541866293|FG002|Overall Study|Withdrew Consent|1|||
150197929|NCT04778397|541866294|FG003|Overall Study|Withdrew Consent|1|||
150197930|NCT04778397|541866291|FG000|Overall Study|Reason Not Specified|1|||
150197931|NCT04778397|541866292|FG001|Overall Study|Reason Not Specified|3|||
150197932|NCT04778397|541866293|FG002|Overall Study|Reason Not Specified|0|||
150197933|NCT04778397|541866294|FG003|Overall Study|Reason Not Specified|2|||
150197934|NCT04778397|541866291|FG000|Overall Study|Lost to Follow-up|2|||
150197935|NCT04778397|541866292|FG001|Overall Study|Lost to Follow-up|1|||
150197936|NCT04778397|541866293|FG002|Overall Study|Lost to Follow-up|0|||
150197937|NCT04778397|541866294|FG003|Overall Study|Lost to Follow-up|1|||
150197938|NCT04294641|541866295|FG000|Overall Study|Screen failure|4|||
150197939|NCT01627574|541866296|FG000|Overall Study|Withdrawal by Subject|8|||
150197940|NCT01627574|541866297|FG001|Overall Study|Withdrawal by Subject|5|||
150197941|NCT01627574|541866296|FG000|Overall Study|Lost to Follow-up|13|||
150197942|NCT01627574|541866297|FG001|Overall Study|Lost to Follow-up|13|||
150197943|NCT04685135|541866304|FG000|Overall Study|Death|126|||
150197944|NCT04685135|541866305|FG001|Overall Study|Death|53|||
150197945|NCT04685135|541866304|FG000|Overall Study|Withdrawal by Subject|12|||
150197946|NCT04685135|541866305|FG001|Overall Study|Withdrawal by Subject|16|||
150197947|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
150197948|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
150197949|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
150197950|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
150197951|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
150197952|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
150197953|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
150197954|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
150197955|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
150197956|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
150197957|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
150197958|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
150197959|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
150197960|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
150197961|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
150197962|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
150197963|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197964|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197965|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197966|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197967|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197968|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
150197969|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
150197970|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
150197971|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197972|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197973|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197974|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197975|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197976|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197977|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
150197978|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
150197979|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
150197980|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
150197981|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
150197982|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
150197983|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
150197984|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
150197985|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
150132868|NCT02858895|541617832|FG000|Overall Study|Disease progression|31|||
150132869|NCT02858895|541617832|FG000|Overall Study|Death|2|||
150132870|NCT02858895|541617832|FG000|Overall Study|Adverse Event|1|||
150132871|NCT02858895|541617832|FG000|Overall Study|Withdrawal by Subject|3|||
150132872|NCT02858895|541617832|FG000|Overall Study|hospice,|1|||
150132873|NCT02858895|541617832|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
150132874|NCT05540522|541617833|FG000|Overall Study|Adverse Event|1|||
150132875|NCT05540522|541617834|FG001|Overall Study|Adverse Event|0|||
150132876|NCT05540522|541617835|FG002|Overall Study|Adverse Event|2|||
150132877|NCT05540522|541617836|FG003|Overall Study|Adverse Event|5|||
150132878|NCT05540522|541617833|FG000|Overall Study|Lost to Follow-up|487|||
150132879|NCT05540522|541617834|FG001|Overall Study|Lost to Follow-up|427|||
150132880|NCT05540522|541617835|FG002|Overall Study|Lost to Follow-up|146|||
150132881|NCT05540522|541617836|FG003|Overall Study|Lost to Follow-up|166|||
150132882|NCT05540522|541617833|FG000|Overall Study|Physician Decision|11|||
150132883|NCT05540522|541617834|FG001|Overall Study|Physician Decision|19|||
150132884|NCT05540522|541617835|FG002|Overall Study|Physician Decision|8|||
150132885|NCT05540522|541617836|FG003|Overall Study|Physician Decision|13|||
150132886|NCT05540522|541617833|FG000|Overall Study|Pregnancy|1|||
150132887|NCT05540522|541617834|FG001|Overall Study|Pregnancy|0|||
150132888|NCT05540522|541617835|FG002|Overall Study|Pregnancy|0|||
150132889|NCT05540522|541617836|FG003|Overall Study|Pregnancy|0|||
150132890|NCT05540522|541617833|FG000|Overall Study|Protocol Violation|3|||
150132891|NCT05540522|541617834|FG001|Overall Study|Protocol Violation|1|||
150132892|NCT05540522|541617835|FG002|Overall Study|Protocol Violation|9|||
150132893|NCT05540522|541617836|FG003|Overall Study|Protocol Violation|7|||
150132894|NCT05540522|541617833|FG000|Overall Study|Withdrawal by Subject|168|||
150132895|NCT05540522|541617834|FG001|Overall Study|Withdrawal by Subject|134|||
150132896|NCT05540522|541617835|FG002|Overall Study|Withdrawal by Subject|331|||
150132897|NCT05540522|541617836|FG003|Overall Study|Withdrawal by Subject|322|||
150132898|NCT05540522|541617833|FG000|Overall Study|Death|7|||
150132899|NCT05540522|541617834|FG001|Overall Study|Death|9|||
150132900|NCT05540522|541617835|FG002|Overall Study|Death|49|||
150132901|NCT05540522|541617836|FG003|Overall Study|Death|46|||
150132902|NCT05540522|541617833|FG000|Overall Study|Not vaccinated|34|||
150132903|NCT05540522|541617834|FG001|Overall Study|Not vaccinated|53|||
150132904|NCT05540522|541617835|FG002|Overall Study|Not vaccinated|57|||
150132905|NCT05540522|541617836|FG003|Overall Study|Not vaccinated|50|||
150132906|NCT05540522|541617833|FG000|Overall Study|No longer meets eligibility criteria|0|||
150132907|NCT05540522|541617834|FG001|Overall Study|No longer meets eligibility criteria|0|||
150132908|NCT05540522|541617835|FG002|Overall Study|No longer meets eligibility criteria|3|||
150132909|NCT05540522|541617836|FG003|Overall Study|No longer meets eligibility criteria|2|||
150132910|NCT05540522|541617833|FG000|Overall Study|Other (Unspecified)|8|||
150132911|NCT05540522|541617834|FG001|Overall Study|Other (Unspecified)|10|||
150132912|NCT05540522|541617835|FG002|Overall Study|Other (Unspecified)|4|||
150132913|NCT05540522|541617836|FG003|Overall Study|Other (Unspecified)|2|||
150132914|NCT03754803|541617839|FG000|Overall Study|Withdrawal by Subject|2|||
150132915|NCT05338333|541617840|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
150132916|NCT05338333|541617841|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
150132917|NCT04348604|541617844|FG000|Week 8|Withdrawal by Subject|1|||
150132918|NCT04348604|541617845|FG001|Week 8|Withdrawal by Subject|1|||
150132919|NCT04348604|541617844|FG000|Week 8|Lost to Follow-up|1|||
150132920|NCT04348604|541617845|FG001|Week 8|Lost to Follow-up|2|||
150132921|NCT04348604|541617844|FG000|Week 8|Suspended|0|||
150132922|NCT04348604|541617845|FG001|Week 8|Suspended|1|||
150132923|NCT04348604|541617844|FG000|Week 12|Lost to Follow-up|1|||
150132924|NCT04348604|541617845|FG001|Week 12|Lost to Follow-up|2|||
150132925|NCT04348604|541617844|FG000|Week 12|Withdrawal by Subject|1|||
150132926|NCT04348604|541617845|FG001|Week 12|Withdrawal by Subject|0|||
150132927|NCT04348604|541617844|FG000|Week 24|Lost to Follow-up|2|||
150132928|NCT04348604|541617845|FG001|Week 24|Lost to Follow-up|1|||
150132929|NCT02097108|541617846|FG000|Overall Study|Adverse Event|1|||
150132930|NCT02097108|541617846|FG000|Overall Study|patient was abroad for 6 months|1|||
150132931|NCT01475136|541617849|FG000|Overall Study|Sponsor Decision|0|||
150132932|NCT01475136|541617850|FG001|Overall Study|Sponsor Decision|1|||
150132933|NCT01475136|541617851|FG002|Overall Study|Sponsor Decision|0|||
150132934|NCT01475136|541617852|FG003|Overall Study|Sponsor Decision|0|||
150132935|NCT01475136|541617849|FG000|Overall Study|Entry Criteria Not Met|0|||
150132936|NCT01475136|541617850|FG001|Overall Study|Entry Criteria Not Met|2|||
150132937|NCT01475136|541617851|FG002|Overall Study|Entry Criteria Not Met|3|||
150132938|NCT01475136|541617852|FG003|Overall Study|Entry Criteria Not Met|1|||
150197986|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
150197987|NCT02315703|541866306|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
150197988|NCT02315703|541866307|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
150197989|NCT02315703|541866308|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
150197990|NCT02315703|541866309|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
150197991|NCT02315703|541866310|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
150197992|NCT02315703|541866311|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
150197993|NCT02315703|541866312|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
150197994|NCT02315703|541866313|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
150197995|NCT02315703|541866306|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
150197996|NCT02315703|541866307|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
150197997|NCT02315703|541866308|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150197998|NCT02315703|541866309|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150197999|NCT02315703|541866310|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150198000|NCT02315703|541866311|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150198001|NCT02315703|541866312|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150198002|NCT02315703|541866313|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
150198003|NCT02315703|541866306|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198004|NCT02315703|541866307|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
150198005|NCT02315703|541866308|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198006|NCT02315703|541866309|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198007|NCT02315703|541866310|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198008|NCT02315703|541866311|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198009|NCT02315703|541866312|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198010|NCT02315703|541866313|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
150198011|NCT02315703|541866306|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
150198012|NCT02315703|541866307|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
150198013|NCT02315703|541866308|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
150198014|NCT02315703|541866309|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
150198015|NCT02315703|541866310|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
150198016|NCT02315703|541866311|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
150198017|NCT02315703|541866312|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
150198018|NCT02315703|541866313|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
150198019|NCT05974501|541866314|FG000|Overall Study|Physician Decision|0|||
150198020|NCT05974501|541866315|FG001|Overall Study|Physician Decision|1|||
150198021|NCT04660539|541866316|FG000|Overall Study|Adverse Event|10|||
150198022|NCT04660539|541866316|FG000|Overall Study|Lack of Efficacy|4|||
150198023|NCT04660539|541866316|FG000|Overall Study|Lost to Follow-up|5|||
150198024|NCT04660539|541866316|FG000|Overall Study|Non-Compliance With Study Drug|3|||
150198025|NCT04660539|541866316|FG000|Overall Study|Reason not Specified|12|||
150198026|NCT04660539|541866316|FG000|Overall Study|Pregnancy|2|||
150198027|NCT04660539|541866316|FG000|Overall Study|Protocol Violation|2|||
150198028|NCT04660539|541866316|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
150198029|NCT04660539|541866316|FG000|Overall Study|Withdrawal by Subject|21|||
150198030|NCT03756662|541866324|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
150198031|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
150198032|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
150198033|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
150198034|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
150198035|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
150198036|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
150198037|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
150198038|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
150198039|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
150198040|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
150198041|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
150198042|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
150198043|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
150198044|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
150198045|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
150198046|NCT01254864|541866330|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
150198047|NCT01254864|541866331|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
150198048|NCT01254864|541866332|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
150198049|NCT01254864|541866330|FG000|Randomization Phase|Adverse Event|0|||
150198050|NCT01254864|541866331|FG001|Randomization Phase|Adverse Event|5|||
150198051|NCT01254864|541866332|FG002|Randomization Phase|Adverse Event|17|||
150198052|NCT01254864|541866330|FG000|Randomization Phase|Death|0|||
150132939|NCT01475136|541617849|FG000|Overall Study|Withdrawal by Subject|0|||
150132940|NCT01475136|541617850|FG001|Overall Study|Withdrawal by Subject|0|||
150132941|NCT01475136|541617851|FG002|Overall Study|Withdrawal by Subject|0|||
150132942|NCT01475136|541617852|FG003|Overall Study|Withdrawal by Subject|2|||
150132943|NCT01475136|541617849|FG000|Overall Study|Adverse Event|1|||
150132944|NCT01475136|541617850|FG001|Overall Study|Adverse Event|0|||
150132945|NCT01475136|541617851|FG002|Overall Study|Adverse Event|0|||
150132946|NCT01475136|541617852|FG003|Overall Study|Adverse Event|1|||
150132947|NCT01475136|541617849|FG000|Overall Study|Death|0|||
150132948|NCT01475136|541617850|FG001|Overall Study|Death|0|||
150132949|NCT01475136|541617851|FG002|Overall Study|Death|0|||
150132950|NCT01475136|541617852|FG003|Overall Study|Death|1|||
150132951|NCT00506493|541617860|FG000|Overall Study|Death|6|||
150132952|NCT00506493|541617860|FG000|Overall Study|Withdrawal by Subject|5|||
150132953|NCT01712009|541619836|FG000|Overall Study|Withdrawal by Subject|24|||
150132954|NCT01712009|541619837|FG001|Overall Study|Withdrawal by Subject|15|||
150132955|NCT01712009|541619838|FG002|Overall Study|Withdrawal by Subject|8|||
150132956|NCT01712009|541619836|FG000|Overall Study|Lost to Follow-up|2|||
150132957|NCT01712009|541619837|FG001|Overall Study|Lost to Follow-up|0|||
150132958|NCT01712009|541619838|FG002|Overall Study|Lost to Follow-up|1|||
150132959|NCT01712009|541619836|FG000|Overall Study|Decision by Sponsor|12|||
150132960|NCT01712009|541619837|FG001|Overall Study|Decision by Sponsor|14|||
150132961|NCT01712009|541619838|FG002|Overall Study|Decision by Sponsor|12|||
150132962|NCT04050865|541619840|FG000|Overall Study|Adverse Event|1|||
150132963|NCT04050865|541619841|FG001|Overall Study|Adverse Event|0|||
150132964|NCT04050865|541619840|FG000|Overall Study|no insert|1|||
150132965|NCT04050865|541619841|FG001|Overall Study|no insert|0|||
150132966|NCT04050865|541619840|FG000|Overall Study|Only 1 insert|2|||
150132967|NCT04050865|541619841|FG001|Overall Study|Only 1 insert|3|||
150132968|NCT04050865|541619840|FG000|Overall Study|Physician Decision|0|||
150132969|NCT04050865|541619841|FG001|Overall Study|Physician Decision|1|||
150132970|NCT04050865|541619840|FG000|Overall Study|Withdrawal by Subject|0|||
150132971|NCT04050865|541619841|FG001|Overall Study|Withdrawal by Subject|1|||
150132972|NCT00857207|541619842|FG000|Overall Study|Withdrawal by Subject|13|||
150132973|NCT00857207|541619843|FG001|Overall Study|Withdrawal by Subject|0|||
150132974|NCT00857207|541619842|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
150132975|NCT00857207|541619843|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
150132976|NCT00857207|541619842|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
150132977|NCT00857207|541619843|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
150132978|NCT01332227|541619844|FG000|Overall Study|Adverse Event|4|||
150132979|NCT01332227|541619845|FG001|Overall Study|Adverse Event|1|||
150132980|NCT01332227|541619844|FG000|Overall Study|Withdrawal by Subject|5|||
150132981|NCT01332227|541619845|FG001|Overall Study|Withdrawal by Subject|1|||
150132982|NCT01332227|541619844|FG000|Overall Study|Lost to Follow-up|2|||
150132983|NCT01332227|541619845|FG001|Overall Study|Lost to Follow-up|0|||
150132984|NCT01332227|541619844|FG000|Overall Study|Lack of Efficacy|3|||
150132985|NCT01332227|541619845|FG001|Overall Study|Lack of Efficacy|1|||
150132986|NCT01332227|541619844|FG000|Overall Study|Poor compliance/noncompliance|1|||
150132987|NCT01332227|541619845|FG001|Overall Study|Poor compliance/noncompliance|1|||
150132988|NCT01332227|541619844|FG000|Overall Study|Patient moved from area|1|||
150132989|NCT01332227|541619845|FG001|Overall Study|Patient moved from area|0|||
150132990|NCT01332227|541619844|FG000|Overall Study|Patient began prohibited medication|0|||
150132991|NCT01332227|541619845|FG001|Overall Study|Patient began prohibited medication|1|||
150132992|NCT03751631|541619848|FG000|Overall Study|Withdrawal by Subject|0|||
150132993|NCT03751631|541619849|FG001|Overall Study|Withdrawal by Subject|0|||
150132994|NCT03751631|541619850|FG002|Overall Study|Withdrawal by Subject|1|||
150132995|NCT03751631|541619851|FG003|Overall Study|Withdrawal by Subject|1|||
150132996|NCT03751631|541619852|FG004|Overall Study|Withdrawal by Subject|0|||
150132997|NCT03751631|541619853|FG005|Overall Study|Withdrawal by Subject|0|||
150132998|NCT02822222|541619857|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
150132999|NCT02822222|541619858|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
150133000|NCT00428090|541619860|FG000|Overall Study|Adverse Event|10|||
150133001|NCT00428090|541619861|FG001|Overall Study|Adverse Event|8|||
150133002|NCT00428090|541619862|FG002|Overall Study|Adverse Event|10|||
150133003|NCT00428090|541619863|FG003|Overall Study|Adverse Event|11|||
150133004|NCT00428090|541619860|FG000|Overall Study|Lost to Follow-up|3|||
150133005|NCT00428090|541619861|FG001|Overall Study|Lost to Follow-up|6|||
150133006|NCT00428090|541619862|FG002|Overall Study|Lost to Follow-up|1|||
150133007|NCT00428090|541619863|FG003|Overall Study|Lost to Follow-up|4|||
150133008|NCT00428090|541619860|FG000|Overall Study|Protocol Violation|3|||
150133009|NCT00428090|541619861|FG001|Overall Study|Protocol Violation|1|||
150133010|NCT00428090|541619862|FG002|Overall Study|Protocol Violation|3|||
150133011|NCT00428090|541619863|FG003|Overall Study|Protocol Violation|3|||
150133012|NCT00428090|541619860|FG000|Overall Study|Withdrawal by Subject|10|||
150198053|NCT01254864|541866331|FG001|Randomization Phase|Death|1|||
150198054|NCT01254864|541866332|FG002|Randomization Phase|Death|0|||
150198055|NCT01254864|541866330|FG000|Randomization Phase|Lost to Follow-up|0|||
150198056|NCT01254864|541866331|FG001|Randomization Phase|Lost to Follow-up|0|||
150198057|NCT01254864|541866332|FG002|Randomization Phase|Lost to Follow-up|1|||
150198058|NCT01254864|541866330|FG000|Randomization Phase|Physician Decision|0|||
150198059|NCT01254864|541866331|FG001|Randomization Phase|Physician Decision|20|||
150198060|NCT01254864|541866332|FG002|Randomization Phase|Physician Decision|25|||
150198061|NCT01254864|541866330|FG000|Randomization Phase|Withdrawal by Subject|0|||
150198062|NCT01254864|541866331|FG001|Randomization Phase|Withdrawal by Subject|4|||
150198063|NCT01254864|541866332|FG002|Randomization Phase|Withdrawal by Subject|2|||
150198064|NCT01254864|541866330|FG000|Randomization Phase|Non-Compliance|0|||
150198065|NCT01254864|541866331|FG001|Randomization Phase|Non-Compliance|1|||
150198066|NCT01254864|541866332|FG002|Randomization Phase|Non-Compliance|0|||
150198067|NCT01254864|541866330|FG000|Randomization Phase|Comorbidities|0|||
150198068|NCT01254864|541866331|FG001|Randomization Phase|Comorbidities|2|||
150198069|NCT01254864|541866332|FG002|Randomization Phase|Comorbidities|1|||
150198070|NCT04625725|541866333|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
150198071|NCT04625725|541866334|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
150198072|NCT04625725|541866335|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
150198073|NCT04625725|541866336|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
150198074|NCT04625725|541866337|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
150198075|NCT04625725|541866338|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
150198076|NCT04625725|541866333|FG000|Provent Main Study|Withdrawal by Subject|242|||
150198077|NCT04625725|541866334|FG001|Provent Main Study|Withdrawal by Subject|144|||
150198078|NCT04625725|541866335|FG002|Provent Main Study|Withdrawal by Subject|0|||
150198079|NCT04625725|541866336|FG003|Provent Main Study|Withdrawal by Subject|0|||
150198080|NCT04625725|541866337|FG004|Provent Main Study|Withdrawal by Subject|0|||
150198081|NCT04625725|541866338|FG005|Provent Main Study|Withdrawal by Subject|0|||
150198082|NCT04625725|541866333|FG000|Provent Main Study|Physician Decision|5|||
150198083|NCT04625725|541866334|FG001|Provent Main Study|Physician Decision|0|||
150198084|NCT04625725|541866335|FG002|Provent Main Study|Physician Decision|0|||
150198085|NCT04625725|541866336|FG003|Provent Main Study|Physician Decision|0|||
150198086|NCT04625725|541866337|FG004|Provent Main Study|Physician Decision|0|||
150198087|NCT04625725|541866338|FG005|Provent Main Study|Physician Decision|0|||
150198088|NCT04625725|541866333|FG000|Provent Main Study|Protocol Violation|1|||
150198089|NCT04625725|541866334|FG001|Provent Main Study|Protocol Violation|0|||
150198090|NCT04625725|541866335|FG002|Provent Main Study|Protocol Violation|0|||
150198091|NCT04625725|541866336|FG003|Provent Main Study|Protocol Violation|0|||
150198092|NCT04625725|541866337|FG004|Provent Main Study|Protocol Violation|0|||
150198093|NCT04625725|541866338|FG005|Provent Main Study|Protocol Violation|0|||
150198094|NCT04625725|541866333|FG000|Provent Main Study|Lost to Follow-up|357|||
150198095|NCT04625725|541866334|FG001|Provent Main Study|Lost to Follow-up|200|||
150198096|NCT04625725|541866335|FG002|Provent Main Study|Lost to Follow-up|0|||
150198097|NCT04625725|541866336|FG003|Provent Main Study|Lost to Follow-up|0|||
150198098|NCT04625725|541866337|FG004|Provent Main Study|Lost to Follow-up|0|||
150198099|NCT04625725|541866338|FG005|Provent Main Study|Lost to Follow-up|0|||
150198100|NCT04625725|541866333|FG000|Provent Main Study|Death|22|||
150198101|NCT04625725|541866334|FG001|Provent Main Study|Death|10|||
150198102|NCT04625725|541866335|FG002|Provent Main Study|Death|0|||
150198103|NCT04625725|541866336|FG003|Provent Main Study|Death|0|||
150198104|NCT04625725|541866337|FG004|Provent Main Study|Death|0|||
150198105|NCT04625725|541866338|FG005|Provent Main Study|Death|0|||
150198106|NCT04625725|541866333|FG000|Provent Main Study|Adverse Event|2|||
150198107|NCT04625725|541866334|FG001|Provent Main Study|Adverse Event|1|||
150198108|NCT04625725|541866335|FG002|Provent Main Study|Adverse Event|0|||
150198109|NCT04625725|541866336|FG003|Provent Main Study|Adverse Event|0|||
150198110|NCT04625725|541866337|FG004|Provent Main Study|Adverse Event|0|||
150198111|NCT04625725|541866338|FG005|Provent Main Study|Adverse Event|0|||
150198112|NCT04625725|541866333|FG000|Provent Main Study|Participants dosed in sub-study|310|||
150198113|NCT04625725|541866334|FG001|Provent Main Study|Participants dosed in sub-study|193|||
150198114|NCT04625725|541866335|FG002|Provent Main Study|Participants dosed in sub-study|0|||
150198115|NCT04625725|541866336|FG003|Provent Main Study|Participants dosed in sub-study|0|||
150198116|NCT04625725|541866337|FG004|Provent Main Study|Participants dosed in sub-study|0|||
150198117|NCT04625725|541866338|FG005|Provent Main Study|Participants dosed in sub-study|0|||
150198118|NCT04625725|541866333|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
150198119|NCT04625725|541866334|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
150198120|NCT04625725|541866335|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
150198121|NCT04625725|541866336|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
150198122|NCT04625725|541866337|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
150198123|NCT04625725|541866338|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
150198124|NCT04625725|541866333|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
150198125|NCT04625725|541866334|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
150198126|NCT04625725|541866335|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
150133013|NCT00428090|541619861|FG001|Overall Study|Withdrawal by Subject|12|||
150133014|NCT00428090|541619862|FG002|Overall Study|Withdrawal by Subject|15|||
150133015|NCT00428090|541619863|FG003|Overall Study|Withdrawal by Subject|5|||
150133016|NCT00428090|541619860|FG000|Overall Study|Sponsor terminated study|0|||
150133017|NCT00428090|541619861|FG001|Overall Study|Sponsor terminated study|1|||
150133018|NCT00428090|541619862|FG002|Overall Study|Sponsor terminated study|0|||
150133019|NCT00428090|541619863|FG003|Overall Study|Sponsor terminated study|0|||
150133020|NCT00428090|541619860|FG000|Overall Study|Non-compliance|4|||
150133021|NCT00428090|541619861|FG001|Overall Study|Non-compliance|0|||
150133022|NCT00428090|541619862|FG002|Overall Study|Non-compliance|1|||
150133023|NCT00428090|541619863|FG003|Overall Study|Non-compliance|3|||
150133024|NCT00428090|541619860|FG000|Overall Study|Par. did not returned to visit|1|||
150133025|NCT00428090|541619861|FG001|Overall Study|Par. did not returned to visit|0|||
150133026|NCT00428090|541619862|FG002|Overall Study|Par. did not returned to visit|0|||
150133027|NCT00428090|541619863|FG003|Overall Study|Par. did not returned to visit|1|||
150133028|NCT00428090|541619860|FG000|Overall Study|Follow-Up visit not possible|1|||
150133029|NCT00428090|541619861|FG001|Overall Study|Follow-Up visit not possible|0|||
150133030|NCT00428090|541619862|FG002|Overall Study|Follow-Up visit not possible|0|||
150133031|NCT00428090|541619863|FG003|Overall Study|Follow-Up visit not possible|0|||
150133032|NCT00428090|541619860|FG000|Overall Study|Prohibited medication used for SAE|1|||
150198127|NCT04625725|541866336|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
150198128|NCT04625725|541866337|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
150198129|NCT04625725|541866338|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
150198130|NCT04625725|541866333|FG000|Provent Main Study|INCARCERATION|3|||
150198131|NCT04625725|541866334|FG001|Provent Main Study|INCARCERATION|0|||
150198132|NCT04625725|541866335|FG002|Provent Main Study|INCARCERATION|0|||
150198133|NCT04625725|541866336|FG003|Provent Main Study|INCARCERATION|0|||
150198134|NCT04625725|541866337|FG004|Provent Main Study|INCARCERATION|0|||
150198135|NCT04625725|541866338|FG005|Provent Main Study|INCARCERATION|0|||
150198136|NCT04625725|541866333|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
150198137|NCT04625725|541866334|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
150198138|NCT04625725|541866335|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
150198139|NCT04625725|541866336|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
150198140|NCT04625725|541866337|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
150198141|NCT04625725|541866338|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
150198142|NCT04625725|541866333|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
150198143|NCT04625725|541866334|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
150198144|NCT04625725|541866335|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
150198145|NCT04625725|541866336|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
150198146|NCT04625725|541866337|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
150198147|NCT04625725|541866338|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
150198148|NCT04625725|541866333|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
150198149|NCT04625725|541866334|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
150198150|NCT04625725|541866335|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
150198151|NCT04625725|541866336|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
150198152|NCT04625725|541866337|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
150198153|NCT04625725|541866338|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
150198154|NCT04625725|541866333|FG000|Provent Main Study|MISSING REASON|0|||
150198155|NCT04625725|541866334|FG001|Provent Main Study|MISSING REASON|1|||
150198156|NCT04625725|541866335|FG002|Provent Main Study|MISSING REASON|0|||
150198157|NCT04625725|541866336|FG003|Provent Main Study|MISSING REASON|0|||
150198158|NCT04625725|541866337|FG004|Provent Main Study|MISSING REASON|0|||
150198159|NCT04625725|541866338|FG005|Provent Main Study|MISSING REASON|0|||
150198160|NCT04625725|541866333|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
150198161|NCT04625725|541866334|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
150198162|NCT04625725|541866335|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
150198163|NCT04625725|541866336|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
150198164|NCT04625725|541866337|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
150198165|NCT04625725|541866338|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
150198166|NCT04625725|541866333|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
150198167|NCT04625725|541866334|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
150198168|NCT04625725|541866335|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
150198169|NCT04625725|541866336|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
150198170|NCT04625725|541866337|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
150198171|NCT04625725|541866338|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
150198172|NCT04625725|541866333|FG000|Provent Sub Study|Lost to Follow-up|0|||
150198173|NCT04625725|541866334|FG001|Provent Sub Study|Lost to Follow-up|0|||
150198174|NCT04625725|541866335|FG002|Provent Sub Study|Lost to Follow-up|20|||
150198175|NCT04625725|541866336|FG003|Provent Sub Study|Lost to Follow-up|10|||
150198176|NCT04625725|541866337|FG004|Provent Sub Study|Lost to Follow-up|6|||
150198177|NCT04625725|541866338|FG005|Provent Sub Study|Lost to Follow-up|4|||
150198178|NCT04625725|541866333|FG000|Provent Sub Study|Death|0|||
150198179|NCT04625725|541866334|FG001|Provent Sub Study|Death|0|||
150198180|NCT04625725|541866335|FG002|Provent Sub Study|Death|8|||
150198181|NCT04625725|541866336|FG003|Provent Sub Study|Death|5|||
150198182|NCT04625725|541866337|FG004|Provent Sub Study|Death|0|||
150198183|NCT04625725|541866338|FG005|Provent Sub Study|Death|1|||
150198184|NCT04625725|541866333|FG000|Provent Sub Study|Adverse Event|0|||
150198185|NCT04625725|541866334|FG001|Provent Sub Study|Adverse Event|0|||
150198186|NCT04625725|541866335|FG002|Provent Sub Study|Adverse Event|0|||
150198187|NCT04625725|541866336|FG003|Provent Sub Study|Adverse Event|0|||
150198188|NCT04625725|541866337|FG004|Provent Sub Study|Adverse Event|0|||
150198189|NCT04625725|541866338|FG005|Provent Sub Study|Adverse Event|1|||
150198190|NCT04625725|541866333|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
150198191|NCT04625725|541866334|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
150198192|NCT04625725|541866335|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
150198193|NCT04625725|541866336|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
150198194|NCT04625725|541866337|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
150198195|NCT04625725|541866338|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
150198196|NCT04625725|541866333|FG000|Provent Sub Study|Withdrawal by Subject|0|||
150198197|NCT04625725|541866334|FG001|Provent Sub Study|Withdrawal by Subject|0|||
150198198|NCT04625725|541866335|FG002|Provent Sub Study|Withdrawal by Subject|11|||
150198199|NCT04625725|541866336|FG003|Provent Sub Study|Withdrawal by Subject|13|||
150198200|NCT04625725|541866337|FG004|Provent Sub Study|Withdrawal by Subject|5|||
150198201|NCT04625725|541866338|FG005|Provent Sub Study|Withdrawal by Subject|6|||
150198202|NCT04625725|541866333|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
150198203|NCT04625725|541866334|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
150198204|NCT04625725|541866335|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
150198205|NCT04625725|541866336|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
150198206|NCT04625725|541866337|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
150198207|NCT04625725|541866338|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
150198208|NCT01828112|541866339|FG000|Treatment Phase|Adverse Event|7|||
150198209|NCT01828112|541866340|FG001|Treatment Phase|Adverse Event|8|||
150198210|NCT01828112|541866341|FG002|Treatment Phase|Adverse Event|0|||
150198211|NCT01828112|541866339|FG000|Treatment Phase|Death|9|||
150198212|NCT01828112|541866340|FG001|Treatment Phase|Death|5|||
150198213|NCT01828112|541866341|FG002|Treatment Phase|Death|0|||
150198214|NCT01828112|541866339|FG000|Treatment Phase|No longer required treatment|0|||
150198215|NCT01828112|541866340|FG001|Treatment Phase|No longer required treatment|1|||
150198216|NCT01828112|541866341|FG002|Treatment Phase|No longer required treatment|0|||
150198217|NCT01828112|541866339|FG000|Treatment Phase|Physician Decision|6|||
150198218|NCT01828112|541866340|FG001|Treatment Phase|Physician Decision|7|||
150198219|NCT01828112|541866341|FG002|Treatment Phase|Physician Decision|0|||
150198220|NCT01828112|541866339|FG000|Treatment Phase|Pregnancy|1|||
150198221|NCT01828112|541866340|FG001|Treatment Phase|Pregnancy|0|||
150198222|NCT01828112|541866341|FG002|Treatment Phase|Pregnancy|0|||
150198223|NCT01828112|541866339|FG000|Treatment Phase|Progressive disease|79|||
150198224|NCT01828112|541866340|FG001|Treatment Phase|Progressive disease|87|||
150198225|NCT01828112|541866341|FG002|Treatment Phase|Progressive disease|0|||
150198226|NCT01828112|541866339|FG000|Treatment Phase|Study terminated by sponsor|1|||
150198227|NCT01828112|541866340|FG001|Treatment Phase|Study terminated by sponsor|0|||
150198228|NCT01828112|541866341|FG002|Treatment Phase|Study terminated by sponsor|0|||
150198229|NCT01828112|541866339|FG000|Treatment Phase|Subject/guardian decision|12|||
150198230|NCT01828112|541866340|FG001|Treatment Phase|Subject/guardian decision|8|||
150198231|NCT01828112|541866341|FG002|Treatment Phase|Subject/guardian decision|0|||
150198232|NCT01828112|541866339|FG000|Extension Treatment Phase|Adverse Event|0|||
150198233|NCT01828112|541866340|FG001|Extension Treatment Phase|Adverse Event|0|||
150198234|NCT01828112|541866341|FG002|Extension Treatment Phase|Adverse Event|6|||
150198235|NCT01828112|541866339|FG000|Extension Treatment Phase|Death|0|||
150198236|NCT01828112|541866340|FG001|Extension Treatment Phase|Death|0|||
150198237|NCT01828112|541866341|FG002|Extension Treatment Phase|Death|17|||
150198238|NCT01828112|541866339|FG000|Extension Treatment Phase|Physician Decision|0|||
150198239|NCT01828112|541866340|FG001|Extension Treatment Phase|Physician Decision|0|||
150198240|NCT01828112|541866341|FG002|Extension Treatment Phase|Physician Decision|5|||
150198241|NCT01828112|541866339|FG000|Extension Treatment Phase|Progressive disease|0|||
150198242|NCT01828112|541866340|FG001|Extension Treatment Phase|Progressive disease|0|||
150198243|NCT01828112|541866341|FG002|Extension Treatment Phase|Progressive disease|46|||
150198244|NCT01828112|541866339|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
150133033|NCT00428090|541619861|FG001|Overall Study|Prohibited medication used for SAE|0|||
150133034|NCT00428090|541619862|FG002|Overall Study|Prohibited medication used for SAE|0|||
150133035|NCT00428090|541619863|FG003|Overall Study|Prohibited medication used for SAE|0|||
150133036|NCT00428090|541619860|FG000|Overall Study|Death of par.|1|||
150133037|NCT00428090|541619861|FG001|Overall Study|Death of par.|0|||
150133038|NCT00428090|541619862|FG002|Overall Study|Death of par.|1|||
150133039|NCT00428090|541619863|FG003|Overall Study|Death of par.|0|||
150133040|NCT00428090|541619860|FG000|Overall Study|Visit 7 exceed the visit window|0|||
150133041|NCT00428090|541619861|FG001|Overall Study|Visit 7 exceed the visit window|1|||
150133042|NCT00428090|541619862|FG002|Overall Study|Visit 7 exceed the visit window|0|||
150133043|NCT00428090|541619863|FG003|Overall Study|Visit 7 exceed the visit window|0|||
150133044|NCT00428090|541619860|FG000|Overall Study|Medical monitor terminated par.|0|||
150133045|NCT00428090|541619861|FG001|Overall Study|Medical monitor terminated par.|1|||
150133046|NCT00428090|541619862|FG002|Overall Study|Medical monitor terminated par.|0|||
150133047|NCT00428090|541619863|FG003|Overall Study|Medical monitor terminated par.|0|||
150133048|NCT00428090|541619860|FG000|Overall Study|Mental status of par. was|0|||
150133049|NCT00428090|541619861|FG001|Overall Study|Mental status of par. was|1|||
150133050|NCT00428090|541619862|FG002|Overall Study|Mental status of par. was|0|||
150133051|NCT00428090|541619863|FG003|Overall Study|Mental status of par. was|0|||
150133052|NCT00428090|541619860|FG000|Overall Study|Worsening of AD|0|||
150133053|NCT00428090|541619861|FG001|Overall Study|Worsening of AD|0|||
150133054|NCT00428090|541619862|FG002|Overall Study|Worsening of AD|1|||
150133055|NCT00428090|541619863|FG003|Overall Study|Worsening of AD|0|||
150133056|NCT00428090|541619860|FG000|Overall Study|Excluded for concerning QTc value|0|||
150133057|NCT00428090|541619861|FG001|Overall Study|Excluded for concerning QTc value|0|||
150133058|NCT00428090|541619862|FG002|Overall Study|Excluded for concerning QTc value|1|||
150133059|NCT00428090|541619863|FG003|Overall Study|Excluded for concerning QTc value|0|||
150133060|NCT00428090|541619860|FG000|Overall Study|Insufficient AD documentation|0|||
150133061|NCT00428090|541619861|FG001|Overall Study|Insufficient AD documentation|0|||
150133062|NCT00428090|541619862|FG002|Overall Study|Insufficient AD documentation|1|||
150133063|NCT00428090|541619863|FG003|Overall Study|Insufficient AD documentation|0|||
150133064|NCT00428090|541619860|FG000|Overall Study|High MMSE scores|0|||
150133065|NCT00428090|541619861|FG001|Overall Study|High MMSE scores|0|||
150133066|NCT00428090|541619862|FG002|Overall Study|High MMSE scores|1|||
150133067|NCT00428090|541619863|FG003|Overall Study|High MMSE scores|0|||
150133068|NCT00428090|541619860|FG000|Overall Study|Deterioration of cognitive status|0|||
150133069|NCT00428090|541619861|FG001|Overall Study|Deterioration of cognitive status|0|||
150133070|NCT00428090|541619862|FG002|Overall Study|Deterioration of cognitive status|1|||
150133071|NCT00428090|541619863|FG003|Overall Study|Deterioration of cognitive status|0|||
150133072|NCT00428090|541619860|FG000|Overall Study|Serious adverse event|0|||
150133073|NCT00428090|541619861|FG001|Overall Study|Serious adverse event|0|||
150133074|NCT00428090|541619862|FG002|Overall Study|Serious adverse event|1|||
150133075|NCT00428090|541619863|FG003|Overall Study|Serious adverse event|0|||
150133076|NCT00428090|541619860|FG000|Overall Study|Excluded for heart insufficiency|0|||
150133077|NCT00428090|541619861|FG001|Overall Study|Excluded for heart insufficiency|0|||
150133078|NCT00428090|541619862|FG002|Overall Study|Excluded for heart insufficiency|1|||
150133079|NCT00428090|541619863|FG003|Overall Study|Excluded for heart insufficiency|0|||
150133080|NCT00428090|541619860|FG000|Overall Study|Raised Creatinine Value|0|||
150133081|NCT00428090|541619861|FG001|Overall Study|Raised Creatinine Value|0|||
150133082|NCT00428090|541619862|FG002|Overall Study|Raised Creatinine Value|0|||
150133083|NCT00428090|541619863|FG003|Overall Study|Raised Creatinine Value|1|||
150133084|NCT02690974|541619867|FG000|Overall Study|Adverse Event|16|||
150133085|NCT02690974|541619867|FG000|Overall Study|Death|9|||
150133086|NCT02690974|541619867|FG000|Overall Study|Subject/guardian decision|4|||
150133087|NCT02690974|541619867|FG000|Overall Study|Lost to Follow-up|3|||
150133088|NCT02690974|541619867|FG000|Overall Study|Withdrawal of Informed Consent|3|||
150133089|NCT02690974|541619867|FG000|Overall Study|Physician Decision|2|||
150133090|NCT02690974|541619867|FG000|Overall Study|Non-compliance with study treatment|1|||
150133091|NCT02690974|541619867|FG000|Overall Study|Protocol-defined stopping criteria|1|||
150133092|NCT02690974|541619867|FG000|Overall Study|Protocol Deviation|1|||
150133093|NCT00863655|541619877|FG000|Overall Study|Protocol Violation|4|||
150133094|NCT00863655|541619878|FG001|Overall Study|Protocol Violation|0|||
150133095|NCT00863655|541619877|FG000|Overall Study|Adverse Event|52|||
150133096|NCT00863655|541619878|FG001|Overall Study|Adverse Event|8|||
150133097|NCT00863655|541619877|FG000|Overall Study|Withdrawal by Subject|47|||
150133098|NCT00863655|541619878|FG001|Overall Study|Withdrawal by Subject|7|||
150133099|NCT00863655|541619877|FG000|Overall Study|Administrative problems|1|||
150133100|NCT00863655|541619878|FG001|Overall Study|Administrative problems|0|||
150133101|NCT00863655|541619877|FG000|Overall Study|Death|7|||
150133102|NCT00863655|541619878|FG001|Overall Study|Death|1|||
150133103|NCT00863655|541619877|FG000|Overall Study|New cancer therapy|5|||
150133104|NCT00863655|541619878|FG001|Overall Study|New cancer therapy|1|||
150133105|NCT00863655|541619877|FG000|Overall Study|Disease progression|364|||
150133106|NCT00863655|541619878|FG001|Overall Study|Disease progression|221|||
150133107|NCT00863655|541619877|FG000|Overall Study|Treatment completed as per protocol|5|||
150133108|NCT00863655|541619878|FG001|Overall Study|Treatment completed as per protocol|1|||
150133109|NCT02548455|541619879|FG000|Overall Study|Withdrawal by Subject|27|||
150133110|NCT02548455|541619879|FG000|Overall Study|Death|26|||
150133111|NCT02548455|541619879|FG000|Overall Study|Lost to Follow-up|14|||
150133112|NCT02548455|541619879|FG000|Overall Study|Visit not completed|173|||
150133113|NCT00530855|541619880|FG000|Overall Study|Lack of Efficacy|20|||
150133114|NCT00530855|541619880|FG000|Overall Study|Withdrawal by Subject|30|||
150133115|NCT00530855|541619880|FG000|Overall Study|Fatal Serious AE|3|||
150133116|NCT00530855|541619880|FG000|Overall Study|Non Fatal Serious AE|7|||
150133117|NCT00530855|541619880|FG000|Overall Study|Non Fatal Non Serious AE|12|||
150133118|NCT00530855|541619880|FG000|Overall Study|Protocol Violation|3|||
150133119|NCT00530855|541619880|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
150133120|NCT00530855|541619880|FG000|Overall Study|Lost to Follow-up|9|||
150133121|NCT00530855|541619880|FG000|Overall Study|Other reason for premature termination|17|||
150133122|NCT01627327|541619881|FG000|Overall Study|Adverse Event|6|||
150133123|NCT01627327|541619882|FG001|Overall Study|Adverse Event|12|||
150133124|NCT01627327|541619881|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
150133125|NCT01627327|541619882|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
150133126|NCT01627327|541619881|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
150133127|NCT01627327|541619882|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
150133128|NCT01627327|541619881|FG000|Overall Study|Protocol Violation|4|||
150133129|NCT01627327|541619882|FG001|Overall Study|Protocol Violation|10|||
150133130|NCT01627327|541619881|FG000|Overall Study|Lost to Follow-up|1|||
150133131|NCT01627327|541619882|FG001|Overall Study|Lost to Follow-up|3|||
150133132|NCT01627327|541619881|FG000|Overall Study|Physician Decision|1|||
150133133|NCT01627327|541619882|FG001|Overall Study|Physician Decision|0|||
150133134|NCT01627327|541619881|FG000|Overall Study|Withdrawal by Subject|3|||
150133135|NCT01627327|541619882|FG001|Overall Study|Withdrawal by Subject|3|||
150133136|NCT01137474|541619886|FG000|Overall Study|Adverse Event|3|||
150133137|NCT01137474|541619887|FG001|Overall Study|Adverse Event|5|||
150133138|NCT01137474|541619888|FG002|Overall Study|Adverse Event|1|||
150133139|NCT01137474|541619889|FG003|Overall Study|Adverse Event|3|||
150133140|NCT01137474|541619886|FG000|Overall Study|Withdrawal by Subject|7|||
150133141|NCT01137474|541619887|FG001|Overall Study|Withdrawal by Subject|2|||
150133142|NCT01137474|541619888|FG002|Overall Study|Withdrawal by Subject|6|||
150133143|NCT01137474|541619889|FG003|Overall Study|Withdrawal by Subject|9|||
150133144|NCT01137474|541619886|FG000|Overall Study|No longer met study criteria|6|||
150133145|NCT01137474|541619887|FG001|Overall Study|No longer met study criteria|1|||
150133146|NCT01137474|541619888|FG002|Overall Study|No longer met study criteria|0|||
150133147|NCT01137474|541619889|FG003|Overall Study|No longer met study criteria|5|||
150133148|NCT01137474|541619886|FG000|Overall Study|Lost to Follow-up|5|||
150133149|NCT01137474|541619887|FG001|Overall Study|Lost to Follow-up|1|||
150133150|NCT01137474|541619888|FG002|Overall Study|Lost to Follow-up|0|||
150133151|NCT01137474|541619889|FG003|Overall Study|Lost to Follow-up|2|||
150133152|NCT01137474|541619886|FG000|Overall Study|Lack of Efficacy|0|||
150133153|NCT01137474|541619887|FG001|Overall Study|Lack of Efficacy|0|||
150133154|NCT01137474|541619888|FG002|Overall Study|Lack of Efficacy|0|||
150133155|NCT01137474|541619889|FG003|Overall Study|Lack of Efficacy|2|||
150133156|NCT01137474|541619886|FG000|Overall Study|Other|3|||
150133157|NCT01137474|541619887|FG001|Overall Study|Other|1|||
150133158|NCT01137474|541619888|FG002|Overall Study|Other|0|||
150133159|NCT01137474|541619889|FG003|Overall Study|Other|0|||
150133160|NCT01137474|541619886|FG000|Overall Study|Pregnancy|0|||
150133161|NCT01137474|541619887|FG001|Overall Study|Pregnancy|1|||
150133162|NCT01137474|541619888|FG002|Overall Study|Pregnancy|0|||
150133163|NCT01137474|541619889|FG003|Overall Study|Pregnancy|0|||
150133164|NCT01137474|541619886|FG000|Overall Study|Administrative reason by sponsor|0|||
150133165|NCT01137474|541619887|FG001|Overall Study|Administrative reason by sponsor|1|||
150133166|NCT01137474|541619888|FG002|Overall Study|Administrative reason by sponsor|0|||
150133167|NCT01137474|541619889|FG003|Overall Study|Administrative reason by sponsor|0|||
150133168|NCT02525874|541619892|FG000|Overall Study|Other|1|||
150133169|NCT02525874|541619892|FG000|Overall Study|Investigator Decision|1|||
150133170|NCT02525874|541619892|FG000|Overall Study|Consent withdrawn|22|||
150133171|NCT02525874|541619892|FG000|Overall Study|Non-compliance with study drug|3|||
150133172|NCT02525874|541619892|FG000|Overall Study|Adverse Event|17|||
150133173|NCT02525874|541619892|FG000|Overall Study|Lost to Follow-up|7|||
150133174|NCT02525874|541619892|FG000|Overall Study|Disease progression, defined by protocol|2|||
150133175|NCT02525874|541619892|FG000|Overall Study|Disease relapse|4|||
150133176|NCT02525874|541619892|FG000|Overall Study|Alternative Treatment for MS|2|||
150133177|NCT02525874|541619892|FG000|Overall Study|New lesions in Brain|1|||
150133178|NCT01692782|541619893|FG000|Overall Study|Adverse Event|12|||
150133179|NCT01692782|541619894|FG001|Overall Study|Adverse Event|32|||
150133180|NCT01692782|541619895|FG002|Overall Study|Adverse Event|2|||
150133181|NCT01692782|541619893|FG000|Overall Study|Lack of Efficacy|1|||
150133182|NCT01692782|541619894|FG001|Overall Study|Lack of Efficacy|2|||
150133183|NCT01692782|541619895|FG002|Overall Study|Lack of Efficacy|0|||
150133184|NCT01692782|541619893|FG000|Overall Study|Lost to Follow-up|2|||
150198245|NCT01828112|541866340|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
150198246|NCT01828112|541866341|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
150198247|NCT01828112|541866339|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
150198248|NCT01828112|541866340|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
150198249|NCT01828112|541866341|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
150198250|NCT04308681|541866342|FG000|Pre-Treatment|Not reported|1|||
150198251|NCT04308681|541866343|FG001|Pre-Treatment|Not reported|1|||
150198252|NCT04308681|541866344|FG002|Pre-Treatment|Not reported|0|||
150198253|NCT04308681|541866345|FG003|Pre-Treatment|Not reported|0|||
150198254|NCT04308681|541866346|FG004|Pre-Treatment|Not reported|0|||
150198255|NCT04308681|541866347|FG005|Pre-Treatment|Not reported|2|||
150198256|NCT04308681|541866348|FG006|Pre-Treatment|Not reported|0|||
150198257|NCT04308681|541866349|FG007|Pre-Treatment|Not reported|0|||
150198258|NCT04308681|541866342|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
150198259|NCT04308681|541866343|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
150198260|NCT04308681|541866344|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
150133185|NCT01692782|541619894|FG001|Overall Study|Lost to Follow-up|7|||
150133186|NCT01692782|541619895|FG002|Overall Study|Lost to Follow-up|1|||
150133187|NCT01692782|541619893|FG000|Overall Study|Pregnancy|1|||
150133188|NCT01692782|541619894|FG001|Overall Study|Pregnancy|0|||
150133189|NCT01692782|541619895|FG002|Overall Study|Pregnancy|0|||
150133190|NCT01692782|541619893|FG000|Overall Study|Protocol Violation|1|||
150133191|NCT01692782|541619894|FG001|Overall Study|Protocol Violation|0|||
150133192|NCT01692782|541619895|FG002|Overall Study|Protocol Violation|2|||
150133193|NCT01692782|541619893|FG000|Overall Study|Non-complance with study drug|0|||
150133194|NCT01692782|541619894|FG001|Overall Study|Non-complance with study drug|4|||
150133195|NCT01692782|541619895|FG002|Overall Study|Non-complance with study drug|1|||
150133196|NCT01692782|541619893|FG000|Overall Study|Non-compliant with study visits|0|||
150133197|NCT01692782|541619894|FG001|Overall Study|Non-compliant with study visits|0|||
150133198|NCT01692782|541619895|FG002|Overall Study|Non-compliant with study visits|1|||
150133199|NCT01692782|541619893|FG000|Overall Study|SAE not related to study drug|0|||
150133200|NCT01692782|541619894|FG001|Overall Study|SAE not related to study drug|1|||
150133201|NCT01692782|541619895|FG002|Overall Study|SAE not related to study drug|0|||
150133202|NCT01692782|541619893|FG000|Overall Study|Withdrawal by Subject|3|||
150133203|NCT01692782|541619894|FG001|Overall Study|Withdrawal by Subject|10|||
150133204|NCT01692782|541619895|FG002|Overall Study|Withdrawal by Subject|3|||
150133205|NCT03945188|541619898|FG000|Overall Study|Protocol Violation|1|||
150133206|NCT03945188|541619899|FG001|Overall Study|Protocol Violation|0|||
150133207|NCT03945188|541619898|FG000|Overall Study|Disease worsening|79|||
150133208|NCT03945188|541619899|FG001|Overall Study|Disease worsening|73|||
150133209|NCT03945188|541619898|FG000|Overall Study|Physician Decision|2|||
150133210|NCT03945188|541619899|FG001|Overall Study|Physician Decision|2|||
150133211|NCT03945188|541619898|FG000|Overall Study|Lack of Efficacy|7|||
150133212|NCT03945188|541619899|FG001|Overall Study|Lack of Efficacy|4|||
150133213|NCT03945188|541619898|FG000|Overall Study|Pregnancy|2|||
150133214|NCT03945188|541619899|FG001|Overall Study|Pregnancy|0|||
150133215|NCT03945188|541619898|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
150133216|NCT03945188|541619899|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
150133217|NCT03945188|541619898|FG000|Overall Study|Adverse Event|10|||
150133218|NCT03945188|541619899|FG001|Overall Study|Adverse Event|5|||
150133219|NCT03945188|541619898|FG000|Overall Study|Other|2|||
150133220|NCT03945188|541619899|FG001|Overall Study|Other|2|||
150133221|NCT03945188|541619898|FG000|Overall Study|Lost to Follow-up|1|||
150133222|NCT03945188|541619899|FG001|Overall Study|Lost to Follow-up|2|||
150133223|NCT00423176|541619901|FG000|Overall Study|Adverse Event|4|||
150133224|NCT00423176|541619902|FG001|Overall Study|Adverse Event|6|||
150133225|NCT00423176|541619901|FG000|Overall Study|Treatment Failure|1|||
150133226|NCT00423176|541619902|FG001|Overall Study|Treatment Failure|6|||
150133227|NCT00423176|541619901|FG000|Overall Study|Lost to Follow-up|4|||
150133228|NCT00423176|541619902|FG001|Overall Study|Lost to Follow-up|7|||
150133229|NCT00423176|541619901|FG000|Overall Study|Withdrawal by Subject|4|||
150133230|NCT00423176|541619902|FG001|Overall Study|Withdrawal by Subject|3|||
150133231|NCT00423176|541619901|FG000|Overall Study|Protocol Violation|1|||
150133232|NCT00423176|541619902|FG001|Overall Study|Protocol Violation|3|||
150133233|NCT00423176|541619901|FG000|Overall Study|Did not meet protocol eligibility|2|||
150133234|NCT00423176|541619902|FG001|Overall Study|Did not meet protocol eligibility|4|||
150133235|NCT05554237|541619903|FG000|Part 2 (7 Days)|Adverse Event|0|||
150133236|NCT05554237|541619904|FG001|Part 2 (7 Days)|Adverse Event|0|||
150133237|NCT05554237|541619905|FG002|Part 2 (7 Days)|Adverse Event|0|||
150133238|NCT05554237|541619906|FG003|Part 2 (7 Days)|Adverse Event|0|||
150133239|NCT05554237|541619907|FG004|Part 2 (7 Days)|Adverse Event|2|||
150133240|NCT05554237|541619908|FG005|Part 2 (7 Days)|Adverse Event|0|||
150133241|NCT05554237|541619909|FG006|Part 2 (7 Days)|Adverse Event|0|||
150133242|NCT05554237|541619910|FG007|Part 2 (7 Days)|Adverse Event|0|||
150133243|NCT05554237|541619911|FG008|Part 2 (7 Days)|Adverse Event|0|||
150133244|NCT05554237|541619912|FG009|Part 2 (7 Days)|Adverse Event|1|||
150133245|NCT05554237|541619913|FG010|Part 2 (7 Days)|Adverse Event|0|||
150133246|NCT05554237|541619914|FG011|Part 2 (7 Days)|Adverse Event|0|||
150133247|NCT05554237|541619915|FG012|Part 2 (7 Days)|Adverse Event|1|||
150133248|NCT05554237|541619916|FG013|Part 2 (7 Days)|Adverse Event|0|||
150133249|NCT02477111|541619917|FG000|Overall Study|Death|28|||
150133250|NCT02477111|541619917|FG000|Overall Study|Withdrawal by Subject|19|||
150133251|NCT02477111|541619917|FG000|Overall Study|Lost to Follow-up|4|||
150133252|NCT01328574|541619918|FG000|Overall Study|Refused further treatment|1|||
150133253|NCT01152580|541619919|FG000|Overall Study|Withdrawal by Subject|0|||
150133254|NCT01152580|541619920|FG001|Overall Study|Withdrawal by Subject|1|||
150133255|NCT00113568|541619934|FG000|Overall Study|Adverse Event|97|||
150133256|NCT00113568|541619934|FG000|Overall Study|Death|1|||
150133257|NCT00113568|541619934|FG000|Overall Study|Lack of Efficacy|30|||
150133258|NCT00113568|541619934|FG000|Overall Study|Lost to Follow-up|156|||
150133259|NCT00113568|541619934|FG000|Overall Study|Protocol Violation|32|||
150133260|NCT00113568|541619934|FG000|Overall Study|Withdrawal by Subject|117|||
150133261|NCT00113568|541619934|FG000|Overall Study|Other|112|||
150133262|NCT02275065|541619936|FG000|Overall Study|Randomized but not treated|1|||
150133263|NCT02275065|541619937|FG001|Overall Study|Randomized but not treated|0|||
150133264|NCT02275065|541619938|FG002|Overall Study|Randomized but not treated|1|||
150133265|NCT02275065|541619939|FG003|Overall Study|Randomized but not treated|1|||
150133266|NCT02275065|541619940|FG004|Overall Study|Randomized but not treated|0|||
150133267|NCT01569438|541619949|FG000|Overall Study|Lack of Efficacy|1|||
150133268|NCT01569438|541619950|FG001|Overall Study|Lack of Efficacy|2|||
150133269|NCT01569438|541619949|FG000|Overall Study|Withdrawal by Subject|0|||
150133270|NCT01569438|541619950|FG001|Overall Study|Withdrawal by Subject|3|||
150133271|NCT01569438|541619949|FG000|Overall Study|Adverse Event|2|||
150133272|NCT01569438|541619950|FG001|Overall Study|Adverse Event|15|||
150133273|NCT01569438|541619949|FG000|Overall Study|Protocol Violation|2|||
150133274|NCT01569438|541619950|FG001|Overall Study|Protocol Violation|0|||
150133275|NCT01569438|541619949|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
150133276|NCT01569438|541619950|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
150133277|NCT01569438|541619949|FG000|Overall Study|Sponsor/Physician decision|1|||
150133278|NCT01569438|541619950|FG001|Overall Study|Sponsor/Physician decision|1|||
150133279|NCT01569438|541619949|FG000|Overall Study|Unable to adhere to study schedule|0|||
150133280|NCT01569438|541619950|FG001|Overall Study|Unable to adhere to study schedule|1|||
150133281|NCT01207102|541619951|FG000|Overall Study|Withdrawal by Subject|5|||
150133282|NCT01207102|541619951|FG000|Overall Study|Adverse Event|2|||
150133283|NCT01207102|541619951|FG000|Overall Study|progression|2|||
150133284|NCT01207102|541619951|FG000|Overall Study|Withdrawal by Treating Physician|1|||
150133285|NCT00736645|541619952|FG000|Overall Study|Adverse Event|0|||
150133286|NCT00736645|541619953|FG001|Overall Study|Adverse Event|2|||
150133287|NCT00736645|541619954|FG002|Overall Study|Adverse Event|0|||
150133288|NCT00736645|541619955|FG003|Overall Study|Adverse Event|0|||
150133289|NCT01330433|541619956|FG000|Overall Study|Death|1|||
150133290|NCT01330433|541619957|FG001|Overall Study|Death|3|||
150133291|NCT01330433|541619956|FG000|Overall Study|Lost to Follow-up|1|||
150133292|NCT01330433|541619957|FG001|Overall Study|Lost to Follow-up|0|||
150133293|NCT04899349|541619965|FG000|Overall Study|Study terminated by Sponsor|2|||
150133294|NCT04899349|541619966|FG001|Overall Study|Study terminated by Sponsor|0|||
150133295|NCT03240692|541619967|FG000|Overall Study|Physician Decision|1|||
150133296|NCT03240692|541619967|FG000|Overall Study|Withdrawal by Subject|1|||
150133297|NCT02300220|541619968|FG000|Overall Study|Lost to Follow-up|1|||
150133298|NCT02300220|541619969|FG001|Overall Study|Lost to Follow-up|2|||
150133299|NCT02300220|541619968|FG000|Overall Study|Death|1|||
150133300|NCT02300220|541619969|FG001|Overall Study|Death|1|||
150133301|NCT02300220|541619968|FG000|Overall Study|Adverse Event|1|||
150133302|NCT02300220|541619969|FG001|Overall Study|Adverse Event|1|||
150133303|NCT02300220|541619968|FG000|Overall Study|Protocol Violation|1|||
150133304|NCT02300220|541619969|FG001|Overall Study|Protocol Violation|0|||
150133305|NCT02300220|541619968|FG000|Overall Study|Withdrawal by Subject|0|||
150133306|NCT02300220|541619969|FG001|Overall Study|Withdrawal by Subject|2|||
150133307|NCT02300220|541619968|FG000|Overall Study|Did not tolerate IMP|0|||
150133308|NCT02300220|541619969|FG001|Overall Study|Did not tolerate IMP|1|||
150133309|NCT04891419|541619970|FG000|Overall Study|Withdrawal by Subject|4|||
150133310|NCT04891419|541619971|FG001|Overall Study|Withdrawal by Subject|0|||
150133311|NCT04891419|541619970|FG000|Overall Study|Lost to Follow-up|1|||
150133312|NCT04891419|541619971|FG001|Overall Study|Lost to Follow-up|3|||
150133313|NCT00127101|541619972|FG000|Base Protocol|Adverse Event|0|||
150133314|NCT00127101|541619973|FG001|Base Protocol|Adverse Event|2|||
150133315|NCT00127101|541619974|FG002|Base Protocol|Adverse Event|1|||
150133316|NCT00127101|541619975|FG003|Base Protocol|Adverse Event|0|||
150133317|NCT00127101|541619976|FG004|Base Protocol|Adverse Event|0|||
150133318|NCT00127101|541619977|FG005|Base Protocol|Adverse Event|0|||
150133319|NCT00127101|541619972|FG000|Base Protocol|Lack of Efficacy|1|||
150133320|NCT00127101|541619973|FG001|Base Protocol|Lack of Efficacy|0|||
150133321|NCT00127101|541619974|FG002|Base Protocol|Lack of Efficacy|0|||
150133322|NCT00127101|541619975|FG003|Base Protocol|Lack of Efficacy|0|||
150133323|NCT00127101|541619976|FG004|Base Protocol|Lack of Efficacy|2|||
150133324|NCT00127101|541619977|FG005|Base Protocol|Lack of Efficacy|0|||
150133325|NCT00127101|541619972|FG000|Base Protocol|Withdrawal by Subject|1|||
150133326|NCT00127101|541619973|FG001|Base Protocol|Withdrawal by Subject|2|||
150133327|NCT00127101|541619974|FG002|Base Protocol|Withdrawal by Subject|1|||
150133328|NCT00127101|541619975|FG003|Base Protocol|Withdrawal by Subject|0|||
150133329|NCT00127101|541619976|FG004|Base Protocol|Withdrawal by Subject|0|||
150133330|NCT00127101|541619977|FG005|Base Protocol|Withdrawal by Subject|1|||
150133331|NCT00127101|541619972|FG000|Continuation Phase|Adverse Event|0|||
150133332|NCT00127101|541619973|FG001|Continuation Phase|Adverse Event|0|||
150133333|NCT00127101|541619974|FG002|Continuation Phase|Adverse Event|0|||
150133334|NCT00127101|541619975|FG003|Continuation Phase|Adverse Event|0|||
150133335|NCT00127101|541619976|FG004|Continuation Phase|Adverse Event|1|||
150133336|NCT00127101|541619977|FG005|Continuation Phase|Adverse Event|1|||
150133337|NCT00127101|541619972|FG000|Continuation Phase|Lack of Efficacy|0|||
150133338|NCT00127101|541619973|FG001|Continuation Phase|Lack of Efficacy|0|||
150133339|NCT00127101|541619974|FG002|Continuation Phase|Lack of Efficacy|0|||
150198261|NCT04308681|541866345|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
150198262|NCT04308681|541866346|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
150198263|NCT04308681|541866347|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
150198264|NCT04308681|541866348|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
150198265|NCT04308681|541866349|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
150198266|NCT04308681|541866342|FG000|Treatment up to Week 26|Other reasons|2|||
150198267|NCT04308681|541866343|FG001|Treatment up to Week 26|Other reasons|0|||
150198268|NCT04308681|541866344|FG002|Treatment up to Week 26|Other reasons|0|||
150198269|NCT04308681|541866345|FG003|Treatment up to Week 26|Other reasons|0|||
150198270|NCT04308681|541866346|FG004|Treatment up to Week 26|Other reasons|1|||
150198271|NCT04308681|541866347|FG005|Treatment up to Week 26|Other reasons|1|||
150198272|NCT04308681|541866348|FG006|Treatment up to Week 26|Other reasons|0|||
150198273|NCT04308681|541866349|FG007|Treatment up to Week 26|Other reasons|0|||
150198274|NCT04308681|541866342|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
150198275|NCT04308681|541866343|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
150198276|NCT04308681|541866344|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
150198277|NCT04308681|541866345|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
150198278|NCT04308681|541866346|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
150198279|NCT04308681|541866347|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
150198280|NCT04308681|541866348|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
150198281|NCT04308681|541866349|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
150198282|NCT04308681|541866342|FG000|Treatment up to Week 26|Adverse Event|6|||
150198283|NCT04308681|541866343|FG001|Treatment up to Week 26|Adverse Event|5|||
150198284|NCT04308681|541866344|FG002|Treatment up to Week 26|Adverse Event|5|||
150198285|NCT04308681|541866345|FG003|Treatment up to Week 26|Adverse Event|0|||
150198286|NCT04308681|541866346|FG004|Treatment up to Week 26|Adverse Event|6|||
150198287|NCT04308681|541866347|FG005|Treatment up to Week 26|Adverse Event|1|||
150198288|NCT04308681|541866348|FG006|Treatment up to Week 26|Adverse Event|0|||
150198289|NCT04308681|541866349|FG007|Treatment up to Week 26|Adverse Event|0|||
150198290|NCT04308681|541866342|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198291|NCT04308681|541866343|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
150198292|NCT04308681|541866344|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
150198293|NCT04308681|541866345|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198294|NCT04308681|541866346|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198295|NCT04308681|541866347|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198296|NCT04308681|541866348|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198297|NCT04308681|541866349|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
150198298|NCT04308681|541866342|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
150198299|NCT04308681|541866343|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
150198300|NCT04308681|541866344|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
150198301|NCT04308681|541866345|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
150198302|NCT04308681|541866346|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
150198303|NCT04308681|541866347|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
150198304|NCT04308681|541866348|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
150198305|NCT04308681|541866349|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
150198306|NCT04308681|541866342|FG000|OTE - 26 Weeks|Death|0|||
150198307|NCT04308681|541866343|FG001|OTE - 26 Weeks|Death|1|||
150198308|NCT04308681|541866344|FG002|OTE - 26 Weeks|Death|0|||
150198309|NCT04308681|541866345|FG003|OTE - 26 Weeks|Death|0|||
150198310|NCT04308681|541866346|FG004|OTE - 26 Weeks|Death|0|||
150198311|NCT04308681|541866347|FG005|OTE - 26 Weeks|Death|0|||
150198312|NCT04308681|541866348|FG006|OTE - 26 Weeks|Death|1|||
150198313|NCT04308681|541866349|FG007|OTE - 26 Weeks|Death|0|||
150198314|NCT04308681|541866342|FG000|OTE - 26 Weeks|Adverse Event|0|||
150198315|NCT04308681|541866343|FG001|OTE - 26 Weeks|Adverse Event|2|||
150198316|NCT04308681|541866344|FG002|OTE - 26 Weeks|Adverse Event|8|||
150198317|NCT04308681|541866345|FG003|OTE - 26 Weeks|Adverse Event|3|||
150198318|NCT04308681|541866346|FG004|OTE - 26 Weeks|Adverse Event|0|||
150198319|NCT04308681|541866347|FG005|OTE - 26 Weeks|Adverse Event|1|||
150198320|NCT04308681|541866348|FG006|OTE - 26 Weeks|Adverse Event|2|||
150198321|NCT04308681|541866349|FG007|OTE - 26 Weeks|Adverse Event|0|||
150198322|NCT04308681|541866342|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
150198323|NCT04308681|541866343|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
150198324|NCT04308681|541866344|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
150198325|NCT04308681|541866345|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
150198326|NCT04308681|541866346|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
150198327|NCT04308681|541866347|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
150198328|NCT04308681|541866348|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
150198329|NCT04308681|541866349|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
150198330|NCT05873556|541866356|FG000|Overall Study|Lost to Follow-up|4|||
150198331|NCT05873556|541866357|FG001|Overall Study|Lost to Follow-up|1|||
150198332|NCT03606408|541866359|FG000|Overall Study|Adverse Event|13|||
150198333|NCT03606408|541866359|FG000|Overall Study|Withdrawal by Subject|7|||
150198334|NCT03606408|541866359|FG000|Overall Study|Physician Decision|4|||
150198335|NCT03606408|541866359|FG000|Overall Study|Lack of Efficacy|2|||
150198336|NCT03606408|541866359|FG000|Overall Study|Death|1|||
150198337|NCT03606408|541866359|FG000|Overall Study|new therapy for study indication|1|||
150198338|NCT04689256|541866360|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
150198339|NCT04689256|541866361|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
150198340|NCT03556293|541866362|FG000|Overall Study|Ineligible for analysis|1904|||
150198341|NCT03556293|541866363|FG001|Overall Study|Ineligible for analysis|1471|||
150198342|NCT03556293|541866364|FG002|Overall Study|Ineligible for analysis|1091|||
150198343|NCT03556293|541866365|FG003|Overall Study|Ineligible for analysis|1269|||
150198344|NCT04862234|541866373|FG000|Overall Study|Surgery cancellation|1|||
150198345|NCT04862234|541866374|FG001|Overall Study|Surgery cancellation|2|||
150198346|NCT04862234|541866373|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
150198347|NCT04862234|541866374|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
150198348|NCT04862234|541866373|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
150198349|NCT04862234|541866374|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
150198350|NCT04132518|541866377|FG000|Overall Study|Prematurely withdrawn from the study|0|||
150198351|NCT04132518|541866378|FG001|Overall Study|Prematurely withdrawn from the study|9|||
150198352|NCT04132518|541866379|FG002|Overall Study|Prematurely withdrawn from the study|1|||
150198353|NCT05425420|541866381|FG000|Overall Study|Physician Decision|1|||
150198354|NCT05425420|541866381|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
150198355|NCT03673501|541866382|FG000|Overall Study|Participants ongoing.|36|||
150198356|NCT03673501|541866383|FG001|Overall Study|Participants ongoing.|24|||
150198357|NCT04599634|541866384|FG000|Overall Study|Dose limiting toxicity|0|||
150198358|NCT04599634|541866385|FG001|Overall Study|Dose limiting toxicity|0|||
150198359|NCT04599634|541866386|FG002|Overall Study|Dose limiting toxicity|2|||
150198360|NCT04599634|541866387|FG003|Overall Study|Dose limiting toxicity|0|||
150198361|NCT02631746|541866395|FG000|Overall Study|Lack of Efficacy|3|||
150198362|NCT04571619|541866396|FG000|Phase 1|Death|22|||
150198363|NCT04571619|541866397|FG001|Phase 1|Death|18|||
150198364|NCT04571619|541866396|FG000|Phase 1|Withdrawal by Subject|7|||
150198365|NCT04571619|541866397|FG001|Phase 1|Withdrawal by Subject|2|||
150198366|NCT04571619|541866396|FG000|Phase 2|Death|13|||
150198367|NCT04571619|541866397|FG001|Phase 2|Death|16|||
150198368|NCT04571619|541866396|FG000|Phase 2|Withdrawal by Subject|6|||
150198369|NCT04571619|541866397|FG001|Phase 2|Withdrawal by Subject|4|||
150198370|NCT04167553|541866398|FG000|Overall Study|Withdrawal by Subject|1|||
150198371|NCT04167553|541866399|FG001|Overall Study|Withdrawal by Subject|0|||
150198372|NCT04167553|541866400|FG002|Overall Study|Withdrawal by Subject|1|||
150198373|NCT04167553|541866401|FG003|Overall Study|Withdrawal by Subject|2|||
150198374|NCT04167553|541866402|FG004|Overall Study|Withdrawal by Subject|1|||
150198375|NCT04167553|541866403|FG005|Overall Study|Withdrawal by Subject|0|||
150198376|NCT04167553|541866404|FG006|Overall Study|Withdrawal by Subject|0|||
150198377|NCT04167553|541866398|FG000|Overall Study|Physician Decision|0|||
150198378|NCT04167553|541866399|FG001|Overall Study|Physician Decision|0|||
150198379|NCT04167553|541866400|FG002|Overall Study|Physician Decision|0|||
150198380|NCT04167553|541866401|FG003|Overall Study|Physician Decision|0|||
150198381|NCT04167553|541866402|FG004|Overall Study|Physician Decision|2|||
150198382|NCT04167553|541866403|FG005|Overall Study|Physician Decision|2|||
150198383|NCT04167553|541866404|FG006|Overall Study|Physician Decision|0|||
150198384|NCT04167553|541866398|FG000|Overall Study|Lost to Follow-up|0|||
150198385|NCT04167553|541866399|FG001|Overall Study|Lost to Follow-up|0|||
150198386|NCT04167553|541866400|FG002|Overall Study|Lost to Follow-up|2|||
150198387|NCT04167553|541866401|FG003|Overall Study|Lost to Follow-up|0|||
150198388|NCT04167553|541866402|FG004|Overall Study|Lost to Follow-up|0|||
150198389|NCT04167553|541866403|FG005|Overall Study|Lost to Follow-up|0|||
150198390|NCT04167553|541866404|FG006|Overall Study|Lost to Follow-up|0|||
150198391|NCT04479761|541866406|FG000|Overall Study|could not perform the balance tasks|1|||
150198392|NCT04479761|541866407|FG001|Overall Study|could not perform the balance tasks|0|||
150198393|NCT04479761|541866408|FG002|Overall Study|could not perform the balance tasks|0|||
150198394|NCT04479761|541866406|FG000|Overall Study|Adverse Event|1|||
150198395|NCT04479761|541866407|FG001|Overall Study|Adverse Event|0|||
150198396|NCT04479761|541866408|FG002|Overall Study|Adverse Event|0|||
150198397|NCT04479761|541866406|FG000|Overall Study|one control did not meet screening criteria|0|||
150198398|NCT04479761|541866407|FG001|Overall Study|one control did not meet screening criteria|0|||
150198399|NCT04479761|541866408|FG002|Overall Study|one control did not meet screening criteria|1|||
150198400|NCT04479761|541866406|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
150198401|NCT04479761|541866407|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
150198402|NCT04479761|541866408|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
150198403|NCT04183283|541868256|FG000|Period 1|Withdrawal by Subject|0|||
150198404|NCT04183283|541868257|FG001|Period 1|Withdrawal by Subject|1|||
150198405|NCT04183283|541868258|FG002|Period 1|Withdrawal by Subject|0|||
150198406|NCT04183283|541868259|FG003|Period 1|Withdrawal by Subject|0|||
150198407|NCT04183283|541868256|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
150198408|NCT04183283|541868257|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
150198409|NCT04183283|541868258|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
150198410|NCT04183283|541868259|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
150198411|NCT03220035|541868261|FG000|Overall Study|Adverse Event|1|||
150198412|NCT03220035|541868261|FG000|Overall Study|Protocol Violation|1|||
150198413|NCT03220035|541868261|FG000|Overall Study|Progressive Disease|2|||
150198414|NCT05452460|541868262|FG000|Overall Study|Lost to Follow-up|3|||
150198415|NCT05452460|541868263|FG001|Overall Study|Lost to Follow-up|3|||
150198416|NCT05452460|541868262|FG000|Overall Study|Did not receive intervention|1|||
150198417|NCT05452460|541868263|FG001|Overall Study|Did not receive intervention|0|||
150198418|NCT03676192|541868266|FG000|Induction Study Period|Adverse Event|21|||
150198419|NCT03676192|541868267|FG001|Induction Study Period|Adverse Event|20|||
150198420|NCT03676192|541868266|FG000|Induction Study Period|Death|23|||
150198421|NCT03676192|541868267|FG001|Induction Study Period|Death|20|||
150198422|NCT03676192|541868266|FG000|Induction Study Period|Lost to Follow-up|3|||
150198423|NCT03676192|541868267|FG001|Induction Study Period|Lost to Follow-up|3|||
150198424|NCT03676192|541868266|FG000|Induction Study Period|Physician Decision|6|||
150198425|NCT03676192|541868267|FG001|Induction Study Period|Physician Decision|3|||
150198426|NCT03676192|541868266|FG000|Induction Study Period|Progressive Disease|32|||
150198427|NCT03676192|541868267|FG001|Induction Study Period|Progressive Disease|21|||
150198428|NCT03676192|541868266|FG000|Induction Study Period|Protocol Violation|1|||
150198429|NCT03676192|541868267|FG001|Induction Study Period|Protocol Violation|2|||
150198430|NCT03676192|541868266|FG000|Induction Study Period|Withdrawal by Subject|20|||
150198431|NCT03676192|541868267|FG001|Induction Study Period|Withdrawal by Subject|15|||
150198432|NCT03386578|541868269|FG000|PK Component|Lost to Follow-up|0|||
150198433|NCT03386578|541868270|FG001|PK Component|Lost to Follow-up|1|||
150198434|NCT03386578|541868271|FG002|PK Component|Lost to Follow-up|0|||
150198435|NCT03386578|541868272|FG003|PK Component|Lost to Follow-up|0|||
150198436|NCT03386578|541868273|FG004|PK Component|Lost to Follow-up|0|||
150198437|NCT03386578|541868274|FG005|PK Component|Lost to Follow-up|0|||
150198438|NCT03386578|541868275|FG006|PK Component|Lost to Follow-up|1|||
150198439|NCT03386578|541868276|FG007|PK Component|Lost to Follow-up|0|||
150198440|NCT03386578|541868277|FG008|PK Component|Lost to Follow-up|0|||
150198441|NCT03386578|541868278|FG009|PK Component|Lost to Follow-up|0|||
150198442|NCT03386578|541868269|FG000|PK Component|Stillbirth/Abortion|0|||
150198443|NCT03386578|541868270|FG001|PK Component|Stillbirth/Abortion|0|||
150198444|NCT03386578|541868271|FG002|PK Component|Stillbirth/Abortion|0|||
150198445|NCT03386578|541868272|FG003|PK Component|Stillbirth/Abortion|0|||
150198446|NCT03386578|541868273|FG004|PK Component|Stillbirth/Abortion|0|||
150198447|NCT03386578|541868274|FG005|PK Component|Stillbirth/Abortion|2|||
150198448|NCT03386578|541868275|FG006|PK Component|Stillbirth/Abortion|0|||
150198449|NCT03386578|541868276|FG007|PK Component|Stillbirth/Abortion|0|||
150198450|NCT03386578|541868277|FG008|PK Component|Stillbirth/Abortion|0|||
150198451|NCT03386578|541868278|FG009|PK Component|Stillbirth/Abortion|0|||
150198452|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198453|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198454|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
150198455|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
150198456|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198457|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198458|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198459|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
150198460|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
150198461|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
150198462|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198463|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198464|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
150198465|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
150198466|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198467|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198468|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198469|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
150198470|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
150198471|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
150198472|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Death|0|||
150198473|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Death|0|||
150198474|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Death|1|||
150198475|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Death|0|||
150198476|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Death|0|||
150198477|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Death|0|||
150198478|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Death|0|||
150198479|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Death|9|||
150198480|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Death|5|||
150198481|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Death|0|||
150198482|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198483|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198484|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198485|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
150198486|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198487|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198488|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198489|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198490|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
150198491|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
150198492|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198493|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198494|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198495|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198496|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198497|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198498|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198499|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
150198500|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
150198501|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
150198502|NCT03386578|541868269|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198503|NCT03386578|541868270|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198504|NCT03386578|541868271|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198505|NCT03386578|541868272|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198506|NCT03386578|541868273|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198507|NCT03386578|541868274|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198508|NCT03386578|541868275|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198509|NCT03386578|541868276|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
150198510|NCT03386578|541868277|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
150198511|NCT03386578|541868278|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
150198512|NCT02694822|541868281|FG000|Phase 1|Death|2|||
150198513|NCT02694822|541868282|FG001|Phase 1|Death|1|||
150198514|NCT02694822|541868283|FG002|Phase 1|Death|6|||
150198515|NCT02694822|541868284|FG003|Phase 1|Death|6|||
150198516|NCT02694822|541868285|FG004|Phase 1|Death|3|||
150198517|NCT02694822|541868286|FG005|Phase 1|Death|0|||
150198518|NCT02694822|541868281|FG000|Phase 1|Withdrawal by Subject|2|||
150198519|NCT02694822|541868282|FG001|Phase 1|Withdrawal by Subject|2|||
150198520|NCT02694822|541868283|FG002|Phase 1|Withdrawal by Subject|4|||
150198521|NCT02694822|541868284|FG003|Phase 1|Withdrawal by Subject|8|||
150198522|NCT02694822|541868285|FG004|Phase 1|Withdrawal by Subject|1|||
150198523|NCT02694822|541868286|FG005|Phase 1|Withdrawal by Subject|0|||
150198524|NCT02694822|541868281|FG000|Phase 2|Death|0|||
150198525|NCT02694822|541868282|FG001|Phase 2|Death|0|||
150198526|NCT02694822|541868283|FG002|Phase 2|Death|0|||
150198527|NCT02694822|541868284|FG003|Phase 2|Death|0|||
150198528|NCT02694822|541868285|FG004|Phase 2|Death|0|||
150198529|NCT02694822|541868286|FG005|Phase 2|Death|26|||
150198530|NCT02694822|541868281|FG000|Phase 2|Withdrawal by Subject|0|||
150198531|NCT02694822|541868282|FG001|Phase 2|Withdrawal by Subject|0|||
150198532|NCT02694822|541868283|FG002|Phase 2|Withdrawal by Subject|0|||
150198533|NCT02694822|541868284|FG003|Phase 2|Withdrawal by Subject|0|||
150198534|NCT02694822|541868285|FG004|Phase 2|Withdrawal by Subject|0|||
150198535|NCT02694822|541868286|FG005|Phase 2|Withdrawal by Subject|13|||
150198536|NCT02694822|541868281|FG000|Phase 2|Administrative Study Closure|0|||
150198537|NCT02694822|541868282|FG001|Phase 2|Administrative Study Closure|0|||
150198538|NCT02694822|541868283|FG002|Phase 2|Administrative Study Closure|0|||
150198539|NCT02694822|541868284|FG003|Phase 2|Administrative Study Closure|0|||
150198540|NCT02694822|541868285|FG004|Phase 2|Administrative Study Closure|0|||
150198541|NCT02694822|541868286|FG005|Phase 2|Administrative Study Closure|2|||
150198542|NCT02694822|541868281|FG000|Phase 2|Lost to Follow-up|0|||
150198543|NCT02694822|541868282|FG001|Phase 2|Lost to Follow-up|0|||
150198544|NCT02694822|541868283|FG002|Phase 2|Lost to Follow-up|0|||
150198545|NCT02694822|541868284|FG003|Phase 2|Lost to Follow-up|0|||
150198546|NCT02694822|541868285|FG004|Phase 2|Lost to Follow-up|0|||
150198547|NCT02694822|541868286|FG005|Phase 2|Lost to Follow-up|1|||
150198548|NCT02694822|541868281|FG000|Phase 2|Participant Transferred to Another Site|0|||
150198549|NCT02694822|541868282|FG001|Phase 2|Participant Transferred to Another Site|0|||
150198550|NCT02694822|541868283|FG002|Phase 2|Participant Transferred to Another Site|0|||
150198551|NCT02694822|541868284|FG003|Phase 2|Participant Transferred to Another Site|0|||
150198552|NCT02694822|541868285|FG004|Phase 2|Participant Transferred to Another Site|0|||
150198553|NCT02694822|541868286|FG005|Phase 2|Participant Transferred to Another Site|1|||
150198554|NCT02424617|541868287|FG000|Overall Study|Adverse Event|0|||
150198555|NCT02424617|541868288|FG001|Overall Study|Adverse Event|1|||
150198556|NCT02424617|541868289|FG002|Overall Study|Adverse Event|0|||
150198557|NCT02424617|541868290|FG003|Overall Study|Adverse Event|0|||
150198558|NCT02424617|541868287|FG000|Overall Study|Investigator Decision|0|||
150198559|NCT02424617|541868288|FG001|Overall Study|Investigator Decision|0|||
150198560|NCT02424617|541868289|FG002|Overall Study|Investigator Decision|0|||
150198561|NCT02424617|541868290|FG003|Overall Study|Investigator Decision|1|||
150198562|NCT02424617|541868287|FG000|Overall Study|Withdrawal by Subject|1|||
150198563|NCT02424617|541868288|FG001|Overall Study|Withdrawal by Subject|1|||
150198564|NCT02424617|541868289|FG002|Overall Study|Withdrawal by Subject|0|||
150198565|NCT02424617|541868290|FG003|Overall Study|Withdrawal by Subject|1|||
150198566|NCT02424617|541868287|FG000|Overall Study|Progressive Disease|7|||
150198567|NCT02424617|541868288|FG001|Overall Study|Progressive Disease|6|||
150198568|NCT02424617|541868289|FG002|Overall Study|Progressive Disease|11|||
150198569|NCT02424617|541868290|FG003|Overall Study|Progressive Disease|10|||
150198570|NCT02424617|541868287|FG000|Overall Study|Other|0|||
150198571|NCT02424617|541868288|FG001|Overall Study|Other|0|||
150198572|NCT02424617|541868289|FG002|Overall Study|Other|0|||
150198573|NCT02424617|541868290|FG003|Overall Study|Other|1|||
150198574|NCT01868997|541868291|FG000|Overall Study|Adverse Event|2|||
150198575|NCT01868997|541868292|FG001|Overall Study|Adverse Event|5|||
150198576|NCT01868997|541868291|FG000|Overall Study|Lack of Efficacy|2|||
150198577|NCT01868997|541868292|FG001|Overall Study|Lack of Efficacy|0|||
150198578|NCT01868997|541868291|FG000|Overall Study|Other|3|||
150198579|NCT01868997|541868292|FG001|Overall Study|Other|1|||
150198580|NCT01960452|541868293|FG000|Overall Study|Withdrawal by Subject|2|||
150198581|NCT01960452|541868294|FG001|Overall Study|Withdrawal by Subject|1|||
150198582|NCT01960452|541868293|FG000|Overall Study|Sleep apnea in Night 1|1|||
150198583|NCT01960452|541868294|FG001|Overall Study|Sleep apnea in Night 1|0|||
150198584|NCT01960452|541868293|FG000|Overall Study|Poor Sleep in Night 1|0|||
150198585|NCT01960452|541868294|FG001|Overall Study|Poor Sleep in Night 1|2|||
150198586|NCT01960452|541868293|FG000|Overall Study|No Sex/Age Match Night 1|1|||
150198587|NCT01960452|541868294|FG001|Overall Study|No Sex/Age Match Night 1|0|||
150198588|NCT01960452|541868293|FG000|Overall Study|No Sex/Age Match Night 2|0|||
150198589|NCT01960452|541868294|FG001|Overall Study|No Sex/Age Match Night 2|2|||
150198590|NCT01960452|541868293|FG000|Overall Study|Technical Difficulties Night 2|2|||
150198591|NCT01960452|541868294|FG001|Overall Study|Technical Difficulties Night 2|0|||
150198592|NCT04766892|541868297|FG000|Overall Study|Withdrawal by Subject|1|||
150198593|NCT04766892|541868297|FG000|Overall Study|Lost to Follow-up|1|||
150198594|NCT04766892|541868297|FG000|Overall Study|Adverse Event|3|||
150198595|NCT04766892|541868297|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
150198596|NCT04730739|541868298|FG000|Overall Study|Death|1|||
150198597|NCT03308877|541868299|FG000|Overall Study|Lost to Follow-up|32|||
150198598|NCT03308877|541868300|FG001|Overall Study|Lost to Follow-up|28|||
150198599|NCT05646355|541868311|FG000|Overall Study|Lost to Follow-up|1|||
150198600|NCT05646355|541868312|FG001|Overall Study|Lost to Follow-up|0|||
150198601|NCT05646355|541868311|FG000|Overall Study|translated materials not available for pilot|2|||
150198602|NCT05646355|541868312|FG001|Overall Study|translated materials not available for pilot|0|||
150198603|NCT05646355|541868311|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
150198604|NCT05646355|541868312|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
150198605|NCT03523572|541868315|FG000|Dose Escalation|Progressive disease|1|||
150198606|NCT03523572|541868316|FG001|Dose Escalation|Progressive disease|0|||
150198607|NCT03523572|541868317|FG002|Dose Escalation|Progressive disease|0|||
150198608|NCT03523572|541868318|FG003|Dose Escalation|Progressive disease|0|||
150198609|NCT03523572|541868319|FG004|Dose Escalation|Progressive disease|0|||
150198610|NCT03523572|541868320|FG005|Dose Escalation|Progressive disease|0|||
150133340|NCT00127101|541619975|FG003|Continuation Phase|Lack of Efficacy|0|||
150133341|NCT00127101|541619976|FG004|Continuation Phase|Lack of Efficacy|0|||
150133342|NCT00127101|541619977|FG005|Continuation Phase|Lack of Efficacy|1|||
150133343|NCT00127101|541619972|FG000|Continuation Phase|Withdrawal by Subject|0|||
150133344|NCT00127101|541619973|FG001|Continuation Phase|Withdrawal by Subject|0|||
150133345|NCT00127101|541619974|FG002|Continuation Phase|Withdrawal by Subject|1|||
150133346|NCT00127101|541619975|FG003|Continuation Phase|Withdrawal by Subject|0|||
150133347|NCT00127101|541619976|FG004|Continuation Phase|Withdrawal by Subject|2|||
150133348|NCT00127101|541619977|FG005|Continuation Phase|Withdrawal by Subject|1|||
150133349|NCT02291614|541619978|FG000|Overall Study|Lost to Follow-up|0|||
150133350|NCT02291614|541619979|FG001|Overall Study|Lost to Follow-up|0|||
150133351|NCT02291614|541619980|FG002|Overall Study|Lost to Follow-up|0|||
150133352|NCT02291614|541619981|FG003|Overall Study|Lost to Follow-up|0|||
150133353|NCT02291614|541619982|FG004|Overall Study|Lost to Follow-up|0|||
150133354|NCT02291614|541619983|FG005|Overall Study|Lost to Follow-up|0|||
150133355|NCT02291614|541619984|FG006|Overall Study|Lost to Follow-up|0|||
150133356|NCT02291614|541619985|FG007|Overall Study|Lost to Follow-up|1|||
150133357|NCT02291614|541619986|FG008|Overall Study|Lost to Follow-up|0|||
150133358|NCT02291614|541619987|FG009|Overall Study|Lost to Follow-up|0|||
150133359|NCT02291614|541619988|FG010|Overall Study|Lost to Follow-up|0|||
150133360|NCT02291614|541619978|FG000|Overall Study|Withdrawal by Subject|0|||
150133361|NCT02291614|541619979|FG001|Overall Study|Withdrawal by Subject|1|||
150133362|NCT02291614|541619980|FG002|Overall Study|Withdrawal by Subject|0|||
150133363|NCT02291614|541619981|FG003|Overall Study|Withdrawal by Subject|0|||
150133364|NCT02291614|541619982|FG004|Overall Study|Withdrawal by Subject|0|||
150133365|NCT02291614|541619983|FG005|Overall Study|Withdrawal by Subject|0|||
150133366|NCT02291614|541619984|FG006|Overall Study|Withdrawal by Subject|0|||
150133367|NCT02291614|541619985|FG007|Overall Study|Withdrawal by Subject|0|||
150133368|NCT02291614|541619986|FG008|Overall Study|Withdrawal by Subject|0|||
150133369|NCT02291614|541619987|FG009|Overall Study|Withdrawal by Subject|2|||
150133370|NCT02291614|541619988|FG010|Overall Study|Withdrawal by Subject|2|||
150133371|NCT02291614|541619978|FG000|Overall Study|Decision by sponsor|0|||
150133372|NCT02291614|541619979|FG001|Overall Study|Decision by sponsor|0|||
150133373|NCT02291614|541619980|FG002|Overall Study|Decision by sponsor|0|||
150133374|NCT02291614|541619981|FG003|Overall Study|Decision by sponsor|1|||
150133375|NCT02291614|541619982|FG004|Overall Study|Decision by sponsor|0|||
150133376|NCT02291614|541619983|FG005|Overall Study|Decision by sponsor|0|||
150133377|NCT02291614|541619984|FG006|Overall Study|Decision by sponsor|0|||
150133378|NCT02291614|541619985|FG007|Overall Study|Decision by sponsor|0|||
150133379|NCT02291614|541619986|FG008|Overall Study|Decision by sponsor|0|||
150133380|NCT02291614|541619987|FG009|Overall Study|Decision by sponsor|0|||
150133381|NCT02291614|541619988|FG010|Overall Study|Decision by sponsor|0|||
150133382|NCT02291614|541619978|FG000|Overall Study|Death|0|||
150133383|NCT02291614|541619979|FG001|Overall Study|Death|0|||
150133384|NCT02291614|541619980|FG002|Overall Study|Death|1|||
150133385|NCT02291614|541619981|FG003|Overall Study|Death|0|||
150133386|NCT02291614|541619982|FG004|Overall Study|Death|1|||
150133387|NCT02291614|541619983|FG005|Overall Study|Death|1|||
150133388|NCT02291614|541619984|FG006|Overall Study|Death|1|||
150133389|NCT02291614|541619985|FG007|Overall Study|Death|0|||
150133390|NCT02291614|541619986|FG008|Overall Study|Death|0|||
150133391|NCT02291614|541619987|FG009|Overall Study|Death|0|||
150133392|NCT02291614|541619988|FG010|Overall Study|Death|0|||
150133393|NCT00843167|541619989|FG000|Treatment Period|Adverse Event|1|||
150133394|NCT00843167|541619990|FG001|Treatment Period|Adverse Event|5|||
150133395|NCT00843167|541619989|FG000|Treatment Period|Withdrawal by Subject|2|||
150133396|NCT00843167|541619990|FG001|Treatment Period|Withdrawal by Subject|3|||
150133397|NCT02432105|541619995|FG000|Overall Study|Lost to Follow-up|1|||
150133398|NCT02432105|541619996|FG001|Overall Study|Lost to Follow-up|1|||
150133399|NCT02432105|541619997|FG002|Overall Study|Lost to Follow-up|0|||
150133400|NCT02432105|541619995|FG000|Overall Study|Withdrawal by Subject|1|||
150133401|NCT02432105|541619996|FG001|Overall Study|Withdrawal by Subject|0|||
150133402|NCT02432105|541619997|FG002|Overall Study|Withdrawal by Subject|1|||
150133403|NCT02432105|541619995|FG000|Overall Study|Culture positive for yeast|0|||
150133404|NCT02432105|541619996|FG001|Overall Study|Culture positive for yeast|1|||
150133405|NCT02432105|541619997|FG002|Overall Study|Culture positive for yeast|0|||
150133406|NCT02432105|541619995|FG000|Overall Study|Randomized in error|0|||
150133407|NCT02432105|541619996|FG001|Overall Study|Randomized in error|0|||
150133408|NCT02432105|541619997|FG002|Overall Study|Randomized in error|2|||
150133409|NCT04302350|541619999|FG000|Overall Study|Physician Decision|1|||
150133410|NCT04302350|541620000|FG001|Overall Study|Physician Decision|1|||
150133411|NCT04302350|541620001|FG002|Overall Study|Physician Decision|2|||
150133412|NCT04302350|541619999|FG000|Overall Study|Lack of Efficacy|1|||
150133413|NCT04302350|541620000|FG001|Overall Study|Lack of Efficacy|1|||
150133414|NCT04302350|541620001|FG002|Overall Study|Lack of Efficacy|4|||
150133415|NCT04302350|541619999|FG000|Overall Study|Adverse Event|0|||
150133416|NCT04302350|541620000|FG001|Overall Study|Adverse Event|1|||
150133417|NCT04302350|541620001|FG002|Overall Study|Adverse Event|2|||
150133418|NCT02012491|541620004|FG000|Overall Study|Lost to Follow-up|1|||
150133419|NCT02012491|541620005|FG001|Overall Study|Lost to Follow-up|0|||
150133420|NCT02012491|541620004|FG000|Overall Study|Protocol Violation|0|||
150133421|NCT02012491|541620005|FG001|Overall Study|Protocol Violation|1|||
150133422|NCT02012491|541620004|FG000|Overall Study|Withdrawal by Subject|1|||
150133423|NCT02012491|541620005|FG001|Overall Study|Withdrawal by Subject|0|||
150133424|NCT05608629|541620016|FG000|Overall Study|Lost to Follow-up|2|||
150133425|NCT03969719|541620017|FG000|Overall Study|Other reasons not specified|1|||
150133426|NCT03969719|541620018|FG001|Overall Study|Other reasons not specified|1|||
150133427|NCT03969719|541620019|FG002|Overall Study|Other reasons not specified|3|||
150133428|NCT03969719|541620017|FG000|Overall Study|Withdrawal by Subject|2|||
150133429|NCT03969719|541620018|FG001|Overall Study|Withdrawal by Subject|3|||
150133430|NCT03969719|541620019|FG002|Overall Study|Withdrawal by Subject|2|||
150133431|NCT03969719|541620017|FG000|Overall Study|Protocol Violation|1|||
150133432|NCT03969719|541620018|FG001|Overall Study|Protocol Violation|2|||
150133433|NCT03969719|541620019|FG002|Overall Study|Protocol Violation|0|||
150133434|NCT03969719|541620017|FG000|Overall Study|Adverse Event|0|||
150133435|NCT03969719|541620018|FG001|Overall Study|Adverse Event|2|||
150133436|NCT03969719|541620019|FG002|Overall Study|Adverse Event|0|||
150133437|NCT03969719|541620017|FG000|Overall Study|Lost to Follow-up|0|||
150133438|NCT03969719|541620018|FG001|Overall Study|Lost to Follow-up|1|||
150133439|NCT03969719|541620019|FG002|Overall Study|Lost to Follow-up|0|||
150133440|NCT02130193|541620020|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
150133441|NCT02130193|541620021|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
150133442|NCT02130193|541620022|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
150133443|NCT02130193|541620020|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
150133444|NCT02130193|541620021|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
150133445|NCT02130193|541620022|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
150133446|NCT02130193|541620020|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
150133447|NCT02130193|541620021|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
150133448|NCT02130193|541620022|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
150133449|NCT02130193|541620020|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
150133450|NCT02130193|541620021|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
150133451|NCT02130193|541620022|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
150133452|NCT01266642|541620023|FG000|Overall Study|Protocol Violation|0|||
150133453|NCT01266642|541620024|FG001|Overall Study|Protocol Violation|1|||
150133454|NCT01323530|541622017|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
150133455|NCT01323530|541622018|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150133456|NCT01323530|541622019|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150133457|NCT01323530|541622020|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150133458|NCT01323530|541622021|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150133459|NCT01323530|541622022|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
150133460|NCT01323530|541622023|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
150133461|NCT01323530|541622017|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
150133462|NCT01323530|541622018|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
150133463|NCT01323530|541622019|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
150133464|NCT01323530|541622020|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150133465|NCT01323530|541622021|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
150133466|NCT01323530|541622022|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150133467|NCT01323530|541622023|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
150133468|NCT01323530|541622017|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
150133469|NCT01323530|541622018|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
150133470|NCT01323530|541622019|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
150133471|NCT01323530|541622020|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
150133472|NCT01323530|541622021|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
150133473|NCT01323530|541622022|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
150133474|NCT01323530|541622023|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
150133475|NCT01323530|541622017|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133476|NCT01323530|541622018|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133477|NCT01323530|541622019|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133478|NCT01323530|541622020|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133479|NCT01323530|541622021|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133480|NCT01323530|541622022|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
150133481|NCT01323530|541622023|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
150133482|NCT01323530|541622017|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133483|NCT01323530|541622018|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133484|NCT01323530|541622019|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133485|NCT01323530|541622020|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133486|NCT01323530|541622021|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133487|NCT01323530|541622022|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
150133488|NCT01323530|541622023|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
150133489|NCT01323530|541622017|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133490|NCT01323530|541622018|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133491|NCT01323530|541622019|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133492|NCT01323530|541622020|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133493|NCT01323530|541622021|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133494|NCT01323530|541622022|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
150133495|NCT01323530|541622023|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
150133496|NCT01323530|541622017|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133497|NCT01323530|541622018|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133498|NCT01323530|541622019|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133499|NCT01323530|541622020|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133500|NCT01323530|541622021|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133501|NCT01323530|541622022|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
150133502|NCT01323530|541622023|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
150133503|NCT01323530|541622017|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133504|NCT01323530|541622018|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133505|NCT01323530|541622019|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133506|NCT01323530|541622020|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133507|NCT01323530|541622021|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133508|NCT01323530|541622022|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
150133509|NCT01323530|541622023|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
150133510|NCT04918784|541622024|FG000|Overall Study|Amputation - no longer eligible|1|||
150133511|NCT04918784|541622025|FG001|Overall Study|Amputation - no longer eligible|2|||
150133512|NCT04918784|541622024|FG000|Overall Study|Death|1|||
150133513|NCT04918784|541622025|FG001|Overall Study|Death|0|||
150133514|NCT04918784|541622024|FG000|Overall Study|patient non-compliance|3|||
150133515|NCT04918784|541622025|FG001|Overall Study|patient non-compliance|1|||
150133516|NCT04918784|541622024|FG000|Overall Study|Adverse Event|1|||
150133517|NCT04918784|541622025|FG001|Overall Study|Adverse Event|0|||
150133518|NCT01266850|541622030|FG000|Overall Study|Lost to Follow-up|19|||
150133519|NCT01266850|541622031|FG001|Overall Study|Lost to Follow-up|19|||
150133520|NCT01266850|541622032|FG002|Overall Study|Lost to Follow-up|13|||
150133521|NCT01266850|541622033|FG003|Overall Study|Lost to Follow-up|13|||
150133522|NCT01266850|541622034|FG004|Overall Study|Lost to Follow-up|12|||
150133523|NCT01266850|541622030|FG000|Overall Study|Withdrawal by Subject|8|||
150133524|NCT01266850|541622031|FG001|Overall Study|Withdrawal by Subject|9|||
150133525|NCT01266850|541622032|FG002|Overall Study|Withdrawal by Subject|6|||
150133526|NCT01266850|541622033|FG003|Overall Study|Withdrawal by Subject|9|||
150133527|NCT01266850|541622034|FG004|Overall Study|Withdrawal by Subject|12|||
150133528|NCT01266850|541622030|FG000|Overall Study|Physician Decision|3|||
150133529|NCT01266850|541622031|FG001|Overall Study|Physician Decision|6|||
150133530|NCT01266850|541622032|FG002|Overall Study|Physician Decision|4|||
150133531|NCT01266850|541622033|FG003|Overall Study|Physician Decision|4|||
150133532|NCT01266850|541622034|FG004|Overall Study|Physician Decision|3|||
150133533|NCT01266850|541622030|FG000|Overall Study|Protocol Violation|0|||
150133534|NCT01266850|541622031|FG001|Overall Study|Protocol Violation|1|||
150133535|NCT01266850|541622032|FG002|Overall Study|Protocol Violation|0|||
150133536|NCT01266850|541622033|FG003|Overall Study|Protocol Violation|1|||
150133537|NCT01266850|541622034|FG004|Overall Study|Protocol Violation|2|||
150133538|NCT01266850|541622030|FG000|Overall Study|Adverse Event|0|||
150133539|NCT01266850|541622031|FG001|Overall Study|Adverse Event|0|||
150133540|NCT01266850|541622032|FG002|Overall Study|Adverse Event|0|||
150133541|NCT01266850|541622033|FG003|Overall Study|Adverse Event|0|||
150133542|NCT01266850|541622034|FG004|Overall Study|Adverse Event|1|||
150133543|NCT01266850|541622030|FG000|Overall Study|Site Closure|0|||
150133544|NCT01266850|541622031|FG001|Overall Study|Site Closure|1|||
150133545|NCT01266850|541622032|FG002|Overall Study|Site Closure|1|||
150133546|NCT01266850|541622033|FG003|Overall Study|Site Closure|1|||
150133547|NCT01266850|541622034|FG004|Overall Study|Site Closure|0|||
150133548|NCT04128293|541622036|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
150133549|NCT04128293|541622037|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
150133550|NCT04128293|541622038|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
150133551|NCT04128293|541622039|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
150133552|NCT02035332|541622040|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
150133553|NCT02030015|541622046|FG000|Overall Study|Withdrawal by Subject|3|||
150133554|NCT02030015|541622046|FG000|Overall Study|Death|13|||
150133555|NCT03014674|541622048|FG000|Overall Study|Withdrawal by Subject|1|||
150133556|NCT03014674|541622049|FG001|Overall Study|Withdrawal by Subject|0|||
150133557|NCT03014674|541622050|FG002|Overall Study|Withdrawal by Subject|0|||
150133558|NCT00514943|541622051|FG000|Stage 1|Progressive disease|4|||
150133559|NCT00514943|541622052|FG001|Stage 1|Progressive disease|8|||
150133560|NCT00514943|541622051|FG000|Stage 1|Other Adverse Event|16|||
150133561|NCT00514943|541622052|FG001|Stage 1|Other Adverse Event|6|||
150133562|NCT00514943|541622051|FG000|Stage 1|Not treated|1|||
150133563|NCT00514943|541622052|FG001|Stage 1|Not treated|2|||
150133564|NCT00514943|541622051|FG000|Stage 1|Patient refused to continue study meds|8|||
150133565|NCT00514943|541622052|FG001|Stage 1|Patient refused to continue study meds|3|||
150133566|NCT00514943|541622051|FG000|Stage 1|Other than stated above|1|||
150133567|NCT00514943|541622052|FG001|Stage 1|Other than stated above|7|||
150133568|NCT00514943|541622051|FG000|Stage 2|Progressive disease|27|||
150133569|NCT00514943|541622052|FG001|Stage 2|Progressive disease|24|||
150133570|NCT00514943|541622051|FG000|Stage 2|Other Adverse Event|3|||
150133571|NCT00514943|541622052|FG001|Stage 2|Other Adverse Event|10|||
150133572|NCT00514943|541622051|FG000|Stage 2|Patient refused to continue study meds|2|||
150133573|NCT00514943|541622052|FG001|Stage 2|Patient refused to continue study meds|0|||
150133574|NCT00514943|541622051|FG000|Stage 2|Other than stated above|0|||
150133575|NCT00514943|541622052|FG001|Stage 2|Other than stated above|2|||
150133576|NCT00833560|541622056|FG000|Overall Study|Toxicity|13|||
150133577|NCT00833560|541622056|FG000|Overall Study|Adverse Event|11|||
150133578|NCT00833560|541622056|FG000|Overall Study|Protocol Violation|6|||
150133579|NCT00833560|541622056|FG000|Overall Study|Lack of Efficacy|4|||
150133580|NCT00833560|541622056|FG000|Overall Study|Death|2|||
150133581|NCT00833560|541622056|FG000|Overall Study|Pregression of other disease|1|||
150133582|NCT00833560|541622056|FG000|Overall Study|Other|5|||
150133583|NCT00499031|541622057|FG000|Overall Study|Improper pre-protocol treatment|1|||
150133584|NCT00499031|541622057|FG000|Overall Study|Required test not done|1|||
150133585|NCT00499031|541622057|FG000|Overall Study|Never treated|1|||
150133586|NCT03382782|541622062|FG000|Cohort 1|Withdrawal by Subject|11|||
150133587|NCT03382782|541622063|FG001|Cohort 1|Withdrawal by Subject|5|||
150133588|NCT03382782|541622064|FG002|Cohort 1|Withdrawal by Subject|0|||
150133589|NCT03382782|541622062|FG000|Cohort 2|Withdrawal by Subject|1|||
150133590|NCT03382782|541622063|FG001|Cohort 2|Withdrawal by Subject|1|||
150133591|NCT03382782|541622064|FG002|Cohort 2|Withdrawal by Subject|0|||
150133592|NCT03382782|541622062|FG000|Cohort 3|Withdrawal by Subject|1|||
150133593|NCT03382782|541622063|FG001|Cohort 3|Withdrawal by Subject|2|||
150133594|NCT03382782|541622064|FG002|Cohort 3|Withdrawal by Subject|0|||
150133595|NCT01791725|541622069|FG000|Overall Study|Withdrawal by Subject|0|||
150133596|NCT01791725|541622070|FG001|Overall Study|Withdrawal by Subject|1|||
150133597|NCT01791725|541622071|FG002|Overall Study|Withdrawal by Subject|0|||
150133598|NCT02583425|541622072|FG000|Screening|Did not meet entry criteria|12|||
150133599|NCT02583425|541622072|FG000|Baseline|Did not meet continued criteria|5|||
150133600|NCT02583425|541622072|FG000|Treatment Period|Adverse Event|1|||
150133601|NCT01644734|541622073|FG000|Overall Study|Adverse Event|4|||
150133602|NCT01644734|541622073|FG000|Overall Study|Lost to Follow-up|17|||
150133603|NCT01644734|541622073|FG000|Overall Study|Reasons other than stated above|7|||
150133604|NCT01644734|541622073|FG000|Overall Study|Missing documentation|238|||
150133605|NCT02450331|541622074|FG000|Overall Study|Death|162|||
150133606|NCT02450331|541622075|FG001|Overall Study|Death|171|||
150133607|NCT02450331|541622074|FG000|Overall Study|Lost to Follow-up|14|||
150133608|NCT02450331|541622075|FG001|Overall Study|Lost to Follow-up|12|||
150133609|NCT02450331|541622074|FG000|Overall Study|Withdrawal by Subject|55|||
150133610|NCT02450331|541622075|FG001|Overall Study|Withdrawal by Subject|44|||
150133611|NCT02450331|541622074|FG000|Overall Study|Non-specified other|1|||
150133612|NCT02450331|541622075|FG001|Overall Study|Non-specified other|1|||
150133613|NCT02157779|541622080|FG000|Overall Study|Logistical|9|||
150133614|NCT02157779|541622081|FG001|Overall Study|Logistical|3|||
150133615|NCT02157779|541622080|FG000|Overall Study|Stopped attending, reason unknown|11|||
150133616|NCT02157779|541622081|FG001|Overall Study|Stopped attending, reason unknown|7|||
150133617|NCT02157779|541622080|FG000|Overall Study|No response to outreach after Baseline|1|||
150133618|NCT02157779|541622081|FG001|Overall Study|No response to outreach after Baseline|1|||
150133619|NCT02157779|541622080|FG000|Overall Study|Moved|1|||
150133620|NCT02157779|541622081|FG001|Overall Study|Moved|0|||
150133621|NCT02157779|541622080|FG000|Overall Study|Medical|1|||
150133622|NCT02157779|541622081|FG001|Overall Study|Medical|0|||
150133623|NCT02157779|541622080|FG000|Overall Study|Legal issue|1|||
150133624|NCT02157779|541622081|FG001|Overall Study|Legal issue|0|||
150133625|NCT01292876|541622083|FG000|Overall Study|Physician Decision|4|||
150133626|NCT04528069|541622086|FG000|Overall Study|Adverse Event|1|||
150133627|NCT04528069|541622086|FG000|Overall Study|Lost to Follow-up|1|||
150133628|NCT04528069|541622086|FG000|Overall Study|Patient Unable to Come|1|||
150133629|NCT04528069|541622086|FG000|Overall Study|Patient Unable to Attend|1|||
150133630|NCT01814371|541622087|FG000|Overall Study|Lost to Follow-up|30|||
150133631|NCT01814371|541622088|FG001|Overall Study|Lost to Follow-up|27|||
150133632|NCT00868439|541622101|FG000|Overall Study|Adverse Event|4|||
150133633|NCT00868439|541622102|FG001|Overall Study|Adverse Event|3|||
150133634|NCT00868439|541622101|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
150133635|NCT00868439|541622102|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
150133636|NCT00868439|541622101|FG000|Overall Study|Death|0|||
150133637|NCT00868439|541622102|FG001|Overall Study|Death|1|||
150133638|NCT00868439|541622101|FG000|Overall Study|Protocol Violation|1|||
150133639|NCT00868439|541622102|FG001|Overall Study|Protocol Violation|1|||
150133640|NCT00868439|541622101|FG000|Overall Study|Physician Decision|1|||
150133641|NCT00868439|541622102|FG001|Overall Study|Physician Decision|0|||
150133642|NCT00868439|541622101|FG000|Overall Study|Withdrawal by Subject|0|||
150133643|NCT00868439|541622102|FG001|Overall Study|Withdrawal by Subject|1|||
150133644|NCT00338884|541622105|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
150133645|NCT00338884|541622105|FG000|Overall Study|Adverse Event|14|||
150133646|NCT00338884|541622105|FG000|Overall Study|Death|8|||
150133647|NCT00338884|541622105|FG000|Overall Study|Other|4|||
150133648|NCT00338884|541622105|FG000|Overall Study|Global Deterioration of Health Status|3|||
150133649|NCT00338884|541622105|FG000|Overall Study|Withdrawal by Subject|3|||
150133650|NCT00338884|541622105|FG000|Overall Study|Lost to Follow-up|1|||
150133651|NCT00338884|541622105|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
150133652|NCT00224874|541622108|FG000|Overall Study|Withdrawal by Subject|0|||
150133653|NCT00224874|541622109|FG001|Overall Study|Withdrawal by Subject|0|||
150133654|NCT00224874|541622110|FG002|Overall Study|Withdrawal by Subject|1|||
150133655|NCT00224874|541622111|FG003|Overall Study|Withdrawal by Subject|0|||
150133656|NCT00911534|541622112|FG000|Overall Study|Adverse Event|4|||
150133657|NCT00911534|541622113|FG001|Overall Study|Adverse Event|4|||
150133658|NCT00911534|541622112|FG000|Overall Study|Lost to Follow-up|2|||
150133659|NCT00911534|541622113|FG001|Overall Study|Lost to Follow-up|4|||
150133660|NCT00911534|541622112|FG000|Overall Study|Withdrawal by Subject|2|||
150133661|NCT00911534|541622113|FG001|Overall Study|Withdrawal by Subject|1|||
150133662|NCT00911534|541622112|FG000|Overall Study|Lack of Efficacy|4|||
150133663|NCT00911534|541622113|FG001|Overall Study|Lack of Efficacy|1|||
150133664|NCT00911534|541622112|FG000|Overall Study|Withdrawal of consent|1|||
150133665|NCT00911534|541622113|FG001|Overall Study|Withdrawal of consent|4|||
150133666|NCT00911534|541622112|FG000|Overall Study|Other|2|||
150133667|NCT00911534|541622113|FG001|Overall Study|Other|2|||
150133668|NCT02355002|541622114|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
150133669|NCT02355002|541622115|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
150133670|NCT02355002|541622114|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
150133671|NCT02355002|541622115|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
150133672|NCT02355002|541622114|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
150133673|NCT02355002|541622115|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
150133674|NCT02355002|541622114|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
150133675|NCT02355002|541622115|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
150133676|NCT02355002|541622114|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
150133677|NCT02355002|541622115|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
150133678|NCT02355002|541622114|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
150133679|NCT02355002|541622115|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
150133680|NCT02355002|541622114|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
150133681|NCT02355002|541622115|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
150133682|NCT05072080|541622116|FG000|Overall Study|Death|0|||
150133683|NCT05072080|541622117|FG001|Overall Study|Death|0|||
150133684|NCT05072080|541622118|FG002|Overall Study|Death|1|||
150133685|NCT05072080|541622119|FG003|Overall Study|Death|0|||
150133686|NCT05072080|541622116|FG000|Overall Study|Lost to Follow-up|65|||
150133687|NCT05072080|541622117|FG001|Overall Study|Lost to Follow-up|70|||
150133688|NCT05072080|541622118|FG002|Overall Study|Lost to Follow-up|58|||
150133689|NCT05072080|541622119|FG003|Overall Study|Lost to Follow-up|23|||
150133690|NCT05072080|541622116|FG000|Overall Study|Physician Decision|2|||
150133691|NCT05072080|541622117|FG001|Overall Study|Physician Decision|1|||
150133692|NCT05072080|541622118|FG002|Overall Study|Physician Decision|1|||
150133693|NCT05072080|541622119|FG003|Overall Study|Physician Decision|0|||
150133694|NCT05072080|541622116|FG000|Overall Study|Withdrawal by Subject|45|||
150133695|NCT05072080|541622117|FG001|Overall Study|Withdrawal by Subject|30|||
150133696|NCT05072080|541622118|FG002|Overall Study|Withdrawal by Subject|27|||
150133697|NCT05072080|541622119|FG003|Overall Study|Withdrawal by Subject|7|||
150133698|NCT05072080|541622116|FG000|Overall Study|Sponsor Decision|0|||
150133699|NCT05072080|541622117|FG001|Overall Study|Sponsor Decision|1|||
150133700|NCT05072080|541622118|FG002|Overall Study|Sponsor Decision|0|||
150133701|NCT05072080|541622119|FG003|Overall Study|Sponsor Decision|0|||
150133702|NCT05072080|541622116|FG000|Overall Study|Subject moved|1|||
150133703|NCT05072080|541622117|FG001|Overall Study|Subject moved|3|||
150133704|NCT05072080|541622118|FG002|Overall Study|Subject moved|5|||
150133705|NCT05072080|541622119|FG003|Overall Study|Subject moved|2|||
150133706|NCT05072080|541622116|FG000|Overall Study|Withdrawal by parent|0|||
150133707|NCT05072080|541622117|FG001|Overall Study|Withdrawal by parent|0|||
150133708|NCT05072080|541622118|FG002|Overall Study|Withdrawal by parent|1|||
150133709|NCT05072080|541622119|FG003|Overall Study|Withdrawal by parent|0|||
150133710|NCT05072080|541622116|FG000|Overall Study|Subject was deployed|0|||
150133711|NCT05072080|541622117|FG001|Overall Study|Subject was deployed|1|||
150133712|NCT05072080|541622118|FG002|Overall Study|Subject was deployed|0|||
150133713|NCT05072080|541622119|FG003|Overall Study|Subject was deployed|0|||
150133714|NCT05072080|541622116|FG000|Overall Study|Subject left site without receiving dose|0|||
150133715|NCT05072080|541622117|FG001|Overall Study|Subject left site without receiving dose|1|||
150133716|NCT05072080|541622118|FG002|Overall Study|Subject left site without receiving dose|0|||
150133717|NCT05072080|541622119|FG003|Overall Study|Subject left site without receiving dose|0|||
150133718|NCT05072080|541622116|FG000|Overall Study|Subject incarcerated|0|||
150133719|NCT05072080|541622117|FG001|Overall Study|Subject incarcerated|1|||
150133720|NCT05072080|541622118|FG002|Overall Study|Subject incarcerated|0|||
150133721|NCT05072080|541622119|FG003|Overall Study|Subject incarcerated|1|||
150133722|NCT05072080|541622116|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
150133723|NCT05072080|541622117|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
150133724|NCT05072080|541622118|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
150133725|NCT05072080|541622119|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
150133726|NCT05072080|541622116|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
150133727|NCT05072080|541622117|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
150133728|NCT05072080|541622118|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
150133729|NCT05072080|541622119|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
150133730|NCT04867369|541622122|FG000|Overall Study|Withdrawal by Subject|1|||
150133731|NCT04867369|541622123|FG001|Overall Study|Withdrawal by Subject|0|||
150133732|NCT02677116|541622133|FG000|Overall Study|Adverse Event|0|||
150133733|NCT02677116|541622134|FG001|Overall Study|Adverse Event|1|||
150133734|NCT02677116|541622135|FG002|Overall Study|Adverse Event|0|||
150133735|NCT02677116|541622136|FG003|Overall Study|Adverse Event|0|||
150133736|NCT02677116|541622137|FG004|Overall Study|Adverse Event|0|||
150133737|NCT02677116|541622138|FG005|Overall Study|Adverse Event|1|||
150133738|NCT02677116|541622139|FG006|Overall Study|Adverse Event|1|||
150133739|NCT02677116|541622140|FG007|Overall Study|Adverse Event|0|||
150133740|NCT02677116|541622141|FG008|Overall Study|Adverse Event|0|||
150133741|NCT02677116|541622133|FG000|Overall Study|Physician Decision|0|||
150133742|NCT02677116|541622134|FG001|Overall Study|Physician Decision|2|||
150133743|NCT02677116|541622135|FG002|Overall Study|Physician Decision|3|||
150133744|NCT02677116|541622136|FG003|Overall Study|Physician Decision|2|||
150133745|NCT02677116|541622137|FG004|Overall Study|Physician Decision|1|||
150133746|NCT02677116|541622138|FG005|Overall Study|Physician Decision|3|||
150133747|NCT02677116|541622139|FG006|Overall Study|Physician Decision|1|||
150133748|NCT02677116|541622140|FG007|Overall Study|Physician Decision|1|||
150133749|NCT02677116|541622141|FG008|Overall Study|Physician Decision|2|||
150133750|NCT02677116|541622133|FG000|Overall Study|Withdrawal by parent or guardian|2|||
150133751|NCT02677116|541622134|FG001|Overall Study|Withdrawal by parent or guardian|1|||
150133752|NCT02677116|541622135|FG002|Overall Study|Withdrawal by parent or guardian|0|||
150133753|NCT02677116|541622136|FG003|Overall Study|Withdrawal by parent or guardian|1|||
150133754|NCT02677116|541622137|FG004|Overall Study|Withdrawal by parent or guardian|0|||
150133755|NCT02677116|541622138|FG005|Overall Study|Withdrawal by parent or guardian|0|||
150133756|NCT02677116|541622139|FG006|Overall Study|Withdrawal by parent or guardian|2|||
150133757|NCT02677116|541622140|FG007|Overall Study|Withdrawal by parent or guardian|1|||
150133758|NCT02677116|541622141|FG008|Overall Study|Withdrawal by parent or guardian|0|||
150133759|NCT02677116|541622133|FG000|Overall Study|Withdrawal by Subject|1|||
150133760|NCT02677116|541622134|FG001|Overall Study|Withdrawal by Subject|0|||
150133761|NCT02677116|541622135|FG002|Overall Study|Withdrawal by Subject|0|||
150133762|NCT02677116|541622136|FG003|Overall Study|Withdrawal by Subject|0|||
150133763|NCT02677116|541622137|FG004|Overall Study|Withdrawal by Subject|0|||
150133764|NCT02677116|541622138|FG005|Overall Study|Withdrawal by Subject|0|||
150133765|NCT02677116|541622139|FG006|Overall Study|Withdrawal by Subject|0|||
150133766|NCT02677116|541622140|FG007|Overall Study|Withdrawal by Subject|0|||
150133767|NCT02677116|541622141|FG008|Overall Study|Withdrawal by Subject|0|||
150133768|NCT03342638|541622142|FG000|Overall Study|Withdrawal by Subject|1|||
150133769|NCT03342638|541622143|FG001|Overall Study|Withdrawal by Subject|0|||
150133770|NCT03342638|541622142|FG000|Overall Study|Physician Decision|0|||
150133771|NCT03342638|541622143|FG001|Overall Study|Physician Decision|1|||
150133772|NCT01292239|541622148|FG000|Overall Study|Other|1|||
150133773|NCT01292239|541622149|FG001|Overall Study|Other|1|||
150133774|NCT01292239|541622148|FG000|Overall Study|Withdrawal by Subject|3|||
150133775|NCT01292239|541622149|FG001|Overall Study|Withdrawal by Subject|6|||
150133776|NCT03213158|541622150|FG000|Overall Study|Withdrawal by Subject|1|||
150133777|NCT03213158|541622150|FG000|Overall Study|Physician Decision|2|||
150133778|NCT03649230|541622151|FG000|Overall Study|Adverse Event|12|||
150133779|NCT03649230|541622151|FG000|Overall Study|Death|8|||
150133780|NCT03649230|541622151|FG000|Overall Study|Withdrawal by Subject|6|||
150133781|NCT03649230|541622151|FG000|Overall Study|Physician Decision|5|||
150133782|NCT03649230|541622151|FG000|Overall Study|Disease progression|5|||
150133783|NCT03649230|541622151|FG000|Overall Study|Switched to non-HEC|5|||
150133784|NCT03649230|541622151|FG000|Overall Study|Chemotherapy discontinued|4|||
150133785|NCT03649230|541622151|FG000|Overall Study|Received only 3 HEC cycles|4|||
150133786|NCT03649230|541622151|FG000|Overall Study|Screen Failure|3|||
150133787|NCT03649230|541622151|FG000|Overall Study|Patient stopped treatment|2|||
150133788|NCT03649230|541622151|FG000|Overall Study|Protocol Violation|1|||
150133789|NCT03649230|541622151|FG000|Overall Study|Non-compliance|1|||
150133790|NCT03649230|541622151|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
150133791|NCT01693068|541622152|FG000|Randomization Period|On-study|2|||
150133792|NCT01693068|541622153|FG001|Randomization Period|On-study|5|||
150133793|NCT01693068|541622154|FG002|Randomization Period|On-study|0|||
150133794|NCT01693068|541622152|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
150133795|NCT01693068|541622153|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
150133796|NCT01693068|541622154|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
150133797|NCT00295022|541622160|FG000|Overall Study|Adverse Event|1|||
150133798|NCT00295022|541622161|FG001|Overall Study|Adverse Event|1|||
150133799|NCT00295022|541622162|FG002|Overall Study|Adverse Event|2|||
150133800|NCT00295022|541622160|FG000|Overall Study|Lost to Follow-up|0|||
150133801|NCT00295022|541622161|FG001|Overall Study|Lost to Follow-up|0|||
150133802|NCT00295022|541622162|FG002|Overall Study|Lost to Follow-up|1|||
150133803|NCT00295022|541622160|FG000|Overall Study|Withdrawal by Subject|0|||
150133804|NCT00295022|541622161|FG001|Overall Study|Withdrawal by Subject|0|||
150133805|NCT00295022|541622162|FG002|Overall Study|Withdrawal by Subject|2|||
150133806|NCT00734630|541622164|FG000|Overall Study|Lack of Efficacy|4|||
150133807|NCT00734630|541622165|FG001|Overall Study|Lack of Efficacy|4|||
150133808|NCT00734630|541622164|FG000|Overall Study|Withdrawal by Subject|7|||
150133809|NCT00734630|541622165|FG001|Overall Study|Withdrawal by Subject|9|||
150133810|NCT00734630|541622164|FG000|Overall Study|Lost to Follow-up|13|||
150133811|NCT00734630|541622165|FG001|Overall Study|Lost to Follow-up|7|||
150133812|NCT00734630|541622164|FG000|Overall Study|Protocol Violation|0|||
150133813|NCT00734630|541622165|FG001|Overall Study|Protocol Violation|3|||
150133814|NCT00734630|541622164|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
150133815|NCT00734630|541622165|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
150133816|NCT00734630|541622164|FG000|Overall Study|Adverse Event|3|||
150198611|NCT03523572|541868315|FG000|Dose Escalation|Clinical Progression|0|||
150198612|NCT03523572|541868316|FG001|Dose Escalation|Clinical Progression|1|||
150198613|NCT03523572|541868317|FG002|Dose Escalation|Clinical Progression|0|||
150198614|NCT03523572|541868318|FG003|Dose Escalation|Clinical Progression|0|||
150198615|NCT03523572|541868319|FG004|Dose Escalation|Clinical Progression|0|||
150198616|NCT03523572|541868320|FG005|Dose Escalation|Clinical Progression|0|||
150198617|NCT03523572|541868315|FG000|Dose Escalation|Adverse Event|2|||
150198618|NCT03523572|541868316|FG001|Dose Escalation|Adverse Event|0|||
150198619|NCT03523572|541868317|FG002|Dose Escalation|Adverse Event|0|||
150198620|NCT03523572|541868318|FG003|Dose Escalation|Adverse Event|0|||
150133817|NCT00734630|541622165|FG001|Overall Study|Adverse Event|6|||
150133818|NCT00734630|541622164|FG000|Overall Study|Randomized in Error|0|||
150133819|NCT00734630|541622165|FG001|Overall Study|Randomized in Error|1|||
150133820|NCT00734630|541622164|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
150133821|NCT00734630|541622165|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
150133822|NCT00734630|541622164|FG000|Overall Study|Poor Compliance|1|||
150133823|NCT00734630|541622165|FG001|Overall Study|Poor Compliance|1|||
150133824|NCT01239030|541622166|FG000|Double Blind|Adverse Event|0|||
150133825|NCT01239030|541622167|FG001|Double Blind|Adverse Event|1|||
150133826|NCT01239030|541622168|FG002|Double Blind|Adverse Event|0|||
150133827|NCT01239030|541622169|FG003|Double Blind|Adverse Event|2|||
150133828|NCT01239030|541622170|FG004|Double Blind|Adverse Event|0|||
150133829|NCT01239030|541622166|FG000|Double Blind|Withdrawal by Subject|0|||
150133830|NCT01239030|541622167|FG001|Double Blind|Withdrawal by Subject|1|||
150133831|NCT01239030|541622168|FG002|Double Blind|Withdrawal by Subject|1|||
150133832|NCT01239030|541622169|FG003|Double Blind|Withdrawal by Subject|0|||
150133833|NCT01239030|541622170|FG004|Double Blind|Withdrawal by Subject|1|||
150133834|NCT01239030|541622166|FG000|Double Blind|Lost to Follow-up|1|||
150198621|NCT03523572|541868319|FG004|Dose Escalation|Adverse Event|0|||
150198622|NCT03523572|541868320|FG005|Dose Escalation|Adverse Event|0|||
150133835|NCT01239030|541622167|FG001|Double Blind|Lost to Follow-up|1|||
150198623|NCT03523572|541868315|FG000|Dose Escalation|Physician Decision|1|||
150133836|NCT01239030|541622168|FG002|Double Blind|Lost to Follow-up|0|||
150133837|NCT01239030|541622169|FG003|Double Blind|Lost to Follow-up|0|||
150133838|NCT01239030|541622170|FG004|Double Blind|Lost to Follow-up|0|||
150133839|NCT01239030|541622166|FG000|Double Blind|Physician Decision|0|||
150133840|NCT01239030|541622167|FG001|Double Blind|Physician Decision|1|||
150133841|NCT01239030|541622168|FG002|Double Blind|Physician Decision|0|||
150133842|NCT01239030|541622169|FG003|Double Blind|Physician Decision|0|||
150133843|NCT01239030|541622170|FG004|Double Blind|Physician Decision|0|||
150133844|NCT01239030|541622166|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
150133845|NCT01239030|541622167|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
150133846|NCT01239030|541622168|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
150133847|NCT01239030|541622169|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
150133848|NCT01239030|541622170|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
150133849|NCT01239030|541622166|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
150133850|NCT01239030|541622167|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
150133851|NCT01239030|541622168|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
150133852|NCT01239030|541622169|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
150133853|NCT01239030|541622170|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
150133854|NCT01239030|541622166|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
150198624|NCT03523572|541868316|FG001|Dose Escalation|Physician Decision|1|||
150198625|NCT03523572|541868317|FG002|Dose Escalation|Physician Decision|0|||
150198626|NCT03523572|541868318|FG003|Dose Escalation|Physician Decision|0|||
150198627|NCT03523572|541868319|FG004|Dose Escalation|Physician Decision|0|||
150198628|NCT03523572|541868320|FG005|Dose Escalation|Physician Decision|0|||
150198629|NCT03523572|541868315|FG000|Dose Expansion|Progressive Disease|0|||
150198630|NCT03523572|541868316|FG001|Dose Expansion|Progressive Disease|0|||
150198631|NCT03523572|541868317|FG002|Dose Expansion|Progressive Disease|9|||
150198632|NCT03523572|541868318|FG003|Dose Expansion|Progressive Disease|11|||
150198633|NCT03523572|541868319|FG004|Dose Expansion|Progressive Disease|15|||
150198634|NCT03523572|541868320|FG005|Dose Expansion|Progressive Disease|2|||
150198635|NCT03523572|541868315|FG000|Dose Expansion|Clinical Progression|0|||
150198636|NCT03523572|541868316|FG001|Dose Expansion|Clinical Progression|0|||
150198637|NCT03523572|541868317|FG002|Dose Expansion|Clinical Progression|2|||
150198638|NCT03523572|541868318|FG003|Dose Expansion|Clinical Progression|2|||
150198639|NCT03523572|541868319|FG004|Dose Expansion|Clinical Progression|2|||
150198640|NCT03523572|541868320|FG005|Dose Expansion|Clinical Progression|0|||
150198641|NCT03523572|541868315|FG000|Dose Expansion|Adverse Event|0|||
150198642|NCT03523572|541868316|FG001|Dose Expansion|Adverse Event|0|||
150198643|NCT03523572|541868317|FG002|Dose Expansion|Adverse Event|10|||
150198644|NCT03523572|541868318|FG003|Dose Expansion|Adverse Event|1|||
150198645|NCT03523572|541868319|FG004|Dose Expansion|Adverse Event|5|||
150198646|NCT03523572|541868320|FG005|Dose Expansion|Adverse Event|2|||
150198647|NCT03523572|541868315|FG000|Dose Expansion|Withdrawal by Subject|0|||
150198648|NCT03523572|541868316|FG001|Dose Expansion|Withdrawal by Subject|0|||
150198649|NCT03523572|541868317|FG002|Dose Expansion|Withdrawal by Subject|1|||
150198650|NCT03523572|541868318|FG003|Dose Expansion|Withdrawal by Subject|1|||
150198651|NCT03523572|541868319|FG004|Dose Expansion|Withdrawal by Subject|0|||
150198652|NCT03523572|541868320|FG005|Dose Expansion|Withdrawal by Subject|0|||
150198653|NCT03523572|541868315|FG000|Dose Expansion|Physician Decision|0|||
150198654|NCT03523572|541868316|FG001|Dose Expansion|Physician Decision|0|||
150198655|NCT03523572|541868317|FG002|Dose Expansion|Physician Decision|1|||
150198656|NCT03523572|541868318|FG003|Dose Expansion|Physician Decision|0|||
150198657|NCT03523572|541868319|FG004|Dose Expansion|Physician Decision|1|||
150133855|NCT01239030|541622167|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
150198658|NCT03523572|541868320|FG005|Dose Expansion|Physician Decision|0|||
150198659|NCT03523572|541868315|FG000|Dose Expansion|Miscellaneous|0|||
150198660|NCT03523572|541868316|FG001|Dose Expansion|Miscellaneous|0|||
150198661|NCT03523572|541868317|FG002|Dose Expansion|Miscellaneous|0|||
150198662|NCT03523572|541868318|FG003|Dose Expansion|Miscellaneous|0|||
150198663|NCT03523572|541868319|FG004|Dose Expansion|Miscellaneous|3|||
150198664|NCT03523572|541868320|FG005|Dose Expansion|Miscellaneous|0|||
150198665|NCT03625115|541868321|FG000|Overall Study|Withdrawal by Subject|4|||
150198666|NCT03625115|541868322|FG001|Overall Study|Withdrawal by Subject|7|||
150198667|NCT03625115|541868321|FG000|Overall Study|Lost to Follow-up|17|||
150198668|NCT03625115|541868322|FG001|Overall Study|Lost to Follow-up|24|||
150198669|NCT04197336|541868323|FG000|Overall Study|Withdrawal by Subject|1|||
150133856|NCT01239030|541622168|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
150133857|NCT01239030|541622169|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
150133858|NCT01239030|541622170|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
150133859|NCT01239030|541622166|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
150133860|NCT01239030|541622167|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
150198670|NCT04304144|541868324|FG000|DLT Observation Period|Physician Decision|0|||
150198671|NCT04304144|541868325|FG001|DLT Observation Period|Physician Decision|1|||
150198672|NCT04304144|541868326|FG002|DLT Observation Period|Physician Decision|0|||
150198673|NCT04304144|541868327|FG003|DLT Observation Period|Physician Decision|0|||
150198674|NCT04304144|541868324|FG000|Continued Treatment Period|Adverse Event|0|||
150198675|NCT04304144|541868325|FG001|Continued Treatment Period|Adverse Event|1|||
150198676|NCT04304144|541868326|FG002|Continued Treatment Period|Adverse Event|0|||
150198677|NCT04304144|541868327|FG003|Continued Treatment Period|Adverse Event|0|||
150198678|NCT04304144|541868324|FG000|Continued Treatment Period|Death|0|||
150198679|NCT04304144|541868325|FG001|Continued Treatment Period|Death|0|||
150198680|NCT04304144|541868326|FG002|Continued Treatment Period|Death|1|||
150198681|NCT04304144|541868327|FG003|Continued Treatment Period|Death|2|||
150198682|NCT04304144|541868324|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
150198683|NCT04304144|541868325|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
150198684|NCT04304144|541868326|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
150198685|NCT04304144|541868327|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
150198686|NCT04304144|541868324|FG000|Continued Treatment Period|Other than specified|2|||
150198687|NCT04304144|541868325|FG001|Continued Treatment Period|Other than specified|0|||
150198688|NCT04304144|541868326|FG002|Continued Treatment Period|Other than specified|1|||
150198689|NCT04304144|541868327|FG003|Continued Treatment Period|Other than specified|1|||
150198690|NCT05868382|541868328|FG000|Overall Study|Lost to Follow-up|5|||
150198691|NCT05868382|541868329|FG001|Overall Study|Lost to Follow-up|0|||
150198692|NCT05868382|541868330|FG002|Overall Study|Lost to Follow-up|6|||
150198693|NCT05868382|541868331|FG003|Overall Study|Lost to Follow-up|4|||
150198694|NCT05868382|541868332|FG004|Overall Study|Lost to Follow-up|2|||
150198695|NCT05868382|541868333|FG005|Overall Study|Lost to Follow-up|6|||
150198696|NCT05868382|541868328|FG000|Overall Study|Withdrawal by Subject|1|||
150133861|NCT01239030|541622168|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
150133862|NCT01239030|541622169|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
150133863|NCT01239030|541622170|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
150133864|NCT01302847|541622174|FG000|Overall Study|Death|0|||
150133865|NCT01302847|541622175|FG001|Overall Study|Death|1|||
150133866|NCT01302847|541622176|FG002|Overall Study|Death|0|||
150133867|NCT01302847|541622177|FG003|Overall Study|Death|0|||
150133868|NCT01302847|541622178|FG004|Overall Study|Death|0|||
150133869|NCT01302847|541622179|FG005|Overall Study|Death|1|||
150133870|NCT01302847|541622180|FG006|Overall Study|Death|1|||
150133871|NCT01302847|541622181|FG007|Overall Study|Death|0|||
150133872|NCT01302847|541622174|FG000|Overall Study|Pregnancy|2|||
150133873|NCT01302847|541622175|FG001|Overall Study|Pregnancy|0|||
150133874|NCT01302847|541622176|FG002|Overall Study|Pregnancy|0|||
150133875|NCT01302847|541622177|FG003|Overall Study|Pregnancy|0|||
150133876|NCT01302847|541622178|FG004|Overall Study|Pregnancy|0|||
150133877|NCT01302847|541622179|FG005|Overall Study|Pregnancy|0|||
150133878|NCT01302847|541622180|FG006|Overall Study|Pregnancy|0|||
150133879|NCT01302847|541622181|FG007|Overall Study|Pregnancy|0|||
150133880|NCT01302847|541622174|FG000|Overall Study|Virologic failure|0|||
150133881|NCT01302847|541622175|FG001|Overall Study|Virologic failure|2|||
150133882|NCT01302847|541622176|FG002|Overall Study|Virologic failure|0|||
150133883|NCT01302847|541622177|FG003|Overall Study|Virologic failure|2|||
150133884|NCT01302847|541622178|FG004|Overall Study|Virologic failure|1|||
150133885|NCT01302847|541622179|FG005|Overall Study|Virologic failure|3|||
150133886|NCT01302847|541622180|FG006|Overall Study|Virologic failure|1|||
150133887|NCT01302847|541622181|FG007|Overall Study|Virologic failure|2|||
150133888|NCT01302847|541622174|FG000|Overall Study|Severe debilitation, unable to continue|0|||
150133889|NCT01302847|541622175|FG001|Overall Study|Severe debilitation, unable to continue|0|||
150133890|NCT01302847|541622176|FG002|Overall Study|Severe debilitation, unable to continue|0|||
150133891|NCT01302847|541622177|FG003|Overall Study|Severe debilitation, unable to continue|0|||
150133892|NCT01302847|541622178|FG004|Overall Study|Severe debilitation, unable to continue|0|||
150133893|NCT01302847|541622179|FG005|Overall Study|Severe debilitation, unable to continue|1|||
150133894|NCT01302847|541622180|FG006|Overall Study|Severe debilitation, unable to continue|1|||
150133895|NCT01302847|541622181|FG007|Overall Study|Severe debilitation, unable to continue|0|||
150133896|NCT01302847|541622174|FG000|Overall Study|Not able to get to clinic|1|||
150133897|NCT01302847|541622175|FG001|Overall Study|Not able to get to clinic|1|||
150133898|NCT01302847|541622176|FG002|Overall Study|Not able to get to clinic|0|||
150133899|NCT01302847|541622177|FG003|Overall Study|Not able to get to clinic|0|||
150133900|NCT01302847|541622178|FG004|Overall Study|Not able to get to clinic|0|||
150198697|NCT05868382|541868329|FG001|Overall Study|Withdrawal by Subject|0|||
150198698|NCT05868382|541868330|FG002|Overall Study|Withdrawal by Subject|0|||
150198699|NCT05868382|541868331|FG003|Overall Study|Withdrawal by Subject|0|||
150198700|NCT05868382|541868332|FG004|Overall Study|Withdrawal by Subject|1|||
150198701|NCT05868382|541868333|FG005|Overall Study|Withdrawal by Subject|0|||
150198702|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
150198703|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
150198704|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
150198705|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
150198706|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
150198707|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
150198708|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
150198709|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Death|0|||
150198710|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Death|1|||
150198711|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Death|0|||
150198712|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Death|0|||
150198713|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Death|0|||
150198714|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Death|0|||
150198715|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Death|0|||
150198716|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
150198717|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198718|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198719|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198720|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198721|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198722|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
150198723|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198724|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
150198725|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198726|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198727|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198728|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198729|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
150198730|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Other|1|||
150198731|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Other|0|||
150198732|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Other|0|||
150198733|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Other|0|||
150198734|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Other|0|||
150198735|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Other|0|||
150198736|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Other|0|||
150198737|NCT04585815|541868334|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
150198738|NCT04585815|541868335|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
150198739|NCT04585815|541868336|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
150133901|NCT01302847|541622179|FG005|Overall Study|Not able to get to clinic|0|||
150133902|NCT01302847|541622180|FG006|Overall Study|Not able to get to clinic|0|||
150133903|NCT01302847|541622181|FG007|Overall Study|Not able to get to clinic|0|||
150133904|NCT01302847|541622174|FG000|Overall Study|Site closing|2|||
150133905|NCT01302847|541622175|FG001|Overall Study|Site closing|2|||
150133906|NCT01302847|541622176|FG002|Overall Study|Site closing|0|||
150133907|NCT01302847|541622177|FG003|Overall Study|Site closing|0|||
150133908|NCT01302847|541622178|FG004|Overall Study|Site closing|0|||
150133909|NCT01302847|541622179|FG005|Overall Study|Site closing|0|||
150133910|NCT01302847|541622180|FG006|Overall Study|Site closing|0|||
150133911|NCT01302847|541622181|FG007|Overall Study|Site closing|0|||
150133912|NCT01302847|541622174|FG000|Overall Study|Withdrawal by Subject|1|||
150133913|NCT01302847|541622175|FG001|Overall Study|Withdrawal by Subject|0|||
150133914|NCT01302847|541622176|FG002|Overall Study|Withdrawal by Subject|0|||
150133915|NCT01302847|541622177|FG003|Overall Study|Withdrawal by Subject|0|||
150133916|NCT01302847|541622178|FG004|Overall Study|Withdrawal by Subject|1|||
150133917|NCT01302847|541622179|FG005|Overall Study|Withdrawal by Subject|0|||
150133918|NCT01302847|541622180|FG006|Overall Study|Withdrawal by Subject|0|||
150198740|NCT04585815|541868337|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
150198741|NCT04585815|541868338|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
150198742|NCT04585815|541868339|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
150198743|NCT04585815|541868340|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
150198744|NCT04585815|541868334|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150133919|NCT01302847|541622181|FG007|Overall Study|Withdrawal by Subject|1|||
150133920|NCT01302847|541622174|FG000|Overall Study|Not willing to adhere to requirements|5|||
150133921|NCT01302847|541622175|FG001|Overall Study|Not willing to adhere to requirements|0|||
150133922|NCT01302847|541622176|FG002|Overall Study|Not willing to adhere to requirements|1|||
150133923|NCT01302847|541622177|FG003|Overall Study|Not willing to adhere to requirements|0|||
150133924|NCT01302847|541622178|FG004|Overall Study|Not willing to adhere to requirements|0|||
150133925|NCT01302847|541622179|FG005|Overall Study|Not willing to adhere to requirements|0|||
150133926|NCT01302847|541622180|FG006|Overall Study|Not willing to adhere to requirements|0|||
150133927|NCT01302847|541622181|FG007|Overall Study|Not willing to adhere to requirements|2|||
150133928|NCT01302847|541622174|FG000|Overall Study|Site unable to contact participant|2|||
150133929|NCT01302847|541622175|FG001|Overall Study|Site unable to contact participant|1|||
150133930|NCT01302847|541622176|FG002|Overall Study|Site unable to contact participant|0|||
150133931|NCT01302847|541622177|FG003|Overall Study|Site unable to contact participant|0|||
150133932|NCT01302847|541622178|FG004|Overall Study|Site unable to contact participant|0|||
150133933|NCT01302847|541622179|FG005|Overall Study|Site unable to contact participant|0|||
150133934|NCT01302847|541622180|FG006|Overall Study|Site unable to contact participant|2|||
150133935|NCT01302847|541622181|FG007|Overall Study|Site unable to contact participant|0|||
150133936|NCT01371851|541622182|FG000|Overall Study|Lost to Follow-up|5|||
150133937|NCT01371851|541622183|FG001|Overall Study|Lost to Follow-up|8|||
150133938|NCT01371851|541622182|FG000|Overall Study|was arrested and put in jail|0|||
150133939|NCT01371851|541622183|FG001|Overall Study|was arrested and put in jail|1|||
150133940|NCT01371851|541622182|FG000|Overall Study|non study related adverse event|1|||
150133941|NCT01371851|541622183|FG001|Overall Study|non study related adverse event|0|||
150133942|NCT01371851|541622182|FG000|Overall Study|Blood Pressure outside study parameters|2|||
150133943|NCT01371851|541622183|FG001|Overall Study|Blood Pressure outside study parameters|0|||
150133944|NCT00450411|541622184|FG000|Overall Study|Protocol Violation|6|||
150133945|NCT00450411|541622184|FG000|Overall Study|No protocol treatment|2|||
150133946|NCT00941330|541622187|FG000|Overall Study|Other|1|||
150133947|NCT00941330|541622188|FG001|Overall Study|Other|0|||
150133948|NCT00941330|541622187|FG000|Overall Study|Physician Decision|0|||
150133949|NCT00941330|541622188|FG001|Overall Study|Physician Decision|2|||
150133950|NCT01194570|541623683|FG000|Overall Study|Adverse Event|22|||
150133951|NCT01194570|541623684|FG001|Overall Study|Adverse Event|40|||
150133952|NCT01194570|541623683|FG000|Overall Study|Death|6|||
150133953|NCT01194570|541623684|FG001|Overall Study|Death|20|||
150133954|NCT01194570|541623683|FG000|Overall Study|Lack of Efficacy|32|||
150133955|NCT01194570|541623684|FG001|Overall Study|Lack of Efficacy|33|||
150133956|NCT01194570|541623683|FG000|Overall Study|Lost to Follow-up|4|||
150133957|NCT01194570|541623684|FG001|Overall Study|Lost to Follow-up|15|||
150133958|NCT01194570|541623683|FG000|Overall Study|Non-Compliance|2|||
150133959|NCT01194570|541623684|FG001|Overall Study|Non-Compliance|2|||
150133960|NCT01194570|541623683|FG000|Overall Study|Non-Compliance With Study Drug|2|||
150133961|NCT01194570|541623684|FG001|Overall Study|Non-Compliance With Study Drug|2|||
150133962|NCT01194570|541623683|FG000|Overall Study|Other|18|||
150133963|NCT01194570|541623684|FG001|Overall Study|Other|47|||
150133964|NCT01194570|541623683|FG000|Overall Study|Physician Decision|10|||
150133965|NCT01194570|541623684|FG001|Overall Study|Physician Decision|25|||
150133966|NCT01194570|541623683|FG000|Overall Study|Protocol Violation|1|||
150133967|NCT01194570|541623684|FG001|Overall Study|Protocol Violation|2|||
150133968|NCT01194570|541623683|FG000|Overall Study|Study Terminated By Sponsor|0|||
150133969|NCT01194570|541623684|FG001|Overall Study|Study Terminated By Sponsor|1|||
150133970|NCT01194570|541623683|FG000|Overall Study|Withdrawal by Subject|57|||
150133971|NCT01194570|541623684|FG001|Overall Study|Withdrawal by Subject|82|||
150133972|NCT01194570|541623683|FG000|Overall Study|Pregnancy|1|||
150133973|NCT01194570|541623684|FG001|Overall Study|Pregnancy|1|||
150133974|NCT01377480|541623685|FG000|Overall Study|Protocol Violation|0|||
150133975|NCT01377480|541623686|FG001|Overall Study|Protocol Violation|0|||
150133976|NCT01377480|541623687|FG002|Overall Study|Protocol Violation|0|||
150133977|NCT01377480|541623688|FG003|Overall Study|Protocol Violation|4|||
150133978|NCT01377480|541623685|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
150133979|NCT01377480|541623686|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
150133980|NCT01377480|541623687|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
150133981|NCT01377480|541623688|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
150133982|NCT01377480|541623685|FG000|Overall Study|Withdrawal by Subject|0|||
150133983|NCT01377480|541623686|FG001|Overall Study|Withdrawal by Subject|0|||
150133984|NCT01377480|541623687|FG002|Overall Study|Withdrawal by Subject|1|||
150133985|NCT01377480|541623688|FG003|Overall Study|Withdrawal by Subject|0|||
150133986|NCT01377480|541623685|FG000|Overall Study|Serious adverse event|0|||
150133987|NCT01377480|541623686|FG001|Overall Study|Serious adverse event|0|||
150133988|NCT01377480|541623687|FG002|Overall Study|Serious adverse event|1|||
150133989|NCT01377480|541623688|FG003|Overall Study|Serious adverse event|1|||
150133990|NCT01377480|541623685|FG000|Overall Study|Other|0|||
150133991|NCT01377480|541623686|FG001|Overall Study|Other|0|||
150133992|NCT01377480|541623687|FG002|Overall Study|Other|7|||
150133993|NCT01377480|541623688|FG003|Overall Study|Other|6|||
150133994|NCT01111123|541623693|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
150133995|NCT01111123|541623694|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
150133996|NCT01111123|541623693|FG000|Maintenance Phase|Lost to Follow-up|0|||
150133997|NCT01111123|541623694|FG001|Maintenance Phase|Lost to Follow-up|2|||
150133998|NCT01203930|541623699|FG000|Overall Study|Disease Progression|0|||
150133999|NCT01203930|541623700|FG001|Overall Study|Disease Progression|4|||
150134000|NCT01203930|541623699|FG000|Overall Study|Death|3|||
150134001|NCT01203930|541623700|FG001|Overall Study|Death|1|||
150134002|NCT01203930|541623699|FG000|Overall Study|Withdrew Consent|1|||
150134003|NCT01203930|541623700|FG001|Overall Study|Withdrew Consent|10|||
150134004|NCT01203930|541623699|FG000|Overall Study|Investigator Request|0|||
150134005|NCT01203930|541623700|FG001|Overall Study|Investigator Request|8|||
150134006|NCT01203930|541623699|FG000|Overall Study|Study Terminated by Sponsor|0|||
150134007|NCT01203930|541623700|FG001|Overall Study|Study Terminated by Sponsor|12|||
150134008|NCT01203930|541623699|FG000|Overall Study|Poor tolerance of study drug|0|||
150134009|NCT01203930|541623700|FG001|Overall Study|Poor tolerance of study drug|1|||
150134010|NCT01203930|541623699|FG000|Overall Study|Adverse Event|17|||
150134011|NCT01203930|541623700|FG001|Overall Study|Adverse Event|5|||
150134012|NCT00289887|541623701|FG000|Overall Study|Adverse Event|3|||
150134013|NCT00289887|541623702|FG001|Overall Study|Adverse Event|3|||
150134014|NCT00289887|541623701|FG000|Overall Study|Lack of Efficacy|3|||
150134015|NCT00289887|541623702|FG001|Overall Study|Lack of Efficacy|11|||
150134016|NCT00289887|541623701|FG000|Overall Study|Lost to Follow-up|3|||
150134017|NCT00289887|541623702|FG001|Overall Study|Lost to Follow-up|3|||
150134018|NCT00289887|541623701|FG000|Overall Study|Protocol Violation|3|||
150134019|NCT00289887|541623702|FG001|Overall Study|Protocol Violation|1|||
150134020|NCT00289887|541623701|FG000|Overall Study|Withdrawal by Subject|3|||
150134021|NCT00289887|541623702|FG001|Overall Study|Withdrawal by Subject|8|||
150134022|NCT00289887|541623701|FG000|Overall Study|Other|7|||
150134023|NCT00289887|541623702|FG001|Overall Study|Other|3|||
150134024|NCT03409666|541623703|FG000|Overall Study|Physician Decision|0|||
150134025|NCT03409666|541623704|FG001|Overall Study|Physician Decision|1|||
150134026|NCT03409666|541623703|FG000|Overall Study|Protocol Violation|0|||
150134027|NCT03409666|541623704|FG001|Overall Study|Protocol Violation|3|||
150134028|NCT00512148|541623705|FG000|Primay Study Period|Withdrawal by Subject|1|||
150134029|NCT01666951|541623712|FG000|Overall Study|Not dosed|1|||
150134030|NCT01666951|541623713|FG001|Overall Study|Not dosed|1|||
150134031|NCT02366910|541623714|FG000|Overall Study|Withdrawal by Subject|2|||
150198745|NCT04585815|541868335|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
150198746|NCT04585815|541868336|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150198747|NCT04585815|541868337|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150198748|NCT04585815|541868338|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150198749|NCT04585815|541868339|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150198750|NCT04585815|541868340|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
150198751|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
150134032|NCT02366910|541623714|FG000|Overall Study|Screen Failure|3|||
150134033|NCT02623322|541623715|FG000|Overall Study|Lost to Follow-up|2|||
150134034|NCT02623322|541623716|FG001|Overall Study|Lost to Follow-up|1|||
150134035|NCT02623322|541623717|FG002|Overall Study|Lost to Follow-up|0|||
150134036|NCT03284788|541623718|FG000|Overall Study|Withdrawal by Subject|2|||
150134037|NCT03563716|541623719|FG000|Overall Study|Death|20|||
150134038|NCT03563716|541623720|FG001|Overall Study|Death|14|||
150134039|NCT03563716|541623719|FG000|Overall Study|Withdrawal by Subject|3|||
150134040|NCT03563716|541623720|FG001|Overall Study|Withdrawal by Subject|3|||
150134041|NCT03563716|541623719|FG000|Overall Study|Still on Study|45|||
150198752|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
150198753|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
150198754|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
150198755|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
150134042|NCT03563716|541623720|FG001|Overall Study|Still on Study|50|||
150134043|NCT04605978|541623724|FG000|Overall Study|Adverse Event|2|||
150134044|NCT04605978|541623725|FG001|Overall Study|Adverse Event|1|||
150134045|NCT04605978|541623724|FG000|Overall Study|Withdrawal nonmedical reason|1|||
150198756|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
150198757|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
150134046|NCT04605978|541623725|FG001|Overall Study|Withdrawal nonmedical reason|1|||
150134047|NCT03813238|541623726|FG000|Overall Study|Adverse Event|0|||
150134048|NCT03813238|541623727|FG001|Overall Study|Adverse Event|6|||
150198758|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Death|0|||
150134049|NCT03813238|541623726|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150134050|NCT03813238|541623727|FG001|Overall Study|Withdrawal by parent/guardian|2|||
150134051|NCT03813238|541623726|FG000|Overall Study|Lost to Follow-up|0|||
150134052|NCT03813238|541623727|FG001|Overall Study|Lost to Follow-up|1|||
150134053|NCT03813238|541623726|FG000|Overall Study|Other than specified|1|||
150134054|NCT03813238|541623727|FG001|Overall Study|Other than specified|2|||
150134055|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
150134056|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
150134057|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
150134058|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
150134059|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
150134060|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
150134061|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
150134062|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
150134063|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
150198759|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Death|0|||
150198760|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Death|0|||
150198761|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Death|1|||
150198762|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Death|0|||
150198763|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Death|0|||
150198764|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Death|0|||
150198765|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
150198766|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
150198767|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
150198768|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
150198769|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
150198770|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
150198771|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
150198772|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150198773|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150198774|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150198775|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
150198776|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150134064|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
150134065|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
150134066|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
150134067|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Death|6|||
150134068|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Death|3|||
150198777|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150198778|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
150198779|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198780|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198781|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198782|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198783|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198784|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
150198785|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
150198786|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
150198787|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
150198788|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
150198789|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
150198790|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
150198791|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
150134069|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Death|0|||
150134070|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Death|1|||
150198792|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
150198793|NCT04585815|541868334|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
150198794|NCT04585815|541868335|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
150198795|NCT04585815|541868336|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
150198796|NCT04585815|541868337|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
150198797|NCT04585815|541868338|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
150198798|NCT04585815|541868339|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
150134071|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Death|1|||
150134072|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Death|0|||
150134073|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
150134074|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
150134075|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
150134076|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
150134077|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
150134078|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
150134079|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
150134080|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
150134081|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
150134082|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
150134083|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
150134084|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
150134085|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
150134086|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
150134087|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
150134088|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
150134089|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
150134090|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
150134091|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
150134092|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
150198799|NCT04585815|541868340|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
150134093|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
150134094|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
150198800|NCT04585815|541868334|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
150198801|NCT04585815|541868335|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
150198802|NCT04585815|541868336|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
150198803|NCT04585815|541868337|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
150198804|NCT04585815|541868338|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
150198805|NCT04585815|541868339|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
150198806|NCT04585815|541868340|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
150198807|NCT04585815|541868334|FG000|Sub-study B- Follow-up Phase|Death|0|||
150198808|NCT04585815|541868335|FG001|Sub-study B- Follow-up Phase|Death|0|||
150198809|NCT04585815|541868336|FG002|Sub-study B- Follow-up Phase|Death|1|||
150198810|NCT04585815|541868337|FG003|Sub-study B- Follow-up Phase|Death|3|||
150198811|NCT04585815|541868338|FG004|Sub-study B- Follow-up Phase|Death|0|||
150198812|NCT04585815|541868339|FG005|Sub-study B- Follow-up Phase|Death|0|||
150198813|NCT04585815|541868340|FG006|Sub-study B- Follow-up Phase|Death|1|||
150198814|NCT02497950|541868343|FG000|Overall Study|Death|209|||
150198815|NCT02497950|541868343|FG000|Overall Study|Transplanted|85|||
150198816|NCT02497950|541868343|FG000|Overall Study|Explanted|8|||
150198817|NCT02497950|541868343|FG000|Overall Study|Device Permanently Deactivated|4|||
150198818|NCT02497950|541868343|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
150198819|NCT02497950|541868343|FG000|Overall Study|Lost to Follow-up|6|||
150198820|NCT02497950|541868343|FG000|Overall Study|Withdrawal by Subject|2|||
150198821|NCT02497950|541868343|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
150198822|NCT02497950|541868343|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
150198823|NCT03655028|541868346|FG000|12-weeks Follow up|Death|1|||
150198824|NCT03655028|541868347|FG001|12-weeks Follow up|Death|0|||
150198825|NCT03655028|541868346|FG000|12-weeks Follow up|Physician Decision|3|||
150198826|NCT03655028|541868347|FG001|12-weeks Follow up|Physician Decision|3|||
150198827|NCT03655028|541868346|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
150198828|NCT03655028|541868347|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
150198829|NCT03655028|541868346|FG000|12-weeks Follow up|Lost to Follow-up|4|||
150198830|NCT03655028|541868347|FG001|12-weeks Follow up|Lost to Follow-up|4|||
150198831|NCT03655028|541868346|FG000|24-weeks|Lost to Follow-up|1|||
150198832|NCT03655028|541868347|FG001|24-weeks|Lost to Follow-up|1|||
150198833|NCT03655028|541868346|FG000|24-weeks|Death|0|||
150198834|NCT03655028|541868347|FG001|24-weeks|Death|1|||
150198835|NCT03852550|541868348|FG000|Overall Study|Lost to Follow-up|4|||
150198836|NCT03852550|541868349|FG001|Overall Study|Lost to Follow-up|3|||
150198837|NCT03852550|541868348|FG000|Overall Study|Only parent outcomes completed|0|||
150198838|NCT03852550|541868349|FG001|Overall Study|Only parent outcomes completed|1|||
150198839|NCT03852550|541868348|FG000|Overall Study|Withdrawal by Subject|1|||
150198840|NCT03852550|541868349|FG001|Overall Study|Withdrawal by Subject|0|||
150198841|NCT00429364|541868359|FG000|Overall Study|Withdrawal by Subject|11|||
150198842|NCT00429364|541868360|FG001|Overall Study|Withdrawal by Subject|5|||
150198843|NCT00429364|541868359|FG000|Overall Study|Physician Decision|4|||
150198844|NCT00429364|541868360|FG001|Overall Study|Physician Decision|2|||
150198845|NCT00429364|541868359|FG000|Overall Study|Lost to Follow-up|7|||
150198846|NCT00429364|541868360|FG001|Overall Study|Lost to Follow-up|6|||
150198847|NCT00429364|541868359|FG000|Overall Study|Death|0|||
150198848|NCT00429364|541868360|FG001|Overall Study|Death|1|||
150198849|NCT00429364|541868359|FG000|Overall Study|Underwent aortic root surgery|10|||
150198850|NCT00429364|541868360|FG001|Overall Study|Underwent aortic root surgery|18|||
150198851|NCT00429364|541868359|FG000|Overall Study|Pregnancy|0|||
150198852|NCT00429364|541868360|FG001|Overall Study|Pregnancy|1|||
150198853|NCT04871529|541868361|FG000|Overall Study|Withdrawal by Subject|0|||
150198854|NCT04871529|541868362|FG001|Overall Study|Withdrawal by Subject|1|||
150198855|NCT04871529|541868361|FG000|Overall Study|Death|0|||
150198856|NCT04871529|541868362|FG001|Overall Study|Death|1|||
150198857|NCT04871529|541868361|FG000|Overall Study|Not protocol specified|0|||
150198858|NCT04871529|541868362|FG001|Overall Study|Not protocol specified|1|||
150198859|NCT05184452|541868363|FG000|Overall Study|Lost to Follow-up|0|||
150198860|NCT05184452|541868364|FG001|Overall Study|Lost to Follow-up|0|||
150198861|NCT05184452|541868365|FG002|Overall Study|Lost to Follow-up|0|||
150198862|NCT05184452|541868366|FG003|Overall Study|Lost to Follow-up|0|||
150198863|NCT05184452|541868367|FG004|Overall Study|Lost to Follow-up|0|||
150198864|NCT05184452|541868368|FG005|Overall Study|Lost to Follow-up|2|||
150198865|NCT05184452|541868369|FG006|Overall Study|Lost to Follow-up|0|||
150198866|NCT05184452|541868370|FG007|Overall Study|Lost to Follow-up|0|||
150198867|NCT05184452|541868371|FG008|Overall Study|Lost to Follow-up|0|||
150198868|NCT05184452|541868372|FG009|Overall Study|Lost to Follow-up|1|||
150198869|NCT05184452|541868363|FG000|Overall Study|Withdrawal by Subject|0|||
150198870|NCT05184452|541868364|FG001|Overall Study|Withdrawal by Subject|0|||
150198871|NCT05184452|541868365|FG002|Overall Study|Withdrawal by Subject|0|||
150198872|NCT05184452|541868366|FG003|Overall Study|Withdrawal by Subject|0|||
150198873|NCT05184452|541868367|FG004|Overall Study|Withdrawal by Subject|0|||
150198874|NCT05184452|541868368|FG005|Overall Study|Withdrawal by Subject|1|||
150198875|NCT05184452|541868369|FG006|Overall Study|Withdrawal by Subject|0|||
150198876|NCT05184452|541868370|FG007|Overall Study|Withdrawal by Subject|0|||
150198877|NCT05184452|541868371|FG008|Overall Study|Withdrawal by Subject|0|||
150198878|NCT05184452|541868372|FG009|Overall Study|Withdrawal by Subject|1|||
150198879|NCT05586490|541868373|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
150198880|NCT05586490|541868374|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
150198881|NCT05586490|541868375|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
150198882|NCT05586490|541868376|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
150198883|NCT05586490|541868377|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
150198884|NCT05586490|541868373|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
150198885|NCT05586490|541868374|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
150198886|NCT05586490|541868375|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
150198887|NCT05586490|541868376|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
150198888|NCT05586490|541868377|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
150198889|NCT05586490|541868373|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
150198890|NCT05586490|541868374|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
150198891|NCT05586490|541868375|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
150198892|NCT05586490|541868376|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
150198893|NCT05586490|541868377|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
150198894|NCT03292484|541868378|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
150198895|NCT03292484|541868378|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
150198896|NCT03292484|541868378|FG000|Overall Study|Protocol Violation|2|||
150198897|NCT03292484|541868378|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
150198898|NCT03292484|541868378|FG000|Overall Study|Sponsor decision|349|||
150198899|NCT03292484|541868378|FG000|Overall Study|Lost to Follow-up|7|||
150198900|NCT03292484|541868378|FG000|Overall Study|Coronavirus Disease 2019|1|||
150198901|NCT03292484|541868378|FG000|Overall Study|Other|20|||
150198902|NCT05290493|541868379|FG000|Overall Study|Withdrawal by Subject|2|||
150198903|NCT05290493|541868380|FG001|Overall Study|Withdrawal by Subject|2|||
150198904|NCT05290493|541868379|FG000|Overall Study|Adverse Event|1|||
150198905|NCT05290493|541868380|FG001|Overall Study|Adverse Event|0|||
150198906|NCT03714815|541868391|FG000|Overall Study|Physician Decision|2|||
150198907|NCT03714815|541868391|FG000|Overall Study|Withdrawal by Subject|2|||
150198908|NCT03714815|541868391|FG000|Overall Study|Death|11|||
150198909|NCT04056611|541868393|FG000|Overall Study|Physician Decision|1|||
150198910|NCT03733925|541868394|FG000|Overall Study|Lost to Follow-up|1|||
150134095|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
150134096|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
150134097|NCT03104699|541623728|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
150134098|NCT03104699|541623729|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
150134099|NCT03104699|541623730|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
150134100|NCT03104699|541623731|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
150134101|NCT03104699|541623732|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
150134102|NCT03104699|541623733|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
150134103|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150134104|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150134105|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150134106|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150134107|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
150134108|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
150134109|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Death|0|||
150134110|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Death|0|||
150134111|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Death|0|||
150134112|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Death|0|||
150134113|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Death|0|||
150198911|NCT03733925|541868394|FG000|Overall Study|Withdrawal by Subject|2|||
150198912|NCT03733925|541868394|FG000|Overall Study|Adverse Event|2|||
150198913|NCT03733925|541868394|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150198914|NCT05035654|541868396|FG000|Overall Study|Physician Decision|0|||
150198915|NCT05035654|541868397|FG001|Overall Study|Physician Decision|1|||
150198916|NCT05035654|541868398|FG002|Overall Study|Physician Decision|0|||
150198917|NCT05035654|541868396|FG000|Overall Study|Adverse Event|0|||
150198918|NCT05035654|541868397|FG001|Overall Study|Adverse Event|1|||
150198919|NCT05035654|541868398|FG002|Overall Study|Adverse Event|0|||
150198920|NCT05035654|541868396|FG000|Overall Study|Withdrawal by Subject|0|||
150198921|NCT05035654|541868397|FG001|Overall Study|Withdrawal by Subject|0|||
150198922|NCT05035654|541868398|FG002|Overall Study|Withdrawal by Subject|4|||
150198923|NCT05035654|541868396|FG000|Overall Study|Bilateral Dislodgement|1|||
150198924|NCT05035654|541868397|FG001|Overall Study|Bilateral Dislodgement|0|||
150198925|NCT05035654|541868398|FG002|Overall Study|Bilateral Dislodgement|0|||
150134114|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Death|107|||
150134115|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
150134116|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
150134117|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
150134118|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
150134119|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
150134120|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
150134121|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
150134122|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
150134123|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
150134124|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
150134125|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
150134126|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
150134127|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150134128|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150134129|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150134130|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150134131|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
150134132|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
150134133|NCT03104699|541623728|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
150134134|NCT03104699|541623729|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
150134135|NCT03104699|541623730|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
150134136|NCT03104699|541623731|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
150134137|NCT03104699|541623732|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
150134138|NCT03104699|541623733|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
150134139|NCT01690130|541623734|FG000|Overall Study|Subject have cancelled visit.|1|||
150134140|NCT01690130|541623735|FG001|Overall Study|Subject have cancelled visit.|0|||
150134141|NCT02462876|541623736|FG000|Overall Study|Death|3|||
150134142|NCT02462876|541623736|FG000|Overall Study|Lost to Follow-up|7|||
150134143|NCT02462876|541623736|FG000|Overall Study|Surgical Bypass|9|||
150134144|NCT02462876|541623736|FG000|Overall Study|Amputation Above the Metatarsals|1|||
150134145|NCT02462876|541623736|FG000|Overall Study|36 months follow-up visit missed|1|||
150134146|NCT02462876|541623736|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
150134147|NCT02462876|541623736|FG000|Overall Study|Patient did not come back to the vascular department|1|||
150134148|NCT02462876|541623736|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
150134149|NCT02462876|541623736|FG000|Overall Study|Patient refused to come back|1|||
150134150|NCT02462876|541623736|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
150134151|NCT02462876|541623736|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
150134152|NCT01786512|541623737|FG000|Overall Study|Lost to Follow-up|0|||
150134153|NCT01786512|541623738|FG001|Overall Study|Lost to Follow-up|0|||
150134154|NCT01786512|541623739|FG002|Overall Study|Lost to Follow-up|0|||
150134155|NCT01786512|541623740|FG003|Overall Study|Lost to Follow-up|0|||
150134156|NCT01786512|541623741|FG004|Overall Study|Lost to Follow-up|0|||
150134157|NCT01786512|541623742|FG005|Overall Study|Lost to Follow-up|0|||
150134158|NCT01786512|541623743|FG006|Overall Study|Lost to Follow-up|0|||
150134159|NCT01786512|541623744|FG007|Overall Study|Lost to Follow-up|0|||
150134160|NCT01786512|541623745|FG008|Overall Study|Lost to Follow-up|0|||
150134161|NCT01786512|541623746|FG009|Overall Study|Lost to Follow-up|1|||
150134162|NCT01786512|541623747|FG010|Overall Study|Lost to Follow-up|0|||
150134163|NCT01786512|541623737|FG000|Overall Study|Decision by sponsor|0|||
150134164|NCT01786512|541623738|FG001|Overall Study|Decision by sponsor|0|||
150134165|NCT01786512|541623739|FG002|Overall Study|Decision by sponsor|0|||
150134166|NCT01786512|541623740|FG003|Overall Study|Decision by sponsor|0|||
150134167|NCT01786512|541623741|FG004|Overall Study|Decision by sponsor|0|||
150134168|NCT01786512|541623742|FG005|Overall Study|Decision by sponsor|0|||
150134169|NCT01786512|541623743|FG006|Overall Study|Decision by sponsor|0|||
150134170|NCT01786512|541623744|FG007|Overall Study|Decision by sponsor|0|||
150134171|NCT01786512|541623745|FG008|Overall Study|Decision by sponsor|0|||
150134172|NCT01786512|541623746|FG009|Overall Study|Decision by sponsor|0|||
150134173|NCT01786512|541623747|FG010|Overall Study|Decision by sponsor|2|||
150134174|NCT01786512|541623737|FG000|Overall Study|Withdrawal by Subject|0|||
150134175|NCT01786512|541623738|FG001|Overall Study|Withdrawal by Subject|1|||
150134176|NCT01786512|541623739|FG002|Overall Study|Withdrawal by Subject|0|||
150134177|NCT01786512|541623740|FG003|Overall Study|Withdrawal by Subject|0|||
150134178|NCT01786512|541623741|FG004|Overall Study|Withdrawal by Subject|0|||
150134179|NCT01786512|541623742|FG005|Overall Study|Withdrawal by Subject|0|||
150134180|NCT01786512|541623743|FG006|Overall Study|Withdrawal by Subject|1|||
150134181|NCT01786512|541623744|FG007|Overall Study|Withdrawal by Subject|0|||
150134182|NCT01786512|541623745|FG008|Overall Study|Withdrawal by Subject|0|||
150134183|NCT01786512|541623746|FG009|Overall Study|Withdrawal by Subject|3|||
150134184|NCT01786512|541623747|FG010|Overall Study|Withdrawal by Subject|7|||
150134185|NCT01786512|541623737|FG000|Overall Study|Death|0|||
150134186|NCT01786512|541623738|FG001|Overall Study|Death|0|||
150134187|NCT01786512|541623739|FG002|Overall Study|Death|0|||
150134188|NCT01786512|541623740|FG003|Overall Study|Death|0|||
150134189|NCT01786512|541623741|FG004|Overall Study|Death|0|||
150134190|NCT01786512|541623742|FG005|Overall Study|Death|0|||
150134191|NCT01786512|541623743|FG006|Overall Study|Death|0|||
150134192|NCT01786512|541623744|FG007|Overall Study|Death|0|||
150134193|NCT01786512|541623745|FG008|Overall Study|Death|4|||
150134194|NCT01786512|541623746|FG009|Overall Study|Death|1|||
150134195|NCT01786512|541623747|FG010|Overall Study|Death|3|||
150134196|NCT00605293|541623748|FG000|Overall Study|Death|2|||
150134197|NCT00605293|541623749|FG001|Overall Study|Death|1|||
150134198|NCT00605293|541623748|FG000|Overall Study|Insufficient Therapeutic Response|2|||
150134199|NCT00605293|541623749|FG001|Overall Study|Insufficient Therapeutic Response|0|||
150134200|NCT00605293|541623748|FG000|Overall Study|Adverse Event|1|||
150134201|NCT00605293|541623749|FG001|Overall Study|Adverse Event|0|||
150134202|NCT00605293|541623748|FG000|Overall Study|Holidays Dialysis Out|1|||
150134203|NCT00605293|541623749|FG001|Overall Study|Holidays Dialysis Out|0|||
150134204|NCT00605293|541623748|FG000|Overall Study|Blood Transfusion|7|||
150134205|NCT00605293|541623749|FG001|Overall Study|Blood Transfusion|1|||
150134206|NCT00605293|541623748|FG000|Overall Study|Renal Transplantation|3|||
150134207|NCT00605293|541623749|FG001|Overall Study|Renal Transplantation|1|||
150134208|NCT00605293|541623748|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
150134209|NCT00605293|541623749|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
150134210|NCT00605293|541623748|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
150134211|NCT00605293|541623749|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
150134212|NCT00605293|541623748|FG000|Overall Study|Principal Investigator Decision|0|||
150134213|NCT00605293|541623749|FG001|Overall Study|Principal Investigator Decision|1|||
150134214|NCT03581981|541623750|FG000|Overall Study|Withdrawal by Subject|12|||
150134215|NCT03581981|541623751|FG001|Overall Study|Withdrawal by Subject|13|||
150134216|NCT03581981|541623750|FG000|Overall Study|Physician Decision|1|||
150134217|NCT03581981|541623751|FG001|Overall Study|Physician Decision|2|||
150134218|NCT03581981|541623750|FG000|Overall Study|Lost to Follow-up|0|||
150134219|NCT03581981|541623751|FG001|Overall Study|Lost to Follow-up|4|||
150134220|NCT02080871|541623752|FG000|Overall Study|Death|1|||
150134221|NCT02080871|541623752|FG000|Overall Study|Lost to Follow-up|1|||
150134222|NCT00234052|541623753|FG000|Treatment|Withdrawal by Subject|3|||
150134223|NCT00234052|541623753|FG000|Treatment|Adverse Event|5|||
150134224|NCT00234052|541623753|FG000|Treatment|Death|2|||
150134225|NCT00234052|541623753|FG000|Treatment|Progressive Disease|11|||
150134226|NCT00234052|541623753|FG000|Follow-up for 5 Years|Death|41|||
150134227|NCT00234052|541623753|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
150134228|NCT00234052|541623753|FG000|Follow-up for 5 Years|Other|7|||
150134229|NCT01410474|541623754|FG000|Overall Study|Withdrawal by Subject|0|||
150134230|NCT01410474|541623755|FG001|Overall Study|Withdrawal by Subject|1|||
150134231|NCT02428296|541623756|FG000|Overall Study|Adverse Event|7|||
150134232|NCT02428296|541623756|FG000|Overall Study|Withdrawal by Subject|2|||
150134233|NCT00828984|541623758|FG000|Overall Study|Adverse Event|2|||
150134234|NCT00828984|541623759|FG001|Overall Study|Adverse Event|3|||
150134235|NCT00828984|541623760|FG002|Overall Study|Adverse Event|0|||
150134236|NCT00828984|541623758|FG000|Overall Study|Lost to Follow-up|5|||
150134237|NCT00828984|541623759|FG001|Overall Study|Lost to Follow-up|3|||
150134238|NCT00828984|541623760|FG002|Overall Study|Lost to Follow-up|1|||
150134239|NCT00828984|541623758|FG000|Overall Study|Withdrawal by Subject|4|||
150134240|NCT00828984|541623759|FG001|Overall Study|Withdrawal by Subject|4|||
150134241|NCT00828984|541623760|FG002|Overall Study|Withdrawal by Subject|4|||
150134242|NCT00828984|541623758|FG000|Overall Study|Ineligable|1|||
150134243|NCT00828984|541623759|FG001|Overall Study|Ineligable|2|||
150134244|NCT00828984|541623760|FG002|Overall Study|Ineligable|0|||
150134245|NCT00828984|541623758|FG000|Overall Study|Medical Contraindication|0|||
150134246|NCT00828984|541623759|FG001|Overall Study|Medical Contraindication|1|||
150134247|NCT00828984|541623760|FG002|Overall Study|Medical Contraindication|0|||
150134248|NCT00828984|541623758|FG000|Overall Study|Noncompliant|1|||
150134249|NCT00828984|541623759|FG001|Overall Study|Noncompliant|2|||
150134250|NCT00828984|541623760|FG002|Overall Study|Noncompliant|3|||
150134251|NCT00828984|541623758|FG000|Overall Study|ConMed|1|||
150134252|NCT00828984|541623759|FG001|Overall Study|ConMed|1|||
150134253|NCT00828984|541623760|FG002|Overall Study|ConMed|1|||
150134254|NCT00420199|541623764|FG000|Overall Study|Participant no longer met study criteria|1|||
150134255|NCT00420199|541623765|FG001|Overall Study|Participant no longer met study criteria|0|||
150134256|NCT02123108|541623771|FG000|Overall Study|Death|2|||
150134257|NCT02123108|541623772|FG001|Overall Study|Death|3|||
150134258|NCT00716092|541623773|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
150134259|NCT00716092|541623774|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
150134260|NCT00716092|541623775|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
150134261|NCT02219048|541623776|FG000|Overall Study|Adverse Event|2|||
150134262|NCT02219048|541623777|FG001|Overall Study|Adverse Event|5|||
150134263|NCT02219048|541623776|FG000|Overall Study|No longer meets eligibility criteria|1|||
150134264|NCT02219048|541623777|FG001|Overall Study|No longer meets eligibility criteria|0|||
150134265|NCT02219048|541623776|FG000|Overall Study|Study terminated by sponsor|16|||
150134266|NCT02219048|541623777|FG001|Overall Study|Study terminated by sponsor|15|||
150134267|NCT02219048|541623776|FG000|Overall Study|Withdrawal by Subject|2|||
150134268|NCT02219048|541623777|FG001|Overall Study|Withdrawal by Subject|0|||
150134269|NCT02219048|541623776|FG000|Overall Study|Other|0|||
150134270|NCT02219048|541623777|FG001|Overall Study|Other|1|||
150134271|NCT02436330|541623778|FG000|Cohort 1|Lost to Follow-up|5|||
150134272|NCT02436330|541623779|FG001|Cohort 1|Lost to Follow-up|2|||
150134273|NCT02436330|541623778|FG000|Cohort 1|Withdrawal by Subject|0|||
150134274|NCT02436330|541623779|FG001|Cohort 1|Withdrawal by Subject|1|||
150134275|NCT02436330|541623778|FG000|Cohort 2|Lost to Follow-up|2|||
150134276|NCT02436330|541623779|FG001|Cohort 2|Lost to Follow-up|0|||
150134277|NCT02436330|541623778|FG000|Cohort 2|Withdrawal by Subject|2|||
150134278|NCT02436330|541623779|FG001|Cohort 2|Withdrawal by Subject|3|||
150134279|NCT02436330|541623778|FG000|Cohort 3|Lost to Follow-up|1|||
150134280|NCT02436330|541623779|FG001|Cohort 3|Lost to Follow-up|0|||
150134281|NCT02436330|541623778|FG000|Cohort 3|Withdrawal by Subject|4|||
150134282|NCT02436330|541623779|FG001|Cohort 3|Withdrawal by Subject|0|||
150134283|NCT02436330|541623778|FG000|Cohort 4|Lost to Follow-up|1|||
150134284|NCT02436330|541623779|FG001|Cohort 4|Lost to Follow-up|0|||
150134285|NCT02436330|541623778|FG000|Cohort 4|Withdrawal by Subject|1|||
150134286|NCT02436330|541623779|FG001|Cohort 4|Withdrawal by Subject|0|||
150134287|NCT02436330|541623778|FG000|Cohort 5|Lost to Follow-up|3|||
150134288|NCT02436330|541623779|FG001|Cohort 5|Lost to Follow-up|2|||
150134289|NCT02436330|541623778|FG000|Cohort 5|Withdrawal by Subject|3|||
150134290|NCT02436330|541623779|FG001|Cohort 5|Withdrawal by Subject|2|||
150134291|NCT02436330|541623778|FG000|Cohort 6|Lost to Follow-up|2|||
150134292|NCT02436330|541623779|FG001|Cohort 6|Lost to Follow-up|0|||
150134293|NCT02436330|541623778|FG000|Cohort 6|Withdrawal by Subject|1|||
150134294|NCT02436330|541623779|FG001|Cohort 6|Withdrawal by Subject|1|||
150134295|NCT02054806|541623780|FG000|Overall Study|Sponsor Decision|31|||
150134296|NCT02054806|541623780|FG000|Overall Study|Withdrawal by Subject|43|||
150134297|NCT02054806|541623780|FG000|Overall Study|Protocol Violation|2|||
150134298|NCT02054806|541623780|FG000|Overall Study|Lost to Follow-up|10|||
150134299|NCT02054806|541623780|FG000|Overall Study|Death|391|||
150134300|NCT01132326|541623781|FG000|Overall Study|Lack of Efficacy|25|||
150134301|NCT01132326|541623781|FG000|Overall Study|Adverse Event|37|||
150134302|NCT01132326|541623781|FG000|Overall Study|Protocol Violation|1|||
150134303|NCT01132326|541623781|FG000|Overall Study|Lost to Follow-up|16|||
150134304|NCT01132326|541623781|FG000|Overall Study|Withdrawal by Subject|40|||
150134305|NCT01132326|541623781|FG000|Overall Study|Physician Decision|10|||
150134306|NCT01132326|541623781|FG000|Overall Study|Study Termination|80|||
150134307|NCT01132326|541623781|FG000|Overall Study|Declining Health|1|||
150134308|NCT01132326|541623781|FG000|Overall Study|Pregnancy|1|||
150134309|NCT01132326|541623781|FG000|Overall Study|Caregiver Withdrew Consent|1|||
150134310|NCT01132326|541623781|FG000|Overall Study|Death|5|||
150134311|NCT01132326|541623781|FG000|Overall Study|Subject Unable to Come To Visits|1|||
150134312|NCT00781391|541623782|FG000|Overall Study|never received study drug|24|||
150134313|NCT00781391|541623783|FG001|Overall Study|never received study drug|23|||
150134314|NCT00781391|541623784|FG002|Overall Study|never received study drug|32|||
150134315|NCT00781391|541623782|FG000|Overall Study|Protocol Violation|19|||
150134316|NCT00781391|541623783|FG001|Overall Study|Protocol Violation|17|||
150134317|NCT00781391|541623784|FG002|Overall Study|Protocol Violation|20|||
150134318|NCT00781391|541623782|FG000|Overall Study|Death|789|||
150134319|NCT00781391|541623783|FG001|Overall Study|Death|730|||
150134320|NCT00781391|541623784|FG002|Overall Study|Death|706|||
150134321|NCT00781391|541623782|FG000|Overall Study|Withdrawal by Subject|47|||
150134322|NCT00781391|541623783|FG001|Overall Study|Withdrawal by Subject|37|||
150134323|NCT00781391|541623784|FG002|Overall Study|Withdrawal by Subject|25|||
150134324|NCT00781391|541623782|FG000|Overall Study|Lost to Follow-up|0|||
150134325|NCT00781391|541623783|FG001|Overall Study|Lost to Follow-up|0|||
150134326|NCT00781391|541623784|FG002|Overall Study|Lost to Follow-up|1|||
150134327|NCT04535947|541623785|FG000|Overall Study|Adverse Event|1|||
150134328|NCT04535947|541623786|FG001|Overall Study|Adverse Event|4|||
150134329|NCT04535947|541623785|FG000|Overall Study|Other reasons not specified|2|||
150134330|NCT04535947|541623786|FG001|Overall Study|Other reasons not specified|0|||
150134331|NCT04535947|541623785|FG000|Overall Study|Withdrawal by Subject|1|||
150134332|NCT04535947|541623786|FG001|Overall Study|Withdrawal by Subject|1|||
150134333|NCT04575051|541623801|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
150134334|NCT04575051|541623802|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
150134335|NCT04575051|541623803|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
150134336|NCT04575051|541623804|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
150134337|NCT04575051|541623805|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
150134338|NCT04575051|541623801|FG000|Time Period 1|Missing follow up|1|||
150134339|NCT04575051|541623802|FG001|Time Period 1|Missing follow up|3|||
150134340|NCT04575051|541623803|FG002|Time Period 1|Missing follow up|1|||
150134341|NCT04575051|541623804|FG003|Time Period 1|Missing follow up|3|||
150134342|NCT04575051|541623805|FG004|Time Period 1|Missing follow up|2|||
150134343|NCT04575051|541623801|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
150134344|NCT04575051|541623802|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
150134345|NCT04575051|541623803|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
150134346|NCT04575051|541623804|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
150134347|NCT04575051|541623805|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
150134348|NCT04575051|541623801|FG000|Time Period 2|Missing follow up|1|||
150134349|NCT04575051|541623802|FG001|Time Period 2|Missing follow up|8|||
150134350|NCT04575051|541623803|FG002|Time Period 2|Missing follow up|7|||
150134351|NCT04575051|541623804|FG003|Time Period 2|Missing follow up|0|||
150134352|NCT04575051|541623805|FG004|Time Period 2|Missing follow up|1|||
150134353|NCT04575051|541623801|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
150134354|NCT04575051|541623802|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
150134355|NCT04575051|541623803|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
150134356|NCT04575051|541623804|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
150134357|NCT04575051|541623805|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
150134358|NCT04575051|541623801|FG000|Time Period 3|Missing follow up|8|||
150134359|NCT04575051|541623802|FG001|Time Period 3|Missing follow up|6|||
150134360|NCT04575051|541623803|FG002|Time Period 3|Missing follow up|4|||
150134361|NCT04575051|541623804|FG003|Time Period 3|Missing follow up|3|||
150134362|NCT04575051|541623805|FG004|Time Period 3|Missing follow up|0|||
150134363|NCT04575051|541623801|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
150134364|NCT04575051|541623802|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
150134365|NCT04575051|541623803|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
150134366|NCT04575051|541623804|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
150134367|NCT04575051|541623805|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
150134368|NCT04575051|541623801|FG000|Time Period 4|Missing follow up|17|||
150134369|NCT04575051|541623802|FG001|Time Period 4|Missing follow up|3|||
150134370|NCT04575051|541623803|FG002|Time Period 4|Missing follow up|4|||
150134371|NCT04575051|541623804|FG003|Time Period 4|Missing follow up|2|||
150134372|NCT04575051|541623805|FG004|Time Period 4|Missing follow up|1|||
150134373|NCT04575051|541623801|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
150134374|NCT04575051|541623802|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
150134375|NCT04575051|541623803|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
150134376|NCT04575051|541623804|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
150134377|NCT04575051|541623805|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
150134378|NCT04575051|541623801|FG000|Time Period 5|Missing follow up|11|||
150134379|NCT04575051|541623802|FG001|Time Period 5|Missing follow up|8|||
150134380|NCT04575051|541623803|FG002|Time Period 5|Missing follow up|12|||
150134381|NCT04575051|541623804|FG003|Time Period 5|Missing follow up|3|||
150134382|NCT04575051|541623805|FG004|Time Period 5|Missing follow up|11|||
150134383|NCT03182868|541623808|FG000|Overall Study|Protocol Violation|3|||
150134384|NCT03182868|541623809|FG001|Overall Study|Protocol Violation|0|||
150134385|NCT03182868|541623810|FG002|Overall Study|Protocol Violation|4|||
150134386|NCT03182868|541623811|FG003|Overall Study|Protocol Violation|1|||
150134387|NCT03182868|541623812|FG004|Overall Study|Protocol Violation|8|||
150134388|NCT01830127|541623819|FG000|Overall Study|Adverse Event|1|||
150134389|NCT01830127|541623820|FG001|Overall Study|Adverse Event|6|||
150134390|NCT01830127|541623819|FG000|Overall Study|Lack of Efficacy|3|||
150198926|NCT05856435|541868405|FG000|Overall Study|Lost to Follow-up|6|||
150198927|NCT05660434|541868406|FG000|Overall Study|Never obtained study materials|2|||
150198928|NCT05660434|541868407|FG001|Overall Study|Never obtained study materials|1|||
150198929|NCT02828358|541868410|FG000|Overall Study|Physician Decision|7|||
150198930|NCT02828358|541868411|FG001|Overall Study|Physician Decision|1|||
150134391|NCT01830127|541623820|FG001|Overall Study|Lack of Efficacy|0|||
150134392|NCT01830127|541623819|FG000|Overall Study|Withdrawal by Subject|1|||
150134393|NCT01830127|541623820|FG001|Overall Study|Withdrawal by Subject|1|||
150134394|NCT01830127|541623819|FG000|Overall Study|Other reason not defined above|0|||
150134395|NCT01830127|541623820|FG001|Overall Study|Other reason not defined above|2|||
150134396|NCT03645759|541623824|FG000|Overall Study|Lost to Follow-up|3|||
150134397|NCT03645759|541623825|FG001|Overall Study|Lost to Follow-up|2|||
150134398|NCT00818753|541623826|FG000|Overall Study|Protocol Violation|1|||
150134399|NCT00818753|541623827|FG001|Overall Study|Protocol Violation|0|||
150134400|NCT00818753|541623828|FG002|Overall Study|Protocol Violation|0|||
150134401|NCT00818753|541623826|FG000|Overall Study|Other reason (not specified)|0|||
150134402|NCT00818753|541623827|FG001|Overall Study|Other reason (not specified)|0|||
150198931|NCT02828358|541868410|FG000|Overall Study|Treatment Failure|6|||
150198932|NCT02828358|541868411|FG001|Overall Study|Treatment Failure|0|||
150198933|NCT02828358|541868410|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
150198934|NCT02828358|541868411|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
150198935|NCT02828358|541868410|FG000|Overall Study|Refusal of further protocol therapy|2|||
150198936|NCT02828358|541868411|FG001|Overall Study|Refusal of further protocol therapy|0|||
150198937|NCT02828358|541868410|FG000|Overall Study|Relapse|25|||
150198938|NCT02828358|541868411|FG001|Overall Study|Relapse|0|||
150198939|NCT02828358|541868410|FG000|Overall Study|Still on therapy|5|||
150198940|NCT02828358|541868411|FG001|Overall Study|Still on therapy|0|||
150198941|NCT05285137|541868428|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
150198942|NCT05285137|541868429|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
150198943|NCT05285137|541868430|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
150198944|NCT05285137|541868431|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
150198945|NCT05285137|541868432|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
150198946|NCT05285137|541868433|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
150198947|NCT05285137|541868434|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
150198948|NCT05285137|541868435|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
150198949|NCT05285137|541868436|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
150198950|NCT05285137|541868428|FG000|Overall Study|Lost to Follow-up|0|||
150198951|NCT05285137|541868429|FG001|Overall Study|Lost to Follow-up|0|||
150198952|NCT05285137|541868430|FG002|Overall Study|Lost to Follow-up|1|||
150198953|NCT05285137|541868431|FG003|Overall Study|Lost to Follow-up|3|||
150198954|NCT05285137|541868432|FG004|Overall Study|Lost to Follow-up|0|||
150198955|NCT05285137|541868433|FG005|Overall Study|Lost to Follow-up|0|||
150198956|NCT05285137|541868434|FG006|Overall Study|Lost to Follow-up|1|||
150198957|NCT05285137|541868435|FG007|Overall Study|Lost to Follow-up|0|||
150198958|NCT05285137|541868436|FG008|Overall Study|Lost to Follow-up|0|||
150198959|NCT05285137|541868428|FG000|Overall Study|Physician Decision|0|||
150198960|NCT05285137|541868429|FG001|Overall Study|Physician Decision|1|||
150198961|NCT05285137|541868430|FG002|Overall Study|Physician Decision|0|||
150198962|NCT05285137|541868431|FG003|Overall Study|Physician Decision|0|||
150198963|NCT05285137|541868432|FG004|Overall Study|Physician Decision|0|||
150198964|NCT05285137|541868433|FG005|Overall Study|Physician Decision|0|||
150198965|NCT05285137|541868434|FG006|Overall Study|Physician Decision|0|||
150198966|NCT05285137|541868435|FG007|Overall Study|Physician Decision|0|||
150198967|NCT05285137|541868436|FG008|Overall Study|Physician Decision|0|||
150198968|NCT05285137|541868428|FG000|Overall Study|Pregnancy|0|||
150198969|NCT05285137|541868429|FG001|Overall Study|Pregnancy|0|||
150198970|NCT05285137|541868430|FG002|Overall Study|Pregnancy|0|||
150198971|NCT05285137|541868431|FG003|Overall Study|Pregnancy|0|||
150198972|NCT05285137|541868432|FG004|Overall Study|Pregnancy|0|||
150198973|NCT05285137|541868433|FG005|Overall Study|Pregnancy|0|||
150198974|NCT05285137|541868434|FG006|Overall Study|Pregnancy|1|||
150198975|NCT05285137|541868435|FG007|Overall Study|Pregnancy|0|||
150198976|NCT05285137|541868436|FG008|Overall Study|Pregnancy|0|||
150198977|NCT05285137|541868428|FG000|Overall Study|Withdrawal by Subject|0|||
150198978|NCT05285137|541868429|FG001|Overall Study|Withdrawal by Subject|1|||
150198979|NCT05285137|541868430|FG002|Overall Study|Withdrawal by Subject|2|||
150198980|NCT05285137|541868431|FG003|Overall Study|Withdrawal by Subject|1|||
150198981|NCT05285137|541868432|FG004|Overall Study|Withdrawal by Subject|0|||
150198982|NCT05285137|541868433|FG005|Overall Study|Withdrawal by Subject|0|||
150198983|NCT05285137|541868434|FG006|Overall Study|Withdrawal by Subject|0|||
150198984|NCT05285137|541868435|FG007|Overall Study|Withdrawal by Subject|0|||
150198985|NCT05285137|541868436|FG008|Overall Study|Withdrawal by Subject|1|||
150198986|NCT03106740|541869445|FG000|Overall Study|Lost to Follow-up|2|||
150198987|NCT03106740|541869446|FG001|Overall Study|Lost to Follow-up|2|||
150198988|NCT03106740|541869445|FG000|Overall Study|Withdrawal by Subject|2|||
150198989|NCT03106740|541869446|FG001|Overall Study|Withdrawal by Subject|4|||
150198990|NCT03106740|541869445|FG000|Overall Study|Physician Decision|0|||
150198991|NCT03106740|541869446|FG001|Overall Study|Physician Decision|1|||
150198992|NCT03106740|541869445|FG000|Overall Study|Partial data|1|||
150198993|NCT03106740|541869446|FG001|Overall Study|Partial data|0|||
150198994|NCT04565990|541869447|FG000|Overall Study|Death|5|||
150198995|NCT04565990|541869447|FG000|Overall Study|Lost to Follow-up|1|||
150198996|NCT04565990|541869447|FG000|Overall Study|Withdrawal by Subject|1|||
150198997|NCT04797858|541869448|FG000|Overall Study|Withdrawal by Subject|0|||
150198998|NCT04797858|541869449|FG001|Overall Study|Withdrawal by Subject|1|||
150198999|NCT04797858|541869448|FG000|Overall Study|Excluded due to administrative error|7|||
150199000|NCT04797858|541869449|FG001|Overall Study|Excluded due to administrative error|8|||
150199001|NCT04433208|541869450|FG000|Overall Study|Withdrawal by Subject|0|||
150199002|NCT04433208|541869451|FG001|Overall Study|Withdrawal by Subject|1|||
150199003|NCT04433208|541869452|FG002|Overall Study|Withdrawal by Subject|1|||
150199004|NCT04433208|541869453|FG003|Overall Study|Withdrawal by Subject|0|||
150199005|NCT04433208|541869454|FG004|Overall Study|Withdrawal by Subject|2|||
150199006|NCT04433208|541869455|FG005|Overall Study|Withdrawal by Subject|1|||
150199007|NCT04433208|541869450|FG000|Overall Study|Lost to Follow-up|0|||
150199008|NCT04433208|541869451|FG001|Overall Study|Lost to Follow-up|0|||
150199009|NCT04433208|541869452|FG002|Overall Study|Lost to Follow-up|0|||
150199010|NCT04433208|541869453|FG003|Overall Study|Lost to Follow-up|0|||
150199011|NCT04433208|541869454|FG004|Overall Study|Lost to Follow-up|0|||
150199012|NCT04433208|541869455|FG005|Overall Study|Lost to Follow-up|1|||
150199013|NCT03476343|541869461|FG000|Overall Study|Clinical exam moved to another scanner|7|||
150199014|NCT03476343|541869461|FG000|Overall Study|Clinical order cancelled|4|||
150199015|NCT03476343|541869461|FG000|Overall Study|Neonate did not settle down for the scan|1|||
150199016|NCT03711474|541869462|FG000|Overall Study|Physician Decision|2|||
150199017|NCT03711474|541869463|FG001|Overall Study|Physician Decision|0|||
150199018|NCT05147116|541869464|FG000|Overall Study|Withdrawal by Subject|0|||
150199019|NCT05147116|541869465|FG001|Overall Study|Withdrawal by Subject|1|||
150199020|NCT05204654|541869468|FG000|Overall Study|Study terminated due to time restraint|2|||
150199021|NCT05204654|541869469|FG001|Overall Study|Study terminated due to time restraint|2|||
150199022|NCT01221948|541869470|FG000|Overall Study|Physician Decision|5|||
150199023|NCT01221948|541869470|FG000|Overall Study|Withdrawal by Subject|2|||
150199024|NCT01221948|541869470|FG000|Overall Study|not disclosed|2|||
150199025|NCT01221948|541869470|FG000|Overall Study|Death|1|||
150199026|NCT01221948|541869470|FG000|Overall Study|Protocol Violation|4|||
150199027|NCT02446236|541869473|FG000|Overall Study|Screen Failure|1|||
150199028|NCT02446236|541869474|FG001|Overall Study|Screen Failure|0|||
150199029|NCT02446236|541869475|FG002|Overall Study|Screen Failure|1|||
150199030|NCT02446236|541869473|FG000|Overall Study|Actively Receiving Therapy|0|||
150199031|NCT02446236|541869474|FG001|Overall Study|Actively Receiving Therapy|0|||
150199032|NCT02446236|541869475|FG002|Overall Study|Actively Receiving Therapy|1|||
150199033|NCT05012163|541869478|FG000|Overall Study|Protocol Violation|0|||
150199034|NCT05012163|541869479|FG001|Overall Study|Protocol Violation|0|||
150199035|NCT05012163|541869480|FG002|Overall Study|Protocol Violation|1|||
150199036|NCT05012163|541869481|FG003|Overall Study|Protocol Violation|1|||
150199037|NCT03381586|541869484|FG000|Overall Study|Adverse Event|1|||
150199038|NCT03381586|541869485|FG001|Overall Study|Adverse Event|1|||
150199039|NCT03381586|541869484|FG000|Overall Study|Protocol Violation|1|||
150199040|NCT03381586|541869485|FG001|Overall Study|Protocol Violation|0|||
150199041|NCT03381586|541869484|FG000|Overall Study|Withdrawal by Subject|1|||
150199042|NCT03381586|541869485|FG001|Overall Study|Withdrawal by Subject|2|||
150199043|NCT05280574|541869490|FG000|Overall Study|Withdrawal by Subject|0|||
150199044|NCT05280574|541869491|FG001|Overall Study|Withdrawal by Subject|2|||
150199045|NCT05280574|541869492|FG002|Overall Study|Withdrawal by Subject|0|||
150199046|NCT05363163|541869493|FG000|Overall Study|Withdrawal by Subject|13|||
150199047|NCT05838027|541869499|FG000|Overall Study|Lost to Follow-up|5|||
150199048|NCT05838027|541869500|FG001|Overall Study|Lost to Follow-up|1|||
150199049|NCT05838027|541869499|FG000|Overall Study|Withdrawal by Subject|1|||
150199050|NCT05838027|541869500|FG001|Overall Study|Withdrawal by Subject|0|||
150199051|NCT03213873|541869501|FG000|Overall Study|Withdrawal by Subject|8|||
150199052|NCT03213873|541869502|FG001|Overall Study|Withdrawal by Subject|9|||
150199053|NCT03213873|541869501|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
150199054|NCT03213873|541869502|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
150199055|NCT03213873|541869501|FG000|Overall Study|Lost to Follow-up|0|||
150199056|NCT03213873|541869502|FG001|Overall Study|Lost to Follow-up|2|||
150199057|NCT04709419|541869503|FG000|Overall Study|Physician Decision|1|||
150199058|NCT04709419|541869504|FG001|Overall Study|Physician Decision|0|||
150199059|NCT03824366|541869509|FG000|Overall Study|Death|1|||
150199060|NCT03824366|541869509|FG000|Overall Study|Previously unidentified metal artifact|1|||
150199061|NCT03824366|541869509|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
150199062|NCT03824366|541869509|FG000|Overall Study|Withdrawal by Subject|1|||
150199063|NCT05069896|541869512|FG000|Overall Study|Adverse Event|0|||
150199064|NCT05069896|541869513|FG001|Overall Study|Adverse Event|1|||
150199065|NCT05069896|541869514|FG002|Overall Study|Adverse Event|1|||
150199066|NCT05069896|541869515|FG003|Overall Study|Adverse Event|0|||
150199067|NCT05069896|541869516|FG004|Overall Study|Adverse Event|0|||
150199068|NCT05069896|541869517|FG005|Overall Study|Adverse Event|0|||
150199069|NCT05069896|541869512|FG000|Overall Study|Lost to Follow-up|0|||
150199070|NCT05069896|541869513|FG001|Overall Study|Lost to Follow-up|0|||
150199071|NCT05069896|541869514|FG002|Overall Study|Lost to Follow-up|1|||
150199072|NCT05069896|541869515|FG003|Overall Study|Lost to Follow-up|0|||
150199073|NCT05069896|541869516|FG004|Overall Study|Lost to Follow-up|1|||
150199074|NCT05069896|541869517|FG005|Overall Study|Lost to Follow-up|2|||
150199075|NCT04068831|541869518|FG000|Overall Study|Disease Progression|10|||
150199076|NCT04068831|541869519|FG001|Overall Study|Disease Progression|8|||
150199077|NCT04580914|541869524|FG000|Overall Study|Withdrawal by Subject|6|||
150199078|NCT04580914|541869524|FG000|Overall Study|Lost to Follow-up|2|||
150199079|NCT05715528|541869525|FG000|Overall Study|Randomized but never treated|11|||
150199080|NCT05715528|541869526|FG001|Overall Study|Randomized but never treated|13|||
150199081|NCT05715528|541869525|FG000|Overall Study|Withdrew consent|7|||
150199082|NCT05715528|541869526|FG001|Overall Study|Withdrew consent|15|||
150199083|NCT05715528|541869525|FG000|Overall Study|Lost to Follow-up|5|||
150199084|NCT05715528|541869526|FG001|Overall Study|Lost to Follow-up|13|||
150199085|NCT05715528|541869525|FG000|Overall Study|Investigator's discretion|3|||
150199086|NCT05715528|541869526|FG001|Overall Study|Investigator's discretion|1|||
150134403|NCT00818753|541623828|FG002|Overall Study|Other reason (not specified)|1|||
150134404|NCT00818753|541623826|FG000|Overall Study|Randomised and not treated|2|||
150134405|NCT00818753|541623827|FG001|Overall Study|Randomised and not treated|0|||
150134406|NCT00818753|541623828|FG002|Overall Study|Randomised and not treated|0|||
150134407|NCT01389973|541623829|FG000|Overall Study|Lost to Follow-up|1|||
150134408|NCT01389973|541623829|FG000|Overall Study|Trial Stopped by Sponsor|9|||
150134409|NCT01389973|541623829|FG000|Overall Study|Other|10|||
150134410|NCT00725296|541623830|FG000|Overall Study|Adverse Event|11|||
150134411|NCT00725296|541623830|FG000|Overall Study|Lack of Efficacy|7|||
150134412|NCT00725296|541623830|FG000|Overall Study|Withdrawal by Subject|3|||
150134413|NCT00725296|541623830|FG000|Overall Study|Non-Compliance|2|||
150134414|NCT00725296|541623830|FG000|Overall Study|Lost to Follow-up|1|||
150134415|NCT00725296|541623830|FG000|Overall Study|Other|38|||
150134416|NCT02693743|541623831|FG000|Overall Study|Physician Decision|1|||
150134417|NCT02693743|541623832|FG001|Overall Study|Physician Decision|0|||
150134418|NCT03360942|541623833|FG000|Overall Study|Device explanted|2|||
150134419|NCT03360942|541623833|FG000|Overall Study|Study closure|1|||
150134420|NCT03360942|541623833|FG000|Overall Study|Withdrawal by Subject|2|||
150134421|NCT02459574|541623839|FG000|Overall Study|Withdrawal by Subject|6|||
150134422|NCT02459574|541623840|FG001|Overall Study|Withdrawal by Subject|6|||
150134423|NCT02459574|541623841|FG002|Overall Study|Withdrawal by Subject|2|||
150134424|NCT02459574|541623839|FG000|Overall Study|Lost to Follow-up|1|||
150134425|NCT02459574|541623840|FG001|Overall Study|Lost to Follow-up|1|||
150134426|NCT02459574|541623841|FG002|Overall Study|Lost to Follow-up|0|||
150134427|NCT02459574|541623839|FG000|Overall Study|Death|0|||
150134428|NCT02459574|541623840|FG001|Overall Study|Death|1|||
150134429|NCT02459574|541623841|FG002|Overall Study|Death|0|||
150134430|NCT01735201|541625939|FG000|Overall Study|Adverse Event|1|||
150134431|NCT01735201|541625940|FG001|Overall Study|Adverse Event|1|||
150134432|NCT01735201|541625941|FG002|Overall Study|Adverse Event|0|||
150134433|NCT01735201|541625942|FG003|Overall Study|Adverse Event|1|||
150134434|NCT01735201|541625943|FG004|Overall Study|Adverse Event|1|||
150134435|NCT01735201|541625944|FG005|Overall Study|Adverse Event|3|||
150134436|NCT01735201|541625945|FG006|Overall Study|Adverse Event|2|||
150134437|NCT01735201|541625946|FG007|Overall Study|Adverse Event|1|||
150134438|NCT01735201|541625939|FG000|Overall Study|Personal Reasons|1|||
150134439|NCT01735201|541625940|FG001|Overall Study|Personal Reasons|0|||
150134440|NCT01735201|541625941|FG002|Overall Study|Personal Reasons|0|||
150134441|NCT01735201|541625942|FG003|Overall Study|Personal Reasons|0|||
150134442|NCT01735201|541625943|FG004|Overall Study|Personal Reasons|0|||
150134443|NCT01735201|541625944|FG005|Overall Study|Personal Reasons|0|||
150134444|NCT01735201|541625945|FG006|Overall Study|Personal Reasons|0|||
150134445|NCT01735201|541625946|FG007|Overall Study|Personal Reasons|0|||
150134446|NCT01735201|541625939|FG000|Overall Study|Protocol Violation|1|||
150134447|NCT01735201|541625940|FG001|Overall Study|Protocol Violation|0|||
150134448|NCT01735201|541625941|FG002|Overall Study|Protocol Violation|0|||
150134449|NCT01735201|541625942|FG003|Overall Study|Protocol Violation|0|||
150134450|NCT01735201|541625943|FG004|Overall Study|Protocol Violation|0|||
150134451|NCT01735201|541625944|FG005|Overall Study|Protocol Violation|0|||
150134452|NCT01735201|541625945|FG006|Overall Study|Protocol Violation|0|||
150134453|NCT01735201|541625946|FG007|Overall Study|Protocol Violation|0|||
150134454|NCT01735201|541625939|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150134455|NCT01735201|541625940|FG001|Overall Study|Other Miscellaneous Reasons|0|||
150134456|NCT01735201|541625941|FG002|Overall Study|Other Miscellaneous Reasons|0|||
150134457|NCT01735201|541625942|FG003|Overall Study|Other Miscellaneous Reasons|1|||
150134458|NCT01735201|541625943|FG004|Overall Study|Other Miscellaneous Reasons|0|||
150134459|NCT01735201|541625944|FG005|Overall Study|Other Miscellaneous Reasons|2|||
150134460|NCT01735201|541625945|FG006|Overall Study|Other Miscellaneous Reasons|1|||
150134461|NCT01735201|541625946|FG007|Overall Study|Other Miscellaneous Reasons|1|||
150134462|NCT00002558|541625958|FG000|Overall Study|Withdrawal by Subject|0|||
150134463|NCT00002558|541625959|FG001|Overall Study|Withdrawal by Subject|1|||
150134464|NCT01260350|541625960|FG000|Overall Study|Lack of Efficacy|0|||
150134465|NCT01260350|541625961|FG001|Overall Study|Lack of Efficacy|0|||
150134466|NCT01260350|541625962|FG002|Overall Study|Lack of Efficacy|0|||
150134467|NCT01260350|541625963|FG003|Overall Study|Lack of Efficacy|0|||
150134468|NCT01260350|541625964|FG004|Overall Study|Lack of Efficacy|0|||
150134469|NCT01260350|541625965|FG005|Overall Study|Lack of Efficacy|0|||
150134470|NCT01260350|541625966|FG006|Overall Study|Lack of Efficacy|0|||
150134471|NCT01260350|541625967|FG007|Overall Study|Lack of Efficacy|0|||
150134472|NCT01260350|541625968|FG008|Overall Study|Lack of Efficacy|0|||
150134473|NCT01260350|541625969|FG009|Overall Study|Lack of Efficacy|0|||
150134474|NCT01260350|541625970|FG010|Overall Study|Lack of Efficacy|0|||
150134475|NCT01260350|541625971|FG011|Overall Study|Lack of Efficacy|0|||
150134476|NCT01260350|541625972|FG012|Overall Study|Lack of Efficacy|0|||
150134477|NCT01260350|541625973|FG013|Overall Study|Lack of Efficacy|0|||
150134478|NCT01260350|541625974|FG014|Overall Study|Lack of Efficacy|0|||
150134479|NCT01260350|541625975|FG015|Overall Study|Lack of Efficacy|0|||
150134480|NCT01260350|541625976|FG016|Overall Study|Lack of Efficacy|0|||
150134481|NCT01260350|541625977|FG017|Overall Study|Lack of Efficacy|1|||
150134482|NCT01260350|541625978|FG018|Overall Study|Lack of Efficacy|0|||
150134483|NCT01260350|541625979|FG019|Overall Study|Lack of Efficacy|0|||
150134484|NCT01260350|541625980|FG020|Overall Study|Lack of Efficacy|3|||
150134485|NCT01260350|541625981|FG021|Overall Study|Lack of Efficacy|0|||
150134486|NCT01260350|541625960|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134487|NCT01260350|541625961|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134488|NCT01260350|541625962|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134489|NCT01260350|541625963|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134490|NCT01260350|541625964|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134491|NCT01260350|541625965|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134492|NCT01260350|541625966|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134493|NCT01260350|541625967|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134494|NCT01260350|541625968|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
150134495|NCT01260350|541625969|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134496|NCT01260350|541625970|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134497|NCT01260350|541625971|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134498|NCT01260350|541625972|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134499|NCT01260350|541625973|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134500|NCT01260350|541625974|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134501|NCT01260350|541625975|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150199087|NCT05715528|541869525|FG000|Overall Study|Protocol Violation|2|||
150199088|NCT05715528|541869526|FG001|Overall Study|Protocol Violation|0|||
150199089|NCT05715528|541869525|FG000|Overall Study|Non-compliance with study drug|0|||
150199090|NCT05715528|541869526|FG001|Overall Study|Non-compliance with study drug|1|||
150199091|NCT03118518|541869527|FG000|Overall Study|Early Exit after treatment|2|||
150199092|NCT03118518|541869528|FG001|Overall Study|Early Exit after treatment|8|||
150199093|NCT03118518|541869527|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
150199094|NCT03118518|541869528|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
150199095|NCT02998528|541869532|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
150199096|NCT02998528|541869533|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
150199097|NCT02998528|541869534|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
150199098|NCT02998528|541869532|FG000|Randomization Period|Participant withdrew consent|0|||
150199099|NCT02998528|541869533|FG001|Randomization Period|Participant withdrew consent|3|||
150199100|NCT02998528|541869534|FG002|Randomization Period|Participant withdrew consent|0|||
150199101|NCT02998528|541869532|FG000|Randomization Period|Participant no longer meets study criteria|1|||
150199102|NCT02998528|541869533|FG001|Randomization Period|Participant no longer meets study criteria|3|||
150199103|NCT02998528|541869534|FG002|Randomization Period|Participant no longer meets study criteria|2|||
150199104|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
150134502|NCT01260350|541625976|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134503|NCT01260350|541625977|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134504|NCT01260350|541625978|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134505|NCT01260350|541625979|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134506|NCT01260350|541625980|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134507|NCT01260350|541625981|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
150134508|NCT00558428|541625984|FG000|Overall Study|Adverse Event|6|||
150134509|NCT00558428|541625985|FG001|Overall Study|Adverse Event|22|||
150134510|NCT00558428|541625986|FG002|Overall Study|Adverse Event|3|||
150134511|NCT00558428|541625987|FG003|Overall Study|Adverse Event|4|||
150134512|NCT00558428|541625984|FG000|Overall Study|Lost to Follow-up|0|||
150134513|NCT00558428|541625985|FG001|Overall Study|Lost to Follow-up|1|||
150134514|NCT00558428|541625986|FG002|Overall Study|Lost to Follow-up|0|||
150134515|NCT00558428|541625987|FG003|Overall Study|Lost to Follow-up|0|||
150134516|NCT00558428|541625984|FG000|Overall Study|Lack of Efficacy|0|||
150134517|NCT00558428|541625985|FG001|Overall Study|Lack of Efficacy|0|||
150134518|NCT00558428|541625986|FG002|Overall Study|Lack of Efficacy|1|||
150134519|NCT00558428|541625987|FG003|Overall Study|Lack of Efficacy|2|||
150134520|NCT00558428|541625984|FG000|Overall Study|Non compliant with protocol|1|||
150134521|NCT00558428|541625985|FG001|Overall Study|Non compliant with protocol|0|||
150134522|NCT00558428|541625986|FG002|Overall Study|Non compliant with protocol|0|||
150134523|NCT00558428|541625987|FG003|Overall Study|Non compliant with protocol|3|||
150134524|NCT00558428|541625984|FG000|Overall Study|Consent withdrawn|2|||
150134525|NCT00558428|541625985|FG001|Overall Study|Consent withdrawn|1|||
150134526|NCT00558428|541625986|FG002|Overall Study|Consent withdrawn|0|||
150134527|NCT00558428|541625987|FG003|Overall Study|Consent withdrawn|1|||
150134528|NCT00558428|541625984|FG000|Overall Study|Other|3|||
150134529|NCT00558428|541625985|FG001|Overall Study|Other|0|||
150199105|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
150134530|NCT00558428|541625986|FG002|Overall Study|Other|0|||
150134531|NCT00558428|541625987|FG003|Overall Study|Other|1|||
150134532|NCT00626028|541625988|FG000|Overall Study|Adverse Event|1|||
150134533|NCT00626028|541625989|FG001|Overall Study|Adverse Event|1|||
150134534|NCT00626028|541625988|FG000|Overall Study|Device Failure|0|||
150134535|NCT00626028|541625989|FG001|Overall Study|Device Failure|1|||
150134536|NCT00626028|541625988|FG000|Overall Study|Physician Decision|2|||
150134537|NCT00626028|541625989|FG001|Overall Study|Physician Decision|1|||
150134538|NCT00626028|541625988|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
150134539|NCT00626028|541625989|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
150134540|NCT05224050|541625990|FG000|Overall Study|Withdrawal by Subject|9|||
150134541|NCT05224050|541625990|FG000|Overall Study|Lost to Follow-up|3|||
150134542|NCT03205371|541625996|FG000|Overall Study|Withdrawal by Subject|4|||
150134543|NCT03205371|541625997|FG001|Overall Study|Withdrawal by Subject|1|||
150134544|NCT03205371|541625998|FG002|Overall Study|Withdrawal by Subject|0|||
150134545|NCT03205371|541625999|FG003|Overall Study|Withdrawal by Subject|0|||
150134546|NCT03205371|541626000|FG004|Overall Study|Withdrawal by Subject|0|||
150134547|NCT03205371|541626001|FG005|Overall Study|Withdrawal by Subject|0|||
150134548|NCT03205371|541626002|FG006|Overall Study|Withdrawal by Subject|4|||
150134549|NCT03205371|541626003|FG007|Overall Study|Withdrawal by Subject|0|||
150134550|NCT03205371|541626004|FG008|Overall Study|Withdrawal by Subject|2|||
150134551|NCT03205371|541626005|FG009|Overall Study|Withdrawal by Subject|0|||
150134552|NCT03205371|541626006|FG010|Overall Study|Withdrawal by Subject|0|||
150134553|NCT03205371|541626007|FG011|Overall Study|Withdrawal by Subject|1|||
150134554|NCT03205371|541625996|FG000|Overall Study|Lost to Follow-up|0|||
150134555|NCT03205371|541625997|FG001|Overall Study|Lost to Follow-up|0|||
150134556|NCT03205371|541625998|FG002|Overall Study|Lost to Follow-up|0|||
150134557|NCT03205371|541625999|FG003|Overall Study|Lost to Follow-up|0|||
150134558|NCT03205371|541626000|FG004|Overall Study|Lost to Follow-up|0|||
150134559|NCT03205371|541626001|FG005|Overall Study|Lost to Follow-up|0|||
150134560|NCT03205371|541626002|FG006|Overall Study|Lost to Follow-up|5|||
150134561|NCT03205371|541626003|FG007|Overall Study|Lost to Follow-up|2|||
150134562|NCT03205371|541626004|FG008|Overall Study|Lost to Follow-up|3|||
150134563|NCT03205371|541626005|FG009|Overall Study|Lost to Follow-up|0|||
150134564|NCT03205371|541626006|FG010|Overall Study|Lost to Follow-up|0|||
150134565|NCT03205371|541626007|FG011|Overall Study|Lost to Follow-up|0|||
150134566|NCT03205371|541625996|FG000|Overall Study|Protocol Violation|0|||
150134567|NCT03205371|541625997|FG001|Overall Study|Protocol Violation|0|||
150134568|NCT03205371|541625998|FG002|Overall Study|Protocol Violation|0|||
150134569|NCT03205371|541625999|FG003|Overall Study|Protocol Violation|0|||
150134570|NCT03205371|541626000|FG004|Overall Study|Protocol Violation|0|||
150134571|NCT03205371|541626001|FG005|Overall Study|Protocol Violation|0|||
150134572|NCT03205371|541626002|FG006|Overall Study|Protocol Violation|1|||
150134573|NCT03205371|541626003|FG007|Overall Study|Protocol Violation|0|||
150134574|NCT03205371|541626004|FG008|Overall Study|Protocol Violation|0|||
150134575|NCT03205371|541626005|FG009|Overall Study|Protocol Violation|0|||
150134576|NCT03205371|541626006|FG010|Overall Study|Protocol Violation|0|||
150134577|NCT03205371|541626007|FG011|Overall Study|Protocol Violation|0|||
150134578|NCT03205371|541625996|FG000|Overall Study|Adverse Event|0|||
150134579|NCT03205371|541625997|FG001|Overall Study|Adverse Event|0|||
150134580|NCT03205371|541625998|FG002|Overall Study|Adverse Event|0|||
150134581|NCT03205371|541625999|FG003|Overall Study|Adverse Event|0|||
150134582|NCT03205371|541626000|FG004|Overall Study|Adverse Event|0|||
150134583|NCT03205371|541626001|FG005|Overall Study|Adverse Event|0|||
150134584|NCT03205371|541626002|FG006|Overall Study|Adverse Event|0|||
150134585|NCT03205371|541626003|FG007|Overall Study|Adverse Event|1|||
150134586|NCT03205371|541626004|FG008|Overall Study|Adverse Event|0|||
150134587|NCT03205371|541626005|FG009|Overall Study|Adverse Event|0|||
150134588|NCT03205371|541626006|FG010|Overall Study|Adverse Event|0|||
150134589|NCT03205371|541626007|FG011|Overall Study|Adverse Event|0|||
150134590|NCT04918147|541626017|FG000|Overall Study|Disease flare as defined in protocol|0|||
150134591|NCT04918147|541626018|FG001|Overall Study|Disease flare as defined in protocol|2|||
150134592|NCT04212091|541626020|FG000|Overall Study|Lost to Follow-up|0|||
150134593|NCT04212091|541626021|FG001|Overall Study|Lost to Follow-up|0|||
150134594|NCT04212091|541626022|FG002|Overall Study|Lost to Follow-up|0|||
150134595|NCT04212091|541626023|FG003|Overall Study|Lost to Follow-up|0|||
150134596|NCT04212091|541626024|FG004|Overall Study|Lost to Follow-up|1|||
150134597|NCT04212091|541626025|FG005|Overall Study|Lost to Follow-up|1|||
150134598|NCT04212091|541626020|FG000|Overall Study|Participant unable to adhere to visit|0|||
150134599|NCT04212091|541626021|FG001|Overall Study|Participant unable to adhere to visit|0|||
150134600|NCT04212091|541626022|FG002|Overall Study|Participant unable to adhere to visit|0|||
150134601|NCT04212091|541626023|FG003|Overall Study|Participant unable to adhere to visit|0|||
150199106|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
150199107|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
150199108|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
150134602|NCT04212091|541626024|FG004|Overall Study|Participant unable to adhere to visit|1|||
150134603|NCT04212091|541626025|FG005|Overall Study|Participant unable to adhere to visit|0|||
150134604|NCT03492281|541626026|FG000|Overall Study|Withdrawal by Subject|21|||
150134605|NCT03492281|541626027|FG001|Overall Study|Withdrawal by Subject|14|||
150134606|NCT03492281|541626028|FG002|Overall Study|Withdrawal by Subject|13|||
150134607|NCT03492281|541626026|FG000|Overall Study|Lost to Follow-up|14|||
150134608|NCT03492281|541626027|FG001|Overall Study|Lost to Follow-up|15|||
150134609|NCT03492281|541626028|FG002|Overall Study|Lost to Follow-up|10|||
150134610|NCT03492281|541626026|FG000|Overall Study|Adverse Event|6|||
150134611|NCT03492281|541626027|FG001|Overall Study|Adverse Event|8|||
150134612|NCT03492281|541626028|FG002|Overall Study|Adverse Event|13|||
150134613|NCT03492281|541626026|FG000|Overall Study|Lack of Efficacy|3|||
150134614|NCT03492281|541626027|FG001|Overall Study|Lack of Efficacy|0|||
150134615|NCT03492281|541626028|FG002|Overall Study|Lack of Efficacy|1|||
150134616|NCT03492281|541626026|FG000|Overall Study|Physician Decision|1|||
150134617|NCT03492281|541626027|FG001|Overall Study|Physician Decision|0|||
150134618|NCT03492281|541626028|FG002|Overall Study|Physician Decision|3|||
150134619|NCT03492281|541626026|FG000|Overall Study|Protocol Violation|0|||
150134620|NCT03492281|541626027|FG001|Overall Study|Protocol Violation|2|||
150134621|NCT03492281|541626028|FG002|Overall Study|Protocol Violation|1|||
150134622|NCT03492281|541626026|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
150134623|NCT03492281|541626027|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
150134624|NCT03492281|541626028|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
150134625|NCT03492281|541626026|FG000|Overall Study|Death|0|||
150134626|NCT03492281|541626027|FG001|Overall Study|Death|0|||
150134627|NCT03492281|541626028|FG002|Overall Study|Death|1|||
150134628|NCT03492281|541626026|FG000|Overall Study|Captured as Other in Database|8|||
150134629|NCT03492281|541626027|FG001|Overall Study|Captured as Other in Database|6|||
150134630|NCT03492281|541626028|FG002|Overall Study|Captured as Other in Database|3|||
150134631|NCT03624504|541626029|FG000|Overall Study|Unsuccessful Implant|1|||
150134632|NCT00951483|541626030|FG000|Overall Study|Physician Decision|4|||
150134633|NCT00951483|541626031|FG001|Overall Study|Physician Decision|0|||
150134634|NCT00951483|541626030|FG000|Overall Study|Withdrawal by Subject|15|||
150134635|NCT00951483|541626031|FG001|Overall Study|Withdrawal by Subject|0|||
150134636|NCT03565887|541626032|FG000|Overall Study|Adverse Event|1|||
150134637|NCT03565887|541626033|FG001|Overall Study|Adverse Event|0|||
150134638|NCT03565887|541626032|FG000|Overall Study|Withdrawal by Subject|0|||
150134639|NCT03565887|541626033|FG001|Overall Study|Withdrawal by Subject|2|||
150199109|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
150199110|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
150199111|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
150199112|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
150199113|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
150199114|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
150199115|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
150199116|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
150199117|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
150199118|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
150199119|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Death|1|||
150199120|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Death|0|||
150199121|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Death|0|||
150199122|NCT02998528|541869532|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
150199123|NCT02998528|541869533|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
150199124|NCT02998528|541869534|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
150199125|NCT02998528|541869532|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
150199126|NCT02998528|541869533|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
150199127|NCT02998528|541869534|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
150199128|NCT02998528|541869532|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
150199129|NCT02998528|541869533|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
150199130|NCT02998528|541869534|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
150199131|NCT02998528|541869532|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
150199132|NCT02998528|541869533|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
150199133|NCT02998528|541869534|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
150199134|NCT02998528|541869532|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
150199135|NCT02998528|541869533|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
150199136|NCT02998528|541869534|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
150199137|NCT02998528|541869532|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
150199138|NCT02998528|541869533|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
150199139|NCT02998528|541869534|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
150199140|NCT02413489|541869539|FG000|Overall Study|Death|11|||
150134640|NCT03364751|541626034|FG000|Overall Study|Withdrawal by Subject|1|||
150134641|NCT03364751|541626035|FG001|Overall Study|Withdrawal by Subject|0|||
150134642|NCT03364751|541626036|FG002|Overall Study|Withdrawal by Subject|0|||
150134643|NCT03364751|541626037|FG003|Overall Study|Withdrawal by Subject|0|||
150134644|NCT03364751|541626034|FG000|Overall Study|Lost to Follow-up|0|||
150134645|NCT03364751|541626035|FG001|Overall Study|Lost to Follow-up|1|||
150134646|NCT03364751|541626036|FG002|Overall Study|Lost to Follow-up|0|||
150134647|NCT03364751|541626037|FG003|Overall Study|Lost to Follow-up|0|||
150134648|NCT02975973|541626038|FG000|Overall Study|Adverse Event|1|||
150199141|NCT02413489|541869540|FG001|Overall Study|Death|3|||
150134649|NCT02975973|541626039|FG001|Overall Study|Adverse Event|1|||
150134650|NCT02975973|541626040|FG002|Overall Study|Adverse Event|1|||
150134651|NCT02975973|541626041|FG003|Overall Study|Adverse Event|0|||
150134652|NCT03804710|541626043|FG000|Overall Study|Adverse Event|0|||
150199142|NCT02413489|541869541|FG002|Overall Study|Death|4|||
150199143|NCT02413489|541869539|FG000|Overall Study|Withdrawal by Subject|2|||
150134653|NCT03804710|541626044|FG001|Overall Study|Adverse Event|3|||
150134654|NCT03804710|541626043|FG000|Overall Study|Withdrawal by Subject|2|||
150134655|NCT03804710|541626044|FG001|Overall Study|Withdrawal by Subject|1|||
150134656|NCT03804710|541626043|FG000|Overall Study|Other|0|||
150134657|NCT03804710|541626044|FG001|Overall Study|Other|1|||
150134658|NCT04542018|541626045|FG000|Overall Study|Withdrawal by Subject|0|||
150134659|NCT04542018|541626046|FG001|Overall Study|Withdrawal by Subject|0|||
150134660|NCT04542018|541626047|FG002|Overall Study|Withdrawal by Subject|4|||
150134661|NCT04542018|541626045|FG000|Overall Study|Protocol Violation|0|||
150134662|NCT04542018|541626046|FG001|Overall Study|Protocol Violation|0|||
150134663|NCT04542018|541626047|FG002|Overall Study|Protocol Violation|2|||
150199144|NCT02413489|541869540|FG001|Overall Study|Withdrawal by Subject|0|||
150199145|NCT02413489|541869541|FG002|Overall Study|Withdrawal by Subject|0|||
150199146|NCT02413489|541869539|FG000|Overall Study|Study Terminated By Sponsor|2|||
150199147|NCT02413489|541869540|FG001|Overall Study|Study Terminated By Sponsor|13|||
150199148|NCT02413489|541869541|FG002|Overall Study|Study Terminated By Sponsor|1|||
150199149|NCT01199133|541869546|FG000|Year 1|Adverse Event|16|||
150199150|NCT01199133|541869547|FG001|Year 1|Adverse Event|4|||
150199151|NCT01199133|541869546|FG000|Year 1|Withdrawal by Subject|8|||
150199152|NCT01199133|541869547|FG001|Year 1|Withdrawal by Subject|4|||
150199153|NCT01199133|541869546|FG000|Year 1|Any other reason not above-mentioned|6|||
150134664|NCT03583554|541626048|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
150134665|NCT03583554|541626049|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
150134666|NCT03583554|541626050|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
150134667|NCT03178266|541626051|FG000|Overall Study|Death|0|||
150134668|NCT03178266|541626052|FG001|Overall Study|Death|1|||
150134669|NCT03178266|541626051|FG000|Overall Study|Disont. Early|0|||
150134670|NCT03178266|541626052|FG001|Overall Study|Disont. Early|1|||
150134671|NCT03178266|541626051|FG000|Overall Study|Withdrawal by Subject|0|||
150134672|NCT03178266|541626052|FG001|Overall Study|Withdrawal by Subject|2|||
150134673|NCT00689221|541626058|FG000|Overall Study|Ongoing at cut-off date|39|||
150199154|NCT01199133|541869547|FG001|Year 1|Any other reason not above-mentioned|7|||
150199155|NCT01199133|541869546|FG000|Year 2|Adverse Event|1|||
150199156|NCT01199133|541869547|FG001|Year 2|Adverse Event|0|||
150199157|NCT01199133|541869546|FG000|Year 2|Withdrawal by Subject|1|||
150199158|NCT01199133|541869547|FG001|Year 2|Withdrawal by Subject|1|||
150199159|NCT01199133|541869546|FG000|Year 2|Any other reason not above-mentioned|1|||
150199160|NCT01199133|541869547|FG001|Year 2|Any other reason not above-mentioned|2|||
150199161|NCT05100628|541869548|FG000|Overall Study|Progressive Disease|1|||
150199162|NCT05100628|541869549|FG001|Overall Study|Progressive Disease|0|||
150199163|NCT05100628|541869550|FG002|Overall Study|Progressive Disease|0|||
150199164|NCT05100628|541869551|FG003|Overall Study|Progressive Disease|0|||
150199165|NCT05100628|541869548|FG000|Overall Study|Study Terminated by Sponsor|0|||
150199166|NCT05100628|541869549|FG001|Overall Study|Study Terminated by Sponsor|0|||
150199167|NCT05100628|541869550|FG002|Overall Study|Study Terminated by Sponsor|3|||
150134674|NCT00689221|541626059|FG001|Overall Study|Ongoing at cut-off date|36|||
150134675|NCT01812655|541626063|FG000|Overall Study|Protocol Violation|1|||
150134676|NCT01812655|541626064|FG001|Overall Study|Protocol Violation|1|||
150134677|NCT01812655|541626065|FG002|Overall Study|Protocol Violation|0|||
150134678|NCT02363946|541626067|FG000|Overall Study|Lost to Follow-up|0|||
150134679|NCT02363946|541626068|FG001|Overall Study|Lost to Follow-up|0|||
150134680|NCT02363946|541626069|FG002|Overall Study|Lost to Follow-up|0|||
150134681|NCT02363946|541626070|FG003|Overall Study|Lost to Follow-up|0|||
150134682|NCT02363946|541626071|FG004|Overall Study|Lost to Follow-up|0|||
150134683|NCT02363946|541626072|FG005|Overall Study|Lost to Follow-up|0|||
150134684|NCT02363946|541626073|FG006|Overall Study|Lost to Follow-up|0|||
150199168|NCT05100628|541869551|FG003|Overall Study|Study Terminated by Sponsor|0|||
150199169|NCT05100628|541869548|FG000|Overall Study|unkown|0|||
150199170|NCT05100628|541869549|FG001|Overall Study|unkown|1|||
150134685|NCT02363946|541626074|FG007|Overall Study|Lost to Follow-up|1|||
150134686|NCT02363946|541626075|FG008|Overall Study|Lost to Follow-up|0|||
150134687|NCT02363946|541626076|FG009|Overall Study|Lost to Follow-up|0|||
150134688|NCT02363946|541626077|FG010|Overall Study|Lost to Follow-up|0|||
150134689|NCT02363946|541626078|FG011|Overall Study|Lost to Follow-up|0|||
150134690|NCT02363946|541626079|FG012|Overall Study|Lost to Follow-up|0|||
150199171|NCT05100628|541869550|FG002|Overall Study|unkown|0|||
150199172|NCT05100628|541869551|FG003|Overall Study|unkown|0|||
150199173|NCT02575950|541869554|FG000|Overall Study|Withdrawal by Subject|0|||
150134691|NCT00262821|541626080|FG000|Overall Study|Ineligible - wrong stage|0|||
150134692|NCT00262821|541626081|FG001|Overall Study|Ineligible - wrong stage|3|||
150134693|NCT00262821|541626080|FG000|Overall Study|Ineligible - wrong cell type|2|||
150134694|NCT00262821|541626081|FG001|Overall Study|Ineligible - wrong cell type|2|||
150134695|NCT00262821|541626080|FG000|Overall Study|Ineligible - wrong primary|0|||
150134696|NCT00262821|541626081|FG001|Overall Study|Ineligible - wrong primary|1|||
150134697|NCT00262821|541626080|FG000|Overall Study|Ineligible - inadequate pathology|1|||
150134698|NCT00262821|541626081|FG001|Overall Study|Ineligible - inadequate pathology|3|||
150134699|NCT00262821|541626080|FG000|Overall Study|Ineligible - elevated creatinine|0|||
150134700|NCT00262821|541626081|FG001|Overall Study|Ineligible - elevated creatinine|2|||
150134701|NCT00262821|541626080|FG000|Overall Study|Ineligible - required test not done|1|||
150134702|NCT00262821|541626081|FG001|Overall Study|Ineligible - required test not done|4|||
150134703|NCT00262821|541626080|FG000|Overall Study|Inevaluable - inadequate data|0|||
150134704|NCT00262821|541626081|FG001|Overall Study|Inevaluable - inadequate data|4|||
150134705|NCT04435665|541626082|FG000|Overall Study|Lost to Follow-up|0|||
150134706|NCT04435665|541626083|FG001|Overall Study|Lost to Follow-up|0|||
150134707|NCT04435665|541626084|FG002|Overall Study|Lost to Follow-up|0|||
150134708|NCT04435665|541626085|FG003|Overall Study|Lost to Follow-up|1|||
150134709|NCT00765388|541626086|FG000|Period 1|Lack of Efficacy|1|||
150134710|NCT00765388|541626087|FG001|Period 1|Lack of Efficacy|2|||
150134711|NCT00765388|541626086|FG000|Period 1|Lost to Follow-up|0|||
150134712|NCT00765388|541626087|FG001|Period 1|Lost to Follow-up|1|||
150134713|NCT00765388|541626086|FG000|Period 1|Herpes Zoster|0|||
150134714|NCT00765388|541626087|FG001|Period 1|Herpes Zoster|1|||
150134715|NCT00765388|541626086|FG000|Period 1|Hip operation|0|||
150134716|NCT00765388|541626087|FG001|Period 1|Hip operation|1|||
150134717|NCT03923933|541626091|FG000|Overall Study|Lost to Follow-up|1|||
150134718|NCT03923933|541626092|FG001|Overall Study|Lost to Follow-up|0|||
150134719|NCT03923933|541626091|FG000|Overall Study|Withdrawal by Subject|0|||
150134720|NCT03923933|541626092|FG001|Overall Study|Withdrawal by Subject|1|||
150134721|NCT02454101|541626093|FG000|Overall Study|Adverse Event|2|||
150134722|NCT02454101|541626094|FG001|Overall Study|Adverse Event|3|||
150134723|NCT02454101|541626093|FG000|Overall Study|Lost to Follow-up|3|||
150134724|NCT02454101|541626094|FG001|Overall Study|Lost to Follow-up|4|||
150134725|NCT01813474|541626095|FG000|Overall Study|Withdrawal by Subject|0|||
150134726|NCT01813474|541626096|FG001|Overall Study|Withdrawal by Subject|0|||
150134727|NCT01813474|541626097|FG002|Overall Study|Withdrawal by Subject|1|||
150134728|NCT01813474|541626095|FG000|Overall Study|Adverse Event|1|||
150134729|NCT01813474|541626096|FG001|Overall Study|Adverse Event|1|||
150134730|NCT01813474|541626097|FG002|Overall Study|Adverse Event|0|||
150134731|NCT01813474|541626095|FG000|Overall Study|Lack of Efficacy|2|||
150134732|NCT01813474|541626096|FG001|Overall Study|Lack of Efficacy|6|||
150134733|NCT01813474|541626097|FG002|Overall Study|Lack of Efficacy|9|||
150134734|NCT01813474|541626095|FG000|Overall Study|Death|0|||
150134735|NCT01813474|541626096|FG001|Overall Study|Death|0|||
150134736|NCT01813474|541626097|FG002|Overall Study|Death|1|||
150134737|NCT00587964|541626100|FG000|Overall Study|Withdrawal by Subject|1|||
150134738|NCT00587964|541626100|FG000|Overall Study|Lost to Follow-up|1|||
150134739|NCT00587964|541626100|FG000|Overall Study|Patient found to be ineligible|1|||
150134740|NCT00587964|541626100|FG000|Overall Study|Patient did not receive intervention|5|||
150134741|NCT00587964|541626100|FG000|Overall Study|Progression of Disease|4|||
150134742|NCT01297959|541626108|FG000|Overall Study|Adverse Event|0|||
150134743|NCT01297959|541626109|FG001|Overall Study|Adverse Event|1|||
150134744|NCT01297959|541626108|FG000|Overall Study|Protocol Violation|2|||
150134745|NCT01297959|541626109|FG001|Overall Study|Protocol Violation|1|||
150134746|NCT01297959|541626108|FG000|Overall Study|Withdrawal by Subject|5|||
150134747|NCT01297959|541626109|FG001|Overall Study|Withdrawal by Subject|4|||
150134748|NCT01297959|541626108|FG000|Overall Study|Physician Decision|0|||
150134749|NCT01297959|541626109|FG001|Overall Study|Physician Decision|1|||
150134750|NCT01297959|541626108|FG000|Overall Study|Unrelated medical illness / complication|0|||
150134751|NCT01297959|541626109|FG001|Overall Study|Unrelated medical illness / complication|2|||
150134752|NCT01297959|541626108|FG000|Overall Study|Other|13|||
150134753|NCT01297959|541626109|FG001|Overall Study|Other|7|||
150134754|NCT00344461|541626110|FG000|Overall Study|Adverse Event|6|||
150134755|NCT00344461|541626110|FG000|Overall Study|Death|1|||
150134756|NCT00344461|541626110|FG000|Overall Study|Lack of Efficacy|2|||
150134757|NCT00344461|541626110|FG000|Overall Study|Lost to Follow-up|2|||
150199174|NCT02575950|541869555|FG001|Overall Study|Withdrawal by Subject|0|||
150134758|NCT00344461|541626110|FG000|Overall Study|Physician Decision|2|||
150134759|NCT00344461|541626110|FG000|Overall Study|Protocol Violation|6|||
150134760|NCT00344461|541626110|FG000|Overall Study|Withdrawal by Subject|2|||
150134761|NCT01667432|541626111|FG000|Overall Study|Premature Study Termination|26|||
150134762|NCT01667432|541626111|FG000|Overall Study|Failure to Return|10|||
150134763|NCT01667432|541626111|FG000|Overall Study|Moved to Another Center|3|||
150134764|NCT01667432|541626111|FG000|Overall Study|Lost to Follow-up|3|||
150134765|NCT01667432|541626111|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
150134766|NCT01667432|541626111|FG000|Overall Study|Insufficient Therapeutic Response|4|||
150134767|NCT01667432|541626111|FG000|Overall Study|Adverse Event|1|||
150134768|NCT01667432|541626111|FG000|Overall Study|Protocol Deviation|2|||
150134769|NCT01667432|541626111|FG000|Overall Study|Principal Investigator Decision|1|||
150134770|NCT01667432|541626111|FG000|Overall Study|Reason Not Specified|2|||
150134771|NCT01667432|541626111|FG000|Overall Study|Missing Information|4|||
150134772|NCT00671931|541626114|FG000|Overall Study|Physician Decision|1|||
150134773|NCT00671931|541626115|FG001|Overall Study|Physician Decision|0|||
150134774|NCT00671931|541626116|FG002|Overall Study|Physician Decision|0|||
150134775|NCT00671931|541626117|FG003|Overall Study|Physician Decision|2|||
150134776|NCT00671931|541626118|FG004|Overall Study|Physician Decision|1|||
150134777|NCT00951275|541626119|FG000|Overall Study|Administrative Reason|1|||
150134778|NCT00951275|541626119|FG000|Overall Study|Adverse Event|7|||
150134779|NCT00951275|541626119|FG000|Overall Study|Withdrawal by Subject|4|||
150134780|NCT00951275|541626119|FG000|Overall Study|Protocol Violation|1|||
150134781|NCT00251745|541626121|FG000|Overall Study|Adverse Event|7|||
150134782|NCT00251745|541626122|FG001|Overall Study|Adverse Event|9|||
150134783|NCT00251745|541626123|FG002|Overall Study|Adverse Event|11|||
150134784|NCT00251745|541626121|FG000|Overall Study|Lost to Follow-up|4|||
150134785|NCT00251745|541626122|FG001|Overall Study|Lost to Follow-up|2|||
150134786|NCT00251745|541626123|FG002|Overall Study|Lost to Follow-up|5|||
150134787|NCT00251745|541626121|FG000|Overall Study|Withdrawal by Subject|13|||
150134788|NCT00251745|541626122|FG001|Overall Study|Withdrawal by Subject|7|||
150134789|NCT00251745|541626123|FG002|Overall Study|Withdrawal by Subject|3|||
150134790|NCT00251745|541626121|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
150134791|NCT00251745|541626122|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
150134792|NCT00251745|541626123|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
150134793|NCT00251745|541626121|FG000|Overall Study|Lack of Efficacy|3|||
150134794|NCT00251745|541626122|FG001|Overall Study|Lack of Efficacy|0|||
150134795|NCT00251745|541626123|FG002|Overall Study|Lack of Efficacy|0|||
150134796|NCT00251745|541626121|FG000|Overall Study|Noncompliant|0|||
150134797|NCT00251745|541626122|FG001|Overall Study|Noncompliant|2|||
150134798|NCT00251745|541626123|FG002|Overall Study|Noncompliant|2|||
150134799|NCT00251745|541626121|FG000|Overall Study|Pregnancy|0|||
150134800|NCT00251745|541626122|FG001|Overall Study|Pregnancy|1|||
150134801|NCT00251745|541626123|FG002|Overall Study|Pregnancy|0|||
150134802|NCT00251745|541626121|FG000|Overall Study|Per Subject Request|0|||
150134803|NCT00251745|541626122|FG001|Overall Study|Per Subject Request|0|||
150134804|NCT00251745|541626123|FG002|Overall Study|Per Subject Request|1|||
150134805|NCT00251745|541626121|FG000|Overall Study|Per Investigator Request|1|||
150134806|NCT00251745|541626122|FG001|Overall Study|Per Investigator Request|0|||
150134807|NCT00251745|541626123|FG002|Overall Study|Per Investigator Request|0|||
150134808|NCT04508699|541626128|FG000|Overall Study|Lack of Efficacy|2|||
150134809|NCT04508699|541626129|FG001|Overall Study|Lack of Efficacy|15|||
150134810|NCT04508699|541626128|FG000|Overall Study|Withdrawal by Subject|0|||
150134811|NCT04508699|541626129|FG001|Overall Study|Withdrawal by Subject|2|||
150134812|NCT04866017|541626130|FG000|Overall Study|Study Terminated by Sponsor|13|||
150134813|NCT04866017|541626131|FG001|Overall Study|Study Terminated by Sponsor|14|||
150134814|NCT04866017|541626132|FG002|Overall Study|Study Terminated by Sponsor|13|||
150134815|NCT04866017|541626130|FG000|Overall Study|Death|8|||
150134816|NCT04866017|541626131|FG001|Overall Study|Death|4|||
150134817|NCT04866017|541626132|FG002|Overall Study|Death|8|||
150134818|NCT04866017|541626130|FG000|Overall Study|Withdrawal by Subject|1|||
150134819|NCT04866017|541626131|FG001|Overall Study|Withdrawal by Subject|0|||
150134820|NCT04866017|541626132|FG002|Overall Study|Withdrawal by Subject|1|||
150134821|NCT04866017|541626130|FG000|Overall Study|Physician Decision|0|||
150134822|NCT04866017|541626131|FG001|Overall Study|Physician Decision|1|||
150134823|NCT04866017|541626132|FG002|Overall Study|Physician Decision|0|||
150134824|NCT01553318|541627927|FG000|Overall Study|Protocol Violation|3|||
150134825|NCT01553318|541627928|FG001|Overall Study|Protocol Violation|2|||
150134826|NCT02178059|541627930|FG000|Washout|Physician Decision|1|||
150134827|NCT02178059|541627931|FG001|Washout|Physician Decision|0|||
150134828|NCT03040713|541627932|FG000|Overall Study|Positive amyloid scan|3|||
150134829|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
150134830|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
150134831|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
150134832|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
150134833|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
150134834|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
150134835|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
150134836|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
150134837|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Other|18|||
150134838|NCT02565914|541627933|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
150134839|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
150134840|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Other|1|||
150134841|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
150134842|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
150134843|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
150134844|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
150134845|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
150134846|NCT02565914|541627933|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
150134847|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
150134848|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
150134849|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
150134850|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
150134851|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
150134852|NCT02565914|541627933|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
150134853|NCT03338894|541627938|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
150134854|NCT04465357|541627939|FG000|Overall Study|Adverse Event|2|||
150134855|NCT04465357|541627939|FG000|Overall Study|Lack of Efficacy|1|||
150134856|NCT04465357|541627939|FG000|Overall Study|Lost to Follow-up|2|||
150134857|NCT04465357|541627939|FG000|Overall Study|Withdrawal by Subject|6|||
150134858|NCT04465357|541627939|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
150134859|NCT02570126|541627944|FG000|Overall Study|Lost to Follow-up|2|||
150134860|NCT02570126|541627945|FG001|Overall Study|Lost to Follow-up|0|||
150134861|NCT02570126|541627944|FG000|Overall Study|Unable To Arrange Visit 3|1|||
150134862|NCT02570126|541627945|FG001|Overall Study|Unable To Arrange Visit 3|0|||
150134863|NCT02570126|541627944|FG000|Overall Study|Violation Of Procedures GSK|0|||
150134864|NCT02570126|541627945|FG001|Overall Study|Violation Of Procedures GSK|1|||
150134865|NCT02570126|541627944|FG000|Overall Study|Protocol Violation|0|||
150134866|NCT02570126|541627945|FG001|Overall Study|Protocol Violation|1|||
150134867|NCT02570126|541627944|FG000|Overall Study|Withdrawal by Subject|3|||
150134868|NCT02570126|541627945|FG001|Overall Study|Withdrawal by Subject|7|||
150134869|NCT04385368|541627947|FG000|Overall Study|Death|5|||
150134870|NCT04385368|541627948|FG001|Overall Study|Death|5|||
150134871|NCT04385368|541627947|FG000|Overall Study|Physician Decision|3|||
150134872|NCT04385368|541627948|FG001|Overall Study|Physician Decision|0|||
150134873|NCT04385368|541627947|FG000|Overall Study|Withdrawal by Subject|4|||
150134874|NCT04385368|541627948|FG001|Overall Study|Withdrawal by Subject|3|||
150134875|NCT00677235|541627949|FG000|Overall Study|Withdrawal by Subject|1|||
150134876|NCT00677235|541627950|FG001|Overall Study|Withdrawal by Subject|1|||
150134877|NCT00677235|541627949|FG000|Overall Study|Lost to Follow-up|2|||
150134878|NCT00677235|541627950|FG001|Overall Study|Lost to Follow-up|1|||
150134879|NCT00677235|541627949|FG000|Overall Study|Death|37|||
150134880|NCT00677235|541627950|FG001|Overall Study|Death|36|||
150134881|NCT00677235|541627949|FG000|Overall Study|Adverse Experience|1|||
150134882|NCT00677235|541627950|FG001|Overall Study|Adverse Experience|0|||
150134883|NCT00952367|541627951|FG000|Overall Study|Withdrawal by Subject|2|||
150134884|NCT00952367|541627951|FG000|Overall Study|Noncoordination|1|||
150134885|NCT00952367|541627951|FG000|Overall Study|Protocol Violation|3|||
150134886|NCT02230956|541627952|FG000|Overall Study|Adverse Event|1|||
150134887|NCT02230956|541627953|FG001|Overall Study|Adverse Event|1|||
150134888|NCT02230956|541627954|FG002|Overall Study|Adverse Event|0|||
150134889|NCT02230956|541627952|FG000|Overall Study|Lack of Efficacy|1|||
150134890|NCT02230956|541627953|FG001|Overall Study|Lack of Efficacy|1|||
150134891|NCT02230956|541627954|FG002|Overall Study|Lack of Efficacy|1|||
150134892|NCT02230956|541627952|FG000|Overall Study|Lost to Follow-up|1|||
150134893|NCT02230956|541627953|FG001|Overall Study|Lost to Follow-up|1|||
150134894|NCT02230956|541627954|FG002|Overall Study|Lost to Follow-up|2|||
150134895|NCT02230956|541627952|FG000|Overall Study|Personal Reasons|2|||
150134896|NCT02230956|541627953|FG001|Overall Study|Personal Reasons|1|||
150134897|NCT02230956|541627954|FG002|Overall Study|Personal Reasons|1|||
150134898|NCT02230956|541627952|FG000|Overall Study|Protocol Violation|0|||
150134899|NCT02230956|541627953|FG001|Overall Study|Protocol Violation|1|||
150134900|NCT02230956|541627954|FG002|Overall Study|Protocol Violation|1|||
150134901|NCT02230956|541627952|FG000|Overall Study|Other Miscellaneous Reason|0|||
150134902|NCT02230956|541627953|FG001|Overall Study|Other Miscellaneous Reason|1|||
150134903|NCT02230956|541627954|FG002|Overall Study|Other Miscellaneous Reason|2|||
150134904|NCT03574597|541627957|FG000|Overall Study|Withdrawal by Subject|67|||
150134905|NCT03574597|541627958|FG001|Overall Study|Withdrawal by Subject|96|||
150134906|NCT03574597|541627957|FG000|Overall Study|Lost to Follow-up|192|||
150134907|NCT03574597|541627958|FG001|Overall Study|Lost to Follow-up|188|||
150134908|NCT02355743|541627969|FG000|Overall Study|Withdrawal by Subject|1|||
150134909|NCT02355743|541627969|FG000|Overall Study|Lost to Follow-up|1|||
150134910|NCT02712905|541627970|FG000|Monotherapy|Death|2|||
150134911|NCT02712905|541627971|FG001|Monotherapy|Death|5|||
150134912|NCT02712905|541627972|FG002|Monotherapy|Death|0|||
150134913|NCT02712905|541627973|FG003|Monotherapy|Death|3|||
150134914|NCT02712905|541627974|FG004|Monotherapy|Death|15|||
150134915|NCT02712905|541627975|FG005|Monotherapy|Death|1|||
150134916|NCT02712905|541627976|FG006|Monotherapy|Death|3|||
150134917|NCT02712905|541627977|FG007|Monotherapy|Death|3|||
150134918|NCT02712905|541627978|FG008|Monotherapy|Death|0|||
150134919|NCT02712905|541627979|FG009|Monotherapy|Death|27|||
150134920|NCT02712905|541627980|FG010|Monotherapy|Death|2|||
150134921|NCT02712905|541627981|FG011|Monotherapy|Death|5|||
150134922|NCT02712905|541627982|FG012|Monotherapy|Death|0|||
150134923|NCT02712905|541627983|FG013|Monotherapy|Death|0|||
150134924|NCT02712905|541627984|FG014|Monotherapy|Death|0|||
150134925|NCT02712905|541627985|FG015|Monotherapy|Death|0|||
150134926|NCT02712905|541627986|FG016|Monotherapy|Death|0|||
150134927|NCT02712905|541627987|FG017|Monotherapy|Death|0|||
150134928|NCT02712905|541627970|FG000|Monotherapy|Lost to Follow-up|0|||
150134929|NCT02712905|541627971|FG001|Monotherapy|Lost to Follow-up|1|||
150134930|NCT02712905|541627972|FG002|Monotherapy|Lost to Follow-up|0|||
150134931|NCT02712905|541627973|FG003|Monotherapy|Lost to Follow-up|1|||
150134932|NCT02712905|541627974|FG004|Monotherapy|Lost to Follow-up|0|||
150134933|NCT02712905|541627975|FG005|Monotherapy|Lost to Follow-up|0|||
150134934|NCT02712905|541627976|FG006|Monotherapy|Lost to Follow-up|0|||
150134935|NCT02712905|541627977|FG007|Monotherapy|Lost to Follow-up|0|||
150134936|NCT02712905|541627978|FG008|Monotherapy|Lost to Follow-up|0|||
150134937|NCT02712905|541627979|FG009|Monotherapy|Lost to Follow-up|2|||
150134938|NCT02712905|541627980|FG010|Monotherapy|Lost to Follow-up|0|||
150134939|NCT02712905|541627981|FG011|Monotherapy|Lost to Follow-up|0|||
150134940|NCT02712905|541627982|FG012|Monotherapy|Lost to Follow-up|0|||
150134941|NCT02712905|541627983|FG013|Monotherapy|Lost to Follow-up|0|||
150134942|NCT02712905|541627984|FG014|Monotherapy|Lost to Follow-up|0|||
150134943|NCT02712905|541627985|FG015|Monotherapy|Lost to Follow-up|0|||
150134944|NCT02712905|541627986|FG016|Monotherapy|Lost to Follow-up|0|||
150134945|NCT02712905|541627987|FG017|Monotherapy|Lost to Follow-up|0|||
150134946|NCT02712905|541627970|FG000|Monotherapy|Physician Decision|1|||
150134947|NCT02712905|541627971|FG001|Monotherapy|Physician Decision|0|||
150134948|NCT02712905|541627972|FG002|Monotherapy|Physician Decision|0|||
150134949|NCT02712905|541627973|FG003|Monotherapy|Physician Decision|1|||
150134950|NCT02712905|541627974|FG004|Monotherapy|Physician Decision|0|||
150134951|NCT02712905|541627975|FG005|Monotherapy|Physician Decision|0|||
150134952|NCT02712905|541627976|FG006|Monotherapy|Physician Decision|0|||
150134953|NCT02712905|541627977|FG007|Monotherapy|Physician Decision|0|||
150134954|NCT02712905|541627978|FG008|Monotherapy|Physician Decision|0|||
150134955|NCT02712905|541627979|FG009|Monotherapy|Physician Decision|1|||
150134956|NCT02712905|541627980|FG010|Monotherapy|Physician Decision|0|||
150134957|NCT02712905|541627981|FG011|Monotherapy|Physician Decision|0|||
150134958|NCT02712905|541627982|FG012|Monotherapy|Physician Decision|0|||
150134959|NCT02712905|541627983|FG013|Monotherapy|Physician Decision|0|||
150134960|NCT02712905|541627984|FG014|Monotherapy|Physician Decision|0|||
150134961|NCT02712905|541627985|FG015|Monotherapy|Physician Decision|0|||
150134962|NCT02712905|541627986|FG016|Monotherapy|Physician Decision|0|||
150134963|NCT02712905|541627987|FG017|Monotherapy|Physician Decision|0|||
150134964|NCT02712905|541627970|FG000|Monotherapy|Study Terminated by Sponsor|0|||
150134965|NCT02712905|541627971|FG001|Monotherapy|Study Terminated by Sponsor|0|||
150134966|NCT02712905|541627972|FG002|Monotherapy|Study Terminated by Sponsor|0|||
150134967|NCT02712905|541627973|FG003|Monotherapy|Study Terminated by Sponsor|0|||
150134968|NCT02712905|541627974|FG004|Monotherapy|Study Terminated by Sponsor|1|||
150134969|NCT02712905|541627975|FG005|Monotherapy|Study Terminated by Sponsor|0|||
150134970|NCT02712905|541627976|FG006|Monotherapy|Study Terminated by Sponsor|0|||
150134971|NCT02712905|541627977|FG007|Monotherapy|Study Terminated by Sponsor|0|||
150134972|NCT02712905|541627978|FG008|Monotherapy|Study Terminated by Sponsor|0|||
150134973|NCT02712905|541627979|FG009|Monotherapy|Study Terminated by Sponsor|2|||
150134974|NCT02712905|541627980|FG010|Monotherapy|Study Terminated by Sponsor|0|||
150134975|NCT02712905|541627981|FG011|Monotherapy|Study Terminated by Sponsor|0|||
150134976|NCT02712905|541627982|FG012|Monotherapy|Study Terminated by Sponsor|0|||
150134977|NCT02712905|541627983|FG013|Monotherapy|Study Terminated by Sponsor|0|||
150134978|NCT02712905|541627984|FG014|Monotherapy|Study Terminated by Sponsor|0|||
150134979|NCT02712905|541627985|FG015|Monotherapy|Study Terminated by Sponsor|0|||
150134980|NCT02712905|541627986|FG016|Monotherapy|Study Terminated by Sponsor|0|||
150134981|NCT02712905|541627987|FG017|Monotherapy|Study Terminated by Sponsor|0|||
150134982|NCT02712905|541627970|FG000|Monotherapy|Withdrawal by Subject|0|||
150134983|NCT02712905|541627971|FG001|Monotherapy|Withdrawal by Subject|0|||
150134984|NCT02712905|541627972|FG002|Monotherapy|Withdrawal by Subject|1|||
150134985|NCT02712905|541627973|FG003|Monotherapy|Withdrawal by Subject|0|||
150134986|NCT02712905|541627974|FG004|Monotherapy|Withdrawal by Subject|2|||
150134987|NCT02712905|541627975|FG005|Monotherapy|Withdrawal by Subject|0|||
150134988|NCT02712905|541627976|FG006|Monotherapy|Withdrawal by Subject|0|||
150134989|NCT02712905|541627977|FG007|Monotherapy|Withdrawal by Subject|0|||
150134990|NCT02712905|541627978|FG008|Monotherapy|Withdrawal by Subject|0|||
150134991|NCT02712905|541627979|FG009|Monotherapy|Withdrawal by Subject|4|||
150134992|NCT02712905|541627980|FG010|Monotherapy|Withdrawal by Subject|1|||
150134993|NCT02712905|541627981|FG011|Monotherapy|Withdrawal by Subject|2|||
150134994|NCT02712905|541627982|FG012|Monotherapy|Withdrawal by Subject|0|||
150134995|NCT02712905|541627983|FG013|Monotherapy|Withdrawal by Subject|0|||
150134996|NCT02712905|541627984|FG014|Monotherapy|Withdrawal by Subject|0|||
150134997|NCT02712905|541627985|FG015|Monotherapy|Withdrawal by Subject|0|||
150134998|NCT02712905|541627986|FG016|Monotherapy|Withdrawal by Subject|0|||
150134999|NCT02712905|541627987|FG017|Monotherapy|Withdrawal by Subject|0|||
150135000|NCT02712905|541627970|FG000|Monotherapy|Started New Cancer Drug|0|||
150135001|NCT02712905|541627971|FG001|Monotherapy|Started New Cancer Drug|0|||
150135002|NCT02712905|541627972|FG002|Monotherapy|Started New Cancer Drug|0|||
150135003|NCT02712905|541627973|FG003|Monotherapy|Started New Cancer Drug|0|||
150135004|NCT02712905|541627974|FG004|Monotherapy|Started New Cancer Drug|0|||
150135005|NCT02712905|541627975|FG005|Monotherapy|Started New Cancer Drug|1|||
150135006|NCT02712905|541627976|FG006|Monotherapy|Started New Cancer Drug|0|||
150135007|NCT02712905|541627977|FG007|Monotherapy|Started New Cancer Drug|0|||
150135008|NCT02712905|541627978|FG008|Monotherapy|Started New Cancer Drug|0|||
150135009|NCT02712905|541627979|FG009|Monotherapy|Started New Cancer Drug|0|||
150135010|NCT02712905|541627980|FG010|Monotherapy|Started New Cancer Drug|0|||
150135011|NCT02712905|541627981|FG011|Monotherapy|Started New Cancer Drug|0|||
150135012|NCT02712905|541627982|FG012|Monotherapy|Started New Cancer Drug|0|||
150135013|NCT02712905|541627983|FG013|Monotherapy|Started New Cancer Drug|0|||
150135014|NCT02712905|541627984|FG014|Monotherapy|Started New Cancer Drug|0|||
150135015|NCT02712905|541627985|FG015|Monotherapy|Started New Cancer Drug|0|||
150135016|NCT02712905|541627986|FG016|Monotherapy|Started New Cancer Drug|0|||
150135017|NCT02712905|541627987|FG017|Monotherapy|Started New Cancer Drug|0|||
150135018|NCT02712905|541627970|FG000|Monotherapy|Adverse Event|0|||
150135019|NCT02712905|541627971|FG001|Monotherapy|Adverse Event|0|||
150135020|NCT02712905|541627972|FG002|Monotherapy|Adverse Event|0|||
150135021|NCT02712905|541627973|FG003|Monotherapy|Adverse Event|0|||
150135022|NCT02712905|541627974|FG004|Monotherapy|Adverse Event|0|||
150135023|NCT02712905|541627975|FG005|Monotherapy|Adverse Event|0|||
150135024|NCT02712905|541627976|FG006|Monotherapy|Adverse Event|0|||
150135025|NCT02712905|541627977|FG007|Monotherapy|Adverse Event|0|||
150135026|NCT02712905|541627978|FG008|Monotherapy|Adverse Event|1|||
150135027|NCT02712905|541627979|FG009|Monotherapy|Adverse Event|0|||
150135028|NCT02712905|541627980|FG010|Monotherapy|Adverse Event|0|||
150135029|NCT02712905|541627981|FG011|Monotherapy|Adverse Event|0|||
150135030|NCT02712905|541627982|FG012|Monotherapy|Adverse Event|0|||
150135031|NCT02712905|541627983|FG013|Monotherapy|Adverse Event|0|||
150135032|NCT02712905|541627984|FG014|Monotherapy|Adverse Event|0|||
150135033|NCT02712905|541627985|FG015|Monotherapy|Adverse Event|0|||
150135034|NCT02712905|541627986|FG016|Monotherapy|Adverse Event|0|||
150135035|NCT02712905|541627987|FG017|Monotherapy|Adverse Event|0|||
150135036|NCT02712905|541627970|FG000|Combination Therapy|Death|0|||
150135037|NCT02712905|541627971|FG001|Combination Therapy|Death|0|||
150135038|NCT02712905|541627972|FG002|Combination Therapy|Death|0|||
150135039|NCT02712905|541627973|FG003|Combination Therapy|Death|0|||
150135040|NCT02712905|541627974|FG004|Combination Therapy|Death|0|||
150135041|NCT02712905|541627975|FG005|Combination Therapy|Death|0|||
150135042|NCT02712905|541627976|FG006|Combination Therapy|Death|0|||
150135043|NCT02712905|541627977|FG007|Combination Therapy|Death|0|||
150135044|NCT02712905|541627978|FG008|Combination Therapy|Death|0|||
150135045|NCT02712905|541627979|FG009|Combination Therapy|Death|0|||
150135046|NCT02712905|541627980|FG010|Combination Therapy|Death|0|||
150135047|NCT02712905|541627981|FG011|Combination Therapy|Death|0|||
150135048|NCT02712905|541627982|FG012|Combination Therapy|Death|5|||
150135049|NCT02712905|541627983|FG013|Combination Therapy|Death|6|||
150135050|NCT02712905|541627984|FG014|Combination Therapy|Death|1|||
150135051|NCT02712905|541627985|FG015|Combination Therapy|Death|3|||
150135052|NCT02712905|541627986|FG016|Combination Therapy|Death|1|||
150135053|NCT02712905|541627987|FG017|Combination Therapy|Death|3|||
150135054|NCT02712905|541627970|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
150135055|NCT02712905|541627971|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
150135056|NCT02712905|541627972|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
150135057|NCT02712905|541627973|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
150135058|NCT02712905|541627974|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
150135059|NCT02712905|541627975|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
150135060|NCT02712905|541627976|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
150135061|NCT02712905|541627977|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
150135062|NCT02712905|541627978|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
150135063|NCT02712905|541627979|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
150135064|NCT02712905|541627980|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
150135065|NCT02712905|541627981|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
150135066|NCT02712905|541627982|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
150135067|NCT02712905|541627983|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
150135068|NCT02712905|541627984|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
150135069|NCT02712905|541627985|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
150135070|NCT02712905|541627986|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
150135071|NCT02712905|541627987|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
150135072|NCT02712905|541627970|FG000|Combination Therapy|Withdrawal by Subject|0|||
150135073|NCT02712905|541627971|FG001|Combination Therapy|Withdrawal by Subject|0|||
150135074|NCT02712905|541627972|FG002|Combination Therapy|Withdrawal by Subject|0|||
150135075|NCT02712905|541627973|FG003|Combination Therapy|Withdrawal by Subject|0|||
150135076|NCT02712905|541627974|FG004|Combination Therapy|Withdrawal by Subject|0|||
150135077|NCT02712905|541627975|FG005|Combination Therapy|Withdrawal by Subject|0|||
150135078|NCT02712905|541627976|FG006|Combination Therapy|Withdrawal by Subject|0|||
150135079|NCT02712905|541627977|FG007|Combination Therapy|Withdrawal by Subject|0|||
150135080|NCT02712905|541627978|FG008|Combination Therapy|Withdrawal by Subject|0|||
150135081|NCT02712905|541627979|FG009|Combination Therapy|Withdrawal by Subject|0|||
150135082|NCT02712905|541627980|FG010|Combination Therapy|Withdrawal by Subject|0|||
150135083|NCT02712905|541627981|FG011|Combination Therapy|Withdrawal by Subject|0|||
150199175|NCT02575950|541869556|FG002|Overall Study|Withdrawal by Subject|0|||
150199176|NCT02575950|541869557|FG003|Overall Study|Withdrawal by Subject|2|||
150199177|NCT02575950|541869554|FG000|Overall Study|Lost to Follow-up|0|||
150199178|NCT02575950|541869555|FG001|Overall Study|Lost to Follow-up|1|||
150199179|NCT02575950|541869556|FG002|Overall Study|Lost to Follow-up|0|||
150199180|NCT02575950|541869557|FG003|Overall Study|Lost to Follow-up|3|||
150199181|NCT04230681|541869558|FG000|Overall Study|Physician Decision|2|||
150199182|NCT04230681|541869559|FG001|Overall Study|Physician Decision|3|||
150199183|NCT04230681|541869558|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
150199184|NCT04230681|541869559|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
150199185|NCT04230681|541869558|FG000|Overall Study|IV inadvertently removed|0|||
150199186|NCT04230681|541869559|FG001|Overall Study|IV inadvertently removed|1|||
150199187|NCT03057054|541869560|FG000|Overall Study|Death|4|||
150199188|NCT03057054|541869561|FG001|Overall Study|Death|4|||
150199189|NCT03057054|541869560|FG000|Overall Study|Withdrawal by Subject|6|||
150199190|NCT03057054|541869561|FG001|Overall Study|Withdrawal by Subject|3|||
150199191|NCT03057054|541869560|FG000|Overall Study|Ineligible|1|||
150199192|NCT03057054|541869561|FG001|Overall Study|Ineligible|1|||
150135084|NCT02712905|541627982|FG012|Combination Therapy|Withdrawal by Subject|0|||
150135085|NCT02712905|541627983|FG013|Combination Therapy|Withdrawal by Subject|0|||
150135086|NCT02712905|541627984|FG014|Combination Therapy|Withdrawal by Subject|0|||
150135087|NCT02712905|541627985|FG015|Combination Therapy|Withdrawal by Subject|1|||
150135088|NCT02712905|541627986|FG016|Combination Therapy|Withdrawal by Subject|0|||
150135089|NCT02712905|541627987|FG017|Combination Therapy|Withdrawal by Subject|2|||
150135090|NCT02712905|541627970|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135091|NCT02712905|541627971|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135092|NCT02712905|541627972|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135093|NCT02712905|541627973|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135094|NCT02712905|541627974|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135095|NCT02712905|541627975|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135096|NCT02712905|541627976|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135097|NCT02712905|541627977|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135098|NCT02712905|541627978|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135099|NCT02712905|541627979|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135100|NCT02712905|541627980|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135101|NCT02712905|541627981|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135102|NCT02712905|541627982|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135103|NCT02712905|541627983|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135104|NCT02712905|541627984|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135105|NCT02712905|541627985|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
150135106|NCT02712905|541627986|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135107|NCT02712905|541627987|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
150135108|NCT03721965|541627988|FG000|Overall Study|Death|1|||
150135109|NCT03721965|541627988|FG000|Overall Study|Study Terminated by Sponsor|1|||
150135110|NCT02862457|541627989|FG000|Overall Study|Death|1|||
150135111|NCT02862457|541627990|FG001|Overall Study|Death|3|||
150135112|NCT02862457|541627991|FG002|Overall Study|Death|2|||
150135113|NCT02862457|541627992|FG003|Overall Study|Death|3|||
150135114|NCT02862457|541627993|FG004|Overall Study|Death|0|||
150135115|NCT02862457|541627994|FG005|Overall Study|Death|2|||
150135116|NCT02862457|541627995|FG006|Overall Study|Death|1|||
150135117|NCT02862457|541627989|FG000|Overall Study|Lost to Follow-up|1|||
150135118|NCT02862457|541627990|FG001|Overall Study|Lost to Follow-up|0|||
150135119|NCT02862457|541627991|FG002|Overall Study|Lost to Follow-up|0|||
150135120|NCT02862457|541627992|FG003|Overall Study|Lost to Follow-up|1|||
150199193|NCT05906784|541871460|FG000|Overall Study|Lost to Follow-up|2|||
150199194|NCT05906784|541871461|FG001|Overall Study|Lost to Follow-up|1|||
150199195|NCT05906784|541871462|FG002|Overall Study|Lost to Follow-up|1|||
150199196|NCT05906784|541871463|FG003|Overall Study|Lost to Follow-up|1|||
150135121|NCT02862457|541627993|FG004|Overall Study|Lost to Follow-up|0|||
150135122|NCT02862457|541627994|FG005|Overall Study|Lost to Follow-up|0|||
150135123|NCT02862457|541627995|FG006|Overall Study|Lost to Follow-up|0|||
150135124|NCT02862457|541627989|FG000|Overall Study|Withdrawal by Subject|0|||
150135125|NCT02862457|541627990|FG001|Overall Study|Withdrawal by Subject|0|||
150135126|NCT02862457|541627991|FG002|Overall Study|Withdrawal by Subject|1|||
150135127|NCT02862457|541627992|FG003|Overall Study|Withdrawal by Subject|0|||
150135128|NCT02862457|541627993|FG004|Overall Study|Withdrawal by Subject|0|||
150135129|NCT02862457|541627994|FG005|Overall Study|Withdrawal by Subject|1|||
150135130|NCT02862457|541627995|FG006|Overall Study|Withdrawal by Subject|0|||
150135131|NCT04085328|541627996|FG000|Overall Study|Witihdrew Consent|16|||
150135132|NCT04085328|541627997|FG001|Overall Study|Witihdrew Consent|16|||
150135133|NCT04085328|541627996|FG000|Overall Study|Adverse Event|8|||
150135134|NCT04085328|541627997|FG001|Overall Study|Adverse Event|7|||
150135135|NCT04085328|541627996|FG000|Overall Study|Lost to Follow-up|7|||
150135136|NCT04085328|541627997|FG001|Overall Study|Lost to Follow-up|2|||
150135137|NCT04085328|541627996|FG000|Overall Study|Physician Decision|0|||
150135138|NCT04085328|541627997|FG001|Overall Study|Physician Decision|1|||
150135139|NCT04085328|541627996|FG000|Overall Study|Pregnancy|0|||
150135140|NCT04085328|541627997|FG001|Overall Study|Pregnancy|1|||
150135141|NCT04085328|541627996|FG000|Overall Study|Reasons Related to COVID-19|5|||
150135142|NCT04085328|541627997|FG001|Overall Study|Reasons Related to COVID-19|8|||
150135143|NCT04085328|541627996|FG000|Overall Study|Did not meet inclusion criteria|1|||
150135144|NCT04085328|541627997|FG001|Overall Study|Did not meet inclusion criteria|1|||
150135145|NCT04085328|541627996|FG000|Overall Study|Early termination|1|||
150135146|NCT04085328|541627997|FG001|Overall Study|Early termination|0|||
150135147|NCT00419263|541628000|FG000|Overall Study|Lost to Follow-up|2|||
150135148|NCT00419263|541628001|FG001|Overall Study|Lost to Follow-up|1|||
150135149|NCT00419263|541628002|FG002|Overall Study|Lost to Follow-up|1|||
150135150|NCT00419263|541628000|FG000|Overall Study|Randomized in Error, Not Treated|1|||
150135151|NCT00419263|541628001|FG001|Overall Study|Randomized in Error, Not Treated|1|||
150135152|NCT00419263|541628002|FG002|Overall Study|Randomized in Error, Not Treated|0|||
150135153|NCT00419263|541628000|FG000|Overall Study|Adverse Event|0|||
150135154|NCT00419263|541628001|FG001|Overall Study|Adverse Event|0|||
150135155|NCT00419263|541628002|FG002|Overall Study|Adverse Event|1|||
150135156|NCT00419263|541628000|FG000|Overall Study|Withdrawal by Subject|0|||
150135157|NCT00419263|541628001|FG001|Overall Study|Withdrawal by Subject|0|||
150135158|NCT00419263|541628002|FG002|Overall Study|Withdrawal by Subject|1|||
150135159|NCT02342886|541628003|FG000|Overall Study|Treatment non-compliance|1|||
150135160|NCT02342886|541628004|FG001|Overall Study|Treatment non-compliance|0|||
150135161|NCT02342886|541628005|FG002|Overall Study|Treatment non-compliance|0|||
150135162|NCT02342886|541628006|FG003|Overall Study|Treatment non-compliance|1|||
150135163|NCT02342886|541628007|FG004|Overall Study|Treatment non-compliance|0|||
150135164|NCT02342886|541628003|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
150135165|NCT02342886|541628004|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
150135166|NCT02342886|541628005|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
150135167|NCT02342886|541628006|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
150135168|NCT02342886|541628007|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
150135169|NCT02342886|541628003|FG000|Overall Study|Adverse event/specific toxicity|4|||
150135170|NCT02342886|541628004|FG001|Overall Study|Adverse event/specific toxicity|3|||
150135171|NCT02342886|541628005|FG002|Overall Study|Adverse event/specific toxicity|11|||
150135172|NCT02342886|541628006|FG003|Overall Study|Adverse event/specific toxicity|2|||
150135173|NCT02342886|541628007|FG004|Overall Study|Adverse event/specific toxicity|1|||
150135174|NCT02342886|541628003|FG000|Overall Study|Lost to Follow-up|1|||
150135175|NCT02342886|541628004|FG001|Overall Study|Lost to Follow-up|0|||
150135176|NCT02342886|541628005|FG002|Overall Study|Lost to Follow-up|0|||
150135177|NCT02342886|541628006|FG003|Overall Study|Lost to Follow-up|0|||
150135178|NCT02342886|541628007|FG004|Overall Study|Lost to Follow-up|0|||
150135179|NCT02342886|541628003|FG000|Overall Study|Death|1|||
150135180|NCT02342886|541628004|FG001|Overall Study|Death|2|||
150135181|NCT02342886|541628005|FG002|Overall Study|Death|1|||
150135182|NCT02342886|541628006|FG003|Overall Study|Death|0|||
150199197|NCT05269966|541871464|FG000|Overall Study|Adverse Event|4|||
150199198|NCT05269966|541871464|FG000|Overall Study|Withdrawal by Subject|1|||
150199199|NCT05269966|541871464|FG000|Overall Study|Lost to Follow-up|4|||
150135183|NCT02342886|541628007|FG004|Overall Study|Death|1|||
150135184|NCT02342886|541628003|FG000|Overall Study|Withdrawal by Subject|0|||
150135185|NCT02342886|541628004|FG001|Overall Study|Withdrawal by Subject|1|||
150135186|NCT02342886|541628005|FG002|Overall Study|Withdrawal by Subject|0|||
150135187|NCT02342886|541628006|FG003|Overall Study|Withdrawal by Subject|1|||
150135188|NCT02342886|541628007|FG004|Overall Study|Withdrawal by Subject|0|||
150135189|NCT02342886|541628003|FG000|Overall Study|Investigator/sponsor decision|0|||
150135190|NCT02342886|541628004|FG001|Overall Study|Investigator/sponsor decision|2|||
150135191|NCT02342886|541628005|FG002|Overall Study|Investigator/sponsor decision|0|||
150135192|NCT02342886|541628006|FG003|Overall Study|Investigator/sponsor decision|3|||
150135193|NCT02342886|541628007|FG004|Overall Study|Investigator/sponsor decision|1|||
150135194|NCT02342886|541628003|FG000|Overall Study|Pregnancy|0|||
150135195|NCT02342886|541628004|FG001|Overall Study|Pregnancy|0|||
150135196|NCT02342886|541628005|FG002|Overall Study|Pregnancy|2|||
150135197|NCT02342886|541628006|FG003|Overall Study|Pregnancy|0|||
150135198|NCT02342886|541628007|FG004|Overall Study|Pregnancy|0|||
150135199|NCT02342886|541628003|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
150135200|NCT02342886|541628004|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
150135201|NCT02342886|541628005|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
150135202|NCT02342886|541628006|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
150135203|NCT02342886|541628007|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
150135204|NCT02342886|541628003|FG000|Overall Study|Protocol Violation|0|||
150135205|NCT02342886|541628004|FG001|Overall Study|Protocol Violation|0|||
150135206|NCT02342886|541628005|FG002|Overall Study|Protocol Violation|0|||
150135207|NCT02342886|541628006|FG003|Overall Study|Protocol Violation|2|||
150135208|NCT02342886|541628007|FG004|Overall Study|Protocol Violation|0|||
150135209|NCT01328080|541628008|FG000|Overall Study|Lost to Follow-up|5|||
150135210|NCT02191267|541628009|FG000|Overall Study|Withdrawal by Subject|1|||
150135211|NCT02191267|541628010|FG001|Overall Study|Withdrawal by Subject|0|||
150135212|NCT02191267|541628011|FG002|Overall Study|Withdrawal by Subject|0|||
150135213|NCT00765674|541628012|FG000|Overall Study|Adverse Event|7|||
150135214|NCT00765674|541628013|FG001|Overall Study|Adverse Event|2|||
150135215|NCT00765674|541628014|FG002|Overall Study|Adverse Event|8|||
150135216|NCT00765674|541628015|FG003|Overall Study|Adverse Event|11|||
150135217|NCT00765674|541628012|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
150135218|NCT00765674|541628013|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
150135219|NCT00765674|541628014|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
150135220|NCT00765674|541628015|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
150135221|NCT00765674|541628012|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
150135222|NCT00765674|541628013|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
150135223|NCT00765674|541628014|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
150135224|NCT00765674|541628015|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
150135225|NCT00765674|541628012|FG000|Overall Study|Lack of Efficacy|2|||
150135226|NCT00765674|541628013|FG001|Overall Study|Lack of Efficacy|3|||
150135227|NCT00765674|541628014|FG002|Overall Study|Lack of Efficacy|1|||
150135228|NCT00765674|541628015|FG003|Overall Study|Lack of Efficacy|2|||
150135229|NCT00765674|541628012|FG000|Overall Study|Protocol Violation|2|||
150135230|NCT00765674|541628013|FG001|Overall Study|Protocol Violation|0|||
150135231|NCT00765674|541628014|FG002|Overall Study|Protocol Violation|1|||
150135232|NCT00765674|541628015|FG003|Overall Study|Protocol Violation|0|||
150135233|NCT00765674|541628012|FG000|Overall Study|Withdrawal by Subject|5|||
150135234|NCT00765674|541628013|FG001|Overall Study|Withdrawal by Subject|7|||
150135235|NCT00765674|541628014|FG002|Overall Study|Withdrawal by Subject|3|||
150135236|NCT00765674|541628015|FG003|Overall Study|Withdrawal by Subject|8|||
150135237|NCT00765674|541628012|FG000|Overall Study|Lost to Follow-up|4|||
150135238|NCT00765674|541628013|FG001|Overall Study|Lost to Follow-up|6|||
150135239|NCT00765674|541628014|FG002|Overall Study|Lost to Follow-up|2|||
150135240|NCT00765674|541628015|FG003|Overall Study|Lost to Follow-up|1|||
150135241|NCT00765674|541628012|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
150135242|NCT00765674|541628013|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
150135243|NCT00765674|541628014|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
150135244|NCT00765674|541628015|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
150135245|NCT03015402|541628016|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
150135246|NCT03015402|541628017|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
150135247|NCT03015402|541628016|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
150135248|NCT03015402|541628017|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
150135249|NCT00316082|541628023|FG000|Overall Study|Lack of Efficacy|2|||
150135250|NCT00316082|541628024|FG001|Overall Study|Lack of Efficacy|3|||
150135251|NCT00316082|541628025|FG002|Overall Study|Lack of Efficacy|3|||
150135252|NCT00316082|541628026|FG003|Overall Study|Lack of Efficacy|4|||
150135253|NCT00316082|541628027|FG004|Overall Study|Lack of Efficacy|6|||
150135254|NCT00316082|541628023|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
150135255|NCT00316082|541628024|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
150135256|NCT00316082|541628025|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
150135257|NCT00316082|541628026|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
150135258|NCT00316082|541628027|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
150135259|NCT00316082|541628023|FG000|Overall Study|Lost to Follow-up|7|||
150135260|NCT00316082|541628024|FG001|Overall Study|Lost to Follow-up|6|||
150135261|NCT00316082|541628025|FG002|Overall Study|Lost to Follow-up|7|||
150135262|NCT00316082|541628026|FG003|Overall Study|Lost to Follow-up|8|||
150135263|NCT00316082|541628027|FG004|Overall Study|Lost to Follow-up|6|||
150135264|NCT00316082|541628023|FG000|Overall Study|Poor/noncompliance|6|||
150135265|NCT00316082|541628024|FG001|Overall Study|Poor/noncompliance|1|||
150135266|NCT00316082|541628025|FG002|Overall Study|Poor/noncompliance|4|||
150135267|NCT00316082|541628026|FG003|Overall Study|Poor/noncompliance|1|||
150135268|NCT00316082|541628027|FG004|Overall Study|Poor/noncompliance|4|||
150135269|NCT00316082|541628023|FG000|Overall Study|Adverse Event|4|||
150135270|NCT00316082|541628024|FG001|Overall Study|Adverse Event|2|||
150135271|NCT00316082|541628025|FG002|Overall Study|Adverse Event|5|||
150135272|NCT00316082|541628026|FG003|Overall Study|Adverse Event|1|||
150135273|NCT00316082|541628027|FG004|Overall Study|Adverse Event|3|||
150135274|NCT00316082|541628023|FG000|Overall Study|Subject no longer meets study criteria|3|||
150135275|NCT00316082|541628024|FG001|Overall Study|Subject no longer meets study criteria|1|||
150135276|NCT00316082|541628025|FG002|Overall Study|Subject no longer meets study criteria|2|||
150135277|NCT00316082|541628026|FG003|Overall Study|Subject no longer meets study criteria|2|||
150135278|NCT00316082|541628027|FG004|Overall Study|Subject no longer meets study criteria|1|||
150135279|NCT00316082|541628023|FG000|Overall Study|Physician Decision|1|||
150135280|NCT00316082|541628024|FG001|Overall Study|Physician Decision|1|||
150135281|NCT00316082|541628025|FG002|Overall Study|Physician Decision|2|||
150135282|NCT00316082|541628026|FG003|Overall Study|Physician Decision|1|||
150135283|NCT00316082|541628027|FG004|Overall Study|Physician Decision|1|||
150135284|NCT00316082|541628023|FG000|Overall Study|Death|0|||
150135285|NCT00316082|541628024|FG001|Overall Study|Death|0|||
150135286|NCT00316082|541628025|FG002|Overall Study|Death|1|||
150135287|NCT00316082|541628026|FG003|Overall Study|Death|0|||
150135288|NCT00316082|541628027|FG004|Overall Study|Death|0|||
150135289|NCT00316082|541628023|FG000|Overall Study|Administrative reason by sponsor|0|||
150135290|NCT00316082|541628024|FG001|Overall Study|Administrative reason by sponsor|0|||
150135291|NCT00316082|541628025|FG002|Overall Study|Administrative reason by sponsor|1|||
150135292|NCT00316082|541628026|FG003|Overall Study|Administrative reason by sponsor|0|||
150135293|NCT00316082|541628027|FG004|Overall Study|Administrative reason by sponsor|0|||
150135294|NCT02216773|541628028|FG000|Overall Study|Disease progression|4|||
150135295|NCT02216773|541628029|FG001|Overall Study|Disease progression|2|||
150135296|NCT02216773|541628028|FG000|Overall Study|Insufficient FLRV|4|||
150135297|NCT02216773|541628029|FG001|Overall Study|Insufficient FLRV|0|||
150135298|NCT02216773|541628028|FG000|Overall Study|Abandoned|4|||
150135299|NCT02216773|541628029|FG001|Overall Study|Abandoned|3|||
150135300|NCT00528775|541628030|FG000|Overall Study|Other not specified|1|||
150135301|NCT01995461|541628031|FG000|Overall Study|Death|1|||
150135302|NCT01995461|541628031|FG000|Overall Study|Lost to Follow-up|2|||
150135303|NCT01995461|541628031|FG000|Overall Study|Withdrawal by Subject|2|||
150135304|NCT00540124|541628032|FG000|Overall Study|Adverse Event|0|||
150135305|NCT00540124|541628033|FG001|Overall Study|Adverse Event|2|||
150135306|NCT00540124|541628034|FG002|Overall Study|Adverse Event|1|||
150135307|NCT00540124|541628032|FG000|Overall Study|Entry Criteria Not Met|2|||
150135308|NCT00540124|541628033|FG001|Overall Study|Entry Criteria Not Met|0|||
150135309|NCT00540124|541628034|FG002|Overall Study|Entry Criteria Not Met|0|||
150135310|NCT00540124|541628032|FG000|Overall Study|Lack of Efficacy|1|||
150135311|NCT00540124|541628033|FG001|Overall Study|Lack of Efficacy|0|||
150135312|NCT00540124|541628034|FG002|Overall Study|Lack of Efficacy|0|||
150135313|NCT00540124|541628032|FG000|Overall Study|Withdrawal by Subject|1|||
150135314|NCT00540124|541628033|FG001|Overall Study|Withdrawal by Subject|1|||
150135315|NCT00540124|541628034|FG002|Overall Study|Withdrawal by Subject|0|||
150135316|NCT01777854|541628043|FG000|Overall Study|Physician Decision|3|||
150135317|NCT01777854|541628044|FG001|Overall Study|Physician Decision|3|||
150135318|NCT02124265|541628048|FG000|Overall Study|Adverse Event|1|||
150135319|NCT01939548|541628049|FG000|Overall Study|Non compliance|0|||
150135320|NCT01939548|541628050|FG001|Overall Study|Non compliance|2|||
150135321|NCT01939548|541628051|FG002|Overall Study|Non compliance|0|||
150135322|NCT01939548|541628049|FG000|Overall Study|Study Terminated by Sponsor|17|||
150135323|NCT01939548|541628050|FG001|Overall Study|Study Terminated by Sponsor|19|||
150135324|NCT01939548|541628051|FG002|Overall Study|Study Terminated by Sponsor|12|||
150135325|NCT01939548|541628049|FG000|Overall Study|Insufficient Clinical Response|1|||
150135326|NCT01939548|541628050|FG001|Overall Study|Insufficient Clinical Response|0|||
150135327|NCT01939548|541628051|FG002|Overall Study|Insufficient Clinical Response|0|||
150135328|NCT01939548|541628049|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
150135329|NCT01939548|541628050|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
150135330|NCT01939548|541628051|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
150135331|NCT01939548|541628049|FG000|Overall Study|Withdrawal by Subject|4|||
150135332|NCT01939548|541628050|FG001|Overall Study|Withdrawal by Subject|4|||
150135333|NCT01939548|541628051|FG002|Overall Study|Withdrawal by Subject|1|||
150135334|NCT01939548|541628049|FG000|Overall Study|Protocol Violation|7|||
150135335|NCT01939548|541628050|FG001|Overall Study|Protocol Violation|6|||
150135336|NCT01939548|541628051|FG002|Overall Study|Protocol Violation|5|||
150135337|NCT01939548|541628049|FG000|Overall Study|Lost to Follow-up|5|||
150135338|NCT01939548|541628050|FG001|Overall Study|Lost to Follow-up|5|||
150135339|NCT01939548|541628051|FG002|Overall Study|Lost to Follow-up|3|||
150135340|NCT01939548|541628049|FG000|Overall Study|Adverse Event|2|||
150135341|NCT01939548|541628050|FG001|Overall Study|Adverse Event|9|||
150135342|NCT01939548|541628051|FG002|Overall Study|Adverse Event|7|||
150135343|NCT01939548|541628049|FG000|Overall Study|Death|0|||
150135344|NCT01939548|541628050|FG001|Overall Study|Death|0|||
150135345|NCT01939548|541628051|FG002|Overall Study|Death|1|||
150135346|NCT01939548|541628049|FG000|Overall Study|Participant dropped|0|||
150135347|NCT01939548|541628050|FG001|Overall Study|Participant dropped|0|||
150135348|NCT01939548|541628051|FG002|Overall Study|Participant dropped|1|||
150135349|NCT01939548|541628049|FG000|Overall Study|Participant unwilling to continue|0|||
150135350|NCT01939548|541628050|FG001|Overall Study|Participant unwilling to continue|1|||
150135351|NCT01939548|541628051|FG002|Overall Study|Participant unwilling to continue|0|||
150135352|NCT01939548|541628049|FG000|Overall Study|Participant withdrew consent|0|||
150135353|NCT01939548|541628050|FG001|Overall Study|Participant withdrew consent|2|||
150135354|NCT01939548|541628051|FG002|Overall Study|Participant withdrew consent|0|||
150135355|NCT01939548|541628049|FG000|Overall Study|Did not complete follow-up|0|||
150135356|NCT01939548|541628050|FG001|Overall Study|Did not complete follow-up|1|||
150135357|NCT01939548|541628051|FG002|Overall Study|Did not complete follow-up|0|||
150135358|NCT03311373|541628052|FG000|Overall Study|Adverse Event|1|||
150135359|NCT03311373|541628052|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
150199200|NCT05269966|541871464|FG000|Overall Study|Physician Decision|1|||
150199201|NCT04101357|541871477|FG000|Overall Study|Death|1|||
150135360|NCT03311373|541628052|FG000|Overall Study|Lost to Follow-up|1|||
150199202|NCT04101357|541871478|FG001|Overall Study|Death|1|||
150199203|NCT04101357|541871479|FG002|Overall Study|Death|1|||
150199204|NCT04101357|541871480|FG003|Overall Study|Death|2|||
150199205|NCT04101357|541871481|FG004|Overall Study|Death|4|||
150199206|NCT04101357|541871482|FG005|Overall Study|Death|11|||
150199207|NCT04101357|541871483|FG006|Overall Study|Death|4|||
150199208|NCT04101357|541871484|FG007|Overall Study|Death|4|||
150199209|NCT04101357|541871485|FG008|Overall Study|Death|5|||
150199210|NCT04101357|541871486|FG009|Overall Study|Death|2|||
150199211|NCT04101357|541871487|FG010|Overall Study|Death|3|||
150199212|NCT04101357|541871477|FG000|Overall Study|Trial closure|0|||
150199213|NCT04101357|541871478|FG001|Overall Study|Trial closure|0|||
150199214|NCT04101357|541871479|FG002|Overall Study|Trial closure|0|||
150199215|NCT04101357|541871480|FG003|Overall Study|Trial closure|0|||
150199216|NCT04101357|541871481|FG004|Overall Study|Trial closure|0|||
150199217|NCT04101357|541871482|FG005|Overall Study|Trial closure|2|||
150199218|NCT04101357|541871483|FG006|Overall Study|Trial closure|2|||
150199219|NCT04101357|541871484|FG007|Overall Study|Trial closure|0|||
150199220|NCT04101357|541871485|FG008|Overall Study|Trial closure|0|||
150135361|NCT03311373|541628052|FG000|Overall Study|Physician Decision|1|||
150135362|NCT03311373|541628052|FG000|Overall Study|Withdrawal by Subject|3|||
150135363|NCT00374322|541628058|FG000|Overall Study|Lost to Follow-up|92|||
150135364|NCT00374322|541628059|FG001|Overall Study|Lost to Follow-up|90|||
150135365|NCT00374322|541628058|FG000|Overall Study|Protocol Violation|8|||
150135366|NCT00374322|541628059|FG001|Overall Study|Protocol Violation|3|||
150135367|NCT00374322|541628058|FG000|Overall Study|Withdrawal by Subject|235|||
150135368|NCT00374322|541628059|FG001|Overall Study|Withdrawal by Subject|167|||
150135369|NCT00374322|541628058|FG000|Overall Study|Sponsor Terminated Study|866|||
150135370|NCT00374322|541628059|FG001|Overall Study|Sponsor Terminated Study|990|||
150135371|NCT00374322|541628058|FG000|Overall Study|Physician Decision|36|||
150135372|NCT00374322|541628059|FG001|Overall Study|Physician Decision|32|||
150199221|NCT04101357|541871486|FG009|Overall Study|Trial closure|0|||
150199222|NCT04101357|541871487|FG010|Overall Study|Trial closure|1|||
150135373|NCT00374322|541628058|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
150135374|NCT00374322|541628059|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
150135375|NCT00374322|541628058|FG000|Overall Study|Sponsor Decision|2|||
150199223|NCT04101357|541871477|FG000|Overall Study|Lost to Follow-up|0|||
150199224|NCT04101357|541871478|FG001|Overall Study|Lost to Follow-up|0|||
150199225|NCT04101357|541871479|FG002|Overall Study|Lost to Follow-up|0|||
150199226|NCT04101357|541871480|FG003|Overall Study|Lost to Follow-up|1|||
150199227|NCT04101357|541871481|FG004|Overall Study|Lost to Follow-up|0|||
150135376|NCT00374322|541628059|FG001|Overall Study|Sponsor Decision|3|||
150135377|NCT00374322|541628058|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
150135378|NCT00374322|541628059|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
150135379|NCT00374322|541628058|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
150135380|NCT00374322|541628059|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
150135381|NCT00374322|541628058|FG000|Overall Study|Severe Toxicity|1|||
150135382|NCT00374322|541628059|FG001|Overall Study|Severe Toxicity|0|||
150135383|NCT00374322|541628058|FG000|Overall Study|Site Closed|2|||
150135384|NCT00374322|541628059|FG001|Overall Study|Site Closed|2|||
150135385|NCT00374322|541628058|FG000|Overall Study|Participant Changed Physician|1|||
150135386|NCT00374322|541628059|FG001|Overall Study|Participant Changed Physician|0|||
150135387|NCT00374322|541628058|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
150135388|NCT00374322|541628059|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
150135389|NCT00374322|541628058|FG000|Overall Study|Noncompliance with Study Requirements|0|||
150135390|NCT00374322|541628059|FG001|Overall Study|Noncompliance with Study Requirements|1|||
150135391|NCT00374322|541628058|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
150135392|NCT00374322|541628059|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
150135393|NCT00374322|541628058|FG000|Overall Study|Did Not Receive Study Medication|8|||
150135394|NCT00374322|541628059|FG001|Overall Study|Did Not Receive Study Medication|6|||
150135395|NCT00553696|541628062|FG000|Overall Study|Adverse Event|2|||
150135396|NCT00553696|541628063|FG001|Overall Study|Adverse Event|4|||
150135397|NCT00553696|541628064|FG002|Overall Study|Adverse Event|0|||
150135398|NCT00553696|541628065|FG003|Overall Study|Adverse Event|1|||
150135399|NCT00553696|541628062|FG000|Overall Study|Global deterioration of health status|0|||
150135400|NCT00553696|541628063|FG001|Overall Study|Global deterioration of health status|2|||
150135401|NCT00553696|541628064|FG002|Overall Study|Global deterioration of health status|0|||
150135402|NCT00553696|541628065|FG003|Overall Study|Global deterioration of health status|0|||
150135403|NCT00553696|541628062|FG000|Overall Study|Objective progression or relapse|2|||
150135404|NCT00553696|541628063|FG001|Overall Study|Objective progression or relapse|9|||
150135405|NCT00553696|541628064|FG002|Overall Study|Objective progression or relapse|6|||
150135406|NCT00553696|541628065|FG003|Overall Study|Objective progression or relapse|0|||
150135407|NCT00553696|541628062|FG000|Overall Study|Withdrawal by Subject|0|||
150135408|NCT00553696|541628063|FG001|Overall Study|Withdrawal by Subject|1|||
150135409|NCT00553696|541628064|FG002|Overall Study|Withdrawal by Subject|0|||
150135410|NCT00553696|541628065|FG003|Overall Study|Withdrawal by Subject|0|||
150135411|NCT00686881|541628068|FG000|Overall Study|Withdrawal by Subject|11|||
150135412|NCT00686881|541628069|FG001|Overall Study|Withdrawal by Subject|18|||
150135413|NCT00686881|541628068|FG000|Overall Study|Lost to Follow-up|0|||
150135414|NCT00686881|541628069|FG001|Overall Study|Lost to Follow-up|1|||
150135415|NCT00686881|541628068|FG000|Overall Study|Treatment-related adverse event|10|||
150135416|NCT00686881|541628069|FG001|Overall Study|Treatment-related adverse event|9|||
150135417|NCT00686881|541628068|FG000|Overall Study|Met discontinuation criteria|5|||
150135418|NCT00686881|541628069|FG001|Overall Study|Met discontinuation criteria|0|||
150135419|NCT00686881|541628068|FG000|Overall Study|Onset of malignant tumor|11|||
150135420|NCT00686881|541628069|FG001|Overall Study|Onset of malignant tumor|11|||
150135421|NCT00686881|541628068|FG000|Overall Study|Lack of Efficacy|4|||
150135422|NCT00686881|541628069|FG001|Overall Study|Lack of Efficacy|3|||
150135423|NCT00686881|541628068|FG000|Overall Study|Physician Decision|1|||
150135424|NCT00686881|541628069|FG001|Overall Study|Physician Decision|0|||
150135425|NCT00686881|541628068|FG000|Overall Study|Circumstances of site|1|||
150135426|NCT00686881|541628069|FG001|Overall Study|Circumstances of site|1|||
150135427|NCT00686881|541628068|FG000|Overall Study|Did not meet protocol eligibility|1|||
150135428|NCT00686881|541628069|FG001|Overall Study|Did not meet protocol eligibility|0|||
150135429|NCT00686881|541628068|FG000|Overall Study|Irregular visits|1|||
150135430|NCT00686881|541628069|FG001|Overall Study|Irregular visits|0|||
150135431|NCT00686881|541628068|FG000|Overall Study|Study discontinuation|35|||
150135432|NCT00686881|541628069|FG001|Overall Study|Study discontinuation|32|||
150135433|NCT00686881|541628068|FG000|Overall Study|Never received study drug|2|||
150135434|NCT00686881|541628069|FG001|Overall Study|Never received study drug|6|||
150135435|NCT02085252|541628072|FG000|Overall Study|Withdrawal of Consent|1|||
150135436|NCT02085252|541628073|FG001|Overall Study|Withdrawal of Consent|0|||
150135437|NCT02085252|541628072|FG000|Overall Study|Adverse Event|0|||
150135438|NCT02085252|541628073|FG001|Overall Study|Adverse Event|1|||
150135439|NCT02085252|541628072|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
150135440|NCT02085252|541628073|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
150135441|NCT02085252|541628072|FG000|Overall Study|Reason Not Specified|0|||
150135442|NCT02085252|541628073|FG001|Overall Study|Reason Not Specified|1|||
150135443|NCT02085252|541628072|FG000|Overall Study|Reason Unknown|0|||
150135444|NCT02085252|541628073|FG001|Overall Study|Reason Unknown|1|||
150135445|NCT03260868|541628075|FG000|Overall Study|Poor Compliance to Protocol|0|||
150135446|NCT03260868|541628076|FG001|Overall Study|Poor Compliance to Protocol|2|||
150135447|NCT03260868|541628075|FG000|Overall Study|Study Terminated By Sponsor|2|||
150135448|NCT03260868|541628076|FG001|Overall Study|Study Terminated By Sponsor|1|||
150135449|NCT03260868|541628075|FG000|Overall Study|Other than specified above|1|||
150135450|NCT03260868|541628076|FG001|Overall Study|Other than specified above|0|||
150135451|NCT02925676|541628077|FG000|Overall Study|Withdrawal by Subject|1|||
150135452|NCT00981084|541628078|FG000|Post Intervention (Data Analysis)|poor effort|1|||
150135453|NCT00981084|541628079|FG001|Post Intervention (Data Analysis)|poor effort|1|||
150135454|NCT00981084|541628078|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
150135455|NCT00981084|541628079|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
150135456|NCT02291679|541628080|FG000|Overall Study|Adverse Event|2|||
150135457|NCT02291679|541628081|FG001|Overall Study|Adverse Event|12|||
150135458|NCT02291679|541628082|FG002|Overall Study|Adverse Event|19|||
150135459|NCT02291679|541628080|FG000|Overall Study|Protocol Violation|5|||
150135460|NCT02291679|541628081|FG001|Overall Study|Protocol Violation|1|||
150135461|NCT02291679|541628082|FG002|Overall Study|Protocol Violation|7|||
150135462|NCT02291679|541628080|FG000|Overall Study|Withdrew Consent|18|||
150135463|NCT02291679|541628081|FG001|Overall Study|Withdrew Consent|10|||
150135464|NCT02291679|541628082|FG002|Overall Study|Withdrew Consent|15|||
150135465|NCT02291679|541628080|FG000|Overall Study|Lost to Follow-up|12|||
150135466|NCT02291679|541628081|FG001|Overall Study|Lost to Follow-up|10|||
150135467|NCT02291679|541628082|FG002|Overall Study|Lost to Follow-up|9|||
150135468|NCT02291679|541628080|FG000|Overall Study|Insufficient Therapeutic Response|5|||
150135469|NCT02291679|541628081|FG001|Overall Study|Insufficient Therapeutic Response|5|||
150135470|NCT02291679|541628082|FG002|Overall Study|Insufficient Therapeutic Response|7|||
150135471|NCT02291679|541628080|FG000|Overall Study|Other|2|||
150135472|NCT02291679|541628081|FG001|Overall Study|Other|4|||
150135473|NCT02291679|541628082|FG002|Overall Study|Other|2|||
150135474|NCT02048072|541628083|FG000|Overall Study|Adverse Event|3|||
150135475|NCT02048072|541628083|FG000|Overall Study|Lost to Follow-up|1|||
150135476|NCT01112579|541628084|FG000|Overall Study|Missed Visit|1|||
150135477|NCT01112579|541628085|FG001|Overall Study|Missed Visit|1|||
150135478|NCT01112579|541628084|FG000|Overall Study|Death|0|||
150135479|NCT01112579|541628085|FG001|Overall Study|Death|2|||
150135480|NCT01648270|541628086|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
150135481|NCT00902694|541628087|FG000|Overall Study|Death|1|||
150135482|NCT00902694|541628088|FG001|Overall Study|Death|3|||
150135483|NCT00902694|541628087|FG000|Overall Study|Lost to Follow-up|1|||
150135484|NCT00902694|541628088|FG001|Overall Study|Lost to Follow-up|0|||
150135485|NCT00902694|541628087|FG000|Overall Study|Censored per protocol|3|||
150135486|NCT00902694|541628088|FG001|Overall Study|Censored per protocol|1|||
150135487|NCT00902694|541628087|FG000|Overall Study|Pregnancy|1|||
150135488|NCT00902694|541628088|FG001|Overall Study|Pregnancy|1|||
150135489|NCT00902694|541628087|FG000|Overall Study|Incarceration|1|||
150135490|NCT00902694|541628088|FG001|Overall Study|Incarceration|0|||
150135491|NCT04969263|541628089|FG000|Overall Study|Death|1|||
150135492|NCT04969263|541628089|FG000|Overall Study|Lost to Follow-up|2|||
150135493|NCT04969263|541628089|FG000|Overall Study|Withdrawal by Subject|5|||
150135494|NCT04969263|541628089|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
150135495|NCT03456700|541628090|FG000|Overall Study|Withdrawal by Subject|1|||
150135496|NCT04154787|541628091|FG000|Overall Study|Adverse Event|0|||
150135497|NCT04154787|541628092|FG001|Overall Study|Adverse Event|1|||
150135498|NCT04154787|541628093|FG002|Overall Study|Adverse Event|0|||
150135499|NCT04154787|541628091|FG000|Overall Study|Patient Requires Other Treatment|0|||
150135500|NCT04154787|541628092|FG001|Overall Study|Patient Requires Other Treatment|1|||
150135501|NCT04154787|541628093|FG002|Overall Study|Patient Requires Other Treatment|0|||
150135502|NCT04154787|541628091|FG000|Overall Study|Study Terminated By Sponsor|0|||
150135503|NCT04154787|541628092|FG001|Overall Study|Study Terminated By Sponsor|6|||
150135504|NCT04154787|541628093|FG002|Overall Study|Study Terminated By Sponsor|1|||
150135505|NCT04154787|541628091|FG000|Overall Study|Subject Decision|0|||
150135506|NCT04154787|541628092|FG001|Overall Study|Subject Decision|1|||
150135507|NCT04154787|541628093|FG002|Overall Study|Subject Decision|0|||
150135508|NCT04154787|541628091|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
150135509|NCT04154787|541628092|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
150135510|NCT04154787|541628093|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
150135511|NCT03053050|541628094|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
150135512|NCT03053050|541628095|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
150135513|NCT03053050|541628096|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
150135514|NCT03053050|541628097|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
150135515|NCT03053050|541628094|FG000|Randomized Phase|Withdrew Consent|16|||
150135516|NCT03053050|541628095|FG001|Randomized Phase|Withdrew Consent|8|||
150135517|NCT03053050|541628096|FG002|Randomized Phase|Withdrew Consent|9|||
150135518|NCT03053050|541628097|FG003|Randomized Phase|Withdrew Consent|0|||
150135519|NCT03053050|541628094|FG000|Randomized Phase|Investigator's Discretion|6|||
150135520|NCT03053050|541628095|FG001|Randomized Phase|Investigator's Discretion|6|||
150135521|NCT03053050|541628096|FG002|Randomized Phase|Investigator's Discretion|3|||
150135522|NCT03053050|541628097|FG003|Randomized Phase|Investigator's Discretion|0|||
150135523|NCT03053050|541628094|FG000|Randomized Phase|Lost to Follow-up|5|||
150135524|NCT03053050|541628095|FG001|Randomized Phase|Lost to Follow-up|1|||
150135525|NCT03053050|541628096|FG002|Randomized Phase|Lost to Follow-up|1|||
150135526|NCT03053050|541628097|FG003|Randomized Phase|Lost to Follow-up|0|||
150135527|NCT03053050|541628094|FG000|Randomized Phase|Adverse Event|0|||
150135528|NCT03053050|541628095|FG001|Randomized Phase|Adverse Event|1|||
150135529|NCT03053050|541628096|FG002|Randomized Phase|Adverse Event|0|||
150135530|NCT03053050|541628097|FG003|Randomized Phase|Adverse Event|0|||
150135531|NCT03053050|541628094|FG000|Randomized Phase|Randomized but Never Treated|2|||
150135532|NCT03053050|541628095|FG001|Randomized Phase|Randomized but Never Treated|2|||
150135533|NCT03053050|541628096|FG002|Randomized Phase|Randomized but Never Treated|2|||
150135534|NCT03053050|541628097|FG003|Randomized Phase|Randomized but Never Treated|0|||
150135535|NCT03053050|541628094|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
150135536|NCT03053050|541628095|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
150135537|NCT03053050|541628096|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
150135538|NCT03053050|541628097|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
150135539|NCT03053050|541628094|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
150135540|NCT03053050|541628095|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
150135541|NCT03053050|541628096|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
150135542|NCT03053050|541628097|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
150135543|NCT03053050|541628094|FG000|Open-label Phase|Withdrew Consent|0|||
150135544|NCT03053050|541628095|FG001|Open-label Phase|Withdrew Consent|0|||
150135545|NCT03053050|541628096|FG002|Open-label Phase|Withdrew Consent|0|||
150135546|NCT03053050|541628097|FG003|Open-label Phase|Withdrew Consent|6|||
150135547|NCT03053050|541628094|FG000|Open-label Phase|Investigator's Discretion|0|||
150135548|NCT03053050|541628095|FG001|Open-label Phase|Investigator's Discretion|0|||
150135549|NCT03053050|541628096|FG002|Open-label Phase|Investigator's Discretion|0|||
150135550|NCT03053050|541628097|FG003|Open-label Phase|Investigator's Discretion|4|||
150135551|NCT03703466|541628098|FG000|Overall Study|Death|2|||
150135552|NCT03703466|541628099|FG001|Overall Study|Death|1|||
150135553|NCT03703466|541628100|FG002|Overall Study|Death|0|||
150135554|NCT03703466|541628098|FG000|Overall Study|Withdrawal by Subject|0|||
150135555|NCT03703466|541628099|FG001|Overall Study|Withdrawal by Subject|3|||
150135556|NCT03703466|541628100|FG002|Overall Study|Withdrawal by Subject|0|||
150135557|NCT03703466|541628098|FG000|Overall Study|Completed < 3 Cycles|2|||
150135558|NCT03703466|541628099|FG001|Overall Study|Completed < 3 Cycles|2|||
150135559|NCT03703466|541628100|FG002|Overall Study|Completed < 3 Cycles|2|||
150135560|NCT03355326|541628101|FG000|Overall Study|Protocol Violation|3|||
150135561|NCT03355326|541628102|FG001|Overall Study|Protocol Violation|3|||
150135562|NCT00175825|541629690|FG000|Overall Study|Adverse Event|3|||
150135563|NCT00175825|541629691|FG001|Overall Study|Adverse Event|2|||
150135564|NCT00175825|541629692|FG002|Overall Study|Adverse Event|1|||
150135565|NCT00175825|541629693|FG003|Overall Study|Adverse Event|1|||
150135566|NCT00175825|541629690|FG000|Overall Study|Lost to Follow-up|1|||
150135567|NCT00175825|541629691|FG001|Overall Study|Lost to Follow-up|2|||
150135568|NCT00175825|541629692|FG002|Overall Study|Lost to Follow-up|0|||
150135569|NCT00175825|541629693|FG003|Overall Study|Lost to Follow-up|0|||
150135570|NCT00175825|541629690|FG000|Overall Study|Withdrawal by Subject|1|||
150135571|NCT00175825|541629691|FG001|Overall Study|Withdrawal by Subject|0|||
150135572|NCT00175825|541629692|FG002|Overall Study|Withdrawal by Subject|0|||
150135573|NCT00175825|541629693|FG003|Overall Study|Withdrawal by Subject|0|||
150135574|NCT04098406|541629694|FG000|Overall Study|Adverse Event|2|||
150135575|NCT04098406|541629695|FG001|Overall Study|Adverse Event|1|||
150135576|NCT04098406|541629694|FG000|Overall Study|Withdrawal by Subject|1|||
150135577|NCT04098406|541629695|FG001|Overall Study|Withdrawal by Subject|0|||
150135578|NCT02001194|541629696|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
150135579|NCT02001194|541629697|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
150135580|NCT02001194|541629698|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
150135581|NCT02001194|541629699|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
150135582|NCT02001194|541629696|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
150135583|NCT02001194|541629697|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
150135584|NCT02001194|541629698|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
150135585|NCT02001194|541629699|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
150135586|NCT00522301|541629700|FG000|Overall Study|Withdrawal by Subject|1|||
150135587|NCT00522301|541629700|FG000|Overall Study|Adverse Event|5|||
150135588|NCT01699022|541629707|FG000|Overall Study|Early discontinuation from the study|3|||
150135589|NCT02066402|541629712|FG000|Overall Study|Adverse Event|1|||
150135590|NCT02066402|541629713|FG001|Overall Study|Adverse Event|2|||
150135591|NCT02066402|541629712|FG000|Overall Study|Lost to Follow-up|11|||
150135592|NCT02066402|541629713|FG001|Overall Study|Lost to Follow-up|8|||
150135593|NCT02066402|541629712|FG000|Overall Study|Withdrawal by Subject|14|||
150135594|NCT02066402|541629713|FG001|Overall Study|Withdrawal by Subject|11|||
150135595|NCT02066402|541629712|FG000|Overall Study|Progressive disease-clinical progression|0|||
150135596|NCT02066402|541629713|FG001|Overall Study|Progressive disease-clinical progression|1|||
150135597|NCT02066402|541629712|FG000|Overall Study|Protocol driven decision point|0|||
150135598|NCT02066402|541629713|FG001|Overall Study|Protocol driven decision point|1|||
150135599|NCT00152464|541629714|FG000|Overall Study|Adverse Event|3|||
150135600|NCT00152464|541629715|FG001|Overall Study|Adverse Event|6|||
150135601|NCT00152464|541629714|FG000|Overall Study|Lost to Follow-up|8|||
150135602|NCT00152464|541629715|FG001|Overall Study|Lost to Follow-up|4|||
150135603|NCT00152464|541629714|FG000|Overall Study|Protocol Violation|3|||
150135604|NCT00152464|541629715|FG001|Overall Study|Protocol Violation|1|||
150135605|NCT00152464|541629714|FG000|Overall Study|Withdrawal by Subject|21|||
150135606|NCT00152464|541629715|FG001|Overall Study|Withdrawal by Subject|22|||
150135607|NCT00152464|541629714|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
150135608|NCT00152464|541629715|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
150135609|NCT00152464|541629714|FG000|Overall Study|Eczema deterioration|0|||
150135610|NCT00152464|541629715|FG001|Overall Study|Eczema deterioration|1|||
150135611|NCT00152464|541629714|FG000|Overall Study|Parent decision|1|||
150135612|NCT00152464|541629715|FG001|Overall Study|Parent decision|1|||
150135613|NCT00152464|541629714|FG000|Overall Study|Investigator decision|1|||
150135614|NCT00152464|541629715|FG001|Overall Study|Investigator decision|0|||
150135615|NCT00152464|541629714|FG000|Overall Study|Lack of Efficacy|1|||
150135616|NCT00152464|541629715|FG001|Overall Study|Lack of Efficacy|0|||
150135617|NCT00152464|541629714|FG000|Overall Study|Eczema poorly controlled|1|||
150135618|NCT00152464|541629715|FG001|Overall Study|Eczema poorly controlled|0|||
150135619|NCT00152464|541629714|FG000|Overall Study|Patient relocated|1|||
150135620|NCT00152464|541629715|FG001|Overall Study|Patient relocated|0|||
150135621|NCT04493931|541629716|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
150135622|NCT04493931|541629717|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135623|NCT04493931|541629718|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135624|NCT04493931|541629719|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135625|NCT04493931|541629720|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135626|NCT04493931|541629721|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135627|NCT04493931|541629722|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
150135628|NCT04493931|541629716|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135629|NCT04493931|541629717|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
150135630|NCT04493931|541629718|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135631|NCT04493931|541629719|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135632|NCT04493931|541629720|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135633|NCT04493931|541629721|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135634|NCT04493931|541629722|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
150135635|NCT04493931|541629716|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135636|NCT04493931|541629717|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
150135637|NCT04493931|541629718|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135638|NCT04493931|541629719|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135639|NCT04493931|541629720|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135640|NCT04493931|541629721|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135641|NCT04493931|541629722|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
150135642|NCT04493931|541629716|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135643|NCT04493931|541629717|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135644|NCT04493931|541629718|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
150135645|NCT04493931|541629719|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135646|NCT04493931|541629720|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135647|NCT04493931|541629721|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135648|NCT04493931|541629722|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
150135649|NCT00266825|541629729|FG000|Completed Follow-Up|Lost to Follow-up|14|||
150135650|NCT00266825|541629730|FG001|Completed Follow-Up|Lost to Follow-up|19|||
150135651|NCT00266825|541629729|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
150135652|NCT00266825|541629730|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
150135653|NCT00430248|541629731|FG000|Overall Study|Adverse Event|49|||
150135654|NCT00430248|541629732|FG001|Overall Study|Adverse Event|61|||
150135655|NCT00430248|541629733|FG002|Overall Study|Adverse Event|64|||
150135656|NCT00430248|541629731|FG000|Overall Study|Protocol Violation|10|||
150135657|NCT00430248|541629732|FG001|Overall Study|Protocol Violation|2|||
150135658|NCT00430248|541629733|FG002|Overall Study|Protocol Violation|4|||
150135659|NCT00430248|541629731|FG000|Overall Study|Personal Reasons|12|||
150135660|NCT00430248|541629732|FG001|Overall Study|Personal Reasons|24|||
150135661|NCT00430248|541629733|FG002|Overall Study|Personal Reasons|9|||
150135662|NCT00430248|541629731|FG000|Overall Study|Lost to Follow-up|28|||
150199228|NCT04101357|541871482|FG005|Overall Study|Lost to Follow-up|0|||
150135663|NCT00430248|541629732|FG001|Overall Study|Lost to Follow-up|33|||
150135664|NCT00430248|541629733|FG002|Overall Study|Lost to Follow-up|28|||
150135665|NCT00430248|541629731|FG000|Overall Study|Therapeutic Failure|1|||
150135666|NCT00430248|541629732|FG001|Overall Study|Therapeutic Failure|1|||
150135667|NCT00430248|541629733|FG002|Overall Study|Therapeutic Failure|1|||
150135668|NCT00430248|541629731|FG000|Overall Study|Withdrawal by Subject|14|||
150135669|NCT00430248|541629732|FG001|Overall Study|Withdrawal by Subject|20|||
150135670|NCT00430248|541629733|FG002|Overall Study|Withdrawal by Subject|16|||
150135671|NCT00430248|541629731|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150135672|NCT00430248|541629732|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
150135673|NCT00430248|541629733|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150135674|NCT00430248|541629731|FG000|Overall Study|Gout Flare|3|||
150135675|NCT00430248|541629732|FG001|Overall Study|Gout Flare|7|||
150135676|NCT00430248|541629733|FG002|Overall Study|Gout Flare|2|||
150135677|NCT00430248|541629731|FG000|Overall Study|Reason Not Specified|8|||
150135678|NCT00430248|541629732|FG001|Overall Study|Reason Not Specified|8|||
150135679|NCT00430248|541629733|FG002|Overall Study|Reason Not Specified|11|||
150135680|NCT00917579|541629734|FG000|Washout >= 2 Weeks|Adverse Event|1|||
150135681|NCT00917579|541629735|FG001|Washout >= 2 Weeks|Adverse Event|0|||
150135682|NCT00917579|541629734|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
150135683|NCT00917579|541629735|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
150135684|NCT00754338|541629736|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
150135685|NCT00754338|541629737|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
150135686|NCT00754338|541629738|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
150135687|NCT00754338|541629739|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
150135688|NCT00754338|541629736|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
150135689|NCT00754338|541629737|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
150135690|NCT00754338|541629738|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
150135691|NCT00754338|541629739|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
150135692|NCT00831779|541629742|FG000|Overall Study|Lost to Follow-up|1|||
150135693|NCT00831779|541629743|FG001|Overall Study|Lost to Follow-up|0|||
150135694|NCT00831779|541629742|FG000|Overall Study|No longer met criteria|0|||
150135695|NCT00831779|541629743|FG001|Overall Study|No longer met criteria|1|||
150135696|NCT04020341|541629744|FG000|Overall Study|Adverse Event|8|||
150135697|NCT04020341|541629745|FG001|Overall Study|Adverse Event|6|||
150135698|NCT04020341|541629744|FG000|Overall Study|Lost to Follow-up|8|||
150135699|NCT04020341|541629745|FG001|Overall Study|Lost to Follow-up|2|||
150135700|NCT04020341|541629744|FG000|Overall Study|Withdrawal by Subject|16|||
150135701|NCT04020341|541629745|FG001|Overall Study|Withdrawal by Subject|16|||
150135702|NCT04020341|541629744|FG000|Overall Study|Participant not able to swallow the tablet|1|||
150135703|NCT04020341|541629745|FG001|Overall Study|Participant not able to swallow the tablet|0|||
150135704|NCT04020341|541629744|FG000|Overall Study|Physician Decision|0|||
150135705|NCT04020341|541629745|FG001|Overall Study|Physician Decision|2|||
150135706|NCT04020341|541629744|FG000|Overall Study|Protocol Deviation|0|||
150135707|NCT04020341|541629745|FG001|Overall Study|Protocol Deviation|2|||
150135708|NCT05763628|541629746|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
150135709|NCT05763628|541629747|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
150135710|NCT05763628|541629746|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
150135711|NCT05763628|541629747|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
150135712|NCT05763628|541629746|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
150135713|NCT05763628|541629747|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
150135714|NCT04683926|541629755|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
150135715|NCT04683926|541629756|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
150135716|NCT04683926|541629757|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
150135717|NCT04683926|541629758|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
150135718|NCT04721925|541629761|FG000|2-Month Assessment|Lost to Follow-up|5|||
150135719|NCT04721925|541629762|FG001|2-Month Assessment|Lost to Follow-up|3|||
150135720|NCT04721925|541629761|FG000|4-Month Assessment|Lost to Follow-up|3|||
150135721|NCT04721925|541629762|FG001|4-Month Assessment|Lost to Follow-up|6|||
150135722|NCT01040260|541629763|FG000|Overall Study|Withdrawal by Subject|12|||
150135723|NCT01040260|541629764|FG001|Overall Study|Withdrawal by Subject|6|||
150135724|NCT01040260|541629763|FG000|Overall Study|Lost to Follow-up|3|||
150135725|NCT01040260|541629764|FG001|Overall Study|Lost to Follow-up|5|||
150135726|NCT01113502|541629768|FG000|Overall Study|Withdrawal by Subject|1|||
150135727|NCT01113502|541629769|FG001|Overall Study|Withdrawal by Subject|0|||
150135728|NCT01113502|541629770|FG002|Overall Study|Withdrawal by Subject|1|||
150135729|NCT01113502|541629771|FG003|Overall Study|Withdrawal by Subject|1|||
150135730|NCT01113502|541629772|FG004|Overall Study|Withdrawal by Subject|0|||
150135731|NCT01113502|541629768|FG000|Overall Study|Adverse Event|0|||
150135732|NCT01113502|541629769|FG001|Overall Study|Adverse Event|0|||
150135733|NCT01113502|541629770|FG002|Overall Study|Adverse Event|3|||
150199229|NCT04101357|541871483|FG006|Overall Study|Lost to Follow-up|0|||
150135734|NCT01113502|541629771|FG003|Overall Study|Adverse Event|2|||
150135735|NCT01113502|541629772|FG004|Overall Study|Adverse Event|0|||
150135736|NCT03002610|541629775|FG000|Overall Study|Withdrawal by Subject|6|||
150135737|NCT03002610|541629776|FG001|Overall Study|Withdrawal by Subject|25|||
150135738|NCT03002610|541629777|FG002|Overall Study|Withdrawal by Subject|13|||
150135739|NCT01970982|541629778|FG000|Overall Study|Withdrawal by Subject|0|||
150199230|NCT04101357|541871484|FG007|Overall Study|Lost to Follow-up|1|||
150199231|NCT04101357|541871485|FG008|Overall Study|Lost to Follow-up|0|||
150135740|NCT01970982|541629779|FG001|Overall Study|Withdrawal by Subject|0|||
150199232|NCT04101357|541871486|FG009|Overall Study|Lost to Follow-up|0|||
150199233|NCT04101357|541871487|FG010|Overall Study|Lost to Follow-up|0|||
150199234|NCT04101357|541871477|FG000|Overall Study|Withdrawal by Subject|1|||
150199235|NCT04101357|541871478|FG001|Overall Study|Withdrawal by Subject|0|||
150135741|NCT01970982|541629780|FG002|Overall Study|Withdrawal by Subject|2|||
150135742|NCT00708916|541629783|FG000|Overall Study|Subject Noncompliance|2|||
150135743|NCT00708916|541629783|FG000|Overall Study|Adverse Event|2|||
150135744|NCT01984684|541629786|FG000|Overall Study|Lost to Follow-up|25|||
150135745|NCT01984684|541629787|FG001|Overall Study|Lost to Follow-up|24|||
150135746|NCT01984684|541629786|FG000|Overall Study|Adverse Event|8|||
150135747|NCT01984684|541629787|FG001|Overall Study|Adverse Event|12|||
150135748|NCT01984684|541629786|FG000|Overall Study|Withdrawal by Subject|9|||
150135749|NCT01984684|541629787|FG001|Overall Study|Withdrawal by Subject|9|||
150135750|NCT01984684|541629786|FG000|Overall Study|Lack of Efficacy|3|||
150135751|NCT01984684|541629787|FG001|Overall Study|Lack of Efficacy|6|||
150135752|NCT01984684|541629786|FG000|Overall Study|Physician Decision|4|||
150135753|NCT01984684|541629787|FG001|Overall Study|Physician Decision|2|||
150135754|NCT01984684|541629786|FG000|Overall Study|Protocol Violation|4|||
150135755|NCT01984684|541629787|FG001|Overall Study|Protocol Violation|2|||
150135756|NCT01984684|541629786|FG000|Overall Study|Death|0|||
150135757|NCT01984684|541629787|FG001|Overall Study|Death|1|||
150135758|NCT01984684|541629786|FG000|Overall Study|Noncompliance with study drug|2|||
150135759|NCT01984684|541629787|FG001|Overall Study|Noncompliance with study drug|1|||
150135760|NCT01984684|541629786|FG000|Overall Study|Subject incarcerated|1|||
150135761|NCT01984684|541629787|FG001|Overall Study|Subject incarcerated|0|||
150135762|NCT01984684|541629786|FG000|Overall Study|Study drug not available at site|1|||
150135763|NCT01984684|541629787|FG001|Overall Study|Study drug not available at site|1|||
150135764|NCT01984684|541629786|FG000|Overall Study|Subject had inadequate IV access|0|||
150135765|NCT01984684|541629787|FG001|Overall Study|Subject had inadequate IV access|1|||
150135766|NCT04555096|541629792|FG000|Overall Study|Death|4|||
150135767|NCT04555096|541629793|FG001|Overall Study|Death|4|||
150135768|NCT04555096|541629792|FG000|Overall Study|Withdrawal by Subject|1|||
150135769|NCT04555096|541629793|FG001|Overall Study|Withdrawal by Subject|0|||
150135770|NCT04555096|541629792|FG000|Overall Study|Other|0|||
150135771|NCT04555096|541629793|FG001|Overall Study|Other|1|||
150135772|NCT02835339|541629794|FG000|Overall Study|Did not receive allocated intervention|13|||
150135773|NCT02835339|541629795|FG001|Overall Study|Did not receive allocated intervention|16|||
150135774|NCT01077544|541629796|FG000|Overall Study|New Cancer Therapy|3|||
150135775|NCT01077544|541629797|FG001|Overall Study|New Cancer Therapy|3|||
150135776|NCT01077544|541629796|FG000|Overall Study|Adverse Event|0|||
150135777|NCT01077544|541629797|FG001|Overall Study|Adverse Event|1|||
150135778|NCT01077544|541629796|FG000|Overall Study|Disease Progression|0|||
150135779|NCT01077544|541629797|FG001|Overall Study|Disease Progression|1|||
150135780|NCT03923959|541629798|FG000|Overall Study|Death|16|||
150135781|NCT03923959|541629799|FG001|Overall Study|Death|12|||
150135782|NCT03923959|541629798|FG000|Overall Study|Lost to Follow-up|56|||
150135783|NCT03923959|541629799|FG001|Overall Study|Lost to Follow-up|56|||
150135784|NCT03923959|541629798|FG000|Overall Study|Withdrawal by Subject|1|||
150135785|NCT03923959|541629799|FG001|Overall Study|Withdrawal by Subject|1|||
150135786|NCT03923959|541629798|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
150135787|NCT03923959|541629799|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
150135788|NCT01362439|541629800|FG000|Overall Study|Adverse Event|1|||
150135789|NCT01362439|541629800|FG000|Overall Study|Lack of Efficacy|3|||
150135790|NCT01362439|541629800|FG000|Overall Study|Lost to Follow-up|2|||
150135791|NCT01362439|541629800|FG000|Overall Study|Study medication non-compliant|1|||
150135792|NCT01362439|541629800|FG000|Overall Study|Participant who withdrew consent|8|||
150199236|NCT04101357|541871479|FG002|Overall Study|Withdrawal by Subject|0|||
150199237|NCT04101357|541871480|FG003|Overall Study|Withdrawal by Subject|0|||
150199238|NCT04101357|541871481|FG004|Overall Study|Withdrawal by Subject|0|||
150199239|NCT04101357|541871482|FG005|Overall Study|Withdrawal by Subject|0|||
150199240|NCT04101357|541871483|FG006|Overall Study|Withdrawal by Subject|0|||
150199241|NCT04101357|541871484|FG007|Overall Study|Withdrawal by Subject|0|||
150199242|NCT04101357|541871485|FG008|Overall Study|Withdrawal by Subject|1|||
150199243|NCT04101357|541871486|FG009|Overall Study|Withdrawal by Subject|1|||
150199244|NCT04101357|541871487|FG010|Overall Study|Withdrawal by Subject|0|||
150135793|NCT03575325|541629801|FG000|Overall Study|Death|1|||
150135794|NCT05711641|541629802|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
150135795|NCT05711641|541629803|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
150135796|NCT05711641|541629802|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
150135797|NCT05711641|541629803|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
150135798|NCT04040751|541629804|FG000|Overall Study|Withdrawal by Subject|2|||
150135799|NCT04040751|541629805|FG001|Overall Study|Withdrawal by Subject|0|||
150199245|NCT04101357|541871477|FG000|Overall Study|Other|0|||
150199246|NCT04101357|541871478|FG001|Overall Study|Other|0|||
150199247|NCT04101357|541871479|FG002|Overall Study|Other|0|||
150199248|NCT04101357|541871480|FG003|Overall Study|Other|0|||
150199249|NCT04101357|541871481|FG004|Overall Study|Other|0|||
150199250|NCT04101357|541871482|FG005|Overall Study|Other|1|||
150199251|NCT04101357|541871483|FG006|Overall Study|Other|2|||
150199252|NCT04101357|541871484|FG007|Overall Study|Other|1|||
150199253|NCT04101357|541871485|FG008|Overall Study|Other|0|||
150199254|NCT04101357|541871486|FG009|Overall Study|Other|0|||
150199255|NCT04101357|541871487|FG010|Overall Study|Other|0|||
150199256|NCT04101357|541871477|FG000|Overall Study|Enrolled but not treated|0|||
150199257|NCT04101357|541871478|FG001|Overall Study|Enrolled but not treated|0|||
150199258|NCT04101357|541871479|FG002|Overall Study|Enrolled but not treated|0|||
150199259|NCT04101357|541871480|FG003|Overall Study|Enrolled but not treated|0|||
150199260|NCT04101357|541871481|FG004|Overall Study|Enrolled but not treated|0|||
150199261|NCT04101357|541871482|FG005|Overall Study|Enrolled but not treated|1|||
150199262|NCT04101357|541871483|FG006|Overall Study|Enrolled but not treated|1|||
150199263|NCT04101357|541871484|FG007|Overall Study|Enrolled but not treated|0|||
150199264|NCT04101357|541871485|FG008|Overall Study|Enrolled but not treated|0|||
150199265|NCT04101357|541871486|FG009|Overall Study|Enrolled but not treated|0|||
150199266|NCT04101357|541871487|FG010|Overall Study|Enrolled but not treated|0|||
150199267|NCT05618587|541871488|FG000|Overall Study|Lost to Follow-up|2|||
150199268|NCT05618587|541871489|FG001|Overall Study|Lost to Follow-up|0|||
150199269|NCT03442309|541871490|FG000|Overall Study|Lost to Follow-up|1676|||
150199270|NCT03442309|541871491|FG001|Overall Study|Lost to Follow-up|1642|||
150199271|NCT04136912|541871494|FG000|Overall Study|Operational reasons|0|||
150199272|NCT04136912|541871495|FG001|Overall Study|Operational reasons|0|||
150199273|NCT04136912|541871496|FG002|Overall Study|Operational reasons|2|||
150199274|NCT04615273|541871505|FG000|Overall Study|Withdrawal by Subject|3|||
150199275|NCT04615273|541871506|FG001|Overall Study|Withdrawal by Subject|1|||
150199276|NCT04615273|541871507|FG002|Overall Study|Withdrawal by Subject|2|||
150199277|NCT04615273|541871505|FG000|Overall Study|Adverse Event|1|||
150199278|NCT04615273|541871506|FG001|Overall Study|Adverse Event|0|||
150199279|NCT04615273|541871507|FG002|Overall Study|Adverse Event|1|||
150199280|NCT04615273|541871505|FG000|Overall Study|Lost to Follow-up|0|||
150199281|NCT04615273|541871506|FG001|Overall Study|Lost to Follow-up|1|||
150199282|NCT04615273|541871507|FG002|Overall Study|Lost to Follow-up|0|||
150199283|NCT04615273|541871505|FG000|Overall Study|Physician Decision|0|||
150199284|NCT04615273|541871506|FG001|Overall Study|Physician Decision|0|||
150199285|NCT04615273|541871507|FG002|Overall Study|Physician Decision|1|||
150199286|NCT04615273|541871505|FG000|Overall Study|Other|0|||
150199287|NCT04615273|541871506|FG001|Overall Study|Other|1|||
150199288|NCT04615273|541871507|FG002|Overall Study|Other|0|||
150199289|NCT04615273|541871505|FG000|Overall Study|Randomized but not treated|1|||
150199290|NCT04615273|541871506|FG001|Overall Study|Randomized but not treated|3|||
150199291|NCT04615273|541871507|FG002|Overall Study|Randomized but not treated|1|||
150135800|NCT04040751|541629806|FG002|Overall Study|Withdrawal by Subject|2|||
150135801|NCT04040751|541629807|FG003|Overall Study|Withdrawal by Subject|0|||
150135802|NCT02612311|541629813|FG000|Overall Study|Adverse Event|16|||
150135803|NCT02612311|541629814|FG001|Overall Study|Adverse Event|12|||
150135804|NCT02612311|541629815|FG002|Overall Study|Adverse Event|7|||
150135805|NCT02612311|541629816|FG003|Overall Study|Adverse Event|13|||
150135806|NCT02612311|541629813|FG000|Overall Study|Death|29|||
150135807|NCT02612311|541629814|FG001|Overall Study|Death|10|||
150135808|NCT02612311|541629815|FG002|Overall Study|Death|11|||
150135809|NCT02612311|541629816|FG003|Overall Study|Death|11|||
150135810|NCT02612311|541629813|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
150135811|NCT02612311|541629814|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
150135812|NCT02612311|541629815|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
150135813|NCT02612311|541629816|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
150135814|NCT02612311|541629813|FG000|Overall Study|Investigator's Decision|11|||
150135815|NCT02612311|541629814|FG001|Overall Study|Investigator's Decision|15|||
150135816|NCT02612311|541629815|FG002|Overall Study|Investigator's Decision|6|||
150135817|NCT02612311|541629816|FG003|Overall Study|Investigator's Decision|6|||
150135818|NCT02612311|541629813|FG000|Overall Study|Lack of Efficacy|0|||
150135819|NCT02612311|541629814|FG001|Overall Study|Lack of Efficacy|0|||
150135820|NCT02612311|541629815|FG002|Overall Study|Lack of Efficacy|1|||
150135821|NCT02612311|541629816|FG003|Overall Study|Lack of Efficacy|1|||
150199292|NCT04003246|541871510|FG000|Overall Study|Death|9|||
150199293|NCT04999111|541871514|FG000|Overall Study|Lost to Follow-up|21|||
150199294|NCT04999111|541871515|FG001|Overall Study|Lost to Follow-up|16|||
150199295|NCT04999111|541871516|FG002|Overall Study|Lost to Follow-up|2|||
150199296|NCT04999111|541871517|FG003|Overall Study|Lost to Follow-up|26|||
150199297|NCT04999111|541871518|FG004|Overall Study|Lost to Follow-up|30|||
150199298|NCT04999111|541871519|FG005|Overall Study|Lost to Follow-up|6|||
150199299|NCT04999111|541871514|FG000|Overall Study|Physician Decision|1|||
150199300|NCT04999111|541871515|FG001|Overall Study|Physician Decision|3|||
150199301|NCT04999111|541871516|FG002|Overall Study|Physician Decision|0|||
150199302|NCT04999111|541871517|FG003|Overall Study|Physician Decision|1|||
150199303|NCT04999111|541871518|FG004|Overall Study|Physician Decision|2|||
150199304|NCT04999111|541871519|FG005|Overall Study|Physician Decision|0|||
150199305|NCT04999111|541871514|FG000|Overall Study|Withdrawal by Subject|23|||
150199306|NCT04999111|541871515|FG001|Overall Study|Withdrawal by Subject|29|||
150199307|NCT04999111|541871516|FG002|Overall Study|Withdrawal by Subject|15|||
150199308|NCT04999111|541871517|FG003|Overall Study|Withdrawal by Subject|30|||
150199309|NCT04999111|541871518|FG004|Overall Study|Withdrawal by Subject|35|||
150199310|NCT04999111|541871519|FG005|Overall Study|Withdrawal by Subject|10|||
150199311|NCT04999111|541871514|FG000|Overall Study|Other|6|||
150199312|NCT04999111|541871515|FG001|Overall Study|Other|6|||
150199313|NCT04999111|541871516|FG002|Overall Study|Other|3|||
150199314|NCT04999111|541871517|FG003|Overall Study|Other|8|||
150199315|NCT04999111|541871518|FG004|Overall Study|Other|8|||
150199316|NCT04999111|541871519|FG005|Overall Study|Other|5|||
150199317|NCT04999111|541871514|FG000|Overall Study|Non-compliance with study schedule|1|||
150199318|NCT04999111|541871515|FG001|Overall Study|Non-compliance with study schedule|0|||
150199319|NCT04999111|541871516|FG002|Overall Study|Non-compliance with study schedule|0|||
150199320|NCT04999111|541871517|FG003|Overall Study|Non-compliance with study schedule|1|||
150199321|NCT04999111|541871518|FG004|Overall Study|Non-compliance with study schedule|1|||
150199322|NCT04999111|541871519|FG005|Overall Study|Non-compliance with study schedule|1|||
150199323|NCT04999111|541871514|FG000|Overall Study|Randomized but not vaccinated|1|||
150199324|NCT04999111|541871515|FG001|Overall Study|Randomized but not vaccinated|2|||
150199325|NCT04999111|541871516|FG002|Overall Study|Randomized but not vaccinated|0|||
150199326|NCT04999111|541871517|FG003|Overall Study|Randomized but not vaccinated|3|||
150199327|NCT04999111|541871518|FG004|Overall Study|Randomized but not vaccinated|3|||
150199328|NCT04999111|541871519|FG005|Overall Study|Randomized but not vaccinated|0|||
150199329|NCT04999111|541871514|FG000|Overall Study|Adverse Event|1|||
150199330|NCT04999111|541871515|FG001|Overall Study|Adverse Event|1|||
150199331|NCT04999111|541871516|FG002|Overall Study|Adverse Event|0|||
150199332|NCT04999111|541871517|FG003|Overall Study|Adverse Event|0|||
150199333|NCT04999111|541871518|FG004|Overall Study|Adverse Event|0|||
150199334|NCT04999111|541871519|FG005|Overall Study|Adverse Event|0|||
150199335|NCT04999111|541871514|FG000|Overall Study|Initiated prohibited medication|0|||
150199336|NCT04999111|541871515|FG001|Overall Study|Initiated prohibited medication|0|||
150199337|NCT04999111|541871516|FG002|Overall Study|Initiated prohibited medication|0|||
150199338|NCT04999111|541871517|FG003|Overall Study|Initiated prohibited medication|0|||
150199339|NCT04999111|541871518|FG004|Overall Study|Initiated prohibited medication|1|||
150199340|NCT04999111|541871519|FG005|Overall Study|Initiated prohibited medication|0|||
150199341|NCT05683340|541871526|FG000|Overall Study|Adverse Event|1|||
150199342|NCT05683340|541871527|FG001|Overall Study|Adverse Event|1|||
150199343|NCT05683340|541871526|FG000|Overall Study|Protocol Violation|1|||
150199344|NCT05683340|541871527|FG001|Overall Study|Protocol Violation|0|||
150199345|NCT05683340|541871526|FG000|Overall Study|Withdrawal by Subject|0|||
150199346|NCT05683340|541871527|FG001|Overall Study|Withdrawal by Subject|2|||
150199347|NCT02224144|541871531|FG000|Overall Study|Lost to Follow-up|3|||
150199348|NCT02224144|541871532|FG001|Overall Study|Lost to Follow-up|1|||
150199349|NCT02224144|541871531|FG000|Overall Study|Death|2|||
150199350|NCT02224144|541871532|FG001|Overall Study|Death|0|||
150199351|NCT02224144|541871531|FG000|Overall Study|Withdrawal by Subject|0|||
150199352|NCT02224144|541871532|FG001|Overall Study|Withdrawal by Subject|1|||
150199353|NCT03505008|541871533|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
150199354|NCT03505008|541871534|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
150199355|NCT03505008|541871535|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
150135822|NCT02612311|541629813|FG000|Overall Study|Lost to Follow-up|2|||
150135823|NCT02612311|541629814|FG001|Overall Study|Lost to Follow-up|2|||
150135824|NCT02612311|541629815|FG002|Overall Study|Lost to Follow-up|1|||
150135825|NCT02612311|541629816|FG003|Overall Study|Lost to Follow-up|2|||
150135826|NCT02612311|541629813|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
150135827|NCT02612311|541629814|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
150135828|NCT02612311|541629815|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
150199356|NCT03505008|541871536|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
150199357|NCT03505008|541871533|FG000|Before Week 24 Randomization|Adverse Event|10|||
150199358|NCT03505008|541871534|FG001|Before Week 24 Randomization|Adverse Event|0|||
150135829|NCT02612311|541629816|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
150135830|NCT02612311|541629813|FG000|Overall Study|Site Terminated by Sponsor|29|||
150135831|NCT02612311|541629814|FG001|Overall Study|Site Terminated by Sponsor|12|||
150135832|NCT02612311|541629815|FG002|Overall Study|Site Terminated by Sponsor|13|||
150199359|NCT03505008|541871535|FG002|Before Week 24 Randomization|Adverse Event|0|||
150199360|NCT03505008|541871536|FG003|Before Week 24 Randomization|Adverse Event|0|||
150199361|NCT03505008|541871533|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
150199362|NCT03505008|541871534|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
150199363|NCT03505008|541871535|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
150199364|NCT03505008|541871536|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
150199365|NCT03505008|541871533|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
150199366|NCT03505008|541871534|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
150199367|NCT03505008|541871535|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
150199368|NCT03505008|541871536|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
150199369|NCT03505008|541871533|FG000|Before Week 24 Randomization|Physician Decision|2|||
150199370|NCT03505008|541871534|FG001|Before Week 24 Randomization|Physician Decision|0|||
150199371|NCT03505008|541871535|FG002|Before Week 24 Randomization|Physician Decision|0|||
150199372|NCT03505008|541871536|FG003|Before Week 24 Randomization|Physician Decision|0|||
150199373|NCT03505008|541871533|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
150199374|NCT03505008|541871534|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
150199375|NCT03505008|541871535|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
150199376|NCT03505008|541871536|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
150199377|NCT03505008|541871533|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
150199378|NCT03505008|541871534|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
150199379|NCT03505008|541871535|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
150199380|NCT03505008|541871536|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
150199381|NCT03505008|541871533|FG000|Before Week 24 Randomization|Complication|1|||
150199382|NCT03505008|541871534|FG001|Before Week 24 Randomization|Complication|0|||
150199383|NCT03505008|541871535|FG002|Before Week 24 Randomization|Complication|0|||
150199384|NCT03505008|541871536|FG003|Before Week 24 Randomization|Complication|0|||
150199385|NCT03505008|541871533|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
150199386|NCT03505008|541871534|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
150199387|NCT03505008|541871535|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
150199388|NCT03505008|541871536|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
150199389|NCT03505008|541871533|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
150199390|NCT03505008|541871534|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
150199391|NCT03505008|541871535|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
150199392|NCT03505008|541871536|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
150199393|NCT03505008|541871533|FG000|After Week 24 Randomization|Adverse Event|0|||
150199394|NCT03505008|541871534|FG001|After Week 24 Randomization|Adverse Event|1|||
150199395|NCT03505008|541871535|FG002|After Week 24 Randomization|Adverse Event|2|||
150199396|NCT03505008|541871536|FG003|After Week 24 Randomization|Adverse Event|2|||
150199397|NCT03505008|541871533|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
150199398|NCT03505008|541871534|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
150199399|NCT03505008|541871535|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
150199400|NCT03505008|541871536|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
150199401|NCT03505008|541871533|FG000|After Week 24 Randomization|Protocol Violation|0|||
150199402|NCT03505008|541871534|FG001|After Week 24 Randomization|Protocol Violation|0|||
150199403|NCT03505008|541871535|FG002|After Week 24 Randomization|Protocol Violation|1|||
150199404|NCT03505008|541871536|FG003|After Week 24 Randomization|Protocol Violation|0|||
150199405|NCT02437136|541871537|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
150199406|NCT02437136|541871538|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199407|NCT02437136|541871539|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199408|NCT02437136|541871540|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199409|NCT02437136|541871541|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199410|NCT02437136|541871542|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199411|NCT02437136|541871543|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
150199412|NCT02437136|541871537|FG000|Expansion (Phase 2)|Death|0|||
150199413|NCT02437136|541871538|FG001|Expansion (Phase 2)|Death|0|||
150199414|NCT02437136|541871539|FG002|Expansion (Phase 2)|Death|0|||
150199415|NCT02437136|541871540|FG003|Expansion (Phase 2)|Death|6|||
150199416|NCT02437136|541871541|FG004|Expansion (Phase 2)|Death|37|||
150199417|NCT02437136|541871542|FG005|Expansion (Phase 2)|Death|29|||
150199418|NCT02437136|541871543|FG006|Expansion (Phase 2)|Death|24|||
150199419|NCT02437136|541871537|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
150199420|NCT02437136|541871538|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
150199421|NCT02437136|541871539|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
150199422|NCT02437136|541871540|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
150199423|NCT02437136|541871541|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
150199424|NCT02437136|541871542|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
150199425|NCT02437136|541871543|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
150199426|NCT02437136|541871537|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
150199427|NCT02437136|541871538|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
150199428|NCT02437136|541871539|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
150199429|NCT02437136|541871540|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
150199430|NCT02437136|541871541|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
150199431|NCT02437136|541871542|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
150199432|NCT02437136|541871543|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
150199433|NCT03276676|541871545|FG000|Overall Study|Withdrawal by Subject|2|||
150199434|NCT03276676|541871546|FG001|Overall Study|Withdrawal by Subject|1|||
150199435|NCT02962076|541871548|FG000|Overall Study|MHED tracer not available|5|||
150199436|NCT02962076|541871548|FG000|Overall Study|Protocol Violation|1|||
150199437|NCT02962076|541871548|FG000|Overall Study|Physician Decision|1|||
150199438|NCT02780700|541871549|FG000|Overall Study|Progressive disease|1|||
150199439|NCT03926130|541871550|FG000|Overall Study|Adverse Event|9|||
150199440|NCT03926130|541871551|FG001|Overall Study|Adverse Event|11|||
150199441|NCT03926130|541871552|FG002|Overall Study|Adverse Event|2|||
150199442|NCT03926130|541871553|FG003|Overall Study|Adverse Event|0|||
150199443|NCT03926130|541871550|FG000|Overall Study|Death|2|||
150199444|NCT03926130|541871551|FG001|Overall Study|Death|0|||
150199445|NCT03926130|541871552|FG002|Overall Study|Death|1|||
150199446|NCT03926130|541871553|FG003|Overall Study|Death|0|||
150199447|NCT03926130|541871550|FG000|Overall Study|Lack of Efficacy|14|||
150199448|NCT03926130|541871551|FG001|Overall Study|Lack of Efficacy|11|||
150199449|NCT03926130|541871552|FG002|Overall Study|Lack of Efficacy|7|||
150199450|NCT03926130|541871553|FG003|Overall Study|Lack of Efficacy|1|||
150199451|NCT03926130|541871550|FG000|Overall Study|Lost to Follow-up|0|||
150199452|NCT03926130|541871551|FG001|Overall Study|Lost to Follow-up|7|||
150199453|NCT03926130|541871552|FG002|Overall Study|Lost to Follow-up|1|||
150199454|NCT03926130|541871553|FG003|Overall Study|Lost to Follow-up|0|||
150199455|NCT03926130|541871550|FG000|Overall Study|As Reported by Investigator|2|||
150199456|NCT03926130|541871551|FG001|Overall Study|As Reported by Investigator|6|||
150199457|NCT03926130|541871552|FG002|Overall Study|As Reported by Investigator|6|||
150199458|NCT03926130|541871553|FG003|Overall Study|As Reported by Investigator|0|||
150199459|NCT03926130|541871550|FG000|Overall Study|Physician Decision|3|||
150199460|NCT03926130|541871551|FG001|Overall Study|Physician Decision|2|||
150199461|NCT03926130|541871552|FG002|Overall Study|Physician Decision|1|||
150199462|NCT03926130|541871553|FG003|Overall Study|Physician Decision|0|||
150199463|NCT03926130|541871550|FG000|Overall Study|Pregnancy|2|||
150199464|NCT03926130|541871551|FG001|Overall Study|Pregnancy|2|||
150199465|NCT03926130|541871552|FG002|Overall Study|Pregnancy|1|||
150199466|NCT03926130|541871553|FG003|Overall Study|Pregnancy|0|||
150199467|NCT03926130|541871550|FG000|Overall Study|Withdrawal by Subject|20|||
150199468|NCT03926130|541871551|FG001|Overall Study|Withdrawal by Subject|28|||
150199469|NCT03926130|541871552|FG002|Overall Study|Withdrawal by Subject|18|||
150199470|NCT03926130|541871553|FG003|Overall Study|Withdrawal by Subject|1|||
150199471|NCT03926130|541871550|FG000|Overall Study|Non-Compliance|1|||
150199472|NCT03926130|541871551|FG001|Overall Study|Non-Compliance|1|||
150199473|NCT03926130|541871552|FG002|Overall Study|Non-Compliance|0|||
150199474|NCT03926130|541871553|FG003|Overall Study|Non-Compliance|0|||
150199475|NCT03926130|541871550|FG000|Overall Study|Disposition Not Captured|0|||
150199476|NCT03926130|541871551|FG001|Overall Study|Disposition Not Captured|2|||
150199477|NCT03926130|541871552|FG002|Overall Study|Disposition Not Captured|1|||
150199478|NCT03926130|541871553|FG003|Overall Study|Disposition Not Captured|0|||
150199479|NCT03583333|541871554|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
150199480|NCT03583333|541871555|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
150199481|NCT03583333|541871554|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
150199482|NCT03583333|541871555|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
150199483|NCT03583333|541871554|FG000|Overall Study|Withdrawal by Subject|9|||
150199484|NCT03583333|541871555|FG001|Overall Study|Withdrawal by Subject|5|||
150199485|NCT03583333|541871554|FG000|Overall Study|Physician Decision|3|||
150199486|NCT03583333|541871555|FG001|Overall Study|Physician Decision|2|||
150199487|NCT03583333|541871554|FG000|Overall Study|Death|12|||
150199488|NCT03583333|541871555|FG001|Overall Study|Death|7|||
150199489|NCT03640286|541871570|FG000|Overall Study|Adverse Event|6|||
150199490|NCT03640286|541871571|FG001|Overall Study|Adverse Event|6|||
150199491|NCT03640286|541871570|FG000|Overall Study|Lost to Follow-up|3|||
150199492|NCT03640286|541871571|FG001|Overall Study|Lost to Follow-up|6|||
150199493|NCT03640286|541871570|FG000|Overall Study|Pregnancy|1|||
150199494|NCT03640286|541871571|FG001|Overall Study|Pregnancy|0|||
150199495|NCT03640286|541871570|FG000|Overall Study|Withdrawal by Subject|10|||
150199496|NCT03640286|541871571|FG001|Overall Study|Withdrawal by Subject|10|||
150199497|NCT03640286|541871570|FG000|Overall Study|Non-compliance|4|||
150199498|NCT03640286|541871571|FG001|Overall Study|Non-compliance|10|||
150199499|NCT03640286|541871570|FG000|Overall Study|Medication change|1|||
150199500|NCT03640286|541871571|FG001|Overall Study|Medication change|0|||
150199501|NCT03640286|541871570|FG000|Overall Study|Other|1|||
150199502|NCT03640286|541871571|FG001|Overall Study|Other|2|||
150199503|NCT03640286|541871570|FG000|Overall Study|Joined another lifestyle program|0|||
150199504|NCT03640286|541871571|FG001|Overall Study|Joined another lifestyle program|1|||
150199505|NCT03181516|541871572|FG000|Overall Study|Withdrawal by Subject|14|||
150199506|NCT03181516|541871573|FG001|Overall Study|Withdrawal by Subject|7|||
150199507|NCT03181516|541871572|FG000|Overall Study|Lost to Follow-up|2|||
150199508|NCT03181516|541871573|FG001|Overall Study|Lost to Follow-up|2|||
150199509|NCT03485729|541871574|FG000|Overall Study|Withdrawal by Subject|0|||
150199510|NCT03485729|541871575|FG001|Overall Study|Withdrawal by Subject|0|||
150199511|NCT03485729|541871576|FG002|Overall Study|Withdrawal by Subject|1|||
150199512|NCT03485729|541871574|FG000|Overall Study|Disease progression|8|||
150199513|NCT03485729|541871575|FG001|Overall Study|Disease progression|13|||
150199514|NCT03485729|541871576|FG002|Overall Study|Disease progression|1|||
150199515|NCT03485729|541871574|FG000|Overall Study|Hospice care|1|||
150199516|NCT03485729|541871575|FG001|Overall Study|Hospice care|0|||
150135833|NCT02612311|541629816|FG003|Overall Study|Site Terminated by Sponsor|5|||
150135834|NCT02612311|541629813|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
150135835|NCT02612311|541629814|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
150135836|NCT02612311|541629815|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
150135837|NCT02612311|541629816|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
150135838|NCT02612311|541629813|FG000|Overall Study|Reason Not Specified|3|||
150135839|NCT02612311|541629814|FG001|Overall Study|Reason Not Specified|7|||
150135840|NCT02612311|541629815|FG002|Overall Study|Reason Not Specified|4|||
150135841|NCT02612311|541629816|FG003|Overall Study|Reason Not Specified|5|||
150135842|NCT02612311|541629813|FG000|Overall Study|Unknown/Missing|10|||
150135843|NCT02612311|541629814|FG001|Overall Study|Unknown/Missing|13|||
150135844|NCT02612311|541629815|FG002|Overall Study|Unknown/Missing|4|||
150135845|NCT02612311|541629816|FG003|Overall Study|Unknown/Missing|0|||
150135846|NCT02612311|541629813|FG000|Overall Study|Non-Compliance with Study|1|||
150135847|NCT02612311|541629814|FG001|Overall Study|Non-Compliance with Study|0|||
150135848|NCT02612311|541629815|FG002|Overall Study|Non-Compliance with Study|0|||
150135849|NCT02612311|541629816|FG003|Overall Study|Non-Compliance with Study|0|||
150135850|NCT01596582|541629817|FG000|Overall Study|Deemed ineligible after study visit|3|||
150135851|NCT01596582|541629818|FG001|Overall Study|Deemed ineligible after study visit|6|||
150135852|NCT01596582|541629817|FG000|Overall Study|Missing all outcome data|1|||
150135853|NCT01596582|541629818|FG001|Overall Study|Missing all outcome data|1|||
150135854|NCT01428076|541629819|FG000|Overall Study|Adverse Event|0|||
150135855|NCT01428076|541629820|FG001|Overall Study|Adverse Event|1|||
150135856|NCT00862134|541629824|FG000|Overall Study|Death|1|||
150135857|NCT00862134|541629825|FG001|Overall Study|Death|0|||
150135858|NCT00862134|541629824|FG000|Overall Study|Physician Decision|0|||
150135859|NCT00862134|541629825|FG001|Overall Study|Physician Decision|1|||
150135860|NCT00862134|541629824|FG000|Overall Study|Withdrawal by Subject|1|||
150135861|NCT00862134|541629825|FG001|Overall Study|Withdrawal by Subject|2|||
150135862|NCT00862134|541629824|FG000|Overall Study|Sponsor terminated study|5|||
150135863|NCT00862134|541629825|FG001|Overall Study|Sponsor terminated study|7|||
150135864|NCT00862134|541629824|FG000|Overall Study|Adverse Event|2|||
150135865|NCT00862134|541629825|FG001|Overall Study|Adverse Event|2|||
150135866|NCT00862134|541629824|FG000|Overall Study|Withdrew prior to dosing|2|||
150135867|NCT00862134|541629825|FG001|Overall Study|Withdrew prior to dosing|0|||
150135868|NCT04510675|541629828|FG000|Overall Study|Withdrawal by Subject|5|||
150135869|NCT01494584|541629831|FG000|Overall Study|Study Closed/Terminated|1|||
150135870|NCT00058123|541629835|FG000|Overall Study|Wrong histology|9|||
150135871|NCT00058123|541629835|FG000|Overall Study|Received >3 prior treatments|1|||
150135872|NCT01298999|541629841|FG000|Overall Study|Physician Decision|0|||
150135873|NCT01298999|541629842|FG001|Overall Study|Physician Decision|1|||
150135874|NCT01298999|541629841|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
150135875|NCT01298999|541629842|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
150135876|NCT02151266|541629843|FG000|Overall Study|Lost to Follow-up|1|||
150135877|NCT02151266|541629844|FG001|Overall Study|Lost to Follow-up|4|||
150135878|NCT02151266|541629845|FG002|Overall Study|Lost to Follow-up|1|||
150135879|NCT02151266|541629843|FG000|Overall Study|Did NOT receive intervention|3|||
150135880|NCT02151266|541629844|FG001|Overall Study|Did NOT receive intervention|6|||
150135881|NCT02151266|541629845|FG002|Overall Study|Did NOT receive intervention|2|||
150135882|NCT02151266|541629843|FG000|Overall Study|Not able to exercise|4|||
150135883|NCT02151266|541629844|FG001|Overall Study|Not able to exercise|5|||
150135884|NCT02151266|541629845|FG002|Overall Study|Not able to exercise|4|||
150135885|NCT04839965|541629847|FG000|Overall Study|Death|6|||
150135886|NCT04839965|541629848|FG001|Overall Study|Death|6|||
150135887|NCT04839965|541629847|FG000|Overall Study|Lost to Follow-up|1|||
150135888|NCT04839965|541629848|FG001|Overall Study|Lost to Follow-up|0|||
150135889|NCT02170025|541629849|FG000|Overall Study|Adverse Event|2|||
150135890|NCT02170025|541629850|FG001|Overall Study|Adverse Event|0|||
150135891|NCT01337674|541631582|FG000|Treatment Period 1|Adverse Event|0|||
150135892|NCT01337674|541631583|FG001|Treatment Period 1|Adverse Event|1|||
150135893|NCT01337674|541631584|FG002|Treatment Period 1|Adverse Event|0|||
150135894|NCT01337674|541631585|FG003|Treatment Period 1|Adverse Event|0|||
150135895|NCT01337674|541631582|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
150135896|NCT01337674|541631583|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
150135897|NCT01337674|541631584|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
150135898|NCT01337674|541631585|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
150135899|NCT01337674|541631582|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150135900|NCT01337674|541631583|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150135901|NCT01337674|541631584|FG002|Treatment Period 2|Withdrawal by Subject|1|||
150135902|NCT01337674|541631585|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150135903|NCT02543658|541631586|FG000|Overall Study|Lack of Efficacy|0|||
150135904|NCT02543658|541631587|FG001|Overall Study|Lack of Efficacy|4|||
150135905|NCT00949884|541631588|FG000|Overall Study|Adverse Event|14|||
150135906|NCT00949884|541631589|FG001|Overall Study|Adverse Event|3|||
150135907|NCT00949884|541631590|FG002|Overall Study|Adverse Event|12|||
150135908|NCT00949884|541631588|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
150135909|NCT00949884|541631589|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
150135910|NCT00949884|541631590|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
150135911|NCT00949884|541631588|FG000|Overall Study|Lost to Follow-up|7|||
150135912|NCT00949884|541631589|FG001|Overall Study|Lost to Follow-up|5|||
150135913|NCT00949884|541631590|FG002|Overall Study|Lost to Follow-up|5|||
150135914|NCT00949884|541631588|FG000|Overall Study|Physician Decision|5|||
150135915|NCT00949884|541631589|FG001|Overall Study|Physician Decision|0|||
150135916|NCT00949884|541631590|FG002|Overall Study|Physician Decision|6|||
150135917|NCT00949884|541631588|FG000|Overall Study|Treatment non-compliance|5|||
150135918|NCT00949884|541631589|FG001|Overall Study|Treatment non-compliance|0|||
150135919|NCT00949884|541631590|FG002|Overall Study|Treatment non-compliance|8|||
150135920|NCT00949884|541631588|FG000|Overall Study|Withdrawal by Subject|13|||
150135921|NCT00949884|541631589|FG001|Overall Study|Withdrawal by Subject|4|||
150135922|NCT00949884|541631590|FG002|Overall Study|Withdrawal by Subject|16|||
150135923|NCT00949884|541631588|FG000|Overall Study|Lack of Efficacy|4|||
150135924|NCT00949884|541631589|FG001|Overall Study|Lack of Efficacy|2|||
150135925|NCT00949884|541631590|FG002|Overall Study|Lack of Efficacy|7|||
150135926|NCT00949884|541631588|FG000|Overall Study|Study terminated by sponsor|0|||
150135927|NCT00949884|541631589|FG001|Overall Study|Study terminated by sponsor|0|||
150135928|NCT00949884|541631590|FG002|Overall Study|Study terminated by sponsor|1|||
150135929|NCT00437645|541631601|FG000|Overall Study|Adverse Event|15|||
150135930|NCT00437645|541631602|FG001|Overall Study|Adverse Event|84|||
150135931|NCT00437645|541631601|FG000|Overall Study|Withdrawal by Subject|10|||
150135932|NCT00437645|541631602|FG001|Overall Study|Withdrawal by Subject|22|||
150135933|NCT00437645|541631601|FG000|Overall Study|Protocol Violation|3|||
150135934|NCT00437645|541631602|FG001|Overall Study|Protocol Violation|3|||
150135935|NCT00437645|541631601|FG000|Overall Study|Lost to Follow-up|2|||
150135936|NCT00437645|541631602|FG001|Overall Study|Lost to Follow-up|3|||
150135937|NCT00437645|541631601|FG000|Overall Study|Administrative problems|2|||
150135938|NCT00437645|541631602|FG001|Overall Study|Administrative problems|1|||
150135939|NCT00437645|541631601|FG000|Overall Study|Lack of Efficacy|2|||
150135940|NCT00437645|541631602|FG001|Overall Study|Lack of Efficacy|1|||
150135941|NCT00437645|541631601|FG000|Overall Study|Condition no longer requires study drug|1|||
150135942|NCT00437645|541631602|FG001|Overall Study|Condition no longer requires study drug|1|||
150135943|NCT00662857|541631603|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
150135944|NCT00662857|541631604|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
150135945|NCT00662857|541631603|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
150135946|NCT00662857|541631604|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
150135947|NCT00662857|541631603|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
150135948|NCT00662857|541631604|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
150135949|NCT03966053|541631605|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
150135950|NCT00989092|541631606|FG000|Overall Study|Physician Decision|9|||
150135951|NCT00989092|541631607|FG001|Overall Study|Physician Decision|6|||
150135952|NCT00989092|541631606|FG000|Overall Study|Adverse Event|20|||
150135953|NCT00989092|541631607|FG001|Overall Study|Adverse Event|1|||
150135954|NCT00989092|541631606|FG000|Overall Study|Chemotherapy initiated|12|||
150135955|NCT00989092|541631607|FG001|Overall Study|Chemotherapy initiated|4|||
150135956|NCT00989092|541631606|FG000|Overall Study|Withdrawal by Subject|17|||
150135957|NCT00989092|541631607|FG001|Overall Study|Withdrawal by Subject|9|||
150135958|NCT00989092|541631606|FG000|Overall Study|Death|14|||
150135959|NCT00989092|541631607|FG001|Overall Study|Death|2|||
150135960|NCT00989092|541631606|FG000|Overall Study|Ineligibility determined|3|||
150135961|NCT00989092|541631607|FG001|Overall Study|Ineligibility determined|3|||
150135962|NCT00989092|541631606|FG000|Overall Study|Lost to Follow-up|6|||
150135963|NCT00989092|541631607|FG001|Overall Study|Lost to Follow-up|2|||
150135964|NCT00989092|541631606|FG000|Overall Study|Other|3|||
150135965|NCT00989092|541631607|FG001|Overall Study|Other|1|||
150135966|NCT00989092|541631606|FG000|Overall Study|Protocol deviation|2|||
150135967|NCT00989092|541631607|FG001|Overall Study|Protocol deviation|0|||
150135968|NCT00989092|541631606|FG000|Overall Study|Erythropoietin therapy initiated|2|||
150135969|NCT00989092|541631607|FG001|Overall Study|Erythropoietin therapy initiated|0|||
150135970|NCT00989092|541631606|FG000|Overall Study|Did not receive study drug|2|||
150135971|NCT00989092|541631607|FG001|Overall Study|Did not receive study drug|0|||
150135972|NCT02832622|541631609|FG000|Overall Study|MPP not programmed|1259|||
150135973|NCT02832622|541631609|FG000|Overall Study|Withdrawal by Subject|123|||
150135974|NCT02832622|541631609|FG000|Overall Study|Death|119|||
150199517|NCT03485729|541871576|FG002|Overall Study|Hospice care|0|||
150199518|NCT03485729|541871574|FG000|Overall Study|Poor performance status|1|||
150199519|NCT03485729|541871575|FG001|Overall Study|Poor performance status|0|||
150199520|NCT03485729|541871576|FG002|Overall Study|Poor performance status|0|||
150199521|NCT03485729|541871574|FG000|Overall Study|Illness|0|||
150199522|NCT03485729|541871575|FG001|Overall Study|Illness|1|||
150199523|NCT03485729|541871576|FG002|Overall Study|Illness|0|||
150199524|NCT02988661|541871577|FG000|Overall Study|Death|2|||
150199525|NCT02988661|541871578|FG001|Overall Study|Death|18|||
150199526|NCT02988661|541871577|FG000|Overall Study|Lost to Follow-up|0|||
150199527|NCT02988661|541871578|FG001|Overall Study|Lost to Follow-up|33|||
150199528|NCT02988661|541871577|FG000|Overall Study|Withdrawal by Subject|0|||
150199529|NCT02988661|541871578|FG001|Overall Study|Withdrawal by Subject|6|||
150199530|NCT02988661|541871577|FG000|Overall Study|Unable to complete the 18-month survey|1|||
150199531|NCT02988661|541871578|FG001|Overall Study|Unable to complete the 18-month survey|27|||
150199532|NCT02839265|541871579|FG000|Overall Study|Screen Failure|2|||
150199533|NCT02839265|541871579|FG000|Overall Study|Death|1|||
150199534|NCT02839265|541871579|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
150199535|NCT04934072|541871580|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
150199536|NCT04934072|541871581|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
150199537|NCT04934072|541871582|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
150199538|NCT04934072|541871583|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
150199539|NCT04934072|541871584|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
150199540|NCT04934072|541871580|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
150199541|NCT04934072|541871581|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
150199542|NCT04934072|541871582|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
150199543|NCT04934072|541871583|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
150199544|NCT04934072|541871584|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
150199545|NCT04934072|541871580|FG000|Day 0 to Week 52|Other|3|||
150199546|NCT04934072|541871581|FG001|Day 0 to Week 52|Other|1|||
150199547|NCT04934072|541871582|FG002|Day 0 to Week 52|Other|0|||
150199548|NCT04934072|541871583|FG003|Day 0 to Week 52|Other|0|||
150199549|NCT04934072|541871584|FG004|Day 0 to Week 52|Other|0|||
150199550|NCT04934072|541871580|FG000|Day 0 to Week 52|Adverse Event|1|||
150199551|NCT04934072|541871581|FG001|Day 0 to Week 52|Adverse Event|3|||
150199552|NCT04934072|541871582|FG002|Day 0 to Week 52|Adverse Event|0|||
150199553|NCT04934072|541871583|FG003|Day 0 to Week 52|Adverse Event|0|||
150199554|NCT04934072|541871584|FG004|Day 0 to Week 52|Adverse Event|0|||
150199555|NCT04934072|541871580|FG000|Week 52 to Week 78|Adverse Event|0|||
150199556|NCT04934072|541871581|FG001|Week 52 to Week 78|Adverse Event|0|||
150199557|NCT04934072|541871582|FG002|Week 52 to Week 78|Adverse Event|0|||
150199558|NCT04934072|541871583|FG003|Week 52 to Week 78|Adverse Event|1|||
150199559|NCT04934072|541871584|FG004|Week 52 to Week 78|Adverse Event|1|||
150199560|NCT04934072|541871580|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
150199561|NCT04934072|541871581|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
150199562|NCT04934072|541871582|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
150199563|NCT04934072|541871583|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
150199564|NCT04934072|541871584|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
150199565|NCT04934072|541871580|FG000|Week 52 to Week 78|Other|0|||
150199566|NCT04934072|541871581|FG001|Week 52 to Week 78|Other|0|||
150199567|NCT04934072|541871582|FG002|Week 52 to Week 78|Other|1|||
150199568|NCT04934072|541871583|FG003|Week 52 to Week 78|Other|0|||
150199569|NCT04934072|541871584|FG004|Week 52 to Week 78|Other|0|||
150199570|NCT04456296|541871592|FG000|Overall Study|Withdrawal by Subject|14|||
150199571|NCT04456296|541871593|FG001|Overall Study|Withdrawal by Subject|21|||
150199572|NCT04456296|541871594|FG002|Overall Study|Withdrawal by Subject|21|||
150199573|NCT04456296|541871592|FG000|Overall Study|Adverse Event|2|||
150199574|NCT04456296|541871593|FG001|Overall Study|Adverse Event|2|||
150199575|NCT04456296|541871594|FG002|Overall Study|Adverse Event|2|||
150199576|NCT04456296|541871592|FG000|Overall Study|Death|1|||
150199577|NCT04456296|541871593|FG001|Overall Study|Death|0|||
150199578|NCT04456296|541871594|FG002|Overall Study|Death|0|||
150199579|NCT04456296|541871592|FG000|Overall Study|Lost to Follow-up|3|||
150199580|NCT04456296|541871593|FG001|Overall Study|Lost to Follow-up|5|||
150199581|NCT04456296|541871594|FG002|Overall Study|Lost to Follow-up|6|||
150199582|NCT04456296|541871592|FG000|Overall Study|Other than specified|0|||
150199583|NCT04456296|541871593|FG001|Overall Study|Other than specified|1|||
150199584|NCT04456296|541871594|FG002|Overall Study|Other than specified|4|||
150199585|NCT04456296|541871592|FG000|Overall Study|Randomized, not treated|2|||
150199586|NCT04456296|541871593|FG001|Overall Study|Randomized, not treated|1|||
150199587|NCT04456296|541871594|FG002|Overall Study|Randomized, not treated|0|||
150199588|NCT05900154|541871595|FG000|Follow-Up Period|Lost to Follow-up|1|||
150199589|NCT05900154|541871596|FG001|Follow-Up Period|Lost to Follow-up|2|||
150199590|NCT05900154|541871597|FG002|Follow-Up Period|Lost to Follow-up|1|||
150199591|NCT05900154|541871598|FG003|Follow-Up Period|Lost to Follow-up|0|||
150199592|NCT05900154|541871599|FG004|Follow-Up Period|Lost to Follow-up|1|||
150135975|NCT02832622|541631609|FG000|Overall Study|Unsuccessful CRT implant|93|||
150135976|NCT02832622|541631609|FG000|Overall Study|Lost to Follow-up|45|||
150135977|NCT02832622|541631609|FG000|Overall Study|Patient non-compliance|42|||
150135978|NCT02832622|541631609|FG000|Overall Study|Withdrawal by other reasons|25|||
150135979|NCT02832622|541631609|FG000|Overall Study|System explant|24|||
150135980|NCT02832622|541631609|FG000|Overall Study|Physician Decision|6|||
150135981|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
150135982|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
150135983|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
150135984|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
150135985|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
150135986|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
150135987|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Death|1|||
150135988|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Death|0|||
150135989|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Adverse Event|1|||
150135990|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Adverse Event|0|||
150135991|NCT02586025|541631612|FG000|Neoadjuvant Treatment|Physician Decision|2|||
150135992|NCT02586025|541631613|FG001|Neoadjuvant Treatment|Physician Decision|1|||
150135993|NCT02586025|541631612|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
150135994|NCT02586025|541631613|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
150135995|NCT02586025|541631612|FG000|Adjuvant Treatment|Recurrent Disease|4|||
150135996|NCT02586025|541631613|FG001|Adjuvant Treatment|Recurrent Disease|5|||
150135997|NCT02586025|541631612|FG000|Adjuvant Treatment|Physician Decision|0|||
150135998|NCT02586025|541631613|FG001|Adjuvant Treatment|Physician Decision|1|||
150135999|NCT02586025|541631612|FG000|Adjuvant Treatment|Pregnancy|1|||
150136000|NCT02586025|541631613|FG001|Adjuvant Treatment|Pregnancy|0|||
150136001|NCT02586025|541631612|FG000|Treatment-Free Follow-Up|Death|11|||
150136002|NCT02586025|541631613|FG001|Treatment-Free Follow-Up|Death|11|||
150136003|NCT02586025|541631612|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
150136004|NCT02586025|541631613|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
150136005|NCT02586025|541631612|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
150136006|NCT02586025|541631613|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
150136007|NCT02586025|541631612|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
150136008|NCT02586025|541631613|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
150136009|NCT02586025|541631612|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
150136010|NCT02586025|541631613|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
150136011|NCT04586569|541631618|FG000|Overall Study|Withdrawal by Subject|0|||
150136012|NCT04586569|541631619|FG001|Overall Study|Withdrawal by Subject|2|||
150136013|NCT04586569|541631618|FG000|Overall Study|No longer eligible|2|||
150136014|NCT04586569|541631619|FG001|Overall Study|No longer eligible|3|||
150136015|NCT04586569|541631618|FG000|Overall Study|Physician Decision|1|||
150136016|NCT04586569|541631619|FG001|Overall Study|Physician Decision|0|||
150136017|NCT00998400|541631620|FG000|Overall Study|Lack of interest/motivation|1|||
150136018|NCT00998400|541631621|FG001|Overall Study|Lack of interest/motivation|2|||
150136019|NCT00998400|541631620|FG000|Overall Study|Logistical problems|1|||
150136020|NCT00998400|541631621|FG001|Overall Study|Logistical problems|0|||
150136021|NCT03704584|541631622|FG000|Overall Study|Withdrawal by Subject|1|||
150136022|NCT03704584|541631623|FG001|Overall Study|Withdrawal by Subject|0|||
150136023|NCT03185832|541631624|FG000|Overall Study|Death|9|||
150136024|NCT03185832|541631625|FG001|Overall Study|Death|14|||
150136025|NCT03185832|541631626|FG002|Overall Study|Death|9|||
150136026|NCT03185832|541631627|FG003|Overall Study|Death|7|||
150136027|NCT03185832|541631624|FG000|Overall Study|Withdrawn - vital status available|0|||
150136028|NCT03185832|541631625|FG001|Overall Study|Withdrawn - vital status available|1|||
150136029|NCT03185832|541631626|FG002|Overall Study|Withdrawn - vital status available|1|||
150136030|NCT03185832|541631627|FG003|Overall Study|Withdrawn - vital status available|4|||
150136031|NCT02127372|541631629|FG000|Overall Study|Withdrawal by Subject|1|||
150136032|NCT02127372|541631630|FG001|Overall Study|Withdrawal by Subject|0|||
150136033|NCT02173548|541631631|FG000|Overall Study|Lost to Follow-up|0|||
150136034|NCT02173548|541631632|FG001|Overall Study|Lost to Follow-up|2|||
150136035|NCT02173548|541631631|FG000|Overall Study|Withdrawal by Subject|1|||
150136036|NCT02173548|541631632|FG001|Overall Study|Withdrawal by Subject|0|||
150136037|NCT03597568|541631633|FG000|Overall Study|Withdrawal by Subject|1|||
150136038|NCT03597568|541631634|FG001|Overall Study|Withdrawal by Subject|1|||
150136039|NCT03597568|541631633|FG000|Overall Study|Unable to analyze vascular data|1|||
150136040|NCT03597568|541631634|FG001|Overall Study|Unable to analyze vascular data|1|||
150136041|NCT03548207|541631639|FG000|Overall Study|Death|10|||
150136042|NCT03548207|541631640|FG001|Overall Study|Death|23|||
150136043|NCT03548207|541631641|FG002|Overall Study|Death|3|||
150136044|NCT03548207|541631639|FG000|Overall Study|Lost to Follow-up|0|||
150136045|NCT03548207|541631640|FG001|Overall Study|Lost to Follow-up|2|||
150136046|NCT03548207|541631641|FG002|Overall Study|Lost to Follow-up|0|||
150136047|NCT03548207|541631639|FG000|Overall Study|Withdrawal by Subject|0|||
150136048|NCT03548207|541631640|FG001|Overall Study|Withdrawal by Subject|3|||
150136049|NCT03548207|541631641|FG002|Overall Study|Withdrawal by Subject|0|||
150136050|NCT03548207|541631639|FG000|Overall Study|Sponsor decision|19|||
150136051|NCT03548207|541631640|FG001|Overall Study|Sponsor decision|40|||
150136052|NCT03548207|541631641|FG002|Overall Study|Sponsor decision|6|||
150136053|NCT03548207|541631639|FG000|Overall Study|Randomized but not treated|6|||
150136054|NCT03548207|541631640|FG001|Overall Study|Randomized but not treated|10|||
150136055|NCT03548207|541631641|FG002|Overall Study|Randomized but not treated|4|||
150136056|NCT01756352|541631642|FG000|Overall Study|moved away and lost to followup|1|||
150136057|NCT03822117|541631643|FG000|Overall Study|Death|18|||
150136058|NCT03822117|541631644|FG001|Overall Study|Death|17|||
150136059|NCT03822117|541631645|FG002|Overall Study|Death|12|||
150136060|NCT03822117|541631646|FG003|Overall Study|Death|4|||
150136061|NCT03822117|541631643|FG000|Overall Study|Lost to Follow-up|1|||
150136062|NCT03822117|541631644|FG001|Overall Study|Lost to Follow-up|2|||
150136063|NCT03822117|541631645|FG002|Overall Study|Lost to Follow-up|3|||
150136064|NCT03822117|541631646|FG003|Overall Study|Lost to Follow-up|0|||
150136065|NCT03822117|541631643|FG000|Overall Study|Study Terminated by Sponsor|25|||
150136066|NCT03822117|541631644|FG001|Overall Study|Study Terminated by Sponsor|11|||
150136067|NCT03822117|541631645|FG002|Overall Study|Study Terminated by Sponsor|6|||
150136068|NCT03822117|541631646|FG003|Overall Study|Study Terminated by Sponsor|0|||
150136069|NCT03822117|541631643|FG000|Overall Study|Withdrawal by Subject|4|||
150136070|NCT03822117|541631644|FG001|Overall Study|Withdrawal by Subject|0|||
150136071|NCT03822117|541631645|FG002|Overall Study|Withdrawal by Subject|3|||
150136072|NCT03822117|541631646|FG003|Overall Study|Withdrawal by Subject|0|||
150136073|NCT03822117|541631643|FG000|Overall Study|Disease Progression|1|||
150136074|NCT03822117|541631644|FG001|Overall Study|Disease Progression|2|||
150136075|NCT03822117|541631645|FG002|Overall Study|Disease Progression|1|||
150136076|NCT03822117|541631646|FG003|Overall Study|Disease Progression|0|||
150136077|NCT03822117|541631643|FG000|Overall Study|Never Returned to Hospital|0|||
150136078|NCT03822117|541631644|FG001|Overall Study|Never Returned to Hospital|0|||
150136079|NCT03822117|541631645|FG002|Overall Study|Never Returned to Hospital|1|||
150136080|NCT03822117|541631646|FG003|Overall Study|Never Returned to Hospital|0|||
150136081|NCT00415610|541631647|FG000|Overall Study|Death|3|||
150136082|NCT00415610|541631648|FG001|Overall Study|Death|2|||
150136083|NCT00415610|541631649|FG002|Overall Study|Death|5|||
150136084|NCT00999466|541631651|FG000|Main Part|Withdrawal by Subject|0|||
150136085|NCT00999466|541631652|FG001|Main Part|Withdrawal by Subject|0|||
150136086|NCT00999466|541631653|FG002|Main Part|Withdrawal by Subject|2|||
150136087|NCT00999466|541631651|FG000|Main Part|Adverse Event|0|||
150136088|NCT00999466|541631652|FG001|Main Part|Adverse Event|4|||
150136089|NCT00999466|541631653|FG002|Main Part|Adverse Event|2|||
150136090|NCT01357616|541631654|FG000|Overall Study|Adverse Event|1|||
150136091|NCT01357616|541631655|FG001|Overall Study|Adverse Event|1|||
150136092|NCT01357616|541631654|FG000|Overall Study|Lost to Follow-up|4|||
150136093|NCT01357616|541631655|FG001|Overall Study|Lost to Follow-up|3|||
150136094|NCT01357616|541631654|FG000|Overall Study|Protocol Violation|0|||
150136095|NCT01357616|541631655|FG001|Overall Study|Protocol Violation|2|||
150136096|NCT01357616|541631654|FG000|Overall Study|Inadequate Control of IOP|1|||
150136097|NCT01357616|541631655|FG001|Overall Study|Inadequate Control of IOP|2|||
150136098|NCT01357616|541631654|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
150136099|NCT01357616|541631655|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
150136100|NCT01357616|541631654|FG000|Overall Study|Withdrawal by Subject|1|||
150136101|NCT01357616|541631655|FG001|Overall Study|Withdrawal by Subject|0|||
150136102|NCT03255824|541631657|FG000|Overall Study|Under-sedation|2|||
150136103|NCT03255824|541631658|FG001|Overall Study|Under-sedation|1|||
150136104|NCT03432364|541631661|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
150136105|NCT00337272|541631662|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
150136106|NCT00337272|541631663|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
150136107|NCT00337272|541631662|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
150136108|NCT00337272|541631663|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
150136109|NCT00337272|541631662|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
150136110|NCT00337272|541631663|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
150136111|NCT00337272|541631662|FG000|Treatment Period|Non-compliance|1|||
150136112|NCT00337272|541631663|FG001|Treatment Period|Non-compliance|1|||
150136113|NCT00337272|541631662|FG000|Treatment Period|Withdrawal by Subject|0|||
150136114|NCT00337272|541631663|FG001|Treatment Period|Withdrawal by Subject|1|||
150136115|NCT00337272|541631662|FG000|Withdrawal Period|Non-compliance|0|||
150136116|NCT00337272|541631663|FG001|Withdrawal Period|Non-compliance|1|||
150136117|NCT04539821|541631667|FG000|Overall Study|Withdrawal by Subject|2|||
150136118|NCT04539821|541631667|FG000|Overall Study|continued care with their physician|20|||
150136119|NCT04539821|541631667|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
150136120|NCT01127646|541631670|FG000|Overall Study|Entry Criteria Not Met|1|||
150136121|NCT01127646|541631671|FG001|Overall Study|Entry Criteria Not Met|0|||
150136122|NCT01127646|541631670|FG000|Overall Study|Protocol Violation|0|||
150136123|NCT01127646|541631671|FG001|Overall Study|Protocol Violation|1|||
150136124|NCT03466086|541631672|FG000|Period 1|Sponsor decision due to study timeline|1|||
150136125|NCT03466086|541631673|FG001|Period 1|Sponsor decision due to study timeline|0|||
150136126|NCT03466086|541631672|FG000|Period 1|Withdrawal by Subject|1|||
150136127|NCT03466086|541631673|FG001|Period 1|Withdrawal by Subject|0|||
150136128|NCT01754467|541631674|FG000|Overall Study|Lost to Follow-up|1|||
150136129|NCT01970462|541631675|FG000|Overall Study|Lost to Follow-up|0|||
150136130|NCT01970462|541631676|FG001|Overall Study|Lost to Follow-up|2|||
150136131|NCT00162370|541631677|FG000|Efficacy Population|Lost to Follow-up|51|||
150136132|NCT01499082|541631680|FG000|Overall Study|Randomized but not Treated|0|||
150136133|NCT01499082|541631681|FG001|Overall Study|Randomized but not Treated|1|||
150136134|NCT01499082|541631680|FG000|Overall Study|Adverse Event|12|||
150136135|NCT01499082|541631681|FG001|Overall Study|Adverse Event|16|||
150136136|NCT01499082|541631680|FG000|Overall Study|Lack of Efficacy|1|||
150136137|NCT01499082|541631681|FG001|Overall Study|Lack of Efficacy|1|||
150136138|NCT01499082|541631680|FG000|Overall Study|Protocol Violation|6|||
150136139|NCT01499082|541631681|FG001|Overall Study|Protocol Violation|8|||
150136140|NCT01499082|541631680|FG000|Overall Study|Diverse Reasons|18|||
150136141|NCT01499082|541631681|FG001|Overall Study|Diverse Reasons|14|||
150136142|NCT01499082|541631680|FG000|Overall Study|Site Closure for Noncompliance|5|||
150136143|NCT01499082|541631681|FG001|Overall Study|Site Closure for Noncompliance|2|||
150136144|NCT01499082|541631680|FG000|Overall Study|Hypoglycemia|2|||
150136145|NCT01499082|541631681|FG001|Overall Study|Hypoglycemia|3|||
150136146|NCT01499082|541631680|FG000|Overall Study|Lost to Follow-up|1|||
150136147|NCT01499082|541631681|FG001|Overall Study|Lost to Follow-up|3|||
150136148|NCT05380947|541631683|FG000|Washout Period 1|Not attend visit|1|||
150136149|NCT05380947|541631684|FG001|Washout Period 1|Not attend visit|0|||
150136150|NCT05380947|541631685|FG002|Washout Period 1|Not attend visit|0|||
150136151|NCT05380947|541631686|FG003|Washout Period 1|Not attend visit|0|||
150136152|NCT05380947|541631683|FG000|Washout Period 2|Adverse Event|1|||
150136153|NCT05380947|541631684|FG001|Washout Period 2|Adverse Event|0|||
150136154|NCT05380947|541631685|FG002|Washout Period 2|Adverse Event|0|||
150136155|NCT05380947|541631686|FG003|Washout Period 2|Adverse Event|0|||
150136156|NCT05380947|541631683|FG000|Washout Period 3|Adverse Event|0|||
150136157|NCT05380947|541631684|FG001|Washout Period 3|Adverse Event|1|||
150136158|NCT05380947|541631685|FG002|Washout Period 3|Adverse Event|0|||
150136159|NCT05380947|541631686|FG003|Washout Period 3|Adverse Event|0|||
150136160|NCT05380947|541631683|FG000|Washout Period 3|Not attend visit|0|||
150136161|NCT05380947|541631684|FG001|Washout Period 3|Not attend visit|1|||
150136162|NCT05380947|541631685|FG002|Washout Period 3|Not attend visit|0|||
150136163|NCT05380947|541631686|FG003|Washout Period 3|Not attend visit|1|||
150136164|NCT01563536|541631687|FG000|Overall Study|Withdrawal by Subject|0|||
150136165|NCT01563536|541631688|FG001|Overall Study|Withdrawal by Subject|2|||
150136166|NCT01563536|541631687|FG000|Overall Study|Lost to Follow-up|1|||
150136167|NCT01563536|541631688|FG001|Overall Study|Lost to Follow-up|0|||
150136168|NCT00538590|541631692|FG000|Overall Study|Death|1|||
150136169|NCT00538590|541631693|FG001|Overall Study|Death|0|||
150136170|NCT01169675|541631701|FG000|Overall Study|Progressive disease|13|||
150136171|NCT01169675|541631702|FG001|Overall Study|Progressive disease|2|||
150136172|NCT01169675|541631703|FG002|Overall Study|Progressive disease|5|||
150136173|NCT01169675|541631704|FG003|Overall Study|Progressive disease|15|||
150136174|NCT01169675|541631705|FG004|Overall Study|Progressive disease|1|||
150136175|NCT01169675|541631701|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
150136176|NCT01169675|541631702|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150136177|NCT01169675|541631703|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150136178|NCT01169675|541631704|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150136179|NCT01169675|541631705|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
150136180|NCT01169675|541631701|FG000|Overall Study|Adverse Event|5|||
150136181|NCT01169675|541631702|FG001|Overall Study|Adverse Event|1|||
150136182|NCT01169675|541631703|FG002|Overall Study|Adverse Event|2|||
150136183|NCT01169675|541631704|FG003|Overall Study|Adverse Event|0|||
150136184|NCT01169675|541631705|FG004|Overall Study|Adverse Event|0|||
150136185|NCT01169675|541631701|FG000|Overall Study|Withdrawal by Subject|1|||
150199593|NCT05900154|541871600|FG005|Follow-Up Period|Lost to Follow-up|1|||
150136186|NCT01169675|541631702|FG001|Overall Study|Withdrawal by Subject|0|||
150136187|NCT01169675|541631703|FG002|Overall Study|Withdrawal by Subject|0|||
150136188|NCT01169675|541631704|FG003|Overall Study|Withdrawal by Subject|1|||
150136189|NCT01169675|541631705|FG004|Overall Study|Withdrawal by Subject|2|||
150136190|NCT01169675|541631701|FG000|Overall Study|Other Reason Not Defined Above|0|||
150136191|NCT01169675|541631702|FG001|Overall Study|Other Reason Not Defined Above|0|||
150136192|NCT01169675|541631703|FG002|Overall Study|Other Reason Not Defined Above|0|||
150136193|NCT01169675|541631704|FG003|Overall Study|Other Reason Not Defined Above|1|||
150136194|NCT01169675|541631705|FG004|Overall Study|Other Reason Not Defined Above|1|||
150199594|NCT02641730|541871603|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
150199595|NCT02641730|541871604|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150199596|NCT02641730|541871605|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
150199597|NCT02641730|541871606|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
150199598|NCT02641730|541871607|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
150199599|NCT02641730|541871603|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
150199600|NCT02641730|541871604|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
150199601|NCT02641730|541871605|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
150199602|NCT02641730|541871606|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
150199603|NCT02641730|541871607|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
150199604|NCT02641730|541871603|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
150199605|NCT02641730|541871604|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
150199606|NCT02641730|541871605|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
150199607|NCT02641730|541871606|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
150199608|NCT02641730|541871607|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
150199609|NCT02641730|541871603|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150199610|NCT02641730|541871604|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150199611|NCT02641730|541871605|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
150199612|NCT02641730|541871606|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
150199613|NCT02641730|541871607|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
150199614|NCT02641730|541871603|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
150199615|NCT02641730|541871604|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
150199616|NCT02641730|541871605|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
150199617|NCT02641730|541871606|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
150199618|NCT02641730|541871607|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
150199619|NCT02641730|541871603|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
150199620|NCT02641730|541871604|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
150199621|NCT02641730|541871605|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
150199622|NCT02641730|541871606|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
150199623|NCT02641730|541871607|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
150199624|NCT05460871|541871608|FG000|Overall Study|Withdrawal by Subject|1|||
150199625|NCT05460871|541871609|FG001|Overall Study|Withdrawal by Subject|2|||
150199626|NCT04271046|541871610|FG000|Overall Study|Death|0|||
150199627|NCT04271046|541871611|FG001|Overall Study|Death|2|||
150199628|NCT04271046|541871612|FG002|Overall Study|Death|0|||
150199629|NCT04271046|541871613|FG003|Overall Study|Death|2|||
150199630|NCT04271046|541871610|FG000|Overall Study|Lost to Follow-up|12|||
150199631|NCT04271046|541871611|FG001|Overall Study|Lost to Follow-up|12|||
150199632|NCT04271046|541871612|FG002|Overall Study|Lost to Follow-up|11|||
150199633|NCT04271046|541871613|FG003|Overall Study|Lost to Follow-up|11|||
150199634|NCT04271046|541871610|FG000|Overall Study|Patient with Dementia Died|2|||
150199635|NCT04271046|541871611|FG001|Overall Study|Patient with Dementia Died|0|||
150199636|NCT04271046|541871612|FG002|Overall Study|Patient with Dementia Died|2|||
150199637|NCT04271046|541871613|FG003|Overall Study|Patient with Dementia Died|0|||
150199638|NCT04271046|541871610|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
150199639|NCT04271046|541871611|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
150199640|NCT04271046|541871612|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
150199641|NCT04271046|541871613|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
150136195|NCT02816138|541631708|FG000|Overall Study|Adverse Event|1|||
150136196|NCT02355028|541631709|FG000|Overall Study|Adverse Event|2|||
150136197|NCT02355028|541631710|FG001|Overall Study|Adverse Event|0|||
150136198|NCT02355028|541631709|FG000|Overall Study|Withdrawal by Subject|1|||
150136199|NCT02355028|541631710|FG001|Overall Study|Withdrawal by Subject|1|||
150136200|NCT02355028|541631709|FG000|Overall Study|Deemed ineligible after randomization|8|||
150136201|NCT02355028|541631710|FG001|Overall Study|Deemed ineligible after randomization|4|||
150136202|NCT02276222|541631711|FG000|Overall Study|Adverse Event|62|||
150136203|NCT02276222|541631712|FG001|Overall Study|Adverse Event|11|||
150136204|NCT02276222|541631711|FG000|Overall Study|Death|3|||
150136205|NCT02276222|541631712|FG001|Overall Study|Death|4|||
150136206|NCT02276222|541631711|FG000|Overall Study|Lack of Efficacy|13|||
150136207|NCT02276222|541631712|FG001|Overall Study|Lack of Efficacy|3|||
150136208|NCT02276222|541631711|FG000|Overall Study|Protocol Violation|3|||
150136209|NCT02276222|541631712|FG001|Overall Study|Protocol Violation|2|||
150136210|NCT02276222|541631711|FG000|Overall Study|Withdrawal by Subject|79|||
150136211|NCT02276222|541631712|FG001|Overall Study|Withdrawal by Subject|33|||
150199642|NCT05158504|541871616|FG000|Overall Study|Lost to Follow-up|2|||
150136212|NCT02276222|541631711|FG000|Overall Study|non compliance with study medication|6|||
150136213|NCT02276222|541631712|FG001|Overall Study|non compliance with study medication|2|||
150199643|NCT05158504|541871617|FG001|Overall Study|Lost to Follow-up|3|||
150199644|NCT03606512|541871618|FG000|Overall Study|Lost to Follow-up|0|||
150199645|NCT03606512|541871619|FG001|Overall Study|Lost to Follow-up|1|||
150199646|NCT03606512|541871618|FG000|Overall Study|'moved from study area|0|||
150136214|NCT02276222|541631711|FG000|Overall Study|sponsor decision|0|||
150136215|NCT02276222|541631712|FG001|Overall Study|sponsor decision|3|||
150136216|NCT02276222|541631711|FG000|Overall Study|Lost to Follow-up|15|||
150136217|NCT02276222|541631712|FG001|Overall Study|Lost to Follow-up|5|||
150136218|NCT02276222|541631711|FG000|Overall Study|Physician Decision|2|||
150136219|NCT02276222|541631712|FG001|Overall Study|Physician Decision|1|||
150136220|NCT02276222|541631711|FG000|Overall Study|sheduling conflict|1|||
150136221|NCT02276222|541631712|FG001|Overall Study|sheduling conflict|0|||
150136222|NCT02276222|541631711|FG000|Overall Study|subject withdrew after randomization|1|||
150136223|NCT02276222|541631712|FG001|Overall Study|subject withdrew after randomization|0|||
150136224|NCT04102579|541631713|FG000|Overall Study|Withdrawal by Subject|3|||
150136225|NCT04102579|541631714|FG001|Overall Study|Withdrawal by Subject|4|||
150136226|NCT04102579|541631713|FG000|Overall Study|Lost to Follow-up|0|||
150136227|NCT04102579|541631714|FG001|Overall Study|Lost to Follow-up|1|||
150136228|NCT04102579|541631713|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
150136229|NCT04102579|541631714|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
150136230|NCT04102579|541631713|FG000|Overall Study|Other than Specified|1|||
150136231|NCT04102579|541631714|FG001|Overall Study|Other than Specified|0|||
150136232|NCT04102579|541631713|FG000|Overall Study|Not Dosed with Study Drug|0|||
150136233|NCT04102579|541631714|FG001|Overall Study|Not Dosed with Study Drug|1|||
150136234|NCT05899686|541631715|FG000|Overall Study|Protocol Violation|1|||
150136235|NCT00572195|541631716|FG000|Overall Study|Withdrawal by Subject|50|||
150136236|NCT00572195|541631716|FG000|Overall Study|Death|9|||
150136237|NCT00572195|541631716|FG000|Overall Study|Adverse Event|4|||
150136238|NCT00572195|541631716|FG000|Overall Study|Lost to Follow-up|5|||
150136239|NCT01525602|541631717|FG000|Overall Study|Adverse Event|1|||
150136240|NCT01525602|541631718|FG001|Overall Study|Adverse Event|0|||
150136241|NCT01525602|541631719|FG002|Overall Study|Adverse Event|1|||
150136242|NCT01525602|541631720|FG003|Overall Study|Adverse Event|1|||
150136243|NCT01525602|541631721|FG004|Overall Study|Adverse Event|3|||
150136244|NCT01525602|541631722|FG005|Overall Study|Adverse Event|3|||
150136245|NCT01525602|541631723|FG006|Overall Study|Adverse Event|0|||
150136246|NCT01525602|541631724|FG007|Overall Study|Adverse Event|1|||
150136247|NCT01525602|541631717|FG000|Overall Study|Disease progression|6|||
150136248|NCT01525602|541631718|FG001|Overall Study|Disease progression|3|||
150136249|NCT01525602|541631719|FG002|Overall Study|Disease progression|2|||
150136250|NCT01525602|541631720|FG003|Overall Study|Disease progression|5|||
150136251|NCT01525602|541631721|FG004|Overall Study|Disease progression|22|||
150136252|NCT01525602|541631722|FG005|Overall Study|Disease progression|2|||
150136253|NCT01525602|541631723|FG006|Overall Study|Disease progression|3|||
150136254|NCT01525602|541631724|FG007|Overall Study|Disease progression|3|||
150136255|NCT01525602|541631717|FG000|Overall Study|Clinical progression|2|||
150136256|NCT01525602|541631718|FG001|Overall Study|Clinical progression|0|||
150136257|NCT01525602|541631719|FG002|Overall Study|Clinical progression|0|||
150136258|NCT01525602|541631720|FG003|Overall Study|Clinical progression|0|||
150136259|NCT01525602|541631721|FG004|Overall Study|Clinical progression|0|||
150136260|NCT01525602|541631722|FG005|Overall Study|Clinical progression|0|||
150136261|NCT01525602|541631723|FG006|Overall Study|Clinical progression|1|||
150136262|NCT01525602|541631724|FG007|Overall Study|Clinical progression|1|||
150136263|NCT01525602|541631717|FG000|Overall Study|Non-compliance|0|||
150136264|NCT01525602|541631718|FG001|Overall Study|Non-compliance|0|||
150136265|NCT01525602|541631719|FG002|Overall Study|Non-compliance|0|||
150136266|NCT01525602|541631720|FG003|Overall Study|Non-compliance|0|||
150136267|NCT01525602|541631721|FG004|Overall Study|Non-compliance|1|||
150136268|NCT01525602|541631722|FG005|Overall Study|Non-compliance|0|||
150136269|NCT01525602|541631723|FG006|Overall Study|Non-compliance|0|||
150136270|NCT01525602|541631724|FG007|Overall Study|Non-compliance|0|||
150136271|NCT01525602|541631717|FG000|Overall Study|Withdrawal by Subject|0|||
150136272|NCT01525602|541631718|FG001|Overall Study|Withdrawal by Subject|0|||
150136273|NCT01525602|541631719|FG002|Overall Study|Withdrawal by Subject|0|||
150136274|NCT01525602|541631720|FG003|Overall Study|Withdrawal by Subject|0|||
150136275|NCT01525602|541631721|FG004|Overall Study|Withdrawal by Subject|3|||
150136276|NCT01525602|541631722|FG005|Overall Study|Withdrawal by Subject|1|||
150136277|NCT01525602|541631723|FG006|Overall Study|Withdrawal by Subject|0|||
150136278|NCT01525602|541631724|FG007|Overall Study|Withdrawal by Subject|1|||
150136279|NCT01525602|541631717|FG000|Overall Study|Physician Decision|0|||
150136280|NCT01525602|541631718|FG001|Overall Study|Physician Decision|0|||
150136281|NCT01525602|541631719|FG002|Overall Study|Physician Decision|0|||
150136282|NCT01525602|541631720|FG003|Overall Study|Physician Decision|0|||
150136283|NCT01525602|541631721|FG004|Overall Study|Physician Decision|3|||
150136284|NCT01525602|541631722|FG005|Overall Study|Physician Decision|0|||
150136285|NCT01525602|541631723|FG006|Overall Study|Physician Decision|1|||
150136286|NCT01525602|541631724|FG007|Overall Study|Physician Decision|0|||
150136287|NCT01525602|541631717|FG000|Overall Study|Death|0|||
150136288|NCT01525602|541631718|FG001|Overall Study|Death|0|||
150136289|NCT01525602|541631719|FG002|Overall Study|Death|0|||
150136290|NCT01525602|541631720|FG003|Overall Study|Death|0|||
150136291|NCT01525602|541631721|FG004|Overall Study|Death|1|||
150136292|NCT01525602|541631722|FG005|Overall Study|Death|1|||
150136293|NCT01525602|541631723|FG006|Overall Study|Death|0|||
150136294|NCT01525602|541631724|FG007|Overall Study|Death|0|||
150136295|NCT01525602|541631717|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136296|NCT01525602|541631718|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136297|NCT01525602|541631719|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136298|NCT01525602|541631720|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136299|NCT01525602|541631721|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136300|NCT01525602|541631722|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
150136301|NCT01525602|541631723|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
150136302|NCT01525602|541631724|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
150136303|NCT02412137|541631725|FG000|Overall Study|Withdrawal by Subject|2|||
150136304|NCT02412137|541631726|FG001|Overall Study|Withdrawal by Subject|0|||
150136305|NCT02412137|541631725|FG000|Overall Study|Lost to Follow-up|21|||
150136306|NCT02412137|541631726|FG001|Overall Study|Lost to Follow-up|14|||
150136307|NCT02412137|541631725|FG000|Overall Study|Physician Decision|28|||
150136308|NCT02412137|541631726|FG001|Overall Study|Physician Decision|9|||
150136309|NCT02532179|541633314|FG000|Overall Study|Lost to Follow-up|1|||
150136310|NCT02532179|541633314|FG000|Overall Study|Pregnancy|1|||
150136311|NCT02532179|541633314|FG000|Overall Study|Subject received depot steroid injection|1|||
150136312|NCT02240108|541633318|FG000|Overall Study|Other than specified|8|||
150136313|NCT02240108|541633319|FG001|Overall Study|Other than specified|6|||
150136314|NCT02240108|541633318|FG000|Overall Study|Adverse Event|1|||
150136315|NCT02240108|541633319|FG001|Overall Study|Adverse Event|9|||
150136316|NCT02240108|541633318|FG000|Overall Study|Pregnancy|1|||
150136317|NCT02240108|541633319|FG001|Overall Study|Pregnancy|0|||
150136318|NCT02240108|541633318|FG000|Overall Study|Withdrawal by Subject|4|||
150136319|NCT02240108|541633319|FG001|Overall Study|Withdrawal by Subject|9|||
150136320|NCT02240108|541633318|FG000|Overall Study|StudyTerminated by Sponsor|0|||
150136321|NCT02240108|541633319|FG001|Overall Study|StudyTerminated by Sponsor|1|||
150136322|NCT00789815|541633320|FG000|Overall Study|Protocol Violation|6|||
150136323|NCT00789815|541633321|FG001|Overall Study|Protocol Violation|1|||
150136324|NCT00789815|541633320|FG000|Overall Study|Intubation due to massive bleeding|1|||
150136325|NCT00789815|541633321|FG001|Overall Study|Intubation due to massive bleeding|0|||
150136326|NCT00119405|541633322|FG000|Overall Study|Withdrawal by Subject|1|||
150136327|NCT04958785|541633326|FG000|Overall Study|Study Terminated by Sponsor|4|||
150136328|NCT04958785|541633327|FG001|Overall Study|Study Terminated by Sponsor|10|||
150136329|NCT04958785|541633328|FG002|Overall Study|Study Terminated by Sponsor|7|||
150136330|NCT04958785|541633329|FG003|Overall Study|Study Terminated by Sponsor|6|||
150136331|NCT04958785|541633330|FG004|Overall Study|Study Terminated by Sponsor|34|||
150136332|NCT04958785|541633326|FG000|Overall Study|Death|2|||
150136333|NCT04958785|541633327|FG001|Overall Study|Death|3|||
150136334|NCT04958785|541633328|FG002|Overall Study|Death|4|||
150136335|NCT04958785|541633329|FG003|Overall Study|Death|5|||
150136336|NCT04958785|541633330|FG004|Overall Study|Death|5|||
150136337|NCT04958785|541633326|FG000|Overall Study|Withdrew consent|2|||
150136338|NCT04958785|541633327|FG001|Overall Study|Withdrew consent|0|||
150136339|NCT04958785|541633328|FG002|Overall Study|Withdrew consent|3|||
150136340|NCT04958785|541633329|FG003|Overall Study|Withdrew consent|1|||
150136341|NCT04958785|541633330|FG004|Overall Study|Withdrew consent|0|||
150136342|NCT04958785|541633326|FG000|Overall Study|Investigator's discretion|0|||
150136343|NCT04958785|541633327|FG001|Overall Study|Investigator's discretion|1|||
150136344|NCT04958785|541633328|FG002|Overall Study|Investigator's discretion|0|||
150136345|NCT04958785|541633329|FG003|Overall Study|Investigator's discretion|1|||
150136346|NCT04958785|541633330|FG004|Overall Study|Investigator's discretion|2|||
150136347|NCT04958785|541633326|FG000|Overall Study|Adverse Event|0|||
150136348|NCT04958785|541633327|FG001|Overall Study|Adverse Event|0|||
150136349|NCT04958785|541633328|FG002|Overall Study|Adverse Event|0|||
150136350|NCT04958785|541633329|FG003|Overall Study|Adverse Event|0|||
150136351|NCT04958785|541633330|FG004|Overall Study|Adverse Event|1|||
150136352|NCT04958785|541633326|FG000|Overall Study|Lost to Follow-up|0|||
150136353|NCT04958785|541633327|FG001|Overall Study|Lost to Follow-up|0|||
150136354|NCT04958785|541633328|FG002|Overall Study|Lost to Follow-up|0|||
150136355|NCT04958785|541633329|FG003|Overall Study|Lost to Follow-up|0|||
150136356|NCT04958785|541633330|FG004|Overall Study|Lost to Follow-up|1|||
150136357|NCT01224925|541633331|FG000|Overall Study|Lost to Follow-up|3|||
150136358|NCT01224925|541633332|FG001|Overall Study|Lost to Follow-up|2|||
150136359|NCT00245102|541633335|FG000|Overall Study|Not Treated|1|||
150136360|NCT00245102|541633336|FG001|Overall Study|Not Treated|0|||
150136361|NCT00245102|541633337|FG002|Overall Study|Not Treated|1|||
150136362|NCT00245102|541633338|FG003|Overall Study|Not Treated|0|||
150136363|NCT00245102|541633339|FG004|Overall Study|Not Treated|0|||
150136364|NCT00245102|541633340|FG005|Overall Study|Not Treated|0|||
150136365|NCT00245102|541633335|FG000|Overall Study|Protocol Violation|1|||
150136366|NCT00245102|541633336|FG001|Overall Study|Protocol Violation|0|||
150136367|NCT00245102|541633337|FG002|Overall Study|Protocol Violation|0|||
150136368|NCT00245102|541633338|FG003|Overall Study|Protocol Violation|0|||
150136369|NCT00245102|541633339|FG004|Overall Study|Protocol Violation|0|||
150136370|NCT00245102|541633340|FG005|Overall Study|Protocol Violation|0|||
150136371|NCT00245102|541633335|FG000|Overall Study|Death|0|||
150136372|NCT00245102|541633336|FG001|Overall Study|Death|0|||
150136373|NCT00245102|541633337|FG002|Overall Study|Death|0|||
150136374|NCT00245102|541633338|FG003|Overall Study|Death|1|||
150136375|NCT00245102|541633339|FG004|Overall Study|Death|0|||
150136376|NCT00245102|541633340|FG005|Overall Study|Death|0|||
150136377|NCT00245102|541633335|FG000|Overall Study|Adverse Event|4|||
150136378|NCT00245102|541633336|FG001|Overall Study|Adverse Event|2|||
150136379|NCT00245102|541633337|FG002|Overall Study|Adverse Event|5|||
150136380|NCT00245102|541633338|FG003|Overall Study|Adverse Event|1|||
150136381|NCT00245102|541633339|FG004|Overall Study|Adverse Event|0|||
150136382|NCT00245102|541633340|FG005|Overall Study|Adverse Event|2|||
150136383|NCT00245102|541633335|FG000|Overall Study|Decline in performance|0|||
150136384|NCT00245102|541633336|FG001|Overall Study|Decline in performance|2|||
150136385|NCT00245102|541633337|FG002|Overall Study|Decline in performance|0|||
150136386|NCT00245102|541633338|FG003|Overall Study|Decline in performance|1|||
150136387|NCT00245102|541633339|FG004|Overall Study|Decline in performance|0|||
150136388|NCT00245102|541633340|FG005|Overall Study|Decline in performance|2|||
150136389|NCT00245102|541633335|FG000|Overall Study|Participant needed surgery|0|||
150136390|NCT00245102|541633336|FG001|Overall Study|Participant needed surgery|0|||
150136391|NCT00245102|541633337|FG002|Overall Study|Participant needed surgery|1|||
150136392|NCT00245102|541633338|FG003|Overall Study|Participant needed surgery|0|||
150136393|NCT00245102|541633339|FG004|Overall Study|Participant needed surgery|0|||
150136394|NCT00245102|541633340|FG005|Overall Study|Participant needed surgery|0|||
150136395|NCT00245102|541633335|FG000|Overall Study|Clinical progression|1|||
150136396|NCT00245102|541633336|FG001|Overall Study|Clinical progression|0|||
150136397|NCT00245102|541633337|FG002|Overall Study|Clinical progression|0|||
150136398|NCT00245102|541633338|FG003|Overall Study|Clinical progression|0|||
150136399|NCT00245102|541633339|FG004|Overall Study|Clinical progression|0|||
150136400|NCT00245102|541633340|FG005|Overall Study|Clinical progression|0|||
150136401|NCT02293395|541633343|FG000|Overall Study|Lost to Follow-up|1|||
150136402|NCT02293395|541633344|FG001|Overall Study|Lost to Follow-up|0|||
150136403|NCT02293395|541633343|FG000|Overall Study|Withdrawal by Subject|8|||
150136404|NCT02293395|541633344|FG001|Overall Study|Withdrawal by Subject|7|||
150136405|NCT00224770|541633350|FG000|Overall Study|Lost to Follow-up|4|||
150136406|NCT00224770|541633351|FG001|Overall Study|Lost to Follow-up|2|||
150136407|NCT00224770|541633352|FG002|Overall Study|Lost to Follow-up|0|||
150136408|NCT01106430|541633353|FG000|Overall Study|Adverse Event|8|||
150136409|NCT01106430|541633354|FG001|Overall Study|Adverse Event|10|||
150136410|NCT01106430|541633353|FG000|Overall Study|Lack of Efficacy|2|||
150136411|NCT01106430|541633354|FG001|Overall Study|Lack of Efficacy|13|||
150136412|NCT01106430|541633353|FG000|Overall Study|Lost to Follow-up|5|||
150136413|NCT01106430|541633354|FG001|Overall Study|Lost to Follow-up|1|||
150136414|NCT01106430|541633353|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
150136415|NCT01106430|541633354|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
150136416|NCT01106430|541633353|FG000|Overall Study|Moved Out Of State|0|||
150136417|NCT01106430|541633354|FG001|Overall Study|Moved Out Of State|1|||
150136418|NCT01106430|541633353|FG000|Overall Study|Refused To Take Medication|0|||
150136419|NCT01106430|541633354|FG001|Overall Study|Refused To Take Medication|1|||
150136420|NCT01106430|541633353|FG000|Overall Study|Noncompliance|0|||
150136421|NCT01106430|541633354|FG001|Overall Study|Noncompliance|1|||
150136422|NCT01106430|541633353|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
150136423|NCT01106430|541633354|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
150136424|NCT01106430|541633353|FG000|Overall Study|Previous Use Of Marijuana|1|||
150136425|NCT01106430|541633354|FG001|Overall Study|Previous Use Of Marijuana|0|||
150136426|NCT01106430|541633353|FG000|Overall Study|Protocol Violation|7|||
150136427|NCT01106430|541633354|FG001|Overall Study|Protocol Violation|2|||
150136428|NCT01106430|541633353|FG000|Overall Study|Withdrawal by Subject|8|||
150136429|NCT01106430|541633354|FG001|Overall Study|Withdrawal by Subject|4|||
150136430|NCT02472652|541633361|FG000|Overall Study|Lost to Follow-up|1|||
150136431|NCT01083641|541633362|FG000|Overall Study|Withdrawal by Subject|2|||
150136432|NCT03439189|541633363|FG000|Overall Study|Protocol Violation|19|||
150136433|NCT03439189|541633363|FG000|Overall Study|Lack of Efficacy|63|||
150136434|NCT03412812|541633364|FG000|Level 1|Death|3|||
150136435|NCT03412812|541633365|FG001|Level 1|Death|0|||
150136436|NCT03412812|541633364|FG000|Level 1|Adverse Event|0|||
150136437|NCT03412812|541633365|FG001|Level 1|Adverse Event|1|||
150136438|NCT01777321|541633366|FG000|Overall Study|Withdrawal by Subject|0|||
150136439|NCT01777321|541633367|FG001|Overall Study|Withdrawal by Subject|1|||
150136440|NCT03837509|541633368|FG000|Phase 1|Death|5|||
150136441|NCT03837509|541633369|FG001|Phase 1|Death|2|||
150136442|NCT03837509|541633370|FG002|Phase 1|Death|0|||
150136443|NCT03837509|541633371|FG003|Phase 1|Death|0|||
150136444|NCT03837509|541633372|FG004|Phase 1|Death|0|||
150136445|NCT03837509|541633368|FG000|Phase 2|Death|0|||
150136446|NCT03837509|541633369|FG001|Phase 2|Death|0|||
150136447|NCT03837509|541633370|FG002|Phase 2|Death|0|||
150199647|NCT03606512|541871619|FG001|Overall Study|'moved from study area|1|||
150199648|NCT05513937|541871620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
150199649|NCT05513937|541871621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
150199650|NCT05513937|541871622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
150199651|NCT05513937|541871623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
150199652|NCT05513937|541871620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
150199653|NCT05513937|541871621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
150199654|NCT05513937|541871622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
150199655|NCT05513937|541871623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
150199656|NCT05513937|541871620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
150199657|NCT05513937|541871621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
150199658|NCT05513937|541871622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
150199659|NCT05513937|541871623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
150199660|NCT05513937|541871620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
150199661|NCT05513937|541871621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
150199662|NCT05513937|541871622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
150199663|NCT05513937|541871623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
150199664|NCT05513937|541871620|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
150199665|NCT05513937|541871621|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
150199666|NCT05513937|541871622|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
150199667|NCT05513937|541871623|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
150199668|NCT05513937|541871620|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
150199669|NCT05513937|541871621|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
150199670|NCT05513937|541871622|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
150199671|NCT05513937|541871623|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
150199672|NCT02846545|541871624|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
150199673|NCT02846545|541871625|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
150199674|NCT02846545|541871624|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
150199675|NCT02846545|541871625|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
150199676|NCT02846545|541871624|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
150199677|NCT02846545|541871625|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
150199678|NCT02846545|541871624|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
150199679|NCT02846545|541871625|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
150199680|NCT02846545|541871624|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
150199681|NCT02846545|541871625|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
150199682|NCT03993392|541871630|FG000|Overall Study|Withdrawal by Subject|3|||
150199683|NCT03993392|541871630|FG000|Overall Study|Lost to Follow-up|2|||
150199684|NCT03993392|541871630|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
150199685|NCT06262477|541872911|FG000|Overall Study|Withdrawal by Subject|1|||
150199686|NCT06262477|541872912|FG001|Overall Study|Withdrawal by Subject|0|||
150199687|NCT06262477|541872911|FG000|Overall Study|Adverse Event|0|||
150199688|NCT06262477|541872912|FG001|Overall Study|Adverse Event|1|||
150199689|NCT06262477|541872911|FG000|Overall Study|Lost to Follow-up|0|||
150199690|NCT06262477|541872912|FG001|Overall Study|Lost to Follow-up|1|||
150199691|NCT01064440|541872913|FG000|Overall Study|Lost to Follow-up|1|||
150199692|NCT01064440|541872914|FG001|Overall Study|Lost to Follow-up|1|||
150199693|NCT01064440|541872915|FG002|Overall Study|Lost to Follow-up|1|||
150199694|NCT01064440|541872913|FG000|Overall Study|Non-compliance|0|||
150199695|NCT01064440|541872914|FG001|Overall Study|Non-compliance|1|||
150199696|NCT01064440|541872915|FG002|Overall Study|Non-compliance|0|||
150199697|NCT01064440|541872913|FG000|Overall Study|Death|1|||
150199698|NCT01064440|541872914|FG001|Overall Study|Death|0|||
150199699|NCT01064440|541872915|FG002|Overall Study|Death|1|||
150199700|NCT01064440|541872913|FG000|Overall Study|Withdrawal by Subject|0|||
150199701|NCT01064440|541872914|FG001|Overall Study|Withdrawal by Subject|1|||
150199702|NCT01064440|541872915|FG002|Overall Study|Withdrawal by Subject|1|||
150199703|NCT01064440|541872913|FG000|Overall Study|Other: amputation|1|||
150199704|NCT01064440|541872914|FG001|Overall Study|Other: amputation|0|||
150199705|NCT01064440|541872915|FG002|Overall Study|Other: amputation|0|||
150199706|NCT01880515|541872919|FG000|Overall Study|Lost to Follow-up|3|||
150199707|NCT01880515|541872920|FG001|Overall Study|Lost to Follow-up|2|||
150199708|NCT01880515|541872919|FG000|Overall Study|Disease Progression|5|||
150199709|NCT01880515|541872920|FG001|Overall Study|Disease Progression|7|||
150199710|NCT05247034|541872922|FG000|Overall Study|Lost to Follow-up|3|||
150199711|NCT05247034|541872923|FG001|Overall Study|Lost to Follow-up|2|||
150199712|NCT05247034|541872922|FG000|Overall Study|Organizational problems when attending appointments|1|||
150199713|NCT05247034|541872923|FG001|Overall Study|Organizational problems when attending appointments|0|||
150199714|NCT04414722|541872926|FG000|Overall Study|Lost to Follow-up|3|||
150199715|NCT04414722|541872927|FG001|Overall Study|Lost to Follow-up|4|||
150199716|NCT04414722|541872928|FG002|Overall Study|Lost to Follow-up|3|||
150199717|NCT04414722|541872929|FG003|Overall Study|Lost to Follow-up|2|||
150199718|NCT04414722|541872930|FG004|Overall Study|Lost to Follow-up|3|||
150199719|NCT04414722|541872926|FG000|Overall Study|Withdrawal by Subject|6|||
150199720|NCT04414722|541872927|FG001|Overall Study|Withdrawal by Subject|3|||
150199721|NCT04414722|541872928|FG002|Overall Study|Withdrawal by Subject|1|||
150199722|NCT04414722|541872929|FG003|Overall Study|Withdrawal by Subject|5|||
150199723|NCT04414722|541872930|FG004|Overall Study|Withdrawal by Subject|1|||
150199724|NCT04414722|541872926|FG000|Overall Study|Physician Decision|0|||
150199725|NCT04414722|541872927|FG001|Overall Study|Physician Decision|1|||
150199726|NCT04414722|541872928|FG002|Overall Study|Physician Decision|2|||
150199727|NCT04414722|541872929|FG003|Overall Study|Physician Decision|0|||
150199728|NCT04414722|541872930|FG004|Overall Study|Physician Decision|0|||
150199729|NCT04414722|541872926|FG000|Overall Study|Non-participatory|0|||
150199730|NCT04414722|541872927|FG001|Overall Study|Non-participatory|1|||
150199731|NCT04414722|541872928|FG002|Overall Study|Non-participatory|1|||
150199732|NCT04414722|541872929|FG003|Overall Study|Non-participatory|0|||
150199733|NCT04414722|541872930|FG004|Overall Study|Non-participatory|0|||
150199734|NCT02668692|541872931|FG000|Overall Study|Adverse Event|1|||
150199735|NCT02668692|541872932|FG001|Overall Study|Adverse Event|0|||
150199736|NCT05524402|541872935|FG000|Overall Study|Withdrawal by Subject|3|||
150199737|NCT05524402|541872936|FG001|Overall Study|Withdrawal by Subject|1|||
150199738|NCT05524402|541872935|FG000|Overall Study|Lost to Follow-up|2|||
150199739|NCT05524402|541872936|FG001|Overall Study|Lost to Follow-up|1|||
150199740|NCT05976334|541872937|FG000|Part B|Death|0|||
150199741|NCT05976334|541872938|FG001|Part B|Death|1|||
150199742|NCT05976334|541872937|FG000|Part B|Study Terminated by Sponsor|0|||
150199743|NCT05976334|541872938|FG001|Part B|Study Terminated by Sponsor|1|||
150199744|NCT05976334|541872937|FG000|Part B|Reason Not Specified|0|||
150199745|NCT05976334|541872938|FG001|Part B|Reason Not Specified|1|||
150199746|NCT05237284|541872939|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
150199747|NCT05237284|541872940|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
150199748|NCT05237284|541872941|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
150199749|NCT05237284|541872942|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
150199750|NCT05237284|541872939|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
150199751|NCT05237284|541872940|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
150199752|NCT05237284|541872941|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
150199753|NCT05237284|541872942|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
150199754|NCT05237284|541872939|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
150199755|NCT05237284|541872940|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
150199756|NCT05237284|541872941|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
150199757|NCT05237284|541872942|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
150199758|NCT05237284|541872939|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
150199759|NCT05237284|541872940|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
150199760|NCT05237284|541872941|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
150199761|NCT05237284|541872942|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
150199762|NCT05237284|541872939|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
150199763|NCT05237284|541872940|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
150199764|NCT05237284|541872941|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
150199765|NCT05237284|541872942|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
150199766|NCT05237284|541872939|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
150199767|NCT05237284|541872940|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
150199768|NCT05237284|541872941|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
150199769|NCT05237284|541872942|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
150199770|NCT05237284|541872939|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
150199771|NCT05237284|541872940|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
150199772|NCT05237284|541872941|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
150199773|NCT05237284|541872942|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
150199774|NCT05237284|541872939|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
150199775|NCT05237284|541872940|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
150199776|NCT05237284|541872941|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
150199777|NCT05237284|541872942|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
150199778|NCT05237284|541872939|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
150199779|NCT05237284|541872940|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
150199780|NCT05237284|541872941|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
150199781|NCT05237284|541872942|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
150199782|NCT02056834|541872945|FG000|Overall Study|Lost to Follow-up|7|||
150199783|NCT04820322|541872956|FG000|Overall Study|Adverse Event|1|||
150199784|NCT04820322|541872957|FG001|Overall Study|Adverse Event|0|||
150199785|NCT03156465|541872958|FG000|Overall Study|Withdrawal by Subject|2|||
150199786|NCT03580356|541872962|FG000|Treatment Period|Withdrawal by Subject|13|||
150199787|NCT03580356|541872963|FG001|Treatment Period|Withdrawal by Subject|0|||
150199788|NCT03580356|541872964|FG002|Treatment Period|Withdrawal by Subject|13|||
150199789|NCT03580356|541872965|FG003|Treatment Period|Withdrawal by Subject|1|||
150199790|NCT03580356|541872966|FG004|Treatment Period|Withdrawal by Subject|17|||
150199791|NCT03580356|541872967|FG005|Treatment Period|Withdrawal by Subject|0|||
150199792|NCT03580356|541872968|FG006|Treatment Period|Withdrawal by Subject|5|||
150199793|NCT03580356|541872969|FG007|Treatment Period|Withdrawal by Subject|0|||
150199794|NCT03580356|541872962|FG000|Treatment Period|Adverse Event|10|||
150199795|NCT03580356|541872963|FG001|Treatment Period|Adverse Event|0|||
150199796|NCT03580356|541872964|FG002|Treatment Period|Adverse Event|13|||
150199797|NCT03580356|541872965|FG003|Treatment Period|Adverse Event|0|||
150199798|NCT03580356|541872966|FG004|Treatment Period|Adverse Event|5|||
150199799|NCT03580356|541872967|FG005|Treatment Period|Adverse Event|0|||
150199800|NCT03580356|541872968|FG006|Treatment Period|Adverse Event|8|||
150199801|NCT03580356|541872969|FG007|Treatment Period|Adverse Event|0|||
150199802|NCT03580356|541872962|FG000|Treatment Period|Protocol Violation|5|||
150199803|NCT03580356|541872963|FG001|Treatment Period|Protocol Violation|0|||
150199804|NCT03580356|541872964|FG002|Treatment Period|Protocol Violation|6|||
150199805|NCT03580356|541872965|FG003|Treatment Period|Protocol Violation|1|||
150199806|NCT03580356|541872966|FG004|Treatment Period|Protocol Violation|9|||
150199807|NCT03580356|541872967|FG005|Treatment Period|Protocol Violation|1|||
150199808|NCT03580356|541872968|FG006|Treatment Period|Protocol Violation|1|||
150199809|NCT03580356|541872969|FG007|Treatment Period|Protocol Violation|0|||
150199810|NCT03580356|541872962|FG000|Treatment Period|Lack of Efficacy|6|||
150199811|NCT03580356|541872963|FG001|Treatment Period|Lack of Efficacy|0|||
150199812|NCT03580356|541872964|FG002|Treatment Period|Lack of Efficacy|2|||
150199813|NCT03580356|541872965|FG003|Treatment Period|Lack of Efficacy|0|||
150199814|NCT03580356|541872966|FG004|Treatment Period|Lack of Efficacy|3|||
150199815|NCT03580356|541872967|FG005|Treatment Period|Lack of Efficacy|0|||
150199816|NCT03580356|541872968|FG006|Treatment Period|Lack of Efficacy|3|||
150199817|NCT03580356|541872969|FG007|Treatment Period|Lack of Efficacy|0|||
150199818|NCT03580356|541872962|FG000|Treatment Period|Pregnancy|1|||
150199819|NCT03580356|541872963|FG001|Treatment Period|Pregnancy|0|||
150199820|NCT03580356|541872964|FG002|Treatment Period|Pregnancy|7|||
150199821|NCT03580356|541872965|FG003|Treatment Period|Pregnancy|0|||
150199822|NCT03580356|541872966|FG004|Treatment Period|Pregnancy|2|||
150199823|NCT03580356|541872967|FG005|Treatment Period|Pregnancy|0|||
150199824|NCT03580356|541872968|FG006|Treatment Period|Pregnancy|1|||
150199825|NCT03580356|541872969|FG007|Treatment Period|Pregnancy|0|||
150199826|NCT03580356|541872962|FG000|Treatment Period|Physician Decision|2|||
150199827|NCT03580356|541872963|FG001|Treatment Period|Physician Decision|0|||
150199828|NCT03580356|541872964|FG002|Treatment Period|Physician Decision|1|||
150199829|NCT03580356|541872965|FG003|Treatment Period|Physician Decision|0|||
150199830|NCT03580356|541872966|FG004|Treatment Period|Physician Decision|4|||
150199831|NCT03580356|541872967|FG005|Treatment Period|Physician Decision|0|||
150199832|NCT03580356|541872968|FG006|Treatment Period|Physician Decision|2|||
150199833|NCT03580356|541872969|FG007|Treatment Period|Physician Decision|0|||
150199834|NCT03580356|541872962|FG000|Treatment Period|Lost to Follow-up|1|||
150199835|NCT03580356|541872963|FG001|Treatment Period|Lost to Follow-up|1|||
150199836|NCT03580356|541872964|FG002|Treatment Period|Lost to Follow-up|1|||
150199837|NCT03580356|541872965|FG003|Treatment Period|Lost to Follow-up|0|||
150199838|NCT03580356|541872966|FG004|Treatment Period|Lost to Follow-up|3|||
150199839|NCT03580356|541872967|FG005|Treatment Period|Lost to Follow-up|0|||
150199840|NCT03580356|541872968|FG006|Treatment Period|Lost to Follow-up|1|||
150199841|NCT03580356|541872969|FG007|Treatment Period|Lost to Follow-up|0|||
150199842|NCT03580356|541872962|FG000|Treatment Period|Death|0|||
150199843|NCT03580356|541872963|FG001|Treatment Period|Death|0|||
150199844|NCT03580356|541872964|FG002|Treatment Period|Death|1|||
150199845|NCT03580356|541872965|FG003|Treatment Period|Death|0|||
150199846|NCT03580356|541872966|FG004|Treatment Period|Death|0|||
150199847|NCT03580356|541872967|FG005|Treatment Period|Death|0|||
150199848|NCT03580356|541872968|FG006|Treatment Period|Death|0|||
150199849|NCT03580356|541872969|FG007|Treatment Period|Death|0|||
150199850|NCT03580356|541872962|FG000|Treatment Period|Technical problems|0|||
150199851|NCT03580356|541872963|FG001|Treatment Period|Technical problems|0|||
150199852|NCT03580356|541872964|FG002|Treatment Period|Technical problems|0|||
150199853|NCT03580356|541872965|FG003|Treatment Period|Technical problems|0|||
150199854|NCT03580356|541872966|FG004|Treatment Period|Technical problems|1|||
150199855|NCT03580356|541872967|FG005|Treatment Period|Technical problems|0|||
150199856|NCT03580356|541872968|FG006|Treatment Period|Technical problems|0|||
150199857|NCT03580356|541872969|FG007|Treatment Period|Technical problems|0|||
150199858|NCT03580356|541872962|FG000|Treatment Period|Misrandomized, no treatment|0|||
150199859|NCT03580356|541872963|FG001|Treatment Period|Misrandomized, no treatment|0|||
150199860|NCT03580356|541872964|FG002|Treatment Period|Misrandomized, no treatment|1|||
150199861|NCT03580356|541872965|FG003|Treatment Period|Misrandomized, no treatment|0|||
150136448|NCT03837509|541633371|FG003|Phase 2|Death|1|||
150136449|NCT03837509|541633372|FG004|Phase 2|Death|1|||
150136450|NCT05131165|541633376|FG000|Overall Study|Death|1|||
150136451|NCT05131165|541633377|FG001|Overall Study|Death|1|||
150136452|NCT05131165|541633378|FG002|Overall Study|Death|0|||
150136453|NCT05131165|541633376|FG000|Overall Study|Lost to Follow-up|2|||
150136454|NCT05131165|541633377|FG001|Overall Study|Lost to Follow-up|2|||
150136455|NCT05131165|541633378|FG002|Overall Study|Lost to Follow-up|5|||
150136456|NCT05131165|541633376|FG000|Overall Study|Transferred out of clinic|1|||
150136457|NCT05131165|541633377|FG001|Overall Study|Transferred out of clinic|0|||
150136458|NCT05131165|541633378|FG002|Overall Study|Transferred out of clinic|3|||
150136459|NCT05131165|541633376|FG000|Overall Study|Dropped out|1|||
150136460|NCT05131165|541633377|FG001|Overall Study|Dropped out|2|||
150136461|NCT05131165|541633378|FG002|Overall Study|Dropped out|0|||
150136462|NCT04570436|541633397|FG000|Overall Study|Adverse Event|0|||
150136463|NCT04570436|541633398|FG001|Overall Study|Adverse Event|0|||
150136464|NCT04570436|541633399|FG002|Overall Study|Adverse Event|1|||
150136465|NCT04570436|541633400|FG003|Overall Study|Adverse Event|0|||
150136466|NCT04570436|541633401|FG004|Overall Study|Adverse Event|0|||
150136467|NCT04570436|541633402|FG005|Overall Study|Adverse Event|0|||
150136468|NCT04570436|541633403|FG006|Overall Study|Adverse Event|0|||
150136469|NCT04570436|541633404|FG007|Overall Study|Adverse Event|0|||
150136470|NCT04570436|541633405|FG008|Overall Study|Adverse Event|0|||
150136471|NCT04570436|541633406|FG009|Overall Study|Adverse Event|0|||
150136472|NCT04570436|541633397|FG000|Overall Study|Physician Decision|1|||
150136473|NCT04570436|541633398|FG001|Overall Study|Physician Decision|0|||
150136474|NCT04570436|541633399|FG002|Overall Study|Physician Decision|0|||
150136475|NCT04570436|541633400|FG003|Overall Study|Physician Decision|0|||
150136476|NCT04570436|541633401|FG004|Overall Study|Physician Decision|0|||
150136477|NCT04570436|541633402|FG005|Overall Study|Physician Decision|0|||
150136478|NCT04570436|541633403|FG006|Overall Study|Physician Decision|0|||
150136479|NCT04570436|541633404|FG007|Overall Study|Physician Decision|0|||
150136480|NCT04570436|541633405|FG008|Overall Study|Physician Decision|0|||
150136481|NCT04570436|541633406|FG009|Overall Study|Physician Decision|0|||
150136482|NCT03802123|541633407|FG000|Overall Study|Withdrawal by Subject|3|||
150136483|NCT03802123|541633407|FG000|Overall Study|Physician Decision|1|||
150136484|NCT03802123|541633407|FG000|Overall Study|Subject moved to hospice care|1|||
150136485|NCT03802123|541633407|FG000|Overall Study|technician error|1|||
150136486|NCT03802123|541633407|FG000|Overall Study|Death|3|||
150136487|NCT01274182|541633408|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
150136488|NCT01274182|541633409|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
150136489|NCT01274182|541633410|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
150136490|NCT01274182|541633408|FG000|Overall Study|Adverse Event|4|||
150136491|NCT01274182|541633409|FG001|Overall Study|Adverse Event|5|||
150136492|NCT01274182|541633410|FG002|Overall Study|Adverse Event|3|||
150136493|NCT01274182|541633408|FG000|Overall Study|Withdrawal by Subject|5|||
150136494|NCT01274182|541633409|FG001|Overall Study|Withdrawal by Subject|5|||
150136495|NCT01274182|541633410|FG002|Overall Study|Withdrawal by Subject|3|||
150136496|NCT01274182|541633408|FG000|Overall Study|Lost to Follow-up|2|||
150136497|NCT01274182|541633409|FG001|Overall Study|Lost to Follow-up|3|||
150136498|NCT01274182|541633410|FG002|Overall Study|Lost to Follow-up|1|||
150136499|NCT01274182|541633408|FG000|Overall Study|Protocol Violation|3|||
150136500|NCT01274182|541633409|FG001|Overall Study|Protocol Violation|2|||
150136501|NCT01274182|541633410|FG002|Overall Study|Protocol Violation|0|||
150136502|NCT01274182|541633408|FG000|Overall Study|Death|1|||
150136503|NCT01274182|541633409|FG001|Overall Study|Death|0|||
150136504|NCT01274182|541633410|FG002|Overall Study|Death|1|||
150136505|NCT01822587|541633411|FG000|Overall Study|Lost to Follow-up|7|||
150136506|NCT01822587|541633412|FG001|Overall Study|Lost to Follow-up|9|||
150136507|NCT01822587|541633413|FG002|Overall Study|Lost to Follow-up|12|||
150136508|NCT01822587|541633411|FG000|Overall Study|Physician Decision|9|||
150136509|NCT01822587|541633412|FG001|Overall Study|Physician Decision|6|||
150136510|NCT01822587|541633413|FG002|Overall Study|Physician Decision|6|||
150136511|NCT00117676|541633416|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
150136512|NCT00117676|541633417|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
150136513|NCT00117676|541633416|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
150136514|NCT00117676|541633417|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
150136515|NCT00117676|541633416|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
150136516|NCT00117676|541633417|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
150136517|NCT00117676|541633416|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
150136518|NCT00117676|541633417|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
150136519|NCT00117676|541633416|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
150136520|NCT00117676|541633417|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
150136521|NCT00117676|541633416|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
150136522|NCT00117676|541633417|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
150136523|NCT00117676|541633416|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
150136524|NCT00117676|541633417|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
150136525|NCT00117676|541633416|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
150136526|NCT00117676|541633417|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
150136527|NCT00117676|541633416|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
150136528|NCT00117676|541633417|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
150136529|NCT00117676|541633416|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
150136530|NCT00117676|541633417|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
150136531|NCT00117676|541633416|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
150136532|NCT00117676|541633417|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
150136533|NCT00117676|541633416|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
150136534|NCT00117676|541633417|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
150136535|NCT00117676|541633416|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
150136536|NCT00117676|541633417|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
150136537|NCT00117676|541633416|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
150136538|NCT00117676|541633417|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
150136539|NCT00117676|541633416|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
150136540|NCT00117676|541633417|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
150136541|NCT00117676|541633416|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
150136542|NCT00117676|541633417|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
150136543|NCT00117676|541633416|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
150136544|NCT00117676|541633417|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
150136545|NCT00117676|541633416|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
150136546|NCT00117676|541633417|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
150136547|NCT00117676|541633416|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
150136548|NCT00117676|541633417|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
150136549|NCT00117676|541633416|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
150136550|NCT00117676|541633417|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
150136551|NCT00117676|541633416|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
150199862|NCT03580356|541872966|FG004|Treatment Period|Misrandomized, no treatment|2|||
150199863|NCT03580356|541872967|FG005|Treatment Period|Misrandomized, no treatment|0|||
150199864|NCT03580356|541872968|FG006|Treatment Period|Misrandomized, no treatment|0|||
150199865|NCT03580356|541872969|FG007|Treatment Period|Misrandomized, no treatment|0|||
150199866|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
150199867|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
150199868|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
150199869|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
150199870|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
150199871|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
150199872|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
150199873|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
150199874|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
150199875|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
150199876|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
150199877|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
150199878|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
150199879|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
150199880|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
150199881|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
150199882|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
150199883|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
150199884|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
150199885|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
150199886|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
150199887|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
150199888|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
150136552|NCT00117676|541633417|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
150136553|NCT00117676|541633416|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
150136554|NCT00117676|541633417|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
150136555|NCT00117676|541633416|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
150136556|NCT00117676|541633417|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
150136557|NCT00117676|541633416|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
150136558|NCT00117676|541633417|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
150136559|NCT00117676|541633416|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
150136560|NCT00117676|541633417|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
150136561|NCT00117676|541633416|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
150136562|NCT00117676|541633417|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
150136563|NCT00117676|541633416|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
150136564|NCT00117676|541633417|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
150136565|NCT00117676|541633416|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
150136566|NCT00117676|541633417|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
150136567|NCT00117676|541633416|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
150136568|NCT00117676|541633417|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
150136569|NCT00117676|541633416|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
150136570|NCT00117676|541633417|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
150136571|NCT00117676|541633416|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
150136572|NCT00117676|541633417|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
150136573|NCT00117676|541633416|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
150136574|NCT00117676|541633417|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
150136575|NCT00117676|541633416|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
150136576|NCT00117676|541633417|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
150136577|NCT00117676|541633416|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
150136578|NCT00117676|541633417|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
150136579|NCT00117676|541633416|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
150136580|NCT00117676|541633417|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
150136581|NCT00594854|541633418|FG000|Overall Study|Study terminated|7|||
150136582|NCT00594854|541633419|FG001|Overall Study|Study terminated|10|||
150136583|NCT03172702|541633420|FG000|Overall Study|Adverse Event|9|||
150136584|NCT03172702|541633420|FG000|Overall Study|Death|2|||
150136585|NCT03172702|541633420|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
150136586|NCT03172702|541633420|FG000|Overall Study|Withdrawal by Subject|5|||
150136587|NCT03172702|541633420|FG000|Overall Study|Other|2|||
150136588|NCT03292146|541633421|FG000|Baseline to 12 months|Relocation|1|||
150136589|NCT03292146|541633422|FG001|Baseline to 12 months|Relocation|0|||
150136590|NCT03292146|541633421|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
150136591|NCT03292146|541633422|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
150136592|NCT03292146|541633421|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
150136593|NCT03292146|541633422|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
150136594|NCT03292146|541633421|FG000|12 months to 24 months|Planning pregnancy|2|||
150136595|NCT03292146|541633422|FG001|12 months to 24 months|Planning pregnancy|2|||
150136596|NCT03292146|541633421|FG000|12 months to 24 months|Personal reasons|1|||
150136597|NCT03292146|541633422|FG001|12 months to 24 months|Personal reasons|0|||
150136598|NCT03292146|541633421|FG000|12 months to 24 months|Lost to Follow-up|0|||
150136599|NCT03292146|541633422|FG001|12 months to 24 months|Lost to Follow-up|1|||
150136600|NCT02954354|541633423|FG000|Overall Study|Adverse Event|2|||
150136601|NCT02954354|541633424|FG001|Overall Study|Adverse Event|2|||
150136602|NCT02954354|541633425|FG002|Overall Study|Adverse Event|4|||
150136603|NCT02954354|541633423|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
150136604|NCT02954354|541633424|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
150136605|NCT02954354|541633425|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
150136606|NCT02954354|541633423|FG000|Overall Study|Lack of Efficacy|0|||
150136607|NCT02954354|541633424|FG001|Overall Study|Lack of Efficacy|2|||
150136608|NCT02954354|541633425|FG002|Overall Study|Lack of Efficacy|0|||
150136609|NCT02954354|541633423|FG000|Overall Study|Withdrawal by Subject|17|||
150136610|NCT02954354|541633424|FG001|Overall Study|Withdrawal by Subject|9|||
150136611|NCT02954354|541633425|FG002|Overall Study|Withdrawal by Subject|11|||
150136612|NCT02954354|541633423|FG000|Overall Study|Lost to Follow-up|12|||
150136613|NCT02954354|541633424|FG001|Overall Study|Lost to Follow-up|5|||
150136614|NCT02954354|541633425|FG002|Overall Study|Lost to Follow-up|0|||
150199889|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
150199890|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199891|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199892|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
150199893|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199894|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
150199895|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199896|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199897|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
150199898|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
150199899|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
150199900|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
150199901|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
150199902|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
150199903|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
150199904|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
150199905|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
150136615|NCT02954354|541633423|FG000|Overall Study|Miscellaneous|2|||
150136616|NCT02954354|541633424|FG001|Overall Study|Miscellaneous|2|||
150136617|NCT02954354|541633425|FG002|Overall Study|Miscellaneous|1|||
150136618|NCT06134180|541633428|FG000|Overall Study|Lost to Follow-up|4|||
150136619|NCT04495179|541633435|FG000|Overall Study|Lost to Follow-up|0|||
150136620|NCT04495179|541633436|FG001|Overall Study|Lost to Follow-up|1|||
150136621|NCT04495179|541633435|FG000|Overall Study|Withdrawal by Subject|2|||
150136622|NCT04495179|541633436|FG001|Overall Study|Withdrawal by Subject|4|||
150136623|NCT04495179|541633435|FG000|Overall Study|Study terminated by sponsor|0|||
150136624|NCT04495179|541633436|FG001|Overall Study|Study terminated by sponsor|18|||
150136625|NCT04495179|541633435|FG000|Overall Study|Death|0|||
150136626|NCT04495179|541633436|FG001|Overall Study|Death|4|||
150136627|NCT04495179|541633435|FG000|Overall Study|Adverse Event|0|||
150136628|NCT04495179|541633436|FG001|Overall Study|Adverse Event|1|||
150136629|NCT00569582|541633437|FG000|Overall Study|Withdrawal by Subject|5|||
150136630|NCT00569582|541633437|FG000|Overall Study|Death|2|||
150136631|NCT00569582|541633437|FG000|Overall Study|Adverse Event|7|||
150136632|NCT00569582|541633437|FG000|Overall Study|Subject was too ill to travel.|1|||
150136633|NCT00569582|541633437|FG000|Overall Study|Subject was non-compliant.|1|||
150136634|NCT04559568|541633441|FG000|Overall Study|Physician Decision|0|||
150136635|NCT04559568|541633442|FG001|Overall Study|Physician Decision|0|||
150136636|NCT04559568|541633443|FG002|Overall Study|Physician Decision|0|||
150136637|NCT04559568|541633444|FG003|Overall Study|Physician Decision|0|||
150136638|NCT04559568|541633445|FG004|Overall Study|Physician Decision|0|||
150136639|NCT04559568|541633446|FG005|Overall Study|Physician Decision|0|||
150136640|NCT04559568|541633447|FG006|Overall Study|Physician Decision|0|||
150136641|NCT04559568|541633448|FG007|Overall Study|Physician Decision|0|||
150136642|NCT04559568|541633449|FG008|Overall Study|Physician Decision|0|||
150136643|NCT04559568|541633450|FG009|Overall Study|Physician Decision|1|||
150136644|NCT04559568|541633451|FG010|Overall Study|Physician Decision|0|||
150136645|NCT04559568|541633441|FG000|Overall Study|Withdrawal by Subject|0|||
150136646|NCT04559568|541633442|FG001|Overall Study|Withdrawal by Subject|0|||
150136647|NCT04559568|541633443|FG002|Overall Study|Withdrawal by Subject|0|||
150136648|NCT04559568|541633444|FG003|Overall Study|Withdrawal by Subject|0|||
150136649|NCT04559568|541633445|FG004|Overall Study|Withdrawal by Subject|0|||
150136650|NCT04559568|541633446|FG005|Overall Study|Withdrawal by Subject|0|||
150136651|NCT04559568|541633447|FG006|Overall Study|Withdrawal by Subject|0|||
150136652|NCT04559568|541633448|FG007|Overall Study|Withdrawal by Subject|0|||
150136653|NCT04559568|541633449|FG008|Overall Study|Withdrawal by Subject|0|||
150136654|NCT04559568|541633450|FG009|Overall Study|Withdrawal by Subject|0|||
150136655|NCT04559568|541633451|FG010|Overall Study|Withdrawal by Subject|1|||
150136656|NCT05608499|541633454|FG000|Overall Study|Lack of Efficacy|1|||
150136657|NCT05608499|541633455|FG001|Overall Study|Lack of Efficacy|0|||
150136658|NCT05608499|541633454|FG000|Overall Study|Lost to Follow-up|0|||
150136659|NCT05608499|541633455|FG001|Overall Study|Lost to Follow-up|1|||
150136660|NCT01422408|541633456|FG000|Overall Study|Adverse Event|1|||
150136661|NCT01422408|541633456|FG000|Overall Study|Withdrawal by Subject|3|||
150136662|NCT01936857|541633457|FG000|Overall Study|Sent to prison or 06 center|11|||
150136663|NCT01936857|541633458|FG001|Overall Study|Sent to prison or 06 center|12|||
150136664|NCT01936857|541633457|FG000|Overall Study|Lost to Follow-up|10|||
150136665|NCT01936857|541633458|FG001|Overall Study|Lost to Follow-up|7|||
150136666|NCT01936857|541633457|FG000|Overall Study|Death|7|||
150136667|NCT01936857|541633458|FG001|Overall Study|Death|3|||
150136668|NCT01936857|541633457|FG000|Overall Study|Moved|2|||
150136669|NCT01936857|541633458|FG001|Overall Study|Moved|1|||
150136670|NCT01936857|541633457|FG000|Overall Study|Withdrawal by Subject|1|||
150136671|NCT01936857|541633458|FG001|Overall Study|Withdrawal by Subject|0|||
150136672|NCT01936857|541633457|FG000|Overall Study|Side effect of medication|1|||
150136673|NCT01936857|541633458|FG001|Overall Study|Side effect of medication|0|||
150136674|NCT01936857|541633457|FG000|Overall Study|Other|2|||
150136675|NCT01936857|541633458|FG001|Overall Study|Other|2|||
150136676|NCT00490282|541633459|FG000|Overall Study|Withdrawal by Subject|3|||
150136677|NCT00810264|541633464|FG000|Overall Study|Lost to Follow-up|191|||
150199906|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
150199907|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
150199908|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
150199909|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
150199910|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
150199911|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
150199912|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
150199913|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
150199914|NCT03580356|541872962|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
150199915|NCT03580356|541872963|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
150199916|NCT03580356|541872964|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
150199917|NCT03580356|541872965|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
150199918|NCT03580356|541872966|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
150199919|NCT03580356|541872967|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
150199920|NCT03580356|541872968|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
150199921|NCT03580356|541872969|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
150199922|NCT04544007|541872970|FG000|Overall Study|Withdrawal by Subject|1|||
150199923|NCT04544007|541872970|FG000|Overall Study|Confirmed Progressive Disease|1|||
150199924|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
150199925|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
150199926|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199927|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199928|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199929|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199930|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199931|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199932|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199933|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199934|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199935|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
150199936|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199937|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
150199938|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199939|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199940|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199941|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199942|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199943|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199944|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199945|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199946|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199947|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
150199948|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
150199949|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
150199950|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199951|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199952|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199953|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199954|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199955|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199956|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199957|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199958|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199959|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
150199960|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199961|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
150199962|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199963|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199964|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199965|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199966|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199967|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199968|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199969|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199970|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199971|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
150199972|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199973|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
150199974|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199975|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199976|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199977|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199978|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199979|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199980|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199981|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199982|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199983|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
150199984|NCT03536884|541872971|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199985|NCT03536884|541872972|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
150199986|NCT03536884|541872973|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199987|NCT03536884|541872974|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199988|NCT03536884|541872975|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199989|NCT03536884|541872976|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199990|NCT03536884|541872977|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199991|NCT03536884|541872978|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199992|NCT03536884|541872979|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199993|NCT03536884|541872980|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199994|NCT03536884|541872981|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199995|NCT03536884|541872982|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
150199996|NCT03536884|541872971|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
150199997|NCT03536884|541872972|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
150199998|NCT03536884|541872973|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
150199999|NCT03536884|541872974|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200000|NCT03536884|541872975|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
150200001|NCT03536884|541872976|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200002|NCT03536884|541872977|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200003|NCT03536884|541872978|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200004|NCT03536884|541872979|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200005|NCT03536884|541872980|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200006|NCT03536884|541872981|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200007|NCT03536884|541872982|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
150200008|NCT03536884|541872971|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200009|NCT03536884|541872972|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200010|NCT03536884|541872973|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
150200011|NCT03536884|541872974|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
150200012|NCT03536884|541872975|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
150200013|NCT03536884|541872976|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200014|NCT03536884|541872977|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200015|NCT03536884|541872978|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200016|NCT03536884|541872979|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200017|NCT03536884|541872980|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200018|NCT03536884|541872981|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200019|NCT03536884|541872982|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
150200020|NCT03536884|541872971|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200021|NCT03536884|541872972|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200022|NCT03536884|541872973|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200023|NCT03536884|541872974|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
150200024|NCT03536884|541872975|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
150200025|NCT03536884|541872976|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200026|NCT03536884|541872977|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200027|NCT03536884|541872978|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200028|NCT03536884|541872979|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200029|NCT03536884|541872980|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200030|NCT03536884|541872981|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200031|NCT03536884|541872982|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
150200032|NCT03536884|541872971|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200033|NCT03536884|541872972|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200034|NCT03536884|541872973|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
150200035|NCT03536884|541872974|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
150200036|NCT03536884|541872975|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
150200037|NCT03536884|541872976|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200038|NCT03536884|541872977|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200039|NCT03536884|541872978|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200040|NCT03536884|541872979|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200041|NCT03536884|541872980|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200042|NCT03536884|541872981|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200043|NCT03536884|541872982|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
150200044|NCT03536884|541872971|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200045|NCT03536884|541872972|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200046|NCT03536884|541872973|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
150200047|NCT03536884|541872974|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
150200048|NCT03536884|541872975|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
150200049|NCT03536884|541872976|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200050|NCT03536884|541872977|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200051|NCT03536884|541872978|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200052|NCT03536884|541872979|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200053|NCT03536884|541872980|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200054|NCT03536884|541872981|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200055|NCT03536884|541872982|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
150200056|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200057|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200058|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200059|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200060|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200061|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
150200062|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
150200063|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
150200064|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
150200065|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200066|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
150200067|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
150136678|NCT00810264|541633464|FG000|Overall Study|Withdrawal by subject or physician|721|||
150136679|NCT00810264|541633464|FG000|Overall Study|Death|641|||
150136680|NCT01256567|541633470|FG000|Overall Study|Withdrawal by Subject|1|||
150136681|NCT00567190|541633476|FG000|Overall Study|Death|235|||
150136682|NCT00567190|541633477|FG001|Overall Study|Death|280|||
150136683|NCT00567190|541633476|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
150136684|NCT00567190|541633477|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
150136685|NCT00636610|541633480|FG000|Overall Study|Adverse Event|4|||
150136686|NCT00636610|541633481|FG001|Overall Study|Adverse Event|4|||
150136687|NCT00636610|541633480|FG000|Overall Study|Death|6|||
150136688|NCT00636610|541633481|FG001|Overall Study|Death|3|||
150136689|NCT00636610|541633480|FG000|Overall Study|Physician decision to withdraw patient|15|||
150136690|NCT00636610|541633481|FG001|Overall Study|Physician decision to withdraw patient|9|||
150136691|NCT00636610|541633480|FG000|Overall Study|Subject decision to withdraw|15|||
150136692|NCT00636610|541633481|FG001|Overall Study|Subject decision to withdraw|11|||
150136693|NCT00636610|541633480|FG000|Overall Study|Disease progression - radiographic|41|||
150136694|NCT00636610|541633481|FG001|Overall Study|Disease progression - radiographic|51|||
150136695|NCT00636610|541633480|FG000|Overall Study|Disease progression - clinical|8|||
150136696|NCT00636610|541633481|FG001|Overall Study|Disease progression - clinical|3|||
150136697|NCT00636610|541633480|FG000|Overall Study|Reason for discontinuation not available|3|||
150136698|NCT00636610|541633481|FG001|Overall Study|Reason for discontinuation not available|2|||
150136699|NCT00313820|541633482|FG000|Assigned to Treatment|Other|1|||
150136700|NCT00313820|541633483|FG001|Assigned to Treatment|Other|0|||
150136701|NCT00313820|541633482|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
150136702|NCT00313820|541633483|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
150136703|NCT00313820|541633482|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
150136704|NCT00313820|541633483|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
150136705|NCT00313820|541633482|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
150136706|NCT00313820|541633483|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
150136707|NCT00313820|541633482|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
150136708|NCT00313820|541633483|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
150136709|NCT00313820|541633482|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
150136710|NCT00313820|541633483|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
150136711|NCT02453685|541633489|FG000|Overall Study|Adverse Event|0|||
150136712|NCT02453685|541633490|FG001|Overall Study|Adverse Event|1|||
150136713|NCT02453685|541633489|FG000|Overall Study|Protocol Violation|7|||
150136714|NCT02453685|541633490|FG001|Overall Study|Protocol Violation|4|||
150136715|NCT02453685|541633489|FG000|Overall Study|Lost to Follow-up|0|||
150136716|NCT02453685|541633490|FG001|Overall Study|Lost to Follow-up|1|||
150136717|NCT02453685|541633489|FG000|Overall Study|Withdrawal by Subject|8|||
150136718|NCT02453685|541633490|FG001|Overall Study|Withdrawal by Subject|4|||
150136719|NCT02453685|541633489|FG000|Overall Study|Unclassified|4|||
150136720|NCT02453685|541633490|FG001|Overall Study|Unclassified|2|||
150136721|NCT00522626|541633495|FG000|Overall Study|Lost to Follow-up|7|||
150136722|NCT03076970|541635312|FG000|Washout Period 2|Adverse Event|0|||
150136723|NCT03076970|541635313|FG001|Washout Period 2|Adverse Event|0|||
150136724|NCT03076970|541635314|FG002|Washout Period 2|Adverse Event|0|||
150136725|NCT03076970|541635315|FG003|Washout Period 2|Adverse Event|0|||
150136726|NCT03076970|541635316|FG004|Washout Period 2|Adverse Event|1|||
150136727|NCT03076970|541635317|FG005|Washout Period 2|Adverse Event|0|||
150136728|NCT03076970|541635312|FG000|Period 3|Withdrawal by Subject|0|||
150136729|NCT03076970|541635313|FG001|Period 3|Withdrawal by Subject|0|||
150136730|NCT03076970|541635314|FG002|Period 3|Withdrawal by Subject|0|||
150136731|NCT03076970|541635315|FG003|Period 3|Withdrawal by Subject|0|||
150136732|NCT03076970|541635316|FG004|Period 3|Withdrawal by Subject|0|||
150136733|NCT03076970|541635317|FG005|Period 3|Withdrawal by Subject|1|||
150136734|NCT03076970|541635312|FG000|Period 3|Failure to meet I/E criteria|0|||
150136735|NCT03076970|541635313|FG001|Period 3|Failure to meet I/E criteria|0|||
150136736|NCT03076970|541635314|FG002|Period 3|Failure to meet I/E criteria|0|||
150136737|NCT03076970|541635315|FG003|Period 3|Failure to meet I/E criteria|0|||
150136738|NCT03076970|541635316|FG004|Period 3|Failure to meet I/E criteria|1|||
150136739|NCT03076970|541635317|FG005|Period 3|Failure to meet I/E criteria|0|||
150136740|NCT00838682|541635318|FG000|Overall Study|Lost to Follow-up|21|||
150136741|NCT00838682|541635319|FG001|Overall Study|Lost to Follow-up|14|||
150136742|NCT00838682|541635318|FG000|Overall Study|detection of exclusion criteria|4|||
150136743|NCT00838682|541635319|FG001|Overall Study|detection of exclusion criteria|3|||
150136744|NCT00838682|541635318|FG000|Overall Study|Protocol Violation|0|||
150136745|NCT00838682|541635319|FG001|Overall Study|Protocol Violation|1|||
150136746|NCT00838682|541635318|FG000|Overall Study|Withdrawal by Subject|0|||
150136747|NCT00838682|541635319|FG001|Overall Study|Withdrawal by Subject|1|||
150136748|NCT03315143|541635329|FG000|Overall Study|Death|240|||
150136749|NCT03315143|541635330|FG001|Overall Study|Death|246|||
150136750|NCT03315143|541635329|FG000|Overall Study|Withdrawal by Subject|57|||
150136751|NCT03315143|541635330|FG001|Overall Study|Withdrawal by Subject|68|||
150136752|NCT03315143|541635329|FG000|Overall Study|Site Terminated by Sponsor|256|||
150136753|NCT03315143|541635330|FG001|Overall Study|Site Terminated by Sponsor|282|||
150136754|NCT03315143|541635329|FG000|Overall Study|Study Terminated by Sponsor|4723|||
150136755|NCT03315143|541635330|FG001|Overall Study|Study Terminated by Sponsor|4664|||
150136756|NCT03315143|541635329|FG000|Overall Study|Reason not Specified|16|||
150136757|NCT03315143|541635330|FG001|Overall Study|Reason not Specified|32|||
150136758|NCT03320018|541635331|FG000|Treatment Period|Withdrawal by Subject|1|||
150200068|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150136759|NCT03320018|541635332|FG001|Treatment Period|Withdrawal by Subject|0|||
150136760|NCT03320018|541635331|FG000|Day 90 Follow up|Death|0|||
150200069|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200070|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200071|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200072|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200073|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
150200074|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
150200075|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
150200076|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
150200077|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200078|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200079|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
150200080|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200081|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200082|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200083|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200084|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200085|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
150200086|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200087|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
150200088|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200089|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200090|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200091|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
150200092|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200093|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200094|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200095|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200096|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200097|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
150200098|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200099|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
150200100|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
150200101|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200102|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200103|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
150200104|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200105|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200106|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200107|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200108|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200109|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
150200110|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
150200111|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
150200112|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
150200113|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200114|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200115|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
150200116|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200117|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200118|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200119|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200120|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200121|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
150200122|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200123|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200124|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200125|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200126|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200127|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
150200128|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200129|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200130|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200131|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200132|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200133|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200134|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
150200135|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150136761|NCT03320018|541635332|FG001|Day 90 Follow up|Death|1|||
150136762|NCT02641392|541635335|FG000|Overall Study|Lost to Follow-up|0|||
150136763|NCT02641392|541635336|FG001|Overall Study|Lost to Follow-up|0|||
150136764|NCT02641392|541635337|FG002|Overall Study|Lost to Follow-up|2|||
150136765|NCT02641392|541635335|FG000|Overall Study|Withdrawal by Subject|0|||
150136766|NCT02641392|541635336|FG001|Overall Study|Withdrawal by Subject|0|||
150136767|NCT02641392|541635337|FG002|Overall Study|Withdrawal by Subject|17|||
150136768|NCT02641392|541635335|FG000|Overall Study|Adverse Event|0|||
150136769|NCT02641392|541635336|FG001|Overall Study|Adverse Event|1|||
150136770|NCT02641392|541635337|FG002|Overall Study|Adverse Event|25|||
150136771|NCT02641392|541635335|FG000|Overall Study|Study Terminated by Sponsor|4|||
150136772|NCT02641392|541635336|FG001|Overall Study|Study Terminated by Sponsor|12|||
150136773|NCT02641392|541635337|FG002|Overall Study|Study Terminated by Sponsor|144|||
150136774|NCT02641392|541635335|FG000|Overall Study|Lack of Efficacy|0|||
150136775|NCT02641392|541635336|FG001|Overall Study|Lack of Efficacy|0|||
150136776|NCT02641392|541635337|FG002|Overall Study|Lack of Efficacy|101|||
150136777|NCT02641392|541635335|FG000|Overall Study|Miscellaneous|0|||
150136778|NCT02641392|541635336|FG001|Overall Study|Miscellaneous|0|||
150136779|NCT02641392|541635337|FG002|Overall Study|Miscellaneous|3|||
150136780|NCT02641392|541635335|FG000|Overall Study|Death|0|||
150136781|NCT02641392|541635336|FG001|Overall Study|Death|0|||
150136782|NCT02641392|541635337|FG002|Overall Study|Death|1|||
150136783|NCT02691182|541635338|FG000|Overall Study|Withdrawal by Subject|4|||
150136784|NCT02691182|541635339|FG001|Overall Study|Withdrawal by Subject|7|||
150136785|NCT02691182|541635340|FG002|Overall Study|Withdrawal by Subject|6|||
150136786|NCT02691182|541635341|FG003|Overall Study|Withdrawal by Subject|8|||
150136787|NCT02691182|541635338|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
150136788|NCT02691182|541635339|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
150136789|NCT02691182|541635340|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
150136790|NCT02691182|541635341|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
150136791|NCT02691182|541635338|FG000|Overall Study|Lost to Follow-up|8|||
150136792|NCT02691182|541635339|FG001|Overall Study|Lost to Follow-up|33|||
150136793|NCT02691182|541635340|FG002|Overall Study|Lost to Follow-up|19|||
150136794|NCT02691182|541635341|FG003|Overall Study|Lost to Follow-up|22|||
150136795|NCT02691182|541635338|FG000|Overall Study|Adverse Event|3|||
150136796|NCT02691182|541635339|FG001|Overall Study|Adverse Event|10|||
150136797|NCT02691182|541635340|FG002|Overall Study|Adverse Event|10|||
150136798|NCT02691182|541635341|FG003|Overall Study|Adverse Event|11|||
150136799|NCT02691182|541635338|FG000|Overall Study|Physician Decision|3|||
150136800|NCT02691182|541635339|FG001|Overall Study|Physician Decision|7|||
150136801|NCT02691182|541635340|FG002|Overall Study|Physician Decision|14|||
150136802|NCT02691182|541635341|FG003|Overall Study|Physician Decision|8|||
150136803|NCT02691182|541635338|FG000|Overall Study|Lack of Efficacy|0|||
150136804|NCT02691182|541635339|FG001|Overall Study|Lack of Efficacy|0|||
150136805|NCT02691182|541635340|FG002|Overall Study|Lack of Efficacy|0|||
150136806|NCT02691182|541635341|FG003|Overall Study|Lack of Efficacy|4|||
150136807|NCT02691182|541635338|FG000|Overall Study|Protocol Violation|2|||
150136808|NCT02691182|541635339|FG001|Overall Study|Protocol Violation|6|||
150136809|NCT02691182|541635340|FG002|Overall Study|Protocol Violation|6|||
150136810|NCT02691182|541635341|FG003|Overall Study|Protocol Violation|8|||
150136811|NCT02691182|541635338|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
150136812|NCT02691182|541635339|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
150136813|NCT02691182|541635340|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
150136814|NCT02691182|541635341|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
150136815|NCT02691182|541635338|FG000|Overall Study|Missing|0|||
150136816|NCT02691182|541635339|FG001|Overall Study|Missing|5|||
150136817|NCT02691182|541635340|FG002|Overall Study|Missing|1|||
150136818|NCT02691182|541635341|FG003|Overall Study|Missing|5|||
150136819|NCT02563002|541635344|FG000|Overall Study|Death|72|||
150136820|NCT02563002|541635345|FG001|Overall Study|Death|87|||
150136821|NCT02563002|541635344|FG000|Overall Study|Lost to Follow-up|5|||
150136822|NCT02563002|541635345|FG001|Overall Study|Lost to Follow-up|0|||
150136823|NCT02563002|541635344|FG000|Overall Study|Physician Decision|0|||
150136824|NCT02563002|541635345|FG001|Overall Study|Physician Decision|2|||
150136825|NCT02563002|541635344|FG000|Overall Study|Withdrawal by Subject|2|||
150136826|NCT02563002|541635345|FG001|Overall Study|Withdrawal by Subject|10|||
150136827|NCT02563002|541635344|FG000|Overall Study|Sponsor decision|74|||
150136828|NCT02563002|541635345|FG001|Overall Study|Sponsor decision|55|||
150136829|NCT03518125|541635352|FG000|Overall Study|Lost to Follow-up|0|||
150136830|NCT03518125|541635353|FG001|Overall Study|Lost to Follow-up|2|||
150136831|NCT03518125|541635354|FG002|Overall Study|Lost to Follow-up|0|||
150136832|NCT03518125|541635355|FG003|Overall Study|Lost to Follow-up|0|||
150136833|NCT03518125|541635356|FG004|Overall Study|Lost to Follow-up|3|||
150136834|NCT03518125|541635357|FG005|Overall Study|Lost to Follow-up|5|||
150136835|NCT03518125|541635352|FG000|Overall Study|Physician Decision|0|||
150136836|NCT03518125|541635353|FG001|Overall Study|Physician Decision|1|||
150136837|NCT03518125|541635354|FG002|Overall Study|Physician Decision|0|||
150136838|NCT03518125|541635355|FG003|Overall Study|Physician Decision|0|||
150136839|NCT03518125|541635356|FG004|Overall Study|Physician Decision|0|||
150136840|NCT03518125|541635357|FG005|Overall Study|Physician Decision|0|||
150136841|NCT03518125|541635352|FG000|Overall Study|Withdrawal by Subject|1|||
150136842|NCT03518125|541635353|FG001|Overall Study|Withdrawal by Subject|1|||
150136843|NCT03518125|541635354|FG002|Overall Study|Withdrawal by Subject|0|||
150136844|NCT03518125|541635355|FG003|Overall Study|Withdrawal by Subject|1|||
150136845|NCT03518125|541635356|FG004|Overall Study|Withdrawal by Subject|1|||
150136846|NCT03518125|541635357|FG005|Overall Study|Withdrawal by Subject|3|||
150136847|NCT03518125|541635352|FG000|Overall Study|Missed Day 394 Visit|1|||
150136848|NCT03518125|541635353|FG001|Overall Study|Missed Day 394 Visit|0|||
150136849|NCT03518125|541635354|FG002|Overall Study|Missed Day 394 Visit|0|||
150136850|NCT03518125|541635355|FG003|Overall Study|Missed Day 394 Visit|0|||
150136851|NCT03518125|541635356|FG004|Overall Study|Missed Day 394 Visit|0|||
150136852|NCT03518125|541635357|FG005|Overall Study|Missed Day 394 Visit|0|||
150136853|NCT04452877|541635358|FG000|Overall Study|Adverse Event|5|||
150136854|NCT04452877|541635358|FG000|Overall Study|Lost to Follow-up|1|||
150136855|NCT04452877|541635358|FG000|Overall Study|Physician Decision|4|||
150136856|NCT04452877|541635358|FG000|Overall Study|Progressive Disease|18|||
150136857|NCT04452877|541635358|FG000|Overall Study|Withdrawal by Subject|3|||
150136858|NCT05453110|541635359|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
150136859|NCT05453110|541635360|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
150136860|NCT05453110|541635361|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
150200136|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200137|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200138|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200139|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
150200140|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200141|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200142|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200143|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200144|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200145|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200146|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
150200147|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200148|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200149|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200150|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200151|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
150200152|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200153|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200154|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200155|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200156|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200157|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
150200158|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200159|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200160|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200161|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200162|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200163|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
150200164|NCT03536884|541872971|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200165|NCT03536884|541872972|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200166|NCT03536884|541872973|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200167|NCT03536884|541872974|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200168|NCT03536884|541872975|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200169|NCT03536884|541872976|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200170|NCT03536884|541872977|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200171|NCT03536884|541872978|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200172|NCT03536884|541872979|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
150200173|NCT03536884|541872980|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150136861|NCT05906368|541635362|FG000|Overall Study|Withdrawal by Subject|1|||
150136862|NCT05906368|541635363|FG001|Overall Study|Withdrawal by Subject|1|||
150136863|NCT05906368|541635362|FG000|Overall Study|Ineligibility criteria identified|2|||
150136864|NCT05906368|541635363|FG001|Overall Study|Ineligibility criteria identified|0|||
150136865|NCT02799784|541635364|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
150136866|NCT02799784|541635365|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
150136867|NCT02799784|541635364|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
150136868|NCT02799784|541635365|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
150136869|NCT02799784|541635364|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
150136870|NCT02799784|541635365|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
150136871|NCT02799784|541635364|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
150136872|NCT02799784|541635365|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
150136873|NCT02799784|541635364|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
150200174|NCT03536884|541872981|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200175|NCT03536884|541872982|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
150200176|NCT03536884|541872971|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200177|NCT03536884|541872972|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200178|NCT03536884|541872973|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200179|NCT03536884|541872974|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200180|NCT03536884|541872975|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200181|NCT03536884|541872976|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200182|NCT03536884|541872977|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200183|NCT03536884|541872978|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200184|NCT03536884|541872979|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
150200185|NCT03536884|541872980|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
150200186|NCT03536884|541872981|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
150200187|NCT03536884|541872982|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
150200188|NCT03536884|541872971|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200189|NCT03536884|541872972|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200190|NCT03536884|541872973|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200191|NCT03536884|541872974|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200192|NCT03536884|541872975|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200193|NCT03536884|541872976|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200194|NCT03536884|541872977|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200195|NCT03536884|541872978|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200196|NCT03536884|541872979|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
150200197|NCT03536884|541872980|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
150200198|NCT03536884|541872981|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
150200199|NCT03536884|541872982|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
150200200|NCT03536884|541872971|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200201|NCT03536884|541872972|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200202|NCT03536884|541872973|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200203|NCT03536884|541872974|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200204|NCT03536884|541872975|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200205|NCT03536884|541872976|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200206|NCT03536884|541872977|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200207|NCT03536884|541872978|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200208|NCT03536884|541872979|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200209|NCT03536884|541872980|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200210|NCT03536884|541872981|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
150200211|NCT03536884|541872982|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
150200212|NCT03536884|541872971|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200213|NCT03536884|541872972|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200214|NCT03536884|541872973|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200215|NCT03536884|541872974|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200216|NCT03536884|541872975|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200217|NCT03536884|541872976|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200218|NCT03536884|541872977|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200219|NCT03536884|541872978|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200220|NCT03536884|541872979|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200221|NCT03536884|541872980|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200222|NCT03536884|541872981|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
150200223|NCT03536884|541872982|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
150200224|NCT03536884|541872971|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200225|NCT03536884|541872972|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200226|NCT03536884|541872973|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200227|NCT03536884|541872974|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200228|NCT03536884|541872975|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200229|NCT03536884|541872976|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200230|NCT03536884|541872977|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200231|NCT03536884|541872978|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200232|NCT03536884|541872979|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200233|NCT03536884|541872980|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200234|NCT03536884|541872981|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
150200235|NCT03536884|541872982|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
150136874|NCT02799784|541635365|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
150136875|NCT02799784|541635364|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
150136876|NCT02799784|541635365|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
150136877|NCT01050816|541635369|FG000|Overall Study|Lost to Follow-up|2|||
150136878|NCT01050816|541635369|FG000|Overall Study|patient's refusal|2|||
150136879|NCT02403180|541635374|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
150136880|NCT02403180|541635375|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
150136881|NCT02403180|541635374|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
150136882|NCT02403180|541635375|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
150136883|NCT01445652|541635376|FG000|Overall Study|Not comfortable in lenses|5|||
150136884|NCT01445652|541635377|FG001|Overall Study|Not comfortable in lenses|0|||
150136885|NCT01445652|541635376|FG000|Overall Study|Failed to attend scheduled visit|2|||
150136886|NCT01445652|541635377|FG001|Overall Study|Failed to attend scheduled visit|3|||
150136887|NCT01445652|541635376|FG000|Overall Study|Failed teach session|2|||
150136888|NCT01445652|541635377|FG001|Overall Study|Failed teach session|0|||
150136889|NCT01445652|541635376|FG000|Overall Study|Adverse Event|1|||
150136890|NCT01445652|541635377|FG001|Overall Study|Adverse Event|0|||
150136891|NCT00929162|541635378|FG000|Overall Study|Adverse Event|8|||
150136892|NCT00929162|541635379|FG001|Overall Study|Adverse Event|5|||
150136893|NCT00929162|541635378|FG000|Overall Study|Withdrawal by Subject|3|||
150136894|NCT00929162|541635379|FG001|Overall Study|Withdrawal by Subject|1|||
150136895|NCT00929162|541635378|FG000|Overall Study|Protocol Violation|32|||
150136896|NCT00929162|541635379|FG001|Overall Study|Protocol Violation|30|||
150136897|NCT00929162|541635378|FG000|Overall Study|Other termination reason|5|||
150136898|NCT00929162|541635379|FG001|Overall Study|Other termination reason|6|||
150136899|NCT00952822|541635380|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
150136900|NCT00952822|541635381|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
150136901|NCT00952822|541635382|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
150136902|NCT00952822|541635383|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
150136903|NCT00952822|541635380|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
150136904|NCT00952822|541635381|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
150136905|NCT00952822|541635382|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
150136906|NCT00952822|541635383|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
150200236|NCT04880733|541872989|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
150200237|NCT04880733|541872990|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
150200238|NCT04880733|541872991|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
150200239|NCT04880733|541872989|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
150200240|NCT04880733|541872990|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
150200241|NCT04880733|541872991|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
150200242|NCT04880733|541872989|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
150200243|NCT04880733|541872990|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
150200244|NCT04880733|541872991|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
150200245|NCT04880733|541872989|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
150200246|NCT04880733|541872990|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
150200247|NCT04880733|541872991|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
150200248|NCT04880733|541872989|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
150200249|NCT04880733|541872990|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
150200250|NCT04880733|541872991|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
150200251|NCT05533190|541872993|FG000|Overall Study|Lost to Follow-up|19|||
150200252|NCT05533190|541872994|FG001|Overall Study|Lost to Follow-up|7|||
150200253|NCT05533190|541872993|FG000|Overall Study|Failed to download app|1|||
150200254|NCT05533190|541872994|FG001|Overall Study|Failed to download app|0|||
150200255|NCT05533190|541872993|FG000|Overall Study|Thought app was a scam|1|||
150200256|NCT05533190|541872994|FG001|Overall Study|Thought app was a scam|0|||
150200257|NCT05533190|541872993|FG000|Overall Study|Withdrawal by Subject|2|||
150200258|NCT05533190|541872994|FG001|Overall Study|Withdrawal by Subject|0|||
150200259|NCT02323880|541872995|FG000|Overall Study|Adverse Event|2|||
150200260|NCT02323880|541872996|FG001|Overall Study|Adverse Event|0|||
150200261|NCT02323880|541872997|FG002|Overall Study|Adverse Event|1|||
150200262|NCT02323880|541872998|FG003|Overall Study|Adverse Event|1|||
150136907|NCT00658567|541635384|FG000|Overall Study|Adverse Event|5|||
150136908|NCT00658567|541635385|FG001|Overall Study|Adverse Event|2|||
150136909|NCT00658567|541635386|FG002|Overall Study|Adverse Event|3|||
150136910|NCT00658567|541635384|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
150136911|NCT00658567|541635385|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
150136912|NCT00658567|541635386|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
150136913|NCT00658567|541635384|FG000|Overall Study|Physician Decision|0|||
150200263|NCT02323880|541872999|FG004|Overall Study|Adverse Event|1|||
150200264|NCT02323880|541873000|FG005|Overall Study|Adverse Event|0|||
150200265|NCT02323880|541873001|FG006|Overall Study|Adverse Event|1|||
150200266|NCT02323880|541873002|FG007|Overall Study|Adverse Event|0|||
150200267|NCT02323880|541872995|FG000|Overall Study|Death|0|||
150200268|NCT02323880|541872996|FG001|Overall Study|Death|0|||
150200269|NCT02323880|541872997|FG002|Overall Study|Death|0|||
150200270|NCT02323880|541872998|FG003|Overall Study|Death|0|||
150200271|NCT02323880|541872999|FG004|Overall Study|Death|0|||
150200272|NCT02323880|541873000|FG005|Overall Study|Death|1|||
150200273|NCT02323880|541873001|FG006|Overall Study|Death|0|||
150200274|NCT02323880|541873002|FG007|Overall Study|Death|0|||
150200275|NCT02323880|541872995|FG000|Overall Study|Lack of Efficacy|4|||
150200276|NCT02323880|541872996|FG001|Overall Study|Lack of Efficacy|11|||
150200277|NCT02323880|541872997|FG002|Overall Study|Lack of Efficacy|5|||
150200278|NCT02323880|541872998|FG003|Overall Study|Lack of Efficacy|5|||
150200279|NCT02323880|541872999|FG004|Overall Study|Lack of Efficacy|4|||
150200280|NCT02323880|541873000|FG005|Overall Study|Lack of Efficacy|8|||
150200281|NCT02323880|541873001|FG006|Overall Study|Lack of Efficacy|4|||
150200282|NCT02323880|541873002|FG007|Overall Study|Lack of Efficacy|6|||
150200283|NCT02323880|541872995|FG000|Overall Study|Physician Decision|0|||
150200284|NCT02323880|541872996|FG001|Overall Study|Physician Decision|0|||
150200285|NCT02323880|541872997|FG002|Overall Study|Physician Decision|0|||
150200286|NCT02323880|541872998|FG003|Overall Study|Physician Decision|0|||
150200287|NCT02323880|541872999|FG004|Overall Study|Physician Decision|1|||
150200288|NCT02323880|541873000|FG005|Overall Study|Physician Decision|1|||
150200289|NCT02323880|541873001|FG006|Overall Study|Physician Decision|1|||
150200290|NCT02323880|541873002|FG007|Overall Study|Physician Decision|0|||
150200291|NCT02323880|541872995|FG000|Overall Study|Withdrawal by Subject|0|||
150200292|NCT02323880|541872996|FG001|Overall Study|Withdrawal by Subject|2|||
150200293|NCT02323880|541872997|FG002|Overall Study|Withdrawal by Subject|0|||
150200294|NCT02323880|541872998|FG003|Overall Study|Withdrawal by Subject|0|||
150200295|NCT02323880|541872999|FG004|Overall Study|Withdrawal by Subject|0|||
150200296|NCT02323880|541873000|FG005|Overall Study|Withdrawal by Subject|0|||
150200297|NCT02323880|541873001|FG006|Overall Study|Withdrawal by Subject|0|||
150200298|NCT02323880|541873002|FG007|Overall Study|Withdrawal by Subject|0|||
150200299|NCT03213678|541873005|FG000|Overall Study|Death|1|||
150200300|NCT03213678|541873005|FG000|Overall Study|Physician Decision|1|||
150200301|NCT03213678|541873005|FG000|Overall Study|Progressive disease|16|||
150200302|NCT04218851|541873006|FG000|Overall Study|Death|1|||
150200303|NCT04218851|541873007|FG001|Overall Study|Death|3|||
150200304|NCT03174275|541873008|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
150200305|NCT03174275|541873008|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
150200306|NCT03174275|541873008|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
150200307|NCT03174275|541873008|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
150200308|NCT03174275|541873008|FG000|Adjuvant Chemotherapy|Progression|1|||
150200309|NCT03174275|541873008|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
150200310|NCT03174275|541873008|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
150200311|NCT03174275|541873008|FG000|Adjuvant Durvalumab|Progression|1|||
150200312|NCT03174275|541873008|FG000|Adjuvant Durvalumab|Adverse Event|3|||
150200313|NCT03174275|541873008|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
150200314|NCT03174275|541873008|FG000|Adjuvant Radiotherapy|Progression|1|||
150136914|NCT00658567|541635385|FG001|Overall Study|Physician Decision|1|||
150136915|NCT00658567|541635386|FG002|Overall Study|Physician Decision|0|||
150136916|NCT00658567|541635384|FG000|Overall Study|At Discretion of Sponsor|1|||
150136917|NCT00658567|541635385|FG001|Overall Study|At Discretion of Sponsor|1|||
150136918|NCT00658567|541635386|FG002|Overall Study|At Discretion of Sponsor|1|||
150136919|NCT01755702|541635387|FG000|Wash Out Period I|Other Reason|3|||
150136920|NCT01755702|541635387|FG000|Washout Period II|Other Reason|5|||
150136921|NCT00691938|541635388|FG000|Overall Study|QTc prolongation|1|||
150136922|NCT00691938|541635389|FG001|Overall Study|QTc prolongation|0|||
150136923|NCT00691938|541635390|FG002|Overall Study|QTc prolongation|0|||
150136924|NCT00691938|541635391|FG003|Overall Study|QTc prolongation|0|||
150136925|NCT00691938|541635392|FG004|Overall Study|QTc prolongation|0|||
150136926|NCT00691938|541635393|FG005|Overall Study|QTc prolongation|0|||
150136927|NCT00691938|541635394|FG006|Overall Study|QTc prolongation|0|||
150136928|NCT04860518|541635396|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
150136929|NCT04860518|541635397|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
150136930|NCT03039023|541635403|FG000|Overall Study|Withdrawal by Subject|1|||
150136931|NCT03039023|541635404|FG001|Overall Study|Withdrawal by Subject|0|||
150136932|NCT03039023|541635405|FG002|Overall Study|Withdrawal by Subject|1|||
150136933|NCT03039023|541635406|FG003|Overall Study|Withdrawal by Subject|1|||
150136934|NCT03039023|541635407|FG004|Overall Study|Withdrawal by Subject|0|||
150200315|NCT03174275|541873008|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
150200316|NCT03717935|541873013|FG000|Overall Study|Withdrawal by Subject|0|||
150200317|NCT03717935|541873014|FG001|Overall Study|Withdrawal by Subject|2|||
150136935|NCT03039023|541635403|FG000|Overall Study|Physician Decision|0|||
150200318|NCT01820611|541873015|FG000|Overall Study|Death|8|||
150136936|NCT03039023|541635404|FG001|Overall Study|Physician Decision|0|||
150136937|NCT03039023|541635405|FG002|Overall Study|Physician Decision|0|||
150136938|NCT03039023|541635406|FG003|Overall Study|Physician Decision|1|||
150136939|NCT03039023|541635407|FG004|Overall Study|Physician Decision|0|||
150136940|NCT03701399|541635408|FG000|Overall Study|Adverse Event|3|||
150136941|NCT03701399|541635409|FG001|Overall Study|Adverse Event|5|||
150136942|NCT03701399|541635408|FG000|Overall Study|Withdrawal by Subject|6|||
150136943|NCT03701399|541635409|FG001|Overall Study|Withdrawal by Subject|3|||
150136944|NCT03701399|541635408|FG000|Overall Study|Investigators decision|1|||
150136945|NCT03701399|541635409|FG001|Overall Study|Investigators decision|2|||
150136946|NCT03701399|541635408|FG000|Overall Study|Lost to Follow-up|1|||
150136947|NCT03701399|541635409|FG001|Overall Study|Lost to Follow-up|2|||
150136948|NCT03701399|541635408|FG000|Overall Study|Death|1|||
150136949|NCT03701399|541635409|FG001|Overall Study|Death|1|||
150136950|NCT03701399|541635408|FG000|Overall Study|Randomized but not treated|1|||
150136951|NCT03701399|541635409|FG001|Overall Study|Randomized but not treated|0|||
150136952|NCT03440372|541635410|FG000|Treatment|Adverse Event|16|||
150136953|NCT03440372|541635411|FG001|Treatment|Adverse Event|8|||
150136954|NCT03440372|541635410|FG000|Treatment|Lack of Efficacy|4|||
150136955|NCT03440372|541635411|FG001|Treatment|Lack of Efficacy|2|||
150136956|NCT03440372|541635410|FG000|Treatment|Withdrawal by Subject|12|||
150136957|NCT03440372|541635411|FG001|Treatment|Withdrawal by Subject|8|||
150136958|NCT03440372|541635410|FG000|Treatment|Lost to Follow-up|1|||
150136959|NCT03440372|541635411|FG001|Treatment|Lost to Follow-up|0|||
150136960|NCT03440372|541635410|FG000|Treatment|Pregnancy|1|||
150136961|NCT03440372|541635411|FG001|Treatment|Pregnancy|0|||
150136962|NCT03440372|541635410|FG000|Treatment|Study Terminated by Sponsor|2|||
150136963|NCT03440372|541635411|FG001|Treatment|Study Terminated by Sponsor|1|||
150200319|NCT01820611|541873015|FG000|Overall Study|Adverse Event|1|||
150200320|NCT01820611|541873015|FG000|Overall Study|Withdrawal by Subject|9|||
150200321|NCT03484819|541873016|FG000|Overall Study|Death|2|||
150200322|NCT03484819|541873016|FG000|Overall Study|Adverse Event|2|||
150200323|NCT03484819|541873016|FG000|Overall Study|Physician Decision|1|||
150200324|NCT03484819|541873016|FG000|Overall Study|Withdrawal by Subject|2|||
150200325|NCT03484819|541873016|FG000|Overall Study|Disease Progression|4|||
150200326|NCT03484819|541873016|FG000|Overall Study|Complicating Condition|1|||
150200327|NCT05970861|541873017|FG000|Overall Study|Physician Decision|4|||
150200328|NCT05970861|541873018|FG001|Overall Study|Physician Decision|4|||
150200329|NCT05970861|541873017|FG000|Overall Study|Lost to Follow-up|4|||
150200330|NCT05970861|541873018|FG001|Overall Study|Lost to Follow-up|3|||
150200331|NCT05736458|541873019|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
150200332|NCT05736458|541873020|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
150200333|NCT05736458|541873021|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
150200334|NCT05736458|541873019|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
150200335|NCT05736458|541873020|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
150200336|NCT05736458|541873021|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
150200337|NCT05736458|541873019|FG000|TMS/fMRI #1|Physician Decision|0|||
150200338|NCT05736458|541873020|FG001|TMS/fMRI #1|Physician Decision|0|||
150200339|NCT05736458|541873021|FG002|TMS/fMRI #1|Physician Decision|2|||
150200340|NCT05736458|541873019|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
150200341|NCT05736458|541873020|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
150200342|NCT05736458|541873021|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
150200343|NCT02990338|541873022|FG000|Overall Study|Randomized and not treated|4|||
150200344|NCT02990338|541873023|FG001|Overall Study|Randomized and not treated|2|||
150200345|NCT02990338|541873022|FG000|Overall Study|Adverse Event|23|||
150200346|NCT02990338|541873023|FG001|Overall Study|Adverse Event|22|||
150200347|NCT02990338|541873022|FG000|Overall Study|Progressive disease|118|||
150200348|NCT02990338|541873023|FG001|Overall Study|Progressive disease|107|||
150200349|NCT02990338|541873022|FG000|Overall Study|Poor compliance to protocol|0|||
150200350|NCT02990338|541873023|FG001|Overall Study|Poor compliance to protocol|1|||
150200351|NCT02990338|541873022|FG000|Overall Study|Withdrawal by Subject|6|||
150136964|NCT03440372|541635410|FG000|Treatment|Other Reason|2|||
150136965|NCT03440372|541635411|FG001|Treatment|Other Reason|3|||
150136966|NCT00448448|541635412|FG000|Overall Study|Withdrawal by Subject|13|||
150136967|NCT00448448|541635413|FG001|Overall Study|Withdrawal by Subject|2|||
150136968|NCT00448448|541635412|FG000|Overall Study|On protocol when study ended|83|||
150136969|NCT00448448|541635413|FG001|Overall Study|On protocol when study ended|36|||
150136970|NCT00448448|541635412|FG000|Overall Study|Lost to Follow-up|2|||
150136971|NCT00448448|541635413|FG001|Overall Study|Lost to Follow-up|1|||
150200352|NCT02990338|541873023|FG001|Overall Study|Withdrawal by Subject|8|||
150200353|NCT02990338|541873022|FG000|Overall Study|Physician's decision|2|||
150200354|NCT02990338|541873023|FG001|Overall Study|Physician's decision|6|||
150200355|NCT02990338|541873022|FG000|Overall Study|Treatment extension study|0|||
150200356|NCT02990338|541873023|FG001|Overall Study|Treatment extension study|6|||
150200357|NCT02990338|541873022|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
150200358|NCT02990338|541873023|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
150200359|NCT02990338|541873022|FG000|Overall Study|Continue with therapy available commercially|0|||
150200360|NCT02990338|541873023|FG001|Overall Study|Continue with therapy available commercially|1|||
150200361|NCT04186819|541873025|FG000|Overall Study|Adverse Event|1|||
150200362|NCT04186819|541873025|FG000|Overall Study|Lost to Follow-up|1|||
150200363|NCT04186819|541873025|FG000|Overall Study|Opted for EBRT|1|||
150200364|NCT04186819|541873025|FG000|Overall Study|Opted SBRT|1|||
150200365|NCT04186819|541873025|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
150200366|NCT04186819|541873025|FG000|Overall Study|Physician Decision|1|||
150200367|NCT04186819|541873025|FG000|Overall Study|RP Delayed|1|||
150200368|NCT04186819|541873025|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
150200369|NCT04186819|541873025|FG000|Overall Study|Subject declined for financial reasons|1|||
150200370|NCT04186819|541873025|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
150200371|NCT04186819|541873025|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
150200372|NCT04186819|541873025|FG000|Overall Study|The subject opted for other treatment option|2|||
150200373|NCT04186819|541873025|FG000|Overall Study|The subject opted for other treatment options|1|||
150200374|NCT04186819|541873025|FG000|Overall Study|Withdrawal by Subject|3|||
150200375|NCT04186819|541873025|FG000|Overall Study|Reason not specified|1|||
150200376|NCT02944968|541873027|FG000|Overall Study|Subject excluded before study procedure|1|||
150200377|NCT02944968|541873027|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
150200378|NCT00721149|541873028|FG000|Overall Study|Physician Decision|1|||
150200379|NCT03663205|541873029|FG000|Overall Study|Death|144|||
150200380|NCT03663205|541873030|FG001|Overall Study|Death|69|||
150200381|NCT03663205|541873029|FG000|Overall Study|Sponsor decision|53|||
150200382|NCT03663205|541873030|FG001|Overall Study|Sponsor decision|19|||
150200383|NCT03663205|541873029|FG000|Overall Study|Withdrawal by Subject|8|||
150200384|NCT03663205|541873030|FG001|Overall Study|Withdrawal by Subject|11|||
150200385|NCT03663205|541873029|FG000|Overall Study|Lost to Follow-up|7|||
150200386|NCT03663205|541873030|FG001|Overall Study|Lost to Follow-up|9|||
150200387|NCT03663205|541873029|FG000|Overall Study|Transferred to long term extension study|11|||
150200388|NCT03663205|541873030|FG001|Overall Study|Transferred to long term extension study|3|||
150200389|NCT02518048|541873034|FG000|Overall Study|Withdrawal by Subject|1|||
150200390|NCT05654662|541873035|FG000|Overall Study|Withdrawal by Subject|1|||
150136972|NCT00448448|541635412|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
150136973|NCT00448448|541635413|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
150136974|NCT00448448|541635412|FG000|Overall Study|Signed consent lost|0|||
150136975|NCT00448448|541635413|FG001|Overall Study|Signed consent lost|1|||
150136976|NCT02340026|541635414|FG000|Treatment Phase|Withdrawal by Subject|2|||
150136977|NCT02340026|541635415|FG001|Treatment Phase|Withdrawal by Subject|2|||
150136978|NCT02340026|541635414|FG000|Follow-up Phase|Lost to Follow-up|1|||
150136979|NCT02340026|541635415|FG001|Follow-up Phase|Lost to Follow-up|0|||
150136980|NCT03945292|541635416|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
150136981|NCT03945292|541635417|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136982|NCT03945292|541635418|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
150136983|NCT03945292|541635419|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136984|NCT03945292|541635420|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136985|NCT03945292|541635421|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136986|NCT03945292|541635422|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136987|NCT03945292|541635423|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
150136988|NCT03945292|541635416|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136989|NCT03945292|541635417|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136990|NCT03945292|541635418|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
150136991|NCT03945292|541635419|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136992|NCT03945292|541635420|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136993|NCT03945292|541635421|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136994|NCT03945292|541635422|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136995|NCT03945292|541635423|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
150136996|NCT03945292|541635416|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150136997|NCT03945292|541635417|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150136998|NCT03945292|541635418|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150136999|NCT03945292|541635419|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150137000|NCT03945292|541635420|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150200391|NCT05654662|541873036|FG001|Overall Study|Withdrawal by Subject|0|||
150200392|NCT05654662|541873035|FG000|Overall Study|A death in the family|1|||
150200393|NCT05654662|541873036|FG001|Overall Study|A death in the family|0|||
150200394|NCT05962814|541873037|FG000|Overall Study|failed eligibility|1|||
150255276|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
150255277|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
150255278|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
150255279|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
150137001|NCT03945292|541635421|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150137002|NCT03945292|541635422|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
150137003|NCT03945292|541635423|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
150137004|NCT02684006|541635424|FG000|Overall Study|Other|18|||
150137005|NCT02684006|541635425|FG001|Overall Study|Other|6|||
150137006|NCT02684006|541635424|FG000|Overall Study|Protocol Violation|2|||
150137007|NCT02684006|541635425|FG001|Overall Study|Protocol Violation|1|||
150137008|NCT02684006|541635424|FG000|Overall Study|Non-compliance with study drug|1|||
150137009|NCT02684006|541635425|FG001|Overall Study|Non-compliance with study drug|1|||
150137010|NCT02684006|541635424|FG000|Overall Study|No longer met eligibility criteria|6|||
150137011|NCT02684006|541635425|FG001|Overall Study|No longer met eligibility criteria|2|||
150137012|NCT02684006|541635424|FG000|Overall Study|Lost to Follow-up|0|||
150137013|NCT02684006|541635425|FG001|Overall Study|Lost to Follow-up|1|||
150137014|NCT02684006|541635424|FG000|Overall Study|Death|25|||
150137015|NCT02684006|541635425|FG001|Overall Study|Death|22|||
150137016|NCT02684006|541635424|FG000|Overall Study|Global deterioration of health status|18|||
150137017|NCT02684006|541635425|FG001|Overall Study|Global deterioration of health status|20|||
150137018|NCT02684006|541635424|FG000|Overall Study|Physician Decision|15|||
150137019|NCT02684006|541635425|FG001|Overall Study|Physician Decision|8|||
150137020|NCT02684006|541635424|FG000|Overall Study|Adverse Event|86|||
150137021|NCT02684006|541635425|FG001|Overall Study|Adverse Event|65|||
150137022|NCT02684006|541635424|FG000|Overall Study|Withdrawal by Subject|29|||
150137023|NCT02684006|541635425|FG001|Overall Study|Withdrawal by Subject|43|||
150137024|NCT02684006|541635424|FG000|Overall Study|Progressive disease|236|||
150137025|NCT02684006|541635425|FG001|Overall Study|Progressive disease|266|||
150137026|NCT02684006|541635424|FG000|Overall Study|Participation terminated by sponsor|6|||
150137027|NCT02684006|541635425|FG001|Overall Study|Participation terminated by sponsor|9|||
150137028|NCT04642898|541635426|FG000|Overall Study|Withdrawal by Subject|2|||
150137029|NCT04642898|541635427|FG001|Overall Study|Withdrawal by Subject|4|||
150137030|NCT04642898|541635428|FG002|Overall Study|Withdrawal by Subject|4|||
150137031|NCT04642898|541635429|FG003|Overall Study|Withdrawal by Subject|6|||
150137032|NCT04642898|541635430|FG004|Overall Study|Withdrawal by Subject|2|||
150137033|NCT04642898|541635431|FG005|Overall Study|Withdrawal by Subject|6|||
150137034|NCT04642898|541635426|FG000|Overall Study|Lost to Follow-up|0|||
150137035|NCT04642898|541635427|FG001|Overall Study|Lost to Follow-up|0|||
150137036|NCT04642898|541635428|FG002|Overall Study|Lost to Follow-up|0|||
150137037|NCT04642898|541635429|FG003|Overall Study|Lost to Follow-up|2|||
150137038|NCT04642898|541635430|FG004|Overall Study|Lost to Follow-up|0|||
150137039|NCT04642898|541635431|FG005|Overall Study|Lost to Follow-up|1|||
150137040|NCT04642898|541635426|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
150137041|NCT04642898|541635427|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
150137042|NCT04642898|541635428|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
150137043|NCT04642898|541635429|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
150137044|NCT04642898|541635430|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
150137045|NCT04642898|541635431|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
150137046|NCT04642898|541635426|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
150137047|NCT04642898|541635427|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
150137048|NCT04642898|541635428|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
150137049|NCT04642898|541635429|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
150137050|NCT04642898|541635430|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
150137051|NCT04642898|541635431|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
150137052|NCT04280562|541635432|FG000|Study|Adverse Event|2|||
150137053|NCT04280562|541635433|FG001|Study|Adverse Event|0|||
150137054|NCT04280562|541635432|FG000|Study|Lost to Follow-up|3|||
150137055|NCT04280562|541635433|FG001|Study|Lost to Follow-up|3|||
150137056|NCT01368965|541635437|FG000|Overall Study|Lost to Follow-up|12|||
150137057|NCT05103384|541635438|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
150137058|NCT00514735|541635439|FG000|Overall Study|Withdrawal by Subject|13|||
150137059|NCT00514735|541635440|FG001|Overall Study|Withdrawal by Subject|5|||
150137060|NCT00514735|541635439|FG000|Overall Study|Death|1|||
150137061|NCT00514735|541635440|FG001|Overall Study|Death|0|||
150137062|NCT00514735|541635439|FG000|Overall Study|Lost to Follow-up|0|||
150137063|NCT00514735|541635440|FG001|Overall Study|Lost to Follow-up|1|||
150137064|NCT00771810|541635446|FG000|Overall Study|Adverse Event|3|||
150137065|NCT00771810|541635447|FG001|Overall Study|Adverse Event|0|||
150137066|NCT00771810|541635448|FG002|Overall Study|Adverse Event|2|||
150137067|NCT00771810|541635446|FG000|Overall Study|Lost to Follow-up|0|||
150137068|NCT00771810|541635447|FG001|Overall Study|Lost to Follow-up|0|||
150137069|NCT00771810|541635448|FG002|Overall Study|Lost to Follow-up|1|||
150137070|NCT00771810|541635446|FG000|Overall Study|Physician Decision|1|||
150137071|NCT00771810|541635447|FG001|Overall Study|Physician Decision|2|||
150137072|NCT00771810|541635448|FG002|Overall Study|Physician Decision|2|||
150137073|NCT00771810|541635446|FG000|Overall Study|Protocol Violation|0|||
150137074|NCT00771810|541635447|FG001|Overall Study|Protocol Violation|1|||
150137075|NCT00771810|541635448|FG002|Overall Study|Protocol Violation|1|||
150137076|NCT00771810|541635446|FG000|Overall Study|Withdrawal by Subject|1|||
150137077|NCT00771810|541635447|FG001|Overall Study|Withdrawal by Subject|2|||
150137078|NCT00771810|541635448|FG002|Overall Study|Withdrawal by Subject|0|||
150137079|NCT00771810|541635446|FG000|Overall Study|Other|0|||
150137080|NCT00771810|541635447|FG001|Overall Study|Other|0|||
150137081|NCT00771810|541635448|FG002|Overall Study|Other|1|||
150137082|NCT02660827|541635452|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
150137083|NCT02660827|541635452|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
150137084|NCT02660827|541635452|FG000|From Study to End of Continued Access|Adverse Event|3|||
150137085|NCT02660827|541635452|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
150137086|NCT02660827|541635452|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
150137087|NCT02660827|541635452|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
150137088|NCT02660827|541635452|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
150137089|NCT02660827|541635452|FG000|Period 2: Continued Access Period|Adverse Event|3|||
150137090|NCT04672941|541635453|FG000|Overall Study|Investigator decision|1|||
150137091|NCT04672941|541635453|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
150137092|NCT04672941|541635453|FG000|Overall Study|COVID-19 related but no adverse event|1|||
150137093|NCT04672941|541635453|FG000|Overall Study|Adverse Event|2|||
150137094|NCT04672941|541635453|FG000|Overall Study|Lost to Follow-up|2|||
150137095|NCT00045305|541635458|FG000|Overall Study|Lack of Efficacy|6|||
150137096|NCT00045305|541635458|FG000|Overall Study|Adverse Event|3|||
150137097|NCT00045305|541635458|FG000|Overall Study|Death|3|||
150137098|NCT00045305|541635458|FG000|Overall Study|site error|2|||
150137099|NCT04274894|541635459|FG000|Overall Study|Adverse Event|7|||
150137100|NCT04274894|541635459|FG000|Overall Study|Withdrew consent|5|||
150137101|NCT04274894|541635459|FG000|Overall Study|Lost to Follow-up|9|||
150200395|NCT03505710|541874305|FG000|Overall Study|Progressive Disease|24|||
150200396|NCT03505710|541874306|FG001|Overall Study|Progressive Disease|17|||
150200397|NCT03505710|541874307|FG002|Overall Study|Progressive Disease|43|||
150200398|NCT03505710|541874305|FG000|Overall Study|Clinical Progression|6|||
150200399|NCT03505710|541874306|FG001|Overall Study|Clinical Progression|8|||
150200400|NCT03505710|541874307|FG002|Overall Study|Clinical Progression|3|||
150200401|NCT03505710|541874305|FG000|Overall Study|Adverse Event|12|||
150200402|NCT03505710|541874306|FG001|Overall Study|Adverse Event|6|||
150200403|NCT03505710|541874307|FG002|Overall Study|Adverse Event|28|||
150200404|NCT03505710|541874305|FG000|Overall Study|Withdrawal by Subject|1|||
150200405|NCT03505710|541874306|FG001|Overall Study|Withdrawal by Subject|3|||
150200406|NCT03505710|541874307|FG002|Overall Study|Withdrawal by Subject|7|||
150200407|NCT03505710|541874305|FG000|Overall Study|Physician Decision|1|||
150200408|NCT03505710|541874306|FG001|Overall Study|Physician Decision|1|||
150200409|NCT03505710|541874307|FG002|Overall Study|Physician Decision|2|||
150200410|NCT03505710|541874305|FG000|Overall Study|Death|4|||
150200411|NCT03505710|541874306|FG001|Overall Study|Death|5|||
150200412|NCT03505710|541874307|FG002|Overall Study|Death|6|||
150200413|NCT03505710|541874305|FG000|Overall Study|Other Reasons|1|||
150200414|NCT03505710|541874306|FG001|Overall Study|Other Reasons|1|||
150200415|NCT03505710|541874307|FG002|Overall Study|Other Reasons|1|||
150200416|NCT03505710|541874305|FG000|Overall Study|Study Terminated by Sponsor|0|||
150200417|NCT03505710|541874306|FG001|Overall Study|Study Terminated by Sponsor|0|||
150200418|NCT03505710|541874307|FG002|Overall Study|Study Terminated by Sponsor|1|||
150200419|NCT03981926|541874310|FG000|Overall Study|Lost to Follow-up|5|||
150200420|NCT03981926|541874311|FG001|Overall Study|Lost to Follow-up|9|||
150200421|NCT06262347|541874312|FG000|Overall Study|Lost to Follow-up|4|||
150200422|NCT06262347|541874313|FG001|Overall Study|Lost to Follow-up|3|||
150200423|NCT06262347|541874312|FG000|Overall Study|Withdrawal by Subject|0|||
150200424|NCT06262347|541874313|FG001|Overall Study|Withdrawal by Subject|1|||
150200425|NCT01314105|541874316|FG000|Overall Study|Progressive Disease|6|||
150200426|NCT01314105|541874317|FG001|Overall Study|Progressive Disease|10|||
150200427|NCT01314105|541874316|FG000|Overall Study|Refused to continue taking medication|0|||
150200428|NCT01314105|541874317|FG001|Overall Study|Refused to continue taking medication|1|||
150137102|NCT04274894|541635459|FG000|Overall Study|COVID-19 infection|1|||
150137103|NCT04274894|541635459|FG000|Overall Study|Other, not specified|20|||
150137104|NCT02279043|541635460|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
150137105|NCT02279043|541635461|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
150200429|NCT01314105|541874316|FG000|Overall Study|Other Adverse Event|1|||
150200430|NCT01314105|541874317|FG001|Overall Study|Other Adverse Event|1|||
150137106|NCT02279043|541635462|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
150137107|NCT02279043|541635460|FG000|Overall Study|Lost to Follow-up|46|||
150200431|NCT04526886|541874318|FG000|Overall Study|Physician Decision|4|||
150200432|NCT03988621|541874344|FG000|Overall Study|Lost to Follow-up|16|||
150200433|NCT03988621|541874345|FG001|Overall Study|Lost to Follow-up|17|||
150200434|NCT03988621|541874344|FG000|Overall Study|Withdrawal by Subject|14|||
150200435|NCT03988621|541874345|FG001|Overall Study|Withdrawal by Subject|7|||
150200436|NCT03988621|541874344|FG000|Overall Study|Patient Lost to Follow Up|15|||
150200437|NCT03988621|541874345|FG001|Overall Study|Patient Lost to Follow Up|15|||
150200438|NCT03988621|541874344|FG000|Overall Study|Patient death|1|||
150200439|NCT03988621|541874345|FG001|Overall Study|Patient death|5|||
150200440|NCT05013385|541874346|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
150200441|NCT04247802|541874347|FG000|Overall Study|Withdrawal by Subject|1|||
150200442|NCT04247802|541874348|FG001|Overall Study|Withdrawal by Subject|3|||
150200443|NCT04247802|541874347|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
150200444|NCT04247802|541874348|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
150200445|NCT01447719|541874351|FG000|Overall Study|Image acquisition failure|2|||
150200446|NCT01447719|541874351|FG000|Overall Study|Invalid image or not imaged|3|||
150200447|NCT01447719|541874351|FG000|Overall Study|Subject still living at end of study|79|||
150200448|NCT01447719|541874351|FG000|Overall Study|Withdrawal by Subject|2|||
150200449|NCT01447719|541874351|FG000|Overall Study|Family withdrew autopsy consent|7|||
150200450|NCT04778410|541874352|FG000|Safety Run-in Period|Death|5|||
150200451|NCT04778410|541874353|FG001|Safety Run-in Period|Death|6|||
150200452|NCT04778410|541874354|FG002|Safety Run-in Period|Death|0|||
150200453|NCT04778410|541874355|FG003|Safety Run-in Period|Death|0|||
150200454|NCT04778410|541874356|FG004|Safety Run-in Period|Death|0|||
150200455|NCT04778410|541874357|FG005|Safety Run-in Period|Death|0|||
150200456|NCT04778410|541874352|FG000|Phase 2 Period|Death|0|||
150200457|NCT04778410|541874353|FG001|Phase 2 Period|Death|0|||
150200458|NCT04778410|541874354|FG002|Phase 2 Period|Death|0|||
150200459|NCT04778410|541874355|FG003|Phase 2 Period|Death|5|||
150200460|NCT04778410|541874356|FG004|Phase 2 Period|Death|18|||
150200461|NCT04778410|541874357|FG005|Phase 2 Period|Death|0|||
150200462|NCT04778410|541874352|FG000|Phase 2 Period|Lost to Follow-up|0|||
150200463|NCT04778410|541874353|FG001|Phase 2 Period|Lost to Follow-up|0|||
150200464|NCT04778410|541874354|FG002|Phase 2 Period|Lost to Follow-up|0|||
150200465|NCT04778410|541874355|FG003|Phase 2 Period|Lost to Follow-up|1|||
150200466|NCT04778410|541874356|FG004|Phase 2 Period|Lost to Follow-up|1|||
150200467|NCT04778410|541874357|FG005|Phase 2 Period|Lost to Follow-up|0|||
150200468|NCT04778410|541874352|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
150200469|NCT04778410|541874353|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
150200470|NCT04778410|541874354|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
150200471|NCT04778410|541874355|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
150200472|NCT04778410|541874356|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
150200473|NCT04778410|541874357|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
150200474|NCT04778410|541874352|FG000|Phase 2 Period|Withdrew Consent|0|||
150200475|NCT04778410|541874353|FG001|Phase 2 Period|Withdrew Consent|0|||
150200476|NCT04778410|541874354|FG002|Phase 2 Period|Withdrew Consent|0|||
150200477|NCT04778410|541874355|FG003|Phase 2 Period|Withdrew Consent|0|||
150200478|NCT04778410|541874356|FG004|Phase 2 Period|Withdrew Consent|2|||
150200479|NCT04778410|541874357|FG005|Phase 2 Period|Withdrew Consent|0|||
150200480|NCT03252288|541874358|FG000|Overall Study|Death|1|||
150200481|NCT03252288|541874359|FG001|Overall Study|Death|0|||
150200482|NCT03252288|541874360|FG002|Overall Study|Death|0|||
150200483|NCT03252288|541874358|FG000|Overall Study|Death|11|||
150200484|NCT03252288|541874359|FG001|Overall Study|Death|0|||
150200485|NCT03252288|541874360|FG002|Overall Study|Death|0|||
150200486|NCT03252288|541874358|FG000|Overall Study|Withdrawal by Subject|2|||
150200487|NCT03252288|541874359|FG001|Overall Study|Withdrawal by Subject|0|||
150200488|NCT03252288|541874360|FG002|Overall Study|Withdrawal by Subject|0|||
150200489|NCT03252288|541874358|FG000|Overall Study|Lost to Follow-up|79|||
150200490|NCT03252288|541874359|FG001|Overall Study|Lost to Follow-up|0|||
150200491|NCT03252288|541874360|FG002|Overall Study|Lost to Follow-up|0|||
150200492|NCT03252288|541874358|FG000|Overall Study|Loss of baseline data on tablets|6|||
150200493|NCT03252288|541874359|FG001|Overall Study|Loss of baseline data on tablets|0|||
150200494|NCT03252288|541874360|FG002|Overall Study|Loss of baseline data on tablets|0|||
150200495|NCT02905331|541874361|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
150200496|NCT02905331|541874362|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
150200497|NCT02905331|541874363|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
150200498|NCT02905331|541874361|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
150200499|NCT02905331|541874362|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
150200500|NCT02905331|541874363|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
150200501|NCT02905331|541874361|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
150200502|NCT02905331|541874362|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
150200503|NCT02905331|541874363|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
150200504|NCT02905331|541874361|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
150200505|NCT02905331|541874362|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
150200506|NCT02905331|541874363|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
150200507|NCT02905331|541874361|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
150200508|NCT02905331|541874362|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
150200509|NCT02905331|541874363|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
150200510|NCT04583280|541874373|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
150200511|NCT04583280|541874374|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
150200512|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
150200513|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
150200514|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
150200515|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
150200516|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
150200517|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
150200518|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
150200519|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
150200520|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
150200521|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
150200522|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
150200523|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
150200524|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
150200525|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
150200526|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
150200527|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
150200528|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
150200529|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
150200530|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
150200531|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
150200532|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
150200533|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
150200534|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
150200535|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
150200536|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
150200537|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
150200538|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
150200539|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
150200540|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
150200541|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
150200542|NCT04614948|541874375|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
150200543|NCT04614948|541874376|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
150200544|NCT04614948|541874377|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
150200545|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
150200546|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
150200547|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
150200548|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
150200549|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
150200550|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
150200551|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
150200552|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
150200553|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
150200554|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
150200555|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
150200556|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
150200557|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
150200558|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
150200559|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
150200560|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
150200561|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
150200562|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
150200563|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
150200564|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
150200565|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
150200566|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
150200567|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
150200568|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
150200569|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
150200570|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
150200571|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
150200572|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
150200573|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
150200574|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
150200575|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
150200576|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
150200577|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
150200578|NCT04614948|541874375|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
150200579|NCT04614948|541874376|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
150200580|NCT04614948|541874377|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
150200581|NCT04129554|541874378|FG000|Overall Study|Withdrawal by Subject|4|||
150200582|NCT04129554|541874379|FG001|Overall Study|Withdrawal by Subject|3|||
150200583|NCT04129554|541874378|FG000|Overall Study|Other|0|||
150200584|NCT04129554|541874379|FG001|Overall Study|Other|2|||
150200585|NCT01570361|541874380|FG000|Overall Study|Subject discontinued|1|||
150200586|NCT01570361|541874381|FG001|Overall Study|Subject discontinued|2|||
150200587|NCT01570361|541874380|FG000|Overall Study|Sponsor closing the study|51|||
150200588|NCT01570361|541874381|FG001|Overall Study|Sponsor closing the study|50|||
150200589|NCT01570361|541874380|FG000|Overall Study|Subject excluded|5|||
150200590|NCT01570361|541874381|FG001|Overall Study|Subject excluded|3|||
150200591|NCT01570361|541874380|FG000|Overall Study|Subject withdrew consent|14|||
150200592|NCT01570361|541874381|FG001|Overall Study|Subject withdrew consent|9|||
150200593|NCT01570361|541874380|FG000|Overall Study|Adverse Event|2|||
150200594|NCT01570361|541874381|FG001|Overall Study|Adverse Event|1|||
150200595|NCT01570361|541874380|FG000|Overall Study|Lost to Follow-up|4|||
150200596|NCT01570361|541874381|FG001|Overall Study|Lost to Follow-up|4|||
150200597|NCT01570361|541874380|FG000|Overall Study|Death|5|||
150200598|NCT01570361|541874381|FG001|Overall Study|Death|4|||
150200599|NCT01570361|541874380|FG000|Overall Study|Other|0|||
150200600|NCT01570361|541874381|FG001|Overall Study|Other|2|||
150200601|NCT03691298|541874386|FG000|Overall Study|Lost to Follow-up|8|||
150200602|NCT03691298|541874386|FG000|Overall Study|Sponsor terminated study|2|||
150200603|NCT02492711|541874390|FG000|Overall Study|Adverse Event|9|||
150200604|NCT02492711|541874391|FG001|Overall Study|Adverse Event|9|||
150200605|NCT02492711|541874392|FG002|Overall Study|Adverse Event|2|||
150200606|NCT02492711|541874390|FG000|Overall Study|Death|3|||
150200607|NCT02492711|541874391|FG001|Overall Study|Death|3|||
150200608|NCT02492711|541874392|FG002|Overall Study|Death|0|||
150200609|NCT02492711|541874390|FG000|Overall Study|Withdrawal by Subject|10|||
150200610|NCT02492711|541874391|FG001|Overall Study|Withdrawal by Subject|16|||
150200611|NCT02492711|541874392|FG002|Overall Study|Withdrawal by Subject|5|||
150200612|NCT02492711|541874390|FG000|Overall Study|Physician Decision|10|||
150200613|NCT02492711|541874391|FG001|Overall Study|Physician Decision|6|||
150200614|NCT02492711|541874392|FG002|Overall Study|Physician Decision|4|||
150200615|NCT02492711|541874390|FG000|Overall Study|Lost to Follow-up|0|||
150200616|NCT02492711|541874391|FG001|Overall Study|Lost to Follow-up|0|||
150200617|NCT02492711|541874392|FG002|Overall Study|Lost to Follow-up|1|||
150200618|NCT02492711|541874390|FG000|Overall Study|study treatment delay|2|||
150200619|NCT02492711|541874391|FG001|Overall Study|study treatment delay|1|||
150200620|NCT02492711|541874392|FG002|Overall Study|study treatment delay|0|||
150200621|NCT02492711|541874390|FG000|Overall Study|change in chemotherapy|0|||
150200622|NCT02492711|541874391|FG001|Overall Study|change in chemotherapy|1|||
150200623|NCT02492711|541874392|FG002|Overall Study|change in chemotherapy|0|||
150200624|NCT02492711|541874390|FG000|Overall Study|never treated|2|||
150200625|NCT02492711|541874391|FG001|Overall Study|never treated|4|||
150200626|NCT02492711|541874392|FG002|Overall Study|never treated|0|||
150200627|NCT02492711|541874390|FG000|Overall Study|Other|0|||
150200628|NCT02492711|541874391|FG001|Overall Study|Other|0|||
150200629|NCT02492711|541874392|FG002|Overall Study|Other|1|||
150200630|NCT04633538|541874395|FG000|Overall Study|Death|1|||
150200631|NCT04633538|541874395|FG000|Overall Study|Lost to Follow-up|3|||
150200632|NCT04633538|541874395|FG000|Overall Study|Withdrawal by Subject|1|||
150200633|NCT02938520|541874396|FG000|Overall Study|On-going at the time of analysis|258|||
150200634|NCT02938520|541874397|FG001|Overall Study|On-going at the time of analysis|261|||
150200635|NCT02938520|541874396|FG000|Overall Study|Physician Decision|2|||
150200636|NCT02938520|541874397|FG001|Overall Study|Physician Decision|5|||
150200637|NCT02938520|541874396|FG000|Overall Study|Lost to Follow-up|2|||
150200638|NCT02938520|541874397|FG001|Overall Study|Lost to Follow-up|2|||
150200639|NCT02938520|541874396|FG000|Overall Study|Withdrawal by Subject|7|||
150200640|NCT02938520|541874397|FG001|Overall Study|Withdrawal by Subject|7|||
150200641|NCT02938520|541874396|FG000|Overall Study|Protocol Violation|0|||
150200642|NCT02938520|541874397|FG001|Overall Study|Protocol Violation|1|||
150200643|NCT02938520|541874396|FG000|Overall Study|Lack of Efficacy|5|||
150200644|NCT02938520|541874397|FG001|Overall Study|Lack of Efficacy|3|||
150200645|NCT02938520|541874396|FG000|Overall Study|Adverse Event|9|||
150200646|NCT02938520|541874397|FG001|Overall Study|Adverse Event|4|||
150200647|NCT05070741|541874398|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
150200648|NCT03245840|541874399|FG000|Overall Study|Adverse Event|6|||
150200649|NCT03245840|541874400|FG001|Overall Study|Adverse Event|0|||
150200650|NCT03245840|541874399|FG000|Overall Study|Death|2|||
150200651|NCT03245840|541874400|FG001|Overall Study|Death|0|||
150200652|NCT03245840|541874399|FG000|Overall Study|Withdrawal by Subject|31|||
150200653|NCT03245840|541874400|FG001|Overall Study|Withdrawal by Subject|1|||
150200654|NCT03245840|541874399|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
150200655|NCT03245840|541874400|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150200656|NCT03245840|541874399|FG000|Overall Study|Physician Decision|4|||
150200657|NCT03245840|541874400|FG001|Overall Study|Physician Decision|1|||
150200658|NCT03245840|541874399|FG000|Overall Study|Study Terminated by Sponsor|56|||
150200659|NCT03245840|541874400|FG001|Overall Study|Study Terminated by Sponsor|6|||
150200660|NCT03245840|541874399|FG000|Overall Study|Site Terminated by Sponsor|4|||
150200661|NCT03245840|541874400|FG001|Overall Study|Site Terminated by Sponsor|0|||
150200662|NCT03245840|541874399|FG000|Overall Study|Lost to Follow-up|12|||
150200663|NCT03245840|541874400|FG001|Overall Study|Lost to Follow-up|2|||
150200664|NCT03245840|541874399|FG000|Overall Study|Pregnancy|2|||
150200665|NCT03245840|541874400|FG001|Overall Study|Pregnancy|0|||
150200666|NCT03245840|541874399|FG000|Overall Study|Non-Compliance with Study Drug|2|||
150200667|NCT03245840|541874400|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150200668|NCT03245840|541874399|FG000|Overall Study|Not treated|1|||
150200669|NCT03245840|541874400|FG001|Overall Study|Not treated|1|||
150200670|NCT03582033|541874405|FG000|Part A|Other|0|||
150200671|NCT03582033|541874406|FG001|Part A|Other|0|||
150200672|NCT03582033|541874407|FG002|Part A|Other|0|||
150200673|NCT03582033|541874408|FG003|Part A|Other|0|||
150200674|NCT03582033|541874409|FG004|Part A|Other|2|||
150200675|NCT03582033|541874410|FG005|Part A|Other|0|||
150200676|NCT03582033|541874411|FG006|Part A|Other|0|||
150200677|NCT03582033|541874412|FG007|Part A|Other|0|||
150200678|NCT03582033|541874413|FG008|Part A|Other|0|||
150200679|NCT03582033|541874414|FG009|Part A|Other|0|||
150200680|NCT03582033|541874405|FG000|Part A|Death|1|||
150200681|NCT03582033|541874406|FG001|Part A|Death|1|||
150200682|NCT03582033|541874407|FG002|Part A|Death|2|||
150200683|NCT03582033|541874408|FG003|Part A|Death|4|||
150200684|NCT03582033|541874409|FG004|Part A|Death|11|||
150200685|NCT03582033|541874410|FG005|Part A|Death|0|||
150200686|NCT03582033|541874411|FG006|Part A|Death|0|||
150200687|NCT03582033|541874412|FG007|Part A|Death|0|||
150200688|NCT03582033|541874413|FG008|Part A|Death|0|||
150200689|NCT03582033|541874414|FG009|Part A|Death|0|||
150200690|NCT03582033|541874405|FG000|Part A|Lost to Follow-up|0|||
150200691|NCT03582033|541874406|FG001|Part A|Lost to Follow-up|0|||
150200692|NCT03582033|541874407|FG002|Part A|Lost to Follow-up|0|||
150200693|NCT03582033|541874408|FG003|Part A|Lost to Follow-up|0|||
150200694|NCT03582033|541874409|FG004|Part A|Lost to Follow-up|1|||
150200695|NCT03582033|541874410|FG005|Part A|Lost to Follow-up|0|||
150200696|NCT03582033|541874411|FG006|Part A|Lost to Follow-up|0|||
150200697|NCT03582033|541874412|FG007|Part A|Lost to Follow-up|0|||
150200698|NCT03582033|541874413|FG008|Part A|Lost to Follow-up|0|||
150200699|NCT03582033|541874414|FG009|Part A|Lost to Follow-up|0|||
150200700|NCT03582033|541874405|FG000|Part A|Study terminated by sponsor|0|||
150200701|NCT03582033|541874406|FG001|Part A|Study terminated by sponsor|0|||
150200702|NCT03582033|541874407|FG002|Part A|Study terminated by sponsor|0|||
150200703|NCT03582033|541874408|FG003|Part A|Study terminated by sponsor|2|||
150200704|NCT03582033|541874409|FG004|Part A|Study terminated by sponsor|1|||
150200705|NCT03582033|541874410|FG005|Part A|Study terminated by sponsor|0|||
150200706|NCT03582033|541874411|FG006|Part A|Study terminated by sponsor|0|||
150200707|NCT03582033|541874412|FG007|Part A|Study terminated by sponsor|0|||
150200708|NCT03582033|541874413|FG008|Part A|Study terminated by sponsor|0|||
150200709|NCT03582033|541874414|FG009|Part A|Study terminated by sponsor|0|||
150200710|NCT03582033|541874405|FG000|Part A|Withdrawal by Subject|1|||
150200711|NCT03582033|541874406|FG001|Part A|Withdrawal by Subject|1|||
150200712|NCT03582033|541874407|FG002|Part A|Withdrawal by Subject|0|||
150200713|NCT03582033|541874408|FG003|Part A|Withdrawal by Subject|1|||
150200714|NCT03582033|541874409|FG004|Part A|Withdrawal by Subject|7|||
150200715|NCT03582033|541874410|FG005|Part A|Withdrawal by Subject|0|||
150200716|NCT03582033|541874411|FG006|Part A|Withdrawal by Subject|0|||
150200717|NCT03582033|541874412|FG007|Part A|Withdrawal by Subject|0|||
150200718|NCT03582033|541874413|FG008|Part A|Withdrawal by Subject|0|||
150200719|NCT03582033|541874414|FG009|Part A|Withdrawal by Subject|0|||
150200720|NCT03582033|541874405|FG000|Part B|Death|0|||
150200721|NCT03582033|541874406|FG001|Part B|Death|0|||
150200722|NCT03582033|541874407|FG002|Part B|Death|0|||
150200723|NCT03582033|541874408|FG003|Part B|Death|0|||
150200724|NCT03582033|541874409|FG004|Part B|Death|0|||
150200725|NCT03582033|541874410|FG005|Part B|Death|2|||
150200726|NCT03582033|541874411|FG006|Part B|Death|0|||
150200727|NCT03582033|541874412|FG007|Part B|Death|0|||
150200728|NCT03582033|541874413|FG008|Part B|Death|0|||
150200729|NCT03582033|541874414|FG009|Part B|Death|0|||
150200730|NCT03582033|541874405|FG000|Part B|Study terminated by sponsor|0|||
150200731|NCT03582033|541874406|FG001|Part B|Study terminated by sponsor|0|||
150200732|NCT03582033|541874407|FG002|Part B|Study terminated by sponsor|0|||
150200733|NCT03582033|541874408|FG003|Part B|Study terminated by sponsor|0|||
150200734|NCT03582033|541874409|FG004|Part B|Study terminated by sponsor|0|||
150200735|NCT03582033|541874410|FG005|Part B|Study terminated by sponsor|12|||
150200736|NCT03582033|541874411|FG006|Part B|Study terminated by sponsor|0|||
150200737|NCT03582033|541874412|FG007|Part B|Study terminated by sponsor|0|||
150200738|NCT03582033|541874413|FG008|Part B|Study terminated by sponsor|0|||
150200739|NCT03582033|541874414|FG009|Part B|Study terminated by sponsor|0|||
150200740|NCT03582033|541874405|FG000|Part B|Withdrawal by Subject|0|||
150200741|NCT03582033|541874406|FG001|Part B|Withdrawal by Subject|0|||
150200742|NCT03582033|541874407|FG002|Part B|Withdrawal by Subject|0|||
150200743|NCT03582033|541874408|FG003|Part B|Withdrawal by Subject|0|||
150200744|NCT03582033|541874409|FG004|Part B|Withdrawal by Subject|0|||
150200745|NCT03582033|541874410|FG005|Part B|Withdrawal by Subject|6|||
150200746|NCT03582033|541874411|FG006|Part B|Withdrawal by Subject|0|||
150200747|NCT03582033|541874412|FG007|Part B|Withdrawal by Subject|0|||
150200748|NCT03582033|541874413|FG008|Part B|Withdrawal by Subject|0|||
150200749|NCT03582033|541874414|FG009|Part B|Withdrawal by Subject|0|||
150200750|NCT03582033|541874405|FG000|Part C|Other|0|||
150200751|NCT03582033|541874406|FG001|Part C|Other|0|||
150200752|NCT03582033|541874407|FG002|Part C|Other|0|||
150200753|NCT03582033|541874408|FG003|Part C|Other|0|||
150200754|NCT03582033|541874409|FG004|Part C|Other|0|||
150200755|NCT03582033|541874410|FG005|Part C|Other|0|||
150200756|NCT03582033|541874411|FG006|Part C|Other|2|||
150200757|NCT03582033|541874412|FG007|Part C|Other|0|||
150200758|NCT03582033|541874413|FG008|Part C|Other|0|||
150200759|NCT03582033|541874414|FG009|Part C|Other|0|||
150200760|NCT03582033|541874405|FG000|Part C|Death|0|||
150200761|NCT03582033|541874406|FG001|Part C|Death|0|||
150200762|NCT03582033|541874407|FG002|Part C|Death|0|||
150200763|NCT03582033|541874408|FG003|Part C|Death|0|||
150200764|NCT03582033|541874409|FG004|Part C|Death|0|||
150200765|NCT03582033|541874410|FG005|Part C|Death|0|||
150200766|NCT03582033|541874411|FG006|Part C|Death|6|||
150200767|NCT03582033|541874412|FG007|Part C|Death|1|||
150200768|NCT03582033|541874413|FG008|Part C|Death|2|||
150200769|NCT03582033|541874414|FG009|Part C|Death|0|||
150200770|NCT03582033|541874405|FG000|Part C|Study terminated by sponsor|0|||
150200771|NCT03582033|541874406|FG001|Part C|Study terminated by sponsor|0|||
150200772|NCT03582033|541874407|FG002|Part C|Study terminated by sponsor|0|||
150200773|NCT03582033|541874408|FG003|Part C|Study terminated by sponsor|0|||
150200774|NCT03582033|541874409|FG004|Part C|Study terminated by sponsor|0|||
150200775|NCT03582033|541874410|FG005|Part C|Study terminated by sponsor|0|||
150200776|NCT03582033|541874411|FG006|Part C|Study terminated by sponsor|3|||
150200777|NCT03582033|541874412|FG007|Part C|Study terminated by sponsor|3|||
150200778|NCT03582033|541874413|FG008|Part C|Study terminated by sponsor|2|||
150200779|NCT03582033|541874414|FG009|Part C|Study terminated by sponsor|0|||
150200780|NCT03582033|541874405|FG000|Part C|Withdrawal by Subject|0|||
150200781|NCT03582033|541874406|FG001|Part C|Withdrawal by Subject|0|||
150200782|NCT03582033|541874407|FG002|Part C|Withdrawal by Subject|0|||
150200783|NCT03582033|541874408|FG003|Part C|Withdrawal by Subject|0|||
150200784|NCT03582033|541874409|FG004|Part C|Withdrawal by Subject|0|||
150200785|NCT03582033|541874410|FG005|Part C|Withdrawal by Subject|0|||
150200786|NCT03582033|541874411|FG006|Part C|Withdrawal by Subject|1|||
150200787|NCT03582033|541874412|FG007|Part C|Withdrawal by Subject|2|||
150200788|NCT03582033|541874413|FG008|Part C|Withdrawal by Subject|1|||
150200789|NCT03582033|541874414|FG009|Part C|Withdrawal by Subject|0|||
150200790|NCT03582033|541874405|FG000|Part D|Death|0|||
150200791|NCT03582033|541874406|FG001|Part D|Death|0|||
150200792|NCT03582033|541874407|FG002|Part D|Death|0|||
150200793|NCT03582033|541874408|FG003|Part D|Death|0|||
150200794|NCT03582033|541874409|FG004|Part D|Death|0|||
150200795|NCT03582033|541874410|FG005|Part D|Death|0|||
150200796|NCT03582033|541874411|FG006|Part D|Death|0|||
150200797|NCT03582033|541874412|FG007|Part D|Death|0|||
150200798|NCT03582033|541874413|FG008|Part D|Death|0|||
150200799|NCT03582033|541874414|FG009|Part D|Death|1|||
150200800|NCT03582033|541874405|FG000|Part D|Study terminated by sponsor|0|||
150200801|NCT03582033|541874406|FG001|Part D|Study terminated by sponsor|0|||
150200802|NCT03582033|541874407|FG002|Part D|Study terminated by sponsor|0|||
150200803|NCT03582033|541874408|FG003|Part D|Study terminated by sponsor|0|||
150200804|NCT03582033|541874409|FG004|Part D|Study terminated by sponsor|0|||
150200805|NCT03582033|541874410|FG005|Part D|Study terminated by sponsor|0|||
150200806|NCT03582033|541874411|FG006|Part D|Study terminated by sponsor|0|||
150200807|NCT03582033|541874412|FG007|Part D|Study terminated by sponsor|0|||
150200808|NCT03582033|541874413|FG008|Part D|Study terminated by sponsor|0|||
150200809|NCT03582033|541874414|FG009|Part D|Study terminated by sponsor|4|||
150200810|NCT06010836|541874415|FG000|Overall Study|Lost to Follow-up|2|||
150200811|NCT06010836|541874416|FG001|Overall Study|Lost to Follow-up|2|||
150200812|NCT06010836|541874415|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
150200813|NCT06010836|541874416|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
150200814|NCT06010836|541874415|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
150200815|NCT06010836|541874416|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
150200816|NCT06010836|541874415|FG000|Overall Study|Did not receive intervention discussion|0|||
150200817|NCT06010836|541874416|FG001|Overall Study|Did not receive intervention discussion|4|||
150200818|NCT04206787|541874417|FG000|Overall Study|Other than listed|2|||
150200819|NCT04206787|541874417|FG000|Overall Study|Investigator decision|1|||
150200820|NCT04206787|541874417|FG000|Overall Study|Death|25|||
150200821|NCT04206787|541874417|FG000|Overall Study|Lost to Follow-up|9|||
150200822|NCT04206787|541874417|FG000|Overall Study|Withdrawal of consent|9|||
150200823|NCT04505410|541874418|FG000|Overall Study|Adverse Event|2|||
150200824|NCT04505410|541874419|FG001|Overall Study|Adverse Event|0|||
150200825|NCT04505410|541874418|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
150200826|NCT04505410|541874419|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
150200827|NCT04505410|541874418|FG000|Overall Study|did not want to follow diet|1|||
150200828|NCT04505410|541874419|FG001|Overall Study|did not want to follow diet|0|||
150200829|NCT04505410|541874418|FG000|Overall Study|flare up of ulcerative colitis|0|||
150200830|NCT04505410|541874419|FG001|Overall Study|flare up of ulcerative colitis|1|||
150200831|NCT04505410|541874418|FG000|Overall Study|Lost to Follow-up|0|||
150200832|NCT04505410|541874419|FG001|Overall Study|Lost to Follow-up|2|||
150200833|NCT04505410|541874418|FG000|Overall Study|Lost to Follow-up|1|||
150200834|NCT04505410|541874419|FG001|Overall Study|Lost to Follow-up|0|||
150200835|NCT04505410|541874418|FG000|Overall Study|initiated another diet on their own|0|||
150200836|NCT04505410|541874419|FG001|Overall Study|initiated another diet on their own|2|||
150200837|NCT04108130|541875759|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
150200838|NCT04108130|541875760|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
150200839|NCT04108130|541875759|FG000|Overall Study|Consent Withdrawn|9|||
150200840|NCT04108130|541875760|FG001|Overall Study|Consent Withdrawn|6|||
150200841|NCT04108130|541875759|FG000|Overall Study|Surgery Cancelled|4|||
150200842|NCT04108130|541875760|FG001|Overall Study|Surgery Cancelled|4|||
150200843|NCT04108130|541875759|FG000|Overall Study|Found Ineligible for Study|4|||
150200844|NCT04108130|541875760|FG001|Overall Study|Found Ineligible for Study|3|||
150200845|NCT04108130|541875759|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
150200846|NCT04108130|541875760|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
150200847|NCT04108130|541875759|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
150200848|NCT04108130|541875760|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
150200849|NCT05507333|541875761|FG000|Overall Study|Protocol Violation|1|||
150200850|NCT01130883|541875762|FG000|Overall Study|Patient Noncompliance|6|||
150200851|NCT01130883|541875762|FG000|Overall Study|Reason Unknown|1|||
150200852|NCT01130883|541875762|FG000|Overall Study|Adverse Event|3|||
150200853|NCT03972150|541875765|FG000|Overall Study|Adverse Event|0|||
150200854|NCT03972150|541875766|FG001|Overall Study|Adverse Event|1|||
150200855|NCT03972150|541875767|FG002|Overall Study|Adverse Event|1|||
150200856|NCT03972150|541875768|FG003|Overall Study|Adverse Event|0|||
150200857|NCT03972150|541875769|FG004|Overall Study|Adverse Event|0|||
150200858|NCT03972150|541875765|FG000|Overall Study|Progressive disease|3|||
150200859|NCT03972150|541875766|FG001|Overall Study|Progressive disease|5|||
150200860|NCT03972150|541875767|FG002|Overall Study|Progressive disease|2|||
150200861|NCT03972150|541875768|FG003|Overall Study|Progressive disease|2|||
150200862|NCT03972150|541875769|FG004|Overall Study|Progressive disease|3|||
150200863|NCT05464069|541875770|FG000|Overall Study|Protocol Violation|3|||
150200864|NCT05464069|541875771|FG001|Overall Study|Protocol Violation|2|||
150200865|NCT03677141|541875775|FG000|Overall Study|Death|2|||
150200866|NCT03677141|541875776|FG001|Overall Study|Death|1|||
150200867|NCT03677141|541875777|FG002|Overall Study|Death|6|||
150200868|NCT03677141|541875778|FG003|Overall Study|Death|9|||
150200869|NCT03677141|541875779|FG004|Overall Study|Death|5|||
150200870|NCT03677141|541875780|FG005|Overall Study|Death|3|||
150200871|NCT03677141|541875775|FG000|Overall Study|Lost to Follow-up|0|||
150200872|NCT03677141|541875776|FG001|Overall Study|Lost to Follow-up|0|||
150200873|NCT03677141|541875777|FG002|Overall Study|Lost to Follow-up|0|||
150200874|NCT03677141|541875778|FG003|Overall Study|Lost to Follow-up|2|||
150200875|NCT03677141|541875779|FG004|Overall Study|Lost to Follow-up|0|||
150200876|NCT03677141|541875780|FG005|Overall Study|Lost to Follow-up|0|||
150200877|NCT03677141|541875775|FG000|Overall Study|Screen failure or enrolled in error|0|||
150200878|NCT03677141|541875776|FG001|Overall Study|Screen failure or enrolled in error|0|||
150200879|NCT03677141|541875777|FG002|Overall Study|Screen failure or enrolled in error|0|||
150200880|NCT03677141|541875778|FG003|Overall Study|Screen failure or enrolled in error|0|||
150200881|NCT03677141|541875779|FG004|Overall Study|Screen failure or enrolled in error|2|||
150200882|NCT03677141|541875780|FG005|Overall Study|Screen failure or enrolled in error|0|||
150200883|NCT03677141|541875775|FG000|Overall Study|Physician Decision|0|||
150200884|NCT03677141|541875776|FG001|Overall Study|Physician Decision|0|||
150200885|NCT03677141|541875777|FG002|Overall Study|Physician Decision|0|||
150200886|NCT03677141|541875778|FG003|Overall Study|Physician Decision|0|||
150200887|NCT03677141|541875779|FG004|Overall Study|Physician Decision|1|||
150200888|NCT03677141|541875780|FG005|Overall Study|Physician Decision|0|||
150200889|NCT03677141|541875775|FG000|Overall Study|Withdrawal by Subject|0|||
150200890|NCT03677141|541875776|FG001|Overall Study|Withdrawal by Subject|0|||
150200891|NCT03677141|541875777|FG002|Overall Study|Withdrawal by Subject|1|||
150200892|NCT03677141|541875778|FG003|Overall Study|Withdrawal by Subject|1|||
150200893|NCT03677141|541875779|FG004|Overall Study|Withdrawal by Subject|1|||
150200894|NCT03677141|541875780|FG005|Overall Study|Withdrawal by Subject|0|||
150200895|NCT06106022|541875789|FG000|Overall Study|Lost to Follow-up|1|||
150200896|NCT06106022|541875790|FG001|Overall Study|Lost to Follow-up|0|||
150200897|NCT06106022|541875789|FG000|Overall Study|Voluntary Withdrawal|0|||
150200898|NCT06106022|541875790|FG001|Overall Study|Voluntary Withdrawal|2|||
150200899|NCT05524116|541875805|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
150200900|NCT05524116|541875806|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
150200901|NCT05524116|541875805|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
150200902|NCT05524116|541875806|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
150200903|NCT05524116|541875805|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
150200904|NCT05524116|541875806|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
150200905|NCT05524116|541875805|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
150200906|NCT05524116|541875806|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
150200907|NCT05524116|541875805|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
150200908|NCT05524116|541875806|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
150200909|NCT02834390|541875808|FG000|Induction Phase|Progressive disease|0|||
150200910|NCT02834390|541875809|FG001|Induction Phase|Progressive disease|1|||
150200911|NCT02834390|541875808|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
150200912|NCT02834390|541875809|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
150200913|NCT02834390|541875808|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
150200914|NCT02834390|541875809|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
150200915|NCT02834390|541875808|FG000|Consolidation Phase|Physician Decision|1|||
150200916|NCT02834390|541875809|FG001|Consolidation Phase|Physician Decision|1|||
150200917|NCT05552508|541875818|FG000|Overall Study|Adverse Event|3|||
150200918|NCT04451772|541875822|FG000|Overall Study|Adverse Event|1|||
150200919|NCT04451772|541875823|FG001|Overall Study|Adverse Event|0|||
150200920|NCT04451772|541875824|FG002|Overall Study|Adverse Event|1|||
150200921|NCT04451772|541875825|FG003|Overall Study|Adverse Event|1|||
150200922|NCT04451772|541875826|FG004|Overall Study|Adverse Event|0|||
150200923|NCT04451772|541875827|FG005|Overall Study|Adverse Event|3|||
150200924|NCT04451772|541875822|FG000|Overall Study|Withdrawal by Subject|2|||
150200925|NCT04451772|541875823|FG001|Overall Study|Withdrawal by Subject|7|||
150200926|NCT04451772|541875824|FG002|Overall Study|Withdrawal by Subject|2|||
150200927|NCT04451772|541875825|FG003|Overall Study|Withdrawal by Subject|1|||
150200928|NCT04451772|541875826|FG004|Overall Study|Withdrawal by Subject|1|||
150200929|NCT04451772|541875827|FG005|Overall Study|Withdrawal by Subject|0|||
150200930|NCT04451772|541875822|FG000|Overall Study|Other, not specified|1|||
150200931|NCT04451772|541875823|FG001|Overall Study|Other, not specified|2|||
150200932|NCT04451772|541875824|FG002|Overall Study|Other, not specified|1|||
150200933|NCT04451772|541875825|FG003|Overall Study|Other, not specified|0|||
150200934|NCT04451772|541875826|FG004|Overall Study|Other, not specified|0|||
150200935|NCT04451772|541875827|FG005|Overall Study|Other, not specified|1|||
150200936|NCT04451772|541875822|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
150200937|NCT04451772|541875823|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
150200938|NCT04451772|541875824|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
150200939|NCT04451772|541875825|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
150137108|NCT02279043|541635461|FG001|Overall Study|Lost to Follow-up|88|||
150137109|NCT02279043|541635462|FG002|Overall Study|Lost to Follow-up|0|||
150137110|NCT06213701|541635464|FG000|Overall Study|Withdrawal by Subject|2|||
150137111|NCT06213701|541635465|FG001|Overall Study|Withdrawal by Subject|1|||
150137112|NCT06213701|541635466|FG002|Overall Study|Withdrawal by Subject|0|||
150137113|NCT00453986|541635467|FG000|Overall Study|Lost to Follow-up|6|||
150137114|NCT00453986|541635468|FG001|Overall Study|Lost to Follow-up|5|||
150137115|NCT00453986|541635469|FG002|Overall Study|Lost to Follow-up|6|||
150137116|NCT00453986|541635470|FG003|Overall Study|Lost to Follow-up|2|||
150137117|NCT00453986|541635471|FG004|Overall Study|Lost to Follow-up|0|||
150137118|NCT01024608|541635474|FG000|Overall Study|Adverse Event|1|||
150137119|NCT01024608|541635475|FG001|Overall Study|Adverse Event|0|||
150137120|NCT01024608|541635474|FG000|Overall Study|Withdrawal by Subject|1|||
150137121|NCT01024608|541635475|FG001|Overall Study|Withdrawal by Subject|0|||
150137122|NCT01024608|541635474|FG000|Overall Study|Lost to Follow-up|0|||
150137123|NCT01024608|541635475|FG001|Overall Study|Lost to Follow-up|1|||
150137124|NCT01024608|541635474|FG000|Overall Study|Protocol Violation|0|||
150137125|NCT01024608|541635475|FG001|Overall Study|Protocol Violation|3|||
150137126|NCT01024608|541635474|FG000|Overall Study|Never received study treatment|2|||
150137127|NCT01024608|541635475|FG001|Overall Study|Never received study treatment|0|||
150137128|NCT00608582|541635490|FG000|Overall Study|Lost to Follow-up|2|||
150137129|NCT00608582|541635491|FG001|Overall Study|Lost to Follow-up|0|||
150137130|NCT00608582|541635490|FG000|Overall Study|No Best Response in Phase 1 located|1|||
150137131|NCT00608582|541635491|FG001|Overall Study|No Best Response in Phase 1 located|1|||
150137132|NCT00608582|541635490|FG000|Overall Study|Illicit Drug Use|1|||
150137133|NCT00608582|541635491|FG001|Overall Study|Illicit Drug Use|0|||
150137134|NCT00608582|541635490|FG000|Overall Study|Early stage Design Change|0|||
150137135|NCT00608582|541635491|FG001|Overall Study|Early stage Design Change|3|||
150137136|NCT00939484|541637168|FG000|Overall Study|Progression/Relapse|8|||
150137137|NCT00939484|541637169|FG001|Overall Study|Progression/Relapse|20|||
150137138|NCT00939484|541637170|FG002|Overall Study|Progression/Relapse|3|||
150137139|NCT04233372|541637171|FG000|Overall Study|Lost to Follow-up|104|||
150137140|NCT04233372|541637171|FG000|Overall Study|Adverse Event|8|||
150137141|NCT04233372|541637171|FG000|Overall Study|Withdrawal by Subject|2|||
150137142|NCT03938454|541637172|FG000|Overall Study|Protocol Violation|1|||
150137143|NCT03938454|541637172|FG000|Overall Study|Withdrawal by Subject|2|||
150137144|NCT03938454|541637172|FG000|Overall Study|Lost to Follow-up|3|||
150137145|NCT01090310|541637173|FG000|Core Study|Adverse Event|2|||
150137146|NCT01090310|541637174|FG001|Core Study|Adverse Event|2|||
150137147|NCT01090310|541637175|FG002|Core Study|Adverse Event|1|||
150137148|NCT01090310|541637176|FG003|Core Study|Adverse Event|1|||
150137149|NCT01090310|541637173|FG000|Core Study|Subject withdrew consent|0|||
150137150|NCT01090310|541637174|FG001|Core Study|Subject withdrew consent|3|||
150137151|NCT01090310|541637175|FG002|Core Study|Subject withdrew consent|1|||
150137152|NCT01090310|541637176|FG003|Core Study|Subject withdrew consent|1|||
150137153|NCT01090310|541637173|FG000|Core Study|Abnormal test procedure result|0|||
150137154|NCT01090310|541637174|FG001|Core Study|Abnormal test procedure result|0|||
150137155|NCT01090310|541637175|FG002|Core Study|Abnormal test procedure result|1|||
150137156|NCT01090310|541637176|FG003|Core Study|Abnormal test procedure result|0|||
150137157|NCT01090310|541637173|FG000|Core Study|Administrative reasons|5|||
150137158|NCT01090310|541637174|FG001|Core Study|Administrative reasons|6|||
150137159|NCT01090310|541637175|FG002|Core Study|Administrative reasons|4|||
150137160|NCT01090310|541637176|FG003|Core Study|Administrative reasons|4|||
150137161|NCT01090310|541637173|FG000|Core Study|Protocol deviation|1|||
150137162|NCT01090310|541637174|FG001|Core Study|Protocol deviation|0|||
150137163|NCT01090310|541637175|FG002|Core Study|Protocol deviation|0|||
150137164|NCT01090310|541637176|FG003|Core Study|Protocol deviation|1|||
150137165|NCT01090310|541637173|FG000|Extension Study|Aministrative problems|13|||
150137166|NCT01090310|541637174|FG001|Extension Study|Aministrative problems|15|||
150137167|NCT01090310|541637175|FG002|Extension Study|Aministrative problems|14|||
150137168|NCT01090310|541637176|FG003|Extension Study|Aministrative problems|18|||
150137169|NCT01090310|541637173|FG000|Extension Study|Adverse Event|0|||
150137170|NCT01090310|541637174|FG001|Extension Study|Adverse Event|0|||
150137171|NCT01090310|541637175|FG002|Extension Study|Adverse Event|0|||
150137172|NCT01090310|541637176|FG003|Extension Study|Adverse Event|1|||
150137173|NCT01090310|541637173|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
150137174|NCT01090310|541637174|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
150137175|NCT01090310|541637175|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
150137176|NCT01090310|541637176|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
150137177|NCT01090310|541637173|FG000|Extension Study|Subject withdrew consent|0|||
150137178|NCT01090310|541637174|FG001|Extension Study|Subject withdrew consent|1|||
150137179|NCT01090310|541637175|FG002|Extension Study|Subject withdrew consent|0|||
150137180|NCT01090310|541637176|FG003|Extension Study|Subject withdrew consent|0|||
150137181|NCT00695786|541637177|FG000|Overall Study|Adverse Event|0|||
150137182|NCT00695786|541637178|FG001|Overall Study|Adverse Event|3|||
150137183|NCT00695786|541637179|FG002|Overall Study|Adverse Event|4|||
150137184|NCT00695786|541637180|FG003|Overall Study|Adverse Event|2|||
150137185|NCT00695786|541637177|FG000|Overall Study|Lost to Follow-up|0|||
150137186|NCT00695786|541637178|FG001|Overall Study|Lost to Follow-up|5|||
150137187|NCT00695786|541637179|FG002|Overall Study|Lost to Follow-up|1|||
150137188|NCT00695786|541637180|FG003|Overall Study|Lost to Follow-up|1|||
150137189|NCT00695786|541637177|FG000|Overall Study|Withdrawal by Subject|0|||
150137190|NCT00695786|541637178|FG001|Overall Study|Withdrawal by Subject|4|||
150137191|NCT00695786|541637179|FG002|Overall Study|Withdrawal by Subject|3|||
150137192|NCT00695786|541637180|FG003|Overall Study|Withdrawal by Subject|1|||
150137193|NCT00695786|541637177|FG000|Overall Study|Deemed Ineligible|1|||
150137194|NCT00695786|541637178|FG001|Overall Study|Deemed Ineligible|0|||
150137195|NCT00695786|541637179|FG002|Overall Study|Deemed Ineligible|0|||
150137196|NCT00695786|541637180|FG003|Overall Study|Deemed Ineligible|0|||
150137197|NCT00695786|541637177|FG000|Overall Study|Lack of Efficacy|0|||
150137198|NCT00695786|541637178|FG001|Overall Study|Lack of Efficacy|0|||
150137199|NCT00695786|541637179|FG002|Overall Study|Lack of Efficacy|0|||
150137200|NCT00695786|541637180|FG003|Overall Study|Lack of Efficacy|4|||
150137201|NCT01364922|541637186|FG000|Open-label (OL) Period|Adverse Event|7|||
150137202|NCT01364922|541637187|FG001|Open-label (OL) Period|Adverse Event|0|||
150137203|NCT01364922|541637188|FG002|Open-label (OL) Period|Adverse Event|0|||
150137204|NCT01364922|541637186|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
150137205|NCT01364922|541637187|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
150137206|NCT01364922|541637188|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
150137207|NCT01364922|541637186|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
150137208|NCT01364922|541637187|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
150137209|NCT01364922|541637188|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
150137210|NCT01364922|541637186|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
150137211|NCT01364922|541637187|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
150137212|NCT01364922|541637188|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
150137213|NCT01364922|541637186|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
150137214|NCT01364922|541637187|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
150137215|NCT01364922|541637188|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
150137216|NCT01364922|541637186|FG000|Open-label (OL) Period|Other, Unspecified|1|||
150137217|NCT01364922|541637187|FG001|Open-label (OL) Period|Other, Unspecified|0|||
150137218|NCT01364922|541637188|FG002|Open-label (OL) Period|Other, Unspecified|0|||
150137219|NCT01364922|541637186|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
150137220|NCT01364922|541637187|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
150137221|NCT01364922|541637188|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
150200940|NCT04451772|541875826|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
150200941|NCT04451772|541875827|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
150200942|NCT04311632|541875828|FG000|Overall Study|Withdrawal by Subject|0|||
150200943|NCT04311632|541875829|FG001|Overall Study|Withdrawal by Subject|0|||
150200944|NCT04311632|541875830|FG002|Overall Study|Withdrawal by Subject|1|||
150200945|NCT04632225|541875831|FG000|Overall Study|Withdrawal by Subject|2|||
150200946|NCT04632225|541875832|FG001|Overall Study|Withdrawal by Subject|2|||
150200947|NCT04605159|541875833|FG000|Overall Study|Adverse Event|6|||
150200948|NCT04605159|541875834|FG001|Overall Study|Adverse Event|3|||
150200949|NCT04605159|541875835|FG002|Overall Study|Adverse Event|21|||
150200950|NCT04605159|541875836|FG003|Overall Study|Adverse Event|4|||
150200951|NCT04605159|541875833|FG000|Overall Study|Lost to Follow-up|74|||
150200952|NCT04605159|541875834|FG001|Overall Study|Lost to Follow-up|45|||
150200953|NCT04605159|541875835|FG002|Overall Study|Lost to Follow-up|119|||
150200954|NCT04605159|541875836|FG003|Overall Study|Lost to Follow-up|80|||
150200955|NCT04605159|541875833|FG000|Overall Study|Protocol Violation|4|||
150200956|NCT04605159|541875834|FG001|Overall Study|Protocol Violation|5|||
150200957|NCT04605159|541875835|FG002|Overall Study|Protocol Violation|2|||
150200958|NCT04605159|541875836|FG003|Overall Study|Protocol Violation|0|||
150200959|NCT04605159|541875833|FG000|Overall Study|Withdrawal by Subject|66|||
150200960|NCT04605159|541875834|FG001|Overall Study|Withdrawal by Subject|37|||
150200961|NCT04605159|541875835|FG002|Overall Study|Withdrawal by Subject|68|||
150200962|NCT04605159|541875836|FG003|Overall Study|Withdrawal by Subject|50|||
150200963|NCT04605159|541875833|FG000|Overall Study|Migrated / moved from the study area|32|||
150200964|NCT04605159|541875834|FG001|Overall Study|Migrated / moved from the study area|22|||
150200965|NCT04605159|541875835|FG002|Overall Study|Migrated / moved from the study area|41|||
150200966|NCT04605159|541875836|FG003|Overall Study|Migrated / moved from the study area|21|||
150200967|NCT04605159|541875833|FG000|Overall Study|Other|1|||
150200968|NCT04605159|541875834|FG001|Overall Study|Other|2|||
150200969|NCT04605159|541875835|FG002|Overall Study|Other|7|||
150200970|NCT04605159|541875836|FG003|Overall Study|Other|3|||
150200971|NCT00844415|541875838|FG000|Overall Study|Withdrawal by Subject|1|||
150200972|NCT03015532|541875839|FG000|Overall Study|Adverse Event|0|||
150200973|NCT03015532|541875840|FG001|Overall Study|Adverse Event|0|||
150200974|NCT03015532|541875841|FG002|Overall Study|Adverse Event|0|||
150200975|NCT03015532|541875842|FG003|Overall Study|Adverse Event|0|||
150200976|NCT03015532|541875843|FG004|Overall Study|Adverse Event|0|||
150200977|NCT03015532|541875844|FG005|Overall Study|Adverse Event|2|||
150200978|NCT03015532|541875845|FG006|Overall Study|Adverse Event|1|||
150200979|NCT03015532|541875846|FG007|Overall Study|Adverse Event|0|||
150200980|NCT03015532|541875839|FG000|Overall Study|Withdrawal by Subject|0|||
150200981|NCT03015532|541875840|FG001|Overall Study|Withdrawal by Subject|0|||
150200982|NCT03015532|541875841|FG002|Overall Study|Withdrawal by Subject|0|||
150200983|NCT03015532|541875842|FG003|Overall Study|Withdrawal by Subject|0|||
150200984|NCT03015532|541875843|FG004|Overall Study|Withdrawal by Subject|0|||
150200985|NCT03015532|541875844|FG005|Overall Study|Withdrawal by Subject|0|||
150200986|NCT03015532|541875845|FG006|Overall Study|Withdrawal by Subject|1|||
150200987|NCT03015532|541875846|FG007|Overall Study|Withdrawal by Subject|0|||
150200988|NCT03914469|541875849|FG000|Overall Study|Lost to Follow-up|1|||
150200989|NCT03914469|541875850|FG001|Overall Study|Lost to Follow-up|4|||
150200990|NCT05422885|541875857|FG000|Overall Study|Lost to Follow-up|1|||
150200991|NCT05422885|541875857|FG000|Overall Study|Withdrawal by Subject|2|||
150200992|NCT04084574|541875858|FG000|Overall Study|Lost to Follow-up|1|||
150200993|NCT04084574|541875859|FG001|Overall Study|Lost to Follow-up|0|||
150200994|NCT04084574|541875858|FG000|Overall Study|Physician Decision|1|||
150200995|NCT04084574|541875859|FG001|Overall Study|Physician Decision|0|||
150200996|NCT04084574|541875858|FG000|Overall Study|Relocated out of state|1|||
150200997|NCT04084574|541875859|FG001|Overall Study|Relocated out of state|0|||
150200998|NCT01121588|541875860|FG000|Overall Study|Death|5|||
150200999|NCT01121588|541875861|FG001|Overall Study|Death|3|||
150201000|NCT01121588|541875862|FG002|Overall Study|Death|13|||
150201001|NCT01121588|541875860|FG000|Overall Study|Study Terminated by Sponsor|1|||
150201002|NCT01121588|541875861|FG001|Overall Study|Study Terminated by Sponsor|1|||
150201003|NCT01121588|541875862|FG002|Overall Study|Study Terminated by Sponsor|0|||
150201004|NCT01121588|541875860|FG000|Overall Study|Participant Refused Further Followup|2|||
150201005|NCT01121588|541875861|FG001|Overall Study|Participant Refused Further Followup|0|||
150201006|NCT01121588|541875862|FG002|Overall Study|Participant Refused Further Followup|2|||
150201007|NCT01121588|541875860|FG000|Overall Study|Lost to Follow-up|0|||
150201008|NCT01121588|541875861|FG001|Overall Study|Lost to Follow-up|1|||
150201009|NCT01121588|541875862|FG002|Overall Study|Lost to Follow-up|1|||
150201010|NCT01121588|541875860|FG000|Overall Study|Non-Specified Reasons|9|||
150201011|NCT01121588|541875861|FG001|Overall Study|Non-Specified Reasons|4|||
150201012|NCT01121588|541875862|FG002|Overall Study|Non-Specified Reasons|2|||
150201013|NCT00942877|541875863|FG000|Overall Study|Refused further treatment|1|||
150201014|NCT00942877|541875864|FG001|Overall Study|Refused further treatment|1|||
150201015|NCT00942877|541875863|FG000|Overall Study|Patient was not treated|1|||
150201016|NCT00942877|541875864|FG001|Overall Study|Patient was not treated|0|||
150201017|NCT00942877|541875863|FG000|Overall Study|Adverse Event|1|||
150201018|NCT00942877|541875864|FG001|Overall Study|Adverse Event|0|||
150201019|NCT00942877|541875863|FG000|Overall Study|Progressive disease|42|||
150201020|NCT00942877|541875864|FG001|Overall Study|Progressive disease|3|||
150201021|NCT04102111|541875865|FG000|Overall Study|Withdrawal by Subject|2|||
150201022|NCT04102111|541875866|FG001|Overall Study|Withdrawal by Subject|3|||
150201023|NCT04102111|541875865|FG000|Overall Study|Adverse Event|1|||
150201024|NCT04102111|541875866|FG001|Overall Study|Adverse Event|1|||
150201025|NCT04102111|541875865|FG000|Overall Study|Study terminated by sponsor|1|||
150201026|NCT04102111|541875866|FG001|Overall Study|Study terminated by sponsor|3|||
150201027|NCT02542631|541875867|FG000|Overall Study|Adverse Event|1|||
150201028|NCT02542631|541875868|FG001|Overall Study|Adverse Event|1|||
150201029|NCT02542631|541875867|FG000|Overall Study|Sponsor Termination|1|||
150201030|NCT02542631|541875868|FG001|Overall Study|Sponsor Termination|0|||
150201031|NCT02542631|541875867|FG000|Overall Study|Withdrawal by Subject|11|||
150201032|NCT02542631|541875868|FG001|Overall Study|Withdrawal by Subject|16|||
150201033|NCT02542631|541875867|FG000|Overall Study|Protocol Violation|1|||
150201034|NCT02542631|541875868|FG001|Overall Study|Protocol Violation|1|||
150201035|NCT02542631|541875867|FG000|Overall Study|Physician Decision|6|||
150201036|NCT02542631|541875868|FG001|Overall Study|Physician Decision|4|||
150201037|NCT02542631|541875867|FG000|Overall Study|Lost to Follow-up|6|||
150201038|NCT02542631|541875868|FG001|Overall Study|Lost to Follow-up|5|||
150201039|NCT02542631|541875867|FG000|Overall Study|Death|1|||
150201040|NCT02542631|541875868|FG001|Overall Study|Death|2|||
150201041|NCT02542631|541875867|FG000|Overall Study|Other|2|||
150201042|NCT02542631|541875868|FG001|Overall Study|Other|1|||
150201043|NCT02542631|541875867|FG000|Overall Study|Used Prohibited Medication|2|||
150201044|NCT02542631|541875868|FG001|Overall Study|Used Prohibited Medication|1|||
150201045|NCT03334695|541875869|FG000|Overall Study|Lost to Follow-up|3|||
150201046|NCT03334695|541875870|FG001|Overall Study|Lost to Follow-up|3|||
150201047|NCT03334695|541875869|FG000|Overall Study|Physician Decision|1|||
150201048|NCT03334695|541875870|FG001|Overall Study|Physician Decision|2|||
150201049|NCT03334695|541875869|FG000|Overall Study|Protocol Violation|0|||
150201050|NCT03334695|541875870|FG001|Overall Study|Protocol Violation|1|||
150201051|NCT02938923|541875871|FG000|Overall Study|Death|1|||
150201052|NCT02938923|541875872|FG001|Overall Study|Death|0|||
150201053|NCT02938923|541875873|FG002|Overall Study|Death|0|||
150201054|NCT02938923|541875871|FG000|Overall Study|Physician Decision|0|||
150201055|NCT02938923|541875872|FG001|Overall Study|Physician Decision|2|||
150201056|NCT02938923|541875873|FG002|Overall Study|Physician Decision|0|||
150201057|NCT02938923|541875871|FG000|Overall Study|Withdrawal by Subject|0|||
150201058|NCT02938923|541875872|FG001|Overall Study|Withdrawal by Subject|1|||
150201059|NCT02938923|541875873|FG002|Overall Study|Withdrawal by Subject|1|||
150201060|NCT03812614|541875876|FG000|Intervention|Withdrawal by Subject|7|||
150201061|NCT03812614|541875877|FG001|Intervention|Withdrawal by Subject|2|||
150201062|NCT03812614|541875878|FG002|Intervention|Withdrawal by Subject|7|||
150201063|NCT03812614|541875879|FG003|Intervention|Withdrawal by Subject|2|||
150201064|NCT03812614|541875876|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
150201065|NCT03812614|541875877|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
150201066|NCT03812614|541875878|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
150201067|NCT03812614|541875879|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
150201068|NCT03812614|541875876|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
150201069|NCT03812614|541875877|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
150201070|NCT03812614|541875878|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
150201071|NCT03812614|541875879|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
150201072|NCT03812614|541875876|FG000|6-month Follow-up|Lost to Follow-up|0|||
150201073|NCT03812614|541875877|FG001|6-month Follow-up|Lost to Follow-up|0|||
150201074|NCT03812614|541875878|FG002|6-month Follow-up|Lost to Follow-up|12|||
150201075|NCT03812614|541875879|FG003|6-month Follow-up|Lost to Follow-up|8|||
150201076|NCT03812614|541875876|FG000|12-month Follow-up|Lost to Follow-up|18|||
150201077|NCT03812614|541875877|FG001|12-month Follow-up|Lost to Follow-up|17|||
150201078|NCT03812614|541875878|FG002|12-month Follow-up|Lost to Follow-up|5|||
150201079|NCT03812614|541875879|FG003|12-month Follow-up|Lost to Follow-up|2|||
150201080|NCT05123027|541875891|FG000|Overall Study|Lost to Follow-up|17|||
150201081|NCT05123027|541875892|FG001|Overall Study|Lost to Follow-up|22|||
150201082|NCT05123027|541875891|FG000|Overall Study|Incarceration|3|||
150201083|NCT05123027|541875892|FG001|Overall Study|Incarceration|4|||
150201084|NCT05123027|541875891|FG000|Overall Study|Death|2|||
150201085|NCT05123027|541875892|FG001|Overall Study|Death|2|||
150201086|NCT05123027|541875891|FG000|Overall Study|Other|2|||
150201087|NCT05123027|541875892|FG001|Overall Study|Other|0|||
150201088|NCT02585323|541877828|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
150201089|NCT02585323|541877829|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
150201090|NCT02585323|541877828|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
150201091|NCT02585323|541877829|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
150201092|NCT02585323|541877828|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
150201093|NCT02585323|541877829|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
150201094|NCT02585323|541877828|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
150201095|NCT02585323|541877829|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
150201096|NCT05311176|541877830|FG000|Overall Study|Death|6|||
150201097|NCT05311176|541877830|FG000|Overall Study|Sponsor discontinued the study|1|||
150201098|NCT04089865|541877834|FG000|Overall Study|Withdrawal by Subject|2|||
150201099|NCT04089865|541877835|FG001|Overall Study|Withdrawal by Subject|2|||
150201100|NCT04089865|541877836|FG002|Overall Study|Withdrawal by Subject|7|||
150201101|NCT04089865|541877837|FG003|Overall Study|Withdrawal by Subject|2|||
150201102|NCT05405985|541877840|FG000|Overall Study|Withdrawal by Subject|1|||
150201103|NCT05405985|541877841|FG001|Overall Study|Withdrawal by Subject|0|||
150201104|NCT05424380|541877846|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
150201105|NCT05424380|541877847|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
150201106|NCT05424380|541877848|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
150201107|NCT05424380|541877849|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
150201108|NCT05424380|541877850|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
150201109|NCT05424380|541877851|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
150201110|NCT05424380|541877846|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
150201111|NCT05424380|541877847|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
150201112|NCT05424380|541877848|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
150201113|NCT05424380|541877849|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
150201114|NCT05424380|541877850|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
150201115|NCT05424380|541877851|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
150201116|NCT05424380|541877846|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
150201117|NCT05424380|541877847|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
150201118|NCT05424380|541877848|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
150201119|NCT05424380|541877849|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
150201120|NCT05424380|541877850|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
150201121|NCT05424380|541877851|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
150201122|NCT05424380|541877846|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
150201123|NCT05424380|541877847|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
150201124|NCT05424380|541877848|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
150201125|NCT05424380|541877849|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
150201126|NCT05424380|541877850|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
150201127|NCT05424380|541877851|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
150201128|NCT05424380|541877846|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
150201129|NCT05424380|541877847|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
150201130|NCT05424380|541877848|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
150201131|NCT05424380|541877849|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
150201132|NCT05424380|541877850|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
150201133|NCT05424380|541877851|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
150201134|NCT05424380|541877846|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
150201135|NCT05424380|541877847|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
150201136|NCT05424380|541877848|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
150201137|NCT05424380|541877849|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
150201138|NCT05424380|541877850|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
150201139|NCT05424380|541877851|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
150201140|NCT05424380|541877846|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
150201141|NCT05424380|541877847|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
150201142|NCT05424380|541877848|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
150201143|NCT05424380|541877849|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
150201144|NCT05424380|541877850|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
150201145|NCT05424380|541877851|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
150201146|NCT05424380|541877846|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
150201147|NCT05424380|541877847|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
150201148|NCT05424380|541877848|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
150201149|NCT05424380|541877849|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
150201150|NCT05424380|541877850|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
150201151|NCT05424380|541877851|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
150201152|NCT05424380|541877846|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201153|NCT05424380|541877847|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201154|NCT05424380|541877848|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201155|NCT05424380|541877849|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
150201156|NCT05424380|541877850|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201157|NCT05424380|541877851|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201158|NCT05424380|541877846|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
150201159|NCT05424380|541877847|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
150201160|NCT05424380|541877848|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
150201161|NCT05424380|541877849|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
150201162|NCT05424380|541877850|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
150201163|NCT05424380|541877851|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
150201164|NCT05424380|541877846|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
150137222|NCT01364922|541637186|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
150137223|NCT01364922|541637187|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
150137224|NCT01364922|541637188|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
150137225|NCT01364922|541637186|FG000|Double-Blind (DB) Period|Adverse Event|0|||
150137226|NCT01364922|541637187|FG001|Double-Blind (DB) Period|Adverse Event|0|||
150137227|NCT01364922|541637188|FG002|Double-Blind (DB) Period|Adverse Event|1|||
150137228|NCT01364922|541637186|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
150137229|NCT01364922|541637187|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
150137230|NCT01364922|541637188|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
150137231|NCT04244396|541637191|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
150137232|NCT04244396|541637191|FG000|Overall Study|Withdrawal by Subject|2|||
150137233|NCT04244396|541637191|FG000|Overall Study|Study termination|37|||
150137234|NCT01787097|541637192|FG000|Overall Study|Withdrawal by Subject|1|||
150137235|NCT01787097|541637193|FG001|Overall Study|Withdrawal by Subject|0|||
150137236|NCT01787097|541637194|FG002|Overall Study|Withdrawal by Subject|0|||
150137237|NCT01787097|541637195|FG003|Overall Study|Withdrawal by Subject|0|||
150137238|NCT05178121|541637196|FG000|Overall Study|Other|4|||
150137239|NCT05178121|541637196|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
150137240|NCT01953003|541637197|FG000|Overall Study|Not treated|0|||
150137241|NCT01953003|541637198|FG001|Overall Study|Not treated|1|||
150137242|NCT01953003|541637197|FG000|Overall Study|Progressive disease|35|||
150137243|NCT01953003|541637198|FG001|Overall Study|Progressive disease|45|||
150137244|NCT01953003|541637197|FG000|Overall Study|Related Adverse events|7|||
150137245|NCT01953003|541637198|FG001|Overall Study|Related Adverse events|2|||
150137246|NCT01953003|541637197|FG000|Overall Study|Non-related adverse events|0|||
150137247|NCT01953003|541637198|FG001|Overall Study|Non-related adverse events|2|||
150137248|NCT01953003|541637197|FG000|Overall Study|Protocol Violation|0|||
150137249|NCT01953003|541637198|FG001|Overall Study|Protocol Violation|1|||
150137250|NCT01953003|541637197|FG000|Overall Study|Withdrawal by Subject|14|||
150137251|NCT01953003|541637198|FG001|Overall Study|Withdrawal by Subject|4|||
150137252|NCT00553501|541637201|FG000|Overall Study|Adverse Event|2|||
150137253|NCT00553501|541637201|FG000|Overall Study|Death|1|||
150137254|NCT00553501|541637201|FG000|Overall Study|Progression|1|||
150137255|NCT01464021|541637205|FG000|Overall Study|Withdrawal by Subject|13|||
150137256|NCT01464021|541637205|FG000|Overall Study|Lost to Follow-up|1|||
150137257|NCT01464021|541637205|FG000|Overall Study|Lack of Efficacy|1|||
150137258|NCT01464021|541637205|FG000|Overall Study|various|11|||
150137259|NCT03391765|541637207|FG000|Overall Study|Adverse Event|2|||
150201165|NCT05424380|541877847|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
150201166|NCT05424380|541877848|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
150137260|NCT03391765|541637208|FG001|Overall Study|Adverse Event|0|||
150137261|NCT03391765|541637209|FG002|Overall Study|Adverse Event|0|||
150137262|NCT03391765|541637210|FG003|Overall Study|Adverse Event|2|||
150137263|NCT03391765|541637207|FG000|Overall Study|Withdrew consent|5|||
150137264|NCT03391765|541637208|FG001|Overall Study|Withdrew consent|7|||
150137265|NCT03391765|541637209|FG002|Overall Study|Withdrew consent|2|||
150137266|NCT03391765|541637210|FG003|Overall Study|Withdrew consent|5|||
150201167|NCT05424380|541877849|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
150201168|NCT05424380|541877850|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
150201169|NCT05424380|541877851|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
150201170|NCT05424380|541877846|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
150201171|NCT05424380|541877847|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
150201172|NCT05424380|541877848|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
150201173|NCT05424380|541877849|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
150201174|NCT05424380|541877850|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
150201175|NCT05424380|541877851|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
150201176|NCT05424380|541877846|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201177|NCT05424380|541877847|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201178|NCT05424380|541877848|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201179|NCT05424380|541877849|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201180|NCT05424380|541877850|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
150201181|NCT05424380|541877851|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
150201182|NCT05424380|541877846|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
150201183|NCT05424380|541877847|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
150201184|NCT05424380|541877848|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
150201185|NCT05424380|541877849|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
150201186|NCT05424380|541877850|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
150201187|NCT05424380|541877851|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
150201188|NCT03858517|541877856|FG000|Overall Study|Adverse Event|1|||
150201189|NCT03858517|541877856|FG000|Overall Study|Lost to Follow-up|1|||
150201190|NCT03858517|541877856|FG000|Overall Study|removed for being incarcerated|1|||
150201191|NCT03858517|541877856|FG000|Overall Study|Sponsor Closure|48|||
150201192|NCT05172232|541877857|FG000|Overall Study|Lost to Follow-up|3|||
150201193|NCT02473445|541877859|FG000|Overall Study|Withdrawal by Subject|2|||
150201194|NCT02473445|541877859|FG000|Overall Study|Sponsor Decision|20|||
150201195|NCT04629339|541877860|FG000|Overall Study|Death|1|||
150201196|NCT04629339|541877861|FG001|Overall Study|Death|0|||
150201197|NCT04629339|541877862|FG002|Overall Study|Death|2|||
150201198|NCT04629339|541877863|FG003|Overall Study|Death|2|||
150201199|NCT04629339|541877864|FG004|Overall Study|Death|0|||
150201200|NCT04629339|541877860|FG000|Overall Study|Disease Progression|0|||
150201201|NCT04629339|541877861|FG001|Overall Study|Disease Progression|0|||
150201202|NCT04629339|541877862|FG002|Overall Study|Disease Progression|1|||
150201203|NCT04629339|541877863|FG003|Overall Study|Disease Progression|1|||
150201204|NCT04629339|541877864|FG004|Overall Study|Disease Progression|0|||
150201205|NCT04629339|541877860|FG000|Overall Study|Lost to Follow-up|0|||
150201206|NCT04629339|541877861|FG001|Overall Study|Lost to Follow-up|0|||
150201207|NCT04629339|541877862|FG002|Overall Study|Lost to Follow-up|0|||
150137267|NCT03391765|541637207|FG000|Overall Study|Other, not specified|44|||
150137268|NCT03391765|541637208|FG001|Overall Study|Other, not specified|38|||
150137269|NCT03391765|541637209|FG002|Overall Study|Other, not specified|21|||
150137270|NCT03391765|541637210|FG003|Overall Study|Other, not specified|16|||
150137271|NCT00944658|541637211|FG000|Treatment 12 Weeks|Adverse Event|0|||
150137272|NCT00944658|541637212|FG001|Treatment 12 Weeks|Adverse Event|2|||
150137273|NCT01255592|541637213|FG000|Overall Study|Adverse Event|5|||
150137274|NCT01255592|541637214|FG001|Overall Study|Adverse Event|0|||
150137275|NCT01255592|541637213|FG000|Overall Study|Withdrawal by Subject|1|||
150137276|NCT01255592|541637214|FG001|Overall Study|Withdrawal by Subject|0|||
150137277|NCT01255592|541637213|FG000|Overall Study|Other|0|||
150137278|NCT01255592|541637214|FG001|Overall Study|Other|1|||
150137279|NCT03928028|541637226|FG000|Overall Study|Physician Decision|9|||
150137280|NCT03928028|541637227|FG001|Overall Study|Physician Decision|6|||
150137281|NCT03928028|541637228|FG002|Overall Study|Physician Decision|3|||
150137282|NCT03928028|541637226|FG000|Overall Study|Withdrawal by Subject|12|||
150137283|NCT03928028|541637227|FG001|Overall Study|Withdrawal by Subject|3|||
150137284|NCT03928028|541637228|FG002|Overall Study|Withdrawal by Subject|3|||
150137285|NCT04525547|541637234|FG000|Overall Study|Not treated with Ofev|2|||
150137286|NCT04525547|541637234|FG000|Overall Study|Off-label use|2|||
150137287|NCT04525547|541637234|FG000|Overall Study|Lost to Follow-up|1|||
150137288|NCT00800202|541637235|FG000|Overall Study|Adverse Event|7|||
150137289|NCT00800202|541637236|FG001|Overall Study|Adverse Event|6|||
150137290|NCT00800202|541637235|FG000|Overall Study|Death|1|||
150137291|NCT00800202|541637236|FG001|Overall Study|Death|0|||
150137292|NCT00800202|541637235|FG000|Overall Study|Other|5|||
150137293|NCT00800202|541637236|FG001|Overall Study|Other|0|||
150137294|NCT00800202|541637235|FG000|Overall Study|Disease Progression|54|||
150137295|NCT00800202|541637236|FG001|Overall Study|Disease Progression|18|||
150201208|NCT04629339|541877863|FG003|Overall Study|Lost to Follow-up|1|||
150137296|NCT00526630|541637247|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
150137297|NCT00526630|541637248|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
150137298|NCT00526630|541637247|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
150137299|NCT00526630|541637248|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
150137300|NCT02052310|541637249|FG000|Overall Study|Death|64|||
150201209|NCT04629339|541877864|FG004|Overall Study|Lost to Follow-up|0|||
150201210|NCT04629339|541877860|FG000|Overall Study|Physician Decision|0|||
150201211|NCT04629339|541877861|FG001|Overall Study|Physician Decision|1|||
150201212|NCT04629339|541877862|FG002|Overall Study|Physician Decision|0|||
150201213|NCT04629339|541877863|FG003|Overall Study|Physician Decision|0|||
150201214|NCT04629339|541877864|FG004|Overall Study|Physician Decision|0|||
150201215|NCT04629339|541877860|FG000|Overall Study|Study Terminated by Sponsor|0|||
150201216|NCT04629339|541877861|FG001|Overall Study|Study Terminated by Sponsor|0|||
150201217|NCT04629339|541877862|FG002|Overall Study|Study Terminated by Sponsor|0|||
150201218|NCT04629339|541877863|FG003|Overall Study|Study Terminated by Sponsor|1|||
150201219|NCT04629339|541877864|FG004|Overall Study|Study Terminated by Sponsor|0|||
150201220|NCT04629339|541877860|FG000|Overall Study|Withdrawal by Subject|0|||
150201221|NCT04629339|541877861|FG001|Overall Study|Withdrawal by Subject|0|||
150201222|NCT04629339|541877862|FG002|Overall Study|Withdrawal by Subject|2|||
150201223|NCT04629339|541877863|FG003|Overall Study|Withdrawal by Subject|2|||
150201224|NCT04629339|541877864|FG004|Overall Study|Withdrawal by Subject|0|||
150201225|NCT04158739|541877869|FG000|Overall Study|Adverse Event|1|||
150201226|NCT04158739|541877870|FG001|Overall Study|Adverse Event|0|||
150201227|NCT04158739|541877869|FG000|Overall Study|Death|0|||
150201228|NCT04158739|541877870|FG001|Overall Study|Death|1|||
150201229|NCT04158739|541877869|FG000|Overall Study|Lack of Efficacy|3|||
150201230|NCT04158739|541877870|FG001|Overall Study|Lack of Efficacy|7|||
150201231|NCT04158739|541877869|FG000|Overall Study|Physician Decision|0|||
150201232|NCT04158739|541877870|FG001|Overall Study|Physician Decision|1|||
150201233|NCT04158739|541877869|FG000|Overall Study|Withdrawal by Subject|3|||
150201234|NCT04158739|541877870|FG001|Overall Study|Withdrawal by Subject|0|||
150201235|NCT00677365|541877875|FG000|Overall Study|Adverse Event|2|||
150201236|NCT00677365|541877876|FG001|Overall Study|Adverse Event|1|||
150201237|NCT00677365|541877877|FG002|Overall Study|Adverse Event|1|||
150201238|NCT00677365|541877878|FG003|Overall Study|Adverse Event|2|||
150201239|NCT00677365|541877875|FG000|Overall Study|Withdrawal by Subject|0|||
150201240|NCT00677365|541877876|FG001|Overall Study|Withdrawal by Subject|0|||
150201241|NCT00677365|541877877|FG002|Overall Study|Withdrawal by Subject|1|||
150201242|NCT00677365|541877878|FG003|Overall Study|Withdrawal by Subject|0|||
150201243|NCT00677365|541877875|FG000|Overall Study|Other reason|0|||
150201244|NCT00677365|541877876|FG001|Overall Study|Other reason|0|||
150201245|NCT00677365|541877877|FG002|Overall Study|Other reason|0|||
150201246|NCT00677365|541877878|FG003|Overall Study|Other reason|1|||
150201247|NCT01385202|541877879|FG000|Overall Study|Lost to Follow-up|6|||
150201248|NCT01385202|541877879|FG000|Overall Study|Not Eligible|11|||
150201249|NCT01385202|541877879|FG000|Overall Study|Withdrawn|1|||
150201250|NCT00964392|541877882|FG000|Overall Study|Withdrawal by Subject|4|||
150201251|NCT00964392|541877883|FG001|Overall Study|Withdrawal by Subject|6|||
150201252|NCT00964392|541877882|FG000|Overall Study|Lost to Follow-up|4|||
150201253|NCT00964392|541877883|FG001|Overall Study|Lost to Follow-up|10|||
150201254|NCT00964392|541877882|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
150201255|NCT00964392|541877883|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
150201256|NCT00964392|541877882|FG000|Overall Study|Not completed|44|||
150201257|NCT00964392|541877883|FG001|Overall Study|Not completed|168|||
150201258|NCT00303459|541877884|FG000|Overall Study|Death|33|||
150201259|NCT00303459|541877885|FG001|Overall Study|Death|44|||
150201260|NCT00303459|541877884|FG000|Overall Study|Withdrawal of consent|32|||
150201261|NCT00303459|541877885|FG001|Overall Study|Withdrawal of consent|26|||
150201262|NCT00303459|541877884|FG000|Overall Study|Lost to Follow-up|5|||
150201263|NCT00303459|541877885|FG001|Overall Study|Lost to Follow-up|4|||
150201264|NCT00303459|541877884|FG000|Overall Study|Administrative reason|7|||
150201265|NCT00303459|541877885|FG001|Overall Study|Administrative reason|7|||
150201266|NCT00303459|541877884|FG000|Overall Study|Decision by the investigator|5|||
150201267|NCT00303459|541877885|FG001|Overall Study|Decision by the investigator|7|||
150201268|NCT00303459|541877884|FG000|Overall Study|Lung transplantation|1|||
150201269|NCT00303459|541877885|FG001|Overall Study|Lung transplantation|1|||
150201270|NCT04214834|541877889|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
150201271|NCT04214834|541877890|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
150201272|NCT04924400|541877891|FG000|Overall Study|Lost to Follow-up|3|||
150201273|NCT04924400|541877892|FG001|Overall Study|Lost to Follow-up|0|||
150201274|NCT04424316|541877893|FG000|Overall Study|Adverse Event|0|||
150201275|NCT04424316|541877894|FG001|Overall Study|Adverse Event|1|||
150201276|NCT04424316|541877895|FG002|Overall Study|Adverse Event|0|||
150201277|NCT04424316|541877896|FG003|Overall Study|Adverse Event|0|||
150201278|NCT04424316|541877893|FG000|Overall Study|Death|1|||
150201279|NCT04424316|541877894|FG001|Overall Study|Death|0|||
150201280|NCT04424316|541877895|FG002|Overall Study|Death|8|||
150201281|NCT04424316|541877896|FG003|Overall Study|Death|14|||
150201282|NCT04424316|541877893|FG000|Overall Study|Lost to Follow-up|93|||
150201283|NCT04424316|541877894|FG001|Overall Study|Lost to Follow-up|88|||
150201284|NCT04424316|541877895|FG002|Overall Study|Lost to Follow-up|224|||
150201285|NCT04424316|541877896|FG003|Overall Study|Lost to Follow-up|211|||
150201286|NCT04424316|541877893|FG000|Overall Study|No longer met eligibility criteria|1|||
150137301|NCT02052310|541637250|FG001|Overall Study|Death|54|||
150137302|NCT02052310|541637249|FG000|Overall Study|Withdrawal by Subject|37|||
150137303|NCT02052310|541637250|FG001|Overall Study|Withdrawal by Subject|49|||
150137304|NCT02052310|541637249|FG000|Overall Study|Other than specified|32|||
150137305|NCT02052310|541637250|FG001|Overall Study|Other than specified|29|||
150137306|NCT02052310|541637249|FG000|Overall Study|Adverse Event|29|||
150137307|NCT02052310|541637250|FG001|Overall Study|Adverse Event|22|||
150137308|NCT02052310|541637249|FG000|Overall Study|Kidney Transplant|23|||
150137309|NCT02052310|541637250|FG001|Overall Study|Kidney Transplant|29|||
150137310|NCT02052310|541637249|FG000|Overall Study|Physician Decision|14|||
150137311|NCT02052310|541637250|FG001|Overall Study|Physician Decision|7|||
150137312|NCT02052310|541637249|FG000|Overall Study|Lack of Efficacy|6|||
150137313|NCT02052310|541637250|FG001|Overall Study|Lack of Efficacy|1|||
150137314|NCT02052310|541637249|FG000|Overall Study|Site Terminated by Sponsor|5|||
150137315|NCT02052310|541637250|FG001|Overall Study|Site Terminated by Sponsor|13|||
150137316|NCT02052310|541637249|FG000|Overall Study|Lost to Follow-up|4|||
150137317|NCT02052310|541637250|FG001|Overall Study|Lost to Follow-up|2|||
150137318|NCT02052310|541637249|FG000|Overall Study|Protocol Violation|1|||
150137319|NCT02052310|541637250|FG001|Overall Study|Protocol Violation|6|||
150137320|NCT00595504|541637253|FG000|Overall Study|Withdrawal by Subject|1|||
150137321|NCT00595504|541637254|FG001|Overall Study|Withdrawal by Subject|3|||
150137322|NCT00595504|541637253|FG000|Overall Study|Physician Decision|1|||
150137323|NCT00595504|541637254|FG001|Overall Study|Physician Decision|0|||
150137324|NCT01949870|541637255|FG000|Overall Study|Lack of Efficacy|2|||
150137325|NCT01949870|541637255|FG000|Overall Study|Adverse Event|1|||
150137326|NCT01949870|541637255|FG000|Overall Study|Study termination|1|||
150137327|NCT01949870|541637255|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
150137328|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
150137329|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
150137330|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
150137331|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
150137332|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
150137333|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
150137334|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
150137335|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
150137336|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
150137337|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
150137338|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
150137339|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
150137340|NCT00293267|541637256|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
150137341|NCT00293267|541637257|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
150137342|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
150137343|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
150137344|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
150137345|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
150137346|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
150137347|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
150137348|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
150137349|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
150137350|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Death|3|||
150137351|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Death|0|||
150137352|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
150137353|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
150137354|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
150137355|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
150137356|NCT00293267|541637256|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
150137357|NCT00293267|541637257|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
150137358|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
150137359|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
150137360|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
150137361|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
150137362|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
150137363|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
150137364|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
150137365|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
150137366|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
150137367|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
150201287|NCT04424316|541877894|FG001|Overall Study|No longer met eligibility criteria|0|||
150201288|NCT04424316|541877895|FG002|Overall Study|No longer met eligibility criteria|0|||
150201289|NCT04424316|541877896|FG003|Overall Study|No longer met eligibility criteria|0|||
150201290|NCT04424316|541877893|FG000|Overall Study|Other|15|||
150201291|NCT04424316|541877894|FG001|Overall Study|Other|11|||
150201292|NCT04424316|541877895|FG002|Overall Study|Other|34|||
150201293|NCT04424316|541877896|FG003|Overall Study|Other|45|||
150201294|NCT04424316|541877893|FG000|Overall Study|Physician Decision|1|||
150201295|NCT04424316|541877894|FG001|Overall Study|Physician Decision|0|||
150201296|NCT04424316|541877895|FG002|Overall Study|Physician Decision|1|||
150201297|NCT04424316|541877896|FG003|Overall Study|Physician Decision|1|||
150201298|NCT04424316|541877893|FG000|Overall Study|Protocol Violation|0|||
150201299|NCT04424316|541877894|FG001|Overall Study|Protocol Violation|1|||
150201300|NCT04424316|541877895|FG002|Overall Study|Protocol Violation|0|||
150201301|NCT04424316|541877896|FG003|Overall Study|Protocol Violation|0|||
150201302|NCT04424316|541877893|FG000|Overall Study|Withdrawal by Subject|71|||
150201303|NCT04424316|541877894|FG001|Overall Study|Withdrawal by Subject|77|||
150201304|NCT04424316|541877895|FG002|Overall Study|Withdrawal by Subject|0|||
150201305|NCT04424316|541877896|FG003|Overall Study|Withdrawal by Subject|0|||
150201306|NCT04424316|541877893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150201307|NCT04424316|541877894|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150201308|NCT04424316|541877895|FG002|Overall Study|Withdrawal by parent/guardian|74|||
150201309|NCT04424316|541877896|FG003|Overall Study|Withdrawal by parent/guardian|81|||
150201310|NCT04424316|541877893|FG000|Overall Study|Randomized but not vaccinated|13|||
150201311|NCT04424316|541877894|FG001|Overall Study|Randomized but not vaccinated|21|||
150201312|NCT04424316|541877895|FG002|Overall Study|Randomized but not vaccinated|0|||
150201313|NCT04424316|541877896|FG003|Overall Study|Randomized but not vaccinated|0|||
150201314|NCT04424316|541877893|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
150201315|NCT04424316|541877894|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
150201316|NCT04424316|541877895|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
150201317|NCT04424316|541877896|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
150201318|NCT04109066|541877899|FG000|Pre-treatment|Participant withdrew consent|2|||
150201319|NCT04109066|541877900|FG001|Pre-treatment|Participant withdrew consent|0|||
150201320|NCT04109066|541877899|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
150201321|NCT04109066|541877900|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
150201322|NCT04109066|541877899|FG000|Treatment|Lack of Efficacy|2|||
150201323|NCT04109066|541877900|FG001|Treatment|Lack of Efficacy|4|||
150201324|NCT04109066|541877899|FG000|Treatment|Adverse Event|23|||
150201325|NCT04109066|541877900|FG001|Treatment|Adverse Event|7|||
150201326|NCT04109066|541877899|FG000|Treatment|Participant request to discontinue Study treatment|15|||
150201327|NCT04109066|541877900|FG001|Treatment|Participant request to discontinue Study treatment|14|||
150201328|NCT04109066|541877899|FG000|Treatment|Withdrawal by Subject|8|||
150201329|NCT04109066|541877900|FG001|Treatment|Withdrawal by Subject|8|||
150201330|NCT04109066|541877899|FG000|Treatment|Death|3|||
150201331|NCT04109066|541877900|FG001|Treatment|Death|0|||
150201332|NCT04109066|541877899|FG000|Treatment|Participant no longer meets study criteria|2|||
150201333|NCT04109066|541877900|FG001|Treatment|Participant no longer meets study criteria|2|||
150201334|NCT04109066|541877899|FG000|Treatment|Administrative reasons by sponsor|2|||
150201335|NCT04109066|541877900|FG001|Treatment|Administrative reasons by sponsor|3|||
150201336|NCT04109066|541877899|FG000|Treatment|Other reasons|17|||
150201337|NCT04109066|541877900|FG001|Treatment|Other reasons|23|||
150201338|NCT04109066|541877899|FG000|Treatment|Disease Progression|4|||
150201339|NCT04109066|541877900|FG001|Treatment|Disease Progression|7|||
150201340|NCT04109066|541877899|FG000|Treatment|Study drug toxicity|12|||
150201341|NCT04109066|541877900|FG001|Treatment|Study drug toxicity|5|||
150201342|NCT04109066|541877899|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
150201343|NCT04109066|541877900|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
150201344|NCT04109066|541877899|FG000|Treatment|Disease Recurrence|0|||
150201345|NCT04109066|541877900|FG001|Treatment|Disease Recurrence|2|||
150201346|NCT04109066|541877899|FG000|Treatment|Not reported|4|||
150201347|NCT04109066|541877900|FG001|Treatment|Not reported|8|||
150201348|NCT05652010|541877901|FG000|First Intervention|Withdrawal by Subject|0|||
150201349|NCT05652010|541877902|FG001|First Intervention|Withdrawal by Subject|1|||
150201350|NCT05652010|541877901|FG000|Second Intervention|Withdrawal by Subject|1|||
150201351|NCT05652010|541877902|FG001|Second Intervention|Withdrawal by Subject|0|||
150201352|NCT05451693|541877904|FG000|Overall Study|Withdrawal by Subject|1|||
150201353|NCT05451693|541877905|FG001|Overall Study|Withdrawal by Subject|1|||
150201354|NCT04707768|541877916|FG000|Overall Study|Adverse Event|9|||
150201355|NCT04707768|541877917|FG001|Overall Study|Adverse Event|18|||
150201356|NCT04707768|541877918|FG002|Overall Study|Adverse Event|3|||
150201357|NCT04707768|541877916|FG000|Overall Study|Investigator's Discretion|8|||
150201358|NCT04707768|541877917|FG001|Overall Study|Investigator's Discretion|4|||
150201359|NCT04707768|541877918|FG002|Overall Study|Investigator's Discretion|3|||
150201360|NCT04707768|541877916|FG000|Overall Study|Withdrawal by Subject|6|||
150201361|NCT04707768|541877917|FG001|Overall Study|Withdrawal by Subject|8|||
150201362|NCT04707768|541877918|FG002|Overall Study|Withdrawal by Subject|2|||
150201363|NCT04707768|541877916|FG000|Overall Study|Lack of Efficacy|1|||
150201364|NCT04707768|541877917|FG001|Overall Study|Lack of Efficacy|3|||
150201365|NCT04707768|541877918|FG002|Overall Study|Lack of Efficacy|0|||
150201366|NCT04707768|541877916|FG000|Overall Study|Lost to Follow-up|0|||
150201367|NCT04707768|541877917|FG001|Overall Study|Lost to Follow-up|0|||
150201368|NCT04707768|541877918|FG002|Overall Study|Lost to Follow-up|3|||
150201369|NCT04707768|541877916|FG000|Overall Study|Death|13|||
150201370|NCT04707768|541877917|FG001|Overall Study|Death|11|||
150201371|NCT04707768|541877918|FG002|Overall Study|Death|13|||
150201372|NCT04707768|541877916|FG000|Overall Study|Protocol Violation|2|||
150201373|NCT04707768|541877917|FG001|Overall Study|Protocol Violation|1|||
150201374|NCT04707768|541877918|FG002|Overall Study|Protocol Violation|0|||
150201375|NCT04707768|541877916|FG000|Overall Study|Non Compliance with Study Drug|1|||
150201376|NCT04707768|541877917|FG001|Overall Study|Non Compliance with Study Drug|0|||
150201377|NCT04707768|541877918|FG002|Overall Study|Non Compliance with Study Drug|0|||
150201378|NCT04707768|541877916|FG000|Overall Study|Transplant|4|||
150201379|NCT04707768|541877917|FG001|Overall Study|Transplant|4|||
150201380|NCT04707768|541877918|FG002|Overall Study|Transplant|8|||
150201381|NCT04707768|541877916|FG000|Overall Study|Other|9|||
150201382|NCT04707768|541877917|FG001|Overall Study|Other|5|||
150201383|NCT04707768|541877918|FG002|Overall Study|Other|2|||
150201384|NCT05953740|541877919|FG000|Period 1|Physician Decision|0|||
150201385|NCT05953740|541877920|FG001|Period 1|Physician Decision|1|||
150201386|NCT05953740|541877921|FG002|Period 1|Physician Decision|0|||
150201387|NCT05953740|541877922|FG003|Period 1|Physician Decision|0|||
150201388|NCT05953740|541877923|FG004|Period 1|Physician Decision|0|||
150201389|NCT05953740|541877924|FG005|Period 1|Physician Decision|0|||
150201390|NCT05953740|541877925|FG006|Period 1|Physician Decision|0|||
150201391|NCT05953740|541877926|FG007|Period 1|Physician Decision|0|||
150201392|NCT05953740|541877919|FG000|Period 2|Withdrawal by Subject|0|||
150201393|NCT05953740|541877920|FG001|Period 2|Withdrawal by Subject|1|||
150201394|NCT05953740|541877921|FG002|Period 2|Withdrawal by Subject|1|||
150201395|NCT05953740|541877922|FG003|Period 2|Withdrawal by Subject|0|||
150201396|NCT05953740|541877923|FG004|Period 2|Withdrawal by Subject|0|||
150201397|NCT05953740|541877924|FG005|Period 2|Withdrawal by Subject|0|||
150201398|NCT05953740|541877925|FG006|Period 2|Withdrawal by Subject|0|||
150201399|NCT05953740|541877926|FG007|Period 2|Withdrawal by Subject|0|||
150201400|NCT05890105|541877927|FG000|Overall Study|Adverse Event|1|||
150201401|NCT05890105|541877928|FG001|Overall Study|Adverse Event|0|||
150201402|NCT05890105|541877929|FG002|Overall Study|Adverse Event|0|||
150201403|NCT05890105|541877927|FG000|Overall Study|Other|1|||
150201404|NCT05890105|541877928|FG001|Overall Study|Other|2|||
150201405|NCT05890105|541877929|FG002|Overall Study|Other|0|||
150201406|NCT03735979|541877932|FG000|Overall Study|Lost to Follow-up|1|||
150201407|NCT03735979|541877933|FG001|Overall Study|Lost to Follow-up|12|||
150201408|NCT03735979|541877934|FG002|Overall Study|Lost to Follow-up|14|||
150201409|NCT03735979|541877932|FG000|Overall Study|Withdrawal by Subject|1|||
150201410|NCT03735979|541877933|FG001|Overall Study|Withdrawal by Subject|5|||
150201411|NCT03735979|541877934|FG002|Overall Study|Withdrawal by Subject|2|||
150201412|NCT03735979|541877932|FG000|Overall Study|Not due to the above reasons|1|||
150201413|NCT03735979|541877933|FG001|Overall Study|Not due to the above reasons|0|||
150201414|NCT03735979|541877934|FG002|Overall Study|Not due to the above reasons|0|||
150201415|NCT00319111|541877937|FG000|Overall Study|Adverse Event|20|||
150201416|NCT00319111|541877937|FG000|Overall Study|Withdrawal of consent|11|||
150201417|NCT00319111|541877937|FG000|Overall Study|Death|9|||
150201418|NCT00319111|541877937|FG000|Overall Study|Lack of clinical improvement|4|||
150201419|NCT00319111|541877937|FG000|Overall Study|Administrative|2|||
150201420|NCT00319111|541877937|FG000|Overall Study|Treatment failure|1|||
150201421|NCT04330040|541877938|FG000|Overall Study|Other: Adverse event|5|||
150201422|NCT04330040|541877939|FG001|Overall Study|Other: Adverse event|0|||
150201423|NCT04330040|541877940|FG002|Overall Study|Other: Adverse event|0|||
150201424|NCT04330040|541877938|FG000|Overall Study|Disease progression|38|||
150201425|NCT04330040|541877939|FG001|Overall Study|Disease progression|10|||
150201426|NCT04330040|541877940|FG002|Overall Study|Disease progression|0|||
150201427|NCT04330040|541877938|FG000|Overall Study|Physician Decision|5|||
150201428|NCT04330040|541877939|FG001|Overall Study|Physician Decision|3|||
150201429|NCT04330040|541877940|FG002|Overall Study|Physician Decision|0|||
150201430|NCT04330040|541877938|FG000|Overall Study|Lost to Follow-up|1|||
150201431|NCT04330040|541877939|FG001|Overall Study|Lost to Follow-up|1|||
150201432|NCT04330040|541877940|FG002|Overall Study|Lost to Follow-up|0|||
150201433|NCT04330040|541877938|FG000|Overall Study|Death|2|||
150201434|NCT04330040|541877939|FG001|Overall Study|Death|1|||
150201435|NCT04330040|541877940|FG002|Overall Study|Death|0|||
150201436|NCT04330040|541877938|FG000|Overall Study|Withdrawal by Subject|3|||
150201437|NCT04330040|541877939|FG001|Overall Study|Withdrawal by Subject|3|||
150201438|NCT04330040|541877940|FG002|Overall Study|Withdrawal by Subject|0|||
150201439|NCT04330040|541877938|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
150201440|NCT04330040|541877939|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
150201441|NCT04330040|541877940|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
150201442|NCT04330040|541877938|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
150201443|NCT04330040|541877939|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
150201444|NCT04330040|541877940|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
150201445|NCT04330040|541877938|FG000|Overall Study|Other: Disease progression|1|||
150201446|NCT04330040|541877939|FG001|Overall Study|Other: Disease progression|0|||
150201447|NCT04330040|541877940|FG002|Overall Study|Other: Disease progression|0|||
150201448|NCT04330040|541877938|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
150201449|NCT04330040|541877939|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
150201450|NCT04330040|541877940|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
150201451|NCT04330040|541877938|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
150201452|NCT04330040|541877939|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
150201453|NCT04330040|541877940|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
150201454|NCT04330040|541877938|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
150201455|NCT04330040|541877939|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
150201456|NCT04330040|541877940|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
150201457|NCT02461134|541877942|FG000|Overall Study|Adverse Event|1|||
150201458|NCT03165955|541877943|FG000|Treatment|Withdrawal by Subject|3|||
150201459|NCT03165955|541877943|FG000|Treatment|Death|1|||
150201460|NCT03165955|541877943|FG000|Treatment|Adverse Event|1|||
150201461|NCT03165955|541877943|FG000|Treatment|Progressive disease|3|||
150201462|NCT02994927|541877946|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150201463|NCT02994927|541877947|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150201464|NCT02994927|541877946|FG000|Overall Study|Did not meet eligibility criteria|0|||
150201465|NCT02994927|541877947|FG001|Overall Study|Did not meet eligibility criteria|1|||
150201466|NCT02994927|541877946|FG000|Overall Study|Physician Decision|4|||
150201467|NCT02994927|541877947|FG001|Overall Study|Physician Decision|3|||
150201468|NCT02994927|541877946|FG000|Overall Study|Death|4|||
150201469|NCT02994927|541877947|FG001|Overall Study|Death|2|||
150201470|NCT02994927|541877946|FG000|Overall Study|Adverse Event|2|||
150201471|NCT02994927|541877947|FG001|Overall Study|Adverse Event|1|||
150201472|NCT02994927|541877946|FG000|Overall Study|Withdrawal by Subject|3|||
150201473|NCT02994927|541877947|FG001|Overall Study|Withdrawal by Subject|6|||
150201474|NCT02994927|541877946|FG000|Overall Study|Lost to Follow-up|2|||
150201475|NCT02994927|541877947|FG001|Overall Study|Lost to Follow-up|1|||
150201476|NCT00626795|541877948|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
150201477|NCT00626795|541877949|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
150201478|NCT00626795|541877950|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
150201479|NCT00626795|541877948|FG000|Blinded Treatment|Lack of Efficacy|2|||
150201480|NCT00626795|541877949|FG001|Blinded Treatment|Lack of Efficacy|0|||
150201481|NCT00626795|541877950|FG002|Blinded Treatment|Lack of Efficacy|0|||
150201482|NCT00626795|541877948|FG000|Blinded Treatment|Unacceptable adverse event|0|||
150201483|NCT00626795|541877949|FG001|Blinded Treatment|Unacceptable adverse event|0|||
150201484|NCT00626795|541877950|FG002|Blinded Treatment|Unacceptable adverse event|1|||
150201485|NCT00626795|541877948|FG000|Blinded Treatment|Protocol Violation|0|||
150201486|NCT00626795|541877949|FG001|Blinded Treatment|Protocol Violation|1|||
150201487|NCT00626795|541877950|FG002|Blinded Treatment|Protocol Violation|1|||
150201488|NCT00626795|541877948|FG000|Blinded Treatment|Withdrawal by Subject|1|||
150201489|NCT00626795|541877949|FG001|Blinded Treatment|Withdrawal by Subject|1|||
150201490|NCT00626795|541877950|FG002|Blinded Treatment|Withdrawal by Subject|0|||
150201491|NCT00626795|541877948|FG000|Blinded Treatment|Other reasons|2|||
150201492|NCT00626795|541877949|FG001|Blinded Treatment|Other reasons|0|||
150201493|NCT00626795|541877950|FG002|Blinded Treatment|Other reasons|2|||
150201494|NCT00626795|541877948|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
150201495|NCT00626795|541877949|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
150201496|NCT00626795|541877950|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
150201497|NCT03533257|541877958|FG000|Overall Study|Adverse Event|4|||
150201498|NCT03533257|541877959|FG001|Overall Study|Adverse Event|2|||
150201499|NCT03533257|541877958|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
150201500|NCT03533257|541877959|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
150201501|NCT02865538|541877960|FG000|Overall Study|Withdrawal by Subject|0|||
150201502|NCT02865538|541877961|FG001|Overall Study|Withdrawal by Subject|0|||
150201503|NCT02865538|541877962|FG002|Overall Study|Withdrawal by Subject|1|||
150201504|NCT02865538|541877963|FG003|Overall Study|Withdrawal by Subject|0|||
150201505|NCT02865538|541877964|FG004|Overall Study|Withdrawal by Subject|0|||
150201506|NCT02865538|541877960|FG000|Overall Study|Lost to Follow-up|1|||
150201507|NCT02865538|541877961|FG001|Overall Study|Lost to Follow-up|0|||
150201508|NCT02865538|541877962|FG002|Overall Study|Lost to Follow-up|0|||
150201509|NCT02865538|541877963|FG003|Overall Study|Lost to Follow-up|0|||
150201510|NCT02865538|541877964|FG004|Overall Study|Lost to Follow-up|0|||
150201511|NCT01917084|541879110|FG000|Overall Study|Withdrawal by Subject|1|||
150201512|NCT03571386|541879111|FG000|Overall Study|scheduling conflict|4|||
150201513|NCT03571386|541879112|FG001|Overall Study|scheduling conflict|0|||
150201514|NCT03571386|541879111|FG000|Overall Study|Withdrawal by Subject|15|||
150201515|NCT03571386|541879112|FG001|Overall Study|Withdrawal by Subject|5|||
150201516|NCT02278211|541879113|FG000|Overall Study|Unable to analyse PET scan|2|||
150201517|NCT02909686|541879114|FG000|Overall Study|Physician Decision|3|||
150201518|NCT02909686|541879114|FG000|Overall Study|Withdrawal by Subject|2|||
150201519|NCT06037668|541879117|FG000|Overall Study|Lost to Follow-up|1|||
150201520|NCT06037668|541879118|FG001|Overall Study|Lost to Follow-up|1|||
150201521|NCT06037668|541879117|FG000|Overall Study|Protocol Violation|1|||
150201522|NCT06037668|541879118|FG001|Overall Study|Protocol Violation|0|||
150201523|NCT06037668|541879117|FG000|Overall Study|Withdrawal by Subject|1|||
150201524|NCT06037668|541879118|FG001|Overall Study|Withdrawal by Subject|0|||
150201525|NCT06037668|541879117|FG000|Overall Study|Other Study Discontinuation Reason|1|||
150201526|NCT06037668|541879118|FG001|Overall Study|Other Study Discontinuation Reason|0|||
150201527|NCT04804540|541879119|FG000|Overall Study|Adverse Event|26|||
150201528|NCT04804540|541879120|FG001|Overall Study|Adverse Event|13|||
150201529|NCT01828021|541879121|FG000|Overall Study|Adverse Event|5|||
150201530|NCT01828021|541879121|FG000|Overall Study|Lack of Efficacy|17|||
150201531|NCT01828021|541879121|FG000|Overall Study|Withdrawal by Subject|2|||
150201532|NCT01828021|541879121|FG000|Overall Study|Ileal obstruction, unrelated|1|||
150201533|NCT02997202|541879122|FG000|Overall Study|Miscellaneous|2|||
150201534|NCT02997202|541879123|FG001|Overall Study|Miscellaneous|2|||
150201535|NCT02997202|541879122|FG000|Overall Study|Withdrawal by Subject|8|||
150201536|NCT02997202|541879123|FG001|Overall Study|Withdrawal by Subject|12|||
150201537|NCT02997202|541879122|FG000|Overall Study|Lost to Follow-up|5|||
150201538|NCT02997202|541879123|FG001|Overall Study|Lost to Follow-up|3|||
150201539|NCT02997202|541879122|FG000|Overall Study|Death|41|||
150201540|NCT02997202|541879123|FG001|Overall Study|Death|45|||
150201541|NCT03681262|541879129|FG000|Overall Study|Continuing on study|3|||
150201542|NCT03681262|541879130|FG001|Overall Study|Continuing on study|3|||
150201543|NCT03681262|541879129|FG000|Overall Study|Lost to Follow-up|1|||
150201544|NCT03681262|541879130|FG001|Overall Study|Lost to Follow-up|0|||
150201545|NCT02782676|541879132|FG000|Overall Study|Lost to Follow-up|0|||
150201546|NCT02782676|541879133|FG001|Overall Study|Lost to Follow-up|1|||
150201547|NCT05007080|541879134|FG000|Overall Study|Lost to Follow-up|0|||
150201548|NCT05007080|541879135|FG001|Overall Study|Lost to Follow-up|1|||
150201549|NCT05007080|541879136|FG002|Overall Study|Lost to Follow-up|0|||
150201550|NCT05007080|541879137|FG003|Overall Study|Lost to Follow-up|1|||
150201551|NCT05007080|541879138|FG004|Overall Study|Lost to Follow-up|1|||
150201552|NCT05007080|541879139|FG005|Overall Study|Lost to Follow-up|1|||
150201553|NCT05007080|541879134|FG000|Overall Study|Death|0|||
150201554|NCT05007080|541879135|FG001|Overall Study|Death|1|||
150201555|NCT05007080|541879136|FG002|Overall Study|Death|0|||
150201556|NCT05007080|541879137|FG003|Overall Study|Death|0|||
150201557|NCT05007080|541879138|FG004|Overall Study|Death|0|||
150201558|NCT05007080|541879139|FG005|Overall Study|Death|0|||
150201559|NCT05007080|541879134|FG000|Overall Study|Withdrawal by Subject|1|||
150201560|NCT05007080|541879135|FG001|Overall Study|Withdrawal by Subject|2|||
150201561|NCT05007080|541879136|FG002|Overall Study|Withdrawal by Subject|0|||
150201562|NCT05007080|541879137|FG003|Overall Study|Withdrawal by Subject|2|||
150201563|NCT05007080|541879138|FG004|Overall Study|Withdrawal by Subject|1|||
150201564|NCT05007080|541879139|FG005|Overall Study|Withdrawal by Subject|1|||
150201565|NCT05007080|541879134|FG000|Overall Study|Other|1|||
150201566|NCT05007080|541879135|FG001|Overall Study|Other|0|||
150201567|NCT05007080|541879136|FG002|Overall Study|Other|1|||
150201568|NCT05007080|541879137|FG003|Overall Study|Other|1|||
150201569|NCT05007080|541879138|FG004|Overall Study|Other|0|||
150201570|NCT05007080|541879139|FG005|Overall Study|Other|2|||
150201571|NCT05007080|541879134|FG000|Overall Study|Randomized not vaccinated|0|||
150201572|NCT05007080|541879135|FG001|Overall Study|Randomized not vaccinated|0|||
150201573|NCT05007080|541879136|FG002|Overall Study|Randomized not vaccinated|0|||
150201574|NCT05007080|541879137|FG003|Overall Study|Randomized not vaccinated|0|||
150201575|NCT05007080|541879138|FG004|Overall Study|Randomized not vaccinated|0|||
150201576|NCT05007080|541879139|FG005|Overall Study|Randomized not vaccinated|1|||
150201577|NCT02874742|541879140|FG000|Overall Study|Death|0|||
150201578|NCT02874742|541879141|FG001|Overall Study|Death|1|||
150201579|NCT02874742|541879142|FG002|Overall Study|Death|0|||
150201580|NCT02874742|541879140|FG000|Overall Study|Lost to Follow-up|5|||
150201581|NCT02874742|541879141|FG001|Overall Study|Lost to Follow-up|4|||
150201582|NCT02874742|541879142|FG002|Overall Study|Lost to Follow-up|1|||
150201583|NCT02874742|541879140|FG000|Overall Study|Withdrawal by Subject|17|||
150201584|NCT02874742|541879141|FG001|Overall Study|Withdrawal by Subject|8|||
150201585|NCT02874742|541879142|FG002|Overall Study|Withdrawal by Subject|0|||
150201586|NCT02874742|541879140|FG000|Overall Study|Other|4|||
150201587|NCT02874742|541879141|FG001|Overall Study|Other|1|||
150201588|NCT02874742|541879142|FG002|Overall Study|Other|0|||
150201589|NCT02874742|541879140|FG000|Overall Study|Progressive Disease|1|||
150201590|NCT02874742|541879141|FG001|Overall Study|Progressive Disease|0|||
150201591|NCT02874742|541879142|FG002|Overall Study|Progressive Disease|0|||
150201592|NCT02874742|541879140|FG000|Overall Study|Screen Failure|0|||
150201593|NCT02874742|541879141|FG001|Overall Study|Screen Failure|2|||
150201594|NCT02874742|541879142|FG002|Overall Study|Screen Failure|0|||
150201595|NCT00631475|541879145|FG000|Overall Study|Death|18|||
150201596|NCT00631475|541879145|FG000|Overall Study|Adverse Event|14|||
150201597|NCT00631475|541879145|FG000|Overall Study|Withdrew consent|5|||
150201598|NCT00631475|541879145|FG000|Overall Study|Preparation for lung transplant|8|||
150201599|NCT05205161|541879149|FG000|Overall Study|Study terminated by sponsor|3|||
150201600|NCT05205161|541879150|FG001|Overall Study|Study terminated by sponsor|3|||
150201601|NCT05205161|541879151|FG002|Overall Study|Study terminated by sponsor|1|||
150201602|NCT05741294|541879152|FG000|Overall Study|Lost to Follow-up|3|||
150201603|NCT05741294|541879152|FG000|Overall Study|Protocol deviation|3|||
150201604|NCT05741294|541879152|FG000|Overall Study|Withdrawal by Subject|1|||
150201605|NCT03880955|541879157|FG000|Overall Study|Adverse Event|1|||
150201606|NCT03880955|541879157|FG000|Overall Study|Death|1|||
150201607|NCT03880955|541879157|FG000|Overall Study|Lost to Follow-up|12|||
150201608|NCT03880955|541879157|FG000|Overall Study|Withdrawal by Subject|4|||
150201609|NCT03880955|541879157|FG000|Overall Study|Missing- Study Site Closed|27|||
150201610|NCT02510235|541879158|FG000|Overall Study|Withdrawal by Subject|1|||
150201611|NCT02510235|541879159|FG001|Overall Study|Withdrawal by Subject|0|||
150201612|NCT00450216|541879160|FG000|Overall Study|Adverse Event|38|||
150201613|NCT00450216|541879161|FG001|Overall Study|Adverse Event|23|||
150201614|NCT00450216|541879160|FG000|Overall Study|Withdrawal by Subject|48|||
150201615|NCT00450216|541879161|FG001|Overall Study|Withdrawal by Subject|26|||
150201616|NCT00450216|541879160|FG000|Overall Study|Lost to Follow-up|16|||
150201617|NCT00450216|541879161|FG001|Overall Study|Lost to Follow-up|9|||
150201618|NCT00450216|541879160|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
150201619|NCT00450216|541879161|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
150201620|NCT00450216|541879160|FG000|Overall Study|misc|21|||
150201621|NCT00450216|541879161|FG001|Overall Study|misc|20|||
150201622|NCT05008055|541879162|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
150201623|NCT05008055|541879163|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
150201624|NCT05008055|541879164|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
150201625|NCT03011034|541879172|FG000|Overall Study|Adverse Event|1|||
150201626|NCT03011034|541879173|FG001|Overall Study|Adverse Event|0|||
150201627|NCT01438853|541879176|FG000|Overall Study|Death|0|||
150201628|NCT01438853|541879177|FG001|Overall Study|Death|0|||
150201629|NCT01438853|541879178|FG002|Overall Study|Death|0|||
150201630|NCT01438853|541879179|FG003|Overall Study|Death|1|||
150201631|NCT01438853|541879176|FG000|Overall Study|Withdrawal by Subject|0|||
150201632|NCT01438853|541879177|FG001|Overall Study|Withdrawal by Subject|0|||
150201633|NCT01438853|541879178|FG002|Overall Study|Withdrawal by Subject|1|||
150201634|NCT01438853|541879179|FG003|Overall Study|Withdrawal by Subject|0|||
150201635|NCT04761198|541879181|FG000|Overall Study|Progressive Disease|1|||
150201636|NCT04761198|541879182|FG001|Overall Study|Progressive Disease|0|||
150201637|NCT04761198|541879183|FG002|Overall Study|Progressive Disease|0|||
150201638|NCT04761198|541879184|FG003|Overall Study|Progressive Disease|1|||
150201639|NCT04761198|541879185|FG004|Overall Study|Progressive Disease|4|||
150201640|NCT04761198|541879186|FG005|Overall Study|Progressive Disease|1|||
150201641|NCT04761198|541879187|FG006|Overall Study|Progressive Disease|2|||
150201642|NCT04761198|541879181|FG000|Overall Study|Protocol Violation|0|||
150201643|NCT04761198|541879182|FG001|Overall Study|Protocol Violation|0|||
150201644|NCT04761198|541879183|FG002|Overall Study|Protocol Violation|0|||
150201645|NCT04761198|541879184|FG003|Overall Study|Protocol Violation|0|||
150201646|NCT04761198|541879185|FG004|Overall Study|Protocol Violation|1|||
150201647|NCT04761198|541879186|FG005|Overall Study|Protocol Violation|0|||
150201648|NCT04761198|541879187|FG006|Overall Study|Protocol Violation|0|||
150201649|NCT04761198|541879181|FG000|Overall Study|Death|2|||
150201650|NCT04761198|541879182|FG001|Overall Study|Death|1|||
150201651|NCT04761198|541879183|FG002|Overall Study|Death|2|||
150201652|NCT04761198|541879184|FG003|Overall Study|Death|5|||
150201653|NCT04761198|541879185|FG004|Overall Study|Death|14|||
150201654|NCT04761198|541879186|FG005|Overall Study|Death|2|||
150201655|NCT04761198|541879187|FG006|Overall Study|Death|5|||
150201656|NCT04761198|541879181|FG000|Overall Study|Lost to Follow-up|0|||
150201657|NCT04761198|541879182|FG001|Overall Study|Lost to Follow-up|0|||
150201658|NCT04761198|541879183|FG002|Overall Study|Lost to Follow-up|0|||
150201659|NCT04761198|541879184|FG003|Overall Study|Lost to Follow-up|0|||
150201660|NCT04761198|541879185|FG004|Overall Study|Lost to Follow-up|1|||
150201661|NCT04761198|541879186|FG005|Overall Study|Lost to Follow-up|0|||
150201662|NCT04761198|541879187|FG006|Overall Study|Lost to Follow-up|0|||
150201663|NCT04761198|541879181|FG000|Overall Study|Withdrawal by Subject|2|||
150201664|NCT04761198|541879182|FG001|Overall Study|Withdrawal by Subject|0|||
150201665|NCT04761198|541879183|FG002|Overall Study|Withdrawal by Subject|1|||
150201666|NCT04761198|541879184|FG003|Overall Study|Withdrawal by Subject|0|||
150201667|NCT04761198|541879185|FG004|Overall Study|Withdrawal by Subject|2|||
150201668|NCT04761198|541879186|FG005|Overall Study|Withdrawal by Subject|0|||
150201669|NCT04761198|541879187|FG006|Overall Study|Withdrawal by Subject|1|||
150201670|NCT04761198|541879181|FG000|Overall Study|Study Terminated by Sponsor|6|||
150201671|NCT04761198|541879182|FG001|Overall Study|Study Terminated by Sponsor|0|||
150201672|NCT04761198|541879183|FG002|Overall Study|Study Terminated by Sponsor|5|||
150201673|NCT04761198|541879184|FG003|Overall Study|Study Terminated by Sponsor|3|||
150201674|NCT04761198|541879185|FG004|Overall Study|Study Terminated by Sponsor|10|||
150201675|NCT04761198|541879186|FG005|Overall Study|Study Terminated by Sponsor|1|||
150201676|NCT04761198|541879187|FG006|Overall Study|Study Terminated by Sponsor|2|||
150201677|NCT03493542|541879190|FG000|Base Study|Withdrawal by Subject|0|||
150201678|NCT03493542|541879191|FG001|Base Study|Withdrawal by Subject|4|||
150201679|NCT03493542|541879192|FG002|Base Study|Withdrawal by Subject|0|||
150201680|NCT03493542|541879190|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
150201681|NCT03493542|541879191|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
150201682|NCT03493542|541879192|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
150201683|NCT03493542|541879190|FG000|Extension Study|Withdrawal by Subject|0|||
150201684|NCT03493542|541879191|FG001|Extension Study|Withdrawal by Subject|0|||
150201685|NCT03493542|541879192|FG002|Extension Study|Withdrawal by Subject|25|||
150201686|NCT04499521|541879193|FG000|Overall Study|Disease Progression|1|||
150201687|NCT04499521|541879194|FG001|Overall Study|Disease Progression|0|||
150201688|NCT05525104|541879195|FG000|Overall Study|Failed caudal analgesia|1|||
150201689|NCT05525104|541879196|FG001|Overall Study|Failed caudal analgesia|3|||
150201690|NCT05525104|541879195|FG000|Overall Study|Premedication needed|0|||
150201691|NCT05525104|541879196|FG001|Overall Study|Premedication needed|1|||
150201692|NCT05525104|541879195|FG000|Overall Study|Protocol Violation|10|||
150201693|NCT05525104|541879196|FG001|Overall Study|Protocol Violation|0|||
150201694|NCT05525104|541879195|FG000|Overall Study|Cancelled operation|1|||
150201695|NCT05525104|541879196|FG001|Overall Study|Cancelled operation|0|||
150201696|NCT02039401|541879197|FG000|Overall Study|Adverse Event|0|||
150201697|NCT02039401|541879198|FG001|Overall Study|Adverse Event|1|||
150201698|NCT04427007|541879992|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
150201699|NCT04427007|541879993|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
150201700|NCT04165213|541879994|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
150201701|NCT04165213|541879995|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
150201702|NCT04165213|541879994|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
150201703|NCT04165213|541879995|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
150201704|NCT04165213|541879994|FG000|Clinician Enrollment|Termination from site|0|||
150201705|NCT04165213|541879995|FG001|Clinician Enrollment|Termination from site|1|||
150201706|NCT04165213|541879994|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
150201707|NCT04165213|541879995|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
150201708|NCT04165213|541879994|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
150201709|NCT04165213|541879995|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
150201710|NCT04165213|541879994|FG000|Caregiver Enrollment|Physician Decision|1|||
150201711|NCT04165213|541879995|FG001|Caregiver Enrollment|Physician Decision|0|||
150201712|NCT04165213|541879994|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
150201713|NCT04165213|541879995|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
150201714|NCT04165213|541879994|FG000|Caregiver Enrollment|PLWD death|2|||
150201715|NCT04165213|541879995|FG001|Caregiver Enrollment|PLWD death|0|||
150201716|NCT04165213|541879994|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
150201717|NCT04165213|541879995|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
150201718|NCT04165213|541879994|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
150201719|NCT04165213|541879995|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
150201720|NCT04165213|541879994|FG000|PLWD Enrollment|Lost to Follow-up|1|||
150201721|NCT04165213|541879995|FG001|PLWD Enrollment|Lost to Follow-up|1|||
150201722|NCT04165213|541879994|FG000|PLWD Enrollment|Physician Decision|1|||
150201723|NCT04165213|541879995|FG001|PLWD Enrollment|Physician Decision|0|||
150201724|NCT04165213|541879994|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
150201725|NCT04165213|541879995|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
150201726|NCT04165213|541879994|FG000|PLWD Enrollment|Death|2|||
150201727|NCT04165213|541879995|FG001|PLWD Enrollment|Death|0|||
150201728|NCT04165213|541879994|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
150201729|NCT04165213|541879995|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
150201730|NCT04464564|541879996|FG000|Period A (Placebo lead-in)|Other|5|||
150201731|NCT04464564|541879997|FG001|Period A (Placebo lead-in)|Other|0|||
150201732|NCT04464564|541879998|FG002|Period A (Placebo lead-in)|Other|0|||
150201733|NCT04464564|541879999|FG003|Period A (Placebo lead-in)|Other|0|||
150201734|NCT04464564|541879996|FG000|Period B (Randomization Period)|Adverse Event|0|||
150201735|NCT04464564|541879997|FG001|Period B (Randomization Period)|Adverse Event|1|||
150201736|NCT04464564|541879998|FG002|Period B (Randomization Period)|Adverse Event|2|||
150201737|NCT04464564|541879999|FG003|Period B (Randomization Period)|Adverse Event|8|||
150201738|NCT04464564|541879996|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
150201739|NCT04464564|541879997|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
150201740|NCT04464564|541879998|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
150201741|NCT04464564|541879999|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
150201742|NCT04464564|541879996|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
150201743|NCT04464564|541879997|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
150201744|NCT04464564|541879998|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
150201745|NCT04464564|541879999|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
150201746|NCT04464564|541879996|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
150201747|NCT04464564|541879997|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
150201748|NCT04464564|541879998|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
150201749|NCT04464564|541879999|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
150201750|NCT04464564|541879996|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
150201751|NCT04464564|541879997|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
150201752|NCT04464564|541879998|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
150201753|NCT04464564|541879999|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
150201754|NCT04464564|541879996|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
150201755|NCT04464564|541879997|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
150201756|NCT04464564|541879998|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
150201757|NCT04464564|541879999|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
150201758|NCT04464564|541879996|FG000|Period B (Randomization Period)|Reason not Specified|0|||
150201759|NCT04464564|541879997|FG001|Period B (Randomization Period)|Reason not Specified|3|||
150201760|NCT04464564|541879998|FG002|Period B (Randomization Period)|Reason not Specified|3|||
150201761|NCT04464564|541879999|FG003|Period B (Randomization Period)|Reason not Specified|3|||
150201762|NCT04389957|541880006|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
150201763|NCT04389957|541880007|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
150201764|NCT04389957|541880008|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
150201765|NCT04389957|541880009|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
150201766|NCT04389957|541880010|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
150201767|NCT04282980|541880013|FG000|Overall Study|Remained on treatment|6|||
150201768|NCT04282980|541880013|FG000|Overall Study|Survival follow-up|11|||
150201769|NCT04282980|541880013|FG000|Overall Study|Withdrawal of informed consent|1|||
150201770|NCT04282980|541880013|FG000|Overall Study|Lost to Follow-up|1|||
150201771|NCT04881461|541880020|FG000|Overall Study|Adverse Event|2|||
150201772|NCT04881461|541880021|FG001|Overall Study|Adverse Event|4|||
150201773|NCT04881461|541880020|FG000|Overall Study|Withdrawal by Subject|19|||
150201774|NCT04881461|541880021|FG001|Overall Study|Withdrawal by Subject|19|||
150201775|NCT04881461|541880020|FG000|Overall Study|Lost to Follow-up|4|||
150201776|NCT04881461|541880021|FG001|Overall Study|Lost to Follow-up|4|||
150201777|NCT04881461|541880020|FG000|Overall Study|Lack of Efficacy|1|||
150201778|NCT04881461|541880021|FG001|Overall Study|Lack of Efficacy|0|||
150201779|NCT04881461|541880020|FG000|Overall Study|"Reason stated as other in CRF"|1|||
150201780|NCT04881461|541880021|FG001|Overall Study|"Reason stated as other in CRF"|2|||
150201781|NCT04055012|541880024|FG000|Overall Study|Withdrawal by Subject|1|||
150201782|NCT04055012|541880025|FG001|Overall Study|Withdrawal by Subject|3|||
150201783|NCT04055012|541880026|FG002|Overall Study|Withdrawal by Subject|1|||
150201784|NCT04055012|541880027|FG003|Overall Study|Withdrawal by Subject|0|||
150201785|NCT04055012|541880024|FG000|Overall Study|Metformin Recall|1|||
150201786|NCT04055012|541880025|FG001|Overall Study|Metformin Recall|1|||
150201787|NCT04055012|541880026|FG002|Overall Study|Metformin Recall|1|||
150201788|NCT04055012|541880027|FG003|Overall Study|Metformin Recall|0|||
150201789|NCT03652272|541880034|FG000|3 Month|Withdrawal by Subject|1|||
150201790|NCT03652272|541880035|FG001|3 Month|Withdrawal by Subject|1|||
150201791|NCT03652272|541880034|FG000|3 Month|Lost to Follow-up|16|||
150201792|NCT03652272|541880035|FG001|3 Month|Lost to Follow-up|14|||
150201793|NCT02326974|541880036|FG000|Overall Study|Withdrawal by Subject|2|||
150201794|NCT02326974|541880036|FG000|Overall Study|failed heterogenity evaluation|5|||
150201795|NCT02577354|541880037|FG000|Overall Study|Lack of Efficacy|4|||
150201796|NCT02577354|541880038|FG001|Overall Study|Lack of Efficacy|4|||
150201797|NCT02577354|541880037|FG000|Overall Study|Lost to Follow-up|3|||
150201798|NCT02577354|541880038|FG001|Overall Study|Lost to Follow-up|1|||
150201799|NCT02577354|541880037|FG000|Overall Study|Missed Visit|4|||
150201800|NCT02577354|541880038|FG001|Overall Study|Missed Visit|3|||
150201801|NCT02577354|541880037|FG000|Overall Study|Adverse Event|4|||
150201802|NCT02577354|541880038|FG001|Overall Study|Adverse Event|5|||
150201803|NCT04490109|541880050|FG000|Overall Study|Lost to Follow-up|3|||
150201804|NCT04490109|541880051|FG001|Overall Study|Lost to Follow-up|10|||
150201805|NCT04490109|541880052|FG002|Overall Study|Lost to Follow-up|4|||
150201806|NCT04490109|541880050|FG000|Overall Study|Withdrawal by Subject|8|||
150201807|NCT04490109|541880051|FG001|Overall Study|Withdrawal by Subject|6|||
150201808|NCT04490109|541880052|FG002|Overall Study|Withdrawal by Subject|9|||
150201809|NCT04490109|541880050|FG000|Overall Study|Physician Decision|0|||
150201810|NCT04490109|541880051|FG001|Overall Study|Physician Decision|2|||
150201811|NCT04490109|541880052|FG002|Overall Study|Physician Decision|3|||
150201812|NCT04490109|541880050|FG000|Overall Study|Adverse Event|2|||
150201813|NCT04490109|541880051|FG001|Overall Study|Adverse Event|1|||
150201814|NCT04490109|541880052|FG002|Overall Study|Adverse Event|0|||
150201815|NCT04490109|541880050|FG000|Overall Study|Significant Non-Compliance|2|||
150201816|NCT04490109|541880051|FG001|Overall Study|Significant Non-Compliance|4|||
150201817|NCT04490109|541880052|FG002|Overall Study|Significant Non-Compliance|4|||
150201818|NCT04490109|541880050|FG000|Overall Study|Significant Clinical Event|0|||
150201819|NCT04490109|541880051|FG001|Overall Study|Significant Clinical Event|1|||
150201820|NCT04490109|541880052|FG002|Overall Study|Significant Clinical Event|0|||
150201821|NCT04490109|541880050|FG000|Overall Study|Other Reason|4|||
150201822|NCT04490109|541880051|FG001|Overall Study|Other Reason|1|||
150201823|NCT04490109|541880052|FG002|Overall Study|Other Reason|1|||
150201824|NCT03372057|541880053|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
150201825|NCT03372057|541880054|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
150201826|NCT03372057|541880055|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
150201827|NCT03372057|541880053|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
150201828|NCT03372057|541880054|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
150201829|NCT03372057|541880055|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
150201830|NCT03372057|541880053|FG000|Dose Optimization Phase|Death|16|||
150201831|NCT03372057|541880054|FG001|Dose Optimization Phase|Death|11|||
150201832|NCT03372057|541880055|FG002|Dose Optimization Phase|Death|0|||
150201833|NCT03372057|541880053|FG000|Expansion Phase|Withdrawal by Subject|0|||
150201834|NCT03372057|541880054|FG001|Expansion Phase|Withdrawal by Subject|0|||
150201835|NCT03372057|541880055|FG002|Expansion Phase|Withdrawal by Subject|4|||
150201836|NCT03372057|541880053|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
150201837|NCT03372057|541880054|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
150201838|NCT03372057|541880055|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
150201839|NCT03372057|541880053|FG000|Expansion Phase|Death|0|||
150201840|NCT03372057|541880054|FG001|Expansion Phase|Death|0|||
150201841|NCT03372057|541880055|FG002|Expansion Phase|Death|78|||
150201842|NCT03372057|541880053|FG000|Expansion Phase|Progressive Disease|0|||
150201843|NCT03372057|541880054|FG001|Expansion Phase|Progressive Disease|0|||
150201844|NCT03372057|541880055|FG002|Expansion Phase|Progressive Disease|1|||
150201845|NCT03372057|541880053|FG000|Expansion Phase|Adverse Event|0|||
150201846|NCT03372057|541880054|FG001|Expansion Phase|Adverse Event|0|||
150201847|NCT03372057|541880055|FG002|Expansion Phase|Adverse Event|1|||
150201848|NCT05112900|541880057|FG000|Overall Study|Withdrawal by Subject|960|||
150201849|NCT05112900|541880058|FG001|Overall Study|Withdrawal by Subject|921|||
150201850|NCT05112900|541880059|FG002|Overall Study|Withdrawal by Subject|968|||
150201851|NCT02919917|541880064|FG000|Overall Study|Withdrawal by Subject|4|||
150201852|NCT02919917|541880065|FG001|Overall Study|Withdrawal by Subject|8|||
150201853|NCT04743973|541880066|FG000|Overall Study|Withdrawal by Subject|5|||
150201854|NCT01756300|541880072|FG000|Overall Study|Death|1|||
150201855|NCT01756300|541880072|FG000|Overall Study|Withdrawal by Subject|1|||
150201856|NCT04678856|541880073|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
150201857|NCT04678856|541880074|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
150201858|NCT04678856|541880073|FG000|Overall Study|Withdrawal by Subject|5|||
150201859|NCT04678856|541880074|FG001|Overall Study|Withdrawal by Subject|1|||
150201860|NCT04244175|541880978|FG000|Overall Study|Adverse Event|3|||
150201861|NCT04244175|541880979|FG001|Overall Study|Adverse Event|2|||
150201862|NCT04244175|541880980|FG002|Overall Study|Adverse Event|5|||
150201863|NCT04244175|541880978|FG000|Overall Study|Lack of Efficacy|1|||
150201864|NCT04244175|541880979|FG001|Overall Study|Lack of Efficacy|0|||
150201865|NCT04244175|541880980|FG002|Overall Study|Lack of Efficacy|1|||
150201866|NCT04244175|541880978|FG000|Overall Study|Lost to Follow-up|1|||
150201867|NCT04244175|541880979|FG001|Overall Study|Lost to Follow-up|0|||
150201868|NCT04244175|541880980|FG002|Overall Study|Lost to Follow-up|0|||
150201869|NCT04244175|541880978|FG000|Overall Study|Non-compliance with study drug|1|||
150201870|NCT04244175|541880979|FG001|Overall Study|Non-compliance with study drug|0|||
150201871|NCT04244175|541880980|FG002|Overall Study|Non-compliance with study drug|1|||
150201872|NCT04244175|541880978|FG000|Overall Study|Protocol deviation|0|||
150201873|NCT04244175|541880979|FG001|Overall Study|Protocol deviation|1|||
150201874|NCT04244175|541880980|FG002|Overall Study|Protocol deviation|0|||
150201875|NCT04244175|541880978|FG000|Overall Study|Withdrawal by Subject|1|||
150201876|NCT04244175|541880979|FG001|Overall Study|Withdrawal by Subject|3|||
150201877|NCT04244175|541880980|FG002|Overall Study|Withdrawal by Subject|1|||
150201878|NCT04244175|541880978|FG000|Overall Study|Other, not specified|0|||
150201879|NCT04244175|541880979|FG001|Overall Study|Other, not specified|1|||
150201880|NCT04244175|541880980|FG002|Overall Study|Other, not specified|2|||
150201881|NCT03417284|541880981|FG000|Overall Study|Inadequate supply on study drug|1|||
150201882|NCT03417284|541880982|FG001|Overall Study|Inadequate supply on study drug|0|||
150201883|NCT03417284|541880983|FG002|Overall Study|Inadequate supply on study drug|0|||
150201884|NCT03417284|541880984|FG003|Overall Study|Inadequate supply on study drug|0|||
150201885|NCT03417284|541880981|FG000|Overall Study|Disease Progression|0|||
150201886|NCT03417284|541880982|FG001|Overall Study|Disease Progression|0|||
150201887|NCT03417284|541880983|FG002|Overall Study|Disease Progression|1|||
150201888|NCT03417284|541880984|FG003|Overall Study|Disease Progression|0|||
150201889|NCT03636490|541880985|FG000|Overall Study|Dropped out or incomplete data|141|||
150201890|NCT02095691|541880996|FG000|Overall Study|Physician Decision|1|||
150201891|NCT00887198|541880997|FG000|Randomized Period|Ongoing|42|||
150201892|NCT00887198|541880998|FG001|Randomized Period|Ongoing|0|||
150201893|NCT00887198|541880999|FG002|Randomized Period|Ongoing|0|||
150201894|NCT00887198|541880997|FG000|Randomized Period|Adverse Event|50|||
150201895|NCT00887198|541880998|FG001|Randomized Period|Adverse Event|33|||
150201896|NCT00887198|541880999|FG002|Randomized Period|Adverse Event|0|||
150201897|NCT00887198|541880997|FG000|Randomized Period|Lost to Follow-up|1|||
150201898|NCT00887198|541880998|FG001|Randomized Period|Lost to Follow-up|0|||
150201899|NCT00887198|541880999|FG002|Randomized Period|Lost to Follow-up|0|||
150201900|NCT00887198|541880997|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
150201901|NCT00887198|541880998|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
150201902|NCT00887198|541880999|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
150201903|NCT00887198|541880997|FG000|Randomized Period|Withdrawal by Subject|41|||
150201904|NCT00887198|541880998|FG001|Randomized Period|Withdrawal by Subject|56|||
150201905|NCT00887198|541880999|FG002|Randomized Period|Withdrawal by Subject|0|||
150201906|NCT00887198|541880997|FG000|Randomized Period|Progressive disease|366|||
150201907|NCT00887198|541880998|FG001|Randomized Period|Progressive disease|370|||
150201908|NCT00887198|541880999|FG002|Randomized Period|Progressive disease|0|||
150201909|NCT00887198|541880997|FG000|Randomized Period|Other|42|||
150201910|NCT00887198|541880998|FG001|Randomized Period|Other|30|||
150201911|NCT00887198|541880999|FG002|Randomized Period|Other|0|||
150201912|NCT00887198|541880997|FG000|Randomized Period|Randomized, Not treated|4|||
150201913|NCT00887198|541880998|FG001|Randomized Period|Randomized, Not treated|2|||
150201914|NCT00887198|541880999|FG002|Randomized Period|Randomized, Not treated|0|||
150201915|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
150201916|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
150201917|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
150201918|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
150201919|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
150201920|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
150201921|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
150201922|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
150201923|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
150201924|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
150201925|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
150201926|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
150201927|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
150201928|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
150201929|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
150201930|NCT00887198|541880997|FG000|Cross Over (Placebo to AA)|Other|0|||
150201931|NCT00887198|541880998|FG001|Cross Over (Placebo to AA)|Other|0|||
150201932|NCT00887198|541880999|FG002|Cross Over (Placebo to AA)|Other|19|||
150201933|NCT05830799|541881007|FG000|Overall Study|Withdrawal by Subject|1|||
150201934|NCT04173247|541881008|FG000|Overall Study|Withdrawal by Subject|0|||
150201935|NCT04173247|541881009|FG001|Overall Study|Withdrawal by Subject|2|||
150201936|NCT04173247|541881008|FG000|Overall Study|Death|1|||
150201937|NCT04173247|541881009|FG001|Overall Study|Death|0|||
150201938|NCT04173247|541881008|FG000|Overall Study|Physician Decision|1|||
150201939|NCT04173247|541881009|FG001|Overall Study|Physician Decision|0|||
150201940|NCT02163694|541881010|FG000|Overall Study|Adverse event- related to progression|4|||
150201941|NCT02163694|541881011|FG001|Overall Study|Adverse event- related to progression|10|||
150201942|NCT02163694|541881010|FG000|Overall Study|Adverse event- not related to progression|7|||
150201943|NCT02163694|541881011|FG001|Overall Study|Adverse event- not related to progression|22|||
150201944|NCT02163694|541881010|FG000|Overall Study|Withdrew consent|13|||
150201945|NCT02163694|541881011|FG001|Overall Study|Withdrew consent|28|||
150201946|NCT02163694|541881010|FG000|Overall Study|Lost to Follow-up|2|||
150201947|NCT02163694|541881011|FG001|Overall Study|Lost to Follow-up|2|||
150201948|NCT02163694|541881010|FG000|Overall Study|Sponsor discontinued study|3|||
150201949|NCT02163694|541881011|FG001|Overall Study|Sponsor discontinued study|29|||
150201950|NCT02163694|541881010|FG000|Overall Study|Progressive disease per protocol|125|||
150201951|NCT02163694|541881011|FG001|Overall Study|Progressive disease per protocol|224|||
150201952|NCT02163694|541881010|FG000|Overall Study|Other, not specified|17|||
150201953|NCT02163694|541881011|FG001|Overall Study|Other, not specified|22|||
150201954|NCT02163694|541881010|FG000|Overall Study|Randomized but Not Treated|1|||
150201955|NCT02163694|541881011|FG001|Overall Study|Randomized but Not Treated|0|||
150201956|NCT02163694|541881010|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
150201957|NCT02163694|541881011|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
150201958|NCT04369911|541881014|FG000|Overall Study|Lost to Follow-up|3|||
150201959|NCT04369911|541881015|FG001|Overall Study|Lost to Follow-up|3|||
150201960|NCT04369911|541881014|FG000|Overall Study|Withdrawal by Subject|1|||
150201961|NCT04369911|541881015|FG001|Overall Study|Withdrawal by Subject|2|||
150201962|NCT03817983|541881016|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
150201963|NCT03817983|541881017|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
150201964|NCT03817983|541881018|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
150201965|NCT03744676|541881019|FG000|Pre-Treatment Phase|Disease related complications|2|||
150201966|NCT03744676|541881019|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
150201967|NCT03744676|541881019|FG000|Pre-Treatment Phase|Death|7|||
150201968|NCT03744676|541881019|FG000|Pre-Treatment Phase|Other Reasons|7|||
150201969|NCT03744676|541881019|FG000|Treatment Phase|Participant withdrew consent|8|||
150201970|NCT03744676|541881019|FG000|Treatment Phase|Death|33|||
150201971|NCT03744676|541881019|FG000|Treatment Phase|other reasons|6|||
150201972|NCT04078152|541881020|FG000|Overall Study|Other|83|||
150201973|NCT04078152|541881021|FG001|Overall Study|Other|22|||
150201974|NCT04078152|541881022|FG002|Overall Study|Other|25|||
150201975|NCT04078152|541881020|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
150201976|NCT04078152|541881021|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
150201977|NCT04078152|541881022|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
150201978|NCT04078152|541881020|FG000|Overall Study|Withdrawal by Subject|5|||
150201979|NCT04078152|541881021|FG001|Overall Study|Withdrawal by Subject|0|||
150201980|NCT04078152|541881022|FG002|Overall Study|Withdrawal by Subject|1|||
150201981|NCT04078152|541881020|FG000|Overall Study|Death|10|||
150201982|NCT04078152|541881021|FG001|Overall Study|Death|2|||
150201983|NCT04078152|541881022|FG002|Overall Study|Death|12|||
150201984|NCT04078152|541881020|FG000|Overall Study|Adverse Event|1|||
150201985|NCT04078152|541881021|FG001|Overall Study|Adverse Event|0|||
150201986|NCT04078152|541881022|FG002|Overall Study|Adverse Event|0|||
150201987|NCT05454514|541881027|FG000|Overall Study|Withdrawal by Subject|4|||
150201988|NCT05541484|541881028|FG000|Overall Study|Withdrawal by Subject|1|||
150201989|NCT05541484|541881029|FG001|Overall Study|Withdrawal by Subject|0|||
150201990|NCT05785130|541881030|FG000|Overall Study|Withdrawal by Subject|1|||
150201991|NCT05785130|541881031|FG001|Overall Study|Withdrawal by Subject|0|||
150201992|NCT05785130|541881030|FG000|Overall Study|Lack of Efficacy|0|||
150201993|NCT05785130|541881031|FG001|Overall Study|Lack of Efficacy|1|||
150201994|NCT02624050|541881032|FG000|Overall Study|Physician Decision|4|||
150201995|NCT02624050|541881033|FG001|Overall Study|Physician Decision|0|||
150201996|NCT02624050|541881032|FG000|Overall Study|Protocol Violation|2|||
150201997|NCT02624050|541881033|FG001|Overall Study|Protocol Violation|0|||
150201998|NCT04157517|541881035|FG000|Overall Study|Death|1|||
150201999|NCT04157517|541881036|FG001|Overall Study|Death|2|||
150202000|NCT04157517|541881037|FG002|Overall Study|Death|2|||
150202001|NCT04157517|541881038|FG003|Overall Study|Death|3|||
150202002|NCT04157517|541881039|FG004|Overall Study|Death|3|||
150202003|NCT04157517|541881040|FG005|Overall Study|Death|4|||
150202004|NCT04157517|541881041|FG006|Overall Study|Death|1|||
150202005|NCT04157517|541881042|FG007|Overall Study|Death|2|||
150202006|NCT04157517|541881043|FG008|Overall Study|Death|4|||
150202007|NCT04157517|541881044|FG009|Overall Study|Death|0|||
150202008|NCT04157517|541881035|FG000|Overall Study|Withdrawal by Subject|1|||
150202009|NCT04157517|541881036|FG001|Overall Study|Withdrawal by Subject|1|||
150202010|NCT04157517|541881037|FG002|Overall Study|Withdrawal by Subject|1|||
150202011|NCT04157517|541881038|FG003|Overall Study|Withdrawal by Subject|0|||
150202012|NCT04157517|541881039|FG004|Overall Study|Withdrawal by Subject|0|||
150202013|NCT04157517|541881040|FG005|Overall Study|Withdrawal by Subject|1|||
150202014|NCT04157517|541881041|FG006|Overall Study|Withdrawal by Subject|0|||
150202015|NCT04157517|541881042|FG007|Overall Study|Withdrawal by Subject|0|||
150202016|NCT04157517|541881043|FG008|Overall Study|Withdrawal by Subject|1|||
150202017|NCT04157517|541881044|FG009|Overall Study|Withdrawal by Subject|0|||
150202018|NCT04157517|541881035|FG000|Overall Study|Other|1|||
150202019|NCT04157517|541881036|FG001|Overall Study|Other|0|||
150202020|NCT04157517|541881037|FG002|Overall Study|Other|0|||
150202021|NCT04157517|541881038|FG003|Overall Study|Other|0|||
150202022|NCT04157517|541881039|FG004|Overall Study|Other|0|||
150202023|NCT04157517|541881040|FG005|Overall Study|Other|1|||
150202024|NCT04157517|541881041|FG006|Overall Study|Other|2|||
150202025|NCT04157517|541881042|FG007|Overall Study|Other|7|||
150202026|NCT04157517|541881043|FG008|Overall Study|Other|7|||
150202027|NCT04157517|541881044|FG009|Overall Study|Other|0|||
150202028|NCT03279978|541881048|FG000|Overall Study|Withdrawal by Subject|0|||
150202029|NCT03279978|541881049|FG001|Overall Study|Withdrawal by Subject|1|||
150202030|NCT03279978|541881050|FG002|Overall Study|Withdrawal by Subject|0|||
150202031|NCT03279978|541881051|FG003|Overall Study|Withdrawal by Subject|0|||
150202032|NCT03279978|541881052|FG004|Overall Study|Withdrawal by Subject|0|||
150202033|NCT03279978|541881053|FG005|Overall Study|Withdrawal by Subject|0|||
150202034|NCT03279978|541881054|FG006|Overall Study|Withdrawal by Subject|0|||
150202035|NCT03279978|541881055|FG007|Overall Study|Withdrawal by Subject|0|||
150202036|NCT03279978|541881056|FG008|Overall Study|Withdrawal by Subject|0|||
150202037|NCT03279978|541881057|FG009|Overall Study|Withdrawal by Subject|1|||
150202038|NCT03279978|541881048|FG000|Overall Study|Lost to Follow-up|1|||
150202039|NCT03279978|541881049|FG001|Overall Study|Lost to Follow-up|0|||
150202040|NCT03279978|541881050|FG002|Overall Study|Lost to Follow-up|1|||
150202041|NCT03279978|541881051|FG003|Overall Study|Lost to Follow-up|0|||
150202042|NCT03279978|541881052|FG004|Overall Study|Lost to Follow-up|0|||
150202043|NCT03279978|541881053|FG005|Overall Study|Lost to Follow-up|0|||
150202044|NCT03279978|541881054|FG006|Overall Study|Lost to Follow-up|0|||
150202045|NCT03279978|541881055|FG007|Overall Study|Lost to Follow-up|0|||
150202046|NCT03279978|541881056|FG008|Overall Study|Lost to Follow-up|0|||
150202047|NCT03279978|541881057|FG009|Overall Study|Lost to Follow-up|0|||
150202048|NCT03279978|541881048|FG000|Overall Study|Other than stated above|0|||
150202049|NCT03279978|541881049|FG001|Overall Study|Other than stated above|0|||
150202050|NCT03279978|541881050|FG002|Overall Study|Other than stated above|0|||
150202051|NCT03279978|541881051|FG003|Overall Study|Other than stated above|0|||
150202052|NCT03279978|541881052|FG004|Overall Study|Other than stated above|0|||
150202053|NCT03279978|541881053|FG005|Overall Study|Other than stated above|0|||
150202054|NCT03279978|541881054|FG006|Overall Study|Other than stated above|1|||
150202055|NCT03279978|541881055|FG007|Overall Study|Other than stated above|0|||
150202056|NCT03279978|541881056|FG008|Overall Study|Other than stated above|0|||
150202057|NCT03279978|541881057|FG009|Overall Study|Other than stated above|0|||
150202058|NCT04780581|541881059|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
150202059|NCT04780581|541881060|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
150202060|NCT04780581|541881059|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
150202061|NCT04780581|541881060|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
150202062|NCT01651000|541881061|FG000|Overall Study|Adverse Event|2|||
150202063|NCT01651000|541881062|FG001|Overall Study|Adverse Event|8|||
150202064|NCT01651000|541881061|FG000|Overall Study|Lost to Follow-up|3|||
150202065|NCT01651000|541881062|FG001|Overall Study|Lost to Follow-up|2|||
150202066|NCT01651000|541881061|FG000|Overall Study|Protocol Violation|0|||
150202067|NCT01651000|541881062|FG001|Overall Study|Protocol Violation|3|||
150202068|NCT01651000|541881061|FG000|Overall Study|Withdrawal by Subject|2|||
150202069|NCT01651000|541881062|FG001|Overall Study|Withdrawal by Subject|10|||
150202070|NCT01651000|541881061|FG000|Overall Study|Subject noncompliance|0|||
150202071|NCT01651000|541881062|FG001|Overall Study|Subject noncompliance|3|||
150202072|NCT01651000|541881061|FG000|Overall Study|Lack of Efficacy|1|||
150202073|NCT01651000|541881062|FG001|Overall Study|Lack of Efficacy|1|||
150202074|NCT01651000|541881061|FG000|Overall Study|Physician Decision|1|||
150202075|NCT01651000|541881062|FG001|Overall Study|Physician Decision|0|||
150202076|NCT01651000|541881061|FG000|Overall Study|Administrative reason|1|||
150202077|NCT01651000|541881062|FG001|Overall Study|Administrative reason|0|||
150202078|NCT01651000|541881061|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
150202079|NCT01651000|541881062|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
150202080|NCT03734029|541881063|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
150202081|NCT03734029|541881064|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
150202082|NCT03734029|541881063|FG000|Overall Study|Adverse Event|60|||
150202083|NCT03734029|541881064|FG001|Overall Study|Adverse Event|14|||
150202084|NCT03734029|541881063|FG000|Overall Study|Withdrawal by Subject|12|||
150202085|NCT03734029|541881064|FG001|Overall Study|Withdrawal by Subject|11|||
150202086|NCT03734029|541881063|FG000|Overall Study|Clinical progression by investigator|10|||
150202087|NCT03734029|541881064|FG001|Overall Study|Clinical progression by investigator|8|||
150202088|NCT03734029|541881063|FG000|Overall Study|Death|5|||
150202089|NCT03734029|541881064|FG001|Overall Study|Death|2|||
150202090|NCT03734029|541881063|FG000|Overall Study|Physician Decision|4|||
150202091|NCT03734029|541881064|FG001|Overall Study|Physician Decision|3|||
150202092|NCT03734029|541881063|FG000|Overall Study|Other|2|||
150202093|NCT03734029|541881064|FG001|Overall Study|Other|0|||
150202094|NCT03734029|541881063|FG000|Overall Study|Lost to Follow-up|0|||
150202095|NCT03734029|541881064|FG001|Overall Study|Lost to Follow-up|1|||
150202096|NCT03734029|541881063|FG000|Overall Study|Randomized, but not treated|2|||
150202097|NCT03734029|541881064|FG001|Overall Study|Randomized, but not treated|12|||
150202098|NCT04631016|541881490|FG000|Overall Study|Adverse Event|3|||
150202099|NCT04631016|541881491|FG001|Overall Study|Adverse Event|0|||
150137368|NCT00293267|541637256|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
150137369|NCT00293267|541637257|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
150137370|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
150137371|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
150137372|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
150137373|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
150137374|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
150202100|NCT04631016|541881490|FG000|Overall Study|Withdrawal by Subject|5|||
150202101|NCT04631016|541881491|FG001|Overall Study|Withdrawal by Subject|4|||
150202102|NCT04631016|541881490|FG000|Overall Study|Reason unspecified|1|||
150202103|NCT04631016|541881491|FG001|Overall Study|Reason unspecified|0|||
150202104|NCT04631016|541881490|FG000|Overall Study|Failure to meet randomization criteria|2|||
150202105|NCT04631016|541881491|FG001|Overall Study|Failure to meet randomization criteria|1|||
150202106|NCT04967599|541881494|FG000|Overall Study|Lost to Follow-up|35|||
150202107|NCT04967599|541881495|FG001|Overall Study|Lost to Follow-up|19|||
150202108|NCT04967599|541881496|FG002|Overall Study|Lost to Follow-up|23|||
150202109|NCT04163991|541881497|FG000|Overall Study|Adverse Event|0|||
150202110|NCT04163991|541881498|FG001|Overall Study|Adverse Event|0|||
150202111|NCT04163991|541881499|FG002|Overall Study|Adverse Event|0|||
150202112|NCT04163991|541881500|FG003|Overall Study|Adverse Event|1|||
150202113|NCT04163991|541881501|FG004|Overall Study|Adverse Event|0|||
150202114|NCT04163991|541881497|FG000|Overall Study|Death|0|||
150202115|NCT04163991|541881498|FG001|Overall Study|Death|0|||
150202116|NCT04163991|541881499|FG002|Overall Study|Death|1|||
150202117|NCT04163991|541881500|FG003|Overall Study|Death|0|||
150202118|NCT04163991|541881501|FG004|Overall Study|Death|0|||
150202119|NCT04163991|541881497|FG000|Overall Study|Lost to Follow-up|0|||
150202120|NCT04163991|541881498|FG001|Overall Study|Lost to Follow-up|1|||
150202121|NCT04163991|541881499|FG002|Overall Study|Lost to Follow-up|0|||
150202122|NCT04163991|541881500|FG003|Overall Study|Lost to Follow-up|0|||
150202123|NCT04163991|541881501|FG004|Overall Study|Lost to Follow-up|0|||
150202124|NCT04163991|541881497|FG000|Overall Study|Withdrawal by Subject|1|||
150202125|NCT04163991|541881498|FG001|Overall Study|Withdrawal by Subject|1|||
150202126|NCT04163991|541881499|FG002|Overall Study|Withdrawal by Subject|3|||
150202127|NCT04163991|541881500|FG003|Overall Study|Withdrawal by Subject|1|||
150202128|NCT04163991|541881501|FG004|Overall Study|Withdrawal by Subject|1|||
150202129|NCT04163991|541881497|FG000|Overall Study|Other, Not Specified|0|||
150202130|NCT04163991|541881498|FG001|Overall Study|Other, Not Specified|1|||
150202131|NCT04163991|541881499|FG002|Overall Study|Other, Not Specified|1|||
150202132|NCT04163991|541881500|FG003|Overall Study|Other, Not Specified|1|||
150202133|NCT04163991|541881501|FG004|Overall Study|Other, Not Specified|0|||
150202134|NCT03418740|541881502|FG000|Overall Study|Lost to Follow-up|13|||
150202135|NCT03418740|541881502|FG000|Overall Study|Scheduling Issues|7|||
150202136|NCT03418740|541881502|FG000|Overall Study|Withdrawal by Subject|2|||
150202137|NCT03418740|541881502|FG000|Overall Study|Unable to Continue Consent|1|||
150202138|NCT01475786|541881507|FG000|Overall Study|Adverse Event|0|||
150202139|NCT01475786|541881508|FG001|Overall Study|Adverse Event|1|||
150202140|NCT01475786|541881509|FG002|Overall Study|Adverse Event|0|||
150202141|NCT01475786|541881507|FG000|Overall Study|Lost to Follow-up|1|||
150202142|NCT01475786|541881508|FG001|Overall Study|Lost to Follow-up|2|||
150202143|NCT01475786|541881509|FG002|Overall Study|Lost to Follow-up|1|||
150202144|NCT01475786|541881507|FG000|Overall Study|Withdrawal by Subject|0|||
150202145|NCT01475786|541881508|FG001|Overall Study|Withdrawal by Subject|1|||
150202146|NCT01475786|541881509|FG002|Overall Study|Withdrawal by Subject|1|||
150137375|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
150202147|NCT01475786|541881507|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
150202148|NCT01475786|541881508|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
150202149|NCT01475786|541881509|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
150202150|NCT01897441|541881510|FG000|Overall Study|Lost to Follow-up|0|||
150202151|NCT01897441|541881511|FG001|Overall Study|Lost to Follow-up|0|||
150202152|NCT01897441|541881512|FG002|Overall Study|Lost to Follow-up|1|||
150202153|NCT01897441|541881513|FG003|Overall Study|Lost to Follow-up|0|||
150202154|NCT01897441|541881514|FG004|Overall Study|Lost to Follow-up|0|||
150202155|NCT01897441|541881515|FG005|Overall Study|Lost to Follow-up|0|||
150202156|NCT01897441|541881510|FG000|Overall Study|Withdrawal by Subject|0|||
150202157|NCT01897441|541881511|FG001|Overall Study|Withdrawal by Subject|0|||
150202158|NCT01897441|541881512|FG002|Overall Study|Withdrawal by Subject|0|||
150202159|NCT01897441|541881513|FG003|Overall Study|Withdrawal by Subject|0|||
150202160|NCT01897441|541881514|FG004|Overall Study|Withdrawal by Subject|1|||
150202161|NCT01897441|541881515|FG005|Overall Study|Withdrawal by Subject|0|||
150202162|NCT01897441|541881510|FG000|Overall Study|Withdrawn by Provider|0|||
150202163|NCT01897441|541881511|FG001|Overall Study|Withdrawn by Provider|2|||
150202164|NCT01897441|541881512|FG002|Overall Study|Withdrawn by Provider|0|||
150202165|NCT01897441|541881513|FG003|Overall Study|Withdrawn by Provider|0|||
150202166|NCT01897441|541881514|FG004|Overall Study|Withdrawn by Provider|0|||
150202167|NCT01897441|541881515|FG005|Overall Study|Withdrawn by Provider|0|||
150202168|NCT04159519|541881516|FG000|Overall Study|Adverse Event|1|||
150202169|NCT04159519|541881517|FG001|Overall Study|Adverse Event|1|||
150202170|NCT04159519|541881516|FG000|Overall Study|Lack of Efficacy|1|||
150202171|NCT04159519|541881517|FG001|Overall Study|Lack of Efficacy|0|||
150202172|NCT04159519|541881516|FG000|Overall Study|Discontinued from study|1|||
150202173|NCT04159519|541881517|FG001|Overall Study|Discontinued from study|0|||
150202174|NCT04159519|541881516|FG000|Overall Study|Protocol Violation|1|||
150202175|NCT04159519|541881517|FG001|Overall Study|Protocol Violation|1|||
150202176|NCT04159519|541881516|FG000|Overall Study|Withdrawal by Subject|4|||
150202177|NCT04159519|541881517|FG001|Overall Study|Withdrawal by Subject|4|||
150202178|NCT01499368|541881518|FG000|Overall Study|Did not meet I/E criteria|8|||
150202179|NCT01499368|541881519|FG001|Overall Study|Did not meet I/E criteria|4|||
150202180|NCT01499368|541881520|FG002|Overall Study|Did not meet I/E criteria|4|||
150202181|NCT01499368|541881518|FG000|Overall Study|Prohibited Concomitant medication|1|||
150202182|NCT01499368|541881519|FG001|Overall Study|Prohibited Concomitant medication|1|||
150202183|NCT01499368|541881520|FG002|Overall Study|Prohibited Concomitant medication|0|||
150202184|NCT01499368|541881518|FG000|Overall Study|Withdrawal by Subject|11|||
150202185|NCT01499368|541881519|FG001|Overall Study|Withdrawal by Subject|10|||
150202186|NCT01499368|541881520|FG002|Overall Study|Withdrawal by Subject|8|||
150202187|NCT01499368|541881518|FG000|Overall Study|Lost to Follow-up|3|||
150202188|NCT01499368|541881519|FG001|Overall Study|Lost to Follow-up|2|||
150202189|NCT01499368|541881520|FG002|Overall Study|Lost to Follow-up|5|||
150202190|NCT01499368|541881518|FG000|Overall Study|Adverse Event|4|||
150202191|NCT01499368|541881519|FG001|Overall Study|Adverse Event|0|||
150202192|NCT01499368|541881520|FG002|Overall Study|Adverse Event|2|||
150202193|NCT01499368|541881518|FG000|Overall Study|Physician Decision|0|||
150202194|NCT01499368|541881519|FG001|Overall Study|Physician Decision|1|||
150202195|NCT01499368|541881520|FG002|Overall Study|Physician Decision|0|||
150202196|NCT01499368|541881518|FG000|Overall Study|Deviation from visit window|0|||
150202197|NCT01499368|541881519|FG001|Overall Study|Deviation from visit window|0|||
150202198|NCT01499368|541881520|FG002|Overall Study|Deviation from visit window|1|||
150202199|NCT01499368|541881518|FG000|Overall Study|Error of Prescriptions|0|||
150202200|NCT01499368|541881519|FG001|Overall Study|Error of Prescriptions|0|||
150202201|NCT01499368|541881520|FG002|Overall Study|Error of Prescriptions|1|||
150202202|NCT02765412|541881521|FG000|Overall Study|Death|482|||
150202203|NCT02765412|541881522|FG001|Overall Study|Death|855|||
150202204|NCT03781089|541882180|FG000|Overall Study|Constipation|1|||
150202205|NCT03781089|541882181|FG001|Overall Study|Constipation|0|||
150202206|NCT03781089|541882180|FG000|Overall Study|Positive pregnancy test|0|||
150202207|NCT03781089|541882181|FG001|Overall Study|Positive pregnancy test|1|||
150202208|NCT02246127|541882182|FG000|First Course Treatment|Adverse Event|9|||
150202209|NCT02246127|541882183|FG001|First Course Treatment|Adverse Event|7|||
150202210|NCT02246127|541882182|FG000|First Course Treatment|Withdrawal by Subject|6|||
150202211|NCT02246127|541882183|FG001|First Course Treatment|Withdrawal by Subject|7|||
150202212|NCT02246127|541882182|FG000|First Course Treatment|Physician Decision|9|||
150202213|NCT02246127|541882183|FG001|First Course Treatment|Physician Decision|9|||
150202214|NCT02246127|541882182|FG000|First Course Treatment|Death|3|||
150202215|NCT02246127|541882183|FG001|First Course Treatment|Death|3|||
150202216|NCT02246127|541882182|FG000|First Course Treatment|Not reported reasons|6|||
150202217|NCT02246127|541882183|FG001|First Course Treatment|Not reported reasons|7|||
150202218|NCT02246127|541882182|FG000|First Course Treatment|Not treated|3|||
150202219|NCT02246127|541882183|FG001|First Course Treatment|Not treated|3|||
150202220|NCT03635567|541882184|FG000|Overall Study|Lost to Follow-up|4|||
150202221|NCT03635567|541882185|FG001|Overall Study|Lost to Follow-up|1|||
150202222|NCT03635567|541882184|FG000|Overall Study|Withdrawal by Subject|11|||
150202223|NCT03635567|541882185|FG001|Overall Study|Withdrawal by Subject|16|||
150202224|NCT03635567|541882184|FG000|Overall Study|Sponsor Decision|99|||
150202225|NCT03635567|541882185|FG001|Overall Study|Sponsor Decision|57|||
150202226|NCT03635567|541882184|FG000|Overall Study|Death|194|||
150202227|NCT03635567|541882185|FG001|Overall Study|Death|235|||
150202228|NCT00942734|541882188|FG000|Overall Study|Adverse Event|2|||
150202229|NCT00942734|541882188|FG000|Overall Study|Protocol Violation|3|||
150202230|NCT00942734|541882188|FG000|Overall Study|Disease Progression|2|||
150202231|NCT00942734|541882188|FG000|Overall Study|Physician Decision|1|||
150202232|NCT05147584|541882189|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
150202233|NCT03884101|541882200|FG000|Overall Study|Participant Ongoing in Study|202|||
150202234|NCT03884101|541882201|FG001|Overall Study|Participant Ongoing in Study|186|||
150202235|NCT03884101|541882200|FG000|Overall Study|Death|212|||
150202236|NCT03884101|541882201|FG001|Overall Study|Death|224|||
150202237|NCT03884101|541882200|FG000|Overall Study|Lost to Follow-up|0|||
150202238|NCT03884101|541882201|FG001|Overall Study|Lost to Follow-up|1|||
150202239|NCT03884101|541882200|FG000|Overall Study|Withdrawal by Subject|6|||
150202240|NCT03884101|541882201|FG001|Overall Study|Withdrawal by Subject|11|||
150202241|NCT03370913|541882202|FG000|Overall Study|Death|1|||
150202242|NCT03370913|541882202|FG000|Overall Study|Lost to Follow-up|1|||
150202243|NCT04560179|541882205|FG000|Overall Study|Physician Decision|1|||
150202244|NCT04560179|541882206|FG001|Overall Study|Physician Decision|0|||
150202245|NCT04560179|541882207|FG002|Overall Study|Physician Decision|0|||
150202246|NCT04560179|541882208|FG003|Overall Study|Physician Decision|0|||
150202247|NCT04560179|541882209|FG004|Overall Study|Physician Decision|0|||
150202248|NCT04560179|541882205|FG000|Overall Study|Adverse Event|0|||
150202249|NCT04560179|541882206|FG001|Overall Study|Adverse Event|0|||
150202250|NCT04560179|541882207|FG002|Overall Study|Adverse Event|0|||
150202251|NCT04560179|541882208|FG003|Overall Study|Adverse Event|1|||
150202252|NCT04560179|541882209|FG004|Overall Study|Adverse Event|0|||
150202253|NCT04496752|541882210|FG000|Second Assessment|Lost to Follow-up|3|||
150202254|NCT04496752|541882211|FG001|Second Assessment|Lost to Follow-up|3|||
150202255|NCT04496752|541882210|FG000|Second Assessment|Adverse Event|2|||
150202256|NCT04496752|541882211|FG001|Second Assessment|Adverse Event|0|||
150202257|NCT03662022|541882212|FG000|Year 1 2019|prevalent case|83|||
150202258|NCT03662022|541882213|FG001|Year 1 2019|prevalent case|116|||
150202259|NCT03662022|541882214|FG002|Year 1 2019|prevalent case|158|||
150202260|NCT03662022|541882215|FG003|Year 1 2019|prevalent case|99|||
150202261|NCT03662022|541882212|FG000|Year 2 2020|incident case|18|||
150202262|NCT03662022|541882213|FG001|Year 2 2020|incident case|18|||
150202263|NCT03662022|541882214|FG002|Year 2 2020|incident case|16|||
150202264|NCT03662022|541882215|FG003|Year 2 2020|incident case|26|||
150202265|NCT03662022|541882212|FG000|Year 2 2020|other case|18|||
150202266|NCT03662022|541882213|FG001|Year 2 2020|other case|16|||
150202267|NCT03662022|541882214|FG002|Year 2 2020|other case|16|||
150202268|NCT03662022|541882215|FG003|Year 2 2020|other case|24|||
150202269|NCT03662022|541882212|FG000|Year 2 2020|Lost to Follow-up|1633|||
150202270|NCT03662022|541882213|FG001|Year 2 2020|Lost to Follow-up|1183|||
150202271|NCT03662022|541882214|FG002|Year 2 2020|Lost to Follow-up|1381|||
150202272|NCT03662022|541882215|FG003|Year 2 2020|Lost to Follow-up|2858|||
150202273|NCT03662022|541882212|FG000|Year 3 2021|incident case|24|||
150202274|NCT03662022|541882213|FG001|Year 3 2021|incident case|27|||
150202275|NCT03662022|541882214|FG002|Year 3 2021|incident case|24|||
150202276|NCT03662022|541882215|FG003|Year 3 2021|incident case|11|||
150202277|NCT03662022|541882212|FG000|Year 3 2021|other case|4|||
150202278|NCT03662022|541882213|FG001|Year 3 2021|other case|15|||
150202279|NCT03662022|541882214|FG002|Year 3 2021|other case|10|||
150202280|NCT03662022|541882215|FG003|Year 3 2021|other case|14|||
150202281|NCT03662022|541882212|FG000|Year 3 2021|Lost to Follow-up|179|||
150202282|NCT03662022|541882213|FG001|Year 3 2021|Lost to Follow-up|244|||
150202283|NCT03662022|541882214|FG002|Year 3 2021|Lost to Follow-up|480|||
150202284|NCT03662022|541882215|FG003|Year 3 2021|Lost to Follow-up|477|||
150202285|NCT03662022|541882212|FG000|Year 4 2022|incident case|25|||
150202286|NCT03662022|541882213|FG001|Year 4 2022|incident case|41|||
150202287|NCT03662022|541882214|FG002|Year 4 2022|incident case|28|||
150202288|NCT03662022|541882215|FG003|Year 4 2022|incident case|7|||
150202289|NCT03662022|541882212|FG000|Year 4 2022|other case|8|||
150202290|NCT03662022|541882213|FG001|Year 4 2022|other case|19|||
150202291|NCT03662022|541882214|FG002|Year 4 2022|other case|13|||
150202292|NCT03662022|541882215|FG003|Year 4 2022|other case|7|||
150202293|NCT03662022|541882212|FG000|Year 4 2022|Lost to Follow-up|986|||
150202294|NCT03662022|541882213|FG001|Year 4 2022|Lost to Follow-up|1079|||
150202295|NCT03662022|541882214|FG002|Year 4 2022|Lost to Follow-up|1236|||
150202296|NCT03662022|541882215|FG003|Year 4 2022|Lost to Follow-up|1826|||
150202297|NCT03248479|541882218|FG000|Overall Study|Death|12|||
150202298|NCT03248479|541882219|FG001|Overall Study|Death|44|||
150202299|NCT03248479|541882220|FG002|Overall Study|Death|1|||
150202300|NCT03248479|541882221|FG003|Overall Study|Death|72|||
150202301|NCT03248479|541882222|FG004|Overall Study|Death|17|||
150202302|NCT03248479|541882223|FG005|Overall Study|Death|6|||
150202303|NCT03248479|541882224|FG006|Overall Study|Death|1|||
150202304|NCT03248479|541882225|FG007|Overall Study|Death|14|||
150202305|NCT03248479|541882226|FG008|Overall Study|Death|3|||
150202306|NCT03248479|541882227|FG009|Overall Study|Death|7|||
150202307|NCT03248479|541882228|FG010|Overall Study|Death|3|||
150202308|NCT03248479|541882229|FG011|Overall Study|Death|1|||
150202309|NCT03248479|541882230|FG012|Overall Study|Death|1|||
150202310|NCT03248479|541882218|FG000|Overall Study|Study terminated by sponsor|12|||
150202311|NCT03248479|541882219|FG001|Overall Study|Study terminated by sponsor|15|||
150202312|NCT03248479|541882220|FG002|Overall Study|Study terminated by sponsor|0|||
150202313|NCT03248479|541882221|FG003|Overall Study|Study terminated by sponsor|5|||
150202314|NCT03248479|541882222|FG004|Overall Study|Study terminated by sponsor|0|||
150202315|NCT03248479|541882223|FG005|Overall Study|Study terminated by sponsor|0|||
150202316|NCT03248479|541882224|FG006|Overall Study|Study terminated by sponsor|0|||
150202317|NCT03248479|541882225|FG007|Overall Study|Study terminated by sponsor|1|||
150202318|NCT03248479|541882226|FG008|Overall Study|Study terminated by sponsor|1|||
150202319|NCT03248479|541882227|FG009|Overall Study|Study terminated by sponsor|0|||
150202320|NCT03248479|541882228|FG010|Overall Study|Study terminated by sponsor|5|||
150202321|NCT03248479|541882229|FG011|Overall Study|Study terminated by sponsor|4|||
150202322|NCT03248479|541882230|FG012|Overall Study|Study terminated by sponsor|0|||
150202323|NCT03248479|541882218|FG000|Overall Study|Consent withdrawn|6|||
150202324|NCT03248479|541882219|FG001|Overall Study|Consent withdrawn|3|||
150202325|NCT03248479|541882220|FG002|Overall Study|Consent withdrawn|0|||
150202326|NCT03248479|541882221|FG003|Overall Study|Consent withdrawn|9|||
150202327|NCT03248479|541882222|FG004|Overall Study|Consent withdrawn|1|||
150202328|NCT03248479|541882223|FG005|Overall Study|Consent withdrawn|0|||
150202329|NCT03248479|541882224|FG006|Overall Study|Consent withdrawn|0|||
150202330|NCT03248479|541882225|FG007|Overall Study|Consent withdrawn|1|||
150202331|NCT03248479|541882226|FG008|Overall Study|Consent withdrawn|0|||
150202332|NCT03248479|541882227|FG009|Overall Study|Consent withdrawn|3|||
150202333|NCT03248479|541882228|FG010|Overall Study|Consent withdrawn|1|||
150202334|NCT03248479|541882229|FG011|Overall Study|Consent withdrawn|0|||
150202335|NCT03248479|541882230|FG012|Overall Study|Consent withdrawn|1|||
150202336|NCT03248479|541882218|FG000|Overall Study|Lost to Follow-up|2|||
150202337|NCT03248479|541882219|FG001|Overall Study|Lost to Follow-up|1|||
150202338|NCT03248479|541882220|FG002|Overall Study|Lost to Follow-up|0|||
150202339|NCT03248479|541882221|FG003|Overall Study|Lost to Follow-up|0|||
150202340|NCT03248479|541882222|FG004|Overall Study|Lost to Follow-up|0|||
150202341|NCT03248479|541882223|FG005|Overall Study|Lost to Follow-up|0|||
150202342|NCT03248479|541882224|FG006|Overall Study|Lost to Follow-up|0|||
150202343|NCT03248479|541882225|FG007|Overall Study|Lost to Follow-up|0|||
150202344|NCT03248479|541882226|FG008|Overall Study|Lost to Follow-up|0|||
150202345|NCT03248479|541882227|FG009|Overall Study|Lost to Follow-up|0|||
150202346|NCT03248479|541882228|FG010|Overall Study|Lost to Follow-up|0|||
150202347|NCT03248479|541882229|FG011|Overall Study|Lost to Follow-up|0|||
150202348|NCT03248479|541882230|FG012|Overall Study|Lost to Follow-up|1|||
150202349|NCT03248479|541882218|FG000|Overall Study|Not reported|0|||
150202350|NCT03248479|541882219|FG001|Overall Study|Not reported|0|||
150202351|NCT03248479|541882220|FG002|Overall Study|Not reported|0|||
150202352|NCT03248479|541882221|FG003|Overall Study|Not reported|1|||
150202353|NCT03248479|541882222|FG004|Overall Study|Not reported|1|||
150202354|NCT03248479|541882223|FG005|Overall Study|Not reported|0|||
150202355|NCT03248479|541882224|FG006|Overall Study|Not reported|0|||
150202356|NCT03248479|541882225|FG007|Overall Study|Not reported|1|||
150202357|NCT03248479|541882226|FG008|Overall Study|Not reported|1|||
150202358|NCT03248479|541882227|FG009|Overall Study|Not reported|0|||
150202359|NCT03248479|541882228|FG010|Overall Study|Not reported|0|||
150202360|NCT03248479|541882229|FG011|Overall Study|Not reported|0|||
150202361|NCT03248479|541882230|FG012|Overall Study|Not reported|0|||
150202362|NCT04679389|541882231|FG000|Overall Study|Adverse Event|1|||
150202363|NCT04679389|541882232|FG001|Overall Study|Adverse Event|0|||
150202364|NCT04679389|541882231|FG000|Overall Study|Protocol Violation|2|||
150202365|NCT04679389|541882232|FG001|Overall Study|Protocol Violation|0|||
150202366|NCT04679389|541882231|FG000|Overall Study|Physician Decision|3|||
150202367|NCT04679389|541882232|FG001|Overall Study|Physician Decision|5|||
150202368|NCT04679389|541882231|FG000|Overall Study|Withdrawal by Subject|5|||
150202369|NCT04679389|541882232|FG001|Overall Study|Withdrawal by Subject|7|||
150202370|NCT03250676|541882245|FG000|Overall Study|Adverse Event|0|||
150202371|NCT03250676|541882246|FG001|Overall Study|Adverse Event|0|||
150202372|NCT03250676|541882247|FG002|Overall Study|Adverse Event|0|||
150202373|NCT03250676|541882248|FG003|Overall Study|Adverse Event|1|||
150202374|NCT03250676|541882249|FG004|Overall Study|Adverse Event|2|||
150202375|NCT03250676|541882250|FG005|Overall Study|Adverse Event|9|||
150202376|NCT03250676|541882245|FG000|Overall Study|Withdrawal by Subject|1|||
150202377|NCT03250676|541882246|FG001|Overall Study|Withdrawal by Subject|0|||
150202378|NCT03250676|541882247|FG002|Overall Study|Withdrawal by Subject|0|||
150202379|NCT03250676|541882248|FG003|Overall Study|Withdrawal by Subject|1|||
150202380|NCT03250676|541882249|FG004|Overall Study|Withdrawal by Subject|1|||
150202381|NCT03250676|541882250|FG005|Overall Study|Withdrawal by Subject|2|||
150202382|NCT03250676|541882245|FG000|Overall Study|Physician Decision|0|||
150202383|NCT03250676|541882246|FG001|Overall Study|Physician Decision|0|||
150202384|NCT03250676|541882247|FG002|Overall Study|Physician Decision|0|||
150202385|NCT03250676|541882248|FG003|Overall Study|Physician Decision|2|||
150202386|NCT03250676|541882249|FG004|Overall Study|Physician Decision|0|||
150202387|NCT03250676|541882250|FG005|Overall Study|Physician Decision|3|||
150202388|NCT03250676|541882245|FG000|Overall Study|Withdrawal of consent|0|||
150202389|NCT03250676|541882246|FG001|Overall Study|Withdrawal of consent|0|||
150202390|NCT03250676|541882247|FG002|Overall Study|Withdrawal of consent|2|||
150202391|NCT03250676|541882248|FG003|Overall Study|Withdrawal of consent|0|||
150202392|NCT03250676|541882249|FG004|Overall Study|Withdrawal of consent|0|||
150202393|NCT03250676|541882250|FG005|Overall Study|Withdrawal of consent|2|||
150202394|NCT03250676|541882245|FG000|Overall Study|Other|1|||
150202395|NCT03250676|541882246|FG001|Overall Study|Other|0|||
150202396|NCT03250676|541882247|FG002|Overall Study|Other|0|||
150202397|NCT03250676|541882248|FG003|Overall Study|Other|0|||
150202398|NCT03250676|541882249|FG004|Overall Study|Other|0|||
150202399|NCT03250676|541882250|FG005|Overall Study|Other|0|||
150202400|NCT03250676|541882245|FG000|Overall Study|Disease progression|4|||
150202401|NCT03250676|541882246|FG001|Overall Study|Disease progression|12|||
150202402|NCT03250676|541882247|FG002|Overall Study|Disease progression|9|||
150202403|NCT03250676|541882248|FG003|Overall Study|Disease progression|7|||
150202404|NCT03250676|541882249|FG004|Overall Study|Disease progression|4|||
150202405|NCT03250676|541882250|FG005|Overall Study|Disease progression|88|||
150202406|NCT04633278|541883243|FG000|Overall Study|Adverse Event|1|||
150202407|NCT04633278|541883244|FG001|Overall Study|Adverse Event|0|||
150202408|NCT04633278|541883243|FG000|Overall Study|Withdrawal by Subject|1|||
150202409|NCT04633278|541883244|FG001|Overall Study|Withdrawal by Subject|0|||
150202410|NCT04633278|541883243|FG000|Overall Study|Death|11|||
150202411|NCT04633278|541883244|FG001|Overall Study|Death|7|||
150202412|NCT04633278|541883243|FG000|Overall Study|Sponsor Decision|3|||
150202413|NCT04633278|541883244|FG001|Overall Study|Sponsor Decision|0|||
150202414|NCT04633278|541883243|FG000|Overall Study|Not Listed|1|||
150202415|NCT04633278|541883244|FG001|Overall Study|Not Listed|0|||
150202416|NCT02076009|541883245|FG000|Overall Study|Death|172|||
150202417|NCT02076009|541883246|FG001|Overall Study|Death|153|||
150202418|NCT02076009|541883245|FG000|Overall Study|Withdrawal by Subject|16|||
150202419|NCT02076009|541883246|FG001|Overall Study|Withdrawal by Subject|12|||
150202420|NCT02076009|541883245|FG000|Overall Study|Lost to Follow-up|4|||
150202421|NCT02076009|541883246|FG001|Overall Study|Lost to Follow-up|2|||
150202422|NCT02076009|541883245|FG000|Overall Study|Progressive Disease|1|||
150202423|NCT02076009|541883246|FG001|Overall Study|Progressive Disease|0|||
150202424|NCT02076009|541883245|FG000|Overall Study|Physician Decision|0|||
150202425|NCT02076009|541883246|FG001|Overall Study|Physician Decision|1|||
150202426|NCT02076009|541883245|FG000|Overall Study|End of data collection|90|||
150202427|NCT02076009|541883246|FG001|Overall Study|End of data collection|118|||
150202428|NCT03786926|541883254|FG000|Overall Study|Adverse Event|0|||
150202429|NCT03786926|541883255|FG001|Overall Study|Adverse Event|0|||
150202430|NCT03786926|541883256|FG002|Overall Study|Adverse Event|0|||
150202431|NCT03786926|541883257|FG003|Overall Study|Adverse Event|0|||
150202432|NCT03786926|541883258|FG004|Overall Study|Adverse Event|0|||
150202433|NCT03786926|541883259|FG005|Overall Study|Adverse Event|0|||
150202434|NCT03786926|541883260|FG006|Overall Study|Adverse Event|0|||
150202435|NCT03786926|541883261|FG007|Overall Study|Adverse Event|1|||
150202436|NCT03786926|541883262|FG008|Overall Study|Adverse Event|1|||
150202437|NCT03786926|541883263|FG009|Overall Study|Adverse Event|0|||
150202438|NCT03786926|541883264|FG010|Overall Study|Adverse Event|1|||
150202439|NCT03786926|541883254|FG000|Overall Study|Progressive disease|3|||
150202440|NCT03786926|541883255|FG001|Overall Study|Progressive disease|0|||
150202441|NCT03786926|541883256|FG002|Overall Study|Progressive disease|3|||
150202442|NCT03786926|541883257|FG003|Overall Study|Progressive disease|1|||
150202443|NCT03786926|541883258|FG004|Overall Study|Progressive disease|2|||
150202444|NCT03786926|541883259|FG005|Overall Study|Progressive disease|2|||
150202445|NCT03786926|541883260|FG006|Overall Study|Progressive disease|1|||
150202446|NCT03786926|541883261|FG007|Overall Study|Progressive disease|6|||
150202447|NCT03786926|541883262|FG008|Overall Study|Progressive disease|1|||
150202448|NCT03786926|541883263|FG009|Overall Study|Progressive disease|1|||
150202449|NCT03786926|541883264|FG010|Overall Study|Progressive disease|1|||
150202450|NCT03786926|541883254|FG000|Overall Study|Death|0|||
150202451|NCT03786926|541883255|FG001|Overall Study|Death|1|||
150202452|NCT03786926|541883256|FG002|Overall Study|Death|1|||
150202453|NCT03786926|541883257|FG003|Overall Study|Death|0|||
150202454|NCT03786926|541883258|FG004|Overall Study|Death|0|||
150202455|NCT03786926|541883259|FG005|Overall Study|Death|0|||
150202456|NCT03786926|541883260|FG006|Overall Study|Death|0|||
150202457|NCT03786926|541883261|FG007|Overall Study|Death|0|||
150202458|NCT03786926|541883262|FG008|Overall Study|Death|0|||
150202459|NCT03786926|541883263|FG009|Overall Study|Death|1|||
150202460|NCT03786926|541883264|FG010|Overall Study|Death|2|||
150202461|NCT03786926|541883254|FG000|Overall Study|Physician Decision|0|||
150202462|NCT03786926|541883255|FG001|Overall Study|Physician Decision|1|||
150202463|NCT03786926|541883256|FG002|Overall Study|Physician Decision|0|||
150202464|NCT03786926|541883257|FG003|Overall Study|Physician Decision|1|||
150202465|NCT03786926|541883258|FG004|Overall Study|Physician Decision|2|||
150202466|NCT03786926|541883259|FG005|Overall Study|Physician Decision|0|||
150202467|NCT03786926|541883260|FG006|Overall Study|Physician Decision|0|||
150202468|NCT03786926|541883261|FG007|Overall Study|Physician Decision|2|||
150202469|NCT03786926|541883262|FG008|Overall Study|Physician Decision|1|||
150202470|NCT03786926|541883263|FG009|Overall Study|Physician Decision|1|||
150202471|NCT03786926|541883264|FG010|Overall Study|Physician Decision|0|||
150202472|NCT03786926|541883254|FG000|Overall Study|Withdrawal by Subject|0|||
150202473|NCT03786926|541883255|FG001|Overall Study|Withdrawal by Subject|1|||
150202474|NCT03786926|541883256|FG002|Overall Study|Withdrawal by Subject|1|||
150202475|NCT03786926|541883257|FG003|Overall Study|Withdrawal by Subject|0|||
150202476|NCT03786926|541883258|FG004|Overall Study|Withdrawal by Subject|0|||
150202477|NCT03786926|541883259|FG005|Overall Study|Withdrawal by Subject|0|||
150202478|NCT03786926|541883260|FG006|Overall Study|Withdrawal by Subject|1|||
150202479|NCT03786926|541883261|FG007|Overall Study|Withdrawal by Subject|0|||
150202480|NCT03786926|541883262|FG008|Overall Study|Withdrawal by Subject|1|||
150202481|NCT03786926|541883263|FG009|Overall Study|Withdrawal by Subject|0|||
150202482|NCT03786926|541883264|FG010|Overall Study|Withdrawal by Subject|1|||
150202483|NCT03786926|541883254|FG000|Overall Study|Study terminated by Sponsor|0|||
150202484|NCT03786926|541883255|FG001|Overall Study|Study terminated by Sponsor|0|||
150202485|NCT03786926|541883256|FG002|Overall Study|Study terminated by Sponsor|0|||
150202486|NCT03786926|541883257|FG003|Overall Study|Study terminated by Sponsor|0|||
150202487|NCT03786926|541883258|FG004|Overall Study|Study terminated by Sponsor|1|||
149737501|NCT02601950|540170379|FG002|Overall Study|Participant refused further study treatment|1|||
150202488|NCT03786926|541883259|FG005|Overall Study|Study terminated by Sponsor|0|||
150202489|NCT03786926|541883260|FG006|Overall Study|Study terminated by Sponsor|0|||
150202490|NCT03786926|541883261|FG007|Overall Study|Study terminated by Sponsor|4|||
150202491|NCT03786926|541883262|FG008|Overall Study|Study terminated by Sponsor|0|||
150202492|NCT03786926|541883263|FG009|Overall Study|Study terminated by Sponsor|0|||
150202493|NCT03786926|541883264|FG010|Overall Study|Study terminated by Sponsor|0|||
150202494|NCT03786926|541883254|FG000|Overall Study|Anti-neoplasm treatment|0|||
150202495|NCT03786926|541883255|FG001|Overall Study|Anti-neoplasm treatment|0|||
150202496|NCT03786926|541883256|FG002|Overall Study|Anti-neoplasm treatment|0|||
150202497|NCT03786926|541883257|FG003|Overall Study|Anti-neoplasm treatment|0|||
150202498|NCT03786926|541883258|FG004|Overall Study|Anti-neoplasm treatment|1|||
150202499|NCT03786926|541883259|FG005|Overall Study|Anti-neoplasm treatment|0|||
150202500|NCT03786926|541883260|FG006|Overall Study|Anti-neoplasm treatment|1|||
150202501|NCT03786926|541883261|FG007|Overall Study|Anti-neoplasm treatment|0|||
150202502|NCT03786926|541883262|FG008|Overall Study|Anti-neoplasm treatment|0|||
150202503|NCT03786926|541883263|FG009|Overall Study|Anti-neoplasm treatment|0|||
150137376|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
150137377|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
150137378|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
150137379|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
150202504|NCT03786926|541883264|FG010|Overall Study|Anti-neoplasm treatment|0|||
150202505|NCT03786926|541883254|FG000|Overall Study|Other|0|||
150202506|NCT03786926|541883255|FG001|Overall Study|Other|0|||
150202507|NCT03786926|541883256|FG002|Overall Study|Other|0|||
150202508|NCT03786926|541883257|FG003|Overall Study|Other|1|||
150202509|NCT03786926|541883258|FG004|Overall Study|Other|0|||
150202510|NCT03786926|541883259|FG005|Overall Study|Other|1|||
150202511|NCT03786926|541883260|FG006|Overall Study|Other|0|||
150202512|NCT03786926|541883261|FG007|Overall Study|Other|0|||
150202513|NCT03786926|541883262|FG008|Overall Study|Other|2|||
150137380|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
150137381|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
150137382|NCT00293267|541637256|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
150137383|NCT00293267|541637257|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
150137384|NCT01804816|541637258|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
150137385|NCT01804816|541637258|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
150137386|NCT03086330|541637259|FG000|Overall Study|Withdrawal by Subject|3|||
150137387|NCT03086330|541637260|FG001|Overall Study|Withdrawal by Subject|2|||
150137388|NCT03086330|541637259|FG000|Overall Study|Lost to Follow-up|1|||
150137389|NCT03086330|541637260|FG001|Overall Study|Lost to Follow-up|2|||
150137390|NCT02182973|541637261|FG000|Overall Study|Withdrawal by Subject|3|||
150137391|NCT02182973|541637262|FG001|Overall Study|Withdrawal by Subject|0|||
150137392|NCT01235546|541637263|FG000|Overall Study|Staff error, medication not administered|1|||
150137393|NCT01235546|541637264|FG001|Overall Study|Staff error, medication not administered|0|||
150137394|NCT01235546|541637263|FG000|Overall Study|Protocol Violation|1|||
150137395|NCT01235546|541637264|FG001|Overall Study|Protocol Violation|1|||
150137396|NCT01123382|541637265|FG000|Overall Study|Withdrawal by Subject|1|||
150137397|NCT01123382|541637266|FG001|Overall Study|Withdrawal by Subject|4|||
150137398|NCT01123382|541637265|FG000|Overall Study|Lost to Follow-up|1|||
150137399|NCT01123382|541637266|FG001|Overall Study|Lost to Follow-up|2|||
150137400|NCT02740049|541637267|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
150137401|NCT01256411|541637268|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
150137402|NCT01256411|541637269|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
150137403|NCT01256411|541637270|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
150137404|NCT01256411|541637271|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
150202514|NCT03786926|541883263|FG009|Overall Study|Other|0|||
150202515|NCT03786926|541883264|FG010|Overall Study|Other|0|||
150202516|NCT05988398|541883267|FG000|Overall Study|Lack of time|21|||
150202517|NCT05988398|541883268|FG001|Overall Study|Lack of time|0|||
150202518|NCT05988398|541883267|FG000|Overall Study|Absent from school|0|||
150202519|NCT05988398|541883268|FG001|Overall Study|Absent from school|38|||
150202520|NCT05988398|541883267|FG000|Overall Study|Chose not to participate|0|||
150202521|NCT05988398|541883268|FG001|Overall Study|Chose not to participate|42|||
150202522|NCT05988398|541883267|FG000|Overall Study|Other commitments (e.g., sports)|0|||
150202523|NCT05988398|541883268|FG001|Overall Study|Other commitments (e.g., sports)|25|||
150202524|NCT00319046|541883270|FG000|Overall Study|withdrawal of subject's consent|7|||
150202525|NCT00319046|541883270|FG000|Overall Study|administrative reason|1|||
150202526|NCT04908930|541883275|FG000|Overall Study|Lost to Follow-up|1|||
150202527|NCT04908930|541883276|FG001|Overall Study|Lost to Follow-up|1|||
150202528|NCT04908930|541883277|FG002|Overall Study|Lost to Follow-up|0|||
150202529|NCT04908930|541883278|FG003|Overall Study|Lost to Follow-up|0|||
150202530|NCT04908930|541883279|FG004|Overall Study|Lost to Follow-up|0|||
150202531|NCT04908930|541883275|FG000|Overall Study|hardware in mouth|1|||
150202532|NCT04908930|541883276|FG001|Overall Study|hardware in mouth|1|||
150202533|NCT04908930|541883277|FG002|Overall Study|hardware in mouth|0|||
150202534|NCT04908930|541883278|FG003|Overall Study|hardware in mouth|0|||
150202535|NCT04908930|541883279|FG004|Overall Study|hardware in mouth|0|||
150202536|NCT04908930|541883275|FG000|Overall Study|wrong team|1|||
150202537|NCT04908930|541883276|FG001|Overall Study|wrong team|0|||
150202538|NCT04908930|541883277|FG002|Overall Study|wrong team|0|||
150202539|NCT04908930|541883278|FG003|Overall Study|wrong team|0|||
150202540|NCT04908930|541883279|FG004|Overall Study|wrong team|0|||
150202541|NCT04908930|541883275|FG000|Overall Study|quit team|2|||
150202542|NCT04908930|541883276|FG001|Overall Study|quit team|4|||
150202543|NCT04908930|541883277|FG002|Overall Study|quit team|0|||
150202544|NCT04908930|541883278|FG003|Overall Study|quit team|0|||
150202545|NCT04908930|541883279|FG004|Overall Study|quit team|0|||
150202546|NCT04908930|541883275|FG000|Overall Study|Withdrawal by Subject|1|||
150202547|NCT04908930|541883276|FG001|Overall Study|Withdrawal by Subject|2|||
150202548|NCT04908930|541883277|FG002|Overall Study|Withdrawal by Subject|0|||
150202549|NCT04908930|541883278|FG003|Overall Study|Withdrawal by Subject|0|||
150202550|NCT04908930|541883279|FG004|Overall Study|Withdrawal by Subject|0|||
150202551|NCT04908930|541883275|FG000|Overall Study|parent not liking program|0|||
150202552|NCT04908930|541883276|FG001|Overall Study|parent not liking program|1|||
150202553|NCT04908930|541883277|FG002|Overall Study|parent not liking program|0|||
150202554|NCT04908930|541883278|FG003|Overall Study|parent not liking program|0|||
150202555|NCT04908930|541883279|FG004|Overall Study|parent not liking program|0|||
150202556|NCT03547271|541883288|FG000|Overall Study|Adverse Event|1|||
150202557|NCT03547271|541883289|FG001|Overall Study|Adverse Event|1|||
150202558|NCT03547271|541883290|FG002|Overall Study|Adverse Event|0|||
150202559|NCT03547271|541883291|FG003|Overall Study|Adverse Event|0|||
150202560|NCT03547271|541883288|FG000|Overall Study|Protocol deviation|5|||
150202561|NCT03547271|541883289|FG001|Overall Study|Protocol deviation|7|||
150202562|NCT03547271|541883290|FG002|Overall Study|Protocol deviation|3|||
150202563|NCT03547271|541883291|FG003|Overall Study|Protocol deviation|0|||
150202564|NCT03547271|541883288|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
150202565|NCT03547271|541883289|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
150202566|NCT03547271|541883290|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
150202567|NCT03547271|541883291|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
150202568|NCT03547271|541883288|FG000|Overall Study|Lost to Follow-up|3|||
150202569|NCT03547271|541883289|FG001|Overall Study|Lost to Follow-up|3|||
150202570|NCT03547271|541883290|FG002|Overall Study|Lost to Follow-up|1|||
150202571|NCT03547271|541883291|FG003|Overall Study|Lost to Follow-up|0|||
150202572|NCT06065735|541883300|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
150202573|NCT06065735|541883301|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
150202574|NCT06065735|541883302|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
150202575|NCT06065735|541883300|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
150202576|NCT06065735|541883301|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
150202577|NCT06065735|541883302|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
150202578|NCT06065735|541883300|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
150202579|NCT06065735|541883301|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
150202580|NCT06065735|541883302|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
150202581|NCT06065735|541883300|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
150202582|NCT06065735|541883301|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
150202583|NCT06065735|541883302|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
150202584|NCT06065735|541883300|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
150202585|NCT06065735|541883301|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
150202586|NCT06065735|541883302|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
150202587|NCT02532621|541883303|FG000|Overall Study|Death|3|||
150202588|NCT02532621|541883303|FG000|Overall Study|Lost to Follow-up|3|||
150202589|NCT02532621|541883303|FG000|Overall Study|Withdrawal by Subject|6|||
150202590|NCT02532621|541883303|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
150202591|NCT02532621|541883303|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
150202592|NCT03522298|541883304|FG000|Overall Study|Adverse Event|1|||
150202593|NCT03522298|541883305|FG001|Overall Study|Adverse Event|0|||
150202594|NCT03522298|541883306|FG002|Overall Study|Adverse Event|0|||
150202595|NCT03522298|541883307|FG003|Overall Study|Adverse Event|1|||
150202596|NCT03522298|541883304|FG000|Overall Study|Death|2|||
150202597|NCT03522298|541883305|FG001|Overall Study|Death|4|||
150202598|NCT03522298|541883306|FG002|Overall Study|Death|8|||
150202599|NCT03522298|541883307|FG003|Overall Study|Death|8|||
150202600|NCT03522298|541883304|FG000|Overall Study|Patient decision|0|||
150202601|NCT03522298|541883305|FG001|Overall Study|Patient decision|2|||
150202602|NCT03522298|541883306|FG002|Overall Study|Patient decision|2|||
150202603|NCT03522298|541883307|FG003|Overall Study|Patient decision|2|||
150202604|NCT04795245|541883308|FG000|Overall Study|Unkown reason|7|||
150202605|NCT04795245|541883308|FG000|Overall Study|Death|17|||
150202606|NCT04795245|541883308|FG000|Overall Study|Other than listed|19|||
150202607|NCT04795245|541883308|FG000|Overall Study|Adverse Event|143|||
150202608|NCT04795245|541883308|FG000|Overall Study|Progressive disease|512|||
150202609|NCT04795245|541883308|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
150202610|NCT03904576|541883309|FG000|Washout Period|Protocol Violation|1|||
150202611|NCT03904576|541883310|FG001|Washout Period|Protocol Violation|1|||
150202612|NCT05718687|541883313|FG000|Overall Study|Withdrawal by Subject|3|||
150202613|NCT05215054|541883314|FG000|Overall Study|Lost to Follow-up|1|||
150202614|NCT05215054|541883315|FG001|Overall Study|Lost to Follow-up|1|||
150202615|NCT05215054|541883314|FG000|Overall Study|Protocol Violation|1|||
150202616|NCT05215054|541883315|FG001|Overall Study|Protocol Violation|1|||
150202617|NCT05215054|541883314|FG000|Overall Study|Withdrawal by Subject|4|||
150202618|NCT05215054|541883315|FG001|Overall Study|Withdrawal by Subject|4|||
150202619|NCT02933489|541883316|FG000|Overall Study|Ineligible|3|||
150202620|NCT02933489|541883317|FG001|Overall Study|Ineligible|3|||
150202621|NCT02933489|541883316|FG000|Overall Study|Withdrawal by Subject|27|||
150202622|NCT02933489|541883317|FG001|Overall Study|Withdrawal by Subject|18|||
150202623|NCT02933489|541883316|FG000|Overall Study|Unable to complete exams (other)|14|||
150202624|NCT02933489|541883317|FG001|Overall Study|Unable to complete exams (other)|7|||
150202625|NCT04626427|541883318|FG000|Overall Study|Death|1|||
150202626|NCT04626427|541883318|FG000|Overall Study|Withdrawal by Subject|1|||
150202627|NCT04626427|541883318|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
150202628|NCT04626427|541883318|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
150202629|NCT03990883|541883319|FG000|Blinded Treatment Phase|Adverse Event|1|||
150202630|NCT03990883|541883320|FG001|Blinded Treatment Phase|Adverse Event|1|||
150202631|NCT03990883|541883321|FG002|Blinded Treatment Phase|Adverse Event|0|||
150202632|NCT03990883|541883319|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
150202633|NCT03990883|541883320|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
150202634|NCT03990883|541883321|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
150202635|NCT03990883|541883319|FG000|Blinded Treatment Phase|Physician Decision|1|||
150202636|NCT03990883|541883320|FG001|Blinded Treatment Phase|Physician Decision|0|||
150202637|NCT03990883|541883321|FG002|Blinded Treatment Phase|Physician Decision|0|||
150202638|NCT03990883|541883319|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
150202639|NCT03990883|541883320|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
150202640|NCT03990883|541883321|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
150202641|NCT03990883|541883319|FG000|Blinded Treatment Phase|COVID-19|3|||
150202642|NCT03990883|541883320|FG001|Blinded Treatment Phase|COVID-19|2|||
150202643|NCT03990883|541883321|FG002|Blinded Treatment Phase|COVID-19|0|||
150202644|NCT03990883|541883319|FG000|Blinded Treatment Phase|Personal Reasons|6|||
150202645|NCT03990883|541883320|FG001|Blinded Treatment Phase|Personal Reasons|3|||
150202646|NCT03990883|541883321|FG002|Blinded Treatment Phase|Personal Reasons|0|||
150202647|NCT03990883|541883319|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
150202648|NCT03990883|541883320|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
150202649|NCT03990883|541883321|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
150202650|NCT03990883|541883319|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
150202651|NCT03990883|541883320|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
150202652|NCT03990883|541883321|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
150202653|NCT03990883|541883319|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
150202654|NCT03990883|541883320|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
150202655|NCT03990883|541883321|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
150202656|NCT04595331|541884367|FG000|Overall Study|Withdrawal by Subject|0|||
150202657|NCT04595331|541884368|FG001|Overall Study|Withdrawal by Subject|1|||
150202658|NCT04595331|541884367|FG000|Overall Study|Lost to Follow-up|0|||
150202659|NCT04595331|541884368|FG001|Overall Study|Lost to Follow-up|5|||
150202660|NCT04595331|541884367|FG000|Overall Study|Medical reason|0|||
150202661|NCT04595331|541884368|FG001|Overall Study|Medical reason|1|||
150202662|NCT05412004|541884372|FG000|Overall Study|Adverse Event|0|||
150202663|NCT05412004|541884373|FG001|Overall Study|Adverse Event|2|||
150202664|NCT05412004|541884374|FG002|Overall Study|Adverse Event|1|||
150202665|NCT05412004|541884375|FG003|Overall Study|Adverse Event|5|||
150202666|NCT05412004|541884372|FG000|Overall Study|Assigned Treatment by Mistake|5|||
150202667|NCT05412004|541884373|FG001|Overall Study|Assigned Treatment by Mistake|10|||
150202668|NCT05412004|541884374|FG002|Overall Study|Assigned Treatment by Mistake|2|||
150202669|NCT05412004|541884375|FG003|Overall Study|Assigned Treatment by Mistake|5|||
150202670|NCT05412004|541884372|FG000|Overall Study|Lost to Follow-up|3|||
150202671|NCT05412004|541884373|FG001|Overall Study|Lost to Follow-up|0|||
150202672|NCT05412004|541884374|FG002|Overall Study|Lost to Follow-up|0|||
150202673|NCT05412004|541884375|FG003|Overall Study|Lost to Follow-up|0|||
150202674|NCT05412004|541884372|FG000|Overall Study|Patient could not travel to site|0|||
150202675|NCT05412004|541884373|FG001|Overall Study|Patient could not travel to site|1|||
150202676|NCT05412004|541884374|FG002|Overall Study|Patient could not travel to site|0|||
150202677|NCT05412004|541884375|FG003|Overall Study|Patient could not travel to site|0|||
150202678|NCT05412004|541884372|FG000|Overall Study|Physician Decision|0|||
150202679|NCT05412004|541884373|FG001|Overall Study|Physician Decision|1|||
150202680|NCT05412004|541884374|FG002|Overall Study|Physician Decision|0|||
150202681|NCT05412004|541884375|FG003|Overall Study|Physician Decision|0|||
150202682|NCT05412004|541884372|FG000|Overall Study|Pregnancy|0|||
150202683|NCT05412004|541884373|FG001|Overall Study|Pregnancy|1|||
150202684|NCT05412004|541884374|FG002|Overall Study|Pregnancy|0|||
150202685|NCT05412004|541884375|FG003|Overall Study|Pregnancy|0|||
150202686|NCT05412004|541884372|FG000|Overall Study|Protocol Violation|1|||
150202687|NCT05412004|541884373|FG001|Overall Study|Protocol Violation|0|||
150202688|NCT05412004|541884374|FG002|Overall Study|Protocol Violation|0|||
150202689|NCT05412004|541884375|FG003|Overall Study|Protocol Violation|0|||
150202690|NCT05412004|541884372|FG000|Overall Study|Withdrawal by Subject|4|||
150202691|NCT05412004|541884373|FG001|Overall Study|Withdrawal by Subject|19|||
150202692|NCT05412004|541884374|FG002|Overall Study|Withdrawal by Subject|4|||
150202693|NCT05412004|541884375|FG003|Overall Study|Withdrawal by Subject|14|||
150202694|NCT05412004|541884372|FG000|Overall Study|Screen Failure|0|||
150202695|NCT05412004|541884373|FG001|Overall Study|Screen Failure|0|||
150202696|NCT05412004|541884374|FG002|Overall Study|Screen Failure|0|||
150202697|NCT05412004|541884375|FG003|Overall Study|Screen Failure|1|||
150202698|NCT05412004|541884372|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
150202699|NCT05412004|541884373|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
150202700|NCT05412004|541884374|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
150202701|NCT05412004|541884375|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
150202702|NCT04644029|541884376|FG000|Overall Study|Death|1|||
150202703|NCT04644029|541884377|FG001|Overall Study|Death|0|||
150202704|NCT04644029|541884376|FG000|Overall Study|Physician Decision|1|||
150202705|NCT04644029|541884377|FG001|Overall Study|Physician Decision|2|||
150202706|NCT04644029|541884376|FG000|Overall Study|Withdrawal by Subject|21|||
150202707|NCT04644029|541884377|FG001|Overall Study|Withdrawal by Subject|19|||
150202708|NCT04644029|541884376|FG000|Overall Study|Lost to Follow-up|31|||
150202709|NCT04644029|541884377|FG001|Overall Study|Lost to Follow-up|34|||
150202710|NCT04644029|541884376|FG000|Overall Study|Study Terminated by Sponsor|308|||
150202711|NCT04644029|541884377|FG001|Overall Study|Study Terminated by Sponsor|309|||
150202712|NCT04644029|541884376|FG000|Overall Study|Randomized in Error|2|||
150202713|NCT04644029|541884377|FG001|Overall Study|Randomized in Error|1|||
150202714|NCT04644029|541884376|FG000|Overall Study|Other|0|||
150202715|NCT04644029|541884377|FG001|Overall Study|Other|1|||
150202716|NCT05020353|541884378|FG000|Overall Study|Protocol Violation|7|||
150202717|NCT05020353|541884378|FG000|Overall Study|Withdrawal by Subject|33|||
150202718|NCT05132400|541884379|FG000|Overall Study|Withdrawal by Subject|14|||
150202719|NCT05132400|541884380|FG001|Overall Study|Withdrawal by Subject|8|||
150202720|NCT05132400|541884379|FG000|Overall Study|Lost to Follow-up|132|||
150202721|NCT05132400|541884380|FG001|Overall Study|Lost to Follow-up|121|||
150202722|NCT02611687|541884383|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
150202723|NCT02611687|541884384|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
150202724|NCT03934931|541884385|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
150202725|NCT03934931|541884386|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
150202726|NCT03934931|541884387|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
150202727|NCT00739908|541884393|FG000|Overall Study|Adverse Event|5|||
150202728|NCT00739908|541884394|FG001|Overall Study|Adverse Event|6|||
150202729|NCT00739908|541884393|FG000|Overall Study|Withdrawal by Subject|4|||
150202730|NCT00739908|541884394|FG001|Overall Study|Withdrawal by Subject|2|||
150202731|NCT00739908|541884393|FG000|Overall Study|Lost to Follow-up|14|||
150202732|NCT00739908|541884394|FG001|Overall Study|Lost to Follow-up|9|||
150202733|NCT00739908|541884393|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
150202734|NCT00739908|541884394|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
150202735|NCT00739908|541884393|FG000|Overall Study|Non-Compliance With Study Medication|0|||
150202736|NCT00739908|541884394|FG001|Overall Study|Non-Compliance With Study Medication|3|||
150202737|NCT00739908|541884393|FG000|Overall Study|Lack of Efficacy|0|||
150202738|NCT00739908|541884394|FG001|Overall Study|Lack of Efficacy|1|||
150202739|NCT00739908|541884393|FG000|Overall Study|Relocation|0|||
150202740|NCT00739908|541884394|FG001|Overall Study|Relocation|1|||
150202741|NCT05157841|541884395|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
150202742|NCT05157841|541884396|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
150202743|NCT05157841|541884397|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
150202744|NCT05157841|541884395|FG000|Part A (14 Days)|Adverse Event|1|||
150202745|NCT05157841|541884396|FG001|Part A (14 Days)|Adverse Event|0|||
150202746|NCT05157841|541884397|FG002|Part A (14 Days)|Adverse Event|0|||
150202747|NCT05157841|541884395|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
150202748|NCT05157841|541884396|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
150202749|NCT05157841|541884397|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
150202750|NCT02075554|541884400|FG000|Overall Study|Lost to Follow-up|7|||
150202751|NCT02075554|541884400|FG000|Overall Study|Withdrawal by Subject|5|||
150202752|NCT02075554|541884400|FG000|Overall Study|Physician Decision|3|||
150202753|NCT04933474|541884406|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
150202754|NCT04933474|541884407|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
150202755|NCT04933474|541884406|FG000|Overall Study|Lost to Follow-up|19|||
150202756|NCT04933474|541884407|FG001|Overall Study|Lost to Follow-up|9|||
150202757|NCT04933474|541884406|FG000|Overall Study|Life Burden - unable to participate|6|||
150202758|NCT04933474|541884407|FG001|Overall Study|Life Burden - unable to participate|2|||
150202759|NCT04933474|541884406|FG000|Overall Study|Disease Burden - unable to participate|4|||
150202760|NCT04933474|541884407|FG001|Overall Study|Disease Burden - unable to participate|1|||
150202761|NCT04933474|541884406|FG000|Overall Study|Surgery/Hospitalization|1|||
150202762|NCT04933474|541884407|FG001|Overall Study|Surgery/Hospitalization|2|||
150202763|NCT04933474|541884406|FG000|Overall Study|Dissatisfied with Intervention|1|||
150202764|NCT04933474|541884407|FG001|Overall Study|Dissatisfied with Intervention|1|||
150202765|NCT04933474|541884406|FG000|Overall Study|Withdrew interest in participation|1|||
150202766|NCT04933474|541884407|FG001|Overall Study|Withdrew interest in participation|0|||
150202767|NCT04933474|541884406|FG000|Overall Study|Had previously enrolled in the study|0|||
150202768|NCT04933474|541884407|FG001|Overall Study|Had previously enrolled in the study|1|||
150202769|NCT01773993|541884408|FG000|Overall Study|No Visit After Treatment|35|||
150202770|NCT04993677|541884409|FG000|Overall Study|Lost to Follow-up|1|||
150202771|NCT04993677|541884410|FG001|Overall Study|Lost to Follow-up|0|||
150202772|NCT04993677|541884411|FG002|Overall Study|Lost to Follow-up|0|||
150202773|NCT04993677|541884412|FG003|Overall Study|Lost to Follow-up|0|||
150202774|NCT04993677|541884409|FG000|Overall Study|Death|11|||
150202775|NCT04993677|541884410|FG001|Overall Study|Death|8|||
150202776|NCT04993677|541884411|FG002|Overall Study|Death|3|||
150202777|NCT04993677|541884412|FG003|Overall Study|Death|1|||
150202778|NCT04993677|541884409|FG000|Overall Study|Subject withdrawal of consent|4|||
150202779|NCT04993677|541884410|FG001|Overall Study|Subject withdrawal of consent|3|||
150202780|NCT04993677|541884411|FG002|Overall Study|Subject withdrawal of consent|0|||
150202781|NCT04993677|541884412|FG003|Overall Study|Subject withdrawal of consent|2|||
150202782|NCT04993677|541884409|FG000|Overall Study|Study termination by sponsor|3|||
150202783|NCT04993677|541884410|FG001|Overall Study|Study termination by sponsor|25|||
150202784|NCT04993677|541884411|FG002|Overall Study|Study termination by sponsor|3|||
150202785|NCT04993677|541884412|FG003|Overall Study|Study termination by sponsor|3|||
150202786|NCT04993677|541884409|FG000|Overall Study|Other|2|||
150202787|NCT04993677|541884410|FG001|Overall Study|Other|3|||
150202788|NCT04993677|541884411|FG002|Overall Study|Other|3|||
150202789|NCT04993677|541884412|FG003|Overall Study|Other|2|||
150202790|NCT05875701|541884417|FG000|Overall Study|Lost to Follow-up|2|||
150202791|NCT05875701|541884418|FG001|Overall Study|Lost to Follow-up|0|||
150202792|NCT05875701|541884417|FG000|Overall Study|Withdrawal by Subject|1|||
150202793|NCT05875701|541884418|FG001|Overall Study|Withdrawal by Subject|1|||
150202794|NCT04408755|541884422|FG000|Period A (Placebo lead-in)|Other|11|||
150202795|NCT04408755|541884423|FG001|Period A (Placebo lead-in)|Other|0|||
150202796|NCT04408755|541884424|FG002|Period A (Placebo lead-in)|Other|0|||
150202797|NCT04408755|541884425|FG003|Period A (Placebo lead-in)|Other|0|||
150202798|NCT04408755|541884422|FG000|Period B (Randomization Period)|Adverse Event|0|||
150202799|NCT04408755|541884423|FG001|Period B (Randomization Period)|Adverse Event|3|||
150202800|NCT04408755|541884424|FG002|Period B (Randomization Period)|Adverse Event|0|||
150202801|NCT04408755|541884425|FG003|Period B (Randomization Period)|Adverse Event|1|||
150202802|NCT04408755|541884422|FG000|Period B (Randomization Period)|Death|0|||
150202803|NCT04408755|541884423|FG001|Period B (Randomization Period)|Death|0|||
150202804|NCT04408755|541884424|FG002|Period B (Randomization Period)|Death|1|||
150202805|NCT04408755|541884425|FG003|Period B (Randomization Period)|Death|0|||
150202806|NCT04408755|541884422|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
150202807|NCT04408755|541884423|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
150202808|NCT04408755|541884424|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
150202809|NCT04408755|541884425|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
150202810|NCT04408755|541884422|FG000|Period B (Randomization Period)|Physician Decision|0|||
150202811|NCT04408755|541884423|FG001|Period B (Randomization Period)|Physician Decision|0|||
150202812|NCT04408755|541884424|FG002|Period B (Randomization Period)|Physician Decision|1|||
150202813|NCT04408755|541884425|FG003|Period B (Randomization Period)|Physician Decision|0|||
150202814|NCT04408755|541884422|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
150202815|NCT04408755|541884423|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
150202816|NCT04408755|541884424|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
150202817|NCT04408755|541884425|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
150202818|NCT04408755|541884422|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
150202819|NCT04408755|541884423|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
150202820|NCT04408755|541884424|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
150202821|NCT04408755|541884425|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
150202822|NCT04408755|541884422|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
150202823|NCT04408755|541884423|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
150202824|NCT04408755|541884424|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
150202825|NCT04408755|541884425|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
150202826|NCT04408755|541884422|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
150202827|NCT04408755|541884423|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
150202828|NCT04408755|541884424|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
150202829|NCT04408755|541884425|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
150202830|NCT04408755|541884422|FG000|Period B (Randomization Period)|Reason not Specified|0|||
150202831|NCT04408755|541884423|FG001|Period B (Randomization Period)|Reason not Specified|1|||
150202832|NCT04408755|541884424|FG002|Period B (Randomization Period)|Reason not Specified|0|||
150202833|NCT04408755|541884425|FG003|Period B (Randomization Period)|Reason not Specified|2|||
150202834|NCT06655818|541884426|FG000|Overall Study|Withdrawal by Subject|1|||
150202835|NCT04214418|541884435|FG000|Overall Study|Withdrawal by Subject|1|||
150202836|NCT04214418|541884436|FG001|Overall Study|Withdrawal by Subject|0|||
150202837|NCT04214418|541884437|FG002|Overall Study|Withdrawal by Subject|0|||
150202838|NCT04214418|541884438|FG003|Overall Study|Withdrawal by Subject|0|||
150202839|NCT04214418|541884439|FG004|Overall Study|Withdrawal by Subject|0|||
150202840|NCT04214418|541884440|FG005|Overall Study|Withdrawal by Subject|0|||
150202841|NCT04214418|541884435|FG000|Overall Study|Adverse Event|0|||
150202842|NCT04214418|541884436|FG001|Overall Study|Adverse Event|2|||
150202843|NCT04214418|541884437|FG002|Overall Study|Adverse Event|0|||
150202844|NCT04214418|541884438|FG003|Overall Study|Adverse Event|0|||
150202845|NCT04214418|541884439|FG004|Overall Study|Adverse Event|0|||
150202846|NCT04214418|541884440|FG005|Overall Study|Adverse Event|0|||
150202847|NCT04214418|541884435|FG000|Overall Study|Death|1|||
150202848|NCT04214418|541884436|FG001|Overall Study|Death|0|||
150202849|NCT04214418|541884437|FG002|Overall Study|Death|0|||
150202850|NCT04214418|541884438|FG003|Overall Study|Death|0|||
150202851|NCT04214418|541884439|FG004|Overall Study|Death|0|||
150202852|NCT04214418|541884440|FG005|Overall Study|Death|0|||
150202853|NCT05836012|541884443|FG000|Overall Study|Lost to Follow-up|1|||
150202854|NCT05836012|541884444|FG001|Overall Study|Lost to Follow-up|0|||
150202855|NCT05836012|541884443|FG000|Overall Study|Withdrawal by Subject|1|||
150202856|NCT05836012|541884444|FG001|Overall Study|Withdrawal by Subject|3|||
150202857|NCT05836012|541884443|FG000|Overall Study|Reason not included in pre-specified categories|2|||
150202858|NCT05836012|541884444|FG001|Overall Study|Reason not included in pre-specified categories|1|||
150202859|NCT02777593|541884449|FG000|Overall Study|Still in study|1|||
150202860|NCT02777593|541884450|FG001|Overall Study|Still in study|32|||
150202861|NCT02777593|541884451|FG002|Overall Study|Still in study|3|||
150202862|NCT02777593|541884452|FG003|Overall Study|Still in study|6|||
150202863|NCT02777593|541884453|FG004|Overall Study|Still in study|5|||
150202864|NCT02777593|541884449|FG000|Overall Study|Death|21|||
150202865|NCT02777593|541884450|FG001|Overall Study|Death|28|||
150202866|NCT02777593|541884451|FG002|Overall Study|Death|0|||
150202867|NCT02777593|541884452|FG003|Overall Study|Death|5|||
150202868|NCT02777593|541884453|FG004|Overall Study|Death|0|||
150202869|NCT02777593|541884449|FG000|Overall Study|Withdrawal by Subject|8|||
150202870|NCT02777593|541884450|FG001|Overall Study|Withdrawal by Subject|4|||
150202871|NCT02777593|541884451|FG002|Overall Study|Withdrawal by Subject|1|||
150202872|NCT02777593|541884452|FG003|Overall Study|Withdrawal by Subject|1|||
150202873|NCT02777593|541884453|FG004|Overall Study|Withdrawal by Subject|0|||
150202874|NCT02777593|541884449|FG000|Overall Study|Lost to Follow-up|8|||
150202875|NCT02777593|541884450|FG001|Overall Study|Lost to Follow-up|16|||
150202876|NCT02777593|541884451|FG002|Overall Study|Lost to Follow-up|5|||
150202877|NCT02777593|541884452|FG003|Overall Study|Lost to Follow-up|0|||
150202878|NCT02777593|541884453|FG004|Overall Study|Lost to Follow-up|1|||
150202879|NCT02777593|541884449|FG000|Overall Study|Physician Decision|2|||
150202880|NCT02777593|541884450|FG001|Overall Study|Physician Decision|2|||
150202881|NCT02777593|541884451|FG002|Overall Study|Physician Decision|0|||
150202882|NCT02777593|541884452|FG003|Overall Study|Physician Decision|0|||
150202883|NCT02777593|541884453|FG004|Overall Study|Physician Decision|0|||
150202884|NCT02777593|541884449|FG000|Overall Study|Discontinued due to Other|1|||
150202885|NCT02777593|541884450|FG001|Overall Study|Discontinued due to Other|0|||
150202886|NCT02777593|541884451|FG002|Overall Study|Discontinued due to Other|0|||
150202887|NCT02777593|541884452|FG003|Overall Study|Discontinued due to Other|0|||
150202888|NCT02777593|541884453|FG004|Overall Study|Discontinued due to Other|0|||
150202889|NCT05485935|541884454|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
150202890|NCT05485935|541884455|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
150202891|NCT05485935|541884454|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
150202892|NCT05485935|541884455|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
150202893|NCT05485935|541884454|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
150202894|NCT05485935|541884455|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
150202895|NCT05485935|541884454|FG000|Period 2 (T2 and V3)|loss of contact|0|||
150202896|NCT05485935|541884455|FG001|Period 2 (T2 and V3)|loss of contact|1|||
150202897|NCT02806726|541884456|FG000|Overall Study|Lost to Follow-up|1|||
150202898|NCT05129501|541884457|FG000|Overall Study|Lost to Follow-up|54|||
150202899|NCT05129501|541884458|FG001|Overall Study|Lost to Follow-up|41|||
150202900|NCT03982186|541884459|FG000|Overall Study|Lost to Follow-up|0|||
150202901|NCT03982186|541884460|FG001|Overall Study|Lost to Follow-up|1|||
150202902|NCT03982186|541884461|FG002|Overall Study|Lost to Follow-up|2|||
150202903|NCT03982186|541884462|FG003|Overall Study|Lost to Follow-up|1|||
150202904|NCT03982186|541884463|FG004|Overall Study|Lost to Follow-up|1|||
150202905|NCT03982186|541884464|FG005|Overall Study|Lost to Follow-up|0|||
150202906|NCT03982186|541884459|FG000|Overall Study|Physician Decision|0|||
150202907|NCT03982186|541884460|FG001|Overall Study|Physician Decision|1|||
150202908|NCT03982186|541884461|FG002|Overall Study|Physician Decision|0|||
150202909|NCT03982186|541884462|FG003|Overall Study|Physician Decision|0|||
150202910|NCT03982186|541884463|FG004|Overall Study|Physician Decision|0|||
150202911|NCT03982186|541884464|FG005|Overall Study|Physician Decision|0|||
150202912|NCT03982186|541884459|FG000|Overall Study|Withdrawal by Subject|3|||
150202913|NCT03982186|541884460|FG001|Overall Study|Withdrawal by Subject|4|||
150202914|NCT03982186|541884461|FG002|Overall Study|Withdrawal by Subject|1|||
150202915|NCT03982186|541884462|FG003|Overall Study|Withdrawal by Subject|7|||
150202916|NCT03982186|541884463|FG004|Overall Study|Withdrawal by Subject|2|||
150202917|NCT03982186|541884464|FG005|Overall Study|Withdrawal by Subject|0|||
150202918|NCT03982186|541884459|FG000|Overall Study|Randomized and not treated|0|||
150202919|NCT03982186|541884460|FG001|Overall Study|Randomized and not treated|0|||
150202920|NCT03982186|541884461|FG002|Overall Study|Randomized and not treated|0|||
150202921|NCT03982186|541884462|FG003|Overall Study|Randomized and not treated|1|||
150202922|NCT03982186|541884463|FG004|Overall Study|Randomized and not treated|0|||
150202923|NCT03982186|541884464|FG005|Overall Study|Randomized and not treated|0|||
150202924|NCT02325154|541884465|FG000|Overall Study|Physician Decision|1|||
150202925|NCT01265537|541884466|FG000|Overall Study|Adverse Event|2|||
150202926|NCT01265537|541884467|FG001|Overall Study|Adverse Event|1|||
150202927|NCT01265537|541884466|FG000|Overall Study|Physician Decision|0|||
150202928|NCT01265537|541884467|FG001|Overall Study|Physician Decision|1|||
150202929|NCT03512301|541885292|FG000|Overall Study|Protocol Violation|2|||
150202930|NCT03512301|541885292|FG000|Overall Study|Did Not Qualify|3|||
150202931|NCT03512301|541885292|FG000|Overall Study|Age-ineligible|1|||
150202932|NCT03512301|541885292|FG000|Overall Study|Inadequate fluency with the English language|3|||
150202933|NCT02720068|541885294|FG000|Overall Study|Adverse Event|0|||
150202934|NCT02720068|541885295|FG001|Overall Study|Adverse Event|0|||
150202935|NCT02720068|541885296|FG002|Overall Study|Adverse Event|0|||
150202936|NCT02720068|541885297|FG003|Overall Study|Adverse Event|0|||
150202937|NCT02720068|541885298|FG004|Overall Study|Adverse Event|0|||
150202938|NCT02720068|541885299|FG005|Overall Study|Adverse Event|0|||
150202939|NCT02720068|541885300|FG006|Overall Study|Adverse Event|0|||
150202940|NCT02720068|541885301|FG007|Overall Study|Adverse Event|0|||
150202941|NCT02720068|541885302|FG008|Overall Study|Adverse Event|0|||
150202942|NCT02720068|541885303|FG009|Overall Study|Adverse Event|0|||
150202943|NCT02720068|541885304|FG010|Overall Study|Adverse Event|0|||
150202944|NCT02720068|541885305|FG011|Overall Study|Adverse Event|1|||
150202945|NCT02720068|541885306|FG012|Overall Study|Adverse Event|0|||
150202946|NCT02720068|541885307|FG013|Overall Study|Adverse Event|0|||
150202947|NCT02720068|541885308|FG014|Overall Study|Adverse Event|0|||
150202948|NCT02720068|541885309|FG015|Overall Study|Adverse Event|0|||
150202949|NCT02720068|541885310|FG016|Overall Study|Adverse Event|0|||
150202950|NCT02720068|541885311|FG017|Overall Study|Adverse Event|0|||
150202951|NCT02720068|541885294|FG000|Overall Study|Death|1|||
150202952|NCT02720068|541885295|FG001|Overall Study|Death|3|||
150202953|NCT02720068|541885296|FG002|Overall Study|Death|2|||
150202954|NCT02720068|541885297|FG003|Overall Study|Death|1|||
150202955|NCT02720068|541885298|FG004|Overall Study|Death|2|||
150202956|NCT02720068|541885299|FG005|Overall Study|Death|1|||
150202957|NCT02720068|541885300|FG006|Overall Study|Death|2|||
150202958|NCT02720068|541885301|FG007|Overall Study|Death|2|||
150202959|NCT02720068|541885302|FG008|Overall Study|Death|3|||
150202960|NCT02720068|541885303|FG009|Overall Study|Death|1|||
150202961|NCT02720068|541885304|FG010|Overall Study|Death|20|||
150202962|NCT02720068|541885305|FG011|Overall Study|Death|166|||
150202963|NCT02720068|541885306|FG012|Overall Study|Death|34|||
150202964|NCT02720068|541885307|FG013|Overall Study|Death|30|||
150202965|NCT02720068|541885308|FG014|Overall Study|Death|45|||
150202966|NCT02720068|541885309|FG015|Overall Study|Death|16|||
150202967|NCT02720068|541885310|FG016|Overall Study|Death|20|||
150202968|NCT02720068|541885311|FG017|Overall Study|Death|28|||
150202969|NCT02720068|541885294|FG000|Overall Study|Lost to Follow-up|0|||
150202970|NCT02720068|541885295|FG001|Overall Study|Lost to Follow-up|0|||
150202971|NCT02720068|541885296|FG002|Overall Study|Lost to Follow-up|0|||
150202972|NCT02720068|541885297|FG003|Overall Study|Lost to Follow-up|0|||
150202973|NCT02720068|541885298|FG004|Overall Study|Lost to Follow-up|0|||
150202974|NCT02720068|541885299|FG005|Overall Study|Lost to Follow-up|0|||
150202975|NCT02720068|541885300|FG006|Overall Study|Lost to Follow-up|0|||
150202976|NCT02720068|541885301|FG007|Overall Study|Lost to Follow-up|0|||
150202977|NCT02720068|541885302|FG008|Overall Study|Lost to Follow-up|0|||
150202978|NCT02720068|541885303|FG009|Overall Study|Lost to Follow-up|0|||
150202979|NCT02720068|541885304|FG010|Overall Study|Lost to Follow-up|0|||
150202980|NCT02720068|541885305|FG011|Overall Study|Lost to Follow-up|1|||
150202981|NCT02720068|541885306|FG012|Overall Study|Lost to Follow-up|0|||
150202982|NCT02720068|541885307|FG013|Overall Study|Lost to Follow-up|1|||
150202983|NCT02720068|541885308|FG014|Overall Study|Lost to Follow-up|2|||
150202984|NCT02720068|541885309|FG015|Overall Study|Lost to Follow-up|0|||
150202985|NCT02720068|541885310|FG016|Overall Study|Lost to Follow-up|0|||
150202986|NCT02720068|541885311|FG017|Overall Study|Lost to Follow-up|1|||
150202987|NCT02720068|541885294|FG000|Overall Study|Physician Decision|0|||
150202988|NCT02720068|541885295|FG001|Overall Study|Physician Decision|0|||
150202989|NCT02720068|541885296|FG002|Overall Study|Physician Decision|0|||
150202990|NCT02720068|541885297|FG003|Overall Study|Physician Decision|1|||
150202991|NCT02720068|541885298|FG004|Overall Study|Physician Decision|0|||
150202992|NCT02720068|541885299|FG005|Overall Study|Physician Decision|0|||
150202993|NCT02720068|541885300|FG006|Overall Study|Physician Decision|0|||
150202994|NCT02720068|541885301|FG007|Overall Study|Physician Decision|0|||
150202995|NCT02720068|541885302|FG008|Overall Study|Physician Decision|0|||
150202996|NCT02720068|541885303|FG009|Overall Study|Physician Decision|0|||
150202997|NCT02720068|541885304|FG010|Overall Study|Physician Decision|0|||
150202998|NCT02720068|541885305|FG011|Overall Study|Physician Decision|1|||
150202999|NCT02720068|541885306|FG012|Overall Study|Physician Decision|0|||
150203000|NCT02720068|541885307|FG013|Overall Study|Physician Decision|0|||
150203001|NCT02720068|541885308|FG014|Overall Study|Physician Decision|0|||
150203002|NCT02720068|541885309|FG015|Overall Study|Physician Decision|0|||
150203003|NCT02720068|541885310|FG016|Overall Study|Physician Decision|0|||
150203004|NCT02720068|541885311|FG017|Overall Study|Physician Decision|1|||
150203005|NCT02720068|541885294|FG000|Overall Study|Progressive Disease|2|||
150203006|NCT02720068|541885295|FG001|Overall Study|Progressive Disease|3|||
150203007|NCT02720068|541885296|FG002|Overall Study|Progressive Disease|1|||
150203008|NCT02720068|541885297|FG003|Overall Study|Progressive Disease|1|||
150203009|NCT02720068|541885298|FG004|Overall Study|Progressive Disease|1|||
150203010|NCT02720068|541885299|FG005|Overall Study|Progressive Disease|2|||
150203011|NCT02720068|541885300|FG006|Overall Study|Progressive Disease|1|||
150203012|NCT02720068|541885301|FG007|Overall Study|Progressive Disease|1|||
150203013|NCT02720068|541885302|FG008|Overall Study|Progressive Disease|0|||
150203014|NCT02720068|541885303|FG009|Overall Study|Progressive Disease|1|||
150203015|NCT02720068|541885304|FG010|Overall Study|Progressive Disease|0|||
150203016|NCT02720068|541885305|FG011|Overall Study|Progressive Disease|4|||
150203017|NCT02720068|541885306|FG012|Overall Study|Progressive Disease|1|||
150203018|NCT02720068|541885307|FG013|Overall Study|Progressive Disease|0|||
150203019|NCT02720068|541885308|FG014|Overall Study|Progressive Disease|0|||
150203020|NCT02720068|541885309|FG015|Overall Study|Progressive Disease|0|||
150203021|NCT02720068|541885310|FG016|Overall Study|Progressive Disease|0|||
150203022|NCT02720068|541885311|FG017|Overall Study|Progressive Disease|0|||
150203023|NCT02720068|541885294|FG000|Overall Study|Sponsor Decision|0|||
150203024|NCT02720068|541885295|FG001|Overall Study|Sponsor Decision|0|||
150203025|NCT02720068|541885296|FG002|Overall Study|Sponsor Decision|0|||
150203026|NCT02720068|541885297|FG003|Overall Study|Sponsor Decision|0|||
150203027|NCT02720068|541885298|FG004|Overall Study|Sponsor Decision|0|||
150203028|NCT02720068|541885299|FG005|Overall Study|Sponsor Decision|0|||
150203029|NCT02720068|541885300|FG006|Overall Study|Sponsor Decision|0|||
150203030|NCT02720068|541885301|FG007|Overall Study|Sponsor Decision|0|||
150203031|NCT02720068|541885302|FG008|Overall Study|Sponsor Decision|0|||
150203032|NCT02720068|541885303|FG009|Overall Study|Sponsor Decision|0|||
150203033|NCT02720068|541885304|FG010|Overall Study|Sponsor Decision|0|||
150203034|NCT02720068|541885305|FG011|Overall Study|Sponsor Decision|6|||
150203035|NCT02720068|541885306|FG012|Overall Study|Sponsor Decision|3|||
150203036|NCT02720068|541885307|FG013|Overall Study|Sponsor Decision|2|||
150203037|NCT02720068|541885308|FG014|Overall Study|Sponsor Decision|4|||
150203038|NCT02720068|541885309|FG015|Overall Study|Sponsor Decision|4|||
150203039|NCT02720068|541885310|FG016|Overall Study|Sponsor Decision|0|||
150203040|NCT02720068|541885311|FG017|Overall Study|Sponsor Decision|8|||
150203041|NCT02720068|541885294|FG000|Overall Study|Withdrawal by Subject|0|||
150203042|NCT02720068|541885295|FG001|Overall Study|Withdrawal by Subject|0|||
150203043|NCT02720068|541885296|FG002|Overall Study|Withdrawal by Subject|0|||
150203044|NCT02720068|541885297|FG003|Overall Study|Withdrawal by Subject|0|||
150203045|NCT02720068|541885298|FG004|Overall Study|Withdrawal by Subject|0|||
150203046|NCT02720068|541885299|FG005|Overall Study|Withdrawal by Subject|0|||
150203047|NCT02720068|541885300|FG006|Overall Study|Withdrawal by Subject|0|||
150203048|NCT02720068|541885301|FG007|Overall Study|Withdrawal by Subject|0|||
150203049|NCT02720068|541885302|FG008|Overall Study|Withdrawal by Subject|0|||
150203050|NCT02720068|541885303|FG009|Overall Study|Withdrawal by Subject|1|||
150203051|NCT02720068|541885304|FG010|Overall Study|Withdrawal by Subject|0|||
150203052|NCT02720068|541885305|FG011|Overall Study|Withdrawal by Subject|27|||
150203053|NCT02720068|541885306|FG012|Overall Study|Withdrawal by Subject|2|||
150203054|NCT02720068|541885307|FG013|Overall Study|Withdrawal by Subject|8|||
150203055|NCT02720068|541885308|FG014|Overall Study|Withdrawal by Subject|7|||
150203056|NCT02720068|541885309|FG015|Overall Study|Withdrawal by Subject|0|||
150203057|NCT02720068|541885310|FG016|Overall Study|Withdrawal by Subject|0|||
150203058|NCT02720068|541885311|FG017|Overall Study|Withdrawal by Subject|2|||
150203059|NCT02720068|541885294|FG000|Overall Study|Protocol Violation|0|||
150203060|NCT02720068|541885295|FG001|Overall Study|Protocol Violation|0|||
150203061|NCT02720068|541885296|FG002|Overall Study|Protocol Violation|0|||
150203062|NCT02720068|541885297|FG003|Overall Study|Protocol Violation|0|||
150203063|NCT02720068|541885298|FG004|Overall Study|Protocol Violation|0|||
150203064|NCT02720068|541885299|FG005|Overall Study|Protocol Violation|0|||
150203065|NCT02720068|541885300|FG006|Overall Study|Protocol Violation|0|||
150203066|NCT02720068|541885301|FG007|Overall Study|Protocol Violation|0|||
150203067|NCT02720068|541885302|FG008|Overall Study|Protocol Violation|0|||
150203068|NCT02720068|541885303|FG009|Overall Study|Protocol Violation|0|||
150203069|NCT02720068|541885304|FG010|Overall Study|Protocol Violation|1|||
150203070|NCT02720068|541885305|FG011|Overall Study|Protocol Violation|0|||
150203071|NCT02720068|541885306|FG012|Overall Study|Protocol Violation|0|||
150203072|NCT02720068|541885307|FG013|Overall Study|Protocol Violation|0|||
150203073|NCT02720068|541885308|FG014|Overall Study|Protocol Violation|1|||
150203074|NCT02720068|541885309|FG015|Overall Study|Protocol Violation|0|||
150203075|NCT02720068|541885310|FG016|Overall Study|Protocol Violation|1|||
150203076|NCT02720068|541885311|FG017|Overall Study|Protocol Violation|0|||
150203077|NCT04174170|541885315|FG000|Placebo Run-in Period|Not Randomized|38|||
150203078|NCT04174170|541885316|FG001|Placebo Run-in Period|Not Randomized|0|||
150203079|NCT04174170|541885317|FG002|Placebo Run-in Period|Not Randomized|0|||
150203080|NCT04174170|541885318|FG003|Placebo Run-in Period|Not Randomized|0|||
150203081|NCT04174170|541885315|FG000|Double Blind Treatment Period|Adverse Event|0|||
150203082|NCT04174170|541885316|FG001|Double Blind Treatment Period|Adverse Event|9|||
150203083|NCT04174170|541885317|FG002|Double Blind Treatment Period|Adverse Event|9|||
150203084|NCT04174170|541885318|FG003|Double Blind Treatment Period|Adverse Event|8|||
150203085|NCT04174170|541885315|FG000|Double Blind Treatment Period|Death|0|||
150203086|NCT04174170|541885316|FG001|Double Blind Treatment Period|Death|1|||
150203087|NCT04174170|541885317|FG002|Double Blind Treatment Period|Death|0|||
150203088|NCT04174170|541885318|FG003|Double Blind Treatment Period|Death|0|||
150203089|NCT04174170|541885315|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
150203090|NCT04174170|541885316|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
150203091|NCT04174170|541885317|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
150203092|NCT04174170|541885318|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
150203093|NCT04174170|541885315|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
150203094|NCT04174170|541885316|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
150203095|NCT04174170|541885317|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
150203096|NCT04174170|541885318|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
150203097|NCT04174170|541885315|FG000|Double Blind Treatment Period|Physician Decision|0|||
150203098|NCT04174170|541885316|FG001|Double Blind Treatment Period|Physician Decision|1|||
150203099|NCT04174170|541885317|FG002|Double Blind Treatment Period|Physician Decision|0|||
150203100|NCT04174170|541885318|FG003|Double Blind Treatment Period|Physician Decision|1|||
150203101|NCT04174170|541885315|FG000|Double Blind Treatment Period|Pregnancy|0|||
150203102|NCT04174170|541885316|FG001|Double Blind Treatment Period|Pregnancy|1|||
150203103|NCT04174170|541885317|FG002|Double Blind Treatment Period|Pregnancy|0|||
150203104|NCT04174170|541885318|FG003|Double Blind Treatment Period|Pregnancy|1|||
150203105|NCT04174170|541885315|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
150203106|NCT04174170|541885316|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
150203107|NCT04174170|541885317|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
150203108|NCT04174170|541885318|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
150203109|NCT04174170|541885315|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
150203110|NCT04174170|541885316|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
150203111|NCT04174170|541885317|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
150203112|NCT04174170|541885318|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
150203113|NCT04174170|541885315|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
150203114|NCT04174170|541885316|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
150203115|NCT04174170|541885317|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
150203116|NCT04174170|541885318|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
150203117|NCT04664881|541885319|FG000|Overall Study|Withdrawal by Subject|1|||
150203118|NCT04664881|541885320|FG001|Overall Study|Withdrawal by Subject|8|||
150203119|NCT04664881|541885319|FG000|Overall Study|Physician Decision|0|||
150203120|NCT04664881|541885320|FG001|Overall Study|Physician Decision|5|||
150203121|NCT04664881|541885319|FG000|Overall Study|Lost to Follow-up|1|||
150203122|NCT04664881|541885320|FG001|Overall Study|Lost to Follow-up|0|||
150203123|NCT04772534|541885324|FG000|Overall Study|Physician Decision|1|||
150203124|NCT04772534|541885325|FG001|Overall Study|Physician Decision|0|||
150203125|NCT04772534|541885326|FG002|Overall Study|Physician Decision|0|||
150203126|NCT04772534|541885324|FG000|Overall Study|Withdrawal by Subject|3|||
150203127|NCT04772534|541885325|FG001|Overall Study|Withdrawal by Subject|0|||
150203128|NCT04772534|541885326|FG002|Overall Study|Withdrawal by Subject|1|||
150203129|NCT04194450|541885327|FG000|Overall Study|not eligible|1|||
150203130|NCT04194450|541885328|FG001|Overall Study|not eligible|0|||
150203131|NCT00308997|541885331|FG000|Overall Study|Subject feigned clinical data|0|||
150203132|NCT00308997|541885332|FG001|Overall Study|Subject feigned clinical data|1|||
150203133|NCT00308997|541885331|FG000|Overall Study|Unable to tolerate intervention|1|||
150203134|NCT00308997|541885332|FG001|Overall Study|Unable to tolerate intervention|0|||
150203135|NCT04490356|541885333|FG000|Overall Study|Lost to Follow-up|1|||
150203136|NCT00412607|541885334|FG000|Overall Study|Withdrawal by Subject|9|||
150203137|NCT00412607|541885334|FG000|Overall Study|Lost to Follow-up|19|||
150203138|NCT00412607|541885334|FG000|Overall Study|Death|61|||
150203139|NCT00412607|541885334|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
150203140|NCT03816397|541885335|FG000|Overall Study|Censored at interim analysis date.|13|||
150203141|NCT03816397|541885336|FG001|Overall Study|Censored at interim analysis date.|6|||
150203142|NCT03816397|541885335|FG000|Overall Study|Withdrawal by Subject|1|||
150203143|NCT03816397|541885336|FG001|Overall Study|Withdrawal by Subject|1|||
150203144|NCT04675034|541885349|FG000|Overall Study|Lost to Follow-up|1|||
150203145|NCT04675034|541885350|FG001|Overall Study|Lost to Follow-up|1|||
150203146|NCT04675034|541885351|FG002|Overall Study|Lost to Follow-up|0|||
150203147|NCT04675034|541885352|FG003|Overall Study|Lost to Follow-up|2|||
150203148|NCT04675034|541885353|FG004|Overall Study|Lost to Follow-up|0|||
150203149|NCT04675034|541885349|FG000|Overall Study|Protocol Violation|1|||
150203150|NCT04675034|541885350|FG001|Overall Study|Protocol Violation|0|||
150203151|NCT04675034|541885351|FG002|Overall Study|Protocol Violation|0|||
150203152|NCT04675034|541885352|FG003|Overall Study|Protocol Violation|1|||
150203153|NCT04675034|541885353|FG004|Overall Study|Protocol Violation|3|||
150203154|NCT04675034|541885349|FG000|Overall Study|Withdrawal by Subject|9|||
150203155|NCT04675034|541885350|FG001|Overall Study|Withdrawal by Subject|3|||
150203156|NCT04675034|541885351|FG002|Overall Study|Withdrawal by Subject|4|||
150203157|NCT04675034|541885352|FG003|Overall Study|Withdrawal by Subject|8|||
150203158|NCT04675034|541885353|FG004|Overall Study|Withdrawal by Subject|6|||
150203159|NCT03884439|541885357|FG000|Overall Study|No informed consent for publication of study results|38|||
150203160|NCT03884439|541885357|FG000|Overall Study|Contract violation/deficiency|7|||
150203161|NCT03092674|541885363|FG000|Overall Study|Adverse Event or Side Effects|1|||
150203162|NCT03092674|541885364|FG001|Overall Study|Adverse Event or Side Effects|4|||
150203163|NCT03092674|541885365|FG002|Overall Study|Adverse Event or Side Effects|4|||
150203164|NCT03092674|541885363|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
150203165|NCT03092674|541885364|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
150203166|NCT03092674|541885365|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
150203167|NCT03092674|541885363|FG000|Overall Study|Progression/Relapse|5|||
150203168|NCT03092674|541885364|FG001|Overall Study|Progression/Relapse|4|||
150203169|NCT03092674|541885365|FG002|Overall Study|Progression/Relapse|8|||
150203170|NCT03092674|541885363|FG000|Overall Study|Death|4|||
150203171|NCT03092674|541885364|FG001|Overall Study|Death|8|||
150203172|NCT03092674|541885365|FG002|Overall Study|Death|2|||
150203173|NCT03092674|541885363|FG000|Overall Study|Other - Not Protocol Specified|11|||
150203174|NCT03092674|541885364|FG001|Overall Study|Other - Not Protocol Specified|8|||
150203175|NCT03092674|541885365|FG002|Overall Study|Other - Not Protocol Specified|8|||
150203176|NCT03587805|541885366|FG000|Overall Study|Adverse Event|72|||
150203177|NCT03587805|541885366|FG000|Overall Study|Death|1|||
150203178|NCT03587805|541885366|FG000|Overall Study|Lost to Follow-up|78|||
150203179|NCT03587805|541885366|FG000|Overall Study|Withdrawal by Subject|105|||
150203180|NCT03587805|541885366|FG000|Overall Study|Lack of Efficacy|119|||
150203181|NCT03587805|541885366|FG000|Overall Study|Reason unknown|26|||
150203182|NCT03587805|541885366|FG000|Overall Study|COVID_19 pandemic|4|||
150203183|NCT03587805|541885366|FG000|Overall Study|Various reasons|121|||
150203184|NCT03587805|541885366|FG000|Overall Study|Withdrawal by parent/guardian|3|||
150203185|NCT01527188|541885367|FG000|Overall Study|Adverse Event|5|||
150203186|NCT01527188|541885368|FG001|Overall Study|Adverse Event|5|||
150203187|NCT01527188|541885369|FG002|Overall Study|Adverse Event|11|||
150203188|NCT01527188|541885370|FG003|Overall Study|Adverse Event|0|||
150203189|NCT01527188|541885367|FG000|Overall Study|Withdrawal by Subject|3|||
150203190|NCT01527188|541885368|FG001|Overall Study|Withdrawal by Subject|6|||
150203191|NCT01527188|541885369|FG002|Overall Study|Withdrawal by Subject|4|||
150203192|NCT01527188|541885370|FG003|Overall Study|Withdrawal by Subject|4|||
150203193|NCT01527188|541885367|FG000|Overall Study|Any other reason not above-mentioned|6|||
150203194|NCT01527188|541885368|FG001|Overall Study|Any other reason not above-mentioned|7|||
150203195|NCT01527188|541885369|FG002|Overall Study|Any other reason not above-mentioned|8|||
150203196|NCT01527188|541885370|FG003|Overall Study|Any other reason not above-mentioned|8|||
150203197|NCT04518943|541886086|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
150203198|NCT04518943|541886087|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
150203199|NCT04518943|541886088|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
150203200|NCT04518943|541886089|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
150203201|NCT04518943|541886090|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
150203202|NCT04518943|541886091|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
150203203|NCT04518943|541886092|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
150203204|NCT04518943|541886093|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
150203205|NCT04518943|541886094|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
150203206|NCT04518943|541886095|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
150203207|NCT04518943|541886096|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
150203208|NCT04518943|541886097|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
150203209|NCT04518943|541886098|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
150203210|NCT04518943|541886099|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
150203211|NCT04518943|541886100|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
150203212|NCT04518943|541886101|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
150203213|NCT03705793|541886105|FG000|Overall Study|Lost to Follow-up|3|||
150203214|NCT03705793|541886106|FG001|Overall Study|Lost to Follow-up|4|||
150203215|NCT03705793|541886105|FG000|Overall Study|Withdrawal by Subject|2|||
150203216|NCT03705793|541886106|FG001|Overall Study|Withdrawal by Subject|1|||
150203217|NCT04757753|541886112|FG000|Overall Study|Lost to Follow-up|7|||
150203218|NCT04757753|541886113|FG001|Overall Study|Lost to Follow-up|7|||
150203219|NCT04757753|541886112|FG000|Overall Study|Withdrawal by Subject|0|||
150203220|NCT04757753|541886113|FG001|Overall Study|Withdrawal by Subject|3|||
150203221|NCT04757753|541886112|FG000|Overall Study|Endodontic treatment failure|1|||
150203222|NCT04757753|541886113|FG001|Overall Study|Endodontic treatment failure|2|||
150203223|NCT04757753|541886112|FG000|Overall Study|Tooth fracture/extraction|3|||
150203224|NCT04757753|541886113|FG001|Overall Study|Tooth fracture/extraction|0|||
150203225|NCT03733626|541886132|FG000|Overall Study|Physician Decision|4|||
150203226|NCT03733626|541886133|FG001|Overall Study|Physician Decision|4|||
150203227|NCT04093869|541886137|FG000|Overall Study|Death|0|||
150203228|NCT04093869|541886138|FG001|Overall Study|Death|1|||
150203229|NCT04093869|541886137|FG000|Overall Study|Withdrawal by Subject|1|||
150203230|NCT04093869|541886138|FG001|Overall Study|Withdrawal by Subject|0|||
150203231|NCT04281498|541886141|FG000|Overall Study|Progression of disease|1|||
150203232|NCT04281498|541886141|FG000|Overall Study|Planned SCT|1|||
150203233|NCT04281498|541886141|FG000|Overall Study|Alternative Treatment|1|||
150203234|NCT01220531|541886142|FG000|Overall Study|Death|7|||
150203235|NCT01220531|541886142|FG000|Overall Study|Lost to Follow-up|1|||
150203236|NCT01553149|541886143|FG000|Overall Study|Adverse Event|0|||
150203237|NCT01553149|541886144|FG001|Overall Study|Adverse Event|9|||
150203238|NCT01553149|541886143|FG000|Overall Study|Physician Decision|5|||
150203239|NCT01553149|541886144|FG001|Overall Study|Physician Decision|10|||
150203240|NCT01553149|541886143|FG000|Overall Study|Ineligible|0|||
150203241|NCT01553149|541886144|FG001|Overall Study|Ineligible|1|||
150203242|NCT05866926|541886146|FG000|Overall Study|Death|16|||
150203243|NCT05866926|541886147|FG001|Overall Study|Death|9|||
150203244|NCT05866926|541886146|FG000|Overall Study|Lost to Follow-up|0|||
150203245|NCT05866926|541886147|FG001|Overall Study|Lost to Follow-up|1|||
150203246|NCT05866926|541886146|FG000|Overall Study|Adverse Event|1|||
150203247|NCT05866926|541886147|FG001|Overall Study|Adverse Event|0|||
150203248|NCT05866926|541886146|FG000|Overall Study|Withdrawal by Subject|5|||
150203249|NCT05866926|541886147|FG001|Overall Study|Withdrawal by Subject|1|||
150203250|NCT05866926|541886146|FG000|Overall Study|Disease progression|1|||
150203251|NCT05866926|541886147|FG001|Overall Study|Disease progression|0|||
150203252|NCT05866926|541886146|FG000|Overall Study|other causes|2|||
150203253|NCT05866926|541886147|FG001|Overall Study|other causes|1|||
150203254|NCT00709956|541886148|FG000|Overall Study|Withdrawal by Subject|1|||
150203255|NCT00709956|541886149|FG001|Overall Study|Withdrawal by Subject|1|||
150203256|NCT00709956|541886148|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
150203257|NCT00709956|541886149|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
150203258|NCT01105091|541886150|FG000|Overall Study|Death|2|||
150203259|NCT01105091|541886151|FG001|Overall Study|Death|0|||
150203260|NCT00968149|541886583|FG000|Overall Study|Adverse Event|5|||
150203261|NCT00968149|541886584|FG001|Overall Study|Adverse Event|1|||
150203262|NCT00968149|541886583|FG000|Overall Study|Lack of Efficacy|0|||
150203263|NCT00968149|541886584|FG001|Overall Study|Lack of Efficacy|4|||
150203264|NCT00968149|541886583|FG000|Overall Study|Lost to Follow-up|0|||
150203265|NCT00968149|541886584|FG001|Overall Study|Lost to Follow-up|1|||
150203266|NCT00968149|541886583|FG000|Overall Study|Protocol Violation|4|||
150203267|NCT00968149|541886584|FG001|Overall Study|Protocol Violation|0|||
150203268|NCT00968149|541886583|FG000|Overall Study|Withdrawal by Subject|2|||
150203269|NCT00968149|541886584|FG001|Overall Study|Withdrawal by Subject|0|||
150203270|NCT00447980|541886585|FG000|Overall Study|Withdrawal by Subject|1|||
150203271|NCT00447980|541886586|FG001|Overall Study|Withdrawal by Subject|1|||
150203272|NCT00447980|541886587|FG002|Overall Study|Withdrawal by Subject|4|||
150203273|NCT00447980|541886588|FG003|Overall Study|Withdrawal by Subject|4|||
150203274|NCT00447980|541886585|FG000|Overall Study|Lost to Follow-up|1|||
150203275|NCT00447980|541886586|FG001|Overall Study|Lost to Follow-up|1|||
150203276|NCT00447980|541886587|FG002|Overall Study|Lost to Follow-up|0|||
150203277|NCT00447980|541886588|FG003|Overall Study|Lost to Follow-up|0|||
150203278|NCT00447980|541886585|FG000|Overall Study|Did not proceed with surgery|3|||
150203279|NCT00447980|541886586|FG001|Overall Study|Did not proceed with surgery|3|||
150203280|NCT00447980|541886587|FG002|Overall Study|Did not proceed with surgery|2|||
150203281|NCT00447980|541886588|FG003|Overall Study|Did not proceed with surgery|2|||
150203282|NCT00113360|541886589|FG000|Overall Study|Adverse Event|3|||
150203283|NCT00113360|541886589|FG000|Overall Study|Subject required surgery|1|||
150203284|NCT00113360|541886589|FG000|Overall Study|Did not meet eligibility criteria|3|||
150203285|NCT02467270|541886600|FG000|Overall Study|Participants Never Treated|0|||
150203286|NCT02467270|541886601|FG001|Overall Study|Participants Never Treated|1|||
150203287|NCT02467270|541886602|FG002|Overall Study|Participants Never Treated|0|||
150203288|NCT02467270|541886600|FG000|Overall Study|Ongoing|50|||
150203289|NCT02467270|541886601|FG001|Overall Study|Ongoing|41|||
150203290|NCT02467270|541886602|FG002|Overall Study|Ongoing|43|||
150203291|NCT02467270|541886600|FG000|Overall Study|Adverse Event|16|||
150203292|NCT02467270|541886601|FG001|Overall Study|Adverse Event|15|||
150203293|NCT02467270|541886602|FG002|Overall Study|Adverse Event|14|||
150203294|NCT02467270|541886600|FG000|Overall Study|Progressive Disease|7|||
150203295|NCT02467270|541886601|FG001|Overall Study|Progressive Disease|7|||
150203296|NCT02467270|541886602|FG002|Overall Study|Progressive Disease|4|||
150203297|NCT02467270|541886600|FG000|Overall Study|Death|2|||
150203298|NCT02467270|541886601|FG001|Overall Study|Death|0|||
150203299|NCT02467270|541886602|FG002|Overall Study|Death|2|||
150203300|NCT02467270|541886600|FG000|Overall Study|Lack of Efficacy|12|||
150203301|NCT02467270|541886601|FG001|Overall Study|Lack of Efficacy|18|||
150203302|NCT02467270|541886602|FG002|Overall Study|Lack of Efficacy|23|||
150203303|NCT02467270|541886600|FG000|Overall Study|Non-compliance With Study Drug|0|||
150203304|NCT02467270|541886601|FG001|Overall Study|Non-compliance With Study Drug|2|||
150203305|NCT02467270|541886602|FG002|Overall Study|Non-compliance With Study Drug|1|||
150203306|NCT02467270|541886600|FG000|Overall Study|Lost to Follow-up|2|||
150203307|NCT02467270|541886601|FG001|Overall Study|Lost to Follow-up|1|||
150203308|NCT02467270|541886602|FG002|Overall Study|Lost to Follow-up|0|||
150203309|NCT02467270|541886600|FG000|Overall Study|Pregnancy|0|||
150203310|NCT02467270|541886601|FG001|Overall Study|Pregnancy|1|||
150203311|NCT02467270|541886602|FG002|Overall Study|Pregnancy|0|||
150203312|NCT02467270|541886600|FG000|Overall Study|Physician Decision|0|||
150203313|NCT02467270|541886601|FG001|Overall Study|Physician Decision|4|||
150203314|NCT02467270|541886602|FG002|Overall Study|Physician Decision|1|||
150203315|NCT02467270|541886600|FG000|Overall Study|Withdrawal by Subject|4|||
150203316|NCT02467270|541886601|FG001|Overall Study|Withdrawal by Subject|3|||
150203317|NCT02467270|541886602|FG002|Overall Study|Withdrawal by Subject|5|||
150203318|NCT02467270|541886600|FG000|Overall Study|Reason not Specified|1|||
150203319|NCT02467270|541886601|FG001|Overall Study|Reason not Specified|2|||
150203320|NCT02467270|541886602|FG002|Overall Study|Reason not Specified|1|||
150203321|NCT02231749|541886615|FG000|Overall Study|Disease progression|229|||
150203322|NCT02231749|541886616|FG001|Overall Study|Disease progression|297|||
150203323|NCT02231749|541886615|FG000|Overall Study|Study Drug Toxicity|134|||
150203324|NCT02231749|541886616|FG001|Overall Study|Study Drug Toxicity|63|||
150203325|NCT02231749|541886615|FG000|Overall Study|Death|1|||
150203326|NCT02231749|541886616|FG001|Overall Study|Death|1|||
150203327|NCT02231749|541886615|FG000|Overall Study|AE unrelated to Study drug|32|||
150203328|NCT02231749|541886616|FG001|Overall Study|AE unrelated to Study drug|31|||
150203329|NCT02231749|541886615|FG000|Overall Study|Participant's request to discontinue|10|||
150203330|NCT02231749|541886616|FG001|Overall Study|Participant's request to discontinue|21|||
150203331|NCT02231749|541886615|FG000|Overall Study|Participant withdrew Consent|8|||
150203332|NCT02231749|541886616|FG001|Overall Study|Participant withdrew Consent|15|||
150203333|NCT02231749|541886615|FG000|Overall Study|Lost to Follow-up|1|||
150203334|NCT02231749|541886616|FG001|Overall Study|Lost to Follow-up|2|||
150203335|NCT02231749|541886615|FG000|Overall Study|Maximum Clinical Benefit|5|||
150203336|NCT02231749|541886616|FG001|Overall Study|Maximum Clinical Benefit|8|||
150203337|NCT02231749|541886615|FG000|Overall Study|Poor/Non-Compliance|0|||
150203338|NCT02231749|541886616|FG001|Overall Study|Poor/Non-Compliance|3|||
150203339|NCT02231749|541886615|FG000|Overall Study|Pregnancy|1|||
150203340|NCT02231749|541886616|FG001|Overall Study|Pregnancy|0|||
150203341|NCT02231749|541886615|FG000|Overall Study|other|0|||
150203342|NCT02231749|541886616|FG001|Overall Study|other|8|||
150203343|NCT02231749|541886615|FG000|Overall Study|No longer meets Study Criteria|1|||
150203344|NCT02231749|541886616|FG001|Overall Study|No longer meets Study Criteria|0|||
150203345|NCT03142009|541886633|FG000|Overall Study|Lost to Follow-up|45|||
150203346|NCT03142009|541886634|FG001|Overall Study|Lost to Follow-up|30|||
150203347|NCT05771467|541886635|FG000|Overall Study|Lost to Follow-up|6|||
150203348|NCT05771467|541886636|FG001|Overall Study|Lost to Follow-up|3|||
150203349|NCT03008382|541886637|FG000|Overall Study|Withdrawal by Subject|2|||
150203350|NCT03008382|541886638|FG001|Overall Study|Withdrawal by Subject|5|||
150203351|NCT03008382|541886639|FG002|Overall Study|Withdrawal by Subject|2|||
150203352|NCT03008382|541886640|FG003|Overall Study|Withdrawal by Subject|0|||
150203353|NCT03008382|541886637|FG000|Overall Study|Protocol Violation|1|||
150203354|NCT03008382|541886638|FG001|Overall Study|Protocol Violation|0|||
150203355|NCT03008382|541886639|FG002|Overall Study|Protocol Violation|0|||
150203356|NCT03008382|541886640|FG003|Overall Study|Protocol Violation|0|||
150203357|NCT03008382|541886637|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
150203358|NCT03008382|541886638|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
150203359|NCT03008382|541886639|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
150203360|NCT03008382|541886640|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
150203361|NCT03008382|541886637|FG000|Overall Study|Lost to Follow-up|0|||
150203362|NCT03008382|541886638|FG001|Overall Study|Lost to Follow-up|0|||
150203363|NCT03008382|541886639|FG002|Overall Study|Lost to Follow-up|1|||
150203364|NCT03008382|541886640|FG003|Overall Study|Lost to Follow-up|0|||
150203365|NCT03008382|541886637|FG000|Overall Study|Screenfail|0|||
150203366|NCT03008382|541886638|FG001|Overall Study|Screenfail|0|||
150203367|NCT03008382|541886639|FG002|Overall Study|Screenfail|2|||
150203368|NCT03008382|541886640|FG003|Overall Study|Screenfail|0|||
150203369|NCT03215706|541886641|FG000|Randomization|Adverse Event unrelated to study drug|1|||
150203370|NCT03215706|541886642|FG001|Randomization|Adverse Event unrelated to study drug|0|||
150203371|NCT03215706|541886641|FG000|Randomization|participant withdrew consent|1|||
150203372|NCT03215706|541886642|FG001|Randomization|participant withdrew consent|3|||
150203373|NCT03215706|541886641|FG000|Randomization|no longer meets study criteria|1|||
150203374|NCT03215706|541886642|FG001|Randomization|no longer meets study criteria|4|||
150203375|NCT03215706|541886641|FG000|Randomization|other reasons|0|||
150203376|NCT03215706|541886642|FG001|Randomization|other reasons|2|||
150203377|NCT03215706|541886641|FG000|Treatment Period|Disease Progression|150|||
150203378|NCT03215706|541886642|FG001|Treatment Period|Disease Progression|142|||
150203379|NCT03215706|541886641|FG000|Treatment Period|Study Drug Toxicity|53|||
150203380|NCT03215706|541886642|FG001|Treatment Period|Study Drug Toxicity|21|||
150203381|NCT03215706|541886641|FG000|Treatment Period|Death|2|||
150203382|NCT03215706|541886642|FG001|Treatment Period|Death|1|||
150203383|NCT03215706|541886641|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
150203384|NCT03215706|541886642|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
150203385|NCT03215706|541886641|FG000|Treatment Period|Request to D/C treatment|1|||
150203386|NCT03215706|541886642|FG001|Treatment Period|Request to D/C treatment|6|||
150203387|NCT03215706|541886641|FG000|Treatment Period|Participant withdrew consent|3|||
150203388|NCT03215706|541886642|FG001|Treatment Period|Participant withdrew consent|4|||
150203389|NCT03215706|541886641|FG000|Treatment Period|Lost to Follow-up|0|||
150203390|NCT03215706|541886642|FG001|Treatment Period|Lost to Follow-up|1|||
150203391|NCT03215706|541886641|FG000|Treatment Period|Other Reasons|4|||
150203392|NCT03215706|541886642|FG001|Treatment Period|Other Reasons|5|||
150203393|NCT03215706|541886641|FG000|Treatment Period|Ongoing in the treatment period|105|||
150203394|NCT03215706|541886642|FG001|Treatment Period|Ongoing in the treatment period|43|||
150203395|NCT05267639|541887330|FG000|Overall Study|Withdrawal by Subject|1|||
150203396|NCT05267639|541887331|FG001|Overall Study|Withdrawal by Subject|0|||
150203397|NCT04732871|541887334|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
150203398|NCT04732871|541887335|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
150203399|NCT04732871|541887336|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
150203400|NCT04732871|541887334|FG000|Overall Study|Lost to Follow-up|7|||
150203401|NCT04732871|541887335|FG001|Overall Study|Lost to Follow-up|4|||
150203402|NCT04732871|541887336|FG002|Overall Study|Lost to Follow-up|3|||
150203403|NCT04732871|541887334|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
150203404|NCT04732871|541887335|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
150203405|NCT04732871|541887336|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
150203406|NCT04732871|541887334|FG000|Overall Study|Migrated / moved from the study area|5|||
150203407|NCT04732871|541887335|FG001|Overall Study|Migrated / moved from the study area|0|||
150203408|NCT04732871|541887336|FG002|Overall Study|Migrated / moved from the study area|0|||
150203409|NCT04732871|541887334|FG000|Overall Study|Other|1|||
150203410|NCT04732871|541887335|FG001|Overall Study|Other|0|||
150203411|NCT04732871|541887336|FG002|Overall Study|Other|1|||
150203412|NCT04732871|541887334|FG000|Overall Study|Ongoing|6|||
150203413|NCT04732871|541887335|FG001|Overall Study|Ongoing|0|||
150203414|NCT04732871|541887336|FG002|Overall Study|Ongoing|1|||
150203415|NCT04732871|541887334|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
150203416|NCT04732871|541887335|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
150203417|NCT04732871|541887336|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
150203418|NCT05180539|541887345|FG000|Overall Study|Lost to Follow-up|27|||
150203419|NCT05180539|541887346|FG001|Overall Study|Lost to Follow-up|30|||
150203420|NCT00994643|541887349|FG000|Overall Study|Withdrawal by Subject|1|||
150203421|NCT02567435|541887350|FG000|Overall Study|Death|1|||
150203422|NCT02567435|541887351|FG001|Overall Study|Death|1|||
150203423|NCT02567435|541887352|FG002|Overall Study|Death|0|||
150203424|NCT02567435|541887353|FG003|Overall Study|Death|0|||
150203425|NCT02567435|541887350|FG000|Overall Study|Ineligible|1|||
150203426|NCT02567435|541887351|FG001|Overall Study|Ineligible|3|||
150203427|NCT02567435|541887352|FG002|Overall Study|Ineligible|0|||
150203428|NCT02567435|541887353|FG003|Overall Study|Ineligible|0|||
150203429|NCT02567435|541887350|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
150203430|NCT02567435|541887351|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
150203431|NCT02567435|541887352|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
150203432|NCT02567435|541887353|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
150203433|NCT02989662|541887354|FG000|Overall Study|Lost to Follow-up|0|||
150203434|NCT02989662|541887355|FG001|Overall Study|Lost to Follow-up|0|||
150203435|NCT02989662|541887356|FG002|Overall Study|Lost to Follow-up|0|||
150203436|NCT02989662|541887357|FG003|Overall Study|Lost to Follow-up|2|||
150203437|NCT02989662|541887354|FG000|Overall Study|Physician Decision|3|||
150203438|NCT02989662|541887355|FG001|Overall Study|Physician Decision|0|||
150203439|NCT02989662|541887356|FG002|Overall Study|Physician Decision|0|||
150203440|NCT02989662|541887357|FG003|Overall Study|Physician Decision|0|||
150203441|NCT02989662|541887354|FG000|Overall Study|Withdrawal by Subject|1|||
150203442|NCT02989662|541887355|FG001|Overall Study|Withdrawal by Subject|0|||
150203443|NCT02989662|541887356|FG002|Overall Study|Withdrawal by Subject|0|||
150203444|NCT02989662|541887357|FG003|Overall Study|Withdrawal by Subject|0|||
150203445|NCT02446600|541887358|FG000|Overall Study|Never treated|20|||
150203446|NCT02446600|541887359|FG001|Overall Study|Never treated|2|||
150203447|NCT02446600|541887360|FG002|Overall Study|Never treated|6|||
150203448|NCT02446600|541887361|FG003|Overall Study|Never treated|0|||
150203449|NCT02446600|541887358|FG000|Overall Study|Withdrawal by Subject|19|||
150203450|NCT02446600|541887359|FG001|Overall Study|Withdrawal by Subject|5|||
150203451|NCT02446600|541887360|FG002|Overall Study|Withdrawal by Subject|17|||
150203452|NCT02446600|541887361|FG003|Overall Study|Withdrawal by Subject|0|||
150203453|NCT02446600|541887358|FG000|Overall Study|Ineligible|1|||
150203454|NCT02446600|541887359|FG001|Overall Study|Ineligible|4|||
150203455|NCT02446600|541887360|FG002|Overall Study|Ineligible|4|||
150203456|NCT02446600|541887361|FG003|Overall Study|Ineligible|1|||
150203457|NCT02446600|541887358|FG000|Overall Study|Duplicate Enrollment|0|||
150203458|NCT02446600|541887359|FG001|Overall Study|Duplicate Enrollment|1|||
150203459|NCT02446600|541887360|FG002|Overall Study|Duplicate Enrollment|0|||
150203460|NCT02446600|541887361|FG003|Overall Study|Duplicate Enrollment|0|||
150203461|NCT00328783|541887362|FG000|Overall Study|Could not tolerate ABC|21|||
150203462|NCT00328783|541887362|FG000|Overall Study|No heart in RT field|4|||
150203463|NCT00328783|541887362|FG000|Overall Study|Withdrawal by Subject|1|||
150203464|NCT00357682|541887363|FG000|Overall Study|Did not receive allocated Treatment|10|||
150203465|NCT00357682|541887364|FG001|Overall Study|Did not receive allocated Treatment|9|||
150203466|NCT00357682|541887365|FG002|Overall Study|Did not receive allocated Treatment|9|||
150203467|NCT00357682|541887366|FG003|Overall Study|Did not receive allocated Treatment|10|||
150203468|NCT00357682|541887363|FG000|Overall Study|Withdrew consent|6|||
150203469|NCT00357682|541887364|FG001|Overall Study|Withdrew consent|6|||
150203470|NCT00357682|541887365|FG002|Overall Study|Withdrew consent|5|||
150203471|NCT00357682|541887366|FG003|Overall Study|Withdrew consent|5|||
150203472|NCT00357682|541887363|FG000|Overall Study|Lost to Follow-up|39|||
150203473|NCT00357682|541887364|FG001|Overall Study|Lost to Follow-up|33|||
150203474|NCT00357682|541887365|FG002|Overall Study|Lost to Follow-up|26|||
150203475|NCT00357682|541887366|FG003|Overall Study|Lost to Follow-up|35|||
150203476|NCT00357682|541887363|FG000|Overall Study|Adverse Event|24|||
150203477|NCT00357682|541887364|FG001|Overall Study|Adverse Event|32|||
150203478|NCT00357682|541887365|FG002|Overall Study|Adverse Event|22|||
150203479|NCT00357682|541887366|FG003|Overall Study|Adverse Event|27|||
150203480|NCT00357682|541887363|FG000|Overall Study|Physician Decision|32|||
150203481|NCT00357682|541887364|FG001|Overall Study|Physician Decision|20|||
150203482|NCT00357682|541887365|FG002|Overall Study|Physician Decision|24|||
150203483|NCT00357682|541887366|FG003|Overall Study|Physician Decision|30|||
150203484|NCT00357682|541887363|FG000|Overall Study|Patient decision|73|||
150203485|NCT00357682|541887364|FG001|Overall Study|Patient decision|80|||
150203486|NCT00357682|541887365|FG002|Overall Study|Patient decision|51|||
150203487|NCT00357682|541887366|FG003|Overall Study|Patient decision|59|||
150203488|NCT00357682|541887363|FG000|Overall Study|Other reason|157|||
150203489|NCT00357682|541887364|FG001|Overall Study|Other reason|130|||
150203490|NCT00357682|541887365|FG002|Overall Study|Other reason|114|||
150203491|NCT00357682|541887366|FG003|Overall Study|Other reason|99|||
150203492|NCT03660930|541887368|FG000|Overall Study|Adverse Event|0|||
150203493|NCT03660930|541887369|FG001|Overall Study|Adverse Event|0|||
150203494|NCT03660930|541887370|FG002|Overall Study|Adverse Event|0|||
150203495|NCT03660930|541887371|FG003|Overall Study|Adverse Event|2|||
150203496|NCT03660930|541887372|FG004|Overall Study|Adverse Event|0|||
150203497|NCT03660930|541887373|FG005|Overall Study|Adverse Event|1|||
150203498|NCT03660930|541887374|FG006|Overall Study|Adverse Event|0|||
150203499|NCT03660930|541887375|FG007|Overall Study|Adverse Event|0|||
150203500|NCT03660930|541887368|FG000|Overall Study|Withdrawal by Subject|0|||
150203501|NCT03660930|541887369|FG001|Overall Study|Withdrawal by Subject|0|||
150203502|NCT03660930|541887370|FG002|Overall Study|Withdrawal by Subject|0|||
150203503|NCT03660930|541887371|FG003|Overall Study|Withdrawal by Subject|0|||
150203504|NCT03660930|541887372|FG004|Overall Study|Withdrawal by Subject|0|||
150203505|NCT03660930|541887373|FG005|Overall Study|Withdrawal by Subject|1|||
150203506|NCT03660930|541887374|FG006|Overall Study|Withdrawal by Subject|0|||
150203507|NCT03660930|541887375|FG007|Overall Study|Withdrawal by Subject|0|||
150203508|NCT02656706|541887378|FG000|Overall Study|Insurance Denial|1|||
150203509|NCT03725332|541887379|FG000|Overall Study|Adverse Event|5|||
150203510|NCT03725332|541887380|FG001|Overall Study|Adverse Event|10|||
150203511|NCT03725332|541887379|FG000|Overall Study|Death|1|||
150203512|NCT03725332|541887380|FG001|Overall Study|Death|3|||
150203513|NCT03725332|541887379|FG000|Overall Study|Lost to Follow-up|43|||
150203514|NCT03725332|541887380|FG001|Overall Study|Lost to Follow-up|122|||
150203515|NCT03725332|541887379|FG000|Overall Study|Withdrawal by Subject|0|||
150203516|NCT03725332|541887380|FG001|Overall Study|Withdrawal by Subject|1|||
150203517|NCT03725332|541887379|FG000|Overall Study|Duplicate enrollment|0|||
150203518|NCT03725332|541887380|FG001|Overall Study|Duplicate enrollment|1|||
150203519|NCT03725332|541887379|FG000|Overall Study|Did not consent|0|||
150203520|NCT03725332|541887380|FG001|Overall Study|Did not consent|1|||
150203521|NCT03201939|541887387|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
150203522|NCT03201939|541887388|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
150203523|NCT03333915|541887389|FG000|Overall Study|Lost to Follow-up|0|||
150203524|NCT03333915|541887390|FG001|Overall Study|Lost to Follow-up|0|||
150203525|NCT03333915|541887391|FG002|Overall Study|Lost to Follow-up|1|||
150203526|NCT03333915|541887392|FG003|Overall Study|Lost to Follow-up|0|||
150203527|NCT03333915|541887393|FG004|Overall Study|Lost to Follow-up|0|||
150203528|NCT03333915|541887389|FG000|Overall Study|Disease Progression|0|||
150203529|NCT03333915|541887390|FG001|Overall Study|Disease Progression|1|||
150203530|NCT03333915|541887391|FG002|Overall Study|Disease Progression|0|||
150203531|NCT03333915|541887392|FG003|Overall Study|Disease Progression|0|||
150203532|NCT03333915|541887393|FG004|Overall Study|Disease Progression|0|||
150203533|NCT03333915|541887389|FG000|Overall Study|Death|0|||
150203534|NCT03333915|541887390|FG001|Overall Study|Death|0|||
150203535|NCT03333915|541887391|FG002|Overall Study|Death|0|||
150203536|NCT03333915|541887392|FG003|Overall Study|Death|37|||
150203537|NCT03333915|541887393|FG004|Overall Study|Death|18|||
150203538|NCT03333915|541887389|FG000|Overall Study|Sponsor's Decision|0|||
150203539|NCT03333915|541887390|FG001|Overall Study|Sponsor's Decision|0|||
150203540|NCT03333915|541887391|FG002|Overall Study|Sponsor's Decision|0|||
150203541|NCT03333915|541887392|FG003|Overall Study|Sponsor's Decision|48|||
150203542|NCT03333915|541887393|FG004|Overall Study|Sponsor's Decision|4|||
150203543|NCT03333915|541887389|FG000|Overall Study|Withdrawal by Subject|0|||
150203544|NCT03333915|541887390|FG001|Overall Study|Withdrawal by Subject|0|||
150203545|NCT03333915|541887391|FG002|Overall Study|Withdrawal by Subject|0|||
150203546|NCT03333915|541887392|FG003|Overall Study|Withdrawal by Subject|5|||
150203547|NCT03333915|541887393|FG004|Overall Study|Withdrawal by Subject|1|||
150203548|NCT04046549|541887394|FG000|Overall Study|Adverse Event|1|||
150203549|NCT04046549|541887394|FG000|Overall Study|Physician Decision|1|||
150203550|NCT04046549|541887394|FG000|Overall Study|Withdrawal by Subject|3|||
150203551|NCT04046549|541887394|FG000|Overall Study|Other, Not Specified|5|||
150203552|NCT04012567|541887395|FG000|Overall Study|Lost to Follow-up|0|||
150203553|NCT04012567|541887396|FG001|Overall Study|Lost to Follow-up|1|||
150203554|NCT04012567|541887395|FG000|Overall Study|Withdrawal by Subject|1|||
150203555|NCT04012567|541887396|FG001|Overall Study|Withdrawal by Subject|0|||
150203556|NCT04940624|541887399|FG000|Overall Study|Adverse Event|4|||
150203557|NCT04940624|541887400|FG001|Overall Study|Adverse Event|11|||
150203558|NCT04940624|541887399|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
150203559|NCT04940624|541887400|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
150203560|NCT04940624|541887399|FG000|Overall Study|Physician Decision|1|||
150203561|NCT04940624|541887400|FG001|Overall Study|Physician Decision|0|||
150203562|NCT04940624|541887399|FG000|Overall Study|Lost to Follow-up|1|||
150203563|NCT04940624|541887400|FG001|Overall Study|Lost to Follow-up|0|||
150203564|NCT04940624|541887399|FG000|Overall Study|Reason Not Specified|1|||
150203565|NCT04940624|541887400|FG001|Overall Study|Reason Not Specified|0|||
150203566|NCT02206828|541887401|FG000|Overall Study|Lost to Follow-up|7|||
150203567|NCT04039113|541887402|FG000|Overall Study|Withdrawal by Subject|8|||
150203568|NCT04039113|541887403|FG001|Overall Study|Withdrawal by Subject|11|||
150203569|NCT04039113|541887402|FG000|Overall Study|Lost to Follow-up|1|||
150203570|NCT04039113|541887403|FG001|Overall Study|Lost to Follow-up|1|||
150203571|NCT04039113|541887402|FG000|Overall Study|Adverse Event|2|||
150203572|NCT04039113|541887403|FG001|Overall Study|Adverse Event|2|||
150203573|NCT04039113|541887402|FG000|Overall Study|Death|2|||
150203574|NCT04039113|541887403|FG001|Overall Study|Death|4|||
150203575|NCT04039113|541887402|FG000|Overall Study|Site Closure|6|||
150203576|NCT04039113|541887403|FG001|Overall Study|Site Closure|0|||
150203577|NCT04039113|541887402|FG000|Overall Study|Failure to meet randomisation criteria|4|||
150203578|NCT04039113|541887403|FG001|Overall Study|Failure to meet randomisation criteria|0|||
150203579|NCT00945724|541887404|FG000|Overall Study|Withdrawal by Subject|2|||
150203580|NCT00945724|541887404|FG000|Overall Study|Physician Decision|1|||
150203581|NCT00945724|541887404|FG000|Overall Study|Adverse Event|5|||
150203582|NCT00945724|541887404|FG000|Overall Study|Second malignancy|1|||
150203583|NCT02502266|541888128|FG000|Overall Study|Adverse Event|0|||
150203584|NCT02502266|541888129|FG001|Overall Study|Adverse Event|0|||
150203585|NCT02502266|541888130|FG002|Overall Study|Adverse Event|0|||
150203586|NCT02502266|541888131|FG003|Overall Study|Adverse Event|0|||
150203587|NCT02502266|541888132|FG004|Overall Study|Adverse Event|1|||
150203588|NCT02502266|541888133|FG005|Overall Study|Adverse Event|1|||
150203589|NCT02502266|541888134|FG006|Overall Study|Adverse Event|1|||
150203590|NCT02502266|541888128|FG000|Overall Study|Withdrawal by Subject|30|||
150203591|NCT02502266|541888129|FG001|Overall Study|Withdrawal by Subject|15|||
150203592|NCT02502266|541888130|FG002|Overall Study|Withdrawal by Subject|16|||
150203593|NCT02502266|541888131|FG003|Overall Study|Withdrawal by Subject|0|||
150203594|NCT02502266|541888132|FG004|Overall Study|Withdrawal by Subject|0|||
150203595|NCT02502266|541888133|FG005|Overall Study|Withdrawal by Subject|0|||
150203596|NCT02502266|541888134|FG006|Overall Study|Withdrawal by Subject|0|||
150203597|NCT02502266|541888128|FG000|Overall Study|Still on Treatment|0|||
150203598|NCT02502266|541888129|FG001|Overall Study|Still on Treatment|0|||
150203599|NCT02502266|541888130|FG002|Overall Study|Still on Treatment|1|||
150203600|NCT02502266|541888131|FG003|Overall Study|Still on Treatment|0|||
150203601|NCT02502266|541888132|FG004|Overall Study|Still on Treatment|0|||
150203602|NCT02502266|541888133|FG005|Overall Study|Still on Treatment|0|||
150203603|NCT02502266|541888134|FG006|Overall Study|Still on Treatment|0|||
150203604|NCT02502266|541888128|FG000|Overall Study|Other Reasons|19|||
150203605|NCT02502266|541888129|FG001|Overall Study|Other Reasons|6|||
150203606|NCT02502266|541888130|FG002|Overall Study|Other Reasons|14|||
150203607|NCT02502266|541888131|FG003|Overall Study|Other Reasons|0|||
150203608|NCT02502266|541888132|FG004|Overall Study|Other Reasons|1|||
150203609|NCT02502266|541888133|FG005|Overall Study|Other Reasons|1|||
150203610|NCT02502266|541888134|FG006|Overall Study|Other Reasons|0|||
150203611|NCT02502266|541888128|FG000|Overall Study|Arm 4 Discontinued|0|||
150203612|NCT02502266|541888129|FG001|Overall Study|Arm 4 Discontinued|0|||
150203613|NCT02502266|541888130|FG002|Overall Study|Arm 4 Discontinued|0|||
150203614|NCT02502266|541888131|FG003|Overall Study|Arm 4 Discontinued|52|||
150203615|NCT02502266|541888132|FG004|Overall Study|Arm 4 Discontinued|0|||
150203616|NCT02502266|541888133|FG005|Overall Study|Arm 4 Discontinued|0|||
150203617|NCT02502266|541888134|FG006|Overall Study|Arm 4 Discontinued|0|||
150203618|NCT02502266|541888128|FG000|Overall Study|Never treated|0|||
150203619|NCT02502266|541888129|FG001|Overall Study|Never treated|0|||
150203620|NCT02502266|541888130|FG002|Overall Study|Never treated|0|||
150203621|NCT02502266|541888131|FG003|Overall Study|Never treated|0|||
150203622|NCT02502266|541888132|FG004|Overall Study|Never treated|0|||
150203623|NCT02502266|541888133|FG005|Overall Study|Never treated|1|||
150203624|NCT02502266|541888134|FG006|Overall Study|Never treated|0|||
150203625|NCT01976936|541888135|FG000|Overall Study|Did not receive at least 9 doses|9|||
150203626|NCT01976936|541888136|FG001|Overall Study|Did not receive at least 9 doses|4|||
150203627|NCT06408870|541888137|FG000|Washout period|Withdrawal by Subject|1|||
150203628|NCT06408870|541888138|FG001|Washout period|Withdrawal by Subject|0|||
150203629|NCT06408870|541888137|FG000|Washout period|Adverse Event|2|||
150203630|NCT06408870|541888138|FG001|Washout period|Adverse Event|0|||
150203631|NCT05162586|541888142|FG000|Overall Study|Other|0|||
150203632|NCT05162586|541888143|FG001|Overall Study|Other|0|||
150203633|NCT05162586|541888144|FG002|Overall Study|Other|0|||
150203634|NCT05162586|541888145|FG003|Overall Study|Other|0|||
150203635|NCT05162586|541888146|FG004|Overall Study|Other|1|||
150203636|NCT05162586|541888147|FG005|Overall Study|Other|0|||
150203637|NCT05162586|541888148|FG006|Overall Study|Other|2|||
150203638|NCT05162586|541888149|FG007|Overall Study|Other|2|||
150203639|NCT05162586|541888142|FG000|Overall Study|Lack of Efficacy|0|||
150203640|NCT05162586|541888143|FG001|Overall Study|Lack of Efficacy|0|||
150203641|NCT05162586|541888144|FG002|Overall Study|Lack of Efficacy|0|||
150203642|NCT05162586|541888145|FG003|Overall Study|Lack of Efficacy|0|||
150203643|NCT05162586|541888146|FG004|Overall Study|Lack of Efficacy|1|||
150203644|NCT05162586|541888147|FG005|Overall Study|Lack of Efficacy|0|||
150203645|NCT05162586|541888148|FG006|Overall Study|Lack of Efficacy|0|||
150203646|NCT05162586|541888149|FG007|Overall Study|Lack of Efficacy|1|||
150203647|NCT05162586|541888142|FG000|Overall Study|Lost to Follow-up|0|||
150203648|NCT05162586|541888143|FG001|Overall Study|Lost to Follow-up|0|||
150203649|NCT05162586|541888144|FG002|Overall Study|Lost to Follow-up|0|||
150203650|NCT05162586|541888145|FG003|Overall Study|Lost to Follow-up|0|||
150203651|NCT05162586|541888146|FG004|Overall Study|Lost to Follow-up|2|||
150203652|NCT05162586|541888147|FG005|Overall Study|Lost to Follow-up|0|||
150203653|NCT05162586|541888148|FG006|Overall Study|Lost to Follow-up|0|||
150203654|NCT05162586|541888149|FG007|Overall Study|Lost to Follow-up|2|||
150203655|NCT05162586|541888142|FG000|Overall Study|Non-Compliance|0|||
150203656|NCT05162586|541888143|FG001|Overall Study|Non-Compliance|1|||
150203657|NCT05162586|541888144|FG002|Overall Study|Non-Compliance|0|||
150203658|NCT05162586|541888145|FG003|Overall Study|Non-Compliance|0|||
150203659|NCT05162586|541888146|FG004|Overall Study|Non-Compliance|1|||
150203660|NCT05162586|541888147|FG005|Overall Study|Non-Compliance|0|||
150203661|NCT05162586|541888148|FG006|Overall Study|Non-Compliance|0|||
150203662|NCT05162586|541888149|FG007|Overall Study|Non-Compliance|1|||
150203663|NCT05162586|541888142|FG000|Overall Study|Withdrawal by Subject|2|||
150203664|NCT05162586|541888143|FG001|Overall Study|Withdrawal by Subject|0|||
150203665|NCT05162586|541888144|FG002|Overall Study|Withdrawal by Subject|0|||
150203666|NCT05162586|541888145|FG003|Overall Study|Withdrawal by Subject|0|||
150203667|NCT05162586|541888146|FG004|Overall Study|Withdrawal by Subject|7|||
150203668|NCT05162586|541888147|FG005|Overall Study|Withdrawal by Subject|6|||
150203669|NCT05162586|541888148|FG006|Overall Study|Withdrawal by Subject|2|||
150203670|NCT05162586|541888149|FG007|Overall Study|Withdrawal by Subject|2|||
150203671|NCT05162586|541888142|FG000|Overall Study|Adverse Event|2|||
150203672|NCT05162586|541888143|FG001|Overall Study|Adverse Event|0|||
150203673|NCT05162586|541888144|FG002|Overall Study|Adverse Event|1|||
150203674|NCT05162586|541888145|FG003|Overall Study|Adverse Event|2|||
150203675|NCT05162586|541888146|FG004|Overall Study|Adverse Event|4|||
150203676|NCT05162586|541888147|FG005|Overall Study|Adverse Event|1|||
150203677|NCT05162586|541888148|FG006|Overall Study|Adverse Event|5|||
150203678|NCT05162586|541888149|FG007|Overall Study|Adverse Event|2|||
150203679|NCT05030584|541888151|FG000|Overall Study|Adverse Event|17|||
150203680|NCT05030584|541888152|FG001|Overall Study|Adverse Event|2|||
150203681|NCT05030584|541888151|FG000|Overall Study|Lack of Efficacy|0|||
150203682|NCT05030584|541888152|FG001|Overall Study|Lack of Efficacy|6|||
150203683|NCT05030584|541888151|FG000|Overall Study|Lost to Follow-up|5|||
150203684|NCT05030584|541888152|FG001|Overall Study|Lost to Follow-up|2|||
150203685|NCT05030584|541888151|FG000|Overall Study|Non-Compliance with Study Drug|2|||
150203686|NCT05030584|541888152|FG001|Overall Study|Non-Compliance with Study Drug|3|||
150203687|NCT05030584|541888151|FG000|Overall Study|Other reason|4|||
150203688|NCT05030584|541888152|FG001|Overall Study|Other reason|3|||
150203689|NCT05030584|541888151|FG000|Overall Study|Physician Decision|1|||
150203690|NCT05030584|541888152|FG001|Overall Study|Physician Decision|4|||
150203691|NCT05030584|541888151|FG000|Overall Study|Protocol Violation|0|||
150203692|NCT05030584|541888152|FG001|Overall Study|Protocol Violation|2|||
150203693|NCT05030584|541888151|FG000|Overall Study|Randomized by Mistake|0|||
150203694|NCT05030584|541888152|FG001|Overall Study|Randomized by Mistake|2|||
150203695|NCT05030584|541888151|FG000|Overall Study|Withdrawal by Subject|21|||
150203696|NCT05030584|541888152|FG001|Overall Study|Withdrawal by Subject|28|||
150203697|NCT05030584|541888151|FG000|Overall Study|Technical Problems|0|||
150203698|NCT05030584|541888152|FG001|Overall Study|Technical Problems|1|||
150203699|NCT05030584|541888151|FG000|Overall Study|Completed post-treatment/FU visits|41|||
150203700|NCT05030584|541888152|FG001|Overall Study|Completed post-treatment/FU visits|31|||
150203701|NCT03705390|541888153|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
150203702|NCT03705390|541888153|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
150203703|NCT03047213|541888154|FG000|Overall Study|Withdrawal by Subject|2|||
150203704|NCT03047213|541888155|FG001|Overall Study|Withdrawal by Subject|0|||
150203705|NCT03047213|541888154|FG000|Overall Study|Adverse Event|2|||
150203706|NCT03047213|541888155|FG001|Overall Study|Adverse Event|0|||
150203707|NCT03242915|541888161|FG000|Overall Study|Adverse Event|5|||
150203708|NCT03242915|541888162|FG001|Overall Study|Adverse Event|1|||
150203709|NCT03242915|541888161|FG000|Overall Study|Withdrawal by Subject|0|||
150203710|NCT03242915|541888162|FG001|Overall Study|Withdrawal by Subject|2|||
150203711|NCT03242915|541888161|FG000|Overall Study|Physician Decision|4|||
150203712|NCT03242915|541888162|FG001|Overall Study|Physician Decision|1|||
150203713|NCT02726386|541888163|FG000|Overall Study|Adverse Event|17|||
150203714|NCT02726386|541888164|FG001|Overall Study|Adverse Event|20|||
150203715|NCT02726386|541888163|FG000|Overall Study|Withdrawal by Subject|14|||
150203716|NCT02726386|541888164|FG001|Overall Study|Withdrawal by Subject|28|||
150203717|NCT02726386|541888163|FG000|Overall Study|Other reasons|7|||
150203718|NCT02726386|541888164|FG001|Overall Study|Other reasons|8|||
150203719|NCT05424718|541888181|FG000|Overall Study|Lost to Follow-up|5|||
150203720|NCT05424718|541888182|FG001|Overall Study|Lost to Follow-up|4|||
150203721|NCT03872466|541888183|FG000|Overall Study|Withdrawal by Subject|1|||
150203722|NCT03872466|541888184|FG001|Overall Study|Withdrawal by Subject|0|||
150203723|NCT03872466|541888183|FG000|Overall Study|Physician Decision|2|||
150203724|NCT03872466|541888184|FG001|Overall Study|Physician Decision|0|||
150203725|NCT01778686|541888185|FG000|Overall Study|Adverse Event|0|||
150203726|NCT01778686|541888186|FG001|Overall Study|Adverse Event|0|||
150203727|NCT01778686|541888187|FG002|Overall Study|Adverse Event|1|||
150203728|NCT06059443|541888188|FG000|Overall Study|Withdrawal by Subject|2|||
150203729|NCT06059443|541888189|FG001|Overall Study|Withdrawal by Subject|0|||
150203730|NCT06059443|541888188|FG000|Overall Study|Lost to Follow-up|2|||
150203731|NCT06059443|541888189|FG001|Overall Study|Lost to Follow-up|2|||
150203732|NCT02890355|541888194|FG000|Overall Study|Adverse Event|5|||
150203733|NCT02890355|541888195|FG001|Overall Study|Adverse Event|5|||
150203734|NCT02890355|541888194|FG000|Overall Study|Refusal unrelated to adverse event|5|||
150203735|NCT02890355|541888195|FG001|Overall Study|Refusal unrelated to adverse event|10|||
150203736|NCT02890355|541888194|FG000|Overall Study|Progression/relapse|46|||
150203737|NCT02890355|541888195|FG001|Overall Study|Progression/relapse|39|||
150203738|NCT02890355|541888194|FG000|Overall Study|Not protocol specified|3|||
150203739|NCT02890355|541888195|FG001|Overall Study|Not protocol specified|4|||
150203740|NCT00353496|541888200|FG000|Overall Study|Adverse Event|1|||
150203741|NCT00353496|541888201|FG001|Overall Study|Adverse Event|0|||
150203742|NCT00353496|541888200|FG000|Overall Study|Protocol Violation|2|||
150203743|NCT00353496|541888201|FG001|Overall Study|Protocol Violation|2|||
150203744|NCT00353496|541888200|FG000|Overall Study|Withdrawal by Subject|3|||
150203745|NCT00353496|541888201|FG001|Overall Study|Withdrawal by Subject|4|||
150203746|NCT00353496|541888200|FG000|Overall Study|Physician Decision|6|||
150203747|NCT00353496|541888201|FG001|Overall Study|Physician Decision|9|||
150203748|NCT00353496|541888200|FG000|Overall Study|Not otherwise specified|4|||
150203749|NCT00353496|541888201|FG001|Overall Study|Not otherwise specified|2|||
150203750|NCT02180867|541888203|FG000|Overall Study|Adverse Event|3|||
150203751|NCT02180867|541888204|FG001|Overall Study|Adverse Event|4|||
150203752|NCT02180867|541888205|FG002|Overall Study|Adverse Event|1|||
150203753|NCT02180867|541888206|FG003|Overall Study|Adverse Event|5|||
150203754|NCT02180867|541888207|FG004|Overall Study|Adverse Event|0|||
150203755|NCT02180867|541888208|FG005|Overall Study|Adverse Event|0|||
150203756|NCT02180867|541888209|FG006|Overall Study|Adverse Event|0|||
150203757|NCT02180867|541888203|FG000|Overall Study|Death|0|||
150203758|NCT02180867|541888204|FG001|Overall Study|Death|0|||
150203759|NCT02180867|541888205|FG002|Overall Study|Death|0|||
150203760|NCT02180867|541888206|FG003|Overall Study|Death|0|||
150203761|NCT02180867|541888207|FG004|Overall Study|Death|1|||
150203762|NCT02180867|541888208|FG005|Overall Study|Death|0|||
150203763|NCT02180867|541888209|FG006|Overall Study|Death|0|||
150203764|NCT02180867|541888203|FG000|Overall Study|Lack of Efficacy|0|||
150203765|NCT02180867|541888204|FG001|Overall Study|Lack of Efficacy|2|||
150203766|NCT02180867|541888205|FG002|Overall Study|Lack of Efficacy|0|||
150203767|NCT02180867|541888206|FG003|Overall Study|Lack of Efficacy|1|||
150203768|NCT02180867|541888207|FG004|Overall Study|Lack of Efficacy|6|||
150203769|NCT02180867|541888208|FG005|Overall Study|Lack of Efficacy|0|||
150203770|NCT02180867|541888209|FG006|Overall Study|Lack of Efficacy|1|||
150203771|NCT02180867|541888203|FG000|Overall Study|Physician Decision|1|||
150203772|NCT02180867|541888204|FG001|Overall Study|Physician Decision|3|||
150203773|NCT02180867|541888205|FG002|Overall Study|Physician Decision|1|||
150203774|NCT02180867|541888206|FG003|Overall Study|Physician Decision|10|||
150203775|NCT02180867|541888207|FG004|Overall Study|Physician Decision|9|||
150203776|NCT02180867|541888208|FG005|Overall Study|Physician Decision|3|||
150203777|NCT02180867|541888209|FG006|Overall Study|Physician Decision|4|||
150203778|NCT02180867|541888203|FG000|Overall Study|Withdrawal by Subject|0|||
150203779|NCT02180867|541888204|FG001|Overall Study|Withdrawal by Subject|0|||
150203780|NCT02180867|541888205|FG002|Overall Study|Withdrawal by Subject|0|||
150203781|NCT02180867|541888206|FG003|Overall Study|Withdrawal by Subject|1|||
150203782|NCT02180867|541888207|FG004|Overall Study|Withdrawal by Subject|1|||
150203783|NCT02180867|541888208|FG005|Overall Study|Withdrawal by Subject|0|||
150203784|NCT02180867|541888209|FG006|Overall Study|Withdrawal by Subject|0|||
150203785|NCT02180867|541888203|FG000|Overall Study|Ineligible|1|||
150203786|NCT02180867|541888204|FG001|Overall Study|Ineligible|2|||
150203787|NCT02180867|541888205|FG002|Overall Study|Ineligible|0|||
150203788|NCT02180867|541888206|FG003|Overall Study|Ineligible|3|||
150203789|NCT02180867|541888207|FG004|Overall Study|Ineligible|5|||
150203790|NCT02180867|541888208|FG005|Overall Study|Ineligible|0|||
150203791|NCT02180867|541888209|FG006|Overall Study|Ineligible|0|||
150203792|NCT02180867|541888203|FG000|Overall Study|Repeat Eligibility Studies|0|||
150203793|NCT02180867|541888204|FG001|Overall Study|Repeat Eligibility Studies|0|||
150203794|NCT02180867|541888205|FG002|Overall Study|Repeat Eligibility Studies|0|||
150203795|NCT02180867|541888206|FG003|Overall Study|Repeat Eligibility Studies|0|||
150203796|NCT02180867|541888207|FG004|Overall Study|Repeat Eligibility Studies|1|||
150203797|NCT02180867|541888208|FG005|Overall Study|Repeat Eligibility Studies|0|||
150203798|NCT02180867|541888209|FG006|Overall Study|Repeat Eligibility Studies|0|||
150203799|NCT02180867|541888203|FG000|Overall Study|Refusal of further protocol therapy|1|||
150203800|NCT02180867|541888204|FG001|Overall Study|Refusal of further protocol therapy|0|||
150203801|NCT02180867|541888205|FG002|Overall Study|Refusal of further protocol therapy|2|||
150203802|NCT02180867|541888206|FG003|Overall Study|Refusal of further protocol therapy|6|||
150203803|NCT02180867|541888207|FG004|Overall Study|Refusal of further protocol therapy|4|||
150203804|NCT02180867|541888208|FG005|Overall Study|Refusal of further protocol therapy|0|||
150203805|NCT02180867|541888209|FG006|Overall Study|Refusal of further protocol therapy|0|||
150203806|NCT04974047|541888808|FG000|Overall Study|Sponsor Ended Study|20|||
150203807|NCT04974047|541888809|FG001|Overall Study|Sponsor Ended Study|22|||
150203808|NCT04974047|541888808|FG000|Overall Study|Death|8|||
150203809|NCT04974047|541888809|FG001|Overall Study|Death|17|||
150203810|NCT04974047|541888808|FG000|Overall Study|Lost to Follow-up|2|||
150203811|NCT04974047|541888809|FG001|Overall Study|Lost to Follow-up|0|||
150203812|NCT04974047|541888808|FG000|Overall Study|Withdrawal by Subject|0|||
150203813|NCT04974047|541888809|FG001|Overall Study|Withdrawal by Subject|1|||
150203814|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Other|0|||
150203815|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Other|2|||
150203816|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Other|1|||
150203817|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Other|2|||
150203818|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Other|2|||
150203819|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Other|0|||
150203820|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Other|0|||
150203821|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Other|0|||
150203822|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Other|0|||
150203823|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Other|0|||
150203824|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Other|0|||
150203825|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Other|0|||
150203826|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Other|0|||
150203827|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Other|0|||
150203828|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Other|0|||
150203829|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Other|0|||
150203830|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Other|0|||
150203831|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
150203832|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
150203833|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
150203834|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
150203835|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
150203836|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
150203837|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203838|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203839|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203840|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203841|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203842|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203843|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203844|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203845|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203846|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203847|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
150203848|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203849|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
150203850|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
150203851|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203852|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
150203853|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
150203854|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203855|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203856|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203857|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203858|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203859|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203860|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203861|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203862|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203863|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203864|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
150203865|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Death|2|||
150203866|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Death|1|||
150203867|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Death|1|||
150203868|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Death|0|||
150203869|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Death|0|||
150203870|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Death|0|||
150203871|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Death|0|||
150203872|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Death|0|||
150203873|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Death|0|||
150203874|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Death|0|||
150203875|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Death|0|||
150203876|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Death|0|||
150203877|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Death|0|||
150203878|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Death|0|||
150203879|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Death|0|||
150203880|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Death|0|||
150203881|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Death|0|||
150203882|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203883|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
150203884|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203885|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203886|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
150203887|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
150203888|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203889|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203890|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203891|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203892|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203893|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203894|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203895|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203896|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203897|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203898|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
150203899|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203900|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203901|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203902|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203903|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
150203904|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
150203905|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203906|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203907|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203908|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203909|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203910|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203911|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203912|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203913|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203914|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203915|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
150203916|NCT02719574|541888810|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203917|NCT02719574|541888811|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203918|NCT02719574|541888812|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
150203919|NCT02719574|541888813|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203920|NCT02719574|541888814|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203921|NCT02719574|541888815|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203922|NCT02719574|541888816|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203923|NCT02719574|541888817|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203924|NCT02719574|541888818|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203925|NCT02719574|541888819|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203926|NCT02719574|541888820|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203927|NCT02719574|541888821|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203928|NCT02719574|541888822|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203929|NCT02719574|541888823|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203930|NCT02719574|541888824|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203931|NCT02719574|541888825|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203932|NCT02719574|541888826|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
150203933|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203934|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203935|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203936|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203937|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203938|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203939|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
150203940|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
150203941|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
150203942|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203943|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203944|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203945|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203946|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203947|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203948|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203949|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
150203950|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203951|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203952|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203953|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203954|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203955|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203956|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
150203957|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
150203958|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203959|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203960|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203961|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203962|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203963|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203964|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203965|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203966|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
150203967|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|Death|0|||
150203968|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|Death|0|||
150203969|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|Death|0|||
150203970|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|Death|0|||
150203971|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|Death|0|||
150203972|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|Death|0|||
150203973|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|Death|1|||
150203974|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|Death|6|||
150203975|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|Death|0|||
150203976|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|Death|0|||
150203977|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|Death|0|||
150203978|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|Death|0|||
150203979|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|Death|0|||
150203980|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|Death|0|||
150203981|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|Death|0|||
150203982|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|Death|0|||
150203983|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|Death|0|||
150203984|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203985|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203986|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203987|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203988|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203989|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203990|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
150203991|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
150203992|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203993|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203994|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203995|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203996|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203997|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203998|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
150203999|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
150204000|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
150204001|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204002|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204003|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204004|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204005|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204006|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204007|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
150204008|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
150204009|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204010|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204011|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204012|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204013|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204014|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204015|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204016|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204017|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
150204018|NCT02719574|541888810|FG000|Phase 1 (Dose Expansion)|Other|0|||
150204019|NCT02719574|541888811|FG001|Phase 1 (Dose Expansion)|Other|0|||
150204020|NCT02719574|541888812|FG002|Phase 1 (Dose Expansion)|Other|0|||
150204021|NCT02719574|541888813|FG003|Phase 1 (Dose Expansion)|Other|0|||
150204022|NCT02719574|541888814|FG004|Phase 1 (Dose Expansion)|Other|0|||
150204023|NCT02719574|541888815|FG005|Phase 1 (Dose Expansion)|Other|0|||
150204024|NCT02719574|541888816|FG006|Phase 1 (Dose Expansion)|Other|1|||
150204025|NCT02719574|541888817|FG007|Phase 1 (Dose Expansion)|Other|7|||
150204026|NCT02719574|541888818|FG008|Phase 1 (Dose Expansion)|Other|0|||
150204027|NCT02719574|541888819|FG009|Phase 1 (Dose Expansion)|Other|0|||
150204028|NCT02719574|541888820|FG010|Phase 1 (Dose Expansion)|Other|0|||
150204029|NCT02719574|541888821|FG011|Phase 1 (Dose Expansion)|Other|0|||
150204030|NCT02719574|541888822|FG012|Phase 1 (Dose Expansion)|Other|0|||
150204031|NCT02719574|541888823|FG013|Phase 1 (Dose Expansion)|Other|0|||
150204032|NCT02719574|541888824|FG014|Phase 1 (Dose Expansion)|Other|0|||
150204033|NCT02719574|541888825|FG015|Phase 1 (Dose Expansion)|Other|0|||
150204034|NCT02719574|541888826|FG016|Phase 1 (Dose Expansion)|Other|0|||
150204035|NCT02719574|541888810|FG000|Phase 2|Protocol Defined Disease Progression|0|||
150204036|NCT02719574|541888811|FG001|Phase 2|Protocol Defined Disease Progression|0|||
150204037|NCT02719574|541888812|FG002|Phase 2|Protocol Defined Disease Progression|0|||
150204038|NCT02719574|541888813|FG003|Phase 2|Protocol Defined Disease Progression|0|||
150204039|NCT02719574|541888814|FG004|Phase 2|Protocol Defined Disease Progression|0|||
150204040|NCT02719574|541888815|FG005|Phase 2|Protocol Defined Disease Progression|0|||
150204041|NCT02719574|541888816|FG006|Phase 2|Protocol Defined Disease Progression|0|||
150204042|NCT02719574|541888817|FG007|Phase 2|Protocol Defined Disease Progression|0|||
150204043|NCT02719574|541888818|FG008|Phase 2|Protocol Defined Disease Progression|0|||
150204044|NCT02719574|541888819|FG009|Phase 2|Protocol Defined Disease Progression|65|||
150204045|NCT02719574|541888820|FG010|Phase 2|Protocol Defined Disease Progression|8|||
150204046|NCT02719574|541888821|FG011|Phase 2|Protocol Defined Disease Progression|2|||
150204047|NCT02719574|541888822|FG012|Phase 2|Protocol Defined Disease Progression|4|||
150204048|NCT02719574|541888823|FG013|Phase 2|Protocol Defined Disease Progression|9|||
150204049|NCT02719574|541888824|FG014|Phase 2|Protocol Defined Disease Progression|11|||
150204050|NCT02719574|541888825|FG015|Phase 2|Protocol Defined Disease Progression|3|||
150204051|NCT02719574|541888826|FG016|Phase 2|Protocol Defined Disease Progression|4|||
150204052|NCT02719574|541888810|FG000|Phase 2|Adverse Event|0|||
150204053|NCT02719574|541888811|FG001|Phase 2|Adverse Event|0|||
150204054|NCT02719574|541888812|FG002|Phase 2|Adverse Event|0|||
150204055|NCT02719574|541888813|FG003|Phase 2|Adverse Event|0|||
150204056|NCT02719574|541888814|FG004|Phase 2|Adverse Event|0|||
150204057|NCT02719574|541888815|FG005|Phase 2|Adverse Event|0|||
150204058|NCT02719574|541888816|FG006|Phase 2|Adverse Event|0|||
150204059|NCT02719574|541888817|FG007|Phase 2|Adverse Event|0|||
150204060|NCT02719574|541888818|FG008|Phase 2|Adverse Event|0|||
150204061|NCT02719574|541888819|FG009|Phase 2|Adverse Event|27|||
150204062|NCT02719574|541888820|FG010|Phase 2|Adverse Event|0|||
150204063|NCT02719574|541888821|FG011|Phase 2|Adverse Event|1|||
150204064|NCT02719574|541888822|FG012|Phase 2|Adverse Event|1|||
150204065|NCT02719574|541888823|FG013|Phase 2|Adverse Event|1|||
150204066|NCT02719574|541888824|FG014|Phase 2|Adverse Event|2|||
150204067|NCT02719574|541888825|FG015|Phase 2|Adverse Event|2|||
150204068|NCT02719574|541888826|FG016|Phase 2|Adverse Event|3|||
150204069|NCT02719574|541888810|FG000|Phase 2|Other|0|||
150204070|NCT02719574|541888811|FG001|Phase 2|Other|0|||
150204071|NCT02719574|541888812|FG002|Phase 2|Other|0|||
150204072|NCT02719574|541888813|FG003|Phase 2|Other|0|||
150204073|NCT02719574|541888814|FG004|Phase 2|Other|0|||
150204074|NCT02719574|541888815|FG005|Phase 2|Other|0|||
150204075|NCT02719574|541888816|FG006|Phase 2|Other|0|||
150204076|NCT02719574|541888817|FG007|Phase 2|Other|0|||
150204077|NCT02719574|541888818|FG008|Phase 2|Other|0|||
150204078|NCT02719574|541888819|FG009|Phase 2|Other|20|||
150204079|NCT02719574|541888820|FG010|Phase 2|Other|7|||
150204080|NCT02719574|541888821|FG011|Phase 2|Other|0|||
150204081|NCT02719574|541888822|FG012|Phase 2|Other|5|||
150204082|NCT02719574|541888823|FG013|Phase 2|Other|7|||
150204083|NCT02719574|541888824|FG014|Phase 2|Other|0|||
150204084|NCT02719574|541888825|FG015|Phase 2|Other|1|||
150204085|NCT02719574|541888826|FG016|Phase 2|Other|4|||
150204086|NCT02719574|541888810|FG000|Phase 2|Transplant|0|||
150204087|NCT02719574|541888811|FG001|Phase 2|Transplant|0|||
150204088|NCT02719574|541888812|FG002|Phase 2|Transplant|0|||
150204089|NCT02719574|541888813|FG003|Phase 2|Transplant|0|||
150204090|NCT02719574|541888814|FG004|Phase 2|Transplant|0|||
150204091|NCT02719574|541888815|FG005|Phase 2|Transplant|0|||
150204092|NCT02719574|541888816|FG006|Phase 2|Transplant|0|||
150204093|NCT02719574|541888817|FG007|Phase 2|Transplant|0|||
150204094|NCT02719574|541888818|FG008|Phase 2|Transplant|0|||
150204095|NCT02719574|541888819|FG009|Phase 2|Transplant|15|||
150204096|NCT02719574|541888820|FG010|Phase 2|Transplant|2|||
150204097|NCT02719574|541888821|FG011|Phase 2|Transplant|0|||
150204098|NCT02719574|541888822|FG012|Phase 2|Transplant|6|||
150204099|NCT02719574|541888823|FG013|Phase 2|Transplant|1|||
150204100|NCT02719574|541888824|FG014|Phase 2|Transplant|1|||
150204101|NCT02719574|541888825|FG015|Phase 2|Transplant|0|||
150204102|NCT02719574|541888826|FG016|Phase 2|Transplant|0|||
150204103|NCT02719574|541888810|FG000|Phase 2|Death|0|||
150204104|NCT02719574|541888811|FG001|Phase 2|Death|0|||
150204105|NCT02719574|541888812|FG002|Phase 2|Death|0|||
150204106|NCT02719574|541888813|FG003|Phase 2|Death|0|||
150204107|NCT02719574|541888814|FG004|Phase 2|Death|0|||
150204108|NCT02719574|541888815|FG005|Phase 2|Death|0|||
150204109|NCT02719574|541888816|FG006|Phase 2|Death|0|||
150204110|NCT02719574|541888817|FG007|Phase 2|Death|0|||
150204111|NCT02719574|541888818|FG008|Phase 2|Death|0|||
150204112|NCT02719574|541888819|FG009|Phase 2|Death|14|||
150204113|NCT02719574|541888820|FG010|Phase 2|Death|0|||
150204114|NCT02719574|541888821|FG011|Phase 2|Death|0|||
150204115|NCT02719574|541888822|FG012|Phase 2|Death|1|||
150204116|NCT02719574|541888823|FG013|Phase 2|Death|1|||
150204117|NCT02719574|541888824|FG014|Phase 2|Death|2|||
150204118|NCT02719574|541888825|FG015|Phase 2|Death|0|||
150204119|NCT02719574|541888826|FG016|Phase 2|Death|0|||
150204120|NCT02719574|541888810|FG000|Phase 2|Investigator Decision|0|||
150204121|NCT02719574|541888811|FG001|Phase 2|Investigator Decision|0|||
150204122|NCT02719574|541888812|FG002|Phase 2|Investigator Decision|0|||
150204123|NCT02719574|541888813|FG003|Phase 2|Investigator Decision|0|||
150204124|NCT02719574|541888814|FG004|Phase 2|Investigator Decision|0|||
150204125|NCT02719574|541888815|FG005|Phase 2|Investigator Decision|0|||
150204126|NCT02719574|541888816|FG006|Phase 2|Investigator Decision|0|||
150204127|NCT02719574|541888817|FG007|Phase 2|Investigator Decision|0|||
150204128|NCT02719574|541888818|FG008|Phase 2|Investigator Decision|0|||
150204129|NCT02719574|541888819|FG009|Phase 2|Investigator Decision|6|||
150204130|NCT02719574|541888820|FG010|Phase 2|Investigator Decision|1|||
150204131|NCT02719574|541888821|FG011|Phase 2|Investigator Decision|2|||
150204132|NCT02719574|541888822|FG012|Phase 2|Investigator Decision|3|||
150204133|NCT02719574|541888823|FG013|Phase 2|Investigator Decision|1|||
150204134|NCT02719574|541888824|FG014|Phase 2|Investigator Decision|3|||
150204135|NCT02719574|541888825|FG015|Phase 2|Investigator Decision|2|||
150204136|NCT02719574|541888826|FG016|Phase 2|Investigator Decision|0|||
150204137|NCT02719574|541888810|FG000|Phase 2|Withdrawal by Subject|0|||
150204138|NCT02719574|541888811|FG001|Phase 2|Withdrawal by Subject|0|||
150204139|NCT02719574|541888812|FG002|Phase 2|Withdrawal by Subject|0|||
150204140|NCT02719574|541888813|FG003|Phase 2|Withdrawal by Subject|0|||
150204141|NCT02719574|541888814|FG004|Phase 2|Withdrawal by Subject|0|||
150204142|NCT02719574|541888815|FG005|Phase 2|Withdrawal by Subject|0|||
150204143|NCT02719574|541888816|FG006|Phase 2|Withdrawal by Subject|0|||
150204144|NCT02719574|541888817|FG007|Phase 2|Withdrawal by Subject|0|||
150204145|NCT02719574|541888818|FG008|Phase 2|Withdrawal by Subject|0|||
150204146|NCT02719574|541888819|FG009|Phase 2|Withdrawal by Subject|5|||
150204147|NCT02719574|541888820|FG010|Phase 2|Withdrawal by Subject|0|||
150204148|NCT02719574|541888821|FG011|Phase 2|Withdrawal by Subject|0|||
150204149|NCT02719574|541888822|FG012|Phase 2|Withdrawal by Subject|0|||
150204150|NCT02719574|541888823|FG013|Phase 2|Withdrawal by Subject|1|||
150204151|NCT02719574|541888824|FG014|Phase 2|Withdrawal by Subject|1|||
150204152|NCT02719574|541888825|FG015|Phase 2|Withdrawal by Subject|2|||
150204153|NCT02719574|541888826|FG016|Phase 2|Withdrawal by Subject|0|||
150204154|NCT02719574|541888810|FG000|Phase 2|Protocol Violation|0|||
150204155|NCT02719574|541888811|FG001|Phase 2|Protocol Violation|0|||
150204156|NCT02719574|541888812|FG002|Phase 2|Protocol Violation|0|||
150204157|NCT02719574|541888813|FG003|Phase 2|Protocol Violation|0|||
150204158|NCT02719574|541888814|FG004|Phase 2|Protocol Violation|0|||
150204159|NCT02719574|541888815|FG005|Phase 2|Protocol Violation|0|||
150204160|NCT02719574|541888816|FG006|Phase 2|Protocol Violation|0|||
150204161|NCT02719574|541888817|FG007|Phase 2|Protocol Violation|0|||
150204162|NCT02719574|541888818|FG008|Phase 2|Protocol Violation|0|||
150204163|NCT02719574|541888819|FG009|Phase 2|Protocol Violation|1|||
150204164|NCT02719574|541888820|FG010|Phase 2|Protocol Violation|0|||
150204165|NCT02719574|541888821|FG011|Phase 2|Protocol Violation|0|||
150204166|NCT02719574|541888822|FG012|Phase 2|Protocol Violation|0|||
150204167|NCT02719574|541888823|FG013|Phase 2|Protocol Violation|0|||
150204168|NCT02719574|541888824|FG014|Phase 2|Protocol Violation|0|||
150204169|NCT02719574|541888825|FG015|Phase 2|Protocol Violation|0|||
150204170|NCT02719574|541888826|FG016|Phase 2|Protocol Violation|0|||
150204171|NCT00495677|541888831|FG000|Stage 1 (25 Days)|Adverse Event|0|||
150204172|NCT00495677|541888832|FG001|Stage 1 (25 Days)|Adverse Event|0|||
150204173|NCT00495677|541888833|FG002|Stage 1 (25 Days)|Adverse Event|1|||
150204174|NCT00495677|541888834|FG003|Stage 1 (25 Days)|Adverse Event|0|||
150204175|NCT00495677|541888835|FG004|Stage 1 (25 Days)|Adverse Event|0|||
150204176|NCT00495677|541888836|FG005|Stage 1 (25 Days)|Adverse Event|0|||
150204177|NCT00495677|541888837|FG006|Stage 1 (25 Days)|Adverse Event|0|||
150204178|NCT04129164|541888842|FG000|Overall Study|Non-compliance with procedures|0|||
150204179|NCT04129164|541888843|FG001|Overall Study|Non-compliance with procedures|0|||
150204180|NCT04129164|541888844|FG002|Overall Study|Non-compliance with procedures|2|||
150204181|NCT04129164|541888845|FG003|Overall Study|Non-compliance with procedures|0|||
150204182|NCT04129164|541888842|FG000|Overall Study|Adverse Event|0|||
150204183|NCT04129164|541888843|FG001|Overall Study|Adverse Event|0|||
150204184|NCT04129164|541888844|FG002|Overall Study|Adverse Event|2|||
150204185|NCT04129164|541888845|FG003|Overall Study|Adverse Event|0|||
150204186|NCT04129164|541888842|FG000|Overall Study|Pregnancy|0|||
150204187|NCT04129164|541888843|FG001|Overall Study|Pregnancy|0|||
150204188|NCT04129164|541888844|FG002|Overall Study|Pregnancy|0|||
150204189|NCT04129164|541888845|FG003|Overall Study|Pregnancy|1|||
150204190|NCT04129164|541888842|FG000|Overall Study|Withdrawal by Subject|3|||
150204191|NCT04129164|541888843|FG001|Overall Study|Withdrawal by Subject|2|||
150204192|NCT04129164|541888844|FG002|Overall Study|Withdrawal by Subject|4|||
150204193|NCT04129164|541888845|FG003|Overall Study|Withdrawal by Subject|6|||
150204194|NCT04129164|541888842|FG000|Overall Study|Death|0|||
150204195|NCT04129164|541888843|FG001|Overall Study|Death|1|||
150204196|NCT04129164|541888844|FG002|Overall Study|Death|0|||
150204197|NCT04129164|541888845|FG003|Overall Study|Death|0|||
150204198|NCT04129164|541888842|FG000|Overall Study|Lost to Follow-up|0|||
150204199|NCT04129164|541888843|FG001|Overall Study|Lost to Follow-up|1|||
150204200|NCT04129164|541888844|FG002|Overall Study|Lost to Follow-up|0|||
150204201|NCT04129164|541888845|FG003|Overall Study|Lost to Follow-up|0|||
150204202|NCT02306161|541888847|FG000|Overall Study|Death|1|||
150204203|NCT02306161|541888848|FG001|Overall Study|Death|3|||
150204204|NCT02306161|541888847|FG000|Overall Study|Lack of Efficacy|20|||
150204205|NCT02306161|541888848|FG001|Overall Study|Lack of Efficacy|43|||
150204206|NCT02306161|541888847|FG000|Overall Study|Physician Decision|30|||
150204207|NCT02306161|541888848|FG001|Overall Study|Physician Decision|18|||
150204208|NCT02306161|541888847|FG000|Overall Study|Withdrawal by Subject|4|||
150204209|NCT02306161|541888848|FG001|Overall Study|Withdrawal by Subject|0|||
150204210|NCT02306161|541888847|FG000|Overall Study|Ineligible|9|||
150204211|NCT02306161|541888848|FG001|Overall Study|Ineligible|5|||
150204212|NCT03983382|541888849|FG000|Overall Study|Death|1|||
150204213|NCT03983382|541888849|FG000|Overall Study|Lost to Follow-up|3|||
150204214|NCT03983382|541888849|FG000|Overall Study|Physician Decision|2|||
150204215|NCT03983382|541888849|FG000|Overall Study|Withdrawal by Subject|10|||
150204216|NCT03983382|541888849|FG000|Overall Study|Change in cancer treatment|2|||
150204217|NCT02166463|541888856|FG000|Overall Study|Lost to Follow-up|0|||
150204218|NCT02166463|541888857|FG001|Overall Study|Lost to Follow-up|1|||
150204219|NCT02166463|541888856|FG000|Overall Study|Physician Decision|10|||
150204220|NCT02166463|541888857|FG001|Overall Study|Physician Decision|10|||
150204221|NCT02166463|541888856|FG000|Overall Study|Ineligible|11|||
150204222|NCT02166463|541888857|FG001|Overall Study|Ineligible|2|||
150204223|NCT02166463|541888856|FG000|Overall Study|Progressive Disease|9|||
150204224|NCT02166463|541888857|FG001|Overall Study|Progressive Disease|6|||
150204225|NCT02166463|541888856|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
150204226|NCT02166463|541888857|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
150204227|NCT02166463|541888856|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
150204228|NCT02166463|541888857|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
150204229|NCT02166463|541888856|FG000|Overall Study|Refusal of further protocol therapy|5|||
150204230|NCT02166463|541888857|FG001|Overall Study|Refusal of further protocol therapy|6|||
150204231|NCT06393127|541888858|FG000|Washout period|Withdrawal by Subject|1|||
150204232|NCT06393127|541888859|FG001|Washout period|Withdrawal by Subject|0|||
150204233|NCT06393127|541888858|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
150204234|NCT06393127|541888859|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
150204235|NCT02466971|541888860|FG000|Overall Study|eligible and never treated|14|||
150204236|NCT02466971|541888861|FG001|Overall Study|eligible and never treated|20|||
150204237|NCT02466971|541888860|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
150204238|NCT02466971|541888861|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
150204239|NCT02466971|541888860|FG000|Overall Study|ineligible and treated|1|||
150204240|NCT02466971|541888861|FG001|Overall Study|ineligible and treated|0|||
150204241|NCT02466971|541888860|FG000|Overall Study|ineligible and never treated|0|||
150204242|NCT02466971|541888861|FG001|Overall Study|ineligible and never treated|1|||
150204243|NCT04174560|541888866|FG000|Overall Study|Lost to Follow-up|1|||
150204244|NCT04174560|541888867|FG001|Overall Study|Lost to Follow-up|0|||
150204245|NCT04174560|541888868|FG002|Overall Study|Lost to Follow-up|0|||
150204246|NCT04174560|541888869|FG003|Overall Study|Lost to Follow-up|0|||
150204247|NCT04174560|541888866|FG000|Overall Study|Withdrawal by Subject|0|||
150204248|NCT04174560|541888867|FG001|Overall Study|Withdrawal by Subject|0|||
150204249|NCT04174560|541888868|FG002|Overall Study|Withdrawal by Subject|2|||
150204250|NCT04174560|541888869|FG003|Overall Study|Withdrawal by Subject|0|||
150204251|NCT04479787|541888872|FG000|Through 6 Months|Withdrawal by Subject|16|||
150204252|NCT04479787|541888873|FG001|Through 6 Months|Withdrawal by Subject|14|||
150204253|NCT04479787|541888872|FG000|Through 6 Months|Unsuccessful Trial|17|||
150204254|NCT04479787|541888873|FG001|Through 6 Months|Unsuccessful Trial|0|||
150204255|NCT04479787|541888872|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
150204256|NCT04479787|541888873|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
150204257|NCT04479787|541888872|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
150204258|NCT04479787|541888873|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
150204259|NCT04479787|541888872|FG000|Through 6 Months|Lost to Follow-up|3|||
150204260|NCT04479787|541888873|FG001|Through 6 Months|Lost to Follow-up|2|||
150204261|NCT04479787|541888872|FG000|Through 6 Months|Death|3|||
150204262|NCT04479787|541888873|FG001|Through 6 Months|Death|0|||
150204263|NCT04479787|541888872|FG000|Through 6 Months|Inclusion/Exclusion|2|||
150204264|NCT04479787|541888873|FG001|Through 6 Months|Inclusion/Exclusion|1|||
150204265|NCT04479787|541888872|FG000|Through 6 Months|Subject Became Pregnant|1|||
150204266|NCT04479787|541888873|FG001|Through 6 Months|Subject Became Pregnant|1|||
150204267|NCT04479787|541888872|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
150204268|NCT04479787|541888873|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
150204269|NCT04479787|541888872|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
150204270|NCT04479787|541888873|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
150204271|NCT04479787|541888872|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
150204272|NCT04479787|541888873|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
150204273|NCT04479787|541888872|FG000|After 6 Months|Withdrawal by Subject|3|||
150204274|NCT04479787|541888873|FG001|After 6 Months|Withdrawal by Subject|13|||
150204275|NCT04479787|541888872|FG000|After 6 Months|Unsuccessful Trial|0|||
150204276|NCT04479787|541888873|FG001|After 6 Months|Unsuccessful Trial|7|||
150204277|NCT04479787|541888872|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
150204278|NCT04479787|541888873|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
150204279|NCT04479787|541888872|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
150204280|NCT04479787|541888873|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
150204281|NCT04479787|541888872|FG000|After 6 Months|Death|2|||
150204282|NCT04479787|541888873|FG001|After 6 Months|Death|0|||
150204283|NCT04479787|541888872|FG000|After 6 Months|Lost to Follow-up|1|||
150204284|NCT04479787|541888873|FG001|After 6 Months|Lost to Follow-up|1|||
150204285|NCT04479787|541888872|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
150204286|NCT04479787|541888873|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
150204287|NCT04479787|541888872|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
150204288|NCT04479787|541888873|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
150204289|NCT04479787|541888872|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
150204290|NCT04479787|541888873|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
150204291|NCT04479787|541888872|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
150204292|NCT04479787|541888873|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
150204293|NCT04129450|541888880|FG000|Overall Study|Lost to Follow-up|20|||
150204294|NCT04129450|541888881|FG001|Overall Study|Lost to Follow-up|10|||
150204295|NCT04129450|541888880|FG000|Overall Study|Withdrawal by Subject|9|||
150204296|NCT04129450|541888881|FG001|Overall Study|Withdrawal by Subject|5|||
150204297|NCT04129450|541888880|FG000|Overall Study|Work Family Obligations|2|||
150204298|NCT04129450|541888881|FG001|Overall Study|Work Family Obligations|0|||
150204299|NCT04129450|541888880|FG000|Overall Study|Other|3|||
150204300|NCT04129450|541888881|FG001|Overall Study|Other|0|||
150204301|NCT03391466|541889440|FG000|Overall Study|Death|84|||
150204302|NCT03391466|541889441|FG001|Overall Study|Death|91|||
150204303|NCT03391466|541889440|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
150204304|NCT03391466|541889441|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
150204305|NCT03391466|541889440|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
150204306|NCT03391466|541889441|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
150204307|NCT03391466|541889440|FG000|Overall Study|Lost to Follow-up|9|||
150204308|NCT03391466|541889441|FG001|Overall Study|Lost to Follow-up|5|||
150204309|NCT03391466|541889440|FG000|Overall Study|Reason Not Specified|2|||
150204310|NCT03391466|541889441|FG001|Overall Study|Reason Not Specified|2|||
150204311|NCT03391466|541889440|FG000|Overall Study|Investigator Decision|0|||
150204312|NCT03391466|541889441|FG001|Overall Study|Investigator Decision|1|||
150204313|NCT03653364|541889442|FG000|Overall Study|Withdrawal by Subject|1|||
150204314|NCT03653364|541889442|FG000|Overall Study|Enrolled in Error|1|||
150204315|NCT03653364|541889442|FG000|Overall Study|Death|1|||
150204316|NCT01171976|541889448|FG000|Overall Study|Protocol Violation|0|||
150204317|NCT01171976|541889449|FG001|Overall Study|Protocol Violation|0|||
150204318|NCT01171976|541889450|FG002|Overall Study|Protocol Violation|1|||
150204319|NCT01171976|541889448|FG000|Overall Study|Death|2|||
150204320|NCT01171976|541889449|FG001|Overall Study|Death|4|||
150204321|NCT01171976|541889450|FG002|Overall Study|Death|1|||
150204322|NCT01171976|541889448|FG000|Overall Study|Lost to Follow-up|4|||
150204323|NCT01171976|541889449|FG001|Overall Study|Lost to Follow-up|0|||
150204324|NCT01171976|541889450|FG002|Overall Study|Lost to Follow-up|2|||
150204325|NCT01171976|541889448|FG000|Overall Study|Withdrawal by Subject|1|||
150204326|NCT01171976|541889449|FG001|Overall Study|Withdrawal by Subject|5|||
150204327|NCT01171976|541889450|FG002|Overall Study|Withdrawal by Subject|6|||
150204328|NCT01171976|541889448|FG000|Overall Study|Abnormal test result|1|||
150204329|NCT01171976|541889449|FG001|Overall Study|Abnormal test result|0|||
150204330|NCT01171976|541889450|FG002|Overall Study|Abnormal test result|0|||
150204331|NCT01171976|541889448|FG000|Overall Study|Adverse Event|6|||
150204332|NCT01171976|541889449|FG001|Overall Study|Adverse Event|2|||
150204333|NCT01171976|541889450|FG002|Overall Study|Adverse Event|5|||
150204334|NCT00003222|541889457|FG000|Overall Study|Physician Decision|0|||
150204335|NCT00003222|541889458|FG001|Overall Study|Physician Decision|1|||
150204336|NCT02115282|541889468|FG000|Overall Study|Disease progression during treatment|216|||
150204337|NCT02115282|541889469|FG001|Overall Study|Disease progression during treatment|229|||
150204338|NCT02115282|541889468|FG000|Overall Study|Adverse Event|49|||
150204339|NCT02115282|541889469|FG001|Overall Study|Adverse Event|23|||
150204340|NCT02115282|541889468|FG000|Overall Study|Death|1|||
150204341|NCT02115282|541889469|FG001|Overall Study|Death|3|||
150204342|NCT02115282|541889468|FG000|Overall Study|Alternative therapy|1|||
150204343|NCT02115282|541889469|FG001|Overall Study|Alternative therapy|1|||
150204344|NCT02115282|541889468|FG000|Overall Study|Complicating disease|0|||
150204345|NCT02115282|541889469|FG001|Overall Study|Complicating disease|3|||
150204346|NCT02115282|541889468|FG000|Overall Study|Withdrawal by Subject|12|||
150204347|NCT02115282|541889469|FG001|Overall Study|Withdrawal by Subject|10|||
150204348|NCT02115282|541889468|FG000|Overall Study|Symptomatic progression/deterioration|7|||
150204349|NCT02115282|541889469|FG001|Overall Study|Symptomatic progression/deterioration|18|||
150204350|NCT02115282|541889468|FG000|Overall Study|Non-compliance|5|||
150204351|NCT02115282|541889469|FG001|Overall Study|Non-compliance|1|||
150204352|NCT02115282|541889468|FG000|Overall Study|Protocol Violation|2|||
150204353|NCT02115282|541889469|FG001|Overall Study|Protocol Violation|2|||
150204354|NCT02115282|541889468|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
150204355|NCT02115282|541889469|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
150204356|NCT02115282|541889468|FG000|Overall Study|Not start protocol therapy|9|||
150204357|NCT02115282|541889469|FG001|Overall Study|Not start protocol therapy|10|||
150204358|NCT01313559|541889470|FG000|Overall Study|Withdrawal by Subject|1|||
150204359|NCT01313559|541889471|FG001|Overall Study|Withdrawal by Subject|2|||
150204360|NCT01313559|541889470|FG000|Overall Study|Disease progression|1|||
150204361|NCT01313559|541889471|FG001|Overall Study|Disease progression|0|||
150204362|NCT01313559|541889470|FG000|Overall Study|Rising PSA|2|||
150204363|NCT01313559|541889471|FG001|Overall Study|Rising PSA|0|||
150204364|NCT02754596|541889472|FG000|Overall Study|Withdrawal by Subject|3|||
150204365|NCT02754596|541889473|FG001|Overall Study|Withdrawal by Subject|4|||
150204366|NCT02754596|541889474|FG002|Overall Study|Withdrawal by Subject|0|||
150204367|NCT02754596|541889472|FG000|Overall Study|Physician Decision|1|||
150204368|NCT02754596|541889473|FG001|Overall Study|Physician Decision|1|||
150204369|NCT02754596|541889474|FG002|Overall Study|Physician Decision|1|||
150204370|NCT02754596|541889472|FG000|Overall Study|Lost to Follow-up|1|||
150204371|NCT02754596|541889473|FG001|Overall Study|Lost to Follow-up|1|||
150204372|NCT02754596|541889474|FG002|Overall Study|Lost to Follow-up|2|||
150204373|NCT02754596|541889472|FG000|Overall Study|Death|0|||
150204374|NCT02754596|541889473|FG001|Overall Study|Death|2|||
150204375|NCT02754596|541889474|FG002|Overall Study|Death|0|||
150204376|NCT02754596|541889472|FG000|Overall Study|Adverse Event|1|||
150204377|NCT02754596|541889473|FG001|Overall Study|Adverse Event|0|||
150204378|NCT02754596|541889474|FG002|Overall Study|Adverse Event|1|||
150204379|NCT02754596|541889472|FG000|Overall Study|Other|1|||
150204380|NCT02754596|541889473|FG001|Overall Study|Other|0|||
150204381|NCT02754596|541889474|FG002|Overall Study|Other|0|||
150204382|NCT02101853|541889477|FG000|Block 1 Induction|Adverse Event|11|||
150204383|NCT02101853|541889478|FG001|Block 1 Induction|Adverse Event|0|||
150204384|NCT02101853|541889479|FG002|Block 1 Induction|Adverse Event|0|||
150204385|NCT02101853|541889480|FG003|Block 1 Induction|Adverse Event|0|||
150204386|NCT02101853|541889481|FG004|Block 1 Induction|Adverse Event|0|||
150204387|NCT02101853|541889482|FG005|Block 1 Induction|Adverse Event|0|||
150204388|NCT02101853|541889477|FG000|Block 1 Induction|Death|20|||
150204389|NCT02101853|541889478|FG001|Block 1 Induction|Death|0|||
150204390|NCT02101853|541889479|FG002|Block 1 Induction|Death|0|||
150204391|NCT02101853|541889480|FG003|Block 1 Induction|Death|0|||
150204392|NCT02101853|541889481|FG004|Block 1 Induction|Death|0|||
150204393|NCT02101853|541889482|FG005|Block 1 Induction|Death|0|||
150204394|NCT02101853|541889477|FG000|Block 1 Induction|Lack of Efficacy|6|||
150204395|NCT02101853|541889478|FG001|Block 1 Induction|Lack of Efficacy|0|||
150204396|NCT02101853|541889479|FG002|Block 1 Induction|Lack of Efficacy|0|||
150204397|NCT02101853|541889480|FG003|Block 1 Induction|Lack of Efficacy|0|||
150204398|NCT02101853|541889481|FG004|Block 1 Induction|Lack of Efficacy|0|||
150204399|NCT02101853|541889482|FG005|Block 1 Induction|Lack of Efficacy|0|||
150204400|NCT02101853|541889477|FG000|Block 1 Induction|Physician Decision|61|||
150204401|NCT02101853|541889478|FG001|Block 1 Induction|Physician Decision|0|||
150204402|NCT02101853|541889479|FG002|Block 1 Induction|Physician Decision|0|||
150204403|NCT02101853|541889480|FG003|Block 1 Induction|Physician Decision|0|||
150204404|NCT02101853|541889481|FG004|Block 1 Induction|Physician Decision|0|||
150204405|NCT02101853|541889482|FG005|Block 1 Induction|Physician Decision|0|||
150204406|NCT02101853|541889477|FG000|Block 1 Induction|Protocol Violation|2|||
150204407|NCT02101853|541889478|FG001|Block 1 Induction|Protocol Violation|0|||
150204408|NCT02101853|541889479|FG002|Block 1 Induction|Protocol Violation|0|||
150204409|NCT02101853|541889480|FG003|Block 1 Induction|Protocol Violation|0|||
150204410|NCT02101853|541889481|FG004|Block 1 Induction|Protocol Violation|0|||
150204411|NCT02101853|541889482|FG005|Block 1 Induction|Protocol Violation|0|||
150204412|NCT02101853|541889477|FG000|Block 1 Induction|Withdrawal by Subject|65|||
150204413|NCT02101853|541889478|FG001|Block 1 Induction|Withdrawal by Subject|0|||
150204414|NCT02101853|541889479|FG002|Block 1 Induction|Withdrawal by Subject|0|||
150204415|NCT02101853|541889480|FG003|Block 1 Induction|Withdrawal by Subject|0|||
150204416|NCT02101853|541889481|FG004|Block 1 Induction|Withdrawal by Subject|0|||
150204417|NCT02101853|541889482|FG005|Block 1 Induction|Withdrawal by Subject|0|||
150204418|NCT02101853|541889477|FG000|Block 1 Induction|Ineligible|8|||
150204419|NCT02101853|541889478|FG001|Block 1 Induction|Ineligible|0|||
150204420|NCT02101853|541889479|FG002|Block 1 Induction|Ineligible|0|||
150204421|NCT02101853|541889480|FG003|Block 1 Induction|Ineligible|0|||
150204422|NCT02101853|541889481|FG004|Block 1 Induction|Ineligible|0|||
150204423|NCT02101853|541889482|FG005|Block 1 Induction|Ineligible|0|||
150204424|NCT02101853|541889477|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
150204425|NCT02101853|541889478|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
150204426|NCT02101853|541889479|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
150204427|NCT02101853|541889480|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
150204428|NCT02101853|541889481|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
150204429|NCT02101853|541889482|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
150204430|NCT02101853|541889477|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
150204431|NCT02101853|541889478|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204432|NCT02101853|541889479|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204433|NCT02101853|541889480|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204434|NCT02101853|541889481|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204435|NCT02101853|541889482|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204436|NCT02101853|541889477|FG000|Post Induction Randomization|Adverse Event|0|||
150204437|NCT02101853|541889478|FG001|Post Induction Randomization|Adverse Event|3|||
150204438|NCT02101853|541889479|FG002|Post Induction Randomization|Adverse Event|8|||
150204439|NCT02101853|541889480|FG003|Post Induction Randomization|Adverse Event|4|||
150204440|NCT02101853|541889481|FG004|Post Induction Randomization|Adverse Event|4|||
150204441|NCT02101853|541889482|FG005|Post Induction Randomization|Adverse Event|0|||
150204442|NCT02101853|541889477|FG000|Post Induction Randomization|Death|0|||
150204443|NCT02101853|541889478|FG001|Post Induction Randomization|Death|9|||
150204444|NCT02101853|541889479|FG002|Post Induction Randomization|Death|2|||
150204445|NCT02101853|541889480|FG003|Post Induction Randomization|Death|2|||
150204446|NCT02101853|541889481|FG004|Post Induction Randomization|Death|0|||
150204447|NCT02101853|541889482|FG005|Post Induction Randomization|Death|0|||
150204448|NCT02101853|541889477|FG000|Post Induction Randomization|Lack of Efficacy|0|||
150204449|NCT02101853|541889478|FG001|Post Induction Randomization|Lack of Efficacy|14|||
150204450|NCT02101853|541889479|FG002|Post Induction Randomization|Lack of Efficacy|23|||
150204451|NCT02101853|541889480|FG003|Post Induction Randomization|Lack of Efficacy|18|||
150204452|NCT02101853|541889481|FG004|Post Induction Randomization|Lack of Efficacy|21|||
150204453|NCT02101853|541889482|FG005|Post Induction Randomization|Lack of Efficacy|0|||
150204454|NCT02101853|541889477|FG000|Post Induction Randomization|Physician Decision|0|||
150204455|NCT02101853|541889478|FG001|Post Induction Randomization|Physician Decision|43|||
150204456|NCT02101853|541889479|FG002|Post Induction Randomization|Physician Decision|23|||
150204457|NCT02101853|541889480|FG003|Post Induction Randomization|Physician Decision|14|||
150204458|NCT02101853|541889481|FG004|Post Induction Randomization|Physician Decision|14|||
150204459|NCT02101853|541889482|FG005|Post Induction Randomization|Physician Decision|0|||
150204460|NCT02101853|541889477|FG000|Post Induction Randomization|Protocol Violation|0|||
150204461|NCT02101853|541889478|FG001|Post Induction Randomization|Protocol Violation|3|||
150204462|NCT02101853|541889479|FG002|Post Induction Randomization|Protocol Violation|0|||
150204463|NCT02101853|541889480|FG003|Post Induction Randomization|Protocol Violation|0|||
150204464|NCT02101853|541889481|FG004|Post Induction Randomization|Protocol Violation|0|||
150204465|NCT02101853|541889482|FG005|Post Induction Randomization|Protocol Violation|0|||
150204466|NCT02101853|541889477|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
150204467|NCT02101853|541889478|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
150204468|NCT02101853|541889479|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
150204469|NCT02101853|541889480|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
150204470|NCT02101853|541889481|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
150204471|NCT02101853|541889482|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
150204472|NCT02101853|541889477|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204473|NCT02101853|541889478|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204474|NCT02101853|541889479|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204475|NCT02101853|541889480|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
150204476|NCT02101853|541889481|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204477|NCT02101853|541889482|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
150204478|NCT02101853|541889477|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
150204479|NCT02101853|541889478|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
150204480|NCT02101853|541889479|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
150204481|NCT02101853|541889480|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
150204482|NCT02101853|541889481|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
150204483|NCT02101853|541889482|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
150204484|NCT02101853|541889477|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
150204485|NCT02101853|541889478|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
150204486|NCT02101853|541889479|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
150204487|NCT02101853|541889480|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
150204488|NCT02101853|541889481|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
150204489|NCT02101853|541889482|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
150204490|NCT02101853|541889477|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
150204491|NCT02101853|541889478|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
150204492|NCT02101853|541889479|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
150204493|NCT02101853|541889480|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
150204494|NCT02101853|541889481|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
150204495|NCT02101853|541889482|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
150204496|NCT02101853|541889477|FG000|Blinatumomab Salvage Therapy|Death|0|||
150204497|NCT02101853|541889478|FG001|Blinatumomab Salvage Therapy|Death|0|||
150204498|NCT02101853|541889479|FG002|Blinatumomab Salvage Therapy|Death|0|||
150204499|NCT02101853|541889480|FG003|Blinatumomab Salvage Therapy|Death|0|||
150204500|NCT02101853|541889481|FG004|Blinatumomab Salvage Therapy|Death|0|||
150204501|NCT02101853|541889482|FG005|Blinatumomab Salvage Therapy|Death|2|||
150204502|NCT02101853|541889477|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
150204503|NCT02101853|541889478|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
150204504|NCT02101853|541889479|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
150204505|NCT02101853|541889480|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
150204506|NCT02101853|541889481|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
150204507|NCT02101853|541889482|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
150204508|NCT02101853|541889477|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
150204509|NCT02101853|541889478|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
150204510|NCT02101853|541889479|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
150204511|NCT02101853|541889480|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
150204512|NCT02101853|541889481|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
150204513|NCT02101853|541889482|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
150204514|NCT02101853|541889477|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
150204515|NCT02101853|541889478|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
150204516|NCT02101853|541889479|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
150204517|NCT02101853|541889480|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
150204518|NCT02101853|541889481|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
150204519|NCT02101853|541889482|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
150204520|NCT02112916|541889486|FG000|Overall Study|Adverse Event|6|||
150204521|NCT02112916|541889487|FG001|Overall Study|Adverse Event|9|||
150204522|NCT02112916|541889488|FG002|Overall Study|Adverse Event|3|||
150204523|NCT02112916|541889489|FG003|Overall Study|Adverse Event|2|||
150204524|NCT02112916|541889486|FG000|Overall Study|Death|9|||
150204525|NCT02112916|541889487|FG001|Overall Study|Death|9|||
150204526|NCT02112916|541889488|FG002|Overall Study|Death|3|||
150204527|NCT02112916|541889489|FG003|Overall Study|Death|4|||
150204528|NCT02112916|541889486|FG000|Overall Study|Lost to Follow-up|1|||
150204529|NCT02112916|541889487|FG001|Overall Study|Lost to Follow-up|0|||
150204530|NCT02112916|541889488|FG002|Overall Study|Lost to Follow-up|0|||
150204531|NCT02112916|541889489|FG003|Overall Study|Lost to Follow-up|0|||
150204532|NCT02112916|541889486|FG000|Overall Study|Physician Decision|94|||
150204533|NCT02112916|541889487|FG001|Overall Study|Physician Decision|72|||
150204534|NCT02112916|541889488|FG002|Overall Study|Physician Decision|24|||
150204535|NCT02112916|541889489|FG003|Overall Study|Physician Decision|15|||
150204536|NCT02112916|541889486|FG000|Overall Study|Withdrawal by Subject|5|||
150204537|NCT02112916|541889487|FG001|Overall Study|Withdrawal by Subject|3|||
150204538|NCT02112916|541889488|FG002|Overall Study|Withdrawal by Subject|1|||
150204539|NCT02112916|541889489|FG003|Overall Study|Withdrawal by Subject|1|||
150204540|NCT02112916|541889486|FG000|Overall Study|Ineligible|4|||
150204541|NCT02112916|541889487|FG001|Overall Study|Ineligible|8|||
150204542|NCT02112916|541889488|FG002|Overall Study|Ineligible|3|||
150204543|NCT02112916|541889489|FG003|Overall Study|Ineligible|8|||
150204544|NCT02112916|541889486|FG000|Overall Study|Inevaluable|6|||
150204545|NCT02112916|541889487|FG001|Overall Study|Inevaluable|4|||
150204546|NCT02112916|541889488|FG002|Overall Study|Inevaluable|5|||
150204547|NCT02112916|541889489|FG003|Overall Study|Inevaluable|5|||
150204548|NCT02112916|541889486|FG000|Overall Study|Refusal of further protocol therapy|19|||
150204549|NCT02112916|541889487|FG001|Overall Study|Refusal of further protocol therapy|16|||
150204550|NCT02112916|541889488|FG002|Overall Study|Refusal of further protocol therapy|1|||
150204551|NCT02112916|541889489|FG003|Overall Study|Refusal of further protocol therapy|7|||
150204552|NCT02112916|541889486|FG000|Overall Study|Development of SMN|1|||
150204553|NCT02112916|541889487|FG001|Overall Study|Development of SMN|0|||
150204554|NCT02112916|541889488|FG002|Overall Study|Development of SMN|0|||
150204555|NCT02112916|541889489|FG003|Overall Study|Development of SMN|1|||
150204556|NCT02112916|541889486|FG000|Overall Study|Relapse/Progression|10|||
150204557|NCT02112916|541889487|FG001|Overall Study|Relapse/Progression|18|||
150204558|NCT02112916|541889488|FG002|Overall Study|Relapse/Progression|15|||
150204559|NCT02112916|541889489|FG003|Overall Study|Relapse/Progression|2|||
150204560|NCT02112916|541889486|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
150204561|NCT02112916|541889487|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
150204562|NCT02112916|541889488|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
150204563|NCT02112916|541889489|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
150204564|NCT02112916|541889486|FG000|Overall Study|Still on Therapy|44|||
150204565|NCT02112916|541889487|FG001|Overall Study|Still on Therapy|47|||
150204566|NCT02112916|541889488|FG002|Overall Study|Still on Therapy|3|||
150204567|NCT02112916|541889489|FG003|Overall Study|Still on Therapy|2|||
150204568|NCT02112916|541889486|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
150204569|NCT02112916|541889487|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
150204570|NCT02112916|541889488|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
150204571|NCT02112916|541889489|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
150204572|NCT02112916|541889486|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
150204573|NCT02112916|541889487|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
150204574|NCT02112916|541889488|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
150204575|NCT02112916|541889489|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
150204576|NCT03782116|541889491|FG000|Completed Intervetion|Lost to Follow-up|11|||
150204577|NCT03782116|541889492|FG001|Completed Intervetion|Lost to Follow-up|7|||
150204578|NCT03782116|541889491|FG000|Completed Intervetion|Withdrawal by Subject|6|||
150204579|NCT03782116|541889492|FG001|Completed Intervetion|Withdrawal by Subject|5|||
150204580|NCT03782116|541889491|FG000|Included in Analysis|Protocol Violation|5|||
150204581|NCT03782116|541889492|FG001|Included in Analysis|Protocol Violation|5|||
150204582|NCT05714059|541889493|FG000|Overall Study|Withdrawal by Subject|2|||
150204583|NCT05714059|541889494|FG001|Overall Study|Withdrawal by Subject|2|||
150204584|NCT05714059|541889493|FG000|Overall Study|Adverse Event|0|||
150204585|NCT05714059|541889494|FG001|Overall Study|Adverse Event|1|||
150204586|NCT05714059|541889493|FG000|Overall Study|Lost to Follow-up|0|||
150204587|NCT05714059|541889494|FG001|Overall Study|Lost to Follow-up|1|||
150204588|NCT05714059|541889493|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
150204589|NCT05714059|541889494|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
150204590|NCT05714059|541889493|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
150204591|NCT05714059|541889494|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
150204592|NCT04899674|541889495|FG000|Test|Adverse Event|1|||
150204593|NCT03774472|541889496|FG000|Overall Study|Physician Decision|1|||
150204594|NCT03774472|541889497|FG001|Overall Study|Physician Decision|0|||
150204595|NCT03774472|541889498|FG002|Overall Study|Physician Decision|0|||
150204596|NCT03774472|541889496|FG000|Overall Study|Progression prior to 4 weeks|0|||
150204597|NCT03774472|541889497|FG001|Overall Study|Progression prior to 4 weeks|1|||
150204598|NCT03774472|541889498|FG002|Overall Study|Progression prior to 4 weeks|0|||
150204599|NCT03774472|541889496|FG000|Overall Study|Withdrawal by Subject|0|||
150204600|NCT03774472|541889497|FG001|Overall Study|Withdrawal by Subject|1|||
150204601|NCT03774472|541889498|FG002|Overall Study|Withdrawal by Subject|0|||
150204602|NCT03150862|541889500|FG000|Overall Study|Death|2|||
150204603|NCT03150862|541889501|FG001|Overall Study|Death|7|||
150204604|NCT03150862|541889502|FG002|Overall Study|Death|8|||
150204605|NCT03150862|541889503|FG003|Overall Study|Death|27|||
150204606|NCT03150862|541889504|FG004|Overall Study|Death|4|||
150204607|NCT03150862|541889505|FG005|Overall Study|Death|8|||
150204608|NCT03150862|541889506|FG006|Overall Study|Death|6|||
150204609|NCT03150862|541889507|FG007|Overall Study|Death|21|||
150204610|NCT03150862|541889500|FG000|Overall Study|Withdrawal by Subject|1|||
150204611|NCT03150862|541889501|FG001|Overall Study|Withdrawal by Subject|1|||
150204612|NCT03150862|541889502|FG002|Overall Study|Withdrawal by Subject|0|||
150204613|NCT03150862|541889503|FG003|Overall Study|Withdrawal by Subject|3|||
150204614|NCT03150862|541889504|FG004|Overall Study|Withdrawal by Subject|1|||
150204615|NCT03150862|541889505|FG005|Overall Study|Withdrawal by Subject|1|||
150204616|NCT03150862|541889506|FG006|Overall Study|Withdrawal by Subject|1|||
150204617|NCT03150862|541889507|FG007|Overall Study|Withdrawal by Subject|3|||
150204618|NCT03150862|541889500|FG000|Overall Study|Lost to Follow-up|0|||
150204619|NCT03150862|541889501|FG001|Overall Study|Lost to Follow-up|0|||
150204620|NCT03150862|541889502|FG002|Overall Study|Lost to Follow-up|1|||
150204621|NCT03150862|541889503|FG003|Overall Study|Lost to Follow-up|0|||
150204622|NCT03150862|541889504|FG004|Overall Study|Lost to Follow-up|0|||
150204623|NCT03150862|541889505|FG005|Overall Study|Lost to Follow-up|0|||
150204624|NCT03150862|541889506|FG006|Overall Study|Lost to Follow-up|0|||
150204625|NCT03150862|541889507|FG007|Overall Study|Lost to Follow-up|2|||
150204626|NCT03150862|541889500|FG000|Overall Study|Sponsor's decision|0|||
150204627|NCT03150862|541889501|FG001|Overall Study|Sponsor's decision|0|||
150204628|NCT03150862|541889502|FG002|Overall Study|Sponsor's decision|0|||
150204629|NCT03150862|541889503|FG003|Overall Study|Sponsor's decision|10|||
150204630|NCT03150862|541889504|FG004|Overall Study|Sponsor's decision|3|||
150204631|NCT03150862|541889505|FG005|Overall Study|Sponsor's decision|0|||
150204632|NCT03150862|541889506|FG006|Overall Study|Sponsor's decision|1|||
150204633|NCT03150862|541889507|FG007|Overall Study|Sponsor's decision|1|||
150204634|NCT03150862|541889500|FG000|Overall Study|Change in Methylation status|0|||
150204635|NCT03150862|541889501|FG001|Overall Study|Change in Methylation status|0|||
150204636|NCT03150862|541889502|FG002|Overall Study|Change in Methylation status|0|||
150204637|NCT03150862|541889503|FG003|Overall Study|Change in Methylation status|0|||
150204638|NCT03150862|541889504|FG004|Overall Study|Change in Methylation status|1|||
150204639|NCT03150862|541889505|FG005|Overall Study|Change in Methylation status|0|||
150204640|NCT03150862|541889506|FG006|Overall Study|Change in Methylation status|0|||
150204641|NCT03150862|541889507|FG007|Overall Study|Change in Methylation status|0|||
150204642|NCT03150862|541889500|FG000|Overall Study|Roll over in to Long Term Extension|0|||
150204643|NCT03150862|541889501|FG001|Overall Study|Roll over in to Long Term Extension|0|||
150204644|NCT03150862|541889502|FG002|Overall Study|Roll over in to Long Term Extension|0|||
150204645|NCT03150862|541889503|FG003|Overall Study|Roll over in to Long Term Extension|0|||
150204646|NCT03150862|541889504|FG004|Overall Study|Roll over in to Long Term Extension|0|||
150204647|NCT03150862|541889505|FG005|Overall Study|Roll over in to Long Term Extension|0|||
150204648|NCT03150862|541889506|FG006|Overall Study|Roll over in to Long Term Extension|0|||
150204649|NCT03150862|541889507|FG007|Overall Study|Roll over in to Long Term Extension|1|||
150204650|NCT03150862|541889500|FG000|Overall Study|Progressive Disease|0|||
150204651|NCT03150862|541889501|FG001|Overall Study|Progressive Disease|0|||
150204652|NCT03150862|541889502|FG002|Overall Study|Progressive Disease|0|||
150204653|NCT03150862|541889503|FG003|Overall Study|Progressive Disease|0|||
150204654|NCT03150862|541889504|FG004|Overall Study|Progressive Disease|0|||
150204655|NCT03150862|541889505|FG005|Overall Study|Progressive Disease|0|||
150204656|NCT03150862|541889506|FG006|Overall Study|Progressive Disease|0|||
150204657|NCT03150862|541889507|FG007|Overall Study|Progressive Disease|2|||
150204658|NCT05039021|541890331|FG000|Overall Study|Death|1|||
150204659|NCT05039021|541890331|FG000|Overall Study|Lost to Follow-up|3|||
150204660|NCT01260896|541890340|FG000|First Intervention|Withdrawn Due to Emesis|2|||
150204661|NCT01260896|541890341|FG001|First Intervention|Withdrawn Due to Emesis|0|||
150204662|NCT00982644|541890343|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
150204663|NCT00982644|541890344|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
150204664|NCT00982644|541890343|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
150204665|NCT00982644|541890344|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
150204666|NCT00982644|541890343|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
150204667|NCT00982644|541890344|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
150204668|NCT00982644|541890343|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
150204669|NCT00982644|541890344|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
150204670|NCT00982644|541890343|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
150204671|NCT00982644|541890344|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
150204672|NCT00982644|541890343|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
150204673|NCT00982644|541890344|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
150204674|NCT00982644|541890343|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
150204675|NCT00982644|541890344|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
150204676|NCT00982644|541890343|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
150204677|NCT00982644|541890344|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
150204678|NCT00982644|541890343|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
150204679|NCT00982644|541890344|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
150204680|NCT00982644|541890343|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
150204681|NCT00982644|541890344|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
150204682|NCT03767335|541890348|FG000|Overall Study|Physician Decision|1|||
150204683|NCT03767335|541890349|FG001|Overall Study|Physician Decision|1|||
150204684|NCT03767335|541890350|FG002|Overall Study|Physician Decision|0|||
150204685|NCT03767335|541890348|FG000|Overall Study|Withdrawal by Subject|0|||
150204686|NCT03767335|541890349|FG001|Overall Study|Withdrawal by Subject|0|||
150204687|NCT03767335|541890350|FG002|Overall Study|Withdrawal by Subject|6|||
150204688|NCT03767335|541890348|FG000|Overall Study|Participant excluded from efficacy population|0|||
150204689|NCT03767335|541890349|FG001|Overall Study|Participant excluded from efficacy population|0|||
150204690|NCT03767335|541890350|FG002|Overall Study|Participant excluded from efficacy population|1|||
150204691|NCT03767335|541890348|FG000|Overall Study|Death|0|||
150204692|NCT03767335|541890349|FG001|Overall Study|Death|0|||
150204693|NCT03767335|541890350|FG002|Overall Study|Death|2|||
150204694|NCT03767335|541890348|FG000|Overall Study|Progressive Disease|2|||
150204695|NCT03767335|541890349|FG001|Overall Study|Progressive Disease|2|||
150204696|NCT03767335|541890350|FG002|Overall Study|Progressive Disease|2|||
150204697|NCT03767335|541890348|FG000|Overall Study|Disease progression needing additional medication|0|||
150204698|NCT03767335|541890349|FG001|Overall Study|Disease progression needing additional medication|0|||
150204699|NCT03767335|541890350|FG002|Overall Study|Disease progression needing additional medication|17|||
150204700|NCT03767335|541890348|FG000|Overall Study|Sponsor decision|0|||
150204701|NCT03767335|541890349|FG001|Overall Study|Sponsor decision|0|||
150204702|NCT03767335|541890350|FG002|Overall Study|Sponsor decision|2|||
150204703|NCT03767335|541890348|FG000|Overall Study|Other Medical Reasons|0|||
150204704|NCT03767335|541890349|FG001|Overall Study|Other Medical Reasons|0|||
150204705|NCT03767335|541890350|FG002|Overall Study|Other Medical Reasons|3|||
150204706|NCT03213457|541890352|FG000|Screening Period|Withdrawal by Subject|0|||
150204707|NCT03213457|541890353|FG001|Screening Period|Withdrawal by Subject|1|||
150204708|NCT03213457|541890354|FG002|Screening Period|Withdrawal by Subject|0|||
150204709|NCT03213457|541890352|FG000|Screening Period|Other|1|||
150204710|NCT03213457|541890353|FG001|Screening Period|Other|0|||
150204711|NCT03213457|541890354|FG002|Screening Period|Other|0|||
150204712|NCT03213457|541890352|FG000|Double-Blind Period|Adverse Event|3|||
150204713|NCT03213457|541890353|FG001|Double-Blind Period|Adverse Event|2|||
150204714|NCT03213457|541890354|FG002|Double-Blind Period|Adverse Event|7|||
150204715|NCT03213457|541890352|FG000|Double-Blind Period|Withdrawal by Subject|14|||
150204716|NCT03213457|541890353|FG001|Double-Blind Period|Withdrawal by Subject|2|||
150204717|NCT03213457|541890354|FG002|Double-Blind Period|Withdrawal by Subject|14|||
150204718|NCT03213457|541890352|FG000|Double-Blind Period|Lost to Follow-up|2|||
150204719|NCT03213457|541890353|FG001|Double-Blind Period|Lost to Follow-up|3|||
150204720|NCT03213457|541890354|FG002|Double-Blind Period|Lost to Follow-up|9|||
150204721|NCT03213457|541890352|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
150204722|NCT03213457|541890353|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
150204723|NCT03213457|541890354|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
150204724|NCT03213457|541890352|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
150204725|NCT03213457|541890353|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
150204726|NCT03213457|541890354|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
150204727|NCT03213457|541890352|FG000|Double-Blind Period|Pregnancy|5|||
150204728|NCT03213457|541890353|FG001|Double-Blind Period|Pregnancy|0|||
150204729|NCT03213457|541890354|FG002|Double-Blind Period|Pregnancy|0|||
150204730|NCT03213457|541890352|FG000|Double-Blind Period|Other|10|||
150204731|NCT03213457|541890353|FG001|Double-Blind Period|Other|3|||
150204732|NCT03213457|541890354|FG002|Double-Blind Period|Other|17|||
150204733|NCT03213457|541890352|FG000|Open-Label Period|Adverse Event|1|||
150204734|NCT03213457|541890353|FG001|Open-Label Period|Adverse Event|2|||
150204735|NCT03213457|541890354|FG002|Open-Label Period|Adverse Event|2|||
150204736|NCT03213457|541890352|FG000|Open-Label Period|Withdrawal by Subject|12|||
150204737|NCT03213457|541890353|FG001|Open-Label Period|Withdrawal by Subject|5|||
150204738|NCT03213457|541890354|FG002|Open-Label Period|Withdrawal by Subject|24|||
150204739|NCT03213457|541890352|FG000|Open-Label Period|Lost to Follow-up|1|||
150204740|NCT03213457|541890353|FG001|Open-Label Period|Lost to Follow-up|2|||
150204741|NCT03213457|541890354|FG002|Open-Label Period|Lost to Follow-up|8|||
150204742|NCT03213457|541890352|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
150204743|NCT03213457|541890353|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
150204744|NCT03213457|541890354|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
150204745|NCT03213457|541890352|FG000|Open-Label Period|Non-compliance with study procedures|1|||
150204746|NCT03213457|541890353|FG001|Open-Label Period|Non-compliance with study procedures|1|||
150204747|NCT03213457|541890354|FG002|Open-Label Period|Non-compliance with study procedures|2|||
150204748|NCT03213457|541890352|FG000|Open-Label Period|Exclusionary medications|0|||
150204749|NCT03213457|541890353|FG001|Open-Label Period|Exclusionary medications|0|||
150204750|NCT03213457|541890354|FG002|Open-Label Period|Exclusionary medications|1|||
150204751|NCT03213457|541890352|FG000|Open-Label Period|Other|1|||
150204752|NCT03213457|541890353|FG001|Open-Label Period|Other|1|||
150204753|NCT03213457|541890354|FG002|Open-Label Period|Other|6|||
150204754|NCT03213457|541890352|FG000|Follow-Up Period|Adverse Event|16|||
150204755|NCT03213457|541890353|FG001|Follow-Up Period|Adverse Event|8|||
150204756|NCT03213457|541890354|FG002|Follow-Up Period|Adverse Event|37|||
150204757|NCT03213457|541890352|FG000|Follow-Up Period|Withdrawal by Subject|18|||
150204758|NCT03213457|541890353|FG001|Follow-Up Period|Withdrawal by Subject|11|||
150204759|NCT03213457|541890354|FG002|Follow-Up Period|Withdrawal by Subject|55|||
150204760|NCT03213457|541890352|FG000|Follow-Up Period|Lost to Follow-up|28|||
150204761|NCT03213457|541890353|FG001|Follow-Up Period|Lost to Follow-up|15|||
150204762|NCT03213457|541890354|FG002|Follow-Up Period|Lost to Follow-up|50|||
150204763|NCT03213457|541890352|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
150204764|NCT03213457|541890353|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
150204765|NCT03213457|541890354|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
150204766|NCT03213457|541890352|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
150204767|NCT03213457|541890353|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
150204768|NCT03213457|541890354|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
150204769|NCT03213457|541890352|FG000|Follow-Up Period|Pregnancy|7|||
150204770|NCT03213457|541890353|FG001|Follow-Up Period|Pregnancy|0|||
150204771|NCT03213457|541890354|FG002|Follow-Up Period|Pregnancy|18|||
150204772|NCT03213457|541890352|FG000|Follow-Up Period|Exclusionary medications|1|||
150204773|NCT03213457|541890353|FG001|Follow-Up Period|Exclusionary medications|1|||
150204774|NCT03213457|541890354|FG002|Follow-Up Period|Exclusionary medications|5|||
150204775|NCT03213457|541890352|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
150204776|NCT03213457|541890353|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
150204777|NCT03213457|541890354|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
150204778|NCT03213457|541890352|FG000|Follow-Up Period|Other|14|||
150204779|NCT03213457|541890353|FG001|Follow-Up Period|Other|10|||
150204780|NCT03213457|541890354|FG002|Follow-Up Period|Other|31|||
150204781|NCT02951052|541890355|FG000|Overall Study|Adverse Event|13|||
150204782|NCT02951052|541890356|FG001|Overall Study|Adverse Event|5|||
150204783|NCT02951052|541890355|FG000|Overall Study|Withdrawal by Subject|1|||
150204784|NCT02951052|541890356|FG001|Overall Study|Withdrawal by Subject|5|||
150204785|NCT02951052|541890355|FG000|Overall Study|Physician Decision|2|||
150204786|NCT02951052|541890356|FG001|Overall Study|Physician Decision|0|||
150204787|NCT02951052|541890355|FG000|Overall Study|Lost to Follow-up|1|||
150204788|NCT02951052|541890356|FG001|Overall Study|Lost to Follow-up|1|||
150204789|NCT02951052|541890355|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
150204790|NCT02951052|541890356|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
150204791|NCT02951052|541890355|FG000|Overall Study|Protocol Violation|5|||
150204792|NCT02951052|541890356|FG001|Overall Study|Protocol Violation|3|||
150204793|NCT02951052|541890355|FG000|Overall Study|Lack of Efficacy|3|||
150204794|NCT02951052|541890356|FG001|Overall Study|Lack of Efficacy|4|||
150204795|NCT02951052|541890355|FG000|Overall Study|Ongoing|1|||
150204796|NCT02951052|541890356|FG001|Overall Study|Ongoing|0|||
150204797|NCT05934292|541890368|FG000|Overall Study|Lost to Follow-up|0|||
150204798|NCT05934292|541890369|FG001|Overall Study|Lost to Follow-up|0|||
150204799|NCT05934292|541890370|FG002|Overall Study|Lost to Follow-up|1|||
150204800|NCT05934292|541890371|FG003|Overall Study|Lost to Follow-up|0|||
150204801|NCT04121741|541890374|FG000|Overall Study|Protocol Violation|1|||
150204802|NCT04121741|541890375|FG001|Overall Study|Protocol Violation|0|||
150204803|NCT04121741|541890376|FG002|Overall Study|Protocol Violation|0|||
150204804|NCT04121741|541890377|FG003|Overall Study|Protocol Violation|0|||
150204805|NCT04121741|541890378|FG004|Overall Study|Protocol Violation|0|||
150204806|NCT04121741|541890379|FG005|Overall Study|Protocol Violation|0|||
150204807|NCT01084863|541890380|FG000|Main Study Treatment Period|Disease progression|11|||
150204808|NCT01084863|541890381|FG001|Main Study Treatment Period|Disease progression|7|||
150204809|NCT01084863|541890380|FG000|Main Study Treatment Period|Adverse Event|5|||
150204810|NCT01084863|541890381|FG001|Main Study Treatment Period|Adverse Event|3|||
150204811|NCT01084863|541890380|FG000|Main Study Treatment Period|Other Reason|0|||
150204812|NCT01084863|541890381|FG001|Main Study Treatment Period|Other Reason|1|||
150204813|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
150204814|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
150204815|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
150204816|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
150204817|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
150204818|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
150204819|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
150204820|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
150204821|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Other|0|||
150204822|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Other|1|||
150204823|NCT01084863|541890380|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
150204824|NCT01084863|541890381|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
150204825|NCT03473223|541890383|FG000|Overall Study|Lost to Follow-up|1|||
150204826|NCT03473223|541890384|FG001|Overall Study|Lost to Follow-up|1|||
150204827|NCT03473223|541890383|FG000|Overall Study|Withdrawal by Subject|47|||
150204828|NCT03473223|541890384|FG001|Overall Study|Withdrawal by Subject|42|||
150204829|NCT03473223|541890383|FG000|Overall Study|Indirect contact|32|||
150204830|NCT03473223|541890384|FG001|Overall Study|Indirect contact|29|||
150204831|NCT03473223|541890383|FG000|Overall Study|Other (Not specified)|32|||
150204832|NCT03473223|541890384|FG001|Overall Study|Other (Not specified)|20|||
150204833|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
150204834|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
150204835|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
150204836|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
150204837|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
150204838|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
150204839|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
150204840|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
150204841|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
150204842|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
150204843|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
150204844|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
150204845|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
150204846|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
150204847|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
150204848|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
150204849|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
150204850|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
150204851|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
150204852|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
150204853|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
150204854|NCT04505722|541890385|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
150204855|NCT04505722|541890386|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
150204856|NCT04505722|541890387|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
150204857|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
150204858|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
150204859|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
150204860|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
150204861|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
150204862|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
150204863|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
150204864|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
150204865|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
150204866|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
150204867|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
150204868|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
150204869|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
150204870|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
150204871|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
150204872|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
150204873|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
150204874|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
150204875|NCT04505722|541890385|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
150204876|NCT04505722|541890386|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
150204877|NCT04505722|541890387|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
150204878|NCT04755595|541890388|FG000|Overall Study|Lost to Follow-up|1|||
150204879|NCT02566889|541890778|FG000|Overall Study|Withdrawal by Subject|3|||
150204880|NCT02566889|541890779|FG001|Overall Study|Withdrawal by Subject|1|||
150204881|NCT02566889|541890778|FG000|Overall Study|Adverse Event|4|||
150204882|NCT02566889|541890779|FG001|Overall Study|Adverse Event|2|||
150204883|NCT02566889|541890778|FG000|Overall Study|Other|6|||
150204884|NCT02566889|541890779|FG001|Overall Study|Other|2|||
150204885|NCT03140670|541890781|FG000|Overall Study|Withdrawal by Subject|2|||
150204886|NCT03140670|541890781|FG000|Overall Study|Lost to Follow-up|1|||
150204887|NCT03140670|541890781|FG000|Overall Study|Physician Decision|1|||
150204888|NCT00220805|541890782|FG000|Overall Study|Adverse Event|1|||
150204889|NCT00220805|541890783|FG001|Overall Study|Adverse Event|3|||
150204890|NCT00220805|541890782|FG000|Overall Study|Withdrawal by Subject|3|||
150204891|NCT00220805|541890783|FG001|Overall Study|Withdrawal by Subject|0|||
150204892|NCT00220805|541890782|FG000|Overall Study|Lack of Efficacy|1|||
150204893|NCT00220805|541890783|FG001|Overall Study|Lack of Efficacy|0|||
150204894|NCT00220805|541890782|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
150204895|NCT00220805|541890783|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
150204896|NCT02325466|541890784|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
150204897|NCT02325466|541890785|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
150204898|NCT02325466|541890786|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
150204899|NCT02325466|541890784|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
150204900|NCT02325466|541890785|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
150204901|NCT02325466|541890786|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
150204902|NCT02325466|541890784|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
150204903|NCT02325466|541890785|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
150204904|NCT02325466|541890786|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
150204905|NCT02325466|541890784|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
150204906|NCT02325466|541890785|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
150204907|NCT02325466|541890786|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
150204908|NCT02325466|541890784|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
150204909|NCT02325466|541890785|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
150204910|NCT02325466|541890786|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
150204911|NCT02325466|541890784|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
150204912|NCT02325466|541890785|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
150204913|NCT02325466|541890786|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
150204914|NCT02325466|541890784|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
150204915|NCT02325466|541890785|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
150204916|NCT02325466|541890786|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
150204917|NCT02325466|541890784|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
150204918|NCT02325466|541890785|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
150204919|NCT02325466|541890786|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
150204920|NCT02325466|541890784|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
150204921|NCT02325466|541890785|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
150204922|NCT02325466|541890786|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
150204923|NCT03699163|541890787|FG000|Overall Study|Physician Decision|12|||
150204924|NCT03699163|541890788|FG001|Overall Study|Physician Decision|0|||
150204925|NCT03699163|541890787|FG000|Overall Study|failed QC measures|205|||
150204926|NCT03699163|541890788|FG001|Overall Study|failed QC measures|206|||
150204927|NCT01639131|541890789|FG000|Overall Study|Disease Progression|6|||
150204928|NCT01964300|541890791|FG000|Overall Study|Ineligible after enrollment|0|||
150204929|NCT01964300|541890792|FG001|Overall Study|Ineligible after enrollment|1|||
150204930|NCT01964300|541890791|FG000|Overall Study|Adverse Event|1|||
150204931|NCT01964300|541890792|FG001|Overall Study|Adverse Event|1|||
150204932|NCT01964300|541890791|FG000|Overall Study|Lack of Efficacy|3|||
150204933|NCT01964300|541890792|FG001|Overall Study|Lack of Efficacy|5|||
150204934|NCT01964300|541890791|FG000|Overall Study|Withdrawal by Subject|0|||
150204935|NCT01964300|541890792|FG001|Overall Study|Withdrawal by Subject|1|||
150204936|NCT01964300|541890791|FG000|Overall Study|To receive alternative therapy|1|||
150204937|NCT01964300|541890792|FG001|Overall Study|To receive alternative therapy|2|||
150204938|NCT01964300|541890791|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
150204939|NCT01964300|541890792|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
150204940|NCT01964300|541890791|FG000|Overall Study|Weight criteria not met|0|||
150204941|NCT01964300|541890792|FG001|Overall Study|Weight criteria not met|1|||
150204942|NCT00557492|541890793|FG000|Overall Study|Change in health insurance|1|||
150204943|NCT04334317|541890795|FG000|Overall Study|Adverse Event|1|||
150204944|NCT04334317|541890796|FG001|Overall Study|Adverse Event|2|||
150204945|NCT04334317|541890797|FG002|Overall Study|Adverse Event|0|||
150204946|NCT04334317|541890798|FG003|Overall Study|Adverse Event|0|||
150204947|NCT04334317|541890795|FG000|Overall Study|Protocol Deviation|0|||
150204948|NCT04334317|541890796|FG001|Overall Study|Protocol Deviation|1|||
150204949|NCT04334317|541890797|FG002|Overall Study|Protocol Deviation|0|||
150204950|NCT04334317|541890798|FG003|Overall Study|Protocol Deviation|0|||
150204951|NCT04334317|541890795|FG000|Overall Study|Withdrawal by Subject|2|||
150204952|NCT04334317|541890796|FG001|Overall Study|Withdrawal by Subject|2|||
150204953|NCT04334317|541890797|FG002|Overall Study|Withdrawal by Subject|0|||
150204954|NCT04334317|541890798|FG003|Overall Study|Withdrawal by Subject|0|||
150204955|NCT03286114|541890802|FG000|Overall Study|Adverse Event|6|||
150204956|NCT03286114|541890802|FG000|Overall Study|Death|3|||
150204957|NCT00943917|541890805|FG000|Stage I|Adverse Event|1|||
150204958|NCT00943917|541890806|FG001|Stage I|Adverse Event|2|||
150204959|NCT00943917|541890807|FG002|Stage I|Adverse Event|2|||
150204960|NCT00943917|541890808|FG003|Stage I|Adverse Event|0|||
150204961|NCT00943917|541890809|FG004|Stage I|Adverse Event|0|||
150204962|NCT00943917|541890810|FG005|Stage I|Adverse Event|0|||
150204963|NCT00943917|541890811|FG006|Stage I|Adverse Event|0|||
150204964|NCT00943917|541890812|FG007|Stage I|Adverse Event|0|||
150204965|NCT00943917|541890813|FG008|Stage I|Adverse Event|0|||
150204966|NCT00943917|541890814|FG009|Stage I|Adverse Event|0|||
150204967|NCT00943917|541890815|FG010|Stage I|Adverse Event|0|||
150204968|NCT00943917|541890816|FG011|Stage I|Adverse Event|0|||
150204969|NCT00943917|541890817|FG012|Stage I|Adverse Event|0|||
150204970|NCT00943917|541890818|FG013|Stage I|Adverse Event|0|||
150204971|NCT00943917|541890819|FG014|Stage I|Adverse Event|0|||
150204972|NCT00943917|541890805|FG000|Stage I|Lost to Follow-up|0|||
150204973|NCT00943917|541890806|FG001|Stage I|Lost to Follow-up|0|||
150204974|NCT00943917|541890807|FG002|Stage I|Lost to Follow-up|1|||
150204975|NCT00943917|541890808|FG003|Stage I|Lost to Follow-up|0|||
150204976|NCT00943917|541890809|FG004|Stage I|Lost to Follow-up|0|||
150204977|NCT00943917|541890810|FG005|Stage I|Lost to Follow-up|0|||
150204978|NCT00943917|541890811|FG006|Stage I|Lost to Follow-up|0|||
150204979|NCT00943917|541890812|FG007|Stage I|Lost to Follow-up|0|||
150204980|NCT00943917|541890813|FG008|Stage I|Lost to Follow-up|0|||
150204981|NCT00943917|541890814|FG009|Stage I|Lost to Follow-up|0|||
150204982|NCT00943917|541890815|FG010|Stage I|Lost to Follow-up|0|||
150204983|NCT00943917|541890816|FG011|Stage I|Lost to Follow-up|0|||
150204984|NCT00943917|541890817|FG012|Stage I|Lost to Follow-up|0|||
150204985|NCT00943917|541890818|FG013|Stage I|Lost to Follow-up|0|||
150204986|NCT00943917|541890819|FG014|Stage I|Lost to Follow-up|0|||
150204987|NCT00943917|541890805|FG000|Stage I|hyperglycemia|0|||
150204988|NCT00943917|541890806|FG001|Stage I|hyperglycemia|0|||
150204989|NCT00943917|541890807|FG002|Stage I|hyperglycemia|1|||
150204990|NCT00943917|541890808|FG003|Stage I|hyperglycemia|0|||
150204991|NCT00943917|541890809|FG004|Stage I|hyperglycemia|0|||
150204992|NCT00943917|541890810|FG005|Stage I|hyperglycemia|0|||
150204993|NCT00943917|541890811|FG006|Stage I|hyperglycemia|0|||
150204994|NCT00943917|541890812|FG007|Stage I|hyperglycemia|0|||
150204995|NCT00943917|541890813|FG008|Stage I|hyperglycemia|0|||
150204996|NCT00943917|541890814|FG009|Stage I|hyperglycemia|0|||
150204997|NCT00943917|541890815|FG010|Stage I|hyperglycemia|0|||
150204998|NCT00943917|541890816|FG011|Stage I|hyperglycemia|0|||
150204999|NCT00943917|541890817|FG012|Stage I|hyperglycemia|0|||
150205000|NCT00943917|541890818|FG013|Stage I|hyperglycemia|0|||
150205001|NCT00943917|541890819|FG014|Stage I|hyperglycemia|0|||
150205002|NCT00943917|541890805|FG000|Stage I|A1C elevation|1|||
150205003|NCT00943917|541890806|FG001|Stage I|A1C elevation|0|||
150205004|NCT00943917|541890807|FG002|Stage I|A1C elevation|0|||
150205005|NCT00943917|541890808|FG003|Stage I|A1C elevation|0|||
150205006|NCT00943917|541890809|FG004|Stage I|A1C elevation|0|||
150205007|NCT00943917|541890810|FG005|Stage I|A1C elevation|0|||
150205008|NCT00943917|541890811|FG006|Stage I|A1C elevation|0|||
150205009|NCT00943917|541890812|FG007|Stage I|A1C elevation|0|||
150205010|NCT00943917|541890813|FG008|Stage I|A1C elevation|0|||
150205011|NCT00943917|541890814|FG009|Stage I|A1C elevation|0|||
150205012|NCT00943917|541890815|FG010|Stage I|A1C elevation|0|||
150205013|NCT00943917|541890816|FG011|Stage I|A1C elevation|0|||
150205014|NCT00943917|541890817|FG012|Stage I|A1C elevation|0|||
150205015|NCT00943917|541890818|FG013|Stage I|A1C elevation|0|||
150205016|NCT00943917|541890819|FG014|Stage I|A1C elevation|0|||
150205017|NCT00943917|541890805|FG000|Stage I|Withdrawal by Subject|2|||
150205018|NCT00943917|541890806|FG001|Stage I|Withdrawal by Subject|1|||
150205019|NCT00943917|541890807|FG002|Stage I|Withdrawal by Subject|2|||
150205020|NCT00943917|541890808|FG003|Stage I|Withdrawal by Subject|0|||
150205021|NCT00943917|541890809|FG004|Stage I|Withdrawal by Subject|0|||
150205022|NCT00943917|541890810|FG005|Stage I|Withdrawal by Subject|0|||
150205023|NCT00943917|541890811|FG006|Stage I|Withdrawal by Subject|0|||
150205024|NCT00943917|541890812|FG007|Stage I|Withdrawal by Subject|0|||
150205025|NCT00943917|541890813|FG008|Stage I|Withdrawal by Subject|0|||
150205026|NCT00943917|541890814|FG009|Stage I|Withdrawal by Subject|0|||
150205027|NCT00943917|541890815|FG010|Stage I|Withdrawal by Subject|0|||
150205028|NCT00943917|541890816|FG011|Stage I|Withdrawal by Subject|0|||
150205029|NCT00943917|541890817|FG012|Stage I|Withdrawal by Subject|0|||
150205030|NCT00943917|541890818|FG013|Stage I|Withdrawal by Subject|0|||
150205031|NCT00943917|541890819|FG014|Stage I|Withdrawal by Subject|0|||
150205032|NCT00943917|541890805|FG000|Stage II|Adverse Event|0|||
150205033|NCT00943917|541890806|FG001|Stage II|Adverse Event|0|||
150205034|NCT00943917|541890807|FG002|Stage II|Adverse Event|0|||
150205035|NCT00943917|541890808|FG003|Stage II|Adverse Event|0|||
150205036|NCT00943917|541890809|FG004|Stage II|Adverse Event|0|||
150205037|NCT00943917|541890810|FG005|Stage II|Adverse Event|1|||
150205038|NCT00943917|541890811|FG006|Stage II|Adverse Event|3|||
150205039|NCT00943917|541890812|FG007|Stage II|Adverse Event|0|||
150205040|NCT00943917|541890813|FG008|Stage II|Adverse Event|1|||
150205041|NCT00943917|541890814|FG009|Stage II|Adverse Event|0|||
150205042|NCT00943917|541890815|FG010|Stage II|Adverse Event|0|||
150205043|NCT00943917|541890816|FG011|Stage II|Adverse Event|0|||
150205044|NCT00943917|541890817|FG012|Stage II|Adverse Event|0|||
150205045|NCT00943917|541890818|FG013|Stage II|Adverse Event|0|||
150205046|NCT00943917|541890819|FG014|Stage II|Adverse Event|0|||
150205047|NCT00943917|541890805|FG000|Stage II|Withdrawal by Subject|0|||
150205048|NCT00943917|541890806|FG001|Stage II|Withdrawal by Subject|0|||
150205049|NCT00943917|541890807|FG002|Stage II|Withdrawal by Subject|0|||
150205050|NCT00943917|541890808|FG003|Stage II|Withdrawal by Subject|0|||
150205051|NCT00943917|541890809|FG004|Stage II|Withdrawal by Subject|0|||
150205052|NCT00943917|541890810|FG005|Stage II|Withdrawal by Subject|1|||
150205053|NCT00943917|541890811|FG006|Stage II|Withdrawal by Subject|0|||
150205054|NCT00943917|541890812|FG007|Stage II|Withdrawal by Subject|0|||
150205055|NCT00943917|541890813|FG008|Stage II|Withdrawal by Subject|0|||
150205056|NCT00943917|541890814|FG009|Stage II|Withdrawal by Subject|0|||
150205057|NCT00943917|541890815|FG010|Stage II|Withdrawal by Subject|0|||
150205058|NCT00943917|541890816|FG011|Stage II|Withdrawal by Subject|0|||
150205059|NCT00943917|541890817|FG012|Stage II|Withdrawal by Subject|0|||
150205060|NCT00943917|541890818|FG013|Stage II|Withdrawal by Subject|0|||
150205061|NCT00943917|541890819|FG014|Stage II|Withdrawal by Subject|0|||
150205062|NCT00943917|541890805|FG000|Stage II|Pregnancy|0|||
150205063|NCT00943917|541890806|FG001|Stage II|Pregnancy|0|||
150205064|NCT00943917|541890807|FG002|Stage II|Pregnancy|0|||
150205065|NCT00943917|541890808|FG003|Stage II|Pregnancy|0|||
150205066|NCT00943917|541890809|FG004|Stage II|Pregnancy|0|||
150205067|NCT00943917|541890810|FG005|Stage II|Pregnancy|1|||
150205068|NCT00943917|541890811|FG006|Stage II|Pregnancy|0|||
150205069|NCT00943917|541890812|FG007|Stage II|Pregnancy|0|||
150205070|NCT00943917|541890813|FG008|Stage II|Pregnancy|0|||
150205071|NCT00943917|541890814|FG009|Stage II|Pregnancy|0|||
150205072|NCT00943917|541890815|FG010|Stage II|Pregnancy|0|||
150205073|NCT00943917|541890816|FG011|Stage II|Pregnancy|0|||
150205074|NCT00943917|541890817|FG012|Stage II|Pregnancy|0|||
150205075|NCT00943917|541890818|FG013|Stage II|Pregnancy|0|||
150205076|NCT00943917|541890819|FG014|Stage II|Pregnancy|0|||
150205077|NCT00943917|541890805|FG000|Stage II Continuation|Adverse Event|0|||
150205078|NCT00943917|541890806|FG001|Stage II Continuation|Adverse Event|0|||
150205079|NCT00943917|541890807|FG002|Stage II Continuation|Adverse Event|0|||
150205080|NCT00943917|541890808|FG003|Stage II Continuation|Adverse Event|0|||
150205081|NCT00943917|541890809|FG004|Stage II Continuation|Adverse Event|0|||
150205082|NCT00943917|541890810|FG005|Stage II Continuation|Adverse Event|0|||
150205083|NCT00943917|541890811|FG006|Stage II Continuation|Adverse Event|0|||
150205084|NCT00943917|541890812|FG007|Stage II Continuation|Adverse Event|0|||
150205085|NCT00943917|541890813|FG008|Stage II Continuation|Adverse Event|0|||
150205086|NCT00943917|541890814|FG009|Stage II Continuation|Adverse Event|0|||
150205087|NCT00943917|541890815|FG010|Stage II Continuation|Adverse Event|0|||
150205088|NCT00943917|541890816|FG011|Stage II Continuation|Adverse Event|1|||
150205089|NCT00943917|541890817|FG012|Stage II Continuation|Adverse Event|2|||
150205090|NCT00943917|541890818|FG013|Stage II Continuation|Adverse Event|1|||
150205091|NCT00943917|541890819|FG014|Stage II Continuation|Adverse Event|1|||
150205092|NCT00943917|541890805|FG000|Stage II Continuation|Withdrawal by Subject|0|||
150205093|NCT00943917|541890806|FG001|Stage II Continuation|Withdrawal by Subject|0|||
150205094|NCT00943917|541890807|FG002|Stage II Continuation|Withdrawal by Subject|0|||
150205095|NCT00943917|541890808|FG003|Stage II Continuation|Withdrawal by Subject|0|||
150205096|NCT00943917|541890809|FG004|Stage II Continuation|Withdrawal by Subject|0|||
150205097|NCT00943917|541890810|FG005|Stage II Continuation|Withdrawal by Subject|0|||
150205098|NCT00943917|541890811|FG006|Stage II Continuation|Withdrawal by Subject|0|||
150205099|NCT00943917|541890812|FG007|Stage II Continuation|Withdrawal by Subject|0|||
150205100|NCT00943917|541890813|FG008|Stage II Continuation|Withdrawal by Subject|0|||
150205101|NCT00943917|541890814|FG009|Stage II Continuation|Withdrawal by Subject|0|||
150205102|NCT00943917|541890815|FG010|Stage II Continuation|Withdrawal by Subject|0|||
150205103|NCT00943917|541890816|FG011|Stage II Continuation|Withdrawal by Subject|0|||
150205104|NCT00943917|541890817|FG012|Stage II Continuation|Withdrawal by Subject|0|||
150205105|NCT00943917|541890818|FG013|Stage II Continuation|Withdrawal by Subject|1|||
150205106|NCT00943917|541890819|FG014|Stage II Continuation|Withdrawal by Subject|3|||
150205107|NCT00943917|541890805|FG000|Stage II Continuation|Protocol Violation|0|||
150205108|NCT00943917|541890806|FG001|Stage II Continuation|Protocol Violation|0|||
150205109|NCT00943917|541890807|FG002|Stage II Continuation|Protocol Violation|0|||
150205110|NCT00943917|541890808|FG003|Stage II Continuation|Protocol Violation|0|||
150205111|NCT00943917|541890809|FG004|Stage II Continuation|Protocol Violation|0|||
150205112|NCT00943917|541890810|FG005|Stage II Continuation|Protocol Violation|0|||
150205113|NCT00943917|541890811|FG006|Stage II Continuation|Protocol Violation|0|||
150205114|NCT00943917|541890812|FG007|Stage II Continuation|Protocol Violation|0|||
150205115|NCT00943917|541890813|FG008|Stage II Continuation|Protocol Violation|0|||
150205116|NCT00943917|541890814|FG009|Stage II Continuation|Protocol Violation|1|||
150205117|NCT00943917|541890815|FG010|Stage II Continuation|Protocol Violation|0|||
150205118|NCT00943917|541890816|FG011|Stage II Continuation|Protocol Violation|1|||
150205119|NCT00943917|541890817|FG012|Stage II Continuation|Protocol Violation|0|||
150205120|NCT00943917|541890818|FG013|Stage II Continuation|Protocol Violation|0|||
150205121|NCT00943917|541890819|FG014|Stage II Continuation|Protocol Violation|0|||
150205122|NCT00943917|541890805|FG000|Stage II Continuation|hypoglycemia|0|||
150205123|NCT00943917|541890806|FG001|Stage II Continuation|hypoglycemia|0|||
150205124|NCT00943917|541890807|FG002|Stage II Continuation|hypoglycemia|0|||
150205125|NCT00943917|541890808|FG003|Stage II Continuation|hypoglycemia|0|||
150205126|NCT00943917|541890809|FG004|Stage II Continuation|hypoglycemia|0|||
150205127|NCT00943917|541890810|FG005|Stage II Continuation|hypoglycemia|0|||
150205128|NCT00943917|541890811|FG006|Stage II Continuation|hypoglycemia|0|||
150205129|NCT00943917|541890812|FG007|Stage II Continuation|hypoglycemia|0|||
150205130|NCT00943917|541890813|FG008|Stage II Continuation|hypoglycemia|0|||
150205131|NCT00943917|541890814|FG009|Stage II Continuation|hypoglycemia|0|||
150205132|NCT00943917|541890815|FG010|Stage II Continuation|hypoglycemia|0|||
150205133|NCT00943917|541890816|FG011|Stage II Continuation|hypoglycemia|0|||
150205134|NCT00943917|541890817|FG012|Stage II Continuation|hypoglycemia|1|||
150205135|NCT00943917|541890818|FG013|Stage II Continuation|hypoglycemia|0|||
150205136|NCT00943917|541890819|FG014|Stage II Continuation|hypoglycemia|0|||
150205137|NCT00943917|541890805|FG000|Stage II Continuation|A1C elevation|0|||
150205138|NCT00943917|541890806|FG001|Stage II Continuation|A1C elevation|0|||
150205139|NCT00943917|541890807|FG002|Stage II Continuation|A1C elevation|0|||
150205140|NCT00943917|541890808|FG003|Stage II Continuation|A1C elevation|0|||
150205141|NCT00943917|541890809|FG004|Stage II Continuation|A1C elevation|0|||
150205142|NCT00943917|541890810|FG005|Stage II Continuation|A1C elevation|0|||
150205143|NCT00943917|541890811|FG006|Stage II Continuation|A1C elevation|0|||
150205144|NCT00943917|541890812|FG007|Stage II Continuation|A1C elevation|0|||
150205145|NCT00943917|541890813|FG008|Stage II Continuation|A1C elevation|0|||
150205146|NCT00943917|541890814|FG009|Stage II Continuation|A1C elevation|0|||
150205147|NCT00943917|541890815|FG010|Stage II Continuation|A1C elevation|0|||
150205148|NCT00943917|541890816|FG011|Stage II Continuation|A1C elevation|0|||
150205149|NCT00943917|541890817|FG012|Stage II Continuation|A1C elevation|0|||
150205150|NCT00943917|541890818|FG013|Stage II Continuation|A1C elevation|1|||
150205151|NCT00943917|541890819|FG014|Stage II Continuation|A1C elevation|0|||
150205152|NCT04018495|541890820|FG000|Overall Study|Physician Decision|1|||
150205153|NCT04908514|541890823|FG000|Overall Study|Lost to Follow-up|2|||
150205154|NCT04908514|541890823|FG000|Overall Study|Withdrawal by Subject|1|||
150205155|NCT04059406|541890825|FG000|Overall Study|Early Treatment Termination|5|||
150205156|NCT04059406|541890826|FG001|Overall Study|Early Treatment Termination|5|||
150205157|NCT04059406|541890827|FG002|Overall Study|Early Treatment Termination|15|||
150205158|NCT05155306|541890828|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
150205159|NCT05155306|541890829|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
150205160|NCT05155306|541890830|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
150205161|NCT05155306|541890831|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
150205162|NCT05155306|541890828|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
150205163|NCT05155306|541890829|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
150205164|NCT05155306|541890830|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
150205165|NCT05155306|541890831|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
150205166|NCT04158141|541890832|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
150205167|NCT04158141|541890833|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
150205168|NCT04158141|541890834|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
150205169|NCT04158141|541890832|FG000|Step 1: Registration|Adverse Event|1|||
150205170|NCT04158141|541890833|FG001|Step 1: Registration|Adverse Event|0|||
150205171|NCT04158141|541890834|FG002|Step 1: Registration|Adverse Event|0|||
150205172|NCT04158141|541890832|FG000|Step 1: Registration|Withdrawal by Subject|1|||
150205173|NCT04158141|541890833|FG001|Step 1: Registration|Withdrawal by Subject|0|||
150205174|NCT04158141|541890834|FG002|Step 1: Registration|Withdrawal by Subject|0|||
150205175|NCT04158141|541890832|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
150205176|NCT04158141|541890833|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
150205177|NCT04158141|541890834|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
150205178|NCT00319696|541890835|FG000|Overall Study|Adverse Event|36|||
150205179|NCT00319696|541890835|FG000|Overall Study|withdrawal of consent|14|||
150205180|NCT00319696|541890835|FG000|Overall Study|administrative|7|||
150205181|NCT00319696|541890835|FG000|Overall Study|Lost to Follow-up|3|||
150205182|NCT00655499|541891374|FG000|Overall Study|not eligible|4|||
150205183|NCT01596972|541891377|FG000|Overall Study|Physician Decision|1|||
150205184|NCT01596972|541891378|FG001|Overall Study|Physician Decision|9|||
150205185|NCT01596972|541891377|FG000|Overall Study|Lost to Follow-up|0|||
150205186|NCT01596972|541891378|FG001|Overall Study|Lost to Follow-up|4|||
150205187|NCT01596972|541891377|FG000|Overall Study|Withdrawal by Subject|0|||
150205188|NCT01596972|541891378|FG001|Overall Study|Withdrawal by Subject|1|||
150205189|NCT02285270|541891379|FG000|Overall Study|Lost to Follow-up|1|||
150205190|NCT02285270|541891379|FG000|Overall Study|Physician Decision|3|||
150205191|NCT02285270|541891379|FG000|Overall Study|Determined to be ineligible|1|||
150205192|NCT00439270|541891380|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
150205193|NCT00439270|541891381|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
150205194|NCT00439270|541891382|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
150205195|NCT00439270|541891383|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
150205196|NCT00439270|541891384|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
150205197|NCT00439270|541891380|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
150205198|NCT00439270|541891381|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
150205199|NCT00439270|541891382|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
150205200|NCT00439270|541891383|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
150205201|NCT00439270|541891384|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
150205202|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
150205203|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
150205204|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
150205205|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
150205206|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
150205207|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
150205208|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
150205209|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
150205210|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
150205211|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
150205212|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
150205213|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
150205214|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
150205215|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
150205216|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
150205217|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
150205218|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
150205219|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
150205220|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
150205221|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
150205222|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
150205223|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
150205224|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
150205225|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
150205226|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
150205227|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
150205228|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
150205229|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
150205230|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
150205231|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
150205232|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
150205233|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
150205234|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
150205235|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
150205236|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
150205237|NCT00439270|541891380|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
150205238|NCT00439270|541891381|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
150205239|NCT00439270|541891382|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
150205240|NCT00439270|541891383|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
150205241|NCT00439270|541891384|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
150205242|NCT04121546|541891390|FG000|Overall Study|Lost to Follow-up|1|||
150205243|NCT04121546|541891391|FG001|Overall Study|Lost to Follow-up|3|||
150205244|NCT03183050|541891392|FG000|Overall Study|Lost to Follow-up|23|||
150205245|NCT03248492|541891394|FG000|Overall Study|Progressive Disease|24|||
150205246|NCT03248492|541891395|FG001|Overall Study|Progressive Disease|23|||
150205247|NCT03248492|541891396|FG002|Overall Study|Progressive Disease|11|||
150205248|NCT03248492|541891397|FG003|Overall Study|Progressive Disease|66|||
150205249|NCT03248492|541891398|FG004|Overall Study|Progressive Disease|1|||
150205250|NCT03248492|541891394|FG000|Overall Study|Adverse Event|14|||
150205251|NCT03248492|541891395|FG001|Overall Study|Adverse Event|13|||
150205252|NCT03248492|541891396|FG002|Overall Study|Adverse Event|9|||
150205253|NCT03248492|541891397|FG003|Overall Study|Adverse Event|22|||
150205254|NCT03248492|541891398|FG004|Overall Study|Adverse Event|2|||
150205255|NCT03248492|541891394|FG000|Overall Study|Withdrawal by Subject|5|||
150205256|NCT03248492|541891395|FG001|Overall Study|Withdrawal by Subject|4|||
150205257|NCT03248492|541891396|FG002|Overall Study|Withdrawal by Subject|0|||
150205258|NCT03248492|541891397|FG003|Overall Study|Withdrawal by Subject|8|||
150205259|NCT03248492|541891398|FG004|Overall Study|Withdrawal by Subject|1|||
150205260|NCT03248492|541891394|FG000|Overall Study|Physician Decision|1|||
150205261|NCT03248492|541891395|FG001|Overall Study|Physician Decision|1|||
150205262|NCT03248492|541891396|FG002|Overall Study|Physician Decision|1|||
150205263|NCT03248492|541891397|FG003|Overall Study|Physician Decision|7|||
150205264|NCT03248492|541891398|FG004|Overall Study|Physician Decision|0|||
150205265|NCT03248492|541891394|FG000|Overall Study|Death|1|||
150205266|NCT03248492|541891395|FG001|Overall Study|Death|1|||
150205267|NCT03248492|541891396|FG002|Overall Study|Death|0|||
150205268|NCT03248492|541891397|FG003|Overall Study|Death|6|||
150205269|NCT03248492|541891398|FG004|Overall Study|Death|0|||
150205270|NCT03248492|541891394|FG000|Overall Study|Study Terminated by Sponsor|3|||
150205271|NCT03248492|541891395|FG001|Overall Study|Study Terminated by Sponsor|1|||
150205272|NCT03248492|541891396|FG002|Overall Study|Study Terminated by Sponsor|0|||
150205273|NCT03248492|541891397|FG003|Overall Study|Study Terminated by Sponsor|7|||
150205274|NCT03248492|541891398|FG004|Overall Study|Study Terminated by Sponsor|0|||
150205275|NCT03248492|541891394|FG000|Overall Study|Other|2|||
150205276|NCT03248492|541891395|FG001|Overall Study|Other|5|||
150205277|NCT03248492|541891396|FG002|Overall Study|Other|0|||
150205278|NCT03248492|541891397|FG003|Overall Study|Other|14|||
150205279|NCT03248492|541891398|FG004|Overall Study|Other|0|||
150205280|NCT04495621|541891399|FG000|Overall Study|Withdrawal by Subject|0|||
150205281|NCT04495621|541891400|FG001|Overall Study|Withdrawal by Subject|3|||
150205282|NCT04495621|541891399|FG000|Overall Study|Death|7|||
150205283|NCT04495621|541891400|FG001|Overall Study|Death|11|||
150205284|NCT04495621|541891399|FG000|Overall Study|Investigator Decision|0|||
150205285|NCT04495621|541891400|FG001|Overall Study|Investigator Decision|7|||
150205286|NCT04495621|541891399|FG000|Overall Study|Lost to Follow-up|0|||
150205287|NCT04495621|541891400|FG001|Overall Study|Lost to Follow-up|1|||
150205288|NCT05707351|541891403|FG000|Overall Study|Withdrawal by Subject|2|||
150205289|NCT05707351|541891403|FG000|Overall Study|Reason Not Specified|1|||
150205290|NCT04305327|541891418|FG000|Overall Study|Study early termination|2|||
150205291|NCT04305327|541891419|FG001|Overall Study|Study early termination|5|||
150205292|NCT04305327|541891420|FG002|Overall Study|Study early termination|2|||
150205293|NCT04305327|541891421|FG003|Overall Study|Study early termination|2|||
150205294|NCT04305327|541891418|FG000|Overall Study|Withdrawal by Subject|0|||
150205295|NCT04305327|541891419|FG001|Overall Study|Withdrawal by Subject|1|||
150205296|NCT04305327|541891420|FG002|Overall Study|Withdrawal by Subject|0|||
150205297|NCT04305327|541891421|FG003|Overall Study|Withdrawal by Subject|0|||
150205298|NCT02500576|541891422|FG000|Overall Study|Adverse Event|0|||
150205299|NCT02500576|541891423|FG001|Overall Study|Adverse Event|1|||
150205300|NCT02500576|541891422|FG000|Overall Study|Death|2|||
150205301|NCT02500576|541891423|FG001|Overall Study|Death|1|||
150205302|NCT02500576|541891422|FG000|Overall Study|Lack of Efficacy|5|||
150205303|NCT02500576|541891423|FG001|Overall Study|Lack of Efficacy|5|||
150205304|NCT02500576|541891422|FG000|Overall Study|Withdrawal by Subject|1|||
150205305|NCT02500576|541891423|FG001|Overall Study|Withdrawal by Subject|1|||
150205306|NCT01983683|541891429|FG000|Overall Study|Withdrawal by Subject|14|||
150205307|NCT01983683|541891430|FG001|Overall Study|Withdrawal by Subject|18|||
150205308|NCT01983683|541891429|FG000|Overall Study|Death|11|||
150205309|NCT01983683|541891430|FG001|Overall Study|Death|15|||
150205310|NCT01983683|541891429|FG000|Overall Study|Physician Decision|8|||
150205311|NCT01983683|541891430|FG001|Overall Study|Physician Decision|9|||
150205312|NCT01983683|541891429|FG000|Overall Study|Lost to Follow-up|4|||
150205313|NCT01983683|541891430|FG001|Overall Study|Lost to Follow-up|8|||
150205314|NCT01983683|541891429|FG000|Overall Study|Sponsor Decision|1|||
150205315|NCT01983683|541891430|FG001|Overall Study|Sponsor Decision|1|||
150205316|NCT00319020|541891433|FG000|Overall Study|Death|2|||
150205317|NCT00319020|541891434|FG001|Overall Study|Death|2|||
150205318|NCT00319020|541891433|FG000|Overall Study|Withdrawal by Subject|4|||
150205319|NCT00319020|541891434|FG001|Overall Study|Withdrawal by Subject|1|||
150205320|NCT00319020|541891433|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
150205321|NCT00319020|541891434|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
150205322|NCT00319020|541891433|FG000|Overall Study|Administrative reason|0|||
150205323|NCT00319020|541891434|FG001|Overall Study|Administrative reason|5|||
150205324|NCT00319020|541891433|FG000|Overall Study|Disease progression|0|||
150205325|NCT00319020|541891434|FG001|Overall Study|Disease progression|2|||
150205326|NCT00319020|541891433|FG000|Overall Study|Transplant|0|||
150205327|NCT00319020|541891434|FG001|Overall Study|Transplant|1|||
150205328|NCT00319020|541891433|FG000|Overall Study|Treatment failure|0|||
150205329|NCT00319020|541891434|FG001|Overall Study|Treatment failure|1|||
150205330|NCT00319020|541891433|FG000|Overall Study|Adverse Event|0|||
150205331|NCT00319020|541891434|FG001|Overall Study|Adverse Event|1|||
150205332|NCT02422615|541892629|FG000|Treatment Period|Progressive disease|314|||
150205333|NCT02422615|541892630|FG001|Treatment Period|Progressive disease|200|||
150205334|NCT02422615|541892629|FG000|Treatment Period|Adverse Event|51|||
150205335|NCT02422615|541892630|FG001|Treatment Period|Adverse Event|9|||
150205336|NCT02422615|541892629|FG000|Treatment Period|Physician Decision|32|||
150205337|NCT02422615|541892630|FG001|Treatment Period|Physician Decision|8|||
150205338|NCT02422615|541892629|FG000|Treatment Period|Subject/guardian decision|38|||
150205339|NCT02422615|541892630|FG001|Treatment Period|Subject/guardian decision|8|||
150205340|NCT02422615|541892629|FG000|Treatment Period|Death|2|||
150205341|NCT02422615|541892630|FG001|Treatment Period|Death|1|||
150205342|NCT02422615|541892629|FG000|Treatment Period|Technical problems|0|||
150205343|NCT02422615|541892630|FG001|Treatment Period|Technical problems|1|||
150205344|NCT02422615|541892629|FG000|Treatment Period|Protocol deviation|1|||
150205345|NCT02422615|541892630|FG001|Treatment Period|Protocol deviation|1|||
150205346|NCT02422615|541892629|FG000|Treatment Period|Study terminated as per protocol|46|||
150205347|NCT02422615|541892630|FG001|Treatment Period|Study terminated as per protocol|14|||
150205348|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
150205349|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150205350|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Death|2|||
150205351|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Death|1|||
150205352|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
150205353|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
150205354|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
150205355|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
150205356|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
150205357|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
150205358|NCT02422615|541892629|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
150205359|NCT02422615|541892630|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
150205360|NCT01036724|541892631|FG000|Overall Study|Adverse Event|1|||
150205361|NCT01036724|541892632|FG001|Overall Study|Adverse Event|2|||
150205362|NCT01036724|541892631|FG000|Overall Study|Lack of Efficacy|1|||
150205363|NCT01036724|541892632|FG001|Overall Study|Lack of Efficacy|1|||
150205364|NCT01036724|541892631|FG000|Overall Study|Protocol Violation|4|||
150205365|NCT01036724|541892632|FG001|Overall Study|Protocol Violation|5|||
150205366|NCT01288443|541892633|FG000|Overall Study|Adverse Event|0|||
150205367|NCT01288443|541892634|FG001|Overall Study|Adverse Event|0|||
150205368|NCT01288443|541892635|FG002|Overall Study|Adverse Event|1|||
150205369|NCT01288443|541892636|FG003|Overall Study|Adverse Event|1|||
150205370|NCT01288443|541892637|FG004|Overall Study|Adverse Event|3|||
150205371|NCT01288443|541892638|FG005|Overall Study|Adverse Event|1|||
150205372|NCT01288443|541892633|FG000|Overall Study|Poor compliance to protocol|0|||
150205373|NCT01288443|541892634|FG001|Overall Study|Poor compliance to protocol|0|||
150205374|NCT01288443|541892635|FG002|Overall Study|Poor compliance to protocol|0|||
150205375|NCT01288443|541892636|FG003|Overall Study|Poor compliance to protocol|0|||
150205376|NCT01288443|541892637|FG004|Overall Study|Poor compliance to protocol|0|||
150205377|NCT01288443|541892638|FG005|Overall Study|Poor compliance to protocol|1|||
150205378|NCT01288443|541892633|FG000|Overall Study|Participant Moved|0|||
150205379|NCT01288443|541892634|FG001|Overall Study|Participant Moved|0|||
150205380|NCT01288443|541892635|FG002|Overall Study|Participant Moved|0|||
150205381|NCT01288443|541892636|FG003|Overall Study|Participant Moved|1|||
150205382|NCT01288443|541892637|FG004|Overall Study|Participant Moved|2|||
150205383|NCT01288443|541892638|FG005|Overall Study|Participant Moved|1|||
150205384|NCT01288443|541892633|FG000|Overall Study|Consent withdrawn by Participant|0|||
150205385|NCT01288443|541892634|FG001|Overall Study|Consent withdrawn by Participant|0|||
150205386|NCT01288443|541892635|FG002|Overall Study|Consent withdrawn by Participant|0|||
150205387|NCT01288443|541892636|FG003|Overall Study|Consent withdrawn by Participant|0|||
150205388|NCT01288443|541892637|FG004|Overall Study|Consent withdrawn by Participant|0|||
150205389|NCT01288443|541892638|FG005|Overall Study|Consent withdrawn by Participant|1|||
150205390|NCT01288443|541892633|FG000|Overall Study|Lost to Follow-up|0|||
150205391|NCT01288443|541892634|FG001|Overall Study|Lost to Follow-up|1|||
150205392|NCT01288443|541892635|FG002|Overall Study|Lost to Follow-up|0|||
150205393|NCT01288443|541892636|FG003|Overall Study|Lost to Follow-up|0|||
150205394|NCT01288443|541892637|FG004|Overall Study|Lost to Follow-up|0|||
150205395|NCT01288443|541892638|FG005|Overall Study|Lost to Follow-up|0|||
150205396|NCT01288443|541892633|FG000|Overall Study|Study drug auto-injector administration|0|||
150205397|NCT01288443|541892634|FG001|Overall Study|Study drug auto-injector administration|0|||
150205398|NCT01288443|541892635|FG002|Overall Study|Study drug auto-injector administration|0|||
150205399|NCT01288443|541892636|FG003|Overall Study|Study drug auto-injector administration|0|||
150205400|NCT01288443|541892637|FG004|Overall Study|Study drug auto-injector administration|1|||
150205401|NCT01288443|541892638|FG005|Overall Study|Study drug auto-injector administration|1|||
150205402|NCT01288443|541892633|FG000|Overall Study|Other than above|0|||
150205403|NCT01288443|541892634|FG001|Overall Study|Other than above|0|||
150205404|NCT01288443|541892635|FG002|Overall Study|Other than above|0|||
150205405|NCT01288443|541892636|FG003|Overall Study|Other than above|2|||
150205406|NCT01288443|541892637|FG004|Overall Study|Other than above|1|||
150205407|NCT01288443|541892638|FG005|Overall Study|Other than above|0|||
150205408|NCT00692913|541892643|FG000|Overall Study|Adverse Event|8|||
150205409|NCT00692913|541892644|FG001|Overall Study|Adverse Event|4|||
150205410|NCT00692913|541892643|FG000|Overall Study|Lost to Follow-up|3|||
150205411|NCT00692913|541892644|FG001|Overall Study|Lost to Follow-up|5|||
150205412|NCT00692913|541892643|FG000|Overall Study|Physician Decision|2|||
150205413|NCT00692913|541892644|FG001|Overall Study|Physician Decision|0|||
150205414|NCT00692913|541892643|FG000|Overall Study|Protocol Violation|1|||
150205415|NCT00692913|541892644|FG001|Overall Study|Protocol Violation|1|||
150205416|NCT00692913|541892643|FG000|Overall Study|Withdrawal by Subject|15|||
150205417|NCT00692913|541892644|FG001|Overall Study|Withdrawal by Subject|20|||
150205418|NCT02291913|541892645|FG000|Overall Study|Progressive Disease|32|||
150205419|NCT02291913|541892645|FG000|Overall Study|Adverse Event|11|||
150205420|NCT02291913|541892645|FG000|Overall Study|Death|2|||
150205421|NCT02291913|541892645|FG000|Overall Study|Physician Decision|1|||
150205422|NCT02291913|541892645|FG000|Overall Study|Withdrawal by Subject|1|||
150205423|NCT02291913|541892645|FG000|Overall Study|Protocol Violation|1|||
150205424|NCT01637402|541892646|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
150205425|NCT01637402|541892647|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
150205426|NCT01637402|541892646|FG000|Standard Dose Regimen|Adverse Event|1|||
150205427|NCT01637402|541892647|FG001|Standard Dose Regimen|Adverse Event|0|||
150205428|NCT01637402|541892646|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
150205429|NCT01637402|541892647|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
150205430|NCT01637402|541892646|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
150205431|NCT01637402|541892647|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
150205432|NCT01637402|541892646|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
150205433|NCT01637402|541892647|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
150205434|NCT01637402|541892646|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
150205435|NCT01637402|541892647|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
150205436|NCT04876417|541892650|FG000|Overall Study|Lost to Follow-up|5|||
150205437|NCT04876417|541892651|FG001|Overall Study|Lost to Follow-up|8|||
150205438|NCT04876417|541892652|FG002|Overall Study|Lost to Follow-up|0|||
150205439|NCT04876417|541892653|FG003|Overall Study|Lost to Follow-up|0|||
150205440|NCT02111096|541892654|FG000|Overall Study|Adverse Event|4|||
150205441|NCT02111096|541892655|FG001|Overall Study|Adverse Event|1|||
150205442|NCT02111096|541892656|FG002|Overall Study|Adverse Event|2|||
150205443|NCT02111096|541892654|FG000|Overall Study|Non-Compliance with Study Drug|1|||
150205444|NCT02111096|541892655|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150205445|NCT02111096|541892656|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150205446|NCT02111096|541892654|FG000|Overall Study|Lost to Follow Up|1|||
150205447|NCT02111096|541892655|FG001|Overall Study|Lost to Follow Up|1|||
150205448|NCT02111096|541892656|FG002|Overall Study|Lost to Follow Up|1|||
150205449|NCT02111096|541892654|FG000|Overall Study|Physician Decision|0|||
150205450|NCT02111096|541892655|FG001|Overall Study|Physician Decision|1|||
150205451|NCT02111096|541892656|FG002|Overall Study|Physician Decision|0|||
150205452|NCT02111096|541892654|FG000|Overall Study|Protocol Violation|1|||
150205453|NCT02111096|541892655|FG001|Overall Study|Protocol Violation|0|||
150205454|NCT02111096|541892656|FG002|Overall Study|Protocol Violation|1|||
150205455|NCT02111096|541892654|FG000|Overall Study|Terminated by Sponsor|53|||
150205456|NCT02111096|541892655|FG001|Overall Study|Terminated by Sponsor|35|||
150205457|NCT02111096|541892656|FG002|Overall Study|Terminated by Sponsor|54|||
150205458|NCT02111096|541892654|FG000|Overall Study|Withdrawal by Subject|4|||
150205459|NCT02111096|541892655|FG001|Overall Study|Withdrawal by Subject|2|||
150205460|NCT02111096|541892656|FG002|Overall Study|Withdrawal by Subject|8|||
150205461|NCT01268306|541892659|FG000|Overall Study|Lost to Follow-up|1|||
150205462|NCT03621735|541892660|FG000|Overall Study|Withdrawal by Subject|13|||
150205463|NCT03621735|541892661|FG001|Overall Study|Withdrawal by Subject|13|||
150205464|NCT03875313|541892662|FG000|Overall Study|Withdrawal by Subject|1|||
150205465|NCT03875313|541892663|FG001|Overall Study|Withdrawal by Subject|3|||
150205466|NCT03875313|541892664|FG002|Overall Study|Withdrawal by Subject|0|||
150205467|NCT03875313|541892665|FG003|Overall Study|Withdrawal by Subject|0|||
150205468|NCT03875313|541892666|FG004|Overall Study|Withdrawal by Subject|0|||
150205469|NCT03875313|541892662|FG000|Overall Study|Death|0|||
150205470|NCT03875313|541892663|FG001|Overall Study|Death|0|||
150205471|NCT03875313|541892664|FG002|Overall Study|Death|0|||
150205472|NCT03875313|541892665|FG003|Overall Study|Death|0|||
150205473|NCT03875313|541892666|FG004|Overall Study|Death|1|||
150205474|NCT03875313|541892662|FG000|Overall Study|Lost to Follow-up|0|||
150205475|NCT03875313|541892663|FG001|Overall Study|Lost to Follow-up|0|||
150205476|NCT03875313|541892664|FG002|Overall Study|Lost to Follow-up|0|||
150205477|NCT03875313|541892665|FG003|Overall Study|Lost to Follow-up|0|||
150205478|NCT03875313|541892666|FG004|Overall Study|Lost to Follow-up|1|||
150205479|NCT03875313|541892662|FG000|Overall Study|Study Termination by Sponsor|0|||
150205480|NCT03875313|541892663|FG001|Overall Study|Study Termination by Sponsor|1|||
150205481|NCT03875313|541892664|FG002|Overall Study|Study Termination by Sponsor|1|||
150205482|NCT03875313|541892665|FG003|Overall Study|Study Termination by Sponsor|0|||
150205483|NCT03875313|541892666|FG004|Overall Study|Study Termination by Sponsor|1|||
150205484|NCT03875313|541892662|FG000|Overall Study|New Anticancer Treatment|0|||
150205485|NCT03875313|541892663|FG001|Overall Study|New Anticancer Treatment|1|||
150205486|NCT03875313|541892664|FG002|Overall Study|New Anticancer Treatment|2|||
150205487|NCT03875313|541892665|FG003|Overall Study|New Anticancer Treatment|1|||
150205488|NCT03875313|541892666|FG004|Overall Study|New Anticancer Treatment|0|||
150205489|NCT03875313|541892662|FG000|Overall Study|Other, Not Specified|2|||
150205490|NCT03875313|541892663|FG001|Overall Study|Other, Not Specified|11|||
150205491|NCT03875313|541892664|FG002|Overall Study|Other, Not Specified|3|||
150205492|NCT03875313|541892665|FG003|Overall Study|Other, Not Specified|3|||
150205493|NCT03875313|541892666|FG004|Overall Study|Other, Not Specified|1|||
150205494|NCT00686595|541892669|FG000|Overall Study|Adverse Event|3|||
150205495|NCT00686595|541892669|FG000|Overall Study|Protocol Violation|1|||
150205496|NCT00686595|541892669|FG000|Overall Study|Lost to Follow-up|1|||
150205497|NCT00686595|541892669|FG000|Overall Study|Lack of Efficacy|1|||
150205498|NCT00686595|541892669|FG000|Overall Study|Poor Compliance|1|||
150205499|NCT01342367|541892670|FG000|Overall Study|Death|1|||
150205500|NCT01342367|541892671|FG001|Overall Study|Death|0|||
150205501|NCT01342367|541892670|FG000|Overall Study|Withdrawal by Subject|1|||
150205502|NCT01342367|541892671|FG001|Overall Study|Withdrawal by Subject|2|||
150205503|NCT02964741|541892672|FG000|Overall Study|Protocol Violation|1|||
150205504|NCT02964741|541892673|FG001|Overall Study|Protocol Violation|0|||
150205505|NCT02964741|541892674|FG002|Overall Study|Protocol Violation|0|||
150205506|NCT02964741|541892672|FG000|Overall Study|Withdrawal by Subject|0|||
150205507|NCT02964741|541892673|FG001|Overall Study|Withdrawal by Subject|1|||
150205508|NCT02964741|541892674|FG002|Overall Study|Withdrawal by Subject|0|||
150205509|NCT02964741|541892672|FG000|Overall Study|claustrophobia|1|||
150205510|NCT02964741|541892673|FG001|Overall Study|claustrophobia|0|||
150205511|NCT02964741|541892674|FG002|Overall Study|claustrophobia|0|||
150205512|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
150205513|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
150205514|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
150205515|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
150205516|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
150205517|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
150205518|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
150205519|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
150205520|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
150205521|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
150205522|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
150205523|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
150205524|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
150205525|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
150205526|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
150205527|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
150205528|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
150205529|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
150205530|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
150205531|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
150205532|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
150205533|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
150205534|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
150205535|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
150205536|NCT01074294|541892678|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
150205537|NCT01074294|541892679|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
150205538|NCT01074294|541892680|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
150205539|NCT01074294|541892681|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
150205540|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
150205541|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
150205542|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
150205543|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
150205544|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
150205545|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
150205546|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
150205547|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
150205548|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
150205549|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
150205550|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
150205551|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
150205552|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
150205553|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
150205554|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
150205555|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
150205556|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
150205557|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
150205558|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
150205559|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
150205560|NCT01074294|541892678|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
150205561|NCT01074294|541892679|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
150205562|NCT01074294|541892680|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
150205563|NCT01074294|541892681|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
150205564|NCT00640159|541892682|FG000|Overall Study|Lost to Follow-up|2|||
150205565|NCT00112359|541892683|FG000|Overall Study|Unrelated adverse event|16|||
150205566|NCT00112359|541892684|FG001|Overall Study|Unrelated adverse event|8|||
150205567|NCT00112359|541892683|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
150205568|NCT00112359|541892684|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
150205569|NCT00112359|541892683|FG000|Overall Study|Related adverse event|5|||
150205570|NCT00112359|541892684|FG001|Overall Study|Related adverse event|3|||
150205571|NCT00112359|541892683|FG000|Overall Study|Lost to Follow-up|0|||
150205572|NCT00112359|541892684|FG001|Overall Study|Lost to Follow-up|1|||
150205573|NCT00112359|541892683|FG000|Overall Study|Personal/administrative|1|||
150205574|NCT00112359|541892684|FG001|Overall Study|Personal/administrative|1|||
150205575|NCT00112359|541892683|FG000|Overall Study|Other|3|||
150205576|NCT00112359|541892684|FG001|Overall Study|Other|0|||
150205577|NCT00312208|541892691|FG000|Overall Study|Adverse Event|97|||
150205578|NCT00312208|541892692|FG001|Overall Study|Adverse Event|61|||
150205579|NCT00312208|541892691|FG000|Overall Study|Protocol Violation|5|||
150205580|NCT00312208|541892692|FG001|Overall Study|Protocol Violation|3|||
150205581|NCT00312208|541892691|FG000|Overall Study|Death|2|||
150205582|NCT00312208|541892692|FG001|Overall Study|Death|1|||
150205583|NCT00312208|541892691|FG000|Overall Study|Lack of Efficacy|7|||
150205584|NCT00312208|541892692|FG001|Overall Study|Lack of Efficacy|4|||
150205585|NCT00312208|541892691|FG000|Overall Study|Lost to Follow-up|3|||
150205586|NCT00312208|541892692|FG001|Overall Study|Lost to Follow-up|5|||
150205587|NCT00312208|541892691|FG000|Overall Study|Withdrawal by Subject|53|||
150205588|NCT00312208|541892692|FG001|Overall Study|Withdrawal by Subject|42|||
150205589|NCT00312208|541892691|FG000|Overall Study|Other|5|||
150205590|NCT00312208|541892692|FG001|Overall Study|Other|7|||
150205591|NCT01315132|541892693|FG000|Overall Study|not treated due to disease progression|1|||
150205592|NCT05521516|541892699|FG000|Overall Study|Withdrawal by Subject|1|||
150205593|NCT05521516|541892700|FG001|Overall Study|Withdrawal by Subject|1|||
150205594|NCT03275285|541892701|FG000|Overall Study|Ongoing|45|||
150205595|NCT03275285|541892702|FG001|Overall Study|Ongoing|69|||
150205596|NCT04882917|541892708|FG000|Overall Study|Adverse Event|0|||
150205597|NCT04882917|541892709|FG001|Overall Study|Adverse Event|1|||
150205598|NCT04882917|541892710|FG002|Overall Study|Adverse Event|2|||
150205599|NCT04882917|541892711|FG003|Overall Study|Adverse Event|2|||
150205600|NCT04882917|541892708|FG000|Overall Study|Withdrawal by Subject|1|||
150205601|NCT04882917|541892709|FG001|Overall Study|Withdrawal by Subject|0|||
150205602|NCT04882917|541892710|FG002|Overall Study|Withdrawal by Subject|2|||
150205603|NCT04882917|541892711|FG003|Overall Study|Withdrawal by Subject|1|||
150205604|NCT04882917|541892708|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
150205605|NCT04882917|541892709|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
150205606|NCT04882917|541892710|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
150137405|NCT01256411|541637272|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
150137406|NCT01256411|541637273|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
150137407|NCT01256411|541637268|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
150137408|NCT01256411|541637269|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
150205607|NCT04882917|541892711|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
150205608|NCT04926740|541892715|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
150205609|NCT04926740|541892716|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
150205610|NCT04926740|541892715|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
150205611|NCT04926740|541892716|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
150205612|NCT04980300|541892717|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
150205613|NCT04980300|541892718|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
150205614|NCT04980300|541892717|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
150205615|NCT04980300|541892718|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
150205616|NCT04980300|541892717|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
150205617|NCT04980300|541892718|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
150205618|NCT04980300|541892717|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
150205619|NCT04980300|541892718|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
150205620|NCT04530487|541893585|FG000|Overall Study|Death|1|||
150205621|NCT04977583|541893586|FG000|Overall Study|Lost to Follow-up|8|||
150205622|NCT04977583|541893587|FG001|Overall Study|Lost to Follow-up|4|||
150205623|NCT04977583|541893588|FG002|Overall Study|Lost to Follow-up|13|||
150205624|NCT04977583|541893586|FG000|Overall Study|Withdrawal by Subject|3|||
150205625|NCT04977583|541893587|FG001|Overall Study|Withdrawal by Subject|2|||
150205626|NCT04977583|541893588|FG002|Overall Study|Withdrawal by Subject|1|||
150205627|NCT00210106|541893595|FG000|Overall Study|Death|1|||
150205628|NCT00210106|541893595|FG000|Overall Study|Protocol Violation|13|||
150205629|NCT00786864|541893596|FG000|Overall Study|Lost to Follow-up|0|||
150205630|NCT00786864|541893597|FG001|Overall Study|Lost to Follow-up|1|||
150205631|NCT00786864|541893596|FG000|Overall Study|Sustained serious back injury|1|||
150205632|NCT00786864|541893597|FG001|Overall Study|Sustained serious back injury|0|||
150205633|NCT03876457|541893601|FG000|Overall Study|Lost to Follow-up|1|||
150205634|NCT03876457|541893602|FG001|Overall Study|Lost to Follow-up|3|||
150205635|NCT01574716|541893604|FG000|Part 1|Death|3|||
150205636|NCT01574716|541893605|FG001|Part 1|Death|1|||
150205637|NCT01574716|541893606|FG002|Part 1|Death|8|||
150205638|NCT01574716|541893607|FG003|Part 1|Death|0|||
150205639|NCT01574716|541893608|FG004|Part 1|Death|0|||
150205640|NCT01574716|541893604|FG000|Part 1|Discontinuation of study by sponsor|0|||
150205641|NCT01574716|541893605|FG001|Part 1|Discontinuation of study by sponsor|0|||
150205642|NCT01574716|541893606|FG002|Part 1|Discontinuation of study by sponsor|1|||
150205643|NCT01574716|541893607|FG003|Part 1|Discontinuation of study by sponsor|0|||
150205644|NCT01574716|541893608|FG004|Part 1|Discontinuation of study by sponsor|0|||
150205645|NCT01574716|541893604|FG000|Part 1|Withdrawal by Subject|0|||
150205646|NCT01574716|541893605|FG001|Part 1|Withdrawal by Subject|2|||
150205647|NCT01574716|541893606|FG002|Part 1|Withdrawal by Subject|0|||
150205648|NCT01574716|541893607|FG003|Part 1|Withdrawal by Subject|0|||
150205649|NCT01574716|541893608|FG004|Part 1|Withdrawal by Subject|0|||
150205650|NCT01574716|541893604|FG000|Part 1|Lost to Follow-up|0|||
150205651|NCT01574716|541893605|FG001|Part 1|Lost to Follow-up|1|||
150205652|NCT01574716|541893606|FG002|Part 1|Lost to Follow-up|0|||
150205653|NCT01574716|541893607|FG003|Part 1|Lost to Follow-up|0|||
150205654|NCT01574716|541893608|FG004|Part 1|Lost to Follow-up|0|||
150205655|NCT01574716|541893604|FG000|Part 2|Progressive disease|0|||
150205656|NCT01574716|541893605|FG001|Part 2|Progressive disease|0|||
150205657|NCT01574716|541893606|FG002|Part 2|Progressive disease|0|||
150205658|NCT01574716|541893607|FG003|Part 2|Progressive disease|1|||
150205659|NCT01574716|541893608|FG004|Part 2|Progressive disease|0|||
150205660|NCT01574716|541893604|FG000|Part 2|Death|0|||
150205661|NCT01574716|541893605|FG001|Part 2|Death|0|||
150205662|NCT01574716|541893606|FG002|Part 2|Death|0|||
150205663|NCT01574716|541893607|FG003|Part 2|Death|76|||
150205664|NCT01574716|541893608|FG004|Part 2|Death|35|||
150205665|NCT01574716|541893604|FG000|Part 2|Discontinuation of study by sponsor|0|||
150205666|NCT01574716|541893605|FG001|Part 2|Discontinuation of study by sponsor|0|||
150205667|NCT01574716|541893606|FG002|Part 2|Discontinuation of study by sponsor|0|||
150205668|NCT01574716|541893607|FG003|Part 2|Discontinuation of study by sponsor|51|||
150205669|NCT01574716|541893608|FG004|Part 2|Discontinuation of study by sponsor|31|||
150205670|NCT01574716|541893604|FG000|Part 2|Withdrawal by Subject|0|||
150205671|NCT01574716|541893605|FG001|Part 2|Withdrawal by Subject|0|||
150205672|NCT01574716|541893606|FG002|Part 2|Withdrawal by Subject|0|||
150205673|NCT01574716|541893607|FG003|Part 2|Withdrawal by Subject|5|||
150205674|NCT01574716|541893608|FG004|Part 2|Withdrawal by Subject|4|||
150205675|NCT01574716|541893604|FG000|Part 2|Brain metastases|0|||
150205676|NCT01574716|541893605|FG001|Part 2|Brain metastases|0|||
150205677|NCT01574716|541893606|FG002|Part 2|Brain metastases|0|||
150205678|NCT01574716|541893607|FG003|Part 2|Brain metastases|1|||
150205679|NCT01574716|541893608|FG004|Part 2|Brain metastases|0|||
150205680|NCT01574716|541893604|FG000|Part 2|Lost to Follow-up|0|||
150205681|NCT01574716|541893605|FG001|Part 2|Lost to Follow-up|0|||
150205682|NCT01574716|541893606|FG002|Part 2|Lost to Follow-up|0|||
150205683|NCT01574716|541893607|FG003|Part 2|Lost to Follow-up|3|||
150205684|NCT01574716|541893608|FG004|Part 2|Lost to Follow-up|0|||
150205685|NCT03709706|541893610|FG000|Overall Study|Adverse Event|0|||
150205686|NCT03709706|541893611|FG001|Overall Study|Adverse Event|1|||
150205687|NCT03709706|541893610|FG000|Overall Study|Physician Decision|14|||
150205688|NCT03709706|541893611|FG001|Overall Study|Physician Decision|8|||
150205689|NCT03709706|541893610|FG000|Overall Study|Withdrawal by Subject|2|||
150205690|NCT03709706|541893611|FG001|Overall Study|Withdrawal by Subject|1|||
150205691|NCT03709706|541893610|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
150205692|NCT03709706|541893611|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
150205693|NCT01105975|541893612|FG000|Overall Study|Adverse Event|2|||
150205694|NCT01105975|541893613|FG001|Overall Study|Adverse Event|1|||
150205695|NCT01105975|541893614|FG002|Overall Study|Adverse Event|5|||
150205696|NCT01105975|541893615|FG003|Overall Study|Adverse Event|1|||
150205697|NCT01105975|541893616|FG004|Overall Study|Adverse Event|0|||
150205698|NCT01105975|541893617|FG005|Overall Study|Adverse Event|1|||
150205699|NCT01105975|541893618|FG006|Overall Study|Adverse Event|2|||
150205700|NCT01105975|541893619|FG007|Overall Study|Adverse Event|4|||
150205701|NCT01105975|541893620|FG008|Overall Study|Adverse Event|1|||
150205702|NCT01105975|541893621|FG009|Overall Study|Adverse Event|4|||
150205703|NCT01105975|541893612|FG000|Overall Study|Withdrawal by Subject|2|||
150205704|NCT01105975|541893613|FG001|Overall Study|Withdrawal by Subject|2|||
150205705|NCT01105975|541893614|FG002|Overall Study|Withdrawal by Subject|2|||
150205706|NCT01105975|541893615|FG003|Overall Study|Withdrawal by Subject|0|||
150205707|NCT01105975|541893616|FG004|Overall Study|Withdrawal by Subject|4|||
150205708|NCT01105975|541893617|FG005|Overall Study|Withdrawal by Subject|1|||
150205709|NCT01105975|541893618|FG006|Overall Study|Withdrawal by Subject|2|||
150205710|NCT01105975|541893619|FG007|Overall Study|Withdrawal by Subject|1|||
150205711|NCT01105975|541893620|FG008|Overall Study|Withdrawal by Subject|0|||
150205712|NCT01105975|541893621|FG009|Overall Study|Withdrawal by Subject|3|||
150205713|NCT01105975|541893612|FG000|Overall Study|Lost to Follow-up|1|||
150205714|NCT01105975|541893613|FG001|Overall Study|Lost to Follow-up|0|||
150205715|NCT01105975|541893614|FG002|Overall Study|Lost to Follow-up|0|||
150205716|NCT01105975|541893615|FG003|Overall Study|Lost to Follow-up|1|||
150205717|NCT01105975|541893616|FG004|Overall Study|Lost to Follow-up|1|||
150205718|NCT01105975|541893617|FG005|Overall Study|Lost to Follow-up|0|||
150205719|NCT01105975|541893618|FG006|Overall Study|Lost to Follow-up|0|||
150205720|NCT01105975|541893619|FG007|Overall Study|Lost to Follow-up|0|||
150205721|NCT01105975|541893620|FG008|Overall Study|Lost to Follow-up|1|||
150205722|NCT01105975|541893621|FG009|Overall Study|Lost to Follow-up|0|||
150205723|NCT01105975|541893612|FG000|Overall Study|Physician Decision|0|||
150205724|NCT01105975|541893613|FG001|Overall Study|Physician Decision|0|||
150205725|NCT01105975|541893614|FG002|Overall Study|Physician Decision|0|||
150205726|NCT01105975|541893615|FG003|Overall Study|Physician Decision|0|||
150205727|NCT01105975|541893616|FG004|Overall Study|Physician Decision|0|||
150205728|NCT01105975|541893617|FG005|Overall Study|Physician Decision|0|||
150205729|NCT01105975|541893618|FG006|Overall Study|Physician Decision|2|||
150205730|NCT01105975|541893619|FG007|Overall Study|Physician Decision|0|||
150205731|NCT01105975|541893620|FG008|Overall Study|Physician Decision|0|||
150205732|NCT01105975|541893621|FG009|Overall Study|Physician Decision|0|||
150205733|NCT01105975|541893612|FG000|Overall Study|Protocol Violation|0|||
150205734|NCT01105975|541893613|FG001|Overall Study|Protocol Violation|2|||
150205735|NCT01105975|541893614|FG002|Overall Study|Protocol Violation|2|||
150205736|NCT01105975|541893615|FG003|Overall Study|Protocol Violation|0|||
150205737|NCT01105975|541893616|FG004|Overall Study|Protocol Violation|1|||
150205738|NCT01105975|541893617|FG005|Overall Study|Protocol Violation|1|||
150205739|NCT01105975|541893618|FG006|Overall Study|Protocol Violation|1|||
150205740|NCT01105975|541893619|FG007|Overall Study|Protocol Violation|1|||
150205741|NCT01105975|541893620|FG008|Overall Study|Protocol Violation|2|||
150205742|NCT01105975|541893621|FG009|Overall Study|Protocol Violation|2|||
150205743|NCT01105975|541893612|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150205744|NCT01105975|541893613|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150205745|NCT01105975|541893614|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150205746|NCT01105975|541893615|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150205747|NCT01105975|541893616|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150205748|NCT01105975|541893617|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
150205749|NCT01105975|541893618|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150205750|NCT01105975|541893619|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
150205751|NCT01105975|541893620|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
150205752|NCT01105975|541893621|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
150205753|NCT04868617|541893622|FG000|Overall Study|Death|1|||
150205754|NCT04868617|541893623|FG001|Overall Study|Death|0|||
150205755|NCT04868617|541893622|FG000|Overall Study|Adverse Event|1|||
150205756|NCT04868617|541893623|FG001|Overall Study|Adverse Event|0|||
150205757|NCT04868617|541893622|FG000|Overall Study|Withdrawal by Subject|1|||
150205758|NCT04868617|541893623|FG001|Overall Study|Withdrawal by Subject|0|||
150205759|NCT04868617|541893622|FG000|Overall Study|Device deficiency|1|||
150205760|NCT04868617|541893623|FG001|Overall Study|Device deficiency|0|||
150205761|NCT02797132|541893625|FG000|Part A (15 Days)|Adverse Event|1|||
150205762|NCT02797132|541893625|FG000|Part B (24 Weeks)|Adverse Event|3|||
150205763|NCT02502526|541893626|FG000|Overall Study|Lost to Follow-up|2|||
150205764|NCT02502526|541893627|FG001|Overall Study|Lost to Follow-up|2|||
150205765|NCT02502526|541893628|FG002|Overall Study|Lost to Follow-up|3|||
150205766|NCT02502526|541893626|FG000|Overall Study|Withdrawal by Subject|0|||
150205767|NCT02502526|541893627|FG001|Overall Study|Withdrawal by Subject|1|||
150205768|NCT02502526|541893628|FG002|Overall Study|Withdrawal by Subject|1|||
150205769|NCT02502526|541893626|FG000|Overall Study|Disqualified due to cataract grading|0|||
150205770|NCT02502526|541893627|FG001|Overall Study|Disqualified due to cataract grading|0|||
150205771|NCT02502526|541893628|FG002|Overall Study|Disqualified due to cataract grading|1|||
150205772|NCT02502526|541893626|FG000|Overall Study|Enrollment suspension|4|||
150205773|NCT02502526|541893627|FG001|Overall Study|Enrollment suspension|1|||
150205774|NCT02502526|541893628|FG002|Overall Study|Enrollment suspension|1|||
150205775|NCT01371994|541893634|FG000|Overall Study|Adverse Event|3|||
150205776|NCT01371994|541893635|FG001|Overall Study|Adverse Event|6|||
150205777|NCT01371994|541893634|FG000|Overall Study|Lack of Efficacy|3|||
150205778|NCT01371994|541893635|FG001|Overall Study|Lack of Efficacy|0|||
150205779|NCT01371994|541893634|FG000|Overall Study|Withdrawal by Subject|13|||
150205780|NCT01371994|541893635|FG001|Overall Study|Withdrawal by Subject|7|||
150205781|NCT01371994|541893634|FG000|Overall Study|Lost to Follow-up|1|||
150205782|NCT01371994|541893635|FG001|Overall Study|Lost to Follow-up|1|||
150205783|NCT01371994|541893634|FG000|Overall Study|Protocol Violation|24|||
150205784|NCT01371994|541893635|FG001|Overall Study|Protocol Violation|17|||
150205785|NCT01371994|541893634|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
150205786|NCT01371994|541893635|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
150205787|NCT01371994|541893634|FG000|Overall Study|Physician Decision|1|||
150205788|NCT01371994|541893635|FG001|Overall Study|Physician Decision|1|||
150205789|NCT01371994|541893634|FG000|Overall Study|Miscellaneous Reasons|6|||
150205790|NCT01371994|541893635|FG001|Overall Study|Miscellaneous Reasons|4|||
150205791|NCT00087685|541893636|FG000|Overall Study|Adverse Event|5|||
150205792|NCT00087685|541893636|FG000|Overall Study|Non-Compliance|1|||
150205793|NCT00087685|541893636|FG000|Overall Study|Progressive Disease|5|||
150205794|NCT00087685|541893636|FG000|Overall Study|Withdrawal by Subject|3|||
150205795|NCT05601882|541893638|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
150205796|NCT05601882|541893639|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
150205797|NCT05601882|541893640|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
150205798|NCT05601882|541893641|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
150205799|NCT05601882|541893638|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
150205800|NCT05601882|541893639|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
150205801|NCT05601882|541893640|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
150205802|NCT05601882|541893641|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
150205803|NCT05601882|541893638|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
150205804|NCT05601882|541893639|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
150205805|NCT05601882|541893640|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
150205806|NCT05601882|541893641|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
150205807|NCT05601882|541893638|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
150205808|NCT05601882|541893639|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
150205809|NCT05601882|541893640|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
150205810|NCT05601882|541893641|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
150205811|NCT05601882|541893638|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
150205812|NCT05601882|541893639|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
150205813|NCT05601882|541893640|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
150205814|NCT05601882|541893641|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
150205815|NCT05601882|541893638|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
150205816|NCT05601882|541893639|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
150205817|NCT05601882|541893640|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
150205818|NCT05601882|541893641|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
150205819|NCT00115934|541893642|FG000|Overall Study|Lost to Follow-up|1|||
150205820|NCT00115934|541893643|FG001|Overall Study|Lost to Follow-up|0|||
150205821|NCT00115934|541893642|FG000|Overall Study|Did not receive intervention|3|||
150205822|NCT00115934|541893643|FG001|Overall Study|Did not receive intervention|2|||
150205823|NCT00747565|541893644|FG000|Overall Study|Withdrawal by Subject|10|||
150205824|NCT00747565|541893645|FG001|Overall Study|Withdrawal by Subject|6|||
150205825|NCT00747565|541893644|FG000|Overall Study|Lost to Follow-up|4|||
150205826|NCT00747565|541893645|FG001|Overall Study|Lost to Follow-up|1|||
150205827|NCT03777657|541893646|FG000|Overall Study|Death|397|||
150205828|NCT03777657|541893647|FG001|Overall Study|Death|431|||
150205829|NCT03777657|541893646|FG000|Overall Study|Study Closed by Sponsor|77|||
150205830|NCT03777657|541893647|FG001|Overall Study|Study Closed by Sponsor|38|||
150205831|NCT03777657|541893646|FG000|Overall Study|Withdrawal by Subject|20|||
150205832|NCT03777657|541893647|FG001|Overall Study|Withdrawal by Subject|17|||
150205833|NCT03777657|541893646|FG000|Overall Study|Lost to Follow-up|6|||
150205834|NCT03777657|541893647|FG001|Overall Study|Lost to Follow-up|10|||
150205835|NCT03789110|541893650|FG000|Overall Study|Adverse Event|2|||
150205836|NCT03789110|541893650|FG000|Overall Study|Physician Decision|1|||
150205837|NCT03789110|541893650|FG000|Overall Study|Withdrawal by Subject|2|||
150205838|NCT03789110|541893650|FG000|Overall Study|Lack of Efficacy|22|||
150205839|NCT03789110|541893650|FG000|Overall Study|still on treatment|3|||
150205840|NCT05827068|541893651|FG000|Overall Study|Lost to Follow-up|1|||
150205841|NCT05827068|541893652|FG001|Overall Study|Lost to Follow-up|4|||
150205842|NCT05827068|541893653|FG002|Overall Study|Lost to Follow-up|1|||
150205843|NCT05827068|541893654|FG003|Overall Study|Lost to Follow-up|1|||
150205844|NCT05827068|541893655|FG004|Overall Study|Lost to Follow-up|2|||
150205845|NCT05827068|541893656|FG005|Overall Study|Lost to Follow-up|4|||
150205846|NCT05827068|541893657|FG006|Overall Study|Lost to Follow-up|1|||
150205847|NCT05827068|541893651|FG000|Overall Study|Withdrawal by Subject|4|||
150205848|NCT05827068|541893652|FG001|Overall Study|Withdrawal by Subject|0|||
150205849|NCT05827068|541893653|FG002|Overall Study|Withdrawal by Subject|1|||
150205850|NCT05827068|541893654|FG003|Overall Study|Withdrawal by Subject|2|||
150205851|NCT05827068|541893655|FG004|Overall Study|Withdrawal by Subject|3|||
150205852|NCT05827068|541893656|FG005|Overall Study|Withdrawal by Subject|0|||
150205853|NCT05827068|541893657|FG006|Overall Study|Withdrawal by Subject|1|||
150205854|NCT05827068|541893651|FG000|Overall Study|Physician Decision|0|||
150205855|NCT05827068|541893652|FG001|Overall Study|Physician Decision|0|||
150205856|NCT05827068|541893653|FG002|Overall Study|Physician Decision|0|||
150205857|NCT05827068|541893654|FG003|Overall Study|Physician Decision|0|||
150205858|NCT05827068|541893655|FG004|Overall Study|Physician Decision|1|||
150205859|NCT05827068|541893656|FG005|Overall Study|Physician Decision|0|||
150205860|NCT05827068|541893657|FG006|Overall Study|Physician Decision|1|||
150205861|NCT05827068|541893651|FG000|Overall Study|Other Than Specified|0|||
150205862|NCT05827068|541893652|FG001|Overall Study|Other Than Specified|1|||
150205863|NCT05827068|541893653|FG002|Overall Study|Other Than Specified|0|||
150205864|NCT05827068|541893654|FG003|Overall Study|Other Than Specified|0|||
150205865|NCT05827068|541893655|FG004|Overall Study|Other Than Specified|0|||
150205866|NCT05827068|541893656|FG005|Overall Study|Other Than Specified|0|||
150205867|NCT05827068|541893657|FG006|Overall Study|Other Than Specified|0|||
150205868|NCT00227266|541893658|FG000|Overall Study|Withdrawal by Subject|0|||
150205869|NCT00227266|541893659|FG001|Overall Study|Withdrawal by Subject|0|||
150205870|NCT00227266|541893660|FG002|Overall Study|Withdrawal by Subject|1|||
150205871|NCT00227266|541893658|FG000|Overall Study|Protocol Violation|1|||
150205872|NCT00227266|541893659|FG001|Overall Study|Protocol Violation|0|||
150205873|NCT00227266|541893660|FG002|Overall Study|Protocol Violation|1|||
150205874|NCT00227266|541893658|FG000|Overall Study|Excessive weight gain|0|||
150205875|NCT00227266|541893659|FG001|Overall Study|Excessive weight gain|0|||
150205876|NCT00227266|541893660|FG002|Overall Study|Excessive weight gain|2|||
150205877|NCT02549352|541893663|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
150205878|NCT02549352|541893664|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
150205879|NCT02549352|541893663|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
150205880|NCT02549352|541893664|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
150205881|NCT02549352|541893663|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
150205882|NCT02549352|541893664|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
150205883|NCT02549352|541893663|FG000|12-month Follow-up|Withdrawal by Subject|4|||
150205884|NCT02549352|541893664|FG001|12-month Follow-up|Withdrawal by Subject|5|||
150205885|NCT02549352|541893663|FG000|12-month Follow-up|Lost to Follow-up|3|||
150205886|NCT02549352|541893664|FG001|12-month Follow-up|Lost to Follow-up|2|||
150205887|NCT02549352|541893663|FG000|12-month Follow-up|Death|0|||
150205888|NCT02549352|541893664|FG001|12-month Follow-up|Death|1|||
150205889|NCT02549352|541893663|FG000|12-month Follow-up|Protocol Violation|0|||
150205890|NCT02549352|541893664|FG001|12-month Follow-up|Protocol Violation|1|||
150205891|NCT02549352|541893663|FG000|12-month Follow-up|Other|1|||
150205892|NCT02549352|541893664|FG001|12-month Follow-up|Other|3|||
150205893|NCT01470144|541893665|FG000|Overall Study|Adverse Event|2|||
150205894|NCT01470144|541893665|FG000|Overall Study|Death|1|||
150205895|NCT01470144|541893665|FG000|Overall Study|Lung transplant|6|||
150205896|NCT01470144|541893665|FG000|Overall Study|Patient's and investigator's decision|1|||
150205897|NCT00593840|541893666|FG000|Overall Study|Withdrawal by Subject|1|||
150205898|NCT04559698|541894654|FG000|Overall Study|Lost to Follow-up|14|||
150205899|NCT04559698|541894655|FG001|Overall Study|Lost to Follow-up|15|||
150205900|NCT04559698|541894654|FG000|Overall Study|Withdrawal by Subject|0|||
150205901|NCT04559698|541894655|FG001|Overall Study|Withdrawal by Subject|1|||
150205902|NCT03437733|541894656|FG000|Overall Study|Eligibility criteria not met|0|||
150205903|NCT03437733|541894657|FG001|Overall Study|Eligibility criteria not met|3|||
150205904|NCT01982682|541894658|FG000|Overall Study|Physician Decision|1|||
150205905|NCT02760654|541894659|FG000|Overall Study|Lost to Follow-up|3|||
150205906|NCT02760654|541894660|FG001|Overall Study|Lost to Follow-up|3|||
150205907|NCT02760654|541894659|FG000|Overall Study|Withdrawal by Subject|4|||
150205908|NCT02760654|541894660|FG001|Overall Study|Withdrawal by Subject|3|||
150205909|NCT00146172|541894661|FG000|Overall Study|Adverse Event|0|||
150205910|NCT00146172|541894662|FG001|Overall Study|Adverse Event|0|||
150205911|NCT00146172|541894663|FG002|Overall Study|Adverse Event|1|||
150205912|NCT00146172|541894664|FG003|Overall Study|Adverse Event|1|||
150205913|NCT00146172|541894665|FG004|Overall Study|Adverse Event|0|||
150205914|NCT00146172|541894666|FG005|Overall Study|Adverse Event|2|||
150205915|NCT00146172|541894667|FG006|Overall Study|Adverse Event|3|||
150205916|NCT00146172|541894668|FG007|Overall Study|Adverse Event|10|||
150205917|NCT00146172|541894661|FG000|Overall Study|Lost to Follow-up|0|||
150205918|NCT00146172|541894662|FG001|Overall Study|Lost to Follow-up|0|||
150205919|NCT00146172|541894663|FG002|Overall Study|Lost to Follow-up|0|||
150205920|NCT00146172|541894664|FG003|Overall Study|Lost to Follow-up|0|||
150205921|NCT00146172|541894665|FG004|Overall Study|Lost to Follow-up|0|||
150205922|NCT00146172|541894666|FG005|Overall Study|Lost to Follow-up|0|||
150205923|NCT00146172|541894667|FG006|Overall Study|Lost to Follow-up|0|||
150205924|NCT00146172|541894668|FG007|Overall Study|Lost to Follow-up|1|||
150205925|NCT00146172|541894661|FG000|Overall Study|Disease Progression|2|||
150205926|NCT00146172|541894662|FG001|Overall Study|Disease Progression|4|||
150205927|NCT00146172|541894663|FG002|Overall Study|Disease Progression|2|||
150205928|NCT00146172|541894664|FG003|Overall Study|Disease Progression|5|||
150205929|NCT00146172|541894665|FG004|Overall Study|Disease Progression|2|||
150205930|NCT00146172|541894666|FG005|Overall Study|Disease Progression|2|||
150205931|NCT00146172|541894667|FG006|Overall Study|Disease Progression|1|||
150205932|NCT00146172|541894668|FG007|Overall Study|Disease Progression|22|||
150205933|NCT00146172|541894661|FG000|Overall Study|Death|0|||
150205934|NCT00146172|541894662|FG001|Overall Study|Death|0|||
150205935|NCT00146172|541894663|FG002|Overall Study|Death|0|||
150205936|NCT00146172|541894664|FG003|Overall Study|Death|0|||
150205937|NCT00146172|541894665|FG004|Overall Study|Death|0|||
150205938|NCT00146172|541894666|FG005|Overall Study|Death|0|||
150205939|NCT00146172|541894667|FG006|Overall Study|Death|1|||
150205940|NCT00146172|541894668|FG007|Overall Study|Death|0|||
150205941|NCT00146172|541894661|FG000|Overall Study|Physician Decision|0|||
150205942|NCT00146172|541894662|FG001|Overall Study|Physician Decision|0|||
150205943|NCT00146172|541894663|FG002|Overall Study|Physician Decision|0|||
150205944|NCT00146172|541894664|FG003|Overall Study|Physician Decision|0|||
150205945|NCT00146172|541894665|FG004|Overall Study|Physician Decision|0|||
150205946|NCT00146172|541894666|FG005|Overall Study|Physician Decision|0|||
150205947|NCT00146172|541894667|FG006|Overall Study|Physician Decision|0|||
150205948|NCT00146172|541894668|FG007|Overall Study|Physician Decision|1|||
150205949|NCT00146172|541894661|FG000|Overall Study|Withdrawal by Subject|0|||
150205950|NCT00146172|541894662|FG001|Overall Study|Withdrawal by Subject|0|||
150205951|NCT00146172|541894663|FG002|Overall Study|Withdrawal by Subject|0|||
150205952|NCT00146172|541894664|FG003|Overall Study|Withdrawal by Subject|0|||
150205953|NCT00146172|541894665|FG004|Overall Study|Withdrawal by Subject|0|||
150205954|NCT00146172|541894666|FG005|Overall Study|Withdrawal by Subject|1|||
150205955|NCT00146172|541894667|FG006|Overall Study|Withdrawal by Subject|1|||
150205956|NCT00146172|541894668|FG007|Overall Study|Withdrawal by Subject|4|||
150205957|NCT00146172|541894661|FG000|Overall Study|Symptomatic Deterioration|1|||
150205958|NCT00146172|541894662|FG001|Overall Study|Symptomatic Deterioration|0|||
150205959|NCT00146172|541894663|FG002|Overall Study|Symptomatic Deterioration|1|||
150205960|NCT00146172|541894664|FG003|Overall Study|Symptomatic Deterioration|0|||
150205961|NCT00146172|541894665|FG004|Overall Study|Symptomatic Deterioration|1|||
150205962|NCT00146172|541894666|FG005|Overall Study|Symptomatic Deterioration|2|||
150205963|NCT00146172|541894667|FG006|Overall Study|Symptomatic Deterioration|0|||
150205964|NCT00146172|541894668|FG007|Overall Study|Symptomatic Deterioration|2|||
150205965|NCT01184326|541894672|FG000|Overall Study|Adverse Event|1|||
150205966|NCT01184326|541894673|FG001|Overall Study|Adverse Event|2|||
150205967|NCT01184326|541894674|FG002|Overall Study|Adverse Event|0|||
150205968|NCT01184326|541894672|FG000|Overall Study|Death|0|||
150205969|NCT01184326|541894673|FG001|Overall Study|Death|0|||
150205970|NCT01184326|541894674|FG002|Overall Study|Death|1|||
150205971|NCT01184326|541894672|FG000|Overall Study|Withdrawal by Subject|0|||
150205972|NCT01184326|541894673|FG001|Overall Study|Withdrawal by Subject|0|||
150205973|NCT01184326|541894674|FG002|Overall Study|Withdrawal by Subject|1|||
150205974|NCT01184326|541894672|FG000|Overall Study|Physician Decision|1|||
150205975|NCT01184326|541894673|FG001|Overall Study|Physician Decision|1|||
150205976|NCT01184326|541894674|FG002|Overall Study|Physician Decision|0|||
150205977|NCT01184326|541894672|FG000|Overall Study|Disease Progression|1|||
150205978|NCT01184326|541894673|FG001|Overall Study|Disease Progression|3|||
150205979|NCT01184326|541894674|FG002|Overall Study|Disease Progression|12|||
150205980|NCT01084694|541894675|FG000|Overall Study|Withdrawal by Subject|2|||
150205981|NCT01084694|541894676|FG001|Overall Study|Withdrawal by Subject|1|||
150205982|NCT01084694|541894675|FG000|Overall Study|Death|2|||
150205983|NCT01084694|541894676|FG001|Overall Study|Death|12|||
150205984|NCT01084694|541894675|FG000|Overall Study|eligibility not maintained|2|||
150205985|NCT01084694|541894676|FG001|Overall Study|eligibility not maintained|7|||
150205986|NCT02438137|541894679|FG000|Overall Study|Lost to Follow-up|3|||
150205987|NCT02438137|541894680|FG001|Overall Study|Lost to Follow-up|2|||
150205988|NCT02438137|541894679|FG000|Overall Study|Adverse Event|1|||
150205989|NCT02438137|541894680|FG001|Overall Study|Adverse Event|0|||
150205990|NCT02438137|541894679|FG000|Overall Study|Withdrawal by Subject|4|||
150205991|NCT02438137|541894680|FG001|Overall Study|Withdrawal by Subject|3|||
150205992|NCT02438137|541894679|FG000|Overall Study|Physician Decision|0|||
150205993|NCT02438137|541894680|FG001|Overall Study|Physician Decision|1|||
150205994|NCT00945321|541894681|FG000|Period 1|Adverse Event|0|||
150205995|NCT00945321|541894682|FG001|Period 1|Adverse Event|0|||
150205996|NCT00945321|541894683|FG002|Period 1|Adverse Event|0|||
150205997|NCT00945321|541894684|FG003|Period 1|Adverse Event|0|||
150205998|NCT00945321|541894685|FG004|Period 1|Adverse Event|1|||
150205999|NCT00945321|541894686|FG005|Period 1|Adverse Event|0|||
150206000|NCT00945321|541894681|FG000|Period 4|Lost to Follow-up|0|||
150206001|NCT00945321|541894682|FG001|Period 4|Lost to Follow-up|0|||
150206002|NCT00945321|541894683|FG002|Period 4|Lost to Follow-up|0|||
150206003|NCT00945321|541894684|FG003|Period 4|Lost to Follow-up|0|||
150206004|NCT00945321|541894685|FG004|Period 4|Lost to Follow-up|0|||
150206005|NCT00945321|541894686|FG005|Period 4|Lost to Follow-up|1|||
150206006|NCT00605306|541894697|FG000|Overall Study|Adverse Event|0|||
150206007|NCT00605306|541894698|FG001|Overall Study|Adverse Event|1|||
150206008|NCT01750684|541894699|FG000|Overall Study|Death|1|||
150206009|NCT01750684|541894700|FG001|Overall Study|Death|0|||
150206010|NCT01750684|541894699|FG000|Overall Study|Non-compliance with Study Drug|0|||
150206011|NCT01750684|541894700|FG001|Overall Study|Non-compliance with Study Drug|1|||
150206012|NCT01750684|541894699|FG000|Overall Study|Withdrawn by Sponsor|0|||
150206013|NCT01750684|541894700|FG001|Overall Study|Withdrawn by Sponsor|1|||
150206014|NCT01750684|541894699|FG000|Overall Study|Protocol Violation|1|||
150206015|NCT01750684|541894700|FG001|Overall Study|Protocol Violation|0|||
150206016|NCT02185794|541894703|FG000|Overall Study|Enrolled but Never Dosed|1|||
150206017|NCT02185794|541894704|FG001|Overall Study|Enrolled but Never Dosed|6|||
150206018|NCT02185794|541894705|FG002|Overall Study|Enrolled but Never Dosed|3|||
150206019|NCT02185794|541894706|FG003|Overall Study|Enrolled but Never Dosed|1|||
150206020|NCT02185794|541894707|FG004|Overall Study|Enrolled but Never Dosed|1|||
150206021|NCT02185794|541894708|FG005|Overall Study|Enrolled but Never Dosed|0|||
150206022|NCT02185794|541894703|FG000|Overall Study|Investigator's Discretion|1|||
150206023|NCT02185794|541894704|FG001|Overall Study|Investigator's Discretion|0|||
150206024|NCT02185794|541894705|FG002|Overall Study|Investigator's Discretion|1|||
150206025|NCT02185794|541894706|FG003|Overall Study|Investigator's Discretion|2|||
150206026|NCT02185794|541894707|FG004|Overall Study|Investigator's Discretion|2|||
150206027|NCT02185794|541894708|FG005|Overall Study|Investigator's Discretion|15|||
150206028|NCT02185794|541894703|FG000|Overall Study|Withdrew Consent|2|||
150206029|NCT02185794|541894704|FG001|Overall Study|Withdrew Consent|5|||
150206030|NCT02185794|541894705|FG002|Overall Study|Withdrew Consent|10|||
150206031|NCT02185794|541894706|FG003|Overall Study|Withdrew Consent|2|||
150206032|NCT02185794|541894707|FG004|Overall Study|Withdrew Consent|0|||
150206033|NCT02185794|541894708|FG005|Overall Study|Withdrew Consent|0|||
150206034|NCT02185794|541894703|FG000|Overall Study|Lost to Follow-up|1|||
150206035|NCT02185794|541894704|FG001|Overall Study|Lost to Follow-up|2|||
150206036|NCT02185794|541894705|FG002|Overall Study|Lost to Follow-up|2|||
150206037|NCT02185794|541894706|FG003|Overall Study|Lost to Follow-up|3|||
150206038|NCT02185794|541894707|FG004|Overall Study|Lost to Follow-up|0|||
150206039|NCT02185794|541894708|FG005|Overall Study|Lost to Follow-up|1|||
150206040|NCT00336505|541894709|FG000|Overall Study|Adverse Event|10|||
150206041|NCT00336505|541894710|FG001|Overall Study|Adverse Event|9|||
150206042|NCT00336505|541894709|FG000|Overall Study|Lack of Efficacy|8|||
150206043|NCT00336505|541894710|FG001|Overall Study|Lack of Efficacy|4|||
150206044|NCT00336505|541894709|FG000|Overall Study|Lost to Follow-up|7|||
150206045|NCT00336505|541894710|FG001|Overall Study|Lost to Follow-up|4|||
150206046|NCT00336505|541894709|FG000|Overall Study|Withdrawal by Subject|5|||
150206047|NCT00336505|541894710|FG001|Overall Study|Withdrawal by Subject|3|||
150206048|NCT00336505|541894709|FG000|Overall Study|Other|7|||
150206049|NCT00336505|541894710|FG001|Overall Study|Other|7|||
150206050|NCT01092416|541894711|FG000|Enrollment|Atherectomy device not inserted|3|||
150206051|NCT01092416|541894711|FG000|30-Day Follow-up|Death|2|||
150206052|NCT01092416|541894711|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
150206053|NCT01092416|541894711|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
150206054|NCT01092416|541894711|FG000|12-Month Follow-up|Death|16|||
150206055|NCT01092416|541894711|FG000|12-Month Follow-up|Lost to Follow-up|4|||
150206056|NCT01092416|541894711|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
150206057|NCT01092416|541894711|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
150206058|NCT01092416|541894711|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
150206059|NCT00246805|541894712|FG000|Phase 1|Lost to Follow-up|1|||
150206060|NCT00246805|541894713|FG001|Phase 1|Lost to Follow-up|0|||
150206061|NCT02284113|541894716|FG000|Overall Study|Adverse Event|1|||
150206062|NCT02284113|541894717|FG001|Overall Study|Adverse Event|0|||
150206063|NCT02284113|541894716|FG000|Overall Study|non-compliance|0|||
150206064|NCT02284113|541894717|FG001|Overall Study|non-compliance|1|||
150206065|NCT02284113|541894716|FG000|Overall Study|Withdrawal by Subject|0|||
150206066|NCT02284113|541894717|FG001|Overall Study|Withdrawal by Subject|1|||
150206067|NCT02284113|541894716|FG000|Overall Study|not provided|0|||
150206068|NCT02284113|541894717|FG001|Overall Study|not provided|1|||
150206069|NCT02284113|541894716|FG000|Overall Study|surgery cancelled|2|||
150206070|NCT02284113|541894717|FG001|Overall Study|surgery cancelled|0|||
150206071|NCT04191824|541894718|FG000|Overall Study|Death|13|||
150206072|NCT04191824|541894719|FG001|Overall Study|Death|12|||
150206073|NCT04191824|541894718|FG000|Overall Study|Lost to Follow-up|456|||
150206074|NCT04191824|541894719|FG001|Overall Study|Lost to Follow-up|435|||
150206075|NCT04191824|541894718|FG000|Overall Study|Physician Decision|2|||
150206076|NCT04191824|541894719|FG001|Overall Study|Physician Decision|1|||
150206077|NCT04191824|541894718|FG000|Overall Study|Protocol Violation|0|||
150206078|NCT04191824|541894719|FG001|Overall Study|Protocol Violation|2|||
150206079|NCT04191824|541894718|FG000|Overall Study|Withdrawal by Subject|16|||
150206080|NCT04191824|541894719|FG001|Overall Study|Withdrawal by Subject|18|||
150206081|NCT04191824|541894718|FG000|Overall Study|Early site closure|24|||
150206082|NCT04191824|541894719|FG001|Overall Study|Early site closure|22|||
150206083|NCT01218009|541894720|FG000|Overall Study|Protocol Violation|2|||
150206084|NCT01218009|541894721|FG001|Overall Study|Protocol Violation|1|||
150206085|NCT01218009|541894720|FG000|Overall Study|Withdrawal by Subject|3|||
150206086|NCT01218009|541894721|FG001|Overall Study|Withdrawal by Subject|1|||
150206087|NCT01218009|541894720|FG000|Overall Study|Sponsor terminated study|161|||
150206088|NCT01218009|541894721|FG001|Overall Study|Sponsor terminated study|163|||
150206089|NCT01324310|541894722|FG000|Overall Study|Adverse Event|1|||
150206090|NCT01324310|541894722|FG000|Overall Study|Disease Progression|1|||
150206091|NCT03170882|541894723|FG000|Overall Study|Death|17|||
150206092|NCT03170882|541894724|FG001|Overall Study|Death|29|||
150206093|NCT03170882|541894723|FG000|Overall Study|Lost to Follow-up|0|||
150206094|NCT03170882|541894724|FG001|Overall Study|Lost to Follow-up|1|||
150206095|NCT03170882|541894723|FG000|Overall Study|Withdrawal by Subject|4|||
150206096|NCT03170882|541894724|FG001|Overall Study|Withdrawal by Subject|7|||
150206097|NCT03170882|541894723|FG000|Overall Study|Reason not Specified|28|||
150206098|NCT03170882|541894724|FG001|Overall Study|Reason not Specified|36|||
150206099|NCT05018143|541894741|FG000|Overall Study|Lost to Follow-up|5|||
150206100|NCT05018143|541894742|FG001|Overall Study|Lost to Follow-up|4|||
150206101|NCT05018143|541894741|FG000|Overall Study|Withdrawal by Subject|0|||
150206102|NCT05018143|541894742|FG001|Overall Study|Withdrawal by Subject|1|||
150206103|NCT01830595|541894743|FG000|First Period|Withdrawal by Subject|1|||
150206104|NCT01830595|541894744|FG001|First Period|Withdrawal by Subject|3|||
150206105|NCT01830595|541894743|FG000|Washout|Withdrawal by Subject|2|||
150206106|NCT01830595|541894744|FG001|Washout|Withdrawal by Subject|2|||
150206107|NCT05116774|541894745|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
150206108|NCT05116774|541894746|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
150206109|NCT05116774|541894745|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
150206110|NCT05116774|541894746|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
150206111|NCT05116774|541894745|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
150206112|NCT05116774|541894746|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
150206113|NCT05116774|541894745|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
150206114|NCT05116774|541894746|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
150206115|NCT03834740|541894747|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
150206116|NCT03834740|541894748|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
150206117|NCT03834740|541894749|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
150206118|NCT03891758|541894750|FG000|Overall Study|Adverse Event|2|||
150206119|NCT03891758|541894751|FG001|Overall Study|Adverse Event|0|||
150206120|NCT03891758|541894750|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150206121|NCT03891758|541894751|FG001|Overall Study|Withdrawal by parent/guardian|2|||
150206122|NCT03691493|541894752|FG000|Overall Study|Withdrawal by Subject|1|||
150206123|NCT05464732|541894762|FG000|Overall Study|Lost to Follow-up|0|||
150206124|NCT05464732|541894763|FG001|Overall Study|Lost to Follow-up|1|||
150206125|NCT05464732|541894762|FG000|Overall Study|Adverse Event|1|||
150206126|NCT05464732|541894763|FG001|Overall Study|Adverse Event|0|||
150206127|NCT03959423|541894768|FG000|Overall Study|Withdrawal by Subject|2|||
150206128|NCT03959423|541894769|FG001|Overall Study|Withdrawal by Subject|3|||
150206129|NCT03959423|541894768|FG000|Overall Study|Physician Decision|0|||
150206130|NCT03959423|541894769|FG001|Overall Study|Physician Decision|1|||
150206131|NCT03959423|541894768|FG000|Overall Study|Lost to Follow-up|1|||
150206132|NCT03959423|541894769|FG001|Overall Study|Lost to Follow-up|0|||
150206133|NCT03959423|541894768|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
150206134|NCT03959423|541894769|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
150206135|NCT05704725|541894771|FG000|Overall Study|Lost to Follow-up|0|||
150206136|NCT05704725|541894772|FG001|Overall Study|Lost to Follow-up|1|||
150206137|NCT05704725|541894771|FG000|Overall Study|Withdrawal by Subject|1|||
150206138|NCT05704725|541894772|FG001|Overall Study|Withdrawal by Subject|0|||
150206139|NCT05864209|541895789|FG000|Overall Study|Lost to Follow-up|2|||
150206140|NCT05864209|541895790|FG001|Overall Study|Lost to Follow-up|3|||
150206141|NCT02722434|541895793|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
150206142|NCT02722434|541895794|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
150206143|NCT02722434|541895793|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
150206144|NCT02722434|541895794|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
150206145|NCT04017611|541895799|FG000|Overall Study|Withdrawn prior to completion|1|||
150206146|NCT00366249|541895800|FG000|Overall Study|Adverse Event|53|||
150206147|NCT00366249|541895801|FG001|Overall Study|Adverse Event|28|||
150206148|NCT00366249|541895800|FG000|Overall Study|Death|0|||
150206149|NCT00366249|541895801|FG001|Overall Study|Death|1|||
150206150|NCT00366249|541895800|FG000|Overall Study|Physician Decision|5|||
150206151|NCT00366249|541895801|FG001|Overall Study|Physician Decision|2|||
150206152|NCT00366249|541895800|FG000|Overall Study|Lost to Follow-up|2|||
150206153|NCT00366249|541895801|FG001|Overall Study|Lost to Follow-up|0|||
150206154|NCT00366249|541895800|FG000|Overall Study|Protocol Violation|1|||
150206155|NCT00366249|541895801|FG001|Overall Study|Protocol Violation|2|||
150206156|NCT00366249|541895800|FG000|Overall Study|Withdrawal by Subject|18|||
150206157|NCT00366249|541895801|FG001|Overall Study|Withdrawal by Subject|4|||
150206158|NCT00366249|541895800|FG000|Overall Study|Lack of Efficacy|21|||
150206159|NCT00366249|541895801|FG001|Overall Study|Lack of Efficacy|21|||
150206160|NCT00366249|541895800|FG000|Overall Study|Most due to osteomylitis status|31|||
150206161|NCT00366249|541895801|FG001|Overall Study|Most due to osteomylitis status|20|||
150206162|NCT01561300|541895802|FG000|Run in on Placebo|Adverse Event|1|||
150206163|NCT01561300|541895803|FG001|Run in on Placebo|Adverse Event|0|||
150206164|NCT03478969|541895804|FG000|Overall Study|Withdrawal by Subject|4|||
150206165|NCT03478969|541895805|FG001|Overall Study|Withdrawal by Subject|7|||
150206166|NCT03478969|541895806|FG002|Overall Study|Withdrawal by Subject|6|||
150206167|NCT03478969|541895804|FG000|Overall Study|Adverse Event|2|||
150206168|NCT03478969|541895805|FG001|Overall Study|Adverse Event|0|||
150206169|NCT03478969|541895806|FG002|Overall Study|Adverse Event|1|||
150206170|NCT03478969|541895804|FG000|Overall Study|Pregnancy|1|||
150206171|NCT03478969|541895805|FG001|Overall Study|Pregnancy|0|||
150206172|NCT03478969|541895806|FG002|Overall Study|Pregnancy|0|||
150206173|NCT03478969|541895804|FG000|Overall Study|Personal Reasons|1|||
150206174|NCT03478969|541895805|FG001|Overall Study|Personal Reasons|0|||
150206175|NCT03478969|541895806|FG002|Overall Study|Personal Reasons|1|||
150206176|NCT03478969|541895804|FG000|Overall Study|Covid-19|1|||
150206177|NCT03478969|541895805|FG001|Overall Study|Covid-19|4|||
150206178|NCT03478969|541895806|FG002|Overall Study|Covid-19|3|||
150206179|NCT03478969|541895804|FG000|Overall Study|Multiple Reasons|0|||
150206180|NCT03478969|541895805|FG001|Overall Study|Multiple Reasons|1|||
150206181|NCT03478969|541895806|FG002|Overall Study|Multiple Reasons|1|||
150206182|NCT03478969|541895804|FG000|Overall Study|Eligibility Criteria|0|||
150206183|NCT03478969|541895805|FG001|Overall Study|Eligibility Criteria|0|||
150206184|NCT03478969|541895806|FG002|Overall Study|Eligibility Criteria|5|||
150206185|NCT03478969|541895804|FG000|Overall Study|Lost to Follow-up|0|||
150206186|NCT03478969|541895805|FG001|Overall Study|Lost to Follow-up|0|||
150206187|NCT03478969|541895806|FG002|Overall Study|Lost to Follow-up|1|||
150206188|NCT01185600|541895807|FG000|Overall Study|Adverse Event|1|||
150206189|NCT01185600|541895808|FG001|Overall Study|Adverse Event|1|||
150206190|NCT01185600|541895807|FG000|Overall Study|Death|0|||
150206191|NCT01185600|541895808|FG001|Overall Study|Death|1|||
150206192|NCT01185600|541895807|FG000|Overall Study|Lost to Follow-up|0|||
150206193|NCT01185600|541895808|FG001|Overall Study|Lost to Follow-up|5|||
150206194|NCT01185600|541895807|FG000|Overall Study|Physician Decision|29|||
150206195|NCT01185600|541895808|FG001|Overall Study|Physician Decision|35|||
150137409|NCT01256411|541637270|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
150137410|NCT01256411|541637271|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
150137411|NCT01256411|541637272|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
150137412|NCT01256411|541637273|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
150137413|NCT01256411|541637268|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
150137414|NCT01256411|541637269|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
150137415|NCT01256411|541637270|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
150137416|NCT01256411|541637271|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
150137417|NCT01256411|541637272|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
150137418|NCT01256411|541637273|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
150137419|NCT01256411|541637268|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
150137420|NCT01256411|541637269|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
150137421|NCT01256411|541637270|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
150137422|NCT01256411|541637271|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
150137423|NCT01256411|541637272|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
150137424|NCT01256411|541637273|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
150137425|NCT01256411|541637268|FG000|Extension by Maximum Treatment|Adverse Event|4|||
150137426|NCT01256411|541637269|FG001|Extension by Maximum Treatment|Adverse Event|2|||
150137427|NCT01256411|541637270|FG002|Extension by Maximum Treatment|Adverse Event|1|||
150137428|NCT01256411|541637271|FG003|Extension by Maximum Treatment|Adverse Event|0|||
150137429|NCT01256411|541637272|FG004|Extension by Maximum Treatment|Adverse Event|0|||
150137430|NCT01256411|541637273|FG005|Extension by Maximum Treatment|Adverse Event|0|||
150137431|NCT01256411|541637268|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
150137432|NCT01256411|541637269|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
150137433|NCT01256411|541637270|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
150137434|NCT01256411|541637271|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
150137435|NCT01256411|541637272|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
150137436|NCT01256411|541637273|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
150137437|NCT01256411|541637268|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
150137438|NCT01256411|541637269|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
150137439|NCT01256411|541637270|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
150137440|NCT01256411|541637271|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
150137441|NCT01256411|541637272|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
150137442|NCT01256411|541637273|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
150137443|NCT01256411|541637268|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
150137444|NCT01256411|541637269|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
150137445|NCT01256411|541637270|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
150137446|NCT01256411|541637271|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
150137447|NCT01256411|541637272|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
150137448|NCT01256411|541637273|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
150137449|NCT01256411|541637268|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
150137450|NCT01256411|541637269|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
150137451|NCT01256411|541637270|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
150137452|NCT01256411|541637271|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
150137453|NCT01256411|541637272|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
150137454|NCT01256411|541637273|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
150137455|NCT01256411|541637268|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
150137456|NCT01256411|541637269|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
150137457|NCT01256411|541637270|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
150137458|NCT01256411|541637271|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
150137459|NCT01256411|541637272|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
150137460|NCT01256411|541637273|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
150137461|NCT02274857|541637274|FG000|Overall Study|Adverse Event|1|||
150137462|NCT02274857|541637275|FG001|Overall Study|Adverse Event|0|||
150137463|NCT02274857|541637274|FG000|Overall Study|Death|1|||
150137464|NCT02274857|541637275|FG001|Overall Study|Death|2|||
150137465|NCT02274857|541637274|FG000|Overall Study|Lost to Follow-up|3|||
150137466|NCT02274857|541637275|FG001|Overall Study|Lost to Follow-up|0|||
150137467|NCT02274857|541637274|FG000|Overall Study|Physician Decision|2|||
150137468|NCT02274857|541637275|FG001|Overall Study|Physician Decision|0|||
150137469|NCT02274857|541637274|FG000|Overall Study|Trial screen failure|0|||
150137470|NCT02274857|541637275|FG001|Overall Study|Trial screen failure|2|||
150137471|NCT02274857|541637274|FG000|Overall Study|Withdrawal by Subject|11|||
150137472|NCT02274857|541637275|FG001|Overall Study|Withdrawal by Subject|2|||
150137473|NCT02274857|541637274|FG000|Overall Study|Other|2|||
150206196|NCT01185600|541895807|FG000|Overall Study|Withdrawal by Subject|1|||
150206197|NCT01185600|541895808|FG001|Overall Study|Withdrawal by Subject|1|||
150206198|NCT01185600|541895807|FG000|Overall Study|Hold by DSMB|1|||
150206199|NCT01185600|541895808|FG001|Overall Study|Hold by DSMB|2|||
150206200|NCT01436175|541895809|FG000|Overall Study|Adverse Event|111|||
150206201|NCT01436175|541895809|FG000|Overall Study|Protocol Violation|49|||
150206202|NCT01436175|541895809|FG000|Overall Study|Withdrawal by Subject|108|||
150206203|NCT01436175|541895809|FG000|Overall Study|Lost to Follow-up|89|||
150206204|NCT01436175|541895809|FG000|Overall Study|Lack of Efficacy|24|||
150206205|NCT01436175|541895809|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
150206206|NCT01436175|541895809|FG000|Overall Study|Other|826|||
150206207|NCT00739934|541895810|FG000|Voriconazole IV|Adverse Event|6|||
150206208|NCT00739934|541895810|FG000|Voriconazole Oral|Other|3|||
150206209|NCT01500200|541895813|FG000|Stage 1|Adverse Event|1|||
150206210|NCT01500200|541895814|FG001|Stage 1|Adverse Event|4|||
150206211|NCT01500200|541895815|FG002|Stage 1|Adverse Event|5|||
150206212|NCT01500200|541895816|FG003|Stage 1|Adverse Event|0|||
150206213|NCT01500200|541895817|FG004|Stage 1|Adverse Event|0|||
150206214|NCT01500200|541895818|FG005|Stage 1|Adverse Event|0|||
150206215|NCT01500200|541895813|FG000|Stage 1|Lost to Follow-up|2|||
150206216|NCT01500200|541895814|FG001|Stage 1|Lost to Follow-up|2|||
150206217|NCT01500200|541895815|FG002|Stage 1|Lost to Follow-up|1|||
150206218|NCT01500200|541895816|FG003|Stage 1|Lost to Follow-up|0|||
150206219|NCT01500200|541895817|FG004|Stage 1|Lost to Follow-up|0|||
150206220|NCT01500200|541895818|FG005|Stage 1|Lost to Follow-up|0|||
150206221|NCT01500200|541895813|FG000|Stage 1|Withdrawal by Subject|3|||
150206222|NCT01500200|541895814|FG001|Stage 1|Withdrawal by Subject|0|||
150206223|NCT01500200|541895815|FG002|Stage 1|Withdrawal by Subject|0|||
150206224|NCT01500200|541895816|FG003|Stage 1|Withdrawal by Subject|0|||
150206225|NCT01500200|541895817|FG004|Stage 1|Withdrawal by Subject|0|||
150206226|NCT01500200|541895818|FG005|Stage 1|Withdrawal by Subject|0|||
150206227|NCT01500200|541895813|FG000|Stage 1|Noncompliance with Study Drug|1|||
150206228|NCT01500200|541895814|FG001|Stage 1|Noncompliance with Study Drug|0|||
150206229|NCT01500200|541895815|FG002|Stage 1|Noncompliance with Study Drug|0|||
150206230|NCT01500200|541895816|FG003|Stage 1|Noncompliance with Study Drug|0|||
150206231|NCT01500200|541895817|FG004|Stage 1|Noncompliance with Study Drug|0|||
150206232|NCT01500200|541895818|FG005|Stage 1|Noncompliance with Study Drug|0|||
150206233|NCT01500200|541895813|FG000|Stage 1|Physician Decision|1|||
150206234|NCT01500200|541895814|FG001|Stage 1|Physician Decision|0|||
150206235|NCT01500200|541895815|FG002|Stage 1|Physician Decision|0|||
150206236|NCT01500200|541895816|FG003|Stage 1|Physician Decision|0|||
150206237|NCT01500200|541895817|FG004|Stage 1|Physician Decision|0|||
150206238|NCT01500200|541895818|FG005|Stage 1|Physician Decision|0|||
150206239|NCT01500200|541895813|FG000|Stage 2|Adverse Event|0|||
150206240|NCT01500200|541895814|FG001|Stage 2|Adverse Event|0|||
150206241|NCT01500200|541895815|FG002|Stage 2|Adverse Event|0|||
150206242|NCT01500200|541895816|FG003|Stage 2|Adverse Event|0|||
150206243|NCT01500200|541895817|FG004|Stage 2|Adverse Event|5|||
150206244|NCT01500200|541895818|FG005|Stage 2|Adverse Event|4|||
150206245|NCT01952366|541895819|FG000|Overall Study|Death|22|||
150206246|NCT01952366|541895819|FG000|Overall Study|Withdrawal by Subject|9|||
150206247|NCT04860505|541895820|FG000|Overall Study|Lost to Follow-up|2|||
150206248|NCT00857766|541895821|FG000|Overall Study|Adverse Event|13|||
150206249|NCT00857766|541895822|FG001|Overall Study|Adverse Event|12|||
150206250|NCT00857766|541895821|FG000|Overall Study|Protocol Violation|11|||
150206251|NCT00857766|541895822|FG001|Overall Study|Protocol Violation|11|||
150206252|NCT00857766|541895821|FG000|Overall Study|Lost to Follow-up|1|||
150206253|NCT00857766|541895822|FG001|Overall Study|Lost to Follow-up|0|||
150206254|NCT00857766|541895821|FG000|Overall Study|Investigator Discretion|2|||
150206255|NCT00857766|541895822|FG001|Overall Study|Investigator Discretion|3|||
150206256|NCT00857766|541895821|FG000|Overall Study|Participant Withdrew Consent|4|||
150206257|NCT00857766|541895822|FG001|Overall Study|Participant Withdrew Consent|4|||
150206258|NCT01961609|541895823|FG000|Initiation|Missing|3|||
150206259|NCT01961609|541895824|FG001|Initiation|Missing|2|||
150206260|NCT01961609|541895825|FG002|Initiation|Missing|0|||
150206261|NCT01961609|541895826|FG003|Initiation|Missing|0|||
150206262|NCT01961609|541895823|FG000|Initiation|Protocol deviation|1|||
150206263|NCT01961609|541895824|FG001|Initiation|Protocol deviation|0|||
150206264|NCT01961609|541895825|FG002|Initiation|Protocol deviation|0|||
150206265|NCT01961609|541895826|FG003|Initiation|Protocol deviation|0|||
150206266|NCT01961609|541895823|FG000|Initiation|Death|0|||
150206267|NCT01961609|541895824|FG001|Initiation|Death|1|||
150206268|NCT01961609|541895825|FG002|Initiation|Death|0|||
150206269|NCT01961609|541895826|FG003|Initiation|Death|0|||
150206270|NCT01961609|541895823|FG000|Initiation|Administrative problems|1|||
150206271|NCT01961609|541895824|FG001|Initiation|Administrative problems|0|||
150137474|NCT02274857|541637275|FG001|Overall Study|Other|0|||
150137475|NCT00645164|541637279|FG000|Overall Study|Lost to Follow-up|2|||
150137476|NCT00645164|541637279|FG000|Overall Study|Withdrawal by Subject|4|||
150137477|NCT00645164|541637279|FG000|Overall Study|Protocol Violation|1|||
150137478|NCT01281644|541637283|FG000|Overall Study|Lost to Follow-up|3|||
150137479|NCT01281644|541637283|FG000|Overall Study|Withdrawal by Subject|2|||
150137480|NCT03338829|541637287|FG000|Overall Study|Lost to Follow-up|4|||
150137481|NCT03338829|541637288|FG001|Overall Study|Lost to Follow-up|2|||
150137482|NCT03338829|541637289|FG002|Overall Study|Lost to Follow-up|4|||
150137483|NCT03338829|541637287|FG000|Overall Study|Pregnancy loss|1|||
150137484|NCT03338829|541637288|FG001|Overall Study|Pregnancy loss|1|||
150137485|NCT03338829|541637289|FG002|Overall Study|Pregnancy loss|0|||
150137486|NCT03338829|541637287|FG000|Overall Study|Protocol Violation|0|||
150137487|NCT03338829|541637288|FG001|Overall Study|Protocol Violation|1|||
150137488|NCT03338829|541637289|FG002|Overall Study|Protocol Violation|0|||
150137489|NCT02618967|541637290|FG000|Overall Study|Lost to Follow-up|0|||
150137490|NCT02618967|541637291|FG001|Overall Study|Lost to Follow-up|0|||
150137491|NCT02618967|541637292|FG002|Overall Study|Lost to Follow-up|1|||
150137492|NCT02618967|541637293|FG003|Overall Study|Lost to Follow-up|0|||
150137493|NCT02618967|541637294|FG004|Overall Study|Lost to Follow-up|2|||
150137494|NCT02618967|541637295|FG005|Overall Study|Lost to Follow-up|0|||
150137495|NCT02618967|541637296|FG006|Overall Study|Lost to Follow-up|0|||
150137496|NCT02618967|541637297|FG007|Overall Study|Lost to Follow-up|0|||
150137497|NCT02618967|541637290|FG000|Overall Study|Withdrawal by Subject|1|||
150137498|NCT02618967|541637291|FG001|Overall Study|Withdrawal by Subject|0|||
150137499|NCT02618967|541637292|FG002|Overall Study|Withdrawal by Subject|0|||
150137500|NCT02618967|541637293|FG003|Overall Study|Withdrawal by Subject|0|||
150137501|NCT02618967|541637294|FG004|Overall Study|Withdrawal by Subject|0|||
150137502|NCT02618967|541637295|FG005|Overall Study|Withdrawal by Subject|0|||
150137503|NCT02618967|541637296|FG006|Overall Study|Withdrawal by Subject|0|||
150137504|NCT02618967|541637297|FG007|Overall Study|Withdrawal by Subject|0|||
150137505|NCT04393441|541637302|FG000|Overall Study|Adverse Event|0|||
150137506|NCT04393441|541637303|FG001|Overall Study|Adverse Event|3|||
150137507|NCT04393441|541637302|FG000|Overall Study|Withdrawal by Subject|5|||
150137508|NCT04393441|541637303|FG001|Overall Study|Withdrawal by Subject|7|||
150137509|NCT04393441|541637302|FG000|Overall Study|Lost to Follow-up|0|||
150137510|NCT04393441|541637303|FG001|Overall Study|Lost to Follow-up|2|||
150137511|NCT04393441|541637302|FG000|Overall Study|Protocol Deviation|2|||
150137512|NCT04393441|541637303|FG001|Overall Study|Protocol Deviation|1|||
150137513|NCT04393441|541637302|FG000|Overall Study|Reason not Specified|1|||
150206272|NCT01961609|541895825|FG002|Initiation|Administrative problems|0|||
150206273|NCT01961609|541895826|FG003|Initiation|Administrative problems|0|||
150206274|NCT01961609|541895823|FG000|Initiation|Withdrawal by Subject|1|||
150206275|NCT01961609|541895824|FG001|Initiation|Withdrawal by Subject|2|||
150206276|NCT01961609|541895825|FG002|Initiation|Withdrawal by Subject|0|||
150206277|NCT01961609|541895826|FG003|Initiation|Withdrawal by Subject|0|||
150206278|NCT01961609|541895823|FG000|Initiation|Lack of Efficacy|2|||
150206279|NCT01961609|541895824|FG001|Initiation|Lack of Efficacy|1|||
150206280|NCT01961609|541895825|FG002|Initiation|Lack of Efficacy|0|||
150206281|NCT01961609|541895826|FG003|Initiation|Lack of Efficacy|0|||
150206282|NCT01961609|541895823|FG000|Initiation|Abnormal lab values|0|||
150206283|NCT01961609|541895824|FG001|Initiation|Abnormal lab values|1|||
150206284|NCT01961609|541895825|FG002|Initiation|Abnormal lab values|0|||
150206285|NCT01961609|541895826|FG003|Initiation|Abnormal lab values|0|||
150206286|NCT01961609|541895823|FG000|Initiation|Adverse Event|3|||
150206287|NCT01961609|541895824|FG001|Initiation|Adverse Event|5|||
150206288|NCT01961609|541895825|FG002|Initiation|Adverse Event|0|||
150206289|NCT01961609|541895826|FG003|Initiation|Adverse Event|0|||
150206290|NCT01961609|541895823|FG000|Initiation|Randomized but not treated|1|||
150206291|NCT01961609|541895824|FG001|Initiation|Randomized but not treated|1|||
150206292|NCT01961609|541895825|FG002|Initiation|Randomized but not treated|0|||
150206293|NCT01961609|541895826|FG003|Initiation|Randomized but not treated|0|||
150206294|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
150206295|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
150206296|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
150206297|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
150206298|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
150206299|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
150206300|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
150206301|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
150206302|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
150206303|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
150206304|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
150206305|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
150206306|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
150206307|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
150206308|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
150206309|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
150206310|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
150206311|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
150206312|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
150206313|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
150206314|NCT01961609|541895823|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
150206315|NCT01961609|541895824|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
150206316|NCT01961609|541895825|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
150206317|NCT01961609|541895826|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
150206318|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
150206319|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
150206320|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
150206321|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
150206322|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
150206323|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
150206324|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
150206325|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
150206326|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
150206327|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
150206328|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
150206329|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
150206330|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
150206331|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
150206332|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
150206333|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
150206334|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
150206335|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
150206336|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
150206337|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
150206338|NCT01961609|541895823|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
150206339|NCT01961609|541895824|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
150206340|NCT01961609|541895825|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
150206341|NCT01961609|541895826|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
150206342|NCT01988402|541895827|FG000|Overall Study|Adverse Event|1|||
150206343|NCT01988402|541895828|FG001|Overall Study|Adverse Event|2|||
150206344|NCT01988402|541895827|FG000|Overall Study|Withdrawal by Subject|1|||
150206345|NCT01988402|541895828|FG001|Overall Study|Withdrawal by Subject|0|||
150206346|NCT01212744|541895829|FG000|Overall Study|Withdrawal by Subject|1|||
150206347|NCT02167451|541895831|FG000|Overall Study|Withdrawal by Subject|1|||
150206348|NCT00571649|541895832|FG000|Treatment Period|Adverse Event|438|||
150206349|NCT00571649|541895833|FG001|Treatment Period|Adverse Event|385|||
150206350|NCT00571649|541895832|FG000|Treatment Period|Clinical endpoint reached|50|||
150206351|NCT00571649|541895833|FG001|Treatment Period|Clinical endpoint reached|56|||
150206352|NCT00571649|541895832|FG000|Treatment Period|Withdrawal by Subject|285|||
150206353|NCT00571649|541895833|FG001|Treatment Period|Withdrawal by Subject|255|||
150206354|NCT00571649|541895832|FG000|Treatment Period|Death|76|||
150206355|NCT00571649|541895833|FG001|Treatment Period|Death|59|||
150206356|NCT00571649|541895832|FG000|Treatment Period|Physician Decision|8|||
150206357|NCT00571649|541895833|FG001|Treatment Period|Physician Decision|9|||
150206358|NCT00571649|541895832|FG000|Treatment Period|Lost to Follow-up|43|||
150206359|NCT00571649|541895833|FG001|Treatment Period|Lost to Follow-up|41|||
150206360|NCT00571649|541895832|FG000|Treatment Period|Non-compliant with study medication|88|||
150206361|NCT00571649|541895833|FG001|Treatment Period|Non-compliant with study medication|89|||
150206362|NCT00571649|541895832|FG000|Treatment Period|Patient convenience|11|||
150206363|NCT00571649|541895833|FG001|Treatment Period|Patient convenience|13|||
150206364|NCT00571649|541895832|FG000|Treatment Period|Protocol Violation|90|||
150206365|NCT00571649|541895833|FG001|Treatment Period|Protocol Violation|92|||
150206366|NCT00571649|541895832|FG000|Treatment Period|Technical problems|3|||
150206367|NCT00571649|541895833|FG001|Treatment Period|Technical problems|5|||
150206368|NCT00571649|541895832|FG000|Follow-up Period|Adverse Event|46|||
150206369|NCT00571649|541895833|FG001|Follow-up Period|Adverse Event|40|||
150206370|NCT00571649|541895832|FG000|Follow-up Period|Clinical endpoint reached|5|||
150206371|NCT00571649|541895833|FG001|Follow-up Period|Clinical endpoint reached|2|||
150206372|NCT00571649|541895832|FG000|Follow-up Period|Withdrawal by Subject|119|||
150206373|NCT00571649|541895833|FG001|Follow-up Period|Withdrawal by Subject|115|||
150206374|NCT00571649|541895832|FG000|Follow-up Period|Death|132|||
150206375|NCT00571649|541895833|FG001|Follow-up Period|Death|133|||
150206376|NCT00571649|541895832|FG000|Follow-up Period|Physician Decision|7|||
150206377|NCT00571649|541895833|FG001|Follow-up Period|Physician Decision|13|||
150206378|NCT00571649|541895832|FG000|Follow-up Period|Lost to Follow-up|95|||
150206379|NCT00571649|541895833|FG001|Follow-up Period|Lost to Follow-up|92|||
150206380|NCT00571649|541895832|FG000|Follow-up Period|Patient convenience|136|||
150206381|NCT00571649|541895833|FG001|Follow-up Period|Patient convenience|121|||
150206382|NCT00571649|541895832|FG000|Follow-up Period|Protocol Violation|5|||
150206383|NCT00571649|541895833|FG001|Follow-up Period|Protocol Violation|12|||
150206384|NCT03066609|541895838|FG000|INDUCTION|Pregnancy|0|||
150206385|NCT03066609|541895839|FG001|INDUCTION|Pregnancy|0|||
150206386|NCT03066609|541895840|FG002|INDUCTION|Pregnancy|1|||
150206387|NCT03066609|541895841|FG003|INDUCTION|Pregnancy|0|||
150206388|NCT03066609|541895838|FG000|INDUCTION|Lack of Efficacy|0|||
150206389|NCT03066609|541895839|FG001|INDUCTION|Lack of Efficacy|0|||
150206390|NCT03066609|541895840|FG002|INDUCTION|Lack of Efficacy|1|||
150206391|NCT03066609|541895841|FG003|INDUCTION|Lack of Efficacy|0|||
150206392|NCT03066609|541895838|FG000|INDUCTION|Adverse Event|2|||
150206393|NCT03066609|541895839|FG001|INDUCTION|Adverse Event|2|||
150206394|NCT03066609|541895840|FG002|INDUCTION|Adverse Event|0|||
150206395|NCT03066609|541895841|FG003|INDUCTION|Adverse Event|0|||
150206396|NCT03066609|541895838|FG000|MAINTENANCE|Adverse Event|0|||
150206397|NCT03066609|541895839|FG001|MAINTENANCE|Adverse Event|0|||
150206398|NCT03066609|541895840|FG002|MAINTENANCE|Adverse Event|0|||
150206399|NCT03066609|541895841|FG003|MAINTENANCE|Adverse Event|1|||
150206400|NCT03066609|541895838|FG000|MAINTENANCE|Withdrawal by Subject|4|||
150206401|NCT03066609|541895839|FG001|MAINTENANCE|Withdrawal by Subject|2|||
150206402|NCT03066609|541895840|FG002|MAINTENANCE|Withdrawal by Subject|1|||
150206403|NCT03066609|541895841|FG003|MAINTENANCE|Withdrawal by Subject|1|||
150206404|NCT03066609|541895838|FG000|MAINTENANCE|Lost to Follow-up|0|||
150206405|NCT03066609|541895839|FG001|MAINTENANCE|Lost to Follow-up|1|||
150206406|NCT03066609|541895840|FG002|MAINTENANCE|Lost to Follow-up|1|||
150206407|NCT03066609|541895841|FG003|MAINTENANCE|Lost to Follow-up|0|||
150206408|NCT03066609|541895838|FG000|MAINTENANCE|Pregnancy|1|||
150206409|NCT03066609|541895839|FG001|MAINTENANCE|Pregnancy|0|||
150206410|NCT03066609|541895840|FG002|MAINTENANCE|Pregnancy|0|||
150206411|NCT03066609|541895841|FG003|MAINTENANCE|Pregnancy|0|||
150206412|NCT03066609|541895838|FG000|MAINTENANCE|Lack of Efficacy|2|||
150206413|NCT03066609|541895839|FG001|MAINTENANCE|Lack of Efficacy|1|||
150206414|NCT03066609|541895840|FG002|MAINTENANCE|Lack of Efficacy|0|||
150206415|NCT03066609|541895841|FG003|MAINTENANCE|Lack of Efficacy|1|||
150206416|NCT03066609|541895838|FG000|OVERALL STUDY|Adverse Event|2|||
150206417|NCT03066609|541895839|FG001|OVERALL STUDY|Adverse Event|2|||
150206418|NCT03066609|541895840|FG002|OVERALL STUDY|Adverse Event|0|||
150206419|NCT03066609|541895841|FG003|OVERALL STUDY|Adverse Event|1|||
150206420|NCT03066609|541895838|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
150206421|NCT03066609|541895839|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
150206422|NCT03066609|541895840|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
150206423|NCT03066609|541895841|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
150206424|NCT03066609|541895838|FG000|OVERALL STUDY|Lost to Follow-up|1|||
150206425|NCT03066609|541895839|FG001|OVERALL STUDY|Lost to Follow-up|1|||
150206426|NCT03066609|541895840|FG002|OVERALL STUDY|Lost to Follow-up|1|||
150206427|NCT03066609|541895841|FG003|OVERALL STUDY|Lost to Follow-up|1|||
150206428|NCT03066609|541895838|FG000|OVERALL STUDY|Pregnancy|1|||
150206429|NCT03066609|541895839|FG001|OVERALL STUDY|Pregnancy|0|||
150206430|NCT03066609|541895840|FG002|OVERALL STUDY|Pregnancy|1|||
150206431|NCT03066609|541895841|FG003|OVERALL STUDY|Pregnancy|0|||
150206432|NCT03066609|541895838|FG000|OVERALL STUDY|Lack of Efficacy|2|||
150206433|NCT03066609|541895839|FG001|OVERALL STUDY|Lack of Efficacy|1|||
150206434|NCT03066609|541895840|FG002|OVERALL STUDY|Lack of Efficacy|1|||
150206435|NCT03066609|541895841|FG003|OVERALL STUDY|Lack of Efficacy|1|||
150206436|NCT03066609|541895838|FG000|OVERALL STUDY|discontinued follow up|0|||
150206437|NCT03066609|541895839|FG001|OVERALL STUDY|discontinued follow up|2|||
150206438|NCT03066609|541895840|FG002|OVERALL STUDY|discontinued follow up|0|||
150206439|NCT03066609|541895841|FG003|OVERALL STUDY|discontinued follow up|0|||
150206440|NCT01566890|541895842|FG000|Overall Study|Adverse Event|1|||
150206441|NCT01566890|541895843|FG001|Overall Study|Adverse Event|0|||
150206442|NCT01566890|541895844|FG002|Overall Study|Adverse Event|0|||
150206443|NCT01566890|541895845|FG003|Overall Study|Adverse Event|0|||
150206444|NCT01566890|541895846|FG004|Overall Study|Adverse Event|0|||
150206445|NCT01566890|541895842|FG000|Overall Study|Withdrawal by Subject|3|||
150206446|NCT01566890|541895843|FG001|Overall Study|Withdrawal by Subject|1|||
150206447|NCT01566890|541895844|FG002|Overall Study|Withdrawal by Subject|1|||
150206448|NCT01566890|541895845|FG003|Overall Study|Withdrawal by Subject|1|||
150206449|NCT01566890|541895846|FG004|Overall Study|Withdrawal by Subject|0|||
150206450|NCT01566890|541895842|FG000|Overall Study|Screen failure|6|||
150206451|NCT01566890|541895843|FG001|Overall Study|Screen failure|0|||
150206452|NCT01566890|541895844|FG002|Overall Study|Screen failure|1|||
150206453|NCT01566890|541895845|FG003|Overall Study|Screen failure|1|||
150206454|NCT01566890|541895846|FG004|Overall Study|Screen failure|0|||
150206455|NCT01566890|541895842|FG000|Overall Study|Incomplete CEU data|1|||
150206456|NCT01566890|541895843|FG001|Overall Study|Incomplete CEU data|3|||
150206457|NCT01566890|541895844|FG002|Overall Study|Incomplete CEU data|5|||
150206458|NCT01566890|541895845|FG003|Overall Study|Incomplete CEU data|8|||
150206459|NCT01566890|541895846|FG004|Overall Study|Incomplete CEU data|0|||
150206460|NCT01566890|541895842|FG000|Overall Study|Lost to Follow-up|0|||
150206461|NCT01566890|541895843|FG001|Overall Study|Lost to Follow-up|0|||
150206462|NCT01566890|541895844|FG002|Overall Study|Lost to Follow-up|4|||
150206463|NCT01566890|541895845|FG003|Overall Study|Lost to Follow-up|4|||
150206464|NCT01566890|541895846|FG004|Overall Study|Lost to Follow-up|0|||
150206465|NCT01566890|541895842|FG000|Overall Study|Other|0|||
150206466|NCT01566890|541895843|FG001|Overall Study|Other|0|||
150206467|NCT01566890|541895844|FG002|Overall Study|Other|0|||
150206468|NCT01566890|541895845|FG003|Overall Study|Other|0|||
150206469|NCT01566890|541895846|FG004|Overall Study|Other|7|||
150206470|NCT00523419|541895857|FG000|Overall Study|Adverse Event|1|||
150206471|NCT00523419|541895857|FG000|Overall Study|Withdrawal by Subject|1|||
150206472|NCT00523419|541895857|FG000|Overall Study|Physician Decision|2|||
150206473|NCT00523419|541895857|FG000|Overall Study|Progressive Disease|22|||
150206474|NCT00523419|541895857|FG000|Overall Study|Death due to Study Disease|4|||
150206475|NCT00523419|541895857|FG000|Overall Study|Death due to Adverse Event|2|||
150206476|NCT00811941|541895858|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
150206477|NCT00811941|541895859|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
150206478|NCT00811941|541895858|FG000|All Treated Patients|Adverse Event|2|||
150206479|NCT00811941|541895859|FG001|All Treated Patients|Adverse Event|43|||
150206480|NCT00811941|541895858|FG000|All Treated Patients|Lack of Efficacy|2|||
150206481|NCT00811941|541895859|FG001|All Treated Patients|Lack of Efficacy|3|||
150206482|NCT00811941|541895858|FG000|All Treated Patients|Non-compliance|1|||
150206483|NCT00811941|541895859|FG001|All Treated Patients|Non-compliance|8|||
150206484|NCT00811941|541895858|FG000|All Treated Patients|Protocol Violation|5|||
150206485|NCT00811941|541895859|FG001|All Treated Patients|Protocol Violation|17|||
150206486|NCT00811941|541895858|FG000|All Treated Patients|Withdrawal by Subject|35|||
150206487|NCT00811941|541895859|FG001|All Treated Patients|Withdrawal by Subject|94|||
150206488|NCT00811941|541895858|FG000|All Treated Patients|Lost to Follow-up|3|||
150206489|NCT00811941|541895859|FG001|All Treated Patients|Lost to Follow-up|12|||
150206490|NCT00811941|541895858|FG000|All Treated Patients|Other Reason|4|||
150206491|NCT00811941|541895859|FG001|All Treated Patients|Other Reason|14|||
150206492|NCT03885232|541895860|FG000|Overall Study|Lost to Follow-up|74|||
150206493|NCT03885232|541895861|FG001|Overall Study|Lost to Follow-up|32|||
150206494|NCT03885232|541895860|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
150206495|NCT03885232|541895861|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
150206496|NCT02397096|541895862|FG000|Day 1 to Week 24|Adverse Event|7|||
150206497|NCT02397096|541895863|FG001|Day 1 to Week 24|Adverse Event|1|||
150206498|NCT02397096|541895862|FG000|Day 1 to Week 24|Death|1|||
150206499|NCT02397096|541895863|FG001|Day 1 to Week 24|Death|0|||
150206500|NCT02397096|541895862|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
150206501|NCT02397096|541895863|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
150206502|NCT02397096|541895862|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
150206503|NCT02397096|541895863|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
150206504|NCT02397096|541895862|FG000|Day 1 to Week 24|Physician Decision|2|||
150206505|NCT02397096|541895863|FG001|Day 1 to Week 24|Physician Decision|3|||
150206506|NCT02397096|541895862|FG000|Day 1 to Week 24|Protocol Violation|1|||
150137514|NCT04393441|541637303|FG001|Overall Study|Reason not Specified|1|||
150137515|NCT04003610|541637304|FG000|Overall Study|Lost to Follow-up|0|||
150137516|NCT04003610|541637305|FG001|Overall Study|Lost to Follow-up|1|||
150137517|NCT04003610|541637306|FG002|Overall Study|Lost to Follow-up|0|||
150137518|NCT04003610|541637304|FG000|Overall Study|Death|0|||
150137519|NCT04003610|541637305|FG001|Overall Study|Death|0|||
150137520|NCT04003610|541637306|FG002|Overall Study|Death|3|||
150137521|NCT04003610|541637304|FG000|Overall Study|Study Terminated by Sponsor|0|||
150137522|NCT04003610|541637305|FG001|Overall Study|Study Terminated by Sponsor|0|||
150137523|NCT04003610|541637306|FG002|Overall Study|Study Terminated by Sponsor|3|||
150137524|NCT02953938|541637311|FG000|Overall Study|Adverse Event|0|||
150137525|NCT02953938|541637312|FG001|Overall Study|Adverse Event|1|||
150137526|NCT02953938|541637311|FG000|Overall Study|Withdrawal by Subject|1|||
150137527|NCT02953938|541637312|FG001|Overall Study|Withdrawal by Subject|1|||
150137528|NCT03848403|541637313|FG000|Period 2 (Day 8)|Adverse Event|1|||
150137529|NCT03848403|541637314|FG001|Period 2 (Day 8)|Adverse Event|2|||
150137530|NCT03848403|541637315|FG002|Period 2 (Day 8)|Adverse Event|2|||
150137531|NCT03848403|541637313|FG000|Period 2 (Day 8)|Physician Decision|0|||
150206507|NCT02397096|541895863|FG001|Day 1 to Week 24|Protocol Violation|4|||
150206508|NCT02397096|541895862|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
150206509|NCT02397096|541895863|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
150206510|NCT02397096|541895862|FG000|Day 1 to Week 24|Randomized, not treated|3|||
150206511|NCT02397096|541895863|FG001|Day 1 to Week 24|Randomized, not treated|0|||
150206512|NCT02397096|541895862|FG000|Week 24 to Week 48|Adverse Event|6|||
150206513|NCT02397096|541895863|FG001|Week 24 to Week 48|Adverse Event|2|||
150206514|NCT02397096|541895862|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
150206515|NCT02397096|541895863|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
150206516|NCT02397096|541895862|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
150206517|NCT02397096|541895863|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
150206518|NCT02397096|541895862|FG000|Week 24 to Week 48|Physician Decision|2|||
150206519|NCT02397096|541895863|FG001|Week 24 to Week 48|Physician Decision|1|||
150206520|NCT02397096|541895862|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
150206521|NCT02397096|541895863|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
150206522|NCT02397096|541895862|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
150206523|NCT02397096|541895863|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
150206524|NCT02397096|541895862|FG000|Study Extension 1|Adverse Event|7|||
150206525|NCT02397096|541895863|FG001|Study Extension 1|Adverse Event|5|||
150206526|NCT02397096|541895862|FG000|Study Extension 1|Death|1|||
150206527|NCT02397096|541895863|FG001|Study Extension 1|Death|0|||
150206528|NCT02397096|541895862|FG000|Study Extension 1|Lack of Efficacy|2|||
150206529|NCT02397096|541895863|FG001|Study Extension 1|Lack of Efficacy|5|||
150206530|NCT02397096|541895862|FG000|Study Extension 1|Lost to Follow-up|2|||
150206531|NCT02397096|541895863|FG001|Study Extension 1|Lost to Follow-up|3|||
150206532|NCT02397096|541895862|FG000|Study Extension 1|Non-compliance with study drug|3|||
150206533|NCT02397096|541895863|FG001|Study Extension 1|Non-compliance with study drug|0|||
150206534|NCT02397096|541895862|FG000|Study Extension 1|Physician Decision|4|||
150206535|NCT02397096|541895863|FG001|Study Extension 1|Physician Decision|2|||
150206536|NCT02397096|541895862|FG000|Study Extension 1|Pregnancy|1|||
150206537|NCT02397096|541895863|FG001|Study Extension 1|Pregnancy|0|||
150206538|NCT02397096|541895862|FG000|Study Extension 1|Protocol Violation|0|||
150206539|NCT02397096|541895863|FG001|Study Extension 1|Protocol Violation|1|||
150206540|NCT02397096|541895862|FG000|Study Extension 1|Withdrawal by Subject|21|||
150206541|NCT02397096|541895863|FG001|Study Extension 1|Withdrawal by Subject|7|||
150206542|NCT02397096|541895862|FG000|Study Extension 2|Adverse Event|3|||
150206543|NCT02397096|541895863|FG001|Study Extension 2|Adverse Event|3|||
150206544|NCT02397096|541895862|FG000|Study Extension 2|Availability of study medication locally|152|||
150206545|NCT02397096|541895863|FG001|Study Extension 2|Availability of study medication locally|64|||
150206546|NCT02397096|541895862|FG000|Study Extension 2|Death|2|||
150206547|NCT02397096|541895863|FG001|Study Extension 2|Death|0|||
150206548|NCT02397096|541895862|FG000|Study Extension 2|Lack of Efficacy|1|||
150206549|NCT02397096|541895863|FG001|Study Extension 2|Lack of Efficacy|0|||
150206550|NCT02397096|541895862|FG000|Study Extension 2|Lost to Follow-up|2|||
150206551|NCT02397096|541895863|FG001|Study Extension 2|Lost to Follow-up|1|||
150206552|NCT02397096|541895862|FG000|Study Extension 2|Non-compliance with study drug|1|||
150206553|NCT02397096|541895863|FG001|Study Extension 2|Non-compliance with study drug|0|||
150206554|NCT02397096|541895862|FG000|Study Extension 2|Physician Decision|2|||
150206555|NCT02397096|541895863|FG001|Study Extension 2|Physician Decision|5|||
150206556|NCT02397096|541895862|FG000|Study Extension 2|Pregnancy|1|||
150206557|NCT02397096|541895863|FG001|Study Extension 2|Pregnancy|0|||
150206558|NCT02397096|541895862|FG000|Study Extension 2|Withdrawal by Subject|10|||
150206559|NCT02397096|541895863|FG001|Study Extension 2|Withdrawal by Subject|3|||
150206560|NCT02397096|541895862|FG000|Study Extension 3|Adverse Event|1|||
150206561|NCT02397096|541895863|FG001|Study Extension 3|Adverse Event|0|||
150206562|NCT02397096|541895862|FG000|Study Extension 3|Availability of study medication locally|11|||
150206563|NCT02397096|541895863|FG001|Study Extension 3|Availability of study medication locally|3|||
150206564|NCT02397096|541895862|FG000|Study Extension 3|Lost to Follow-up|1|||
150206565|NCT02397096|541895863|FG001|Study Extension 3|Lost to Follow-up|0|||
150206566|NCT02397096|541895862|FG000|Study Extension 3|Withdrawal by Subject|2|||
150206567|NCT02397096|541895863|FG001|Study Extension 3|Withdrawal by Subject|1|||
150206568|NCT03840902|541895864|FG000|Overall Study|Randomized but not treated|1|||
150206569|NCT03840902|541895865|FG001|Overall Study|Randomized but not treated|1|||
150206570|NCT00918203|541895869|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
150206571|NCT00918203|541895870|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
150206572|NCT00918203|541895871|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
150206573|NCT00918203|541895869|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
150206574|NCT00918203|541895870|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
150206575|NCT00918203|541895871|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
150206576|NCT00918203|541895869|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
150206577|NCT00918203|541895870|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
150206578|NCT00918203|541895871|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
150206579|NCT00918203|541895869|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
150206580|NCT00918203|541895870|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
150206581|NCT00918203|541895871|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
150206582|NCT05139992|541895876|FG000|Overall Study|Withdrawal by Subject|12|||
150206583|NCT05139992|541895876|FG000|Overall Study|Lost to Follow-up|6|||
150206584|NCT01208974|541895877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
150206585|NCT01208974|541895878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
150206586|NCT01208974|541895879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
150206587|NCT01208974|541895880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
150206588|NCT01208974|541895877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
150206589|NCT01208974|541895878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
150206590|NCT01208974|541895879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
150206591|NCT01208974|541895880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
150206592|NCT01208974|541895877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
150206593|NCT01208974|541895878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
150206594|NCT01208974|541895879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
150206595|NCT01208974|541895880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
150206596|NCT03593226|541895881|FG000|Overall Study|Disease progression|6|||
150206597|NCT03593226|541895882|FG001|Overall Study|Disease progression|13|||
150206598|NCT03593226|541895883|FG002|Overall Study|Disease progression|5|||
150206599|NCT03593226|541895884|FG003|Overall Study|Disease progression|6|||
150206600|NCT03593226|541895881|FG000|Overall Study|Adverse Event|0|||
150206601|NCT03593226|541895882|FG001|Overall Study|Adverse Event|1|||
150206602|NCT03593226|541895883|FG002|Overall Study|Adverse Event|0|||
150206603|NCT03593226|541895884|FG003|Overall Study|Adverse Event|0|||
150206604|NCT03593226|541895881|FG000|Overall Study|Withdrawal by Subject|0|||
150206605|NCT03593226|541895882|FG001|Overall Study|Withdrawal by Subject|4|||
150206606|NCT03593226|541895883|FG002|Overall Study|Withdrawal by Subject|1|||
150206607|NCT03593226|541895884|FG003|Overall Study|Withdrawal by Subject|0|||
150206608|NCT03593226|541895881|FG000|Overall Study|Physician Decision|0|||
150206609|NCT03593226|541895882|FG001|Overall Study|Physician Decision|1|||
150206610|NCT03593226|541895883|FG002|Overall Study|Physician Decision|0|||
150206611|NCT03593226|541895884|FG003|Overall Study|Physician Decision|0|||
150206612|NCT03593226|541895881|FG000|Overall Study|Clinical disease progression|0|||
150206613|NCT03593226|541895882|FG001|Overall Study|Clinical disease progression|0|||
150206614|NCT03593226|541895883|FG002|Overall Study|Clinical disease progression|1|||
150206615|NCT03593226|541895884|FG003|Overall Study|Clinical disease progression|0|||
150206616|NCT00545545|541895885|FG000|Overall Study|Progressive Neoplastic Disease|1|||
150206617|NCT00545545|541895886|FG001|Overall Study|Progressive Neoplastic Disease|5|||
150206618|NCT00545545|541895887|FG002|Overall Study|Progressive Neoplastic Disease|0|||
150206619|NCT00545545|541895888|FG003|Overall Study|Progressive Neoplastic Disease|4|||
150206620|NCT00545545|541895889|FG004|Overall Study|Progressive Neoplastic Disease|8|||
150206621|NCT00545545|541895890|FG005|Overall Study|Progressive Neoplastic Disease|7|||
150206622|NCT00545545|541895885|FG000|Overall Study|Withdrawal by Subject|0|||
150206623|NCT00545545|541895886|FG001|Overall Study|Withdrawal by Subject|1|||
150206624|NCT00545545|541895887|FG002|Overall Study|Withdrawal by Subject|0|||
150206625|NCT00545545|541895888|FG003|Overall Study|Withdrawal by Subject|0|||
150206626|NCT00545545|541895889|FG004|Overall Study|Withdrawal by Subject|0|||
150206627|NCT00545545|541895890|FG005|Overall Study|Withdrawal by Subject|0|||
150206628|NCT00545545|541895885|FG000|Overall Study|Physician Decision|1|||
150206629|NCT00545545|541895886|FG001|Overall Study|Physician Decision|0|||
150206630|NCT00545545|541895887|FG002|Overall Study|Physician Decision|0|||
150206631|NCT00545545|541895888|FG003|Overall Study|Physician Decision|0|||
150206632|NCT00545545|541895889|FG004|Overall Study|Physician Decision|0|||
150206633|NCT00545545|541895890|FG005|Overall Study|Physician Decision|1|||
150206634|NCT00545545|541895885|FG000|Overall Study|Irinotecan intolerance|1|||
150206635|NCT00545545|541895886|FG001|Overall Study|Irinotecan intolerance|1|||
150206636|NCT00545545|541895887|FG002|Overall Study|Irinotecan intolerance|0|||
150206637|NCT00545545|541895888|FG003|Overall Study|Irinotecan intolerance|0|||
150206638|NCT00545545|541895889|FG004|Overall Study|Irinotecan intolerance|0|||
150206639|NCT00545545|541895890|FG005|Overall Study|Irinotecan intolerance|0|||
150206640|NCT00545545|541895885|FG000|Overall Study|No target lesions to track post surgery|0|||
150206641|NCT00545545|541895886|FG001|Overall Study|No target lesions to track post surgery|0|||
150206642|NCT00545545|541895887|FG002|Overall Study|No target lesions to track post surgery|0|||
150206643|NCT00545545|541895888|FG003|Overall Study|No target lesions to track post surgery|0|||
150206644|NCT00545545|541895889|FG004|Overall Study|No target lesions to track post surgery|1|||
150206645|NCT00545545|541895890|FG005|Overall Study|No target lesions to track post surgery|1|||
150206646|NCT02678689|541895891|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
150206647|NCT02678689|541895892|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
150206648|NCT04153890|541895893|FG000|Overall Study|Lost to Follow-up|9|||
150206649|NCT04153890|541895894|FG001|Overall Study|Lost to Follow-up|0|||
150206650|NCT04153890|541895895|FG002|Overall Study|Lost to Follow-up|9|||
150206651|NCT04153890|541895896|FG003|Overall Study|Lost to Follow-up|0|||
150206652|NCT04153890|541895893|FG000|Overall Study|Death|0|||
150206653|NCT04153890|541895894|FG001|Overall Study|Death|2|||
150206654|NCT04153890|541895895|FG002|Overall Study|Death|0|||
150206655|NCT04153890|541895896|FG003|Overall Study|Death|0|||
150206656|NCT04153890|541895893|FG000|Overall Study|Withdrawal by Subject|0|||
150206657|NCT04153890|541895894|FG001|Overall Study|Withdrawal by Subject|0|||
150206658|NCT04153890|541895895|FG002|Overall Study|Withdrawal by Subject|0|||
150206659|NCT04153890|541895896|FG003|Overall Study|Withdrawal by Subject|2|||
150206660|NCT02798471|541895897|FG000|Overall Study|Adverse Event|7|||
150206661|NCT02798471|541895898|FG001|Overall Study|Adverse Event|2|||
150206662|NCT02798471|541895897|FG000|Overall Study|Physician Decision|3|||
150206663|NCT02798471|541895898|FG001|Overall Study|Physician Decision|7|||
150206664|NCT02798471|541895897|FG000|Overall Study|Death|2|||
150206665|NCT02798471|541895898|FG001|Overall Study|Death|3|||
150206666|NCT02798471|541895897|FG000|Overall Study|Lost to Follow-up|0|||
150206667|NCT02798471|541895898|FG001|Overall Study|Lost to Follow-up|1|||
150206668|NCT02798471|541895897|FG000|Overall Study|Other|5|||
150206669|NCT02798471|541895898|FG001|Overall Study|Other|3|||
150206670|NCT02798471|541895897|FG000|Overall Study|Subject withdrew consent|0|||
150206671|NCT02798471|541895898|FG001|Overall Study|Subject withdrew consent|6|||
150206672|NCT02798471|541895897|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
150206673|NCT02798471|541895898|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
150206674|NCT02798471|541895897|FG000|Overall Study|Randomized, but not treated|0|||
150206675|NCT02798471|541895898|FG001|Overall Study|Randomized, but not treated|2|||
150206676|NCT04503681|541897364|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
150206677|NCT04503681|541897365|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
150206678|NCT03352713|541897368|FG000|Overall Study|Lost to Follow-up|8|||
150206679|NCT03352713|541897368|FG000|Overall Study|Withdrawn by investigator|5|||
150206680|NCT03352713|541897368|FG000|Overall Study|Completed 0 EMAs|8|||
150206681|NCT03352713|541897368|FG000|Overall Study|Device incompatible/stolen|5|||
150206682|NCT01812759|541897369|FG000|Overall Study|Physician Decision|0|||
150206683|NCT01812759|541897370|FG001|Overall Study|Physician Decision|0|||
150206684|NCT01812759|541897371|FG002|Overall Study|Physician Decision|1|||
150206685|NCT00536120|541897372|FG000|Overall Study|Lost to Follow-up|1|||
150206686|NCT00536120|541897373|FG001|Overall Study|Lost to Follow-up|0|||
150206687|NCT00536120|541897372|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
150206688|NCT00536120|541897373|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
150206689|NCT00536120|541897372|FG000|Overall Study|Non-compliance|1|||
150206690|NCT00536120|541897373|FG001|Overall Study|Non-compliance|0|||
150206691|NCT00536120|541897372|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
150206692|NCT00536120|541897373|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
150206693|NCT00536120|541897372|FG000|Overall Study|Steroid Use|0|||
150206694|NCT00536120|541897373|FG001|Overall Study|Steroid Use|2|||
150206695|NCT00536120|541897372|FG000|Overall Study|Missed Study Visit|0|||
150206696|NCT00536120|541897373|FG001|Overall Study|Missed Study Visit|1|||
150206697|NCT04989816|541897374|FG000|Overall Study|Death|77|||
150206698|NCT04989816|541897374|FG000|Overall Study|Lost to Follow-up|3|||
150206699|NCT04213807|541897380|FG000|Overall Study|Physician Decision|0|||
150206700|NCT04213807|541897381|FG001|Overall Study|Physician Decision|0|||
150206701|NCT04213807|541897382|FG002|Overall Study|Physician Decision|1|||
150206702|NCT01128595|541897385|FG000|Treatment Period 3|Withdrawal by Subject|0|||
150206703|NCT01128595|541897386|FG001|Treatment Period 3|Withdrawal by Subject|1|||
150206704|NCT01128595|541897387|FG002|Treatment Period 3|Withdrawal by Subject|0|||
150206705|NCT01128595|541897388|FG003|Treatment Period 3|Withdrawal by Subject|0|||
150206706|NCT00372775|541897389|FG000|Overall Study|Adverse Event|8|||
150206707|NCT00372775|541897389|FG000|Overall Study|Death|15|||
150206708|NCT00372775|541897389|FG000|Overall Study|Objective progression or relapse|30|||
150206709|NCT00372775|541897389|FG000|Overall Study|Global deterioration of health status|6|||
150206710|NCT00372775|541897389|FG000|Overall Study|Withdrawal by Subject|1|||
150206711|NCT00372775|541897389|FG000|Overall Study|Other|1|||
150206712|NCT00372775|541897389|FG000|Overall Study|Not Treated|2|||
150206713|NCT00777049|541897390|FG000|Overall Study|Withdrawal by Subject|1|||
150206714|NCT00777049|541897391|FG001|Overall Study|Withdrawal by Subject|0|||
150206715|NCT00777049|541897390|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
150206716|NCT00777049|541897391|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
150206717|NCT00609869|541897392|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
150206718|NCT00609869|541897392|FG000|Overall Study|Severe hematologic toxicity|1|||
150206719|NCT00609869|541897392|FG000|Overall Study|Withdrawal by Subject|1|||
150206720|NCT00609869|541897392|FG000|Overall Study|Seizures|1|||
150206721|NCT00609869|541897392|FG000|Overall Study|Severe tumor flare reaction|1|||
150206722|NCT00609869|541897392|FG000|Overall Study|Hepatitis B infection|1|||
150206723|NCT00609869|541897392|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
150206724|NCT00609869|541897392|FG000|Overall Study|Mantle cell: not evaluable|4|||
150206725|NCT00724126|541897394|FG000|Overall Study|Adverse Event|2|||
150206726|NCT00724126|541897395|FG001|Overall Study|Adverse Event|0|||
150206727|NCT00724126|541897394|FG000|Overall Study|Withdrawal by Subject|8|||
150206728|NCT00724126|541897395|FG001|Overall Study|Withdrawal by Subject|6|||
150206729|NCT00724126|541897394|FG000|Overall Study|Lost to Follow-up|6|||
150206730|NCT00724126|541897395|FG001|Overall Study|Lost to Follow-up|6|||
150206731|NCT00724126|541897394|FG000|Overall Study|Noncompliance|2|||
150206732|NCT00724126|541897395|FG001|Overall Study|Noncompliance|1|||
150206733|NCT00724126|541897394|FG000|Overall Study|Subject randomized although ineligible|1|||
150206734|NCT00724126|541897395|FG001|Overall Study|Subject randomized although ineligible|1|||
150206735|NCT00724126|541897394|FG000|Overall Study|Subject had to leave vicinity of site|0|||
150206736|NCT00724126|541897395|FG001|Overall Study|Subject had to leave vicinity of site|1|||
150206737|NCT05405244|541897397|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
150206738|NCT05405244|541897398|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
150206739|NCT05405244|541897397|FG000|Washout (2 Weeks)|Adverse Event|2|||
150206740|NCT05405244|541897398|FG001|Washout (2 Weeks)|Adverse Event|0|||
150206741|NCT05405244|541897397|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
150206742|NCT05405244|541897398|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
150206743|NCT03418922|541897399|FG000|Overall Study|Withdrawal by Subject|0|||
150206744|NCT03418922|541897400|FG001|Overall Study|Withdrawal by Subject|2|||
150206745|NCT03418922|541897399|FG000|Overall Study|Adverse Event|2|||
150206746|NCT03418922|541897400|FG001|Overall Study|Adverse Event|2|||
150206747|NCT03418922|541897399|FG000|Overall Study|Death|0|||
150206748|NCT03418922|541897400|FG001|Overall Study|Death|1|||
150206749|NCT03418922|541897399|FG000|Overall Study|Physician Decision|0|||
150206750|NCT03418922|541897400|FG001|Overall Study|Physician Decision|1|||
150206751|NCT03577106|541897401|FG000|Overall Study|Withdrawal by Subject|3|||
150206752|NCT01579318|541897402|FG000|Overall Study|Disease Progression|1|||
150206753|NCT03601715|541897405|FG000|Second Intervention|Lost to Follow-up|1|||
150206754|NCT03601715|541897406|FG001|Second Intervention|Lost to Follow-up|1|||
150206755|NCT03601715|541897407|FG002|Second Intervention|Lost to Follow-up|0|||
150206756|NCT02347332|541897408|FG000|Overall Study|Not treated|5|||
150206757|NCT02347332|541897409|FG001|Overall Study|Not treated|2|||
150206758|NCT02347332|541897408|FG000|Overall Study|Progressive disease|141|||
150206759|NCT02347332|541897409|FG001|Overall Study|Progressive disease|159|||
150206760|NCT02347332|541897408|FG000|Overall Study|Adverse Event|50|||
150206761|NCT02347332|541897409|FG001|Overall Study|Adverse Event|41|||
150206762|NCT02347332|541897408|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
150206763|NCT02347332|541897409|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
150206764|NCT02347332|541897408|FG000|Overall Study|Protocol Violation|1|||
150206765|NCT02347332|541897409|FG001|Overall Study|Protocol Violation|1|||
150206766|NCT02347332|541897408|FG000|Overall Study|Lost to Follow-up|2|||
150206767|NCT02347332|541897409|FG001|Overall Study|Lost to Follow-up|1|||
150206768|NCT02347332|541897408|FG000|Overall Study|Physician Decision|4|||
150206769|NCT02347332|541897409|FG001|Overall Study|Physician Decision|3|||
150206770|NCT02347332|541897408|FG000|Overall Study|Withdrawal by Subject|20|||
150206771|NCT02347332|541897409|FG001|Overall Study|Withdrawal by Subject|14|||
150206772|NCT02347332|541897408|FG000|Overall Study|Protocol requirement|1|||
150206773|NCT02347332|541897409|FG001|Overall Study|Protocol requirement|1|||
150206774|NCT02347332|541897408|FG000|Overall Study|Switch Post-Trial program|0|||
150206775|NCT02347332|541897409|FG001|Overall Study|Switch Post-Trial program|1|||
150206776|NCT01478594|541897411|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
150206777|NCT01478594|541897412|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
150206778|NCT01478594|541897411|FG000|Overall Study|Death|45|||
150206779|NCT01478594|541897412|FG001|Overall Study|Death|18|||
150206780|NCT01478594|541897411|FG000|Overall Study|Lost to Follow-up|3|||
150206781|NCT01478594|541897412|FG001|Overall Study|Lost to Follow-up|1|||
150137532|NCT03848403|541637314|FG001|Period 2 (Day 8)|Physician Decision|1|||
150137533|NCT03848403|541637315|FG002|Period 2 (Day 8)|Physician Decision|0|||
150137534|NCT03848403|541637313|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
150137535|NCT03848403|541637314|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
150137536|NCT03848403|541637315|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
150137537|NCT00168038|541637316|FG000|Overall Study|Adverse Event|1|||
150137538|NCT00168038|541637316|FG000|Overall Study|Therapy failure|1|||
150137539|NCT04198805|541637319|FG000|Overall Study|Death|0|||
150137540|NCT04198805|541637320|FG001|Overall Study|Death|0|||
150137541|NCT04198805|541637321|FG002|Overall Study|Death|0|||
150137542|NCT04198805|541637322|FG003|Overall Study|Death|1|||
150137543|NCT04198805|541637319|FG000|Overall Study|Early Termination|8|||
150137544|NCT04198805|541637320|FG001|Overall Study|Early Termination|4|||
150137545|NCT04198805|541637321|FG002|Overall Study|Early Termination|6|||
150137546|NCT04198805|541637322|FG003|Overall Study|Early Termination|9|||
150137547|NCT03599349|541637325|FG000|Overall Study|Lost to Follow-up|1|||
150137548|NCT02638948|541637330|FG000|Overall Study|Withdrawal by Subject|4|||
150137549|NCT02638948|541637331|FG001|Overall Study|Withdrawal by Subject|5|||
150137550|NCT02638948|541637332|FG002|Overall Study|Withdrawal by Subject|3|||
150137551|NCT02638948|541637333|FG003|Overall Study|Withdrawal by Subject|1|||
150137552|NCT02638948|541637330|FG000|Overall Study|Administrative Reason by Sponsor|0|||
150137553|NCT02638948|541637331|FG001|Overall Study|Administrative Reason by Sponsor|1|||
150137554|NCT02638948|541637332|FG002|Overall Study|Administrative Reason by Sponsor|0|||
150137555|NCT02638948|541637333|FG003|Overall Study|Administrative Reason by Sponsor|4|||
150137556|NCT02638948|541637330|FG000|Overall Study|Adverse Event|0|||
150137557|NCT02638948|541637331|FG001|Overall Study|Adverse Event|0|||
150137558|NCT02638948|541637332|FG002|Overall Study|Adverse Event|1|||
150137559|NCT02638948|541637333|FG003|Overall Study|Adverse Event|1|||
150137560|NCT02638948|541637330|FG000|Overall Study|Lack of Efficacy|1|||
150137561|NCT02638948|541637331|FG001|Overall Study|Lack of Efficacy|1|||
150137562|NCT02638948|541637332|FG002|Overall Study|Lack of Efficacy|0|||
150137563|NCT02638948|541637333|FG003|Overall Study|Lack of Efficacy|0|||
150137564|NCT02638948|541637330|FG000|Overall Study|Lost to Follow-up|0|||
150137565|NCT02638948|541637331|FG001|Overall Study|Lost to Follow-up|0|||
150137566|NCT02638948|541637332|FG002|Overall Study|Lost to Follow-up|1|||
150137567|NCT02638948|541637333|FG003|Overall Study|Lost to Follow-up|1|||
150137568|NCT02638948|541637330|FG000|Overall Study|Poor/Non-Compliance|0|||
150137569|NCT02638948|541637331|FG001|Overall Study|Poor/Non-Compliance|2|||
150137570|NCT02638948|541637332|FG002|Overall Study|Poor/Non-Compliance|1|||
150137571|NCT02638948|541637333|FG003|Overall Study|Poor/Non-Compliance|0|||
150137572|NCT02638948|541637330|FG000|Overall Study|Participant no longer met study criteria|0|||
150137573|NCT02638948|541637331|FG001|Overall Study|Participant no longer met study criteria|1|||
150137574|NCT02638948|541637332|FG002|Overall Study|Participant no longer met study criteria|0|||
150137575|NCT02638948|541637333|FG003|Overall Study|Participant no longer met study criteria|0|||
150137576|NCT02638948|541637330|FG000|Overall Study|Other than specified above|4|||
150137577|NCT02638948|541637331|FG001|Overall Study|Other than specified above|1|||
150137578|NCT02638948|541637332|FG002|Overall Study|Other than specified above|1|||
150137579|NCT02638948|541637333|FG003|Overall Study|Other than specified above|1|||
150137580|NCT05007392|541637334|FG000|Overall Study|Randomized but not treated|1|||
150137581|NCT05007392|541637335|FG001|Overall Study|Randomized but not treated|2|||
150137582|NCT05007392|541637334|FG000|Overall Study|Other|5|||
150137583|NCT05007392|541637335|FG001|Overall Study|Other|4|||
150137584|NCT05007392|541637334|FG000|Overall Study|Lost to Follow-up|1|||
150137585|NCT05007392|541637335|FG001|Overall Study|Lost to Follow-up|2|||
150137586|NCT05007392|541637334|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
150137587|NCT05007392|541637335|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
150137588|NCT05007392|541637334|FG000|Overall Study|Use of prohibited concomitant drug|1|||
150137589|NCT05007392|541637335|FG001|Overall Study|Use of prohibited concomitant drug|1|||
150137590|NCT05007392|541637334|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
150137591|NCT05007392|541637335|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
150137592|NCT05007392|541637334|FG000|Overall Study|Adverse Event|10|||
150137593|NCT05007392|541637335|FG001|Overall Study|Adverse Event|6|||
150137594|NCT05007392|541637334|FG000|Overall Study|Participant choice|5|||
150137595|NCT05007392|541637335|FG001|Overall Study|Participant choice|10|||
150137596|NCT05007392|541637334|FG000|Overall Study|Withdrawal of consent|5|||
150137597|NCT05007392|541637335|FG001|Overall Study|Withdrawal of consent|4|||
150137598|NCT01352585|541638736|FG000|Overall Study|Adverse Event|2|||
150137599|NCT01352585|541638737|FG001|Overall Study|Adverse Event|1|||
150137600|NCT01352585|541638736|FG000|Overall Study|Lost to Follow-up|1|||
150137601|NCT01352585|541638737|FG001|Overall Study|Lost to Follow-up|0|||
150206782|NCT01478594|541897411|FG000|Overall Study|Withdrawal by Subject|9|||
150206783|NCT01478594|541897412|FG001|Overall Study|Withdrawal by Subject|3|||
150206784|NCT01478594|541897411|FG000|Overall Study|Study Closed by Sponsor|8|||
150206785|NCT01478594|541897412|FG001|Overall Study|Study Closed by Sponsor|5|||
150206786|NCT01313884|541897414|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
150206787|NCT01970007|541897415|FG000|Overall Study|Death|5|||
150206788|NCT01970007|541897415|FG000|Overall Study|Withdrawal by Subject|23|||
150206789|NCT01970007|541897415|FG000|Overall Study|Lost to Follow-up|24|||
150206790|NCT01970007|541897415|FG000|Overall Study|"Other endpoint"|3|||
150206791|NCT02854436|541897416|FG000|Overall Study|Adverse Event|1|||
150206792|NCT02854436|541897416|FG000|Overall Study|Death|208|||
150206793|NCT02854436|541897416|FG000|Overall Study|Lost to Follow-up|5|||
150206794|NCT02854436|541897416|FG000|Overall Study|Withdrawal by Subject|24|||
150206795|NCT02854436|541897416|FG000|Overall Study|Other|45|||
150206796|NCT02854436|541897416|FG000|Overall Study|Physician Decision|6|||
150206797|NCT00754065|541897418|FG000|Overall Study|Never received treatment|12|||
150206798|NCT00754065|541897419|FG001|Overall Study|Never received treatment|2|||
150206799|NCT00754065|541897418|FG000|Overall Study|Adverse Event|19|||
150206800|NCT00754065|541897419|FG001|Overall Study|Adverse Event|25|||
150206801|NCT00754065|541897418|FG000|Overall Study|Lost to Follow-up|7|||
150206802|NCT00754065|541897419|FG001|Overall Study|Lost to Follow-up|11|||
150206803|NCT00754065|541897418|FG000|Overall Study|Protocol Violation|12|||
150206804|NCT00754065|541897419|FG001|Overall Study|Protocol Violation|10|||
150206805|NCT00754065|541897418|FG000|Overall Study|Withdrawal by Subject|4|||
150206806|NCT00754065|541897419|FG001|Overall Study|Withdrawal by Subject|5|||
150206807|NCT00754065|541897418|FG000|Overall Study|Pregnancy|6|||
150206808|NCT00754065|541897419|FG001|Overall Study|Pregnancy|0|||
150206809|NCT00754065|541897418|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
150206810|NCT00754065|541897419|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
150206811|NCT04353492|541897422|FG000|Overall Study|Subject decision|24|||
150206812|NCT04353492|541897422|FG000|Overall Study|Physician Decision|5|||
150206813|NCT04353492|541897422|FG000|Overall Study|Adverse Event|3|||
150206814|NCT04353492|541897422|FG000|Overall Study|Pregnancy|3|||
150206815|NCT04353492|541897422|FG000|Overall Study|Lost to Follow-up|2|||
150206816|NCT04353492|541897422|FG000|Overall Study|Protocol deviation|1|||
150206817|NCT04353492|541897422|FG000|Overall Study|Technical problems|1|||
150206818|NCT04250194|541897423|FG000|Overall Study|Declined to schedule biopsy|6|||
150206819|NCT04250194|541897424|FG001|Overall Study|Declined to schedule biopsy|10|||
150206820|NCT04250194|541897423|FG000|Overall Study|Medically Unfit for Biopsy|2|||
150206821|NCT04250194|541897424|FG001|Overall Study|Medically Unfit for Biopsy|1|||
150206822|NCT04250194|541897423|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
150206823|NCT04250194|541897424|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
150206824|NCT04250194|541897423|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
150206825|NCT04250194|541897424|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
150206826|NCT04250194|541897423|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
150206827|NCT04250194|541897424|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
150206828|NCT00623194|541897427|FG000|Overall Study|Lack of Efficacy|1|||
150206829|NCT00623194|541897427|FG000|Overall Study|Protocol Violation|3|||
150206830|NCT00623194|541897427|FG000|Overall Study|Unclassified|1|||
150206831|NCT01218659|541897430|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
150206832|NCT01218659|541897431|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
150206833|NCT01218659|541897432|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
150206834|NCT01218659|541897430|FG000|18-Month Randomized Period|Did not receive study drug|0|||
150206835|NCT01218659|541897431|FG001|18-Month Randomized Period|Did not receive study drug|3|||
150206836|NCT01218659|541897432|FG002|18-Month Randomized Period|Did not receive study drug|0|||
150206837|NCT01218659|541897430|FG000|12-Month OLE|Withdrawal by Subject|0|||
150206838|NCT01218659|541897431|FG001|12-Month OLE|Withdrawal by Subject|0|||
150206839|NCT01218659|541897432|FG002|12-Month OLE|Withdrawal by Subject|2|||
150206840|NCT01218659|541897430|FG000|12-Month OLE|Physician Decision|0|||
150206841|NCT01218659|541897431|FG001|12-Month OLE|Physician Decision|0|||
150206842|NCT01218659|541897432|FG002|12-Month OLE|Physician Decision|1|||
150206843|NCT01218659|541897430|FG000|12-Month OLE|Lost to Follow-up|0|||
150206844|NCT01218659|541897431|FG001|12-Month OLE|Lost to Follow-up|0|||
150206845|NCT01218659|541897432|FG002|12-Month OLE|Lost to Follow-up|1|||
150206846|NCT01218659|541897430|FG000|12-Month OLE|Pregnancy|0|||
150206847|NCT01218659|541897431|FG001|12-Month OLE|Pregnancy|0|||
150206848|NCT01218659|541897432|FG002|12-Month OLE|Pregnancy|1|||
150206849|NCT01218659|541897430|FG000|12-Month OLE|Lack of Efficacy|0|||
150206850|NCT01218659|541897431|FG001|12-Month OLE|Lack of Efficacy|0|||
150206851|NCT01218659|541897432|FG002|12-Month OLE|Lack of Efficacy|1|||
150206852|NCT01218659|541897430|FG000|12-Month OLE|Declined to participate in the OLE|0|||
150206853|NCT01218659|541897431|FG001|12-Month OLE|Declined to participate in the OLE|0|||
150206854|NCT01218659|541897432|FG002|12-Month OLE|Declined to participate in the OLE|4|||
150206855|NCT03355573|541897435|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
150206856|NCT03355573|541897435|FG000|Overall Study|Sponsor's decision|1|||
150206857|NCT03355573|541897435|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
150206858|NCT03355573|541897435|FG000|Overall Study|PI's decision|2|||
150206859|NCT03355573|541897435|FG000|Overall Study|Withdrawal by Subject|23|||
150206860|NCT03355573|541897435|FG000|Overall Study|Lost to Follow-up|4|||
150206861|NCT03355573|541897435|FG000|Overall Study|Lack of Efficacy|2|||
150206862|NCT03355573|541897435|FG000|Overall Study|Adverse Event, non-fatal|17|||
150206863|NCT03355573|541897435|FG000|Overall Study|Adverse Event, serious fatal|2|||
150206864|NCT00174252|541897441|FG000|Overall Study|Protocol Violation|2|||
150206865|NCT03357952|541897442|FG000|Overall Study|Withdrawal by Subject|0|||
150206866|NCT03357952|541897443|FG001|Overall Study|Withdrawal by Subject|1|||
150206867|NCT03357952|541897442|FG000|Overall Study|Sponsor Decision|9|||
150206868|NCT03357952|541897443|FG001|Overall Study|Sponsor Decision|0|||
150206869|NCT02016872|541897444|FG000|Overall Study|Withdrawal by Subject|10|||
150206870|NCT02016872|541897444|FG000|Overall Study|Death Progression|2|||
150206871|NCT02016872|541897444|FG000|Overall Study|No FMISO scan|1|||
150206872|NCT02016872|541897444|FG000|Overall Study|Ineligible|2|||
150206873|NCT06688357|541897445|FG000|Overall Study|Adverse Event|0|||
150206874|NCT06688357|541897446|FG001|Overall Study|Adverse Event|1|||
150206875|NCT03222609|541897447|FG000|Overall Study|Withdrew consent|2|||
150206876|NCT03222609|541897448|FG001|Overall Study|Withdrew consent|3|||
150206877|NCT03222609|541897449|FG002|Overall Study|Withdrew consent|4|||
150206878|NCT03222609|541897450|FG003|Overall Study|Withdrew consent|2|||
150206879|NCT03222609|541897447|FG000|Overall Study|Lost to Follow-up|1|||
150206880|NCT03222609|541897448|FG001|Overall Study|Lost to Follow-up|0|||
150206881|NCT03222609|541897449|FG002|Overall Study|Lost to Follow-up|0|||
150206882|NCT03222609|541897450|FG003|Overall Study|Lost to Follow-up|0|||
150206883|NCT03222609|541897447|FG000|Overall Study|Death|16|||
150206884|NCT03222609|541897448|FG001|Overall Study|Death|13|||
150206885|NCT03222609|541897449|FG002|Overall Study|Death|9|||
150206886|NCT03222609|541897450|FG003|Overall Study|Death|6|||
150206887|NCT03222609|541897447|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
150206888|NCT03222609|541897448|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
150206889|NCT03222609|541897449|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
150206890|NCT03222609|541897450|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
150206891|NCT04517435|541897467|FG000|Overall Study|Withdrawal by Subject|0|||
150206892|NCT04517435|541897468|FG001|Overall Study|Withdrawal by Subject|0|||
150206893|NCT04517435|541897469|FG002|Overall Study|Withdrawal by Subject|1|||
150206894|NCT04517435|541897467|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
150206895|NCT04517435|541897468|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
150206896|NCT04517435|541897469|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
150206897|NCT03211247|541897470|FG000|Overall Study|Adverse Event|8|||
150206898|NCT03211247|541897471|FG001|Overall Study|Adverse Event|0|||
150206899|NCT03211247|541897472|FG002|Overall Study|Adverse Event|1|||
150206900|NCT03211247|541897473|FG003|Overall Study|Adverse Event|0|||
150206901|NCT03211247|541897474|FG004|Overall Study|Adverse Event|0|||
150206902|NCT03211247|541897470|FG000|Overall Study|Lost to Follow-up|2|||
150206903|NCT03211247|541897471|FG001|Overall Study|Lost to Follow-up|1|||
150206904|NCT03211247|541897472|FG002|Overall Study|Lost to Follow-up|0|||
150206905|NCT03211247|541897473|FG003|Overall Study|Lost to Follow-up|0|||
150206906|NCT03211247|541897474|FG004|Overall Study|Lost to Follow-up|0|||
150206907|NCT03211247|541897470|FG000|Overall Study|Physician Decision|1|||
150206908|NCT03211247|541897471|FG001|Overall Study|Physician Decision|2|||
150206909|NCT03211247|541897472|FG002|Overall Study|Physician Decision|0|||
150206910|NCT03211247|541897473|FG003|Overall Study|Physician Decision|0|||
150206911|NCT03211247|541897474|FG004|Overall Study|Physician Decision|0|||
150206912|NCT03211247|541897470|FG000|Overall Study|Non-compliance with study drug|2|||
150206913|NCT03211247|541897471|FG001|Overall Study|Non-compliance with study drug|0|||
150206914|NCT03211247|541897472|FG002|Overall Study|Non-compliance with study drug|0|||
150206915|NCT03211247|541897473|FG003|Overall Study|Non-compliance with study drug|0|||
150206916|NCT03211247|541897474|FG004|Overall Study|Non-compliance with study drug|0|||
150206917|NCT03211247|541897470|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
150137602|NCT01352585|541638736|FG000|Overall Study|Other|5|||
150137603|NCT01352585|541638737|FG001|Overall Study|Other|2|||
150137604|NCT02459262|541638739|FG000|Overall Study|Withdrawal by Subject|0|||
150137605|NCT02459262|541638740|FG001|Overall Study|Withdrawal by Subject|0|||
150137606|NCT02459262|541638741|FG002|Overall Study|Withdrawal by Subject|0|||
150137607|NCT02459262|541638742|FG003|Overall Study|Withdrawal by Subject|0|||
150137608|NCT02459262|541638743|FG004|Overall Study|Withdrawal by Subject|0|||
150137609|NCT02459262|541638744|FG005|Overall Study|Withdrawal by Subject|0|||
150137610|NCT02459262|541638745|FG006|Overall Study|Withdrawal by Subject|0|||
150137611|NCT02459262|541638746|FG007|Overall Study|Withdrawal by Subject|0|||
150137612|NCT02459262|541638747|FG008|Overall Study|Withdrawal by Subject|0|||
150137613|NCT02459262|541638748|FG009|Overall Study|Withdrawal by Subject|1|||
150137614|NCT02459262|541638749|FG010|Overall Study|Withdrawal by Subject|0|||
150137615|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
150137616|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
150137617|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
150137618|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
150137619|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
150137620|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
150137621|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
150137622|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
150137623|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
150137624|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
150137625|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
150137626|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
150137627|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
150137628|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
150137629|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
150137630|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
150137631|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
150137632|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
150137633|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
150137634|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
150137635|NCT00549757|541638756|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
150137636|NCT00549757|541638757|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
150137637|NCT00549757|541638756|FG000|Extension Period (in Average 9 Months)|Death|143|||
150137638|NCT00549757|541638757|FG001|Extension Period (in Average 9 Months)|Death|136|||
150137639|NCT00549757|541638756|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
150137640|NCT00549757|541638757|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
150137641|NCT00549757|541638756|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
150137642|NCT00549757|541638757|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
150137643|NCT00549757|541638756|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
150137644|NCT00549757|541638757|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
150137645|NCT01964326|541638758|FG000|Overall Study|Adverse Event|48|||
150137646|NCT01964326|541638758|FG000|Overall Study|Death|2|||
150137647|NCT01964326|541638758|FG000|Overall Study|Protocol Violation|4|||
150137648|NCT01964326|541638758|FG000|Overall Study|Lost to Follow-up|88|||
150137649|NCT01964326|541638758|FG000|Overall Study|Withdrawal by Subject|87|||
150137650|NCT01964326|541638758|FG000|Overall Study|Pregnancy|1|||
150137651|NCT01964326|541638758|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
150137652|NCT01964326|541638758|FG000|Overall Study|Physician Decision|55|||
150137653|NCT01964326|541638758|FG000|Overall Study|Investigator Discretion|1|||
150137654|NCT01964326|541638758|FG000|Overall Study|Other|9|||
150137655|NCT01964326|541638758|FG000|Overall Study|Did not meet eligibility criteria|1|||
150137656|NCT02347657|541638759|FG000|Overall Study|Physician Decision|0|||
150137657|NCT02347657|541638760|FG001|Overall Study|Physician Decision|1|||
150137658|NCT02347657|541638759|FG000|Overall Study|Adverse Event|8|||
150137659|NCT02347657|541638760|FG001|Overall Study|Adverse Event|4|||
150137660|NCT02347657|541638759|FG000|Overall Study|Withdrawal by Subject|6|||
150137661|NCT02347657|541638760|FG001|Overall Study|Withdrawal by Subject|7|||
150137662|NCT02347657|541638759|FG000|Overall Study|Randomized but not treated|1|||
150137663|NCT02347657|541638760|FG001|Overall Study|Randomized but not treated|0|||
150137664|NCT02347657|541638759|FG000|Overall Study|Other|3|||
150137665|NCT02347657|541638760|FG001|Overall Study|Other|3|||
150137666|NCT02093663|541638765|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
150137667|NCT02093663|541638766|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
150137668|NCT02093663|541638767|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
150137669|NCT02093663|541638768|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
150137670|NCT02093663|541638769|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
150137671|NCT02093663|541638765|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
150137672|NCT02093663|541638766|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137673|NCT02093663|541638767|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137674|NCT02093663|541638768|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137675|NCT02093663|541638769|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137676|NCT02093663|541638765|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
150137677|NCT02093663|541638766|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
150137678|NCT02093663|541638767|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
150137679|NCT02093663|541638768|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
150137680|NCT02093663|541638769|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
150137681|NCT02093663|541638765|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
150137682|NCT02093663|541638766|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
150137683|NCT02093663|541638767|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
150137684|NCT02093663|541638768|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
150137685|NCT02093663|541638769|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
150137686|NCT02093663|541638765|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137687|NCT02093663|541638766|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137688|NCT02093663|541638767|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
150137689|NCT02093663|541638768|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137690|NCT02093663|541638769|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
150137691|NCT02093663|541638765|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
150137692|NCT02093663|541638766|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
150137693|NCT02093663|541638767|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
150137694|NCT02093663|541638768|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
150137695|NCT02093663|541638769|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
150137696|NCT02093663|541638765|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
150137697|NCT02093663|541638766|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
150137698|NCT02093663|541638767|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
150137699|NCT02093663|541638768|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
150137700|NCT02093663|541638769|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
150137701|NCT02093663|541638765|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
150137702|NCT02093663|541638766|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
150137703|NCT02093663|541638767|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
150137704|NCT02093663|541638768|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
150137705|NCT02093663|541638769|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
150137706|NCT02093663|541638765|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
150137707|NCT02093663|541638766|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
150137708|NCT02093663|541638767|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
150137709|NCT02093663|541638768|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
150137710|NCT02093663|541638769|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
150137711|NCT00508404|541638770|FG000|Overall Study|Ongoing at Data Cut-off|12|||
150137712|NCT00508404|541638770|FG000|Overall Study|Adverse Event|2|||
150137713|NCT00508404|541638770|FG000|Overall Study|Death|16|||
150137714|NCT00508404|541638770|FG000|Overall Study|Physician Decision|2|||
150137715|NCT00508404|541638770|FG000|Overall Study|Withdrawal by Subject|3|||
150137716|NCT00508404|541638770|FG000|Overall Study|Protocol-specified Criteria|2|||
150137717|NCT00508404|541638770|FG000|Overall Study|Lost to Follow-up|2|||
150137718|NCT00508404|541638770|FG000|Overall Study|Other - Not Specified|3|||
150137719|NCT01505387|541638771|FG000|Overall Study|Protocol Violation|1|||
150137720|NCT01505387|541638772|FG001|Overall Study|Protocol Violation|0|||
150137721|NCT01505387|541638771|FG000|Overall Study|Withdrawal by Subject|1|||
150137722|NCT01505387|541638772|FG001|Overall Study|Withdrawal by Subject|1|||
150137723|NCT01424930|541638773|FG000|Overall Study|Adverse Event|0|||
150137724|NCT01424930|541638774|FG001|Overall Study|Adverse Event|1|||
150137725|NCT01424930|541638773|FG000|Overall Study|Death|1|||
150137726|NCT01424930|541638774|FG001|Overall Study|Death|0|||
150137727|NCT01424930|541638773|FG000|Overall Study|Progressive Disease|3|||
150137728|NCT01424930|541638774|FG001|Overall Study|Progressive Disease|6|||
150137729|NCT01424930|541638773|FG000|Overall Study|Screen Failure|0|||
150137730|NCT01424930|541638774|FG001|Overall Study|Screen Failure|1|||
150137731|NCT01424930|541638773|FG000|Overall Study|Reason not specified|0|||
150137732|NCT01424930|541638774|FG001|Overall Study|Reason not specified|6|||
150137733|NCT01301391|541638775|FG000|Overall Study|Death|13|||
150137734|NCT01301391|541638775|FG000|Overall Study|Lost to Follow-up|3|||
150137735|NCT01301391|541638775|FG000|Overall Study|Physician Decision|2|||
150137736|NCT01301391|541638775|FG000|Overall Study|Sponsor's decision|8|||
150137737|NCT01621880|541638778|FG000|Overall Study|Adverse Event|5|||
150137738|NCT01621880|541638779|FG001|Overall Study|Adverse Event|1|||
150137739|NCT01621880|541638778|FG000|Overall Study|Withdrawal by Subject|5|||
150137740|NCT01621880|541638779|FG001|Overall Study|Withdrawal by Subject|4|||
150137741|NCT01662063|541638780|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
150137742|NCT01662063|541638781|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
150206918|NCT03211247|541897471|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
150206919|NCT03211247|541897472|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
150206920|NCT03211247|541897473|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
150206921|NCT03211247|541897474|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
150206922|NCT03211247|541897470|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
150206923|NCT03211247|541897471|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
150206924|NCT03211247|541897472|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
150206925|NCT03211247|541897473|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
150206926|NCT03211247|541897474|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
150206927|NCT03211247|541897470|FG000|Overall Study|Protocol Violation|0|||
150206928|NCT03211247|541897471|FG001|Overall Study|Protocol Violation|1|||
150206929|NCT03211247|541897472|FG002|Overall Study|Protocol Violation|0|||
150206930|NCT03211247|541897473|FG003|Overall Study|Protocol Violation|0|||
150206931|NCT03211247|541897474|FG004|Overall Study|Protocol Violation|0|||
150206932|NCT02415127|541897475|FG000|Overall Study|Adverse Event|1|||
150206933|NCT02415127|541897476|FG001|Overall Study|Adverse Event|0|||
150206934|NCT02761187|541897477|FG000|Overall Study|Too ill to Participate|13|||
150206935|NCT02761187|541897478|FG001|Overall Study|Too ill to Participate|8|||
150206936|NCT02761187|541897477|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
150206937|NCT02761187|541897478|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
150206938|NCT02761187|541897477|FG000|Overall Study|Patient withdrew consent|64|||
150206939|NCT02761187|541897478|FG001|Overall Study|Patient withdrew consent|58|||
150206940|NCT02761187|541897477|FG000|Overall Study|Physician discretion|4|||
150206941|NCT02761187|541897478|FG001|Overall Study|Physician discretion|8|||
150206942|NCT02761187|541897477|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
150206943|NCT02761187|541897478|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
150206944|NCT02761187|541897477|FG000|Overall Study|On Hospice|20|||
150206945|NCT02761187|541897478|FG001|Overall Study|On Hospice|26|||
150206946|NCT02761187|541897477|FG000|Overall Study|Deceased|474|||
150206947|NCT02761187|541897478|FG001|Overall Study|Deceased|642|||
150206948|NCT02761187|541897477|FG000|Overall Study|Lost to Follow-up|73|||
150206949|NCT02761187|541897478|FG001|Overall Study|Lost to Follow-up|63|||
150206950|NCT02761187|541897477|FG000|Overall Study|Due to study discontinued at site|100|||
150206951|NCT02761187|541897478|FG001|Overall Study|Due to study discontinued at site|85|||
150206952|NCT02761187|541897477|FG000|Overall Study|Reason not Specified|1484|||
150206953|NCT02761187|541897478|FG001|Overall Study|Reason not Specified|937|||
150206954|NCT00490139|541897483|FG000|Overall Study|Lost to Follow-up|249|||
150206955|NCT00490139|541897484|FG001|Overall Study|Lost to Follow-up|216|||
150206956|NCT00490139|541897485|FG002|Overall Study|Lost to Follow-up|205|||
150206957|NCT00490139|541897486|FG003|Overall Study|Lost to Follow-up|229|||
150206958|NCT00490139|541897483|FG000|Overall Study|Withdrawal by Subject|333|||
150206959|NCT00490139|541897484|FG001|Overall Study|Withdrawal by Subject|322|||
150206960|NCT00490139|541897485|FG002|Overall Study|Withdrawal by Subject|396|||
150206961|NCT00490139|541897486|FG003|Overall Study|Withdrawal by Subject|295|||
150206962|NCT00490139|541897483|FG000|Overall Study|Patient did not sign ICF 12|169|||
150206963|NCT00490139|541897484|FG001|Overall Study|Patient did not sign ICF 12|176|||
150206964|NCT00490139|541897485|FG002|Overall Study|Patient did not sign ICF 12|139|||
150206965|NCT00490139|541897486|FG003|Overall Study|Patient did not sign ICF 12|167|||
150206966|NCT00490139|541897483|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
150206967|NCT00490139|541897484|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
150206968|NCT00490139|541897485|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
150206969|NCT00490139|541897486|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
150206970|NCT00490139|541897483|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
150206971|NCT00490139|541897484|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
150206972|NCT00490139|541897485|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
150206973|NCT00490139|541897486|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
150206974|NCT00490139|541897483|FG000|Overall Study|Other reasons as defined per protocol|98|||
150206975|NCT00490139|541897484|FG001|Overall Study|Other reasons as defined per protocol|84|||
150206976|NCT00490139|541897485|FG002|Overall Study|Other reasons as defined per protocol|82|||
150206977|NCT00490139|541897486|FG003|Overall Study|Other reasons as defined per protocol|105|||
150206978|NCT03664804|541897488|FG000|Overall Study|Withdrawal by Subject|7|||
150206979|NCT05529992|541897489|FG000|Overall Study|Withdrawal by Subject|1|||
150206980|NCT06140290|541897490|FG000|Period 1|Adverse Event|1|||
150206981|NCT06140290|541897491|FG001|Period 1|Adverse Event|0|||
150206982|NCT06140290|541897490|FG000|Period 2|Assigned but not treated|0|||
150206983|NCT06140290|541897491|FG001|Period 2|Assigned but not treated|1|||
150206984|NCT06140290|541897490|FG000|Period 2|Withdrawal by Subject|0|||
150206985|NCT06140290|541897491|FG001|Period 2|Withdrawal by Subject|1|||
150206986|NCT03752684|541898818|FG000|Overall Study|Lost to Follow-up|4|||
150206987|NCT05250115|541898819|FG000|Overall Study|Premature study end|40|||
150206988|NCT05250115|541898819|FG000|Overall Study|Adverse Event|8|||
150206989|NCT05250115|541898819|FG000|Overall Study|Lost to Follow-up|7|||
150206990|NCT05250115|541898819|FG000|Overall Study|Withdrawal by Subject|6|||
150206991|NCT05250115|541898819|FG000|Overall Study|Withdrawal of informed consent|1|||
150206992|NCT05250115|541898819|FG000|Overall Study|Other|7|||
150206993|NCT03758638|541898820|FG000|Overall Study|Pregnancy|17|||
150206994|NCT03758638|541898821|FG001|Overall Study|Pregnancy|25|||
150206995|NCT03758638|541898820|FG000|Overall Study|Lost to Follow-up|60|||
150206996|NCT03758638|541898821|FG001|Overall Study|Lost to Follow-up|54|||
150206997|NCT03758638|541898820|FG000|Overall Study|Protocol Violation|2|||
150206998|NCT03758638|541898821|FG001|Overall Study|Protocol Violation|0|||
150206999|NCT03758638|541898820|FG000|Overall Study|Withdrawal by Subject|8|||
150207000|NCT03758638|541898821|FG001|Overall Study|Withdrawal by Subject|2|||
150207001|NCT03758638|541898820|FG000|Overall Study|Providers not included in the primary outcome.|183|||
150207002|NCT03758638|541898821|FG001|Overall Study|Providers not included in the primary outcome.|128|||
150207003|NCT00582972|541898822|FG000|Overall Study|Protocol Violation|2|||
150207004|NCT02101775|541898827|FG000|Overall Study|Adverse Event|4|||
150207005|NCT02101775|541898828|FG001|Overall Study|Adverse Event|0|||
150207006|NCT02101775|541898829|FG002|Overall Study|Adverse Event|0|||
150207007|NCT02101775|541898827|FG000|Overall Study|Admission to Hospital|0|||
150207008|NCT02101775|541898828|FG001|Overall Study|Admission to Hospital|1|||
150207009|NCT02101775|541898829|FG002|Overall Study|Admission to Hospital|0|||
150207010|NCT01211184|541898832|FG000|Overall Study|Withdrawal by Subject|0|||
150207011|NCT01211184|541898833|FG001|Overall Study|Withdrawal by Subject|2|||
150207012|NCT01211184|541898834|FG002|Overall Study|Withdrawal by Subject|1|||
150207013|NCT01421667|541898835|FG000|Overall Study|Withdrawal by Subject|0|||
150207014|NCT01421667|541898836|FG001|Overall Study|Withdrawal by Subject|1|||
150207015|NCT01421667|541898837|FG002|Overall Study|Withdrawal by Subject|2|||
150207016|NCT01421667|541898838|FG003|Overall Study|Withdrawal by Subject|1|||
150207017|NCT01421667|541898835|FG000|Overall Study|Lost to Follow-up|0|||
150207018|NCT01421667|541898836|FG001|Overall Study|Lost to Follow-up|1|||
150207019|NCT01421667|541898837|FG002|Overall Study|Lost to Follow-up|0|||
150207020|NCT01421667|541898838|FG003|Overall Study|Lost to Follow-up|0|||
150207021|NCT00822120|541898839|FG000|Initial Registration|Adverse Event|1|||
150207022|NCT00822120|541898840|FG001|Initial Registration|Adverse Event|0|||
150207023|NCT00822120|541898841|FG002|Initial Registration|Adverse Event|0|||
150207024|NCT00822120|541898842|FG003|Initial Registration|Adverse Event|0|||
150207025|NCT00822120|541898843|FG004|Initial Registration|Adverse Event|0|||
150207026|NCT00822120|541898844|FG005|Initial Registration|Adverse Event|0|||
150207027|NCT00822120|541898839|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
150207028|NCT00822120|541898840|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
150207029|NCT00822120|541898841|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
150207030|NCT00822120|541898842|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
150207031|NCT00822120|541898843|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
150207032|NCT00822120|541898844|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
150207033|NCT00822120|541898839|FG000|Initial Registration|Reasons not Protocol Specified|2|||
150207034|NCT00822120|541898840|FG001|Initial Registration|Reasons not Protocol Specified|0|||
150207035|NCT00822120|541898841|FG002|Initial Registration|Reasons not Protocol Specified|0|||
150207036|NCT00822120|541898842|FG003|Initial Registration|Reasons not Protocol Specified|0|||
150207037|NCT00822120|541898843|FG004|Initial Registration|Reasons not Protocol Specified|0|||
150207038|NCT00822120|541898844|FG005|Initial Registration|Reasons not Protocol Specified|0|||
150207039|NCT00822120|541898839|FG000|Initial Registration|Ineligible|22|||
150207040|NCT00822120|541898840|FG001|Initial Registration|Ineligible|1|||
150207041|NCT00822120|541898841|FG002|Initial Registration|Ineligible|0|||
150207042|NCT00822120|541898842|FG003|Initial Registration|Ineligible|0|||
150207043|NCT00822120|541898843|FG004|Initial Registration|Ineligible|0|||
150207044|NCT00822120|541898844|FG005|Initial Registration|Ineligible|0|||
150207045|NCT00822120|541898839|FG000|PET-directed Therapy|Adverse Event|0|||
150207046|NCT00822120|541898840|FG001|PET-directed Therapy|Adverse Event|0|||
150207047|NCT00822120|541898841|FG002|PET-directed Therapy|Adverse Event|0|||
150207048|NCT00822120|541898842|FG003|PET-directed Therapy|Adverse Event|1|||
150207049|NCT00822120|541898843|FG004|PET-directed Therapy|Adverse Event|0|||
150207050|NCT00822120|541898844|FG005|PET-directed Therapy|Adverse Event|0|||
150207051|NCT00822120|541898839|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
150207052|NCT00822120|541898840|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
150207053|NCT00822120|541898841|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
150207054|NCT00822120|541898842|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
150207055|NCT00822120|541898843|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
150207056|NCT00822120|541898844|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
150207057|NCT00822120|541898839|FG000|PET-directed Therapy|Death|0|||
150207058|NCT00822120|541898840|FG001|PET-directed Therapy|Death|0|||
150207059|NCT00822120|541898841|FG002|PET-directed Therapy|Death|0|||
150207060|NCT00822120|541898842|FG003|PET-directed Therapy|Death|2|||
150207061|NCT00822120|541898843|FG004|PET-directed Therapy|Death|0|||
150207062|NCT00822120|541898844|FG005|PET-directed Therapy|Death|0|||
150207063|NCT00822120|541898839|FG000|PET-directed Therapy|Protocol Violation|0|||
150207064|NCT00822120|541898840|FG001|PET-directed Therapy|Protocol Violation|0|||
150207065|NCT00822120|541898841|FG002|PET-directed Therapy|Protocol Violation|0|||
150207066|NCT00822120|541898842|FG003|PET-directed Therapy|Protocol Violation|6|||
150207067|NCT00822120|541898843|FG004|PET-directed Therapy|Protocol Violation|0|||
150207068|NCT00822120|541898844|FG005|PET-directed Therapy|Protocol Violation|0|||
150207069|NCT00503906|541898845|FG000|Overall Study|Withdrawal by Subject|1|||
150207070|NCT04060212|541898847|FG000|Overall Study|Withdrawal by Subject|7|||
150207071|NCT03631407|541898848|FG000|Overall Study|Withdrawal by Subject|3|||
150207072|NCT03631407|541898849|FG001|Overall Study|Withdrawal by Subject|2|||
150207073|NCT03631407|541898848|FG000|Overall Study|Sponsor Decision|0|||
150207074|NCT03631407|541898849|FG001|Overall Study|Sponsor Decision|2|||
150207075|NCT03631407|541898848|FG000|Overall Study|Death|16|||
150207076|NCT03631407|541898849|FG001|Overall Study|Death|16|||
150207077|NCT03631407|541898848|FG000|Overall Study|Randomized by mistake without study treatment|1|||
150207078|NCT03631407|541898849|FG001|Overall Study|Randomized by mistake without study treatment|0|||
150207079|NCT01437319|541898851|FG000|Phase I|Lost to Follow-up|2|||
150207080|NCT01437319|541898852|FG001|Phase I|Lost to Follow-up|0|||
150207081|NCT01437319|541898853|FG002|Phase I|Lost to Follow-up|0|||
150207082|NCT01437319|541898851|FG000|Phase I|Protocol Violation|1|||
150207083|NCT01437319|541898852|FG001|Phase I|Protocol Violation|0|||
150207084|NCT01437319|541898853|FG002|Phase I|Protocol Violation|0|||
150207085|NCT01437319|541898851|FG000|Phase I|Study related symptoms/complaints|27|||
150207086|NCT01437319|541898852|FG001|Phase I|Study related symptoms/complaints|0|||
150207087|NCT01437319|541898853|FG002|Phase I|Study related symptoms/complaints|0|||
150207088|NCT01437319|541898851|FG000|Phase I|Withdrawal by Subject|25|||
150207089|NCT01437319|541898852|FG001|Phase I|Withdrawal by Subject|0|||
150207090|NCT01437319|541898853|FG002|Phase I|Withdrawal by Subject|0|||
150207091|NCT01437319|541898851|FG000|Phase II|Withdrawal by Subject|0|||
150207092|NCT01437319|541898852|FG001|Phase II|Withdrawal by Subject|8|||
150207093|NCT01437319|541898853|FG002|Phase II|Withdrawal by Subject|16|||
150207094|NCT01437319|541898851|FG000|Phase II|Lost to Follow-up|0|||
150207095|NCT01437319|541898852|FG001|Phase II|Lost to Follow-up|7|||
150207096|NCT01437319|541898853|FG002|Phase II|Lost to Follow-up|2|||
150207097|NCT01437319|541898851|FG000|Phase II|Study related symptoms/complaints|0|||
150207098|NCT01437319|541898852|FG001|Phase II|Study related symptoms/complaints|28|||
150207099|NCT01437319|541898853|FG002|Phase II|Study related symptoms/complaints|19|||
150207100|NCT01437319|541898851|FG000|Phase II|Protocol Violation|0|||
150207101|NCT01437319|541898852|FG001|Phase II|Protocol Violation|1|||
150207102|NCT01437319|541898853|FG002|Phase II|Protocol Violation|0|||
150207103|NCT01499849|541898854|FG000|Overall Study|Adverse Event|28|||
150207104|NCT01499849|541898855|FG001|Overall Study|Adverse Event|32|||
150207105|NCT01499849|541898854|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
150207106|NCT01499849|541898855|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
150207107|NCT01499849|541898854|FG000|Overall Study|Withdrawal by Subject|43|||
150207108|NCT01499849|541898855|FG001|Overall Study|Withdrawal by Subject|43|||
150207109|NCT01499849|541898854|FG000|Overall Study|Death|5|||
150207110|NCT01499849|541898855|FG001|Overall Study|Death|7|||
150207111|NCT01499849|541898854|FG000|Overall Study|Disease Progression|11|||
150207112|NCT01499849|541898855|FG001|Overall Study|Disease Progression|10|||
150207113|NCT01499849|541898854|FG000|Overall Study|Protocol Violation|11|||
150207114|NCT01499849|541898855|FG001|Overall Study|Protocol Violation|11|||
150207115|NCT01499849|541898854|FG000|Overall Study|Physician Decision|20|||
150207116|NCT01499849|541898855|FG001|Overall Study|Physician Decision|19|||
150207117|NCT01499849|541898854|FG000|Overall Study|Lack of Efficacy|3|||
150207118|NCT01499849|541898855|FG001|Overall Study|Lack of Efficacy|4|||
150207119|NCT01499849|541898854|FG000|Overall Study|Lost to Follow-up|6|||
150207120|NCT01499849|541898855|FG001|Overall Study|Lost to Follow-up|3|||
150207121|NCT01499849|541898854|FG000|Overall Study|Other Reasons|27|||
150207122|NCT01499849|541898855|FG001|Overall Study|Other Reasons|30|||
150207123|NCT03802994|541898858|FG000|Overall Study|Lost to Follow-up|0|||
150207124|NCT03802994|541898859|FG001|Overall Study|Lost to Follow-up|2|||
150207125|NCT03802994|541898860|FG002|Overall Study|Lost to Follow-up|3|||
150207126|NCT03802994|541898861|FG003|Overall Study|Lost to Follow-up|2|||
150207127|NCT03802994|541898862|FG004|Overall Study|Lost to Follow-up|2|||
150207128|NCT00983294|541898863|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
150207129|NCT00983294|541898863|FG000|Colchicine With Azithromycin|Adverse Event|1|||
150207130|NCT00622700|541898864|FG000|Core Treatment Period|Randomized but Not Treated|0|||
150207131|NCT00622700|541898865|FG001|Core Treatment Period|Randomized but Not Treated|2|||
150207132|NCT00622700|541898866|FG002|Core Treatment Period|Randomized but Not Treated|2|||
150207133|NCT00622700|541898867|FG003|Core Treatment Period|Randomized but Not Treated|0|||
150207134|NCT00622700|541898868|FG004|Core Treatment Period|Randomized but Not Treated|0|||
150207135|NCT00622700|541898869|FG005|Core Treatment Period|Randomized but Not Treated|0|||
150207136|NCT00622700|541898870|FG006|Core Treatment Period|Randomized but Not Treated|0|||
150207137|NCT00622700|541898864|FG000|Core Treatment Period|Adverse Event|18|||
150207138|NCT00622700|541898865|FG001|Core Treatment Period|Adverse Event|25|||
150207139|NCT00622700|541898866|FG002|Core Treatment Period|Adverse Event|18|||
150207140|NCT00622700|541898867|FG003|Core Treatment Period|Adverse Event|0|||
150207141|NCT00622700|541898868|FG004|Core Treatment Period|Adverse Event|0|||
150207142|NCT00622700|541898869|FG005|Core Treatment Period|Adverse Event|0|||
150207143|NCT00622700|541898870|FG006|Core Treatment Period|Adverse Event|0|||
150207144|NCT00622700|541898864|FG000|Core Treatment Period|Lack of Efficacy|19|||
150207145|NCT00622700|541898865|FG001|Core Treatment Period|Lack of Efficacy|6|||
150207146|NCT00622700|541898866|FG002|Core Treatment Period|Lack of Efficacy|12|||
150207147|NCT00622700|541898867|FG003|Core Treatment Period|Lack of Efficacy|0|||
150207148|NCT00622700|541898868|FG004|Core Treatment Period|Lack of Efficacy|0|||
150207149|NCT00622700|541898869|FG005|Core Treatment Period|Lack of Efficacy|0|||
150207150|NCT00622700|541898870|FG006|Core Treatment Period|Lack of Efficacy|0|||
150207151|NCT00622700|541898864|FG000|Core Treatment Period|Lost to Follow-up|1|||
150207152|NCT00622700|541898865|FG001|Core Treatment Period|Lost to Follow-up|1|||
150207153|NCT00622700|541898866|FG002|Core Treatment Period|Lost to Follow-up|1|||
150207154|NCT00622700|541898867|FG003|Core Treatment Period|Lost to Follow-up|0|||
150207155|NCT00622700|541898868|FG004|Core Treatment Period|Lost to Follow-up|0|||
150207156|NCT00622700|541898869|FG005|Core Treatment Period|Lost to Follow-up|0|||
150207157|NCT00622700|541898870|FG006|Core Treatment Period|Lost to Follow-up|0|||
150207158|NCT00622700|541898864|FG000|Core Treatment Period|Death|1|||
150207159|NCT00622700|541898865|FG001|Core Treatment Period|Death|0|||
150207160|NCT00622700|541898866|FG002|Core Treatment Period|Death|0|||
150207161|NCT00622700|541898867|FG003|Core Treatment Period|Death|0|||
150207162|NCT00622700|541898868|FG004|Core Treatment Period|Death|0|||
150207163|NCT00622700|541898869|FG005|Core Treatment Period|Death|0|||
150207164|NCT00622700|541898870|FG006|Core Treatment Period|Death|0|||
150207165|NCT00622700|541898864|FG000|Core Treatment Period|Progressive Disease|3|||
150207166|NCT00622700|541898865|FG001|Core Treatment Period|Progressive Disease|1|||
150207167|NCT00622700|541898866|FG002|Core Treatment Period|Progressive Disease|0|||
150207168|NCT00622700|541898867|FG003|Core Treatment Period|Progressive Disease|0|||
150207169|NCT00622700|541898868|FG004|Core Treatment Period|Progressive Disease|0|||
150207170|NCT00622700|541898869|FG005|Core Treatment Period|Progressive Disease|0|||
150207171|NCT00622700|541898870|FG006|Core Treatment Period|Progressive Disease|0|||
150207172|NCT00622700|541898864|FG000|Core Treatment Period|Withdrawal by Subject|12|||
150207173|NCT00622700|541898865|FG001|Core Treatment Period|Withdrawal by Subject|18|||
150207174|NCT00622700|541898866|FG002|Core Treatment Period|Withdrawal by Subject|15|||
150207175|NCT00622700|541898867|FG003|Core Treatment Period|Withdrawal by Subject|0|||
150207176|NCT00622700|541898868|FG004|Core Treatment Period|Withdrawal by Subject|0|||
150207177|NCT00622700|541898869|FG005|Core Treatment Period|Withdrawal by Subject|0|||
150207178|NCT00622700|541898870|FG006|Core Treatment Period|Withdrawal by Subject|0|||
150207179|NCT00622700|541898864|FG000|Core Treatment Period|Other than specified above|2|||
150207180|NCT00622700|541898865|FG001|Core Treatment Period|Other than specified above|2|||
150207181|NCT00622700|541898866|FG002|Core Treatment Period|Other than specified above|5|||
150207182|NCT00622700|541898867|FG003|Core Treatment Period|Other than specified above|0|||
150207183|NCT00622700|541898868|FG004|Core Treatment Period|Other than specified above|0|||
150207184|NCT00622700|541898869|FG005|Core Treatment Period|Other than specified above|0|||
150207185|NCT00622700|541898870|FG006|Core Treatment Period|Other than specified above|0|||
150207186|NCT00622700|541898864|FG000|Extension Treatment Period|Adverse Event|0|||
150207187|NCT00622700|541898865|FG001|Extension Treatment Period|Adverse Event|0|||
150207188|NCT00622700|541898866|FG002|Extension Treatment Period|Adverse Event|0|||
150207189|NCT00622700|541898867|FG003|Extension Treatment Period|Adverse Event|5|||
150207190|NCT00622700|541898868|FG004|Extension Treatment Period|Adverse Event|9|||
150207191|NCT00622700|541898869|FG005|Extension Treatment Period|Adverse Event|6|||
150207192|NCT00622700|541898870|FG006|Extension Treatment Period|Adverse Event|8|||
150207193|NCT00622700|541898864|FG000|Extension Treatment Period|Lack of Efficacy|0|||
150207194|NCT00622700|541898865|FG001|Extension Treatment Period|Lack of Efficacy|0|||
150207195|NCT00622700|541898866|FG002|Extension Treatment Period|Lack of Efficacy|0|||
150207196|NCT00622700|541898867|FG003|Extension Treatment Period|Lack of Efficacy|2|||
150207197|NCT00622700|541898868|FG004|Extension Treatment Period|Lack of Efficacy|8|||
150207198|NCT00622700|541898869|FG005|Extension Treatment Period|Lack of Efficacy|1|||
150207199|NCT00622700|541898870|FG006|Extension Treatment Period|Lack of Efficacy|9|||
150207200|NCT00622700|541898864|FG000|Extension Treatment Period|Protocol Violation|0|||
150207201|NCT00622700|541898865|FG001|Extension Treatment Period|Protocol Violation|0|||
150207202|NCT00622700|541898866|FG002|Extension Treatment Period|Protocol Violation|0|||
150207203|NCT00622700|541898867|FG003|Extension Treatment Period|Protocol Violation|0|||
150207204|NCT00622700|541898868|FG004|Extension Treatment Period|Protocol Violation|0|||
150207205|NCT00622700|541898869|FG005|Extension Treatment Period|Protocol Violation|2|||
150207206|NCT00622700|541898870|FG006|Extension Treatment Period|Protocol Violation|0|||
150207207|NCT00622700|541898864|FG000|Extension Treatment Period|Lost to Follow-up|0|||
150207208|NCT00622700|541898865|FG001|Extension Treatment Period|Lost to Follow-up|0|||
150207209|NCT00622700|541898866|FG002|Extension Treatment Period|Lost to Follow-up|0|||
150207210|NCT00622700|541898867|FG003|Extension Treatment Period|Lost to Follow-up|0|||
150207211|NCT00622700|541898868|FG004|Extension Treatment Period|Lost to Follow-up|1|||
150207212|NCT00622700|541898869|FG005|Extension Treatment Period|Lost to Follow-up|0|||
150207213|NCT00622700|541898870|FG006|Extension Treatment Period|Lost to Follow-up|0|||
150207214|NCT00622700|541898864|FG000|Extension Treatment Period|Progressive Disease|0|||
150207215|NCT00622700|541898865|FG001|Extension Treatment Period|Progressive Disease|0|||
150137743|NCT01662063|541638782|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
150137744|NCT01662063|541638780|FG000|Overall Study|Lack of Efficacy|1|||
150137745|NCT01662063|541638781|FG001|Overall Study|Lack of Efficacy|6|||
150137746|NCT01662063|541638782|FG002|Overall Study|Lack of Efficacy|0|||
150137747|NCT01662063|541638780|FG000|Overall Study|Lost to Follow-up|0|||
150137748|NCT01662063|541638781|FG001|Overall Study|Lost to Follow-up|4|||
150137749|NCT01662063|541638782|FG002|Overall Study|Lost to Follow-up|0|||
150137750|NCT01662063|541638780|FG000|Overall Study|Protocol Violation|1|||
150137751|NCT01662063|541638781|FG001|Overall Study|Protocol Violation|0|||
150137752|NCT01662063|541638782|FG002|Overall Study|Protocol Violation|0|||
150137753|NCT01662063|541638780|FG000|Overall Study|Withdrawal by Subject|2|||
150207216|NCT00622700|541898866|FG002|Extension Treatment Period|Progressive Disease|0|||
150207217|NCT00622700|541898867|FG003|Extension Treatment Period|Progressive Disease|1|||
150207218|NCT00622700|541898868|FG004|Extension Treatment Period|Progressive Disease|2|||
150207219|NCT00622700|541898869|FG005|Extension Treatment Period|Progressive Disease|0|||
150207220|NCT00622700|541898870|FG006|Extension Treatment Period|Progressive Disease|2|||
150207221|NCT00622700|541898864|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
150207222|NCT00622700|541898865|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
150207223|NCT00622700|541898866|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
150207224|NCT00622700|541898867|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
150207225|NCT00622700|541898868|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
150207226|NCT00622700|541898869|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
150207227|NCT00622700|541898870|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
150207228|NCT00622700|541898864|FG000|Extension Treatment Period|Missing|0|||
150207229|NCT00622700|541898865|FG001|Extension Treatment Period|Missing|0|||
150207230|NCT00622700|541898866|FG002|Extension Treatment Period|Missing|0|||
150207231|NCT00622700|541898867|FG003|Extension Treatment Period|Missing|2|||
150207232|NCT00622700|541898868|FG004|Extension Treatment Period|Missing|3|||
150207233|NCT00622700|541898869|FG005|Extension Treatment Period|Missing|1|||
150207234|NCT00622700|541898870|FG006|Extension Treatment Period|Missing|0|||
150207235|NCT00622700|541898864|FG000|Extension Treatment Period|Other than specified above|0|||
150207236|NCT00622700|541898865|FG001|Extension Treatment Period|Other than specified above|0|||
150207237|NCT00622700|541898866|FG002|Extension Treatment Period|Other than specified above|0|||
150207238|NCT00622700|541898867|FG003|Extension Treatment Period|Other than specified above|0|||
150207239|NCT00622700|541898868|FG004|Extension Treatment Period|Other than specified above|0|||
150207240|NCT00622700|541898869|FG005|Extension Treatment Period|Other than specified above|1|||
150207241|NCT00622700|541898870|FG006|Extension Treatment Period|Other than specified above|1|||
150207242|NCT00942266|541898871|FG000|Overall Study|Withdrawal by Subject|1|||
150207243|NCT00942266|541898872|FG001|Overall Study|Withdrawal by Subject|0|||
150207244|NCT00942266|541898871|FG000|Overall Study|Adverse Event|2|||
150207245|NCT00942266|541898872|FG001|Overall Study|Adverse Event|1|||
150207246|NCT00942266|541898871|FG000|Overall Study|Disease Progression|38|||
150207247|NCT00942266|541898872|FG001|Overall Study|Disease Progression|11|||
150207248|NCT00942266|541898871|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
150207249|NCT00942266|541898872|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
150207250|NCT00942266|541898871|FG000|Overall Study|Intercurrent illness|0|||
150207251|NCT00942266|541898872|FG001|Overall Study|Intercurrent illness|1|||
150207252|NCT00942266|541898871|FG000|Overall Study|Physician Decision|2|||
150207253|NCT00942266|541898872|FG001|Overall Study|Physician Decision|0|||
150207254|NCT00942266|541898871|FG000|Overall Study|medical deterioration (pneumonia)|0|||
150207255|NCT00942266|541898872|FG001|Overall Study|medical deterioration (pneumonia)|1|||
150207256|NCT03611556|541898873|FG000|Overall Study|Death|7|||
150207257|NCT03611556|541898874|FG001|Overall Study|Death|7|||
150207258|NCT03611556|541898875|FG002|Overall Study|Death|3|||
150207259|NCT03611556|541898876|FG003|Overall Study|Death|8|||
150207260|NCT03611556|541898877|FG004|Overall Study|Death|47|||
150207261|NCT03611556|541898878|FG005|Overall Study|Death|32|||
150207262|NCT03611556|541898879|FG006|Overall Study|Death|53|||
150207263|NCT03611556|541898873|FG000|Overall Study|Withdrawal by Subject|0|||
150207264|NCT03611556|541898874|FG001|Overall Study|Withdrawal by Subject|0|||
150207265|NCT03611556|541898875|FG002|Overall Study|Withdrawal by Subject|0|||
150207266|NCT03611556|541898876|FG003|Overall Study|Withdrawal by Subject|0|||
150207267|NCT03611556|541898877|FG004|Overall Study|Withdrawal by Subject|4|||
150207268|NCT03611556|541898878|FG005|Overall Study|Withdrawal by Subject|2|||
150207269|NCT03611556|541898879|FG006|Overall Study|Withdrawal by Subject|4|||
150207270|NCT03611556|541898873|FG000|Overall Study|Sponsor decision|0|||
150207271|NCT03611556|541898874|FG001|Overall Study|Sponsor decision|0|||
150207272|NCT03611556|541898875|FG002|Overall Study|Sponsor decision|0|||
150207273|NCT03611556|541898876|FG003|Overall Study|Sponsor decision|0|||
150207274|NCT03611556|541898877|FG004|Overall Study|Sponsor decision|9|||
150207275|NCT03611556|541898878|FG005|Overall Study|Sponsor decision|4|||
150207276|NCT03611556|541898879|FG006|Overall Study|Sponsor decision|12|||
150207277|NCT03611556|541898873|FG000|Overall Study|Reasons|0|||
150207278|NCT03611556|541898874|FG001|Overall Study|Reasons|0|||
150207279|NCT03611556|541898875|FG002|Overall Study|Reasons|0|||
150207280|NCT03611556|541898876|FG003|Overall Study|Reasons|0|||
150207281|NCT03611556|541898877|FG004|Overall Study|Reasons|2|||
150207282|NCT03611556|541898878|FG005|Overall Study|Reasons|0|||
150207283|NCT03611556|541898879|FG006|Overall Study|Reasons|1|||
150207284|NCT02646618|541898885|FG000|Overall Study|Lost to Follow-up|10|||
150207285|NCT02646618|541898886|FG001|Overall Study|Lost to Follow-up|14|||
150207286|NCT02844439|541898887|FG000|Overall Study|Withdrawal by Subject|1|||
150207287|NCT02844439|541898887|FG000|Overall Study|Lost to Follow-up|2|||
150207288|NCT02844439|541898887|FG000|Overall Study|Termination by Sponsor|4|||
150207289|NCT02844439|541898887|FG000|Overall Study|Death|28|||
150207290|NCT02844439|541898887|FG000|Overall Study|Other|5|||
150207291|NCT04035447|541898890|FG000|Treatment Period|Lost to Follow-up|6|||
150207292|NCT04035447|541898891|FG001|Treatment Period|Lost to Follow-up|5|||
150207293|NCT04035447|541898890|FG000|Treatment Period|Physician Decision|0|||
150207294|NCT04035447|541898891|FG001|Treatment Period|Physician Decision|2|||
150207295|NCT03473743|541898892|FG000|Overall Study|Withdrawal by Subject|0|||
150207296|NCT03473743|541898893|FG001|Overall Study|Withdrawal by Subject|0|||
150207297|NCT03473743|541898894|FG002|Overall Study|Withdrawal by Subject|0|||
150207298|NCT03473743|541898895|FG003|Overall Study|Withdrawal by Subject|0|||
150207299|NCT03473743|541898896|FG004|Overall Study|Withdrawal by Subject|0|||
150207300|NCT03473743|541898897|FG005|Overall Study|Withdrawal by Subject|0|||
150207301|NCT03473743|541898898|FG006|Overall Study|Withdrawal by Subject|0|||
150207302|NCT03473743|541898899|FG007|Overall Study|Withdrawal by Subject|3|||
150207303|NCT03473743|541898892|FG000|Overall Study|Other|0|||
150207304|NCT03473743|541898893|FG001|Overall Study|Other|0|||
150207305|NCT03473743|541898894|FG002|Overall Study|Other|0|||
150207306|NCT03473743|541898895|FG003|Overall Study|Other|1|||
150207307|NCT03473743|541898896|FG004|Overall Study|Other|0|||
150207308|NCT03473743|541898897|FG005|Overall Study|Other|0|||
150207309|NCT03473743|541898898|FG006|Overall Study|Other|0|||
150207310|NCT03473743|541898899|FG007|Overall Study|Other|0|||
150207311|NCT03473743|541898892|FG000|Overall Study|Ongoing|0|||
150207312|NCT03473743|541898893|FG001|Overall Study|Ongoing|0|||
150207313|NCT03473743|541898894|FG002|Overall Study|Ongoing|6|||
150207314|NCT03473743|541898895|FG003|Overall Study|Ongoing|8|||
150207315|NCT03473743|541898896|FG004|Overall Study|Ongoing|1|||
150207316|NCT03473743|541898897|FG005|Overall Study|Ongoing|1|||
150207317|NCT03473743|541898898|FG006|Overall Study|Ongoing|22|||
150207318|NCT03473743|541898899|FG007|Overall Study|Ongoing|24|||
150207319|NCT03473743|541898892|FG000|Overall Study|Randomized but not treated|0|||
150207320|NCT03473743|541898893|FG001|Overall Study|Randomized but not treated|0|||
150207321|NCT03473743|541898894|FG002|Overall Study|Randomized but not treated|0|||
150207322|NCT03473743|541898895|FG003|Overall Study|Randomized but not treated|0|||
150207323|NCT03473743|541898896|FG004|Overall Study|Randomized but not treated|0|||
150207324|NCT03473743|541898897|FG005|Overall Study|Randomized but not treated|0|||
150207325|NCT03473743|541898898|FG006|Overall Study|Randomized but not treated|1|||
150207326|NCT03473743|541898899|FG007|Overall Study|Randomized but not treated|1|||
150207327|NCT00980954|541898900|FG000|Overall Study|Protocol Violation|9|||
150207328|NCT00980954|541898901|FG001|Overall Study|Protocol Violation|15|||
150207329|NCT03304587|541898905|FG000|Overall Study|Headache after intervention|0|||
150207330|NCT03304587|541898906|FG001|Overall Study|Headache after intervention|1|||
150207331|NCT03304587|541898905|FG000|Overall Study|Withdrawal by Subject|1|||
150207332|NCT03304587|541898906|FG001|Overall Study|Withdrawal by Subject|0|||
150207333|NCT03500549|541898907|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
150207334|NCT03500549|541898908|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
150207335|NCT03500549|541898907|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
150207336|NCT03500549|541898908|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
150207337|NCT02107261|541898911|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
150207338|NCT02107261|541898912|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
150207339|NCT02107261|541898911|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
150207340|NCT02107261|541898912|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
150207341|NCT04337931|541898914|FG000|Overall Study|Death|4|||
150207342|NCT04337931|541898915|FG001|Overall Study|Death|1|||
150207343|NCT04337931|541898916|FG002|Overall Study|Death|7|||
150207344|NCT04337931|541898914|FG000|Overall Study|Withdrawal by Subject|0|||
150207345|NCT04337931|541898915|FG001|Overall Study|Withdrawal by Subject|1|||
150207346|NCT04337931|541898916|FG002|Overall Study|Withdrawal by Subject|0|||
150207347|NCT04337931|541898914|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
150207348|NCT04337931|541898915|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
150207349|NCT04337931|541898916|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
150207350|NCT04337931|541898914|FG000|Overall Study|Study terminated by sponsor|3|||
150207351|NCT04337931|541898915|FG001|Overall Study|Study terminated by sponsor|6|||
150207352|NCT04337931|541898916|FG002|Overall Study|Study terminated by sponsor|2|||
150207353|NCT04337931|541898914|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
150207354|NCT04337931|541898915|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
150207355|NCT04337931|541898916|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
150207356|NCT04337931|541898914|FG000|Overall Study|Colorectal cancer treatment|1|||
150207357|NCT04337931|541898915|FG001|Overall Study|Colorectal cancer treatment|0|||
150207358|NCT04337931|541898916|FG002|Overall Study|Colorectal cancer treatment|0|||
150207359|NCT04337931|541898914|FG000|Overall Study|Participant decision|0|||
150207360|NCT04337931|541898915|FG001|Overall Study|Participant decision|1|||
150207361|NCT04337931|541898916|FG002|Overall Study|Participant decision|0|||
150207362|NCT01738438|541898918|FG000|Overall Study|Disease Progression|32|||
150207363|NCT01738438|541898918|FG000|Overall Study|Adverse Event|3|||
150207364|NCT02928172|541898920|FG000|Overall Study|Device did not record data|1|||
150207365|NCT01532999|541898921|FG000|Overall Study|Lost to Follow-up|14|||
150207366|NCT01532999|541898922|FG001|Overall Study|Lost to Follow-up|8|||
150207367|NCT01532999|541898921|FG000|Overall Study|Physician Decision|1|||
150207368|NCT01532999|541898922|FG001|Overall Study|Physician Decision|2|||
150207369|NCT01532999|541898921|FG000|Overall Study|Withdrawal by Subject|5|||
150207370|NCT01532999|541898922|FG001|Overall Study|Withdrawal by Subject|0|||
150207371|NCT01532999|541898921|FG000|Overall Study|Relocated|2|||
150207372|NCT01532999|541898922|FG001|Overall Study|Relocated|0|||
150207373|NCT01532999|541898921|FG000|Overall Study|should not have been randomized|1|||
150207374|NCT01532999|541898922|FG001|Overall Study|should not have been randomized|0|||
150207375|NCT01532999|541898921|FG000|Overall Study|substantial noncompliance|2|||
150207376|NCT01532999|541898922|FG001|Overall Study|substantial noncompliance|0|||
150207377|NCT01532999|541898921|FG000|Overall Study|no show for week 9 assessments|6|||
150207378|NCT01532999|541898922|FG001|Overall Study|no show for week 9 assessments|4|||
150207379|NCT01532999|541898921|FG000|Overall Study|Adverse Event|0|||
150207380|NCT01532999|541898922|FG001|Overall Study|Adverse Event|1|||
150207381|NCT01532999|541898921|FG000|Overall Study|incarcerated|0|||
150207382|NCT01532999|541898922|FG001|Overall Study|incarcerated|1|||
150207383|NCT01532999|541898921|FG000|Overall Study|New job|0|||
150207384|NCT01532999|541898922|FG001|Overall Study|New job|2|||
150207385|NCT02408887|541898923|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
150207386|NCT02408887|541898924|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
150207387|NCT02408887|541898923|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
150207388|NCT02408887|541898924|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
150207389|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
150207390|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
150207391|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
150207392|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150207393|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
150207394|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
150207395|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
150207396|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
150207397|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
150207398|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
150207399|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
150207400|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
150207401|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
150207402|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
150207403|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
150207404|NCT03333109|541898925|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
150207405|NCT03333109|541898926|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
150207406|NCT03333109|541898927|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
150207407|NCT03333109|541898925|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
150207408|NCT03333109|541898926|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
150207409|NCT03333109|541898927|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
150207410|NCT03333109|541898925|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
150207411|NCT03333109|541898926|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
150207412|NCT03333109|541898927|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
150207413|NCT00701701|541898929|FG000|Overall Study|Withdrawal by Subject|0|||
150207414|NCT00701701|541898930|FG001|Overall Study|Withdrawal by Subject|1|||
150207415|NCT00701701|541898929|FG000|Overall Study|Adverse Event|0|||
150207416|NCT00701701|541898930|FG001|Overall Study|Adverse Event|1|||
150207417|NCT00589875|541898931|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
150207418|NCT00589875|541898931|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
150207419|NCT03280030|541898934|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
150207420|NCT03280030|541898935|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
150207421|NCT03280030|541898936|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
150207422|NCT03280030|541898934|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
150207423|NCT03280030|541898935|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
150207424|NCT03280030|541898936|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
150207425|NCT03280030|541898934|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
150207426|NCT03280030|541898935|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
150207427|NCT03280030|541898936|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
150207428|NCT03280030|541898934|FG000|Part 2 - Efficacy|Adverse Event|0|||
150207429|NCT03280030|541898935|FG001|Part 2 - Efficacy|Adverse Event|4|||
150207430|NCT03280030|541898936|FG002|Part 2 - Efficacy|Adverse Event|6|||
150207431|NCT03280030|541898934|FG000|Part 2 - Efficacy|Death|0|||
150207432|NCT03280030|541898935|FG001|Part 2 - Efficacy|Death|3|||
150207433|NCT03280030|541898936|FG002|Part 2 - Efficacy|Death|0|||
150207434|NCT03280030|541898934|FG000|Part 2 - Efficacy|Physician Decision|0|||
150207435|NCT03280030|541898935|FG001|Part 2 - Efficacy|Physician Decision|10|||
150207436|NCT03280030|541898936|FG002|Part 2 - Efficacy|Physician Decision|16|||
150207437|NCT03280030|541898934|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
150207438|NCT03280030|541898935|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
150207439|NCT03280030|541898936|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
150207440|NCT03280030|541898934|FG000|Part 2 - Efficacy|Progressive disease|0|||
150207441|NCT03280030|541898935|FG001|Part 2 - Efficacy|Progressive disease|7|||
150207442|NCT03280030|541898936|FG002|Part 2 - Efficacy|Progressive disease|5|||
150207443|NCT06191679|541898937|FG000|Baseline|Lost to Follow-up|1|||
150207444|NCT06191679|541898938|FG001|Baseline|Lost to Follow-up|0|||
150207445|NCT06191679|541898939|FG002|Baseline|Lost to Follow-up|1|||
150207446|NCT06191679|541898940|FG003|Baseline|Lost to Follow-up|0|||
150207447|NCT06191679|541898937|FG000|Allocation to Group|Withdrawal by Subject|0|||
150207448|NCT06191679|541898938|FG001|Allocation to Group|Withdrawal by Subject|1|||
150207449|NCT06191679|541898939|FG002|Allocation to Group|Withdrawal by Subject|2|||
150207450|NCT06191679|541898940|FG003|Allocation to Group|Withdrawal by Subject|0|||
150207451|NCT06191679|541898937|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
150207452|NCT06191679|541898938|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
150207453|NCT06191679|541898939|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
150207454|NCT06191679|541898940|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
150207455|NCT06191679|541898937|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
150207456|NCT06191679|541898938|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
150207457|NCT06191679|541898939|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
150207458|NCT06191679|541898940|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
150207459|NCT06191679|541898937|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
150207460|NCT06191679|541898938|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
150207461|NCT06191679|541898939|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
150207462|NCT06191679|541898940|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
150207463|NCT03997474|541898941|FG000|Overall Study|Death|6|||
150207464|NCT03997474|541898942|FG001|Overall Study|Death|2|||
150207465|NCT03997474|541898943|FG002|Overall Study|Death|1|||
150207466|NCT03997474|541898941|FG000|Overall Study|Physician Decision|2|||
150207467|NCT03997474|541898942|FG001|Overall Study|Physician Decision|0|||
150207468|NCT03997474|541898943|FG002|Overall Study|Physician Decision|0|||
150207469|NCT03997474|541898941|FG000|Overall Study|study terminated by sponsor|1|||
150207470|NCT03997474|541898942|FG001|Overall Study|study terminated by sponsor|0|||
150207471|NCT03997474|541898943|FG002|Overall Study|study terminated by sponsor|1|||
150207472|NCT05630833|541898946|FG000|Overall Study|Adverse Event|3|||
150207473|NCT05630833|541898947|FG001|Overall Study|Adverse Event|0|||
150207474|NCT05630833|541898946|FG000|Overall Study|Lack of Efficacy|0|||
150207475|NCT05630833|541898947|FG001|Overall Study|Lack of Efficacy|1|||
150207476|NCT05630833|541898946|FG000|Overall Study|Lost to Follow-up|1|||
150207477|NCT05630833|541898947|FG001|Overall Study|Lost to Follow-up|0|||
150207478|NCT05630833|541898946|FG000|Overall Study|Withdrawal by Subject|3|||
150207479|NCT05630833|541898947|FG001|Overall Study|Withdrawal by Subject|1|||
150207480|NCT03459196|541900733|FG000|Overall Study|Subject didn't receive study catheter|2|||
150207481|NCT01171898|541900736|FG000|Overall Study|Death|0|||
150207482|NCT01171898|541900737|FG001|Overall Study|Death|0|||
150207483|NCT01171898|541900738|FG002|Overall Study|Death|2|||
150207484|NCT01171898|541900739|FG003|Overall Study|Death|0|||
150207485|NCT01171898|541900736|FG000|Overall Study|Lost to Follow-up|0|||
150207486|NCT01171898|541900737|FG001|Overall Study|Lost to Follow-up|1|||
150207487|NCT01171898|541900738|FG002|Overall Study|Lost to Follow-up|1|||
150207488|NCT01171898|541900739|FG003|Overall Study|Lost to Follow-up|1|||
150207489|NCT01171898|541900736|FG000|Overall Study|Withdrawal by Subject|1|||
150207490|NCT01171898|541900737|FG001|Overall Study|Withdrawal by Subject|4|||
150207491|NCT01171898|541900738|FG002|Overall Study|Withdrawal by Subject|6|||
150207492|NCT01171898|541900739|FG003|Overall Study|Withdrawal by Subject|3|||
150207493|NCT01171898|541900736|FG000|Overall Study|Terminated by Sponsor|1|||
150207494|NCT01171898|541900737|FG001|Overall Study|Terminated by Sponsor|0|||
150207495|NCT01171898|541900738|FG002|Overall Study|Terminated by Sponsor|0|||
150207496|NCT01171898|541900739|FG003|Overall Study|Terminated by Sponsor|0|||
150207497|NCT01171898|541900736|FG000|Overall Study|Ongoing|1|||
150207498|NCT01171898|541900737|FG001|Overall Study|Ongoing|9|||
150207499|NCT01171898|541900738|FG002|Overall Study|Ongoing|3|||
150207500|NCT01171898|541900739|FG003|Overall Study|Ongoing|0|||
150207501|NCT01171898|541900736|FG000|Overall Study|Other|1|||
150207502|NCT01171898|541900737|FG001|Overall Study|Other|5|||
150207503|NCT01171898|541900738|FG002|Overall Study|Other|0|||
150207504|NCT01171898|541900739|FG003|Overall Study|Other|2|||
150207505|NCT02932410|541900740|FG000|Overall Study|Death|7|||
150207506|NCT02932410|541900741|FG001|Overall Study|Death|6|||
150207507|NCT02932410|541900742|FG002|Overall Study|Death|0|||
150207508|NCT02932410|541900743|FG003|Overall Study|Death|0|||
150207509|NCT02932410|541900740|FG000|Overall Study|Lost to Follow-up|1|||
150207510|NCT02932410|541900741|FG001|Overall Study|Lost to Follow-up|2|||
150207511|NCT02932410|541900742|FG002|Overall Study|Lost to Follow-up|0|||
150207512|NCT02932410|541900743|FG003|Overall Study|Lost to Follow-up|0|||
150207513|NCT02932410|541900740|FG000|Overall Study|Parent/Subjects decision|6|||
150207514|NCT02932410|541900741|FG001|Overall Study|Parent/Subjects decision|6|||
150207515|NCT02932410|541900742|FG002|Overall Study|Parent/Subjects decision|1|||
150207516|NCT02932410|541900743|FG003|Overall Study|Parent/Subjects decision|0|||
150207517|NCT02932410|541900740|FG000|Overall Study|Physician Decision|0|||
150207518|NCT02932410|541900741|FG001|Overall Study|Physician Decision|1|||
150207519|NCT02932410|541900742|FG002|Overall Study|Physician Decision|0|||
150207520|NCT02932410|541900743|FG003|Overall Study|Physician Decision|0|||
150207521|NCT00048932|541900744|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
150207522|NCT00048932|541900745|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
150207523|NCT00048932|541900746|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
150207524|NCT00048932|541900744|FG000|Double Blind Period (DB)|Adverse Event|51|||
150207525|NCT00048932|541900745|FG001|Double Blind Period (DB)|Adverse Event|19|||
150207526|NCT00048932|541900746|FG002|Double Blind Period (DB)|Adverse Event|0|||
150207527|NCT00048932|541900744|FG000|Double Blind Period (DB)|Death|5|||
150207528|NCT00048932|541900745|FG001|Double Blind Period (DB)|Death|3|||
150207529|NCT00048932|541900746|FG002|Double Blind Period (DB)|Death|0|||
150207530|NCT00048932|541900744|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
150207531|NCT00048932|541900745|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
150207532|NCT00048932|541900746|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
150207533|NCT00048932|541900744|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
150207534|NCT00048932|541900745|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
150207535|NCT00048932|541900746|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
150207536|NCT00048932|541900744|FG000|Double Blind Period (DB)|Relocation|1|||
150207537|NCT00048932|541900745|FG001|Double Blind Period (DB)|Relocation|0|||
150207538|NCT00048932|541900746|FG002|Double Blind Period (DB)|Relocation|0|||
150207539|NCT00048932|541900744|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
150207540|NCT00048932|541900745|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
150207541|NCT00048932|541900746|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
150207542|NCT00048932|541900744|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
150207543|NCT00048932|541900745|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
150207544|NCT00048932|541900746|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
150207545|NCT00048932|541900744|FG000|Double Blind Period (DB)|Pregnancy|1|||
150207546|NCT00048932|541900745|FG001|Double Blind Period (DB)|Pregnancy|0|||
150207547|NCT00048932|541900746|FG002|Double Blind Period (DB)|Pregnancy|0|||
150207548|NCT00048932|541900744|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
150207549|NCT00048932|541900745|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
150207550|NCT00048932|541900746|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
150207551|NCT00048932|541900744|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
150207552|NCT00048932|541900745|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
150207553|NCT00048932|541900746|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
150207554|NCT00048932|541900744|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
150207555|NCT00048932|541900745|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
150207556|NCT00048932|541900746|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
150207557|NCT00048932|541900744|FG000|Open Label Period (OL)|Death|0|||
150207558|NCT00048932|541900745|FG001|Open Label Period (OL)|Death|0|||
150207559|NCT00048932|541900746|FG002|Open Label Period (OL)|Death|25|||
150207560|NCT00048932|541900744|FG000|Open Label Period (OL)|Adverse Event|0|||
150207561|NCT00048932|541900745|FG001|Open Label Period (OL)|Adverse Event|0|||
150207562|NCT00048932|541900746|FG002|Open Label Period (OL)|Adverse Event|103|||
150207563|NCT00048932|541900744|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
150207564|NCT00048932|541900745|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
150207565|NCT00048932|541900746|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
150207566|NCT00048932|541900744|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
150207567|NCT00048932|541900745|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
150207568|NCT00048932|541900746|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
150207569|NCT00048932|541900744|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
150207570|NCT00048932|541900745|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
150207571|NCT00048932|541900746|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
150207572|NCT00048932|541900744|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
150207573|NCT00048932|541900745|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
150207574|NCT00048932|541900746|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
150207575|NCT00048932|541900744|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
150207576|NCT00048932|541900745|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
150207577|NCT00048932|541900746|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
150207578|NCT00048932|541900744|FG000|Open Label Period (OL)|Pregnancy|0|||
150137754|NCT01662063|541638781|FG001|Overall Study|Withdrawal by Subject|4|||
150137755|NCT01662063|541638782|FG002|Overall Study|Withdrawal by Subject|1|||
150137756|NCT01662063|541638780|FG000|Overall Study|Physician Decision|0|||
150137757|NCT01662063|541638781|FG001|Overall Study|Physician Decision|2|||
150137758|NCT01662063|541638782|FG002|Overall Study|Physician Decision|0|||
150137759|NCT01662063|541638780|FG000|Overall Study|Other|0|||
150137760|NCT01662063|541638781|FG001|Overall Study|Other|1|||
150137761|NCT01662063|541638782|FG002|Overall Study|Other|0|||
150207579|NCT00048932|541900745|FG001|Open Label Period (OL)|Pregnancy|0|||
150137762|NCT01477853|541638789|FG000|Phase A|Adverse Event|1|||
150207580|NCT00048932|541900746|FG002|Open Label Period (OL)|Pregnancy|6|||
150207581|NCT00048932|541900744|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
150207582|NCT00048932|541900745|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
150207583|NCT00048932|541900746|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
150207584|NCT00048932|541900744|FG000|Open Label Period (OL)|Investigator Retiring|0|||
150207585|NCT00048932|541900745|FG001|Open Label Period (OL)|Investigator Retiring|0|||
150207586|NCT00048932|541900746|FG002|Open Label Period (OL)|Investigator Retiring|2|||
150207587|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
150207588|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
150207589|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
150207590|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Relocated|0|||
150207591|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Relocated|0|||
150207592|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Relocated|6|||
150207593|NCT00048932|541900744|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
150207594|NCT00048932|541900745|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
150207595|NCT00048932|541900746|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
150207596|NCT00048932|541900744|FG000|Open Label Period (OL)|Site Closure|0|||
150207597|NCT00048932|541900745|FG001|Open Label Period (OL)|Site Closure|0|||
150207598|NCT00048932|541900746|FG002|Open Label Period (OL)|Site Closure|3|||
150207599|NCT00048932|541900744|FG000|Open Label Period (OL)|Trial Terminated|0|||
150207600|NCT00048932|541900745|FG001|Open Label Period (OL)|Trial Terminated|0|||
150207601|NCT00048932|541900746|FG002|Open Label Period (OL)|Trial Terminated|1|||
150207602|NCT00048932|541900744|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
150207603|NCT00048932|541900745|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
150207604|NCT00048932|541900746|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
150207605|NCT00048932|541900744|FG000|Open Label Period (OL)|Patient Decision|0|||
150207606|NCT00048932|541900745|FG001|Open Label Period (OL)|Patient Decision|0|||
150207607|NCT00048932|541900746|FG002|Open Label Period (OL)|Patient Decision|4|||
150207608|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
150207609|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
150207610|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
150207611|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
150207612|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
150207613|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
150207614|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
150207615|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
150207616|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
150207617|NCT00048932|541900744|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
150207618|NCT00048932|541900745|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
150207619|NCT00048932|541900746|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
150207620|NCT00048932|541900744|FG000|Open Label Period (OL)|Investigator Decision|0|||
150207621|NCT00048932|541900745|FG001|Open Label Period (OL)|Investigator Decision|0|||
150137763|NCT01477853|541638790|FG001|Phase A|Adverse Event|2|||
150137764|NCT01477853|541638791|FG002|Phase A|Adverse Event|2|||
150137765|NCT01477853|541638789|FG000|Phase A|Lost to Follow-up|4|||
150137766|NCT01477853|541638790|FG001|Phase A|Lost to Follow-up|3|||
150137767|NCT01477853|541638791|FG002|Phase A|Lost to Follow-up|2|||
150137768|NCT01477853|541638789|FG000|Phase A|Physician Decision|1|||
150137769|NCT01477853|541638790|FG001|Phase A|Physician Decision|0|||
150137770|NCT01477853|541638791|FG002|Phase A|Physician Decision|1|||
150137771|NCT01477853|541638789|FG000|Phase A|Study terminated by sponsor|37|||
150137772|NCT01477853|541638790|FG001|Phase A|Study terminated by sponsor|40|||
150137773|NCT01477853|541638791|FG002|Phase A|Study terminated by sponsor|39|||
150137774|NCT01477853|541638789|FG000|Phase B|Lost to Follow-up|0|||
150137775|NCT01477853|541638790|FG001|Phase B|Lost to Follow-up|1|||
150137776|NCT01477853|541638791|FG002|Phase B|Lost to Follow-up|0|||
150137777|NCT01477853|541638789|FG000|Phase B|Study terminated by sponsor|12|||
150137778|NCT01477853|541638790|FG001|Phase B|Study terminated by sponsor|10|||
150137779|NCT01477853|541638791|FG002|Phase B|Study terminated by sponsor|11|||
150137780|NCT00677352|541638792|FG000|Treatment Phase|Adverse Event|14|||
150137781|NCT00677352|541638793|FG001|Treatment Phase|Adverse Event|22|||
150137782|NCT00677352|541638792|FG000|Treatment Phase|Lack of Efficacy|2|||
150137783|NCT00677352|541638793|FG001|Treatment Phase|Lack of Efficacy|3|||
150137784|NCT00677352|541638792|FG000|Treatment Phase|Lost to Follow-up|0|||
150137785|NCT00677352|541638793|FG001|Treatment Phase|Lost to Follow-up|1|||
150137786|NCT00677352|541638792|FG000|Treatment Phase|Withdrawal by Subject|7|||
150137787|NCT00677352|541638793|FG001|Treatment Phase|Withdrawal by Subject|7|||
150137788|NCT00677352|541638792|FG000|Treatment Phase|Physician Decision|1|||
150137789|NCT00677352|541638793|FG001|Treatment Phase|Physician Decision|0|||
150137790|NCT00677352|541638792|FG000|Treatment Phase|Pregnancy|0|||
150137791|NCT00677352|541638793|FG001|Treatment Phase|Pregnancy|1|||
150137792|NCT00677352|541638792|FG000|Treatment Phase|Protocol Violation|1|||
150137793|NCT00677352|541638793|FG001|Treatment Phase|Protocol Violation|1|||
150137794|NCT00677352|541638792|FG000|Treatment Phase|Transference or work related matter|0|||
150137795|NCT00677352|541638793|FG001|Treatment Phase|Transference or work related matter|5|||
150137796|NCT00677352|541638792|FG000|Treatment Phase|Not treated|0|||
150137797|NCT00677352|541638793|FG001|Treatment Phase|Not treated|2|||
150137798|NCT00677352|541638792|FG000|Tapering Phase|Adverse Event|1|||
150137799|NCT00677352|541638793|FG001|Tapering Phase|Adverse Event|5|||
150137800|NCT00677352|541638792|FG000|Tapering Phase|Withdrawal by Subject|5|||
150137801|NCT00677352|541638793|FG001|Tapering Phase|Withdrawal by Subject|3|||
150137802|NCT00677352|541638792|FG000|Tapering Phase|Pregnancy|0|||
150137803|NCT00677352|541638793|FG001|Tapering Phase|Pregnancy|1|||
150137804|NCT00677352|541638792|FG000|Tapering Phase|Job transfer|0|||
150137805|NCT00677352|541638793|FG001|Tapering Phase|Job transfer|1|||
150137806|NCT01814748|541638794|FG000|Overall Study|Lost to Follow-up|1|||
150137807|NCT01814748|541638795|FG001|Overall Study|Lost to Follow-up|2|||
150137808|NCT01814748|541638794|FG000|Overall Study|Study site terminated by sponsor|1|||
150137809|NCT01814748|541638795|FG001|Overall Study|Study site terminated by sponsor|1|||
150137810|NCT01814748|541638794|FG000|Overall Study|Withdrawal by Subject|6|||
150137811|NCT01814748|541638795|FG001|Overall Study|Withdrawal by Subject|4|||
150137812|NCT02782169|541638802|FG000|Overall Study|Lost to Follow-up|1|||
150137813|NCT02782169|541638803|FG001|Overall Study|Lost to Follow-up|2|||
150137814|NCT04751942|541638804|FG000|Overall Study|Lost to Follow-up|9|||
150137815|NCT04751942|541638805|FG001|Overall Study|Lost to Follow-up|6|||
150137816|NCT00724152|541638815|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
150137817|NCT00724152|541638816|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
150137818|NCT00724152|541638817|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
150137819|NCT00724152|541638815|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
150137820|NCT00724152|541638816|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
150137821|NCT00724152|541638817|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
150137822|NCT00386022|541638818|FG000|Plus Estrogen|Lost to Follow-up|2|||
150137823|NCT00386022|541638819|FG001|Plus Estrogen|Lost to Follow-up|0|||
150137824|NCT00386022|541638818|FG000|Plus Estrogen|Adverse Event|0|||
150137825|NCT00386022|541638819|FG001|Plus Estrogen|Adverse Event|1|||
150137826|NCT03266770|541638822|FG000|Overall Study|Physician Decision|3|||
150137827|NCT03266770|541638822|FG000|Overall Study|Insufficient study supplies|1|||
150137828|NCT03266770|541638822|FG000|Overall Study|Adverse Event|1|||
150137829|NCT02657031|541638826|FG000|Overall Study|Adverse Event|1|||
150137830|NCT02657031|541638827|FG001|Overall Study|Adverse Event|2|||
150137831|NCT03078816|541638828|FG000|Overall Study|Withdrawal by Subject|1|||
150137832|NCT02114151|541638829|FG000|Overall Study|Death|1|||
150137833|NCT02114151|541638829|FG000|Overall Study|Lost to Follow-up|1|||
150137834|NCT02114151|541638829|FG000|Overall Study|Withdrawal by Subject|5|||
150137835|NCT01218126|541638830|FG000|Overall Study|Adverse Event|8|||
150137836|NCT01218126|541638831|FG001|Overall Study|Adverse Event|10|||
150137837|NCT01218126|541638832|FG002|Overall Study|Adverse Event|12|||
150137838|NCT01218126|541638833|FG003|Overall Study|Adverse Event|16|||
150137839|NCT01218126|541638830|FG000|Overall Study|Lack of Efficacy|7|||
150137840|NCT01218126|541638831|FG001|Overall Study|Lack of Efficacy|2|||
150207622|NCT00048932|541900746|FG002|Open Label Period (OL)|Investigator Decision|4|||
150207623|NCT00048932|541900744|FG000|Open Label Period (OL)|Site Staff Issues|0|||
150207624|NCT00048932|541900745|FG001|Open Label Period (OL)|Site Staff Issues|0|||
150207625|NCT00048932|541900746|FG002|Open Label Period (OL)|Site Staff Issues|2|||
150207626|NCT00048932|541900744|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
150207627|NCT00048932|541900745|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
150207628|NCT00048932|541900746|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
150207629|NCT00048932|541900744|FG000|Open Label Period (OL)|Participant Surgery|0|||
150207630|NCT00048932|541900745|FG001|Open Label Period (OL)|Participant Surgery|0|||
150207631|NCT00048932|541900746|FG002|Open Label Period (OL)|Participant Surgery|1|||
150207632|NCT00065182|541900753|FG000|Overall Study|Adverse Event|24|||
150207633|NCT00065182|541900754|FG001|Overall Study|Adverse Event|17|||
150207634|NCT00065182|541900753|FG000|Overall Study|Lost to Follow-up|0|||
150207635|NCT00065182|541900754|FG001|Overall Study|Lost to Follow-up|4|||
150207636|NCT00065182|541900753|FG000|Overall Study|Protocol Violation|3|||
150207637|NCT00065182|541900754|FG001|Overall Study|Protocol Violation|4|||
150207638|NCT00065182|541900753|FG000|Overall Study|Serious adverse events (SAE)|1|||
150207639|NCT00065182|541900754|FG001|Overall Study|Serious adverse events (SAE)|0|||
150207640|NCT00065182|541900753|FG000|Overall Study|Sponsor Decision|11|||
150207641|NCT00065182|541900754|FG001|Overall Study|Sponsor Decision|7|||
150207642|NCT00065182|541900753|FG000|Overall Study|Withdrawal by Subject|8|||
150207643|NCT00065182|541900754|FG001|Overall Study|Withdrawal by Subject|3|||
150207644|NCT00065182|541900753|FG000|Overall Study|No clinical benefit|1|||
150207645|NCT00065182|541900754|FG001|Overall Study|No clinical benefit|0|||
150207646|NCT00065182|541900753|FG000|Overall Study|Death|0|||
150207647|NCT00065182|541900754|FG001|Overall Study|Death|1|||
150207648|NCT00065182|541900753|FG000|Overall Study|Decline in Status|0|||
150207649|NCT00065182|541900754|FG001|Overall Study|Decline in Status|1|||
150207650|NCT02633215|541900755|FG000|Overall Study|Lost to Follow-up|2|||
150207651|NCT02633215|541900756|FG001|Overall Study|Lost to Follow-up|3|||
150207652|NCT00754325|541900757|FG000|Initial Treatment|Continuing Active Treatment|4|||
150207653|NCT00754325|541900758|FG001|Initial Treatment|Continuing Active Treatment|5|||
150207654|NCT00754325|541900757|FG000|Initial Treatment|Adverse Event|7|||
150207655|NCT00754325|541900758|FG001|Initial Treatment|Adverse Event|6|||
150207656|NCT00754325|541900757|FG000|Initial Treatment|Withdrawal by Subject|2|||
150207657|NCT00754325|541900758|FG001|Initial Treatment|Withdrawal by Subject|2|||
150207658|NCT00754325|541900757|FG000|Initial Treatment|Physician Decision|2|||
150207659|NCT00754325|541900758|FG001|Initial Treatment|Physician Decision|0|||
150207660|NCT00754325|541900757|FG000|Initial Treatment|Sponsor Request|0|||
150207661|NCT00754325|541900758|FG001|Initial Treatment|Sponsor Request|1|||
150207662|NCT00754325|541900757|FG000|Initial Treatment|Disease Progression|35|||
150207663|NCT00754325|541900758|FG001|Initial Treatment|Disease Progression|35|||
150207664|NCT03442777|541900759|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
150207665|NCT03442777|541900760|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
150207666|NCT03442777|541900761|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
150207667|NCT03801148|541900762|FG000|Period 1 (2 Days)|Adverse Event|1|||
150207668|NCT03801148|541900763|FG001|Period 1 (2 Days)|Adverse Event|1|||
150207669|NCT03801148|541900764|FG002|Period 1 (2 Days)|Adverse Event|0|||
150207670|NCT03801148|541900765|FG003|Period 1 (2 Days)|Adverse Event|0|||
150207671|NCT03801148|541900762|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
150207672|NCT03801148|541900763|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
150207673|NCT03801148|541900764|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
150207674|NCT03801148|541900765|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
150207675|NCT03801148|541900762|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
150207676|NCT03801148|541900763|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
150207677|NCT03801148|541900764|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
150207678|NCT03801148|541900765|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
150207679|NCT03801148|541900762|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
150207680|NCT03801148|541900763|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
150207681|NCT03801148|541900764|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
150207682|NCT03801148|541900765|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
150207683|NCT00790569|541900766|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
150207684|NCT00790569|541900767|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
150207685|NCT00790569|541900768|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
150207686|NCT00790569|541900766|FG000|End of Treatment (6 Month Interview)|Death|0|||
150207687|NCT00790569|541900767|FG001|End of Treatment (6 Month Interview)|Death|2|||
150207688|NCT00790569|541900768|FG002|End of Treatment (6 Month Interview)|Death|1|||
150207689|NCT00790569|541900766|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
150207690|NCT00790569|541900767|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
150207691|NCT00790569|541900768|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
150207692|NCT00790569|541900766|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
150207693|NCT00790569|541900767|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
150207694|NCT00790569|541900768|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
150207695|NCT00790569|541900766|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
150207696|NCT00790569|541900767|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
150207697|NCT00790569|541900768|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
150207698|NCT00790569|541900766|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
150207699|NCT00790569|541900767|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
150207700|NCT00790569|541900768|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
150207701|NCT01627561|541900769|FG000|Overall Study|Lost to Follow-up|1|||
150207702|NCT01627561|541900770|FG001|Overall Study|Lost to Follow-up|0|||
150207703|NCT01627561|541900769|FG000|Overall Study|Withdrawal by Subject|0|||
150207704|NCT01627561|541900770|FG001|Overall Study|Withdrawal by Subject|1|||
150207705|NCT01627561|541900769|FG000|Overall Study|Migrated/moved from study area|0|||
150207706|NCT01627561|541900770|FG001|Overall Study|Migrated/moved from study area|2|||
150207707|NCT03244800|541900771|FG000|Overall Study|Adverse Event|0|||
150207708|NCT03244800|541900772|FG001|Overall Study|Adverse Event|1|||
150207709|NCT03244800|541900773|FG002|Overall Study|Adverse Event|0|||
150207710|NCT03244800|541900774|FG003|Overall Study|Adverse Event|1|||
150207711|NCT03244800|541900771|FG000|Overall Study|Withdrew treatment|0|||
150207712|NCT03244800|541900772|FG001|Overall Study|Withdrew treatment|0|||
150207713|NCT03244800|541900773|FG002|Overall Study|Withdrew treatment|0|||
150207714|NCT03244800|541900774|FG003|Overall Study|Withdrew treatment|1|||
150207715|NCT00890591|541900782|FG000|Overall Study|Lack of Efficacy|20|||
150207716|NCT02941549|541900783|FG000|Overall Study|Adverse Event|1|||
150207717|NCT02941549|541900784|FG001|Overall Study|Adverse Event|0|||
150207718|NCT02941549|541900785|FG002|Overall Study|Adverse Event|0|||
150207719|NCT02941549|541900783|FG000|Overall Study|Withdrawal by Subject|2|||
150207720|NCT02941549|541900784|FG001|Overall Study|Withdrawal by Subject|1|||
150207721|NCT02941549|541900785|FG002|Overall Study|Withdrawal by Subject|2|||
150207722|NCT03451422|541900791|FG000|Overall Study|Lost to Follow-up|0|||
150207723|NCT03451422|541900792|FG001|Overall Study|Lost to Follow-up|0|||
150207724|NCT03451422|541900793|FG002|Overall Study|Lost to Follow-up|0|||
150207725|NCT03451422|541900794|FG003|Overall Study|Lost to Follow-up|0|||
150207726|NCT03451422|541900795|FG004|Overall Study|Lost to Follow-up|0|||
150207727|NCT03451422|541900796|FG005|Overall Study|Lost to Follow-up|1|||
150207728|NCT03451422|541900791|FG000|Overall Study|Decision by sponsor|1|||
150207729|NCT03451422|541900792|FG001|Overall Study|Decision by sponsor|0|||
150207730|NCT03451422|541900793|FG002|Overall Study|Decision by sponsor|1|||
150207731|NCT03451422|541900794|FG003|Overall Study|Decision by sponsor|0|||
150207732|NCT03451422|541900795|FG004|Overall Study|Decision by sponsor|0|||
150207733|NCT03451422|541900796|FG005|Overall Study|Decision by sponsor|0|||
150207734|NCT03451422|541900791|FG000|Overall Study|Withdrawal by Subject|0|||
150207735|NCT03451422|541900792|FG001|Overall Study|Withdrawal by Subject|0|||
150207736|NCT03451422|541900793|FG002|Overall Study|Withdrawal by Subject|2|||
150207737|NCT03451422|541900794|FG003|Overall Study|Withdrawal by Subject|3|||
150207738|NCT03451422|541900795|FG004|Overall Study|Withdrawal by Subject|2|||
150207739|NCT03451422|541900796|FG005|Overall Study|Withdrawal by Subject|1|||
150207740|NCT04384172|541900798|FG000|Overall Study|Lost to Follow-up|0|||
150207741|NCT04384172|541900799|FG001|Overall Study|Lost to Follow-up|2|||
150207742|NCT04384172|541900798|FG000|Overall Study|Pregnancy|1|||
150207743|NCT04384172|541900799|FG001|Overall Study|Pregnancy|0|||
150207744|NCT04384172|541900798|FG000|Overall Study|Withdrawal by Subject|0|||
150207745|NCT04384172|541900799|FG001|Overall Study|Withdrawal by Subject|1|||
150207746|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
150207747|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
150207748|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207749|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207750|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207751|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
150207752|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
150207753|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207754|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207755|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207756|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207757|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207758|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207759|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
150207760|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207761|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207762|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207763|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207764|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207765|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
150207766|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
150207767|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207768|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207769|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207770|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207771|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207772|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207773|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
150207774|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
150207775|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207776|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207777|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207778|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207779|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207780|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
150207781|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207782|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207783|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207784|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207785|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207786|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207787|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
150207788|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207789|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207790|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207791|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207792|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207793|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
150207794|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
150207795|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207796|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207797|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207798|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207799|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207800|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207801|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
150207802|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207803|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207804|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207805|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207806|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207807|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207808|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
150207809|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207810|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207811|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207812|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207813|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207814|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207815|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
150207816|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
150207817|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
150207818|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
150207819|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207820|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207821|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
150207822|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
150137841|NCT01218126|541638832|FG002|Overall Study|Lack of Efficacy|2|||
150137842|NCT01218126|541638833|FG003|Overall Study|Lack of Efficacy|6|||
150137843|NCT01218126|541638830|FG000|Overall Study|Protocol Violation|5|||
150137844|NCT01218126|541638831|FG001|Overall Study|Protocol Violation|2|||
150137845|NCT01218126|541638832|FG002|Overall Study|Protocol Violation|2|||
150137846|NCT01218126|541638833|FG003|Overall Study|Protocol Violation|3|||
150137847|NCT01218126|541638830|FG000|Overall Study|Protocol-defined stopping criteria|1|||
150137848|NCT01218126|541638831|FG001|Overall Study|Protocol-defined stopping criteria|1|||
150137849|NCT01218126|541638832|FG002|Overall Study|Protocol-defined stopping criteria|0|||
150137850|NCT01218126|541638833|FG003|Overall Study|Protocol-defined stopping criteria|0|||
150137851|NCT01218126|541638830|FG000|Overall Study|Lost to Follow-up|0|||
150137852|NCT01218126|541638831|FG001|Overall Study|Lost to Follow-up|0|||
150137853|NCT01218126|541638832|FG002|Overall Study|Lost to Follow-up|0|||
150137854|NCT01218126|541638833|FG003|Overall Study|Lost to Follow-up|2|||
150137855|NCT01218126|541638830|FG000|Overall Study|Physician Decision|1|||
150137856|NCT01218126|541638831|FG001|Overall Study|Physician Decision|2|||
150137857|NCT01218126|541638832|FG002|Overall Study|Physician Decision|4|||
150137858|NCT01218126|541638833|FG003|Overall Study|Physician Decision|2|||
150137859|NCT01218126|541638830|FG000|Overall Study|Withdrawal by Subject|2|||
150137860|NCT01218126|541638831|FG001|Overall Study|Withdrawal by Subject|5|||
150137861|NCT01218126|541638832|FG002|Overall Study|Withdrawal by Subject|4|||
150137862|NCT01218126|541638833|FG003|Overall Study|Withdrawal by Subject|6|||
150137863|NCT02134587|541638836|FG000|Overall Study|Did not completed all meetings|30|||
150137864|NCT00265889|541638837|FG000|Overall Study|Physician Decision|1|||
150137865|NCT00265889|541638837|FG000|Overall Study|Protocol Violation|1|||
150137866|NCT00265889|541638837|FG000|Overall Study|Insurance denied the request|3|||
150137867|NCT02778100|541638839|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
150137868|NCT02778100|541638840|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
150137869|NCT01515748|541638848|FG000|Overall Study|Withdrawal by Subject|32|||
150137870|NCT01515748|541638849|FG001|Overall Study|Withdrawal by Subject|41|||
150137871|NCT01515748|541638848|FG000|Overall Study|Lost to Follow-up|2|||
150137872|NCT01515748|541638849|FG001|Overall Study|Lost to Follow-up|4|||
150137873|NCT01515748|541638848|FG000|Overall Study|Other than specified above|5|||
150137874|NCT01515748|541638849|FG001|Overall Study|Other than specified above|10|||
150137875|NCT03221387|541638850|FG000|Overall Study|Lost to Follow-up|1|||
150137876|NCT03221387|541638850|FG000|Overall Study|Lung transplant|1|||
150137877|NCT00803452|541638851|FG000|Overall Study|Adverse Event|0|||
150137878|NCT00803452|541638852|FG001|Overall Study|Adverse Event|2|||
150137879|NCT00803452|541638851|FG000|Overall Study|Lost to Follow-up|0|||
150137880|NCT00803452|541638852|FG001|Overall Study|Lost to Follow-up|3|||
150137881|NCT00657618|541638855|FG000|Overall Study|Adverse Event|32|||
150137882|NCT00657618|541638855|FG000|Overall Study|Withdrawal by Subject|8|||
150137883|NCT00657618|541638855|FG000|Overall Study|negative for leishmaniasis|2|||
150137884|NCT00657618|541638855|FG000|Overall Study|didn't start due to schedule conflicts|1|||
150137885|NCT01659151|541638856|FG000|Overall Study|Inadequate TIL growth|1|||
150137886|NCT05774197|541638857|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
150137887|NCT05073133|541638861|FG000|Overall Study|Death|2|||
150137888|NCT05002218|541638865|FG000|Overall Study|Lost to Follow-up|5|||
150137889|NCT05002218|541638866|FG001|Overall Study|Lost to Follow-up|6|||
150137890|NCT04120233|541638867|FG000|Overall Study|Adverse Event|0|||
150137891|NCT04120233|541638868|FG001|Overall Study|Adverse Event|0|||
150137892|NCT04120233|541638869|FG002|Overall Study|Adverse Event|0|||
150137893|NCT04120233|541638870|FG003|Overall Study|Adverse Event|0|||
150137894|NCT04120233|541638871|FG004|Overall Study|Adverse Event|1|||
150137895|NCT04120233|541638872|FG005|Overall Study|Adverse Event|0|||
150207823|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207824|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207825|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207826|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207827|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207828|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207829|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
150207830|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207831|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
150207832|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207833|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207834|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207835|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
150207836|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207837|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207838|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207839|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207840|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207841|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207842|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207843|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
150207844|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
150207845|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207846|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207847|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207848|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207849|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
150207850|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207851|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207852|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207853|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207854|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207855|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207856|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207857|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
150207858|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207859|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207860|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207861|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
150207862|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
150207863|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207864|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207865|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
150207866|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
150207867|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207868|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207869|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207870|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207871|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
150207872|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207873|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207874|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207875|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207876|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207877|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207878|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207879|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
150207880|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
150207881|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207882|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207883|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207884|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207885|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
150207886|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207887|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207888|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207889|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207890|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207891|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207892|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207893|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207894|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
150207895|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207896|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207897|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207898|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207899|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
150207900|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207901|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207902|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207903|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
150207904|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207905|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207906|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207907|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207908|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207909|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207910|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207911|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207912|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207913|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
150207914|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207915|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207916|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207917|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207918|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207919|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207920|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207921|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
150207922|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
150207923|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207924|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207925|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207926|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207927|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
150207928|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207929|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207930|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207931|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207932|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207933|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207934|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207935|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
150207936|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207937|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207938|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207939|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207940|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207941|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
150207942|NCT04033445|541900800|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207943|NCT04033445|541900801|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207944|NCT04033445|541900802|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207945|NCT04033445|541900803|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207946|NCT04033445|541900804|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207947|NCT04033445|541900805|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207948|NCT04033445|541900806|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207949|NCT04033445|541900807|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
150207950|NCT04033445|541900808|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207951|NCT04033445|541900809|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207952|NCT04033445|541900810|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207953|NCT04033445|541900811|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207954|NCT04033445|541900812|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207955|NCT04033445|541900813|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
150207956|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207957|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207958|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207959|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207960|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207961|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207962|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207963|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207964|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
150207965|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
150207966|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
150207967|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
150207968|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
150207969|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
150207970|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207971|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207972|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207973|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207974|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207975|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207976|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207977|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207978|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
150207979|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
150207980|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
150207981|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
150207982|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
150207983|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
150207984|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207985|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207986|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207987|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207988|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207989|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207990|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207991|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207992|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207993|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207994|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
150207995|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
150207996|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
150207997|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
150207998|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150207999|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208000|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208001|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208002|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208003|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208004|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208005|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208006|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208007|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
150208008|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
150208009|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
150208010|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
150208011|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
150208012|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208013|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208014|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208015|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208016|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208017|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208018|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208019|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208020|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
150208021|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
150208022|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
150208023|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
150208024|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
150208025|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
150208026|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208027|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208028|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208029|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208030|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208031|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208032|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208033|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208034|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208035|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208036|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208037|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208038|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
150208039|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
150208040|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208041|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208042|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208043|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208044|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208045|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208046|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208047|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208048|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
150208049|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
150208050|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
150208051|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
150208052|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
150208053|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
150208054|NCT04033445|541900800|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208055|NCT04033445|541900801|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208056|NCT04033445|541900802|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208057|NCT04033445|541900803|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208058|NCT04033445|541900804|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208059|NCT04033445|541900805|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208060|NCT04033445|541900806|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208061|NCT04033445|541900807|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208062|NCT04033445|541900808|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208063|NCT04033445|541900809|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
150208064|NCT04033445|541900810|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208065|NCT04033445|541900811|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
150208066|NCT04033445|541900812|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
150208067|NCT04033445|541900813|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
150208068|NCT00776009|541900814|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
150208069|NCT00776009|541900815|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
150208070|NCT00776009|541900816|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
150208071|NCT00776009|541900817|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
150208072|NCT00776009|541900818|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
150208073|NCT00776009|541900819|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
150208074|NCT00776009|541900814|FG000|Period 1: First Intervention|Protocol Violation|0|||
150208075|NCT00776009|541900815|FG001|Period 1: First Intervention|Protocol Violation|1|||
150208076|NCT00776009|541900816|FG002|Period 1: First Intervention|Protocol Violation|0|||
150208077|NCT00776009|541900817|FG003|Period 1: First Intervention|Protocol Violation|0|||
150208078|NCT00776009|541900818|FG004|Period 1: First Intervention|Protocol Violation|1|||
150208079|NCT00776009|541900819|FG005|Period 1: First Intervention|Protocol Violation|0|||
150208080|NCT00776009|541900814|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
150208081|NCT00776009|541900815|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
150208082|NCT00776009|541900816|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
150208083|NCT00776009|541900817|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
150208084|NCT00776009|541900818|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
150208085|NCT00776009|541900819|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
150208086|NCT00776009|541900814|FG000|Period 2: Second Intervention|Protocol Violation|1|||
150208087|NCT00776009|541900815|FG001|Period 2: Second Intervention|Protocol Violation|0|||
150208088|NCT00776009|541900816|FG002|Period 2: Second Intervention|Protocol Violation|1|||
150208089|NCT00776009|541900817|FG003|Period 2: Second Intervention|Protocol Violation|0|||
150208090|NCT00776009|541900818|FG004|Period 2: Second Intervention|Protocol Violation|0|||
150208091|NCT00776009|541900819|FG005|Period 2: Second Intervention|Protocol Violation|0|||
150208092|NCT00776009|541900814|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
150208093|NCT00776009|541900815|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
150208094|NCT00776009|541900816|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
150208095|NCT00776009|541900817|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
150208096|NCT00776009|541900818|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
150208097|NCT00776009|541900819|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
150208098|NCT01640951|541900820|FG000|Overall Study|Adverse Event|8|||
150208099|NCT01640951|541900821|FG001|Overall Study|Adverse Event|3|||
150208100|NCT01640951|541900822|FG002|Overall Study|Adverse Event|10|||
150208101|NCT01640951|541900823|FG003|Overall Study|Adverse Event|6|||
150208102|NCT01640951|541900824|FG004|Overall Study|Adverse Event|1|||
150208103|NCT01640951|541900825|FG005|Overall Study|Adverse Event|11|||
150208104|NCT01640951|541900826|FG006|Overall Study|Adverse Event|1|||
150208105|NCT01640951|541900827|FG007|Overall Study|Adverse Event|3|||
150208106|NCT01640951|541900820|FG000|Overall Study|Lack of Efficacy|20|||
150208107|NCT01640951|541900821|FG001|Overall Study|Lack of Efficacy|1|||
150208108|NCT01640951|541900822|FG002|Overall Study|Lack of Efficacy|7|||
150208109|NCT01640951|541900823|FG003|Overall Study|Lack of Efficacy|14|||
150208110|NCT01640951|541900824|FG004|Overall Study|Lack of Efficacy|0|||
150208111|NCT01640951|541900825|FG005|Overall Study|Lack of Efficacy|6|||
150208112|NCT01640951|541900826|FG006|Overall Study|Lack of Efficacy|5|||
150208113|NCT01640951|541900827|FG007|Overall Study|Lack of Efficacy|6|||
150208114|NCT01640951|541900820|FG000|Overall Study|Lost to Follow-up|1|||
150208115|NCT01640951|541900821|FG001|Overall Study|Lost to Follow-up|0|||
150208116|NCT01640951|541900822|FG002|Overall Study|Lost to Follow-up|6|||
150208117|NCT01640951|541900823|FG003|Overall Study|Lost to Follow-up|2|||
150208118|NCT01640951|541900824|FG004|Overall Study|Lost to Follow-up|2|||
150208119|NCT01640951|541900825|FG005|Overall Study|Lost to Follow-up|3|||
150208120|NCT01640951|541900826|FG006|Overall Study|Lost to Follow-up|1|||
150208121|NCT01640951|541900827|FG007|Overall Study|Lost to Follow-up|1|||
150208122|NCT01640951|541900820|FG000|Overall Study|Non-compliance with study treatment|0|||
150208123|NCT01640951|541900821|FG001|Overall Study|Non-compliance with study treatment|0|||
150208124|NCT01640951|541900822|FG002|Overall Study|Non-compliance with study treatment|1|||
150208125|NCT01640951|541900823|FG003|Overall Study|Non-compliance with study treatment|1|||
150208126|NCT01640951|541900824|FG004|Overall Study|Non-compliance with study treatment|1|||
150208127|NCT01640951|541900825|FG005|Overall Study|Non-compliance with study treatment|4|||
150208128|NCT01640951|541900826|FG006|Overall Study|Non-compliance with study treatment|1|||
150208129|NCT01640951|541900827|FG007|Overall Study|Non-compliance with study treatment|0|||
150208130|NCT01640951|541900820|FG000|Overall Study|Physician Decision|2|||
150208131|NCT01640951|541900821|FG001|Overall Study|Physician Decision|5|||
150208132|NCT01640951|541900822|FG002|Overall Study|Physician Decision|2|||
150208133|NCT01640951|541900823|FG003|Overall Study|Physician Decision|2|||
150208134|NCT01640951|541900824|FG004|Overall Study|Physician Decision|2|||
150208135|NCT01640951|541900825|FG005|Overall Study|Physician Decision|3|||
150208136|NCT01640951|541900826|FG006|Overall Study|Physician Decision|3|||
150208137|NCT01640951|541900827|FG007|Overall Study|Physician Decision|0|||
150208138|NCT01640951|541900820|FG000|Overall Study|Pregnancy|3|||
150208139|NCT01640951|541900821|FG001|Overall Study|Pregnancy|0|||
150208140|NCT01640951|541900822|FG002|Overall Study|Pregnancy|0|||
150208141|NCT01640951|541900823|FG003|Overall Study|Pregnancy|4|||
150208142|NCT01640951|541900824|FG004|Overall Study|Pregnancy|0|||
150208143|NCT01640951|541900825|FG005|Overall Study|Pregnancy|0|||
150208144|NCT01640951|541900826|FG006|Overall Study|Pregnancy|2|||
150208145|NCT01640951|541900827|FG007|Overall Study|Pregnancy|0|||
150208146|NCT01640951|541900820|FG000|Overall Study|Protocol Deviation|0|||
150208147|NCT01640951|541900821|FG001|Overall Study|Protocol Deviation|1|||
150208148|NCT01640951|541900822|FG002|Overall Study|Protocol Deviation|2|||
150208149|NCT01640951|541900823|FG003|Overall Study|Protocol Deviation|1|||
150208150|NCT01640951|541900824|FG004|Overall Study|Protocol Deviation|0|||
150208151|NCT01640951|541900825|FG005|Overall Study|Protocol Deviation|1|||
150208152|NCT01640951|541900826|FG006|Overall Study|Protocol Deviation|0|||
150208153|NCT01640951|541900827|FG007|Overall Study|Protocol Deviation|0|||
150208154|NCT01640951|541900820|FG000|Overall Study|Subject/Guardian decision|12|||
150208155|NCT01640951|541900821|FG001|Overall Study|Subject/Guardian decision|4|||
150208156|NCT01640951|541900822|FG002|Overall Study|Subject/Guardian decision|13|||
150208157|NCT01640951|541900823|FG003|Overall Study|Subject/Guardian decision|15|||
150208158|NCT01640951|541900824|FG004|Overall Study|Subject/Guardian decision|7|||
150208159|NCT01640951|541900825|FG005|Overall Study|Subject/Guardian decision|19|||
150208160|NCT01640951|541900826|FG006|Overall Study|Subject/Guardian decision|5|||
150208161|NCT01640951|541900827|FG007|Overall Study|Subject/Guardian decision|4|||
150208162|NCT01640951|541900820|FG000|Overall Study|Death|0|||
150208163|NCT01640951|541900821|FG001|Overall Study|Death|1|||
150208164|NCT01640951|541900822|FG002|Overall Study|Death|1|||
150208165|NCT01640951|541900823|FG003|Overall Study|Death|0|||
150208166|NCT01640951|541900824|FG004|Overall Study|Death|0|||
150208167|NCT01640951|541900825|FG005|Overall Study|Death|0|||
150208168|NCT01640951|541900826|FG006|Overall Study|Death|0|||
150208169|NCT01640951|541900827|FG007|Overall Study|Death|2|||
150208170|NCT04949542|541900828|FG000|Overall Study|Lost to Follow-up|4|||
150208171|NCT04949542|541900829|FG001|Overall Study|Lost to Follow-up|1|||
150208172|NCT01536093|541900830|FG000|Overall Study|Death|1|||
150208173|NCT01536093|541900831|FG001|Overall Study|Death|2|||
150208174|NCT01536093|541900830|FG000|Overall Study|absence of maternal colostrum|2|||
150208175|NCT01536093|541900831|FG001|Overall Study|absence of maternal colostrum|0|||
150208176|NCT01536093|541900830|FG000|Overall Study|Withdrawal by Subject|0|||
150208177|NCT01536093|541900831|FG001|Overall Study|Withdrawal by Subject|1|||
150208178|NCT02365597|541900833|FG000|Overall Study|Lost to Follow-up|0|||
150208179|NCT02365597|541900834|FG001|Overall Study|Lost to Follow-up|1|||
150208180|NCT02365597|541900835|FG002|Overall Study|Lost to Follow-up|0|||
150208181|NCT02365597|541900836|FG003|Overall Study|Lost to Follow-up|1|||
150208182|NCT02365597|541900833|FG000|Overall Study|Withdrawal by Subject|1|||
150208183|NCT02365597|541900834|FG001|Overall Study|Withdrawal by Subject|8|||
150208184|NCT02365597|541900835|FG002|Overall Study|Withdrawal by Subject|5|||
150208185|NCT02365597|541900836|FG003|Overall Study|Withdrawal by Subject|1|||
150208186|NCT02365597|541900833|FG000|Overall Study|Sponsor's decision|1|||
150208187|NCT02365597|541900834|FG001|Overall Study|Sponsor's decision|3|||
150208188|NCT02365597|541900835|FG002|Overall Study|Sponsor's decision|13|||
150208189|NCT02365597|541900836|FG003|Overall Study|Sponsor's decision|0|||
150208190|NCT02365597|541900833|FG000|Overall Study|Other|0|||
150208191|NCT02365597|541900834|FG001|Overall Study|Other|4|||
150208192|NCT02365597|541900835|FG002|Overall Study|Other|0|||
150208193|NCT02365597|541900836|FG003|Overall Study|Other|0|||
150208194|NCT02365597|541900833|FG000|Overall Study|Enrolled but not treated|0|||
150208195|NCT02365597|541900834|FG001|Overall Study|Enrolled but not treated|1|||
150208196|NCT02365597|541900835|FG002|Overall Study|Enrolled but not treated|1|||
150208197|NCT02365597|541900836|FG003|Overall Study|Enrolled but not treated|0|||
150208198|NCT02365597|541900833|FG000|Overall Study|Ongoing|0|||
150208199|NCT02365597|541900834|FG001|Overall Study|Ongoing|0|||
150208200|NCT02365597|541900835|FG002|Overall Study|Ongoing|0|||
150208201|NCT02365597|541900836|FG003|Overall Study|Ongoing|17|||
150208202|NCT02275611|541900837|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
150208203|NCT02275611|541900838|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
150208204|NCT02275611|541900839|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
150208205|NCT02275611|541900840|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
150208206|NCT00293397|541900846|FG000|Overall Study|Death|2|||
150208207|NCT01759862|541900847|FG000|Overall Study|Physician Decision|3|||
150208208|NCT01759862|541900848|FG001|Overall Study|Physician Decision|1|||
150208209|NCT01759862|541900847|FG000|Overall Study|Adverse Event|0|||
150208210|NCT01759862|541900848|FG001|Overall Study|Adverse Event|1|||
150208211|NCT01458366|541900852|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
150208212|NCT01458366|541900853|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
150208213|NCT01458366|541900854|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
150208214|NCT01458366|541900855|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
150208215|NCT01458366|541900856|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
150208216|NCT01458366|541900852|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
150208217|NCT01458366|541900853|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
150208218|NCT01458366|541900854|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
150208219|NCT01458366|541900855|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
150208220|NCT01458366|541900856|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
150208221|NCT04647487|541900859|FG000|Overall Study|Protocol Deviation|0|||
150208222|NCT04647487|541900860|FG001|Overall Study|Protocol Deviation|0|||
150208223|NCT04647487|541900861|FG002|Overall Study|Protocol Deviation|1|||
150208224|NCT04647487|541900859|FG000|Overall Study|Withdrawal by Subject|1|||
150208225|NCT04647487|541900860|FG001|Overall Study|Withdrawal by Subject|0|||
150208226|NCT04647487|541900861|FG002|Overall Study|Withdrawal by Subject|2|||
150208227|NCT03466411|541900862|FG000|Overall Study|Lost to Follow-up|0|||
150208228|NCT03466411|541900863|FG001|Overall Study|Lost to Follow-up|1|||
150208229|NCT03466411|541900864|FG002|Overall Study|Lost to Follow-up|1|||
150208230|NCT03466411|541900865|FG003|Overall Study|Lost to Follow-up|0|||
150208231|NCT03466411|541900866|FG004|Overall Study|Lost to Follow-up|0|||
150208232|NCT03466411|541900867|FG005|Overall Study|Lost to Follow-up|0|||
150208233|NCT03466411|541900868|FG006|Overall Study|Lost to Follow-up|1|||
150208234|NCT03466411|541900869|FG007|Overall Study|Lost to Follow-up|1|||
150208235|NCT03466411|541900870|FG008|Overall Study|Lost to Follow-up|0|||
150208236|NCT03466411|541900871|FG009|Overall Study|Lost to Follow-up|1|||
150208237|NCT03466411|541900872|FG010|Overall Study|Lost to Follow-up|1|||
150208238|NCT03466411|541900873|FG011|Overall Study|Lost to Follow-up|1|||
150208239|NCT03466411|541900874|FG012|Overall Study|Lost to Follow-up|0|||
150208240|NCT03466411|541900862|FG000|Overall Study|Withdrawal by Subject|14|||
150208241|NCT03466411|541900863|FG001|Overall Study|Withdrawal by Subject|7|||
150208242|NCT03466411|541900864|FG002|Overall Study|Withdrawal by Subject|8|||
150208243|NCT03466411|541900865|FG003|Overall Study|Withdrawal by Subject|4|||
150208244|NCT03466411|541900866|FG004|Overall Study|Withdrawal by Subject|6|||
150208245|NCT03466411|541900867|FG005|Overall Study|Withdrawal by Subject|3|||
150208246|NCT03466411|541900868|FG006|Overall Study|Withdrawal by Subject|6|||
150208247|NCT03466411|541900869|FG007|Overall Study|Withdrawal by Subject|9|||
150208248|NCT03466411|541900870|FG008|Overall Study|Withdrawal by Subject|6|||
150208249|NCT03466411|541900871|FG009|Overall Study|Withdrawal by Subject|11|||
150208250|NCT03466411|541900872|FG010|Overall Study|Withdrawal by Subject|14|||
150208251|NCT03466411|541900873|FG011|Overall Study|Withdrawal by Subject|12|||
150208252|NCT03466411|541900874|FG012|Overall Study|Withdrawal by Subject|7|||
150208253|NCT03466411|541900862|FG000|Overall Study|Other|1|||
150208254|NCT03466411|541900863|FG001|Overall Study|Other|1|||
150208255|NCT03466411|541900864|FG002|Overall Study|Other|0|||
150208256|NCT03466411|541900865|FG003|Overall Study|Other|1|||
150208257|NCT03466411|541900866|FG004|Overall Study|Other|2|||
150208258|NCT03466411|541900867|FG005|Overall Study|Other|0|||
150208259|NCT03466411|541900868|FG006|Overall Study|Other|0|||
150208260|NCT03466411|541900869|FG007|Overall Study|Other|0|||
150208261|NCT03466411|541900870|FG008|Overall Study|Other|0|||
150208262|NCT03466411|541900871|FG009|Overall Study|Other|1|||
150208263|NCT03466411|541900872|FG010|Overall Study|Other|2|||
150208264|NCT03466411|541900873|FG011|Overall Study|Other|0|||
150208265|NCT03466411|541900874|FG012|Overall Study|Other|0|||
150208266|NCT03466411|541900862|FG000|Overall Study|Randomized but not Treated|0|||
150208267|NCT03466411|541900863|FG001|Overall Study|Randomized but not Treated|0|||
150137896|NCT06223373|541638873|FG000|Overall Study|Lost to Follow-up|1|||
150137897|NCT06223373|541638874|FG001|Overall Study|Lost to Follow-up|2|||
150137898|NCT03764774|541638877|FG000|Overall Study|Withdrawal by Subject|0|||
150137899|NCT03764774|541638878|FG001|Overall Study|Withdrawal by Subject|0|||
150137900|NCT03764774|541638879|FG002|Overall Study|Withdrawal by Subject|0|||
150137901|NCT03764774|541638880|FG003|Overall Study|Withdrawal by Subject|0|||
150137902|NCT03764774|541638881|FG004|Overall Study|Withdrawal by Subject|0|||
150137903|NCT03764774|541638882|FG005|Overall Study|Withdrawal by Subject|0|||
150137904|NCT03764774|541638883|FG006|Overall Study|Withdrawal by Subject|0|||
150137905|NCT03764774|541638884|FG007|Overall Study|Withdrawal by Subject|0|||
150137906|NCT03764774|541638885|FG008|Overall Study|Withdrawal by Subject|0|||
150137907|NCT03764774|541638886|FG009|Overall Study|Withdrawal by Subject|0|||
150137908|NCT03764774|541638887|FG010|Overall Study|Withdrawal by Subject|1|||
150137909|NCT03764774|541638888|FG011|Overall Study|Withdrawal by Subject|0|||
150137910|NCT03764774|541638889|FG012|Overall Study|Withdrawal by Subject|0|||
150137911|NCT03764774|541638890|FG013|Overall Study|Withdrawal by Subject|0|||
150137912|NCT03764774|541638877|FG000|Overall Study|Adverse Event|0|||
150137913|NCT03764774|541638878|FG001|Overall Study|Adverse Event|0|||
150137914|NCT03764774|541638879|FG002|Overall Study|Adverse Event|0|||
150137915|NCT03764774|541638880|FG003|Overall Study|Adverse Event|0|||
150137916|NCT03764774|541638881|FG004|Overall Study|Adverse Event|0|||
150208268|NCT03466411|541900864|FG002|Overall Study|Randomized but not Treated|0|||
150208269|NCT03466411|541900865|FG003|Overall Study|Randomized but not Treated|0|||
150208270|NCT03466411|541900866|FG004|Overall Study|Randomized but not Treated|0|||
150208271|NCT03466411|541900867|FG005|Overall Study|Randomized but not Treated|0|||
150208272|NCT03466411|541900868|FG006|Overall Study|Randomized but not Treated|1|||
150208273|NCT03466411|541900869|FG007|Overall Study|Randomized but not Treated|0|||
150208274|NCT03466411|541900870|FG008|Overall Study|Randomized but not Treated|0|||
150208275|NCT03466411|541900871|FG009|Overall Study|Randomized but not Treated|0|||
150208276|NCT03466411|541900872|FG010|Overall Study|Randomized but not Treated|0|||
150208277|NCT03466411|541900873|FG011|Overall Study|Randomized but not Treated|0|||
150208278|NCT03466411|541900874|FG012|Overall Study|Randomized but not Treated|0|||
150208279|NCT05580003|541900883|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208280|NCT05580003|541900884|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208281|NCT05580003|541900885|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208282|NCT05580003|541900886|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208283|NCT05580003|541900887|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208284|NCT05580003|541900888|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208285|NCT05580003|541900889|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
150208286|NCT05580003|541900890|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208287|NCT05580003|541900891|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208288|NCT05580003|541900892|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208289|NCT05580003|541900893|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208290|NCT05580003|541900894|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208291|NCT05580003|541900895|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208292|NCT05580003|541900896|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208293|NCT05580003|541900897|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208294|NCT05580003|541900898|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208295|NCT05580003|541900899|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208296|NCT05580003|541900900|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208297|NCT05580003|541900901|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208298|NCT05580003|541900902|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208299|NCT05580003|541900903|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208300|NCT05580003|541900904|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208301|NCT05580003|541900905|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208302|NCT05580003|541900906|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208303|NCT05580003|541900907|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208304|NCT05580003|541900908|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208305|NCT05580003|541900909|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208306|NCT05580003|541900910|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
150208307|NCT05580003|541900883|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208308|NCT05580003|541900884|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208309|NCT05580003|541900885|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208310|NCT05580003|541900886|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208311|NCT05580003|541900887|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208312|NCT05580003|541900888|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
150208313|NCT05580003|541900889|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208314|NCT05580003|541900890|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208315|NCT05580003|541900891|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208316|NCT05580003|541900892|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208317|NCT05580003|541900893|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208318|NCT05580003|541900894|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208319|NCT05580003|541900895|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208320|NCT05580003|541900896|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208321|NCT05580003|541900897|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208322|NCT05580003|541900898|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208323|NCT05580003|541900899|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208324|NCT05580003|541900900|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208325|NCT05580003|541900901|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208326|NCT05580003|541900902|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208327|NCT05580003|541900903|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208328|NCT05580003|541900904|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208329|NCT05580003|541900905|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208330|NCT05580003|541900906|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208331|NCT05580003|541900907|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208332|NCT05580003|541900908|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208333|NCT05580003|541900909|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208334|NCT05580003|541900910|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
150208335|NCT05580003|541900883|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208336|NCT05580003|541900884|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208337|NCT05580003|541900885|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208338|NCT05580003|541900886|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
150208339|NCT05580003|541900887|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208340|NCT05580003|541900888|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208341|NCT05580003|541900889|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208342|NCT05580003|541900890|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208343|NCT05580003|541900891|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208344|NCT05580003|541900892|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208345|NCT05580003|541900893|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208346|NCT05580003|541900894|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208347|NCT05580003|541900895|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208348|NCT05580003|541900896|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208349|NCT05580003|541900897|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208350|NCT05580003|541900898|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208351|NCT05580003|541900899|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208352|NCT05580003|541900900|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208353|NCT05580003|541900901|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208354|NCT05580003|541900902|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208355|NCT05580003|541900903|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208356|NCT05580003|541900904|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208357|NCT05580003|541900905|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208358|NCT05580003|541900906|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208359|NCT05580003|541900907|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208360|NCT05580003|541900908|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208361|NCT05580003|541900909|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208362|NCT05580003|541900910|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
150208363|NCT05580003|541900883|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208364|NCT05580003|541900884|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
150208365|NCT05580003|541900885|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208366|NCT05580003|541900886|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208367|NCT05580003|541900887|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208368|NCT05580003|541900888|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208369|NCT05580003|541900889|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208370|NCT05580003|541900890|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208371|NCT05580003|541900891|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208372|NCT05580003|541900892|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208373|NCT05580003|541900893|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208374|NCT05580003|541900894|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208375|NCT05580003|541900895|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208376|NCT05580003|541900896|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208377|NCT05580003|541900897|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208378|NCT05580003|541900898|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208379|NCT05580003|541900899|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208380|NCT05580003|541900900|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208381|NCT05580003|541900901|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208382|NCT05580003|541900902|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208383|NCT05580003|541900903|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208384|NCT05580003|541900904|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208385|NCT05580003|541900905|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208386|NCT05580003|541900906|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208387|NCT05580003|541900907|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208388|NCT05580003|541900908|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208389|NCT05580003|541900909|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208390|NCT05580003|541900910|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
150208391|NCT05580003|541900883|FG000|Part 2 (up to 10 Days)|Other|0|||
150208392|NCT05580003|541900884|FG001|Part 2 (up to 10 Days)|Other|0|||
150208393|NCT05580003|541900885|FG002|Part 2 (up to 10 Days)|Other|0|||
150208394|NCT05580003|541900886|FG003|Part 2 (up to 10 Days)|Other|0|||
150208395|NCT05580003|541900887|FG004|Part 2 (up to 10 Days)|Other|0|||
150208396|NCT05580003|541900888|FG005|Part 2 (up to 10 Days)|Other|0|||
150208397|NCT05580003|541900889|FG006|Part 2 (up to 10 Days)|Other|0|||
150208398|NCT05580003|541900890|FG007|Part 2 (up to 10 Days)|Other|0|||
150208399|NCT05580003|541900891|FG008|Part 2 (up to 10 Days)|Other|0|||
150208400|NCT05580003|541900892|FG009|Part 2 (up to 10 Days)|Other|1|||
150208401|NCT05580003|541900893|FG010|Part 2 (up to 10 Days)|Other|0|||
150208402|NCT05580003|541900894|FG011|Part 2 (up to 10 Days)|Other|0|||
150208403|NCT05580003|541900895|FG012|Part 2 (up to 10 Days)|Other|0|||
150208404|NCT05580003|541900896|FG013|Part 2 (up to 10 Days)|Other|0|||
150208405|NCT05580003|541900897|FG014|Part 2 (up to 10 Days)|Other|0|||
150208406|NCT05580003|541900898|FG015|Part 2 (up to 10 Days)|Other|0|||
150208407|NCT05580003|541900899|FG016|Part 2 (up to 10 Days)|Other|0|||
150208408|NCT05580003|541900900|FG017|Part 2 (up to 10 Days)|Other|0|||
150208409|NCT05580003|541900901|FG018|Part 2 (up to 10 Days)|Other|0|||
150208410|NCT05580003|541900902|FG019|Part 2 (up to 10 Days)|Other|0|||
150208411|NCT05580003|541900903|FG020|Part 2 (up to 10 Days)|Other|0|||
150208412|NCT05580003|541900904|FG021|Part 2 (up to 10 Days)|Other|0|||
150208413|NCT05580003|541900905|FG022|Part 2 (up to 10 Days)|Other|0|||
150208414|NCT05580003|541900906|FG023|Part 2 (up to 10 Days)|Other|0|||
150208415|NCT05580003|541900907|FG024|Part 2 (up to 10 Days)|Other|0|||
150208416|NCT05580003|541900908|FG025|Part 2 (up to 10 Days)|Other|0|||
150208417|NCT05580003|541900909|FG026|Part 2 (up to 10 Days)|Other|0|||
150208418|NCT05580003|541900910|FG027|Part 2 (up to 10 Days)|Other|0|||
150208419|NCT05580003|541900883|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208420|NCT05580003|541900884|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208421|NCT05580003|541900885|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208422|NCT05580003|541900886|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208423|NCT05580003|541900887|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208424|NCT05580003|541900888|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208425|NCT05580003|541900889|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208426|NCT05580003|541900890|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208427|NCT05580003|541900891|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208428|NCT05580003|541900892|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208429|NCT05580003|541900893|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208430|NCT05580003|541900894|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208431|NCT05580003|541900895|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208432|NCT05580003|541900896|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208433|NCT05580003|541900897|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208434|NCT05580003|541900898|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208435|NCT05580003|541900899|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208436|NCT05580003|541900900|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208437|NCT05580003|541900901|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208438|NCT05580003|541900902|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
150208439|NCT05580003|541900903|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208440|NCT05580003|541900904|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208441|NCT05580003|541900905|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208442|NCT05580003|541900906|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208443|NCT05580003|541900907|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208444|NCT05580003|541900908|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208445|NCT05580003|541900909|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208446|NCT05580003|541900910|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
150208447|NCT05580003|541900883|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208448|NCT05580003|541900884|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208449|NCT05580003|541900885|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208450|NCT05580003|541900886|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208451|NCT05580003|541900887|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208452|NCT05580003|541900888|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208453|NCT05580003|541900889|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208454|NCT05580003|541900890|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208455|NCT05580003|541900891|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208456|NCT05580003|541900892|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208457|NCT05580003|541900893|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208458|NCT05580003|541900894|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208459|NCT05580003|541900895|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208460|NCT05580003|541900896|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208461|NCT05580003|541900897|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208462|NCT05580003|541900898|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208463|NCT05580003|541900899|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208464|NCT05580003|541900900|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208465|NCT05580003|541900901|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208466|NCT05580003|541900902|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208467|NCT05580003|541900903|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
150208468|NCT05580003|541900904|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208469|NCT05580003|541900905|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208470|NCT05580003|541900906|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208471|NCT05580003|541900907|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208472|NCT05580003|541900908|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208473|NCT05580003|541900909|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208474|NCT05580003|541900910|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
150208475|NCT05580003|541900883|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208476|NCT05580003|541900884|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208477|NCT05580003|541900885|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208478|NCT05580003|541900886|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208479|NCT05580003|541900887|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208480|NCT05580003|541900888|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208481|NCT05580003|541900889|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208482|NCT05580003|541900890|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208483|NCT05580003|541900891|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208484|NCT05580003|541900892|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208485|NCT05580003|541900893|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208486|NCT05580003|541900894|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208487|NCT05580003|541900895|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208488|NCT05580003|541900896|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208489|NCT05580003|541900897|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208490|NCT05580003|541900898|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208491|NCT05580003|541900899|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208492|NCT05580003|541900900|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208493|NCT05580003|541900901|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208494|NCT05580003|541900902|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208495|NCT05580003|541900903|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208496|NCT05580003|541900904|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
150208497|NCT05580003|541900905|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208498|NCT05580003|541900906|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208499|NCT05580003|541900907|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208500|NCT05580003|541900908|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208501|NCT05580003|541900909|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208502|NCT05580003|541900910|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
150208503|NCT05580003|541900883|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208504|NCT05580003|541900884|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208505|NCT05580003|541900885|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208506|NCT05580003|541900886|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208507|NCT05580003|541900887|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208508|NCT05580003|541900888|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208509|NCT05580003|541900889|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208510|NCT05580003|541900890|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208511|NCT05580003|541900891|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208512|NCT05580003|541900892|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208513|NCT05580003|541900893|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208514|NCT05580003|541900894|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208515|NCT05580003|541900895|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208516|NCT05580003|541900896|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208517|NCT05580003|541900897|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208518|NCT05580003|541900898|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208519|NCT05580003|541900899|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208520|NCT05580003|541900900|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208521|NCT05580003|541900901|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208522|NCT05580003|541900902|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208523|NCT05580003|541900903|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208524|NCT05580003|541900904|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208525|NCT05580003|541900905|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208526|NCT05580003|541900906|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208527|NCT05580003|541900907|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208528|NCT05580003|541900908|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208529|NCT05580003|541900909|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
150208530|NCT05580003|541900910|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
150208531|NCT05580003|541900883|FG000|Part 6 Period 2 (Day 1)|Other|0|||
150208532|NCT05580003|541900884|FG001|Part 6 Period 2 (Day 1)|Other|0|||
150208533|NCT05580003|541900885|FG002|Part 6 Period 2 (Day 1)|Other|0|||
150208534|NCT05580003|541900886|FG003|Part 6 Period 2 (Day 1)|Other|0|||
150208535|NCT05580003|541900887|FG004|Part 6 Period 2 (Day 1)|Other|0|||
150208536|NCT05580003|541900888|FG005|Part 6 Period 2 (Day 1)|Other|0|||
150208537|NCT05580003|541900889|FG006|Part 6 Period 2 (Day 1)|Other|0|||
150208538|NCT05580003|541900890|FG007|Part 6 Period 2 (Day 1)|Other|0|||
150208539|NCT05580003|541900891|FG008|Part 6 Period 2 (Day 1)|Other|0|||
150208540|NCT05580003|541900892|FG009|Part 6 Period 2 (Day 1)|Other|0|||
150208541|NCT05580003|541900893|FG010|Part 6 Period 2 (Day 1)|Other|0|||
150208542|NCT05580003|541900894|FG011|Part 6 Period 2 (Day 1)|Other|0|||
150208543|NCT05580003|541900895|FG012|Part 6 Period 2 (Day 1)|Other|0|||
150208544|NCT05580003|541900896|FG013|Part 6 Period 2 (Day 1)|Other|0|||
150208545|NCT05580003|541900897|FG014|Part 6 Period 2 (Day 1)|Other|0|||
150208546|NCT05580003|541900898|FG015|Part 6 Period 2 (Day 1)|Other|0|||
150208547|NCT05580003|541900899|FG016|Part 6 Period 2 (Day 1)|Other|0|||
150208548|NCT05580003|541900900|FG017|Part 6 Period 2 (Day 1)|Other|0|||
150208549|NCT05580003|541900901|FG018|Part 6 Period 2 (Day 1)|Other|0|||
150208550|NCT05580003|541900902|FG019|Part 6 Period 2 (Day 1)|Other|0|||
150208551|NCT05580003|541900903|FG020|Part 6 Period 2 (Day 1)|Other|0|||
150208552|NCT05580003|541900904|FG021|Part 6 Period 2 (Day 1)|Other|0|||
150208553|NCT05580003|541900905|FG022|Part 6 Period 2 (Day 1)|Other|0|||
150208554|NCT05580003|541900906|FG023|Part 6 Period 2 (Day 1)|Other|0|||
150208555|NCT05580003|541900907|FG024|Part 6 Period 2 (Day 1)|Other|1|||
150208556|NCT05580003|541900908|FG025|Part 6 Period 2 (Day 1)|Other|0|||
150208557|NCT05580003|541900909|FG026|Part 6 Period 2 (Day 1)|Other|0|||
150208558|NCT05580003|541900910|FG027|Part 6 Period 2 (Day 1)|Other|0|||
150208559|NCT01753999|541900911|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
150208560|NCT01753999|541900912|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
150208561|NCT01753999|541900911|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
150208562|NCT01753999|541900912|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
150208563|NCT01753999|541900911|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
150208564|NCT01753999|541900912|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
150208565|NCT01753999|541900911|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
150208566|NCT01753999|541900912|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
150208567|NCT01753999|541900911|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
150208568|NCT01753999|541900912|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
150208569|NCT01753999|541900911|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
150208570|NCT01753999|541900912|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
150208571|NCT00274261|541900917|FG000|Overall Study|Adverse Event|19|||
150208572|NCT00274261|541900918|FG001|Overall Study|Adverse Event|11|||
150208573|NCT00274261|541900917|FG000|Overall Study|Pregnancy|114|||
150208574|NCT00274261|541900918|FG001|Overall Study|Pregnancy|83|||
150208575|NCT00274261|541900917|FG000|Overall Study|Withdrawal by Subject|179|||
150208576|NCT00274261|541900918|FG001|Overall Study|Withdrawal by Subject|126|||
150208577|NCT00274261|541900917|FG000|Overall Study|Protocol Violation|71|||
150208578|NCT00274261|541900918|FG001|Overall Study|Protocol Violation|42|||
150208579|NCT00274261|541900917|FG000|Overall Study|Lost to Follow-up|106|||
150208580|NCT00274261|541900918|FG001|Overall Study|Lost to Follow-up|75|||
150208581|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
150208582|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
150208583|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
150208584|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
150208585|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
150208586|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
150208587|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
150208588|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
150208589|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
150208590|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
150208591|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
150208592|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
150208593|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
150208594|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
150208595|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
150208596|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
150208597|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
150208598|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
150208599|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
150208600|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
150208601|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
150208602|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
150208603|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
150208604|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
150208605|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
150208606|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
150208607|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
150208608|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
150208609|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
150208610|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
150208611|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
150208612|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
150208613|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
150208614|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
150208615|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
150208616|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
150208617|NCT02392234|541900919|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
150208618|NCT02392234|541900920|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
150208619|NCT02392234|541900921|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
150208620|NCT02392234|541900922|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
150208621|NCT02392234|541900923|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
150208622|NCT02392234|541900924|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
150208623|NCT02392234|541900919|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
150208624|NCT02392234|541900920|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
150208625|NCT02392234|541900921|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
150208626|NCT02392234|541900922|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
150208627|NCT02392234|541900923|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
150208628|NCT02392234|541900924|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
150208629|NCT02029235|541900925|FG000|Overall Study|Non-compliance with study meds or diary|4|||
150208630|NCT02029235|541900926|FG001|Overall Study|Non-compliance with study meds or diary|1|||
150208631|NCT01387516|541900927|FG000|Overall Study|Lost to Follow-up|4|||
150208632|NCT01387516|541900928|FG001|Overall Study|Lost to Follow-up|4|||
150208633|NCT01387516|541900929|FG002|Overall Study|Lost to Follow-up|2|||
150208634|NCT01387516|541900930|FG003|Overall Study|Lost to Follow-up|3|||
150208635|NCT01387516|541900927|FG000|Overall Study|Withdrawal by Subject|1|||
150208636|NCT01387516|541900928|FG001|Overall Study|Withdrawal by Subject|1|||
150208637|NCT01387516|541900929|FG002|Overall Study|Withdrawal by Subject|2|||
150208638|NCT01387516|541900930|FG003|Overall Study|Withdrawal by Subject|0|||
150208639|NCT01387516|541900927|FG000|Overall Study|Death|0|||
150208640|NCT01387516|541900928|FG001|Overall Study|Death|0|||
150208641|NCT01387516|541900929|FG002|Overall Study|Death|0|||
150208642|NCT01387516|541900930|FG003|Overall Study|Death|1|||
150208643|NCT03582475|541900931|FG000|Treatment Period|Withdrawal by Subject|0|||
150208644|NCT03582475|541900932|FG001|Treatment Period|Withdrawal by Subject|1|||
150208645|NCT03582475|541900931|FG000|Follow-up Period|Withdrawal by Subject|0|||
150208646|NCT03582475|541900932|FG001|Follow-up Period|Withdrawal by Subject|1|||
150208647|NCT03170648|541900935|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
150208648|NCT03170648|541900935|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
150208649|NCT02052440|541900936|FG000|Overall Study|Withdrawal by Subject|0|||
150208650|NCT02052440|541900937|FG001|Overall Study|Withdrawal by Subject|1|||
150208651|NCT04325828|541900938|FG000|Overall Study|Ongoing|26|||
150208652|NCT05509816|541900939|FG000|Overall Study|Lost to Follow-up|1|||
150208653|NCT04436289|541900940|FG000|Overall Study|Death prior to hospital discharge|8|||
150208654|NCT04436289|541900941|FG001|Overall Study|Death prior to hospital discharge|5|||
150208655|NCT04436289|541900942|FG002|Overall Study|Death prior to hospital discharge|0|||
150208656|NCT04436289|541900943|FG003|Overall Study|Death prior to hospital discharge|1|||
150208657|NCT04436289|541900940|FG000|Overall Study|Withdrawal by Subject|0|||
150208658|NCT04436289|541900941|FG001|Overall Study|Withdrawal by Subject|1|||
150208659|NCT04436289|541900942|FG002|Overall Study|Withdrawal by Subject|4|||
150208660|NCT04436289|541900943|FG003|Overall Study|Withdrawal by Subject|0|||
150208661|NCT04436289|541900940|FG000|Overall Study|Extended hospital stay|0|||
150208662|NCT04436289|541900941|FG001|Overall Study|Extended hospital stay|1|||
150208663|NCT04436289|541900942|FG002|Overall Study|Extended hospital stay|0|||
150208664|NCT04436289|541900943|FG003|Overall Study|Extended hospital stay|0|||
150208665|NCT04436289|541900940|FG000|Overall Study|Lost to Follow-up|0|||
150208666|NCT04436289|541900941|FG001|Overall Study|Lost to Follow-up|4|||
150208667|NCT04436289|541900942|FG002|Overall Study|Lost to Follow-up|1|||
150208668|NCT04436289|541900943|FG003|Overall Study|Lost to Follow-up|3|||
150208669|NCT02130557|541900944|FG000|Overall Study|Withdrawal by Subject|12|||
150208670|NCT02130557|541900945|FG001|Overall Study|Withdrawal by Subject|12|||
150208671|NCT02130557|541900944|FG000|Overall Study|Investigator Request|0|||
150208672|NCT02130557|541900945|FG001|Overall Study|Investigator Request|2|||
150208673|NCT02130557|541900944|FG000|Overall Study|Deceased|14|||
150208674|NCT02130557|541900945|FG001|Overall Study|Deceased|14|||
150208675|NCT02130557|541900944|FG000|Overall Study|Lost to Follow-up|6|||
150208676|NCT02130557|541900945|FG001|Overall Study|Lost to Follow-up|7|||
150208677|NCT02130557|541900944|FG000|Overall Study|Other|2|||
150208678|NCT02130557|541900945|FG001|Overall Study|Other|1|||
150208679|NCT02130557|541900944|FG000|Overall Study|Missing|2|||
150208680|NCT02130557|541900945|FG001|Overall Study|Missing|1|||
150208681|NCT04066075|541900946|FG000|Overall Study|Lost to Follow-up|3|||
150208682|NCT04066075|541900947|FG001|Overall Study|Lost to Follow-up|3|||
150208683|NCT04066075|541900946|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
150208684|NCT04066075|541900947|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
150208685|NCT04066075|541900946|FG000|Overall Study|Withdrawal by Subject|2|||
150208686|NCT04066075|541900947|FG001|Overall Study|Withdrawal by Subject|2|||
150208687|NCT00309166|541900948|FG000|Overall Study|Adverse event, non-fatal|1|||
150208688|NCT00309166|541900949|FG001|Overall Study|Adverse event, non-fatal|0|||
150208689|NCT00309166|541900948|FG000|Overall Study|Withdrawal by Subject|4|||
150208690|NCT00309166|541900949|FG001|Overall Study|Withdrawal by Subject|3|||
150208691|NCT05786612|541900953|FG000|Overall Study|Adverse Event|1|||
150208692|NCT05786612|541900954|FG001|Overall Study|Adverse Event|2|||
150208693|NCT05786612|541900953|FG000|Overall Study|one screening failure|0|||
150208694|NCT05786612|541900954|FG001|Overall Study|one screening failure|2|||
150208695|NCT03277989|541900958|FG000|Overall Study|Lost to Follow-up|6|||
150208696|NCT03277989|541900958|FG000|Overall Study|Adverse Event|6|||
150208697|NCT03277989|541900958|FG000|Overall Study|Withdrawal by Subject|3|||
150208698|NCT03277989|541900958|FG000|Overall Study|Didn't Receive Study Device|7|||
150208699|NCT03277989|541900958|FG000|Overall Study|Site Closure|26|||
150208700|NCT03277989|541900958|FG000|Overall Study|Sponsor Closure|107|||
150208701|NCT03083366|541902304|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
150208702|NCT03083366|541902305|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
150208703|NCT03083366|541902304|FG000|Enrollment Period|Lack of Efficacy|1|||
150208704|NCT03083366|541902305|FG001|Enrollment Period|Lack of Efficacy|0|||
150208705|NCT06056310|541902310|FG000|Overall Study|Other Reasons|2|||
150208706|NCT06056310|541902310|FG000|Overall Study|Sponsor Request|16|||
150208707|NCT02702843|541902312|FG000|Overall Study|Insufficient data to analyze|15|||
150208708|NCT02702843|541902313|FG001|Overall Study|Insufficient data to analyze|23|||
150208709|NCT05802173|541902316|FG000|Overall Study|Withdrawal by Subject|2|||
150208710|NCT05802173|541902317|FG001|Overall Study|Withdrawal by Subject|0|||
150208711|NCT05802173|541902318|FG002|Overall Study|Withdrawal by Subject|0|||
150208712|NCT05802173|541902316|FG000|Overall Study|Protocol Violation|1|||
150208713|NCT05802173|541902317|FG001|Overall Study|Protocol Violation|0|||
150208714|NCT05802173|541902318|FG002|Overall Study|Protocol Violation|0|||
150208715|NCT05802173|541902316|FG000|Overall Study|Lost to Follow-up|0|||
150208716|NCT05802173|541902317|FG001|Overall Study|Lost to Follow-up|6|||
150208717|NCT05802173|541902318|FG002|Overall Study|Lost to Follow-up|4|||
150208718|NCT05802173|541902316|FG000|Overall Study|non-compliance|0|||
150208719|NCT05802173|541902317|FG001|Overall Study|non-compliance|1|||
150208720|NCT05802173|541902318|FG002|Overall Study|non-compliance|0|||
150208721|NCT00360269|541902319|FG000|Overall Study|Lost to Follow-up|7|||
150208722|NCT00360269|541902320|FG001|Overall Study|Lost to Follow-up|9|||
150208723|NCT00360269|541902319|FG000|Overall Study|Physician Decision|1|||
150208724|NCT00360269|541902320|FG001|Overall Study|Physician Decision|2|||
150208725|NCT00360269|541902319|FG000|Overall Study|Adverse Event|1|||
150208726|NCT00360269|541902320|FG001|Overall Study|Adverse Event|0|||
150208727|NCT00360269|541902319|FG000|Overall Study|Withdrawal by Subject|1|||
150208728|NCT00360269|541902320|FG001|Overall Study|Withdrawal by Subject|1|||
150208729|NCT02232737|541902323|FG000|Overall Study|Lost to Follow-up|18|||
150208730|NCT02232737|541902324|FG001|Overall Study|Lost to Follow-up|28|||
150208731|NCT02232737|541902325|FG002|Overall Study|Lost to Follow-up|33|||
150208732|NCT02232737|541902323|FG000|Overall Study|Personal reasons|7|||
150208733|NCT02232737|541902324|FG001|Overall Study|Personal reasons|8|||
150208734|NCT02232737|541902325|FG002|Overall Study|Personal reasons|14|||
150208735|NCT02232737|541902323|FG000|Overall Study|Adverse Event|6|||
150208736|NCT02232737|541902324|FG001|Overall Study|Adverse Event|3|||
150208737|NCT02232737|541902325|FG002|Overall Study|Adverse Event|8|||
150208738|NCT02232737|541902323|FG000|Overall Study|Incarcerated|2|||
150208739|NCT02232737|541902324|FG001|Overall Study|Incarcerated|1|||
150208740|NCT02232737|541902325|FG002|Overall Study|Incarcerated|2|||
150208741|NCT02232737|541902323|FG000|Overall Study|Withdrawal by Subject|0|||
150208742|NCT02232737|541902324|FG001|Overall Study|Withdrawal by Subject|1|||
150208743|NCT02232737|541902325|FG002|Overall Study|Withdrawal by Subject|2|||
150208744|NCT02232737|541902323|FG000|Overall Study|Death|0|||
150208745|NCT02232737|541902324|FG001|Overall Study|Death|1|||
150208746|NCT02232737|541902325|FG002|Overall Study|Death|1|||
150208747|NCT02232737|541902323|FG000|Overall Study|Physician Decision|1|||
150208748|NCT02232737|541902324|FG001|Overall Study|Physician Decision|3|||
150208749|NCT02232737|541902325|FG002|Overall Study|Physician Decision|1|||
150208750|NCT02232737|541902323|FG000|Overall Study|Protocol Violation|1|||
150208751|NCT02232737|541902324|FG001|Overall Study|Protocol Violation|0|||
150208752|NCT02232737|541902325|FG002|Overall Study|Protocol Violation|1|||
150208753|NCT02232737|541902323|FG000|Overall Study|Reason unknown|1|||
150208754|NCT02232737|541902324|FG001|Overall Study|Reason unknown|0|||
150208755|NCT02232737|541902325|FG002|Overall Study|Reason unknown|0|||
150208756|NCT02866942|541902327|FG000|Overall Study|Invalid consent|1|||
150208757|NCT00918333|541902328|FG000|Overall Study|Drug not taken per protocol|1|||
150208758|NCT00918333|541902329|FG001|Overall Study|Drug not taken per protocol|0|||
150208759|NCT00918333|541902328|FG000|Overall Study|Inadequate amount of drugs provided|1|||
150208760|NCT00918333|541902329|FG001|Overall Study|Inadequate amount of drugs provided|4|||
150208761|NCT00918333|541902328|FG000|Overall Study|Ineligible|1|||
150208762|NCT00918333|541902329|FG001|Overall Study|Ineligible|0|||
150208763|NCT00918333|541902328|FG000|Overall Study|Withdrawal by Subject|0|||
150208764|NCT00918333|541902329|FG001|Overall Study|Withdrawal by Subject|1|||
150208765|NCT00263757|541902330|FG000|Overall Study|Withdrawal by Subject|5|||
150208766|NCT00263757|541902331|FG001|Overall Study|Withdrawal by Subject|4|||
150208767|NCT00263757|541902330|FG000|Overall Study|Screen failure|0|||
150208768|NCT00263757|541902331|FG001|Overall Study|Screen failure|1|||
150208769|NCT00263757|541902330|FG000|Overall Study|Adverse Event|3|||
150208770|NCT00263757|541902331|FG001|Overall Study|Adverse Event|3|||
150208771|NCT00713596|541902332|FG000|Overall Study|Study was terminated|2|||
150208772|NCT00713596|541902333|FG001|Overall Study|Study was terminated|3|||
150208773|NCT00713596|541902334|FG002|Overall Study|Study was terminated|2|||
150208774|NCT04545619|541902335|FG000|Overall Study|due to equipment challenges|1|||
150208775|NCT00390884|541902340|FG000|Overall Study|Withdrawal by Subject|2|||
150208776|NCT00390884|541902341|FG001|Overall Study|Withdrawal by Subject|2|||
150208777|NCT00756574|541902342|FG000|Overall Study|Withdrawal by Subject|9|||
150208778|NCT00756574|541902343|FG001|Overall Study|Withdrawal by Subject|7|||
150208779|NCT00756574|541902342|FG000|Overall Study|Lost to Follow-up|4|||
150208780|NCT00756574|541902343|FG001|Overall Study|Lost to Follow-up|4|||
150208781|NCT04622332|541902344|FG000|Overall Study|Withdrawal by Subject|4|||
150208782|NCT04622332|541902345|FG001|Overall Study|Withdrawal by Subject|2|||
150208783|NCT04622332|541902344|FG000|Overall Study|Physician Decision|1|||
150208784|NCT04622332|541902345|FG001|Overall Study|Physician Decision|1|||
150208785|NCT04622332|541902344|FG000|Overall Study|Adverse Event|0|||
150208786|NCT04622332|541902345|FG001|Overall Study|Adverse Event|2|||
150208787|NCT04622332|541902344|FG000|Overall Study|Protocol Violation|0|||
150208788|NCT04622332|541902345|FG001|Overall Study|Protocol Violation|1|||
150208789|NCT05036278|541902346|FG000|Overall Study|Withdrawal by Subject|1|||
150208790|NCT05036278|541902346|FG000|Overall Study|Adverse Event|1|||
150208791|NCT01946204|541902349|FG000|Overall Study|Death|38|||
150208792|NCT01946204|541902350|FG001|Overall Study|Death|59|||
150208793|NCT01946204|541902349|FG000|Overall Study|Withdrawal by Subject|37|||
150208794|NCT01946204|541902350|FG001|Overall Study|Withdrawal by Subject|50|||
150208795|NCT01946204|541902349|FG000|Overall Study|Lost to Follow-up|3|||
150208796|NCT01946204|541902350|FG001|Overall Study|Lost to Follow-up|7|||
150208797|NCT01946204|541902349|FG000|Overall Study|Ongoing|316|||
150208798|NCT01946204|541902350|FG001|Overall Study|Ongoing|687|||
150208799|NCT01946204|541902349|FG000|Overall Study|Other|7|||
150208800|NCT01946204|541902350|FG001|Overall Study|Other|3|||
150208801|NCT02787005|541902351|FG000|Overall Study|Adverse Event|24|||
150208802|NCT02787005|541902352|FG001|Overall Study|Adverse Event|9|||
150208803|NCT02787005|541902353|FG002|Overall Study|Adverse Event|9|||
150208804|NCT02787005|541902354|FG003|Overall Study|Adverse Event|7|||
150208805|NCT02787005|541902355|FG004|Overall Study|Adverse Event|2|||
150208806|NCT02787005|541902351|FG000|Overall Study|Death|100|||
150208807|NCT02787005|541902352|FG001|Overall Study|Death|53|||
150208808|NCT02787005|541902353|FG002|Overall Study|Death|48|||
150208809|NCT02787005|541902354|FG003|Overall Study|Death|69|||
150208810|NCT02787005|541902355|FG004|Overall Study|Death|38|||
150208811|NCT02787005|541902351|FG000|Overall Study|Sponsor Decision|7|||
150208812|NCT02787005|541902352|FG001|Overall Study|Sponsor Decision|4|||
150208813|NCT02787005|541902353|FG002|Overall Study|Sponsor Decision|0|||
150208814|NCT02787005|541902354|FG003|Overall Study|Sponsor Decision|4|||
150208815|NCT02787005|541902355|FG004|Overall Study|Sponsor Decision|5|||
150208816|NCT02787005|541902351|FG000|Overall Study|Withdrawal by Subject|2|||
150208817|NCT02787005|541902352|FG001|Overall Study|Withdrawal by Subject|1|||
150208818|NCT02787005|541902353|FG002|Overall Study|Withdrawal by Subject|1|||
150208819|NCT02787005|541902354|FG003|Overall Study|Withdrawal by Subject|0|||
150208820|NCT02787005|541902355|FG004|Overall Study|Withdrawal by Subject|1|||
150208821|NCT02787005|541902351|FG000|Overall Study|Screen Failure|0|||
150208822|NCT02787005|541902352|FG001|Overall Study|Screen Failure|2|||
150208823|NCT02787005|541902353|FG002|Overall Study|Screen Failure|0|||
150208824|NCT02787005|541902354|FG003|Overall Study|Screen Failure|0|||
150208825|NCT02787005|541902355|FG004|Overall Study|Screen Failure|1|||
150208826|NCT02787005|541902351|FG000|Overall Study|Lost to Follow-up|0|||
150208827|NCT02787005|541902352|FG001|Overall Study|Lost to Follow-up|0|||
150208828|NCT02787005|541902353|FG002|Overall Study|Lost to Follow-up|0|||
150208829|NCT02787005|541902354|FG003|Overall Study|Lost to Follow-up|1|||
150208830|NCT02787005|541902355|FG004|Overall Study|Lost to Follow-up|0|||
150208831|NCT03516812|541902356|FG000|Overall Study|Adverse Event|4|||
150208832|NCT03516812|541902356|FG000|Overall Study|Lack of Efficacy|2|||
150208833|NCT03509909|541902361|FG000|Overall Study|Withdrawal by Subject|16|||
150208834|NCT03509909|541902362|FG001|Overall Study|Withdrawal by Subject|9|||
150208835|NCT03509909|541902361|FG000|Overall Study|Lost to Follow-up|3|||
150208836|NCT03509909|541902362|FG001|Overall Study|Lost to Follow-up|4|||
150208837|NCT03509909|541902361|FG000|Overall Study|Adverse Event|2|||
150208838|NCT03509909|541902362|FG001|Overall Study|Adverse Event|0|||
150208839|NCT03431350|541902363|FG000|Overall Study|ONGOING|0|||
150208840|NCT03431350|541902364|FG001|Overall Study|ONGOING|0|||
150208841|NCT03431350|541902365|FG002|Overall Study|ONGOING|2|||
150208842|NCT03431350|541902366|FG003|Overall Study|ONGOING|0|||
150208843|NCT03431350|541902367|FG004|Overall Study|ONGOING|1|||
150208844|NCT03431350|541902368|FG005|Overall Study|ONGOING|3|||
150208845|NCT03431350|541902369|FG006|Overall Study|ONGOING|0|||
150208846|NCT03431350|541902370|FG007|Overall Study|ONGOING|1|||
150208847|NCT03431350|541902371|FG008|Overall Study|ONGOING|3|||
150208848|NCT03431350|541902372|FG009|Overall Study|ONGOING|4|||
150208849|NCT03431350|541902373|FG010|Overall Study|ONGOING|2|||
150208850|NCT03431350|541902374|FG011|Overall Study|ONGOING|1|||
150208851|NCT03431350|541902363|FG000|Overall Study|Death|6|||
150208852|NCT03431350|541902364|FG001|Overall Study|Death|5|||
150208853|NCT03431350|541902365|FG002|Overall Study|Death|18|||
150208854|NCT03431350|541902366|FG003|Overall Study|Death|7|||
150208855|NCT03431350|541902367|FG004|Overall Study|Death|4|||
150208856|NCT03431350|541902368|FG005|Overall Study|Death|3|||
150208857|NCT03431350|541902369|FG006|Overall Study|Death|2|||
150208858|NCT03431350|541902370|FG007|Overall Study|Death|0|||
150208859|NCT03431350|541902371|FG008|Overall Study|Death|0|||
150208860|NCT03431350|541902372|FG009|Overall Study|Death|0|||
150208861|NCT03431350|541902373|FG010|Overall Study|Death|4|||
150208862|NCT03431350|541902374|FG011|Overall Study|Death|0|||
150208863|NCT03431350|541902363|FG000|Overall Study|Lost to Follow-up|0|||
150208864|NCT03431350|541902364|FG001|Overall Study|Lost to Follow-up|1|||
150208865|NCT03431350|541902365|FG002|Overall Study|Lost to Follow-up|0|||
150208866|NCT03431350|541902366|FG003|Overall Study|Lost to Follow-up|0|||
150208867|NCT03431350|541902367|FG004|Overall Study|Lost to Follow-up|0|||
150208868|NCT03431350|541902368|FG005|Overall Study|Lost to Follow-up|0|||
150208869|NCT03431350|541902369|FG006|Overall Study|Lost to Follow-up|0|||
150208870|NCT03431350|541902370|FG007|Overall Study|Lost to Follow-up|0|||
150208871|NCT03431350|541902371|FG008|Overall Study|Lost to Follow-up|0|||
150208872|NCT03431350|541902372|FG009|Overall Study|Lost to Follow-up|0|||
150208873|NCT03431350|541902373|FG010|Overall Study|Lost to Follow-up|0|||
150208874|NCT03431350|541902374|FG011|Overall Study|Lost to Follow-up|0|||
150208875|NCT03431350|541902363|FG000|Overall Study|Withdrawal by Subject|0|||
150208876|NCT03431350|541902364|FG001|Overall Study|Withdrawal by Subject|0|||
150208877|NCT03431350|541902365|FG002|Overall Study|Withdrawal by Subject|0|||
150208878|NCT03431350|541902366|FG003|Overall Study|Withdrawal by Subject|1|||
150208879|NCT03431350|541902367|FG004|Overall Study|Withdrawal by Subject|1|||
150208880|NCT03431350|541902368|FG005|Overall Study|Withdrawal by Subject|1|||
150208881|NCT03431350|541902369|FG006|Overall Study|Withdrawal by Subject|0|||
150208882|NCT03431350|541902370|FG007|Overall Study|Withdrawal by Subject|0|||
150208883|NCT03431350|541902371|FG008|Overall Study|Withdrawal by Subject|0|||
150208884|NCT03431350|541902372|FG009|Overall Study|Withdrawal by Subject|2|||
150208885|NCT03431350|541902373|FG010|Overall Study|Withdrawal by Subject|0|||
150208886|NCT03431350|541902374|FG011|Overall Study|Withdrawal by Subject|1|||
150208887|NCT03431350|541902363|FG000|Overall Study|Other|0|||
150208888|NCT03431350|541902364|FG001|Overall Study|Other|0|||
150208889|NCT03431350|541902365|FG002|Overall Study|Other|1|||
150208890|NCT03431350|541902366|FG003|Overall Study|Other|3|||
150208891|NCT03431350|541902367|FG004|Overall Study|Other|2|||
150208892|NCT03431350|541902368|FG005|Overall Study|Other|2|||
150208893|NCT03431350|541902369|FG006|Overall Study|Other|4|||
150208894|NCT03431350|541902370|FG007|Overall Study|Other|0|||
150208895|NCT03431350|541902371|FG008|Overall Study|Other|14|||
150208896|NCT03431350|541902372|FG009|Overall Study|Other|11|||
150208897|NCT03431350|541902373|FG010|Overall Study|Other|11|||
150208898|NCT03431350|541902374|FG011|Overall Study|Other|15|||
150208899|NCT04801420|541902383|FG000|Overall Study|Other|1|||
150208900|NCT04801420|541902384|FG001|Overall Study|Other|2|||
150208901|NCT04801420|541902385|FG002|Overall Study|Other|1|||
150208902|NCT04801420|541902383|FG000|Overall Study|Lost to Follow-up|7|||
150208903|NCT04801420|541902384|FG001|Overall Study|Lost to Follow-up|9|||
150208904|NCT04801420|541902385|FG002|Overall Study|Lost to Follow-up|10|||
150208905|NCT04801420|541902383|FG000|Overall Study|Moved from study area|0|||
150208906|NCT04801420|541902384|FG001|Overall Study|Moved from study area|1|||
150208907|NCT04801420|541902385|FG002|Overall Study|Moved from study area|1|||
150208908|NCT04801420|541902383|FG000|Overall Study|Withdrawal by Subject|5|||
150208909|NCT04801420|541902384|FG001|Overall Study|Withdrawal by Subject|1|||
150208910|NCT04801420|541902385|FG002|Overall Study|Withdrawal by Subject|4|||
150208911|NCT04801420|541902383|FG000|Overall Study|Individual stopping criteria reached|0|||
150208912|NCT04801420|541902384|FG001|Overall Study|Individual stopping criteria reached|1|||
150208913|NCT04801420|541902385|FG002|Overall Study|Individual stopping criteria reached|0|||
150208914|NCT04801420|541902383|FG000|Overall Study|Ongoing in the study|195|||
150208915|NCT04801420|541902384|FG001|Overall Study|Ongoing in the study|195|||
150208916|NCT04801420|541902385|FG002|Overall Study|Ongoing in the study|192|||
150208917|NCT03414684|541902386|FG000|First-course Treatment|Complete response|0|||
150208918|NCT03414684|541902387|FG001|First-course Treatment|Complete response|1|||
150208919|NCT03414684|541902386|FG000|First-course Treatment|Intercurrent illness|1|||
150208920|NCT03414684|541902387|FG001|First-course Treatment|Intercurrent illness|0|||
150208921|NCT03414684|541902386|FG000|First-course Treatment|Progressive Disease|31|||
150208922|NCT03414684|541902387|FG001|First-course Treatment|Progressive Disease|32|||
150208923|NCT03414684|541902386|FG000|First-course Treatment|Adverse Event|1|||
150208924|NCT03414684|541902387|FG001|First-course Treatment|Adverse Event|2|||
150208925|NCT03414684|541902386|FG000|First-course Treatment|Physician Decision|0|||
150208926|NCT03414684|541902387|FG001|First-course Treatment|Physician Decision|1|||
150208927|NCT03414684|541902386|FG000|First-course Treatment|Withdrawal by Subject|0|||
150208928|NCT03414684|541902387|FG001|First-course Treatment|Withdrawal by Subject|1|||
150208929|NCT03414684|541902386|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
150208930|NCT03414684|541902387|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
150208931|NCT03414684|541902386|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
150208932|NCT03414684|541902387|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
150208933|NCT03414684|541902386|FG000|First-course Treatment|Still on treatment|3|||
150208934|NCT03414684|541902387|FG001|First-course Treatment|Still on treatment|0|||
150208935|NCT03414684|541902386|FG000|First-course Treatment|Never started protocol therapy|2|||
150208936|NCT03414684|541902387|FG001|First-course Treatment|Never started protocol therapy|1|||
150208937|NCT03414684|541902386|FG000|Crossover Treatment|Progressive disease|0|||
150208938|NCT03414684|541902387|FG001|Crossover Treatment|Progressive disease|12|||
150208939|NCT03414684|541902386|FG000|Crossover Treatment|Adverse Event|0|||
150208940|NCT03414684|541902387|FG001|Crossover Treatment|Adverse Event|3|||
150208941|NCT03414684|541902386|FG000|Crossover Treatment|Physician Decision|0|||
150208942|NCT03414684|541902387|FG001|Crossover Treatment|Physician Decision|1|||
150208943|NCT03414684|541902386|FG000|Crossover Treatment|Still on treatment|0|||
150208944|NCT03414684|541902387|FG001|Crossover Treatment|Still on treatment|2|||
150208945|NCT02078648|541902388|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
150208946|NCT02078648|541902389|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
150208947|NCT02078648|541902388|FG000|Overall Study|Adverse Event|0|||
150208948|NCT02078648|541902389|FG001|Overall Study|Adverse Event|1|||
150208949|NCT02078648|541902388|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
150208950|NCT02078648|541902389|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
150208951|NCT02078648|541902388|FG000|Overall Study|Withdrawal by Subject|3|||
150208952|NCT02078648|541902389|FG001|Overall Study|Withdrawal by Subject|1|||
150208953|NCT02078648|541902388|FG000|Overall Study|Investigator Decision|5|||
150208954|NCT02078648|541902389|FG001|Overall Study|Investigator Decision|7|||
150208955|NCT02078648|541902388|FG000|Overall Study|Death|1|||
150208956|NCT02078648|541902389|FG001|Overall Study|Death|1|||
150208957|NCT02078648|541902388|FG000|Overall Study|Undefined|0|||
150208958|NCT02078648|541902389|FG001|Overall Study|Undefined|1|||
150208959|NCT04088227|541902390|FG000|Overall Study|Withdrawal by Subject|1|||
150208960|NCT04088227|541902391|FG001|Overall Study|Withdrawal by Subject|0|||
150208961|NCT04088227|541902390|FG000|Overall Study|Surgery postponed >5weeks|1|||
150208962|NCT04088227|541902391|FG001|Overall Study|Surgery postponed >5weeks|0|||
150208963|NCT01675492|541902392|FG000|Overall Study|study completed early - product approval|42|||
150208964|NCT03160885|541902393|FG000|Initial Treatment Period|Not dosed|2|||
150208965|NCT03160885|541902394|FG001|Initial Treatment Period|Not dosed|0|||
150208966|NCT03160885|541902395|FG002|Initial Treatment Period|Not dosed|0|||
150208967|NCT03160885|541902396|FG003|Initial Treatment Period|Not dosed|0|||
150208968|NCT03160885|541902397|FG004|Initial Treatment Period|Not dosed|0|||
150208969|NCT03160885|541902398|FG005|Initial Treatment Period|Not dosed|0|||
150208970|NCT03160885|541902399|FG006|Initial Treatment Period|Not dosed|0|||
150208971|NCT03160885|541902393|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
150208972|NCT03160885|541902394|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
150208973|NCT03160885|541902395|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150208974|NCT03160885|541902396|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150208975|NCT03160885|541902397|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150208976|NCT03160885|541902398|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150208977|NCT03160885|541902399|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
150208978|NCT03160885|541902393|FG000|Open-label Treatment|Not dosed|0|||
150208979|NCT03160885|541902394|FG001|Open-label Treatment|Not dosed|0|||
150208980|NCT03160885|541902395|FG002|Open-label Treatment|Not dosed|0|||
150208981|NCT03160885|541902396|FG003|Open-label Treatment|Not dosed|0|||
150208982|NCT03160885|541902397|FG004|Open-label Treatment|Not dosed|0|||
150208983|NCT03160885|541902398|FG005|Open-label Treatment|Not dosed|0|||
150208984|NCT03160885|541902399|FG006|Open-label Treatment|Not dosed|2|||
150208985|NCT03160885|541902393|FG000|Open-label Treatment|Discontinued IMP|0|||
150208986|NCT03160885|541902394|FG001|Open-label Treatment|Discontinued IMP|0|||
150208987|NCT03160885|541902395|FG002|Open-label Treatment|Discontinued IMP|0|||
150208988|NCT03160885|541902396|FG003|Open-label Treatment|Discontinued IMP|0|||
150208989|NCT03160885|541902397|FG004|Open-label Treatment|Discontinued IMP|0|||
150208990|NCT03160885|541902398|FG005|Open-label Treatment|Discontinued IMP|0|||
150208991|NCT03160885|541902399|FG006|Open-label Treatment|Discontinued IMP|131|||
150208992|NCT03160885|541902393|FG000|Open-label Treatment|Completed Week 50|0|||
150208993|NCT03160885|541902394|FG001|Open-label Treatment|Completed Week 50|0|||
150208994|NCT03160885|541902395|FG002|Open-label Treatment|Completed Week 50|0|||
150208995|NCT03160885|541902396|FG003|Open-label Treatment|Completed Week 50|0|||
150208996|NCT03160885|541902397|FG004|Open-label Treatment|Completed Week 50|0|||
150208997|NCT03160885|541902398|FG005|Open-label Treatment|Completed Week 50|0|||
150208998|NCT03160885|541902399|FG006|Open-label Treatment|Completed Week 50|4|||
150208999|NCT03160885|541902393|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209000|NCT03160885|541902394|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209001|NCT03160885|541902395|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209002|NCT03160885|541902396|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
150209003|NCT03160885|541902397|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209004|NCT03160885|541902398|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209005|NCT03160885|541902399|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
150209006|NCT03160885|541902393|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
150209007|NCT03160885|541902394|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
150209008|NCT03160885|541902395|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
150209009|NCT03160885|541902396|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
150209010|NCT03160885|541902397|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
150209011|NCT03160885|541902398|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
150209012|NCT03160885|541902399|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
150209013|NCT03160885|541902393|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150209014|NCT03160885|541902394|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150209015|NCT03160885|541902395|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
150209016|NCT03160885|541902396|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
150209017|NCT03160885|541902397|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
150209018|NCT03160885|541902398|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
150209019|NCT03160885|541902399|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
150209020|NCT03160885|541902393|FG000|Maintenance Treatment Period|Completed Week 50|0|||
150209021|NCT03160885|541902394|FG001|Maintenance Treatment Period|Completed Week 50|0|||
150209022|NCT03160885|541902395|FG002|Maintenance Treatment Period|Completed Week 50|1|||
150209023|NCT03160885|541902396|FG003|Maintenance Treatment Period|Completed Week 50|0|||
150209024|NCT03160885|541902397|FG004|Maintenance Treatment Period|Completed Week 50|0|||
150209025|NCT03160885|541902398|FG005|Maintenance Treatment Period|Completed Week 50|0|||
150209026|NCT03160885|541902399|FG006|Maintenance Treatment Period|Completed Week 50|0|||
150209027|NCT02307682|541902400|FG000|Overall Study|Adverse Event|9|||
150209028|NCT02307682|541902401|FG001|Overall Study|Adverse Event|8|||
150209029|NCT02307682|541902402|FG002|Overall Study|Adverse Event|12|||
150209030|NCT02307682|541902400|FG000|Overall Study|Lack of Efficacy|1|||
150209031|NCT02307682|541902401|FG001|Overall Study|Lack of Efficacy|0|||
150209032|NCT02307682|541902402|FG002|Overall Study|Lack of Efficacy|1|||
150209033|NCT02307682|541902400|FG000|Overall Study|Physician Decision|2|||
150209034|NCT02307682|541902401|FG001|Overall Study|Physician Decision|2|||
150209035|NCT02307682|541902402|FG002|Overall Study|Physician Decision|8|||
150209036|NCT02307682|541902400|FG000|Overall Study|Progressive Disease|1|||
150209037|NCT02307682|541902401|FG001|Overall Study|Progressive Disease|0|||
150209038|NCT02307682|541902402|FG002|Overall Study|Progressive Disease|0|||
150209039|NCT02307682|541902400|FG000|Overall Study|Withdrawal by Subject|26|||
150209040|NCT02307682|541902401|FG001|Overall Study|Withdrawal by Subject|34|||
150209041|NCT02307682|541902402|FG002|Overall Study|Withdrawal by Subject|23|||
150209042|NCT02307682|541902400|FG000|Overall Study|Death|9|||
150209043|NCT02307682|541902401|FG001|Overall Study|Death|7|||
150209044|NCT02307682|541902402|FG002|Overall Study|Death|12|||
150209045|NCT02307682|541902400|FG000|Overall Study|Lost to Follow-up|1|||
150209046|NCT02307682|541902401|FG001|Overall Study|Lost to Follow-up|5|||
150209047|NCT02307682|541902402|FG002|Overall Study|Lost to Follow-up|6|||
150209048|NCT02307682|541902400|FG000|Overall Study|Protocol Deviation|0|||
150209049|NCT02307682|541902401|FG001|Overall Study|Protocol Deviation|0|||
150209050|NCT02307682|541902402|FG002|Overall Study|Protocol Deviation|2|||
150209051|NCT02307682|541902400|FG000|Overall Study|Other|1|||
150137917|NCT03764774|541638882|FG005|Overall Study|Adverse Event|0|||
150137918|NCT03764774|541638883|FG006|Overall Study|Adverse Event|0|||
150137919|NCT03764774|541638884|FG007|Overall Study|Adverse Event|0|||
150137920|NCT03764774|541638885|FG008|Overall Study|Adverse Event|0|||
150137921|NCT03764774|541638886|FG009|Overall Study|Adverse Event|0|||
150137922|NCT03764774|541638887|FG010|Overall Study|Adverse Event|0|||
150137923|NCT03764774|541638888|FG011|Overall Study|Adverse Event|0|||
150137924|NCT03764774|541638889|FG012|Overall Study|Adverse Event|2|||
150137925|NCT03764774|541638890|FG013|Overall Study|Adverse Event|0|||
150137926|NCT03764774|541638877|FG000|Overall Study|Lost to Follow-up|0|||
150137927|NCT03764774|541638878|FG001|Overall Study|Lost to Follow-up|0|||
150137928|NCT03764774|541638879|FG002|Overall Study|Lost to Follow-up|0|||
150137929|NCT03764774|541638880|FG003|Overall Study|Lost to Follow-up|0|||
150137930|NCT03764774|541638881|FG004|Overall Study|Lost to Follow-up|0|||
150137931|NCT03764774|541638882|FG005|Overall Study|Lost to Follow-up|0|||
150137932|NCT03764774|541638883|FG006|Overall Study|Lost to Follow-up|0|||
150137933|NCT03764774|541638884|FG007|Overall Study|Lost to Follow-up|0|||
150137934|NCT03764774|541638885|FG008|Overall Study|Lost to Follow-up|0|||
150137935|NCT03764774|541638886|FG009|Overall Study|Lost to Follow-up|0|||
150137936|NCT03764774|541638887|FG010|Overall Study|Lost to Follow-up|0|||
150137937|NCT03764774|541638888|FG011|Overall Study|Lost to Follow-up|0|||
150137938|NCT03764774|541638889|FG012|Overall Study|Lost to Follow-up|0|||
150137939|NCT03764774|541638890|FG013|Overall Study|Lost to Follow-up|1|||
150137940|NCT03764774|541638877|FG000|Overall Study|Physician Decision|0|||
150137941|NCT03764774|541638878|FG001|Overall Study|Physician Decision|0|||
150137942|NCT03764774|541638879|FG002|Overall Study|Physician Decision|0|||
150137943|NCT03764774|541638880|FG003|Overall Study|Physician Decision|0|||
150137944|NCT03764774|541638881|FG004|Overall Study|Physician Decision|0|||
150137945|NCT03764774|541638882|FG005|Overall Study|Physician Decision|0|||
150137946|NCT03764774|541638883|FG006|Overall Study|Physician Decision|0|||
150137947|NCT03764774|541638884|FG007|Overall Study|Physician Decision|0|||
150137948|NCT03764774|541638885|FG008|Overall Study|Physician Decision|0|||
150137949|NCT03764774|541638886|FG009|Overall Study|Physician Decision|4|||
150137950|NCT03764774|541638887|FG010|Overall Study|Physician Decision|1|||
150137951|NCT03764774|541638888|FG011|Overall Study|Physician Decision|4|||
150137952|NCT03764774|541638889|FG012|Overall Study|Physician Decision|9|||
150137953|NCT03764774|541638890|FG013|Overall Study|Physician Decision|0|||
150137954|NCT03764774|541638877|FG000|Overall Study|Study Termination|0|||
150137955|NCT03764774|541638878|FG001|Overall Study|Study Termination|0|||
150137956|NCT03764774|541638879|FG002|Overall Study|Study Termination|0|||
150137957|NCT03764774|541638880|FG003|Overall Study|Study Termination|0|||
150137958|NCT03764774|541638881|FG004|Overall Study|Study Termination|0|||
150137959|NCT03764774|541638882|FG005|Overall Study|Study Termination|0|||
150137960|NCT03764774|541638883|FG006|Overall Study|Study Termination|0|||
150137961|NCT03764774|541638884|FG007|Overall Study|Study Termination|0|||
150137962|NCT03764774|541638885|FG008|Overall Study|Study Termination|0|||
150137963|NCT03764774|541638886|FG009|Overall Study|Study Termination|1|||
150137964|NCT03764774|541638887|FG010|Overall Study|Study Termination|0|||
150137965|NCT03764774|541638888|FG011|Overall Study|Study Termination|0|||
150137966|NCT03764774|541638889|FG012|Overall Study|Study Termination|0|||
150137967|NCT03764774|541638890|FG013|Overall Study|Study Termination|2|||
150137968|NCT04922554|541638891|FG000|Overall Study|Adverse Event|4|||
150137969|NCT04922554|541638892|FG001|Overall Study|Adverse Event|0|||
150137970|NCT04922554|541638891|FG000|Overall Study|Withdrawal by Subject|1|||
150137971|NCT04922554|541638892|FG001|Overall Study|Withdrawal by Subject|0|||
150137972|NCT01345630|541640240|FG000|Overall Study|Adverse Event|22|||
150137973|NCT01345630|541640241|FG001|Overall Study|Adverse Event|23|||
150137974|NCT01345630|541640240|FG000|Overall Study|Lost to Follow-up|17|||
150137975|NCT01345630|541640241|FG001|Overall Study|Lost to Follow-up|16|||
150137976|NCT01345630|541640240|FG000|Overall Study|Protocol Violation|4|||
150137977|NCT01345630|541640241|FG001|Overall Study|Protocol Violation|1|||
150137978|NCT01345630|541640240|FG000|Overall Study|Medication error without associated AE|0|||
150137979|NCT01345630|541640241|FG001|Overall Study|Medication error without associated AE|1|||
150137980|NCT01345630|541640240|FG000|Overall Study|Study terminated by sponsor|254|||
150137981|NCT01345630|541640241|FG001|Overall Study|Study terminated by sponsor|285|||
150137982|NCT01345630|541640240|FG000|Overall Study|Other reasons|6|||
150137983|NCT01345630|541640241|FG001|Overall Study|Other reasons|8|||
150137984|NCT01345630|541640240|FG000|Overall Study|Withdrawn due to pregnancy|1|||
150137985|NCT01345630|541640241|FG001|Overall Study|Withdrawn due to pregnancy|2|||
150137986|NCT01345630|541640240|FG000|Overall Study|No longer willing to participate|9|||
150137987|NCT01345630|541640241|FG001|Overall Study|No longer willing to participate|12|||
150137988|NCT01345630|541640240|FG000|Overall Study|Insufficient clinical response|48|||
150209052|NCT02307682|541902401|FG001|Overall Study|Other|1|||
150209053|NCT02307682|541902402|FG002|Overall Study|Other|0|||
150209054|NCT04306367|541902404|FG000|Overall Study|Progression of Disease|9|||
150209055|NCT04306367|541902404|FG000|Overall Study|Adverse Event|3|||
150209056|NCT04306367|541902404|FG000|Overall Study|Withdrawal by Subject|1|||
150209057|NCT02751528|541902405|FG000|Overall Study|Withdrawal by Subject|1|||
150209058|NCT02751528|541902405|FG000|Overall Study|Adverse Event|1|||
150209059|NCT05485805|541902406|FG000|Overall Study|Withdrawal by Subject|1|||
150209060|NCT05485805|541902407|FG001|Overall Study|Withdrawal by Subject|2|||
150209061|NCT05485805|541902408|FG002|Overall Study|Withdrawal by Subject|2|||
150209062|NCT05485805|541902409|FG003|Overall Study|Withdrawal by Subject|0|||
150209063|NCT05485805|541902410|FG004|Overall Study|Withdrawal by Subject|2|||
150209064|NCT05485805|541902406|FG000|Overall Study|Adverse Event|0|||
150209065|NCT05485805|541902407|FG001|Overall Study|Adverse Event|1|||
150209066|NCT05485805|541902408|FG002|Overall Study|Adverse Event|0|||
150209067|NCT05485805|541902409|FG003|Overall Study|Adverse Event|0|||
150209068|NCT05485805|541902410|FG004|Overall Study|Adverse Event|0|||
150209069|NCT05485805|541902406|FG000|Overall Study|Lost to Follow-up|1|||
150209070|NCT05485805|541902407|FG001|Overall Study|Lost to Follow-up|1|||
150209071|NCT05485805|541902408|FG002|Overall Study|Lost to Follow-up|3|||
150209072|NCT05485805|541902409|FG003|Overall Study|Lost to Follow-up|1|||
150209073|NCT05485805|541902410|FG004|Overall Study|Lost to Follow-up|0|||
150209074|NCT04218357|541902411|FG000|1st Allocation|Withdrawal by Subject|1|||
150209075|NCT04218357|541902412|FG001|1st Allocation|Withdrawal by Subject|0|||
150209076|NCT05349838|541902413|FG000|Overall Study|Virological Failure|1|||
150209077|NCT05349838|541902414|FG001|Overall Study|Virological Failure|2|||
150209078|NCT05349838|541902413|FG000|Overall Study|Withdrawal by Subject|2|||
150209079|NCT05349838|541902414|FG001|Overall Study|Withdrawal by Subject|3|||
150209080|NCT05349838|541902413|FG000|Overall Study|Adverse Event|3|||
150209081|NCT05349838|541902414|FG001|Overall Study|Adverse Event|1|||
150209082|NCT05349838|541902413|FG000|Overall Study|Lost to Follow-up|1|||
150209083|NCT05349838|541902414|FG001|Overall Study|Lost to Follow-up|2|||
150209084|NCT05349838|541902413|FG000|Overall Study|Other reasons|5|||
150209085|NCT05349838|541902414|FG001|Overall Study|Other reasons|1|||
150209086|NCT04484623|541902416|FG000|Overall Study|Lost to Follow-up|0|||
150209087|NCT04484623|541902417|FG001|Overall Study|Lost to Follow-up|1|||
150209088|NCT04484623|541902416|FG000|Overall Study|Protocol Deviation|1|||
150209089|NCT04484623|541902417|FG001|Overall Study|Protocol Deviation|0|||
150209090|NCT04484623|541902416|FG000|Overall Study|Physician Decision|1|||
150209091|NCT04484623|541902417|FG001|Overall Study|Physician Decision|0|||
150209092|NCT04484623|541902416|FG000|Overall Study|Withdrawal by Subject|11|||
150209093|NCT04484623|541902417|FG001|Overall Study|Withdrawal by Subject|8|||
150209094|NCT04484623|541902416|FG000|Overall Study|Ongoing|94|||
150209095|NCT04484623|541902417|FG001|Overall Study|Ongoing|84|||
150209096|NCT05037513|541902418|FG000|Intervention Period|Lost to Follow-up|1|||
150209097|NCT05037513|541902419|FG001|Intervention Period|Lost to Follow-up|2|||
150209098|NCT05037513|541902418|FG000|Follow Up Period|Lost to Follow-up|16|||
150209099|NCT05037513|541902419|FG001|Follow Up Period|Lost to Follow-up|21|||
150209100|NCT05037513|541902418|FG000|Follow Up Period|Death|0|||
150209101|NCT05037513|541902419|FG001|Follow Up Period|Death|1|||
150209102|NCT05037513|541902418|FG000|Follow Up Period|Incarcerated|4|||
150209103|NCT05037513|541902419|FG001|Follow Up Period|Incarcerated|2|||
150209104|NCT05886777|541902420|FG000|Overall Study|Lost to Follow-up|1|||
150209105|NCT05886777|541902421|FG001|Overall Study|Lost to Follow-up|0|||
150209106|NCT05886777|541902422|FG002|Overall Study|Lost to Follow-up|2|||
150209107|NCT05886777|541902423|FG003|Overall Study|Lost to Follow-up|1|||
150209108|NCT05886777|541902424|FG004|Overall Study|Lost to Follow-up|0|||
150209109|NCT05886777|541902425|FG005|Overall Study|Lost to Follow-up|2|||
150209110|NCT05886777|541902426|FG006|Overall Study|Lost to Follow-up|0|||
150209111|NCT05886777|541902420|FG000|Overall Study|Other|0|||
150209112|NCT05886777|541902421|FG001|Overall Study|Other|2|||
150209113|NCT05886777|541902422|FG002|Overall Study|Other|1|||
150209114|NCT05886777|541902423|FG003|Overall Study|Other|0|||
150209115|NCT05886777|541902424|FG004|Overall Study|Other|0|||
150209116|NCT05886777|541902425|FG005|Overall Study|Other|0|||
150209117|NCT05886777|541902426|FG006|Overall Study|Other|0|||
150209118|NCT05886777|541902420|FG000|Overall Study|Withdrawal by Subject|1|||
150209119|NCT05886777|541902421|FG001|Overall Study|Withdrawal by Subject|0|||
150209120|NCT05886777|541902422|FG002|Overall Study|Withdrawal by Subject|1|||
150209121|NCT05886777|541902423|FG003|Overall Study|Withdrawal by Subject|4|||
150209122|NCT05886777|541902424|FG004|Overall Study|Withdrawal by Subject|3|||
150209123|NCT05886777|541902425|FG005|Overall Study|Withdrawal by Subject|1|||
150209124|NCT05886777|541902426|FG006|Overall Study|Withdrawal by Subject|1|||
150209125|NCT05886777|541902420|FG000|Overall Study|Protocol Violation|0|||
150209126|NCT05886777|541902421|FG001|Overall Study|Protocol Violation|0|||
150209127|NCT05886777|541902422|FG002|Overall Study|Protocol Violation|1|||
150209128|NCT05886777|541902423|FG003|Overall Study|Protocol Violation|0|||
150209129|NCT05886777|541902424|FG004|Overall Study|Protocol Violation|0|||
150209130|NCT05886777|541902425|FG005|Overall Study|Protocol Violation|0|||
150209131|NCT05886777|541902426|FG006|Overall Study|Protocol Violation|0|||
150209132|NCT05886777|541902420|FG000|Overall Study|No longer met eligibility criteria|0|||
150209133|NCT05886777|541902421|FG001|Overall Study|No longer met eligibility criteria|1|||
150209134|NCT05886777|541902422|FG002|Overall Study|No longer met eligibility criteria|0|||
150209135|NCT05886777|541902423|FG003|Overall Study|No longer met eligibility criteria|0|||
150209136|NCT05886777|541902424|FG004|Overall Study|No longer met eligibility criteria|0|||
150209137|NCT05886777|541902425|FG005|Overall Study|No longer met eligibility criteria|0|||
150209138|NCT05886777|541902426|FG006|Overall Study|No longer met eligibility criteria|0|||
150209139|NCT03773107|541902427|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
150209140|NCT03773107|541902428|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
150209141|NCT03773107|541902429|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
150209142|NCT03773107|541902430|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
150209143|NCT03367156|541903636|FG000|Overall Study|Lack of interest|3|||
150209144|NCT03367156|541903637|FG001|Overall Study|Lack of interest|1|||
150209145|NCT03367156|541903636|FG000|Overall Study|Death|2|||
150209146|NCT03367156|541903637|FG001|Overall Study|Death|0|||
150209147|NCT03367156|541903636|FG000|Overall Study|Lost to Follow-up|2|||
150209148|NCT03367156|541903637|FG001|Overall Study|Lost to Follow-up|1|||
150209149|NCT03367156|541903636|FG000|Overall Study|Became ineligible|1|||
150209150|NCT03367156|541903637|FG001|Overall Study|Became ineligible|2|||
150209151|NCT03367156|541903636|FG000|Overall Study|Hospitalization|1|||
150209152|NCT03367156|541903637|FG001|Overall Study|Hospitalization|0|||
150209153|NCT03367156|541903636|FG000|Overall Study|Concerned about Treatment|11|||
150209154|NCT03367156|541903637|FG001|Overall Study|Concerned about Treatment|3|||
150209155|NCT03367156|541903636|FG000|Overall Study|Started new treatment|4|||
150209156|NCT03367156|541903637|FG001|Overall Study|Started new treatment|1|||
150209157|NCT02036970|541903640|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
150209158|NCT02036970|541903641|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
150209159|NCT02036970|541903642|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
150209160|NCT02036970|541903643|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
150209161|NCT02036970|541903644|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
150209162|NCT02036970|541903645|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
150209163|NCT02036970|541903646|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
150209164|NCT02036970|541903647|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
150209165|NCT02036970|541903648|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
150209166|NCT02036970|541903649|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
150209167|NCT02036970|541903640|FG000|Part 1: Day 1 Through Week 16|Death|0|||
150209168|NCT02036970|541903641|FG001|Part 1: Day 1 Through Week 16|Death|0|||
150209169|NCT02036970|541903642|FG002|Part 1: Day 1 Through Week 16|Death|0|||
150209170|NCT02036970|541903643|FG003|Part 1: Day 1 Through Week 16|Death|0|||
150209171|NCT02036970|541903644|FG004|Part 1: Day 1 Through Week 16|Death|0|||
150209172|NCT02036970|541903645|FG005|Part 1: Day 1 Through Week 16|Death|0|||
150209173|NCT02036970|541903646|FG006|Part 1: Day 1 Through Week 16|Death|0|||
150209174|NCT02036970|541903647|FG007|Part 1: Day 1 Through Week 16|Death|0|||
150209175|NCT02036970|541903648|FG008|Part 1: Day 1 Through Week 16|Death|1|||
150209176|NCT02036970|541903649|FG009|Part 1: Day 1 Through Week 16|Death|0|||
150209177|NCT02036970|541903640|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
150209178|NCT02036970|541903641|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209179|NCT02036970|541903642|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
150209180|NCT02036970|541903643|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209181|NCT02036970|541903644|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209182|NCT02036970|541903645|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209183|NCT02036970|541903646|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209184|NCT02036970|541903647|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209185|NCT02036970|541903648|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
150209186|NCT02036970|541903649|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
150209187|NCT02036970|541903640|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209188|NCT02036970|541903641|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209189|NCT02036970|541903642|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209190|NCT02036970|541903643|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209191|NCT02036970|541903644|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
150209192|NCT02036970|541903645|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209193|NCT02036970|541903646|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209194|NCT02036970|541903647|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
150209195|NCT02036970|541903648|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
150209196|NCT02036970|541903649|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
150209197|NCT02036970|541903640|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209198|NCT02036970|541903641|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209199|NCT02036970|541903642|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209200|NCT02036970|541903643|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
150209201|NCT02036970|541903644|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209202|NCT02036970|541903645|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209203|NCT02036970|541903646|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209204|NCT02036970|541903647|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209205|NCT02036970|541903648|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209206|NCT02036970|541903649|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
150209207|NCT02036970|541903640|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
150209208|NCT02036970|541903641|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
150209209|NCT02036970|541903642|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
150209210|NCT02036970|541903643|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
150209211|NCT02036970|541903644|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
150209212|NCT02036970|541903645|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
150209213|NCT02036970|541903646|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
150209214|NCT02036970|541903647|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
150209215|NCT02036970|541903648|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
150209216|NCT02036970|541903649|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
150209217|NCT02036970|541903640|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209218|NCT02036970|541903641|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209219|NCT02036970|541903642|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209220|NCT02036970|541903643|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209221|NCT02036970|541903644|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209222|NCT02036970|541903645|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209223|NCT02036970|541903646|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209224|NCT02036970|541903647|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
150209225|NCT02036970|541903648|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209226|NCT02036970|541903649|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
150209227|NCT02036970|541903640|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209228|NCT02036970|541903641|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
150209229|NCT02036970|541903642|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
150209230|NCT02036970|541903643|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209231|NCT02036970|541903644|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209232|NCT02036970|541903645|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209233|NCT02036970|541903646|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209234|NCT02036970|541903647|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209235|NCT02036970|541903648|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
150209236|NCT02036970|541903649|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
150209237|NCT02036970|541903640|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209238|NCT02036970|541903641|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
150209239|NCT02036970|541903642|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
150209240|NCT02036970|541903643|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
150209241|NCT02036970|541903644|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209242|NCT02036970|541903645|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209243|NCT02036970|541903646|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209244|NCT02036970|541903647|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209245|NCT02036970|541903648|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
150209246|NCT02036970|541903649|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
150209247|NCT03738228|541903654|FG000|Overall Study|Never received study treatment|2|||
150209248|NCT03738228|541903655|FG001|Overall Study|Never received study treatment|2|||
150209249|NCT06212752|541903656|FG000|Overall Study|Death|5|||
150209250|NCT06212752|541903657|FG001|Overall Study|Death|3|||
150209251|NCT06212752|541903656|FG000|Overall Study|Participants ongoing|23|||
150209252|NCT06212752|541903657|FG001|Overall Study|Participants ongoing|8|||
150209253|NCT01641900|541903658|FG000|Overall Study|Withdrawal by Subject|2|||
150209254|NCT01641900|541903659|FG001|Overall Study|Withdrawal by Subject|2|||
150209255|NCT02568215|541903660|FG000|Overall Study|Death|1|||
150209256|NCT02568215|541903661|FG001|Overall Study|Death|2|||
150209257|NCT02568215|541903662|FG002|Overall Study|Death|0|||
150209258|NCT02568215|541903660|FG000|Overall Study|Physician Decision|2|||
150209259|NCT02568215|541903661|FG001|Overall Study|Physician Decision|2|||
150209260|NCT02568215|541903662|FG002|Overall Study|Physician Decision|2|||
150209261|NCT02568215|541903660|FG000|Overall Study|Lost to Follow-up|29|||
150209262|NCT02568215|541903661|FG001|Overall Study|Lost to Follow-up|32|||
150209263|NCT02568215|541903662|FG002|Overall Study|Lost to Follow-up|41|||
150209264|NCT02568215|541903660|FG000|Overall Study|Withdrawal by Subject|21|||
150209265|NCT02568215|541903661|FG001|Overall Study|Withdrawal by Subject|19|||
150209266|NCT02568215|541903662|FG002|Overall Study|Withdrawal by Subject|22|||
150209267|NCT02568215|541903660|FG000|Overall Study|Protocol Violation|1|||
150209268|NCT02568215|541903661|FG001|Overall Study|Protocol Violation|1|||
150209269|NCT02568215|541903662|FG002|Overall Study|Protocol Violation|0|||
150209270|NCT02568215|541903660|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
150209271|NCT02568215|541903661|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
150209272|NCT02568215|541903662|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
150209273|NCT02568215|541903660|FG000|Overall Study|Other|0|||
150209274|NCT02568215|541903661|FG001|Overall Study|Other|1|||
150209275|NCT02568215|541903662|FG002|Overall Study|Other|4|||
150209276|NCT00371345|541903663|FG000|Overall Study|Disease Progression|21|||
150209277|NCT00371345|541903664|FG001|Overall Study|Disease Progression|35|||
150209278|NCT00371345|541903663|FG000|Overall Study|Study Drug Toxicity|1|||
150209279|NCT00371345|541903664|FG001|Overall Study|Study Drug Toxicity|7|||
150209280|NCT00371345|541903663|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
150209281|NCT00371345|541903664|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
150209282|NCT00371345|541903663|FG000|Overall Study|Participant Request|1|||
150209283|NCT00371345|541903664|FG001|Overall Study|Participant Request|1|||
150209284|NCT00371345|541903663|FG000|Overall Study|Participant Withdrew Consent|0|||
150209285|NCT00371345|541903664|FG001|Overall Study|Participant Withdrew Consent|1|||
150209286|NCT05966155|541903668|FG000|Overall Study|Death|1|||
150209287|NCT05966155|541903669|FG001|Overall Study|Death|2|||
150209288|NCT05966155|541903668|FG000|Overall Study|Lost to Follow-up|63|||
150209289|NCT05966155|541903669|FG001|Overall Study|Lost to Follow-up|67|||
150209290|NCT05966155|541903668|FG000|Overall Study|Protocol Violation|1|||
150209291|NCT05966155|541903669|FG001|Overall Study|Protocol Violation|0|||
150209292|NCT05966155|541903668|FG000|Overall Study|Withdrawal by Subject|8|||
150209293|NCT05966155|541903669|FG001|Overall Study|Withdrawal by Subject|9|||
150209294|NCT05966155|541903668|FG000|Overall Study|Enrolled Erroneously|0|||
150209295|NCT05966155|541903669|FG001|Overall Study|Enrolled Erroneously|1|||
150209296|NCT05966155|541903668|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
150209297|NCT05966155|541903669|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
150209298|NCT04795167|541903672|FG000|Overall Study|Death|1|||
150209299|NCT04795167|541903673|FG001|Overall Study|Death|18|||
150209300|NCT04795167|541903674|FG002|Overall Study|Death|1|||
150209301|NCT04795167|541903672|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
150209302|NCT04795167|541903673|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
150209303|NCT04795167|541903674|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
150209304|NCT02257736|541903675|FG000|Overall Study|Progressive disease|365|||
150209305|NCT02257736|541903676|FG001|Overall Study|Progressive disease|327|||
150209306|NCT02257736|541903675|FG000|Overall Study|Adverse Event|45|||
150209307|NCT02257736|541903676|FG001|Overall Study|Adverse Event|56|||
150209308|NCT02257736|541903675|FG000|Overall Study|Withdrawal by Subject|21|||
150209309|NCT02257736|541903676|FG001|Overall Study|Withdrawal by Subject|38|||
150209310|NCT02257736|541903675|FG000|Overall Study|Death|11|||
150209311|NCT02257736|541903676|FG001|Overall Study|Death|6|||
150209312|NCT02257736|541903675|FG000|Overall Study|Physician Decision|5|||
150209313|NCT02257736|541903676|FG001|Overall Study|Physician Decision|9|||
150209314|NCT02257736|541903675|FG000|Overall Study|Non-Compliance with study drug|1|||
150209315|NCT02257736|541903676|FG001|Overall Study|Non-Compliance with study drug|2|||
150209316|NCT02257736|541903675|FG000|Overall Study|Protocol Violation|1|||
150209317|NCT02257736|541903676|FG001|Overall Study|Protocol Violation|0|||
150209318|NCT02257736|541903675|FG000|Overall Study|Other|1|||
150209319|NCT02257736|541903676|FG001|Overall Study|Other|7|||
150209320|NCT02257736|541903675|FG000|Overall Study|Randomized, not treated|1|||
150209321|NCT02257736|541903676|FG001|Overall Study|Randomized, not treated|2|||
150209322|NCT02628626|541903678|FG000|Overall Study|Withdrawal by Subject|2|||
150209323|NCT02628626|541903679|FG001|Overall Study|Withdrawal by Subject|2|||
150209324|NCT02744066|541903680|FG000|Overall Study|Withdrawal by parent|0|||
150209325|NCT02744066|541903681|FG001|Overall Study|Withdrawal by parent|1|||
150209326|NCT02744066|541903680|FG000|Overall Study|Discharged from NICU prior to completion|0|||
150209327|NCT02744066|541903681|FG001|Overall Study|Discharged from NICU prior to completion|4|||
150209328|NCT01400958|541903686|FG000|Overall Study|Physician Decision|0|||
150209329|NCT01400958|541903687|FG001|Overall Study|Physician Decision|1|||
150209330|NCT01400958|541903686|FG000|Overall Study|Withdrawal by Subject|0|||
150209331|NCT01400958|541903687|FG001|Overall Study|Withdrawal by Subject|1|||
150209332|NCT01400958|541903686|FG000|Overall Study|Adverse Event|1|||
150209333|NCT01400958|541903687|FG001|Overall Study|Adverse Event|0|||
150209334|NCT05663866|541903688|FG000|Overall Study|Adverse Event|0|||
150209335|NCT05663866|541903689|FG001|Overall Study|Adverse Event|0|||
150209336|NCT05663866|541903690|FG002|Overall Study|Adverse Event|1|||
150209337|NCT05663866|541903691|FG003|Overall Study|Adverse Event|0|||
150209338|NCT05663866|541903688|FG000|Overall Study|Physician Decision|0|||
150209339|NCT05663866|541903689|FG001|Overall Study|Physician Decision|0|||
150209340|NCT05663866|541903690|FG002|Overall Study|Physician Decision|0|||
150209341|NCT05663866|541903691|FG003|Overall Study|Physician Decision|1|||
150209342|NCT05663866|541903688|FG000|Overall Study|Withdrawal by Subject|0|||
150209343|NCT05663866|541903689|FG001|Overall Study|Withdrawal by Subject|2|||
150137989|NCT01345630|541640241|FG001|Overall Study|Insufficient clinical response|11|||
150137990|NCT04737109|541640242|FG000|Study Treatment|Disease Progression|5|||
150137991|NCT04737109|541640243|FG001|Study Treatment|Disease Progression|0|||
150137992|NCT04737109|541640244|FG002|Study Treatment|Disease Progression|0|||
150137993|NCT04737109|541640245|FG003|Study Treatment|Disease Progression|0|||
150137994|NCT04737109|541640242|FG000|Study Treatment|Death on study|1|||
150137995|NCT04737109|541640243|FG001|Study Treatment|Death on study|0|||
150137996|NCT04737109|541640244|FG002|Study Treatment|Death on study|0|||
150137997|NCT04737109|541640245|FG003|Study Treatment|Death on study|0|||
150137998|NCT03092375|541640246|FG000|Overall Study|Lack of Efficacy|0|||
150137999|NCT03092375|541640247|FG001|Overall Study|Lack of Efficacy|1|||
150138000|NCT03092375|541640248|FG002|Overall Study|Lack of Efficacy|1|||
150138001|NCT03092375|541640249|FG003|Overall Study|Lack of Efficacy|0|||
150138002|NCT01289418|541640250|FG000|Day 8 Survey|email address invalid|283|||
150138003|NCT01289418|541640250|FG000|Day 8 Survey|participants did not complete the survey|1935|||
150138004|NCT01289418|541640250|FG000|Day 29 Survey|email address invalid|283|||
150138005|NCT01289418|541640250|FG000|Day 29 Survey|participants did not complete the survey|2185|||
150138006|NCT03122119|541640254|FG000|Overall Study|Did not meet eligibility critria|1|||
150138007|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
150138008|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
150138009|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
150138010|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
150138011|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
150138012|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
150138013|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
150138014|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
150138015|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
150138016|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
150138017|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
150138018|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
150138019|NCT01493687|541640263|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
150138020|NCT01493687|541640264|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
150138021|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
150138022|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
150138023|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
150138024|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
150138025|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
150138026|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
150138027|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
150138028|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
150138029|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
150138030|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
150138031|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
150138032|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
150138033|NCT01493687|541640263|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
150138034|NCT01493687|541640264|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
150138035|NCT01493687|541640263|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
150138036|NCT01493687|541640264|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
150138037|NCT02323646|541640267|FG000|Treatment Course 1|Adverse Event|1|||
150138038|NCT02323646|541640268|FG001|Treatment Course 1|Adverse Event|0|||
150138039|NCT02323646|541640269|FG002|Treatment Course 1|Adverse Event|1|||
150138040|NCT02323646|541640267|FG000|Treatment Course 1|Heavy Bleeding|1|||
150138041|NCT02323646|541640268|FG001|Treatment Course 1|Heavy Bleeding|1|||
150138042|NCT02323646|541640269|FG002|Treatment Course 1|Heavy Bleeding|0|||
150138043|NCT02323646|541640267|FG000|Treatment Course 1|Lost to Follow-up|1|||
150138044|NCT02323646|541640268|FG001|Treatment Course 1|Lost to Follow-up|0|||
150138045|NCT02323646|541640269|FG002|Treatment Course 1|Lost to Follow-up|2|||
150138046|NCT02323646|541640267|FG000|Treatment Course 1|Withdrawal by Subject|0|||
150138047|NCT02323646|541640268|FG001|Treatment Course 1|Withdrawal by Subject|2|||
150138048|NCT02323646|541640269|FG002|Treatment Course 1|Withdrawal by Subject|0|||
150138049|NCT02323646|541640267|FG000|Treatment Course 2|Adverse Event|1|||
150138050|NCT02323646|541640268|FG001|Treatment Course 2|Adverse Event|0|||
150138051|NCT02323646|541640269|FG002|Treatment Course 2|Adverse Event|1|||
150138052|NCT02323646|541640267|FG000|Treatment Course 2|Lost to Follow-up|0|||
150138053|NCT02323646|541640268|FG001|Treatment Course 2|Lost to Follow-up|0|||
150138054|NCT02323646|541640269|FG002|Treatment Course 2|Lost to Follow-up|1|||
150138055|NCT02323646|541640267|FG000|Treatment Course 2|Non-compliance|0|||
150138056|NCT02323646|541640268|FG001|Treatment Course 2|Non-compliance|1|||
150209344|NCT05663866|541903690|FG002|Overall Study|Withdrawal by Subject|1|||
150209345|NCT05663866|541903691|FG003|Overall Study|Withdrawal by Subject|2|||
150209346|NCT05663866|541903688|FG000|Overall Study|Progressive disease|4|||
150209347|NCT05663866|541903689|FG001|Overall Study|Progressive disease|8|||
150209348|NCT05663866|541903690|FG002|Overall Study|Progressive disease|5|||
150209349|NCT05663866|541903691|FG003|Overall Study|Progressive disease|2|||
150209350|NCT05663866|541903688|FG000|Overall Study|Other|1|||
150209351|NCT05663866|541903689|FG001|Overall Study|Other|0|||
150209352|NCT05663866|541903690|FG002|Overall Study|Other|0|||
150209353|NCT05663866|541903691|FG003|Overall Study|Other|0|||
150209354|NCT05663866|541903688|FG000|Overall Study|Ongoing|1|||
150209355|NCT05663866|541903689|FG001|Overall Study|Ongoing|27|||
150209356|NCT05663866|541903690|FG002|Overall Study|Ongoing|6|||
150209357|NCT05663866|541903691|FG003|Overall Study|Ongoing|1|||
150209358|NCT03598907|541903692|FG000|Overall Study|Physician Decision|14|||
150209359|NCT03598907|541903693|FG001|Overall Study|Physician Decision|19|||
150209360|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
150209361|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
150209362|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
150209363|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
150209364|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
150209365|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
150209366|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
150209367|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
150209368|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
150209369|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
150209370|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
150209371|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
150209372|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
150209373|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
150209374|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
150209375|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
150209376|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
150209377|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
150209378|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
150209379|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
150209380|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
150209381|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
150209382|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
150209383|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
150209384|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
150209385|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
150209386|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
150209387|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
150209388|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
150209389|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
150209390|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
150209391|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
150209392|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
150209393|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
150209394|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
150209395|NCT03656718|541903696|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
150209396|NCT03656718|541903697|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
150209397|NCT03656718|541903698|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
150209398|NCT03656718|541903699|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
150209399|NCT03656718|541903700|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
150209400|NCT03656718|541903701|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
150209401|NCT03656718|541903702|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
150209402|NCT03656718|541903696|FG000|Treatment Period Part C|Disease progression|0|||
150209403|NCT03656718|541903697|FG001|Treatment Period Part C|Disease progression|0|||
150209404|NCT03656718|541903698|FG002|Treatment Period Part C|Disease progression|0|||
150209405|NCT03656718|541903699|FG003|Treatment Period Part C|Disease progression|0|||
150209406|NCT03656718|541903700|FG004|Treatment Period Part C|Disease progression|12|||
150209407|NCT03656718|541903701|FG005|Treatment Period Part C|Disease progression|0|||
150209408|NCT03656718|541903702|FG006|Treatment Period Part C|Disease progression|0|||
150209409|NCT03656718|541903696|FG000|Treatment Period Part C|Death|0|||
150209410|NCT03656718|541903697|FG001|Treatment Period Part C|Death|0|||
150209411|NCT03656718|541903698|FG002|Treatment Period Part C|Death|0|||
150209412|NCT03656718|541903699|FG003|Treatment Period Part C|Death|0|||
150209413|NCT03656718|541903700|FG004|Treatment Period Part C|Death|1|||
150209414|NCT03656718|541903701|FG005|Treatment Period Part C|Death|0|||
150209415|NCT03656718|541903702|FG006|Treatment Period Part C|Death|0|||
150209416|NCT03656718|541903696|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209417|NCT03656718|541903697|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209418|NCT03656718|541903698|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209419|NCT03656718|541903699|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209420|NCT03656718|541903700|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
150209421|NCT03656718|541903701|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209422|NCT03656718|541903702|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
150209423|NCT03656718|541903696|FG000|Treatment Period Part C|Other reasons|0|||
150209424|NCT03656718|541903697|FG001|Treatment Period Part C|Other reasons|0|||
150209425|NCT03656718|541903698|FG002|Treatment Period Part C|Other reasons|0|||
150209426|NCT03656718|541903699|FG003|Treatment Period Part C|Other reasons|0|||
150209427|NCT03656718|541903700|FG004|Treatment Period Part C|Other reasons|1|||
150209428|NCT03656718|541903701|FG005|Treatment Period Part C|Other reasons|0|||
150209429|NCT03656718|541903702|FG006|Treatment Period Part C|Other reasons|0|||
150209430|NCT03656718|541903696|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
150209431|NCT03656718|541903697|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
150209432|NCT03656718|541903698|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
150209433|NCT03656718|541903699|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
150209434|NCT03656718|541903700|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
150209435|NCT03656718|541903701|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
150209436|NCT03656718|541903702|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
150209437|NCT01855750|541903703|FG000|Overall Study|Death|78|||
150209438|NCT01855750|541903704|FG001|Overall Study|Death|78|||
150209439|NCT01855750|541903703|FG000|Overall Study|Lost to Follow-up|9|||
150209440|NCT01855750|541903704|FG001|Overall Study|Lost to Follow-up|23|||
150209441|NCT01855750|541903703|FG000|Overall Study|Withdrawal by Subject|35|||
150209442|NCT01855750|541903704|FG001|Overall Study|Withdrawal by Subject|28|||
150209443|NCT01855750|541903703|FG000|Overall Study|Sponsor ends the study|297|||
150209444|NCT01855750|541903704|FG001|Overall Study|Sponsor ends the study|290|||
150209445|NCT05379270|541903705|FG000|Overall Study|Withdrawal by Subject|1|||
150209446|NCT05379270|541903706|FG001|Overall Study|Withdrawal by Subject|1|||
150209447|NCT03425682|541903707|FG000|Overall Study|Lost to Follow-up|2|||
150209448|NCT03425682|541903708|FG001|Overall Study|Lost to Follow-up|4|||
150209449|NCT03425682|541903707|FG000|Overall Study|Withdrawal by Subject|0|||
150209450|NCT03425682|541903708|FG001|Overall Study|Withdrawal by Subject|3|||
150209451|NCT03425682|541903707|FG000|Overall Study|Subject did not meet I/E|4|||
150209452|NCT03425682|541903708|FG001|Overall Study|Subject did not meet I/E|10|||
150209453|NCT03610581|541903709|FG000|Overall Study|Study terminated by sponsor|2|||
150209454|NCT03610581|541903710|FG001|Overall Study|Study terminated by sponsor|0|||
150209455|NCT03610581|541903709|FG000|Overall Study|Other|0|||
150209456|NCT03610581|541903710|FG001|Overall Study|Other|1|||
150209457|NCT03610581|541903709|FG000|Overall Study|Withdrawal by Subject|1|||
150209458|NCT03610581|541903710|FG001|Overall Study|Withdrawal by Subject|0|||
150209459|NCT00489307|541903713|FG000|Overall Study|Death|1|||
150209460|NCT00489307|541903714|FG001|Overall Study|Death|1|||
150209461|NCT00489307|541903713|FG000|Overall Study|Lost to Follow-up|2|||
150209462|NCT00489307|541903714|FG001|Overall Study|Lost to Follow-up|2|||
150209463|NCT00489307|541903713|FG000|Overall Study|Physician Decision|1|||
150209464|NCT00489307|541903714|FG001|Overall Study|Physician Decision|0|||
150209465|NCT00489307|541903713|FG000|Overall Study|Withdrawal by Subject|2|||
150209466|NCT00489307|541903714|FG001|Overall Study|Withdrawal by Subject|4|||
150209467|NCT00489307|541903713|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
150209468|NCT00489307|541903714|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
150209469|NCT00489307|541903713|FG000|Overall Study|Surgery after assignment|1|||
150209470|NCT00489307|541903714|FG001|Overall Study|Surgery after assignment|0|||
150209471|NCT00489307|541903713|FG000|Overall Study|Did not fill up the forms|2|||
150209472|NCT00489307|541903714|FG001|Overall Study|Did not fill up the forms|1|||
150209473|NCT00489307|541903713|FG000|Overall Study|Patient or family refusal|5|||
150209474|NCT00489307|541903714|FG001|Overall Study|Patient or family refusal|9|||
150209475|NCT02517268|541903717|FG000|Overall Study|Withdrawal by Subject|1|||
150209476|NCT02517268|541903718|FG001|Overall Study|Withdrawal by Subject|0|||
150209477|NCT02401815|541903725|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209478|NCT02401815|541903726|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209479|NCT02401815|541903727|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209480|NCT02401815|541903728|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
150209481|NCT02401815|541903729|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209482|NCT02401815|541903730|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209483|NCT02401815|541903731|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209484|NCT02401815|541903732|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209485|NCT02401815|541903733|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209486|NCT02401815|541903734|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
150209487|NCT02401815|541903725|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
150209488|NCT02401815|541903726|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209489|NCT02401815|541903727|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209490|NCT02401815|541903728|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
150209491|NCT02401815|541903729|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209492|NCT02401815|541903730|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209493|NCT02401815|541903731|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209494|NCT02401815|541903732|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209495|NCT02401815|541903733|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209496|NCT02401815|541903734|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
150209497|NCT02401815|541903725|FG000|Dose Escalation (up to 670 Days)|Death|1|||
150209498|NCT02401815|541903726|FG001|Dose Escalation (up to 670 Days)|Death|2|||
150209499|NCT02401815|541903727|FG002|Dose Escalation (up to 670 Days)|Death|3|||
150209500|NCT02401815|541903728|FG003|Dose Escalation (up to 670 Days)|Death|5|||
150209501|NCT02401815|541903729|FG004|Dose Escalation (up to 670 Days)|Death|4|||
150209502|NCT02401815|541903730|FG005|Dose Escalation (up to 670 Days)|Death|0|||
150209503|NCT02401815|541903731|FG006|Dose Escalation (up to 670 Days)|Death|0|||
150209504|NCT02401815|541903732|FG007|Dose Escalation (up to 670 Days)|Death|0|||
150209505|NCT02401815|541903733|FG008|Dose Escalation (up to 670 Days)|Death|0|||
150209506|NCT02401815|541903734|FG009|Dose Escalation (up to 670 Days)|Death|0|||
150209507|NCT02401815|541903725|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209508|NCT02401815|541903726|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
150209509|NCT02401815|541903727|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209510|NCT02401815|541903728|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209511|NCT02401815|541903729|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
150209512|NCT02401815|541903730|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209513|NCT02401815|541903731|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209514|NCT02401815|541903732|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209515|NCT02401815|541903733|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209516|NCT02401815|541903734|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
150209517|NCT02401815|541903725|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
150209518|NCT02401815|541903726|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209519|NCT02401815|541903727|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209520|NCT02401815|541903728|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209521|NCT02401815|541903729|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
150209522|NCT02401815|541903730|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209523|NCT02401815|541903731|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209524|NCT02401815|541903732|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209525|NCT02401815|541903733|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209526|NCT02401815|541903734|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
150209527|NCT02401815|541903725|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209528|NCT02401815|541903726|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209529|NCT02401815|541903727|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209530|NCT02401815|541903728|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209531|NCT02401815|541903729|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209532|NCT02401815|541903730|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
150209533|NCT02401815|541903731|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209534|NCT02401815|541903732|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209535|NCT02401815|541903733|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209536|NCT02401815|541903734|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
150209537|NCT02401815|541903725|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209538|NCT02401815|541903726|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209539|NCT02401815|541903727|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209540|NCT02401815|541903728|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209541|NCT02401815|541903729|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209542|NCT02401815|541903730|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209543|NCT02401815|541903731|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
150209544|NCT02401815|541903732|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209545|NCT02401815|541903733|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209546|NCT02401815|541903734|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209547|NCT02401815|541903725|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209548|NCT02401815|541903726|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209549|NCT02401815|541903727|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209550|NCT02401815|541903728|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209551|NCT02401815|541903729|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209552|NCT02401815|541903730|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
150209553|NCT02401815|541903731|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
150209554|NCT02401815|541903732|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209555|NCT02401815|541903733|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209556|NCT02401815|541903734|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
150209557|NCT02401815|541903725|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209558|NCT02401815|541903726|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209559|NCT02401815|541903727|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209560|NCT02401815|541903728|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209561|NCT02401815|541903729|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209562|NCT02401815|541903730|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
150209563|NCT02401815|541903731|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209564|NCT02401815|541903732|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209565|NCT02401815|541903733|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209566|NCT02401815|541903734|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
150209567|NCT02401815|541903725|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209568|NCT02401815|541903726|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209569|NCT02401815|541903727|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209570|NCT02401815|541903728|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209571|NCT02401815|541903729|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209572|NCT02401815|541903730|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209573|NCT02401815|541903731|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
150209574|NCT02401815|541903732|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
150209575|NCT02401815|541903733|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
150209576|NCT02401815|541903734|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
150209577|NCT02401815|541903725|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209578|NCT02401815|541903726|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209579|NCT02401815|541903727|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209580|NCT02401815|541903728|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209581|NCT02401815|541903729|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209582|NCT02401815|541903730|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209583|NCT02401815|541903731|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209584|NCT02401815|541903732|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
150209585|NCT02401815|541903733|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
150209586|NCT02401815|541903734|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
150209587|NCT02401815|541903725|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209588|NCT02401815|541903726|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209589|NCT02401815|541903727|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209590|NCT02401815|541903728|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209591|NCT02401815|541903729|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209592|NCT02401815|541903730|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209593|NCT02401815|541903731|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209594|NCT02401815|541903732|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209595|NCT02401815|541903733|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
150209596|NCT02401815|541903734|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
150209597|NCT02401815|541903725|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209598|NCT02401815|541903726|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209599|NCT02401815|541903727|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209600|NCT02401815|541903728|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209601|NCT02401815|541903729|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209602|NCT02401815|541903730|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209603|NCT02401815|541903731|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209604|NCT02401815|541903732|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209605|NCT02401815|541903733|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
150209606|NCT02401815|541903734|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
150209607|NCT02401815|541903725|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209608|NCT02401815|541903726|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209609|NCT02401815|541903727|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209610|NCT02401815|541903728|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209611|NCT02401815|541903729|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209612|NCT02401815|541903730|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209613|NCT02401815|541903731|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209614|NCT02401815|541903732|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
150209615|NCT02401815|541903733|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
150209616|NCT02401815|541903734|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
150209617|NCT00748709|541903735|FG000|Overall Study|Progressive disease|15|||
150209618|NCT00748709|541903735|FG000|Overall Study|Drug reducing Toxity|2|||
150209619|NCT00748709|541903735|FG000|Overall Study|Other Adverse Event|1|||
150209620|NCT00748709|541903735|FG000|Overall Study|Withdrawal by Subject|1|||
150209621|NCT00748709|541903735|FG000|Overall Study|Other Reasons|1|||
150209622|NCT07204444|541903741|FG000|Overall Study|Medical/Hospitalization|6|||
150209623|NCT07204444|541903742|FG001|Overall Study|Medical/Hospitalization|9|||
150138057|NCT02323646|541640269|FG002|Treatment Course 2|Non-compliance|1|||
150138058|NCT00521144|541640270|FG000|Overall Study|Not Treated|0|||
150138059|NCT00521144|541640271|FG001|Overall Study|Not Treated|0|||
150138060|NCT00521144|541640272|FG002|Overall Study|Not Treated|0|||
150138061|NCT00521144|541640273|FG003|Overall Study|Not Treated|1|||
150138062|NCT00521144|541640274|FG004|Overall Study|Not Treated|0|||
150138063|NCT00521144|541640270|FG000|Overall Study|Adverse Event|0|||
150138064|NCT00521144|541640271|FG001|Overall Study|Adverse Event|1|||
150138065|NCT00521144|541640272|FG002|Overall Study|Adverse Event|0|||
150138066|NCT00521144|541640273|FG003|Overall Study|Adverse Event|0|||
150138067|NCT00521144|541640274|FG004|Overall Study|Adverse Event|1|||
150138068|NCT00521144|541640270|FG000|Overall Study|Progressive Disease|4|||
150138069|NCT00521144|541640271|FG001|Overall Study|Progressive Disease|2|||
150138070|NCT00521144|541640272|FG002|Overall Study|Progressive Disease|2|||
150138071|NCT00521144|541640273|FG003|Overall Study|Progressive Disease|0|||
150138072|NCT00521144|541640274|FG004|Overall Study|Progressive Disease|6|||
150138073|NCT01370525|541640275|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
150138074|NCT01370525|541640276|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
150138075|NCT01370525|541640275|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
150138076|NCT01370525|541640276|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
150138077|NCT01370525|541640275|FG000|Overall Study|Adverse Event|0|||
150138078|NCT01370525|541640276|FG001|Overall Study|Adverse Event|1|||
150138079|NCT01370525|541640275|FG000|Overall Study|Protocol Violation|2|||
150138080|NCT01370525|541640276|FG001|Overall Study|Protocol Violation|1|||
150138081|NCT01370525|541640275|FG000|Overall Study|Lost to follow up|2|||
150138082|NCT01370525|541640276|FG001|Overall Study|Lost to follow up|6|||
150138083|NCT04791761|541640277|FG000|Overall Study|Lost to Follow-up|8|||
150138084|NCT04791761|541640278|FG001|Overall Study|Lost to Follow-up|6|||
150138085|NCT04791761|541640279|FG002|Overall Study|Lost to Follow-up|10|||
150138086|NCT04791761|541640277|FG000|Overall Study|Withdrawal by Subject|0|||
150138087|NCT04791761|541640278|FG001|Overall Study|Withdrawal by Subject|1|||
150138088|NCT04791761|541640279|FG002|Overall Study|Withdrawal by Subject|1|||
150138089|NCT04791761|541640277|FG000|Overall Study|Protocol Violation|0|||
150138090|NCT04791761|541640278|FG001|Overall Study|Protocol Violation|1|||
150138091|NCT04791761|541640279|FG002|Overall Study|Protocol Violation|1|||
150138092|NCT00180479|541640282|FG000|Overall Study|Death|4|||
150138093|NCT00180479|541640283|FG001|Overall Study|Death|2|||
150138094|NCT00180479|541640282|FG000|Overall Study|Lost to Follow-up|9|||
150138095|NCT00180479|541640283|FG001|Overall Study|Lost to Follow-up|7|||
150138096|NCT00180479|541640282|FG000|Overall Study|Withdrawal by Subject|3|||
150138097|NCT00180479|541640283|FG001|Overall Study|Withdrawal by Subject|3|||
150138098|NCT00180479|541640282|FG000|Overall Study|Informed consent not signed|0|||
150138099|NCT00180479|541640283|FG001|Overall Study|Informed consent not signed|1|||
150138100|NCT05168579|541640284|FG000|Overall Study|Lack of Consent|1|||
150138101|NCT05168579|541640285|FG001|Overall Study|Lack of Consent|0|||
150138102|NCT05168579|541640284|FG000|Overall Study|Conflicts with time|2|||
150138103|NCT05168579|541640285|FG001|Overall Study|Conflicts with time|0|||
150138104|NCT05168579|541640284|FG000|Overall Study|Time slots were full|3|||
150138105|NCT05168579|541640285|FG001|Overall Study|Time slots were full|0|||
150138106|NCT05168579|541640284|FG000|Overall Study|Lost to Follow-up|0|||
150138107|NCT05168579|541640285|FG001|Overall Study|Lost to Follow-up|15|||
150138108|NCT00105235|541640286|FG000|Overall Study|Death|4|||
150138109|NCT00105235|541640286|FG000|Overall Study|Physician Decision|1|||
150138110|NCT00105235|541640286|FG000|Overall Study|Withdrawal by Subject|2|||
150138111|NCT01197508|541640293|FG000|Overall Study|Withdrawal by Subject|8|||
150138112|NCT01197508|541640294|FG001|Overall Study|Withdrawal by Subject|7|||
150138113|NCT01197508|541640295|FG002|Overall Study|Withdrawal by Subject|15|||
150138114|NCT01197508|541640296|FG003|Overall Study|Withdrawal by Subject|4|||
150138115|NCT01197508|541640293|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
150209624|NCT07204444|541903743|FG002|Overall Study|Medical/Hospitalization|6|||
150209625|NCT07204444|541903741|FG000|Overall Study|Treatment Provider Issue|1|||
150209626|NCT07204444|541903742|FG001|Overall Study|Treatment Provider Issue|3|||
150209627|NCT07204444|541903743|FG002|Overall Study|Treatment Provider Issue|0|||
150209628|NCT07204444|541903741|FG000|Overall Study|Withdrawal by Subject|11|||
150209629|NCT07204444|541903742|FG001|Overall Study|Withdrawal by Subject|5|||
150209630|NCT07204444|541903743|FG002|Overall Study|Withdrawal by Subject|5|||
150209631|NCT07204444|541903741|FG000|Overall Study|Death|3|||
150209632|NCT07204444|541903742|FG001|Overall Study|Death|6|||
150209633|NCT07204444|541903743|FG002|Overall Study|Death|1|||
150209634|NCT07204444|541903741|FG000|Overall Study|Unable To Reach|29|||
150138116|NCT01197508|541640294|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
150138117|NCT01197508|541640295|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
150138118|NCT01197508|541640296|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
150138119|NCT01197508|541640293|FG000|Overall Study|Adverse Event|10|||
150138120|NCT01197508|541640294|FG001|Overall Study|Adverse Event|13|||
150138121|NCT01197508|541640295|FG002|Overall Study|Adverse Event|23|||
150138122|NCT01197508|541640296|FG003|Overall Study|Adverse Event|3|||
150138123|NCT01197508|541640293|FG000|Overall Study|Severe non-compliance to protocol|0|||
150138124|NCT01197508|541640294|FG001|Overall Study|Severe non-compliance to protocol|3|||
150209635|NCT07204444|541903742|FG001|Overall Study|Unable To Reach|26|||
150209636|NCT07204444|541903743|FG002|Overall Study|Unable To Reach|17|||
150209637|NCT07204444|541903741|FG000|Overall Study|Protocol Deviation|3|||
150209638|NCT07204444|541903742|FG001|Overall Study|Protocol Deviation|2|||
150209639|NCT07204444|541903743|FG002|Overall Study|Protocol Deviation|0|||
150209640|NCT00092534|541905081|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
150209641|NCT00092534|541905082|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
150209642|NCT00092534|541905083|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
150209643|NCT00092534|541905084|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
150209644|NCT00092534|541905085|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
150209645|NCT00092534|541905081|FG000|Base Study Vaccination Period|Adverse Event|3|||
150209646|NCT00092534|541905082|FG001|Base Study Vaccination Period|Adverse Event|1|||
150209647|NCT00092534|541905083|FG002|Base Study Vaccination Period|Adverse Event|0|||
150209648|NCT00092534|541905084|FG003|Base Study Vaccination Period|Adverse Event|0|||
150209649|NCT00092534|541905085|FG004|Base Study Vaccination Period|Adverse Event|0|||
150138125|NCT01197508|541640295|FG002|Overall Study|Severe non-compliance to protocol|1|||
150209650|NCT00092534|541905081|FG000|Base Study Vaccination Period|Death|5|||
150209651|NCT00092534|541905082|FG001|Base Study Vaccination Period|Death|4|||
150209652|NCT00092534|541905083|FG002|Base Study Vaccination Period|Death|0|||
150209653|NCT00092534|541905084|FG003|Base Study Vaccination Period|Death|0|||
150209654|NCT00092534|541905085|FG004|Base Study Vaccination Period|Death|0|||
150209655|NCT00092534|541905081|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
150138126|NCT01197508|541640296|FG003|Overall Study|Severe non-compliance to protocol|3|||
150209656|NCT00092534|541905082|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
150138127|NCT01197508|541640293|FG000|Overall Study|Condition under investigation worsened|1|||
150138128|NCT01197508|541640294|FG001|Overall Study|Condition under investigation worsened|1|||
150209657|NCT00092534|541905083|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
150209658|NCT00092534|541905084|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
150209659|NCT00092534|541905085|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
150209660|NCT00092534|541905081|FG000|Base Study Vaccination Period|Physician Decision|1|||
150209661|NCT00092534|541905082|FG001|Base Study Vaccination Period|Physician Decision|0|||
150209662|NCT00092534|541905083|FG002|Base Study Vaccination Period|Physician Decision|0|||
150209663|NCT00092534|541905084|FG003|Base Study Vaccination Period|Physician Decision|0|||
150209664|NCT00092534|541905085|FG004|Base Study Vaccination Period|Physician Decision|0|||
150209665|NCT00092534|541905081|FG000|Base Study Vaccination Period|Pregnancy|9|||
150209666|NCT00092534|541905082|FG001|Base Study Vaccination Period|Pregnancy|7|||
150209667|NCT00092534|541905083|FG002|Base Study Vaccination Period|Pregnancy|0|||
150209668|NCT00092534|541905084|FG003|Base Study Vaccination Period|Pregnancy|0|||
150209669|NCT00092534|541905085|FG004|Base Study Vaccination Period|Pregnancy|0|||
150209670|NCT00092534|541905081|FG000|Base Study Vaccination Period|Protocol Violation|2|||
150209671|NCT00092534|541905082|FG001|Base Study Vaccination Period|Protocol Violation|1|||
150209672|NCT00092534|541905083|FG002|Base Study Vaccination Period|Protocol Violation|0|||
150209673|NCT00092534|541905084|FG003|Base Study Vaccination Period|Protocol Violation|0|||
150209674|NCT00092534|541905085|FG004|Base Study Vaccination Period|Protocol Violation|0|||
150209675|NCT00092534|541905081|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
150209676|NCT00092534|541905082|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
150209677|NCT00092534|541905083|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
150209678|NCT00092534|541905084|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
150209679|NCT00092534|541905085|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
150209680|NCT00092534|541905081|FG000|Base Study Vaccination Period|Moved|14|||
150209681|NCT00092534|541905082|FG001|Base Study Vaccination Period|Moved|12|||
150209682|NCT00092534|541905083|FG002|Base Study Vaccination Period|Moved|0|||
150209683|NCT00092534|541905084|FG003|Base Study Vaccination Period|Moved|0|||
150209684|NCT00092534|541905085|FG004|Base Study Vaccination Period|Moved|0|||
150209685|NCT00092534|541905081|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
150209686|NCT00092534|541905082|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
150209687|NCT00092534|541905083|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
150209688|NCT00092534|541905084|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
150209689|NCT00092534|541905085|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
150209690|NCT00092534|541905081|FG000|Base Study Vaccination Period|Travel|1|||
150209691|NCT00092534|541905082|FG001|Base Study Vaccination Period|Travel|0|||
150209692|NCT00092534|541905083|FG002|Base Study Vaccination Period|Travel|0|||
150209693|NCT00092534|541905084|FG003|Base Study Vaccination Period|Travel|0|||
150209694|NCT00092534|541905085|FG004|Base Study Vaccination Period|Travel|0|||
150209695|NCT00092534|541905081|FG000|Base Study Vaccination Period|Site Closed|0|||
150209696|NCT00092534|541905082|FG001|Base Study Vaccination Period|Site Closed|1|||
150209697|NCT00092534|541905083|FG002|Base Study Vaccination Period|Site Closed|0|||
150209698|NCT00092534|541905084|FG003|Base Study Vaccination Period|Site Closed|0|||
150209699|NCT00092534|541905085|FG004|Base Study Vaccination Period|Site Closed|0|||
150209700|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Adverse Event|2|||
150138129|NCT01197508|541640295|FG002|Overall Study|Condition under investigation worsened|1|||
150138130|NCT01197508|541640296|FG003|Overall Study|Condition under investigation worsened|1|||
150138131|NCT01197508|541640293|FG000|Overall Study|Lack of Efficacy|1|||
150138132|NCT01197508|541640294|FG001|Overall Study|Lack of Efficacy|2|||
150138133|NCT01197508|541640295|FG002|Overall Study|Lack of Efficacy|2|||
150138134|NCT01197508|541640296|FG003|Overall Study|Lack of Efficacy|1|||
150138135|NCT01197508|541640293|FG000|Overall Study|Study-specific withdrawal criteria|0|||
150138136|NCT01197508|541640294|FG001|Overall Study|Study-specific withdrawal criteria|0|||
150138137|NCT01197508|541640295|FG002|Overall Study|Study-specific withdrawal criteria|1|||
150138138|NCT01197508|541640296|FG003|Overall Study|Study-specific withdrawal criteria|2|||
150209701|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Adverse Event|4|||
150209702|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Adverse Event|0|||
150209703|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Adverse Event|0|||
150138139|NCT01197508|541640293|FG000|Overall Study|Lost to Follow-up|1|||
150138140|NCT01197508|541640294|FG001|Overall Study|Lost to Follow-up|1|||
150138141|NCT01197508|541640295|FG002|Overall Study|Lost to Follow-up|2|||
150138142|NCT01197508|541640296|FG003|Overall Study|Lost to Follow-up|0|||
150138143|NCT01197508|541640293|FG000|Overall Study|Other|2|||
150138144|NCT01197508|541640294|FG001|Overall Study|Other|3|||
150138145|NCT01197508|541640295|FG002|Overall Study|Other|2|||
150138146|NCT01197508|541640296|FG003|Overall Study|Other|2|||
150138147|NCT01078155|541640297|FG000|Overall Study|Adverse Event|7|||
150138148|NCT01078155|541640297|FG000|Overall Study|Lack of Efficacy|16|||
150209704|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Adverse Event|0|||
150209705|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Death|2|||
150209706|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Death|1|||
150209707|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Death|0|||
150138149|NCT01078155|541640297|FG000|Overall Study|Participant's Decision|6|||
150209708|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Death|0|||
150209709|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Death|0|||
150209710|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
150209711|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
150209712|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
150209713|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
150209714|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
150209715|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Pregnancy|6|||
150209716|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Pregnancy|10|||
150209717|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Pregnancy|0|||
150209718|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Pregnancy|0|||
150209719|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Pregnancy|0|||
150209720|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
150209721|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
150209722|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
150209723|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
150209724|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
150209725|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
150138150|NCT01078155|541640297|FG000|Overall Study|Lost to Follow-up|15|||
150138151|NCT03286751|541640298|FG000|Washout Period 1|Withdrawal by Subject|0|||
150138152|NCT03286751|541640299|FG001|Washout Period 1|Withdrawal by Subject|0|||
150138153|NCT03286751|541640300|FG002|Washout Period 1|Withdrawal by Subject|0|||
150138154|NCT03286751|541640301|FG003|Washout Period 1|Withdrawal by Subject|0|||
150138155|NCT03286751|541640302|FG004|Washout Period 1|Withdrawal by Subject|1|||
150138156|NCT03286751|541640303|FG005|Washout Period 1|Withdrawal by Subject|0|||
150138157|NCT03286751|541640298|FG000|Washout Period 2|Personal Reasons|0|||
150138158|NCT03286751|541640299|FG001|Washout Period 2|Personal Reasons|1|||
150138159|NCT03286751|541640300|FG002|Washout Period 2|Personal Reasons|0|||
150138160|NCT03286751|541640301|FG003|Washout Period 2|Personal Reasons|0|||
150138161|NCT03286751|541640302|FG004|Washout Period 2|Personal Reasons|0|||
150138162|NCT03286751|541640303|FG005|Washout Period 2|Personal Reasons|0|||
150138163|NCT03286751|541640298|FG000|Washout Period 5|Adverse Event|0|||
150138164|NCT03286751|541640299|FG001|Washout Period 5|Adverse Event|0|||
150138165|NCT03286751|541640300|FG002|Washout Period 5|Adverse Event|0|||
150138166|NCT03286751|541640301|FG003|Washout Period 5|Adverse Event|0|||
150138167|NCT03286751|541640302|FG004|Washout Period 5|Adverse Event|1|||
150138168|NCT03286751|541640303|FG005|Washout Period 5|Adverse Event|0|||
150138169|NCT04044456|541640311|FG000|Overall Study|Lost to Follow-up|4|||
150138170|NCT04044456|541640312|FG001|Overall Study|Lost to Follow-up|1|||
150138171|NCT04044456|541640311|FG000|Overall Study|Withdrawal by Subject|1|||
150138172|NCT04044456|541640312|FG001|Overall Study|Withdrawal by Subject|0|||
150138173|NCT01972529|541640313|FG000|Overall Study|Adverse Event|0|||
150138174|NCT01972529|541640314|FG001|Overall Study|Adverse Event|1|||
150138175|NCT01972529|541640315|FG002|Overall Study|Adverse Event|0|||
150138176|NCT01972529|541640316|FG003|Overall Study|Adverse Event|0|||
150209726|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
150209727|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
150209728|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
150209729|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
150209730|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Moved|62|||
150209731|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Moved|58|||
150209732|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Moved|0|||
150209733|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Moved|0|||
150209734|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Moved|0|||
150209735|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Travel|10|||
150209736|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Travel|7|||
150209737|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Travel|0|||
150209738|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Travel|0|||
150138177|NCT01972529|541640313|FG000|Overall Study|Lost to Follow-up|1|||
150138178|NCT01972529|541640314|FG001|Overall Study|Lost to Follow-up|0|||
150138179|NCT01972529|541640315|FG002|Overall Study|Lost to Follow-up|0|||
150138180|NCT01972529|541640316|FG003|Overall Study|Lost to Follow-up|0|||
150138181|NCT01972529|541640313|FG000|Overall Study|Participant Choice|0|||
150138182|NCT01972529|541640314|FG001|Overall Study|Participant Choice|1|||
150209739|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Travel|0|||
150209740|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Site Closed|0|||
150209741|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Site Closed|2|||
150209742|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Site Closed|0|||
150138183|NCT01972529|541640315|FG002|Overall Study|Participant Choice|0|||
150138184|NCT01972529|541640316|FG003|Overall Study|Participant Choice|0|||
150209743|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Site Closed|0|||
150209744|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Site Closed|0|||
150209745|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
150209746|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
150209747|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
150209748|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
150209749|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
150209750|NCT00092534|541905081|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
150209751|NCT00092534|541905082|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
150209752|NCT00092534|541905083|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
150209753|NCT00092534|541905084|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
150209754|NCT00092534|541905085|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
150209755|NCT00092534|541905081|FG000|Base Study EXT|Lost to Follow-up|0|||
150138185|NCT01972529|541640313|FG000|Overall Study|Withdrawl of Consent|1|||
150138186|NCT01972529|541640314|FG001|Overall Study|Withdrawl of Consent|2|||
150138187|NCT01972529|541640315|FG002|Overall Study|Withdrawl of Consent|0|||
150138188|NCT01972529|541640316|FG003|Overall Study|Withdrawl of Consent|1|||
150138189|NCT01972529|541640313|FG000|Overall Study|Other|0|||
150138190|NCT01972529|541640314|FG001|Overall Study|Other|0|||
150138191|NCT01972529|541640315|FG002|Overall Study|Other|0|||
150138192|NCT01972529|541640316|FG003|Overall Study|Other|2|||
150138193|NCT01972529|541640313|FG000|Overall Study|Not treated|0|||
150138194|NCT01972529|541640314|FG001|Overall Study|Not treated|1|||
150138195|NCT01972529|541640315|FG002|Overall Study|Not treated|2|||
150138196|NCT01972529|541640316|FG003|Overall Study|Not treated|1|||
150138197|NCT00330174|541640318|FG000|Overall Study|Withdrawal by Subject|7|||
150138198|NCT00330174|541640319|FG001|Overall Study|Withdrawal by Subject|7|||
150138199|NCT00330174|541640318|FG000|Overall Study|Lost to Follow-up|4|||
150138200|NCT00330174|541640319|FG001|Overall Study|Lost to Follow-up|1|||
150138201|NCT00330174|541640318|FG000|Overall Study|Clinical deterioration|1|||
150138202|NCT00330174|541640319|FG001|Overall Study|Clinical deterioration|2|||
150138203|NCT00330174|541640318|FG000|Overall Study|Excessive missed visits|3|||
150138204|NCT00330174|541640319|FG001|Overall Study|Excessive missed visits|8|||
150138205|NCT00330174|541640318|FG000|Overall Study|Miscellaneous reasons|7|||
150138206|NCT00330174|541640319|FG001|Overall Study|Miscellaneous reasons|1|||
150138207|NCT02316769|541640322|FG000|Overall Study|Physician Decision|1|||
150138208|NCT02316769|541640323|FG001|Overall Study|Physician Decision|0|||
150138209|NCT02316769|541640322|FG000|Overall Study|Withdrawal by Subject|1|||
150138210|NCT02316769|541640323|FG001|Overall Study|Withdrawal by Subject|0|||
150138211|NCT01201811|541640324|FG000|Overall Study|Adverse Event|6|||
150138212|NCT01201811|541640324|FG000|Overall Study|Disease progression|3|||
150209756|NCT00092534|541905082|FG001|Base Study EXT|Lost to Follow-up|0|||
150209757|NCT00092534|541905083|FG002|Base Study EXT|Lost to Follow-up|41|||
150209758|NCT00092534|541905084|FG003|Base Study EXT|Lost to Follow-up|0|||
150209759|NCT00092534|541905085|FG004|Base Study EXT|Lost to Follow-up|0|||
150209760|NCT00092534|541905081|FG000|Base Study EXT|Physician Decision|0|||
150209761|NCT00092534|541905082|FG001|Base Study EXT|Physician Decision|0|||
150209762|NCT00092534|541905083|FG002|Base Study EXT|Physician Decision|1|||
150209763|NCT00092534|541905084|FG003|Base Study EXT|Physician Decision|0|||
150209764|NCT00092534|541905085|FG004|Base Study EXT|Physician Decision|0|||
150209765|NCT00092534|541905081|FG000|Base Study EXT|Pregnancy|0|||
150209766|NCT00092534|541905082|FG001|Base Study EXT|Pregnancy|0|||
150209767|NCT00092534|541905083|FG002|Base Study EXT|Pregnancy|12|||
150209768|NCT00092534|541905084|FG003|Base Study EXT|Pregnancy|0|||
150209769|NCT00092534|541905085|FG004|Base Study EXT|Pregnancy|0|||
150209770|NCT00092534|541905081|FG000|Base Study EXT|Withdrawal by Subject|0|||
150209771|NCT00092534|541905082|FG001|Base Study EXT|Withdrawal by Subject|0|||
150209772|NCT00092534|541905083|FG002|Base Study EXT|Withdrawal by Subject|18|||
150209773|NCT00092534|541905084|FG003|Base Study EXT|Withdrawal by Subject|0|||
150138213|NCT01201811|541640324|FG000|Overall Study|Withdrawal by Subject|3|||
150138214|NCT01201811|541640324|FG000|Overall Study|Death|4|||
150138215|NCT01201811|541640324|FG000|Overall Study|Treatment Failure|2|||
150138216|NCT01201811|541640324|FG000|Overall Study|Physician Decision|1|||
150138217|NCT02277990|541640330|FG000|Overall Study|Death|170|||
150138218|NCT02277990|541640331|FG001|Overall Study|Death|188|||
150138219|NCT02277990|541640330|FG000|Overall Study|Withdrawal by Subject|64|||
150138220|NCT02277990|541640331|FG001|Overall Study|Withdrawal by Subject|53|||
150209774|NCT00092534|541905085|FG004|Base Study EXT|Withdrawal by Subject|0|||
150209775|NCT00092534|541905081|FG000|Base Study EXT|Participant moved|0|||
150209776|NCT00092534|541905082|FG001|Base Study EXT|Participant moved|0|||
150209777|NCT00092534|541905083|FG002|Base Study EXT|Participant moved|6|||
150209778|NCT00092534|541905084|FG003|Base Study EXT|Participant moved|0|||
150209779|NCT00092534|541905085|FG004|Base Study EXT|Participant moved|0|||
150138221|NCT02277990|541640330|FG000|Overall Study|Physician Decision|40|||
150138222|NCT02277990|541640331|FG001|Overall Study|Physician Decision|34|||
150209780|NCT00092534|541905081|FG000|Base Study EXT|Travel|0|||
150209781|NCT00092534|541905082|FG001|Base Study EXT|Travel|0|||
150209782|NCT00092534|541905083|FG002|Base Study EXT|Travel|2|||
150209783|NCT00092534|541905084|FG003|Base Study EXT|Travel|0|||
150209784|NCT00092534|541905085|FG004|Base Study EXT|Travel|0|||
150209785|NCT00092534|541905081|FG000|Base Study EXT|Site closed|0|||
150209786|NCT00092534|541905082|FG001|Base Study EXT|Site closed|0|||
150209787|NCT00092534|541905083|FG002|Base Study EXT|Site closed|21|||
150209788|NCT00092534|541905084|FG003|Base Study EXT|Site closed|0|||
150209789|NCT00092534|541905085|FG004|Base Study EXT|Site closed|0|||
150209790|NCT00092534|541905081|FG000|Base Study EXT|Study ended|0|||
150209791|NCT00092534|541905082|FG001|Base Study EXT|Study ended|0|||
150209792|NCT00092534|541905083|FG002|Base Study EXT|Study ended|29|||
150209793|NCT00092534|541905084|FG003|Base Study EXT|Study ended|0|||
150209794|NCT00092534|541905085|FG004|Base Study EXT|Study ended|0|||
150138223|NCT02277990|541640330|FG000|Overall Study|Lost to Follow-up|66|||
150138224|NCT02277990|541640331|FG001|Overall Study|Lost to Follow-up|69|||
150138225|NCT02277990|541640330|FG000|Overall Study|Had other reason|26|||
150138226|NCT02277990|541640331|FG001|Overall Study|Had other reason|32|||
150138227|NCT00946296|541640332|FG000|Overall Study|Physician Decision|3|||
150138228|NCT00946296|541640333|FG001|Overall Study|Physician Decision|0|||
150138229|NCT03434678|541640336|FG000|Overall Study|Withdrawal by Subject|13|||
150138230|NCT03434678|541640337|FG001|Overall Study|Withdrawal by Subject|13|||
150138231|NCT03434678|541640336|FG000|Overall Study|Found to be ineligible post randomization|2|||
150138232|NCT03434678|541640337|FG001|Overall Study|Found to be ineligible post randomization|1|||
150138233|NCT06060457|541640340|FG000|Overall Study|Adverse Event|1|||
150138234|NCT06060457|541640341|FG001|Overall Study|Adverse Event|1|||
150138235|NCT06060457|541640340|FG000|Overall Study|Death|2|||
150138236|NCT06060457|541640341|FG001|Overall Study|Death|2|||
150138237|NCT06060457|541640340|FG000|Overall Study|Lost to Follow-up|17|||
150138238|NCT06060457|541640341|FG001|Overall Study|Lost to Follow-up|19|||
150138239|NCT06060457|541640340|FG000|Overall Study|Physician Decision|0|||
150138240|NCT06060457|541640341|FG001|Overall Study|Physician Decision|1|||
150138241|NCT06060457|541640340|FG000|Overall Study|Protocol Violation|1|||
150138242|NCT06060457|541640341|FG001|Overall Study|Protocol Violation|1|||
150138243|NCT06060457|541640340|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
150138244|NCT06060457|541640341|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
150138245|NCT06060457|541640340|FG000|Overall Study|Withdrawal by Subject|12|||
150138246|NCT06060457|541640341|FG001|Overall Study|Withdrawal by Subject|15|||
150138247|NCT06060457|541640340|FG000|Overall Study|Other Than Specified|2|||
150138248|NCT06060457|541640341|FG001|Overall Study|Other Than Specified|1|||
150138249|NCT02061202|541640342|FG000|Overall Study|Lost to Follow-up|1|||
150138250|NCT02061202|541640343|FG001|Overall Study|Lost to Follow-up|1|||
150138251|NCT01533493|541640344|FG000|Overall Study|Adverse Event|2|||
150138252|NCT01533493|541640345|FG001|Overall Study|Adverse Event|1|||
150138253|NCT01533493|541640344|FG000|Overall Study|Withdrawal by Subject|1|||
150138254|NCT01533493|541640345|FG001|Overall Study|Withdrawal by Subject|2|||
150138255|NCT01533493|541640344|FG000|Overall Study|Lost to Follow-up|2|||
150138256|NCT01533493|541640345|FG001|Overall Study|Lost to Follow-up|0|||
150138257|NCT01860703|541640346|FG000|Overall Study|Adverse Event|1|||
150138258|NCT01860703|541640347|FG001|Overall Study|Adverse Event|4|||
150138259|NCT01860703|541640348|FG002|Overall Study|Adverse Event|0|||
150138260|NCT01860703|541640349|FG003|Overall Study|Adverse Event|2|||
150138261|NCT01860703|541640346|FG000|Overall Study|Withdrawal by Subject|0|||
150138262|NCT01860703|541640347|FG001|Overall Study|Withdrawal by Subject|1|||
150138263|NCT01860703|541640348|FG002|Overall Study|Withdrawal by Subject|0|||
150138264|NCT01860703|541640349|FG003|Overall Study|Withdrawal by Subject|0|||
150138265|NCT01860703|541640346|FG000|Overall Study|Personal reason|1|||
150138266|NCT01860703|541640347|FG001|Overall Study|Personal reason|0|||
150138267|NCT01860703|541640348|FG002|Overall Study|Personal reason|1|||
150138268|NCT01860703|541640349|FG003|Overall Study|Personal reason|0|||
150138269|NCT00696410|541640353|FG000|Overall Study|Lost to Follow-up|2|||
150138270|NCT00696410|541640354|FG001|Overall Study|Lost to Follow-up|0|||
150209795|NCT00092534|541905081|FG000|Base Study EXT|Protocol Violation|0|||
150209796|NCT00092534|541905082|FG001|Base Study EXT|Protocol Violation|0|||
150138271|NCT00696410|541640353|FG000|Overall Study|Withdrawal by Subject|8|||
150138272|NCT00696410|541640354|FG001|Overall Study|Withdrawal by Subject|0|||
150138273|NCT00696410|541640353|FG000|Overall Study|Physician Decision|3|||
150138274|NCT00696410|541640354|FG001|Overall Study|Physician Decision|0|||
150138275|NCT03184792|541640358|FG000|Overall Study|Pandemic|2|||
150209797|NCT00092534|541905083|FG002|Base Study EXT|Protocol Violation|15|||
150209798|NCT00092534|541905084|FG003|Base Study EXT|Protocol Violation|0|||
150209799|NCT00092534|541905085|FG004|Base Study EXT|Protocol Violation|0|||
150209800|NCT00092534|541905081|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
150138276|NCT03184792|541640359|FG001|Overall Study|Pandemic|2|||
150209801|NCT00092534|541905082|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
150138277|NCT02495025|541640360|FG000|Overall Study|Lost to Follow-up|21|||
150138278|NCT02495025|541640361|FG001|Overall Study|Lost to Follow-up|14|||
150138279|NCT02495025|541640360|FG000|Overall Study|Withdrawal by Subject|5|||
150138280|NCT02495025|541640361|FG001|Overall Study|Withdrawal by Subject|0|||
150138281|NCT02365519|541640365|FG000|Randomized and Treated|Adverse Event|0|||
150138282|NCT02365519|541640366|FG001|Randomized and Treated|Adverse Event|1|||
150138283|NCT02365519|541640367|FG002|Randomized and Treated|Adverse Event|0|||
150138284|NCT02365519|541640365|FG000|Randomized and Treated|Withdrawal by Subject|0|||
150138285|NCT02365519|541640366|FG001|Randomized and Treated|Withdrawal by Subject|1|||
150138286|NCT02365519|541640367|FG002|Randomized and Treated|Withdrawal by Subject|1|||
150138287|NCT01971723|541640368|FG000|Overall Study|Withdrawal by Subject|1|||
150138288|NCT01971723|541640369|FG001|Overall Study|Withdrawal by Subject|1|||
150138289|NCT01971723|541640368|FG000|Overall Study|Protocol Violation|1|||
150138290|NCT01971723|541640369|FG001|Overall Study|Protocol Violation|2|||
150138291|NCT03657277|541640373|FG000|Overall Study|Physician Decision|2|||
150138292|NCT03657277|541640373|FG000|Overall Study|Lost to Follow-up|1|||
150138293|NCT03657277|541640373|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
150138294|NCT04981678|541640377|FG000|Overall Study|Lost to Follow-up|0|||
150138295|NCT04981678|541640378|FG001|Overall Study|Lost to Follow-up|1|||
150138296|NCT03421808|541640379|FG000|Overall Study|COVID related problems|2|||
150138297|NCT03421808|541640380|FG001|Overall Study|COVID related problems|0|||
150138298|NCT03421808|541640379|FG000|Overall Study|Withdrawal by Subject|1|||
150138299|NCT03421808|541640380|FG001|Overall Study|Withdrawal by Subject|0|||
150138300|NCT03421808|541640379|FG000|Overall Study|Protocol Violation|0|||
150138301|NCT03421808|541640380|FG001|Overall Study|Protocol Violation|1|||
150138302|NCT05809596|541640383|FG000|Overall Study|Death|16|||
150138303|NCT05809596|541640383|FG000|Overall Study|Withdrawal by Subject|4|||
150138304|NCT05809596|541640383|FG000|Overall Study|Physician Decision|1|||
150138305|NCT05809596|541640383|FG000|Overall Study|Missed Visit|2|||
150138306|NCT05809596|541640383|FG000|Overall Study|Other|3|||
150138307|NCT03770494|541640385|FG000|Overall Study|Lost to Follow-up|0|||
150138308|NCT03770494|541640386|FG001|Overall Study|Lost to Follow-up|0|||
150138309|NCT03770494|541640387|FG002|Overall Study|Lost to Follow-up|1|||
150138310|NCT03770494|541640388|FG003|Overall Study|Lost to Follow-up|1|||
150138311|NCT03770494|541640389|FG004|Overall Study|Lost to Follow-up|1|||
150138312|NCT03770494|541640390|FG005|Overall Study|Lost to Follow-up|0|||
150138313|NCT03770494|541640391|FG006|Overall Study|Lost to Follow-up|0|||
150138314|NCT03770494|541640392|FG007|Overall Study|Lost to Follow-up|0|||
150138315|NCT03770494|541640393|FG008|Overall Study|Lost to Follow-up|0|||
150138316|NCT03770494|541640394|FG009|Overall Study|Lost to Follow-up|0|||
150138317|NCT03770494|541640395|FG010|Overall Study|Lost to Follow-up|0|||
150138318|NCT03770494|541640396|FG011|Overall Study|Lost to Follow-up|0|||
150138319|NCT03770494|541640397|FG012|Overall Study|Lost to Follow-up|0|||
150138320|NCT03770494|541640398|FG013|Overall Study|Lost to Follow-up|0|||
150138321|NCT03770494|541640385|FG000|Overall Study|Study terminated by sponsor|1|||
150138322|NCT03770494|541640386|FG001|Overall Study|Study terminated by sponsor|2|||
150138323|NCT03770494|541640387|FG002|Overall Study|Study terminated by sponsor|1|||
150138324|NCT03770494|541640388|FG003|Overall Study|Study terminated by sponsor|1|||
150138325|NCT03770494|541640389|FG004|Overall Study|Study terminated by sponsor|1|||
150138326|NCT03770494|541640390|FG005|Overall Study|Study terminated by sponsor|2|||
150138327|NCT03770494|541640391|FG006|Overall Study|Study terminated by sponsor|1|||
150138328|NCT03770494|541640392|FG007|Overall Study|Study terminated by sponsor|2|||
150138329|NCT03770494|541640393|FG008|Overall Study|Study terminated by sponsor|1|||
150138330|NCT03770494|541640394|FG009|Overall Study|Study terminated by sponsor|2|||
150138331|NCT03770494|541640395|FG010|Overall Study|Study terminated by sponsor|1|||
150138332|NCT03770494|541640396|FG011|Overall Study|Study terminated by sponsor|2|||
150138333|NCT03770494|541640397|FG012|Overall Study|Study terminated by sponsor|0|||
150138334|NCT03770494|541640398|FG013|Overall Study|Study terminated by sponsor|0|||
150138335|NCT03770494|541640385|FG000|Overall Study|Withdrawal by Subject|1|||
150138336|NCT03770494|541640386|FG001|Overall Study|Withdrawal by Subject|1|||
150138337|NCT03770494|541640387|FG002|Overall Study|Withdrawal by Subject|0|||
150138338|NCT03770494|541640388|FG003|Overall Study|Withdrawal by Subject|0|||
150138339|NCT03770494|541640389|FG004|Overall Study|Withdrawal by Subject|2|||
150138340|NCT03770494|541640390|FG005|Overall Study|Withdrawal by Subject|2|||
150138341|NCT03770494|541640391|FG006|Overall Study|Withdrawal by Subject|2|||
150138342|NCT03770494|541640392|FG007|Overall Study|Withdrawal by Subject|0|||
150138343|NCT03770494|541640393|FG008|Overall Study|Withdrawal by Subject|2|||
150209802|NCT00092534|541905083|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
150209803|NCT00092534|541905084|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
150209804|NCT00092534|541905085|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
150209805|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
150209806|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
150138344|NCT03770494|541640394|FG009|Overall Study|Withdrawal by Subject|3|||
150138345|NCT03770494|541640395|FG010|Overall Study|Withdrawal by Subject|1|||
150138346|NCT03770494|541640396|FG011|Overall Study|Withdrawal by Subject|0|||
150209807|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
150209808|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
150209809|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
150209810|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
150209811|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
150209812|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
150138347|NCT03770494|541640397|FG012|Overall Study|Withdrawal by Subject|0|||
150138348|NCT03770494|541640398|FG013|Overall Study|Withdrawal by Subject|0|||
150138349|NCT01984697|541641980|FG000|Overall Study|Adverse Event|0|||
150138350|NCT01984697|541641981|FG001|Overall Study|Adverse Event|0|||
150138351|NCT01984697|541641982|FG002|Overall Study|Adverse Event|2|||
150138352|NCT01984697|541641983|FG003|Overall Study|Adverse Event|0|||
150138353|NCT01984697|541641984|FG004|Overall Study|Adverse Event|0|||
150138354|NCT01984697|541641980|FG000|Overall Study|Lost to Follow-up|14|||
150138355|NCT01984697|541641981|FG001|Overall Study|Lost to Follow-up|5|||
150138356|NCT01984697|541641982|FG002|Overall Study|Lost to Follow-up|10|||
150138357|NCT01984697|541641983|FG003|Overall Study|Lost to Follow-up|6|||
150209813|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
150209814|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
150209815|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
150209816|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
150209817|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
150209818|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
150209819|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
150209820|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
150209821|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
150209822|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
150209823|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
150209824|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
150209825|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
150209826|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
150209827|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
150209828|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
150209829|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
150209830|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Other|1|||
150209831|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Other|0|||
150209832|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Other|0|||
150209833|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Other|0|||
150209834|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Other|0|||
150209835|NCT02386098|541905086|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
150209836|NCT02386098|541905087|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
150209837|NCT02386098|541905088|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
150209838|NCT02386098|541905089|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
150209839|NCT02386098|541905090|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
150209840|NCT03002194|541905093|FG000|Overall Study|Lost to Follow-up|6|||
150209841|NCT03002194|541905093|FG000|Overall Study|Adverse Event|1|||
150209842|NCT03002194|541905093|FG000|Overall Study|Lack of Efficacy|1|||
150209843|NCT03002194|541905093|FG000|Overall Study|Withdrawal by Subject|2|||
150209844|NCT04162210|541905096|FG000|Overall Study|Lost to Follow-up|4|||
150209845|NCT04162210|541905097|FG001|Overall Study|Lost to Follow-up|1|||
150209846|NCT04162210|541905096|FG000|Overall Study|Withdrawal by Subject|17|||
150209847|NCT04162210|541905097|FG001|Overall Study|Withdrawal by Subject|9|||
150209848|NCT04162210|541905096|FG000|Overall Study|Ongoing|113|||
150209849|NCT04162210|541905097|FG001|Overall Study|Ongoing|59|||
150209850|NCT04497415|541905098|FG000|Overall Study|Lost to Follow-up|43|||
150209851|NCT04497415|541905099|FG001|Overall Study|Lost to Follow-up|27|||
150209852|NCT02463448|541905102|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
150209853|NCT02463448|541905102|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
150209854|NCT02463448|541905102|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
150209855|NCT02463448|541905102|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
150209856|NCT03021993|541905103|FG000|Overall Study|Withdrawal by Subject|4|||
150209857|NCT03021993|541905103|FG000|Overall Study|Physician Decision|1|||
150209858|NCT03021993|541905103|FG000|Overall Study|enrolled but were not treated|1|||
150209859|NCT03021993|541905103|FG000|Overall Study|Death|3|||
150209860|NCT03890289|541905108|FG000|Overall Study|Adverse Event|1|||
150138358|NCT01984697|541641984|FG004|Overall Study|Lost to Follow-up|21|||
150209861|NCT03890289|541905108|FG000|Overall Study|Physician Decision|1|||
150209862|NCT03890289|541905108|FG000|Overall Study|Lack of Efficacy|2|||
150138359|NCT01984697|541641980|FG000|Overall Study|Physician Decision|3|||
150209863|NCT02816398|541905114|FG000|Overall Study|Death|5|||
150209864|NCT02816398|541905114|FG000|Overall Study|Lack of Efficacy|8|||
150209865|NCT02816398|541905114|FG000|Overall Study|Lost to Follow-up|1|||
150209866|NCT01588951|541905119|FG000|Overall Study|Ineligible in retrospect|0|||
150209867|NCT01588951|541905120|FG001|Overall Study|Ineligible in retrospect|0|||
150209868|NCT01588951|541905121|FG002|Overall Study|Ineligible in retrospect|1|||
150209869|NCT03683576|541905122|FG000|Overall Study|Withdrawal by Subject|2|||
150209870|NCT03683576|541905123|FG001|Overall Study|Withdrawal by Subject|0|||
150209871|NCT03683576|541905124|FG002|Overall Study|Withdrawal by Subject|8|||
150209872|NCT03683576|541905125|FG003|Overall Study|Withdrawal by Subject|3|||
150138360|NCT01984697|541641981|FG001|Overall Study|Physician Decision|0|||
150138361|NCT01984697|541641982|FG002|Overall Study|Physician Decision|0|||
150138362|NCT01984697|541641983|FG003|Overall Study|Physician Decision|1|||
150138363|NCT01984697|541641984|FG004|Overall Study|Physician Decision|0|||
150138364|NCT01984697|541641980|FG000|Overall Study|Protocol Violation|8|||
150138365|NCT01984697|541641981|FG001|Overall Study|Protocol Violation|5|||
150138366|NCT01984697|541641982|FG002|Overall Study|Protocol Violation|3|||
150138367|NCT01984697|541641983|FG003|Overall Study|Protocol Violation|2|||
150138368|NCT01984697|541641984|FG004|Overall Study|Protocol Violation|0|||
150138369|NCT01984697|541641980|FG000|Overall Study|Withdrawal by Subject|15|||
150138370|NCT01984697|541641981|FG001|Overall Study|Withdrawal by Subject|21|||
150138371|NCT01984697|541641982|FG002|Overall Study|Withdrawal by Subject|13|||
150138372|NCT01984697|541641983|FG003|Overall Study|Withdrawal by Subject|11|||
150138373|NCT01984697|541641984|FG004|Overall Study|Withdrawal by Subject|13|||
150138374|NCT01984697|541641980|FG000|Overall Study|Missed last follow-up visit|1|||
150138375|NCT01984697|541641981|FG001|Overall Study|Missed last follow-up visit|0|||
150138376|NCT01984697|541641982|FG002|Overall Study|Missed last follow-up visit|0|||
150138377|NCT01984697|541641983|FG003|Overall Study|Missed last follow-up visit|0|||
150138378|NCT01984697|541641984|FG004|Overall Study|Missed last follow-up visit|0|||
150138379|NCT01984697|541641980|FG000|Overall Study|Death|0|||
150138380|NCT01984697|541641981|FG001|Overall Study|Death|0|||
150138381|NCT01984697|541641982|FG002|Overall Study|Death|0|||
150138382|NCT01984697|541641983|FG003|Overall Study|Death|1|||
150138383|NCT01984697|541641984|FG004|Overall Study|Death|0|||
150138384|NCT01984697|541641980|FG000|Overall Study|Pregnancy|2|||
150138385|NCT01984697|541641981|FG001|Overall Study|Pregnancy|0|||
150138386|NCT01984697|541641982|FG002|Overall Study|Pregnancy|1|||
150138387|NCT01984697|541641983|FG003|Overall Study|Pregnancy|0|||
150138388|NCT01984697|541641984|FG004|Overall Study|Pregnancy|1|||
150138389|NCT00949715|541641992|FG000|Overall Study|Physician Decision|1|||
150138390|NCT00949715|541641993|FG001|Overall Study|Physician Decision|0|||
150138391|NCT00949715|541641992|FG000|Overall Study|Lost to Follow-up|1|||
150138392|NCT00949715|541641993|FG001|Overall Study|Lost to Follow-up|0|||
150138393|NCT00949715|541641992|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
150209873|NCT03683576|541905122|FG000|Overall Study|Adverse Event|3|||
150209874|NCT03683576|541905123|FG001|Overall Study|Adverse Event|0|||
150209875|NCT03683576|541905124|FG002|Overall Study|Adverse Event|0|||
150209876|NCT03683576|541905125|FG003|Overall Study|Adverse Event|4|||
150209877|NCT03683576|541905122|FG000|Overall Study|Lack of Efficacy|1|||
150138394|NCT00949715|541641993|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
150138395|NCT01582789|541641995|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
150138396|NCT01582789|541641996|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
150138397|NCT00861614|541641997|FG000|Overall Study|Disease Progression|182|||
150138398|NCT00861614|541641998|FG001|Overall Study|Disease Progression|263|||
150138399|NCT00861614|541641997|FG000|Overall Study|Study Drug Toxicity|79|||
150138400|NCT00861614|541641998|FG001|Overall Study|Study Drug Toxicity|6|||
150138401|NCT00861614|541641997|FG000|Overall Study|Death|32|||
150138402|NCT00861614|541641998|FG001|Overall Study|Death|19|||
150138403|NCT00861614|541641997|FG000|Overall Study|Adverse Event|27|||
150138404|NCT00861614|541641998|FG001|Overall Study|Adverse Event|23|||
150138405|NCT00861614|541641997|FG000|Overall Study|Withdrawal by Subject|34|||
150138406|NCT00861614|541641998|FG001|Overall Study|Withdrawal by Subject|35|||
150138407|NCT00861614|541641997|FG000|Overall Study|Other|17|||
150138408|NCT00861614|541641998|FG001|Overall Study|Other|22|||
150138409|NCT05050578|541641999|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
150138410|NCT05050578|541642000|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
150138411|NCT05050578|541641999|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
150138412|NCT05050578|541642000|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
150138413|NCT05050578|541641999|FG000|Period 2, 30 Days|Protocol Violation|0|||
150138414|NCT05050578|541642000|FG001|Period 2, 30 Days|Protocol Violation|1|||
150138415|NCT02243280|541642001|FG000|Treated|Adverse Event|1|||
150138416|NCT02243280|541642002|FG001|Treated|Adverse Event|0|||
150138417|NCT02243280|541642003|FG002|Treated|Adverse Event|0|||
150209878|NCT03683576|541905123|FG001|Overall Study|Lack of Efficacy|0|||
150209879|NCT03683576|541905124|FG002|Overall Study|Lack of Efficacy|1|||
150209880|NCT03683576|541905125|FG003|Overall Study|Lack of Efficacy|1|||
150209881|NCT03683576|541905122|FG000|Overall Study|Lost to Follow-up|0|||
150138418|NCT02243280|541642004|FG003|Treated|Adverse Event|0|||
150138419|NCT02243280|541642005|FG004|Treated|Adverse Event|0|||
150138420|NCT02243280|541642006|FG005|Treated|Adverse Event|0|||
150138421|NCT02243280|541642007|FG006|Treated|Adverse Event|0|||
150138422|NCT02243280|541642008|FG007|Treated|Adverse Event|0|||
150138423|NCT02243280|541642009|FG008|Treated|Adverse Event|0|||
150138424|NCT02243280|541642010|FG009|Treated|Adverse Event|0|||
150138425|NCT02243280|541642011|FG010|Treated|Adverse Event|1|||
150138426|NCT02243280|541642001|FG000|Treated|Lost to Follow-up|0|||
150138427|NCT02243280|541642002|FG001|Treated|Lost to Follow-up|0|||
150138428|NCT02243280|541642003|FG002|Treated|Lost to Follow-up|0|||
150138429|NCT02243280|541642004|FG003|Treated|Lost to Follow-up|0|||
150138430|NCT02243280|541642005|FG004|Treated|Lost to Follow-up|0|||
150138431|NCT02243280|541642006|FG005|Treated|Lost to Follow-up|0|||
150138432|NCT02243280|541642007|FG006|Treated|Lost to Follow-up|0|||
150138433|NCT02243280|541642008|FG007|Treated|Lost to Follow-up|0|||
150138434|NCT02243280|541642009|FG008|Treated|Lost to Follow-up|1|||
150138435|NCT02243280|541642010|FG009|Treated|Lost to Follow-up|0|||
150138436|NCT02243280|541642011|FG010|Treated|Lost to Follow-up|2|||
150138437|NCT02710292|541642016|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
150138438|NCT02710292|541642017|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
150138439|NCT02710292|541642016|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
150138440|NCT02710292|541642017|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
150138441|NCT02364180|541642018|FG000|Overall Study|Screen Fail|1|||
150138442|NCT01783418|541642019|FG000|Overall Study|Withdrawal by Subject|1|||
150138443|NCT01783418|541642020|FG001|Overall Study|Withdrawal by Subject|0|||
150138444|NCT00089141|541642021|FG000|Overall Study|Termination of trial|18|||
150138445|NCT00089141|541642022|FG001|Overall Study|Termination of trial|24|||
150138446|NCT00508261|541642023|FG000|Overall Study|Other|0|||
150138447|NCT00508261|541642024|FG001|Overall Study|Other|1|||
150138448|NCT00508261|541642025|FG002|Overall Study|Other|1|||
150138449|NCT00508261|541642026|FG003|Overall Study|Other|0|||
150138450|NCT00508261|541642023|FG000|Overall Study|Serious Adverse Event|0|||
150138451|NCT00508261|541642024|FG001|Overall Study|Serious Adverse Event|1|||
150138452|NCT00508261|541642025|FG002|Overall Study|Serious Adverse Event|0|||
150138453|NCT00508261|541642026|FG003|Overall Study|Serious Adverse Event|0|||
150138454|NCT00508261|541642023|FG000|Overall Study|Withdrawal by Subject|3|||
150138455|NCT00508261|541642024|FG001|Overall Study|Withdrawal by Subject|4|||
150138456|NCT00508261|541642025|FG002|Overall Study|Withdrawal by Subject|4|||
150138457|NCT00508261|541642026|FG003|Overall Study|Withdrawal by Subject|0|||
150138458|NCT00508261|541642023|FG000|Overall Study|Migrated/ moved from study area|0|||
150138459|NCT00508261|541642024|FG001|Overall Study|Migrated/ moved from study area|1|||
150138460|NCT00508261|541642025|FG002|Overall Study|Migrated/ moved from study area|0|||
150138461|NCT00508261|541642026|FG003|Overall Study|Migrated/ moved from study area|0|||
150138462|NCT00508261|541642023|FG000|Overall Study|Lost to Follow-up|0|||
150138463|NCT00508261|541642024|FG001|Overall Study|Lost to Follow-up|1|||
150138464|NCT00508261|541642025|FG002|Overall Study|Lost to Follow-up|1|||
150138465|NCT00508261|541642026|FG003|Overall Study|Lost to Follow-up|1|||
150138466|NCT01242748|541642027|FG000|Overall Study|Adverse Event|10|||
150138467|NCT01242748|541642028|FG001|Overall Study|Adverse Event|5|||
150138468|NCT01242748|541642027|FG000|Overall Study|Lost to Follow-up|6|||
150138469|NCT01242748|541642028|FG001|Overall Study|Lost to Follow-up|2|||
150138470|NCT01242748|541642027|FG000|Overall Study|Physician Decision|3|||
150138471|NCT01242748|541642028|FG001|Overall Study|Physician Decision|2|||
150138472|NCT01242748|541642027|FG000|Overall Study|Protocol Violation|1|||
150138473|NCT01242748|541642028|FG001|Overall Study|Protocol Violation|0|||
150138474|NCT01242748|541642027|FG000|Overall Study|Withdrawal by Subject|10|||
150138475|NCT01242748|541642028|FG001|Overall Study|Withdrawal by Subject|2|||
150138476|NCT01242748|541642027|FG000|Overall Study|Miscellaneous reasons|8|||
150138477|NCT01242748|541642028|FG001|Overall Study|Miscellaneous reasons|3|||
150138478|NCT00840801|541642029|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
150138479|NCT00840801|541642030|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
150138480|NCT00840801|541642031|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
150138481|NCT00840801|541642029|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
150138482|NCT00840801|541642030|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
150138483|NCT00840801|541642031|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
150138484|NCT00840801|541642029|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
150138485|NCT00840801|541642030|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
150138486|NCT00840801|541642031|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
150138487|NCT00840801|541642029|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
150138488|NCT00840801|541642030|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
150138489|NCT00840801|541642031|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
150138490|NCT00335452|541642032|FG000|Overall Study|Death|156|||
150138491|NCT00335452|541642033|FG001|Overall Study|Death|144|||
150138492|NCT00335452|541642034|FG002|Overall Study|Death|158|||
150138493|NCT00335452|541642035|FG003|Overall Study|Death|129|||
150138494|NCT00335452|541642032|FG000|Overall Study|Lost to Follow-up|2|||
150138495|NCT00335452|541642033|FG001|Overall Study|Lost to Follow-up|3|||
150138496|NCT00335452|541642034|FG002|Overall Study|Lost to Follow-up|1|||
150138497|NCT00335452|541642035|FG003|Overall Study|Lost to Follow-up|2|||
150138498|NCT02736825|541642037|FG000|Overall Study|Lost to Follow-up|10|||
150138499|NCT02736825|541642038|FG001|Overall Study|Lost to Follow-up|11|||
150138500|NCT02736825|541642037|FG000|Overall Study|Early Termination|0|||
150138501|NCT02736825|541642038|FG001|Overall Study|Early Termination|1|||
150138502|NCT00790452|541642039|FG000|Overall Study|Drug supply issue|1|||
150138503|NCT00790452|541642040|FG001|Overall Study|Drug supply issue|0|||
150138504|NCT02901626|541642041|FG000|Overall Study|Lost to Follow-up|1|||
150138505|NCT02901626|541642042|FG001|Overall Study|Lost to Follow-up|1|||
150138506|NCT04082884|541642043|FG000|Overall Study|Withdrawal by Subject|1|||
150138507|NCT02940574|541642045|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
150138508|NCT02940574|541642046|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
150138509|NCT02940574|541642045|FG000|1-year Follow-up|Lost to Follow-up|3|||
150138510|NCT02940574|541642046|FG001|1-year Follow-up|Lost to Follow-up|4|||
150138511|NCT00659490|541642049|FG000|Overall Study|Lost to Follow-up|2|||
150138512|NCT00659490|541642050|FG001|Overall Study|Lost to Follow-up|0|||
150138513|NCT00659490|541642051|FG002|Overall Study|Lost to Follow-up|1|||
150138514|NCT05674890|541642052|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
150138515|NCT05674890|541642053|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
150138516|NCT05674890|541642052|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
150138517|NCT05674890|541642053|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
150138518|NCT05674890|541642052|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
150138519|NCT05674890|541642053|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
150138520|NCT00827541|541642054|FG000|Overall Study|Exitus|1|||
150138521|NCT00827541|541642055|FG001|Overall Study|Exitus|8|||
150138522|NCT00827541|541642054|FG000|Overall Study|Other|1|||
150138523|NCT00827541|541642055|FG001|Overall Study|Other|3|||
150138524|NCT00827541|541642054|FG000|Overall Study|Pathogen not susceptible|1|||
150138525|NCT00827541|541642055|FG001|Overall Study|Pathogen not susceptible|0|||
150138526|NCT00827541|541642054|FG000|Overall Study|Lack of effectiveness|1|||
150138527|NCT00827541|541642055|FG001|Overall Study|Lack of effectiveness|0|||
150138528|NCT01649232|541642056|FG000|Overall Study|Physician Decision|2|||
150138529|NCT01649232|541642057|FG001|Overall Study|Physician Decision|0|||
150138530|NCT01750879|541642058|FG000|Overall Study|Adverse Event|8|||
150138531|NCT01750879|541642059|FG001|Overall Study|Adverse Event|0|||
150138532|NCT01750879|541642058|FG000|Overall Study|Lack of Efficacy|1|||
150138533|NCT01750879|541642059|FG001|Overall Study|Lack of Efficacy|0|||
150138534|NCT01750879|541642058|FG000|Overall Study|Withdrawal by Subject|1|||
150138535|NCT01750879|541642059|FG001|Overall Study|Withdrawal by Subject|0|||
150138536|NCT01750879|541642058|FG000|Overall Study|Did not complete per protocol|0|||
150138537|NCT01750879|541642059|FG001|Overall Study|Did not complete per protocol|3|||
150138538|NCT02421666|541642060|FG000|6-month Follow-up|Lost to Follow-up|8|||
150138539|NCT02421666|541642061|FG001|6-month Follow-up|Lost to Follow-up|7|||
150138540|NCT02421666|541642060|FG000|6-month Follow-up|Withdrawal by Subject|5|||
150138541|NCT02421666|541642061|FG001|6-month Follow-up|Withdrawal by Subject|6|||
150138542|NCT02421666|541642060|FG000|12-month Follow-up|Lost to Follow-up|5|||
150138543|NCT02421666|541642061|FG001|12-month Follow-up|Lost to Follow-up|5|||
150138544|NCT02421666|541642060|FG000|12-month Follow-up|Withdrawal by Subject|6|||
150138545|NCT02421666|541642061|FG001|12-month Follow-up|Withdrawal by Subject|11|||
150138546|NCT04810221|541642062|FG000|Overall Study|Physician Decision|3|||
150138547|NCT03642938|541642063|FG000|Overall Study|Withdrawal by Subject|0|||
150138548|NCT03642938|541642064|FG001|Overall Study|Withdrawal by Subject|0|||
150138549|NCT03642938|541642065|FG002|Overall Study|Withdrawal by Subject|0|||
150138550|NCT03642938|541642066|FG003|Overall Study|Withdrawal by Subject|1|||
150138551|NCT01119768|541642069|FG000|Treatment Period|Lack of Efficacy|18|||
150138552|NCT01119768|541642070|FG001|Treatment Period|Lack of Efficacy|25|||
150138553|NCT01059643|541642071|FG000|Overall Study|Adverse Event|3|||
150138554|NCT01059643|541642071|FG000|Overall Study|Withdrawal by Subject|2|||
150138555|NCT01059643|541642071|FG000|Overall Study|Physician Decision|1|||
150138556|NCT00246337|541642072|FG000|Overall Study|Lost to Follow-up|3|||
150138557|NCT00246337|541642073|FG001|Overall Study|Lost to Follow-up|0|||
150138558|NCT00246337|541642074|FG002|Overall Study|Lost to Follow-up|0|||
150138559|NCT00246337|541642075|FG003|Overall Study|Lost to Follow-up|0|||
150138560|NCT00246337|541642076|FG004|Overall Study|Lost to Follow-up|2|||
150138561|NCT00246337|541642077|FG005|Overall Study|Lost to Follow-up|2|||
150138562|NCT00246337|541642078|FG006|Overall Study|Lost to Follow-up|1|||
150138563|NCT00246337|541642079|FG007|Overall Study|Lost to Follow-up|2|||
150138564|NCT00246337|541642080|FG008|Overall Study|Lost to Follow-up|0|||
150138565|NCT00246337|541642072|FG000|Overall Study|Protocol Violation|1|||
150138566|NCT00246337|541642073|FG001|Overall Study|Protocol Violation|0|||
150138567|NCT00246337|541642074|FG002|Overall Study|Protocol Violation|0|||
150138568|NCT00246337|541642075|FG003|Overall Study|Protocol Violation|0|||
150138569|NCT00246337|541642076|FG004|Overall Study|Protocol Violation|1|||
150138570|NCT00246337|541642077|FG005|Overall Study|Protocol Violation|0|||
150138571|NCT00246337|541642078|FG006|Overall Study|Protocol Violation|1|||
150138572|NCT00246337|541642079|FG007|Overall Study|Protocol Violation|1|||
150138573|NCT00246337|541642080|FG008|Overall Study|Protocol Violation|0|||
150138574|NCT00246337|541642072|FG000|Overall Study|Withdrawal by Subject|2|||
150138575|NCT00246337|541642073|FG001|Overall Study|Withdrawal by Subject|0|||
150138576|NCT00246337|541642074|FG002|Overall Study|Withdrawal by Subject|0|||
150138577|NCT00246337|541642075|FG003|Overall Study|Withdrawal by Subject|0|||
150138578|NCT00246337|541642076|FG004|Overall Study|Withdrawal by Subject|0|||
150138579|NCT00246337|541642077|FG005|Overall Study|Withdrawal by Subject|0|||
150138580|NCT00246337|541642078|FG006|Overall Study|Withdrawal by Subject|1|||
150138581|NCT00246337|541642079|FG007|Overall Study|Withdrawal by Subject|1|||
150138582|NCT00246337|541642080|FG008|Overall Study|Withdrawal by Subject|0|||
150138583|NCT00246337|541642072|FG000|Overall Study|Lack of Qualifying Event|8|||
150138584|NCT00246337|541642073|FG001|Overall Study|Lack of Qualifying Event|2|||
150138585|NCT00246337|541642074|FG002|Overall Study|Lack of Qualifying Event|1|||
150138586|NCT00246337|541642075|FG003|Overall Study|Lack of Qualifying Event|1|||
150138587|NCT00246337|541642076|FG004|Overall Study|Lack of Qualifying Event|1|||
150138588|NCT00246337|541642077|FG005|Overall Study|Lack of Qualifying Event|3|||
150209882|NCT03683576|541905123|FG001|Overall Study|Lost to Follow-up|1|||
150209883|NCT03683576|541905124|FG002|Overall Study|Lost to Follow-up|2|||
150209884|NCT03683576|541905125|FG003|Overall Study|Lost to Follow-up|0|||
150209885|NCT03683576|541905122|FG000|Overall Study|Other, Not Specified|0|||
150138589|NCT00246337|541642078|FG006|Overall Study|Lack of Qualifying Event|3|||
150138590|NCT00246337|541642079|FG007|Overall Study|Lack of Qualifying Event|2|||
150138591|NCT00246337|541642080|FG008|Overall Study|Lack of Qualifying Event|5|||
150138592|NCT00246337|541642072|FG000|Overall Study|Site Terminated|10|||
150138593|NCT00246337|541642073|FG001|Overall Study|Site Terminated|0|||
150138594|NCT00246337|541642074|FG002|Overall Study|Site Terminated|0|||
150138595|NCT00246337|541642075|FG003|Overall Study|Site Terminated|0|||
150138596|NCT00246337|541642076|FG004|Overall Study|Site Terminated|0|||
150138597|NCT00246337|541642077|FG005|Overall Study|Site Terminated|7|||
150138598|NCT00246337|541642078|FG006|Overall Study|Site Terminated|1|||
150138599|NCT00246337|541642079|FG007|Overall Study|Site Terminated|6|||
150138600|NCT00246337|541642080|FG008|Overall Study|Site Terminated|2|||
150138601|NCT00246337|541642072|FG000|Overall Study|Abnormal baseline lab values|7|||
150138602|NCT00246337|541642073|FG001|Overall Study|Abnormal baseline lab values|0|||
150138603|NCT00246337|541642074|FG002|Overall Study|Abnormal baseline lab values|2|||
150138604|NCT00246337|541642075|FG003|Overall Study|Abnormal baseline lab values|0|||
150138605|NCT00246337|541642076|FG004|Overall Study|Abnormal baseline lab values|0|||
150138606|NCT00246337|541642077|FG005|Overall Study|Abnormal baseline lab values|2|||
150138607|NCT00246337|541642078|FG006|Overall Study|Abnormal baseline lab values|2|||
150138608|NCT00246337|541642079|FG007|Overall Study|Abnormal baseline lab values|0|||
150138609|NCT00246337|541642080|FG008|Overall Study|Abnormal baseline lab values|4|||
150138610|NCT00246337|541642072|FG000|Overall Study|Overwhelmed|0|||
150138611|NCT00246337|541642073|FG001|Overall Study|Overwhelmed|0|||
150138612|NCT00246337|541642074|FG002|Overall Study|Overwhelmed|0|||
150138613|NCT00246337|541642075|FG003|Overall Study|Overwhelmed|0|||
150138614|NCT00246337|541642076|FG004|Overall Study|Overwhelmed|0|||
150138615|NCT00246337|541642077|FG005|Overall Study|Overwhelmed|1|||
150138616|NCT00246337|541642078|FG006|Overall Study|Overwhelmed|0|||
150138617|NCT00246337|541642079|FG007|Overall Study|Overwhelmed|0|||
150138618|NCT00246337|541642080|FG008|Overall Study|Overwhelmed|0|||
150138619|NCT00246337|541642072|FG000|Overall Study|Protocol Violator|1|||
150138620|NCT00246337|541642073|FG001|Overall Study|Protocol Violator|0|||
150138621|NCT00246337|541642074|FG002|Overall Study|Protocol Violator|0|||
150138622|NCT00246337|541642075|FG003|Overall Study|Protocol Violator|0|||
150138623|NCT00246337|541642076|FG004|Overall Study|Protocol Violator|0|||
150138624|NCT00246337|541642077|FG005|Overall Study|Protocol Violator|0|||
150138625|NCT00246337|541642078|FG006|Overall Study|Protocol Violator|0|||
150138626|NCT00246337|541642079|FG007|Overall Study|Protocol Violator|0|||
150138627|NCT00246337|541642080|FG008|Overall Study|Protocol Violator|0|||
150138628|NCT00246337|541642072|FG000|Overall Study|Reported as completing trial in error|0|||
150138629|NCT00246337|541642073|FG001|Overall Study|Reported as completing trial in error|0|||
150138630|NCT00246337|541642074|FG002|Overall Study|Reported as completing trial in error|0|||
150138631|NCT00246337|541642075|FG003|Overall Study|Reported as completing trial in error|0|||
150138632|NCT00246337|541642076|FG004|Overall Study|Reported as completing trial in error|0|||
150138633|NCT00246337|541642077|FG005|Overall Study|Reported as completing trial in error|0|||
150209886|NCT03683576|541905123|FG001|Overall Study|Other, Not Specified|2|||
150209887|NCT03683576|541905124|FG002|Overall Study|Other, Not Specified|0|||
150209888|NCT03683576|541905125|FG003|Overall Study|Other, Not Specified|0|||
150138634|NCT00246337|541642078|FG006|Overall Study|Reported as completing trial in error|0|||
150138635|NCT00246337|541642079|FG007|Overall Study|Reported as completing trial in error|1|||
150138636|NCT00246337|541642080|FG008|Overall Study|Reported as completing trial in error|0|||
150138637|NCT01226511|541642085|FG000|Acute Treatment Period|Adverse Event|7|||
150138638|NCT01226511|541642086|FG001|Acute Treatment Period|Adverse Event|6|||
150138639|NCT01226511|541642085|FG000|Acute Treatment Period|Lack of Efficacy|2|||
150138640|NCT01226511|541642086|FG001|Acute Treatment Period|Lack of Efficacy|1|||
150138641|NCT01226511|541642085|FG000|Acute Treatment Period|Lost to Follow-up|3|||
150138642|NCT01226511|541642086|FG001|Acute Treatment Period|Lost to Follow-up|6|||
150138643|NCT01226511|541642085|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
150138644|NCT01226511|541642086|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
150138645|NCT01226511|541642085|FG000|Acute Treatment Period|Protocol Violation|5|||
150138646|NCT01226511|541642086|FG001|Acute Treatment Period|Protocol Violation|5|||
150138647|NCT01226511|541642085|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
150138648|NCT01226511|541642086|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
150138649|NCT01226511|541642085|FG000|Extension Treatment Period|Adverse Event|8|||
150138650|NCT01226511|541642086|FG001|Extension Treatment Period|Adverse Event|8|||
150138651|NCT01226511|541642085|FG000|Extension Treatment Period|Lack of Efficacy|3|||
150138652|NCT01226511|541642086|FG001|Extension Treatment Period|Lack of Efficacy|2|||
150138653|NCT01226511|541642085|FG000|Extension Treatment Period|Lost to Follow-up|4|||
150138654|NCT01226511|541642086|FG001|Extension Treatment Period|Lost to Follow-up|3|||
150138655|NCT01226511|541642085|FG000|Extension Treatment Period|Protocol Violation|2|||
150138656|NCT01226511|541642086|FG001|Extension Treatment Period|Protocol Violation|2|||
150138657|NCT01226511|541642085|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
150138658|NCT01226511|541642086|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
150138659|NCT01226511|541642085|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
150138660|NCT01226511|541642086|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
150138661|NCT01226511|541642085|FG000|Extension Treatment Period|Sponsor Decision|1|||
150138662|NCT01226511|541642086|FG001|Extension Treatment Period|Sponsor Decision|1|||
150138663|NCT01226511|541642085|FG000|Taper Period|Adverse Event|1|||
150138664|NCT01226511|541642086|FG001|Taper Period|Adverse Event|0|||
150138665|NCT01226511|541642085|FG000|Taper Period|Lost to Follow-up|2|||
150138666|NCT01226511|541642086|FG001|Taper Period|Lost to Follow-up|2|||
150138667|NCT01226511|541642085|FG000|Taper Period|Protocol Violation|1|||
150138668|NCT01226511|541642086|FG001|Taper Period|Protocol Violation|0|||
150138669|NCT01226511|541642085|FG000|Taper Period|Parent/Caregiver Decision|1|||
150138670|NCT01226511|541642086|FG001|Taper Period|Parent/Caregiver Decision|1|||
150138671|NCT05614089|541642100|FG000|Overall Study|Pregnancy|5|||
150138672|NCT05614089|541642101|FG001|Overall Study|Pregnancy|2|||
150138673|NCT05614089|541642100|FG000|Overall Study|Lost to Follow-up|5|||
150138674|NCT05614089|541642101|FG001|Overall Study|Lost to Follow-up|1|||
150138675|NCT05614089|541642100|FG000|Overall Study|Death|0|||
150138676|NCT05614089|541642101|FG001|Overall Study|Death|1|||
150138677|NCT05614089|541642100|FG000|Overall Study|Adverse Event|1|||
150138678|NCT05614089|541642101|FG001|Overall Study|Adverse Event|0|||
150138679|NCT05701995|541642103|FG000|Pre-Treatment|Randomization Error|1|||
150138680|NCT05701995|541642104|FG001|Pre-Treatment|Randomization Error|1|||
150138681|NCT05701995|541642103|FG000|Treatment|Withdrawal by Subject|8|||
150138682|NCT05701995|541642104|FG001|Treatment|Withdrawal by Subject|4|||
150138683|NCT05701995|541642103|FG000|Treatment|Lost to Follow-up|2|||
150138684|NCT05701995|541642104|FG001|Treatment|Lost to Follow-up|3|||
150138685|NCT05701995|541642103|FG000|Treatment|Adverse Event|3|||
150138686|NCT05701995|541642104|FG001|Treatment|Adverse Event|1|||
150138687|NCT05701995|541642103|FG000|Treatment|Other Reason|1|||
150138688|NCT05701995|541642104|FG001|Treatment|Other Reason|1|||
150138689|NCT05701995|541642103|FG000|Treatment|Death|1|||
150138690|NCT05701995|541642104|FG001|Treatment|Death|0|||
150138691|NCT05701995|541642103|FG000|Treatment|Physician Decision|0|||
150138692|NCT05701995|541642104|FG001|Treatment|Physician Decision|1|||
150138693|NCT00715429|541642105|FG000|Overall Study|Did not complete the study diary|0|||
150138694|NCT00715429|541642106|FG001|Overall Study|Did not complete the study diary|1|||
150138695|NCT04899245|541642111|FG000|Overall Study|Withdrawal by Subject|3|||
150138696|NCT04899245|541642112|FG001|Overall Study|Withdrawal by Subject|5|||
150138697|NCT04899245|541642113|FG002|Overall Study|Withdrawal by Subject|2|||
150138698|NCT04899245|541642111|FG000|Overall Study|No longer eligible - Left staff position|0|||
150138699|NCT04899245|541642112|FG001|Overall Study|No longer eligible - Left staff position|0|||
150138700|NCT04899245|541642113|FG002|Overall Study|No longer eligible - Left staff position|1|||
150138701|NCT04899245|541642111|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
150138702|NCT04899245|541642112|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
150138703|NCT04899245|541642113|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
150138704|NCT04899245|541642111|FG000|Overall Study|No longer eligible - Moved away from area|2|||
150138705|NCT04899245|541642112|FG001|Overall Study|No longer eligible - Moved away from area|2|||
150138706|NCT04899245|541642113|FG002|Overall Study|No longer eligible - Moved away from area|0|||
150138707|NCT03779906|541642127|FG000|Overall Study|Lost to Follow-up|7|||
150138708|NCT03779906|541642127|FG000|Overall Study|COVID pandemic|1|||
150138709|NCT02276066|541643627|FG000|Overall Study|Lost to Follow-up|21|||
150138710|NCT02276066|541643628|FG001|Overall Study|Lost to Follow-up|11|||
150138711|NCT03386032|541643630|FG000|Overall Study|Lack of Efficacy|6|||
150138712|NCT03386032|541643631|FG001|Overall Study|Lack of Efficacy|2|||
150138713|NCT03386032|541643632|FG002|Overall Study|Lack of Efficacy|0|||
150138714|NCT03386032|541643630|FG000|Overall Study|Adverse Event|2|||
150138715|NCT03386032|541643631|FG001|Overall Study|Adverse Event|2|||
150138716|NCT03386032|541643632|FG002|Overall Study|Adverse Event|0|||
150138717|NCT03386032|541643630|FG000|Overall Study|Withdrawal by Subject|1|||
150138718|NCT03386032|541643631|FG001|Overall Study|Withdrawal by Subject|0|||
150138719|NCT03386032|541643632|FG002|Overall Study|Withdrawal by Subject|0|||
150138720|NCT03386032|541643630|FG000|Overall Study|Lost to Follow-up|9|||
150138721|NCT03386032|541643631|FG001|Overall Study|Lost to Follow-up|3|||
150138722|NCT03386032|541643632|FG002|Overall Study|Lost to Follow-up|0|||
150138723|NCT01807156|541643633|FG000|Overall Study|Physician Decision|1|||
150138724|NCT04857034|541643634|FG000|Placebo-Controlled Period|Request to discontinue|2|||
150138725|NCT04857034|541643635|FG001|Placebo-Controlled Period|Request to discontinue|2|||
150138726|NCT04857034|541643636|FG002|Placebo-Controlled Period|Request to discontinue|0|||
150138727|NCT04857034|541643637|FG003|Placebo-Controlled Period|Request to discontinue|0|||
150138728|NCT04857034|541643638|FG004|Placebo-Controlled Period|Request to discontinue|0|||
150138729|NCT04857034|541643634|FG000|Placebo-Controlled Period|withdrew consent|1|||
150138730|NCT04857034|541643635|FG001|Placebo-Controlled Period|withdrew consent|1|||
150138731|NCT04857034|541643636|FG002|Placebo-Controlled Period|withdrew consent|2|||
150138732|NCT04857034|541643637|FG003|Placebo-Controlled Period|withdrew consent|0|||
150138733|NCT04857034|541643638|FG004|Placebo-Controlled Period|withdrew consent|0|||
150138734|NCT04857034|541643634|FG000|Placebo-Controlled Period|Pregnancy|1|||
150138735|NCT04857034|541643635|FG001|Placebo-Controlled Period|Pregnancy|1|||
150138736|NCT04857034|541643636|FG002|Placebo-Controlled Period|Pregnancy|0|||
150138737|NCT04857034|541643637|FG003|Placebo-Controlled Period|Pregnancy|0|||
150138738|NCT04857034|541643638|FG004|Placebo-Controlled Period|Pregnancy|0|||
150138739|NCT04857034|541643634|FG000|Placebo-Controlled Period|Ongoing study period|0|||
150138740|NCT04857034|541643635|FG001|Placebo-Controlled Period|Ongoing study period|1|||
150138741|NCT04857034|541643636|FG002|Placebo-Controlled Period|Ongoing study period|0|||
150138742|NCT04857034|541643637|FG003|Placebo-Controlled Period|Ongoing study period|0|||
150138743|NCT04857034|541643638|FG004|Placebo-Controlled Period|Ongoing study period|0|||
150138744|NCT04857034|541643634|FG000|Active Treatment Period|Lack of Efficacy|1|||
150138745|NCT04857034|541643635|FG001|Active Treatment Period|Lack of Efficacy|0|||
150138746|NCT04857034|541643636|FG002|Active Treatment Period|Lack of Efficacy|0|||
150138747|NCT04857034|541643637|FG003|Active Treatment Period|Lack of Efficacy|0|||
150138748|NCT04857034|541643638|FG004|Active Treatment Period|Lack of Efficacy|0|||
150138749|NCT04857034|541643634|FG000|Active Treatment Period|request to discontinue|0|||
150138750|NCT04857034|541643635|FG001|Active Treatment Period|request to discontinue|1|||
150138751|NCT04857034|541643636|FG002|Active Treatment Period|request to discontinue|0|||
150138752|NCT04857034|541643637|FG003|Active Treatment Period|request to discontinue|1|||
150138753|NCT04857034|541643638|FG004|Active Treatment Period|request to discontinue|0|||
150138754|NCT04857034|541643634|FG000|Active Treatment Period|administrative reason by sponsor|1|||
150138755|NCT04857034|541643635|FG001|Active Treatment Period|administrative reason by sponsor|5|||
150138756|NCT04857034|541643636|FG002|Active Treatment Period|administrative reason by sponsor|0|||
150138757|NCT04857034|541643637|FG003|Active Treatment Period|administrative reason by sponsor|2|||
150138758|NCT04857034|541643638|FG004|Active Treatment Period|administrative reason by sponsor|2|||
150138759|NCT04857034|541643634|FG000|Active Treatment Period|other reasons|1|||
150138760|NCT04857034|541643635|FG001|Active Treatment Period|other reasons|1|||
150138761|NCT04857034|541643636|FG002|Active Treatment Period|other reasons|0|||
150138762|NCT04857034|541643637|FG003|Active Treatment Period|other reasons|0|||
150138763|NCT04857034|541643638|FG004|Active Treatment Period|other reasons|1|||
150138764|NCT04857034|541643634|FG000|Active Treatment Period|Ongoing Study Period|2|||
150138765|NCT04857034|541643635|FG001|Active Treatment Period|Ongoing Study Period|4|||
150138766|NCT04857034|541643636|FG002|Active Treatment Period|Ongoing Study Period|0|||
150138767|NCT04857034|541643637|FG003|Active Treatment Period|Ongoing Study Period|1|||
150138768|NCT04857034|541643638|FG004|Active Treatment Period|Ongoing Study Period|0|||
150138769|NCT00387894|541643639|FG000|Overall Study|Withdrawal by Subject|1|||
150138770|NCT02923739|541643641|FG000|Overall Study|Withdrawal by Subject|2|||
150138771|NCT02923739|541643642|FG001|Overall Study|Withdrawal by Subject|0|||
150138772|NCT02923739|541643643|FG002|Overall Study|Withdrawal by Subject|0|||
150138773|NCT02923739|541643644|FG003|Overall Study|Withdrawal by Subject|0|||
150138774|NCT02923739|541643641|FG000|Overall Study|Failed Screening|3|||
150138775|NCT02923739|541643642|FG001|Overall Study|Failed Screening|0|||
150138776|NCT02923739|541643643|FG002|Overall Study|Failed Screening|0|||
150138777|NCT02923739|541643644|FG003|Overall Study|Failed Screening|0|||
150138778|NCT00948974|541643647|FG000|Overall Study|Lost to Follow-up|23|||
150138779|NCT00948974|541643648|FG001|Overall Study|Lost to Follow-up|20|||
150138780|NCT00409682|541643660|FG000|Open-label Induction Period|Adverse Event|1|||
150138781|NCT00409682|541643661|FG001|Open-label Induction Period|Adverse Event|0|||
150138782|NCT00409682|541643662|FG002|Open-label Induction Period|Adverse Event|0|||
150138783|NCT00409682|541643660|FG000|Open-label Induction Period|Lack of Efficacy|1|||
150138784|NCT00409682|541643661|FG001|Open-label Induction Period|Lack of Efficacy|0|||
150138785|NCT00409682|541643662|FG002|Open-label Induction Period|Lack of Efficacy|0|||
150138786|NCT00409682|541643660|FG000|Open-label Induction Period|Protocol Violation|1|||
150138787|NCT00409682|541643661|FG001|Open-label Induction Period|Protocol Violation|0|||
150138788|NCT00409682|541643662|FG002|Open-label Induction Period|Protocol Violation|0|||
150138789|NCT00409682|541643660|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
150138790|NCT00409682|541643661|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
150138791|NCT00409682|541643662|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
150138792|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
150138793|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
150138794|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
150138795|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
150138796|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
150138797|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
150138798|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
150138799|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
150138800|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
150138801|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
150138802|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
150138803|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
150138804|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
150138805|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
150138806|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
150138807|NCT00409682|541643660|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
150138808|NCT00409682|541643661|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
150138809|NCT00409682|541643662|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
150138810|NCT01896869|541643665|FG000|Overall Study|Withdrawal by Subject|0|||
150138811|NCT01896869|541643666|FG001|Overall Study|Withdrawal by Subject|6|||
150138812|NCT01896869|541643665|FG000|Overall Study|Lost to Follow-up|1|||
150138813|NCT01896869|541643666|FG001|Overall Study|Lost to Follow-up|0|||
150138814|NCT04710927|541643674|FG000|Overall Study|Lost to Follow-up|7|||
150138815|NCT04710927|541643675|FG001|Overall Study|Lost to Follow-up|6|||
150138816|NCT04710927|541643676|FG002|Overall Study|Lost to Follow-up|5|||
150138817|NCT00118716|541643678|FG000|Overall Study|Adverse Event|2|||
150138818|NCT00118716|541643679|FG001|Overall Study|Adverse Event|7|||
150138819|NCT00118716|541643678|FG000|Overall Study|Protocol Violation|5|||
150138820|NCT00118716|541643679|FG001|Overall Study|Protocol Violation|4|||
150138821|NCT00118716|541643678|FG000|Overall Study|Withdrawal by Subject|0|||
150138822|NCT00118716|541643679|FG001|Overall Study|Withdrawal by Subject|1|||
150138823|NCT00118716|541643678|FG000|Overall Study|Exacerbation|2|||
150138824|NCT00118716|541643679|FG001|Overall Study|Exacerbation|2|||
150138825|NCT00118716|541643678|FG000|Overall Study|Discontinued by sponsor|1|||
150138826|NCT00118716|541643679|FG001|Overall Study|Discontinued by sponsor|1|||
150138827|NCT00118716|541643678|FG000|Overall Study|Non-compliance|1|||
150138828|NCT00118716|541643679|FG001|Overall Study|Non-compliance|3|||
150138829|NCT00118716|541643678|FG000|Overall Study|misrandomized|1|||
150138830|NCT00118716|541643679|FG001|Overall Study|misrandomized|1|||
150138831|NCT00118716|541643678|FG000|Overall Study|Expired drug use|1|||
150138832|NCT00118716|541643679|FG001|Overall Study|Expired drug use|2|||
150138833|NCT00118716|541643678|FG000|Overall Study|Investigator discretion|0|||
150138834|NCT00118716|541643679|FG001|Overall Study|Investigator discretion|1|||
150138835|NCT00855062|541643680|FG000|Step1|Early Study Closure|5|||
150138836|NCT00855062|541643681|FG001|Step1|Early Study Closure|7|||
150138837|NCT00855062|541643680|FG000|Step1|Adverse Event|1|||
150138838|NCT00855062|541643681|FG001|Step1|Adverse Event|1|||
150138839|NCT00855062|541643680|FG000|Step1|Protocol Violation|1|||
150138840|NCT00855062|541643681|FG001|Step1|Protocol Violation|0|||
150138841|NCT00855062|541643680|FG000|Step1|Pregnancy|1|||
150138842|NCT00855062|541643681|FG001|Step1|Pregnancy|0|||
150138843|NCT00855062|541643680|FG000|Step1|Withdrawal by Subject|2|||
150138844|NCT00855062|541643681|FG001|Step1|Withdrawal by Subject|3|||
150138845|NCT00855062|541643680|FG000|Step2|Early Study Closure|6|||
150138846|NCT00855062|541643681|FG001|Step2|Early Study Closure|2|||
150138847|NCT00855062|541643680|FG000|Step2|Adverse Event|0|||
150138848|NCT00855062|541643681|FG001|Step2|Adverse Event|3|||
150138849|NCT00855062|541643680|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
150138850|NCT00855062|541643681|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
150138851|NCT04209725|541643687|FG000|Overall Study|Adverse Event|1|||
150138852|NCT02857426|541643688|FG000|Overall Study|Disease progression|34|||
150138853|NCT02857426|541643689|FG001|Overall Study|Disease progression|13|||
150138854|NCT02857426|541643688|FG000|Overall Study|Study drug toxicity|4|||
150138855|NCT02857426|541643689|FG001|Overall Study|Study drug toxicity|1|||
150138856|NCT02857426|541643688|FG000|Overall Study|Death|1|||
150138857|NCT02857426|541643689|FG001|Overall Study|Death|0|||
150138858|NCT02857426|541643688|FG000|Overall Study|Adverse event unrelated to study drug|6|||
150138859|NCT02857426|541643689|FG001|Overall Study|Adverse event unrelated to study drug|2|||
150138860|NCT02857426|541643688|FG000|Overall Study|Participant withdrew consent|1|||
150138861|NCT02857426|541643689|FG001|Overall Study|Participant withdrew consent|1|||
150138862|NCT02857426|541643688|FG000|Overall Study|Maximum clinical benefit|1|||
150138863|NCT02857426|541643689|FG001|Overall Study|Maximum clinical benefit|0|||
150138864|NCT02857426|541643688|FG000|Overall Study|Completed treatment|0|||
150138865|NCT02857426|541643689|FG001|Overall Study|Completed treatment|2|||
150138866|NCT02634788|541643690|FG000|Overall Study|Adverse Event|0|||
150138867|NCT02634788|541643691|FG001|Overall Study|Adverse Event|8|||
150138868|NCT02634788|541643692|FG002|Overall Study|Adverse Event|3|||
150138869|NCT02634788|541643693|FG003|Overall Study|Adverse Event|1|||
150138870|NCT02634788|541643690|FG000|Overall Study|Lack of Efficacy|4|||
150138871|NCT02634788|541643691|FG001|Overall Study|Lack of Efficacy|0|||
150138872|NCT02634788|541643692|FG002|Overall Study|Lack of Efficacy|1|||
150138873|NCT02634788|541643693|FG003|Overall Study|Lack of Efficacy|4|||
150138874|NCT02634788|541643690|FG000|Overall Study|Lost to Follow-up|0|||
150138875|NCT02634788|541643691|FG001|Overall Study|Lost to Follow-up|1|||
150138876|NCT02634788|541643692|FG002|Overall Study|Lost to Follow-up|0|||
150138877|NCT02634788|541643693|FG003|Overall Study|Lost to Follow-up|0|||
150138878|NCT02634788|541643690|FG000|Overall Study|Withdrawal by Subject|0|||
150138879|NCT02634788|541643691|FG001|Overall Study|Withdrawal by Subject|1|||
150138880|NCT02634788|541643692|FG002|Overall Study|Withdrawal by Subject|1|||
150138881|NCT02634788|541643693|FG003|Overall Study|Withdrawal by Subject|0|||
150138882|NCT01780935|541643705|FG000|Overall Study|Admin problems due to early termination|321|||
150138883|NCT01780935|541643706|FG001|Overall Study|Admin problems due to early termination|309|||
150138884|NCT01780935|541643705|FG000|Overall Study|Adverse Event|2|||
150138885|NCT01780935|541643706|FG001|Overall Study|Adverse Event|4|||
150138886|NCT01780935|541643705|FG000|Overall Study|Death|1|||
150138887|NCT01780935|541643706|FG001|Overall Study|Death|6|||
150138888|NCT01780935|541643705|FG000|Overall Study|Lost to Follow-up|2|||
150138889|NCT01780935|541643706|FG001|Overall Study|Lost to Follow-up|6|||
150138890|NCT01780935|541643705|FG000|Overall Study|Physician Decision|1|||
150138891|NCT01780935|541643706|FG001|Overall Study|Physician Decision|1|||
150138892|NCT01780935|541643705|FG000|Overall Study|Protocol deviation|0|||
150138893|NCT01780935|541643706|FG001|Overall Study|Protocol deviation|1|||
150138894|NCT01780935|541643705|FG000|Overall Study|Patient withdrew consent|8|||
150138895|NCT01780935|541643706|FG001|Overall Study|Patient withdrew consent|9|||
150138896|NCT02831257|541643707|FG000|Overall Study|Lack of Efficacy|3|||
150138897|NCT02831257|541643707|FG000|Overall Study|Adverse Event|2|||
150138898|NCT02831257|541643707|FG000|Overall Study|Physician Decision|1|||
150138899|NCT02831257|541643707|FG000|Overall Study|Withdrawal by Subject|6|||
150138900|NCT00855595|541643708|FG000|Overall Study|Withdrawal by Subject|1|||
150138901|NCT00855595|541643709|FG001|Overall Study|Withdrawal by Subject|2|||
150138902|NCT00855595|541643708|FG000|Overall Study|Lost to Follow-up|3|||
150138903|NCT00855595|541643709|FG001|Overall Study|Lost to Follow-up|3|||
150138904|NCT00855595|541643708|FG000|Overall Study|Adverse Event|1|||
150138905|NCT00855595|541643709|FG001|Overall Study|Adverse Event|1|||
150138906|NCT00855595|541643708|FG000|Overall Study|patient moved out of state|1|||
150138907|NCT00855595|541643709|FG001|Overall Study|patient moved out of state|0|||
150138908|NCT00855595|541643708|FG000|Overall Study|patient left country|0|||
150138909|NCT00855595|541643709|FG001|Overall Study|patient left country|1|||
150138910|NCT01844284|541643710|FG000|Overall Study|Lost to Follow-up|12|||
150138911|NCT01844284|541643711|FG001|Overall Study|Lost to Follow-up|7|||
150138912|NCT00611858|541643712|FG000|Overall Study|Adverse Event|2|||
150138913|NCT00611858|541643712|FG000|Overall Study|Withdrawal by Subject|2|||
150138914|NCT01820559|541643713|FG000|Overall Study|Adverse Event|4|||
150138915|NCT01820559|541643714|FG001|Overall Study|Adverse Event|6|||
150138916|NCT01820559|541643715|FG002|Overall Study|Adverse Event|13|||
150138917|NCT01820559|541643713|FG000|Overall Study|Withdrawal by Subject|1|||
150138918|NCT01820559|541643714|FG001|Overall Study|Withdrawal by Subject|2|||
150138919|NCT01820559|541643715|FG002|Overall Study|Withdrawal by Subject|5|||
150138920|NCT01820559|541643713|FG000|Overall Study|Protocol Violation|2|||
150138921|NCT01820559|541643714|FG001|Overall Study|Protocol Violation|1|||
150138922|NCT01820559|541643715|FG002|Overall Study|Protocol Violation|3|||
150138923|NCT01820559|541643713|FG000|Overall Study|Subject's non-compliance|1|||
150138924|NCT01820559|541643714|FG001|Overall Study|Subject's non-compliance|0|||
150138925|NCT01820559|541643715|FG002|Overall Study|Subject's non-compliance|2|||
150138926|NCT01820559|541643713|FG000|Overall Study|Lost to Follow-up|3|||
150138927|NCT01820559|541643714|FG001|Overall Study|Lost to Follow-up|2|||
150138928|NCT01820559|541643715|FG002|Overall Study|Lost to Follow-up|2|||
150138929|NCT01820559|541643713|FG000|Overall Study|At sponsor request|0|||
150138930|NCT01820559|541643714|FG001|Overall Study|At sponsor request|0|||
150138931|NCT01820559|541643715|FG002|Overall Study|At sponsor request|1|||
150138932|NCT01820559|541643713|FG000|Overall Study|Lack of Efficacy|3|||
150138933|NCT01820559|541643714|FG001|Overall Study|Lack of Efficacy|2|||
150138934|NCT01820559|541643715|FG002|Overall Study|Lack of Efficacy|3|||
150138935|NCT01591382|541643717|FG000|Overall Study|Discharged Prior to Study Completion|2|||
150138936|NCT01591382|541643718|FG001|Overall Study|Discharged Prior to Study Completion|1|||
150138937|NCT01591382|541643717|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
150138938|NCT01591382|541643718|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
150138939|NCT05163522|541643723|FG000|Overall Study|Withdrawal by Subject|0|||
150138940|NCT05163522|541643724|FG001|Overall Study|Withdrawal by Subject|0|||
150138941|NCT05163522|541643725|FG002|Overall Study|Withdrawal by Subject|1|||
150138942|NCT05163522|541643726|FG003|Overall Study|Withdrawal by Subject|0|||
150138943|NCT05163522|541643727|FG004|Overall Study|Withdrawal by Subject|0|||
150138944|NCT05163522|541643728|FG005|Overall Study|Withdrawal by Subject|0|||
150138945|NCT05163522|541643729|FG006|Overall Study|Withdrawal by Subject|0|||
150138946|NCT05163522|541643730|FG007|Overall Study|Withdrawal by Subject|0|||
150138947|NCT05163522|541643731|FG008|Overall Study|Withdrawal by Subject|0|||
150138948|NCT05163522|541643732|FG009|Overall Study|Withdrawal by Subject|0|||
150138949|NCT05163522|541643733|FG010|Overall Study|Withdrawal by Subject|0|||
150138950|NCT02521285|541643735|FG000|Overall Study|Lost to Follow-up|1|||
150138951|NCT02521285|541643736|FG001|Overall Study|Lost to Follow-up|1|||
150138952|NCT02521285|541643735|FG000|Overall Study|Withdrawal by Subject|1|||
150138953|NCT02521285|541643736|FG001|Overall Study|Withdrawal by Subject|1|||
150138954|NCT02521285|541643735|FG000|Overall Study|Adverse Event|0|||
150138955|NCT02521285|541643736|FG001|Overall Study|Adverse Event|1|||
150138956|NCT00689026|541643741|FG000|Overall Study|Withdrawal by Subject|13|||
150138957|NCT00689026|541643742|FG001|Overall Study|Withdrawal by Subject|6|||
150138958|NCT01666808|541643743|FG000|Overall Study|Lost to Follow-up|9|||
150138959|NCT01666808|541643744|FG001|Overall Study|Lost to Follow-up|15|||
150138960|NCT01666808|541643743|FG000|Overall Study|Withdrawal by Subject|3|||
150138961|NCT01666808|541643744|FG001|Overall Study|Withdrawal by Subject|1|||
150138962|NCT01666808|541643743|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
150138963|NCT01666808|541643744|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
150138964|NCT03933826|541643745|FG000|Overall Study|Withdrawal by Subject|8|||
150138965|NCT03933826|541643746|FG001|Overall Study|Withdrawal by Subject|1|||
150138966|NCT03933826|541643745|FG000|Overall Study|Death|19|||
150138967|NCT03933826|541643746|FG001|Overall Study|Death|11|||
150138968|NCT03933826|541643745|FG000|Overall Study|Lost to Follow-up|41|||
150138969|NCT03933826|541643746|FG001|Overall Study|Lost to Follow-up|13|||
150138970|NCT04992546|541643747|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
150138971|NCT04992546|541643747|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
150138972|NCT04992546|541643747|FG000|Open-Label Treatment Period|Adverse Event|3|||
150138973|NCT04992546|541643747|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
150138974|NCT02703922|541643749|FG000|Overall Study|Death|5|||
150138975|NCT02703922|541643750|FG001|Overall Study|Death|8|||
150138976|NCT02703922|541643749|FG000|Overall Study|Lost to Follow-up|10|||
150138977|NCT02703922|541643750|FG001|Overall Study|Lost to Follow-up|10|||
150138978|NCT01648348|541643753|FG000|Overall Study|Cancel|1|||
150138979|NCT01648348|541643754|FG001|Overall Study|Cancel|0|||
150138980|NCT01648348|541643755|FG002|Overall Study|Cancel|0|||
150138981|NCT01648348|541643756|FG003|Overall Study|Cancel|0|||
150138982|NCT01648348|541643757|FG004|Overall Study|Cancel|3|||
150138983|NCT01648348|541643758|FG005|Overall Study|Cancel|6|||
150138984|NCT01648348|541643753|FG000|Overall Study|Replaced for MTD analysis|1|||
150138985|NCT01648348|541643754|FG001|Overall Study|Replaced for MTD analysis|0|||
150138986|NCT01648348|541643755|FG002|Overall Study|Replaced for MTD analysis|1|||
150138987|NCT01648348|541643756|FG003|Overall Study|Replaced for MTD analysis|0|||
150138988|NCT01648348|541643757|FG004|Overall Study|Replaced for MTD analysis|0|||
150138989|NCT01648348|541643758|FG005|Overall Study|Replaced for MTD analysis|0|||
150138990|NCT03419364|541643759|FG000|Overall Study|Delivery due to maternal condition|2|||
150138991|NCT03419364|541643760|FG001|Overall Study|Delivery due to maternal condition|0|||
150138992|NCT03419364|541643761|FG002|Overall Study|Delivery due to maternal condition|0|||
150138993|NCT00552084|541643762|FG000|Overall Study|Adverse Event|2|||
150138994|NCT00552084|541643763|FG001|Overall Study|Adverse Event|3|||
150138995|NCT00552084|541643762|FG000|Overall Study|Withdrawal by Subject|4|||
150138996|NCT00552084|541643763|FG001|Overall Study|Withdrawal by Subject|5|||
150138997|NCT00552084|541643762|FG000|Overall Study|Protocol Violation|1|||
150138998|NCT00552084|541643763|FG001|Overall Study|Protocol Violation|0|||
150138999|NCT00552084|541643762|FG000|Overall Study|change in anti-arrythmic drug|1|||
150139000|NCT00552084|541643763|FG001|Overall Study|change in anti-arrythmic drug|1|||
150139001|NCT01338025|541643764|FG000|Overall Study|Unexpected closure of study|10|||
150139002|NCT01338025|541643765|FG001|Overall Study|Unexpected closure of study|9|||
150139003|NCT01338025|541643764|FG000|Overall Study|Withdrawal by Subject|0|||
150139004|NCT01338025|541643765|FG001|Overall Study|Withdrawal by Subject|2|||
150139005|NCT01338025|541643764|FG000|Overall Study|Found ineligible after starting|1|||
150139006|NCT01338025|541643765|FG001|Overall Study|Found ineligible after starting|0|||
150139007|NCT03188055|541643766|FG000|Overall Study|Unavailable for training|0|||
150139008|NCT03188055|541643767|FG001|Overall Study|Unavailable for training|0|||
150139009|NCT03188055|541643768|FG002|Overall Study|Unavailable for training|19|||
150139010|NCT03188055|541643769|FG003|Overall Study|Unavailable for training|0|||
150139011|NCT03188055|541643770|FG004|Overall Study|Unavailable for training|0|||
150139012|NCT03188055|541643771|FG005|Overall Study|Unavailable for training|0|||
150139013|NCT03188055|541643766|FG000|Overall Study|Lost to Follow-up|0|||
150139014|NCT03188055|541643767|FG001|Overall Study|Lost to Follow-up|18|||
150139015|NCT03188055|541643768|FG002|Overall Study|Lost to Follow-up|0|||
150139016|NCT03188055|541643769|FG003|Overall Study|Lost to Follow-up|11|||
150139017|NCT03188055|541643770|FG004|Overall Study|Lost to Follow-up|0|||
150139018|NCT03188055|541643771|FG005|Overall Study|Lost to Follow-up|0|||
150139019|NCT03188055|541643766|FG000|Overall Study|Withdrawal by Subject|0|||
150139020|NCT03188055|541643767|FG001|Overall Study|Withdrawal by Subject|1|||
150139021|NCT03188055|541643768|FG002|Overall Study|Withdrawal by Subject|0|||
150139022|NCT03188055|541643769|FG003|Overall Study|Withdrawal by Subject|1|||
150139023|NCT03188055|541643770|FG004|Overall Study|Withdrawal by Subject|0|||
150139024|NCT03188055|541643771|FG005|Overall Study|Withdrawal by Subject|0|||
150139025|NCT03017079|541643772|FG000|Overall Study|Physician Decision|1|||
150139026|NCT03017079|541643773|FG001|Overall Study|Physician Decision|1|||
150139027|NCT03017079|541643772|FG000|Overall Study|Death|3|||
150139028|NCT03017079|541643773|FG001|Overall Study|Death|2|||
150139029|NCT03017079|541643772|FG000|Overall Study|Lack of Efficacy|2|||
150139030|NCT03017079|541643773|FG001|Overall Study|Lack of Efficacy|2|||
150139031|NCT03017079|541643772|FG000|Overall Study|Protocol Violation|0|||
150139032|NCT03017079|541643773|FG001|Overall Study|Protocol Violation|1|||
150139033|NCT04349280|541643774|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
150139034|NCT04349280|541643775|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
150139035|NCT04349280|541643774|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
150139036|NCT04349280|541643775|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
150139037|NCT04349280|541643774|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
150139038|NCT04349280|541643775|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
150139039|NCT02286089|541643778|FG000|Overall Study|Ongoing in Study|1|||
150139040|NCT02286089|541643779|FG001|Overall Study|Ongoing in Study|1|||
150139041|NCT02286089|541643780|FG002|Overall Study|Ongoing in Study|4|||
150139042|NCT02286089|541643781|FG003|Overall Study|Ongoing in Study|10|||
150139043|NCT02286089|541643778|FG000|Overall Study|Withdrawal by Subject|0|||
150139044|NCT02286089|541643779|FG001|Overall Study|Withdrawal by Subject|0|||
150139045|NCT02286089|541643780|FG002|Overall Study|Withdrawal by Subject|2|||
150139046|NCT02286089|541643781|FG003|Overall Study|Withdrawal by Subject|2|||
150139047|NCT00847405|541645396|FG000|First Intervention|Adverse Event|0|||
150139048|NCT00847405|541645397|FG001|First Intervention|Adverse Event|1|||
150139049|NCT00847405|541645396|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
150139050|NCT00847405|541645397|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
150139051|NCT01728792|541645398|FG000|Overall Study|Withdrawal of Consent|1|||
150139052|NCT01728792|541645399|FG001|Overall Study|Withdrawal of Consent|1|||
150139053|NCT01728792|541645400|FG002|Overall Study|Withdrawal of Consent|0|||
150139054|NCT01728792|541645401|FG003|Overall Study|Withdrawal of Consent|1|||
150139055|NCT01728792|541645402|FG004|Overall Study|Withdrawal of Consent|0|||
150139056|NCT01728792|541645398|FG000|Overall Study|Lost to Follow-up|2|||
150139057|NCT01728792|541645399|FG001|Overall Study|Lost to Follow-up|1|||
150139058|NCT01728792|541645400|FG002|Overall Study|Lost to Follow-up|4|||
150139059|NCT01728792|541645401|FG003|Overall Study|Lost to Follow-up|2|||
150139060|NCT01728792|541645402|FG004|Overall Study|Lost to Follow-up|0|||
150139061|NCT03559218|541645403|FG000|Overall Study|Withdrawal by Subject|1|||
150139062|NCT03559218|541645404|FG001|Overall Study|Withdrawal by Subject|0|||
150139063|NCT04277455|541645405|FG000|Overall Study|Lost to Follow-up|1|||
150139064|NCT01679301|541645408|FG000|Screening Period|screen failure|3|||
150139065|NCT01679301|541645409|FG001|Screening Period|screen failure|0|||
150139066|NCT01679301|541645410|FG002|Screening Period|screen failure|0|||
150139067|NCT02259517|541645411|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
150139068|NCT02259517|541645412|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
150139069|NCT02259517|541645413|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
150139070|NCT02259517|541645411|FG000|Overall Study|Withdrawal by Subject|0|||
150139071|NCT02259517|541645412|FG001|Overall Study|Withdrawal by Subject|0|||
150139072|NCT02259517|541645413|FG002|Overall Study|Withdrawal by Subject|3|||
150139073|NCT02305381|541645414|FG000|Overall Study|Unclassified|5|||
150139074|NCT02305381|541645415|FG001|Overall Study|Unclassified|5|||
150139075|NCT02305381|541645416|FG002|Overall Study|Unclassified|7|||
150139076|NCT01564368|541645424|FG000|Overall Study|Ineligible|18|||
150139077|NCT01564368|541645424|FG000|Overall Study|Not Randomized in Parent study|116|||
150139078|NCT01564368|541645424|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
150139079|NCT01564368|541645424|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
150139080|NCT01802437|541645425|FG000|Overall Study|Lost to Follow-up|1|||
150139081|NCT01802437|541645426|FG001|Overall Study|Lost to Follow-up|0|||
150139082|NCT01802437|541645425|FG000|Overall Study|Withdrawal by Subject|3|||
150139083|NCT01802437|541645426|FG001|Overall Study|Withdrawal by Subject|4|||
150139084|NCT04538144|541645431|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
150139085|NCT04538144|541645432|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
150139086|NCT04538144|541645433|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
150139087|NCT04538144|541645434|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
150139088|NCT00429663|541645435|FG000|Overall Study|Lost to Follow-up|24|||
150139089|NCT00429663|541645436|FG001|Overall Study|Lost to Follow-up|31|||
150139090|NCT00429663|541645435|FG000|Overall Study|Physician Decision|6|||
150139091|NCT00429663|541645436|FG001|Overall Study|Physician Decision|3|||
150139092|NCT00429663|541645435|FG000|Overall Study|Withdrawal by Subject|2|||
150139093|NCT00429663|541645436|FG001|Overall Study|Withdrawal by Subject|5|||
150139094|NCT00429663|541645435|FG000|Overall Study|Death|4|||
150139095|NCT00429663|541645436|FG001|Overall Study|Death|0|||
150139096|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
150139097|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
150139098|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
150139099|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
150139100|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
150139101|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
150139102|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
150139103|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
150139104|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
150139105|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
150139106|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
150139107|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
150139108|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
150139109|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
150139110|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
150139111|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
150139112|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
150139113|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150139114|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150139115|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
150139116|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Death|2|||
150139117|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Death|2|||
150139118|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Death|0|||
150139119|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Death|0|||
150139120|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Death|0|||
150139121|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
150139122|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
150139123|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
150139124|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
150139125|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
150139126|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
150139127|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
150139128|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
150139129|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
150139130|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
150139131|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
150139132|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
150139133|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
150139134|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
150139135|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
150139136|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
150139137|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
150139138|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
150139139|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
150139140|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
150139141|NCT03420781|541645437|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
150139142|NCT03420781|541645438|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
150139143|NCT03420781|541645439|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
150139144|NCT03420781|541645440|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
150139145|NCT03420781|541645441|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
150209889|NCT03683576|541905122|FG000|Overall Study|Protocol Violation|0|||
150209890|NCT03683576|541905123|FG001|Overall Study|Protocol Violation|1|||
150209891|NCT03683576|541905124|FG002|Overall Study|Protocol Violation|1|||
150139146|NCT03420781|541645437|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
150139147|NCT03420781|541645438|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
150139148|NCT03420781|541645439|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
150139149|NCT03420781|541645440|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
150139150|NCT03420781|541645441|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
150139151|NCT03420781|541645437|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
150139152|NCT03420781|541645438|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
150139153|NCT03420781|541645439|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
150139154|NCT03420781|541645440|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
150139155|NCT03420781|541645441|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
150139156|NCT03420781|541645437|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
150139157|NCT03420781|541645438|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
150139158|NCT03420781|541645439|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
150139159|NCT03420781|541645440|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
150139160|NCT03420781|541645441|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
150139161|NCT02313909|541645445|FG000|Overall Study|Consent withdrawn by participant|33|||
150139162|NCT02313909|541645446|FG001|Overall Study|Consent withdrawn by participant|33|||
150139163|NCT02313909|541645445|FG000|Overall Study|Lost to Follow-up|24|||
150139164|NCT02313909|541645446|FG001|Overall Study|Lost to Follow-up|17|||
150139165|NCT00643123|541645452|FG000|Overall Study|Lost to Follow-up|4|||
150139166|NCT00643123|541645453|FG001|Overall Study|Lost to Follow-up|0|||
150139167|NCT00643123|541645452|FG000|Overall Study|Withdrawal by Subject|1|||
150139168|NCT00643123|541645453|FG001|Overall Study|Withdrawal by Subject|1|||
150139169|NCT05292534|541645454|FG000|Overall Study|Protocol Violation|3|||
150139170|NCT05292534|541645455|FG001|Overall Study|Protocol Violation|4|||
150139171|NCT05292534|541645454|FG000|Overall Study|Withdrawal by Subject|0|||
150139172|NCT05292534|541645455|FG001|Overall Study|Withdrawal by Subject|1|||
150139173|NCT01538472|541645456|FG000|Overall Study|Disease Progression|3|||
150139174|NCT01538472|541645456|FG000|Overall Study|Death|1|||
150139175|NCT02309112|541645457|FG000|Overall Study|Withdrawal by Subject|1|||
150139176|NCT02309112|541645458|FG001|Overall Study|Withdrawal by Subject|0|||
150139177|NCT02309112|541645459|FG002|Overall Study|Withdrawal by Subject|1|||
150139178|NCT02309112|541645457|FG000|Overall Study|Lost to Follow-up|0|||
150139179|NCT02309112|541645458|FG001|Overall Study|Lost to Follow-up|1|||
150139180|NCT02309112|541645459|FG002|Overall Study|Lost to Follow-up|0|||
150139181|NCT02133872|541645460|FG000|Overall Study|Withdrawal by Subject|5|||
150139182|NCT02133872|541645461|FG001|Overall Study|Withdrawal by Subject|3|||
150139183|NCT02133872|541645462|FG002|Overall Study|Withdrawal by Subject|0|||
150139184|NCT00238433|541645466|FG000|Overall Study|Screen failure|1|||
150139185|NCT00238433|541645466|FG000|Overall Study|Lost to Follow-up|1|||
150139186|NCT00238433|541645466|FG000|Overall Study|Death|1|||
150139187|NCT00454571|541645467|FG000|Overall Study|Adverse Event|2|||
150139188|NCT00454571|541645468|FG001|Overall Study|Adverse Event|0|||
150139189|NCT00454571|541645467|FG000|Overall Study|Physician Decision|0|||
150139190|NCT00454571|541645468|FG001|Overall Study|Physician Decision|1|||
150139191|NCT00454571|541645467|FG000|Overall Study|Protocol Violation|1|||
150139192|NCT00454571|541645468|FG001|Overall Study|Protocol Violation|0|||
150139193|NCT00454571|541645467|FG000|Overall Study|Withdrawal by Subject|10|||
150139194|NCT00454571|541645468|FG001|Overall Study|Withdrawal by Subject|5|||
150139195|NCT01376323|541645469|FG000|Overall Study|Adverse Event|1|||
150139196|NCT01376323|541645470|FG001|Overall Study|Adverse Event|0|||
150139197|NCT01376323|541645471|FG002|Overall Study|Adverse Event|0|||
150139198|NCT01376323|541645472|FG003|Overall Study|Adverse Event|2|||
150139199|NCT01376323|541645473|FG004|Overall Study|Adverse Event|0|||
150139200|NCT01376323|541645469|FG000|Overall Study|Lost to Follow-up|0|||
150139201|NCT01376323|541645470|FG001|Overall Study|Lost to Follow-up|0|||
150139202|NCT01376323|541645471|FG002|Overall Study|Lost to Follow-up|0|||
150139203|NCT01376323|541645472|FG003|Overall Study|Lost to Follow-up|2|||
150139204|NCT01376323|541645473|FG004|Overall Study|Lost to Follow-up|0|||
150139205|NCT01376323|541645469|FG000|Overall Study|Physician Decision|1|||
150139206|NCT01376323|541645470|FG001|Overall Study|Physician Decision|0|||
150139207|NCT01376323|541645471|FG002|Overall Study|Physician Decision|2|||
150139208|NCT01376323|541645472|FG003|Overall Study|Physician Decision|1|||
150139209|NCT01376323|541645473|FG004|Overall Study|Physician Decision|1|||
150209892|NCT03683576|541905125|FG003|Overall Study|Protocol Violation|0|||
150209893|NCT01593020|541905128|FG000|Overall Study|Adverse Event|1|||
150139210|NCT01376323|541645469|FG000|Overall Study|Withdrawal by Subject|0|||
150139211|NCT01376323|541645470|FG001|Overall Study|Withdrawal by Subject|1|||
150139212|NCT01376323|541645471|FG002|Overall Study|Withdrawal by Subject|1|||
150209894|NCT01593020|541905129|FG001|Overall Study|Adverse Event|1|||
150209895|NCT01593020|541905128|FG000|Overall Study|Death|0|||
150209896|NCT01593020|541905129|FG001|Overall Study|Death|1|||
150209897|NCT01593020|541905128|FG000|Overall Study|Ineligible|1|||
150209898|NCT01593020|541905129|FG001|Overall Study|Ineligible|0|||
150209899|NCT02350634|541905130|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
150209900|NCT03492177|541905140|FG000|Overall Study|Adverse Event|1|||
150209901|NCT03492177|541905141|FG001|Overall Study|Adverse Event|0|||
150209902|NCT03492177|541905142|FG002|Overall Study|Adverse Event|0|||
150209903|NCT03492177|541905140|FG000|Overall Study|Death|3|||
150209904|NCT03492177|541905141|FG001|Overall Study|Death|0|||
150209905|NCT03492177|541905142|FG002|Overall Study|Death|3|||
150209906|NCT03492177|541905140|FG000|Overall Study|Lack of Efficacy|1|||
150209907|NCT03492177|541905141|FG001|Overall Study|Lack of Efficacy|2|||
150209908|NCT03492177|541905142|FG002|Overall Study|Lack of Efficacy|0|||
150209909|NCT03492177|541905140|FG000|Overall Study|Other|1|||
150209910|NCT03492177|541905141|FG001|Overall Study|Other|0|||
150209911|NCT03492177|541905142|FG002|Overall Study|Other|0|||
150209912|NCT03492177|541905140|FG000|Overall Study|Ongoing|16|||
150209913|NCT03492177|541905141|FG001|Overall Study|Ongoing|19|||
150209914|NCT03492177|541905142|FG002|Overall Study|Ongoing|17|||
150209915|NCT02499328|541905143|FG000|Overall Study|Withdrawal by Subject|1|||
150209916|NCT02499328|541905144|FG001|Overall Study|Withdrawal by Subject|1|||
150209917|NCT02499328|541905145|FG002|Overall Study|Withdrawal by Subject|5|||
150209918|NCT02499328|541905146|FG003|Overall Study|Withdrawal by Subject|3|||
150209919|NCT02499328|541905147|FG004|Overall Study|Withdrawal by Subject|5|||
150209920|NCT02499328|541905148|FG005|Overall Study|Withdrawal by Subject|0|||
150209921|NCT02499328|541905149|FG006|Overall Study|Withdrawal by Subject|0|||
150209922|NCT02499328|541905150|FG007|Overall Study|Withdrawal by Subject|0|||
150209923|NCT02499328|541905151|FG008|Overall Study|Withdrawal by Subject|2|||
150209924|NCT02499328|541905152|FG009|Overall Study|Withdrawal by Subject|2|||
150209925|NCT02499328|541905153|FG010|Overall Study|Withdrawal by Subject|0|||
150209926|NCT02499328|541905154|FG011|Overall Study|Withdrawal by Subject|3|||
150209927|NCT02499328|541905155|FG012|Overall Study|Withdrawal by Subject|7|||
150209928|NCT02499328|541905156|FG013|Overall Study|Withdrawal by Subject|3|||
150209929|NCT02499328|541905157|FG014|Overall Study|Withdrawal by Subject|1|||
150139213|NCT01376323|541645472|FG003|Overall Study|Withdrawal by Subject|0|||
150139214|NCT01376323|541645473|FG004|Overall Study|Withdrawal by Subject|0|||
150139215|NCT04681729|541645474|FG000|Overall Study|Lack of Efficacy|2|||
150139216|NCT04681729|541645475|FG001|Overall Study|Lack of Efficacy|2|||
150139217|NCT04681729|541645474|FG000|Overall Study|Withdrawal by Subject|8|||
150139218|NCT04681729|541645475|FG001|Overall Study|Withdrawal by Subject|9|||
150139219|NCT02436811|541645476|FG000|Overall Study|Lost to Follow-up|2|||
150209930|NCT02499328|541905158|FG015|Overall Study|Withdrawal by Subject|0|||
150209931|NCT02499328|541905159|FG016|Overall Study|Withdrawal by Subject|0|||
150209932|NCT02499328|541905160|FG017|Overall Study|Withdrawal by Subject|3|||
150209933|NCT02499328|541905161|FG018|Overall Study|Withdrawal by Subject|0|||
150209934|NCT02499328|541905143|FG000|Overall Study|Lost to Follow-up|0|||
150209935|NCT02499328|541905144|FG001|Overall Study|Lost to Follow-up|1|||
150209936|NCT02499328|541905145|FG002|Overall Study|Lost to Follow-up|1|||
150209937|NCT02499328|541905146|FG003|Overall Study|Lost to Follow-up|2|||
150209938|NCT02499328|541905147|FG004|Overall Study|Lost to Follow-up|0|||
150139220|NCT02436811|541645477|FG001|Overall Study|Lost to Follow-up|9|||
150139221|NCT02436811|541645478|FG002|Overall Study|Lost to Follow-up|7|||
150139222|NCT03595332|541645479|FG000|Overall Study|Lost to Follow-up|16|||
150139223|NCT03595332|541645480|FG001|Overall Study|Lost to Follow-up|22|||
150139224|NCT03595332|541645479|FG000|Overall Study|Unable to retrieve ID from school|0|||
150139225|NCT03595332|541645480|FG001|Overall Study|Unable to retrieve ID from school|2|||
150139226|NCT02227875|541645481|FG000|Overall Study|Protocol Violation|10|||
150139227|NCT02227875|541645482|FG001|Overall Study|Protocol Violation|7|||
150139228|NCT02227875|541645481|FG000|Overall Study|Other|1|||
150139229|NCT02227875|541645482|FG001|Overall Study|Other|3|||
150139230|NCT02227875|541645481|FG000|Overall Study|Physician Decision|1|||
150139231|NCT02227875|541645482|FG001|Overall Study|Physician Decision|0|||
150139232|NCT02227875|541645481|FG000|Overall Study|Adverse Event|3|||
150139233|NCT02227875|541645482|FG001|Overall Study|Adverse Event|0|||
150139234|NCT02227875|541645481|FG000|Overall Study|Withdrawal by Subject|12|||
150139235|NCT02227875|541645482|FG001|Overall Study|Withdrawal by Subject|13|||
150139236|NCT02227875|541645481|FG000|Overall Study|Lost to Follow-up|10|||
150139237|NCT02227875|541645482|FG001|Overall Study|Lost to Follow-up|10|||
150139238|NCT02657317|541645485|FG000|Overall Study|Withdrawal by Subject|2|||
150209939|NCT02499328|541905148|FG005|Overall Study|Lost to Follow-up|0|||
150209940|NCT02499328|541905149|FG006|Overall Study|Lost to Follow-up|0|||
150139239|NCT02657317|541645486|FG001|Overall Study|Withdrawal by Subject|0|||
150139240|NCT02657317|541645485|FG000|Overall Study|Lost to Follow-up|3|||
150139241|NCT02657317|541645486|FG001|Overall Study|Lost to Follow-up|3|||
150139242|NCT02856113|541645487|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
150139243|NCT02856113|541645488|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
150139244|NCT02856113|541645487|FG000|Overall Study|Significant Protocol Deviation|1|||
150139245|NCT02856113|541645488|FG001|Overall Study|Significant Protocol Deviation|0|||
150139246|NCT02856113|541645487|FG000|Overall Study|Lost to Follow-up|3|||
150209941|NCT02499328|541905150|FG007|Overall Study|Lost to Follow-up|2|||
150209942|NCT02499328|541905151|FG008|Overall Study|Lost to Follow-up|3|||
150209943|NCT02499328|541905152|FG009|Overall Study|Lost to Follow-up|0|||
150209944|NCT02499328|541905153|FG010|Overall Study|Lost to Follow-up|0|||
150209945|NCT02499328|541905154|FG011|Overall Study|Lost to Follow-up|0|||
150209946|NCT02499328|541905155|FG012|Overall Study|Lost to Follow-up|0|||
150209947|NCT02499328|541905156|FG013|Overall Study|Lost to Follow-up|0|||
150209948|NCT02499328|541905157|FG014|Overall Study|Lost to Follow-up|0|||
150209949|NCT02499328|541905158|FG015|Overall Study|Lost to Follow-up|0|||
150209950|NCT02499328|541905159|FG016|Overall Study|Lost to Follow-up|0|||
150209951|NCT02499328|541905160|FG017|Overall Study|Lost to Follow-up|0|||
150209952|NCT02499328|541905161|FG018|Overall Study|Lost to Follow-up|1|||
150209953|NCT02499328|541905143|FG000|Overall Study|Death|0|||
150209954|NCT02499328|541905144|FG001|Overall Study|Death|3|||
150209955|NCT02499328|541905145|FG002|Overall Study|Death|3|||
150209956|NCT02499328|541905146|FG003|Overall Study|Death|2|||
150209957|NCT02499328|541905147|FG004|Overall Study|Death|4|||
150209958|NCT02499328|541905148|FG005|Overall Study|Death|7|||
150209959|NCT02499328|541905149|FG006|Overall Study|Death|3|||
150209960|NCT02499328|541905150|FG007|Overall Study|Death|0|||
150209961|NCT02499328|541905151|FG008|Overall Study|Death|2|||
150139247|NCT02856113|541645488|FG001|Overall Study|Lost to Follow-up|5|||
150139248|NCT02856113|541645487|FG000|Overall Study|Voluntary Withdrawal|3|||
150139249|NCT02856113|541645488|FG001|Overall Study|Voluntary Withdrawal|5|||
150139250|NCT02856113|541645487|FG000|Overall Study|Pregnancy|0|||
150139251|NCT02856113|541645488|FG001|Overall Study|Pregnancy|1|||
150139252|NCT02856113|541645487|FG000|Overall Study|Principal Investigator Discretion|2|||
150139253|NCT02856113|541645488|FG001|Overall Study|Principal Investigator Discretion|1|||
150139254|NCT02856113|541645487|FG000|Overall Study|Randomized but not Treated|1|||
150209962|NCT02499328|541905152|FG009|Overall Study|Death|6|||
150209963|NCT02499328|541905153|FG010|Overall Study|Death|6|||
150209964|NCT02499328|541905154|FG011|Overall Study|Death|20|||
150209965|NCT02499328|541905155|FG012|Overall Study|Death|9|||
150209966|NCT02499328|541905156|FG013|Overall Study|Death|7|||
150209967|NCT02499328|541905157|FG014|Overall Study|Death|3|||
150209968|NCT02499328|541905158|FG015|Overall Study|Death|1|||
150209969|NCT02499328|541905159|FG016|Overall Study|Death|1|||
150209970|NCT02499328|541905160|FG017|Overall Study|Death|16|||
150209971|NCT02499328|541905161|FG018|Overall Study|Death|5|||
150209972|NCT02499328|541905143|FG000|Overall Study|"Other"|2|||
150139255|NCT02856113|541645488|FG001|Overall Study|Randomized but not Treated|0|||
150139256|NCT02856113|541645487|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
150139257|NCT02856113|541645488|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
150139258|NCT03494166|541645489|FG000|Overall Study|Death|0|||
150139259|NCT03494166|541645490|FG001|Overall Study|Death|0|||
150139260|NCT03494166|541645491|FG002|Overall Study|Death|0|||
150139261|NCT03494166|541645492|FG003|Overall Study|Death|1|||
150139262|NCT03494166|541645493|FG004|Overall Study|Death|3|||
150139263|NCT03494166|541645494|FG005|Overall Study|Death|0|||
150209973|NCT02499328|541905144|FG001|Overall Study|"Other"|2|||
150209974|NCT02499328|541905145|FG002|Overall Study|"Other"|1|||
150209975|NCT02499328|541905146|FG003|Overall Study|"Other"|3|||
150209976|NCT02499328|541905147|FG004|Overall Study|"Other"|6|||
150209977|NCT02499328|541905148|FG005|Overall Study|"Other"|2|||
150209978|NCT02499328|541905149|FG006|Overall Study|"Other"|3|||
150209979|NCT02499328|541905150|FG007|Overall Study|"Other"|4|||
150209980|NCT02499328|541905151|FG008|Overall Study|"Other"|6|||
150209981|NCT02499328|541905152|FG009|Overall Study|"Other"|16|||
150209982|NCT02499328|541905153|FG010|Overall Study|"Other"|13|||
150209983|NCT02499328|541905154|FG011|Overall Study|"Other"|31|||
150139264|NCT03494166|541645489|FG000|Overall Study|Lost to Follow-up|2|||
150139265|NCT03494166|541645490|FG001|Overall Study|Lost to Follow-up|2|||
150139266|NCT03494166|541645491|FG002|Overall Study|Lost to Follow-up|2|||
150139267|NCT03494166|541645492|FG003|Overall Study|Lost to Follow-up|2|||
150139268|NCT03494166|541645493|FG004|Overall Study|Lost to Follow-up|14|||
150139269|NCT03494166|541645494|FG005|Overall Study|Lost to Follow-up|0|||
150139270|NCT03494166|541645489|FG000|Overall Study|Withdrawal by Subject|10|||
150139271|NCT03494166|541645490|FG001|Overall Study|Withdrawal by Subject|7|||
150139272|NCT03494166|541645491|FG002|Overall Study|Withdrawal by Subject|0|||
150139273|NCT03494166|541645492|FG003|Overall Study|Withdrawal by Subject|5|||
150139274|NCT03494166|541645493|FG004|Overall Study|Withdrawal by Subject|3|||
150139275|NCT03494166|541645494|FG005|Overall Study|Withdrawal by Subject|17|||
150139276|NCT03494166|541645489|FG000|Overall Study|Screen failure|1|||
150139277|NCT03494166|541645490|FG001|Overall Study|Screen failure|0|||
150139278|NCT03494166|541645491|FG002|Overall Study|Screen failure|0|||
150209984|NCT02499328|541905155|FG012|Overall Study|"Other"|8|||
150209985|NCT02499328|541905156|FG013|Overall Study|"Other"|7|||
150209986|NCT02499328|541905157|FG014|Overall Study|"Other"|6|||
150209987|NCT02499328|541905158|FG015|Overall Study|"Other"|0|||
150209988|NCT02499328|541905159|FG016|Overall Study|"Other"|0|||
150209989|NCT02499328|541905160|FG017|Overall Study|"Other"|34|||
150209990|NCT02499328|541905161|FG018|Overall Study|"Other"|43|||
150209991|NCT02499328|541905143|FG000|Overall Study|Disease Progression|0|||
150209992|NCT02499328|541905144|FG001|Overall Study|Disease Progression|0|||
150209993|NCT02499328|541905145|FG002|Overall Study|Disease Progression|0|||
150209994|NCT02499328|541905146|FG003|Overall Study|Disease Progression|0|||
150209995|NCT02499328|541905147|FG004|Overall Study|Disease Progression|0|||
150209996|NCT02499328|541905148|FG005|Overall Study|Disease Progression|0|||
150209997|NCT02499328|541905149|FG006|Overall Study|Disease Progression|1|||
150209998|NCT02499328|541905150|FG007|Overall Study|Disease Progression|0|||
150209999|NCT02499328|541905151|FG008|Overall Study|Disease Progression|1|||
150210000|NCT02499328|541905152|FG009|Overall Study|Disease Progression|0|||
150139279|NCT03494166|541645492|FG003|Overall Study|Screen failure|0|||
150139280|NCT03494166|541645493|FG004|Overall Study|Screen failure|1|||
150139281|NCT03494166|541645494|FG005|Overall Study|Screen failure|0|||
150139282|NCT01960725|541645495|FG000|Overall Study|Lost to Follow-up|4|||
150139283|NCT01960725|541645496|FG001|Overall Study|Lost to Follow-up|3|||
150139284|NCT01960725|541645495|FG000|Overall Study|Withdrawal by Subject|1|||
150139285|NCT01960725|541645496|FG001|Overall Study|Withdrawal by Subject|0|||
150139286|NCT01960725|541645495|FG000|Overall Study|unable to obtain blood sample|1|||
150139287|NCT01960725|541645496|FG001|Overall Study|unable to obtain blood sample|2|||
150139288|NCT00758459|541645501|FG000|Overall Study|Adverse Event|3|||
150139289|NCT00758459|541645502|FG001|Overall Study|Adverse Event|2|||
150139290|NCT00758459|541645501|FG000|Overall Study|Protocol Violation|0|||
150139291|NCT00758459|541645502|FG001|Overall Study|Protocol Violation|1|||
150139292|NCT00758459|541645501|FG000|Overall Study|Withdrawal by Subject|0|||
150139293|NCT00758459|541645502|FG001|Overall Study|Withdrawal by Subject|1|||
150139294|NCT01058304|541645504|FG000|Overall Study|Withdrawal by Subject|8|||
150139295|NCT01058304|541645505|FG001|Overall Study|Withdrawal by Subject|5|||
150139296|NCT01058304|541645504|FG000|Overall Study|Lost to Follow-up|13|||
150139297|NCT01058304|541645505|FG001|Overall Study|Lost to Follow-up|16|||
150139298|NCT01058304|541645504|FG000|Overall Study|Developed exclusion criterion|6|||
150139299|NCT01058304|541645505|FG001|Overall Study|Developed exclusion criterion|12|||
150139300|NCT02755597|541645506|FG000|Overall Study|Withdrew consent|27|||
150139301|NCT02755597|541645507|FG001|Overall Study|Withdrew consent|11|||
150139302|NCT02755597|541645506|FG000|Overall Study|Lost to Follow-up|1|||
150139303|NCT02755597|541645507|FG001|Overall Study|Lost to Follow-up|0|||
150139304|NCT02755597|541645506|FG000|Overall Study|Death|78|||
150139305|NCT02755597|541645507|FG001|Overall Study|Death|36|||
150139306|NCT02755597|541645506|FG000|Overall Study|Study terminated by Sponsor|67|||
150139307|NCT02755597|541645507|FG001|Overall Study|Study terminated by Sponsor|47|||
150139308|NCT02755597|541645506|FG000|Overall Study|Other, not specified|20|||
150210001|NCT02499328|541905153|FG010|Overall Study|Disease Progression|1|||
150139309|NCT02755597|541645507|FG001|Overall Study|Other, not specified|3|||
150210002|NCT02499328|541905154|FG011|Overall Study|Disease Progression|0|||
150210003|NCT02499328|541905155|FG012|Overall Study|Disease Progression|0|||
150210004|NCT02499328|541905156|FG013|Overall Study|Disease Progression|0|||
150210005|NCT02499328|541905157|FG014|Overall Study|Disease Progression|0|||
150139310|NCT02755597|541645506|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
150139311|NCT02755597|541645507|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
150139312|NCT02496767|541645508|FG000|Open-label Lead-in Phase|Adverse Event|176|||
150139313|NCT02496767|541645509|FG001|Open-label Lead-in Phase|Adverse Event|0|||
150139314|NCT02496767|541645510|FG002|Open-label Lead-in Phase|Adverse Event|0|||
150139315|NCT02496767|541645511|FG003|Open-label Lead-in Phase|Adverse Event|0|||
150139316|NCT02496767|541645512|FG004|Open-label Lead-in Phase|Adverse Event|0|||
150139317|NCT02496767|541645513|FG005|Open-label Lead-in Phase|Adverse Event|0|||
150139318|NCT02496767|541645514|FG006|Open-label Lead-in Phase|Adverse Event|0|||
150139319|NCT02496767|541645515|FG007|Open-label Lead-in Phase|Adverse Event|0|||
150139320|NCT02496767|541645508|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
150139321|NCT02496767|541645509|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
150139322|NCT02496767|541645510|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
150139323|NCT02496767|541645511|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
150139324|NCT02496767|541645512|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
150139325|NCT02496767|541645513|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
150139326|NCT02496767|541645514|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
150139327|NCT02496767|541645515|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
150139328|NCT02496767|541645508|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
150139329|NCT02496767|541645509|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139330|NCT02496767|541645510|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139331|NCT02496767|541645511|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139332|NCT02496767|541645512|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139333|NCT02496767|541645513|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139334|NCT02496767|541645514|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139335|NCT02496767|541645515|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
150139336|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
150139337|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
150139338|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
150139339|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
150139340|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
150139341|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
150139342|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
150139343|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
150139344|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
150139345|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
150139346|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
150139347|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
150139348|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
150139349|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
150139350|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
150139351|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
150139352|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
150139353|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
150139354|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
150139355|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
150139356|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
150139357|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
150139358|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
150139359|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
150139360|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
150139361|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
150139362|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
150139363|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
150139364|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
150139365|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
150139366|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
150139367|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
150139368|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
150139369|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
150139370|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
150139371|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
150139372|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
150139373|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
150139374|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
150139375|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
150139376|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139377|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
150139378|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
150139379|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139380|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139381|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139382|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139383|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
150139384|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150139385|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
150139386|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150139387|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
150210006|NCT02499328|541905158|FG015|Overall Study|Disease Progression|0|||
150210007|NCT02499328|541905159|FG016|Overall Study|Disease Progression|0|||
150210008|NCT02499328|541905160|FG017|Overall Study|Disease Progression|2|||
150210009|NCT02499328|541905161|FG018|Overall Study|Disease Progression|0|||
150210010|NCT02499328|541905143|FG000|Overall Study|Adverse Event|1|||
150210011|NCT02499328|541905144|FG001|Overall Study|Adverse Event|0|||
150210012|NCT02499328|541905145|FG002|Overall Study|Adverse Event|0|||
150210013|NCT02499328|541905146|FG003|Overall Study|Adverse Event|1|||
150210014|NCT02499328|541905147|FG004|Overall Study|Adverse Event|0|||
150210015|NCT02499328|541905148|FG005|Overall Study|Adverse Event|0|||
150210016|NCT02499328|541905149|FG006|Overall Study|Adverse Event|0|||
150210017|NCT02499328|541905150|FG007|Overall Study|Adverse Event|0|||
150210018|NCT02499328|541905151|FG008|Overall Study|Adverse Event|0|||
150210019|NCT02499328|541905152|FG009|Overall Study|Adverse Event|0|||
150210020|NCT02499328|541905153|FG010|Overall Study|Adverse Event|0|||
150210021|NCT02499328|541905154|FG011|Overall Study|Adverse Event|0|||
150210022|NCT02499328|541905155|FG012|Overall Study|Adverse Event|1|||
150210023|NCT02499328|541905156|FG013|Overall Study|Adverse Event|0|||
150210024|NCT02499328|541905157|FG014|Overall Study|Adverse Event|0|||
150210025|NCT02499328|541905158|FG015|Overall Study|Adverse Event|0|||
150210026|NCT02499328|541905159|FG016|Overall Study|Adverse Event|0|||
150210027|NCT02499328|541905160|FG017|Overall Study|Adverse Event|0|||
150210028|NCT02499328|541905161|FG018|Overall Study|Adverse Event|0|||
150210029|NCT03102034|541905162|FG000|Overall Study|Withdrawal by Subject|1|||
150210030|NCT03102034|541905163|FG001|Overall Study|Withdrawal by Subject|0|||
150210031|NCT02063659|541905167|FG000|Double-Blind Treatment Period|Adverse Event|1|||
150210032|NCT02063659|541905168|FG001|Double-Blind Treatment Period|Adverse Event|2|||
150210033|NCT02063659|541905169|FG002|Double-Blind Treatment Period|Adverse Event|0|||
150210034|NCT02063659|541905170|FG003|Double-Blind Treatment Period|Adverse Event|0|||
150210035|NCT02063659|541905167|FG000|Double-Blind Treatment Period|Physician Decision|1|||
150210036|NCT02063659|541905168|FG001|Double-Blind Treatment Period|Physician Decision|0|||
150210037|NCT02063659|541905169|FG002|Double-Blind Treatment Period|Physician Decision|0|||
150210038|NCT02063659|541905170|FG003|Double-Blind Treatment Period|Physician Decision|0|||
150210039|NCT02063659|541905167|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
150210040|NCT02063659|541905168|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
150210041|NCT02063659|541905169|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
150210042|NCT02063659|541905170|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
150210043|NCT02063659|541905167|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
150210044|NCT02063659|541905168|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
150210045|NCT02063659|541905169|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
150210046|NCT02063659|541905170|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
150210047|NCT02063659|541905167|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
150210048|NCT02063659|541905168|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
150210049|NCT02063659|541905169|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
150210050|NCT02063659|541905170|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
150210051|NCT02063659|541905167|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
150210052|NCT02063659|541905168|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
150210053|NCT02063659|541905169|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
150210054|NCT02063659|541905170|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
150210055|NCT02063659|541905167|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
150210056|NCT02063659|541905168|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
150210057|NCT02063659|541905169|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
150210058|NCT02063659|541905170|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
150210059|NCT02063659|541905167|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
150210060|NCT02063659|541905168|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
150210061|NCT02063659|541905169|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
150210062|NCT02063659|541905170|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
150139388|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
150210063|NCT02972359|541905171|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
150210064|NCT02972359|541905171|FG000|Overall Study|Lack of Efficacy|1|||
150210065|NCT02972359|541905171|FG000|Overall Study|Adverse Event|4|||
150210066|NCT02972359|541905171|FG000|Overall Study|Death|1|||
150210067|NCT02972359|541905171|FG000|Overall Study|Withdrawal by Subject|30|||
150210068|NCT02972359|541905171|FG000|Overall Study|Protocol Violation|1|||
150210069|NCT02972359|541905171|FG000|Overall Study|Lost to Follow-up|26|||
150210070|NCT02972359|541905171|FG000|Overall Study|Other reasons|5|||
150210071|NCT02972359|541905171|FG000|Overall Study|Missing|1|||
150210072|NCT03488719|541905174|FG000|Overall Study|Adverse Event|0|||
150210073|NCT03488719|541905175|FG001|Overall Study|Adverse Event|4|||
150210074|NCT03488719|541905176|FG002|Overall Study|Adverse Event|2|||
150210075|NCT03488719|541905174|FG000|Overall Study|Other|0|||
150210076|NCT03488719|541905175|FG001|Overall Study|Other|0|||
150210077|NCT03488719|541905176|FG002|Overall Study|Other|5|||
150210078|NCT03477175|541905179|FG000|Overall Study|Unable to travel due to COVID-19|0|||
150210079|NCT03477175|541905180|FG001|Overall Study|Unable to travel due to COVID-19|1|||
150210080|NCT03477175|541905179|FG000|Overall Study|Physician Decision|1|||
150210081|NCT03477175|541905180|FG001|Overall Study|Physician Decision|0|||
150210082|NCT03477175|541905179|FG000|Overall Study|Transitioned to commercial drug|6|||
150210083|NCT03477175|541905180|FG001|Overall Study|Transitioned to commercial drug|6|||
150210084|NCT03477175|541905179|FG000|Overall Study|Lost to Follow-up|1|||
150210085|NCT03477175|541905180|FG001|Overall Study|Lost to Follow-up|1|||
150210086|NCT03477175|541905179|FG000|Overall Study|Withdrawal by Subject|3|||
150210087|NCT03477175|541905180|FG001|Overall Study|Withdrawal by Subject|1|||
150210088|NCT03477175|541905179|FG000|Overall Study|Adverse Event|1|||
150210089|NCT03477175|541905180|FG001|Overall Study|Adverse Event|5|||
150210090|NCT03477175|541905179|FG000|Overall Study|Disease Progression|7|||
150210091|NCT03477175|541905180|FG001|Overall Study|Disease Progression|7|||
150210092|NCT03371017|541905181|FG000|Overall Study|Physician Decision|0|||
150210093|NCT03371017|541905182|FG001|Overall Study|Physician Decision|1|||
150210094|NCT03371017|541905181|FG000|Overall Study|Reason not Specified|0|||
150210095|NCT03371017|541905182|FG001|Overall Study|Reason not Specified|1|||
150210096|NCT03371017|541905181|FG000|Overall Study|Lost to Follow-up|13|||
150210097|NCT03371017|541905182|FG001|Overall Study|Lost to Follow-up|16|||
150210098|NCT03371017|541905181|FG000|Overall Study|Death|228|||
150210099|NCT03371017|541905182|FG001|Overall Study|Death|215|||
150210100|NCT03371017|541905181|FG000|Overall Study|Withdrawal by Subject|20|||
150210101|NCT03371017|541905182|FG001|Overall Study|Withdrawal by Subject|25|||
150210102|NCT03371017|541905181|FG000|Overall Study|Study Ended by Sponsor|37|||
150210103|NCT03371017|541905182|FG001|Overall Study|Study Ended by Sponsor|38|||
150210104|NCT03371017|541905181|FG000|Overall Study|Protocol Deviation|0|||
150210105|NCT03371017|541905182|FG001|Overall Study|Protocol Deviation|1|||
150210106|NCT05525572|541905183|FG000|Overall Study|Lost to Follow-up|2|||
150210107|NCT05025384|541905190|FG000|Overall Study|Physician Decision|5|||
150210108|NCT05025384|541905191|FG001|Overall Study|Physician Decision|6|||
150210109|NCT04686266|541905192|FG000|Overall Study|Withdrawal by Subject|0|||
150210110|NCT04686266|541905193|FG001|Overall Study|Withdrawal by Subject|1|||
150210111|NCT03227861|541905196|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
150210112|NCT03227861|541905196|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
150210113|NCT03227861|541905196|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
150210114|NCT03227861|541905196|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
150210115|NCT03227861|541905196|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
150210116|NCT03227861|541905196|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
150210117|NCT03227861|541905196|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
150210118|NCT03227861|541905196|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
150210119|NCT03227861|541905196|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
150210120|NCT03227861|541905196|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
150210121|NCT05071430|541905198|FG000|Overall Study|Adverse Event|1|||
150210122|NCT05071430|541905199|FG001|Overall Study|Adverse Event|2|||
150210123|NCT05071430|541905198|FG000|Overall Study|Lost to Follow-up|4|||
150210124|NCT05071430|541905199|FG001|Overall Study|Lost to Follow-up|4|||
150210125|NCT05071430|541905198|FG000|Overall Study|Protocol Violation|1|||
150210126|NCT05071430|541905199|FG001|Overall Study|Protocol Violation|0|||
150210127|NCT05071430|541905198|FG000|Overall Study|Withdrawal by Subject|3|||
150210128|NCT05071430|541905199|FG001|Overall Study|Withdrawal by Subject|2|||
150210129|NCT05071430|541905198|FG000|Overall Study|Other|1|||
150210130|NCT05071430|541905199|FG001|Overall Study|Other|1|||
150210131|NCT01958021|541905200|FG000|Treatment|Progressive disease|206|||
150210132|NCT01958021|541905201|FG001|Treatment|Progressive disease|265|||
150210133|NCT01958021|541905200|FG000|Treatment|Adverse Event|38|||
150210134|NCT01958021|541905201|FG001|Treatment|Adverse Event|10|||
150210135|NCT01958021|541905200|FG000|Treatment|Subject/guardian decision|29|||
150210136|NCT01958021|541905201|FG001|Treatment|Subject/guardian decision|25|||
150210137|NCT01958021|541905200|FG000|Treatment|Physician Decision|28|||
150210138|NCT01958021|541905201|FG001|Treatment|Physician Decision|21|||
150210139|NCT01958021|541905200|FG000|Treatment|Death|6|||
150210140|NCT01958021|541905201|FG001|Treatment|Death|1|||
150210141|NCT01958021|541905200|FG000|Treatment|Protocol deviation|3|||
150210142|NCT01958021|541905201|FG001|Treatment|Protocol deviation|1|||
150210143|NCT01958021|541905200|FG000|Treatment|Sponsor decision|24|||
150210144|NCT01958021|541905201|FG001|Treatment|Sponsor decision|11|||
150139389|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150139390|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150139391|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
150139392|NCT02496767|541645508|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139393|NCT02496767|541645509|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
150139394|NCT02496767|541645510|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139395|NCT02496767|541645511|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139396|NCT02496767|541645512|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139397|NCT02496767|541645513|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150210145|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
150210146|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
150210147|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Death|1|||
150210148|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Death|0|||
150210149|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
150210150|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
150210151|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
150210152|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
150210153|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
150210154|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
150210155|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
150210156|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
150210157|NCT01958021|541905200|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
150210158|NCT01958021|541905201|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
150210159|NCT05810285|541905205|FG000|Overall Study|Death|4|||
150210160|NCT05810285|541905206|FG001|Overall Study|Death|21|||
150210161|NCT05810285|541905205|FG000|Overall Study|Adverse Event|18|||
150210162|NCT05810285|541905206|FG001|Overall Study|Adverse Event|16|||
150210163|NCT05470114|541905207|FG000|Overall Study|Withdrawal by Subject|1|||
150210164|NCT05470114|541905208|FG001|Overall Study|Withdrawal by Subject|0|||
150210165|NCT05470114|541905207|FG000|Overall Study|Lost to Follow-up|1|||
150210166|NCT05470114|541905208|FG001|Overall Study|Lost to Follow-up|0|||
150210167|NCT04649047|541905209|FG000|Overall Study|Withdrawal by Subject|3|||
150210168|NCT02488408|541905210|FG000|Part A|Adverse Event|2|||
150210169|NCT02488408|541905211|FG001|Part A|Adverse Event|0|||
150210170|NCT02488408|541905212|FG002|Part A|Adverse Event|0|||
150210171|NCT02488408|541905213|FG003|Part A|Adverse Event|0|||
150210172|NCT02488408|541905214|FG004|Part A|Adverse Event|0|||
150210173|NCT02488408|541905215|FG005|Part A|Adverse Event|0|||
150210174|NCT02488408|541905216|FG006|Part A|Adverse Event|0|||
150210175|NCT02488408|541905217|FG007|Part A|Adverse Event|0|||
150210176|NCT02488408|541905218|FG008|Part A|Adverse Event|0|||
150210177|NCT02488408|541905219|FG009|Part A|Adverse Event|0|||
150210178|NCT02488408|541905210|FG000|Part A|Death|1|||
150210179|NCT02488408|541905211|FG001|Part A|Death|5|||
150210180|NCT02488408|541905212|FG002|Part A|Death|0|||
150210181|NCT02488408|541905213|FG003|Part A|Death|0|||
150210182|NCT02488408|541905214|FG004|Part A|Death|3|||
150210183|NCT02488408|541905215|FG005|Part A|Death|0|||
150210184|NCT02488408|541905216|FG006|Part A|Death|0|||
150210185|NCT02488408|541905217|FG007|Part A|Death|0|||
150210186|NCT02488408|541905218|FG008|Part A|Death|0|||
150210187|NCT02488408|541905219|FG009|Part A|Death|0|||
150210188|NCT02488408|541905210|FG000|Part A|Disease Progression|2|||
150210189|NCT02488408|541905211|FG001|Part A|Disease Progression|8|||
150210190|NCT02488408|541905212|FG002|Part A|Disease Progression|2|||
150210191|NCT02488408|541905213|FG003|Part A|Disease Progression|3|||
150210192|NCT02488408|541905214|FG004|Part A|Disease Progression|4|||
150210193|NCT02488408|541905215|FG005|Part A|Disease Progression|0|||
150210194|NCT02488408|541905216|FG006|Part A|Disease Progression|0|||
150210195|NCT02488408|541905217|FG007|Part A|Disease Progression|0|||
150210196|NCT02488408|541905218|FG008|Part A|Disease Progression|0|||
150210197|NCT02488408|541905219|FG009|Part A|Disease Progression|0|||
150210198|NCT02488408|541905210|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
150210199|NCT02488408|541905211|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
150210200|NCT02488408|541905212|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
150210201|NCT02488408|541905213|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
150210202|NCT02488408|541905214|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
150210203|NCT02488408|541905215|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
150210204|NCT02488408|541905216|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
150210205|NCT02488408|541905217|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
150210206|NCT02488408|541905218|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
150210207|NCT02488408|541905219|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
150210208|NCT02488408|541905210|FG000|Part A|Investigator Decision|0|||
150210209|NCT02488408|541905211|FG001|Part A|Investigator Decision|1|||
150210210|NCT02488408|541905212|FG002|Part A|Investigator Decision|1|||
150210211|NCT02488408|541905213|FG003|Part A|Investigator Decision|0|||
150210212|NCT02488408|541905214|FG004|Part A|Investigator Decision|0|||
150210213|NCT02488408|541905215|FG005|Part A|Investigator Decision|0|||
150210214|NCT02488408|541905216|FG006|Part A|Investigator Decision|0|||
150210215|NCT02488408|541905217|FG007|Part A|Investigator Decision|0|||
150210216|NCT02488408|541905218|FG008|Part A|Investigator Decision|0|||
150210217|NCT02488408|541905219|FG009|Part A|Investigator Decision|0|||
150210218|NCT02488408|541905210|FG000|Part A|Withdrawal by Subject|0|||
150210219|NCT02488408|541905211|FG001|Part A|Withdrawal by Subject|0|||
150210220|NCT02488408|541905212|FG002|Part A|Withdrawal by Subject|2|||
150210221|NCT02488408|541905213|FG003|Part A|Withdrawal by Subject|0|||
150210222|NCT02488408|541905214|FG004|Part A|Withdrawal by Subject|0|||
150210223|NCT02488408|541905215|FG005|Part A|Withdrawal by Subject|0|||
150210224|NCT02488408|541905216|FG006|Part A|Withdrawal by Subject|0|||
150210225|NCT02488408|541905217|FG007|Part A|Withdrawal by Subject|0|||
150210226|NCT02488408|541905218|FG008|Part A|Withdrawal by Subject|0|||
150210227|NCT02488408|541905219|FG009|Part A|Withdrawal by Subject|0|||
150210228|NCT02488408|541905210|FG000|Part A|Other|1|||
150210229|NCT02488408|541905211|FG001|Part A|Other|0|||
150210230|NCT02488408|541905212|FG002|Part A|Other|0|||
150210231|NCT02488408|541905213|FG003|Part A|Other|0|||
150210232|NCT02488408|541905214|FG004|Part A|Other|0|||
150210233|NCT02488408|541905215|FG005|Part A|Other|0|||
150210234|NCT02488408|541905216|FG006|Part A|Other|0|||
150210235|NCT02488408|541905217|FG007|Part A|Other|0|||
150210236|NCT02488408|541905218|FG008|Part A|Other|0|||
150210237|NCT02488408|541905219|FG009|Part A|Other|0|||
150210238|NCT02488408|541905210|FG000|Part B|Adverse Event|0|||
150210239|NCT02488408|541905211|FG001|Part B|Adverse Event|0|||
150210240|NCT02488408|541905212|FG002|Part B|Adverse Event|0|||
150210241|NCT02488408|541905213|FG003|Part B|Adverse Event|0|||
150210242|NCT02488408|541905214|FG004|Part B|Adverse Event|0|||
150210243|NCT02488408|541905215|FG005|Part B|Adverse Event|2|||
150210244|NCT02488408|541905216|FG006|Part B|Adverse Event|2|||
150210245|NCT02488408|541905217|FG007|Part B|Adverse Event|7|||
150210246|NCT02488408|541905218|FG008|Part B|Adverse Event|2|||
150210247|NCT02488408|541905219|FG009|Part B|Adverse Event|2|||
150210248|NCT02488408|541905210|FG000|Part B|Death|0|||
150210249|NCT02488408|541905211|FG001|Part B|Death|0|||
150210250|NCT02488408|541905212|FG002|Part B|Death|0|||
150210251|NCT02488408|541905213|FG003|Part B|Death|0|||
150210252|NCT02488408|541905214|FG004|Part B|Death|0|||
150210253|NCT02488408|541905215|FG005|Part B|Death|3|||
150210254|NCT02488408|541905216|FG006|Part B|Death|1|||
150210255|NCT02488408|541905217|FG007|Part B|Death|2|||
150210256|NCT02488408|541905218|FG008|Part B|Death|2|||
150210257|NCT02488408|541905219|FG009|Part B|Death|2|||
150210258|NCT02488408|541905210|FG000|Part B|Death due to Disease Progression|0|||
150210259|NCT02488408|541905211|FG001|Part B|Death due to Disease Progression|0|||
150210260|NCT02488408|541905212|FG002|Part B|Death due to Disease Progression|0|||
150210261|NCT02488408|541905213|FG003|Part B|Death due to Disease Progression|0|||
150210262|NCT02488408|541905214|FG004|Part B|Death due to Disease Progression|0|||
150210263|NCT02488408|541905215|FG005|Part B|Death due to Disease Progression|2|||
150210264|NCT02488408|541905216|FG006|Part B|Death due to Disease Progression|2|||
150210265|NCT02488408|541905217|FG007|Part B|Death due to Disease Progression|1|||
150210266|NCT02488408|541905218|FG008|Part B|Death due to Disease Progression|1|||
150210267|NCT02488408|541905219|FG009|Part B|Death due to Disease Progression|1|||
150210268|NCT02488408|541905210|FG000|Part B|Disease Progression|0|||
150210269|NCT02488408|541905211|FG001|Part B|Disease Progression|0|||
150210270|NCT02488408|541905212|FG002|Part B|Disease Progression|0|||
150210271|NCT02488408|541905213|FG003|Part B|Disease Progression|0|||
150210272|NCT02488408|541905214|FG004|Part B|Disease Progression|0|||
150210273|NCT02488408|541905215|FG005|Part B|Disease Progression|6|||
150210274|NCT02488408|541905216|FG006|Part B|Disease Progression|9|||
150210275|NCT02488408|541905217|FG007|Part B|Disease Progression|7|||
150210276|NCT02488408|541905218|FG008|Part B|Disease Progression|9|||
150210277|NCT02488408|541905219|FG009|Part B|Disease Progression|11|||
150210278|NCT02488408|541905210|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
150210279|NCT02488408|541905211|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
150210280|NCT02488408|541905212|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
150210281|NCT02488408|541905213|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
150210282|NCT02488408|541905214|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
150139398|NCT02496767|541645514|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139399|NCT02496767|541645515|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
150139400|NCT02496767|541645508|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139401|NCT02496767|541645509|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139402|NCT02496767|541645510|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139403|NCT02496767|541645511|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139404|NCT02496767|541645512|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139405|NCT02496767|541645513|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
150139406|NCT02496767|541645514|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
150139407|NCT02496767|541645515|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
150139408|NCT02496767|541645508|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
150139409|NCT02496767|541645509|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
150139410|NCT02496767|541645510|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
150139411|NCT02496767|541645511|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
150139412|NCT02496767|541645512|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
150139413|NCT02496767|541645513|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
150139414|NCT02496767|541645514|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
150139415|NCT02496767|541645515|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
150139416|NCT02496767|541645508|FG000|Double-blind, Withdrawal Phase|Death|0|||
150139417|NCT02496767|541645509|FG001|Double-blind, Withdrawal Phase|Death|0|||
150139418|NCT02496767|541645510|FG002|Double-blind, Withdrawal Phase|Death|0|||
150139419|NCT02496767|541645511|FG003|Double-blind, Withdrawal Phase|Death|0|||
150139420|NCT02496767|541645512|FG004|Double-blind, Withdrawal Phase|Death|0|||
150139421|NCT02496767|541645513|FG005|Double-blind, Withdrawal Phase|Death|0|||
150139422|NCT02496767|541645514|FG006|Double-blind, Withdrawal Phase|Death|1|||
150139423|NCT02496767|541645515|FG007|Double-blind, Withdrawal Phase|Death|2|||
150139424|NCT02496767|541645508|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
150139425|NCT02496767|541645509|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
150139426|NCT02496767|541645510|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
150139427|NCT02496767|541645511|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
150139428|NCT02496767|541645512|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
150139429|NCT02496767|541645513|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
150139430|NCT02496767|541645514|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
150139431|NCT02496767|541645515|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
150139432|NCT00166296|541645516|FG000|Overall Study|Withdrawal by Subject|1|||
150139433|NCT00166296|541645517|FG001|Overall Study|Withdrawal by Subject|3|||
150139434|NCT00166296|541645516|FG000|Overall Study|Adverse Event|2|||
150139435|NCT00166296|541645517|FG001|Overall Study|Adverse Event|4|||
150139436|NCT00166296|541645516|FG000|Overall Study|Lost to Follow-up|4|||
150139437|NCT00166296|541645517|FG001|Overall Study|Lost to Follow-up|2|||
150139438|NCT04035200|541645518|FG000|Overall Study|Lost to Follow-up|0|||
150139439|NCT04035200|541645519|FG001|Overall Study|Lost to Follow-up|1|||
150139440|NCT04035200|541645520|FG002|Overall Study|Lost to Follow-up|0|||
150139441|NCT04035200|541645518|FG000|Overall Study|Withdrawal by Subject|1|||
150139442|NCT04035200|541645519|FG001|Overall Study|Withdrawal by Subject|4|||
150139443|NCT04035200|541645520|FG002|Overall Study|Withdrawal by Subject|4|||
150139444|NCT04035200|541645518|FG000|Overall Study|COVID-19|1|||
150139445|NCT04035200|541645519|FG001|Overall Study|COVID-19|0|||
150139446|NCT04035200|541645520|FG002|Overall Study|COVID-19|0|||
150139447|NCT04035200|541645518|FG000|Overall Study|Early Termination|0|||
150139448|NCT04035200|541645519|FG001|Overall Study|Early Termination|1|||
150139449|NCT04035200|541645520|FG002|Overall Study|Early Termination|0|||
150139450|NCT04035200|541645518|FG000|Overall Study|Non-compliance|0|||
150139451|NCT04035200|541645519|FG001|Overall Study|Non-compliance|1|||
150139452|NCT04035200|541645520|FG002|Overall Study|Non-compliance|0|||
150139453|NCT03351738|541645521|FG000|Overall Study|Withdrawal by Subject|0|||
150139454|NCT03351738|541645522|FG001|Overall Study|Withdrawal by Subject|1|||
150139455|NCT03351738|541645523|FG002|Overall Study|Withdrawal by Subject|0|||
150139456|NCT03351738|541645524|FG003|Overall Study|Withdrawal by Subject|1|||
150139457|NCT03351738|541645525|FG004|Overall Study|Withdrawal by Subject|0|||
150139458|NCT03351738|541645526|FG005|Overall Study|Withdrawal by Subject|0|||
150139459|NCT05479604|541645529|FG000|Overall Study|Lost to Follow-up|1|||
150139460|NCT05479604|541645530|FG001|Overall Study|Lost to Follow-up|5|||
150139461|NCT03138733|541645533|FG000|Overall Study|Death|17|||
150139462|NCT03138733|541645534|FG001|Overall Study|Death|18|||
150139463|NCT03138733|541645533|FG000|Overall Study|Withdrawal by Subject|11|||
150139464|NCT03138733|541645534|FG001|Overall Study|Withdrawal by Subject|6|||
150139465|NCT03138733|541645533|FG000|Overall Study|Lost to Follow-up|3|||
150139466|NCT03138733|541645534|FG001|Overall Study|Lost to Follow-up|2|||
150139467|NCT03138733|541645533|FG000|Overall Study|Adverse Event|1|||
150139468|NCT03138733|541645534|FG001|Overall Study|Adverse Event|0|||
150139469|NCT03138733|541645533|FG000|Overall Study|Protocol Violation|1|||
150139470|NCT03138733|541645534|FG001|Overall Study|Protocol Violation|3|||
150139471|NCT03138733|541645533|FG000|Overall Study|Administrative or logistical reason|1|||
150139472|NCT03138733|541645534|FG001|Overall Study|Administrative or logistical reason|0|||
150139473|NCT03138733|541645533|FG000|Overall Study|The patient was transferred to another hospital|1|||
150139474|NCT03138733|541645534|FG001|Overall Study|The patient was transferred to another hospital|0|||
150139475|NCT01089374|541645535|FG000|Overall Study|Lost to Follow-up|3|||
150139476|NCT01089374|541645536|FG001|Overall Study|Lost to Follow-up|0|||
150139477|NCT01089374|541645535|FG000|Overall Study|Withdrawal by Subject|1|||
150139478|NCT01089374|541645536|FG001|Overall Study|Withdrawal by Subject|0|||
150139479|NCT01089374|541645535|FG000|Overall Study|Study closed early - low accrual|6|||
150139480|NCT01089374|541645536|FG001|Overall Study|Study closed early - low accrual|0|||
150139481|NCT04179032|541645542|FG000|Part B (Up to Week 52)|Adverse Event|1|||
150139482|NCT04179032|541645542|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
150139483|NCT04179032|541645542|FG000|Access Extension Phase|Ongoing|11|||
150139484|NCT03641313|541645548|FG000|Overall Study|Death|1|||
150139485|NCT03641313|541645548|FG000|Overall Study|Withdrawal by Subject|2|||
150139486|NCT03641313|541645548|FG000|Overall Study|Declining health|1|||
150139487|NCT03641313|541645548|FG000|Overall Study|Adverse Event|1|||
150139488|NCT03033225|541645549|FG000|Overall Study|Withdrawal by Subject|5|||
150139489|NCT03371940|541645553|FG000|Overall Study|Withdrawal by Subject|8|||
150139490|NCT03371940|541645554|FG001|Overall Study|Withdrawal by Subject|1|||
150139491|NCT03371940|541645555|FG002|Overall Study|Withdrawal by Subject|3|||
150139492|NCT03371940|541645556|FG003|Overall Study|Withdrawal by Subject|4|||
150139493|NCT05099926|541645557|FG000|Overall Study|Lost to Follow-up|1|||
150139494|NCT00031486|541645560|FG000|Overall Study|Adverse Event|1|||
150139495|NCT00031486|541645561|FG001|Overall Study|Adverse Event|0|||
150139496|NCT00031486|541645560|FG000|Overall Study|Lost to Follow-up|0|||
150139497|NCT00031486|541645561|FG001|Overall Study|Lost to Follow-up|1|||
150139498|NCT00031486|541645560|FG000|Overall Study|Withdrawal by Subject|3|||
150139499|NCT00031486|541645561|FG001|Overall Study|Withdrawal by Subject|2|||
150139500|NCT00031486|541645560|FG000|Overall Study|Death|0|||
150139501|NCT00031486|541645561|FG001|Overall Study|Death|3|||
150139502|NCT00031486|541645560|FG000|Overall Study|Non-compliant|0|||
150139503|NCT00031486|541645561|FG001|Overall Study|Non-compliant|4|||
150139504|NCT00031486|541645560|FG000|Overall Study|Did not meet eligibility requirement|2|||
150139505|NCT00031486|541645561|FG001|Overall Study|Did not meet eligibility requirement|1|||
150139506|NCT00031486|541645560|FG000|Overall Study|Other|1|||
150139507|NCT00031486|541645561|FG001|Overall Study|Other|1|||
150139508|NCT01685138|541645562|FG000|Overall Study|Lost to Follow-up|1|||
150139509|NCT01685138|541645562|FG000|Overall Study|Protocol Violation|1|||
150139510|NCT01685138|541645562|FG000|Overall Study|No longer requires treatment|1|||
150139511|NCT01685138|541645562|FG000|Overall Study|Subject/guardian decision|2|||
150139512|NCT01685138|541645562|FG000|Overall Study|Physician Decision|6|||
150139513|NCT01685138|541645562|FG000|Overall Study|Death|10|||
150139514|NCT01685138|541645562|FG000|Overall Study|Adverse Event|18|||
150139515|NCT01685138|541645562|FG000|Overall Study|Progressive disease|53|||
150139516|NCT02068495|541645563|FG000|Overall Study|Case Report Forms Uncollected|60|||
150139517|NCT02068495|541645563|FG000|Overall Study|Protocol Deviation|49|||
150139518|NCT03988166|541645564|FG000|Overall Study|Lost to Follow-up|2|||
150139519|NCT03988166|541645564|FG000|Overall Study|Death|1|||
150139520|NCT00500903|541645565|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
150139521|NCT00500903|541645566|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
150139522|NCT00500903|541645567|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
150139523|NCT00500903|541645565|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
150139524|NCT00500903|541645566|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
150139525|NCT00500903|541645567|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
150139526|NCT00500903|541645565|FG000|Overall Study|Progressive Disease|41|||
150139527|NCT00500903|541645566|FG001|Overall Study|Progressive Disease|2|||
150139528|NCT00500903|541645567|FG002|Overall Study|Progressive Disease|15|||
150139529|NCT00500903|541645565|FG000|Overall Study|Patient Declined Further Treatment|0|||
150139530|NCT00500903|541645566|FG001|Overall Study|Patient Declined Further Treatment|0|||
150139531|NCT00500903|541645567|FG002|Overall Study|Patient Declined Further Treatment|3|||
150139532|NCT00500903|541645565|FG000|Overall Study|Symptomatic Deterioration|2|||
150139533|NCT00500903|541645566|FG001|Overall Study|Symptomatic Deterioration|0|||
150139534|NCT00500903|541645567|FG002|Overall Study|Symptomatic Deterioration|0|||
150139535|NCT00500903|541645565|FG000|Overall Study|Reason Not Specified|10|||
150139536|NCT00500903|541645566|FG001|Overall Study|Reason Not Specified|0|||
150139537|NCT00500903|541645567|FG002|Overall Study|Reason Not Specified|2|||
150139538|NCT00717860|541645569|FG000|Overall Study|Clinical adverse experience|5|||
150139539|NCT00717860|541645570|FG001|Overall Study|Clinical adverse experience|9|||
150139540|NCT00717860|541645569|FG000|Overall Study|Laboratory adverse experience|2|||
150139541|NCT00717860|541645570|FG001|Overall Study|Laboratory adverse experience|2|||
150139542|NCT00717860|541645569|FG000|Overall Study|Lack of Efficacy|7|||
150139543|NCT00717860|541645570|FG001|Overall Study|Lack of Efficacy|13|||
150210283|NCT02488408|541905215|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
150210284|NCT02488408|541905216|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
150210285|NCT02488408|541905217|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
150210286|NCT02488408|541905218|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
150139544|NCT00717860|541645569|FG000|Overall Study|Discontinued for other reason|6|||
150139545|NCT00717860|541645570|FG001|Overall Study|Discontinued for other reason|1|||
150139546|NCT00717860|541645569|FG000|Overall Study|Withdrew consent|7|||
150139547|NCT00717860|541645570|FG001|Overall Study|Withdrew consent|3|||
150139548|NCT04058353|541645571|FG000|Overall Study|Adverse Event|2|||
150139549|NCT04058353|541645572|FG001|Overall Study|Adverse Event|1|||
150139550|NCT04058353|541645571|FG000|Overall Study|Physician Decision|1|||
150139551|NCT04058353|541645572|FG001|Overall Study|Physician Decision|0|||
150139552|NCT04058353|541645571|FG000|Overall Study|Other|1|||
150139553|NCT04058353|541645572|FG001|Overall Study|Other|0|||
150139554|NCT01951638|541645575|FG000|Treatment Period|Protocol Violation|0|||
150139555|NCT01951638|541645576|FG001|Treatment Period|Protocol Violation|0|||
150139556|NCT01951638|541645577|FG002|Treatment Period|Protocol Violation|0|||
150139557|NCT01951638|541645578|FG003|Treatment Period|Protocol Violation|2|||
150139558|NCT01951638|541645579|FG004|Treatment Period|Protocol Violation|0|||
150139559|NCT01951638|541645575|FG000|Treatment Period|Protocol-driven decision point|1|||
150210287|NCT02488408|541905219|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
150139560|NCT01951638|541645576|FG001|Treatment Period|Protocol-driven decision point|3|||
150139561|NCT01951638|541645577|FG002|Treatment Period|Protocol-driven decision point|0|||
150139562|NCT01951638|541645578|FG003|Treatment Period|Protocol-driven decision point|0|||
150139563|NCT01951638|541645579|FG004|Treatment Period|Protocol-driven decision point|0|||
150139564|NCT01951638|541645575|FG000|Treatment Period|Logistical difficulties|0|||
150139565|NCT01951638|541645576|FG001|Treatment Period|Logistical difficulties|1|||
150139566|NCT01951638|541645577|FG002|Treatment Period|Logistical difficulties|1|||
150139567|NCT01951638|541645578|FG003|Treatment Period|Logistical difficulties|0|||
150139568|NCT01951638|541645579|FG004|Treatment Period|Logistical difficulties|0|||
150139569|NCT01951638|541645575|FG000|Treatment Period|Withdrawal by Subject|9|||
150139570|NCT01951638|541645576|FG001|Treatment Period|Withdrawal by Subject|6|||
150139571|NCT01951638|541645577|FG002|Treatment Period|Withdrawal by Subject|4|||
150139572|NCT01951638|541645578|FG003|Treatment Period|Withdrawal by Subject|5|||
150139573|NCT01951638|541645579|FG004|Treatment Period|Withdrawal by Subject|4|||
150139574|NCT01951638|541645575|FG000|Treatment Period|Death|0|||
150139575|NCT01951638|541645576|FG001|Treatment Period|Death|0|||
150139576|NCT01951638|541645577|FG002|Treatment Period|Death|0|||
150139577|NCT01951638|541645578|FG003|Treatment Period|Death|3|||
150139578|NCT01951638|541645579|FG004|Treatment Period|Death|1|||
150139579|NCT01951638|541645575|FG000|Treatment Period|Adverse Event|3|||
150139580|NCT01951638|541645576|FG001|Treatment Period|Adverse Event|4|||
150139581|NCT01951638|541645577|FG002|Treatment Period|Adverse Event|8|||
150139582|NCT01951638|541645578|FG003|Treatment Period|Adverse Event|6|||
150139583|NCT01951638|541645579|FG004|Treatment Period|Adverse Event|5|||
150139584|NCT01951638|541645575|FG000|Follow-up Period|Protocol Violation|0|||
150139585|NCT01951638|541645576|FG001|Follow-up Period|Protocol Violation|0|||
150139586|NCT01951638|541645577|FG002|Follow-up Period|Protocol Violation|0|||
150139587|NCT01951638|541645578|FG003|Follow-up Period|Protocol Violation|1|||
150139588|NCT01951638|541645579|FG004|Follow-up Period|Protocol Violation|0|||
150139589|NCT01951638|541645575|FG000|Follow-up Period|Logistical difficulties|0|||
150139590|NCT01951638|541645576|FG001|Follow-up Period|Logistical difficulties|2|||
150139591|NCT01951638|541645577|FG002|Follow-up Period|Logistical difficulties|0|||
150139592|NCT01951638|541645578|FG003|Follow-up Period|Logistical difficulties|0|||
150139593|NCT01951638|541645579|FG004|Follow-up Period|Logistical difficulties|1|||
150139594|NCT01951638|541645575|FG000|Follow-up Period|Withdrawal by Subject|1|||
150139595|NCT01951638|541645576|FG001|Follow-up Period|Withdrawal by Subject|5|||
150139596|NCT01951638|541645577|FG002|Follow-up Period|Withdrawal by Subject|2|||
150139597|NCT01951638|541645578|FG003|Follow-up Period|Withdrawal by Subject|1|||
150139598|NCT01951638|541645579|FG004|Follow-up Period|Withdrawal by Subject|2|||
150139599|NCT01951638|541645575|FG000|Follow-up Period|Lost to Follow-up|0|||
150139600|NCT01951638|541645576|FG001|Follow-up Period|Lost to Follow-up|1|||
150139601|NCT01951638|541645577|FG002|Follow-up Period|Lost to Follow-up|0|||
150139602|NCT01951638|541645578|FG003|Follow-up Period|Lost to Follow-up|1|||
150139603|NCT01951638|541645579|FG004|Follow-up Period|Lost to Follow-up|0|||
150139604|NCT01951638|541645575|FG000|Follow-up Period|Death|1|||
150139605|NCT01951638|541645576|FG001|Follow-up Period|Death|0|||
150139606|NCT01951638|541645577|FG002|Follow-up Period|Death|1|||
150139607|NCT01951638|541645578|FG003|Follow-up Period|Death|4|||
150139608|NCT01951638|541645579|FG004|Follow-up Period|Death|1|||
150139609|NCT01951638|541645575|FG000|Follow-up Period|Adverse Event|0|||
150139610|NCT01951638|541645576|FG001|Follow-up Period|Adverse Event|1|||
150139611|NCT01951638|541645577|FG002|Follow-up Period|Adverse Event|2|||
150139612|NCT01951638|541645578|FG003|Follow-up Period|Adverse Event|1|||
150139613|NCT01951638|541645579|FG004|Follow-up Period|Adverse Event|1|||
150139614|NCT00766675|541647159|FG000|Overall Study|Adverse Event|16|||
150139615|NCT00766675|541647159|FG000|Overall Study|Lost to Follow-up|2|||
150139616|NCT00766675|541647159|FG000|Overall Study|Withdrawal by Subject|11|||
150139617|NCT00766675|541647159|FG000|Overall Study|Protocol Violation|8|||
150139618|NCT00766675|541647159|FG000|Overall Study|Participant took prohibited medication|1|||
150139619|NCT00766675|541647159|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
150139620|NCT00766675|541647159|FG000|Overall Study|Insufficient therapy|1|||
150139621|NCT03308825|541647160|FG000|Overall Study|Lost to Follow-up|2|||
150139622|NCT03308825|541647161|FG001|Overall Study|Lost to Follow-up|2|||
150139623|NCT03308825|541647162|FG002|Overall Study|Lost to Follow-up|1|||
150139624|NCT03308825|541647163|FG003|Overall Study|Lost to Follow-up|0|||
150139625|NCT03308825|541647160|FG000|Overall Study|Protocol Violation|0|||
150139626|NCT03308825|541647161|FG001|Overall Study|Protocol Violation|2|||
150139627|NCT03308825|541647162|FG002|Overall Study|Protocol Violation|0|||
150139628|NCT03308825|541647163|FG003|Overall Study|Protocol Violation|0|||
150139629|NCT03935217|541647166|FG000|Overall Study|Adverse Event|1|||
150139630|NCT03935217|541647167|FG001|Overall Study|Adverse Event|0|||
150139631|NCT03935217|541647166|FG000|Overall Study|Lost to Follow-up|0|||
150210288|NCT02488408|541905210|FG000|Part B|Investigator Decision|0|||
150210289|NCT02488408|541905211|FG001|Part B|Investigator Decision|0|||
150210290|NCT02488408|541905212|FG002|Part B|Investigator Decision|0|||
150210291|NCT02488408|541905213|FG003|Part B|Investigator Decision|0|||
150139632|NCT03935217|541647167|FG001|Overall Study|Lost to Follow-up|1|||
150139633|NCT03935217|541647166|FG000|Overall Study|Withdrawal by Subject|0|||
150139634|NCT03935217|541647167|FG001|Overall Study|Withdrawal by Subject|2|||
150139635|NCT01782742|541647168|FG000|Double-blind Treatment Phase|Adverse Event|1|||
150139636|NCT01782742|541647169|FG001|Double-blind Treatment Phase|Adverse Event|0|||
150139637|NCT02882282|541647170|FG000|Overall Study|Adverse Event|1|||
150139638|NCT02882282|541647171|FG001|Overall Study|Adverse Event|0|||
150139639|NCT00514683|541647172|FG000|Overall Study|Not treated|2|||
150139640|NCT00514683|541647173|FG001|Overall Study|Not treated|1|||
150139641|NCT00514683|541647174|FG002|Overall Study|Not treated|0|||
150139642|NCT00514683|541647175|FG003|Overall Study|Not treated|0|||
150139643|NCT00514683|541647176|FG004|Overall Study|Not treated|1|||
150139644|NCT00514683|541647172|FG000|Overall Study|Adverse Event|21|||
150139645|NCT00514683|541647173|FG001|Overall Study|Adverse Event|20|||
150139646|NCT00514683|541647174|FG002|Overall Study|Adverse Event|15|||
150139647|NCT00514683|541647175|FG003|Overall Study|Adverse Event|13|||
150139648|NCT00514683|541647176|FG004|Overall Study|Adverse Event|27|||
150139649|NCT00514683|541647172|FG000|Overall Study|Protocol Violation|1|||
150139650|NCT00514683|541647173|FG001|Overall Study|Protocol Violation|1|||
150139651|NCT00514683|541647174|FG002|Overall Study|Protocol Violation|0|||
150139652|NCT00514683|541647175|FG003|Overall Study|Protocol Violation|1|||
150139653|NCT00514683|541647176|FG004|Overall Study|Protocol Violation|0|||
150139654|NCT00514683|541647172|FG000|Overall Study|Withdrawal by Subject|2|||
150139655|NCT00514683|541647173|FG001|Overall Study|Withdrawal by Subject|2|||
150210292|NCT02488408|541905214|FG004|Part B|Investigator Decision|0|||
150210293|NCT02488408|541905215|FG005|Part B|Investigator Decision|0|||
150139656|NCT00514683|541647174|FG002|Overall Study|Withdrawal by Subject|1|||
150139657|NCT00514683|541647175|FG003|Overall Study|Withdrawal by Subject|0|||
150139658|NCT00514683|541647176|FG004|Overall Study|Withdrawal by Subject|4|||
150139659|NCT00514683|541647172|FG000|Overall Study|Reason other than listed above|0|||
150139660|NCT00514683|541647173|FG001|Overall Study|Reason other than listed above|1|||
150139661|NCT00514683|541647174|FG002|Overall Study|Reason other than listed above|2|||
150139662|NCT00514683|541647175|FG003|Overall Study|Reason other than listed above|0|||
150139663|NCT00514683|541647176|FG004|Overall Study|Reason other than listed above|1|||
150139664|NCT02487498|541647177|FG000|Period: Period 1|Adverse Event|2|||
150139665|NCT02487498|541647178|FG001|Period: Period 1|Adverse Event|4|||
150210294|NCT02488408|541905216|FG006|Part B|Investigator Decision|1|||
150210295|NCT02488408|541905217|FG007|Part B|Investigator Decision|0|||
150210296|NCT02488408|541905218|FG008|Part B|Investigator Decision|2|||
150210297|NCT02488408|541905219|FG009|Part B|Investigator Decision|1|||
150210298|NCT00719888|541905220|FG000|Overall Study|Death|24|||
150210299|NCT00719888|541905221|FG001|Overall Study|Death|9|||
150139666|NCT02487498|541647177|FG000|Period: Period 1|Subject/guardian decision|2|||
150139667|NCT02487498|541647178|FG001|Period: Period 1|Subject/guardian decision|4|||
150139668|NCT02487498|541647177|FG000|Period: Period 1|Lost to Follow-up|0|||
150139669|NCT02487498|541647178|FG001|Period: Period 1|Lost to Follow-up|2|||
150139670|NCT02487498|541647177|FG000|Period: Period 1|Lack of Efficacy|1|||
150139671|NCT02487498|541647178|FG001|Period: Period 1|Lack of Efficacy|0|||
150139672|NCT02487498|541647177|FG000|Period: Period 1|Physician Decision|0|||
150139673|NCT02487498|541647178|FG001|Period: Period 1|Physician Decision|1|||
150139674|NCT02487498|541647177|FG000|Period: Period 1|Protocol deviation|1|||
150139675|NCT02487498|541647178|FG001|Period: Period 1|Protocol deviation|0|||
150139676|NCT02487498|541647177|FG000|Period: Washout|Subject/guardian decision|0|||
150139677|NCT02487498|541647178|FG001|Period: Washout|Subject/guardian decision|5|||
150139678|NCT02487498|541647177|FG000|Period: Washout|Lack of Efficacy|1|||
150139679|NCT02487498|541647178|FG001|Period: Washout|Lack of Efficacy|1|||
150139680|NCT02487498|541647177|FG000|Period: Washout|Physician Decision|1|||
150139681|NCT02487498|541647178|FG001|Period: Washout|Physician Decision|0|||
150139682|NCT02487498|541647177|FG000|Period: Washout|Non-compliance with study treatment|0|||
150139683|NCT02487498|541647178|FG001|Period: Washout|Non-compliance with study treatment|1|||
150139684|NCT02487498|541647177|FG000|Period: Period 2|Adverse Event|2|||
150139685|NCT02487498|541647178|FG001|Period: Period 2|Adverse Event|2|||
150139686|NCT02487498|541647177|FG000|Period: Period 2|Subject/guardian decision|2|||
150139687|NCT02487498|541647178|FG001|Period: Period 2|Subject/guardian decision|1|||
150139688|NCT02487498|541647177|FG000|Period: Period 2|Lost to Follow-up|1|||
150139689|NCT02487498|541647178|FG001|Period: Period 2|Lost to Follow-up|1|||
150139690|NCT02487498|541647177|FG000|Period: Period 2|Death|0|||
150139691|NCT02487498|541647178|FG001|Period: Period 2|Death|1|||
150139692|NCT02487498|541647177|FG000|Period: Period 2|Physician Decision|1|||
150139693|NCT02487498|541647178|FG001|Period: Period 2|Physician Decision|0|||
150139694|NCT00676130|541647179|FG000|Overall Study|Lost to Follow-up|0|||
150139695|NCT00676130|541647180|FG001|Overall Study|Lost to Follow-up|1|||
150139696|NCT00676130|541647179|FG000|Overall Study|Found ineligible|3|||
150139697|NCT00676130|541647180|FG001|Overall Study|Found ineligible|2|||
150139698|NCT00676130|541647179|FG000|Overall Study|Withdrawal by Subject|0|||
150139699|NCT00676130|541647180|FG001|Overall Study|Withdrawal by Subject|1|||
150139700|NCT02228967|541647184|FG000|Overall Study|Lost to Follow-up|146|||
150139701|NCT02228967|541647185|FG001|Overall Study|Lost to Follow-up|142|||
150139702|NCT02228967|541647184|FG000|Overall Study|Withdrawal by Subject|13|||
150139703|NCT02228967|541647185|FG001|Overall Study|Withdrawal by Subject|18|||
150139704|NCT00520975|541647186|FG000|Overall Study|Disease progression|31|||
150139705|NCT00520975|541647187|FG001|Overall Study|Disease progression|23|||
150139706|NCT00520975|541647186|FG000|Overall Study|Adverse Event|7|||
150139707|NCT00520975|541647187|FG001|Overall Study|Adverse Event|10|||
150139708|NCT00520975|541647186|FG000|Overall Study|Death|0|||
150139709|NCT00520975|541647187|FG001|Overall Study|Death|2|||
150139710|NCT00520975|541647186|FG000|Overall Study|Withdrawal by Subject|3|||
150139711|NCT00520975|541647187|FG001|Overall Study|Withdrawal by Subject|5|||
150210300|NCT00719888|541905220|FG000|Overall Study|Relapse|8|||
150210301|NCT00719888|541905221|FG001|Overall Study|Relapse|3|||
150210302|NCT00719888|541905220|FG000|Overall Study|Physician Decision|1|||
150139712|NCT00520975|541647186|FG000|Overall Study|Other therapy|2|||
150139713|NCT00520975|541647187|FG001|Overall Study|Other therapy|4|||
150139714|NCT00520975|541647186|FG000|Overall Study|Other reasons|4|||
150210303|NCT00719888|541905221|FG001|Overall Study|Physician Decision|0|||
150210304|NCT00719888|541905220|FG000|Overall Study|Withdrawal by Subject|1|||
150210305|NCT00719888|541905221|FG001|Overall Study|Withdrawal by Subject|0|||
150210306|NCT05199571|541906292|FG000|Treatment Period|Participant decision|3|||
150210307|NCT05199571|541906292|FG000|Treatment Period|Physician Decision|1|||
150210308|NCT05199571|541906292|FG000|Post-treatment Follow up Period|Participant decision|3|||
150210309|NCT03762850|541906293|FG000|Overall Study|Death|0|||
150210310|NCT03762850|541906294|FG001|Overall Study|Death|1|||
150210311|NCT03762850|541906293|FG000|Overall Study|Lost to Follow-up|0|||
150210312|NCT03762850|541906294|FG001|Overall Study|Lost to Follow-up|1|||
150210313|NCT03762850|541906293|FG000|Overall Study|Physician Decision|0|||
150210314|NCT03762850|541906294|FG001|Overall Study|Physician Decision|1|||
150210315|NCT03762850|541906293|FG000|Overall Study|Withdrawal by Subject|4|||
150210316|NCT03762850|541906294|FG001|Overall Study|Withdrawal by Subject|9|||
150210317|NCT02200705|541906295|FG000|Overall Study|Excluded|12|||
150210318|NCT02200705|541906295|FG000|Overall Study|Death|21|||
150210319|NCT02200705|541906295|FG000|Overall Study|Withdrawal by Subject|22|||
150210320|NCT02200705|541906295|FG000|Overall Study|Lost to Follow-up|13|||
150210321|NCT02200705|541906295|FG000|Overall Study|Physician Decision|5|||
150210322|NCT02200705|541906295|FG000|Overall Study|Adverse Event|2|||
150210323|NCT04083976|541906296|FG000|Overall Study|Lost to Follow-up|3|||
150210324|NCT04083976|541906297|FG001|Overall Study|Lost to Follow-up|0|||
150210325|NCT04083976|541906298|FG002|Overall Study|Lost to Follow-up|0|||
150210326|NCT04083976|541906299|FG003|Overall Study|Lost to Follow-up|1|||
150210327|NCT04083976|541906296|FG000|Overall Study|Withdrawal by Subject|16|||
150210328|NCT04083976|541906297|FG001|Overall Study|Withdrawal by Subject|1|||
150210329|NCT04083976|541906298|FG002|Overall Study|Withdrawal by Subject|9|||
150210330|NCT04083976|541906299|FG003|Overall Study|Withdrawal by Subject|0|||
150210331|NCT04083976|541906296|FG000|Overall Study|Sponsor Decision|14|||
150210332|NCT04083976|541906297|FG001|Overall Study|Sponsor Decision|0|||
150210333|NCT04083976|541906298|FG002|Overall Study|Sponsor Decision|0|||
150210334|NCT04083976|541906299|FG003|Overall Study|Sponsor Decision|7|||
150210335|NCT04083976|541906296|FG000|Overall Study|Other|1|||
150210336|NCT04083976|541906297|FG001|Overall Study|Other|0|||
150210337|NCT04083976|541906298|FG002|Overall Study|Other|1|||
150210338|NCT04083976|541906299|FG003|Overall Study|Other|0|||
150210339|NCT00512252|541906306|FG000|Overall Study|Lost to Follow-up|0|||
150210340|NCT00512252|541906307|FG001|Overall Study|Lost to Follow-up|0|||
150210341|NCT00512252|541906308|FG002|Overall Study|Lost to Follow-up|1|||
150210342|NCT00512252|541906306|FG000|Overall Study|Protocol Violation|0|||
150210343|NCT00512252|541906307|FG001|Overall Study|Protocol Violation|0|||
150210344|NCT00512252|541906308|FG002|Overall Study|Protocol Violation|1|||
150210345|NCT00512252|541906306|FG000|Overall Study|Death|0|||
150210346|NCT00512252|541906307|FG001|Overall Study|Death|0|||
150210347|NCT00512252|541906308|FG002|Overall Study|Death|1|||
150139715|NCT00520975|541647187|FG001|Overall Study|Other reasons|2|||
150139716|NCT00520975|541647186|FG000|Overall Study|Not start protocol therapy|1|||
150139717|NCT00520975|541647187|FG001|Overall Study|Not start protocol therapy|2|||
150139718|NCT01181726|541647188|FG000|First Intervention|Adverse Event|1|||
150139719|NCT01181726|541647189|FG001|First Intervention|Adverse Event|0|||
150139720|NCT04998604|541647190|FG000|Overall Study|Adverse Event|3|||
150139721|NCT04998604|541647191|FG001|Overall Study|Adverse Event|2|||
150139722|NCT04998604|541647190|FG000|Overall Study|Withdrawal by Subject|2|||
150139723|NCT04998604|541647191|FG001|Overall Study|Withdrawal by Subject|4|||
150139724|NCT04998604|541647190|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
150139725|NCT04998604|541647191|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
150139726|NCT00642902|541647192|FG000|Overall Study|Adverse Event|0|||
150139727|NCT00642902|541647193|FG001|Overall Study|Adverse Event|1|||
150139728|NCT00642902|541647194|FG002|Overall Study|Adverse Event|3|||
150139729|NCT00642902|541647195|FG003|Overall Study|Adverse Event|1|||
150139730|NCT00642902|541647192|FG000|Overall Study|Lost to Follow-up|1|||
150139731|NCT00642902|541647193|FG001|Overall Study|Lost to Follow-up|1|||
150210348|NCT00705406|541906309|FG000|Overall Study|Lost to Follow-up|3|||
150210349|NCT00705406|541906310|FG001|Overall Study|Lost to Follow-up|3|||
150210350|NCT00705406|541906309|FG000|Overall Study|Did not receive study drug|1|||
150210351|NCT00705406|541906310|FG001|Overall Study|Did not receive study drug|2|||
150139732|NCT00642902|541647194|FG002|Overall Study|Lost to Follow-up|0|||
150139733|NCT00642902|541647195|FG003|Overall Study|Lost to Follow-up|0|||
150210352|NCT02357966|541906311|FG000|Overall Study|Death|0|||
150210353|NCT02357966|541906312|FG001|Overall Study|Death|0|||
150210354|NCT02357966|541906313|FG002|Overall Study|Death|1|||
150210355|NCT02357966|541906314|FG003|Overall Study|Death|0|||
150210356|NCT02357966|541906315|FG004|Overall Study|Death|2|||
150210357|NCT02357966|541906316|FG005|Overall Study|Death|0|||
150210358|NCT02357966|541906311|FG000|Overall Study|Physician Decision|1|||
150139734|NCT00642902|541647192|FG000|Overall Study|Lack of Efficacy|0|||
150139735|NCT00642902|541647193|FG001|Overall Study|Lack of Efficacy|3|||
150139736|NCT00642902|541647194|FG002|Overall Study|Lack of Efficacy|3|||
150139737|NCT00642902|541647195|FG003|Overall Study|Lack of Efficacy|0|||
150139738|NCT00642902|541647192|FG000|Overall Study|Death|1|||
150139739|NCT00642902|541647193|FG001|Overall Study|Death|0|||
150139740|NCT00642902|541647194|FG002|Overall Study|Death|0|||
150139741|NCT00642902|541647195|FG003|Overall Study|Death|0|||
150139742|NCT00642902|541647192|FG000|Overall Study|Premature termination of clinical trial|37|||
150139743|NCT00642902|541647193|FG001|Overall Study|Premature termination of clinical trial|32|||
150139744|NCT00642902|541647194|FG002|Overall Study|Premature termination of clinical trial|35|||
150139745|NCT00642902|541647195|FG003|Overall Study|Premature termination of clinical trial|35|||
150139746|NCT00642902|541647192|FG000|Overall Study|Randomized, but not treated|0|||
150139747|NCT00642902|541647193|FG001|Overall Study|Randomized, but not treated|0|||
150139748|NCT00642902|541647194|FG002|Overall Study|Randomized, but not treated|1|||
150139749|NCT00642902|541647195|FG003|Overall Study|Randomized, but not treated|0|||
150139750|NCT00642902|541647192|FG000|Overall Study|Other|1|||
150139751|NCT00642902|541647193|FG001|Overall Study|Other|5|||
150139752|NCT00642902|541647194|FG002|Overall Study|Other|1|||
150139753|NCT00642902|541647195|FG003|Overall Study|Other|4|||
150139754|NCT03953898|541647201|FG000|Overall Study|Lack of Efficacy|8|||
150139755|NCT03953898|541647201|FG000|Overall Study|Death|3|||
150210359|NCT02357966|541906312|FG001|Overall Study|Physician Decision|0|||
150210360|NCT02357966|541906313|FG002|Overall Study|Physician Decision|0|||
150210361|NCT02357966|541906314|FG003|Overall Study|Physician Decision|0|||
150210362|NCT02357966|541906315|FG004|Overall Study|Physician Decision|1|||
150210363|NCT02357966|541906316|FG005|Overall Study|Physician Decision|0|||
150210364|NCT01779700|541906317|FG000|Overall Study|Adverse Event|4|||
150210365|NCT01779700|541906318|FG001|Overall Study|Adverse Event|3|||
150210366|NCT01779700|541906317|FG000|Overall Study|Withdrawal by Subject|0|||
150210367|NCT01779700|541906318|FG001|Overall Study|Withdrawal by Subject|2|||
150210368|NCT00442104|541906320|FG000|Overall Study|Adverse Event|5|||
150210369|NCT00442104|541906320|FG000|Overall Study|Death|2|||
150210370|NCT00442104|541906320|FG000|Overall Study|Lost to Follow-up|3|||
150210371|NCT00442104|541906320|FG000|Overall Study|Withdrawal by Subject|5|||
150210372|NCT00442104|541906320|FG000|Overall Study|Insufficient Clinical Response|10|||
150210373|NCT00442104|541906320|FG000|Overall Study|Other|21|||
150210374|NCT00442104|541906320|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
150210375|NCT04608409|541906321|FG000|Overall Study|Physician Decision|1|||
150210376|NCT04608409|541906322|FG001|Overall Study|Physician Decision|1|||
150210377|NCT04608409|541906323|FG002|Overall Study|Physician Decision|2|||
150210378|NCT03712371|541906326|FG000|Overall Study|Lack of Efficacy|0|||
150210379|NCT03712371|541906327|FG001|Overall Study|Lack of Efficacy|0|||
150210380|NCT03712371|541906328|FG002|Overall Study|Lack of Efficacy|0|||
150210381|NCT03712371|541906329|FG003|Overall Study|Lack of Efficacy|1|||
150210382|NCT00229658|541906333|FG000|Overall Study|Administrative|2|||
150210383|NCT00229658|541906334|FG001|Overall Study|Administrative|1|||
150210384|NCT00229658|541906333|FG000|Overall Study|Investigator decision|13|||
150210385|NCT00229658|541906334|FG001|Overall Study|Investigator decision|10|||
150210386|NCT00229658|541906333|FG000|Overall Study|Other|80|||
150210387|NCT00229658|541906334|FG001|Overall Study|Other|60|||
150210388|NCT00229658|541906333|FG000|Overall Study|Lost to Follow-up|82|||
150210389|NCT00229658|541906334|FG001|Overall Study|Lost to Follow-up|55|||
150210390|NCT00229658|541906333|FG000|Overall Study|Serious Adverse Event|2|||
150210391|NCT00229658|541906334|FG001|Overall Study|Serious Adverse Event|2|||
150210392|NCT00229658|541906333|FG000|Overall Study|Withdrawal of consent|46|||
150210393|NCT00229658|541906334|FG001|Overall Study|Withdrawal of consent|39|||
150210394|NCT02157116|541906335|FG000|Overall Study|Withdrawal by Subject|4|||
150210395|NCT02157116|541906335|FG000|Overall Study|Physician Decision|3|||
150210396|NCT02157116|541906335|FG000|Overall Study|Failed Screening|2|||
150210397|NCT00975585|541906336|FG000|Overall Study|Adverse Event|0|||
150210398|NCT00975585|541906337|FG001|Overall Study|Adverse Event|4|||
150210399|NCT00975585|541906336|FG000|Overall Study|Lost to Follow-up|3|||
150210400|NCT00975585|541906337|FG001|Overall Study|Lost to Follow-up|5|||
150210401|NCT00975585|541906336|FG000|Overall Study|Withdrawal by Subject|2|||
150139756|NCT03953898|541647201|FG000|Overall Study|Withdrawal by Subject|2|||
150139757|NCT03953898|541647201|FG000|Overall Study|Adverse Event|1|||
150139758|NCT03261271|541647202|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
150210402|NCT00975585|541906337|FG001|Overall Study|Withdrawal by Subject|1|||
150210403|NCT00975585|541906336|FG000|Overall Study|Lens issue|2|||
150210404|NCT00975585|541906337|FG001|Overall Study|Lens issue|2|||
150210405|NCT01953224|541906338|FG000|Overall Study|Lost to Follow-up|1|||
150210406|NCT01953224|541906339|FG001|Overall Study|Lost to Follow-up|1|||
150210407|NCT01953224|541906338|FG000|Overall Study|Withdrawal by Subject|1|||
150210408|NCT01953224|541906339|FG001|Overall Study|Withdrawal by Subject|2|||
150210409|NCT00683800|541906341|FG000|Overall Study|Adverse Event|195|||
150210410|NCT00683800|541906342|FG001|Overall Study|Adverse Event|102|||
150210411|NCT00683800|541906341|FG000|Overall Study|Death|0|||
150210412|NCT00683800|541906342|FG001|Overall Study|Death|1|||
150210413|NCT00683800|541906341|FG000|Overall Study|Lost to Follow-up|57|||
150210414|NCT00683800|541906342|FG001|Overall Study|Lost to Follow-up|44|||
150210415|NCT00683800|541906341|FG000|Overall Study|Other|5|||
150210416|NCT00683800|541906342|FG001|Overall Study|Other|2|||
150210417|NCT00683800|541906341|FG000|Overall Study|Protocol Violation|13|||
150210418|NCT00683800|541906342|FG001|Overall Study|Protocol Violation|16|||
150210419|NCT00683800|541906341|FG000|Overall Study|Withdrawal by Subject|66|||
150210420|NCT00683800|541906342|FG001|Overall Study|Withdrawal by Subject|64|||
150210421|NCT00683800|541906341|FG000|Overall Study|Lack of Efficacy|61|||
150210422|NCT00683800|541906342|FG001|Overall Study|Lack of Efficacy|104|||
150210423|NCT00683800|541906341|FG000|Overall Study|Randomized, not treated|35|||
150210424|NCT00683800|541906342|FG001|Overall Study|Randomized, not treated|33|||
150210425|NCT00463229|541906347|FG000|Overall Study|Lost to Follow-up|5|||
150210426|NCT00463229|541906348|FG001|Overall Study|Lost to Follow-up|7|||
150210427|NCT00463229|541906347|FG000|Overall Study|Death|4|||
150210428|NCT00463229|541906348|FG001|Overall Study|Death|3|||
150210429|NCT02406092|541906363|FG000|Overall Study|Screen failure|10|||
150210430|NCT02406092|541906364|FG001|Overall Study|Screen failure|7|||
150210431|NCT02406092|541906363|FG000|Overall Study|Death|22|||
150210432|NCT02406092|541906364|FG001|Overall Study|Death|5|||
150210433|NCT02406092|541906363|FG000|Overall Study|Lost to Follow-up|4|||
150210434|NCT02406092|541906364|FG001|Overall Study|Lost to Follow-up|1|||
150210435|NCT02406092|541906363|FG000|Overall Study|Adverse Event|1|||
150210436|NCT02406092|541906364|FG001|Overall Study|Adverse Event|0|||
150210437|NCT02406092|541906363|FG000|Overall Study|Withdrawal by Subject|1|||
150210438|NCT02406092|541906364|FG001|Overall Study|Withdrawal by Subject|0|||
150210439|NCT03041233|541906365|FG000|Overall Study|Death|5|||
150210440|NCT03041233|541906365|FG000|Overall Study|Physician Decision|1|||
150210441|NCT03041233|541906365|FG000|Overall Study|Lost to Follow-up|16|||
150210442|NCT03041233|541906365|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
150210443|NCT03041233|541906365|FG000|Overall Study|Sponsor Request|1|||
150210444|NCT03041233|541906365|FG000|Overall Study|Duplicate subject|1|||
150210445|NCT03041233|541906365|FG000|Overall Study|Re-ablation|1|||
150210446|NCT00853593|541906369|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
150210447|NCT00853593|541906369|FG000|Overall Study|Model 4396 lead not attempted|29|||
150210448|NCT00853593|541906369|FG000|Overall Study|Implant not attempted|4|||
150210449|NCT04200664|541906370|FG000|Overall Study|Withdrawal by Subject|1|||
150210450|NCT04200664|541906371|FG001|Overall Study|Withdrawal by Subject|0|||
150210451|NCT04200664|541906372|FG002|Overall Study|Withdrawal by Subject|0|||
150210452|NCT03362190|541906377|FG000|Overall Study|Adverse Event|0|||
150210453|NCT03362190|541906378|FG001|Overall Study|Adverse Event|0|||
150210454|NCT03362190|541906379|FG002|Overall Study|Adverse Event|0|||
150210455|NCT03362190|541906380|FG003|Overall Study|Adverse Event|1|||
150210456|NCT03362190|541906377|FG000|Overall Study|Withdrawal by Subject|0|||
150210457|NCT03362190|541906378|FG001|Overall Study|Withdrawal by Subject|0|||
150210458|NCT03362190|541906379|FG002|Overall Study|Withdrawal by Subject|0|||
150210459|NCT03362190|541906380|FG003|Overall Study|Withdrawal by Subject|1|||
150210460|NCT00687219|541906381|FG000|Overall Study|Adverse Event|8|||
150210461|NCT00687219|541906381|FG000|Overall Study|Discontinuance criteria met|7|||
150210462|NCT00687219|541906381|FG000|Overall Study|HCV-RNA positive conversion|34|||
150210463|NCT00687219|541906381|FG000|Overall Study|Withdrawal by Subject|1|||
150210464|NCT00687219|541906381|FG000|Overall Study|Lack of Efficacy|1|||
150210465|NCT01367236|541906389|FG000|Overall Study|Withdrawal by Subject|3|||
150210466|NCT01367236|541906390|FG001|Overall Study|Withdrawal by Subject|1|||
150210467|NCT02235298|541906391|FG000|Overall Study|Lost to Follow-up|6|||
150210468|NCT02235298|541906392|FG001|Overall Study|Lost to Follow-up|5|||
150210469|NCT02235298|541906391|FG000|Overall Study|Adverse Event|2|||
150210470|NCT02235298|541906392|FG001|Overall Study|Adverse Event|2|||
150210471|NCT02235298|541906391|FG000|Overall Study|Withdrawal by Subject|0|||
150210472|NCT02235298|541906392|FG001|Overall Study|Withdrawal by Subject|1|||
150210473|NCT00914966|541906399|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
150210474|NCT00914966|541906399|FG000|Step 1: 1500 Units|Physician Decision|1|||
150210475|NCT00914966|541906399|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
150210476|NCT04038580|541906400|FG000|Washout 1|Death|0|||
150210477|NCT04038580|541906401|FG001|Washout 1|Death|0|||
150210478|NCT04038580|541906402|FG002|Washout 1|Death|0|||
150210479|NCT04038580|541906403|FG003|Washout 1|Death|1|||
150210480|NCT04038580|541906404|FG004|Washout 1|Death|0|||
150210481|NCT04038580|541906405|FG005|Washout 1|Death|0|||
150210482|NCT04038580|541906400|FG000|Washout 1|Withdrawal by Subject|0|||
150210483|NCT04038580|541906401|FG001|Washout 1|Withdrawal by Subject|0|||
150210484|NCT04038580|541906402|FG002|Washout 1|Withdrawal by Subject|0|||
150210485|NCT04038580|541906403|FG003|Washout 1|Withdrawal by Subject|0|||
150210486|NCT04038580|541906404|FG004|Washout 1|Withdrawal by Subject|1|||
150210487|NCT04038580|541906405|FG005|Washout 1|Withdrawal by Subject|0|||
150210488|NCT04038580|541906400|FG000|Wash-out 2|Withdrawal by Subject|1|||
150210489|NCT04038580|541906401|FG001|Wash-out 2|Withdrawal by Subject|0|||
150210490|NCT04038580|541906402|FG002|Wash-out 2|Withdrawal by Subject|0|||
150210491|NCT04038580|541906403|FG003|Wash-out 2|Withdrawal by Subject|2|||
150210492|NCT04038580|541906404|FG004|Wash-out 2|Withdrawal by Subject|0|||
150210493|NCT04038580|541906405|FG005|Wash-out 2|Withdrawal by Subject|1|||
150210494|NCT04038580|541906400|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
150210495|NCT04038580|541906401|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
150210496|NCT04038580|541906402|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
150210497|NCT04038580|541906403|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
150210498|NCT04038580|541906404|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
150210499|NCT04038580|541906405|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
150210500|NCT04038580|541906400|FG000|Wash-out 3|Withdrawal by Subject|1|||
150210501|NCT04038580|541906401|FG001|Wash-out 3|Withdrawal by Subject|0|||
150210502|NCT04038580|541906402|FG002|Wash-out 3|Withdrawal by Subject|2|||
150210503|NCT04038580|541906403|FG003|Wash-out 3|Withdrawal by Subject|0|||
150210504|NCT04038580|541906404|FG004|Wash-out 3|Withdrawal by Subject|0|||
150210505|NCT04038580|541906405|FG005|Wash-out 3|Withdrawal by Subject|0|||
150210506|NCT04021862|541906406|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
150210507|NCT04021862|541906407|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
150210508|NCT04021862|541906408|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
150210509|NCT04021862|541906409|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
150210510|NCT04021862|541906410|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
150210511|NCT04021862|541906411|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
150210512|NCT04021862|541906406|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
150210513|NCT04021862|541906407|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
150210514|NCT04021862|541906408|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
150210515|NCT04021862|541906409|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
150210516|NCT04021862|541906410|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
150210517|NCT04021862|541906411|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
150210518|NCT04021862|541906406|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
150210519|NCT04021862|541906407|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
150210520|NCT04021862|541906408|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
150210521|NCT04021862|541906409|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
150210522|NCT04021862|541906410|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
150210523|NCT04021862|541906411|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
150210524|NCT04021862|541906406|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
150210525|NCT04021862|541906407|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
150210526|NCT04021862|541906408|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
150210527|NCT04021862|541906409|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
150210528|NCT04021862|541906410|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
150210529|NCT04021862|541906411|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
150210530|NCT04021862|541906406|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
150210531|NCT04021862|541906407|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
150210532|NCT04021862|541906408|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
150210533|NCT04021862|541906409|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
150210534|NCT04021862|541906410|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
150210535|NCT04021862|541906411|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
150210536|NCT04300023|541906412|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
150210537|NCT04300023|541906413|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
150210538|NCT04057131|541906414|FG000|Overall Study|Protocol Violation|24|||
150210539|NCT05251363|541906415|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
150210540|NCT05251363|541906415|FG000|Overall Study After Implant Period|Death|9|||
150210541|NCT05251363|541906415|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
150210542|NCT05251363|541906415|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
150210543|NCT05251363|541906415|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
150210544|NCT05251363|541906415|FG000|Overall Study After Implant Period|Physician Decision|1|||
150210545|NCT05251363|541906415|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
150210546|NCT03835754|541906416|FG000|Overall Study|Death|4|||
150210547|NCT02830204|541906417|FG000|Overall Study|Death|9|||
150210548|NCT02830204|541906417|FG000|Overall Study|Withdrawal by Subject|1|||
150210549|NCT03861052|541907760|FG000|Overall Study|Adverse Event|1|||
150210550|NCT03861052|541907761|FG001|Overall Study|Adverse Event|1|||
150210551|NCT03861052|541907762|FG002|Overall Study|Adverse Event|2|||
150210552|NCT03861052|541907763|FG003|Overall Study|Adverse Event|4|||
150210553|NCT03861052|541907760|FG000|Overall Study|Lost to Follow-up|0|||
150210554|NCT03861052|541907761|FG001|Overall Study|Lost to Follow-up|0|||
150210555|NCT03861052|541907762|FG002|Overall Study|Lost to Follow-up|0|||
150210556|NCT03861052|541907763|FG003|Overall Study|Lost to Follow-up|1|||
150210557|NCT03861052|541907760|FG000|Overall Study|Physician Decision|0|||
150210558|NCT03861052|541907761|FG001|Overall Study|Physician Decision|1|||
150210559|NCT03861052|541907762|FG002|Overall Study|Physician Decision|0|||
150210560|NCT03861052|541907763|FG003|Overall Study|Physician Decision|0|||
150210561|NCT03861052|541907760|FG000|Overall Study|Withdrawal by Subject|2|||
150210562|NCT03861052|541907761|FG001|Overall Study|Withdrawal by Subject|5|||
150210563|NCT03861052|541907762|FG002|Overall Study|Withdrawal by Subject|3|||
150210564|NCT03861052|541907763|FG003|Overall Study|Withdrawal by Subject|0|||
150210565|NCT03861052|541907760|FG000|Overall Study|Relocation to other city|1|||
150210566|NCT03861052|541907761|FG001|Overall Study|Relocation to other city|0|||
150210567|NCT03861052|541907762|FG002|Overall Study|Relocation to other city|0|||
150210568|NCT03861052|541907763|FG003|Overall Study|Relocation to other city|0|||
150210569|NCT00205179|541907776|FG000|Overall Study|Death|0|||
150210570|NCT00205179|541907777|FG001|Overall Study|Death|2|||
150210571|NCT00205179|541907776|FG000|Overall Study|Physician Decision|1|||
150210572|NCT00205179|541907777|FG001|Overall Study|Physician Decision|1|||
150210573|NCT00205179|541907776|FG000|Overall Study|Adverse Event|1|||
150210574|NCT00205179|541907777|FG001|Overall Study|Adverse Event|1|||
150210575|NCT01359150|541907778|FG000|Overall Study|Lack of Efficacy|1|||
150210576|NCT01359150|541907779|FG001|Overall Study|Lack of Efficacy|1|||
150210577|NCT01359150|541907778|FG000|Overall Study|Withdrawal by Subject|1|||
150210578|NCT01359150|541907779|FG001|Overall Study|Withdrawal by Subject|1|||
150210579|NCT01359150|541907778|FG000|Overall Study|Adverse Event|4|||
150210580|NCT01359150|541907779|FG001|Overall Study|Adverse Event|3|||
150210581|NCT01359150|541907778|FG000|Overall Study|Other|1|||
150210582|NCT01359150|541907779|FG001|Overall Study|Other|0|||
150210583|NCT01700205|541907780|FG000|Overall Study|Withdrawal by Subject|13|||
150210584|NCT01700205|541907781|FG001|Overall Study|Withdrawal by Subject|13|||
150210585|NCT01700205|541907780|FG000|Overall Study|Protocol Violation|2|||
150210586|NCT01700205|541907781|FG001|Overall Study|Protocol Violation|2|||
150210587|NCT01728324|541907782|FG000|Termination of DBV|Adverse Event|14|||
150210588|NCT01728324|541907783|FG001|Termination of DBV|Adverse Event|13|||
150210589|NCT01728324|541907784|FG002|Termination of DBV|Adverse Event|4|||
150210590|NCT01728324|541907782|FG000|Termination of DBV|Lack of Efficacy|14|||
150210591|NCT01728324|541907783|FG001|Termination of DBV|Lack of Efficacy|12|||
150210592|NCT01728324|541907784|FG002|Termination of DBV|Lack of Efficacy|8|||
150210593|NCT01728324|541907782|FG000|Termination of DBV|Withdrawal by Subject|9|||
150210594|NCT01728324|541907783|FG001|Termination of DBV|Withdrawal by Subject|6|||
150210595|NCT01728324|541907784|FG002|Termination of DBV|Withdrawal by Subject|2|||
150210596|NCT01728324|541907782|FG000|Termination of DBV|Other than stated|1|||
150210597|NCT01728324|541907783|FG001|Termination of DBV|Other than stated|3|||
150210598|NCT01728324|541907784|FG002|Termination of DBV|Other than stated|0|||
150210599|NCT01728324|541907782|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
150210600|NCT01728324|541907783|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
150210601|NCT01728324|541907784|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
150210602|NCT01728324|541907782|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
150210603|NCT01728324|541907783|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
150210604|NCT01728324|541907784|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
150210605|NCT01728324|541907782|FG000|Termination of FDV|Adverse Event|14|||
150210606|NCT01728324|541907783|FG001|Termination of FDV|Adverse Event|13|||
150210607|NCT01728324|541907784|FG002|Termination of FDV|Adverse Event|4|||
150210608|NCT01728324|541907782|FG000|Termination of FDV|Lack of Efficacy|14|||
150210609|NCT01728324|541907783|FG001|Termination of FDV|Lack of Efficacy|12|||
150210610|NCT01728324|541907784|FG002|Termination of FDV|Lack of Efficacy|8|||
150210611|NCT01728324|541907782|FG000|Termination of FDV|Withdrawal by Subject|9|||
150210612|NCT01728324|541907783|FG001|Termination of FDV|Withdrawal by Subject|6|||
150210613|NCT01728324|541907784|FG002|Termination of FDV|Withdrawal by Subject|2|||
150210614|NCT01728324|541907782|FG000|Termination of FDV|Other than stated|1|||
150210615|NCT01728324|541907783|FG001|Termination of FDV|Other than stated|3|||
150210616|NCT01728324|541907784|FG002|Termination of FDV|Other than stated|0|||
150210617|NCT01728324|541907782|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
150210618|NCT01728324|541907783|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
150210619|NCT01728324|541907784|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
150210620|NCT01728324|541907782|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
150210621|NCT01728324|541907783|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
150210622|NCT01728324|541907784|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
150210623|NCT01728324|541907782|FG000|Termination of RBV|Adverse Event|15|||
150210624|NCT01728324|541907783|FG001|Termination of RBV|Adverse Event|16|||
150210625|NCT01728324|541907784|FG002|Termination of RBV|Adverse Event|5|||
150210626|NCT01728324|541907782|FG000|Termination of RBV|Lack of Efficacy|14|||
150210627|NCT01728324|541907783|FG001|Termination of RBV|Lack of Efficacy|11|||
150210628|NCT01728324|541907784|FG002|Termination of RBV|Lack of Efficacy|7|||
150210629|NCT01728324|541907782|FG000|Termination of RBV|Withdrawal by Subject|9|||
150210630|NCT01728324|541907783|FG001|Termination of RBV|Withdrawal by Subject|5|||
150210631|NCT01728324|541907784|FG002|Termination of RBV|Withdrawal by Subject|2|||
150210632|NCT01728324|541907782|FG000|Termination of RBV|Other than stated|1|||
150210633|NCT01728324|541907783|FG001|Termination of RBV|Other than stated|3|||
150210634|NCT01728324|541907784|FG002|Termination of RBV|Other than stated|1|||
150210635|NCT01728324|541907782|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
150210636|NCT01728324|541907783|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
150210637|NCT01728324|541907784|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
150210638|NCT01728324|541907782|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
150210639|NCT01728324|541907783|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
150210640|NCT01728324|541907784|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
150210641|NCT01619059|541907785|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
150210642|NCT01619059|541907786|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
150210643|NCT01619059|541907785|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
150210644|NCT01619059|541907786|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
150210645|NCT01619059|541907785|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
150210646|NCT01619059|541907786|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
150210647|NCT01619059|541907785|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
150210648|NCT01619059|541907786|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
150210649|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
150210650|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
150210651|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
150210652|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
150210653|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
150210654|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
150210655|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Death|1|||
150210656|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Death|0|||
150210657|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
150210658|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
150210659|NCT01619059|541907785|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
150210660|NCT01619059|541907786|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
150210661|NCT01787032|541907789|FG000|Overall Study|Protocol Violation|0|||
150210662|NCT01787032|541907790|FG001|Overall Study|Protocol Violation|0|||
150210663|NCT01787032|541907791|FG002|Overall Study|Protocol Violation|0|||
150210664|NCT01787032|541907792|FG003|Overall Study|Protocol Violation|0|||
150210665|NCT01787032|541907793|FG004|Overall Study|Protocol Violation|1|||
150210666|NCT01787032|541907794|FG005|Overall Study|Protocol Violation|1|||
150210667|NCT02040870|541907795|FG000|Overall Study|Completed treatment phase|6|||
150210668|NCT02040870|541907795|FG000|Overall Study|Adverse Event|7|||
150210669|NCT02040870|541907795|FG000|Overall Study|Progressive disease|58|||
150210670|NCT02040870|541907795|FG000|Overall Study|Physician Decision|6|||
150210671|NCT02040870|541907795|FG000|Overall Study|Subject/guardian decision|10|||
150210672|NCT02040870|541907795|FG000|Overall Study|Lost to Follow-up|3|||
150210673|NCT02040870|541907795|FG000|Overall Study|Death|13|||
150210674|NCT00388726|541907796|FG000|Overall Study|Adverse Event|50|||
150210675|NCT00388726|541907797|FG001|Overall Study|Adverse Event|24|||
150210676|NCT00388726|541907796|FG000|Overall Study|Progressive Disease|336|||
150210677|NCT00388726|541907797|FG001|Overall Study|Progressive Disease|153|||
150210678|NCT00388726|541907796|FG000|Overall Study|Clinical Progression|61|||
150210679|NCT00388726|541907797|FG001|Overall Study|Clinical Progression|36|||
150210680|NCT00388726|541907796|FG000|Overall Study|Withdrawal by Subject|10|||
150210681|NCT00388726|541907797|FG001|Overall Study|Withdrawal by Subject|7|||
150210682|NCT00388726|541907796|FG000|Overall Study|Administrative|6|||
150210683|NCT00388726|541907797|FG001|Overall Study|Administrative|9|||
150210684|NCT00388726|541907796|FG000|Overall Study|Physician Decision|18|||
150210685|NCT00388726|541907797|FG001|Overall Study|Physician Decision|13|||
150210686|NCT00388726|541907796|FG000|Overall Study|Death|3|||
150210687|NCT00388726|541907797|FG001|Overall Study|Death|2|||
150210688|NCT04971733|541907798|FG000|Overall Study|Adverse Event|1|||
150210689|NCT04971733|541907799|FG001|Overall Study|Adverse Event|1|||
150210690|NCT04971733|541907798|FG000|Overall Study|Subject choice|2|||
150210691|NCT04971733|541907799|FG001|Overall Study|Subject choice|0|||
150210692|NCT04971733|541907798|FG000|Overall Study|Withdrawal by Subject|1|||
150210693|NCT04971733|541907799|FG001|Overall Study|Withdrawal by Subject|0|||
150210694|NCT04971733|541907798|FG000|Overall Study|Other|1|||
150210695|NCT04971733|541907799|FG001|Overall Study|Other|0|||
150210696|NCT03229408|541907800|FG000|Overall Study|Withdrawal by Subject|4|||
150210697|NCT03229408|541907801|FG001|Overall Study|Withdrawal by Subject|1|||
150210698|NCT03229408|541907800|FG000|Overall Study|Adverse Event|2|||
150210699|NCT03229408|541907801|FG001|Overall Study|Adverse Event|0|||
150210700|NCT03229408|541907800|FG000|Overall Study|Pregnancy|0|||
150210701|NCT03229408|541907801|FG001|Overall Study|Pregnancy|1|||
150210702|NCT03229408|541907800|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
150210703|NCT03229408|541907801|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
150210704|NCT03745313|541907802|FG000|At 30 Days Follow-up|Death|2|||
150210705|NCT03745313|541907802|FG000|At 6 Months Follow-up|Death|1|||
150210706|NCT03745313|541907802|FG000|At 6 Months Follow-up|Missed Visit|1|||
150210707|NCT03745313|541907802|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
150210708|NCT03745313|541907802|FG000|At 1 Year Follow-up|Death|2|||
150210709|NCT03745313|541907802|FG000|At 1 Year Follow-up|Missed Visit|2|||
150210710|NCT03745313|541907802|FG000|At 2 Year Follow-up|Missed Visit|1|||
150210711|NCT01706159|541907804|FG000|Overall Study|Withdrawal Criteria|2|||
150210712|NCT01706159|541907805|FG001|Overall Study|Withdrawal Criteria|1|||
150210713|NCT01706159|541907804|FG000|Overall Study|Unclassified|6|||
150210714|NCT01706159|541907805|FG001|Overall Study|Unclassified|1|||
150210715|NCT02454959|541907806|FG000|Overall Study|Protocol-Specified Criteria|3|||
150210716|NCT02454959|541907806|FG000|Overall Study|Physician Decision|1|||
150210717|NCT02454959|541907806|FG000|Overall Study|Withdrawal by Subject|3|||
150210718|NCT02454959|541907806|FG000|Overall Study|Adverse Event|2|||
150210719|NCT03611075|541907807|FG000|Overall Study|Physician Decision|0|||
150210720|NCT03611075|541907808|FG001|Overall Study|Physician Decision|1|||
150210721|NCT03611075|541907809|FG002|Overall Study|Physician Decision|1|||
150210722|NCT03611075|541907810|FG003|Overall Study|Physician Decision|0|||
150210723|NCT03611075|541907811|FG004|Overall Study|Physician Decision|0|||
150210724|NCT03611075|541907812|FG005|Overall Study|Physician Decision|0|||
150210725|NCT03611075|541907813|FG006|Overall Study|Physician Decision|0|||
150210726|NCT03611075|541907814|FG007|Overall Study|Physician Decision|0|||
150210727|NCT03611075|541907815|FG008|Overall Study|Physician Decision|0|||
150210728|NCT03611075|541907807|FG000|Overall Study|Lost to Follow-up|1|||
150210729|NCT03611075|541907808|FG001|Overall Study|Lost to Follow-up|0|||
150210730|NCT03611075|541907809|FG002|Overall Study|Lost to Follow-up|0|||
150210731|NCT03611075|541907810|FG003|Overall Study|Lost to Follow-up|2|||
150210732|NCT03611075|541907811|FG004|Overall Study|Lost to Follow-up|0|||
150210733|NCT03611075|541907812|FG005|Overall Study|Lost to Follow-up|0|||
150210734|NCT03611075|541907813|FG006|Overall Study|Lost to Follow-up|0|||
150210735|NCT03611075|541907814|FG007|Overall Study|Lost to Follow-up|0|||
150210736|NCT03611075|541907815|FG008|Overall Study|Lost to Follow-up|0|||
150210737|NCT03611075|541907807|FG000|Overall Study|Withdrawal by Subject|0|||
150210738|NCT03611075|541907808|FG001|Overall Study|Withdrawal by Subject|1|||
150210739|NCT03611075|541907809|FG002|Overall Study|Withdrawal by Subject|1|||
150210740|NCT03611075|541907810|FG003|Overall Study|Withdrawal by Subject|1|||
150210741|NCT03611075|541907811|FG004|Overall Study|Withdrawal by Subject|0|||
150210742|NCT03611075|541907812|FG005|Overall Study|Withdrawal by Subject|0|||
150210743|NCT03611075|541907813|FG006|Overall Study|Withdrawal by Subject|1|||
150210744|NCT03611075|541907814|FG007|Overall Study|Withdrawal by Subject|0|||
150210745|NCT03611075|541907815|FG008|Overall Study|Withdrawal by Subject|0|||
150210746|NCT03611075|541907807|FG000|Overall Study|Reason unknown|0|||
150210747|NCT03611075|541907808|FG001|Overall Study|Reason unknown|0|||
150210748|NCT03611075|541907809|FG002|Overall Study|Reason unknown|0|||
150210749|NCT03611075|541907810|FG003|Overall Study|Reason unknown|1|||
150210750|NCT03611075|541907811|FG004|Overall Study|Reason unknown|0|||
150210751|NCT03611075|541907812|FG005|Overall Study|Reason unknown|0|||
150210752|NCT03611075|541907813|FG006|Overall Study|Reason unknown|1|||
150210753|NCT03611075|541907814|FG007|Overall Study|Reason unknown|0|||
150210754|NCT03611075|541907815|FG008|Overall Study|Reason unknown|0|||
150210755|NCT01701401|541907816|FG000|Overall Study|Randomized But Not Treated|3|||
150210756|NCT01701401|541907817|FG001|Overall Study|Randomized But Not Treated|1|||
150210757|NCT01701401|541907818|FG002|Overall Study|Randomized But Not Treated|0|||
150210758|NCT01701401|541907819|FG003|Overall Study|Randomized But Not Treated|1|||
150210759|NCT01701401|541907816|FG000|Overall Study|Lost to Follow-up|5|||
150210760|NCT01701401|541907817|FG001|Overall Study|Lost to Follow-up|5|||
150210761|NCT01701401|541907818|FG002|Overall Study|Lost to Follow-up|1|||
150210762|NCT01701401|541907819|FG003|Overall Study|Lost to Follow-up|3|||
150210763|NCT01701401|541907816|FG000|Overall Study|Withdrew Consent|0|||
150210764|NCT01701401|541907817|FG001|Overall Study|Withdrew Consent|3|||
150210765|NCT01701401|541907818|FG002|Overall Study|Withdrew Consent|1|||
150210766|NCT01701401|541907819|FG003|Overall Study|Withdrew Consent|2|||
150210767|NCT01701401|541907816|FG000|Overall Study|Lack of Efficacy|1|||
150210768|NCT01701401|541907817|FG001|Overall Study|Lack of Efficacy|0|||
150210769|NCT01701401|541907818|FG002|Overall Study|Lack of Efficacy|2|||
150210770|NCT01701401|541907819|FG003|Overall Study|Lack of Efficacy|0|||
150210771|NCT01701401|541907816|FG000|Overall Study|Adverse Event|1|||
150210772|NCT01701401|541907817|FG001|Overall Study|Adverse Event|0|||
150210773|NCT01701401|541907818|FG002|Overall Study|Adverse Event|0|||
150210774|NCT01701401|541907819|FG003|Overall Study|Adverse Event|0|||
150210775|NCT01701401|541907816|FG000|Overall Study|Protocol Violation|0|||
150210776|NCT01701401|541907817|FG001|Overall Study|Protocol Violation|0|||
150210777|NCT01701401|541907818|FG002|Overall Study|Protocol Violation|1|||
150210778|NCT01701401|541907819|FG003|Overall Study|Protocol Violation|0|||
150210779|NCT04445831|541907831|FG000|Overall Study|Withdrawal by Subject|2|||
150210780|NCT04445831|541907832|FG001|Overall Study|Withdrawal by Subject|1|||
150210781|NCT04445831|541907833|FG002|Overall Study|Withdrawal by Subject|1|||
150210782|NCT04445831|541907834|FG003|Overall Study|Withdrawal by Subject|0|||
150210783|NCT04445831|541907835|FG004|Overall Study|Withdrawal by Subject|0|||
150210784|NCT04445831|541907836|FG005|Overall Study|Withdrawal by Subject|0|||
150210785|NCT04445831|541907837|FG006|Overall Study|Withdrawal by Subject|0|||
150210786|NCT04445831|541907831|FG000|Overall Study|Subject withdrawal by caregiver|0|||
150210787|NCT04445831|541907832|FG001|Overall Study|Subject withdrawal by caregiver|1|||
150210788|NCT04445831|541907833|FG002|Overall Study|Subject withdrawal by caregiver|0|||
150210789|NCT04445831|541907834|FG003|Overall Study|Subject withdrawal by caregiver|0|||
150210790|NCT04445831|541907835|FG004|Overall Study|Subject withdrawal by caregiver|0|||
150210791|NCT04445831|541907836|FG005|Overall Study|Subject withdrawal by caregiver|0|||
150210792|NCT04445831|541907837|FG006|Overall Study|Subject withdrawal by caregiver|0|||
150210793|NCT05613907|541907841|FG000|Overall Study|Lost to Follow-up|5|||
150210794|NCT05613907|541907841|FG000|Overall Study|Death|3|||
150210795|NCT05613907|541907841|FG000|Overall Study|Withdrawal by Subject|2|||
150210796|NCT03789656|541907853|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
150210797|NCT03789656|541907854|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
150210798|NCT03789656|541907855|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
150210799|NCT03789656|541907856|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
150210800|NCT03789656|541907857|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
150210801|NCT03789656|541907853|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
150210802|NCT03789656|541907854|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
150210803|NCT03789656|541907855|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
150210804|NCT03789656|541907856|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
150210805|NCT03789656|541907857|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
150210806|NCT03789656|541907853|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
150210807|NCT03789656|541907854|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
150210808|NCT03789656|541907855|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
150210809|NCT03789656|541907856|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
150210810|NCT03789656|541907857|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
150210811|NCT03789656|541907853|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
150210812|NCT03789656|541907854|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
150210813|NCT03789656|541907855|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
150210814|NCT03789656|541907856|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
150210815|NCT03789656|541907857|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
150210816|NCT05325294|541907867|FG000|Overall Study|Adverse Event|3|||
150210817|NCT05325294|541907868|FG001|Overall Study|Adverse Event|3|||
150210818|NCT05325294|541907867|FG000|Overall Study|Physician Decision|0|||
150210819|NCT05325294|541907868|FG001|Overall Study|Physician Decision|1|||
150210820|NCT05325294|541907867|FG000|Overall Study|Withdrawal by Subject|0|||
150210821|NCT05325294|541907868|FG001|Overall Study|Withdrawal by Subject|3|||
150210822|NCT05325294|541907867|FG000|Overall Study|Lost to Follow-up|1|||
150210823|NCT05325294|541907868|FG001|Overall Study|Lost to Follow-up|0|||
150210824|NCT05325294|541907867|FG000|Overall Study|Sponsor Request|0|||
150210825|NCT05325294|541907868|FG001|Overall Study|Sponsor Request|2|||
150210826|NCT04701203|541907871|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
150210827|NCT04701203|541907872|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
150210828|NCT04701203|541907873|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
150210829|NCT04701203|541907871|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
150210830|NCT04701203|541907872|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
150210831|NCT04701203|541907873|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
150210832|NCT04701203|541907871|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
150210833|NCT04701203|541907872|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
150210834|NCT04701203|541907873|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
150210835|NCT04701203|541907871|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
150210836|NCT04701203|541907872|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
150210837|NCT04701203|541907873|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
150210838|NCT04577651|541907874|FG000|Overall Study|Screen Failure|7|||
150210839|NCT04577651|541907874|FG000|Overall Study|Adverse Event|1|||
150210840|NCT04577651|541907874|FG000|Overall Study|Death|1|||
150210841|NCT04577651|541907874|FG000|Overall Study|Physician Decision|1|||
150210842|NCT04577651|541907874|FG000|Overall Study|Withdrawal by Subject|3|||
150210843|NCT05293717|541907876|FG000|Overall Study|Physician Decision|1|||
150210844|NCT05422339|541909123|FG000|Overall Study|Withdrawal by Subject|17|||
150210845|NCT05422339|541909124|FG001|Overall Study|Withdrawal by Subject|15|||
150210846|NCT04172675|541909125|FG000|Overall Study|Withdrawal by Subject|7|||
150210847|NCT04172675|541909126|FG001|Overall Study|Withdrawal by Subject|5|||
150210848|NCT04172675|541909127|FG002|Overall Study|Withdrawal by Subject|1|||
150210849|NCT04172675|541909128|FG003|Overall Study|Withdrawal by Subject|4|||
150210850|NCT05029284|541909129|FG000|Overall Study|Lost to Follow-up|1|||
150210851|NCT03070392|541909130|FG000|Overall Study|Not Treated|7|||
150210852|NCT03070392|541909131|FG001|Overall Study|Not Treated|0|||
150210853|NCT03070392|541909132|FG002|Overall Study|Not Treated|3|||
150210854|NCT03070392|541909133|FG003|Overall Study|Not Treated|12|||
150210855|NCT03070392|541909130|FG000|Overall Study|Death|3|||
150210856|NCT03070392|541909131|FG001|Overall Study|Death|0|||
150210857|NCT03070392|541909132|FG002|Overall Study|Death|0|||
150210858|NCT03070392|541909133|FG003|Overall Study|Death|1|||
150210859|NCT03070392|541909130|FG000|Overall Study|Withdrawal by Subject|7|||
150210860|NCT03070392|541909131|FG001|Overall Study|Withdrawal by Subject|0|||
150210861|NCT03070392|541909132|FG002|Overall Study|Withdrawal by Subject|0|||
150210862|NCT03070392|541909133|FG003|Overall Study|Withdrawal by Subject|3|||
150210863|NCT03070392|541909130|FG000|Overall Study|Physician Decision|1|||
150210864|NCT03070392|541909131|FG001|Overall Study|Physician Decision|0|||
150210865|NCT03070392|541909132|FG002|Overall Study|Physician Decision|0|||
150210866|NCT03070392|541909133|FG003|Overall Study|Physician Decision|2|||
150210867|NCT03070392|541909130|FG000|Overall Study|Progressive Disease|154|||
150210868|NCT03070392|541909131|FG001|Overall Study|Progressive Disease|6|||
150210869|NCT03070392|541909132|FG002|Overall Study|Progressive Disease|2|||
150210870|NCT03070392|541909133|FG003|Overall Study|Progressive Disease|70|||
150210871|NCT03070392|541909130|FG000|Overall Study|Adverse Event|6|||
150210872|NCT03070392|541909131|FG001|Overall Study|Adverse Event|1|||
150210873|NCT03070392|541909132|FG002|Overall Study|Adverse Event|1|||
150210874|NCT03070392|541909133|FG003|Overall Study|Adverse Event|3|||
150210875|NCT03070392|541909130|FG000|Overall Study|Alternate anticancer treatment|1|||
150210876|NCT03070392|541909131|FG001|Overall Study|Alternate anticancer treatment|0|||
150210877|NCT03070392|541909132|FG002|Overall Study|Alternate anticancer treatment|0|||
150210878|NCT03070392|541909133|FG003|Overall Study|Alternate anticancer treatment|1|||
150210879|NCT03070392|541909130|FG000|Overall Study|Ongoing|73|||
150210880|NCT03070392|541909131|FG001|Overall Study|Ongoing|0|||
150210881|NCT03070392|541909132|FG002|Overall Study|Ongoing|0|||
150210882|NCT03070392|541909133|FG003|Overall Study|Ongoing|11|||
150210883|NCT02972034|541909134|FG000|Overall Study|Death|11|||
150210884|NCT02972034|541909135|FG001|Overall Study|Death|1|||
150210885|NCT02972034|541909136|FG002|Overall Study|Death|3|||
150210886|NCT02972034|541909137|FG003|Overall Study|Death|3|||
150210887|NCT02972034|541909138|FG004|Overall Study|Death|2|||
150210888|NCT02972034|541909139|FG005|Overall Study|Death|2|||
150210889|NCT02972034|541909140|FG006|Overall Study|Death|3|||
150210890|NCT02972034|541909141|FG007|Overall Study|Death|4|||
150210891|NCT02972034|541909142|FG008|Overall Study|Death|8|||
150210892|NCT02972034|541909143|FG009|Overall Study|Death|11|||
150210893|NCT02972034|541909144|FG010|Overall Study|Death|3|||
150210894|NCT02972034|541909145|FG011|Overall Study|Death|2|||
150210895|NCT02972034|541909146|FG012|Overall Study|Death|11|||
150210896|NCT02972034|541909147|FG013|Overall Study|Death|10|||
150210897|NCT02972034|541909148|FG014|Overall Study|Death|9|||
150210898|NCT02972034|541909134|FG000|Overall Study|Lost to Follow-up|0|||
150210899|NCT02972034|541909135|FG001|Overall Study|Lost to Follow-up|0|||
150210900|NCT02972034|541909136|FG002|Overall Study|Lost to Follow-up|0|||
150210901|NCT02972034|541909137|FG003|Overall Study|Lost to Follow-up|0|||
150210902|NCT02972034|541909138|FG004|Overall Study|Lost to Follow-up|1|||
150210903|NCT02972034|541909139|FG005|Overall Study|Lost to Follow-up|0|||
150210904|NCT02972034|541909140|FG006|Overall Study|Lost to Follow-up|0|||
150210905|NCT02972034|541909141|FG007|Overall Study|Lost to Follow-up|1|||
150210906|NCT02972034|541909142|FG008|Overall Study|Lost to Follow-up|0|||
150210907|NCT02972034|541909143|FG009|Overall Study|Lost to Follow-up|0|||
150210908|NCT02972034|541909144|FG010|Overall Study|Lost to Follow-up|0|||
150210909|NCT02972034|541909145|FG011|Overall Study|Lost to Follow-up|0|||
150210910|NCT02972034|541909146|FG012|Overall Study|Lost to Follow-up|0|||
150210911|NCT02972034|541909147|FG013|Overall Study|Lost to Follow-up|0|||
150210912|NCT02972034|541909148|FG014|Overall Study|Lost to Follow-up|1|||
150210913|NCT02972034|541909134|FG000|Overall Study|Physician Decision|0|||
150210914|NCT02972034|541909135|FG001|Overall Study|Physician Decision|0|||
150210915|NCT02972034|541909136|FG002|Overall Study|Physician Decision|0|||
150210916|NCT02972034|541909137|FG003|Overall Study|Physician Decision|0|||
150210917|NCT02972034|541909138|FG004|Overall Study|Physician Decision|0|||
150210918|NCT02972034|541909139|FG005|Overall Study|Physician Decision|0|||
150210919|NCT02972034|541909140|FG006|Overall Study|Physician Decision|0|||
150210920|NCT02972034|541909141|FG007|Overall Study|Physician Decision|1|||
150210921|NCT02972034|541909142|FG008|Overall Study|Physician Decision|0|||
150210922|NCT02972034|541909143|FG009|Overall Study|Physician Decision|0|||
150210923|NCT02972034|541909144|FG010|Overall Study|Physician Decision|1|||
150210924|NCT02972034|541909145|FG011|Overall Study|Physician Decision|0|||
150210925|NCT02972034|541909146|FG012|Overall Study|Physician Decision|0|||
150210926|NCT02972034|541909147|FG013|Overall Study|Physician Decision|0|||
150210927|NCT02972034|541909148|FG014|Overall Study|Physician Decision|0|||
150210928|NCT02972034|541909134|FG000|Overall Study|Sponsor Decision|0|||
150210929|NCT02972034|541909135|FG001|Overall Study|Sponsor Decision|0|||
150210930|NCT02972034|541909136|FG002|Overall Study|Sponsor Decision|0|||
150210931|NCT02972034|541909137|FG003|Overall Study|Sponsor Decision|1|||
150210932|NCT02972034|541909138|FG004|Overall Study|Sponsor Decision|0|||
150210933|NCT02972034|541909139|FG005|Overall Study|Sponsor Decision|0|||
150210934|NCT02972034|541909140|FG006|Overall Study|Sponsor Decision|1|||
150210935|NCT02972034|541909141|FG007|Overall Study|Sponsor Decision|1|||
150210936|NCT02972034|541909142|FG008|Overall Study|Sponsor Decision|1|||
150210937|NCT02972034|541909143|FG009|Overall Study|Sponsor Decision|2|||
150210938|NCT02972034|541909144|FG010|Overall Study|Sponsor Decision|2|||
150210939|NCT02972034|541909145|FG011|Overall Study|Sponsor Decision|0|||
150210940|NCT02972034|541909146|FG012|Overall Study|Sponsor Decision|1|||
150210941|NCT02972034|541909147|FG013|Overall Study|Sponsor Decision|0|||
150210942|NCT02972034|541909148|FG014|Overall Study|Sponsor Decision|1|||
150210943|NCT02972034|541909134|FG000|Overall Study|Withdrawal by Subject|3|||
150210944|NCT02972034|541909135|FG001|Overall Study|Withdrawal by Subject|0|||
150210945|NCT02972034|541909136|FG002|Overall Study|Withdrawal by Subject|0|||
150210946|NCT02972034|541909137|FG003|Overall Study|Withdrawal by Subject|0|||
150210947|NCT02972034|541909138|FG004|Overall Study|Withdrawal by Subject|1|||
150210948|NCT02972034|541909139|FG005|Overall Study|Withdrawal by Subject|1|||
150210949|NCT02972034|541909140|FG006|Overall Study|Withdrawal by Subject|0|||
150210950|NCT02972034|541909141|FG007|Overall Study|Withdrawal by Subject|0|||
150210951|NCT02972034|541909142|FG008|Overall Study|Withdrawal by Subject|1|||
150210952|NCT02972034|541909143|FG009|Overall Study|Withdrawal by Subject|1|||
150210953|NCT02972034|541909144|FG010|Overall Study|Withdrawal by Subject|2|||
150210954|NCT02972034|541909145|FG011|Overall Study|Withdrawal by Subject|1|||
150210955|NCT02972034|541909146|FG012|Overall Study|Withdrawal by Subject|1|||
150210956|NCT02972034|541909147|FG013|Overall Study|Withdrawal by Subject|1|||
150210957|NCT02972034|541909148|FG014|Overall Study|Withdrawal by Subject|0|||
150210958|NCT02972034|541909134|FG000|Overall Study|Screen Failure|0|||
150210959|NCT02972034|541909135|FG001|Overall Study|Screen Failure|0|||
150210960|NCT02972034|541909136|FG002|Overall Study|Screen Failure|0|||
150210961|NCT02972034|541909137|FG003|Overall Study|Screen Failure|0|||
150210962|NCT02972034|541909138|FG004|Overall Study|Screen Failure|0|||
150210963|NCT02972034|541909139|FG005|Overall Study|Screen Failure|0|||
150210964|NCT02972034|541909140|FG006|Overall Study|Screen Failure|0|||
150210965|NCT02972034|541909141|FG007|Overall Study|Screen Failure|0|||
150210966|NCT02972034|541909142|FG008|Overall Study|Screen Failure|0|||
150210967|NCT02972034|541909143|FG009|Overall Study|Screen Failure|0|||
150210968|NCT02972034|541909144|FG010|Overall Study|Screen Failure|0|||
150210969|NCT02972034|541909145|FG011|Overall Study|Screen Failure|0|||
150210970|NCT02972034|541909146|FG012|Overall Study|Screen Failure|1|||
150210971|NCT02972034|541909147|FG013|Overall Study|Screen Failure|0|||
150210972|NCT02972034|541909148|FG014|Overall Study|Screen Failure|0|||
150210973|NCT03009344|541909149|FG000|Overall Study|Lack of Efficacy|5|||
150210974|NCT03009344|541909149|FG000|Overall Study|Withdrawal by Subject|1|||
150210975|NCT03009344|541909149|FG000|Overall Study|Adverse Event|1|||
150210976|NCT00378898|541909150|FG000|Overall Study|Withdrawal by Subject|10|||
150210977|NCT00378898|541909151|FG001|Overall Study|Withdrawal by Subject|5|||
150210978|NCT00378898|541909150|FG000|Overall Study|Protocol Violation|1|||
150210979|NCT00378898|541909151|FG001|Overall Study|Protocol Violation|1|||
150210980|NCT02372799|541909160|FG000|Treatment Period|Adverse Event|3|||
150210981|NCT02372799|541909161|FG001|Treatment Period|Adverse Event|10|||
150210982|NCT02372799|541909162|FG002|Treatment Period|Adverse Event|6|||
150210983|NCT02372799|541909160|FG000|Treatment Period|Insufficient therapeutic response|2|||
150210984|NCT02372799|541909161|FG001|Treatment Period|Insufficient therapeutic response|2|||
150210985|NCT02372799|541909162|FG002|Treatment Period|Insufficient therapeutic response|0|||
150210986|NCT02372799|541909160|FG000|Treatment Period|Withdrawal by Subject|10|||
150210987|NCT02372799|541909161|FG001|Treatment Period|Withdrawal by Subject|10|||
150210988|NCT02372799|541909162|FG002|Treatment Period|Withdrawal by Subject|2|||
150210989|NCT02372799|541909160|FG000|Treatment Period|Lost to Follow-up|11|||
150210990|NCT02372799|541909161|FG001|Treatment Period|Lost to Follow-up|5|||
150210991|NCT02372799|541909162|FG002|Treatment Period|Lost to Follow-up|3|||
150210992|NCT02372799|541909160|FG000|Treatment Period|Protocol Violation|3|||
150210993|NCT02372799|541909161|FG001|Treatment Period|Protocol Violation|0|||
150210994|NCT02372799|541909162|FG002|Treatment Period|Protocol Violation|0|||
150210995|NCT02372799|541909160|FG000|Treatment Period|Non-compliance with study drug|4|||
150210996|NCT02372799|541909161|FG001|Treatment Period|Non-compliance with study drug|4|||
150210997|NCT02372799|541909162|FG002|Treatment Period|Non-compliance with study drug|4|||
150210998|NCT02372799|541909160|FG000|Treatment Period|Miscellaneous Reasons|1|||
150210999|NCT02372799|541909161|FG001|Treatment Period|Miscellaneous Reasons|1|||
150211000|NCT02372799|541909162|FG002|Treatment Period|Miscellaneous Reasons|0|||
150211001|NCT02372799|541909160|FG000|Down-taper Period|Lost to Follow-up|1|||
150211002|NCT02372799|541909161|FG001|Down-taper Period|Lost to Follow-up|2|||
150211003|NCT02372799|541909162|FG002|Down-taper Period|Lost to Follow-up|2|||
150211004|NCT04652869|541909167|FG000|Overall Study|Withdrawal by Subject|0|||
150211005|NCT04652869|541909168|FG001|Overall Study|Withdrawal by Subject|2|||
150211006|NCT04652869|541909169|FG002|Overall Study|Withdrawal by Subject|0|||
150211007|NCT00562094|541909170|FG000|Overall Study|Lost to Follow-up|62|||
150211008|NCT01613417|541909171|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
150211009|NCT01613417|541909172|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
150211010|NCT00019604|541909173|FG000|Overall Study|Death|1|||
150211011|NCT00019604|541909173|FG000|Overall Study|Progressive disease|23|||
150211012|NCT00019604|541909173|FG000|Overall Study|Refused treatment|1|||
150211013|NCT00019604|541909173|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
150211014|NCT00019604|541909173|FG000|Overall Study|Going to have liver transplant|1|||
150211015|NCT00019604|541909173|FG000|Overall Study|Move to a different study|1|||
150211016|NCT00019604|541909173|FG000|Overall Study|Non compliant on systemic CH|1|||
150211017|NCT00019604|541909173|FG000|Overall Study|Non compliant|1|||
150211018|NCT00019604|541909173|FG000|Overall Study|Resectable disease|1|||
150211019|NCT00019604|541909173|FG000|Overall Study|Started new chemo regimen|1|||
150211020|NCT00019604|541909173|FG000|Overall Study|Pt going to immunotherapy study|1|||
150211021|NCT00019604|541909173|FG000|Overall Study|Too much disease|1|||
150211022|NCT00019604|541909173|FG000|Overall Study|Unable to evaluate|1|||
150211023|NCT00019604|541909173|FG000|Overall Study|Details for other not available|4|||
150211024|NCT00454194|541909176|FG000|Overall Study|Adverse Event|7|||
150211025|NCT00454194|541909177|FG001|Overall Study|Adverse Event|2|||
150211026|NCT00454194|541909176|FG000|Overall Study|Withdrawal by Subject|12|||
150211027|NCT00454194|541909177|FG001|Overall Study|Withdrawal by Subject|8|||
150211028|NCT00454194|541909176|FG000|Overall Study|Other Medical Problems|1|||
150211029|NCT00454194|541909177|FG001|Overall Study|Other Medical Problems|2|||
150211030|NCT00454194|541909176|FG000|Overall Study|Other Unspecified Reason|2|||
150211031|NCT00454194|541909177|FG001|Overall Study|Other Unspecified Reason|2|||
150211032|NCT00093496|541909183|FG000|Overall Study|Protocol Violation|1|||
150211033|NCT00093496|541909184|FG001|Overall Study|Protocol Violation|3|||
150211034|NCT00586313|541909185|FG000|Overall Study|Lack of Efficacy|2|||
150211035|NCT01932970|541909186|FG000|Overall Study|Withdrawal by Subject|5|||
150211036|NCT01932970|541909186|FG000|Overall Study|Death|1|||
150211037|NCT01932970|541909186|FG000|Overall Study|Lost to Follow-up|2|||
150211038|NCT01932970|541909186|FG000|Overall Study|Protocol Specified Criteria|10|||
150211039|NCT03205566|541909188|FG000|Phase 1|Protocol Violation|1|||
150211040|NCT03205566|541909189|FG001|Phase 1|Protocol Violation|1|||
150211041|NCT03184987|541909190|FG000|Overall Study|Withdrawal by Subject|0|||
150211042|NCT03184987|541909191|FG001|Overall Study|Withdrawal by Subject|1|||
150211043|NCT03184987|541909192|FG002|Overall Study|Withdrawal by Subject|2|||
150211044|NCT03184987|541909190|FG000|Overall Study|Physician Decision|0|||
150211045|NCT03184987|541909191|FG001|Overall Study|Physician Decision|0|||
150211046|NCT03184987|541909192|FG002|Overall Study|Physician Decision|1|||
150211047|NCT03184987|541909190|FG000|Overall Study|Adverse Event|1|||
150211048|NCT03184987|541909191|FG001|Overall Study|Adverse Event|0|||
150211049|NCT03184987|541909192|FG002|Overall Study|Adverse Event|1|||
150211050|NCT00853580|541909193|FG000|Overall Study|Lost to Follow-up|3|||
150211051|NCT00853580|541909194|FG001|Overall Study|Lost to Follow-up|5|||
150211052|NCT00853580|541909193|FG000|Overall Study|Protocol Violation|2|||
150211053|NCT00853580|541909194|FG001|Overall Study|Protocol Violation|1|||
150211054|NCT00853580|541909193|FG000|Overall Study|Withdrawal by Subject|2|||
150211055|NCT00853580|541909194|FG001|Overall Study|Withdrawal by Subject|8|||
150211056|NCT00853580|541909193|FG000|Overall Study|Commenced contraindicated therapy|0|||
150211057|NCT00853580|541909194|FG001|Overall Study|Commenced contraindicated therapy|2|||
150211058|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
150211059|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
150211060|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
150211061|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
150211062|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
150211063|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
150211064|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
150211065|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
150211066|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
150211067|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
150211068|NCT01767467|541909195|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
150211069|NCT01767467|541909196|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
150211070|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
150211071|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
150211072|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
150211073|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
150211074|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
150211075|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
150211076|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
150211077|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
150211078|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
150211079|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
150211080|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
150211081|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
150211082|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
150211083|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
150211084|NCT01767467|541909195|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
150211085|NCT01767467|541909196|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
150211086|NCT03113409|541909207|FG000|Overall Study|Withdrawal by Subject|5|||
150211087|NCT03113409|541909208|FG001|Overall Study|Withdrawal by Subject|0|||
150211088|NCT03113409|541909209|FG002|Overall Study|Withdrawal by Subject|0|||
150211089|NCT01160354|541909214|FG000|Overall Study|Death|0|||
150211090|NCT01160354|541909215|FG001|Overall Study|Death|1|||
150211091|NCT01160354|541909216|FG002|Overall Study|Death|1|||
150211092|NCT00600353|541909219|FG000|Overall Study|history of malignancy within 5 years|1|||
150211093|NCT00600353|541909220|FG001|Overall Study|history of malignancy within 5 years|0|||
150211094|NCT00600353|541909219|FG000|Overall Study|History of prepartive regimen|0|||
150211095|NCT00600353|541909220|FG001|Overall Study|History of prepartive regimen|1|||
150211096|NCT04941482|541909221|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
150211097|NCT04941482|541909222|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
150211098|NCT04827732|541909223|FG000|Overall Study|Did not start treatment|0|||
150211099|NCT04827732|541909224|FG001|Overall Study|Did not start treatment|1|||
150211100|NCT04827732|541909225|FG002|Overall Study|Did not start treatment|0|||
150211101|NCT04827732|541909226|FG003|Overall Study|Did not start treatment|1|||
150211102|NCT01690624|541909227|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
150211103|NCT01690624|541909228|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
150211104|NCT01690624|541909229|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
150211105|NCT01690624|541909230|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
150211106|NCT01690624|541909227|FG000|Overall Study|Adverse event (other than DLT)|3|||
150211107|NCT01690624|541909228|FG001|Overall Study|Adverse event (other than DLT)|1|||
150211108|NCT01690624|541909229|FG002|Overall Study|Adverse event (other than DLT)|1|||
150211109|NCT01690624|541909230|FG003|Overall Study|Adverse event (other than DLT)|1|||
150211110|NCT01690624|541909227|FG000|Overall Study|Withdrawal by Subject|0|||
150211111|NCT01690624|541909228|FG001|Overall Study|Withdrawal by Subject|0|||
150211112|NCT01690624|541909229|FG002|Overall Study|Withdrawal by Subject|1|||
150211113|NCT01690624|541909230|FG003|Overall Study|Withdrawal by Subject|0|||
150211114|NCT01690624|541909227|FG000|Overall Study|Sponsor is ending trial|0|||
150211115|NCT01690624|541909228|FG001|Overall Study|Sponsor is ending trial|0|||
150211116|NCT01690624|541909229|FG002|Overall Study|Sponsor is ending trial|0|||
150211117|NCT01690624|541909230|FG003|Overall Study|Sponsor is ending trial|1|||
150211118|NCT01690624|541909227|FG000|Overall Study|Physician Decision|0|||
150211119|NCT01690624|541909228|FG001|Overall Study|Physician Decision|0|||
150211120|NCT01690624|541909229|FG002|Overall Study|Physician Decision|0|||
150211121|NCT01690624|541909230|FG003|Overall Study|Physician Decision|1|||
150211122|NCT01690624|541909227|FG000|Overall Study|Withdrawal by Subject|0|||
150211123|NCT01690624|541909228|FG001|Overall Study|Withdrawal by Subject|1|||
150211124|NCT01690624|541909229|FG002|Overall Study|Withdrawal by Subject|0|||
150211125|NCT01690624|541909230|FG003|Overall Study|Withdrawal by Subject|0|||
150211126|NCT01690624|541909227|FG000|Overall Study|Lack of Efficacy|1|||
150211127|NCT01690624|541909228|FG001|Overall Study|Lack of Efficacy|1|||
150211128|NCT01690624|541909229|FG002|Overall Study|Lack of Efficacy|3|||
150211129|NCT01690624|541909230|FG003|Overall Study|Lack of Efficacy|0|||
150211130|NCT02434328|541909235|FG000|Overall Study|Adverse Event|9|||
150211131|NCT02434328|541909236|FG001|Overall Study|Adverse Event|4|||
150211132|NCT02434328|541909235|FG000|Overall Study|Lack of Efficacy|0|||
150211133|NCT02434328|541909236|FG001|Overall Study|Lack of Efficacy|2|||
150211134|NCT02434328|541909235|FG000|Overall Study|Physician Decision|0|||
150211135|NCT02434328|541909236|FG001|Overall Study|Physician Decision|1|||
150211136|NCT02434328|541909235|FG000|Overall Study|Withdrawal by Subject|12|||
150211137|NCT02434328|541909236|FG001|Overall Study|Withdrawal by Subject|21|||
150211138|NCT02434328|541909235|FG000|Overall Study|Death|4|||
150211139|NCT02434328|541909236|FG001|Overall Study|Death|7|||
150211140|NCT02434328|541909235|FG000|Overall Study|Lost to Follow-up|1|||
150211141|NCT02434328|541909236|FG001|Overall Study|Lost to Follow-up|6|||
150211142|NCT02434328|541909235|FG000|Overall Study|Other|4|||
150211143|NCT02434328|541909236|FG001|Overall Study|Other|1|||
150211144|NCT00491894|541909237|FG000|Overall Study|Adverse Event|14|||
150211145|NCT00491894|541909237|FG000|Overall Study|Withdrawal by Subject|5|||
150211146|NCT00491894|541909237|FG000|Overall Study|Death|3|||
150211147|NCT00491894|541909237|FG000|Overall Study|Lost to Follow-up|3|||
150211148|NCT00491894|541909237|FG000|Overall Study|Lack of Efficacy|2|||
150211149|NCT00491894|541909237|FG000|Overall Study|Other-Failed to meet any criteria|2|||
150211150|NCT00491894|541909237|FG000|Overall Study|Physician Decision|2|||
150211151|NCT00491894|541909237|FG000|Overall Study|Protocol Violation|2|||
150211152|NCT00491894|541909237|FG000|Overall Study|Other-Intake of prohibited medication|1|||
150211153|NCT01563185|541909238|FG000|Overall Study|Withdrawal by Subject|1|||
150211154|NCT01563185|541909238|FG000|Overall Study|Non-Compliance with study drug|1|||
150211155|NCT01278030|541910656|FG000|Overall Study|Withdrawal by Subject|8|||
150211156|NCT01278030|541910657|FG001|Overall Study|Withdrawal by Subject|4|||
150211157|NCT00458783|541910659|FG000|Overall Study|Protocol Violation|1228|||
150211158|NCT00458783|541910660|FG001|Overall Study|Protocol Violation|1220|||
150211159|NCT01737398|541910661|FG000|Overall Study|Adverse event or SAE|16|||
150211160|NCT01737398|541910662|FG001|Overall Study|Adverse event or SAE|1|||
150211161|NCT01737398|541910661|FG000|Overall Study|Stopping rule met|2|||
150211162|NCT01737398|541910662|FG001|Overall Study|Stopping rule met|1|||
150211163|NCT01737398|541910661|FG000|Overall Study|Voluntary withdrawal|2|||
150211164|NCT01737398|541910662|FG001|Overall Study|Voluntary withdrawal|3|||
150211165|NCT01737398|541910661|FG000|Overall Study|Ineligibility|1|||
150211166|NCT01737398|541910662|FG001|Overall Study|Ineligibility|0|||
150211167|NCT01737398|541910661|FG000|Overall Study|Liver transplant|1|||
150211168|NCT01737398|541910662|FG001|Overall Study|Liver transplant|0|||
150211169|NCT01737398|541910661|FG000|Overall Study|Disease progression|2|||
150211170|NCT01737398|541910662|FG001|Overall Study|Disease progression|3|||
150211171|NCT01737398|541910661|FG000|Overall Study|Sponsor's decision|2|||
150211172|NCT01737398|541910662|FG001|Overall Study|Sponsor's decision|0|||
150211173|NCT00089609|541910664|FG000|Overall Study|Withdrawal by Subject|3|||
150211174|NCT00089609|541910665|FG001|Overall Study|Withdrawal by Subject|1|||
150211175|NCT05815342|541910667|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
150211176|NCT05815342|541910667|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
150211177|NCT05815342|541910667|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
150211178|NCT05815342|541910667|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
150211179|NCT05815342|541910667|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
150211180|NCT03116464|541910668|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
150211181|NCT00747006|541910669|FG000|Overall Study|Adverse Event|1|||
150211182|NCT00747006|541910670|FG001|Overall Study|Adverse Event|0|||
150211183|NCT00747006|541910671|FG002|Overall Study|Adverse Event|0|||
150211184|NCT00747006|541910669|FG000|Overall Study|Lost to Follow-up|0|||
150211185|NCT00747006|541910670|FG001|Overall Study|Lost to Follow-up|1|||
150211186|NCT00747006|541910671|FG002|Overall Study|Lost to Follow-up|0|||
150211187|NCT00747006|541910669|FG000|Overall Study|Physician Decision|2|||
150211188|NCT00747006|541910670|FG001|Overall Study|Physician Decision|0|||
150211189|NCT00747006|541910671|FG002|Overall Study|Physician Decision|1|||
150211190|NCT00357994|541910672|FG000|Overall Study|Adverse Event|1|||
150211191|NCT00357994|541910673|FG001|Overall Study|Adverse Event|2|||
150211192|NCT00357994|541910672|FG000|Overall Study|Lack of Efficacy|0|||
150211193|NCT00357994|541910673|FG001|Overall Study|Lack of Efficacy|1|||
150211194|NCT00357994|541910672|FG000|Overall Study|Protocol Violation|1|||
150211195|NCT00357994|541910673|FG001|Overall Study|Protocol Violation|0|||
150211196|NCT00345046|541910676|FG000|Overall Study|Protocol Violation|1|||
150211197|NCT00345046|541910677|FG001|Overall Study|Protocol Violation|1|||
150211198|NCT00345046|541910678|FG002|Overall Study|Protocol Violation|2|||
150211199|NCT03689946|541910681|FG000|Overall Study|Withdrawal by Subject|3|||
150211200|NCT03689946|541910681|FG000|Overall Study|Lost to Follow-up|3|||
150211201|NCT03689946|541910681|FG000|Overall Study|Data corruption|2|||
150211202|NCT01555138|541910682|FG000|Overall Study|Death|0|||
150211203|NCT01555138|541910683|FG001|Overall Study|Death|1|||
150211204|NCT01555138|541910682|FG000|Overall Study|Lost to Follow-up|1|||
150211205|NCT01555138|541910683|FG001|Overall Study|Lost to Follow-up|0|||
150211206|NCT01555138|541910682|FG000|Overall Study|Abnormal Lab reults|1|||
150211207|NCT01555138|541910683|FG001|Overall Study|Abnormal Lab reults|3|||
150211208|NCT01555138|541910682|FG000|Overall Study|Lack of Efficacy|2|||
150211209|NCT01555138|541910683|FG001|Overall Study|Lack of Efficacy|2|||
150211210|NCT01555138|541910682|FG000|Overall Study|Protocol Violation|5|||
150211211|NCT01555138|541910683|FG001|Overall Study|Protocol Violation|3|||
150211212|NCT01555138|541910682|FG000|Overall Study|Administrative problems|8|||
150211213|NCT01555138|541910683|FG001|Overall Study|Administrative problems|0|||
150211214|NCT01555138|541910682|FG000|Overall Study|Withdrawal by Subject|16|||
150211215|NCT01555138|541910683|FG001|Overall Study|Withdrawal by Subject|15|||
150211216|NCT01555138|541910682|FG000|Overall Study|Adverse Event|14|||
150211217|NCT01555138|541910683|FG001|Overall Study|Adverse Event|14|||
150211218|NCT03220724|541910684|FG000|Overall Study|Lost to Follow-up|2|||
150211219|NCT03220724|541910685|FG001|Overall Study|Lost to Follow-up|2|||
150211220|NCT03220724|541910686|FG002|Overall Study|Lost to Follow-up|0|||
150211221|NCT03220724|541910687|FG003|Overall Study|Lost to Follow-up|3|||
150211222|NCT03220724|541910688|FG004|Overall Study|Lost to Follow-up|1|||
150211223|NCT03220724|541910689|FG005|Overall Study|Lost to Follow-up|0|||
150211224|NCT03220724|541910690|FG006|Overall Study|Lost to Follow-up|2|||
150211225|NCT03220724|541910691|FG007|Overall Study|Lost to Follow-up|1|||
150211226|NCT03220724|541910692|FG008|Overall Study|Lost to Follow-up|0|||
150211227|NCT03220724|541910684|FG000|Overall Study|Withdrawal by Subject|1|||
150211228|NCT03220724|541910685|FG001|Overall Study|Withdrawal by Subject|0|||
150211229|NCT03220724|541910686|FG002|Overall Study|Withdrawal by Subject|1|||
150211230|NCT03220724|541910687|FG003|Overall Study|Withdrawal by Subject|0|||
150211231|NCT03220724|541910688|FG004|Overall Study|Withdrawal by Subject|0|||
150211232|NCT03220724|541910689|FG005|Overall Study|Withdrawal by Subject|0|||
150211233|NCT03220724|541910690|FG006|Overall Study|Withdrawal by Subject|0|||
150211234|NCT03220724|541910691|FG007|Overall Study|Withdrawal by Subject|0|||
150211235|NCT03220724|541910692|FG008|Overall Study|Withdrawal by Subject|0|||
150211236|NCT00599196|541910695|FG000|Overall Study|Lack of Efficacy|22|||
150211237|NCT00599196|541910695|FG000|Overall Study|Adverse Event|93|||
150211238|NCT00599196|541910695|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
150211239|NCT00599196|541910695|FG000|Overall Study|Subject withdrew consent|43|||
150211240|NCT00599196|541910695|FG000|Overall Study|Study ended per sponsor|197|||
150211241|NCT00599196|541910695|FG000|Overall Study|Lost to Follow-up|17|||
150211242|NCT00599196|541910695|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
150211243|NCT00599196|541910695|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
150211244|NCT00599196|541910695|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
150211245|NCT00599196|541910695|FG000|Overall Study|Other: Pt Moved To Australia|1|||
150211246|NCT00599196|541910695|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
150211247|NCT00599196|541910695|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
150211248|NCT03345979|541910700|FG000|Overall Study|Withdrawal by Subject|20|||
150211249|NCT03345979|541910701|FG001|Overall Study|Withdrawal by Subject|31|||
150211250|NCT03345979|541910700|FG000|Overall Study|Adverse Event|10|||
150211251|NCT03345979|541910701|FG001|Overall Study|Adverse Event|11|||
150211252|NCT03345979|541910700|FG000|Overall Study|Lost to Follow-up|8|||
150211253|NCT03345979|541910701|FG001|Overall Study|Lost to Follow-up|9|||
150211254|NCT03345979|541910700|FG000|Overall Study|Lack of Efficacy|4|||
150211255|NCT03345979|541910701|FG001|Overall Study|Lack of Efficacy|2|||
150211256|NCT03345979|541910700|FG000|Overall Study|Protocol Violation|1|||
150211257|NCT03345979|541910701|FG001|Overall Study|Protocol Violation|3|||
150211258|NCT03345979|541910700|FG000|Overall Study|Physician Decision|0|||
150211259|NCT03345979|541910701|FG001|Overall Study|Physician Decision|2|||
150211260|NCT00620854|541910702|FG000|Washout 1|Withdrawal by Subject|0|||
150211261|NCT00620854|541910703|FG001|Washout 1|Withdrawal by Subject|0|||
150211262|NCT00620854|541910704|FG002|Washout 1|Withdrawal by Subject|1|||
150211263|NCT00620854|541910705|FG003|Washout 1|Withdrawal by Subject|1|||
150211264|NCT00620854|541910706|FG004|Washout 1|Withdrawal by Subject|0|||
150211265|NCT00620854|541910707|FG005|Washout 1|Withdrawal by Subject|0|||
150211266|NCT00734578|541910710|FG000|Overall Study|Adverse Event|4|||
150211267|NCT00734578|541910711|FG001|Overall Study|Adverse Event|6|||
150211268|NCT00734578|541910712|FG002|Overall Study|Adverse Event|1|||
150211269|NCT00734578|541910710|FG000|Overall Study|Protocol Violation|8|||
150211270|NCT00734578|541910711|FG001|Overall Study|Protocol Violation|6|||
150211271|NCT00734578|541910712|FG002|Overall Study|Protocol Violation|3|||
150211272|NCT00734578|541910710|FG000|Overall Study|Withdrawal by Subject|7|||
150211273|NCT00734578|541910711|FG001|Overall Study|Withdrawal by Subject|8|||
150211274|NCT00734578|541910712|FG002|Overall Study|Withdrawal by Subject|11|||
150211275|NCT00734578|541910710|FG000|Overall Study|Lost to Follow-up|9|||
150211276|NCT00734578|541910711|FG001|Overall Study|Lost to Follow-up|3|||
150211277|NCT00734578|541910712|FG002|Overall Study|Lost to Follow-up|5|||
150211278|NCT00734578|541910710|FG000|Overall Study|Lack of Efficacy|3|||
150211279|NCT00734578|541910711|FG001|Overall Study|Lack of Efficacy|2|||
150211280|NCT00734578|541910712|FG002|Overall Study|Lack of Efficacy|5|||
150211281|NCT00734578|541910710|FG000|Overall Study|Randomized in error|1|||
150211282|NCT00734578|541910711|FG001|Overall Study|Randomized in error|0|||
150211283|NCT00734578|541910712|FG002|Overall Study|Randomized in error|0|||
150211284|NCT00734578|541910710|FG000|Overall Study|Exclusion criteria|1|||
150211285|NCT00734578|541910711|FG001|Overall Study|Exclusion criteria|0|||
150211286|NCT00734578|541910712|FG002|Overall Study|Exclusion criteria|0|||
150211287|NCT00999596|541910713|FG000|Overall Study|Statistical population not required|101|||
150211288|NCT02095145|541910714|FG000|Overall Study|Withdrawal by Subject|1|||
150211289|NCT02095145|541910715|FG001|Overall Study|Withdrawal by Subject|0|||
150211290|NCT02085941|541910716|FG000|Overall Study|Lack of Efficacy|1|||
150211291|NCT02085941|541910717|FG001|Overall Study|Lack of Efficacy|0|||
150211292|NCT02085941|541910716|FG000|Overall Study|Death|6|||
150211293|NCT02085941|541910717|FG001|Overall Study|Death|1|||
150211294|NCT02085941|541910716|FG000|Overall Study|Lost to Follow-up|1|||
150211295|NCT02085941|541910717|FG001|Overall Study|Lost to Follow-up|0|||
150211296|NCT02085941|541910716|FG000|Overall Study|Physician Decision|0|||
150211297|NCT02085941|541910717|FG001|Overall Study|Physician Decision|2|||
150211298|NCT01170208|541910723|FG000|Overall Study|Withdrawal by Subject|5|||
150211299|NCT01170208|541910724|FG001|Overall Study|Withdrawal by Subject|0|||
150211300|NCT01170208|541910725|FG002|Overall Study|Withdrawal by Subject|1|||
150211301|NCT01170208|541910723|FG000|Overall Study|Protocol Violation|1|||
150211302|NCT01170208|541910724|FG001|Overall Study|Protocol Violation|0|||
150211303|NCT01170208|541910725|FG002|Overall Study|Protocol Violation|1|||
150211304|NCT03335488|541910728|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
150211305|NCT03335488|541910729|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
150211306|NCT03335488|541910728|FG000|Safety Extension Period|Adverse Event|1|||
150211307|NCT03335488|541910729|FG001|Safety Extension Period|Adverse Event|0|||
150211308|NCT03335488|541910728|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
150211309|NCT03335488|541910729|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
150211310|NCT00641537|541910733|FG000|96-week Period|Adverse Event|0|||
150211311|NCT00641537|541910734|FG001|96-week Period|Adverse Event|1|||
150211312|NCT00641537|541910735|FG002|96-week Period|Adverse Event|3|||
150211313|NCT00641537|541910736|FG003|96-week Period|Adverse Event|0|||
150211314|NCT00641537|541910737|FG004|96-week Period|Adverse Event|2|||
150211315|NCT00641537|541910738|FG005|96-week Period|Adverse Event|0|||
150211316|NCT00641537|541910739|FG006|96-week Period|Adverse Event|0|||
150211317|NCT00641537|541910740|FG007|96-week Period|Adverse Event|0|||
150211318|NCT00641537|541910733|FG000|96-week Period|Lost to Follow-up|3|||
150211319|NCT00641537|541910734|FG001|96-week Period|Lost to Follow-up|1|||
150211320|NCT00641537|541910735|FG002|96-week Period|Lost to Follow-up|2|||
150211321|NCT00641537|541910736|FG003|96-week Period|Lost to Follow-up|2|||
150211322|NCT00641537|541910737|FG004|96-week Period|Lost to Follow-up|4|||
150211323|NCT00641537|541910738|FG005|96-week Period|Lost to Follow-up|0|||
150211324|NCT00641537|541910739|FG006|96-week Period|Lost to Follow-up|1|||
150211325|NCT00641537|541910740|FG007|96-week Period|Lost to Follow-up|0|||
150211326|NCT00641537|541910733|FG000|96-week Period|Protocol Violation|0|||
150211327|NCT00641537|541910734|FG001|96-week Period|Protocol Violation|1|||
150211328|NCT00641537|541910735|FG002|96-week Period|Protocol Violation|0|||
150211329|NCT00641537|541910736|FG003|96-week Period|Protocol Violation|1|||
150211330|NCT00641537|541910737|FG004|96-week Period|Protocol Violation|0|||
150211331|NCT00641537|541910738|FG005|96-week Period|Protocol Violation|1|||
150211332|NCT00641537|541910739|FG006|96-week Period|Protocol Violation|0|||
150211333|NCT00641537|541910740|FG007|96-week Period|Protocol Violation|0|||
150211334|NCT00641537|541910733|FG000|96-week Period|Death|2|||
150211335|NCT00641537|541910734|FG001|96-week Period|Death|0|||
150211336|NCT00641537|541910735|FG002|96-week Period|Death|1|||
150211337|NCT00641537|541910736|FG003|96-week Period|Death|0|||
150211338|NCT00641537|541910737|FG004|96-week Period|Death|0|||
150211339|NCT00641537|541910738|FG005|96-week Period|Death|0|||
150211340|NCT00641537|541910739|FG006|96-week Period|Death|0|||
150211341|NCT00641537|541910740|FG007|96-week Period|Death|0|||
150211342|NCT00641537|541910733|FG000|96-week Period|Other|4|||
150211343|NCT00641537|541910734|FG001|96-week Period|Other|7|||
150211344|NCT00641537|541910735|FG002|96-week Period|Other|14|||
150211345|NCT00641537|541910736|FG003|96-week Period|Other|9|||
150211346|NCT00641537|541910737|FG004|96-week Period|Other|11|||
150211347|NCT00641537|541910738|FG005|96-week Period|Other|6|||
150211348|NCT00641537|541910739|FG006|96-week Period|Other|4|||
150211349|NCT00641537|541910740|FG007|96-week Period|Other|6|||
150211350|NCT00641537|541910733|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
150211351|NCT00641537|541910734|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
150211352|NCT00641537|541910735|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
150211353|NCT00641537|541910736|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
150211354|NCT00641537|541910737|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
150211355|NCT00641537|541910738|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
150211356|NCT00641537|541910739|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
150211357|NCT00641537|541910740|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
150211358|NCT00641537|541910733|FG000|24-Week Supplemental Follow-up Period|Other|0|||
150211359|NCT00641537|541910734|FG001|24-Week Supplemental Follow-up Period|Other|2|||
150211360|NCT00641537|541910735|FG002|24-Week Supplemental Follow-up Period|Other|2|||
150211361|NCT00641537|541910736|FG003|24-Week Supplemental Follow-up Period|Other|1|||
150211362|NCT00641537|541910737|FG004|24-Week Supplemental Follow-up Period|Other|3|||
150211363|NCT00641537|541910738|FG005|24-Week Supplemental Follow-up Period|Other|0|||
150211364|NCT00641537|541910739|FG006|24-Week Supplemental Follow-up Period|Other|1|||
150211365|NCT00641537|541910740|FG007|24-Week Supplemental Follow-up Period|Other|1|||
150211366|NCT02743819|541910742|FG000|Overall Study|Lack of Efficacy|5|||
150211367|NCT02743819|541910742|FG000|Overall Study|Death|2|||
150211368|NCT02743819|541910742|FG000|Overall Study|Adverse Event|1|||
150211369|NCT03389802|541910743|FG000|Overall Study|Lack of Efficacy|3|||
150211370|NCT03389802|541910744|FG001|Overall Study|Lack of Efficacy|3|||
150211371|NCT03389802|541910745|FG002|Overall Study|Lack of Efficacy|13|||
150211372|NCT03389802|541910746|FG003|Overall Study|Lack of Efficacy|6|||
150211373|NCT03389802|541910747|FG004|Overall Study|Lack of Efficacy|1|||
150211374|NCT03389802|541910743|FG000|Overall Study|Adverse Event|0|||
150211375|NCT03389802|541910744|FG001|Overall Study|Adverse Event|0|||
150211376|NCT03389802|541910745|FG002|Overall Study|Adverse Event|1|||
150211377|NCT03389802|541910746|FG003|Overall Study|Adverse Event|0|||
150211378|NCT03389802|541910747|FG004|Overall Study|Adverse Event|4|||
150211379|NCT03389802|541910743|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
150211380|NCT03389802|541910744|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
150211381|NCT03389802|541910745|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
150211382|NCT03389802|541910746|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
150211383|NCT03389802|541910747|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
150211384|NCT02426138|541910748|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
150211385|NCT02426138|541910749|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
150211386|NCT04677738|541910754|FG000|Overall Study|Withdrawal by Subject|4|||
150211387|NCT04677738|541910755|FG001|Overall Study|Withdrawal by Subject|2|||
150211388|NCT03697603|541910758|FG000|Overall Study|Adverse Event|3|||
150211389|NCT03697603|541910759|FG001|Overall Study|Adverse Event|18|||
150211390|NCT03697603|541910760|FG002|Overall Study|Adverse Event|3|||
150211391|NCT03697603|541910758|FG000|Overall Study|Physician Decision|1|||
150211392|NCT03697603|541910759|FG001|Overall Study|Physician Decision|0|||
150211393|NCT03697603|541910760|FG002|Overall Study|Physician Decision|2|||
150211394|NCT03697603|541910758|FG000|Overall Study|Protocol Violation|3|||
150211395|NCT03697603|541910759|FG001|Overall Study|Protocol Violation|8|||
150211396|NCT03697603|541910760|FG002|Overall Study|Protocol Violation|5|||
150211397|NCT03697603|541910758|FG000|Overall Study|Withdrawal by Subject|5|||
150211398|NCT03697603|541910759|FG001|Overall Study|Withdrawal by Subject|1|||
150211399|NCT03697603|541910760|FG002|Overall Study|Withdrawal by Subject|1|||
150211400|NCT03697603|541910758|FG000|Overall Study|Protocol Violation|0|||
150211401|NCT03697603|541910759|FG001|Overall Study|Protocol Violation|0|||
150211402|NCT03697603|541910760|FG002|Overall Study|Protocol Violation|1|||
150211403|NCT00553332|541910761|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
150211404|NCT03520036|541910763|FG000|Overall Study|Adverse Event|1|||
150211405|NCT03520036|541910764|FG001|Overall Study|Adverse Event|2|||
150211406|NCT03520036|541910765|FG002|Overall Study|Adverse Event|0|||
150211407|NCT03520036|541910763|FG000|Overall Study|Protocol Violation|1|||
150211408|NCT03520036|541910764|FG001|Overall Study|Protocol Violation|0|||
150211409|NCT03520036|541910765|FG002|Overall Study|Protocol Violation|0|||
150211410|NCT03520036|541910763|FG000|Overall Study|Withdrawal by Subject|0|||
150211411|NCT03520036|541910764|FG001|Overall Study|Withdrawal by Subject|1|||
150211412|NCT03520036|541910765|FG002|Overall Study|Withdrawal by Subject|4|||
150211413|NCT03520036|541910763|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
150211414|NCT03520036|541910764|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
150211415|NCT03520036|541910765|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
150211416|NCT00467272|541910768|FG000|Overall Study|Pneumonia|2|||
150211417|NCT00467272|541910768|FG000|Overall Study|Thrombophlebitis|1|||
150211418|NCT00145470|541910769|FG000|Overall Study|Adverse Event|19|||
150211419|NCT00145470|541910770|FG001|Overall Study|Adverse Event|25|||
150211420|NCT00145470|541910769|FG000|Overall Study|Lack of Efficacy|27|||
150211421|NCT00145470|541910770|FG001|Overall Study|Lack of Efficacy|13|||
150211422|NCT00145470|541910769|FG000|Overall Study|Withdrawal by Subject|36|||
150211423|NCT00145470|541910770|FG001|Overall Study|Withdrawal by Subject|34|||
150211424|NCT00145470|541910769|FG000|Overall Study|Lost to Follow-up|21|||
150211425|NCT00145470|541910770|FG001|Overall Study|Lost to Follow-up|17|||
150211426|NCT00145470|541910769|FG000|Overall Study|Reason Not Reported|9|||
150211427|NCT00145470|541910770|FG001|Overall Study|Reason Not Reported|9|||
150211428|NCT04762277|541910771|FG000|Overall Study|Withdrawal by Subject|0|||
150211429|NCT04762277|541910772|FG001|Overall Study|Withdrawal by Subject|2|||
150211430|NCT04762277|541910771|FG000|Overall Study|Protocol Violation|0|||
150211431|NCT04762277|541910772|FG001|Overall Study|Protocol Violation|1|||
150211432|NCT04762277|541910771|FG000|Overall Study|Adverse Event|1|||
150211433|NCT04762277|541910772|FG001|Overall Study|Adverse Event|0|||
150211434|NCT05824559|541910773|FG000|Overall Study|Adverse Event|2|||
150211435|NCT05824559|541910773|FG000|Overall Study|Physician Decision|2|||
150211436|NCT05824559|541910773|FG000|Overall Study|Progressive Disease|16|||
150211437|NCT05824559|541910773|FG000|Overall Study|Study Terminated by Sponsor|1|||
150211438|NCT05824559|541910773|FG000|Overall Study|Withdrawal by Subject|2|||
150211439|NCT04912856|541910777|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
150211440|NCT04912856|541910778|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
150211441|NCT04912856|541910777|FG000|Overall Study|Not reported in synoptic CSR.|0|||
150211442|NCT04912856|541910778|FG001|Overall Study|Not reported in synoptic CSR.|1|||
150211443|NCT00647387|541910779|FG000|Overall Study|Lost to Follow-up|6|||
150211444|NCT00647387|541910779|FG000|Overall Study|Unsuccessful implant|5|||
150211445|NCT00647387|541910779|FG000|Overall Study|Device explanted|3|||
150211446|NCT00647387|541910779|FG000|Overall Study|Other Reason|3|||
150211447|NCT00647387|541910779|FG000|Overall Study|Death|2|||
150211448|NCT03147287|541910780|FG000|Overall Study|Randomized Not Treated|2|||
150211449|NCT03147287|541910781|FG001|Overall Study|Randomized Not Treated|1|||
150211450|NCT03147287|541910782|FG002|Overall Study|Randomized Not Treated|1|||
150211451|NCT03147287|541910780|FG000|Overall Study|Progressive Disease RECIST|31|||
150211452|NCT03147287|541910781|FG001|Overall Study|Progressive Disease RECIST|72|||
150211453|NCT03147287|541910782|FG002|Overall Study|Progressive Disease RECIST|32|||
150211454|NCT03147287|541910780|FG000|Overall Study|Progressive Disease not RECIST|13|||
150211455|NCT03147287|541910781|FG001|Overall Study|Progressive Disease not RECIST|21|||
150211456|NCT03147287|541910782|FG002|Overall Study|Progressive Disease not RECIST|13|||
150211457|NCT03147287|541910780|FG000|Overall Study|Physician Decision|1|||
150211458|NCT03147287|541910781|FG001|Overall Study|Physician Decision|2|||
150211459|NCT03147287|541910782|FG002|Overall Study|Physician Decision|1|||
150211460|NCT03147287|541910780|FG000|Overall Study|Intercurrent illness|0|||
150211461|NCT03147287|541910781|FG001|Overall Study|Intercurrent illness|1|||
150211462|NCT03147287|541910782|FG002|Overall Study|Intercurrent illness|0|||
150211463|NCT03147287|541910780|FG000|Overall Study|Withdrawal by Subject|2|||
150211464|NCT03147287|541910781|FG001|Overall Study|Withdrawal by Subject|3|||
150211465|NCT03147287|541910782|FG002|Overall Study|Withdrawal by Subject|2|||
150211466|NCT03147287|541910780|FG000|Overall Study|Patient Non-Compliance|0|||
150211467|NCT03147287|541910781|FG001|Overall Study|Patient Non-Compliance|2|||
150211468|NCT03147287|541910782|FG002|Overall Study|Patient Non-Compliance|0|||
150211469|NCT03147287|541910780|FG000|Overall Study|Patient moved|0|||
150211470|NCT03147287|541910781|FG001|Overall Study|Patient moved|1|||
150211471|NCT03147287|541910782|FG002|Overall Study|Patient moved|0|||
150211472|NCT03147287|541910780|FG000|Overall Study|Arm A crossover without PD|1|||
150211473|NCT03147287|541910781|FG001|Overall Study|Arm A crossover without PD|0|||
150211474|NCT03147287|541910782|FG002|Overall Study|Arm A crossover without PD|0|||
150211475|NCT03147287|541910780|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
150211476|NCT03147287|541910781|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
150211477|NCT03147287|541910782|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
150211478|NCT02534233|541912117|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
150211479|NCT00925548|541912118|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
150211480|NCT00925548|541912119|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
150211481|NCT01372085|541912122|FG000|Washout Period 2|Physician Decision|0|||
150211482|NCT01372085|541912123|FG001|Washout Period 2|Physician Decision|0|||
150211483|NCT01372085|541912124|FG002|Washout Period 2|Physician Decision|0|||
150211484|NCT01372085|541912125|FG003|Washout Period 2|Physician Decision|0|||
150211485|NCT01372085|541912126|FG004|Washout Period 2|Physician Decision|1|||
150211486|NCT01372085|541912127|FG005|Washout Period 2|Physician Decision|0|||
150211487|NCT01372085|541912128|FG006|Washout Period 2|Physician Decision|0|||
150211488|NCT01372085|541912129|FG007|Washout Period 2|Physician Decision|0|||
150211489|NCT01372085|541912130|FG008|Washout Period 2|Physician Decision|0|||
150211490|NCT01372085|541912131|FG009|Washout Period 2|Physician Decision|0|||
150211491|NCT01372085|541912122|FG000|Washout Period 3|Withdrawal by Subject|0|||
150211492|NCT01372085|541912123|FG001|Washout Period 3|Withdrawal by Subject|0|||
150211493|NCT01372085|541912124|FG002|Washout Period 3|Withdrawal by Subject|0|||
150211494|NCT01372085|541912125|FG003|Washout Period 3|Withdrawal by Subject|0|||
150211495|NCT01372085|541912126|FG004|Washout Period 3|Withdrawal by Subject|0|||
150211496|NCT01372085|541912127|FG005|Washout Period 3|Withdrawal by Subject|2|||
150211497|NCT01372085|541912128|FG006|Washout Period 3|Withdrawal by Subject|0|||
150211498|NCT01372085|541912129|FG007|Washout Period 3|Withdrawal by Subject|0|||
150211499|NCT01372085|541912130|FG008|Washout Period 3|Withdrawal by Subject|0|||
150211500|NCT01372085|541912131|FG009|Washout Period 3|Withdrawal by Subject|0|||
150211501|NCT00047385|541912133|FG000|Overall Study|Death before any screening|2|||
150211502|NCT00047385|541912134|FG001|Overall Study|Death before any screening|5|||
150211503|NCT00047385|541912133|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
150211504|NCT00047385|541912134|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
150211505|NCT00047385|541912133|FG000|Overall Study|Eligible for screening but had no screen|260|||
150211506|NCT00047385|541912134|FG001|Overall Study|Eligible for screening but had no screen|492|||
150211507|NCT03865732|541912135|FG000|Overall Study|Adverse Event|0|||
150211508|NCT03865732|541912136|FG001|Overall Study|Adverse Event|1|||
150211509|NCT01009645|541912150|FG000|Overall Study|Lost to Follow-up|2|||
150211510|NCT01009645|541912151|FG001|Overall Study|Lost to Follow-up|8|||
150211511|NCT01009645|541912152|FG002|Overall Study|Lost to Follow-up|4|||
150211512|NCT01009645|541912153|FG003|Overall Study|Lost to Follow-up|5|||
150211513|NCT00795184|541912159|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
150211514|NCT00795184|541912160|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
150211515|NCT03781375|541912161|FG000|Double-blind Phase|Adverse Event|0|||
150211516|NCT03781375|541912162|FG001|Double-blind Phase|Adverse Event|1|||
150211517|NCT03781375|541912161|FG000|Double-blind Phase|Lack of Response|6|||
150211518|NCT03781375|541912162|FG001|Double-blind Phase|Lack of Response|2|||
150211519|NCT03781375|541912161|FG000|Double-blind Phase|Other|1|||
150211520|NCT03781375|541912162|FG001|Double-blind Phase|Other|3|||
150211521|NCT03781375|541912161|FG000|Open-label Phase|Protocol Issues|0|||
150211522|NCT03781375|541912162|FG001|Open-label Phase|Protocol Issues|1|||
150211523|NCT03781375|541912161|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
150211524|NCT03781375|541912162|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
150211525|NCT03781375|541912161|FG000|Open-label Phase|Other|2|||
150211526|NCT03781375|541912162|FG001|Open-label Phase|Other|2|||
150211527|NCT02079649|541912163|FG000|Overall Study|Lost to Follow-up|0|||
150211528|NCT02079649|541912164|FG001|Overall Study|Lost to Follow-up|0|||
150211529|NCT02079649|541912165|FG002|Overall Study|Lost to Follow-up|0|||
150211530|NCT02079649|541912166|FG003|Overall Study|Lost to Follow-up|1|||
150211531|NCT02079649|541912163|FG000|Overall Study|Withdrawal by Subject|0|||
150211532|NCT02079649|541912164|FG001|Overall Study|Withdrawal by Subject|0|||
150211533|NCT02079649|541912165|FG002|Overall Study|Withdrawal by Subject|0|||
150211534|NCT02079649|541912166|FG003|Overall Study|Withdrawal by Subject|1|||
150211535|NCT02079649|541912163|FG000|Overall Study|Randomization error (prior to treatment)|1|||
150211536|NCT02079649|541912164|FG001|Overall Study|Randomization error (prior to treatment)|0|||
150211537|NCT02079649|541912165|FG002|Overall Study|Randomization error (prior to treatment)|1|||
150211538|NCT02079649|541912166|FG003|Overall Study|Randomization error (prior to treatment)|0|||
150211539|NCT03739866|541912189|FG000|Overall Study|Lost to Follow-up|0|||
150211540|NCT03739866|541912190|FG001|Overall Study|Lost to Follow-up|0|||
150211541|NCT03739866|541912191|FG002|Overall Study|Lost to Follow-up|0|||
150211542|NCT03739866|541912192|FG003|Overall Study|Lost to Follow-up|1|||
150211543|NCT03739866|541912193|FG004|Overall Study|Lost to Follow-up|0|||
150211544|NCT03739866|541912194|FG005|Overall Study|Lost to Follow-up|0|||
150211545|NCT03739866|541912195|FG006|Overall Study|Lost to Follow-up|0|||
150211546|NCT03739866|541912196|FG007|Overall Study|Lost to Follow-up|0|||
150211547|NCT03739866|541912189|FG000|Overall Study|Enrolled but not treated|0|||
150211548|NCT03739866|541912190|FG001|Overall Study|Enrolled but not treated|0|||
150211549|NCT03739866|541912191|FG002|Overall Study|Enrolled but not treated|1|||
150211550|NCT03739866|541912192|FG003|Overall Study|Enrolled but not treated|0|||
150211551|NCT03739866|541912193|FG004|Overall Study|Enrolled but not treated|1|||
150211552|NCT03739866|541912194|FG005|Overall Study|Enrolled but not treated|0|||
150211553|NCT03739866|541912195|FG006|Overall Study|Enrolled but not treated|0|||
150211554|NCT03739866|541912196|FG007|Overall Study|Enrolled but not treated|0|||
150211555|NCT01968967|541912197|FG000|Treatment Period|Other|22|||
150211556|NCT01968967|541912198|FG001|Treatment Period|Other|22|||
150211557|NCT01968967|541912199|FG002|Treatment Period|Other|0|||
150211558|NCT01968967|541912200|FG003|Treatment Period|Other|0|||
150211559|NCT01968967|541912201|FG004|Treatment Period|Other|0|||
150211560|NCT01968967|541912197|FG000|Treatment Period|Withdrawal by Subject|71|||
150211561|NCT01968967|541912198|FG001|Treatment Period|Withdrawal by Subject|61|||
150211562|NCT01968967|541912199|FG002|Treatment Period|Withdrawal by Subject|0|||
150211563|NCT01968967|541912200|FG003|Treatment Period|Withdrawal by Subject|0|||
150211564|NCT01968967|541912201|FG004|Treatment Period|Withdrawal by Subject|0|||
150211565|NCT01968967|541912197|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
150211566|NCT01968967|541912198|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
150211567|NCT01968967|541912199|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
150211568|NCT01968967|541912200|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
150211569|NCT01968967|541912201|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
150211570|NCT01968967|541912197|FG000|Treatment Period|Lost to Follow-up|26|||
150211571|NCT01968967|541912198|FG001|Treatment Period|Lost to Follow-up|31|||
150211572|NCT01968967|541912199|FG002|Treatment Period|Lost to Follow-up|0|||
150211573|NCT01968967|541912200|FG003|Treatment Period|Lost to Follow-up|0|||
150211574|NCT01968967|541912201|FG004|Treatment Period|Lost to Follow-up|0|||
150211575|NCT01968967|541912197|FG000|Treatment Period|Protocol Violation|1|||
150211576|NCT01968967|541912198|FG001|Treatment Period|Protocol Violation|2|||
150211577|NCT01968967|541912199|FG002|Treatment Period|Protocol Violation|0|||
150211578|NCT01968967|541912200|FG003|Treatment Period|Protocol Violation|0|||
150211579|NCT01968967|541912201|FG004|Treatment Period|Protocol Violation|0|||
150211580|NCT01968967|541912197|FG000|Treatment Period|Adverse Event|9|||
150211581|NCT01968967|541912198|FG001|Treatment Period|Adverse Event|8|||
150211582|NCT01968967|541912199|FG002|Treatment Period|Adverse Event|0|||
150211583|NCT01968967|541912200|FG003|Treatment Period|Adverse Event|0|||
150211584|NCT01968967|541912201|FG004|Treatment Period|Adverse Event|0|||
150211585|NCT01968967|541912197|FG000|Treatment Period|Death|9|||
150211586|NCT01968967|541912198|FG001|Treatment Period|Death|2|||
150211587|NCT01968967|541912199|FG002|Treatment Period|Death|0|||
150211588|NCT01968967|541912200|FG003|Treatment Period|Death|0|||
150211589|NCT01968967|541912201|FG004|Treatment Period|Death|0|||
150211590|NCT01968967|541912197|FG000|Treatment Period|Randomized Not Treated|6|||
150211591|NCT01968967|541912198|FG001|Treatment Period|Randomized Not Treated|5|||
150211592|NCT01968967|541912199|FG002|Treatment Period|Randomized Not Treated|0|||
150211593|NCT01968967|541912200|FG003|Treatment Period|Randomized Not Treated|0|||
150211594|NCT01968967|541912201|FG004|Treatment Period|Randomized Not Treated|0|||
150211595|NCT01968967|541912197|FG000|Extension Period|Withdrew Consent|0|||
150211596|NCT01968967|541912198|FG001|Extension Period|Withdrew Consent|0|||
150211597|NCT01968967|541912199|FG002|Extension Period|Withdrew Consent|2|||
150211598|NCT01968967|541912200|FG003|Extension Period|Withdrew Consent|0|||
150211599|NCT01968967|541912201|FG004|Extension Period|Withdrew Consent|5|||
150211600|NCT03489369|541912202|FG000|Overall Study|Documented Progressive Disease|3|||
150211601|NCT03489369|541912203|FG001|Overall Study|Documented Progressive Disease|2|||
150211602|NCT03489369|541912204|FG002|Overall Study|Documented Progressive Disease|3|||
150211603|NCT03489369|541912205|FG003|Overall Study|Documented Progressive Disease|6|||
150211604|NCT03489369|541912202|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
150211605|NCT03489369|541912203|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
150211606|NCT03489369|541912204|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
150211607|NCT03489369|541912205|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
150211608|NCT02203799|541912210|FG000|Overall Study|Withdrawal by Subject|3|||
150211609|NCT01604824|541912213|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
150211610|NCT01604824|541912214|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
150211611|NCT01604824|541912215|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
150211612|NCT01604824|541912216|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
150211613|NCT01604824|541912217|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
150211614|NCT01604824|541912218|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
150211615|NCT01604824|541912213|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
150211616|NCT01604824|541912214|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
150211617|NCT01604824|541912215|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
150211618|NCT01604824|541912216|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
150211619|NCT01604824|541912217|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
150211620|NCT01604824|541912218|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
150211621|NCT02630966|541912219|FG000|Overall Study|Adverse Event|1|||
150211622|NCT02630966|541912220|FG001|Overall Study|Adverse Event|3|||
150211623|NCT02630966|541912219|FG000|Overall Study|Significant Protocol Deviation|0|||
150211624|NCT02630966|541912220|FG001|Overall Study|Significant Protocol Deviation|2|||
150211625|NCT02630966|541912219|FG000|Overall Study|Voluntary Withdrawal|1|||
150211626|NCT02630966|541912220|FG001|Overall Study|Voluntary Withdrawal|1|||
150211627|NCT02630966|541912219|FG000|Overall Study|Lack of Efficacy|0|||
150211628|NCT02630966|541912220|FG001|Overall Study|Lack of Efficacy|2|||
150211629|NCT01801007|541912221|FG000|Overall Study|Adverse Event|2|||
150211630|NCT01801007|541912221|FG000|Overall Study|Lost to Follow-up|4|||
150211631|NCT01801007|541912221|FG000|Overall Study|Withdrawal by Subject|5|||
150211632|NCT00665392|541912222|FG000|Overall Study|not treated|1|||
150211633|NCT01683409|541912227|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
150211634|NCT01683409|541912228|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
150211635|NCT01683409|541912229|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
150211636|NCT01683409|541912230|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
150211637|NCT01683409|541912231|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
150211638|NCT01683409|541912227|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
150211639|NCT01683409|541912228|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
150211640|NCT01683409|541912229|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
150211641|NCT01683409|541912230|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
150211642|NCT01683409|541912231|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
150211643|NCT01683409|541912227|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
150211644|NCT01683409|541912228|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
150211645|NCT01683409|541912229|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
150211646|NCT01683409|541912230|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
150211647|NCT01683409|541912231|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
150211648|NCT01683409|541912227|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
150211649|NCT01683409|541912228|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
150211650|NCT01683409|541912229|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
150211651|NCT01683409|541912230|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
150211652|NCT01683409|541912231|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
150211653|NCT01683409|541912227|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
150211654|NCT01683409|541912228|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
150211655|NCT01683409|541912229|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
150211656|NCT01683409|541912230|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
150211657|NCT01683409|541912231|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
150211658|NCT01683409|541912227|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
150211659|NCT01683409|541912228|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
150211660|NCT01683409|541912229|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
150211661|NCT01683409|541912230|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
150211662|NCT01683409|541912231|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
150211663|NCT01683409|541912227|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
150211664|NCT01683409|541912228|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
150211665|NCT01683409|541912229|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
150211666|NCT01683409|541912230|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
150211667|NCT01683409|541912231|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
150211668|NCT01683409|541912227|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
150211669|NCT01683409|541912228|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
150211670|NCT01683409|541912229|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
150211671|NCT01683409|541912230|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
150211672|NCT01683409|541912231|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
150211673|NCT01683409|541912227|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
150211674|NCT01683409|541912228|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
150211675|NCT01683409|541912229|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
150211676|NCT01683409|541912230|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
150211677|NCT01683409|541912231|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
150211678|NCT01683409|541912227|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
150211679|NCT01683409|541912228|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
150211680|NCT01683409|541912229|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
150211681|NCT01683409|541912230|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
150211682|NCT01683409|541912231|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
150211683|NCT01683409|541912227|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
150211684|NCT01683409|541912228|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
150211685|NCT01683409|541912229|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
150211686|NCT01683409|541912230|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
150211687|NCT01683409|541912231|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
150211688|NCT04218864|541912233|FG000|Overall Study|Lost to Follow-up|8|||
150211689|NCT04218864|541912234|FG001|Overall Study|Lost to Follow-up|4|||
150211690|NCT04218864|541912233|FG000|Overall Study|Withdrawal by Subject|1|||
150211691|NCT04218864|541912234|FG001|Overall Study|Withdrawal by Subject|3|||
150211692|NCT04745676|541912240|FG000|Overall Study|Death|1|||
150211693|NCT04745676|541912241|FG001|Overall Study|Death|0|||
150139759|NCT03261271|541647203|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
150139760|NCT02696564|541647207|FG000|Overall Study|Death|1|||
150139761|NCT02696564|541647208|FG001|Overall Study|Death|2|||
150139762|NCT02696564|541647207|FG000|Overall Study|Withdrawal by Subject|3|||
150139763|NCT02696564|541647208|FG001|Overall Study|Withdrawal by Subject|2|||
150139764|NCT02696564|541647207|FG000|Overall Study|Lost to Follow-up|3|||
150139765|NCT02696564|541647208|FG001|Overall Study|Lost to Follow-up|3|||
150139766|NCT02696564|541647207|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
150139767|NCT02696564|541647208|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
150139768|NCT02696564|541647207|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
150139769|NCT02696564|541647208|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
150139770|NCT02696564|541647207|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
150139771|NCT02696564|541647208|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
150139772|NCT02696564|541647207|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
150139773|NCT02696564|541647208|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
150139774|NCT02696564|541647207|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
150139775|NCT02696564|541647208|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
150139776|NCT05267600|541647209|FG000|Overall Study|Adverse Event|1|||
150139777|NCT05267600|541647210|FG001|Overall Study|Adverse Event|4|||
150139778|NCT05267600|541647209|FG000|Overall Study|Death|1|||
150139779|NCT05267600|541647210|FG001|Overall Study|Death|2|||
150139780|NCT05267600|541647209|FG000|Overall Study|Lack of Efficacy|1|||
150139781|NCT05267600|541647210|FG001|Overall Study|Lack of Efficacy|2|||
150139782|NCT05267600|541647209|FG000|Overall Study|Lost to Follow-up|3|||
150139783|NCT05267600|541647210|FG001|Overall Study|Lost to Follow-up|0|||
150139784|NCT05267600|541647209|FG000|Overall Study|Physician Decision|4|||
150139785|NCT05267600|541647210|FG001|Overall Study|Physician Decision|0|||
150139786|NCT05267600|541647209|FG000|Overall Study|Treatment Unblinded|0|||
150139787|NCT05267600|541647210|FG001|Overall Study|Treatment Unblinded|1|||
150139788|NCT05267600|541647209|FG000|Overall Study|Withdrawal by Subject|5|||
150139789|NCT05267600|541647210|FG001|Overall Study|Withdrawal by Subject|4|||
150139790|NCT04067401|541647211|FG000|Overall Study|Withdrawal by Subject|7|||
150139791|NCT04067401|541647212|FG001|Overall Study|Withdrawal by Subject|0|||
150139792|NCT04067401|541647211|FG000|Overall Study|no data provided|1|||
150139793|NCT04067401|541647212|FG001|Overall Study|no data provided|0|||
150139794|NCT00106184|541647214|FG000|Overall Study|Withdrawal by Subject|3|||
150139795|NCT00106184|541647215|FG001|Overall Study|Withdrawal by Subject|2|||
150139796|NCT01722162|541647216|FG000|Overall Study|Withdrawal by Subject|1|||
150139797|NCT01722162|541647217|FG001|Overall Study|Withdrawal by Subject|1|||
150139798|NCT01722162|541647216|FG000|Overall Study|Found ineligible|1|||
150139799|NCT01722162|541647217|FG001|Overall Study|Found ineligible|0|||
150139800|NCT01722162|541647216|FG000|Overall Study|Unrelated to study adverse event|2|||
150139801|NCT01722162|541647217|FG001|Overall Study|Unrelated to study adverse event|2|||
150139802|NCT01722162|541647216|FG000|Overall Study|Adverse Event|1|||
150139803|NCT01722162|541647217|FG001|Overall Study|Adverse Event|1|||
150139804|NCT01722162|541647216|FG000|Overall Study|Insurance denial post enrollment|0|||
150139805|NCT01722162|541647217|FG001|Overall Study|Insurance denial post enrollment|1|||
150139806|NCT01722162|541647216|FG000|Overall Study|Noncompliance|0|||
150139807|NCT01722162|541647217|FG001|Overall Study|Noncompliance|1|||
150139808|NCT01889186|541647219|FG000|Overall Study|Adverse event- not related to progression|18|||
150139809|NCT01889186|541647220|FG001|Overall Study|Adverse event- not related to progression|5|||
150139810|NCT01889186|541647219|FG000|Overall Study|Adverse event- related to progression|7|||
150139811|NCT01889186|541647220|FG001|Overall Study|Adverse event- related to progression|2|||
150139812|NCT01889186|541647219|FG000|Overall Study|COVID-19 logistical restrictions|1|||
150211694|NCT04745676|541912242|FG002|Overall Study|Death|0|||
150211695|NCT00676091|541912246|FG000|Infant Series|Parent or legal guardian request|10|||
150211696|NCT00676091|541912247|FG001|Infant Series|Parent or legal guardian request|8|||
150211697|NCT00676091|541912246|FG000|Infant Series|Protocol Violation|6|||
150211698|NCT00676091|541912247|FG001|Infant Series|Protocol Violation|3|||
150211699|NCT00676091|541912246|FG000|Infant Series|Adverse Event|2|||
150211700|NCT00676091|541912247|FG001|Infant Series|Adverse Event|3|||
150211701|NCT00676091|541912246|FG000|Infant Series|Failed to return|1|||
150211702|NCT00676091|541912247|FG001|Infant Series|Failed to return|3|||
150211703|NCT00676091|541912246|FG000|Infant Series|Lost to Follow-up|1|||
150211704|NCT00676091|541912247|FG001|Infant Series|Lost to Follow-up|0|||
150211705|NCT00676091|541912246|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
150211706|NCT00676091|541912247|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
150211707|NCT00676091|541912246|FG000|After Infant Series|Adverse Event|0|||
150211708|NCT00676091|541912247|FG001|After Infant Series|Adverse Event|1|||
150211709|NCT00676091|541912246|FG000|After Infant Series|Protocol Violation|0|||
150211710|NCT00676091|541912247|FG001|After Infant Series|Protocol Violation|1|||
150211711|NCT00676091|541912246|FG000|After Infant Series|Failed to return|1|||
150211712|NCT00676091|541912247|FG001|After Infant Series|Failed to return|1|||
150211713|NCT00676091|541912246|FG000|Toddler Dose|Failed to return|2|||
150211714|NCT00676091|541912247|FG001|Toddler Dose|Failed to return|0|||
150211715|NCT00676091|541912246|FG000|Toddler Dose|Parent or legal guardian request|1|||
150211716|NCT00676091|541912247|FG001|Toddler Dose|Parent or legal guardian request|0|||
150211717|NCT00933270|541912253|FG000|Overall Study|Withdrawal by Subject|26|||
150211718|NCT00933270|541912253|FG000|Overall Study|Insufficient Follow-up|10|||
150211719|NCT00933270|541912253|FG000|Overall Study|Lost to Follow-up|14|||
150211720|NCT00933270|541912253|FG000|Overall Study|Adverse Event|1|||
150211721|NCT00933270|541912253|FG000|Overall Study|Missed Visit|2|||
150211722|NCT00933270|541912253|FG000|Overall Study|Death|24|||
150211723|NCT00933270|541912253|FG000|Overall Study|Moved or would not return|10|||
150211724|NCT00989196|541912254|FG000|Treatment Period|Lost to Follow-up|1|||
150211725|NCT00989196|541912255|FG001|Treatment Period|Lost to Follow-up|0|||
150211726|NCT02409680|541912261|FG000|Overall Study|Lost to Follow-up|15|||
150211727|NCT02409680|541912262|FG001|Overall Study|Lost to Follow-up|30|||
150211728|NCT05366751|541912263|FG000|Overall Study|Adverse Event|25|||
150211729|NCT05366751|541912263|FG000|Overall Study|Physician Decision|3|||
150211730|NCT05366751|541912263|FG000|Overall Study|Lost to Follow-up|2|||
150211731|NCT05366751|541912263|FG000|Overall Study|Withdrawal by Subject|14|||
150211732|NCT05366751|541912263|FG000|Overall Study|Study Terminated by Sponsor|50|||
150211733|NCT05366751|541912263|FG000|Overall Study|Site Terminated by Sponsor|3|||
150211734|NCT03678688|541913996|FG000|Overall Study|Reason not Specified|0|||
150211735|NCT03678688|541913997|FG001|Overall Study|Reason not Specified|0|||
150211736|NCT03678688|541913998|FG002|Overall Study|Reason not Specified|3|||
150211737|NCT03678688|541913999|FG003|Overall Study|Reason not Specified|0|||
150211738|NCT03678688|541914000|FG004|Overall Study|Reason not Specified|1|||
150211739|NCT03678688|541914001|FG005|Overall Study|Reason not Specified|0|||
150211740|NCT03678688|541914002|FG006|Overall Study|Reason not Specified|0|||
150211741|NCT03678688|541914003|FG007|Overall Study|Reason not Specified|0|||
150211742|NCT03678688|541914004|FG008|Overall Study|Reason not Specified|0|||
150211743|NCT03678688|541913996|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
150211744|NCT03678688|541913997|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
150211745|NCT03678688|541913998|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
150211746|NCT03678688|541913999|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
150211747|NCT03678688|541914000|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
150211748|NCT03678688|541914001|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
150211749|NCT03678688|541914002|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
150211750|NCT03678688|541914003|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
150211751|NCT03678688|541914004|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
150211752|NCT03678688|541913996|FG000|Overall Study|Covid Related Adverse Event|0|||
150211753|NCT03678688|541913997|FG001|Overall Study|Covid Related Adverse Event|0|||
150211754|NCT03678688|541913998|FG002|Overall Study|Covid Related Adverse Event|0|||
150211755|NCT03678688|541913999|FG003|Overall Study|Covid Related Adverse Event|0|||
150211756|NCT03678688|541914000|FG004|Overall Study|Covid Related Adverse Event|0|||
150211757|NCT03678688|541914001|FG005|Overall Study|Covid Related Adverse Event|3|||
150211758|NCT03678688|541914002|FG006|Overall Study|Covid Related Adverse Event|1|||
150211759|NCT03678688|541914003|FG007|Overall Study|Covid Related Adverse Event|1|||
150211760|NCT03678688|541914004|FG008|Overall Study|Covid Related Adverse Event|0|||
150211761|NCT03678688|541913996|FG000|Overall Study|Physician Decision|0|||
150211762|NCT03678688|541913997|FG001|Overall Study|Physician Decision|0|||
150211763|NCT03678688|541913998|FG002|Overall Study|Physician Decision|0|||
150211764|NCT03678688|541913999|FG003|Overall Study|Physician Decision|0|||
150211765|NCT03678688|541914000|FG004|Overall Study|Physician Decision|0|||
150211766|NCT03678688|541914001|FG005|Overall Study|Physician Decision|1|||
150211767|NCT03678688|541914002|FG006|Overall Study|Physician Decision|0|||
150211768|NCT03678688|541914003|FG007|Overall Study|Physician Decision|0|||
150211769|NCT03678688|541914004|FG008|Overall Study|Physician Decision|0|||
150139813|NCT01889186|541647220|FG001|Overall Study|COVID-19 logistical restrictions|0|||
150139814|NCT01889186|541647219|FG000|Overall Study|Investigator request|1|||
150139815|NCT01889186|541647220|FG001|Overall Study|Investigator request|1|||
150139816|NCT01889186|541647219|FG000|Overall Study|Progressive disease- Richter's|12|||
150139817|NCT01889186|541647220|FG001|Overall Study|Progressive disease- Richter's|7|||
150139818|NCT01889186|541647219|FG000|Overall Study|Progressive disease per protocol|46|||
150139819|NCT01889186|541647220|FG001|Overall Study|Progressive disease per protocol|17|||
150139820|NCT01889186|541647219|FG000|Overall Study|Stem cell transplant|2|||
150139821|NCT01889186|541647220|FG001|Overall Study|Stem cell transplant|1|||
150139822|NCT01889186|541647219|FG000|Overall Study|Withdrew consent|2|||
150139823|NCT01889186|541647220|FG001|Overall Study|Withdrew consent|3|||
150139824|NCT01889186|541647219|FG000|Overall Study|Other, not specified|18|||
150139825|NCT01889186|541647220|FG001|Overall Study|Other, not specified|15|||
150139826|NCT02110901|541647221|FG000|Overall Study|Death|6|||
150139827|NCT02110901|541647222|FG001|Overall Study|Death|3|||
150139828|NCT02110901|541647221|FG000|Overall Study|Lost to Follow-up|12|||
150139829|NCT02110901|541647222|FG001|Overall Study|Lost to Follow-up|8|||
150139830|NCT02110901|541647221|FG000|Overall Study|Withdrawal by Subject|7|||
150139831|NCT02110901|541647222|FG001|Overall Study|Withdrawal by Subject|3|||
150139832|NCT02110901|541647221|FG000|Overall Study|received a kidney transplant|5|||
150139833|NCT02110901|541647222|FG001|Overall Study|received a kidney transplant|0|||
150139834|NCT04711603|541647223|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
150139835|NCT04711603|541647224|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
150139836|NCT04711603|541647225|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
150139837|NCT04711603|541647226|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
150139838|NCT04711603|541647223|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
150139839|NCT04711603|541647224|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
150139840|NCT04711603|541647225|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
150139841|NCT04711603|541647226|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
150139842|NCT04711603|541647223|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
150139843|NCT04711603|541647224|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
150139844|NCT04711603|541647225|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
150139845|NCT04711603|541647226|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
150139846|NCT04711603|541647223|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
150139847|NCT04711603|541647224|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
150139848|NCT04711603|541647225|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
150139849|NCT04711603|541647226|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
150139850|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
150139851|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
150139852|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
150139853|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
150139854|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
150139855|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
150139856|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
150139857|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
150139858|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
150139859|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
150139860|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
150139861|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
150139862|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
150139863|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
150139864|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
150139865|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
150139866|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
150139867|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
150139868|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
150139869|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
150139870|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
150211770|NCT03678688|541913996|FG000|Overall Study|Withdrawal by Subject|0|||
150211771|NCT03678688|541913997|FG001|Overall Study|Withdrawal by Subject|0|||
150211772|NCT03678688|541913998|FG002|Overall Study|Withdrawal by Subject|0|||
150211773|NCT03678688|541913999|FG003|Overall Study|Withdrawal by Subject|0|||
150211774|NCT03678688|541914000|FG004|Overall Study|Withdrawal by Subject|0|||
150211775|NCT03678688|541914001|FG005|Overall Study|Withdrawal by Subject|0|||
150211776|NCT03678688|541914002|FG006|Overall Study|Withdrawal by Subject|2|||
150211777|NCT03678688|541914003|FG007|Overall Study|Withdrawal by Subject|1|||
150211778|NCT03678688|541914004|FG008|Overall Study|Withdrawal by Subject|0|||
150211779|NCT03136159|541914005|FG000|Overall Study|chorioamnionitis|2|||
150211780|NCT03136159|541914006|FG001|Overall Study|chorioamnionitis|0|||
150211781|NCT03136159|541914005|FG000|Overall Study|vertical skin incision|1|||
150211782|NCT03136159|541914006|FG001|Overall Study|vertical skin incision|0|||
150211783|NCT03136159|541914005|FG000|Overall Study|additional dressing|1|||
150211784|NCT03136159|541914006|FG001|Overall Study|additional dressing|0|||
150211785|NCT03136159|541914005|FG000|Overall Study|never got dressing placed|1|||
150211786|NCT03136159|541914006|FG001|Overall Study|never got dressing placed|0|||
150211787|NCT00489554|541914007|FG000|Overall Study|Adverse Event|2|||
150211788|NCT00489554|541914007|FG000|Overall Study|Withdrawal by Subject|1|||
150211789|NCT00489554|541914007|FG000|Overall Study|Lost to Follow-up|1|||
150211790|NCT01732757|541914008|FG000|Overall Study|Lost to Follow-up|1|||
150211791|NCT01732757|541914009|FG001|Overall Study|Lost to Follow-up|0|||
150211792|NCT01732757|541914010|FG002|Overall Study|Lost to Follow-up|0|||
150211793|NCT02278796|541914011|FG000|Overall Study|Death|2|||
150211794|NCT02278796|541914012|FG001|Overall Study|Death|3|||
150211795|NCT03214081|541914013|FG000|Overall Study|Case Report Forms Uncollected|9|||
150211796|NCT03214081|541914013|FG000|Overall Study|Protocol Deviation|54|||
150211797|NCT02962284|541914014|FG000|Overall Study|Death|2|||
150211798|NCT02962284|541914015|FG001|Overall Study|Death|0|||
150211799|NCT02962284|541914014|FG000|Overall Study|Progressive disease|2|||
150211800|NCT02962284|541914015|FG001|Overall Study|Progressive disease|3|||
150211801|NCT02962284|541914014|FG000|Overall Study|Withdrawal by Subject|1|||
150211802|NCT02962284|541914015|FG001|Overall Study|Withdrawal by Subject|0|||
150211803|NCT02132949|541914020|FG000|Overall Study|Death|7|||
150211804|NCT02132949|541914021|FG001|Overall Study|Death|13|||
150211805|NCT02132949|541914020|FG000|Overall Study|Lost to Follow-up|14|||
150211806|NCT02132949|541914021|FG001|Overall Study|Lost to Follow-up|4|||
150211807|NCT02132949|541914020|FG000|Overall Study|Withdrawal by Subject|6|||
150211808|NCT02132949|541914021|FG001|Overall Study|Withdrawal by Subject|5|||
150211809|NCT02132949|541914020|FG000|Overall Study|Noncompliance|5|||
150211810|NCT02132949|541914021|FG001|Overall Study|Noncompliance|1|||
150211811|NCT02132949|541914020|FG000|Overall Study|Physician Decision|3|||
150211812|NCT02132949|541914021|FG001|Overall Study|Physician Decision|1|||
150211813|NCT02132949|541914020|FG000|Overall Study|Disease Progression|3|||
150211814|NCT02132949|541914021|FG001|Overall Study|Disease Progression|0|||
150211815|NCT02132949|541914020|FG000|Overall Study|Adverse Event|2|||
150211816|NCT02132949|541914021|FG001|Overall Study|Adverse Event|1|||
150211817|NCT02132949|541914020|FG000|Overall Study|Withdrew Prior to Treatment|1|||
150211818|NCT02132949|541914021|FG001|Overall Study|Withdrew Prior to Treatment|2|||
150211819|NCT02132949|541914020|FG000|Overall Study|Reason Unspecified|0|||
150211820|NCT02132949|541914021|FG001|Overall Study|Reason Unspecified|1|||
150211821|NCT01583166|541914024|FG000|Overall Study|Withdrawal by Subject|4|||
150211822|NCT01583166|541914025|FG001|Overall Study|Withdrawal by Subject|6|||
150211823|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
150211824|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
150211825|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
150211826|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
150211827|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
150211828|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
150211829|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
150211830|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
150211831|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
150211832|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
150211833|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
150211834|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
150211835|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Other|1|||
150211836|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Other|0|||
150211837|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Other|0|||
150211838|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
150211839|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
150211840|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
150211841|NCT00887224|541914026|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
150211842|NCT00887224|541914027|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
150211843|NCT00887224|541914028|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
150211844|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
150211845|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
150211846|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
150211847|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
150211848|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
150211849|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
150211850|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
150211851|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
150211852|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
150211853|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
150211854|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
150211855|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
150211856|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Other|1|||
150211857|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Other|0|||
150211858|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Other|0|||
150211859|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
150139871|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
150139872|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
150139873|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
150139874|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
150139875|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
150211860|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
150211861|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
150211862|NCT00887224|541914026|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
150211863|NCT00887224|541914027|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
150211864|NCT00887224|541914028|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
150211865|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
150211866|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
150211867|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
150211868|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
150211869|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
150211870|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
150211871|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
150211872|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
150211873|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
150211874|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
150211875|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
150211876|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
150211877|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Other|30|||
150211878|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Other|0|||
150211879|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Other|0|||
150211880|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
150211881|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
150211882|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
150211883|NCT00887224|541914026|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
150211884|NCT00887224|541914027|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
150211885|NCT00887224|541914028|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
150211886|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Adverse Event|0|||
150211887|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Adverse Event|7|||
150211888|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Adverse Event|2|||
150211889|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Failed to return|0|||
150211890|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Failed to return|2|||
150211891|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Failed to return|2|||
150211892|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
150211893|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
150211894|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
150211895|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
150211896|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
150211897|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
150211898|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Other|0|||
150211899|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Other|2|||
150211900|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Other|0|||
150211901|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
150211902|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
150211903|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
150211904|NCT00887224|541914026|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
150211905|NCT00887224|541914027|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
150211906|NCT00887224|541914028|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
150211907|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
150211908|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
150211909|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
150211910|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
150211911|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
150211912|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
150211913|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
150211914|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
150211915|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
150211916|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
150211917|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
150211918|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
150211919|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
150211920|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
150211921|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
150211922|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
150211923|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
150211924|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
150211925|NCT00887224|541914026|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
150211926|NCT00887224|541914027|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
150211927|NCT00887224|541914028|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
150211928|NCT02000752|541914033|FG000|Overall Study|Dystocic delivery|19|||
150211929|NCT02000752|541914034|FG001|Overall Study|Dystocic delivery|8|||
150211930|NCT02000752|541914033|FG000|Overall Study|Shift Changes|12|||
150211931|NCT02000752|541914034|FG001|Overall Study|Shift Changes|5|||
150211932|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
150211933|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
150211934|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
150211935|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
150211936|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
150211937|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
150211938|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
150211939|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
150211940|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
150211941|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
150211942|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
150211943|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
150211944|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
150211945|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
150211946|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
150211947|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
150211948|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
150211949|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
150211950|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
150211951|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
150211952|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
150211953|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
150211954|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
150211955|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
150211956|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
150211957|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
150211958|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
150211959|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
150211960|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
150211961|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
150211962|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
150211963|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
150211964|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
150211965|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
150211966|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
150211967|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
150211968|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
150211969|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
150211970|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
150211971|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
150211972|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
150211973|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
150211974|NCT03732807|541914040|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211975|NCT03732807|541914041|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211976|NCT03732807|541914042|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211977|NCT03732807|541914043|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211978|NCT03732807|541914044|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211979|NCT03732807|541914045|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
150211980|NCT03732807|541914046|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
150211981|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
150211982|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
150211983|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
150211984|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
150211985|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
150211986|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
150211987|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
150211988|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
150211989|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
150211990|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
150211991|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
150211992|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
150211993|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
150211994|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
150211995|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
150211996|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
150211997|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
150211998|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
150211999|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
150212000|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
150212001|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
150212002|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212003|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
150212004|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212005|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212006|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212007|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212008|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
150212009|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
150212010|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
150212011|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
150212012|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
150212013|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
150212014|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
150212015|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
150212016|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
150212017|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
150212018|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
150212019|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
150212020|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
150212021|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
150212022|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
150212023|NCT03732807|541914040|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
150212024|NCT03732807|541914041|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
150212025|NCT03732807|541914042|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
150212026|NCT03732807|541914043|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
150212027|NCT03732807|541914044|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
150212028|NCT03732807|541914045|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
150212029|NCT03732807|541914046|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
150212030|NCT03392194|541914047|FG000|Overall Study|Withdrawal by Subject|1|||
150212031|NCT03392194|541914048|FG001|Overall Study|Withdrawal by Subject|2|||
150212032|NCT03392194|541914047|FG000|Overall Study|Conflicts with personal schedule|1|||
150212033|NCT03392194|541914048|FG001|Overall Study|Conflicts with personal schedule|0|||
150212034|NCT01079806|541914052|FG000|Day 1 to Week 96|Adverse Event|0|||
150212035|NCT01079806|541914053|FG001|Day 1 to Week 96|Adverse Event|3|||
150212036|NCT01079806|541914052|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
150212037|NCT01079806|541914053|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
150212038|NCT01079806|541914052|FG000|Day 1 to Week 96|Pregnancy|0|||
150212039|NCT01079806|541914053|FG001|Day 1 to Week 96|Pregnancy|1|||
150212040|NCT01079806|541914052|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
150212041|NCT01079806|541914053|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
150212042|NCT01079806|541914052|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
150212043|NCT01079806|541914053|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
150212044|NCT01079806|541914052|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
150212045|NCT01079806|541914053|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
150212046|NCT01079806|541914052|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
150212047|NCT01079806|541914053|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
150212048|NCT01079806|541914052|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
150212049|NCT01079806|541914053|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
150212050|NCT01079806|541914052|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
150212051|NCT01079806|541914053|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
150212052|NCT01079806|541914052|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
150212053|NCT01079806|541914053|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
150212054|NCT02788981|541914058|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
150212055|NCT02788981|541914059|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
150212056|NCT05553366|541914060|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
150212057|NCT05553366|541914061|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
150212058|NCT05553366|541914062|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
150212059|NCT05553366|541914060|FG000|Overall Study|Lost to Follow-up|3|||
150212060|NCT05553366|541914061|FG001|Overall Study|Lost to Follow-up|3|||
150212061|NCT05553366|541914062|FG002|Overall Study|Lost to Follow-up|3|||
150212062|NCT05553366|541914060|FG000|Overall Study|Other non-compliance|1|||
150212063|NCT05553366|541914061|FG001|Overall Study|Other non-compliance|1|||
150212064|NCT05553366|541914062|FG002|Overall Study|Other non-compliance|0|||
150212065|NCT05553366|541914060|FG000|Overall Study|Randomized but not dosed|0|||
150212066|NCT05553366|541914061|FG001|Overall Study|Randomized but not dosed|0|||
150212067|NCT05553366|541914062|FG002|Overall Study|Randomized but not dosed|2|||
150212068|NCT00249769|541914063|FG000|Overall Study|Withdrawal by Subject|1|||
150212069|NCT00249769|541914064|FG001|Overall Study|Withdrawal by Subject|10|||
150212070|NCT00249769|541914065|FG002|Overall Study|Withdrawal by Subject|6|||
150212071|NCT00249769|541914063|FG000|Overall Study|Migration from Study Area|1|||
150212072|NCT00249769|541914064|FG001|Overall Study|Migration from Study Area|3|||
150212073|NCT00249769|541914065|FG002|Overall Study|Migration from Study Area|14|||
150212074|NCT00249769|541914063|FG000|Overall Study|Miscellaneous|0|||
150212075|NCT00249769|541914064|FG001|Overall Study|Miscellaneous|2|||
150212076|NCT00249769|541914065|FG002|Overall Study|Miscellaneous|2|||
150212077|NCT00249769|541914063|FG000|Overall Study|Adverse Event|0|||
150212078|NCT00249769|541914064|FG001|Overall Study|Adverse Event|0|||
150212079|NCT00249769|541914065|FG002|Overall Study|Adverse Event|1|||
150212080|NCT00249769|541914063|FG000|Overall Study|Physician Decision|0|||
150212081|NCT00249769|541914064|FG001|Overall Study|Physician Decision|0|||
150212082|NCT00249769|541914065|FG002|Overall Study|Physician Decision|2|||
150212083|NCT00249769|541914063|FG000|Overall Study|Lost to Follow-up|0|||
150212084|NCT00249769|541914064|FG001|Overall Study|Lost to Follow-up|0|||
150212085|NCT00249769|541914065|FG002|Overall Study|Lost to Follow-up|3|||
150212086|NCT02022657|541914069|FG000|Overall Study|Withdrawal by Subject|2|||
150212087|NCT02022657|541914070|FG001|Overall Study|Withdrawal by Subject|0|||
150212088|NCT02022657|541914071|FG002|Overall Study|Withdrawal by Subject|1|||
150212089|NCT02022657|541914072|FG003|Overall Study|Withdrawal by Subject|0|||
150212090|NCT02022657|541914073|FG004|Overall Study|Withdrawal by Subject|0|||
150212091|NCT02022657|541914074|FG005|Overall Study|Withdrawal by Subject|0|||
150212092|NCT02022657|541914069|FG000|Overall Study|Physician Decision|0|||
150212093|NCT02022657|541914070|FG001|Overall Study|Physician Decision|0|||
150212094|NCT02022657|541914071|FG002|Overall Study|Physician Decision|0|||
150212095|NCT02022657|541914072|FG003|Overall Study|Physician Decision|0|||
150212096|NCT02022657|541914073|FG004|Overall Study|Physician Decision|0|||
150212097|NCT02022657|541914074|FG005|Overall Study|Physician Decision|1|||
150212098|NCT03274076|541914075|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
150212099|NCT03274076|541914076|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
150212100|NCT03274076|541914077|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
150212101|NCT03274076|541914078|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
150212102|NCT03274076|541914075|FG000|24 Weeks Open Label|Adverse Event|0|||
150212103|NCT03274076|541914076|FG001|24 Weeks Open Label|Adverse Event|0|||
150212104|NCT03274076|541914077|FG002|24 Weeks Open Label|Adverse Event|2|||
150212105|NCT03274076|541914078|FG003|24 Weeks Open Label|Adverse Event|0|||
150212106|NCT03274076|541914075|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
150212107|NCT03274076|541914076|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
150212108|NCT03274076|541914077|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
150212109|NCT03274076|541914078|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
150212110|NCT00836498|541914082|FG000|Overall Study|Adverse Event|1|||
150212111|NCT00836498|541914083|FG001|Overall Study|Adverse Event|0|||
150212112|NCT00836498|541914082|FG000|Overall Study|Lost to Follow-up|1|||
150212113|NCT00836498|541914083|FG001|Overall Study|Lost to Follow-up|0|||
150212114|NCT00836498|541914082|FG000|Overall Study|Withdrawal by Subject|2|||
150212115|NCT00836498|541914083|FG001|Overall Study|Withdrawal by Subject|1|||
150212116|NCT01034306|541914084|FG000|Overall Study|Adverse Event|1|||
150212117|NCT01034306|541914085|FG001|Overall Study|Adverse Event|0|||
150212118|NCT01034306|541914084|FG000|Overall Study|Lost to Follow-up|0|||
150212119|NCT01034306|541914085|FG001|Overall Study|Lost to Follow-up|1|||
150212120|NCT01034306|541914084|FG000|Overall Study|Withdrawal by Subject|2|||
150212121|NCT01034306|541914085|FG001|Overall Study|Withdrawal by Subject|2|||
150212122|NCT01034306|541914084|FG000|Overall Study|hospitalized and decided to stop|1|||
150212123|NCT01034306|541914085|FG001|Overall Study|hospitalized and decided to stop|0|||
150212124|NCT01034306|541914084|FG000|Overall Study|Noncomplience|1|||
150212125|NCT01034306|541914085|FG001|Overall Study|Noncomplience|0|||
150212126|NCT02384382|541914088|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
150212127|NCT02384382|541914088|FG000|Overall Study|Death|1|||
150212128|NCT02384382|541914088|FG000|Overall Study|Adverse Event|1|||
150212129|NCT02384382|541914088|FG000|Overall Study|Disease progression|16|||
150212130|NCT01953692|541914089|FG000|Overall Study|Adverse Event|5|||
150212131|NCT01953692|541914090|FG001|Overall Study|Adverse Event|2|||
150212132|NCT01953692|541914091|FG002|Overall Study|Adverse Event|4|||
150212133|NCT01953692|541914092|FG003|Overall Study|Adverse Event|2|||
150212134|NCT01953692|541914093|FG004|Overall Study|Adverse Event|1|||
150212135|NCT01953692|541914094|FG005|Overall Study|Adverse Event|2|||
150212136|NCT01953692|541914095|FG006|Overall Study|Adverse Event|0|||
150212137|NCT01953692|541914096|FG007|Overall Study|Adverse Event|0|||
150212138|NCT01953692|541914097|FG008|Overall Study|Adverse Event|0|||
150212139|NCT01953692|541914089|FG000|Overall Study|Clinical Progression|0|||
150212140|NCT01953692|541914090|FG001|Overall Study|Clinical Progression|15|||
150212141|NCT01953692|541914091|FG002|Overall Study|Clinical Progression|7|||
150212142|NCT01953692|541914092|FG003|Overall Study|Clinical Progression|5|||
150212143|NCT01953692|541914093|FG004|Overall Study|Clinical Progression|0|||
150212144|NCT01953692|541914094|FG005|Overall Study|Clinical Progression|7|||
150212145|NCT01953692|541914095|FG006|Overall Study|Clinical Progression|20|||
150212146|NCT01953692|541914096|FG007|Overall Study|Clinical Progression|3|||
150212147|NCT01953692|541914097|FG008|Overall Study|Clinical Progression|3|||
150212148|NCT01953692|541914089|FG000|Overall Study|Death|5|||
150212149|NCT01953692|541914090|FG001|Overall Study|Death|0|||
150212150|NCT01953692|541914091|FG002|Overall Study|Death|2|||
150212151|NCT01953692|541914092|FG003|Overall Study|Death|2|||
150212152|NCT01953692|541914093|FG004|Overall Study|Death|1|||
150212153|NCT01953692|541914094|FG005|Overall Study|Death|3|||
150212154|NCT01953692|541914095|FG006|Overall Study|Death|6|||
150212155|NCT01953692|541914096|FG007|Overall Study|Death|2|||
150212156|NCT01953692|541914097|FG008|Overall Study|Death|1|||
150212157|NCT01953692|541914089|FG000|Overall Study|Excluded Medication|1|||
150212158|NCT01953692|541914090|FG001|Overall Study|Excluded Medication|0|||
150212159|NCT01953692|541914091|FG002|Overall Study|Excluded Medication|0|||
150212160|NCT01953692|541914092|FG003|Overall Study|Excluded Medication|0|||
150212161|NCT01953692|541914093|FG004|Overall Study|Excluded Medication|0|||
150212162|NCT01953692|541914094|FG005|Overall Study|Excluded Medication|0|||
150212163|NCT01953692|541914095|FG006|Overall Study|Excluded Medication|0|||
150212164|NCT01953692|541914096|FG007|Overall Study|Excluded Medication|0|||
150212165|NCT01953692|541914097|FG008|Overall Study|Excluded Medication|0|||
150212166|NCT01953692|541914089|FG000|Overall Study|Lost to Follow-up|1|||
150212167|NCT01953692|541914090|FG001|Overall Study|Lost to Follow-up|0|||
150212168|NCT01953692|541914091|FG002|Overall Study|Lost to Follow-up|3|||
150212169|NCT01953692|541914092|FG003|Overall Study|Lost to Follow-up|1|||
150212170|NCT01953692|541914093|FG004|Overall Study|Lost to Follow-up|0|||
150212171|NCT01953692|541914094|FG005|Overall Study|Lost to Follow-up|1|||
150212172|NCT01953692|541914095|FG006|Overall Study|Lost to Follow-up|0|||
150212173|NCT01953692|541914096|FG007|Overall Study|Lost to Follow-up|0|||
150212174|NCT01953692|541914097|FG008|Overall Study|Lost to Follow-up|0|||
150212175|NCT01953692|541914089|FG000|Overall Study|Physician Decision|11|||
150212176|NCT01953692|541914090|FG001|Overall Study|Physician Decision|4|||
150212177|NCT01953692|541914091|FG002|Overall Study|Physician Decision|2|||
150212178|NCT01953692|541914092|FG003|Overall Study|Physician Decision|2|||
150212179|NCT01953692|541914093|FG004|Overall Study|Physician Decision|1|||
150212180|NCT01953692|541914094|FG005|Overall Study|Physician Decision|2|||
150212181|NCT01953692|541914095|FG006|Overall Study|Physician Decision|4|||
150212182|NCT01953692|541914096|FG007|Overall Study|Physician Decision|1|||
150212183|NCT01953692|541914097|FG008|Overall Study|Physician Decision|0|||
150212184|NCT01953692|541914089|FG000|Overall Study|Protocol Violation|0|||
150212185|NCT01953692|541914090|FG001|Overall Study|Protocol Violation|2|||
150212186|NCT01953692|541914091|FG002|Overall Study|Protocol Violation|1|||
150212187|NCT01953692|541914092|FG003|Overall Study|Protocol Violation|0|||
150212188|NCT01953692|541914093|FG004|Overall Study|Protocol Violation|0|||
150212189|NCT01953692|541914094|FG005|Overall Study|Protocol Violation|0|||
150212190|NCT01953692|541914095|FG006|Overall Study|Protocol Violation|0|||
150212191|NCT01953692|541914096|FG007|Overall Study|Protocol Violation|1|||
150212192|NCT01953692|541914097|FG008|Overall Study|Protocol Violation|0|||
150212193|NCT01953692|541914089|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212194|NCT01953692|541914090|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212195|NCT01953692|541914091|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212196|NCT01953692|541914092|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212197|NCT01953692|541914093|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212198|NCT01953692|541914094|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212199|NCT01953692|541914095|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212200|NCT01953692|541914096|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
150212201|NCT01953692|541914097|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
150212202|NCT01953692|541914089|FG000|Overall Study|Withdrawal by Subject|4|||
150212203|NCT01953692|541914090|FG001|Overall Study|Withdrawal by Subject|2|||
150212204|NCT01953692|541914091|FG002|Overall Study|Withdrawal by Subject|1|||
150212205|NCT01953692|541914092|FG003|Overall Study|Withdrawal by Subject|2|||
150212206|NCT01953692|541914093|FG004|Overall Study|Withdrawal by Subject|0|||
150212207|NCT01953692|541914094|FG005|Overall Study|Withdrawal by Subject|3|||
150212208|NCT01953692|541914095|FG006|Overall Study|Withdrawal by Subject|2|||
150212209|NCT01953692|541914096|FG007|Overall Study|Withdrawal by Subject|1|||
150212210|NCT01953692|541914097|FG008|Overall Study|Withdrawal by Subject|1|||
150212211|NCT02022670|541914098|FG000|Overall Study|Adverse Event|1|||
150212212|NCT02022670|541914099|FG001|Overall Study|Adverse Event|0|||
150212213|NCT02022670|541914100|FG002|Overall Study|Adverse Event|1|||
150212214|NCT02113449|541914101|FG000|Overall Study|Adverse Event|4|||
150212215|NCT01328496|541914104|FG000|Overall Study|Significant Change in Health Status|1|||
150212216|NCT01328496|541914105|FG001|Overall Study|Significant Change in Health Status|0|||
150212217|NCT02091752|541914108|FG000|Overall Study|Study terminated by Sponsor|2|||
150212218|NCT02091752|541914108|FG000|Overall Study|Adverse Event|1|||
150212219|NCT04029090|541914115|FG000|Overall Study|Protocol Violation|1|||
150212220|NCT04029090|541914116|FG001|Overall Study|Protocol Violation|0|||
150212221|NCT04029090|541914117|FG002|Overall Study|Protocol Violation|0|||
150212222|NCT04029090|541914115|FG000|Overall Study|Withdrawal by Subject|0|||
150212223|NCT04029090|541914116|FG001|Overall Study|Withdrawal by Subject|1|||
150212224|NCT04029090|541914117|FG002|Overall Study|Withdrawal by Subject|0|||
150212225|NCT01065779|541914118|FG000|Overall Study|Duplicate Investigation|1|||
150212226|NCT01065779|541914118|FG000|Overall Study|Investigation Before Contract Date|37|||
150212227|NCT01065779|541914118|FG000|Overall Study|Non-enrollment Period Administration|10|||
150212228|NCT01065779|541914118|FG000|Overall Study|Not Administered With Study Drug|17|||
150212229|NCT01065779|541914118|FG000|Overall Study|Failed to Follow-up|10|||
150212230|NCT01065779|541914118|FG000|Overall Study|Inclusion Criteria Violation|7|||
150212231|NCT02157948|541914119|FG000|Overall Study|Withdrawal by Subject|4|||
150212232|NCT02157948|541914120|FG001|Overall Study|Withdrawal by Subject|5|||
150212233|NCT02157948|541914119|FG000|Overall Study|Lost to Follow-up|3|||
150212234|NCT02157948|541914120|FG001|Overall Study|Lost to Follow-up|2|||
150212235|NCT02157948|541914119|FG000|Overall Study|Protocol Specified Criteria|2|||
150212236|NCT02157948|541914120|FG001|Overall Study|Protocol Specified Criteria|1|||
150212237|NCT02157948|541914119|FG000|Overall Study|Decision by Sponsor|0|||
150212238|NCT02157948|541914120|FG001|Overall Study|Decision by Sponsor|1|||
150212239|NCT04248803|541914136|FG000|Overall Study|Lost to Follow-up|7|||
150212240|NCT04248803|541914137|FG001|Overall Study|Lost to Follow-up|7|||
150212241|NCT04248803|541914138|FG002|Overall Study|Lost to Follow-up|7|||
150212242|NCT04248803|541914139|FG003|Overall Study|Lost to Follow-up|7|||
150212243|NCT04248803|541914140|FG004|Overall Study|Lost to Follow-up|7|||
150212244|NCT04248803|541914141|FG005|Overall Study|Lost to Follow-up|7|||
150212245|NCT03683030|541914142|FG000|Overall Study|Enrolled but screen failures|12|||
150212246|NCT03683030|541914143|FG001|Overall Study|Enrolled but screen failures|7|||
150212247|NCT03683030|541914142|FG000|Overall Study|Enrolled but no catheter inserted|11|||
150212248|NCT03683030|541914143|FG001|Overall Study|Enrolled but no catheter inserted|13|||
150212249|NCT03683030|541914142|FG000|Overall Study|Withdrawal by Subject|0|||
150212250|NCT03683030|541914143|FG001|Overall Study|Withdrawal by Subject|2|||
150212251|NCT03683030|541914142|FG000|Overall Study|Early termination by subject|1|||
150212252|NCT03683030|541914143|FG001|Overall Study|Early termination by subject|0|||
150212253|NCT03683030|541914142|FG000|Overall Study|Lost to Follow-up|0|||
150212254|NCT03683030|541914143|FG001|Overall Study|Lost to Follow-up|6|||
150212255|NCT03683030|541914142|FG000|Overall Study|Death|0|||
150212256|NCT03683030|541914143|FG001|Overall Study|Death|2|||
150212257|NCT03683030|541914142|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
150212258|NCT03683030|541914143|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
150212259|NCT03343704|541914148|FG000|Overall Study|Refused to complete follow up|0|||
150212260|NCT03343704|541914149|FG001|Overall Study|Refused to complete follow up|1|||
150212261|NCT03343704|541914148|FG000|Overall Study|Death|0|||
150212262|NCT03343704|541914149|FG001|Overall Study|Death|1|||
150212263|NCT03343704|541914148|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
150212264|NCT03343704|541914149|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
150212265|NCT00302211|541914155|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
150212266|NCT00302211|541914156|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
150212267|NCT00302211|541914157|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
150212268|NCT00302211|541914158|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
150212269|NCT00302211|541914159|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
150212270|NCT00302211|541914155|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
150212271|NCT00302211|541914156|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
150212272|NCT00302211|541914157|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
150212273|NCT00302211|541914158|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
150212274|NCT00302211|541914159|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
150212275|NCT00302211|541914155|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
150212276|NCT00302211|541914156|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
150212277|NCT00302211|541914157|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
150212278|NCT00302211|541914158|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
150212279|NCT00302211|541914159|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
150212280|NCT00302211|541914155|FG000|Double Blind Period (New Patients)|Disease progression|0|||
150212281|NCT00302211|541914156|FG001|Double Blind Period (New Patients)|Disease progression|1|||
150212282|NCT00302211|541914157|FG002|Double Blind Period (New Patients)|Disease progression|1|||
150212283|NCT00302211|541914158|FG003|Double Blind Period (New Patients)|Disease progression|0|||
150212284|NCT00302211|541914159|FG004|Double Blind Period (New Patients)|Disease progression|0|||
150212285|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
150212286|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
150212287|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
150212288|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
150212289|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
150212290|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
150212291|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
150212292|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
150212293|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
150212294|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
150212295|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
150212296|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
150212297|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
150212298|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
150212299|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
150212300|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
150212301|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
150212302|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
150212303|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
150212304|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
150212305|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Death|0|||
150212306|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Death|0|||
150212307|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Death|0|||
150212308|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Death|1|||
150212309|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Death|1|||
150212310|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
150212311|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
150212312|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
150212313|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
150212314|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
150212315|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
150212316|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
150212317|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
150212318|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
150212319|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
150212320|NCT00302211|541914155|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
150212321|NCT00302211|541914156|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
150212322|NCT00302211|541914157|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
150212323|NCT00302211|541914158|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
150212324|NCT00302211|541914159|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
150139876|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
150139877|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
150139878|NCT04711603|541647223|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
150139879|NCT04711603|541647224|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
150139880|NCT04711603|541647225|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
150139881|NCT04711603|541647226|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
150139882|NCT04252742|541647228|FG000|Overall Study|Decision by sponsor|0|||
150139883|NCT04252742|541647229|FG001|Overall Study|Decision by sponsor|2|||
150139884|NCT04252742|541647228|FG000|Overall Study|Withdrawal by Subject|15|||
150139885|NCT04252742|541647229|FG001|Overall Study|Withdrawal by Subject|9|||
150139886|NCT04252742|541647228|FG000|Overall Study|Lost to Follow-up|0|||
150139887|NCT04252742|541647229|FG001|Overall Study|Lost to Follow-up|1|||
150139888|NCT02597036|541647230|FG000|Overall Study|Progressive Disease|0|||
150139889|NCT02597036|541647231|FG001|Overall Study|Progressive Disease|0|||
150139890|NCT02597036|541647232|FG002|Overall Study|Progressive Disease|0|||
150139891|NCT02597036|541647233|FG003|Overall Study|Progressive Disease|0|||
150139892|NCT02597036|541647234|FG004|Overall Study|Progressive Disease|1|||
150139893|NCT02597036|541647235|FG005|Overall Study|Progressive Disease|1|||
150139894|NCT02597036|541647236|FG006|Overall Study|Progressive Disease|1|||
150139895|NCT02597036|541647237|FG007|Overall Study|Progressive Disease|0|||
150139896|NCT02597036|541647238|FG008|Overall Study|Progressive Disease|0|||
150139897|NCT02597036|541647239|FG009|Overall Study|Progressive Disease|0|||
150139898|NCT02597036|541647240|FG010|Overall Study|Progressive Disease|0|||
150139899|NCT02597036|541647241|FG011|Overall Study|Progressive Disease|0|||
150139900|NCT02597036|541647230|FG000|Overall Study|Adverse Event|0|||
150139901|NCT02597036|541647231|FG001|Overall Study|Adverse Event|0|||
150139902|NCT02597036|541647232|FG002|Overall Study|Adverse Event|0|||
150139903|NCT02597036|541647233|FG003|Overall Study|Adverse Event|0|||
150139904|NCT02597036|541647234|FG004|Overall Study|Adverse Event|0|||
150139905|NCT02597036|541647235|FG005|Overall Study|Adverse Event|0|||
150139906|NCT02597036|541647236|FG006|Overall Study|Adverse Event|0|||
150139907|NCT02597036|541647237|FG007|Overall Study|Adverse Event|1|||
150139908|NCT02597036|541647238|FG008|Overall Study|Adverse Event|0|||
150139909|NCT02597036|541647239|FG009|Overall Study|Adverse Event|0|||
150139910|NCT02597036|541647240|FG010|Overall Study|Adverse Event|0|||
150139911|NCT02597036|541647241|FG011|Overall Study|Adverse Event|1|||
150139912|NCT02597036|541647230|FG000|Overall Study|Death|0|||
150139913|NCT02597036|541647231|FG001|Overall Study|Death|0|||
150139914|NCT02597036|541647232|FG002|Overall Study|Death|0|||
150139915|NCT02597036|541647233|FG003|Overall Study|Death|0|||
150139916|NCT02597036|541647234|FG004|Overall Study|Death|0|||
150139917|NCT02597036|541647235|FG005|Overall Study|Death|0|||
150139918|NCT02597036|541647236|FG006|Overall Study|Death|0|||
150139919|NCT02597036|541647237|FG007|Overall Study|Death|0|||
150139920|NCT02597036|541647238|FG008|Overall Study|Death|0|||
150139921|NCT02597036|541647239|FG009|Overall Study|Death|1|||
150139922|NCT02597036|541647240|FG010|Overall Study|Death|1|||
150139923|NCT02597036|541647241|FG011|Overall Study|Death|0|||
150139924|NCT02597036|541647230|FG000|Overall Study|Lost to Follow-up|0|||
150139925|NCT02597036|541647231|FG001|Overall Study|Lost to Follow-up|0|||
150139926|NCT02597036|541647232|FG002|Overall Study|Lost to Follow-up|0|||
150139927|NCT02597036|541647233|FG003|Overall Study|Lost to Follow-up|0|||
150139928|NCT02597036|541647234|FG004|Overall Study|Lost to Follow-up|0|||
150139929|NCT02597036|541647235|FG005|Overall Study|Lost to Follow-up|0|||
150139930|NCT02597036|541647236|FG006|Overall Study|Lost to Follow-up|0|||
150139931|NCT02597036|541647237|FG007|Overall Study|Lost to Follow-up|0|||
150139932|NCT02597036|541647238|FG008|Overall Study|Lost to Follow-up|0|||
150139933|NCT02597036|541647239|FG009|Overall Study|Lost to Follow-up|0|||
150139934|NCT02597036|541647240|FG010|Overall Study|Lost to Follow-up|1|||
150139935|NCT02597036|541647241|FG011|Overall Study|Lost to Follow-up|0|||
150139936|NCT02597036|541647230|FG000|Overall Study|Withdrawal by Subject|0|||
150139937|NCT02597036|541647231|FG001|Overall Study|Withdrawal by Subject|0|||
150139938|NCT02597036|541647232|FG002|Overall Study|Withdrawal by Subject|0|||
150139939|NCT02597036|541647233|FG003|Overall Study|Withdrawal by Subject|0|||
150139940|NCT02597036|541647234|FG004|Overall Study|Withdrawal by Subject|0|||
150139941|NCT02597036|541647235|FG005|Overall Study|Withdrawal by Subject|0|||
150139942|NCT02597036|541647236|FG006|Overall Study|Withdrawal by Subject|0|||
150139943|NCT02597036|541647237|FG007|Overall Study|Withdrawal by Subject|0|||
150139944|NCT02597036|541647238|FG008|Overall Study|Withdrawal by Subject|0|||
150139945|NCT02597036|541647239|FG009|Overall Study|Withdrawal by Subject|0|||
150139946|NCT02597036|541647240|FG010|Overall Study|Withdrawal by Subject|0|||
150139947|NCT02597036|541647241|FG011|Overall Study|Withdrawal by Subject|1|||
150139948|NCT06351371|541647242|FG000|Overall Study|Mutation Status Not Confirmed|9|||
150139949|NCT06351371|541647242|FG000|Overall Study|Ineligible|1|||
150139950|NCT06351371|541647242|FG000|Overall Study|Adverse Event|4|||
150212325|NCT00551421|541915703|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
150212326|NCT03823703|541915704|FG000|Overall Study|Sponsor request|0|||
150212327|NCT03823703|541915705|FG001|Overall Study|Sponsor request|3|||
150212328|NCT03823703|541915706|FG002|Overall Study|Sponsor request|4|||
150212329|NCT03823703|541915704|FG000|Overall Study|Adverse Event|3|||
150212330|NCT03823703|541915705|FG001|Overall Study|Adverse Event|1|||
150212331|NCT03823703|541915706|FG002|Overall Study|Adverse Event|0|||
150212332|NCT03823703|541915704|FG000|Overall Study|Withdrawal by Subject|0|||
150212333|NCT03823703|541915705|FG001|Overall Study|Withdrawal by Subject|1|||
150212334|NCT03823703|541915706|FG002|Overall Study|Withdrawal by Subject|0|||
150212335|NCT00799409|541915707|FG000|Overall Study|Withdrawal by Subject|1|||
150212336|NCT00799409|541915708|FG001|Overall Study|Withdrawal by Subject|0|||
150212337|NCT00799409|541915709|FG002|Overall Study|Withdrawal by Subject|0|||
150212338|NCT00799409|541915707|FG000|Overall Study|Lost to Follow-up|1|||
150212339|NCT00799409|541915708|FG001|Overall Study|Lost to Follow-up|0|||
150212340|NCT00799409|541915709|FG002|Overall Study|Lost to Follow-up|0|||
150212341|NCT00799409|541915707|FG000|Overall Study|Optimal Dose Not Achieved|2|||
150212342|NCT00799409|541915708|FG001|Overall Study|Optimal Dose Not Achieved|0|||
150212343|NCT00799409|541915709|FG002|Overall Study|Optimal Dose Not Achieved|0|||
150212344|NCT00799409|541915707|FG000|Overall Study|Failure to follow study protocol)|1|||
150212345|NCT00799409|541915708|FG001|Overall Study|Failure to follow study protocol)|0|||
150212346|NCT00799409|541915709|FG002|Overall Study|Failure to follow study protocol)|0|||
150212347|NCT00799409|541915707|FG000|Overall Study|Did not attend lab school day 1|1|||
150212348|NCT00799409|541915708|FG001|Overall Study|Did not attend lab school day 1|0|||
150212349|NCT00799409|541915709|FG002|Overall Study|Did not attend lab school day 1|0|||
150212350|NCT00799409|541915707|FG000|Overall Study|medication compliance|1|||
150212351|NCT00799409|541915708|FG001|Overall Study|medication compliance|0|||
150212352|NCT00799409|541915709|FG002|Overall Study|medication compliance|0|||
150212353|NCT03137459|541915710|FG000|2-month Assessment|Withdrawal by Subject|13|||
150212354|NCT03137459|541915711|FG001|2-month Assessment|Withdrawal by Subject|3|||
150212355|NCT03137459|541915710|FG000|2-month Assessment|Unable to reach|42|||
150212356|NCT03137459|541915711|FG001|2-month Assessment|Unable to reach|32|||
150212357|NCT03137459|541915710|FG000|2-month Assessment|Refused assessment|7|||
150212358|NCT03137459|541915711|FG001|2-month Assessment|Refused assessment|5|||
150212359|NCT03137459|541915710|FG000|2-month Assessment|Acutely ill|6|||
150212360|NCT03137459|541915711|FG001|2-month Assessment|Acutely ill|2|||
150212361|NCT03137459|541915710|FG000|4-month Assessment|Death|4|||
150212362|NCT03137459|541915711|FG001|4-month Assessment|Death|2|||
150212363|NCT03137459|541915710|FG000|4-month Assessment|Withdrawal by Subject|4|||
150212364|NCT03137459|541915711|FG001|4-month Assessment|Withdrawal by Subject|2|||
150212365|NCT03137459|541915710|FG000|4-month Assessment|Unable to reach|44|||
150212366|NCT03137459|541915711|FG001|4-month Assessment|Unable to reach|29|||
150212367|NCT03137459|541915710|FG000|4-month Assessment|Refused assessment|24|||
150212368|NCT03137459|541915711|FG001|4-month Assessment|Refused assessment|10|||
150212369|NCT03137459|541915710|FG000|4-month Assessment|Acutely ill|2|||
150212370|NCT03137459|541915711|FG001|4-month Assessment|Acutely ill|3|||
150212371|NCT03137459|541915710|FG000|6-months|Lost to Follow-up|14|||
150212372|NCT03137459|541915711|FG001|6-months|Lost to Follow-up|11|||
150212373|NCT03137459|541915710|FG000|6-months|Death|0|||
150212374|NCT03137459|541915711|FG001|6-months|Death|2|||
150212375|NCT03137459|541915710|FG000|6-months|Refused assessment|6|||
150212376|NCT03137459|541915711|FG001|6-months|Refused assessment|3|||
150212377|NCT03137459|541915710|FG000|6-months|Acutely ill|1|||
150212378|NCT03137459|541915711|FG001|6-months|Acutely ill|1|||
150212379|NCT04323800|541915712|FG000|Overall Study|Withdrawal by Subject|4|||
150212380|NCT04323800|541915713|FG001|Overall Study|Withdrawal by Subject|4|||
150212381|NCT04323800|541915712|FG000|Overall Study|Incomplete transfusion|1|||
150212382|NCT04323800|541915713|FG001|Overall Study|Incomplete transfusion|0|||
150212383|NCT04323800|541915712|FG000|Overall Study|Other|0|||
150212384|NCT04323800|541915713|FG001|Overall Study|Other|1|||
150212385|NCT04323800|541915712|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
150212386|NCT04323800|541915713|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
150212387|NCT00731692|541915714|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
150212388|NCT00731692|541915715|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
150212389|NCT00731692|541915716|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
150212390|NCT00731692|541915714|FG000|Core Study (36 Months)|Physician Decision|1|||
150212391|NCT00731692|541915715|FG001|Core Study (36 Months)|Physician Decision|0|||
150212392|NCT00731692|541915716|FG002|Core Study (36 Months)|Physician Decision|2|||
150212393|NCT00731692|541915714|FG000|Core Study (36 Months)|Death|2|||
150212394|NCT00731692|541915715|FG001|Core Study (36 Months)|Death|1|||
150212395|NCT00731692|541915716|FG002|Core Study (36 Months)|Death|2|||
150212396|NCT00731692|541915714|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
150212397|NCT00731692|541915715|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
150212398|NCT00731692|541915716|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
150212399|NCT00731692|541915714|FG000|Core Study (36 Months)|Administrative|2|||
150212400|NCT00731692|541915715|FG001|Core Study (36 Months)|Administrative|2|||
150212401|NCT00731692|541915716|FG002|Core Study (36 Months)|Administrative|6|||
150212402|NCT00731692|541915714|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
150212403|NCT00731692|541915715|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
150212404|NCT00731692|541915716|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
150212405|NCT00731692|541915714|FG000|Core Study (36 Months)|Protocol Violation|4|||
150212406|NCT00731692|541915715|FG001|Core Study (36 Months)|Protocol Violation|5|||
150212407|NCT00731692|541915716|FG002|Core Study (36 Months)|Protocol Violation|8|||
150212408|NCT00731692|541915714|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
150212409|NCT00731692|541915715|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
150212410|NCT00731692|541915716|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
150212411|NCT00731692|541915714|FG000|Core Study (36 Months)|Adverse Event|25|||
150212412|NCT00731692|541915715|FG001|Core Study (36 Months)|Adverse Event|28|||
150212413|NCT00731692|541915716|FG002|Core Study (36 Months)|Adverse Event|29|||
150212414|NCT00731692|541915714|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
150212415|NCT00731692|541915715|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
150212416|NCT00731692|541915716|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
150212417|NCT00731692|541915714|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
150212418|NCT00731692|541915715|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
150212419|NCT00731692|541915716|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
150212420|NCT00731692|541915714|FG000|Extension Phase|Abnormal test procedure|0|||
150212421|NCT00731692|541915715|FG001|Extension Phase|Abnormal test procedure|0|||
150212422|NCT00731692|541915716|FG002|Extension Phase|Abnormal test procedure|1|||
150212423|NCT00731692|541915714|FG000|Extension Phase|Abnormal lab values|0|||
150212424|NCT00731692|541915715|FG001|Extension Phase|Abnormal lab values|0|||
150212425|NCT00731692|541915716|FG002|Extension Phase|Abnormal lab values|1|||
150212426|NCT00731692|541915714|FG000|Extension Phase|Lost to Follow-up|0|||
150212427|NCT00731692|541915715|FG001|Extension Phase|Lost to Follow-up|1|||
150212428|NCT00731692|541915716|FG002|Extension Phase|Lost to Follow-up|4|||
150212429|NCT00731692|541915714|FG000|Extension Phase|Withdrawal by Subject|4|||
150212430|NCT00731692|541915715|FG001|Extension Phase|Withdrawal by Subject|5|||
150212431|NCT00731692|541915716|FG002|Extension Phase|Withdrawal by Subject|3|||
150212432|NCT00731692|541915714|FG000|Extension Phase|Adverse Event|1|||
150212433|NCT00731692|541915715|FG001|Extension Phase|Adverse Event|1|||
150212434|NCT00731692|541915716|FG002|Extension Phase|Adverse Event|15|||
150212435|NCT04921358|541915717|FG000|Overall Study|Withdrawal by Subject|6|||
150212436|NCT04921358|541915718|FG001|Overall Study|Withdrawal by Subject|13|||
150212437|NCT04921358|541915717|FG000|Overall Study|Lost to Follow-up|3|||
150212438|NCT04921358|541915718|FG001|Overall Study|Lost to Follow-up|6|||
150212439|NCT04921358|541915717|FG000|Overall Study|Study Terminated by Sponsor|86|||
150212440|NCT04921358|541915718|FG001|Overall Study|Study Terminated by Sponsor|89|||
150212441|NCT04921358|541915717|FG000|Overall Study|Death|92|||
150212442|NCT04921358|541915718|FG001|Overall Study|Death|82|||
150212443|NCT04926857|541915719|FG000|Overall Study|Withdrawal by Subject|40|||
150212444|NCT04926857|541915719|FG000|Overall Study|Death|9|||
150212445|NCT04926857|541915719|FG000|Overall Study|Study product no longer in use|44|||
150212446|NCT04926857|541915719|FG000|Overall Study|Inadequate data to address primary objective|16|||
150212447|NCT02637063|541915720|FG000|Overall Study|Lost to Follow-up|3|||
150212448|NCT02637063|541915721|FG001|Overall Study|Lost to Follow-up|2|||
150212449|NCT02637063|541915722|FG002|Overall Study|Lost to Follow-up|3|||
150212450|NCT02637063|541915720|FG000|Overall Study|Withdrawal by Subject|2|||
150212451|NCT02637063|541915721|FG001|Overall Study|Withdrawal by Subject|2|||
150212452|NCT02637063|541915722|FG002|Overall Study|Withdrawal by Subject|3|||
150212453|NCT00491400|541915723|FG000|Overall Study|Withdrawal by Subject|5|||
150212454|NCT00491400|541915724|FG001|Overall Study|Withdrawal by Subject|4|||
150212455|NCT00745875|541915727|FG000|Overall Study|Continuing study treatment|4|||
150212456|NCT00745875|541915728|FG001|Overall Study|Continuing study treatment|4|||
150212457|NCT02310581|541915729|FG000|Overall Study|Adverse Event|1|||
150212458|NCT02310581|541915730|FG001|Overall Study|Adverse Event|1|||
150212459|NCT02310581|541915731|FG002|Overall Study|Adverse Event|1|||
150212460|NCT02310581|541915732|FG003|Overall Study|Adverse Event|0|||
150212461|NCT02310581|541915729|FG000|Overall Study|Withdrawal by Subject|2|||
150212462|NCT02310581|541915730|FG001|Overall Study|Withdrawal by Subject|1|||
150212463|NCT02310581|541915731|FG002|Overall Study|Withdrawal by Subject|0|||
150212464|NCT02310581|541915732|FG003|Overall Study|Withdrawal by Subject|1|||
150212465|NCT01833455|541915733|FG000|Overall Study|Withdrawal by Subject|1|||
150212466|NCT01833455|541915734|FG001|Overall Study|Withdrawal by Subject|0|||
150212467|NCT01256359|541915735|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
150212468|NCT01256359|541915736|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
150212469|NCT01256359|541915735|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
150212470|NCT01256359|541915736|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
150212471|NCT03960645|541915737|FG000|Overall Study|Protocol Violation|1|||
150212472|NCT03960645|541915738|FG001|Overall Study|Protocol Violation|0|||
150212473|NCT04938453|541915739|FG000|Washout Period 1|Adverse Event|1|||
150212474|NCT04938453|541915740|FG001|Washout Period 1|Adverse Event|0|||
150212475|NCT04938453|541915739|FG000|Washout Period 1|Physician Decision|0|||
150212476|NCT04938453|541915740|FG001|Washout Period 1|Physician Decision|1|||
150212477|NCT03292406|541915741|FG000|Overall Study|Progressive Disease|6|||
150212478|NCT03292406|541915742|FG001|Overall Study|Progressive Disease|3|||
150212479|NCT03292406|541915743|FG002|Overall Study|Progressive Disease|4|||
150212480|NCT03292406|541915741|FG000|Overall Study|Adverse Event|7|||
150212481|NCT03292406|541915742|FG001|Overall Study|Adverse Event|1|||
150212482|NCT03292406|541915743|FG002|Overall Study|Adverse Event|4|||
150212483|NCT03292406|541915741|FG000|Overall Study|Withdrawal by Subject|0|||
150212484|NCT03292406|541915742|FG001|Overall Study|Withdrawal by Subject|7|||
150212485|NCT03292406|541915743|FG002|Overall Study|Withdrawal by Subject|2|||
150212486|NCT03292406|541915741|FG000|Overall Study|Protocol Violation|0|||
150212487|NCT03292406|541915742|FG001|Overall Study|Protocol Violation|1|||
150212488|NCT03292406|541915743|FG002|Overall Study|Protocol Violation|1|||
150212489|NCT03292406|541915741|FG000|Overall Study|Other|0|||
150212490|NCT03292406|541915742|FG001|Overall Study|Other|1|||
150212491|NCT03292406|541915743|FG002|Overall Study|Other|2|||
150212492|NCT00487240|541915749|FG000|Overall Study|Withdrawal by Subject|12|||
150212493|NCT00487240|541915750|FG001|Overall Study|Withdrawal by Subject|6|||
150212494|NCT00487240|541915749|FG000|Overall Study|Lost to Follow-up|7|||
150212495|NCT00487240|541915750|FG001|Overall Study|Lost to Follow-up|6|||
150212496|NCT00487240|541915749|FG000|Overall Study|Adverse Event|0|||
150212497|NCT00487240|541915750|FG001|Overall Study|Adverse Event|4|||
150212498|NCT00487240|541915749|FG000|Overall Study|Protocol Violation|5|||
150212499|NCT00487240|541915750|FG001|Overall Study|Protocol Violation|5|||
150212500|NCT00487240|541915749|FG000|Overall Study|Entry Criteria Not Met|3|||
150212501|NCT00487240|541915750|FG001|Overall Study|Entry Criteria Not Met|4|||
150212502|NCT00487240|541915749|FG000|Overall Study|Sponsor Decision|2|||
150212503|NCT00487240|541915750|FG001|Overall Study|Sponsor Decision|1|||
150212504|NCT00487240|541915749|FG000|Overall Study|Physician Decision|2|||
150212505|NCT00487240|541915750|FG001|Overall Study|Physician Decision|0|||
150212506|NCT01698918|541915751|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
150212507|NCT01698918|541915751|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
150212508|NCT01698918|541915751|FG000|First Line Treatment (Core+Extension)|Death|2|||
150212509|NCT01698918|541915751|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
150212510|NCT01698918|541915751|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
150212511|NCT01698918|541915751|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
150212512|NCT01698918|541915751|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
150212513|NCT01698918|541915751|FG000|Second Line Treatment (Core+Extension)|Death|1|||
150212514|NCT01698918|541915751|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
150212515|NCT01698918|541915751|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
150212516|NCT04237792|541915752|FG000|Treatment (Day 1)|Adverse Event|1|||
150212517|NCT04237792|541915753|FG001|Treatment (Day 1)|Adverse Event|0|||
150212518|NCT04237792|541915754|FG002|Treatment (Day 1)|Adverse Event|0|||
150212519|NCT04237792|541915755|FG003|Treatment (Day 1)|Adverse Event|0|||
150212520|NCT04237792|541915756|FG004|Treatment (Day 1)|Adverse Event|1|||
150212521|NCT04237792|541915757|FG005|Treatment (Day 1)|Adverse Event|1|||
150212522|NCT04237792|541915752|FG000|Treatment (Day 1)|Other|0|||
150212523|NCT04237792|541915753|FG001|Treatment (Day 1)|Other|0|||
150212524|NCT04237792|541915754|FG002|Treatment (Day 1)|Other|1|||
150212525|NCT04237792|541915755|FG003|Treatment (Day 1)|Other|0|||
150212526|NCT04237792|541915756|FG004|Treatment (Day 1)|Other|0|||
150212527|NCT04237792|541915757|FG005|Treatment (Day 1)|Other|1|||
150212528|NCT04237792|541915752|FG000|Treatment (Day 1)|Not treated|1|||
150212529|NCT04237792|541915753|FG001|Treatment (Day 1)|Not treated|1|||
150212530|NCT04237792|541915754|FG002|Treatment (Day 1)|Not treated|2|||
150212531|NCT04237792|541915755|FG003|Treatment (Day 1)|Not treated|1|||
150212532|NCT04237792|541915756|FG004|Treatment (Day 1)|Not treated|0|||
150212533|NCT04237792|541915757|FG005|Treatment (Day 1)|Not treated|1|||
150212534|NCT04693637|541915758|FG000|Overall Study|Death|4|||
150212535|NCT04693637|541915758|FG000|Overall Study|Withdrawal by Subject|3|||
150212536|NCT04693637|541915758|FG000|Overall Study|Physician Decision|2|||
150212537|NCT04693637|541915758|FG000|Overall Study|Lost to Follow-up|1|||
150212538|NCT00910962|541915759|FG000|Overall Study|Adverse Event|5|||
150212539|NCT00910962|541915760|FG001|Overall Study|Adverse Event|20|||
150212540|NCT00910962|541915761|FG002|Overall Study|Adverse Event|17|||
150212541|NCT00910962|541915759|FG000|Overall Study|Protocol Violation|1|||
150212542|NCT00910962|541915760|FG001|Overall Study|Protocol Violation|3|||
150212543|NCT00910962|541915761|FG002|Overall Study|Protocol Violation|3|||
150212544|NCT00910962|541915759|FG000|Overall Study|Lost to Follow-up|0|||
150212545|NCT00910962|541915760|FG001|Overall Study|Lost to Follow-up|3|||
150212546|NCT00910962|541915761|FG002|Overall Study|Lost to Follow-up|1|||
150212547|NCT00910962|541915759|FG000|Overall Study|Physician Decision|0|||
150212548|NCT00910962|541915760|FG001|Overall Study|Physician Decision|6|||
150212549|NCT00910962|541915761|FG002|Overall Study|Physician Decision|6|||
150212550|NCT00910962|541915759|FG000|Overall Study|Withdrawal by Subject|25|||
150212551|NCT00910962|541915760|FG001|Overall Study|Withdrawal by Subject|32|||
150212552|NCT00910962|541915761|FG002|Overall Study|Withdrawal by Subject|32|||
150212553|NCT00910962|541915759|FG000|Overall Study|Reached defined stopping criteria|12|||
150212554|NCT00910962|541915760|FG001|Overall Study|Reached defined stopping criteria|14|||
150212555|NCT00910962|541915761|FG002|Overall Study|Reached defined stopping criteria|17|||
150212556|NCT01629589|541915762|FG000|Overall Study|Protocol Violation|4|||
150212557|NCT01629589|541915763|FG001|Overall Study|Protocol Violation|2|||
150212558|NCT01629589|541915762|FG000|Overall Study|Lost to Follow-up|2|||
150212559|NCT01629589|541915763|FG001|Overall Study|Lost to Follow-up|1|||
150212560|NCT01629589|541915762|FG000|Overall Study|Withdrawal by Subject|2|||
150212561|NCT01629589|541915763|FG001|Overall Study|Withdrawal by Subject|3|||
150212562|NCT01629589|541915762|FG000|Overall Study|Did not receive study vaccine|0|||
150212563|NCT01629589|541915763|FG001|Overall Study|Did not receive study vaccine|1|||
150212564|NCT03057600|541915767|FG000|Overall Study|Adverse Event|0|||
150212565|NCT03057600|541915768|FG001|Overall Study|Adverse Event|0|||
150212566|NCT03057600|541915769|FG002|Overall Study|Adverse Event|4|||
150212567|NCT03057600|541915770|FG003|Overall Study|Adverse Event|0|||
150212568|NCT03057600|541915767|FG000|Overall Study|Radiologic Disease Progression|8|||
150212569|NCT03057600|541915768|FG001|Overall Study|Radiologic Disease Progression|7|||
150212570|NCT03057600|541915769|FG002|Overall Study|Radiologic Disease Progression|13|||
150212571|NCT03057600|541915770|FG003|Overall Study|Radiologic Disease Progression|10|||
150212572|NCT03057600|541915767|FG000|Overall Study|Symptomatic Deterioration|0|||
150212573|NCT03057600|541915768|FG001|Overall Study|Symptomatic Deterioration|1|||
150212574|NCT03057600|541915769|FG002|Overall Study|Symptomatic Deterioration|1|||
150212575|NCT03057600|541915770|FG003|Overall Study|Symptomatic Deterioration|0|||
150212576|NCT03057600|541915767|FG000|Overall Study|Investigator Decision|0|||
150212577|NCT03057600|541915768|FG001|Overall Study|Investigator Decision|0|||
150212578|NCT03057600|541915769|FG002|Overall Study|Investigator Decision|1|||
150212579|NCT03057600|541915770|FG003|Overall Study|Investigator Decision|0|||
150212580|NCT03057600|541915767|FG000|Overall Study|Study Termination by Sponsor|0|||
150212581|NCT03057600|541915768|FG001|Overall Study|Study Termination by Sponsor|0|||
150212582|NCT03057600|541915769|FG002|Overall Study|Study Termination by Sponsor|0|||
150212583|NCT03057600|541915770|FG003|Overall Study|Study Termination by Sponsor|2|||
150212584|NCT03057600|541915767|FG000|Overall Study|Withdrawal by Subject|0|||
150212585|NCT03057600|541915768|FG001|Overall Study|Withdrawal by Subject|1|||
150212586|NCT03057600|541915769|FG002|Overall Study|Withdrawal by Subject|0|||
150212587|NCT03057600|541915770|FG003|Overall Study|Withdrawal by Subject|0|||
150212588|NCT03057600|541915767|FG000|Overall Study|Other, Not Specified|1|||
150212589|NCT03057600|541915768|FG001|Overall Study|Other, Not Specified|1|||
150212590|NCT03057600|541915769|FG002|Overall Study|Other, Not Specified|1|||
150212591|NCT03057600|541915770|FG003|Overall Study|Other, Not Specified|1|||
150212592|NCT05352230|541915780|FG000|First Intervention (3 Months)|study terminated|2|||
150212593|NCT05352230|541915781|FG001|First Intervention (3 Months)|study terminated|2|||
150212594|NCT04399837|541915782|FG000|Overall Study|Other than listed|0|||
150212595|NCT04399837|541915783|FG001|Overall Study|Other than listed|2|||
150212596|NCT04399837|541915784|FG002|Overall Study|Other than listed|2|||
150212597|NCT04399837|541915785|FG003|Overall Study|Other than listed|3|||
150212598|NCT04399837|541915782|FG000|Overall Study|Withdrawal by Subject|1|||
150212599|NCT04399837|541915783|FG001|Overall Study|Withdrawal by Subject|2|||
150212600|NCT04399837|541915784|FG002|Overall Study|Withdrawal by Subject|1|||
150212601|NCT04399837|541915785|FG003|Overall Study|Withdrawal by Subject|1|||
150212602|NCT02060487|541915786|FG000|Overall Study|Other|1|||
150212603|NCT02060487|541915787|FG001|Overall Study|Other|2|||
150212604|NCT02060487|541915788|FG002|Overall Study|Other|1|||
150212605|NCT02060487|541915786|FG000|Overall Study|Lack of Efficacy|0|||
150212606|NCT02060487|541915787|FG001|Overall Study|Lack of Efficacy|1|||
150212607|NCT02060487|541915788|FG002|Overall Study|Lack of Efficacy|0|||
150212608|NCT02060487|541915786|FG000|Overall Study|Withdrawal by Subject|3|||
150212609|NCT02060487|541915787|FG001|Overall Study|Withdrawal by Subject|10|||
150212610|NCT02060487|541915788|FG002|Overall Study|Withdrawal by Subject|4|||
150212611|NCT02060487|541915786|FG000|Overall Study|Study Terminated By Sponsor|87|||
150212612|NCT02060487|541915787|FG001|Overall Study|Study Terminated By Sponsor|89|||
150212613|NCT02060487|541915788|FG002|Overall Study|Study Terminated By Sponsor|100|||
150212614|NCT02060487|541915786|FG000|Overall Study|Randomized in error|1|||
150212615|NCT02060487|541915787|FG001|Overall Study|Randomized in error|0|||
150212616|NCT02060487|541915788|FG002|Overall Study|Randomized in error|0|||
150212617|NCT02060487|541915786|FG000|Overall Study|Protocol Violation|0|||
150212618|NCT02060487|541915787|FG001|Overall Study|Protocol Violation|1|||
150212619|NCT02060487|541915788|FG002|Overall Study|Protocol Violation|1|||
150212620|NCT02060487|541915786|FG000|Overall Study|Lost to Follow-up|3|||
150212621|NCT02060487|541915787|FG001|Overall Study|Lost to Follow-up|0|||
150212622|NCT02060487|541915788|FG002|Overall Study|Lost to Follow-up|2|||
150212623|NCT02060487|541915786|FG000|Overall Study|Death|34|||
150212624|NCT02060487|541915787|FG001|Overall Study|Death|25|||
150212625|NCT02060487|541915788|FG002|Overall Study|Death|19|||
150212626|NCT02060487|541915786|FG000|Overall Study|Adverse Event|0|||
150212627|NCT02060487|541915787|FG001|Overall Study|Adverse Event|0|||
150212628|NCT02060487|541915788|FG002|Overall Study|Adverse Event|1|||
150212629|NCT05182606|541915792|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
150212630|NCT02309294|541915795|FG000|Overall Study|Withdrawal by Subject|2|||
150212631|NCT01227421|541915796|FG000|Overall Study|Lost to Follow-up|6|||
150212632|NCT01227421|541915797|FG001|Overall Study|Lost to Follow-up|7|||
150212633|NCT01227421|541915798|FG002|Overall Study|Lost to Follow-up|5|||
150212634|NCT01227421|541915796|FG000|Overall Study|Adverse Event|2|||
150212635|NCT01227421|541915797|FG001|Overall Study|Adverse Event|7|||
150212636|NCT01227421|541915798|FG002|Overall Study|Adverse Event|2|||
150212637|NCT01227421|541915796|FG000|Overall Study|Withdrawal by Subject|1|||
150212638|NCT01227421|541915797|FG001|Overall Study|Withdrawal by Subject|2|||
150212639|NCT01227421|541915798|FG002|Overall Study|Withdrawal by Subject|1|||
150212640|NCT01227421|541915796|FG000|Overall Study|Protocol Violation|1|||
150212641|NCT01227421|541915797|FG001|Overall Study|Protocol Violation|1|||
150212642|NCT01227421|541915798|FG002|Overall Study|Protocol Violation|2|||
150212643|NCT01227421|541915796|FG000|Overall Study|Randomized in error|1|||
150212644|NCT01227421|541915797|FG001|Overall Study|Randomized in error|1|||
150212645|NCT01227421|541915798|FG002|Overall Study|Randomized in error|0|||
150212646|NCT01827839|541915799|FG000|Overall Study|Adverse Event|1|||
150212647|NCT01827839|541915799|FG000|Overall Study|Consent Withdrawal|2|||
150212648|NCT00614614|541915802|FG000|Primary Vaccination Phase|Adverse Event|6|||
150212649|NCT00614614|541915803|FG001|Primary Vaccination Phase|Adverse Event|0|||
150212650|NCT00614614|541915804|FG002|Primary Vaccination Phase|Adverse Event|0|||
150212651|NCT00614614|541915805|FG003|Primary Vaccination Phase|Adverse Event|0|||
150212652|NCT00614614|541915806|FG004|Primary Vaccination Phase|Adverse Event|0|||
150212653|NCT00614614|541915802|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
150212654|NCT00614614|541915803|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
150212655|NCT00614614|541915804|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
150212656|NCT00614614|541915805|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
150212657|NCT00614614|541915806|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
150212658|NCT00614614|541915802|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
150212659|NCT00614614|541915803|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
150212660|NCT00614614|541915804|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
150212661|NCT00614614|541915805|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
150212662|NCT00614614|541915806|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
150212663|NCT00614614|541915802|FG000|Primary Vaccination Phase|Protocol Violation|9|||
150212664|NCT00614614|541915803|FG001|Primary Vaccination Phase|Protocol Violation|3|||
150212665|NCT00614614|541915804|FG002|Primary Vaccination Phase|Protocol Violation|0|||
150212666|NCT00614614|541915805|FG003|Primary Vaccination Phase|Protocol Violation|0|||
150212667|NCT00614614|541915806|FG004|Primary Vaccination Phase|Protocol Violation|0|||
150212668|NCT00614614|541915802|FG000|Primary Vaccination Phase|Other|4|||
150212669|NCT00614614|541915803|FG001|Primary Vaccination Phase|Other|0|||
150212670|NCT00614614|541915804|FG002|Primary Vaccination Phase|Other|0|||
150212671|NCT00614614|541915805|FG003|Primary Vaccination Phase|Other|0|||
150212672|NCT00614614|541915806|FG004|Primary Vaccination Phase|Other|0|||
150212673|NCT00614614|541915802|FG000|Booster Vaccination Phase|Adverse Event|0|||
150212674|NCT00614614|541915803|FG001|Booster Vaccination Phase|Adverse Event|0|||
150212675|NCT00614614|541915804|FG002|Booster Vaccination Phase|Adverse Event|1|||
150212676|NCT00614614|541915805|FG003|Booster Vaccination Phase|Adverse Event|1|||
150212677|NCT00614614|541915806|FG004|Booster Vaccination Phase|Adverse Event|0|||
150212678|NCT00614614|541915802|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
150212679|NCT00614614|541915803|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
150212680|NCT00614614|541915804|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
150212681|NCT00614614|541915805|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
150212682|NCT00614614|541915806|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
150212683|NCT00614614|541915802|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
150212684|NCT00614614|541915803|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
150212685|NCT00614614|541915804|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
150212686|NCT00614614|541915805|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
150212687|NCT00614614|541915806|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
150212688|NCT00614614|541915802|FG000|Booster Vaccination Phase|Protocol Violation|0|||
150212689|NCT00614614|541915803|FG001|Booster Vaccination Phase|Protocol Violation|0|||
150212690|NCT00614614|541915804|FG002|Booster Vaccination Phase|Protocol Violation|2|||
150212691|NCT00614614|541915805|FG003|Booster Vaccination Phase|Protocol Violation|3|||
150212692|NCT00614614|541915806|FG004|Booster Vaccination Phase|Protocol Violation|0|||
150212693|NCT00614614|541915802|FG000|Booster Vaccination Phase|Other|0|||
150212694|NCT00614614|541915803|FG001|Booster Vaccination Phase|Other|1|||
150212695|NCT00614614|541915804|FG002|Booster Vaccination Phase|Other|3|||
150212696|NCT00614614|541915805|FG003|Booster Vaccination Phase|Other|2|||
150212697|NCT00614614|541915806|FG004|Booster Vaccination Phase|Other|1|||
150212698|NCT05426109|541915807|FG000|Overall Study|Withdrawal by Subject|0|||
150212699|NCT05426109|541915808|FG001|Overall Study|Withdrawal by Subject|1|||
150212700|NCT05212285|541915809|FG000|Overall Study|Lack of Efficacy|12|||
150139951|NCT06351371|541647242|FG000|Overall Study|Death|1|||
150139952|NCT06351371|541647242|FG000|Overall Study|Disease progression|14|||
150139953|NCT06351371|541647242|FG000|Overall Study|Withdrawal by Subject|3|||
150139954|NCT06351371|541647242|FG000|Overall Study|Physician Decision|3|||
150139955|NCT03759834|541647243|FG000|Overall Study|Withdrawal by Subject|1|||
150139956|NCT03937219|541647248|FG000|Overall Study|Death|223|||
150139957|NCT03937219|541647249|FG001|Overall Study|Death|211|||
150139958|NCT03937219|541647248|FG000|Overall Study|Withdrawal by Subject|17|||
150139959|NCT03937219|541647249|FG001|Overall Study|Withdrawal by Subject|25|||
150139960|NCT03937219|541647248|FG000|Overall Study|Lost to Follow-up|3|||
150139961|NCT03937219|541647249|FG001|Overall Study|Lost to Follow-up|4|||
150139962|NCT02515279|541647250|FG000|Overall Study|Adverse Event|7|||
150139963|NCT02515279|541647250|FG000|Overall Study|Lack of Efficacy|31|||
150139964|NCT02515279|541647250|FG000|Overall Study|Lost to Follow-up|9|||
150139965|NCT02515279|541647250|FG000|Overall Study|Withdrawal by Subject|18|||
150139966|NCT02515279|541647250|FG000|Overall Study|End-of-treatment visit not attended|17|||
150139967|NCT02515279|541647250|FG000|Overall Study|Other|22|||
150139968|NCT01800968|541647251|FG000|Overall Study|Death|23|||
150139969|NCT01800968|541647252|FG001|Overall Study|Death|16|||
150139970|NCT01800968|541647251|FG000|Overall Study|Lost to Follow-up|5|||
150139971|NCT01800968|541647252|FG001|Overall Study|Lost to Follow-up|7|||
150139972|NCT01800968|541647251|FG000|Overall Study|Withdrawal by Subject|7|||
150139973|NCT01800968|541647252|FG001|Overall Study|Withdrawal by Subject|9|||
150139974|NCT01800968|541647251|FG000|Overall Study|Physician Decision|1|||
150139975|NCT01800968|541647252|FG001|Overall Study|Physician Decision|0|||
150139976|NCT04987762|541647254|FG000|Overall Study|Study was Terminated by Sponsor|103|||
150139977|NCT03185481|541647255|FG000|Overall Study|Adverse Event|1|||
150139978|NCT03185481|541647255|FG000|Overall Study|Study Terminated by Sponsor|4|||
150139979|NCT00701038|541647261|FG000|Overall Study|study amended pilot group of patients|4|||
150139980|NCT00701038|541647262|FG001|Overall Study|study amended pilot group of patients|4|||
150139981|NCT00504426|541647265|FG000|Overall Study|Adverse Event|0|||
150139982|NCT00504426|541647266|FG001|Overall Study|Adverse Event|0|||
150139983|NCT00504426|541647267|FG002|Overall Study|Adverse Event|2|||
150139984|NCT00504426|541647268|FG003|Overall Study|Adverse Event|0|||
150139985|NCT00504426|541647265|FG000|Overall Study|Protocol Violation|1|||
150139986|NCT00504426|541647266|FG001|Overall Study|Protocol Violation|1|||
150139987|NCT00504426|541647267|FG002|Overall Study|Protocol Violation|2|||
150139988|NCT00504426|541647268|FG003|Overall Study|Protocol Violation|0|||
150139989|NCT00504426|541647265|FG000|Overall Study|Withdrawal by Subject|2|||
150139990|NCT00504426|541647266|FG001|Overall Study|Withdrawal by Subject|0|||
150139991|NCT00504426|541647267|FG002|Overall Study|Withdrawal by Subject|0|||
150139992|NCT00504426|541647268|FG003|Overall Study|Withdrawal by Subject|0|||
150139993|NCT03685591|541647274|FG000|Overall Study|Global Deterioration of Health Status|0|||
150139994|NCT03685591|541647275|FG001|Overall Study|Global Deterioration of Health Status|0|||
150139995|NCT03685591|541647276|FG002|Overall Study|Global Deterioration of Health Status|0|||
150139996|NCT03685591|541647277|FG003|Overall Study|Global Deterioration of Health Status|1|||
150139997|NCT03685591|541647278|FG004|Overall Study|Global Deterioration of Health Status|2|||
150139998|NCT03685591|541647279|FG005|Overall Study|Global Deterioration of Health Status|4|||
150139999|NCT03685591|541647280|FG006|Overall Study|Global Deterioration of Health Status|1|||
150140000|NCT03685591|541647281|FG007|Overall Study|Global Deterioration of Health Status|1|||
150140001|NCT03685591|541647282|FG008|Overall Study|Global Deterioration of Health Status|0|||
150140002|NCT03685591|541647274|FG000|Overall Study|Progressive Disease|1|||
150140003|NCT03685591|541647275|FG001|Overall Study|Progressive Disease|1|||
150140004|NCT03685591|541647276|FG002|Overall Study|Progressive Disease|0|||
150140005|NCT03685591|541647277|FG003|Overall Study|Progressive Disease|3|||
150140006|NCT03685591|541647278|FG004|Overall Study|Progressive Disease|5|||
150140007|NCT03685591|541647279|FG005|Overall Study|Progressive Disease|4|||
150140008|NCT03685591|541647280|FG006|Overall Study|Progressive Disease|3|||
150140009|NCT03685591|541647281|FG007|Overall Study|Progressive Disease|2|||
150140010|NCT03685591|541647282|FG008|Overall Study|Progressive Disease|1|||
150140011|NCT03685591|541647274|FG000|Overall Study|Other|0|||
150140012|NCT03685591|541647275|FG001|Overall Study|Other|0|||
150140013|NCT03685591|541647276|FG002|Overall Study|Other|1|||
150140014|NCT03685591|541647277|FG003|Overall Study|Other|0|||
150140015|NCT03685591|541647278|FG004|Overall Study|Other|2|||
150140016|NCT03685591|541647279|FG005|Overall Study|Other|3|||
150140017|NCT03685591|541647280|FG006|Overall Study|Other|0|||
150140018|NCT03685591|541647281|FG007|Overall Study|Other|0|||
150140019|NCT03685591|541647282|FG008|Overall Study|Other|0|||
150140020|NCT03685591|541647274|FG000|Overall Study|Withdrawal by Subject|0|||
150140021|NCT03685591|541647275|FG001|Overall Study|Withdrawal by Subject|0|||
150140022|NCT03685591|541647276|FG002|Overall Study|Withdrawal by Subject|0|||
150140023|NCT03685591|541647277|FG003|Overall Study|Withdrawal by Subject|0|||
150140024|NCT03685591|541647278|FG004|Overall Study|Withdrawal by Subject|3|||
150140025|NCT03685591|541647279|FG005|Overall Study|Withdrawal by Subject|2|||
150140026|NCT03685591|541647280|FG006|Overall Study|Withdrawal by Subject|0|||
150140027|NCT03685591|541647281|FG007|Overall Study|Withdrawal by Subject|0|||
150140028|NCT03685591|541647282|FG008|Overall Study|Withdrawal by Subject|1|||
150212701|NCT05212285|541915810|FG001|Overall Study|Lack of Efficacy|8|||
150212702|NCT05212285|541915809|FG000|Overall Study|Withdrawal by Subject|8|||
150212703|NCT05212285|541915810|FG001|Overall Study|Withdrawal by Subject|1|||
150212704|NCT05212285|541915809|FG000|Overall Study|Lost to Follow-up|13|||
150212705|NCT05212285|541915810|FG001|Overall Study|Lost to Follow-up|1|||
150212706|NCT05212285|541915809|FG000|Overall Study|miss data|21|||
150212707|NCT05212285|541915810|FG001|Overall Study|miss data|2|||
150212708|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
150212709|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
150212710|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
150212711|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
150212712|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
150212713|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
150212714|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
150212715|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
150212716|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
150212717|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
150212718|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
150212719|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
150212720|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
150212721|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
150212722|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
150212723|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
150212724|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
150212725|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
150212726|NCT02222493|541915811|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
150212727|NCT02222493|541915812|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
150212728|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
150212729|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
150212730|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
150212731|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
150212732|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
150212733|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
150212734|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
150212735|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
150212736|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
150212737|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
150212738|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
150212739|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
150212740|NCT02222493|541915811|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
150212741|NCT02222493|541915812|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
150212742|NCT02222493|541915811|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
150212743|NCT02222493|541915812|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
150212744|NCT02222493|541915811|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
150212745|NCT02222493|541915812|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
150212746|NCT02222493|541915811|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
150212747|NCT02222493|541915812|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
150212748|NCT02222493|541915811|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
150212749|NCT02222493|541915812|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
150212750|NCT02222493|541915811|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
150212751|NCT02222493|541915812|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
150212752|NCT01000805|541915815|FG000|Overall Study|Adverse Event|21|||
150212753|NCT01000805|541915816|FG001|Overall Study|Adverse Event|9|||
150212754|NCT01000805|541915815|FG000|Overall Study|Lack of Efficacy|5|||
150212755|NCT01000805|541915816|FG001|Overall Study|Lack of Efficacy|16|||
150212756|NCT01000805|541915815|FG000|Overall Study|Lost to Follow-up|16|||
150212757|NCT01000805|541915816|FG001|Overall Study|Lost to Follow-up|21|||
150212758|NCT01000805|541915815|FG000|Overall Study|Physician Decision|0|||
150212759|NCT01000805|541915816|FG001|Overall Study|Physician Decision|1|||
150212760|NCT01000805|541915815|FG000|Overall Study|Protocol Violation|12|||
150212761|NCT01000805|541915816|FG001|Overall Study|Protocol Violation|8|||
150212762|NCT01000805|541915815|FG000|Overall Study|Withdrawal by Subject|16|||
150212763|NCT01000805|541915816|FG001|Overall Study|Withdrawal by Subject|6|||
150212764|NCT01000805|541915815|FG000|Overall Study|Sponsor Decision|0|||
150212765|NCT01000805|541915816|FG001|Overall Study|Sponsor Decision|1|||
150212766|NCT02542943|541915817|FG000|Overall Study|Lost to Follow-up|1|||
150212767|NCT02542943|541915818|FG001|Overall Study|Lost to Follow-up|0|||
150212768|NCT02542943|541915819|FG002|Overall Study|Lost to Follow-up|0|||
150212769|NCT02542943|541915817|FG000|Overall Study|Withdrawal by Subject|0|||
150212770|NCT02542943|541915818|FG001|Overall Study|Withdrawal by Subject|1|||
150212771|NCT02542943|541915819|FG002|Overall Study|Withdrawal by Subject|0|||
150212772|NCT05432986|541915822|FG000|Overall Study|Withdrawal by Subject|2|||
150212773|NCT05432986|541915822|FG000|Overall Study|incomplete measurement|7|||
150212774|NCT02556918|541917521|FG000|Overall Study|Protocol Violation|5|||
150212775|NCT02556918|541917522|FG001|Overall Study|Protocol Violation|6|||
150212776|NCT02556918|541917521|FG000|Overall Study|Withdrawal by Subject|4|||
150212777|NCT02556918|541917522|FG001|Overall Study|Withdrawal by Subject|4|||
150212778|NCT04511702|541917530|FG000|Overall Study|Lost to Follow-up|3|||
150212779|NCT04511702|541917531|FG001|Overall Study|Lost to Follow-up|0|||
150212780|NCT04511702|541917532|FG002|Overall Study|Lost to Follow-up|4|||
150212781|NCT04511702|541917530|FG000|Overall Study|Withdrawal by Subject|17|||
150212782|NCT04511702|541917531|FG001|Overall Study|Withdrawal by Subject|1|||
150212783|NCT04511702|541917532|FG002|Overall Study|Withdrawal by Subject|8|||
150212784|NCT05349721|541917533|FG000|Part A (24 Weeks)|Adverse Event|9|||
150212785|NCT05349721|541917534|FG001|Part A (24 Weeks)|Adverse Event|2|||
150212786|NCT05349721|541917533|FG000|Part A (24 Weeks)|Death|8|||
150212787|NCT05349721|541917534|FG001|Part A (24 Weeks)|Death|3|||
150212788|NCT05349721|541917533|FG000|Part A (24 Weeks)|Disease Progression|1|||
150212789|NCT05349721|541917534|FG001|Part A (24 Weeks)|Disease Progression|1|||
150212790|NCT05349721|541917533|FG000|Part A (24 Weeks)|Screen Failure|2|||
150212791|NCT05349721|541917534|FG001|Part A (24 Weeks)|Screen Failure|0|||
150212792|NCT05349721|541917533|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
150212793|NCT05349721|541917534|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
150212794|NCT05349721|541917533|FG000|Part A (24 Weeks)|Other Than Specified|5|||
150212795|NCT05349721|541917534|FG001|Part A (24 Weeks)|Other Than Specified|1|||
150212796|NCT05349721|541917533|FG000|Part B (28 Weeks)|Adverse Event|3|||
150212797|NCT05349721|541917534|FG001|Part B (28 Weeks)|Adverse Event|0|||
150212798|NCT05349721|541917533|FG000|Part B (28 Weeks)|Death|21|||
150212799|NCT05349721|541917534|FG001|Part B (28 Weeks)|Death|11|||
150212800|NCT05349721|541917533|FG000|Part B (28 Weeks)|Disease Progression|2|||
150212801|NCT05349721|541917534|FG001|Part B (28 Weeks)|Disease Progression|1|||
150212802|NCT05349721|541917533|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
150212803|NCT05349721|541917534|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
150212804|NCT05349721|541917533|FG000|Part B (28 Weeks)|Physician Decision|1|||
150212805|NCT05349721|541917534|FG001|Part B (28 Weeks)|Physician Decision|0|||
150212806|NCT05349721|541917533|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
150212807|NCT05349721|541917534|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
150212808|NCT05349721|541917533|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
150212809|NCT05349721|541917534|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
150212810|NCT05349721|541917533|FG000|Part B (28 Weeks)|Other Than Specified|4|||
150212811|NCT05349721|541917534|FG001|Part B (28 Weeks)|Other Than Specified|2|||
150212812|NCT05349721|541917533|FG000|Part C (108 Weeks)|Death|0|||
150212813|NCT05349721|541917534|FG001|Part C (108 Weeks)|Death|1|||
150212814|NCT05349721|541917533|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
150212815|NCT05349721|541917534|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
150212816|NCT05349721|541917533|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
150212817|NCT05349721|541917534|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
150212818|NCT05349721|541917533|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
150212819|NCT05349721|541917534|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
150212820|NCT00985088|541917538|FG000|Overall Study|Serious Adverse Event|1|||
150212821|NCT00985088|541917539|FG001|Overall Study|Serious Adverse Event|1|||
150212822|NCT00985088|541917540|FG002|Overall Study|Serious Adverse Event|0|||
150212823|NCT00985088|541917541|FG003|Overall Study|Serious Adverse Event|0|||
150212824|NCT00985088|541917542|FG004|Overall Study|Serious Adverse Event|0|||
150212825|NCT00985088|541917543|FG005|Overall Study|Serious Adverse Event|0|||
150212826|NCT00985088|541917544|FG006|Overall Study|Serious Adverse Event|0|||
150212827|NCT00985088|541917545|FG007|Overall Study|Serious Adverse Event|1|||
150212828|NCT00985088|541917538|FG000|Overall Study|Adverse Event|0|||
150212829|NCT00985088|541917539|FG001|Overall Study|Adverse Event|0|||
150212830|NCT00985088|541917540|FG002|Overall Study|Adverse Event|1|||
150212831|NCT00985088|541917541|FG003|Overall Study|Adverse Event|0|||
150212832|NCT00985088|541917542|FG004|Overall Study|Adverse Event|0|||
150212833|NCT00985088|541917543|FG005|Overall Study|Adverse Event|0|||
150212834|NCT00985088|541917544|FG006|Overall Study|Adverse Event|0|||
150212835|NCT00985088|541917545|FG007|Overall Study|Adverse Event|0|||
150212836|NCT00985088|541917538|FG000|Overall Study|Withdrawal by Subject|4|||
150212837|NCT00985088|541917539|FG001|Overall Study|Withdrawal by Subject|0|||
150212838|NCT00985088|541917540|FG002|Overall Study|Withdrawal by Subject|0|||
150212839|NCT00985088|541917541|FG003|Overall Study|Withdrawal by Subject|1|||
150212840|NCT00985088|541917542|FG004|Overall Study|Withdrawal by Subject|3|||
150212841|NCT00985088|541917543|FG005|Overall Study|Withdrawal by Subject|2|||
150212842|NCT00985088|541917544|FG006|Overall Study|Withdrawal by Subject|1|||
150212843|NCT00985088|541917545|FG007|Overall Study|Withdrawal by Subject|2|||
150212844|NCT00985088|541917538|FG000|Overall Study|Migrated/moved from study area|0|||
150212845|NCT00985088|541917539|FG001|Overall Study|Migrated/moved from study area|0|||
150212846|NCT00985088|541917540|FG002|Overall Study|Migrated/moved from study area|1|||
150212847|NCT00985088|541917541|FG003|Overall Study|Migrated/moved from study area|0|||
150212848|NCT00985088|541917542|FG004|Overall Study|Migrated/moved from study area|0|||
150212849|NCT00985088|541917543|FG005|Overall Study|Migrated/moved from study area|0|||
150212850|NCT00985088|541917544|FG006|Overall Study|Migrated/moved from study area|0|||
150212851|NCT00985088|541917545|FG007|Overall Study|Migrated/moved from study area|1|||
150212852|NCT00985088|541917538|FG000|Overall Study|Lost to Follow-up|6|||
150212853|NCT00985088|541917539|FG001|Overall Study|Lost to Follow-up|1|||
150212854|NCT00985088|541917540|FG002|Overall Study|Lost to Follow-up|2|||
150212855|NCT00985088|541917541|FG003|Overall Study|Lost to Follow-up|6|||
150212856|NCT00985088|541917542|FG004|Overall Study|Lost to Follow-up|6|||
150212857|NCT00985088|541917543|FG005|Overall Study|Lost to Follow-up|5|||
150212858|NCT00985088|541917544|FG006|Overall Study|Lost to Follow-up|3|||
150212859|NCT00985088|541917545|FG007|Overall Study|Lost to Follow-up|2|||
150212860|NCT01970878|541917547|FG000|Overall Study|Withdrawal by Subject|11|||
150212861|NCT01970878|541917548|FG001|Overall Study|Withdrawal by Subject|10|||
150212862|NCT01970878|541917549|FG002|Overall Study|Withdrawal by Subject|14|||
150212863|NCT01970878|541917550|FG003|Overall Study|Withdrawal by Subject|7|||
150212864|NCT01970878|541917547|FG000|Overall Study|Lost to Follow-up|1|||
150212865|NCT01970878|541917548|FG001|Overall Study|Lost to Follow-up|3|||
150212866|NCT01970878|541917549|FG002|Overall Study|Lost to Follow-up|2|||
150212867|NCT01970878|541917550|FG003|Overall Study|Lost to Follow-up|4|||
150212868|NCT01970878|541917547|FG000|Overall Study|Administrative Reasons|1|||
150212869|NCT01970878|541917548|FG001|Overall Study|Administrative Reasons|0|||
150212870|NCT01970878|541917549|FG002|Overall Study|Administrative Reasons|0|||
150212871|NCT01970878|541917550|FG003|Overall Study|Administrative Reasons|4|||
150212872|NCT01970878|541917547|FG000|Overall Study|Lack of Efficacy|2|||
150212873|NCT01970878|541917548|FG001|Overall Study|Lack of Efficacy|1|||
150212874|NCT01970878|541917549|FG002|Overall Study|Lack of Efficacy|2|||
150212875|NCT01970878|541917550|FG003|Overall Study|Lack of Efficacy|0|||
150212876|NCT01970878|541917547|FG000|Overall Study|Adverse Event|12|||
150212877|NCT01970878|541917548|FG001|Overall Study|Adverse Event|7|||
150212878|NCT01970878|541917549|FG002|Overall Study|Adverse Event|4|||
150212879|NCT01970878|541917550|FG003|Overall Study|Adverse Event|3|||
150212880|NCT01970878|541917547|FG000|Overall Study|Protocol Specified Criteria|10|||
150212881|NCT01970878|541917548|FG001|Overall Study|Protocol Specified Criteria|4|||
150212882|NCT01970878|541917549|FG002|Overall Study|Protocol Specified Criteria|3|||
150212883|NCT01970878|541917550|FG003|Overall Study|Protocol Specified Criteria|6|||
150212884|NCT01970878|541917547|FG000|Overall Study|Physician Decision|0|||
150212885|NCT01970878|541917548|FG001|Overall Study|Physician Decision|1|||
150212886|NCT01970878|541917549|FG002|Overall Study|Physician Decision|1|||
150212887|NCT01970878|541917550|FG003|Overall Study|Physician Decision|0|||
150212888|NCT01970878|541917547|FG000|Overall Study|No Completion Status|0|||
150212889|NCT01970878|541917548|FG001|Overall Study|No Completion Status|1|||
150212890|NCT01970878|541917549|FG002|Overall Study|No Completion Status|0|||
150212891|NCT01970878|541917550|FG003|Overall Study|No Completion Status|0|||
150212892|NCT06571695|541917551|FG000|Overall Study|Lost to Follow-up|1|||
150212893|NCT06571695|541917552|FG001|Overall Study|Lost to Follow-up|6|||
150212894|NCT00597376|541917553|FG000|Overall Study|Withdrawal by Subject|4|||
150212895|NCT00597376|541917554|FG001|Overall Study|Withdrawal by Subject|3|||
150212896|NCT00597376|541917553|FG000|Overall Study|Adverse Event|4|||
150212897|NCT00597376|541917554|FG001|Overall Study|Adverse Event|1|||
150212898|NCT02634307|541917555|FG000|Overall Study|Adverse Event|50|||
150212899|NCT02634307|541917556|FG001|Overall Study|Adverse Event|24|||
150212900|NCT02634307|541917557|FG002|Overall Study|Adverse Event|14|||
150212901|NCT02634307|541917555|FG000|Overall Study|Lost to Follow-up|21|||
150212902|NCT02634307|541917556|FG001|Overall Study|Lost to Follow-up|5|||
150212903|NCT02634307|541917557|FG002|Overall Study|Lost to Follow-up|6|||
150212904|NCT02634307|541917555|FG000|Overall Study|Pregnancy|5|||
150212905|NCT02634307|541917556|FG001|Overall Study|Pregnancy|1|||
150212906|NCT02634307|541917557|FG002|Overall Study|Pregnancy|3|||
150212907|NCT02634307|541917555|FG000|Overall Study|Withdrawal by Subject|38|||
150212908|NCT02634307|541917556|FG001|Overall Study|Withdrawal by Subject|24|||
150212909|NCT02634307|541917557|FG002|Overall Study|Withdrawal by Subject|18|||
150212910|NCT02634307|541917555|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150212911|NCT02634307|541917556|FG001|Overall Study|Non-Compliance with Study Drug|2|||
150212912|NCT02634307|541917557|FG002|Overall Study|Non-Compliance with Study Drug|2|||
150212913|NCT02634307|541917555|FG000|Overall Study|Lack of Efficacy|1|||
150212914|NCT02634307|541917556|FG001|Overall Study|Lack of Efficacy|5|||
150212915|NCT02634307|541917557|FG002|Overall Study|Lack of Efficacy|3|||
150212916|NCT02634307|541917555|FG000|Overall Study|Physician Decision|7|||
150212917|NCT02634307|541917556|FG001|Overall Study|Physician Decision|5|||
150212918|NCT02634307|541917557|FG002|Overall Study|Physician Decision|5|||
150212919|NCT02634307|541917555|FG000|Overall Study|Reason not Specified|3|||
150212920|NCT02634307|541917556|FG001|Overall Study|Reason not Specified|5|||
150212921|NCT02634307|541917557|FG002|Overall Study|Reason not Specified|10|||
150212922|NCT01532648|541917565|FG000|Overall Study|Lost to Follow-up|3|||
150212923|NCT01532648|541917566|FG001|Overall Study|Lost to Follow-up|4|||
150212924|NCT01532648|541917565|FG000|Overall Study|Lack of Efficacy|4|||
150212925|NCT01532648|541917566|FG001|Overall Study|Lack of Efficacy|1|||
150212926|NCT01532648|541917565|FG000|Overall Study|Protocol Violation|1|||
150212927|NCT01532648|541917566|FG001|Overall Study|Protocol Violation|1|||
150212928|NCT01532648|541917565|FG000|Overall Study|Adverse Event|12|||
150212929|NCT01532648|541917566|FG001|Overall Study|Adverse Event|9|||
150212930|NCT01532648|541917565|FG000|Overall Study|Withdrawal by Subject|16|||
150212931|NCT01532648|541917566|FG001|Overall Study|Withdrawal by Subject|2|||
150212932|NCT02824198|541917567|FG000|Overall Study|Non-compliance with the protocol|5|||
150212933|NCT02824198|541917568|FG001|Overall Study|Non-compliance with the protocol|1|||
150212934|NCT02824198|541917567|FG000|Overall Study|Lost to Follow-up|5|||
150212935|NCT02824198|541917568|FG001|Overall Study|Lost to Follow-up|2|||
150212936|NCT02824198|541917567|FG000|Overall Study|Withdrawal by Subject|5|||
150212937|NCT02824198|541917568|FG001|Overall Study|Withdrawal by Subject|0|||
150212938|NCT03883828|541917569|FG000|Overall Study|Did not start radiotherapy|1|||
150212939|NCT03883828|541917570|FG001|Overall Study|Did not start radiotherapy|2|||
150212940|NCT03737110|541917576|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
150212941|NCT03737110|541917577|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
150212942|NCT03737110|541917578|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
150212943|NCT03737110|541917579|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
150212944|NCT03737110|541917580|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
150212945|NCT03737110|541917581|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
150212946|NCT03737110|541917576|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
150212947|NCT03737110|541917577|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
150212948|NCT03737110|541917578|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
150212949|NCT03737110|541917579|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
150212950|NCT03737110|541917580|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
150212951|NCT03737110|541917581|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
150212952|NCT03737110|541917576|FG000|Run-in (RI) Period|Adverse Event|4|||
150212953|NCT03737110|541917577|FG001|Run-in (RI) Period|Adverse Event|0|||
150212954|NCT03737110|541917578|FG002|Run-in (RI) Period|Adverse Event|0|||
150212955|NCT03737110|541917579|FG003|Run-in (RI) Period|Adverse Event|0|||
150212956|NCT03737110|541917580|FG004|Run-in (RI) Period|Adverse Event|0|||
150212957|NCT03737110|541917581|FG005|Run-in (RI) Period|Adverse Event|0|||
150212958|NCT03737110|541917576|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
150212959|NCT03737110|541917577|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
150212960|NCT03737110|541917578|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
150212961|NCT03737110|541917579|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
150212962|NCT03737110|541917580|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
150212963|NCT03737110|541917581|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
150212964|NCT03737110|541917576|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
150212965|NCT03737110|541917577|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
150212966|NCT03737110|541917578|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
150212967|NCT03737110|541917579|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
150212968|NCT03737110|541917580|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
150212969|NCT03737110|541917581|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
150212970|NCT03737110|541917576|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
150212971|NCT03737110|541917577|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
150212972|NCT03737110|541917578|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
150212973|NCT03737110|541917579|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
150212974|NCT03737110|541917580|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
150212975|NCT03737110|541917581|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
150212976|NCT03737110|541917576|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
150212977|NCT03737110|541917577|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
150212978|NCT03737110|541917578|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
150212979|NCT03737110|541917579|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
150212980|NCT03737110|541917580|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
150212981|NCT03737110|541917581|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
150212982|NCT03737110|541917576|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
150212983|NCT03737110|541917577|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
150212984|NCT03737110|541917578|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
150212985|NCT03737110|541917579|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
150212986|NCT03737110|541917580|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
150212987|NCT03737110|541917581|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
150212988|NCT02575365|541917582|FG000|Overall Study|Lost to Follow-up|4|||
150212989|NCT01019135|541917583|FG000|Overall Study|Did not receive allocated intervention|12|||
150212990|NCT01019135|541917584|FG001|Overall Study|Did not receive allocated intervention|6|||
150212991|NCT01019135|541917585|FG002|Overall Study|Did not receive allocated intervention|25|||
150212992|NCT01019135|541917583|FG000|Overall Study|Did not attend CR|8|||
150212993|NCT01019135|541917584|FG001|Overall Study|Did not attend CR|13|||
150212994|NCT01019135|541917585|FG002|Overall Study|Did not attend CR|6|||
150212995|NCT04885998|541917587|FG000|Overall Study|Withdrawal by Subject|0|||
150212996|NCT04885998|541917588|FG001|Overall Study|Withdrawal by Subject|2|||
150212997|NCT04885998|541917589|FG002|Overall Study|Withdrawal by Subject|0|||
150212998|NCT04885998|541917590|FG003|Overall Study|Withdrawal by Subject|3|||
150212999|NCT04885998|541917587|FG000|Overall Study|Lost to Follow-up|1|||
150213000|NCT04885998|541917588|FG001|Overall Study|Lost to Follow-up|1|||
150213001|NCT04885998|541917589|FG002|Overall Study|Lost to Follow-up|0|||
150213002|NCT04885998|541917590|FG003|Overall Study|Lost to Follow-up|0|||
150213003|NCT04885998|541917587|FG000|Overall Study|Death|2|||
150213004|NCT04885998|541917588|FG001|Overall Study|Death|1|||
150213005|NCT04885998|541917589|FG002|Overall Study|Death|2|||
150213006|NCT04885998|541917590|FG003|Overall Study|Death|2|||
150213007|NCT04885998|541917587|FG000|Overall Study|Decision by sponsor|1|||
150213008|NCT04885998|541917588|FG001|Overall Study|Decision by sponsor|1|||
150213009|NCT04885998|541917589|FG002|Overall Study|Decision by sponsor|0|||
150213010|NCT04885998|541917590|FG003|Overall Study|Decision by sponsor|0|||
150213011|NCT01858688|541917591|FG000|Overall Study|Withdrawal by Subject|8|||
150213012|NCT01858688|541917591|FG000|Overall Study|Participant began another therapy|3|||
150213013|NCT01858688|541917591|FG000|Overall Study|Physician Decision|2|||
150213014|NCT01858688|541917591|FG000|Overall Study|Progressive Disease|2|||
150213015|NCT01858688|541917591|FG000|Overall Study|Reason not reproted|5|||
150213016|NCT00195819|541917592|FG000|Double-Blind|Withdrawal by Subject|1|||
150213017|NCT00195819|541917593|FG001|Double-Blind|Withdrawal by Subject|0|||
150213018|NCT00195819|541917592|FG000|Double-Blind|Moved|1|||
150213019|NCT00195819|541917593|FG001|Double-Blind|Moved|0|||
150213020|NCT00195819|541917592|FG000|Open-label|Adverse Event|0|||
150213021|NCT00195819|541917593|FG001|Open-label|Adverse Event|9|||
150213022|NCT00195819|541917592|FG000|Open-label|Lack of Efficacy|0|||
150213023|NCT00195819|541917593|FG001|Open-label|Lack of Efficacy|2|||
150213024|NCT00195819|541917592|FG000|Open-label|Pregnancy|0|||
150213025|NCT00195819|541917593|FG001|Open-label|Pregnancy|1|||
150213026|NCT00195819|541917592|FG000|Open-label|Protocol Violation|0|||
150213027|NCT00195819|541917593|FG001|Open-label|Protocol Violation|2|||
150213028|NCT00195819|541917592|FG000|Open-label|Moved|0|||
150213029|NCT00195819|541917593|FG001|Open-label|Moved|1|||
150213030|NCT00195819|541917592|FG000|Open-label|Withdrawal by Subject|0|||
150213031|NCT00195819|541917593|FG001|Open-label|Withdrawal by Subject|5|||
150213032|NCT01124045|541917594|FG000|Overall Study|Lost to Follow-up|0|||
150213033|NCT01124045|541917595|FG001|Overall Study|Lost to Follow-up|1|||
150213034|NCT01124045|541917594|FG000|Overall Study|Physician Decision|0|||
150213035|NCT01124045|541917595|FG001|Overall Study|Physician Decision|2|||
150213036|NCT03298087|541917597|FG000|Overall Study|Withdrawal by Subject|4|||
150213037|NCT01530334|541917598|FG000|Overall Study|Adverse Event|3|||
150213038|NCT01530334|541917598|FG000|Overall Study|unknown reason|1|||
150213039|NCT01530334|541917598|FG000|Overall Study|Progressive disease|47|||
150213040|NCT01303510|541917599|FG000|Overall Study|Lost to Follow-up|1|||
150213041|NCT01303510|541917600|FG001|Overall Study|Lost to Follow-up|0|||
150213042|NCT00822900|541917601|FG000|Overall Study|Withdrawal by Subject|14|||
150213043|NCT00822900|541917602|FG001|Overall Study|Withdrawal by Subject|14|||
150213044|NCT00822900|541917601|FG000|Overall Study|Lost to Follow-up|9|||
150213045|NCT00822900|541917602|FG001|Overall Study|Lost to Follow-up|9|||
150213046|NCT00822900|541917601|FG000|Overall Study|Death|83|||
150213047|NCT00822900|541917602|FG001|Overall Study|Death|69|||
150213048|NCT00822900|541917601|FG000|Overall Study|Became a ward of the state|2|||
150213049|NCT00822900|541917602|FG001|Overall Study|Became a ward of the state|1|||
150213050|NCT00701415|541917603|FG000|Overall Study|Adverse Event|0|||
150213051|NCT00701415|541917604|FG001|Overall Study|Adverse Event|1|||
150213052|NCT00701415|541917603|FG000|Overall Study|Social/family issues and needle phobia|1|||
150213053|NCT00701415|541917604|FG001|Overall Study|Social/family issues and needle phobia|0|||
150213054|NCT02106884|541917605|FG000|Overall Study|Change of diagnosis/exclusion|0|||
150213055|NCT02106884|541917606|FG001|Overall Study|Change of diagnosis/exclusion|1|||
150213056|NCT00109031|541917609|FG000|Overall Study|Adverse Event|0|||
150213057|NCT00109031|541917610|FG001|Overall Study|Adverse Event|0|||
150213058|NCT00109031|541917611|FG002|Overall Study|Adverse Event|1|||
150213059|NCT00109031|541917612|FG003|Overall Study|Adverse Event|0|||
150213060|NCT00109031|541917609|FG000|Overall Study|Withdrawal by Subject|0|||
150213061|NCT00109031|541917610|FG001|Overall Study|Withdrawal by Subject|1|||
150213062|NCT00109031|541917611|FG002|Overall Study|Withdrawal by Subject|0|||
150213063|NCT00109031|541917612|FG003|Overall Study|Withdrawal by Subject|0|||
150213064|NCT00109031|541917609|FG000|Overall Study|Physician Decision|0|||
150213065|NCT00109031|541917610|FG001|Overall Study|Physician Decision|1|||
150213066|NCT00109031|541917611|FG002|Overall Study|Physician Decision|0|||
150213067|NCT00109031|541917612|FG003|Overall Study|Physician Decision|0|||
150213068|NCT00109031|541917609|FG000|Overall Study|Protocol Violation|0|||
150213069|NCT00109031|541917610|FG001|Overall Study|Protocol Violation|0|||
150213070|NCT00109031|541917611|FG002|Overall Study|Protocol Violation|1|||
150213071|NCT00109031|541917612|FG003|Overall Study|Protocol Violation|0|||
150213072|NCT01822756|541917613|FG000|Overall Study|Adverse Event|0|||
150213073|NCT01822756|541917614|FG001|Overall Study|Adverse Event|0|||
150213074|NCT01822756|541917615|FG002|Overall Study|Adverse Event|0|||
150213075|NCT01822756|541917616|FG003|Overall Study|Adverse Event|2|||
150213076|NCT01822756|541917617|FG004|Overall Study|Adverse Event|0|||
150213077|NCT01822756|541917613|FG000|Overall Study|Disease progression|11|||
150213078|NCT01822756|541917614|FG001|Overall Study|Disease progression|1|||
150213079|NCT01822756|541917615|FG002|Overall Study|Disease progression|7|||
150213080|NCT01822756|541917616|FG003|Overall Study|Disease progression|2|||
150213081|NCT01822756|541917617|FG004|Overall Study|Disease progression|6|||
150213082|NCT01822756|541917613|FG000|Overall Study|Death|2|||
150213083|NCT01822756|541917614|FG001|Overall Study|Death|2|||
150213084|NCT01822756|541917615|FG002|Overall Study|Death|1|||
150213085|NCT01822756|541917616|FG003|Overall Study|Death|0|||
150213086|NCT01822756|541917617|FG004|Overall Study|Death|0|||
150213087|NCT01822756|541917613|FG000|Overall Study|Lost to Follow-up|1|||
150213088|NCT01822756|541917614|FG001|Overall Study|Lost to Follow-up|0|||
150213089|NCT01822756|541917615|FG002|Overall Study|Lost to Follow-up|1|||
150213090|NCT01822756|541917616|FG003|Overall Study|Lost to Follow-up|0|||
150213091|NCT01822756|541917617|FG004|Overall Study|Lost to Follow-up|1|||
150213092|NCT01822756|541917613|FG000|Overall Study|Physician Decision|0|||
150213093|NCT01822756|541917614|FG001|Overall Study|Physician Decision|1|||
150213094|NCT01822756|541917615|FG002|Overall Study|Physician Decision|0|||
150213095|NCT01822756|541917616|FG003|Overall Study|Physician Decision|0|||
150213096|NCT01822756|541917617|FG004|Overall Study|Physician Decision|0|||
150213097|NCT01822756|541917613|FG000|Overall Study|disease progression & patient preference|2|||
150213098|NCT01822756|541917614|FG001|Overall Study|disease progression & patient preference|0|||
150213099|NCT01822756|541917615|FG002|Overall Study|disease progression & patient preference|1|||
150213100|NCT01822756|541917616|FG003|Overall Study|disease progression & patient preference|0|||
150213101|NCT01822756|541917617|FG004|Overall Study|disease progression & patient preference|0|||
150213102|NCT02208843|541917618|FG000|Overall Study|Clinical symptoms of progression|2|||
150213103|NCT02208843|541917618|FG000|Overall Study|Progression disease according to RECIST|24|||
150213104|NCT02208843|541917618|FG000|Overall Study|Adverse Event|12|||
150213105|NCT02208843|541917618|FG000|Overall Study|Protocol Violation|1|||
150213106|NCT02208843|541917618|FG000|Overall Study|Withdrawal by Subject|1|||
150213107|NCT02208843|541917618|FG000|Overall Study|Switched to commercial afatinib|20|||
150213108|NCT03822832|541917623|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
150213109|NCT03822832|541917624|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
150213110|NCT03822832|541917623|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
150213111|NCT03822832|541917624|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
150213112|NCT03822832|541917623|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
150213113|NCT03822832|541917624|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
150213114|NCT03822832|541917623|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
150213115|NCT03822832|541917624|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
150213116|NCT03822832|541917623|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
150213117|NCT03822832|541917624|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
150213118|NCT03822832|541917623|FG000|Re-allocation|Not re-allocated to open label period|2|||
150213119|NCT03822832|541917624|FG001|Re-allocation|Not re-allocated to open label period|6|||
150213120|NCT03822832|541917623|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
150213121|NCT03822832|541917624|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
150213122|NCT03822832|541917623|FG000|Period 2 - Open Label Period|Adverse Event|0|||
150213123|NCT03822832|541917624|FG001|Period 2 - Open Label Period|Adverse Event|3|||
150213124|NCT00243867|541917625|FG000|Overall Study|Adverse Event|24|||
150213125|NCT00243867|541917626|FG001|Overall Study|Adverse Event|34|||
150213126|NCT00243867|541917625|FG000|Overall Study|Lack of Efficacy|115|||
150213127|NCT00243867|541917626|FG001|Overall Study|Lack of Efficacy|78|||
150213128|NCT00243867|541917625|FG000|Overall Study|Withdrawal by Subject|11|||
150213129|NCT00243867|541917626|FG001|Overall Study|Withdrawal by Subject|23|||
150213130|NCT00243867|541917625|FG000|Overall Study|Lost to Follow-up|2|||
150213131|NCT00243867|541917626|FG001|Overall Study|Lost to Follow-up|1|||
150213132|NCT00243867|541917625|FG000|Overall Study|Physician Decision|2|||
150213133|NCT00243867|541917626|FG001|Overall Study|Physician Decision|7|||
150213134|NCT00243867|541917625|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
150213135|NCT00243867|541917626|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
150213136|NCT01321073|541917627|FG000|Overall Study|Did not attempt implant|4|||
150213137|NCT01321073|541917627|FG000|Overall Study|Death|3|||
150213138|NCT02686658|541917634|FG000|Overall Study|Adverse Event|0|||
150213139|NCT02686658|541917635|FG001|Overall Study|Adverse Event|0|||
150213140|NCT02686658|541917636|FG002|Overall Study|Adverse Event|1|||
150213141|NCT02686658|541917637|FG003|Overall Study|Adverse Event|1|||
150213142|NCT02686658|541917638|FG004|Overall Study|Adverse Event|2|||
150213143|NCT02686658|541917639|FG005|Overall Study|Adverse Event|1|||
150213144|NCT02686658|541917634|FG000|Overall Study|Investigator decision|0|||
150213145|NCT02686658|541917635|FG001|Overall Study|Investigator decision|0|||
150213146|NCT02686658|541917636|FG002|Overall Study|Investigator decision|0|||
150213147|NCT02686658|541917637|FG003|Overall Study|Investigator decision|1|||
150213148|NCT02686658|541917638|FG004|Overall Study|Investigator decision|2|||
150213149|NCT02686658|541917639|FG005|Overall Study|Investigator decision|1|||
150213150|NCT02686658|541917634|FG000|Overall Study|Sponsor decision|1|||
150213151|NCT02686658|541917635|FG001|Overall Study|Sponsor decision|2|||
150213152|NCT02686658|541917636|FG002|Overall Study|Sponsor decision|1|||
150213153|NCT02686658|541917637|FG003|Overall Study|Sponsor decision|5|||
150213154|NCT02686658|541917638|FG004|Overall Study|Sponsor decision|13|||
150213155|NCT02686658|541917639|FG005|Overall Study|Sponsor decision|2|||
150213156|NCT02686658|541917634|FG000|Overall Study|Lost to Follow-up|0|||
150213157|NCT02686658|541917635|FG001|Overall Study|Lost to Follow-up|0|||
150213158|NCT02686658|541917636|FG002|Overall Study|Lost to Follow-up|2|||
150213159|NCT02686658|541917637|FG003|Overall Study|Lost to Follow-up|0|||
150213160|NCT02686658|541917638|FG004|Overall Study|Lost to Follow-up|0|||
150213161|NCT02686658|541917639|FG005|Overall Study|Lost to Follow-up|1|||
150213162|NCT02686658|541917634|FG000|Overall Study|Death|1|||
150213163|NCT02686658|541917635|FG001|Overall Study|Death|0|||
150213164|NCT02686658|541917636|FG002|Overall Study|Death|0|||
150213165|NCT02686658|541917637|FG003|Overall Study|Death|1|||
150213166|NCT02686658|541917638|FG004|Overall Study|Death|1|||
150213167|NCT02686658|541917639|FG005|Overall Study|Death|1|||
150213168|NCT02686658|541917634|FG000|Overall Study|Withdrawal by Subject|2|||
150213169|NCT02686658|541917635|FG001|Overall Study|Withdrawal by Subject|5|||
150213170|NCT02686658|541917636|FG002|Overall Study|Withdrawal by Subject|4|||
150213171|NCT02686658|541917637|FG003|Overall Study|Withdrawal by Subject|4|||
150213172|NCT02686658|541917638|FG004|Overall Study|Withdrawal by Subject|17|||
150213173|NCT02686658|541917639|FG005|Overall Study|Withdrawal by Subject|8|||
150213174|NCT02686658|541917634|FG000|Overall Study|Placed in hospice care|0|||
150213175|NCT02686658|541917635|FG001|Overall Study|Placed in hospice care|0|||
150213176|NCT02686658|541917636|FG002|Overall Study|Placed in hospice care|1|||
150213177|NCT02686658|541917637|FG003|Overall Study|Placed in hospice care|0|||
150213178|NCT02686658|541917638|FG004|Overall Study|Placed in hospice care|0|||
150213179|NCT02686658|541917639|FG005|Overall Study|Placed in hospice care|0|||
150213180|NCT02686658|541917634|FG000|Overall Study|Participant non-compliance|0|||
150213181|NCT02686658|541917635|FG001|Overall Study|Participant non-compliance|0|||
150213182|NCT02686658|541917636|FG002|Overall Study|Participant non-compliance|0|||
150213183|NCT02686658|541917637|FG003|Overall Study|Participant non-compliance|0|||
150213184|NCT02686658|541917638|FG004|Overall Study|Participant non-compliance|0|||
150213185|NCT02686658|541917639|FG005|Overall Study|Participant non-compliance|1|||
150213186|NCT02686658|541917634|FG000|Overall Study|Concern over coronavirus disease care|0|||
150213187|NCT02686658|541917635|FG001|Overall Study|Concern over coronavirus disease care|0|||
150213188|NCT02686658|541917636|FG002|Overall Study|Concern over coronavirus disease care|0|||
150213189|NCT02686658|541917637|FG003|Overall Study|Concern over coronavirus disease care|0|||
150213190|NCT02686658|541917638|FG004|Overall Study|Concern over coronavirus disease care|2|||
150213191|NCT02686658|541917639|FG005|Overall Study|Concern over coronavirus disease care|1|||
150213192|NCT03476798|541917645|FG000|Overall Study|Death|1|||
150213193|NCT03476798|541917645|FG000|Overall Study|Withdrawal by Subject|2|||
150213194|NCT03476798|541917645|FG000|Overall Study|Protocol Violation|2|||
150213195|NCT06269003|541917646|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
150213196|NCT06269003|541917647|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
150213197|NCT06269003|541917648|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
150213198|NCT06269003|541917649|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
150213199|NCT05865392|541917650|FG000|Overall Study|Withdrawal by Subject|4|||
150213200|NCT05865392|541917651|FG001|Overall Study|Withdrawal by Subject|0|||
150213201|NCT05865392|541917650|FG000|Overall Study|Didn't meet inclusion criteria|4|||
150213202|NCT05865392|541917651|FG001|Overall Study|Didn't meet inclusion criteria|0|||
150213203|NCT04447027|541917654|FG000|Dose Escalation|Withdrawal by Subject|1|||
150140029|NCT03685591|541647274|FG000|Overall Study|Adverse Event|0|||
150140030|NCT03685591|541647275|FG001|Overall Study|Adverse Event|0|||
150140031|NCT03685591|541647276|FG002|Overall Study|Adverse Event|0|||
150140032|NCT03685591|541647277|FG003|Overall Study|Adverse Event|1|||
150140033|NCT03685591|541647278|FG004|Overall Study|Adverse Event|1|||
150140034|NCT03685591|541647279|FG005|Overall Study|Adverse Event|4|||
150140035|NCT03685591|541647280|FG006|Overall Study|Adverse Event|0|||
150140036|NCT03685591|541647281|FG007|Overall Study|Adverse Event|1|||
150140037|NCT03685591|541647282|FG008|Overall Study|Adverse Event|1|||
150140038|NCT02220894|541647288|FG000|Overall Study|Adverse Event|127|||
150140039|NCT02220894|541647289|FG001|Overall Study|Adverse Event|74|||
150140040|NCT02220894|541647288|FG000|Overall Study|Death|418|||
150140041|NCT02220894|541647289|FG001|Overall Study|Death|508|||
150140042|NCT02220894|541647288|FG000|Overall Study|Lost to Follow-up|0|||
150140043|NCT02220894|541647289|FG001|Overall Study|Lost to Follow-up|4|||
150140044|NCT02220894|541647288|FG000|Overall Study|Site Terminated by Sponsor|2|||
150140045|NCT02220894|541647289|FG001|Overall Study|Site Terminated by Sponsor|0|||
150213204|NCT04447027|541917655|FG001|Dose Escalation|Withdrawal by Subject|4|||
150213205|NCT04447027|541917656|FG002|Dose Escalation|Withdrawal by Subject|3|||
150213206|NCT04447027|541917657|FG003|Dose Escalation|Withdrawal by Subject|3|||
150213207|NCT04447027|541917658|FG004|Dose Escalation|Withdrawal by Subject|1|||
150213208|NCT04447027|541917659|FG005|Dose Escalation|Withdrawal by Subject|0|||
150213209|NCT04447027|541917660|FG006|Dose Escalation|Withdrawal by Subject|0|||
150213210|NCT04447027|541917661|FG007|Dose Escalation|Withdrawal by Subject|0|||
150213211|NCT04447027|541917662|FG008|Dose Escalation|Withdrawal by Subject|0|||
150213212|NCT04447027|541917654|FG000|Dose Escalation|Refused further treatment|0|||
150213213|NCT04447027|541917655|FG001|Dose Escalation|Refused further treatment|1|||
150213214|NCT04447027|541917656|FG002|Dose Escalation|Refused further treatment|1|||
150213215|NCT04447027|541917657|FG003|Dose Escalation|Refused further treatment|0|||
150213216|NCT04447027|541917658|FG004|Dose Escalation|Refused further treatment|0|||
150213217|NCT04447027|541917659|FG005|Dose Escalation|Refused further treatment|0|||
150213218|NCT04447027|541917660|FG006|Dose Escalation|Refused further treatment|0|||
150213219|NCT04447027|541917661|FG007|Dose Escalation|Refused further treatment|0|||
150213220|NCT04447027|541917662|FG008|Dose Escalation|Refused further treatment|0|||
150213221|NCT04447027|541917654|FG000|Dose Expansion|Withdrawal by Subject|0|||
150213222|NCT04447027|541917655|FG001|Dose Expansion|Withdrawal by Subject|0|||
150213223|NCT04447027|541917656|FG002|Dose Expansion|Withdrawal by Subject|0|||
150213224|NCT04447027|541917657|FG003|Dose Expansion|Withdrawal by Subject|0|||
150213225|NCT04447027|541917658|FG004|Dose Expansion|Withdrawal by Subject|0|||
150213226|NCT04447027|541917659|FG005|Dose Expansion|Withdrawal by Subject|2|||
150213227|NCT04447027|541917660|FG006|Dose Expansion|Withdrawal by Subject|0|||
150213228|NCT04447027|541917661|FG007|Dose Expansion|Withdrawal by Subject|2|||
150213229|NCT04447027|541917662|FG008|Dose Expansion|Withdrawal by Subject|0|||
150213230|NCT04118894|541917663|FG000|Overall Study|Lost to Follow-up|21|||
150213231|NCT04118894|541917663|FG000|Overall Study|Withdrawal by Subject|10|||
150213232|NCT04118894|541917663|FG000|Overall Study|Adverse Event|4|||
150213233|NCT00108355|541919314|FG000|Overall Study|Peritonitis at index paracentesis|1|||
150213234|NCT00108355|541919315|FG001|Overall Study|Peritonitis at index paracentesis|1|||
150213235|NCT00108355|541919314|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
150213236|NCT00108355|541919315|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
150213237|NCT01364597|541919316|FG000|Overall Study|Adverse Event|4|||
150213238|NCT01364597|541919317|FG001|Overall Study|Adverse Event|5|||
150213239|NCT01364597|541919318|FG002|Overall Study|Adverse Event|16|||
150213240|NCT01364597|541919319|FG003|Overall Study|Adverse Event|7|||
150213241|NCT01364597|541919316|FG000|Overall Study|Lack of Efficacy|4|||
150213242|NCT01364597|541919317|FG001|Overall Study|Lack of Efficacy|4|||
150213243|NCT01364597|541919318|FG002|Overall Study|Lack of Efficacy|23|||
150213244|NCT01364597|541919319|FG003|Overall Study|Lack of Efficacy|8|||
150213245|NCT01364597|541919316|FG000|Overall Study|Protocol Violation|0|||
150213246|NCT01364597|541919317|FG001|Overall Study|Protocol Violation|0|||
150213247|NCT01364597|541919318|FG002|Overall Study|Protocol Violation|2|||
150213248|NCT01364597|541919319|FG003|Overall Study|Protocol Violation|0|||
150213249|NCT01364597|541919316|FG000|Overall Study|Lost to Follow-up|0|||
150213250|NCT01364597|541919317|FG001|Overall Study|Lost to Follow-up|0|||
150213251|NCT01364597|541919318|FG002|Overall Study|Lost to Follow-up|5|||
150213252|NCT01364597|541919319|FG003|Overall Study|Lost to Follow-up|3|||
150213253|NCT01364597|541919316|FG000|Overall Study|Withdrawal by Subject|4|||
150213254|NCT01364597|541919317|FG001|Overall Study|Withdrawal by Subject|1|||
150213255|NCT01364597|541919318|FG002|Overall Study|Withdrawal by Subject|18|||
150213256|NCT01364597|541919319|FG003|Overall Study|Withdrawal by Subject|6|||
150213257|NCT01364597|541919316|FG000|Overall Study|Non compliance|1|||
150213258|NCT01364597|541919317|FG001|Overall Study|Non compliance|0|||
150213259|NCT01364597|541919318|FG002|Overall Study|Non compliance|1|||
150213260|NCT01364597|541919319|FG003|Overall Study|Non compliance|0|||
150213261|NCT01364597|541919316|FG000|Overall Study|Lack of compliance|1|||
150213262|NCT01364597|541919317|FG001|Overall Study|Lack of compliance|0|||
150213263|NCT01364597|541919318|FG002|Overall Study|Lack of compliance|0|||
150213264|NCT01364597|541919319|FG003|Overall Study|Lack of compliance|0|||
150213265|NCT01364597|541919316|FG000|Overall Study|End of treatment epilepsy|1|||
150213266|NCT01364597|541919317|FG001|Overall Study|End of treatment epilepsy|0|||
150213267|NCT01364597|541919318|FG002|Overall Study|End of treatment epilepsy|0|||
150213268|NCT01364597|541919319|FG003|Overall Study|End of treatment epilepsy|0|||
150213269|NCT01364597|541919316|FG000|Overall Study|No Seizures|1|||
150213270|NCT01364597|541919317|FG001|Overall Study|No Seizures|0|||
150213271|NCT01364597|541919318|FG002|Overall Study|No Seizures|0|||
150213272|NCT01364597|541919319|FG003|Overall Study|No Seizures|0|||
150213273|NCT01364597|541919316|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
150213274|NCT01364597|541919317|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
150213275|NCT01364597|541919318|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
150213276|NCT01364597|541919319|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
150213277|NCT01364597|541919316|FG000|Overall Study|Cure|1|||
150213278|NCT01364597|541919317|FG001|Overall Study|Cure|0|||
150213279|NCT01364597|541919318|FG002|Overall Study|Cure|0|||
150213280|NCT01364597|541919319|FG003|Overall Study|Cure|0|||
150213281|NCT01364597|541919316|FG000|Overall Study|Patient was moving|0|||
150213282|NCT01364597|541919317|FG001|Overall Study|Patient was moving|1|||
150213283|NCT01364597|541919318|FG002|Overall Study|Patient was moving|0|||
150213284|NCT01364597|541919319|FG003|Overall Study|Patient was moving|0|||
150213285|NCT01364597|541919316|FG000|Overall Study|Seizures resolved|0|||
150213286|NCT01364597|541919317|FG001|Overall Study|Seizures resolved|0|||
150213287|NCT01364597|541919318|FG002|Overall Study|Seizures resolved|1|||
150213288|NCT01364597|541919319|FG003|Overall Study|Seizures resolved|0|||
150213289|NCT01364597|541919316|FG000|Overall Study|Patient became seizure-free after surgery|0|||
150213290|NCT01364597|541919317|FG001|Overall Study|Patient became seizure-free after surgery|0|||
150213291|NCT01364597|541919318|FG002|Overall Study|Patient became seizure-free after surgery|1|||
150213292|NCT01364597|541919319|FG003|Overall Study|Patient became seizure-free after surgery|0|||
150213293|NCT01364597|541919316|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
150213294|NCT01364597|541919317|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
150213295|NCT01364597|541919318|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
150213296|NCT01364597|541919319|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
150213297|NCT01364597|541919316|FG000|Overall Study|Patient cured from Epilepsy|0|||
150213298|NCT01364597|541919317|FG001|Overall Study|Patient cured from Epilepsy|0|||
150213299|NCT01364597|541919318|FG002|Overall Study|Patient cured from Epilepsy|1|||
150213300|NCT01364597|541919319|FG003|Overall Study|Patient cured from Epilepsy|0|||
150213301|NCT01364597|541919316|FG000|Overall Study|Investigator decision|0|||
150213302|NCT01364597|541919317|FG001|Overall Study|Investigator decision|0|||
150213303|NCT01364597|541919318|FG002|Overall Study|Investigator decision|1|||
150213304|NCT01364597|541919319|FG003|Overall Study|Investigator decision|0|||
150213305|NCT01364597|541919316|FG000|Overall Study|Sponsor recommended discontinuation|0|||
150213306|NCT01364597|541919317|FG001|Overall Study|Sponsor recommended discontinuation|0|||
150213307|NCT01364597|541919318|FG002|Overall Study|Sponsor recommended discontinuation|0|||
150213308|NCT01364597|541919319|FG003|Overall Study|Sponsor recommended discontinuation|1|||
150213309|NCT01364597|541919316|FG000|Overall Study|Parents went abroad with the patient|0|||
150213310|NCT01364597|541919317|FG001|Overall Study|Parents went abroad with the patient|0|||
150213311|NCT01364597|541919318|FG002|Overall Study|Parents went abroad with the patient|1|||
150213312|NCT01364597|541919319|FG003|Overall Study|Parents went abroad with the patient|0|||
150213313|NCT01364597|541919316|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
150213314|NCT01364597|541919317|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
150213315|NCT01364597|541919318|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
150213316|NCT01364597|541919319|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
150213317|NCT01364597|541919316|FG000|Overall Study|BRV administration dropout|0|||
150213318|NCT01364597|541919317|FG001|Overall Study|BRV administration dropout|0|||
150213319|NCT01364597|541919318|FG002|Overall Study|BRV administration dropout|1|||
150213320|NCT01364597|541919319|FG003|Overall Study|BRV administration dropout|0|||
150213321|NCT01364597|541919316|FG000|Overall Study|Dropout|0|||
150213322|NCT01364597|541919317|FG001|Overall Study|Dropout|0|||
150213323|NCT01364597|541919318|FG002|Overall Study|Dropout|3|||
150213324|NCT01364597|541919319|FG003|Overall Study|Dropout|1|||
150213325|NCT01364597|541919316|FG000|Overall Study|Unreliable subject|0|||
150213326|NCT01364597|541919317|FG001|Overall Study|Unreliable subject|0|||
150213327|NCT01364597|541919318|FG002|Overall Study|Unreliable subject|0|||
150213328|NCT01364597|541919319|FG003|Overall Study|Unreliable subject|1|||
150213329|NCT01364597|541919316|FG000|Overall Study|Other|0|||
150213330|NCT01364597|541919317|FG001|Overall Study|Other|0|||
150213331|NCT01364597|541919318|FG002|Overall Study|Other|0|||
150213332|NCT01364597|541919319|FG003|Overall Study|Other|1|||
150213333|NCT03493282|541919320|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
150213334|NCT03493282|541919321|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
150213335|NCT03493282|541919322|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
150213336|NCT03493282|541919320|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
150213337|NCT03493282|541919321|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
150213338|NCT03493282|541919322|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
150213339|NCT02038049|541919323|FG000|Overall Study|Lost to Follow-up|1|||
150213340|NCT02038049|541919324|FG001|Overall Study|Lost to Follow-up|0|||
150213341|NCT00667017|541919325|FG000|Overall Study|Withdrawal by Subject|1|||
150213342|NCT01823224|541919326|FG000|Overall Study|Lost to Follow-up|5|||
150213343|NCT01823224|541919327|FG001|Overall Study|Lost to Follow-up|6|||
150213344|NCT01823224|541919326|FG000|Overall Study|didn't qualify|1|||
150213345|NCT01823224|541919327|FG001|Overall Study|didn't qualify|2|||
150213346|NCT01823224|541919326|FG000|Overall Study|pharmacy error|0|||
150213347|NCT01823224|541919327|FG001|Overall Study|pharmacy error|1|||
150213348|NCT01823224|541919326|FG000|Overall Study|missed med dose|0|||
150213349|NCT01823224|541919327|FG001|Overall Study|missed med dose|1|||
150213350|NCT01823224|541919326|FG000|Overall Study|Withdrawal by Subject|0|||
150213351|NCT01823224|541919327|FG001|Overall Study|Withdrawal by Subject|1|||
150213352|NCT00587171|541919328|FG000|Overall Study|Lost to Follow-up|1|||
150213353|NCT00587171|541919329|FG001|Overall Study|Lost to Follow-up|1|||
150213354|NCT02148705|541919333|FG000|Overall Study|Death|2|||
150213355|NCT02148705|541919334|FG001|Overall Study|Death|0|||
150213356|NCT02148705|541919335|FG002|Overall Study|Death|0|||
150213357|NCT02148705|541919333|FG000|Overall Study|Lost to Follow-up|13|||
150213358|NCT02148705|541919334|FG001|Overall Study|Lost to Follow-up|4|||
150213359|NCT02148705|541919335|FG002|Overall Study|Lost to Follow-up|10|||
150213360|NCT02148705|541919333|FG000|Overall Study|Withdrawal by Subject|3|||
150213361|NCT02148705|541919334|FG001|Overall Study|Withdrawal by Subject|0|||
150213362|NCT02148705|541919335|FG002|Overall Study|Withdrawal by Subject|2|||
150213363|NCT02148705|541919333|FG000|Overall Study|Not Treated|0|||
150213364|NCT02148705|541919334|FG001|Overall Study|Not Treated|1|||
150213365|NCT02148705|541919335|FG002|Overall Study|Not Treated|5|||
150213366|NCT01737021|541919338|FG000|Overall Study|Lost to Follow-up|5|||
150213367|NCT01737021|541919339|FG001|Overall Study|Lost to Follow-up|3|||
150213368|NCT01673594|541919340|FG000|Overall Study|Adverse Event|3|||
150213369|NCT01673594|541919341|FG001|Overall Study|Adverse Event|1|||
150213370|NCT01673594|541919340|FG000|Overall Study|Lost to Follow-up|1|||
150213371|NCT01673594|541919341|FG001|Overall Study|Lost to Follow-up|0|||
150213372|NCT01673594|541919340|FG000|Overall Study|Physician Decision|2|||
150213373|NCT01673594|541919341|FG001|Overall Study|Physician Decision|4|||
150213374|NCT01673594|541919340|FG000|Overall Study|Withdrawal by Subject|0|||
150213375|NCT01673594|541919341|FG001|Overall Study|Withdrawal by Subject|1|||
150213376|NCT02605174|541919345|FG000|Overall Study|Adverse Event|0|||
150213377|NCT02605174|541919346|FG001|Overall Study|Adverse Event|0|||
150213378|NCT02605174|541919347|FG002|Overall Study|Adverse Event|1|||
150213379|NCT02605174|541919348|FG003|Overall Study|Adverse Event|0|||
150213380|NCT02605174|541919349|FG004|Overall Study|Adverse Event|4|||
150213381|NCT02605174|541919350|FG005|Overall Study|Adverse Event|0|||
150213382|NCT02605174|541919351|FG006|Overall Study|Adverse Event|0|||
150213383|NCT02605174|541919345|FG000|Overall Study|Lost to Follow-up|20|||
150213384|NCT02605174|541919346|FG001|Overall Study|Lost to Follow-up|7|||
150213385|NCT02605174|541919347|FG002|Overall Study|Lost to Follow-up|27|||
150213386|NCT02605174|541919348|FG003|Overall Study|Lost to Follow-up|10|||
150213387|NCT02605174|541919349|FG004|Overall Study|Lost to Follow-up|20|||
150213388|NCT02605174|541919350|FG005|Overall Study|Lost to Follow-up|10|||
150213389|NCT02605174|541919351|FG006|Overall Study|Lost to Follow-up|29|||
150213390|NCT02605174|541919345|FG000|Overall Study|Protocol Violation|10|||
150213391|NCT02605174|541919346|FG001|Overall Study|Protocol Violation|4|||
150213392|NCT02605174|541919347|FG002|Overall Study|Protocol Violation|14|||
150213393|NCT02605174|541919348|FG003|Overall Study|Protocol Violation|6|||
150213394|NCT02605174|541919349|FG004|Overall Study|Protocol Violation|7|||
150213395|NCT02605174|541919350|FG005|Overall Study|Protocol Violation|7|||
150213396|NCT02605174|541919351|FG006|Overall Study|Protocol Violation|12|||
150213397|NCT02605174|541919345|FG000|Overall Study|Pregnancy|1|||
150213398|NCT02605174|541919346|FG001|Overall Study|Pregnancy|0|||
150213399|NCT02605174|541919347|FG002|Overall Study|Pregnancy|0|||
150213400|NCT02605174|541919348|FG003|Overall Study|Pregnancy|2|||
150213401|NCT02605174|541919349|FG004|Overall Study|Pregnancy|0|||
150213402|NCT02605174|541919350|FG005|Overall Study|Pregnancy|0|||
150213403|NCT02605174|541919351|FG006|Overall Study|Pregnancy|0|||
150213404|NCT02605174|541919345|FG000|Overall Study|Withdrawal by Subject|9|||
150213405|NCT02605174|541919346|FG001|Overall Study|Withdrawal by Subject|6|||
150213406|NCT02605174|541919347|FG002|Overall Study|Withdrawal by Subject|14|||
150213407|NCT02605174|541919348|FG003|Overall Study|Withdrawal by Subject|11|||
150213408|NCT02605174|541919349|FG004|Overall Study|Withdrawal by Subject|6|||
150213409|NCT02605174|541919350|FG005|Overall Study|Withdrawal by Subject|4|||
150213410|NCT02605174|541919351|FG006|Overall Study|Withdrawal by Subject|15|||
150213411|NCT02605174|541919345|FG000|Overall Study|Physician Decision|2|||
150213412|NCT02605174|541919346|FG001|Overall Study|Physician Decision|0|||
150213413|NCT02605174|541919347|FG002|Overall Study|Physician Decision|0|||
150213414|NCT02605174|541919348|FG003|Overall Study|Physician Decision|0|||
150213415|NCT02605174|541919349|FG004|Overall Study|Physician Decision|0|||
150213416|NCT02605174|541919350|FG005|Overall Study|Physician Decision|0|||
150213417|NCT02605174|541919351|FG006|Overall Study|Physician Decision|3|||
150213418|NCT02605174|541919345|FG000|Overall Study|Randomization Failure|22|||
150213419|NCT02605174|541919346|FG001|Overall Study|Randomization Failure|6|||
150213420|NCT02605174|541919347|FG002|Overall Study|Randomization Failure|20|||
150213421|NCT02605174|541919348|FG003|Overall Study|Randomization Failure|7|||
150213422|NCT02605174|541919349|FG004|Overall Study|Randomization Failure|16|||
150213423|NCT02605174|541919350|FG005|Overall Study|Randomization Failure|11|||
150213424|NCT02605174|541919351|FG006|Overall Study|Randomization Failure|30|||
150213425|NCT04250636|541919352|FG000|Overall Study|Lost to Follow-up|2|||
150213426|NCT01779050|541919353|FG000|Overall Study|Withdrawal by Subject|1|||
150213427|NCT01779050|541919354|FG001|Overall Study|Withdrawal by Subject|0|||
150213428|NCT01353274|541919355|FG000|Overall Study|No case report form (CRF) collected|28|||
150213429|NCT03648541|541919356|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
150213430|NCT03648541|541919357|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
150213431|NCT03648541|541919356|FG000|Re-induction Period Only|Lack of Efficacy|7|||
150213432|NCT03648541|541919357|FG001|Re-induction Period Only|Lack of Efficacy|0|||
150213433|NCT03648541|541919356|FG000|Maintenance Period Only|Missing|0|||
150213434|NCT03648541|541919357|FG001|Maintenance Period Only|Missing|1|||
150213435|NCT03648541|541919356|FG000|Maintenance Period Only|Other not listed below|0|||
150213436|NCT03648541|541919357|FG001|Maintenance Period Only|Other not listed below|4|||
150213437|NCT03648541|541919356|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
150213438|NCT03648541|541919357|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
150213439|NCT03648541|541919356|FG000|Maintenance Period Only|Protocol Violation|0|||
150213440|NCT03648541|541919357|FG001|Maintenance Period Only|Protocol Violation|1|||
150213441|NCT03648541|541919356|FG000|Maintenance Period Only|Lack of Efficacy|0|||
150213442|NCT03648541|541919357|FG001|Maintenance Period Only|Lack of Efficacy|18|||
150213443|NCT03648541|541919356|FG000|Maintenance Period Only|Adverse Event|0|||
150213444|NCT03648541|541919357|FG001|Maintenance Period Only|Adverse Event|4|||
150213445|NCT03648541|541919356|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
150213446|NCT03648541|541919357|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
150213447|NCT00273052|541919360|FG000|Overall Study|Withdrawal by Subject|16|||
150213448|NCT00273052|541919361|FG001|Overall Study|Withdrawal by Subject|19|||
150213449|NCT00273052|541919360|FG000|Overall Study|Adverse Event|21|||
150213450|NCT00273052|541919361|FG001|Overall Study|Adverse Event|19|||
150213451|NCT00273052|541919360|FG000|Overall Study|Protocol Violation|14|||
150213452|NCT00273052|541919361|FG001|Overall Study|Protocol Violation|18|||
150213453|NCT00273052|541919360|FG000|Overall Study|Lost to Follow-up|7|||
150213454|NCT00273052|541919361|FG001|Overall Study|Lost to Follow-up|25|||
150213455|NCT00273052|541919360|FG000|Overall Study|Lack of Efficacy|6|||
150213456|NCT00273052|541919361|FG001|Overall Study|Lack of Efficacy|4|||
150213457|NCT00273052|541919360|FG000|Overall Study|Non-Compliance|3|||
150213458|NCT00273052|541919361|FG001|Overall Study|Non-Compliance|1|||
150213459|NCT00273052|541919360|FG000|Overall Study|Other|2|||
150213460|NCT00273052|541919361|FG001|Overall Study|Other|0|||
150213461|NCT00273052|541919360|FG000|Overall Study|Worsening serum lipid levels|0|||
150213462|NCT00273052|541919361|FG001|Overall Study|Worsening serum lipid levels|2|||
150213463|NCT01852045|541919364|FG000|Overall Study|Adverse Event|1|||
150213464|NCT01852045|541919365|FG001|Overall Study|Adverse Event|0|||
150213465|NCT01852045|541919366|FG002|Overall Study|Adverse Event|0|||
150213466|NCT01852045|541919364|FG000|Overall Study|Lack of Efficacy|3|||
150213467|NCT01852045|541919365|FG001|Overall Study|Lack of Efficacy|0|||
150213468|NCT01852045|541919366|FG002|Overall Study|Lack of Efficacy|0|||
150213469|NCT01852045|541919364|FG000|Overall Study|Lost to Follow-up|0|||
150213470|NCT01852045|541919365|FG001|Overall Study|Lost to Follow-up|1|||
150213471|NCT01852045|541919366|FG002|Overall Study|Lost to Follow-up|1|||
150213472|NCT01852045|541919364|FG000|Overall Study|Withdrawal by Subject|1|||
150213473|NCT01852045|541919365|FG001|Overall Study|Withdrawal by Subject|0|||
150213474|NCT01852045|541919366|FG002|Overall Study|Withdrawal by Subject|1|||
150213475|NCT01852045|541919364|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150213476|NCT01852045|541919365|FG001|Overall Study|Other Miscellaneous Reasons|3|||
150213477|NCT01852045|541919366|FG002|Overall Study|Other Miscellaneous Reasons|2|||
150213478|NCT02827201|541919367|FG000|Overall Study|Death|1|||
150213479|NCT02827201|541919368|FG001|Overall Study|Death|2|||
150213480|NCT02827201|541919367|FG000|Overall Study|Patients not treated|1|||
150213481|NCT02827201|541919368|FG001|Overall Study|Patients not treated|1|||
150213482|NCT02736188|541919369|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
150213483|NCT02736188|541919369|FG000|Overall Study|Adverse Event|1|||
150213484|NCT02736188|541919369|FG000|Overall Study|Withdrawal by Subject|1|||
150213485|NCT02736188|541919369|FG000|Overall Study|Other|6|||
150213486|NCT02630186|541919370|FG000|Overall Study|Withdrawal by Subject|1|||
150213487|NCT00439218|541919371|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
150213488|NCT03176407|541919372|FG000|Overall Study|Protocol Violation|1|||
150213489|NCT03176407|541919372|FG000|Overall Study|human failure|1|||
150213490|NCT03176407|541919372|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
150213491|NCT01428583|541919374|FG000|Overall Study|Adverse Event|75|||
150213492|NCT01428583|541919374|FG000|Overall Study|Withdrawal by Subject|51|||
150213493|NCT01428583|541919374|FG000|Overall Study|Lack of Efficacy|37|||
150213494|NCT01428583|541919374|FG000|Overall Study|Lost to Follow-up|17|||
150213495|NCT01428583|541919374|FG000|Overall Study|Death|1|||
150213496|NCT01428583|541919374|FG000|Overall Study|Pregnancy|1|||
150213497|NCT01428583|541919374|FG000|Overall Study|Protocol Violation|1|||
150213498|NCT01428583|541919374|FG000|Overall Study|Physician Decision|12|||
150213499|NCT01428583|541919374|FG000|Overall Study|Non-compliant|25|||
150213500|NCT01428583|541919374|FG000|Overall Study|Confirmed positive urine drug test|8|||
150213501|NCT01428583|541919374|FG000|Overall Study|Sponsor's request|3|||
150213502|NCT01428583|541919374|FG000|Overall Study|Other|6|||
150213503|NCT00768755|541919377|FG000|Phase 1|Death|6|||
150213504|NCT00768755|541919378|FG001|Phase 1|Death|0|||
150213505|NCT00768755|541919379|FG002|Phase 1|Death|0|||
150213506|NCT00768755|541919380|FG003|Phase 1|Death|0|||
150213507|NCT00768755|541919377|FG000|Phase 1|Other|4|||
150213508|NCT00768755|541919378|FG001|Phase 1|Other|0|||
150213509|NCT00768755|541919379|FG002|Phase 1|Other|0|||
150213510|NCT00768755|541919380|FG003|Phase 1|Other|0|||
150213511|NCT00768755|541919377|FG000|Phase 2|Death|0|||
150213512|NCT00768755|541919378|FG001|Phase 2|Death|37|||
150213513|NCT00768755|541919379|FG002|Phase 2|Death|48|||
150213514|NCT00768755|541919380|FG003|Phase 2|Death|31|||
150213515|NCT00768755|541919377|FG000|Phase 2|Protocol Violation|0|||
150213516|NCT00768755|541919378|FG001|Phase 2|Protocol Violation|2|||
150213517|NCT00768755|541919379|FG002|Phase 2|Protocol Violation|0|||
150213518|NCT00768755|541919380|FG003|Phase 2|Protocol Violation|1|||
150213519|NCT00768755|541919377|FG000|Phase 2|Lost to Follow-up|0|||
150213520|NCT00768755|541919378|FG001|Phase 2|Lost to Follow-up|1|||
150213521|NCT00768755|541919379|FG002|Phase 2|Lost to Follow-up|1|||
150213522|NCT00768755|541919380|FG003|Phase 2|Lost to Follow-up|4|||
150213523|NCT00768755|541919377|FG000|Phase 2|Withdrawal by Subject|0|||
150213524|NCT00768755|541919378|FG001|Phase 2|Withdrawal by Subject|1|||
150213525|NCT00768755|541919379|FG002|Phase 2|Withdrawal by Subject|0|||
150213526|NCT00768755|541919380|FG003|Phase 2|Withdrawal by Subject|1|||
150213527|NCT00768755|541919377|FG000|Phase 2|Other|0|||
150213528|NCT00768755|541919378|FG001|Phase 2|Other|1|||
150213529|NCT00768755|541919379|FG002|Phase 2|Other|2|||
150213530|NCT00768755|541919380|FG003|Phase 2|Other|4|||
150213531|NCT00768755|541919377|FG000|Phase 2|Study Terminated by Sponsor|0|||
150213532|NCT00768755|541919378|FG001|Phase 2|Study Terminated by Sponsor|13|||
150213533|NCT00768755|541919379|FG002|Phase 2|Study Terminated by Sponsor|7|||
150213534|NCT00768755|541919380|FG003|Phase 2|Study Terminated by Sponsor|14|||
150213535|NCT00768755|541919377|FG000|Phase 2|Randomized but not treated|0|||
150213536|NCT00768755|541919378|FG001|Phase 2|Randomized but not treated|0|||
150213537|NCT00768755|541919379|FG002|Phase 2|Randomized but not treated|0|||
150213538|NCT00768755|541919380|FG003|Phase 2|Randomized but not treated|2|||
150213539|NCT00670488|541919381|FG000|Overall Study|Adverse Event|0|||
150213540|NCT00670488|541919382|FG001|Overall Study|Adverse Event|7|||
150213541|NCT00670488|541919383|FG002|Overall Study|Adverse Event|0|||
150213542|NCT00670488|541919384|FG003|Overall Study|Adverse Event|3|||
150213543|NCT00670488|541919385|FG004|Overall Study|Adverse Event|1|||
150213544|NCT00670488|541919386|FG005|Overall Study|Adverse Event|1|||
150213545|NCT00670488|541919387|FG006|Overall Study|Adverse Event|5|||
150213546|NCT00670488|541919388|FG007|Overall Study|Adverse Event|1|||
150213547|NCT00670488|541919389|FG008|Overall Study|Adverse Event|0|||
150213548|NCT00670488|541919390|FG009|Overall Study|Adverse Event|1|||
150213549|NCT00670488|541919381|FG000|Overall Study|Physician Decision|1|||
150213550|NCT00670488|541919382|FG001|Overall Study|Physician Decision|9|||
150213551|NCT00670488|541919383|FG002|Overall Study|Physician Decision|0|||
150213552|NCT00670488|541919384|FG003|Overall Study|Physician Decision|1|||
150213553|NCT00670488|541919385|FG004|Overall Study|Physician Decision|0|||
150213554|NCT00670488|541919386|FG005|Overall Study|Physician Decision|0|||
150213555|NCT00670488|541919387|FG006|Overall Study|Physician Decision|0|||
150213556|NCT00670488|541919388|FG007|Overall Study|Physician Decision|0|||
150213557|NCT00670488|541919389|FG008|Overall Study|Physician Decision|0|||
150213558|NCT00670488|541919390|FG009|Overall Study|Physician Decision|0|||
150213559|NCT00670488|541919381|FG000|Overall Study|Progressive Disease|2|||
150213560|NCT00670488|541919382|FG001|Overall Study|Progressive Disease|41|||
150213561|NCT00670488|541919383|FG002|Overall Study|Progressive Disease|3|||
150213562|NCT00670488|541919384|FG003|Overall Study|Progressive Disease|2|||
150213563|NCT00670488|541919385|FG004|Overall Study|Progressive Disease|2|||
150213564|NCT00670488|541919386|FG005|Overall Study|Progressive Disease|4|||
150213565|NCT00670488|541919387|FG006|Overall Study|Progressive Disease|11|||
150213566|NCT00670488|541919388|FG007|Overall Study|Progressive Disease|2|||
150213567|NCT00670488|541919389|FG008|Overall Study|Progressive Disease|2|||
150213568|NCT00670488|541919390|FG009|Overall Study|Progressive Disease|1|||
150213569|NCT00670488|541919381|FG000|Overall Study|Withdrawal by Subject|0|||
150213570|NCT00670488|541919382|FG001|Overall Study|Withdrawal by Subject|1|||
150213571|NCT00670488|541919383|FG002|Overall Study|Withdrawal by Subject|0|||
150213572|NCT00670488|541919384|FG003|Overall Study|Withdrawal by Subject|1|||
150213573|NCT00670488|541919385|FG004|Overall Study|Withdrawal by Subject|0|||
150213574|NCT00670488|541919386|FG005|Overall Study|Withdrawal by Subject|0|||
150213575|NCT00670488|541919387|FG006|Overall Study|Withdrawal by Subject|1|||
150213576|NCT00670488|541919388|FG007|Overall Study|Withdrawal by Subject|0|||
150213577|NCT00670488|541919389|FG008|Overall Study|Withdrawal by Subject|1|||
150213578|NCT00670488|541919390|FG009|Overall Study|Withdrawal by Subject|0|||
150213579|NCT02708498|541919391|FG000|Overall Study|Death|20|||
150213580|NCT02708498|541919392|FG001|Overall Study|Death|19|||
150213581|NCT02708498|541919393|FG002|Overall Study|Death|0|||
150213582|NCT02708498|541919394|FG003|Overall Study|Death|0|||
150213583|NCT02708498|541919395|FG004|Overall Study|Death|1|||
150213584|NCT02708498|541919396|FG005|Overall Study|Death|0|||
150213585|NCT02708498|541919397|FG006|Overall Study|Death|0|||
150213586|NCT02708498|541919398|FG007|Overall Study|Death|0|||
150213587|NCT02708498|541919391|FG000|Overall Study|Unknown reason, missing data|0|||
150213588|NCT02708498|541919392|FG001|Overall Study|Unknown reason, missing data|0|||
150213589|NCT02708498|541919393|FG002|Overall Study|Unknown reason, missing data|62|||
150213590|NCT02708498|541919394|FG003|Overall Study|Unknown reason, missing data|51|||
150213591|NCT02708498|541919395|FG004|Overall Study|Unknown reason, missing data|195|||
150213592|NCT02708498|541919396|FG005|Overall Study|Unknown reason, missing data|132|||
150213593|NCT02708498|541919397|FG006|Overall Study|Unknown reason, missing data|0|||
150213594|NCT02708498|541919398|FG007|Overall Study|Unknown reason, missing data|0|||
150213595|NCT03052517|541919401|FG000|Overall Study|Study Terminated By Sponsor|928|||
150213596|NCT03052517|541919402|FG001|Overall Study|Study Terminated By Sponsor|938|||
150213597|NCT03052517|541919403|FG002|Overall Study|Study Terminated By Sponsor|296|||
150213598|NCT03052517|541919401|FG000|Overall Study|Subject/Guardian Decision|50|||
150213599|NCT03052517|541919402|FG001|Overall Study|Subject/Guardian Decision|45|||
150213600|NCT03052517|541919403|FG002|Overall Study|Subject/Guardian Decision|22|||
150213601|NCT03052517|541919401|FG000|Overall Study|Lack of Efficacy|23|||
150213602|NCT03052517|541919402|FG001|Overall Study|Lack of Efficacy|14|||
150213603|NCT03052517|541919403|FG002|Overall Study|Lack of Efficacy|7|||
150213604|NCT03052517|541919401|FG000|Overall Study|Adverse Event|6|||
150213605|NCT03052517|541919402|FG001|Overall Study|Adverse Event|5|||
150213606|NCT03052517|541919403|FG002|Overall Study|Adverse Event|0|||
150213607|NCT03052517|541919401|FG000|Overall Study|Physician Decision|4|||
150213608|NCT03052517|541919402|FG001|Overall Study|Physician Decision|5|||
150213609|NCT03052517|541919403|FG002|Overall Study|Physician Decision|1|||
150213610|NCT03052517|541919401|FG000|Overall Study|Death|3|||
150213611|NCT03052517|541919402|FG001|Overall Study|Death|0|||
150213612|NCT03052517|541919403|FG002|Overall Study|Death|1|||
150213613|NCT03052517|541919401|FG000|Overall Study|Lost to Follow-up|2|||
150213614|NCT03052517|541919402|FG001|Overall Study|Lost to Follow-up|4|||
150213615|NCT03052517|541919403|FG002|Overall Study|Lost to Follow-up|0|||
150213616|NCT03052517|541919401|FG000|Overall Study|Pregnancy|1|||
150213617|NCT03052517|541919402|FG001|Overall Study|Pregnancy|0|||
150213618|NCT03052517|541919403|FG002|Overall Study|Pregnancy|1|||
150213619|NCT03052517|541919401|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
150213620|NCT03052517|541919402|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
150213621|NCT03052517|541919403|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
150213622|NCT03052517|541919401|FG000|Overall Study|Technical Problems|0|||
150213623|NCT03052517|541919402|FG001|Overall Study|Technical Problems|1|||
150213624|NCT03052517|541919403|FG002|Overall Study|Technical Problems|0|||
150213625|NCT05260437|541919407|FG000|Overall Study|Lost to Follow-up|5|||
150213626|NCT05260437|541919408|FG001|Overall Study|Lost to Follow-up|2|||
150213627|NCT05260437|541919409|FG002|Overall Study|Lost to Follow-up|1|||
150213628|NCT05260437|541919410|FG003|Overall Study|Lost to Follow-up|2|||
150213629|NCT05260437|541919411|FG004|Overall Study|Lost to Follow-up|2|||
150213630|NCT05260437|541919407|FG000|Overall Study|Withdrawal by Subject|3|||
150213631|NCT05260437|541919408|FG001|Overall Study|Withdrawal by Subject|0|||
150213632|NCT05260437|541919409|FG002|Overall Study|Withdrawal by Subject|4|||
150213633|NCT05260437|541919410|FG003|Overall Study|Withdrawal by Subject|5|||
150213634|NCT05260437|541919411|FG004|Overall Study|Withdrawal by Subject|0|||
150213635|NCT05260437|541919407|FG000|Overall Study|Vaccine Not Administered|0|||
150213636|NCT05260437|541919408|FG001|Overall Study|Vaccine Not Administered|1|||
150213637|NCT05260437|541919409|FG002|Overall Study|Vaccine Not Administered|0|||
150213638|NCT05260437|541919410|FG003|Overall Study|Vaccine Not Administered|0|||
150213639|NCT05260437|541919411|FG004|Overall Study|Vaccine Not Administered|0|||
150213640|NCT00787176|541919412|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
150213641|NCT00787176|541919413|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
150213642|NCT00787176|541919414|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
150213643|NCT00787176|541919415|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
150213644|NCT01485887|541919420|FG000|Overall Study|Withdrawal by Subject|2|||
150213645|NCT01485887|541919420|FG000|Overall Study|Adverse Event|8|||
150213646|NCT01485887|541919420|FG000|Overall Study|Deterioration of primary disease|1|||
150213647|NCT01485887|541919420|FG000|Overall Study|Primary disease markedly improved|1|||
150213648|NCT03418545|541919424|FG000|Overall Study|Withdrawal by Participant|2|||
150213649|NCT03418545|541919425|FG001|Overall Study|Withdrawal by Participant|4|||
150213650|NCT03418545|541919424|FG000|Overall Study|Lost to Follow-up|3|||
150213651|NCT03418545|541919425|FG001|Overall Study|Lost to Follow-up|5|||
150213652|NCT03418545|541919424|FG000|Overall Study|Reason Not Specified|0|||
150213653|NCT03418545|541919425|FG001|Overall Study|Reason Not Specified|1|||
150213654|NCT03418545|541919424|FG000|Overall Study|Missing Completion Status|0|||
150213655|NCT03418545|541919425|FG001|Overall Study|Missing Completion Status|1|||
150213656|NCT01972776|541919436|FG000|Part 1|Withdrawal by Subject|0|||
150213657|NCT01972776|541919437|FG001|Part 1|Withdrawal by Subject|0|||
150213658|NCT01972776|541919438|FG002|Part 1|Withdrawal by Subject|1|||
150213659|NCT01972776|541919439|FG003|Part 1|Withdrawal by Subject|0|||
150213660|NCT01972776|541919440|FG004|Part 1|Withdrawal by Subject|0|||
150213661|NCT01972776|541919441|FG005|Part 1|Withdrawal by Subject|0|||
150213662|NCT01972776|541919436|FG000|Part 1|Adverse Event|0|||
150213663|NCT01972776|541919437|FG001|Part 1|Adverse Event|0|||
150213664|NCT01972776|541919438|FG002|Part 1|Adverse Event|1|||
150213665|NCT01972776|541919439|FG003|Part 1|Adverse Event|1|||
150213666|NCT01972776|541919440|FG004|Part 1|Adverse Event|0|||
150213667|NCT01972776|541919441|FG005|Part 1|Adverse Event|0|||
150213668|NCT01972776|541919436|FG000|Part 2|Adverse Event|0|||
150213669|NCT01972776|541919437|FG001|Part 2|Adverse Event|0|||
150213670|NCT01972776|541919438|FG002|Part 2|Adverse Event|0|||
150213671|NCT01972776|541919439|FG003|Part 2|Adverse Event|0|||
150213672|NCT01972776|541919440|FG004|Part 2|Adverse Event|3|||
150213673|NCT01972776|541919441|FG005|Part 2|Adverse Event|0|||
150213674|NCT01972776|541919436|FG000|Part 2|Administrative problems|0|||
150213675|NCT01972776|541919437|FG001|Part 2|Administrative problems|0|||
150213676|NCT01972776|541919438|FG002|Part 2|Administrative problems|0|||
150213677|NCT01972776|541919439|FG003|Part 2|Administrative problems|0|||
150213678|NCT01972776|541919440|FG004|Part 2|Administrative problems|10|||
150213679|NCT01972776|541919441|FG005|Part 2|Administrative problems|7|||
150213680|NCT03162614|541919447|FG000|Overall Study|Lost to Follow-up|2|||
150213681|NCT03162614|541919448|FG001|Overall Study|Lost to Follow-up|1|||
150213682|NCT03162614|541919449|FG002|Overall Study|Lost to Follow-up|1|||
150213683|NCT03162614|541919450|FG003|Overall Study|Lost to Follow-up|1|||
150213684|NCT03162614|541919451|FG004|Overall Study|Lost to Follow-up|2|||
150213685|NCT03162614|541919452|FG005|Overall Study|Lost to Follow-up|0|||
150213686|NCT03162614|541919447|FG000|Overall Study|Protocol Violation|0|||
150213687|NCT03162614|541919448|FG001|Overall Study|Protocol Violation|1|||
150213688|NCT03162614|541919449|FG002|Overall Study|Protocol Violation|0|||
150213689|NCT03162614|541919450|FG003|Overall Study|Protocol Violation|1|||
150213690|NCT03162614|541919451|FG004|Overall Study|Protocol Violation|0|||
150213691|NCT03162614|541919452|FG005|Overall Study|Protocol Violation|0|||
150213692|NCT03162614|541919447|FG000|Overall Study|Withdrawal by Subject|2|||
150213693|NCT03162614|541919448|FG001|Overall Study|Withdrawal by Subject|1|||
150213694|NCT03162614|541919449|FG002|Overall Study|Withdrawal by Subject|1|||
150213695|NCT03162614|541919450|FG003|Overall Study|Withdrawal by Subject|1|||
150213696|NCT03162614|541919451|FG004|Overall Study|Withdrawal by Subject|0|||
150213697|NCT03162614|541919452|FG005|Overall Study|Withdrawal by Subject|0|||
150213698|NCT03162614|541919447|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
150213699|NCT03162614|541919448|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
150213700|NCT03162614|541919449|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
150213701|NCT03162614|541919450|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
150213702|NCT03162614|541919451|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
150213703|NCT03162614|541919452|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
150213704|NCT04638816|541919453|FG000|Overall Study|Withdrawal by Subject|0|||
150213705|NCT04638816|541919454|FG001|Overall Study|Withdrawal by Subject|1|||
150213706|NCT04638816|541919453|FG000|Overall Study|Lost to Follow-up|0|||
150213707|NCT04638816|541919454|FG001|Overall Study|Lost to Follow-up|1|||
150213708|NCT02251652|541919455|FG000|Overall Study|Withdrawal by Subject|1|||
150213709|NCT01957163|541919458|FG000|Overall Study|Adverse Event|5|||
150213710|NCT01957163|541919459|FG001|Overall Study|Adverse Event|2|||
150213711|NCT01957163|541919460|FG002|Overall Study|Adverse Event|4|||
150213712|NCT01957163|541919458|FG000|Overall Study|Lack of Efficacy|5|||
150213713|NCT01957163|541919459|FG001|Overall Study|Lack of Efficacy|4|||
150213714|NCT01957163|541919460|FG002|Overall Study|Lack of Efficacy|9|||
150213715|NCT01957163|541919458|FG000|Overall Study|Protocol Violation|1|||
150213716|NCT01957163|541919459|FG001|Overall Study|Protocol Violation|2|||
150213717|NCT01957163|541919460|FG002|Overall Study|Protocol Violation|0|||
150213718|NCT01957163|541919458|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
150213719|NCT01957163|541919459|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
150213720|NCT01957163|541919460|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
150213721|NCT01957163|541919458|FG000|Overall Study|Lost to Follow-up|0|||
150213722|NCT01957163|541919459|FG001|Overall Study|Lost to Follow-up|1|||
150213723|NCT01957163|541919460|FG002|Overall Study|Lost to Follow-up|0|||
150213724|NCT01957163|541919458|FG000|Overall Study|Withdrawal by Subject|4|||
150213725|NCT01957163|541919459|FG001|Overall Study|Withdrawal by Subject|2|||
150213726|NCT01957163|541919460|FG002|Overall Study|Withdrawal by Subject|4|||
150213727|NCT04224272|541919467|FG000|Part 1 - Dose Finding|Death|4|||
150213728|NCT04224272|541919467|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
150213729|NCT04224272|541919467|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
150213730|NCT04224272|541919467|FG000|Part 2 - Dose Expansion|Death|10|||
150213731|NCT04224272|541919467|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
150213732|NCT02609048|541919468|FG000|Overall Study|Adverse Event|3|||
150213733|NCT02609048|541919469|FG001|Overall Study|Adverse Event|0|||
150213734|NCT02609048|541919470|FG002|Overall Study|Adverse Event|0|||
150213735|NCT02609048|541919468|FG000|Overall Study|Randomized but never treated|1|||
150213736|NCT02609048|541919469|FG001|Overall Study|Randomized but never treated|1|||
150213737|NCT02609048|541919470|FG002|Overall Study|Randomized but never treated|1|||
150213738|NCT02609048|541919468|FG000|Overall Study|Withdrawal of informed consent|1|||
150213739|NCT02609048|541919469|FG001|Overall Study|Withdrawal of informed consent|0|||
150213740|NCT02609048|541919470|FG002|Overall Study|Withdrawal of informed consent|0|||
150213741|NCT02609048|541919468|FG000|Overall Study|Reason not specified|6|||
150213742|NCT02609048|541919469|FG001|Overall Study|Reason not specified|9|||
150213743|NCT02609048|541919470|FG002|Overall Study|Reason not specified|9|||
150213744|NCT02969356|541919477|FG000|Overall Study|Adverse Event|7|||
150213745|NCT02969356|541919477|FG000|Overall Study|Consent withdrawn|2|||
150213746|NCT02969356|541919477|FG000|Overall Study|Lost to Follow-up|3|||
150213747|NCT02969356|541919477|FG000|Overall Study|Did not need to be reinjected|6|||
150213748|NCT02969356|541919477|FG000|Overall Study|Personal reasons|5|||
150213749|NCT04924608|541921170|FG000|Overall Study|Adverse Event|10|||
150213750|NCT04924608|541921171|FG001|Overall Study|Adverse Event|6|||
150213751|NCT04924608|541921170|FG000|Overall Study|Lost to Follow-up|1|||
150213752|NCT04924608|541921171|FG001|Overall Study|Lost to Follow-up|1|||
150213753|NCT04924608|541921170|FG000|Overall Study|Ongoing at the data cut-off date|54|||
150213754|NCT04924608|541921171|FG001|Overall Study|Ongoing at the data cut-off date|60|||
150213755|NCT04924608|541921170|FG000|Overall Study|Progressive Disease|2|||
150213756|NCT04924608|541921171|FG001|Overall Study|Progressive Disease|0|||
150213757|NCT04924608|541921170|FG000|Overall Study|Withdrawal by Subject|3|||
150213758|NCT04924608|541921171|FG001|Overall Study|Withdrawal by Subject|6|||
150213759|NCT04924608|541921170|FG000|Overall Study|Other reason|1|||
150213760|NCT04924608|541921171|FG001|Overall Study|Other reason|1|||
150213761|NCT04992273|541921172|FG000|Overall Study|Lost to Follow-up|0|||
150213762|NCT04992273|541921173|FG001|Overall Study|Lost to Follow-up|1|||
150213763|NCT01380145|541921177|FG000|Overall Study|Progressive disease|4|||
150213764|NCT02698475|541921178|FG000|Main Study Period|Lack of Efficacy|1|||
150213765|NCT02698475|541921178|FG000|Main Study Period|Protocol Violation|2|||
150213766|NCT02698475|541921178|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
150213767|NCT02698475|541921178|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
150213768|NCT02698475|541921178|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
150213769|NCT02698475|541921178|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
150213770|NCT02698475|541921178|FG000|Long-Term Extension Period|Other|1|||
150213771|NCT02771366|541921179|FG000|Period 1|Withdrawal by Subject|0|||
150213772|NCT02771366|541921180|FG001|Period 1|Withdrawal by Subject|2|||
150213773|NCT02771366|541921179|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
150213774|NCT02771366|541921180|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
150213775|NCT02660086|541921182|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
150213776|NCT02660086|541921183|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
150213777|NCT02660086|541921182|FG000|Overall Study- 12-month|Left full-time employment|12|||
150213778|NCT02660086|541921183|FG001|Overall Study- 12-month|Left full-time employment|20|||
150213779|NCT02660086|541921182|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
150213780|NCT02660086|541921183|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
150213781|NCT02660086|541921182|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
150213782|NCT02660086|541921183|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
150213783|NCT02660086|541921182|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
150213784|NCT02660086|541921183|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
150213785|NCT02660086|541921182|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
150213786|NCT02660086|541921183|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
150213787|NCT01214200|541921187|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
150213788|NCT01214200|541921187|FG000|Overall Study|Withdrawal by Subject|2|||
150213789|NCT03928743|541921190|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
150213790|NCT03928743|541921191|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
150213791|NCT03928743|541921192|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
150213792|NCT03928743|541921190|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
150213793|NCT03928743|541921191|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
150213794|NCT03928743|541921192|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
150213795|NCT03928743|541921190|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
150213796|NCT03928743|541921191|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
150213797|NCT03928743|541921192|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
150213798|NCT03928743|541921190|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
150213799|NCT03928743|541921191|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
150213800|NCT03928743|541921192|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
150213801|NCT03928743|541921190|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
150213802|NCT03928743|541921191|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
150213803|NCT03928743|541921192|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
150213804|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
150213805|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
150213806|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
150213807|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
150213808|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
150213809|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
150213810|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
150213811|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
150213812|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
150213813|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
150213814|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
150213815|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
150213816|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
150213817|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
150213818|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
150213819|NCT03928743|541921190|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
150213820|NCT03928743|541921191|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
150213821|NCT03928743|541921192|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
150213822|NCT00022672|541921194|FG000|Main Phase: 24 Months|Adverse Event|6|||
150213823|NCT00022672|541921195|FG001|Main Phase: 24 Months|Adverse Event|0|||
150213824|NCT00022672|541921194|FG000|Main Phase: 24 Months|Death|0|||
150213825|NCT00022672|541921195|FG001|Main Phase: 24 Months|Death|3|||
150213826|NCT00022672|541921194|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
150213827|NCT00022672|541921195|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
150213828|NCT00022672|541921194|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
150213829|NCT00022672|541921195|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
150213830|NCT00022672|541921194|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
150213831|NCT00022672|541921195|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
150213832|NCT00022672|541921194|FG000|Main Phase: 24 Months|Refused Treatment|3|||
150213833|NCT00022672|541921195|FG001|Main Phase: 24 Months|Refused Treatment|4|||
150213834|NCT00022672|541921194|FG000|Main Phase: 24 Months|Failure to Return|1|||
150213835|NCT00022672|541921195|FG001|Main Phase: 24 Months|Failure to Return|1|||
150213836|NCT00022672|541921194|FG000|Main Phase: 24 Months|Other|1|||
150213837|NCT00022672|541921195|FG001|Main Phase: 24 Months|Other|0|||
150213838|NCT00022672|541921194|FG000|Extension Phase|Adverse Event|1|||
150213839|NCT00022672|541921195|FG001|Extension Phase|Adverse Event|3|||
150213840|NCT00022672|541921194|FG000|Extension Phase|Death|0|||
150213841|NCT00022672|541921195|FG001|Extension Phase|Death|1|||
150213842|NCT00022672|541921194|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
150213843|NCT00022672|541921195|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
150213844|NCT00022672|541921194|FG000|Extension Phase|Refused Treatment|0|||
150213845|NCT00022672|541921195|FG001|Extension Phase|Refused Treatment|2|||
150213846|NCT00022672|541921194|FG000|Extension Phase|Other|1|||
150213847|NCT00022672|541921195|FG001|Extension Phase|Other|1|||
150213848|NCT00403494|541921196|FG000|Overall Study|Adverse Event|10|||
150213849|NCT00403494|541921197|FG001|Overall Study|Adverse Event|8|||
150213850|NCT00403494|541921196|FG000|Overall Study|Withdrew Consent|3|||
150213851|NCT00403494|541921197|FG001|Overall Study|Withdrew Consent|2|||
150213852|NCT00403494|541921196|FG000|Overall Study|Inappropriately enrolled|0|||
150213853|NCT00403494|541921197|FG001|Overall Study|Inappropriately enrolled|1|||
150213854|NCT00403494|541921196|FG000|Overall Study|Lost to Follow-up|0|||
150213855|NCT00403494|541921197|FG001|Overall Study|Lost to Follow-up|2|||
150213856|NCT00403494|541921196|FG000|Overall Study|Protocol noncompliance|0|||
150213857|NCT00403494|541921197|FG001|Overall Study|Protocol noncompliance|1|||
150213858|NCT00403494|541921196|FG000|Overall Study|Death|1|||
150213859|NCT00403494|541921197|FG001|Overall Study|Death|0|||
150213860|NCT00403494|541921196|FG000|Overall Study|Sponsor Request|1|||
150213861|NCT00403494|541921197|FG001|Overall Study|Sponsor Request|0|||
150213862|NCT05005247|541921198|FG000|Overall Study|Withdrawal by Subject|0|||
150213863|NCT05005247|541921199|FG001|Overall Study|Withdrawal by Subject|1|||
150213864|NCT05005247|541921200|FG002|Overall Study|Withdrawal by Subject|0|||
150213865|NCT04658784|541921203|FG000|6-month Follow-up|Lost to Follow-up|2|||
150213866|NCT04658784|541921204|FG001|6-month Follow-up|Lost to Follow-up|5|||
150213867|NCT02958553|541921205|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
150213868|NCT02958553|541921205|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
150213869|NCT01951703|541921217|FG000|First Intervention|Withdrawal by Subject|1|||
150213870|NCT01951703|541921218|FG001|First Intervention|Withdrawal by Subject|0|||
150213871|NCT01951703|541921217|FG000|First Intervention|Subject was not compliant|1|||
150213872|NCT01951703|541921218|FG001|First Intervention|Subject was not compliant|1|||
150213873|NCT01951703|541921217|FG000|First Intervention|Physician Decision|1|||
150213874|NCT01951703|541921218|FG001|First Intervention|Physician Decision|0|||
150213875|NCT01951703|541921217|FG000|Second Intervention|Protocol Violation|0|||
150213876|NCT01951703|541921218|FG001|Second Intervention|Protocol Violation|1|||
150213877|NCT01951703|541921217|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
150213878|NCT01951703|541921218|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
150213879|NCT00240994|541921221|FG000|Overall Study|Lost to Follow-up|1|||
150213880|NCT00240994|541921221|FG000|Overall Study|Protocol Violation|1|||
150213881|NCT00240994|541921221|FG000|Overall Study|Graft failure|1|||
150213882|NCT05124210|541921222|FG000|Overall Study|Lost to Follow-up|1|||
150213883|NCT05124210|541921223|FG001|Overall Study|Lost to Follow-up|0|||
150213884|NCT05124210|541921222|FG000|Overall Study|Withdrawal by Subject|1|||
150213885|NCT05124210|541921223|FG001|Overall Study|Withdrawal by Subject|0|||
150213886|NCT03142932|541921227|FG000|Overall Study|Lost to Follow-up|2|||
150213887|NCT03142932|541921228|FG001|Overall Study|Lost to Follow-up|11|||
150213888|NCT02128269|541921229|FG000|Treatment Period|Adverse Event|1|||
150213889|NCT02128269|541921229|FG000|Treatment Period|Physician Decision|1|||
150213890|NCT00878189|541921230|FG000|Overall Study|Death|0|||
150213891|NCT00878189|541921231|FG001|Overall Study|Death|1|||
150213892|NCT00878189|541921232|FG002|Overall Study|Death|0|||
150213893|NCT00878189|541921233|FG003|Overall Study|Death|1|||
150213894|NCT00878189|541921234|FG004|Overall Study|Death|0|||
150213895|NCT00878189|541921235|FG005|Overall Study|Death|0|||
150213896|NCT00878189|541921236|FG006|Overall Study|Death|0|||
150213897|NCT00878189|541921237|FG007|Overall Study|Death|0|||
150213898|NCT00878189|541921238|FG008|Overall Study|Death|1|||
150213899|NCT00878189|541921230|FG000|Overall Study|Participant Refused to Follow-up|0|||
150213900|NCT00878189|541921231|FG001|Overall Study|Participant Refused to Follow-up|0|||
150213901|NCT00878189|541921232|FG002|Overall Study|Participant Refused to Follow-up|0|||
150213902|NCT00878189|541921233|FG003|Overall Study|Participant Refused to Follow-up|0|||
150213903|NCT00878189|541921234|FG004|Overall Study|Participant Refused to Follow-up|0|||
150213904|NCT00878189|541921235|FG005|Overall Study|Participant Refused to Follow-up|4|||
150213905|NCT00878189|541921236|FG006|Overall Study|Participant Refused to Follow-up|0|||
150213906|NCT00878189|541921237|FG007|Overall Study|Participant Refused to Follow-up|0|||
150213907|NCT00878189|541921238|FG008|Overall Study|Participant Refused to Follow-up|0|||
150213908|NCT00878189|541921230|FG000|Overall Study|Other|3|||
150213909|NCT00878189|541921231|FG001|Overall Study|Other|2|||
150213910|NCT00878189|541921232|FG002|Overall Study|Other|4|||
150213911|NCT00878189|541921233|FG003|Overall Study|Other|7|||
150213912|NCT00878189|541921234|FG004|Overall Study|Other|4|||
150213913|NCT00878189|541921235|FG005|Overall Study|Other|18|||
150213914|NCT00878189|541921236|FG006|Overall Study|Other|15|||
150213915|NCT00878189|541921237|FG007|Overall Study|Other|3|||
150213916|NCT00878189|541921238|FG008|Overall Study|Other|4|||
150213917|NCT00878189|541921230|FG000|Overall Study|Lost to Follow-up|0|||
150213918|NCT00878189|541921231|FG001|Overall Study|Lost to Follow-up|0|||
150213919|NCT00878189|541921232|FG002|Overall Study|Lost to Follow-up|0|||
150213920|NCT00878189|541921233|FG003|Overall Study|Lost to Follow-up|0|||
150213921|NCT00878189|541921234|FG004|Overall Study|Lost to Follow-up|0|||
150213922|NCT00878189|541921235|FG005|Overall Study|Lost to Follow-up|1|||
150213923|NCT00878189|541921236|FG006|Overall Study|Lost to Follow-up|1|||
150213924|NCT00878189|541921237|FG007|Overall Study|Lost to Follow-up|0|||
150213925|NCT00878189|541921238|FG008|Overall Study|Lost to Follow-up|0|||
150213926|NCT00878189|541921230|FG000|Overall Study|Objection Progression or Relapse|0|||
150213927|NCT00878189|541921231|FG001|Overall Study|Objection Progression or Relapse|0|||
150213928|NCT00878189|541921232|FG002|Overall Study|Objection Progression or Relapse|0|||
150213929|NCT00878189|541921233|FG003|Overall Study|Objection Progression or Relapse|0|||
150213930|NCT00878189|541921234|FG004|Overall Study|Objection Progression or Relapse|0|||
150213931|NCT00878189|541921235|FG005|Overall Study|Objection Progression or Relapse|0|||
150213932|NCT00878189|541921236|FG006|Overall Study|Objection Progression or Relapse|0|||
150213933|NCT00878189|541921237|FG007|Overall Study|Objection Progression or Relapse|0|||
150213934|NCT00878189|541921238|FG008|Overall Study|Objection Progression or Relapse|3|||
150213935|NCT00638456|541921239|FG000|Overall Study|Withdrawal by Subject|6|||
150213936|NCT00638456|541921240|FG001|Overall Study|Withdrawal by Subject|2|||
150213937|NCT02007070|541921241|FG000|Overall Study|Adverse Event|4|||
150213938|NCT02007070|541921241|FG000|Overall Study|Clinical Progression|4|||
150213939|NCT02007070|541921241|FG000|Overall Study|Death|1|||
150213940|NCT02007070|541921241|FG000|Overall Study|Protocol Violation|2|||
150213941|NCT02007070|541921241|FG000|Overall Study|Physician Decision|1|||
150213942|NCT02007070|541921241|FG000|Overall Study|Progressive Disease|21|||
150213943|NCT01640288|541921242|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
150213944|NCT01640288|541921243|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
150213945|NCT01640288|541921242|FG000|Overall Study|Screen Failure|20|||
150213946|NCT01640288|541921243|FG001|Overall Study|Screen Failure|18|||
150213947|NCT01640288|541921242|FG000|Overall Study|Withdrawn by PI|5|||
150213948|NCT01640288|541921243|FG001|Overall Study|Withdrawn by PI|0|||
150213949|NCT01640288|541921242|FG000|Overall Study|Withdrawal by Subject|1|||
150213950|NCT01640288|541921243|FG001|Overall Study|Withdrawal by Subject|0|||
150213951|NCT02234141|541921244|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213952|NCT02234141|541921245|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213953|NCT02234141|541921246|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213954|NCT02234141|541921247|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
150213955|NCT02234141|541921248|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213956|NCT02234141|541921249|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213957|NCT02234141|541921250|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
150213958|NCT02234141|541921244|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213959|NCT02234141|541921245|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
150213960|NCT02234141|541921246|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213961|NCT02234141|541921247|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213962|NCT02234141|541921248|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213963|NCT02234141|541921249|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213964|NCT02234141|541921250|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
150213965|NCT02234141|541921244|FG000|Treatment Period (24 Weeks)|Death|1|||
150213966|NCT02234141|541921245|FG001|Treatment Period (24 Weeks)|Death|2|||
150213967|NCT02234141|541921246|FG002|Treatment Period (24 Weeks)|Death|0|||
150213968|NCT02234141|541921247|FG003|Treatment Period (24 Weeks)|Death|1|||
150213969|NCT02234141|541921248|FG004|Treatment Period (24 Weeks)|Death|0|||
150213970|NCT02234141|541921249|FG005|Treatment Period (24 Weeks)|Death|0|||
150213971|NCT02234141|541921250|FG006|Treatment Period (24 Weeks)|Death|0|||
150213972|NCT02234141|541921244|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
150213973|NCT02234141|541921245|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
150213974|NCT02234141|541921246|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
150213975|NCT02234141|541921247|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
150213976|NCT02234141|541921248|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
150213977|NCT02234141|541921249|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
150213978|NCT02234141|541921250|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
150213979|NCT02234141|541921244|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213980|NCT02234141|541921245|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
150213981|NCT02234141|541921246|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213982|NCT02234141|541921247|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213983|NCT02234141|541921248|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213984|NCT02234141|541921249|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213985|NCT02234141|541921250|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
150213986|NCT02234141|541921244|FG000|Long-Term Treatment Period|Death|0|||
150213987|NCT02234141|541921245|FG001|Long-Term Treatment Period|Death|0|||
150213988|NCT02234141|541921246|FG002|Long-Term Treatment Period|Death|0|||
150213989|NCT02234141|541921247|FG003|Long-Term Treatment Period|Death|0|||
150213990|NCT02234141|541921248|FG004|Long-Term Treatment Period|Death|0|||
150213991|NCT02234141|541921249|FG005|Long-Term Treatment Period|Death|1|||
150213992|NCT02234141|541921250|FG006|Long-Term Treatment Period|Death|0|||
150213993|NCT02234141|541921244|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
150213994|NCT02234141|541921245|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
150213995|NCT02234141|541921246|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
150213996|NCT02234141|541921247|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
150213997|NCT02234141|541921248|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
150213998|NCT02234141|541921249|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
150213999|NCT02234141|541921250|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
150214000|NCT02234141|541921244|FG000|Long-Term Treatment Period|Adverse Event|4|||
150214001|NCT02234141|541921245|FG001|Long-Term Treatment Period|Adverse Event|0|||
150214002|NCT02234141|541921246|FG002|Long-Term Treatment Period|Adverse Event|5|||
150214003|NCT02234141|541921247|FG003|Long-Term Treatment Period|Adverse Event|0|||
150214004|NCT02234141|541921248|FG004|Long-Term Treatment Period|Adverse Event|1|||
150214005|NCT02234141|541921249|FG005|Long-Term Treatment Period|Adverse Event|1|||
150214006|NCT02234141|541921250|FG006|Long-Term Treatment Period|Adverse Event|1|||
150214007|NCT02234141|541921244|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
150214008|NCT02234141|541921245|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
150214009|NCT02234141|541921246|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
150214010|NCT02234141|541921247|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
150214011|NCT02234141|541921248|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
150214012|NCT02234141|541921249|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
150214013|NCT02234141|541921250|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
150214014|NCT02234141|541921244|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
150214015|NCT02234141|541921245|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
150214016|NCT02234141|541921246|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
150214017|NCT02234141|541921247|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
150214018|NCT02234141|541921248|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
150214019|NCT02234141|541921249|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
150214020|NCT02234141|541921250|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
150214021|NCT00895245|541921251|FG000|Overall Study|Lack of Efficacy|6|||
150214022|NCT02095678|541921252|FG000|Overall Study|Withdrawal by Subject|0|||
150214023|NCT02095678|541921253|FG001|Overall Study|Withdrawal by Subject|1|||
150214024|NCT02095678|541921252|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
150214025|NCT02095678|541921253|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
150214026|NCT02095678|541921252|FG000|Overall Study|lesion impacted by previous treatment|1|||
150214027|NCT02095678|541921253|FG001|Overall Study|lesion impacted by previous treatment|1|||
150214028|NCT02095678|541921252|FG000|Overall Study|No Confirmed Diagnosis|0|||
150214029|NCT02095678|541921253|FG001|Overall Study|No Confirmed Diagnosis|3|||
150214030|NCT02095678|541921252|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
150214031|NCT02095678|541921253|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
150214032|NCT02095678|541921252|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
150214033|NCT02095678|541921253|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
150214034|NCT00681109|541921254|FG000|Overall Study|Lost to Follow-up|2|||
150214035|NCT00681109|541921255|FG001|Overall Study|Lost to Follow-up|6|||
150214036|NCT00681109|541921256|FG002|Overall Study|Lost to Follow-up|0|||
150214037|NCT02706483|541921257|FG000|Overall Study|Adverse Event|97|||
150214038|NCT02706483|541921257|FG000|Overall Study|Death|1|||
150214039|NCT02706483|541921257|FG000|Overall Study|Lack of Efficacy|39|||
150214040|NCT02706483|541921257|FG000|Overall Study|Lost to Follow-up|101|||
150214041|NCT02706483|541921257|FG000|Overall Study|Non-compliance with study drug|15|||
150214042|NCT02706483|541921257|FG000|Overall Study|Physician Decision|6|||
150214043|NCT02706483|541921257|FG000|Overall Study|Pregnancy|6|||
150214044|NCT02706483|541921257|FG000|Overall Study|Protocol Violation|18|||
150214045|NCT02706483|541921257|FG000|Overall Study|Withdrawal by Subject|136|||
150214046|NCT02706483|541921257|FG000|Overall Study|Non-compliance with visits|6|||
150214047|NCT02706483|541921257|FG000|Overall Study|Site closure|4|||
150214048|NCT02706483|541921257|FG000|Overall Study|Subject moved|1|||
150214049|NCT04660799|541921258|FG000|Overall Study|Progressive Disease|1|||
150214050|NCT04660799|541921259|FG001|Overall Study|Progressive Disease|1|||
150214051|NCT04660799|541921258|FG000|Overall Study|Death|2|||
150214052|NCT04660799|541921259|FG001|Overall Study|Death|1|||
150214053|NCT04660799|541921258|FG000|Overall Study|Adverse Event|2|||
150214054|NCT04660799|541921259|FG001|Overall Study|Adverse Event|1|||
150214055|NCT04660799|541921258|FG000|Overall Study|Withdrawal by Subject|2|||
150214056|NCT04660799|541921259|FG001|Overall Study|Withdrawal by Subject|5|||
150214057|NCT01228734|541921263|FG000|Overall Study|Randomized, but not treated|0|||
150214058|NCT01228734|541921264|FG001|Overall Study|Randomized, but not treated|4|||
150214059|NCT00659373|541921271|FG000|Overall Study|Withdrawal by Subject|3|||
150214060|NCT00659373|541921272|FG001|Overall Study|Withdrawal by Subject|5|||
150214061|NCT00659373|541921271|FG000|Overall Study|Assessment Missed|2|||
150214062|NCT00659373|541921272|FG001|Overall Study|Assessment Missed|2|||
150214063|NCT03042767|541921273|FG000|Overall Study|Lost to Follow-up|1|||
150214064|NCT03042767|541921274|FG001|Overall Study|Lost to Follow-up|2|||
150214065|NCT02382640|541921277|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
150214066|NCT02382640|541921278|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
150214067|NCT02382640|541921279|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
150214068|NCT02382640|541921280|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
150214069|NCT01543204|541921281|FG000|Overall Study|Non-compliance|1|||
150214070|NCT01543204|541921281|FG000|Overall Study|Adverse Event|1|||
150214071|NCT01543204|541921281|FG000|Overall Study|Withdrawal by Subject|4|||
150214072|NCT01543204|541921281|FG000|Overall Study|Requirement for Alternative Therapy|1|||
150214073|NCT01543204|541921281|FG000|Overall Study|Lost to Follow-up|1|||
150214074|NCT01220999|541921282|FG000|Overall Study|Progressive disease|0|||
150214075|NCT01220999|541921283|FG001|Overall Study|Progressive disease|0|||
150214076|NCT01220999|541921284|FG002|Overall Study|Progressive disease|1|||
150214077|NCT01220999|541921285|FG003|Overall Study|Progressive disease|0|||
150214078|NCT01220999|541921286|FG004|Overall Study|Progressive disease|0|||
150214079|NCT01560429|541921288|FG000|Overall Study|Protocol Violation|3|||
150214080|NCT01560429|541921289|FG001|Overall Study|Protocol Violation|6|||
150214081|NCT02449902|541921290|FG000|Overall Study|Adverse Event|0|||
150214082|NCT02449902|541921291|FG001|Overall Study|Adverse Event|1|||
150214083|NCT02449902|541921290|FG000|Overall Study|Withdrawal by Subject|0|||
150214084|NCT02449902|541921291|FG001|Overall Study|Withdrawal by Subject|1|||
150214085|NCT01365546|541921292|FG000|Overall Study|Withdrawal by Subject|1|||
150214086|NCT01365546|541921292|FG000|Overall Study|Screen failure|9|||
150214087|NCT01365546|541921292|FG000|Overall Study|Study termination|1|||
150214088|NCT03326856|541921293|FG000|Overall Study|Lost to Follow-up|1|||
150214089|NCT03326856|541921294|FG001|Overall Study|Lost to Follow-up|1|||
150214090|NCT03326856|541921295|FG002|Overall Study|Lost to Follow-up|0|||
150214091|NCT03326856|541921296|FG003|Overall Study|Lost to Follow-up|0|||
150214092|NCT03326856|541921297|FG004|Overall Study|Lost to Follow-up|0|||
150214093|NCT02037568|541921298|FG000|Overall Study|Withdrawal by Subject|17|||
150214094|NCT02037568|541921299|FG001|Overall Study|Withdrawal by Subject|24|||
150214095|NCT02037568|541921298|FG000|Overall Study|Lost to Follow-up|16|||
150214096|NCT02037568|541921299|FG001|Overall Study|Lost to Follow-up|13|||
150214097|NCT02037568|541921298|FG000|Overall Study|Screen Failure|3|||
150214098|NCT02037568|541921299|FG001|Overall Study|Screen Failure|1|||
150214099|NCT02037568|541921298|FG000|Overall Study|Patient did not receive transplant|0|||
150214100|NCT02037568|541921299|FG001|Overall Study|Patient did not receive transplant|1|||
150214101|NCT00721734|541921300|FG000|Overall Study|Progressive Disease|3|||
150214102|NCT00721734|541921301|FG001|Overall Study|Progressive Disease|10|||
150214103|NCT00721734|541921302|FG002|Overall Study|Progressive Disease|4|||
150214104|NCT00721734|541921303|FG003|Overall Study|Progressive Disease|5|||
150214105|NCT00721734|541921304|FG004|Overall Study|Progressive Disease|2|||
150214106|NCT00721734|541921300|FG000|Overall Study|Adverse Event|3|||
150214107|NCT00721734|541921301|FG001|Overall Study|Adverse Event|1|||
150214108|NCT00721734|541921302|FG002|Overall Study|Adverse Event|4|||
150214109|NCT00721734|541921303|FG003|Overall Study|Adverse Event|0|||
150214110|NCT00721734|541921304|FG004|Overall Study|Adverse Event|3|||
150214111|NCT00721734|541921300|FG000|Overall Study|Withdrawal by Subject|2|||
150214112|NCT00721734|541921301|FG001|Overall Study|Withdrawal by Subject|1|||
150214113|NCT00721734|541921302|FG002|Overall Study|Withdrawal by Subject|0|||
150214114|NCT00721734|541921303|FG003|Overall Study|Withdrawal by Subject|0|||
150214115|NCT00721734|541921304|FG004|Overall Study|Withdrawal by Subject|1|||
150214116|NCT00721734|541921300|FG000|Overall Study|Other|0|||
150214117|NCT00721734|541921301|FG001|Overall Study|Other|0|||
150214118|NCT00721734|541921302|FG002|Overall Study|Other|0|||
150214119|NCT00721734|541921303|FG003|Overall Study|Other|1|||
150214120|NCT00721734|541921304|FG004|Overall Study|Other|0|||
150214121|NCT01074242|541921307|FG000|Overall Study|Case report before date of contract|40|||
150214122|NCT01074242|541921307|FG000|Overall Study|Lost to Follow-up|1|||
150214123|NCT01074242|541921307|FG000|Overall Study|Case report unclear|6|||
150214124|NCT01074242|541921307|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
150214125|NCT01074242|541921307|FG000|Overall Study|Duplicate Case Report Form|5|||
150214126|NCT04186247|541921313|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
150214127|NCT04186247|541921314|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
150214128|NCT04186247|541921315|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
150214129|NCT04186247|541921316|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
150214130|NCT04186247|541921317|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
150214131|NCT04493424|541922883|FG000|Overall Study|Termination of the trial by the sponsor|89|||
150214132|NCT04493424|541922883|FG000|Overall Study|Withdrawal by Subject|9|||
150214133|NCT04493424|541922883|FG000|Overall Study|Lost to Follow-up|2|||
150214134|NCT04493424|541922883|FG000|Overall Study|Lack of Efficacy|3|||
150214135|NCT04493424|541922883|FG000|Overall Study|Adverse Event|5|||
150214136|NCT00949117|541922884|FG000|Overall Study|Lack of Efficacy|2|||
150214137|NCT00949117|541922885|FG001|Overall Study|Lack of Efficacy|3|||
150214138|NCT00949117|541922884|FG000|Overall Study|Protocol Violation|1|||
150214139|NCT00949117|541922885|FG001|Overall Study|Protocol Violation|1|||
150214140|NCT00949117|541922884|FG000|Overall Study|Adverse Event|0|||
150214141|NCT00949117|541922885|FG001|Overall Study|Adverse Event|1|||
150214142|NCT03769090|541922886|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
150214143|NCT03769090|541922887|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
150214144|NCT03769090|541922888|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
150214145|NCT03769090|541922886|FG000|Overall Study|Withdrawal by Subject|52|||
150214146|NCT03769090|541922887|FG001|Overall Study|Withdrawal by Subject|62|||
150214147|NCT03769090|541922888|FG002|Overall Study|Withdrawal by Subject|74|||
150214148|NCT03769090|541922886|FG000|Overall Study|Death|4|||
150214149|NCT03769090|541922887|FG001|Overall Study|Death|2|||
150214150|NCT03769090|541922888|FG002|Overall Study|Death|2|||
150214151|NCT03769090|541922886|FG000|Overall Study|Adverse Event|7|||
150214152|NCT03769090|541922887|FG001|Overall Study|Adverse Event|7|||
150214153|NCT03769090|541922888|FG002|Overall Study|Adverse Event|8|||
150214154|NCT03769090|541922886|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
150214155|NCT03769090|541922887|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
150214156|NCT03769090|541922888|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
150214157|NCT03769090|541922886|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
150214158|NCT03769090|541922887|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
150214159|NCT03769090|541922888|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
150214160|NCT03769090|541922886|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
150214161|NCT03769090|541922887|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
150214162|NCT03769090|541922888|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
150214163|NCT03769090|541922886|FG000|Overall Study|Protocol Violation|5|||
150214164|NCT03769090|541922887|FG001|Overall Study|Protocol Violation|6|||
150214165|NCT03769090|541922888|FG002|Overall Study|Protocol Violation|8|||
150214166|NCT03769090|541922886|FG000|Overall Study|Pregnancy|1|||
150214167|NCT03769090|541922887|FG001|Overall Study|Pregnancy|0|||
150214168|NCT03769090|541922888|FG002|Overall Study|Pregnancy|3|||
150214169|NCT03769090|541922886|FG000|Overall Study|Lost to Follow-up|19|||
150214170|NCT03769090|541922887|FG001|Overall Study|Lost to Follow-up|25|||
150214171|NCT03769090|541922888|FG002|Overall Study|Lost to Follow-up|21|||
150214172|NCT03769090|541922886|FG000|Overall Study|Condition under investigation worsened|2|||
150214173|NCT03769090|541922887|FG001|Overall Study|Condition under investigation worsened|0|||
150214174|NCT03769090|541922888|FG002|Overall Study|Condition under investigation worsened|1|||
150214175|NCT03769090|541922886|FG000|Overall Study|Lack of Efficacy|1|||
150214176|NCT03769090|541922887|FG001|Overall Study|Lack of Efficacy|2|||
150214177|NCT03769090|541922888|FG002|Overall Study|Lack of Efficacy|2|||
150214178|NCT03769090|541922886|FG000|Overall Study|Other reasons|8|||
150214179|NCT03769090|541922887|FG001|Overall Study|Other reasons|12|||
150214180|NCT03769090|541922888|FG002|Overall Study|Other reasons|15|||
150214181|NCT03964974|541922889|FG000|Overall Study|Lost to Follow-up|3|||
150214182|NCT03964974|541922890|FG001|Overall Study|Lost to Follow-up|2|||
150214183|NCT03964974|541922889|FG000|Overall Study|Withdrawal by Subject|0|||
150214184|NCT03964974|541922890|FG001|Overall Study|Withdrawal by Subject|3|||
150214185|NCT02014402|541922891|FG000|Overall Study|Adverse Event|1|||
150214186|NCT02014402|541922892|FG001|Overall Study|Adverse Event|0|||
150214187|NCT02014402|541922893|FG002|Overall Study|Adverse Event|0|||
150214188|NCT02014402|541922894|FG003|Overall Study|Adverse Event|0|||
150214189|NCT02014402|541922891|FG000|Overall Study|Withdrawal by Subject|1|||
150214190|NCT02014402|541922892|FG001|Overall Study|Withdrawal by Subject|2|||
150214191|NCT02014402|541922893|FG002|Overall Study|Withdrawal by Subject|2|||
150214192|NCT02014402|541922894|FG003|Overall Study|Withdrawal by Subject|1|||
150214193|NCT02014402|541922891|FG000|Overall Study|Subject did not have transportation|0|||
150214194|NCT02014402|541922892|FG001|Overall Study|Subject did not have transportation|1|||
150214195|NCT02014402|541922893|FG002|Overall Study|Subject did not have transportation|0|||
150214196|NCT02014402|541922894|FG003|Overall Study|Subject did not have transportation|0|||
150214197|NCT02014402|541922891|FG000|Overall Study|Lost to Follow-up|0|||
150214198|NCT02014402|541922892|FG001|Overall Study|Lost to Follow-up|0|||
150214199|NCT02014402|541922893|FG002|Overall Study|Lost to Follow-up|1|||
150214200|NCT02014402|541922894|FG003|Overall Study|Lost to Follow-up|2|||
150214201|NCT02713594|541922898|FG000|Overall Study|Withdrawal by Subject|32|||
150214202|NCT02713594|541922899|FG001|Overall Study|Withdrawal by Subject|22|||
150214203|NCT02713594|541922898|FG000|Overall Study|Lost to Follow-up|358|||
150214204|NCT02713594|541922899|FG001|Overall Study|Lost to Follow-up|374|||
150214205|NCT00670449|541922900|FG000|Overall Study|Adverse Event|6|||
150214206|NCT00670449|541922901|FG001|Overall Study|Adverse Event|2|||
150214207|NCT00670449|541922902|FG002|Overall Study|Adverse Event|8|||
150214208|NCT00670449|541922903|FG003|Overall Study|Adverse Event|5|||
150214209|NCT00670449|541922900|FG000|Overall Study|Protocol Deviation|1|||
150214210|NCT00670449|541922901|FG001|Overall Study|Protocol Deviation|2|||
150214211|NCT00670449|541922902|FG002|Overall Study|Protocol Deviation|0|||
150214212|NCT00670449|541922903|FG003|Overall Study|Protocol Deviation|1|||
150214213|NCT00670449|541922900|FG000|Overall Study|Administrative Problems|0|||
150214214|NCT00670449|541922901|FG001|Overall Study|Administrative Problems|2|||
150214215|NCT00670449|541922902|FG002|Overall Study|Administrative Problems|0|||
150214216|NCT00670449|541922903|FG003|Overall Study|Administrative Problems|1|||
150214217|NCT00670449|541922900|FG000|Overall Study|Subject Withdrew Consent|0|||
150214218|NCT00670449|541922901|FG001|Overall Study|Subject Withdrew Consent|2|||
150214219|NCT00670449|541922902|FG002|Overall Study|Subject Withdrew Consent|0|||
150214220|NCT00670449|541922903|FG003|Overall Study|Subject Withdrew Consent|1|||
150214221|NCT00670449|541922900|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
150214222|NCT00670449|541922901|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150214223|NCT00670449|541922902|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
150214224|NCT00670449|541922903|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
150214225|NCT00670449|541922900|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
150214226|NCT00670449|541922901|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
150214227|NCT00670449|541922902|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
150214228|NCT00670449|541922903|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
150214229|NCT00413283|541922904|FG000|Overall Study|Withdrawal by Subject|1|||
150214230|NCT00413283|541922905|FG001|Overall Study|Withdrawal by Subject|0|||
150214231|NCT00413283|541922906|FG002|Overall Study|Withdrawal by Subject|0|||
150214232|NCT00413283|541922907|FG003|Overall Study|Withdrawal by Subject|1|||
150214233|NCT00413283|541922904|FG000|Overall Study|Death|0|||
150214234|NCT00413283|541922905|FG001|Overall Study|Death|0|||
150214235|NCT00413283|541922906|FG002|Overall Study|Death|1|||
150214236|NCT00413283|541922907|FG003|Overall Study|Death|1|||
150214237|NCT00413283|541922904|FG000|Overall Study|Adverse Event|0|||
150214238|NCT00413283|541922905|FG001|Overall Study|Adverse Event|0|||
150214239|NCT00413283|541922906|FG002|Overall Study|Adverse Event|0|||
150214240|NCT00413283|541922907|FG003|Overall Study|Adverse Event|1|||
150214241|NCT00413283|541922904|FG000|Overall Study|Ineligibility determined|0|||
150214242|NCT00413283|541922905|FG001|Overall Study|Ineligibility determined|0|||
150214243|NCT00413283|541922906|FG002|Overall Study|Ineligibility determined|0|||
150214244|NCT00413283|541922907|FG003|Overall Study|Ineligibility determined|1|||
150214245|NCT00413283|541922904|FG000|Overall Study|Protocol deviation|0|||
150214246|NCT00413283|541922905|FG001|Overall Study|Protocol deviation|1|||
150214247|NCT00413283|541922906|FG002|Overall Study|Protocol deviation|0|||
150214248|NCT00413283|541922907|FG003|Overall Study|Protocol deviation|0|||
150214249|NCT00413283|541922904|FG000|Overall Study|Requirement for alternative therapy|0|||
150214250|NCT00413283|541922905|FG001|Overall Study|Requirement for alternative therapy|2|||
150214251|NCT00413283|541922906|FG002|Overall Study|Requirement for alternative therapy|0|||
150214252|NCT00413283|541922907|FG003|Overall Study|Requirement for alternative therapy|0|||
150214253|NCT00413283|541922904|FG000|Overall Study|Other|0|||
150214254|NCT00413283|541922905|FG001|Overall Study|Other|0|||
150214255|NCT00413283|541922906|FG002|Overall Study|Other|1|||
150214256|NCT00413283|541922907|FG003|Overall Study|Other|0|||
150214257|NCT02002689|541922909|FG000|Overall Study|Disease Progression|7|||
150214258|NCT02002689|541922909|FG000|Overall Study|Adverse Event|3|||
150214259|NCT00671853|541922910|FG000|Overall Study|Lack of Efficacy|3|||
150214260|NCT00671853|541922911|FG001|Overall Study|Lack of Efficacy|7|||
150214261|NCT00671853|541922910|FG000|Overall Study|Adverse Event|7|||
150214262|NCT00671853|541922911|FG001|Overall Study|Adverse Event|1|||
150214263|NCT00671853|541922910|FG000|Overall Study|Withdrawal by Subject|1|||
150214264|NCT00671853|541922911|FG001|Overall Study|Withdrawal by Subject|5|||
150214265|NCT00671853|541922910|FG000|Overall Study|Lost to Follow-up|8|||
150214266|NCT00671853|541922911|FG001|Overall Study|Lost to Follow-up|8|||
150214267|NCT00671853|541922910|FG000|Overall Study|Physician Decision|0|||
150214268|NCT00671853|541922911|FG001|Overall Study|Physician Decision|2|||
150214269|NCT00671853|541922910|FG000|Overall Study|Non-adherence with study procedures|1|||
150214270|NCT00671853|541922911|FG001|Overall Study|Non-adherence with study procedures|4|||
150214271|NCT01450007|541922912|FG000|Overall Study|Late exclusion before treatment|2|||
150214272|NCT01450007|541922913|FG001|Overall Study|Late exclusion before treatment|3|||
150214273|NCT01450007|541922914|FG002|Overall Study|Late exclusion before treatment|2|||
150214274|NCT01450007|541922912|FG000|Overall Study|Protocol Violation|0|||
150140046|NCT02220894|541647288|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
150140047|NCT02220894|541647289|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
150140048|NCT02220894|541647288|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150140049|NCT02220894|541647289|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150140050|NCT02220894|541647288|FG000|Overall Study|Withdrawal by Subject|10|||
150140051|NCT02220894|541647289|FG001|Overall Study|Withdrawal by Subject|9|||
150140052|NCT04098250|541647292|FG000|Overall Study|Withdrawal by Subject|1|||
150140053|NCT04098250|541647293|FG001|Overall Study|Withdrawal by Subject|0|||
150140054|NCT04098250|541647292|FG000|Overall Study|Lost to Follow-up|0|||
150140055|NCT04098250|541647293|FG001|Overall Study|Lost to Follow-up|1|||
150140056|NCT00633464|541647294|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
150140057|NCT00633464|541647295|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
150140058|NCT00633464|541647294|FG000|Overall Study|Never Treated (Randomized in error)|0|||
150140059|NCT00633464|541647295|FG001|Overall Study|Never Treated (Randomized in error)|1|||
150140060|NCT00394355|541647296|FG000|Overall Study|Adverse Event|10|||
150140061|NCT00394355|541647297|FG001|Overall Study|Adverse Event|6|||
150140062|NCT00394355|541647298|FG002|Overall Study|Adverse Event|7|||
150140063|NCT00394355|541647299|FG003|Overall Study|Adverse Event|8|||
150140064|NCT00394355|541647296|FG000|Overall Study|Did not meet protocol eligibility|1|||
150140065|NCT00394355|541647297|FG001|Overall Study|Did not meet protocol eligibility|5|||
150140066|NCT00394355|541647298|FG002|Overall Study|Did not meet protocol eligibility|4|||
150140067|NCT00394355|541647299|FG003|Overall Study|Did not meet protocol eligibility|2|||
150140068|NCT00394355|541647296|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
150140069|NCT00394355|541647297|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
150140070|NCT00394355|541647298|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
150140071|NCT00394355|541647299|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
150140072|NCT00394355|541647296|FG000|Overall Study|Subject withdrawal - related to drug|1|||
150140073|NCT00394355|541647297|FG001|Overall Study|Subject withdrawal - related to drug|0|||
150140074|NCT00394355|541647298|FG002|Overall Study|Subject withdrawal - related to drug|0|||
150140075|NCT00394355|541647299|FG003|Overall Study|Subject withdrawal - related to drug|0|||
150140076|NCT00394355|541647296|FG000|Overall Study|Lost to Follow-up|7|||
150140077|NCT00394355|541647297|FG001|Overall Study|Lost to Follow-up|5|||
150140078|NCT00394355|541647298|FG002|Overall Study|Lost to Follow-up|4|||
150140079|NCT00394355|541647299|FG003|Overall Study|Lost to Follow-up|3|||
150140080|NCT00394355|541647296|FG000|Overall Study|Noncompliance with protocol|4|||
150140081|NCT00394355|541647297|FG001|Overall Study|Noncompliance with protocol|3|||
150140082|NCT00394355|541647298|FG002|Overall Study|Noncompliance with protocol|10|||
150140083|NCT00394355|541647299|FG003|Overall Study|Noncompliance with protocol|8|||
150140084|NCT00394355|541647296|FG000|Overall Study|Administrative|0|||
150140085|NCT00394355|541647297|FG001|Overall Study|Administrative|1|||
150140086|NCT00394355|541647298|FG002|Overall Study|Administrative|1|||
150140087|NCT00394355|541647299|FG003|Overall Study|Administrative|1|||
150140088|NCT00394355|541647296|FG000|Overall Study|Lack of Efficacy|0|||
150140089|NCT00394355|541647297|FG001|Overall Study|Lack of Efficacy|0|||
150140090|NCT00394355|541647298|FG002|Overall Study|Lack of Efficacy|2|||
150140091|NCT00394355|541647299|FG003|Overall Study|Lack of Efficacy|3|||
150140092|NCT02612064|541647302|FG000|Overall Study|Withdrawal by Subject|1|||
150140093|NCT02612064|541647303|FG001|Overall Study|Withdrawal by Subject|1|||
150140094|NCT02612064|541647302|FG000|Overall Study|Other|0|||
150140095|NCT02612064|541647303|FG001|Overall Study|Other|2|||
150140096|NCT00698646|541647311|FG000|Overall Study|Adverse Event|8|||
150140097|NCT00698646|541647312|FG001|Overall Study|Adverse Event|7|||
150140098|NCT00698646|541647313|FG002|Overall Study|Adverse Event|8|||
150140099|NCT00698646|541647311|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
150140100|NCT00698646|541647312|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
150140101|NCT00698646|541647313|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
150140102|NCT00698646|541647311|FG000|Overall Study|Protocol Deviation|6|||
150140103|NCT00698646|541647312|FG001|Overall Study|Protocol Deviation|2|||
150140104|NCT00698646|541647313|FG002|Overall Study|Protocol Deviation|3|||
150140105|NCT00698646|541647311|FG000|Overall Study|Withdrawal by Subject|10|||
150140106|NCT00698646|541647312|FG001|Overall Study|Withdrawal by Subject|11|||
150140107|NCT00698646|541647313|FG002|Overall Study|Withdrawal by Subject|8|||
150140108|NCT00698646|541647311|FG000|Overall Study|Lost to Follow-up|0|||
150140109|NCT00698646|541647312|FG001|Overall Study|Lost to Follow-up|0|||
150140110|NCT00698646|541647313|FG002|Overall Study|Lost to Follow-up|2|||
150140111|NCT00698646|541647311|FG000|Overall Study|Administrative problems|1|||
150140112|NCT00698646|541647312|FG001|Overall Study|Administrative problems|0|||
150140113|NCT00698646|541647313|FG002|Overall Study|Administrative problems|1|||
150140114|NCT00316173|541647316|FG000|Run-in Phase|Adverse Event|1|||
150140115|NCT00316173|541647317|FG001|Run-in Phase|Adverse Event|0|||
150140116|NCT00316173|541647316|FG000|Run-in Phase|Protocol Violation|1|||
150140117|NCT00316173|541647317|FG001|Run-in Phase|Protocol Violation|0|||
150140118|NCT00316173|541647316|FG000|Run-in Phase|Study Follow-up Stopped|5|||
150140119|NCT00316173|541647317|FG001|Run-in Phase|Study Follow-up Stopped|0|||
150214275|NCT01450007|541922913|FG001|Overall Study|Protocol Violation|1|||
150214276|NCT01450007|541922914|FG002|Overall Study|Protocol Violation|1|||
150214277|NCT01450007|541922912|FG000|Overall Study|Adverse Event|0|||
150214278|NCT01450007|541922913|FG001|Overall Study|Adverse Event|1|||
150214279|NCT01450007|541922914|FG002|Overall Study|Adverse Event|0|||
150214280|NCT02224755|541922915|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
150214281|NCT02224755|541922916|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
150214282|NCT02224755|541922915|FG000|Two Year Follow up Post-implant|Death|103|||
150214283|NCT02224755|541922916|FG001|Two Year Follow up Post-implant|Death|98|||
150214284|NCT02224755|541922915|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
150214285|NCT02224755|541922916|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
150214286|NCT02224755|541922915|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
150214287|NCT02224755|541922916|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
150214288|NCT02224755|541922915|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
150214289|NCT02224755|541922916|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
150214290|NCT00703092|541922919|FG000|Overall Study|Withdrawal by Subject|2|||
150214291|NCT01480258|541922920|FG000|Infant Series|Protocol Violation|2|||
150214292|NCT01480258|541922921|FG001|Infant Series|Protocol Violation|0|||
150214293|NCT01480258|541922920|FG000|Infant Series|Physician Decision|0|||
150214294|NCT01480258|541922921|FG001|Infant Series|Physician Decision|1|||
150214295|NCT01480258|541922920|FG000|Infant Series|Not Vaccinated|3|||
150214296|NCT01480258|541922921|FG001|Infant Series|Not Vaccinated|0|||
150214297|NCT01480258|541922920|FG000|Infant Series|Adverse Event|1|||
150214298|NCT01480258|541922921|FG001|Infant Series|Adverse Event|1|||
150214299|NCT01480258|541922920|FG000|Infant Series|Withdrawal by Subject|1|||
150214300|NCT01480258|541922921|FG001|Infant Series|Withdrawal by Subject|6|||
150214301|NCT01480258|541922920|FG000|Interim Period|Lost to Follow-up|0|||
150214302|NCT01480258|541922921|FG001|Interim Period|Lost to Follow-up|2|||
150214303|NCT01480258|541922920|FG000|Interim Period|Physician Decision|1|||
150214304|NCT01480258|541922921|FG001|Interim Period|Physician Decision|0|||
150214305|NCT01480258|541922920|FG000|Interim Period|Protocol Violation|0|||
150214306|NCT01480258|541922921|FG001|Interim Period|Protocol Violation|1|||
150214307|NCT01480258|541922920|FG000|Interim Period|Withdrawal by Subject|9|||
150214308|NCT01480258|541922921|FG001|Interim Period|Withdrawal by Subject|6|||
150214309|NCT03131713|541922926|FG000|Overall Study|Lost to Follow-up|5|||
150214310|NCT03131713|541922927|FG001|Overall Study|Lost to Follow-up|0|||
150214311|NCT02362789|541922931|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
150214312|NCT02362789|541922932|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
150214313|NCT02362789|541922933|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
150214314|NCT02362789|541922931|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
150214315|NCT02362789|541922932|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
150214316|NCT02362789|541922933|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
150214317|NCT02362789|541922931|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
150214318|NCT02362789|541922932|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
150214319|NCT02362789|541922933|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
150214320|NCT02362789|541922931|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
150214321|NCT02362789|541922932|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
150214322|NCT02362789|541922933|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
150214323|NCT02362789|541922931|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
150214324|NCT02362789|541922932|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
150214325|NCT02362789|541922933|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
150214326|NCT03861234|541922937|FG000|Overall Study|Not treated|0|||
150214327|NCT03861234|541922938|FG001|Overall Study|Not treated|0|||
150214328|NCT03861234|541922939|FG002|Overall Study|Not treated|0|||
150214329|NCT03861234|541922940|FG003|Overall Study|Not treated|0|||
150214330|NCT03861234|541922941|FG004|Overall Study|Not treated|0|||
150214331|NCT03861234|541922942|FG005|Overall Study|Not treated|1|||
150214332|NCT03861234|541922943|FG006|Overall Study|Not treated|0|||
150214333|NCT03861234|541922944|FG007|Overall Study|Not treated|0|||
150214334|NCT03861234|541922937|FG000|Overall Study|Adverse Event|0|||
150214335|NCT03861234|541922938|FG001|Overall Study|Adverse Event|0|||
150214336|NCT03861234|541922939|FG002|Overall Study|Adverse Event|0|||
150214337|NCT03861234|541922940|FG003|Overall Study|Adverse Event|0|||
150214338|NCT03861234|541922941|FG004|Overall Study|Adverse Event|0|||
150214339|NCT03861234|541922942|FG005|Overall Study|Adverse Event|1|||
150214340|NCT03861234|541922943|FG006|Overall Study|Adverse Event|0|||
150214341|NCT03861234|541922944|FG007|Overall Study|Adverse Event|0|||
150214342|NCT03861234|541922937|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
150214343|NCT03861234|541922938|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
150214344|NCT03861234|541922939|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
150214345|NCT03861234|541922940|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
150214346|NCT03861234|541922941|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
150214347|NCT03861234|541922942|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
150214348|NCT03861234|541922943|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
150214349|NCT03861234|541922944|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
150214350|NCT03861234|541922937|FG000|Overall Study|As per sponsor decision|0|||
150214351|NCT03861234|541922938|FG001|Overall Study|As per sponsor decision|0|||
150214352|NCT03861234|541922939|FG002|Overall Study|As per sponsor decision|0|||
150214353|NCT03861234|541922940|FG003|Overall Study|As per sponsor decision|0|||
150214354|NCT03861234|541922941|FG004|Overall Study|As per sponsor decision|0|||
150214355|NCT03861234|541922942|FG005|Overall Study|As per sponsor decision|0|||
150214356|NCT03861234|541922943|FG006|Overall Study|As per sponsor decision|1|||
150214357|NCT03861234|541922944|FG007|Overall Study|As per sponsor decision|0|||
150214358|NCT03861234|541922937|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
150214359|NCT03861234|541922938|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
150214360|NCT03861234|541922939|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
150214361|NCT03861234|541922940|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
150214362|NCT03861234|541922941|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
150214363|NCT03861234|541922942|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
150214364|NCT03861234|541922943|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
150214365|NCT03861234|541922944|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
150214366|NCT00621842|541922945|FG000|Overall Study|Adverse Event|6|||
150214367|NCT00621842|541922945|FG000|Overall Study|Withdrawal by Subject|7|||
150214368|NCT00621842|541922945|FG000|Overall Study|Protocol Violation|4|||
150214369|NCT00621842|541922945|FG000|Overall Study|Lack of Efficacy|2|||
150214370|NCT00526994|541922947|FG000|Overall Study|Lost to Follow-up|98|||
150214371|NCT00526994|541922948|FG001|Overall Study|Lost to Follow-up|108|||
150214372|NCT00526994|541922949|FG002|Overall Study|Lost to Follow-up|96|||
150214373|NCT00526994|541922947|FG000|Overall Study|Death|4|||
150214374|NCT00526994|541922948|FG001|Overall Study|Death|3|||
150214375|NCT00526994|541922949|FG002|Overall Study|Death|3|||
150214376|NCT00526994|541922947|FG000|Overall Study|Withdrawal by Subject|2|||
150214377|NCT00526994|541922948|FG001|Overall Study|Withdrawal by Subject|7|||
150214378|NCT00526994|541922949|FG002|Overall Study|Withdrawal by Subject|5|||
150214379|NCT00526994|541922947|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
150214380|NCT00526994|541922948|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
150214381|NCT00526994|541922949|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
150214382|NCT03026166|541922950|FG000|Overall Study|Death|22|||
150214383|NCT03026166|541922951|FG001|Overall Study|Death|7|||
150214384|NCT03026166|541922950|FG000|Overall Study|Physician Decision|2|||
150214385|NCT03026166|541922951|FG001|Overall Study|Physician Decision|0|||
150214386|NCT03026166|541922950|FG000|Overall Study|Withdrawal by Subject|1|||
150214387|NCT03026166|541922951|FG001|Overall Study|Withdrawal by Subject|2|||
150214388|NCT03026166|541922950|FG000|Overall Study|Lost to Follow-up|1|||
150214389|NCT03026166|541922951|FG001|Overall Study|Lost to Follow-up|0|||
150214390|NCT03026166|541922950|FG000|Overall Study|Study Terminated by Sponsor|3|||
150214391|NCT03026166|541922951|FG001|Overall Study|Study Terminated by Sponsor|3|||
150214392|NCT03026166|541922950|FG000|Overall Study|Other|1|||
150214393|NCT03026166|541922951|FG001|Overall Study|Other|0|||
150214394|NCT05270460|541922952|FG000|Overall Study|Adverse Event|0|||
150214395|NCT05270460|541922953|FG001|Overall Study|Adverse Event|1|||
150214396|NCT05270460|541922954|FG002|Overall Study|Adverse Event|0|||
150214397|NCT05270460|541922952|FG000|Overall Study|Early Termination|0|||
150214398|NCT05270460|541922953|FG001|Overall Study|Early Termination|1|||
150214399|NCT05270460|541922954|FG002|Overall Study|Early Termination|0|||
150214400|NCT00380250|541922955|FG000|Overall Study|Withdrawal by Subject|39|||
150214401|NCT00380250|541922956|FG001|Overall Study|Withdrawal by Subject|28|||
150214402|NCT00380250|541922955|FG000|Overall Study|Adverse Event|20|||
150214403|NCT00380250|541922956|FG001|Overall Study|Adverse Event|9|||
150214404|NCT00380250|541922955|FG000|Overall Study|Lack of Efficacy|10|||
150214405|NCT00380250|541922956|FG001|Overall Study|Lack of Efficacy|8|||
150214406|NCT00380250|541922955|FG000|Overall Study|Protocol Violation|15|||
150214407|NCT00380250|541922956|FG001|Overall Study|Protocol Violation|5|||
150214408|NCT00380250|541922955|FG000|Overall Study|Lost to Follow-up|14|||
150214409|NCT00380250|541922956|FG001|Overall Study|Lost to Follow-up|5|||
150214410|NCT00380250|541922955|FG000|Overall Study|Physician Decision|1|||
150214411|NCT00380250|541922956|FG001|Overall Study|Physician Decision|0|||
150214412|NCT02833948|541922959|FG000|Overall Study|Death|2|||
150214413|NCT02833948|541922960|FG001|Overall Study|Death|3|||
150214414|NCT02833948|541922959|FG000|Overall Study|were not scanned|8|||
150214415|NCT02833948|541922960|FG001|Overall Study|were not scanned|13|||
150214416|NCT02833948|541922959|FG000|Overall Study|scans could not be evaluated|5|||
150214417|NCT02833948|541922960|FG001|Overall Study|scans could not be evaluated|2|||
150214418|NCT00680771|541922966|FG000|Overall Study|Withdrawal by Subject|1|||
150214419|NCT00680771|541922967|FG001|Overall Study|Withdrawal by Subject|0|||
150214420|NCT00680771|541922966|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
150214421|NCT00680771|541922967|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
150214422|NCT00680771|541922966|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
150214423|NCT00680771|541922967|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
150214424|NCT02691702|541922968|FG000|Overall Study|Adverse Event|1|||
150214425|NCT02691702|541922969|FG001|Overall Study|Adverse Event|0|||
150214426|NCT02691702|541922970|FG002|Overall Study|Adverse Event|0|||
150214427|NCT02691702|541922971|FG003|Overall Study|Adverse Event|0|||
150214428|NCT02691702|541922972|FG004|Overall Study|Adverse Event|0|||
150214429|NCT02691702|541922973|FG005|Overall Study|Adverse Event|0|||
150214430|NCT02691702|541922974|FG006|Overall Study|Adverse Event|0|||
150214431|NCT02691702|541922975|FG007|Overall Study|Adverse Event|0|||
150214432|NCT02691702|541922976|FG008|Overall Study|Adverse Event|1|||
150214433|NCT02691702|541922977|FG009|Overall Study|Adverse Event|0|||
150214434|NCT02691702|541922978|FG010|Overall Study|Adverse Event|1|||
150214435|NCT02691702|541922968|FG000|Overall Study|Lost to Follow-up|0|||
150214436|NCT02691702|541922969|FG001|Overall Study|Lost to Follow-up|0|||
150214437|NCT02691702|541922970|FG002|Overall Study|Lost to Follow-up|1|||
150214438|NCT02691702|541922971|FG003|Overall Study|Lost to Follow-up|0|||
150214439|NCT02691702|541922972|FG004|Overall Study|Lost to Follow-up|0|||
150214440|NCT02691702|541922973|FG005|Overall Study|Lost to Follow-up|2|||
150214441|NCT02691702|541922974|FG006|Overall Study|Lost to Follow-up|0|||
150214442|NCT02691702|541922975|FG007|Overall Study|Lost to Follow-up|0|||
150214443|NCT02691702|541922976|FG008|Overall Study|Lost to Follow-up|0|||
150214444|NCT02691702|541922977|FG009|Overall Study|Lost to Follow-up|0|||
150214445|NCT02691702|541922978|FG010|Overall Study|Lost to Follow-up|1|||
150214446|NCT02691702|541922968|FG000|Overall Study|Withdrawal by Subject|1|||
150214447|NCT02691702|541922969|FG001|Overall Study|Withdrawal by Subject|1|||
150214448|NCT02691702|541922970|FG002|Overall Study|Withdrawal by Subject|0|||
150214449|NCT02691702|541922971|FG003|Overall Study|Withdrawal by Subject|0|||
150214450|NCT02691702|541922972|FG004|Overall Study|Withdrawal by Subject|0|||
150214451|NCT02691702|541922973|FG005|Overall Study|Withdrawal by Subject|1|||
150214452|NCT02691702|541922974|FG006|Overall Study|Withdrawal by Subject|2|||
150214453|NCT02691702|541922975|FG007|Overall Study|Withdrawal by Subject|0|||
150214454|NCT02691702|541922976|FG008|Overall Study|Withdrawal by Subject|0|||
150214455|NCT02691702|541922977|FG009|Overall Study|Withdrawal by Subject|0|||
150214456|NCT02691702|541922978|FG010|Overall Study|Withdrawal by Subject|0|||
150214457|NCT02691702|541922968|FG000|Overall Study|Other|0|||
150214458|NCT02691702|541922969|FG001|Overall Study|Other|0|||
150214459|NCT02691702|541922970|FG002|Overall Study|Other|0|||
150214460|NCT02691702|541922971|FG003|Overall Study|Other|0|||
150214461|NCT02691702|541922972|FG004|Overall Study|Other|0|||
150214462|NCT02691702|541922973|FG005|Overall Study|Other|0|||
150214463|NCT02691702|541922974|FG006|Overall Study|Other|1|||
150214464|NCT02691702|541922975|FG007|Overall Study|Other|0|||
150214465|NCT02691702|541922976|FG008|Overall Study|Other|1|||
150214466|NCT02691702|541922977|FG009|Overall Study|Other|0|||
150214467|NCT02691702|541922978|FG010|Overall Study|Other|0|||
150214468|NCT02691702|541922968|FG000|Overall Study|Protocol Violation|0|||
150214469|NCT02691702|541922969|FG001|Overall Study|Protocol Violation|0|||
150214470|NCT02691702|541922970|FG002|Overall Study|Protocol Violation|0|||
150214471|NCT02691702|541922971|FG003|Overall Study|Protocol Violation|0|||
150214472|NCT02691702|541922972|FG004|Overall Study|Protocol Violation|0|||
150214473|NCT02691702|541922973|FG005|Overall Study|Protocol Violation|0|||
150214474|NCT02691702|541922974|FG006|Overall Study|Protocol Violation|0|||
150214475|NCT02691702|541922975|FG007|Overall Study|Protocol Violation|0|||
150214476|NCT02691702|541922976|FG008|Overall Study|Protocol Violation|0|||
150214477|NCT02691702|541922977|FG009|Overall Study|Protocol Violation|2|||
150214478|NCT02691702|541922978|FG010|Overall Study|Protocol Violation|0|||
150214479|NCT05613088|541922979|FG000|Treatment|Ongoing Study Treatment|9|||
150214480|NCT05613088|541922980|FG001|Treatment|Ongoing Study Treatment|2|||
150214481|NCT05613088|541922979|FG000|Treatment|Adverse Event|3|||
150214482|NCT05613088|541922980|FG001|Treatment|Adverse Event|1|||
150214483|NCT05613088|541922979|FG000|Treatment|Other Reasons|0|||
150214484|NCT05613088|541922980|FG001|Treatment|Other Reasons|1|||
150214485|NCT05613088|541922979|FG000|Treatment|Progressive Disease|58|||
150214486|NCT05613088|541922980|FG001|Treatment|Progressive Disease|26|||
150214487|NCT05613088|541922979|FG000|Treatment|Withdrawal by Subject|0|||
150214488|NCT05613088|541922980|FG001|Treatment|Withdrawal by Subject|4|||
150214489|NCT05169684|541922981|FG000|Overall Study|Adverse Event|1|||
150214490|NCT05169684|541922982|FG001|Overall Study|Adverse Event|3|||
150214491|NCT05169684|541922981|FG000|Overall Study|Physician Decision|0|||
150214492|NCT05169684|541922982|FG001|Overall Study|Physician Decision|1|||
150214493|NCT05169684|541922981|FG000|Overall Study|Progressive Disease|1|||
150214494|NCT05169684|541922982|FG001|Overall Study|Progressive Disease|1|||
150214495|NCT05169684|541922981|FG000|Overall Study|Participant request to discontinue treatment|0|||
150214496|NCT05169684|541922982|FG001|Overall Study|Participant request to discontinue treatment|1|||
150214497|NCT05169684|541922981|FG000|Overall Study|Other Reason|0|||
150214498|NCT05169684|541922982|FG001|Overall Study|Other Reason|1|||
150214499|NCT01668719|541922983|FG000|Phase I|On treatment|1|||
150214500|NCT01668719|541922984|FG001|Phase I|On treatment|0|||
150214501|NCT01668719|541922985|FG002|Phase I|On treatment|0|||
150214502|NCT01668719|541922983|FG000|Phase I|Adverse Event|2|||
150214503|NCT01668719|541922984|FG001|Phase I|Adverse Event|0|||
150214504|NCT01668719|541922985|FG002|Phase I|Adverse Event|0|||
150214505|NCT01668719|541922983|FG000|Phase I|Progression/relapse|1|||
150214506|NCT01668719|541922984|FG001|Phase I|Progression/relapse|0|||
150214507|NCT01668719|541922985|FG002|Phase I|Progression/relapse|0|||
150214508|NCT01668719|541922983|FG000|Phase I|not protocol specified|2|||
150214509|NCT01668719|541922984|FG001|Phase I|not protocol specified|0|||
150214510|NCT01668719|541922985|FG002|Phase I|not protocol specified|0|||
150214511|NCT01668719|541922983|FG000|Phase II|On treatment|0|||
150214512|NCT01668719|541922984|FG001|Phase II|On treatment|4|||
150214513|NCT01668719|541922985|FG002|Phase II|On treatment|3|||
150214514|NCT01668719|541922983|FG000|Phase II|Adverse Event|0|||
150214515|NCT01668719|541922984|FG001|Phase II|Adverse Event|18|||
150214516|NCT01668719|541922985|FG002|Phase II|Adverse Event|18|||
150214517|NCT01668719|541922983|FG000|Phase II|Refusal unrelated to adverse event|0|||
150214518|NCT01668719|541922984|FG001|Phase II|Refusal unrelated to adverse event|4|||
150214519|NCT01668719|541922985|FG002|Phase II|Refusal unrelated to adverse event|1|||
150214520|NCT01668719|541922983|FG000|Phase II|Progression/relapse|0|||
150214521|NCT01668719|541922984|FG001|Phase II|Progression/relapse|13|||
150214522|NCT01668719|541922985|FG002|Phase II|Progression/relapse|17|||
150214523|NCT01668719|541922983|FG000|Phase II|Death|0|||
150214524|NCT01668719|541922984|FG001|Phase II|Death|0|||
150214525|NCT01668719|541922985|FG002|Phase II|Death|2|||
150214526|NCT01668719|541922983|FG000|Phase II|not protocol specified|0|||
150214527|NCT01668719|541922984|FG001|Phase II|not protocol specified|13|||
150214528|NCT01668719|541922985|FG002|Phase II|not protocol specified|7|||
150214529|NCT03539055|541922986|FG000|Overall Study|Death|4|||
150214530|NCT03539055|541922986|FG000|Overall Study|Lost to Follow-up|1|||
150214531|NCT03539055|541922986|FG000|Overall Study|Withdrawal by Subject|2|||
150214532|NCT03539055|541922986|FG000|Overall Study|Screen Fail|7|||
150214533|NCT03539055|541922986|FG000|Overall Study|Drug Intolerance|2|||
150214534|NCT01638000|541922995|FG000|Overall Study|Randomized but Never Received Drug|7|||
150214535|NCT01638000|541922996|FG001|Overall Study|Randomized but Never Received Drug|10|||
150214536|NCT01638000|541922995|FG000|Overall Study|Adverse Event|14|||
150214537|NCT01638000|541922996|FG001|Overall Study|Adverse Event|16|||
150214538|NCT01638000|541922995|FG000|Overall Study|Lack of Efficacy|5|||
150214539|NCT01638000|541922996|FG001|Overall Study|Lack of Efficacy|6|||
150214540|NCT01638000|541922995|FG000|Overall Study|Protocol Violation|11|||
150214541|NCT01638000|541922996|FG001|Overall Study|Protocol Violation|13|||
150214542|NCT01638000|541922995|FG000|Overall Study|Withdrawal by Subject|21|||
150214543|NCT01638000|541922996|FG001|Overall Study|Withdrawal by Subject|24|||
150214544|NCT01638000|541922995|FG000|Overall Study|Miscellaneous|2|||
150214545|NCT01638000|541922996|FG001|Overall Study|Miscellaneous|2|||
150214546|NCT05484661|541922997|FG000|Overall Study|Withdrawal by Subject|1|||
150214547|NCT05484661|541922998|FG001|Overall Study|Withdrawal by Subject|0|||
150214548|NCT00875706|541922999|FG000|Overall Study|Withdrawal by Subject|1|||
150214549|NCT00875706|541923000|FG001|Overall Study|Withdrawal by Subject|0|||
150214550|NCT00875706|541923001|FG002|Overall Study|Withdrawal by Subject|0|||
150214551|NCT03652610|541923002|FG000|Overall Study|Lost to Follow-up|1|||
150214552|NCT03652610|541923003|FG001|Overall Study|Lost to Follow-up|0|||
150214553|NCT03652610|541923002|FG000|Overall Study|Withdrawal by Subject|3|||
150214554|NCT03652610|541923003|FG001|Overall Study|Withdrawal by Subject|5|||
150214555|NCT03775213|541923004|FG000|Overall Study|Withdrawal by Subject|51|||
150214556|NCT03775213|541923005|FG001|Overall Study|Withdrawal by Subject|53|||
150214557|NCT03775213|541923004|FG000|Overall Study|Incomplete Survey|7|||
150214558|NCT03775213|541923005|FG001|Overall Study|Incomplete Survey|7|||
150214559|NCT00786188|541923006|FG000|Overall Study|Adverse Event|3|||
150214560|NCT00786188|541923007|FG001|Overall Study|Adverse Event|1|||
150214561|NCT00786188|541923006|FG000|Overall Study|Withdrawal by Subject|2|||
150214562|NCT00786188|541923007|FG001|Overall Study|Withdrawal by Subject|0|||
150214563|NCT00326183|541923008|FG000|Overall Study|Lost to Follow-up|104|||
150214564|NCT00326183|541923009|FG001|Overall Study|Lost to Follow-up|56|||
150214565|NCT00326183|541923008|FG000|Overall Study|Protocol Violation|6|||
150214566|NCT00326183|541923009|FG001|Overall Study|Protocol Violation|3|||
150214567|NCT00326183|541923008|FG000|Overall Study|Withdrawal by Subject|35|||
150140120|NCT00316173|541647316|FG000|Treatment Phase|Adverse Event|0|||
150140121|NCT00316173|541647317|FG001|Treatment Phase|Adverse Event|1|||
150140122|NCT00316173|541647316|FG000|Treatment Phase|Lack of Efficacy|0|||
150140123|NCT00316173|541647317|FG001|Treatment Phase|Lack of Efficacy|3|||
150140124|NCT00316173|541647316|FG000|Treatment Phase|Lost to Follow-up|0|||
150140125|NCT00316173|541647317|FG001|Treatment Phase|Lost to Follow-up|3|||
150140126|NCT00316173|541647316|FG000|Treatment Phase|Withdrawal by Subject|0|||
150140127|NCT00316173|541647317|FG001|Treatment Phase|Withdrawal by Subject|1|||
150140128|NCT00316173|541647316|FG000|Treatment Phase|Study Follow-up Stopped|0|||
150140129|NCT00316173|541647317|FG001|Treatment Phase|Study Follow-up Stopped|34|||
150140130|NCT02044848|541648723|FG000|Overall Study|Administrative Problems|2|||
150140131|NCT02044848|541648724|FG001|Overall Study|Administrative Problems|3|||
150140132|NCT00045708|541648725|FG000|Phase 1|early progressive disease|0|||
150140133|NCT00045708|541648726|FG001|Phase 1|early progressive disease|1|||
150140134|NCT00045708|541648727|FG002|Phase 1|early progressive disease|0|||
150140135|NCT00685945|541648729|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
150140136|NCT03183388|541648730|FG000|Overall Study|Lost to Follow-up|3|||
150140137|NCT03183388|541648731|FG001|Overall Study|Lost to Follow-up|5|||
150140138|NCT03183388|541648730|FG000|Overall Study|Physician Decision|1|||
150140139|NCT03183388|541648731|FG001|Overall Study|Physician Decision|4|||
150140140|NCT03183388|541648730|FG000|Overall Study|Withdrawal by Subject|4|||
150140141|NCT03183388|541648731|FG001|Overall Study|Withdrawal by Subject|1|||
150140142|NCT03183388|541648730|FG000|Overall Study|Moved|1|||
150140143|NCT03183388|541648731|FG001|Overall Study|Moved|0|||
150140144|NCT03183388|541648730|FG000|Overall Study|Met Exclusion Criteria|2|||
150140145|NCT03183388|541648731|FG001|Overall Study|Met Exclusion Criteria|2|||
150140146|NCT03183388|541648730|FG000|Overall Study|COVID Pandemic Related|2|||
150140147|NCT03183388|541648731|FG001|Overall Study|COVID Pandemic Related|4|||
150140148|NCT01493960|541648734|FG000|Overall Study|Adverse Event|0|||
150140149|NCT01493960|541648735|FG001|Overall Study|Adverse Event|1|||
150140150|NCT01493960|541648734|FG000|Overall Study|Lack of Efficacy|15|||
150140151|NCT01493960|541648735|FG001|Overall Study|Lack of Efficacy|9|||
150140152|NCT01493960|541648734|FG000|Overall Study|Protocol Violation|3|||
150140153|NCT01493960|541648735|FG001|Overall Study|Protocol Violation|0|||
150140154|NCT01493960|541648734|FG000|Overall Study|Withdrawal by Subject|10|||
150140155|NCT01493960|541648735|FG001|Overall Study|Withdrawal by Subject|4|||
150140156|NCT01493960|541648734|FG000|Overall Study|Non-specified|4|||
150140157|NCT01493960|541648735|FG001|Overall Study|Non-specified|4|||
150140158|NCT01679236|541648740|FG000|Overall Study|Lost to Follow-up|15|||
150140159|NCT01679236|541648741|FG001|Overall Study|Lost to Follow-up|15|||
150140160|NCT00284141|541648742|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
150140161|NCT00284141|541648742|FG000|Overall Study|Adverse Event|19|||
150140162|NCT00284141|541648742|FG000|Overall Study|Participant's request|9|||
150140163|NCT00284141|541648742|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
150140164|NCT00284141|541648742|FG000|Overall Study|Clinical deterioration / death|2|||
150140165|NCT00284141|541648742|FG000|Overall Study|General decline|1|||
150140166|NCT00284141|541648742|FG000|Overall Study|Pneumonia|1|||
150140167|NCT00284141|541648742|FG000|Overall Study|Did not take study medication|2|||
150140168|NCT00284141|541648742|FG000|Overall Study|Ongoing treatment|2|||
150140169|NCT01160484|541648752|FG000|Overall Study|Lack of Efficacy|9|||
150140170|NCT01160484|541648752|FG000|Overall Study|Adverse Event|6|||
150140171|NCT01160484|541648752|FG000|Overall Study|Withdrawal by Subject|2|||
150140172|NCT01160484|541648752|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
150140173|NCT00803101|541648753|FG000|Overall Study|Death / Serious Adverse Event|4|||
150140174|NCT00803101|541648754|FG001|Overall Study|Death / Serious Adverse Event|6|||
150140175|NCT00803101|541648753|FG000|Overall Study|Withdrawal by Subject|6|||
150140176|NCT00803101|541648754|FG001|Overall Study|Withdrawal by Subject|4|||
150140177|NCT00803101|541648753|FG000|Overall Study|Lost to Follow-up|2|||
150140178|NCT00803101|541648754|FG001|Overall Study|Lost to Follow-up|2|||
150214568|NCT00326183|541923009|FG001|Overall Study|Withdrawal by Subject|7|||
150214569|NCT00326183|541923008|FG000|Overall Study|Subject Moved|7|||
150214570|NCT00326183|541923009|FG001|Overall Study|Subject Moved|4|||
150214571|NCT00326183|541923008|FG000|Overall Study|Other|47|||
150214572|NCT00326183|541923009|FG001|Overall Study|Other|13|||
150214573|NCT00326183|541923008|FG000|Overall Study|Adverse Event|1|||
150214574|NCT00326183|541923009|FG001|Overall Study|Adverse Event|0|||
150214575|NCT00570505|541923015|FG000|Overall Study|Adverse Event|7|||
150214576|NCT00570505|541923015|FG000|Overall Study|Withdrawal by Subject|7|||
150214577|NCT00570505|541923015|FG000|Overall Study|Lost to Follow-up|23|||
150214578|NCT00570505|541923015|FG000|Overall Study|Other loss to follow-up|4|||
150214579|NCT02485925|541923018|FG000|Overall Study|Withdrawal by Subject|3|||
150214580|NCT02485925|541923018|FG000|Overall Study|Death|1|||
150214581|NCT02485925|541923018|FG000|Overall Study|Lost to Follow-up|11|||
150214582|NCT01668355|541924611|FG000|Overall Study|Death|3|||
150214583|NCT01668355|541924612|FG001|Overall Study|Death|1|||
150214584|NCT01668355|541924611|FG000|Overall Study|Withdrawal by Subject|6|||
150214585|NCT01668355|541924612|FG001|Overall Study|Withdrawal by Subject|1|||
150214586|NCT01190124|541924617|FG000|Overall Study|Death|3|||
150214587|NCT01190124|541924618|FG001|Overall Study|Death|0|||
150214588|NCT01190124|541924619|FG002|Overall Study|Death|0|||
150214589|NCT01190124|541924617|FG000|Overall Study|Therapeutic Failure|12|||
150214590|NCT01190124|541924618|FG001|Overall Study|Therapeutic Failure|0|||
150214591|NCT01190124|541924619|FG002|Overall Study|Therapeutic Failure|1|||
150214592|NCT01190124|541924617|FG000|Overall Study|Lost to Follow-up|2|||
150214593|NCT01190124|541924618|FG001|Overall Study|Lost to Follow-up|0|||
150214594|NCT01190124|541924619|FG002|Overall Study|Lost to Follow-up|0|||
150214595|NCT00070707|541924620|FG000|Overall Study|Adverse Event|1|||
150214596|NCT00070707|541924621|FG001|Overall Study|Adverse Event|2|||
150214597|NCT00070707|541924620|FG000|Overall Study|Lack of Efficacy|4|||
150214598|NCT00070707|541924621|FG001|Overall Study|Lack of Efficacy|1|||
150214599|NCT00070707|541924620|FG000|Overall Study|Protocol Violation|8|||
150214600|NCT00070707|541924621|FG001|Overall Study|Protocol Violation|4|||
150214601|NCT00070707|541924620|FG000|Overall Study|Unrelated to Study Medication|1|||
150214602|NCT00070707|541924621|FG001|Overall Study|Unrelated to Study Medication|0|||
150214603|NCT03690219|541924622|FG000|Overall Study|no injuries|9|||
150214604|NCT03690219|541924623|FG001|Overall Study|no injuries|20|||
150214605|NCT03690219|541924622|FG000|Overall Study|missing information|7|||
150214606|NCT03690219|541924623|FG001|Overall Study|missing information|7|||
150214607|NCT01523392|541924624|FG000|Treatment Period 1|Withdrawal by Subject|2|||
150214608|NCT01523392|541924625|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150214609|NCT01523392|541924624|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
150214610|NCT01523392|541924625|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
150214611|NCT01523392|541924624|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
150214612|NCT01523392|541924625|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
150214613|NCT04809623|541924626|FG000|Overall Study|Study Terminated by Sponsor|1|||
150214614|NCT04809623|541924627|FG001|Overall Study|Study Terminated by Sponsor|0|||
150214615|NCT02354417|541924628|FG000|Overall Study|Physician Decision|1|||
150214616|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
150214617|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150214618|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150214619|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150214620|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
150214621|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150214622|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150214623|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150214624|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
150214625|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150214626|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150214627|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150214628|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
150214629|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150214630|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150214631|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150214632|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
150214633|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150214634|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150214635|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150214636|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
150214637|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150214638|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150214639|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150214640|NCT01185340|541924631|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
150214641|NCT01185340|541924632|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150214642|NCT01185340|541924633|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150214643|NCT01185340|541924634|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150214644|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
150214645|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
150214646|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
150214647|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
150214648|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
150214649|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
150214650|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
150214651|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
150214652|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
150214653|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
150214654|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
150214655|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
150214656|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150214657|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
150214658|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150214659|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
150214660|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
150214661|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
150214662|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
150214663|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
150214664|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
150214665|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
150214666|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
150214667|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
150214668|NCT01185340|541924631|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150214669|NCT01185340|541924632|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150214670|NCT01185340|541924633|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
150214671|NCT01185340|541924634|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
150214672|NCT01719172|541924635|FG000|Overall Study|Lost to Follow-up|1|||
150214673|NCT01719172|541924635|FG000|Overall Study|Death|1|||
150214674|NCT01148017|541924636|FG000|Overall Study|Withdrawal by Subject|31|||
150214675|NCT01148017|541924637|FG001|Overall Study|Withdrawal by Subject|14|||
150214676|NCT01148017|541924638|FG002|Overall Study|Withdrawal by Subject|0|||
150214677|NCT01148017|541924639|FG003|Overall Study|Withdrawal by Subject|0|||
150214678|NCT01148017|541924636|FG000|Overall Study|Lost to Follow-up|23|||
150214679|NCT01148017|541924637|FG001|Overall Study|Lost to Follow-up|10|||
150214680|NCT01148017|541924638|FG002|Overall Study|Lost to Follow-up|0|||
150214681|NCT01148017|541924639|FG003|Overall Study|Lost to Follow-up|0|||
150214682|NCT01148017|541924636|FG000|Overall Study|Inappropriate enrollment|1|||
150214683|NCT01148017|541924637|FG001|Overall Study|Inappropriate enrollment|0|||
150214684|NCT01148017|541924638|FG002|Overall Study|Inappropriate enrollment|0|||
150214685|NCT01148017|541924639|FG003|Overall Study|Inappropriate enrollment|0|||
150214686|NCT01148017|541924636|FG000|Overall Study|Administrative reason|22|||
150214687|NCT01148017|541924637|FG001|Overall Study|Administrative reason|9|||
150214688|NCT01148017|541924638|FG002|Overall Study|Administrative reason|0|||
150214689|NCT01148017|541924639|FG003|Overall Study|Administrative reason|0|||
150214690|NCT01148017|541924636|FG000|Overall Study|Unable to classify|3|||
150214691|NCT01148017|541924637|FG001|Overall Study|Unable to classify|1|||
150214692|NCT01148017|541924638|FG002|Overall Study|Unable to classify|0|||
150214693|NCT01148017|541924639|FG003|Overall Study|Unable to classify|0|||
150214694|NCT01848483|541924640|FG000|Overall Study|Death|2|||
150214695|NCT01848483|541924641|FG001|Overall Study|Death|1|||
150214696|NCT01848483|541924640|FG000|Overall Study|Lost to Follow-up|6|||
150214697|NCT01848483|541924641|FG001|Overall Study|Lost to Follow-up|8|||
150214698|NCT01848483|541924640|FG000|Overall Study|Withdrawal by Subject|1|||
150214699|NCT01848483|541924641|FG001|Overall Study|Withdrawal by Subject|0|||
150214700|NCT01848483|541924640|FG000|Overall Study|Incarceration|2|||
150214701|NCT01848483|541924641|FG001|Overall Study|Incarceration|2|||
150214702|NCT00246129|541924646|FG000|Overall Study|Lost to Follow-up|1|||
150214703|NCT00246129|541924647|FG001|Overall Study|Lost to Follow-up|0|||
150214704|NCT00246129|541924646|FG000|Overall Study|Death|2|||
150214705|NCT00246129|541924647|FG001|Overall Study|Death|1|||
150214706|NCT00246129|541924646|FG000|Overall Study|suffered primary non-function|1|||
150214707|NCT00246129|541924647|FG001|Overall Study|suffered primary non-function|0|||
150214708|NCT00246129|541924646|FG000|Overall Study|grafts failed|3|||
150214709|NCT00246129|541924647|FG001|Overall Study|grafts failed|1|||
150214710|NCT03740737|541924648|FG000|Overall Study|Protocol deviation|13|||
150214711|NCT03740737|541924649|FG001|Overall Study|Protocol deviation|0|||
150214712|NCT03740737|541924648|FG000|Overall Study|Adverse Event|2|||
150214713|NCT03740737|541924649|FG001|Overall Study|Adverse Event|0|||
150214714|NCT03740737|541924648|FG000|Overall Study|Lost to Follow-up|1|||
150214715|NCT03740737|541924649|FG001|Overall Study|Lost to Follow-up|0|||
150214716|NCT03740737|541924648|FG000|Overall Study|Randomization failure|1|||
150214717|NCT03740737|541924649|FG001|Overall Study|Randomization failure|0|||
150214718|NCT03740737|541924648|FG000|Overall Study|Participant withdrew consent|1|||
150214719|NCT03740737|541924649|FG001|Overall Study|Participant withdrew consent|0|||
150214720|NCT03740737|541924648|FG000|Overall Study|Participant withdrew from trial|2|||
150214721|NCT03740737|541924649|FG001|Overall Study|Participant withdrew from trial|1|||
150214722|NCT03469258|541924650|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
150214723|NCT02236611|541924652|FG000|Overall Study|Adverse Event|10|||
150214724|NCT02236611|541924653|FG001|Overall Study|Adverse Event|16|||
150214725|NCT02236611|541924652|FG000|Overall Study|Lack of Efficacy|4|||
150214726|NCT02236611|541924653|FG001|Overall Study|Lack of Efficacy|7|||
150214727|NCT02236611|541924652|FG000|Overall Study|Lost to Follow-up|0|||
150214728|NCT02236611|541924653|FG001|Overall Study|Lost to Follow-up|2|||
150214729|NCT02236611|541924652|FG000|Overall Study|Protocol deviation|3|||
150214730|NCT02236611|541924653|FG001|Overall Study|Protocol deviation|5|||
150214731|NCT02236611|541924652|FG000|Overall Study|Withdrew consent|9|||
150214732|NCT02236611|541924653|FG001|Overall Study|Withdrew consent|4|||
150214733|NCT03041090|541924654|FG000|Overall Study|technical error|0|||
150214734|NCT03041090|541924655|FG001|Overall Study|technical error|3|||
150214735|NCT03403036|541924656|FG000|Overall Study|Lack of Efficacy|5|||
150214736|NCT02701296|541924657|FG000|Overall Study|Incomplete Data|0|||
150214737|NCT02701296|541924658|FG001|Overall Study|Incomplete Data|2|||
150214738|NCT01409837|541924661|FG000|Overall Study|Withdrawal by Subject|2|||
150214739|NCT01409837|541924662|FG001|Overall Study|Withdrawal by Subject|1|||
150214740|NCT01409837|541924661|FG000|Overall Study|Lost to Follow-up|1|||
150214741|NCT01409837|541924662|FG001|Overall Study|Lost to Follow-up|0|||
150214742|NCT01409837|541924661|FG000|Overall Study|Physician Decision|0|||
150214743|NCT01409837|541924662|FG001|Overall Study|Physician Decision|1|||
150214744|NCT03851094|541924664|FG000|Overall Study|Withdrawal by Subject|0|||
150214745|NCT03851094|541924665|FG001|Overall Study|Withdrawal by Subject|1|||
150214746|NCT03851094|541924664|FG000|Overall Study|Participant lost device|0|||
150214747|NCT03851094|541924665|FG001|Overall Study|Participant lost device|1|||
150214748|NCT03851094|541924664|FG000|Overall Study|Participant returned device|0|||
150214749|NCT03851094|541924665|FG001|Overall Study|Participant returned device|2|||
150214750|NCT00484198|541924666|FG000|Overall Study|Participant Withdrew Consent|12|||
150214751|NCT00484198|541924667|FG001|Overall Study|Participant Withdrew Consent|21|||
150214752|NCT00484198|541924668|FG002|Overall Study|Participant Withdrew Consent|47|||
150214753|NCT00484198|541924669|FG003|Overall Study|Participant Withdrew Consent|59|||
150214754|NCT00484198|541924666|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
150214755|NCT00484198|541924667|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
150214756|NCT00484198|541924668|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
150214757|NCT00484198|541924669|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
150214758|NCT00484198|541924666|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
150214759|NCT00484198|541924667|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
150214760|NCT00484198|541924668|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
150214761|NCT00484198|541924669|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
150214762|NCT00484198|541924666|FG000|Overall Study|Adverse Event|3|||
150214763|NCT00484198|541924667|FG001|Overall Study|Adverse Event|11|||
150214764|NCT00484198|541924668|FG002|Overall Study|Adverse Event|32|||
150214765|NCT00484198|541924669|FG003|Overall Study|Adverse Event|31|||
150214766|NCT00484198|541924666|FG000|Overall Study|Protocol Violation|0|||
150214767|NCT00484198|541924667|FG001|Overall Study|Protocol Violation|5|||
150214768|NCT00484198|541924668|FG002|Overall Study|Protocol Violation|6|||
150214769|NCT00484198|541924669|FG003|Overall Study|Protocol Violation|8|||
150214770|NCT00484198|541924666|FG000|Overall Study|Other|7|||
150214771|NCT00484198|541924667|FG001|Overall Study|Other|10|||
150214772|NCT00484198|541924668|FG002|Overall Study|Other|31|||
150214773|NCT00484198|541924669|FG003|Overall Study|Other|28|||
150214774|NCT01536704|541924672|FG000|Washout Period 1|Withdrawal by Subject|1|||
150214775|NCT01536704|541924673|FG001|Washout Period 1|Withdrawal by Subject|2|||
150214776|NCT01536704|541924674|FG002|Washout Period 1|Withdrawal by Subject|0|||
150214777|NCT01536704|541924675|FG003|Washout Period 1|Withdrawal by Subject|0|||
150214778|NCT01536704|541924672|FG000|Washout Period 2|Adverse Event|1|||
150214779|NCT01536704|541924673|FG001|Washout Period 2|Adverse Event|0|||
150214780|NCT01536704|541924674|FG002|Washout Period 2|Adverse Event|0|||
150214781|NCT01536704|541924675|FG003|Washout Period 2|Adverse Event|0|||
150214782|NCT01536704|541924672|FG000|Washout Period 2|Withdrawal by Subject|0|||
150214783|NCT01536704|541924673|FG001|Washout Period 2|Withdrawal by Subject|0|||
150214784|NCT01536704|541924674|FG002|Washout Period 2|Withdrawal by Subject|0|||
150214785|NCT01536704|541924675|FG003|Washout Period 2|Withdrawal by Subject|1|||
150214786|NCT01536704|541924672|FG000|Period 3|Adverse Event|0|||
150214787|NCT01536704|541924673|FG001|Period 3|Adverse Event|0|||
150214788|NCT01536704|541924674|FG002|Period 3|Adverse Event|0|||
150214789|NCT01536704|541924675|FG003|Period 3|Adverse Event|1|||
150214790|NCT01536704|541924672|FG000|Washout Period 3|Adverse Event|0|||
150214791|NCT01536704|541924673|FG001|Washout Period 3|Adverse Event|0|||
150214792|NCT01536704|541924674|FG002|Washout Period 3|Adverse Event|1|||
150214793|NCT01536704|541924675|FG003|Washout Period 3|Adverse Event|0|||
150214794|NCT03490032|541924676|FG000|Overall Study|family issue (child custody)|1|||
150214795|NCT03490032|541924677|FG001|Overall Study|family issue (child custody)|0|||
150214796|NCT03490032|541924678|FG002|Overall Study|family issue (child custody)|0|||
150214797|NCT00308308|541924679|FG000|Overall Study|Adverse Event|17|||
150214798|NCT00308308|541924680|FG001|Overall Study|Adverse Event|2|||
150214799|NCT00308308|541924679|FG000|Overall Study|Lost to Follow-up|5|||
150214800|NCT00308308|541924680|FG001|Overall Study|Lost to Follow-up|5|||
150214801|NCT00308308|541924679|FG000|Overall Study|Physician Decision|15|||
150214802|NCT00308308|541924680|FG001|Overall Study|Physician Decision|7|||
150214803|NCT00308308|541924679|FG000|Overall Study|Protocol Violation|3|||
150214804|NCT00308308|541924680|FG001|Overall Study|Protocol Violation|14|||
150214805|NCT00308308|541924679|FG000|Overall Study|Withdrawal by Subject|47|||
150214806|NCT00308308|541924680|FG001|Overall Study|Withdrawal by Subject|19|||
150214807|NCT00308308|541924679|FG000|Overall Study|Various|7|||
150214808|NCT00308308|541924680|FG001|Overall Study|Various|5|||
150214809|NCT00308308|541924679|FG000|Overall Study|Randomized but not dosed|8|||
150214810|NCT00308308|541924680|FG001|Overall Study|Randomized but not dosed|16|||
150214811|NCT00308308|541924679|FG000|Overall Study|Other|1|||
150214812|NCT00308308|541924680|FG001|Overall Study|Other|0|||
150214813|NCT02392507|541924681|FG000|Induction Regimen|Death|3|||
150214814|NCT02392507|541924681|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
150214815|NCT02392507|541924681|FG000|Induction Regimen|Physician Decision|1|||
150214816|NCT02392507|541924681|FG000|Induction Regimen|Withdrawal by Subject|2|||
150214817|NCT02392507|541924681|FG000|Maintenance Regimen|Death|1|||
150214818|NCT02392507|541924681|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
150214819|NCT01802333|541924684|FG000|Overall Study|Ineligible|2|||
150214820|NCT01802333|541924685|FG001|Overall Study|Ineligible|6|||
150214821|NCT01802333|541924686|FG002|Overall Study|Ineligible|8|||
150214822|NCT01802333|541924684|FG000|Overall Study|Adverse Event|1|||
150214823|NCT01802333|541924685|FG001|Overall Study|Adverse Event|8|||
150214824|NCT01802333|541924686|FG002|Overall Study|Adverse Event|8|||
150214825|NCT01802333|541924684|FG000|Overall Study|Withdrawal by Subject|6|||
150214826|NCT01802333|541924685|FG001|Overall Study|Withdrawal by Subject|6|||
150214827|NCT01802333|541924686|FG002|Overall Study|Withdrawal by Subject|5|||
150214828|NCT01802333|541924684|FG000|Overall Study|Progression/relapse|1|||
150214829|NCT01802333|541924685|FG001|Overall Study|Progression/relapse|3|||
150214830|NCT01802333|541924686|FG002|Overall Study|Progression/relapse|0|||
150214831|NCT01802333|541924684|FG000|Overall Study|Death|7|||
150214832|NCT01802333|541924685|FG001|Overall Study|Death|14|||
150214833|NCT01802333|541924686|FG002|Overall Study|Death|13|||
150214834|NCT01802333|541924684|FG000|Overall Study|Other - not protocol specified|32|||
150214835|NCT01802333|541924685|FG001|Overall Study|Other - not protocol specified|22|||
150214836|NCT01802333|541924686|FG002|Overall Study|Other - not protocol specified|24|||
150214837|NCT01802333|541924684|FG000|Overall Study|Did not start treatment|0|||
150214838|NCT01802333|541924685|FG001|Overall Study|Did not start treatment|2|||
150214839|NCT01802333|541924686|FG002|Overall Study|Did not start treatment|5|||
150214840|NCT01021748|541924691|FG000|Overall Study|Adverse Event|2|||
150214841|NCT01021748|541924692|FG001|Overall Study|Adverse Event|1|||
150214842|NCT01021748|541924693|FG002|Overall Study|Adverse Event|2|||
150214843|NCT01021748|541924694|FG003|Overall Study|Adverse Event|0|||
150214844|NCT01021748|541924695|FG004|Overall Study|Adverse Event|2|||
150214845|NCT01021748|541924696|FG005|Overall Study|Adverse Event|0|||
150214846|NCT01021748|541924697|FG006|Overall Study|Adverse Event|1|||
150214847|NCT01021748|541924698|FG007|Overall Study|Adverse Event|0|||
150214848|NCT01021748|541924699|FG008|Overall Study|Adverse Event|7|||
150214849|NCT01021748|541924691|FG000|Overall Study|Physician Decision|1|||
150214850|NCT01021748|541924692|FG001|Overall Study|Physician Decision|0|||
150214851|NCT01021748|541924693|FG002|Overall Study|Physician Decision|1|||
150214852|NCT01021748|541924694|FG003|Overall Study|Physician Decision|1|||
150214853|NCT01021748|541924695|FG004|Overall Study|Physician Decision|0|||
150214854|NCT01021748|541924696|FG005|Overall Study|Physician Decision|0|||
150214855|NCT01021748|541924697|FG006|Overall Study|Physician Decision|1|||
150214856|NCT01021748|541924698|FG007|Overall Study|Physician Decision|1|||
150214857|NCT01021748|541924699|FG008|Overall Study|Physician Decision|2|||
150214858|NCT01021748|541924691|FG000|Overall Study|Progressive Disease|3|||
150214859|NCT01021748|541924692|FG001|Overall Study|Progressive Disease|3|||
150214860|NCT01021748|541924693|FG002|Overall Study|Progressive Disease|4|||
150214861|NCT01021748|541924694|FG003|Overall Study|Progressive Disease|6|||
150214862|NCT01021748|541924695|FG004|Overall Study|Progressive Disease|7|||
150214863|NCT01021748|541924696|FG005|Overall Study|Progressive Disease|3|||
150214864|NCT01021748|541924697|FG006|Overall Study|Progressive Disease|0|||
150214865|NCT01021748|541924698|FG007|Overall Study|Progressive Disease|5|||
150214866|NCT01021748|541924699|FG008|Overall Study|Progressive Disease|6|||
150214867|NCT01021748|541924691|FG000|Overall Study|Withdrawal by Subject|0|||
150214868|NCT01021748|541924692|FG001|Overall Study|Withdrawal by Subject|0|||
150214869|NCT01021748|541924693|FG002|Overall Study|Withdrawal by Subject|0|||
150214870|NCT01021748|541924694|FG003|Overall Study|Withdrawal by Subject|0|||
150214871|NCT01021748|541924695|FG004|Overall Study|Withdrawal by Subject|0|||
150214872|NCT01021748|541924696|FG005|Overall Study|Withdrawal by Subject|0|||
150214873|NCT01021748|541924697|FG006|Overall Study|Withdrawal by Subject|1|||
150214874|NCT01021748|541924698|FG007|Overall Study|Withdrawal by Subject|0|||
150214875|NCT01021748|541924699|FG008|Overall Study|Withdrawal by Subject|1|||
150214876|NCT01021748|541924691|FG000|Overall Study|Not Treated|0|||
150214877|NCT01021748|541924692|FG001|Overall Study|Not Treated|1|||
150214878|NCT01021748|541924693|FG002|Overall Study|Not Treated|0|||
150214879|NCT01021748|541924694|FG003|Overall Study|Not Treated|0|||
150214880|NCT01021748|541924695|FG004|Overall Study|Not Treated|0|||
150214881|NCT01021748|541924696|FG005|Overall Study|Not Treated|0|||
150214882|NCT01021748|541924697|FG006|Overall Study|Not Treated|0|||
150214883|NCT01021748|541924698|FG007|Overall Study|Not Treated|0|||
150214884|NCT01021748|541924699|FG008|Overall Study|Not Treated|0|||
150214885|NCT01829711|541924700|FG000|Overall Study|Lost to Follow-up|2|||
150214886|NCT01829711|541924700|FG000|Overall Study|Withdrawal by Subject|3|||
150214887|NCT01829711|541924700|FG000|Overall Study|Death|4|||
150214888|NCT01829711|541924700|FG000|Overall Study|Started new therapies|17|||
150214889|NCT01829711|541924700|FG000|Overall Study|Adverse Event|3|||
150214890|NCT01829711|541924700|FG000|Overall Study|Due to progression of disease|13|||
150214891|NCT01829711|541924700|FG000|Overall Study|Due to lack of response|1|||
150214892|NCT03259568|541924701|FG000|Overall Study|Participant performance was low|3|||
150214893|NCT04248868|541924702|FG000|Overall Study|Death|1|||
150214894|NCT04248868|541924702|FG000|Overall Study|Lost to Follow-up|3|||
150214895|NCT04248868|541924702|FG000|Overall Study|Protocol Violation|2|||
150214896|NCT03128099|541924703|FG000|Overall Study|High dose task was too long|0|||
150214897|NCT03128099|541924704|FG001|Overall Study|High dose task was too long|4|||
150214898|NCT03128099|541924705|FG002|Overall Study|High dose task was too long|0|||
150214899|NCT03128099|541924703|FG000|Overall Study|Participant got a full time job.|1|||
150214900|NCT03128099|541924704|FG001|Overall Study|Participant got a full time job.|0|||
150214901|NCT03128099|541924705|FG002|Overall Study|Participant got a full time job.|0|||
150214902|NCT03128099|541924703|FG000|Overall Study|Became homeless and lost contact|1|||
150214903|NCT03128099|541924704|FG001|Overall Study|Became homeless and lost contact|0|||
150214904|NCT03128099|541924705|FG002|Overall Study|Became homeless and lost contact|0|||
150214905|NCT03128099|541924703|FG000|Overall Study|Did not complete all the assessments|0|||
150214906|NCT03128099|541924704|FG001|Overall Study|Did not complete all the assessments|0|||
150214907|NCT03128099|541924705|FG002|Overall Study|Did not complete all the assessments|1|||
150214908|NCT00089791|541924706|FG000|Overall Study|Physician Decision|6|||
150214909|NCT00089791|541924707|FG001|Overall Study|Physician Decision|3|||
150214910|NCT00089791|541924706|FG000|Overall Study|Adverse Event|81|||
150214911|NCT00089791|541924707|FG001|Overall Study|Adverse Event|93|||
150214912|NCT00089791|541924706|FG000|Overall Study|Withdrawal by Subject|403|||
150214913|NCT00089791|541924707|FG001|Overall Study|Withdrawal by Subject|344|||
150214914|NCT00089791|541924706|FG000|Overall Study|Death|78|||
150214915|NCT00089791|541924707|FG001|Overall Study|Death|62|||
150214916|NCT00089791|541924706|FG000|Overall Study|Disease progression|7|||
150214917|NCT00089791|541924707|FG001|Overall Study|Disease progression|3|||
150214918|NCT00089791|541924706|FG000|Overall Study|Ineligibility determined|12|||
150214919|NCT00089791|541924707|FG001|Overall Study|Ineligibility determined|9|||
150214920|NCT00089791|541924706|FG000|Overall Study|Lost to Follow-up|57|||
150214921|NCT00089791|541924707|FG001|Overall Study|Lost to Follow-up|57|||
150214922|NCT00089791|541924706|FG000|Overall Study|Noncompliance|17|||
150214923|NCT00089791|541924707|FG001|Overall Study|Noncompliance|13|||
150214924|NCT00089791|541924706|FG000|Overall Study|Other|20|||
150214925|NCT00089791|541924707|FG001|Overall Study|Other|32|||
150214926|NCT00089791|541924706|FG000|Overall Study|Protocol deviation|12|||
150214927|NCT00089791|541924707|FG001|Overall Study|Protocol deviation|10|||
150214928|NCT00089791|541924706|FG000|Overall Study|Requirement for alternative therapy|7|||
150214929|NCT00089791|541924707|FG001|Overall Study|Requirement for alternative therapy|4|||
150214930|NCT05074433|541924715|FG000|Overall Study|Adverse Event|0|||
150214931|NCT05074433|541924716|FG001|Overall Study|Adverse Event|2|||
150214932|NCT05074433|541924717|FG002|Overall Study|Adverse Event|0|||
150214933|NCT05074433|541924718|FG003|Overall Study|Adverse Event|1|||
150214934|NCT05074433|541924715|FG000|Overall Study|Sponsor Request|0|||
150214935|NCT05074433|541924716|FG001|Overall Study|Sponsor Request|1|||
150214936|NCT05074433|541924717|FG002|Overall Study|Sponsor Request|1|||
150214937|NCT05074433|541924718|FG003|Overall Study|Sponsor Request|0|||
150214938|NCT05074433|541924715|FG000|Overall Study|Death|1|||
150214939|NCT05074433|541924716|FG001|Overall Study|Death|0|||
150214940|NCT05074433|541924717|FG002|Overall Study|Death|0|||
150214941|NCT05074433|541924718|FG003|Overall Study|Death|0|||
150214942|NCT05074433|541924715|FG000|Overall Study|Lost to Follow-up|0|||
150214943|NCT05074433|541924716|FG001|Overall Study|Lost to Follow-up|0|||
150214944|NCT05074433|541924717|FG002|Overall Study|Lost to Follow-up|2|||
150214945|NCT05074433|541924718|FG003|Overall Study|Lost to Follow-up|0|||
150214946|NCT05074433|541924715|FG000|Overall Study|Subject Decision|8|||
150214947|NCT05074433|541924716|FG001|Overall Study|Subject Decision|6|||
150214948|NCT05074433|541924717|FG002|Overall Study|Subject Decision|4|||
150214949|NCT05074433|541924718|FG003|Overall Study|Subject Decision|5|||
150214950|NCT04397263|541924719|FG000|Overall Study|Withdrawal by Subject|2|||
150214951|NCT01989689|541924720|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
150214952|NCT01989689|541924721|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
150214953|NCT01989689|541924720|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
150214954|NCT01989689|541924721|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
150214955|NCT02066636|541924722|FG000|Overall Study|Disease progression|51|||
150214956|NCT02066636|541924723|FG001|Overall Study|Disease progression|60|||
150214957|NCT02066636|541924724|FG002|Overall Study|Disease progression|700|||
150214958|NCT02066636|541924722|FG000|Overall Study|Study drug toxicity|13|||
150214959|NCT02066636|541924723|FG001|Overall Study|Study drug toxicity|2|||
150214960|NCT02066636|541924724|FG002|Overall Study|Study drug toxicity|58|||
150214961|NCT02066636|541924722|FG000|Overall Study|Death|4|||
150214962|NCT02066636|541924723|FG001|Overall Study|Death|2|||
150214963|NCT02066636|541924724|FG002|Overall Study|Death|158|||
150214964|NCT02066636|541924722|FG000|Overall Study|Adverse event unrelated to study drug|6|||
150214965|NCT02066636|541924723|FG001|Overall Study|Adverse event unrelated to study drug|4|||
150214966|NCT02066636|541924724|FG002|Overall Study|Adverse event unrelated to study drug|45|||
150214967|NCT02066636|541924722|FG000|Overall Study|Participant request to discontinue treatment|12|||
150214968|NCT02066636|541924723|FG001|Overall Study|Participant request to discontinue treatment|12|||
150214969|NCT02066636|541924724|FG002|Overall Study|Participant request to discontinue treatment|70|||
150214970|NCT02066636|541924722|FG000|Overall Study|Participant withdrew consent|10|||
150214971|NCT02066636|541924723|FG001|Overall Study|Participant withdrew consent|18|||
150214972|NCT02066636|541924724|FG002|Overall Study|Participant withdrew consent|61|||
150214973|NCT02066636|541924722|FG000|Overall Study|Lost to Follow-up|0|||
150214974|NCT02066636|541924723|FG001|Overall Study|Lost to Follow-up|2|||
150214975|NCT02066636|541924724|FG002|Overall Study|Lost to Follow-up|2|||
150214976|NCT02066636|541924722|FG000|Overall Study|Maximum clinical benefit|2|||
150214977|NCT02066636|541924723|FG001|Overall Study|Maximum clinical benefit|2|||
150214978|NCT02066636|541924724|FG002|Overall Study|Maximum clinical benefit|3|||
150214979|NCT02066636|541924722|FG000|Overall Study|Poor/non-compliance|2|||
150214980|NCT02066636|541924723|FG001|Overall Study|Poor/non-compliance|1|||
150214981|NCT02066636|541924724|FG002|Overall Study|Poor/non-compliance|1|||
150214982|NCT02066636|541924722|FG000|Overall Study|Participant no loner meets study criteria|3|||
150214983|NCT02066636|541924723|FG001|Overall Study|Participant no loner meets study criteria|2|||
150214984|NCT02066636|541924724|FG002|Overall Study|Participant no loner meets study criteria|28|||
150214985|NCT02066636|541924722|FG000|Overall Study|Administrative reasons by sponsor|8|||
150214986|NCT02066636|541924723|FG001|Overall Study|Administrative reasons by sponsor|5|||
150214987|NCT02066636|541924724|FG002|Overall Study|Administrative reasons by sponsor|0|||
150214988|NCT02066636|541924722|FG000|Overall Study|Other reasons|16|||
150214989|NCT02066636|541924723|FG001|Overall Study|Other reasons|15|||
150214990|NCT02066636|541924724|FG002|Overall Study|Other reasons|50|||
150214991|NCT00391170|541924731|FG000|Overall Study|Withdrawal by Subject|1|||
150214992|NCT00391170|541924732|FG001|Overall Study|Withdrawal by Subject|0|||
150214993|NCT00391170|541924731|FG000|Overall Study|Adverse Event|3|||
150214994|NCT00391170|541924732|FG001|Overall Study|Adverse Event|2|||
150214995|NCT00391170|541924731|FG000|Overall Study|Physician Decision|2|||
150214996|NCT00391170|541924732|FG001|Overall Study|Physician Decision|2|||
150214997|NCT03567616|541924739|FG000|Overall Study|Disease progression|4|||
150214998|NCT03567616|541924739|FG000|Overall Study|Withdrawal by Subject|1|||
150214999|NCT03567616|541924739|FG000|Overall Study|Physician Decision|1|||
150215000|NCT03567616|541924739|FG000|Overall Study|Death|1|||
150215001|NCT03567616|541924739|FG000|Overall Study|Adverse Event|1|||
150215002|NCT00705159|541924745|FG000|Overall Study|Withdrawal by Subject|0|||
150215003|NCT00705159|541924746|FG001|Overall Study|Withdrawal by Subject|1|||
150215004|NCT00705159|541924747|FG002|Overall Study|Withdrawal by Subject|1|||
150215005|NCT00705159|541924748|FG003|Overall Study|Withdrawal by Subject|1|||
150215006|NCT00705159|541924745|FG000|Overall Study|Protocol Violation|0|||
150215007|NCT00705159|541924746|FG001|Overall Study|Protocol Violation|1|||
150215008|NCT00705159|541924747|FG002|Overall Study|Protocol Violation|0|||
150215009|NCT00705159|541924748|FG003|Overall Study|Protocol Violation|0|||
150215010|NCT00705159|541924745|FG000|Overall Study|Adverse Event|0|||
150215011|NCT00705159|541924746|FG001|Overall Study|Adverse Event|0|||
150215012|NCT00705159|541924747|FG002|Overall Study|Adverse Event|1|||
150215013|NCT00705159|541924748|FG003|Overall Study|Adverse Event|0|||
150215014|NCT00705159|541924745|FG000|Overall Study|Lost to Follow-up|0|||
150215015|NCT00705159|541924746|FG001|Overall Study|Lost to Follow-up|0|||
150215016|NCT00705159|541924747|FG002|Overall Study|Lost to Follow-up|3|||
150215017|NCT00705159|541924748|FG003|Overall Study|Lost to Follow-up|2|||
150215018|NCT00705159|541924745|FG000|Overall Study|Screen Failure|0|||
150215019|NCT00705159|541924746|FG001|Overall Study|Screen Failure|0|||
150215020|NCT00705159|541924747|FG002|Overall Study|Screen Failure|0|||
150215021|NCT00705159|541924748|FG003|Overall Study|Screen Failure|1|||
150215022|NCT03205488|541924749|FG000|Overall Study|Adverse Event|1|||
150215023|NCT03205488|541924750|FG001|Overall Study|Adverse Event|2|||
150215024|NCT03205488|541924751|FG002|Overall Study|Adverse Event|4|||
150215025|NCT03205488|541924749|FG000|Overall Study|Protocol Violation|0|||
150215026|NCT03205488|541924750|FG001|Overall Study|Protocol Violation|0|||
150215027|NCT03205488|541924751|FG002|Overall Study|Protocol Violation|1|||
150215028|NCT00824408|541924752|FG000|Run-in Phase|Progressive disease|4|||
150215029|NCT00824408|541924753|FG001|Run-in Phase|Progressive disease|4|||
150215030|NCT00824408|541924754|FG002|Run-in Phase|Progressive disease|0|||
150215031|NCT00824408|541924755|FG003|Run-in Phase|Progressive disease|0|||
150215032|NCT00824408|541924756|FG004|Run-in Phase|Progressive disease|0|||
150215033|NCT00824408|541924752|FG000|Run-in Phase|Adverse Event|1|||
150215034|NCT00824408|541924753|FG001|Run-in Phase|Adverse Event|1|||
150215035|NCT00824408|541924754|FG002|Run-in Phase|Adverse Event|0|||
150215036|NCT00824408|541924755|FG003|Run-in Phase|Adverse Event|0|||
150215037|NCT00824408|541924756|FG004|Run-in Phase|Adverse Event|0|||
150215038|NCT00824408|541924752|FG000|Run-in Phase|Refused to continue medication|1|||
150215039|NCT00824408|541924753|FG001|Run-in Phase|Refused to continue medication|0|||
150215040|NCT00824408|541924754|FG002|Run-in Phase|Refused to continue medication|0|||
150215041|NCT00824408|541924755|FG003|Run-in Phase|Refused to continue medication|0|||
150215042|NCT00824408|541924756|FG004|Run-in Phase|Refused to continue medication|0|||
150215043|NCT00824408|541924752|FG000|Run-in Phase|Other reason not defined above|0|||
150215044|NCT00824408|541924753|FG001|Run-in Phase|Other reason not defined above|1|||
150215045|NCT00824408|541924754|FG002|Run-in Phase|Other reason not defined above|0|||
150215046|NCT00824408|541924755|FG003|Run-in Phase|Other reason not defined above|0|||
150215047|NCT00824408|541924756|FG004|Run-in Phase|Other reason not defined above|0|||
150215048|NCT00824408|541924752|FG000|Randomized Phase|Not treated|0|||
150215049|NCT00824408|541924753|FG001|Randomized Phase|Not treated|0|||
150215050|NCT00824408|541924754|FG002|Randomized Phase|Not treated|1|||
150215051|NCT00824408|541924755|FG003|Randomized Phase|Not treated|1|||
150215052|NCT00824408|541924756|FG004|Randomized Phase|Not treated|1|||
150215053|NCT00824408|541924752|FG000|Randomized Phase|Progressive disease|0|||
150215054|NCT00824408|541924753|FG001|Randomized Phase|Progressive disease|0|||
150215055|NCT00824408|541924754|FG002|Randomized Phase|Progressive disease|25|||
150215056|NCT00824408|541924755|FG003|Randomized Phase|Progressive disease|36|||
150215057|NCT00824408|541924756|FG004|Randomized Phase|Progressive disease|34|||
150215058|NCT00824408|541924752|FG000|Randomized Phase|Adverse Event|0|||
150215059|NCT00824408|541924753|FG001|Randomized Phase|Adverse Event|0|||
150215060|NCT00824408|541924754|FG002|Randomized Phase|Adverse Event|4|||
150215061|NCT00824408|541924755|FG003|Randomized Phase|Adverse Event|5|||
150215062|NCT00824408|541924756|FG004|Randomized Phase|Adverse Event|5|||
150215063|NCT00824408|541924752|FG000|Randomized Phase|Refused to continue medication|0|||
150215064|NCT00824408|541924753|FG001|Randomized Phase|Refused to continue medication|0|||
150215065|NCT00824408|541924754|FG002|Randomized Phase|Refused to continue medication|2|||
150215066|NCT00824408|541924755|FG003|Randomized Phase|Refused to continue medication|2|||
150215067|NCT00824408|541924756|FG004|Randomized Phase|Refused to continue medication|2|||
150215068|NCT00824408|541924752|FG000|Randomized Phase|Other reason not defined above|0|||
150215069|NCT00824408|541924753|FG001|Randomized Phase|Other reason not defined above|0|||
150215070|NCT00824408|541924754|FG002|Randomized Phase|Other reason not defined above|4|||
150215071|NCT00824408|541924755|FG003|Randomized Phase|Other reason not defined above|2|||
150215072|NCT00824408|541924756|FG004|Randomized Phase|Other reason not defined above|4|||
150215073|NCT04821271|541924759|FG000|Period 1|Withdrawal by Subject|2|||
150215074|NCT04821271|541924760|FG001|Period 1|Withdrawal by Subject|0|||
150215075|NCT02521493|541924761|FG000|Overall Study|Death|3|||
150215076|NCT02521493|541924762|FG001|Overall Study|Death|4|||
150215077|NCT02521493|541924763|FG002|Overall Study|Death|1|||
150215078|NCT02521493|541924761|FG000|Overall Study|Physician Decision|19|||
150215079|NCT02521493|541924762|FG001|Overall Study|Physician Decision|1|||
150215080|NCT02521493|541924763|FG002|Overall Study|Physician Decision|2|||
150215081|NCT02521493|541924761|FG000|Overall Study|Withdrawal by Subject|3|||
150215082|NCT02521493|541924762|FG001|Overall Study|Withdrawal by Subject|0|||
150215083|NCT02521493|541924763|FG002|Overall Study|Withdrawal by Subject|0|||
150215084|NCT02521493|541924761|FG000|Overall Study|Ineligible|0|||
150215085|NCT02521493|541924762|FG001|Overall Study|Ineligible|1|||
150215086|NCT02521493|541924763|FG002|Overall Study|Ineligible|0|||
150215087|NCT02521493|541924761|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
150215088|NCT02521493|541924762|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
150215089|NCT02521493|541924763|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
150215090|NCT02521493|541924761|FG000|Overall Study|No MRD result|0|||
150215091|NCT02521493|541924762|FG001|Overall Study|No MRD result|0|||
150215092|NCT02521493|541924763|FG002|Overall Study|No MRD result|4|||
150215093|NCT01218594|541924764|FG000|Overall Study|Death|1|||
150215094|NCT01218594|541924764|FG000|Overall Study|Withdrawal by Subject|3|||
150215095|NCT01218594|541924764|FG000|Overall Study|Adverse Event|2|||
150215096|NCT01218594|541924764|FG000|Overall Study|Physician Decision|6|||
150215097|NCT03905642|541924769|FG000|Overall Study|Withdrawal by Subject|3|||
150215098|NCT03905642|541924769|FG000|Overall Study|Pregnancy|1|||
150215099|NCT03905642|541924769|FG000|Overall Study|Adverse Event|1|||
150215100|NCT03905642|541924769|FG000|Overall Study|Lack of Efficacy|1|||
150215101|NCT03905642|541924769|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
150215102|NCT02159989|541924770|FG000|Overall Study|Adverse Event|1|||
150215103|NCT02159989|541924771|FG001|Overall Study|Adverse Event|0|||
150215104|NCT02159989|541924772|FG002|Overall Study|Adverse Event|0|||
150215105|NCT02159989|541924773|FG003|Overall Study|Adverse Event|0|||
150215106|NCT02159989|541924774|FG004|Overall Study|Adverse Event|1|||
150215107|NCT02159989|541924775|FG005|Overall Study|Adverse Event|0|||
150215108|NCT02159989|541924776|FG006|Overall Study|Adverse Event|1|||
150215109|NCT02159989|541924777|FG007|Overall Study|Adverse Event|2|||
150215110|NCT02159989|541924778|FG008|Overall Study|Adverse Event|0|||
150215111|NCT02159989|541924779|FG009|Overall Study|Adverse Event|2|||
150215112|NCT02159989|541924780|FG010|Overall Study|Adverse Event|1|||
150215113|NCT02159989|541924770|FG000|Overall Study|Death|0|||
150215114|NCT02159989|541924771|FG001|Overall Study|Death|0|||
150215115|NCT02159989|541924772|FG002|Overall Study|Death|0|||
150215116|NCT02159989|541924773|FG003|Overall Study|Death|0|||
150215117|NCT02159989|541924774|FG004|Overall Study|Death|0|||
150215118|NCT02159989|541924775|FG005|Overall Study|Death|0|||
150215119|NCT02159989|541924776|FG006|Overall Study|Death|0|||
150215120|NCT02159989|541924777|FG007|Overall Study|Death|0|||
150215121|NCT02159989|541924778|FG008|Overall Study|Death|0|||
150215122|NCT02159989|541924779|FG009|Overall Study|Death|0|||
150215123|NCT02159989|541924780|FG010|Overall Study|Death|1|||
150215124|NCT02159989|541924770|FG000|Overall Study|Lack of Efficacy|2|||
150215125|NCT02159989|541924771|FG001|Overall Study|Lack of Efficacy|3|||
150215126|NCT02159989|541924772|FG002|Overall Study|Lack of Efficacy|3|||
150215127|NCT02159989|541924773|FG003|Overall Study|Lack of Efficacy|0|||
150215128|NCT02159989|541924774|FG004|Overall Study|Lack of Efficacy|2|||
150215129|NCT02159989|541924775|FG005|Overall Study|Lack of Efficacy|3|||
150215130|NCT02159989|541924776|FG006|Overall Study|Lack of Efficacy|3|||
150215131|NCT02159989|541924777|FG007|Overall Study|Lack of Efficacy|1|||
150215132|NCT02159989|541924778|FG008|Overall Study|Lack of Efficacy|3|||
150215133|NCT02159989|541924779|FG009|Overall Study|Lack of Efficacy|6|||
150215134|NCT02159989|541924780|FG010|Overall Study|Lack of Efficacy|7|||
150215135|NCT02159989|541924770|FG000|Overall Study|Lost to Follow-up|0|||
150215136|NCT02159989|541924771|FG001|Overall Study|Lost to Follow-up|0|||
150215137|NCT02159989|541924772|FG002|Overall Study|Lost to Follow-up|0|||
150215138|NCT02159989|541924773|FG003|Overall Study|Lost to Follow-up|1|||
150215139|NCT02159989|541924774|FG004|Overall Study|Lost to Follow-up|0|||
150215140|NCT02159989|541924775|FG005|Overall Study|Lost to Follow-up|0|||
150215141|NCT02159989|541924776|FG006|Overall Study|Lost to Follow-up|0|||
150215142|NCT02159989|541924777|FG007|Overall Study|Lost to Follow-up|0|||
150215143|NCT02159989|541924778|FG008|Overall Study|Lost to Follow-up|0|||
150215144|NCT02159989|541924779|FG009|Overall Study|Lost to Follow-up|0|||
150215145|NCT02159989|541924780|FG010|Overall Study|Lost to Follow-up|1|||
150215146|NCT02159989|541924770|FG000|Overall Study|Withdrawal by Subject|2|||
150215147|NCT02159989|541924771|FG001|Overall Study|Withdrawal by Subject|0|||
150215148|NCT02159989|541924772|FG002|Overall Study|Withdrawal by Subject|0|||
150215149|NCT02159989|541924773|FG003|Overall Study|Withdrawal by Subject|2|||
150215150|NCT02159989|541924774|FG004|Overall Study|Withdrawal by Subject|1|||
150215151|NCT02159989|541924775|FG005|Overall Study|Withdrawal by Subject|0|||
150215152|NCT02159989|541924776|FG006|Overall Study|Withdrawal by Subject|3|||
150215153|NCT02159989|541924777|FG007|Overall Study|Withdrawal by Subject|1|||
150215154|NCT02159989|541924778|FG008|Overall Study|Withdrawal by Subject|0|||
150215155|NCT02159989|541924779|FG009|Overall Study|Withdrawal by Subject|0|||
150215156|NCT02159989|541924780|FG010|Overall Study|Withdrawal by Subject|0|||
150215157|NCT02159989|541924770|FG000|Overall Study|New treatment|0|||
150215158|NCT02159989|541924771|FG001|Overall Study|New treatment|1|||
150215159|NCT02159989|541924772|FG002|Overall Study|New treatment|0|||
150215160|NCT02159989|541924773|FG003|Overall Study|New treatment|0|||
150215161|NCT02159989|541924774|FG004|Overall Study|New treatment|0|||
150215162|NCT02159989|541924775|FG005|Overall Study|New treatment|0|||
150215163|NCT02159989|541924776|FG006|Overall Study|New treatment|0|||
150215164|NCT02159989|541924777|FG007|Overall Study|New treatment|0|||
150215165|NCT02159989|541924778|FG008|Overall Study|New treatment|0|||
150215166|NCT02159989|541924779|FG009|Overall Study|New treatment|0|||
150215167|NCT02159989|541924780|FG010|Overall Study|New treatment|0|||
150215168|NCT02159989|541924770|FG000|Overall Study|Insurance Issues|0|||
150215169|NCT02159989|541924771|FG001|Overall Study|Insurance Issues|0|||
150215170|NCT02159989|541924772|FG002|Overall Study|Insurance Issues|0|||
150215171|NCT02159989|541924773|FG003|Overall Study|Insurance Issues|0|||
150215172|NCT02159989|541924774|FG004|Overall Study|Insurance Issues|0|||
150215173|NCT02159989|541924775|FG005|Overall Study|Insurance Issues|0|||
150215174|NCT02159989|541924776|FG006|Overall Study|Insurance Issues|0|||
150215175|NCT02159989|541924777|FG007|Overall Study|Insurance Issues|0|||
150215176|NCT02159989|541924778|FG008|Overall Study|Insurance Issues|0|||
150215177|NCT02159989|541924779|FG009|Overall Study|Insurance Issues|1|||
150215178|NCT02159989|541924780|FG010|Overall Study|Insurance Issues|0|||
150215179|NCT05338476|541924781|FG000|Period 2|Adverse Event|0|||
150215180|NCT05338476|541924782|FG001|Period 2|Adverse Event|1|||
150215181|NCT04937504|541924785|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
150215182|NCT04937504|541924786|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
150215183|NCT04937504|541924785|FG000|9 Months Assessment|Lost to Follow-up|3|||
150215184|NCT04937504|541924786|FG001|9 Months Assessment|Lost to Follow-up|2|||
150215185|NCT01128959|541927066|FG000|Lead in Period|Adverse Event|3|||
150215186|NCT01128959|541927066|FG000|Treatment Period|Adverse Event|3|||
150215187|NCT01128959|541927066|FG000|Treatment Period|Withdrawal by Subject|1|||
150215188|NCT01332266|541927067|FG000|Phase 1b|Death|3|||
150215189|NCT01332266|541927068|FG001|Phase 1b|Death|3|||
150215190|NCT01332266|541927069|FG002|Phase 1b|Death|2|||
150215191|NCT01332266|541927070|FG003|Phase 1b|Death|0|||
150215192|NCT01332266|541927071|FG004|Phase 1b|Death|0|||
150215193|NCT01332266|541927067|FG000|Phase 1b|Lost to Follow-up|0|||
150215194|NCT01332266|541927068|FG001|Phase 1b|Lost to Follow-up|1|||
150215195|NCT01332266|541927069|FG002|Phase 1b|Lost to Follow-up|0|||
150215196|NCT01332266|541927070|FG003|Phase 1b|Lost to Follow-up|0|||
150215197|NCT01332266|541927071|FG004|Phase 1b|Lost to Follow-up|0|||
150215198|NCT01332266|541927067|FG000|Phase 1b|Withdrawal by Subject|1|||
150215199|NCT01332266|541927068|FG001|Phase 1b|Withdrawal by Subject|1|||
150215200|NCT01332266|541927069|FG002|Phase 1b|Withdrawal by Subject|1|||
150215201|NCT01332266|541927070|FG003|Phase 1b|Withdrawal by Subject|0|||
150215202|NCT01332266|541927071|FG004|Phase 1b|Withdrawal by Subject|0|||
150215203|NCT01332266|541927067|FG000|Phase 2|Death|0|||
150215204|NCT01332266|541927068|FG001|Phase 2|Death|0|||
150215205|NCT01332266|541927069|FG002|Phase 2|Death|0|||
150215206|NCT01332266|541927070|FG003|Phase 2|Death|33|||
150215207|NCT01332266|541927071|FG004|Phase 2|Death|36|||
150215208|NCT01332266|541927067|FG000|Phase 2|Lost to Follow-up|0|||
150215209|NCT01332266|541927068|FG001|Phase 2|Lost to Follow-up|0|||
150215210|NCT01332266|541927069|FG002|Phase 2|Lost to Follow-up|0|||
150215211|NCT01332266|541927070|FG003|Phase 2|Lost to Follow-up|2|||
150215212|NCT01332266|541927071|FG004|Phase 2|Lost to Follow-up|0|||
150215213|NCT01332266|541927067|FG000|Phase 2|Physician Decision|0|||
150215214|NCT01332266|541927068|FG001|Phase 2|Physician Decision|0|||
150215215|NCT01332266|541927069|FG002|Phase 2|Physician Decision|0|||
150215216|NCT01332266|541927070|FG003|Phase 2|Physician Decision|3|||
150215217|NCT01332266|541927071|FG004|Phase 2|Physician Decision|1|||
150215218|NCT01332266|541927067|FG000|Phase 2|Symptomatic deterioration|0|||
150215219|NCT01332266|541927068|FG001|Phase 2|Symptomatic deterioration|0|||
150215220|NCT01332266|541927069|FG002|Phase 2|Symptomatic deterioration|0|||
150215221|NCT01332266|541927070|FG003|Phase 2|Symptomatic deterioration|0|||
150215222|NCT01332266|541927071|FG004|Phase 2|Symptomatic deterioration|1|||
150215223|NCT01332266|541927067|FG000|Phase 2|Progression Disease|0|||
150215224|NCT01332266|541927068|FG001|Phase 2|Progression Disease|0|||
150215225|NCT01332266|541927069|FG002|Phase 2|Progression Disease|0|||
150215226|NCT01332266|541927070|FG003|Phase 2|Progression Disease|2|||
150215227|NCT01332266|541927071|FG004|Phase 2|Progression Disease|1|||
150215228|NCT01332266|541927067|FG000|Phase 2|Withdrawal by Subject|0|||
150215229|NCT01332266|541927068|FG001|Phase 2|Withdrawal by Subject|0|||
150215230|NCT01332266|541927069|FG002|Phase 2|Withdrawal by Subject|0|||
150215231|NCT01332266|541927070|FG003|Phase 2|Withdrawal by Subject|2|||
150215232|NCT01332266|541927071|FG004|Phase 2|Withdrawal by Subject|2|||
150215233|NCT01947491|541927072|FG000|Overall Study|Lost to Follow-up|5|||
150215234|NCT01947491|541927073|FG001|Overall Study|Lost to Follow-up|3|||
150215235|NCT01947491|541927074|FG002|Overall Study|Lost to Follow-up|1|||
150215236|NCT01947491|541927075|FG003|Overall Study|Lost to Follow-up|2|||
150215237|NCT01947491|541927072|FG000|Overall Study|Lack of Efficacy|1|||
150215238|NCT01947491|541927073|FG001|Overall Study|Lack of Efficacy|0|||
150215239|NCT01947491|541927074|FG002|Overall Study|Lack of Efficacy|0|||
150215240|NCT01947491|541927075|FG003|Overall Study|Lack of Efficacy|1|||
150215241|NCT01947491|541927072|FG000|Overall Study|Protocol Violation|1|||
150215242|NCT01947491|541927073|FG001|Overall Study|Protocol Violation|0|||
150215243|NCT01947491|541927074|FG002|Overall Study|Protocol Violation|0|||
150215244|NCT01947491|541927075|FG003|Overall Study|Protocol Violation|0|||
150215245|NCT01947491|541927072|FG000|Overall Study|Withdrawal by Subject|1|||
150215246|NCT01947491|541927073|FG001|Overall Study|Withdrawal by Subject|1|||
150215247|NCT01947491|541927074|FG002|Overall Study|Withdrawal by Subject|1|||
150215248|NCT01947491|541927075|FG003|Overall Study|Withdrawal by Subject|0|||
150215249|NCT01947491|541927072|FG000|Overall Study|Worsening of condition|0|||
150215250|NCT01947491|541927073|FG001|Overall Study|Worsening of condition|1|||
150215251|NCT01947491|541927074|FG002|Overall Study|Worsening of condition|0|||
150215252|NCT01947491|541927075|FG003|Overall Study|Worsening of condition|0|||
150215253|NCT01947491|541927072|FG000|Overall Study|Adverse Event|0|||
150215254|NCT01947491|541927073|FG001|Overall Study|Adverse Event|1|||
150215255|NCT01947491|541927074|FG002|Overall Study|Adverse Event|0|||
150215256|NCT01947491|541927075|FG003|Overall Study|Adverse Event|2|||
150215257|NCT03236779|541927077|FG000|Overall Study|Lost to Follow-up|13|||
150215258|NCT03236779|541927078|FG001|Overall Study|Lost to Follow-up|21|||
150215259|NCT02935673|541927083|FG000|Overall Study|Adverse Event|0|||
150215260|NCT02935673|541927084|FG001|Overall Study|Adverse Event|1|||
150215261|NCT02935673|541927085|FG002|Overall Study|Adverse Event|0|||
150215262|NCT02935673|541927083|FG000|Overall Study|Withdrawal by Subject|1|||
150215263|NCT02935673|541927084|FG001|Overall Study|Withdrawal by Subject|2|||
150215264|NCT02935673|541927085|FG002|Overall Study|Withdrawal by Subject|0|||
150215265|NCT01836523|541927086|FG000|Overall Study|Adverse Event|15|||
150215266|NCT01836523|541927087|FG001|Overall Study|Adverse Event|41|||
150215267|NCT01836523|541927088|FG002|Overall Study|Adverse Event|49|||
150215268|NCT01836523|541927089|FG003|Overall Study|Adverse Event|14|||
150215269|NCT01836523|541927086|FG000|Overall Study|Protocol Violation|6|||
150215270|NCT01836523|541927087|FG001|Overall Study|Protocol Violation|3|||
150215271|NCT01836523|541927088|FG002|Overall Study|Protocol Violation|2|||
150215272|NCT01836523|541927089|FG003|Overall Study|Protocol Violation|4|||
150215273|NCT01836523|541927086|FG000|Overall Study|Met Withdrawal Criteria|13|||
150215274|NCT01836523|541927087|FG001|Overall Study|Met Withdrawal Criteria|13|||
150215275|NCT01836523|541927088|FG002|Overall Study|Met Withdrawal Criteria|21|||
150215276|NCT01836523|541927089|FG003|Overall Study|Met Withdrawal Criteria|27|||
150215277|NCT01836523|541927086|FG000|Overall Study|Unclassified|17|||
150215278|NCT01836523|541927087|FG001|Overall Study|Unclassified|28|||
150215279|NCT01836523|541927088|FG002|Overall Study|Unclassified|19|||
150215280|NCT01836523|541927089|FG003|Overall Study|Unclassified|29|||
150215281|NCT00624377|541927092|FG000|Overall Study|Lost to Follow-up|355|||
150215282|NCT00624377|541927092|FG000|Overall Study|Withdrawal by Subject|100|||
150215283|NCT00624377|541927092|FG000|Overall Study|Adverse Event|14|||
150215284|NCT00624377|541927092|FG000|Overall Study|Other|91|||
150215285|NCT00624377|541927092|FG000|Overall Study|Non-evaluable population|84|||
150215286|NCT00148122|541927096|FG000|Overall Study|Withdrawal by Subject|2|||
150215287|NCT00274287|541927097|FG000|Overall Study|Withdrawal by Subject|1|||
150215288|NCT00274287|541927097|FG000|Overall Study|subject non-compliance|1|||
150215289|NCT04492475|541927098|FG000|Overall Study|Enrolled but not treated|8|||
150215290|NCT04492475|541927099|FG001|Overall Study|Enrolled but not treated|8|||
150215291|NCT04492475|541927098|FG000|Overall Study|Withdrawal by Subject|4|||
150215292|NCT04492475|541927099|FG001|Overall Study|Withdrawal by Subject|0|||
150215293|NCT04492475|541927098|FG000|Overall Study|Became ineligible after enrollment|2|||
150215294|NCT04492475|541927099|FG001|Overall Study|Became ineligible after enrollment|0|||
150215295|NCT03200574|541927108|FG000|Overall Study|Death|4|||
150215296|NCT03200574|541927108|FG000|Overall Study|Withdrawal by Subject|8|||
150215297|NCT03200574|541927108|FG000|Overall Study|Long-Term need for anticoagulation|1|||
150215298|NCT03200574|541927108|FG000|Overall Study|Relocation|2|||
150215299|NCT03200574|541927108|FG000|Overall Study|Lost to Follow-up|2|||
150215300|NCT03035942|541927112|FG000|Overall Study|Adverse Event|8|||
150215301|NCT03035942|541927113|FG001|Overall Study|Adverse Event|4|||
150215302|NCT03035942|541927114|FG002|Overall Study|Adverse Event|5|||
150215303|NCT01989104|541927115|FG000|Overall Study|Withdrawal by Subject|3|||
150215304|NCT01989104|541927116|FG001|Overall Study|Withdrawal by Subject|0|||
150215305|NCT01989104|541927117|FG002|Overall Study|Withdrawal by Subject|0|||
150215306|NCT01989104|541927118|FG003|Overall Study|Withdrawal by Subject|0|||
150215307|NCT01989104|541927119|FG004|Overall Study|Withdrawal by Subject|0|||
150215308|NCT05163353|541927123|FG000|Overall Study|Adverse Event|1|||
150215309|NCT05163353|541927124|FG001|Overall Study|Adverse Event|0|||
150215310|NCT05163353|541927123|FG000|Overall Study|Withdrawal by Subject|21|||
150215311|NCT05163353|541927124|FG001|Overall Study|Withdrawal by Subject|6|||
150215312|NCT05163353|541927123|FG000|Overall Study|Protocol Violation|0|||
150215313|NCT05163353|541927124|FG001|Overall Study|Protocol Violation|1|||
150215314|NCT05163353|541927123|FG000|Overall Study|Lost to Follow-up|13|||
150215315|NCT05163353|541927124|FG001|Overall Study|Lost to Follow-up|2|||
150215316|NCT06086028|541927126|FG000|Overall Study|Withdrawal by Subject|1|||
150215317|NCT06086028|541927127|FG001|Overall Study|Withdrawal by Subject|1|||
150215318|NCT06086028|541927126|FG000|Overall Study|Lost to Follow-up|2|||
150215319|NCT06086028|541927127|FG001|Overall Study|Lost to Follow-up|3|||
150215320|NCT04083781|541927133|FG000|Main Part|Physician Decision|0|||
150215321|NCT04083781|541927134|FG001|Main Part|Physician Decision|1|||
150215322|NCT04083781|541927135|FG002|Main Part|Physician Decision|2|||
150215323|NCT04083781|541927136|FG003|Main Part|Physician Decision|0|||
150215324|NCT04083781|541927133|FG000|Main Part|Death|1|||
150215325|NCT04083781|541927134|FG001|Main Part|Death|3|||
150215326|NCT04083781|541927135|FG002|Main Part|Death|1|||
150215327|NCT04083781|541927136|FG003|Main Part|Death|0|||
150215328|NCT04083781|541927133|FG000|Main Part|Withdrawal by Subject|5|||
150215329|NCT04083781|541927134|FG001|Main Part|Withdrawal by Subject|2|||
150215330|NCT04083781|541927135|FG002|Main Part|Withdrawal by Subject|3|||
150215331|NCT04083781|541927136|FG003|Main Part|Withdrawal by Subject|7|||
150215332|NCT04083781|541927133|FG000|Extension Part|Physician Decision|0|||
150215333|NCT04083781|541927134|FG001|Extension Part|Physician Decision|0|||
150215334|NCT04083781|541927135|FG002|Extension Part|Physician Decision|0|||
150215335|NCT04083781|541927136|FG003|Extension Part|Physician Decision|1|||
150215336|NCT04083781|541927133|FG000|Extension Part|Death|0|||
150215337|NCT04083781|541927134|FG001|Extension Part|Death|1|||
150215338|NCT04083781|541927135|FG002|Extension Part|Death|0|||
150215339|NCT04083781|541927136|FG003|Extension Part|Death|1|||
150215340|NCT04083781|541927133|FG000|Extension Part|Withdrawal by Subject|0|||
150215341|NCT04083781|541927134|FG001|Extension Part|Withdrawal by Subject|1|||
150215342|NCT04083781|541927135|FG002|Extension Part|Withdrawal by Subject|0|||
150215343|NCT04083781|541927136|FG003|Extension Part|Withdrawal by Subject|0|||
150215344|NCT04083781|541927133|FG000|Extension Part|Ongoing|13|||
150215345|NCT04083781|541927134|FG001|Extension Part|Ongoing|25|||
150215346|NCT04083781|541927135|FG002|Extension Part|Ongoing|15|||
150215347|NCT04083781|541927136|FG003|Extension Part|Ongoing|51|||
150215348|NCT03803475|541927137|FG000|Overall Study|Physician Decision|1|||
150215349|NCT01880736|541927138|FG000|Overall Study|Adverse Event|0|||
150215350|NCT01880736|541927139|FG001|Overall Study|Adverse Event|0|||
150215351|NCT01880736|541927140|FG002|Overall Study|Adverse Event|0|||
150215352|NCT01880736|541927141|FG003|Overall Study|Adverse Event|1|||
150215353|NCT01880736|541927138|FG000|Overall Study|Withdrawal Criteria|1|||
150215354|NCT01880736|541927139|FG001|Overall Study|Withdrawal Criteria|2|||
150215355|NCT01880736|541927140|FG002|Overall Study|Withdrawal Criteria|1|||
150215356|NCT01880736|541927141|FG003|Overall Study|Withdrawal Criteria|5|||
150215357|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
150215358|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
150215359|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
150215360|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
150215361|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
150215362|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
150215363|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
150215364|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
150215365|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
150215366|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
150215367|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
150215368|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
150215369|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
150215370|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
150215371|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
150215372|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
150215373|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
150215374|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
150215375|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
150215376|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
150215377|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
150215378|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
150215379|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
150215380|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
150215381|NCT02203032|541927145|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
150215382|NCT02203032|541927146|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
150215383|NCT02203032|541927147|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
150215384|NCT02203032|541927148|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
150215385|NCT02203032|541927145|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
150215386|NCT02203032|541927146|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
150215387|NCT02203032|541927147|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
150215388|NCT02203032|541927148|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
150215389|NCT02203032|541927145|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
150215390|NCT02203032|541927146|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
150215391|NCT02203032|541927147|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
150215392|NCT02203032|541927148|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
150215393|NCT02203032|541927145|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
150215394|NCT02203032|541927146|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
150215395|NCT02203032|541927147|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
150215396|NCT02203032|541927148|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
150215397|NCT02203032|541927145|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
150215398|NCT02203032|541927146|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
150215399|NCT02203032|541927147|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
150215400|NCT02203032|541927148|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
150215401|NCT02203032|541927145|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
150215402|NCT02203032|541927146|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
150215403|NCT02203032|541927147|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
150215404|NCT02203032|541927148|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
150215405|NCT02241785|541927151|FG000|Overall Study|Sponsor Termination|43|||
150215406|NCT02241785|541927151|FG000|Overall Study|Withdrawal by Subject|1|||
150215407|NCT02241785|541927151|FG000|Overall Study|Lost to Follow-up|2|||
150215408|NCT02241785|541927151|FG000|Overall Study|Adverse Event|1|||
150215409|NCT04748341|541927152|FG000|Overall Study|Lost to Follow-up|1|||
150215410|NCT04748341|541927153|FG001|Overall Study|Lost to Follow-up|1|||
150215411|NCT02106325|541927156|FG000|Phase 1|Lost to Follow-up|2|||
150215412|NCT02106325|541927157|FG001|Phase 1|Lost to Follow-up|2|||
150215413|NCT02106325|541927156|FG000|Phase 2|Lost to Follow-up|2|||
150215414|NCT02106325|541927157|FG001|Phase 2|Lost to Follow-up|3|||
150215415|NCT02106325|541927156|FG000|Phase 3|Lost to Follow-up|2|||
150215416|NCT02106325|541927157|FG001|Phase 3|Lost to Follow-up|1|||
150215417|NCT00452114|541927158|FG000|Overall Study|Physician Decision|3|||
150215418|NCT00452114|541927159|FG001|Overall Study|Physician Decision|3|||
150215419|NCT04197713|541927161|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
150215420|NCT04197713|541927162|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
150215421|NCT02334215|541927163|FG000|Overall Study|Death|1|||
150215422|NCT02334215|541927164|FG001|Overall Study|Death|1|||
150215423|NCT02334215|541927165|FG002|Overall Study|Death|0|||
150215424|NCT02334215|541927163|FG000|Overall Study|Lost to Follow-up|1|||
150215425|NCT02334215|541927164|FG001|Overall Study|Lost to Follow-up|0|||
150215426|NCT02334215|541927165|FG002|Overall Study|Lost to Follow-up|4|||
150215427|NCT02334215|541927163|FG000|Overall Study|Withdrawal by Subject|2|||
150215428|NCT02334215|541927164|FG001|Overall Study|Withdrawal by Subject|2|||
150215429|NCT02334215|541927165|FG002|Overall Study|Withdrawal by Subject|1|||
150215430|NCT02334215|541927163|FG000|Overall Study|Not released from incarceration on time|3|||
150215431|NCT02334215|541927164|FG001|Overall Study|Not released from incarceration on time|3|||
150215432|NCT02334215|541927165|FG002|Overall Study|Not released from incarceration on time|3|||
150215433|NCT02334215|541927163|FG000|Overall Study|Incarcerated|0|||
150215434|NCT02334215|541927164|FG001|Overall Study|Incarcerated|0|||
150215435|NCT02334215|541927165|FG002|Overall Study|Incarcerated|7|||
150215436|NCT05615363|541927166|FG000|Overall Study|Adverse Event|0|||
150215437|NCT05615363|541927167|FG001|Overall Study|Adverse Event|4|||
150215438|NCT05615363|541927168|FG002|Overall Study|Adverse Event|4|||
150215439|NCT05615363|541927169|FG003|Overall Study|Adverse Event|3|||
150215440|NCT05615363|541927170|FG004|Overall Study|Adverse Event|1|||
150215441|NCT05615363|541927166|FG000|Overall Study|Physician Decision|2|||
150215442|NCT05615363|541927167|FG001|Overall Study|Physician Decision|0|||
150215443|NCT05615363|541927168|FG002|Overall Study|Physician Decision|4|||
150215444|NCT05615363|541927169|FG003|Overall Study|Physician Decision|1|||
150215445|NCT05615363|541927170|FG004|Overall Study|Physician Decision|3|||
150215446|NCT05615363|541927166|FG000|Overall Study|Protocol Violation|2|||
150215447|NCT05615363|541927167|FG001|Overall Study|Protocol Violation|0|||
150215448|NCT05615363|541927168|FG002|Overall Study|Protocol Violation|0|||
150215449|NCT05615363|541927169|FG003|Overall Study|Protocol Violation|0|||
150215450|NCT05615363|541927170|FG004|Overall Study|Protocol Violation|1|||
150215451|NCT05615363|541927166|FG000|Overall Study|Withdrawal by Subject|0|||
150215452|NCT05615363|541927167|FG001|Overall Study|Withdrawal by Subject|0|||
150215453|NCT05615363|541927168|FG002|Overall Study|Withdrawal by Subject|1|||
150215454|NCT05615363|541927169|FG003|Overall Study|Withdrawal by Subject|0|||
150215455|NCT05615363|541927170|FG004|Overall Study|Withdrawal by Subject|0|||
150215456|NCT04602728|541927173|FG000|Overall Study|Lost to Follow-up|4|||
150215457|NCT04602728|541927174|FG001|Overall Study|Lost to Follow-up|4|||
150215458|NCT05289037|541927184|FG000|Overall Study|Withdrawal by Subject|7|||
150215459|NCT05289037|541927185|FG001|Overall Study|Withdrawal by Subject|0|||
150215460|NCT05289037|541927186|FG002|Overall Study|Withdrawal by Subject|3|||
150215461|NCT05289037|541927187|FG003|Overall Study|Withdrawal by Subject|3|||
150215462|NCT05289037|541927188|FG004|Overall Study|Withdrawal by Subject|1|||
150215463|NCT05289037|541927189|FG005|Overall Study|Withdrawal by Subject|5|||
150215464|NCT05289037|541927190|FG006|Overall Study|Withdrawal by Subject|2|||
150215465|NCT05289037|541927191|FG007|Overall Study|Withdrawal by Subject|1|||
150215466|NCT05289037|541927192|FG008|Overall Study|Withdrawal by Subject|2|||
150215467|NCT05289037|541927193|FG009|Overall Study|Withdrawal by Subject|2|||
150215468|NCT05289037|541927194|FG010|Overall Study|Withdrawal by Subject|1|||
150215469|NCT05289037|541927195|FG011|Overall Study|Withdrawal by Subject|0|||
150215470|NCT05289037|541927196|FG012|Overall Study|Withdrawal by Subject|1|||
150215471|NCT05289037|541927197|FG013|Overall Study|Withdrawal by Subject|2|||
150215472|NCT05289037|541927198|FG014|Overall Study|Withdrawal by Subject|0|||
150215473|NCT05289037|541927199|FG015|Overall Study|Withdrawal by Subject|3|||
150215474|NCT05289037|541927200|FG016|Overall Study|Withdrawal by Subject|3|||
150215475|NCT05289037|541927184|FG000|Overall Study|Lost to Follow-up|1|||
150215476|NCT05289037|541927185|FG001|Overall Study|Lost to Follow-up|4|||
150215477|NCT05289037|541927186|FG002|Overall Study|Lost to Follow-up|3|||
150215478|NCT05289037|541927187|FG003|Overall Study|Lost to Follow-up|3|||
150215479|NCT05289037|541927188|FG004|Overall Study|Lost to Follow-up|3|||
150215480|NCT05289037|541927189|FG005|Overall Study|Lost to Follow-up|2|||
150215481|NCT05289037|541927190|FG006|Overall Study|Lost to Follow-up|3|||
150215482|NCT05289037|541927191|FG007|Overall Study|Lost to Follow-up|2|||
150215483|NCT05289037|541927192|FG008|Overall Study|Lost to Follow-up|2|||
150215484|NCT05289037|541927193|FG009|Overall Study|Lost to Follow-up|1|||
150215485|NCT05289037|541927194|FG010|Overall Study|Lost to Follow-up|3|||
150215486|NCT05289037|541927195|FG011|Overall Study|Lost to Follow-up|4|||
150215487|NCT05289037|541927196|FG012|Overall Study|Lost to Follow-up|2|||
150215488|NCT05289037|541927197|FG013|Overall Study|Lost to Follow-up|7|||
150215489|NCT05289037|541927198|FG014|Overall Study|Lost to Follow-up|4|||
150215490|NCT05289037|541927199|FG015|Overall Study|Lost to Follow-up|6|||
150215491|NCT05289037|541927200|FG016|Overall Study|Lost to Follow-up|4|||
150215492|NCT05289037|541927184|FG000|Overall Study|Death|0|||
150215493|NCT05289037|541927185|FG001|Overall Study|Death|0|||
150215494|NCT05289037|541927186|FG002|Overall Study|Death|0|||
150215495|NCT05289037|541927187|FG003|Overall Study|Death|0|||
150215496|NCT05289037|541927188|FG004|Overall Study|Death|0|||
150215497|NCT05289037|541927189|FG005|Overall Study|Death|1|||
150215498|NCT05289037|541927190|FG006|Overall Study|Death|0|||
150215499|NCT05289037|541927191|FG007|Overall Study|Death|0|||
150215500|NCT05289037|541927192|FG008|Overall Study|Death|0|||
150215501|NCT05289037|541927193|FG009|Overall Study|Death|0|||
150215502|NCT05289037|541927194|FG010|Overall Study|Death|0|||
150215503|NCT05289037|541927195|FG011|Overall Study|Death|0|||
150215504|NCT05289037|541927196|FG012|Overall Study|Death|0|||
150215505|NCT05289037|541927197|FG013|Overall Study|Death|0|||
150215506|NCT05289037|541927198|FG014|Overall Study|Death|1|||
150215507|NCT05289037|541927199|FG015|Overall Study|Death|0|||
150215508|NCT05289037|541927200|FG016|Overall Study|Death|0|||
150215509|NCT05289037|541927184|FG000|Overall Study|Did not receive vaccine|0|||
150215510|NCT05289037|541927185|FG001|Overall Study|Did not receive vaccine|3|||
150215511|NCT05289037|541927186|FG002|Overall Study|Did not receive vaccine|0|||
150215512|NCT05289037|541927187|FG003|Overall Study|Did not receive vaccine|0|||
150215513|NCT05289037|541927188|FG004|Overall Study|Did not receive vaccine|1|||
150215514|NCT05289037|541927189|FG005|Overall Study|Did not receive vaccine|1|||
150215515|NCT05289037|541927190|FG006|Overall Study|Did not receive vaccine|1|||
150215516|NCT05289037|541927191|FG007|Overall Study|Did not receive vaccine|0|||
150215517|NCT05289037|541927192|FG008|Overall Study|Did not receive vaccine|0|||
150215518|NCT05289037|541927193|FG009|Overall Study|Did not receive vaccine|0|||
150215519|NCT05289037|541927194|FG010|Overall Study|Did not receive vaccine|0|||
150215520|NCT05289037|541927195|FG011|Overall Study|Did not receive vaccine|0|||
150215521|NCT05289037|541927196|FG012|Overall Study|Did not receive vaccine|0|||
150215522|NCT05289037|541927197|FG013|Overall Study|Did not receive vaccine|0|||
150215523|NCT05289037|541927198|FG014|Overall Study|Did not receive vaccine|1|||
150215524|NCT05289037|541927199|FG015|Overall Study|Did not receive vaccine|0|||
150215525|NCT05289037|541927200|FG016|Overall Study|Did not receive vaccine|0|||
150215526|NCT05289037|541927184|FG000|Overall Study|Unable to make last visit|0|||
150215527|NCT05289037|541927185|FG001|Overall Study|Unable to make last visit|0|||
150215528|NCT05289037|541927186|FG002|Overall Study|Unable to make last visit|1|||
150215529|NCT05289037|541927187|FG003|Overall Study|Unable to make last visit|0|||
150215530|NCT05289037|541927188|FG004|Overall Study|Unable to make last visit|0|||
150215531|NCT05289037|541927189|FG005|Overall Study|Unable to make last visit|0|||
150215532|NCT05289037|541927190|FG006|Overall Study|Unable to make last visit|0|||
150215533|NCT05289037|541927191|FG007|Overall Study|Unable to make last visit|0|||
150215534|NCT05289037|541927192|FG008|Overall Study|Unable to make last visit|0|||
150215535|NCT05289037|541927193|FG009|Overall Study|Unable to make last visit|0|||
150215536|NCT05289037|541927194|FG010|Overall Study|Unable to make last visit|0|||
150215537|NCT05289037|541927195|FG011|Overall Study|Unable to make last visit|0|||
150215538|NCT05289037|541927196|FG012|Overall Study|Unable to make last visit|0|||
150215539|NCT05289037|541927197|FG013|Overall Study|Unable to make last visit|0|||
150215540|NCT05289037|541927198|FG014|Overall Study|Unable to make last visit|0|||
150215541|NCT05289037|541927199|FG015|Overall Study|Unable to make last visit|0|||
150215542|NCT05289037|541927200|FG016|Overall Study|Unable to make last visit|0|||
150215543|NCT05289037|541927184|FG000|Overall Study|Protocol deviation|0|||
150215544|NCT05289037|541927185|FG001|Overall Study|Protocol deviation|0|||
150215545|NCT05289037|541927186|FG002|Overall Study|Protocol deviation|0|||
150215546|NCT05289037|541927187|FG003|Overall Study|Protocol deviation|0|||
150215547|NCT05289037|541927188|FG004|Overall Study|Protocol deviation|0|||
150215548|NCT05289037|541927189|FG005|Overall Study|Protocol deviation|0|||
150215549|NCT05289037|541927190|FG006|Overall Study|Protocol deviation|0|||
150215550|NCT05289037|541927191|FG007|Overall Study|Protocol deviation|0|||
150215551|NCT05289037|541927192|FG008|Overall Study|Protocol deviation|0|||
150215552|NCT05289037|541927193|FG009|Overall Study|Protocol deviation|0|||
150215553|NCT05289037|541927194|FG010|Overall Study|Protocol deviation|0|||
150215554|NCT05289037|541927195|FG011|Overall Study|Protocol deviation|0|||
150215555|NCT05289037|541927196|FG012|Overall Study|Protocol deviation|0|||
150215556|NCT05289037|541927197|FG013|Overall Study|Protocol deviation|0|||
150215557|NCT05289037|541927198|FG014|Overall Study|Protocol deviation|0|||
150215558|NCT05289037|541927199|FG015|Overall Study|Protocol deviation|1|||
150215559|NCT05289037|541927200|FG016|Overall Study|Protocol deviation|0|||
150215560|NCT02831049|541927201|FG000|Overall Study|Lost to Follow-up|0|||
150215561|NCT02831049|541927202|FG001|Overall Study|Lost to Follow-up|0|||
150215562|NCT02831049|541927203|FG002|Overall Study|Lost to Follow-up|1|||
150215563|NCT02831049|541927201|FG000|Overall Study|Withdrawal by Subject|0|||
150215564|NCT02831049|541927202|FG001|Overall Study|Withdrawal by Subject|1|||
150215565|NCT02831049|541927203|FG002|Overall Study|Withdrawal by Subject|1|||
150215566|NCT02831049|541927201|FG000|Overall Study|Pandemic shutdown|1|||
150215567|NCT02831049|541927202|FG001|Overall Study|Pandemic shutdown|0|||
150215568|NCT02831049|541927203|FG002|Overall Study|Pandemic shutdown|0|||
150215569|NCT05995977|541927204|FG000|Overall Study|Withdrawal by Subject|1|||
150215570|NCT05995977|541927205|FG001|Overall Study|Withdrawal by Subject|4|||
150215571|NCT05995977|541927204|FG000|Overall Study|Lost to Follow-up|2|||
150215572|NCT05995977|541927205|FG001|Overall Study|Lost to Follow-up|0|||
150215573|NCT04181788|541927206|FG000|TREATMENT|Adverse Event|0|||
150215574|NCT04181788|541927207|FG001|TREATMENT|Adverse Event|2|||
150215575|NCT04181788|541927208|FG002|TREATMENT|Adverse Event|1|||
150215576|NCT04181788|541927209|FG003|TREATMENT|Adverse Event|0|||
150215577|NCT04181788|541927210|FG004|TREATMENT|Adverse Event|1|||
150215578|NCT04181788|541927211|FG005|TREATMENT|Adverse Event|3|||
150215579|NCT04181788|541927206|FG000|TREATMENT|Death|0|||
150215580|NCT04181788|541927207|FG001|TREATMENT|Death|0|||
150215581|NCT04181788|541927208|FG002|TREATMENT|Death|0|||
150215582|NCT04181788|541927209|FG003|TREATMENT|Death|0|||
150140179|NCT00803101|541648753|FG000|Overall Study|Protocol Violation|1|||
150140180|NCT00803101|541648754|FG001|Overall Study|Protocol Violation|7|||
150140181|NCT00803101|541648753|FG000|Overall Study|Surgery finished outside protocol window|1|||
150140182|NCT00803101|541648754|FG001|Overall Study|Surgery finished outside protocol window|1|||
150140183|NCT00803101|541648753|FG000|Overall Study|Patient died outside SAE report period|1|||
150140184|NCT00803101|541648754|FG001|Overall Study|Patient died outside SAE report period|0|||
150140185|NCT00803101|541648753|FG000|Overall Study|Patient did not attend scheduled visit|2|||
150140186|NCT00803101|541648754|FG001|Overall Study|Patient did not attend scheduled visit|1|||
150140187|NCT00803101|541648753|FG000|Overall Study|Patient did not have surgery|1|||
150140188|NCT00803101|541648754|FG001|Overall Study|Patient did not have surgery|1|||
150140189|NCT01529008|541648757|FG000|Bone Marrow Harvesting|Physician Decision|1|||
150140190|NCT01529008|541648758|FG001|Bone Marrow Harvesting|Physician Decision|1|||
150140191|NCT01529008|541648757|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
150140192|NCT01529008|541648758|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
150140193|NCT01529008|541648757|FG000|Treatment|Adverse Event|6|||
150140194|NCT01529008|541648758|FG001|Treatment|Adverse Event|0|||
150140195|NCT01529008|541648757|FG000|Treatment|Other|3|||
150140196|NCT01529008|541648758|FG001|Treatment|Other|1|||
150140197|NCT01529008|541648757|FG000|Efficacy Analysis|Protocol Violation|2|||
150140198|NCT01529008|541648758|FG001|Efficacy Analysis|Protocol Violation|0|||
150140199|NCT01529008|541648757|FG000|Efficacy Analysis|Physician Decision|0|||
150140200|NCT01529008|541648758|FG001|Efficacy Analysis|Physician Decision|1|||
150140201|NCT01529008|541648757|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
150140202|NCT01529008|541648758|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
150140203|NCT00332332|541648759|FG000|Overall Study|Adverse Event|13|||
150140204|NCT00332332|541648759|FG000|Overall Study|Death|1|||
150140205|NCT00332332|541648759|FG000|Overall Study|Withdrawal by Subject|8|||
150140206|NCT00332332|541648759|FG000|Overall Study|Physician Decision|1|||
150140207|NCT00332332|541648759|FG000|Overall Study|Lost to Follow-up|3|||
150140208|NCT00332332|541648759|FG000|Overall Study|Protocol deviation|4|||
150140209|NCT00332332|541648759|FG000|Overall Study|Noncompliance|2|||
150140210|NCT00332332|541648759|FG000|Overall Study|Disease progression|2|||
150140211|NCT00332332|541648759|FG000|Overall Study|Other|18|||
150140212|NCT00332332|541648759|FG000|Overall Study|Did not receive study treatment|16|||
150140213|NCT01382602|541648760|FG000|Overall Study|Protocol Violation|0|||
150140214|NCT01382602|541648761|FG001|Overall Study|Protocol Violation|3|||
150140215|NCT01382602|541648760|FG000|Overall Study|Withdrawal by Subject|0|||
150140216|NCT01382602|541648761|FG001|Overall Study|Withdrawal by Subject|1|||
150140217|NCT02790073|541648764|FG000|Overall Study|Death|1|||
150140218|NCT02790073|541648764|FG000|Overall Study|Withdrawal from HD|1|||
150140219|NCT02790073|541648764|FG000|Overall Study|Withdrawal by Subject|1|||
150140220|NCT04170686|541648765|FG000|Screening|Physician Decision|12|||
150140221|NCT04170686|541648766|FG001|Screening|Physician Decision|13|||
150140222|NCT04170686|541648765|FG000|Randomization and Treatment|Lost to Follow-up|26|||
150140223|NCT04170686|541648766|FG001|Randomization and Treatment|Lost to Follow-up|15|||
150140224|NCT03328143|541648767|FG000|Overall Study|Declined|3|||
150140225|NCT03328143|541648767|FG000|Overall Study|Required increased sedation|4|||
150140226|NCT03328143|541648767|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
150140227|NCT03328143|541648767|FG000|Overall Study|Surgery cancelled|1|||
150140228|NCT00331344|541648770|FG000|Phase I|Adverse Event|0|||
150140229|NCT00331344|541648771|FG001|Phase I|Adverse Event|0|||
150140230|NCT00331344|541648772|FG002|Phase I|Adverse Event|0|||
150140231|NCT00331344|541648773|FG003|Phase I|Adverse Event|1|||
150140232|NCT00331344|541648774|FG004|Phase I|Adverse Event|2|||
150140233|NCT00331344|541648775|FG005|Phase I|Adverse Event|2|||
150140234|NCT00331344|541648776|FG006|Phase I|Adverse Event|0|||
150140235|NCT00331344|541648777|FG007|Phase I|Adverse Event|1|||
150215583|NCT04181788|541927210|FG004|TREATMENT|Death|8|||
150215584|NCT04181788|541927211|FG005|TREATMENT|Death|8|||
150215585|NCT04181788|541927206|FG000|TREATMENT|Physician Decision|0|||
150215586|NCT04181788|541927207|FG001|TREATMENT|Physician Decision|0|||
150215587|NCT04181788|541927208|FG002|TREATMENT|Physician Decision|0|||
150215588|NCT04181788|541927209|FG003|TREATMENT|Physician Decision|0|||
150215589|NCT04181788|541927210|FG004|TREATMENT|Physician Decision|0|||
150215590|NCT04181788|541927211|FG005|TREATMENT|Physician Decision|1|||
150215591|NCT04181788|541927206|FG000|TREATMENT|Progressive disease|3|||
150215592|NCT04181788|541927207|FG001|TREATMENT|Progressive disease|3|||
150215593|NCT04181788|541927208|FG002|TREATMENT|Progressive disease|5|||
150215594|NCT04181788|541927209|FG003|TREATMENT|Progressive disease|7|||
150215595|NCT04181788|541927210|FG004|TREATMENT|Progressive disease|20|||
150215596|NCT04181788|541927211|FG005|TREATMENT|Progressive disease|38|||
150215597|NCT04181788|541927206|FG000|TREATMENT|Global deterioration of health status|0|||
150215598|NCT04181788|541927207|FG001|TREATMENT|Global deterioration of health status|2|||
150215599|NCT04181788|541927208|FG002|TREATMENT|Global deterioration of health status|0|||
150215600|NCT04181788|541927209|FG003|TREATMENT|Global deterioration of health status|0|||
150215601|NCT04181788|541927210|FG004|TREATMENT|Global deterioration of health status|2|||
150215602|NCT04181788|541927211|FG005|TREATMENT|Global deterioration of health status|8|||
150215603|NCT04181788|541927206|FG000|TREATMENT|Withdrawal by Subject|1|||
150215604|NCT04181788|541927207|FG001|TREATMENT|Withdrawal by Subject|2|||
150215605|NCT04181788|541927208|FG002|TREATMENT|Withdrawal by Subject|0|||
150215606|NCT04181788|541927209|FG003|TREATMENT|Withdrawal by Subject|0|||
150215607|NCT04181788|541927210|FG004|TREATMENT|Withdrawal by Subject|3|||
150215608|NCT04181788|541927211|FG005|TREATMENT|Withdrawal by Subject|5|||
150215609|NCT04181788|541927206|FG000|TREATMENT|Other unspecified|0|||
150215610|NCT04181788|541927207|FG001|TREATMENT|Other unspecified|0|||
150215611|NCT04181788|541927208|FG002|TREATMENT|Other unspecified|0|||
150215612|NCT04181788|541927209|FG003|TREATMENT|Other unspecified|0|||
150215613|NCT04181788|541927210|FG004|TREATMENT|Other unspecified|0|||
150215614|NCT04181788|541927211|FG005|TREATMENT|Other unspecified|2|||
150215615|NCT04181788|541927206|FG000|TREATMENT|Ongoing|0|||
150215616|NCT04181788|541927207|FG001|TREATMENT|Ongoing|3|||
150215617|NCT04181788|541927208|FG002|TREATMENT|Ongoing|0|||
150215618|NCT04181788|541927209|FG003|TREATMENT|Ongoing|5|||
150215619|NCT04181788|541927210|FG004|TREATMENT|Ongoing|7|||
150215620|NCT04181788|541927211|FG005|TREATMENT|Ongoing|15|||
150215621|NCT04181788|541927206|FG000|FOLLOW-UP|Death|0|||
150215622|NCT04181788|541927207|FG001|FOLLOW-UP|Death|0|||
150215623|NCT04181788|541927208|FG002|FOLLOW-UP|Death|1|||
150215624|NCT04181788|541927209|FG003|FOLLOW-UP|Death|2|||
150215625|NCT04181788|541927210|FG004|FOLLOW-UP|Death|8|||
150215626|NCT04181788|541927211|FG005|FOLLOW-UP|Death|20|||
150215627|NCT04181788|541927206|FG000|FOLLOW-UP|Lost to Follow-up|0|||
150215628|NCT04181788|541927207|FG001|FOLLOW-UP|Lost to Follow-up|0|||
150215629|NCT04181788|541927208|FG002|FOLLOW-UP|Lost to Follow-up|0|||
150215630|NCT04181788|541927209|FG003|FOLLOW-UP|Lost to Follow-up|0|||
150215631|NCT04181788|541927210|FG004|FOLLOW-UP|Lost to Follow-up|0|||
150215632|NCT04181788|541927211|FG005|FOLLOW-UP|Lost to Follow-up|2|||
150215633|NCT04181788|541927206|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
150215634|NCT04181788|541927207|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
150215635|NCT04181788|541927208|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
150215636|NCT04181788|541927209|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
150215637|NCT04181788|541927210|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
150215638|NCT04181788|541927211|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
150215639|NCT04181788|541927206|FG000|FOLLOW-UP|Other unspecified|0|||
150215640|NCT04181788|541927207|FG001|FOLLOW-UP|Other unspecified|1|||
150215641|NCT04181788|541927208|FG002|FOLLOW-UP|Other unspecified|0|||
150215642|NCT04181788|541927209|FG003|FOLLOW-UP|Other unspecified|0|||
150215643|NCT04181788|541927210|FG004|FOLLOW-UP|Other unspecified|0|||
150215644|NCT04181788|541927211|FG005|FOLLOW-UP|Other unspecified|3|||
150215645|NCT04181788|541927206|FG000|FOLLOW-UP|Ongoing|0|||
150215646|NCT04181788|541927207|FG001|FOLLOW-UP|Ongoing|0|||
150215647|NCT04181788|541927208|FG002|FOLLOW-UP|Ongoing|1|||
150215648|NCT04181788|541927209|FG003|FOLLOW-UP|Ongoing|3|||
150215649|NCT04181788|541927210|FG004|FOLLOW-UP|Ongoing|2|||
150215650|NCT04181788|541927211|FG005|FOLLOW-UP|Ongoing|2|||
150215651|NCT04535414|541927213|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
150215652|NCT04535414|541927214|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
150215653|NCT04535414|541927213|FG000|Overall Study|Cancelled appointment|1|||
150215654|NCT04535414|541927214|FG001|Overall Study|Cancelled appointment|0|||
150215655|NCT04535414|541927213|FG000|Overall Study|cancelled - food in stomach|2|||
150215656|NCT04535414|541927214|FG001|Overall Study|cancelled - food in stomach|0|||
150215657|NCT04535414|541927213|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
150215658|NCT04535414|541927214|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
150215659|NCT04535414|541927213|FG000|Overall Study|Withdrawal by Subject|0|||
150215660|NCT04535414|541927214|FG001|Overall Study|Withdrawal by Subject|1|||
150215661|NCT03662659|541927215|FG000|Pre-treatment|Participant no longer met study criteria|1|||
150215662|NCT03662659|541927216|FG001|Pre-treatment|Participant no longer met study criteria|1|||
150215663|NCT03662659|541927215|FG000|Pre-treatment|Other reasons|1|||
150215664|NCT03662659|541927216|FG001|Pre-treatment|Other reasons|0|||
150215665|NCT03662659|541927215|FG000|Treatment|Completed Treatment|0|||
150215666|NCT03662659|541927216|FG001|Treatment|Completed Treatment|2|||
150215667|NCT03662659|541927215|FG000|Treatment|Disease Progression|85|||
150215668|NCT03662659|541927216|FG001|Treatment|Disease Progression|97|||
150215669|NCT03662659|541927215|FG000|Treatment|Study Drug Toxicity|19|||
150215670|NCT03662659|541927216|FG001|Treatment|Study Drug Toxicity|9|||
150215671|NCT03662659|541927215|FG000|Treatment|Death|11|||
150215672|NCT03662659|541927216|FG001|Treatment|Death|9|||
150215673|NCT03662659|541927215|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
150215674|NCT03662659|541927216|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
150215675|NCT03662659|541927215|FG000|Treatment|Withdrawal by Subject|1|||
150215676|NCT03662659|541927216|FG001|Treatment|Withdrawal by Subject|1|||
150215677|NCT03662659|541927215|FG000|Treatment|Poor/Non-compliance|1|||
150215678|NCT03662659|541927216|FG001|Treatment|Poor/Non-compliance|0|||
150215679|NCT03662659|541927215|FG000|Treatment|Participant no longer meets study criteria|1|||
150215680|NCT03662659|541927216|FG001|Treatment|Participant no longer meets study criteria|0|||
150215681|NCT03662659|541927215|FG000|Treatment|Other reasons|10|||
150215682|NCT03662659|541927216|FG001|Treatment|Other reasons|8|||
150215683|NCT03662659|541927215|FG000|Treatment|Administrative reasons by sponsor|1|||
150215684|NCT03662659|541927216|FG001|Treatment|Administrative reasons by sponsor|0|||
150215685|NCT03662659|541927215|FG000|Treatment|maximum clinical benefit|0|||
150215686|NCT03662659|541927216|FG001|Treatment|maximum clinical benefit|2|||
150215687|NCT04852978|541927217|FG000|Overall Study|Physician Decision|0|||
150215688|NCT04852978|541927218|FG001|Overall Study|Physician Decision|1|||
150215689|NCT04852978|541927219|FG002|Overall Study|Physician Decision|0|||
150215690|NCT04852978|541927220|FG003|Overall Study|Physician Decision|0|||
150215691|NCT04852978|541927221|FG004|Overall Study|Physician Decision|0|||
150215692|NCT04852978|541927222|FG005|Overall Study|Physician Decision|0|||
150215693|NCT04852978|541927223|FG006|Overall Study|Physician Decision|0|||
150215694|NCT04852978|541927224|FG007|Overall Study|Physician Decision|2|||
150215695|NCT04852978|541927225|FG008|Overall Study|Physician Decision|0|||
150215696|NCT04852978|541927217|FG000|Overall Study|Sponsor request|0|||
150215697|NCT04852978|541927218|FG001|Overall Study|Sponsor request|0|||
150215698|NCT04852978|541927219|FG002|Overall Study|Sponsor request|1|||
150215699|NCT04852978|541927220|FG003|Overall Study|Sponsor request|0|||
150215700|NCT04852978|541927221|FG004|Overall Study|Sponsor request|0|||
150215701|NCT04852978|541927222|FG005|Overall Study|Sponsor request|0|||
150215702|NCT04852978|541927223|FG006|Overall Study|Sponsor request|0|||
150215703|NCT04852978|541927224|FG007|Overall Study|Sponsor request|0|||
150215704|NCT04852978|541927225|FG008|Overall Study|Sponsor request|0|||
150215705|NCT04852978|541927217|FG000|Overall Study|Death|0|||
150215706|NCT04852978|541927218|FG001|Overall Study|Death|0|||
150215707|NCT04852978|541927219|FG002|Overall Study|Death|0|||
150215708|NCT04852978|541927220|FG003|Overall Study|Death|0|||
150215709|NCT04852978|541927221|FG004|Overall Study|Death|0|||
150215710|NCT04852978|541927222|FG005|Overall Study|Death|0|||
150215711|NCT04852978|541927223|FG006|Overall Study|Death|1|||
150215712|NCT04852978|541927224|FG007|Overall Study|Death|0|||
150215713|NCT04852978|541927225|FG008|Overall Study|Death|0|||
150215714|NCT04852978|541927217|FG000|Overall Study|Lost to Follow-up|3|||
150215715|NCT04852978|541927218|FG001|Overall Study|Lost to Follow-up|2|||
150215716|NCT04852978|541927219|FG002|Overall Study|Lost to Follow-up|2|||
150215717|NCT04852978|541927220|FG003|Overall Study|Lost to Follow-up|0|||
150215718|NCT04852978|541927221|FG004|Overall Study|Lost to Follow-up|2|||
150215719|NCT04852978|541927222|FG005|Overall Study|Lost to Follow-up|4|||
150215720|NCT04852978|541927223|FG006|Overall Study|Lost to Follow-up|1|||
150215721|NCT04852978|541927224|FG007|Overall Study|Lost to Follow-up|2|||
150215722|NCT04852978|541927225|FG008|Overall Study|Lost to Follow-up|2|||
150215723|NCT04852978|541927217|FG000|Overall Study|Withdrawal by Subject|4|||
150215724|NCT04852978|541927218|FG001|Overall Study|Withdrawal by Subject|2|||
150215725|NCT04852978|541927219|FG002|Overall Study|Withdrawal by Subject|2|||
150215726|NCT04852978|541927220|FG003|Overall Study|Withdrawal by Subject|1|||
150215727|NCT04852978|541927221|FG004|Overall Study|Withdrawal by Subject|5|||
150215728|NCT04852978|541927222|FG005|Overall Study|Withdrawal by Subject|3|||
150215729|NCT04852978|541927223|FG006|Overall Study|Withdrawal by Subject|2|||
150215730|NCT04852978|541927224|FG007|Overall Study|Withdrawal by Subject|2|||
150215731|NCT04852978|541927225|FG008|Overall Study|Withdrawal by Subject|1|||
150215732|NCT01276509|541929082|FG000|Overall Study|Adverse Event|9|||
150215733|NCT01276509|541929083|FG001|Overall Study|Adverse Event|8|||
150215734|NCT01276509|541929084|FG002|Overall Study|Adverse Event|4|||
150215735|NCT01276509|541929085|FG003|Overall Study|Adverse Event|3|||
150215736|NCT01276509|541929082|FG000|Overall Study|Lack of Efficacy|2|||
150215737|NCT01276509|541929083|FG001|Overall Study|Lack of Efficacy|1|||
150215738|NCT01276509|541929084|FG002|Overall Study|Lack of Efficacy|1|||
150215739|NCT01276509|541929085|FG003|Overall Study|Lack of Efficacy|2|||
150215740|NCT01276509|541929082|FG000|Overall Study|Pregnancy|1|||
150215741|NCT01276509|541929083|FG001|Overall Study|Pregnancy|0|||
150215742|NCT01276509|541929084|FG002|Overall Study|Pregnancy|0|||
150215743|NCT01276509|541929085|FG003|Overall Study|Pregnancy|0|||
150215744|NCT01276509|541929082|FG000|Overall Study|Withdrawal by Subject|1|||
150215745|NCT01276509|541929083|FG001|Overall Study|Withdrawal by Subject|2|||
150215746|NCT01276509|541929084|FG002|Overall Study|Withdrawal by Subject|0|||
150215747|NCT01276509|541929085|FG003|Overall Study|Withdrawal by Subject|0|||
150215748|NCT01276509|541929082|FG000|Overall Study|Other|0|||
150215749|NCT01276509|541929083|FG001|Overall Study|Other|1|||
150215750|NCT01276509|541929084|FG002|Overall Study|Other|0|||
150215751|NCT01276509|541929085|FG003|Overall Study|Other|0|||
150215752|NCT00535626|541929091|FG000|Overall Study|Death|15|||
150215753|NCT00535626|541929091|FG000|Overall Study|Lost to Follow-up|29|||
150215754|NCT00535626|541929091|FG000|Overall Study|Withdrawal by Subject|20|||
150215755|NCT00535626|541929091|FG000|Overall Study|Removal/revision of study component|8|||
150215756|NCT00535626|541929091|FG000|Overall Study|Subject terminated|31|||
150215757|NCT00535626|541929091|FG000|Overall Study|Unable to return|2|||
150215758|NCT02830893|541929092|FG000|Overall Study|Relocation to out of the country|1|||
150215759|NCT02830893|541929093|FG001|Overall Study|Relocation to out of the country|0|||
150215760|NCT02830893|541929092|FG000|Overall Study|Lost to Follow-up|0|||
150215761|NCT02830893|541929093|FG001|Overall Study|Lost to Follow-up|2|||
150215762|NCT02830893|541929092|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
150215763|NCT02830893|541929093|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
150215764|NCT01277302|541929094|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
150215765|NCT01277302|541929095|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
150215766|NCT01277302|541929096|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
150215767|NCT01277302|541929094|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
150215768|NCT01277302|541929095|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
150215769|NCT01277302|541929096|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
150215770|NCT01277302|541929094|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
150215771|NCT01277302|541929095|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
150215772|NCT01277302|541929096|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
150215773|NCT01277302|541929094|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
150215774|NCT01277302|541929095|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
150215775|NCT01277302|541929096|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
150215776|NCT01277302|541929094|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
150215777|NCT01277302|541929095|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
150215778|NCT01277302|541929096|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
150215779|NCT01277302|541929094|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
150215780|NCT01277302|541929095|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
150215781|NCT01277302|541929096|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
150215782|NCT01277302|541929094|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
150215783|NCT01277302|541929095|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
150215784|NCT01277302|541929096|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
150215785|NCT01277302|541929094|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
150215786|NCT01277302|541929095|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
150215787|NCT01277302|541929096|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
150215788|NCT01277302|541929094|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
150215789|NCT01277302|541929095|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
150215790|NCT01277302|541929096|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
150215791|NCT02710669|541929099|FG000|Overall Study|Physician Decision|2|||
150215792|NCT02710669|541929100|FG001|Overall Study|Physician Decision|1|||
150215793|NCT02710669|541929101|FG002|Overall Study|Physician Decision|0|||
150215794|NCT02710669|541929099|FG000|Overall Study|Institutional delays (including COVID)|2|||
150215795|NCT02710669|541929100|FG001|Overall Study|Institutional delays (including COVID)|2|||
150215796|NCT02710669|541929101|FG002|Overall Study|Institutional delays (including COVID)|0|||
150215797|NCT02710669|541929099|FG000|Overall Study|arrived in afib/aflutter|10|||
150215798|NCT02710669|541929100|FG001|Overall Study|arrived in afib/aflutter|8|||
150215799|NCT02710669|541929101|FG002|Overall Study|arrived in afib/aflutter|2|||
150215800|NCT03332589|541929102|FG000|Overall Study|Lack of Efficacy|2|||
150215801|NCT03332589|541929103|FG001|Overall Study|Lack of Efficacy|0|||
150215802|NCT03332589|541929104|FG002|Overall Study|Lack of Efficacy|0|||
150215803|NCT03332589|541929102|FG000|Overall Study|Adverse Event|1|||
150215804|NCT03332589|541929103|FG001|Overall Study|Adverse Event|0|||
150215805|NCT03332589|541929104|FG002|Overall Study|Adverse Event|0|||
150215806|NCT03332589|541929102|FG000|Overall Study|Death|1|||
150215807|NCT03332589|541929103|FG001|Overall Study|Death|0|||
150215808|NCT03332589|541929104|FG002|Overall Study|Death|0|||
150215809|NCT04633200|541929105|FG000|Overall Study|Lost to Follow-up|3|||
150215810|NCT04633200|541929106|FG001|Overall Study|Lost to Follow-up|5|||
150215811|NCT02507297|541929107|FG000|Overall Study|Withdrawal by Subject|1|||
150215812|NCT02507297|541929108|FG001|Overall Study|Withdrawal by Subject|0|||
150215813|NCT02507297|541929107|FG000|Overall Study|Lost to Follow-up|0|||
150215814|NCT02507297|541929108|FG001|Overall Study|Lost to Follow-up|1|||
150215815|NCT02489799|541929109|FG000|Overall Study|Lost to Follow-up|4|||
150215816|NCT02489799|541929110|FG001|Overall Study|Lost to Follow-up|1|||
150215817|NCT02489799|541929109|FG000|Overall Study|Failure to Maintain Eligibility|4|||
150215818|NCT02489799|541929110|FG001|Overall Study|Failure to Maintain Eligibility|6|||
150215819|NCT02489799|541929109|FG000|Overall Study|Withdrawal by Subject|1|||
150215820|NCT02489799|541929110|FG001|Overall Study|Withdrawal by Subject|1|||
150215821|NCT02489799|541929109|FG000|Overall Study|Death|0|||
150215822|NCT02489799|541929110|FG001|Overall Study|Death|1|||
150215823|NCT01808534|541929120|FG000|Overall Study|Disease progression|3|||
150215824|NCT01808534|541929120|FG000|Overall Study|Physician Decision|1|||
150215825|NCT01377844|541929121|FG000|Overall Study|Withdrawal by Subject|25|||
150215826|NCT01377844|541929122|FG001|Overall Study|Withdrawal by Subject|28|||
150215827|NCT01377844|541929121|FG000|Overall Study|Protocol Violation|2|||
150215828|NCT01377844|541929122|FG001|Overall Study|Protocol Violation|3|||
150215829|NCT01377844|541929121|FG000|Overall Study|Adverse Event|3|||
150215830|NCT01377844|541929122|FG001|Overall Study|Adverse Event|0|||
150215831|NCT01377844|541929121|FG000|Overall Study|Physician Decision|6|||
150215832|NCT01377844|541929122|FG001|Overall Study|Physician Decision|3|||
150215833|NCT01377844|541929121|FG000|Overall Study|Study terminated by Sponsor|0|||
150215834|NCT01377844|541929122|FG001|Overall Study|Study terminated by Sponsor|1|||
150215835|NCT02092285|541929123|FG000|Induction Phase|Adverse Event|7|||
150215836|NCT02092285|541929123|FG000|Induction Phase|Physician Decision|4|||
150215837|NCT02092285|541929123|FG000|Induction Phase|Pregnancy|1|||
150215838|NCT02092285|541929123|FG000|Induction Phase|Relapse/Recurrence|7|||
150215839|NCT02092285|541929123|FG000|Induction Phase|Withdrawal by Subject|2|||
150215840|NCT02092285|541929123|FG000|Induction Phase|Lack of Efficacy|14|||
150215841|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
150215842|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
150215843|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
150215844|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
150215845|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
150215846|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
150215847|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
150215848|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
150215849|NCT02092285|541929123|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
150215850|NCT00087516|541929124|FG000|Overall Study|Adverse Event|10|||
150215851|NCT00087516|541929125|FG001|Overall Study|Adverse Event|10|||
150215852|NCT00087516|541929126|FG002|Overall Study|Adverse Event|3|||
150215853|NCT00087516|541929127|FG003|Overall Study|Adverse Event|6|||
150215854|NCT00087516|541929124|FG000|Overall Study|Lack of Efficacy|82|||
150215855|NCT00087516|541929125|FG001|Overall Study|Lack of Efficacy|80|||
150215856|NCT00087516|541929126|FG002|Overall Study|Lack of Efficacy|39|||
150215857|NCT00087516|541929127|FG003|Overall Study|Lack of Efficacy|29|||
150215858|NCT00087516|541929124|FG000|Overall Study|Lost to Follow-up|8|||
150215859|NCT00087516|541929125|FG001|Overall Study|Lost to Follow-up|6|||
150215860|NCT00087516|541929126|FG002|Overall Study|Lost to Follow-up|5|||
150215861|NCT00087516|541929127|FG003|Overall Study|Lost to Follow-up|5|||
150215862|NCT00087516|541929124|FG000|Overall Study|Protocol Violation|4|||
150215863|NCT00087516|541929125|FG001|Overall Study|Protocol Violation|8|||
150215864|NCT00087516|541929126|FG002|Overall Study|Protocol Violation|3|||
150215865|NCT00087516|541929127|FG003|Overall Study|Protocol Violation|6|||
150215866|NCT00087516|541929124|FG000|Overall Study|Withdrawal by Subject|16|||
150215867|NCT00087516|541929125|FG001|Overall Study|Withdrawal by Subject|27|||
150215868|NCT00087516|541929126|FG002|Overall Study|Withdrawal by Subject|11|||
150215869|NCT00087516|541929127|FG003|Overall Study|Withdrawal by Subject|12|||
150215870|NCT00087516|541929124|FG000|Overall Study|Site terminated|0|||
150215871|NCT00087516|541929125|FG001|Overall Study|Site terminated|2|||
150215872|NCT00087516|541929126|FG002|Overall Study|Site terminated|1|||
150215873|NCT00087516|541929127|FG003|Overall Study|Site terminated|0|||
150215874|NCT00087516|541929124|FG000|Overall Study|Protocol specified discontinuation|35|||
150215875|NCT00087516|541929125|FG001|Overall Study|Protocol specified discontinuation|33|||
150215876|NCT00087516|541929126|FG002|Overall Study|Protocol specified discontinuation|33|||
150215877|NCT00087516|541929127|FG003|Overall Study|Protocol specified discontinuation|26|||
150215878|NCT00087516|541929124|FG000|Overall Study|Patient moved|3|||
150215879|NCT00087516|541929125|FG001|Overall Study|Patient moved|2|||
150215880|NCT00087516|541929126|FG002|Overall Study|Patient moved|1|||
150215881|NCT00087516|541929127|FG003|Overall Study|Patient moved|0|||
150215882|NCT00087516|541929124|FG000|Overall Study|Patient was non-compliant|3|||
150215883|NCT00087516|541929125|FG001|Overall Study|Patient was non-compliant|1|||
150215884|NCT00087516|541929126|FG002|Overall Study|Patient was non-compliant|0|||
150215885|NCT00087516|541929127|FG003|Overall Study|Patient was non-compliant|0|||
150215886|NCT00087516|541929124|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
150215887|NCT00087516|541929125|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
150215888|NCT00087516|541929126|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
150215889|NCT00087516|541929127|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
150215890|NCT00087516|541929124|FG000|Overall Study|Other|0|||
150215891|NCT00087516|541929125|FG001|Overall Study|Other|0|||
150215892|NCT00087516|541929126|FG002|Overall Study|Other|1|||
150215893|NCT00087516|541929127|FG003|Overall Study|Other|0|||
150215894|NCT00278395|541929128|FG000|Overall Study|Adverse Event|2|||
150215895|NCT00278395|541929128|FG000|Overall Study|Nonevaluable|1|||
150215896|NCT02202317|541929133|FG000|Overall Study|Lost to Follow-up|1|||
150215897|NCT02338999|541929134|FG000|First Intervention|Withdrawal by Subject|3|||
150215898|NCT02338999|541929135|FG001|First Intervention|Withdrawal by Subject|1|||
150215899|NCT02338999|541929134|FG000|Washout Period|Withdrawal by Subject|0|||
150215900|NCT02338999|541929135|FG001|Washout Period|Withdrawal by Subject|2|||
150215901|NCT02338999|541929134|FG000|Second Intervention|Withdrawal by Subject|0|||
150215902|NCT02338999|541929135|FG001|Second Intervention|Withdrawal by Subject|2|||
150215903|NCT00569166|541929137|FG000|Overall Study|Withdrawal by Subject|7|||
150215904|NCT00569166|541929138|FG001|Overall Study|Withdrawal by Subject|5|||
150215905|NCT00569166|541929139|FG002|Overall Study|Withdrawal by Subject|3|||
150215906|NCT00569166|541929137|FG000|Overall Study|Lost to Follow-up|2|||
150215907|NCT00569166|541929138|FG001|Overall Study|Lost to Follow-up|1|||
150215908|NCT00569166|541929139|FG002|Overall Study|Lost to Follow-up|1|||
150215909|NCT01853384|541929141|FG000|Randomized|Adverse Event|5|||
150215910|NCT01853384|541929142|FG001|Randomized|Adverse Event|3|||
150215911|NCT01853384|541929141|FG000|Randomized|Death|1|||
150215912|NCT01853384|541929142|FG001|Randomized|Death|2|||
150215913|NCT01853384|541929141|FG000|Randomized|Lost to Follow-up|1|||
150215914|NCT01853384|541929142|FG001|Randomized|Lost to Follow-up|1|||
150215915|NCT01853384|541929141|FG000|Randomized|Withdrawal by Subject|5|||
150215916|NCT01853384|541929142|FG001|Randomized|Withdrawal by Subject|3|||
150215917|NCT01853384|541929141|FG000|Randomized|Sponsor Decision|47|||
150215918|NCT01853384|541929142|FG001|Randomized|Sponsor Decision|34|||
150215919|NCT01853384|541929141|FG000|Randomized|Other|3|||
150215920|NCT01853384|541929142|FG001|Randomized|Other|3|||
150215921|NCT01853384|541929141|FG000|Completed Follow up Visit 1|Early Termination|13|||
150215922|NCT01853384|541929142|FG001|Completed Follow up Visit 1|Early Termination|9|||
150215923|NCT01853384|541929141|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
150215924|NCT01853384|541929142|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
150215925|NCT01853384|541929141|FG000|Completed Follow up Visit 2|Adverse Event|1|||
150215926|NCT01853384|541929142|FG001|Completed Follow up Visit 2|Adverse Event|0|||
150215927|NCT01853384|541929141|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
150215928|NCT01853384|541929142|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
150215929|NCT01853384|541929141|FG000|Completed Follow up Visit 2|Death|1|||
150215930|NCT01853384|541929142|FG001|Completed Follow up Visit 2|Death|0|||
150215931|NCT01853384|541929141|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
150215932|NCT01853384|541929142|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
150215933|NCT02067663|541929143|FG000|Overall Study|Lost to Follow-up|13|||
150215934|NCT02067663|541929144|FG001|Overall Study|Lost to Follow-up|14|||
150215935|NCT00704340|541929145|FG000|Overall Study|Lost to Follow-up|2|||
150215936|NCT00704340|541929146|FG001|Overall Study|Lost to Follow-up|1|||
150215937|NCT00704340|541929145|FG000|Overall Study|Death|0|||
150215938|NCT00704340|541929146|FG001|Overall Study|Death|1|||
150215939|NCT00486954|541929147|FG000|Pilot Part|Adverse Event|4|||
150215940|NCT00486954|541929148|FG001|Pilot Part|Adverse Event|0|||
150215941|NCT00486954|541929149|FG002|Pilot Part|Adverse Event|5|||
150215942|NCT00486954|541929150|FG003|Pilot Part|Adverse Event|0|||
150215943|NCT00486954|541929151|FG004|Pilot Part|Adverse Event|0|||
150215944|NCT00486954|541929147|FG000|Pilot Part|Disease Progression|2|||
150215945|NCT00486954|541929148|FG001|Pilot Part|Disease Progression|0|||
150215946|NCT00486954|541929149|FG002|Pilot Part|Disease Progression|1|||
150215947|NCT00486954|541929150|FG003|Pilot Part|Disease Progression|0|||
150215948|NCT00486954|541929151|FG004|Pilot Part|Disease Progression|0|||
150215949|NCT00486954|541929147|FG000|Randomized Part|Lost to Follow-up|0|||
150215950|NCT00486954|541929148|FG001|Randomized Part|Lost to Follow-up|0|||
150215951|NCT00486954|541929149|FG002|Randomized Part|Lost to Follow-up|0|||
150215952|NCT00486954|541929150|FG003|Randomized Part|Lost to Follow-up|0|||
150215953|NCT00486954|541929151|FG004|Randomized Part|Lost to Follow-up|1|||
150215954|NCT00486954|541929147|FG000|Randomized Part|Withdrawal by Subject|0|||
150215955|NCT00486954|541929148|FG001|Randomized Part|Withdrawal by Subject|0|||
150215956|NCT00486954|541929149|FG002|Randomized Part|Withdrawal by Subject|0|||
150215957|NCT00486954|541929150|FG003|Randomized Part|Withdrawal by Subject|1|||
150215958|NCT00486954|541929151|FG004|Randomized Part|Withdrawal by Subject|0|||
150215959|NCT00486954|541929147|FG000|Randomized Part|Sponsor Terminated Study|0|||
150215960|NCT00486954|541929148|FG001|Randomized Part|Sponsor Terminated Study|0|||
150215961|NCT00486954|541929149|FG002|Randomized Part|Sponsor Terminated Study|0|||
150215962|NCT00486954|541929150|FG003|Randomized Part|Sponsor Terminated Study|19|||
150215963|NCT00486954|541929151|FG004|Randomized Part|Sponsor Terminated Study|13|||
150215964|NCT00403845|541929152|FG000|Treatment Period 1|Subject withdrew consent|1|||
150215965|NCT00403845|541929153|FG001|Treatment Period 1|Subject withdrew consent|0|||
150215966|NCT00403845|541929154|FG002|Treatment Period 1|Subject withdrew consent|0|||
150215967|NCT00403845|541929155|FG003|Treatment Period 1|Subject withdrew consent|0|||
150215968|NCT00403845|541929152|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
150215969|NCT00403845|541929153|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
150215970|NCT00403845|541929154|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
150215971|NCT00403845|541929155|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
150215972|NCT00403845|541929152|FG000|Treatment Period 2|Subject withdrew consent|1|||
150215973|NCT00403845|541929153|FG001|Treatment Period 2|Subject withdrew consent|0|||
150215974|NCT00403845|541929154|FG002|Treatment Period 2|Subject withdrew consent|0|||
150215975|NCT00403845|541929155|FG003|Treatment Period 2|Subject withdrew consent|0|||
150215976|NCT00403845|541929152|FG000|Treatment Period 3|Subject withdrew consent|0|||
150215977|NCT00403845|541929153|FG001|Treatment Period 3|Subject withdrew consent|0|||
150215978|NCT00403845|541929154|FG002|Treatment Period 3|Subject withdrew consent|0|||
150215979|NCT00403845|541929155|FG003|Treatment Period 3|Subject withdrew consent|1|||
150215980|NCT00403845|541929152|FG000|Treatment Period 3|Adverse Event|0|||
150215981|NCT00403845|541929153|FG001|Treatment Period 3|Adverse Event|0|||
150215982|NCT00403845|541929154|FG002|Treatment Period 3|Adverse Event|0|||
150215983|NCT00403845|541929155|FG003|Treatment Period 3|Adverse Event|1|||
150215984|NCT03316170|541929156|FG000|Overall Study|Death|1|||
150215985|NCT03316170|541929157|FG001|Overall Study|Death|0|||
150215986|NCT03316170|541929156|FG000|Overall Study|Lost to Follow-up|6|||
150215987|NCT03316170|541929157|FG001|Overall Study|Lost to Follow-up|7|||
150215988|NCT02169414|541929158|FG000|Overall Study|Withdrawal by Subject|1|||
150215989|NCT02169414|541929159|FG001|Overall Study|Withdrawal by Subject|0|||
150215990|NCT02169414|541929160|FG002|Overall Study|Withdrawal by Subject|0|||
150215991|NCT02169414|541929161|FG003|Overall Study|Withdrawal by Subject|0|||
150215992|NCT02169414|541929158|FG000|Overall Study|Adverse Event|0|||
150215993|NCT02169414|541929159|FG001|Overall Study|Adverse Event|1|||
150215994|NCT02169414|541929160|FG002|Overall Study|Adverse Event|0|||
150215995|NCT02169414|541929161|FG003|Overall Study|Adverse Event|0|||
150215996|NCT00578344|541929162|FG000|Overall Study|Insurance problems|1|||
150215997|NCT00578344|541929162|FG000|Overall Study|Graft failure|1|||
150215998|NCT03374254|541929165|FG000|Overall Study|Death|5|||
150215999|NCT03374254|541929166|FG001|Overall Study|Death|16|||
150216000|NCT03374254|541929167|FG002|Overall Study|Death|13|||
150216001|NCT03374254|541929168|FG003|Overall Study|Death|11|||
150216002|NCT03374254|541929169|FG004|Overall Study|Death|9|||
150216003|NCT03374254|541929170|FG005|Overall Study|Death|12|||
150216004|NCT03374254|541929171|FG006|Overall Study|Death|11|||
150216005|NCT03374254|541929172|FG007|Overall Study|Death|6|||
150216006|NCT03374254|541929173|FG008|Overall Study|Death|7|||
150216007|NCT03374254|541929165|FG000|Overall Study|Lost to Follow-up|0|||
150216008|NCT03374254|541929166|FG001|Overall Study|Lost to Follow-up|0|||
150216009|NCT03374254|541929167|FG002|Overall Study|Lost to Follow-up|0|||
150216010|NCT03374254|541929168|FG003|Overall Study|Lost to Follow-up|0|||
150216011|NCT03374254|541929169|FG004|Overall Study|Lost to Follow-up|0|||
150216012|NCT03374254|541929170|FG005|Overall Study|Lost to Follow-up|0|||
150216013|NCT03374254|541929171|FG006|Overall Study|Lost to Follow-up|2|||
150216014|NCT03374254|541929172|FG007|Overall Study|Lost to Follow-up|0|||
150216015|NCT03374254|541929173|FG008|Overall Study|Lost to Follow-up|0|||
150216016|NCT03374254|541929165|FG000|Overall Study|Sponsor Decision|1|||
150216017|NCT03374254|541929166|FG001|Overall Study|Sponsor Decision|0|||
150216018|NCT03374254|541929167|FG002|Overall Study|Sponsor Decision|2|||
150216019|NCT03374254|541929168|FG003|Overall Study|Sponsor Decision|3|||
150216020|NCT03374254|541929169|FG004|Overall Study|Sponsor Decision|2|||
150216021|NCT03374254|541929170|FG005|Overall Study|Sponsor Decision|3|||
150216022|NCT03374254|541929171|FG006|Overall Study|Sponsor Decision|3|||
150216023|NCT03374254|541929172|FG007|Overall Study|Sponsor Decision|3|||
150216024|NCT03374254|541929173|FG008|Overall Study|Sponsor Decision|4|||
150216025|NCT03374254|541929165|FG000|Overall Study|Withdrawal by Subject|0|||
150216026|NCT03374254|541929166|FG001|Overall Study|Withdrawal by Subject|0|||
150216027|NCT03374254|541929167|FG002|Overall Study|Withdrawal by Subject|0|||
150216028|NCT03374254|541929168|FG003|Overall Study|Withdrawal by Subject|2|||
150216029|NCT03374254|541929169|FG004|Overall Study|Withdrawal by Subject|0|||
150216030|NCT03374254|541929170|FG005|Overall Study|Withdrawal by Subject|1|||
150216031|NCT03374254|541929171|FG006|Overall Study|Withdrawal by Subject|0|||
150216032|NCT03374254|541929172|FG007|Overall Study|Withdrawal by Subject|0|||
150216033|NCT03374254|541929173|FG008|Overall Study|Withdrawal by Subject|0|||
150216034|NCT02309515|541929174|FG000|Overall Study|Withdrawal by Subject|0|||
150216035|NCT02309515|541929175|FG001|Overall Study|Withdrawal by Subject|1|||
150216036|NCT04070105|541929182|FG000|Overall Study|Lost to Follow-up|0|||
150216037|NCT04070105|541929183|FG001|Overall Study|Lost to Follow-up|0|||
150216038|NCT04070105|541929184|FG002|Overall Study|Lost to Follow-up|0|||
150216039|NCT04070105|541929185|FG003|Overall Study|Lost to Follow-up|0|||
150216040|NCT04070105|541929186|FG004|Overall Study|Lost to Follow-up|0|||
150216041|NCT04070105|541929187|FG005|Overall Study|Lost to Follow-up|1|||
150216042|NCT00749944|541929195|FG000|Overall Study|Lost to Follow-up|2|||
150216043|NCT00749944|541929196|FG001|Overall Study|Lost to Follow-up|1|||
150216044|NCT00749944|541929195|FG000|Overall Study|Other|1|||
150216045|NCT00749944|541929196|FG001|Overall Study|Other|0|||
150216046|NCT00749944|541929195|FG000|Overall Study|Withdrawal by Subject|2|||
150216047|NCT00749944|541929196|FG001|Overall Study|Withdrawal by Subject|0|||
150216048|NCT02547974|541929197|FG000|Overall Study|Withdrawal by Subject|1|||
150216049|NCT02547974|541929198|FG001|Overall Study|Withdrawal by Subject|0|||
150216050|NCT02547974|541929199|FG002|Overall Study|Withdrawal by Subject|0|||
150216051|NCT02547974|541929200|FG003|Overall Study|Withdrawal by Subject|0|||
150216052|NCT00923078|541929204|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
150216053|NCT00923078|541929205|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
150216054|NCT00923078|541929206|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
150216055|NCT00923078|541929204|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
150216056|NCT00923078|541929205|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
150216057|NCT00923078|541929206|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
150216058|NCT01102426|541929207|FG000|Overall Study|Randomized but not treated|4|||
150216059|NCT01102426|541929208|FG001|Overall Study|Randomized but not treated|1|||
150216060|NCT01102426|541929207|FG000|Overall Study|Adverse Events (treatment-related)|15|||
150216061|NCT01102426|541929208|FG001|Overall Study|Adverse Events (treatment-related)|8|||
150216062|NCT01102426|541929207|FG000|Overall Study|Physician Decision|9|||
150216063|NCT01102426|541929208|FG001|Overall Study|Physician Decision|6|||
150216064|NCT01102426|541929207|FG000|Overall Study|Progressive Disease|85|||
150216065|NCT01102426|541929208|FG001|Overall Study|Progressive Disease|44|||
150216066|NCT01102426|541929207|FG000|Overall Study|Adverse Events (unrelated to|9|||
150216067|NCT01102426|541929208|FG001|Overall Study|Adverse Events (unrelated to|1|||
150216068|NCT01102426|541929207|FG000|Overall Study|Patient Refusal|24|||
150216069|NCT01102426|541929208|FG001|Overall Study|Patient Refusal|12|||
150216070|NCT01102426|541929207|FG000|Overall Study|Death (due to adverse events|0|||
150216071|NCT01102426|541929208|FG001|Overall Study|Death (due to adverse events|1|||
150216072|NCT01102426|541929207|FG000|Overall Study|Death (non-related to the study|19|||
150216073|NCT01102426|541929208|FG001|Overall Study|Death (non-related to the study|8|||
150216074|NCT01393964|541929209|FG000|Overall Study|Disease Progression|4|||
150216075|NCT01393964|541929210|FG001|Overall Study|Disease Progression|3|||
150216076|NCT01393964|541929211|FG002|Overall Study|Disease Progression|5|||
150216077|NCT01393964|541929209|FG000|Overall Study|Study drug toxicity|1|||
150216078|NCT01393964|541929210|FG001|Overall Study|Study drug toxicity|0|||
150216079|NCT01393964|541929211|FG002|Overall Study|Study drug toxicity|0|||
150216080|NCT01393964|541929209|FG000|Overall Study|Withdrawal by Subject|0|||
150216081|NCT01393964|541929210|FG001|Overall Study|Withdrawal by Subject|0|||
150216082|NCT01393964|541929211|FG002|Overall Study|Withdrawal by Subject|1|||
150216083|NCT01393964|541929209|FG000|Overall Study|Adverse event unrelated to study drug|0|||
150216084|NCT01393964|541929210|FG001|Overall Study|Adverse event unrelated to study drug|3|||
150216085|NCT01393964|541929211|FG002|Overall Study|Adverse event unrelated to study drug|0|||
150216086|NCT01393964|541929209|FG000|Overall Study|Subject request stop study treatment|0|||
150216087|NCT01393964|541929210|FG001|Overall Study|Subject request stop study treatment|1|||
150216088|NCT01393964|541929211|FG002|Overall Study|Subject request stop study treatment|0|||
150216089|NCT01393964|541929209|FG000|Overall Study|Subject decided to move to transplant|1|||
150216090|NCT01393964|541929210|FG001|Overall Study|Subject decided to move to transplant|0|||
150216091|NCT01393964|541929211|FG002|Overall Study|Subject decided to move to transplant|0|||
150216092|NCT01393964|541929209|FG000|Overall Study|Subject switched to commercial supply|1|||
150216093|NCT01393964|541929210|FG001|Overall Study|Subject switched to commercial supply|0|||
150216094|NCT01393964|541929211|FG002|Overall Study|Subject switched to commercial supply|2|||
150216095|NCT01393964|541929209|FG000|Overall Study|Subject plateaued in terms of effect|1|||
150216096|NCT01393964|541929210|FG001|Overall Study|Subject plateaued in terms of effect|0|||
150216097|NCT01393964|541929211|FG002|Overall Study|Subject plateaued in terms of effect|0|||
150216098|NCT01393964|541929209|FG000|Overall Study|Investigator removed subject from study|0|||
150216099|NCT01393964|541929210|FG001|Overall Study|Investigator removed subject from study|1|||
150216100|NCT01393964|541929211|FG002|Overall Study|Investigator removed subject from study|0|||
150216101|NCT01393964|541929209|FG000|Overall Study|Subject converted to roll-over study|0|||
150216102|NCT01393964|541929210|FG001|Overall Study|Subject converted to roll-over study|1|||
150216103|NCT01393964|541929211|FG002|Overall Study|Subject converted to roll-over study|0|||
150216104|NCT01393964|541929209|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
150216105|NCT01393964|541929210|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
150216106|NCT01393964|541929211|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
150216107|NCT02988713|541929212|FG000|Overall Study|Withdrawal by Subject|1|||
150216108|NCT02988713|541929212|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
150216109|NCT04679675|541929213|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
150216110|NCT04679675|541929214|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
150216111|NCT04679675|541929215|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
150216112|NCT04679675|541929216|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
150216113|NCT04679675|541929213|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
150216114|NCT04679675|541929214|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
150216115|NCT04679675|541929215|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
150216116|NCT04679675|541929216|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
150216117|NCT03265132|541929218|FG000|Overall Study|Adverse Event|0|||
150216118|NCT03265132|541929219|FG001|Overall Study|Adverse Event|1|||
150216119|NCT03265132|541929218|FG000|Overall Study|Lack of Efficacy|0|||
150216120|NCT03265132|541929219|FG001|Overall Study|Lack of Efficacy|2|||
150216121|NCT03265132|541929218|FG000|Overall Study|Progressive disease|0|||
150216122|NCT03265132|541929219|FG001|Overall Study|Progressive disease|2|||
150216123|NCT03265132|541929218|FG000|Overall Study|Withdrawal by Subject|0|||
150216124|NCT03265132|541929219|FG001|Overall Study|Withdrawal by Subject|1|||
150216125|NCT03909100|541929222|FG000|Overall Study|Protocol Deviation|2|||
150216126|NCT03909100|541929222|FG000|Overall Study|Technical Problems|4|||
150216127|NCT03909100|541929222|FG000|Overall Study|Withdrawal by Subject|4|||
150216128|NCT03909100|541929222|FG000|Overall Study|Lost to Follow-up|1|||
150216129|NCT03909100|541929222|FG000|Overall Study|Reason not Specified|4|||
150216130|NCT01263496|541929225|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
150216131|NCT01263496|541929226|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216132|NCT01263496|541929227|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216133|NCT01263496|541929228|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216134|NCT01263496|541929229|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216135|NCT01263496|541929230|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216136|NCT01263496|541929231|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216137|NCT01263496|541929232|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216138|NCT01263496|541929233|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
150216139|NCT01263496|541929225|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216140|NCT01263496|541929226|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216141|NCT01263496|541929227|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216142|NCT01263496|541929228|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
150216143|NCT01263496|541929229|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
150216144|NCT01263496|541929230|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216145|NCT01263496|541929231|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216146|NCT01263496|541929232|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216147|NCT01263496|541929233|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
150216148|NCT01263496|541929225|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
150216149|NCT01263496|541929226|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
150216150|NCT01263496|541929227|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
150216151|NCT01263496|541929228|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
150216152|NCT01263496|541929229|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
150216153|NCT01263496|541929230|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
150216154|NCT01263496|541929231|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
150216155|NCT01263496|541929232|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
150216156|NCT01263496|541929233|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
150216157|NCT01263496|541929225|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216158|NCT01263496|541929226|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
150216159|NCT01263496|541929227|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216160|NCT01263496|541929228|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216161|NCT01263496|541929229|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216162|NCT01263496|541929230|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216163|NCT01263496|541929231|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216164|NCT01263496|541929232|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216165|NCT01263496|541929233|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150216166|NCT01263496|541929225|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
150216167|NCT01263496|541929226|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
150216168|NCT01263496|541929227|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
150216169|NCT01263496|541929228|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
150216170|NCT01263496|541929229|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
150216171|NCT01263496|541929230|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
150216172|NCT01263496|541929231|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
150216173|NCT01263496|541929232|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
150216174|NCT01263496|541929233|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
150216175|NCT01263496|541929225|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
150216176|NCT01263496|541929226|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
150216177|NCT01263496|541929227|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
150216178|NCT01263496|541929228|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
150216179|NCT01263496|541929229|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
150216180|NCT01263496|541929230|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
150216181|NCT01263496|541929231|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
150216182|NCT01263496|541929232|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
150216183|NCT01263496|541929233|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
150216184|NCT01263496|541929225|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216185|NCT01263496|541929226|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216186|NCT01263496|541929227|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216187|NCT01263496|541929228|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216188|NCT01263496|541929229|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216189|NCT01263496|541929230|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216190|NCT01263496|541929231|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216191|NCT01263496|541929232|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
150216192|NCT01263496|541929233|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150216193|NCT00266656|541929240|FG000|Overall Study|Death|1|||
150216194|NCT00266656|541929241|FG001|Overall Study|Death|0|||
150216195|NCT00266656|541929240|FG000|Overall Study|Lost to Follow-up|4|||
150216196|NCT00266656|541929241|FG001|Overall Study|Lost to Follow-up|1|||
150216197|NCT00266656|541929240|FG000|Overall Study|Withdrawal by Subject|4|||
150216198|NCT00266656|541929241|FG001|Overall Study|Withdrawal by Subject|2|||
150216199|NCT00266656|541929240|FG000|Overall Study|Did Not Reach Final Height|4|||
150216200|NCT00266656|541929241|FG001|Overall Study|Did Not Reach Final Height|8|||
150216201|NCT00266656|541929240|FG000|Overall Study|Parent/Caregiver Decision|1|||
150216202|NCT00266656|541929241|FG001|Overall Study|Parent/Caregiver Decision|2|||
150216203|NCT03242863|541929242|FG000|Study Week 1|Withdrawal by Subject|0|||
150216204|NCT03242863|541929243|FG001|Study Week 1|Withdrawal by Subject|1|||
150216205|NCT03242863|541929244|FG002|Study Week 1|Withdrawal by Subject|0|||
150216206|NCT03242863|541929245|FG003|Study Week 1|Withdrawal by Subject|0|||
150216207|NCT03242863|541929246|FG004|Study Week 1|Withdrawal by Subject|3|||
150216208|NCT03242863|541929247|FG005|Study Week 1|Withdrawal by Subject|0|||
150216209|NCT04369664|541930855|FG000|Overall Study|Physician Decision|1|||
150216210|NCT04369664|541930856|FG001|Overall Study|Physician Decision|0|||
150216211|NCT01567852|541930859|FG000|Overall Study|Withdrawal by Subject|3|||
150216212|NCT01567852|541930860|FG001|Overall Study|Withdrawal by Subject|6|||
150216213|NCT01567852|541930859|FG000|Overall Study|ECT discontinued|1|||
150216214|NCT01567852|541930860|FG001|Overall Study|ECT discontinued|1|||
150216215|NCT00215943|541930861|FG000|Overall Study|Disease Progression|3|||
150216216|NCT00215943|541930862|FG001|Overall Study|Disease Progression|5|||
150216217|NCT00215943|541930861|FG000|Overall Study|Alternate therapy|0|||
150216218|NCT00215943|541930862|FG001|Overall Study|Alternate therapy|1|||
150216219|NCT00215943|541930861|FG000|Overall Study|Adverse Event|3|||
150216220|NCT00215943|541930862|FG001|Overall Study|Adverse Event|6|||
150216221|NCT00215943|541930861|FG000|Overall Study|Other disease|0|||
150216222|NCT00215943|541930862|FG001|Overall Study|Other disease|1|||
150216223|NCT00215943|541930861|FG000|Overall Study|Other complications|3|||
150216224|NCT00215943|541930862|FG001|Overall Study|Other complications|1|||
150216225|NCT00443820|541930863|FG000|Overall Study|Adverse Event|1|||
150216226|NCT00443820|541930864|FG001|Overall Study|Adverse Event|1|||
150216227|NCT00443820|541930865|FG002|Overall Study|Adverse Event|0|||
150216228|NCT00443820|541930866|FG003|Overall Study|Adverse Event|0|||
150216229|NCT00443820|541930863|FG000|Overall Study|Lack of Efficacy|3|||
150216230|NCT00443820|541930864|FG001|Overall Study|Lack of Efficacy|2|||
150216231|NCT00443820|541930865|FG002|Overall Study|Lack of Efficacy|1|||
150216232|NCT00443820|541930866|FG003|Overall Study|Lack of Efficacy|1|||
150216233|NCT00443820|541930863|FG000|Overall Study|Protocol Violation|2|||
150216234|NCT00443820|541930864|FG001|Overall Study|Protocol Violation|1|||
150216235|NCT00443820|541930865|FG002|Overall Study|Protocol Violation|2|||
150216236|NCT00443820|541930866|FG003|Overall Study|Protocol Violation|1|||
150216237|NCT00443820|541930863|FG000|Overall Study|Withdrawal by Subject|6|||
150216238|NCT00443820|541930864|FG001|Overall Study|Withdrawal by Subject|7|||
150216239|NCT00443820|541930865|FG002|Overall Study|Withdrawal by Subject|8|||
150216240|NCT00443820|541930866|FG003|Overall Study|Withdrawal by Subject|9|||
150216241|NCT00443820|541930863|FG000|Overall Study|Lost to Follow-up|9|||
150216242|NCT00443820|541930864|FG001|Overall Study|Lost to Follow-up|8|||
150216243|NCT00443820|541930865|FG002|Overall Study|Lost to Follow-up|6|||
150216244|NCT00443820|541930866|FG003|Overall Study|Lost to Follow-up|5|||
150216245|NCT00443820|541930863|FG000|Overall Study|Administrative problems|0|||
150216246|NCT00443820|541930864|FG001|Overall Study|Administrative problems|0|||
150216247|NCT00443820|541930865|FG002|Overall Study|Administrative problems|0|||
150216248|NCT00443820|541930866|FG003|Overall Study|Administrative problems|1|||
150216249|NCT00443820|541930863|FG000|Overall Study|Death|0|||
150216250|NCT00443820|541930864|FG001|Overall Study|Death|0|||
150216251|NCT00443820|541930865|FG002|Overall Study|Death|1|||
150216252|NCT00443820|541930866|FG003|Overall Study|Death|0|||
150216253|NCT01686152|541930872|FG000|Overall Study|Withdrawal by Subject|11|||
150216254|NCT01686152|541930873|FG001|Overall Study|Withdrawal by Subject|11|||
150216255|NCT01686152|541930874|FG002|Overall Study|Withdrawal by Subject|3|||
150216256|NCT01686152|541930872|FG000|Overall Study|Drug Code Unblinded|0|||
150216257|NCT01686152|541930873|FG001|Overall Study|Drug Code Unblinded|1|||
150216258|NCT01686152|541930874|FG002|Overall Study|Drug Code Unblinded|0|||
150216259|NCT01686152|541930872|FG000|Overall Study|Protocol Violation|6|||
150216260|NCT01686152|541930873|FG001|Overall Study|Protocol Violation|1|||
150216261|NCT01686152|541930874|FG002|Overall Study|Protocol Violation|0|||
150216262|NCT01686152|541930872|FG000|Overall Study|Adverse Event|12|||
150216263|NCT01686152|541930873|FG001|Overall Study|Adverse Event|11|||
150216264|NCT01686152|541930874|FG002|Overall Study|Adverse Event|0|||
150216265|NCT01686152|541930872|FG000|Overall Study|Lack of Efficacy|0|||
150216266|NCT01686152|541930873|FG001|Overall Study|Lack of Efficacy|0|||
150216267|NCT01686152|541930874|FG002|Overall Study|Lack of Efficacy|1|||
150216268|NCT01686152|541930872|FG000|Overall Study|IP Non-compliance|5|||
150216269|NCT01686152|541930873|FG001|Overall Study|IP Non-compliance|5|||
150216270|NCT01686152|541930874|FG002|Overall Study|IP Non-compliance|0|||
150216271|NCT01686152|541930872|FG000|Overall Study|Lost to Follow-up|7|||
150216272|NCT01686152|541930873|FG001|Overall Study|Lost to Follow-up|6|||
150216273|NCT01686152|541930874|FG002|Overall Study|Lost to Follow-up|5|||
150216274|NCT00929526|541930875|FG000|Overall Study|Withdrawal by Subject|1|||
150216275|NCT00929526|541930876|FG001|Overall Study|Withdrawal by Subject|11|||
150216276|NCT00929526|541930875|FG000|Overall Study|Lost to Follow-up|8|||
150216277|NCT00929526|541930876|FG001|Overall Study|Lost to Follow-up|12|||
150216278|NCT00929526|541930875|FG000|Overall Study|Other|8|||
150216279|NCT00929526|541930876|FG001|Overall Study|Other|6|||
150216280|NCT04803734|541930879|FG000|Overall Study|Withdrawal by Subject|0|||
150216281|NCT04803734|541930880|FG001|Overall Study|Withdrawal by Subject|1|||
150216282|NCT04803734|541930879|FG000|Overall Study|Protocol Violation|0|||
150216283|NCT04803734|541930880|FG001|Overall Study|Protocol Violation|1|||
150216284|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
150216285|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
150216286|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
150216287|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
150216288|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Adverse Event|7|||
150216289|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Adverse Event|8|||
150216290|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Adverse Event|8|||
150216291|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Adverse Event|9|||
150216292|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
150216293|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
150216294|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
150216295|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
150216296|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
150216297|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
150216298|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
150216299|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
150216300|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Pregnancy|0|||
150216301|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Pregnancy|2|||
150216302|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Pregnancy|2|||
150216303|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Pregnancy|0|||
150216304|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Non-compliance|1|||
150216305|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Non-compliance|0|||
150216306|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Non-compliance|0|||
150216307|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Non-compliance|3|||
150216308|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Other|3|||
150216309|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Other|0|||
150216310|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Other|3|||
150216311|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Other|2|||
150216312|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
150216313|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
150216314|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
150216315|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
150216316|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
150216317|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
150216318|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
150216319|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
150216320|NCT02143713|541930882|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
150216321|NCT02143713|541930883|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
150216322|NCT02143713|541930884|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
150216323|NCT02143713|541930885|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
150216324|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
150216325|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
150216326|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
150216327|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
150216328|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
150216329|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
150216330|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
150216331|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
150216332|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
150216333|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
150216334|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
150216335|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
150216336|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
150216337|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
150216338|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
150216339|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
150216340|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
150216341|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
150216342|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
150216343|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
150216344|NCT02143713|541930882|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
150216345|NCT02143713|541930883|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
150216346|NCT02143713|541930884|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
150216347|NCT02143713|541930885|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
150216348|NCT01768572|541930888|FG000|Overall Study|Adverse Event|7|||
150216349|NCT01768572|541930889|FG001|Overall Study|Adverse Event|8|||
150216350|NCT01768572|541930890|FG002|Overall Study|Adverse Event|4|||
150216351|NCT01768572|541930888|FG000|Overall Study|Lack of Efficacy|1|||
150216352|NCT01768572|541930889|FG001|Overall Study|Lack of Efficacy|3|||
150216353|NCT01768572|541930890|FG002|Overall Study|Lack of Efficacy|1|||
150216354|NCT01768572|541930888|FG000|Overall Study|Other, Not due to an adverse event|1|||
150216355|NCT01768572|541930889|FG001|Overall Study|Other, Not due to an adverse event|1|||
150216356|NCT01768572|541930890|FG002|Overall Study|Other, Not due to an adverse event|1|||
150216357|NCT02245620|541930891|FG000|Overall Study|Physician Decision|1|||
150216358|NCT02245620|541930892|FG001|Overall Study|Physician Decision|1|||
150216359|NCT01999335|541930893|FG000|Overall Study|Discontinued before receiving treatment|0|||
150216360|NCT01999335|541930894|FG001|Overall Study|Discontinued before receiving treatment|0|||
150216361|NCT01999335|541930895|FG002|Overall Study|Discontinued before receiving treatment|0|||
150216362|NCT01999335|541930896|FG003|Overall Study|Discontinued before receiving treatment|0|||
150216363|NCT01999335|541930897|FG004|Overall Study|Discontinued before receiving treatment|2|||
150216364|NCT04766996|541930898|FG000|Overall Study|Withdrawal by Subject|1|||
150216365|NCT04766996|541930899|FG001|Overall Study|Withdrawal by Subject|0|||
150216366|NCT04766996|541930900|FG002|Overall Study|Withdrawal by Subject|13|||
150216367|NCT00080119|541930901|FG000|Overall Study|Discontinued because of study closure|0|||
150216368|NCT00080119|541930902|FG001|Overall Study|Discontinued because of study closure|0|||
150216369|NCT00080119|541930903|FG002|Overall Study|Discontinued because of study closure|130|||
150216370|NCT00080119|541930904|FG003|Overall Study|Discontinued because of study closure|141|||
150216371|NCT00080119|541930901|FG000|Overall Study|Unable to get to clinic|24|||
150216372|NCT00080119|541930902|FG001|Overall Study|Unable to get to clinic|24|||
150216373|NCT00080119|541930903|FG002|Overall Study|Unable to get to clinic|7|||
150216374|NCT00080119|541930904|FG003|Overall Study|Unable to get to clinic|1|||
150216375|NCT00080119|541930901|FG000|Overall Study|Consent withdrawn|13|||
150216376|NCT00080119|541930902|FG001|Overall Study|Consent withdrawn|17|||
150216377|NCT00080119|541930903|FG002|Overall Study|Consent withdrawn|4|||
150216378|NCT00080119|541930904|FG003|Overall Study|Consent withdrawn|6|||
150216379|NCT00080119|541930901|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
150216380|NCT00080119|541930902|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
150216381|NCT00080119|541930903|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
150216382|NCT00080119|541930904|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
150216383|NCT00080119|541930901|FG000|Overall Study|Lost to Follow-up|16|||
150216384|NCT00080119|541930902|FG001|Overall Study|Lost to Follow-up|19|||
150216385|NCT00080119|541930903|FG002|Overall Study|Lost to Follow-up|19|||
150216386|NCT00080119|541930904|FG003|Overall Study|Lost to Follow-up|14|||
150216387|NCT01322386|541930905|FG000|Overall Study|Protocol Violation|0|||
150216388|NCT01322386|541930906|FG001|Overall Study|Protocol Violation|1|||
150216389|NCT01322386|541930905|FG000|Overall Study|Physician Decision|0|||
150216390|NCT01322386|541930906|FG001|Overall Study|Physician Decision|1|||
150216391|NCT00871494|541930915|FG000|Overall Study|Protocol Violation|5|||
150216392|NCT00871494|541930915|FG000|Overall Study|Lack of Efficacy|4|||
150216393|NCT00871494|541930915|FG000|Overall Study|Adverse Event|4|||
150216394|NCT00871494|541930915|FG000|Overall Study|Lost to Follow-up|1|||
150216395|NCT00889863|541930919|FG000|Part I: Open Label|Death|1|||
150216396|NCT00889863|541930920|FG001|Part I: Open Label|Death|0|||
150216397|NCT00889863|541930919|FG000|Part I: Open Label|Adverse Event|4|||
150216398|NCT00889863|541930920|FG001|Part I: Open Label|Adverse Event|0|||
150216399|NCT00889863|541930919|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
150216400|NCT00889863|541930920|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
150216401|NCT00889863|541930919|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
150216402|NCT00889863|541930920|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
150216403|NCT00889863|541930919|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
150216404|NCT00889863|541930920|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
150216405|NCT00889863|541930919|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
150216406|NCT00889863|541930920|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
150216407|NCT00889863|541930919|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
150216408|NCT00889863|541930920|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
150216409|NCT04410445|541930929|FG000|Overall Study|Lost to Follow-up|3|||
150216410|NCT04410445|541930930|FG001|Overall Study|Lost to Follow-up|9|||
150216411|NCT04410445|541930929|FG000|Overall Study|Withdrawal by Subject|27|||
150216412|NCT04410445|541930930|FG001|Overall Study|Withdrawal by Subject|15|||
150216413|NCT01320683|541930931|FG000|Overall Study|Positive antibody response|1|||
150216414|NCT02291861|541930932|FG000|Overall Study|Adverse Event|2|||
150216415|NCT02291861|541930933|FG001|Overall Study|Adverse Event|4|||
150216416|NCT02291861|541930934|FG002|Overall Study|Adverse Event|1|||
150216417|NCT02291861|541930935|FG003|Overall Study|Adverse Event|2|||
150216418|NCT02291861|541930932|FG000|Overall Study|Death|0|||
150216419|NCT02291861|541930933|FG001|Overall Study|Death|0|||
150216420|NCT02291861|541930934|FG002|Overall Study|Death|1|||
150216421|NCT02291861|541930935|FG003|Overall Study|Death|1|||
150216422|NCT02291861|541930932|FG000|Overall Study|Protocol Violation|1|||
150216423|NCT02291861|541930933|FG001|Overall Study|Protocol Violation|0|||
150216424|NCT02291861|541930934|FG002|Overall Study|Protocol Violation|0|||
150216425|NCT02291861|541930935|FG003|Overall Study|Protocol Violation|1|||
150216426|NCT02291861|541930932|FG000|Overall Study|Withdrawal by Subject|1|||
150216427|NCT02291861|541930933|FG001|Overall Study|Withdrawal by Subject|2|||
150216428|NCT02291861|541930934|FG002|Overall Study|Withdrawal by Subject|1|||
150216429|NCT02291861|541930935|FG003|Overall Study|Withdrawal by Subject|4|||
150216430|NCT02291861|541930932|FG000|Overall Study|Noncompliance|1|||
150216431|NCT02291861|541930933|FG001|Overall Study|Noncompliance|1|||
150216432|NCT02291861|541930934|FG002|Overall Study|Noncompliance|2|||
150216433|NCT02291861|541930935|FG003|Overall Study|Noncompliance|1|||
150216434|NCT02291861|541930932|FG000|Overall Study|Lost to Follow-up|2|||
150216435|NCT02291861|541930933|FG001|Overall Study|Lost to Follow-up|1|||
150216436|NCT02291861|541930934|FG002|Overall Study|Lost to Follow-up|4|||
150216437|NCT02291861|541930935|FG003|Overall Study|Lost to Follow-up|0|||
150216438|NCT02291861|541930932|FG000|Overall Study|Other|0|||
150216439|NCT02291861|541930933|FG001|Overall Study|Other|0|||
150216440|NCT02291861|541930934|FG002|Overall Study|Other|0|||
150216441|NCT02291861|541930935|FG003|Overall Study|Other|1|||
150216442|NCT03547154|541930943|FG000|Overall Study|Disease Progression/Recurrence|6|||
150216443|NCT03547154|541930944|FG001|Overall Study|Disease Progression/Recurrence|14|||
150216444|NCT03547154|541930943|FG000|Overall Study|Adverse Event|26|||
150216445|NCT03547154|541930944|FG001|Overall Study|Adverse Event|31|||
150216446|NCT03547154|541930943|FG000|Overall Study|Protocol Violation|6|||
150216447|NCT03547154|541930944|FG001|Overall Study|Protocol Violation|1|||
150216448|NCT03547154|541930943|FG000|Overall Study|Physician Decision|4|||
150216449|NCT03547154|541930944|FG001|Overall Study|Physician Decision|3|||
150216450|NCT03547154|541930943|FG000|Overall Study|Insufficient Therapeutic Response|13|||
150216451|NCT03547154|541930944|FG001|Overall Study|Insufficient Therapeutic Response|10|||
150216452|NCT03547154|541930943|FG000|Overall Study|Withdrawal by Subject|10|||
150216453|NCT03547154|541930944|FG001|Overall Study|Withdrawal by Subject|6|||
150216454|NCT03547154|541930943|FG000|Overall Study|Not Selected|0|||
150216455|NCT03547154|541930944|FG001|Overall Study|Not Selected|1|||
150216456|NCT03547154|541930943|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
150216457|NCT03547154|541930944|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
150216458|NCT02404441|541930945|FG000|Phase 1 Part|Adverse Event|1|||
150216459|NCT02404441|541930946|FG001|Phase 1 Part|Adverse Event|0|||
150216460|NCT02404441|541930947|FG002|Phase 1 Part|Adverse Event|0|||
150216461|NCT02404441|541930948|FG003|Phase 1 Part|Adverse Event|0|||
150216462|NCT02404441|541930949|FG004|Phase 1 Part|Adverse Event|0|||
150216463|NCT02404441|541930950|FG005|Phase 1 Part|Adverse Event|0|||
150216464|NCT02404441|541930951|FG006|Phase 1 Part|Adverse Event|0|||
150216465|NCT02404441|541930952|FG007|Phase 1 Part|Adverse Event|0|||
150216466|NCT02404441|541930953|FG008|Phase 1 Part|Adverse Event|0|||
150216467|NCT02404441|541930954|FG009|Phase 1 Part|Adverse Event|0|||
150216468|NCT02404441|541930945|FG000|Phase 1 Part|Physician Decision|0|||
150216469|NCT02404441|541930946|FG001|Phase 1 Part|Physician Decision|1|||
150216470|NCT02404441|541930947|FG002|Phase 1 Part|Physician Decision|0|||
150216471|NCT02404441|541930948|FG003|Phase 1 Part|Physician Decision|0|||
150216472|NCT02404441|541930949|FG004|Phase 1 Part|Physician Decision|0|||
150216473|NCT02404441|541930950|FG005|Phase 1 Part|Physician Decision|0|||
150216474|NCT02404441|541930951|FG006|Phase 1 Part|Physician Decision|0|||
150216475|NCT02404441|541930952|FG007|Phase 1 Part|Physician Decision|0|||
150216476|NCT02404441|541930953|FG008|Phase 1 Part|Physician Decision|0|||
150216477|NCT02404441|541930954|FG009|Phase 1 Part|Physician Decision|0|||
150216478|NCT02404441|541930945|FG000|Phase 1 Part|Progressive Disease|14|||
150216479|NCT02404441|541930946|FG001|Phase 1 Part|Progressive Disease|11|||
150216480|NCT02404441|541930947|FG002|Phase 1 Part|Progressive Disease|7|||
150216481|NCT02404441|541930948|FG003|Phase 1 Part|Progressive Disease|6|||
150216482|NCT02404441|541930949|FG004|Phase 1 Part|Progressive Disease|9|||
150216483|NCT02404441|541930950|FG005|Phase 1 Part|Progressive Disease|0|||
150216484|NCT02404441|541930951|FG006|Phase 1 Part|Progressive Disease|0|||
150216485|NCT02404441|541930952|FG007|Phase 1 Part|Progressive Disease|0|||
150216486|NCT02404441|541930953|FG008|Phase 1 Part|Progressive Disease|0|||
150216487|NCT02404441|541930954|FG009|Phase 1 Part|Progressive Disease|0|||
150216488|NCT02404441|541930945|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
150216489|NCT02404441|541930946|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
150216490|NCT02404441|541930947|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
150216491|NCT02404441|541930948|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
150140236|NCT00331344|541648778|FG008|Phase I|Adverse Event|0|||
150140237|NCT00331344|541648770|FG000|Phase II|Death|0|||
150140238|NCT00331344|541648771|FG001|Phase II|Death|0|||
150140239|NCT00331344|541648772|FG002|Phase II|Death|0|||
150140240|NCT00331344|541648773|FG003|Phase II|Death|0|||
150140241|NCT00331344|541648774|FG004|Phase II|Death|0|||
150140242|NCT00331344|541648775|FG005|Phase II|Death|0|||
150140243|NCT00331344|541648776|FG006|Phase II|Death|0|||
150140244|NCT00331344|541648777|FG007|Phase II|Death|0|||
150140245|NCT00331344|541648778|FG008|Phase II|Death|4|||
150140246|NCT03633929|541648781|FG000|Overall Study|Lost to Follow-up|1|||
150140247|NCT03633929|541648781|FG000|Overall Study|Did not login to software. Did not participate|3|||
150140248|NCT02487810|541648782|FG000|Overall Study|Withdrawal by Subject|1|||
150140249|NCT02487810|541648783|FG001|Overall Study|Withdrawal by Subject|0|||
150140250|NCT02889133|541648786|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
150140251|NCT02889133|541648787|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
150140252|NCT02889133|541648786|FG000|Completed Primary Outcome|Manufacturing error|3|||
150216492|NCT02404441|541930949|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
150216493|NCT02404441|541930950|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
150216494|NCT02404441|541930951|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
150216495|NCT02404441|541930952|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
150216496|NCT02404441|541930953|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
150140253|NCT02889133|541648787|FG001|Completed Primary Outcome|Manufacturing error|8|||
150140254|NCT02889133|541648786|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
150216497|NCT02404441|541930954|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
150216498|NCT02404441|541930945|FG000|Phase 1 Part|Death|1|||
150216499|NCT02404441|541930946|FG001|Phase 1 Part|Death|1|||
150216500|NCT02404441|541930947|FG002|Phase 1 Part|Death|1|||
150216501|NCT02404441|541930948|FG003|Phase 1 Part|Death|0|||
150216502|NCT02404441|541930949|FG004|Phase 1 Part|Death|1|||
150216503|NCT02404441|541930950|FG005|Phase 1 Part|Death|0|||
150216504|NCT02404441|541930951|FG006|Phase 1 Part|Death|0|||
150216505|NCT02404441|541930952|FG007|Phase 1 Part|Death|0|||
150216506|NCT02404441|541930953|FG008|Phase 1 Part|Death|0|||
150216507|NCT02404441|541930954|FG009|Phase 1 Part|Death|0|||
150216508|NCT02404441|541930945|FG000|Phase 2 Part|Adverse Event|0|||
150216509|NCT02404441|541930946|FG001|Phase 2 Part|Adverse Event|0|||
150216510|NCT02404441|541930947|FG002|Phase 2 Part|Adverse Event|0|||
150216511|NCT02404441|541930948|FG003|Phase 2 Part|Adverse Event|0|||
150216512|NCT02404441|541930949|FG004|Phase 2 Part|Adverse Event|0|||
150216513|NCT02404441|541930950|FG005|Phase 2 Part|Adverse Event|2|||
150216514|NCT02404441|541930951|FG006|Phase 2 Part|Adverse Event|3|||
150216515|NCT02404441|541930952|FG007|Phase 2 Part|Adverse Event|3|||
150216516|NCT02404441|541930953|FG008|Phase 2 Part|Adverse Event|6|||
150216517|NCT02404441|541930954|FG009|Phase 2 Part|Adverse Event|1|||
150216518|NCT02404441|541930945|FG000|Phase 2 Part|Physician Decision|0|||
150216519|NCT02404441|541930946|FG001|Phase 2 Part|Physician Decision|0|||
150216520|NCT02404441|541930947|FG002|Phase 2 Part|Physician Decision|0|||
150216521|NCT02404441|541930948|FG003|Phase 2 Part|Physician Decision|0|||
150216522|NCT02404441|541930949|FG004|Phase 2 Part|Physician Decision|0|||
150216523|NCT02404441|541930950|FG005|Phase 2 Part|Physician Decision|7|||
150216524|NCT02404441|541930951|FG006|Phase 2 Part|Physician Decision|9|||
150216525|NCT02404441|541930952|FG007|Phase 2 Part|Physician Decision|2|||
150216526|NCT02404441|541930953|FG008|Phase 2 Part|Physician Decision|1|||
150216527|NCT02404441|541930954|FG009|Phase 2 Part|Physician Decision|3|||
150216528|NCT02404441|541930945|FG000|Phase 2 Part|Progressive disease|0|||
150216529|NCT02404441|541930946|FG001|Phase 2 Part|Progressive disease|0|||
150216530|NCT02404441|541930947|FG002|Phase 2 Part|Progressive disease|0|||
150216531|NCT02404441|541930948|FG003|Phase 2 Part|Progressive disease|0|||
150216532|NCT02404441|541930949|FG004|Phase 2 Part|Progressive disease|0|||
150216533|NCT02404441|541930950|FG005|Phase 2 Part|Progressive disease|43|||
150216534|NCT02404441|541930951|FG006|Phase 2 Part|Progressive disease|32|||
150216535|NCT02404441|541930952|FG007|Phase 2 Part|Progressive disease|31|||
150216536|NCT02404441|541930953|FG008|Phase 2 Part|Progressive disease|39|||
150216537|NCT02404441|541930954|FG009|Phase 2 Part|Progressive disease|27|||
150216538|NCT02404441|541930945|FG000|Phase 2 Part|Subject/guardian decision|0|||
150216539|NCT02404441|541930946|FG001|Phase 2 Part|Subject/guardian decision|0|||
150216540|NCT02404441|541930947|FG002|Phase 2 Part|Subject/guardian decision|0|||
150216541|NCT02404441|541930948|FG003|Phase 2 Part|Subject/guardian decision|0|||
150216542|NCT02404441|541930949|FG004|Phase 2 Part|Subject/guardian decision|0|||
150216543|NCT02404441|541930950|FG005|Phase 2 Part|Subject/guardian decision|3|||
150216544|NCT02404441|541930951|FG006|Phase 2 Part|Subject/guardian decision|9|||
150216545|NCT02404441|541930952|FG007|Phase 2 Part|Subject/guardian decision|0|||
150216546|NCT02404441|541930953|FG008|Phase 2 Part|Subject/guardian decision|3|||
150216547|NCT02404441|541930954|FG009|Phase 2 Part|Subject/guardian decision|2|||
150216548|NCT02404441|541930945|FG000|Phase 2 Part|Death|0|||
150216549|NCT02404441|541930946|FG001|Phase 2 Part|Death|0|||
150216550|NCT02404441|541930947|FG002|Phase 2 Part|Death|0|||
150216551|NCT02404441|541930948|FG003|Phase 2 Part|Death|0|||
150216552|NCT02404441|541930949|FG004|Phase 2 Part|Death|0|||
150216553|NCT02404441|541930950|FG005|Phase 2 Part|Death|4|||
150216554|NCT02404441|541930951|FG006|Phase 2 Part|Death|8|||
150216555|NCT02404441|541930952|FG007|Phase 2 Part|Death|4|||
150216556|NCT02404441|541930953|FG008|Phase 2 Part|Death|10|||
150216557|NCT02404441|541930954|FG009|Phase 2 Part|Death|9|||
150216558|NCT01918033|541930955|FG000|Overall Study|Adverse Event|1|||
150216559|NCT01918033|541930956|FG001|Overall Study|Adverse Event|0|||
150216560|NCT01918033|541930957|FG002|Overall Study|Adverse Event|2|||
150216561|NCT01918033|541930955|FG000|Overall Study|Lost to Follow-up|0|||
150216562|NCT01918033|541930956|FG001|Overall Study|Lost to Follow-up|1|||
150216563|NCT01918033|541930957|FG002|Overall Study|Lost to Follow-up|0|||
150216564|NCT01918033|541930955|FG000|Overall Study|Protocol Violation|2|||
150216565|NCT01918033|541930956|FG001|Overall Study|Protocol Violation|0|||
150216566|NCT01918033|541930957|FG002|Overall Study|Protocol Violation|1|||
150216567|NCT01918033|541930955|FG000|Overall Study|Withdrawal by Subject|2|||
150216568|NCT01918033|541930956|FG001|Overall Study|Withdrawal by Subject|1|||
150216569|NCT01918033|541930957|FG002|Overall Study|Withdrawal by Subject|0|||
150216570|NCT00088166|541930965|FG000|Overall Study|Adverse Event|11|||
150216571|NCT00088166|541930966|FG001|Overall Study|Adverse Event|9|||
150216572|NCT00088166|541930965|FG000|Overall Study|Death|3|||
150216573|NCT00088166|541930966|FG001|Overall Study|Death|1|||
150216574|NCT00088166|541930965|FG000|Overall Study|Lost to Follow-up|0|||
150216575|NCT00088166|541930966|FG001|Overall Study|Lost to Follow-up|1|||
150216576|NCT00088166|541930965|FG000|Overall Study|Physician Decision|4|||
150216577|NCT00088166|541930966|FG001|Overall Study|Physician Decision|1|||
150216578|NCT00088166|541930965|FG000|Overall Study|Protocol Violation|1|||
150216579|NCT00088166|541930966|FG001|Overall Study|Protocol Violation|5|||
150216580|NCT00088166|541930965|FG000|Overall Study|Patient deterioration|29|||
150216581|NCT00088166|541930966|FG001|Overall Study|Patient deterioration|39|||
150216582|NCT00088166|541930965|FG000|Overall Study|Withdrawal by Subject|5|||
150216583|NCT00088166|541930966|FG001|Overall Study|Withdrawal by Subject|5|||
150216584|NCT02671266|541930967|FG000|Overall Study|Withdrawal by Subject|1|||
150216585|NCT02671266|541930968|FG001|Overall Study|Withdrawal by Subject|1|||
150216586|NCT00666705|541930974|FG000|Overall Study|Withdrawal by Subject|1|||
150216587|NCT01976507|541930975|FG000|Overall Study|Adverse Event|6|||
150216588|NCT01976507|541930975|FG000|Overall Study|ablation not done, drug not given|1|||
150216589|NCT01794299|541930977|FG000|Overall Study|ATIR manufacturing not possible|1|||
150216590|NCT01794299|541930977|FG000|Overall Study|Death|14|||
150216591|NCT01794299|541930977|FG000|Overall Study|Graft failure|1|||
150216592|NCT01794299|541930977|FG000|Overall Study|ATIR batch rejected|2|||
150216593|NCT01794299|541930977|FG000|Overall Study|Relapse|2|||
150216594|NCT01794299|541930977|FG000|Overall Study|Discontinued from active follow-up|1|||
150216595|NCT01794299|541930977|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
150216596|NCT01029704|541930979|FG000|Overall Study|Adverse Event|0|||
150216597|NCT01029704|541930980|FG001|Overall Study|Adverse Event|0|||
150216598|NCT01029704|541930981|FG002|Overall Study|Adverse Event|0|||
150216599|NCT01029704|541930982|FG003|Overall Study|Adverse Event|0|||
150216600|NCT01029704|541930983|FG004|Overall Study|Adverse Event|0|||
150216601|NCT01029704|541930984|FG005|Overall Study|Adverse Event|0|||
150216602|NCT01029704|541930985|FG006|Overall Study|Adverse Event|1|||
150216603|NCT01029704|541930986|FG007|Overall Study|Adverse Event|1|||
150216604|NCT01029704|541930987|FG008|Overall Study|Adverse Event|0|||
150216605|NCT01029704|541930979|FG000|Overall Study|Withdrawal by Subject|0|||
150216606|NCT01029704|541930980|FG001|Overall Study|Withdrawal by Subject|0|||
150216607|NCT01029704|541930981|FG002|Overall Study|Withdrawal by Subject|0|||
150216608|NCT01029704|541930982|FG003|Overall Study|Withdrawal by Subject|0|||
150216609|NCT01029704|541930983|FG004|Overall Study|Withdrawal by Subject|2|||
150216610|NCT01029704|541930984|FG005|Overall Study|Withdrawal by Subject|1|||
150216611|NCT01029704|541930985|FG006|Overall Study|Withdrawal by Subject|1|||
150216612|NCT01029704|541930986|FG007|Overall Study|Withdrawal by Subject|1|||
150216613|NCT01029704|541930987|FG008|Overall Study|Withdrawal by Subject|0|||
150216614|NCT01029704|541930979|FG000|Overall Study|Lost to Follow-up|0|||
150216615|NCT01029704|541930980|FG001|Overall Study|Lost to Follow-up|0|||
150216616|NCT01029704|541930981|FG002|Overall Study|Lost to Follow-up|0|||
150216617|NCT01029704|541930982|FG003|Overall Study|Lost to Follow-up|0|||
150216618|NCT01029704|541930983|FG004|Overall Study|Lost to Follow-up|0|||
150216619|NCT01029704|541930984|FG005|Overall Study|Lost to Follow-up|0|||
150216620|NCT01029704|541930985|FG006|Overall Study|Lost to Follow-up|1|||
150216621|NCT01029704|541930986|FG007|Overall Study|Lost to Follow-up|1|||
150216622|NCT01029704|541930987|FG008|Overall Study|Lost to Follow-up|1|||
150216623|NCT01029704|541930979|FG000|Overall Study|Lack of Efficacy|0|||
150216624|NCT01029704|541930980|FG001|Overall Study|Lack of Efficacy|0|||
150216625|NCT01029704|541930981|FG002|Overall Study|Lack of Efficacy|0|||
150216626|NCT01029704|541930982|FG003|Overall Study|Lack of Efficacy|0|||
150216627|NCT01029704|541930983|FG004|Overall Study|Lack of Efficacy|2|||
150216628|NCT01029704|541930984|FG005|Overall Study|Lack of Efficacy|3|||
150216629|NCT01029704|541930985|FG006|Overall Study|Lack of Efficacy|1|||
150216630|NCT01029704|541930986|FG007|Overall Study|Lack of Efficacy|2|||
150216631|NCT01029704|541930987|FG008|Overall Study|Lack of Efficacy|0|||
150216632|NCT01029704|541930979|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
150216633|NCT01029704|541930980|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
150216634|NCT01029704|541930981|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
150216635|NCT01029704|541930982|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
150216636|NCT01029704|541930983|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
150216637|NCT01029704|541930984|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
150216638|NCT01029704|541930985|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
150216639|NCT01029704|541930986|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
150216640|NCT01029704|541930987|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
150216641|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
150216642|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
150216643|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
150216644|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
150216645|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Death|0|||
150216646|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Death|0|||
150216647|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Death|1|||
150216648|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Death|0|||
150216649|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
150216650|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
150216651|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
150216652|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
150216653|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
150216654|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
150216655|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
150216656|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
150216657|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
150216658|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
150216659|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
150216660|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
150216661|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
150216662|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
150216663|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
150216664|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
150216665|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
150216666|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
150216667|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
150216668|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
150216669|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Other|2|||
150216670|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Other|0|||
150216671|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Other|0|||
150216672|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Other|0|||
150216673|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
150216674|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
150216675|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
150216676|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
150216677|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
150216678|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
150216679|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
150216680|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
150216681|NCT03845517|541930988|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
150216682|NCT03845517|541930989|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
150216683|NCT03845517|541930990|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
150216684|NCT03845517|541930991|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
150216685|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
150216686|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
150216687|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
150216688|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
150216689|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Death|0|||
150216690|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Death|0|||
150216691|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Death|1|||
150216692|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Death|1|||
150216693|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
150216694|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
150216695|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
150216696|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
150216697|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
150216698|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
150216699|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
150216700|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
150216701|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
150216702|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
150216703|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
150216704|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
150216705|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Other|1|||
150216706|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Other|0|||
150216707|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Other|1|||
150216708|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Other|0|||
150216709|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
150216710|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
150216711|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
150216712|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
150216713|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
150216714|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
150216715|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
150216716|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
150216717|NCT03845517|541930988|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
150216718|NCT03845517|541930989|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
150216719|NCT03845517|541930990|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
150216720|NCT03845517|541930991|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
150216721|NCT03006393|541930992|FG000|Overall Study|Withdrawal by Subject|1|||
150216722|NCT03006393|541930993|FG001|Overall Study|Withdrawal by Subject|1|||
150216723|NCT03006393|541930992|FG000|Overall Study|Pregnancy|0|||
150216724|NCT03006393|541930993|FG001|Overall Study|Pregnancy|1|||
150216725|NCT03006393|541930992|FG000|Overall Study|Lost to Follow-up|0|||
150216726|NCT03006393|541930993|FG001|Overall Study|Lost to Follow-up|1|||
150216727|NCT01109979|541930994|FG000|Overall Study|Physician Decision|2|||
150216728|NCT01109979|541930995|FG001|Overall Study|Physician Decision|0|||
150216729|NCT01109979|541930994|FG000|Overall Study|Withdrawal by Subject|0|||
150216730|NCT01109979|541930995|FG001|Overall Study|Withdrawal by Subject|1|||
150216731|NCT00807599|541930998|FG000|Overall Study|Not treated on protocol study|0|||
150216732|NCT00807599|541930999|FG001|Overall Study|Not treated on protocol study|0|||
150216733|NCT00807599|541931000|FG002|Overall Study|Not treated on protocol study|2|||
150216734|NCT00807599|541930998|FG000|Overall Study|Adverse Event|0|||
150216735|NCT00807599|541930999|FG001|Overall Study|Adverse Event|0|||
150216736|NCT00807599|541931000|FG002|Overall Study|Adverse Event|5|||
150216737|NCT00807599|541930998|FG000|Overall Study|Inadequate response to induction|0|||
150216738|NCT00807599|541930999|FG001|Overall Study|Inadequate response to induction|0|||
150216739|NCT00807599|541931000|FG002|Overall Study|Inadequate response to induction|9|||
150216740|NCT00807599|541930998|FG000|Overall Study|Withdrawal by Subject|0|||
150216741|NCT00807599|541930999|FG001|Overall Study|Withdrawal by Subject|0|||
150216742|NCT00807599|541931000|FG002|Overall Study|Withdrawal by Subject|1|||
150216743|NCT02161458|541931001|FG000|Overall Study|Withdrawal by Subject|0|||
150216744|NCT02161458|541931002|FG001|Overall Study|Withdrawal by Subject|4|||
150216745|NCT02161458|541931003|FG002|Overall Study|Withdrawal by Subject|4|||
150216746|NCT02161458|541931004|FG003|Overall Study|Withdrawal by Subject|0|||
150216747|NCT02161458|541931001|FG000|Overall Study|Lost to Follow-up|0|||
150216748|NCT02161458|541931002|FG001|Overall Study|Lost to Follow-up|2|||
150216749|NCT02161458|541931003|FG002|Overall Study|Lost to Follow-up|1|||
150216750|NCT02161458|541931004|FG003|Overall Study|Lost to Follow-up|0|||
150216751|NCT03136861|541931005|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
150216752|NCT03136861|541931006|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
150216753|NCT03136861|541931007|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
150216754|NCT03136861|541931008|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
150216755|NCT03136861|541931009|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
150216756|NCT03136861|541931010|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
150216757|NCT03136861|541931011|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
150216758|NCT03136861|541931005|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
150216759|NCT03136861|541931006|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
150216760|NCT03136861|541931007|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
150216761|NCT03136861|541931008|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
150216762|NCT03136861|541931009|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
150216763|NCT03136861|541931010|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
150216764|NCT03136861|541931011|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
150216765|NCT03136861|541931005|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
150216766|NCT03136861|541931006|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
150216767|NCT03136861|541931007|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
150216768|NCT03136861|541931008|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
150216769|NCT03136861|541931009|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
150216770|NCT03136861|541931010|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
150216771|NCT03136861|541931011|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
150216772|NCT03136861|541931005|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216773|NCT03136861|541931006|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
150216774|NCT03136861|541931007|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216775|NCT03136861|541931008|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216776|NCT03136861|541931009|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216777|NCT03136861|541931010|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216778|NCT03136861|541931011|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
150216779|NCT03136861|541931005|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
150216780|NCT03136861|541931006|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
150216781|NCT03136861|541931007|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
150216782|NCT03136861|541931008|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
150216783|NCT03136861|541931009|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
150216784|NCT03136861|541931010|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
150216785|NCT03136861|541931011|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
150216786|NCT03136861|541931005|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
150216787|NCT03136861|541931006|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
150216788|NCT03136861|541931007|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
150216789|NCT03136861|541931008|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
150216790|NCT03136861|541931009|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
150216791|NCT03136861|541931010|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
150216792|NCT03136861|541931011|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
150216793|NCT03136861|541931005|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216794|NCT03136861|541931006|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216795|NCT03136861|541931007|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
150216796|NCT03136861|541931008|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216797|NCT03136861|541931009|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216798|NCT03136861|541931010|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216799|NCT03136861|541931011|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
150216800|NCT03136861|541931005|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216801|NCT03136861|541931006|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216802|NCT03136861|541931007|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
150216803|NCT03136861|541931008|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216804|NCT03136861|541931009|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216805|NCT03136861|541931010|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216806|NCT03136861|541931011|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
150216807|NCT03390166|541931012|FG000|Overall Study|Death|0|||
150216808|NCT03390166|541931013|FG001|Overall Study|Death|1|||
150216809|NCT03390166|541931012|FG000|Overall Study|Lost to Follow-up|6|||
150216810|NCT03390166|541931013|FG001|Overall Study|Lost to Follow-up|4|||
150216811|NCT03390166|541931012|FG000|Overall Study|Physician Decision|2|||
150216812|NCT03390166|541931013|FG001|Overall Study|Physician Decision|1|||
150216813|NCT03390166|541931012|FG000|Overall Study|Move from study area|3|||
150216814|NCT03390166|541931013|FG001|Overall Study|Move from study area|2|||
150216815|NCT03390166|541931012|FG000|Overall Study|To militarycamp for conscript|1|||
150216816|NCT03390166|541931013|FG001|Overall Study|To militarycamp for conscript|0|||
150216817|NCT03390166|541931012|FG000|Overall Study|To drug therapy course|0|||
150216818|NCT03390166|541931013|FG001|Overall Study|To drug therapy course|1|||
150216819|NCT03390166|541931012|FG000|Overall Study|Move to work oversea|0|||
150216820|NCT03390166|541931013|FG001|Overall Study|Move to work oversea|1|||
150216821|NCT01262456|541931015|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
150216822|NCT01262456|541931016|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
150216823|NCT01262456|541931017|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
150216824|NCT01262456|541931015|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
150216825|NCT01262456|541931016|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
150216826|NCT01262456|541931017|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
150216827|NCT01262456|541931015|FG000|3-Month Double-Blind Period|Adverse Event|6|||
150216828|NCT01262456|541931016|FG001|3-Month Double-Blind Period|Adverse Event|4|||
150216829|NCT01262456|541931017|FG002|3-Month Double-Blind Period|Adverse Event|8|||
150216830|NCT01262456|541931015|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
150216831|NCT01262456|541931016|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
150216832|NCT01262456|541931017|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
150216833|NCT01262456|541931015|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
150216834|NCT01262456|541931016|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
150216835|NCT01262456|541931017|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
150216836|NCT01262456|541931015|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
150216837|NCT01262456|541931016|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
150216838|NCT01262456|541931017|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
150216839|NCT01262456|541931015|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
150216840|NCT01262456|541931016|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
150216841|NCT01262456|541931017|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
150216842|NCT01262456|541931015|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
150216843|NCT01262456|541931016|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
150216844|NCT01262456|541931017|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
150216845|NCT01262456|541931015|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
150216846|NCT01262456|541931016|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
150216847|NCT01262456|541931017|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
150216848|NCT03938272|541931018|FG000|Overall Study|Withdrawal by Subject|1|||
150216849|NCT03938272|541931019|FG001|Overall Study|Withdrawal by Subject|0|||
150216850|NCT03938272|541931018|FG000|Overall Study|Physician Decision|0|||
150216851|NCT03938272|541931019|FG001|Overall Study|Physician Decision|2|||
150216852|NCT03938272|541931018|FG000|Overall Study|Study termination by sponsor|10|||
150216853|NCT03938272|541931019|FG001|Overall Study|Study termination by sponsor|8|||
150216854|NCT02538094|541931020|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
150216855|NCT02538094|541931021|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
150216856|NCT02538094|541931020|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
150216857|NCT02538094|541931021|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
150216858|NCT01860079|541931024|FG000|Overall Study|Physician Decision|14|||
150216859|NCT01860079|541931025|FG001|Overall Study|Physician Decision|22|||
150216860|NCT01323790|541931026|FG000|Overall Study|Other|3|||
150216861|NCT01323790|541931027|FG001|Overall Study|Other|2|||
150216862|NCT01323790|541931028|FG002|Overall Study|Other|1|||
150216863|NCT01323790|541931026|FG000|Overall Study|Lost to Follow-up|11|||
150216864|NCT01323790|541931027|FG001|Overall Study|Lost to Follow-up|9|||
150216865|NCT01323790|541931028|FG002|Overall Study|Lost to Follow-up|9|||
150216866|NCT01323790|541931026|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
150216867|NCT01323790|541931027|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
150216868|NCT01323790|541931028|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
150216869|NCT01323790|541931026|FG000|Overall Study|Lack of Efficacy|3|||
150216870|NCT01323790|541931027|FG001|Overall Study|Lack of Efficacy|0|||
150216871|NCT01323790|541931028|FG002|Overall Study|Lack of Efficacy|3|||
150216872|NCT01323790|541931026|FG000|Overall Study|Adverse Event|11|||
150216873|NCT01323790|541931027|FG001|Overall Study|Adverse Event|24|||
150216874|NCT01323790|541931028|FG002|Overall Study|Adverse Event|12|||
150216875|NCT01323790|541931026|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
150216876|NCT01323790|541931027|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
150216877|NCT01323790|541931028|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
150216878|NCT01323790|541931026|FG000|Overall Study|Withdrawal by Subject|23|||
150216879|NCT01323790|541931027|FG001|Overall Study|Withdrawal by Subject|20|||
150216880|NCT01323790|541931028|FG002|Overall Study|Withdrawal by Subject|13|||
150216881|NCT01323790|541931026|FG000|Overall Study|Did Not Receive Treatment|2|||
150216882|NCT01323790|541931027|FG001|Overall Study|Did Not Receive Treatment|0|||
150216883|NCT01323790|541931028|FG002|Overall Study|Did Not Receive Treatment|1|||
150216884|NCT01323790|541931026|FG000|Overall Study|Severe non-compliance with protocol|2|||
150216885|NCT01323790|541931027|FG001|Overall Study|Severe non-compliance with protocol|2|||
150216886|NCT01323790|541931028|FG002|Overall Study|Severe non-compliance with protocol|2|||
150216887|NCT02915783|541931029|FG000|Overall Study|Death|21|||
150216888|NCT02915783|541931029|FG000|Overall Study|Lost to Follow-up|1|||
150216889|NCT02915783|541931029|FG000|Overall Study|Withdrawal by Subject|2|||
150216890|NCT02950961|541931030|FG000|Overall Study|Study had to stop due to COVID.|7|||
150216891|NCT02114515|541931033|FG000|Overall Study|Lost to Follow-up|52|||
150216892|NCT02114515|541931034|FG001|Overall Study|Lost to Follow-up|55|||
150216893|NCT02114515|541931033|FG000|Overall Study|Death|12|||
150216894|NCT02114515|541931034|FG001|Overall Study|Death|12|||
150216895|NCT02114515|541931033|FG000|Overall Study|Withdrawal by Subject|4|||
150216896|NCT02114515|541931034|FG001|Overall Study|Withdrawal by Subject|22|||
150216897|NCT02114515|541931033|FG000|Overall Study|Other|65|||
150216898|NCT02114515|541931034|FG001|Overall Study|Other|61|||
150216899|NCT00667732|541931035|FG000|Run -In (8 Weeks)|Adverse Event|4|||
150216900|NCT00667732|541931036|FG001|Run -In (8 Weeks)|Adverse Event|0|||
150216901|NCT00667732|541931037|FG002|Run -In (8 Weeks)|Adverse Event|0|||
150216902|NCT00667732|541931035|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
150216903|NCT00667732|541931036|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
150216904|NCT00667732|541931037|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
150216905|NCT00667732|541931035|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
150216906|NCT00667732|541931036|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
150216907|NCT00667732|541931037|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
150216908|NCT00747149|541932245|FG000|Overall Study|Adverse Event|0|||
150216909|NCT00747149|541932246|FG001|Overall Study|Adverse Event|15|||
150216910|NCT00747149|541932245|FG000|Overall Study|Lost to Follow-up|0|||
150216911|NCT00747149|541932246|FG001|Overall Study|Lost to Follow-up|10|||
150216912|NCT00747149|541932245|FG000|Overall Study|Withdrawal by Subject|0|||
150216913|NCT00747149|541932246|FG001|Overall Study|Withdrawal by Subject|6|||
150216914|NCT00747149|541932245|FG000|Overall Study|Did not receive treatment|0|||
150216915|NCT00747149|541932246|FG001|Overall Study|Did not receive treatment|1|||
150216916|NCT00747149|541932245|FG000|Overall Study|Incorrect enrollment|0|||
150216917|NCT00747149|541932246|FG001|Overall Study|Incorrect enrollment|6|||
150216918|NCT00747149|541932245|FG000|Overall Study|Severe non-compliance to protocol|0|||
150216919|NCT00747149|541932246|FG001|Overall Study|Severe non-compliance to protocol|1|||
150216920|NCT00747149|541932245|FG000|Overall Study|Not reported|1|||
150216921|NCT00747149|541932246|FG001|Overall Study|Not reported|4|||
150216922|NCT03840200|541932251|FG000|Overall Study|Death|6|||
150216923|NCT03840200|541932252|FG001|Overall Study|Death|3|||
150216924|NCT03840200|541932253|FG002|Overall Study|Death|6|||
150216925|NCT03840200|541932254|FG003|Overall Study|Death|10|||
150216926|NCT03840200|541932251|FG000|Overall Study|Reason Not Specified|2|||
150216927|NCT03840200|541932252|FG001|Overall Study|Reason Not Specified|2|||
150216928|NCT03840200|541932253|FG002|Overall Study|Reason Not Specified|1|||
150216929|NCT03840200|541932254|FG003|Overall Study|Reason Not Specified|15|||
150216930|NCT03840200|541932251|FG000|Overall Study|Physician Decision|0|||
150216931|NCT03840200|541932252|FG001|Overall Study|Physician Decision|0|||
150216932|NCT03840200|541932253|FG002|Overall Study|Physician Decision|0|||
150216933|NCT03840200|541932254|FG003|Overall Study|Physician Decision|2|||
150216934|NCT03840200|541932251|FG000|Overall Study|Progressive Disease|0|||
150216935|NCT03840200|541932252|FG001|Overall Study|Progressive Disease|0|||
150216936|NCT03840200|541932253|FG002|Overall Study|Progressive Disease|0|||
150216937|NCT03840200|541932254|FG003|Overall Study|Progressive Disease|1|||
150216938|NCT03840200|541932251|FG000|Overall Study|Withdrawal by Subject|0|||
150216939|NCT03840200|541932252|FG001|Overall Study|Withdrawal by Subject|1|||
150216940|NCT03840200|541932253|FG002|Overall Study|Withdrawal by Subject|0|||
150216941|NCT03840200|541932254|FG003|Overall Study|Withdrawal by Subject|2|||
150216942|NCT05522777|541932255|FG000|Overall Study|Lack of Efficacy|1|||
150216943|NCT05522777|541932255|FG000|Overall Study|Withdrawal by Subject|1|||
150216944|NCT05487300|541932258|FG000|Overall Study|Withdrawal by Subject|1|||
150216945|NCT05487300|541932259|FG001|Overall Study|Withdrawal by Subject|0|||
150216946|NCT03141177|541932260|FG000|Overall Study|Death|62|||
150216947|NCT03141177|541932261|FG001|Overall Study|Death|13|||
150216948|NCT03141177|541932262|FG002|Overall Study|Death|84|||
150216949|NCT03141177|541932260|FG000|Overall Study|Participant withdrew consent|9|||
150216950|NCT03141177|541932261|FG001|Overall Study|Participant withdrew consent|2|||
150216951|NCT03141177|541932262|FG002|Overall Study|Participant withdrew consent|13|||
150216952|NCT03141177|541932260|FG000|Overall Study|Not reported|1|||
150216953|NCT03141177|541932261|FG001|Overall Study|Not reported|0|||
150216954|NCT03141177|541932262|FG002|Overall Study|Not reported|1|||
150216955|NCT03141177|541932260|FG000|Overall Study|Lost to Follow-up|2|||
150216956|NCT03141177|541932261|FG001|Overall Study|Lost to Follow-up|1|||
150216957|NCT03141177|541932262|FG002|Overall Study|Lost to Follow-up|1|||
150216958|NCT03141177|541932260|FG000|Overall Study|Other reasons|4|||
150216959|NCT03141177|541932261|FG001|Overall Study|Other reasons|0|||
150216960|NCT03141177|541932262|FG002|Overall Study|Other reasons|11|||
150216961|NCT03141177|541932260|FG000|Overall Study|Participants did not start treatment period|3|||
150216962|NCT03141177|541932261|FG001|Overall Study|Participants did not start treatment period|0|||
150216963|NCT03141177|541932262|FG002|Overall Study|Participants did not start treatment period|8|||
150216964|NCT05006703|541932263|FG000|Overall Study|Withdrawal by Subject|1|||
150216965|NCT05006703|541932264|FG001|Overall Study|Withdrawal by Subject|0|||
150216966|NCT05006703|541932263|FG000|Overall Study|Lost to Follow-up|13|||
150216967|NCT05006703|541932264|FG001|Overall Study|Lost to Follow-up|5|||
150216968|NCT02196259|541932267|FG000|Overall Study|Researcher choice|0|||
150216969|NCT02196259|541932268|FG001|Overall Study|Researcher choice|0|||
150216970|NCT02196259|541932269|FG002|Overall Study|Researcher choice|1|||
150216971|NCT02196259|541932267|FG000|Overall Study|Partial data analysis|0|||
150216972|NCT02196259|541932268|FG001|Overall Study|Partial data analysis|3|||
150216973|NCT02196259|541932269|FG002|Overall Study|Partial data analysis|0|||
150216974|NCT04909593|541932270|FG000|Overall Study|Withdrawal by Subject|1|||
150216975|NCT01018992|541932271|FG000|Overall Study|Adverse Event|8|||
150216976|NCT01018992|541932272|FG001|Overall Study|Adverse Event|3|||
150216977|NCT01018992|541932271|FG000|Overall Study|Withdrawal by Subject|3|||
150216978|NCT01018992|541932272|FG001|Overall Study|Withdrawal by Subject|8|||
150216979|NCT01018992|541932271|FG000|Overall Study|Protocol Violation|0|||
150216980|NCT01018992|541932272|FG001|Overall Study|Protocol Violation|4|||
150216981|NCT01018992|541932271|FG000|Overall Study|Lost to Follow-up|5|||
150216982|NCT01018992|541932272|FG001|Overall Study|Lost to Follow-up|1|||
150216983|NCT01825785|541932273|FG000|Overall Study|Adverse Event|0|||
150216984|NCT01825785|541932274|FG001|Overall Study|Adverse Event|0|||
150216985|NCT01825785|541932275|FG002|Overall Study|Adverse Event|0|||
150216986|NCT01825785|541932276|FG003|Overall Study|Adverse Event|0|||
150216987|NCT01825785|541932277|FG004|Overall Study|Adverse Event|1|||
150216988|NCT01825785|541932278|FG005|Overall Study|Adverse Event|0|||
150216989|NCT01825785|541932279|FG006|Overall Study|Adverse Event|0|||
150216990|NCT01825785|541932273|FG000|Overall Study|Withdrawal by Subject|0|||
150216991|NCT01825785|541932274|FG001|Overall Study|Withdrawal by Subject|0|||
150216992|NCT01825785|541932275|FG002|Overall Study|Withdrawal by Subject|0|||
150216993|NCT01825785|541932276|FG003|Overall Study|Withdrawal by Subject|0|||
150216994|NCT01825785|541932277|FG004|Overall Study|Withdrawal by Subject|1|||
150216995|NCT01825785|541932278|FG005|Overall Study|Withdrawal by Subject|1|||
150216996|NCT01825785|541932279|FG006|Overall Study|Withdrawal by Subject|0|||
150216997|NCT01205126|541932281|FG000|Titration Phase|Adverse Event|5|||
150216998|NCT01205126|541932282|FG001|Titration Phase|Adverse Event|3|||
150216999|NCT01205126|541932281|FG000|Titration Phase|Withdrawal by Subject|5|||
150217000|NCT01205126|541932282|FG001|Titration Phase|Withdrawal by Subject|5|||
150217001|NCT01205126|541932281|FG000|Titration Phase|Lost to Follow-up|2|||
150217002|NCT01205126|541932282|FG001|Titration Phase|Lost to Follow-up|2|||
150217003|NCT01205126|541932281|FG000|Titration Phase|No stable titration dose|1|||
150217004|NCT01205126|541932282|FG001|Titration Phase|No stable titration dose|0|||
150217005|NCT01205126|541932281|FG000|Titration Phase|More than maximum dosage required|2|||
150217006|NCT01205126|541932282|FG001|Titration Phase|More than maximum dosage required|3|||
150217007|NCT01205126|541932281|FG000|Titration Phase|Other|8|||
150217008|NCT01205126|541932282|FG001|Titration Phase|Other|6|||
150217009|NCT01205126|541932281|FG000|Between Titration & Maintenance Phase|Other|0|||
150217010|NCT01205126|541932282|FG001|Between Titration & Maintenance Phase|Other|4|||
150217011|NCT01205126|541932281|FG000|Maintenance Phase|Adverse Event|3|||
150217012|NCT01205126|541932282|FG001|Maintenance Phase|Adverse Event|7|||
150217013|NCT01205126|541932281|FG000|Maintenance Phase|Death|4|||
150217014|NCT01205126|541932282|FG001|Maintenance Phase|Death|4|||
150217015|NCT01205126|541932281|FG000|Maintenance Phase|More than the maximum dosage required|5|||
150217016|NCT01205126|541932282|FG001|Maintenance Phase|More than the maximum dosage required|5|||
150217017|NCT01205126|541932281|FG000|Maintenance Phase|Prohibited drugs used|1|||
150217018|NCT01205126|541932282|FG001|Maintenance Phase|Prohibited drugs used|0|||
150217019|NCT01205126|541932281|FG000|Maintenance Phase|Other|11|||
150217020|NCT01205126|541932282|FG001|Maintenance Phase|Other|8|||
150217021|NCT01205126|541932281|FG000|Maintenance Phase|Lost to Follow-up|5|||
150217022|NCT01205126|541932282|FG001|Maintenance Phase|Lost to Follow-up|5|||
150217023|NCT01205126|541932281|FG000|Maintenance Phase|Withdrawal by Subject|8|||
150217024|NCT01205126|541932282|FG001|Maintenance Phase|Withdrawal by Subject|11|||
150217025|NCT00805792|541932283|FG000|Overall Study|Death|3|||
150217026|NCT00805792|541932283|FG000|Overall Study|Lost to Follow-up|2|||
150217027|NCT01393600|541932287|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
150217028|NCT01393600|541932288|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
150217029|NCT01393600|541932289|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
150217030|NCT01393600|541932290|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
150217031|NCT01393600|541932287|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
150217032|NCT01393600|541932288|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
150217033|NCT01393600|541932289|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
150217034|NCT01393600|541932290|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
150217035|NCT01393600|541932287|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
150217036|NCT01393600|541932288|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
150217037|NCT01393600|541932289|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
150217038|NCT01393600|541932290|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
150217039|NCT01393600|541932287|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
150217040|NCT01393600|541932288|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
150217041|NCT01393600|541932289|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
150217042|NCT01393600|541932290|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
150217043|NCT01393600|541932287|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
150217044|NCT01393600|541932288|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
150217045|NCT01393600|541932289|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
150217046|NCT01393600|541932290|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
150217047|NCT01393600|541932287|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
150217048|NCT01393600|541932288|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
150217049|NCT01393600|541932289|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
150217050|NCT01393600|541932290|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
150217051|NCT01393600|541932287|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
150217052|NCT01393600|541932288|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
150217053|NCT01393600|541932289|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
150217054|NCT01393600|541932290|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
150217055|NCT01072149|541932291|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217056|NCT01072149|541932292|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217057|NCT01072149|541932293|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
150217058|NCT01072149|541932294|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217059|NCT01072149|541932295|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217060|NCT01072149|541932296|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217061|NCT01072149|541932297|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217062|NCT01072149|541932298|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217063|NCT01072149|541932299|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217064|NCT01072149|541932300|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217065|NCT01072149|541932301|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217066|NCT01072149|541932302|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217067|NCT01072149|541932303|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217068|NCT01072149|541932304|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217069|NCT01072149|541932305|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217070|NCT01072149|541932306|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217071|NCT01072149|541932307|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217072|NCT01072149|541932308|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
150217073|NCT01072149|541932291|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217074|NCT01072149|541932292|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217075|NCT01072149|541932293|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217076|NCT01072149|541932294|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217077|NCT01072149|541932295|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217078|NCT01072149|541932296|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217079|NCT01072149|541932297|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217080|NCT01072149|541932298|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217081|NCT01072149|541932299|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217082|NCT01072149|541932300|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217083|NCT01072149|541932301|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217084|NCT01072149|541932302|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217085|NCT01072149|541932303|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217086|NCT01072149|541932304|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217087|NCT01072149|541932305|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217088|NCT01072149|541932306|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217089|NCT01072149|541932307|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
150217090|NCT01072149|541932308|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
150217091|NCT01072149|541932291|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217092|NCT01072149|541932292|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217093|NCT01072149|541932293|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217094|NCT01072149|541932294|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217095|NCT01072149|541932295|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217096|NCT01072149|541932296|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217097|NCT01072149|541932297|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217098|NCT01072149|541932298|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217099|NCT01072149|541932299|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217100|NCT01072149|541932300|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217101|NCT01072149|541932301|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
150217102|NCT01072149|541932302|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217103|NCT01072149|541932303|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217104|NCT01072149|541932304|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217105|NCT01072149|541932305|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217106|NCT01072149|541932306|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217107|NCT01072149|541932307|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217108|NCT01072149|541932308|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
150217109|NCT01072149|541932291|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217110|NCT01072149|541932292|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
150217111|NCT01072149|541932293|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217112|NCT01072149|541932294|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217113|NCT01072149|541932295|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217114|NCT01072149|541932296|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217115|NCT01072149|541932297|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217116|NCT01072149|541932298|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217117|NCT01072149|541932299|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217118|NCT01072149|541932300|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217119|NCT01072149|541932301|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217120|NCT01072149|541932302|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217121|NCT01072149|541932303|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217122|NCT01072149|541932304|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217123|NCT01072149|541932305|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217124|NCT01072149|541932306|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217125|NCT01072149|541932307|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217126|NCT01072149|541932308|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
150217127|NCT01072149|541932291|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217128|NCT01072149|541932292|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217129|NCT01072149|541932293|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
150217130|NCT01072149|541932294|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217131|NCT01072149|541932295|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217132|NCT01072149|541932296|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217133|NCT01072149|541932297|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217134|NCT01072149|541932298|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217135|NCT01072149|541932299|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217136|NCT01072149|541932300|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217137|NCT01072149|541932301|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217138|NCT01072149|541932302|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217139|NCT01072149|541932303|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217140|NCT01072149|541932304|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217141|NCT01072149|541932305|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217142|NCT01072149|541932306|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217143|NCT01072149|541932307|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217144|NCT01072149|541932308|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
150217145|NCT01072149|541932291|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217146|NCT01072149|541932292|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217147|NCT01072149|541932293|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217148|NCT01072149|541932294|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217149|NCT01072149|541932295|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217150|NCT01072149|541932296|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217151|NCT01072149|541932297|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217152|NCT01072149|541932298|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
150217153|NCT01072149|541932299|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217154|NCT01072149|541932300|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217155|NCT01072149|541932301|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217156|NCT01072149|541932302|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217157|NCT01072149|541932303|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217158|NCT01072149|541932304|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217159|NCT01072149|541932305|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217160|NCT01072149|541932306|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217161|NCT01072149|541932307|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217162|NCT01072149|541932308|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
150217163|NCT01072149|541932291|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
150217164|NCT01072149|541932292|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
150217165|NCT01072149|541932293|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
150217166|NCT01072149|541932294|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
150217167|NCT01072149|541932295|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
150217168|NCT01072149|541932296|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
150217169|NCT01072149|541932297|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
150217170|NCT01072149|541932298|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
150217171|NCT01072149|541932299|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
150217172|NCT01072149|541932300|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
150217173|NCT01072149|541932301|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
150217174|NCT01072149|541932302|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
150217175|NCT01072149|541932303|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
150217176|NCT01072149|541932304|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
150217177|NCT01072149|541932305|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
150217178|NCT01072149|541932306|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
150217179|NCT01072149|541932307|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
150217180|NCT01072149|541932308|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
150217181|NCT01072149|541932291|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217182|NCT01072149|541932292|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217183|NCT01072149|541932293|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217184|NCT01072149|541932294|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217185|NCT01072149|541932295|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217186|NCT01072149|541932296|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217187|NCT01072149|541932297|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217188|NCT01072149|541932298|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217189|NCT01072149|541932299|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217190|NCT01072149|541932300|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217191|NCT01072149|541932301|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217192|NCT01072149|541932302|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217193|NCT01072149|541932303|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217194|NCT01072149|541932304|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217195|NCT01072149|541932305|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217196|NCT01072149|541932306|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
150217197|NCT01072149|541932307|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217198|NCT01072149|541932308|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
150217199|NCT01072149|541932291|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
150217200|NCT01072149|541932292|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
150217201|NCT01072149|541932293|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
150217202|NCT01072149|541932294|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
150217203|NCT01072149|541932295|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
150217204|NCT01072149|541932296|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
150217205|NCT01072149|541932297|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
150217206|NCT01072149|541932298|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
150217207|NCT01072149|541932299|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
150217208|NCT01072149|541932300|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
150217209|NCT01072149|541932301|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
150217210|NCT01072149|541932302|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
150217211|NCT01072149|541932303|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
150217212|NCT01072149|541932304|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
150217213|NCT01072149|541932305|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
150217214|NCT01072149|541932306|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
150217215|NCT01072149|541932307|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
150217216|NCT01072149|541932308|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
150217217|NCT01072149|541932291|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217218|NCT01072149|541932292|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217219|NCT01072149|541932293|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217220|NCT01072149|541932294|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217221|NCT01072149|541932295|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217222|NCT01072149|541932296|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217223|NCT01072149|541932297|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217224|NCT01072149|541932298|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217225|NCT01072149|541932299|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217226|NCT01072149|541932300|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150140255|NCT02889133|541648787|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
150140256|NCT02889133|541648786|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
150140257|NCT02889133|541648787|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
150140258|NCT02889133|541648786|FG000|Completed Primary Outcome|Protocol Violation|1|||
150140259|NCT02889133|541648787|FG001|Completed Primary Outcome|Protocol Violation|0|||
150140260|NCT02889133|541648786|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
150140261|NCT02889133|541648787|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
150140262|NCT02889133|541648786|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
150140263|NCT02889133|541648787|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
150140264|NCT02889133|541648786|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
150140265|NCT02889133|541648787|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
150140266|NCT02889133|541648786|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
150217227|NCT01072149|541932301|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217228|NCT01072149|541932302|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150140267|NCT02889133|541648787|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
150140268|NCT02889133|541648786|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
150140269|NCT02889133|541648787|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
150140270|NCT04359784|541648788|FG000|Overall Study|Death|2|||
150140271|NCT02753595|541648789|FG000|Overall Study|Sponsor termination|2|||
150140272|NCT02753595|541648790|FG001|Overall Study|Sponsor termination|2|||
150140273|NCT03217747|541648800|FG000|Overall Study|Adverse Event|0|||
150140274|NCT03217747|541648801|FG001|Overall Study|Adverse Event|1|||
150140275|NCT03217747|541648802|FG002|Overall Study|Adverse Event|0|||
150140276|NCT03217747|541648803|FG003|Overall Study|Adverse Event|0|||
150140277|NCT03217747|541648804|FG004|Overall Study|Adverse Event|0|||
150140278|NCT03217747|541648805|FG005|Overall Study|Adverse Event|0|||
150140279|NCT03217747|541648806|FG006|Overall Study|Adverse Event|0|||
150140280|NCT03217747|541648807|FG007|Overall Study|Adverse Event|0|||
150140281|NCT03217747|541648808|FG008|Overall Study|Adverse Event|0|||
150140282|NCT03217747|541648809|FG009|Overall Study|Adverse Event|0|||
150140283|NCT03217747|541648810|FG010|Overall Study|Adverse Event|0|||
150140284|NCT03217747|541648811|FG011|Overall Study|Adverse Event|0|||
150140285|NCT03217747|541648812|FG012|Overall Study|Adverse Event|1|||
150140286|NCT03217747|541648813|FG013|Overall Study|Adverse Event|1|||
150140287|NCT03217747|541648800|FG000|Overall Study|Death|0|||
150140288|NCT03217747|541648801|FG001|Overall Study|Death|0|||
150140289|NCT03217747|541648802|FG002|Overall Study|Death|0|||
150140290|NCT03217747|541648803|FG003|Overall Study|Death|0|||
150140291|NCT03217747|541648804|FG004|Overall Study|Death|0|||
150140292|NCT03217747|541648805|FG005|Overall Study|Death|0|||
150140293|NCT03217747|541648806|FG006|Overall Study|Death|0|||
150140294|NCT03217747|541648807|FG007|Overall Study|Death|0|||
150140295|NCT03217747|541648808|FG008|Overall Study|Death|1|||
150140296|NCT03217747|541648809|FG009|Overall Study|Death|0|||
150140297|NCT03217747|541648810|FG010|Overall Study|Death|0|||
150140298|NCT03217747|541648811|FG011|Overall Study|Death|0|||
150140299|NCT03217747|541648812|FG012|Overall Study|Death|0|||
150140300|NCT03217747|541648813|FG013|Overall Study|Death|0|||
150140301|NCT03217747|541648800|FG000|Overall Study|Lack of Efficacy|12|||
150140302|NCT03217747|541648801|FG001|Overall Study|Lack of Efficacy|6|||
150140303|NCT03217747|541648802|FG002|Overall Study|Lack of Efficacy|15|||
150140304|NCT03217747|541648803|FG003|Overall Study|Lack of Efficacy|11|||
150140305|NCT03217747|541648804|FG004|Overall Study|Lack of Efficacy|3|||
150140306|NCT03217747|541648805|FG005|Overall Study|Lack of Efficacy|14|||
150140307|NCT03217747|541648806|FG006|Overall Study|Lack of Efficacy|10|||
150140308|NCT03217747|541648807|FG007|Overall Study|Lack of Efficacy|4|||
150140309|NCT03217747|541648808|FG008|Overall Study|Lack of Efficacy|2|||
150140310|NCT03217747|541648809|FG009|Overall Study|Lack of Efficacy|7|||
150140311|NCT03217747|541648810|FG010|Overall Study|Lack of Efficacy|3|||
150140312|NCT03217747|541648811|FG011|Overall Study|Lack of Efficacy|1|||
150140313|NCT03217747|541648812|FG012|Overall Study|Lack of Efficacy|3|||
150140314|NCT03217747|541648813|FG013|Overall Study|Lack of Efficacy|1|||
150140315|NCT03217747|541648800|FG000|Overall Study|Withdrawal by Subject|2|||
150140316|NCT03217747|541648801|FG001|Overall Study|Withdrawal by Subject|1|||
150140317|NCT03217747|541648802|FG002|Overall Study|Withdrawal by Subject|1|||
150140318|NCT03217747|541648803|FG003|Overall Study|Withdrawal by Subject|1|||
150140319|NCT03217747|541648804|FG004|Overall Study|Withdrawal by Subject|1|||
150140320|NCT03217747|541648805|FG005|Overall Study|Withdrawal by Subject|2|||
150140321|NCT03217747|541648806|FG006|Overall Study|Withdrawal by Subject|1|||
150140322|NCT03217747|541648807|FG007|Overall Study|Withdrawal by Subject|0|||
150140323|NCT03217747|541648808|FG008|Overall Study|Withdrawal by Subject|0|||
150140324|NCT03217747|541648809|FG009|Overall Study|Withdrawal by Subject|0|||
150140325|NCT03217747|541648810|FG010|Overall Study|Withdrawal by Subject|0|||
150140326|NCT03217747|541648811|FG011|Overall Study|Withdrawal by Subject|1|||
150140327|NCT03217747|541648812|FG012|Overall Study|Withdrawal by Subject|0|||
150140328|NCT03217747|541648813|FG013|Overall Study|Withdrawal by Subject|1|||
150140329|NCT03217747|541648800|FG000|Overall Study|Toxicity and progression|1|||
150140330|NCT03217747|541648801|FG001|Overall Study|Toxicity and progression|0|||
150140331|NCT03217747|541648802|FG002|Overall Study|Toxicity and progression|0|||
150140332|NCT03217747|541648803|FG003|Overall Study|Toxicity and progression|0|||
150140333|NCT03217747|541648804|FG004|Overall Study|Toxicity and progression|0|||
150140334|NCT03217747|541648805|FG005|Overall Study|Toxicity and progression|0|||
150140335|NCT03217747|541648806|FG006|Overall Study|Toxicity and progression|0|||
150140336|NCT03217747|541648807|FG007|Overall Study|Toxicity and progression|0|||
150140337|NCT03217747|541648808|FG008|Overall Study|Toxicity and progression|0|||
150140338|NCT03217747|541648809|FG009|Overall Study|Toxicity and progression|0|||
150140339|NCT03217747|541648810|FG010|Overall Study|Toxicity and progression|0|||
150140340|NCT03217747|541648811|FG011|Overall Study|Toxicity and progression|0|||
150140341|NCT03217747|541648812|FG012|Overall Study|Toxicity and progression|0|||
150140342|NCT03217747|541648813|FG013|Overall Study|Toxicity and progression|0|||
150140343|NCT03217747|541648800|FG000|Overall Study|Removal of sole target lesion|1|||
150140344|NCT03217747|541648801|FG001|Overall Study|Removal of sole target lesion|0|||
150140345|NCT03217747|541648802|FG002|Overall Study|Removal of sole target lesion|0|||
150140346|NCT03217747|541648803|FG003|Overall Study|Removal of sole target lesion|0|||
150140347|NCT03217747|541648804|FG004|Overall Study|Removal of sole target lesion|0|||
150140348|NCT03217747|541648805|FG005|Overall Study|Removal of sole target lesion|0|||
150140349|NCT03217747|541648806|FG006|Overall Study|Removal of sole target lesion|0|||
150140350|NCT03217747|541648807|FG007|Overall Study|Removal of sole target lesion|0|||
150140351|NCT03217747|541648808|FG008|Overall Study|Removal of sole target lesion|0|||
150140352|NCT03217747|541648809|FG009|Overall Study|Removal of sole target lesion|0|||
150140353|NCT03217747|541648810|FG010|Overall Study|Removal of sole target lesion|0|||
150140354|NCT03217747|541648811|FG011|Overall Study|Removal of sole target lesion|0|||
150140355|NCT03217747|541648812|FG012|Overall Study|Removal of sole target lesion|0|||
150140356|NCT03217747|541648813|FG013|Overall Study|Removal of sole target lesion|0|||
150140357|NCT03217747|541648800|FG000|Overall Study|Stroke|0|||
150140358|NCT03217747|541648801|FG001|Overall Study|Stroke|0|||
150140359|NCT03217747|541648802|FG002|Overall Study|Stroke|0|||
150140360|NCT03217747|541648803|FG003|Overall Study|Stroke|0|||
150140361|NCT03217747|541648804|FG004|Overall Study|Stroke|0|||
150140362|NCT03217747|541648805|FG005|Overall Study|Stroke|1|||
150140363|NCT03217747|541648806|FG006|Overall Study|Stroke|0|||
150140364|NCT03217747|541648807|FG007|Overall Study|Stroke|0|||
150140365|NCT03217747|541648808|FG008|Overall Study|Stroke|0|||
150140366|NCT03217747|541648809|FG009|Overall Study|Stroke|0|||
150140367|NCT03217747|541648810|FG010|Overall Study|Stroke|0|||
150140368|NCT03217747|541648811|FG011|Overall Study|Stroke|1|||
150140369|NCT03217747|541648812|FG012|Overall Study|Stroke|0|||
150140370|NCT03217747|541648813|FG013|Overall Study|Stroke|0|||
150140371|NCT03996291|541648814|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
150140372|NCT03996291|541648815|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
150140373|NCT03996291|541648816|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
150140374|NCT03996291|541648817|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
150140375|NCT03996291|541648818|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
150140376|NCT03996291|541648819|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
150140377|NCT03996291|541648820|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
150140378|NCT03996291|541648821|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
150140379|NCT03996291|541648814|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150140380|NCT03996291|541648815|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150140381|NCT03996291|541648816|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150217229|NCT01072149|541932303|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
150140382|NCT03996291|541648817|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150140383|NCT03996291|541648818|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150140384|NCT03996291|541648819|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
150140385|NCT03996291|541648820|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
150140386|NCT03996291|541648821|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
150140387|NCT03996291|541648814|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150217230|NCT01072149|541932304|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217231|NCT01072149|541932305|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150217232|NCT01072149|541932306|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150140388|NCT03996291|541648815|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150140389|NCT03996291|541648816|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150140390|NCT03996291|541648817|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150140391|NCT03996291|541648818|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
150140392|NCT03996291|541648819|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150140393|NCT03996291|541648820|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
150140394|NCT03996291|541648821|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
150140395|NCT03996291|541648814|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
150140396|NCT03996291|541648815|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
150140397|NCT03996291|541648816|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
150140398|NCT03996291|541648817|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
150140399|NCT03996291|541648818|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
150140400|NCT03996291|541648819|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
150140401|NCT03996291|541648820|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
150140402|NCT03996291|541648821|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
150140403|NCT03996291|541648814|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140404|NCT03996291|541648815|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140405|NCT03996291|541648816|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140406|NCT03996291|541648817|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140407|NCT03996291|541648818|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
150140408|NCT03996291|541648819|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140409|NCT03996291|541648820|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140410|NCT03996291|541648821|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
150140411|NCT03248375|541648822|FG000|Overall Study|Lost to Follow-up|5|||
150140412|NCT05805657|541648823|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
150140413|NCT05805657|541648824|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
150140414|NCT02390531|541648828|FG000|Overall Study|Death|0|||
150140415|NCT02390531|541648829|FG001|Overall Study|Death|2|||
150140416|NCT02390531|541648830|FG002|Overall Study|Death|0|||
150140417|NCT02390531|541648831|FG003|Overall Study|Death|1|||
150140418|NCT02390531|541648832|FG004|Overall Study|Death|0|||
150140419|NCT02390531|541648833|FG005|Overall Study|Death|0|||
150140420|NCT02390531|541648834|FG006|Overall Study|Death|0|||
150140421|NCT02390531|541648835|FG007|Overall Study|Death|1|||
150140422|NCT02390531|541648828|FG000|Overall Study|Protocol Violation|0|||
150140423|NCT02390531|541648829|FG001|Overall Study|Protocol Violation|0|||
150140424|NCT02390531|541648830|FG002|Overall Study|Protocol Violation|0|||
150140425|NCT02390531|541648831|FG003|Overall Study|Protocol Violation|0|||
150140426|NCT02390531|541648832|FG004|Overall Study|Protocol Violation|1|||
150140427|NCT02390531|541648833|FG005|Overall Study|Protocol Violation|0|||
150140428|NCT02390531|541648834|FG006|Overall Study|Protocol Violation|2|||
150140429|NCT02390531|541648835|FG007|Overall Study|Protocol Violation|0|||
150140430|NCT00511875|541648836|FG000|Overall Study|Lost to Follow-up|4|||
150140431|NCT00511875|541648837|FG001|Overall Study|Lost to Follow-up|0|||
150140432|NCT00511875|541648836|FG000|Overall Study|Missing variables|1|||
150140433|NCT00511875|541648837|FG001|Overall Study|Missing variables|0|||
150140434|NCT02618616|541648838|FG000|Overall Study|Lack of Efficacy|4|||
150140435|NCT02618616|541648839|FG001|Overall Study|Lack of Efficacy|0|||
150140436|NCT02618616|541648838|FG000|Overall Study|Pregnancy|0|||
150140437|NCT02618616|541648839|FG001|Overall Study|Pregnancy|1|||
150140438|NCT02618616|541648838|FG000|Overall Study|Adverse Event|8|||
150140439|NCT02618616|541648839|FG001|Overall Study|Adverse Event|0|||
150140440|NCT02618616|541648838|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
150140441|NCT02618616|541648839|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
150140442|NCT02618616|541648838|FG000|Overall Study|Consent withdrawn by subject|8|||
150140443|NCT02618616|541648839|FG001|Overall Study|Consent withdrawn by subject|5|||
150140444|NCT02618616|541648838|FG000|Overall Study|Lost to Follow-up|0|||
150140445|NCT02618616|541648839|FG001|Overall Study|Lost to Follow-up|1|||
150140446|NCT03764072|541648840|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
150140447|NCT03764072|541648841|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
150140448|NCT03764072|541648842|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
150140449|NCT03764072|541648843|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
150140450|NCT03764072|541648844|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
150140451|NCT03764072|541648845|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
150140452|NCT03764072|541648840|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
150140453|NCT03764072|541648841|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
150140454|NCT03764072|541648842|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
150140455|NCT03764072|541648843|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
150140456|NCT03764072|541648844|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
150140457|NCT03764072|541648845|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
150140458|NCT03764072|541648840|FG000|Overall Study|Lost to Follow-up|0|||
150140459|NCT03764072|541648841|FG001|Overall Study|Lost to Follow-up|0|||
150140460|NCT03764072|541648842|FG002|Overall Study|Lost to Follow-up|0|||
150140461|NCT03764072|541648843|FG003|Overall Study|Lost to Follow-up|0|||
150140462|NCT03764072|541648844|FG004|Overall Study|Lost to Follow-up|1|||
150140463|NCT03764072|541648845|FG005|Overall Study|Lost to Follow-up|0|||
150140464|NCT00459342|541648847|FG000|Overall Study|Not eligible|1|||
150140465|NCT02686034|541648848|FG000|Run-In Period 1|Eligibility|12|||
150140466|NCT02686034|541648849|FG001|Run-In Period 1|Eligibility|10|||
150140467|NCT02686034|541648848|FG000|Run-In Period 1|Withdrawal by Subject|4|||
150140468|NCT02686034|541648849|FG001|Run-In Period 1|Withdrawal by Subject|3|||
150140469|NCT02686034|541648848|FG000|Run-In Period 1|Lost to Follow-up|4|||
150140470|NCT02686034|541648849|FG001|Run-In Period 1|Lost to Follow-up|4|||
150140471|NCT02686034|541648848|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
150140472|NCT02686034|541648849|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
150140473|NCT02686034|541648848|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
150140474|NCT02686034|541648849|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
150140475|NCT02686034|541648848|FG000|Randomized Controlled Period 2|Adverse Event|0|||
150140476|NCT02686034|541648849|FG001|Randomized Controlled Period 2|Adverse Event|2|||
150140477|NCT02686034|541648848|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
150140478|NCT02686034|541648849|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
150140479|NCT02686034|541648848|FG000|Open Label Period 3|Lost to Follow-up|0|||
150140480|NCT02686034|541648849|FG001|Open Label Period 3|Lost to Follow-up|1|||
150140481|NCT00542880|541648850|FG000|Period 1|Eligibility criteria not fulfilled|2|||
150140482|NCT00542880|541648851|FG001|Period 1|Eligibility criteria not fulfilled|6|||
150140483|NCT00542880|541648850|FG000|Period 1|Adverse Event|2|||
150140484|NCT00542880|541648851|FG001|Period 1|Adverse Event|2|||
150140485|NCT00542880|541648850|FG000|Period 1|Development of study-specific criteria|1|||
150140486|NCT00542880|541648851|FG001|Period 1|Development of study-specific criteria|2|||
150140487|NCT00542880|541648850|FG000|Period 1|Withdrawal by Subject|1|||
150140488|NCT00542880|541648851|FG001|Period 1|Withdrawal by Subject|1|||
150140489|NCT00542880|541648850|FG000|Period 1|Protocol Violation|0|||
150140490|NCT00542880|541648851|FG001|Period 1|Protocol Violation|1|||
150140491|NCT00542880|541648850|FG000|Period 2|Adverse Event|5|||
150140492|NCT00542880|541648851|FG001|Period 2|Adverse Event|7|||
150140493|NCT00542880|541648850|FG000|Period 2|Eligibility not fulfilled|0|||
150140494|NCT00542880|541648851|FG001|Period 2|Eligibility not fulfilled|1|||
150140495|NCT00542880|541648850|FG000|Period 2|Discontinuation criteria|2|||
150140496|NCT00542880|541648851|FG001|Period 2|Discontinuation criteria|0|||
150140497|NCT00542880|541648850|FG000|Period 2|Severe non-compliance|0|||
150140498|NCT00542880|541648851|FG001|Period 2|Severe non-compliance|1|||
150140499|NCT00542880|541648850|FG000|Period 2|Other|0|||
150140500|NCT00542880|541648851|FG001|Period 2|Other|1|||
150140501|NCT00542880|541648850|FG000|Period 3|Adverse Event|0|||
150140502|NCT00542880|541648851|FG001|Period 3|Adverse Event|2|||
150140503|NCT00696384|541648852|FG000|Open Label Phase|Adverse Event|27|||
150140504|NCT00696384|541648853|FG001|Open Label Phase|Adverse Event|0|||
150140505|NCT00696384|541648854|FG002|Open Label Phase|Adverse Event|0|||
150140506|NCT00696384|541648852|FG000|Open Label Phase|Protocol Violation|18|||
150140507|NCT00696384|541648853|FG001|Open Label Phase|Protocol Violation|0|||
150140508|NCT00696384|541648854|FG002|Open Label Phase|Protocol Violation|0|||
150140509|NCT00696384|541648852|FG000|Open Label Phase|Lost to Follow-up|24|||
150140510|NCT00696384|541648853|FG001|Open Label Phase|Lost to Follow-up|0|||
150140511|NCT00696384|541648854|FG002|Open Label Phase|Lost to Follow-up|0|||
150140512|NCT00696384|541648852|FG000|Open Label Phase|Withdrawal by Subject|37|||
150140513|NCT00696384|541648853|FG001|Open Label Phase|Withdrawal by Subject|0|||
150140514|NCT00696384|541648854|FG002|Open Label Phase|Withdrawal by Subject|0|||
150140515|NCT00696384|541648852|FG000|Open Label Phase|Other|6|||
150140516|NCT00696384|541648853|FG001|Open Label Phase|Other|0|||
150140517|NCT00696384|541648854|FG002|Open Label Phase|Other|0|||
150140518|NCT00696384|541648852|FG000|Open Label Phase|Lack of Efficacy|3|||
150140519|NCT00696384|541648853|FG001|Open Label Phase|Lack of Efficacy|0|||
150140520|NCT00696384|541648854|FG002|Open Label Phase|Lack of Efficacy|0|||
150140521|NCT00696384|541648852|FG000|Open Label Phase|Physician Decision|4|||
150140522|NCT00696384|541648853|FG001|Open Label Phase|Physician Decision|0|||
150140523|NCT00696384|541648854|FG002|Open Label Phase|Physician Decision|0|||
150140524|NCT00696384|541648852|FG000|Double Blind Phase|Adverse Event|0|||
150140525|NCT00696384|541648853|FG001|Double Blind Phase|Adverse Event|2|||
150140526|NCT00696384|541648854|FG002|Double Blind Phase|Adverse Event|2|||
150140527|NCT00696384|541648852|FG000|Double Blind Phase|Lost to Follow-up|0|||
150140528|NCT00696384|541648853|FG001|Double Blind Phase|Lost to Follow-up|2|||
150140529|NCT00696384|541648854|FG002|Double Blind Phase|Lost to Follow-up|1|||
150140530|NCT00696384|541648852|FG000|Double Blind Phase|Withdrawal by Subject|0|||
150140531|NCT00696384|541648853|FG001|Double Blind Phase|Withdrawal by Subject|4|||
150140532|NCT00696384|541648854|FG002|Double Blind Phase|Withdrawal by Subject|3|||
150140533|NCT00696384|541648852|FG000|Double Blind Phase|Lack of Efficacy|0|||
150140534|NCT00696384|541648853|FG001|Double Blind Phase|Lack of Efficacy|1|||
150140535|NCT00696384|541648854|FG002|Double Blind Phase|Lack of Efficacy|0|||
150140536|NCT00696384|541648852|FG000|Double Blind Phase|Physician Decision|0|||
150140537|NCT00696384|541648853|FG001|Double Blind Phase|Physician Decision|2|||
150140538|NCT00696384|541648854|FG002|Double Blind Phase|Physician Decision|0|||
150140539|NCT01678131|541648855|FG000|Overall Study|Adverse Event|0|||
150140540|NCT01678131|541648856|FG001|Overall Study|Adverse Event|1|||
150140541|NCT01678131|541648857|FG002|Overall Study|Adverse Event|0|||
150140542|NCT01678131|541648855|FG000|Overall Study|Withdrawal by Subject|0|||
150140543|NCT01678131|541648856|FG001|Overall Study|Withdrawal by Subject|0|||
150140544|NCT01678131|541648857|FG002|Overall Study|Withdrawal by Subject|2|||
150140545|NCT04179721|541648860|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
150140546|NCT04179721|541648861|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
150140547|NCT04179721|541648860|FG000|Overall Study|Lost to Follow-up|0|||
150140548|NCT04179721|541648861|FG001|Overall Study|Lost to Follow-up|1|||
150140549|NCT04225988|541648862|FG000|Overall Study|Withdrawal by Subject|2|||
150140550|NCT04225988|541648863|FG001|Overall Study|Withdrawal by Subject|0|||
150140551|NCT04425902|541650113|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
150140552|NCT01191840|541650114|FG000|Overall Study|withdrew consent|2|||
150140553|NCT01191840|541650115|FG001|Overall Study|withdrew consent|1|||
150140554|NCT01191840|541650114|FG000|Overall Study|Subject discontinued treatment|1|||
150140555|NCT01191840|541650115|FG001|Overall Study|Subject discontinued treatment|2|||
150140556|NCT01191840|541650114|FG000|Overall Study|Lost to Follow-up|4|||
150140557|NCT01191840|541650115|FG001|Overall Study|Lost to Follow-up|6|||
150140558|NCT01191840|541650114|FG000|Overall Study|Non Staph Infection|4|||
150140559|NCT01191840|541650115|FG001|Overall Study|Non Staph Infection|3|||
150140560|NCT01191840|541650114|FG000|Overall Study|ineligible at enrollment|1|||
150140561|NCT01191840|541650115|FG001|Overall Study|ineligible at enrollment|0|||
150140562|NCT01191840|541650114|FG000|Overall Study|IRB approval lapse|0|||
150140563|NCT01191840|541650115|FG001|Overall Study|IRB approval lapse|2|||
150140564|NCT01191840|541650114|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
150140565|NCT01191840|541650115|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
150140566|NCT01191840|541650114|FG000|Overall Study|Withdrawal by Subject|2|||
150140567|NCT01191840|541650115|FG001|Overall Study|Withdrawal by Subject|0|||
150140568|NCT04669600|541650116|FG000|Overall Study|Withdrawal by Subject|1|||
150140569|NCT04669600|541650116|FG000|Overall Study|Other|6|||
150140570|NCT01682213|541650124|FG000|Overall Study|Withdrawal by Subject|2|||
150140571|NCT01264380|541650125|FG000|Period C|Disease Progression|0|||
150140572|NCT01264380|541650126|FG001|Period C|Disease Progression|0|||
150140573|NCT01264380|541650127|FG002|Period C|Disease Progression|4|||
150140574|NCT01264380|541650125|FG000|Period C|Death|0|||
150140575|NCT01264380|541650126|FG001|Period C|Death|0|||
150140576|NCT01264380|541650127|FG002|Period C|Death|2|||
150140577|NCT01264380|541650125|FG000|Period C|Follow-up for survival status|0|||
150140578|NCT01264380|541650126|FG001|Period C|Follow-up for survival status|0|||
150140579|NCT01264380|541650127|FG002|Period C|Follow-up for survival status|6|||
150140580|NCT01264380|541650125|FG000|Period C|Withdrawal by Subject|0|||
150140581|NCT01264380|541650126|FG001|Period C|Withdrawal by Subject|0|||
150140582|NCT01264380|541650127|FG002|Period C|Withdrawal by Subject|1|||
150140583|NCT01264380|541650125|FG000|Period C|Adverse Event|0|||
150140584|NCT01264380|541650126|FG001|Period C|Adverse Event|0|||
150140585|NCT01264380|541650127|FG002|Period C|Adverse Event|1|||
150140586|NCT03474107|541650131|FG000|Overall Study|Adverse Event|42|||
150140587|NCT03474107|541650132|FG001|Overall Study|Adverse Event|46|||
150140588|NCT03474107|541650131|FG000|Overall Study|Death|2|||
150140589|NCT03474107|541650132|FG001|Overall Study|Death|2|||
150140590|NCT03474107|541650131|FG000|Overall Study|Lost to Follow-up|0|||
150140591|NCT03474107|541650132|FG001|Overall Study|Lost to Follow-up|1|||
150140592|NCT03474107|541650131|FG000|Overall Study|Progressive Disease|177|||
150140593|NCT03474107|541650132|FG001|Overall Study|Progressive Disease|180|||
150140594|NCT03474107|541650131|FG000|Overall Study|Protocol Violation|1|||
150140595|NCT03474107|541650132|FG001|Overall Study|Protocol Violation|1|||
150140596|NCT03474107|541650131|FG000|Overall Study|Withdrawal by Subject|15|||
150140597|NCT03474107|541650132|FG001|Overall Study|Withdrawal by Subject|27|||
150140598|NCT03474107|541650131|FG000|Overall Study|Physician Decision|7|||
150140599|NCT03474107|541650132|FG001|Overall Study|Physician Decision|22|||
150140600|NCT03474107|541650131|FG000|Overall Study|Miscellaneous|1|||
150140601|NCT03474107|541650132|FG001|Overall Study|Miscellaneous|6|||
150140602|NCT01932697|541650133|FG000|Overall Study|Received a different amount of tx|1|||
150140603|NCT01932697|541650134|FG001|Overall Study|Received a different amount of tx|0|||
150140604|NCT01932697|541650133|FG000|Overall Study|Ineligible|1|||
150140605|NCT01932697|541650134|FG001|Overall Study|Ineligible|0|||
150140606|NCT01330316|541650138|FG000|Overall Study|Adverse Event|2|||
150140607|NCT01330316|541650139|FG001|Overall Study|Adverse Event|2|||
150140608|NCT01330316|541650138|FG000|Overall Study|Lack of Efficacy|0|||
150140609|NCT01330316|541650139|FG001|Overall Study|Lack of Efficacy|10|||
150140610|NCT01330316|541650138|FG000|Overall Study|Lost to Follow-up|0|||
150140611|NCT01330316|541650139|FG001|Overall Study|Lost to Follow-up|1|||
150140612|NCT01330316|541650138|FG000|Overall Study|Withdrawal by Subject|0|||
150140613|NCT01330316|541650139|FG001|Overall Study|Withdrawal by Subject|1|||
150140614|NCT01330316|541650138|FG000|Overall Study|other than above|0|||
150140615|NCT01330316|541650139|FG001|Overall Study|other than above|1|||
150140616|NCT01337986|541650140|FG000|Overall Study|Adverse Event|2|||
150140617|NCT01337986|541650141|FG001|Overall Study|Adverse Event|2|||
150140618|NCT01337986|541650140|FG000|Overall Study|Lost to Follow-up|1|||
150140619|NCT01337986|541650141|FG001|Overall Study|Lost to Follow-up|0|||
150140620|NCT01337986|541650140|FG000|Overall Study|Protocol Violation|0|||
150140621|NCT01337986|541650141|FG001|Overall Study|Protocol Violation|3|||
150140622|NCT01520402|541650143|FG000|Overall Study|Withdrawal by Subject|2|||
150140623|NCT01520402|541650143|FG000|Overall Study|Physician Decision|3|||
150140624|NCT02287584|541650144|FG000|the Double-blind Phase|Adverse Event|17|||
150140625|NCT02287584|541650145|FG001|the Double-blind Phase|Adverse Event|17|||
150140626|NCT02287584|541650146|FG002|the Double-blind Phase|Adverse Event|12|||
150140627|NCT02287584|541650147|FG003|the Double-blind Phase|Adverse Event|0|||
150140628|NCT02287584|541650148|FG004|the Double-blind Phase|Adverse Event|0|||
150140629|NCT02287584|541650149|FG005|the Double-blind Phase|Adverse Event|0|||
150140630|NCT02287584|541650144|FG000|the Double-blind Phase|Lack of Efficacy|18|||
150140631|NCT02287584|541650145|FG001|the Double-blind Phase|Lack of Efficacy|8|||
150140632|NCT02287584|541650146|FG002|the Double-blind Phase|Lack of Efficacy|8|||
150140633|NCT02287584|541650147|FG003|the Double-blind Phase|Lack of Efficacy|0|||
150140634|NCT02287584|541650148|FG004|the Double-blind Phase|Lack of Efficacy|0|||
150140635|NCT02287584|541650149|FG005|the Double-blind Phase|Lack of Efficacy|0|||
150140636|NCT02287584|541650144|FG000|the Double-blind Phase|Lost to Follow-up|0|||
150140637|NCT02287584|541650145|FG001|the Double-blind Phase|Lost to Follow-up|1|||
150140638|NCT02287584|541650146|FG002|the Double-blind Phase|Lost to Follow-up|1|||
150140639|NCT02287584|541650147|FG003|the Double-blind Phase|Lost to Follow-up|0|||
150140640|NCT02287584|541650148|FG004|the Double-blind Phase|Lost to Follow-up|0|||
150140641|NCT02287584|541650149|FG005|the Double-blind Phase|Lost to Follow-up|0|||
150140642|NCT02287584|541650144|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
150140643|NCT02287584|541650145|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
150140644|NCT02287584|541650146|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
150140645|NCT02287584|541650147|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
150140646|NCT02287584|541650148|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
150140647|NCT02287584|541650149|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
150140648|NCT02287584|541650144|FG000|the Double-blind Phase|Pregnancy|0|||
150140649|NCT02287584|541650145|FG001|the Double-blind Phase|Pregnancy|1|||
150140650|NCT02287584|541650146|FG002|the Double-blind Phase|Pregnancy|0|||
150140651|NCT02287584|541650147|FG003|the Double-blind Phase|Pregnancy|0|||
150140652|NCT02287584|541650148|FG004|the Double-blind Phase|Pregnancy|0|||
150140653|NCT02287584|541650149|FG005|the Double-blind Phase|Pregnancy|0|||
150140654|NCT02287584|541650144|FG000|the Double-blind Phase|Protocol Violation|0|||
150140655|NCT02287584|541650145|FG001|the Double-blind Phase|Protocol Violation|3|||
150140656|NCT02287584|541650146|FG002|the Double-blind Phase|Protocol Violation|0|||
150140657|NCT02287584|541650147|FG003|the Double-blind Phase|Protocol Violation|0|||
150140658|NCT02287584|541650148|FG004|the Double-blind Phase|Protocol Violation|0|||
150140659|NCT02287584|541650149|FG005|the Double-blind Phase|Protocol Violation|0|||
150140660|NCT02287584|541650144|FG000|the Double-blind Phase|other reasons|0|||
150140661|NCT02287584|541650145|FG001|the Double-blind Phase|other reasons|0|||
150140662|NCT02287584|541650146|FG002|the Double-blind Phase|other reasons|1|||
150140663|NCT02287584|541650147|FG003|the Double-blind Phase|other reasons|0|||
150140664|NCT02287584|541650148|FG004|the Double-blind Phase|other reasons|0|||
150140665|NCT02287584|541650149|FG005|the Double-blind Phase|other reasons|0|||
150140666|NCT02287584|541650144|FG000|the Open-label Phase|Did not receive drug|0|||
150140667|NCT02287584|541650145|FG001|the Open-label Phase|Did not receive drug|0|||
150140668|NCT02287584|541650146|FG002|the Open-label Phase|Did not receive drug|0|||
150140669|NCT02287584|541650147|FG003|the Open-label Phase|Did not receive drug|7|||
150140670|NCT02287584|541650148|FG004|the Open-label Phase|Did not receive drug|6|||
150140671|NCT02287584|541650149|FG005|the Open-label Phase|Did not receive drug|4|||
150140672|NCT02287584|541650144|FG000|the Open-label Phase|Adverse Event|0|||
150140673|NCT02287584|541650145|FG001|the Open-label Phase|Adverse Event|0|||
150140674|NCT02287584|541650146|FG002|the Open-label Phase|Adverse Event|0|||
150140675|NCT02287584|541650147|FG003|the Open-label Phase|Adverse Event|15|||
150140676|NCT02287584|541650148|FG004|the Open-label Phase|Adverse Event|12|||
150140677|NCT02287584|541650149|FG005|the Open-label Phase|Adverse Event|16|||
150140678|NCT02287584|541650144|FG000|the Open-label Phase|Lack of Efficacy|0|||
150140679|NCT02287584|541650145|FG001|the Open-label Phase|Lack of Efficacy|0|||
150140680|NCT02287584|541650146|FG002|the Open-label Phase|Lack of Efficacy|0|||
150140681|NCT02287584|541650147|FG003|the Open-label Phase|Lack of Efficacy|8|||
150140682|NCT02287584|541650148|FG004|the Open-label Phase|Lack of Efficacy|3|||
150140683|NCT02287584|541650149|FG005|the Open-label Phase|Lack of Efficacy|7|||
150140684|NCT02287584|541650144|FG000|the Open-label Phase|Lost to Follow-up|0|||
150140685|NCT02287584|541650145|FG001|the Open-label Phase|Lost to Follow-up|0|||
150140686|NCT02287584|541650146|FG002|the Open-label Phase|Lost to Follow-up|0|||
150140687|NCT02287584|541650147|FG003|the Open-label Phase|Lost to Follow-up|4|||
150140688|NCT02287584|541650148|FG004|the Open-label Phase|Lost to Follow-up|1|||
150140689|NCT02287584|541650149|FG005|the Open-label Phase|Lost to Follow-up|2|||
150140690|NCT02287584|541650144|FG000|the Open-label Phase|Withdrawal by Subject|0|||
150140691|NCT02287584|541650145|FG001|the Open-label Phase|Withdrawal by Subject|0|||
150140692|NCT02287584|541650146|FG002|the Open-label Phase|Withdrawal by Subject|0|||
150140693|NCT02287584|541650147|FG003|the Open-label Phase|Withdrawal by Subject|18|||
150140694|NCT02287584|541650148|FG004|the Open-label Phase|Withdrawal by Subject|29|||
150140695|NCT02287584|541650149|FG005|the Open-label Phase|Withdrawal by Subject|21|||
150140696|NCT02287584|541650144|FG000|the Open-label Phase|non-compliance|0|||
150140697|NCT02287584|541650145|FG001|the Open-label Phase|non-compliance|0|||
150140698|NCT02287584|541650146|FG002|the Open-label Phase|non-compliance|0|||
150140699|NCT02287584|541650147|FG003|the Open-label Phase|non-compliance|2|||
150140700|NCT02287584|541650148|FG004|the Open-label Phase|non-compliance|5|||
150140701|NCT02287584|541650149|FG005|the Open-label Phase|non-compliance|1|||
150140702|NCT02287584|541650144|FG000|the Open-label Phase|other reasons|0|||
150140703|NCT02287584|541650145|FG001|the Open-label Phase|other reasons|0|||
150140704|NCT02287584|541650146|FG002|the Open-label Phase|other reasons|0|||
150140705|NCT02287584|541650147|FG003|the Open-label Phase|other reasons|3|||
150140706|NCT02287584|541650148|FG004|the Open-label Phase|other reasons|6|||
150140707|NCT02287584|541650149|FG005|the Open-label Phase|other reasons|6|||
150140708|NCT01492686|541650152|FG000|Double-blind Phase|Adverse Event|0|||
150140709|NCT01492686|541650153|FG001|Double-blind Phase|Adverse Event|2|||
150140710|NCT01492686|541650152|FG000|Double-blind Phase|Physician Decision|0|||
150140711|NCT01492686|541650153|FG001|Double-blind Phase|Physician Decision|1|||
150140712|NCT01492686|541650152|FG000|Double-blind Phase|Withdrawal by Subject|0|||
150140713|NCT01492686|541650153|FG001|Double-blind Phase|Withdrawal by Subject|2|||
150140714|NCT01492686|541650152|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
150140715|NCT01492686|541650153|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
150140716|NCT01492686|541650152|FG000|Open-label Phase|Adverse Event|1|||
150140717|NCT01492686|541650153|FG001|Open-label Phase|Adverse Event|2|||
150140718|NCT01492686|541650152|FG000|Open-label Phase|Physician Decision|1|||
150140719|NCT01492686|541650153|FG001|Open-label Phase|Physician Decision|0|||
150140720|NCT01492686|541650152|FG000|Open-label Phase|Withdrawal by Subject|6|||
150140721|NCT01492686|541650153|FG001|Open-label Phase|Withdrawal by Subject|7|||
150140722|NCT01492686|541650152|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
150140723|NCT01492686|541650153|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
150140724|NCT03086018|541650155|FG000|Final Testing for End of Trial|Adverse Event|1|||
150140725|NCT03086018|541650155|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
150140726|NCT01892345|541650156|FG000|Overall Study|Adverse Event|0|||
150140727|NCT01892345|541650157|FG001|Overall Study|Adverse Event|2|||
150140728|NCT01892345|541650156|FG000|Overall Study|Death|1|||
150140729|NCT01892345|541650157|FG001|Overall Study|Death|0|||
150140730|NCT01892345|541650156|FG000|Overall Study|Lost to Follow-up|3|||
150140731|NCT01892345|541650157|FG001|Overall Study|Lost to Follow-up|0|||
150140732|NCT01892345|541650156|FG000|Overall Study|Withdrawal by Subject|12|||
150140733|NCT01892345|541650157|FG001|Overall Study|Withdrawal by Subject|1|||
150140734|NCT00077064|541650161|FG000|Overall Study|Adverse Event|0|||
150140735|NCT00077064|541650162|FG001|Overall Study|Adverse Event|4|||
150140736|NCT00077064|541650161|FG000|Overall Study|Patient refusal|0|||
150140737|NCT00077064|541650162|FG001|Overall Study|Patient refusal|2|||
150140738|NCT00621543|541650163|FG000|Overall Study|Lost to Follow-up|23|||
150140739|NCT02192970|541650166|FG000|Overall Study|Lost to Follow-up|6|||
150140740|NCT02192970|541650167|FG001|Overall Study|Lost to Follow-up|0|||
150140741|NCT00792103|541650168|FG000|Overall Study|Enrolled, not treated|15|||
150140742|NCT00792103|541650168|FG000|Overall Study|Lost to Follow-up|17|||
150140743|NCT00792103|541650168|FG000|Overall Study|Adverse Event|25|||
150140744|NCT00792103|541650168|FG000|Overall Study|Withdrawal by Subject|52|||
150140745|NCT00792103|541650168|FG000|Overall Study|Protocol Violation|10|||
150140746|NCT00792103|541650168|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
150140747|NCT03745222|541650169|FG000|Overall Study|Withdrawal by Subject|0|||
150140748|NCT03745222|541650170|FG001|Overall Study|Withdrawal by Subject|1|||
150140749|NCT03745222|541650171|FG002|Overall Study|Withdrawal by Subject|0|||
150140750|NCT01281202|541650175|FG000|Overall Study|Adverse Event|2|||
150140751|NCT01281202|541650176|FG001|Overall Study|Adverse Event|0|||
150140752|NCT01281202|541650175|FG000|Overall Study|Withdrawal by Subject|2|||
150140753|NCT01281202|541650176|FG001|Overall Study|Withdrawal by Subject|2|||
150140754|NCT01281202|541650175|FG000|Overall Study|Protocol Violation|11|||
150140755|NCT01281202|541650176|FG001|Overall Study|Protocol Violation|10|||
150140756|NCT01281202|541650175|FG000|Overall Study|Administrative|2|||
150140757|NCT01281202|541650176|FG001|Overall Study|Administrative|8|||
150140758|NCT01281202|541650175|FG000|Overall Study|Lost to Follow-up|11|||
150140759|NCT01281202|541650176|FG001|Overall Study|Lost to Follow-up|13|||
150140760|NCT01281202|541650175|FG000|Overall Study|Incarceration|0|||
150140761|NCT01281202|541650176|FG001|Overall Study|Incarceration|3|||
150140762|NCT02063828|541650179|FG000|Overall Study|Withdrawal by Subject|4|||
150140763|NCT02063828|541650180|FG001|Overall Study|Withdrawal by Subject|6|||
150140764|NCT02063828|541650181|FG002|Overall Study|Withdrawal by Subject|3|||
150140765|NCT02063828|541650179|FG000|Overall Study|Death|0|||
150140766|NCT02063828|541650180|FG001|Overall Study|Death|0|||
150140767|NCT02063828|541650181|FG002|Overall Study|Death|1|||
150140768|NCT03483038|541650182|FG000|Overall Study|Subjects still in follow-up|18|||
150140769|NCT01064297|541650183|FG000|Overall Study|Lost to Follow-up|791|||
150140770|NCT01064297|541650184|FG001|Overall Study|Lost to Follow-up|48|||
150140771|NCT01064297|541650185|FG002|Overall Study|Lost to Follow-up|133|||
150140772|NCT00558064|541650198|FG000|Overall Study|Adverse Event|3|||
150140773|NCT00558064|541650199|FG001|Overall Study|Adverse Event|2|||
150140774|NCT00558064|541650198|FG000|Overall Study|Lack of Efficacy|0|||
150140775|NCT00558064|541650199|FG001|Overall Study|Lack of Efficacy|1|||
150140776|NCT00558064|541650198|FG000|Overall Study|Protocol Violation|1|||
150140777|NCT00558064|541650199|FG001|Overall Study|Protocol Violation|0|||
150140778|NCT00558064|541650198|FG000|Overall Study|Lost to Follow-up|0|||
150140779|NCT00558064|541650199|FG001|Overall Study|Lost to Follow-up|1|||
150140780|NCT00558064|541650198|FG000|Overall Study|Withdrawal by Subject|0|||
150140781|NCT00558064|541650199|FG001|Overall Study|Withdrawal by Subject|1|||
150140782|NCT00558064|541650198|FG000|Overall Study|No visit within allowance period|1|||
150140783|NCT00558064|541650199|FG001|Overall Study|No visit within allowance period|0|||
150140784|NCT02027402|541650203|FG000|Overall Study|Withdrawal by Subject|4|||
150140785|NCT02027402|541650204|FG001|Overall Study|Withdrawal by Subject|1|||
150140786|NCT00982930|541650207|FG000|Overall Study|Adverse Event|1|||
150140787|NCT00982930|541650207|FG000|Overall Study|Withdrawal by Subject|1|||
150140788|NCT00982930|541650207|FG000|Overall Study|Administrative Problems|2|||
150140789|NCT00941798|541650208|FG000|Overall Study|Withdrawal by Subject|72|||
150140790|NCT00941798|541650209|FG001|Overall Study|Withdrawal by Subject|74|||
150140791|NCT00941798|541650208|FG000|Overall Study|Adverse Event|43|||
150140792|NCT00941798|541650209|FG001|Overall Study|Adverse Event|23|||
150140793|NCT00941798|541650208|FG000|Overall Study|Lost to Follow-up|29|||
150140794|NCT00941798|541650209|FG001|Overall Study|Lost to Follow-up|23|||
150140795|NCT00941798|541650208|FG000|Overall Study|Protocol Violation|17|||
150140796|NCT00941798|541650209|FG001|Overall Study|Protocol Violation|20|||
150140797|NCT00941798|541650208|FG000|Overall Study|Administrative problems|13|||
150140798|NCT00941798|541650209|FG001|Overall Study|Administrative problems|23|||
150140799|NCT00941798|541650208|FG000|Overall Study|Lack of Efficacy|10|||
150140800|NCT00941798|541650209|FG001|Overall Study|Lack of Efficacy|17|||
150140801|NCT00941798|541650208|FG000|Overall Study|Patient's inability to use device|6|||
150140802|NCT00941798|541650209|FG001|Overall Study|Patient's inability to use device|1|||
150140803|NCT00941798|541650208|FG000|Overall Study|Abnormal test procedure results|3|||
150140804|NCT00941798|541650209|FG001|Overall Study|Abnormal test procedure results|1|||
150140805|NCT00941798|541650208|FG000|Overall Study|Abnormal laboratory values|1|||
150140806|NCT00941798|541650209|FG001|Overall Study|Abnormal laboratory values|2|||
150140807|NCT00941798|541650208|FG000|Overall Study|Death|0|||
150140808|NCT00941798|541650209|FG001|Overall Study|Death|1|||
150140809|NCT04108000|541650210|FG000|Overall Study|Death of patient|1|||
150140810|NCT04108000|541650211|FG001|Overall Study|Death of patient|0|||
150140811|NCT04108000|541650212|FG002|Overall Study|Death of patient|1|||
150140812|NCT04108000|541650213|FG003|Overall Study|Death of patient|0|||
150140813|NCT04108000|541650210|FG000|Overall Study|Withdrawal by Subject|2|||
150140814|NCT04108000|541650211|FG001|Overall Study|Withdrawal by Subject|2|||
150140815|NCT04108000|541650212|FG002|Overall Study|Withdrawal by Subject|0|||
150140816|NCT04108000|541650213|FG003|Overall Study|Withdrawal by Subject|0|||
150140817|NCT04108000|541650210|FG000|Overall Study|Death of surrogate partner|0|||
150140818|NCT04108000|541650211|FG001|Overall Study|Death of surrogate partner|1|||
150140819|NCT04108000|541650212|FG002|Overall Study|Death of surrogate partner|0|||
150140820|NCT04108000|541650213|FG003|Overall Study|Death of surrogate partner|1|||
150140821|NCT03904043|541650216|FG000|Overall Study|Adverse Event|1|||
150140822|NCT03904043|541650217|FG001|Overall Study|Adverse Event|1|||
150140823|NCT03904043|541650216|FG000|Overall Study|Withdrawal by Subject|1|||
150140824|NCT03904043|541650217|FG001|Overall Study|Withdrawal by Subject|0|||
150140825|NCT03904043|541650216|FG000|Overall Study|Non-compliance|1|||
150140826|NCT03904043|541650217|FG001|Overall Study|Non-compliance|0|||
150140827|NCT03904043|541650216|FG000|Overall Study|Did not start treatment|1|||
150140828|NCT03904043|541650217|FG001|Overall Study|Did not start treatment|0|||
150140829|NCT05559866|541650218|FG000|Overall Study|Withdrawal by Subject|1|||
150140830|NCT05559866|541650219|FG001|Overall Study|Withdrawal by Subject|0|||
150140831|NCT03750006|541650220|FG000|Overall Study|Withdrawal by Subject|8|||
150140832|NCT03750006|541650220|FG000|Overall Study|COVID PANDEMIC|11|||
150140833|NCT05619003|541650221|FG000|Overall Study|Adverse Event|1|||
150140834|NCT03538951|541650222|FG000|Overall Study|Withdrawal by Subject|1|||
150140835|NCT03538951|541650223|FG001|Overall Study|Withdrawal by Subject|2|||
150140836|NCT07018999|541650229|FG000|Overall Study|Protocol Violation|0|||
150140837|NCT07018999|541650230|FG001|Overall Study|Protocol Violation|1|||
150140838|NCT07018999|541650229|FG000|Overall Study|Incomplete data entry|4|||
150140839|NCT07018999|541650230|FG001|Overall Study|Incomplete data entry|7|||
150140840|NCT03444376|541650231|FG000|Part A|Disease relapse or Progression|1|||
150140841|NCT03444376|541650231|FG000|Part A|Withdrawal by Subject|2|||
150140842|NCT03444376|541650231|FG000|Part A|Adverse Event|1|||
150140843|NCT03444376|541650231|FG000|Part B|Disease relapse or Progression|18|||
150140844|NCT03444376|541650231|FG000|Part B|Withdrawal by Subject|2|||
150140845|NCT03444376|541650231|FG000|Part B|Adverse Event|2|||
150140846|NCT03444376|541650231|FG000|Part B|Physician Decision|1|||
150140847|NCT03444376|541650231|FG000|Part C|Disease relapse or Progression|43|||
150140848|NCT03444376|541650231|FG000|Part C|Withdrawal by Subject|5|||
150140849|NCT03444376|541650231|FG000|Part C|Adverse Event|2|||
150140850|NCT03444376|541650231|FG000|Part C|Physician Decision|2|||
150140851|NCT03444376|541650231|FG000|Part C|Death|1|||
150140852|NCT01373931|541651940|FG000|Lead-in Period|Adverse Event|2|||
150140853|NCT01373931|541651941|FG001|Lead-in Period|Adverse Event|0|||
150140854|NCT01373931|541651940|FG000|Period 1|Adverse Event|2|||
150140855|NCT01373931|541651941|FG001|Period 1|Adverse Event|0|||
150140856|NCT01373931|541651940|FG000|Period 1|Withdrawal by Subject|0|||
150140857|NCT01373931|541651941|FG001|Period 1|Withdrawal by Subject|2|||
150140858|NCT01995539|541651942|FG000|Overall Study|Screening Failure|1|||
150140859|NCT01995539|541651942|FG000|Overall Study|Withdrawal by Investigator|15|||
150140860|NCT01995539|541651942|FG000|Overall Study|Withdrawal by Subject|11|||
150140861|NCT01995539|541651942|FG000|Overall Study|Lost to Follow-up|5|||
150140862|NCT01995539|541651942|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
150140863|NCT01147822|541651943|FG000|Overall Study|Lost to Follow-up|14|||
150140864|NCT01147822|541651944|FG001|Overall Study|Lost to Follow-up|6|||
150140865|NCT01147822|541651943|FG000|Overall Study|Withdrawal by Subject|10|||
150140866|NCT01147822|541651944|FG001|Overall Study|Withdrawal by Subject|16|||
150140867|NCT01147822|541651943|FG000|Overall Study|Physician Decision|9|||
150140868|NCT01147822|541651944|FG001|Overall Study|Physician Decision|8|||
150140869|NCT01147822|541651943|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
150140870|NCT01147822|541651944|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
150140871|NCT01147822|541651943|FG000|Overall Study|Protocol Violation|1|||
150140872|NCT01147822|541651944|FG001|Overall Study|Protocol Violation|1|||
150140873|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
150140874|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
150140875|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
150140876|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
150140877|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
150140878|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
150140879|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
150140880|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
150140881|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
150140882|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
150140883|NCT00261495|541651947|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
150140884|NCT00261495|541651948|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
150140885|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
150140886|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
150140887|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
150140888|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
150140889|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
150140890|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
150140891|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
150140892|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
150140893|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
150140894|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
150140895|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
150140896|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
150140897|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
150140898|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
150140899|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
150140900|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
150140901|NCT00261495|541651947|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
150140902|NCT00261495|541651948|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
150140903|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
150140904|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
150140905|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
150140906|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
150140907|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
150140908|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
150140909|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
150140910|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
150140911|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
150140912|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
150140913|NCT00261495|541651947|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
150140914|NCT00261495|541651948|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
150140915|NCT04207840|541651949|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
150140916|NCT04207840|541651950|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
150140917|NCT04207840|541651951|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
150140918|NCT04207840|541651949|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
150140919|NCT04207840|541651950|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
150140920|NCT04207840|541651951|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
150140921|NCT03243422|541651952|FG000|Overall Study|Death|20|||
150140922|NCT03243422|541651953|FG001|Overall Study|Death|21|||
150140923|NCT03243422|541651952|FG000|Overall Study|Lost to Follow-up|9|||
150140924|NCT03243422|541651953|FG001|Overall Study|Lost to Follow-up|21|||
150140925|NCT03243422|541651952|FG000|Overall Study|Withdrawal by Subject|22|||
150140926|NCT03243422|541651953|FG001|Overall Study|Withdrawal by Subject|8|||
150140927|NCT02173054|541651954|FG000|Overall Study|lack of compliance|1|||
150140928|NCT02173054|541651955|FG001|Overall Study|lack of compliance|0|||
150140929|NCT02173054|541651956|FG002|Overall Study|lack of compliance|0|||
150140930|NCT02173054|541651954|FG000|Overall Study|Withdrawal by Subject|0|||
150140931|NCT02173054|541651955|FG001|Overall Study|Withdrawal by Subject|0|||
150217233|NCT01072149|541932307|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150140932|NCT02173054|541651956|FG002|Overall Study|Withdrawal by Subject|1|||
150140933|NCT03430063|541651959|FG000|Overall Study|Adverse Event|0|||
150140934|NCT03430063|541651960|FG001|Overall Study|Adverse Event|1|||
150140935|NCT03430063|541651961|FG002|Overall Study|Adverse Event|0|||
150140936|NCT03430063|541651959|FG000|Overall Study|Death|3|||
150140937|NCT03430063|541651960|FG001|Overall Study|Death|2|||
150140938|NCT03430063|541651961|FG002|Overall Study|Death|3|||
150140939|NCT03430063|541651959|FG000|Overall Study|Lost to Follow-up|0|||
150140940|NCT03430063|541651960|FG001|Overall Study|Lost to Follow-up|1|||
150140941|NCT03430063|541651961|FG002|Overall Study|Lost to Follow-up|0|||
150140942|NCT03430063|541651959|FG000|Overall Study|Withdrawal by Subject|0|||
150140943|NCT03430063|541651960|FG001|Overall Study|Withdrawal by Subject|0|||
150140944|NCT03430063|541651961|FG002|Overall Study|Withdrawal by Subject|1|||
150140945|NCT03430063|541651959|FG000|Overall Study|Withdrawal of consent|3|||
150140946|NCT03430063|541651960|FG001|Overall Study|Withdrawal of consent|1|||
150140947|NCT03430063|541651961|FG002|Overall Study|Withdrawal of consent|2|||
150140948|NCT03430063|541651959|FG000|Overall Study|Progressive disease|1|||
150140949|NCT03430063|541651960|FG001|Overall Study|Progressive disease|2|||
150140950|NCT03430063|541651961|FG002|Overall Study|Progressive disease|1|||
150140951|NCT03430063|541651959|FG000|Overall Study|Other un-specified|1|||
150140952|NCT03430063|541651960|FG001|Overall Study|Other un-specified|1|||
150140953|NCT03430063|541651961|FG002|Overall Study|Other un-specified|0|||
150140954|NCT03430063|541651959|FG000|Overall Study|Randomized, but never treated|0|||
150140955|NCT03430063|541651960|FG001|Overall Study|Randomized, but never treated|0|||
150140956|NCT03430063|541651961|FG002|Overall Study|Randomized, but never treated|1|||
150140957|NCT03124199|541651962|FG000|Overall Study|Lost to Follow-up|4|||
150140958|NCT02798211|541651963|FG000|Period 1|Adverse Event|1|||
150140959|NCT02798211|541651964|FG001|Period 1|Adverse Event|1|||
150140960|NCT02798211|541651965|FG002|Period 1|Adverse Event|0|||
150140961|NCT02798211|541651966|FG003|Period 1|Adverse Event|0|||
150140962|NCT02798211|541651967|FG004|Period 1|Adverse Event|0|||
150140963|NCT02798211|541651968|FG005|Period 1|Adverse Event|0|||
150140964|NCT02798211|541651963|FG000|Period 1|Lost to Follow-up|2|||
150140965|NCT02798211|541651964|FG001|Period 1|Lost to Follow-up|1|||
150140966|NCT02798211|541651965|FG002|Period 1|Lost to Follow-up|0|||
150140967|NCT02798211|541651966|FG003|Period 1|Lost to Follow-up|0|||
150140968|NCT02798211|541651967|FG004|Period 1|Lost to Follow-up|0|||
150140969|NCT02798211|541651968|FG005|Period 1|Lost to Follow-up|0|||
150140970|NCT02798211|541651963|FG000|Period 1|Protocol Violation|0|||
150140971|NCT02798211|541651964|FG001|Period 1|Protocol Violation|0|||
150140972|NCT02798211|541651965|FG002|Period 1|Protocol Violation|2|||
150140973|NCT02798211|541651966|FG003|Period 1|Protocol Violation|0|||
150140974|NCT02798211|541651967|FG004|Period 1|Protocol Violation|0|||
150140975|NCT02798211|541651968|FG005|Period 1|Protocol Violation|0|||
150140976|NCT02798211|541651963|FG000|Period 1|Withdrawal by Subject|1|||
150140977|NCT02798211|541651964|FG001|Period 1|Withdrawal by Subject|1|||
150140978|NCT02798211|541651965|FG002|Period 1|Withdrawal by Subject|0|||
150140979|NCT02798211|541651966|FG003|Period 1|Withdrawal by Subject|0|||
150140980|NCT02798211|541651967|FG004|Period 1|Withdrawal by Subject|0|||
150140981|NCT02798211|541651968|FG005|Period 1|Withdrawal by Subject|0|||
150140982|NCT02798211|541651963|FG000|Period 1|Death|0|||
150140983|NCT02798211|541651964|FG001|Period 1|Death|0|||
150140984|NCT02798211|541651965|FG002|Period 1|Death|1|||
150140985|NCT02798211|541651966|FG003|Period 1|Death|0|||
150140986|NCT02798211|541651967|FG004|Period 1|Death|0|||
150140987|NCT02798211|541651968|FG005|Period 1|Death|0|||
150140988|NCT02798211|541651963|FG000|Period 1|Withdrawal of Informed Consent|2|||
150140989|NCT02798211|541651964|FG001|Period 1|Withdrawal of Informed Consent|7|||
150140990|NCT02798211|541651965|FG002|Period 1|Withdrawal of Informed Consent|3|||
150140991|NCT02798211|541651966|FG003|Period 1|Withdrawal of Informed Consent|0|||
150140992|NCT02798211|541651967|FG004|Period 1|Withdrawal of Informed Consent|0|||
150140993|NCT02798211|541651968|FG005|Period 1|Withdrawal of Informed Consent|0|||
150140994|NCT02798211|541651963|FG000|Period 2|Withdrawal by Subject|2|||
150140995|NCT02798211|541651964|FG001|Period 2|Withdrawal by Subject|0|||
150140996|NCT02798211|541651965|FG002|Period 2|Withdrawal by Subject|0|||
150140997|NCT02798211|541651966|FG003|Period 2|Withdrawal by Subject|0|||
150140998|NCT02798211|541651967|FG004|Period 2|Withdrawal by Subject|2|||
150140999|NCT02798211|541651968|FG005|Period 2|Withdrawal by Subject|2|||
150141000|NCT02798211|541651963|FG000|Period 2|Adverse Event|5|||
150141001|NCT02798211|541651964|FG001|Period 2|Adverse Event|0|||
150141002|NCT02798211|541651965|FG002|Period 2|Adverse Event|0|||
150141003|NCT02798211|541651966|FG003|Period 2|Adverse Event|0|||
150141004|NCT02798211|541651967|FG004|Period 2|Adverse Event|1|||
150141005|NCT02798211|541651968|FG005|Period 2|Adverse Event|0|||
150141006|NCT02798211|541651963|FG000|Period 2|Lack of Efficacy|1|||
150141007|NCT02798211|541651964|FG001|Period 2|Lack of Efficacy|0|||
150141008|NCT02798211|541651965|FG002|Period 2|Lack of Efficacy|0|||
150141009|NCT02798211|541651966|FG003|Period 2|Lack of Efficacy|1|||
150141010|NCT02798211|541651967|FG004|Period 2|Lack of Efficacy|0|||
150141011|NCT02798211|541651968|FG005|Period 2|Lack of Efficacy|1|||
150141012|NCT02798211|541651963|FG000|Period 2|Lost to Follow-up|3|||
150141013|NCT02798211|541651964|FG001|Period 2|Lost to Follow-up|0|||
150141014|NCT02798211|541651965|FG002|Period 2|Lost to Follow-up|0|||
150141015|NCT02798211|541651966|FG003|Period 2|Lost to Follow-up|0|||
150141016|NCT02798211|541651967|FG004|Period 2|Lost to Follow-up|2|||
150141017|NCT02798211|541651968|FG005|Period 2|Lost to Follow-up|0|||
150141018|NCT02798211|541651963|FG000|Period 2|Physician Decision|1|||
150141019|NCT02798211|541651964|FG001|Period 2|Physician Decision|0|||
150141020|NCT02798211|541651965|FG002|Period 2|Physician Decision|0|||
150141021|NCT02798211|541651966|FG003|Period 2|Physician Decision|1|||
150141022|NCT02798211|541651967|FG004|Period 2|Physician Decision|1|||
150141023|NCT02798211|541651968|FG005|Period 2|Physician Decision|0|||
150141024|NCT02798211|541651963|FG000|Period 2|Pregnancy|0|||
150141025|NCT02798211|541651964|FG001|Period 2|Pregnancy|0|||
150141026|NCT02798211|541651965|FG002|Period 2|Pregnancy|0|||
150141027|NCT02798211|541651966|FG003|Period 2|Pregnancy|2|||
150141028|NCT02798211|541651967|FG004|Period 2|Pregnancy|0|||
150141029|NCT02798211|541651968|FG005|Period 2|Pregnancy|0|||
150141030|NCT02798211|541651963|FG000|Period 2|Technical problems|1|||
150141031|NCT02798211|541651964|FG001|Period 2|Technical problems|0|||
150141032|NCT02798211|541651965|FG002|Period 2|Technical problems|0|||
150141033|NCT02798211|541651966|FG003|Period 2|Technical problems|1|||
150141034|NCT02798211|541651967|FG004|Period 2|Technical problems|0|||
150141035|NCT02798211|541651968|FG005|Period 2|Technical problems|0|||
150141036|NCT02798211|541651963|FG000|Period 2|Withdrawal of Informed Consent|1|||
150141037|NCT02798211|541651964|FG001|Period 2|Withdrawal of Informed Consent|0|||
150141038|NCT02798211|541651965|FG002|Period 2|Withdrawal of Informed Consent|0|||
150141039|NCT02798211|541651966|FG003|Period 2|Withdrawal of Informed Consent|2|||
150141040|NCT02798211|541651967|FG004|Period 2|Withdrawal of Informed Consent|2|||
150141041|NCT02798211|541651968|FG005|Period 2|Withdrawal of Informed Consent|3|||
150141042|NCT01782872|541651969|FG000|Overall Study|Protocol Violation|0|||
150141043|NCT01782872|541651970|FG001|Overall Study|Protocol Violation|0|||
150141044|NCT01782872|541651971|FG002|Overall Study|Protocol Violation|0|||
150141045|NCT01782872|541651972|FG003|Overall Study|Protocol Violation|1|||
150141046|NCT01782872|541651969|FG000|Overall Study|Withdrawal by Subject|0|||
150141047|NCT01782872|541651970|FG001|Overall Study|Withdrawal by Subject|1|||
150141048|NCT01782872|541651971|FG002|Overall Study|Withdrawal by Subject|0|||
150141049|NCT01782872|541651972|FG003|Overall Study|Withdrawal by Subject|0|||
150141050|NCT00659984|541651975|FG000|Overall Study|Adverse Event|1|||
150141051|NCT04026165|541651978|FG000|Run-in Placebo Period|Enrollment Error|13|||
150141052|NCT04026165|541651979|FG001|Run-in Placebo Period|Enrollment Error|0|||
150141053|NCT04026165|541651980|FG002|Run-in Placebo Period|Enrollment Error|0|||
150141054|NCT04026165|541651981|FG003|Run-in Placebo Period|Enrollment Error|0|||
150141055|NCT04026165|541651978|FG000|Run-in Placebo Period|Run-in Failure|4|||
150141056|NCT04026165|541651979|FG001|Run-in Placebo Period|Run-in Failure|0|||
150141057|NCT04026165|541651980|FG002|Run-in Placebo Period|Run-in Failure|0|||
150141058|NCT04026165|541651981|FG003|Run-in Placebo Period|Run-in Failure|0|||
150141059|NCT04026165|541651978|FG000|Run-in Placebo Period|Protocol Violation|2|||
150141060|NCT04026165|541651979|FG001|Run-in Placebo Period|Protocol Violation|0|||
150141061|NCT04026165|541651980|FG002|Run-in Placebo Period|Protocol Violation|0|||
150141062|NCT04026165|541651981|FG003|Run-in Placebo Period|Protocol Violation|0|||
150141063|NCT04026165|541651978|FG000|Run-in Placebo Period|Withdrew Consent|2|||
150141064|NCT04026165|541651979|FG001|Run-in Placebo Period|Withdrew Consent|0|||
150141065|NCT04026165|541651980|FG002|Run-in Placebo Period|Withdrew Consent|0|||
150141066|NCT04026165|541651981|FG003|Run-in Placebo Period|Withdrew Consent|0|||
150141067|NCT04026165|541651978|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
150141068|NCT04026165|541651979|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
150141069|NCT04026165|541651980|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
150141070|NCT04026165|541651981|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
150141071|NCT04026165|541651978|FG000|Run-in SEL Period|Run-in Failure|0|||
150141072|NCT04026165|541651979|FG001|Run-in SEL Period|Run-in Failure|26|||
150141073|NCT04026165|541651980|FG002|Run-in SEL Period|Run-in Failure|0|||
150141074|NCT04026165|541651981|FG003|Run-in SEL Period|Run-in Failure|0|||
150141075|NCT04026165|541651978|FG000|Run-in SEL Period|Withdrew Consent|0|||
150141076|NCT04026165|541651979|FG001|Run-in SEL Period|Withdrew Consent|10|||
150141077|NCT04026165|541651980|FG002|Run-in SEL Period|Withdrew Consent|0|||
150141078|NCT04026165|541651981|FG003|Run-in SEL Period|Withdrew Consent|0|||
150141079|NCT04026165|541651978|FG000|Run-in SEL Period|Enrollment Error|0|||
150141080|NCT04026165|541651979|FG001|Run-in SEL Period|Enrollment Error|4|||
150141081|NCT04026165|541651980|FG002|Run-in SEL Period|Enrollment Error|0|||
150141082|NCT04026165|541651981|FG003|Run-in SEL Period|Enrollment Error|0|||
150141083|NCT04026165|541651978|FG000|Run-in SEL Period|Protocol Violation|0|||
150141084|NCT04026165|541651979|FG001|Run-in SEL Period|Protocol Violation|3|||
150141085|NCT04026165|541651980|FG002|Run-in SEL Period|Protocol Violation|0|||
150141086|NCT04026165|541651981|FG003|Run-in SEL Period|Protocol Violation|0|||
150141087|NCT04026165|541651978|FG000|Run-in SEL Period|Investigator's Discretion|0|||
150141088|NCT04026165|541651979|FG001|Run-in SEL Period|Investigator's Discretion|2|||
150141089|NCT04026165|541651980|FG002|Run-in SEL Period|Investigator's Discretion|0|||
150141090|NCT04026165|541651981|FG003|Run-in SEL Period|Investigator's Discretion|0|||
150141091|NCT04026165|541651978|FG000|Run-in SEL Period|Death|0|||
150141092|NCT04026165|541651979|FG001|Run-in SEL Period|Death|1|||
150141093|NCT04026165|541651980|FG002|Run-in SEL Period|Death|0|||
150141094|NCT04026165|541651981|FG003|Run-in SEL Period|Death|0|||
150141095|NCT04026165|541651978|FG000|Randomized Period|Withdrew Consent|0|||
150141096|NCT04026165|541651979|FG001|Randomized Period|Withdrew Consent|0|||
150141097|NCT04026165|541651980|FG002|Randomized Period|Withdrew Consent|5|||
150141098|NCT04026165|541651981|FG003|Randomized Period|Withdrew Consent|8|||
150141099|NCT04026165|541651978|FG000|Randomized Period|Death|0|||
150141100|NCT04026165|541651979|FG001|Randomized Period|Death|0|||
150141101|NCT04026165|541651980|FG002|Randomized Period|Death|5|||
150141102|NCT04026165|541651981|FG003|Randomized Period|Death|7|||
150141103|NCT04026165|541651978|FG000|Randomized Period|Investigator's Discretion|0|||
150141104|NCT04026165|541651979|FG001|Randomized Period|Investigator's Discretion|0|||
150141105|NCT04026165|541651980|FG002|Randomized Period|Investigator's Discretion|2|||
150141106|NCT04026165|541651981|FG003|Randomized Period|Investigator's Discretion|2|||
150141107|NCT04026165|541651978|FG000|Randomized Period|Lost to Follow-up|0|||
150141108|NCT04026165|541651979|FG001|Randomized Period|Lost to Follow-up|0|||
150141109|NCT04026165|541651980|FG002|Randomized Period|Lost to Follow-up|2|||
150141110|NCT04026165|541651981|FG003|Randomized Period|Lost to Follow-up|2|||
150141111|NCT01059630|541651982|FG000|Overall Study|Death|100|||
150141112|NCT01059630|541651983|FG001|Overall Study|Death|84|||
150141113|NCT01059630|541651982|FG000|Overall Study|Lost to Follow-up|4|||
150141114|NCT01059630|541651983|FG001|Overall Study|Lost to Follow-up|1|||
150141115|NCT01059630|541651982|FG000|Overall Study|Physician Decision|2|||
150141116|NCT01059630|541651983|FG001|Overall Study|Physician Decision|4|||
150141117|NCT01059630|541651982|FG000|Overall Study|Withdrawal by Subject|21|||
150141118|NCT01059630|541651983|FG001|Overall Study|Withdrawal by Subject|14|||
150141119|NCT03170375|541651984|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
150141120|NCT03170375|541651985|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
150141121|NCT03170375|541651986|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
150141122|NCT03170375|541651984|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
150141123|NCT03170375|541651985|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
150141124|NCT03170375|541651986|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
150141125|NCT00441701|541651987|FG000|Overall Study|Adverse Event|3|||
150141126|NCT00441701|541651988|FG001|Overall Study|Adverse Event|2|||
150141127|NCT00441701|541651989|FG002|Overall Study|Adverse Event|1|||
150141128|NCT00441701|541651990|FG003|Overall Study|Adverse Event|0|||
150141129|NCT00441701|541651991|FG004|Overall Study|Adverse Event|2|||
150141130|NCT00441701|541651992|FG005|Overall Study|Adverse Event|2|||
150141131|NCT00441701|541651993|FG006|Overall Study|Adverse Event|0|||
150141132|NCT00441701|541651994|FG007|Overall Study|Adverse Event|0|||
150141133|NCT00441701|541651995|FG008|Overall Study|Adverse Event|0|||
150141134|NCT00441701|541651996|FG009|Overall Study|Adverse Event|0|||
150141135|NCT00441701|541651987|FG000|Overall Study|Lack of Efficacy|2|||
150141136|NCT00441701|541651988|FG001|Overall Study|Lack of Efficacy|0|||
150141137|NCT00441701|541651989|FG002|Overall Study|Lack of Efficacy|2|||
150141138|NCT00441701|541651990|FG003|Overall Study|Lack of Efficacy|2|||
150141139|NCT00441701|541651991|FG004|Overall Study|Lack of Efficacy|0|||
150141140|NCT00441701|541651992|FG005|Overall Study|Lack of Efficacy|1|||
150141141|NCT00441701|541651993|FG006|Overall Study|Lack of Efficacy|0|||
150141142|NCT00441701|541651994|FG007|Overall Study|Lack of Efficacy|0|||
150141143|NCT00441701|541651995|FG008|Overall Study|Lack of Efficacy|0|||
150141144|NCT00441701|541651996|FG009|Overall Study|Lack of Efficacy|0|||
150141145|NCT00441701|541651987|FG000|Overall Study|Withdrawal by Subject|0|||
150141146|NCT00441701|541651988|FG001|Overall Study|Withdrawal by Subject|2|||
150141147|NCT00441701|541651989|FG002|Overall Study|Withdrawal by Subject|1|||
150141148|NCT00441701|541651990|FG003|Overall Study|Withdrawal by Subject|1|||
150141149|NCT00441701|541651991|FG004|Overall Study|Withdrawal by Subject|0|||
150141150|NCT00441701|541651992|FG005|Overall Study|Withdrawal by Subject|0|||
150141151|NCT00441701|541651993|FG006|Overall Study|Withdrawal by Subject|0|||
150141152|NCT00441701|541651994|FG007|Overall Study|Withdrawal by Subject|0|||
150141153|NCT00441701|541651995|FG008|Overall Study|Withdrawal by Subject|0|||
150141154|NCT00441701|541651996|FG009|Overall Study|Withdrawal by Subject|0|||
150141155|NCT01287611|541652002|FG000|Overall Study|Lost to Follow-up|29|||
150141156|NCT01287611|541652003|FG001|Overall Study|Lost to Follow-up|16|||
150141157|NCT01287611|541652002|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
150141158|NCT01287611|541652003|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
150141159|NCT00763958|541652004|FG000|Overall Study|did not meet final criteria|4|||
150141160|NCT00763958|541652005|FG001|Overall Study|did not meet final criteria|4|||
150141161|NCT00763958|541652004|FG000|Overall Study|Lost to Follow-up|10|||
150141162|NCT00763958|541652005|FG001|Overall Study|Lost to Follow-up|2|||
150141163|NCT00763958|541652004|FG000|Overall Study|Believed they were receiving placebo|0|||
150141164|NCT00763958|541652005|FG001|Overall Study|Believed they were receiving placebo|5|||
150141165|NCT04074590|541652006|FG000|Overall Study|Adverse Event|1|||
150141166|NCT04074590|541652007|FG001|Overall Study|Adverse Event|0|||
150141167|NCT04074590|541652006|FG000|Overall Study|Physician Decision|1|||
150141168|NCT04074590|541652007|FG001|Overall Study|Physician Decision|0|||
150141169|NCT04074590|541652006|FG000|Overall Study|Withdrawal by Subject|2|||
150141170|NCT04074590|541652007|FG001|Overall Study|Withdrawal by Subject|0|||
150141171|NCT03299686|541652009|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
150141172|NCT03299686|541652010|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
150141173|NCT03299686|541652009|FG000|Treatment Epoch|Physician Decision|1|||
150141174|NCT03299686|541652010|FG001|Treatment Epoch|Physician Decision|0|||
150141175|NCT03299686|541652009|FG000|Treatment Epoch|Adverse Event|8|||
150141176|NCT03299686|541652010|FG001|Treatment Epoch|Adverse Event|4|||
150141177|NCT03299686|541652009|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
150141178|NCT03299686|541652010|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
150141179|NCT02709005|541652011|FG000|Overall Study|Lost to Follow-up|1|||
150141180|NCT02709005|541652012|FG001|Overall Study|Lost to Follow-up|1|||
150141181|NCT02709005|541652011|FG000|Overall Study|Withdrawal by Subject|3|||
150141182|NCT02709005|541652012|FG001|Overall Study|Withdrawal by Subject|0|||
150141183|NCT00499863|541652018|FG000|Overall Study|Lack of Efficacy|21|||
150141184|NCT00499863|541652019|FG001|Overall Study|Lack of Efficacy|27|||
150217234|NCT01072149|541932308|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
150141185|NCT00499863|541652018|FG000|Overall Study|Protocol Violation|12|||
150141186|NCT00499863|541652019|FG001|Overall Study|Protocol Violation|7|||
150141187|NCT00499863|541652018|FG000|Overall Study|Withdrawal by Subject|6|||
150141188|NCT00499863|541652019|FG001|Overall Study|Withdrawal by Subject|4|||
150141189|NCT00499863|541652018|FG000|Overall Study|Adverse Event|8|||
150141190|NCT00499863|541652019|FG001|Overall Study|Adverse Event|2|||
150141191|NCT00499863|541652018|FG000|Overall Study|Sponsor decision|2|||
150141192|NCT00499863|541652019|FG001|Overall Study|Sponsor decision|2|||
150141193|NCT00499863|541652018|FG000|Overall Study|Lost to Follow-up|1|||
150141194|NCT00499863|541652019|FG001|Overall Study|Lost to Follow-up|1|||
150141195|NCT02535364|541652020|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
150141196|NCT02535364|541652020|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
150141197|NCT02535364|541652020|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
150141198|NCT02535364|541652020|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
150141199|NCT02535364|541652020|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
150141200|NCT02535364|541652020|FG000|Part B Screening|Death|2|||
150141201|NCT02535364|541652020|FG000|Part B Screening|Physician Decision|1|||
150141202|NCT02535364|541652020|FG000|Part B Screening|Withdrawal by Subject|1|||
150141203|NCT02535364|541652020|FG000|Part B Screening|Adverse Event|1|||
150141204|NCT02535364|541652020|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
150141205|NCT02535364|541652020|FG000|Study Treatment|Death|1|||
150141206|NCT02535364|541652020|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
150141207|NCT02535364|541652020|FG000|12-Month Follow-up Period|Disease progression|22|||
150141208|NCT02535364|541652020|FG000|12-Month Follow-up Period|Death|5|||
150141209|NCT02535364|541652020|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
150141210|NCT02535364|541652020|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
150141211|NCT02535364|541652020|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
150141212|NCT00571701|541652021|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
150141213|NCT00571701|541652022|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
150141214|NCT00571701|541652021|FG000|First Intervention 12 Months|Death|1|||
150141215|NCT00571701|541652022|FG001|First Intervention 12 Months|Death|0|||
150141216|NCT00571701|541652021|FG000|Second Intervention 12 Months|Adverse Event|0|||
150141217|NCT00571701|541652022|FG001|Second Intervention 12 Months|Adverse Event|1|||
150141218|NCT00571701|541652021|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
150141219|NCT00571701|541652022|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
150141220|NCT04707196|541652023|FG000|Overall Study|Withdrawal by Subject|9|||
150141221|NCT04707196|541652024|FG001|Overall Study|Withdrawal by Subject|6|||
150141222|NCT04707196|541652023|FG000|Overall Study|Lost to Follow-up|1|||
150141223|NCT04707196|541652024|FG001|Overall Study|Lost to Follow-up|0|||
150141224|NCT04707196|541652023|FG000|Overall Study|Protocol Violation|4|||
150141225|NCT04707196|541652024|FG001|Overall Study|Protocol Violation|1|||
150141226|NCT04707196|541652023|FG000|Overall Study|Adverse Event|2|||
150141227|NCT04707196|541652024|FG001|Overall Study|Adverse Event|2|||
150141228|NCT04707196|541652023|FG000|Overall Study|Death|3|||
150141229|NCT04707196|541652024|FG001|Overall Study|Death|1|||
150141230|NCT04707196|541652023|FG000|Overall Study|Non-compliance with study drug|1|||
150141231|NCT04707196|541652024|FG001|Overall Study|Non-compliance with study drug|0|||
150141232|NCT04707196|541652023|FG000|Overall Study|Progressive disease|9|||
150141233|NCT04707196|541652024|FG001|Overall Study|Progressive disease|10|||
150141234|NCT01862796|541652025|FG000|Overall Study|Prohibited medications|0|||
150141235|NCT01862796|541652026|FG001|Overall Study|Prohibited medications|0|||
150141236|NCT01862796|541652027|FG002|Overall Study|Prohibited medications|1|||
150141237|NCT01462162|541652028|FG000|Overall Study|Adverse Event|5|||
150141238|NCT01462162|541652028|FG000|Overall Study|Lack of Efficacy|4|||
150141239|NCT01462162|541652028|FG000|Overall Study|Abnormal laboratory parameters|1|||
150141240|NCT01462162|541652028|FG000|Overall Study|Other|2|||
150141241|NCT03485911|541652029|FG000|Part 1|Perceived lack of efficacy|1|||
150141242|NCT03485911|541652030|FG001|Part 1|Perceived lack of efficacy|1|||
150141243|NCT03485911|541652031|FG002|Part 1|Perceived lack of efficacy|2|||
150141244|NCT03485911|541652032|FG003|Part 1|Perceived lack of efficacy|0|||
150141245|NCT03485911|541652029|FG000|Part 1|Subject withdrew consent|0|||
150141246|NCT03485911|541652030|FG001|Part 1|Subject withdrew consent|1|||
150141247|NCT03485911|541652031|FG002|Part 1|Subject withdrew consent|0|||
150141248|NCT03485911|541652032|FG003|Part 1|Subject withdrew consent|1|||
150141249|NCT03485911|541652029|FG000|Part 1|Lab abnormalities/AEs|3|||
150141250|NCT03485911|541652030|FG001|Part 1|Lab abnormalities/AEs|1|||
150141251|NCT03485911|541652031|FG002|Part 1|Lab abnormalities/AEs|1|||
150141252|NCT03485911|541652032|FG003|Part 1|Lab abnormalities/AEs|0|||
150141253|NCT03485911|541652029|FG000|Part 1|Withdrew Consent prior to dosing|0|||
150141254|NCT03485911|541652030|FG001|Part 1|Withdrew Consent prior to dosing|0|||
150141255|NCT03485911|541652031|FG002|Part 1|Withdrew Consent prior to dosing|0|||
150217235|NCT01072149|541932291|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217236|NCT01072149|541932292|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150141256|NCT03485911|541652032|FG003|Part 1|Withdrew Consent prior to dosing|1|||
150141257|NCT03485911|541652029|FG000|Part 1|Other NOS|0|||
150141258|NCT03485911|541652030|FG001|Part 1|Other NOS|0|||
150141259|NCT03485911|541652031|FG002|Part 1|Other NOS|0|||
150141260|NCT03485911|541652032|FG003|Part 1|Other NOS|1|||
150141261|NCT03485911|541652029|FG000|Part 2|Perceived lack of efficacy|5|||
150141262|NCT03485911|541652030|FG001|Part 2|Perceived lack of efficacy|3|||
150141263|NCT03485911|541652031|FG002|Part 2|Perceived lack of efficacy|0|||
150141264|NCT03485911|541652032|FG003|Part 2|Perceived lack of efficacy|2|||
150141265|NCT03485911|541652029|FG000|Part 2|Subject withdrew consent|1|||
150141266|NCT03485911|541652030|FG001|Part 2|Subject withdrew consent|0|||
150141267|NCT03485911|541652031|FG002|Part 2|Subject withdrew consent|2|||
150141268|NCT03485911|541652032|FG003|Part 2|Subject withdrew consent|1|||
150141269|NCT03485911|541652029|FG000|Part 2|Lab abnormalities/AEs|1|||
150141270|NCT03485911|541652030|FG001|Part 2|Lab abnormalities/AEs|2|||
150141271|NCT03485911|541652031|FG002|Part 2|Lab abnormalities/AEs|0|||
150141272|NCT03485911|541652032|FG003|Part 2|Lab abnormalities/AEs|0|||
150141273|NCT03485911|541652029|FG000|Part 2|Other NOS|0|||
150141274|NCT03485911|541652030|FG001|Part 2|Other NOS|1|||
150141275|NCT03485911|541652031|FG002|Part 2|Other NOS|0|||
150141276|NCT03485911|541652032|FG003|Part 2|Other NOS|0|||
150141277|NCT03485911|541652029|FG000|Part 2|Intercurrent illness/new medical condition|1|||
150141278|NCT03485911|541652030|FG001|Part 2|Intercurrent illness/new medical condition|0|||
150141279|NCT03485911|541652031|FG002|Part 2|Intercurrent illness/new medical condition|0|||
150141280|NCT03485911|541652032|FG003|Part 2|Intercurrent illness/new medical condition|0|||
150141281|NCT03485911|541652029|FG000|Part 2|Investigator judgement|1|||
150141282|NCT03485911|541652030|FG001|Part 2|Investigator judgement|0|||
150141283|NCT03485911|541652031|FG002|Part 2|Investigator judgement|0|||
150141284|NCT03485911|541652032|FG003|Part 2|Investigator judgement|0|||
150141285|NCT03485911|541652029|FG000|Part 3|Perceived lack of efficacy|2|||
150141286|NCT03485911|541652030|FG001|Part 3|Perceived lack of efficacy|2|||
150141287|NCT03485911|541652031|FG002|Part 3|Perceived lack of efficacy|2|||
150217237|NCT01072149|541932293|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
150217238|NCT01072149|541932294|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217239|NCT01072149|541932295|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217240|NCT01072149|541932296|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217241|NCT01072149|541932297|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217242|NCT01072149|541932298|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217243|NCT01072149|541932299|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217244|NCT01072149|541932300|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217245|NCT01072149|541932301|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217246|NCT01072149|541932302|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217247|NCT01072149|541932303|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217248|NCT01072149|541932304|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
150217249|NCT01072149|541932305|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217250|NCT01072149|541932306|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217251|NCT01072149|541932307|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217252|NCT01072149|541932308|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
150217253|NCT02784834|541932309|FG000|Overall Study|Lack of Efficacy|1|||
150217254|NCT01090739|541932315|FG000|Enrollment|Withdrawal by Subject|24|||
150217255|NCT01090739|541932315|FG000|Enrollment|Protocol Violation|14|||
150217256|NCT01090739|541932315|FG000|Enrollment|Lost to Follow-up|5|||
150217257|NCT01090739|541932315|FG000|Enrollment|Physician Decision|5|||
150217258|NCT01090739|541932315|FG000|Enrollment|Sponsor termination of site|4|||
150217259|NCT01090739|541932315|FG000|Enrollment|Study implant limit reached|2|||
150217260|NCT01090739|541932315|FG000|Enrollment|Adverse Event|1|||
150217261|NCT01090739|541932315|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
150217262|NCT01090739|541932315|FG000|12 Month Follow-up|Lost to Follow-up|1|||
150217263|NCT01090739|541932315|FG000|12 Month Follow-up|Physician Decision|1|||
150217264|NCT01090739|541932315|FG000|12 Month Follow-up|Death|1|||
150217265|NCT01090739|541932315|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
150217266|NCT01090739|541932315|FG000|24 Month Follow-up|Lost to Follow-up|1|||
150217267|NCT01090739|541932315|FG000|24 Month Follow-up|Death|1|||
150217268|NCT01090739|541932315|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
150217269|NCT01090739|541932315|FG000|36 Month Follow-up|Visit still pending|17|||
150217270|NCT00988429|541932316|FG000|Overall Study|Adverse Event|9|||
150217271|NCT00988429|541932317|FG001|Overall Study|Adverse Event|21|||
150217272|NCT00988429|541932318|FG002|Overall Study|Adverse Event|45|||
150217273|NCT00988429|541932316|FG000|Overall Study|Lack of Efficacy|0|||
150217274|NCT00988429|541932317|FG001|Overall Study|Lack of Efficacy|0|||
150217275|NCT00988429|541932318|FG002|Overall Study|Lack of Efficacy|1|||
150217276|NCT00988429|541932316|FG000|Overall Study|Non-Compliance with Study Drug|5|||
150217277|NCT00988429|541932317|FG001|Overall Study|Non-Compliance with Study Drug|1|||
150217278|NCT00988429|541932318|FG002|Overall Study|Non-Compliance with Study Drug|3|||
150217279|NCT00988429|541932316|FG000|Overall Study|Physician Decision|1|||
150217280|NCT00988429|541932317|FG001|Overall Study|Physician Decision|0|||
150217281|NCT00988429|541932318|FG002|Overall Study|Physician Decision|3|||
150217282|NCT00988429|541932316|FG000|Overall Study|Pregnancy|2|||
150217283|NCT00988429|541932317|FG001|Overall Study|Pregnancy|1|||
150217284|NCT00988429|541932318|FG002|Overall Study|Pregnancy|0|||
150217285|NCT00988429|541932316|FG000|Overall Study|Protocol Violation|4|||
150217286|NCT00988429|541932317|FG001|Overall Study|Protocol Violation|3|||
150141288|NCT03485911|541652032|FG003|Part 3|Perceived lack of efficacy|0|||
150141289|NCT03485911|541652029|FG000|Part 3|Subject withdrew consent|1|||
150141290|NCT03485911|541652030|FG001|Part 3|Subject withdrew consent|4|||
150141291|NCT03485911|541652031|FG002|Part 3|Subject withdrew consent|0|||
150141292|NCT03485911|541652032|FG003|Part 3|Subject withdrew consent|1|||
150217287|NCT00988429|541932318|FG002|Overall Study|Protocol Violation|3|||
150217288|NCT00988429|541932316|FG000|Overall Study|Withdrawal by Subject|7|||
150217289|NCT00988429|541932317|FG001|Overall Study|Withdrawal by Subject|7|||
150217290|NCT00988429|541932318|FG002|Overall Study|Withdrawal by Subject|12|||
150217291|NCT00988429|541932316|FG000|Overall Study|Administrative Reasons|1|||
150217292|NCT00988429|541932317|FG001|Overall Study|Administrative Reasons|2|||
150217293|NCT00988429|541932318|FG002|Overall Study|Administrative Reasons|1|||
150217294|NCT00988429|541932316|FG000|Overall Study|other reasons|8|||
150217295|NCT00988429|541932317|FG001|Overall Study|other reasons|8|||
150217296|NCT00988429|541932318|FG002|Overall Study|other reasons|1|||
150217297|NCT00441168|541932319|FG000|Treatment Period|Death|3|||
150217298|NCT00441168|541932320|FG001|Treatment Period|Death|0|||
150217299|NCT00441168|541932319|FG000|Treatment Period|Adverse Event|1|||
150217300|NCT00441168|541932320|FG001|Treatment Period|Adverse Event|2|||
150217301|NCT00441168|541932319|FG000|Treatment Period|Progressive Disease|0|||
150217302|NCT00441168|541932320|FG001|Treatment Period|Progressive Disease|2|||
150217303|NCT00441168|541932319|FG000|Treatment Period|Protocol Violation|0|||
150217304|NCT00441168|541932320|FG001|Treatment Period|Protocol Violation|1|||
150217305|NCT00441168|541932319|FG000|Treatment Period|Lost to Follow-up|0|||
150217306|NCT00441168|541932320|FG001|Treatment Period|Lost to Follow-up|1|||
150217307|NCT00441168|541932319|FG000|Treatment Period|Withdrawal by Subject|3|||
150217308|NCT00441168|541932320|FG001|Treatment Period|Withdrawal by Subject|0|||
150217309|NCT00441168|541932319|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
150217310|NCT00441168|541932320|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
150217311|NCT00441168|541932319|FG000|Treatment Period|refractory disease|1|||
150217312|NCT00441168|541932320|FG001|Treatment Period|refractory disease|0|||
150217313|NCT00441168|541932319|FG000|Follow-up Period|Death|3|||
150217314|NCT00441168|541932320|FG001|Follow-up Period|Death|0|||
150217315|NCT00441168|541932319|FG000|Follow-up Period|Lost to Follow-up|5|||
150217316|NCT00441168|541932320|FG001|Follow-up Period|Lost to Follow-up|6|||
150217317|NCT00441168|541932319|FG000|Follow-up Period|Withdrawal by Subject|3|||
150217318|NCT00441168|541932320|FG001|Follow-up Period|Withdrawal by Subject|0|||
150217319|NCT00441168|541932319|FG000|Follow-up Period|Other|1|||
150217320|NCT00441168|541932320|FG001|Follow-up Period|Other|3|||
150217321|NCT02964234|541932321|FG000|Overall Study|Lost to Follow-up|22|||
150217322|NCT02964234|541932322|FG001|Overall Study|Lost to Follow-up|13|||
150217323|NCT01799993|541932324|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
150217324|NCT01799993|541932325|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
150217325|NCT01799993|541932324|FG000|Overall Study|Death|61|||
150217326|NCT01799993|541932325|FG001|Overall Study|Death|45|||
150217327|NCT01799993|541932324|FG000|Overall Study|Withdrawal by Subject|23|||
150217328|NCT01799993|541932325|FG001|Overall Study|Withdrawal by Subject|24|||
150217329|NCT01799993|541932324|FG000|Overall Study|Lost to Follow-up|5|||
150217330|NCT01799993|541932325|FG001|Overall Study|Lost to Follow-up|8|||
150217331|NCT01799993|541932324|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
150217332|NCT01799993|541932325|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
150217333|NCT01799993|541932324|FG000|Overall Study|Protocol driven decision point|0|||
150217334|NCT01799993|541932325|FG001|Overall Study|Protocol driven decision point|3|||
150217335|NCT01799993|541932324|FG000|Overall Study|Protocol Violation|1|||
150217336|NCT01799993|541932325|FG001|Overall Study|Protocol Violation|1|||
150217337|NCT01799993|541932324|FG000|Overall Study|Deterioration of general conditions|2|||
150217338|NCT01799993|541932325|FG001|Overall Study|Deterioration of general conditions|0|||
150217339|NCT01799993|541932324|FG000|Overall Study|Screen failure|0|||
150217340|NCT01799993|541932325|FG001|Overall Study|Screen failure|1|||
150217341|NCT01799993|541932324|FG000|Overall Study|Adverse Event|1|||
150217342|NCT01799993|541932325|FG001|Overall Study|Adverse Event|0|||
150217343|NCT01799993|541932324|FG000|Overall Study|Lack of Efficacy|1|||
150217344|NCT01799993|541932325|FG001|Overall Study|Lack of Efficacy|0|||
150217345|NCT01799993|541932324|FG000|Overall Study|Recovery|0|||
150217346|NCT01799993|541932325|FG001|Overall Study|Recovery|1|||
150217347|NCT01799993|541932324|FG000|Overall Study|Logistical difficulties|1|||
150217348|NCT01799993|541932325|FG001|Overall Study|Logistical difficulties|0|||
150217349|NCT01799993|541932324|FG000|Overall Study|Protocol deviation|1|||
150217350|NCT01799993|541932325|FG001|Overall Study|Protocol deviation|0|||
150217351|NCT01799993|541932324|FG000|Overall Study|Non-compliance with medical device|1|||
150217352|NCT01799993|541932325|FG001|Overall Study|Non-compliance with medical device|0|||
150217353|NCT01799993|541932324|FG000|Overall Study|Withdrawal by parent/guardian|0|||
150217354|NCT01799993|541932325|FG001|Overall Study|Withdrawal by parent/guardian|1|||
150217355|NCT01799993|541932324|FG000|Overall Study|Other|1|||
150217356|NCT01799993|541932325|FG001|Overall Study|Other|0|||
150217357|NCT01799993|541932324|FG000|Overall Study|Subject didn't return for follow-up|0|||
150217358|NCT01799993|541932325|FG001|Overall Study|Subject didn't return for follow-up|1|||
150217359|NCT01328756|541932335|FG000|Overall Study|Protocol Violation|4|||
150217360|NCT01328756|541932335|FG000|Overall Study|Adverse Event|39|||
150217361|NCT01328756|541932335|FG000|Overall Study|Lack of Efficacy|5|||
150217362|NCT01328756|541932335|FG000|Overall Study|Withdrawal by Subject|41|||
150217363|NCT01328756|541932335|FG000|Overall Study|Lost to Follow-up|5|||
150217364|NCT01328756|541932335|FG000|Overall Study|Other|29|||
150217365|NCT03692871|541932338|FG000|Overall Study|Death|1|||
150217366|NCT03692871|541932339|FG001|Overall Study|Death|1|||
150217367|NCT03692871|541932338|FG000|Overall Study|Lost to Follow-up|24|||
150217368|NCT03692871|541932339|FG001|Overall Study|Lost to Follow-up|9|||
150217369|NCT03692871|541932338|FG000|Overall Study|Physician Decision|22|||
150217370|NCT03692871|541932339|FG001|Overall Study|Physician Decision|7|||
150217371|NCT03692871|541932338|FG000|Overall Study|Protocol Deviation|1|||
150217372|NCT03692871|541932339|FG001|Overall Study|Protocol Deviation|0|||
150217373|NCT03692871|541932338|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
150217374|NCT03692871|541932339|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
150217375|NCT02852824|541932342|FG000|Overall Study|Withdrawal by Subject|1|||
150217376|NCT02852824|541932343|FG001|Overall Study|Withdrawal by Subject|0|||
150217377|NCT02852824|541932344|FG002|Overall Study|Withdrawal by Subject|0|||
150217378|NCT02852824|541932345|FG003|Overall Study|Withdrawal by Subject|0|||
150217379|NCT02852824|541932346|FG004|Overall Study|Withdrawal by Subject|0|||
150217380|NCT02852824|541932347|FG005|Overall Study|Withdrawal by Subject|0|||
150217381|NCT02852824|541932348|FG006|Overall Study|Withdrawal by Subject|0|||
150217382|NCT02852824|541932342|FG000|Overall Study|Adverse Event|0|||
150217383|NCT02852824|541932343|FG001|Overall Study|Adverse Event|0|||
150217384|NCT02852824|541932344|FG002|Overall Study|Adverse Event|0|||
150217385|NCT02852824|541932345|FG003|Overall Study|Adverse Event|0|||
150217386|NCT02852824|541932346|FG004|Overall Study|Adverse Event|2|||
150217387|NCT02852824|541932347|FG005|Overall Study|Adverse Event|0|||
150217388|NCT02852824|541932348|FG006|Overall Study|Adverse Event|0|||
150217389|NCT01316913|541932349|FG000|Overall Study|Adverse Event|17|||
150217390|NCT01316913|541932350|FG001|Overall Study|Adverse Event|20|||
150217391|NCT01316913|541932351|FG002|Overall Study|Adverse Event|15|||
150217392|NCT01316913|541932352|FG003|Overall Study|Adverse Event|11|||
150217393|NCT01316913|541932349|FG000|Overall Study|Lack of Efficacy|22|||
150217394|NCT01316913|541932350|FG001|Overall Study|Lack of Efficacy|12|||
150217395|NCT01316913|541932351|FG002|Overall Study|Lack of Efficacy|9|||
150217396|NCT01316913|541932352|FG003|Overall Study|Lack of Efficacy|13|||
150217397|NCT01316913|541932349|FG000|Overall Study|Protocol Violation|1|||
150217398|NCT01316913|541932350|FG001|Overall Study|Protocol Violation|4|||
150217399|NCT01316913|541932351|FG002|Overall Study|Protocol Violation|4|||
150217400|NCT01316913|541932352|FG003|Overall Study|Protocol Violation|1|||
150217401|NCT01316913|541932349|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
150217402|NCT01316913|541932350|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
150217403|NCT01316913|541932351|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
150217404|NCT01316913|541932352|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
150217405|NCT01316913|541932349|FG000|Overall Study|Lost to Follow-up|0|||
150217406|NCT01316913|541932350|FG001|Overall Study|Lost to Follow-up|1|||
150217407|NCT01316913|541932351|FG002|Overall Study|Lost to Follow-up|0|||
150217408|NCT01316913|541932352|FG003|Overall Study|Lost to Follow-up|2|||
150217409|NCT01316913|541932349|FG000|Overall Study|Withdrawal by Subject|10|||
150217410|NCT01316913|541932350|FG001|Overall Study|Withdrawal by Subject|9|||
150217411|NCT01316913|541932351|FG002|Overall Study|Withdrawal by Subject|10|||
150217412|NCT01316913|541932352|FG003|Overall Study|Withdrawal by Subject|6|||
150217413|NCT04867382|541932353|FG000|Overall Study|Did not complete the survey|2|||
150217414|NCT04867382|541932354|FG001|Overall Study|Did not complete the survey|1|||
150217415|NCT02102724|541932355|FG000|Overall Study|Lost to Follow-up|1|||
150217416|NCT02102724|541932356|FG001|Overall Study|Lost to Follow-up|0|||
150217417|NCT02102724|541932355|FG000|Overall Study|surgery for brain aneurysm|1|||
150217418|NCT02102724|541932356|FG001|Overall Study|surgery for brain aneurysm|1|||
150217419|NCT05445557|541932357|FG000|Double Blind Part|Lost to Follow-up|1|||
150217420|NCT02008916|541932358|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
150217421|NCT02008916|541932359|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
150217422|NCT02008916|541932360|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
150217423|NCT02008916|541932358|FG000|Week 16 - 156|Adverse Event|4|||
150217424|NCT02008916|541932359|FG001|Week 16 - 156|Adverse Event|2|||
150217425|NCT02008916|541932360|FG002|Week 16 - 156|Adverse Event|3|||
150217426|NCT02008916|541932358|FG000|Week 16 - 156|Withdrawal by Subject|7|||
150217427|NCT02008916|541932359|FG001|Week 16 - 156|Withdrawal by Subject|3|||
150217428|NCT02008916|541932360|FG002|Week 16 - 156|Withdrawal by Subject|5|||
150217429|NCT02008916|541932358|FG000|Week 16 - 156|No longer requires treatment|0|||
150217430|NCT02008916|541932359|FG001|Week 16 - 156|No longer requires treatment|1|||
150217431|NCT02008916|541932360|FG002|Week 16 - 156|No longer requires treatment|0|||
150217432|NCT02008916|541932358|FG000|Week 16 - 156|Lost to Follow-up|5|||
150217433|NCT02008916|541932359|FG001|Week 16 - 156|Lost to Follow-up|0|||
150217434|NCT02008916|541932360|FG002|Week 16 - 156|Lost to Follow-up|0|||
150217435|NCT02008916|541932358|FG000|Week 16 - 156|Lack of Efficacy|3|||
150217436|NCT02008916|541932359|FG001|Week 16 - 156|Lack of Efficacy|5|||
150217437|NCT02008916|541932360|FG002|Week 16 - 156|Lack of Efficacy|2|||
150217438|NCT02008916|541932358|FG000|Week 16 - 156|Pregnancy|0|||
150217439|NCT02008916|541932359|FG001|Week 16 - 156|Pregnancy|1|||
150217440|NCT02008916|541932360|FG002|Week 16 - 156|Pregnancy|0|||
150217441|NCT02008916|541932358|FG000|Week 16 - 156|Physician Decision|0|||
150217442|NCT02008916|541932359|FG001|Week 16 - 156|Physician Decision|1|||
150217443|NCT02008916|541932360|FG002|Week 16 - 156|Physician Decision|0|||
150217444|NCT01915914|541932364|FG000|Acute Phase|Withdrawal by Subject|4|||
150217445|NCT01915914|541932365|FG001|Acute Phase|Withdrawal by Subject|0|||
150217446|NCT01915914|541932366|FG002|Acute Phase|Withdrawal by Subject|0|||
150217447|NCT01915914|541932367|FG003|Acute Phase|Withdrawal by Subject|0|||
150217448|NCT01915914|541932364|FG000|Acute Phase|Lost to Follow-up|4|||
150217449|NCT01915914|541932365|FG001|Acute Phase|Lost to Follow-up|0|||
150217450|NCT01915914|541932366|FG002|Acute Phase|Lost to Follow-up|0|||
150217451|NCT01915914|541932367|FG003|Acute Phase|Lost to Follow-up|0|||
150217452|NCT01915914|541932364|FG000|Acute Phase|Physician Decision|1|||
150217453|NCT01915914|541932365|FG001|Acute Phase|Physician Decision|0|||
150217454|NCT01915914|541932366|FG002|Acute Phase|Physician Decision|0|||
150217455|NCT01915914|541932367|FG003|Acute Phase|Physician Decision|0|||
150217456|NCT01915914|541932364|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
150217457|NCT01915914|541932365|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
150217458|NCT01915914|541932366|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
150217459|NCT01915914|541932367|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
150217460|NCT01915914|541932364|FG000|Acute Phase|"Not Achieved treatment success"|1|||
150217461|NCT01915914|541932365|FG001|Acute Phase|"Not Achieved treatment success"|0|||
150217462|NCT01915914|541932366|FG002|Acute Phase|"Not Achieved treatment success"|0|||
150217463|NCT01915914|541932367|FG003|Acute Phase|"Not Achieved treatment success"|0|||
150217464|NCT01915914|541932364|FG000|Acute Phase|Missing|1|||
150217465|NCT01915914|541932365|FG001|Acute Phase|Missing|0|||
150217466|NCT01915914|541932366|FG002|Acute Phase|Missing|0|||
150217467|NCT01915914|541932367|FG003|Acute Phase|Missing|0|||
150217468|NCT01915914|541932364|FG000|Maintenance Phase|Withdrawal by Subject|0|||
150217469|NCT01915914|541932365|FG001|Maintenance Phase|Withdrawal by Subject|1|||
150217470|NCT01915914|541932366|FG002|Maintenance Phase|Withdrawal by Subject|1|||
150217471|NCT01915914|541932367|FG003|Maintenance Phase|Withdrawal by Subject|0|||
150217472|NCT01915914|541932364|FG000|Maintenance Phase|Lost to Follow-up|0|||
150217473|NCT01915914|541932365|FG001|Maintenance Phase|Lost to Follow-up|4|||
150217474|NCT01915914|541932366|FG002|Maintenance Phase|Lost to Follow-up|1|||
150217475|NCT01915914|541932367|FG003|Maintenance Phase|Lost to Follow-up|0|||
150217476|NCT01915914|541932364|FG000|Maintenance Phase|Missing|0|||
150217477|NCT01915914|541932365|FG001|Maintenance Phase|Missing|1|||
150217478|NCT01915914|541932366|FG002|Maintenance Phase|Missing|0|||
150217479|NCT01915914|541932367|FG003|Maintenance Phase|Missing|0|||
150217480|NCT01915914|541932364|FG000|Follow-up Phase|Withdrawal by Subject|0|||
150217481|NCT01915914|541932365|FG001|Follow-up Phase|Withdrawal by Subject|0|||
150217482|NCT01915914|541932366|FG002|Follow-up Phase|Withdrawal by Subject|0|||
150217483|NCT01915914|541932367|FG003|Follow-up Phase|Withdrawal by Subject|1|||
150217484|NCT01915914|541932364|FG000|Follow-up Phase|Physician Decision|0|||
150217485|NCT01915914|541932365|FG001|Follow-up Phase|Physician Decision|0|||
150217486|NCT01915914|541932366|FG002|Follow-up Phase|Physician Decision|0|||
150217487|NCT01915914|541932367|FG003|Follow-up Phase|Physician Decision|1|||
150217488|NCT00428714|541932369|FG000|Overall Study|Progressive Disease|28|||
150217489|NCT00428714|541932370|FG001|Overall Study|Progressive Disease|36|||
150217490|NCT00428714|541932369|FG000|Overall Study|Withdrawal by Subject|0|||
150217491|NCT00428714|541932370|FG001|Overall Study|Withdrawal by Subject|3|||
150217492|NCT00428714|541932369|FG000|Overall Study|Adverse Event|0|||
150217493|NCT00428714|541932370|FG001|Overall Study|Adverse Event|2|||
150217494|NCT00428714|541932369|FG000|Overall Study|Physician Decision|1|||
150217495|NCT00428714|541932370|FG001|Overall Study|Physician Decision|1|||
150217496|NCT00428714|541932369|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
150217497|NCT00428714|541932370|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
150217498|NCT00428714|541932369|FG000|Overall Study|Death due to other then PD|1|||
150217499|NCT00428714|541932370|FG001|Overall Study|Death due to other then PD|0|||
150217500|NCT02432274|541932371|FG000|Overall Study|Death|2|||
150217501|NCT02432274|541932372|FG001|Overall Study|Death|6|||
150217502|NCT02432274|541932373|FG002|Overall Study|Death|7|||
150217503|NCT02432274|541932374|FG003|Overall Study|Death|0|||
150217504|NCT02432274|541932375|FG004|Overall Study|Death|27|||
150217505|NCT02432274|541932376|FG005|Overall Study|Death|7|||
150217506|NCT02432274|541932377|FG006|Overall Study|Death|9|||
150217507|NCT02432274|541932378|FG007|Overall Study|Death|14|||
150217508|NCT02432274|541932371|FG000|Overall Study|Withdrawal of Consent|0|||
150217509|NCT02432274|541932372|FG001|Overall Study|Withdrawal of Consent|0|||
150217510|NCT02432274|541932373|FG002|Overall Study|Withdrawal of Consent|0|||
150217511|NCT02432274|541932374|FG003|Overall Study|Withdrawal of Consent|0|||
150217512|NCT02432274|541932375|FG004|Overall Study|Withdrawal of Consent|2|||
150217513|NCT02432274|541932376|FG005|Overall Study|Withdrawal of Consent|0|||
150217514|NCT02432274|541932377|FG006|Overall Study|Withdrawal of Consent|1|||
150217515|NCT02432274|541932378|FG007|Overall Study|Withdrawal of Consent|2|||
150217516|NCT01736475|541932381|FG000|Overall Study|Adverse Event|4|||
150217517|NCT01736475|541932382|FG001|Overall Study|Adverse Event|0|||
150217518|NCT01736475|541932381|FG000|Overall Study|Withdrawal by Subject|2|||
150217519|NCT01736475|541932382|FG001|Overall Study|Withdrawal by Subject|0|||
150217520|NCT01736475|541932381|FG000|Overall Study|Protocol Violation|4|||
150217521|NCT01736475|541932382|FG001|Overall Study|Protocol Violation|0|||
150217522|NCT01736475|541932381|FG000|Overall Study|Other - Screen failure|1|||
150217523|NCT01736475|541932382|FG001|Overall Study|Other - Screen failure|0|||
150217524|NCT01736475|541932381|FG000|Overall Study|Other - Surgical procedure|1|||
150217525|NCT01736475|541932382|FG001|Overall Study|Other - Surgical procedure|0|||
150217526|NCT00513071|541932383|FG000|Overall Study|Adverse Event|1|||
150217527|NCT00513071|541932383|FG000|Overall Study|Withdrawal by Subject|1|||
150217528|NCT00513071|541932383|FG000|Overall Study|Physician Decision|3|||
150217529|NCT00264576|541934098|FG000|Overall Study|Lost to Follow-up|1|||
150217530|NCT00264576|541934099|FG001|Overall Study|Lost to Follow-up|1|||
150217531|NCT02659059|541934100|FG000|Overall Study|Other reasons|6|||
150217532|NCT02659059|541934101|FG001|Overall Study|Other reasons|1|||
150217533|NCT02659059|541934100|FG000|Overall Study|Disease Progression|143|||
150217534|NCT02659059|541934101|FG001|Overall Study|Disease Progression|16|||
150217535|NCT02659059|541934100|FG000|Overall Study|Study Drug toxicity|56|||
150217536|NCT02659059|541934101|FG001|Overall Study|Study Drug toxicity|9|||
150217537|NCT02659059|541934100|FG000|Overall Study|Death|3|||
150217538|NCT02659059|541934101|FG001|Overall Study|Death|1|||
150217539|NCT02659059|541934100|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
150217540|NCT02659059|541934101|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
150217541|NCT02659059|541934100|FG000|Overall Study|Participant request to discontinue study treatment|5|||
150217542|NCT02659059|541934101|FG001|Overall Study|Participant request to discontinue study treatment|0|||
150217543|NCT02659059|541934100|FG000|Overall Study|Participant withdrew consent|6|||
150217544|NCT02659059|541934101|FG001|Overall Study|Participant withdrew consent|1|||
150217545|NCT00092456|541934102|FG000|Overall Study|Adverse Event|0|||
150217546|NCT00092456|541934103|FG001|Overall Study|Adverse Event|0|||
150217547|NCT00092456|541934104|FG002|Overall Study|Adverse Event|1|||
150217548|NCT00092456|541934105|FG003|Overall Study|Adverse Event|1|||
150217549|NCT00092456|541934102|FG000|Overall Study|Lost to Follow-up|2|||
150217550|NCT00092456|541934103|FG001|Overall Study|Lost to Follow-up|2|||
150217551|NCT00092456|541934104|FG002|Overall Study|Lost to Follow-up|1|||
150217552|NCT00092456|541934105|FG003|Overall Study|Lost to Follow-up|2|||
150217553|NCT00092456|541934102|FG000|Overall Study|Protocol Violation|5|||
150217554|NCT00092456|541934103|FG001|Overall Study|Protocol Violation|7|||
150217555|NCT00092456|541934104|FG002|Overall Study|Protocol Violation|8|||
150217556|NCT00092456|541934105|FG003|Overall Study|Protocol Violation|6|||
150217557|NCT00092456|541934102|FG000|Overall Study|Withdrawal by Subject|13|||
150217558|NCT00092456|541934103|FG001|Overall Study|Withdrawal by Subject|5|||
150217559|NCT00092456|541934104|FG002|Overall Study|Withdrawal by Subject|16|||
150217560|NCT00092456|541934105|FG003|Overall Study|Withdrawal by Subject|6|||
150217561|NCT00092456|541934102|FG000|Overall Study|Moved|1|||
150217562|NCT00092456|541934103|FG001|Overall Study|Moved|1|||
150217563|NCT00092456|541934104|FG002|Overall Study|Moved|0|||
150217564|NCT00092456|541934105|FG003|Overall Study|Moved|1|||
150217565|NCT00092456|541934102|FG000|Overall Study|Other|4|||
150217566|NCT00092456|541934103|FG001|Overall Study|Other|2|||
150217567|NCT00092456|541934104|FG002|Overall Study|Other|3|||
150217568|NCT00092456|541934105|FG003|Overall Study|Other|0|||
150217569|NCT04783389|541934106|FG000|Overall Study|Withdrawal by Subject|2|||
150217570|NCT04783389|541934107|FG001|Overall Study|Withdrawal by Subject|0|||
150217571|NCT04783389|541934108|FG002|Overall Study|Withdrawal by Subject|0|||
150217572|NCT04783389|541934106|FG000|Overall Study|Termination of Study by Sponsor|10|||
150217573|NCT04783389|541934107|FG001|Overall Study|Termination of Study by Sponsor|12|||
150217574|NCT04783389|541934108|FG002|Overall Study|Termination of Study by Sponsor|14|||
150217575|NCT01241448|541934109|FG000|Overall Study|Adverse Event|1|||
150217576|NCT01241448|541934110|FG001|Overall Study|Adverse Event|0|||
150217577|NCT01241448|541934111|FG002|Overall Study|Adverse Event|2|||
150217578|NCT01241448|541934112|FG003|Overall Study|Adverse Event|2|||
150217579|NCT01241448|541934109|FG000|Overall Study|Lost to Follow-up|2|||
150217580|NCT01241448|541934110|FG001|Overall Study|Lost to Follow-up|1|||
150217581|NCT01241448|541934111|FG002|Overall Study|Lost to Follow-up|1|||
150217582|NCT01241448|541934112|FG003|Overall Study|Lost to Follow-up|1|||
150217583|NCT01241448|541934109|FG000|Overall Study|Physician Decision|0|||
150217584|NCT01241448|541934110|FG001|Overall Study|Physician Decision|2|||
150217585|NCT01241448|541934111|FG002|Overall Study|Physician Decision|0|||
150217586|NCT01241448|541934112|FG003|Overall Study|Physician Decision|0|||
150217587|NCT01241448|541934109|FG000|Overall Study|Protocol Violation|10|||
150217588|NCT01241448|541934110|FG001|Overall Study|Protocol Violation|5|||
150217589|NCT01241448|541934111|FG002|Overall Study|Protocol Violation|3|||
150217590|NCT01241448|541934112|FG003|Overall Study|Protocol Violation|6|||
150217591|NCT01241448|541934109|FG000|Overall Study|Sponsor Decision|17|||
150217592|NCT01241448|541934110|FG001|Overall Study|Sponsor Decision|14|||
150217593|NCT01241448|541934111|FG002|Overall Study|Sponsor Decision|12|||
150217594|NCT01241448|541934112|FG003|Overall Study|Sponsor Decision|6|||
150217595|NCT01241448|541934109|FG000|Overall Study|Withdrawal by Subject|4|||
150217596|NCT01241448|541934110|FG001|Overall Study|Withdrawal by Subject|5|||
150141293|NCT03485911|541652029|FG000|Part 3|Lab abnormalities/AEs|1|||
150141294|NCT03485911|541652030|FG001|Part 3|Lab abnormalities/AEs|1|||
150141295|NCT03485911|541652031|FG002|Part 3|Lab abnormalities/AEs|0|||
150141296|NCT03485911|541652032|FG003|Part 3|Lab abnormalities/AEs|2|||
150141297|NCT03485911|541652029|FG000|Part 3|Other NOS|1|||
150141298|NCT03485911|541652030|FG001|Part 3|Other NOS|1|||
150141299|NCT03485911|541652031|FG002|Part 3|Other NOS|0|||
150141300|NCT03485911|541652032|FG003|Part 3|Other NOS|0|||
150141301|NCT03485911|541652029|FG000|Part 3|Intercurrent illness/new medical condition|0|||
150141302|NCT03485911|541652030|FG001|Part 3|Intercurrent illness/new medical condition|1|||
150141303|NCT03485911|541652031|FG002|Part 3|Intercurrent illness/new medical condition|1|||
150141304|NCT03485911|541652032|FG003|Part 3|Intercurrent illness/new medical condition|0|||
150141305|NCT03485911|541652029|FG000|Part 3|Sponsor discontinuation|1|||
150141306|NCT03485911|541652030|FG001|Part 3|Sponsor discontinuation|0|||
150141307|NCT03485911|541652031|FG002|Part 3|Sponsor discontinuation|0|||
150141308|NCT03485911|541652032|FG003|Part 3|Sponsor discontinuation|0|||
150141309|NCT03485911|541652029|FG000|Part 3|Berotralstat provided by alternative means|13|||
150141310|NCT03485911|541652030|FG001|Part 3|Berotralstat provided by alternative means|13|||
150141311|NCT03485911|541652031|FG002|Part 3|Berotralstat provided by alternative means|7|||
150141312|NCT03485911|541652032|FG003|Part 3|Berotralstat provided by alternative means|7|||
150141313|NCT03333928|541652033|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
150141314|NCT03333928|541652034|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
150141315|NCT03333928|541652035|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
150141316|NCT03333928|541652033|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
150141317|NCT03333928|541652034|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
150141318|NCT03333928|541652035|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
150141319|NCT03333928|541652033|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
150141320|NCT03333928|541652034|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
150141321|NCT03333928|541652035|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
150141322|NCT03333928|541652033|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
150141323|NCT03333928|541652034|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
150141324|NCT03333928|541652035|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
150141325|NCT03333928|541652033|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
150141326|NCT03333928|541652034|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
150141327|NCT03333928|541652035|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
150141328|NCT03333928|541652033|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
150141329|NCT03333928|541652034|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
150141330|NCT03333928|541652035|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
150141331|NCT03333928|541652033|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
150141332|NCT03333928|541652034|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
150141333|NCT03333928|541652035|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
150141334|NCT03333928|541652033|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
150141335|NCT03333928|541652034|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
150141336|NCT03333928|541652035|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
150141337|NCT01375205|541652046|FG000|Overall Study|Lost to Follow-up|15|||
150141338|NCT01375205|541652047|FG001|Overall Study|Lost to Follow-up|12|||
150141339|NCT01375205|541652046|FG000|Overall Study|Withdrawal by Subject|6|||
150141340|NCT01375205|541652047|FG001|Overall Study|Withdrawal by Subject|1|||
150141341|NCT01674621|541652048|FG000|Overall Study|Adverse Event|3|||
150141342|NCT01674621|541652049|FG001|Overall Study|Adverse Event|2|||
150141343|NCT01674621|541652050|FG002|Overall Study|Adverse Event|5|||
150141344|NCT01674621|541652051|FG003|Overall Study|Adverse Event|5|||
150141345|NCT01674621|541652052|FG004|Overall Study|Adverse Event|1|||
150141346|NCT01674621|541652048|FG000|Overall Study|Inability to Complete Study Procedures|0|||
150141347|NCT01674621|541652049|FG001|Overall Study|Inability to Complete Study Procedures|0|||
150141348|NCT01674621|541652050|FG002|Overall Study|Inability to Complete Study Procedures|0|||
150141349|NCT01674621|541652051|FG003|Overall Study|Inability to Complete Study Procedures|0|||
150141350|NCT01674621|541652052|FG004|Overall Study|Inability to Complete Study Procedures|2|||
150141351|NCT01674621|541652048|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
150141352|NCT01674621|541652049|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
150141353|NCT01674621|541652050|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
150141354|NCT01674621|541652051|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
150141355|NCT01674621|541652052|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
150141356|NCT01674621|541652048|FG000|Overall Study|Withdrawal by Subject|2|||
150217597|NCT01241448|541934111|FG002|Overall Study|Withdrawal by Subject|3|||
150217598|NCT01241448|541934112|FG003|Overall Study|Withdrawal by Subject|6|||
150217599|NCT01241448|541934109|FG000|Overall Study|Excluded due to data integrity issues|3|||
150217600|NCT01241448|541934110|FG001|Overall Study|Excluded due to data integrity issues|2|||
150217601|NCT01241448|541934111|FG002|Overall Study|Excluded due to data integrity issues|2|||
150217602|NCT01241448|541934112|FG003|Overall Study|Excluded due to data integrity issues|2|||
150217603|NCT01304940|541934113|FG000|Overall Study|not meet symptom severity requirement|3|||
150217604|NCT01304940|541934114|FG001|Overall Study|not meet symptom severity requirement|0|||
150217605|NCT02065895|541934115|FG000|Overall Study|Protocol Violation|1|||
150217606|NCT02065895|541934116|FG001|Overall Study|Protocol Violation|0|||
150217607|NCT02065895|541934117|FG002|Overall Study|Protocol Violation|0|||
150217608|NCT02065895|541934118|FG003|Overall Study|Protocol Violation|1|||
150217609|NCT02065895|541934119|FG004|Overall Study|Protocol Violation|0|||
150217610|NCT02065895|541934120|FG005|Overall Study|Protocol Violation|0|||
150217611|NCT02065895|541934115|FG000|Overall Study|Scheduling conflicts|0|||
150217612|NCT02065895|541934116|FG001|Overall Study|Scheduling conflicts|1|||
150217613|NCT02065895|541934117|FG002|Overall Study|Scheduling conflicts|0|||
150217614|NCT02065895|541934118|FG003|Overall Study|Scheduling conflicts|0|||
150217615|NCT02065895|541934119|FG004|Overall Study|Scheduling conflicts|0|||
150217616|NCT02065895|541934120|FG005|Overall Study|Scheduling conflicts|0|||
150217617|NCT03137784|541934121|FG000|Overall Study|Adverse Event|1|||
150217618|NCT03137784|541934122|FG001|Overall Study|Adverse Event|1|||
150217619|NCT03137784|541934123|FG002|Overall Study|Adverse Event|0|||
150217620|NCT03137784|541934124|FG003|Overall Study|Adverse Event|0|||
150217621|NCT03137784|541934125|FG004|Overall Study|Adverse Event|0|||
150217622|NCT03137784|541934126|FG005|Overall Study|Adverse Event|0|||
150217623|NCT03137784|541934121|FG000|Overall Study|Subject/guardian decision|1|||
150217624|NCT03137784|541934122|FG001|Overall Study|Subject/guardian decision|0|||
150217625|NCT03137784|541934123|FG002|Overall Study|Subject/guardian decision|0|||
150217626|NCT03137784|541934124|FG003|Overall Study|Subject/guardian decision|0|||
150217627|NCT03137784|541934125|FG004|Overall Study|Subject/guardian decision|0|||
150217628|NCT03137784|541934126|FG005|Overall Study|Subject/guardian decision|0|||
150217629|NCT03137784|541934121|FG000|Overall Study|Non-compliance with study treatment|0|||
150217630|NCT03137784|541934122|FG001|Overall Study|Non-compliance with study treatment|0|||
150217631|NCT03137784|541934123|FG002|Overall Study|Non-compliance with study treatment|0|||
150217632|NCT03137784|541934124|FG003|Overall Study|Non-compliance with study treatment|0|||
150217633|NCT03137784|541934125|FG004|Overall Study|Non-compliance with study treatment|1|||
150217634|NCT03137784|541934126|FG005|Overall Study|Non-compliance with study treatment|0|||
150217635|NCT04311983|541934127|FG000|Overall Study|Lost to Follow-up|421|||
150217636|NCT04311983|541934128|FG001|Overall Study|Lost to Follow-up|456|||
150217637|NCT04311983|541934127|FG000|Overall Study|Incomplete survey|7|||
150217638|NCT04311983|541934128|FG001|Overall Study|Incomplete survey|9|||
150217639|NCT04311983|541934127|FG000|Overall Study|Death|1|||
150217640|NCT04311983|541934128|FG001|Overall Study|Death|0|||
150217641|NCT02165202|541934132|FG000|Oral Phase|Refused further participation|5|||
150217642|NCT02165202|541934133|FG001|Oral Phase|Refused further participation|1|||
150217643|NCT02165202|541934132|FG000|Oral Phase|Study product Related Toxicity|1|||
150217644|NCT02165202|541934133|FG001|Oral Phase|Study product Related Toxicity|0|||
150217645|NCT02165202|541934132|FG000|Oral Phase|Unable to contact Participant|1|||
150217646|NCT02165202|541934133|FG001|Oral Phase|Unable to contact Participant|1|||
150217647|NCT02165202|541934132|FG000|Oral Phase|Clinical reasons|1|||
150217648|NCT02165202|541934133|FG001|Oral Phase|Clinical reasons|0|||
150217649|NCT02165202|541934132|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
150217650|NCT02165202|541934133|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
150217651|NCT02165202|541934132|FG000|Oral Phase|CMC advised termination|1|||
150217652|NCT02165202|541934133|FG001|Oral Phase|CMC advised termination|0|||
150217653|NCT02165202|541934132|FG000|Oral Phase|Relocated, no follow-up planned|1|||
150217654|NCT02165202|541934133|FG001|Oral Phase|Relocated, no follow-up planned|0|||
150217655|NCT02165202|541934132|FG000|Oral Phase|Abnormal EKG|0|||
150217656|NCT02165202|541934133|FG001|Oral Phase|Abnormal EKG|1|||
150217657|NCT02165202|541934132|FG000|Injection Phase|Abnormal Lab Value|5|||
150217658|NCT02165202|541934133|FG001|Injection Phase|Abnormal Lab Value|1|||
150217659|NCT02165202|541934132|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
150217660|NCT02165202|541934133|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
150217661|NCT02165202|541934132|FG000|Injection Phase|Unable to attend within Visit Window|1|||
150217662|NCT02165202|541934133|FG001|Injection Phase|Unable to attend within Visit Window|0|||
150217663|NCT02165202|541934132|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
150217664|NCT02165202|541934133|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
150217665|NCT02165202|541934132|FG000|Injection Phase|End of Study|2|||
150217666|NCT02165202|541934133|FG001|Injection Phase|End of Study|1|||
150217667|NCT02165202|541934132|FG000|Injection Phase|Study Product related Toxicity|1|||
150217668|NCT02165202|541934133|FG001|Injection Phase|Study Product related Toxicity|0|||
150217669|NCT02165202|541934132|FG000|Injection Phase|No longer interested|0|||
150217670|NCT02165202|541934133|FG001|Injection Phase|No longer interested|1|||
150217671|NCT02165202|541934132|FG000|Injection Phase|Participant unwilling to comply|1|||
150217672|NCT02165202|541934133|FG001|Injection Phase|Participant unwilling to comply|0|||
150217673|NCT01975701|541934139|FG000|Overall Study|Lost to Follow-up|1|||
150217674|NCT01975701|541934139|FG000|Overall Study|Death|23|||
150217675|NCT01975701|541934139|FG000|Overall Study|Physician Decision|1|||
150217676|NCT01655498|541934140|FG000|Overall Study|Unrelated health issue|2|||
150217677|NCT01655498|541934140|FG000|Overall Study|Protocol Violation|2|||
150217678|NCT01655498|541934140|FG000|Overall Study|Withdrawal by Subject|1|||
150217679|NCT02753075|541934141|FG000|Overall Study|Adverse Event|2|||
150217680|NCT02753075|541934142|FG001|Overall Study|Adverse Event|1|||
150217681|NCT02753075|541934143|FG002|Overall Study|Adverse Event|0|||
150217682|NCT02753075|541934141|FG000|Overall Study|Lost to Follow-up|2|||
150217683|NCT02753075|541934142|FG001|Overall Study|Lost to Follow-up|0|||
150217684|NCT02753075|541934143|FG002|Overall Study|Lost to Follow-up|0|||
150217685|NCT02753075|541934141|FG000|Overall Study|Withdrawal of Consent|1|||
150217686|NCT02753075|541934142|FG001|Overall Study|Withdrawal of Consent|1|||
150217687|NCT02753075|541934143|FG002|Overall Study|Withdrawal of Consent|3|||
150217688|NCT02753075|541934141|FG000|Overall Study|Physician Decision|3|||
150217689|NCT02753075|541934142|FG001|Overall Study|Physician Decision|1|||
150217690|NCT02753075|541934143|FG002|Overall Study|Physician Decision|0|||
150217691|NCT04361617|541934145|FG000|Overall Study|Withdrawal by Subject|0|||
150217692|NCT04361617|541934146|FG001|Overall Study|Withdrawal by Subject|1|||
150217693|NCT02005484|541934147|FG000|Overall Study|Death|1|||
150217694|NCT02005484|541934147|FG000|Overall Study|Disease progression|1|||
150217695|NCT02005484|541934147|FG000|Overall Study|Changed to a Different Study|1|||
150217696|NCT02005484|541934147|FG000|Overall Study|Sponsor decision|1|||
150217697|NCT00687297|541934148|FG000|Randomization|Withdrawal by Subject|2|||
150217698|NCT00687297|541934149|FG001|Randomization|Withdrawal by Subject|0|||
150217699|NCT00687297|541934148|FG000|Randomization|Withdrew before treatment, ineligible|1|||
150217700|NCT00687297|541934149|FG001|Randomization|Withdrew before treatment, ineligible|1|||
150217701|NCT00687297|541934148|FG000|Induction|Withdrawal by Subject|4|||
150217702|NCT00687297|541934149|FG001|Induction|Withdrawal by Subject|4|||
150217703|NCT00687297|541934148|FG000|Induction|Adverse Event|16|||
150217704|NCT00687297|541934149|FG001|Induction|Adverse Event|15|||
150217705|NCT00687297|541934148|FG000|Induction|Death|7|||
150217706|NCT00687297|541934149|FG001|Induction|Death|11|||
150217707|NCT00687297|541934148|FG000|Induction|Lack of Efficacy|17|||
150217708|NCT00687297|541934149|FG001|Induction|Lack of Efficacy|21|||
150217709|NCT00687297|541934148|FG000|Induction|Ineligible|0|||
150217710|NCT00687297|541934149|FG001|Induction|Ineligible|1|||
150217711|NCT00687297|541934148|FG000|Induction|Patient Noncompliance|1|||
150217712|NCT00687297|541934149|FG001|Induction|Patient Noncompliance|0|||
150217713|NCT00687297|541934148|FG000|Induction|Physician Decision|0|||
150217714|NCT00687297|541934149|FG001|Induction|Physician Decision|2|||
150217715|NCT00687297|541934148|FG000|Induction|Other|0|||
150217716|NCT00687297|541934149|FG001|Induction|Other|1|||
150217717|NCT03695185|541934152|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
150217718|NCT03695185|541934152|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
150217719|NCT03695185|541934152|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
150217720|NCT03695185|541934152|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
150217721|NCT03695185|541934152|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
150217722|NCT03695185|541934152|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
150217723|NCT01670877|541934153|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
150217724|NCT01670877|541934154|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
150217725|NCT01670877|541934155|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
150217726|NCT01670877|541934156|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
150217727|NCT01670877|541934157|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
150217728|NCT01670877|541934158|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
150217729|NCT01670877|541934153|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
150217730|NCT01670877|541934154|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
150217731|NCT01670877|541934155|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
150217732|NCT01670877|541934156|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
150217733|NCT01670877|541934157|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
150217734|NCT01670877|541934158|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
150217735|NCT01670877|541934153|FG000|Part I and Part 2|Grade 2 vomiting|0|||
150217736|NCT01670877|541934154|FG001|Part I and Part 2|Grade 2 vomiting|0|||
150217737|NCT01670877|541934155|FG002|Part I and Part 2|Grade 2 vomiting|0|||
150217738|NCT01670877|541934156|FG003|Part I and Part 2|Grade 2 vomiting|1|||
150217739|NCT01670877|541934157|FG004|Part I and Part 2|Grade 2 vomiting|0|||
150217740|NCT01670877|541934158|FG005|Part I and Part 2|Grade 2 vomiting|0|||
150217741|NCT01670877|541934153|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
150217742|NCT01670877|541934154|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
150217743|NCT01670877|541934155|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
150217744|NCT01670877|541934156|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
150217745|NCT01670877|541934157|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
150217746|NCT01670877|541934158|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
150217747|NCT01670877|541934153|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
150217748|NCT01670877|541934154|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
150217749|NCT01670877|541934155|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
150217750|NCT01670877|541934156|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
150217751|NCT01670877|541934157|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
150217752|NCT01670877|541934158|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
150217753|NCT02525744|541934159|FG000|Period 1|Physician Decision|0|||
150217754|NCT02525744|541934160|FG001|Period 1|Physician Decision|0|||
150217755|NCT02525744|541934161|FG002|Period 1|Physician Decision|1|||
150217756|NCT02525744|541934162|FG003|Period 1|Physician Decision|0|||
150217757|NCT02525744|541934159|FG000|Period 3|Adverse Event|0|||
150217758|NCT02525744|541934160|FG001|Period 3|Adverse Event|1|||
150217759|NCT02525744|541934161|FG002|Period 3|Adverse Event|0|||
150217760|NCT02525744|541934162|FG003|Period 3|Adverse Event|0|||
150217761|NCT02525744|541934159|FG000|Period 4|Withdrawal by Subject|1|||
150217762|NCT02525744|541934160|FG001|Period 4|Withdrawal by Subject|0|||
150217763|NCT02525744|541934161|FG002|Period 4|Withdrawal by Subject|0|||
150217764|NCT02525744|541934162|FG003|Period 4|Withdrawal by Subject|0|||
150217765|NCT02525744|541934159|FG000|Period 5|Physician Decision|1|||
150217766|NCT02525744|541934160|FG001|Period 5|Physician Decision|0|||
150217767|NCT02525744|541934161|FG002|Period 5|Physician Decision|0|||
150217768|NCT02525744|541934162|FG003|Period 5|Physician Decision|0|||
150217769|NCT02069379|541934163|FG000|Baseline Measurements|Lost to Follow-up|1|||
150217770|NCT02069379|541934164|FG001|Baseline Measurements|Lost to Follow-up|0|||
150217771|NCT02069379|541934165|FG002|Baseline Measurements|Lost to Follow-up|0|||
150217772|NCT02069379|541934166|FG003|Baseline Measurements|Lost to Follow-up|0|||
150217773|NCT02069379|541934163|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
150217774|NCT02069379|541934164|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
150217775|NCT02069379|541934165|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
150217776|NCT02069379|541934166|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
150217777|NCT02069379|541934163|FG000|First Treatment Arm|Lost to Follow-up|0|||
150217778|NCT02069379|541934164|FG001|First Treatment Arm|Lost to Follow-up|1|||
150217779|NCT02069379|541934165|FG002|First Treatment Arm|Lost to Follow-up|1|||
150217780|NCT02069379|541934166|FG003|First Treatment Arm|Lost to Follow-up|0|||
150217781|NCT02069379|541934163|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
150217782|NCT02069379|541934164|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
150217783|NCT02069379|541934165|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
150217784|NCT02069379|541934166|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
150217785|NCT02069379|541934163|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
150217786|NCT02069379|541934164|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
150217787|NCT02069379|541934165|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
150217788|NCT02069379|541934166|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
150217789|NCT02069379|541934163|FG000|Second Treatment Arm|Lost to Follow-up|0|||
150217790|NCT02069379|541934164|FG001|Second Treatment Arm|Lost to Follow-up|0|||
150217791|NCT02069379|541934165|FG002|Second Treatment Arm|Lost to Follow-up|1|||
150217792|NCT02069379|541934166|FG003|Second Treatment Arm|Lost to Follow-up|0|||
150217793|NCT02206607|541934167|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
150217794|NCT02206607|541934168|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
150217795|NCT02206607|541934169|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
150217796|NCT02206607|541934170|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
150217797|NCT02206607|541934171|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
150217798|NCT02206607|541934167|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
150217799|NCT02206607|541934168|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
150217800|NCT02206607|541934169|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
150217801|NCT02206607|541934170|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
150217802|NCT02206607|541934171|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
150217803|NCT04183491|541934176|FG000|Overall Study|Withdrawal by Subject|0|||
150217804|NCT04183491|541934177|FG001|Overall Study|Withdrawal by Subject|0|||
150217805|NCT04183491|541934178|FG002|Overall Study|Withdrawal by Subject|1|||
150217806|NCT04183491|541934179|FG003|Overall Study|Withdrawal by Subject|0|||
150217807|NCT04183491|541934180|FG004|Overall Study|Withdrawal by Subject|0|||
150217808|NCT04183491|541934181|FG005|Overall Study|Withdrawal by Subject|1|||
150217809|NCT04183491|541934182|FG006|Overall Study|Withdrawal by Subject|0|||
150217810|NCT00337610|541934184|FG000|Overall Study|Adverse Event|2|||
150217811|NCT00337610|541934185|FG001|Overall Study|Adverse Event|2|||
150217812|NCT00337610|541934184|FG000|Overall Study|Death|0|||
150217813|NCT00337610|541934185|FG001|Overall Study|Death|1|||
150217814|NCT00337610|541934184|FG000|Overall Study|Lack of Efficacy|6|||
150217815|NCT00337610|541934185|FG001|Overall Study|Lack of Efficacy|3|||
150217816|NCT00337610|541934184|FG000|Overall Study|Lost to Follow-up|3|||
150217817|NCT00337610|541934185|FG001|Overall Study|Lost to Follow-up|3|||
150217818|NCT00337610|541934184|FG000|Overall Study|Withdrawal by Subject|6|||
150217819|NCT00337610|541934185|FG001|Overall Study|Withdrawal by Subject|5|||
150217820|NCT01441596|541934193|FG000|Overall Study|Other reason not defined below|0|||
150217821|NCT01441596|541934194|FG001|Overall Study|Other reason not defined below|2|||
150217822|NCT01441596|541934195|FG002|Overall Study|Other reason not defined below|1|||
150217823|NCT01441596|541934193|FG000|Overall Study|Withdrawal by Subject|4|||
150217824|NCT01441596|541934194|FG001|Overall Study|Withdrawal by Subject|0|||
150217825|NCT01441596|541934195|FG002|Overall Study|Withdrawal by Subject|2|||
150217826|NCT01441596|541934193|FG000|Overall Study|Not treated|0|||
150217827|NCT01441596|541934194|FG001|Overall Study|Not treated|1|||
150217828|NCT01441596|541934195|FG002|Overall Study|Not treated|1|||
150217829|NCT03055988|541934196|FG000|Period 1|Adverse Event|0|||
150217830|NCT03055988|541934197|FG001|Period 1|Adverse Event|1|||
150217831|NCT03055988|541934196|FG000|Period 1|Lost to Follow-up|1|||
150217832|NCT03055988|541934197|FG001|Period 1|Lost to Follow-up|0|||
150217833|NCT03055988|541934196|FG000|Period 1|Withdrawal by Subject|0|||
150217834|NCT03055988|541934197|FG001|Period 1|Withdrawal by Subject|4|||
150217835|NCT03055988|541934196|FG000|Period 2|Adverse Event|0|||
150217836|NCT03055988|541934197|FG001|Period 2|Adverse Event|1|||
150217837|NCT03055988|541934196|FG000|Period 2|Other than listed|1|||
150217838|NCT03055988|541934197|FG001|Period 2|Other than listed|1|||
150217839|NCT01528605|541934198|FG000|Overall Study|Lost to Follow-up|1|||
150217840|NCT01528605|541934199|FG001|Overall Study|Lost to Follow-up|0|||
150217841|NCT01528605|541934200|FG002|Overall Study|Lost to Follow-up|1|||
150217842|NCT01528605|541934201|FG003|Overall Study|Lost to Follow-up|1|||
150217843|NCT01528605|541934202|FG004|Overall Study|Lost to Follow-up|0|||
150217844|NCT01528605|541934203|FG005|Overall Study|Lost to Follow-up|0|||
150217845|NCT01528605|541934198|FG000|Overall Study|Death|1|||
150217846|NCT01528605|541934199|FG001|Overall Study|Death|0|||
150217847|NCT01528605|541934200|FG002|Overall Study|Death|0|||
150217848|NCT01528605|541934201|FG003|Overall Study|Death|0|||
150217849|NCT01528605|541934202|FG004|Overall Study|Death|0|||
150217850|NCT01528605|541934203|FG005|Overall Study|Death|0|||
150217851|NCT01681511|541934204|FG000|Overall Study|No Treatment Received|1|||
150217852|NCT01681511|541934205|FG001|Overall Study|No Treatment Received|3|||
150217853|NCT01681511|541934204|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
150217854|NCT01681511|541934205|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
150217855|NCT01681511|541934204|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
150217856|NCT01681511|541934205|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
150217857|NCT01681511|541934204|FG000|Overall Study|No Daily Urine Sample Collected|0|||
150217858|NCT01681511|541934205|FG001|Overall Study|No Daily Urine Sample Collected|1|||
150217859|NCT01681511|541934204|FG000|Overall Study|No post-catheter sample collected|11|||
150217860|NCT01681511|541934205|FG001|Overall Study|No post-catheter sample collected|4|||
150217861|NCT01156675|541934206|FG000|Overall Study|Death|5|||
150217862|NCT01156675|541934207|FG001|Overall Study|Death|3|||
150217863|NCT01156675|541934208|FG002|Overall Study|Death|0|||
150217864|NCT01156675|541934206|FG000|Overall Study|No data|29|||
150217865|NCT01156675|541934207|FG001|Overall Study|No data|22|||
150217866|NCT01156675|541934208|FG002|Overall Study|No data|2|||
150217867|NCT02613403|541934222|FG000|Overall Study|Lost to Follow-up|0|||
150217868|NCT02613403|541934223|FG001|Overall Study|Lost to Follow-up|1|||
150217869|NCT02613403|541934224|FG002|Overall Study|Lost to Follow-up|0|||
150217870|NCT02613403|541934225|FG003|Overall Study|Lost to Follow-up|0|||
150217871|NCT02613403|541934226|FG004|Overall Study|Lost to Follow-up|0|||
150217872|NCT02613403|541934222|FG000|Overall Study|Withdrawal by Subject|2|||
150217873|NCT02613403|541934223|FG001|Overall Study|Withdrawal by Subject|0|||
150217874|NCT02613403|541934224|FG002|Overall Study|Withdrawal by Subject|0|||
150217875|NCT02613403|541934225|FG003|Overall Study|Withdrawal by Subject|0|||
150217876|NCT02613403|541934226|FG004|Overall Study|Withdrawal by Subject|0|||
150217877|NCT02807857|541934227|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
150217878|NCT02807857|541934227|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
150217879|NCT02807857|541934227|FG000|Follow-Up Set|Withdrawal by Subject|8|||
150217880|NCT02807857|541934227|FG000|Follow-Up Set|Lost to Follow-up|7|||
150217881|NCT02807857|541934227|FG000|Follow-Up Set|Physician Decision|6|||
150217882|NCT02807857|541934227|FG000|Follow-Up Set|Adverse Event|3|||
150217883|NCT02807857|541934227|FG000|Follow-Up Set|Death|27|||
150217884|NCT02807857|541934227|FG000|Follow-Up Set|Relocation|2|||
150217885|NCT00800176|541934228|FG000|Overall Study|Adverse Event|2|||
150217886|NCT00800176|541934229|FG001|Overall Study|Adverse Event|1|||
150217887|NCT00800176|541934230|FG002|Overall Study|Adverse Event|0|||
150217888|NCT00800176|541934231|FG003|Overall Study|Adverse Event|2|||
150217889|NCT00800176|541934232|FG004|Overall Study|Adverse Event|1|||
150217890|NCT00800176|541934233|FG005|Overall Study|Adverse Event|1|||
150217891|NCT00800176|541934228|FG000|Overall Study|Refused treatment|3|||
150217892|NCT00800176|541934229|FG001|Overall Study|Refused treatment|2|||
150217893|NCT00800176|541934230|FG002|Overall Study|Refused treatment|0|||
150217894|NCT00800176|541934231|FG003|Overall Study|Refused treatment|0|||
150217895|NCT00800176|541934232|FG004|Overall Study|Refused treatment|1|||
150217896|NCT00800176|541934233|FG005|Overall Study|Refused treatment|4|||
150217897|NCT00800176|541934228|FG000|Overall Study|Failure to return|3|||
150217898|NCT00800176|541934229|FG001|Overall Study|Failure to return|3|||
150217899|NCT00800176|541934230|FG002|Overall Study|Failure to return|0|||
150217900|NCT00800176|541934231|FG003|Overall Study|Failure to return|2|||
150217901|NCT00800176|541934232|FG004|Overall Study|Failure to return|0|||
150217902|NCT00800176|541934233|FG005|Overall Study|Failure to return|0|||
150217903|NCT00800176|541934228|FG000|Overall Study|Other|1|||
150217904|NCT00800176|541934229|FG001|Overall Study|Other|0|||
150217905|NCT00800176|541934230|FG002|Overall Study|Other|0|||
150217906|NCT00800176|541934231|FG003|Overall Study|Other|0|||
150217907|NCT00800176|541934232|FG004|Overall Study|Other|2|||
150217908|NCT00800176|541934233|FG005|Overall Study|Other|0|||
150217909|NCT02326220|541934236|FG000|Double-blind Treatment Period|Adverse Event|1|||
150217910|NCT02326220|541934237|FG001|Double-blind Treatment Period|Adverse Event|2|||
150217911|NCT02326220|541934238|FG002|Double-blind Treatment Period|Adverse Event|0|||
150217912|NCT02326220|541934236|FG000|Double-blind Treatment Period|Protocol Violation|0|||
150217913|NCT02326220|541934237|FG001|Double-blind Treatment Period|Protocol Violation|1|||
150217914|NCT02326220|541934238|FG002|Double-blind Treatment Period|Protocol Violation|0|||
150217915|NCT02326220|541934236|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
150217916|NCT02326220|541934237|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
150217917|NCT02326220|541934238|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
150217918|NCT02326220|541934236|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
150217919|NCT02326220|541934237|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
150217920|NCT02326220|541934238|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
150217921|NCT02326220|541934236|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
150217922|NCT02326220|541934237|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
150217923|NCT02326220|541934238|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
150217924|NCT02699099|541934239|FG000|Overall Study|Adverse Event|1|||
150217925|NCT02699099|541934240|FG001|Overall Study|Adverse Event|0|||
150217926|NCT02699099|541934241|FG002|Overall Study|Adverse Event|2|||
150217927|NCT02699099|541934239|FG000|Overall Study|Lost to Follow-up|0|||
150217928|NCT02699099|541934240|FG001|Overall Study|Lost to Follow-up|1|||
150217929|NCT02699099|541934241|FG002|Overall Study|Lost to Follow-up|0|||
150217930|NCT02699099|541934239|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
150217931|NCT02699099|541934240|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
150217932|NCT02699099|541934241|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
150217933|NCT01240590|541934244|FG000|Phase I|Refused further treatment|0|||
150217934|NCT01240590|541934245|FG001|Phase I|Refused further treatment|0|||
150217935|NCT01240590|541934246|FG002|Phase I|Refused further treatment|3|||
150217936|NCT01240590|541934247|FG003|Phase I|Refused further treatment|0|||
150217937|NCT01240590|541934248|FG004|Phase I|Refused further treatment|0|||
150217938|NCT01240590|541934244|FG000|Phase II|Refused further treatment|0|||
150217939|NCT01240590|541934245|FG001|Phase II|Refused further treatment|0|||
150217940|NCT01240590|541934246|FG002|Phase II|Refused further treatment|0|||
150217941|NCT01240590|541934247|FG003|Phase II|Refused further treatment|2|||
150217942|NCT01240590|541934248|FG004|Phase II|Refused further treatment|1|||
150217943|NCT02659540|541934249|FG000|Overall Study|Adverse Event|3|||
150217944|NCT02659540|541934250|FG001|Overall Study|Adverse Event|2|||
150217945|NCT02659540|541934249|FG000|Overall Study|Death|1|||
150217946|NCT02659540|541934250|FG001|Overall Study|Death|0|||
150217947|NCT02659540|541934249|FG000|Overall Study|Progressive disease|2|||
150217948|NCT02659540|541934250|FG001|Overall Study|Progressive disease|6|||
150217949|NCT00824850|541934251|FG000|Overall Study|Withdrawal by Subject|0|||
150217950|NCT00824850|541934252|FG001|Overall Study|Withdrawal by Subject|1|||
150217951|NCT01075152|541934254|FG000|Overall Study|Withdrawal by Subject|1|||
150217952|NCT01075152|541934255|FG001|Overall Study|Withdrawal by Subject|0|||
150217953|NCT04820491|541934256|FG000|Overall Study|Withdrawal by Subject|1|||
150217954|NCT04820491|541934257|FG001|Overall Study|Withdrawal by Subject|0|||
150217955|NCT02144285|541934260|FG000|Overall Study|Withdrawal by Subject|0|||
150217956|NCT02144285|541934261|FG001|Overall Study|Withdrawal by Subject|0|||
150217957|NCT02144285|541934262|FG002|Overall Study|Withdrawal by Subject|0|||
150217958|NCT02144285|541934263|FG003|Overall Study|Withdrawal by Subject|0|||
150217959|NCT02144285|541934264|FG004|Overall Study|Withdrawal by Subject|1|||
150217960|NCT02144285|541934265|FG005|Overall Study|Withdrawal by Subject|0|||
150217961|NCT02144285|541934266|FG006|Overall Study|Withdrawal by Subject|0|||
150217962|NCT02144285|541934267|FG007|Overall Study|Withdrawal by Subject|0|||
150217963|NCT02144285|541934268|FG008|Overall Study|Withdrawal by Subject|0|||
150217964|NCT02144285|541934269|FG009|Overall Study|Withdrawal by Subject|0|||
150217965|NCT01529632|541934270|FG000|Overall Study|Administrative problem|2|||
150217966|NCT01529632|541934271|FG001|Overall Study|Administrative problem|1|||
150217967|NCT01529632|541934270|FG000|Overall Study|Protocol Violation|0|||
150217968|NCT01529632|541934271|FG001|Overall Study|Protocol Violation|1|||
150217969|NCT01529632|541934270|FG000|Overall Study|Adverse Event|1|||
150217970|NCT01529632|541934271|FG001|Overall Study|Adverse Event|1|||
150217971|NCT05184062|541934273|FG000|Overall Study|Lost to Follow-up|5|||
150217972|NCT05184062|541934274|FG001|Overall Study|Lost to Follow-up|1|||
150217973|NCT05184062|541934273|FG000|Overall Study|Withdrawal by Subject|1|||
150217974|NCT05184062|541934274|FG001|Overall Study|Withdrawal by Subject|0|||
150217975|NCT03659136|541934279|FG000|Overall Study|Not treated|2|||
150217976|NCT03659136|541934280|FG001|Overall Study|Not treated|0|||
150217977|NCT03659136|541934279|FG000|Overall Study|Covid-19 related|1|||
150217978|NCT03659136|541934280|FG001|Overall Study|Covid-19 related|1|||
150217979|NCT03659136|541934279|FG000|Overall Study|Withdrawal by Subject|1|||
150217980|NCT03659136|541934280|FG001|Overall Study|Withdrawal by Subject|6|||
150217981|NCT03659136|541934279|FG000|Overall Study|Adverse Event|4|||
150217982|NCT03659136|541934280|FG001|Overall Study|Adverse Event|6|||
150217983|NCT03659136|541934279|FG000|Overall Study|Progressive disease|37|||
150217984|NCT03659136|541934280|FG001|Overall Study|Progressive disease|31|||
150217985|NCT03659136|541934279|FG000|Overall Study|Study closure|2|||
150217986|NCT03659136|541934280|FG001|Overall Study|Study closure|2|||
150217987|NCT03659136|541934279|FG000|Overall Study|Sponsor decision/recommendation|3|||
150217988|NCT03659136|541934280|FG001|Overall Study|Sponsor decision/recommendation|2|||
150217989|NCT03659136|541934279|FG000|Overall Study|Switched to other drug/therapy|2|||
150217990|NCT03659136|541934280|FG001|Overall Study|Switched to other drug/therapy|2|||
150217991|NCT03659136|541934279|FG000|Overall Study|Lack of clinical benefit|0|||
150217992|NCT03659136|541934280|FG001|Overall Study|Lack of clinical benefit|1|||
150217993|NCT03786471|541934281|FG000|Overall Study|Death|254|||
150217994|NCT03786471|541934282|FG001|Overall Study|Death|223|||
150217995|NCT03786471|541934283|FG002|Overall Study|Death|37|||
150217996|NCT03786471|541934281|FG000|Overall Study|Lost to Follow-up|63|||
150217997|NCT03786471|541934282|FG001|Overall Study|Lost to Follow-up|50|||
150217998|NCT03786471|541934283|FG002|Overall Study|Lost to Follow-up|15|||
150217999|NCT03786471|541934281|FG000|Overall Study|Withdrawal by Subject|99|||
150218000|NCT03786471|541934282|FG001|Overall Study|Withdrawal by Subject|81|||
150218001|NCT03786471|541934283|FG002|Overall Study|Withdrawal by Subject|11|||
150218002|NCT04328467|541935483|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
150218003|NCT04328467|541935484|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
150218004|NCT04328467|541935485|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
150218005|NCT00990184|541935486|FG000|Overall Study|Physician Decision|1|||
150218006|NCT02152384|541935491|FG000|Period 1|Withdrawal by Subject|0|||
150218007|NCT02152384|541935492|FG001|Period 1|Withdrawal by Subject|1|||
150218008|NCT02152384|541935491|FG000|Period 1|Adverse Event|1|||
150218009|NCT02152384|541935492|FG001|Period 1|Adverse Event|1|||
150218010|NCT00603798|541935494|FG000|Overall Study|Adverse Event|4|||
150218011|NCT00603798|541935495|FG001|Overall Study|Adverse Event|2|||
150218012|NCT00603798|541935496|FG002|Overall Study|Adverse Event|1|||
150218013|NCT00603798|541935494|FG000|Overall Study|Withdrawal by Subject|4|||
150218014|NCT00603798|541935495|FG001|Overall Study|Withdrawal by Subject|3|||
150218015|NCT00603798|541935496|FG002|Overall Study|Withdrawal by Subject|4|||
150218016|NCT00603798|541935494|FG000|Overall Study|Lost to Follow-up|1|||
150218017|NCT00603798|541935495|FG001|Overall Study|Lost to Follow-up|0|||
150218018|NCT00603798|541935496|FG002|Overall Study|Lost to Follow-up|1|||
150218019|NCT00603798|541935494|FG000|Overall Study|Non-compliance with study procedures|0|||
150218020|NCT00603798|541935495|FG001|Overall Study|Non-compliance with study procedures|1|||
150218021|NCT00603798|541935496|FG002|Overall Study|Non-compliance with study procedures|0|||
150218022|NCT00603798|541935494|FG000|Overall Study|Not due to AE|1|||
150218023|NCT00603798|541935495|FG001|Overall Study|Not due to AE|1|||
150218024|NCT00603798|541935496|FG002|Overall Study|Not due to AE|4|||
150218025|NCT01215253|541935499|FG000|Overall Study|Withdrawal by Subject|57|||
150218026|NCT01215253|541935500|FG001|Overall Study|Withdrawal by Subject|35|||
150218027|NCT01215253|541935499|FG000|Overall Study|Physician Decision|9|||
150218028|NCT01215253|541935500|FG001|Overall Study|Physician Decision|12|||
150218029|NCT01215253|541935499|FG000|Overall Study|Lost to Follow-up|6|||
150218030|NCT01215253|541935500|FG001|Overall Study|Lost to Follow-up|4|||
150218031|NCT01215253|541935499|FG000|Overall Study|Other|14|||
150218032|NCT01215253|541935500|FG001|Overall Study|Other|12|||
150218033|NCT02137785|541935505|FG000|Overall Study|Lost to Follow-up|1|||
150218034|NCT02137785|541935506|FG001|Overall Study|Lost to Follow-up|0|||
150218035|NCT02137785|541935505|FG000|Overall Study|Withdrawal by Subject|1|||
150218036|NCT02137785|541935506|FG001|Overall Study|Withdrawal by Subject|4|||
150218037|NCT02137785|541935505|FG000|Overall Study|subject moved out of state|1|||
150218038|NCT02137785|541935506|FG001|Overall Study|subject moved out of state|0|||
150218039|NCT02584257|541935507|FG000|Period 1|Withdrawal by Subject|0|||
150218040|NCT02584257|541935508|FG001|Period 1|Withdrawal by Subject|0|||
150218041|NCT02584257|541935509|FG002|Period 1|Withdrawal by Subject|0|||
150218042|NCT02584257|541935510|FG003|Period 1|Withdrawal by Subject|0|||
150218043|NCT02584257|541935511|FG004|Period 1|Withdrawal by Subject|0|||
150218044|NCT02584257|541935512|FG005|Period 1|Withdrawal by Subject|0|||
150218045|NCT02584257|541935513|FG006|Period 1|Withdrawal by Subject|1|||
150218046|NCT02584257|541935514|FG007|Period 1|Withdrawal by Subject|0|||
150218047|NCT02584257|541935515|FG008|Period 1|Withdrawal by Subject|0|||
150218048|NCT02584257|541935507|FG000|Period 2|Physician Decision|1|||
150218049|NCT02584257|541935508|FG001|Period 2|Physician Decision|0|||
150218050|NCT02584257|541935509|FG002|Period 2|Physician Decision|0|||
150218051|NCT02584257|541935510|FG003|Period 2|Physician Decision|0|||
150218052|NCT02584257|541935511|FG004|Period 2|Physician Decision|0|||
150218053|NCT02584257|541935512|FG005|Period 2|Physician Decision|0|||
150218054|NCT02584257|541935513|FG006|Period 2|Physician Decision|0|||
150218055|NCT02584257|541935514|FG007|Period 2|Physician Decision|0|||
150218056|NCT02584257|541935515|FG008|Period 2|Physician Decision|0|||
150218057|NCT02584257|541935507|FG000|Period 2|Adverse Event|0|||
150218058|NCT02584257|541935508|FG001|Period 2|Adverse Event|1|||
150218059|NCT02584257|541935509|FG002|Period 2|Adverse Event|0|||
150218060|NCT02584257|541935510|FG003|Period 2|Adverse Event|0|||
150218061|NCT02584257|541935511|FG004|Period 2|Adverse Event|0|||
150218062|NCT02584257|541935512|FG005|Period 2|Adverse Event|0|||
150218063|NCT02584257|541935513|FG006|Period 2|Adverse Event|0|||
150218064|NCT02584257|541935514|FG007|Period 2|Adverse Event|0|||
150218065|NCT02584257|541935515|FG008|Period 2|Adverse Event|0|||
150218066|NCT00417885|541935516|FG000|Overall Study|Adverse Event|1|||
150218067|NCT00417885|541935516|FG000|Overall Study|Objective Progression or Relapse|3|||
150218068|NCT00417885|541935516|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
150218069|NCT02309892|541935517|FG000|Overall Study|Physician Decision|1|||
150218070|NCT02309892|541935518|FG001|Overall Study|Physician Decision|0|||
150218071|NCT02309892|541935519|FG002|Overall Study|Physician Decision|0|||
150218072|NCT02309892|541935520|FG003|Overall Study|Physician Decision|0|||
150218073|NCT02309892|541935521|FG004|Overall Study|Physician Decision|0|||
150218074|NCT02309892|541935522|FG005|Overall Study|Physician Decision|0|||
150218075|NCT02309892|541935523|FG006|Overall Study|Physician Decision|0|||
150218076|NCT02309892|541935517|FG000|Overall Study|Adverse Event|1|||
150218077|NCT02309892|541935518|FG001|Overall Study|Adverse Event|0|||
150218078|NCT02309892|541935519|FG002|Overall Study|Adverse Event|1|||
150218079|NCT02309892|541935520|FG003|Overall Study|Adverse Event|0|||
150218080|NCT02309892|541935521|FG004|Overall Study|Adverse Event|0|||
150218081|NCT02309892|541935522|FG005|Overall Study|Adverse Event|0|||
150218082|NCT02309892|541935523|FG006|Overall Study|Adverse Event|0|||
150218083|NCT02309892|541935517|FG000|Overall Study|Progressive Disease|0|||
150218084|NCT02309892|541935518|FG001|Overall Study|Progressive Disease|1|||
150218085|NCT02309892|541935519|FG002|Overall Study|Progressive Disease|0|||
150218086|NCT02309892|541935520|FG003|Overall Study|Progressive Disease|0|||
150218087|NCT02309892|541935521|FG004|Overall Study|Progressive Disease|1|||
150218088|NCT02309892|541935522|FG005|Overall Study|Progressive Disease|0|||
150218089|NCT02309892|541935523|FG006|Overall Study|Progressive Disease|0|||
150218090|NCT02309892|541935517|FG000|Overall Study|Death|0|||
150218091|NCT02309892|541935518|FG001|Overall Study|Death|0|||
150218092|NCT02309892|541935519|FG002|Overall Study|Death|0|||
150218093|NCT02309892|541935520|FG003|Overall Study|Death|0|||
150218094|NCT02309892|541935521|FG004|Overall Study|Death|0|||
150218095|NCT02309892|541935522|FG005|Overall Study|Death|1|||
150218096|NCT02309892|541935523|FG006|Overall Study|Death|0|||
150218097|NCT03146845|541935526|FG000|Overall Study|Reference ulcer healed|1|||
150218098|NCT03146845|541935527|FG001|Overall Study|Reference ulcer healed|0|||
150218099|NCT03146845|541935526|FG000|Overall Study|Physician Decision|1|||
150218100|NCT03146845|541935527|FG001|Overall Study|Physician Decision|0|||
150218101|NCT03146845|541935526|FG000|Overall Study|Adverse Event|1|||
150218102|NCT03146845|541935527|FG001|Overall Study|Adverse Event|0|||
150218103|NCT03146845|541935526|FG000|Overall Study|Withdrawal by Subject|2|||
150218104|NCT03146845|541935527|FG001|Overall Study|Withdrawal by Subject|0|||
150218105|NCT03146845|541935526|FG000|Overall Study|Noncompliance|0|||
150218106|NCT03146845|541935527|FG001|Overall Study|Noncompliance|1|||
150218107|NCT03146845|541935526|FG000|Overall Study|Protocol Violation|0|||
150218108|NCT03146845|541935527|FG001|Overall Study|Protocol Violation|2|||
150218109|NCT03146845|541935526|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
150218110|NCT03146845|541935527|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
150218111|NCT05376397|541935528|FG000|Overall Study|Lost to Follow-up|1|||
150218112|NCT02721147|541935529|FG000|Overall Study|Lost to Follow-up|2|||
150218113|NCT02721147|541935530|FG001|Overall Study|Lost to Follow-up|0|||
150218114|NCT02721147|541935531|FG002|Overall Study|Lost to Follow-up|0|||
150218115|NCT01722097|541935534|FG000|Overall Study|Patient sheets not returned|6|||
150218116|NCT01722097|541935535|FG001|Overall Study|Patient sheets not returned|5|||
150218117|NCT01535261|541935537|FG000|Overall Study|Physician Decision|8|||
150218118|NCT01535261|541935537|FG000|Overall Study|Protocol Violation|3|||
150218119|NCT01535261|541935537|FG000|Overall Study|Death|5|||
150218120|NCT01535261|541935537|FG000|Overall Study|Lost to Follow-up|8|||
150218121|NCT01535261|541935537|FG000|Overall Study|Withdrawal by Subject|14|||
150218122|NCT01535261|541935537|FG000|Overall Study|Adverse Event|12|||
150218123|NCT01137682|541935538|FG000|Overall Study|Adverse Event-CORE|2|||
150218124|NCT01137682|541935539|FG001|Overall Study|Adverse Event-CORE|4|||
150218125|NCT01137682|541935540|FG002|Overall Study|Adverse Event-CORE|0|||
150218126|NCT01137682|541935538|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
150218127|NCT01137682|541935539|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
150218128|NCT01137682|541935540|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
150218129|NCT01137682|541935538|FG000|Overall Study|Administrative problems-CORE|2|||
150218130|NCT01137682|541935539|FG001|Overall Study|Administrative problems-CORE|1|||
150218131|NCT01137682|541935540|FG002|Overall Study|Administrative problems-CORE|0|||
150218132|NCT01137682|541935538|FG000|Overall Study|Protocol Violation-CORE|0|||
150218133|NCT01137682|541935539|FG001|Overall Study|Protocol Violation-CORE|1|||
150218134|NCT01137682|541935540|FG002|Overall Study|Protocol Violation-CORE|1|||
150218135|NCT01137682|541935538|FG000|Overall Study|Adverse Event-Extension|4|||
150218136|NCT01137682|541935539|FG001|Overall Study|Adverse Event-Extension|8|||
150218137|NCT01137682|541935540|FG002|Overall Study|Adverse Event-Extension|7|||
150218138|NCT01137682|541935538|FG000|Overall Study|Lack of Efficacy-Extension|15|||
150218139|NCT01137682|541935539|FG001|Overall Study|Lack of Efficacy-Extension|9|||
150218140|NCT01137682|541935540|FG002|Overall Study|Lack of Efficacy-Extension|13|||
150218141|NCT01137682|541935538|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
150218142|NCT01137682|541935539|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
150218143|NCT01137682|541935540|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
150218144|NCT01137682|541935538|FG000|Overall Study|Lost to Follow Up-Extension|0|||
150218145|NCT01137682|541935539|FG001|Overall Study|Lost to Follow Up-Extension|1|||
150218146|NCT01137682|541935540|FG002|Overall Study|Lost to Follow Up-Extension|0|||
150218147|NCT01137682|541935538|FG000|Overall Study|Administrative problems-Extension|0|||
150218148|NCT01137682|541935539|FG001|Overall Study|Administrative problems-Extension|2|||
150218149|NCT01137682|541935540|FG002|Overall Study|Administrative problems-Extension|0|||
150218150|NCT01137682|541935538|FG000|Overall Study|Death-Extension|2|||
150218151|NCT01137682|541935539|FG001|Overall Study|Death-Extension|0|||
150218152|NCT01137682|541935540|FG002|Overall Study|Death-Extension|0|||
150218153|NCT01137682|541935538|FG000|Overall Study|Protocol Violation-Extension|2|||
150218154|NCT01137682|541935539|FG001|Overall Study|Protocol Violation-Extension|1|||
150218155|NCT01137682|541935540|FG002|Overall Study|Protocol Violation-Extension|0|||
150218156|NCT01137682|541935538|FG000|Overall Study|Did not enter extension|2|||
150218157|NCT01137682|541935539|FG001|Overall Study|Did not enter extension|3|||
150218158|NCT01137682|541935540|FG002|Overall Study|Did not enter extension|2|||
150218159|NCT01137682|541935538|FG000|Overall Study|Did not receive treatment in extension|0|||
150218160|NCT01137682|541935539|FG001|Overall Study|Did not receive treatment in extension|0|||
150218161|NCT01137682|541935540|FG002|Overall Study|Did not receive treatment in extension|1|||
150218162|NCT01912599|541935541|FG000|Overall Study|Withdrawal by Subject|0|||
150218163|NCT01912599|541935542|FG001|Overall Study|Withdrawal by Subject|1|||
150218164|NCT00042939|541935547|FG000|Overall Study|Adverse Event|6|||
150218165|NCT00042939|541935548|FG001|Overall Study|Adverse Event|7|||
150218166|NCT00042939|541935547|FG000|Overall Study|Death|3|||
150218167|NCT00042939|541935548|FG001|Overall Study|Death|2|||
150218168|NCT00042939|541935547|FG000|Overall Study|Withdrawal by Subject|3|||
150218169|NCT00042939|541935548|FG001|Overall Study|Withdrawal by Subject|4|||
150218170|NCT00042939|541935547|FG000|Overall Study|Other disease|1|||
150218171|NCT00042939|541935548|FG001|Overall Study|Other disease|0|||
150218172|NCT00042939|541935547|FG000|Overall Study|Ineligible|2|||
150218173|NCT00042939|541935548|FG001|Overall Study|Ineligible|2|||
150218174|NCT00042939|541935547|FG000|Overall Study|Deterioration of health|3|||
150218175|NCT00042939|541935548|FG001|Overall Study|Deterioration of health|4|||
150218176|NCT00042939|541935547|FG000|Overall Study|QOL diminished|1|||
150218177|NCT00042939|541935548|FG001|Overall Study|QOL diminished|0|||
150218178|NCT00042939|541935547|FG000|Overall Study|Rising ca 19-9|1|||
150218179|NCT00042939|541935548|FG001|Overall Study|Rising ca 19-9|0|||
150218180|NCT00042939|541935547|FG000|Overall Study|Patient non-compliance|1|||
150218181|NCT00042939|541935548|FG001|Overall Study|Patient non-compliance|0|||
150218182|NCT00042939|541935547|FG000|Overall Study|Still on treatment|1|||
150218183|NCT00042939|541935548|FG001|Overall Study|Still on treatment|0|||
150218184|NCT00042939|541935547|FG000|Overall Study|Treatment break > 4 weeks|0|||
150218185|NCT00042939|541935548|FG001|Overall Study|Treatment break > 4 weeks|1|||
150218186|NCT00042939|541935547|FG000|Overall Study|Did not start treatment|2|||
150218187|NCT00042939|541935548|FG001|Overall Study|Did not start treatment|1|||
150218188|NCT03349476|541935549|FG000|Overall Study|Physician Decision|3|||
150218189|NCT00472082|541935556|FG000|Overall Study|Study prematurely terminated|5|||
150218190|NCT00248794|541935557|FG000|Overall Study|Lost to Follow-up|6|||
150218191|NCT00248794|541935558|FG001|Overall Study|Lost to Follow-up|8|||
150218192|NCT00248794|541935559|FG002|Overall Study|Lost to Follow-up|3|||
150218193|NCT03449979|541935560|FG000|Overall Study|Technical difficulty|0|||
150218194|NCT03449979|541935561|FG001|Overall Study|Technical difficulty|0|||
150218195|NCT03449979|541935562|FG002|Overall Study|Technical difficulty|0|||
150218196|NCT03449979|541935563|FG003|Overall Study|Technical difficulty|1|||
150218197|NCT04617847|541935566|FG000|Overall Study|Withdrawal by Subject|1|||
150218198|NCT04617847|541935567|FG001|Overall Study|Withdrawal by Subject|0|||
150218199|NCT04617847|541935566|FG000|Overall Study|Adverse Event|0|||
150218200|NCT04617847|541935567|FG001|Overall Study|Adverse Event|2|||
150218201|NCT04617847|541935566|FG000|Overall Study|Death|0|||
150218202|NCT04617847|541935567|FG001|Overall Study|Death|1|||
150218203|NCT04617847|541935566|FG000|Overall Study|Termination of Study by Sponsor|2|||
150218204|NCT04617847|541935567|FG001|Overall Study|Termination of Study by Sponsor|21|||
150218205|NCT01762345|541935568|FG000|Overall Study|Adverse Event|5|||
150218206|NCT01762345|541935568|FG000|Overall Study|Protocol Violation|2|||
150218207|NCT00700999|541935569|FG000|Overall Study|Lost to Follow-up|7|||
150218208|NCT00700999|541935570|FG001|Overall Study|Lost to Follow-up|7|||
150218209|NCT00700999|541935569|FG000|Overall Study|Excluded - did not meet study criteria|0|||
150218210|NCT00700999|541935570|FG001|Overall Study|Excluded - did not meet study criteria|1|||
150218211|NCT00700999|541935569|FG000|Overall Study|Withdrawal by Subject|8|||
150218212|NCT00700999|541935570|FG001|Overall Study|Withdrawal by Subject|1|||
150218213|NCT02379078|541935571|FG000|Overall Study|Lost to Follow-up|33|||
150218214|NCT02379078|541935572|FG001|Overall Study|Lost to Follow-up|30|||
150218215|NCT02379078|541935571|FG000|Overall Study|Withdrawal by Subject|6|||
150218216|NCT02379078|541935572|FG001|Overall Study|Withdrawal by Subject|5|||
150218217|NCT00244751|541935573|FG000|Overall Study|Adverse Event|7|||
150218218|NCT00244751|541935574|FG001|Overall Study|Adverse Event|7|||
150218219|NCT00244751|541935575|FG002|Overall Study|Adverse Event|5|||
150218220|NCT00244751|541935573|FG000|Overall Study|Lost to Follow-up|0|||
150218221|NCT00244751|541935574|FG001|Overall Study|Lost to Follow-up|1|||
150218222|NCT00244751|541935575|FG002|Overall Study|Lost to Follow-up|0|||
150218223|NCT00244751|541935573|FG000|Overall Study|Protocol Violation|1|||
150218224|NCT00244751|541935574|FG001|Overall Study|Protocol Violation|0|||
150218225|NCT00244751|541935575|FG002|Overall Study|Protocol Violation|1|||
150218226|NCT00244751|541935573|FG000|Overall Study|Withdrawal by Subject|7|||
150218227|NCT00244751|541935574|FG001|Overall Study|Withdrawal by Subject|5|||
150218228|NCT00244751|541935575|FG002|Overall Study|Withdrawal by Subject|3|||
150218229|NCT00244751|541935573|FG000|Overall Study|Elevated liver enzymes|1|||
150218230|NCT00244751|541935574|FG001|Overall Study|Elevated liver enzymes|0|||
150218231|NCT00244751|541935575|FG002|Overall Study|Elevated liver enzymes|0|||
150218232|NCT00244751|541935573|FG000|Overall Study|Lack of compliance with protocol|0|||
150218233|NCT00244751|541935574|FG001|Overall Study|Lack of compliance with protocol|1|||
150218234|NCT00244751|541935575|FG002|Overall Study|Lack of compliance with protocol|0|||
150218235|NCT00244751|541935573|FG000|Overall Study|Safety reasons|0|||
150218236|NCT00244751|541935574|FG001|Overall Study|Safety reasons|1|||
150218237|NCT00244751|541935575|FG002|Overall Study|Safety reasons|0|||
150218238|NCT00244751|541935573|FG000|Overall Study|Participant randomized by mistake|0|||
150218239|NCT00244751|541935574|FG001|Overall Study|Participant randomized by mistake|0|||
150218240|NCT00244751|541935575|FG002|Overall Study|Participant randomized by mistake|1|||
150218241|NCT00761267|541935576|FG000|Overall Study|Death|1|||
150218242|NCT00761267|541935577|FG001|Overall Study|Death|2|||
150218243|NCT00761267|541935578|FG002|Overall Study|Death|5|||
150218244|NCT00761267|541935576|FG000|Overall Study|Lost to Follow-up|0|||
150218245|NCT00761267|541935577|FG001|Overall Study|Lost to Follow-up|0|||
150218246|NCT00761267|541935578|FG002|Overall Study|Lost to Follow-up|1|||
150218247|NCT00761267|541935576|FG000|Overall Study|Randomized but not treated|1|||
150218248|NCT00761267|541935577|FG001|Overall Study|Randomized but not treated|1|||
150218249|NCT00761267|541935578|FG002|Overall Study|Randomized but not treated|0|||
150218250|NCT00761267|541935576|FG000|Overall Study|Withdrawal by Subject|0|||
150218251|NCT00761267|541935577|FG001|Overall Study|Withdrawal by Subject|1|||
150218252|NCT00761267|541935578|FG002|Overall Study|Withdrawal by Subject|0|||
150218253|NCT01777932|541935582|FG000|Overall Study|Disease progression|136|||
150218254|NCT01777932|541935582|FG000|Overall Study|Death|3|||
150218255|NCT01777932|541935582|FG000|Overall Study|Adverse Event|34|||
150218256|NCT01777932|541935582|FG000|Overall Study|Lost to Follow-up|3|||
150218257|NCT01777932|541935582|FG000|Overall Study|Investigator decision|10|||
150218258|NCT01777932|541935582|FG000|Overall Study|Reimbursement limit|9|||
150218259|NCT01777932|541935582|FG000|Overall Study|Patient refused further treatment|10|||
150218260|NCT00068107|541935587|FG000|Overall Study|end-stage renal disease|6|||
150218261|NCT00068107|541935587|FG000|Overall Study|Death|2|||
150218262|NCT00068107|541935587|FG000|Overall Study|Withdrawal by Subject|1|||
150218263|NCT03288506|541935588|FG000|Overall Study|Withdrawal by Subject|52|||
150218264|NCT00090519|541935589|FG000|Overall Study|Adverse Event|5|||
150218265|NCT00090519|541935590|FG001|Overall Study|Adverse Event|4|||
150218266|NCT00090519|541935589|FG000|Overall Study|Death|9|||
150218267|NCT00090519|541935590|FG001|Overall Study|Death|9|||
150218268|NCT00090519|541935589|FG000|Overall Study|Lost to Follow-up|26|||
150218269|NCT00090519|541935590|FG001|Overall Study|Lost to Follow-up|29|||
150218270|NCT00090519|541935589|FG000|Overall Study|Withdrawal by Subject|28|||
150218271|NCT00090519|541935590|FG001|Overall Study|Withdrawal by Subject|29|||
150218272|NCT00090519|541935589|FG000|Overall Study|Physician Decision|2|||
150218273|NCT00090519|541935590|FG001|Overall Study|Physician Decision|3|||
150218274|NCT00090519|541935589|FG000|Overall Study|Sponsor Decision|3|||
150218275|NCT00090519|541935590|FG001|Overall Study|Sponsor Decision|1|||
150218276|NCT00116649|541935591|FG000|Overall Study|Adverse Event|20|||
150218277|NCT00116649|541935591|FG000|Overall Study|Lack of Efficacy|1|||
150218278|NCT00116649|541935591|FG000|Overall Study|Lost to Follow-up|32|||
150218279|NCT00116649|541935591|FG000|Overall Study|Withdrawal by Subject|68|||
150218280|NCT00116649|541935591|FG000|Overall Study|Local Skin Reaction|9|||
150218281|NCT00116649|541935591|FG000|Overall Study|Various Reasons|18|||
150218282|NCT00116649|541935591|FG000|Overall Study|Protocol Specified|7|||
150218283|NCT02161146|541935592|FG000|Overall Study|Adverse Event|1|||
150218284|NCT02161146|541935593|FG001|Overall Study|Adverse Event|1|||
150218285|NCT02161146|541935594|FG002|Overall Study|Adverse Event|0|||
150218286|NCT02161146|541935595|FG003|Overall Study|Adverse Event|1|||
150218287|NCT02161146|541935596|FG004|Overall Study|Adverse Event|0|||
150218288|NCT02161146|541935592|FG000|Overall Study|Lost to Follow-up|0|||
150218289|NCT02161146|541935593|FG001|Overall Study|Lost to Follow-up|1|||
150218290|NCT02161146|541935594|FG002|Overall Study|Lost to Follow-up|0|||
150218291|NCT02161146|541935595|FG003|Overall Study|Lost to Follow-up|0|||
150218292|NCT02161146|541935596|FG004|Overall Study|Lost to Follow-up|0|||
150218293|NCT02161146|541935592|FG000|Overall Study|Personal Reasons|0|||
150218294|NCT02161146|541935593|FG001|Overall Study|Personal Reasons|1|||
150218295|NCT02161146|541935594|FG002|Overall Study|Personal Reasons|0|||
150218296|NCT02161146|541935595|FG003|Overall Study|Personal Reasons|2|||
150218297|NCT02161146|541935596|FG004|Overall Study|Personal Reasons|1|||
150218298|NCT02161146|541935592|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150218299|NCT02161146|541935593|FG001|Overall Study|Other Miscellaneous Reasons|1|||
150218300|NCT02161146|541935594|FG002|Overall Study|Other Miscellaneous Reasons|0|||
150218301|NCT02161146|541935595|FG003|Overall Study|Other Miscellaneous Reasons|0|||
150218302|NCT02161146|541935596|FG004|Overall Study|Other Miscellaneous Reasons|0|||
150218303|NCT00845520|541935597|FG000|Overall Study|Death|1|||
150218304|NCT00845520|541935598|FG001|Overall Study|Death|2|||
150218305|NCT00845520|541935599|FG002|Overall Study|Death|0|||
150218306|NCT00845520|541935597|FG000|Overall Study|Lost to Follow-up|1|||
150218307|NCT00845520|541935598|FG001|Overall Study|Lost to Follow-up|0|||
150218308|NCT00845520|541935599|FG002|Overall Study|Lost to Follow-up|0|||
150218309|NCT00845520|541935597|FG000|Overall Study|Adverse Event|0|||
150218310|NCT00845520|541935598|FG001|Overall Study|Adverse Event|0|||
150218311|NCT00845520|541935599|FG002|Overall Study|Adverse Event|1|||
150218312|NCT01079949|541935601|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
150218313|NCT01079949|541935602|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
150218314|NCT01079949|541935601|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
150218315|NCT01079949|541935602|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
150218316|NCT01079949|541935601|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
150218317|NCT01079949|541935602|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
150218318|NCT01079949|541935601|FG000|Overall Study|Randomized but not treated|1|||
150218319|NCT01079949|541935602|FG001|Overall Study|Randomized but not treated|0|||
150218320|NCT00452452|541935603|FG000|Overall Study|Protocol Violation|0|||
150218321|NCT00452452|541935604|FG001|Overall Study|Protocol Violation|0|||
150218322|NCT00452452|541935605|FG002|Overall Study|Protocol Violation|1|||
150218323|NCT00452452|541935603|FG000|Overall Study|Withdrawal by Subject|1|||
150218324|NCT00452452|541935604|FG001|Overall Study|Withdrawal by Subject|0|||
150218325|NCT00452452|541935605|FG002|Overall Study|Withdrawal by Subject|0|||
150218326|NCT00452452|541935603|FG000|Overall Study|Lost to Follow-up|1|||
150218327|NCT00452452|541935604|FG001|Overall Study|Lost to Follow-up|0|||
150218328|NCT00452452|541935605|FG002|Overall Study|Lost to Follow-up|0|||
150218329|NCT04620733|541937275|FG000|Overall Study|Adverse Event|4|||
150218330|NCT04620733|541937276|FG001|Overall Study|Adverse Event|3|||
150218331|NCT04620733|541937275|FG000|Overall Study|Withdrawal by Subject|2|||
150218332|NCT04620733|541937276|FG001|Overall Study|Withdrawal by Subject|5|||
150218333|NCT04620733|541937275|FG000|Overall Study|Lost to Follow-up|1|||
150218334|NCT04620733|541937276|FG001|Overall Study|Lost to Follow-up|1|||
150218335|NCT04620733|541937275|FG000|Overall Study|Protocol Deviation|1|||
150218336|NCT04620733|541937276|FG001|Overall Study|Protocol Deviation|1|||
150218337|NCT04620733|541937275|FG000|Overall Study|Reason Not Specified|0|||
150218338|NCT04620733|541937276|FG001|Overall Study|Reason Not Specified|1|||
150218339|NCT00451906|541937287|FG000|Overall Study|Adverse Event|515|||
150218340|NCT00451906|541937287|FG000|Overall Study|Lost to Follow-up|31|||
150218341|NCT00451906|541937287|FG000|Overall Study|Withdrawal by Subject|111|||
150218342|NCT00451906|541937287|FG000|Overall Study|Protocol Violation|21|||
150218343|NCT00451906|541937287|FG000|Overall Study|Progressive disease|1328|||
150218344|NCT00451906|541937287|FG000|Overall Study|Termination of the study|108|||
150218345|NCT00451906|541937287|FG000|Overall Study|Other Reasons|121|||
150218346|NCT00451906|541937287|FG000|Overall Study|Did not complete final visit|4|||
150218347|NCT02121808|541937293|FG000|Overall Study|Technical problem|3|||
150218348|NCT02164578|541937294|FG000|Treatment Period|Withdrawal by Subject|3|||
150218349|NCT02164578|541937295|FG001|Treatment Period|Withdrawal by Subject|3|||
150218350|NCT02164578|541937294|FG000|Treatment Period|Adverse Event|13|||
150218351|NCT02164578|541937295|FG001|Treatment Period|Adverse Event|6|||
150218352|NCT02164578|541937294|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
150218353|NCT02164578|541937295|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
150218354|NCT02164578|541937294|FG000|Treatment Period|Protocol Violation|0|||
150218355|NCT02164578|541937295|FG001|Treatment Period|Protocol Violation|2|||
150218356|NCT02164578|541937294|FG000|Extension Period|Withdrawal by Subject|2|||
150218357|NCT02164578|541937295|FG001|Extension Period|Withdrawal by Subject|0|||
150218358|NCT02164578|541937294|FG000|Extension Period|Adverse Event|4|||
150218359|NCT02164578|541937295|FG001|Extension Period|Adverse Event|0|||
150218360|NCT02164578|541937294|FG000|Extension Period|Expiry of study medication|1|||
150218361|NCT02164578|541937295|FG001|Extension Period|Expiry of study medication|0|||
150218362|NCT02164578|541937294|FG000|Extension Period|Protocol Violation|0|||
150218363|NCT02164578|541937295|FG001|Extension Period|Protocol Violation|1|||
150218364|NCT03924193|541937301|FG000|Overall Study|Adverse Event|10|||
150218365|NCT03924193|541937302|FG001|Overall Study|Adverse Event|0|||
150218366|NCT03924193|541937303|FG002|Overall Study|Adverse Event|10|||
150218367|NCT03924193|541937301|FG000|Overall Study|Withdrawal by Subject|5|||
150218368|NCT03924193|541937302|FG001|Overall Study|Withdrawal by Subject|10|||
150218369|NCT03924193|541937303|FG002|Overall Study|Withdrawal by Subject|2|||
150218370|NCT01562275|541937304|FG000|Stage 1|Adverse Event|0|||
150218371|NCT01562275|541937305|FG001|Stage 1|Adverse Event|0|||
150218372|NCT01562275|541937306|FG002|Stage 1|Adverse Event|0|||
150218373|NCT01562275|541937307|FG003|Stage 1|Adverse Event|1|||
150218374|NCT01562275|541937308|FG004|Stage 1|Adverse Event|1|||
150218375|NCT01562275|541937309|FG005|Stage 1|Adverse Event|0|||
150218376|NCT01562275|541937310|FG006|Stage 1|Adverse Event|0|||
150218377|NCT01562275|541937311|FG007|Stage 1|Adverse Event|0|||
150218378|NCT01562275|541937312|FG008|Stage 1|Adverse Event|0|||
150218379|NCT01562275|541937313|FG009|Stage 1|Adverse Event|1|||
150218380|NCT01562275|541937314|FG010|Stage 1|Adverse Event|0|||
150218381|NCT01562275|541937315|FG011|Stage 1|Adverse Event|0|||
150218382|NCT01562275|541937316|FG012|Stage 1|Adverse Event|0|||
150218383|NCT01562275|541937304|FG000|Stage 1|Death|1|||
150218384|NCT01562275|541937305|FG001|Stage 1|Death|0|||
150218385|NCT01562275|541937306|FG002|Stage 1|Death|0|||
150218386|NCT01562275|541937307|FG003|Stage 1|Death|0|||
150218387|NCT01562275|541937308|FG004|Stage 1|Death|0|||
150218388|NCT01562275|541937309|FG005|Stage 1|Death|0|||
150218389|NCT01562275|541937310|FG006|Stage 1|Death|0|||
150218390|NCT01562275|541937311|FG007|Stage 1|Death|0|||
150218391|NCT01562275|541937312|FG008|Stage 1|Death|0|||
150218392|NCT01562275|541937313|FG009|Stage 1|Death|0|||
150218393|NCT01562275|541937314|FG010|Stage 1|Death|0|||
150218394|NCT01562275|541937315|FG011|Stage 1|Death|0|||
150218395|NCT01562275|541937316|FG012|Stage 1|Death|0|||
150218396|NCT01562275|541937304|FG000|Stage 1|Non Compliance|0|||
150218397|NCT01562275|541937305|FG001|Stage 1|Non Compliance|0|||
150218398|NCT01562275|541937306|FG002|Stage 1|Non Compliance|1|||
150218399|NCT01562275|541937307|FG003|Stage 1|Non Compliance|0|||
150218400|NCT01562275|541937308|FG004|Stage 1|Non Compliance|0|||
150218401|NCT01562275|541937309|FG005|Stage 1|Non Compliance|0|||
150218402|NCT01562275|541937310|FG006|Stage 1|Non Compliance|0|||
150218403|NCT01562275|541937311|FG007|Stage 1|Non Compliance|0|||
150218404|NCT01562275|541937312|FG008|Stage 1|Non Compliance|0|||
150218405|NCT01562275|541937313|FG009|Stage 1|Non Compliance|0|||
150218406|NCT01562275|541937314|FG010|Stage 1|Non Compliance|0|||
150218407|NCT01562275|541937315|FG011|Stage 1|Non Compliance|0|||
150218408|NCT01562275|541937316|FG012|Stage 1|Non Compliance|0|||
150218409|NCT01562275|541937304|FG000|Stage 1|Physician Decision|0|||
150218410|NCT01562275|541937305|FG001|Stage 1|Physician Decision|0|||
150218411|NCT01562275|541937306|FG002|Stage 1|Physician Decision|0|||
150218412|NCT01562275|541937307|FG003|Stage 1|Physician Decision|0|||
150218413|NCT01562275|541937308|FG004|Stage 1|Physician Decision|1|||
150218414|NCT01562275|541937309|FG005|Stage 1|Physician Decision|0|||
150218415|NCT01562275|541937310|FG006|Stage 1|Physician Decision|1|||
150218416|NCT01562275|541937311|FG007|Stage 1|Physician Decision|0|||
150218417|NCT01562275|541937312|FG008|Stage 1|Physician Decision|1|||
150218418|NCT01562275|541937313|FG009|Stage 1|Physician Decision|0|||
150218419|NCT01562275|541937314|FG010|Stage 1|Physician Decision|0|||
150218420|NCT01562275|541937315|FG011|Stage 1|Physician Decision|0|||
150218421|NCT01562275|541937316|FG012|Stage 1|Physician Decision|0|||
150218422|NCT01562275|541937304|FG000|Stage 1|Progression of Disease|2|||
150218423|NCT01562275|541937305|FG001|Stage 1|Progression of Disease|6|||
150218424|NCT01562275|541937306|FG002|Stage 1|Progression of Disease|2|||
150218425|NCT01562275|541937307|FG003|Stage 1|Progression of Disease|1|||
150218426|NCT01562275|541937308|FG004|Stage 1|Progression of Disease|2|||
150218427|NCT01562275|541937309|FG005|Stage 1|Progression of Disease|4|||
150218428|NCT01562275|541937310|FG006|Stage 1|Progression of Disease|1|||
150218429|NCT01562275|541937311|FG007|Stage 1|Progression of Disease|7|||
150218430|NCT01562275|541937312|FG008|Stage 1|Progression of Disease|2|||
150218431|NCT01562275|541937313|FG009|Stage 1|Progression of Disease|5|||
150218432|NCT01562275|541937314|FG010|Stage 1|Progression of Disease|3|||
150218433|NCT01562275|541937315|FG011|Stage 1|Progression of Disease|0|||
150218434|NCT01562275|541937316|FG012|Stage 1|Progression of Disease|0|||
150218435|NCT01562275|541937304|FG000|Stage 1|Withdrawal by Subject|0|||
150218436|NCT01562275|541937305|FG001|Stage 1|Withdrawal by Subject|1|||
150218437|NCT01562275|541937306|FG002|Stage 1|Withdrawal by Subject|0|||
150218438|NCT01562275|541937307|FG003|Stage 1|Withdrawal by Subject|2|||
150218439|NCT01562275|541937308|FG004|Stage 1|Withdrawal by Subject|0|||
150218440|NCT01562275|541937309|FG005|Stage 1|Withdrawal by Subject|0|||
150218441|NCT01562275|541937310|FG006|Stage 1|Withdrawal by Subject|1|||
150218442|NCT01562275|541937311|FG007|Stage 1|Withdrawal by Subject|0|||
150218443|NCT01562275|541937312|FG008|Stage 1|Withdrawal by Subject|0|||
150218444|NCT01562275|541937313|FG009|Stage 1|Withdrawal by Subject|1|||
150218445|NCT01562275|541937314|FG010|Stage 1|Withdrawal by Subject|0|||
150218446|NCT01562275|541937315|FG011|Stage 1|Withdrawal by Subject|0|||
150218447|NCT01562275|541937316|FG012|Stage 1|Withdrawal by Subject|0|||
150218448|NCT01562275|541937304|FG000|Stage 2|Death|0|||
150218449|NCT01562275|541937305|FG001|Stage 2|Death|0|||
150218450|NCT01562275|541937306|FG002|Stage 2|Death|0|||
150218451|NCT01562275|541937307|FG003|Stage 2|Death|0|||
150218452|NCT01562275|541937308|FG004|Stage 2|Death|0|||
150218453|NCT01562275|541937309|FG005|Stage 2|Death|0|||
150218454|NCT01562275|541937310|FG006|Stage 2|Death|0|||
150218455|NCT01562275|541937311|FG007|Stage 2|Death|0|||
150218456|NCT01562275|541937312|FG008|Stage 2|Death|0|||
150218457|NCT01562275|541937313|FG009|Stage 2|Death|0|||
150218458|NCT01562275|541937314|FG010|Stage 2|Death|0|||
150218459|NCT01562275|541937315|FG011|Stage 2|Death|2|||
150218460|NCT01562275|541937316|FG012|Stage 2|Death|1|||
150218461|NCT01562275|541937304|FG000|Stage 2|Progression of Disease|0|||
150218462|NCT01562275|541937305|FG001|Stage 2|Progression of Disease|0|||
150218463|NCT01562275|541937306|FG002|Stage 2|Progression of Disease|0|||
150218464|NCT01562275|541937307|FG003|Stage 2|Progression of Disease|0|||
150218465|NCT01562275|541937308|FG004|Stage 2|Progression of Disease|0|||
150218466|NCT01562275|541937309|FG005|Stage 2|Progression of Disease|0|||
150218467|NCT01562275|541937310|FG006|Stage 2|Progression of Disease|0|||
150218468|NCT01562275|541937311|FG007|Stage 2|Progression of Disease|0|||
150218469|NCT01562275|541937312|FG008|Stage 2|Progression of Disease|0|||
150218470|NCT01562275|541937313|FG009|Stage 2|Progression of Disease|0|||
150218471|NCT01562275|541937314|FG010|Stage 2|Progression of Disease|0|||
150218472|NCT01562275|541937315|FG011|Stage 2|Progression of Disease|12|||
150218473|NCT01562275|541937316|FG012|Stage 2|Progression of Disease|4|||
150218474|NCT01863368|541937317|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
150218475|NCT01863368|541937318|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
150218476|NCT01863368|541937317|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
150218477|NCT01863368|541937318|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
150218478|NCT01863368|541937317|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
150218479|NCT01863368|541937318|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
150218480|NCT01863368|541937317|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
150218481|NCT01863368|541937318|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
150218482|NCT01863368|541937317|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
150218483|NCT01863368|541937318|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
150218484|NCT01863368|541937317|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
150218485|NCT01863368|541937318|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
150218486|NCT00647699|541937319|FG000|Overall Study|Lost to Follow-up|5|||
150218487|NCT00647699|541937320|FG001|Overall Study|Lost to Follow-up|4|||
150218488|NCT00647699|541937319|FG000|Overall Study|Withdrawal by Subject|3|||
150218489|NCT00647699|541937320|FG001|Overall Study|Withdrawal by Subject|8|||
150218490|NCT00515112|541937322|FG000|Overall Study|Death|0|||
150218491|NCT00515112|541937323|FG001|Overall Study|Death|1|||
150218492|NCT00515112|541937322|FG000|Overall Study|The study was terminated|3|||
150218493|NCT00515112|541937323|FG001|Overall Study|The study was terminated|2|||
150218494|NCT03029585|541937326|FG000|Overall Study|Death|1|||
150218495|NCT03029585|541937327|FG001|Overall Study|Death|1|||
150218496|NCT03029585|541937326|FG000|Overall Study|Withdrawal by Subject|1|||
150218497|NCT03029585|541937327|FG001|Overall Study|Withdrawal by Subject|0|||
150218498|NCT00307489|541937328|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
150218499|NCT00307489|541937329|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
150218500|NCT00307489|541937328|FG000|Baseline Through Week 48|Physician Decision|1|||
150218501|NCT00307489|541937329|FG001|Baseline Through Week 48|Physician Decision|0|||
150218502|NCT00307489|541937328|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
150218503|NCT00307489|541937329|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
150218504|NCT00307489|541937328|FG000|Week 48 Through Week 168|Adverse Event|1|||
150218505|NCT00307489|541937329|FG001|Week 48 Through Week 168|Adverse Event|0|||
150218506|NCT00307489|541937328|FG000|Week 48 Through Week 168|Physician Decision|1|||
150218507|NCT00307489|541937329|FG001|Week 48 Through Week 168|Physician Decision|0|||
150218508|NCT00307489|541937328|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
150218509|NCT00307489|541937329|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
150218510|NCT00307489|541937328|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
150218511|NCT00307489|541937329|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
150218512|NCT00307489|541937328|FG000|Week 48 Through Week 168|Death|0|||
150218513|NCT00307489|541937329|FG001|Week 48 Through Week 168|Death|1|||
150218514|NCT00307489|541937328|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
150218515|NCT00307489|541937329|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
150218516|NCT00307489|541937328|FG000|Week 48 Through Week 168|Seroconversion|1|||
150218517|NCT00307489|541937329|FG001|Week 48 Through Week 168|Seroconversion|0|||
150218518|NCT04425252|541937330|FG000|Overall Study|Withdrawal by Subject|2|||
150218519|NCT04425252|541937331|FG001|Overall Study|Withdrawal by Subject|1|||
150218520|NCT04425252|541937330|FG000|Overall Study|Lost to Follow-up|1|||
150218521|NCT04425252|541937331|FG001|Overall Study|Lost to Follow-up|0|||
150218522|NCT04425252|541937330|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
150218523|NCT04425252|541937331|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
150218524|NCT00304278|541937333|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
150218525|NCT00304278|541937333|FG000|Overall Study|PT had medical condition preventing TX|1|||
150218526|NCT04025762|541937334|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
150218527|NCT04025762|541937335|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
150218528|NCT03340961|541937337|FG000|Overall Study|Adverse Event|1|||
150218529|NCT03340961|541937338|FG001|Overall Study|Adverse Event|3|||
150218530|NCT03340961|541937339|FG002|Overall Study|Adverse Event|2|||
150218531|NCT03340961|541937340|FG003|Overall Study|Adverse Event|4|||
150218532|NCT03340961|541937337|FG000|Overall Study|Lost to Follow-up|0|||
150218533|NCT03340961|541937338|FG001|Overall Study|Lost to Follow-up|1|||
150218534|NCT03340961|541937339|FG002|Overall Study|Lost to Follow-up|0|||
150218535|NCT03340961|541937340|FG003|Overall Study|Lost to Follow-up|1|||
150218536|NCT03340961|541937337|FG000|Overall Study|Withdrawal by Subject|3|||
150218537|NCT03340961|541937338|FG001|Overall Study|Withdrawal by Subject|2|||
150218538|NCT03340961|541937339|FG002|Overall Study|Withdrawal by Subject|4|||
150218539|NCT03340961|541937340|FG003|Overall Study|Withdrawal by Subject|7|||
150218540|NCT03340961|541937337|FG000|Overall Study|Use of prohibited treatment|0|||
150218541|NCT03340961|541937338|FG001|Overall Study|Use of prohibited treatment|3|||
150218542|NCT03340961|541937339|FG002|Overall Study|Use of prohibited treatment|2|||
150218543|NCT03340961|541937340|FG003|Overall Study|Use of prohibited treatment|4|||
150218544|NCT03340961|541937337|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
150218545|NCT03340961|541937338|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
150218546|NCT03340961|541937339|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
150218547|NCT03340961|541937340|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
150218548|NCT03340961|541937337|FG000|Overall Study|Subject developed an exclusion criterion|0|||
150218549|NCT03340961|541937338|FG001|Overall Study|Subject developed an exclusion criterion|1|||
150218550|NCT03340961|541937339|FG002|Overall Study|Subject developed an exclusion criterion|0|||
150218551|NCT03340961|541937340|FG003|Overall Study|Subject developed an exclusion criterion|0|||
150218552|NCT03340961|541937337|FG000|Overall Study|Protocol Violation|1|||
150218553|NCT03340961|541937338|FG001|Overall Study|Protocol Violation|0|||
150218554|NCT03340961|541937339|FG002|Overall Study|Protocol Violation|1|||
150218555|NCT03340961|541937340|FG003|Overall Study|Protocol Violation|0|||
150218556|NCT03340961|541937337|FG000|Overall Study|Adverse Event|1|||
150218557|NCT03340961|541937338|FG001|Overall Study|Adverse Event|1|||
150218558|NCT03340961|541937339|FG002|Overall Study|Adverse Event|0|||
150218559|NCT03340961|541937340|FG003|Overall Study|Adverse Event|0|||
150218560|NCT03340961|541937337|FG000|Overall Study|Lack of Efficacy|0|||
150218561|NCT03340961|541937338|FG001|Overall Study|Lack of Efficacy|0|||
150218562|NCT03340961|541937339|FG002|Overall Study|Lack of Efficacy|0|||
150218563|NCT03340961|541937340|FG003|Overall Study|Lack of Efficacy|1|||
150218564|NCT01286311|541937341|FG000|Overall Study|Physician did not want outreach sent|14|||
150218565|NCT01286311|541937342|FG001|Overall Study|Physician did not want outreach sent|0|||
150218566|NCT01381549|541937345|FG000|Overall Study|Ineligible: No organisms isolated|0|||
150218567|NCT01381549|541937346|FG001|Overall Study|Ineligible: No organisms isolated|0|||
150218568|NCT01381549|541937347|FG002|Overall Study|Ineligible: No organisms isolated|1|||
150218569|NCT02981953|541937348|FG000|Overall Study|Death|9|||
150218570|NCT02981953|541937348|FG000|Overall Study|Withdrawal by Subject|1|||
150218571|NCT02981953|541937348|FG000|Overall Study|Withdrawal to non-compliance|1|||
150218572|NCT02446015|541937351|FG000|Overall Study|Adverse Event|0|||
150218573|NCT02446015|541937352|FG001|Overall Study|Adverse Event|1|||
150218574|NCT02446015|541937351|FG000|Overall Study|Withdrawal by Subject|1|||
150218575|NCT02446015|541937352|FG001|Overall Study|Withdrawal by Subject|0|||
150218576|NCT00759681|541937353|FG000|Overall Study|Death|2|||
150218577|NCT00759681|541937354|FG001|Overall Study|Death|5|||
150218578|NCT00759681|541937353|FG000|Overall Study|Lost to Follow-up|8|||
150218579|NCT00759681|541937354|FG001|Overall Study|Lost to Follow-up|5|||
150218580|NCT00473512|541937355|FG000|Period 1 (Phase 1)|Adverse Event|0|||
150218581|NCT00473512|541937356|FG001|Period 1 (Phase 1)|Adverse Event|0|||
150218582|NCT00473512|541937357|FG002|Period 1 (Phase 1)|Adverse Event|0|||
150218583|NCT00473512|541937358|FG003|Period 1 (Phase 1)|Adverse Event|5|||
150218584|NCT00473512|541937359|FG004|Period 1 (Phase 1)|Adverse Event|0|||
150218585|NCT00473512|541937355|FG000|Period 1 (Phase 1)|Death|0|||
150218586|NCT00473512|541937356|FG001|Period 1 (Phase 1)|Death|0|||
150218587|NCT00473512|541937357|FG002|Period 1 (Phase 1)|Death|0|||
150218588|NCT00473512|541937358|FG003|Period 1 (Phase 1)|Death|1|||
150218589|NCT00473512|541937359|FG004|Period 1 (Phase 1)|Death|0|||
150218590|NCT00473512|541937355|FG000|Period 1 (Phase 1)|Disease Progression|1|||
150218591|NCT00473512|541937356|FG001|Period 1 (Phase 1)|Disease Progression|1|||
150218592|NCT00473512|541937357|FG002|Period 1 (Phase 1)|Disease Progression|0|||
150218593|NCT00473512|541937358|FG003|Period 1 (Phase 1)|Disease Progression|10|||
150218594|NCT00473512|541937359|FG004|Period 1 (Phase 1)|Disease Progression|1|||
150218595|NCT00473512|541937355|FG000|Period 1 (Phase 1)|Other|0|||
150218596|NCT00473512|541937356|FG001|Period 1 (Phase 1)|Other|0|||
150218597|NCT00473512|541937357|FG002|Period 1 (Phase 1)|Other|0|||
150218598|NCT00473512|541937358|FG003|Period 1 (Phase 1)|Other|1|||
150218599|NCT00473512|541937359|FG004|Period 1 (Phase 1)|Other|0|||
150218600|NCT00473512|541937355|FG000|Period 2 (Phase 2)|Adverse Event|0|||
150218601|NCT00473512|541937356|FG001|Period 2 (Phase 2)|Adverse Event|0|||
150218602|NCT00473512|541937357|FG002|Period 2 (Phase 2)|Adverse Event|0|||
150218603|NCT00473512|541937358|FG003|Period 2 (Phase 2)|Adverse Event|1|||
150218604|NCT00473512|541937359|FG004|Period 2 (Phase 2)|Adverse Event|0|||
150218605|NCT00473512|541937355|FG000|Period 2 (Phase 2)|Death|0|||
150218606|NCT00473512|541937356|FG001|Period 2 (Phase 2)|Death|0|||
150218607|NCT00473512|541937357|FG002|Period 2 (Phase 2)|Death|0|||
150218608|NCT00473512|541937358|FG003|Period 2 (Phase 2)|Death|1|||
150218609|NCT00473512|541937359|FG004|Period 2 (Phase 2)|Death|1|||
150218610|NCT00473512|541937355|FG000|Period 2 (Phase 2)|Disease Progression|0|||
150218611|NCT00473512|541937356|FG001|Period 2 (Phase 2)|Disease Progression|2|||
150218612|NCT00473512|541937357|FG002|Period 2 (Phase 2)|Disease Progression|2|||
150218613|NCT00473512|541937358|FG003|Period 2 (Phase 2)|Disease Progression|17|||
150218614|NCT00473512|541937359|FG004|Period 2 (Phase 2)|Disease Progression|1|||
150218615|NCT00473512|541937355|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
150218616|NCT00473512|541937356|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
150218617|NCT00473512|541937357|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
150218618|NCT00473512|541937358|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
150218619|NCT00473512|541937359|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
150218620|NCT00473512|541937355|FG000|Period 2 (Phase 2)|Other|1|||
150218621|NCT00473512|541937356|FG001|Period 2 (Phase 2)|Other|0|||
150218622|NCT00473512|541937357|FG002|Period 2 (Phase 2)|Other|0|||
150218623|NCT00473512|541937358|FG003|Period 2 (Phase 2)|Other|3|||
150218624|NCT00473512|541937359|FG004|Period 2 (Phase 2)|Other|0|||
150218625|NCT00267956|541937364|FG000|Controlled Period|Adverse Event|4|||
150218626|NCT00267956|541937365|FG001|Controlled Period|Adverse Event|1|||
150218627|NCT00267956|541937366|FG002|Controlled Period|Adverse Event|0|||
150218628|NCT00267956|541937367|FG003|Controlled Period|Adverse Event|0|||
150218629|NCT00267956|541937364|FG000|Controlled Period|Lack of Efficacy|4|||
150218630|NCT00267956|541937365|FG001|Controlled Period|Lack of Efficacy|2|||
150218631|NCT00267956|541937366|FG002|Controlled Period|Lack of Efficacy|0|||
150218632|NCT00267956|541937367|FG003|Controlled Period|Lack of Efficacy|0|||
150218633|NCT00267956|541937364|FG000|Controlled Period|Lost to Follow-up|2|||
150218634|NCT00267956|541937365|FG001|Controlled Period|Lost to Follow-up|0|||
150218635|NCT00267956|541937366|FG002|Controlled Period|Lost to Follow-up|0|||
150218636|NCT00267956|541937367|FG003|Controlled Period|Lost to Follow-up|0|||
150218637|NCT00267956|541937364|FG000|Controlled Period|Withdrew consent|3|||
150218638|NCT00267956|541937365|FG001|Controlled Period|Withdrew consent|1|||
150218639|NCT00267956|541937366|FG002|Controlled Period|Withdrew consent|0|||
150218640|NCT00267956|541937367|FG003|Controlled Period|Withdrew consent|0|||
150218641|NCT00267956|541937364|FG000|After Controlled Period|Adverse Event|0|||
150218642|NCT00267956|541937365|FG001|After Controlled Period|Adverse Event|0|||
150218643|NCT00267956|541937366|FG002|After Controlled Period|Adverse Event|2|||
150218644|NCT00267956|541937367|FG003|After Controlled Period|Adverse Event|1|||
150218645|NCT00267956|541937364|FG000|After Controlled Period|Lack of Efficacy|0|||
150218646|NCT00267956|541937365|FG001|After Controlled Period|Lack of Efficacy|0|||
150218647|NCT00267956|541937366|FG002|After Controlled Period|Lack of Efficacy|1|||
150218648|NCT00267956|541937367|FG003|After Controlled Period|Lack of Efficacy|1|||
150218649|NCT00267956|541937364|FG000|After Controlled Period|Lost to Follow-up|0|||
150218650|NCT00267956|541937365|FG001|After Controlled Period|Lost to Follow-up|0|||
150218651|NCT00267956|541937366|FG002|After Controlled Period|Lost to Follow-up|1|||
150218652|NCT00267956|541937367|FG003|After Controlled Period|Lost to Follow-up|0|||
150218653|NCT00267956|541937364|FG000|After Controlled Period|Withdrew consent|0|||
150218654|NCT00267956|541937365|FG001|After Controlled Period|Withdrew consent|0|||
150218655|NCT00267956|541937366|FG002|After Controlled Period|Withdrew consent|1|||
150218656|NCT00267956|541937367|FG003|After Controlled Period|Withdrew consent|0|||
150218657|NCT01263223|541937368|FG000|Period 2|Withdrawal by Subject|0|||
150218658|NCT01263223|541937369|FG001|Period 2|Withdrawal by Subject|1|||
150218659|NCT01263223|541937368|FG000|7-day Follow-up|Withdrawal by Subject|0|||
150218660|NCT01263223|541937369|FG001|7-day Follow-up|Withdrawal by Subject|1|||
150218661|NCT01263223|541937368|FG000|7-day Follow-up|Lost to Follow-up|1|||
150218662|NCT01263223|541937369|FG001|7-day Follow-up|Lost to Follow-up|0|||
150218663|NCT02246647|541937370|FG000|Overall Study|Withdrawal by Subject|1|||
150218664|NCT02246647|541937371|FG001|Overall Study|Withdrawal by Subject|1|||
150218665|NCT01113541|541937376|FG000|Overall Study|Withdrawal by Subject|1|||
150218666|NCT01113541|541937376|FG000|Overall Study|Protocol Violation|1|||
150218667|NCT01113541|541937376|FG000|Overall Study|Study Terminated by Sponsor|7|||
150218668|NCT01113541|541937376|FG000|Overall Study|Adverse Event|4|||
150218669|NCT01584648|541937379|FG000|Overall Study|Death|136|||
150218670|NCT01584648|541937380|FG001|Overall Study|Death|146|||
150218671|NCT01584648|541937379|FG000|Overall Study|Lost to Follow-up|9|||
150218672|NCT01584648|541937380|FG001|Overall Study|Lost to Follow-up|9|||
150218673|NCT01584648|541937379|FG000|Overall Study|Investigator discretion|3|||
150218674|NCT01584648|541937380|FG001|Overall Study|Investigator discretion|2|||
150218675|NCT01584648|541937379|FG000|Overall Study|Withdrew consent|13|||
150218676|NCT01584648|541937380|FG001|Overall Study|Withdrew consent|4|||
150218677|NCT01584648|541937379|FG000|Overall Study|Study closed/terminated|50|||
150218678|NCT01584648|541937380|FG001|Overall Study|Study closed/terminated|23|||
150218679|NCT01584648|541937379|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
150218680|NCT01584648|541937380|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
150218681|NCT02009332|541937386|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
150218682|NCT02009332|541937387|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
150218683|NCT02009332|541937388|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
150218684|NCT02009332|541937389|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
150218685|NCT02009332|541937390|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
150218686|NCT02009332|541937391|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
150218687|NCT02009332|541937386|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
150218688|NCT02009332|541937387|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
150218689|NCT02009332|541937388|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
150218690|NCT02009332|541937389|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
150218691|NCT02009332|541937390|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
150218692|NCT02009332|541937391|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
150218693|NCT02009332|541937386|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
150218694|NCT02009332|541937387|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
150218695|NCT02009332|541937388|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
150218696|NCT02009332|541937389|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
150218697|NCT02009332|541937390|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
150218698|NCT02009332|541937391|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
150218699|NCT01757288|541937393|FG000|Overall Study|Consent withdrawal|0|||
150218700|NCT01757288|541937394|FG001|Overall Study|Consent withdrawal|4|||
150218701|NCT01757288|541937395|FG002|Overall Study|Consent withdrawal|4|||
150218702|NCT01757288|541937393|FG000|Overall Study|Patient off study, IRB hold.|0|||
150218703|NCT01757288|541937394|FG001|Overall Study|Patient off study, IRB hold.|0|||
150218704|NCT01757288|541937395|FG002|Overall Study|Patient off study, IRB hold.|1|||
150218705|NCT01757288|541937393|FG000|Overall Study|Patient death prior to starting treatment|0|||
150218706|NCT01757288|541937394|FG001|Overall Study|Patient death prior to starting treatment|0|||
150218707|NCT01757288|541937395|FG002|Overall Study|Patient death prior to starting treatment|1|||
150218708|NCT01757288|541937393|FG000|Overall Study|Wrong medication administered|0|||
150218709|NCT01757288|541937394|FG001|Overall Study|Wrong medication administered|1|||
150218710|NCT01757288|541937395|FG002|Overall Study|Wrong medication administered|0|||
150218711|NCT01757288|541937393|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
150218712|NCT01757288|541937394|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
150218713|NCT01757288|541937395|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
150218714|NCT01757288|541937393|FG000|Overall Study|Not meeting protocol constraints|0|||
150218715|NCT01757288|541937394|FG001|Overall Study|Not meeting protocol constraints|1|||
150218716|NCT01757288|541937395|FG002|Overall Study|Not meeting protocol constraints|1|||
150218717|NCT01757288|541937393|FG000|Overall Study|Multiple missed appointments|0|||
150218718|NCT01757288|541937394|FG001|Overall Study|Multiple missed appointments|1|||
150218719|NCT01757288|541937395|FG002|Overall Study|Multiple missed appointments|0|||
150218720|NCT01757288|541937393|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
150218721|NCT01757288|541937394|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
150218722|NCT01757288|541937395|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
150218723|NCT01757288|541937393|FG000|Overall Study|>2 weeks treatment break|0|||
150218724|NCT01757288|541937394|FG001|Overall Study|>2 weeks treatment break|0|||
150218725|NCT01757288|541937395|FG002|Overall Study|>2 weeks treatment break|1|||
150218726|NCT02825550|541937396|FG000|Overall Study|Physician Decision|1|||
150218727|NCT03386344|541937397|FG000|Overall Study|Adverse Event|6|||
150218728|NCT03386344|541937398|FG001|Overall Study|Adverse Event|3|||
150218729|NCT03386344|541937399|FG002|Overall Study|Adverse Event|1|||
150218730|NCT03386344|541937397|FG000|Overall Study|Poor Compliance to Protocol|0|||
150218731|NCT03386344|541937398|FG001|Overall Study|Poor Compliance to Protocol|1|||
150218732|NCT03386344|541937399|FG002|Overall Study|Poor Compliance to Protocol|0|||
150218733|NCT03386344|541937397|FG000|Overall Study|Study Terminated by Sponsor|101|||
150218734|NCT03386344|541937398|FG001|Overall Study|Study Terminated by Sponsor|102|||
150218735|NCT03386344|541937399|FG002|Overall Study|Study Terminated by Sponsor|106|||
150218736|NCT03386344|541937397|FG000|Overall Study|Lost to Follow-up|3|||
150218737|NCT03386344|541937398|FG001|Overall Study|Lost to Follow-up|2|||
150218738|NCT03386344|541937399|FG002|Overall Study|Lost to Follow-up|1|||
150218739|NCT03386344|541937397|FG000|Overall Study|At the Participant's own Request|7|||
150218740|NCT03386344|541937398|FG001|Overall Study|At the Participant's own Request|7|||
150218741|NCT03386344|541937399|FG002|Overall Study|At the Participant's own Request|8|||
150218742|NCT03386344|541937397|FG000|Overall Study|Reason not Specified|0|||
150218743|NCT03386344|541937398|FG001|Overall Study|Reason not Specified|1|||
150218744|NCT03386344|541937399|FG002|Overall Study|Reason not Specified|0|||
150218745|NCT00795639|541937400|FG000|Overall Study|Death|1|||
150218746|NCT00795639|541937401|FG001|Overall Study|Death|6|||
150218747|NCT00795639|541937400|FG000|Overall Study|Withdrawal by Subject|1|||
150218748|NCT00795639|541937401|FG001|Overall Study|Withdrawal by Subject|3|||
150218749|NCT00795639|541937400|FG000|Overall Study|Pregnancy|1|||
150218750|NCT00795639|541937401|FG001|Overall Study|Pregnancy|0|||
150218751|NCT00795639|541937400|FG000|Overall Study|Adverse Event|5|||
150218752|NCT00795639|541937401|FG001|Overall Study|Adverse Event|2|||
150218753|NCT00795639|541937400|FG000|Overall Study|Other|0|||
150218754|NCT00795639|541937401|FG001|Overall Study|Other|2|||
150218755|NCT00795639|541937400|FG000|Overall Study|Terminated by sponsor|13|||
150218756|NCT00795639|541937401|FG001|Overall Study|Terminated by sponsor|12|||
150218757|NCT00795639|541937400|FG000|Overall Study|Randomized and not treated|0|||
150218758|NCT00795639|541937401|FG001|Overall Study|Randomized and not treated|1|||
150218759|NCT04421456|541937402|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
150218760|NCT04421456|541937403|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
150218761|NCT04421456|541937404|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
150218762|NCT04421456|541937402|FG000|Randomized Treatment Period|Adverse Event|0|||
150218763|NCT04421456|541937403|FG001|Randomized Treatment Period|Adverse Event|1|||
150218764|NCT04421456|541937404|FG002|Randomized Treatment Period|Adverse Event|0|||
150218765|NCT04421456|541937402|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
150218766|NCT04421456|541937403|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
150218767|NCT04421456|541937404|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
150218768|NCT04421456|541937402|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
150218769|NCT04421456|541937403|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
150218770|NCT04421456|541937404|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
150218771|NCT04421456|541937402|FG000|Randomized Treatment Period|Participant non-compliance|1|||
150218772|NCT04421456|541937403|FG001|Randomized Treatment Period|Participant non-compliance|1|||
150218773|NCT04421456|541937404|FG002|Randomized Treatment Period|Participant non-compliance|2|||
150218774|NCT04421456|541937402|FG000|Randomized Treatment Period|Other|0|||
150218775|NCT04421456|541937403|FG001|Randomized Treatment Period|Other|1|||
150218776|NCT04421456|541937404|FG002|Randomized Treatment Period|Other|3|||
150218777|NCT01419184|541937405|FG000|Overall Study|Site data not available|3|||
150218778|NCT01419184|541937406|FG001|Overall Study|Site data not available|2|||
150218779|NCT01419184|541937405|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
150218780|NCT01419184|541937406|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
150218781|NCT01419184|541937405|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
150218782|NCT01419184|541937406|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
150218783|NCT01419184|541937405|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
150218784|NCT01419184|541937406|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
150218785|NCT01419184|541937405|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
150218786|NCT01419184|541937406|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
150218787|NCT01419184|541937405|FG000|Overall Study|Participant randomized, not treated|1|||
150218788|NCT01419184|541937406|FG001|Overall Study|Participant randomized, not treated|0|||
150218789|NCT03989232|541937411|FG000|Overall Study|Lost to Follow-up|3|||
150218790|NCT03989232|541937412|FG001|Overall Study|Lost to Follow-up|10|||
150218791|NCT03989232|541937411|FG000|Overall Study|Withdrawal by Subject|6|||
150218792|NCT03989232|541937412|FG001|Overall Study|Withdrawal by Subject|6|||
150218793|NCT03989232|541937411|FG000|Overall Study|Death|1|||
150218794|NCT03989232|541937412|FG001|Overall Study|Death|2|||
150218795|NCT02644122|541937416|FG000|Overall Study|Withdrawal by Subject|1|||
150218796|NCT03031782|541937419|FG000|Treatment Period 1|Lack of Efficacy|3|||
150218797|NCT03031782|541937420|FG001|Treatment Period 1|Lack of Efficacy|0|||
150218798|NCT03031782|541937421|FG002|Treatment Period 1|Lack of Efficacy|0|||
150218799|NCT03031782|541937422|FG003|Treatment Period 1|Lack of Efficacy|0|||
150218800|NCT03031782|541937423|FG004|Treatment Period 1|Lack of Efficacy|0|||
150218801|NCT03031782|541937419|FG000|Treatment Period 2|Physician Decision|0|||
150218802|NCT03031782|541937420|FG001|Treatment Period 2|Physician Decision|1|||
150218803|NCT03031782|541937421|FG002|Treatment Period 2|Physician Decision|0|||
150218804|NCT03031782|541937422|FG003|Treatment Period 2|Physician Decision|0|||
150218805|NCT03031782|541937423|FG004|Treatment Period 2|Physician Decision|3|||
150218806|NCT03031782|541937419|FG000|Treatment Period 2|Lack of Efficacy|0|||
150218807|NCT03031782|541937420|FG001|Treatment Period 2|Lack of Efficacy|1|||
150218808|NCT03031782|541937421|FG002|Treatment Period 2|Lack of Efficacy|0|||
150218809|NCT03031782|541937422|FG003|Treatment Period 2|Lack of Efficacy|0|||
150218810|NCT03031782|541937423|FG004|Treatment Period 2|Lack of Efficacy|1|||
150218811|NCT03031782|541937419|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150218812|NCT03031782|541937420|FG001|Treatment Period 2|Withdrawal by Subject|3|||
150218813|NCT03031782|541937421|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150218814|NCT03031782|541937422|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150218815|NCT03031782|541937423|FG004|Treatment Period 2|Withdrawal by Subject|1|||
150218816|NCT03031782|541937419|FG000|Treatment Period 2|Adverse Event|0|||
150218817|NCT03031782|541937420|FG001|Treatment Period 2|Adverse Event|1|||
150218818|NCT03031782|541937421|FG002|Treatment Period 2|Adverse Event|2|||
150218819|NCT03031782|541937422|FG003|Treatment Period 2|Adverse Event|0|||
150218820|NCT03031782|541937423|FG004|Treatment Period 2|Adverse Event|0|||
150218821|NCT03031782|541937419|FG000|Treatment Period 3|Withdrawal by Subject|0|||
150218822|NCT03031782|541937420|FG001|Treatment Period 3|Withdrawal by Subject|0|||
150218823|NCT03031782|541937421|FG002|Treatment Period 3|Withdrawal by Subject|0|||
150218824|NCT03031782|541937422|FG003|Treatment Period 3|Withdrawal by Subject|1|||
150218825|NCT03031782|541937423|FG004|Treatment Period 3|Withdrawal by Subject|0|||
150218826|NCT01930188|541937424|FG000|Overall Study|unclassified|4|||
150218827|NCT01930188|541937425|FG001|Overall Study|unclassified|5|||
150218828|NCT01930188|541937426|FG002|Overall Study|unclassified|3|||
150218829|NCT01930188|541937424|FG000|Overall Study|Missing follow-up information|2|||
150218830|NCT01930188|541937425|FG001|Overall Study|Missing follow-up information|2|||
150218831|NCT01930188|541937426|FG002|Overall Study|Missing follow-up information|3|||
150218832|NCT01930188|541937424|FG000|Overall Study|Lost to Follow-up|5|||
150218833|NCT01930188|541937425|FG001|Overall Study|Lost to Follow-up|2|||
150218834|NCT01930188|541937426|FG002|Overall Study|Lost to Follow-up|2|||
150218835|NCT01930188|541937424|FG000|Overall Study|Death|2|||
150218836|NCT01930188|541937425|FG001|Overall Study|Death|1|||
150218837|NCT01930188|541937426|FG002|Overall Study|Death|3|||
150218838|NCT01930188|541937424|FG000|Overall Study|Withdrawal by Subject|9|||
150218839|NCT01930188|541937425|FG001|Overall Study|Withdrawal by Subject|11|||
150218840|NCT01930188|541937426|FG002|Overall Study|Withdrawal by Subject|8|||
150218841|NCT02170207|541937429|FG000|Overall Study|Case report forms unavailable|5|||
150218842|NCT03122860|541937430|FG000|Overall Study|Discontinued Before Treatment|1|||
150218843|NCT03122860|541937431|FG001|Overall Study|Discontinued Before Treatment|1|||
150218844|NCT03122860|541937432|FG002|Overall Study|Discontinued Before Treatment|2|||
150218845|NCT03122860|541937433|FG003|Overall Study|Discontinued Before Treatment|0|||
150218846|NCT03122860|541937434|FG004|Overall Study|Discontinued Before Treatment|1|||
150218847|NCT03122860|541937435|FG005|Overall Study|Discontinued Before Treatment|0|||
150218848|NCT03122860|541937430|FG000|Overall Study|Adverse Event|1|||
150218849|NCT03122860|541937431|FG001|Overall Study|Adverse Event|0|||
150218850|NCT03122860|541937432|FG002|Overall Study|Adverse Event|1|||
150218851|NCT03122860|541937433|FG003|Overall Study|Adverse Event|1|||
150218852|NCT03122860|541937434|FG004|Overall Study|Adverse Event|0|||
150218853|NCT03122860|541937435|FG005|Overall Study|Adverse Event|0|||
150218854|NCT03122860|541937430|FG000|Overall Study|Lost to Follow-up|5|||
150218855|NCT03122860|541937431|FG001|Overall Study|Lost to Follow-up|2|||
150218856|NCT03122860|541937432|FG002|Overall Study|Lost to Follow-up|3|||
150218857|NCT03122860|541937433|FG003|Overall Study|Lost to Follow-up|3|||
150218858|NCT03122860|541937434|FG004|Overall Study|Lost to Follow-up|5|||
150218859|NCT03122860|541937435|FG005|Overall Study|Lost to Follow-up|4|||
150218860|NCT03122860|541937430|FG000|Overall Study|Subject Non-Compliance|0|||
150218861|NCT03122860|541937431|FG001|Overall Study|Subject Non-Compliance|0|||
150218862|NCT03122860|541937432|FG002|Overall Study|Subject Non-Compliance|1|||
150218863|NCT03122860|541937433|FG003|Overall Study|Subject Non-Compliance|0|||
150218864|NCT03122860|541937434|FG004|Overall Study|Subject Non-Compliance|0|||
150218865|NCT03122860|541937435|FG005|Overall Study|Subject Non-Compliance|0|||
150218866|NCT03122860|541937430|FG000|Overall Study|Withdrawal by Subject|3|||
150218867|NCT03122860|541937431|FG001|Overall Study|Withdrawal by Subject|2|||
150218868|NCT03122860|541937432|FG002|Overall Study|Withdrawal by Subject|5|||
150218869|NCT03122860|541937433|FG003|Overall Study|Withdrawal by Subject|7|||
150218870|NCT03122860|541937434|FG004|Overall Study|Withdrawal by Subject|9|||
150218871|NCT03122860|541937435|FG005|Overall Study|Withdrawal by Subject|8|||
150218872|NCT01138657|541937436|FG000|Overall Study|Adverse Event|3|||
150218873|NCT01138657|541937437|FG001|Overall Study|Adverse Event|10|||
150218874|NCT01138657|541937436|FG000|Overall Study|Lack of Efficacy|2|||
150218875|NCT01138657|541937437|FG001|Overall Study|Lack of Efficacy|1|||
150218876|NCT01138657|541937436|FG000|Overall Study|Lost to Follow-up|0|||
150218877|NCT01138657|541937437|FG001|Overall Study|Lost to Follow-up|3|||
150218878|NCT01138657|541937436|FG000|Overall Study|Miscellaneous Reasons|3|||
150218879|NCT01138657|541937437|FG001|Overall Study|Miscellaneous Reasons|4|||
150218880|NCT00346398|541937440|FG000|Overall Study|Lost to Follow-up|3|||
150218881|NCT00346398|541937441|FG001|Overall Study|Lost to Follow-up|0|||
150218882|NCT00346398|541937440|FG000|Overall Study|Withdrawal by Subject|0|||
150218883|NCT00346398|541937441|FG001|Overall Study|Withdrawal by Subject|2|||
150218884|NCT03979040|541937442|FG000|Overall Study|Withdrawal by Subject|24|||
150218885|NCT03979040|541937443|FG001|Overall Study|Withdrawal by Subject|32|||
150218886|NCT03979040|541937442|FG000|Overall Study|randomized but never started treatment|32|||
150218887|NCT03979040|541937443|FG001|Overall Study|randomized but never started treatment|39|||
150218888|NCT03979040|541937442|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
150218889|NCT03979040|541937443|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
150218890|NCT02203513|541937451|FG000|Overall Study|Refused further treatment|2|||
150218891|NCT02203513|541937452|FG001|Overall Study|Refused further treatment|0|||
150218892|NCT02203513|541937453|FG002|Overall Study|Refused further treatment|1|||
150218893|NCT02203513|541937454|FG003|Overall Study|Refused further treatment|0|||
150218894|NCT02203513|541937455|FG004|Overall Study|Refused further treatment|0|||
150218895|NCT02203513|541937451|FG000|Overall Study|Switched to alternative treatment|3|||
150218896|NCT02203513|541937452|FG001|Overall Study|Switched to alternative treatment|4|||
150218897|NCT02203513|541937453|FG002|Overall Study|Switched to alternative treatment|0|||
150218898|NCT02203513|541937454|FG003|Overall Study|Switched to alternative treatment|0|||
150218899|NCT02203513|541937455|FG004|Overall Study|Switched to alternative treatment|4|||
150218900|NCT02203513|541937451|FG000|Overall Study|Did not receive investigational product (IP)|0|||
150218901|NCT02203513|541937452|FG001|Overall Study|Did not receive investigational product (IP)|1|||
150218902|NCT02203513|541937453|FG002|Overall Study|Did not receive investigational product (IP)|0|||
150218903|NCT02203513|541937454|FG003|Overall Study|Did not receive investigational product (IP)|0|||
150218904|NCT02203513|541937455|FG004|Overall Study|Did not receive investigational product (IP)|0|||
150218905|NCT02203513|541937451|FG000|Overall Study|Death (unrelated to study therapy)|1|||
150218906|NCT02203513|541937452|FG001|Overall Study|Death (unrelated to study therapy)|3|||
150218907|NCT02203513|541937453|FG002|Overall Study|Death (unrelated to study therapy)|1|||
150218908|NCT02203513|541937454|FG003|Overall Study|Death (unrelated to study therapy)|0|||
150218909|NCT02203513|541937455|FG004|Overall Study|Death (unrelated to study therapy)|2|||
150218910|NCT02203513|541937451|FG000|Overall Study|Lost to Follow-up|0|||
150218911|NCT02203513|541937452|FG001|Overall Study|Lost to Follow-up|0|||
150218912|NCT02203513|541937453|FG002|Overall Study|Lost to Follow-up|1|||
150218913|NCT02203513|541937454|FG003|Overall Study|Lost to Follow-up|1|||
150218914|NCT02203513|541937455|FG004|Overall Study|Lost to Follow-up|0|||
150218915|NCT03347396|541937456|FG000|Part A (26 Weeks)|Adverse Event|1|||
150218916|NCT03347396|541937457|FG001|Part A (26 Weeks)|Adverse Event|0|||
150218917|NCT03347396|541937456|FG000|Part A (26 Weeks)|Death|0|||
150218918|NCT03347396|541937457|FG001|Part A (26 Weeks)|Death|1|||
150218919|NCT03347396|541937456|FG000|Part B (149 Weeks)|Adverse Event|1|||
150218920|NCT03347396|541937457|FG001|Part B (149 Weeks)|Adverse Event|1|||
150218921|NCT03347396|541937456|FG000|Part B (149 Weeks)|Death|1|||
150218922|NCT03347396|541937457|FG001|Part B (149 Weeks)|Death|0|||
150218923|NCT00805441|541937465|FG000|Overall Study|Adverse Event|5|||
150218924|NCT00805441|541937466|FG001|Overall Study|Adverse Event|2|||
150218925|NCT00805441|541937465|FG000|Overall Study|Lack of Efficacy|0|||
150218926|NCT00805441|541937466|FG001|Overall Study|Lack of Efficacy|2|||
150218927|NCT00805441|541937465|FG000|Overall Study|Protocol Violation|4|||
150218928|NCT00805441|541937466|FG001|Overall Study|Protocol Violation|8|||
150218929|NCT00805441|541937465|FG000|Overall Study|Lost to Follow-up|10|||
150218930|NCT00805441|541937466|FG001|Overall Study|Lost to Follow-up|13|||
150218931|NCT00805441|541937465|FG000|Overall Study|Withdrawal by Subject|15|||
150218932|NCT00805441|541937466|FG001|Overall Study|Withdrawal by Subject|9|||
150218933|NCT00805441|541937465|FG000|Overall Study|Physician Decision|0|||
150218934|NCT00805441|541937466|FG001|Overall Study|Physician Decision|1|||
150218935|NCT00805441|541937465|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
150218936|NCT00805441|541937466|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
150218937|NCT02935894|541937467|FG000|Overall Study|Subject dismissed|1|||
150218938|NCT04914897|541939601|FG000|Overall Study|Withdrawal by Subject|3|||
150218939|NCT04914897|541939602|FG001|Overall Study|Withdrawal by Subject|1|||
150218940|NCT04914897|541939603|FG002|Overall Study|Withdrawal by Subject|1|||
150218941|NCT04914897|541939604|FG003|Overall Study|Withdrawal by Subject|1|||
150218942|NCT04914897|541939601|FG000|Overall Study|Poor compliance to protocol|0|||
150218943|NCT04914897|541939602|FG001|Overall Study|Poor compliance to protocol|0|||
150218944|NCT04914897|541939603|FG002|Overall Study|Poor compliance to protocol|1|||
150218945|NCT04914897|541939604|FG003|Overall Study|Poor compliance to protocol|0|||
150218946|NCT04914897|541939601|FG000|Overall Study|Progressive disease|5|||
150218947|NCT04914897|541939602|FG001|Overall Study|Progressive disease|14|||
150218948|NCT04914897|541939603|FG002|Overall Study|Progressive disease|30|||
150218949|NCT04914897|541939604|FG003|Overall Study|Progressive disease|21|||
150218950|NCT04914897|541939601|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
150218951|NCT04914897|541939602|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
150218952|NCT04914897|541939603|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
150218953|NCT04914897|541939604|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
150218954|NCT04914897|541939601|FG000|Overall Study|Other|1|||
150218955|NCT04914897|541939602|FG001|Overall Study|Other|0|||
150218956|NCT04914897|541939603|FG002|Overall Study|Other|0|||
150218957|NCT04914897|541939604|FG003|Overall Study|Other|1|||
150218958|NCT03020914|541939605|FG000|Overall Study|Surgery Cancelled|1|||
150218959|NCT03020914|541939606|FG001|Overall Study|Surgery Cancelled|0|||
150218960|NCT03976102|541939607|FG000|Overall Study|Withdrawal by Subject|4|||
150218961|NCT03976102|541939608|FG001|Overall Study|Withdrawal by Subject|4|||
150218962|NCT03976102|541939607|FG000|Overall Study|Adverse Event|2|||
150218963|NCT03976102|541939608|FG001|Overall Study|Adverse Event|4|||
150218964|NCT03976102|541939607|FG000|Overall Study|Not related to Covid-19|9|||
150218965|NCT03976102|541939608|FG001|Overall Study|Not related to Covid-19|13|||
150218966|NCT03976102|541939607|FG000|Overall Study|Lost to Follow-up|0|||
150218967|NCT03976102|541939608|FG001|Overall Study|Lost to Follow-up|2|||
150218968|NCT03976102|541939607|FG000|Overall Study|Death|3|||
150218969|NCT03976102|541939608|FG001|Overall Study|Death|2|||
150218970|NCT03976102|541939607|FG000|Overall Study|Physician Decision|1|||
150218971|NCT03976102|541939608|FG001|Overall Study|Physician Decision|1|||
150218972|NCT05066230|541939611|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
150218973|NCT05066230|541939612|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
150218974|NCT05066230|541939611|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
150218975|NCT05066230|541939612|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
150218976|NCT05066230|541939611|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
150218977|NCT05066230|541939612|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
150218978|NCT05066230|541939611|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
150218979|NCT05066230|541939612|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
150218980|NCT05066230|541939611|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
150218981|NCT05066230|541939612|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
150218982|NCT05066230|541939611|FG000|After Week 48|Adverse Event|1|||
150218983|NCT05066230|541939612|FG001|After Week 48|Adverse Event|0|||
150218984|NCT05066230|541939611|FG000|After Week 48|Non-compliance with study schedule|1|||
150218985|NCT05066230|541939612|FG001|After Week 48|Non-compliance with study schedule|0|||
150218986|NCT05066230|541939611|FG000|After Week 48|Withdrawal by Subject|0|||
150218987|NCT05066230|541939612|FG001|After Week 48|Withdrawal by Subject|1|||
150218988|NCT05066230|541939611|FG000|After Week 48|Lost to Follow-up|3|||
150218989|NCT05066230|541939612|FG001|After Week 48|Lost to Follow-up|3|||
150218990|NCT05066230|541939611|FG000|After Week 48|Sponsor Request|115|||
150218991|NCT05066230|541939612|FG001|After Week 48|Sponsor Request|111|||
150218992|NCT03072238|541939613|FG000|Overall Study|Withdrawal by Subject|44|||
150218993|NCT03072238|541939614|FG001|Overall Study|Withdrawal by Subject|64|||
150218994|NCT03072238|541939613|FG000|Overall Study|Lost to Follow-up|14|||
150218995|NCT03072238|541939614|FG001|Overall Study|Lost to Follow-up|5|||
150218996|NCT03072238|541939613|FG000|Overall Study|Physician Decision|4|||
150218997|NCT03072238|541939614|FG001|Overall Study|Physician Decision|6|||
150218998|NCT03072238|541939613|FG000|Overall Study|Death|351|||
150218999|NCT03072238|541939614|FG001|Overall Study|Death|318|||
150219000|NCT03072238|541939613|FG000|Overall Study|Progressive Disease|3|||
150219001|NCT03072238|541939614|FG001|Overall Study|Progressive Disease|4|||
150219002|NCT03072238|541939613|FG000|Overall Study|Reason Not Specified|138|||
150219003|NCT03072238|541939614|FG001|Overall Study|Reason Not Specified|150|||
150219004|NCT02889900|541939618|FG000|Overall Study|Adverse Event|11|||
150219005|NCT02889900|541939618|FG000|Overall Study|Condition under investigation worsened|32|||
150219006|NCT02889900|541939618|FG000|Overall Study|Other|5|||
150219007|NCT02889900|541939618|FG000|Overall Study|Withdrawal by Subject|7|||
150219008|NCT02889900|541939618|FG000|Overall Study|Not treated|2|||
150219009|NCT00813709|541939625|FG000|Double Blind Period|Adverse Event|4|||
150219010|NCT00813709|541939626|FG001|Double Blind Period|Adverse Event|1|||
150219011|NCT00813709|541939627|FG002|Double Blind Period|Adverse Event|4|||
150219012|NCT00813709|541939628|FG003|Double Blind Period|Adverse Event|0|||
150219013|NCT00813709|541939629|FG004|Double Blind Period|Adverse Event|0|||
150219014|NCT00813709|541939630|FG005|Double Blind Period|Adverse Event|0|||
150219015|NCT00813709|541939625|FG000|Double Blind Period|Lost to Follow-up|3|||
150219016|NCT00813709|541939626|FG001|Double Blind Period|Lost to Follow-up|2|||
150219017|NCT00813709|541939627|FG002|Double Blind Period|Lost to Follow-up|2|||
150219018|NCT00813709|541939628|FG003|Double Blind Period|Lost to Follow-up|0|||
150219019|NCT00813709|541939629|FG004|Double Blind Period|Lost to Follow-up|0|||
150219020|NCT00813709|541939630|FG005|Double Blind Period|Lost to Follow-up|0|||
150219021|NCT00813709|541939625|FG000|Double Blind Period|Switched to open label phase|9|||
150219022|NCT00813709|541939626|FG001|Double Blind Period|Switched to open label phase|26|||
150219023|NCT00813709|541939627|FG002|Double Blind Period|Switched to open label phase|18|||
150219024|NCT00813709|541939628|FG003|Double Blind Period|Switched to open label phase|0|||
150219025|NCT00813709|541939629|FG004|Double Blind Period|Switched to open label phase|0|||
150219026|NCT00813709|541939630|FG005|Double Blind Period|Switched to open label phase|0|||
150219027|NCT00813709|541939625|FG000|Double Blind Period|Randomized but not treated|1|||
150219028|NCT00813709|541939626|FG001|Double Blind Period|Randomized but not treated|3|||
150219029|NCT00813709|541939627|FG002|Double Blind Period|Randomized but not treated|1|||
150219030|NCT00813709|541939628|FG003|Double Blind Period|Randomized but not treated|0|||
150219031|NCT00813709|541939629|FG004|Double Blind Period|Randomized but not treated|0|||
150219032|NCT00813709|541939630|FG005|Double Blind Period|Randomized but not treated|0|||
150219033|NCT00813709|541939625|FG000|Double Blind Period|Other|14|||
150219034|NCT00813709|541939626|FG001|Double Blind Period|Other|9|||
150219035|NCT00813709|541939627|FG002|Double Blind Period|Other|6|||
150219036|NCT00813709|541939628|FG003|Double Blind Period|Other|0|||
150219037|NCT00813709|541939629|FG004|Double Blind Period|Other|0|||
150219038|NCT00813709|541939630|FG005|Double Blind Period|Other|0|||
150219039|NCT00813709|541939625|FG000|Open Label Period|Adverse Event|0|||
150219040|NCT00813709|541939626|FG001|Open Label Period|Adverse Event|0|||
150219041|NCT00813709|541939627|FG002|Open Label Period|Adverse Event|0|||
150219042|NCT00813709|541939628|FG003|Open Label Period|Adverse Event|5|||
150219043|NCT00813709|541939629|FG004|Open Label Period|Adverse Event|4|||
150219044|NCT00813709|541939630|FG005|Open Label Period|Adverse Event|3|||
150219045|NCT00813709|541939625|FG000|Open Label Period|Lack of Efficacy|0|||
150219046|NCT00813709|541939626|FG001|Open Label Period|Lack of Efficacy|0|||
150219047|NCT00813709|541939627|FG002|Open Label Period|Lack of Efficacy|0|||
150219048|NCT00813709|541939628|FG003|Open Label Period|Lack of Efficacy|3|||
150219049|NCT00813709|541939629|FG004|Open Label Period|Lack of Efficacy|1|||
150219050|NCT00813709|541939630|FG005|Open Label Period|Lack of Efficacy|1|||
150219051|NCT00813709|541939625|FG000|Open Label Period|Randomized but not treated|0|||
150219052|NCT00813709|541939626|FG001|Open Label Period|Randomized but not treated|0|||
150219053|NCT00813709|541939627|FG002|Open Label Period|Randomized but not treated|0|||
150219054|NCT00813709|541939628|FG003|Open Label Period|Randomized but not treated|1|||
150219055|NCT00813709|541939629|FG004|Open Label Period|Randomized but not treated|0|||
150219056|NCT00813709|541939630|FG005|Open Label Period|Randomized but not treated|1|||
150219057|NCT00813709|541939625|FG000|Open Label Period|Other|0|||
150219058|NCT00813709|541939626|FG001|Open Label Period|Other|0|||
150219059|NCT00813709|541939627|FG002|Open Label Period|Other|0|||
150219060|NCT00813709|541939628|FG003|Open Label Period|Other|11|||
150219061|NCT00813709|541939629|FG004|Open Label Period|Other|5|||
150219062|NCT00813709|541939630|FG005|Open Label Period|Other|6|||
150219063|NCT03840993|541939631|FG000|Overall Study|Adverse Event|1|||
150219064|NCT03840993|541939632|FG001|Overall Study|Adverse Event|0|||
150219065|NCT03840993|541939631|FG000|Overall Study|Lost to Follow-up|4|||
150219066|NCT03840993|541939632|FG001|Overall Study|Lost to Follow-up|0|||
150219067|NCT03840993|541939631|FG000|Overall Study|Physician Decision|0|||
150219068|NCT03840993|541939632|FG001|Overall Study|Physician Decision|1|||
150219069|NCT03840993|541939631|FG000|Overall Study|Pregnancy|0|||
150219070|NCT03840993|541939632|FG001|Overall Study|Pregnancy|1|||
150219071|NCT03840993|541939631|FG000|Overall Study|Withdrawal by Subject|1|||
150219072|NCT03840993|541939632|FG001|Overall Study|Withdrawal by Subject|3|||
150219073|NCT03840993|541939631|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
150219074|NCT03840993|541939632|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
150219075|NCT01587703|541939633|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
150219076|NCT01587703|541939634|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219077|NCT01587703|541939635|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219078|NCT01587703|541939636|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219079|NCT01587703|541939637|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219080|NCT01587703|541939638|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219081|NCT01587703|541939639|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219082|NCT01587703|541939640|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219083|NCT01587703|541939641|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219084|NCT01587703|541939642|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219085|NCT01587703|541939643|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219086|NCT01587703|541939644|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219087|NCT01587703|541939645|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219088|NCT01587703|541939646|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219089|NCT01587703|541939647|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219090|NCT01587703|541939648|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219091|NCT01587703|541939649|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219092|NCT01587703|541939650|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219093|NCT01587703|541939651|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
150219094|NCT01587703|541939633|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219095|NCT01587703|541939634|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219096|NCT01587703|541939635|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219097|NCT01587703|541939636|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219098|NCT01587703|541939637|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219099|NCT01587703|541939638|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
150219100|NCT01587703|541939639|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219101|NCT01587703|541939640|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
150219102|NCT01587703|541939641|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219103|NCT01587703|541939642|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219104|NCT01587703|541939643|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219105|NCT01587703|541939644|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219106|NCT01587703|541939645|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219107|NCT01587703|541939646|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219108|NCT01587703|541939647|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219109|NCT01587703|541939648|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219110|NCT01587703|541939649|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219111|NCT01587703|541939650|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219112|NCT01587703|541939651|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
150219113|NCT01587703|541939633|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219114|NCT01587703|541939634|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219115|NCT01587703|541939635|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219116|NCT01587703|541939636|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219117|NCT01587703|541939637|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219118|NCT01587703|541939638|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219119|NCT01587703|541939639|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
150219120|NCT01587703|541939640|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219121|NCT01587703|541939641|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219122|NCT01587703|541939642|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219123|NCT01587703|541939643|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219124|NCT01587703|541939644|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219125|NCT01587703|541939645|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219126|NCT01587703|541939646|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219127|NCT01587703|541939647|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219128|NCT01587703|541939648|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219129|NCT01587703|541939649|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219130|NCT01587703|541939650|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219131|NCT01587703|541939651|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
150219132|NCT01587703|541939633|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
150219133|NCT01587703|541939634|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
150219134|NCT01587703|541939635|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
150219135|NCT01587703|541939636|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
150219136|NCT01587703|541939637|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
150219137|NCT01587703|541939638|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
150219138|NCT01587703|541939639|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
150219139|NCT01587703|541939640|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
150219140|NCT01587703|541939641|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219141|NCT01587703|541939642|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219142|NCT01587703|541939643|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219143|NCT01587703|541939644|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219144|NCT01587703|541939645|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219145|NCT01587703|541939646|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219146|NCT01587703|541939647|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219147|NCT01587703|541939648|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219148|NCT01587703|541939649|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219149|NCT01587703|541939650|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219150|NCT01587703|541939651|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
150219151|NCT01587703|541939633|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219152|NCT01587703|541939634|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219153|NCT01587703|541939635|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219154|NCT01587703|541939636|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219155|NCT01587703|541939637|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219156|NCT01587703|541939638|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219157|NCT01587703|541939639|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219158|NCT01587703|541939640|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219159|NCT01587703|541939641|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
150219160|NCT01587703|541939642|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
150219161|NCT01587703|541939643|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
150219162|NCT01587703|541939644|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219163|NCT01587703|541939645|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219164|NCT01587703|541939646|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219165|NCT01587703|541939647|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219166|NCT01587703|541939648|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219167|NCT01587703|541939649|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219168|NCT01587703|541939650|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219169|NCT01587703|541939651|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
150219170|NCT01587703|541939633|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219171|NCT01587703|541939634|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219172|NCT01587703|541939635|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219173|NCT01587703|541939636|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219174|NCT01587703|541939637|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219175|NCT01587703|541939638|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219176|NCT01587703|541939639|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219177|NCT01587703|541939640|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219178|NCT01587703|541939641|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
150219179|NCT01587703|541939642|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219180|NCT01587703|541939643|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
150219181|NCT01587703|541939644|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219182|NCT01587703|541939645|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219183|NCT01587703|541939646|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219184|NCT01587703|541939647|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219185|NCT01587703|541939648|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219186|NCT01587703|541939649|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219187|NCT01587703|541939650|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219188|NCT01587703|541939651|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
150219189|NCT01587703|541939633|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219190|NCT01587703|541939634|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219191|NCT01587703|541939635|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219192|NCT01587703|541939636|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219193|NCT01587703|541939637|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219194|NCT01587703|541939638|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219195|NCT01587703|541939639|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219196|NCT01587703|541939640|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219197|NCT01587703|541939641|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219198|NCT01587703|541939642|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
150219199|NCT01587703|541939643|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
150219200|NCT01587703|541939644|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219201|NCT01587703|541939645|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219202|NCT01587703|541939646|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219203|NCT01587703|541939647|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219204|NCT01587703|541939648|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219205|NCT01587703|541939649|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219206|NCT01587703|541939650|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219207|NCT01587703|541939651|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
150219208|NCT01587703|541939633|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219209|NCT01587703|541939634|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219210|NCT01587703|541939635|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219211|NCT01587703|541939636|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219212|NCT01587703|541939637|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219213|NCT01587703|541939638|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219214|NCT01587703|541939639|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219215|NCT01587703|541939640|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219216|NCT01587703|541939641|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
150219217|NCT01587703|541939642|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219218|NCT01587703|541939643|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219219|NCT01587703|541939644|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219220|NCT01587703|541939645|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219221|NCT01587703|541939646|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219222|NCT01587703|541939647|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219223|NCT01587703|541939648|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219224|NCT01587703|541939649|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219225|NCT01587703|541939650|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219226|NCT01587703|541939651|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
150219227|NCT01587703|541939633|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219228|NCT01587703|541939634|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219229|NCT01587703|541939635|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219230|NCT01587703|541939636|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219231|NCT01587703|541939637|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219232|NCT01587703|541939638|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219233|NCT01587703|541939639|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219234|NCT01587703|541939640|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219235|NCT01587703|541939641|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219236|NCT01587703|541939642|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219237|NCT01587703|541939643|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219238|NCT01587703|541939644|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219239|NCT01587703|541939645|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219240|NCT01587703|541939646|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219241|NCT01587703|541939647|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219242|NCT01587703|541939648|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219243|NCT01587703|541939649|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219244|NCT01587703|541939650|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
150219245|NCT01587703|541939651|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
150219246|NCT01587703|541939633|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219247|NCT01587703|541939634|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219248|NCT01587703|541939635|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219249|NCT01587703|541939636|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219250|NCT01587703|541939637|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219251|NCT01587703|541939638|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219252|NCT01587703|541939639|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219253|NCT01587703|541939640|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219254|NCT01587703|541939641|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219255|NCT01587703|541939642|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219256|NCT01587703|541939643|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219257|NCT01587703|541939644|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219258|NCT01587703|541939645|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219259|NCT01587703|541939646|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219260|NCT01587703|541939647|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219261|NCT01587703|541939648|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219262|NCT01587703|541939649|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
150219263|NCT01587703|541939650|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
150219264|NCT01587703|541939651|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
150219265|NCT01587703|541939633|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219266|NCT01587703|541939634|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219267|NCT01587703|541939635|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219268|NCT01587703|541939636|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219269|NCT01587703|541939637|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219270|NCT01587703|541939638|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219271|NCT01587703|541939639|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219272|NCT01587703|541939640|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219273|NCT01587703|541939641|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219274|NCT01587703|541939642|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219275|NCT01587703|541939643|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219276|NCT01587703|541939644|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219277|NCT01587703|541939645|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219278|NCT01587703|541939646|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219279|NCT01587703|541939647|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219280|NCT01587703|541939648|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
150219281|NCT01587703|541939649|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219282|NCT01587703|541939650|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219283|NCT01587703|541939651|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
150219284|NCT01587703|541939633|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219285|NCT01587703|541939634|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219286|NCT01587703|541939635|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219287|NCT01587703|541939636|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219288|NCT01587703|541939637|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219289|NCT01587703|541939638|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219290|NCT01587703|541939639|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219291|NCT01587703|541939640|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219292|NCT01587703|541939641|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219293|NCT01587703|541939642|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219294|NCT01587703|541939643|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219295|NCT01587703|541939644|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
150219296|NCT01587703|541939645|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219297|NCT01587703|541939646|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219298|NCT01587703|541939647|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
150219299|NCT01587703|541939648|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219300|NCT01587703|541939649|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219301|NCT01587703|541939650|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219302|NCT01587703|541939651|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
150219303|NCT01587703|541939633|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219304|NCT01587703|541939634|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219305|NCT01587703|541939635|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219306|NCT01587703|541939636|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219307|NCT01587703|541939637|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219308|NCT01587703|541939638|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219309|NCT01587703|541939639|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219310|NCT01587703|541939640|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219311|NCT01587703|541939641|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219312|NCT01587703|541939642|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219313|NCT01587703|541939643|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219314|NCT01587703|541939644|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
150219315|NCT01587703|541939645|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
150219316|NCT01587703|541939646|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
150219317|NCT01587703|541939647|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
150219318|NCT01587703|541939648|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
150219319|NCT01587703|541939649|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
150219320|NCT01587703|541939650|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219321|NCT01587703|541939651|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
150219322|NCT01587703|541939633|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219323|NCT01587703|541939634|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219324|NCT01587703|541939635|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219325|NCT01587703|541939636|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219326|NCT01587703|541939637|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219327|NCT01587703|541939638|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219328|NCT01587703|541939639|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219329|NCT01587703|541939640|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219330|NCT01587703|541939641|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219331|NCT01587703|541939642|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219332|NCT01587703|541939643|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219333|NCT01587703|541939644|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
150219334|NCT01587703|541939645|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
150219335|NCT01587703|541939646|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
150219336|NCT01587703|541939647|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
150219337|NCT01587703|541939648|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
150219338|NCT01587703|541939649|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
150219339|NCT01587703|541939650|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219340|NCT01587703|541939651|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
150219341|NCT01587703|541939633|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219342|NCT01587703|541939634|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219343|NCT01587703|541939635|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219344|NCT01587703|541939636|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219345|NCT01587703|541939637|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219346|NCT01587703|541939638|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219347|NCT01587703|541939639|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219348|NCT01587703|541939640|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219349|NCT01587703|541939641|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219350|NCT01587703|541939642|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219351|NCT01587703|541939643|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219352|NCT01587703|541939644|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
150219353|NCT01587703|541939645|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219354|NCT01587703|541939646|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219355|NCT01587703|541939647|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219356|NCT01587703|541939648|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219357|NCT01587703|541939649|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219358|NCT01587703|541939650|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219359|NCT01587703|541939651|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
150219360|NCT04751929|541939652|FG000|Overall Study|Withdrawal by Subject|2|||
150219361|NCT04751929|541939653|FG001|Overall Study|Withdrawal by Subject|0|||
150219362|NCT04751929|541939654|FG002|Overall Study|Withdrawal by Subject|0|||
150219363|NCT04751929|541939655|FG003|Overall Study|Withdrawal by Subject|0|||
150219364|NCT04751929|541939652|FG000|Overall Study|Rising PSA|0|||
150219365|NCT04751929|541939653|FG001|Overall Study|Rising PSA|1|||
150219366|NCT04751929|541939654|FG002|Overall Study|Rising PSA|0|||
150219367|NCT04751929|541939655|FG003|Overall Study|Rising PSA|0|||
150219368|NCT04751929|541939652|FG000|Overall Study|Adverse Event|1|||
150219369|NCT04751929|541939653|FG001|Overall Study|Adverse Event|2|||
150219370|NCT04751929|541939654|FG002|Overall Study|Adverse Event|0|||
150219371|NCT04751929|541939655|FG003|Overall Study|Adverse Event|0|||
150219372|NCT04751929|541939652|FG000|Overall Study|Progressive Disease|3|||
150219373|NCT04751929|541939653|FG001|Overall Study|Progressive Disease|4|||
150219374|NCT04751929|541939654|FG002|Overall Study|Progressive Disease|4|||
150219375|NCT04751929|541939655|FG003|Overall Study|Progressive Disease|0|||
150219376|NCT04751929|541939652|FG000|Overall Study|Death|1|||
150219377|NCT04751929|541939653|FG001|Overall Study|Death|1|||
150219378|NCT04751929|541939654|FG002|Overall Study|Death|0|||
150219379|NCT04751929|541939655|FG003|Overall Study|Death|0|||
150219380|NCT01123356|541939656|FG000|Overall Study|Adverse Event|2|||
150219381|NCT01123356|541939656|FG000|Overall Study|Lack of Efficacy|4|||
150219382|NCT01123356|541939656|FG000|Overall Study|Withdrawal by Subject|1|||
150219383|NCT00376259|541939659|FG000|Overall Study|Sponsor request - study termination|21|||
150219384|NCT00376259|541939660|FG001|Overall Study|Sponsor request - study termination|21|||
150219385|NCT00376259|541939659|FG000|Overall Study|Patient request|1|||
150219386|NCT00376259|541939660|FG001|Overall Study|Patient request|0|||
150219387|NCT00930644|541939662|FG000|Overall Study|Withdrawal by Subject|4|||
150219388|NCT00930644|541939662|FG000|Overall Study|Physician Decision|2|||
150219389|NCT00930644|541939662|FG000|Overall Study|Death|1|||
150219390|NCT00930644|541939662|FG000|Overall Study|Adverse Event|16|||
150219391|NCT01877720|541939663|FG000|Overall Study|Adverse Event|1|||
150219392|NCT01877720|541939664|FG001|Overall Study|Adverse Event|0|||
150219393|NCT01129011|541939667|FG000|Overall Study|Adverse Event|20|||
150219394|NCT01129011|541939668|FG001|Overall Study|Adverse Event|30|||
150219395|NCT01129011|541939667|FG000|Overall Study|Withdrawal by Subject|24|||
150219396|NCT01129011|541939668|FG001|Overall Study|Withdrawal by Subject|8|||
150219397|NCT01129011|541939667|FG000|Overall Study|Lost to Follow-up|6|||
150219398|NCT01129011|541939668|FG001|Overall Study|Lost to Follow-up|7|||
150219399|NCT01129011|541939667|FG000|Overall Study|Duodenal Ulcer|2|||
150219400|NCT01129011|541939668|FG001|Overall Study|Duodenal Ulcer|8|||
150219401|NCT01129011|541939667|FG000|Overall Study|misc|7|||
150219402|NCT01129011|541939668|FG001|Overall Study|misc|4|||
150219403|NCT01012999|541939669|FG000|Overall Study|Protocol Violation|1|||
150219404|NCT01369147|541939670|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
150219405|NCT01369147|541939671|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
150219406|NCT01369147|541939672|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
150219407|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
150219408|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
150219409|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
150219410|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
150219411|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
150219412|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
150219413|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
150219414|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
150219415|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
150219416|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
150219417|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
150219418|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
150219419|NCT01494467|541939675|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
150219420|NCT01494467|541939676|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
150219421|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
150219422|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
150219423|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
150219424|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
150219425|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
150219426|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
150219427|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
150219428|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
150219429|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
150219430|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
150219431|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
150219432|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
150219433|NCT01494467|541939675|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
150219434|NCT01494467|541939676|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
150219435|NCT02410278|541939679|FG000|Run-in Period|Adverse Event|5|||
150219436|NCT02410278|541939680|FG001|Run-in Period|Adverse Event|0|||
150219437|NCT02410278|541939681|FG002|Run-in Period|Adverse Event|0|||
150219438|NCT02410278|541939679|FG000|Run-in Period|GSRS Threshold Not Met|30|||
150219439|NCT02410278|541939680|FG001|Run-in Period|GSRS Threshold Not Met|0|||
150219440|NCT02410278|541939681|FG002|Run-in Period|GSRS Threshold Not Met|0|||
150219441|NCT02410278|541939679|FG000|Run-in Period|Lost to Follow-up|1|||
150219442|NCT02410278|541939680|FG001|Run-in Period|Lost to Follow-up|0|||
150219443|NCT02410278|541939681|FG002|Run-in Period|Lost to Follow-up|0|||
150219444|NCT02410278|541939679|FG000|Run-in Period|Withdrawal by Subject|1|||
150219445|NCT02410278|541939680|FG001|Run-in Period|Withdrawal by Subject|0|||
150219446|NCT02410278|541939681|FG002|Run-in Period|Withdrawal by Subject|0|||
150219447|NCT02410278|541939679|FG000|Run-in Period|Pregnancy|1|||
150219448|NCT02410278|541939680|FG001|Run-in Period|Pregnancy|0|||
150219449|NCT02410278|541939681|FG002|Run-in Period|Pregnancy|0|||
150219450|NCT02410278|541939679|FG000|Study Treatment Period|Adverse Event|0|||
150219451|NCT02410278|541939680|FG001|Study Treatment Period|Adverse Event|6|||
150219452|NCT02410278|541939681|FG002|Study Treatment Period|Adverse Event|3|||
150219453|NCT02410278|541939679|FG000|Study Treatment Period|Physician Decision|0|||
150219454|NCT02410278|541939680|FG001|Study Treatment Period|Physician Decision|0|||
150219455|NCT02410278|541939681|FG002|Study Treatment Period|Physician Decision|1|||
150219456|NCT02410278|541939679|FG000|Study Treatment Period|Withdrawal by Subject|0|||
150219457|NCT02410278|541939680|FG001|Study Treatment Period|Withdrawal by Subject|1|||
150219458|NCT02410278|541939681|FG002|Study Treatment Period|Withdrawal by Subject|0|||
150219459|NCT02410278|541939679|FG000|Study Treatment Period|Other|0|||
150219460|NCT02410278|541939680|FG001|Study Treatment Period|Other|3|||
150219461|NCT02410278|541939681|FG002|Study Treatment Period|Other|0|||
150219462|NCT02410278|541939679|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
150219463|NCT02410278|541939680|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
150219464|NCT02410278|541939681|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
150219465|NCT01280721|541939686|FG000|Overall Study|Adverse Event|4|||
150219466|NCT01280721|541939686|FG000|Overall Study|Physician Decision|3|||
150219467|NCT01280721|541939686|FG000|Overall Study|Withdrawal by Subject|6|||
150219468|NCT01280721|541939686|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
150219469|NCT01280721|541939686|FG000|Overall Study|No tolerability for the lowest dose|2|||
150219470|NCT01180400|541939687|FG000|Overall Study|Withdrawal by Subject|5|||
150219471|NCT01180400|541939688|FG001|Overall Study|Withdrawal by Subject|6|||
150219472|NCT01180400|541939687|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
150219473|NCT01180400|541939688|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
150219474|NCT01180400|541939687|FG000|Overall Study|Adverse Event|12|||
150219475|NCT01180400|541939688|FG001|Overall Study|Adverse Event|10|||
150219476|NCT01180400|541939687|FG000|Overall Study|Severe non-compliance to protocol|1|||
150219477|NCT01180400|541939688|FG001|Overall Study|Severe non-compliance to protocol|2|||
150219478|NCT01180400|541939687|FG000|Overall Study|Condition under investigation worsened|2|||
150219479|NCT01180400|541939688|FG001|Overall Study|Condition under investigation worsened|1|||
150219480|NCT01180400|541939687|FG000|Overall Study|Lack of Efficacy|2|||
150219481|NCT01180400|541939688|FG001|Overall Study|Lack of Efficacy|0|||
150219482|NCT01180400|541939687|FG000|Overall Study|Study-specific withdrawal criteria|1|||
150219483|NCT01180400|541939688|FG001|Overall Study|Study-specific withdrawal criteria|2|||
150219484|NCT01180400|541939687|FG000|Overall Study|Lost to Follow-up|2|||
150219485|NCT01180400|541939688|FG001|Overall Study|Lost to Follow-up|3|||
150219486|NCT01180400|541939687|FG000|Overall Study|Other|0|||
150219487|NCT01180400|541939688|FG001|Overall Study|Other|1|||
150219488|NCT01182285|541939690|FG000|First Intervention Week 1-10|Disease progression|1|||
150219489|NCT01182285|541939691|FG001|First Intervention Week 1-10|Disease progression|0|||
150219490|NCT01182285|541939692|FG002|First Intervention Week 1-10|Disease progression|0|||
150219491|NCT01182285|541939690|FG000|First Intervention Week 1-10|Adverse Event|1|||
150219492|NCT01182285|541939691|FG001|First Intervention Week 1-10|Adverse Event|0|||
150219493|NCT01182285|541939692|FG002|First Intervention Week 1-10|Adverse Event|0|||
150219494|NCT01182285|541939690|FG000|First Intervention Week 1-10|Non-compliance|1|||
150219495|NCT01182285|541939691|FG001|First Intervention Week 1-10|Non-compliance|0|||
150219496|NCT01182285|541939692|FG002|First Intervention Week 1-10|Non-compliance|0|||
150219497|NCT01182285|541939690|FG000|Third Intervention Week 11-52|Disease Progression|0|||
150219498|NCT01182285|541939691|FG001|Third Intervention Week 11-52|Disease Progression|0|||
150219499|NCT01182285|541939692|FG002|Third Intervention Week 11-52|Disease Progression|6|||
150219500|NCT01182285|541939690|FG000|Third Intervention Week 11-52|Other|0|||
150219501|NCT01182285|541939691|FG001|Third Intervention Week 11-52|Other|0|||
150219502|NCT01182285|541939692|FG002|Third Intervention Week 11-52|Other|2|||
150219503|NCT03209492|541939693|FG000|Overall Study|Case Report Forms Uncollected|5|||
150219504|NCT01525875|541939694|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
150219505|NCT01525875|541939695|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
150219506|NCT01525875|541939694|FG000|Open-label Period|Lost to Follow-up|0|||
150219507|NCT01525875|541939695|FG001|Open-label Period|Lost to Follow-up|2|||
150219508|NCT03481725|541939696|FG000|Overall Study|Withdrawal by Subject|1|||
150219509|NCT03481725|541939697|FG001|Overall Study|Withdrawal by Subject|0|||
150219510|NCT01894620|541939702|FG000|Overall Study|Withdrawal by Subject|0|||
150219511|NCT01894620|541939703|FG001|Overall Study|Withdrawal by Subject|1|||
150219512|NCT02877680|541939704|FG000|Overall Study|Lost to Follow-up|1|||
150219513|NCT02877680|541939705|FG001|Overall Study|Lost to Follow-up|1|||
150219514|NCT01133678|541939706|FG000|Overall Study|Death|1|||
150219515|NCT01133678|541939707|FG001|Overall Study|Death|1|||
150219516|NCT00879710|541939714|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
150219517|NCT00879710|541939715|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
150219518|NCT00879710|541939716|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
150219519|NCT00879710|541939717|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
150219520|NCT00879710|541939714|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
150219521|NCT00879710|541939715|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
150219522|NCT00879710|541939716|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
150219523|NCT00879710|541939717|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
150219524|NCT01864200|541939718|FG000|Overall Study|Lost to Follow-up|1|||
150219525|NCT01864200|541939719|FG001|Overall Study|Lost to Follow-up|3|||
150219526|NCT01864200|541939718|FG000|Overall Study|Protocol Violation|1|||
150219527|NCT01864200|541939719|FG001|Overall Study|Protocol Violation|0|||
150219528|NCT00424476|541939720|FG000|Overall Study|Withdrawal by Subject|7|||
150219529|NCT00424476|541939721|FG001|Overall Study|Withdrawal by Subject|6|||
150219530|NCT00424476|541939722|FG002|Overall Study|Withdrawal by Subject|3|||
150219531|NCT00424476|541939720|FG000|Overall Study|Adverse Event|19|||
150219532|NCT00424476|541939721|FG001|Overall Study|Adverse Event|16|||
150219533|NCT00424476|541939722|FG002|Overall Study|Adverse Event|15|||
150219534|NCT00424476|541939720|FG000|Overall Study|Lack of Efficacy|16|||
150219535|NCT00424476|541939721|FG001|Overall Study|Lack of Efficacy|12|||
150219536|NCT00424476|541939722|FG002|Overall Study|Lack of Efficacy|12|||
150219537|NCT00424476|541939720|FG000|Overall Study|Lack of Compliance|1|||
150219538|NCT00424476|541939721|FG001|Overall Study|Lack of Compliance|1|||
150219539|NCT00424476|541939722|FG002|Overall Study|Lack of Compliance|1|||
150219540|NCT00424476|541939720|FG000|Overall Study|Lost to Follow-up|4|||
150219541|NCT00424476|541939721|FG001|Overall Study|Lost to Follow-up|6|||
150219542|NCT00424476|541939722|FG002|Overall Study|Lost to Follow-up|3|||
150219543|NCT00424476|541939720|FG000|Overall Study|Protocol Violation|7|||
150219544|NCT00424476|541939721|FG001|Overall Study|Protocol Violation|2|||
150219545|NCT00424476|541939722|FG002|Overall Study|Protocol Violation|3|||
150219546|NCT00424476|541939720|FG000|Overall Study|Physician Decision|3|||
150219547|NCT00424476|541939721|FG001|Overall Study|Physician Decision|2|||
150219548|NCT00424476|541939722|FG002|Overall Study|Physician Decision|3|||
150219549|NCT00424476|541939720|FG000|Overall Study|Other|4|||
150219550|NCT00424476|541939721|FG001|Overall Study|Other|3|||
150219551|NCT00424476|541939722|FG002|Overall Study|Other|9|||
150219552|NCT02514824|541939723|FG000|Overall Study|Withdrawal by Subject|1|||
150219553|NCT02514824|541939724|FG001|Overall Study|Withdrawal by Subject|0|||
150219554|NCT02514824|541939725|FG002|Overall Study|Withdrawal by Subject|0|||
150219555|NCT02514824|541939726|FG003|Overall Study|Withdrawal by Subject|0|||
150219556|NCT02514824|541939723|FG000|Overall Study|Dose-Limiting Toxicity|0|||
150219557|NCT02514824|541939724|FG001|Overall Study|Dose-Limiting Toxicity|1|||
150219558|NCT02514824|541939725|FG002|Overall Study|Dose-Limiting Toxicity|0|||
150219559|NCT02514824|541939726|FG003|Overall Study|Dose-Limiting Toxicity|0|||
150219560|NCT00529529|541939727|FG000|Overall Study|Adverse Event|12|||
150219561|NCT00529529|541939728|FG001|Overall Study|Adverse Event|17|||
150219562|NCT00529529|541939729|FG002|Overall Study|Adverse Event|8|||
150219563|NCT00529529|541939727|FG000|Overall Study|Subject withdrew consent|12|||
150219564|NCT00529529|541939728|FG001|Overall Study|Subject withdrew consent|9|||
150219565|NCT00529529|541939729|FG002|Overall Study|Subject withdrew consent|12|||
150219566|NCT00529529|541939727|FG000|Overall Study|Protocol deviation|8|||
150219567|NCT00529529|541939728|FG001|Overall Study|Protocol deviation|12|||
150219568|NCT00529529|541939729|FG002|Overall Study|Protocol deviation|5|||
150219569|NCT00529529|541939727|FG000|Overall Study|Lost to Follow-up|5|||
150219570|NCT00529529|541939728|FG001|Overall Study|Lost to Follow-up|3|||
150219571|NCT00529529|541939729|FG002|Overall Study|Lost to Follow-up|1|||
150219572|NCT00529529|541939727|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
150219573|NCT00529529|541939728|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150219574|NCT00529529|541939729|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
150219575|NCT00529529|541939727|FG000|Overall Study|Death|2|||
150219576|NCT00529529|541939728|FG001|Overall Study|Death|0|||
150219577|NCT00529529|541939729|FG002|Overall Study|Death|0|||
150219578|NCT00529529|541939727|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150219579|NCT00529529|541939728|FG001|Overall Study|Abnormal test procedure result(s)|0|||
150219580|NCT00529529|541939729|FG002|Overall Study|Abnormal test procedure result(s)|0|||
150219581|NCT00529529|541939727|FG000|Overall Study|Administrative problems|1|||
150219582|NCT00529529|541939728|FG001|Overall Study|Administrative problems|0|||
150219583|NCT00529529|541939729|FG002|Overall Study|Administrative problems|3|||
150219584|NCT02607956|541939730|FG000|Double-Blinded Phase|Withdrew Consent|17|||
150219585|NCT02607956|541939731|FG001|Double-Blinded Phase|Withdrew Consent|19|||
150219586|NCT02607956|541939732|FG002|Double-Blinded Phase|Withdrew Consent|0|||
150219587|NCT02607956|541939733|FG003|Double-Blinded Phase|Withdrew Consent|0|||
150219588|NCT02607956|541939730|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
150219589|NCT02607956|541939731|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
150219590|NCT02607956|541939732|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
150219591|NCT02607956|541939733|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
150219592|NCT02607956|541939730|FG000|Double-Blinded Phase|Randomized but never treated|7|||
150219593|NCT02607956|541939731|FG001|Double-Blinded Phase|Randomized but never treated|5|||
150219594|NCT02607956|541939732|FG002|Double-Blinded Phase|Randomized but never treated|0|||
150219595|NCT02607956|541939733|FG003|Double-Blinded Phase|Randomized but never treated|0|||
150219596|NCT02607956|541939730|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
150219597|NCT02607956|541939731|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
150219598|NCT02607956|541939732|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
150219599|NCT02607956|541939733|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
150219600|NCT02607956|541939730|FG000|Double-Blinded Phase|Death|4|||
150219601|NCT02607956|541939731|FG001|Double-Blinded Phase|Death|4|||
150219602|NCT02607956|541939732|FG002|Double-Blinded Phase|Death|0|||
150219603|NCT02607956|541939733|FG003|Double-Blinded Phase|Death|0|||
150219604|NCT02607956|541939730|FG000|Double-Blinded Phase|Adverse Event|4|||
150219605|NCT02607956|541939731|FG001|Double-Blinded Phase|Adverse Event|3|||
150219606|NCT02607956|541939732|FG002|Double-Blinded Phase|Adverse Event|0|||
150219607|NCT02607956|541939733|FG003|Double-Blinded Phase|Adverse Event|0|||
150219608|NCT02607956|541939730|FG000|Double-Blinded Phase|Protocol Violation|3|||
150219609|NCT02607956|541939731|FG001|Double-Blinded Phase|Protocol Violation|1|||
150219610|NCT02607956|541939732|FG002|Double-Blinded Phase|Protocol Violation|0|||
150219611|NCT02607956|541939733|FG003|Double-Blinded Phase|Protocol Violation|0|||
150219612|NCT02607956|541939730|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
150219613|NCT02607956|541939731|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
150219614|NCT02607956|541939732|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
150219615|NCT02607956|541939733|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
150219616|NCT02607956|541939730|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
150219617|NCT02607956|541939731|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
150219618|NCT02607956|541939732|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
150219619|NCT02607956|541939733|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
150219620|NCT02607956|541939730|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
150219621|NCT02607956|541939731|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
150219622|NCT02607956|541939732|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
150219623|NCT02607956|541939733|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
150219624|NCT02607956|541939730|FG000|Open-Label Extension Phase|Death|0|||
150219625|NCT02607956|541939731|FG001|Open-Label Extension Phase|Death|0|||
150219626|NCT02607956|541939732|FG002|Open-Label Extension Phase|Death|1|||
150219627|NCT02607956|541939733|FG003|Open-Label Extension Phase|Death|3|||
150219628|NCT02607956|541939730|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
150219629|NCT02607956|541939731|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
150219630|NCT02607956|541939732|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
150219631|NCT02607956|541939733|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
150219632|NCT02607956|541939730|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
150219633|NCT02607956|541939731|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
150219634|NCT02607956|541939732|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
150219635|NCT02607956|541939733|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
150219636|NCT02607956|541939730|FG000|Open-Label Extension Phase|Protocol Violation|0|||
150219637|NCT02607956|541939731|FG001|Open-Label Extension Phase|Protocol Violation|0|||
150219638|NCT02607956|541939732|FG002|Open-Label Extension Phase|Protocol Violation|0|||
150219639|NCT02607956|541939733|FG003|Open-Label Extension Phase|Protocol Violation|2|||
150219640|NCT02607956|541939730|FG000|Open-Label Extension Phase|Pregnancy|0|||
150219641|NCT02607956|541939731|FG001|Open-Label Extension Phase|Pregnancy|0|||
150219642|NCT02607956|541939732|FG002|Open-Label Extension Phase|Pregnancy|0|||
150219643|NCT02607956|541939733|FG003|Open-Label Extension Phase|Pregnancy|1|||
150219644|NCT01916109|541939734|FG000|Overall Study|Withdrawal by Subject|1|||
150219645|NCT00103857|541939737|FG000|54-Week Base Study|Adverse Event|12|||
150219646|NCT00103857|541939738|FG001|54-Week Base Study|Adverse Event|9|||
150219647|NCT00103857|541939739|FG002|54-Week Base Study|Adverse Event|11|||
150219648|NCT00103857|541939740|FG003|54-Week Base Study|Adverse Event|6|||
150219649|NCT00103857|541939741|FG004|54-Week Base Study|Adverse Event|5|||
150219650|NCT00103857|541939742|FG005|54-Week Base Study|Adverse Event|11|||
150219651|NCT00103857|541939743|FG006|54-Week Base Study|Adverse Event|3|||
150219652|NCT00103857|541939737|FG000|54-Week Base Study|Death|0|||
150219653|NCT00103857|541939738|FG001|54-Week Base Study|Death|0|||
150219654|NCT00103857|541939739|FG002|54-Week Base Study|Death|0|||
150219655|NCT00103857|541939740|FG003|54-Week Base Study|Death|0|||
150219656|NCT00103857|541939741|FG004|54-Week Base Study|Death|1|||
150219657|NCT00103857|541939742|FG005|54-Week Base Study|Death|1|||
150219658|NCT00103857|541939743|FG006|54-Week Base Study|Death|0|||
150219659|NCT00103857|541939737|FG000|54-Week Base Study|Lack of Efficacy|11|||
150219660|NCT00103857|541939738|FG001|54-Week Base Study|Lack of Efficacy|14|||
150219661|NCT00103857|541939739|FG002|54-Week Base Study|Lack of Efficacy|8|||
150219662|NCT00103857|541939740|FG003|54-Week Base Study|Lack of Efficacy|4|||
150219663|NCT00103857|541939741|FG004|54-Week Base Study|Lack of Efficacy|3|||
150219664|NCT00103857|541939742|FG005|54-Week Base Study|Lack of Efficacy|14|||
150219665|NCT00103857|541939743|FG006|54-Week Base Study|Lack of Efficacy|19|||
150219666|NCT00103857|541939737|FG000|54-Week Base Study|Lost to Follow-up|5|||
150219667|NCT00103857|541939738|FG001|54-Week Base Study|Lost to Follow-up|4|||
150219668|NCT00103857|541939739|FG002|54-Week Base Study|Lost to Follow-up|7|||
150219669|NCT00103857|541939740|FG003|54-Week Base Study|Lost to Follow-up|5|||
150219670|NCT00103857|541939741|FG004|54-Week Base Study|Lost to Follow-up|10|||
150219671|NCT00103857|541939742|FG005|54-Week Base Study|Lost to Follow-up|9|||
150219672|NCT00103857|541939743|FG006|54-Week Base Study|Lost to Follow-up|3|||
150219673|NCT00103857|541939737|FG000|54-Week Base Study|Physician Decision|1|||
150219674|NCT00103857|541939738|FG001|54-Week Base Study|Physician Decision|1|||
150219675|NCT00103857|541939739|FG002|54-Week Base Study|Physician Decision|0|||
150219676|NCT00103857|541939740|FG003|54-Week Base Study|Physician Decision|0|||
150219677|NCT00103857|541939741|FG004|54-Week Base Study|Physician Decision|1|||
150219678|NCT00103857|541939742|FG005|54-Week Base Study|Physician Decision|0|||
150219679|NCT00103857|541939743|FG006|54-Week Base Study|Physician Decision|0|||
150219680|NCT00103857|541939737|FG000|54-Week Base Study|Pregnancy|1|||
150219681|NCT00103857|541939738|FG001|54-Week Base Study|Pregnancy|0|||
150219682|NCT00103857|541939739|FG002|54-Week Base Study|Pregnancy|0|||
150219683|NCT00103857|541939740|FG003|54-Week Base Study|Pregnancy|0|||
150219684|NCT00103857|541939741|FG004|54-Week Base Study|Pregnancy|1|||
150219685|NCT00103857|541939742|FG005|54-Week Base Study|Pregnancy|0|||
150219686|NCT00103857|541939743|FG006|54-Week Base Study|Pregnancy|1|||
150219687|NCT00103857|541939737|FG000|54-Week Base Study|Protocol Violation|6|||
150219688|NCT00103857|541939738|FG001|54-Week Base Study|Protocol Violation|4|||
150219689|NCT00103857|541939739|FG002|54-Week Base Study|Protocol Violation|2|||
150219690|NCT00103857|541939740|FG003|54-Week Base Study|Protocol Violation|4|||
150219691|NCT00103857|541939741|FG004|54-Week Base Study|Protocol Violation|0|||
150219692|NCT00103857|541939742|FG005|54-Week Base Study|Protocol Violation|3|||
150219693|NCT00103857|541939743|FG006|54-Week Base Study|Protocol Violation|3|||
150219694|NCT00103857|541939737|FG000|54-Week Base Study|Withdrawal by Subject|17|||
150219695|NCT00103857|541939738|FG001|54-Week Base Study|Withdrawal by Subject|16|||
150219696|NCT00103857|541939739|FG002|54-Week Base Study|Withdrawal by Subject|16|||
150219697|NCT00103857|541939740|FG003|54-Week Base Study|Withdrawal by Subject|15|||
150219698|NCT00103857|541939741|FG004|54-Week Base Study|Withdrawal by Subject|10|||
150219699|NCT00103857|541939742|FG005|54-Week Base Study|Withdrawal by Subject|15|||
150219700|NCT00103857|541939743|FG006|54-Week Base Study|Withdrawal by Subject|4|||
150219701|NCT00103857|541939737|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
150219702|NCT00103857|541939738|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
150219703|NCT00103857|541939739|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
150219704|NCT00103857|541939740|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
150219705|NCT00103857|541939741|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
150219706|NCT00103857|541939742|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
150219707|NCT00103857|541939743|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
150219708|NCT00103857|541939737|FG000|54-Week Base Study|patient moved|0|||
150219709|NCT00103857|541939738|FG001|54-Week Base Study|patient moved|1|||
150219710|NCT00103857|541939739|FG002|54-Week Base Study|patient moved|1|||
150219711|NCT00103857|541939740|FG003|54-Week Base Study|patient moved|2|||
150219712|NCT00103857|541939741|FG004|54-Week Base Study|patient moved|3|||
150219713|NCT00103857|541939742|FG005|54-Week Base Study|patient moved|1|||
150219714|NCT00103857|541939743|FG006|54-Week Base Study|patient moved|0|||
150219715|NCT00103857|541939737|FG000|54-Week Base Study|non-compliance with study procedures|1|||
150219716|NCT00103857|541939738|FG001|54-Week Base Study|non-compliance with study procedures|2|||
150219717|NCT00103857|541939739|FG002|54-Week Base Study|non-compliance with study procedures|0|||
150219718|NCT00103857|541939740|FG003|54-Week Base Study|non-compliance with study procedures|0|||
150219719|NCT00103857|541939741|FG004|54-Week Base Study|non-compliance with study procedures|0|||
150219720|NCT00103857|541939742|FG005|54-Week Base Study|non-compliance with study procedures|2|||
150219721|NCT00103857|541939743|FG006|54-Week Base Study|non-compliance with study procedures|0|||
150219722|NCT00103857|541939737|FG000|54-Week Base Study|patient incarcerated|0|||
150219723|NCT00103857|541939738|FG001|54-Week Base Study|patient incarcerated|0|||
150219724|NCT00103857|541939739|FG002|54-Week Base Study|patient incarcerated|0|||
150219725|NCT00103857|541939740|FG003|54-Week Base Study|patient incarcerated|0|||
150219726|NCT00103857|541939741|FG004|54-Week Base Study|patient incarcerated|1|||
150219727|NCT00103857|541939742|FG005|54-Week Base Study|patient incarcerated|1|||
150219728|NCT00103857|541939743|FG006|54-Week Base Study|patient incarcerated|0|||
150219729|NCT00103857|541939737|FG000|54-Week Base Study|laboratory reporting error|0|||
150219730|NCT00103857|541939738|FG001|54-Week Base Study|laboratory reporting error|0|||
150219731|NCT00103857|541939739|FG002|54-Week Base Study|laboratory reporting error|0|||
150219732|NCT00103857|541939740|FG003|54-Week Base Study|laboratory reporting error|0|||
150219733|NCT00103857|541939741|FG004|54-Week Base Study|laboratory reporting error|1|||
150219734|NCT00103857|541939742|FG005|54-Week Base Study|laboratory reporting error|0|||
150219735|NCT00103857|541939743|FG006|54-Week Base Study|laboratory reporting error|0|||
150219736|NCT00103857|541939737|FG000|54-Week Base Study|site error|0|||
150219737|NCT00103857|541939738|FG001|54-Week Base Study|site error|0|||
150219738|NCT00103857|541939739|FG002|54-Week Base Study|site error|0|||
150219739|NCT00103857|541939740|FG003|54-Week Base Study|site error|0|||
150219740|NCT00103857|541939741|FG004|54-Week Base Study|site error|0|||
150219741|NCT00103857|541939742|FG005|54-Week Base Study|site error|1|||
150219742|NCT00103857|541939743|FG006|54-Week Base Study|site error|0|||
150219743|NCT00103857|541939737|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
150219744|NCT00103857|541939738|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219745|NCT00103857|541939739|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219746|NCT00103857|541939740|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219747|NCT00103857|541939741|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219748|NCT00103857|541939742|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219749|NCT00103857|541939743|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
150219750|NCT00103857|541939737|FG000|50-Week Extension Study|Adverse Event|2|||
150219751|NCT00103857|541939738|FG001|50-Week Extension Study|Adverse Event|3|||
150219752|NCT00103857|541939739|FG002|50-Week Extension Study|Adverse Event|2|||
150219753|NCT00103857|541939740|FG003|50-Week Extension Study|Adverse Event|0|||
150219754|NCT00103857|541939741|FG004|50-Week Extension Study|Adverse Event|1|||
150219755|NCT00103857|541939742|FG005|50-Week Extension Study|Adverse Event|1|||
150219756|NCT00103857|541939743|FG006|50-Week Extension Study|Adverse Event|0|||
150219757|NCT00103857|541939737|FG000|50-Week Extension Study|Death|0|||
150219758|NCT00103857|541939738|FG001|50-Week Extension Study|Death|0|||
150219759|NCT00103857|541939739|FG002|50-Week Extension Study|Death|0|||
150219760|NCT00103857|541939740|FG003|50-Week Extension Study|Death|1|||
150219761|NCT00103857|541939741|FG004|50-Week Extension Study|Death|0|||
150219762|NCT00103857|541939742|FG005|50-Week Extension Study|Death|1|||
150219763|NCT00103857|541939743|FG006|50-Week Extension Study|Death|0|||
150219764|NCT00103857|541939737|FG000|50-Week Extension Study|Lack of Efficacy|26|||
150219765|NCT00103857|541939738|FG001|50-Week Extension Study|Lack of Efficacy|15|||
150219766|NCT00103857|541939739|FG002|50-Week Extension Study|Lack of Efficacy|13|||
150219767|NCT00103857|541939740|FG003|50-Week Extension Study|Lack of Efficacy|16|||
150219768|NCT00103857|541939741|FG004|50-Week Extension Study|Lack of Efficacy|8|||
150219769|NCT00103857|541939742|FG005|50-Week Extension Study|Lack of Efficacy|8|||
150219770|NCT00103857|541939743|FG006|50-Week Extension Study|Lack of Efficacy|0|||
150219771|NCT00103857|541939737|FG000|50-Week Extension Study|Lost to Follow-up|4|||
150219772|NCT00103857|541939738|FG001|50-Week Extension Study|Lost to Follow-up|0|||
150219773|NCT00103857|541939739|FG002|50-Week Extension Study|Lost to Follow-up|1|||
150219774|NCT00103857|541939740|FG003|50-Week Extension Study|Lost to Follow-up|4|||
150219775|NCT00103857|541939741|FG004|50-Week Extension Study|Lost to Follow-up|3|||
150219776|NCT00103857|541939742|FG005|50-Week Extension Study|Lost to Follow-up|3|||
150219777|NCT00103857|541939743|FG006|50-Week Extension Study|Lost to Follow-up|0|||
150219778|NCT00103857|541939737|FG000|50-Week Extension Study|Physician Decision|0|||
150219779|NCT00103857|541939738|FG001|50-Week Extension Study|Physician Decision|1|||
150219780|NCT00103857|541939739|FG002|50-Week Extension Study|Physician Decision|1|||
150219781|NCT00103857|541939740|FG003|50-Week Extension Study|Physician Decision|0|||
150219782|NCT00103857|541939741|FG004|50-Week Extension Study|Physician Decision|0|||
150219783|NCT00103857|541939742|FG005|50-Week Extension Study|Physician Decision|0|||
150219784|NCT00103857|541939743|FG006|50-Week Extension Study|Physician Decision|0|||
150219785|NCT00103857|541939737|FG000|50-Week Extension Study|Pregnancy|0|||
150219786|NCT00103857|541939738|FG001|50-Week Extension Study|Pregnancy|0|||
150219787|NCT00103857|541939739|FG002|50-Week Extension Study|Pregnancy|1|||
150219788|NCT00103857|541939740|FG003|50-Week Extension Study|Pregnancy|0|||
150219789|NCT00103857|541939741|FG004|50-Week Extension Study|Pregnancy|1|||
150219790|NCT00103857|541939742|FG005|50-Week Extension Study|Pregnancy|0|||
150219791|NCT00103857|541939743|FG006|50-Week Extension Study|Pregnancy|0|||
150219792|NCT00103857|541939737|FG000|50-Week Extension Study|Protocol Violation|1|||
150219793|NCT00103857|541939738|FG001|50-Week Extension Study|Protocol Violation|1|||
150219794|NCT00103857|541939739|FG002|50-Week Extension Study|Protocol Violation|1|||
150219795|NCT00103857|541939740|FG003|50-Week Extension Study|Protocol Violation|2|||
150219796|NCT00103857|541939741|FG004|50-Week Extension Study|Protocol Violation|0|||
150219797|NCT00103857|541939742|FG005|50-Week Extension Study|Protocol Violation|1|||
150219798|NCT00103857|541939743|FG006|50-Week Extension Study|Protocol Violation|0|||
150219799|NCT00103857|541939737|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
150219800|NCT00103857|541939738|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
150219801|NCT00103857|541939739|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
150219802|NCT00103857|541939740|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
150219803|NCT00103857|541939741|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
150219804|NCT00103857|541939742|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
150219805|NCT00103857|541939743|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
150219806|NCT00103857|541939737|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
150219807|NCT00103857|541939738|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
150219808|NCT00103857|541939739|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
150219809|NCT00103857|541939740|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
150219810|NCT00103857|541939741|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
150219811|NCT00103857|541939742|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
150219812|NCT00103857|541939743|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
150219813|NCT00103857|541939737|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
150219814|NCT00103857|541939738|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
150219815|NCT00103857|541939739|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
150219816|NCT00103857|541939740|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
150219817|NCT00103857|541939741|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
150219818|NCT00103857|541939742|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
150219819|NCT00103857|541939743|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
150219820|NCT00103857|541939737|FG000|50-Week Extension Study|patient moved|0|||
150219821|NCT00103857|541939738|FG001|50-Week Extension Study|patient moved|0|||
150219822|NCT00103857|541939739|FG002|50-Week Extension Study|patient moved|1|||
150219823|NCT00103857|541939740|FG003|50-Week Extension Study|patient moved|2|||
150219824|NCT00103857|541939741|FG004|50-Week Extension Study|patient moved|0|||
150219825|NCT00103857|541939742|FG005|50-Week Extension Study|patient moved|0|||
150219826|NCT00103857|541939743|FG006|50-Week Extension Study|patient moved|0|||
150219827|NCT00103857|541939737|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219828|NCT00103857|541939738|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219829|NCT00103857|541939739|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
150219830|NCT00103857|541939740|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219831|NCT00103857|541939741|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219832|NCT00103857|541939742|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219833|NCT00103857|541939743|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
150219834|NCT00103857|541939737|FG000|50-Week Extension Study|reason unspecified|0|||
150219835|NCT00103857|541939738|FG001|50-Week Extension Study|reason unspecified|0|||
150219836|NCT00103857|541939739|FG002|50-Week Extension Study|reason unspecified|0|||
150219837|NCT00103857|541939740|FG003|50-Week Extension Study|reason unspecified|0|||
150219838|NCT00103857|541939741|FG004|50-Week Extension Study|reason unspecified|1|||
150219839|NCT00103857|541939742|FG005|50-Week Extension Study|reason unspecified|0|||
150219840|NCT00103857|541939743|FG006|50-Week Extension Study|reason unspecified|0|||
150219841|NCT03541369|541939746|FG000|Overall Study|Death|0|||
150219842|NCT03541369|541939747|FG001|Overall Study|Death|0|||
150219843|NCT03541369|541939748|FG002|Overall Study|Death|0|||
150219844|NCT03541369|541939749|FG003|Overall Study|Death|0|||
150219845|NCT03541369|541939750|FG004|Overall Study|Death|1|||
150219846|NCT03541369|541939751|FG005|Overall Study|Death|1|||
150219847|NCT03541369|541939752|FG006|Overall Study|Death|0|||
150219848|NCT03541369|541939753|FG007|Overall Study|Death|2|||
150219849|NCT03541369|541939754|FG008|Overall Study|Death|1|||
150219850|NCT03541369|541939755|FG009|Overall Study|Death|2|||
150219851|NCT03541369|541939756|FG010|Overall Study|Death|1|||
150219852|NCT03541369|541939757|FG011|Overall Study|Death|0|||
150219853|NCT03541369|541939758|FG012|Overall Study|Death|2|||
150219854|NCT03541369|541939759|FG013|Overall Study|Death|1|||
150219855|NCT03541369|541939760|FG014|Overall Study|Death|1|||
150219856|NCT03541369|541939761|FG015|Overall Study|Death|1|||
150219857|NCT03541369|541939762|FG016|Overall Study|Death|0|||
150219858|NCT03541369|541939763|FG017|Overall Study|Death|1|||
150219859|NCT03541369|541939746|FG000|Overall Study|Decision by sponsor|0|||
150219860|NCT03541369|541939747|FG001|Overall Study|Decision by sponsor|0|||
150219861|NCT03541369|541939748|FG002|Overall Study|Decision by sponsor|0|||
150219862|NCT03541369|541939749|FG003|Overall Study|Decision by sponsor|1|||
150219863|NCT03541369|541939750|FG004|Overall Study|Decision by sponsor|0|||
150219864|NCT03541369|541939751|FG005|Overall Study|Decision by sponsor|2|||
150219865|NCT03541369|541939752|FG006|Overall Study|Decision by sponsor|0|||
150219866|NCT03541369|541939753|FG007|Overall Study|Decision by sponsor|1|||
150219867|NCT03541369|541939754|FG008|Overall Study|Decision by sponsor|2|||
150219868|NCT03541369|541939755|FG009|Overall Study|Decision by sponsor|0|||
150219869|NCT03541369|541939756|FG010|Overall Study|Decision by sponsor|0|||
150219870|NCT03541369|541939757|FG011|Overall Study|Decision by sponsor|0|||
150219871|NCT03541369|541939758|FG012|Overall Study|Decision by sponsor|2|||
150219872|NCT03541369|541939759|FG013|Overall Study|Decision by sponsor|2|||
150219873|NCT03541369|541939760|FG014|Overall Study|Decision by sponsor|0|||
150219874|NCT03541369|541939761|FG015|Overall Study|Decision by sponsor|1|||
150219875|NCT03541369|541939762|FG016|Overall Study|Decision by sponsor|1|||
150219876|NCT03541369|541939763|FG017|Overall Study|Decision by sponsor|1|||
150219877|NCT03541369|541939746|FG000|Overall Study|Withdrawal by Subject|0|||
150219878|NCT03541369|541939747|FG001|Overall Study|Withdrawal by Subject|0|||
150219879|NCT03541369|541939748|FG002|Overall Study|Withdrawal by Subject|0|||
150219880|NCT03541369|541939749|FG003|Overall Study|Withdrawal by Subject|0|||
150219881|NCT03541369|541939750|FG004|Overall Study|Withdrawal by Subject|0|||
150219882|NCT03541369|541939751|FG005|Overall Study|Withdrawal by Subject|0|||
150219883|NCT03541369|541939752|FG006|Overall Study|Withdrawal by Subject|1|||
150219884|NCT03541369|541939753|FG007|Overall Study|Withdrawal by Subject|0|||
150219885|NCT03541369|541939754|FG008|Overall Study|Withdrawal by Subject|0|||
150219886|NCT03541369|541939755|FG009|Overall Study|Withdrawal by Subject|0|||
150219887|NCT03541369|541939756|FG010|Overall Study|Withdrawal by Subject|0|||
150219888|NCT03541369|541939757|FG011|Overall Study|Withdrawal by Subject|1|||
150219889|NCT03541369|541939758|FG012|Overall Study|Withdrawal by Subject|0|||
150219890|NCT03541369|541939759|FG013|Overall Study|Withdrawal by Subject|0|||
150219891|NCT03541369|541939760|FG014|Overall Study|Withdrawal by Subject|3|||
150219892|NCT03541369|541939761|FG015|Overall Study|Withdrawal by Subject|0|||
150219893|NCT03541369|541939762|FG016|Overall Study|Withdrawal by Subject|4|||
150219894|NCT03541369|541939763|FG017|Overall Study|Withdrawal by Subject|2|||
150219895|NCT03541369|541939746|FG000|Overall Study|Lost to Follow-up|0|||
150219896|NCT03541369|541939747|FG001|Overall Study|Lost to Follow-up|0|||
150219897|NCT03541369|541939748|FG002|Overall Study|Lost to Follow-up|0|||
150219898|NCT03541369|541939749|FG003|Overall Study|Lost to Follow-up|0|||
150219899|NCT03541369|541939750|FG004|Overall Study|Lost to Follow-up|1|||
150219900|NCT03541369|541939751|FG005|Overall Study|Lost to Follow-up|0|||
150219901|NCT03541369|541939752|FG006|Overall Study|Lost to Follow-up|0|||
150219902|NCT03541369|541939753|FG007|Overall Study|Lost to Follow-up|0|||
150219903|NCT03541369|541939754|FG008|Overall Study|Lost to Follow-up|1|||
150219904|NCT03541369|541939755|FG009|Overall Study|Lost to Follow-up|0|||
150219905|NCT03541369|541939756|FG010|Overall Study|Lost to Follow-up|0|||
150219906|NCT03541369|541939757|FG011|Overall Study|Lost to Follow-up|0|||
150219907|NCT03541369|541939758|FG012|Overall Study|Lost to Follow-up|1|||
150219908|NCT03541369|541939759|FG013|Overall Study|Lost to Follow-up|0|||
150219909|NCT03541369|541939760|FG014|Overall Study|Lost to Follow-up|0|||
150219910|NCT03541369|541939761|FG015|Overall Study|Lost to Follow-up|0|||
150219911|NCT03541369|541939762|FG016|Overall Study|Lost to Follow-up|0|||
150219912|NCT03541369|541939763|FG017|Overall Study|Lost to Follow-up|0|||
150219913|NCT02707952|541939764|FG000|Overall Study|Adverse Event|1|||
150219914|NCT02707952|541939765|FG001|Overall Study|Adverse Event|0|||
150219915|NCT02707952|541939766|FG002|Overall Study|Adverse Event|0|||
150219916|NCT02707952|541939767|FG003|Overall Study|Adverse Event|0|||
150219917|NCT02707952|541939764|FG000|Overall Study|Lost to Follow-up|1|||
150219918|NCT02707952|541939765|FG001|Overall Study|Lost to Follow-up|0|||
150219919|NCT02707952|541939766|FG002|Overall Study|Lost to Follow-up|0|||
150219920|NCT02707952|541939767|FG003|Overall Study|Lost to Follow-up|0|||
150219921|NCT02707952|541939764|FG000|Overall Study|Withdrawal by Subject|0|||
150219922|NCT02707952|541939765|FG001|Overall Study|Withdrawal by Subject|1|||
150219923|NCT02707952|541939766|FG002|Overall Study|Withdrawal by Subject|2|||
150219924|NCT02707952|541939767|FG003|Overall Study|Withdrawal by Subject|0|||
150219925|NCT00696241|541939768|FG000|Overall Study|Adverse Event|11|||
150219926|NCT00696241|541939769|FG001|Overall Study|Adverse Event|3|||
150219927|NCT00696241|541939770|FG002|Overall Study|Adverse Event|6|||
150219928|NCT00696241|541939771|FG003|Overall Study|Adverse Event|4|||
150219929|NCT00696241|541939772|FG004|Overall Study|Adverse Event|5|||
150219930|NCT00696241|541939768|FG000|Overall Study|Protocol Violation|1|||
150219931|NCT00696241|541939769|FG001|Overall Study|Protocol Violation|1|||
150219932|NCT00696241|541939770|FG002|Overall Study|Protocol Violation|2|||
150219933|NCT00696241|541939771|FG003|Overall Study|Protocol Violation|0|||
150219934|NCT00696241|541939772|FG004|Overall Study|Protocol Violation|3|||
150219935|NCT00696241|541939768|FG000|Overall Study|Lost to Follow-up|1|||
150219936|NCT00696241|541939769|FG001|Overall Study|Lost to Follow-up|4|||
150219937|NCT00696241|541939770|FG002|Overall Study|Lost to Follow-up|1|||
150219938|NCT00696241|541939771|FG003|Overall Study|Lost to Follow-up|2|||
150219939|NCT00696241|541939772|FG004|Overall Study|Lost to Follow-up|0|||
150219940|NCT00696241|541939768|FG000|Overall Study|Withdrawal by Subject|4|||
150219941|NCT00696241|541939769|FG001|Overall Study|Withdrawal by Subject|8|||
150219942|NCT00696241|541939770|FG002|Overall Study|Withdrawal by Subject|6|||
150219943|NCT00696241|541939771|FG003|Overall Study|Withdrawal by Subject|1|||
150219944|NCT00696241|541939772|FG004|Overall Study|Withdrawal by Subject|0|||
150219945|NCT00696241|541939768|FG000|Overall Study|Lack of Efficacy|1|||
150219946|NCT00696241|541939769|FG001|Overall Study|Lack of Efficacy|5|||
150219947|NCT00696241|541939770|FG002|Overall Study|Lack of Efficacy|4|||
150219948|NCT00696241|541939771|FG003|Overall Study|Lack of Efficacy|5|||
150219949|NCT00696241|541939772|FG004|Overall Study|Lack of Efficacy|3|||
150219950|NCT00696241|541939768|FG000|Overall Study|Other|6|||
150219951|NCT00696241|541939769|FG001|Overall Study|Other|1|||
150219952|NCT00696241|541939770|FG002|Overall Study|Other|5|||
150219953|NCT00696241|541939771|FG003|Overall Study|Other|2|||
150219954|NCT00696241|541939772|FG004|Overall Study|Other|1|||
150219955|NCT02279732|541939773|FG000|Overall Study|Death|23|||
150219956|NCT02279732|541939774|FG001|Overall Study|Death|20|||
150219957|NCT02279732|541939773|FG000|Overall Study|Disease Progression|13|||
150219958|NCT02279732|541939774|FG001|Overall Study|Disease Progression|3|||
150219959|NCT02279732|541939773|FG000|Overall Study|Withdrawal by Subject|2|||
150219960|NCT02279732|541939774|FG001|Overall Study|Withdrawal by Subject|7|||
150219961|NCT02279732|541939773|FG000|Overall Study|Adverse Event|1|||
150219962|NCT02279732|541939774|FG001|Overall Study|Adverse Event|2|||
150219963|NCT02279732|541939773|FG000|Overall Study|Administrative Reason By Sponsor|0|||
150219964|NCT02279732|541939774|FG001|Overall Study|Administrative Reason By Sponsor|2|||
150219965|NCT02279732|541939773|FG000|Overall Study|Study Drug Toxicity|2|||
150219966|NCT02279732|541939774|FG001|Overall Study|Study Drug Toxicity|0|||
150219967|NCT02279732|541939773|FG000|Overall Study|Lost to Follow-up|0|||
150219968|NCT02279732|541939774|FG001|Overall Study|Lost to Follow-up|1|||
150219969|NCT02279732|541939773|FG000|Overall Study|Maximum Clinical Benefit|1|||
150219970|NCT02279732|541939774|FG001|Overall Study|Maximum Clinical Benefit|0|||
150219971|NCT02279732|541939773|FG000|Overall Study|Subject Requested to Discontinue|0|||
150219972|NCT02279732|541939774|FG001|Overall Study|Subject Requested to Discontinue|1|||
150219973|NCT02279732|541939773|FG000|Overall Study|Other|53|||
150219974|NCT02279732|541939774|FG001|Overall Study|Other|67|||
150219975|NCT02279732|541939773|FG000|Overall Study|Other|3|||
150219976|NCT02279732|541939774|FG001|Overall Study|Other|3|||
150219977|NCT03072862|541939777|FG000|Overall Study|Withdrawal by Subject|4|||
150219978|NCT03072862|541939777|FG000|Overall Study|Lost to Follow-up|6|||
150219979|NCT03072862|541939777|FG000|Overall Study|Protocol Violation|4|||
150219980|NCT03072862|541939777|FG000|Overall Study|Physician Decision|2|||
150219981|NCT03072862|541939777|FG000|Overall Study|Death|1|||
150219982|NCT03072862|541939777|FG000|Overall Study|Adverse Event|1|||
150219983|NCT02513667|541939778|FG000|Overall Study|Withdrawal by Subject|0|||
150219984|NCT02513667|541939779|FG001|Overall Study|Withdrawal by Subject|1|||
150219985|NCT01670526|541939786|FG000|Overall Study|Withdrawal by Subject|3|||
150219986|NCT01670526|541939787|FG001|Overall Study|Withdrawal by Subject|1|||
150219987|NCT01670526|541939786|FG000|Overall Study|Lost to Follow-up|9|||
150219988|NCT01670526|541939787|FG001|Overall Study|Lost to Follow-up|5|||
150219989|NCT00392197|541939788|FG000|Overall Study|Adverse Event|4|||
150219990|NCT00392197|541939789|FG001|Overall Study|Adverse Event|12|||
150219991|NCT00392197|541939788|FG000|Overall Study|Lack of Efficacy|3|||
150219992|NCT00392197|541939789|FG001|Overall Study|Lack of Efficacy|4|||
150219993|NCT00392197|541939788|FG000|Overall Study|Lost to Follow-up|0|||
150219994|NCT00392197|541939789|FG001|Overall Study|Lost to Follow-up|1|||
150219995|NCT00392197|541939788|FG000|Overall Study|Physician Decision|3|||
150219996|NCT00392197|541939789|FG001|Overall Study|Physician Decision|2|||
150219997|NCT00392197|541939788|FG000|Overall Study|Protocol Violation|7|||
150219998|NCT00392197|541939789|FG001|Overall Study|Protocol Violation|5|||
150219999|NCT00392197|541939788|FG000|Overall Study|Withdrawal by Subject|4|||
150220000|NCT00392197|541939789|FG001|Overall Study|Withdrawal by Subject|6|||
150220001|NCT01970527|541939790|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
150220002|NCT01970527|541939791|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
150220003|NCT01970527|541939790|FG000|Treatment|Disease progression|0|||
150220004|NCT01970527|541939791|FG001|Treatment|Disease progression|1|||
150220005|NCT01970527|541939790|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
150220006|NCT01970527|541939791|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
150220007|NCT01970527|541939790|FG000|Treatment|Death|0|||
150220008|NCT01970527|541939791|FG001|Treatment|Death|1|||
150220009|NCT01970527|541939790|FG000|Follow-up Clinic Visit|Disease progression|1|||
150220010|NCT01970527|541939791|FG001|Follow-up Clinic Visit|Disease progression|1|||
150220011|NCT01970527|541939790|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
150220012|NCT01970527|541939791|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
150220013|NCT01970527|541939790|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
150220014|NCT01970527|541939791|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
150220015|NCT03060525|541939792|FG000|Overall Study|moved out of state|1|||
150220016|NCT03060525|541939793|FG001|Overall Study|moved out of state|1|||
150220017|NCT03060525|541939794|FG002|Overall Study|moved out of state|1|||
150220018|NCT03060525|541939795|FG003|Overall Study|moved out of state|1|||
150220019|NCT03060525|541939792|FG000|Overall Study|unable to meet time commitment required of study|2|||
150220020|NCT03060525|541939793|FG001|Overall Study|unable to meet time commitment required of study|3|||
150220021|NCT03060525|541939794|FG002|Overall Study|unable to meet time commitment required of study|3|||
150220022|NCT03060525|541939795|FG003|Overall Study|unable to meet time commitment required of study|1|||
150220023|NCT03060525|541939792|FG000|Overall Study|no longer interested in doing intervention|0|||
150220024|NCT03060525|541939793|FG001|Overall Study|no longer interested in doing intervention|0|||
150220025|NCT03060525|541939794|FG002|Overall Study|no longer interested in doing intervention|0|||
150220026|NCT03060525|541939795|FG003|Overall Study|no longer interested in doing intervention|1|||
150220027|NCT02147093|541939796|FG000|Period 1|Lost to Follow-up|0|||
150220028|NCT02147093|541939797|FG001|Period 1|Lost to Follow-up|1|||
150220029|NCT02147093|541939796|FG000|Period 2|Protocol Violation|2|||
150220030|NCT02147093|541939797|FG001|Period 2|Protocol Violation|0|||
150220031|NCT01437540|541941658|FG000|Overall Study|Not listed below|7|||
150220032|NCT01437540|541941659|FG001|Overall Study|Not listed below|6|||
150220033|NCT01437540|541941658|FG000|Overall Study|COPD exacerbation|13|||
150220034|NCT01437540|541941659|FG001|Overall Study|COPD exacerbation|3|||
150220035|NCT01437540|541941658|FG000|Overall Study|Lost to Follow-up|3|||
150220036|NCT01437540|541941659|FG001|Overall Study|Lost to Follow-up|5|||
150220037|NCT01437540|541941658|FG000|Overall Study|Lack of Efficacy|23|||
150220038|NCT01437540|541941659|FG001|Overall Study|Lack of Efficacy|11|||
150220039|NCT01437540|541941658|FG000|Overall Study|Protocol Violation|24|||
150220040|NCT01437540|541941659|FG001|Overall Study|Protocol Violation|12|||
150220041|NCT01437540|541941658|FG000|Overall Study|Adverse Event|26|||
150220042|NCT01437540|541941659|FG001|Overall Study|Adverse Event|13|||
150220043|NCT01437540|541941658|FG000|Overall Study|Withdrawal by Subject|31|||
150220044|NCT01437540|541941659|FG001|Overall Study|Withdrawal by Subject|15|||
150220045|NCT00608959|541941665|FG000|Part 1|Did not meet eligibility criteria|1|||
150220046|NCT01416285|541941666|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
150220047|NCT01416285|541941667|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
150220048|NCT01005602|541941668|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
150220049|NCT01005602|541941669|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
150220050|NCT01248715|541941670|FG000|Overall Study|Not influenza positive|501|||
150220051|NCT01248715|541941671|FG001|Overall Study|Not influenza positive|510|||
150220052|NCT01919489|541941675|FG000|Overall Study|Rejected the need of injections|4|||
150220053|NCT01919489|541941676|FG001|Overall Study|Rejected the need of injections|7|||
150220054|NCT01919489|541941675|FG000|Overall Study|Adverse Event|10|||
150220055|NCT01919489|541941676|FG001|Overall Study|Adverse Event|0|||
150220056|NCT01919489|541941675|FG000|Overall Study|Hospital readmission|2|||
150220057|NCT01919489|541941676|FG001|Overall Study|Hospital readmission|9|||
150220058|NCT01919489|541941675|FG000|Overall Study|Death|2|||
150220059|NCT01919489|541941676|FG001|Overall Study|Death|1|||
150220060|NCT01919489|541941675|FG000|Overall Study|Lost to Follow-up|38|||
150220061|NCT01919489|541941676|FG001|Overall Study|Lost to Follow-up|27|||
150220062|NCT03761849|541941677|FG000|Overall Study|transferred to OpenLabelExtension|35|||
150220063|NCT03761849|541941678|FG001|Overall Study|transferred to OpenLabelExtension|34|||
150220064|NCT03761849|541941679|FG002|Overall Study|transferred to OpenLabelExtension|36|||
150220065|NCT03761849|541941680|FG003|Overall Study|transferred to OpenLabelExtension|0|||
150220066|NCT03761849|541941681|FG004|Overall Study|transferred to OpenLabelExtension|0|||
150220067|NCT03761849|541941682|FG005|Overall Study|transferred to OpenLabelExtension|0|||
150220068|NCT03761849|541941677|FG000|Overall Study|Adverse Event|1|||
150220069|NCT03761849|541941678|FG001|Overall Study|Adverse Event|0|||
150220070|NCT03761849|541941679|FG002|Overall Study|Adverse Event|0|||
150220071|NCT03761849|541941680|FG003|Overall Study|Adverse Event|0|||
150220072|NCT03761849|541941681|FG004|Overall Study|Adverse Event|2|||
150220073|NCT03761849|541941682|FG005|Overall Study|Adverse Event|3|||
150220074|NCT03761849|541941677|FG000|Overall Study|Withdrawal by Subject|0|||
150220075|NCT03761849|541941678|FG001|Overall Study|Withdrawal by Subject|0|||
150220076|NCT03761849|541941679|FG002|Overall Study|Withdrawal by Subject|0|||
150220077|NCT03761849|541941680|FG003|Overall Study|Withdrawal by Subject|41|||
150220078|NCT03761849|541941681|FG004|Overall Study|Withdrawal by Subject|43|||
150220079|NCT03761849|541941682|FG005|Overall Study|Withdrawal by Subject|35|||
150220080|NCT03761849|541941677|FG000|Overall Study|Lost to Follow-up|0|||
150220081|NCT03761849|541941678|FG001|Overall Study|Lost to Follow-up|1|||
150220082|NCT03761849|541941679|FG002|Overall Study|Lost to Follow-up|0|||
150220083|NCT03761849|541941680|FG003|Overall Study|Lost to Follow-up|2|||
150220084|NCT03761849|541941681|FG004|Overall Study|Lost to Follow-up|4|||
150220085|NCT03761849|541941682|FG005|Overall Study|Lost to Follow-up|5|||
150220086|NCT03761849|541941677|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
150220087|NCT03761849|541941678|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
150220088|NCT03761849|541941679|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
150220089|NCT03761849|541941680|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
150220090|NCT03761849|541941681|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
150220091|NCT03761849|541941682|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
150220092|NCT03761849|541941677|FG000|Overall Study|Physician Decision|0|||
150220093|NCT03761849|541941678|FG001|Overall Study|Physician Decision|0|||
150220094|NCT03761849|541941679|FG002|Overall Study|Physician Decision|0|||
150220095|NCT03761849|541941680|FG003|Overall Study|Physician Decision|1|||
150220096|NCT03761849|541941681|FG004|Overall Study|Physician Decision|4|||
150220097|NCT03761849|541941682|FG005|Overall Study|Physician Decision|4|||
150220098|NCT03761849|541941677|FG000|Overall Study|Death|0|||
150220099|NCT03761849|541941678|FG001|Overall Study|Death|0|||
150220100|NCT03761849|541941679|FG002|Overall Study|Death|0|||
150220101|NCT03761849|541941680|FG003|Overall Study|Death|1|||
150220102|NCT03761849|541941681|FG004|Overall Study|Death|1|||
150220103|NCT03761849|541941682|FG005|Overall Study|Death|3|||
150220104|NCT03761849|541941677|FG000|Overall Study|Protocol Violation|0|||
150220105|NCT03761849|541941678|FG001|Overall Study|Protocol Violation|0|||
150220106|NCT03761849|541941679|FG002|Overall Study|Protocol Violation|0|||
150220107|NCT03761849|541941680|FG003|Overall Study|Protocol Violation|2|||
150220108|NCT03761849|541941681|FG004|Overall Study|Protocol Violation|2|||
150220109|NCT03761849|541941682|FG005|Overall Study|Protocol Violation|1|||
150220110|NCT03761849|541941677|FG000|Overall Study|Participant could not come to site|0|||
150220111|NCT03761849|541941678|FG001|Overall Study|Participant could not come to site|0|||
150220112|NCT03761849|541941679|FG002|Overall Study|Participant could not come to site|0|||
150220113|NCT03761849|541941680|FG003|Overall Study|Participant could not come to site|0|||
150220114|NCT03761849|541941681|FG004|Overall Study|Participant could not come to site|1|||
150220115|NCT03761849|541941682|FG005|Overall Study|Participant could not come to site|0|||
150220116|NCT03761849|541941677|FG000|Overall Study|SF- safety Finding|0|||
150220117|NCT03761849|541941678|FG001|Overall Study|SF- safety Finding|0|||
150220118|NCT03761849|541941679|FG002|Overall Study|SF- safety Finding|0|||
150220119|NCT03761849|541941680|FG003|Overall Study|SF- safety Finding|0|||
150220120|NCT03761849|541941681|FG004|Overall Study|SF- safety Finding|0|||
150220121|NCT03761849|541941682|FG005|Overall Study|SF- safety Finding|1|||
150220122|NCT03761849|541941677|FG000|Overall Study|Patient did not attend visit|0|||
150220123|NCT03761849|541941678|FG001|Overall Study|Patient did not attend visit|0|||
150220124|NCT03761849|541941679|FG002|Overall Study|Patient did not attend visit|0|||
150220125|NCT03761849|541941680|FG003|Overall Study|Patient did not attend visit|0|||
150220126|NCT03761849|541941681|FG004|Overall Study|Patient did not attend visit|0|||
150220127|NCT03761849|541941682|FG005|Overall Study|Patient did not attend visit|1|||
150220128|NCT01131325|541941683|FG000|Overall Study|Adverse Event|1|||
150220129|NCT01131325|541941683|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
150220130|NCT03884478|541941684|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
150220131|NCT03884478|541941685|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
150220132|NCT03884478|541941686|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
150220133|NCT03884478|541941684|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
150220134|NCT03884478|541941685|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
150220135|NCT03884478|541941686|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
150220136|NCT03884478|541941684|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
150220137|NCT03884478|541941685|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
150220138|NCT03884478|541941686|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
150220139|NCT03884478|541941684|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
150220140|NCT03884478|541941685|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
150220141|NCT03884478|541941686|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
150220142|NCT01807234|541941687|FG000|Overall Study|Lost to Follow-up|2|||
150220143|NCT01807234|541941688|FG001|Overall Study|Lost to Follow-up|5|||
150220144|NCT01807234|541941689|FG002|Overall Study|Lost to Follow-up|1|||
150220145|NCT01807234|541941690|FG003|Overall Study|Lost to Follow-up|1|||
150220146|NCT01807234|541941691|FG004|Overall Study|Lost to Follow-up|1|||
150220147|NCT01807234|541941692|FG005|Overall Study|Lost to Follow-up|2|||
150220148|NCT01807234|541941687|FG000|Overall Study|Withdrawal by Subject|3|||
150220149|NCT01807234|541941688|FG001|Overall Study|Withdrawal by Subject|1|||
150220150|NCT01807234|541941689|FG002|Overall Study|Withdrawal by Subject|1|||
150220151|NCT01807234|541941690|FG003|Overall Study|Withdrawal by Subject|1|||
150220152|NCT01807234|541941691|FG004|Overall Study|Withdrawal by Subject|2|||
150220153|NCT01807234|541941692|FG005|Overall Study|Withdrawal by Subject|1|||
150220154|NCT01807234|541941687|FG000|Overall Study|Lack of Efficacy|0|||
150220155|NCT01807234|541941688|FG001|Overall Study|Lack of Efficacy|0|||
150220156|NCT01807234|541941689|FG002|Overall Study|Lack of Efficacy|0|||
150220157|NCT01807234|541941690|FG003|Overall Study|Lack of Efficacy|0|||
150220158|NCT01807234|541941691|FG004|Overall Study|Lack of Efficacy|1|||
150220159|NCT01807234|541941692|FG005|Overall Study|Lack of Efficacy|1|||
150220160|NCT01540474|541941693|FG000|Vaccination Period|Lost to Follow-up|0|||
150220161|NCT01540474|541941694|FG001|Vaccination Period|Lost to Follow-up|1|||
150220162|NCT01540474|541941695|FG002|Vaccination Period|Lost to Follow-up|0|||
150220163|NCT01540474|541941696|FG003|Vaccination Period|Lost to Follow-up|0|||
150220164|NCT00857311|541941697|FG000|Overall Study|Lost to Follow-up|1|||
150220165|NCT00857311|541941698|FG001|Overall Study|Lost to Follow-up|0|||
150220166|NCT00857311|541941699|FG002|Overall Study|Lost to Follow-up|0|||
150220167|NCT00857311|541941700|FG003|Overall Study|Lost to Follow-up|0|||
150220168|NCT00828139|541941701|FG000|Overall Study|Adverse Event|8|||
150220169|NCT00828139|541941702|FG001|Overall Study|Adverse Event|1|||
150220170|NCT00828139|541941703|FG002|Overall Study|Adverse Event|10|||
150220171|NCT00828139|541941704|FG003|Overall Study|Adverse Event|5|||
150220172|NCT00828139|541941701|FG000|Overall Study|Death|2|||
150220173|NCT00828139|541941702|FG001|Overall Study|Death|1|||
150220174|NCT00828139|541941703|FG002|Overall Study|Death|0|||
150220175|NCT00828139|541941704|FG003|Overall Study|Death|2|||
150220176|NCT00828139|541941701|FG000|Overall Study|Refusal unrelated to toxicity|3|||
150220177|NCT00828139|541941702|FG001|Overall Study|Refusal unrelated to toxicity|4|||
150220178|NCT00828139|541941703|FG002|Overall Study|Refusal unrelated to toxicity|5|||
150220179|NCT00828139|541941704|FG003|Overall Study|Refusal unrelated to toxicity|3|||
150220180|NCT00828139|541941701|FG000|Overall Study|Disease Progression|24|||
150220181|NCT00828139|541941702|FG001|Overall Study|Disease Progression|33|||
150220182|NCT00828139|541941703|FG002|Overall Study|Disease Progression|35|||
150220183|NCT00828139|541941704|FG003|Overall Study|Disease Progression|39|||
150220184|NCT00828139|541941701|FG000|Overall Study|Other|4|||
150220185|NCT00828139|541941702|FG001|Overall Study|Other|2|||
150220186|NCT00828139|541941703|FG002|Overall Study|Other|5|||
150220187|NCT00828139|541941704|FG003|Overall Study|Other|2|||
150220188|NCT01714947|541941705|FG000|Part B|Progressive Disease|3|||
150220189|NCT04271254|541941706|FG000|Overall Study|Withdrawal by Subject|3|||
150220190|NCT02068352|541941707|FG000|Overall Study|Lost to Follow-up|0|||
150220191|NCT02068352|541941708|FG001|Overall Study|Lost to Follow-up|2|||
150220192|NCT02068352|541941709|FG002|Overall Study|Lost to Follow-up|0|||
150220193|NCT02068352|541941707|FG000|Overall Study|Adverse Event|4|||
150220194|NCT02068352|541941708|FG001|Overall Study|Adverse Event|2|||
150220195|NCT02068352|541941709|FG002|Overall Study|Adverse Event|7|||
150220196|NCT02068352|541941707|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
150220197|NCT02068352|541941708|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
150220198|NCT02068352|541941709|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
150220199|NCT02068352|541941707|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
150220200|NCT02068352|541941708|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
150220201|NCT02068352|541941709|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
150220202|NCT02068352|541941707|FG000|Overall Study|Protocol Deviation|0|||
150220203|NCT02068352|541941708|FG001|Overall Study|Protocol Deviation|0|||
150220204|NCT02068352|541941709|FG002|Overall Study|Protocol Deviation|1|||
150220205|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
150220206|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
150220207|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
150220208|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
150220209|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
150220210|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
150220211|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
150220212|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
150220213|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
150220214|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
150220215|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150220216|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150220217|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150220218|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
150220219|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
150220220|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
150220221|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
150220222|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
150220223|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
150220224|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
150220225|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
150220226|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220227|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
150220228|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220229|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220230|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220231|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220232|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
150220233|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
150220234|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
150220235|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
150220236|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150220237|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150220238|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150220239|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
150220240|NCT03745651|541941713|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
150220241|NCT03745651|541941714|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
150220242|NCT03745651|541941715|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
150220243|NCT03745651|541941716|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
150220244|NCT03745651|541941717|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
150220245|NCT03745651|541941718|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
150220246|NCT03745651|541941719|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
150220247|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220248|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220249|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220250|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220251|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220252|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
150220253|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
150220254|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150220255|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150220256|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150220257|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
150220258|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
150220259|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
150220260|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
150220261|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
150220262|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
150220263|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
150220264|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
150220265|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
150220266|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
150220267|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
150220268|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
150220269|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
150220270|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
150220271|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
150220272|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
150220273|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
150220274|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
150220275|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
150220276|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
150220277|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
150220278|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
150220279|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
150220280|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
150220281|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
150220282|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220283|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220284|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220285|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220286|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220287|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
150220288|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
150220289|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
150220290|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
150220291|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
150220292|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
150220293|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
150220294|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
150220295|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
150220296|NCT03745651|541941713|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
150220297|NCT03745651|541941714|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
150220298|NCT03745651|541941715|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
150220299|NCT03745651|541941716|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
150220300|NCT03745651|541941717|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
150220301|NCT03745651|541941718|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
150220302|NCT03745651|541941719|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
150220303|NCT04175834|541941720|FG000|Overall Study|Withdrawal by Subject|1|||
150220304|NCT04175834|541941721|FG001|Overall Study|Withdrawal by Subject|0|||
150220305|NCT01322347|541941722|FG000|Overall Study|Adverse Event|7|||
150220306|NCT01322347|541941723|FG001|Overall Study|Adverse Event|2|||
150220307|NCT01322347|541941722|FG000|Overall Study|Death|5|||
150220308|NCT01322347|541941723|FG001|Overall Study|Death|3|||
150220309|NCT01322347|541941722|FG000|Overall Study|Physician Decision|2|||
150220310|NCT01322347|541941723|FG001|Overall Study|Physician Decision|1|||
150220311|NCT01322347|541941722|FG000|Overall Study|Protocol Violation|5|||
150220312|NCT01322347|541941723|FG001|Overall Study|Protocol Violation|2|||
150220313|NCT01322347|541941722|FG000|Overall Study|Withdrawal by Subject|1|||
150220314|NCT01322347|541941723|FG001|Overall Study|Withdrawal by Subject|4|||
150220315|NCT01322347|541941722|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
150220316|NCT01322347|541941723|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
150220317|NCT01322347|541941722|FG000|Overall Study|blood transfusion|5|||
150220318|NCT01322347|541941723|FG001|Overall Study|blood transfusion|5|||
150220319|NCT01322347|541941722|FG000|Overall Study|sponsor decision|1|||
150220320|NCT01322347|541941723|FG001|Overall Study|sponsor decision|3|||
150220321|NCT01322347|541941722|FG000|Overall Study|ineligible|6|||
150220322|NCT01322347|541941723|FG001|Overall Study|ineligible|3|||
150220323|NCT01322347|541941722|FG000|Overall Study|kidney transplant|3|||
150220324|NCT01322347|541941723|FG001|Overall Study|kidney transplant|1|||
150220325|NCT01322347|541941722|FG000|Overall Study|study drug withheld > 12 wks|0|||
150220326|NCT01322347|541941723|FG001|Overall Study|study drug withheld > 12 wks|1|||
150220327|NCT01322347|541941722|FG000|Overall Study|moved/changed dialysis|2|||
150220328|NCT01322347|541941723|FG001|Overall Study|moved/changed dialysis|4|||
150220329|NCT04883541|541941724|FG000|Overall Study|Not attending regular yoga class|16|||
150220330|NCT04883541|541941725|FG001|Overall Study|Not attending regular yoga class|0|||
150220331|NCT04883541|541941724|FG000|Overall Study|Not attending the pregnancy school|0|||
150220332|NCT04883541|541941725|FG001|Overall Study|Not attending the pregnancy school|9|||
150220333|NCT02823574|541941726|FG000|Randomization|Disease Progression|0|||
150220334|NCT02823574|541941727|FG001|Randomization|Disease Progression|0|||
150220335|NCT02823574|541941728|FG002|Randomization|Disease Progression|1|||
150220336|NCT02823574|541941729|FG003|Randomization|Disease Progression|0|||
150220337|NCT02823574|541941726|FG000|Randomization|AE unrelated to Study Drug|1|||
150220338|NCT02823574|541941727|FG001|Randomization|AE unrelated to Study Drug|0|||
150220339|NCT02823574|541941728|FG002|Randomization|AE unrelated to Study Drug|0|||
150220340|NCT02823574|541941729|FG003|Randomization|AE unrelated to Study Drug|0|||
150220341|NCT02823574|541941726|FG000|Treatment Period|Poor/Non Compliance|1|||
150220342|NCT02823574|541941727|FG001|Treatment Period|Poor/Non Compliance|0|||
150220343|NCT02823574|541941728|FG002|Treatment Period|Poor/Non Compliance|0|||
150220344|NCT02823574|541941729|FG003|Treatment Period|Poor/Non Compliance|1|||
150220345|NCT02823574|541941726|FG000|Treatment Period|Maximum Clinical Benefit|8|||
150220346|NCT02823574|541941727|FG001|Treatment Period|Maximum Clinical Benefit|4|||
150220347|NCT02823574|541941728|FG002|Treatment Period|Maximum Clinical Benefit|7|||
150220348|NCT02823574|541941729|FG003|Treatment Period|Maximum Clinical Benefit|1|||
150220349|NCT02823574|541941726|FG000|Treatment Period|Lost to Follow-up|1|||
150220350|NCT02823574|541941727|FG001|Treatment Period|Lost to Follow-up|1|||
150220351|NCT02823574|541941728|FG002|Treatment Period|Lost to Follow-up|0|||
150220352|NCT02823574|541941729|FG003|Treatment Period|Lost to Follow-up|0|||
150220353|NCT02823574|541941726|FG000|Treatment Period|Participant withdrew consent|4|||
150220354|NCT02823574|541941727|FG001|Treatment Period|Participant withdrew consent|0|||
150220355|NCT02823574|541941728|FG002|Treatment Period|Participant withdrew consent|0|||
150220356|NCT02823574|541941729|FG003|Treatment Period|Participant withdrew consent|1|||
150220357|NCT02823574|541941726|FG000|Treatment Period|Participant request to discontinue|5|||
150220358|NCT02823574|541941727|FG001|Treatment Period|Participant request to discontinue|0|||
150220359|NCT02823574|541941728|FG002|Treatment Period|Participant request to discontinue|3|||
150220360|NCT02823574|541941729|FG003|Treatment Period|Participant request to discontinue|2|||
150220361|NCT02823574|541941726|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
150220362|NCT02823574|541941727|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
150220363|NCT02823574|541941728|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
150220364|NCT02823574|541941729|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
150220365|NCT02823574|541941726|FG000|Treatment Period|Study Drug Toxicity|11|||
150220366|NCT02823574|541941727|FG001|Treatment Period|Study Drug Toxicity|2|||
150220367|NCT02823574|541941728|FG002|Treatment Period|Study Drug Toxicity|14|||
150220368|NCT02823574|541941729|FG003|Treatment Period|Study Drug Toxicity|4|||
150220369|NCT02823574|541941726|FG000|Treatment Period|Disease Progression|113|||
150220370|NCT02823574|541941727|FG001|Treatment Period|Disease Progression|64|||
150220371|NCT02823574|541941728|FG002|Treatment Period|Disease Progression|82|||
150220372|NCT02823574|541941729|FG003|Treatment Period|Disease Progression|43|||
150220373|NCT02823574|541941726|FG000|Treatment Period|Other reasons|5|||
150220374|NCT02823574|541941727|FG001|Treatment Period|Other reasons|9|||
150220375|NCT02823574|541941728|FG002|Treatment Period|Other reasons|3|||
150220376|NCT02823574|541941729|FG003|Treatment Period|Other reasons|6|||
150220377|NCT02823574|541941726|FG000|Treatment Period|Participant no longer meets study criteria|0|||
150220378|NCT02823574|541941727|FG001|Treatment Period|Participant no longer meets study criteria|0|||
150220379|NCT02823574|541941728|FG002|Treatment Period|Participant no longer meets study criteria|1|||
150220380|NCT02823574|541941729|FG003|Treatment Period|Participant no longer meets study criteria|0|||
150220381|NCT02823574|541941726|FG000|Treatment Period|Death|0|||
150220382|NCT02823574|541941727|FG001|Treatment Period|Death|0|||
150220383|NCT02823574|541941728|FG002|Treatment Period|Death|3|||
150220384|NCT02823574|541941729|FG003|Treatment Period|Death|1|||
150220385|NCT00590759|541941730|FG000|Overall Study|Death|52|||
150220386|NCT00590759|541941730|FG000|Overall Study|Lost to Follow-up|28|||
150220387|NCT02542696|541941735|FG000|Overall Study|Adverse Event|167|||
150220388|NCT02542696|541941735|FG000|Overall Study|Lack of Efficacy|26|||
150220389|NCT02542696|541941735|FG000|Overall Study|Lost to Follow-up|6|||
150220390|NCT02542696|541941735|FG000|Overall Study|Withdrawal by Subject|104|||
150220391|NCT02542696|541941735|FG000|Overall Study|Protocol Violation|5|||
150220392|NCT02542696|541941735|FG000|Overall Study|Death|8|||
150220393|NCT02542696|541941735|FG000|Overall Study|DECREASED OFF TIME|1|||
150220394|NCT02542696|541941735|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
150220395|NCT02542696|541941735|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
150220396|NCT02542696|541941735|FG000|Overall Study|MEDICAL HISTORY|1|||
150220397|NCT02542696|541941735|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
150220398|NCT02542696|541941735|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
150220399|NCT02542696|541941735|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
150220400|NCT02542696|541941735|FG000|Overall Study|SPONSOR DECISION|3|||
150220401|NCT02542696|541941735|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
150220402|NCT02542696|541941735|FG000|Overall Study|SUBJECT DECISION|2|||
150220403|NCT03693989|541941736|FG000|Overall Study|Protocol Violation|3|||
150220404|NCT03693989|541941737|FG001|Overall Study|Protocol Violation|4|||
150220405|NCT01190436|541941738|FG000|Overall Study|Lost to Follow-up|35|||
150220406|NCT01190436|541941738|FG000|Overall Study|Other|4|||
150220407|NCT02077374|541941739|FG000|Overall Study|Withdrawal by Subject|0|||
150220408|NCT02077374|541941740|FG001|Overall Study|Withdrawal by Subject|1|||
150220409|NCT02077374|541941739|FG000|Overall Study|Protocol Violation|0|||
150220410|NCT02077374|541941740|FG001|Overall Study|Protocol Violation|1|||
150220411|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
150220412|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
150220413|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
150220414|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
150220415|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
150220416|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Adverse Event|0|||
150220417|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Adverse Event|1|||
150220418|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Adverse Event|1|||
150220419|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Adverse Event|0|||
150220420|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Adverse Event|0|||
150220421|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
150220422|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
150220423|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
150220424|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
150220425|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
150220426|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Physician Decision|1|||
150220427|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Physician Decision|0|||
150220428|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Physician Decision|0|||
150220429|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Physician Decision|0|||
150220430|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Physician Decision|0|||
150220431|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
150220432|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
150220433|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
150220434|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
150220435|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
150220436|NCT00446095|541941741|FG000|Phase II (8 Weeks)|Ongoing|0|||
150220437|NCT00446095|541941742|FG001|Phase II (8 Weeks)|Ongoing|0|||
150220438|NCT00446095|541941743|FG002|Phase II (8 Weeks)|Ongoing|1|||
150220439|NCT00446095|541941744|FG003|Phase II (8 Weeks)|Ongoing|0|||
150220440|NCT00446095|541941745|FG004|Phase II (8 Weeks)|Ongoing|0|||
150220441|NCT00446095|541941741|FG000|Phase I (28 Days)|Adverse Event|0|||
150220442|NCT00446095|541941742|FG001|Phase I (28 Days)|Adverse Event|0|||
150220443|NCT00446095|541941743|FG002|Phase I (28 Days)|Adverse Event|0|||
150220444|NCT00446095|541941744|FG003|Phase I (28 Days)|Adverse Event|1|||
150220445|NCT00446095|541941745|FG004|Phase I (28 Days)|Adverse Event|0|||
150220446|NCT00446095|541941741|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
150220447|NCT00446095|541941742|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
150220448|NCT00446095|541941743|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
150220449|NCT00446095|541941744|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
150220450|NCT00446095|541941745|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
150220451|NCT00886834|541941749|FG000|Overall Study|Protocol Violation|0|||
150220452|NCT00886834|541941750|FG001|Overall Study|Protocol Violation|3|||
150220453|NCT00657709|541941751|FG000|Overall Study|AE or Death|7|||
150220454|NCT00657709|541941752|FG001|Overall Study|AE or Death|7|||
150220455|NCT00657709|541941753|FG002|Overall Study|AE or Death|6|||
150220456|NCT00657709|541941754|FG003|Overall Study|AE or Death|7|||
150220457|NCT00657709|541941755|FG004|Overall Study|AE or Death|1|||
150220458|NCT00657709|541941751|FG000|Overall Study|Withdrawal by Subject|7|||
150220459|NCT00657709|541941752|FG001|Overall Study|Withdrawal by Subject|15|||
150220460|NCT00657709|541941753|FG002|Overall Study|Withdrawal by Subject|15|||
150220461|NCT00657709|541941754|FG003|Overall Study|Withdrawal by Subject|5|||
150220462|NCT00657709|541941755|FG004|Overall Study|Withdrawal by Subject|9|||
150220463|NCT00657709|541941751|FG000|Overall Study|Lost to Follow-up|9|||
150220464|NCT00657709|541941752|FG001|Overall Study|Lost to Follow-up|9|||
150220465|NCT00657709|541941753|FG002|Overall Study|Lost to Follow-up|7|||
150220466|NCT00657709|541941754|FG003|Overall Study|Lost to Follow-up|1|||
150220467|NCT00657709|541941755|FG004|Overall Study|Lost to Follow-up|21|||
150220468|NCT00657709|541941751|FG000|Overall Study|Protocol Violation|0|||
150220469|NCT00657709|541941752|FG001|Overall Study|Protocol Violation|2|||
150220470|NCT00657709|541941753|FG002|Overall Study|Protocol Violation|0|||
150220471|NCT00657709|541941754|FG003|Overall Study|Protocol Violation|1|||
150220472|NCT00657709|541941755|FG004|Overall Study|Protocol Violation|2|||
150220473|NCT02574286|541941756|FG000|Overall Study|Adverse Event|3|||
150220474|NCT02574286|541941756|FG000|Overall Study|Withdrawal by Subject|2|||
150220475|NCT03875729|541941757|FG000|Overall Study|Adverse Event|0|||
150220476|NCT03875729|541941758|FG001|Overall Study|Adverse Event|5|||
150220477|NCT03875729|541941757|FG000|Overall Study|Withdrawal by Subject|8|||
150220478|NCT03875729|541941758|FG001|Overall Study|Withdrawal by Subject|11|||
150220479|NCT03875729|541941757|FG000|Overall Study|Pregnancy|0|||
150220480|NCT03875729|541941758|FG001|Overall Study|Pregnancy|1|||
150220481|NCT03875729|541941757|FG000|Overall Study|Lost to Follow-up|0|||
150220482|NCT03875729|541941758|FG001|Overall Study|Lost to Follow-up|5|||
150220483|NCT03875729|541941757|FG000|Overall Study|Personal reasons|2|||
150220484|NCT03875729|541941758|FG001|Overall Study|Personal reasons|0|||
150220485|NCT02764320|541941759|FG000|Overall Study|Withdrawal by Subject|35|||
150220486|NCT02764320|541941760|FG001|Overall Study|Withdrawal by Subject|38|||
150220487|NCT02764320|541941759|FG000|Overall Study|Protocol Violation|11|||
150220488|NCT02764320|541941760|FG001|Overall Study|Protocol Violation|6|||
150220489|NCT02764320|541941759|FG000|Overall Study|Adverse Event|2|||
150220490|NCT02764320|541941760|FG001|Overall Study|Adverse Event|0|||
150220491|NCT02764320|541941759|FG000|Overall Study|Health Issues unable to continue|2|||
150220492|NCT02764320|541941760|FG001|Overall Study|Health Issues unable to continue|0|||
150220493|NCT02764320|541941759|FG000|Overall Study|Did not meet inclusion criteria|1|||
150220494|NCT02764320|541941760|FG001|Overall Study|Did not meet inclusion criteria|0|||
150220495|NCT02764320|541941759|FG000|Overall Study|Subject moved|0|||
150220496|NCT02764320|541941760|FG001|Overall Study|Subject moved|2|||
150220497|NCT02764320|541941759|FG000|Overall Study|Overused medication unavailable|0|||
150220498|NCT02764320|541941760|FG001|Overall Study|Overused medication unavailable|1|||
150220499|NCT02764320|541941759|FG000|Overall Study|Seeking care outside site|0|||
150220500|NCT02764320|541941760|FG001|Overall Study|Seeking care outside site|1|||
150220501|NCT02764320|541941759|FG000|Overall Study|Technology barriers|0|||
150220502|NCT02764320|541941760|FG001|Overall Study|Technology barriers|1|||
150220503|NCT00753896|541941763|FG000|Overall Study|Adverse Event|4|||
150220504|NCT00753896|541941763|FG000|Overall Study|Death|1|||
150220505|NCT00753896|541941763|FG000|Overall Study|Lost to Follow-up|2|||
150220506|NCT00753896|541941763|FG000|Overall Study|Protocol Violation|1|||
150220507|NCT00753896|541941763|FG000|Overall Study|Withdrawal by Subject|4|||
150220508|NCT00753896|541941763|FG000|Overall Study|Entry Criteria Not Met|4|||
150220509|NCT01280656|541941764|FG000|Overall Study|Adverse Event|1|||
150220510|NCT01280656|541941765|FG001|Overall Study|Adverse Event|14|||
150220511|NCT01280656|541941766|FG002|Overall Study|Adverse Event|13|||
150220512|NCT01280656|541941764|FG000|Overall Study|Lack of Efficacy|1|||
150220513|NCT01280656|541941765|FG001|Overall Study|Lack of Efficacy|22|||
150220514|NCT01280656|541941766|FG002|Overall Study|Lack of Efficacy|38|||
150220515|NCT01280656|541941764|FG000|Overall Study|Treatment shortening (RGT)|0|||
150220516|NCT01280656|541941765|FG001|Overall Study|Treatment shortening (RGT)|4|||
150220517|NCT01280656|541941766|FG002|Overall Study|Treatment shortening (RGT)|5|||
150220518|NCT01280656|541941764|FG000|Overall Study|Other|1|||
150220519|NCT01280656|541941765|FG001|Overall Study|Other|7|||
150220520|NCT01280656|541941766|FG002|Overall Study|Other|7|||
150220521|NCT04085614|541941767|FG000|Overall Study|Protocol Violation|9|||
150220522|NCT04085614|541941768|FG001|Overall Study|Protocol Violation|6|||
150220523|NCT00952523|541941769|FG000|Overall Study|Withdrawal by Subject|7|||
150220524|NCT05265247|541941770|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
150220525|NCT05265247|541941771|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
150220526|NCT05265247|541941770|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
150220527|NCT05265247|541941771|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
150220528|NCT05265247|541941770|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
150220529|NCT05265247|541941771|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
150220530|NCT01029925|541941772|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
150220531|NCT01029925|541941772|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
150220532|NCT01029925|541941772|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
150220533|NCT02399449|541941773|FG000|Overall Study|Withdrawal by Subject|3|||
150220534|NCT02399449|541941774|FG001|Overall Study|Withdrawal by Subject|9|||
150220535|NCT02399449|541941773|FG000|Overall Study|Physician Decision|0|||
150220536|NCT02399449|541941774|FG001|Overall Study|Physician Decision|1|||
150220537|NCT02516202|541941775|FG000|Overall Study|Withdrawal by Subject|1|||
150220538|NCT02516202|541941776|FG001|Overall Study|Withdrawal by Subject|0|||
150220539|NCT02516202|541941777|FG002|Overall Study|Withdrawal by Subject|1|||
150220540|NCT02516202|541941775|FG000|Overall Study|Lost to Follow-up|1|||
150220541|NCT02516202|541941776|FG001|Overall Study|Lost to Follow-up|1|||
150220542|NCT02516202|541941777|FG002|Overall Study|Lost to Follow-up|1|||
150220543|NCT02516202|541941775|FG000|Overall Study|Stopped Follow-up|0|||
150220544|NCT02516202|541941776|FG001|Overall Study|Stopped Follow-up|0|||
150220545|NCT02516202|541941777|FG002|Overall Study|Stopped Follow-up|1|||
150220546|NCT02159352|541941780|FG000|Overall Study|Adverse Event|3|||
150220547|NCT02159352|541941781|FG001|Overall Study|Adverse Event|1|||
150220548|NCT02159352|541941780|FG000|Overall Study|Withdrawal by Subject|0|||
150220549|NCT02159352|541941781|FG001|Overall Study|Withdrawal by Subject|1|||
150220550|NCT01020435|541941782|FG000|Overall Study|Lost to Follow-up|0|||
150220551|NCT01020435|541941783|FG001|Overall Study|Lost to Follow-up|1|||
150220552|NCT03065400|541941784|FG000|Overall Study|Adverse Event|1|||
150220553|NCT03065400|541941784|FG000|Overall Study|Physician Decision|3|||
150220554|NCT03065400|541941784|FG000|Overall Study|Withdrawal by Subject|1|||
150220555|NCT03065400|541941784|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
150220556|NCT04749797|541941785|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
150220557|NCT04749797|541941786|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
150220558|NCT04749797|541941787|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
150220559|NCT00632736|541941788|FG000|Overall Study|Adverse Event|104|||
150220560|NCT00632736|541941788|FG000|Overall Study|Lost to Follow-up|15|||
150220561|NCT00632736|541941788|FG000|Overall Study|Protocol Violation|14|||
150220562|NCT00632736|541941788|FG000|Overall Study|Withdrawal by Subject|99|||
150220563|NCT00632736|541941788|FG000|Overall Study|Lack of Efficacy|5|||
150220564|NCT00632736|541941788|FG000|Overall Study|Sponsor terminated study|5|||
150220565|NCT00632736|541941788|FG000|Overall Study|Non-compliance|10|||
150220566|NCT00632736|541941788|FG000|Overall Study|Other|16|||
150220567|NCT00871715|541941789|FG000|Overall Study|Withdrawal by Subject|6|||
150220568|NCT00871715|541941790|FG001|Overall Study|Withdrawal by Subject|10|||
150220569|NCT00871715|541941791|FG002|Overall Study|Withdrawal by Subject|15|||
150220570|NCT00871715|541941789|FG000|Overall Study|Physician Decision|6|||
150220571|NCT00871715|541941790|FG001|Overall Study|Physician Decision|0|||
150220572|NCT00871715|541941791|FG002|Overall Study|Physician Decision|2|||
150220573|NCT00871715|541941789|FG000|Overall Study|Lost to Follow-up|3|||
150220574|NCT00871715|541941790|FG001|Overall Study|Lost to Follow-up|6|||
150220575|NCT00871715|541941791|FG002|Overall Study|Lost to Follow-up|9|||
150220576|NCT02189759|541941792|FG000|Overall Study|Lost to Follow-up|0|||
150220577|NCT02189759|541941793|FG001|Overall Study|Lost to Follow-up|0|||
150220578|NCT02189759|541941794|FG002|Overall Study|Lost to Follow-up|2|||
150220579|NCT02189759|541941795|FG003|Overall Study|Lost to Follow-up|5|||
150220580|NCT01147471|541941796|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
150220581|NCT01147471|541941797|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
150220582|NCT01147471|541941796|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
150220583|NCT01147471|541941797|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
150220584|NCT01147471|541941796|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
150220585|NCT01147471|541941797|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
150220586|NCT01147471|541941796|FG000|3 Month Follow Up|Lost to Follow-up|1|||
150220587|NCT01147471|541941797|FG001|3 Month Follow Up|Lost to Follow-up|1|||
150220588|NCT01147471|541941796|FG000|3 Month Follow Up|Physician Decision|0|||
150220589|NCT01147471|541941797|FG001|3 Month Follow Up|Physician Decision|1|||
150220590|NCT01147471|541941796|FG000|6 Month Follow Up|Lost to Follow-up|4|||
150220591|NCT01147471|541941797|FG001|6 Month Follow Up|Lost to Follow-up|2|||
150220592|NCT03890484|541941801|FG000|Overall Study|Lost to Follow-up|1|||
150220593|NCT03890484|541941802|FG001|Overall Study|Lost to Follow-up|1|||
150220594|NCT00518206|541941803|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
150220595|NCT00518206|541941804|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
150220596|NCT00518206|541941803|FG000|Overall Study|Withdrawal by Subject|2|||
150220597|NCT00518206|541941804|FG001|Overall Study|Withdrawal by Subject|0|||
150220598|NCT00518206|541941803|FG000|Overall Study|Drug Supply Issue|1|||
150220599|NCT00518206|541941804|FG001|Overall Study|Drug Supply Issue|0|||
150220600|NCT00518206|541941803|FG000|Overall Study|Reason Unknown|1|||
150220601|NCT00518206|541941804|FG001|Overall Study|Reason Unknown|0|||
150220602|NCT00518206|541941803|FG000|Overall Study|Completion Status Unknown|1|||
150220603|NCT00518206|541941804|FG001|Overall Study|Completion Status Unknown|0|||
150220604|NCT01294644|541941805|FG000|Overall Study|Adverse Event|2|||
150220605|NCT01294644|541941806|FG001|Overall Study|Adverse Event|0|||
150220606|NCT01294644|541941807|FG002|Overall Study|Adverse Event|1|||
150220607|NCT01294644|541941805|FG000|Overall Study|Withdrawal by Subject|3|||
150220608|NCT01294644|541941806|FG001|Overall Study|Withdrawal by Subject|7|||
150220609|NCT01294644|541941807|FG002|Overall Study|Withdrawal by Subject|4|||
150220610|NCT01294644|541941805|FG000|Overall Study|Lost to Follow-up|3|||
150220611|NCT01294644|541941806|FG001|Overall Study|Lost to Follow-up|2|||
150220612|NCT01294644|541941807|FG002|Overall Study|Lost to Follow-up|5|||
150220613|NCT01294644|541941805|FG000|Overall Study|Miscellaneous Reason|2|||
150220614|NCT01294644|541941806|FG001|Overall Study|Miscellaneous Reason|1|||
150220615|NCT01294644|541941807|FG002|Overall Study|Miscellaneous Reason|4|||
150220616|NCT02188459|541941808|FG000|Overall Study|Lost to Follow-up|3|||
150220617|NCT02188459|541941809|FG001|Overall Study|Lost to Follow-up|4|||
150220618|NCT02188459|541941808|FG000|Overall Study|Early Termination|0|||
150220619|NCT02188459|541941809|FG001|Overall Study|Early Termination|3|||
150220620|NCT02612285|541941810|FG000|Overall Study|Withdrawal by Subject|1|||
150220621|NCT02548585|541941811|FG000|Overall Study|Withdrawal by Subject|0|||
150220622|NCT02548585|541941812|FG001|Overall Study|Withdrawal by Subject|0|||
150220623|NCT02548585|541941813|FG002|Overall Study|Withdrawal by Subject|0|||
150220624|NCT02548585|541941814|FG003|Overall Study|Withdrawal by Subject|0|||
150220625|NCT02548585|541941815|FG004|Overall Study|Withdrawal by Subject|0|||
150220626|NCT02548585|541941816|FG005|Overall Study|Withdrawal by Subject|1|||
150220627|NCT02548585|541941817|FG006|Overall Study|Withdrawal by Subject|0|||
150220628|NCT02548585|541941811|FG000|Overall Study|Lost to Follow-up|1|||
150220629|NCT02548585|541941812|FG001|Overall Study|Lost to Follow-up|0|||
150220630|NCT02548585|541941813|FG002|Overall Study|Lost to Follow-up|0|||
150220631|NCT02548585|541941814|FG003|Overall Study|Lost to Follow-up|0|||
150220632|NCT02548585|541941815|FG004|Overall Study|Lost to Follow-up|0|||
150220633|NCT02548585|541941816|FG005|Overall Study|Lost to Follow-up|0|||
150220634|NCT02548585|541941817|FG006|Overall Study|Lost to Follow-up|0|||
150220635|NCT02548585|541941811|FG000|Overall Study|Other|1|||
150220636|NCT02548585|541941812|FG001|Overall Study|Other|0|||
150220637|NCT02548585|541941813|FG002|Overall Study|Other|0|||
150220638|NCT02548585|541941814|FG003|Overall Study|Other|2|||
150220639|NCT02548585|541941815|FG004|Overall Study|Other|3|||
150220640|NCT02548585|541941816|FG005|Overall Study|Other|0|||
150220641|NCT02548585|541941817|FG006|Overall Study|Other|1|||
150220642|NCT02548585|541941811|FG000|Overall Study|Randomized but not treated|0|||
150220643|NCT02548585|541941812|FG001|Overall Study|Randomized but not treated|0|||
150220644|NCT02548585|541941813|FG002|Overall Study|Randomized but not treated|0|||
150220645|NCT02548585|541941814|FG003|Overall Study|Randomized but not treated|0|||
150220646|NCT02548585|541941815|FG004|Overall Study|Randomized but not treated|0|||
150220647|NCT02548585|541941816|FG005|Overall Study|Randomized but not treated|1|||
150220648|NCT02548585|541941817|FG006|Overall Study|Randomized but not treated|0|||
150220649|NCT00853957|541941822|FG000|Overall Study|Adverse Event|9|||
150220650|NCT00853957|541941823|FG001|Overall Study|Adverse Event|3|||
150220651|NCT00853957|541941822|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150220652|NCT00853957|541941823|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150220653|NCT00853957|541941822|FG000|Overall Study|Subject withdrew consent|4|||
150220654|NCT00853957|541941823|FG001|Overall Study|Subject withdrew consent|5|||
150220655|NCT00853957|541941822|FG000|Overall Study|Lost to Follow-up|1|||
150220656|NCT00853957|541941823|FG001|Overall Study|Lost to Follow-up|6|||
150220657|NCT00853957|541941822|FG000|Overall Study|Protocol deviation|0|||
150220658|NCT00853957|541941823|FG001|Overall Study|Protocol deviation|3|||
150220659|NCT02942771|541941824|FG000|Overall Study|Adverse Event|1|||
150220660|NCT02942771|541941825|FG001|Overall Study|Adverse Event|0|||
150220661|NCT02942771|541941826|FG002|Overall Study|Adverse Event|0|||
150220662|NCT02942771|541941827|FG003|Overall Study|Adverse Event|0|||
150220663|NCT02942771|541941828|FG004|Overall Study|Adverse Event|2|||
150220664|NCT02942771|541941824|FG000|Overall Study|Lost to Follow-up|1|||
150220665|NCT02942771|541941825|FG001|Overall Study|Lost to Follow-up|0|||
150220666|NCT02942771|541941826|FG002|Overall Study|Lost to Follow-up|0|||
150220667|NCT02942771|541941827|FG003|Overall Study|Lost to Follow-up|0|||
150220668|NCT02942771|541941828|FG004|Overall Study|Lost to Follow-up|0|||
150220669|NCT02942771|541941824|FG000|Overall Study|Withdrawal by Subject|1|||
150220670|NCT02942771|541941825|FG001|Overall Study|Withdrawal by Subject|0|||
150220671|NCT02942771|541941826|FG002|Overall Study|Withdrawal by Subject|0|||
150220672|NCT02942771|541941827|FG003|Overall Study|Withdrawal by Subject|0|||
150220673|NCT02942771|541941828|FG004|Overall Study|Withdrawal by Subject|2|||
150220674|NCT01186809|541941829|FG000|Overall Study|Death|30|||
150220675|NCT04895085|541941830|FG000|Overall Study|Death|1|||
150220676|NCT04895085|541941830|FG000|Overall Study|Withdrawal by Subject|1|||
150220677|NCT04895085|541941830|FG000|Overall Study|No longer eligible: Moved from area|1|||
150220678|NCT04919499|541941835|FG000|Overall Study|Adverse Event|0|||
150220679|NCT04919499|541941836|FG001|Overall Study|Adverse Event|0|||
150220680|NCT04919499|541941837|FG002|Overall Study|Adverse Event|0|||
150220681|NCT04919499|541941838|FG003|Overall Study|Adverse Event|0|||
150220682|NCT04919499|541941839|FG004|Overall Study|Adverse Event|2|||
150220683|NCT04919499|541941835|FG000|Overall Study|Not treated|0|||
150220684|NCT04919499|541941836|FG001|Overall Study|Not treated|0|||
150220685|NCT04919499|541941837|FG002|Overall Study|Not treated|0|||
150220686|NCT04919499|541941838|FG003|Overall Study|Not treated|1|||
150220687|NCT04919499|541941839|FG004|Overall Study|Not treated|0|||
150220688|NCT00711555|541943216|FG000|Overall Study|Adverse Event|3|||
150220689|NCT02400749|541943220|FG000|Week 0 -16|Withdrawal by Subject|5|||
150220690|NCT02400749|541943221|FG001|Week 0 -16|Withdrawal by Subject|5|||
150220691|NCT02400749|541943220|FG000|Week 0 -16|Adverse Event|3|||
150220692|NCT02400749|541943221|FG001|Week 0 -16|Adverse Event|1|||
150220693|NCT02400749|541943220|FG000|Week 0 -16|Lost to Follow-up|2|||
150220694|NCT02400749|541943221|FG001|Week 0 -16|Lost to Follow-up|0|||
150220695|NCT02400749|541943220|FG000|Week 0 -16|Protocol Violation|1|||
150220696|NCT02400749|541943221|FG001|Week 0 -16|Protocol Violation|0|||
150220697|NCT02400749|541943220|FG000|Week 17 - 32|Withdrawal by Subject|3|||
150220698|NCT02400749|541943221|FG001|Week 17 - 32|Withdrawal by Subject|2|||
150220699|NCT02400749|541943220|FG000|Week 17 - 32|Adverse Event|2|||
150220700|NCT02400749|541943221|FG001|Week 17 - 32|Adverse Event|1|||
150220701|NCT00507429|541943222|FG000|Treatment Phase|Disease Progression|12|||
150220702|NCT00507429|541943223|FG001|Treatment Phase|Disease Progression|5|||
150220703|NCT00507429|541943222|FG000|Treatment Phase|Adverse Event|12|||
150220704|NCT00507429|541943223|FG001|Treatment Phase|Adverse Event|5|||
150220705|NCT00507429|541943222|FG000|Treatment Phase|Withdrawal by Subject|3|||
150220706|NCT00507429|541943223|FG001|Treatment Phase|Withdrawal by Subject|3|||
150220707|NCT00507429|541943222|FG000|Treatment Phase|Physician Decision|4|||
150220708|NCT00507429|541943223|FG001|Treatment Phase|Physician Decision|2|||
150220709|NCT00507429|541943222|FG000|Treatment Phase|Other|6|||
150220710|NCT00507429|541943223|FG001|Treatment Phase|Other|3|||
150220711|NCT00507429|541943222|FG000|Maintenance Phase|Progressive Disease|14|||
150220712|NCT00507429|541943223|FG001|Maintenance Phase|Progressive Disease|0|||
150220713|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
150220714|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
150220715|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
150220716|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
150220717|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
150220718|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
150220719|NCT03557307|541943228|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
150220720|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
150220721|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Death|3|||
150220722|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
150220723|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
150220724|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
150220725|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
150220726|NCT03557307|541943228|FG000|Period 2: Maintenance Phase|other|3|||
150220727|NCT03456856|541943232|FG000|Overall Study|Lost to Follow-up|2|||
150220728|NCT03456856|541943232|FG000|Overall Study|Withdrawal by Subject|1|||
150220729|NCT00113529|541943233|FG000|Overall Study|Adverse Event|4|||
150220730|NCT00113529|541943233|FG000|Overall Study|Lack of Efficacy|20|||
150220731|NCT00113529|541943233|FG000|Overall Study|Decision of sponsor|6|||
150220732|NCT00113529|541943233|FG000|Overall Study|Withdrawal by Subject|4|||
150220733|NCT00648895|541943234|FG000|Overall Study|Lack of Efficacy|0|||
150220734|NCT00648895|541943235|FG001|Overall Study|Lack of Efficacy|1|||
150220735|NCT01077284|541943238|FG000|Overall Study|Adverse Event|2|||
150220736|NCT01077284|541943239|FG001|Overall Study|Adverse Event|0|||
150220737|NCT01077284|541943240|FG002|Overall Study|Adverse Event|1|||
150220738|NCT01077284|541943238|FG000|Overall Study|Lost to Follow-up|1|||
150220739|NCT01077284|541943239|FG001|Overall Study|Lost to Follow-up|2|||
150220740|NCT01077284|541943240|FG002|Overall Study|Lost to Follow-up|0|||
150220741|NCT01077284|541943238|FG000|Overall Study|Withdrawal by Subject|2|||
150220742|NCT01077284|541943239|FG001|Overall Study|Withdrawal by Subject|3|||
150220743|NCT01077284|541943240|FG002|Overall Study|Withdrawal by Subject|1|||
150220744|NCT01077284|541943238|FG000|Overall Study|Other|0|||
150220745|NCT01077284|541943239|FG001|Overall Study|Other|0|||
150220746|NCT01077284|541943240|FG002|Overall Study|Other|1|||
150220747|NCT00096278|541943241|FG000|Overall Study|No follow-up data|15|||
150220748|NCT00096278|541943242|FG001|Overall Study|No follow-up data|18|||
150220749|NCT00096278|541943241|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
150220750|NCT00096278|541943242|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
150220751|NCT04626128|541943243|FG000|Overall Study|Withdrawal by Subject|0|||
150220752|NCT04626128|541943244|FG001|Overall Study|Withdrawal by Subject|1|||
150220753|NCT04626128|541943245|FG002|Overall Study|Withdrawal by Subject|0|||
150220754|NCT04626128|541943246|FG003|Overall Study|Withdrawal by Subject|0|||
150220755|NCT00841321|541943247|FG000|Overall Study|Lost to Follow-up|1|||
150220756|NCT00841321|541943248|FG001|Overall Study|Lost to Follow-up|1|||
150220757|NCT00841321|541943247|FG000|Overall Study|Adverse Event|0|||
150220758|NCT00841321|541943248|FG001|Overall Study|Adverse Event|2|||
150220759|NCT02632747|541943251|FG000|Wash-out Period|Adverse Event|1|||
150220760|NCT02632747|541943252|FG001|Wash-out Period|Adverse Event|0|||
150220761|NCT00379210|541943253|FG000|Overall Study|Withdrawal by Subject|10|||
150220762|NCT00379210|541943254|FG001|Overall Study|Withdrawal by Subject|7|||
150220763|NCT03444155|541943255|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
150220764|NCT03444155|541943256|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
150220765|NCT02991118|541943257|FG000|Overall Study|Death|3|||
150220766|NCT02991118|541943258|FG001|Overall Study|Death|8|||
150220767|NCT02991118|541943257|FG000|Overall Study|Protocol Violation|0|||
150220768|NCT02991118|541943258|FG001|Overall Study|Protocol Violation|3|||
150220769|NCT02991118|541943257|FG000|Overall Study|Physician Decision|0|||
150220770|NCT02991118|541943258|FG001|Overall Study|Physician Decision|1|||
150220771|NCT02991118|541943257|FG000|Overall Study|Moved out of the country|0|||
150220772|NCT02991118|541943258|FG001|Overall Study|Moved out of the country|1|||
150220773|NCT02991118|541943257|FG000|Overall Study|Adverse Event|2|||
150220774|NCT02991118|541943258|FG001|Overall Study|Adverse Event|2|||
150220775|NCT02991118|541943257|FG000|Overall Study|Withdrawal by Subject|1|||
150220776|NCT02991118|541943258|FG001|Overall Study|Withdrawal by Subject|7|||
150220777|NCT02991118|541943257|FG000|Overall Study|Could not attend study visits|0|||
150220778|NCT02991118|541943258|FG001|Overall Study|Could not attend study visits|1|||
150220779|NCT02991118|541943257|FG000|Overall Study|Lost to Follow-up|1|||
150220780|NCT02991118|541943258|FG001|Overall Study|Lost to Follow-up|9|||
150220781|NCT01000649|541943264|FG000|Overall Study|Adverse Event|5|||
150220782|NCT01000649|541943265|FG001|Overall Study|Adverse Event|1|||
150220783|NCT01000649|541943266|FG002|Overall Study|Adverse Event|2|||
150220784|NCT01000649|541943267|FG003|Overall Study|Adverse Event|4|||
150220785|NCT01000649|541943264|FG000|Overall Study|Lost to Follow-up|0|||
150220786|NCT01000649|541943265|FG001|Overall Study|Lost to Follow-up|2|||
150220787|NCT01000649|541943266|FG002|Overall Study|Lost to Follow-up|0|||
150220788|NCT01000649|541943267|FG003|Overall Study|Lost to Follow-up|2|||
150220789|NCT01856569|541943270|FG000|Overall Study|Other|1|||
150220790|NCT01856569|541943270|FG000|Overall Study|Changed Site/Structure|1|||
150220791|NCT01856569|541943270|FG000|Overall Study|Lost to Follow-up|3|||
150220792|NCT01856569|541943270|FG000|Overall Study|Did not met inclusion criteria|8|||
150220793|NCT01287832|541943271|FG000|Overall Study|Adverse Event|1|||
150220794|NCT01287832|541943272|FG001|Overall Study|Adverse Event|0|||
150220795|NCT01287832|541943271|FG000|Overall Study|Death|0|||
150220796|NCT01287832|541943272|FG001|Overall Study|Death|1|||
150220797|NCT01794689|541943273|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
150220798|NCT01794689|541943274|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
150220799|NCT01794689|541943275|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
150220800|NCT01794689|541943276|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
150220801|NCT01794689|541943273|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
150220802|NCT01794689|541943274|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
150220803|NCT01794689|541943275|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
150220804|NCT01794689|541943276|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
150220805|NCT01794689|541943273|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
150220806|NCT01794689|541943274|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
150220807|NCT01794689|541943275|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
150220808|NCT01794689|541943276|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
150220809|NCT01794689|541943273|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
150220810|NCT01794689|541943274|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
150220811|NCT01794689|541943275|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
150220812|NCT01794689|541943276|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
150220813|NCT00537914|541943277|FG000|Overall Study|Death|1|||
150220814|NCT00537914|541943277|FG000|Overall Study|Adverse Event|7|||
150220815|NCT00537914|541943277|FG000|Overall Study|Treatment failure|10|||
150220816|NCT00537914|541943277|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
150220817|NCT00537914|541943277|FG000|Overall Study|Lost to Follow-up|19|||
150220818|NCT00537914|541943277|FG000|Overall Study|Withdrawal of informed consent|59|||
150220819|NCT02312258|541943278|FG000|Overall Study|Lost to Follow-up|8|||
150220820|NCT02312258|541943279|FG001|Overall Study|Lost to Follow-up|8|||
150220821|NCT02312258|541943278|FG000|Overall Study|Withdrawal by Patient|49|||
150220822|NCT02312258|541943279|FG001|Overall Study|Withdrawal by Patient|76|||
150220823|NCT02312258|541943278|FG000|Overall Study|Reason not Specified|107|||
150220824|NCT02312258|541943279|FG001|Overall Study|Reason not Specified|159|||
150220825|NCT02312258|541943278|FG000|Overall Study|Missing|2|||
150220826|NCT02312258|541943279|FG001|Overall Study|Missing|1|||
150220827|NCT02312258|541943278|FG000|Overall Study|Death|115|||
150220828|NCT02312258|541943279|FG001|Overall Study|Death|181|||
150220829|NCT01697956|541943280|FG000|Overall Study|Protocol Violation|1|||
150220830|NCT01697956|541943281|FG001|Overall Study|Protocol Violation|1|||
150220831|NCT01964547|541943282|FG000|Overall Study|Adverse Event|8|||
150220832|NCT01964547|541943283|FG001|Overall Study|Adverse Event|2|||
150220833|NCT01964547|541943282|FG000|Overall Study|Withdrawal by Subject|4|||
150220834|NCT01964547|541943283|FG001|Overall Study|Withdrawal by Subject|7|||
150220835|NCT01964547|541943282|FG000|Overall Study|Lost to Follow-up|0|||
150220836|NCT01964547|541943283|FG001|Overall Study|Lost to Follow-up|1|||
150220837|NCT01964547|541943282|FG000|Overall Study|Withdrawal by Investigator|0|||
150220838|NCT01964547|541943283|FG001|Overall Study|Withdrawal by Investigator|1|||
150220839|NCT01115309|541943284|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
150220840|NCT01115309|541943284|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
150220841|NCT01115309|541943284|FG000|Long-term Follow-up|Lost to Follow-up|6|||
150220842|NCT05700851|541943285|FG000|Overall Study|Received a kidney transplant|1|||
150220843|NCT05700851|541943285|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
150220844|NCT05700851|541943285|FG000|Overall Study|Withdrawal by Subject|1|||
150220845|NCT03246724|541943286|FG000|Overall Study|Withdrawal by Subject|5|||
150220846|NCT03246724|541943287|FG001|Overall Study|Withdrawal by Subject|2|||
150220847|NCT03246724|541943288|FG002|Overall Study|Withdrawal by Subject|4|||
150220848|NCT03246724|541943289|FG003|Overall Study|Withdrawal by Subject|2|||
150220849|NCT03246724|541943286|FG000|Overall Study|Ineligible on day of surgery|7|||
150220850|NCT03246724|541943287|FG001|Overall Study|Ineligible on day of surgery|2|||
150220851|NCT03246724|541943288|FG002|Overall Study|Ineligible on day of surgery|0|||
150220852|NCT03246724|541943289|FG003|Overall Study|Ineligible on day of surgery|3|||
150220853|NCT03246724|541943286|FG000|Overall Study|Study completed before surgical date|2|||
150220854|NCT03246724|541943287|FG001|Overall Study|Study completed before surgical date|1|||
150220855|NCT03246724|541943288|FG002|Overall Study|Study completed before surgical date|8|||
150220856|NCT03246724|541943289|FG003|Overall Study|Study completed before surgical date|1|||
150220857|NCT03246724|541943286|FG000|Overall Study|Transferred to other arm|0|||
150220858|NCT03246724|541943287|FG001|Overall Study|Transferred to other arm|0|||
150220859|NCT03246724|541943288|FG002|Overall Study|Transferred to other arm|1|||
150220860|NCT03246724|541943289|FG003|Overall Study|Transferred to other arm|0|||
150220861|NCT03246724|541943286|FG000|Overall Study|Unable to obtain medication timely|0|||
150220862|NCT03246724|541943287|FG001|Overall Study|Unable to obtain medication timely|2|||
150220863|NCT03246724|541943288|FG002|Overall Study|Unable to obtain medication timely|2|||
150220864|NCT03246724|541943289|FG003|Overall Study|Unable to obtain medication timely|1|||
150220865|NCT03246724|541943286|FG000|Overall Study|Re-consented to participate|0|||
150220866|NCT03246724|541943287|FG001|Overall Study|Re-consented to participate|0|||
150220867|NCT03246724|541943288|FG002|Overall Study|Re-consented to participate|0|||
150220868|NCT03246724|541943289|FG003|Overall Study|Re-consented to participate|1|||
150220869|NCT02978716|541943290|FG000|Overall Study|Death|25|||
150220870|NCT02978716|541943291|FG001|Overall Study|Death|13|||
150220871|NCT02978716|541943292|FG002|Overall Study|Death|20|||
150220872|NCT02978716|541943290|FG000|Overall Study|Lost to Follow-up|0|||
150220873|NCT02978716|541943291|FG001|Overall Study|Lost to Follow-up|0|||
150220874|NCT02978716|541943292|FG002|Overall Study|Lost to Follow-up|1|||
150220875|NCT02978716|541943290|FG000|Overall Study|Withdrawal by Subject|6|||
150220876|NCT02978716|541943291|FG001|Overall Study|Withdrawal by Subject|4|||
150220877|NCT02978716|541943292|FG002|Overall Study|Withdrawal by Subject|5|||
150220878|NCT02978716|541943290|FG000|Overall Study|Sponsor terminated|2|||
150220879|NCT02978716|541943291|FG001|Overall Study|Sponsor terminated|13|||
150220880|NCT02978716|541943292|FG002|Overall Study|Sponsor terminated|9|||
150220881|NCT02978716|541943290|FG000|Overall Study|Other|1|||
150220882|NCT02978716|541943291|FG001|Overall Study|Other|3|||
150220883|NCT02978716|541943292|FG002|Overall Study|Other|0|||
150220884|NCT00589628|541943293|FG000|Overall Study|Lost to Follow-up|0|||
150220885|NCT00589628|541943294|FG001|Overall Study|Lost to Follow-up|1|||
150220886|NCT00689351|541943298|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
150220887|NCT00689351|541943299|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
150220888|NCT00689351|541943298|FG000|Infant Series of Dosing|Adverse Event|1|||
150220889|NCT00689351|541943299|FG001|Infant Series of Dosing|Adverse Event|0|||
150220890|NCT00689351|541943298|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
150220891|NCT00689351|541943299|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
150220892|NCT00689351|541943298|FG000|After Infant Series|Parent/legal guardian request|1|||
150220893|NCT00689351|541943299|FG001|After Infant Series|Parent/legal guardian request|0|||
150220894|NCT01766206|541943300|FG000|Overall Study|Withdrawal by Subject|22|||
150220895|NCT01766206|541943300|FG000|Overall Study|Lost to Follow-up|10|||
150220896|NCT01766206|541943300|FG000|Overall Study|Inappropriate enrollment|18|||
150220897|NCT01766206|541943300|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
150220898|NCT01662505|541943301|FG000|Overall Study|Progressive disease|6|||
150220899|NCT01662505|541943302|FG001|Overall Study|Progressive disease|1|||
150220900|NCT01662505|541943303|FG002|Overall Study|Progressive disease|5|||
150220901|NCT01662505|541943301|FG000|Overall Study|Refused cont. medication|0|||
150220902|NCT01662505|541943302|FG001|Overall Study|Refused cont. medication|0|||
150220903|NCT01662505|541943303|FG002|Overall Study|Refused cont. medication|1|||
150220904|NCT01662505|541943301|FG000|Overall Study|Not specified above|1|||
150220905|NCT01662505|541943302|FG001|Overall Study|Not specified above|3|||
150220906|NCT01662505|541943303|FG002|Overall Study|Not specified above|2|||
150220907|NCT01661972|541943306|FG000|Overall Study|Adverse Event|1|||
150220908|NCT01661972|541943307|FG001|Overall Study|Adverse Event|2|||
150220909|NCT01661972|541943306|FG000|Overall Study|Death during Treatment period|1|||
150220910|NCT01661972|541943307|FG001|Overall Study|Death during Treatment period|1|||
150220911|NCT01661972|541943306|FG000|Overall Study|Withdrawal by Subject|0|||
150220912|NCT01661972|541943307|FG001|Overall Study|Withdrawal by Subject|1|||
150220913|NCT01229176|541943308|FG000|Overall Study|Withdrawal by Subject|0|||
150220914|NCT01229176|541943309|FG001|Overall Study|Withdrawal by Subject|0|||
150220915|NCT01229176|541943310|FG002|Overall Study|Withdrawal by Subject|0|||
150220916|NCT01229176|541943311|FG003|Overall Study|Withdrawal by Subject|1|||
150220917|NCT01229176|541943312|FG004|Overall Study|Withdrawal by Subject|1|||
150220918|NCT01229176|541943313|FG005|Overall Study|Withdrawal by Subject|1|||
150220919|NCT01229176|541943314|FG006|Overall Study|Withdrawal by Subject|0|||
150220920|NCT01229176|541943315|FG007|Overall Study|Withdrawal by Subject|1|||
150220921|NCT01229176|541943308|FG000|Overall Study|Lost to Follow-up|0|||
150220922|NCT01229176|541943309|FG001|Overall Study|Lost to Follow-up|3|||
150220923|NCT01229176|541943310|FG002|Overall Study|Lost to Follow-up|0|||
150220924|NCT01229176|541943311|FG003|Overall Study|Lost to Follow-up|0|||
150220925|NCT01229176|541943312|FG004|Overall Study|Lost to Follow-up|1|||
150220926|NCT01229176|541943313|FG005|Overall Study|Lost to Follow-up|1|||
150220927|NCT01229176|541943314|FG006|Overall Study|Lost to Follow-up|0|||
150220928|NCT01229176|541943315|FG007|Overall Study|Lost to Follow-up|2|||
150220929|NCT03075878|541943316|FG000|Overall Study|Physician Decision|1|||
150220930|NCT00882050|541943321|FG000|Overall Study|Physician Decision|1|||
150220931|NCT00882050|541943322|FG001|Overall Study|Physician Decision|0|||
150220932|NCT00882050|541943323|FG002|Overall Study|Physician Decision|0|||
150220933|NCT01986348|541943324|FG000|Overall Study|Death|8|||
150220934|NCT01986348|541943325|FG001|Overall Study|Death|22|||
150220935|NCT01986348|541943326|FG002|Overall Study|Death|10|||
150220936|NCT01986348|541943327|FG003|Overall Study|Death|21|||
150220937|NCT01986348|541943324|FG000|Overall Study|Lost to Follow-up|0|||
150220938|NCT01986348|541943325|FG001|Overall Study|Lost to Follow-up|0|||
150220939|NCT01986348|541943326|FG002|Overall Study|Lost to Follow-up|0|||
150220940|NCT01986348|541943327|FG003|Overall Study|Lost to Follow-up|2|||
150220941|NCT01986348|541943324|FG000|Overall Study|Physician Decision|0|||
150220942|NCT01986348|541943325|FG001|Overall Study|Physician Decision|0|||
150220943|NCT01986348|541943326|FG002|Overall Study|Physician Decision|0|||
150220944|NCT01986348|541943327|FG003|Overall Study|Physician Decision|1|||
150220945|NCT01986348|541943324|FG000|Overall Study|Progressive Disease|0|||
150220946|NCT01986348|541943325|FG001|Overall Study|Progressive Disease|0|||
150220947|NCT01986348|541943326|FG002|Overall Study|Progressive Disease|2|||
150220948|NCT01986348|541943327|FG003|Overall Study|Progressive Disease|0|||
150220949|NCT01986348|541943324|FG000|Overall Study|Withdrawal by Participant|0|||
150220950|NCT01986348|541943325|FG001|Overall Study|Withdrawal by Participant|1|||
150220951|NCT01986348|541943326|FG002|Overall Study|Withdrawal by Participant|2|||
150220952|NCT01986348|541943327|FG003|Overall Study|Withdrawal by Participant|1|||
150220953|NCT01986348|541943324|FG000|Overall Study|Study Terminated by Sponsor|0|||
150220954|NCT01986348|541943325|FG001|Overall Study|Study Terminated by Sponsor|0|||
150220955|NCT01986348|541943326|FG002|Overall Study|Study Terminated by Sponsor|0|||
150220956|NCT01986348|541943327|FG003|Overall Study|Study Terminated by Sponsor|3|||
150220957|NCT01986348|541943324|FG000|Overall Study|Other-unspecified|0|||
150220958|NCT01986348|541943325|FG001|Overall Study|Other-unspecified|1|||
150220959|NCT01986348|541943326|FG002|Overall Study|Other-unspecified|0|||
150220960|NCT01986348|541943327|FG003|Overall Study|Other-unspecified|2|||
150220961|NCT02158806|541943329|FG000|Overall Study|Death|2|||
150220962|NCT02158806|541943330|FG001|Overall Study|Death|0|||
150220963|NCT02158806|541943329|FG000|Overall Study|Withdrawal by Subject|2|||
150220964|NCT02158806|541943330|FG001|Overall Study|Withdrawal by Subject|0|||
150220965|NCT02158806|541943329|FG000|Overall Study|Lost to Follow-up|0|||
150220966|NCT02158806|541943330|FG001|Overall Study|Lost to Follow-up|3|||
150220967|NCT02158806|541943329|FG000|Overall Study|Moved out of area|0|||
150220968|NCT02158806|541943330|FG001|Overall Study|Moved out of area|1|||
150220969|NCT02158806|541943329|FG000|Overall Study|Transferred to palliative care|0|||
150220970|NCT02158806|541943330|FG001|Overall Study|Transferred to palliative care|1|||
150220971|NCT01898299|541943331|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
150220972|NCT01898299|541943332|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
150220973|NCT02340806|541943333|FG000|Overall Study|Protocol Violation|2|||
150220974|NCT02340806|541943334|FG001|Overall Study|Protocol Violation|0|||
150220975|NCT02340806|541943333|FG000|Overall Study|epidural catheter replaced|2|||
150220976|NCT02340806|541943334|FG001|Overall Study|epidural catheter replaced|1|||
150220977|NCT02340806|541943333|FG000|Overall Study|history of chronic pain medication|1|||
150220978|NCT02340806|541943334|FG001|Overall Study|history of chronic pain medication|0|||
150220979|NCT02340806|541943333|FG000|Overall Study|re-dose < 90 min of CSE|1|||
150220980|NCT02340806|541943334|FG001|Overall Study|re-dose < 90 min of CSE|3|||
150220981|NCT01159600|541943336|FG000|Overall Study|Not treated|0|||
150220982|NCT01159600|541943337|FG001|Overall Study|Not treated|0|||
150220983|NCT01159600|541943338|FG002|Overall Study|Not treated|1|||
150220984|NCT01159600|541943339|FG003|Overall Study|Not treated|0|||
150220985|NCT01159600|541943340|FG004|Overall Study|Not treated|0|||
150220986|NCT01159600|541943341|FG005|Overall Study|Not treated|1|||
150220987|NCT01159600|541943342|FG006|Overall Study|Not treated|2|||
150220988|NCT01159600|541943343|FG007|Overall Study|Not treated|2|||
150220989|NCT01159600|541943336|FG000|Overall Study|Adverse Event|7|||
150220990|NCT01159600|541943337|FG001|Overall Study|Adverse Event|2|||
150220991|NCT01159600|541943338|FG002|Overall Study|Adverse Event|5|||
150220992|NCT01159600|541943339|FG003|Overall Study|Adverse Event|1|||
150220993|NCT01159600|541943340|FG004|Overall Study|Adverse Event|8|||
150220994|NCT01159600|541943341|FG005|Overall Study|Adverse Event|6|||
150220995|NCT01159600|541943342|FG006|Overall Study|Adverse Event|7|||
150220996|NCT01159600|541943343|FG007|Overall Study|Adverse Event|5|||
150220997|NCT01159600|541943336|FG000|Overall Study|Lack of Efficacy|0|||
150220998|NCT01159600|541943337|FG001|Overall Study|Lack of Efficacy|0|||
150220999|NCT01159600|541943338|FG002|Overall Study|Lack of Efficacy|0|||
150221000|NCT01159600|541943339|FG003|Overall Study|Lack of Efficacy|0|||
150221001|NCT01159600|541943340|FG004|Overall Study|Lack of Efficacy|2|||
150221002|NCT01159600|541943341|FG005|Overall Study|Lack of Efficacy|0|||
150221003|NCT01159600|541943342|FG006|Overall Study|Lack of Efficacy|0|||
150221004|NCT01159600|541943343|FG007|Overall Study|Lack of Efficacy|1|||
150221005|NCT01159600|541943336|FG000|Overall Study|Non compliant with protocol|2|||
150221006|NCT01159600|541943337|FG001|Overall Study|Non compliant with protocol|1|||
150221007|NCT01159600|541943338|FG002|Overall Study|Non compliant with protocol|0|||
150221008|NCT01159600|541943339|FG003|Overall Study|Non compliant with protocol|0|||
150221009|NCT01159600|541943340|FG004|Overall Study|Non compliant with protocol|2|||
150221010|NCT01159600|541943341|FG005|Overall Study|Non compliant with protocol|0|||
150221011|NCT01159600|541943342|FG006|Overall Study|Non compliant with protocol|2|||
150221012|NCT01159600|541943343|FG007|Overall Study|Non compliant with protocol|0|||
150221013|NCT01159600|541943336|FG000|Overall Study|Lost to Follow-up|2|||
150221014|NCT01159600|541943337|FG001|Overall Study|Lost to Follow-up|3|||
150221015|NCT01159600|541943338|FG002|Overall Study|Lost to Follow-up|4|||
150221016|NCT01159600|541943339|FG003|Overall Study|Lost to Follow-up|3|||
150221017|NCT01159600|541943340|FG004|Overall Study|Lost to Follow-up|3|||
150221018|NCT01159600|541943341|FG005|Overall Study|Lost to Follow-up|0|||
150221019|NCT01159600|541943342|FG006|Overall Study|Lost to Follow-up|3|||
150221020|NCT01159600|541943343|FG007|Overall Study|Lost to Follow-up|2|||
150221021|NCT01159600|541943336|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
150221022|NCT01159600|541943337|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
150221023|NCT01159600|541943338|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
150221024|NCT01159600|541943339|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
150221025|NCT01159600|541943340|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
150221026|NCT01159600|541943341|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
150221027|NCT01159600|541943342|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
150221028|NCT01159600|541943343|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
150221029|NCT01159600|541943336|FG000|Overall Study|Other reason not defined above|3|||
150221030|NCT01159600|541943337|FG001|Overall Study|Other reason not defined above|0|||
150221031|NCT01159600|541943338|FG002|Overall Study|Other reason not defined above|4|||
150221032|NCT01159600|541943339|FG003|Overall Study|Other reason not defined above|2|||
150221033|NCT01159600|541943340|FG004|Overall Study|Other reason not defined above|5|||
150221034|NCT01159600|541943341|FG005|Overall Study|Other reason not defined above|7|||
150221035|NCT01159600|541943342|FG006|Overall Study|Other reason not defined above|3|||
150221036|NCT01159600|541943343|FG007|Overall Study|Other reason not defined above|3|||
150221037|NCT00760877|541945162|FG000|Overall Study|Protocol Violation|1|||
150221038|NCT00760877|541945163|FG001|Overall Study|Protocol Violation|0|||
150221039|NCT00760877|541945162|FG000|Overall Study|Non-compliance with protocol treatment|2|||
150221040|NCT00760877|541945163|FG001|Overall Study|Non-compliance with protocol treatment|1|||
150221041|NCT00760877|541945162|FG000|Overall Study|Pregnancy|1|||
150221042|NCT00760877|541945163|FG001|Overall Study|Pregnancy|4|||
150221043|NCT00760877|541945162|FG000|Overall Study|Death|2|||
150221044|NCT00760877|541945163|FG001|Overall Study|Death|1|||
150221045|NCT00760877|541945162|FG000|Overall Study|Withdrawal by Subject|7|||
150221046|NCT00760877|541945163|FG001|Overall Study|Withdrawal by Subject|3|||
150221047|NCT00760877|541945162|FG000|Overall Study|Adverse Event|19|||
150221048|NCT00760877|541945163|FG001|Overall Study|Adverse Event|12|||
150221049|NCT00760877|541945162|FG000|Overall Study|Participant diagnosed with AML|0|||
150221050|NCT00760877|541945163|FG001|Overall Study|Participant diagnosed with AML|1|||
150221051|NCT00760877|541945162|FG000|Overall Study|Participant not eligible to cross-over|0|||
150221052|NCT00760877|541945163|FG001|Overall Study|Participant not eligible to cross-over|1|||
150221053|NCT00760877|541945162|FG000|Overall Study|Physician Decision|1|||
150221054|NCT00760877|541945163|FG001|Overall Study|Physician Decision|2|||
150221055|NCT00760877|541945162|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
150221056|NCT00760877|541945163|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
150221057|NCT00760877|541945162|FG000|Overall Study|Treatment failure|1|||
150221058|NCT00760877|541945163|FG001|Overall Study|Treatment failure|0|||
150221059|NCT04820023|541945168|FG000|Overall Study|Death|0|||
150221060|NCT04820023|541945169|FG001|Overall Study|Death|0|||
150221061|NCT04820023|541945170|FG002|Overall Study|Death|0|||
150221062|NCT04820023|541945171|FG003|Overall Study|Death|0|||
150221063|NCT04820023|541945172|FG004|Overall Study|Death|0|||
150221064|NCT04820023|541945173|FG005|Overall Study|Death|0|||
150221065|NCT04820023|541945174|FG006|Overall Study|Death|1|||
150221066|NCT04820023|541945175|FG007|Overall Study|Death|0|||
150221067|NCT04820023|541945176|FG008|Overall Study|Death|1|||
150221068|NCT04820023|541945168|FG000|Overall Study|Withdrawal by Subject|1|||
150221069|NCT04820023|541945169|FG001|Overall Study|Withdrawal by Subject|2|||
150141357|NCT01674621|541652049|FG001|Overall Study|Withdrawal by Subject|5|||
150141358|NCT01674621|541652050|FG002|Overall Study|Withdrawal by Subject|2|||
150141359|NCT01674621|541652051|FG003|Overall Study|Withdrawal by Subject|0|||
150141360|NCT01674621|541652052|FG004|Overall Study|Withdrawal by Subject|1|||
150141361|NCT01674621|541652048|FG000|Overall Study|Other than specified|0|||
150141362|NCT01674621|541652049|FG001|Overall Study|Other than specified|1|||
150141363|NCT01674621|541652050|FG002|Overall Study|Other than specified|0|||
150141364|NCT01674621|541652051|FG003|Overall Study|Other than specified|0|||
150141365|NCT01674621|541652052|FG004|Overall Study|Other than specified|2|||
150141366|NCT01148862|541652053|FG000|Second Intervention|Withdrawal by Subject|0|||
150141367|NCT01148862|541652054|FG001|Second Intervention|Withdrawal by Subject|2|||
150141368|NCT05031078|541652055|FG000|Overall Study|Withdrawal by Subject|0|||
150141369|NCT05031078|541652056|FG001|Overall Study|Withdrawal by Subject|1|||
150141370|NCT05031078|541652057|FG002|Overall Study|Withdrawal by Subject|0|||
150141371|NCT05398796|541652058|FG000|Overall Study|Participant moved from the area|0|||
150141372|NCT05398796|541652059|FG001|Overall Study|Participant moved from the area|1|||
150141373|NCT05398796|541652060|FG002|Overall Study|Participant moved from the area|0|||
150141374|NCT05398796|541652061|FG003|Overall Study|Participant moved from the area|0|||
150141375|NCT04270747|541652063|FG000|Through Week 16|Adverse Event|1|||
150141376|NCT04270747|541652064|FG001|Through Week 16|Adverse Event|2|||
150141377|NCT04270747|541652065|FG002|Through Week 16|Adverse Event|0|||
150141378|NCT04270747|541652063|FG000|Through Week 16|Death|0|||
150141379|NCT04270747|541652064|FG001|Through Week 16|Death|2|||
150141380|NCT04270747|541652065|FG002|Through Week 16|Death|0|||
150141381|NCT04270747|541652063|FG000|Through Week 16|Consent Withdrawn|3|||
150141382|NCT04270747|541652064|FG001|Through Week 16|Consent Withdrawn|3|||
150141383|NCT04270747|541652065|FG002|Through Week 16|Consent Withdrawn|0|||
150141384|NCT04270747|541652063|FG000|Through Week 16|Physician Decision|1|||
150141385|NCT04270747|541652064|FG001|Through Week 16|Physician Decision|1|||
150141386|NCT04270747|541652065|FG002|Through Week 16|Physician Decision|0|||
150141387|NCT04270747|541652063|FG000|Through Week 16|Lost to Follow-up|2|||
150141388|NCT04270747|541652064|FG001|Through Week 16|Lost to Follow-up|0|||
150221070|NCT04820023|541945170|FG002|Overall Study|Withdrawal by Subject|2|||
150221071|NCT04820023|541945171|FG003|Overall Study|Withdrawal by Subject|1|||
150221072|NCT04820023|541945172|FG004|Overall Study|Withdrawal by Subject|4|||
150221073|NCT04820023|541945173|FG005|Overall Study|Withdrawal by Subject|3|||
150221074|NCT04820023|541945174|FG006|Overall Study|Withdrawal by Subject|3|||
150221075|NCT04820023|541945175|FG007|Overall Study|Withdrawal by Subject|6|||
150221076|NCT04820023|541945176|FG008|Overall Study|Withdrawal by Subject|5|||
150221077|NCT04820023|541945168|FG000|Overall Study|Progressive Disease|3|||
150221078|NCT04820023|541945169|FG001|Overall Study|Progressive Disease|0|||
150221079|NCT04820023|541945170|FG002|Overall Study|Progressive Disease|2|||
150221080|NCT04820023|541945171|FG003|Overall Study|Progressive Disease|2|||
150221081|NCT04820023|541945172|FG004|Overall Study|Progressive Disease|2|||
150221082|NCT04820023|541945173|FG005|Overall Study|Progressive Disease|0|||
150221083|NCT04820023|541945174|FG006|Overall Study|Progressive Disease|1|||
150221084|NCT04820023|541945175|FG007|Overall Study|Progressive Disease|1|||
150221085|NCT04820023|541945176|FG008|Overall Study|Progressive Disease|0|||
150221086|NCT04820023|541945168|FG000|Overall Study|New anti-cancer therapy|0|||
150221087|NCT04820023|541945169|FG001|Overall Study|New anti-cancer therapy|0|||
150221088|NCT04820023|541945170|FG002|Overall Study|New anti-cancer therapy|0|||
150221089|NCT04820023|541945171|FG003|Overall Study|New anti-cancer therapy|0|||
150221090|NCT04820023|541945172|FG004|Overall Study|New anti-cancer therapy|2|||
150221091|NCT04820023|541945173|FG005|Overall Study|New anti-cancer therapy|0|||
150221092|NCT04820023|541945174|FG006|Overall Study|New anti-cancer therapy|0|||
150221093|NCT04820023|541945175|FG007|Overall Study|New anti-cancer therapy|0|||
150221094|NCT04820023|541945176|FG008|Overall Study|New anti-cancer therapy|0|||
150221095|NCT04820023|541945168|FG000|Overall Study|Other|0|||
150221096|NCT04820023|541945169|FG001|Overall Study|Other|1|||
150221097|NCT04820023|541945170|FG002|Overall Study|Other|0|||
150221098|NCT04820023|541945171|FG003|Overall Study|Other|0|||
150221099|NCT04820023|541945172|FG004|Overall Study|Other|0|||
150221100|NCT04820023|541945173|FG005|Overall Study|Other|0|||
150221101|NCT04820023|541945174|FG006|Overall Study|Other|0|||
150221102|NCT04820023|541945175|FG007|Overall Study|Other|2|||
150221103|NCT04820023|541945176|FG008|Overall Study|Other|0|||
150221104|NCT01945593|541945179|FG000|Overall Study|Adverse Event|0|||
150221105|NCT01945593|541945180|FG001|Overall Study|Adverse Event|0|||
150221106|NCT01945593|541945181|FG002|Overall Study|Adverse Event|0|||
150221107|NCT01945593|541945182|FG003|Overall Study|Adverse Event|5|||
150221108|NCT01945593|541945179|FG000|Overall Study|Physician Decision|0|||
150221109|NCT01945593|541945180|FG001|Overall Study|Physician Decision|0|||
150221110|NCT01945593|541945181|FG002|Overall Study|Physician Decision|1|||
150221111|NCT01945593|541945182|FG003|Overall Study|Physician Decision|1|||
150221112|NCT01945593|541945179|FG000|Overall Study|Withdrawal by Subject|0|||
150221113|NCT01945593|541945180|FG001|Overall Study|Withdrawal by Subject|2|||
150221114|NCT01945593|541945181|FG002|Overall Study|Withdrawal by Subject|0|||
150221115|NCT01945593|541945182|FG003|Overall Study|Withdrawal by Subject|4|||
150221116|NCT01945593|541945179|FG000|Overall Study|Protocol Violation|0|||
150221117|NCT01945593|541945180|FG001|Overall Study|Protocol Violation|2|||
150221118|NCT01945593|541945181|FG002|Overall Study|Protocol Violation|1|||
150221119|NCT01945593|541945182|FG003|Overall Study|Protocol Violation|3|||
150221120|NCT01945593|541945179|FG000|Overall Study|Death|0|||
150221121|NCT01945593|541945180|FG001|Overall Study|Death|0|||
150221122|NCT01945593|541945181|FG002|Overall Study|Death|1|||
150221123|NCT01945593|541945182|FG003|Overall Study|Death|0|||
150221124|NCT01945593|541945179|FG000|Overall Study|Other: Terminated|0|||
150221125|NCT01945593|541945180|FG001|Overall Study|Other: Terminated|0|||
150221126|NCT01945593|541945181|FG002|Overall Study|Other: Terminated|0|||
150221127|NCT01945593|541945182|FG003|Overall Study|Other: Terminated|1|||
150221128|NCT01945593|541945179|FG000|Overall Study|Other: Surgical Procedure|0|||
150221129|NCT01945593|541945180|FG001|Overall Study|Other: Surgical Procedure|2|||
150221130|NCT01945593|541945181|FG002|Overall Study|Other: Surgical Procedure|0|||
150221131|NCT01945593|541945182|FG003|Overall Study|Other: Surgical Procedure|6|||
150221132|NCT01945593|541945179|FG000|Overall Study|Other: Screen Failure|0|||
150221133|NCT01945593|541945180|FG001|Overall Study|Other: Screen Failure|2|||
150221134|NCT01945593|541945181|FG002|Overall Study|Other: Screen Failure|0|||
150221135|NCT01945593|541945182|FG003|Overall Study|Other: Screen Failure|0|||
150221136|NCT00228813|541945183|FG000|Overall Study|Death|4|||
150221137|NCT01279447|541945185|FG000|Overall Study|Lost to Follow-up|3|||
150221138|NCT01279447|541945186|FG001|Overall Study|Lost to Follow-up|1|||
150221139|NCT02213094|541945187|FG000|Overall Study|Adverse Event|1|||
150221140|NCT02213094|541945188|FG001|Overall Study|Adverse Event|0|||
150221141|NCT01074229|541945189|FG000|Overall Study|Lost to Follow-up|1|||
150221142|NCT01074229|541945190|FG001|Overall Study|Lost to Follow-up|0|||
150221143|NCT01074229|541945191|FG002|Overall Study|Lost to Follow-up|0|||
150221144|NCT01074229|541945189|FG000|Overall Study|Change to open surgical procedure|1|||
150221145|NCT01074229|541945190|FG001|Overall Study|Change to open surgical procedure|3|||
150221146|NCT01074229|541945191|FG002|Overall Study|Change to open surgical procedure|4|||
150221147|NCT02163499|541945192|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
150221148|NCT02163499|541945192|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
150221149|NCT02163499|541945192|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
150221150|NCT02163499|541945192|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
150221151|NCT02163499|541945192|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
150221152|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
150221153|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
150221154|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
150221155|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
150221156|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
150221157|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
150221158|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
150221159|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
150221160|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
150221161|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Death|8|||
150221162|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
150221163|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
150221164|NCT02163499|541945192|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
150221165|NCT01922102|541945193|FG000|Overall Study|Withdrawal by Subject|7|||
150221166|NCT01922102|541945194|FG001|Overall Study|Withdrawal by Subject|3|||
150221167|NCT01922102|541945195|FG002|Overall Study|Withdrawal by Subject|7|||
150221168|NCT01922102|541945193|FG000|Overall Study|Physician Decision|0|||
150221169|NCT01922102|541945194|FG001|Overall Study|Physician Decision|2|||
150221170|NCT01922102|541945195|FG002|Overall Study|Physician Decision|1|||
150221171|NCT01922102|541945193|FG000|Overall Study|Adverse Event|1|||
150221172|NCT01922102|541945194|FG001|Overall Study|Adverse Event|2|||
150221173|NCT01922102|541945195|FG002|Overall Study|Adverse Event|0|||
150221174|NCT01922102|541945193|FG000|Overall Study|Lost to Follow-up|1|||
150221175|NCT01922102|541945194|FG001|Overall Study|Lost to Follow-up|0|||
150221176|NCT01922102|541945195|FG002|Overall Study|Lost to Follow-up|0|||
150221177|NCT01922102|541945193|FG000|Overall Study|Administrative problems|0|||
150221178|NCT01922102|541945194|FG001|Overall Study|Administrative problems|2|||
150221179|NCT01922102|541945195|FG002|Overall Study|Administrative problems|0|||
150221180|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
150221181|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
150221182|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
150221183|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
150221184|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
150221185|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
150221186|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
150221187|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
150221188|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
150221189|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
150221190|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
150221191|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
150221192|NCT01345253|541945203|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
150221193|NCT01345253|541945204|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
150221194|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
150221195|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
150221196|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
150221197|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
150221198|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
150221199|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
150221200|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
150221201|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
150221202|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
150221203|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
150221204|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
150221205|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
150221206|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
150221207|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
150221208|NCT01345253|541945203|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
150221209|NCT01345253|541945204|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
150221210|NCT00476151|541945207|FG000|Overall Study|Adverse Event|0|||
150221211|NCT00476151|541945208|FG001|Overall Study|Adverse Event|2|||
150221212|NCT00476151|541945207|FG000|Overall Study|Protocol Violation|1|||
150221213|NCT00476151|541945208|FG001|Overall Study|Protocol Violation|3|||
150221214|NCT00476151|541945207|FG000|Overall Study|Withdrawal by Subject|2|||
150221215|NCT00476151|541945208|FG001|Overall Study|Withdrawal by Subject|0|||
150221216|NCT00476151|541945207|FG000|Overall Study|Physician Decision|0|||
150221217|NCT00476151|541945208|FG001|Overall Study|Physician Decision|2|||
150221218|NCT00447499|541945209|FG000|Overall Study|Adverse Event|1|||
150221219|NCT00447499|541945209|FG000|Overall Study|Patient Decision|4|||
150221220|NCT00447499|541945209|FG000|Overall Study|Sponsor Decision|1|||
150221221|NCT00447499|541945209|FG000|Overall Study|Physician Decision|1|||
150221222|NCT01767376|541945212|FG000|Overall Study|Lost to Follow-up|3|||
150221223|NCT01767376|541945213|FG001|Overall Study|Lost to Follow-up|2|||
150221224|NCT01767376|541945214|FG002|Overall Study|Lost to Follow-up|0|||
150221225|NCT01767376|541945212|FG000|Overall Study|Withdrawal by Subject|1|||
150221226|NCT01767376|541945213|FG001|Overall Study|Withdrawal by Subject|1|||
150221227|NCT01767376|541945214|FG002|Overall Study|Withdrawal by Subject|0|||
150221228|NCT00946088|541945215|FG000|Overall Study|Withdrawal by Subject|0|||
150221229|NCT00946088|541945216|FG001|Overall Study|Withdrawal by Subject|1|||
150221230|NCT04239911|541945217|FG000|Overall Study|Lost to Follow-up|2|||
150221231|NCT04239911|541945218|FG001|Overall Study|Lost to Follow-up|1|||
150221232|NCT01052272|541945220|FG000|Overall Study|Death|0|||
150221233|NCT01052272|541945221|FG001|Overall Study|Death|0|||
150221234|NCT01052272|541945222|FG002|Overall Study|Death|1|||
150221235|NCT01052272|541945223|FG003|Overall Study|Death|1|||
150221236|NCT01052272|541945220|FG000|Overall Study|Physician Decision|0|||
150221237|NCT01052272|541945221|FG001|Overall Study|Physician Decision|1|||
150221238|NCT01052272|541945222|FG002|Overall Study|Physician Decision|0|||
150221239|NCT01052272|541945223|FG003|Overall Study|Physician Decision|0|||
150221240|NCT01052272|541945220|FG000|Overall Study|patient refuses follow-up|5|||
150221241|NCT01052272|541945221|FG001|Overall Study|patient refuses follow-up|4|||
150221242|NCT01052272|541945222|FG002|Overall Study|patient refuses follow-up|2|||
150221243|NCT01052272|541945223|FG003|Overall Study|patient refuses follow-up|4|||
150221244|NCT01052272|541945220|FG000|Overall Study|Withdrawal by Subject|0|||
150221245|NCT01052272|541945221|FG001|Overall Study|Withdrawal by Subject|2|||
150221246|NCT01052272|541945222|FG002|Overall Study|Withdrawal by Subject|3|||
150221247|NCT01052272|541945223|FG003|Overall Study|Withdrawal by Subject|2|||
150221248|NCT01052272|541945220|FG000|Overall Study|placed in long-term care|0|||
150221249|NCT01052272|541945221|FG001|Overall Study|placed in long-term care|0|||
150221250|NCT01052272|541945222|FG002|Overall Study|placed in long-term care|1|||
150221251|NCT01052272|541945223|FG003|Overall Study|placed in long-term care|0|||
150221252|NCT01052272|541945220|FG000|Overall Study|decline in health|0|||
150221253|NCT01052272|541945221|FG001|Overall Study|decline in health|0|||
150221254|NCT01052272|541945222|FG002|Overall Study|decline in health|1|||
150221255|NCT01052272|541945223|FG003|Overall Study|decline in health|0|||
150221256|NCT04908488|541945226|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
150221257|NCT04908488|541945227|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
150221258|NCT04908488|541945226|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
150221259|NCT04908488|541945227|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
150221260|NCT01107912|541945228|FG000|Period 1|Adverse Event|0|||
150221261|NCT01107912|541945229|FG001|Period 1|Adverse Event|0|||
150221262|NCT01107912|541945230|FG002|Period 1|Adverse Event|0|||
150221263|NCT01107912|541945231|FG003|Period 1|Adverse Event|0|||
150221264|NCT01107912|541945232|FG004|Period 1|Adverse Event|2|||
150221265|NCT01107912|541945233|FG005|Period 1|Adverse Event|0|||
150221266|NCT01107912|541945228|FG000|Period 1|Physician Decision|0|||
150221267|NCT01107912|541945229|FG001|Period 1|Physician Decision|0|||
150221268|NCT01107912|541945230|FG002|Period 1|Physician Decision|0|||
150221269|NCT01107912|541945231|FG003|Period 1|Physician Decision|0|||
150221270|NCT01107912|541945232|FG004|Period 1|Physician Decision|1|||
150221271|NCT01107912|541945233|FG005|Period 1|Physician Decision|0|||
150221272|NCT01107912|541945228|FG000|Period 1|Withdrawal by Subject|1|||
150221273|NCT01107912|541945229|FG001|Period 1|Withdrawal by Subject|0|||
150221274|NCT01107912|541945230|FG002|Period 1|Withdrawal by Subject|0|||
150221275|NCT01107912|541945231|FG003|Period 1|Withdrawal by Subject|0|||
150221276|NCT01107912|541945232|FG004|Period 1|Withdrawal by Subject|0|||
150221277|NCT01107912|541945233|FG005|Period 1|Withdrawal by Subject|0|||
150221278|NCT01107912|541945228|FG000|Period 2|Physician Decision|0|||
150221279|NCT01107912|541945229|FG001|Period 2|Physician Decision|0|||
150221280|NCT01107912|541945230|FG002|Period 2|Physician Decision|1|||
150221281|NCT01107912|541945231|FG003|Period 2|Physician Decision|0|||
150221282|NCT01107912|541945232|FG004|Period 2|Physician Decision|0|||
150221283|NCT01107912|541945233|FG005|Period 2|Physician Decision|0|||
150221284|NCT01107912|541945228|FG000|Period 3|Adverse Event|0|||
150221285|NCT01107912|541945229|FG001|Period 3|Adverse Event|1|||
150221286|NCT01107912|541945230|FG002|Period 3|Adverse Event|1|||
150221287|NCT01107912|541945231|FG003|Period 3|Adverse Event|0|||
150221288|NCT01107912|541945232|FG004|Period 3|Adverse Event|0|||
150221289|NCT01107912|541945233|FG005|Period 3|Adverse Event|0|||
150221290|NCT01107912|541945228|FG000|Period 3|Withdrawal by Subject|0|||
150221291|NCT01107912|541945229|FG001|Period 3|Withdrawal by Subject|0|||
150221292|NCT01107912|541945230|FG002|Period 3|Withdrawal by Subject|0|||
150221293|NCT01107912|541945231|FG003|Period 3|Withdrawal by Subject|1|||
150221294|NCT01107912|541945232|FG004|Period 3|Withdrawal by Subject|0|||
150221295|NCT01107912|541945233|FG005|Period 3|Withdrawal by Subject|0|||
150221296|NCT01124916|541945238|FG000|Overall Study|Lost to Follow-up|3|||
150221297|NCT01124916|541945239|FG001|Overall Study|Lost to Follow-up|2|||
150221298|NCT00595959|541945246|FG000|Overall Study|Withdrawal by Subject|1|||
150221299|NCT00595959|541945246|FG000|Overall Study|Lost to Follow-up|1|||
150221300|NCT00963924|541945251|FG000|Overall Study|Adverse Event|1|||
150221301|NCT00963924|541945252|FG001|Overall Study|Adverse Event|0|||
150221302|NCT00963924|541945251|FG000|Overall Study|Withdrawal by Subject|0|||
150221303|NCT00963924|541945252|FG001|Overall Study|Withdrawal by Subject|1|||
150221304|NCT00963924|541945251|FG000|Overall Study|Changed antipsychotic|0|||
150221305|NCT00963924|541945252|FG001|Overall Study|Changed antipsychotic|1|||
150221306|NCT00963924|541945251|FG000|Overall Study|Lost to Follow-up|0|||
150221307|NCT00963924|541945252|FG001|Overall Study|Lost to Follow-up|1|||
150221308|NCT04765046|541945255|FG000|Overall Study|Screen Failure|2|||
150221309|NCT04765046|541945255|FG000|Overall Study|Withdrawal by Subject|4|||
150221310|NCT04765046|541945255|FG000|Overall Study|Physician Decision|4|||
150221311|NCT04765046|541945255|FG000|Overall Study|Surgery Cancelled|8|||
150221312|NCT02959866|541945256|FG000|Overall Study|Withdrawal by Subject|1|||
150221313|NCT03150589|541945257|FG000|Overall Study|Withdrawal by Subject|16|||
150221314|NCT03150589|541945258|FG001|Overall Study|Withdrawal by Subject|9|||
150221315|NCT03150589|541945257|FG000|Overall Study|Adverse Event|7|||
150221316|NCT03150589|541945258|FG001|Overall Study|Adverse Event|6|||
150221317|NCT03150589|541945257|FG000|Overall Study|Protocol Violation|4|||
150221318|NCT03150589|541945258|FG001|Overall Study|Protocol Violation|3|||
150221319|NCT03150589|541945257|FG000|Overall Study|Lost to Follow-up|3|||
150221320|NCT03150589|541945258|FG001|Overall Study|Lost to Follow-up|3|||
150221321|NCT03150589|541945257|FG000|Overall Study|Death|2|||
150221322|NCT03150589|541945258|FG001|Overall Study|Death|3|||
150221323|NCT03150589|541945257|FG000|Overall Study|IP non-compliance and other reasons|12|||
150221324|NCT03150589|541945258|FG001|Overall Study|IP non-compliance and other reasons|3|||
150221325|NCT03529942|541945259|FG000|Overall Study|Withdrawal by Subject|13|||
150221326|NCT03529942|541945259|FG000|Overall Study|Physician Decision|1|||
150221327|NCT03529942|541945259|FG000|Overall Study|Lost to Follow-up|7|||
150221328|NCT03529942|541945259|FG000|Overall Study|Needle inserted but no drug administered|1|||
150221329|NCT03529942|541945259|FG000|Overall Study|Personal reasons|1|||
150221330|NCT00476957|541945266|FG000|Overall Study|Lost to Follow-up|176|||
150221331|NCT00476957|541945267|FG001|Overall Study|Lost to Follow-up|193|||
150221332|NCT00409747|541945268|FG000|Overall Study|Withdrawal by Subject|1|||
150221333|NCT00636168|541945269|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
150221334|NCT00636168|541945270|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
150221335|NCT00636168|541945269|FG000|Randomized to Study Drug|Adverse Event|1|||
150221336|NCT00636168|541945270|FG001|Randomized to Study Drug|Adverse Event|0|||
150221337|NCT00636168|541945269|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
150221338|NCT00636168|541945270|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
150221339|NCT00636168|541945269|FG000|Treated With Study Drug|Recurrence of disease|135|||
150221340|NCT00636168|541945270|FG001|Treated With Study Drug|Recurrence of disease|282|||
150221341|NCT00636168|541945269|FG000|Treated With Study Drug|Adverse Event|250|||
150221342|NCT00636168|541945270|FG001|Treated With Study Drug|Adverse Event|22|||
150221343|NCT00636168|541945269|FG000|Treated With Study Drug|Participant withdrew consent|16|||
150221344|NCT00636168|541945270|FG001|Treated With Study Drug|Participant withdrew consent|21|||
150221345|NCT00636168|541945269|FG000|Treated With Study Drug|Poor/non-compliance|1|||
150221346|NCT00636168|541945270|FG001|Treated With Study Drug|Poor/non-compliance|3|||
150221347|NCT00636168|541945269|FG000|Treated With Study Drug|Death|3|||
150221348|NCT00636168|541945270|FG001|Treated With Study Drug|Death|0|||
150221349|NCT00636168|541945269|FG000|Treated With Study Drug|Pregnancy|1|||
150221350|NCT00636168|541945270|FG001|Treated With Study Drug|Pregnancy|0|||
150221351|NCT00636168|541945269|FG000|Treated With Study Drug|No longer meets study criteria|1|||
150221352|NCT00636168|541945270|FG001|Treated With Study Drug|No longer meets study criteria|0|||
150221353|NCT00636168|541945269|FG000|Treated With Study Drug|Other reason|1|||
150221354|NCT00636168|541945270|FG001|Treated With Study Drug|Other reason|3|||
150221355|NCT00636168|541945269|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
150221356|NCT00636168|541945270|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
150221357|NCT00636168|541945269|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
150221358|NCT00636168|541945270|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
150221359|NCT00636168|541945269|FG000|Long Term Follow-Up|Death|8|||
150221360|NCT00636168|541945270|FG001|Long Term Follow-Up|Death|9|||
150221361|NCT02006641|541945276|FG000|Overall Study|Withdrawal before treatment|2|||
150221362|NCT02006641|541945277|FG001|Overall Study|Withdrawal before treatment|5|||
150221363|NCT02006641|541945278|FG002|Overall Study|Withdrawal before treatment|3|||
150221364|NCT02006641|541945276|FG000|Overall Study|Adverse Event|15|||
150221365|NCT02006641|541945277|FG001|Overall Study|Adverse Event|11|||
150221366|NCT02006641|541945278|FG002|Overall Study|Adverse Event|15|||
150221367|NCT02006641|541945276|FG000|Overall Study|Protocol Violation|0|||
150221368|NCT02006641|541945277|FG001|Overall Study|Protocol Violation|2|||
150221369|NCT02006641|541945278|FG002|Overall Study|Protocol Violation|2|||
150221370|NCT02006641|541945276|FG000|Overall Study|Lost to Follow-up|0|||
150221371|NCT02006641|541945277|FG001|Overall Study|Lost to Follow-up|1|||
150221372|NCT02006641|541945278|FG002|Overall Study|Lost to Follow-up|0|||
150221373|NCT02006641|541945276|FG000|Overall Study|Withdrawal by Subject|7|||
150221374|NCT02006641|541945277|FG001|Overall Study|Withdrawal by Subject|12|||
150221375|NCT02006641|541945278|FG002|Overall Study|Withdrawal by Subject|11|||
150221376|NCT02006641|541945276|FG000|Overall Study|Other reason: patient didn't show up|1|||
150221377|NCT02006641|541945277|FG001|Overall Study|Other reason: patient didn't show up|0|||
150221378|NCT02006641|541945278|FG002|Overall Study|Other reason: patient didn't show up|0|||
150221379|NCT02006641|541945276|FG000|Overall Study|Other reason:patient didn't want to come|0|||
150221380|NCT02006641|541945277|FG001|Overall Study|Other reason:patient didn't want to come|0|||
150221381|NCT02006641|541945278|FG002|Overall Study|Other reason:patient didn't want to come|1|||
150221382|NCT02006641|541945276|FG000|Overall Study|Other reason: patient has moved|1|||
150221383|NCT02006641|541945277|FG001|Overall Study|Other reason: patient has moved|0|||
150221384|NCT02006641|541945278|FG002|Overall Study|Other reason: patient has moved|1|||
150221385|NCT02006641|541945276|FG000|Overall Study|Other reason: caregiver in hospital|0|||
150221386|NCT02006641|541945277|FG001|Overall Study|Other reason: caregiver in hospital|1|||
150221387|NCT02006641|541945278|FG002|Overall Study|Other reason: caregiver in hospital|0|||
150221388|NCT02006641|541945276|FG000|Overall Study|Other reason: patient's wife has died|0|||
150221389|NCT02006641|541945277|FG001|Overall Study|Other reason: patient's wife has died|0|||
150221390|NCT02006641|541945278|FG002|Overall Study|Other reason: patient's wife has died|1|||
150221391|NCT02006641|541945276|FG000|Overall Study|Other reason: hospitalisation|0|||
150221392|NCT02006641|541945277|FG001|Overall Study|Other reason: hospitalisation|1|||
150221393|NCT02006641|541945278|FG002|Overall Study|Other reason: hospitalisation|0|||
150221394|NCT02006641|541945276|FG000|Overall Study|Other reason: caregiver impossibility|0|||
150221395|NCT02006641|541945277|FG001|Overall Study|Other reason: caregiver impossibility|0|||
150221396|NCT02006641|541945278|FG002|Overall Study|Other reason: caregiver impossibility|1|||
150221397|NCT02006641|541945276|FG000|Overall Study|Other reason: protocol non-compliance|0|||
150221398|NCT02006641|541945277|FG001|Overall Study|Other reason: protocol non-compliance|0|||
150221399|NCT02006641|541945278|FG002|Overall Study|Other reason: protocol non-compliance|1|||
150221400|NCT02132195|541945279|FG000|Initial Assignment|Relapsed|14|||
150221401|NCT02132195|541945280|FG001|Initial Assignment|Relapsed|0|||
150221402|NCT02132195|541945281|FG002|Initial Assignment|Relapsed|0|||
150221403|NCT02132195|541945279|FG000|Rescue Therapy|Relapsed|0|||
150221404|NCT02132195|541945280|FG001|Rescue Therapy|Relapsed|0|||
150221405|NCT02132195|541945281|FG002|Rescue Therapy|Relapsed|7|||
150221406|NCT02132195|541945279|FG000|Rescue Therapy|Physician Decision|0|||
150221407|NCT02132195|541945280|FG001|Rescue Therapy|Physician Decision|0|||
150221408|NCT02132195|541945281|FG002|Rescue Therapy|Physician Decision|1|||
150221409|NCT02132195|541945279|FG000|Rescue Therapy|Withdrawal by Subject|0|||
150141389|NCT04270747|541652065|FG002|Through Week 16|Lost to Follow-up|0|||
150141390|NCT04270747|541652063|FG000|Through Week 16|Protocol Violation|1|||
150141391|NCT04270747|541652064|FG001|Through Week 16|Protocol Violation|2|||
150221410|NCT02132195|541945280|FG001|Rescue Therapy|Withdrawal by Subject|0|||
150221411|NCT02132195|541945281|FG002|Rescue Therapy|Withdrawal by Subject|1|||
150221412|NCT02132195|541945279|FG000|Rescue Therapy|Adverse Event|0|||
150221413|NCT02132195|541945280|FG001|Rescue Therapy|Adverse Event|0|||
150221414|NCT02132195|541945281|FG002|Rescue Therapy|Adverse Event|2|||
150221415|NCT03015220|541945282|FG000|Overall Study|Withdrawal by Subject|3|||
150221416|NCT03015220|541945283|FG001|Overall Study|Withdrawal by Subject|2|||
150221417|NCT03015220|541945284|FG002|Overall Study|Withdrawal by Subject|2|||
150221418|NCT03015220|541945285|FG003|Overall Study|Withdrawal by Subject|2|||
150221419|NCT03015220|541945282|FG000|Overall Study|Lost to Follow-up|0|||
150221420|NCT03015220|541945283|FG001|Overall Study|Lost to Follow-up|0|||
150221421|NCT03015220|541945284|FG002|Overall Study|Lost to Follow-up|1|||
150221422|NCT03015220|541945285|FG003|Overall Study|Lost to Follow-up|0|||
150221423|NCT00912964|541945286|FG000|Overall Study|Eligibility criterion not met|1|||
150221424|NCT00912964|541945287|FG001|Overall Study|Eligibility criterion not met|1|||
150221425|NCT00912964|541945288|FG002|Overall Study|Eligibility criterion not met|0|||
150221426|NCT00912964|541945286|FG000|Overall Study|Adverse Event|15|||
150221427|NCT00912964|541945287|FG001|Overall Study|Adverse Event|18|||
150221428|NCT00912964|541945288|FG002|Overall Study|Adverse Event|12|||
150221429|NCT00912964|541945286|FG000|Overall Study|Lack of Efficacy|11|||
150141392|NCT04270747|541652065|FG002|Through Week 16|Protocol Violation|0|||
150221430|NCT00912964|541945287|FG001|Overall Study|Lack of Efficacy|4|||
150221431|NCT00912964|541945288|FG002|Overall Study|Lack of Efficacy|3|||
150221432|NCT00912964|541945286|FG000|Overall Study|Withdrawal by Subject|20|||
150221433|NCT00912964|541945287|FG001|Overall Study|Withdrawal by Subject|12|||
150221434|NCT00912964|541945288|FG002|Overall Study|Withdrawal by Subject|18|||
150221435|NCT00912964|541945286|FG000|Overall Study|Lost to Follow-up|4|||
150221436|NCT00912964|541945287|FG001|Overall Study|Lost to Follow-up|3|||
150221437|NCT00912964|541945288|FG002|Overall Study|Lost to Follow-up|3|||
150221438|NCT00912964|541945286|FG000|Overall Study|Protocol Violation|5|||
150221439|NCT00912964|541945287|FG001|Overall Study|Protocol Violation|3|||
150221440|NCT00912964|541945288|FG002|Overall Study|Protocol Violation|8|||
150221441|NCT00912964|541945286|FG000|Overall Study|Taking exclusionary medications|7|||
150221442|NCT00912964|541945287|FG001|Overall Study|Taking exclusionary medications|4|||
150221443|NCT00912964|541945288|FG002|Overall Study|Taking exclusionary medications|8|||
150221444|NCT00912964|541945286|FG000|Overall Study|Medical History|1|||
150221445|NCT00912964|541945287|FG001|Overall Study|Medical History|0|||
150221446|NCT00912964|541945288|FG002|Overall Study|Medical History|0|||
150221447|NCT00912964|541945286|FG000|Overall Study|Non-compliance with study procedures|2|||
150221448|NCT00912964|541945287|FG001|Overall Study|Non-compliance with study procedures|0|||
150221449|NCT00912964|541945288|FG002|Overall Study|Non-compliance with study procedures|0|||
150221450|NCT00912964|541945286|FG000|Overall Study|Violation of exclusion criterion|0|||
150221451|NCT00912964|541945287|FG001|Overall Study|Violation of exclusion criterion|0|||
150221452|NCT00912964|541945288|FG002|Overall Study|Violation of exclusion criterion|2|||
150221453|NCT00912964|541945286|FG000|Overall Study|Randomized but never received study drug|0|||
150221454|NCT00912964|541945287|FG001|Overall Study|Randomized but never received study drug|1|||
150221455|NCT00912964|541945288|FG002|Overall Study|Randomized but never received study drug|0|||
150221456|NCT04447287|541945289|FG000|Period 1: Run-in Period|Adverse Event|3|||
150221457|NCT04447287|541945290|FG001|Period 1: Run-in Period|Adverse Event|0|||
150221458|NCT04447287|541945291|FG002|Period 1: Run-in Period|Adverse Event|0|||
150221459|NCT04447287|541945289|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
150221460|NCT04447287|541945290|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
150221461|NCT04447287|541945291|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
150221462|NCT04447287|541945289|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
150221463|NCT04447287|541945290|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
150221464|NCT04447287|541945291|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
150221465|NCT00655824|541945294|FG000|Overall Study|Adverse Event|3|||
150221466|NCT00655824|541945294|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
150221467|NCT00655824|541945294|FG000|Overall Study|Protocol Violation|1|||
150221468|NCT00655824|541945294|FG000|Overall Study|Withdrawal by Subject|4|||
150221469|NCT00655824|541945294|FG000|Overall Study|Deterioration of Trial Disease|2|||
150221470|NCT00960206|541945295|FG000|Overall Study|Death|7|||
150221471|NCT00960206|541945296|FG001|Overall Study|Death|4|||
150221472|NCT00960206|541945297|FG002|Overall Study|Death|1|||
150221473|NCT00960206|541945295|FG000|Overall Study|Unwilling/Unable to return|1|||
150221474|NCT00960206|541945296|FG001|Overall Study|Unwilling/Unable to return|2|||
150221475|NCT00960206|541945297|FG002|Overall Study|Unwilling/Unable to return|0|||
150221476|NCT00960206|541945295|FG000|Overall Study|Lost to Follow-up|8|||
150221477|NCT00960206|541945296|FG001|Overall Study|Lost to Follow-up|14|||
150221478|NCT00960206|541945297|FG002|Overall Study|Lost to Follow-up|8|||
150221479|NCT00960206|541945295|FG000|Overall Study|Withdrawal by Subject|2|||
150221480|NCT00960206|541945296|FG001|Overall Study|Withdrawal by Subject|4|||
150221481|NCT00960206|541945297|FG002|Overall Study|Withdrawal by Subject|0|||
150221482|NCT00960206|541945295|FG000|Overall Study|Revision of study component|2|||
150221483|NCT00960206|541945296|FG001|Overall Study|Revision of study component|2|||
150221484|NCT00960206|541945297|FG002|Overall Study|Revision of study component|2|||
150221485|NCT00960206|541945295|FG000|Overall Study|Missing 10 year data|20|||
150221486|NCT00960206|541945296|FG001|Overall Study|Missing 10 year data|1|||
150221487|NCT00960206|541945297|FG002|Overall Study|Missing 10 year data|1|||
150221488|NCT02470806|541945302|FG000|Overall Study|Lost to Follow-up|1|||
150221489|NCT02470806|541945303|FG001|Overall Study|Lost to Follow-up|1|||
150221490|NCT02470806|541945302|FG000|Overall Study|Adverse Event|5|||
150221491|NCT02470806|541945303|FG001|Overall Study|Adverse Event|2|||
150221492|NCT02470806|541945302|FG000|Overall Study|Protocol Violation|4|||
150221493|NCT02470806|541945303|FG001|Overall Study|Protocol Violation|11|||
150221494|NCT02470806|541945302|FG000|Overall Study|Physician Decision|0|||
150221495|NCT02470806|541945303|FG001|Overall Study|Physician Decision|3|||
150221496|NCT02470806|541945302|FG000|Overall Study|Withdrawal by Subject|3|||
150221497|NCT02470806|541945303|FG001|Overall Study|Withdrawal by Subject|10|||
150221498|NCT02470806|541945302|FG000|Overall Study|Lack of Efficacy|5|||
150221499|NCT02470806|541945303|FG001|Overall Study|Lack of Efficacy|15|||
150221500|NCT03032198|541945304|FG000|Overall Study|Screen Fail|1|||
150221501|NCT00866619|541945305|FG000|Overall Study|Adverse Event|112|||
150221502|NCT00866619|541945306|FG001|Overall Study|Adverse Event|106|||
150221503|NCT00866619|541945307|FG002|Overall Study|Adverse Event|47|||
150221504|NCT00866619|541945308|FG003|Overall Study|Adverse Event|44|||
150221505|NCT00866619|541945305|FG000|Overall Study|Protocol Violation|2|||
150221506|NCT00866619|541945306|FG001|Overall Study|Protocol Violation|39|||
150221507|NCT00866619|541945307|FG002|Overall Study|Protocol Violation|2|||
150221508|NCT00866619|541945308|FG003|Overall Study|Protocol Violation|17|||
150221509|NCT00866619|541945305|FG000|Overall Study|Withdrawal by Subject|587|||
150221510|NCT00866619|541945306|FG001|Overall Study|Withdrawal by Subject|295|||
150221511|NCT00866619|541945307|FG002|Overall Study|Withdrawal by Subject|272|||
150221512|NCT00866619|541945308|FG003|Overall Study|Withdrawal by Subject|144|||
150221513|NCT00866619|541945305|FG000|Overall Study|Lost to Follow-up|1145|||
150221514|NCT00866619|541945306|FG001|Overall Study|Lost to Follow-up|830|||
150221515|NCT00866619|541945307|FG002|Overall Study|Lost to Follow-up|568|||
150221516|NCT00866619|541945308|FG003|Overall Study|Lost to Follow-up|425|||
150221517|NCT02892019|541945310|FG000|Overall Study|randomized but not treated|0|||
150221518|NCT02892019|541945311|FG001|Overall Study|randomized but not treated|1|||
150221519|NCT02892019|541945310|FG000|Overall Study|Withdrawal by Subject|0|||
150221520|NCT02892019|541945311|FG001|Overall Study|Withdrawal by Subject|1|||
150221521|NCT02892019|541945310|FG000|Overall Study|Adverse Event|1|||
150221522|NCT02892019|541945311|FG001|Overall Study|Adverse Event|1|||
150221523|NCT01313663|541945312|FG000|Overall Study|Study Closed/Terminated|2|||
150221524|NCT01313663|541945313|FG001|Overall Study|Study Closed/Terminated|4|||
150221525|NCT01313663|541945312|FG000|Overall Study|Lost to Follow-up|0|||
150221526|NCT01313663|541945313|FG001|Overall Study|Lost to Follow-up|1|||
150221527|NCT01313663|541945312|FG000|Overall Study|Physician Decision|0|||
150221528|NCT01313663|541945313|FG001|Overall Study|Physician Decision|2|||
150221529|NCT01313663|541945312|FG000|Overall Study|Withdrawal by Subject|2|||
150221530|NCT01313663|541945313|FG001|Overall Study|Withdrawal by Subject|1|||
150221531|NCT02367794|541945314|FG000|Overall Study|Death|252|||
150221532|NCT02367794|541945315|FG001|Overall Study|Death|245|||
150221533|NCT02367794|541945316|FG002|Overall Study|Death|243|||
150221534|NCT02367794|541945314|FG000|Overall Study|Lost to Follow-up|1|||
150221535|NCT02367794|541945315|FG001|Overall Study|Lost to Follow-up|2|||
150221536|NCT02367794|541945316|FG002|Overall Study|Lost to Follow-up|2|||
150221537|NCT02367794|541945314|FG000|Overall Study|Physician Decision|0|||
150221538|NCT02367794|541945315|FG001|Overall Study|Physician Decision|5|||
150221539|NCT02367794|541945316|FG002|Overall Study|Physician Decision|3|||
150221540|NCT02367794|541945314|FG000|Overall Study|Protocol Violation|1|||
150221541|NCT02367794|541945315|FG001|Overall Study|Protocol Violation|0|||
150221542|NCT02367794|541945316|FG002|Overall Study|Protocol Violation|1|||
150141393|NCT04270747|541652063|FG000|Through Week 16|Protocol Specified Criteria|6|||
150141394|NCT04270747|541652064|FG001|Through Week 16|Protocol Specified Criteria|7|||
150141395|NCT04270747|541652065|FG002|Through Week 16|Protocol Specified Criteria|0|||
150141396|NCT04270747|541652063|FG000|Through Week 16|Miscellaneous|1|||
150141397|NCT04270747|541652064|FG001|Through Week 16|Miscellaneous|1|||
150141398|NCT04270747|541652065|FG002|Through Week 16|Miscellaneous|0|||
150141399|NCT04270747|541652063|FG000|Post Week 16|Adverse Event|7|||
150141400|NCT04270747|541652064|FG001|Post Week 16|Adverse Event|5|||
150141401|NCT04270747|541652065|FG002|Post Week 16|Adverse Event|1|||
150141402|NCT04270747|541652063|FG000|Post Week 16|Death|2|||
150141403|NCT04270747|541652064|FG001|Post Week 16|Death|0|||
150141404|NCT04270747|541652065|FG002|Post Week 16|Death|2|||
150141405|NCT04270747|541652063|FG000|Post Week 16|Consent Withdrawn|4|||
150141406|NCT04270747|541652064|FG001|Post Week 16|Consent Withdrawn|3|||
150141407|NCT04270747|541652065|FG002|Post Week 16|Consent Withdrawn|6|||
150141408|NCT04270747|541652063|FG000|Post Week 16|Physician Decision|3|||
150141409|NCT04270747|541652064|FG001|Post Week 16|Physician Decision|1|||
150141410|NCT04270747|541652065|FG002|Post Week 16|Physician Decision|1|||
150141411|NCT04270747|541652063|FG000|Post Week 16|Lost to Follow-up|2|||
150141412|NCT04270747|541652064|FG001|Post Week 16|Lost to Follow-up|1|||
150141413|NCT04270747|541652065|FG002|Post Week 16|Lost to Follow-up|0|||
150141414|NCT04270747|541652063|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
150141415|NCT04270747|541652064|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
150141416|NCT04270747|541652065|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
150141417|NCT04270747|541652063|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
150141418|NCT04270747|541652064|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
150141419|NCT04270747|541652065|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
150141420|NCT04270747|541652063|FG000|Post Week 16|Miscellaneous|1|||
150141421|NCT04270747|541652064|FG001|Post Week 16|Miscellaneous|0|||
150141422|NCT04270747|541652065|FG002|Post Week 16|Miscellaneous|1|||
150141423|NCT01784068|541652067|FG000|NTCS Phase|Adverse Event|5|||
150141424|NCT01784068|541652068|FG001|NTCS Phase|Adverse Event|0|||
150141425|NCT01784068|541652067|FG000|NTCS Phase|Physician Decision|2|||
150141426|NCT01784068|541652068|FG001|NTCS Phase|Physician Decision|0|||
150141427|NCT01784068|541652067|FG000|NTCS Phase|Patient/guardian decision|3|||
150141428|NCT01784068|541652068|FG001|NTCS Phase|Patient/guardian decision|0|||
150141429|NCT01784068|541652067|FG000|NTCS Phase|Death|2|||
150141430|NCT01784068|541652068|FG001|NTCS Phase|Death|0|||
150221543|NCT02367794|541945314|FG000|Overall Study|Withdrawal by Subject|25|||
150221544|NCT02367794|541945315|FG001|Overall Study|Withdrawal by Subject|12|||
150221545|NCT02367794|541945316|FG002|Overall Study|Withdrawal by Subject|20|||
150221546|NCT02367794|541945314|FG000|Overall Study|Brain metastasis|1|||
150221547|NCT02367794|541945315|FG001|Overall Study|Brain metastasis|0|||
150221548|NCT02367794|541945316|FG002|Overall Study|Brain metastasis|0|||
150141431|NCT01784068|541652067|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
150221549|NCT02367794|541945314|FG000|Overall Study|Randomized in error|0|||
150221550|NCT02367794|541945315|FG001|Overall Study|Randomized in error|0|||
150221551|NCT02367794|541945316|FG002|Overall Study|Randomized in error|1|||
150221552|NCT02367794|541945314|FG000|Overall Study|Patient unable to receive carboplatin|0|||
150221553|NCT02367794|541945315|FG001|Overall Study|Patient unable to receive carboplatin|0|||
150221554|NCT02367794|541945316|FG002|Overall Study|Patient unable to receive carboplatin|1|||
150221555|NCT02367794|541945314|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
150221556|NCT02367794|541945315|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
150221557|NCT02367794|541945316|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
150221558|NCT02367794|541945314|FG000|Overall Study|Adverse Event|0|||
150221559|NCT02367794|541945315|FG001|Overall Study|Adverse Event|0|||
150221560|NCT02367794|541945316|FG002|Overall Study|Adverse Event|2|||
150221561|NCT02367794|541945314|FG000|Overall Study|Study Terminated By Sponsor|0|||
150221562|NCT02367794|541945315|FG001|Overall Study|Study Terminated By Sponsor|1|||
150221563|NCT02367794|541945316|FG002|Overall Study|Study Terminated By Sponsor|1|||
150221564|NCT02367794|541945314|FG000|Overall Study|Moved to Roll-Over Study|0|||
150221565|NCT02367794|541945315|FG001|Overall Study|Moved to Roll-Over Study|15|||
150221566|NCT02367794|541945316|FG002|Overall Study|Moved to Roll-Over Study|13|||
150221567|NCT02367794|541945314|FG000|Overall Study|Sponsor Request|60|||
150221568|NCT02367794|541945315|FG001|Overall Study|Sponsor Request|57|||
150221569|NCT02367794|541945316|FG002|Overall Study|Sponsor Request|45|||
150221570|NCT02367794|541945314|FG000|Overall Study|Moved into PTAP Study|0|||
150221571|NCT02367794|541945315|FG001|Overall Study|Moved into PTAP Study|2|||
150221572|NCT02367794|541945316|FG002|Overall Study|Moved into PTAP Study|3|||
150221573|NCT02367794|541945314|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
150221574|NCT02367794|541945315|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
150221575|NCT02367794|541945316|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
150221576|NCT02367794|541945314|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
150221577|NCT02367794|541945315|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
150221578|NCT02367794|541945316|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
150221579|NCT02367794|541945314|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
150221580|NCT02367794|541945315|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
150221581|NCT02367794|541945316|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
150221582|NCT02367794|541945314|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
150221583|NCT02367794|541945315|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
150221584|NCT02367794|541945316|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
150221585|NCT00946998|541946484|FG000|Overall Study|Exited prior to first outcome assessment|5|||
150221586|NCT00946998|541946485|FG001|Overall Study|Exited prior to first outcome assessment|3|||
150221587|NCT01020487|541946490|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
150221588|NCT01020487|541946491|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
150221589|NCT01020487|541946492|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
150221590|NCT01020487|541946490|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
150221591|NCT01020487|541946491|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
150221592|NCT01020487|541946492|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
150221593|NCT01020487|541946490|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
150221594|NCT01020487|541946491|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
150221595|NCT01020487|541946492|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
150221596|NCT01020487|541946490|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
150221597|NCT01020487|541946491|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
150221598|NCT01020487|541946492|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
150221599|NCT01020487|541946490|FG000|Part 2 Open-label Period|Adverse Event|0|||
150221600|NCT01020487|541946491|FG001|Part 2 Open-label Period|Adverse Event|4|||
150221601|NCT01020487|541946492|FG002|Part 2 Open-label Period|Adverse Event|1|||
150221602|NCT00538629|541946507|FG000|Overall Study|At subject's request|1|||
150221603|NCT00538629|541946507|FG000|Overall Study|Adverse Event|2|||
150221604|NCT00538629|541946507|FG000|Overall Study|Lack of Efficacy|12|||
150221605|NCT00538629|541946507|FG000|Overall Study|Lost to Follow-up|6|||
150221606|NCT00538629|541946507|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
150221607|NCT00555620|541946515|FG000|Overall Study|Death|0|||
150221608|NCT00555620|541946516|FG001|Overall Study|Death|1|||
150221609|NCT00555620|541946517|FG002|Overall Study|Death|0|||
150221610|NCT00555620|541946518|FG003|Overall Study|Death|0|||
150221611|NCT00555620|541946519|FG004|Overall Study|Death|0|||
150221612|NCT00555620|541946520|FG005|Overall Study|Death|1|||
150221613|NCT00555620|541946515|FG000|Overall Study|Study terminated by sponsor|0|||
150221614|NCT00555620|541946516|FG001|Overall Study|Study terminated by sponsor|0|||
150221615|NCT00555620|541946517|FG002|Overall Study|Study terminated by sponsor|1|||
150221616|NCT00555620|541946518|FG003|Overall Study|Study terminated by sponsor|0|||
150221617|NCT00555620|541946519|FG004|Overall Study|Study terminated by sponsor|0|||
150221618|NCT00555620|541946520|FG005|Overall Study|Study terminated by sponsor|0|||
150221619|NCT00555620|541946515|FG000|Overall Study|Adverse Event|0|||
150221620|NCT00555620|541946516|FG001|Overall Study|Adverse Event|0|||
150221621|NCT00555620|541946517|FG002|Overall Study|Adverse Event|1|||
150221622|NCT00555620|541946518|FG003|Overall Study|Adverse Event|5|||
150221623|NCT00555620|541946519|FG004|Overall Study|Adverse Event|0|||
150221624|NCT00555620|541946520|FG005|Overall Study|Adverse Event|1|||
150221625|NCT00555620|541946515|FG000|Overall Study|Objective progression or relapse|6|||
150221626|NCT00555620|541946516|FG001|Overall Study|Objective progression or relapse|5|||
150221627|NCT00555620|541946517|FG002|Overall Study|Objective progression or relapse|12|||
150221628|NCT00555620|541946518|FG003|Overall Study|Objective progression or relapse|17|||
150221629|NCT00555620|541946519|FG004|Overall Study|Objective progression or relapse|3|||
150221630|NCT00555620|541946520|FG005|Overall Study|Objective progression or relapse|16|||
150221631|NCT00555620|541946515|FG000|Overall Study|Participant refused treatment|0|||
150221632|NCT00555620|541946516|FG001|Overall Study|Participant refused treatment|1|||
150221633|NCT00555620|541946517|FG002|Overall Study|Participant refused treatment|1|||
150221634|NCT00555620|541946518|FG003|Overall Study|Participant refused treatment|0|||
150221635|NCT00555620|541946519|FG004|Overall Study|Participant refused treatment|0|||
150221636|NCT00555620|541946520|FG005|Overall Study|Participant refused treatment|1|||
150221637|NCT00555620|541946515|FG000|Overall Study|Other|0|||
150221638|NCT00555620|541946516|FG001|Overall Study|Other|0|||
150221639|NCT00555620|541946517|FG002|Overall Study|Other|0|||
150221640|NCT00555620|541946518|FG003|Overall Study|Other|1|||
150141432|NCT01784068|541652068|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
150221641|NCT00555620|541946519|FG004|Overall Study|Other|0|||
150221642|NCT00555620|541946520|FG005|Overall Study|Other|3|||
150221643|NCT05203822|541946521|FG000|Overall Study|Adverse Event|1|||
150221644|NCT05203822|541946521|FG000|Overall Study|Withdrawal by Subject|1|||
150221645|NCT05361304|541946522|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
150221646|NCT05361304|541946523|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
150221647|NCT05361304|541946522|FG000|Overall Study|COVID-19 Related|1|||
150221648|NCT05361304|541946523|FG001|Overall Study|COVID-19 Related|2|||
150221649|NCT05361304|541946522|FG000|Overall Study|Withdrawal by Subject|1|||
150221650|NCT05361304|541946523|FG001|Overall Study|Withdrawal by Subject|0|||
150221651|NCT03320941|541946524|FG000|Overall Study|subject/guardian decision|0|||
150221652|NCT03320941|541946525|FG001|Overall Study|subject/guardian decision|0|||
150221653|NCT03320941|541946526|FG002|Overall Study|subject/guardian decision|0|||
150221654|NCT03320941|541946527|FG003|Overall Study|subject/guardian decision|1|||
150221655|NCT03320941|541946528|FG004|Overall Study|subject/guardian decision|0|||
150221656|NCT03360071|541946529|FG000|Overall Study|Lost to Follow-up|1|||
150221657|NCT03360071|541946530|FG001|Overall Study|Lost to Follow-up|0|||
150221658|NCT01193283|541946534|FG000|Overall Study|Death|1|||
150221659|NCT03184519|541946538|FG000|Overall Study|Lost to Follow-up|6|||
150221660|NCT03184519|541946538|FG000|Overall Study|Physician Decision|21|||
150221661|NCT01183013|541946539|FG000|Overall Study|Adverse Event|6|||
150221662|NCT01183013|541946540|FG001|Overall Study|Adverse Event|8|||
150221663|NCT01183013|541946541|FG002|Overall Study|Adverse Event|5|||
150221664|NCT01183013|541946542|FG003|Overall Study|Adverse Event|5|||
150221665|NCT01183013|541946543|FG004|Overall Study|Adverse Event|10|||
150221666|NCT01183013|541946544|FG005|Overall Study|Adverse Event|10|||
150221667|NCT01183013|541946545|FG006|Overall Study|Adverse Event|6|||
150221668|NCT01183013|541946539|FG000|Overall Study|Lack of Efficacy|3|||
150221669|NCT01183013|541946540|FG001|Overall Study|Lack of Efficacy|2|||
150221670|NCT01183013|541946541|FG002|Overall Study|Lack of Efficacy|1|||
150221671|NCT01183013|541946542|FG003|Overall Study|Lack of Efficacy|2|||
150221672|NCT01183013|541946543|FG004|Overall Study|Lack of Efficacy|1|||
150221673|NCT01183013|541946544|FG005|Overall Study|Lack of Efficacy|2|||
150221674|NCT01183013|541946545|FG006|Overall Study|Lack of Efficacy|0|||
150221675|NCT01183013|541946539|FG000|Overall Study|Protocol Violation|5|||
150221676|NCT01183013|541946540|FG001|Overall Study|Protocol Violation|2|||
150221677|NCT01183013|541946541|FG002|Overall Study|Protocol Violation|4|||
150221678|NCT01183013|541946542|FG003|Overall Study|Protocol Violation|0|||
150221679|NCT01183013|541946543|FG004|Overall Study|Protocol Violation|4|||
150221680|NCT01183013|541946544|FG005|Overall Study|Protocol Violation|3|||
150221681|NCT01183013|541946545|FG006|Overall Study|Protocol Violation|3|||
150221682|NCT01183013|541946539|FG000|Overall Study|Lost to Follow-up|7|||
150221683|NCT01183013|541946540|FG001|Overall Study|Lost to Follow-up|3|||
150221684|NCT01183013|541946541|FG002|Overall Study|Lost to Follow-up|4|||
150221685|NCT01183013|541946542|FG003|Overall Study|Lost to Follow-up|3|||
150221686|NCT01183013|541946543|FG004|Overall Study|Lost to Follow-up|2|||
150221687|NCT01183013|541946544|FG005|Overall Study|Lost to Follow-up|6|||
150221688|NCT01183013|541946545|FG006|Overall Study|Lost to Follow-up|5|||
150221689|NCT01183013|541946539|FG000|Overall Study|Withdrawal by Subject|9|||
150221690|NCT01183013|541946540|FG001|Overall Study|Withdrawal by Subject|13|||
150221691|NCT01183013|541946541|FG002|Overall Study|Withdrawal by Subject|10|||
150221692|NCT01183013|541946542|FG003|Overall Study|Withdrawal by Subject|8|||
150221693|NCT01183013|541946543|FG004|Overall Study|Withdrawal by Subject|7|||
150221694|NCT01183013|541946544|FG005|Overall Study|Withdrawal by Subject|9|||
150221695|NCT01183013|541946545|FG006|Overall Study|Withdrawal by Subject|10|||
150221696|NCT01183013|541946539|FG000|Overall Study|Reasons other than stated above|15|||
150221697|NCT01183013|541946540|FG001|Overall Study|Reasons other than stated above|11|||
150221698|NCT01183013|541946541|FG002|Overall Study|Reasons other than stated above|17|||
150221699|NCT01183013|541946542|FG003|Overall Study|Reasons other than stated above|12|||
150221700|NCT01183013|541946543|FG004|Overall Study|Reasons other than stated above|12|||
150221701|NCT01183013|541946544|FG005|Overall Study|Reasons other than stated above|15|||
150221702|NCT01183013|541946545|FG006|Overall Study|Reasons other than stated above|13|||
150221703|NCT00584909|541946547|FG000|Overall Study|Adverse Event|4|||
150221704|NCT03262389|541946548|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
150221705|NCT03262389|541946548|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
150221706|NCT03262389|541946548|FG000|Overall Study|opted out of PET/MR|1|||
150221707|NCT02865083|541946551|FG000|Overall Study|Early Termination|3|||
150221708|NCT02865083|541946552|FG001|Overall Study|Early Termination|1|||
150221709|NCT02105688|541946553|FG000|Part A: Double-Blind|Adverse Event|1|||
150221710|NCT02105688|541946554|FG001|Part A: Double-Blind|Adverse Event|0|||
150221711|NCT02105688|541946553|FG000|Part A: Double-Blind|Death|0|||
150221712|NCT02105688|541946554|FG001|Part A: Double-Blind|Death|1|||
150221713|NCT02105688|541946553|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
150221714|NCT02105688|541946554|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
150221715|NCT02105688|541946553|FG000|Part A: Double-Blind|Physician Decision|0|||
150221716|NCT02105688|541946554|FG001|Part A: Double-Blind|Physician Decision|1|||
150221717|NCT02105688|541946553|FG000|Part A: Double-Blind|Status Unknown|0|||
150221718|NCT02105688|541946554|FG001|Part A: Double-Blind|Status Unknown|2|||
150221719|NCT02105688|541946553|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
150221720|NCT02105688|541946554|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
150221721|NCT02105688|541946553|FG000|Part B: Observational Follow-up|Death|2|||
150221722|NCT02105688|541946554|FG001|Part B: Observational Follow-up|Death|1|||
150221723|NCT02105688|541946553|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
150221724|NCT02105688|541946554|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
150221725|NCT02105688|541946553|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
150221726|NCT02105688|541946554|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
150221727|NCT02105688|541946553|FG000|Part B: Observational Follow-up|Physician Decision|3|||
150221728|NCT02105688|541946554|FG001|Part B: Observational Follow-up|Physician Decision|1|||
150221729|NCT01358175|541946555|FG000|Overall Study|Death|1|||
150221730|NCT01358175|541946556|FG001|Overall Study|Death|0|||
150221731|NCT01358175|541946557|FG002|Overall Study|Death|1|||
150221732|NCT01358175|541946555|FG000|Overall Study|Withdrawal by Subject|9|||
150221733|NCT01358175|541946556|FG001|Overall Study|Withdrawal by Subject|5|||
150221734|NCT01358175|541946557|FG002|Overall Study|Withdrawal by Subject|10|||
150221735|NCT01358175|541946555|FG000|Overall Study|Technical issues|0|||
150221736|NCT01358175|541946556|FG001|Overall Study|Technical issues|1|||
150221737|NCT01358175|541946557|FG002|Overall Study|Technical issues|0|||
150221738|NCT01358175|541946555|FG000|Overall Study|Pregnancy|0|||
150221739|NCT01358175|541946556|FG001|Overall Study|Pregnancy|1|||
150221740|NCT01358175|541946557|FG002|Overall Study|Pregnancy|0|||
150221741|NCT01358175|541946555|FG000|Overall Study|Physician Decision|1|||
150221742|NCT01358175|541946556|FG001|Overall Study|Physician Decision|0|||
150221743|NCT01358175|541946557|FG002|Overall Study|Physician Decision|0|||
150221744|NCT01358175|541946555|FG000|Overall Study|Non Compliance with Study Treatment|0|||
150221745|NCT01358175|541946556|FG001|Overall Study|Non Compliance with Study Treatment|1|||
150221746|NCT01358175|541946557|FG002|Overall Study|Non Compliance with Study Treatment|1|||
150221747|NCT01358175|541946555|FG000|Overall Study|Lost to Follow-up|1|||
150221748|NCT01358175|541946556|FG001|Overall Study|Lost to Follow-up|1|||
150221749|NCT01358175|541946557|FG002|Overall Study|Lost to Follow-up|3|||
150221750|NCT01358175|541946555|FG000|Overall Study|Lack of Efficacy|3|||
150221751|NCT01358175|541946556|FG001|Overall Study|Lack of Efficacy|8|||
150221752|NCT01358175|541946557|FG002|Overall Study|Lack of Efficacy|6|||
150221753|NCT01358175|541946555|FG000|Overall Study|Adverse Event|6|||
150221754|NCT01358175|541946556|FG001|Overall Study|Adverse Event|11|||
150221755|NCT01358175|541946557|FG002|Overall Study|Adverse Event|11|||
150221756|NCT02469155|541946559|FG000|Overall Study|Adverse Event|6|||
150221757|NCT02469155|541946560|FG001|Overall Study|Adverse Event|0|||
150221758|NCT02469155|541946561|FG002|Overall Study|Adverse Event|1|||
150221759|NCT02469155|541946562|FG003|Overall Study|Adverse Event|10|||
150221760|NCT02469155|541946559|FG000|Overall Study|Lack of Efficacy|13|||
150221761|NCT02469155|541946560|FG001|Overall Study|Lack of Efficacy|10|||
150221762|NCT02469155|541946561|FG002|Overall Study|Lack of Efficacy|10|||
150221763|NCT02469155|541946562|FG003|Overall Study|Lack of Efficacy|8|||
150221764|NCT02469155|541946559|FG000|Overall Study|Death|0|||
150221765|NCT02469155|541946560|FG001|Overall Study|Death|0|||
150221766|NCT02469155|541946561|FG002|Overall Study|Death|0|||
150221767|NCT02469155|541946562|FG003|Overall Study|Death|1|||
150221768|NCT02469155|541946559|FG000|Overall Study|Lost to Follow-up|5|||
150221769|NCT02469155|541946560|FG001|Overall Study|Lost to Follow-up|2|||
150221770|NCT02469155|541946561|FG002|Overall Study|Lost to Follow-up|7|||
150221771|NCT02469155|541946562|FG003|Overall Study|Lost to Follow-up|2|||
150221772|NCT02469155|541946559|FG000|Overall Study|Physician Decision|0|||
150221773|NCT02469155|541946560|FG001|Overall Study|Physician Decision|0|||
150221774|NCT02469155|541946561|FG002|Overall Study|Physician Decision|1|||
150221775|NCT02469155|541946562|FG003|Overall Study|Physician Decision|0|||
150221776|NCT02469155|541946559|FG000|Overall Study|Withdrawal by Subject|34|||
150221777|NCT02469155|541946560|FG001|Overall Study|Withdrawal by Subject|30|||
150221778|NCT02469155|541946561|FG002|Overall Study|Withdrawal by Subject|20|||
150221779|NCT02469155|541946562|FG003|Overall Study|Withdrawal by Subject|37|||
150221780|NCT02469155|541946559|FG000|Overall Study|Other|3|||
150221781|NCT02469155|541946560|FG001|Overall Study|Other|3|||
150221782|NCT02469155|541946561|FG002|Overall Study|Other|2|||
150221783|NCT02469155|541946562|FG003|Overall Study|Other|10|||
150221784|NCT02469155|541946559|FG000|Overall Study|Protocol Violation|0|||
150221785|NCT02469155|541946560|FG001|Overall Study|Protocol Violation|1|||
150221786|NCT02469155|541946561|FG002|Overall Study|Protocol Violation|0|||
150221787|NCT02469155|541946562|FG003|Overall Study|Protocol Violation|1|||
150221788|NCT00901459|541946563|FG000|Overall Study|Withdrawal by Subject|6|||
150221789|NCT01405508|541946570|FG000|Overall Study|AE, non-serious non-fatal|1|||
150221790|NCT01405508|541946571|FG001|Overall Study|AE, non-serious non-fatal|1|||
150221791|NCT01405508|541946572|FG002|Overall Study|AE, non-serious non-fatal|0|||
150221792|NCT01405508|541946573|FG003|Overall Study|AE, non-serious non-fatal|0|||
150221793|NCT02291549|541946574|FG000|Overall Study|Lost to Follow-up|1|||
150221794|NCT02291549|541946575|FG001|Overall Study|Lost to Follow-up|0|||
150221795|NCT02291549|541946574|FG000|Overall Study|Withdrawal by Subject|0|||
150221796|NCT02291549|541946575|FG001|Overall Study|Withdrawal by Subject|1|||
150221797|NCT02138838|541946579|FG000|Overall Study|Study Closure|7|||
150221798|NCT02138838|541946580|FG001|Overall Study|Study Closure|6|||
150221799|NCT02138838|541946579|FG000|Overall Study|Withdrawal by Subject|1|||
150221800|NCT02138838|541946580|FG001|Overall Study|Withdrawal by Subject|5|||
150221801|NCT02010684|541946582|FG000|Overall Study|Lost to Follow-up|8|||
150221802|NCT02010684|541946583|FG001|Overall Study|Lost to Follow-up|18|||
150221803|NCT02010684|541946582|FG000|Overall Study|Withdrawal by Subject|4|||
150221804|NCT02010684|541946583|FG001|Overall Study|Withdrawal by Subject|5|||
150221805|NCT01517282|541946588|FG000|Overall Study|Consent withdrawn|0|||
150221806|NCT01517282|541946589|FG001|Overall Study|Consent withdrawn|1|||
150221807|NCT01517282|541946590|FG002|Overall Study|Consent withdrawn|1|||
150221808|NCT01517282|541946591|FG003|Overall Study|Consent withdrawn|1|||
150221809|NCT01517282|541946588|FG000|Overall Study|Physician Decision|1|||
150221810|NCT01517282|541946589|FG001|Overall Study|Physician Decision|0|||
150221811|NCT01517282|541946590|FG002|Overall Study|Physician Decision|0|||
150221812|NCT01517282|541946591|FG003|Overall Study|Physician Decision|0|||
150221813|NCT01884571|541946592|FG000|Overall Study|Adverse Event|1|||
150221814|NCT01884571|541946592|FG000|Overall Study|Death|2|||
150221815|NCT01884571|541946592|FG000|Overall Study|Withdrawal by Subject|2|||
150221816|NCT01884571|541946592|FG000|Overall Study|Disease progression|3|||
150221817|NCT01199302|541946597|FG000|Overall Study|Adverse Event|1|||
150221818|NCT01199302|541946598|FG001|Overall Study|Adverse Event|1|||
150221819|NCT01199302|541946599|FG002|Overall Study|Adverse Event|2|||
150221820|NCT01199302|541946600|FG003|Overall Study|Adverse Event|0|||
150221821|NCT01199302|541946597|FG000|Overall Study|Withdrawal by Subject|2|||
150221822|NCT01199302|541946598|FG001|Overall Study|Withdrawal by Subject|2|||
150221823|NCT01199302|541946599|FG002|Overall Study|Withdrawal by Subject|3|||
150221824|NCT01199302|541946600|FG003|Overall Study|Withdrawal by Subject|0|||
150221825|NCT01199302|541946597|FG000|Overall Study|Disease Progression|3|||
150221826|NCT01199302|541946598|FG001|Overall Study|Disease Progression|4|||
150221827|NCT01199302|541946599|FG002|Overall Study|Disease Progression|4|||
150221828|NCT01199302|541946600|FG003|Overall Study|Disease Progression|2|||
150221829|NCT01199302|541946597|FG000|Overall Study|Study Termination|13|||
150221830|NCT01199302|541946598|FG001|Overall Study|Study Termination|8|||
150221831|NCT01199302|541946599|FG002|Overall Study|Study Termination|11|||
150221832|NCT01199302|541946600|FG003|Overall Study|Study Termination|9|||
150221833|NCT01199302|541946597|FG000|Overall Study|Lost to Follow-up|0|||
150221834|NCT01199302|541946598|FG001|Overall Study|Lost to Follow-up|1|||
150221835|NCT01199302|541946599|FG002|Overall Study|Lost to Follow-up|0|||
150221836|NCT01199302|541946600|FG003|Overall Study|Lost to Follow-up|0|||
150221837|NCT01199302|541946597|FG000|Overall Study|Other|1|||
150221838|NCT01199302|541946598|FG001|Overall Study|Other|0|||
150221839|NCT01199302|541946599|FG002|Overall Study|Other|0|||
150221840|NCT01199302|541946600|FG003|Overall Study|Other|0|||
150221841|NCT04433091|541946601|FG000|Overall Study|Lost to Follow-up|1|||
150221842|NCT04433091|541946602|FG001|Overall Study|Lost to Follow-up|0|||
150221843|NCT04433091|541946601|FG000|Overall Study|Withdrawn .|2|||
150221844|NCT04433091|541946602|FG001|Overall Study|Withdrawn .|4|||
150221845|NCT01730118|541947816|FG000|Dose Escalation|Death on study|5|||
150221846|NCT01730118|541947817|FG001|Dose Escalation|Death on study|7|||
150221847|NCT01730118|541947818|FG002|Dose Escalation|Death on study|2|||
150221848|NCT01730118|541947819|FG003|Dose Escalation|Death on study|6|||
150221849|NCT01730118|541947820|FG004|Dose Escalation|Death on study|0|||
150221850|NCT01730118|541947821|FG005|Dose Escalation|Death on study|0|||
150221851|NCT01730118|541947822|FG006|Dose Escalation|Death on study|0|||
150221852|NCT01730118|541947816|FG000|Dose Escalation|Died before treatment|0|||
150221853|NCT01730118|541947817|FG001|Dose Escalation|Died before treatment|0|||
150221854|NCT01730118|541947818|FG002|Dose Escalation|Died before treatment|0|||
150221855|NCT01730118|541947819|FG003|Dose Escalation|Died before treatment|0|||
150221856|NCT01730118|541947820|FG004|Dose Escalation|Died before treatment|0|||
150221857|NCT01730118|541947821|FG005|Dose Escalation|Died before treatment|0|||
150221858|NCT01730118|541947822|FG006|Dose Escalation|Died before treatment|1|||
150221859|NCT01730118|541947816|FG000|Dose Escalation|Chose to start a different treatment|1|||
150221860|NCT01730118|541947817|FG001|Dose Escalation|Chose to start a different treatment|0|||
150221861|NCT01730118|541947818|FG002|Dose Escalation|Chose to start a different treatment|0|||
150221862|NCT01730118|541947819|FG003|Dose Escalation|Chose to start a different treatment|0|||
150221863|NCT01730118|541947820|FG004|Dose Escalation|Chose to start a different treatment|0|||
150221864|NCT01730118|541947821|FG005|Dose Escalation|Chose to start a different treatment|0|||
150221865|NCT01730118|541947822|FG006|Dose Escalation|Chose to start a different treatment|0|||
150221866|NCT01730118|541947816|FG000|Dose Escalation|Withdrawal by Subject|0|||
150221867|NCT01730118|541947817|FG001|Dose Escalation|Withdrawal by Subject|0|||
150221868|NCT01730118|541947818|FG002|Dose Escalation|Withdrawal by Subject|1|||
150221869|NCT01730118|541947819|FG003|Dose Escalation|Withdrawal by Subject|0|||
150221870|NCT01730118|541947820|FG004|Dose Escalation|Withdrawal by Subject|0|||
150221871|NCT01730118|541947821|FG005|Dose Escalation|Withdrawal by Subject|0|||
150221872|NCT01730118|541947822|FG006|Dose Escalation|Withdrawal by Subject|0|||
150221873|NCT01730118|541947816|FG000|Dose Escalation|Disease progression prior to treatment|0|||
150221874|NCT01730118|541947817|FG001|Dose Escalation|Disease progression prior to treatment|0|||
150221875|NCT01730118|541947818|FG002|Dose Escalation|Disease progression prior to treatment|0|||
150221876|NCT01730118|541947819|FG003|Dose Escalation|Disease progression prior to treatment|0|||
150221877|NCT01730118|541947820|FG004|Dose Escalation|Disease progression prior to treatment|0|||
150221878|NCT01730118|541947821|FG005|Dose Escalation|Disease progression prior to treatment|0|||
150221879|NCT01730118|541947822|FG006|Dose Escalation|Disease progression prior to treatment|1|||
150221880|NCT01730118|541947816|FG000|Dose Expansion|Death|0|||
150221881|NCT01730118|541947817|FG001|Dose Expansion|Death|0|||
150221882|NCT01730118|541947818|FG002|Dose Expansion|Death|0|||
150221883|NCT01730118|541947819|FG003|Dose Expansion|Death|0|||
150221884|NCT01730118|541947820|FG004|Dose Expansion|Death|1|||
150221885|NCT01730118|541947821|FG005|Dose Expansion|Death|0|||
150221886|NCT01730118|541947822|FG006|Dose Expansion|Death|0|||
150221887|NCT01730118|541947816|FG000|Dose Expansion|Other medical condition|0|||
150221888|NCT01730118|541947817|FG001|Dose Expansion|Other medical condition|0|||
150221889|NCT01730118|541947818|FG002|Dose Expansion|Other medical condition|0|||
150221890|NCT01730118|541947819|FG003|Dose Expansion|Other medical condition|0|||
150221891|NCT01730118|541947820|FG004|Dose Expansion|Other medical condition|1|||
150221892|NCT01730118|541947821|FG005|Dose Expansion|Other medical condition|0|||
150221893|NCT01730118|541947822|FG006|Dose Expansion|Other medical condition|0|||
150221894|NCT01730118|541947816|FG000|Dose Expansion|Withdrawal by Subject|0|||
150221895|NCT01730118|541947817|FG001|Dose Expansion|Withdrawal by Subject|0|||
150221896|NCT01730118|541947818|FG002|Dose Expansion|Withdrawal by Subject|0|||
150221897|NCT01730118|541947819|FG003|Dose Expansion|Withdrawal by Subject|0|||
150221898|NCT01730118|541947820|FG004|Dose Expansion|Withdrawal by Subject|1|||
150221899|NCT01730118|541947821|FG005|Dose Expansion|Withdrawal by Subject|0|||
150221900|NCT01730118|541947822|FG006|Dose Expansion|Withdrawal by Subject|0|||
150221901|NCT01730118|541947816|FG000|Dose Expansion|Disease progression|0|||
150221902|NCT01730118|541947817|FG001|Dose Expansion|Disease progression|0|||
150221903|NCT01730118|541947818|FG002|Dose Expansion|Disease progression|0|||
150221904|NCT01730118|541947819|FG003|Dose Expansion|Disease progression|0|||
150221905|NCT01730118|541947820|FG004|Dose Expansion|Disease progression|0|||
150221906|NCT01730118|541947821|FG005|Dose Expansion|Disease progression|1|||
150221907|NCT01730118|541947822|FG006|Dose Expansion|Disease progression|0|||
150221908|NCT01730118|541947816|FG000|Dose Expansion|Inability to return|0|||
150221909|NCT01730118|541947817|FG001|Dose Expansion|Inability to return|0|||
150221910|NCT01730118|541947818|FG002|Dose Expansion|Inability to return|0|||
150221911|NCT01730118|541947819|FG003|Dose Expansion|Inability to return|0|||
150221912|NCT01730118|541947820|FG004|Dose Expansion|Inability to return|0|||
150221913|NCT01730118|541947821|FG005|Dose Expansion|Inability to return|1|||
150221914|NCT01730118|541947822|FG006|Dose Expansion|Inability to return|0|||
150221915|NCT01730118|541947816|FG000|Dose Expansion|Physician Decision|0|||
150221916|NCT01730118|541947817|FG001|Dose Expansion|Physician Decision|0|||
150221917|NCT01730118|541947818|FG002|Dose Expansion|Physician Decision|0|||
150221918|NCT01730118|541947819|FG003|Dose Expansion|Physician Decision|0|||
150221919|NCT01730118|541947820|FG004|Dose Expansion|Physician Decision|0|||
150221920|NCT01730118|541947821|FG005|Dose Expansion|Physician Decision|1|||
150221921|NCT01730118|541947822|FG006|Dose Expansion|Physician Decision|0|||
150221922|NCT05379400|541947823|FG000|Overall Study|Lost to Follow-up|1|||
150221923|NCT05379400|541947824|FG001|Overall Study|Lost to Follow-up|1|||
150221924|NCT02101554|541947827|FG000|Overall Study|Protocol Violation|0|||
150221925|NCT02101554|541947828|FG001|Overall Study|Protocol Violation|1|||
150221926|NCT02101554|541947829|FG002|Overall Study|Protocol Violation|0|||
150221927|NCT02101554|541947827|FG000|Overall Study|Insufficient Clinical Response|0|||
150221928|NCT02101554|541947828|FG001|Overall Study|Insufficient Clinical Response|2|||
150221929|NCT02101554|541947829|FG002|Overall Study|Insufficient Clinical Response|0|||
150221930|NCT02101554|541947827|FG000|Overall Study|Adverse Event|2|||
150221931|NCT02101554|541947828|FG001|Overall Study|Adverse Event|1|||
150221932|NCT02101554|541947829|FG002|Overall Study|Adverse Event|1|||
150221933|NCT02101554|541947827|FG000|Overall Study|Lost to Follow-up|0|||
150221934|NCT02101554|541947828|FG001|Overall Study|Lost to Follow-up|1|||
150221935|NCT02101554|541947829|FG002|Overall Study|Lost to Follow-up|0|||
150221936|NCT02101554|541947827|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
150221937|NCT02101554|541947828|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
150221938|NCT02101554|541947829|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
150221939|NCT04049578|541947830|FG000|Overall Study|Physician Decision|1|||
150221940|NCT03409276|541947831|FG000|Overall Study|Withdrawal by Subject|0|||
150221941|NCT03409276|541947832|FG001|Overall Study|Withdrawal by Subject|0|||
150221942|NCT03409276|541947833|FG002|Overall Study|Withdrawal by Subject|0|||
150221943|NCT03409276|541947834|FG003|Overall Study|Withdrawal by Subject|0|||
150221944|NCT03409276|541947835|FG004|Overall Study|Withdrawal by Subject|1|||
150221945|NCT03409276|541947831|FG000|Overall Study|Lost to Follow-up|0|||
150221946|NCT03409276|541947832|FG001|Overall Study|Lost to Follow-up|0|||
150221947|NCT03409276|541947833|FG002|Overall Study|Lost to Follow-up|0|||
150221948|NCT03409276|541947834|FG003|Overall Study|Lost to Follow-up|2|||
150221949|NCT03409276|541947835|FG004|Overall Study|Lost to Follow-up|2|||
150221950|NCT03605745|541947836|FG000|Overall Study|Study was terminated for business reasons|47|||
150221951|NCT04454125|541947837|FG000|Overall Study|Lost to Follow-up|0|||
150221952|NCT04454125|541947838|FG001|Overall Study|Lost to Follow-up|1|||
150221953|NCT03345407|541947843|FG000|Overall Study|Withdrawal by Subject|11|||
150221954|NCT03345407|541947844|FG001|Overall Study|Withdrawal by Subject|1|||
150221955|NCT03345407|541947845|FG002|Overall Study|Withdrawal by Subject|5|||
150221956|NCT03345407|541947846|FG003|Overall Study|Withdrawal by Subject|6|||
150221957|NCT03345407|541947847|FG004|Overall Study|Withdrawal by Subject|3|||
150221958|NCT03345407|541947848|FG005|Overall Study|Withdrawal by Subject|6|||
150221959|NCT03345407|541947849|FG006|Overall Study|Withdrawal by Subject|16|||
150221960|NCT03345407|541947843|FG000|Overall Study|Physician Decision|3|||
150221961|NCT03345407|541947844|FG001|Overall Study|Physician Decision|1|||
150221962|NCT03345407|541947845|FG002|Overall Study|Physician Decision|0|||
150221963|NCT03345407|541947846|FG003|Overall Study|Physician Decision|0|||
150221964|NCT03345407|541947847|FG004|Overall Study|Physician Decision|1|||
150221965|NCT03345407|541947848|FG005|Overall Study|Physician Decision|2|||
150221966|NCT03345407|541947849|FG006|Overall Study|Physician Decision|3|||
150221967|NCT03345407|541947843|FG000|Overall Study|Lost to Follow-up|2|||
150221968|NCT03345407|541947844|FG001|Overall Study|Lost to Follow-up|0|||
150221969|NCT03345407|541947845|FG002|Overall Study|Lost to Follow-up|1|||
150221970|NCT03345407|541947846|FG003|Overall Study|Lost to Follow-up|0|||
150221971|NCT03345407|541947847|FG004|Overall Study|Lost to Follow-up|1|||
150221972|NCT03345407|541947848|FG005|Overall Study|Lost to Follow-up|2|||
150221973|NCT03345407|541947849|FG006|Overall Study|Lost to Follow-up|3|||
150221974|NCT03345407|541947843|FG000|Overall Study|Protocol-defined stopping criteria|9|||
150221975|NCT03345407|541947844|FG001|Overall Study|Protocol-defined stopping criteria|0|||
150221976|NCT03345407|541947845|FG002|Overall Study|Protocol-defined stopping criteria|0|||
150221977|NCT03345407|541947846|FG003|Overall Study|Protocol-defined stopping criteria|0|||
150221978|NCT03345407|541947847|FG004|Overall Study|Protocol-defined stopping criteria|2|||
150221979|NCT03345407|541947848|FG005|Overall Study|Protocol-defined stopping criteria|1|||
150221980|NCT03345407|541947849|FG006|Overall Study|Protocol-defined stopping criteria|1|||
150221981|NCT03345407|541947843|FG000|Overall Study|Protocol Violation|2|||
150221982|NCT03345407|541947844|FG001|Overall Study|Protocol Violation|0|||
150221983|NCT03345407|541947845|FG002|Overall Study|Protocol Violation|0|||
150221984|NCT03345407|541947846|FG003|Overall Study|Protocol Violation|0|||
150221985|NCT03345407|541947847|FG004|Overall Study|Protocol Violation|1|||
150221986|NCT03345407|541947848|FG005|Overall Study|Protocol Violation|0|||
150221987|NCT03345407|541947849|FG006|Overall Study|Protocol Violation|3|||
150221988|NCT03345407|541947843|FG000|Overall Study|Lack of Efficacy|1|||
150221989|NCT03345407|541947844|FG001|Overall Study|Lack of Efficacy|1|||
150221990|NCT03345407|541947845|FG002|Overall Study|Lack of Efficacy|1|||
150221991|NCT03345407|541947846|FG003|Overall Study|Lack of Efficacy|1|||
150221992|NCT03345407|541947847|FG004|Overall Study|Lack of Efficacy|1|||
150221993|NCT03345407|541947848|FG005|Overall Study|Lack of Efficacy|0|||
150221994|NCT03345407|541947849|FG006|Overall Study|Lack of Efficacy|3|||
150221995|NCT03345407|541947843|FG000|Overall Study|Adverse Event|4|||
150221996|NCT03345407|541947844|FG001|Overall Study|Adverse Event|0|||
150221997|NCT03345407|541947845|FG002|Overall Study|Adverse Event|5|||
150221998|NCT03345407|541947846|FG003|Overall Study|Adverse Event|4|||
150221999|NCT03345407|541947847|FG004|Overall Study|Adverse Event|6|||
150222000|NCT03345407|541947848|FG005|Overall Study|Adverse Event|5|||
150222001|NCT03345407|541947849|FG006|Overall Study|Adverse Event|16|||
150222002|NCT02256553|541947851|FG000|Period I|Adverse Event|5|||
150222003|NCT02256553|541947851|FG000|Period I|Protocol Violation|1|||
150222004|NCT02256553|541947851|FG000|Period II|Adverse Event|1|||
150222005|NCT02256553|541947851|FG000|Period II|Subject Moved|1|||
150222006|NCT02256553|541947851|FG000|Period III|Adverse Event|3|||
150222007|NCT02092909|541947852|FG000|Overall Study|Adverse Event|0|||
150222008|NCT02092909|541947853|FG001|Overall Study|Adverse Event|0|||
150222009|NCT02092909|541947854|FG002|Overall Study|Adverse Event|4|||
150222010|NCT02092909|541947855|FG003|Overall Study|Adverse Event|2|||
150222011|NCT02092909|541947852|FG000|Overall Study|Lack of Efficacy|0|||
150222012|NCT02092909|541947853|FG001|Overall Study|Lack of Efficacy|2|||
150222013|NCT02092909|541947854|FG002|Overall Study|Lack of Efficacy|1|||
150222014|NCT02092909|541947855|FG003|Overall Study|Lack of Efficacy|0|||
150222015|NCT02092909|541947852|FG000|Overall Study|Withdrawal by Subject|0|||
150222016|NCT02092909|541947853|FG001|Overall Study|Withdrawal by Subject|0|||
150222017|NCT02092909|541947854|FG002|Overall Study|Withdrawal by Subject|2|||
150222018|NCT02092909|541947855|FG003|Overall Study|Withdrawal by Subject|1|||
150222019|NCT02092909|541947852|FG000|Overall Study|Study terminated by Sponsor|0|||
150222020|NCT02092909|541947853|FG001|Overall Study|Study terminated by Sponsor|0|||
150222021|NCT02092909|541947854|FG002|Overall Study|Study terminated by Sponsor|0|||
150222022|NCT02092909|541947855|FG003|Overall Study|Study terminated by Sponsor|2|||
150222023|NCT02092909|541947852|FG000|Overall Study|Miscellaneous|1|||
150222024|NCT02092909|541947853|FG001|Overall Study|Miscellaneous|1|||
150222025|NCT02092909|541947854|FG002|Overall Study|Miscellaneous|2|||
150222026|NCT02092909|541947855|FG003|Overall Study|Miscellaneous|1|||
150222027|NCT03436797|541947856|FG000|Main Study|Withdrawal by Subject|2|||
150222028|NCT03436797|541947856|FG000|Main Study|Adverse Event|4|||
150222029|NCT03436797|541947856|FG000|Main Study|Lost to Follow-up|1|||
150222030|NCT03436797|541947856|FG000|Main Study|Death|1|||
150222031|NCT03436797|541947856|FG000|Main Study|Non-Specific|2|||
150222032|NCT03436797|541947856|FG000|Extended Dosing|Patient decision|1|||
150222033|NCT04739306|541947857|FG000|Main Study Period|Adverse Event|6|||
150222034|NCT04739306|541947858|FG001|Main Study Period|Adverse Event|7|||
150222035|NCT04739306|541947857|FG000|Main Study Period|Lost to Follow-up|4|||
150222036|NCT04739306|541947858|FG001|Main Study Period|Lost to Follow-up|6|||
150222037|NCT04739306|541947857|FG000|Main Study Period|Physician Decision|1|||
150222038|NCT04739306|541947858|FG001|Main Study Period|Physician Decision|1|||
150222039|NCT04739306|541947857|FG000|Main Study Period|Withdrawal by Subject|8|||
150222040|NCT04739306|541947858|FG001|Main Study Period|Withdrawal by Subject|6|||
150222041|NCT04739306|541947857|FG000|Main Study Period|Protocol Violation|0|||
150222042|NCT04739306|541947858|FG001|Main Study Period|Protocol Violation|1|||
150222043|NCT04739306|541947857|FG000|Main Study Period|War in Ukraine|1|||
150222044|NCT04739306|541947858|FG001|Main Study Period|War in Ukraine|1|||
150222045|NCT03651271|541947859|FG000|Overall Study|Death|4|||
150222046|NCT03651271|541947860|FG001|Overall Study|Death|37|||
150222047|NCT03651271|541947861|FG002|Overall Study|Death|0|||
150222048|NCT03651271|541947862|FG003|Overall Study|Death|2|||
150222049|NCT03651271|541947863|FG004|Overall Study|Death|6|||
150222050|NCT03651271|541947859|FG000|Overall Study|Lost to Follow-up|1|||
150222051|NCT03651271|541947860|FG001|Overall Study|Lost to Follow-up|5|||
150222052|NCT03651271|541947861|FG002|Overall Study|Lost to Follow-up|0|||
150222053|NCT03651271|541947862|FG003|Overall Study|Lost to Follow-up|1|||
150222054|NCT03651271|541947863|FG004|Overall Study|Lost to Follow-up|0|||
150222055|NCT03651271|541947859|FG000|Overall Study|Physician Decision|0|||
150222056|NCT03651271|541947860|FG001|Overall Study|Physician Decision|2|||
150222057|NCT03651271|541947861|FG002|Overall Study|Physician Decision|0|||
150222058|NCT03651271|541947862|FG003|Overall Study|Physician Decision|0|||
150222059|NCT03651271|541947863|FG004|Overall Study|Physician Decision|0|||
150222060|NCT03651271|541947859|FG000|Overall Study|Withdrawal by Subject|1|||
150222061|NCT03651271|541947860|FG001|Overall Study|Withdrawal by Subject|15|||
150222062|NCT03651271|541947861|FG002|Overall Study|Withdrawal by Subject|0|||
150222063|NCT03651271|541947862|FG003|Overall Study|Withdrawal by Subject|0|||
150222064|NCT03651271|541947863|FG004|Overall Study|Withdrawal by Subject|1|||
150222065|NCT03651271|541947859|FG000|Overall Study|Patient medically unable to continue|0|||
150222066|NCT03651271|541947860|FG001|Overall Study|Patient medically unable to continue|0|||
150222067|NCT03651271|541947861|FG002|Overall Study|Patient medically unable to continue|0|||
150222068|NCT03651271|541947862|FG003|Overall Study|Patient medically unable to continue|1|||
150222069|NCT03651271|541947863|FG004|Overall Study|Patient medically unable to continue|0|||
150222070|NCT00821093|541947864|FG000|Overall Study|Adverse Event|20|||
150222071|NCT00821093|541947865|FG001|Overall Study|Adverse Event|12|||
150222072|NCT00821093|541947864|FG000|Overall Study|Withdrawal by Subject|9|||
150222073|NCT00821093|541947865|FG001|Overall Study|Withdrawal by Subject|13|||
150222074|NCT00821093|541947864|FG000|Overall Study|Lost to Follow-up|9|||
150222075|NCT00821093|541947865|FG001|Overall Study|Lost to Follow-up|3|||
150222076|NCT00821093|541947864|FG000|Overall Study|Protocol deviation|3|||
150222077|NCT00821093|541947865|FG001|Overall Study|Protocol deviation|6|||
150222078|NCT00821093|541947864|FG000|Overall Study|Abnormal laboratory value(s)|2|||
150222079|NCT00821093|541947865|FG001|Overall Study|Abnormal laboratory value(s)|0|||
150222080|NCT00821093|541947864|FG000|Overall Study|Lack of Efficacy|2|||
150222081|NCT00821093|541947865|FG001|Overall Study|Lack of Efficacy|2|||
150222082|NCT00821093|541947864|FG000|Overall Study|Death|2|||
150222083|NCT00821093|541947865|FG001|Overall Study|Death|1|||
150222084|NCT00821093|541947864|FG000|Overall Study|Abnormal test procedure result(s)|1|||
150222085|NCT00821093|541947865|FG001|Overall Study|Abnormal test procedure result(s)|1|||
150222086|NCT00821093|541947864|FG000|Overall Study|Administrative problems|1|||
150222087|NCT00821093|541947865|FG001|Overall Study|Administrative problems|2|||
150222088|NCT05104242|541947870|FG000|Overall Study|Withdrawal by Subject|1|||
150222089|NCT05104242|541947871|FG001|Overall Study|Withdrawal by Subject|5|||
150222090|NCT05104242|541947870|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
150222091|NCT05104242|541947871|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
150222092|NCT04930263|541947873|FG000|Overall Study|Withdrawal by Subject|3|||
150222093|NCT04930263|541947874|FG001|Overall Study|Withdrawal by Subject|5|||
150222094|NCT02812706|541947875|FG000|Phase 1|Adverse Event|0|||
150222095|NCT02812706|541947876|FG001|Phase 1|Adverse Event|2|||
150222096|NCT02812706|541947877|FG002|Phase 1|Adverse Event|0|||
150222097|NCT02812706|541947875|FG000|Phase 1|Progressive disease|3|||
150222098|NCT02812706|541947876|FG001|Phase 1|Progressive disease|3|||
150222099|NCT02812706|541947877|FG002|Phase 1|Progressive disease|0|||
150222100|NCT02812706|541947875|FG000|Phase 2|Adverse Event|0|||
150222101|NCT02812706|541947876|FG001|Phase 2|Adverse Event|0|||
150222102|NCT02812706|541947877|FG002|Phase 2|Adverse Event|2|||
150222103|NCT02812706|541947875|FG000|Phase 2|Progressive disease|0|||
150222104|NCT02812706|541947876|FG001|Phase 2|Progressive disease|0|||
150222105|NCT02812706|541947877|FG002|Phase 2|Progressive disease|22|||
150222106|NCT02812706|541947875|FG000|Phase 2|Other-Unspecified|0|||
150222107|NCT02812706|541947876|FG001|Phase 2|Other-Unspecified|0|||
150222108|NCT02812706|541947877|FG002|Phase 2|Other-Unspecified|4|||
150222109|NCT00910871|541947883|FG000|Overall Study|Adverse Event|5|||
150222110|NCT00910871|541947883|FG000|Overall Study|Death|12|||
150222111|NCT00910871|541947883|FG000|Overall Study|Lost to Follow-up|8|||
150222112|NCT00910871|541947883|FG000|Overall Study|Protocol Violation|11|||
150222113|NCT00910871|541947883|FG000|Overall Study|Withdrawal by Subject|12|||
150222114|NCT00910871|541947883|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
150222115|NCT00910871|541947883|FG000|Overall Study|Undefined|1|||
150222116|NCT01989156|541947884|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
150222117|NCT01989156|541947885|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
150222118|NCT01989156|541947886|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
150222119|NCT01989156|541947884|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
150222120|NCT01989156|541947885|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
150222121|NCT01989156|541947886|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
150222122|NCT01989156|541947884|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
150222123|NCT01989156|541947885|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
150222124|NCT01989156|541947886|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
150222125|NCT01989156|541947884|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
150222126|NCT01989156|541947885|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
150222127|NCT01989156|541947886|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
150222128|NCT01989156|541947884|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
150222129|NCT01989156|541947885|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
150222130|NCT01989156|541947886|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
150222131|NCT01989156|541947884|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
150222132|NCT01989156|541947885|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
150222133|NCT01989156|541947886|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
150222134|NCT01989156|541947884|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
150222135|NCT01989156|541947885|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
150222136|NCT01989156|541947886|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
150222137|NCT01989156|541947884|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
150222138|NCT01989156|541947885|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
150222139|NCT01989156|541947886|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
150222140|NCT00850993|541947887|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
150222141|NCT00850993|541947888|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
150222142|NCT00850993|541947889|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
150222143|NCT00850993|541947890|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
150222144|NCT03839355|541947891|FG000|Overall Study|Withdrawal by Subject|1|||
150222145|NCT03839355|541947892|FG001|Overall Study|Withdrawal by Subject|0|||
150222146|NCT04501614|541947898|FG000|Overall Study|Study Terminated by Sponsor|6|||
150222147|NCT04501614|541947899|FG001|Overall Study|Study Terminated by Sponsor|3|||
150222148|NCT04501614|541947898|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
150222149|NCT04501614|541947899|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
150222150|NCT02555397|541947900|FG000|Overall Study|Withdrawal by Subject|1|||
150222151|NCT02555397|541947901|FG001|Overall Study|Withdrawal by Subject|0|||
150222152|NCT02555397|541947902|FG002|Overall Study|Withdrawal by Subject|0|||
150222153|NCT02555397|541947903|FG003|Overall Study|Withdrawal by Subject|0|||
150222154|NCT02555397|541947904|FG004|Overall Study|Withdrawal by Subject|0|||
150222155|NCT04529941|541947905|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
150222156|NCT04529941|541947906|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
150222157|NCT01240785|541947907|FG000|Overall Study|Lost to Follow-up|1|||
150222158|NCT01240785|541947908|FG001|Overall Study|Lost to Follow-up|0|||
150222159|NCT01240785|541947907|FG000|Overall Study|Protocol Violation|0|||
150222160|NCT01240785|541947908|FG001|Overall Study|Protocol Violation|3|||
150222161|NCT00237809|541947909|FG000|Overall Study|Lost to Follow-up|11|||
150222162|NCT00237809|541947910|FG001|Overall Study|Lost to Follow-up|10|||
150222163|NCT00237809|541947911|FG002|Overall Study|Lost to Follow-up|9|||
150222164|NCT00237809|541947912|FG003|Overall Study|Lost to Follow-up|9|||
150222165|NCT01468597|541947919|FG000|Overall Study|Found ineligible|17|||
150222166|NCT01468597|541947919|FG000|Overall Study|concomitant valves|12|||
150222167|NCT01468597|541947919|FG000|Overall Study|off-pump CABG|1|||
150222168|NCT01468597|541947919|FG000|Overall Study|no platelet function data|5|||
150222169|NCT00091572|541947920|FG000|Overall Study|Lost to Follow-up|1|||
150222170|NCT00091572|541947921|FG001|Overall Study|Lost to Follow-up|1|||
150222171|NCT00091572|541947920|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
150222172|NCT00091572|541947921|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
150222173|NCT00091572|541947920|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
150222174|NCT00091572|541947921|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
150222175|NCT00091572|541947920|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
150222176|NCT00091572|541947921|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
150222177|NCT00091572|541947920|FG000|Overall Study|Other Reason|6|||
150222178|NCT00091572|541947921|FG001|Overall Study|Other Reason|13|||
150222179|NCT00091572|541947920|FG000|Overall Study|Ongoing (still on treatment)|8|||
150222180|NCT00091572|541947921|FG001|Overall Study|Ongoing (still on treatment)|12|||
150222181|NCT00091572|541947920|FG000|Overall Study|Major Protocol Violation|2|||
150222182|NCT00091572|541947921|FG001|Overall Study|Major Protocol Violation|0|||
150222183|NCT00091572|541947920|FG000|Overall Study|Toxicity (Related AE)|53|||
150222184|NCT00091572|541947921|FG001|Overall Study|Toxicity (Related AE)|9|||
150222185|NCT02332889|541947929|FG000|Overall Study|Physician Decision|1|||
150222186|NCT01634165|541947932|FG000|Period 2|Adverse Event|0|||
150222187|NCT01634165|541947933|FG001|Period 2|Adverse Event|1|||
150222188|NCT01634165|541947934|FG002|Period 2|Adverse Event|0|||
150222189|NCT01634165|541947935|FG003|Period 2|Adverse Event|0|||
150222190|NCT04097535|541947938|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
150222191|NCT04520256|541947940|FG000|Overall Study|Lost to Follow-up|6|||
150222192|NCT04520256|541947941|FG001|Overall Study|Lost to Follow-up|4|||
150222193|NCT04520256|541947942|FG002|Overall Study|Lost to Follow-up|2|||
150222194|NCT04520256|541947943|FG003|Overall Study|Lost to Follow-up|3|||
150222195|NCT04520256|541947944|FG004|Overall Study|Lost to Follow-up|6|||
150222196|NCT04520256|541947945|FG005|Overall Study|Lost to Follow-up|6|||
150222197|NCT04520256|541947946|FG006|Overall Study|Lost to Follow-up|4|||
150222198|NCT04520256|541947947|FG007|Overall Study|Lost to Follow-up|6|||
150222199|NCT04520256|541947948|FG008|Overall Study|Lost to Follow-up|1|||
150222200|NCT04520256|541947949|FG009|Overall Study|Lost to Follow-up|3|||
150222201|NCT04520256|541947950|FG010|Overall Study|Lost to Follow-up|3|||
150222202|NCT04520256|541947951|FG011|Overall Study|Lost to Follow-up|2|||
150222203|NCT04520256|541947952|FG012|Overall Study|Lost to Follow-up|5|||
150222204|NCT04520256|541947953|FG013|Overall Study|Lost to Follow-up|3|||
150222205|NCT04520256|541947954|FG014|Overall Study|Lost to Follow-up|3|||
150222206|NCT04520256|541947955|FG015|Overall Study|Lost to Follow-up|6|||
150222207|NCT04520256|541947956|FG016|Overall Study|Lost to Follow-up|6|||
150222208|NCT04520256|541947957|FG017|Overall Study|Lost to Follow-up|4|||
150222209|NCT04520256|541947958|FG018|Overall Study|Lost to Follow-up|3|||
150222210|NCT04520256|541947959|FG019|Overall Study|Lost to Follow-up|3|||
150222211|NCT04520256|541947960|FG020|Overall Study|Lost to Follow-up|7|||
150222212|NCT04520256|541947961|FG021|Overall Study|Lost to Follow-up|3|||
150222213|NCT04520256|541947962|FG022|Overall Study|Lost to Follow-up|3|||
150222214|NCT04520256|541947963|FG023|Overall Study|Lost to Follow-up|8|||
150141433|NCT01784068|541652067|FG000|TFR Phase|Physician Decision|0|||
150222215|NCT04520256|541947964|FG024|Overall Study|Lost to Follow-up|5|||
150222216|NCT04520256|541947965|FG025|Overall Study|Lost to Follow-up|4|||
150222217|NCT04520256|541947966|FG026|Overall Study|Lost to Follow-up|3|||
150222218|NCT04520256|541947967|FG027|Overall Study|Lost to Follow-up|4|||
150222219|NCT04520256|541947968|FG028|Overall Study|Lost to Follow-up|3|||
150222220|NCT04520256|541947969|FG029|Overall Study|Lost to Follow-up|4|||
150222221|NCT04520256|541947970|FG030|Overall Study|Lost to Follow-up|4|||
150222222|NCT04520256|541947971|FG031|Overall Study|Lost to Follow-up|4|||
150222223|NCT05356130|541949487|FG000|Overall Study|Withdrawal by Subject|0|||
150222224|NCT05356130|541949488|FG001|Overall Study|Withdrawal by Subject|0|||
150222225|NCT05356130|541949489|FG002|Overall Study|Withdrawal by Subject|3|||
150222226|NCT04851587|541949490|FG000|Overall Study|Lost to Follow-up|18|||
150222227|NCT02109172|541949491|FG000|Overall Study|Withdrawal by Subject|1|||
150222228|NCT02109172|541949492|FG001|Overall Study|Withdrawal by Subject|0|||
150222229|NCT02109172|541949493|FG002|Overall Study|Withdrawal by Subject|0|||
150222230|NCT02109172|541949494|FG003|Overall Study|Withdrawal by Subject|1|||
150222231|NCT02109172|541949495|FG004|Overall Study|Withdrawal by Subject|0|||
150222232|NCT02109172|541949496|FG005|Overall Study|Withdrawal by Subject|0|||
150222233|NCT02109172|541949491|FG000|Overall Study|Adverse Event|0|||
150222234|NCT02109172|541949492|FG001|Overall Study|Adverse Event|0|||
150222235|NCT02109172|541949493|FG002|Overall Study|Adverse Event|1|||
150222236|NCT02109172|541949494|FG003|Overall Study|Adverse Event|0|||
150222237|NCT02109172|541949495|FG004|Overall Study|Adverse Event|0|||
150222238|NCT02109172|541949496|FG005|Overall Study|Adverse Event|1|||
150222239|NCT02109172|541949491|FG000|Overall Study|Death|0|||
150222240|NCT02109172|541949492|FG001|Overall Study|Death|0|||
150222241|NCT02109172|541949493|FG002|Overall Study|Death|0|||
150222242|NCT02109172|541949494|FG003|Overall Study|Death|0|||
150222243|NCT02109172|541949495|FG004|Overall Study|Death|1|||
150222244|NCT02109172|541949496|FG005|Overall Study|Death|0|||
150222245|NCT01816165|541949502|FG000|Overall Study|Adverse Event|1|||
150222246|NCT01816165|541949503|FG001|Overall Study|Adverse Event|0|||
150222247|NCT01816165|541949504|FG002|Overall Study|Adverse Event|0|||
150222248|NCT01816165|541949505|FG003|Overall Study|Adverse Event|0|||
150222249|NCT03960437|541949506|FG000|Overall Study|Removed by PI|4|||
150222250|NCT03960437|541949506|FG000|Overall Study|Lost to Follow-up|2|||
150222251|NCT03960437|541949506|FG000|Overall Study|Withdrawal by Subject|1|||
150222252|NCT03960437|541949506|FG000|Overall Study|Death|2|||
150222253|NCT03614923|541949507|FG000|Overall Study|Withdrawal by Subject|2|||
150222254|NCT03614923|541949508|FG001|Overall Study|Withdrawal by Subject|1|||
150222255|NCT03614923|541949509|FG002|Overall Study|Withdrawal by Subject|1|||
150222256|NCT03614923|541949507|FG000|Overall Study|Adverse Event|0|||
150222257|NCT03614923|541949508|FG001|Overall Study|Adverse Event|2|||
150222258|NCT03614923|541949509|FG002|Overall Study|Adverse Event|1|||
150222259|NCT03614923|541949507|FG000|Overall Study|Lost to Follow-up|1|||
150222260|NCT03614923|541949508|FG001|Overall Study|Lost to Follow-up|0|||
150222261|NCT03614923|541949509|FG002|Overall Study|Lost to Follow-up|1|||
150222262|NCT03614923|541949507|FG000|Overall Study|Lack of Efficacy|2|||
150222263|NCT03614923|541949508|FG001|Overall Study|Lack of Efficacy|0|||
150222264|NCT03614923|541949509|FG002|Overall Study|Lack of Efficacy|1|||
150222265|NCT03614923|541949507|FG000|Overall Study|Non-compliance|0|||
150222266|NCT03614923|541949508|FG001|Overall Study|Non-compliance|1|||
150222267|NCT03614923|541949509|FG002|Overall Study|Non-compliance|0|||
150222268|NCT03614923|541949507|FG000|Overall Study|Other|0|||
150222269|NCT03614923|541949508|FG001|Overall Study|Other|1|||
150222270|NCT03614923|541949509|FG002|Overall Study|Other|1|||
150222271|NCT01882088|541949511|FG000|Overall Study|Intolerance of esophageal manometry|1|||
150222272|NCT01882088|541949511|FG000|Overall Study|no possibility to place the catheter|1|||
150222273|NCT01882088|541949511|FG000|Overall Study|Protocol Violation|1|||
150222274|NCT01882088|541949511|FG000|Overall Study|inadequate pH-impedance tracings|2|||
150222275|NCT01951105|541949522|FG000|Overall Study|Adverse Event|0|||
150222276|NCT01951105|541949523|FG001|Overall Study|Adverse Event|5|||
150222277|NCT01951105|541949524|FG002|Overall Study|Adverse Event|0|||
150222278|NCT01951105|541949522|FG000|Overall Study|Lost to Follow-up|0|||
150222279|NCT01951105|541949523|FG001|Overall Study|Lost to Follow-up|1|||
150222280|NCT01951105|541949524|FG002|Overall Study|Lost to Follow-up|0|||
150222281|NCT01951105|541949522|FG000|Overall Study|Protocol Violation|1|||
150222282|NCT01951105|541949523|FG001|Overall Study|Protocol Violation|1|||
150222283|NCT01951105|541949524|FG002|Overall Study|Protocol Violation|1|||
150222284|NCT01951105|541949522|FG000|Overall Study|Withdrawal by Subject|0|||
150222285|NCT01951105|541949523|FG001|Overall Study|Withdrawal by Subject|3|||
150222286|NCT01951105|541949524|FG002|Overall Study|Withdrawal by Subject|1|||
150222287|NCT04175392|541949525|FG000|Overall Study|Withdrawal by Subject|3|||
150222288|NCT04175392|541949526|FG001|Overall Study|Withdrawal by Subject|2|||
150222289|NCT02727998|541949527|FG000|Overall Study|Lost to Follow-up|3|||
150222290|NCT02727998|541949528|FG001|Overall Study|Lost to Follow-up|3|||
150222291|NCT02727998|541949527|FG000|Overall Study|Withdrawal by Subject|0|||
150222292|NCT02727998|541949528|FG001|Overall Study|Withdrawal by Subject|1|||
150222293|NCT05072795|541949529|FG000|Overall Study|Lost to Follow-up|5|||
150222294|NCT01601821|541949532|FG000|Overall Study|Death|2|||
150222295|NCT01601821|541949533|FG001|Overall Study|Death|5|||
150222296|NCT01601821|541949532|FG000|Overall Study|Protocol Violation|2|||
150222297|NCT01601821|541949533|FG001|Overall Study|Protocol Violation|2|||
150222298|NCT01601821|541949532|FG000|Overall Study|Lost to Follow-up|6|||
150222299|NCT01601821|541949533|FG001|Overall Study|Lost to Follow-up|14|||
150222300|NCT01601821|541949532|FG000|Overall Study|Withdrawal by Subject|1|||
150222301|NCT01601821|541949533|FG001|Overall Study|Withdrawal by Subject|0|||
150222302|NCT01601821|541949532|FG000|Overall Study|Graft Loss|6|||
150222303|NCT01601821|541949533|FG001|Overall Study|Graft Loss|6|||
150222304|NCT01601821|541949532|FG000|Overall Study|Study Events|7|||
150222305|NCT01601821|541949533|FG001|Overall Study|Study Events|1|||
150222306|NCT01601821|541949532|FG000|Overall Study|Other|5|||
150222307|NCT01601821|541949533|FG001|Overall Study|Other|1|||
150222308|NCT01901302|541949537|FG000|Overall Study|Adverse Event|2|||
150222309|NCT01901302|541949538|FG001|Overall Study|Adverse Event|1|||
150222310|NCT01901302|541949537|FG000|Overall Study|Lack of Efficacy|0|||
150222311|NCT01901302|541949538|FG001|Overall Study|Lack of Efficacy|2|||
150222312|NCT01901302|541949537|FG000|Overall Study|Study Terminated by Sponsor|23|||
150141434|NCT01784068|541652068|FG001|TFR Phase|Physician Decision|1|||
150141435|NCT01784068|541652067|FG000|TFR Phase|Patient/guardian decision|0|||
150141436|NCT01784068|541652068|FG001|TFR Phase|Patient/guardian decision|3|||
150141437|NCT01784068|541652067|FG000|TFR Phase|Death|0|||
150141438|NCT01784068|541652068|FG001|TFR Phase|Death|1|||
150141439|NCT01784068|541652067|FG000|TFR Phase|Lack of Efficacy|0|||
150141440|NCT01784068|541652068|FG001|TFR Phase|Lack of Efficacy|88|||
150141441|NCT04954586|541652069|FG000|Overall Study|Withdrawal by Subject|5|||
150141442|NCT00532155|541652070|FG000|Overall Study|Adverse Event|66|||
150141443|NCT00532155|541652071|FG001|Overall Study|Adverse Event|123|||
150141444|NCT00532155|541652070|FG000|Overall Study|Lack of Efficacy|332|||
150141445|NCT00532155|541652071|FG001|Overall Study|Lack of Efficacy|255|||
150141446|NCT00532155|541652070|FG000|Overall Study|Protocol Violation|1|||
150141447|NCT00532155|541652071|FG001|Overall Study|Protocol Violation|3|||
150141448|NCT00532155|541652070|FG000|Overall Study|Lost to Follow-up|2|||
150141449|NCT00532155|541652071|FG001|Overall Study|Lost to Follow-up|0|||
150141450|NCT00532155|541652070|FG000|Overall Study|Physician Decision|16|||
150141451|NCT00532155|541652071|FG001|Overall Study|Physician Decision|15|||
150141452|NCT00532155|541652070|FG000|Overall Study|Withdrawal by Subject|23|||
150141453|NCT00532155|541652071|FG001|Overall Study|Withdrawal by Subject|44|||
150141454|NCT00532155|541652070|FG000|Overall Study|Consent withdrawn|5|||
150141455|NCT00532155|541652071|FG001|Overall Study|Consent withdrawn|7|||
150141456|NCT00532155|541652070|FG000|Overall Study|Moved|1|||
150141457|NCT00532155|541652071|FG001|Overall Study|Moved|0|||
150141458|NCT00532155|541652070|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
150141459|NCT00532155|541652071|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
150141460|NCT00532155|541652070|FG000|Overall Study|Occurence of a second cancer|0|||
150141461|NCT00532155|541652071|FG001|Overall Study|Occurence of a second cancer|1|||
150141462|NCT00532155|541652070|FG000|Overall Study|Occurence of a secondary cancer|0|||
150141463|NCT00532155|541652071|FG001|Overall Study|Occurence of a secondary cancer|1|||
150141464|NCT00532155|541652070|FG000|Overall Study|Promotor ended study|1|||
150141465|NCT00532155|541652071|FG001|Overall Study|Promotor ended study|0|||
150141466|NCT00532155|541652070|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
150141467|NCT00532155|541652071|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
150141468|NCT00532155|541652070|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
150141469|NCT00532155|541652071|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
150141470|NCT00532155|541652070|FG000|Overall Study|Study stopped|1|||
150141471|NCT00532155|541652071|FG001|Overall Study|Study stopped|0|||
150141472|NCT00532155|541652070|FG000|Overall Study|Study terminated by sponsor|1|||
150141473|NCT00532155|541652071|FG001|Overall Study|Study terminated by sponsor|0|||
150141474|NCT00532155|541652070|FG000|Overall Study|Study termination stop further treatment|4|||
150141475|NCT00532155|541652071|FG001|Overall Study|Study termination stop further treatment|0|||
150141476|NCT00532155|541652070|FG000|Overall Study|Did not receive study medication|2|||
150141477|NCT00532155|541652071|FG001|Overall Study|Did not receive study medication|6|||
150141478|NCT02134925|541652072|FG000|Overall Study|Withdrawal by Subject|1|||
150141479|NCT02134925|541652073|FG001|Overall Study|Withdrawal by Subject|0|||
150141480|NCT02134925|541652072|FG000|Overall Study|Cancel|1|||
150141481|NCT02134925|541652073|FG001|Overall Study|Cancel|6|||
150141482|NCT04027348|541652074|FG000|Overall Study|Adverse Event|2|||
150141483|NCT02158884|541652075|FG000|Baseline Assessment|Missed performance assessment|3|||
150141484|NCT02158884|541652075|FG000|Baseline Assessment|Missed SMFA|1|||
150141485|NCT02158884|541652075|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
150141486|NCT02158884|541652075|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
150141487|NCT02158884|541652075|FG000|6 Month Assessment|Missed SMFA|20|||
150141488|NCT02158884|541652075|FG000|12 Month Assessment|Missed SMFA|17|||
150141489|NCT04843930|541652080|FG000|Randomization|Withdrawal by Subject|6|||
150141490|NCT04843930|541652081|FG001|Randomization|Withdrawal by Subject|6|||
150141491|NCT04843930|541652082|FG002|Randomization|Withdrawal by Subject|0|||
150141492|NCT04843930|541652083|FG003|Randomization|Withdrawal by Subject|0|||
150141493|NCT04843930|541652080|FG000|Week 6 Assessment|Adverse Event|3|||
150141494|NCT04843930|541652081|FG001|Week 6 Assessment|Adverse Event|0|||
150141495|NCT04843930|541652082|FG002|Week 6 Assessment|Adverse Event|0|||
150141496|NCT04843930|541652083|FG003|Week 6 Assessment|Adverse Event|0|||
150141497|NCT04843930|541652080|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
150141498|NCT04843930|541652081|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
150222313|NCT01901302|541949538|FG001|Overall Study|Study Terminated by Sponsor|20|||
150222314|NCT01901302|541949537|FG000|Overall Study|Withdrawal by Subject|2|||
150222315|NCT01901302|541949538|FG001|Overall Study|Withdrawal by Subject|0|||
150222316|NCT00422162|541949539|FG000|Overall Study|Adverse Event|11|||
150222317|NCT00422162|541949540|FG001|Overall Study|Adverse Event|9|||
150222318|NCT00422162|541949539|FG000|Overall Study|Lack of Efficacy|4|||
150222319|NCT00422162|541949540|FG001|Overall Study|Lack of Efficacy|10|||
150222320|NCT00422162|541949539|FG000|Overall Study|Withdrawal by Subject|7|||
150222321|NCT00422162|541949540|FG001|Overall Study|Withdrawal by Subject|6|||
150222322|NCT00422162|541949539|FG000|Overall Study|Lost to Follow-up|1|||
150222323|NCT00422162|541949540|FG001|Overall Study|Lost to Follow-up|2|||
150222324|NCT00422162|541949539|FG000|Overall Study|Non-Compliant with Protocol|1|||
150222325|NCT00422162|541949540|FG001|Overall Study|Non-Compliant with Protocol|1|||
150222326|NCT00422162|541949539|FG000|Overall Study|Other|0|||
150222327|NCT00422162|541949540|FG001|Overall Study|Other|1|||
150222328|NCT00422162|541949539|FG000|Overall Study|Didn't Receive Treatment|0|||
150222329|NCT00422162|541949540|FG001|Overall Study|Didn't Receive Treatment|1|||
150222330|NCT05274906|541949541|FG000|Overall Study|Withdrawal by Subject|2|||
150222331|NCT05274906|541949542|FG001|Overall Study|Withdrawal by Subject|1|||
150222332|NCT01005914|541949546|FG000|Overall Study|Adverse Event|4|||
150222333|NCT01005914|541949546|FG000|Overall Study|Death|4|||
150222334|NCT01005914|541949546|FG000|Overall Study|Lack of Efficacy|1|||
150222335|NCT01005914|541949546|FG000|Overall Study|Withdrawal by Subject|1|||
150222336|NCT01613599|541949547|FG000|Overall Study|Death|9|||
150222337|NCT01613599|541949547|FG000|Overall Study|Lost to Follow-up|5|||
150222338|NCT01613599|541949547|FG000|Overall Study|Withdrawal by Subject|8|||
150222339|NCT01613599|541949547|FG000|Overall Study|Reason not specified|3|||
150222340|NCT00321555|541949548|FG000|Overall Study|Developed antibodies|1|||
150222341|NCT00321555|541949548|FG000|Overall Study|Switched to alternative treatment|3|||
150222342|NCT00321555|541949548|FG000|Overall Study|Physician Decision|1|||
150222343|NCT00321555|541949548|FG000|Overall Study|Disease progression on study|1|||
150222344|NCT02066389|541949549|FG000|Overall Study|Adverse Event|1|||
150222345|NCT02066389|541949550|FG001|Overall Study|Adverse Event|1|||
150222346|NCT02066389|541949551|FG002|Overall Study|Adverse Event|1|||
150222347|NCT02066389|541949552|FG003|Overall Study|Adverse Event|1|||
150222348|NCT02066389|541949553|FG004|Overall Study|Adverse Event|5|||
150222349|NCT02066389|541949554|FG005|Overall Study|Adverse Event|1|||
150222350|NCT02066389|541949549|FG000|Overall Study|Withdrawal by Subject|4|||
150222351|NCT02066389|541949550|FG001|Overall Study|Withdrawal by Subject|0|||
150222352|NCT02066389|541949551|FG002|Overall Study|Withdrawal by Subject|5|||
150222353|NCT02066389|541949552|FG003|Overall Study|Withdrawal by Subject|1|||
150222354|NCT02066389|541949553|FG004|Overall Study|Withdrawal by Subject|1|||
150222355|NCT02066389|541949554|FG005|Overall Study|Withdrawal by Subject|2|||
150222356|NCT02066389|541949549|FG000|Overall Study|Lost to Follow-up|0|||
150222357|NCT02066389|541949550|FG001|Overall Study|Lost to Follow-up|0|||
150222358|NCT02066389|541949551|FG002|Overall Study|Lost to Follow-up|0|||
150222359|NCT02066389|541949552|FG003|Overall Study|Lost to Follow-up|1|||
150222360|NCT02066389|541949553|FG004|Overall Study|Lost to Follow-up|1|||
150222361|NCT02066389|541949554|FG005|Overall Study|Lost to Follow-up|1|||
150222362|NCT02066389|541949549|FG000|Overall Study|Randomized in Error|0|||
150222363|NCT02066389|541949550|FG001|Overall Study|Randomized in Error|0|||
150222364|NCT02066389|541949551|FG002|Overall Study|Randomized in Error|0|||
150222365|NCT02066389|541949552|FG003|Overall Study|Randomized in Error|0|||
150222366|NCT02066389|541949553|FG004|Overall Study|Randomized in Error|0|||
150222367|NCT02066389|541949554|FG005|Overall Study|Randomized in Error|1|||
150222368|NCT01755598|541949555|FG000|Overall Study|Other|109|||
150222369|NCT01755598|541949556|FG001|Overall Study|Other|109|||
150222370|NCT01755598|541949555|FG000|Overall Study|Lost to Follow-up|32|||
150222371|NCT01755598|541949556|FG001|Overall Study|Lost to Follow-up|43|||
150222372|NCT01755598|541949555|FG000|Overall Study|Migrated/moved from study area|76|||
150222373|NCT01755598|541949556|FG001|Overall Study|Migrated/moved from study area|65|||
150222374|NCT01755598|541949555|FG000|Overall Study|Withdrawal by Subject|22|||
150222375|NCT01755598|541949556|FG001|Overall Study|Withdrawal by Subject|31|||
150222376|NCT01755598|541949555|FG000|Overall Study|Protocol Violation|7|||
150222377|NCT01755598|541949556|FG001|Overall Study|Protocol Violation|7|||
150222378|NCT01755598|541949555|FG000|Overall Study|Adverse Event|19|||
150222379|NCT01755598|541949556|FG001|Overall Study|Adverse Event|28|||
150222380|NCT04016415|541949557|FG000|Overall Study|Adverse Event|2|||
150222381|NCT04016415|541949558|FG001|Overall Study|Adverse Event|1|||
150222382|NCT04016415|541949557|FG000|Overall Study|Lost to Follow-up|6|||
150222383|NCT04016415|541949558|FG001|Overall Study|Lost to Follow-up|2|||
150222384|NCT04016415|541949557|FG000|Overall Study|Physician Decision|5|||
150222385|NCT04016415|541949558|FG001|Overall Study|Physician Decision|1|||
150222386|NCT04016415|541949557|FG000|Overall Study|Pregnancy|0|||
150222387|NCT04016415|541949558|FG001|Overall Study|Pregnancy|1|||
150222388|NCT04016415|541949557|FG000|Overall Study|Withdrawal by Subject|24|||
150222389|NCT04016415|541949558|FG001|Overall Study|Withdrawal by Subject|27|||
150222390|NCT04016415|541949557|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
150222391|NCT04016415|541949558|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
150222392|NCT02260154|541949567|FG000|Overall Study|Screening failure|2|||
150222393|NCT02561195|541949569|FG000|Vaccination 1 to 3|Adverse Event|4|||
150222394|NCT02561195|541949570|FG001|Vaccination 1 to 3|Adverse Event|5|||
150222395|NCT02561195|541949571|FG002|Vaccination 1 to 3|Adverse Event|0|||
150222396|NCT02561195|541949572|FG003|Vaccination 1 to 3|Adverse Event|3|||
150222397|NCT02561195|541949573|FG004|Vaccination 1 to 3|Adverse Event|4|||
150222398|NCT02561195|541949574|FG005|Vaccination 1 to 3|Adverse Event|0|||
150222399|NCT02561195|541949575|FG006|Vaccination 1 to 3|Adverse Event|0|||
150222400|NCT02561195|541949576|FG007|Vaccination 1 to 3|Adverse Event|0|||
150222401|NCT02561195|541949577|FG008|Vaccination 1 to 3|Adverse Event|0|||
150222402|NCT02561195|541949578|FG009|Vaccination 1 to 3|Adverse Event|0|||
150222403|NCT02561195|541949579|FG010|Vaccination 1 to 3|Adverse Event|0|||
150222404|NCT02561195|541949580|FG011|Vaccination 1 to 3|Adverse Event|0|||
150222405|NCT02561195|541949581|FG012|Vaccination 1 to 3|Adverse Event|0|||
150222406|NCT02561195|541949582|FG013|Vaccination 1 to 3|Adverse Event|0|||
150222407|NCT02561195|541949569|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
150222408|NCT02561195|541949570|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
150222409|NCT02561195|541949571|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
150222410|NCT02561195|541949572|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
150222411|NCT02561195|541949573|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
150222412|NCT02561195|541949574|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
150222413|NCT02561195|541949575|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
150222414|NCT02561195|541949576|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
150222415|NCT02561195|541949577|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
150222416|NCT02561195|541949578|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
150222417|NCT02561195|541949579|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
150222418|NCT02561195|541949580|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
150222419|NCT02561195|541949581|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
150222420|NCT02561195|541949582|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
150222421|NCT02561195|541949569|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222422|NCT02561195|541949570|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
150222423|NCT02561195|541949571|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222424|NCT02561195|541949572|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
150222425|NCT02561195|541949573|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
150222426|NCT02561195|541949574|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
150222427|NCT02561195|541949575|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222428|NCT02561195|541949576|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222429|NCT02561195|541949577|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222430|NCT02561195|541949578|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222431|NCT02561195|541949579|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222432|NCT02561195|541949580|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222433|NCT02561195|541949581|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222434|NCT02561195|541949582|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
150222435|NCT02561195|541949569|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
150222436|NCT02561195|541949570|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
150222437|NCT02561195|541949571|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
150222438|NCT02561195|541949572|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
150222439|NCT02561195|541949573|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
150222440|NCT02561195|541949574|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
150222441|NCT02561195|541949575|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
150222442|NCT02561195|541949576|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
150222443|NCT02561195|541949577|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
150222444|NCT02561195|541949578|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
150222445|NCT02561195|541949579|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
150222446|NCT02561195|541949580|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
150222447|NCT02561195|541949581|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
150222448|NCT02561195|541949582|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
150222449|NCT02561195|541949569|FG000|Vaccination 1 to 3|Other|7|||
150222450|NCT02561195|541949570|FG001|Vaccination 1 to 3|Other|3|||
150222451|NCT02561195|541949571|FG002|Vaccination 1 to 3|Other|1|||
150222452|NCT02561195|541949572|FG003|Vaccination 1 to 3|Other|7|||
150222453|NCT02561195|541949573|FG004|Vaccination 1 to 3|Other|5|||
150222454|NCT02561195|541949574|FG005|Vaccination 1 to 3|Other|1|||
150222455|NCT02561195|541949575|FG006|Vaccination 1 to 3|Other|0|||
150222456|NCT02561195|541949576|FG007|Vaccination 1 to 3|Other|0|||
150222457|NCT02561195|541949577|FG008|Vaccination 1 to 3|Other|0|||
150222458|NCT02561195|541949578|FG009|Vaccination 1 to 3|Other|0|||
150222459|NCT02561195|541949579|FG010|Vaccination 1 to 3|Other|0|||
150222460|NCT02561195|541949580|FG011|Vaccination 1 to 3|Other|0|||
150222461|NCT02561195|541949581|FG012|Vaccination 1 to 3|Other|0|||
150222462|NCT02561195|541949582|FG013|Vaccination 1 to 3|Other|0|||
150222463|NCT02561195|541949569|FG000|Vaccination 1 to 3|Protocol Violation|1|||
150222464|NCT02561195|541949570|FG001|Vaccination 1 to 3|Protocol Violation|0|||
150222465|NCT02561195|541949571|FG002|Vaccination 1 to 3|Protocol Violation|1|||
150222466|NCT02561195|541949572|FG003|Vaccination 1 to 3|Protocol Violation|2|||
150222467|NCT02561195|541949573|FG004|Vaccination 1 to 3|Protocol Violation|5|||
150222468|NCT02561195|541949574|FG005|Vaccination 1 to 3|Protocol Violation|2|||
150222469|NCT02561195|541949575|FG006|Vaccination 1 to 3|Protocol Violation|0|||
150222470|NCT02561195|541949576|FG007|Vaccination 1 to 3|Protocol Violation|0|||
150222471|NCT02561195|541949577|FG008|Vaccination 1 to 3|Protocol Violation|0|||
150222472|NCT02561195|541949578|FG009|Vaccination 1 to 3|Protocol Violation|0|||
150222473|NCT02561195|541949579|FG010|Vaccination 1 to 3|Protocol Violation|0|||
150222474|NCT02561195|541949580|FG011|Vaccination 1 to 3|Protocol Violation|0|||
150222475|NCT02561195|541949581|FG012|Vaccination 1 to 3|Protocol Violation|0|||
150222476|NCT02561195|541949582|FG013|Vaccination 1 to 3|Protocol Violation|0|||
150222477|NCT02561195|541949569|FG000|Vaccination 1 to 3|Death|2|||
150222478|NCT02561195|541949570|FG001|Vaccination 1 to 3|Death|1|||
150222479|NCT02561195|541949571|FG002|Vaccination 1 to 3|Death|0|||
150222480|NCT02561195|541949572|FG003|Vaccination 1 to 3|Death|2|||
150222481|NCT02561195|541949573|FG004|Vaccination 1 to 3|Death|0|||
150222482|NCT02561195|541949574|FG005|Vaccination 1 to 3|Death|0|||
150222483|NCT02561195|541949575|FG006|Vaccination 1 to 3|Death|0|||
150222484|NCT02561195|541949576|FG007|Vaccination 1 to 3|Death|0|||
150222485|NCT02561195|541949577|FG008|Vaccination 1 to 3|Death|0|||
150222486|NCT02561195|541949578|FG009|Vaccination 1 to 3|Death|0|||
150222487|NCT02561195|541949579|FG010|Vaccination 1 to 3|Death|0|||
150222488|NCT02561195|541949580|FG011|Vaccination 1 to 3|Death|0|||
150222489|NCT02561195|541949581|FG012|Vaccination 1 to 3|Death|0|||
150222490|NCT02561195|541949582|FG013|Vaccination 1 to 3|Death|0|||
150222491|NCT02561195|541949569|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
150222492|NCT02561195|541949570|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
150222493|NCT02561195|541949571|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
150222494|NCT02561195|541949572|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
150222495|NCT02561195|541949573|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
150222496|NCT02561195|541949574|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222497|NCT02561195|541949575|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222498|NCT02561195|541949576|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222499|NCT02561195|541949577|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222500|NCT02561195|541949578|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222501|NCT02561195|541949579|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222502|NCT02561195|541949580|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222503|NCT02561195|541949581|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222504|NCT02561195|541949582|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
150222505|NCT02561195|541949569|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
150222506|NCT02561195|541949570|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
150222507|NCT02561195|541949571|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
150222508|NCT02561195|541949572|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
150222509|NCT02561195|541949573|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
150222510|NCT02561195|541949574|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
150222511|NCT02561195|541949575|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
150222512|NCT02561195|541949576|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
150222513|NCT02561195|541949577|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
150222514|NCT02561195|541949578|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
150222515|NCT02561195|541949579|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
150222516|NCT02561195|541949580|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
150222517|NCT02561195|541949581|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
150222518|NCT02561195|541949582|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
150222519|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222520|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222521|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222522|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222523|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222524|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222525|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222526|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222527|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
150222528|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
150222529|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
150222530|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
150222531|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
150222532|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
150222533|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222534|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222535|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222536|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222537|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222538|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222539|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222540|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222541|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222542|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222543|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222544|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222545|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
150222546|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
150222547|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Death|0|||
150222548|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Death|0|||
150222549|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Death|0|||
150222550|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Death|0|||
150222551|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Death|0|||
150222552|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Death|0|||
150222553|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Death|0|||
150222554|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Death|0|||
150222555|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Death|0|||
150222556|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Death|1|||
150222557|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Death|0|||
150222558|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Death|0|||
150222559|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Death|0|||
150222560|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Death|0|||
150222561|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222562|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222563|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222564|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222565|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222566|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222567|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
150222568|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
150222569|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222570|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
150222571|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
150222572|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
150222573|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
150222574|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
150222575|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222576|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222577|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222578|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222579|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222580|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222581|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222582|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222583|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222584|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222585|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
150222586|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
150222587|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
150222588|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
150222589|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Other|0|||
150222590|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Other|0|||
150222591|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Other|0|||
150222592|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Other|0|||
150222593|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Other|0|||
150222594|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Other|0|||
150222595|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Other|0|||
150222596|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Other|0|||
150222597|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Other|0|||
150222598|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Other|0|||
150222599|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Other|2|||
150222600|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Other|2|||
150222601|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Other|1|||
150222602|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Other|0|||
150222603|NCT02561195|541949569|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222604|NCT02561195|541949570|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222605|NCT02561195|541949571|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222606|NCT02561195|541949572|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222607|NCT02561195|541949573|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222608|NCT02561195|541949574|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222609|NCT02561195|541949575|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
150222610|NCT02561195|541949576|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222611|NCT02561195|541949577|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222612|NCT02561195|541949578|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222613|NCT02561195|541949579|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
150222614|NCT02561195|541949580|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
150222615|NCT02561195|541949581|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
150222616|NCT02561195|541949582|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
150222617|NCT03905512|541949585|FG000|Overall Study|Withdrawal by Subject|9|||
150222618|NCT03905512|541949586|FG001|Overall Study|Withdrawal by Subject|8|||
150222619|NCT03905512|541949585|FG000|Overall Study|Adverse Event|1|||
150222620|NCT03905512|541949586|FG001|Overall Study|Adverse Event|2|||
150222621|NCT03905512|541949585|FG000|Overall Study|Lost to Follow-up|4|||
150222622|NCT03905512|541949586|FG001|Overall Study|Lost to Follow-up|3|||
150222623|NCT03905512|541949585|FG000|Overall Study|Other than Specified|7|||
150222624|NCT03905512|541949586|FG001|Overall Study|Other than Specified|4|||
150222625|NCT03547167|541949593|FG000|Overall Study|Withdrawal by Subject|34|||
150222626|NCT03547167|541949594|FG001|Overall Study|Withdrawal by Subject|12|||
150222627|NCT03547167|541949593|FG000|Overall Study|Screen Failure|0|||
150222628|NCT03547167|541949594|FG001|Overall Study|Screen Failure|1|||
150222629|NCT03547167|541949593|FG000|Overall Study|Lost to Follow-up|59|||
150222630|NCT03547167|541949594|FG001|Overall Study|Lost to Follow-up|15|||
150222631|NCT03547167|541949593|FG000|Overall Study|Death|4|||
150222632|NCT03547167|541949594|FG001|Overall Study|Death|2|||
150222633|NCT00070317|541949595|FG000|Overall Study|Inevaluable (Never Treated)|1|||
150222634|NCT00070317|541949595|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
150222635|NCT00070317|541949595|FG000|Overall Study|Ineligible required test not done|1|||
150222636|NCT00070317|541949595|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
150222637|NCT00070317|541949595|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
150222638|NCT00736502|541949596|FG000|Overall Study|Adverse Event|22|||
150222639|NCT00736502|541949596|FG000|Overall Study|Lack of Efficacy|16|||
150222640|NCT00736502|541949596|FG000|Overall Study|Lost to Follow-up|27|||
150222641|NCT00645411|541949597|FG000|Overall Study|Adverse Event|0|||
150222642|NCT00645411|541949598|FG001|Overall Study|Adverse Event|0|||
150222643|NCT00645411|541949599|FG002|Overall Study|Adverse Event|0|||
150222644|NCT00645411|541949600|FG003|Overall Study|Adverse Event|2|||
150222645|NCT00645411|541949597|FG000|Overall Study|Withdrawal by Subject|2|||
150222646|NCT00645411|541949598|FG001|Overall Study|Withdrawal by Subject|1|||
150222647|NCT00645411|541949599|FG002|Overall Study|Withdrawal by Subject|19|||
150222648|NCT00645411|541949600|FG003|Overall Study|Withdrawal by Subject|21|||
150222649|NCT00645411|541949597|FG000|Overall Study|Lost to Follow-up|10|||
150222650|NCT00645411|541949598|FG001|Overall Study|Lost to Follow-up|5|||
150222651|NCT00645411|541949599|FG002|Overall Study|Lost to Follow-up|124|||
150222652|NCT00645411|541949600|FG003|Overall Study|Lost to Follow-up|75|||
150222653|NCT00645411|541949597|FG000|Overall Study|Protocol Violation|1|||
150222654|NCT00645411|541949598|FG001|Overall Study|Protocol Violation|0|||
150222655|NCT00645411|541949599|FG002|Overall Study|Protocol Violation|1|||
150222656|NCT00645411|541949600|FG003|Overall Study|Protocol Violation|0|||
150222657|NCT00645411|541949597|FG000|Overall Study|Inappropriate enrollment|0|||
150222658|NCT00645411|541949598|FG001|Overall Study|Inappropriate enrollment|0|||
150222659|NCT00645411|541949599|FG002|Overall Study|Inappropriate enrollment|4|||
150222660|NCT00645411|541949600|FG003|Overall Study|Inappropriate enrollment|1|||
150222661|NCT00645411|541949597|FG000|Overall Study|Unable to classify|0|||
150222662|NCT00645411|541949598|FG001|Overall Study|Unable to classify|0|||
150222663|NCT00645411|541949599|FG002|Overall Study|Unable to classify|3|||
150222664|NCT00645411|541949600|FG003|Overall Study|Unable to classify|4|||
150222665|NCT03560206|541949601|FG000|Overall Study|Lost to Follow-up|19|||
150222666|NCT03560206|541949602|FG001|Overall Study|Lost to Follow-up|11|||
150222667|NCT03560206|541949601|FG000|Overall Study|Withdrawal by Subject|2|||
150222668|NCT03560206|541949602|FG001|Overall Study|Withdrawal by Subject|4|||
150222669|NCT03560206|541949601|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
150222670|NCT03560206|541949602|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
150222671|NCT03560206|541949601|FG000|Overall Study|Busy schedule|14|||
150222672|NCT03560206|541949602|FG001|Overall Study|Busy schedule|2|||
150222673|NCT03560206|541949601|FG000|Overall Study|patients' new health condition such as cancer|10|||
150222674|NCT03560206|541949602|FG001|Overall Study|patients' new health condition such as cancer|1|||
150222675|NCT03100370|541949603|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150222676|NCT03100370|541949604|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150222677|NCT03100370|541949605|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150222678|NCT03100370|541949606|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
150222679|NCT03100370|541949607|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150222680|NCT03100370|541949608|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
150222681|NCT01307800|541949611|FG000|Overall Study|Adverse Event|9|||
150222682|NCT01307800|541949612|FG001|Overall Study|Adverse Event|8|||
150222683|NCT01307800|541949613|FG002|Overall Study|Adverse Event|10|||
150222684|NCT01307800|541949614|FG003|Overall Study|Adverse Event|14|||
150222685|NCT01307800|541949611|FG000|Overall Study|Entry Criteria Not Met|0|||
150222686|NCT01307800|541949612|FG001|Overall Study|Entry Criteria Not Met|0|||
150222687|NCT01307800|541949613|FG002|Overall Study|Entry Criteria Not Met|0|||
150222688|NCT01307800|541949614|FG003|Overall Study|Entry Criteria Not Met|2|||
150222689|NCT01307800|541949611|FG000|Overall Study|Lost to Follow-up|5|||
150222690|NCT01307800|541949612|FG001|Overall Study|Lost to Follow-up|6|||
150222691|NCT01307800|541949613|FG002|Overall Study|Lost to Follow-up|2|||
150222692|NCT01307800|541949614|FG003|Overall Study|Lost to Follow-up|8|||
150222693|NCT01307800|541949611|FG000|Overall Study|Perceived Lack of Efficacy|24|||
150222694|NCT01307800|541949612|FG001|Overall Study|Perceived Lack of Efficacy|23|||
150222695|NCT01307800|541949613|FG002|Overall Study|Perceived Lack of Efficacy|20|||
150222696|NCT01307800|541949614|FG003|Overall Study|Perceived Lack of Efficacy|33|||
150222697|NCT01307800|541949611|FG000|Overall Study|Protocol Violation|0|||
150222698|NCT01307800|541949612|FG001|Overall Study|Protocol Violation|3|||
150222699|NCT01307800|541949613|FG002|Overall Study|Protocol Violation|4|||
150222700|NCT01307800|541949614|FG003|Overall Study|Protocol Violation|5|||
150222701|NCT01307800|541949611|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
150222702|NCT01307800|541949612|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
150222703|NCT01307800|541949613|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
150222704|NCT01307800|541949614|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
150222705|NCT01307800|541949611|FG000|Overall Study|Sponsor Decision|6|||
150222706|NCT01307800|541949612|FG001|Overall Study|Sponsor Decision|9|||
150222707|NCT01307800|541949613|FG002|Overall Study|Sponsor Decision|12|||
150222708|NCT01307800|541949614|FG003|Overall Study|Sponsor Decision|28|||
150222709|NCT01307800|541949611|FG000|Overall Study|Withdrawal by Subject|10|||
150222710|NCT01307800|541949612|FG001|Overall Study|Withdrawal by Subject|11|||
150222711|NCT01307800|541949613|FG002|Overall Study|Withdrawal by Subject|8|||
150222712|NCT01307800|541949614|FG003|Overall Study|Withdrawal by Subject|15|||
150222713|NCT01307800|541949611|FG000|Overall Study|Participant Moved|0|||
150222714|NCT01307800|541949612|FG001|Overall Study|Participant Moved|2|||
150222715|NCT01307800|541949613|FG002|Overall Study|Participant Moved|1|||
150222716|NCT01307800|541949614|FG003|Overall Study|Participant Moved|3|||
150222717|NCT02674399|541949615|FG000|Overall Study|Lost to Follow-up|2|||
150222718|NCT02674399|541949616|FG001|Overall Study|Lost to Follow-up|0|||
150222719|NCT02255474|541949617|FG000|Overall Study|Lost to Follow-up|1|||
150222720|NCT02255474|541949618|FG001|Overall Study|Lost to Follow-up|1|||
150222721|NCT02255474|541949619|FG002|Overall Study|Lost to Follow-up|3|||
150222722|NCT02255474|541949617|FG000|Overall Study|Withdrawal by Subject|1|||
150222723|NCT02255474|541949618|FG001|Overall Study|Withdrawal by Subject|1|||
150222724|NCT02255474|541949619|FG002|Overall Study|Withdrawal by Subject|0|||
150222725|NCT01084772|541949626|FG000|Baseline|Withdrawal by Subject|7|||
150222726|NCT01084772|541949627|FG001|Baseline|Withdrawal by Subject|6|||
150222727|NCT01084772|541949626|FG000|3 Months|Death|1|||
150222728|NCT01084772|541949627|FG001|3 Months|Death|0|||
150222729|NCT01084772|541949626|FG000|3 Months|Study Termination|2|||
150222730|NCT01084772|541949627|FG001|3 Months|Study Termination|2|||
150222731|NCT01084772|541949626|FG000|1 Year|Withdrawal by Subject|0|||
150222732|NCT01084772|541949627|FG001|1 Year|Withdrawal by Subject|1|||
150222733|NCT01084772|541949626|FG000|1 Year|Lost to Follow-up|3|||
150222734|NCT01084772|541949627|FG001|1 Year|Lost to Follow-up|0|||
150222735|NCT01084772|541949626|FG000|1 Year|Study Termination|0|||
150222736|NCT01084772|541949627|FG001|1 Year|Study Termination|7|||
150222737|NCT01084772|541949626|FG000|2 Years|Withdrawal by Subject|1|||
150222738|NCT01084772|541949627|FG001|2 Years|Withdrawal by Subject|0|||
150222739|NCT01084772|541949626|FG000|2 Years|Lost to Follow-up|5|||
150222740|NCT01084772|541949627|FG001|2 Years|Lost to Follow-up|2|||
150222741|NCT01084772|541949626|FG000|2 Years|Study Termination|3|||
150222742|NCT01084772|541949627|FG001|2 Years|Study Termination|2|||
150222743|NCT01867307|541949628|FG000|Overall Study|Protocol Violation|2|||
150222744|NCT01867307|541949629|FG001|Overall Study|Protocol Violation|0|||
150222745|NCT01867307|541949628|FG000|Overall Study|Other Adverse Event|1|||
150222746|NCT01867307|541949629|FG001|Overall Study|Other Adverse Event|3|||
150222747|NCT02009865|541949637|FG000|Overall Study|Adverse Event|0|||
150222748|NCT02009865|541949638|FG001|Overall Study|Adverse Event|2|||
150222749|NCT02009865|541949637|FG000|Overall Study|Protocol Violation|0|||
150222750|NCT02009865|541949638|FG001|Overall Study|Protocol Violation|2|||
150222751|NCT02009865|541949637|FG000|Overall Study|Withdrawal by Subject|1|||
150222752|NCT02009865|541949638|FG001|Overall Study|Withdrawal by Subject|1|||
150222753|NCT03070301|541949639|FG000|Overall Study|Progression of disease|16|||
150222754|NCT03070301|541949639|FG000|Overall Study|Physician Decision|3|||
150222755|NCT03070301|541949639|FG000|Overall Study|Withdrawal by Subject|1|||
150222756|NCT00489489|541950540|FG000|Overall Study|Not treated due to protocol violation|0|||
150222757|NCT00489489|541950541|FG001|Overall Study|Not treated due to protocol violation|1|||
150222758|NCT00489489|541950542|FG002|Overall Study|Not treated due to protocol violation|1|||
150222759|NCT00489489|541950540|FG000|Overall Study|Adverse Event|1|||
150222760|NCT00489489|541950541|FG001|Overall Study|Adverse Event|1|||
150222761|NCT00489489|541950542|FG002|Overall Study|Adverse Event|1|||
150222762|NCT00489489|541950540|FG000|Overall Study|Protocol Violation|1|||
150222763|NCT00489489|541950541|FG001|Overall Study|Protocol Violation|0|||
150222764|NCT00489489|541950542|FG002|Overall Study|Protocol Violation|1|||
150222765|NCT00489489|541950540|FG000|Overall Study|Progressive disease|0|||
150222766|NCT00489489|541950541|FG001|Overall Study|Progressive disease|1|||
150222767|NCT00489489|541950542|FG002|Overall Study|Progressive disease|0|||
150222768|NCT00489489|541950540|FG000|Overall Study|Participant did not wish to continue|1|||
150222769|NCT00489489|541950541|FG001|Overall Study|Participant did not wish to continue|1|||
150222770|NCT00489489|541950542|FG002|Overall Study|Participant did not wish to continue|0|||
150222771|NCT00489489|541950540|FG000|Overall Study|Other than above|0|||
150222772|NCT00489489|541950541|FG001|Overall Study|Other than above|1|||
150222773|NCT00489489|541950542|FG002|Overall Study|Other than above|0|||
150222774|NCT03978130|541950545|FG000|Overall Study|Lost to Follow-up|13|||
150222775|NCT03978130|541950546|FG001|Overall Study|Lost to Follow-up|14|||
150222776|NCT03978130|541950545|FG000|Overall Study|Withdrawal by Subject|12|||
150222777|NCT03978130|541950546|FG001|Overall Study|Withdrawal by Subject|2|||
150222778|NCT03978130|541950545|FG000|Overall Study|Adverse Event|2|||
150222779|NCT03978130|541950546|FG001|Overall Study|Adverse Event|1|||
150222780|NCT02880293|541950549|FG000|Overall Study|Inevaluable|5|||
150222781|NCT04198428|541950550|FG000|Overall Study|Withdrawal by Subject|150|||
150222782|NCT04198428|541950551|FG001|Overall Study|Withdrawal by Subject|156|||
150222783|NCT00668746|541950555|FG000|Overall Study|Lost to Follow-up|2|||
150222784|NCT00668746|541950556|FG001|Overall Study|Lost to Follow-up|1|||
150222785|NCT03696342|541950558|FG000|Overall Study|Lost to Follow-up|1|||
150222786|NCT03696342|541950559|FG001|Overall Study|Lost to Follow-up|0|||
150222787|NCT02409732|541950560|FG000|Overall Study|Withdrawal by Subject|4|||
150222788|NCT02409732|541950560|FG000|Overall Study|Lost to Follow-up|2|||
150222789|NCT01838499|541950562|FG000|Overall Study|Protocol Violation|0|||
150222790|NCT01838499|541950563|FG001|Overall Study|Protocol Violation|1|||
150222791|NCT01838499|541950562|FG000|Overall Study|Lost to Follow-up|2|||
150222792|NCT01838499|541950563|FG001|Overall Study|Lost to Follow-up|4|||
150222793|NCT01838499|541950562|FG000|Overall Study|Lack of Efficacy|1|||
150222794|NCT01838499|541950563|FG001|Overall Study|Lack of Efficacy|2|||
150222795|NCT01838499|541950562|FG000|Overall Study|Adverse Event|2|||
150222796|NCT01838499|541950563|FG001|Overall Study|Adverse Event|1|||
150222797|NCT01838499|541950562|FG000|Overall Study|Withdrawal by Subject|19|||
150222798|NCT01838499|541950563|FG001|Overall Study|Withdrawal by Subject|9|||
150222799|NCT01797705|541950564|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
150222800|NCT01797705|541950564|FG000|Overall Study|Withdrawal by Subject|1|||
150222801|NCT01838447|541950565|FG000|Overall Study|Change in surgical plan|1|||
150222802|NCT01838447|541950566|FG001|Overall Study|Change in surgical plan|2|||
150222803|NCT01838447|541950565|FG000|Overall Study|Withdrawal by Subject|1|||
150222804|NCT01838447|541950566|FG001|Overall Study|Withdrawal by Subject|1|||
150222805|NCT00168805|541950568|FG000|Overall Study|Adverse Event|7|||
150222806|NCT00168805|541950569|FG001|Overall Study|Adverse Event|11|||
150222807|NCT00168805|541950570|FG002|Overall Study|Adverse Event|16|||
150222808|NCT00168805|541950568|FG000|Overall Study|Protocol Violation|12|||
150222809|NCT00168805|541950569|FG001|Overall Study|Protocol Violation|11|||
150222810|NCT00168805|541950570|FG002|Overall Study|Protocol Violation|8|||
150222811|NCT00168805|541950568|FG000|Overall Study|Lost to Follow-up|12|||
150222812|NCT00168805|541950569|FG001|Overall Study|Lost to Follow-up|17|||
150222813|NCT00168805|541950570|FG002|Overall Study|Lost to Follow-up|11|||
150222814|NCT00168805|541950568|FG000|Overall Study|Withdrawal by Subject|16|||
150222815|NCT00168805|541950569|FG001|Overall Study|Withdrawal by Subject|18|||
150222816|NCT00168805|541950570|FG002|Overall Study|Withdrawal by Subject|21|||
150222817|NCT00168805|541950568|FG000|Overall Study|Other|24|||
150222818|NCT00168805|541950569|FG001|Overall Study|Other|21|||
150222819|NCT00168805|541950570|FG002|Overall Study|Other|22|||
150222820|NCT00168805|541950568|FG000|Treatment|Adverse Event|25|||
150222821|NCT00168805|541950569|FG001|Treatment|Adverse Event|26|||
150222822|NCT00168805|541950570|FG002|Treatment|Adverse Event|32|||
150222823|NCT00168805|541950568|FG000|Treatment|Protocol Violation|3|||
150222824|NCT00168805|541950569|FG001|Treatment|Protocol Violation|5|||
150222825|NCT00168805|541950570|FG002|Treatment|Protocol Violation|5|||
150222826|NCT00168805|541950568|FG000|Treatment|Withdrawal by Subject|3|||
150222827|NCT00168805|541950569|FG001|Treatment|Withdrawal by Subject|7|||
150222828|NCT00168805|541950570|FG002|Treatment|Withdrawal by Subject|8|||
150222829|NCT00168805|541950568|FG000|Treatment|Other|18|||
150222830|NCT00168805|541950569|FG001|Treatment|Other|18|||
150222831|NCT00168805|541950570|FG002|Treatment|Other|17|||
150222832|NCT01114217|541950571|FG000|Overall Study|Adverse Event|5|||
150222833|NCT01114217|541950572|FG001|Overall Study|Adverse Event|3|||
150222834|NCT01114217|541950571|FG000|Overall Study|Lost to Follow-up|17|||
150222835|NCT01114217|541950572|FG001|Overall Study|Lost to Follow-up|33|||
150222836|NCT01114217|541950571|FG000|Overall Study|Withdrawal by Subject|21|||
150222837|NCT01114217|541950572|FG001|Overall Study|Withdrawal by Subject|28|||
150222838|NCT01114217|541950571|FG000|Overall Study|Other-Clerical Error|3|||
150222839|NCT01114217|541950572|FG001|Overall Study|Other-Clerical Error|0|||
150222840|NCT01114217|541950571|FG000|Overall Study|Other-Early termination|6|||
150222841|NCT01114217|541950572|FG001|Overall Study|Other-Early termination|10|||
150222842|NCT01114217|541950571|FG000|Overall Study|Other-Procedure|1|||
150222843|NCT01114217|541950572|FG001|Overall Study|Other-Procedure|1|||
150222844|NCT01114217|541950571|FG000|Overall Study|Other-Pregnancy|2|||
150222845|NCT01114217|541950572|FG001|Overall Study|Other-Pregnancy|4|||
150222846|NCT01114217|541950571|FG000|Overall Study|Other-Protocol Violation|1|||
150222847|NCT01114217|541950572|FG001|Overall Study|Other-Protocol Violation|3|||
150222848|NCT01114217|541950571|FG000|Overall Study|Other-Lack of Efficacy|1|||
150222849|NCT01114217|541950572|FG001|Overall Study|Other-Lack of Efficacy|0|||
150222850|NCT01114217|541950571|FG000|Overall Study|Other-Non Compliance|2|||
150222851|NCT01114217|541950572|FG001|Overall Study|Other-Non Compliance|0|||
150222852|NCT01114217|541950571|FG000|Overall Study|Other-Physician Decision|1|||
150222853|NCT01114217|541950572|FG001|Overall Study|Other-Physician Decision|1|||
150222854|NCT01114217|541950571|FG000|Overall Study|Other-Sponsor Decision|10|||
150222855|NCT01114217|541950572|FG001|Overall Study|Other-Sponsor Decision|12|||
150222856|NCT01114217|541950571|FG000|Overall Study|Other-Study Termination|0|||
150222857|NCT01114217|541950572|FG001|Overall Study|Other-Study Termination|1|||
150222858|NCT01114217|541950571|FG000|Overall Study|Other-Study Withdrawn|1|||
150222859|NCT01114217|541950572|FG001|Overall Study|Other-Study Withdrawn|1|||
150222860|NCT01114217|541950571|FG000|Overall Study|Other-Site Stopped Communicating|2|||
150222861|NCT01114217|541950572|FG001|Overall Study|Other-Site Stopped Communicating|0|||
150222862|NCT01114217|541950571|FG000|Overall Study|Other-Lost to Follow-up|1|||
150222863|NCT01114217|541950572|FG001|Overall Study|Other-Lost to Follow-up|0|||
150222864|NCT01114217|541950571|FG000|Overall Study|Other-Withdrawal by Subject|1|||
150222865|NCT01114217|541950572|FG001|Overall Study|Other-Withdrawal by Subject|1|||
150222866|NCT06247488|541950573|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
150222867|NCT06247488|541950574|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
150222868|NCT06247488|541950575|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
150222869|NCT06247488|541950576|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
150222870|NCT06247488|541950577|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
150222871|NCT06247488|541950578|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
150222872|NCT06247488|541950573|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
150222873|NCT06247488|541950574|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
150222874|NCT06247488|541950575|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
150222875|NCT06247488|541950576|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
150222876|NCT06247488|541950577|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
150222877|NCT06247488|541950578|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
150222878|NCT06247488|541950573|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
150222879|NCT06247488|541950574|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
150222880|NCT06247488|541950575|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
150222881|NCT06247488|541950576|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
150222882|NCT06247488|541950577|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
150222883|NCT06247488|541950578|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
150222884|NCT06247488|541950573|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
150222885|NCT06247488|541950574|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
150222886|NCT06247488|541950575|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
150222887|NCT06247488|541950576|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
150222888|NCT06247488|541950577|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
150222889|NCT06247488|541950578|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
150222890|NCT06247488|541950573|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
150222891|NCT06247488|541950574|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
150222892|NCT06247488|541950575|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
150222893|NCT06247488|541950576|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
150222894|NCT06247488|541950577|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
150222895|NCT06247488|541950578|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
150222896|NCT06247488|541950573|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
150222897|NCT06247488|541950574|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
150222898|NCT06247488|541950575|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
150222899|NCT06247488|541950576|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
150222900|NCT06247488|541950577|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
150222901|NCT06247488|541950578|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
150222902|NCT06247488|541950573|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
150222903|NCT06247488|541950574|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
150222904|NCT06247488|541950575|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
150222905|NCT06247488|541950576|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
150222906|NCT06247488|541950577|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
150222907|NCT06247488|541950578|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
150222908|NCT00561678|541950579|FG000|Overall Study|Withdrawal by Subject|4|||
150222909|NCT00561678|541950580|FG001|Overall Study|Withdrawal by Subject|3|||
150222910|NCT00561678|541950579|FG000|Overall Study|surgery cancelled|1|||
150222911|NCT00561678|541950580|FG001|Overall Study|surgery cancelled|1|||
150222912|NCT00561678|541950579|FG000|Overall Study|surgery rescheduled to different site|2|||
150222913|NCT00561678|541950580|FG001|Overall Study|surgery rescheduled to different site|2|||
150222914|NCT00561678|541950579|FG000|Overall Study|anesthesia provider refusal|1|||
150222915|NCT00561678|541950580|FG001|Overall Study|anesthesia provider refusal|0|||
150222916|NCT01103141|541950581|FG000|Overall Study|Death|0|||
150222917|NCT01103141|541950582|FG001|Overall Study|Death|1|||
150222918|NCT01103141|541950581|FG000|Overall Study|Lost to Follow-up|2|||
150222919|NCT01103141|541950582|FG001|Overall Study|Lost to Follow-up|1|||
150222920|NCT00848198|541950586|FG000|Overall Study|Incomplete Case Report Forms|15|||
150222921|NCT02062827|541950587|FG000|Overall Study|Death|1|||
150222922|NCT02062827|541950588|FG001|Overall Study|Death|0|||
150222923|NCT02062827|541950589|FG002|Overall Study|Death|0|||
150222924|NCT02062827|541950590|FG003|Overall Study|Death|0|||
150222925|NCT02062827|541950591|FG004|Overall Study|Death|0|||
150222926|NCT02062827|541950592|FG005|Overall Study|Death|0|||
150222927|NCT02062827|541950593|FG006|Overall Study|Death|0|||
150222928|NCT02062827|541950594|FG007|Overall Study|Death|0|||
150222929|NCT02062827|541950587|FG000|Overall Study|Withdrawal by Subject|3|||
150222930|NCT02062827|541950588|FG001|Overall Study|Withdrawal by Subject|1|||
150222931|NCT02062827|541950589|FG002|Overall Study|Withdrawal by Subject|1|||
150222932|NCT02062827|541950590|FG003|Overall Study|Withdrawal by Subject|2|||
150222933|NCT02062827|541950591|FG004|Overall Study|Withdrawal by Subject|6|||
150222934|NCT02062827|541950592|FG005|Overall Study|Withdrawal by Subject|0|||
150222935|NCT02062827|541950593|FG006|Overall Study|Withdrawal by Subject|5|||
150222936|NCT02062827|541950594|FG007|Overall Study|Withdrawal by Subject|0|||
150222937|NCT02062827|541950587|FG000|Overall Study|Screen Fail|0|||
150222938|NCT02062827|541950588|FG001|Overall Study|Screen Fail|0|||
150222939|NCT02062827|541950589|FG002|Overall Study|Screen Fail|0|||
150222940|NCT02062827|541950590|FG003|Overall Study|Screen Fail|0|||
150222941|NCT02062827|541950591|FG004|Overall Study|Screen Fail|0|||
150222942|NCT02062827|541950592|FG005|Overall Study|Screen Fail|0|||
150222943|NCT02062827|541950593|FG006|Overall Study|Screen Fail|0|||
150222944|NCT02062827|541950594|FG007|Overall Study|Screen Fail|8|||
150222945|NCT03708744|541950595|FG000|Overall Study|Withdrawal by Subject|0|||
150222946|NCT03708744|541950596|FG001|Overall Study|Withdrawal by Subject|0|||
150222947|NCT03708744|541950597|FG002|Overall Study|Withdrawal by Subject|1|||
150222948|NCT03708744|541950598|FG003|Overall Study|Withdrawal by Subject|0|||
150222949|NCT02604199|541950599|FG000|Overall Study|Pregnancy|0|||
150222950|NCT02604199|541950600|FG001|Overall Study|Pregnancy|0|||
150222951|NCT02604199|541950601|FG002|Overall Study|Pregnancy|0|||
150222952|NCT02604199|541950602|FG003|Overall Study|Pregnancy|1|||
150222953|NCT02604199|541950599|FG000|Overall Study|Study terminated by sponsor|0|||
150222954|NCT02604199|541950600|FG001|Overall Study|Study terminated by sponsor|2|||
150222955|NCT02604199|541950601|FG002|Overall Study|Study terminated by sponsor|0|||
150222956|NCT02604199|541950602|FG003|Overall Study|Study terminated by sponsor|2|||
150222957|NCT02604199|541950599|FG000|Overall Study|Withdrawal by Subject|0|||
150222958|NCT02604199|541950600|FG001|Overall Study|Withdrawal by Subject|1|||
150222959|NCT02604199|541950601|FG002|Overall Study|Withdrawal by Subject|0|||
150222960|NCT02604199|541950602|FG003|Overall Study|Withdrawal by Subject|0|||
150222961|NCT04362176|541950609|FG000|Overall Study|Lost to Follow-up|5|||
150222962|NCT04362176|541950610|FG001|Overall Study|Lost to Follow-up|8|||
150222963|NCT04362176|541950609|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
150222964|NCT04362176|541950610|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
150222965|NCT05740371|541950613|FG000|Overall Study|Death|1|||
150222966|NCT00617708|541950616|FG000|Overall Study|Adverse Event|0|||
150222967|NCT00617708|541950617|FG001|Overall Study|Adverse Event|6|||
150222968|NCT00617708|541950618|FG002|Overall Study|Adverse Event|9|||
150222969|NCT00617708|541950616|FG000|Overall Study|Withdrawal by Subject|1|||
150222970|NCT00617708|541950617|FG001|Overall Study|Withdrawal by Subject|1|||
150222971|NCT00617708|541950618|FG002|Overall Study|Withdrawal by Subject|7|||
150222972|NCT00617708|541950616|FG000|Overall Study|Death|0|||
150222973|NCT00617708|541950617|FG001|Overall Study|Death|6|||
150222974|NCT00617708|541950618|FG002|Overall Study|Death|5|||
150222975|NCT00617708|541950616|FG000|Overall Study|Progression/Relapse|7|||
150222976|NCT00617708|541950617|FG001|Overall Study|Progression/Relapse|40|||
150222977|NCT00617708|541950618|FG002|Overall Study|Progression/Relapse|36|||
150222978|NCT00617708|541950616|FG000|Overall Study|Not protocol specified|1|||
150222979|NCT00617708|541950617|FG001|Overall Study|Not protocol specified|4|||
150222980|NCT00617708|541950618|FG002|Overall Study|Not protocol specified|2|||
150222981|NCT00617708|541950616|FG000|Overall Study|Not eligible|1|||
150222982|NCT00617708|541950617|FG001|Overall Study|Not eligible|3|||
150222983|NCT00617708|541950618|FG002|Overall Study|Not eligible|5|||
150222984|NCT02991456|541950619|FG000|Overall Study|Adverse Event|2|||
150222985|NCT02991456|541950620|FG001|Overall Study|Adverse Event|0|||
150222986|NCT02991456|541950619|FG000|Overall Study|Lost to Follow-up|0|||
150222987|NCT02991456|541950620|FG001|Overall Study|Lost to Follow-up|2|||
150222988|NCT02991456|541950619|FG000|Overall Study|Withdrawal by Subject|1|||
150222989|NCT02991456|541950620|FG001|Overall Study|Withdrawal by Subject|0|||
150222990|NCT01699178|541950621|FG000|Overall Study|Adverse Event|1|||
150222991|NCT01699178|541950622|FG001|Overall Study|Adverse Event|5|||
150222992|NCT01699178|541950621|FG000|Overall Study|Lost to Follow-up|1|||
150222993|NCT01699178|541950622|FG001|Overall Study|Lost to Follow-up|6|||
150222994|NCT01699178|541950621|FG000|Overall Study|Non-compliance with Study Drug|3|||
150222995|NCT01699178|541950622|FG001|Overall Study|Non-compliance with Study Drug|1|||
150222996|NCT01699178|541950621|FG000|Overall Study|Physician Decision|1|||
150222997|NCT01699178|541950622|FG001|Overall Study|Physician Decision|0|||
150222998|NCT01699178|541950621|FG000|Overall Study|Withdrawal by Subject|4|||
150222999|NCT01699178|541950622|FG001|Overall Study|Withdrawal by Subject|12|||
150223000|NCT01699178|541950621|FG000|Overall Study|Hematocrit >54%|1|||
150223001|NCT01699178|541950622|FG001|Overall Study|Hematocrit >54%|1|||
150223002|NCT01699178|541950621|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
150223003|NCT01699178|541950622|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
150223004|NCT01699178|541950621|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
150223005|NCT01699178|541950622|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
150223006|NCT01885559|541950628|FG000|Overall Study|Lost to Follow-up|15|||
150223007|NCT01885559|541950629|FG001|Overall Study|Lost to Follow-up|16|||
150223008|NCT01885559|541950628|FG000|Overall Study|Less than full participation|9|||
150223009|NCT01885559|541950629|FG001|Overall Study|Less than full participation|19|||
150223010|NCT01885559|541950628|FG000|Overall Study|Protocol Violation|0|||
150223011|NCT01885559|541950629|FG001|Overall Study|Protocol Violation|1|||
150223012|NCT03987074|541950631|FG000|Overall Study|Withdrew Consent|1|||
150223013|NCT03987074|541950632|FG001|Overall Study|Withdrew Consent|1|||
150223014|NCT03987074|541950633|FG002|Overall Study|Withdrew Consent|0|||
150223015|NCT03987074|541950634|FG003|Overall Study|Withdrew Consent|2|||
150223016|NCT03987074|541950635|FG004|Overall Study|Withdrew Consent|1|||
150223017|NCT03987074|541950631|FG000|Overall Study|Adverse Event|2|||
150223018|NCT03987074|541950632|FG001|Overall Study|Adverse Event|1|||
150223019|NCT03987074|541950633|FG002|Overall Study|Adverse Event|0|||
150223020|NCT03987074|541950634|FG003|Overall Study|Adverse Event|0|||
150223021|NCT03987074|541950635|FG004|Overall Study|Adverse Event|1|||
150223022|NCT03987074|541950631|FG000|Overall Study|Lost to Follow-up|0|||
150223023|NCT03987074|541950632|FG001|Overall Study|Lost to Follow-up|0|||
150223024|NCT03987074|541950633|FG002|Overall Study|Lost to Follow-up|1|||
150223025|NCT03987074|541950634|FG003|Overall Study|Lost to Follow-up|1|||
150223026|NCT03987074|541950635|FG004|Overall Study|Lost to Follow-up|0|||
150223027|NCT03987074|541950631|FG000|Overall Study|Investigator's Discretion|0|||
150223028|NCT03987074|541950632|FG001|Overall Study|Investigator's Discretion|0|||
150223029|NCT03987074|541950633|FG002|Overall Study|Investigator's Discretion|0|||
150223030|NCT03987074|541950634|FG003|Overall Study|Investigator's Discretion|1|||
150223031|NCT03987074|541950635|FG004|Overall Study|Investigator's Discretion|0|||
150223032|NCT00508144|541950636|FG000|Overall Study|Not eligible|6|||
150223033|NCT00508144|541950636|FG000|Overall Study|Death|5|||
150223034|NCT00525915|541950637|FG000|Overall Study|Non-Compliance|0|||
150223035|NCT00525915|541950638|FG001|Overall Study|Non-Compliance|1|||
150223036|NCT00525915|541950637|FG000|Overall Study|Disease Progression|5|||
150223037|NCT00525915|541950638|FG001|Overall Study|Disease Progression|6|||
150223038|NCT00525915|541950637|FG000|Overall Study|Withdrawal by Subject|1|||
150223039|NCT00525915|541950638|FG001|Overall Study|Withdrawal by Subject|0|||
150223040|NCT00525915|541950637|FG000|Overall Study|Refused Surgery|1|||
150223041|NCT00525915|541950638|FG001|Overall Study|Refused Surgery|2|||
150223042|NCT00525915|541950637|FG000|Overall Study|Unrelated illness|1|||
150223043|NCT00525915|541950638|FG001|Overall Study|Unrelated illness|0|||
150223044|NCT02135445|541950640|FG000|Overall Study|Lost to Follow-up|1|||
150223045|NCT02135445|541950641|FG001|Overall Study|Lost to Follow-up|0|||
150223046|NCT02135445|541950640|FG000|Overall Study|Withdrawal by Subject|1|||
150223047|NCT02135445|541950641|FG001|Overall Study|Withdrawal by Subject|0|||
150223048|NCT03820024|541950642|FG000|Overall Study|Physician Decision|1|||
150223049|NCT03820024|541950643|FG001|Overall Study|Physician Decision|2|||
150223050|NCT03556891|541950644|FG000|Initial Pivotal Study|Adverse Event|4|||
150223051|NCT03556891|541950644|FG000|Initial Pivotal Study|MRI Need|3|||
150223052|NCT03556891|541950644|FG000|Initial Pivotal Study|Device Failure|1|||
150223053|NCT03556891|541950644|FG000|Initial Pivotal Study|Death|1|||
150223054|NCT03556891|541950644|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
150223055|NCT03556891|541950644|FG000|Initial Pivotal Study|Missing at random|1|||
150223056|NCT03556891|541950644|FG000|Initial Pivotal Study|Missing due to COVID|1|||
150223057|NCT03556891|541950644|FG000|Initial Pivotal Study|Protocol Violation|1|||
150223058|NCT02136797|541951665|FG000|Overall Study|Not Treated|8|||
150223059|NCT04523571|541951666|FG000|Received 2 Doses|Withdrawal by Subject|0|||
150223060|NCT04523571|541951667|FG001|Received 2 Doses|Withdrawal by Subject|0|||
150223061|NCT04523571|541951668|FG002|Received 2 Doses|Withdrawal by Subject|0|||
150223062|NCT04523571|541951669|FG003|Received 2 Doses|Withdrawal by Subject|1|||
150223063|NCT04523571|541951670|FG004|Received 2 Doses|Withdrawal by Subject|1|||
150223064|NCT04523571|541951671|FG005|Received 2 Doses|Withdrawal by Subject|0|||
150223065|NCT04523571|541951666|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
150223066|NCT04523571|541951667|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
150223067|NCT04523571|541951668|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
150223068|NCT04523571|541951669|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
150223069|NCT04523571|541951670|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
150223070|NCT04523571|541951671|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
150223071|NCT04523571|541951666|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
150223072|NCT04523571|541951667|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
150223073|NCT04523571|541951668|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
150223074|NCT04523571|541951669|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
150223075|NCT04523571|541951670|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
150223076|NCT04523571|541951671|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
150223077|NCT04523571|541951666|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
150223078|NCT04523571|541951667|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
150223079|NCT04523571|541951668|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
150223080|NCT04523571|541951669|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
150223081|NCT04523571|541951670|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
150223082|NCT04523571|541951671|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
150223083|NCT02123797|541951673|FG000|Baseline Intervention|Death|9|||
150223084|NCT02123797|541951674|FG001|Baseline Intervention|Death|16|||
150223085|NCT02123797|541951675|FG002|Baseline Intervention|Death|0|||
150223086|NCT02123797|541951676|FG003|Baseline Intervention|Death|0|||
150223087|NCT02123797|541951677|FG004|Baseline Intervention|Death|0|||
150223088|NCT02123797|541951673|FG000|Baseline Intervention|Withdrawal by Subject|2|||
150223089|NCT02123797|541951674|FG001|Baseline Intervention|Withdrawal by Subject|8|||
150223090|NCT02123797|541951675|FG002|Baseline Intervention|Withdrawal by Subject|0|||
150223091|NCT02123797|541951676|FG003|Baseline Intervention|Withdrawal by Subject|0|||
150223092|NCT02123797|541951677|FG004|Baseline Intervention|Withdrawal by Subject|0|||
150223093|NCT02123797|541951673|FG000|Baseline Intervention|Relocation|2|||
150223094|NCT02123797|541951674|FG001|Baseline Intervention|Relocation|0|||
150223095|NCT02123797|541951675|FG002|Baseline Intervention|Relocation|0|||
150223096|NCT02123797|541951676|FG003|Baseline Intervention|Relocation|0|||
150223097|NCT02123797|541951677|FG004|Baseline Intervention|Relocation|0|||
150223098|NCT02123797|541951673|FG000|Baseline Intervention|Out of window for initial survey|6|||
150223099|NCT02123797|541951674|FG001|Baseline Intervention|Out of window for initial survey|13|||
150223100|NCT02123797|541951675|FG002|Baseline Intervention|Out of window for initial survey|0|||
150223101|NCT02123797|541951676|FG003|Baseline Intervention|Out of window for initial survey|0|||
150223102|NCT02123797|541951677|FG004|Baseline Intervention|Out of window for initial survey|0|||
150223103|NCT02123797|541951673|FG000|Baseline Intervention|Lost to Follow-up|0|||
150223104|NCT02123797|541951674|FG001|Baseline Intervention|Lost to Follow-up|5|||
150223105|NCT02123797|541951675|FG002|Baseline Intervention|Lost to Follow-up|0|||
150223106|NCT02123797|541951676|FG003|Baseline Intervention|Lost to Follow-up|0|||
150223107|NCT02123797|541951677|FG004|Baseline Intervention|Lost to Follow-up|0|||
150223108|NCT02123797|541951673|FG000|Baseline Intervention|Other Disease|3|||
150223109|NCT02123797|541951674|FG001|Baseline Intervention|Other Disease|0|||
150223110|NCT02123797|541951675|FG002|Baseline Intervention|Other Disease|0|||
150223111|NCT02123797|541951676|FG003|Baseline Intervention|Other Disease|0|||
150223112|NCT02123797|541951677|FG004|Baseline Intervention|Other Disease|0|||
150223113|NCT02123797|541951673|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
150223114|NCT02123797|541951674|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
150223115|NCT02123797|541951675|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
150223116|NCT02123797|541951676|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
150223117|NCT02123797|541951677|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
150223118|NCT02123797|541951673|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
150223119|NCT02123797|541951674|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
150223120|NCT02123797|541951675|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
150223121|NCT02123797|541951676|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
150223122|NCT02123797|541951677|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
150223123|NCT02123797|541951673|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
150223124|NCT02123797|541951674|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
150223125|NCT02123797|541951675|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223126|NCT02123797|541951676|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223127|NCT02123797|541951677|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223128|NCT02123797|541951673|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
150223129|NCT02123797|541951674|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
150223130|NCT02123797|541951675|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
150223131|NCT02123797|541951676|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
150223132|NCT02123797|541951677|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
150223133|NCT02123797|541951673|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
150223134|NCT02123797|541951674|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
150223135|NCT02123797|541951675|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
150223136|NCT02123797|541951676|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
150223137|NCT02123797|541951677|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
150223138|NCT02123797|541951673|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
150223139|NCT02123797|541951674|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
150223140|NCT02123797|541951675|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
150223141|NCT02123797|541951676|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
150223142|NCT02123797|541951677|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
150223143|NCT02123797|541951673|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
150223144|NCT02123797|541951674|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
150223145|NCT02123797|541951675|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
150223146|NCT02123797|541951676|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
150223147|NCT02123797|541951677|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
150223148|NCT02123797|541951673|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
150223149|NCT02123797|541951674|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
150223150|NCT02123797|541951675|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223151|NCT02123797|541951676|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223152|NCT02123797|541951677|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
150223153|NCT02123797|541951673|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
150223154|NCT02123797|541951674|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
150223155|NCT02123797|541951675|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
150223156|NCT02123797|541951676|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
150223157|NCT02123797|541951677|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
150223158|NCT05878990|541951680|FG000|Overall Study|Lost to Follow-up|7|||
150223159|NCT05878990|541951680|FG000|Overall Study|Withdrawal by Subject|1|||
150223160|NCT02011568|541951683|FG000|Overall Study|Withdrawal by Subject|8|||
150223161|NCT02011568|541951684|FG001|Overall Study|Withdrawal by Subject|10|||
150223162|NCT02011568|541951683|FG000|Overall Study|Physician Decision|1|||
150223163|NCT02011568|541951684|FG001|Overall Study|Physician Decision|3|||
150223164|NCT03344458|541951685|FG000|Overall Study|Physician Decision|1|||
150223165|NCT03344458|541951685|FG000|Overall Study|Withdrawal by Subject|16|||
150223166|NCT03344458|541951685|FG000|Overall Study|Other reasons|10|||
150223167|NCT03344458|541951685|FG000|Overall Study|Lost to Follow-up|9|||
150223168|NCT03344458|541951685|FG000|Overall Study|Protocol Violation|3|||
150223169|NCT00396409|541951686|FG000|Period 1 - 2007|Adverse Event|0|||
150223170|NCT00396409|541951687|FG001|Period 1 - 2007|Adverse Event|1|||
150223171|NCT00396409|541951686|FG000|Period 1 - 2007|Lack of Efficacy|0|||
150223172|NCT00396409|541951687|FG001|Period 1 - 2007|Lack of Efficacy|1|||
150223173|NCT00396409|541951686|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
150223174|NCT00396409|541951687|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
150223175|NCT00396409|541951686|FG000|Period 1 - 2007|Lost to Follow-up|2|||
150223176|NCT00396409|541951687|FG001|Period 1 - 2007|Lost to Follow-up|3|||
150223177|NCT00396409|541951686|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
150223178|NCT00396409|541951687|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
150223179|NCT00396409|541951686|FG000|Period 2 - 2008|Protocol Violation|1|||
150223180|NCT00396409|541951687|FG001|Period 2 - 2008|Protocol Violation|0|||
150223181|NCT00396409|541951686|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
150223182|NCT00396409|541951687|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
150223183|NCT00396409|541951686|FG000|Period 2 - 2008|Lost to Follow-up|3|||
150223184|NCT00396409|541951687|FG001|Period 2 - 2008|Lost to Follow-up|1|||
150223185|NCT00331799|541951688|FG000|Overall Study|Withdrawal by Subject|2|||
150223186|NCT00331799|541951688|FG000|Overall Study|Sedation|1|||
150223187|NCT02889809|541951689|FG000|Overall Study|Withdrawal by Subject|30|||
150223188|NCT02889809|541951690|FG001|Overall Study|Withdrawal by Subject|21|||
150223189|NCT02889809|541951689|FG000|Overall Study|Lost to Follow-up|1|||
150223190|NCT02889809|541951690|FG001|Overall Study|Lost to Follow-up|1|||
150223191|NCT02889809|541951689|FG000|Overall Study|Site Closed|12|||
150223192|NCT02889809|541951690|FG001|Overall Study|Site Closed|11|||
150223193|NCT04203199|541951691|FG000|First Intervention Period|Lost to Follow-up|0|||
150223194|NCT04203199|541951692|FG001|First Intervention Period|Lost to Follow-up|1|||
150223195|NCT04203199|541951691|FG000|Second Intervention Period|Medication change|1|||
150223196|NCT04203199|541951692|FG001|Second Intervention Period|Medication change|0|||
150223197|NCT03314233|541951700|FG000|Overall Study|No longer eligible at time of delivery|1|||
150223198|NCT02030847|541951701|FG000|Overall Study|Death|10|||
150223199|NCT02030847|541951701|FG000|Overall Study|Disease Progression|15|||
150223200|NCT02030847|541951701|FG000|Overall Study|New Cancer Therapy|8|||
150223201|NCT02030847|541951701|FG000|Overall Study|Physician Decision|3|||
150223202|NCT02030847|541951701|FG000|Overall Study|Withdrawal by Subject|1|||
150223203|NCT03785210|541951704|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
150223204|NCT03785210|541951705|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
150223205|NCT00460434|541951706|FG000|Overall Study|Lost to Follow-up|3|||
150223206|NCT00460434|541951707|FG001|Overall Study|Lost to Follow-up|7|||
150223207|NCT00510783|541951710|FG000|Overall Study|Lost to Follow-up|29|||
150223208|NCT00510783|541951711|FG001|Overall Study|Lost to Follow-up|25|||
150223209|NCT00510783|541951710|FG000|Overall Study|Withdrawal by Subject|2|||
150223210|NCT00510783|541951711|FG001|Overall Study|Withdrawal by Subject|3|||
150223211|NCT00510783|541951710|FG000|Overall Study|Protocol Violation|0|||
150223212|NCT00510783|541951711|FG001|Overall Study|Protocol Violation|1|||
150223213|NCT00316121|541951712|FG000|Overall Study|Death|1|||
150223214|NCT00316121|541951713|FG001|Overall Study|Death|0|||
150223215|NCT00316121|541951712|FG000|Overall Study|Lost to Follow-up|14|||
150223216|NCT00316121|541951713|FG001|Overall Study|Lost to Follow-up|8|||
150223217|NCT00316121|541951712|FG000|Overall Study|Withdrawal by Subject|2|||
150223218|NCT00316121|541951713|FG001|Overall Study|Withdrawal by Subject|0|||
150223219|NCT00316121|541951712|FG000|Overall Study|Reason is missing|1|||
150223220|NCT00316121|541951713|FG001|Overall Study|Reason is missing|0|||
150223221|NCT00316121|541951712|FG000|Overall Study|Subject relocated|1|||
150223222|NCT00316121|541951713|FG001|Overall Study|Subject relocated|1|||
150223223|NCT00316121|541951712|FG000|Overall Study|Subject refused to return|1|||
150223224|NCT00316121|541951713|FG001|Overall Study|Subject refused to return|0|||
150223225|NCT00316121|541951712|FG000|Overall Study|Subject no show for visit x 3|1|||
150223226|NCT00316121|541951713|FG001|Overall Study|Subject no show for visit x 3|0|||
150223227|NCT00316121|541951712|FG000|Overall Study|Subject did not have 24 month visit|1|||
150223228|NCT00316121|541951713|FG001|Overall Study|Subject did not have 24 month visit|0|||
150223229|NCT00460577|541951719|FG000|Overall Study|Protocol Violation|2|||
150223230|NCT00460577|541951720|FG001|Overall Study|Protocol Violation|6|||
150223231|NCT02632045|541951724|FG000|Overall Study|Withdrawal by Subject|1|||
150223232|NCT02632045|541951725|FG001|Overall Study|Withdrawal by Subject|2|||
150223233|NCT05878522|541951726|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223234|NCT05878522|541951727|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223235|NCT05878522|541951728|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223236|NCT05878522|541951729|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223237|NCT05878522|541951730|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223238|NCT05878522|541951731|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223239|NCT05878522|541951732|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223240|NCT05878522|541951733|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223241|NCT05878522|541951734|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
150223242|NCT05878522|541951735|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223243|NCT05878522|541951736|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223244|NCT05878522|541951737|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
150223245|NCT05878522|541951726|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
150223246|NCT05878522|541951727|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223247|NCT05878522|541951728|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223248|NCT05878522|541951729|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223249|NCT05878522|541951730|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223250|NCT05878522|541951731|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223251|NCT05878522|541951732|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223252|NCT05878522|541951733|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223253|NCT05878522|541951734|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223254|NCT05878522|541951735|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
150223255|NCT05878522|541951736|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223256|NCT05878522|541951737|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
150223257|NCT05878522|541951726|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223258|NCT05878522|541951727|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
150223259|NCT05878522|541951728|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223260|NCT05878522|541951729|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
150223261|NCT05878522|541951730|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223262|NCT05878522|541951731|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223263|NCT05878522|541951732|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223264|NCT05878522|541951733|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223265|NCT05878522|541951734|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223266|NCT05878522|541951735|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223267|NCT05878522|541951736|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223268|NCT05878522|541951737|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
150223269|NCT05878522|541951726|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223270|NCT05878522|541951727|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223271|NCT05878522|541951728|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223272|NCT05878522|541951729|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223273|NCT05878522|541951730|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
150223274|NCT05878522|541951731|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223275|NCT05878522|541951732|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223276|NCT05878522|541951733|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223277|NCT05878522|541951734|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223278|NCT05878522|541951735|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223279|NCT05878522|541951736|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223280|NCT05878522|541951737|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
150223281|NCT04551053|541951738|FG000|Overall Study|Death|10|||
150223282|NCT04551053|541951739|FG001|Overall Study|Death|9|||
150223283|NCT04551053|541951738|FG000|Overall Study|Lost to Follow-up|0|||
150223284|NCT04551053|541951739|FG001|Overall Study|Lost to Follow-up|2|||
150223285|NCT04551053|541951738|FG000|Overall Study|Study Terminated by Sponsor|57|||
150223286|NCT04551053|541951739|FG001|Overall Study|Study Terminated by Sponsor|65|||
150223287|NCT04551053|541951738|FG000|Overall Study|Withdrawal by Subject|12|||
150223288|NCT04551053|541951739|FG001|Overall Study|Withdrawal by Subject|5|||
150223289|NCT04551053|541951738|FG000|Overall Study|Adverse Event|2|||
150223290|NCT04551053|541951739|FG001|Overall Study|Adverse Event|0|||
150223291|NCT04551053|541951738|FG000|Overall Study|Lack of Efficacy|2|||
150223292|NCT04551053|541951739|FG001|Overall Study|Lack of Efficacy|1|||
150223293|NCT04551053|541951738|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
150223294|NCT04551053|541951739|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
150223295|NCT04551053|541951738|FG000|Overall Study|Splenapendectomi|1|||
150223296|NCT04551053|541951739|FG001|Overall Study|Splenapendectomi|0|||
150223297|NCT04551053|541951738|FG000|Overall Study|Medical Decision|1|||
150223298|NCT04551053|541951739|FG001|Overall Study|Medical Decision|1|||
150223299|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
150223300|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
150223301|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
150223302|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
150223303|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
150223304|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
150223305|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
150223306|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
150223307|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
150223308|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
150223309|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
150223310|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
150223311|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
150223312|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
150223313|NCT02971683|541951740|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
150223314|NCT02971683|541951741|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
150223315|NCT02971683|541951740|FG000|Open-Label|Lost to Follow-up|1|||
150223316|NCT02971683|541951741|FG001|Open-Label|Lost to Follow-up|0|||
150223317|NCT02971683|541951740|FG000|Open-Label|Participants withdrew consent|0|||
150223318|NCT02971683|541951741|FG001|Open-Label|Participants withdrew consent|2|||
150223319|NCT02971683|541951740|FG000|Open-Label|Participant request to discontinue study treatment|1|||
150223320|NCT02971683|541951741|FG001|Open-Label|Participant request to discontinue study treatment|0|||
150223321|NCT02971683|541951740|FG000|Open-Label|Lack of Efficacy|2|||
150223322|NCT02971683|541951741|FG001|Open-Label|Lack of Efficacy|0|||
150223323|NCT02971683|541951740|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
150223324|NCT02971683|541951741|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
150223325|NCT02971683|541951740|FG000|Long-Term Open Label|Participant withdrew consent|1|||
150223326|NCT02971683|541951741|FG001|Long-Term Open Label|Participant withdrew consent|0|||
150223327|NCT02971683|541951740|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
150223328|NCT02971683|541951741|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
150223329|NCT02971683|541951740|FG000|Long-Term Open Label|Adverse Event|1|||
150223330|NCT02971683|541951741|FG001|Long-Term Open Label|Adverse Event|2|||
150223331|NCT02971683|541951740|FG000|Long-Term Open Label|Lack of Efficacy|1|||
150223332|NCT02971683|541951741|FG001|Long-Term Open Label|Lack of Efficacy|1|||
150223333|NCT03503188|541951747|FG000|Overall Study|Non eligible in the sub study|0|||
150223334|NCT03503188|541951748|FG001|Overall Study|Non eligible in the sub study|1|||
150223335|NCT02993926|541951749|FG000|Enantone Treatment Phase|Adverse Event|1|||
150223336|NCT02993926|541951750|FG001|Enantone Treatment Phase|Adverse Event|0|||
150223337|NCT02993926|541951751|FG002|Enantone Treatment Phase|Adverse Event|0|||
150223338|NCT02993926|541951749|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
150223339|NCT02993926|541951750|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
150223340|NCT02993926|541951751|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
150223341|NCT02993926|541951749|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
150223342|NCT02993926|541951750|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
150223343|NCT02993926|541951751|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
150223344|NCT02993926|541951749|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
150223345|NCT02993926|541951750|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
150223346|NCT02993926|541951751|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
150223347|NCT00732498|541951755|FG000|Overall Study|Ineligible|1|||
150223348|NCT00732498|541951755|FG000|Overall Study|Adverse Event|2|||
150223349|NCT00732498|541951755|FG000|Overall Study|Physician Decision|3|||
150223350|NCT03394508|541951759|FG000|Overall Study|Protocol Violation|0|||
150223351|NCT03394508|541951760|FG001|Overall Study|Protocol Violation|3|||
150223352|NCT03394508|541951759|FG000|Overall Study|Lost to Follow-up|1|||
150223353|NCT03394508|541951760|FG001|Overall Study|Lost to Follow-up|0|||
150223354|NCT00267865|541951761|FG000|Induction Treatment|Died before completing.|2|||
150223355|NCT00267865|541951761|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
150223356|NCT04295499|541951765|FG000|Overall Study|moving out of state|1|||
150223357|NCT04295499|541951766|FG001|Overall Study|moving out of state|0|||
150255337|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
150255338|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
150255339|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
150255340|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
150255341|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
150255342|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
150255343|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
150255344|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
150255345|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
150255346|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
150255347|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
150255348|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
150255349|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
150255350|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
150255351|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
150255352|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
150255353|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
150255354|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
150255355|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
150255356|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
150255357|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
150255358|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
150255359|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
150255360|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
150255361|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
150255362|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
150255363|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
150255364|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
150255365|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
150255366|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
150255367|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
150255368|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
150255369|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
150255370|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
150255371|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
150255372|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
150255373|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
150255374|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
150255375|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
150255376|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
150255377|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
150255378|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
150255379|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
150255380|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
150255381|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
150255382|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
150255383|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
150255384|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
150255385|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
150255386|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
150255387|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
150255388|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
150255389|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
150255390|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
150255391|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
150255392|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
150255393|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
150223358|NCT04295499|541951765|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
150223359|NCT04295499|541951766|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
150223360|NCT03122548|541951767|FG000|Overall Study|Death|2|||
150223361|NCT03122548|541951767|FG000|Overall Study|Progression - subject went into hospice|1|||
150223362|NCT03122548|541951767|FG000|Overall Study|Study Terminated by Sponsor|2|||
150223363|NCT00308113|541951768|FG000|Overall Study|Protocol closure|0|||
150223364|NCT00308113|541951769|FG001|Overall Study|Protocol closure|0|||
150223365|NCT00308113|541951770|FG002|Overall Study|Protocol closure|0|||
150223366|NCT00308113|541951771|FG003|Overall Study|Protocol closure|1|||
150223367|NCT02819141|541951772|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
150223368|NCT02819141|541951773|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
150223369|NCT00676195|541953184|FG000|Overall Study|Lost to Follow-up|1|||
150223370|NCT00676195|541953184|FG000|Overall Study|Adverse Event|1|||
150223371|NCT00676195|541953184|FG000|Overall Study|Physician Decision|1|||
150223372|NCT01184859|541953185|FG000|Period 1: Single Dose|Insufficient urine production|0|||
150223373|NCT01184859|541953186|FG001|Period 1: Single Dose|Insufficient urine production|1|||
150223374|NCT01184859|541953187|FG002|Period 1: Single Dose|Insufficient urine production|0|||
150223375|NCT01184859|541953188|FG003|Period 1: Single Dose|Insufficient urine production|0|||
150223376|NCT01184859|541953189|FG004|Period 1: Single Dose|Insufficient urine production|0|||
150223377|NCT01184859|541953185|FG000|Period 1: Single Dose|Protocol Violation|0|||
150223378|NCT01184859|541953186|FG001|Period 1: Single Dose|Protocol Violation|1|||
150223379|NCT01184859|541953187|FG002|Period 1: Single Dose|Protocol Violation|0|||
150223380|NCT01184859|541953188|FG003|Period 1: Single Dose|Protocol Violation|0|||
150223381|NCT01184859|541953189|FG004|Period 1: Single Dose|Protocol Violation|0|||
150223382|NCT01184859|541953185|FG000|Period 1: Single Dose|Adverse Event|0|||
150223383|NCT01184859|541953186|FG001|Period 1: Single Dose|Adverse Event|0|||
150223384|NCT01184859|541953187|FG002|Period 1: Single Dose|Adverse Event|0|||
150223385|NCT01184859|541953188|FG003|Period 1: Single Dose|Adverse Event|0|||
150223386|NCT01184859|541953189|FG004|Period 1: Single Dose|Adverse Event|1|||
150223387|NCT01184859|541953185|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
150223388|NCT01184859|541953186|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
150223389|NCT01184859|541953187|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
150223390|NCT01184859|541953188|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
150223391|NCT01184859|541953189|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
150223392|NCT01184859|541953185|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
150223393|NCT01184859|541953186|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
150223394|NCT01184859|541953187|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
150223395|NCT01184859|541953188|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
150223396|NCT01184859|541953189|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
150223397|NCT00961298|541953190|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
150223398|NCT00961298|541953190|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
150223399|NCT00961298|541953190|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
150223400|NCT02388932|541953191|FG000|Overall Study|Death|1|||
150223401|NCT05927753|541953194|FG000|Overall Study|Withdrawal by Subject|0|||
150223402|NCT05927753|541953195|FG001|Overall Study|Withdrawal by Subject|2|||
150223403|NCT05927753|541953194|FG000|Overall Study|Physician Decision|0|||
150223404|NCT05927753|541953195|FG001|Overall Study|Physician Decision|1|||
150223405|NCT00627523|541953197|FG000|Overall Study|Lack of Efficacy|1|||
150223406|NCT00627523|541953198|FG001|Overall Study|Lack of Efficacy|0|||
150223407|NCT00627523|541953197|FG000|Overall Study|Withdrawal by Subject|0|||
150223408|NCT00627523|541953198|FG001|Overall Study|Withdrawal by Subject|2|||
150223409|NCT00627523|541953197|FG000|Overall Study|Other|1|||
150223410|NCT00627523|541953198|FG001|Overall Study|Other|0|||
150223411|NCT01038128|541953200|FG000|Overall Study|Lack of Efficacy|1|||
150223412|NCT01038128|541953200|FG000|Overall Study|Lost to Follow-up|1|||
150223413|NCT01038128|541953200|FG000|Overall Study|Withdrawal by Subject|2|||
150223414|NCT01136733|541953206|FG000|Phase 1b|Adverse Event|0|||
150223415|NCT01136733|541953207|FG001|Phase 1b|Adverse Event|3|||
150223416|NCT01136733|541953208|FG002|Phase 1b|Adverse Event|1|||
150223417|NCT01136733|541953209|FG003|Phase 1b|Adverse Event|0|||
150223418|NCT01136733|541953210|FG004|Phase 1b|Adverse Event|0|||
150223419|NCT01136733|541953211|FG005|Phase 1b|Adverse Event|0|||
150223420|NCT01136733|541953212|FG006|Phase 1b|Adverse Event|0|||
150223421|NCT01136733|541953206|FG000|Phase 1b|Participant Choice|0|||
150223422|NCT01136733|541953207|FG001|Phase 1b|Participant Choice|0|||
150223423|NCT01136733|541953208|FG002|Phase 1b|Participant Choice|1|||
150223424|NCT01136733|541953209|FG003|Phase 1b|Participant Choice|0|||
150223425|NCT01136733|541953210|FG004|Phase 1b|Participant Choice|0|||
150223426|NCT01136733|541953211|FG005|Phase 1b|Participant Choice|0|||
150223427|NCT01136733|541953212|FG006|Phase 1b|Participant Choice|0|||
150223428|NCT01136733|541953206|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
150223429|NCT01136733|541953207|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
150223430|NCT01136733|541953208|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
150223431|NCT01136733|541953209|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
150223432|NCT01136733|541953210|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
150223433|NCT01136733|541953211|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
150223434|NCT01136733|541953212|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
150223435|NCT01136733|541953206|FG000|Phase 1b|Clinical Progression|1|||
150223436|NCT01136733|541953207|FG001|Phase 1b|Clinical Progression|1|||
150223437|NCT01136733|541953208|FG002|Phase 1b|Clinical Progression|0|||
150223438|NCT01136733|541953209|FG003|Phase 1b|Clinical Progression|0|||
150223439|NCT01136733|541953210|FG004|Phase 1b|Clinical Progression|0|||
150223440|NCT01136733|541953211|FG005|Phase 1b|Clinical Progression|0|||
150223441|NCT01136733|541953212|FG006|Phase 1b|Clinical Progression|0|||
150223442|NCT01136733|541953206|FG000|Phase 2|Disease Progression|0|||
150223443|NCT01136733|541953207|FG001|Phase 2|Disease Progression|0|||
150223444|NCT01136733|541953208|FG002|Phase 2|Disease Progression|0|||
150223445|NCT01136733|541953209|FG003|Phase 2|Disease Progression|0|||
150223446|NCT01136733|541953210|FG004|Phase 2|Disease Progression|30|||
150223447|NCT01136733|541953211|FG005|Phase 2|Disease Progression|32|||
150223448|NCT01136733|541953212|FG006|Phase 2|Disease Progression|38|||
150223449|NCT01136733|541953206|FG000|Phase 2|Adverse Event|0|||
150223450|NCT01136733|541953207|FG001|Phase 2|Adverse Event|0|||
150223451|NCT01136733|541953208|FG002|Phase 2|Adverse Event|0|||
150223452|NCT01136733|541953209|FG003|Phase 2|Adverse Event|0|||
150223453|NCT01136733|541953210|FG004|Phase 2|Adverse Event|11|||
150223454|NCT01136733|541953211|FG005|Phase 2|Adverse Event|13|||
150223455|NCT01136733|541953212|FG006|Phase 2|Adverse Event|5|||
150223456|NCT01136733|541953206|FG000|Phase 2|Participant Choice|0|||
150223457|NCT01136733|541953207|FG001|Phase 2|Participant Choice|0|||
150223458|NCT01136733|541953208|FG002|Phase 2|Participant Choice|0|||
150223459|NCT01136733|541953209|FG003|Phase 2|Participant Choice|0|||
150223460|NCT01136733|541953210|FG004|Phase 2|Participant Choice|3|||
150223461|NCT01136733|541953211|FG005|Phase 2|Participant Choice|0|||
150223462|NCT01136733|541953212|FG006|Phase 2|Participant Choice|1|||
150223463|NCT01136733|541953206|FG000|Phase 2|Administrative-Withdrew Consent|0|||
150223464|NCT01136733|541953207|FG001|Phase 2|Administrative-Withdrew Consent|0|||
150223465|NCT01136733|541953208|FG002|Phase 2|Administrative-Withdrew Consent|0|||
150223466|NCT01136733|541953209|FG003|Phase 2|Administrative-Withdrew Consent|0|||
150223467|NCT01136733|541953210|FG004|Phase 2|Administrative-Withdrew Consent|1|||
150223468|NCT01136733|541953211|FG005|Phase 2|Administrative-Withdrew Consent|0|||
150223469|NCT01136733|541953212|FG006|Phase 2|Administrative-Withdrew Consent|0|||
150223470|NCT01136733|541953206|FG000|Phase 2|Other|0|||
150223471|NCT01136733|541953207|FG001|Phase 2|Other|0|||
150223472|NCT01136733|541953208|FG002|Phase 2|Other|0|||
150223473|NCT01136733|541953209|FG003|Phase 2|Other|0|||
150223474|NCT01136733|541953210|FG004|Phase 2|Other|6|||
150223475|NCT01136733|541953211|FG005|Phase 2|Other|7|||
150223476|NCT01136733|541953212|FG006|Phase 2|Other|6|||
150223477|NCT01745380|541953213|FG000|Overall Study|Lost to Follow-up|1|||
150223478|NCT01745380|541953214|FG001|Overall Study|Lost to Follow-up|0|||
150223479|NCT01745380|541953213|FG000|Overall Study|Lack of Efficacy|0|||
150223480|NCT01745380|541953214|FG001|Overall Study|Lack of Efficacy|1|||
150223481|NCT02186015|541953215|FG000|Overall Study|Physician Decision|1|||
150223482|NCT02186015|541953216|FG001|Overall Study|Physician Decision|0|||
150223483|NCT02368691|541953217|FG000|Overall Study|Death|13|||
150223484|NCT02368691|541953217|FG000|Overall Study|Lack of Efficacy|15|||
150223485|NCT02368691|541953217|FG000|Overall Study|Physician Decision|4|||
150223486|NCT02069366|541953220|FG000|Overall Study|Lost to Follow-up|0|||
150223487|NCT02069366|541953221|FG001|Overall Study|Lost to Follow-up|0|||
150223488|NCT02069366|541953222|FG002|Overall Study|Lost to Follow-up|1|||
150223489|NCT02069366|541953223|FG003|Overall Study|Lost to Follow-up|0|||
150223490|NCT02069366|541953224|FG004|Overall Study|Lost to Follow-up|0|||
150223491|NCT02069366|541953225|FG005|Overall Study|Lost to Follow-up|2|||
150223492|NCT02069366|541953220|FG000|Overall Study|Protocol Violation|0|||
150223493|NCT02069366|541953221|FG001|Overall Study|Protocol Violation|0|||
150223494|NCT02069366|541953222|FG002|Overall Study|Protocol Violation|1|||
150223495|NCT02069366|541953223|FG003|Overall Study|Protocol Violation|0|||
150223496|NCT02069366|541953224|FG004|Overall Study|Protocol Violation|0|||
150223497|NCT02069366|541953225|FG005|Overall Study|Protocol Violation|0|||
150223498|NCT02069366|541953220|FG000|Overall Study|Withdrawal by Subject|1|||
150223499|NCT02069366|541953221|FG001|Overall Study|Withdrawal by Subject|0|||
150223500|NCT02069366|541953222|FG002|Overall Study|Withdrawal by Subject|1|||
150223501|NCT02069366|541953223|FG003|Overall Study|Withdrawal by Subject|2|||
150223502|NCT02069366|541953224|FG004|Overall Study|Withdrawal by Subject|0|||
150223503|NCT02069366|541953225|FG005|Overall Study|Withdrawal by Subject|0|||
150223504|NCT01533181|541953226|FG000|Overall Study|Disease progression pre-active treatment|0|||
150223505|NCT01533181|541953227|FG001|Overall Study|Disease progression pre-active treatment|1|||
150223506|NCT01533181|541953226|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
150223507|NCT01533181|541953227|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
150223508|NCT01837719|541953228|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
150223509|NCT01837719|541953228|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
150223510|NCT01703988|541953229|FG000|Overall Study|Investigator Judgment|0|||
150223511|NCT01703988|541953230|FG001|Overall Study|Investigator Judgment|0|||
150223512|NCT01703988|541953231|FG002|Overall Study|Investigator Judgment|0|||
150223513|NCT01703988|541953232|FG003|Overall Study|Investigator Judgment|1|||
150223514|NCT04468633|541953233|FG000|Overall Study|Withdrawal by Subject|4|||
150223515|NCT04468633|541953234|FG001|Overall Study|Withdrawal by Subject|0|||
150223516|NCT02722278|541953235|FG000|Overall Study|Withdrawal by Subject|5|||
150223517|NCT02722278|541953236|FG001|Overall Study|Withdrawal by Subject|3|||
150223518|NCT02722278|541953235|FG000|Overall Study|Adverse Event|4|||
150223519|NCT02722278|541953236|FG001|Overall Study|Adverse Event|1|||
150223520|NCT02722278|541953235|FG000|Overall Study|Lost to Follow-up|2|||
150223521|NCT02722278|541953236|FG001|Overall Study|Lost to Follow-up|0|||
150223522|NCT02722278|541953235|FG000|Overall Study|Protocol Violation|1|||
150223523|NCT02722278|541953236|FG001|Overall Study|Protocol Violation|0|||
150223524|NCT02722278|541953235|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
150223525|NCT02722278|541953236|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
150223526|NCT02722278|541953235|FG000|Overall Study|Subject declined after tx assignment|0|||
150223527|NCT02722278|541953236|FG001|Overall Study|Subject declined after tx assignment|1|||
150223528|NCT02722278|541953235|FG000|Overall Study|Site closure not study related|0|||
150223529|NCT02722278|541953236|FG001|Overall Study|Site closure not study related|1|||
150223530|NCT01403805|541953237|FG000|Overall Study|Withdrawal by Subject|0|||
150223531|NCT01403805|541953238|FG001|Overall Study|Withdrawal by Subject|4|||
150223532|NCT01403805|541953237|FG000|Overall Study|Lost to Follow-up|0|||
150223533|NCT01403805|541953238|FG001|Overall Study|Lost to Follow-up|2|||
150223534|NCT01403805|541953237|FG000|Overall Study|Death|0|||
150223535|NCT01403805|541953238|FG001|Overall Study|Death|1|||
150223536|NCT02213458|541953242|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
150223537|NCT02213458|541953243|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
150255394|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
150255395|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
150255396|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
150255397|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
150255398|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
150255399|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
150255400|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
150255401|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
150255402|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
150255403|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
150255404|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
150255405|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
150255406|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
150255407|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
150255408|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
150255409|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
150255410|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
150255411|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
150255412|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
150255413|NCT00700427|542070609|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
150255414|NCT00700427|542070610|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
150255415|NCT00700427|542070611|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
150255416|NCT00700427|542070612|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
150255417|NCT00700427|542070613|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
150255418|NCT02057523|542070616|FG000|Overall Study|Withdrawal by Subject|1|||
150255419|NCT02057523|542070616|FG000|Overall Study|Lack of Efficacy|1|||
150255420|NCT00964886|542070621|FG000|Overall Study|Lost to Follow-up|2|||
150255421|NCT00964886|542070622|FG001|Overall Study|Lost to Follow-up|2|||
150255422|NCT00964886|542070623|FG002|Overall Study|Lost to Follow-up|6|||
150255423|NCT00964886|542070624|FG003|Overall Study|Lost to Follow-up|4|||
150255424|NCT00964886|542070621|FG000|Overall Study|Withdrawal by Subject|6|||
150255425|NCT00964886|542070622|FG001|Overall Study|Withdrawal by Subject|2|||
150255426|NCT00964886|542070623|FG002|Overall Study|Withdrawal by Subject|5|||
150255427|NCT00964886|542070624|FG003|Overall Study|Withdrawal by Subject|3|||
150255428|NCT00964886|542070621|FG000|Overall Study|Adverse Event|3|||
150255429|NCT00964886|542070622|FG001|Overall Study|Adverse Event|1|||
150255430|NCT00964886|542070623|FG002|Overall Study|Adverse Event|5|||
150255431|NCT00964886|542070624|FG003|Overall Study|Adverse Event|2|||
150255432|NCT00964886|542070621|FG000|Overall Study|Protocol Violation|0|||
150255433|NCT00964886|542070622|FG001|Overall Study|Protocol Violation|2|||
150255434|NCT00964886|542070623|FG002|Overall Study|Protocol Violation|0|||
150255435|NCT00964886|542070624|FG003|Overall Study|Protocol Violation|0|||
150255436|NCT03500159|542070629|FG000|Overall Study|Study Terminated|2|||
150255437|NCT03500159|542070630|FG001|Overall Study|Study Terminated|1|||
150255438|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
150255439|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
150255440|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
150255441|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
150255442|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
150255443|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
150223538|NCT02213458|541953242|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
150223539|NCT02213458|541953243|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
150223540|NCT02213458|541953242|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
150223541|NCT02213458|541953243|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
150223542|NCT02213458|541953242|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
150223543|NCT02213458|541953243|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
150223544|NCT02213458|541953242|FG000|Overall Study|Refused re-consent|6|||
150223545|NCT02213458|541953243|FG001|Overall Study|Refused re-consent|0|||
150223546|NCT02213458|541953242|FG000|Overall Study|Lost to Follow-up|2|||
150223547|NCT02213458|541953243|FG001|Overall Study|Lost to Follow-up|2|||
150223548|NCT02213458|541953242|FG000|Overall Study|Withdrawal by Subject|26|||
150223549|NCT02213458|541953243|FG001|Overall Study|Withdrawal by Subject|8|||
150223550|NCT04043806|541953244|FG000|Overall Study|Commercial drug is available for participants|13|||
150223551|NCT04043806|541953244|FG000|Overall Study|Physician Decision|2|||
150223552|NCT04043806|541953244|FG000|Overall Study|Other|12|||
150223553|NCT04043806|541953244|FG000|Overall Study|Adverse Event|2|||
150223554|NCT04043806|541953244|FG000|Overall Study|Lost to Follow-up|6|||
150223555|NCT04043806|541953244|FG000|Overall Study|Other non-compliance|2|||
150223556|NCT04043806|541953244|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
150223557|NCT04043806|541953244|FG000|Overall Study|Never Dosed|1|||
150223558|NCT01622088|541953245|FG000|Overall Study|Adverse Event|20|||
150223559|NCT01622088|541953245|FG000|Overall Study|Lost to Follow-up|1|||
150223560|NCT01622088|541953245|FG000|Overall Study|Withdrawal by Subject|20|||
150223561|NCT01622088|541953245|FG000|Overall Study|Investigator Decision|1|||
150223562|NCT01622088|541953245|FG000|Overall Study|Death|53|||
150223563|NCT01622088|541953245|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
150223564|NCT01721109|541953251|FG000|Overall Study|Lack of Efficacy|1|||
150223565|NCT01721109|541953251|FG000|Overall Study|Non- Compliance with Study Drug|3|||
150223566|NCT01721109|541953251|FG000|Overall Study|Withdrew Consent|1|||
150223567|NCT01721109|541953251|FG000|Overall Study|Lost to Follow-up|2|||
150223568|NCT03045302|541953252|FG000|Overall Study|Pre-treatment adverse event|1|||
150223569|NCT00134056|541953253|FG000|Randomization|Not eligible for assigned treatment|22|||
150223570|NCT00134056|541953254|FG001|Randomization|Not eligible for assigned treatment|20|||
150223571|NCT00134056|541953253|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
150223572|NCT00134056|541953254|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
150223573|NCT00134056|541953253|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
150223574|NCT00134056|541953254|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
150223575|NCT00134056|541953253|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
150223576|NCT00134056|541953254|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
150223577|NCT00134056|541953253|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
150223578|NCT00134056|541953254|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
150223579|NCT03166215|541953255|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
150223580|NCT03166215|541953256|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
150223581|NCT03166215|541953257|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
150223582|NCT03166215|541953255|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
150223583|NCT03166215|541953256|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
150223584|NCT03166215|541953257|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
150223585|NCT00742560|541953259|FG000|Overall Study|Adverse Event|0|||
150223586|NCT00742560|541953260|FG001|Overall Study|Adverse Event|0|||
150223587|NCT00742560|541953261|FG002|Overall Study|Adverse Event|1|||
150223588|NCT00742560|541953262|FG003|Overall Study|Adverse Event|1|||
150223589|NCT00742560|541953263|FG004|Overall Study|Adverse Event|1|||
150223590|NCT00742560|541953259|FG000|Overall Study|Death|0|||
150223591|NCT00742560|541953260|FG001|Overall Study|Death|2|||
150223592|NCT00742560|541953261|FG002|Overall Study|Death|0|||
150223593|NCT00742560|541953262|FG003|Overall Study|Death|2|||
150223594|NCT00742560|541953263|FG004|Overall Study|Death|3|||
150223595|NCT00742560|541953259|FG000|Overall Study|Subject's Decision|1|||
150223596|NCT00742560|541953260|FG001|Overall Study|Subject's Decision|0|||
150223597|NCT00742560|541953261|FG002|Overall Study|Subject's Decision|2|||
150223598|NCT00742560|541953262|FG003|Overall Study|Subject's Decision|3|||
150223599|NCT00742560|541953263|FG004|Overall Study|Subject's Decision|3|||
150223600|NCT00742560|541953259|FG000|Overall Study|Investigator's Decision|0|||
150223601|NCT00742560|541953260|FG001|Overall Study|Investigator's Decision|0|||
150223602|NCT00742560|541953261|FG002|Overall Study|Investigator's Decision|4|||
150223603|NCT00742560|541953262|FG003|Overall Study|Investigator's Decision|1|||
150223604|NCT00742560|541953263|FG004|Overall Study|Investigator's Decision|0|||
150223605|NCT00742560|541953259|FG000|Overall Study|Disease Progression|1|||
150223606|NCT00742560|541953260|FG001|Overall Study|Disease Progression|0|||
150223607|NCT00742560|541953261|FG002|Overall Study|Disease Progression|5|||
150223608|NCT00742560|541953262|FG003|Overall Study|Disease Progression|17|||
150223609|NCT00742560|541953263|FG004|Overall Study|Disease Progression|16|||
150223610|NCT00742560|541953259|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
150223611|NCT00742560|541953260|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
150223612|NCT00742560|541953261|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
150223613|NCT00742560|541953262|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
150223614|NCT00742560|541953263|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
150223615|NCT00742560|541953259|FG000|Overall Study|Other|0|||
150223616|NCT00742560|541953260|FG001|Overall Study|Other|1|||
150223617|NCT00742560|541953261|FG002|Overall Study|Other|8|||
150223618|NCT00742560|541953262|FG003|Overall Study|Other|9|||
150223619|NCT00742560|541953263|FG004|Overall Study|Other|9|||
150223620|NCT00742560|541953259|FG000|Overall Study|MIssing|0|||
150223621|NCT00742560|541953260|FG001|Overall Study|MIssing|0|||
150223622|NCT00742560|541953261|FG002|Overall Study|MIssing|0|||
150223623|NCT00742560|541953262|FG003|Overall Study|MIssing|0|||
150223624|NCT00742560|541953263|FG004|Overall Study|MIssing|1|||
150223625|NCT04985604|541953265|FG000|Overall Study|Death|4|||
150223626|NCT04985604|541953266|FG001|Overall Study|Death|6|||
150223627|NCT04985604|541953265|FG000|Overall Study|Withdrawal by Subject|0|||
150223628|NCT04985604|541953266|FG001|Overall Study|Withdrawal by Subject|1|||
150223629|NCT04598776|541953267|FG000|Overall Study|Protocol Violation|5|||
150223630|NCT04598776|541953267|FG000|Overall Study|Physician Decision|4|||
150223631|NCT00348283|541953268|FG000|Induction|Adverse Event|0|||
150223632|NCT00348283|541953269|FG001|Induction|Adverse Event|2|||
150223633|NCT00348283|541953268|FG000|Induction|Protocol Violation|0|||
150223634|NCT00348283|541953269|FG001|Induction|Protocol Violation|4|||
150223635|NCT00348283|541953268|FG000|Double Blind|Adverse Event|2|||
150223636|NCT00348283|541953269|FG001|Double Blind|Adverse Event|5|||
150223637|NCT00348283|541953268|FG000|Double Blind|Withdrawal by Subject|1|||
150223638|NCT00348283|541953269|FG001|Double Blind|Withdrawal by Subject|1|||
150223639|NCT00348283|541953268|FG000|Double Blind|Protocol Violation|0|||
150223640|NCT00348283|541953269|FG001|Double Blind|Protocol Violation|1|||
150223641|NCT00348283|541953268|FG000|Double Blind|Lack of Efficacy|2|||
150223642|NCT00348283|541953269|FG001|Double Blind|Lack of Efficacy|2|||
150223643|NCT00348283|541953268|FG000|Double Blind|Pregnancy|0|||
150223644|NCT00348283|541953269|FG001|Double Blind|Pregnancy|1|||
150223645|NCT00348283|541953268|FG000|Open Label|Adverse Event|0|||
150223646|NCT00348283|541953269|FG001|Open Label|Adverse Event|8|||
150223647|NCT00348283|541953268|FG000|Open Label|Withdrawal by Subject|0|||
150223648|NCT00348283|541953269|FG001|Open Label|Withdrawal by Subject|4|||
150223649|NCT00348283|541953268|FG000|Open Label|Lost to Follow-up|0|||
150223650|NCT00348283|541953269|FG001|Open Label|Lost to Follow-up|1|||
150223651|NCT00348283|541953268|FG000|Open Label|Lack of Efficacy|0|||
150223652|NCT00348283|541953269|FG001|Open Label|Lack of Efficacy|13|||
150223653|NCT00348283|541953268|FG000|Open Label|Administrative reasons|0|||
150223654|NCT00348283|541953269|FG001|Open Label|Administrative reasons|5|||
150223655|NCT00348283|541953268|FG000|Open Label|Subject moved to the United States|0|||
150223656|NCT00348283|541953269|FG001|Open Label|Subject moved to the United States|1|||
150223657|NCT00348283|541953268|FG000|Open Label|Pregnancy|0|||
150223658|NCT00348283|541953269|FG001|Open Label|Pregnancy|1|||
150223659|NCT00348283|541953268|FG000|Open Label|Sponsor decision|0|||
150223660|NCT00348283|541953269|FG001|Open Label|Sponsor decision|1|||
150223661|NCT02282761|541953272|FG000|Overall Study|Death|0|||
150223662|NCT02282761|541953273|FG001|Overall Study|Death|0|||
150223663|NCT02282761|541953274|FG002|Overall Study|Death|1|||
150223664|NCT02282761|541953272|FG000|Overall Study|Adverse Event|6|||
150223665|NCT02282761|541953273|FG001|Overall Study|Adverse Event|2|||
150223666|NCT02282761|541953274|FG002|Overall Study|Adverse Event|0|||
150223667|NCT02282761|541953272|FG000|Overall Study|Lack of Efficacy|11|||
150223668|NCT02282761|541953273|FG001|Overall Study|Lack of Efficacy|6|||
150223669|NCT02282761|541953274|FG002|Overall Study|Lack of Efficacy|17|||
150223670|NCT02282761|541953272|FG000|Overall Study|Lost to Follow-up|2|||
150223671|NCT02282761|541953273|FG001|Overall Study|Lost to Follow-up|2|||
150223672|NCT02282761|541953274|FG002|Overall Study|Lost to Follow-up|1|||
150223673|NCT02282761|541953272|FG000|Overall Study|Physician Decision|0|||
150223674|NCT02282761|541953273|FG001|Overall Study|Physician Decision|0|||
150223675|NCT02282761|541953274|FG002|Overall Study|Physician Decision|2|||
150223676|NCT02282761|541953272|FG000|Overall Study|Withdrawal by Subject|8|||
150223677|NCT02282761|541953273|FG001|Overall Study|Withdrawal by Subject|10|||
150223678|NCT02282761|541953274|FG002|Overall Study|Withdrawal by Subject|16|||
150223679|NCT02282761|541953272|FG000|Overall Study|Other|3|||
150223680|NCT02282761|541953273|FG001|Overall Study|Other|2|||
150223681|NCT02282761|541953274|FG002|Overall Study|Other|1|||
150223682|NCT00658632|541953277|FG000|Overall Study|Adverse Event|13|||
150223683|NCT00658632|541953278|FG001|Overall Study|Adverse Event|11|||
150223684|NCT00658632|541953277|FG000|Overall Study|Lost to Follow-up|25|||
150223685|NCT00658632|541953278|FG001|Overall Study|Lost to Follow-up|23|||
150223686|NCT00658632|541953277|FG000|Overall Study|Withdrawal by Subject|10|||
150223687|NCT00658632|541953278|FG001|Overall Study|Withdrawal by Subject|7|||
150223688|NCT00658632|541953277|FG000|Overall Study|Lack of Efficacy|0|||
150223689|NCT00658632|541953278|FG001|Overall Study|Lack of Efficacy|1|||
150223690|NCT00658632|541953277|FG000|Overall Study|Withdrawal of consent|8|||
150223691|NCT00658632|541953278|FG001|Overall Study|Withdrawal of consent|14|||
150223692|NCT00658632|541953277|FG000|Overall Study|Pregnancy|1|||
150223693|NCT00658632|541953278|FG001|Overall Study|Pregnancy|1|||
150223694|NCT00658632|541953277|FG000|Overall Study|Other|7|||
150223695|NCT00658632|541953278|FG001|Overall Study|Other|8|||
150223696|NCT06312566|541953280|FG000|Overall Study|Protocol Violation|0|||
150223697|NCT06312566|541953281|FG001|Overall Study|Protocol Violation|1|||
150223698|NCT03747575|541953282|FG000|Overall Study|Withdrawal by Subject|6|||
150223699|NCT03747575|541953283|FG001|Overall Study|Withdrawal by Subject|3|||
150223700|NCT03747575|541953282|FG000|Overall Study|Lost to Follow-up|3|||
150223701|NCT03747575|541953283|FG001|Overall Study|Lost to Follow-up|3|||
150223702|NCT03747575|541953282|FG000|Overall Study|Adverse Event|0|||
150223703|NCT03747575|541953283|FG001|Overall Study|Adverse Event|1|||
150223704|NCT05615870|541953288|FG000|Overall Study|Lost to Follow-up|10|||
150223705|NCT05615870|541953289|FG001|Overall Study|Lost to Follow-up|13|||
150223706|NCT05615870|541953288|FG000|Overall Study|Physician Decision|2|||
150223707|NCT05615870|541953289|FG001|Overall Study|Physician Decision|0|||
150223708|NCT05615870|541953288|FG000|Overall Study|Withdrawal by Subject|0|||
150223709|NCT05615870|541953289|FG001|Overall Study|Withdrawal by Subject|2|||
150223710|NCT05615870|541953288|FG000|Overall Study|Protocol Violation|0|||
150223711|NCT05615870|541953289|FG001|Overall Study|Protocol Violation|3|||
150223712|NCT05615870|541953288|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
150223713|NCT05615870|541953289|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
150223714|NCT05615870|541953288|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
150223715|NCT05615870|541953289|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
150223716|NCT05615870|541953288|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
150223717|NCT05615870|541953289|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
150223718|NCT02130401|541953290|FG000|Overall Study|Poor enrollment|6|||
150223719|NCT01549951|541953296|FG000|Overall Study|Adverse Event|15|||
150223720|NCT01549951|541953296|FG000|Overall Study|Withdrawal by Subject|2|||
150223721|NCT01549951|541953296|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
150223722|NCT01549951|541953296|FG000|Overall Study|Progressive disease|29|||
150223723|NCT01549951|541953296|FG000|Overall Study|Symptomatic deterioration|1|||
150223724|NCT01549951|541953296|FG000|Overall Study|Other|2|||
150223725|NCT00738400|541953299|FG000|Overall Study|Adverse Event|3|||
150223726|NCT00738400|541953300|FG001|Overall Study|Adverse Event|1|||
150223727|NCT00738400|541953299|FG000|Overall Study|Withdrawal by Subject|0|||
150223728|NCT00738400|541953300|FG001|Overall Study|Withdrawal by Subject|1|||
150223729|NCT00738400|541953299|FG000|Overall Study|Lack of Efficacy|0|||
150223730|NCT00738400|541953300|FG001|Overall Study|Lack of Efficacy|1|||
150223731|NCT00738400|541953299|FG000|Overall Study|Lost to Follow-up|0|||
150223732|NCT00738400|541953300|FG001|Overall Study|Lost to Follow-up|3|||
150223733|NCT00738400|541953299|FG000|Overall Study|Protocol Violation|1|||
150223734|NCT00738400|541953300|FG001|Overall Study|Protocol Violation|0|||
150223735|NCT00738400|541953299|FG000|Overall Study|Non-compliant with study medication|0|||
150223736|NCT00738400|541953300|FG001|Overall Study|Non-compliant with study medication|1|||
150223737|NCT00990314|541953303|FG000|Overall Study|Death|2|||
150223738|NCT00990314|541953303|FG000|Overall Study|Adverse Event|2|||
150223739|NCT00990314|541953303|FG000|Overall Study|Withdrawal by Subject|3|||
150223740|NCT00990314|541953303|FG000|Overall Study|Non-Compliance|1|||
150223741|NCT00990314|541953303|FG000|Overall Study|Physician Decision|3|||
150223742|NCT00990314|541953303|FG000|Overall Study|Lack of Efficacy|1|||
150223743|NCT01760876|541953304|FG000|Overall Study|Non-cardiac death (head injury)|1|||
150223744|NCT01760876|541953304|FG000|Overall Study|Carcinoma of prostate|1|||
150223745|NCT01760876|541953304|FG000|Overall Study|Impaired renal function|1|||
150223746|NCT01760876|541953304|FG000|Overall Study|Major depression|1|||
150223747|NCT01760876|541953304|FG000|Overall Study|Very poor baseline OCT quality|2|||
150223748|NCT03689452|541953310|FG000|Overall Study|Lost to Follow-up|1|||
150223749|NCT03689452|541953311|FG001|Overall Study|Lost to Follow-up|1|||
150223750|NCT02676778|541953312|FG000|Overall Study|Disease Progression|7|||
150223751|NCT02676778|541953313|FG001|Overall Study|Disease Progression|3|||
150223752|NCT02676778|541953314|FG002|Overall Study|Disease Progression|1|||
150223753|NCT02676778|541953312|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
150223754|NCT02676778|541953313|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
150223755|NCT02676778|541953314|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
150223756|NCT02676778|541953312|FG000|Overall Study|Withdrawal by Subject|3|||
150223757|NCT02676778|541953313|FG001|Overall Study|Withdrawal by Subject|2|||
150223758|NCT02676778|541953314|FG002|Overall Study|Withdrawal by Subject|0|||
150223759|NCT02676778|541953312|FG000|Overall Study|Other|4|||
150223760|NCT02676778|541953313|FG001|Overall Study|Other|3|||
150223761|NCT02676778|541953314|FG002|Overall Study|Other|0|||
150223762|NCT02676778|541953312|FG000|Overall Study|Adverse Event|2|||
150223763|NCT02676778|541953313|FG001|Overall Study|Adverse Event|3|||
150223764|NCT02676778|541953314|FG002|Overall Study|Adverse Event|0|||
150223765|NCT03686176|541953321|FG000|Overall Study|Procedure cancelled|1|||
150223766|NCT03686176|541953322|FG001|Overall Study|Procedure cancelled|0|||
150223767|NCT03686176|541953323|FG002|Overall Study|Procedure cancelled|0|||
150223768|NCT03686176|541953321|FG000|Overall Study|VR Malfunction|1|||
150223769|NCT03686176|541953322|FG001|Overall Study|VR Malfunction|0|||
150223770|NCT03686176|541953323|FG002|Overall Study|VR Malfunction|0|||
150223771|NCT04413149|541955397|FG000|Overall Study|Death|10|||
150223772|NCT04413149|541955398|FG001|Overall Study|Death|5|||
150223773|NCT04413149|541955397|FG000|Overall Study|Lung transplantation|1|||
150223774|NCT04413149|541955398|FG001|Overall Study|Lung transplantation|0|||
150223775|NCT02878590|541955401|FG000|Overall Study|Withdrawal by Subject|2|||
150223776|NCT02661490|541955402|FG000|Overall Study|Lost to Follow-up|0|||
150223777|NCT02661490|541955403|FG001|Overall Study|Lost to Follow-up|1|||
150223778|NCT02661490|541955404|FG002|Overall Study|Lost to Follow-up|0|||
150223779|NCT02661490|541955405|FG003|Overall Study|Lost to Follow-up|0|||
150223780|NCT02661490|541955406|FG004|Overall Study|Lost to Follow-up|2|||
150223781|NCT02661490|541955402|FG000|Overall Study|Withdrawal by Subject|2|||
150223782|NCT02661490|541955403|FG001|Overall Study|Withdrawal by Subject|0|||
150223783|NCT02661490|541955404|FG002|Overall Study|Withdrawal by Subject|2|||
150223784|NCT02661490|541955405|FG003|Overall Study|Withdrawal by Subject|0|||
150223785|NCT02661490|541955406|FG004|Overall Study|Withdrawal by Subject|0|||
150223786|NCT02661490|541955402|FG000|Overall Study|Death|1|||
150223787|NCT02661490|541955403|FG001|Overall Study|Death|1|||
150223788|NCT02661490|541955404|FG002|Overall Study|Death|0|||
150223789|NCT02661490|541955405|FG003|Overall Study|Death|1|||
150223790|NCT02661490|541955406|FG004|Overall Study|Death|0|||
150223791|NCT02661490|541955402|FG000|Overall Study|Reason not Specified|0|||
150223792|NCT02661490|541955403|FG001|Overall Study|Reason not Specified|0|||
150223793|NCT02661490|541955404|FG002|Overall Study|Reason not Specified|0|||
150223794|NCT02661490|541955405|FG003|Overall Study|Reason not Specified|0|||
150223795|NCT02661490|541955406|FG004|Overall Study|Reason not Specified|1|||
150223796|NCT03322514|541955407|FG000|Overall Study|Withdrawal by Subject|1|||
150223797|NCT03322514|541955408|FG001|Overall Study|Withdrawal by Subject|1|||
150223798|NCT00814632|541955409|FG000|Overall Study|Lack of Efficacy|2|||
150223799|NCT02514577|541955410|FG000|Overall Study|Lost to Follow-up|6|||
150223800|NCT02514577|541955411|FG001|Overall Study|Lost to Follow-up|6|||
150223801|NCT02514577|541955410|FG000|Overall Study|Protocol Violation|1|||
150223802|NCT02514577|541955411|FG001|Overall Study|Protocol Violation|0|||
150223803|NCT02514577|541955410|FG000|Overall Study|Withdrawal by Subject|6|||
150223804|NCT02514577|541955411|FG001|Overall Study|Withdrawal by Subject|6|||
150223805|NCT02514577|541955410|FG000|Overall Study|Adverse Event|1|||
150223806|NCT02514577|541955411|FG001|Overall Study|Adverse Event|1|||
150223807|NCT00409006|541955412|FG000|Overall Study|Death|15|||
150223808|NCT00409006|541955413|FG001|Overall Study|Death|6|||
150223809|NCT00409006|541955412|FG000|Overall Study|Lost to Follow-up|1|||
150223810|NCT00409006|541955413|FG001|Overall Study|Lost to Follow-up|2|||
150223811|NCT00409006|541955412|FG000|Overall Study|Withdrawal by Subject|3|||
150223812|NCT00409006|541955413|FG001|Overall Study|Withdrawal by Subject|2|||
150223813|NCT00409006|541955412|FG000|Overall Study|Physician Decision|1|||
150223814|NCT00409006|541955413|FG001|Overall Study|Physician Decision|2|||
150223815|NCT03050372|541955416|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
150223816|NCT03050372|541955417|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
150223817|NCT03050372|541955416|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
150223818|NCT03050372|541955417|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
150223819|NCT03602053|541955423|FG000|Overall Study|Withdrawal by Subject|7|||
150223820|NCT03602053|541955424|FG001|Overall Study|Withdrawal by Subject|9|||
150223821|NCT03602053|541955425|FG002|Overall Study|Withdrawal by Subject|7|||
150223822|NCT03602053|541955423|FG000|Overall Study|Lost to Follow-up|5|||
150223823|NCT03602053|541955424|FG001|Overall Study|Lost to Follow-up|6|||
150223824|NCT03602053|541955425|FG002|Overall Study|Lost to Follow-up|0|||
150223825|NCT03602053|541955423|FG000|Overall Study|Protocol Violation|3|||
150223826|NCT03602053|541955424|FG001|Overall Study|Protocol Violation|0|||
150223827|NCT03602053|541955425|FG002|Overall Study|Protocol Violation|4|||
150223828|NCT03602053|541955423|FG000|Overall Study|Physician Decision|1|||
150223829|NCT03602053|541955424|FG001|Overall Study|Physician Decision|0|||
150223830|NCT03602053|541955425|FG002|Overall Study|Physician Decision|0|||
150223831|NCT03602053|541955423|FG000|Overall Study|migration|2|||
150223832|NCT03602053|541955424|FG001|Overall Study|migration|3|||
150223833|NCT03602053|541955425|FG002|Overall Study|migration|0|||
150223834|NCT03602053|541955423|FG000|Overall Study|Other|1|||
150223835|NCT03602053|541955424|FG001|Overall Study|Other|0|||
150223836|NCT03602053|541955425|FG002|Overall Study|Other|0|||
150223837|NCT01234675|541955426|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
150223838|NCT01234675|541955427|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
150223839|NCT01234675|541955426|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
150223840|NCT01234675|541955427|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
150223841|NCT01107353|541955432|FG000|Overall Study|Positive Drug Screen|1|||
150223842|NCT01107353|541955433|FG001|Overall Study|Positive Drug Screen|0|||
150223843|NCT02660034|541955434|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
150223844|NCT02660034|541955435|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
150223845|NCT02660034|541955436|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
150223846|NCT02660034|541955437|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
150223847|NCT02660034|541955438|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
150223848|NCT02660034|541955439|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
150223849|NCT02660034|541955440|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
150223850|NCT02660034|541955441|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
150223851|NCT02660034|541955442|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
150223852|NCT02660034|541955443|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
150223853|NCT02660034|541955444|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
150223854|NCT02660034|541955445|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
150223855|NCT02660034|541955446|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
150223856|NCT02660034|541955447|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
150223857|NCT02660034|541955434|FG000|Overall Study|Progressive Disease (Clinical)|7|||
150223858|NCT02660034|541955435|FG001|Overall Study|Progressive Disease (Clinical)|8|||
150223859|NCT02660034|541955436|FG002|Overall Study|Progressive Disease (Clinical)|3|||
150223860|NCT02660034|541955437|FG003|Overall Study|Progressive Disease (Clinical)|9|||
150223861|NCT02660034|541955438|FG004|Overall Study|Progressive Disease (Clinical)|3|||
150223862|NCT02660034|541955439|FG005|Overall Study|Progressive Disease (Clinical)|0|||
150223863|NCT02660034|541955440|FG006|Overall Study|Progressive Disease (Clinical)|0|||
150223864|NCT02660034|541955441|FG007|Overall Study|Progressive Disease (Clinical)|0|||
150223865|NCT02660034|541955442|FG008|Overall Study|Progressive Disease (Clinical)|0|||
150223866|NCT02660034|541955443|FG009|Overall Study|Progressive Disease (Clinical)|0|||
150223867|NCT02660034|541955444|FG010|Overall Study|Progressive Disease (Clinical)|0|||
150223868|NCT02660034|541955445|FG011|Overall Study|Progressive Disease (Clinical)|0|||
150223869|NCT02660034|541955446|FG012|Overall Study|Progressive Disease (Clinical)|0|||
150223870|NCT02660034|541955447|FG013|Overall Study|Progressive Disease (Clinical)|0|||
150223871|NCT02660034|541955434|FG000|Overall Study|Lost to Follow-up|0|||
150223872|NCT02660034|541955435|FG001|Overall Study|Lost to Follow-up|0|||
150223873|NCT02660034|541955436|FG002|Overall Study|Lost to Follow-up|1|||
150223874|NCT02660034|541955437|FG003|Overall Study|Lost to Follow-up|1|||
150223875|NCT02660034|541955438|FG004|Overall Study|Lost to Follow-up|0|||
150223876|NCT02660034|541955439|FG005|Overall Study|Lost to Follow-up|0|||
150223877|NCT02660034|541955440|FG006|Overall Study|Lost to Follow-up|0|||
150223878|NCT02660034|541955441|FG007|Overall Study|Lost to Follow-up|0|||
150223879|NCT02660034|541955442|FG008|Overall Study|Lost to Follow-up|0|||
150223880|NCT02660034|541955443|FG009|Overall Study|Lost to Follow-up|1|||
150223881|NCT02660034|541955444|FG010|Overall Study|Lost to Follow-up|1|||
150223882|NCT02660034|541955445|FG011|Overall Study|Lost to Follow-up|1|||
150223883|NCT02660034|541955446|FG012|Overall Study|Lost to Follow-up|0|||
150223884|NCT02660034|541955447|FG013|Overall Study|Lost to Follow-up|0|||
150223885|NCT02660034|541955434|FG000|Overall Study|Participant moved into special access scheme|1|||
150223886|NCT02660034|541955435|FG001|Overall Study|Participant moved into special access scheme|2|||
150223887|NCT02660034|541955436|FG002|Overall Study|Participant moved into special access scheme|0|||
150223888|NCT02660034|541955437|FG003|Overall Study|Participant moved into special access scheme|0|||
150223889|NCT02660034|541955438|FG004|Overall Study|Participant moved into special access scheme|0|||
150223890|NCT02660034|541955439|FG005|Overall Study|Participant moved into special access scheme|0|||
150223891|NCT02660034|541955440|FG006|Overall Study|Participant moved into special access scheme|0|||
150223892|NCT02660034|541955441|FG007|Overall Study|Participant moved into special access scheme|0|||
150223893|NCT02660034|541955442|FG008|Overall Study|Participant moved into special access scheme|0|||
150223894|NCT02660034|541955443|FG009|Overall Study|Participant moved into special access scheme|0|||
150223895|NCT02660034|541955444|FG010|Overall Study|Participant moved into special access scheme|0|||
150223896|NCT02660034|541955445|FG011|Overall Study|Participant moved into special access scheme|0|||
150223897|NCT02660034|541955446|FG012|Overall Study|Participant moved into special access scheme|0|||
150223898|NCT02660034|541955447|FG013|Overall Study|Participant moved into special access scheme|0|||
150223899|NCT02660034|541955434|FG000|Overall Study|Adverse Event|1|||
150223900|NCT02660034|541955435|FG001|Overall Study|Adverse Event|0|||
150223901|NCT02660034|541955436|FG002|Overall Study|Adverse Event|0|||
150223902|NCT02660034|541955437|FG003|Overall Study|Adverse Event|0|||
150223903|NCT02660034|541955438|FG004|Overall Study|Adverse Event|0|||
150223904|NCT02660034|541955439|FG005|Overall Study|Adverse Event|0|||
150223905|NCT02660034|541955440|FG006|Overall Study|Adverse Event|0|||
150223906|NCT02660034|541955441|FG007|Overall Study|Adverse Event|0|||
150223907|NCT02660034|541955442|FG008|Overall Study|Adverse Event|0|||
150223908|NCT02660034|541955443|FG009|Overall Study|Adverse Event|0|||
150223909|NCT02660034|541955444|FG010|Overall Study|Adverse Event|0|||
150223910|NCT02660034|541955445|FG011|Overall Study|Adverse Event|0|||
150223911|NCT02660034|541955446|FG012|Overall Study|Adverse Event|0|||
150223912|NCT02660034|541955447|FG013|Overall Study|Adverse Event|0|||
150223913|NCT02660034|541955434|FG000|Overall Study|Sponsor Decision|0|||
150223914|NCT02660034|541955435|FG001|Overall Study|Sponsor Decision|1|||
150223915|NCT02660034|541955436|FG002|Overall Study|Sponsor Decision|2|||
150223916|NCT02660034|541955437|FG003|Overall Study|Sponsor Decision|2|||
150223917|NCT02660034|541955438|FG004|Overall Study|Sponsor Decision|3|||
150223918|NCT02660034|541955439|FG005|Overall Study|Sponsor Decision|0|||
150223919|NCT02660034|541955440|FG006|Overall Study|Sponsor Decision|0|||
150223920|NCT02660034|541955441|FG007|Overall Study|Sponsor Decision|0|||
150223921|NCT02660034|541955442|FG008|Overall Study|Sponsor Decision|0|||
150223922|NCT02660034|541955443|FG009|Overall Study|Sponsor Decision|0|||
150223923|NCT02660034|541955444|FG010|Overall Study|Sponsor Decision|0|||
150223924|NCT02660034|541955445|FG011|Overall Study|Sponsor Decision|0|||
150223925|NCT02660034|541955446|FG012|Overall Study|Sponsor Decision|0|||
150223926|NCT02660034|541955447|FG013|Overall Study|Sponsor Decision|1|||
150223927|NCT02660034|541955434|FG000|Overall Study|Withdrawal by Subject|0|||
150223928|NCT02660034|541955435|FG001|Overall Study|Withdrawal by Subject|0|||
150223929|NCT02660034|541955436|FG002|Overall Study|Withdrawal by Subject|0|||
150223930|NCT02660034|541955437|FG003|Overall Study|Withdrawal by Subject|0|||
150223931|NCT02660034|541955438|FG004|Overall Study|Withdrawal by Subject|0|||
150223932|NCT02660034|541955439|FG005|Overall Study|Withdrawal by Subject|0|||
150223933|NCT02660034|541955440|FG006|Overall Study|Withdrawal by Subject|1|||
150223934|NCT02660034|541955441|FG007|Overall Study|Withdrawal by Subject|1|||
150223935|NCT02660034|541955442|FG008|Overall Study|Withdrawal by Subject|1|||
150223936|NCT02660034|541955443|FG009|Overall Study|Withdrawal by Subject|0|||
150223937|NCT02660034|541955444|FG010|Overall Study|Withdrawal by Subject|0|||
150223938|NCT02660034|541955445|FG011|Overall Study|Withdrawal by Subject|1|||
150223939|NCT02660034|541955446|FG012|Overall Study|Withdrawal by Subject|2|||
150223940|NCT02660034|541955447|FG013|Overall Study|Withdrawal by Subject|0|||
150223941|NCT02660034|541955434|FG000|Overall Study|Death|0|||
150223942|NCT02660034|541955435|FG001|Overall Study|Death|0|||
150223943|NCT02660034|541955436|FG002|Overall Study|Death|0|||
150223944|NCT02660034|541955437|FG003|Overall Study|Death|0|||
150223945|NCT02660034|541955438|FG004|Overall Study|Death|0|||
150223946|NCT02660034|541955439|FG005|Overall Study|Death|13|||
150223947|NCT02660034|541955440|FG006|Overall Study|Death|14|||
150223948|NCT02660034|541955441|FG007|Overall Study|Death|10|||
150223949|NCT02660034|541955442|FG008|Overall Study|Death|9|||
150223950|NCT02660034|541955443|FG009|Overall Study|Death|21|||
150223951|NCT02660034|541955444|FG010|Overall Study|Death|17|||
150223952|NCT02660034|541955445|FG011|Overall Study|Death|15|||
150223953|NCT02660034|541955446|FG012|Overall Study|Death|18|||
150223954|NCT02660034|541955447|FG013|Overall Study|Death|7|||
150223955|NCT02660034|541955434|FG000|Overall Study|Physician Decision|0|||
150223956|NCT02660034|541955435|FG001|Overall Study|Physician Decision|0|||
150223957|NCT02660034|541955436|FG002|Overall Study|Physician Decision|0|||
150223958|NCT02660034|541955437|FG003|Overall Study|Physician Decision|0|||
150223959|NCT02660034|541955438|FG004|Overall Study|Physician Decision|0|||
150223960|NCT02660034|541955439|FG005|Overall Study|Physician Decision|0|||
150223961|NCT02660034|541955440|FG006|Overall Study|Physician Decision|0|||
150223962|NCT02660034|541955441|FG007|Overall Study|Physician Decision|0|||
150223963|NCT02660034|541955442|FG008|Overall Study|Physician Decision|0|||
150223964|NCT02660034|541955443|FG009|Overall Study|Physician Decision|0|||
150223965|NCT02660034|541955444|FG010|Overall Study|Physician Decision|0|||
150223966|NCT02660034|541955445|FG011|Overall Study|Physician Decision|0|||
150223967|NCT02660034|541955446|FG012|Overall Study|Physician Decision|0|||
150223968|NCT02660034|541955447|FG013|Overall Study|Physician Decision|1|||
150223969|NCT02660034|541955434|FG000|Overall Study|Participants transferred to LTE|0|||
150223970|NCT02660034|541955435|FG001|Overall Study|Participants transferred to LTE|0|||
150223971|NCT02660034|541955436|FG002|Overall Study|Participants transferred to LTE|0|||
150223972|NCT02660034|541955437|FG003|Overall Study|Participants transferred to LTE|0|||
150223973|NCT02660034|541955438|FG004|Overall Study|Participants transferred to LTE|0|||
150223974|NCT02660034|541955439|FG005|Overall Study|Participants transferred to LTE|10|||
150223975|NCT02660034|541955440|FG006|Overall Study|Participants transferred to LTE|8|||
150223976|NCT02660034|541955441|FG007|Overall Study|Participants transferred to LTE|8|||
150223977|NCT02660034|541955442|FG008|Overall Study|Participants transferred to LTE|10|||
150223978|NCT02660034|541955443|FG009|Overall Study|Participants transferred to LTE|1|||
150223979|NCT02660034|541955444|FG010|Overall Study|Participants transferred to LTE|2|||
150223980|NCT02660034|541955445|FG011|Overall Study|Participants transferred to LTE|4|||
150223981|NCT02660034|541955446|FG012|Overall Study|Participants transferred to LTE|1|||
150223982|NCT02660034|541955447|FG013|Overall Study|Participants transferred to LTE|1|||
150223983|NCT02995733|541955450|FG000|Overall Study|Study site closed|9|||
150223984|NCT02995733|541955451|FG001|Overall Study|Study site closed|10|||
150223985|NCT02995733|541955450|FG000|Overall Study|Death|3|||
150223986|NCT02995733|541955451|FG001|Overall Study|Death|4|||
150223987|NCT02995733|541955450|FG000|Overall Study|Withdrawal by Subject|6|||
150223988|NCT02995733|541955451|FG001|Overall Study|Withdrawal by Subject|2|||
150223989|NCT02995733|541955450|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
150223990|NCT02995733|541955451|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
150223991|NCT02995733|541955450|FG000|Overall Study|Lost to Follow-up|48|||
150223992|NCT02995733|541955451|FG001|Overall Study|Lost to Follow-up|37|||
150223993|NCT02995733|541955450|FG000|Overall Study|Other|0|||
150223994|NCT02995733|541955451|FG001|Overall Study|Other|1|||
150223995|NCT02720198|541955459|FG000|Overall Study|Withdrawal by Subject|0|||
150223996|NCT02720198|541955460|FG001|Overall Study|Withdrawal by Subject|1|||
150223997|NCT04879823|541955461|FG000|Overall Study|Physician Decision|3|||
150223998|NCT04879823|541955462|FG001|Overall Study|Physician Decision|1|||
150223999|NCT04879823|541955461|FG000|Overall Study|Protocol Violation|2|||
150224000|NCT04879823|541955462|FG001|Overall Study|Protocol Violation|3|||
150224001|NCT04879823|541955461|FG000|Overall Study|Lost to Follow-up|43|||
150224002|NCT04879823|541955462|FG001|Overall Study|Lost to Follow-up|35|||
150224003|NCT01498445|541955465|FG000|Overall Study|Lack of Efficacy|0|||
150224004|NCT01498445|541955466|FG001|Overall Study|Lack of Efficacy|0|||
150224005|NCT01498445|541955467|FG002|Overall Study|Lack of Efficacy|1|||
150224006|NCT01498445|541955468|FG003|Overall Study|Lack of Efficacy|2|||
150224007|NCT01498445|541955469|FG004|Overall Study|Lack of Efficacy|0|||
150224008|NCT01498445|541955470|FG005|Overall Study|Lack of Efficacy|0|||
150224009|NCT01498445|541955465|FG000|Overall Study|Screen Failure|0|||
150224010|NCT01498445|541955466|FG001|Overall Study|Screen Failure|0|||
150224011|NCT01498445|541955467|FG002|Overall Study|Screen Failure|0|||
150224012|NCT01498445|541955468|FG003|Overall Study|Screen Failure|0|||
150224013|NCT01498445|541955469|FG004|Overall Study|Screen Failure|1|||
150224014|NCT01498445|541955470|FG005|Overall Study|Screen Failure|1|||
150224015|NCT02465866|541955471|FG000|Period 3|Withdrawal by Subject|0|||
150224016|NCT02465866|541955472|FG001|Period 3|Withdrawal by Subject|1|||
150224017|NCT02465866|541955473|FG002|Period 3|Withdrawal by Subject|0|||
150224018|NCT02465866|541955474|FG003|Period 3|Withdrawal by Subject|0|||
150224019|NCT02023099|541955475|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
150224020|NCT02023099|541955476|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
150224021|NCT02023099|541955477|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
150224022|NCT02023099|541955475|FG000|Overall Study|Withdrawn Consent|3|||
150224023|NCT02023099|541955476|FG001|Overall Study|Withdrawn Consent|0|||
150224024|NCT02023099|541955477|FG002|Overall Study|Withdrawn Consent|1|||
150224025|NCT02023099|541955475|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
150224026|NCT02023099|541955476|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
150224027|NCT02023099|541955477|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
150224028|NCT00203502|541955478|FG000|Overall Study|Death|1|||
150224029|NCT02592434|541955479|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
150224030|NCT02592434|541955480|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
150224031|NCT02592434|541955481|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
150224032|NCT02592434|541955479|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
150224033|NCT02592434|541955480|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
150224034|NCT02592434|541955481|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
150224035|NCT02592434|541955479|FG000|Open-Label Phase (18 Weeks)|Other|3|||
150224036|NCT02592434|541955480|FG001|Open-Label Phase (18 Weeks)|Other|0|||
150224037|NCT02592434|541955481|FG002|Open-Label Phase (18 Weeks)|Other|0|||
150224038|NCT02592434|541955479|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
150224039|NCT02592434|541955480|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
150224040|NCT02592434|541955481|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
150224041|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
150224042|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
150224043|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
150224044|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
150224045|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
150224046|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
150224047|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Other|0|||
150224048|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Other|1|||
150224049|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Other|0|||
150224050|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
150224051|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
150224052|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
150224053|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
150224054|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
150224055|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
150224056|NCT02592434|541955479|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
150224057|NCT02592434|541955480|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
150224058|NCT02592434|541955481|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
150224059|NCT01469819|541955482|FG000|Overall Study|Withdrawal by Subject|1|||
150224060|NCT01469819|541955482|FG000|Overall Study|Did not meet inclusionary criteria|2|||
150224061|NCT01469819|541955482|FG000|Overall Study|Could not swallow SmartPill|2|||
150224062|NCT01469819|541955482|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
150224063|NCT01695993|541955485|FG000|Overall Study|Lost to Follow-up|2|||
150224064|NCT01695993|541955486|FG001|Overall Study|Lost to Follow-up|1|||
150224065|NCT01695993|541955487|FG002|Overall Study|Lost to Follow-up|3|||
150224066|NCT01695993|541955485|FG000|Overall Study|Withdrawal by Subject|2|||
150224067|NCT01695993|541955486|FG001|Overall Study|Withdrawal by Subject|2|||
150224068|NCT01695993|541955487|FG002|Overall Study|Withdrawal by Subject|2|||
150224069|NCT01695993|541955485|FG000|Overall Study|To ill to continue|1|||
150224070|NCT01695993|541955486|FG001|Overall Study|To ill to continue|2|||
150224071|NCT01695993|541955487|FG002|Overall Study|To ill to continue|0|||
150224072|NCT01695993|541955485|FG000|Overall Study|Changed Medical Facility|0|||
150224073|NCT01695993|541955486|FG001|Overall Study|Changed Medical Facility|0|||
150224074|NCT01695993|541955487|FG002|Overall Study|Changed Medical Facility|1|||
150224075|NCT00147745|541955488|FG000|Overall Study|Withdrawal by Subject|1|||
150224076|NCT00147745|541955489|FG001|Overall Study|Withdrawal by Subject|0|||
150224077|NCT00147745|541955490|FG002|Overall Study|Withdrawal by Subject|0|||
150224078|NCT00385697|541955492|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
150224079|NCT00385697|541955493|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
150224080|NCT00385697|541955494|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
150224081|NCT00385697|541955495|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
150224082|NCT00385697|541955496|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
150224083|NCT00385697|541955492|FG000|Open-label Segment 1|Lost to Follow-up|1|||
150224084|NCT00385697|541955493|FG001|Open-label Segment 1|Lost to Follow-up|0|||
150224085|NCT00385697|541955494|FG002|Open-label Segment 1|Lost to Follow-up|0|||
150224086|NCT00385697|541955495|FG003|Open-label Segment 1|Lost to Follow-up|0|||
150224087|NCT00385697|541955496|FG004|Open-label Segment 1|Lost to Follow-up|0|||
150224088|NCT00385697|541955492|FG000|Double-blind Segment 2|Adverse Event|0|||
150224089|NCT00385697|541955493|FG001|Double-blind Segment 2|Adverse Event|3|||
150224090|NCT00385697|541955494|FG002|Double-blind Segment 2|Adverse Event|1|||
150224091|NCT00385697|541955495|FG003|Double-blind Segment 2|Adverse Event|0|||
150224092|NCT00385697|541955496|FG004|Double-blind Segment 2|Adverse Event|0|||
150224093|NCT00385697|541955492|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
150224094|NCT00385697|541955493|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
150224095|NCT00385697|541955494|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
150224096|NCT00385697|541955495|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
150224097|NCT00385697|541955496|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
150224098|NCT00385697|541955492|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
150224099|NCT00385697|541955493|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
150224100|NCT00385697|541955494|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
150224101|NCT00385697|541955495|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
150224102|NCT00385697|541955496|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
150224103|NCT00385697|541955492|FG000|Double-blind Segment 2|Other|0|||
150224104|NCT00385697|541955493|FG001|Double-blind Segment 2|Other|2|||
150224105|NCT00385697|541955494|FG002|Double-blind Segment 2|Other|0|||
150224106|NCT00385697|541955495|FG003|Double-blind Segment 2|Other|0|||
150224107|NCT00385697|541955496|FG004|Double-blind Segment 2|Other|0|||
150224108|NCT02305797|541955497|FG000|Overall Study|Adverse Event|11|||
150224109|NCT02305797|541955498|FG001|Overall Study|Adverse Event|2|||
150224110|NCT02305797|541955497|FG000|Overall Study|Withdrawal by Subject|9|||
150224111|NCT02305797|541955498|FG001|Overall Study|Withdrawal by Subject|10|||
150224112|NCT02305797|541955497|FG000|Overall Study|Lack of Efficacy|6|||
150224113|NCT02305797|541955498|FG001|Overall Study|Lack of Efficacy|0|||
150224114|NCT02305797|541955497|FG000|Overall Study|Lost to Follow-up|5|||
150224115|NCT02305797|541955498|FG001|Overall Study|Lost to Follow-up|11|||
150224116|NCT02305797|541955497|FG000|Overall Study|Pregnancy|0|||
150224117|NCT02305797|541955498|FG001|Overall Study|Pregnancy|2|||
150224118|NCT02305797|541955497|FG000|Overall Study|Noncompliance|14|||
150224119|NCT02305797|541955498|FG001|Overall Study|Noncompliance|12|||
150224120|NCT02305797|541955497|FG000|Overall Study|Reason not collected|0|||
150224121|NCT02305797|541955498|FG001|Overall Study|Reason not collected|1|||
150224122|NCT01648699|541955506|FG000|Overall Study|Death|1|||
150224123|NCT01648699|541955506|FG000|Overall Study|Lost to Follow-up|2|||
150224124|NCT01648699|541955506|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
150224125|NCT01536795|541955507|FG000|Overall Study|Lost to Follow-up|0|||
150224126|NCT01536795|541955508|FG001|Overall Study|Lost to Follow-up|2|||
150224127|NCT01536795|541955507|FG000|Overall Study|Lack of Efficacy|1|||
150224128|NCT01536795|541955508|FG001|Overall Study|Lack of Efficacy|0|||
150224129|NCT02267746|541955509|FG000|Overall Study|Adverse Event|0|||
150224130|NCT02267746|541955510|FG001|Overall Study|Adverse Event|2|||
150224131|NCT02267746|541955511|FG002|Overall Study|Adverse Event|1|||
150224132|NCT02267746|541955509|FG000|Overall Study|Protocol Violation|8|||
150224133|NCT02267746|541955510|FG001|Overall Study|Protocol Violation|7|||
150224134|NCT02267746|541955511|FG002|Overall Study|Protocol Violation|3|||
150224135|NCT02267746|541955509|FG000|Overall Study|Lack of Efficacy|11|||
150224136|NCT02267746|541955510|FG001|Overall Study|Lack of Efficacy|11|||
150224137|NCT02267746|541955511|FG002|Overall Study|Lack of Efficacy|15|||
150224138|NCT02267746|541955509|FG000|Overall Study|Protocol Violation|1|||
150224139|NCT02267746|541955510|FG001|Overall Study|Protocol Violation|2|||
150224140|NCT02267746|541955511|FG002|Overall Study|Protocol Violation|1|||
150224141|NCT02267746|541955509|FG000|Overall Study|Miscellaneous|1|||
150224142|NCT02267746|541955510|FG001|Overall Study|Miscellaneous|0|||
150224143|NCT02267746|541955511|FG002|Overall Study|Miscellaneous|1|||
150224144|NCT01812837|541955512|FG000|Overall Study|Lost to Follow-up|1|||
150224145|NCT01812837|541955513|FG001|Overall Study|Lost to Follow-up|1|||
150224146|NCT01812837|541955514|FG002|Overall Study|Lost to Follow-up|0|||
150224147|NCT01812837|541955512|FG000|Overall Study|Protocol Violation|1|||
150224148|NCT01812837|541955513|FG001|Overall Study|Protocol Violation|0|||
150224149|NCT01812837|541955514|FG002|Overall Study|Protocol Violation|0|||
150224150|NCT05008224|541955519|FG000|Overall Study|Death|3|||
150224151|NCT05008224|541955519|FG000|Overall Study|Lost to Follow-up|2|||
150224152|NCT05008224|541955519|FG000|Overall Study|Did Not Continue on Extension Study|39|||
150224153|NCT05008224|541955519|FG000|Overall Study|Transferred to Extension Study|100|||
150224154|NCT05008224|541955519|FG000|Overall Study|Withdrawal by Subject|2|||
150224155|NCT05234632|541955520|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
150224156|NCT05234632|541955521|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
150224157|NCT05234632|541955520|FG000|Overall Study|Withdrawal by Subject|2|||
150224158|NCT05234632|541955521|FG001|Overall Study|Withdrawal by Subject|0|||
150224159|NCT05234632|541955520|FG000|Overall Study|Adverse Event|0|||
150224160|NCT05234632|541955521|FG001|Overall Study|Adverse Event|4|||
150224161|NCT05234632|541955520|FG000|Overall Study|Physician Decision|1|||
150224162|NCT05234632|541955521|FG001|Overall Study|Physician Decision|1|||
150224163|NCT05234632|541955520|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
150224164|NCT05234632|541955521|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
150224165|NCT05234632|541955520|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
150224166|NCT05234632|541955521|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
150224167|NCT05263492|541955522|FG000|Overall Study|Adverse Event|1|||
150224168|NCT05263492|541955522|FG000|Overall Study|Disease progression during active treatment|3|||
150224169|NCT03345420|541955525|FG000|Overall Study|Withdrawal by Subject|1|||
150224170|NCT05216835|541955526|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
150224171|NCT05216835|541955527|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
150224172|NCT05216835|541955528|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
150224173|NCT05216835|541955529|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
150224174|NCT05216835|541955530|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
150224175|NCT05216835|541955531|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
150224176|NCT05216835|541955532|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
150224177|NCT05216835|541955533|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
150224178|NCT05216835|541955526|FG000|Overall Study|Death|0|||
150224179|NCT05216835|541955527|FG001|Overall Study|Death|0|||
150224180|NCT05216835|541955528|FG002|Overall Study|Death|0|||
150224181|NCT05216835|541955529|FG003|Overall Study|Death|1|||
150224182|NCT05216835|541955530|FG004|Overall Study|Death|1|||
150224183|NCT05216835|541955531|FG005|Overall Study|Death|1|||
150224184|NCT05216835|541955532|FG006|Overall Study|Death|1|||
150224185|NCT05216835|541955533|FG007|Overall Study|Death|1|||
150224186|NCT05216835|541955526|FG000|Overall Study|Physician Decision|0|||
150224187|NCT05216835|541955527|FG001|Overall Study|Physician Decision|0|||
150224188|NCT05216835|541955528|FG002|Overall Study|Physician Decision|0|||
150224189|NCT05216835|541955529|FG003|Overall Study|Physician Decision|0|||
150224190|NCT05216835|541955530|FG004|Overall Study|Physician Decision|0|||
150224191|NCT05216835|541955531|FG005|Overall Study|Physician Decision|1|||
150224192|NCT05216835|541955532|FG006|Overall Study|Physician Decision|1|||
150224193|NCT05216835|541955533|FG007|Overall Study|Physician Decision|0|||
150224194|NCT05216835|541955526|FG000|Overall Study|Study terminated by Sponsor|0|||
150224195|NCT05216835|541955527|FG001|Overall Study|Study terminated by Sponsor|0|||
150224196|NCT05216835|541955528|FG002|Overall Study|Study terminated by Sponsor|0|||
150224197|NCT05216835|541955529|FG003|Overall Study|Study terminated by Sponsor|0|||
150224198|NCT05216835|541955530|FG004|Overall Study|Study terminated by Sponsor|0|||
150224199|NCT05216835|541955531|FG005|Overall Study|Study terminated by Sponsor|0|||
150224200|NCT05216835|541955532|FG006|Overall Study|Study terminated by Sponsor|0|||
150224201|NCT05216835|541955533|FG007|Overall Study|Study terminated by Sponsor|1|||
150224202|NCT05216835|541955526|FG000|Overall Study|Withdrawal by Subject|1|||
150224203|NCT05216835|541955527|FG001|Overall Study|Withdrawal by Subject|0|||
150224204|NCT05216835|541955528|FG002|Overall Study|Withdrawal by Subject|1|||
150224205|NCT05216835|541955529|FG003|Overall Study|Withdrawal by Subject|0|||
150224206|NCT05216835|541955530|FG004|Overall Study|Withdrawal by Subject|1|||
150224207|NCT05216835|541955531|FG005|Overall Study|Withdrawal by Subject|0|||
150224208|NCT05216835|541955532|FG006|Overall Study|Withdrawal by Subject|0|||
150224209|NCT05216835|541955533|FG007|Overall Study|Withdrawal by Subject|1|||
150224210|NCT05216835|541955526|FG000|Overall Study|Other|0|||
150224211|NCT05216835|541955527|FG001|Overall Study|Other|1|||
150224212|NCT05216835|541955528|FG002|Overall Study|Other|0|||
150224213|NCT05216835|541955529|FG003|Overall Study|Other|0|||
150224214|NCT05216835|541955530|FG004|Overall Study|Other|0|||
150224215|NCT05216835|541955531|FG005|Overall Study|Other|0|||
150224216|NCT05216835|541955532|FG006|Overall Study|Other|0|||
150224217|NCT05216835|541955533|FG007|Overall Study|Other|0|||
150224218|NCT05179603|541955534|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
150224219|NCT05179603|541955534|FG000|Overall Study|Withdrawal by Subject|1|||
150224220|NCT05179603|541955534|FG000|Overall Study|Progressive disease|4|||
150224221|NCT05179603|541955534|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
150224222|NCT03861078|541955535|FG000|Overall Study|COVID-19 shut down|4|||
150224223|NCT03861078|541955535|FG000|Overall Study|Lost to Follow-up|1|||
150224224|NCT03861078|541955535|FG000|Overall Study|Protocol Violation|2|||
150224225|NCT03861078|541955535|FG000|Overall Study|lack of venous access|1|||
150224226|NCT01075815|541955536|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
150224227|NCT01075815|541955537|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
150224228|NCT01075815|541955536|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
150224229|NCT01075815|541955537|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
150224230|NCT01075815|541955536|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
150224231|NCT01075815|541955537|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
150224232|NCT00596960|541955538|FG000|Overall Study|Death|1|||
150224233|NCT00596960|541955539|FG001|Overall Study|Death|2|||
150224234|NCT00596960|541955538|FG000|Overall Study|Lost to Follow-up|6|||
150224235|NCT00596960|541955539|FG001|Overall Study|Lost to Follow-up|5|||
150224236|NCT00596960|541955538|FG000|Overall Study|Withdrawal by Subject|1|||
150224237|NCT00596960|541955539|FG001|Overall Study|Withdrawal by Subject|0|||
150224238|NCT00596960|541955538|FG000|Overall Study|Incarcerated|2|||
150224239|NCT00596960|541955539|FG001|Overall Study|Incarcerated|0|||
150224240|NCT00596960|541955538|FG000|Overall Study|Physician Decision|1|||
150224241|NCT00596960|541955539|FG001|Overall Study|Physician Decision|0|||
150224242|NCT00596960|541955538|FG000|Overall Study|Protocol Violation|0|||
150224243|NCT00596960|541955539|FG001|Overall Study|Protocol Violation|1|||
150224244|NCT00596960|541955538|FG000|Overall Study|No alcohol use data|0|||
150224245|NCT00596960|541955539|FG001|Overall Study|No alcohol use data|1|||
150224246|NCT02058992|541955540|FG000|Overall Study|Lost to Follow-up|4|||
150224247|NCT02058992|541955540|FG000|Overall Study|Protocol Violation|92|||
150224248|NCT02058992|541955540|FG000|Overall Study|CRF Uncollected|20|||
150224249|NCT02924051|541955543|FG000|Overall Study|Withdrawal by Subject|1|||
150224250|NCT02924051|541955544|FG001|Overall Study|Withdrawal by Subject|9|||
150224251|NCT00914732|541955549|FG000|Overall Study|Lost to Follow-up|6|||
150224252|NCT00914732|541955550|FG001|Overall Study|Lost to Follow-up|7|||
150224253|NCT00914732|541955551|FG002|Overall Study|Lost to Follow-up|9|||
150224254|NCT00914732|541955549|FG000|Overall Study|Withdrawal by Subject|3|||
150224255|NCT00914732|541955550|FG001|Overall Study|Withdrawal by Subject|0|||
150224256|NCT00914732|541955551|FG002|Overall Study|Withdrawal by Subject|2|||
150224257|NCT00914732|541955549|FG000|Overall Study|Adverse Event|1|||
150224258|NCT00914732|541955550|FG001|Overall Study|Adverse Event|0|||
150224259|NCT00914732|541955551|FG002|Overall Study|Adverse Event|0|||
150224260|NCT03005106|541955552|FG000|Overall Study|Lost to Follow-up|16|||
150224261|NCT03005106|541955552|FG000|Overall Study|Adverse Event|1|||
150224262|NCT03005106|541955552|FG000|Overall Study|Physician Decision|1|||
150224263|NCT03005106|541955552|FG000|Overall Study|Death|2|||
150224264|NCT01855399|541955553|FG000|6 Month|Lost to Follow-up|12|||
150224265|NCT01855399|541955554|FG001|6 Month|Lost to Follow-up|9|||
150224266|NCT01855399|541955553|FG000|6 Month|Withdrawal by Subject|8|||
150224267|NCT01855399|541955554|FG001|6 Month|Withdrawal by Subject|6|||
150224268|NCT01855399|541955553|FG000|12 Month|Lost to Follow-up|7|||
150224269|NCT01855399|541955554|FG001|12 Month|Lost to Follow-up|11|||
150224270|NCT00321672|541955555|FG000|Overall Study|Withdrawal by Subject|5|||
150224271|NCT00321672|541955556|FG001|Overall Study|Withdrawal by Subject|1|||
150224272|NCT00321672|541955557|FG002|Overall Study|Withdrawal by Subject|2|||
150224273|NCT00321672|541955558|FG003|Overall Study|Withdrawal by Subject|0|||
150224274|NCT00321672|541955555|FG000|Overall Study|Noncompliance|1|||
150224275|NCT00321672|541955556|FG001|Overall Study|Noncompliance|2|||
150224276|NCT00321672|541955557|FG002|Overall Study|Noncompliance|1|||
150224277|NCT00321672|541955558|FG003|Overall Study|Noncompliance|0|||
150224278|NCT00321672|541955555|FG000|Overall Study|Adverse Event|1|||
150224279|NCT00321672|541955556|FG001|Overall Study|Adverse Event|1|||
150224280|NCT00321672|541955557|FG002|Overall Study|Adverse Event|0|||
150224281|NCT00321672|541955558|FG003|Overall Study|Adverse Event|0|||
150224282|NCT00321672|541955555|FG000|Overall Study|Lack of Efficacy|1|||
150224283|NCT00321672|541955556|FG001|Overall Study|Lack of Efficacy|1|||
150224284|NCT00321672|541955557|FG002|Overall Study|Lack of Efficacy|0|||
150224285|NCT00321672|541955558|FG003|Overall Study|Lack of Efficacy|0|||
150224286|NCT00321672|541955555|FG000|Overall Study|Lost to Follow-up|2|||
150224287|NCT00321672|541955556|FG001|Overall Study|Lost to Follow-up|0|||
150224288|NCT00321672|541955557|FG002|Overall Study|Lost to Follow-up|4|||
150224289|NCT00321672|541955558|FG003|Overall Study|Lost to Follow-up|2|||
150224290|NCT00321672|541955555|FG000|Overall Study|Death|1|||
150224291|NCT00321672|541955556|FG001|Overall Study|Death|0|||
150224292|NCT00321672|541955557|FG002|Overall Study|Death|0|||
150224293|NCT00321672|541955558|FG003|Overall Study|Death|0|||
150224294|NCT00321672|541955555|FG000|Overall Study|Too far to travel for visits|1|||
150224295|NCT00321672|541955556|FG001|Overall Study|Too far to travel for visits|0|||
150224296|NCT00321672|541955557|FG002|Overall Study|Too far to travel for visits|0|||
150224297|NCT00321672|541955558|FG003|Overall Study|Too far to travel for visits|0|||
150224298|NCT00321672|541955555|FG000|Overall Study|Incarcerated|0|||
150224299|NCT00321672|541955556|FG001|Overall Study|Incarcerated|0|||
150224300|NCT00321672|541955557|FG002|Overall Study|Incarcerated|2|||
150224301|NCT00321672|541955558|FG003|Overall Study|Incarcerated|0|||
150224302|NCT00321672|541955555|FG000|Overall Study|Moved out of state|0|||
150224303|NCT00321672|541955556|FG001|Overall Study|Moved out of state|1|||
150224304|NCT00321672|541955557|FG002|Overall Study|Moved out of state|1|||
150224305|NCT00321672|541955558|FG003|Overall Study|Moved out of state|0|||
150224306|NCT00321672|541955555|FG000|Overall Study|Protocol Violation|0|||
150224307|NCT00321672|541955556|FG001|Overall Study|Protocol Violation|0|||
150224308|NCT00321672|541955557|FG002|Overall Study|Protocol Violation|1|||
150224309|NCT00321672|541955558|FG003|Overall Study|Protocol Violation|0|||
150224310|NCT00321672|541955555|FG000|Overall Study|Diagnosis of testicular cancer|0|||
150224311|NCT00321672|541955556|FG001|Overall Study|Diagnosis of testicular cancer|1|||
150224312|NCT00321672|541955557|FG002|Overall Study|Diagnosis of testicular cancer|0|||
150224313|NCT00321672|541955558|FG003|Overall Study|Diagnosis of testicular cancer|0|||
150224314|NCT00321672|541955555|FG000|Overall Study|Extensive travel required for new job|0|||
150224315|NCT00321672|541955556|FG001|Overall Study|Extensive travel required for new job|1|||
150224316|NCT00321672|541955557|FG002|Overall Study|Extensive travel required for new job|0|||
150224317|NCT00321672|541955558|FG003|Overall Study|Extensive travel required for new job|0|||
150224318|NCT00512902|541955559|FG000|Overall Study|Adverse Event|7|||
150224319|NCT00512902|541955559|FG000|Overall Study|Lost to Follow-up|1|||
150224320|NCT03019289|541955560|FG000|Overall Study|Adverse Event|1|||
150224321|NCT03019289|541955561|FG001|Overall Study|Adverse Event|0|||
150224322|NCT03019289|541955562|FG002|Overall Study|Adverse Event|0|||
150224323|NCT03019289|541955563|FG003|Overall Study|Adverse Event|0|||
150224324|NCT03019289|541955564|FG004|Overall Study|Adverse Event|0|||
150224325|NCT03019289|541955565|FG005|Overall Study|Adverse Event|0|||
150224326|NCT03019289|541955566|FG006|Overall Study|Adverse Event|0|||
150224327|NCT03019289|541955567|FG007|Overall Study|Adverse Event|0|||
150224328|NCT03019289|541955568|FG008|Overall Study|Adverse Event|1|||
150224329|NCT03019289|541955560|FG000|Overall Study|Other|1|||
150224330|NCT03019289|541955561|FG001|Overall Study|Other|0|||
150224331|NCT03019289|541955562|FG002|Overall Study|Other|0|||
150224332|NCT03019289|541955563|FG003|Overall Study|Other|0|||
150224333|NCT03019289|541955564|FG004|Overall Study|Other|0|||
150224334|NCT03019289|541955565|FG005|Overall Study|Other|0|||
150224335|NCT03019289|541955566|FG006|Overall Study|Other|0|||
150224336|NCT03019289|541955567|FG007|Overall Study|Other|0|||
150224337|NCT03019289|541955568|FG008|Overall Study|Other|0|||
150224338|NCT00936065|541955569|FG000|Overall Study|Adverse Event|1|||
150224339|NCT00936065|541955570|FG001|Overall Study|Adverse Event|0|||
150224340|NCT00936065|541955571|FG002|Overall Study|Adverse Event|1|||
150224341|NCT00936065|541955569|FG000|Overall Study|Lack of Efficacy|1|||
150224342|NCT00936065|541955570|FG001|Overall Study|Lack of Efficacy|0|||
150224343|NCT00936065|541955571|FG002|Overall Study|Lack of Efficacy|1|||
150224344|NCT00936065|541955569|FG000|Overall Study|Lost to Follow-up|1|||
150224345|NCT00936065|541955570|FG001|Overall Study|Lost to Follow-up|0|||
150224346|NCT00936065|541955571|FG002|Overall Study|Lost to Follow-up|0|||
150224347|NCT00936065|541955569|FG000|Overall Study|Protocol Violation|1|||
150224348|NCT00936065|541955570|FG001|Overall Study|Protocol Violation|2|||
150224349|NCT00936065|541955571|FG002|Overall Study|Protocol Violation|1|||
150224350|NCT00936065|541955569|FG000|Overall Study|Withdrawal by Subject|0|||
150224351|NCT00936065|541955570|FG001|Overall Study|Withdrawal by Subject|2|||
150224352|NCT00936065|541955571|FG002|Overall Study|Withdrawal by Subject|4|||
150224353|NCT01052714|541955574|FG000|Overall Study|Adverse Event|6|||
150224354|NCT01052714|541955575|FG001|Overall Study|Adverse Event|3|||
150224355|NCT01052714|541955576|FG002|Overall Study|Adverse Event|0|||
150224356|NCT01052714|541955574|FG000|Overall Study|Death|1|||
150224357|NCT01052714|541955575|FG001|Overall Study|Death|2|||
150224358|NCT01052714|541955576|FG002|Overall Study|Death|0|||
150224359|NCT01052714|541955574|FG000|Overall Study|Lost to Follow-up|2|||
150224360|NCT01052714|541955575|FG001|Overall Study|Lost to Follow-up|3|||
150224361|NCT01052714|541955576|FG002|Overall Study|Lost to Follow-up|0|||
150224362|NCT01052714|541955574|FG000|Overall Study|Physician Decision|9|||
150224363|NCT01052714|541955575|FG001|Overall Study|Physician Decision|9|||
150224364|NCT01052714|541955576|FG002|Overall Study|Physician Decision|1|||
150224365|NCT01052714|541955574|FG000|Overall Study|Withdrawal by Subject|7|||
150224366|NCT01052714|541955575|FG001|Overall Study|Withdrawal by Subject|12|||
150224367|NCT01052714|541955576|FG002|Overall Study|Withdrawal by Subject|1|||
150224368|NCT01288729|541955579|FG000|Overall Study|Withdrawal by Subject|1|||
150224369|NCT01288729|541955580|FG001|Overall Study|Withdrawal by Subject|0|||
150224370|NCT03214198|541955581|FG000|Overall Study|Case Report Forms Uncollected|18|||
150224371|NCT03214198|541955581|FG000|Overall Study|Protocol Deviation|18|||
150224372|NCT04448561|541955584|FG000|Overall Study|Noncompliance|1|||
150224373|NCT04448561|541955585|FG001|Overall Study|Noncompliance|0|||
150224374|NCT01232569|541957359|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
150224375|NCT01232569|541957360|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
150224376|NCT01232569|541957361|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
150224377|NCT01232569|541957362|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
150224378|NCT01232569|541957359|FG000|Double-blind Treatment Period|Escape|2|||
150224379|NCT01232569|541957360|FG001|Double-blind Treatment Period|Escape|2|||
150224380|NCT01232569|541957361|FG002|Double-blind Treatment Period|Escape|0|||
150224381|NCT01232569|541957362|FG003|Double-blind Treatment Period|Escape|0|||
150224382|NCT01232569|541957359|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
150224383|NCT01232569|541957360|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
150224384|NCT01232569|541957361|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
150224385|NCT01232569|541957362|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
150224386|NCT01232569|541957359|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
150224387|NCT01232569|541957360|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
150224388|NCT01232569|541957361|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
150224389|NCT01232569|541957362|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
150224390|NCT01232569|541957359|FG000|Double-blind Treatment Period|Physician Decision|1|||
150224391|NCT01232569|541957360|FG001|Double-blind Treatment Period|Physician Decision|0|||
150224392|NCT01232569|541957361|FG002|Double-blind Treatment Period|Physician Decision|0|||
150224393|NCT01232569|541957362|FG003|Double-blind Treatment Period|Physician Decision|0|||
150224394|NCT01232569|541957359|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
150224395|NCT01232569|541957360|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
150224396|NCT01232569|541957361|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
150224397|NCT01232569|541957362|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
150224398|NCT01232569|541957359|FG000|Double-blind Treatment Period|Death|2|||
150224399|NCT01232569|541957360|FG001|Double-blind Treatment Period|Death|0|||
150224400|NCT01232569|541957361|FG002|Double-blind Treatment Period|Death|0|||
150224401|NCT01232569|541957362|FG003|Double-blind Treatment Period|Death|0|||
150224402|NCT05335005|541957368|FG000|Overall Study|Lost to Follow-up|1|||
150224403|NCT00678899|541957373|FG000|Overall Study|Adverse Event|1|||
150224404|NCT03672188|541957384|FG000|Overall Study|Withdrawal by Subject|0|||
150224405|NCT03672188|541957385|FG001|Overall Study|Withdrawal by Subject|0|||
150224406|NCT03672188|541957386|FG002|Overall Study|Withdrawal by Subject|0|||
150224407|NCT03672188|541957387|FG003|Overall Study|Withdrawal by Subject|3|||
150224408|NCT03672188|541957388|FG004|Overall Study|Withdrawal by Subject|0|||
150224409|NCT03672188|541957389|FG005|Overall Study|Withdrawal by Subject|0|||
150224410|NCT03672188|541957390|FG006|Overall Study|Withdrawal by Subject|0|||
150224411|NCT03672188|541957391|FG007|Overall Study|Withdrawal by Subject|0|||
150224412|NCT03672188|541957392|FG008|Overall Study|Withdrawal by Subject|0|||
150224413|NCT03672188|541957393|FG009|Overall Study|Withdrawal by Subject|0|||
150224414|NCT03672188|541957394|FG010|Overall Study|Withdrawal by Subject|0|||
150224415|NCT03672188|541957395|FG011|Overall Study|Withdrawal by Subject|0|||
150224416|NCT03672188|541957396|FG012|Overall Study|Withdrawal by Subject|0|||
150224417|NCT03672188|541957397|FG013|Overall Study|Withdrawal by Subject|0|||
150224418|NCT03672188|541957398|FG014|Overall Study|Withdrawal by Subject|0|||
150224419|NCT03672188|541957384|FG000|Overall Study|Death|0|||
150224420|NCT03672188|541957385|FG001|Overall Study|Death|0|||
150224421|NCT03672188|541957386|FG002|Overall Study|Death|0|||
150224422|NCT03672188|541957387|FG003|Overall Study|Death|0|||
150224423|NCT03672188|541957388|FG004|Overall Study|Death|0|||
150224424|NCT03672188|541957389|FG005|Overall Study|Death|0|||
150224425|NCT03672188|541957390|FG006|Overall Study|Death|0|||
150224426|NCT03672188|541957391|FG007|Overall Study|Death|0|||
150224427|NCT03672188|541957392|FG008|Overall Study|Death|0|||
150224428|NCT03672188|541957393|FG009|Overall Study|Death|0|||
150224429|NCT03672188|541957394|FG010|Overall Study|Death|0|||
150224430|NCT03672188|541957395|FG011|Overall Study|Death|0|||
150224431|NCT03672188|541957396|FG012|Overall Study|Death|1|||
150224432|NCT03672188|541957397|FG013|Overall Study|Death|0|||
150224433|NCT03672188|541957398|FG014|Overall Study|Death|0|||
150224434|NCT03672188|541957384|FG000|Overall Study|Lost to Follow-up|0|||
150224435|NCT03672188|541957385|FG001|Overall Study|Lost to Follow-up|0|||
150224436|NCT03672188|541957386|FG002|Overall Study|Lost to Follow-up|1|||
150224437|NCT03672188|541957387|FG003|Overall Study|Lost to Follow-up|0|||
150224438|NCT03672188|541957388|FG004|Overall Study|Lost to Follow-up|0|||
150224439|NCT03672188|541957389|FG005|Overall Study|Lost to Follow-up|0|||
150224440|NCT03672188|541957390|FG006|Overall Study|Lost to Follow-up|0|||
150224441|NCT03672188|541957391|FG007|Overall Study|Lost to Follow-up|0|||
150224442|NCT03672188|541957392|FG008|Overall Study|Lost to Follow-up|0|||
150224443|NCT03672188|541957393|FG009|Overall Study|Lost to Follow-up|0|||
150224444|NCT03672188|541957394|FG010|Overall Study|Lost to Follow-up|0|||
150224445|NCT03672188|541957395|FG011|Overall Study|Lost to Follow-up|0|||
150224446|NCT03672188|541957396|FG012|Overall Study|Lost to Follow-up|0|||
150224447|NCT03672188|541957397|FG013|Overall Study|Lost to Follow-up|0|||
150224448|NCT03672188|541957398|FG014|Overall Study|Lost to Follow-up|0|||
150224449|NCT03997409|541957399|FG000|Overall Study|Protocol Violation|1|||
150224450|NCT03997409|541957400|FG001|Overall Study|Protocol Violation|1|||
150224451|NCT03997409|541957401|FG002|Overall Study|Protocol Violation|0|||
150224452|NCT03997409|541957399|FG000|Overall Study|Withdrawal by Subject|3|||
150224453|NCT03997409|541957400|FG001|Overall Study|Withdrawal by Subject|0|||
150224454|NCT03997409|541957401|FG002|Overall Study|Withdrawal by Subject|0|||
150224455|NCT03997409|541957399|FG000|Overall Study|Lost to Follow-up|0|||
150224456|NCT03997409|541957400|FG001|Overall Study|Lost to Follow-up|0|||
150224457|NCT03997409|541957401|FG002|Overall Study|Lost to Follow-up|1|||
150224458|NCT01753323|541957402|FG000|Overall Study|Lack of Efficacy|0|||
150224459|NCT01753323|541957403|FG001|Overall Study|Lack of Efficacy|0|||
150224460|NCT01753323|541957404|FG002|Overall Study|Lack of Efficacy|8|||
150224461|NCT01753323|541957402|FG000|Overall Study|Protocol deviation|1|||
150224462|NCT01753323|541957403|FG001|Overall Study|Protocol deviation|0|||
150224463|NCT01753323|541957404|FG002|Overall Study|Protocol deviation|0|||
150224464|NCT01753323|541957402|FG000|Overall Study|Adverse Event|0|||
150224465|NCT01753323|541957403|FG001|Overall Study|Adverse Event|0|||
150224466|NCT01753323|541957404|FG002|Overall Study|Adverse Event|1|||
150224467|NCT01870999|541957406|FG000|Overall Study|Adverse Event|0|||
150224468|NCT01870999|541957407|FG001|Overall Study|Adverse Event|4|||
150224469|NCT01870999|541957408|FG002|Overall Study|Adverse Event|1|||
150224470|NCT01870999|541957406|FG000|Overall Study|Subject met withdrawal criteria|3|||
150224471|NCT01870999|541957407|FG001|Overall Study|Subject met withdrawal criteria|2|||
150224472|NCT01870999|541957408|FG002|Overall Study|Subject met withdrawal criteria|0|||
150224473|NCT01870999|541957406|FG000|Overall Study|Subject withdrawn by Investigator|1|||
150224474|NCT01870999|541957407|FG001|Overall Study|Subject withdrawn by Investigator|0|||
150224475|NCT01870999|541957408|FG002|Overall Study|Subject withdrawn by Investigator|0|||
150224476|NCT01870999|541957406|FG000|Overall Study|Withdrawal by Subject|0|||
150224477|NCT01870999|541957407|FG001|Overall Study|Withdrawal by Subject|2|||
150224478|NCT01870999|541957408|FG002|Overall Study|Withdrawal by Subject|5|||
150224479|NCT01870999|541957406|FG000|Overall Study|Protocol Violation|0|||
150224480|NCT01870999|541957407|FG001|Overall Study|Protocol Violation|0|||
150224481|NCT01870999|541957408|FG002|Overall Study|Protocol Violation|1|||
150224482|NCT01636258|541957409|FG000|Overall Study|Lost to Follow-up|1|||
150224483|NCT01636258|541957410|FG001|Overall Study|Lost to Follow-up|0|||
150224484|NCT00116584|541957421|FG000|Overall Study|Withdrawal by Subject|1|||
150224485|NCT00116584|541957422|FG001|Overall Study|Withdrawal by Subject|0|||
150224486|NCT00116584|541957421|FG000|Overall Study|Protocol Violation|1|||
150224487|NCT00116584|541957422|FG001|Overall Study|Protocol Violation|1|||
150224488|NCT03034772|541957423|FG000|Overall Study|Adverse Event|0|||
150224489|NCT03034772|541957424|FG001|Overall Study|Adverse Event|1|||
150224490|NCT03034772|541957423|FG000|Overall Study|Withdrawal by Subject|0|||
150224491|NCT03034772|541957424|FG001|Overall Study|Withdrawal by Subject|1|||
150224492|NCT02798861|541957427|FG000|Overall Study|Lost to Follow-up|22|||
150224493|NCT02798861|541957427|FG000|Overall Study|Withdrawal by Subject|1|||
150224494|NCT04057937|541957452|FG000|Placebo-controlled Phase|Adverse Event|3|||
150224495|NCT04057937|541957453|FG001|Placebo-controlled Phase|Adverse Event|0|||
150224496|NCT04057937|541957452|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
150224497|NCT04057937|541957453|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
150224498|NCT04057937|541957452|FG000|Active-treatment Phase|Pregnancy|0|||
150224499|NCT04057937|541957453|FG001|Active-treatment Phase|Pregnancy|1|||
150224500|NCT04057937|541957452|FG000|Active-treatment Phase|Physician Decision|0|||
150224501|NCT04057937|541957453|FG001|Active-treatment Phase|Physician Decision|1|||
150224502|NCT02029521|541957454|FG000|Overall Study|Protocol Violation|1|||
150224503|NCT02029521|541957455|FG001|Overall Study|Protocol Violation|0|||
150224504|NCT02029521|541957454|FG000|Overall Study|Withdrawal by Subject|1|||
150224505|NCT02029521|541957455|FG001|Overall Study|Withdrawal by Subject|1|||
150224506|NCT01072396|541957456|FG000|Period One|Adverse Event|1|||
150224507|NCT01072396|541957457|FG001|Period One|Adverse Event|1|||
150224508|NCT01072396|541957456|FG000|Period One|Protocol Violation|2|||
150224509|NCT01072396|541957457|FG001|Period One|Protocol Violation|1|||
150224510|NCT01072396|541957456|FG000|Period One|Withdrawal by Subject|2|||
150224511|NCT01072396|541957457|FG001|Period One|Withdrawal by Subject|0|||
150224512|NCT01072396|541957456|FG000|Washout Period|Missing termination information|0|||
150224513|NCT01072396|541957457|FG001|Washout Period|Missing termination information|1|||
150224514|NCT01072396|541957456|FG000|Period Two|Adverse Event|0|||
150224515|NCT01072396|541957457|FG001|Period Two|Adverse Event|3|||
150224516|NCT01072396|541957456|FG000|Period Two|Lost to Follow-up|1|||
150224517|NCT01072396|541957457|FG001|Period Two|Lost to Follow-up|0|||
150224518|NCT00472199|541957458|FG000|Overall Study|Adverse Event|19|||
150224519|NCT00472199|541957459|FG001|Overall Study|Adverse Event|23|||
150224520|NCT00472199|541957458|FG000|Overall Study|Lack of Efficacy|4|||
150224521|NCT00472199|541957459|FG001|Overall Study|Lack of Efficacy|25|||
150224522|NCT00472199|541957458|FG000|Overall Study|Lost to Follow-up|2|||
150224523|NCT00472199|541957459|FG001|Overall Study|Lost to Follow-up|4|||
150224524|NCT00472199|541957458|FG000|Overall Study|Protocol Violation|3|||
150224525|NCT00472199|541957459|FG001|Overall Study|Protocol Violation|2|||
150224526|NCT00472199|541957458|FG000|Overall Study|Withdrawal by Subject|6|||
150224527|NCT00472199|541957459|FG001|Overall Study|Withdrawal by Subject|5|||
150224528|NCT00472199|541957458|FG000|Overall Study|personal reason|0|||
150224529|NCT00472199|541957459|FG001|Overall Study|personal reason|1|||
150224530|NCT00472199|541957458|FG000|Overall Study|patient was asymptomatic|1|||
150224531|NCT00472199|541957459|FG001|Overall Study|patient was asymptomatic|0|||
150224532|NCT02446912|541957461|FG000|Overall Study|Adverse Event|3|||
150224533|NCT02446912|541957462|FG001|Overall Study|Adverse Event|13|||
150224534|NCT02446912|541957463|FG002|Overall Study|Adverse Event|5|||
150224535|NCT02446912|541957461|FG000|Overall Study|Condition under investigation worsened|0|||
150224536|NCT02446912|541957462|FG001|Overall Study|Condition under investigation worsened|1|||
150224537|NCT02446912|541957463|FG002|Overall Study|Condition under investigation worsened|1|||
150224538|NCT02446912|541957461|FG000|Overall Study|Study-specific withdrawal criteria|1|||
150224539|NCT02446912|541957462|FG001|Overall Study|Study-specific withdrawal criteria|0|||
150224540|NCT02446912|541957463|FG002|Overall Study|Study-specific withdrawal criteria|0|||
150224541|NCT02446912|541957461|FG000|Overall Study|Lack of Efficacy|1|||
150224542|NCT02446912|541957462|FG001|Overall Study|Lack of Efficacy|4|||
150224543|NCT02446912|541957463|FG002|Overall Study|Lack of Efficacy|7|||
150224544|NCT02446912|541957461|FG000|Overall Study|Lost to Follow-up|0|||
150224545|NCT02446912|541957462|FG001|Overall Study|Lost to Follow-up|0|||
150224546|NCT02446912|541957463|FG002|Overall Study|Lost to Follow-up|2|||
150224547|NCT02446912|541957461|FG000|Overall Study|Severe non-compliance to protocol|1|||
150224548|NCT02446912|541957462|FG001|Overall Study|Severe non-compliance to protocol|0|||
150224549|NCT02446912|541957463|FG002|Overall Study|Severe non-compliance to protocol|1|||
150224550|NCT02446912|541957461|FG000|Overall Study|Withdrawal by Subject|10|||
150224551|NCT02446912|541957462|FG001|Overall Study|Withdrawal by Subject|15|||
150224552|NCT02446912|541957463|FG002|Overall Study|Withdrawal by Subject|15|||
150224553|NCT02446912|541957461|FG000|Overall Study|Miscellaneous|2|||
150224554|NCT02446912|541957462|FG001|Overall Study|Miscellaneous|2|||
150224555|NCT02446912|541957463|FG002|Overall Study|Miscellaneous|4|||
150224556|NCT01268488|541957464|FG000|Overall Study|Adverse Event|3|||
150224557|NCT01268488|541957464|FG000|Overall Study|Physician Decision|2|||
150224558|NCT01106586|541957467|FG000|Overall Study|Adverse Event|9|||
150224559|NCT01106586|541957468|FG001|Overall Study|Adverse Event|15|||
150224560|NCT01106586|541957467|FG000|Overall Study|Death|1|||
150224561|NCT01106586|541957468|FG001|Overall Study|Death|3|||
150224562|NCT01106586|541957467|FG000|Overall Study|Pregnancy|2|||
150224563|NCT01106586|541957468|FG001|Overall Study|Pregnancy|2|||
150224564|NCT01106586|541957467|FG000|Overall Study|Lack of Efficacy|1|||
150224565|NCT01106586|541957468|FG001|Overall Study|Lack of Efficacy|0|||
150224566|NCT01106586|541957467|FG000|Overall Study|Investigator's Discretion|5|||
150224567|NCT01106586|541957468|FG001|Overall Study|Investigator's Discretion|8|||
150224568|NCT01106586|541957467|FG000|Overall Study|Withdrew Consent|18|||
150224569|NCT01106586|541957468|FG001|Overall Study|Withdrew Consent|30|||
150224570|NCT01106586|541957467|FG000|Overall Study|Lost to Follow-up|24|||
150224571|NCT01106586|541957468|FG001|Overall Study|Lost to Follow-up|20|||
150224572|NCT01106586|541957467|FG000|Overall Study|Participant Noncompliance|12|||
150224573|NCT01106586|541957468|FG001|Overall Study|Participant Noncompliance|10|||
150224574|NCT01106586|541957467|FG000|Overall Study|Protocol Violation|1|||
150224575|NCT01106586|541957468|FG001|Overall Study|Protocol Violation|0|||
150224576|NCT01106586|541957467|FG000|Overall Study|Participant Transferred to Another Study|212|||
150224577|NCT01106586|541957468|FG001|Overall Study|Participant Transferred to Another Study|197|||
150224578|NCT01757171|541957469|FG000|Overall Study|Adverse Event|5|||
150224579|NCT01757171|541957470|FG001|Overall Study|Adverse Event|1|||
150224580|NCT01757171|541957469|FG000|Overall Study|Disease Progression|1|||
150224581|NCT01757171|541957470|FG001|Overall Study|Disease Progression|0|||
150224582|NCT01757171|541957469|FG000|Overall Study|Hospitalization|1|||
150224583|NCT01757171|541957470|FG001|Overall Study|Hospitalization|0|||
150224584|NCT01757171|541957469|FG000|Overall Study|ECOG decline|1|||
150224585|NCT01757171|541957470|FG001|Overall Study|ECOG decline|0|||
150224586|NCT00105521|541957472|FG000|Overall Study|Other|1|||
150224587|NCT00105521|541957473|FG001|Overall Study|Other|1|||
150224588|NCT00105521|541957474|FG002|Overall Study|Other|2|||
150224589|NCT00105521|541957475|FG003|Overall Study|Other|0|||
150224590|NCT00105521|541957472|FG000|Overall Study|Adverse Event|10|||
150224591|NCT00105521|541957473|FG001|Overall Study|Adverse Event|4|||
150224592|NCT00105521|541957474|FG002|Overall Study|Adverse Event|10|||
150224593|NCT00105521|541957475|FG003|Overall Study|Adverse Event|8|||
150224594|NCT00105521|541957472|FG000|Overall Study|Withdrawal by Subject|1|||
150224595|NCT00105521|541957473|FG001|Overall Study|Withdrawal by Subject|0|||
150224596|NCT00105521|541957474|FG002|Overall Study|Withdrawal by Subject|1|||
150224597|NCT00105521|541957475|FG003|Overall Study|Withdrawal by Subject|4|||
150224598|NCT00105521|541957472|FG000|Overall Study|Lack of Efficacy|0|||
150224599|NCT00105521|541957473|FG001|Overall Study|Lack of Efficacy|0|||
150224600|NCT00105521|541957474|FG002|Overall Study|Lack of Efficacy|0|||
150224601|NCT00105521|541957475|FG003|Overall Study|Lack of Efficacy|1|||
150224602|NCT00105521|541957472|FG000|Overall Study|Protocol Violation|3|||
150224603|NCT00105521|541957473|FG001|Overall Study|Protocol Violation|5|||
150224604|NCT00105521|541957474|FG002|Overall Study|Protocol Violation|4|||
150224605|NCT00105521|541957475|FG003|Overall Study|Protocol Violation|4|||
150224606|NCT00105521|541957472|FG000|Overall Study|Lost to Follow-up|0|||
150224607|NCT00105521|541957473|FG001|Overall Study|Lost to Follow-up|1|||
150224608|NCT00105521|541957474|FG002|Overall Study|Lost to Follow-up|0|||
150224609|NCT00105521|541957475|FG003|Overall Study|Lost to Follow-up|0|||
150224610|NCT00442559|541957478|FG000|Overall Study|Lost to Follow-up|32|||
150224611|NCT00442559|541957479|FG001|Overall Study|Lost to Follow-up|34|||
150224612|NCT00442559|541957478|FG000|Overall Study|Protocol Violation|1|||
150224613|NCT00442559|541957479|FG001|Overall Study|Protocol Violation|1|||
150224614|NCT00442559|541957478|FG000|Overall Study|Withdrawal by Subject|1|||
150224615|NCT00442559|541957479|FG001|Overall Study|Withdrawal by Subject|0|||
150224616|NCT03906240|541957480|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
150224617|NCT03906240|541957481|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
150224618|NCT03906240|541957480|FG000|Overall Study|Lost to Follow-up|1|||
150224619|NCT03906240|541957481|FG001|Overall Study|Lost to Follow-up|0|||
150224620|NCT03906240|541957480|FG000|Overall Study|Withdrawal by Subject|0|||
150224621|NCT03906240|541957481|FG001|Overall Study|Withdrawal by Subject|1|||
150224622|NCT01426217|541957499|FG000|Overall Study|lost sample|8|||
150224623|NCT01426217|541957500|FG001|Overall Study|lost sample|14|||
150224624|NCT03023878|541957501|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
150224625|NCT03023878|541957501|FG000|Pre-Study Run-In Period|Death|1|||
150224626|NCT03023878|541957501|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
150224627|NCT03023878|541957501|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
150224628|NCT03023878|541957501|FG000|Treatment Period|Disease Progression|1|||
150224629|NCT03023878|541957501|FG000|Treatment Period|Withdrawal by Subject|1|||
150224630|NCT03023878|541957501|FG000|Treatment Period|Adverse Event|1|||
150224631|NCT03023878|541957501|FG000|Long Term Follow-Up Period|Death|2|||
150224632|NCT00288353|541957502|FG000|Overall Study|Lack of Efficacy|2|||
150224633|NCT00288353|541957503|FG001|Overall Study|Lack of Efficacy|2|||
150224634|NCT00288353|541957502|FG000|Overall Study|Withdrawal by Subject|5|||
150224635|NCT00288353|541957503|FG001|Overall Study|Withdrawal by Subject|5|||
150224636|NCT04799587|541957504|FG000|Overall Study|Withdrawal by Subject|0|||
150224637|NCT04799587|541957505|FG001|Overall Study|Withdrawal by Subject|1|||
150224638|NCT00728884|541957506|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
150224639|NCT00728884|541957506|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
150224640|NCT02849509|541957507|FG000|Overall Study|Worsening of disease under study|1|||
150224641|NCT02849509|541957508|FG001|Overall Study|Worsening of disease under study|1|||
150224642|NCT02849509|541957509|FG002|Overall Study|Worsening of disease under study|1|||
150224643|NCT02849509|541957507|FG000|Overall Study|Worsening of other pre-existing disease|0|||
150224644|NCT02849509|541957508|FG001|Overall Study|Worsening of other pre-existing disease|1|||
150224645|NCT02849509|541957509|FG002|Overall Study|Worsening of other pre-existing disease|2|||
150224646|NCT02849509|541957507|FG000|Overall Study|Other adverse event|36|||
150224647|NCT02849509|541957508|FG001|Overall Study|Other adverse event|41|||
150224648|NCT02849509|541957509|FG002|Overall Study|Other adverse event|8|||
150224649|NCT02849509|541957507|FG000|Overall Study|Withdrawal by Subject|6|||
150224650|NCT02849509|541957508|FG001|Overall Study|Withdrawal by Subject|17|||
150224651|NCT02849509|541957509|FG002|Overall Study|Withdrawal by Subject|12|||
150224652|NCT02849509|541957507|FG000|Overall Study|Lost to Follow-up|27|||
150224653|NCT02849509|541957508|FG001|Overall Study|Lost to Follow-up|67|||
150224654|NCT02849509|541957509|FG002|Overall Study|Lost to Follow-up|36|||
150224655|NCT02849509|541957507|FG000|Overall Study|Other, reason not specified|14|||
150224656|NCT02849509|541957508|FG001|Overall Study|Other, reason not specified|29|||
150224657|NCT02849509|541957509|FG002|Overall Study|Other, reason not specified|25|||
150224658|NCT02849509|541957507|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
150224659|NCT02849509|541957508|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
150224660|NCT02849509|541957509|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
150224661|NCT02374476|541957516|FG000|VT Induced Ablation|Screening Failures|36|||
150224662|NCT02374476|541957517|FG001|VT Induced Ablation|Screening Failures|0|||
150224663|NCT02374476|541957518|FG002|VT Induced Ablation|Screening Failures|0|||
150224664|NCT02374476|541957516|FG000|Arm Assignment|Withdrawal by Subject|0|||
150224665|NCT02374476|541957517|FG001|Arm Assignment|Withdrawal by Subject|0|||
150224666|NCT02374476|541957518|FG002|Arm Assignment|Withdrawal by Subject|1|||
150224667|NCT05431543|541957519|FG000|Overall Study|Medical History|1|||
150224668|NCT05431543|541957520|FG001|Overall Study|Medical History|0|||
150224669|NCT05431543|541957521|FG002|Overall Study|Medical History|0|||
150224670|NCT02389894|541957522|FG000|Overall Study|Death|4|||
150224671|NCT02389894|541957523|FG001|Overall Study|Death|5|||
150224672|NCT02389894|541957524|FG002|Overall Study|Death|3|||
150224673|NCT02389894|541957522|FG000|Overall Study|Withdrawal by Subject|2|||
150224674|NCT02389894|541957523|FG001|Overall Study|Withdrawal by Subject|4|||
150224675|NCT02389894|541957524|FG002|Overall Study|Withdrawal by Subject|5|||
150224676|NCT02389894|541957522|FG000|Overall Study|Lost to Follow-up|2|||
150224677|NCT02389894|541957523|FG001|Overall Study|Lost to Follow-up|1|||
150224678|NCT02389894|541957524|FG002|Overall Study|Lost to Follow-up|1|||
150224679|NCT03138499|541957529|FG000|Overall Study|Lost to Follow-up|1|||
150224680|NCT03138499|541957530|FG001|Overall Study|Lost to Follow-up|0|||
150224681|NCT03138499|541957529|FG000|Overall Study|Participants withdrew consent|1|||
150224682|NCT03138499|541957530|FG001|Overall Study|Participants withdrew consent|0|||
150224683|NCT03138499|541957529|FG000|Overall Study|Participant discontinued study before treatment|0|||
150224684|NCT03138499|541957530|FG001|Overall Study|Participant discontinued study before treatment|1|||
150224685|NCT03138499|541957529|FG000|Overall Study|Disease Progression|2|||
150224686|NCT03138499|541957530|FG001|Overall Study|Disease Progression|6|||
150224687|NCT03138499|541957529|FG000|Overall Study|Study drug toxicity|2|||
150224688|NCT03138499|541957530|FG001|Overall Study|Study drug toxicity|2|||
150224689|NCT03138499|541957529|FG000|Overall Study|Participant request to discontinue study treatment|1|||
150224690|NCT03138499|541957530|FG001|Overall Study|Participant request to discontinue study treatment|1|||
150224691|NCT03138499|541957529|FG000|Overall Study|Other reasons|2|||
150224692|NCT03138499|541957530|FG001|Overall Study|Other reasons|0|||
150224693|NCT01334606|541957531|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
150224694|NCT02312245|541957532|FG000|Overall Study|Death|0|||
150224695|NCT02312245|541957533|FG001|Overall Study|Death|0|||
150224696|NCT02312245|541957534|FG002|Overall Study|Death|0|||
150224697|NCT02312245|541957535|FG003|Overall Study|Death|1|||
150224698|NCT02312245|541957532|FG000|Overall Study|Withdrawal by Subject|1|||
150224699|NCT02312245|541957533|FG001|Overall Study|Withdrawal by Subject|1|||
150224700|NCT02312245|541957534|FG002|Overall Study|Withdrawal by Subject|0|||
150224701|NCT02312245|541957535|FG003|Overall Study|Withdrawal by Subject|2|||
150224702|NCT02312245|541957532|FG000|Overall Study|Alternative Therapy|1|||
150224703|NCT02312245|541957533|FG001|Overall Study|Alternative Therapy|0|||
150224704|NCT02312245|541957534|FG002|Overall Study|Alternative Therapy|0|||
150224705|NCT02312245|541957535|FG003|Overall Study|Alternative Therapy|0|||
150224706|NCT02312245|541957532|FG000|Overall Study|Progression|0|||
150224707|NCT02312245|541957533|FG001|Overall Study|Progression|0|||
150224708|NCT02312245|541957534|FG002|Overall Study|Progression|0|||
150224709|NCT02312245|541957535|FG003|Overall Study|Progression|5|||
150224710|NCT02312245|541957532|FG000|Overall Study|Patient went to hospice|0|||
150224711|NCT02312245|541957533|FG001|Overall Study|Patient went to hospice|0|||
150224712|NCT02312245|541957534|FG002|Overall Study|Patient went to hospice|0|||
150224713|NCT02312245|541957535|FG003|Overall Study|Patient went to hospice|1|||
150224714|NCT02312245|541957532|FG000|Overall Study|Ineligible|1|||
150224715|NCT02312245|541957533|FG001|Overall Study|Ineligible|0|||
150224716|NCT02312245|541957534|FG002|Overall Study|Ineligible|0|||
150224717|NCT02312245|541957535|FG003|Overall Study|Ineligible|0|||
150224718|NCT00448344|541957536|FG000|Overall Study|Lost to Follow-up|20|||
150224719|NCT00448344|541957537|FG001|Overall Study|Lost to Follow-up|22|||
150224720|NCT00448344|541957536|FG000|Overall Study|Withdrawal by Subject|6|||
150224721|NCT00448344|541957537|FG001|Overall Study|Withdrawal by Subject|8|||
150224722|NCT00448344|541957536|FG000|Overall Study|Death|3|||
150224723|NCT00448344|541957537|FG001|Overall Study|Death|4|||
150224724|NCT00448344|541957536|FG000|Overall Study|Physician Decision|1|||
150224725|NCT00448344|541957537|FG001|Overall Study|Physician Decision|2|||
150224726|NCT01123200|541957541|FG000|Overall Study|Withdrawal by Subject|1|||
150224727|NCT04044352|541959136|FG000|Overall Study|Lost to Follow-up|9|||
150224728|NCT04044352|541959136|FG000|Overall Study|Withdrawal by Subject|2|||
150224729|NCT02176356|541959137|FG000|Overall Study|Screen Failure|14|||
150224730|NCT02176356|541959137|FG000|Overall Study|Lost to Follow-up|4|||
150224731|NCT02176356|541959137|FG000|Overall Study|Personal Reasons|3|||
150224732|NCT02176356|541959137|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150224733|NCT03087851|541959139|FG000|Overall Study|Withdraw on medical grounds|0|||
150224734|NCT03087851|541959140|FG001|Overall Study|Withdraw on medical grounds|1|||
150224735|NCT03087851|541959141|FG002|Overall Study|Withdraw on medical grounds|2|||
150224736|NCT00644332|541959142|FG000|Overall Study|Adverse Event|11|||
150224737|NCT00644332|541959142|FG000|Overall Study|Withdrawal by Subject|6|||
150224738|NCT00644332|541959142|FG000|Overall Study|Completion Status Unknown|2|||
150224739|NCT00644332|541959142|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
150224740|NCT00644332|541959142|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
150224741|NCT03694210|541959143|FG000|Overall Study|Death|1|||
150224742|NCT03694210|541959143|FG000|Overall Study|Screen Failure|7|||
150224743|NCT00443755|541959146|FG000|Overall Study|Withdrawal by Subject|2|||
150224744|NCT00443755|541959147|FG001|Overall Study|Withdrawal by Subject|1|||
150224745|NCT02775214|541959148|FG000|Overall Study|Withdrawal by Subject|2|||
150224746|NCT02775214|541959149|FG001|Overall Study|Withdrawal by Subject|0|||
150224747|NCT02706834|541959151|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
150224748|NCT02706834|541959152|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
150224749|NCT02706834|541959153|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
150224750|NCT02706834|541959154|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
150224751|NCT02706834|541959155|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
150224752|NCT02706834|541959156|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
150224753|NCT02706834|541959157|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
150224754|NCT02706834|541959158|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
150224755|NCT02706834|541959159|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
150224756|NCT02706834|541959160|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
150224757|NCT02706834|541959161|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
150224758|NCT02706834|541959151|FG000|Overall Study|Lost to Follow-up|0|||
150224759|NCT02706834|541959152|FG001|Overall Study|Lost to Follow-up|0|||
150224760|NCT02706834|541959153|FG002|Overall Study|Lost to Follow-up|1|||
150224761|NCT02706834|541959154|FG003|Overall Study|Lost to Follow-up|0|||
150224762|NCT02706834|541959155|FG004|Overall Study|Lost to Follow-up|0|||
150224763|NCT02706834|541959156|FG005|Overall Study|Lost to Follow-up|0|||
150224764|NCT02706834|541959157|FG006|Overall Study|Lost to Follow-up|0|||
150224765|NCT02706834|541959158|FG007|Overall Study|Lost to Follow-up|0|||
150224766|NCT02706834|541959159|FG008|Overall Study|Lost to Follow-up|0|||
150224767|NCT02706834|541959160|FG009|Overall Study|Lost to Follow-up|0|||
150224768|NCT02706834|541959161|FG010|Overall Study|Lost to Follow-up|0|||
150224769|NCT02706834|541959151|FG000|Overall Study|Voluntary Withdrawal|1|||
150224770|NCT02706834|541959152|FG001|Overall Study|Voluntary Withdrawal|0|||
150224771|NCT02706834|541959153|FG002|Overall Study|Voluntary Withdrawal|0|||
150224772|NCT02706834|541959154|FG003|Overall Study|Voluntary Withdrawal|0|||
150224773|NCT02706834|541959155|FG004|Overall Study|Voluntary Withdrawal|0|||
150224774|NCT02706834|541959156|FG005|Overall Study|Voluntary Withdrawal|0|||
150224775|NCT02706834|541959157|FG006|Overall Study|Voluntary Withdrawal|0|||
150224776|NCT02706834|541959158|FG007|Overall Study|Voluntary Withdrawal|0|||
150224777|NCT02706834|541959159|FG008|Overall Study|Voluntary Withdrawal|0|||
150224778|NCT02706834|541959160|FG009|Overall Study|Voluntary Withdrawal|1|||
150224779|NCT02706834|541959161|FG010|Overall Study|Voluntary Withdrawal|0|||
150224780|NCT02706834|541959151|FG000|Overall Study|Other Reason Not Specified|1|||
150224781|NCT02706834|541959152|FG001|Overall Study|Other Reason Not Specified|0|||
150224782|NCT02706834|541959153|FG002|Overall Study|Other Reason Not Specified|0|||
150224783|NCT02706834|541959154|FG003|Overall Study|Other Reason Not Specified|0|||
150224784|NCT02706834|541959155|FG004|Overall Study|Other Reason Not Specified|1|||
150224785|NCT02706834|541959156|FG005|Overall Study|Other Reason Not Specified|0|||
150224786|NCT02706834|541959157|FG006|Overall Study|Other Reason Not Specified|0|||
150224787|NCT02706834|541959158|FG007|Overall Study|Other Reason Not Specified|0|||
150224788|NCT02706834|541959159|FG008|Overall Study|Other Reason Not Specified|0|||
150224789|NCT02706834|541959160|FG009|Overall Study|Other Reason Not Specified|0|||
150224790|NCT02706834|541959161|FG010|Overall Study|Other Reason Not Specified|0|||
150224791|NCT04385849|541959162|FG000|Overall Study|Lost to Follow-up|1|||
150224792|NCT04385849|541959163|FG001|Overall Study|Lost to Follow-up|0|||
150224793|NCT00355784|541959164|FG000|Overall Study|Withdrawal by Subject|0|||
150224794|NCT00355784|541959165|FG001|Overall Study|Withdrawal by Subject|0|||
150224795|NCT00355784|541959166|FG002|Overall Study|Withdrawal by Subject|2|||
150224796|NCT02543294|541959167|FG000|Overall Study|Lost to Follow-up|3|||
150224797|NCT02543294|541959167|FG000|Overall Study|Physician Decision|2|||
150224798|NCT02543294|541959167|FG000|Overall Study|Withdrawal by Subject|7|||
150224799|NCT00907517|541959168|FG000|Overall Study|Progressive Disease|3|||
150224800|NCT00907517|541959169|FG001|Overall Study|Progressive Disease|3|||
150224801|NCT00907517|541959170|FG002|Overall Study|Progressive Disease|4|||
150224802|NCT00907517|541959171|FG003|Overall Study|Progressive Disease|4|||
150224803|NCT00907517|541959172|FG004|Overall Study|Progressive Disease|4|||
150224804|NCT00907517|541959168|FG000|Overall Study|Symptomatic Deterioration|0|||
150224805|NCT00907517|541959169|FG001|Overall Study|Symptomatic Deterioration|0|||
150224806|NCT00907517|541959170|FG002|Overall Study|Symptomatic Deterioration|0|||
150224807|NCT00907517|541959171|FG003|Overall Study|Symptomatic Deterioration|0|||
150224808|NCT00907517|541959172|FG004|Overall Study|Symptomatic Deterioration|1|||
150224809|NCT00730925|541959173|FG000|Overall Study|Progressive Disease|21|||
150224810|NCT00730925|541959173|FG000|Overall Study|Dose reducing Event|2|||
150224811|NCT00730925|541959173|FG000|Overall Study|Other Averse Event|7|||
150224812|NCT00730925|541959173|FG000|Overall Study|Protocol Violation|1|||
150224813|NCT00730925|541959173|FG000|Overall Study|Withdrawal by Subject|1|||
150224814|NCT00730925|541959173|FG000|Overall Study|Switch to combination therapy|8|||
150224815|NCT00730925|541959173|FG000|Overall Study|Other|1|||
150224816|NCT02137239|541959174|FG000|Overall Study|Discontinued Study Treatment|0|||
150224817|NCT02137239|541959175|FG001|Overall Study|Discontinued Study Treatment|3|||
150224818|NCT02137239|541959174|FG000|Overall Study|Withdrew Consent|1|||
150224819|NCT02137239|541959175|FG001|Overall Study|Withdrew Consent|1|||
150224820|NCT02137239|541959174|FG000|Overall Study|Adverse Event|2|||
150224821|NCT02137239|541959175|FG001|Overall Study|Adverse Event|2|||
150224822|NCT00428441|541959178|FG000|Overall Study|Lost to Follow-up|1|||
150224823|NCT02475733|541959179|FG000|Overall Study|Withdrawal by Subject|1|||
150224824|NCT02475733|541959180|FG001|Overall Study|Withdrawal by Subject|0|||
150224825|NCT02475733|541959179|FG000|Overall Study|Physician Decision|1|||
150224826|NCT02475733|541959180|FG001|Overall Study|Physician Decision|0|||
150224827|NCT02131155|541959184|FG000|Overall Study|Adverse Event|1|||
150224828|NCT02131155|541959185|FG001|Overall Study|Adverse Event|0|||
150224829|NCT02131155|541959184|FG000|Overall Study|Treatment completed|1|||
150224830|NCT02131155|541959185|FG001|Overall Study|Treatment completed|0|||
150224831|NCT02131155|541959184|FG000|Overall Study|Primary tumour recurrence|2|||
150224832|NCT02131155|541959185|FG001|Overall Study|Primary tumour recurrence|1|||
150224833|NCT02131155|541959184|FG000|Overall Study|Refused to continue study medication|1|||
150224834|NCT02131155|541959185|FG001|Overall Study|Refused to continue study medication|0|||
150224835|NCT02131155|541959184|FG000|Overall Study|Study early termination|20|||
150224836|NCT02131155|541959185|FG001|Overall Study|Study early termination|10|||
150224837|NCT02744898|541959186|FG000|Overall Study|Progressive Disease|2|||
150224838|NCT02744898|541959186|FG000|Overall Study|Physician Decision|1|||
150224839|NCT02744898|541959186|FG000|Overall Study|Toxicity|1|||
150224840|NCT01014013|541959187|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
150224841|NCT01014013|541959188|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
150224842|NCT01014013|541959187|FG000|Overall Study|Clinical adverse experience|4|||
150224843|NCT01014013|541959188|FG001|Overall Study|Clinical adverse experience|2|||
150224844|NCT01014013|541959187|FG000|Overall Study|Laboratory adverse experience|1|||
150224845|NCT01014013|541959188|FG001|Overall Study|Laboratory adverse experience|1|||
150224846|NCT01014013|541959187|FG000|Overall Study|Protocol Violation|1|||
150224847|NCT01014013|541959188|FG001|Overall Study|Protocol Violation|3|||
150224848|NCT01014013|541959187|FG000|Overall Study|Withdrawal by Subject|7|||
150224849|NCT01014013|541959188|FG001|Overall Study|Withdrawal by Subject|4|||
150224850|NCT01014013|541959187|FG000|Overall Study|Clinical/microbiologic failure|1|||
150224851|NCT01014013|541959188|FG001|Overall Study|Clinical/microbiologic failure|2|||
150224852|NCT01014013|541959187|FG000|Overall Study|Pathogen culture = no growth|26|||
150224853|NCT01014013|541959188|FG001|Overall Study|Pathogen culture = no growth|34|||
150224854|NCT01014013|541959187|FG000|Overall Study|Negative urine culture|2|||
150224855|NCT01014013|541959188|FG001|Overall Study|Negative urine culture|0|||
150224856|NCT01014013|541959187|FG000|Overall Study|Pathogen resistant|7|||
150224857|NCT01014013|541959188|FG001|Overall Study|Pathogen resistant|4|||
150224858|NCT01014013|541959187|FG000|Overall Study|Physician Decision|0|||
150224859|NCT01014013|541959188|FG001|Overall Study|Physician Decision|1|||
150224860|NCT01014013|541959187|FG000|Overall Study|Another antibiotic therapy required|0|||
150224861|NCT01014013|541959188|FG001|Overall Study|Another antibiotic therapy required|1|||
150224862|NCT01014013|541959187|FG000|Overall Study|Appendectomy|1|||
150224863|NCT01014013|541959188|FG001|Overall Study|Appendectomy|0|||
150224864|NCT01014013|541959187|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
150224865|NCT01014013|541959188|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
150224866|NCT03508830|541959189|FG000|Overall Study|Withdrawal by Subject|3|||
150224867|NCT03508830|541959190|FG001|Overall Study|Withdrawal by Subject|4|||
150224868|NCT03508830|541959189|FG000|Overall Study|Physician Decision|2|||
150224869|NCT03508830|541959190|FG001|Overall Study|Physician Decision|2|||
150224870|NCT01446042|541959193|FG000|Overall Study|Withdrawal by Subject|12|||
150224871|NCT01446042|541959194|FG001|Overall Study|Withdrawal by Subject|2|||
150224872|NCT01446042|541959195|FG002|Overall Study|Withdrawal by Subject|4|||
150224873|NCT01446042|541959193|FG000|Overall Study|Adverse Event|1|||
150224874|NCT01446042|541959194|FG001|Overall Study|Adverse Event|0|||
150224875|NCT01446042|541959195|FG002|Overall Study|Adverse Event|4|||
150224876|NCT01446042|541959193|FG000|Overall Study|Lost to Follow-up|5|||
150224877|NCT01446042|541959194|FG001|Overall Study|Lost to Follow-up|0|||
150224878|NCT01446042|541959195|FG002|Overall Study|Lost to Follow-up|0|||
150224879|NCT01446042|541959193|FG000|Overall Study|Other reasons|2|||
150224880|NCT01446042|541959194|FG001|Overall Study|Other reasons|1|||
150224881|NCT01446042|541959195|FG002|Overall Study|Other reasons|1|||
150224882|NCT04908800|541959197|FG000|Overall Study|Adverse Event|0|||
150224883|NCT04908800|541959198|FG001|Overall Study|Adverse Event|0|||
150224884|NCT04908800|541959199|FG002|Overall Study|Adverse Event|0|||
150224885|NCT04908800|541959200|FG003|Overall Study|Adverse Event|0|||
150224886|NCT04908800|541959201|FG004|Overall Study|Adverse Event|0|||
150224887|NCT04908800|541959202|FG005|Overall Study|Adverse Event|0|||
150224888|NCT04908800|541959203|FG006|Overall Study|Adverse Event|0|||
150224889|NCT04908800|541959204|FG007|Overall Study|Adverse Event|0|||
150224890|NCT04908800|541959205|FG008|Overall Study|Adverse Event|0|||
150224891|NCT04908800|541959206|FG009|Overall Study|Adverse Event|0|||
150224892|NCT04908800|541959207|FG010|Overall Study|Adverse Event|1|||
150224893|NCT04908800|541959208|FG011|Overall Study|Adverse Event|0|||
150224894|NCT04908800|541959209|FG012|Overall Study|Adverse Event|0|||
150224895|NCT03751280|541959210|FG000|Overall Study|Adverse Event|0|||
150224896|NCT03751280|541959211|FG001|Overall Study|Adverse Event|1|||
150224897|NCT03751280|541959210|FG000|Overall Study|Lost to Follow-up|3|||
150224898|NCT03751280|541959211|FG001|Overall Study|Lost to Follow-up|5|||
150224899|NCT03751280|541959210|FG000|Overall Study|Physician Decision|0|||
150224900|NCT03751280|541959211|FG001|Overall Study|Physician Decision|2|||
150224901|NCT03751280|541959210|FG000|Overall Study|Protocol Violation|0|||
150224902|NCT03751280|541959211|FG001|Overall Study|Protocol Violation|2|||
150224903|NCT03751280|541959210|FG000|Overall Study|Withdrawal by Subject|5|||
150224904|NCT03751280|541959211|FG001|Overall Study|Withdrawal by Subject|2|||
150224905|NCT00296504|541959212|FG000|Interim Analysis|Withdrawal by Subject|8|||
150224906|NCT00296504|541959213|FG001|Interim Analysis|Withdrawal by Subject|0|||
150224907|NCT00296504|541959214|FG002|Interim Analysis|Withdrawal by Subject|12|||
150224908|NCT00296504|541959215|FG003|Interim Analysis|Withdrawal by Subject|0|||
150224909|NCT00296504|541959216|FG004|Interim Analysis|Withdrawal by Subject|5|||
150224910|NCT00296504|541959217|FG005|Interim Analysis|Withdrawal by Subject|5|||
150224911|NCT00296504|541959218|FG006|Interim Analysis|Withdrawal by Subject|9|||
150224912|NCT00296504|541959219|FG007|Interim Analysis|Withdrawal by Subject|3|||
150224913|NCT00296504|541959220|FG008|Interim Analysis|Withdrawal by Subject|0|||
150224914|NCT00296504|541959212|FG000|Interim Analysis|Lost to Follow-up|13|||
150224915|NCT00296504|541959213|FG001|Interim Analysis|Lost to Follow-up|3|||
150224916|NCT00296504|541959214|FG002|Interim Analysis|Lost to Follow-up|26|||
150224917|NCT00296504|541959215|FG003|Interim Analysis|Lost to Follow-up|8|||
150224918|NCT00296504|541959216|FG004|Interim Analysis|Lost to Follow-up|14|||
150224919|NCT00296504|541959217|FG005|Interim Analysis|Lost to Follow-up|4|||
150224920|NCT00296504|541959218|FG006|Interim Analysis|Lost to Follow-up|11|||
150224921|NCT00296504|541959219|FG007|Interim Analysis|Lost to Follow-up|4|||
150224922|NCT00296504|541959220|FG008|Interim Analysis|Lost to Follow-up|0|||
150224923|NCT00296504|541959212|FG000|Interim Analysis|Clinical Progression|1|||
150224924|NCT00296504|541959213|FG001|Interim Analysis|Clinical Progression|0|||
150224925|NCT00296504|541959214|FG002|Interim Analysis|Clinical Progression|1|||
150224926|NCT00296504|541959215|FG003|Interim Analysis|Clinical Progression|1|||
150224927|NCT00296504|541959216|FG004|Interim Analysis|Clinical Progression|0|||
150224928|NCT00296504|541959217|FG005|Interim Analysis|Clinical Progression|2|||
150224929|NCT00296504|541959218|FG006|Interim Analysis|Clinical Progression|1|||
150224930|NCT00296504|541959219|FG007|Interim Analysis|Clinical Progression|2|||
150224931|NCT00296504|541959220|FG008|Interim Analysis|Clinical Progression|0|||
150224932|NCT00296504|541959212|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
150224933|NCT00296504|541959213|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
150224934|NCT00296504|541959214|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
150224935|NCT00296504|541959215|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
150224936|NCT00296504|541959216|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
150224937|NCT00296504|541959217|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
150224938|NCT00296504|541959218|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
150224939|NCT00296504|541959219|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
150224940|NCT00296504|541959220|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
150224941|NCT00296504|541959212|FG000|Interim Analysis|Adverse Event|0|||
150224942|NCT00296504|541959213|FG001|Interim Analysis|Adverse Event|0|||
150224943|NCT00296504|541959214|FG002|Interim Analysis|Adverse Event|13|||
150224944|NCT00296504|541959215|FG003|Interim Analysis|Adverse Event|4|||
150224945|NCT00296504|541959216|FG004|Interim Analysis|Adverse Event|6|||
150224946|NCT00296504|541959217|FG005|Interim Analysis|Adverse Event|3|||
150224947|NCT00296504|541959218|FG006|Interim Analysis|Adverse Event|4|||
150224948|NCT00296504|541959219|FG007|Interim Analysis|Adverse Event|5|||
150224949|NCT00296504|541959220|FG008|Interim Analysis|Adverse Event|0|||
150224950|NCT00296504|541959212|FG000|Interim Analysis|Protocol Violation|0|||
150224951|NCT00296504|541959213|FG001|Interim Analysis|Protocol Violation|0|||
150224952|NCT00296504|541959214|FG002|Interim Analysis|Protocol Violation|2|||
150224953|NCT00296504|541959215|FG003|Interim Analysis|Protocol Violation|0|||
150224954|NCT00296504|541959216|FG004|Interim Analysis|Protocol Violation|1|||
150224955|NCT00296504|541959217|FG005|Interim Analysis|Protocol Violation|0|||
150224956|NCT00296504|541959218|FG006|Interim Analysis|Protocol Violation|0|||
150224957|NCT00296504|541959219|FG007|Interim Analysis|Protocol Violation|1|||
150224958|NCT00296504|541959220|FG008|Interim Analysis|Protocol Violation|0|||
150224959|NCT00296504|541959212|FG000|Interim Analysis|Insufficient CD4 Response|0|||
150224960|NCT00296504|541959213|FG001|Interim Analysis|Insufficient CD4 Response|0|||
150224961|NCT00296504|541959214|FG002|Interim Analysis|Insufficient CD4 Response|0|||
150224962|NCT00296504|541959215|FG003|Interim Analysis|Insufficient CD4 Response|0|||
150224963|NCT00296504|541959216|FG004|Interim Analysis|Insufficient CD4 Response|1|||
150224964|NCT00296504|541959217|FG005|Interim Analysis|Insufficient CD4 Response|1|||
150224965|NCT00296504|541959218|FG006|Interim Analysis|Insufficient CD4 Response|0|||
150224966|NCT00296504|541959219|FG007|Interim Analysis|Insufficient CD4 Response|0|||
150224967|NCT00296504|541959220|FG008|Interim Analysis|Insufficient CD4 Response|0|||
150224968|NCT00296504|541959212|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
150224969|NCT00296504|541959213|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
150224970|NCT00296504|541959214|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
150224971|NCT00296504|541959215|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
150224972|NCT00296504|541959216|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
150224973|NCT00296504|541959217|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
150224974|NCT00296504|541959218|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
150224975|NCT00296504|541959219|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
150224976|NCT00296504|541959220|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
150224977|NCT00296504|541959212|FG000|Interim Analysis|Pregnancy|4|||
150224978|NCT00296504|541959213|FG001|Interim Analysis|Pregnancy|1|||
150224979|NCT00296504|541959214|FG002|Interim Analysis|Pregnancy|4|||
150224980|NCT00296504|541959215|FG003|Interim Analysis|Pregnancy|2|||
150224981|NCT00296504|541959216|FG004|Interim Analysis|Pregnancy|0|||
150224982|NCT00296504|541959217|FG005|Interim Analysis|Pregnancy|1|||
150224983|NCT00296504|541959218|FG006|Interim Analysis|Pregnancy|1|||
150224984|NCT00296504|541959219|FG007|Interim Analysis|Pregnancy|1|||
150224985|NCT00296504|541959220|FG008|Interim Analysis|Pregnancy|0|||
150224986|NCT00296504|541959212|FG000|Interim Analysis|Death|1|||
150224987|NCT00296504|541959213|FG001|Interim Analysis|Death|0|||
150224988|NCT00296504|541959214|FG002|Interim Analysis|Death|3|||
150224989|NCT00296504|541959215|FG003|Interim Analysis|Death|0|||
150224990|NCT00296504|541959216|FG004|Interim Analysis|Death|0|||
150224991|NCT00296504|541959217|FG005|Interim Analysis|Death|0|||
150224992|NCT00296504|541959218|FG006|Interim Analysis|Death|0|||
150224993|NCT00296504|541959219|FG007|Interim Analysis|Death|0|||
150224994|NCT00296504|541959220|FG008|Interim Analysis|Death|0|||
150224995|NCT00296504|541959212|FG000|Interim Analysis|Participant Non-compliant|0|||
150224996|NCT00296504|541959213|FG001|Interim Analysis|Participant Non-compliant|1|||
150224997|NCT00296504|541959214|FG002|Interim Analysis|Participant Non-compliant|2|||
150224998|NCT00296504|541959215|FG003|Interim Analysis|Participant Non-compliant|1|||
150224999|NCT00296504|541959216|FG004|Interim Analysis|Participant Non-compliant|1|||
150225000|NCT00296504|541959217|FG005|Interim Analysis|Participant Non-compliant|3|||
150225001|NCT00296504|541959218|FG006|Interim Analysis|Participant Non-compliant|6|||
150225002|NCT00296504|541959219|FG007|Interim Analysis|Participant Non-compliant|2|||
150225003|NCT00296504|541959220|FG008|Interim Analysis|Participant Non-compliant|0|||
150225004|NCT00296504|541959212|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225005|NCT00296504|541959213|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225006|NCT00296504|541959214|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
150225007|NCT00296504|541959215|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225008|NCT00296504|541959216|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225009|NCT00296504|541959217|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
150225010|NCT00296504|541959218|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225011|NCT00296504|541959219|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225012|NCT00296504|541959220|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
150225013|NCT00296504|541959212|FG000|Interim Analysis|To Simplify Treatment|0|||
150225014|NCT00296504|541959213|FG001|Interim Analysis|To Simplify Treatment|0|||
150225015|NCT00296504|541959214|FG002|Interim Analysis|To Simplify Treatment|1|||
150225016|NCT00296504|541959215|FG003|Interim Analysis|To Simplify Treatment|0|||
150225017|NCT00296504|541959216|FG004|Interim Analysis|To Simplify Treatment|0|||
150225018|NCT00296504|541959217|FG005|Interim Analysis|To Simplify Treatment|0|||
150225019|NCT00296504|541959218|FG006|Interim Analysis|To Simplify Treatment|2|||
150225020|NCT00296504|541959219|FG007|Interim Analysis|To Simplify Treatment|0|||
150225021|NCT00296504|541959220|FG008|Interim Analysis|To Simplify Treatment|0|||
150225022|NCT00296504|541959212|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225023|NCT00296504|541959213|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225024|NCT00296504|541959214|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
150225025|NCT00296504|541959215|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225026|NCT00296504|541959216|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225027|NCT00296504|541959217|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225028|NCT00296504|541959218|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225029|NCT00296504|541959219|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225030|NCT00296504|541959220|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
150225031|NCT00296504|541959212|FG000|Interim Analysis|Participant Moved|1|||
150225032|NCT00296504|541959213|FG001|Interim Analysis|Participant Moved|0|||
150225033|NCT00296504|541959214|FG002|Interim Analysis|Participant Moved|1|||
150225034|NCT00296504|541959215|FG003|Interim Analysis|Participant Moved|0|||
150225035|NCT00296504|541959216|FG004|Interim Analysis|Participant Moved|0|||
150225036|NCT00296504|541959217|FG005|Interim Analysis|Participant Moved|1|||
150225037|NCT00296504|541959218|FG006|Interim Analysis|Participant Moved|1|||
150225038|NCT00296504|541959219|FG007|Interim Analysis|Participant Moved|0|||
150225039|NCT00296504|541959220|FG008|Interim Analysis|Participant Moved|0|||
150225040|NCT00296504|541959212|FG000|Interim Analysis|Participant Was Incarcerated|2|||
150225041|NCT00296504|541959213|FG001|Interim Analysis|Participant Was Incarcerated|0|||
150225042|NCT00296504|541959214|FG002|Interim Analysis|Participant Was Incarcerated|1|||
150225043|NCT00296504|541959215|FG003|Interim Analysis|Participant Was Incarcerated|0|||
150225044|NCT00296504|541959216|FG004|Interim Analysis|Participant Was Incarcerated|0|||
150225045|NCT00296504|541959217|FG005|Interim Analysis|Participant Was Incarcerated|0|||
150225046|NCT00296504|541959218|FG006|Interim Analysis|Participant Was Incarcerated|0|||
150225047|NCT00296504|541959219|FG007|Interim Analysis|Participant Was Incarcerated|0|||
150225048|NCT00296504|541959220|FG008|Interim Analysis|Participant Was Incarcerated|0|||
150225049|NCT00296504|541959212|FG000|Interim Analysis|Resistance to FPV|0|||
150225050|NCT00296504|541959213|FG001|Interim Analysis|Resistance to FPV|0|||
150225051|NCT00296504|541959214|FG002|Interim Analysis|Resistance to FPV|1|||
150225052|NCT00296504|541959215|FG003|Interim Analysis|Resistance to FPV|0|||
150225053|NCT00296504|541959216|FG004|Interim Analysis|Resistance to FPV|0|||
150225054|NCT00296504|541959217|FG005|Interim Analysis|Resistance to FPV|0|||
150225055|NCT00296504|541959218|FG006|Interim Analysis|Resistance to FPV|0|||
150225056|NCT00296504|541959219|FG007|Interim Analysis|Resistance to FPV|0|||
150225057|NCT00296504|541959220|FG008|Interim Analysis|Resistance to FPV|0|||
150225058|NCT00296504|541959212|FG000|Interim Analysis|Physician Decision|0|||
150225059|NCT00296504|541959213|FG001|Interim Analysis|Physician Decision|0|||
150225060|NCT00296504|541959214|FG002|Interim Analysis|Physician Decision|1|||
150225061|NCT00296504|541959215|FG003|Interim Analysis|Physician Decision|0|||
150225062|NCT00296504|541959216|FG004|Interim Analysis|Physician Decision|0|||
150225063|NCT00296504|541959217|FG005|Interim Analysis|Physician Decision|0|||
150225064|NCT00296504|541959218|FG006|Interim Analysis|Physician Decision|0|||
150225065|NCT00296504|541959219|FG007|Interim Analysis|Physician Decision|0|||
150225066|NCT00296504|541959220|FG008|Interim Analysis|Physician Decision|0|||
150225067|NCT00296504|541959212|FG000|Interim Analysis|Principle Investigator Discretion|2|||
150225068|NCT00296504|541959213|FG001|Interim Analysis|Principle Investigator Discretion|0|||
150225069|NCT00296504|541959214|FG002|Interim Analysis|Principle Investigator Discretion|1|||
150225070|NCT00296504|541959215|FG003|Interim Analysis|Principle Investigator Discretion|1|||
150225071|NCT00296504|541959216|FG004|Interim Analysis|Principle Investigator Discretion|0|||
150225072|NCT00296504|541959217|FG005|Interim Analysis|Principle Investigator Discretion|0|||
150225073|NCT00296504|541959218|FG006|Interim Analysis|Principle Investigator Discretion|0|||
150225074|NCT00296504|541959219|FG007|Interim Analysis|Principle Investigator Discretion|0|||
150225075|NCT00296504|541959220|FG008|Interim Analysis|Principle Investigator Discretion|0|||
150225076|NCT00296504|541959212|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
150225077|NCT00296504|541959213|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
150225078|NCT00296504|541959214|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
150225079|NCT00296504|541959215|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
150225080|NCT00296504|541959216|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
150225081|NCT00296504|541959217|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
150225082|NCT00296504|541959218|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
150225083|NCT00296504|541959219|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
150225084|NCT00296504|541959220|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
150225085|NCT00296504|541959212|FG000|Interim Analysis|Non-adherence|2|||
150225086|NCT00296504|541959213|FG001|Interim Analysis|Non-adherence|0|||
150225087|NCT00296504|541959214|FG002|Interim Analysis|Non-adherence|0|||
150225088|NCT00296504|541959215|FG003|Interim Analysis|Non-adherence|0|||
150225089|NCT00296504|541959216|FG004|Interim Analysis|Non-adherence|1|||
150225090|NCT00296504|541959217|FG005|Interim Analysis|Non-adherence|0|||
150225091|NCT00296504|541959218|FG006|Interim Analysis|Non-adherence|0|||
150225092|NCT00296504|541959219|FG007|Interim Analysis|Non-adherence|1|||
150225093|NCT00296504|541959220|FG008|Interim Analysis|Non-adherence|0|||
150225094|NCT00296504|541959212|FG000|Interim Analysis|Site Closing|1|||
150225095|NCT00296504|541959213|FG001|Interim Analysis|Site Closing|0|||
150225096|NCT00296504|541959214|FG002|Interim Analysis|Site Closing|0|||
150225097|NCT00296504|541959215|FG003|Interim Analysis|Site Closing|0|||
150225098|NCT00296504|541959216|FG004|Interim Analysis|Site Closing|0|||
150225099|NCT00296504|541959217|FG005|Interim Analysis|Site Closing|1|||
150225100|NCT00296504|541959218|FG006|Interim Analysis|Site Closing|2|||
150225101|NCT00296504|541959219|FG007|Interim Analysis|Site Closing|0|||
150225102|NCT00296504|541959220|FG008|Interim Analysis|Site Closing|0|||
150225103|NCT00296504|541959212|FG000|Interim Analysis|Lack of Personnel at Site|1|||
150225104|NCT00296504|541959213|FG001|Interim Analysis|Lack of Personnel at Site|0|||
150225105|NCT00296504|541959214|FG002|Interim Analysis|Lack of Personnel at Site|0|||
150225106|NCT00296504|541959215|FG003|Interim Analysis|Lack of Personnel at Site|0|||
150225107|NCT00296504|541959216|FG004|Interim Analysis|Lack of Personnel at Site|0|||
150225108|NCT00296504|541959217|FG005|Interim Analysis|Lack of Personnel at Site|0|||
150225109|NCT00296504|541959218|FG006|Interim Analysis|Lack of Personnel at Site|0|||
150225110|NCT00296504|541959219|FG007|Interim Analysis|Lack of Personnel at Site|0|||
150225111|NCT00296504|541959220|FG008|Interim Analysis|Lack of Personnel at Site|0|||
150225112|NCT00296504|541959212|FG000|Interim Analysis|Missed Schedule Date|1|||
150225113|NCT00296504|541959213|FG001|Interim Analysis|Missed Schedule Date|0|||
150225114|NCT00296504|541959214|FG002|Interim Analysis|Missed Schedule Date|0|||
150225115|NCT00296504|541959215|FG003|Interim Analysis|Missed Schedule Date|0|||
150225116|NCT00296504|541959216|FG004|Interim Analysis|Missed Schedule Date|0|||
150225117|NCT00296504|541959217|FG005|Interim Analysis|Missed Schedule Date|0|||
150225118|NCT00296504|541959218|FG006|Interim Analysis|Missed Schedule Date|0|||
150225119|NCT00296504|541959219|FG007|Interim Analysis|Missed Schedule Date|0|||
150225120|NCT00296504|541959220|FG008|Interim Analysis|Missed Schedule Date|0|||
150225121|NCT00296504|541959212|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
150225122|NCT00296504|541959213|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
150225123|NCT00296504|541959214|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
150225124|NCT00296504|541959215|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
150225125|NCT00296504|541959216|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
150225126|NCT00296504|541959217|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
150225127|NCT00296504|541959218|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
150225128|NCT00296504|541959219|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
150225129|NCT00296504|541959220|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
150225130|NCT00296504|541959212|FG000|Interim Analysis|Participant Stopped|0|||
150225131|NCT00296504|541959213|FG001|Interim Analysis|Participant Stopped|0|||
150225132|NCT00296504|541959214|FG002|Interim Analysis|Participant Stopped|0|||
150225133|NCT00296504|541959215|FG003|Interim Analysis|Participant Stopped|0|||
150225134|NCT00296504|541959216|FG004|Interim Analysis|Participant Stopped|1|||
150225135|NCT00296504|541959217|FG005|Interim Analysis|Participant Stopped|0|||
150225136|NCT00296504|541959218|FG006|Interim Analysis|Participant Stopped|0|||
150225137|NCT00296504|541959219|FG007|Interim Analysis|Participant Stopped|0|||
150225138|NCT00296504|541959220|FG008|Interim Analysis|Participant Stopped|0|||
150225139|NCT00296504|541959212|FG000|Interim Analysis|Physician and Participant Decision|0|||
150225140|NCT00296504|541959213|FG001|Interim Analysis|Physician and Participant Decision|0|||
150225141|NCT00296504|541959214|FG002|Interim Analysis|Physician and Participant Decision|0|||
150225142|NCT00296504|541959215|FG003|Interim Analysis|Physician and Participant Decision|0|||
150225143|NCT00296504|541959216|FG004|Interim Analysis|Physician and Participant Decision|0|||
150225144|NCT00296504|541959217|FG005|Interim Analysis|Physician and Participant Decision|1|||
150225145|NCT00296504|541959218|FG006|Interim Analysis|Physician and Participant Decision|0|||
150225146|NCT00296504|541959219|FG007|Interim Analysis|Physician and Participant Decision|0|||
150225147|NCT00296504|541959220|FG008|Interim Analysis|Physician and Participant Decision|0|||
150225148|NCT00296504|541959212|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
150225149|NCT00296504|541959213|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
150225150|NCT00296504|541959214|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
150225151|NCT00296504|541959215|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
150225152|NCT00296504|541959216|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
150225153|NCT00296504|541959217|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
150225154|NCT00296504|541959218|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
150225155|NCT00296504|541959219|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
150225156|NCT00296504|541959220|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
150225157|NCT00296504|541959212|FG000|Interim Analysis|Study Ended|0|||
150225158|NCT00296504|541959213|FG001|Interim Analysis|Study Ended|0|||
150225159|NCT00296504|541959214|FG002|Interim Analysis|Study Ended|0|||
150225160|NCT00296504|541959215|FG003|Interim Analysis|Study Ended|0|||
150225161|NCT00296504|541959216|FG004|Interim Analysis|Study Ended|0|||
150225162|NCT00296504|541959217|FG005|Interim Analysis|Study Ended|0|||
150225163|NCT00296504|541959218|FG006|Interim Analysis|Study Ended|1|||
150225164|NCT00296504|541959219|FG007|Interim Analysis|Study Ended|0|||
150225165|NCT00296504|541959220|FG008|Interim Analysis|Study Ended|0|||
150225166|NCT00296504|541959212|FG000|Interim Analysis|Participant Needed Interferon|0|||
150225167|NCT00296504|541959213|FG001|Interim Analysis|Participant Needed Interferon|0|||
150225168|NCT00296504|541959214|FG002|Interim Analysis|Participant Needed Interferon|0|||
150225169|NCT00296504|541959215|FG003|Interim Analysis|Participant Needed Interferon|0|||
150225170|NCT00296504|541959216|FG004|Interim Analysis|Participant Needed Interferon|0|||
150225171|NCT00296504|541959217|FG005|Interim Analysis|Participant Needed Interferon|0|||
150225172|NCT00296504|541959218|FG006|Interim Analysis|Participant Needed Interferon|0|||
150225173|NCT00296504|541959219|FG007|Interim Analysis|Participant Needed Interferon|1|||
150225174|NCT00296504|541959220|FG008|Interim Analysis|Participant Needed Interferon|0|||
150225175|NCT00296504|541959212|FG000|Interim Analysis|Ongoing|32|||
150225176|NCT00296504|541959213|FG001|Interim Analysis|Ongoing|12|||
150225177|NCT00296504|541959214|FG002|Interim Analysis|Ongoing|16|||
150225178|NCT00296504|541959215|FG003|Interim Analysis|Ongoing|22|||
150225179|NCT00296504|541959216|FG004|Interim Analysis|Ongoing|0|||
150225180|NCT00296504|541959217|FG005|Interim Analysis|Ongoing|0|||
150225181|NCT00296504|541959218|FG006|Interim Analysis|Ongoing|30|||
150225182|NCT00296504|541959219|FG007|Interim Analysis|Ongoing|1|||
150225183|NCT00296504|541959220|FG008|Interim Analysis|Ongoing|0|||
150225184|NCT00296504|541959212|FG000|Final Analysis|Withdrawal by Subject|0|||
150225185|NCT00296504|541959213|FG001|Final Analysis|Withdrawal by Subject|0|||
150225186|NCT00296504|541959214|FG002|Final Analysis|Withdrawal by Subject|0|||
150225187|NCT00296504|541959215|FG003|Final Analysis|Withdrawal by Subject|0|||
150225188|NCT00296504|541959216|FG004|Final Analysis|Withdrawal by Subject|0|||
150225189|NCT00296504|541959217|FG005|Final Analysis|Withdrawal by Subject|0|||
150225190|NCT00296504|541959218|FG006|Final Analysis|Withdrawal by Subject|0|||
150225191|NCT00296504|541959219|FG007|Final Analysis|Withdrawal by Subject|0|||
150225192|NCT00296504|541959220|FG008|Final Analysis|Withdrawal by Subject|1|||
150225193|NCT00296504|541959212|FG000|Final Analysis|Lost to Follow-up|0|||
150225194|NCT00296504|541959213|FG001|Final Analysis|Lost to Follow-up|0|||
150225195|NCT00296504|541959214|FG002|Final Analysis|Lost to Follow-up|0|||
150225196|NCT00296504|541959215|FG003|Final Analysis|Lost to Follow-up|0|||
150225197|NCT00296504|541959216|FG004|Final Analysis|Lost to Follow-up|0|||
150225198|NCT00296504|541959217|FG005|Final Analysis|Lost to Follow-up|0|||
150225199|NCT00296504|541959218|FG006|Final Analysis|Lost to Follow-up|0|||
150225200|NCT00296504|541959219|FG007|Final Analysis|Lost to Follow-up|0|||
150225201|NCT00296504|541959220|FG008|Final Analysis|Lost to Follow-up|5|||
150225202|NCT00296504|541959212|FG000|Final Analysis|Insufficient Viral Load Response|0|||
150225203|NCT00296504|541959213|FG001|Final Analysis|Insufficient Viral Load Response|0|||
150225204|NCT00296504|541959214|FG002|Final Analysis|Insufficient Viral Load Response|0|||
150225205|NCT00296504|541959215|FG003|Final Analysis|Insufficient Viral Load Response|0|||
150225206|NCT00296504|541959216|FG004|Final Analysis|Insufficient Viral Load Response|0|||
150225207|NCT00296504|541959217|FG005|Final Analysis|Insufficient Viral Load Response|0|||
150225208|NCT00296504|541959218|FG006|Final Analysis|Insufficient Viral Load Response|0|||
150225209|NCT00296504|541959219|FG007|Final Analysis|Insufficient Viral Load Response|0|||
150225210|NCT00296504|541959220|FG008|Final Analysis|Insufficient Viral Load Response|6|||
150225211|NCT00296504|541959212|FG000|Final Analysis|Adverse Event|0|||
150225212|NCT00296504|541959213|FG001|Final Analysis|Adverse Event|0|||
150225213|NCT00296504|541959214|FG002|Final Analysis|Adverse Event|0|||
150225214|NCT00296504|541959215|FG003|Final Analysis|Adverse Event|0|||
150225215|NCT00296504|541959216|FG004|Final Analysis|Adverse Event|0|||
150225216|NCT00296504|541959217|FG005|Final Analysis|Adverse Event|0|||
150225217|NCT00296504|541959218|FG006|Final Analysis|Adverse Event|0|||
150225218|NCT00296504|541959219|FG007|Final Analysis|Adverse Event|0|||
150225219|NCT00296504|541959220|FG008|Final Analysis|Adverse Event|2|||
150225220|NCT00296504|541959212|FG000|Final Analysis|Pregnancy|0|||
150225221|NCT00296504|541959213|FG001|Final Analysis|Pregnancy|0|||
150225222|NCT00296504|541959214|FG002|Final Analysis|Pregnancy|0|||
150225223|NCT00296504|541959215|FG003|Final Analysis|Pregnancy|0|||
150225224|NCT00296504|541959216|FG004|Final Analysis|Pregnancy|0|||
150225225|NCT00296504|541959217|FG005|Final Analysis|Pregnancy|0|||
150225226|NCT00296504|541959218|FG006|Final Analysis|Pregnancy|0|||
150225227|NCT00296504|541959219|FG007|Final Analysis|Pregnancy|0|||
150225228|NCT00296504|541959220|FG008|Final Analysis|Pregnancy|4|||
150225229|NCT00296504|541959212|FG000|Final Analysis|Tuberculosis|0|||
150225230|NCT00296504|541959213|FG001|Final Analysis|Tuberculosis|0|||
150225231|NCT00296504|541959214|FG002|Final Analysis|Tuberculosis|0|||
150225232|NCT00296504|541959215|FG003|Final Analysis|Tuberculosis|0|||
150225233|NCT00296504|541959216|FG004|Final Analysis|Tuberculosis|0|||
150225234|NCT00296504|541959217|FG005|Final Analysis|Tuberculosis|0|||
150225235|NCT00296504|541959218|FG006|Final Analysis|Tuberculosis|0|||
150225236|NCT00296504|541959219|FG007|Final Analysis|Tuberculosis|0|||
150225237|NCT00296504|541959220|FG008|Final Analysis|Tuberculosis|1|||
150225238|NCT00296504|541959212|FG000|Final Analysis|Participant Moved to Another Country|0|||
150225239|NCT00296504|541959213|FG001|Final Analysis|Participant Moved to Another Country|0|||
150225240|NCT00296504|541959214|FG002|Final Analysis|Participant Moved to Another Country|0|||
150225241|NCT00296504|541959215|FG003|Final Analysis|Participant Moved to Another Country|0|||
150225242|NCT00296504|541959216|FG004|Final Analysis|Participant Moved to Another Country|0|||
150225243|NCT00296504|541959217|FG005|Final Analysis|Participant Moved to Another Country|0|||
150225244|NCT00296504|541959218|FG006|Final Analysis|Participant Moved to Another Country|0|||
150225245|NCT00296504|541959219|FG007|Final Analysis|Participant Moved to Another Country|0|||
150225246|NCT00296504|541959220|FG008|Final Analysis|Participant Moved to Another Country|1|||
150225247|NCT00296504|541959212|FG000|Final Analysis|Poor Adherence|0|||
150225248|NCT00296504|541959213|FG001|Final Analysis|Poor Adherence|0|||
150225249|NCT00296504|541959214|FG002|Final Analysis|Poor Adherence|0|||
150225250|NCT00296504|541959215|FG003|Final Analysis|Poor Adherence|0|||
150225251|NCT00296504|541959216|FG004|Final Analysis|Poor Adherence|0|||
150225252|NCT00296504|541959217|FG005|Final Analysis|Poor Adherence|0|||
150225253|NCT00296504|541959218|FG006|Final Analysis|Poor Adherence|0|||
150225254|NCT00296504|541959219|FG007|Final Analysis|Poor Adherence|0|||
150225255|NCT00296504|541959220|FG008|Final Analysis|Poor Adherence|1|||
150225256|NCT01323309|541959221|FG000|Overall Study|Death|9|||
150225257|NCT01323309|541959222|FG001|Overall Study|Death|15|||
150225258|NCT01323309|541959223|FG002|Overall Study|Death|5|||
150225259|NCT01323309|541959221|FG000|Overall Study|Lost to Follow-up|11|||
150225260|NCT01323309|541959222|FG001|Overall Study|Lost to Follow-up|14|||
150225261|NCT01323309|541959223|FG002|Overall Study|Lost to Follow-up|24|||
150225262|NCT01323309|541959221|FG000|Overall Study|Withdrawal by Subject|14|||
150225263|NCT01323309|541959222|FG001|Overall Study|Withdrawal by Subject|14|||
150225264|NCT01323309|541959223|FG002|Overall Study|Withdrawal by Subject|18|||
150225265|NCT01323309|541959221|FG000|Overall Study|Disease progression|5|||
150225266|NCT01323309|541959222|FG001|Overall Study|Disease progression|11|||
150225267|NCT01323309|541959223|FG002|Overall Study|Disease progression|4|||
150225268|NCT01047306|541959228|FG000|Overall Study|Withdrawal by Subject|2|||
150225269|NCT01047306|541959229|FG001|Overall Study|Withdrawal by Subject|0|||
150225270|NCT01047306|541959228|FG000|Overall Study|Lost to Follow-up|1|||
150225271|NCT01047306|541959229|FG001|Overall Study|Lost to Follow-up|0|||
150225272|NCT01878253|541959230|FG000|Overall Study|Death|1|||
150225273|NCT01878253|541959230|FG000|Overall Study|SIdus System Removal|3|||
150225274|NCT01878253|541959230|FG000|Overall Study|Withdrawal by Subject|1|||
150225275|NCT01878253|541959230|FG000|Overall Study|Lost to Follow-up|2|||
150225276|NCT01878253|541959230|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
150225277|NCT03647709|541959231|FG000|Overall Study|Lost to Follow-up|5|||
150225278|NCT03647709|541959231|FG000|Overall Study|Physician Decision|6|||
150225279|NCT03647709|541959231|FG000|Overall Study|Withdrawal by Subject|3|||
150225280|NCT00449033|541959238|FG000|Treatment Period|Adverse Event|117|||
150225281|NCT00449033|541959239|FG001|Treatment Period|Adverse Event|83|||
150225282|NCT00449033|541959238|FG000|Treatment Period|Death|21|||
150225283|NCT00449033|541959239|FG001|Treatment Period|Death|12|||
150225284|NCT00449033|541959238|FG000|Treatment Period|Lost to Follow-up|0|||
150225285|NCT00449033|541959239|FG001|Treatment Period|Lost to Follow-up|2|||
150225286|NCT00449033|541959238|FG000|Treatment Period|Physician Decision|4|||
150225287|NCT00449033|541959239|FG001|Treatment Period|Physician Decision|5|||
150225288|NCT00449033|541959238|FG000|Treatment Period|Protocol Violation|8|||
150225289|NCT00449033|541959239|FG001|Treatment Period|Protocol Violation|7|||
150225290|NCT00449033|541959238|FG000|Treatment Period|Disease Progression|231|||
150225291|NCT00449033|541959239|FG001|Treatment Period|Disease Progression|288|||
150225292|NCT00449033|541959238|FG000|Treatment Period|Consent Withdrawn|36|||
150225293|NCT00449033|541959239|FG001|Treatment Period|Consent Withdrawn|20|||
150225294|NCT00449033|541959238|FG000|Treatment Period|Amended Protocol Criteria|22|||
150225295|NCT00449033|541959239|FG001|Treatment Period|Amended Protocol Criteria|18|||
150225296|NCT00449033|541959238|FG000|Treatment Period|Non-compliance|7|||
150225297|NCT00449033|541959239|FG001|Treatment Period|Non-compliance|8|||
150225298|NCT00449033|541959238|FG000|Treatment Period|Second Malignancy|0|||
150225299|NCT00449033|541959239|FG001|Treatment Period|Second Malignancy|1|||
150225300|NCT00449033|541959238|FG000|Treatment Period|Reason Missing|0|||
150225301|NCT00449033|541959239|FG001|Treatment Period|Reason Missing|4|||
150225302|NCT00449033|541959238|FG000|Treatment Period|Treatment Ongoing|6|||
150225303|NCT00449033|541959239|FG001|Treatment Period|Treatment Ongoing|4|||
150225304|NCT00449033|541959238|FG000|Follow-up Period|Death|299|||
150225305|NCT00449033|541959239|FG001|Follow-up Period|Death|311|||
150225306|NCT00449033|541959238|FG000|Follow-up Period|Lost to Follow-up|6|||
150225307|NCT00449033|541959239|FG001|Follow-up Period|Lost to Follow-up|10|||
150225308|NCT00449033|541959238|FG000|Follow-up Period|Reason Missing|120|||
150225309|NCT00449033|541959239|FG001|Follow-up Period|Reason Missing|113|||
150225310|NCT04393779|541959240|FG000|Overall Study|Death|1|||
150225311|NCT04393779|541959240|FG000|Overall Study|Device reintervention or explant|4|||
150225312|NCT03802513|541959242|FG000|Overall Study|Lost to Follow-up|1|||
150225313|NCT00274846|541959243|FG000|Overall Study|Did not receive adequate NK cells|1|||
150225314|NCT01190228|541959247|FG000|Overall Study|Protocol Violation|4|||
150225315|NCT01190228|541959248|FG001|Overall Study|Protocol Violation|0|||
150225316|NCT01190228|541959249|FG002|Overall Study|Protocol Violation|0|||
150225317|NCT01190228|541959247|FG000|Overall Study|Withdrawal by Subject|1|||
150225318|NCT01190228|541959248|FG001|Overall Study|Withdrawal by Subject|0|||
150225319|NCT01190228|541959249|FG002|Overall Study|Withdrawal by Subject|0|||
150225320|NCT01395914|541959253|FG000|Overall Study|Unrelated to study drug AE|6|||
150225321|NCT01395914|541959254|FG001|Overall Study|Unrelated to study drug AE|1|||
150225322|NCT01395914|541959253|FG000|Overall Study|Death|23|||
150225323|NCT01395914|541959254|FG001|Overall Study|Death|17|||
150225324|NCT01395914|541959253|FG000|Overall Study|Other|9|||
150225325|NCT01395914|541959254|FG001|Overall Study|Other|3|||
150225326|NCT01395914|541959253|FG000|Overall Study|Withdrawal by patient|27|||
150225327|NCT01395914|541959254|FG001|Overall Study|Withdrawal by patient|14|||
150225328|NCT01395914|541959253|FG000|Overall Study|Study drug-related AE|1|||
150225329|NCT01395914|541959254|FG001|Overall Study|Study drug-related AE|0|||
150225330|NCT01395914|541959253|FG000|Overall Study|Lost to Follow-up|6|||
150225331|NCT01395914|541959254|FG001|Overall Study|Lost to Follow-up|2|||
150225332|NCT05287178|541959255|FG000|Overall Study|Lost to Follow-up|2|||
150225333|NCT01920178|541959256|FG000|Overall Study|Lost to Follow-up|2|||
150225334|NCT01920178|541959257|FG001|Overall Study|Lost to Follow-up|1|||
150225335|NCT00145496|541959262|FG000|Overall Study|Adverse Event|42|||
150225336|NCT00145496|541959263|FG001|Overall Study|Adverse Event|30|||
150225337|NCT00145496|541959262|FG000|Overall Study|Lack of Efficacy|12|||
150225338|NCT00145496|541959263|FG001|Overall Study|Lack of Efficacy|7|||
150225339|NCT00145496|541959262|FG000|Overall Study|Withdrawal by Subject|32|||
150225340|NCT00145496|541959263|FG001|Overall Study|Withdrawal by Subject|26|||
150225341|NCT00145496|541959262|FG000|Overall Study|Lost to Follow-up|12|||
150225342|NCT00145496|541959263|FG001|Overall Study|Lost to Follow-up|5|||
150225343|NCT00145496|541959262|FG000|Overall Study|Other|25|||
150225344|NCT00145496|541959263|FG001|Overall Study|Other|13|||
150225345|NCT01429285|541959265|FG000|Overall Study|Protocol Violation|9|||
150225346|NCT01429285|541959266|FG001|Overall Study|Protocol Violation|4|||
150225347|NCT01429285|541959265|FG000|Overall Study|Missing Data|5|||
150225348|NCT01429285|541959266|FG001|Overall Study|Missing Data|3|||
150225349|NCT01429285|541959265|FG000|Overall Study|Erroneously Enrolled Twice|8|||
150225350|NCT01429285|541959266|FG001|Overall Study|Erroneously Enrolled Twice|2|||
150225351|NCT02577315|541959269|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
150225352|NCT02577315|541959270|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
150225353|NCT00705614|541960778|FG000|Initial Intervention|Adverse Event|40|||
150225354|NCT00705614|541960779|FG001|Initial Intervention|Adverse Event|21|||
150225355|NCT00705614|541960778|FG000|Initial Intervention|Lost to Follow-up|310|||
150225356|NCT00705614|541960779|FG001|Initial Intervention|Lost to Follow-up|191|||
150225357|NCT00705614|541960778|FG000|Initial Intervention|Withdrawal by Subject|114|||
150225358|NCT00705614|541960779|FG001|Initial Intervention|Withdrawal by Subject|71|||
150225359|NCT00705614|541960778|FG000|Initial Intervention|Administrative Reason|51|||
150225360|NCT00705614|541960779|FG001|Initial Intervention|Administrative Reason|38|||
150225361|NCT00705614|541960778|FG000|Initial Intervention|Status completion unknown|3|||
150225362|NCT00705614|541960779|FG001|Initial Intervention|Status completion unknown|0|||
150225363|NCT00705614|541960778|FG000|Switch to Remicade|Adverse Event|0|||
150225364|NCT00705614|541960779|FG001|Switch to Remicade|Adverse Event|5|||
150225365|NCT00705614|541960778|FG000|Switch to Remicade|Lost to Follow-up|0|||
150225366|NCT00705614|541960779|FG001|Switch to Remicade|Lost to Follow-up|23|||
150225367|NCT00705614|541960778|FG000|Switch to Remicade|Withdrawal by Subject|0|||
150225368|NCT00705614|541960779|FG001|Switch to Remicade|Withdrawal by Subject|12|||
150225369|NCT00705614|541960778|FG000|Switch to Remicade|Administrative Reason|0|||
150225370|NCT00705614|541960779|FG001|Switch to Remicade|Administrative Reason|9|||
150225371|NCT00925288|541960780|FG000|Overall Study|Lost to Follow-up|9|||
150225372|NCT00925288|541960781|FG001|Overall Study|Lost to Follow-up|7|||
150225373|NCT00088452|541960782|FG000|Overall Study|Did not receive intervention|1|||
150225374|NCT00088452|541960783|FG001|Overall Study|Did not receive intervention|0|||
150225375|NCT00088452|541960784|FG002|Overall Study|Did not receive intervention|1|||
150225376|NCT02081196|541960786|FG000|Overall Study|Lost to Follow-up|1|||
150225377|NCT00434577|541960791|FG000|Months 0-3|Serious Adverse Event|0|||
150225378|NCT00434577|541960792|FG001|Months 0-3|Serious Adverse Event|0|||
150225379|NCT00434577|541960793|FG002|Months 0-3|Serious Adverse Event|1|||
150225380|NCT00434577|541960794|FG003|Months 0-3|Serious Adverse Event|0|||
150225381|NCT00434577|541960795|FG004|Months 0-3|Serious Adverse Event|0|||
150225382|NCT00434577|541960791|FG000|Months 0-3|Adverse Event|0|||
150225383|NCT00434577|541960792|FG001|Months 0-3|Adverse Event|1|||
150225384|NCT00434577|541960793|FG002|Months 0-3|Adverse Event|1|||
150225385|NCT00434577|541960794|FG003|Months 0-3|Adverse Event|0|||
150225386|NCT00434577|541960795|FG004|Months 0-3|Adverse Event|0|||
150225387|NCT00434577|541960791|FG000|Months 0-3|Lost to Follow-up|0|||
150225388|NCT00434577|541960792|FG001|Months 0-3|Lost to Follow-up|0|||
150225389|NCT00434577|541960793|FG002|Months 0-3|Lost to Follow-up|0|||
150225390|NCT00434577|541960794|FG003|Months 0-3|Lost to Follow-up|0|||
150225391|NCT00434577|541960795|FG004|Months 0-3|Lost to Follow-up|2|||
150225392|NCT00434577|541960791|FG000|Months 0-3|Protocol Violation|1|||
150225393|NCT00434577|541960792|FG001|Months 0-3|Protocol Violation|0|||
150225394|NCT00434577|541960793|FG002|Months 0-3|Protocol Violation|1|||
150225395|NCT00434577|541960794|FG003|Months 0-3|Protocol Violation|0|||
150225396|NCT00434577|541960795|FG004|Months 0-3|Protocol Violation|0|||
150225397|NCT00434577|541960791|FG000|Months 0-3|Withdrawal by Subject|2|||
150225398|NCT00434577|541960792|FG001|Months 0-3|Withdrawal by Subject|1|||
150225399|NCT00434577|541960793|FG002|Months 0-3|Withdrawal by Subject|1|||
150225400|NCT00434577|541960794|FG003|Months 0-3|Withdrawal by Subject|1|||
150225401|NCT00434577|541960795|FG004|Months 0-3|Withdrawal by Subject|1|||
150225402|NCT01904019|541960802|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
150225403|NCT01904019|541960802|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
150225404|NCT01904019|541960802|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
150225405|NCT01904019|541960802|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
150225406|NCT01904019|541960802|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
150225407|NCT01904019|541960802|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
150225408|NCT00635570|541960803|FG000|Overall Study|Lost to Follow-up|8|||
150225409|NCT00635570|541960804|FG001|Overall Study|Lost to Follow-up|8|||
150225410|NCT00635570|541960803|FG000|Overall Study|Withdrawal by Subject|1|||
150225411|NCT00635570|541960804|FG001|Overall Study|Withdrawal by Subject|1|||
150225412|NCT00635570|541960803|FG000|Overall Study|Adverse Event|2|||
150225413|NCT00635570|541960804|FG001|Overall Study|Adverse Event|0|||
150225414|NCT00635570|541960803|FG000|Overall Study|Physician Decision|1|||
150225415|NCT00635570|541960804|FG001|Overall Study|Physician Decision|0|||
150225416|NCT00635570|541960803|FG000|Overall Study|Did not complete survey|2|||
150225417|NCT00635570|541960804|FG001|Overall Study|Did not complete survey|1|||
150225418|NCT00635570|541960803|FG000|Overall Study|Early termination(No sexual activity)|1|||
150225419|NCT00635570|541960804|FG001|Overall Study|Early termination(No sexual activity)|1|||
150225420|NCT01537120|541960810|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
150225421|NCT01537120|541960810|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
150225422|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
150225423|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
150225424|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
150225425|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
150225426|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
150225427|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
150225428|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
150225429|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
150225430|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
150225431|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
150225432|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
150225433|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
150225434|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
150141499|NCT04843930|541652082|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
150141500|NCT04843930|541652083|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
150141501|NCT04843930|541652080|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
150141502|NCT04843930|541652081|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
150141503|NCT04843930|541652082|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
150141504|NCT04843930|541652083|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
150141505|NCT01489189|541652086|FG000|Overall Study|Withdrawal by Subject|20|||
150141506|NCT01489189|541652087|FG001|Overall Study|Withdrawal by Subject|23|||
150141507|NCT01489189|541652086|FG000|Overall Study|Death|10|||
150141508|NCT01489189|541652087|FG001|Overall Study|Death|8|||
150141509|NCT01489189|541652086|FG000|Overall Study|Missed Visit|1|||
150141510|NCT01489189|541652087|FG001|Overall Study|Missed Visit|4|||
150141511|NCT00112580|541652088|FG000|Overall Study|Adverse Event|1|||
150141512|NCT00112580|541652089|FG001|Overall Study|Adverse Event|2|||
150141513|NCT00112580|541652088|FG000|Overall Study|Disease progression|5|||
150141514|NCT00112580|541652089|FG001|Overall Study|Disease progression|16|||
150141515|NCT00112580|541652088|FG000|Overall Study|Participant withdrew consent|2|||
150141516|NCT00112580|541652089|FG001|Overall Study|Participant withdrew consent|1|||
150141517|NCT05597722|541652092|FG000|Overall Study|Study was terminated|6|||
150141518|NCT05597722|541652093|FG001|Overall Study|Study was terminated|1|||
150141519|NCT00404495|541652094|FG000|Overall Study|Death|37|||
150141520|NCT00404495|541652095|FG001|Overall Study|Death|11|||
150141521|NCT00404495|541652094|FG000|Overall Study|Lost to Follow-up|5|||
150141522|NCT00404495|541652095|FG001|Overall Study|Lost to Follow-up|0|||
150141523|NCT00404495|541652094|FG000|Overall Study|Other|1|||
150141524|NCT00404495|541652095|FG001|Overall Study|Other|0|||
150141525|NCT00404495|541652094|FG000|Overall Study|Withdrawal by Subject|1|||
150225435|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
150225436|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
150225437|NCT00332488|541960812|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
150225438|NCT00332488|541960813|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
150225439|NCT00332488|541960814|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
150225440|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
150225441|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
150225442|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
150225443|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
150225444|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
150141526|NCT00404495|541652095|FG001|Overall Study|Withdrawal by Subject|0|||
150225445|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
150225446|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
150225447|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
150225448|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
150225449|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
150225450|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
150225451|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
150225452|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
150225453|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
150225454|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
150225455|NCT00332488|541960812|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
150225456|NCT00332488|541960813|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
150225457|NCT00332488|541960814|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
150225458|NCT04816708|541960815|FG000|Overall Study|Lost to Follow-up|10|||
150225459|NCT04816708|541960816|FG001|Overall Study|Lost to Follow-up|4|||
150225460|NCT03451292|541960822|FG000|Overall Study|Death|44|||
150225461|NCT03451292|541960823|FG001|Overall Study|Death|59|||
150225462|NCT03451292|541960822|FG000|Overall Study|Withdrawal by Subject|18|||
150225463|NCT03451292|541960823|FG001|Overall Study|Withdrawal by Subject|13|||
150225464|NCT03451292|541960822|FG000|Overall Study|Transplantation|18|||
150225465|NCT03451292|541960823|FG001|Overall Study|Transplantation|12|||
150225466|NCT03451292|541960822|FG000|Overall Study|Lost to Follow-up|4|||
150225467|NCT03451292|541960823|FG001|Overall Study|Lost to Follow-up|12|||
150225468|NCT03451292|541960822|FG000|Overall Study|Physician Decision|4|||
150225469|NCT03451292|541960823|FG001|Overall Study|Physician Decision|3|||
150225470|NCT03451292|541960822|FG000|Overall Study|Adverse Event|3|||
150225471|NCT03451292|541960823|FG001|Overall Study|Adverse Event|3|||
150225472|NCT03451292|541960822|FG000|Overall Study|Non-compliance with Study Drug|2|||
150225473|NCT03451292|541960823|FG001|Overall Study|Non-compliance with Study Drug|0|||
150225474|NCT01375777|541960824|FG000|Overall Study|Withdrawal by Subject|0|||
150225475|NCT01375777|541960825|FG001|Overall Study|Withdrawal by Subject|2|||
150225476|NCT01375777|541960826|FG002|Overall Study|Withdrawal by Subject|1|||
150225477|NCT01375777|541960827|FG003|Overall Study|Withdrawal by Subject|0|||
150225478|NCT01375777|541960828|FG004|Overall Study|Withdrawal by Subject|1|||
150225479|NCT01375777|541960829|FG005|Overall Study|Withdrawal by Subject|1|||
150225480|NCT01375777|541960830|FG006|Overall Study|Withdrawal by Subject|1|||
150225481|NCT01375777|541960831|FG007|Overall Study|Withdrawal by Subject|2|||
150225482|NCT01375777|541960832|FG008|Overall Study|Withdrawal by Subject|1|||
150225483|NCT01375777|541960824|FG000|Overall Study|Lost to Follow-up|1|||
150225484|NCT01375777|541960825|FG001|Overall Study|Lost to Follow-up|0|||
150225485|NCT01375777|541960826|FG002|Overall Study|Lost to Follow-up|0|||
150225486|NCT01375777|541960827|FG003|Overall Study|Lost to Follow-up|0|||
150225487|NCT01375777|541960828|FG004|Overall Study|Lost to Follow-up|0|||
150225488|NCT01375777|541960829|FG005|Overall Study|Lost to Follow-up|0|||
150225489|NCT01375777|541960830|FG006|Overall Study|Lost to Follow-up|1|||
150225490|NCT01375777|541960831|FG007|Overall Study|Lost to Follow-up|0|||
150225491|NCT01375777|541960832|FG008|Overall Study|Lost to Follow-up|0|||
150225492|NCT01375777|541960824|FG000|Overall Study|Other|1|||
150225493|NCT01375777|541960825|FG001|Overall Study|Other|1|||
150225494|NCT01375777|541960826|FG002|Overall Study|Other|0|||
150225495|NCT01375777|541960827|FG003|Overall Study|Other|0|||
150225496|NCT01375777|541960828|FG004|Overall Study|Other|0|||
150225497|NCT01375777|541960829|FG005|Overall Study|Other|0|||
150225498|NCT01375777|541960830|FG006|Overall Study|Other|0|||
150225499|NCT01375777|541960831|FG007|Overall Study|Other|0|||
150225500|NCT01375777|541960832|FG008|Overall Study|Other|1|||
150225501|NCT01887418|541960835|FG000|Overall Study|Travelling difficulties|0|||
150225502|NCT01887418|541960836|FG001|Overall Study|Travelling difficulties|0|||
150225503|NCT01887418|541960837|FG002|Overall Study|Travelling difficulties|1|||
150225504|NCT03132753|541960838|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
150225505|NCT03132753|541960839|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
150225506|NCT03132753|541960838|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
150225507|NCT03132753|541960839|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
150225508|NCT02097056|541960840|FG000|Overall Study|Protocol Violation|2|||
150225509|NCT02097056|541960840|FG000|Overall Study|Withdrawal by Subject|15|||
150225510|NCT02097056|541960840|FG000|Overall Study|Lost to Follow-up|2|||
150225511|NCT02097056|541960840|FG000|Overall Study|Adverse Event|37|||
150225512|NCT02097056|541960840|FG000|Overall Study|Other|2|||
150225513|NCT00157209|541960842|FG000|Overall Study|Ongoing at data cut-off|10|||
150225514|NCT00157209|541960843|FG001|Overall Study|Ongoing at data cut-off|0|||
150225515|NCT02162771|541960844|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
150225516|NCT02162771|541960845|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
150225517|NCT02162771|541960844|FG000|Core Study Period (Part 2)|Adverse Event|4|||
150225518|NCT02162771|541960845|FG001|Core Study Period (Part 2)|Adverse Event|1|||
150225519|NCT02162771|541960844|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
150225520|NCT02162771|541960845|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
150225521|NCT02162771|541960844|FG000|Core Study Period (Part 2)|Physician Decision|0|||
150225522|NCT02162771|541960845|FG001|Core Study Period (Part 2)|Physician Decision|2|||
150225523|NCT02162771|541960844|FG000|Core Study Period (Part 2)|Death|1|||
150225524|NCT02162771|541960845|FG001|Core Study Period (Part 2)|Death|0|||
150225525|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
150225526|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
150225527|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
150225528|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
150225529|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Death|2|||
150225530|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Death|1|||
150225531|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
150225532|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
150225533|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
150225534|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
150225535|NCT02162771|541960844|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
150225536|NCT02162771|541960845|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
150225537|NCT01348763|541960846|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
150225538|NCT01348763|541960846|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
150225539|NCT01078571|541960850|FG000|Overall Study|Adverse Event|36|||
150225540|NCT01078571|541960850|FG000|Overall Study|Lack of effectiveness|36|||
150225541|NCT01078571|541960850|FG000|Overall Study|Reason not reported|21|||
150225542|NCT01078571|541960850|FG000|Overall Study|Withdrawal by Subject|12|||
150225543|NCT01078571|541960850|FG000|Overall Study|Lost to Follow-up|8|||
150225544|NCT01078571|541960850|FG000|Overall Study|Protocol Violation|2|||
150225545|NCT02332824|541960863|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
150225546|NCT02332824|541960864|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
150225547|NCT02332824|541960865|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
150225548|NCT02332824|541960866|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
150225549|NCT02332824|541960867|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
150225550|NCT02332824|541960868|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
150225551|NCT02332824|541960863|FG000|Overall Study|Voluntary Withdrawal|1|||
150225552|NCT02332824|541960864|FG001|Overall Study|Voluntary Withdrawal|0|||
150225553|NCT02332824|541960865|FG002|Overall Study|Voluntary Withdrawal|0|||
150225554|NCT02332824|541960866|FG003|Overall Study|Voluntary Withdrawal|0|||
150225555|NCT02332824|541960867|FG004|Overall Study|Voluntary Withdrawal|0|||
150225556|NCT02332824|541960868|FG005|Overall Study|Voluntary Withdrawal|0|||
150225557|NCT02332824|541960863|FG000|Overall Study|Inconvenient schedule|1|||
150225558|NCT02332824|541960864|FG001|Overall Study|Inconvenient schedule|1|||
150225559|NCT02332824|541960865|FG002|Overall Study|Inconvenient schedule|0|||
150225560|NCT02332824|541960866|FG003|Overall Study|Inconvenient schedule|0|||
150225561|NCT02332824|541960867|FG004|Overall Study|Inconvenient schedule|0|||
150225562|NCT02332824|541960868|FG005|Overall Study|Inconvenient schedule|0|||
150225563|NCT02332824|541960863|FG000|Overall Study|Transfer|0|||
150225564|NCT02332824|541960864|FG001|Overall Study|Transfer|0|||
150225565|NCT02332824|541960865|FG002|Overall Study|Transfer|1|||
150225566|NCT02332824|541960866|FG003|Overall Study|Transfer|1|||
150225567|NCT02332824|541960867|FG004|Overall Study|Transfer|0|||
150225568|NCT02332824|541960868|FG005|Overall Study|Transfer|0|||
150225569|NCT00498797|541960869|FG000|Overall Study|Withdrawal by Subject|4|||
150225570|NCT00498797|541960870|FG001|Overall Study|Withdrawal by Subject|2|||
150225571|NCT00498797|541960869|FG000|Overall Study|Adverse Event|12|||
150225572|NCT00498797|541960870|FG001|Overall Study|Adverse Event|5|||
150225573|NCT00498797|541960869|FG000|Overall Study|Condition under investigation worsened|19|||
150225574|NCT00498797|541960870|FG001|Overall Study|Condition under investigation worsened|21|||
150225575|NCT00498797|541960869|FG000|Overall Study|Other|3|||
150225576|NCT00498797|541960870|FG001|Overall Study|Other|1|||
150225577|NCT02784535|541960871|FG000|Overall Study|Adverse Event|1|||
150225578|NCT02784535|541960872|FG001|Overall Study|Adverse Event|0|||
150225579|NCT02784535|541960871|FG000|Overall Study|Withdrawal by Subject|0|||
150225580|NCT02784535|541960872|FG001|Overall Study|Withdrawal by Subject|1|||
150225581|NCT02784535|541960871|FG000|Overall Study|Physician Decision|0|||
150225582|NCT02784535|541960872|FG001|Overall Study|Physician Decision|1|||
150225583|NCT03953079|541960875|FG000|Core Study|Withdrawal by Subject|1|||
150225584|NCT03953079|541960876|FG001|Core Study|Withdrawal by Subject|2|||
150225585|NCT03953079|541960877|FG002|Core Study|Withdrawal by Subject|1|||
150225586|NCT03953079|541960875|FG000|Core Study|COVID-19|0|||
150225587|NCT03953079|541960876|FG001|Core Study|COVID-19|1|||
150225588|NCT03953079|541960877|FG002|Core Study|COVID-19|0|||
150225589|NCT03953079|541960875|FG000|Core Study|Difficulties leaving the house|0|||
150225590|NCT03953079|541960876|FG001|Core Study|Difficulties leaving the house|1|||
150225591|NCT03953079|541960877|FG002|Core Study|Difficulties leaving the house|0|||
150225592|NCT03953079|541960875|FG000|Extension Study|Withdrawal by Subject|1|||
150225593|NCT03953079|541960876|FG001|Extension Study|Withdrawal by Subject|0|||
150225594|NCT03953079|541960877|FG002|Extension Study|Withdrawal by Subject|0|||
150225595|NCT03953079|541960875|FG000|Extension Study|Received Rescue Treatment|5|||
150225596|NCT03953079|541960876|FG001|Extension Study|Received Rescue Treatment|6|||
150225597|NCT03953079|541960877|FG002|Extension Study|Received Rescue Treatment|5|||
150225598|NCT04743999|541960879|FG000|3-month Questionnaire|Death|1|||
150225599|NCT04743999|541960879|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
150225600|NCT04743999|541960879|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
150225601|NCT04743999|541960879|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
150225602|NCT01721759|541960880|FG000|Treatment Period|Disease Progression|85|||
150225603|NCT01721759|541960880|FG000|Treatment Period|Study drug toxicity|14|||
150225604|NCT01721759|541960880|FG000|Treatment Period|Death|1|||
150225605|NCT01721759|541960880|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
150225606|NCT01721759|541960880|FG000|Treatment Period|Participant request to withdraw|3|||
150225607|NCT01721759|541960880|FG000|Treatment Period|Other Reasons|3|||
150225608|NCT01721759|541960880|FG000|End of Study Period|Participant Withdrew Consent|5|||
150225609|NCT01721759|541960880|FG000|End of Study Period|Death|101|||
150225610|NCT01721759|541960880|FG000|End of Study Period|Lost to Follow-up|1|||
150225611|NCT01721759|541960880|FG000|End of Study Period|Other Reasons|10|||
150225612|NCT00417989|541960887|FG000|Overall Study|Withdrawal by Subject|13|||
150225613|NCT00417989|541960888|FG001|Overall Study|Withdrawal by Subject|13|||
150225614|NCT00417989|541960887|FG000|Overall Study|Lost to Follow-up|1|||
150225615|NCT00417989|541960888|FG001|Overall Study|Lost to Follow-up|6|||
150225616|NCT00417989|541960887|FG000|Overall Study|Protocol Violation|1|||
150225617|NCT00417989|541960888|FG001|Overall Study|Protocol Violation|0|||
150225618|NCT00417989|541960887|FG000|Overall Study|Death|0|||
150225619|NCT00417989|541960888|FG001|Overall Study|Death|1|||
150225620|NCT00417989|541960887|FG000|Overall Study|Physician Decision|5|||
150225621|NCT00417989|541960888|FG001|Overall Study|Physician Decision|2|||
150225622|NCT01636778|541960889|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
150225623|NCT01636778|541960890|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
150225624|NCT01636778|541960891|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
150225625|NCT01636778|541960889|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
150225626|NCT01636778|541960890|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
150225627|NCT01636778|541960891|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
150225628|NCT01636778|541960889|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
150225629|NCT01636778|541960890|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
150225630|NCT01636778|541960891|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
150225631|NCT01636778|541960889|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
150225632|NCT01636778|541960890|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
150225633|NCT01636778|541960891|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
150225634|NCT01636778|541960889|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
150225635|NCT01636778|541960890|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
150225636|NCT01636778|541960891|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
150225637|NCT01636778|541960889|FG000|Follow-up Period After Part 2|Other|0|||
150225638|NCT01636778|541960890|FG001|Follow-up Period After Part 2|Other|0|||
150225639|NCT01636778|541960891|FG002|Follow-up Period After Part 2|Other|1|||
150225640|NCT01636778|541960889|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
150225641|NCT01636778|541960890|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
150225642|NCT01636778|541960891|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
150225643|NCT01636778|541960889|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
150225644|NCT01636778|541960890|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
150225645|NCT01636778|541960891|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
150225646|NCT00990821|541960897|FG000|Overall Study|Withdrawal by Subject|0|||
150225647|NCT00990821|541960898|FG001|Overall Study|Withdrawal by Subject|2|||
150225648|NCT00990821|541960899|FG002|Overall Study|Withdrawal by Subject|0|||
150225649|NCT00990821|541960900|FG003|Overall Study|Withdrawal by Subject|0|||
150225650|NCT00990821|541960901|FG004|Overall Study|Withdrawal by Subject|3|||
150225651|NCT00990821|541960902|FG005|Overall Study|Withdrawal by Subject|3|||
150225652|NCT00990821|541960903|FG006|Overall Study|Withdrawal by Subject|1|||
150225653|NCT00990821|541960904|FG007|Overall Study|Withdrawal by Subject|0|||
150225654|NCT00990821|541960905|FG008|Overall Study|Withdrawal by Subject|0|||
150225655|NCT00990821|541960906|FG009|Overall Study|Withdrawal by Subject|1|||
150225656|NCT00990821|541960907|FG010|Overall Study|Withdrawal by Subject|3|||
150225657|NCT00990821|541960908|FG011|Overall Study|Withdrawal by Subject|5|||
150225658|NCT00990821|541960909|FG012|Overall Study|Withdrawal by Subject|2|||
150225659|NCT00990821|541960910|FG013|Overall Study|Withdrawal by Subject|1|||
150225660|NCT03530345|541960911|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
150225661|NCT03530345|541960912|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
150225662|NCT03530345|541960911|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
150225663|NCT03530345|541960912|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
150225664|NCT03530345|541960911|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
150225665|NCT03530345|541960912|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
150225666|NCT03530345|541960911|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
150225667|NCT03530345|541960912|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
150225668|NCT04150250|541960913|FG000|Overall Study|Lost to Follow-up|0|||
150225669|NCT04150250|541960914|FG001|Overall Study|Lost to Follow-up|2|||
150225670|NCT01945086|541960917|FG000|Overall Study|Withdrawal by Subject|1|||
150225671|NCT01945086|541960918|FG001|Overall Study|Withdrawal by Subject|0|||
150225672|NCT01945086|541960919|FG002|Overall Study|Withdrawal by Subject|1|||
150225673|NCT01945086|541960917|FG000|Overall Study|Adverse Event|0|||
150225674|NCT01945086|541960918|FG001|Overall Study|Adverse Event|0|||
150225675|NCT01945086|541960919|FG002|Overall Study|Adverse Event|1|||
150225676|NCT04853394|541960920|FG000|Follow-up Interviews|Lost to Follow-up|22|||
150225677|NCT04853394|541960921|FG001|Follow-up Interviews|Lost to Follow-up|15|||
150225678|NCT00748098|541960927|FG000|First Treatment Intervention Period|Adverse Event|1|||
150225679|NCT00748098|541960928|FG001|First Treatment Intervention Period|Adverse Event|1|||
150225680|NCT00748098|541960927|FG000|First Treatment Intervention Period|Protocol Violation|1|||
150225681|NCT00748098|541960928|FG001|First Treatment Intervention Period|Protocol Violation|0|||
150225682|NCT00748098|541960927|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
150225683|NCT00748098|541960928|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
150225684|NCT00748098|541960927|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
150225685|NCT00748098|541960928|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
150225686|NCT00748098|541960927|FG000|First Taper Period|Protocol Violation|1|||
150225687|NCT00748098|541960928|FG001|First Taper Period|Protocol Violation|0|||
150225688|NCT00748098|541960927|FG000|First Taper Period|Withdrawal by Subject|2|||
150225689|NCT00748098|541960928|FG001|First Taper Period|Withdrawal by Subject|0|||
150225690|NCT00748098|541960927|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
150225691|NCT00748098|541960928|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
150225692|NCT00748098|541960927|FG000|1-Week Washout Period|Adverse Event|0|||
150225693|NCT00748098|541960928|FG001|1-Week Washout Period|Adverse Event|1|||
150225694|NCT00748098|541960927|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
150225695|NCT00748098|541960928|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
150225696|NCT00748098|541960927|FG000|Second Treatment Intervention Period|Adverse Event|4|||
150225697|NCT00748098|541960928|FG001|Second Treatment Intervention Period|Adverse Event|1|||
150225698|NCT00748098|541960927|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
150225699|NCT00748098|541960928|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
150225700|NCT00748098|541960927|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
150225701|NCT00748098|541960928|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
150225702|NCT04212299|541960929|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
150225703|NCT02442622|541960932|FG000|Overall Study|Withdrawal by Subject|3|||
150225704|NCT02442622|541960933|FG001|Overall Study|Withdrawal by Subject|1|||
150225705|NCT01002547|541963062|FG000|Overall Study|Withdrawal by Subject|4|||
150225706|NCT01002547|541963063|FG001|Overall Study|Withdrawal by Subject|0|||
150225707|NCT01002547|541963064|FG002|Overall Study|Withdrawal by Subject|5|||
150225708|NCT01002547|541963062|FG000|Overall Study|Lost to Follow-up|2|||
150225709|NCT01002547|541963063|FG001|Overall Study|Lost to Follow-up|1|||
150225710|NCT01002547|541963064|FG002|Overall Study|Lost to Follow-up|1|||
150225711|NCT01002547|541963062|FG000|Overall Study|Physician Decision|1|||
150225712|NCT01002547|541963063|FG001|Overall Study|Physician Decision|0|||
150225713|NCT01002547|541963064|FG002|Overall Study|Physician Decision|0|||
150225714|NCT01002547|541963062|FG000|Overall Study|Death|0|||
150225715|NCT01002547|541963063|FG001|Overall Study|Death|2|||
150225716|NCT01002547|541963064|FG002|Overall Study|Death|2|||
150225717|NCT01002547|541963062|FG000|Overall Study|Adverse Event|1|||
150225718|NCT01002547|541963063|FG001|Overall Study|Adverse Event|0|||
150225719|NCT01002547|541963064|FG002|Overall Study|Adverse Event|0|||
150225720|NCT00958711|541963069|FG000|Overall Study|Withdrawal by Subject|0|||
150225721|NCT00958711|541963070|FG001|Overall Study|Withdrawal by Subject|4|||
150225722|NCT00958711|541963069|FG000|Overall Study|Physician Decision|5|||
150225723|NCT00958711|541963070|FG001|Overall Study|Physician Decision|7|||
150225724|NCT00958711|541963069|FG000|Overall Study|Lost to Follow-up|4|||
150225725|NCT00958711|541963070|FG001|Overall Study|Lost to Follow-up|1|||
150225726|NCT00958711|541963069|FG000|Overall Study|Other|2|||
150225727|NCT00958711|541963070|FG001|Overall Study|Other|5|||
150225728|NCT00958711|541963069|FG000|Overall Study|Death|1|||
150225729|NCT00958711|541963070|FG001|Overall Study|Death|2|||
150225730|NCT00958711|541963069|FG000|Overall Study|Adverse Event|1|||
150225731|NCT00958711|541963070|FG001|Overall Study|Adverse Event|2|||
150225732|NCT03722485|541963071|FG000|Overall Study|Withdrawal by Subject|1|||
150225733|NCT03722485|541963072|FG001|Overall Study|Withdrawal by Subject|0|||
150225734|NCT03722485|541963071|FG000|Overall Study|Adverse Event|0|||
150225735|NCT03722485|541963072|FG001|Overall Study|Adverse Event|2|||
150225736|NCT03722485|541963071|FG000|Overall Study|subject discharged prior to study completion|1|||
150225737|NCT03722485|541963072|FG001|Overall Study|subject discharged prior to study completion|5|||
150225738|NCT03722485|541963071|FG000|Overall Study|eligibility criteria not met|2|||
150225739|NCT03722485|541963072|FG001|Overall Study|eligibility criteria not met|0|||
150225740|NCT02151643|541963073|FG000|Overall Study|Adverse Event|2|||
150225741|NCT02151643|541963074|FG001|Overall Study|Adverse Event|0|||
150225742|NCT02151643|541963075|FG002|Overall Study|Adverse Event|1|||
150225743|NCT02151643|541963076|FG003|Overall Study|Adverse Event|4|||
150225744|NCT02151643|541963077|FG004|Overall Study|Adverse Event|0|||
150225745|NCT02151643|541963073|FG000|Overall Study|Withdrawal by Subject|0|||
150225746|NCT02151643|541963074|FG001|Overall Study|Withdrawal by Subject|1|||
150225747|NCT02151643|541963075|FG002|Overall Study|Withdrawal by Subject|1|||
150225748|NCT02151643|541963076|FG003|Overall Study|Withdrawal by Subject|1|||
150225749|NCT02151643|541963077|FG004|Overall Study|Withdrawal by Subject|1|||
150225750|NCT02151643|541963073|FG000|Overall Study|Hyperphosphataemia|1|||
150225751|NCT02151643|541963074|FG001|Overall Study|Hyperphosphataemia|0|||
150225752|NCT02151643|541963075|FG002|Overall Study|Hyperphosphataemia|0|||
150225753|NCT02151643|541963076|FG003|Overall Study|Hyperphosphataemia|0|||
150225754|NCT02151643|541963077|FG004|Overall Study|Hyperphosphataemia|1|||
150225755|NCT02151643|541963073|FG000|Overall Study|High Ferritin levels|3|||
150225756|NCT02151643|541963074|FG001|Overall Study|High Ferritin levels|3|||
150225757|NCT02151643|541963075|FG002|Overall Study|High Ferritin levels|2|||
150225758|NCT02151643|541963076|FG003|Overall Study|High Ferritin levels|2|||
150225759|NCT02151643|541963077|FG004|Overall Study|High Ferritin levels|1|||
150225760|NCT00197106|541963078|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
150225761|NCT00197106|541963079|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
150225762|NCT00197106|541963080|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
150225763|NCT00197106|541963078|FG000|Overall Treatment Period|Lack of Efficacy|0|||
150225764|NCT00197106|541963079|FG001|Overall Treatment Period|Lack of Efficacy|1|||
150225765|NCT00197106|541963080|FG002|Overall Treatment Period|Lack of Efficacy|0|||
150225766|NCT00197106|541963078|FG000|Overall Treatment Period|Lost to Follow-up|0|||
150225767|NCT00197106|541963079|FG001|Overall Treatment Period|Lost to Follow-up|0|||
150225768|NCT00197106|541963080|FG002|Overall Treatment Period|Lost to Follow-up|2|||
150225769|NCT00197106|541963078|FG000|Overall Treatment Period|Protocol Violation|0|||
150225770|NCT00197106|541963079|FG001|Overall Treatment Period|Protocol Violation|0|||
150225771|NCT00197106|541963080|FG002|Overall Treatment Period|Protocol Violation|2|||
150225772|NCT00197106|541963078|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
150225773|NCT00197106|541963079|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
150225774|NCT00197106|541963080|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
150225775|NCT01503515|541963081|FG000|Overall Study|Adverse Event|4|||
150225776|NCT01503515|541963082|FG001|Overall Study|Adverse Event|5|||
150225777|NCT01503515|541963081|FG000|Overall Study|Death|0|||
150225778|NCT01503515|541963082|FG001|Overall Study|Death|1|||
150225779|NCT01503515|541963081|FG000|Overall Study|Physician Decision|14|||
150225780|NCT01503515|541963082|FG001|Overall Study|Physician Decision|23|||
150225781|NCT01503515|541963081|FG000|Overall Study|Withdrawal by Subject|0|||
150225782|NCT01503515|541963082|FG001|Overall Study|Withdrawal by Subject|1|||
150225783|NCT01503515|541963081|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
150225784|NCT01503515|541963082|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
150225785|NCT01503515|541963081|FG000|Overall Study|Ineligible|1|||
150225786|NCT01503515|541963082|FG001|Overall Study|Ineligible|1|||
150225787|NCT04050722|541963083|FG000|Overall Study|Withdrawal by Subject|1|||
150225788|NCT04050722|541963084|FG001|Overall Study|Withdrawal by Subject|0|||
150225789|NCT01350102|541963085|FG000|Overall Study|Adverse Event|0|||
150225790|NCT01350102|541963086|FG001|Overall Study|Adverse Event|0|||
150225791|NCT01350102|541963087|FG002|Overall Study|Adverse Event|1|||
150225792|NCT01350102|541963088|FG003|Overall Study|Adverse Event|0|||
150225793|NCT00377312|541963092|FG000|Overall Study|Adverse Event|1|||
150225794|NCT00377312|541963093|FG001|Overall Study|Adverse Event|1|||
150225795|NCT00762723|541963094|FG000|Overall Study|Study Terminated slow enrollement|5|||
150225796|NCT00762723|541963095|FG001|Overall Study|Study Terminated slow enrollement|5|||
150225797|NCT00762723|541963096|FG002|Overall Study|Study Terminated slow enrollement|3|||
150225798|NCT01572493|541963097|FG000|Overall Study|Physician Decision|1|||
150225799|NCT01572493|541963098|FG001|Overall Study|Physician Decision|0|||
150225800|NCT01572493|541963099|FG002|Overall Study|Physician Decision|0|||
150225801|NCT01572493|541963100|FG003|Overall Study|Physician Decision|0|||
150225802|NCT01572493|541963101|FG004|Overall Study|Physician Decision|0|||
150225803|NCT01572493|541963102|FG005|Overall Study|Physician Decision|0|||
150225804|NCT01572493|541963103|FG006|Overall Study|Physician Decision|0|||
150225805|NCT01572493|541963104|FG007|Overall Study|Physician Decision|0|||
150225806|NCT01572493|541963105|FG008|Overall Study|Physician Decision|0|||
150225807|NCT01572493|541963097|FG000|Overall Study|Switched to alternative treatment|0|||
150225808|NCT01572493|541963098|FG001|Overall Study|Switched to alternative treatment|1|||
150225809|NCT01572493|541963099|FG002|Overall Study|Switched to alternative treatment|2|||
150225810|NCT01572493|541963100|FG003|Overall Study|Switched to alternative treatment|1|||
150225811|NCT01572493|541963101|FG004|Overall Study|Switched to alternative treatment|2|||
150225812|NCT01572493|541963102|FG005|Overall Study|Switched to alternative treatment|0|||
150225813|NCT01572493|541963103|FG006|Overall Study|Switched to alternative treatment|2|||
150225814|NCT01572493|541963104|FG007|Overall Study|Switched to alternative treatment|0|||
150225815|NCT01572493|541963105|FG008|Overall Study|Switched to alternative treatment|2|||
150225816|NCT01572493|541963097|FG000|Overall Study|Death|0|||
150225817|NCT01572493|541963098|FG001|Overall Study|Death|0|||
150225818|NCT01572493|541963099|FG002|Overall Study|Death|0|||
150225819|NCT01572493|541963100|FG003|Overall Study|Death|1|||
150225820|NCT01572493|541963101|FG004|Overall Study|Death|0|||
150225821|NCT01572493|541963102|FG005|Overall Study|Death|1|||
150225822|NCT01572493|541963103|FG006|Overall Study|Death|0|||
150225823|NCT01572493|541963104|FG007|Overall Study|Death|0|||
150225824|NCT01572493|541963105|FG008|Overall Study|Death|0|||
150225825|NCT01572493|541963097|FG000|Overall Study|Adverse Event|0|||
150225826|NCT01572493|541963098|FG001|Overall Study|Adverse Event|0|||
150225827|NCT01572493|541963099|FG002|Overall Study|Adverse Event|0|||
150225828|NCT01572493|541963100|FG003|Overall Study|Adverse Event|0|||
150225829|NCT01572493|541963101|FG004|Overall Study|Adverse Event|0|||
150225830|NCT01572493|541963102|FG005|Overall Study|Adverse Event|0|||
150225831|NCT01572493|541963103|FG006|Overall Study|Adverse Event|1|||
150225832|NCT01572493|541963104|FG007|Overall Study|Adverse Event|0|||
150225833|NCT01572493|541963105|FG008|Overall Study|Adverse Event|0|||
150225834|NCT00609245|541963106|FG000|Overall Study|Adverse Event|1|||
150225835|NCT01090076|541963107|FG000|Overall Study|Death|1|||
150225836|NCT01090076|541963108|FG001|Overall Study|Death|1|||
150225837|NCT01090076|541963107|FG000|Overall Study|Withdrawal by Subject|0|||
150225838|NCT01090076|541963108|FG001|Overall Study|Withdrawal by Subject|1|||
150225839|NCT02402465|541963111|FG000|Overall Study|Withdrawal by Subject|0|||
150225840|NCT02402465|541963112|FG001|Overall Study|Withdrawal by Subject|0|||
150225841|NCT02402465|541963113|FG002|Overall Study|Withdrawal by Subject|0|||
150225842|NCT02402465|541963114|FG003|Overall Study|Withdrawal by Subject|0|||
150225843|NCT02402465|541963115|FG004|Overall Study|Withdrawal by Subject|0|||
150225844|NCT02402465|541963116|FG005|Overall Study|Withdrawal by Subject|1|||
150225845|NCT02402465|541963111|FG000|Overall Study|Lost to Follow-up|0|||
150225846|NCT02402465|541963112|FG001|Overall Study|Lost to Follow-up|1|||
150225847|NCT02402465|541963113|FG002|Overall Study|Lost to Follow-up|0|||
150225848|NCT02402465|541963114|FG003|Overall Study|Lost to Follow-up|0|||
150225849|NCT02402465|541963115|FG004|Overall Study|Lost to Follow-up|1|||
150225850|NCT02402465|541963116|FG005|Overall Study|Lost to Follow-up|0|||
150225851|NCT01284634|541963117|FG000|Overall Study|Adverse Event|1|||
150225852|NCT01284634|541963118|FG001|Overall Study|Adverse Event|0|||
150225853|NCT01284634|541963119|FG002|Overall Study|Adverse Event|2|||
150225854|NCT01284634|541963120|FG003|Overall Study|Adverse Event|1|||
150225855|NCT02236598|541963121|FG000|Overall Study|Adverse Event|0|||
150225856|NCT02236598|541963122|FG001|Overall Study|Adverse Event|1|||
150225857|NCT02236598|541963121|FG000|Overall Study|Withdrawal by Subject|0|||
150225858|NCT02236598|541963122|FG001|Overall Study|Withdrawal by Subject|1|||
150225859|NCT01654289|541963128|FG000|Overall Study|Withdrawal by Subject|10|||
150225860|NCT01654289|541963129|FG001|Overall Study|Withdrawal by Subject|8|||
150225861|NCT01654289|541963130|FG002|Overall Study|Withdrawal by Subject|5|||
150225862|NCT01654289|541963128|FG000|Overall Study|Withdrew from intervention only|17|||
150225863|NCT01654289|541963129|FG001|Overall Study|Withdrew from intervention only|20|||
150225864|NCT01654289|541963130|FG002|Overall Study|Withdrew from intervention only|0|||
150225865|NCT01732627|541963131|FG000|Overall Study|Withdrawal by Subject|1|||
150225866|NCT01732627|541963132|FG001|Overall Study|Withdrawal by Subject|0|||
150225867|NCT04736602|541963134|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
150225868|NCT04736602|541963134|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
150225869|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Adverse Event|3|||
150225870|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Adverse Event|0|||
150225871|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
150225872|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
150225873|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Disease Progression|23|||
150225874|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Disease Progression|22|||
150225875|NCT01379521|541963135|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
150225876|NCT01379521|541963136|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
150225877|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
150225878|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
150225879|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
150225880|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
150225881|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
150225882|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
150225883|NCT01379521|541963135|FG000|Overall Study -Treatment Period|Death|2|||
150225884|NCT01379521|541963136|FG001|Overall Study -Treatment Period|Death|1|||
150225885|NCT01379521|541963135|FG000|Post-Treatment Evaluations|Disease Progression|22|||
150225886|NCT01379521|541963136|FG001|Post-Treatment Evaluations|Disease Progression|20|||
150225887|NCT01379521|541963135|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
150225888|NCT01379521|541963136|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
150225889|NCT01379521|541963135|FG000|Post-Treatment Evaluations|Death|1|||
150225890|NCT01379521|541963136|FG001|Post-Treatment Evaluations|Death|0|||
150225891|NCT00938041|541963137|FG000|Overall Study|Lost to Follow-up|6|||
150225892|NCT00938041|541963137|FG000|Overall Study|Received Alternative Therapy|1|||
150225893|NCT00938041|541963137|FG000|Overall Study|Progressive Disease|5|||
150225894|NCT00938041|541963137|FG000|Overall Study|Death|12|||
150225895|NCT00938041|541963137|FG000|Overall Study|Adrenal Insufficiency|3|||
150225896|NCT02504502|541963138|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
150225897|NCT02504502|541963139|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
150225898|NCT02504502|541963138|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
150225899|NCT02504502|541963139|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
150225900|NCT03042559|541963140|FG000|Overall Study|drop out|1|||
150225901|NCT03042559|541963141|FG001|Overall Study|drop out|1|||
150225902|NCT01485991|541963147|FG000|Overall Study|Adverse Event|0|||
150225903|NCT01485991|541963148|FG001|Overall Study|Adverse Event|4|||
150225904|NCT01485991|541963147|FG000|Overall Study|Lost to Follow-up|13|||
150225905|NCT01485991|541963148|FG001|Overall Study|Lost to Follow-up|10|||
150225906|NCT01485991|541963147|FG000|Overall Study|Withdrawal by Subject|13|||
150225907|NCT01485991|541963148|FG001|Overall Study|Withdrawal by Subject|20|||
150225908|NCT01485991|541963147|FG000|Overall Study|randomized but not treated|6|||
150225909|NCT01485991|541963148|FG001|Overall Study|randomized but not treated|2|||
150225910|NCT02538471|541963149|FG000|Overall Study|Progression of disease|2|||
150225911|NCT01475370|541963150|FG000|Overall Study|Exacerbation of primary disease|2|||
150225912|NCT01475370|541963151|FG001|Overall Study|Exacerbation of primary disease|2|||
150225913|NCT01475370|541963152|FG002|Overall Study|Exacerbation of primary disease|2|||
150225914|NCT01475370|541963150|FG000|Overall Study|Study drug administration difficult|0|||
150225915|NCT01475370|541963151|FG001|Overall Study|Study drug administration difficult|1|||
150225916|NCT01475370|541963152|FG002|Overall Study|Study drug administration difficult|1|||
150225917|NCT01475370|541963150|FG000|Overall Study|Other than specified|1|||
150225918|NCT01475370|541963151|FG001|Overall Study|Other than specified|0|||
150225919|NCT01475370|541963152|FG002|Overall Study|Other than specified|0|||
150225920|NCT00475735|541963153|FG000|Treatment Period 1|Adverse Event|2|||
150225921|NCT00475735|541963154|FG001|Treatment Period 1|Adverse Event|0|||
150225922|NCT00475735|541963155|FG002|Treatment Period 1|Adverse Event|0|||
150225923|NCT00475735|541963156|FG003|Treatment Period 1|Adverse Event|0|||
150225924|NCT00475735|541963157|FG004|Treatment Period 1|Adverse Event|0|||
150225925|NCT00475735|541963158|FG005|Treatment Period 1|Adverse Event|0|||
150225926|NCT00475735|541963153|FG000|Treatment Period 1|Lack of Efficacy|1|||
150225927|NCT00475735|541963154|FG001|Treatment Period 1|Lack of Efficacy|0|||
150225928|NCT00475735|541963155|FG002|Treatment Period 1|Lack of Efficacy|0|||
150225929|NCT00475735|541963156|FG003|Treatment Period 1|Lack of Efficacy|0|||
150225930|NCT00475735|541963157|FG004|Treatment Period 1|Lack of Efficacy|0|||
150225931|NCT00475735|541963158|FG005|Treatment Period 1|Lack of Efficacy|0|||
150225932|NCT00475735|541963153|FG000|Treatment Period 1|Lost to Follow-up|0|||
150225933|NCT00475735|541963154|FG001|Treatment Period 1|Lost to Follow-up|0|||
150225934|NCT00475735|541963155|FG002|Treatment Period 1|Lost to Follow-up|0|||
150225935|NCT00475735|541963156|FG003|Treatment Period 1|Lost to Follow-up|0|||
150225936|NCT00475735|541963157|FG004|Treatment Period 1|Lost to Follow-up|0|||
150225937|NCT00475735|541963158|FG005|Treatment Period 1|Lost to Follow-up|1|||
150225938|NCT00475735|541963153|FG000|Treatment Period 1|Protocol Violation|0|||
150225939|NCT00475735|541963154|FG001|Treatment Period 1|Protocol Violation|0|||
150225940|NCT00475735|541963155|FG002|Treatment Period 1|Protocol Violation|0|||
150225941|NCT00475735|541963156|FG003|Treatment Period 1|Protocol Violation|1|||
150225942|NCT00475735|541963157|FG004|Treatment Period 1|Protocol Violation|0|||
150225943|NCT00475735|541963158|FG005|Treatment Period 1|Protocol Violation|0|||
150225944|NCT00475735|541963153|FG000|Treatment Period 1|Withdrawal by Subject|1|||
150225945|NCT00475735|541963154|FG001|Treatment Period 1|Withdrawal by Subject|1|||
150225946|NCT00475735|541963155|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150225947|NCT00475735|541963156|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150225948|NCT00475735|541963157|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150225949|NCT00475735|541963158|FG005|Treatment Period 1|Withdrawal by Subject|0|||
150225950|NCT00475735|541963153|FG000|Treatment Period 1|DC due to AE but continuing|0|||
150225951|NCT00475735|541963154|FG001|Treatment Period 1|DC due to AE but continuing|0|||
150225952|NCT00475735|541963155|FG002|Treatment Period 1|DC due to AE but continuing|0|||
150225953|NCT00475735|541963156|FG003|Treatment Period 1|DC due to AE but continuing|1|||
150225954|NCT00475735|541963157|FG004|Treatment Period 1|DC due to AE but continuing|2|||
150225955|NCT00475735|541963158|FG005|Treatment Period 1|DC due to AE but continuing|2|||
150225956|NCT00475735|541963153|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
150225957|NCT00475735|541963154|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
150225958|NCT00475735|541963155|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
150225959|NCT00475735|541963156|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
150225960|NCT00475735|541963157|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
150225961|NCT00475735|541963158|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
150225962|NCT00475735|541963153|FG000|Treatment Washout|Lost to Follow-up|0|||
150225963|NCT00475735|541963154|FG001|Treatment Washout|Lost to Follow-up|1|||
150225964|NCT00475735|541963155|FG002|Treatment Washout|Lost to Follow-up|0|||
150225965|NCT00475735|541963156|FG003|Treatment Washout|Lost to Follow-up|0|||
150225966|NCT00475735|541963157|FG004|Treatment Washout|Lost to Follow-up|0|||
150225967|NCT00475735|541963158|FG005|Treatment Washout|Lost to Follow-up|0|||
150225968|NCT00475735|541963153|FG000|Treatment Washout|Protocol Violation|0|||
150225969|NCT00475735|541963154|FG001|Treatment Washout|Protocol Violation|1|||
150225970|NCT00475735|541963155|FG002|Treatment Washout|Protocol Violation|0|||
150225971|NCT00475735|541963156|FG003|Treatment Washout|Protocol Violation|0|||
150225972|NCT00475735|541963157|FG004|Treatment Washout|Protocol Violation|0|||
150225973|NCT00475735|541963158|FG005|Treatment Washout|Protocol Violation|0|||
150225974|NCT00475735|541963153|FG000|Treatment Period 2|Adverse Event|0|||
150225975|NCT00475735|541963154|FG001|Treatment Period 2|Adverse Event|1|||
150225976|NCT00475735|541963155|FG002|Treatment Period 2|Adverse Event|0|||
150225977|NCT00475735|541963156|FG003|Treatment Period 2|Adverse Event|2|||
150225978|NCT00475735|541963157|FG004|Treatment Period 2|Adverse Event|0|||
150225979|NCT00475735|541963158|FG005|Treatment Period 2|Adverse Event|0|||
150225980|NCT00475735|541963153|FG000|Treatment Period 2|Lack of Efficacy|0|||
150225981|NCT00475735|541963154|FG001|Treatment Period 2|Lack of Efficacy|0|||
150225982|NCT00475735|541963155|FG002|Treatment Period 2|Lack of Efficacy|0|||
150225983|NCT00475735|541963156|FG003|Treatment Period 2|Lack of Efficacy|0|||
150225984|NCT00475735|541963157|FG004|Treatment Period 2|Lack of Efficacy|0|||
150225985|NCT00475735|541963158|FG005|Treatment Period 2|Lack of Efficacy|1|||
150225986|NCT00475735|541963153|FG000|Treatment Period 2|Withdrawal by Subject|0|||
150225987|NCT00475735|541963154|FG001|Treatment Period 2|Withdrawal by Subject|0|||
150225988|NCT00475735|541963155|FG002|Treatment Period 2|Withdrawal by Subject|0|||
150225989|NCT00475735|541963156|FG003|Treatment Period 2|Withdrawal by Subject|0|||
150225990|NCT00475735|541963157|FG004|Treatment Period 2|Withdrawal by Subject|1|||
150225991|NCT00475735|541963158|FG005|Treatment Period 2|Withdrawal by Subject|0|||
150225992|NCT00084747|541963159|FG000|Overall Study|Relapsed|8|||
150225993|NCT00084747|541963159|FG000|Overall Study|Death|3|||
150225994|NCT00084747|541963159|FG000|Overall Study|Withdrawal by Subject|2|||
150225995|NCT00125853|541963161|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
150225996|NCT00125853|541963162|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
150141527|NCT00856167|541652096|FG000|Period 1|Withdrawal by Subject|1|||
150141528|NCT00856167|541652097|FG001|Period 1|Withdrawal by Subject|4|||
150141529|NCT00856167|541652098|FG002|Period 1|Withdrawal by Subject|0|||
150141530|NCT00856167|541652099|FG003|Period 1|Withdrawal by Subject|0|||
150141531|NCT00856167|541652096|FG000|Period 1|Lost to Follow-up|2|||
150141532|NCT00856167|541652097|FG001|Period 1|Lost to Follow-up|1|||
150141533|NCT00856167|541652098|FG002|Period 1|Lost to Follow-up|0|||
150141534|NCT00856167|541652099|FG003|Period 1|Lost to Follow-up|0|||
150141535|NCT00856167|541652096|FG000|Period 2|Lost to Follow-up|0|||
150141536|NCT00856167|541652097|FG001|Period 2|Lost to Follow-up|0|||
150141537|NCT00856167|541652098|FG002|Period 2|Lost to Follow-up|3|||
150141538|NCT00856167|541652099|FG003|Period 2|Lost to Follow-up|1|||
150141539|NCT00856167|541652096|FG000|Period 2|Withdrawal by Subject|0|||
150141540|NCT00856167|541652097|FG001|Period 2|Withdrawal by Subject|0|||
150141541|NCT00856167|541652098|FG002|Period 2|Withdrawal by Subject|2|||
150141542|NCT00856167|541652099|FG003|Period 2|Withdrawal by Subject|4|||
150141543|NCT06027619|541652100|FG000|Overall Study|Adverse Event|0|||
150141544|NCT06027619|541652101|FG001|Overall Study|Adverse Event|0|||
150141545|NCT06027619|541652102|FG002|Overall Study|Adverse Event|1|||
150141546|NCT01108458|541653947|FG000|Overall Study|Withdrawal by Subject|1|||
150141547|NCT01392300|541653957|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
150141548|NCT01392300|541653958|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
150141549|NCT01392300|541653959|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
150141550|NCT01392300|541653957|FG000|Main Period (MP)|Withdrawal by Subject|5|||
150141551|NCT01392300|541653958|FG001|Main Period (MP)|Withdrawal by Subject|1|||
150141552|NCT01392300|541653959|FG002|Main Period (MP)|Withdrawal by Subject|0|||
150141553|NCT01392300|541653957|FG000|Main Period (MP)|Lost to Follow-up|3|||
150141554|NCT01392300|541653958|FG001|Main Period (MP)|Lost to Follow-up|3|||
150141555|NCT01392300|541653959|FG002|Main Period (MP)|Lost to Follow-up|0|||
150141556|NCT01392300|541653957|FG000|Main Period (MP)|Non-compliance|1|||
150141557|NCT01392300|541653958|FG001|Main Period (MP)|Non-compliance|0|||
150141558|NCT01392300|541653959|FG002|Main Period (MP)|Non-compliance|0|||
150141559|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
150141560|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
150141561|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
150141562|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
150141563|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
150141564|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
150141565|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
150141566|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
150141567|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
150141568|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Death|0|||
150141569|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Death|0|||
150141570|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Death|4|||
150141571|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
150141572|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
150141573|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
150141574|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
150141575|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
150141576|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
150141577|NCT01392300|541653957|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
150141578|NCT01392300|541653958|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
150141579|NCT01392300|541653959|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
150141580|NCT05056870|541653960|FG000|Period 1|Site COVID-19 Related|3|||
150141581|NCT05056870|541653961|FG001|Period 1|Site COVID-19 Related|3|||
150141582|NCT05056870|541653960|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
150141583|NCT05056870|541653961|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
150141584|NCT05056870|541653960|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
150141585|NCT05056870|541653961|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
150141586|NCT05056870|541653960|FG000|Period 2|COVID-19 Related|1|||
150141587|NCT05056870|541653961|FG001|Period 2|COVID-19 Related|0|||
150141588|NCT05056870|541653960|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
150141589|NCT05056870|541653961|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
150141590|NCT00755222|541653962|FG000|Overall Study|Withdrawal by Subject|4|||
150141591|NCT00755222|541653963|FG001|Overall Study|Withdrawal by Subject|2|||
150141592|NCT00755222|541653962|FG000|Overall Study|Adverse Event|2|||
150141593|NCT00755222|541653963|FG001|Overall Study|Adverse Event|0|||
150141594|NCT00755222|541653962|FG000|Overall Study|Protocol Violation|2|||
150141595|NCT00755222|541653963|FG001|Overall Study|Protocol Violation|0|||
150141596|NCT00742079|541653974|FG000|Overall Study|Lost to Follow-up|0|||
150141597|NCT00742079|541653975|FG001|Overall Study|Lost to Follow-up|1|||
150141598|NCT02243202|541653976|FG000|Overall Study|Adverse Event|5|||
150141599|NCT02243202|541653977|FG001|Overall Study|Adverse Event|6|||
150141600|NCT02243202|541653978|FG002|Overall Study|Adverse Event|10|||
150225997|NCT02522299|541963171|FG000|Overall Study|Adverse Event|2|||
150225998|NCT02522299|541963172|FG001|Overall Study|Adverse Event|0|||
150225999|NCT02522299|541963171|FG000|Overall Study|Physician Decision|0|||
150226000|NCT02522299|541963172|FG001|Overall Study|Physician Decision|1|||
150226001|NCT02522299|541963171|FG000|Overall Study|Withdrawal by Subject|2|||
150226002|NCT02522299|541963172|FG001|Overall Study|Withdrawal by Subject|0|||
150226003|NCT03575572|541963175|FG000|Overall Study|Withdrawal by Subject|2|||
150226004|NCT03575572|541963175|FG000|Overall Study|Physician Decision|2|||
150226005|NCT04474691|541963176|FG000|Overall Study|Withdrawal by Subject|9|||
150226006|NCT01257698|541963178|FG000|Overall Study|Protocol Violation|4|||
150226007|NCT01257698|541963179|FG001|Overall Study|Protocol Violation|0|||
150226008|NCT00050167|541963181|FG000|Overall Study|not eligible not invasive|1|||
150226009|NCT00050167|541963182|FG001|Overall Study|not eligible not invasive|1|||
150226010|NCT04372186|541963186|FG000|Overall Study|Death|24|||
150226011|NCT04372186|541963187|FG001|Overall Study|Death|11|||
150226012|NCT04372186|541963186|FG000|Overall Study|Transferred to a different facility for care|0|||
150226013|NCT04372186|541963187|FG001|Overall Study|Transferred to a different facility for care|2|||
150226014|NCT00577096|541963188|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
150226015|NCT00577096|541963189|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
150226016|NCT00577096|541963188|FG000|Short Term Participation|Withdrawal by Subject|3|||
150226017|NCT00577096|541963189|FG001|Short Term Participation|Withdrawal by Subject|5|||
150226018|NCT00577096|541963188|FG000|Short Term Participation|Death|1|||
150226019|NCT00577096|541963189|FG001|Short Term Participation|Death|1|||
150226020|NCT00832650|541963190|FG000|Overall Study|Randomized but not treated|0|||
150226021|NCT00832650|541963191|FG001|Overall Study|Randomized but not treated|0|||
150226022|NCT00832650|541963192|FG002|Overall Study|Randomized but not treated|1|||
150226023|NCT03219216|541963193|FG000|Overall Study|Lost to Follow-up|0|||
150226024|NCT03219216|541963194|FG001|Overall Study|Lost to Follow-up|1|||
150226025|NCT03305458|541963195|FG000|Overall Study|Withdrawal by Subject|50|||
150226026|NCT03305458|541963196|FG001|Overall Study|Withdrawal by Subject|46|||
150226027|NCT03305458|541963197|FG002|Overall Study|Withdrawal by Subject|93|||
150226028|NCT03305458|541963195|FG000|Overall Study|Lost to Follow-up|85|||
150226029|NCT03305458|541963196|FG001|Overall Study|Lost to Follow-up|85|||
150226030|NCT03305458|541963197|FG002|Overall Study|Lost to Follow-up|35|||
150226031|NCT00440037|541963199|FG000|Overall Study|Withdrawal by Subject|6|||
150226032|NCT00440037|541963199|FG000|Overall Study|Administrative decision|3|||
150226033|NCT03562117|541963200|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
150226034|NCT03562117|541963201|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
150226035|NCT03562117|541963202|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
150226036|NCT03928821|541963203|FG000|Overall Study|Death|0|||
150226037|NCT03928821|541963204|FG001|Overall Study|Death|1|||
150226038|NCT03928821|541963205|FG002|Overall Study|Death|0|||
150226039|NCT03928821|541963206|FG003|Overall Study|Death|0|||
150226040|NCT03928821|541963203|FG000|Overall Study|Lost to Follow-up|0|||
150226041|NCT03928821|541963204|FG001|Overall Study|Lost to Follow-up|2|||
150226042|NCT03928821|541963205|FG002|Overall Study|Lost to Follow-up|3|||
150226043|NCT03928821|541963206|FG003|Overall Study|Lost to Follow-up|0|||
150226044|NCT03928821|541963203|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
150226045|NCT03928821|541963204|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
150226046|NCT03928821|541963205|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
150226047|NCT03928821|541963206|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
150226048|NCT03740919|541963213|FG000|Lead-in Period|Lost to Follow-up|1|||
150226049|NCT03740919|541963214|FG001|Lead-in Period|Lost to Follow-up|0|||
150226050|NCT03740919|541963215|FG002|Lead-in Period|Lost to Follow-up|0|||
150226051|NCT03740919|541963216|FG003|Lead-in Period|Lost to Follow-up|0|||
150226052|NCT03740919|541963213|FG000|Lead-in Period|Physician Decision|2|||
150226053|NCT03740919|541963214|FG001|Lead-in Period|Physician Decision|0|||
150226054|NCT03740919|541963215|FG002|Lead-in Period|Physician Decision|0|||
150226055|NCT03740919|541963216|FG003|Lead-in Period|Physician Decision|0|||
150226056|NCT03740919|541963213|FG000|Lead-in Period|Protocol Violation|1|||
150226057|NCT03740919|541963214|FG001|Lead-in Period|Protocol Violation|0|||
150226058|NCT03740919|541963215|FG002|Lead-in Period|Protocol Violation|0|||
150226059|NCT03740919|541963216|FG003|Lead-in Period|Protocol Violation|0|||
150226060|NCT03740919|541963213|FG000|Lead-in Period|Withdrawal by Subject|10|||
150226061|NCT03740919|541963214|FG001|Lead-in Period|Withdrawal by Subject|0|||
150226062|NCT03740919|541963215|FG002|Lead-in Period|Withdrawal by Subject|0|||
150226063|NCT03740919|541963216|FG003|Lead-in Period|Withdrawal by Subject|0|||
150226064|NCT03740919|541963213|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
150226065|NCT03740919|541963214|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
150226066|NCT03740919|541963215|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
150226067|NCT03740919|541963216|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
150226068|NCT03740919|541963213|FG000|Lead-in Period|Study Task Too Burdensome|1|||
150226069|NCT03740919|541963214|FG001|Lead-in Period|Study Task Too Burdensome|0|||
150226070|NCT03740919|541963215|FG002|Lead-in Period|Study Task Too Burdensome|0|||
150226071|NCT03740919|541963216|FG003|Lead-in Period|Study Task Too Burdensome|0|||
150226072|NCT03740919|541963213|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
150226073|NCT03740919|541963214|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
150226074|NCT03740919|541963215|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
150226075|NCT03740919|541963216|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
150226076|NCT03740919|541963213|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
150226077|NCT03740919|541963214|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
150226078|NCT03740919|541963215|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
150226079|NCT03740919|541963216|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
150226080|NCT03740919|541963213|FG000|Treatment Period|Adverse Event|0|||
150226081|NCT03740919|541963214|FG001|Treatment Period|Adverse Event|0|||
150226082|NCT03740919|541963215|FG002|Treatment Period|Adverse Event|2|||
150226083|NCT03740919|541963216|FG003|Treatment Period|Adverse Event|0|||
150226084|NCT03740919|541963213|FG000|Treatment Period|Protocol Violation|0|||
150226085|NCT03740919|541963214|FG001|Treatment Period|Protocol Violation|1|||
150226086|NCT03740919|541963215|FG002|Treatment Period|Protocol Violation|0|||
150226087|NCT03740919|541963216|FG003|Treatment Period|Protocol Violation|0|||
150226088|NCT03740919|541963213|FG000|Treatment Period|Withdrawal by Subject|0|||
150226089|NCT03740919|541963214|FG001|Treatment Period|Withdrawal by Subject|7|||
150226090|NCT03740919|541963215|FG002|Treatment Period|Withdrawal by Subject|6|||
150226091|NCT03740919|541963216|FG003|Treatment Period|Withdrawal by Subject|2|||
150226092|NCT03740919|541963213|FG000|Treatment Period|Terminated by Sponsor|0|||
150226093|NCT03740919|541963214|FG001|Treatment Period|Terminated by Sponsor|1|||
150226094|NCT03740919|541963215|FG002|Treatment Period|Terminated by Sponsor|0|||
150226095|NCT03740919|541963216|FG003|Treatment Period|Terminated by Sponsor|0|||
150226096|NCT03740919|541963213|FG000|Treatment Period|Issue with Insulin Pump|0|||
150226097|NCT03740919|541963214|FG001|Treatment Period|Issue with Insulin Pump|1|||
150226098|NCT03740919|541963215|FG002|Treatment Period|Issue with Insulin Pump|0|||
150226099|NCT03740919|541963216|FG003|Treatment Period|Issue with Insulin Pump|0|||
150226100|NCT03740919|541963213|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
150226101|NCT03740919|541963214|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
150226102|NCT03740919|541963215|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
150226103|NCT03740919|541963216|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
150226104|NCT03740919|541963213|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
150226105|NCT03740919|541963214|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
150226106|NCT03740919|541963215|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
150226107|NCT03740919|541963216|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
150226108|NCT03740919|541963213|FG000|Treatment Period|Not Completing Diary|0|||
150226109|NCT03740919|541963214|FG001|Treatment Period|Not Completing Diary|0|||
150226110|NCT03740919|541963215|FG002|Treatment Period|Not Completing Diary|1|||
150226111|NCT03740919|541963216|FG003|Treatment Period|Not Completing Diary|0|||
150226112|NCT03740919|541963213|FG000|Treatment Period|Insulin Painful to Participant|0|||
150226113|NCT03740919|541963214|FG001|Treatment Period|Insulin Painful to Participant|0|||
150226114|NCT03740919|541963215|FG002|Treatment Period|Insulin Painful to Participant|1|||
150226115|NCT03740919|541963216|FG003|Treatment Period|Insulin Painful to Participant|0|||
150226116|NCT00985621|541963219|FG000|Overall Study|Adverse Event|2|||
150226117|NCT00985621|541963220|FG001|Overall Study|Adverse Event|3|||
150226118|NCT00985621|541963221|FG002|Overall Study|Adverse Event|4|||
150226119|NCT00985621|541963222|FG003|Overall Study|Adverse Event|16|||
150226120|NCT00985621|541963219|FG000|Overall Study|Lack of Efficacy|10|||
150226121|NCT00985621|541963220|FG001|Overall Study|Lack of Efficacy|6|||
150226122|NCT00985621|541963221|FG002|Overall Study|Lack of Efficacy|5|||
150226123|NCT00985621|541963222|FG003|Overall Study|Lack of Efficacy|12|||
150226124|NCT00985621|541963219|FG000|Overall Study|Lost to Follow-up|2|||
150226125|NCT00985621|541963220|FG001|Overall Study|Lost to Follow-up|3|||
150226126|NCT00985621|541963221|FG002|Overall Study|Lost to Follow-up|4|||
150226127|NCT00985621|541963222|FG003|Overall Study|Lost to Follow-up|4|||
150226128|NCT00985621|541963219|FG000|Overall Study|Study Terminated by Sponsor|89|||
150226129|NCT00985621|541963220|FG001|Overall Study|Study Terminated by Sponsor|108|||
150226130|NCT00985621|541963221|FG002|Overall Study|Study Terminated by Sponsor|99|||
150226131|NCT00985621|541963222|FG003|Overall Study|Study Terminated by Sponsor|92|||
150226132|NCT00985621|541963219|FG000|Overall Study|Protocol Violation|1|||
150226133|NCT00985621|541963220|FG001|Overall Study|Protocol Violation|1|||
150226134|NCT00985621|541963221|FG002|Overall Study|Protocol Violation|1|||
150226135|NCT00985621|541963222|FG003|Overall Study|Protocol Violation|0|||
150226136|NCT00985621|541963219|FG000|Overall Study|Withdrawal by Subject|8|||
150226137|NCT00985621|541963220|FG001|Overall Study|Withdrawal by Subject|10|||
150226138|NCT00985621|541963221|FG002|Overall Study|Withdrawal by Subject|8|||
150226139|NCT00985621|541963222|FG003|Overall Study|Withdrawal by Subject|12|||
150226140|NCT00985621|541963219|FG000|Overall Study|Other|1|||
150226141|NCT00985621|541963220|FG001|Overall Study|Other|0|||
150226142|NCT00985621|541963221|FG002|Overall Study|Other|0|||
150226143|NCT00985621|541963222|FG003|Overall Study|Other|0|||
150226144|NCT00985621|541963219|FG000|Overall Study|Randomized but not Treated|1|||
150226145|NCT00985621|541963220|FG001|Overall Study|Randomized but not Treated|0|||
150226146|NCT00985621|541963221|FG002|Overall Study|Randomized but not Treated|2|||
150226147|NCT00985621|541963222|FG003|Overall Study|Randomized but not Treated|1|||
150226148|NCT01911819|541963223|FG000|Overall Study|Adverse Event|0|||
150226149|NCT01911819|541963224|FG001|Overall Study|Adverse Event|1|||
150226150|NCT01911819|541963225|FG002|Overall Study|Adverse Event|0|||
150226151|NCT01911819|541963223|FG000|Overall Study|Withdrawal by Subject|1|||
150226152|NCT01911819|541963224|FG001|Overall Study|Withdrawal by Subject|1|||
150226153|NCT01911819|541963225|FG002|Overall Study|Withdrawal by Subject|0|||
150226154|NCT04394624|541963229|FG000|Overall Study|Adverse Event|6|||
150226155|NCT04394624|541963230|FG001|Overall Study|Adverse Event|0|||
150226156|NCT04394624|541963229|FG000|Overall Study|Progressive disease|24|||
150226157|NCT04394624|541963230|FG001|Overall Study|Progressive disease|0|||
150226158|NCT04394624|541963229|FG000|Overall Study|Not related to COVID-19|1|||
150226159|NCT04394624|541963230|FG001|Overall Study|Not related to COVID-19|0|||
150226160|NCT00603278|541963231|FG000|Overall Study|Lack of Efficacy|35|||
150226161|NCT00603278|541963232|FG001|Overall Study|Lack of Efficacy|10|||
150226162|NCT00603278|541963233|FG002|Overall Study|Lack of Efficacy|11|||
150226163|NCT00603278|541963234|FG003|Overall Study|Lack of Efficacy|8|||
150226164|NCT00603278|541963235|FG004|Overall Study|Lack of Efficacy|7|||
150226165|NCT00603278|541963236|FG005|Overall Study|Lack of Efficacy|14|||
150226166|NCT00603278|541963231|FG000|Overall Study|Adverse Event|0|||
150226167|NCT00603278|541963232|FG001|Overall Study|Adverse Event|3|||
150226168|NCT00603278|541963233|FG002|Overall Study|Adverse Event|1|||
150226169|NCT00603278|541963234|FG003|Overall Study|Adverse Event|0|||
150226170|NCT00603278|541963235|FG004|Overall Study|Adverse Event|2|||
150226171|NCT00603278|541963236|FG005|Overall Study|Adverse Event|1|||
150226172|NCT00603278|541963231|FG000|Overall Study|Withdrawal by Subject|2|||
150226173|NCT00603278|541963232|FG001|Overall Study|Withdrawal by Subject|3|||
150226174|NCT00603278|541963233|FG002|Overall Study|Withdrawal by Subject|1|||
150226175|NCT00603278|541963234|FG003|Overall Study|Withdrawal by Subject|2|||
150226176|NCT00603278|541963235|FG004|Overall Study|Withdrawal by Subject|1|||
150226177|NCT00603278|541963236|FG005|Overall Study|Withdrawal by Subject|2|||
150226178|NCT00603278|541963231|FG000|Overall Study|Protocol Violation|3|||
150226179|NCT00603278|541963232|FG001|Overall Study|Protocol Violation|0|||
150226180|NCT00603278|541963233|FG002|Overall Study|Protocol Violation|1|||
150226181|NCT00603278|541963234|FG003|Overall Study|Protocol Violation|1|||
150226182|NCT00603278|541963235|FG004|Overall Study|Protocol Violation|0|||
150226183|NCT00603278|541963236|FG005|Overall Study|Protocol Violation|1|||
150226184|NCT00603278|541963231|FG000|Overall Study|Physician Decision|0|||
150226185|NCT00603278|541963232|FG001|Overall Study|Physician Decision|1|||
150226186|NCT00603278|541963233|FG002|Overall Study|Physician Decision|0|||
150226187|NCT00603278|541963234|FG003|Overall Study|Physician Decision|0|||
150226188|NCT00603278|541963235|FG004|Overall Study|Physician Decision|2|||
150226189|NCT00603278|541963236|FG005|Overall Study|Physician Decision|1|||
150226190|NCT00603278|541963231|FG000|Overall Study|Lost to Follow-up|1|||
150226191|NCT00603278|541963232|FG001|Overall Study|Lost to Follow-up|0|||
150226192|NCT00603278|541963233|FG002|Overall Study|Lost to Follow-up|0|||
150226193|NCT00603278|541963234|FG003|Overall Study|Lost to Follow-up|0|||
150226194|NCT00603278|541963235|FG004|Overall Study|Lost to Follow-up|1|||
150226195|NCT00603278|541963236|FG005|Overall Study|Lost to Follow-up|0|||
150226196|NCT02418819|541963237|FG000|Overall Study|Adverse Event|0|||
150226197|NCT02418819|541963238|FG001|Overall Study|Adverse Event|0|||
150226198|NCT02418819|541963239|FG002|Overall Study|Adverse Event|1|||
150226199|NCT02418819|541963240|FG003|Overall Study|Adverse Event|0|||
150226200|NCT02418819|541963237|FG000|Overall Study|Lost to Follow-up|1|||
150226201|NCT02418819|541963238|FG001|Overall Study|Lost to Follow-up|0|||
150226202|NCT02418819|541963239|FG002|Overall Study|Lost to Follow-up|0|||
150226203|NCT02418819|541963240|FG003|Overall Study|Lost to Follow-up|0|||
150226204|NCT02418819|541963237|FG000|Overall Study|No longer meets eligibility criteria|0|||
150226205|NCT02418819|541963238|FG001|Overall Study|No longer meets eligibility criteria|0|||
150226206|NCT02418819|541963239|FG002|Overall Study|No longer meets eligibility criteria|1|||
150226207|NCT02418819|541963240|FG003|Overall Study|No longer meets eligibility criteria|0|||
150226208|NCT02418819|541963237|FG000|Overall Study|No longer willing to participate|0|||
150226209|NCT02418819|541963238|FG001|Overall Study|No longer willing to participate|0|||
150226210|NCT02418819|541963239|FG002|Overall Study|No longer willing to participate|2|||
150226211|NCT02418819|541963240|FG003|Overall Study|No longer willing to participate|1|||
150226212|NCT04374253|541963244|FG000|Overall Study|Adverse Event|0|||
150226213|NCT04374253|541963245|FG001|Overall Study|Adverse Event|26|||
150226214|NCT04374253|541963246|FG002|Overall Study|Adverse Event|2|||
150226215|NCT04374253|541963247|FG003|Overall Study|Adverse Event|12|||
150226216|NCT04374253|541963244|FG000|Overall Study|Study terminated by sponsor|13|||
150226217|NCT04374253|541963245|FG001|Overall Study|Study terminated by sponsor|593|||
150226218|NCT04374253|541963246|FG002|Overall Study|Study terminated by sponsor|21|||
150226219|NCT04374253|541963247|FG003|Overall Study|Study terminated by sponsor|567|||
150226220|NCT04374253|541963244|FG000|Overall Study|Withdrawal by Subject|0|||
150226221|NCT04374253|541963245|FG001|Overall Study|Withdrawal by Subject|55|||
150226222|NCT04374253|541963246|FG002|Overall Study|Withdrawal by Subject|3|||
150226223|NCT04374253|541963247|FG003|Overall Study|Withdrawal by Subject|40|||
150226224|NCT04374253|541963244|FG000|Overall Study|Physician Decision|1|||
150226225|NCT04374253|541963245|FG001|Overall Study|Physician Decision|10|||
150226226|NCT04374253|541963246|FG002|Overall Study|Physician Decision|1|||
150226227|NCT04374253|541963247|FG003|Overall Study|Physician Decision|10|||
150226228|NCT04374253|541963244|FG000|Overall Study|Protocol Violation|0|||
150226229|NCT04374253|541963245|FG001|Overall Study|Protocol Violation|0|||
150226230|NCT04374253|541963246|FG002|Overall Study|Protocol Violation|0|||
150226231|NCT04374253|541963247|FG003|Overall Study|Protocol Violation|2|||
150226232|NCT04374253|541963244|FG000|Overall Study|Death|0|||
150226233|NCT04374253|541963245|FG001|Overall Study|Death|3|||
150226234|NCT04374253|541963246|FG002|Overall Study|Death|1|||
150226235|NCT04374253|541963247|FG003|Overall Study|Death|1|||
150226236|NCT04374253|541963244|FG000|Overall Study|Lack of Efficacy|0|||
150226237|NCT04374253|541963245|FG001|Overall Study|Lack of Efficacy|0|||
150226238|NCT04374253|541963246|FG002|Overall Study|Lack of Efficacy|0|||
150226239|NCT04374253|541963247|FG003|Overall Study|Lack of Efficacy|1|||
150226240|NCT04374253|541963244|FG000|Overall Study|Lost to Follow-up|1|||
150226241|NCT04374253|541963245|FG001|Overall Study|Lost to Follow-up|1|||
150226242|NCT04374253|541963246|FG002|Overall Study|Lost to Follow-up|0|||
150226243|NCT04374253|541963247|FG003|Overall Study|Lost to Follow-up|2|||
150226244|NCT04374253|541963244|FG000|Overall Study|Reason Not Specified|0|||
150226245|NCT04374253|541963245|FG001|Overall Study|Reason Not Specified|8|||
150226246|NCT04374253|541963246|FG002|Overall Study|Reason Not Specified|0|||
150226247|NCT04374253|541963247|FG003|Overall Study|Reason Not Specified|8|||
150226248|NCT00651937|541964980|FG000|Overall Study|Withdrawal by Subject|4|||
150226249|NCT00651937|541964981|FG001|Overall Study|Withdrawal by Subject|1|||
150226250|NCT04357964|541964984|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
150226251|NCT04357964|541964985|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
150226252|NCT04357964|541964984|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
150226253|NCT04357964|541964985|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
150226254|NCT04357964|541964984|FG000|Overall Study|Adipose sample was insufficient quality|0|||
150226255|NCT04357964|541964985|FG001|Overall Study|Adipose sample was insufficient quality|1|||
150226256|NCT00733226|541964986|FG000|Overall Study|Withdrawal by Subject|1|||
150226257|NCT00733226|541964987|FG001|Overall Study|Withdrawal by Subject|0|||
150226258|NCT00733226|541964986|FG000|Overall Study|Lost to Follow-up|2|||
150226259|NCT00733226|541964987|FG001|Overall Study|Lost to Follow-up|0|||
150226260|NCT00733226|541964986|FG000|Overall Study|moved to another place|2|||
150226261|NCT00733226|541964987|FG001|Overall Study|moved to another place|0|||
150226262|NCT02561078|541964988|FG000|Overall Study|Adverse Event|5|||
150226263|NCT02561078|541964989|FG001|Overall Study|Adverse Event|2|||
150226264|NCT02561078|541964988|FG000|Overall Study|Death|2|||
150226265|NCT02561078|541964989|FG001|Overall Study|Death|1|||
150226266|NCT02561078|541964988|FG000|Overall Study|Lost to Follow-up|2|||
150226267|NCT02561078|541964989|FG001|Overall Study|Lost to Follow-up|6|||
150226268|NCT02561078|541964988|FG000|Overall Study|Non-Compliance with Study Drug|6|||
150226269|NCT02561078|541964989|FG001|Overall Study|Non-Compliance with Study Drug|3|||
150226270|NCT02561078|541964988|FG000|Overall Study|Physician Decision|2|||
150226271|NCT02561078|541964989|FG001|Overall Study|Physician Decision|3|||
150226272|NCT02561078|541964988|FG000|Overall Study|Withdrawal by Subject|13|||
150226273|NCT02561078|541964989|FG001|Overall Study|Withdrawal by Subject|10|||
150226274|NCT00043186|541964990|FG000|Overall Study|Physician Decision|0|||
150226275|NCT00043186|541964991|FG001|Overall Study|Physician Decision|0|||
150226276|NCT00043186|541964992|FG002|Overall Study|Physician Decision|3|||
150226277|NCT00043186|541964993|FG003|Overall Study|Physician Decision|0|||
150226278|NCT00043186|541964994|FG004|Overall Study|Physician Decision|1|||
150226279|NCT00043186|541964995|FG005|Overall Study|Physician Decision|0|||
150226280|NCT00043186|541964996|FG006|Overall Study|Physician Decision|0|||
150226281|NCT00043186|541964997|FG007|Overall Study|Physician Decision|1|||
150226282|NCT00043186|541964998|FG008|Overall Study|Physician Decision|1|||
150226283|NCT00043186|541964990|FG000|Overall Study|Adverse Event|2|||
150226284|NCT00043186|541964991|FG001|Overall Study|Adverse Event|2|||
150226285|NCT00043186|541964992|FG002|Overall Study|Adverse Event|2|||
150226286|NCT00043186|541964993|FG003|Overall Study|Adverse Event|3|||
150226287|NCT00043186|541964994|FG004|Overall Study|Adverse Event|2|||
150226288|NCT00043186|541964995|FG005|Overall Study|Adverse Event|1|||
150226289|NCT00043186|541964996|FG006|Overall Study|Adverse Event|2|||
150226290|NCT00043186|541964997|FG007|Overall Study|Adverse Event|1|||
150226291|NCT00043186|541964998|FG008|Overall Study|Adverse Event|3|||
150226292|NCT00043186|541964990|FG000|Overall Study|Withdrawal by Subject|11|||
150226293|NCT00043186|541964991|FG001|Overall Study|Withdrawal by Subject|8|||
150226294|NCT00043186|541964992|FG002|Overall Study|Withdrawal by Subject|11|||
150226295|NCT00043186|541964993|FG003|Overall Study|Withdrawal by Subject|13|||
150226296|NCT00043186|541964994|FG004|Overall Study|Withdrawal by Subject|14|||
150226297|NCT00043186|541964995|FG005|Overall Study|Withdrawal by Subject|6|||
150226298|NCT00043186|541964996|FG006|Overall Study|Withdrawal by Subject|12|||
150226299|NCT00043186|541964997|FG007|Overall Study|Withdrawal by Subject|9|||
150226300|NCT00043186|541964998|FG008|Overall Study|Withdrawal by Subject|10|||
150226301|NCT00043186|541964990|FG000|Overall Study|Death|0|||
150226302|NCT00043186|541964991|FG001|Overall Study|Death|0|||
150226303|NCT00043186|541964992|FG002|Overall Study|Death|1|||
150226304|NCT00043186|541964993|FG003|Overall Study|Death|0|||
150226305|NCT00043186|541964994|FG004|Overall Study|Death|0|||
150226306|NCT00043186|541964995|FG005|Overall Study|Death|0|||
150226307|NCT00043186|541964996|FG006|Overall Study|Death|2|||
150226308|NCT00043186|541964997|FG007|Overall Study|Death|0|||
150226309|NCT00043186|541964998|FG008|Overall Study|Death|0|||
150226310|NCT00043186|541964990|FG000|Overall Study|Disease progression|1|||
150226311|NCT00043186|541964991|FG001|Overall Study|Disease progression|0|||
150226312|NCT00043186|541964992|FG002|Overall Study|Disease progression|0|||
150226313|NCT00043186|541964993|FG003|Overall Study|Disease progression|3|||
150226314|NCT00043186|541964994|FG004|Overall Study|Disease progression|0|||
150226315|NCT00043186|541964995|FG005|Overall Study|Disease progression|0|||
150226316|NCT00043186|541964996|FG006|Overall Study|Disease progression|0|||
150226317|NCT00043186|541964997|FG007|Overall Study|Disease progression|4|||
150226318|NCT00043186|541964998|FG008|Overall Study|Disease progression|0|||
150226319|NCT00043186|541964990|FG000|Overall Study|Ineligibility determined|0|||
150226320|NCT00043186|541964991|FG001|Overall Study|Ineligibility determined|0|||
150226321|NCT00043186|541964992|FG002|Overall Study|Ineligibility determined|0|||
150226322|NCT00043186|541964993|FG003|Overall Study|Ineligibility determined|0|||
150226323|NCT00043186|541964994|FG004|Overall Study|Ineligibility determined|0|||
150226324|NCT00043186|541964995|FG005|Overall Study|Ineligibility determined|0|||
150226325|NCT00043186|541964996|FG006|Overall Study|Ineligibility determined|0|||
150226326|NCT00043186|541964997|FG007|Overall Study|Ineligibility determined|0|||
150226327|NCT00043186|541964998|FG008|Overall Study|Ineligibility determined|1|||
150226328|NCT00043186|541964990|FG000|Overall Study|Lost to Follow-up|3|||
150226329|NCT00043186|541964991|FG001|Overall Study|Lost to Follow-up|5|||
150226330|NCT00043186|541964992|FG002|Overall Study|Lost to Follow-up|1|||
150226331|NCT00043186|541964993|FG003|Overall Study|Lost to Follow-up|1|||
150226332|NCT00043186|541964994|FG004|Overall Study|Lost to Follow-up|1|||
150226333|NCT00043186|541964995|FG005|Overall Study|Lost to Follow-up|1|||
150226334|NCT00043186|541964996|FG006|Overall Study|Lost to Follow-up|1|||
150226335|NCT00043186|541964997|FG007|Overall Study|Lost to Follow-up|1|||
150226336|NCT00043186|541964998|FG008|Overall Study|Lost to Follow-up|2|||
150226337|NCT00043186|541964990|FG000|Overall Study|Noncompliance|0|||
150226338|NCT00043186|541964991|FG001|Overall Study|Noncompliance|0|||
150226339|NCT00043186|541964992|FG002|Overall Study|Noncompliance|1|||
150226340|NCT00043186|541964993|FG003|Overall Study|Noncompliance|1|||
150226341|NCT00043186|541964994|FG004|Overall Study|Noncompliance|0|||
150226342|NCT00043186|541964995|FG005|Overall Study|Noncompliance|0|||
150226343|NCT00043186|541964996|FG006|Overall Study|Noncompliance|0|||
150226344|NCT00043186|541964997|FG007|Overall Study|Noncompliance|0|||
150226345|NCT00043186|541964998|FG008|Overall Study|Noncompliance|0|||
150226346|NCT00043186|541964990|FG000|Overall Study|Other|0|||
150226347|NCT00043186|541964991|FG001|Overall Study|Other|0|||
150226348|NCT00043186|541964992|FG002|Overall Study|Other|1|||
150226349|NCT00043186|541964993|FG003|Overall Study|Other|1|||
150226350|NCT00043186|541964994|FG004|Overall Study|Other|0|||
150226351|NCT00043186|541964995|FG005|Overall Study|Other|0|||
150226352|NCT00043186|541964996|FG006|Overall Study|Other|0|||
150226353|NCT00043186|541964997|FG007|Overall Study|Other|0|||
150226354|NCT00043186|541964998|FG008|Overall Study|Other|0|||
150226355|NCT00726388|541965004|FG000|Overall Study|Withdrawal by Subject|5|||
150226356|NCT00726388|541965004|FG000|Overall Study|Adverse Event|3|||
150226357|NCT00726388|541965004|FG000|Overall Study|Lost to Follow-up|10|||
150226358|NCT00726388|541965004|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
150226359|NCT00726388|541965004|FG000|Overall Study|Other|5|||
150226360|NCT00726388|541965004|FG000|Overall Study|Enrolled, Not Treated|79|||
150226361|NCT00382408|541965008|FG000|Overall Study|Did not meet protocol requirement|3|||
150226362|NCT00382408|541965009|FG001|Overall Study|Did not meet protocol requirement|3|||
150226363|NCT00382408|541965008|FG000|Overall Study|Protocol Violation|2|||
150226364|NCT00382408|541965009|FG001|Overall Study|Protocol Violation|2|||
150226365|NCT00382408|541965008|FG000|Overall Study|Physician Decision|1|||
150226366|NCT00382408|541965009|FG001|Overall Study|Physician Decision|0|||
150226367|NCT00382408|541965008|FG000|Overall Study|Withdrawal by Subject|17|||
150226368|NCT00382408|541965009|FG001|Overall Study|Withdrawal by Subject|6|||
150226369|NCT00382408|541965008|FG000|Overall Study|Pregnancy|2|||
150226370|NCT00382408|541965009|FG001|Overall Study|Pregnancy|0|||
150226371|NCT00382408|541965008|FG000|Overall Study|Lost to Follow-up|19|||
150226372|NCT00382408|541965009|FG001|Overall Study|Lost to Follow-up|8|||
150226373|NCT00382408|541965008|FG000|Overall Study|Other|100|||
150226374|NCT00382408|541965009|FG001|Overall Study|Other|35|||
150226375|NCT01145417|541965010|FG000|Overall Study|Death|1|||
150226376|NCT01145417|541965011|FG001|Overall Study|Death|0|||
150226377|NCT01145417|541965010|FG000|Overall Study|Lost to Follow-up|2|||
150226378|NCT01145417|541965011|FG001|Overall Study|Lost to Follow-up|1|||
150226379|NCT01145417|541965010|FG000|Overall Study|Withdrawal by Subject|1|||
150226380|NCT01145417|541965011|FG001|Overall Study|Withdrawal by Subject|2|||
150226381|NCT01145417|541965010|FG000|Overall Study|Pregnancy|1|||
150226382|NCT01145417|541965011|FG001|Overall Study|Pregnancy|0|||
150226383|NCT01145417|541965010|FG000|Overall Study|Adverse Event|0|||
150226384|NCT01145417|541965011|FG001|Overall Study|Adverse Event|1|||
150226385|NCT01145417|541965010|FG000|Overall Study|Study terminated by sponsor|35|||
150226386|NCT01145417|541965011|FG001|Overall Study|Study terminated by sponsor|43|||
150226387|NCT01145417|541965010|FG000|Overall Study|Other|1|||
150226388|NCT01145417|541965011|FG001|Overall Study|Other|0|||
150226389|NCT01116440|541965016|FG000|Treatment|Withdrawal by Subject|2|||
150226390|NCT01116440|541965017|FG001|Treatment|Withdrawal by Subject|2|||
150226391|NCT01116440|541965016|FG000|Treatment|Lost to Follow-up|1|||
150226392|NCT01116440|541965017|FG001|Treatment|Lost to Follow-up|1|||
150226393|NCT01116440|541965016|FG000|Treatment|Protocol Violation|0|||
150226394|NCT01116440|541965017|FG001|Treatment|Protocol Violation|2|||
150226395|NCT01116440|541965016|FG000|Treatment|Lack of Efficacy|0|||
150226396|NCT01116440|541965017|FG001|Treatment|Lack of Efficacy|1|||
150226397|NCT01116440|541965016|FG000|Treatment|Adverse Event|0|||
150226398|NCT01116440|541965017|FG001|Treatment|Adverse Event|1|||
150226399|NCT01116440|541965016|FG000|Withdrawal|Withdrawal by Subject|0|||
150226400|NCT01116440|541965017|FG001|Withdrawal|Withdrawal by Subject|1|||
150226401|NCT01116440|541965016|FG000|Withdrawal|Lost to Follow-up|0|||
150226402|NCT01116440|541965017|FG001|Withdrawal|Lost to Follow-up|1|||
150226403|NCT01116440|541965016|FG000|Follow-up|Lost to Follow-up|0|||
150226404|NCT01116440|541965017|FG001|Follow-up|Lost to Follow-up|1|||
150226405|NCT01116440|541965016|FG000|Follow-up|Withdrawal by Subject|0|||
150226406|NCT01116440|541965017|FG001|Follow-up|Withdrawal by Subject|1|||
150226407|NCT05012397|541965028|FG000|Overall Study|Death|10|||
150226408|NCT05012397|541965028|FG000|Overall Study|Physician Decision|9|||
150226409|NCT05012397|541965028|FG000|Overall Study|Withdrawal by Subject|5|||
150226410|NCT05012397|541965028|FG000|Overall Study|Lost to Follow-up|2|||
150226411|NCT03334747|541965029|FG000|Treatment Phase|Technical problems|0|||
150226412|NCT03334747|541965030|FG001|Treatment Phase|Technical problems|0|||
150226413|NCT03334747|541965031|FG002|Treatment Phase|Technical problems|0|||
150226414|NCT03334747|541965032|FG003|Treatment Phase|Technical problems|0|||
150226415|NCT03334747|541965033|FG004|Treatment Phase|Technical problems|1|||
150226416|NCT03334747|541965034|FG005|Treatment Phase|Technical problems|0|||
150226417|NCT03334747|541965035|FG006|Treatment Phase|Technical problems|0|||
150226418|NCT03334747|541965036|FG007|Treatment Phase|Technical problems|0|||
150226419|NCT03334747|541965037|FG008|Treatment Phase|Technical problems|0|||
150226420|NCT03334747|541965029|FG000|Treatment Phase|Subject/guardian decision|1|||
150226421|NCT03334747|541965030|FG001|Treatment Phase|Subject/guardian decision|0|||
150226422|NCT03334747|541965031|FG002|Treatment Phase|Subject/guardian decision|0|||
150226423|NCT03334747|541965032|FG003|Treatment Phase|Subject/guardian decision|0|||
150226424|NCT03334747|541965033|FG004|Treatment Phase|Subject/guardian decision|0|||
150226425|NCT03334747|541965034|FG005|Treatment Phase|Subject/guardian decision|1|||
150226426|NCT03334747|541965035|FG006|Treatment Phase|Subject/guardian decision|0|||
150226427|NCT03334747|541965036|FG007|Treatment Phase|Subject/guardian decision|0|||
150226428|NCT03334747|541965037|FG008|Treatment Phase|Subject/guardian decision|0|||
150226429|NCT03334747|541965029|FG000|Follow-Up Phase|Subject/guardian decision|0|||
150226430|NCT03334747|541965030|FG001|Follow-Up Phase|Subject/guardian decision|0|||
150226431|NCT03334747|541965031|FG002|Follow-Up Phase|Subject/guardian decision|0|||
150226432|NCT03334747|541965032|FG003|Follow-Up Phase|Subject/guardian decision|0|||
150226433|NCT03334747|541965033|FG004|Follow-Up Phase|Subject/guardian decision|0|||
150226434|NCT03334747|541965034|FG005|Follow-Up Phase|Subject/guardian decision|0|||
150226435|NCT03334747|541965035|FG006|Follow-Up Phase|Subject/guardian decision|1|||
150226436|NCT03334747|541965036|FG007|Follow-Up Phase|Subject/guardian decision|0|||
150226437|NCT03334747|541965037|FG008|Follow-Up Phase|Subject/guardian decision|1|||
150226438|NCT03303521|541965044|FG000|Overall Study|Withdrawal by Subject|2|||
150226439|NCT03303521|541965045|FG001|Overall Study|Withdrawal by Subject|0|||
150226440|NCT03303521|541965044|FG000|Overall Study|Death|1|||
150226441|NCT03303521|541965045|FG001|Overall Study|Death|0|||
150226442|NCT03303521|541965044|FG000|Overall Study|Kidney transplantation|0|||
150226443|NCT03303521|541965045|FG001|Overall Study|Kidney transplantation|1|||
150226444|NCT03303521|541965044|FG000|Overall Study|Investigational product discontinuation|0|||
150226445|NCT03303521|541965045|FG001|Overall Study|Investigational product discontinuation|1|||
150226446|NCT03303521|541965044|FG000|Overall Study|Transferred to non-study dialysis center|1|||
150226447|NCT03303521|541965045|FG001|Overall Study|Transferred to non-study dialysis center|0|||
150226448|NCT03303521|541965044|FG000|Overall Study|Non-comliance to study protocol|0|||
150226449|NCT03303521|541965045|FG001|Overall Study|Non-comliance to study protocol|1|||
150226450|NCT03303521|541965044|FG000|Overall Study|Adverse Event|1|||
150226451|NCT03303521|541965045|FG001|Overall Study|Adverse Event|0|||
150226452|NCT00191984|541965046|FG000|Overall Study|Disease Progression|21|||
150226453|NCT00191984|541965046|FG000|Overall Study|Adverse Event|4|||
150226454|NCT00191984|541965046|FG000|Overall Study|Death|2|||
150226455|NCT00191984|541965046|FG000|Overall Study|Entry Criteria Exclusion|1|||
150226456|NCT00191984|541965046|FG000|Overall Study|Withdrawal by Subject|7|||
150226457|NCT00191984|541965046|FG000|Overall Study|Physician Decision|4|||
150226458|NCT00005908|541965049|FG000|Overall Study|Withdrawal by Subject|1|||
150226459|NCT00005908|541965050|FG001|Overall Study|Withdrawal by Subject|0|||
150226460|NCT01536535|541965056|FG000|Overall Study|Withdrawal by Subject|10|||
150226461|NCT01536535|541965057|FG001|Overall Study|Withdrawal by Subject|5|||
150226462|NCT01536535|541965056|FG000|Overall Study|Lost to Follow-up|4|||
150226463|NCT01536535|541965057|FG001|Overall Study|Lost to Follow-up|6|||
150226464|NCT01536535|541965056|FG000|Overall Study|Physician Decision|1|||
150226465|NCT01536535|541965057|FG001|Overall Study|Physician Decision|1|||
150226466|NCT01536535|541965056|FG000|Overall Study|Participant moved|0|||
150226467|NCT01536535|541965057|FG001|Overall Study|Participant moved|1|||
150226468|NCT00404547|541965059|FG000|Overall Study|Adverse Event|39|||
150226469|NCT00404547|541965060|FG001|Overall Study|Adverse Event|6|||
150226470|NCT00404547|541965059|FG000|Overall Study|Withdrawal by Subject|19|||
150226471|NCT00404547|541965060|FG001|Overall Study|Withdrawal by Subject|2|||
150226472|NCT00404547|541965059|FG000|Overall Study|Protocol Violation|0|||
150226473|NCT00404547|541965060|FG001|Overall Study|Protocol Violation|1|||
150226474|NCT00404547|541965059|FG000|Overall Study|Lost to Follow-up|20|||
150226475|NCT00404547|541965060|FG001|Overall Study|Lost to Follow-up|9|||
150226476|NCT00404547|541965059|FG000|Overall Study|Lack of compliance|5|||
150226477|NCT00404547|541965060|FG001|Overall Study|Lack of compliance|1|||
150226478|NCT00404547|541965059|FG000|Overall Study|Other|4|||
150226479|NCT00404547|541965060|FG001|Overall Study|Other|0|||
150226480|NCT00404547|541965059|FG000|Overall Study|Reason not stated|3|||
150226481|NCT00404547|541965060|FG001|Overall Study|Reason not stated|6|||
150226482|NCT00679549|541965061|FG000|Overall Study|dropout|2|||
150226483|NCT00679549|541965062|FG001|Overall Study|dropout|4|||
150226484|NCT00679549|541965061|FG000|Overall Study|missing outcome echocardiograms|4|||
150226485|NCT00679549|541965062|FG001|Overall Study|missing outcome echocardiograms|5|||
150226486|NCT02350127|541965068|FG000|4-Month Assessment|Withdrawal by Subject|10|||
150226487|NCT02350127|541965069|FG001|4-Month Assessment|Withdrawal by Subject|9|||
150226488|NCT02350127|541965068|FG000|4-Month Assessment|Death|1|||
150226489|NCT02350127|541965069|FG001|4-Month Assessment|Death|0|||
150226490|NCT02350127|541965068|FG000|8-Month Assessment|Death|1|||
150226491|NCT02350127|541965069|FG001|8-Month Assessment|Death|1|||
150226492|NCT02350127|541965068|FG000|8-Month Assessment|Withdrawal by Subject|5|||
150226493|NCT02350127|541965069|FG001|8-Month Assessment|Withdrawal by Subject|8|||
150226494|NCT03048058|541965070|FG000|Overall Study|Lost to Follow-up|4|||
150226495|NCT03048058|541965071|FG001|Overall Study|Lost to Follow-up|0|||
150226496|NCT03048058|541965070|FG000|Overall Study|Withdrawal by Subject|0|||
150226497|NCT03048058|541965071|FG001|Overall Study|Withdrawal by Subject|4|||
150226498|NCT02038803|541965072|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
150226499|NCT02038803|541965072|FG000|Overall Study|Lost to Follow-up|1|||
150226500|NCT04754594|541965073|FG000|Blinded Period|Withdrawal by Subject|4|||
150226501|NCT04754594|541965074|FG001|Blinded Period|Withdrawal by Subject|9|||
150226502|NCT04754594|541965075|FG002|Blinded Period|Withdrawal by Subject|0|||
150226503|NCT04754594|541965076|FG003|Blinded Period|Withdrawal by Subject|0|||
150226504|NCT04754594|541965073|FG000|Blinded Period|Protocol Violation|2|||
150226505|NCT04754594|541965074|FG001|Blinded Period|Protocol Violation|2|||
150226506|NCT04754594|541965075|FG002|Blinded Period|Protocol Violation|0|||
150226507|NCT04754594|541965076|FG003|Blinded Period|Protocol Violation|0|||
150226508|NCT04754594|541965073|FG000|Blinded Period|Lost to Follow-up|1|||
150226509|NCT04754594|541965074|FG001|Blinded Period|Lost to Follow-up|1|||
150226510|NCT04754594|541965075|FG002|Blinded Period|Lost to Follow-up|0|||
150226511|NCT04754594|541965076|FG003|Blinded Period|Lost to Follow-up|0|||
150226512|NCT04754594|541965073|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
150226513|NCT04754594|541965074|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
150226514|NCT04754594|541965075|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
150226515|NCT04754594|541965076|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
150226516|NCT04754594|541965073|FG000|Unblinded Period|Withdrawal by Subject|6|||
150226517|NCT04754594|541965074|FG001|Unblinded Period|Withdrawal by Subject|8|||
150226518|NCT04754594|541965075|FG002|Unblinded Period|Withdrawal by Subject|0|||
150226519|NCT04754594|541965076|FG003|Unblinded Period|Withdrawal by Subject|0|||
150226520|NCT04754594|541965073|FG000|Unblinded Period|Lost to Follow-up|5|||
150226521|NCT04754594|541965074|FG001|Unblinded Period|Lost to Follow-up|3|||
150226522|NCT04754594|541965075|FG002|Unblinded Period|Lost to Follow-up|0|||
150226523|NCT04754594|541965076|FG003|Unblinded Period|Lost to Follow-up|0|||
150226524|NCT04754594|541965073|FG000|Unblinded Period|Protocol Violation|2|||
150226525|NCT04754594|541965074|FG001|Unblinded Period|Protocol Violation|4|||
150226526|NCT04754594|541965075|FG002|Unblinded Period|Protocol Violation|0|||
150226527|NCT04754594|541965076|FG003|Unblinded Period|Protocol Violation|0|||
150226528|NCT04754594|541965073|FG000|Unblinded Period|Other|3|||
150226529|NCT04754594|541965074|FG001|Unblinded Period|Other|0|||
150226530|NCT04754594|541965075|FG002|Unblinded Period|Other|0|||
150226531|NCT04754594|541965076|FG003|Unblinded Period|Other|0|||
150226532|NCT04754594|541965073|FG000|Infant Participants|Withdrawal by Subject|0|||
150226533|NCT04754594|541965074|FG001|Infant Participants|Withdrawal by Subject|0|||
150226534|NCT04754594|541965075|FG002|Infant Participants|Withdrawal by Subject|9|||
150226535|NCT04754594|541965076|FG003|Infant Participants|Withdrawal by Subject|17|||
150226536|NCT04754594|541965073|FG000|Infant Participants|Lost to Follow-up|0|||
150226537|NCT04754594|541965074|FG001|Infant Participants|Lost to Follow-up|0|||
150226538|NCT04754594|541965075|FG002|Infant Participants|Lost to Follow-up|4|||
150226539|NCT04754594|541965076|FG003|Infant Participants|Lost to Follow-up|10|||
150226540|NCT04754594|541965073|FG000|Infant Participants|Death|0|||
150226541|NCT04754594|541965074|FG001|Infant Participants|Death|0|||
150226542|NCT04754594|541965075|FG002|Infant Participants|Death|1|||
150226543|NCT04754594|541965076|FG003|Infant Participants|Death|1|||
150226544|NCT04754594|541965073|FG000|Infant Participants|Other|0|||
150226545|NCT04754594|541965074|FG001|Infant Participants|Other|0|||
150226546|NCT04754594|541965075|FG002|Infant Participants|Other|1|||
150226547|NCT04754594|541965076|FG003|Infant Participants|Other|1|||
150226548|NCT01247922|541965077|FG000|Overall Study|Disease progression|4|||
150226549|NCT02588027|541965078|FG000|Overall Study|Withdrawal by Subject|1|||
150226550|NCT02588027|541965079|FG001|Overall Study|Withdrawal by Subject|3|||
150226551|NCT02588027|541965078|FG000|Overall Study|Protocol Violation|4|||
150226552|NCT02588027|541965079|FG001|Overall Study|Protocol Violation|1|||
150226553|NCT04736472|541965080|FG000|Overall Study|Lost to Follow-up|1|||
150226554|NCT04736472|541965081|FG001|Overall Study|Lost to Follow-up|0|||
150226555|NCT04736472|541965082|FG002|Overall Study|Lost to Follow-up|0|||
150226556|NCT04736472|541965080|FG000|Overall Study|Withdrawal by Subject|2|||
150226557|NCT04736472|541965081|FG001|Overall Study|Withdrawal by Subject|0|||
150226558|NCT04736472|541965082|FG002|Overall Study|Withdrawal by Subject|0|||
150226559|NCT04736472|541965080|FG000|Overall Study|Protocol Violation|48|||
150226560|NCT04736472|541965081|FG001|Overall Study|Protocol Violation|0|||
150226561|NCT04736472|541965082|FG002|Overall Study|Protocol Violation|6|||
150226562|NCT02116582|541965083|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
150226563|NCT02116582|541965083|FG000|Overall Study|Adverse Event|22|||
150226564|NCT02116582|541965083|FG000|Overall Study|Death|9|||
150226565|NCT02116582|541965083|FG000|Overall Study|Progressive Disease|148|||
150226566|NCT02116582|541965083|FG000|Overall Study|Protocol Violation|3|||
150226567|NCT02116582|541965083|FG000|Overall Study|Withdrawal by Subject|8|||
150226568|NCT02116582|541965083|FG000|Overall Study|Other: Miscellaneous|11|||
150226569|NCT02116582|541965083|FG000|Overall Study|Lost to Follow-up|1|||
150226570|NCT02116582|541965083|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
150226571|NCT01876823|541965084|FG000|Overall Study|Withdrawal by Subject|5|||
150226572|NCT01876823|541965084|FG000|Overall Study|Physician Decision|2|||
150226573|NCT01876823|541965084|FG000|Overall Study|Patients moved|2|||
150226574|NCT02256488|541965085|FG000|Overall Study|Lost to Follow-up|6|||
150226575|NCT02256488|541965086|FG001|Overall Study|Lost to Follow-up|6|||
150226576|NCT02256488|541965087|FG002|Overall Study|Lost to Follow-up|9|||
150226577|NCT02256488|541965088|FG003|Overall Study|Lost to Follow-up|3|||
150226578|NCT02256488|541965085|FG000|Overall Study|OTHER|1|||
150226579|NCT02256488|541965086|FG001|Overall Study|OTHER|0|||
150226580|NCT02256488|541965087|FG002|Overall Study|OTHER|1|||
150226581|NCT02256488|541965088|FG003|Overall Study|OTHER|1|||
150226582|NCT02256488|541965085|FG000|Overall Study|Withdrawal by Subject|1|||
150226583|NCT02256488|541965086|FG001|Overall Study|Withdrawal by Subject|0|||
150226584|NCT02256488|541965087|FG002|Overall Study|Withdrawal by Subject|0|||
150226585|NCT02256488|541965088|FG003|Overall Study|Withdrawal by Subject|2|||
150226586|NCT00975130|541965089|FG000|Study Part 1|Adverse Event|150|||
150226587|NCT00975130|541965090|FG001|Study Part 1|Adverse Event|0|||
150226588|NCT00975130|541965091|FG002|Study Part 1|Adverse Event|0|||
150226589|NCT00975130|541965089|FG000|Study Part 1|Lost to Follow-up|19|||
150226590|NCT00975130|541965090|FG001|Study Part 1|Lost to Follow-up|0|||
150226591|NCT00975130|541965091|FG002|Study Part 1|Lost to Follow-up|0|||
150226592|NCT00975130|541965089|FG000|Study Part 1|Withdrawal by Subject|61|||
150226593|NCT00975130|541965090|FG001|Study Part 1|Withdrawal by Subject|0|||
150226594|NCT00975130|541965091|FG002|Study Part 1|Withdrawal by Subject|0|||
150226595|NCT00975130|541965089|FG000|Study Part 1|Protocol Violation|13|||
150226596|NCT00975130|541965090|FG001|Study Part 1|Protocol Violation|0|||
150226597|NCT00975130|541965091|FG002|Study Part 1|Protocol Violation|0|||
150226598|NCT00975130|541965089|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
150226599|NCT00975130|541965090|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
150226600|NCT00975130|541965091|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
150226601|NCT00975130|541965089|FG000|Study Part 1|Administrative|4|||
150226602|NCT00975130|541965090|FG001|Study Part 1|Administrative|0|||
150226603|NCT00975130|541965091|FG002|Study Part 1|Administrative|0|||
150226604|NCT00975130|541965089|FG000|Study Part 1|Withdrew Consent|24|||
150226605|NCT00975130|541965090|FG001|Study Part 1|Withdrew Consent|0|||
150226606|NCT00975130|541965091|FG002|Study Part 1|Withdrew Consent|0|||
150226607|NCT00975130|541965089|FG000|Study Part 2|Adverse Event|0|||
150226608|NCT00975130|541965090|FG001|Study Part 2|Adverse Event|14|||
150226609|NCT00975130|541965091|FG002|Study Part 2|Adverse Event|7|||
150226610|NCT00975130|541965089|FG000|Study Part 2|Lost to Follow-up|0|||
150226611|NCT00975130|541965090|FG001|Study Part 2|Lost to Follow-up|0|||
150226612|NCT00975130|541965091|FG002|Study Part 2|Lost to Follow-up|1|||
150226613|NCT00975130|541965089|FG000|Study Part 2|Withdrawal by Subject|0|||
150226614|NCT00975130|541965090|FG001|Study Part 2|Withdrawal by Subject|13|||
150226615|NCT00975130|541965091|FG002|Study Part 2|Withdrawal by Subject|5|||
150226616|NCT00975130|541965089|FG000|Study Part 2|Withdrew Consent|0|||
150226617|NCT00975130|541965090|FG001|Study Part 2|Withdrew Consent|6|||
150226618|NCT00975130|541965091|FG002|Study Part 2|Withdrew Consent|2|||
150226619|NCT00975130|541965089|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
150226620|NCT00975130|541965090|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
150226621|NCT00975130|541965091|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
150226622|NCT00975130|541965089|FG000|Study Part 2|Administrative|0|||
150226623|NCT00975130|541965090|FG001|Study Part 2|Administrative|1|||
150226624|NCT00975130|541965091|FG002|Study Part 2|Administrative|0|||
150226625|NCT00975130|541965089|FG000|Study Part 2|Protocol Violation|0|||
150226626|NCT00975130|541965090|FG001|Study Part 2|Protocol Violation|0|||
150226627|NCT00975130|541965091|FG002|Study Part 2|Protocol Violation|1|||
150226628|NCT02268526|541965092|FG000|Overall Study|Adverse Event|0|||
150226629|NCT02268526|541965093|FG001|Overall Study|Adverse Event|2|||
150226630|NCT02268526|541965094|FG002|Overall Study|Adverse Event|1|||
150226631|NCT02268526|541965092|FG000|Overall Study|Death|1|||
150226632|NCT02268526|541965093|FG001|Overall Study|Death|11|||
150226633|NCT02268526|541965094|FG002|Overall Study|Death|0|||
150226634|NCT02268526|541965092|FG000|Overall Study|protocol deviation|0|||
150226635|NCT02268526|541965093|FG001|Overall Study|protocol deviation|1|||
150226636|NCT02268526|541965094|FG002|Overall Study|protocol deviation|0|||
150226637|NCT02268526|541965092|FG000|Overall Study|Physician Decision|0|||
150226638|NCT02268526|541965093|FG001|Overall Study|Physician Decision|0|||
150226639|NCT02268526|541965094|FG002|Overall Study|Physician Decision|1|||
150226640|NCT02268526|541965092|FG000|Overall Study|Subject/guardian decision|0|||
150226641|NCT02268526|541965093|FG001|Overall Study|Subject/guardian decision|7|||
150226642|NCT02268526|541965094|FG002|Overall Study|Subject/guardian decision|3|||
150226643|NCT01261793|541965095|FG000|Overall Study|Lack of Efficacy|44|||
150226644|NCT01261793|541965096|FG001|Overall Study|Lack of Efficacy|37|||
150226645|NCT01261793|541965097|FG002|Overall Study|Lack of Efficacy|32|||
150226646|NCT01261793|541965095|FG000|Overall Study|Protocol Violation|3|||
150226647|NCT01261793|541965096|FG001|Overall Study|Protocol Violation|5|||
150226648|NCT01261793|541965097|FG002|Overall Study|Protocol Violation|6|||
150226649|NCT01261793|541965095|FG000|Overall Study|Lost to Follow-up|10|||
150226650|NCT01261793|541965096|FG001|Overall Study|Lost to Follow-up|3|||
150226651|NCT01261793|541965097|FG002|Overall Study|Lost to Follow-up|7|||
150226652|NCT01261793|541965095|FG000|Overall Study|Withdrawal by Subject|12|||
150226653|NCT01261793|541965096|FG001|Overall Study|Withdrawal by Subject|14|||
150226654|NCT01261793|541965097|FG002|Overall Study|Withdrawal by Subject|14|||
150226655|NCT01261793|541965095|FG000|Overall Study|Death|3|||
150226656|NCT01261793|541965096|FG001|Overall Study|Death|1|||
150226657|NCT01261793|541965097|FG002|Overall Study|Death|0|||
150226658|NCT01261793|541965095|FG000|Overall Study|Adverse Event|9|||
150226659|NCT01261793|541965096|FG001|Overall Study|Adverse Event|24|||
150226660|NCT01261793|541965097|FG002|Overall Study|Adverse Event|19|||
150226661|NCT01261793|541965095|FG000|Overall Study|Patient non-availability|1|||
150226662|NCT01261793|541965096|FG001|Overall Study|Patient non-availability|1|||
150226663|NCT01261793|541965097|FG002|Overall Study|Patient non-availability|1|||
150226664|NCT01261793|541965095|FG000|Overall Study|Suspected pregnancy|1|||
150226665|NCT01261793|541965096|FG001|Overall Study|Suspected pregnancy|1|||
150226666|NCT01261793|541965097|FG002|Overall Study|Suspected pregnancy|0|||
150226667|NCT01261793|541965095|FG000|Overall Study|Patient non-compliance|1|||
150226668|NCT01261793|541965096|FG001|Overall Study|Patient non-compliance|0|||
150226669|NCT01261793|541965097|FG002|Overall Study|Patient non-compliance|1|||
150226670|NCT01261793|541965095|FG000|Overall Study|Patient pregnant|1|||
150226671|NCT01261793|541965096|FG001|Overall Study|Patient pregnant|0|||
150226672|NCT01261793|541965097|FG002|Overall Study|Patient pregnant|0|||
150226673|NCT01261793|541965095|FG000|Overall Study|Outside the study area|0|||
150226674|NCT01261793|541965096|FG001|Overall Study|Outside the study area|2|||
150226675|NCT01261793|541965097|FG002|Overall Study|Outside the study area|1|||
150226676|NCT01261793|541965095|FG000|Overall Study|Lack of efficacy & patient not available|0|||
150226677|NCT01261793|541965096|FG001|Overall Study|Lack of efficacy & patient not available|1|||
150226678|NCT01261793|541965097|FG002|Overall Study|Lack of efficacy & patient not available|0|||
150226679|NCT01261793|541965095|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
150226680|NCT01261793|541965096|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
150226681|NCT01261793|541965097|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
150226682|NCT01261793|541965095|FG000|Overall Study|Randomization error|0|||
150226683|NCT01261793|541965096|FG001|Overall Study|Randomization error|1|||
150226684|NCT01261793|541965097|FG002|Overall Study|Randomization error|0|||
150226685|NCT01261793|541965095|FG000|Overall Study|Patient unable to start IV line|0|||
150226686|NCT01261793|541965096|FG001|Overall Study|Patient unable to start IV line|0|||
150226687|NCT01261793|541965097|FG002|Overall Study|Patient unable to start IV line|1|||
150226688|NCT01207453|541965100|FG000|First Intervention|Adverse Event|2|||
150226689|NCT01207453|541965101|FG001|First Intervention|Adverse Event|1|||
150226690|NCT01207453|541965100|FG000|Washout|Adverse Event|1|||
150226691|NCT01207453|541965101|FG001|Washout|Adverse Event|0|||
150226692|NCT01207453|541965100|FG000|Washout|Lost to Follow-up|1|||
150226693|NCT01207453|541965101|FG001|Washout|Lost to Follow-up|0|||
150226694|NCT01207453|541965100|FG000|2nd Intervention|Adverse Event|1|||
150226695|NCT01207453|541965101|FG001|2nd Intervention|Adverse Event|2|||
150226696|NCT01207453|541965100|FG000|2nd Intervention|Lost to Follow-up|1|||
150226697|NCT01207453|541965101|FG001|2nd Intervention|Lost to Follow-up|0|||
150226698|NCT00676663|541965102|FG000|Overall Study|Death|43|||
150226699|NCT00676663|541965103|FG001|Overall Study|Death|27|||
150226700|NCT00676663|541965102|FG000|Overall Study|Withdrew Consent|1|||
150226701|NCT00676663|541965103|FG001|Overall Study|Withdrew Consent|8|||
150226702|NCT00676663|541965102|FG000|Overall Study|Lost to Follow-up|1|||
150226703|NCT00676663|541965103|FG001|Overall Study|Lost to Follow-up|3|||
150226704|NCT01399905|541965111|FG000|Overall Study|Withdrawal by Subject|1|||
150226705|NCT01399905|541965112|FG001|Overall Study|Withdrawal by Subject|1|||
150226706|NCT01524887|541965120|FG000|Overall Study|Withdrawal by Subject|6|||
150226707|NCT01524887|541965121|FG001|Overall Study|Withdrawal by Subject|2|||
150226708|NCT01524887|541965122|FG002|Overall Study|Withdrawal by Subject|3|||
150226709|NCT01524887|541965120|FG000|Overall Study|Adverse Event|5|||
150226710|NCT01524887|541965121|FG001|Overall Study|Adverse Event|1|||
150226711|NCT01524887|541965122|FG002|Overall Study|Adverse Event|1|||
150226712|NCT01524887|541965120|FG000|Overall Study|Protocol Violation|0|||
150226713|NCT01524887|541965121|FG001|Overall Study|Protocol Violation|0|||
150226714|NCT01524887|541965122|FG002|Overall Study|Protocol Violation|1|||
150226715|NCT01524887|541965120|FG000|Overall Study|Study termination|73|||
150226716|NCT01524887|541965121|FG001|Overall Study|Study termination|87|||
150226717|NCT01524887|541965122|FG002|Overall Study|Study termination|79|||
150226718|NCT01524887|541965120|FG000|Overall Study|Withdrawal by Caregiver|0|||
150226719|NCT01524887|541965121|FG001|Overall Study|Withdrawal by Caregiver|0|||
150226720|NCT01524887|541965122|FG002|Overall Study|Withdrawal by Caregiver|2|||
150226721|NCT01524887|541965120|FG000|Overall Study|Use of prohibited medication|1|||
150226722|NCT01524887|541965121|FG001|Overall Study|Use of prohibited medication|0|||
150226723|NCT01524887|541965122|FG002|Overall Study|Use of prohibited medication|0|||
150226724|NCT00383500|541965125|FG000|Overall Study|Withdrawal by Subject|8|||
150226725|NCT00383500|541965126|FG001|Overall Study|Withdrawal by Subject|3|||
150226726|NCT00383500|541965127|FG002|Overall Study|Withdrawal by Subject|0|||
150226727|NCT00383500|541965125|FG000|Overall Study|Lost to Follow-up|0|||
150226728|NCT00383500|541965126|FG001|Overall Study|Lost to Follow-up|0|||
150226729|NCT00383500|541965127|FG002|Overall Study|Lost to Follow-up|2|||
150226730|NCT01816685|541966421|FG000|Overall Study|Lost to Follow-up|7|||
150226731|NCT01816685|541966422|FG001|Overall Study|Lost to Follow-up|9|||
150226732|NCT01816685|541966421|FG000|Overall Study|Surgery Cancelled|3|||
150226733|NCT01816685|541966422|FG001|Overall Study|Surgery Cancelled|2|||
150226734|NCT02720185|541966423|FG000|Overall Study|Lost to Follow-up|1|||
150226735|NCT00381888|541966424|FG000|Overall Study|Death|1|||
150226736|NCT00381888|541966424|FG000|Overall Study|Withdrawal by Subject|1|||
150226737|NCT00381888|541966424|FG000|Overall Study|Physician Decision|1|||
150226738|NCT00381888|541966424|FG000|Overall Study|Protocol Violation|9|||
150226739|NCT00381888|541966424|FG000|Overall Study|Had laparoscopic surgery|2|||
150226740|NCT00381888|541966424|FG000|Overall Study|Surgery was cancelled|2|||
150226741|NCT00381888|541966424|FG000|Overall Study|Adverse Event|1|||
150226742|NCT02507687|541966430|FG000|Overall Study|Adverse Event|3|||
150226743|NCT02507687|541966431|FG001|Overall Study|Adverse Event|2|||
150226744|NCT02507687|541966432|FG002|Overall Study|Adverse Event|2|||
150226745|NCT02507687|541966433|FG003|Overall Study|Adverse Event|2|||
150226746|NCT02507687|541966430|FG000|Overall Study|Withdrawal by Subject|1|||
150226747|NCT02507687|541966431|FG001|Overall Study|Withdrawal by Subject|4|||
150226748|NCT02507687|541966432|FG002|Overall Study|Withdrawal by Subject|6|||
150226749|NCT02507687|541966433|FG003|Overall Study|Withdrawal by Subject|6|||
150226750|NCT02507687|541966430|FG000|Overall Study|Protocol Violation|1|||
150226751|NCT02507687|541966431|FG001|Overall Study|Protocol Violation|0|||
150226752|NCT02507687|541966432|FG002|Overall Study|Protocol Violation|2|||
150226753|NCT02507687|541966433|FG003|Overall Study|Protocol Violation|0|||
150226754|NCT02507687|541966430|FG000|Overall Study|Lost to Follow-up|0|||
150226755|NCT02507687|541966431|FG001|Overall Study|Lost to Follow-up|0|||
150226756|NCT02507687|541966432|FG002|Overall Study|Lost to Follow-up|2|||
150226757|NCT02507687|541966433|FG003|Overall Study|Lost to Follow-up|1|||
150226758|NCT02507687|541966430|FG000|Overall Study|Screen Failure|0|||
150226759|NCT02507687|541966431|FG001|Overall Study|Screen Failure|0|||
150226760|NCT02507687|541966432|FG002|Overall Study|Screen Failure|1|||
150226761|NCT02507687|541966433|FG003|Overall Study|Screen Failure|0|||
150226762|NCT02507687|541966430|FG000|Overall Study|Other, Not Specified|0|||
150226763|NCT02507687|541966431|FG001|Overall Study|Other, Not Specified|0|||
150226764|NCT02507687|541966432|FG002|Overall Study|Other, Not Specified|2|||
150226765|NCT02507687|541966433|FG003|Overall Study|Other, Not Specified|4|||
150226766|NCT00848393|541966438|FG000|Overall Study|Protocol Violation|0|||
150226767|NCT00848393|541966439|FG001|Overall Study|Protocol Violation|0|||
150226768|NCT00848393|541966440|FG002|Overall Study|Protocol Violation|1|||
150226769|NCT00848393|541966438|FG000|Overall Study|surgical complications unrelated to stud|0|||
150226770|NCT00848393|541966439|FG001|Overall Study|surgical complications unrelated to stud|0|||
150226771|NCT00848393|541966440|FG002|Overall Study|surgical complications unrelated to stud|2|||
150226772|NCT00598871|541966443|FG000|Overall Study|Adverse Event|0|||
150226773|NCT00598871|541966444|FG001|Overall Study|Adverse Event|1|||
150226774|NCT00443898|541966447|FG000|Overall Study|Adverse Event|0|||
150226775|NCT00443898|541966448|FG001|Overall Study|Adverse Event|0|||
150226776|NCT00443898|541966449|FG002|Overall Study|Adverse Event|1|||
150226777|NCT00443898|541966450|FG003|Overall Study|Adverse Event|1|||
150226778|NCT00443898|541966447|FG000|Overall Study|Lack of Efficacy|2|||
150226779|NCT00443898|541966448|FG001|Overall Study|Lack of Efficacy|3|||
150226780|NCT00443898|541966449|FG002|Overall Study|Lack of Efficacy|3|||
150226781|NCT00443898|541966450|FG003|Overall Study|Lack of Efficacy|1|||
150226782|NCT00443898|541966447|FG000|Overall Study|Protocol Violation|1|||
150226783|NCT00443898|541966448|FG001|Overall Study|Protocol Violation|1|||
150226784|NCT00443898|541966449|FG002|Overall Study|Protocol Violation|1|||
150226785|NCT00443898|541966450|FG003|Overall Study|Protocol Violation|0|||
150226786|NCT00443898|541966447|FG000|Overall Study|Withdrawal by Subject|11|||
150226787|NCT00443898|541966448|FG001|Overall Study|Withdrawal by Subject|10|||
150226788|NCT00443898|541966449|FG002|Overall Study|Withdrawal by Subject|10|||
150226789|NCT00443898|541966450|FG003|Overall Study|Withdrawal by Subject|6|||
150226790|NCT00443898|541966447|FG000|Overall Study|Lost to Follow-up|10|||
150226791|NCT00443898|541966448|FG001|Overall Study|Lost to Follow-up|10|||
150226792|NCT00443898|541966449|FG002|Overall Study|Lost to Follow-up|14|||
150226793|NCT00443898|541966450|FG003|Overall Study|Lost to Follow-up|10|||
150226794|NCT00443898|541966447|FG000|Overall Study|Death|0|||
150226795|NCT00443898|541966448|FG001|Overall Study|Death|1|||
150226796|NCT00443898|541966449|FG002|Overall Study|Death|0|||
150226797|NCT00443898|541966450|FG003|Overall Study|Death|0|||
150226798|NCT00755716|541966451|FG000|Overall Study|Adverse Event|1|||
150226799|NCT00755716|541966452|FG001|Overall Study|Adverse Event|4|||
150226800|NCT00755716|541966453|FG002|Overall Study|Adverse Event|1|||
150226801|NCT00755716|541966451|FG000|Overall Study|Lack of Efficacy|2|||
150226802|NCT00755716|541966452|FG001|Overall Study|Lack of Efficacy|0|||
150226803|NCT00755716|541966453|FG002|Overall Study|Lack of Efficacy|0|||
150226804|NCT00755716|541966451|FG000|Overall Study|Lost to Follow-up|5|||
150226805|NCT00755716|541966452|FG001|Overall Study|Lost to Follow-up|3|||
150226806|NCT00755716|541966453|FG002|Overall Study|Lost to Follow-up|1|||
150226807|NCT00755716|541966451|FG000|Overall Study|work schedule issues|0|||
150226808|NCT00755716|541966452|FG001|Overall Study|work schedule issues|1|||
150226809|NCT00755716|541966453|FG002|Overall Study|work schedule issues|1|||
150226810|NCT03681353|541966454|FG000|Overall Study|Lost to Follow-up|2|||
150226811|NCT03681353|541966454|FG000|Overall Study|Withdrawal by Subject|3|||
150226812|NCT03681353|541966454|FG000|Overall Study|withdrawn by PI|2|||
150226813|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
150226814|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
150226815|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
150226816|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
150226817|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
150226818|NCT00520403|541966455|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
150226819|NCT00520403|541966455|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
150226820|NCT00520403|541966455|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
150226821|NCT01797562|541966456|FG000|Overall Study|Protocol Violation|5|||
150226822|NCT00917462|541966459|FG000|Overall Study|Clinical Deterioration|1|||
150226823|NCT03341312|541966466|FG000|Period 1|Withdrawal by Subject|0|||
150226824|NCT03341312|541966467|FG001|Period 1|Withdrawal by Subject|1|||
150226825|NCT03341312|541966468|FG002|Period 1|Withdrawal by Subject|0|||
150226826|NCT03341312|541966469|FG003|Period 1|Withdrawal by Subject|0|||
150226827|NCT01812707|541966470|FG000|Overall Study|Adverse Event|0|||
150226828|NCT01812707|541966471|FG001|Overall Study|Adverse Event|0|||
150226829|NCT01812707|541966472|FG002|Overall Study|Adverse Event|0|||
150226830|NCT01812707|541966473|FG003|Overall Study|Adverse Event|2|||
150226831|NCT01812707|541966470|FG000|Overall Study|Poor compliance to protocol|1|||
150226832|NCT01812707|541966471|FG001|Overall Study|Poor compliance to protocol|0|||
150226833|NCT01812707|541966472|FG002|Overall Study|Poor compliance to protocol|0|||
150226834|NCT01812707|541966473|FG003|Overall Study|Poor compliance to protocol|0|||
150226835|NCT01812707|541966470|FG000|Overall Study|Consent withdrawn by participant|1|||
150226836|NCT01812707|541966471|FG001|Overall Study|Consent withdrawn by participant|0|||
150226837|NCT01812707|541966472|FG002|Overall Study|Consent withdrawn by participant|0|||
150226838|NCT01812707|541966473|FG003|Overall Study|Consent withdrawn by participant|0|||
150226839|NCT01631825|541966474|FG000|Overall Study|Adverse Event|42|||
150226840|NCT01631825|541966474|FG000|Overall Study|Lack of Efficacy|7|||
150226841|NCT01631825|541966474|FG000|Overall Study|Withdrawal by Subject|9|||
150226842|NCT01631825|541966474|FG000|Overall Study|Protocol Violation|4|||
150226843|NCT01631825|541966474|FG000|Overall Study|Discontinuation criteria|1|||
150226844|NCT01631825|541966474|FG000|Overall Study|Physician Decision|2|||
150226845|NCT05372913|541966483|FG000|Overall Study|Withdrawal by Subject|0|||
150226846|NCT05372913|541966484|FG001|Overall Study|Withdrawal by Subject|2|||
150226847|NCT05372913|541966483|FG000|Overall Study|Protocol Violation|2|||
150226848|NCT05372913|541966484|FG001|Overall Study|Protocol Violation|2|||
150226849|NCT05372913|541966483|FG000|Overall Study|Adverse Event|0|||
150226850|NCT05372913|541966484|FG001|Overall Study|Adverse Event|1|||
150226851|NCT03193216|541966485|FG000|Overall Study|Lost to Follow-up|1|||
150226852|NCT03193216|541966486|FG001|Overall Study|Lost to Follow-up|0|||
150226853|NCT03193216|541966485|FG000|Overall Study|Withdrawal by Subject|5|||
150226854|NCT03193216|541966486|FG001|Overall Study|Withdrawal by Subject|0|||
150226855|NCT03193216|541966485|FG000|Overall Study|Physician Decision|4|||
150226856|NCT03193216|541966486|FG001|Overall Study|Physician Decision|0|||
150226857|NCT03275402|541966487|FG000|Overall Study|Death|17|||
150226858|NCT03275402|541966487|FG000|Overall Study|Study terminated by sponsor|21|||
150226859|NCT03275402|541966487|FG000|Overall Study|Withdrawal by Subject|1|||
150226860|NCT01514864|541966488|FG000|Overall Study|Disease progression|7|||
150226861|NCT01514864|541966489|FG001|Overall Study|Disease progression|5|||
150226862|NCT01514864|541966488|FG000|Overall Study|Study drug toxicity|2|||
150226863|NCT01514864|541966489|FG001|Overall Study|Study drug toxicity|0|||
150226864|NCT05135156|541966490|FG000|Overall Study|Lost to Follow-up|0|||
150226865|NCT05135156|541966491|FG001|Overall Study|Lost to Follow-up|0|||
150226866|NCT05135156|541966492|FG002|Overall Study|Lost to Follow-up|2|||
150226867|NCT02986659|541966493|FG000|First Intervention Period|Adverse Event|3|||
150226868|NCT02986659|541966494|FG001|First Intervention Period|Adverse Event|1|||
150226869|NCT02986659|541966493|FG000|First Intervention Period|Lost to Follow-up|1|||
150226870|NCT02986659|541966494|FG001|First Intervention Period|Lost to Follow-up|0|||
150226871|NCT02986659|541966493|FG000|First Intervention Period|Withdrawal by Subject|0|||
150226872|NCT02986659|541966494|FG001|First Intervention Period|Withdrawal by Subject|1|||
150226873|NCT02986659|541966493|FG000|Second Intervention Period|Adverse Event|0|||
150226874|NCT02986659|541966494|FG001|Second Intervention Period|Adverse Event|6|||
150226875|NCT02254681|541966500|FG000|Overall Study|Lack of Efficacy|6|||
150226876|NCT02469077|541966501|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
150226877|NCT02469077|541966502|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
150226878|NCT02469077|541966501|FG000|Post Randomization/Intervention Period|Relocated|1|||
150226879|NCT02469077|541966502|FG001|Post Randomization/Intervention Period|Relocated|1|||
150226880|NCT02469077|541966501|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
150226881|NCT02469077|541966502|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
150226882|NCT02469077|541966501|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
150226883|NCT02469077|541966502|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
150226884|NCT01059526|541966503|FG000|Overall Study|Patient enrolled but not treated|20|||
150226885|NCT01059526|541966504|FG001|Overall Study|Patient enrolled but not treated|17|||
150226886|NCT01059526|541966503|FG000|Overall Study|Adverse Event|2|||
150226887|NCT01059526|541966504|FG001|Overall Study|Adverse Event|2|||
150226888|NCT01059526|541966503|FG000|Overall Study|Protocol Violation|0|||
150226889|NCT01059526|541966504|FG001|Overall Study|Protocol Violation|1|||
150226890|NCT01059526|541966503|FG000|Overall Study|Withdrawal by Subject|3|||
150226891|NCT01059526|541966504|FG001|Overall Study|Withdrawal by Subject|1|||
150226892|NCT01059526|541966503|FG000|Overall Study|Lost to Follow-up|4|||
150226893|NCT01059526|541966504|FG001|Overall Study|Lost to Follow-up|1|||
150226894|NCT01059526|541966503|FG000|Overall Study|Patient found to be dermatographic|1|||
150226895|NCT01059526|541966504|FG001|Overall Study|Patient found to be dermatographic|0|||
150226896|NCT01732588|541966505|FG000|First Intervention (7 Days)|Adverse Event|0|||
150226897|NCT01732588|541966506|FG001|First Intervention (7 Days)|Adverse Event|1|||
150226898|NCT01732588|541966507|FG002|First Intervention (7 Days)|Adverse Event|0|||
150226899|NCT02005029|541966508|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
150226900|NCT02005029|541966509|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
150226901|NCT01370018|541966510|FG000|Overall Study|Did not meet criteria for analysis|1|||
150226902|NCT01525641|541966513|FG000|Overall Study|Case report form not collected|25|||
150226903|NCT01525641|541966513|FG000|Overall Study|No visit since the first visit|16|||
150226904|NCT01525641|541966513|FG000|Overall Study|Adverse Event|73|||
150226905|NCT01525641|541966513|FG000|Overall Study|Lack of Efficacy|24|||
150226906|NCT01525641|541966513|FG000|Overall Study|Improvement|5|||
150226907|NCT01525641|541966513|FG000|Overall Study|Lost to follow-up (relocation)|1|||
150226908|NCT01525641|541966513|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
150226909|NCT01525641|541966513|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
150226910|NCT01525641|541966513|FG000|Overall Study|Other than stated above|7|||
150226911|NCT03772041|541966514|FG000|Overall Study|Adverse Event|8|||
150226912|NCT03772041|541966515|FG001|Overall Study|Adverse Event|3|||
150226913|NCT03772041|541966514|FG000|Overall Study|Withdrawal by Subject|0|||
150226914|NCT03772041|541966515|FG001|Overall Study|Withdrawal by Subject|2|||
150226915|NCT03772041|541966514|FG000|Overall Study|Protocol Violation|4|||
150226916|NCT03772041|541966515|FG001|Overall Study|Protocol Violation|2|||
150226917|NCT03772041|541966514|FG000|Overall Study|Physician Decision|2|||
150226918|NCT03772041|541966515|FG001|Overall Study|Physician Decision|3|||
150226919|NCT02204319|541966516|FG000|Overall Study|Pregnancy|1|||
150226920|NCT02204319|541966516|FG000|Overall Study|Withdrawal by Subject|2|||
150226921|NCT03544229|541966521|FG000|Overall Study|Adverse Event|1|||
150226922|NCT03544229|541966522|FG001|Overall Study|Adverse Event|0|||
150226923|NCT03544229|541966523|FG002|Overall Study|Adverse Event|1|||
150226924|NCT03544229|541966524|FG003|Overall Study|Adverse Event|0|||
150226925|NCT03544229|541966521|FG000|Overall Study|Protocol Deviation|0|||
150226926|NCT03544229|541966522|FG001|Overall Study|Protocol Deviation|0|||
150226927|NCT03544229|541966523|FG002|Overall Study|Protocol Deviation|1|||
150226928|NCT03544229|541966524|FG003|Overall Study|Protocol Deviation|0|||
150226929|NCT03544229|541966521|FG000|Overall Study|Lost to Follow-up|3|||
150226930|NCT03544229|541966522|FG001|Overall Study|Lost to Follow-up|0|||
150226931|NCT03544229|541966523|FG002|Overall Study|Lost to Follow-up|0|||
150226932|NCT03544229|541966524|FG003|Overall Study|Lost to Follow-up|2|||
150226933|NCT03544229|541966521|FG000|Overall Study|Voluntary Withdrawal|2|||
150226934|NCT03544229|541966522|FG001|Overall Study|Voluntary Withdrawal|1|||
150226935|NCT03544229|541966523|FG002|Overall Study|Voluntary Withdrawal|3|||
150226936|NCT03544229|541966524|FG003|Overall Study|Voluntary Withdrawal|0|||
150226937|NCT03544229|541966521|FG000|Overall Study|Lack of Efficacy|0|||
150226938|NCT03544229|541966522|FG001|Overall Study|Lack of Efficacy|1|||
150226939|NCT03544229|541966523|FG002|Overall Study|Lack of Efficacy|0|||
150226940|NCT03544229|541966524|FG003|Overall Study|Lack of Efficacy|0|||
150226941|NCT04748445|541966525|FG000|Overall Study|No longer met eligibility criteria|12|||
150226942|NCT04748445|541966525|FG000|Overall Study|Other|36|||
150226943|NCT04748445|541966525|FG000|Overall Study|Withdrawal by Subject|553|||
150226944|NCT04748445|541966525|FG000|Overall Study|Lost to Follow-up|30|||
150226945|NCT00139659|541966532|FG000|Overall Study|Adverse Event|12|||
150226946|NCT00139659|541966533|FG001|Overall Study|Adverse Event|1|||
150226947|NCT00139659|541966532|FG000|Overall Study|Lack of Efficacy|1|||
150226948|NCT00139659|541966533|FG001|Overall Study|Lack of Efficacy|1|||
150226949|NCT00139659|541966532|FG000|Overall Study|Lost to Follow-up|7|||
150226950|NCT00139659|541966533|FG001|Overall Study|Lost to Follow-up|3|||
150226951|NCT00139659|541966532|FG000|Overall Study|Reason not Specified|6|||
150226952|NCT00139659|541966533|FG001|Overall Study|Reason not Specified|3|||
150226953|NCT00139659|541966532|FG000|Overall Study|Withdrawal by Subject|14|||
150226954|NCT00139659|541966533|FG001|Overall Study|Withdrawal by Subject|10|||
150226955|NCT03356145|541966552|FG000|Overall Study|Withdrawal by Subject|2|||
150226956|NCT03356145|541966553|FG001|Overall Study|Withdrawal by Subject|1|||
150226957|NCT03356145|541966552|FG000|Overall Study|Did not meet inclusion criteria|1|||
150226958|NCT03356145|541966553|FG001|Overall Study|Did not meet inclusion criteria|0|||
150226959|NCT00905255|541966556|FG000|Overall Study|Adverse Event|7|||
150226960|NCT00905255|541966557|FG001|Overall Study|Adverse Event|5|||
150226961|NCT00905255|541966556|FG000|Overall Study|Withdrawal by Subject|5|||
150226962|NCT00905255|541966557|FG001|Overall Study|Withdrawal by Subject|4|||
150226963|NCT00905255|541966556|FG000|Overall Study|Familial and Personal Reasons|1|||
150226964|NCT00905255|541966557|FG001|Overall Study|Familial and Personal Reasons|0|||
150226965|NCT01332318|541966560|FG000|Overall Study|Adverse Event|0|||
150226966|NCT01332318|541966561|FG001|Overall Study|Adverse Event|3|||
150226967|NCT01332318|541966562|FG002|Overall Study|Adverse Event|0|||
150226968|NCT01332318|541966563|FG003|Overall Study|Adverse Event|0|||
150226969|NCT01332318|541966560|FG000|Overall Study|Withdrawal by Subject|1|||
150226970|NCT01332318|541966561|FG001|Overall Study|Withdrawal by Subject|1|||
150226971|NCT01332318|541966562|FG002|Overall Study|Withdrawal by Subject|0|||
150226972|NCT01332318|541966563|FG003|Overall Study|Withdrawal by Subject|1|||
150226973|NCT01332318|541966560|FG000|Overall Study|Protocol Violation|1|||
150226974|NCT01332318|541966561|FG001|Overall Study|Protocol Violation|0|||
150226975|NCT01332318|541966562|FG002|Overall Study|Protocol Violation|1|||
150226976|NCT01332318|541966563|FG003|Overall Study|Protocol Violation|1|||
150226977|NCT02040532|541966564|FG000|Overall Study|Lost to Follow-up|1|||
150226978|NCT02040532|541966564|FG000|Overall Study|Physician Decision|4|||
150226979|NCT02040532|541966564|FG000|Overall Study|Adverse Event|4|||
150226980|NCT02040532|541966564|FG000|Overall Study|Withdrawal by Subject|3|||
150226981|NCT04382053|541966565|FG000|Overall Study|Death|6|||
150226982|NCT04382053|541966566|FG001|Overall Study|Death|8|||
150226983|NCT04382053|541966565|FG000|Overall Study|Lost to Follow-up|0|||
150226984|NCT04382053|541966566|FG001|Overall Study|Lost to Follow-up|2|||
150226985|NCT04382053|541966565|FG000|Overall Study|Protocol Deviation|1|||
150226986|NCT04382053|541966566|FG001|Overall Study|Protocol Deviation|2|||
150226987|NCT04382053|541966565|FG000|Overall Study|Withdrawal by Subject|2|||
150226988|NCT04382053|541966566|FG001|Overall Study|Withdrawal by Subject|1|||
150226989|NCT00714688|541966567|FG000|Overall Study|Lack of Efficacy|14|||
150226990|NCT00714688|541966568|FG001|Overall Study|Lack of Efficacy|1|||
150226991|NCT00714688|541966569|FG002|Overall Study|Lack of Efficacy|4|||
150226992|NCT00714688|541966567|FG000|Overall Study|Withdrawal by Subject|4|||
150226993|NCT00714688|541966568|FG001|Overall Study|Withdrawal by Subject|3|||
150226994|NCT00714688|541966569|FG002|Overall Study|Withdrawal by Subject|3|||
150226995|NCT00714688|541966567|FG000|Overall Study|Lost to Follow-up|5|||
150226996|NCT00714688|541966568|FG001|Overall Study|Lost to Follow-up|2|||
150226997|NCT00714688|541966569|FG002|Overall Study|Lost to Follow-up|0|||
150226998|NCT00714688|541966567|FG000|Overall Study|Adverse Event|2|||
150226999|NCT00714688|541966568|FG001|Overall Study|Adverse Event|15|||
150227000|NCT00714688|541966569|FG002|Overall Study|Adverse Event|19|||
150227001|NCT00714688|541966567|FG000|Overall Study|Subject Non-compliant|3|||
150227002|NCT00714688|541966568|FG001|Overall Study|Subject Non-compliant|5|||
150227003|NCT00714688|541966569|FG002|Overall Study|Subject Non-compliant|5|||
150227004|NCT00714688|541966567|FG000|Overall Study|Ineligible to Continue the Study|0|||
150227005|NCT00714688|541966568|FG001|Overall Study|Ineligible to Continue the Study|1|||
150227006|NCT00714688|541966569|FG002|Overall Study|Ineligible to Continue the Study|1|||
150227007|NCT00714688|541966567|FG000|Overall Study|Sponsor's Decision|0|||
150227008|NCT00714688|541966568|FG001|Overall Study|Sponsor's Decision|2|||
150227009|NCT00714688|541966569|FG002|Overall Study|Sponsor's Decision|0|||
150227010|NCT00714688|541966567|FG000|Overall Study|Other|1|||
150227011|NCT00714688|541966568|FG001|Overall Study|Other|6|||
150227012|NCT00714688|541966569|FG002|Overall Study|Other|5|||
150227013|NCT01786551|541966570|FG000|Overall Study|Participant withdrew consent|2|||
150227014|NCT00170950|541966571|FG000|Overall Study|Death|236|||
150227015|NCT00170950|541966572|FG001|Overall Study|Death|274|||
150227016|NCT00170950|541966571|FG000|Overall Study|Withdrawal by Subject|496|||
150227017|NCT00170950|541966572|FG001|Overall Study|Withdrawal by Subject|498|||
150227018|NCT00170950|541966571|FG000|Overall Study|Lost to Follow-up|134|||
150227019|NCT00170950|541966572|FG001|Overall Study|Lost to Follow-up|115|||
150227020|NCT00170950|541966571|FG000|Overall Study|Missing|2|||
150227021|NCT00170950|541966572|FG001|Overall Study|Missing|1|||
150227022|NCT00170950|541966571|FG000|Overall Study|Termination Data Not Recorded|17|||
150227023|NCT00170950|541966572|FG001|Overall Study|Termination Data Not Recorded|22|||
150227024|NCT01808144|541966573|FG000|Overall Study|Death|1|||
150227025|NCT01808144|541966574|FG001|Overall Study|Death|0|||
150227026|NCT01808144|541966573|FG000|Overall Study|Withdrawal by Subject|16|||
150227027|NCT01808144|541966574|FG001|Overall Study|Withdrawal by Subject|23|||
150227028|NCT01808144|541966573|FG000|Overall Study|Lost to Follow-up|6|||
150227029|NCT01808144|541966574|FG001|Overall Study|Lost to Follow-up|3|||
150227030|NCT01808144|541966573|FG000|Overall Study|Protocol Violation|6|||
150227031|NCT01808144|541966574|FG001|Overall Study|Protocol Violation|6|||
150227032|NCT01808144|541966573|FG000|Overall Study|Gout flare|0|||
150227033|NCT01808144|541966574|FG001|Overall Study|Gout flare|1|||
150227034|NCT01808144|541966573|FG000|Overall Study|Adverse Event|11|||
150227035|NCT01808144|541966574|FG001|Overall Study|Adverse Event|15|||
150227036|NCT01123642|541966575|FG000|Overall Study|Lost to Follow-up|23|||
150227037|NCT01123642|541966575|FG000|Overall Study|Withdrawal by Subject|9|||
150227038|NCT01123642|541966575|FG000|Overall Study|ineligible at baseline assessment|36|||
150227039|NCT03098797|541968166|FG000|Part 2 Open Label Extension|Adverse Event|2|||
150227040|NCT03098797|541968167|FG001|Part 2 Open Label Extension|Adverse Event|0|||
150227041|NCT00509821|541968168|FG000|Study Period 1 (Induction)|Death|0|||
150227042|NCT00509821|541968169|FG001|Study Period 1 (Induction)|Death|1|||
150227043|NCT00509821|541968168|FG000|Study Period 1 (Induction)|Adverse Event|0|||
150227044|NCT00509821|541968169|FG001|Study Period 1 (Induction)|Adverse Event|2|||
150227045|NCT00509821|541968168|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
150227046|NCT00509821|541968169|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
150141601|NCT02243202|541653979|FG003|Overall Study|Adverse Event|4|||
150141602|NCT02243202|541653976|FG000|Overall Study|Lost to Follow-up|9|||
150141603|NCT02243202|541653977|FG001|Overall Study|Lost to Follow-up|9|||
150141604|NCT02243202|541653978|FG002|Overall Study|Lost to Follow-up|14|||
150141605|NCT02243202|541653979|FG003|Overall Study|Lost to Follow-up|11|||
150141606|NCT02243202|541653976|FG000|Overall Study|Protocol Violation|3|||
150141607|NCT02243202|541653977|FG001|Overall Study|Protocol Violation|1|||
150141608|NCT02243202|541653978|FG002|Overall Study|Protocol Violation|2|||
150141609|NCT02243202|541653979|FG003|Overall Study|Protocol Violation|1|||
150141610|NCT02243202|541653976|FG000|Overall Study|Withdrawal by Subject|7|||
150141611|NCT02243202|541653977|FG001|Overall Study|Withdrawal by Subject|6|||
150141612|NCT02243202|541653978|FG002|Overall Study|Withdrawal by Subject|4|||
150141613|NCT02243202|541653979|FG003|Overall Study|Withdrawal by Subject|4|||
150141614|NCT02243202|541653976|FG000|Overall Study|Other|1|||
150141615|NCT02243202|541653977|FG001|Overall Study|Other|3|||
150141616|NCT02243202|541653978|FG002|Overall Study|Other|1|||
150141617|NCT02243202|541653979|FG003|Overall Study|Other|2|||
150227047|NCT00552513|541968172|FG000|Overall Study|Lost to Follow-up|5|||
150227048|NCT00552513|541968173|FG001|Overall Study|Lost to Follow-up|1|||
150227049|NCT01589523|541968174|FG000|Overall Study|Withdrawal by Subject|1|||
150227050|NCT00961896|541968175|FG000|Overall Study|Abnormal laboratory value|0|||
150227051|NCT00961896|541968176|FG001|Overall Study|Abnormal laboratory value|0|||
150227052|NCT00961896|541968177|FG002|Overall Study|Abnormal laboratory value|1|||
150227053|NCT00506922|541968178|FG000|Overall Study|Physician Decision|0|||
150227054|NCT00506922|541968179|FG001|Overall Study|Physician Decision|0|||
150227055|NCT00506922|541968180|FG002|Overall Study|Physician Decision|0|||
150227056|NCT00506922|541968181|FG003|Overall Study|Physician Decision|2|||
150227057|NCT00506922|541968182|FG004|Overall Study|Physician Decision|0|||
150227058|NCT00506922|541968178|FG000|Overall Study|Withdrawal by Subject|0|||
150227059|NCT00506922|541968179|FG001|Overall Study|Withdrawal by Subject|0|||
150227060|NCT00506922|541968180|FG002|Overall Study|Withdrawal by Subject|0|||
150227061|NCT00506922|541968181|FG003|Overall Study|Withdrawal by Subject|0|||
150227062|NCT00506922|541968182|FG004|Overall Study|Withdrawal by Subject|1|||
150227063|NCT00792259|541968183|FG000|Overall Study|Poor Quality Scans|1|||
150227064|NCT00792259|541968184|FG001|Overall Study|Poor Quality Scans|0|||
150227065|NCT00792259|541968185|FG002|Overall Study|Poor Quality Scans|0|||
150227066|NCT00371462|541968186|FG000|Overall Study|Withdrawal by Subject|1|||
150227067|NCT00371462|541968187|FG001|Overall Study|Withdrawal by Subject|0|||
150227068|NCT00371462|541968186|FG000|Overall Study|Other|7|||
150227069|NCT00371462|541968187|FG001|Overall Study|Other|8|||
150227070|NCT03721978|541968188|FG000|Overall Study|Withdrawal by Subject|6|||
150227071|NCT03721978|541968189|FG001|Overall Study|Withdrawal by Subject|1|||
150227072|NCT03721978|541968188|FG000|Overall Study|Adverse Event|1|||
150227073|NCT03721978|541968189|FG001|Overall Study|Adverse Event|1|||
150227074|NCT03721978|541968188|FG000|Overall Study|Progressive Disease|1|||
150227075|NCT03721978|541968189|FG001|Overall Study|Progressive Disease|0|||
150227076|NCT03721978|541968188|FG000|Overall Study|Lost to Follow-up|5|||
150227077|NCT03721978|541968189|FG001|Overall Study|Lost to Follow-up|1|||
150227078|NCT03721978|541968188|FG000|Overall Study|Reason not Specified|0|||
150227079|NCT03721978|541968189|FG001|Overall Study|Reason not Specified|2|||
150227080|NCT05244226|541968190|FG000|Overall Study|Adverse Event|1|||
150227081|NCT05244226|541968191|FG001|Overall Study|Adverse Event|0|||
150227082|NCT05244226|541968192|FG002|Overall Study|Adverse Event|0|||
150227083|NCT05244226|541968190|FG000|Overall Study|Lost to Follow-up|0|||
150227084|NCT05244226|541968191|FG001|Overall Study|Lost to Follow-up|0|||
150227085|NCT05244226|541968192|FG002|Overall Study|Lost to Follow-up|1|||
150227086|NCT05244226|541968190|FG000|Overall Study|Protocol Violation|0|||
150227087|NCT05244226|541968191|FG001|Overall Study|Protocol Violation|2|||
150227088|NCT05244226|541968192|FG002|Overall Study|Protocol Violation|2|||
150227089|NCT02675998|541968197|FG000|8-Week Treatment Period|Adverse Event|6|||
150227090|NCT02675998|541968198|FG001|8-Week Treatment Period|Adverse Event|5|||
150227091|NCT02675998|541968199|FG002|8-Week Treatment Period|Adverse Event|6|||
150227092|NCT02675998|541968200|FG003|8-Week Treatment Period|Adverse Event|0|||
150227093|NCT02675998|541968197|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
150227094|NCT02675998|541968198|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
150227095|NCT02675998|541968199|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
150227096|NCT02675998|541968200|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
150227097|NCT02675998|541968197|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
150227098|NCT02675998|541968198|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
150227099|NCT02675998|541968199|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
150227100|NCT02675998|541968200|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
150227101|NCT02675998|541968197|FG000|8-Week Treatment Period|Physician Decision|1|||
150227102|NCT02675998|541968198|FG001|8-Week Treatment Period|Physician Decision|0|||
150227103|NCT02675998|541968199|FG002|8-Week Treatment Period|Physician Decision|2|||
150227104|NCT02675998|541968200|FG003|8-Week Treatment Period|Physician Decision|0|||
150227105|NCT02675998|541968197|FG000|8-Week Treatment Period|GI side Effects|1|||
150227106|NCT02675998|541968198|FG001|8-Week Treatment Period|GI side Effects|4|||
150227107|NCT02675998|541968199|FG002|8-Week Treatment Period|GI side Effects|2|||
150227108|NCT02675998|541968200|FG003|8-Week Treatment Period|GI side Effects|0|||
150227109|NCT02675998|541968197|FG000|8-Week Treatment Period|Protocol Violation|1|||
150227110|NCT02675998|541968198|FG001|8-Week Treatment Period|Protocol Violation|1|||
150227111|NCT02675998|541968199|FG002|8-Week Treatment Period|Protocol Violation|1|||
150227112|NCT02675998|541968200|FG003|8-Week Treatment Period|Protocol Violation|0|||
150227113|NCT02675998|541968197|FG000|8-Week Treatment Period|Other|3|||
150227114|NCT02675998|541968198|FG001|8-Week Treatment Period|Other|1|||
150227115|NCT02675998|541968199|FG002|8-Week Treatment Period|Other|2|||
150227116|NCT02675998|541968200|FG003|8-Week Treatment Period|Other|0|||
150227117|NCT02675998|541968197|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
150227118|NCT02675998|541968198|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
150227119|NCT02675998|541968199|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
150227120|NCT02675998|541968200|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
150227121|NCT02675998|541968197|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
150227122|NCT02675998|541968198|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
150227123|NCT02675998|541968199|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
150227124|NCT02675998|541968200|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
150227125|NCT02675998|541968197|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
150227126|NCT02675998|541968198|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
150227127|NCT02675998|541968199|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
150227128|NCT02675998|541968200|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
150227129|NCT02675998|541968197|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
150227130|NCT02675998|541968198|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
150227131|NCT02675998|541968199|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
150227132|NCT02675998|541968200|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
150227133|NCT02675998|541968197|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
150227134|NCT02675998|541968198|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
150227135|NCT02675998|541968199|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
150227136|NCT02675998|541968200|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
150227137|NCT00275301|541968201|FG000|Overall Study|Adverse Event|5|||
150227138|NCT01194271|541968206|FG000|Overall Study|Withdrawal by Subject|1|||
150227139|NCT01194271|541968206|FG000|Overall Study|Ineligible, Screen Failure|1|||
150227140|NCT01194271|541968206|FG000|Overall Study|Death|1|||
150227141|NCT00349622|541968207|FG000|Overall Study|Death|168|||
150227142|NCT00349622|541968208|FG001|Overall Study|Death|86|||
150227143|NCT00349622|541968207|FG000|Overall Study|Lost to Follow-up|5|||
150227144|NCT00349622|541968208|FG001|Overall Study|Lost to Follow-up|1|||
150227145|NCT00349622|541968207|FG000|Overall Study|Withdrawal by Subject|5|||
150227146|NCT00349622|541968208|FG001|Overall Study|Withdrawal by Subject|9|||
150227147|NCT00508274|541968211|FG000|Overall Study|Adverse Event|5|||
150227148|NCT00508274|541968211|FG000|Overall Study|Death|7|||
150227149|NCT00508274|541968211|FG000|Overall Study|Disease progression|32|||
150227150|NCT00508274|541968211|FG000|Overall Study|Withdrawal by Subject|1|||
150227151|NCT00508274|541968211|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
150227152|NCT00508274|541968211|FG000|Overall Study|Missing|3|||
150227153|NCT03296566|541968212|FG000|Overall Study|Lost to Follow-up|19|||
150227154|NCT03296566|541968213|FG001|Overall Study|Lost to Follow-up|46|||
150227155|NCT03296566|541968212|FG000|Overall Study|Withdrawal by Subject|0|||
150227156|NCT03296566|541968213|FG001|Overall Study|Withdrawal by Subject|3|||
150227157|NCT00550771|541968221|FG000|Overall Study|Adverse Event|11|||
150227158|NCT00550771|541968222|FG001|Overall Study|Adverse Event|3|||
150227159|NCT00550771|541968221|FG000|Overall Study|Discontinued for study-related reasons|0|||
150227160|NCT00550771|541968222|FG001|Overall Study|Discontinued for study-related reasons|1|||
150227161|NCT00550771|541968221|FG000|Overall Study|Physician Decision|2|||
150227162|NCT00550771|541968222|FG001|Overall Study|Physician Decision|0|||
150227163|NCT00550771|541968221|FG000|Overall Study|Withdrawal by Subject|0|||
150227164|NCT00550771|541968222|FG001|Overall Study|Withdrawal by Subject|1|||
150227165|NCT00550771|541968221|FG000|Overall Study|Protocol Violation|4|||
150227166|NCT00550771|541968222|FG001|Overall Study|Protocol Violation|5|||
150227167|NCT01441583|541968223|FG000|Overall Study|Withdrawal by Subject|1|||
150227168|NCT01441583|541968224|FG001|Overall Study|Withdrawal by Subject|1|||
150227169|NCT01441583|541968225|FG002|Overall Study|Withdrawal by Subject|1|||
150227170|NCT01441583|541968223|FG000|Overall Study|Death|1|||
150227171|NCT01441583|541968224|FG001|Overall Study|Death|0|||
150227172|NCT01441583|541968225|FG002|Overall Study|Death|4|||
150227173|NCT01441583|541968223|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
150227174|NCT01441583|541968224|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
150227175|NCT01441583|541968225|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
150227176|NCT00839306|541968226|FG000|Overall Study|Adverse Event|3|||
150227177|NCT00839306|541968227|FG001|Overall Study|Adverse Event|5|||
150227178|NCT00839306|541968226|FG000|Overall Study|Lost to Follow-up|6|||
150227179|NCT00839306|541968227|FG001|Overall Study|Lost to Follow-up|9|||
150227180|NCT00839306|541968226|FG000|Overall Study|Withdrawal by Subject|5|||
150227181|NCT00839306|541968227|FG001|Overall Study|Withdrawal by Subject|7|||
150227182|NCT00839306|541968226|FG000|Overall Study|Lack of Efficacy|5|||
150227183|NCT00839306|541968227|FG001|Overall Study|Lack of Efficacy|4|||
150227184|NCT00839306|541968226|FG000|Overall Study|Other|6|||
150227185|NCT00839306|541968227|FG001|Overall Study|Other|18|||
150227186|NCT02396758|541968231|FG000|Overall Study|Withdrawal by Subject|2|||
150227187|NCT02396758|541968232|FG001|Overall Study|Withdrawal by Subject|0|||
150227188|NCT02396758|541968233|FG002|Overall Study|Withdrawal by Subject|0|||
150227189|NCT02396758|541968234|FG003|Overall Study|Withdrawal by Subject|1|||
150227190|NCT02396758|541968231|FG000|Overall Study|Lost to Follow-up|8|||
150227191|NCT02396758|541968232|FG001|Overall Study|Lost to Follow-up|5|||
150227192|NCT02396758|541968233|FG002|Overall Study|Lost to Follow-up|3|||
150227193|NCT02396758|541968234|FG003|Overall Study|Lost to Follow-up|3|||
150227194|NCT02396758|541968231|FG000|Overall Study|Death|1|||
150227195|NCT02396758|541968232|FG001|Overall Study|Death|1|||
150227196|NCT02396758|541968233|FG002|Overall Study|Death|0|||
150227197|NCT02396758|541968234|FG003|Overall Study|Death|1|||
150227198|NCT02396758|541968231|FG000|Overall Study|Randomized but not treated|1|||
150227199|NCT02396758|541968232|FG001|Overall Study|Randomized but not treated|0|||
150227200|NCT02396758|541968233|FG002|Overall Study|Randomized but not treated|1|||
150227201|NCT02396758|541968234|FG003|Overall Study|Randomized but not treated|0|||
150227202|NCT02176018|541968235|FG000|Overall Study|Adverse Event|0|||
150227203|NCT02176018|541968236|FG001|Overall Study|Adverse Event|2|||
150227204|NCT02176018|541968235|FG000|Overall Study|Lost to Follow-up|3|||
150227205|NCT02176018|541968236|FG001|Overall Study|Lost to Follow-up|1|||
150227206|NCT02176018|541968235|FG000|Overall Study|Protocol Violation|1|||
150227207|NCT02176018|541968236|FG001|Overall Study|Protocol Violation|1|||
150227208|NCT02176018|541968235|FG000|Overall Study|Withdrawal by Subject|1|||
150227209|NCT02176018|541968236|FG001|Overall Study|Withdrawal by Subject|2|||
150227210|NCT00265096|541968237|FG000|Overall Study|Adverse Event|14|||
150227211|NCT00265096|541968238|FG001|Overall Study|Adverse Event|18|||
150227212|NCT00265096|541968239|FG002|Overall Study|Adverse Event|18|||
150227213|NCT00265096|541968237|FG000|Overall Study|Lost to Follow-up|2|||
150227214|NCT00265096|541968238|FG001|Overall Study|Lost to Follow-up|5|||
150227215|NCT00265096|541968239|FG002|Overall Study|Lost to Follow-up|3|||
150227216|NCT00265096|541968237|FG000|Overall Study|Death|0|||
150227217|NCT00265096|541968238|FG001|Overall Study|Death|1|||
150227218|NCT00265096|541968239|FG002|Overall Study|Death|2|||
150227219|NCT00265096|541968237|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
150227220|NCT00265096|541968238|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
150227221|NCT00265096|541968239|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
150227222|NCT00265096|541968237|FG000|Overall Study|Other|11|||
150227223|NCT00265096|541968238|FG001|Overall Study|Other|19|||
150227224|NCT00265096|541968239|FG002|Overall Study|Other|10|||
150227225|NCT03022045|541968240|FG000|Overall Study|Adverse Event|0|||
150227226|NCT03022045|541968241|FG001|Overall Study|Adverse Event|1|||
150227227|NCT03022045|541968240|FG000|Overall Study|Withdrawal by Subject|1|||
150227228|NCT03022045|541968241|FG001|Overall Study|Withdrawal by Subject|1|||
150227229|NCT03568708|541968245|FG000|Overall Study|Withdrawal by Subject|1|||
150227230|NCT03568708|541968246|FG001|Overall Study|Withdrawal by Subject|1|||
150227231|NCT03568708|541968245|FG000|Overall Study|Lost to Follow-up|0|||
150227232|NCT03568708|541968246|FG001|Overall Study|Lost to Follow-up|1|||
150227233|NCT01126879|541968247|FG000|Overall Study|Progressive Disease|3|||
150227234|NCT01126879|541968248|FG001|Overall Study|Progressive Disease|1|||
150227235|NCT01126879|541968247|FG000|Overall Study|Withdrawal by Subject|1|||
150227236|NCT01126879|541968248|FG001|Overall Study|Withdrawal by Subject|0|||
150227237|NCT01126879|541968247|FG000|Overall Study|Adverse Event|0|||
150227238|NCT01126879|541968248|FG001|Overall Study|Adverse Event|1|||
150227239|NCT01126879|541968247|FG000|Overall Study|Physician Decision|1|||
150227240|NCT01126879|541968248|FG001|Overall Study|Physician Decision|0|||
150227241|NCT00666835|541968249|FG000|Overall Study|Withdrawal by Subject|5|||
150227242|NCT00666835|541968250|FG001|Overall Study|Withdrawal by Subject|2|||
150227243|NCT00666835|541968249|FG000|Overall Study|Lack of Efficacy|0|||
150227244|NCT00666835|541968250|FG001|Overall Study|Lack of Efficacy|1|||
150227245|NCT00666835|541968249|FG000|Overall Study|Incl./excl. not fulfilled|7|||
150227246|NCT00666835|541968250|FG001|Overall Study|Incl./excl. not fulfilled|2|||
150227247|NCT00666835|541968249|FG000|Overall Study|Adverse Event|7|||
150227248|NCT00666835|541968250|FG001|Overall Study|Adverse Event|6|||
150227249|NCT00666835|541968249|FG000|Overall Study|Protocol Violation|2|||
150227250|NCT00666835|541968250|FG001|Overall Study|Protocol Violation|0|||
150227251|NCT00666835|541968249|FG000|Overall Study|Death|15|||
150227252|NCT00666835|541968250|FG001|Overall Study|Death|4|||
150227253|NCT00666835|541968249|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
150227254|NCT00666835|541968250|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
150227255|NCT00666835|541968249|FG000|Overall Study|Hemoglobulin concentration|4|||
150227256|NCT00666835|541968250|FG001|Overall Study|Hemoglobulin concentration|3|||
150227257|NCT00666835|541968249|FG000|Overall Study|Planned operation|2|||
150227258|NCT00666835|541968250|FG001|Overall Study|Planned operation|0|||
150227259|NCT00666835|541968249|FG000|Overall Study|Physician Decision|1|||
150227260|NCT00666835|541968250|FG001|Overall Study|Physician Decision|2|||
150227261|NCT00511147|541968253|FG000|Overall Study|Withdrawal by Subject|1|||
150227262|NCT00511147|541968253|FG000|Overall Study|Disease progression|5|||
150227263|NCT00511147|541968253|FG000|Overall Study|Required platelet transfusion|1|||
150227264|NCT00899379|541968254|FG000|Overall Study|Adverse Event|2|||
150227265|NCT00899379|541968255|FG001|Overall Study|Adverse Event|2|||
150227266|NCT00899379|541968256|FG002|Overall Study|Adverse Event|1|||
150227267|NCT00899379|541968257|FG003|Overall Study|Adverse Event|1|||
150227268|NCT00899379|541968258|FG004|Overall Study|Adverse Event|2|||
150227269|NCT00899379|541968254|FG000|Overall Study|Lack of Efficacy|0|||
150227270|NCT00899379|541968255|FG001|Overall Study|Lack of Efficacy|4|||
150227271|NCT00899379|541968256|FG002|Overall Study|Lack of Efficacy|3|||
150227272|NCT00899379|541968257|FG003|Overall Study|Lack of Efficacy|0|||
150227273|NCT00899379|541968258|FG004|Overall Study|Lack of Efficacy|1|||
150227274|NCT00899379|541968254|FG000|Overall Study|Lost to Follow-up|9|||
150227275|NCT00899379|541968255|FG001|Overall Study|Lost to Follow-up|3|||
150227276|NCT00899379|541968256|FG002|Overall Study|Lost to Follow-up|0|||
150227277|NCT00899379|541968257|FG003|Overall Study|Lost to Follow-up|6|||
150227278|NCT00899379|541968258|FG004|Overall Study|Lost to Follow-up|2|||
150141618|NCT02243202|541653976|FG000|Overall Study|Randomized but not received treatment|0|||
150141619|NCT02243202|541653977|FG001|Overall Study|Randomized but not received treatment|0|||
150141620|NCT02243202|541653978|FG002|Overall Study|Randomized but not received treatment|0|||
150141621|NCT02243202|541653979|FG003|Overall Study|Randomized but not received treatment|1|||
150141622|NCT04382924|541653981|FG000|Overall Study|Death|2|||
150141623|NCT04382924|541653982|FG001|Overall Study|Death|5|||
150141624|NCT04382924|541653983|FG002|Overall Study|Death|4|||
150141625|NCT04382924|541653981|FG000|Overall Study|Protocol Violation|0|||
150141626|NCT04382924|541653982|FG001|Overall Study|Protocol Violation|1|||
150141627|NCT04382924|541653983|FG002|Overall Study|Protocol Violation|1|||
150141628|NCT04382924|541653981|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
150141629|NCT04382924|541653982|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
150141630|NCT04382924|541653983|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
150141631|NCT04382924|541653981|FG000|Overall Study|Withdrawal by Subject|6|||
150141632|NCT04382924|541653982|FG001|Overall Study|Withdrawal by Subject|3|||
150141633|NCT04382924|541653983|FG002|Overall Study|Withdrawal by Subject|6|||
150141634|NCT01114204|541653989|FG000|Overall Study|Adverse Event|3|||
150141635|NCT01114204|541653990|FG001|Overall Study|Adverse Event|2|||
150141636|NCT01114204|541653989|FG000|Overall Study|Lost to Follow-up|1|||
150141637|NCT01114204|541653990|FG001|Overall Study|Lost to Follow-up|0|||
150141638|NCT01114204|541653989|FG000|Overall Study|Withdrawal by Subject|10|||
150141639|NCT01114204|541653990|FG001|Overall Study|Withdrawal by Subject|6|||
150141640|NCT01114204|541653989|FG000|Overall Study|Death|1|||
150141641|NCT01114204|541653990|FG001|Overall Study|Death|0|||
150141642|NCT01114204|541653989|FG000|Overall Study|Other-Personal reasons|2|||
150141643|NCT01114204|541653990|FG001|Overall Study|Other-Personal reasons|0|||
150141644|NCT01114204|541653989|FG000|Overall Study|Other-Medical monitor request|1|||
150141645|NCT01114204|541653990|FG001|Overall Study|Other-Medical monitor request|0|||
150141646|NCT01114204|541653989|FG000|Overall Study|Other-Participant request|2|||
150141647|NCT01114204|541653990|FG001|Overall Study|Other-Participant request|0|||
150141648|NCT01114204|541653989|FG000|Overall Study|Other-Protocol Violation|1|||
150141649|NCT01114204|541653990|FG001|Overall Study|Other-Protocol Violation|0|||
150141650|NCT00991341|541653995|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
150141651|NCT00991341|541653996|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
150141652|NCT00991341|541653995|FG000|Overall Study|Death|3|||
150141653|NCT00991341|541653996|FG001|Overall Study|Death|0|||
150141654|NCT00991341|541653995|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
150141655|NCT00991341|541653996|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
150141656|NCT00991341|541653995|FG000|Overall Study|Physician Decision|1|||
150141657|NCT00991341|541653996|FG001|Overall Study|Physician Decision|2|||
150141658|NCT00991341|541653995|FG000|Overall Study|Withdrawal by Subject|3|||
150141659|NCT00991341|541653996|FG001|Overall Study|Withdrawal by Subject|4|||
150141660|NCT00215540|541654001|FG000|Overall Study|Withdrew from study medication|1|||
150141661|NCT00215540|541654002|FG001|Overall Study|Withdrew from study medication|0|||
150141662|NCT00215540|541654003|FG002|Overall Study|Withdrew from study medication|0|||
150141663|NCT03010462|541654004|FG000|Overall Study|Withdrawal by Subject|3|||
150227279|NCT00899379|541968254|FG000|Overall Study|Protocol Violation|0|||
150227280|NCT00899379|541968255|FG001|Overall Study|Protocol Violation|0|||
150227281|NCT00899379|541968256|FG002|Overall Study|Protocol Violation|1|||
150227282|NCT00899379|541968257|FG003|Overall Study|Protocol Violation|1|||
150227283|NCT00899379|541968258|FG004|Overall Study|Protocol Violation|0|||
150227284|NCT00899379|541968254|FG000|Overall Study|Withdrawal by Subject|2|||
150227285|NCT00899379|541968255|FG001|Overall Study|Withdrawal by Subject|4|||
150227286|NCT00899379|541968256|FG002|Overall Study|Withdrawal by Subject|2|||
150227287|NCT00899379|541968257|FG003|Overall Study|Withdrawal by Subject|3|||
150227288|NCT00899379|541968258|FG004|Overall Study|Withdrawal by Subject|6|||
150227289|NCT00899379|541968254|FG000|Overall Study|Pregnancy|0|||
150227290|NCT00899379|541968255|FG001|Overall Study|Pregnancy|0|||
150227291|NCT00899379|541968256|FG002|Overall Study|Pregnancy|1|||
150227292|NCT00899379|541968257|FG003|Overall Study|Pregnancy|0|||
150227293|NCT00899379|541968258|FG004|Overall Study|Pregnancy|1|||
150227294|NCT00899379|541968254|FG000|Overall Study|Patient Uncooperative|0|||
150227295|NCT00899379|541968255|FG001|Overall Study|Patient Uncooperative|1|||
150227296|NCT00899379|541968256|FG002|Overall Study|Patient Uncooperative|0|||
150227297|NCT00899379|541968257|FG003|Overall Study|Patient Uncooperative|1|||
150227298|NCT00899379|541968258|FG004|Overall Study|Patient Uncooperative|2|||
150227299|NCT00899379|541968254|FG000|Overall Study|Abnormal Baseline ECG|0|||
150227300|NCT00899379|541968255|FG001|Overall Study|Abnormal Baseline ECG|0|||
150227301|NCT00899379|541968256|FG002|Overall Study|Abnormal Baseline ECG|0|||
150227302|NCT00899379|541968257|FG003|Overall Study|Abnormal Baseline ECG|1|||
150227303|NCT00899379|541968258|FG004|Overall Study|Abnormal Baseline ECG|0|||
150227304|NCT00899379|541968254|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
150227305|NCT00899379|541968255|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
150227306|NCT00899379|541968256|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
150227307|NCT00899379|541968257|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227308|NCT00899379|541968258|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227309|NCT00899379|541968254|FG000|Overall Study|Not Completed/Entered Extn|5|||
150227310|NCT00899379|541968255|FG001|Overall Study|Not Completed/Entered Extn|1|||
150227311|NCT00899379|541968256|FG002|Overall Study|Not Completed/Entered Extn|6|||
150227312|NCT00899379|541968257|FG003|Overall Study|Not Completed/Entered Extn|4|||
150227313|NCT00899379|541968258|FG004|Overall Study|Not Completed/Entered Extn|3|||
150227314|NCT00899379|541968254|FG000|Overall Study|Study Terminated|3|||
150227315|NCT00899379|541968255|FG001|Overall Study|Study Terminated|0|||
150227316|NCT00899379|541968256|FG002|Overall Study|Study Terminated|3|||
150227317|NCT00899379|541968257|FG003|Overall Study|Study Terminated|3|||
150227318|NCT00899379|541968258|FG004|Overall Study|Study Terminated|1|||
150227319|NCT00899379|541968254|FG000|Overall Study|Lost to Follow-up|3|||
150227320|NCT00899379|541968255|FG001|Overall Study|Lost to Follow-up|1|||
150227321|NCT00899379|541968256|FG002|Overall Study|Lost to Follow-up|0|||
150227322|NCT00899379|541968257|FG003|Overall Study|Lost to Follow-up|2|||
150227323|NCT00899379|541968258|FG004|Overall Study|Lost to Follow-up|5|||
150227324|NCT00899379|541968254|FG000|Overall Study|Withdrawal by Subject|4|||
150227325|NCT00899379|541968255|FG001|Overall Study|Withdrawal by Subject|7|||
150227326|NCT00899379|541968256|FG002|Overall Study|Withdrawal by Subject|4|||
150227327|NCT00899379|541968257|FG003|Overall Study|Withdrawal by Subject|7|||
150227328|NCT00899379|541968258|FG004|Overall Study|Withdrawal by Subject|2|||
150227329|NCT00899379|541968254|FG000|Overall Study|Pregnancy|1|||
150227330|NCT00899379|541968255|FG001|Overall Study|Pregnancy|0|||
150227331|NCT00899379|541968256|FG002|Overall Study|Pregnancy|0|||
150227332|NCT00899379|541968257|FG003|Overall Study|Pregnancy|0|||
150227333|NCT00899379|541968258|FG004|Overall Study|Pregnancy|0|||
150227334|NCT00899379|541968254|FG000|Overall Study|Patient Uncooperative|0|||
150227335|NCT00899379|541968255|FG001|Overall Study|Patient Uncooperative|0|||
150227336|NCT00899379|541968256|FG002|Overall Study|Patient Uncooperative|0|||
150227337|NCT00899379|541968257|FG003|Overall Study|Patient Uncooperative|1|||
150227338|NCT00899379|541968258|FG004|Overall Study|Patient Uncooperative|0|||
150227339|NCT00899379|541968254|FG000|Overall Study|Abnormal Prestudy Labs|0|||
150227340|NCT00899379|541968255|FG001|Overall Study|Abnormal Prestudy Labs|0|||
150227341|NCT00899379|541968256|FG002|Overall Study|Abnormal Prestudy Labs|0|||
150227342|NCT00899379|541968257|FG003|Overall Study|Abnormal Prestudy Labs|0|||
150227343|NCT00899379|541968258|FG004|Overall Study|Abnormal Prestudy Labs|2|||
150227344|NCT00899379|541968254|FG000|Overall Study|Abnormal Baseline ECG|0|||
150227345|NCT00899379|541968255|FG001|Overall Study|Abnormal Baseline ECG|0|||
150227346|NCT00899379|541968256|FG002|Overall Study|Abnormal Baseline ECG|1|||
150227347|NCT00899379|541968257|FG003|Overall Study|Abnormal Baseline ECG|1|||
150227348|NCT00899379|541968258|FG004|Overall Study|Abnormal Baseline ECG|0|||
150227349|NCT00899379|541968254|FG000|Overall Study|No Attack Pretreatment|3|||
150227350|NCT00899379|541968255|FG001|Overall Study|No Attack Pretreatment|5|||
150227351|NCT00899379|541968256|FG002|Overall Study|No Attack Pretreatment|5|||
150227352|NCT00899379|541968257|FG003|Overall Study|No Attack Pretreatment|6|||
150227353|NCT00899379|541968258|FG004|Overall Study|No Attack Pretreatment|4|||
150227354|NCT00899379|541968254|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
150227355|NCT00899379|541968255|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227356|NCT00899379|541968256|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227357|NCT00899379|541968257|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227358|NCT00899379|541968258|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
150227359|NCT00899379|541968254|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
150227360|NCT00899379|541968255|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
150227361|NCT00899379|541968256|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
150227362|NCT00899379|541968257|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
150227363|NCT00899379|541968258|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
150227364|NCT00809783|541968259|FG000|Overall Study|Death|1|||
150227365|NCT00809783|541968260|FG001|Overall Study|Death|0|||
150227366|NCT00809783|541968261|FG002|Overall Study|Death|0|||
150227367|NCT00809783|541968259|FG000|Overall Study|Adverse Event|34|||
150227368|NCT00809783|541968260|FG001|Overall Study|Adverse Event|52|||
150227369|NCT00809783|541968261|FG002|Overall Study|Adverse Event|71|||
150227370|NCT00809783|541968259|FG000|Overall Study|Lack of Efficacy|39|||
150227371|NCT00809783|541968260|FG001|Overall Study|Lack of Efficacy|52|||
150227372|NCT00809783|541968261|FG002|Overall Study|Lack of Efficacy|63|||
150227373|NCT00809783|541968259|FG000|Overall Study|Lost to Follow-up|0|||
150227374|NCT00809783|541968260|FG001|Overall Study|Lost to Follow-up|3|||
150227375|NCT00809783|541968261|FG002|Overall Study|Lost to Follow-up|4|||
150227376|NCT00809783|541968259|FG000|Overall Study|Withdrawal by Subject|47|||
150227377|NCT00809783|541968260|FG001|Overall Study|Withdrawal by Subject|72|||
150227378|NCT00809783|541968261|FG002|Overall Study|Withdrawal by Subject|64|||
150227379|NCT00809783|541968259|FG000|Overall Study|Protocol Violation|2|||
150227380|NCT00809783|541968260|FG001|Overall Study|Protocol Violation|6|||
150227381|NCT00809783|541968261|FG002|Overall Study|Protocol Violation|5|||
150227382|NCT00809783|541968259|FG000|Overall Study|Randomized, but not treated|3|||
150227383|NCT00809783|541968260|FG001|Overall Study|Randomized, but not treated|0|||
150227384|NCT00809783|541968261|FG002|Overall Study|Randomized, but not treated|2|||
150227385|NCT00809783|541968259|FG000|Overall Study|Study Terminated by Sponsor|378|||
150227386|NCT00809783|541968260|FG001|Overall Study|Study Terminated by Sponsor|626|||
150227387|NCT00809783|541968261|FG002|Overall Study|Study Terminated by Sponsor|565|||
150227388|NCT00809783|541968259|FG000|Overall Study|Other|21|||
150227389|NCT00809783|541968260|FG001|Overall Study|Other|21|||
150227390|NCT00809783|541968261|FG002|Overall Study|Other|16|||
150227391|NCT00126555|541968262|FG000|Overall Study|Withdrawal by Subject|1|||
150227392|NCT00126555|541968262|FG000|Overall Study|Adverse Event|2|||
150227393|NCT00126555|541968262|FG000|Overall Study|Progressive Disease|3|||
150227394|NCT01780545|541968269|FG000|Overall Study|Withdrawal by Subject|3|||
150227395|NCT01780545|541968270|FG001|Overall Study|Withdrawal by Subject|1|||
150227396|NCT01780545|541968269|FG000|Overall Study|Lost to Follow-up|1|||
150227397|NCT01780545|541968270|FG001|Overall Study|Lost to Follow-up|1|||
150227398|NCT02253147|541968271|FG000|Overall Study|Protocol Violation|30|||
150227399|NCT02253147|541968271|FG000|Overall Study|Did not consent to study extension|9|||
150227400|NCT02253147|541968271|FG000|Overall Study|Conditional re-treatment at W52|5|||
150227401|NCT02253147|541968271|FG000|Overall Study|Lost to Follow-up|2|||
150227402|NCT02253147|541968271|FG000|Overall Study|Withdrawal by Subject|1|||
150227403|NCT00396097|541968275|FG000|Overall Study|Withdrawal by Subject|17|||
150227404|NCT00396097|541968276|FG001|Overall Study|Withdrawal by Subject|17|||
150227405|NCT00396097|541968275|FG000|Overall Study|Lost to Follow-up|4|||
150227406|NCT00396097|541968276|FG001|Overall Study|Lost to Follow-up|9|||
150227407|NCT00396097|541968275|FG000|Overall Study|Other|3|||
150227408|NCT00396097|541968276|FG001|Overall Study|Other|5|||
150227409|NCT00396097|541968275|FG000|Overall Study|Protocol Violation|0|||
150227410|NCT00396097|541968276|FG001|Overall Study|Protocol Violation|6|||
150227411|NCT00396097|541968275|FG000|Overall Study|Adverse Event|1|||
150227412|NCT00396097|541968276|FG001|Overall Study|Adverse Event|5|||
150227413|NCT00396097|541968275|FG000|Overall Study|Insufficient Clinical Response|1|||
150227414|NCT00396097|541968276|FG001|Overall Study|Insufficient Clinical Response|4|||
150227415|NCT02973477|541968277|FG000|First Intervention|Lost to Follow-up|0|||
150227416|NCT02973477|541968278|FG001|First Intervention|Lost to Follow-up|2|||
150227417|NCT02973477|541968277|FG000|Washout|Withdrawal by Subject|1|||
150227418|NCT02973477|541968278|FG001|Washout|Withdrawal by Subject|0|||
150227419|NCT02973477|541968277|FG000|Second Intervention|Lost to Follow-up|1|||
150227420|NCT02973477|541968278|FG001|Second Intervention|Lost to Follow-up|0|||
150227421|NCT03461211|541968279|FG000|Overall Study|Adverse Event|1|||
150227422|NCT03461211|541968280|FG001|Overall Study|Adverse Event|1|||
150227423|NCT03461211|541968279|FG000|Overall Study|Lack of Efficacy|0|||
150227424|NCT03461211|541968280|FG001|Overall Study|Lack of Efficacy|1|||
150227425|NCT03807700|541968281|FG000|Overall Study|Withdrawal by Subject|2|||
150227426|NCT03807700|541968282|FG001|Overall Study|Withdrawal by Subject|1|||
150227427|NCT03187353|541968286|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
150227428|NCT03187353|541968287|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
150227429|NCT03187353|541968286|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
150227430|NCT03187353|541968287|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
150227431|NCT03187353|541968286|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
150227432|NCT03187353|541968287|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
150227433|NCT03187353|541968286|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
150227434|NCT03187353|541968287|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
150227435|NCT03187353|541968286|FG000|Washout (2 Weeks)|Adverse Event|2|||
150227436|NCT03187353|541968287|FG001|Washout (2 Weeks)|Adverse Event|0|||
150227437|NCT03187353|541968286|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
150227438|NCT03187353|541968287|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
150227439|NCT02359552|541968290|FG000|Overall Study|Lost to Follow-up|3|||
150227440|NCT02359552|541968291|FG001|Overall Study|Lost to Follow-up|4|||
150227441|NCT01747629|541968292|FG000|Overall Study|Adverse Event|1|||
150227442|NCT01747629|541968293|FG001|Overall Study|Adverse Event|2|||
150227443|NCT01747629|541968292|FG000|Overall Study|Withdrawal by Subject|2|||
150227444|NCT01747629|541968293|FG001|Overall Study|Withdrawal by Subject|2|||
150227445|NCT01747629|541968292|FG000|Overall Study|Noncompliance|1|||
150227446|NCT01747629|541968293|FG001|Overall Study|Noncompliance|1|||
150227447|NCT01747629|541968292|FG000|Overall Study|Inclusion criteria not met|1|||
150227448|NCT01747629|541968293|FG001|Overall Study|Inclusion criteria not met|0|||
150227449|NCT01747629|541968292|FG000|Overall Study|Not treated|1|||
150227450|NCT01747629|541968293|FG001|Overall Study|Not treated|0|||
150227451|NCT01747629|541968292|FG000|Overall Study|Other|2|||
150227452|NCT01747629|541968293|FG001|Overall Study|Other|1|||
150227453|NCT00794573|541968311|FG000|Overall Study|Death|3|||
150227454|NCT00794573|541968312|FG001|Overall Study|Death|0|||
150227455|NCT00794573|541968311|FG000|Overall Study|Withdrawal by Subject|9|||
150227456|NCT00794573|541968312|FG001|Overall Study|Withdrawal by Subject|12|||
150227457|NCT00794573|541968311|FG000|Overall Study|Lost to Follow-up|26|||
150227458|NCT00794573|541968312|FG001|Overall Study|Lost to Follow-up|33|||
150227459|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
150227460|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
150227461|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
150227462|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
150227463|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
150227464|NCT00500539|541968313|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
150227465|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
150227466|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
150227467|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
150227468|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
150227469|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Death|1|||
150227470|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
150227471|NCT00500539|541968313|FG000|Follow-up Period (16 Weeks)|Missing|3|||
150227472|NCT03993054|541968314|FG000|Overall Study|PI Decision|1|||
150227473|NCT00497198|541968318|FG000|Overall Study|Adverse Event|4|||
150227474|NCT00497198|541968319|FG001|Overall Study|Adverse Event|2|||
150227475|NCT00497198|541968318|FG000|Overall Study|Physician Decision|1|||
150227476|NCT00497198|541968319|FG001|Overall Study|Physician Decision|2|||
150227477|NCT00497198|541968318|FG000|Overall Study|Withdrawal by Subject|0|||
150227478|NCT00497198|541968319|FG001|Overall Study|Withdrawal by Subject|1|||
150227479|NCT01983462|541970543|FG000|Overall Study|Adverse Event|1|||
150227480|NCT01983462|541970544|FG001|Overall Study|Adverse Event|0|||
150227481|NCT01983462|541970545|FG002|Overall Study|Adverse Event|0|||
150227482|NCT02229396|541970546|FG000|Overall Study|Adverse Event|6|||
150227483|NCT02229396|541970547|FG001|Overall Study|Adverse Event|12|||
150227484|NCT02229396|541970548|FG002|Overall Study|Adverse Event|12|||
150227485|NCT02229396|541970546|FG000|Overall Study|Death|2|||
150227486|NCT02229396|541970547|FG001|Overall Study|Death|3|||
150227487|NCT02229396|541970548|FG002|Overall Study|Death|1|||
150227488|NCT02229396|541970546|FG000|Overall Study|Lost to Follow-up|14|||
150227489|NCT02229396|541970547|FG001|Overall Study|Lost to Follow-up|14|||
150227490|NCT02229396|541970548|FG002|Overall Study|Lost to Follow-up|21|||
150227491|NCT02229396|541970546|FG000|Overall Study|Protocol Violation|2|||
150227492|NCT02229396|541970547|FG001|Overall Study|Protocol Violation|1|||
150227493|NCT02229396|541970548|FG002|Overall Study|Protocol Violation|0|||
150227494|NCT02229396|541970546|FG000|Overall Study|Patient Incorrectly Randomized|0|||
150227495|NCT02229396|541970547|FG001|Overall Study|Patient Incorrectly Randomized|0|||
150227496|NCT02229396|541970548|FG002|Overall Study|Patient Incorrectly Randomized|1|||
150227497|NCT02229396|541970546|FG000|Overall Study|Other|10|||
150227498|NCT02229396|541970547|FG001|Overall Study|Other|18|||
150227499|NCT02229396|541970548|FG002|Overall Study|Other|15|||
150227500|NCT02229396|541970546|FG000|Overall Study|Withdrawal by Subject|42|||
150227501|NCT02229396|541970547|FG001|Overall Study|Withdrawal by Subject|28|||
150227502|NCT02229396|541970548|FG002|Overall Study|Withdrawal by Subject|41|||
150227503|NCT02229396|541970546|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
150227504|NCT02229396|541970547|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
150227505|NCT02229396|541970548|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
150227506|NCT02229396|541970546|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
150227507|NCT02229396|541970547|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
150227508|NCT02229396|541970548|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
150227509|NCT02679079|541970549|FG000|Overall Study|Adverse Event|2|||
150227510|NCT02679079|541970550|FG001|Overall Study|Adverse Event|0|||
150227511|NCT02679079|541970551|FG002|Overall Study|Adverse Event|2|||
150227512|NCT02679079|541970549|FG000|Overall Study|Protocol Violation|0|||
150227513|NCT02679079|541970550|FG001|Overall Study|Protocol Violation|1|||
150227514|NCT02679079|541970551|FG002|Overall Study|Protocol Violation|0|||
150227515|NCT02679079|541970549|FG000|Overall Study|Withdrawal by Subject|2|||
150227516|NCT02679079|541970550|FG001|Overall Study|Withdrawal by Subject|1|||
150227517|NCT02679079|541970551|FG002|Overall Study|Withdrawal by Subject|0|||
150227518|NCT03924947|541970552|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
150227519|NCT03924947|541970553|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
150227520|NCT03924947|541970554|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
150227521|NCT03924947|541970555|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
150227522|NCT03924947|541970556|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
150227523|NCT03924947|541970557|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
150227524|NCT00805285|541970560|FG000|Overall Study|Lack of Efficacy|1|||
150227525|NCT05060237|541970561|FG000|Overall Study|Withdrawal by Subject|4|||
150227526|NCT05060237|541970561|FG000|Overall Study|Screening failure|8|||
150227527|NCT01066897|541970562|FG000|Overall Study|Withdrawal by Subject|1|||
150227528|NCT01066897|541970563|FG001|Overall Study|Withdrawal by Subject|0|||
150227529|NCT01066897|541970562|FG000|Overall Study|stopped study after developing the flu.|1|||
150227530|NCT01066897|541970563|FG001|Overall Study|stopped study after developing the flu.|0|||
150227531|NCT01697592|541970564|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
150227532|NCT01697592|541970565|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227533|NCT01697592|541970566|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227534|NCT01697592|541970567|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227535|NCT01697592|541970568|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227536|NCT01697592|541970569|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227537|NCT01697592|541970570|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227538|NCT01697592|541970571|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227539|NCT01697592|541970572|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227540|NCT01697592|541970573|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
150227541|NCT01697592|541970564|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227542|NCT01697592|541970565|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227543|NCT01697592|541970566|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227544|NCT01697592|541970567|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227545|NCT01697592|541970568|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227546|NCT01697592|541970569|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
150227547|NCT01697592|541970570|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227548|NCT01697592|541970571|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227549|NCT01697592|541970572|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227550|NCT01697592|541970573|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
150227551|NCT01697592|541970564|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
150227552|NCT01697592|541970565|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227553|NCT01697592|541970566|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227554|NCT01697592|541970567|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227555|NCT01697592|541970568|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227556|NCT01697592|541970569|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227557|NCT01697592|541970570|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227558|NCT01697592|541970571|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227559|NCT01697592|541970572|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227560|NCT01697592|541970573|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
150227561|NCT01697592|541970564|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
150227562|NCT01697592|541970565|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
150227563|NCT01697592|541970566|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227564|NCT01697592|541970567|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227565|NCT01697592|541970568|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227566|NCT01697592|541970569|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227567|NCT01697592|541970570|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
150227568|NCT01697592|541970571|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227569|NCT01697592|541970572|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
150227570|NCT01697592|541970573|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
150227571|NCT01697592|541970564|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
150227572|NCT01697592|541970565|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
150227573|NCT01697592|541970566|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
150227574|NCT01697592|541970567|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
150227575|NCT01697592|541970568|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
150227576|NCT01697592|541970569|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
150227577|NCT01697592|541970570|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
150227578|NCT01697592|541970571|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
150227579|NCT01697592|541970572|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
150227580|NCT01697592|541970573|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
150227581|NCT01697592|541970564|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
150227582|NCT01697592|541970565|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227583|NCT01697592|541970566|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227584|NCT01697592|541970567|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
150227585|NCT01697592|541970568|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227586|NCT01697592|541970569|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227587|NCT01697592|541970570|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227588|NCT01697592|541970571|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227589|NCT01697592|541970572|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227590|NCT01697592|541970573|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
150227591|NCT01697592|541970564|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
150227592|NCT01697592|541970565|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227593|NCT01697592|541970566|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227594|NCT01697592|541970567|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227595|NCT01697592|541970568|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227596|NCT01697592|541970569|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
150227597|NCT01697592|541970570|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227598|NCT01697592|541970571|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
150227599|NCT01697592|541970572|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227600|NCT01697592|541970573|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
150227601|NCT01697592|541970564|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
150227602|NCT01697592|541970565|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
150227603|NCT01697592|541970566|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
150227604|NCT01697592|541970567|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
150227605|NCT01697592|541970568|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
150227606|NCT01697592|541970569|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
150227607|NCT01697592|541970570|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
150227608|NCT01697592|541970571|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
150227609|NCT01697592|541970572|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
150227610|NCT01697592|541970573|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
150227611|NCT02110225|541970574|FG000|Overall Study|Lost to Follow-up|0|||
150227612|NCT02110225|541970575|FG001|Overall Study|Lost to Follow-up|1|||
150227613|NCT02110225|541970576|FG002|Overall Study|Lost to Follow-up|0|||
150227614|NCT00774306|541970577|FG000|Overall Study|Adverse Event|3|||
150227615|NCT00774306|541970578|FG001|Overall Study|Adverse Event|0|||
150227616|NCT00774306|541970579|FG002|Overall Study|Adverse Event|0|||
150227617|NCT00774306|541970580|FG003|Overall Study|Adverse Event|0|||
150227618|NCT00774306|541970577|FG000|Overall Study|Protocol Violation|2|||
150227619|NCT00774306|541970578|FG001|Overall Study|Protocol Violation|0|||
150227620|NCT00774306|541970579|FG002|Overall Study|Protocol Violation|3|||
150227621|NCT00774306|541970580|FG003|Overall Study|Protocol Violation|0|||
150227622|NCT00774306|541970577|FG000|Overall Study|Withdrawal by Subject|6|||
150227623|NCT00774306|541970578|FG001|Overall Study|Withdrawal by Subject|1|||
150227624|NCT00774306|541970579|FG002|Overall Study|Withdrawal by Subject|1|||
150227625|NCT00774306|541970580|FG003|Overall Study|Withdrawal by Subject|0|||
150227626|NCT00774306|541970577|FG000|Overall Study|Lost to Follow-up|6|||
150227627|NCT00774306|541970578|FG001|Overall Study|Lost to Follow-up|0|||
150227628|NCT00774306|541970579|FG002|Overall Study|Lost to Follow-up|4|||
150227629|NCT00774306|541970580|FG003|Overall Study|Lost to Follow-up|5|||
150227630|NCT00774306|541970577|FG000|Overall Study|Death|1|||
150227631|NCT00774306|541970578|FG001|Overall Study|Death|1|||
150141664|NCT03010462|541654005|FG001|Overall Study|Withdrawal by Subject|1|||
150141665|NCT03505476|541654006|FG000|Overall Study|Physician Decision|18|||
150141666|NCT03505476|541654006|FG000|Overall Study|Device Malfunctioned|101|||
150141667|NCT03505476|541654006|FG000|Overall Study|Data Corrupt|6|||
150141668|NCT03505476|541654006|FG000|Overall Study|Device application insufficiant|3|||
150141669|NCT02748694|541654007|FG000|Overall Study|Voluntary Withdrawal|0|||
150141670|NCT02748694|541654008|FG001|Overall Study|Voluntary Withdrawal|0|||
150141671|NCT02748694|541654009|FG002|Overall Study|Voluntary Withdrawal|0|||
150141672|NCT02748694|541654010|FG003|Overall Study|Voluntary Withdrawal|0|||
150141673|NCT02748694|541654011|FG004|Overall Study|Voluntary Withdrawal|0|||
150141674|NCT02748694|541654012|FG005|Overall Study|Voluntary Withdrawal|0|||
150141675|NCT02748694|541654013|FG006|Overall Study|Voluntary Withdrawal|0|||
150141676|NCT02748694|541654014|FG007|Overall Study|Voluntary Withdrawal|0|||
150141677|NCT02748694|541654015|FG008|Overall Study|Voluntary Withdrawal|0|||
150141678|NCT02748694|541654016|FG009|Overall Study|Voluntary Withdrawal|0|||
150141679|NCT02748694|541654017|FG010|Overall Study|Voluntary Withdrawal|0|||
150141680|NCT02748694|541654018|FG011|Overall Study|Voluntary Withdrawal|0|||
150141681|NCT02748694|541654019|FG012|Overall Study|Voluntary Withdrawal|0|||
150141682|NCT02748694|541654020|FG013|Overall Study|Voluntary Withdrawal|0|||
150141683|NCT02748694|541654021|FG014|Overall Study|Voluntary Withdrawal|2|||
150141684|NCT02007434|541654022|FG000|Overall Study|Lost to Follow-up|0|||
150141685|NCT02007434|541654023|FG001|Overall Study|Lost to Follow-up|1|||
150141686|NCT02007434|541654024|FG002|Overall Study|Lost to Follow-up|0|||
150141687|NCT02007434|541654025|FG003|Overall Study|Lost to Follow-up|0|||
150141688|NCT02007434|541654026|FG004|Overall Study|Lost to Follow-up|0|||
150227632|NCT00774306|541970579|FG002|Overall Study|Death|0|||
150141689|NCT02007434|541654027|FG005|Overall Study|Lost to Follow-up|0|||
150227633|NCT00774306|541970580|FG003|Overall Study|Death|0|||
150227634|NCT02621047|541970581|FG000|Overall Study|Adverse Event|0|||
150227635|NCT02621047|541970582|FG001|Overall Study|Adverse Event|0|||
150227636|NCT02621047|541970583|FG002|Overall Study|Adverse Event|1|||
150227637|NCT01264887|541970587|FG000|Overall Study|Adverse Event|5|||
150227638|NCT01264887|541970587|FG000|Overall Study|Death|7|||
150227639|NCT01264887|541970587|FG000|Overall Study|Lack of Efficacy|5|||
150227640|NCT01264887|541970587|FG000|Overall Study|Physician Decision|4|||
150227641|NCT01264887|541970587|FG000|Overall Study|Withdrawal by Subject|6|||
150227642|NCT01264887|541970587|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
150227643|NCT01264887|541970587|FG000|Overall Study|Other|2|||
150227644|NCT00591409|541970588|FG000|Overall Study|Not Treated|0|||
150227645|NCT00591409|541970589|FG001|Overall Study|Not Treated|0|||
150227646|NCT00591409|541970590|FG002|Overall Study|Not Treated|0|||
150227647|NCT00591409|541970591|FG003|Overall Study|Not Treated|0|||
150227648|NCT00591409|541970592|FG004|Overall Study|Not Treated|1|||
150227649|NCT00591409|541970593|FG005|Overall Study|Not Treated|0|||
150227650|NCT00591409|541970594|FG006|Overall Study|Not Treated|0|||
150227651|NCT00591409|541970595|FG007|Overall Study|Not Treated|0|||
150227652|NCT00591409|541970596|FG008|Overall Study|Not Treated|0|||
150227653|NCT00591409|541970597|FG009|Overall Study|Not Treated|1|||
150227654|NCT02171130|541970598|FG000|Overall Study|Death|1|||
150227655|NCT02171130|541970598|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
150227656|NCT02171130|541970598|FG000|Overall Study|Discontinued; Site Termination|5|||
150227657|NCT02171130|541970598|FG000|Overall Study|Withdrawal by Subject|3|||
150227658|NCT02171130|541970598|FG000|Overall Study|Physician Decision|1|||
150227659|NCT02171130|541970598|FG000|Overall Study|Lost to Follow-up|1|||
150227660|NCT02171130|541970598|FG000|Overall Study|Met Exclusion Criteria|1|||
150227661|NCT04531813|541970599|FG000|Overall Study|Protocol Violation|1|||
150227662|NCT04531813|541970599|FG000|Overall Study|Withdrawal by Subject|1|||
150227663|NCT02853305|541970600|FG000|Overall Study|Death|287|||
150227664|NCT02853305|541970601|FG001|Overall Study|Death|249|||
150227665|NCT02853305|541970602|FG002|Overall Study|Death|300|||
150227666|NCT02853305|541970600|FG000|Overall Study|Withdrawal by Subject|2|||
150227667|NCT02853305|541970601|FG001|Overall Study|Withdrawal by Subject|8|||
150227668|NCT02853305|541970602|FG002|Overall Study|Withdrawal by Subject|3|||
150227669|NCT02853305|541970600|FG000|Overall Study|Transferred to Extension Study|46|||
150227670|NCT02853305|541970601|FG001|Overall Study|Transferred to Extension Study|30|||
150227671|NCT02853305|541970602|FG002|Overall Study|Transferred to Extension Study|25|||
150227672|NCT02853305|541970600|FG000|Overall Study|Did Not Continue on Extension Study|16|||
150227673|NCT02853305|541970601|FG001|Overall Study|Did Not Continue on Extension Study|20|||
150227674|NCT02853305|541970602|FG002|Overall Study|Did Not Continue on Extension Study|24|||
150227675|NCT04772313|541970603|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
150227676|NCT04772313|541970603|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
150227677|NCT01836198|541970604|FG000|Part A, Period 2|Protocol Violation|0|||
150227678|NCT01836198|541970605|FG001|Part A, Period 2|Protocol Violation|1|||
150227679|NCT01836198|541970606|FG002|Part A, Period 2|Protocol Violation|0|||
150227680|NCT01061775|541970609|FG000|Overall Study|Physician Decision|2|||
150227681|NCT01061775|541970609|FG000|Overall Study|Lost to Follow-up|1|||
150227682|NCT00588341|541970610|FG000|Overall Study|Withdrawal by Subject|3|||
150227683|NCT00588341|541970610|FG000|Overall Study|Not treated due to metastatic disease|1|||
150227684|NCT00588341|541970610|FG000|Overall Study|Patient ineligible|1|||
150227685|NCT02567227|541970611|FG000|9 Weeks|Adverse Event|5|||
150227686|NCT02567227|541970612|FG001|9 Weeks|Adverse Event|5|||
150227687|NCT02567227|541970611|FG000|9 Weeks|Withdrawal by Subject|18|||
150227688|NCT02567227|541970612|FG001|9 Weeks|Withdrawal by Subject|8|||
150227689|NCT02567227|541970611|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
150227690|NCT02567227|541970612|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
150227691|NCT02567227|541970611|FG000|6 Month|Death|2|||
150227692|NCT02567227|541970612|FG001|6 Month|Death|0|||
150227693|NCT02567227|541970611|FG000|6 Month|Lost to Follow-up|43|||
150227694|NCT02567227|541970612|FG001|6 Month|Lost to Follow-up|40|||
150227695|NCT02567227|541970611|FG000|12 Months|Lost to Follow-up|31|||
150227696|NCT02567227|541970612|FG001|12 Months|Lost to Follow-up|32|||
150227697|NCT02567227|541970611|FG000|12 Months|Death|0|||
150227698|NCT02567227|541970612|FG001|12 Months|Death|2|||
150227699|NCT03746483|541970613|FG000|Overall Study|Adverse Event|0|||
150227700|NCT03746483|541970614|FG001|Overall Study|Adverse Event|1|||
150227701|NCT03746483|541970613|FG000|Overall Study|Lack of Efficacy|3|||
150227702|NCT03746483|541970614|FG001|Overall Study|Lack of Efficacy|2|||
150227703|NCT03746483|541970613|FG000|Overall Study|Lost to Follow-up|1|||
150227704|NCT03746483|541970614|FG001|Overall Study|Lost to Follow-up|0|||
150227705|NCT03746483|541970613|FG000|Overall Study|Protocol Violation|2|||
150227706|NCT03746483|541970614|FG001|Overall Study|Protocol Violation|0|||
150227707|NCT01954771|541970619|FG000|Overall Study|Missing HbA1c of end-point|1|||
150227708|NCT01954771|541970620|FG001|Overall Study|Missing HbA1c of end-point|1|||
150227709|NCT01954771|541970621|FG002|Overall Study|Missing HbA1c of end-point|0|||
150227710|NCT01954771|541970619|FG000|Overall Study|Missing CGMS of end-point|1|||
150227711|NCT01954771|541970620|FG001|Overall Study|Missing CGMS of end-point|1|||
150227712|NCT01954771|541970621|FG002|Overall Study|Missing CGMS of end-point|0|||
150227713|NCT01954771|541970619|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
150227714|NCT01954771|541970620|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
150227715|NCT01954771|541970621|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
150227716|NCT01026103|541970626|FG000|Overall Study|Physician Decision|1|||
150227717|NCT01026103|541970626|FG000|Overall Study|did not receive study device bc of error|1|||
150227718|NCT03635775|541970627|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
150227719|NCT03635775|541970628|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
150227720|NCT03635775|541970629|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
150227721|NCT03635775|541970630|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
150227722|NCT02498418|541970631|FG000|Overall Study|Lack of Efficacy|0|||
150227723|NCT02498418|541970632|FG001|Overall Study|Lack of Efficacy|0|||
150227724|NCT02498418|541970633|FG002|Overall Study|Lack of Efficacy|1|||
150227725|NCT02498418|541970631|FG000|Overall Study|Withdrawal by Subject|2|||
150227726|NCT02498418|541970632|FG001|Overall Study|Withdrawal by Subject|0|||
150227727|NCT02498418|541970633|FG002|Overall Study|Withdrawal by Subject|3|||
150227728|NCT02498418|541970631|FG000|Overall Study|Lost to Follow-up|0|||
150227729|NCT02498418|541970632|FG001|Overall Study|Lost to Follow-up|1|||
150227730|NCT02498418|541970633|FG002|Overall Study|Lost to Follow-up|1|||
150227731|NCT02498418|541970631|FG000|Overall Study|Participant taken prohibited medication|0|||
150227732|NCT02498418|541970632|FG001|Overall Study|Participant taken prohibited medication|1|||
150227733|NCT02498418|541970633|FG002|Overall Study|Participant taken prohibited medication|1|||
150227734|NCT00762502|541970634|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
150227735|NCT00762502|541970635|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
150227736|NCT00762502|541970636|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
150227737|NCT00762502|541970634|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
150227738|NCT00762502|541970635|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
150227739|NCT00762502|541970636|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
150227740|NCT00762502|541970634|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
150227741|NCT00762502|541970635|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
150227742|NCT00762502|541970636|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
150227743|NCT01675050|541970638|FG000|Period One Treatment|Withdrawal by Subject|1|||
150227744|NCT01675050|541970639|FG001|Period One Treatment|Withdrawal by Subject|0|||
150227745|NCT00264498|541970640|FG000|Randomized Treatment|Death|0|||
150227746|NCT00264498|541970641|FG001|Randomized Treatment|Death|3|||
150227747|NCT00264498|541970640|FG000|Randomized Treatment|Withdrawal by Subject|0|||
150227748|NCT00264498|541970641|FG001|Randomized Treatment|Withdrawal by Subject|1|||
150227749|NCT00264498|541970640|FG000|Randomized Treatment|Objective disease Progression|13|||
150227750|NCT00264498|541970641|FG001|Randomized Treatment|Objective disease Progression|14|||
150227751|NCT00264498|541970640|FG000|Randomized Treatment|Physician Decision|1|||
150227752|NCT00264498|541970641|FG001|Randomized Treatment|Physician Decision|0|||
150227753|NCT00264498|541970640|FG000|Randomized Treatment|Incorrectly randomized|1|||
150227754|NCT00264498|541970641|FG001|Randomized Treatment|Incorrectly randomized|0|||
150227755|NCT00264498|541970640|FG000|Randomized Treatment|Study Closure|1|||
150227756|NCT00264498|541970641|FG001|Randomized Treatment|Study Closure|0|||
150227757|NCT00264498|541970640|FG000|Randomized Treatment|Protocol Violation|1|||
150227758|NCT00264498|541970641|FG001|Randomized Treatment|Protocol Violation|0|||
150227759|NCT00264498|541970640|FG000|Crossover Treatment|Death|1|||
150227760|NCT00264498|541970641|FG001|Crossover Treatment|Death|3|||
150227761|NCT00264498|541970640|FG000|Crossover Treatment|Objective disease progression|4|||
150227762|NCT00264498|541970641|FG001|Crossover Treatment|Objective disease progression|5|||
150227763|NCT00264498|541970640|FG000|Crossover Treatment|Study closure|0|||
150227764|NCT00264498|541970641|FG001|Crossover Treatment|Study closure|1|||
150227765|NCT00264498|541970640|FG000|Crossover Treatment|Withdrawal by Subject|1|||
150227766|NCT00264498|541970641|FG001|Crossover Treatment|Withdrawal by Subject|0|||
150227767|NCT03794609|541970642|FG000|Overall Study|Other|10|||
150227768|NCT03794609|541970642|FG000|Overall Study|Withdrawal by Subject|66|||
150227769|NCT03794609|541970642|FG000|Overall Study|The child is enrolled in an interventional study|70|||
150227770|NCT03794609|541970642|FG000|Overall Study|Inclusion/exclusion criteria|8|||
150227771|NCT03794609|541970642|FG000|Overall Study|At sponsor's request|151|||
150227772|NCT03794609|541970642|FG000|Overall Study|Physician Decision|1|||
150227773|NCT03794609|541970642|FG000|Overall Study|Lost to Follow-up|5|||
150227774|NCT04543942|541970643|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
150227775|NCT04543942|541970644|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
150227776|NCT04543942|541970643|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
150227777|NCT04543942|541970644|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
150227778|NCT02205476|541970645|FG000|Overall Study|Study termination by Sponsor|7|||
150227779|NCT02205476|541970646|FG001|Overall Study|Study termination by Sponsor|3|||
150227780|NCT02625922|541970652|FG000|Overall Study|Non-availability of IMP|1|||
150227781|NCT02625922|541970653|FG001|Overall Study|Non-availability of IMP|1|||
150227782|NCT02625922|541970652|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
150227783|NCT02625922|541970653|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
150227784|NCT02391116|541970654|FG000|Treatment|Withdrawal by Subject|1|||
150227785|NCT02391116|541970654|FG000|Treatment|Protocol Violation|1|||
150227786|NCT02391116|541970654|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
150227787|NCT02391116|541970654|FG000|Treatment|AE with Clinical PD|3|||
150227788|NCT02391116|541970654|FG000|Safety Follow-up|Adverse Event|1|||
150227789|NCT02391116|541970654|FG000|Safety Follow-up|Withdrawal by Subject|4|||
150227790|NCT02391116|541970654|FG000|Safety Follow-up|Switching to Other Therapy|4|||
150227791|NCT02391116|541970654|FG000|Safety Follow-up|No Follow Up|1|||
150227792|NCT02391116|541970654|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
150227793|NCT02391116|541970654|FG000|Active Follow-up|Withdrawal by Subject|1|||
150227794|NCT02391116|541970654|FG000|Active Follow-up|Switching to Other Therapy|2|||
150227795|NCT02391116|541970654|FG000|Survival Follow-up|Withdrawal by Subject|3|||
150227796|NCT02391116|541970654|FG000|Survival Follow-up|Switching to Other Therapy|1|||
150227797|NCT02391545|541970661|FG000|Overall Study|Death|0|||
150227798|NCT02391545|541970662|FG001|Overall Study|Death|2|||
150227799|NCT02391545|541970661|FG000|Overall Study|Lost to Follow-up|0|||
150227800|NCT02391545|541970662|FG001|Overall Study|Lost to Follow-up|1|||
150227801|NCT02391545|541970661|FG000|Overall Study|Termination of study by sponsor|20|||
150227802|NCT02391545|541970662|FG001|Overall Study|Termination of study by sponsor|20|||
150227803|NCT02391545|541970661|FG000|Overall Study|Withdrawal by Subject|0|||
150227804|NCT02391545|541970662|FG001|Overall Study|Withdrawal by Subject|1|||
150227805|NCT02391545|541970661|FG000|Overall Study|Other Reasons|6|||
150227806|NCT02391545|541970662|FG001|Overall Study|Other Reasons|4|||
150227807|NCT01222078|541970663|FG000|Overall Study|Early termination of the study|1|||
150227808|NCT04089332|541970664|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
150227809|NCT04089332|541970664|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
150227810|NCT04089332|541970664|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
150227811|NCT01363297|541970666|FG000|Overall Study|Other|0|||
150227812|NCT01363297|541970667|FG001|Overall Study|Other|0|||
150227813|NCT01363297|541970668|FG002|Overall Study|Other|0|||
150227814|NCT01363297|541970669|FG003|Overall Study|Other|0|||
150227815|NCT01363297|541970670|FG004|Overall Study|Other|1|||
150227816|NCT01363297|541970666|FG000|Overall Study|Death|3|||
150227817|NCT01363297|541970667|FG001|Overall Study|Death|6|||
150227818|NCT01363297|541970668|FG002|Overall Study|Death|6|||
150227819|NCT01363297|541970669|FG003|Overall Study|Death|10|||
150227820|NCT01363297|541970670|FG004|Overall Study|Death|30|||
150227821|NCT00495612|541970673|FG000|Overall Study|Lost to Follow-up|1|||
150227822|NCT00495612|541970674|FG001|Overall Study|Lost to Follow-up|0|||
150227823|NCT00495612|541970673|FG000|Overall Study|Subject's Decision to Withdraw|3|||
150227824|NCT00495612|541970674|FG001|Overall Study|Subject's Decision to Withdraw|0|||
150227825|NCT06016127|541970677|FG000|Overall Study|Withdrawal by Subject|4|||
150227826|NCT06016127|541970678|FG001|Overall Study|Withdrawal by Subject|3|||
150227827|NCT02864147|541970685|FG000|Overall Study|Withdrawal by Subject|3|||
150227828|NCT02864147|541970686|FG001|Overall Study|Withdrawal by Subject|2|||
150227829|NCT02864147|541970687|FG002|Overall Study|Withdrawal by Subject|1|||
150227830|NCT02864147|541970685|FG000|Overall Study|Lost to Follow-up|0|||
150227831|NCT02864147|541970686|FG001|Overall Study|Lost to Follow-up|4|||
150227832|NCT02864147|541970687|FG002|Overall Study|Lost to Follow-up|0|||
150227833|NCT02864147|541970685|FG000|Overall Study|Adverse Event|0|||
150227834|NCT02864147|541970686|FG001|Overall Study|Adverse Event|1|||
150227835|NCT02864147|541970687|FG002|Overall Study|Adverse Event|0|||
150227836|NCT02864147|541970685|FG000|Overall Study|Pregnancy|4|||
150227837|NCT02864147|541970686|FG001|Overall Study|Pregnancy|0|||
150227838|NCT02864147|541970687|FG002|Overall Study|Pregnancy|0|||
150227839|NCT02864147|541970685|FG000|Overall Study|Physician Decision|0|||
150227840|NCT02864147|541970686|FG001|Overall Study|Physician Decision|0|||
150227841|NCT02864147|541970687|FG002|Overall Study|Physician Decision|1|||
150227842|NCT02864147|541970685|FG000|Overall Study|Opted for excisional procedures|0|||
150227843|NCT02864147|541970686|FG001|Overall Study|Opted for excisional procedures|0|||
150227844|NCT02864147|541970687|FG002|Overall Study|Opted for excisional procedures|3|||
150227845|NCT00734851|541970688|FG000|Overall Study|Withdrawal by Subject|2|||
150227846|NCT00734851|541970688|FG000|Overall Study|Lost to Follow-up|1|||
150227847|NCT00734851|541970688|FG000|Overall Study|Physician Decision|18|||
150227848|NCT01770509|541970689|FG000|Overall Study|Injury|0|||
150227849|NCT01770509|541970690|FG001|Overall Study|Injury|1|||
150227850|NCT01770509|541970689|FG000|Overall Study|Lost to Follow-up|1|||
150227851|NCT01770509|541970690|FG001|Overall Study|Lost to Follow-up|2|||
150227852|NCT00981578|541970694|FG000|Overall Study|Death|1|||
150227853|NCT00981578|541970694|FG000|Overall Study|Withdrawal by Subject|2|||
150141690|NCT02007434|541654028|FG006|Overall Study|Lost to Follow-up|0|||
150141691|NCT02007434|541654029|FG007|Overall Study|Lost to Follow-up|0|||
150141692|NCT02007434|541654022|FG000|Overall Study|Non-compliance|1|||
150141693|NCT02007434|541654023|FG001|Overall Study|Non-compliance|0|||
150141694|NCT02007434|541654024|FG002|Overall Study|Non-compliance|1|||
150141695|NCT02007434|541654025|FG003|Overall Study|Non-compliance|0|||
150141696|NCT02007434|541654026|FG004|Overall Study|Non-compliance|0|||
150141697|NCT02007434|541654027|FG005|Overall Study|Non-compliance|0|||
150141698|NCT02007434|541654028|FG006|Overall Study|Non-compliance|0|||
150141699|NCT02007434|541654029|FG007|Overall Study|Non-compliance|0|||
150141700|NCT00691132|541654044|FG000|Overall Study|Adverse Event|2|||
150141701|NCT00691132|541654045|FG001|Overall Study|Adverse Event|3|||
150141702|NCT00691132|541654044|FG000|Overall Study|Withdrawal by Subject|10|||
150141703|NCT00691132|541654045|FG001|Overall Study|Withdrawal by Subject|10|||
150141704|NCT04766086|541654048|FG000|Overall Study|Lost to Follow-up|3|||
150141705|NCT04766086|541654049|FG001|Overall Study|Lost to Follow-up|5|||
150141706|NCT04766086|541654050|FG002|Overall Study|Lost to Follow-up|3|||
150141707|NCT04766086|541654048|FG000|Overall Study|Withdrawal by Subject|1|||
150141708|NCT04766086|541654049|FG001|Overall Study|Withdrawal by Subject|1|||
150141709|NCT04766086|541654050|FG002|Overall Study|Withdrawal by Subject|2|||
150141710|NCT04766086|541654048|FG000|Overall Study|Other|0|||
150141711|NCT04766086|541654049|FG001|Overall Study|Other|0|||
150141712|NCT04766086|541654050|FG002|Overall Study|Other|1|||
150141713|NCT01959347|541654051|FG000|Overall Study|Protocol Violation|9|||
150141714|NCT01959347|541654052|FG001|Overall Study|Protocol Violation|7|||
150141715|NCT03541044|541654055|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
150141716|NCT03541044|541654056|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
150141717|NCT03541044|541654055|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
150141718|NCT03541044|541654056|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
150141719|NCT00860067|541654057|FG000|Overall Study|Lost to Follow-up|46|||
150141720|NCT00860067|541654058|FG001|Overall Study|Lost to Follow-up|9|||
150141721|NCT00860067|541654059|FG002|Overall Study|Lost to Follow-up|9|||
150141722|NCT00860067|541654057|FG000|Overall Study|Withdrawal by Subject|4|||
150141723|NCT00860067|541654058|FG001|Overall Study|Withdrawal by Subject|0|||
150141724|NCT00860067|541654059|FG002|Overall Study|Withdrawal by Subject|0|||
150141725|NCT00860067|541654057|FG000|Overall Study|Pregnancy|1|||
150141726|NCT00860067|541654058|FG001|Overall Study|Pregnancy|0|||
150141727|NCT00860067|541654059|FG002|Overall Study|Pregnancy|0|||
150141728|NCT01282801|541654060|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
150141729|NCT01282801|541654061|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
150141730|NCT01060553|541654064|FG000|Overall Study|Lost to Follow-up|3|||
150141731|NCT01060553|541654065|FG001|Overall Study|Lost to Follow-up|5|||
150141732|NCT01060553|541654064|FG000|Overall Study|Withdrawal by Subject|5|||
150141733|NCT01060553|541654065|FG001|Overall Study|Withdrawal by Subject|5|||
150141734|NCT01060553|541654064|FG000|Overall Study|Lack of Efficacy|1|||
150141735|NCT01060553|541654065|FG001|Overall Study|Lack of Efficacy|0|||
150141736|NCT01498822|541654067|FG000|Overall Study|Protocol Violation|8|||
150141737|NCT01498822|541654068|FG001|Overall Study|Protocol Violation|4|||
150141738|NCT01498822|541654067|FG000|Overall Study|Other Reason|5|||
150141739|NCT01498822|541654068|FG001|Overall Study|Other Reason|2|||
150141740|NCT01498822|541654067|FG000|Overall Study|Lack of Efficacy|7|||
150141741|NCT01498822|541654068|FG001|Overall Study|Lack of Efficacy|2|||
150141742|NCT01498822|541654067|FG000|Overall Study|AE, non-serious non-fatal|8|||
150141743|NCT01498822|541654068|FG001|Overall Study|AE, non-serious non-fatal|17|||
150141744|NCT01498822|541654067|FG000|Overall Study|SAE, non-fatal|2|||
150141745|NCT01498822|541654068|FG001|Overall Study|SAE, non-fatal|2|||
150141746|NCT01498822|541654067|FG000|Overall Study|Adverse Event, serious fatal|1|||
150141747|NCT01498822|541654068|FG001|Overall Study|Adverse Event, serious fatal|1|||
150141748|NCT01498822|541654067|FG000|Overall Study|Withdrawal by Subject|15|||
150141749|NCT01498822|541654068|FG001|Overall Study|Withdrawal by Subject|25|||
150141750|NCT01498822|541654067|FG000|Overall Study|Lost to Follow-up|8|||
150141751|NCT01498822|541654068|FG001|Overall Study|Lost to Follow-up|3|||
150141752|NCT04581200|541654069|FG000|Overall Study|Lost to Follow-up|6|||
150141753|NCT04581200|541654070|FG001|Overall Study|Lost to Follow-up|5|||
150227854|NCT02865135|541970695|FG000|Overall Study|Death|0|||
150227855|NCT02865135|541970696|FG001|Overall Study|Death|1|||
150227856|NCT02865135|541970697|FG002|Overall Study|Death|0|||
150227857|NCT02865135|541970695|FG000|Overall Study|Progression|6|||
150227858|NCT02865135|541970696|FG001|Overall Study|Progression|2|||
150227859|NCT02865135|541970697|FG002|Overall Study|Progression|2|||
150227860|NCT01294358|541970698|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
150227861|NCT01294358|541970699|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
150227862|NCT01294358|541970700|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
150227863|NCT01294358|541970701|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
150227864|NCT01294358|541970702|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
150227865|NCT01294358|541970698|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
150227866|NCT01294358|541970699|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
150227867|NCT01294358|541970700|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
150227868|NCT01294358|541970701|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
150227869|NCT01294358|541970702|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
150227870|NCT01294358|541970698|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
150227871|NCT01294358|541970699|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
150227872|NCT01294358|541970700|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
150227873|NCT01294358|541970701|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
150227874|NCT01294358|541970702|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
150227875|NCT01294358|541970698|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
150227876|NCT01294358|541970699|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
150227877|NCT01294358|541970700|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
150227878|NCT01294358|541970701|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
150227879|NCT01294358|541970702|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
150227880|NCT02963922|541970703|FG000|Overall Study|Adverse Event|15|||
150227881|NCT02963922|541970704|FG001|Overall Study|Adverse Event|6|||
150227882|NCT02963922|541970703|FG000|Overall Study|Protocol deviation|6|||
150227883|NCT02963922|541970704|FG001|Overall Study|Protocol deviation|6|||
150227884|NCT02963922|541970703|FG000|Overall Study|Lack of Efficacy|1|||
150227885|NCT02963922|541970704|FG001|Overall Study|Lack of Efficacy|1|||
150227886|NCT02963922|541970703|FG000|Overall Study|Lost to Follow-up|2|||
150227887|NCT02963922|541970704|FG001|Overall Study|Lost to Follow-up|3|||
150227888|NCT02963922|541970703|FG000|Overall Study|Other|8|||
150227889|NCT02963922|541970704|FG001|Overall Study|Other|14|||
150227890|NCT01180790|541970710|FG000|Overall Study|Adverse Event|1|||
150227891|NCT01180790|541970711|FG001|Overall Study|Adverse Event|1|||
150227892|NCT01180790|541970712|FG002|Overall Study|Adverse Event|2|||
150227893|NCT01180790|541970713|FG003|Overall Study|Adverse Event|0|||
150227894|NCT01180790|541970714|FG004|Overall Study|Adverse Event|1|||
150227895|NCT01180790|541970715|FG005|Overall Study|Adverse Event|3|||
150227896|NCT01180790|541970716|FG006|Overall Study|Adverse Event|0|||
150227897|NCT01180790|541970710|FG000|Overall Study|Withdrawal by Subject|3|||
150227898|NCT01180790|541970711|FG001|Overall Study|Withdrawal by Subject|0|||
150227899|NCT01180790|541970712|FG002|Overall Study|Withdrawal by Subject|5|||
150227900|NCT01180790|541970713|FG003|Overall Study|Withdrawal by Subject|0|||
150227901|NCT01180790|541970714|FG004|Overall Study|Withdrawal by Subject|2|||
150227902|NCT01180790|541970715|FG005|Overall Study|Withdrawal by Subject|1|||
150227903|NCT01180790|541970716|FG006|Overall Study|Withdrawal by Subject|0|||
150227904|NCT01180790|541970710|FG000|Overall Study|Lost to Follow-up|3|||
150227905|NCT01180790|541970711|FG001|Overall Study|Lost to Follow-up|1|||
150227906|NCT01180790|541970712|FG002|Overall Study|Lost to Follow-up|0|||
150227907|NCT01180790|541970713|FG003|Overall Study|Lost to Follow-up|2|||
150227908|NCT01180790|541970714|FG004|Overall Study|Lost to Follow-up|1|||
150227909|NCT01180790|541970715|FG005|Overall Study|Lost to Follow-up|0|||
150227910|NCT01180790|541970716|FG006|Overall Study|Lost to Follow-up|1|||
150227911|NCT01180790|541970710|FG000|Overall Study|Physician Decision|1|||
150227912|NCT01180790|541970711|FG001|Overall Study|Physician Decision|0|||
150227913|NCT01180790|541970712|FG002|Overall Study|Physician Decision|0|||
150227914|NCT01180790|541970713|FG003|Overall Study|Physician Decision|1|||
150227915|NCT01180790|541970714|FG004|Overall Study|Physician Decision|0|||
150227916|NCT01180790|541970715|FG005|Overall Study|Physician Decision|0|||
150227917|NCT01180790|541970716|FG006|Overall Study|Physician Decision|0|||
150227918|NCT01180790|541970710|FG000|Overall Study|Lack of Efficacy|1|||
150227919|NCT01180790|541970711|FG001|Overall Study|Lack of Efficacy|2|||
150227920|NCT01180790|541970712|FG002|Overall Study|Lack of Efficacy|5|||
150227921|NCT01180790|541970713|FG003|Overall Study|Lack of Efficacy|6|||
150227922|NCT01180790|541970714|FG004|Overall Study|Lack of Efficacy|1|||
150227923|NCT01180790|541970715|FG005|Overall Study|Lack of Efficacy|3|||
150227924|NCT01180790|541970716|FG006|Overall Study|Lack of Efficacy|0|||
150227925|NCT01180790|541970710|FG000|Overall Study|compliance|0|||
150227926|NCT01180790|541970711|FG001|Overall Study|compliance|1|||
150227927|NCT01180790|541970712|FG002|Overall Study|compliance|0|||
150227928|NCT01180790|541970713|FG003|Overall Study|compliance|0|||
150227929|NCT01180790|541970714|FG004|Overall Study|compliance|0|||
150227930|NCT01180790|541970715|FG005|Overall Study|compliance|0|||
150227931|NCT01180790|541970716|FG006|Overall Study|compliance|0|||
150227932|NCT01180790|541970710|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227933|NCT01180790|541970711|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227934|NCT01180790|541970712|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
150227935|NCT01180790|541970713|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227936|NCT01180790|541970714|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227937|NCT01180790|541970715|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227938|NCT01180790|541970716|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
150227939|NCT00655668|541970717|FG000|Overall Study|Adverse Event|6|||
150227940|NCT00655668|541970717|FG000|Overall Study|Death|5|||
150227941|NCT00655668|541970717|FG000|Overall Study|Disease Progression|27|||
150227942|NCT00655668|541970717|FG000|Overall Study|Study Terminated|9|||
150227943|NCT00655668|541970717|FG000|Overall Study|Other|1|||
150227944|NCT00655668|541970717|FG000|Overall Study|New Lymphoma Treatment Started|4|||
150227945|NCT00655668|541970717|FG000|Overall Study|Withdrawal by Subject|2|||
150227946|NCT03840148|541970720|FG000|Study Drug Disposition|Adverse Event|13|||
150227947|NCT03840148|541970721|FG001|Study Drug Disposition|Adverse Event|2|||
150227948|NCT03840148|541970720|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
150227949|NCT03840148|541970721|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
150227950|NCT03840148|541970720|FG000|Study Drug Disposition|Lack of Efficacy|3|||
150227951|NCT03840148|541970721|FG001|Study Drug Disposition|Lack of Efficacy|0|||
150227952|NCT03840148|541970720|FG000|Study Drug Disposition|Physician Decision|2|||
150227953|NCT03840148|541970721|FG001|Study Drug Disposition|Physician Decision|0|||
150227954|NCT03840148|541970720|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
150227955|NCT03840148|541970721|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
150227956|NCT03840148|541970720|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
150227957|NCT03840148|541970721|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
150227958|NCT03840148|541970720|FG000|Study Completion Disposition|Physician Decision|2|||
150227959|NCT03840148|541970721|FG001|Study Completion Disposition|Physician Decision|0|||
150227960|NCT03840148|541970720|FG000|Study Completion Disposition|Covid-19 related|2|||
150227961|NCT03840148|541970721|FG001|Study Completion Disposition|Covid-19 related|0|||
150227962|NCT03840148|541970720|FG000|Study Completion Disposition|Lost to Follow-up|1|||
150227963|NCT03840148|541970721|FG001|Study Completion Disposition|Lost to Follow-up|1|||
150227964|NCT03840148|541970720|FG000|Study Completion Disposition|Death|1|||
150227965|NCT03840148|541970721|FG001|Study Completion Disposition|Death|0|||
150227966|NCT03840148|541970720|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
150227967|NCT03840148|541970721|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
150227968|NCT03615404|541970722|FG000|Overall Study|Death|1|||
150227969|NCT03615404|541970722|FG000|Overall Study|vaccine did not pass quality assurance|1|||
150227970|NCT00257556|541970723|FG000|Overall Study|Adverse Event|1|||
150227971|NCT00257556|541970724|FG001|Overall Study|Adverse Event|4|||
150227972|NCT00257556|541970723|FG000|Overall Study|Physician Decision|6|||
150227973|NCT00257556|541970724|FG001|Overall Study|Physician Decision|0|||
150227974|NCT00257556|541970723|FG000|Overall Study|Did not meet hCG criterion|3|||
150227975|NCT00257556|541970724|FG001|Overall Study|Did not meet hCG criterion|0|||
150227976|NCT00257556|541970723|FG000|Overall Study|other reason|4|||
150227977|NCT00257556|541970724|FG001|Overall Study|other reason|6|||
150227978|NCT03849300|541970726|FG000|Overall Study|move out to different area|1|||
150227979|NCT03849300|541970727|FG001|Overall Study|move out to different area|3|||
150227980|NCT03849300|541970728|FG002|Overall Study|move out to different area|1|||
150227981|NCT03849300|541970729|FG003|Overall Study|move out to different area|4|||
150227982|NCT03849300|541970726|FG000|Overall Study|scheduling/transportation conflict|4|||
150227983|NCT03849300|541970727|FG001|Overall Study|scheduling/transportation conflict|4|||
150227984|NCT03849300|541970728|FG002|Overall Study|scheduling/transportation conflict|3|||
150227985|NCT03849300|541970729|FG003|Overall Study|scheduling/transportation conflict|2|||
150227986|NCT01774929|541970730|FG000|Overall Study|Adverse Event|3|||
150227987|NCT04839289|541970731|FG000|Overall Study|Withdrawal by Subject|1|||
150227988|NCT04839289|541970732|FG001|Overall Study|Withdrawal by Subject|0|||
150227989|NCT04853238|541970734|FG000|Overall Study|Death|4|||
150227990|NCT04853238|541970735|FG001|Overall Study|Death|0|||
150227991|NCT04853238|541970736|FG002|Overall Study|Death|2|||
150227992|NCT04853238|541970734|FG000|Overall Study|Lost to Follow-up|16|||
150227993|NCT04853238|541970735|FG001|Overall Study|Lost to Follow-up|2|||
150227994|NCT04853238|541970736|FG002|Overall Study|Lost to Follow-up|37|||
150227995|NCT04853238|541970734|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
150227996|NCT04853238|541970735|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
150227997|NCT04853238|541970736|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
150227998|NCT04853238|541970734|FG000|Overall Study|Withdrawal by Subject|6|||
150227999|NCT04853238|541970735|FG001|Overall Study|Withdrawal by Subject|0|||
150228000|NCT04853238|541970736|FG002|Overall Study|Withdrawal by Subject|21|||
150228001|NCT04853238|541970734|FG000|Overall Study|Physician Decision|0|||
150228002|NCT04853238|541970735|FG001|Overall Study|Physician Decision|0|||
150228003|NCT04853238|541970736|FG002|Overall Study|Physician Decision|2|||
150228004|NCT04853238|541970734|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
150228005|NCT04853238|541970735|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
150228006|NCT04853238|541970736|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
150228007|NCT02093897|541972059|FG000|Overall Study|Physician Decision|1|||
150228008|NCT02093897|541972059|FG000|Overall Study|Planned age group closure - no's reached|17|||
150228009|NCT02093897|541972059|FG000|Overall Study|Adverse event, non-fatal|1|||
150228010|NCT02972242|541972060|FG000|Overall Study|Withdrawal by Subject|1|||
150228011|NCT02972242|541972061|FG001|Overall Study|Withdrawal by Subject|0|||
150228012|NCT02956278|541972062|FG000|Overall Study|Withdrawal by Subject|6|||
150228013|NCT02956278|541972063|FG001|Overall Study|Withdrawal by Subject|2|||
150228014|NCT02956278|541972064|FG002|Overall Study|Withdrawal by Subject|0|||
150228015|NCT02329223|541972065|FG000|Overall Study|Withdrawal by Subject|1|||
150228016|NCT02329223|541972066|FG001|Overall Study|Withdrawal by Subject|2|||
150228017|NCT02329223|541972067|FG002|Overall Study|Withdrawal by Subject|5|||
150228018|NCT02329223|541972065|FG000|Overall Study|Physician Decision|0|||
150228019|NCT02329223|541972066|FG001|Overall Study|Physician Decision|0|||
150228020|NCT02329223|541972067|FG002|Overall Study|Physician Decision|1|||
150228021|NCT02329223|541972065|FG000|Overall Study|Adverse Event|0|||
150228022|NCT02329223|541972066|FG001|Overall Study|Adverse Event|1|||
150228023|NCT02329223|541972067|FG002|Overall Study|Adverse Event|0|||
150228024|NCT01157351|541972070|FG000|Overall Study|Adverse Event|5|||
150228025|NCT01157351|541972071|FG001|Overall Study|Adverse Event|4|||
150228026|NCT01157351|541972070|FG000|Overall Study|Death|1|||
150228027|NCT01157351|541972071|FG001|Overall Study|Death|0|||
150228028|NCT01157351|541972070|FG000|Overall Study|Lost to Follow-up|53|||
150228029|NCT01157351|541972071|FG001|Overall Study|Lost to Follow-up|55|||
150228030|NCT01157351|541972070|FG000|Overall Study|Withdrawal by Subject|37|||
150228031|NCT01157351|541972071|FG001|Overall Study|Withdrawal by Subject|27|||
150228032|NCT01157351|541972070|FG000|Overall Study|Physician Decision|5|||
150228033|NCT01157351|541972071|FG001|Overall Study|Physician Decision|4|||
150228034|NCT01157351|541972070|FG000|Overall Study|Protocol Violation|0|||
150228035|NCT01157351|541972071|FG001|Overall Study|Protocol Violation|1|||
150228036|NCT01157351|541972070|FG000|Overall Study|Other|32|||
150228037|NCT01157351|541972071|FG001|Overall Study|Other|36|||
150228038|NCT01157351|541972070|FG000|Overall Study|Noncompliance with Study Drug|0|||
150228039|NCT01157351|541972071|FG001|Overall Study|Noncompliance with Study Drug|3|||
150228040|NCT01157351|541972070|FG000|Overall Study|Randomized but not Treated|4|||
150228041|NCT01157351|541972071|FG001|Overall Study|Randomized but not Treated|2|||
150228042|NCT00684203|541972072|FG000|Overall Study|Adverse Event|6|||
150228043|NCT00684203|541972073|FG001|Overall Study|Adverse Event|4|||
150228044|NCT00684203|541972074|FG002|Overall Study|Adverse Event|8|||
150228045|NCT00684203|541972075|FG003|Overall Study|Adverse Event|0|||
150228046|NCT00684203|541972076|FG004|Overall Study|Adverse Event|0|||
150228047|NCT00684203|541972077|FG005|Overall Study|Adverse Event|0|||
150228048|NCT00684203|541972072|FG000|Overall Study|Protocol-defined clinical event|3|||
150228049|NCT00684203|541972073|FG001|Overall Study|Protocol-defined clinical event|1|||
150228050|NCT00684203|541972074|FG002|Overall Study|Protocol-defined clinical event|0|||
150228051|NCT00684203|541972075|FG003|Overall Study|Protocol-defined clinical event|0|||
150228052|NCT00684203|541972076|FG004|Overall Study|Protocol-defined clinical event|0|||
150228053|NCT00684203|541972077|FG005|Overall Study|Protocol-defined clinical event|0|||
150228054|NCT00684203|541972072|FG000|Overall Study|Withdrawal by Subject|0|||
150228055|NCT00684203|541972073|FG001|Overall Study|Withdrawal by Subject|2|||
150228056|NCT00684203|541972074|FG002|Overall Study|Withdrawal by Subject|1|||
150228057|NCT00684203|541972075|FG003|Overall Study|Withdrawal by Subject|0|||
150228058|NCT00684203|541972076|FG004|Overall Study|Withdrawal by Subject|0|||
150228059|NCT00684203|541972077|FG005|Overall Study|Withdrawal by Subject|0|||
150228060|NCT00684203|541972072|FG000|Overall Study|Did not meet protocol eligibility|0|||
150228061|NCT00684203|541972073|FG001|Overall Study|Did not meet protocol eligibility|1|||
150228062|NCT00684203|541972074|FG002|Overall Study|Did not meet protocol eligibility|0|||
150228063|NCT00684203|541972075|FG003|Overall Study|Did not meet protocol eligibility|0|||
150228064|NCT00684203|541972076|FG004|Overall Study|Did not meet protocol eligibility|0|||
150228065|NCT00684203|541972077|FG005|Overall Study|Did not meet protocol eligibility|0|||
150228066|NCT04140266|541972078|FG000|Overall Study|Physician Decision|2|||
150228067|NCT04140266|541972079|FG001|Overall Study|Physician Decision|0|||
150228068|NCT04140266|541972078|FG000|Overall Study|Withdrawal by Subject|4|||
150228069|NCT04140266|541972079|FG001|Overall Study|Withdrawal by Subject|2|||
150228070|NCT03511378|541972082|FG000|Overall Study|Withdrawal by Subject|2|||
150228071|NCT03511378|541972083|FG001|Overall Study|Withdrawal by Subject|2|||
150228072|NCT03511378|541972082|FG000|Overall Study|Patient not coming or schedule visit|1|||
150228073|NCT03511378|541972083|FG001|Overall Study|Patient not coming or schedule visit|0|||
150228074|NCT00730847|541972085|FG000|Overall Study|Adverse Event|1|||
150228075|NCT00730847|541972085|FG000|Overall Study|Protocol Violation|2|||
150228076|NCT00730847|541972085|FG000|Overall Study|Withdrawal by Subject|16|||
150228077|NCT00730847|541972085|FG000|Overall Study|Lost to Follow-up|67|||
150228078|NCT00730847|541972085|FG000|Overall Study|Unknown completion status|21|||
150228079|NCT00730847|541972085|FG000|Overall Study|Other|24|||
150228080|NCT00280683|541972086|FG000|Overall Study|Withdrawal by Subject|1|||
150228081|NCT00280683|541972087|FG001|Overall Study|Withdrawal by Subject|2|||
150228082|NCT00280683|541972086|FG000|Overall Study|Adverse Event|1|||
150228083|NCT00280683|541972087|FG001|Overall Study|Adverse Event|1|||
150228084|NCT01243411|541972088|FG000|Overall Study|Withdrawal by Subject|18|||
150228085|NCT01243411|541972088|FG000|Overall Study|Lost to Follow-up|10|||
150228086|NCT01243411|541972088|FG000|Overall Study|Adverse Event|5|||
150228087|NCT01243411|541972088|FG000|Overall Study|Other|8|||
150228088|NCT03022578|541972091|FG000|Overall Study|Adverse Event|1|||
150228089|NCT03022578|541972091|FG000|Overall Study|Lack of Efficacy|2|||
150228090|NCT03022578|541972091|FG000|Overall Study|Withdrawal by Subject|1|||
150228091|NCT02499835|541972105|FG000|Overall Study|Withdrawal by Subject|1|||
150228092|NCT02499835|541972106|FG001|Overall Study|Withdrawal by Subject|0|||
150228093|NCT02499835|541972107|FG002|Overall Study|Withdrawal by Subject|0|||
150228094|NCT02499835|541972108|FG003|Overall Study|Withdrawal by Subject|1|||
150228095|NCT02499835|541972105|FG000|Overall Study|Physician Decision|0|||
150228096|NCT02499835|541972106|FG001|Overall Study|Physician Decision|3|||
150228097|NCT02499835|541972107|FG002|Overall Study|Physician Decision|18|||
150228098|NCT02499835|541972108|FG003|Overall Study|Physician Decision|7|||
150228099|NCT02499835|541972105|FG000|Overall Study|Adverse Event|0|||
150228100|NCT02499835|541972106|FG001|Overall Study|Adverse Event|0|||
150228101|NCT02499835|541972107|FG002|Overall Study|Adverse Event|0|||
150228102|NCT02499835|541972108|FG003|Overall Study|Adverse Event|1|||
150228103|NCT02499835|541972105|FG000|Overall Study|Disease progression|2|||
150228104|NCT02499835|541972106|FG001|Overall Study|Disease progression|1|||
150228105|NCT02499835|541972107|FG002|Overall Study|Disease progression|0|||
150228106|NCT02499835|541972108|FG003|Overall Study|Disease progression|7|||
150228107|NCT03319719|541972116|FG000|Overall Study|Lost to Follow-up|1|||
150228108|NCT00498433|541972117|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
150228109|NCT00498433|541972118|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
150228110|NCT00498433|541972119|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
150228111|NCT00498433|541972117|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
150228112|NCT00498433|541972118|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
150228113|NCT00498433|541972119|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
150228114|NCT00498433|541972117|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
150228115|NCT00498433|541972118|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
150228116|NCT00498433|541972119|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
150228117|NCT00498433|541972117|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
150228118|NCT00498433|541972118|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
150228119|NCT00498433|541972119|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
150228120|NCT00744796|541972120|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
150228121|NCT02581189|541972124|FG000|Overall Study|Failure to return|36|||
150228122|NCT02581189|541972124|FG000|Overall Study|Withdrew consent|5|||
150228123|NCT02581189|541972124|FG000|Overall Study|Death|3|||
150228124|NCT02581189|541972124|FG000|Overall Study|Insufficient virological response|2|||
150228125|NCT02581189|541972124|FG000|Overall Study|Other, not specified|7|||
150228126|NCT02720081|541972125|FG000|Overall Study|Adverse Event|0|||
150228127|NCT02720081|541972126|FG001|Overall Study|Adverse Event|3|||
150228128|NCT02720081|541972125|FG000|Overall Study|Protocol Violation|4|||
150228129|NCT02720081|541972126|FG001|Overall Study|Protocol Violation|1|||
150228130|NCT02316847|541972127|FG000|Overall Study|Adverse Event|0|||
150228131|NCT02316847|541972128|FG001|Overall Study|Adverse Event|3|||
150228132|NCT02316847|541972127|FG000|Overall Study|Lost to Follow-up|0|||
150228133|NCT02316847|541972128|FG001|Overall Study|Lost to Follow-up|2|||
150228134|NCT02316847|541972127|FG000|Overall Study|Physician Decision|0|||
150228135|NCT02316847|541972128|FG001|Overall Study|Physician Decision|1|||
150228136|NCT02316847|541972127|FG000|Overall Study|Pregnancy|0|||
150228137|NCT02316847|541972128|FG001|Overall Study|Pregnancy|1|||
150228138|NCT02316847|541972127|FG000|Overall Study|Withdrawal by Subject|2|||
150228139|NCT02316847|541972128|FG001|Overall Study|Withdrawal by Subject|9|||
150228140|NCT02316847|541972127|FG000|Overall Study|Noncompliance with study drug|0|||
150228141|NCT02316847|541972128|FG001|Overall Study|Noncompliance with study drug|3|||
150228142|NCT02316847|541972127|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
150141754|NCT03131960|541654071|FG000|Overall Study|Adverse Event|0|||
150141755|NCT03131960|541654072|FG001|Overall Study|Adverse Event|1|||
150141756|NCT04404478|541654076|FG000|Overall Study|Withdrawal by Subject|1|||
150141757|NCT04404478|541654077|FG001|Overall Study|Withdrawal by Subject|3|||
150141758|NCT01215357|541654078|FG000|Overall Study|Withdrawal by Subject|3|||
150141759|NCT01215357|541654078|FG000|Overall Study|Protocol Violation|9|||
150141760|NCT01859793|541654079|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
150141761|NCT01859793|541654080|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
150141762|NCT01859793|541654079|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
150141763|NCT01859793|541654080|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
150141764|NCT01859793|541654079|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
150141765|NCT01859793|541654080|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
150141766|NCT01859793|541654079|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
150141767|NCT01859793|541654080|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
150141768|NCT03815019|541654083|FG000|Overall Study|Withdrawal by Subject|6|||
150141769|NCT03815019|541654084|FG001|Overall Study|Withdrawal by Subject|8|||
150141770|NCT05960097|541654085|FG000|Overall Study|Lost to Follow-up|3|||
150141771|NCT05960097|541654086|FG001|Overall Study|Lost to Follow-up|1|||
150141772|NCT05960097|541654087|FG002|Overall Study|Lost to Follow-up|1|||
150141773|NCT05960097|541654088|FG003|Overall Study|Lost to Follow-up|2|||
150141774|NCT05960097|541654089|FG004|Overall Study|Lost to Follow-up|1|||
150141775|NCT05960097|541654090|FG005|Overall Study|Lost to Follow-up|1|||
150141776|NCT05960097|541654091|FG006|Overall Study|Lost to Follow-up|2|||
150141777|NCT05960097|541654092|FG007|Overall Study|Lost to Follow-up|3|||
150141778|NCT05960097|541654085|FG000|Overall Study|Physician Decision|0|||
150141779|NCT05960097|541654086|FG001|Overall Study|Physician Decision|0|||
150141780|NCT05960097|541654087|FG002|Overall Study|Physician Decision|0|||
150141781|NCT05960097|541654088|FG003|Overall Study|Physician Decision|0|||
150141782|NCT05960097|541654089|FG004|Overall Study|Physician Decision|0|||
150141783|NCT05960097|541654090|FG005|Overall Study|Physician Decision|0|||
150141784|NCT05960097|541654091|FG006|Overall Study|Physician Decision|1|||
150141785|NCT05960097|541654092|FG007|Overall Study|Physician Decision|0|||
150141786|NCT05960097|541654085|FG000|Overall Study|Withdrawal by Subject|1|||
150141787|NCT05960097|541654086|FG001|Overall Study|Withdrawal by Subject|0|||
150141788|NCT05960097|541654087|FG002|Overall Study|Withdrawal by Subject|0|||
150141789|NCT05960097|541654088|FG003|Overall Study|Withdrawal by Subject|1|||
150141790|NCT05960097|541654089|FG004|Overall Study|Withdrawal by Subject|1|||
150141791|NCT05960097|541654090|FG005|Overall Study|Withdrawal by Subject|0|||
150141792|NCT05960097|541654091|FG006|Overall Study|Withdrawal by Subject|0|||
150141793|NCT05960097|541654092|FG007|Overall Study|Withdrawal by Subject|0|||
150141794|NCT05960097|541654085|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141795|NCT05960097|541654086|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141796|NCT05960097|541654087|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
150141797|NCT05960097|541654088|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141798|NCT05960097|541654089|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141799|NCT05960097|541654090|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141800|NCT05960097|541654091|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141801|NCT05960097|541654092|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
150141802|NCT00728962|541654095|FG000|Implant Placement Surgery|Adverse Event|8|||
150141803|NCT00728962|541654095|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
150141804|NCT00728962|541654095|FG000|Implant Placement Surgery|Protocol Violation|1|||
150141805|NCT00728962|541654095|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
150141806|NCT00728962|541654095|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
150141807|NCT02487472|541654096|FG000|Overall Study|Did not complete telephonic interviews|9|||
150141808|NCT02487472|541654096|FG000|Overall Study|Other|2|||
150141809|NCT02010632|541654097|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
150141810|NCT02010632|541654098|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
150228143|NCT02316847|541972128|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
150228144|NCT03371485|541972133|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
150228145|NCT03371485|541972133|FG000|2-year Follow-up|Death|5|||
150228146|NCT02381652|541972140|FG000|Overall Study|Withdrawal by Subject|0|||
150228147|NCT02381652|541972141|FG001|Overall Study|Withdrawal by Subject|0|||
150228148|NCT02381652|541972142|FG002|Overall Study|Withdrawal by Subject|1|||
150228149|NCT01340300|541972143|FG000|Overall Study|Lost to Follow-up|3|||
150228150|NCT01340300|541972144|FG001|Overall Study|Lost to Follow-up|0|||
150228151|NCT01340300|541972145|FG002|Overall Study|Lost to Follow-up|5|||
150228152|NCT01340300|541972146|FG003|Overall Study|Lost to Follow-up|10|||
150228153|NCT01340300|541972143|FG000|Overall Study|Withdrawal by Subject|5|||
150228154|NCT01340300|541972144|FG001|Overall Study|Withdrawal by Subject|6|||
150228155|NCT01340300|541972145|FG002|Overall Study|Withdrawal by Subject|6|||
150228156|NCT01340300|541972146|FG003|Overall Study|Withdrawal by Subject|3|||
150228157|NCT01340300|541972143|FG000|Overall Study|Adverse Event|1|||
150228158|NCT01340300|541972144|FG001|Overall Study|Adverse Event|0|||
150228159|NCT01340300|541972145|FG002|Overall Study|Adverse Event|4|||
150228160|NCT01340300|541972146|FG003|Overall Study|Adverse Event|0|||
150228161|NCT01340300|541972143|FG000|Overall Study|Physician Decision|0|||
150228162|NCT01340300|541972144|FG001|Overall Study|Physician Decision|1|||
150228163|NCT01340300|541972145|FG002|Overall Study|Physician Decision|0|||
150228164|NCT01340300|541972146|FG003|Overall Study|Physician Decision|0|||
150228165|NCT01340300|541972143|FG000|Overall Study|Unrelated sickness|0|||
150228166|NCT01340300|541972144|FG001|Overall Study|Unrelated sickness|2|||
150228167|NCT01340300|541972145|FG002|Overall Study|Unrelated sickness|0|||
150228168|NCT01340300|541972146|FG003|Overall Study|Unrelated sickness|1|||
150228169|NCT03280108|541972149|FG000|Overall Study|Lost to Follow-up|2|||
150228170|NCT03280108|541972150|FG001|Overall Study|Lost to Follow-up|0|||
150228171|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
150228172|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150228173|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150228174|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150228175|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
150228176|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
150228177|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150228178|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150228179|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150228180|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
150228181|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
150228182|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150228183|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150228184|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150228185|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
150228186|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
150228187|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150228188|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150228189|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150228190|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
150228191|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
150228192|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150228193|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150228194|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150228195|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
150228196|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
150228197|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150228198|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150228199|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150228200|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
150228201|NCT01187407|541972151|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
150228202|NCT01187407|541972152|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150228203|NCT01187407|541972153|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150228204|NCT01187407|541972154|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150228205|NCT01187407|541972155|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
150228206|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
150228207|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
150228208|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
150228209|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
150228210|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
150228211|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
150228212|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
150228213|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
150228214|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
150228215|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
150228216|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
150228217|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
150228218|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
150228219|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
150228220|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
150228221|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150228222|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150228223|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
150228224|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
150228225|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
150228226|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
150228227|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
150228228|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
150228229|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
150228230|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
150228231|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
150228232|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
150228233|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
150228234|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
150228235|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
150228236|NCT01187407|541972151|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
150228237|NCT01187407|541972152|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
150228238|NCT01187407|541972153|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
150228239|NCT01187407|541972154|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
150228240|NCT01187407|541972155|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
150228241|NCT01820637|541972156|FG000|Overall Study|Death|2|||
150228242|NCT01820637|541972156|FG000|Overall Study|Withdrawal by Subject|1|||
150228243|NCT00583115|541972157|FG000|Overall Study|Death|1|||
150228244|NCT02382406|541972158|FG000|Study Treatment|Disease Progression|8|||
150228245|NCT02382406|541972159|FG001|Study Treatment|Disease Progression|0|||
150228246|NCT02382406|541972160|FG002|Study Treatment|Disease Progression|20|||
150228247|NCT02382406|541972158|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
150228248|NCT02382406|541972159|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
150228249|NCT02382406|541972160|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
150228250|NCT02382406|541972158|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
150228251|NCT02382406|541972159|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
150228252|NCT02382406|541972160|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
150228253|NCT02382406|541972158|FG000|Study Treatment|symptomatic deterioration|1|||
150228254|NCT02382406|541972159|FG001|Study Treatment|symptomatic deterioration|0|||
150228255|NCT02382406|541972160|FG002|Study Treatment|symptomatic deterioration|1|||
150228256|NCT02382406|541972158|FG000|Study Treatment|Death|0|||
150228257|NCT02382406|541972159|FG001|Study Treatment|Death|0|||
150228258|NCT02382406|541972160|FG002|Study Treatment|Death|2|||
150228259|NCT02382406|541972158|FG000|Follow up|Death|11|||
150228260|NCT02382406|541972159|FG001|Follow up|Death|0|||
150228261|NCT02382406|541972160|FG002|Follow up|Death|19|||
150228262|NCT02382406|541972158|FG000|Follow up|Symptomatic deterioration|1|||
150228263|NCT02382406|541972159|FG001|Follow up|Symptomatic deterioration|0|||
150228264|NCT02382406|541972160|FG002|Follow up|Symptomatic deterioration|1|||
150228265|NCT02382406|541972158|FG000|Follow up|Patient Refused Follow-up|1|||
150228266|NCT02382406|541972159|FG001|Follow up|Patient Refused Follow-up|0|||
150228267|NCT02382406|541972160|FG002|Follow up|Patient Refused Follow-up|0|||
150228268|NCT02382406|541972158|FG000|Follow up|Study Terminated|1|||
150228269|NCT02382406|541972159|FG001|Follow up|Study Terminated|0|||
150228270|NCT02382406|541972160|FG002|Follow up|Study Terminated|8|||
150228271|NCT02382406|541972158|FG000|Follow up|Withdrawal by Subject|0|||
150228272|NCT02382406|541972159|FG001|Follow up|Withdrawal by Subject|0|||
150228273|NCT02382406|541972160|FG002|Follow up|Withdrawal by Subject|2|||
150228274|NCT01713998|541972161|FG000|Overall Study|Lost to Follow-up|2|||
150228275|NCT01713998|541972162|FG001|Overall Study|Lost to Follow-up|0|||
150228276|NCT01713998|541972163|FG002|Overall Study|Lost to Follow-up|2|||
150228277|NCT01713998|541972161|FG000|Overall Study|Withdrawal by Subject|1|||
150228278|NCT01713998|541972162|FG001|Overall Study|Withdrawal by Subject|0|||
150228279|NCT01713998|541972163|FG002|Overall Study|Withdrawal by Subject|0|||
150228280|NCT03638258|541972164|FG000|Overall Study|Adverse Event|1|||
150228281|NCT03638258|541972165|FG001|Overall Study|Adverse Event|0|||
150228282|NCT03638258|541972166|FG002|Overall Study|Adverse Event|2|||
150228283|NCT03638258|541972164|FG000|Overall Study|Lost to Follow-up|2|||
150228284|NCT03638258|541972165|FG001|Overall Study|Lost to Follow-up|4|||
150228285|NCT03638258|541972166|FG002|Overall Study|Lost to Follow-up|5|||
150228286|NCT03638258|541972164|FG000|Overall Study|Pregnancy|0|||
150228287|NCT03638258|541972165|FG001|Overall Study|Pregnancy|0|||
150228288|NCT03638258|541972166|FG002|Overall Study|Pregnancy|1|||
150228289|NCT03638258|541972164|FG000|Overall Study|Protocol Violation|0|||
150228290|NCT03638258|541972165|FG001|Overall Study|Protocol Violation|0|||
150228291|NCT03638258|541972166|FG002|Overall Study|Protocol Violation|1|||
150228292|NCT03638258|541972164|FG000|Overall Study|Withdrawal by Subject|4|||
150228293|NCT03638258|541972165|FG001|Overall Study|Withdrawal by Subject|5|||
150228294|NCT03638258|541972166|FG002|Overall Study|Withdrawal by Subject|12|||
150228295|NCT03638258|541972164|FG000|Overall Study|Lack of Efficacy|0|||
150228296|NCT03638258|541972165|FG001|Overall Study|Lack of Efficacy|0|||
150228297|NCT03638258|541972166|FG002|Overall Study|Lack of Efficacy|2|||
150228298|NCT00607789|541972168|FG000|Overall Study|Adverse Event|3|||
150228299|NCT00607789|541972169|FG001|Overall Study|Adverse Event|0|||
150228300|NCT00607789|541972168|FG000|Overall Study|Lack of Efficacy|0|||
150228301|NCT00607789|541972169|FG001|Overall Study|Lack of Efficacy|1|||
150228302|NCT00607789|541972168|FG000|Overall Study|Inadequate adherence|3|||
150228303|NCT00607789|541972169|FG001|Overall Study|Inadequate adherence|0|||
150228304|NCT00607789|541972168|FG000|Overall Study|Lost to Follow-up|0|||
150228305|NCT00607789|541972169|FG001|Overall Study|Lost to Follow-up|5|||
150228306|NCT00607789|541972168|FG000|Overall Study|Withdrawal by Subject|1|||
150228307|NCT00607789|541972169|FG001|Overall Study|Withdrawal by Subject|0|||
150228308|NCT01313299|541972170|FG000|Overall Study|Adverse Event|3|||
150228309|NCT01313299|541972171|FG001|Overall Study|Adverse Event|1|||
150228310|NCT01313299|541972172|FG002|Overall Study|Adverse Event|1|||
150228311|NCT01313299|541972170|FG000|Overall Study|Lost to Follow-up|1|||
150228312|NCT01313299|541972171|FG001|Overall Study|Lost to Follow-up|0|||
150228313|NCT01313299|541972172|FG002|Overall Study|Lost to Follow-up|0|||
150228314|NCT01313299|541972170|FG000|Overall Study|Protocol Violation|2|||
150228315|NCT01313299|541972171|FG001|Overall Study|Protocol Violation|0|||
150228316|NCT01313299|541972172|FG002|Overall Study|Protocol Violation|0|||
150228317|NCT01313299|541972170|FG000|Overall Study|Withdrawal by Subject|1|||
150228318|NCT01313299|541972171|FG001|Overall Study|Withdrawal by Subject|0|||
150228319|NCT01313299|541972172|FG002|Overall Study|Withdrawal by Subject|2|||
150228320|NCT01313299|541972170|FG000|Overall Study|Family reason and moved out of state|0|||
150228321|NCT01313299|541972171|FG001|Overall Study|Family reason and moved out of state|2|||
150228322|NCT01313299|541972172|FG002|Overall Study|Family reason and moved out of state|0|||
150228323|NCT01313299|541972170|FG000|Overall Study|Lack of subject compliance|0|||
150228324|NCT01313299|541972171|FG001|Overall Study|Lack of subject compliance|0|||
150228325|NCT01313299|541972172|FG002|Overall Study|Lack of subject compliance|1|||
150228326|NCT02506881|541972173|FG000|First Intervention (Day 1)|Protocol Violation|0|||
150228327|NCT02506881|541972174|FG001|First Intervention (Day 1)|Protocol Violation|0|||
150228328|NCT02506881|541972175|FG002|First Intervention (Day 1)|Protocol Violation|1|||
150228329|NCT02506881|541972176|FG003|First Intervention (Day 1)|Protocol Violation|0|||
150228330|NCT02506881|541972173|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
150228331|NCT02506881|541972174|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
150228332|NCT02506881|541972175|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
150228333|NCT02506881|541972176|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
150228334|NCT02506881|541972173|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
150228335|NCT02506881|541972174|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
150228336|NCT02506881|541972175|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
150228337|NCT02506881|541972176|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
150228338|NCT01919398|541972177|FG000|Overall Study|Progressive Disease|0|||
150228339|NCT01919398|541972178|FG001|Overall Study|Progressive Disease|0|||
150228340|NCT01919398|541972179|FG002|Overall Study|Progressive Disease|4|||
150228341|NCT02016690|541972181|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
150228342|NCT02016690|541972181|FG000|Overall Study|Excluded from SAS: Duplication|2|||
150228343|NCT02016690|541972181|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
150228344|NCT02016690|541972181|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
150228345|NCT02016690|541972181|FG000|Overall Study|Did not meet inclusion criteria|13|||
150228346|NCT02016690|541972181|FG000|Overall Study|Hospitalized for RSV at study start|3|||
150228347|NCT00884793|541972190|FG000|Overall Study|Withdrawal by Subject|1|||
150228348|NCT00663923|541972191|FG000|Overall Study|Lost to Follow-up|2|||
150228349|NCT02785900|541972192|FG000|Overall Study|Study Termination by Sponsor|64|||
150228350|NCT02785900|541972193|FG001|Overall Study|Study Termination by Sponsor|81|||
150228351|NCT02785900|541972192|FG000|Overall Study|Death|46|||
150228352|NCT02785900|541972193|FG001|Overall Study|Death|32|||
150228353|NCT02785900|541972192|FG000|Overall Study|Withdrawal by Subject|4|||
150228354|NCT02785900|541972193|FG001|Overall Study|Withdrawal by Subject|8|||
150228355|NCT02785900|541972192|FG000|Overall Study|Physician Decision|3|||
150228356|NCT02785900|541972193|FG001|Overall Study|Physician Decision|2|||
150228357|NCT04341584|541972194|FG000|Overall Study|Withdrew consent|0|||
150228358|NCT04341584|541972195|FG001|Overall Study|Withdrew consent|2|||
150228359|NCT04341584|541972196|FG002|Overall Study|Withdrew consent|2|||
150228360|NCT04341584|541972197|FG003|Overall Study|Withdrew consent|1|||
150228361|NCT01772147|541974373|FG000|Overall Study|Adverse Event|13|||
150228362|NCT01772147|541974374|FG001|Overall Study|Adverse Event|10|||
150228363|NCT01772147|541974375|FG002|Overall Study|Adverse Event|6|||
150228364|NCT01772147|541974373|FG000|Overall Study|Withdrew Consent|7|||
150228365|NCT01772147|541974374|FG001|Overall Study|Withdrew Consent|8|||
150228366|NCT01772147|541974375|FG002|Overall Study|Withdrew Consent|4|||
150228367|NCT01772147|541974373|FG000|Overall Study|Lost to Follow-up|1|||
150228368|NCT01772147|541974374|FG001|Overall Study|Lost to Follow-up|0|||
150228369|NCT01772147|541974375|FG002|Overall Study|Lost to Follow-up|1|||
150228370|NCT01772147|541974373|FG000|Overall Study|Protocol Deviation|2|||
150228371|NCT01772147|541974374|FG001|Overall Study|Protocol Deviation|1|||
150228372|NCT01772147|541974375|FG002|Overall Study|Protocol Deviation|1|||
150228373|NCT01772147|541974373|FG000|Overall Study|Lack of Efficacy|8|||
150228374|NCT01772147|541974374|FG001|Overall Study|Lack of Efficacy|6|||
150228375|NCT01772147|541974375|FG002|Overall Study|Lack of Efficacy|6|||
150228376|NCT04572997|541974380|FG000|Overall Study|Adverse Event|1|||
150228377|NCT01967719|541974381|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
150228378|NCT01967719|541974382|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
150228379|NCT01967719|541974383|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
150228380|NCT01967719|541974384|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
150228381|NCT01967719|541974381|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
150228382|NCT01967719|541974382|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
150228383|NCT01967719|541974383|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
150228384|NCT01967719|541974384|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
150228385|NCT00796614|541974394|FG000|Overall Study|Adverse Event|1|||
150228386|NCT00796614|541974395|FG001|Overall Study|Adverse Event|2|||
150228387|NCT00796614|541974396|FG002|Overall Study|Adverse Event|0|||
150228388|NCT00796614|541974397|FG003|Overall Study|Adverse Event|0|||
150228389|NCT00796614|541974394|FG000|Overall Study|Protocol Violation|0|||
150228390|NCT00796614|541974395|FG001|Overall Study|Protocol Violation|0|||
150228391|NCT00796614|541974396|FG002|Overall Study|Protocol Violation|2|||
150228392|NCT00796614|541974397|FG003|Overall Study|Protocol Violation|0|||
150228393|NCT00796614|541974394|FG000|Overall Study|Lost to Follow-up|2|||
150228394|NCT00796614|541974395|FG001|Overall Study|Lost to Follow-up|2|||
150228395|NCT00796614|541974396|FG002|Overall Study|Lost to Follow-up|1|||
150228396|NCT00796614|541974397|FG003|Overall Study|Lost to Follow-up|0|||
150228397|NCT00796614|541974394|FG000|Overall Study|Withdrawal by Subject|1|||
150228398|NCT00796614|541974395|FG001|Overall Study|Withdrawal by Subject|0|||
150228399|NCT00796614|541974396|FG002|Overall Study|Withdrawal by Subject|0|||
150228400|NCT00796614|541974397|FG003|Overall Study|Withdrawal by Subject|1|||
150228401|NCT00796614|541974394|FG000|Overall Study|Other than stated|1|||
150228402|NCT00796614|541974395|FG001|Overall Study|Other than stated|0|||
150228403|NCT00796614|541974396|FG002|Overall Study|Other than stated|0|||
150228404|NCT00796614|541974397|FG003|Overall Study|Other than stated|0|||
150228405|NCT00740597|541974398|FG000|Overall Study|insurance would not cover treatment|1|||
150228406|NCT00746785|541974400|FG000|Overall Study|Lost to Follow-up|29|||
150228407|NCT00746785|541974401|FG001|Overall Study|Lost to Follow-up|25|||
150228408|NCT00746785|541974402|FG002|Overall Study|Lost to Follow-up|27|||
150228409|NCT01231464|541974403|FG000|Overall Study|Adverse Event|0|||
150228410|NCT01231464|541974404|FG001|Overall Study|Adverse Event|1|||
150228411|NCT01231464|541974403|FG000|Overall Study|Protocol Violation|1|||
150228412|NCT01231464|541974404|FG001|Overall Study|Protocol Violation|2|||
150228413|NCT01231464|541974403|FG000|Overall Study|Lost to Follow-up|1|||
150228414|NCT01231464|541974404|FG001|Overall Study|Lost to Follow-up|2|||
150228415|NCT01231464|541974403|FG000|Overall Study|Withdrawal by Subject|3|||
150228416|NCT01231464|541974404|FG001|Overall Study|Withdrawal by Subject|2|||
150228417|NCT03449134|541974405|FG000|52-Week Treatment Period|Death|2|||
150228418|NCT03449134|541974406|FG001|52-Week Treatment Period|Death|1|||
150228419|NCT03449134|541974407|FG002|52-Week Treatment Period|Death|0|||
150228420|NCT03449134|541974405|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
150228421|NCT03449134|541974406|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
150228422|NCT03449134|541974407|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
150228423|NCT03449134|541974405|FG000|52-Week Treatment Period|Physician Decision|2|||
150228424|NCT03449134|541974406|FG001|52-Week Treatment Period|Physician Decision|3|||
150228425|NCT03449134|541974407|FG002|52-Week Treatment Period|Physician Decision|3|||
150228426|NCT03449134|541974405|FG000|52-Week Treatment Period|Screen Failure|1|||
150228427|NCT03449134|541974406|FG001|52-Week Treatment Period|Screen Failure|0|||
150228428|NCT03449134|541974407|FG002|52-Week Treatment Period|Screen Failure|1|||
150228429|NCT03449134|541974405|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
150228430|NCT03449134|541974406|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
150228431|NCT03449134|541974407|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
150228432|NCT03449134|541974405|FG000|52-Week Treatment Period|Site Closure|1|||
150228433|NCT03449134|541974406|FG001|52-Week Treatment Period|Site Closure|0|||
150228434|NCT03449134|541974407|FG002|52-Week Treatment Period|Site Closure|0|||
150228435|NCT00957996|541974413|FG000|Overall Study|Death|4|||
150228436|NCT00957996|541974414|FG001|Overall Study|Death|10|||
150228437|NCT00957996|541974413|FG000|Overall Study|Lost to Follow-up|4|||
150228438|NCT00957996|541974414|FG001|Overall Study|Lost to Follow-up|7|||
150228439|NCT00957996|541974413|FG000|Overall Study|Withdrawal by Subject|9|||
150228440|NCT00957996|541974414|FG001|Overall Study|Withdrawal by Subject|2|||
150228441|NCT00957996|541974413|FG000|Overall Study|Adverse Event|2|||
150228442|NCT00957996|541974414|FG001|Overall Study|Adverse Event|1|||
150228443|NCT00957996|541974413|FG000|Overall Study|Physician Decision|1|||
150228444|NCT00957996|541974414|FG001|Overall Study|Physician Decision|1|||
150228445|NCT00957996|541974413|FG000|Overall Study|Influenza-related complication|0|||
150228446|NCT00957996|541974414|FG001|Overall Study|Influenza-related complication|1|||
150228447|NCT00957996|541974413|FG000|Overall Study|Missing|1|||
150228448|NCT00957996|541974414|FG001|Overall Study|Missing|0|||
150228449|NCT00957996|541974413|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
150228450|NCT00957996|541974414|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
150228451|NCT00381797|541974421|FG000|Overall Study|Withdrawal by Subject|1|||
150228452|NCT00381797|541974422|FG001|Overall Study|Withdrawal by Subject|1|||
150228453|NCT00381797|541974423|FG002|Overall Study|Withdrawal by Subject|0|||
150228454|NCT00381797|541974424|FG003|Overall Study|Withdrawal by Subject|0|||
150228455|NCT00381797|541974425|FG004|Overall Study|Withdrawal by Subject|2|||
150228456|NCT00381797|541974421|FG000|Overall Study|Ineligible|0|||
150228457|NCT00381797|541974422|FG001|Overall Study|Ineligible|0|||
150228458|NCT00381797|541974423|FG002|Overall Study|Ineligible|0|||
150228459|NCT00381797|541974424|FG003|Overall Study|Ineligible|1|||
150228460|NCT00381797|541974425|FG004|Overall Study|Ineligible|0|||
150228461|NCT01902381|541974428|FG000|Overall Study|Withdrawal by Subject|1|||
150228462|NCT02762500|541974429|FG000|Overall Study|Lack of Efficacy|1|||
150228463|NCT02762500|541974430|FG001|Overall Study|Lack of Efficacy|0|||
150228464|NCT02762500|541974429|FG000|Overall Study|Withdrawal by Subject|1|||
150228465|NCT02762500|541974430|FG001|Overall Study|Withdrawal by Subject|1|||
150228466|NCT02762500|541974429|FG000|Overall Study|Adverse Event|0|||
150228467|NCT02762500|541974430|FG001|Overall Study|Adverse Event|2|||
150228468|NCT00329550|541974432|FG000|Overall Study|Adverse Event|3|||
150228469|NCT00329550|541974433|FG001|Overall Study|Adverse Event|4|||
150228470|NCT00329550|541974434|FG002|Overall Study|Adverse Event|2|||
150228471|NCT00329550|541974432|FG000|Overall Study|Withdrawal of Consent|1|||
150228472|NCT00329550|541974433|FG001|Overall Study|Withdrawal of Consent|0|||
150228473|NCT00329550|541974434|FG002|Overall Study|Withdrawal of Consent|1|||
150228474|NCT00329550|541974432|FG000|Overall Study|Due to Relocation|0|||
150228475|NCT00329550|541974433|FG001|Overall Study|Due to Relocation|0|||
150228476|NCT00329550|541974434|FG002|Overall Study|Due to Relocation|1|||
150228477|NCT00488319|541974437|FG000|Overall Study|Adverse Event|1|||
150228478|NCT00488319|541974438|FG001|Overall Study|Adverse Event|2|||
150228479|NCT00488319|541974439|FG002|Overall Study|Adverse Event|23|||
150228480|NCT00488319|541974437|FG000|Overall Study|Lack of Efficacy|6|||
150228481|NCT00488319|541974438|FG001|Overall Study|Lack of Efficacy|12|||
150228482|NCT00488319|541974439|FG002|Overall Study|Lack of Efficacy|27|||
150228483|NCT00488319|541974437|FG000|Overall Study|Lost to Follow-up|3|||
150228484|NCT00488319|541974438|FG001|Overall Study|Lost to Follow-up|5|||
150228485|NCT00488319|541974439|FG002|Overall Study|Lost to Follow-up|16|||
150228486|NCT00488319|541974437|FG000|Overall Study|Withdrawal by Subject|5|||
150228487|NCT00488319|541974438|FG001|Overall Study|Withdrawal by Subject|20|||
150228488|NCT00488319|541974439|FG002|Overall Study|Withdrawal by Subject|44|||
150228489|NCT00488319|541974437|FG000|Overall Study|Other reasons for withdrawal|0|||
150228490|NCT00488319|541974438|FG001|Overall Study|Other reasons for withdrawal|4|||
150228491|NCT00488319|541974439|FG002|Overall Study|Other reasons for withdrawal|12|||
150228492|NCT00111839|541974442|FG000|Overall Study|Disease Progression|30|||
150228493|NCT00111839|541974443|FG001|Overall Study|Disease Progression|33|||
150228494|NCT00111839|541974444|FG002|Overall Study|Disease Progression|33|||
150228495|NCT00111839|541974442|FG000|Overall Study|Adverse Event|5|||
150228496|NCT00111839|541974443|FG001|Overall Study|Adverse Event|3|||
150228497|NCT00111839|541974444|FG002|Overall Study|Adverse Event|1|||
150228498|NCT00111839|541974442|FG000|Overall Study|Protocol Violation|2|||
150228499|NCT00111839|541974443|FG001|Overall Study|Protocol Violation|4|||
150228500|NCT00111839|541974444|FG002|Overall Study|Protocol Violation|2|||
150228501|NCT00111839|541974442|FG000|Overall Study|Death|1|||
150228502|NCT00111839|541974443|FG001|Overall Study|Death|1|||
150228503|NCT00111839|541974444|FG002|Overall Study|Death|6|||
150228504|NCT00111839|541974442|FG000|Overall Study|Withdrawal by Subject|2|||
150228505|NCT00111839|541974443|FG001|Overall Study|Withdrawal by Subject|2|||
150228506|NCT00111839|541974444|FG002|Overall Study|Withdrawal by Subject|2|||
150228507|NCT00111839|541974442|FG000|Overall Study|Lost to Follow-up|1|||
150228508|NCT00111839|541974443|FG001|Overall Study|Lost to Follow-up|0|||
150228509|NCT00111839|541974444|FG002|Overall Study|Lost to Follow-up|0|||
150228510|NCT00111839|541974442|FG000|Overall Study|Logistical Constraint|1|||
150228511|NCT00111839|541974443|FG001|Overall Study|Logistical Constraint|0|||
150228512|NCT00111839|541974444|FG002|Overall Study|Logistical Constraint|0|||
150228513|NCT00111839|541974442|FG000|Overall Study|Other|6|||
150228514|NCT00111839|541974443|FG001|Overall Study|Other|3|||
150228515|NCT00111839|541974444|FG002|Overall Study|Other|3|||
150228516|NCT00111839|541974442|FG000|Overall Study|Randomized but Not Treated|0|||
150228517|NCT00111839|541974443|FG001|Overall Study|Randomized but Not Treated|0|||
150228518|NCT00111839|541974444|FG002|Overall Study|Randomized but Not Treated|2|||
150228519|NCT01011049|541974445|FG000|Overall Study|Protocol Violation|0|||
150228520|NCT01011049|541974446|FG001|Overall Study|Protocol Violation|0|||
150228521|NCT01011049|541974447|FG002|Overall Study|Protocol Violation|2|||
150228522|NCT01011049|541974448|FG003|Overall Study|Protocol Violation|0|||
150228523|NCT01011049|541974445|FG000|Overall Study|Lost to Follow-up|1|||
150228524|NCT01011049|541974446|FG001|Overall Study|Lost to Follow-up|2|||
150228525|NCT01011049|541974447|FG002|Overall Study|Lost to Follow-up|1|||
150228526|NCT01011049|541974448|FG003|Overall Study|Lost to Follow-up|0|||
150228527|NCT01011049|541974445|FG000|Overall Study|Withdrawal by Subject|0|||
150228528|NCT01011049|541974446|FG001|Overall Study|Withdrawal by Subject|0|||
150228529|NCT01011049|541974447|FG002|Overall Study|Withdrawal by Subject|1|||
150228530|NCT01011049|541974448|FG003|Overall Study|Withdrawal by Subject|0|||
150228531|NCT00352053|541974451|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
150228532|NCT00352053|541974452|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
150228533|NCT00352053|541974451|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
150228534|NCT00352053|541974452|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
150228535|NCT00352053|541974451|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
150228536|NCT00352053|541974452|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
150228537|NCT00352053|541974451|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
150228538|NCT00352053|541974452|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
150228539|NCT00352053|541974451|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
150228540|NCT00352053|541974452|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
150228541|NCT00352053|541974451|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
150228542|NCT00352053|541974452|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
150228543|NCT00352053|541974451|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
150228544|NCT00352053|541974452|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
150228545|NCT00352053|541974451|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
150228546|NCT00352053|541974452|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
150228547|NCT00352053|541974451|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
150228548|NCT00352053|541974452|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
150228549|NCT00352053|541974451|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
150228550|NCT00352053|541974452|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
150228551|NCT00352053|541974451|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
150228552|NCT00352053|541974452|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
150228553|NCT00352053|541974451|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
150228554|NCT00352053|541974452|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
150228555|NCT00352053|541974451|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
150228556|NCT00352053|541974452|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
150228557|NCT02435381|541974453|FG000|Overall Study|Lost to Follow-up|2|||
150228558|NCT02435381|541974454|FG001|Overall Study|Lost to Follow-up|1|||
150228559|NCT04150341|541974457|FG000|Overall Study|Physician Decision|0|||
150228560|NCT04150341|541974458|FG001|Overall Study|Physician Decision|0|||
150228561|NCT04150341|541974459|FG002|Overall Study|Physician Decision|1|||
150228562|NCT04150341|541974460|FG003|Overall Study|Physician Decision|0|||
150228563|NCT04150341|541974461|FG004|Overall Study|Physician Decision|0|||
150228564|NCT04150341|541974462|FG005|Overall Study|Physician Decision|0|||
150228565|NCT04150341|541974457|FG000|Overall Study|Adverse Event|0|||
150228566|NCT04150341|541974458|FG001|Overall Study|Adverse Event|0|||
150228567|NCT04150341|541974459|FG002|Overall Study|Adverse Event|0|||
150228568|NCT04150341|541974460|FG003|Overall Study|Adverse Event|0|||
150228569|NCT04150341|541974461|FG004|Overall Study|Adverse Event|1|||
150228570|NCT04150341|541974462|FG005|Overall Study|Adverse Event|0|||
150228571|NCT00833898|541974463|FG000|Overall Study|Withdrawal by Subject|33|||
150228572|NCT00833898|541974464|FG001|Overall Study|Withdrawal by Subject|27|||
150228573|NCT00833898|541974463|FG000|Overall Study|Lost to Follow-up|7|||
150228574|NCT00833898|541974464|FG001|Overall Study|Lost to Follow-up|7|||
150228575|NCT00833898|541974463|FG000|Overall Study|Patient did not receive transplant|0|||
150228576|NCT00833898|541974464|FG001|Overall Study|Patient did not receive transplant|2|||
150228577|NCT05109117|541974466|FG000|Overall Study|Lost to Follow-up|1|||
150228578|NCT05109117|541974466|FG000|Overall Study|Discontinued for non-compliance|1|||
150228579|NCT03972137|541974467|FG000|Overall Study|Lost to Follow-up|2|||
150228580|NCT03972137|541974467|FG000|Overall Study|Withdrawal by Subject|4|||
150228581|NCT03220776|541974468|FG000|Overall Study|Claustrophobia|0|||
150228582|NCT03220776|541974469|FG001|Overall Study|Claustrophobia|1|||
150228583|NCT03220776|541974470|FG002|Overall Study|Claustrophobia|1|||
150228584|NCT03220776|541974471|FG003|Overall Study|Claustrophobia|0|||
150228585|NCT03220776|541974472|FG004|Overall Study|Claustrophobia|1|||
150228586|NCT03220776|541974473|FG005|Overall Study|Claustrophobia|0|||
150228587|NCT03220776|541974468|FG000|Overall Study|MRI Equipment Failure|1|||
150228588|NCT03220776|541974469|FG001|Overall Study|MRI Equipment Failure|0|||
150228589|NCT03220776|541974470|FG002|Overall Study|MRI Equipment Failure|0|||
150228590|NCT03220776|541974471|FG003|Overall Study|MRI Equipment Failure|0|||
150228591|NCT03220776|541974472|FG004|Overall Study|MRI Equipment Failure|0|||
150228592|NCT03220776|541974473|FG005|Overall Study|MRI Equipment Failure|0|||
150228593|NCT03220776|541974468|FG000|Overall Study|Inclimate Weather|0|||
150228594|NCT03220776|541974469|FG001|Overall Study|Inclimate Weather|0|||
150228595|NCT03220776|541974470|FG002|Overall Study|Inclimate Weather|0|||
150228596|NCT03220776|541974471|FG003|Overall Study|Inclimate Weather|0|||
150228597|NCT03220776|541974472|FG004|Overall Study|Inclimate Weather|0|||
150228598|NCT03220776|541974473|FG005|Overall Study|Inclimate Weather|1|||
150228599|NCT03220776|541974468|FG000|Overall Study|Physician Decision|0|||
150228600|NCT03220776|541974469|FG001|Overall Study|Physician Decision|0|||
150228601|NCT03220776|541974470|FG002|Overall Study|Physician Decision|0|||
150228602|NCT03220776|541974471|FG003|Overall Study|Physician Decision|1|||
150228603|NCT03220776|541974472|FG004|Overall Study|Physician Decision|0|||
150228604|NCT03220776|541974473|FG005|Overall Study|Physician Decision|0|||
150228605|NCT03220776|541974468|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
150228606|NCT03220776|541974469|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
150228607|NCT03220776|541974470|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
150228608|NCT03220776|541974471|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
150228609|NCT03220776|541974472|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
150228610|NCT03220776|541974473|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
150228611|NCT03220776|541974468|FG000|Overall Study|Protocol Violation|0|||
150228612|NCT03220776|541974469|FG001|Overall Study|Protocol Violation|0|||
150228613|NCT03220776|541974470|FG002|Overall Study|Protocol Violation|0|||
150228614|NCT03220776|541974471|FG003|Overall Study|Protocol Violation|2|||
150228615|NCT03220776|541974472|FG004|Overall Study|Protocol Violation|0|||
150228616|NCT03220776|541974473|FG005|Overall Study|Protocol Violation|1|||
150228617|NCT03220776|541974468|FG000|Overall Study|Withdrawal by Subject|1|||
150228618|NCT03220776|541974469|FG001|Overall Study|Withdrawal by Subject|0|||
150228619|NCT03220776|541974470|FG002|Overall Study|Withdrawal by Subject|0|||
150228620|NCT03220776|541974471|FG003|Overall Study|Withdrawal by Subject|0|||
150228621|NCT03220776|541974472|FG004|Overall Study|Withdrawal by Subject|0|||
150228622|NCT03220776|541974473|FG005|Overall Study|Withdrawal by Subject|0|||
150228623|NCT02490878|541974475|FG000|Overall Study|deemed ineligible|0|||
150228624|NCT02490878|541974476|FG001|Overall Study|deemed ineligible|1|||
150228625|NCT02490878|541974475|FG000|Overall Study|progression prior to treatment|0|||
150228626|NCT02490878|541974476|FG001|Overall Study|progression prior to treatment|1|||
150228627|NCT02490878|541974475|FG000|Overall Study|only submitted baseline QOL|0|||
150228628|NCT02490878|541974476|FG001|Overall Study|only submitted baseline QOL|1|||
150228629|NCT02959177|541974477|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
150228630|NCT02959177|541974478|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
150228631|NCT02959177|541974479|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
150228632|NCT02959177|541974477|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
150228633|NCT02959177|541974478|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
150228634|NCT02959177|541974479|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
150228635|NCT02959177|541974477|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
150228636|NCT02959177|541974478|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
150228637|NCT02959177|541974479|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
150228638|NCT02959177|541974477|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
150228639|NCT02959177|541974478|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
150228640|NCT02959177|541974479|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
150228641|NCT02959177|541974477|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
150228642|NCT02959177|541974478|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
150228643|NCT02959177|541974479|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
150228644|NCT02959177|541974477|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
150228645|NCT02959177|541974478|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
150228646|NCT02959177|541974479|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
150228647|NCT02959177|541974477|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
150228648|NCT02959177|541974478|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
150228649|NCT02959177|541974479|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
150228650|NCT02215954|541974481|FG000|Overall Study|Adverse Event|0|||
150228651|NCT02215954|541974482|FG001|Overall Study|Adverse Event|0|||
150228652|NCT02215954|541974483|FG002|Overall Study|Adverse Event|1|||
150228653|NCT02215954|541974481|FG000|Overall Study|Withdrawal by Subject|0|||
150228654|NCT02215954|541974482|FG001|Overall Study|Withdrawal by Subject|0|||
150228655|NCT02215954|541974483|FG002|Overall Study|Withdrawal by Subject|2|||
150228656|NCT02215954|541974481|FG000|Overall Study|Not exposed|1|||
150228657|NCT02215954|541974482|FG001|Overall Study|Not exposed|1|||
150228658|NCT02215954|541974483|FG002|Overall Study|Not exposed|3|||
150228659|NCT02642159|541974484|FG000|Overall Study|Randomized but not treated|1|||
150228660|NCT02642159|541974485|FG001|Overall Study|Randomized but not treated|0|||
150228661|NCT02642159|541974484|FG000|Overall Study|Adverse Event|10|||
150228662|NCT02642159|541974485|FG001|Overall Study|Adverse Event|4|||
150228663|NCT02642159|541974484|FG000|Overall Study|Withdrawal by Subject|9|||
150228664|NCT02642159|541974485|FG001|Overall Study|Withdrawal by Subject|1|||
150228665|NCT02642159|541974484|FG000|Overall Study|Poor compliance to study protocol|1|||
150228666|NCT02642159|541974485|FG001|Overall Study|Poor compliance to study protocol|0|||
150228667|NCT02642159|541974484|FG000|Overall Study|Other than specified above|10|||
150228668|NCT02642159|541974485|FG001|Overall Study|Other than specified above|3|||
150228669|NCT04194541|541974486|FG000|Day 1 Through 13|Lost to Follow-up|3|||
150228670|NCT04194541|541974486|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
150228671|NCT04194541|541974486|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
150228672|NCT01287416|541974487|FG000|Pre-post Training|Withdrawal by Subject|17|||
150228673|NCT01287416|541974488|FG001|Pre-post Training|Withdrawal by Subject|24|||
150228674|NCT01287416|541974487|FG000|Pre-post Training|Lost to Follow-up|5|||
150228675|NCT01287416|541974488|FG001|Pre-post Training|Lost to Follow-up|1|||
150228676|NCT01287416|541974487|FG000|6 Month Follow-up|Lost to Follow-up|3|||
150228677|NCT01287416|541974488|FG001|6 Month Follow-up|Lost to Follow-up|2|||
150228678|NCT03340766|541974490|FG000|Overall Study|Withdrawal by Subject|2|||
150228679|NCT03340766|541974491|FG001|Overall Study|Withdrawal by Subject|1|||
150228680|NCT03340766|541974492|FG002|Overall Study|Withdrawal by Subject|3|||
150228681|NCT03340766|541974490|FG000|Overall Study|Lost to Follow-up|0|||
150228682|NCT03340766|541974491|FG001|Overall Study|Lost to Follow-up|0|||
150228683|NCT03340766|541974492|FG002|Overall Study|Lost to Follow-up|1|||
150228684|NCT03340766|541974490|FG000|Overall Study|Death|6|||
150228685|NCT03340766|541974491|FG001|Overall Study|Death|7|||
150228686|NCT03340766|541974492|FG002|Overall Study|Death|4|||
150228687|NCT00853021|541974493|FG000|Overall Study|Adverse Event|2|||
150228688|NCT00853021|541974493|FG000|Overall Study|Withdrawal by Subject|2|||
150228689|NCT00853021|541974493|FG000|Overall Study|Death|1|||
150228690|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
150228691|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
150228692|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
150228693|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
150228694|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
150228695|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
150228696|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
150228697|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
150228698|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
150228699|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
150228700|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
150228701|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
150228702|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
150228703|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
150228704|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
150228705|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
150228706|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
150228707|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
150228708|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
150228709|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
150228710|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
150228711|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
150228712|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
150228713|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
150228714|NCT02269917|541974494|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
150228715|NCT02269917|541974495|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
150228716|NCT02269917|541974496|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
150228717|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
150228718|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
150228719|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
150228720|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
150228721|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
150228722|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
150228723|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
150228724|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
150228725|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
150228726|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
150228727|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
150228728|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
150228729|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
150228730|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
150228731|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
150228732|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
150228733|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
150228734|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
150228735|NCT02269917|541974494|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
150228736|NCT02269917|541974495|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
150228737|NCT02269917|541974496|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
150228738|NCT00240097|541974497|FG000|Part I|Adverse Event|1|||
150228739|NCT00240097|541974497|FG000|Part I|Death|1|||
150228740|NCT00240097|541974497|FG000|Part I|histology|1|||
150228741|NCT00240097|541974497|FG000|Part I|unevaluable|1|||
150228742|NCT00240097|541974497|FG000|Part II|did not continue from Part I|23|||
150228743|NCT02383927|541974498|FG000|Overall Study|Disease Progression|8|||
150228744|NCT02383927|541974499|FG001|Overall Study|Disease Progression|8|||
150228745|NCT02383927|541974500|FG002|Overall Study|Disease Progression|15|||
150228746|NCT02383927|541974501|FG003|Overall Study|Disease Progression|4|||
150228747|NCT02383927|541974498|FG000|Overall Study|Physician Decision|0|||
150228748|NCT02383927|541974499|FG001|Overall Study|Physician Decision|0|||
150228749|NCT02383927|541974500|FG002|Overall Study|Physician Decision|2|||
150228750|NCT02383927|541974501|FG003|Overall Study|Physician Decision|0|||
150228751|NCT02383927|541974498|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
150228752|NCT02383927|541974499|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
150228753|NCT02383927|541974500|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
150228754|NCT02383927|541974501|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
150228755|NCT02383927|541974498|FG000|Overall Study|Adverse Event|4|||
150228756|NCT02383927|541974499|FG001|Overall Study|Adverse Event|1|||
150228757|NCT02383927|541974500|FG002|Overall Study|Adverse Event|3|||
150228758|NCT02383927|541974501|FG003|Overall Study|Adverse Event|5|||
150228759|NCT02383927|541974498|FG000|Overall Study|Miscellaneous|1|||
150228760|NCT02383927|541974499|FG001|Overall Study|Miscellaneous|0|||
150228761|NCT02383927|541974500|FG002|Overall Study|Miscellaneous|0|||
150228762|NCT02383927|541974501|FG003|Overall Study|Miscellaneous|1|||
150228763|NCT02383927|541974498|FG000|Overall Study|Withdrawal by Subject|0|||
150228764|NCT02383927|541974499|FG001|Overall Study|Withdrawal by Subject|1|||
150228765|NCT02383927|541974500|FG002|Overall Study|Withdrawal by Subject|4|||
150228766|NCT02383927|541974501|FG003|Overall Study|Withdrawal by Subject|0|||
150228767|NCT00818519|541974502|FG000|Overall Study|Adverse Event|2|||
150228768|NCT00818519|541974503|FG001|Overall Study|Adverse Event|2|||
150228769|NCT00818519|541974502|FG000|Overall Study|Lost to Follow-up|4|||
150228770|NCT00818519|541974503|FG001|Overall Study|Lost to Follow-up|6|||
150228771|NCT00818519|541974502|FG000|Overall Study|Protocol Violation|2|||
150228772|NCT00818519|541974503|FG001|Overall Study|Protocol Violation|1|||
150228773|NCT00818519|541974502|FG000|Overall Study|Pregnancy|0|||
150228774|NCT00818519|541974503|FG001|Overall Study|Pregnancy|1|||
150228775|NCT00818519|541974502|FG000|Overall Study|Withdrawal by Subject|4|||
150228776|NCT00818519|541974503|FG001|Overall Study|Withdrawal by Subject|9|||
150228777|NCT00818519|541974502|FG000|Overall Study|participant recovered completely|1|||
150228778|NCT00818519|541974503|FG001|Overall Study|participant recovered completely|0|||
150228779|NCT00818519|541974502|FG000|Overall Study|participant will leave for long tme|1|||
150228780|NCT00818519|541974503|FG001|Overall Study|participant will leave for long tme|0|||
150228781|NCT02335242|541974506|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
150228782|NCT02335242|541974507|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
150228783|NCT02335242|541974506|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
150228784|NCT02335242|541974507|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
150228785|NCT02335242|541974506|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
150228786|NCT02335242|541974507|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
150228787|NCT03873038|541974508|FG000|Part 2|Withdrawal by Subject|0|||
150228788|NCT03873038|541974509|FG001|Part 2|Withdrawal by Subject|0|||
150228789|NCT03873038|541974510|FG002|Part 2|Withdrawal by Subject|0|||
150228790|NCT03873038|541974511|FG003|Part 2|Withdrawal by Subject|0|||
150228791|NCT03873038|541974512|FG004|Part 2|Withdrawal by Subject|0|||
150228792|NCT03873038|541974513|FG005|Part 2|Withdrawal by Subject|1|||
150228793|NCT03873038|541974508|FG000|Part 2|Unknon|0|||
150228794|NCT03873038|541974509|FG001|Part 2|Unknon|0|||
150228795|NCT03873038|541974510|FG002|Part 2|Unknon|0|||
150228796|NCT03873038|541974511|FG003|Part 2|Unknon|0|||
150228797|NCT03873038|541974512|FG004|Part 2|Unknon|1|||
150228798|NCT03873038|541974513|FG005|Part 2|Unknon|0|||
150228799|NCT04222088|541974514|FG000|Overall Study|Lost to Follow-up|5|||
150228800|NCT04222088|541974515|FG001|Overall Study|Lost to Follow-up|1|||
150228801|NCT04222088|541974514|FG000|Overall Study|Withdrawal by Subject|4|||
150228802|NCT04222088|541974515|FG001|Overall Study|Withdrawal by Subject|0|||
150228803|NCT00595764|541974516|FG000|Overall Study|Protocol Violation|24|||
150228804|NCT00595764|541974517|FG001|Overall Study|Protocol Violation|19|||
150228805|NCT00595764|541974516|FG000|Overall Study|Missed Medication >1 week|10|||
150228806|NCT00595764|541974517|FG001|Overall Study|Missed Medication >1 week|17|||
150228807|NCT00595764|541974516|FG000|Overall Study|Missed 3 PM visits|1|||
150228808|NCT00595764|541974517|FG001|Overall Study|Missed 3 PM visits|7|||
150228809|NCT00595764|541974516|FG000|Overall Study|Withdrawal by Subject|4|||
150228810|NCT00595764|541974517|FG001|Overall Study|Withdrawal by Subject|0|||
150228811|NCT00464737|541974519|FG000|Overall Study|Adverse Event|12|||
150228812|NCT00464737|541974520|FG001|Overall Study|Adverse Event|17|||
150228813|NCT00464737|541974521|FG002|Overall Study|Adverse Event|33|||
150228814|NCT00464737|541974519|FG000|Overall Study|Lack of Efficacy|7|||
150228815|NCT00464737|541974520|FG001|Overall Study|Lack of Efficacy|7|||
150228816|NCT00464737|541974521|FG002|Overall Study|Lack of Efficacy|4|||
150228817|NCT00464737|541974519|FG000|Overall Study|Withdrawal by Subject|5|||
150228818|NCT00464737|541974520|FG001|Overall Study|Withdrawal by Subject|3|||
150228819|NCT00464737|541974521|FG002|Overall Study|Withdrawal by Subject|5|||
150228820|NCT00464737|541974519|FG000|Overall Study|Protocol Violation|1|||
150228821|NCT00464737|541974520|FG001|Overall Study|Protocol Violation|1|||
150228822|NCT00464737|541974521|FG002|Overall Study|Protocol Violation|5|||
150228823|NCT00464737|541974519|FG000|Overall Study|Non-compliance|0|||
150228824|NCT00464737|541974520|FG001|Overall Study|Non-compliance|1|||
150228825|NCT00464737|541974521|FG002|Overall Study|Non-compliance|1|||
150228826|NCT00464737|541974519|FG000|Overall Study|Lost to Follow-up|5|||
150228827|NCT00464737|541974520|FG001|Overall Study|Lost to Follow-up|2|||
150228828|NCT00464737|541974521|FG002|Overall Study|Lost to Follow-up|5|||
150228829|NCT00464737|541974519|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
150228830|NCT00464737|541974520|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
150228831|NCT00464737|541974521|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
150228832|NCT00464737|541974519|FG000|Overall Study|Other: Subject left town; family illness|1|||
150228833|NCT00464737|541974520|FG001|Overall Study|Other: Subject left town; family illness|0|||
150228834|NCT00464737|541974521|FG002|Overall Study|Other: Subject left town; family illness|0|||
150228835|NCT00464737|541974519|FG000|Overall Study|Other: Study demands too great|0|||
150228836|NCT00464737|541974520|FG001|Overall Study|Other: Study demands too great|1|||
150228837|NCT00464737|541974521|FG002|Overall Study|Other: Study demands too great|0|||
150228838|NCT00464737|541974519|FG000|Overall Study|Other: Personal family reasons|0|||
150228839|NCT00464737|541974520|FG001|Overall Study|Other: Personal family reasons|0|||
150228840|NCT00464737|541974521|FG002|Overall Study|Other: Personal family reasons|1|||
150228841|NCT00464737|541974519|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
150228842|NCT00464737|541974520|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
150228843|NCT00464737|541974521|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
150228844|NCT01544153|541974524|FG000|Overall Study|Under 18|0|||
150228845|NCT01544153|541974525|FG001|Overall Study|Under 18|1|||
150228846|NCT01544153|541974526|FG002|Overall Study|Under 18|0|||
150228847|NCT01544153|541974527|FG003|Overall Study|Under 18|0|||
150228848|NCT01544153|541974524|FG000|Overall Study|Non-smoker|0|||
150228849|NCT01544153|541974525|FG001|Overall Study|Non-smoker|0|||
150228850|NCT01544153|541974526|FG002|Overall Study|Non-smoker|1|||
150228851|NCT01544153|541974527|FG003|Overall Study|Non-smoker|0|||
150228852|NCT00390806|541974532|FG000|Overall Study|Lost to Follow-up|7|||
150228853|NCT00390806|541974533|FG001|Overall Study|Lost to Follow-up|6|||
150228854|NCT00390806|541974532|FG000|Overall Study|Protocol Violation|2|||
150228855|NCT00390806|541974533|FG001|Overall Study|Protocol Violation|2|||
150228856|NCT00390806|541974532|FG000|Overall Study|Withdrawal by Subject|12|||
150228857|NCT00390806|541974533|FG001|Overall Study|Withdrawal by Subject|15|||
150228858|NCT00390806|541974532|FG000|Overall Study|Investigator Decision|4|||
150228859|NCT00390806|541974533|FG001|Overall Study|Investigator Decision|6|||
150228860|NCT00390806|541974532|FG000|Overall Study|Death|1|||
150228861|NCT00390806|541974533|FG001|Overall Study|Death|0|||
150228862|NCT00390806|541974532|FG000|Overall Study|Physician Decision|0|||
150228863|NCT00390806|541974533|FG001|Overall Study|Physician Decision|1|||
150228864|NCT00390806|541974532|FG000|Overall Study|Ongoing|4|||
150228865|NCT00390806|541974533|FG001|Overall Study|Ongoing|2|||
150228866|NCT03169530|541974536|FG000|Overall Study|Study ended by NIH|15|||
150228867|NCT03169530|541974537|FG001|Overall Study|Study ended by NIH|17|||
150228868|NCT01032200|541974538|FG000|Overall Study|Death|1|||
150228869|NCT01032200|541974539|FG001|Overall Study|Death|1|||
150228870|NCT01032200|541974538|FG000|Overall Study|Withdrawal by Subject|1|||
150228871|NCT01032200|541974539|FG001|Overall Study|Withdrawal by Subject|3|||
150228872|NCT01032200|541974538|FG000|Overall Study|Toxicity|0|||
150228873|NCT01032200|541974539|FG001|Overall Study|Toxicity|2|||
150228874|NCT01032200|541974538|FG000|Overall Study|Progression|1|||
150228875|NCT01032200|541974539|FG001|Overall Study|Progression|0|||
150228876|NCT01032200|541974538|FG000|Overall Study|Multiple|1|||
150228877|NCT01032200|541974539|FG001|Overall Study|Multiple|1|||
150228878|NCT00727259|541974543|FG000|Overall Study|Not all questionnaires completed|1055|||
150228879|NCT01021683|541974544|FG000|Overall Study|Lack of Efficacy|12|||
150228880|NCT01021683|541974544|FG000|Overall Study|Recovery of neutrophil count|51|||
150228881|NCT01021683|541974544|FG000|Overall Study|Other|8|||
150228882|NCT00645099|541974545|FG000|Overall Study|Lack of Efficacy|15|||
150228883|NCT00645099|541974546|FG001|Overall Study|Lack of Efficacy|6|||
150228884|NCT00645099|541974545|FG000|Overall Study|Withdrawal by Subject|30|||
150228885|NCT00645099|541974546|FG001|Overall Study|Withdrawal by Subject|22|||
150228886|NCT00645099|541974545|FG000|Overall Study|Lost to Follow-up|6|||
150228887|NCT00645099|541974546|FG001|Overall Study|Lost to Follow-up|4|||
150228888|NCT00645099|541974545|FG000|Overall Study|Adverse Event|11|||
150228889|NCT00645099|541974546|FG001|Overall Study|Adverse Event|5|||
150228890|NCT00645099|541974545|FG000|Overall Study|Other|9|||
150228891|NCT00645099|541974546|FG001|Overall Study|Other|5|||
150228892|NCT01201915|541974547|FG000|Overall Study|Adverse Event|2|||
150228893|NCT01201915|541974548|FG001|Overall Study|Adverse Event|1|||
150228894|NCT01201915|541974549|FG002|Overall Study|Adverse Event|1|||
150228895|NCT01201915|541974547|FG000|Overall Study|Lost to Follow-up|0|||
150228896|NCT01201915|541974548|FG001|Overall Study|Lost to Follow-up|4|||
150228897|NCT01201915|541974549|FG002|Overall Study|Lost to Follow-up|0|||
150228898|NCT01201915|541974547|FG000|Overall Study|Physician Decision|3|||
150228899|NCT01201915|541974548|FG001|Overall Study|Physician Decision|0|||
150228900|NCT01201915|541974549|FG002|Overall Study|Physician Decision|0|||
150228901|NCT01201915|541974547|FG000|Overall Study|Subject Decision|3|||
150228902|NCT01201915|541974548|FG001|Overall Study|Subject Decision|3|||
150228903|NCT01201915|541974549|FG002|Overall Study|Subject Decision|5|||
150228904|NCT01201915|541974547|FG000|Overall Study|Target Lesion Progression|0|||
150228905|NCT01201915|541974548|FG001|Overall Study|Target Lesion Progression|3|||
150228906|NCT01201915|541974549|FG002|Overall Study|Target Lesion Progression|0|||
150228907|NCT03406507|541974550|FG000|Extension Period|Lack of Efficacy|0|||
150228908|NCT03406507|541974551|FG001|Extension Period|Lack of Efficacy|1|||
150228909|NCT02316171|541974553|FG000|Overall Study|difficulties with urinary catheter|1|||
150228910|NCT02316171|541974554|FG001|Overall Study|difficulties with urinary catheter|0|||
150228911|NCT02316171|541974555|FG002|Overall Study|difficulties with urinary catheter|0|||
150228912|NCT02316171|541974556|FG003|Overall Study|difficulties with urinary catheter|0|||
150228913|NCT01804140|541974557|FG000|Overall Study|No sampling or biopsy procedures done|114|||
150228914|NCT00547300|541974560|FG000|Overall Study|Study was Administratively Terminated|25|||
150228915|NCT00547300|541974561|FG001|Overall Study|Study was Administratively Terminated|24|||
150228916|NCT00547300|541974560|FG000|Overall Study|Did not Meet Entry Criteria|0|||
150228917|NCT00547300|541974561|FG001|Overall Study|Did not Meet Entry Criteria|2|||
150255280|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
150255281|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
150255282|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
150255283|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
150255284|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
150255285|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
150255286|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
150255287|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
150255288|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
150255289|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
150255290|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
150255291|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
150255292|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
150255293|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
150255294|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
150255295|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
150255296|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
150255297|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
150255298|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
150255299|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
150255300|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
150255301|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
150255302|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
150255303|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
150255304|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
150255305|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
150255306|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
150255307|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
150255308|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
150255309|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
150255310|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
150255311|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
150255312|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
150255313|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
150255314|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
150255315|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
150255316|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
150255317|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
150255318|NCT00700427|542070609|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
150255319|NCT00700427|542070610|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
150255320|NCT00700427|542070611|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
150255321|NCT00700427|542070612|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
150255322|NCT00700427|542070613|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
150255323|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
150255324|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
150255325|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
150255326|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
150255327|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
150255328|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
150255329|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
150255330|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
150255331|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
150255332|NCT00700427|542070613|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
150255333|NCT00700427|542070609|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
150228918|NCT01960348|541976687|FG000|Overall Study|Adverse event, not serious|2|||
150228919|NCT01960348|541976688|FG001|Overall Study|Adverse event, not serious|2|||
150141811|NCT01669798|541654099|FG000|Overall Study|Physician Decision|5|||
150141812|NCT05918978|541654103|FG000|Overall Study|Study Terminated by Sponsor|17|||
150141813|NCT05918978|541654104|FG001|Overall Study|Study Terminated by Sponsor|11|||
150141814|NCT05918978|541654103|FG000|Overall Study|Withdrawal by Subject|1|||
150141815|NCT05918978|541654104|FG001|Overall Study|Withdrawal by Subject|1|||
150141816|NCT05918978|541654103|FG000|Overall Study|Adverse Event|1|||
150141817|NCT05918978|541654104|FG001|Overall Study|Adverse Event|0|||
150141818|NCT05918978|541654103|FG000|Overall Study|Other|0|||
150141819|NCT05918978|541654104|FG001|Overall Study|Other|1|||
150141820|NCT00622180|541654105|FG000|Overall Study|Lost to Follow-up|1|||
150141821|NCT00622180|541654106|FG001|Overall Study|Lost to Follow-up|2|||
150141822|NCT06387472|541654109|FG000|Overall Study|Withdrawal by Subject|1|||
150141823|NCT06387472|541654109|FG000|Overall Study|Lost to Follow-up|2|||
150141824|NCT06387472|541654109|FG000|Overall Study|Physician Decision|1|||
150141825|NCT02332590|541654110|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
150141826|NCT02332590|541654111|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
150141827|NCT02332590|541654110|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
150141828|NCT02332590|541654111|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
150141829|NCT02332590|541654110|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
150141830|NCT02332590|541654111|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
150141831|NCT02332590|541654110|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
150141832|NCT02332590|541654111|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
150141833|NCT02332590|541654110|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
150228920|NCT01960348|541976687|FG000|Overall Study|Adverse event, serious fatal|6|||
150228921|NCT01960348|541976688|FG001|Overall Study|Adverse event, serious fatal|5|||
150228922|NCT01960348|541976687|FG000|Overall Study|Adverse event, serious non-fatal|0|||
150228923|NCT01960348|541976688|FG001|Overall Study|Adverse event, serious non-fatal|3|||
150228924|NCT01960348|541976687|FG000|Overall Study|Withdrawal by Subject|1|||
150228925|NCT01960348|541976688|FG001|Overall Study|Withdrawal by Subject|11|||
150228926|NCT01960348|541976687|FG000|Overall Study|Physician Decision|0|||
150228927|NCT01960348|541976688|FG001|Overall Study|Physician Decision|1|||
150228928|NCT01960348|541976687|FG000|Overall Study|Protocol Violation|1|||
150141834|NCT02332590|541654111|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
150141835|NCT02332590|541654110|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
150141836|NCT02332590|541654111|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
150228929|NCT01960348|541976688|FG001|Overall Study|Protocol Violation|0|||
150228930|NCT01580995|541976689|FG000|Overall Study|Lost to Follow-up|2|||
150228931|NCT01580995|541976690|FG001|Overall Study|Lost to Follow-up|2|||
150141837|NCT02332590|541654110|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
150141838|NCT02332590|541654111|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
150141839|NCT02332590|541654110|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
150228932|NCT01821729|541976691|FG000|Overall Study|Withdrawal by Subject|1|||
150228933|NCT02916706|541976692|FG000|Overall Study|Adverse Event|0|||
150228934|NCT02916706|541976693|FG001|Overall Study|Adverse Event|1|||
150228935|NCT02916706|541976692|FG000|Overall Study|Lost to Follow-up|0|||
150228936|NCT02916706|541976693|FG001|Overall Study|Lost to Follow-up|1|||
150228937|NCT02916706|541976692|FG000|Overall Study|Physician Decision|1|||
150228938|NCT02916706|541976693|FG001|Overall Study|Physician Decision|0|||
150228939|NCT02916706|541976692|FG000|Overall Study|Protocol Violation|3|||
150228940|NCT02916706|541976693|FG001|Overall Study|Protocol Violation|1|||
150228941|NCT02916706|541976692|FG000|Overall Study|Withdrawal by Subject|6|||
150228942|NCT02916706|541976693|FG001|Overall Study|Withdrawal by Subject|9|||
150228943|NCT02916706|541976692|FG000|Overall Study|Other|5|||
150228944|NCT02916706|541976693|FG001|Overall Study|Other|19|||
150228945|NCT00719212|541976696|FG000|Overall Study|Death|41|||
150228946|NCT00719212|541976696|FG000|Overall Study|Lost to Follow-up|2|||
150228947|NCT00719212|541976696|FG000|Overall Study|Withdrawal by Subject|1|||
150228948|NCT00837096|541976697|FG000|Overall Study|Physician Decision|1|||
150228949|NCT00837096|541976698|FG001|Overall Study|Physician Decision|1|||
150228950|NCT00837096|541976697|FG000|Overall Study|Not reported|9|||
150228951|NCT00837096|541976698|FG001|Overall Study|Not reported|8|||
150228952|NCT00494026|541976699|FG000|Overall Study|Sponsor Decision|4|||
150228953|NCT02466243|541976700|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
150228954|NCT02466243|541976701|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
150228955|NCT02466243|541976700|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
150228956|NCT02466243|541976701|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
150228957|NCT02466243|541976700|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
150228958|NCT02466243|541976701|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
150228959|NCT02466243|541976700|FG000|Part B Open-label Treatment Period|Missing|2|||
150228960|NCT02466243|541976701|FG001|Part B Open-label Treatment Period|Missing|2|||
150228961|NCT00875615|541976702|FG000|Overall Study|Withdrawal by Subject|1|||
150228962|NCT00405912|541976704|FG000|Overall Study|Withdrawal by Subject|12|||
150228963|NCT00405912|541976705|FG001|Overall Study|Withdrawal by Subject|11|||
150228964|NCT00405912|541976706|FG002|Overall Study|Withdrawal by Subject|12|||
150228965|NCT00405912|541976704|FG000|Overall Study|Lost to Follow-up|4|||
150228966|NCT00405912|541976705|FG001|Overall Study|Lost to Follow-up|8|||
150228967|NCT00405912|541976706|FG002|Overall Study|Lost to Follow-up|4|||
150228968|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
150228969|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
150228970|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
150228971|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
150228972|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
150228973|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
150228974|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
150228975|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
150228976|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Death|6|||
150228977|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Death|2|||
150228978|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Death|2|||
150228979|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Death|9|||
150228980|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
150228981|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
150228982|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
150228983|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
150228984|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
150228985|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
150228986|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
150228987|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
150228988|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
150228989|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
150228990|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
150228991|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
150228992|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
150228993|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
150228994|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
150228995|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
150228996|NCT03730662|541976707|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
150228997|NCT03730662|541976708|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
150228998|NCT03730662|541976709|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
150228999|NCT03730662|541976710|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
150229000|NCT03730662|541976707|FG000|Variable Treatment Period|Adverse Event|1|||
150229001|NCT03730662|541976708|FG001|Variable Treatment Period|Adverse Event|2|||
150229002|NCT03730662|541976709|FG002|Variable Treatment Period|Adverse Event|0|||
150229003|NCT03730662|541976710|FG003|Variable Treatment Period|Adverse Event|7|||
150229004|NCT03730662|541976707|FG000|Variable Treatment Period|Death|9|||
150229005|NCT03730662|541976708|FG001|Variable Treatment Period|Death|0|||
150229006|NCT03730662|541976709|FG002|Variable Treatment Period|Death|6|||
150229007|NCT03730662|541976710|FG003|Variable Treatment Period|Death|26|||
150229008|NCT03730662|541976707|FG000|Variable Treatment Period|Lost to Follow-up|2|||
150229009|NCT03730662|541976708|FG001|Variable Treatment Period|Lost to Follow-up|1|||
150229010|NCT03730662|541976709|FG002|Variable Treatment Period|Lost to Follow-up|4|||
150229011|NCT03730662|541976710|FG003|Variable Treatment Period|Lost to Follow-up|11|||
150229012|NCT03730662|541976707|FG000|Variable Treatment Period|Personal Reason|0|||
150229013|NCT03730662|541976708|FG001|Variable Treatment Period|Personal Reason|2|||
150229014|NCT03730662|541976709|FG002|Variable Treatment Period|Personal Reason|1|||
150229015|NCT03730662|541976710|FG003|Variable Treatment Period|Personal Reason|6|||
150229016|NCT03730662|541976707|FG000|Variable Treatment Period|Physician Decision|0|||
150229017|NCT03730662|541976708|FG001|Variable Treatment Period|Physician Decision|0|||
150229018|NCT03730662|541976709|FG002|Variable Treatment Period|Physician Decision|0|||
150229019|NCT03730662|541976710|FG003|Variable Treatment Period|Physician Decision|3|||
150229020|NCT03730662|541976707|FG000|Variable Treatment Period|Protocol Violation|0|||
150229021|NCT03730662|541976708|FG001|Variable Treatment Period|Protocol Violation|1|||
150229022|NCT03730662|541976709|FG002|Variable Treatment Period|Protocol Violation|1|||
150229023|NCT03730662|541976710|FG003|Variable Treatment Period|Protocol Violation|1|||
150229024|NCT03730662|541976707|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
150229025|NCT03730662|541976708|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
150229026|NCT03730662|541976709|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
150229027|NCT03730662|541976710|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
150229028|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
150229029|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
150229030|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
150229031|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
150229032|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Death|0|||
150229033|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Death|1|||
150229034|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
150229035|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
150229036|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
150229037|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
150229038|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
150229039|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
150229040|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
150229041|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
150229042|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
150229043|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
150229044|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
150229045|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
150229046|NCT01309243|541976716|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
150229047|NCT01309243|541976717|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
150229048|NCT01309243|541976716|FG000|Extension Phase|Lost to Follow-up|6|||
150229049|NCT01309243|541976717|FG001|Extension Phase|Lost to Follow-up|0|||
150229050|NCT00632931|541976718|FG000|Part 1, Period 1|Protocol Violation|1|||
150229051|NCT00632931|541976719|FG001|Part 1, Period 1|Protocol Violation|0|||
150229052|NCT00632931|541976720|FG002|Part 1, Period 1|Protocol Violation|0|||
150229053|NCT00632931|541976718|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
150229054|NCT00632931|541976719|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
150229055|NCT00632931|541976720|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
150229056|NCT00632931|541976718|FG000|Part 2|Adverse Event|0|||
150229057|NCT00632931|541976719|FG001|Part 2|Adverse Event|0|||
150229058|NCT00632931|541976720|FG002|Part 2|Adverse Event|3|||
150229059|NCT00632931|541976718|FG000|Part 2|Death|0|||
150229060|NCT00632931|541976719|FG001|Part 2|Death|0|||
150229061|NCT00632931|541976720|FG002|Part 2|Death|1|||
150229062|NCT00632931|541976718|FG000|Part 2|Lack of Efficacy|0|||
150229063|NCT00632931|541976719|FG001|Part 2|Lack of Efficacy|0|||
150229064|NCT00632931|541976720|FG002|Part 2|Lack of Efficacy|17|||
150229065|NCT00632931|541976718|FG000|Part 2|Withdrawal by Subject|0|||
150229066|NCT00632931|541976719|FG001|Part 2|Withdrawal by Subject|0|||
150229067|NCT00632931|541976720|FG002|Part 2|Withdrawal by Subject|3|||
150229068|NCT01402063|541976723|FG000|Overall Study|Withdrawal by Subject|3|||
150229069|NCT01402063|541976724|FG001|Overall Study|Withdrawal by Subject|3|||
150229070|NCT03712449|541976727|FG000|Overall Study|Withdraw Consent|0|||
150229071|NCT03712449|541976728|FG001|Overall Study|Withdraw Consent|1|||
150229072|NCT00666198|541976731|FG000|Overall Study|Protocol Violation|10|||
150229073|NCT00666198|541976731|FG000|Overall Study|No Visit After First Day of Treatment|13|||
150229074|NCT00666198|541976731|FG000|Overall Study|Safety Not Assessable|6|||
150229075|NCT00666198|541976731|FG000|Overall Study|No Drug Administration|4|||
150229076|NCT05153499|541976732|FG000|Overall Study|Withdrawal by Subject|1|||
150229077|NCT05153499|541976733|FG001|Overall Study|Withdrawal by Subject|0|||
150229078|NCT05153499|541976732|FG000|Overall Study|Clinical Hold|1|||
150229079|NCT05153499|541976733|FG001|Overall Study|Clinical Hold|0|||
150229080|NCT05153499|541976732|FG000|Overall Study|Study Termination|6|||
150229081|NCT05153499|541976733|FG001|Overall Study|Study Termination|5|||
150229082|NCT03226353|541976739|FG000|Overall Study|Withdrawal by Subject|1|||
150229083|NCT03226353|541976739|FG000|Overall Study|Screen Failure|5|||
150229084|NCT03441789|541976740|FG000|Overall Study|Withdrawal by Subject|1|||
150229085|NCT03441789|541976741|FG001|Overall Study|Withdrawal by Subject|1|||
150229086|NCT03441789|541976740|FG000|Overall Study|Adverse Event|0|||
150229087|NCT03441789|541976741|FG001|Overall Study|Adverse Event|1|||
150229088|NCT03441789|541976740|FG000|Overall Study|Protocol Violation|0|||
150229089|NCT03441789|541976741|FG001|Overall Study|Protocol Violation|1|||
150229090|NCT03441789|541976740|FG000|Overall Study|Lost to Follow-up|0|||
150229091|NCT03441789|541976741|FG001|Overall Study|Lost to Follow-up|1|||
150229092|NCT03168425|541976744|FG000|Overall Study|Lost to Follow-up|5|||
150229093|NCT03168425|541976745|FG001|Overall Study|Lost to Follow-up|8|||
150229094|NCT03168425|541976744|FG000|Overall Study|unable to confirm post op opioids|2|||
150229095|NCT03168425|541976745|FG001|Overall Study|unable to confirm post op opioids|3|||
150229096|NCT02166047|541976746|FG000|Overall Study|Withdrawal by Participant|0|||
150229097|NCT02166047|541976747|FG001|Overall Study|Withdrawal by Participant|1|||
150229098|NCT02166047|541976748|FG002|Overall Study|Withdrawal by Participant|2|||
150229099|NCT02166047|541976749|FG003|Overall Study|Withdrawal by Participant|0|||
150229100|NCT02166047|541976750|FG004|Overall Study|Withdrawal by Participant|0|||
150229101|NCT02166047|541976751|FG005|Overall Study|Withdrawal by Participant|0|||
150229102|NCT02166047|541976752|FG006|Overall Study|Withdrawal by Participant|1|||
150229103|NCT02166047|541976753|FG007|Overall Study|Withdrawal by Participant|0|||
150229104|NCT02166047|541976754|FG008|Overall Study|Withdrawal by Participant|0|||
150229105|NCT02166047|541976755|FG009|Overall Study|Withdrawal by Participant|0|||
150229106|NCT02166047|541976756|FG010|Overall Study|Withdrawal by Participant|0|||
150229107|NCT02166047|541976757|FG011|Overall Study|Withdrawal by Participant|0|||
150229108|NCT02166047|541976746|FG000|Overall Study|Adverse Event|0|||
150229109|NCT02166047|541976747|FG001|Overall Study|Adverse Event|0|||
150229110|NCT02166047|541976748|FG002|Overall Study|Adverse Event|0|||
150229111|NCT02166047|541976749|FG003|Overall Study|Adverse Event|0|||
150229112|NCT02166047|541976750|FG004|Overall Study|Adverse Event|1|||
150229113|NCT02166047|541976751|FG005|Overall Study|Adverse Event|0|||
150229114|NCT02166047|541976752|FG006|Overall Study|Adverse Event|1|||
150229115|NCT02166047|541976753|FG007|Overall Study|Adverse Event|0|||
150229116|NCT02166047|541976754|FG008|Overall Study|Adverse Event|0|||
150229117|NCT02166047|541976755|FG009|Overall Study|Adverse Event|0|||
150229118|NCT02166047|541976756|FG010|Overall Study|Adverse Event|2|||
150229119|NCT02166047|541976757|FG011|Overall Study|Adverse Event|0|||
150229120|NCT01960114|541976758|FG000|Overall Study|Adverse Event|1|||
150229121|NCT01960114|541976759|FG001|Overall Study|Adverse Event|0|||
150229122|NCT01960114|541976758|FG000|Overall Study|Could not swallow study medication|0|||
150229123|NCT01960114|541976759|FG001|Overall Study|Could not swallow study medication|1|||
150229124|NCT00468858|541976764|FG000|Overall Study|Adverse Event|0|||
150229125|NCT00468858|541976765|FG001|Overall Study|Adverse Event|1|||
150229126|NCT00468858|541976766|FG002|Overall Study|Adverse Event|0|||
150229127|NCT00468858|541976764|FG000|Overall Study|Withdrawal by Subject|7|||
150229128|NCT00468858|541976765|FG001|Overall Study|Withdrawal by Subject|4|||
150229129|NCT00468858|541976766|FG002|Overall Study|Withdrawal by Subject|5|||
150229130|NCT00468858|541976764|FG000|Overall Study|Relocation|1|||
150229131|NCT00468858|541976765|FG001|Overall Study|Relocation|3|||
150229132|NCT00468858|541976766|FG002|Overall Study|Relocation|3|||
150229133|NCT00468858|541976764|FG000|Overall Study|Lost to Follow-up|1|||
150229134|NCT00468858|541976765|FG001|Overall Study|Lost to Follow-up|2|||
150229135|NCT00468858|541976766|FG002|Overall Study|Lost to Follow-up|5|||
150229136|NCT00468858|541976764|FG000|Overall Study|Other|0|||
150229137|NCT00468858|541976765|FG001|Overall Study|Other|0|||
150229138|NCT00468858|541976766|FG002|Overall Study|Other|1|||
150229139|NCT01885936|541976769|FG000|Overall Study|Withdrawal by Subject|1|||
150229140|NCT01885936|541976770|FG001|Overall Study|Withdrawal by Subject|0|||
150229141|NCT00317603|541976773|FG000|Overall Study|Progressive Disease|3|||
150229142|NCT00523549|541976774|FG000|Overall Study|Adverse Event|6|||
150229143|NCT00523549|541976775|FG001|Overall Study|Adverse Event|3|||
150229144|NCT00523549|541976774|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150229145|NCT00523549|541976775|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150229146|NCT00523549|541976774|FG000|Overall Study|Protocol Deviation|3|||
150229147|NCT00523549|541976775|FG001|Overall Study|Protocol Deviation|1|||
150229148|NCT00523549|541976774|FG000|Overall Study|Patient withdrew consent|7|||
150229149|NCT00523549|541976775|FG001|Overall Study|Patient withdrew consent|6|||
150229150|NCT00523549|541976774|FG000|Overall Study|Lost to Follow-up|3|||
150229151|NCT00523549|541976775|FG001|Overall Study|Lost to Follow-up|5|||
150229152|NCT00427778|541976780|FG000|First Intervention (4 Weeks)|no longer interested|1|||
150229153|NCT00427778|541976781|FG001|First Intervention (4 Weeks)|no longer interested|0|||
150229154|NCT00427778|541976780|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
150229155|NCT00427778|541976781|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
150229156|NCT00427778|541976780|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
150229157|NCT00427778|541976781|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
150229158|NCT00427778|541976780|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
150229159|NCT00427778|541976781|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
150229160|NCT00439647|541976782|FG000|Overall Study|Withdrawal by Subject|25|||
150229161|NCT00439647|541976783|FG001|Overall Study|Withdrawal by Subject|22|||
150229162|NCT00439647|541976782|FG000|Overall Study|Death|15|||
150229163|NCT00439647|541976783|FG001|Overall Study|Death|18|||
150229164|NCT00439647|541976782|FG000|Overall Study|Adverse Event|11|||
150229165|NCT00439647|541976783|FG001|Overall Study|Adverse Event|11|||
150229166|NCT00439647|541976782|FG000|Overall Study|Lost to Follow-up|4|||
150229167|NCT00439647|541976783|FG001|Overall Study|Lost to Follow-up|12|||
150229168|NCT00439647|541976782|FG000|Overall Study|Protocol Violation|3|||
150229169|NCT00439647|541976783|FG001|Overall Study|Protocol Violation|4|||
150229170|NCT00439647|541976782|FG000|Overall Study|Lack of Efficacy|0|||
150229171|NCT00439647|541976783|FG001|Overall Study|Lack of Efficacy|4|||
150229172|NCT00843115|541976785|FG000|Overall Study|Death|4|||
150229173|NCT00843115|541976785|FG000|Overall Study|Adverse Event|30|||
150229174|NCT00843115|541976785|FG000|Overall Study|Lost to Follow-up|4|||
150229175|NCT00843115|541976785|FG000|Overall Study|Withdrawal by Subject|17|||
150229176|NCT00843115|541976785|FG000|Overall Study|Family wanted meds stopped|1|||
150229177|NCT00843115|541976785|FG000|Overall Study|Family does not want continuation|1|||
150229178|NCT00843115|541976785|FG000|Overall Study|Patient forgot to take meds|1|||
150229179|NCT00843115|541976785|FG000|Overall Study|Does not meet entrance criteria|1|||
150229180|NCT00843115|541976785|FG000|Overall Study|Physician Decision|1|||
150229181|NCT00843115|541976785|FG000|Overall Study|Family discontinued meds|1|||
150229182|NCT00843115|541976785|FG000|Overall Study|patient took for 2 days then stopped|1|||
150229183|NCT00843115|541976785|FG000|Overall Study|patient never took the medication|1|||
150229184|NCT00843115|541976785|FG000|Overall Study|hospitalized due to deterioration|1|||
150229185|NCT00843115|541976785|FG000|Overall Study|week 12 not done|1|||
150229186|NCT00843115|541976785|FG000|Overall Study|Syndrome De Glissement|1|||
150229187|NCT02845375|541976786|FG000|Overall Study|upper airway obstruction|1|||
150229188|NCT02845375|541976787|FG001|Overall Study|upper airway obstruction|2|||
150229189|NCT02845375|541976788|FG002|Overall Study|upper airway obstruction|1|||
150229190|NCT00225277|541976789|FG000|Overall Study|Adverse Event|30|||
150229191|NCT00225277|541976790|FG001|Overall Study|Adverse Event|34|||
150229192|NCT00225277|541976789|FG000|Overall Study|Lack of Efficacy|4|||
150229193|NCT00225277|541976790|FG001|Overall Study|Lack of Efficacy|1|||
150229194|NCT00225277|541976789|FG000|Overall Study|Lost to Follow-up|4|||
150229195|NCT00225277|541976790|FG001|Overall Study|Lost to Follow-up|6|||
150229196|NCT00225277|541976789|FG000|Overall Study|Physician Decision|6|||
150229197|NCT00225277|541976790|FG001|Overall Study|Physician Decision|8|||
150229198|NCT00225277|541976789|FG000|Overall Study|Protocol Violation|6|||
150229199|NCT00225277|541976790|FG001|Overall Study|Protocol Violation|3|||
150229200|NCT00225277|541976789|FG000|Overall Study|Withdrawal by Subject|40|||
150229201|NCT00225277|541976790|FG001|Overall Study|Withdrawal by Subject|34|||
150229202|NCT00225277|541976789|FG000|Overall Study|Other|7|||
150229203|NCT00225277|541976790|FG001|Overall Study|Other|9|||
150229204|NCT01177137|541976793|FG000|Overall Study|Withdrawal by Subject|10|||
150229205|NCT01177137|541976794|FG001|Overall Study|Withdrawal by Subject|10|||
150229206|NCT01177137|541976795|FG002|Overall Study|Withdrawal by Subject|2|||
150229207|NCT00677092|541976797|FG000|Overall Study|Adverse Event|1|||
150229208|NCT00677092|541976797|FG000|Overall Study|Lost to Follow-up|1|||
150229209|NCT00677092|541976797|FG000|Overall Study|Withdrawal by Subject|3|||
150229210|NCT00677092|541976797|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
150229211|NCT02460562|541976800|FG000|Overall Study|Lost to Follow-up|15|||
150229212|NCT02460562|541976801|FG001|Overall Study|Lost to Follow-up|16|||
150229213|NCT00784277|541976802|FG000|IR Treatment|Adverse Event|4|||
150229214|NCT00784277|541976803|FG001|IR Treatment|Adverse Event|8|||
150229215|NCT00784277|541976804|FG002|IR Treatment|Adverse Event|19|||
150229216|NCT00784277|541976805|FG003|IR Treatment|Adverse Event|35|||
150229217|NCT00784277|541976806|FG004|IR Treatment|Adverse Event|0|||
150229218|NCT00784277|541976807|FG005|IR Treatment|Adverse Event|0|||
150229219|NCT00784277|541976808|FG006|IR Treatment|Adverse Event|0|||
150229220|NCT00784277|541976802|FG000|IR Treatment|Lack of Efficacy|4|||
150229221|NCT00784277|541976803|FG001|IR Treatment|Lack of Efficacy|4|||
150229222|NCT00784277|541976804|FG002|IR Treatment|Lack of Efficacy|1|||
150229223|NCT00784277|541976805|FG003|IR Treatment|Lack of Efficacy|0|||
150229224|NCT00784277|541976806|FG004|IR Treatment|Lack of Efficacy|0|||
150229225|NCT00784277|541976807|FG005|IR Treatment|Lack of Efficacy|0|||
150229226|NCT00784277|541976808|FG006|IR Treatment|Lack of Efficacy|0|||
150229227|NCT00784277|541976802|FG000|IR Treatment|Lost to Follow-up|1|||
150229228|NCT00784277|541976803|FG001|IR Treatment|Lost to Follow-up|0|||
150229229|NCT00784277|541976804|FG002|IR Treatment|Lost to Follow-up|1|||
150229230|NCT00784277|541976805|FG003|IR Treatment|Lost to Follow-up|0|||
150229231|NCT00784277|541976806|FG004|IR Treatment|Lost to Follow-up|0|||
150229232|NCT00784277|541976807|FG005|IR Treatment|Lost to Follow-up|0|||
150229233|NCT00784277|541976808|FG006|IR Treatment|Lost to Follow-up|0|||
150229234|NCT00784277|541976802|FG000|IR Treatment|Withdrawal by Subject|5|||
150229235|NCT00784277|541976803|FG001|IR Treatment|Withdrawal by Subject|1|||
150229236|NCT00784277|541976804|FG002|IR Treatment|Withdrawal by Subject|4|||
150229237|NCT00784277|541976805|FG003|IR Treatment|Withdrawal by Subject|6|||
150229238|NCT00784277|541976806|FG004|IR Treatment|Withdrawal by Subject|0|||
150229239|NCT00784277|541976807|FG005|IR Treatment|Withdrawal by Subject|0|||
150229240|NCT00784277|541976808|FG006|IR Treatment|Withdrawal by Subject|0|||
150229241|NCT00784277|541976802|FG000|IR Treatment|Resolution Of Pain|0|||
150229242|NCT00784277|541976803|FG001|IR Treatment|Resolution Of Pain|1|||
150229243|NCT00784277|541976804|FG002|IR Treatment|Resolution Of Pain|0|||
150229244|NCT00784277|541976805|FG003|IR Treatment|Resolution Of Pain|0|||
150229245|NCT00784277|541976806|FG004|IR Treatment|Resolution Of Pain|0|||
150229246|NCT00784277|541976807|FG005|IR Treatment|Resolution Of Pain|0|||
150229247|NCT00784277|541976808|FG006|IR Treatment|Resolution Of Pain|0|||
150229248|NCT00784277|541976802|FG000|IR Treatment|Other|2|||
150229249|NCT00784277|541976803|FG001|IR Treatment|Other|3|||
150229250|NCT00784277|541976804|FG002|IR Treatment|Other|3|||
150229251|NCT00784277|541976805|FG003|IR Treatment|Other|2|||
150229252|NCT00784277|541976806|FG004|IR Treatment|Other|0|||
150229253|NCT00784277|541976807|FG005|IR Treatment|Other|0|||
150229254|NCT00784277|541976808|FG006|IR Treatment|Other|0|||
150229255|NCT00784277|541976802|FG000|ER Treatment|Adverse Event|0|||
150229256|NCT00784277|541976803|FG001|ER Treatment|Adverse Event|0|||
150229257|NCT00784277|541976804|FG002|ER Treatment|Adverse Event|0|||
150229258|NCT00784277|541976805|FG003|ER Treatment|Adverse Event|0|||
150229259|NCT00784277|541976806|FG004|ER Treatment|Adverse Event|1|||
150229260|NCT00784277|541976807|FG005|ER Treatment|Adverse Event|7|||
150229261|NCT00784277|541976808|FG006|ER Treatment|Adverse Event|7|||
150229262|NCT00784277|541976802|FG000|ER Treatment|Lack of Efficacy|0|||
150229263|NCT00784277|541976803|FG001|ER Treatment|Lack of Efficacy|0|||
150229264|NCT00784277|541976804|FG002|ER Treatment|Lack of Efficacy|0|||
150229265|NCT00784277|541976805|FG003|ER Treatment|Lack of Efficacy|0|||
150229266|NCT00784277|541976806|FG004|ER Treatment|Lack of Efficacy|3|||
150229267|NCT00784277|541976807|FG005|ER Treatment|Lack of Efficacy|4|||
150229268|NCT00784277|541976808|FG006|ER Treatment|Lack of Efficacy|0|||
150229269|NCT00784277|541976802|FG000|ER Treatment|Lost to Follow-up|0|||
150229270|NCT00784277|541976803|FG001|ER Treatment|Lost to Follow-up|0|||
150229271|NCT00784277|541976804|FG002|ER Treatment|Lost to Follow-up|0|||
150229272|NCT00784277|541976805|FG003|ER Treatment|Lost to Follow-up|0|||
150229273|NCT00784277|541976806|FG004|ER Treatment|Lost to Follow-up|0|||
150229274|NCT00784277|541976807|FG005|ER Treatment|Lost to Follow-up|2|||
150229275|NCT00784277|541976808|FG006|ER Treatment|Lost to Follow-up|0|||
150229276|NCT00784277|541976802|FG000|ER Treatment|Withdrawal by Subject|0|||
150229277|NCT00784277|541976803|FG001|ER Treatment|Withdrawal by Subject|0|||
150229278|NCT00784277|541976804|FG002|ER Treatment|Withdrawal by Subject|0|||
150229279|NCT00784277|541976805|FG003|ER Treatment|Withdrawal by Subject|0|||
150229280|NCT00784277|541976806|FG004|ER Treatment|Withdrawal by Subject|2|||
150229281|NCT00784277|541976807|FG005|ER Treatment|Withdrawal by Subject|5|||
150229282|NCT00784277|541976808|FG006|ER Treatment|Withdrawal by Subject|3|||
150229283|NCT00784277|541976802|FG000|ER Treatment|Study Medication Non-Compliant|0|||
150229284|NCT00784277|541976803|FG001|ER Treatment|Study Medication Non-Compliant|0|||
150229285|NCT00784277|541976804|FG002|ER Treatment|Study Medication Non-Compliant|0|||
150229286|NCT00784277|541976805|FG003|ER Treatment|Study Medication Non-Compliant|0|||
150229287|NCT00784277|541976806|FG004|ER Treatment|Study Medication Non-Compliant|2|||
150229288|NCT00784277|541976807|FG005|ER Treatment|Study Medication Non-Compliant|3|||
150229289|NCT00784277|541976808|FG006|ER Treatment|Study Medication Non-Compliant|3|||
150229290|NCT00784277|541976802|FG000|ER Treatment|Other|0|||
150229291|NCT00784277|541976803|FG001|ER Treatment|Other|0|||
150229292|NCT00784277|541976804|FG002|ER Treatment|Other|0|||
150229293|NCT00784277|541976805|FG003|ER Treatment|Other|0|||
150229294|NCT00784277|541976806|FG004|ER Treatment|Other|1|||
150229295|NCT00784277|541976807|FG005|ER Treatment|Other|3|||
150229296|NCT00784277|541976808|FG006|ER Treatment|Other|2|||
150229297|NCT01093222|541976809|FG000|Overall Study|Ineligible|6|||
150141840|NCT02332590|541654111|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
150141841|NCT02332590|541654110|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
150141842|NCT02332590|541654111|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
150141843|NCT00279201|541654112|FG000|Initiation|Death|1|||
150141844|NCT00279201|541654113|FG001|Initiation|Death|5|||
150141845|NCT00279201|541654114|FG002|Initiation|Death|0|||
150141846|NCT00279201|541654115|FG003|Initiation|Death|0|||
150141847|NCT00279201|541654116|FG004|Initiation|Death|0|||
150141848|NCT00279201|541654117|FG005|Initiation|Death|0|||
150141849|NCT00279201|541654112|FG000|Initiation|Adverse Event|6|||
150141850|NCT00279201|541654113|FG001|Initiation|Adverse Event|15|||
150141851|NCT00279201|541654114|FG002|Initiation|Adverse Event|0|||
150141852|NCT00279201|541654115|FG003|Initiation|Adverse Event|0|||
150141853|NCT00279201|541654116|FG004|Initiation|Adverse Event|0|||
150141854|NCT00279201|541654117|FG005|Initiation|Adverse Event|0|||
150141855|NCT00279201|541654112|FG000|Initiation|Lost to Follow-up|42|||
150141856|NCT00279201|541654113|FG001|Initiation|Lost to Follow-up|41|||
150141857|NCT00279201|541654114|FG002|Initiation|Lost to Follow-up|0|||
150141858|NCT00279201|541654115|FG003|Initiation|Lost to Follow-up|0|||
150141859|NCT00279201|541654116|FG004|Initiation|Lost to Follow-up|0|||
150141860|NCT00279201|541654117|FG005|Initiation|Lost to Follow-up|0|||
150141861|NCT00279201|541654112|FG000|Initiation|Entry Criteria Exclusion|7|||
150141862|NCT00279201|541654113|FG001|Initiation|Entry Criteria Exclusion|9|||
150141863|NCT00279201|541654114|FG002|Initiation|Entry Criteria Exclusion|0|||
150141864|NCT00279201|541654115|FG003|Initiation|Entry Criteria Exclusion|0|||
150141865|NCT00279201|541654116|FG004|Initiation|Entry Criteria Exclusion|0|||
150141866|NCT00279201|541654117|FG005|Initiation|Entry Criteria Exclusion|0|||
150141867|NCT00279201|541654112|FG000|Initiation|Protocol Violation|9|||
150141868|NCT00279201|541654113|FG001|Initiation|Protocol Violation|10|||
150141869|NCT00279201|541654114|FG002|Initiation|Protocol Violation|0|||
150141870|NCT00279201|541654115|FG003|Initiation|Protocol Violation|0|||
150141871|NCT00279201|541654116|FG004|Initiation|Protocol Violation|0|||
150141872|NCT00279201|541654117|FG005|Initiation|Protocol Violation|0|||
150141873|NCT00279201|541654112|FG000|Initiation|Withdrawal by Subject|35|||
150141874|NCT00279201|541654113|FG001|Initiation|Withdrawal by Subject|41|||
150141875|NCT00279201|541654114|FG002|Initiation|Withdrawal by Subject|0|||
150141876|NCT00279201|541654115|FG003|Initiation|Withdrawal by Subject|0|||
150229298|NCT01093222|541976809|FG000|Overall Study|Adverse Event|7|||
150229299|NCT01093222|541976809|FG000|Overall Study|Progression/relapse|24|||
150229300|NCT01093222|541976809|FG000|Overall Study|Death|2|||
150229301|NCT01093222|541976809|FG000|Overall Study|Not protocol specified|1|||
150229302|NCT00187135|541976812|FG000|Visit One|Withdrawal by Subject|1|||
150229303|NCT00187135|541976813|FG001|Visit One|Withdrawal by Subject|0|||
150229304|NCT00187135|541976814|FG002|Visit One|Withdrawal by Subject|0|||
150229305|NCT00187135|541976815|FG003|Visit One|Withdrawal by Subject|0|||
150229306|NCT00187135|541976816|FG004|Visit One|Withdrawal by Subject|0|||
150229307|NCT00187135|541976817|FG005|Visit One|Withdrawal by Subject|1|||
150229308|NCT00187135|541976812|FG000|Visit One|Physician Decision|3|||
150229309|NCT00187135|541976813|FG001|Visit One|Physician Decision|1|||
150229310|NCT00187135|541976814|FG002|Visit One|Physician Decision|0|||
150229311|NCT00187135|541976815|FG003|Visit One|Physician Decision|0|||
150229312|NCT00187135|541976816|FG004|Visit One|Physician Decision|0|||
150229313|NCT00187135|541976817|FG005|Visit One|Physician Decision|1|||
150229314|NCT00187135|541976812|FG000|Visit Two|Death|0|||
150229315|NCT00187135|541976813|FG001|Visit Two|Death|0|||
150229316|NCT00187135|541976814|FG002|Visit Two|Death|0|||
150229317|NCT00187135|541976815|FG003|Visit Two|Death|1|||
150229318|NCT00187135|541976816|FG004|Visit Two|Death|0|||
150229319|NCT00187135|541976817|FG005|Visit Two|Death|1|||
150229320|NCT00187135|541976812|FG000|Visit Two|Physician Decision|1|||
150229321|NCT00187135|541976813|FG001|Visit Two|Physician Decision|0|||
150229322|NCT00187135|541976814|FG002|Visit Two|Physician Decision|0|||
150229323|NCT00187135|541976815|FG003|Visit Two|Physician Decision|0|||
150229324|NCT00187135|541976816|FG004|Visit Two|Physician Decision|0|||
150229325|NCT00187135|541976817|FG005|Visit Two|Physician Decision|0|||
150229326|NCT00187135|541976812|FG000|Visit Two|Withdrawal by Subject|1|||
150229327|NCT00187135|541976813|FG001|Visit Two|Withdrawal by Subject|1|||
150229328|NCT00187135|541976814|FG002|Visit Two|Withdrawal by Subject|1|||
150229329|NCT00187135|541976815|FG003|Visit Two|Withdrawal by Subject|0|||
150229330|NCT00187135|541976816|FG004|Visit Two|Withdrawal by Subject|1|||
150229331|NCT00187135|541976817|FG005|Visit Two|Withdrawal by Subject|1|||
150229332|NCT00187135|541976812|FG000|Visit Two|Study Discontinued|3|||
150229333|NCT00187135|541976813|FG001|Visit Two|Study Discontinued|2|||
150229334|NCT00187135|541976814|FG002|Visit Two|Study Discontinued|1|||
150229335|NCT00187135|541976815|FG003|Visit Two|Study Discontinued|7|||
150229336|NCT00187135|541976816|FG004|Visit Two|Study Discontinued|5|||
150229337|NCT00187135|541976817|FG005|Visit Two|Study Discontinued|6|||
150229338|NCT00187135|541976812|FG000|Visit Three|Death|0|||
150229339|NCT00187135|541976813|FG001|Visit Three|Death|0|||
150229340|NCT00187135|541976814|FG002|Visit Three|Death|1|||
150229341|NCT00187135|541976815|FG003|Visit Three|Death|0|||
150229342|NCT00187135|541976816|FG004|Visit Three|Death|1|||
150229343|NCT00187135|541976817|FG005|Visit Three|Death|0|||
150229344|NCT00187135|541976812|FG000|Visit Three|Withdrawal by Subject|0|||
150229345|NCT00187135|541976813|FG001|Visit Three|Withdrawal by Subject|1|||
150229346|NCT00187135|541976814|FG002|Visit Three|Withdrawal by Subject|1|||
150229347|NCT00187135|541976815|FG003|Visit Three|Withdrawal by Subject|2|||
150229348|NCT00187135|541976816|FG004|Visit Three|Withdrawal by Subject|0|||
150229349|NCT00187135|541976817|FG005|Visit Three|Withdrawal by Subject|0|||
150229350|NCT00187135|541976812|FG000|Visit Three|Study Discontinued|7|||
150229351|NCT00187135|541976813|FG001|Visit Three|Study Discontinued|6|||
150229352|NCT00187135|541976814|FG002|Visit Three|Study Discontinued|7|||
150229353|NCT00187135|541976815|FG003|Visit Three|Study Discontinued|7|||
150229354|NCT00187135|541976816|FG004|Visit Three|Study Discontinued|7|||
150229355|NCT00187135|541976817|FG005|Visit Three|Study Discontinued|6|||
150229356|NCT01951261|541976818|FG000|Overall Study|Death|1|||
150229357|NCT01951261|541976819|FG001|Overall Study|Death|0|||
150229358|NCT01951261|541976818|FG000|Overall Study|Lost to Follow-up|4|||
150229359|NCT01951261|541976819|FG001|Overall Study|Lost to Follow-up|3|||
150229360|NCT01951261|541976818|FG000|Overall Study|Protocol Violation|4|||
150229361|NCT01951261|541976819|FG001|Overall Study|Protocol Violation|3|||
150229362|NCT01924806|541976820|FG000|Overall Study|Physician Decision|2|||
150229363|NCT01924806|541976821|FG001|Overall Study|Physician Decision|1|||
150229364|NCT00297778|541976829|FG000|Overall Study|Adverse Event|16|||
150229365|NCT00297778|541976830|FG001|Overall Study|Adverse Event|10|||
150229366|NCT00297778|541976829|FG000|Overall Study|Withdrawal by Subject|1|||
150229367|NCT00297778|541976830|FG001|Overall Study|Withdrawal by Subject|5|||
150229368|NCT00297778|541976829|FG000|Overall Study|Lack of Efficacy|2|||
150229369|NCT00297778|541976830|FG001|Overall Study|Lack of Efficacy|1|||
150229370|NCT00297778|541976829|FG000|Overall Study|Non-compliant with trial protocol|0|||
150229371|NCT00297778|541976830|FG001|Overall Study|Non-compliant with trial protocol|3|||
150229372|NCT00297778|541976829|FG000|Overall Study|Other|0|||
150229373|NCT00297778|541976830|FG001|Overall Study|Other|1|||
150229374|NCT02996097|541976831|FG000|Overall Study|Lost to Follow-up|11|||
150141877|NCT00279201|541654116|FG004|Initiation|Withdrawal by Subject|0|||
150229375|NCT02996097|541976832|FG001|Overall Study|Lost to Follow-up|11|||
150229376|NCT02201771|541976833|FG000|Overall Study|Death|3|||
150229377|NCT02201771|541976834|FG001|Overall Study|Death|2|||
150229378|NCT02201771|541976835|FG002|Overall Study|Death|0|||
150229379|NCT02201771|541976833|FG000|Overall Study|Protocol Violation|10|||
150229380|NCT02201771|541976834|FG001|Overall Study|Protocol Violation|8|||
150229381|NCT02201771|541976835|FG002|Overall Study|Protocol Violation|10|||
150229382|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
150229383|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
150229384|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
150229385|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
150229386|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
150229387|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
150229388|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
150229389|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
150229390|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
150229391|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
150229392|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
150229393|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
150229394|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
150229395|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
150229396|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
150229397|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
150229398|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
150229399|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
150229400|NCT03569475|541976836|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
150229401|NCT03569475|541976837|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
150229402|NCT03569475|541976838|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
150229403|NCT03569475|541976836|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
150229404|NCT03569475|541976837|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
150229405|NCT03569475|541976838|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
150229406|NCT03569475|541976836|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
150229407|NCT03569475|541976837|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
150229408|NCT03569475|541976838|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
150229409|NCT02109107|541976839|FG000|Overall Study|Lost to Follow-up|2|||
150229410|NCT03078751|541976844|FG000|Overall Study|Adverse Event|4|||
150229411|NCT03078751|541976845|FG001|Overall Study|Adverse Event|0|||
150229412|NCT03078751|541976844|FG000|Overall Study|Physician Decision|1|||
150229413|NCT03078751|541976845|FG001|Overall Study|Physician Decision|0|||
150229414|NCT03078751|541976844|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
150229415|NCT03078751|541976845|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
150229416|NCT03078751|541976844|FG000|Overall Study|Subject/guardian decision|8|||
150229417|NCT03078751|541976845|FG001|Overall Study|Subject/guardian decision|1|||
150229418|NCT03078751|541976844|FG000|Overall Study|Untreated|0|||
150229419|NCT03078751|541976845|FG001|Overall Study|Untreated|4|||
150229420|NCT00580047|541976850|FG000|Overall Study|Lost to Follow-up|1|||
150229421|NCT00580047|541976851|FG001|Overall Study|Lost to Follow-up|1|||
150229422|NCT00580047|541976852|FG002|Overall Study|Lost to Follow-up|0|||
150229423|NCT00580047|541976850|FG000|Overall Study|Withdrawal by Subject|1|||
150229424|NCT00580047|541976851|FG001|Overall Study|Withdrawal by Subject|1|||
150229425|NCT00580047|541976852|FG002|Overall Study|Withdrawal by Subject|2|||
150229426|NCT00580047|541976850|FG000|Overall Study|Withdrawal by Subject|1|||
150229427|NCT00580047|541976851|FG001|Overall Study|Withdrawal by Subject|0|||
150229428|NCT00580047|541976852|FG002|Overall Study|Withdrawal by Subject|0|||
150229429|NCT02820298|541976853|FG000|Overall Study|Withdrawal by Subject|0|||
150229430|NCT02820298|541976854|FG001|Overall Study|Withdrawal by Subject|1|||
150229431|NCT02820298|541976853|FG000|Overall Study|Physician Decision|1|||
150229432|NCT02820298|541976854|FG001|Overall Study|Physician Decision|0|||
150229433|NCT02820298|541976853|FG000|Overall Study|Protocol Violation|0|||
150229434|NCT02820298|541976854|FG001|Overall Study|Protocol Violation|1|||
150229435|NCT01064856|541976857|FG000|Double-blind (DB) Period|Adverse Event|1|||
150229436|NCT01064856|541976858|FG001|Double-blind (DB) Period|Adverse Event|0|||
150229437|NCT01064856|541976859|FG002|Double-blind (DB) Period|Adverse Event|0|||
150229438|NCT01064856|541976860|FG003|Double-blind (DB) Period|Adverse Event|0|||
150229439|NCT01064856|541976857|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
150229440|NCT01064856|541976858|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
150229441|NCT01064856|541976859|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
150229442|NCT01064856|541976860|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
150229443|NCT01064856|541976857|FG000|Open-label (OL) Period|Adverse Event|0|||
150229444|NCT01064856|541976858|FG001|Open-label (OL) Period|Adverse Event|0|||
150229445|NCT01064856|541976859|FG002|Open-label (OL) Period|Adverse Event|12|||
150141878|NCT00279201|541654117|FG005|Initiation|Withdrawal by Subject|0|||
150141879|NCT00279201|541654112|FG000|Initiation|Physician Decision|15|||
150141880|NCT00279201|541654113|FG001|Initiation|Physician Decision|18|||
150141881|NCT00279201|541654114|FG002|Initiation|Physician Decision|0|||
150141882|NCT00279201|541654115|FG003|Initiation|Physician Decision|0|||
150141883|NCT00279201|541654116|FG004|Initiation|Physician Decision|0|||
150141884|NCT00279201|541654117|FG005|Initiation|Physician Decision|0|||
150141885|NCT00279201|541654112|FG000|Initiation|Sponsor Decision|13|||
150141886|NCT00279201|541654113|FG001|Initiation|Sponsor Decision|5|||
150141887|NCT00279201|541654114|FG002|Initiation|Sponsor Decision|0|||
150141888|NCT00279201|541654115|FG003|Initiation|Sponsor Decision|0|||
150141889|NCT00279201|541654116|FG004|Initiation|Sponsor Decision|0|||
150141890|NCT00279201|541654117|FG005|Initiation|Sponsor Decision|0|||
150141891|NCT00279201|541654112|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
150141892|NCT00279201|541654113|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
150141893|NCT00279201|541654114|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
150141894|NCT00279201|541654115|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
150141895|NCT00279201|541654116|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
150141896|NCT00279201|541654117|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
150141897|NCT00279201|541654112|FG000|Maintenance|Lack of Efficacy|32|||
150141898|NCT00279201|541654113|FG001|Maintenance|Lack of Efficacy|30|||
150141899|NCT00279201|541654114|FG002|Maintenance|Lack of Efficacy|0|||
150141900|NCT00279201|541654115|FG003|Maintenance|Lack of Efficacy|0|||
150141901|NCT00279201|541654116|FG004|Maintenance|Lack of Efficacy|0|||
150141902|NCT00279201|541654117|FG005|Maintenance|Lack of Efficacy|0|||
150229446|NCT01064856|541976860|FG003|Open-label (OL) Period|Adverse Event|6|||
150229447|NCT01064856|541976857|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
150229448|NCT01064856|541976858|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
150229449|NCT01064856|541976859|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
150229450|NCT01064856|541976860|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
150229451|NCT01064856|541976857|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
150229452|NCT01064856|541976858|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
150229453|NCT01064856|541976859|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
150229454|NCT01064856|541976860|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
150229455|NCT01064856|541976857|FG000|Open-label (OL) Period|Other|0|||
150229456|NCT01064856|541976858|FG001|Open-label (OL) Period|Other|0|||
150229457|NCT01064856|541976859|FG002|Open-label (OL) Period|Other|7|||
150229458|NCT01064856|541976860|FG003|Open-label (OL) Period|Other|7|||
150229459|NCT01894256|541976861|FG000|Part A|Adverse Event|0|||
150229460|NCT01894256|541976862|FG001|Part A|Adverse Event|1|||
150229461|NCT01894256|541976863|FG002|Part A|Adverse Event|0|||
150229462|NCT01894256|541976861|FG000|Part B|Death|0|||
150229463|NCT01894256|541976862|FG001|Part B|Death|1|||
150229464|NCT01894256|541976863|FG002|Part B|Death|1|||
150229465|NCT01894256|541976861|FG000|Part B|Withdrawal by Subject|0|||
150229466|NCT01894256|541976862|FG001|Part B|Withdrawal by Subject|1|||
150229467|NCT01894256|541976863|FG002|Part B|Withdrawal by Subject|0|||
150229468|NCT01894256|541976861|FG000|Part B|Lack of Efficacy|15|||
150229469|NCT01894256|541976862|FG001|Part B|Lack of Efficacy|12|||
150229470|NCT01894256|541976863|FG002|Part B|Lack of Efficacy|13|||
150229471|NCT01780584|541976864|FG000|Overall Study|Death|1|||
150229472|NCT01780584|541976865|FG001|Overall Study|Death|0|||
150229473|NCT01780584|541976866|FG002|Overall Study|Death|1|||
150229474|NCT01780584|541976864|FG000|Overall Study|Adverse Event|0|||
150229475|NCT01780584|541976865|FG001|Overall Study|Adverse Event|1|||
150229476|NCT01780584|541976866|FG002|Overall Study|Adverse Event|0|||
150229477|NCT01780584|541976864|FG000|Overall Study|Protocol Violation|0|||
150229478|NCT01780584|541976865|FG001|Overall Study|Protocol Violation|0|||
150229479|NCT01780584|541976866|FG002|Overall Study|Protocol Violation|1|||
150229480|NCT00141271|541976869|FG000|Overall Study|Adverse Event|31|||
150229481|NCT00141271|541976870|FG001|Overall Study|Adverse Event|19|||
150229482|NCT00141271|541976871|FG002|Overall Study|Adverse Event|17|||
150229483|NCT00141271|541976869|FG000|Overall Study|Laboratory Abnormality|2|||
150229484|NCT00141271|541976870|FG001|Overall Study|Laboratory Abnormality|1|||
150229485|NCT00141271|541976871|FG002|Overall Study|Laboratory Abnormality|1|||
150229486|NCT00141271|541976869|FG000|Overall Study|Lack of Efficacy|7|||
150229487|NCT00141271|541976870|FG001|Overall Study|Lack of Efficacy|7|||
150229488|NCT00141271|541976871|FG002|Overall Study|Lack of Efficacy|3|||
150229489|NCT00141271|541976869|FG000|Overall Study|Lost to Follow-up|15|||
150229490|NCT00141271|541976870|FG001|Overall Study|Lost to Follow-up|15|||
150229491|NCT00141271|541976871|FG002|Overall Study|Lost to Follow-up|21|||
150229492|NCT00141271|541976869|FG000|Overall Study|Withdrawal by Subject|14|||
150229493|NCT00141271|541976870|FG001|Overall Study|Withdrawal by Subject|9|||
150229494|NCT00141271|541976871|FG002|Overall Study|Withdrawal by Subject|10|||
150229495|NCT00141271|541976869|FG000|Overall Study|Other|11|||
150229496|NCT00141271|541976870|FG001|Overall Study|Other|12|||
150229497|NCT00141271|541976871|FG002|Overall Study|Other|5|||
150229498|NCT02133131|541976872|FG000|Overall Study|Adverse Event|0|||
150229499|NCT02133131|541976873|FG001|Overall Study|Adverse Event|0|||
150229500|NCT02133131|541976874|FG002|Overall Study|Adverse Event|0|||
150229501|NCT02133131|541976875|FG003|Overall Study|Adverse Event|1|||
150229502|NCT02133131|541976876|FG004|Overall Study|Adverse Event|0|||
150229503|NCT02133131|541976877|FG005|Overall Study|Adverse Event|0|||
150229504|NCT02133131|541976878|FG006|Overall Study|Adverse Event|0|||
150229505|NCT02133131|541976872|FG000|Overall Study|Lost to Follow-up|1|||
150229506|NCT02133131|541976873|FG001|Overall Study|Lost to Follow-up|0|||
150229507|NCT02133131|541976874|FG002|Overall Study|Lost to Follow-up|0|||
150229508|NCT02133131|541976875|FG003|Overall Study|Lost to Follow-up|1|||
150229509|NCT02133131|541976876|FG004|Overall Study|Lost to Follow-up|0|||
150229510|NCT02133131|541976877|FG005|Overall Study|Lost to Follow-up|0|||
150229511|NCT02133131|541976878|FG006|Overall Study|Lost to Follow-up|0|||
150229512|NCT02133131|541976872|FG000|Overall Study|Status not recorded|4|||
150229513|NCT02133131|541976873|FG001|Overall Study|Status not recorded|5|||
150229514|NCT02133131|541976874|FG002|Overall Study|Status not recorded|1|||
150229515|NCT02133131|541976875|FG003|Overall Study|Status not recorded|4|||
150229516|NCT02133131|541976876|FG004|Overall Study|Status not recorded|0|||
150229517|NCT02133131|541976877|FG005|Overall Study|Status not recorded|0|||
150229518|NCT02133131|541976878|FG006|Overall Study|Status not recorded|0|||
150229519|NCT02133131|541976872|FG000|Overall Study|Ongoing in study|0|||
150229520|NCT02133131|541976873|FG001|Overall Study|Ongoing in study|0|||
150229521|NCT02133131|541976874|FG002|Overall Study|Ongoing in study|0|||
150229522|NCT02133131|541976875|FG003|Overall Study|Ongoing in study|0|||
150229523|NCT02133131|541976876|FG004|Overall Study|Ongoing in study|15|||
150229524|NCT02133131|541976877|FG005|Overall Study|Ongoing in study|14|||
150229525|NCT02133131|541976878|FG006|Overall Study|Ongoing in study|11|||
150229526|NCT02133131|541976872|FG000|Overall Study|Protocol Violation|0|||
150229527|NCT02133131|541976873|FG001|Overall Study|Protocol Violation|0|||
150229528|NCT02133131|541976874|FG002|Overall Study|Protocol Violation|0|||
150229529|NCT02133131|541976875|FG003|Overall Study|Protocol Violation|0|||
150229530|NCT02133131|541976876|FG004|Overall Study|Protocol Violation|0|||
150229531|NCT02133131|541976877|FG005|Overall Study|Protocol Violation|0|||
150229532|NCT02133131|541976878|FG006|Overall Study|Protocol Violation|1|||
150229533|NCT04783519|541976879|FG000|Overall Study|Withdrawal by Subject|2|||
150229534|NCT04783519|541976880|FG001|Overall Study|Withdrawal by Subject|7|||
150229535|NCT04783519|541976881|FG002|Overall Study|Withdrawal by Subject|3|||
150229536|NCT04783519|541976879|FG000|Overall Study|Lost to Follow-up|9|||
150229537|NCT04783519|541976880|FG001|Overall Study|Lost to Follow-up|7|||
150229538|NCT04783519|541976881|FG002|Overall Study|Lost to Follow-up|6|||
150229539|NCT04435522|541976882|FG000|Overall Study|Withdrawal by Subject|2|||
150229540|NCT04130061|541976883|FG000|Overall Study|OR team forgot to request membrane|1|||
150229541|NCT04130061|541976884|FG001|Overall Study|OR team forgot to request membrane|0|||
150229542|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
150229543|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
150229544|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
150229545|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
150229546|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
150229547|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
150229548|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
150229549|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
150229550|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
150229551|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
150229552|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
150229553|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
150229554|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
150229555|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
150229556|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
150229557|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
150229558|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
150229559|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
150229560|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
150229561|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
150229562|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
150229563|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
150229564|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
150229565|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
150229566|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
150229567|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
150229568|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
150229569|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
150229570|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
150229571|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
150229572|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
150229573|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
150229574|NCT00092521|541977828|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
150229575|NCT00092521|541977829|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
150229576|NCT00092521|541977830|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
150229577|NCT00092521|541977831|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
150229578|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
150229579|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
150229580|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
150229581|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
150229582|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
150229583|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
150229584|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
150229585|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
150229586|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
150229587|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
150229588|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
150229589|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
150229590|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Death|2|||
150229591|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Death|0|||
150229592|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Death|1|||
150229593|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Death|0|||
150229594|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
150229595|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
150229596|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
150229597|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
150229598|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
150229599|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
150229600|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
150229601|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
150229602|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
150229603|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
150229604|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
150229605|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
150229606|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Moved|32|||
150229607|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Moved|2|||
150229608|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Moved|28|||
150229609|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Moved|0|||
150229610|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
150229611|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
150229612|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
150229613|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
150229614|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Travel|2|||
150229615|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Travel|0|||
150229616|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Travel|0|||
150229617|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Travel|0|||
150229618|NCT00092521|541977828|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
150229619|NCT00092521|541977829|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
150229620|NCT00092521|541977830|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
150229621|NCT00092521|541977831|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
150229622|NCT00092521|541977828|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
150229623|NCT00092521|541977829|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
150229624|NCT00092521|541977830|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
150229625|NCT00092521|541977831|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
150229626|NCT00092521|541977828|FG000|Extension Study (Group 4)|Adverse Event|0|||
150229627|NCT00092521|541977829|FG001|Extension Study (Group 4)|Adverse Event|0|||
150229628|NCT00092521|541977830|FG002|Extension Study (Group 4)|Adverse Event|0|||
150229629|NCT00092521|541977831|FG003|Extension Study (Group 4)|Adverse Event|2|||
150229630|NCT00092521|541977828|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
150229631|NCT00092521|541977829|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
150229632|NCT00092521|541977830|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
150229633|NCT00092521|541977831|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
150229634|NCT00092521|541977828|FG000|Extension Study (Group 4)|Pregnancy|0|||
150229635|NCT00092521|541977829|FG001|Extension Study (Group 4)|Pregnancy|0|||
150229636|NCT00092521|541977830|FG002|Extension Study (Group 4)|Pregnancy|0|||
150229637|NCT00092521|541977831|FG003|Extension Study (Group 4)|Pregnancy|4|||
150229638|NCT00092521|541977828|FG000|Extension Study (Group 4)|Protocol Violation|0|||
150229639|NCT00092521|541977829|FG001|Extension Study (Group 4)|Protocol Violation|0|||
150229640|NCT00092521|541977830|FG002|Extension Study (Group 4)|Protocol Violation|0|||
150229641|NCT00092521|541977831|FG003|Extension Study (Group 4)|Protocol Violation|2|||
150229642|NCT00092521|541977828|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
150229643|NCT00092521|541977829|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
150229644|NCT00092521|541977830|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
150229645|NCT00092521|541977831|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
150229646|NCT00092521|541977828|FG000|Extension Study (Group 4)|Moved|0|||
150229647|NCT00092521|541977829|FG001|Extension Study (Group 4)|Moved|0|||
150229648|NCT00092521|541977830|FG002|Extension Study (Group 4)|Moved|0|||
150229649|NCT00092521|541977831|FG003|Extension Study (Group 4)|Moved|16|||
150229650|NCT00092521|541977828|FG000|Extension Study (Group 4)|Site Terminated|0|||
150229651|NCT00092521|541977829|FG001|Extension Study (Group 4)|Site Terminated|0|||
150229652|NCT00092521|541977830|FG002|Extension Study (Group 4)|Site Terminated|0|||
150229653|NCT00092521|541977831|FG003|Extension Study (Group 4)|Site Terminated|4|||
150229654|NCT00092521|541977828|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
150229655|NCT00092521|541977829|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
150229656|NCT00092521|541977830|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
150229657|NCT00092521|541977831|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
150229658|NCT01878383|541977832|FG000|Overall Study|Lost to Follow-up|0|||
150229659|NCT01878383|541977833|FG001|Overall Study|Lost to Follow-up|1499|||
150229660|NCT03464383|541977834|FG000|Overall Study|Lost to Follow-up|1|||
150229661|NCT03464383|541977835|FG001|Overall Study|Lost to Follow-up|0|||
150229662|NCT03464383|541977836|FG002|Overall Study|Lost to Follow-up|0|||
150229663|NCT03464383|541977834|FG000|Overall Study|Withdrawal by Subject|0|||
150229664|NCT03464383|541977835|FG001|Overall Study|Withdrawal by Subject|1|||
150229665|NCT03464383|541977836|FG002|Overall Study|Withdrawal by Subject|0|||
150229666|NCT00560313|541977837|FG000|Overall Study|Adverse Events or Death|2|||
150229667|NCT00560313|541977837|FG000|Overall Study|Withdrawal by Subject|2|||
150229668|NCT00560313|541977837|FG000|Overall Study|Lost to Follow-up|1|||
150229669|NCT00560313|541977837|FG000|Overall Study|Protocol Violation|1|||
150229670|NCT03475056|541977838|FG000|Overall Study|Lost to Follow-up|0|||
150229671|NCT03475056|541977839|FG001|Overall Study|Lost to Follow-up|1|||
150229672|NCT03475056|541977838|FG000|Overall Study|Moved from Area|0|||
150229673|NCT03475056|541977839|FG001|Overall Study|Moved from Area|2|||
150229674|NCT00113269|541977842|FG000|Overall Study|Not transplanted, donor issues|4|||
150229675|NCT00113269|541977843|FG001|Overall Study|Not transplanted, donor issues|0|||
150229676|NCT00113269|541977844|FG002|Overall Study|Not transplanted, donor issues|2|||
150229677|NCT00113269|541977845|FG003|Overall Study|Not transplanted, donor issues|2|||
150229678|NCT00113269|541977842|FG000|Overall Study|Not transplanted, recipient issues|2|||
150229679|NCT00113269|541977843|FG001|Overall Study|Not transplanted, recipient issues|1|||
150229680|NCT00113269|541977844|FG002|Overall Study|Not transplanted, recipient issues|7|||
150229681|NCT00113269|541977845|FG003|Overall Study|Not transplanted, recipient issues|4|||
150229682|NCT00113269|541977842|FG000|Overall Study|Early graft loss, technical|0|||
150229683|NCT00113269|541977843|FG001|Overall Study|Early graft loss, technical|0|||
150229684|NCT00113269|541977844|FG002|Overall Study|Early graft loss, technical|2|||
150229685|NCT00113269|541977845|FG003|Overall Study|Early graft loss, technical|0|||
150229686|NCT00113269|541977842|FG000|Overall Study|Death in operating room|0|||
150229687|NCT00113269|541977843|FG001|Overall Study|Death in operating room|0|||
150229688|NCT00113269|541977844|FG002|Overall Study|Death in operating room|0|||
150229689|NCT00113269|541977845|FG003|Overall Study|Death in operating room|1|||
150229690|NCT00113269|541977842|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
150229691|NCT00113269|541977843|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
150229692|NCT00113269|541977844|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
150229693|NCT00113269|541977845|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
150229694|NCT00113269|541977842|FG000|Overall Study|Adverse Event|2|||
150229695|NCT00113269|541977843|FG001|Overall Study|Adverse Event|7|||
150229696|NCT00113269|541977844|FG002|Overall Study|Adverse Event|11|||
150229697|NCT00113269|541977845|FG003|Overall Study|Adverse Event|7|||
150229698|NCT00113269|541977842|FG000|Overall Study|Withdrawal by Subject|4|||
150229699|NCT00113269|541977843|FG001|Overall Study|Withdrawal by Subject|3|||
150229700|NCT00113269|541977844|FG002|Overall Study|Withdrawal by Subject|4|||
150229701|NCT00113269|541977845|FG003|Overall Study|Withdrawal by Subject|2|||
150229702|NCT00113269|541977842|FG000|Overall Study|Graft loss|6|||
150229703|NCT00113269|541977843|FG001|Overall Study|Graft loss|6|||
150229704|NCT00113269|541977844|FG002|Overall Study|Graft loss|4|||
150229705|NCT00113269|541977845|FG003|Overall Study|Graft loss|9|||
150229706|NCT00113269|541977842|FG000|Overall Study|Protocol Violation|1|||
150229707|NCT00113269|541977843|FG001|Overall Study|Protocol Violation|0|||
150229708|NCT00113269|541977844|FG002|Overall Study|Protocol Violation|4|||
150229709|NCT00113269|541977845|FG003|Overall Study|Protocol Violation|2|||
150229710|NCT00113269|541977842|FG000|Overall Study|Lost to Follow-up|2|||
150229711|NCT00113269|541977843|FG001|Overall Study|Lost to Follow-up|3|||
150229712|NCT00113269|541977844|FG002|Overall Study|Lost to Follow-up|6|||
150229713|NCT00113269|541977845|FG003|Overall Study|Lost to Follow-up|3|||
150229714|NCT00113269|541977842|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
150229715|NCT00113269|541977843|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
150229716|NCT00113269|541977844|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
150229717|NCT00113269|541977845|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
150229718|NCT00113269|541977842|FG000|Overall Study|Discontinued due to rejection|0|||
150229719|NCT00113269|541977843|FG001|Overall Study|Discontinued due to rejection|0|||
150229720|NCT00113269|541977844|FG002|Overall Study|Discontinued due to rejection|1|||
150229721|NCT00113269|541977845|FG003|Overall Study|Discontinued due to rejection|0|||
150229722|NCT00113269|541977842|FG000|Overall Study|Moved|0|||
150229723|NCT00113269|541977843|FG001|Overall Study|Moved|1|||
150229724|NCT00113269|541977844|FG002|Overall Study|Moved|0|||
150229725|NCT00113269|541977845|FG003|Overall Study|Moved|3|||
150229726|NCT00113269|541977842|FG000|Overall Study|Received pancreas transplant|0|||
150229727|NCT00113269|541977843|FG001|Overall Study|Received pancreas transplant|0|||
150229728|NCT00113269|541977844|FG002|Overall Study|Received pancreas transplant|0|||
150229729|NCT00113269|541977845|FG003|Overall Study|Received pancreas transplant|2|||
150229730|NCT00113269|541977842|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
150229731|NCT00113269|541977843|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
150229732|NCT00113269|541977844|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
150229733|NCT00113269|541977845|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
150229734|NCT00113269|541977842|FG000|Overall Study|Did not meet eligibility criteria|1|||
150229735|NCT00113269|541977843|FG001|Overall Study|Did not meet eligibility criteria|0|||
150229736|NCT00113269|541977844|FG002|Overall Study|Did not meet eligibility criteria|0|||
150229737|NCT00113269|541977845|FG003|Overall Study|Did not meet eligibility criteria|1|||
150229738|NCT00113269|541977842|FG000|Overall Study|Unable to return for follow up|2|||
150229739|NCT00113269|541977843|FG001|Overall Study|Unable to return for follow up|1|||
150229740|NCT00113269|541977844|FG002|Overall Study|Unable to return for follow up|0|||
150229741|NCT00113269|541977845|FG003|Overall Study|Unable to return for follow up|0|||
150229742|NCT00451555|541977848|FG000|Overall Study|Protocol Violation|2|||
150229743|NCT00451555|541977849|FG001|Overall Study|Protocol Violation|2|||
150229744|NCT00451555|541977848|FG000|Overall Study|Adverse Event|3|||
150229745|NCT00451555|541977849|FG001|Overall Study|Adverse Event|1|||
150229746|NCT00451555|541977848|FG000|Overall Study|Withdrawal by Subject|6|||
150229747|NCT00451555|541977849|FG001|Overall Study|Withdrawal by Subject|0|||
150229748|NCT00451555|541977848|FG000|Overall Study|Physician Decision|2|||
150229749|NCT00451555|541977849|FG001|Overall Study|Physician Decision|1|||
150229750|NCT00922441|541977854|FG000|Overall Study|Protocol Violation|0|||
150229751|NCT00922441|541977855|FG001|Overall Study|Protocol Violation|0|||
150229752|NCT00922441|541977856|FG002|Overall Study|Protocol Violation|2|||
150229753|NCT00922441|541977854|FG000|Overall Study|Withdrawal by Subject|0|||
150229754|NCT00922441|541977855|FG001|Overall Study|Withdrawal by Subject|0|||
150229755|NCT00922441|541977856|FG002|Overall Study|Withdrawal by Subject|1|||
150229756|NCT00809341|541977862|FG000|Overall Study|Physician Decision|0|||
150229757|NCT00809341|541977863|FG001|Overall Study|Physician Decision|1|||
150229758|NCT00570921|541977864|FG000|Overall Study|Protocol Violation|1|||
150229759|NCT00570921|541977864|FG000|Overall Study|Physician Decision|1|||
150229760|NCT03927222|541977868|FG000|Overall Study|Progression|3|||
150229761|NCT03927222|541977868|FG000|Overall Study|CMV testing results inconclusive|1|||
150229762|NCT03927222|541977868|FG000|Overall Study|Unable to generate enough vaccines|1|||
150229763|NCT03927222|541977868|FG000|Overall Study|Early study termination|1|||
150229764|NCT00745121|541977869|FG000|Overall Study|Death|3|||
150229765|NCT00745121|541977870|FG001|Overall Study|Death|0|||
150229766|NCT00745121|541977869|FG000|Overall Study|Adverse Event|1|||
150229767|NCT00745121|541977870|FG001|Overall Study|Adverse Event|0|||
150229768|NCT00745121|541977869|FG000|Overall Study|Lost to Follow-up|1|||
150229769|NCT00745121|541977870|FG001|Overall Study|Lost to Follow-up|0|||
150229770|NCT00745121|541977869|FG000|Overall Study|Withdrawal by Subject|4|||
150229771|NCT00745121|541977870|FG001|Overall Study|Withdrawal by Subject|2|||
150229772|NCT03723915|541977871|FG000|Screening|Failed to meet screening requirements.|2|||
150229773|NCT03723915|541977871|FG000|On Treatment|Failed to meet treatment requirements|2|||
150229774|NCT00740870|541977872|FG000|Overall Study|Not Catheterized|4|||
150229775|NCT00740870|541977872|FG000|Overall Study|Further testing contraindicated implant|17|||
150229776|NCT00640042|541977874|FG000|Enrollment|Did not receive study drug|83|||
150229777|NCT02515097|541977889|FG000|Overall Study|Lost to Follow-up|4|||
150229778|NCT02515097|541977890|FG001|Overall Study|Lost to Follow-up|2|||
150229779|NCT02515097|541977889|FG000|Overall Study|Withdrawal by Subject|1|||
150229780|NCT02515097|541977890|FG001|Overall Study|Withdrawal by Subject|3|||
150229781|NCT02515097|541977889|FG000|Overall Study|Adverse Event|2|||
150229782|NCT02515097|541977890|FG001|Overall Study|Adverse Event|1|||
150229783|NCT03613454|541977891|FG000|Overall Study|Protocol Violation|1|||
150229784|NCT03613454|541977892|FG001|Overall Study|Protocol Violation|0|||
150229785|NCT03613454|541977891|FG000|Overall Study|Protocol Violation|0|||
150229786|NCT03613454|541977892|FG001|Overall Study|Protocol Violation|1|||
150229787|NCT01592383|541977893|FG000|Overall Study|Adverse Event|1|||
150229788|NCT04167085|541977894|FG000|Baseline|Withdrawal by Subject|2|||
150229789|NCT04167085|541977895|FG001|Baseline|Withdrawal by Subject|1|||
150229790|NCT04167085|541977894|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
150229791|NCT04167085|541977895|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
150229792|NCT02273180|541977899|FG000|Overall Study|Adverse Event|2|||
150229793|NCT02273180|541977900|FG001|Overall Study|Adverse Event|2|||
150229794|NCT02273180|541977899|FG000|Overall Study|Lack of Efficacy|1|||
150229795|NCT02273180|541977900|FG001|Overall Study|Lack of Efficacy|0|||
150229796|NCT02273180|541977899|FG000|Overall Study|Protocol Violation|1|||
150229797|NCT02273180|541977900|FG001|Overall Study|Protocol Violation|7|||
150229798|NCT02273180|541977899|FG000|Overall Study|Randomized but not treated|1|||
150229799|NCT02273180|541977900|FG001|Overall Study|Randomized but not treated|0|||
150229800|NCT02273180|541977899|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
150229801|NCT02273180|541977900|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
150229802|NCT02273180|541977899|FG000|Overall Study|Other than specified above|21|||
150229803|NCT02273180|541977900|FG001|Overall Study|Other than specified above|10|||
150229804|NCT02154516|541977901|FG000|Overall Study|Withdrawal by Subject|0|||
150229805|NCT02154516|541977902|FG001|Overall Study|Withdrawal by Subject|1|||
150229806|NCT02154516|541977901|FG000|Overall Study|Lost to Follow-up|1|||
150229807|NCT02154516|541977902|FG001|Overall Study|Lost to Follow-up|0|||
150229808|NCT02154516|541977901|FG000|Overall Study|Removal/revision of device|1|||
150229809|NCT02154516|541977902|FG001|Overall Study|Removal/revision of device|0|||
150229810|NCT02154516|541977901|FG000|Overall Study|Death|2|||
150229811|NCT02154516|541977902|FG001|Overall Study|Death|1|||
150229812|NCT02965599|541977906|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
150229813|NCT02965599|541977907|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
150229814|NCT02799745|541977911|FG000|Overall Study|Participant moved out of state|1|||
150229815|NCT02799745|541977912|FG001|Overall Study|Participant moved out of state|0|||
150229816|NCT02799745|541977911|FG000|Overall Study|Discontinued due to planned surgery|1|||
150229817|NCT02799745|541977912|FG001|Overall Study|Discontinued due to planned surgery|0|||
150229818|NCT02799745|541977911|FG000|Overall Study|Withdrawal by Subject|16|||
150229819|NCT02799745|541977912|FG001|Overall Study|Withdrawal by Subject|25|||
150229820|NCT02799745|541977911|FG000|Overall Study|Protocol Deviation|4|||
150229821|NCT02799745|541977912|FG001|Overall Study|Protocol Deviation|5|||
150229822|NCT02799745|541977911|FG000|Overall Study|Progressive Disease|28|||
150229823|NCT02799745|541977912|FG001|Overall Study|Progressive Disease|38|||
150229824|NCT02799745|541977911|FG000|Overall Study|Lost to Follow-up|3|||
150229825|NCT02799745|541977912|FG001|Overall Study|Lost to Follow-up|2|||
150229826|NCT02799745|541977911|FG000|Overall Study|Death|3|||
150229827|NCT02799745|541977912|FG001|Overall Study|Death|0|||
150229828|NCT02799745|541977911|FG000|Overall Study|Adverse Event|0|||
150229829|NCT02799745|541977912|FG001|Overall Study|Adverse Event|1|||
150229830|NCT00853372|541979545|FG000|Overall Study|Death|30|||
150229831|NCT00853372|541979546|FG001|Overall Study|Death|26|||
150229832|NCT00853372|541979545|FG000|Overall Study|Lost to Follow-up|1|||
150229833|NCT00853372|541979546|FG001|Overall Study|Lost to Follow-up|2|||
150229834|NCT00853372|541979545|FG000|Overall Study|Full Consent Withdrawn|1|||
150229835|NCT00853372|541979546|FG001|Overall Study|Full Consent Withdrawn|1|||
150229836|NCT02517528|541979547|FG000|Overall Study|Withdrawal by Subject|1|||
150229837|NCT01093599|541979551|FG000|Overall Study|Lost to Follow-up|32|||
150229838|NCT01093599|541979552|FG001|Overall Study|Lost to Follow-up|46|||
150229839|NCT01703845|541979553|FG000|Overall Study|Adverse Event|1|||
150229840|NCT01703845|541979554|FG001|Overall Study|Adverse Event|0|||
150229841|NCT01703845|541979553|FG000|Overall Study|Protocol Violation|1|||
150229842|NCT01703845|541979554|FG001|Overall Study|Protocol Violation|0|||
150229843|NCT01703845|541979553|FG000|Overall Study|other than stated above|1|||
150229844|NCT01703845|541979554|FG001|Overall Study|other than stated above|0|||
150229845|NCT01845649|541979560|FG000|Overall Study|Adverse Event|7|||
150229846|NCT01845649|541979561|FG001|Overall Study|Adverse Event|10|||
150229847|NCT01845649|541979560|FG000|Overall Study|Lack of Efficacy|1|||
150229848|NCT01845649|541979561|FG001|Overall Study|Lack of Efficacy|1|||
150229849|NCT01845649|541979560|FG000|Overall Study|Lost to Follow-up|2|||
150229850|NCT01845649|541979561|FG001|Overall Study|Lost to Follow-up|2|||
150229851|NCT01845649|541979560|FG000|Overall Study|Withdrew Consent|12|||
150229852|NCT01845649|541979561|FG001|Overall Study|Withdrew Consent|4|||
150229853|NCT01845649|541979560|FG000|Overall Study|Protocol Deviation|7|||
150229854|NCT01845649|541979561|FG001|Overall Study|Protocol Deviation|4|||
150229855|NCT01845649|541979560|FG000|Overall Study|Reason not Specified|2|||
150229856|NCT01845649|541979561|FG001|Overall Study|Reason not Specified|1|||
150229857|NCT03991988|541979562|FG000|Overall Study|Withdrawal by Subject|2|||
150229858|NCT03991988|541979563|FG001|Overall Study|Withdrawal by Subject|2|||
150229859|NCT01222533|541979565|FG000|Overall Study|Adverse Event|5|||
150229860|NCT01222533|541979565|FG000|Overall Study|Withdrawal by Subject|5|||
150229861|NCT01222533|541979565|FG000|Overall Study|Other|4|||
150229862|NCT03418493|541979566|FG000|Overall Study|Adverse Event|1|||
150229863|NCT03418493|541979567|FG001|Overall Study|Adverse Event|0|||
150229864|NCT03418493|541979568|FG002|Overall Study|Adverse Event|0|||
150229865|NCT03418493|541979569|FG003|Overall Study|Adverse Event|0|||
150229866|NCT03418493|541979570|FG004|Overall Study|Adverse Event|0|||
150229867|NCT03418493|541979571|FG005|Overall Study|Adverse Event|0|||
150229868|NCT03418493|541979572|FG006|Overall Study|Adverse Event|0|||
150229869|NCT03418493|541979573|FG007|Overall Study|Adverse Event|0|||
150229870|NCT03418493|541979574|FG008|Overall Study|Adverse Event|0|||
150229871|NCT03418493|541979575|FG009|Overall Study|Adverse Event|0|||
150229872|NCT03418493|541979576|FG010|Overall Study|Adverse Event|0|||
150229873|NCT03418493|541979566|FG000|Overall Study|Protocol Violation|0|||
150229874|NCT03418493|541979567|FG001|Overall Study|Protocol Violation|0|||
150229875|NCT03418493|541979568|FG002|Overall Study|Protocol Violation|0|||
150229876|NCT03418493|541979569|FG003|Overall Study|Protocol Violation|0|||
150229877|NCT03418493|541979570|FG004|Overall Study|Protocol Violation|0|||
150229878|NCT03418493|541979571|FG005|Overall Study|Protocol Violation|0|||
150229879|NCT03418493|541979572|FG006|Overall Study|Protocol Violation|0|||
150229880|NCT03418493|541979573|FG007|Overall Study|Protocol Violation|0|||
150229881|NCT03418493|541979574|FG008|Overall Study|Protocol Violation|0|||
150229882|NCT03418493|541979575|FG009|Overall Study|Protocol Violation|1|||
150229883|NCT03418493|541979576|FG010|Overall Study|Protocol Violation|0|||
150229884|NCT00526097|541979580|FG000|Overall Study|Adverse Event|6|||
150229885|NCT00526097|541979581|FG001|Overall Study|Adverse Event|44|||
150229886|NCT00526097|541979580|FG000|Overall Study|Protocol Violation|4|||
150229887|NCT00526097|541979581|FG001|Overall Study|Protocol Violation|10|||
150229888|NCT00526097|541979580|FG000|Overall Study|Withdrawal by Subject|3|||
150229889|NCT00526097|541979581|FG001|Overall Study|Withdrawal by Subject|1|||
150229890|NCT00526097|541979580|FG000|Overall Study|Other|2|||
150229891|NCT00526097|541979581|FG001|Overall Study|Other|1|||
150229892|NCT00966979|541979582|FG000|Overall Study|Death|1|||
150229893|NCT00966979|541979582|FG000|Overall Study|Lost to Follow-up|6|||
150229894|NCT00966979|541979582|FG000|Overall Study|Withdrawal by Subject|14|||
150229895|NCT00966979|541979582|FG000|Overall Study|Adverse Event|5|||
150229896|NCT00966979|541979582|FG000|Overall Study|Sponsor terminated early|49|||
150229897|NCT00966979|541979582|FG000|Overall Study|Censored because surgery not done|2|||
150229898|NCT00966979|541979582|FG000|Overall Study|Censored because study device was not implanted|14|||
150229899|NCT00966979|541979582|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
150229900|NCT00943618|541979586|FG000|Overall Study|Lost to Follow-up|38|||
150229901|NCT00943618|541979587|FG001|Overall Study|Lost to Follow-up|48|||
150229902|NCT00943618|541979588|FG002|Overall Study|Lost to Follow-up|20|||
150229903|NCT00943618|541979586|FG000|Overall Study|Discontinued Medication|17|||
150229904|NCT00943618|541979587|FG001|Overall Study|Discontinued Medication|29|||
150229905|NCT00943618|541979588|FG002|Overall Study|Discontinued Medication|11|||
150229906|NCT03713281|541979593|FG000|Overall Study|Lens handling difficuluties|2|||
150229907|NCT03713281|541979593|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
150229908|NCT01990313|541979595|FG000|Overall Study|Lost to Follow-up|1|||
150229909|NCT02412111|541979596|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
150229910|NCT02412111|541979597|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
150229911|NCT02412111|541979598|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
150229912|NCT02412111|541979596|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
150229913|NCT02412111|541979597|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
150229914|NCT02412111|541979598|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
150229915|NCT02412111|541979596|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
150229916|NCT02412111|541979597|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
150229917|NCT02412111|541979598|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
150229918|NCT02412111|541979596|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
150229919|NCT02412111|541979597|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
150229920|NCT02412111|541979598|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
150229921|NCT02412111|541979596|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
150229922|NCT02412111|541979597|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
150229923|NCT02412111|541979598|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
150229924|NCT02412111|541979596|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
150229925|NCT02412111|541979597|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
150229926|NCT02412111|541979598|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
150229927|NCT02412111|541979596|FG000|Active Comparator Period (8 Weeks)|Other|0|||
150229928|NCT02412111|541979597|FG001|Active Comparator Period (8 Weeks)|Other|0|||
150229929|NCT02412111|541979598|FG002|Active Comparator Period (8 Weeks)|Other|2|||
150229930|NCT00630552|541979600|FG000|Overall Study|Adverse Event|0|||
150229931|NCT00630552|541979601|FG001|Overall Study|Adverse Event|1|||
150229932|NCT00630552|541979602|FG002|Overall Study|Adverse Event|5|||
150229933|NCT00630552|541979603|FG003|Overall Study|Adverse Event|4|||
150229934|NCT00630552|541979604|FG004|Overall Study|Adverse Event|2|||
150229935|NCT00630552|541979600|FG000|Overall Study|Disease progression|5|||
150229936|NCT00630552|541979601|FG001|Overall Study|Disease progression|6|||
150229937|NCT00630552|541979602|FG002|Overall Study|Disease progression|27|||
150229938|NCT00630552|541979603|FG003|Overall Study|Disease progression|22|||
150229939|NCT00630552|541979604|FG004|Overall Study|Disease progression|31|||
150229940|NCT00630552|541979600|FG000|Overall Study|Never received IP|0|||
150229941|NCT00630552|541979601|FG001|Overall Study|Never received IP|0|||
150229942|NCT00630552|541979602|FG002|Overall Study|Never received IP|0|||
150229943|NCT00630552|541979603|FG003|Overall Study|Never received IP|2|||
150229944|NCT00630552|541979604|FG004|Overall Study|Never received IP|2|||
150229945|NCT00630552|541979600|FG000|Overall Study|Ineligibility determined|0|||
150229946|NCT00630552|541979601|FG001|Overall Study|Ineligibility determined|0|||
150229947|NCT00630552|541979602|FG002|Overall Study|Ineligibility determined|0|||
150229948|NCT00630552|541979603|FG003|Overall Study|Ineligibility determined|0|||
150229949|NCT00630552|541979604|FG004|Overall Study|Ineligibility determined|1|||
150229950|NCT00630552|541979600|FG000|Overall Study|Protocol Violation|0|||
150229951|NCT00630552|541979601|FG001|Overall Study|Protocol Violation|0|||
150229952|NCT00630552|541979602|FG002|Overall Study|Protocol Violation|0|||
150229953|NCT00630552|541979603|FG003|Overall Study|Protocol Violation|1|||
150229954|NCT00630552|541979604|FG004|Overall Study|Protocol Violation|0|||
150229955|NCT00630552|541979600|FG000|Overall Study|Physician Decision|0|||
150229956|NCT00630552|541979601|FG001|Overall Study|Physician Decision|0|||
150229957|NCT00630552|541979602|FG002|Overall Study|Physician Decision|0|||
150229958|NCT00630552|541979603|FG003|Overall Study|Physician Decision|0|||
150229959|NCT00630552|541979604|FG004|Overall Study|Physician Decision|1|||
150229960|NCT00630552|541979600|FG000|Overall Study|Death|0|||
150229961|NCT00630552|541979601|FG001|Overall Study|Death|0|||
150229962|NCT00630552|541979602|FG002|Overall Study|Death|1|||
150229963|NCT00630552|541979603|FG003|Overall Study|Death|2|||
150229964|NCT00630552|541979604|FG004|Overall Study|Death|2|||
150229965|NCT00630552|541979600|FG000|Overall Study|Withdrawal by Subject|0|||
150229966|NCT00630552|541979601|FG001|Overall Study|Withdrawal by Subject|0|||
150229967|NCT00630552|541979602|FG002|Overall Study|Withdrawal by Subject|0|||
150229968|NCT00630552|541979603|FG003|Overall Study|Withdrawal by Subject|1|||
150229969|NCT00630552|541979604|FG004|Overall Study|Withdrawal by Subject|0|||
150229970|NCT00630552|541979600|FG000|Overall Study|Other|0|||
150229971|NCT00630552|541979601|FG001|Overall Study|Other|0|||
150229972|NCT00630552|541979602|FG002|Overall Study|Other|4|||
150229973|NCT00630552|541979603|FG003|Overall Study|Other|2|||
150229974|NCT00630552|541979604|FG004|Overall Study|Other|0|||
150229975|NCT03226106|541979605|FG000|Overall Study|Withdrawal by Subject|2|||
150229976|NCT03226106|541979606|FG001|Overall Study|Withdrawal by Subject|0|||
150229977|NCT03226106|541979605|FG000|Overall Study|Adverse Event|1|||
150229978|NCT03226106|541979606|FG001|Overall Study|Adverse Event|0|||
150229979|NCT03226106|541979605|FG000|Overall Study|Lost to Follow-up|2|||
150229980|NCT03226106|541979606|FG001|Overall Study|Lost to Follow-up|0|||
150229981|NCT04349644|541979607|FG000|Allocation/Pretest|Lost to pretest|0|||
150229982|NCT04349644|541979608|FG001|Allocation/Pretest|Lost to pretest|3|||
150229983|NCT04349644|541979607|FG000|Posttest|Lost to posttest|0|||
150229984|NCT04349644|541979608|FG001|Posttest|Lost to posttest|8|||
150229985|NCT04349644|541979607|FG000|Posttest|Discontinued intervention|6|||
150229986|NCT04349644|541979608|FG001|Posttest|Discontinued intervention|0|||
150229987|NCT04349644|541979607|FG000|Follow-up|Lost to Follow-up|0|||
150229988|NCT04349644|541979608|FG001|Follow-up|Lost to Follow-up|2|||
150229989|NCT01084239|541979609|FG000|28-Day Follow-up|Lost to Follow-up|4|||
150229990|NCT01084239|541979610|FG001|28-Day Follow-up|Lost to Follow-up|9|||
150229991|NCT00721214|541979611|FG000|Overall Study|Chose another center for transplant|1|||
150229992|NCT00721214|541979611|FG000|Overall Study|Death|3|||
150229993|NCT00983905|541979612|FG000|Theophylline Alone|Adverse Event|1|||
150229994|NCT00983905|541979612|FG000|Colchicine Alone|Adverse Event|2|||
150229995|NCT05006417|541979613|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
150229996|NCT01169636|541979614|FG000|Overall Study|Adverse Event|0|||
150229997|NCT01169636|541979615|FG001|Overall Study|Adverse Event|0|||
150229998|NCT01169636|541979616|FG002|Overall Study|Adverse Event|1|||
150229999|NCT01169636|541979617|FG003|Overall Study|Adverse Event|1|||
150230000|NCT01169636|541979618|FG004|Overall Study|Adverse Event|0|||
150230001|NCT01169636|541979614|FG000|Overall Study|Screen failure|0|||
150230002|NCT01169636|541979615|FG001|Overall Study|Screen failure|0|||
150230003|NCT01169636|541979616|FG002|Overall Study|Screen failure|2|||
150230004|NCT01169636|541979617|FG003|Overall Study|Screen failure|0|||
150230005|NCT01169636|541979618|FG004|Overall Study|Screen failure|0|||
150230006|NCT01169636|541979614|FG000|Overall Study|Withdrawal by Subject|0|||
150230007|NCT01169636|541979615|FG001|Overall Study|Withdrawal by Subject|0|||
150230008|NCT01169636|541979616|FG002|Overall Study|Withdrawal by Subject|0|||
150230009|NCT01169636|541979617|FG003|Overall Study|Withdrawal by Subject|0|||
150230010|NCT01169636|541979618|FG004|Overall Study|Withdrawal by Subject|3|||
150230011|NCT02396953|541979619|FG000|Overall Study|Withdrawal by Subject|0|||
150230012|NCT02396953|541979620|FG001|Overall Study|Withdrawal by Subject|0|||
150230013|NCT02396953|541979621|FG002|Overall Study|Withdrawal by Subject|1|||
150230014|NCT02396953|541979619|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
150230015|NCT02396953|541979620|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
150230016|NCT02396953|541979621|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
150230017|NCT02396953|541979619|FG000|Overall Study|Personal Reasons|1|||
150230018|NCT02396953|541979620|FG001|Overall Study|Personal Reasons|1|||
150230019|NCT02396953|541979621|FG002|Overall Study|Personal Reasons|0|||
150230020|NCT02624869|541979622|FG000|Overall Study|Lost to Follow-up|0|||
150230021|NCT02624869|541979623|FG001|Overall Study|Lost to Follow-up|0|||
150230022|NCT02624869|541979624|FG002|Overall Study|Lost to Follow-up|1|||
150230023|NCT02624869|541979622|FG000|Overall Study|Withdrawal by Subject|1|||
150230024|NCT02624869|541979623|FG001|Overall Study|Withdrawal by Subject|3|||
150230025|NCT02624869|541979624|FG002|Overall Study|Withdrawal by Subject|1|||
150230026|NCT00510198|541979625|FG000|Overall Study|Withdrawal by Subject|5|||
150230027|NCT00510198|541979626|FG001|Overall Study|Withdrawal by Subject|4|||
150230028|NCT02994784|541979627|FG000|6 Months Follow-up|Lost to Follow-up|3|||
150230029|NCT01917006|541979628|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
150230030|NCT01917006|541979629|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
150230031|NCT01917006|541979630|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
150230032|NCT01917006|541979631|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
150230033|NCT01917006|541979632|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
150230034|NCT01917006|541979633|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
150230035|NCT01917006|541979634|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
150230036|NCT01917006|541979635|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
150230037|NCT01917006|541979628|FG000|Randomized-treatment Period|Personal Reasons|0|||
150230038|NCT01917006|541979629|FG001|Randomized-treatment Period|Personal Reasons|0|||
150230039|NCT01917006|541979630|FG002|Randomized-treatment Period|Personal Reasons|0|||
150230040|NCT01917006|541979631|FG003|Randomized-treatment Period|Personal Reasons|0|||
150230041|NCT01917006|541979632|FG004|Randomized-treatment Period|Personal Reasons|0|||
150230042|NCT01917006|541979633|FG005|Randomized-treatment Period|Personal Reasons|1|||
150230043|NCT01917006|541979634|FG006|Randomized-treatment Period|Personal Reasons|0|||
150230044|NCT01917006|541979635|FG007|Randomized-treatment Period|Personal Reasons|0|||
150230045|NCT01917006|541979628|FG000|Randomized-treatment Period|Protocol Violation|1|||
150230046|NCT01917006|541979629|FG001|Randomized-treatment Period|Protocol Violation|0|||
150230047|NCT01917006|541979630|FG002|Randomized-treatment Period|Protocol Violation|0|||
150230048|NCT01917006|541979631|FG003|Randomized-treatment Period|Protocol Violation|0|||
150230049|NCT01917006|541979632|FG004|Randomized-treatment Period|Protocol Violation|0|||
150230050|NCT01917006|541979633|FG005|Randomized-treatment Period|Protocol Violation|0|||
150230051|NCT01917006|541979634|FG006|Randomized-treatment Period|Protocol Violation|0|||
150230052|NCT01917006|541979635|FG007|Randomized-treatment Period|Protocol Violation|0|||
150230053|NCT01917006|541979628|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230054|NCT01917006|541979629|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230055|NCT01917006|541979630|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230056|NCT01917006|541979631|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230057|NCT01917006|541979632|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230058|NCT01917006|541979633|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230059|NCT01917006|541979634|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
150230060|NCT01917006|541979635|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
150230061|NCT01917006|541979628|FG000|Open-label Period|Adverse Event|0|||
150230062|NCT01917006|541979629|FG001|Open-label Period|Adverse Event|0|||
150230063|NCT01917006|541979630|FG002|Open-label Period|Adverse Event|0|||
150230064|NCT01917006|541979631|FG003|Open-label Period|Adverse Event|0|||
150230065|NCT01917006|541979632|FG004|Open-label Period|Adverse Event|0|||
150230066|NCT01917006|541979633|FG005|Open-label Period|Adverse Event|0|||
150230067|NCT01917006|541979634|FG006|Open-label Period|Adverse Event|0|||
150230068|NCT01917006|541979635|FG007|Open-label Period|Adverse Event|1|||
150230069|NCT01917006|541979628|FG000|Open-label Period|Lost to Follow-up|0|||
150230070|NCT01917006|541979629|FG001|Open-label Period|Lost to Follow-up|0|||
150230071|NCT01917006|541979630|FG002|Open-label Period|Lost to Follow-up|0|||
150230072|NCT01917006|541979631|FG003|Open-label Period|Lost to Follow-up|0|||
150230073|NCT01917006|541979632|FG004|Open-label Period|Lost to Follow-up|0|||
150230074|NCT01917006|541979633|FG005|Open-label Period|Lost to Follow-up|0|||
150230075|NCT01917006|541979634|FG006|Open-label Period|Lost to Follow-up|0|||
150230076|NCT01917006|541979635|FG007|Open-label Period|Lost to Follow-up|1|||
150230077|NCT02158247|541979636|FG000|Overall Study|Invisible vocal cords|5|||
150230078|NCT01649557|541979637|FG000|Overall Study|Lost to Follow-up|5|||
150230079|NCT01649557|541979638|FG001|Overall Study|Lost to Follow-up|0|||
150230080|NCT01649557|541979639|FG002|Overall Study|Lost to Follow-up|3|||
150230081|NCT01649557|541979637|FG000|Overall Study|Adverse Event|7|||
150230082|NCT01649557|541979638|FG001|Overall Study|Adverse Event|5|||
150230083|NCT01649557|541979639|FG002|Overall Study|Adverse Event|1|||
150230084|NCT01649557|541979637|FG000|Overall Study|Met withdrawal criteria|4|||
150230085|NCT01649557|541979638|FG001|Overall Study|Met withdrawal criteria|0|||
150230086|NCT01649557|541979639|FG002|Overall Study|Met withdrawal criteria|0|||
150230087|NCT01649557|541979637|FG000|Overall Study|Physician Decision|8|||
150230088|NCT01649557|541979638|FG001|Overall Study|Physician Decision|2|||
150230089|NCT01649557|541979639|FG002|Overall Study|Physician Decision|1|||
150230090|NCT01649557|541979637|FG000|Overall Study|Withdrawal by Subject|15|||
150230091|NCT01649557|541979638|FG001|Overall Study|Withdrawal by Subject|5|||
150230092|NCT01649557|541979639|FG002|Overall Study|Withdrawal by Subject|4|||
150230093|NCT01649557|541979637|FG000|Overall Study|Protocol deviation|0|||
150230094|NCT01649557|541979638|FG001|Overall Study|Protocol deviation|2|||
150230095|NCT01649557|541979639|FG002|Overall Study|Protocol deviation|0|||
150230096|NCT01649557|541979637|FG000|Overall Study|Lack of Efficacy|5|||
150230097|NCT01649557|541979638|FG001|Overall Study|Lack of Efficacy|0|||
150230098|NCT01649557|541979639|FG002|Overall Study|Lack of Efficacy|0|||
150230099|NCT03029234|541979642|FG000|Overall Study|Sponsor Decision|1|||
150230100|NCT03029234|541979642|FG000|Overall Study|Withdrawal by Subject|5|||
150230101|NCT03029234|541979642|FG000|Overall Study|Death|91|||
150230102|NCT03029234|541979642|FG000|Overall Study|Lost to Follow-up|2|||
150230103|NCT04491006|541979643|FG000|Overall Study|Adverse Event|0|||
150230104|NCT04491006|541979644|FG001|Overall Study|Adverse Event|3|||
150230105|NCT04491006|541979645|FG002|Overall Study|Adverse Event|5|||
150230106|NCT04491006|541979643|FG000|Overall Study|Withdrawal by Subject|1|||
150230107|NCT04491006|541979644|FG001|Overall Study|Withdrawal by Subject|0|||
150230108|NCT04491006|541979645|FG002|Overall Study|Withdrawal by Subject|2|||
150230109|NCT03036150|541979651|FG000|Overall Study|Withdrawal by Subject|8|||
150230110|NCT03036150|541979652|FG001|Overall Study|Withdrawal by Subject|3|||
150230111|NCT03036150|541979651|FG000|Overall Study|Lost to Follow-up|2|||
150230112|NCT03036150|541979652|FG001|Overall Study|Lost to Follow-up|2|||
150230113|NCT01990664|541979653|FG000|Overall Study|Lost to Follow-up|2|||
150230114|NCT01990664|541979654|FG001|Overall Study|Lost to Follow-up|6|||
150230115|NCT01990664|541979653|FG000|Overall Study|Withdrawal by Subject|2|||
150230116|NCT01990664|541979654|FG001|Overall Study|Withdrawal by Subject|3|||
150230117|NCT01990664|541979653|FG000|Overall Study|Protocol Violation|1|||
150230118|NCT01990664|541979654|FG001|Overall Study|Protocol Violation|0|||
150230119|NCT01990664|541979653|FG000|Overall Study|Lens Discomfort|1|||
150230120|NCT01990664|541979654|FG001|Overall Study|Lens Discomfort|1|||
150230121|NCT01990664|541979653|FG000|Overall Study|Lens Handling Difficulties|1|||
150230122|NCT01990664|541979654|FG001|Overall Study|Lens Handling Difficulties|0|||
150230123|NCT01990664|541979653|FG000|Overall Study|Unsatisfactory Visual Response|0|||
150230124|NCT01990664|541979654|FG001|Overall Study|Unsatisfactory Visual Response|1|||
150230125|NCT03891641|541979665|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
150230126|NCT03891641|541979666|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
150230127|NCT04016805|541979668|FG000|Overall Study|Sponsor's Discretion|30|||
150230128|NCT04016805|541979669|FG001|Overall Study|Sponsor's Discretion|6|||
150230129|NCT04016805|541979670|FG002|Overall Study|Sponsor's Discretion|5|||
150230130|NCT00819013|541979672|FG000|Overall Study|Not meeting continuing study eligibility|2|||
150230131|NCT00819013|541979673|FG001|Overall Study|Not meeting continuing study eligibility|1|||
150230132|NCT00819013|541979674|FG002|Overall Study|Not meeting continuing study eligibility|2|||
150230133|NCT00819013|541979675|FG003|Overall Study|Not meeting continuing study eligibility|1|||
150230134|NCT00819013|541979672|FG000|Overall Study|Adverse Event|0|||
150230135|NCT00819013|541979673|FG001|Overall Study|Adverse Event|0|||
150230136|NCT00819013|541979674|FG002|Overall Study|Adverse Event|1|||
150230137|NCT00819013|541979675|FG003|Overall Study|Adverse Event|0|||
150230138|NCT00819013|541979672|FG000|Overall Study|Withdrawal by Subject|1|||
150230139|NCT00819013|541979673|FG001|Overall Study|Withdrawal by Subject|0|||
150230140|NCT00819013|541979674|FG002|Overall Study|Withdrawal by Subject|1|||
150230141|NCT00819013|541979675|FG003|Overall Study|Withdrawal by Subject|0|||
150230142|NCT00819013|541979672|FG000|Overall Study|Lost to Follow-up|0|||
150230143|NCT00819013|541979673|FG001|Overall Study|Lost to Follow-up|0|||
150230144|NCT00819013|541979674|FG002|Overall Study|Lost to Follow-up|1|||
150230145|NCT00819013|541979675|FG003|Overall Study|Lost to Follow-up|2|||
150230146|NCT00819013|541979672|FG000|Overall Study|Death|0|||
150230147|NCT00819013|541979673|FG001|Overall Study|Death|0|||
150230148|NCT00819013|541979674|FG002|Overall Study|Death|0|||
150230149|NCT00819013|541979675|FG003|Overall Study|Death|1|||
150230150|NCT00607997|541979676|FG000|Overall Study|Lack of Efficacy|6|||
150230151|NCT00607997|541979677|FG001|Overall Study|Lack of Efficacy|20|||
150230152|NCT00607997|541979678|FG002|Overall Study|Lack of Efficacy|14|||
150230153|NCT00607997|541979679|FG003|Overall Study|Lack of Efficacy|10|||
150230154|NCT00607997|541979676|FG000|Overall Study|Death|8|||
150230155|NCT00607997|541979677|FG001|Overall Study|Death|5|||
150230156|NCT00607997|541979678|FG002|Overall Study|Death|2|||
150230157|NCT00607997|541979679|FG003|Overall Study|Death|5|||
150230158|NCT00607997|541979676|FG000|Overall Study|Adverse Event|3|||
150230159|NCT00607997|541979677|FG001|Overall Study|Adverse Event|1|||
150230160|NCT00607997|541979678|FG002|Overall Study|Adverse Event|2|||
150230161|NCT00607997|541979679|FG003|Overall Study|Adverse Event|0|||
150230162|NCT00607997|541979676|FG000|Overall Study|Physician Decision|4|||
150230163|NCT00607997|541979677|FG001|Overall Study|Physician Decision|1|||
150230164|NCT00607997|541979678|FG002|Overall Study|Physician Decision|0|||
150230165|NCT00607997|541979679|FG003|Overall Study|Physician Decision|0|||
150230166|NCT00607997|541979676|FG000|Overall Study|Relapse, recurrent illness|4|||
150230167|NCT00607997|541979677|FG001|Overall Study|Relapse, recurrent illness|0|||
150230168|NCT00607997|541979678|FG002|Overall Study|Relapse, recurrent illness|2|||
150230169|NCT00607997|541979679|FG003|Overall Study|Relapse, recurrent illness|0|||
150230170|NCT00607997|541979676|FG000|Overall Study|Other without explanation|2|||
150230171|NCT00607997|541979677|FG001|Overall Study|Other without explanation|0|||
150230172|NCT00607997|541979678|FG002|Overall Study|Other without explanation|4|||
150230173|NCT00607997|541979679|FG003|Overall Study|Other without explanation|1|||
150230174|NCT00839332|541979680|FG000|Phase 1|Disease Progression|38|||
150230175|NCT00839332|541979681|FG001|Phase 1|Disease Progression|0|||
150230176|NCT00839332|541979682|FG002|Phase 1|Disease Progression|0|||
150230177|NCT00839332|541979680|FG000|Phase 1|Adverse Event|6|||
150230178|NCT00839332|541979681|FG001|Phase 1|Adverse Event|0|||
150230179|NCT00839332|541979682|FG002|Phase 1|Adverse Event|0|||
150230180|NCT00839332|541979680|FG000|Phase 1|Withdrawal by Subject|4|||
150230181|NCT00839332|541979681|FG001|Phase 1|Withdrawal by Subject|0|||
150230182|NCT00839332|541979682|FG002|Phase 1|Withdrawal by Subject|0|||
150230183|NCT00839332|541979680|FG000|Phase 1|Physician Decision|2|||
150230184|NCT00839332|541979681|FG001|Phase 1|Physician Decision|0|||
150230185|NCT00839332|541979682|FG002|Phase 1|Physician Decision|0|||
150230186|NCT00839332|541979680|FG000|Phase 2|Protocol Violation|0|||
150230187|NCT00839332|541979681|FG001|Phase 2|Protocol Violation|1|||
150230188|NCT00839332|541979682|FG002|Phase 2|Protocol Violation|0|||
150230189|NCT00839332|541979680|FG000|Phase 2|Disease Progression|0|||
150230190|NCT00839332|541979681|FG001|Phase 2|Disease Progression|46|||
150230191|NCT00839332|541979682|FG002|Phase 2|Disease Progression|21|||
150230192|NCT00839332|541979680|FG000|Phase 2|Adverse Event|0|||
150230193|NCT00839332|541979681|FG001|Phase 2|Adverse Event|8|||
150230194|NCT00839332|541979682|FG002|Phase 2|Adverse Event|6|||
150230195|NCT00839332|541979680|FG000|Phase 2|Death|0|||
150230196|NCT00839332|541979681|FG001|Phase 2|Death|4|||
150230197|NCT00839332|541979682|FG002|Phase 2|Death|2|||
150230198|NCT00839332|541979680|FG000|Phase 2|Withdrawal by Subject|0|||
150230199|NCT00839332|541979681|FG001|Phase 2|Withdrawal by Subject|5|||
150230200|NCT00839332|541979682|FG002|Phase 2|Withdrawal by Subject|8|||
150230201|NCT00839332|541979680|FG000|Phase 2|Physician Decision|0|||
150230202|NCT00839332|541979681|FG001|Phase 2|Physician Decision|4|||
150230203|NCT00839332|541979682|FG002|Phase 2|Physician Decision|1|||
150230204|NCT00839332|541979680|FG000|Phase 2|Lost to Follow-up|0|||
150230205|NCT00839332|541979681|FG001|Phase 2|Lost to Follow-up|0|||
150230206|NCT00839332|541979682|FG002|Phase 2|Lost to Follow-up|1|||
150230207|NCT04414397|541979688|FG000|Control Period|Withdrawal by Subject|2|||
150230208|NCT04414397|541979689|FG001|Control Period|Withdrawal by Subject|2|||
150230209|NCT04414397|541979688|FG000|Control Period|Lost to Follow-up|0|||
150230210|NCT04414397|541979689|FG001|Control Period|Lost to Follow-up|4|||
150230211|NCT04414397|541979688|FG000|Control Period|Protocol deviation|0|||
150230212|NCT04414397|541979689|FG001|Control Period|Protocol deviation|1|||
150230213|NCT04414397|541979688|FG000|Post-Control Period|Withdrawal by Subject|3|||
150230214|NCT04414397|541979689|FG001|Post-Control Period|Withdrawal by Subject|6|||
150230215|NCT04414397|541979688|FG000|Post-Control Period|Lost to Follow-up|4|||
150230216|NCT04414397|541979689|FG001|Post-Control Period|Lost to Follow-up|9|||
150230217|NCT04414397|541979688|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
150230218|NCT04414397|541979689|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
150230219|NCT04414397|541979688|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
150230220|NCT04414397|541979689|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
150230221|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
150230222|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
150230223|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
150230224|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Other|1|||
150230225|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Other|0|||
150230226|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Other|0|||
150230227|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Physician Decision|3|||
150230228|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Physician Decision|0|||
150230229|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Physician Decision|0|||
150230230|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
150230231|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
150230232|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
150230233|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
150230234|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
150230235|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
150230236|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Adverse Event|18|||
150230237|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Adverse Event|0|||
150230238|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Adverse Event|0|||
150230239|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
150230240|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
150230241|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
150230242|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
150230243|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
150230244|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
150230245|NCT03030599|541979692|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
150230246|NCT03030599|541979693|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
150230247|NCT03030599|541979694|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
150230248|NCT03030599|541979692|FG000|Stable Dose|Protocol deviation|3|||
150230249|NCT03030599|541979693|FG001|Stable Dose|Protocol deviation|0|||
150230250|NCT03030599|541979694|FG002|Stable Dose|Protocol deviation|0|||
150230251|NCT03030599|541979692|FG000|Stable Dose|Adverse Event|1|||
150230252|NCT03030599|541979693|FG001|Stable Dose|Adverse Event|0|||
150230253|NCT03030599|541979694|FG002|Stable Dose|Adverse Event|0|||
150230254|NCT03030599|541979692|FG000|Stable Dose|Lost to Follow-up|1|||
150230255|NCT03030599|541979693|FG001|Stable Dose|Lost to Follow-up|0|||
150230256|NCT03030599|541979694|FG002|Stable Dose|Lost to Follow-up|0|||
150230257|NCT03030599|541979692|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
150230258|NCT03030599|541979693|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
150230259|NCT03030599|541979694|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
150230260|NCT03030599|541979692|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
150230261|NCT03030599|541979693|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
150230262|NCT03030599|541979694|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
150230263|NCT03030599|541979692|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
150230264|NCT03030599|541979693|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
150230265|NCT03030599|541979694|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
150230266|NCT03030599|541979692|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
150230267|NCT03030599|541979693|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
150230268|NCT03030599|541979694|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
150230269|NCT03030599|541979692|FG000|Open-label Extension|Adverse Event|3|||
150230270|NCT03030599|541979693|FG001|Open-label Extension|Adverse Event|0|||
150230271|NCT03030599|541979694|FG002|Open-label Extension|Adverse Event|0|||
150230272|NCT03030599|541979692|FG000|Open-label Extension|Lost to Follow-up|2|||
150230273|NCT03030599|541979693|FG001|Open-label Extension|Lost to Follow-up|0|||
150230274|NCT03030599|541979694|FG002|Open-label Extension|Lost to Follow-up|0|||
150230275|NCT03030599|541979692|FG000|Open-label Extension|Lack of Efficacy|1|||
150230276|NCT03030599|541979693|FG001|Open-label Extension|Lack of Efficacy|0|||
150230277|NCT03030599|541979694|FG002|Open-label Extension|Lack of Efficacy|0|||
150230278|NCT03030599|541979692|FG000|Open-label Extension|Other Reason|1|||
150230279|NCT03030599|541979693|FG001|Open-label Extension|Other Reason|0|||
150230280|NCT03030599|541979694|FG002|Open-label Extension|Other Reason|0|||
150230281|NCT03640754|541979695|FG000|Overall Study|Withdrawal by Subject|1|||
150230282|NCT03640754|541979696|FG001|Overall Study|Withdrawal by Subject|0|||
150230283|NCT03640754|541979695|FG000|Overall Study|Lost to Follow-up|0|||
150230284|NCT03640754|541979696|FG001|Overall Study|Lost to Follow-up|1|||
150230285|NCT01679613|541979699|FG000|Overall Study|other than stated above|0|||
150230286|NCT01679613|541979700|FG001|Overall Study|other than stated above|1|||
150230287|NCT01679613|541979701|FG002|Overall Study|other than stated above|2|||
150230288|NCT01679613|541979702|FG003|Overall Study|other than stated above|2|||
150230289|NCT01374971|541979703|FG000|Overall Study|Withdrawal by Subject|1|||
150230290|NCT00509925|541979704|FG000|Overall Study|Personal reasons|0|||
150230291|NCT00509925|541979705|FG001|Overall Study|Personal reasons|1|||
150230292|NCT00230971|541979707|FG000|Randomization|No study drug administered|3|||
150230293|NCT00230971|541979708|FG001|Randomization|No study drug administered|3|||
150230294|NCT00230971|541979707|FG000|Baseline Participants|Lost to Follow-up|5|||
150230295|NCT00230971|541979708|FG001|Baseline Participants|Lost to Follow-up|12|||
150230296|NCT00230971|541979707|FG000|Baseline Participants|Death|6|||
150230297|NCT00230971|541979708|FG001|Baseline Participants|Death|5|||
150230298|NCT00230971|541979707|FG000|Baseline Participants|Withdrawal by Subject|7|||
150230299|NCT00230971|541979708|FG001|Baseline Participants|Withdrawal by Subject|1|||
150230300|NCT00230971|541979707|FG000|Baseline Participants|Adverse Event|1|||
150230301|NCT00230971|541979708|FG001|Baseline Participants|Adverse Event|0|||
150230302|NCT00230971|541979707|FG000|Baseline Participants|No bacteria observed|1|||
150230303|NCT00230971|541979708|FG001|Baseline Participants|No bacteria observed|0|||
150230304|NCT00230971|541979707|FG000|Baseline Participants|Failure to return|1|||
150230305|NCT00230971|541979708|FG001|Baseline Participants|Failure to return|1|||
150230306|NCT00230971|541979707|FG000|Baseline Participants|Reintervention|1|||
150230307|NCT00230971|541979708|FG001|Baseline Participants|Reintervention|0|||
150230308|NCT01268098|541981695|FG000|Overall Study|Adverse Event|1|||
150230309|NCT01268098|541981696|FG001|Overall Study|Adverse Event|0|||
150230310|NCT01644188|541981697|FG000|Overall Study|Adverse Event|44|||
150230311|NCT01644188|541981698|FG001|Overall Study|Adverse Event|20|||
150230312|NCT01644188|541981697|FG000|Overall Study|Poor compliance to protocol|26|||
150230313|NCT01644188|541981698|FG001|Overall Study|Poor compliance to protocol|14|||
150230314|NCT01644188|541981697|FG000|Overall Study|Physician Decision|1|||
150230315|NCT01644188|541981698|FG001|Overall Study|Physician Decision|3|||
150230316|NCT01644188|541981697|FG000|Overall Study|Participant moved|7|||
150230317|NCT01644188|541981698|FG001|Overall Study|Participant moved|2|||
150230318|NCT01644188|541981697|FG000|Overall Study|Related to auto-injector administration|2|||
150230319|NCT01644188|541981698|FG001|Overall Study|Related to auto-injector administration|2|||
150230320|NCT01644188|541981697|FG000|Overall Study|Consent withdrawn by participant|14|||
150230321|NCT01644188|541981698|FG001|Overall Study|Consent withdrawn by participant|7|||
150230322|NCT01644188|541981697|FG000|Overall Study|Selection criteria finally not met|2|||
150230323|NCT01644188|541981698|FG001|Overall Study|Selection criteria finally not met|0|||
150230324|NCT01644188|541981697|FG000|Overall Study|Lost to Follow-up|1|||
150230325|NCT01644188|541981698|FG001|Overall Study|Lost to Follow-up|0|||
150230326|NCT01644188|541981697|FG000|Overall Study|Death|4|||
150230327|NCT01644188|541981698|FG001|Overall Study|Death|3|||
150230328|NCT01644188|541981697|FG000|Overall Study|Last visit outside protocol visit window|14|||
150230329|NCT01644188|541981698|FG001|Overall Study|Last visit outside protocol visit window|16|||
150230330|NCT01644188|541981697|FG000|Overall Study|Site closure|1|||
150230331|NCT01644188|541981698|FG001|Overall Study|Site closure|1|||
150230332|NCT01644188|541981697|FG000|Overall Study|Other than specified above|6|||
150230333|NCT01644188|541981698|FG001|Overall Study|Other than specified above|7|||
150230334|NCT01929876|541981699|FG000|Period 2|Non-Compliance|1|||
150230335|NCT01947517|541981700|FG000|Overall Study|Withdrawal by Subject|1|||
150230336|NCT01947517|541981701|FG001|Overall Study|Withdrawal by Subject|1|||
150230337|NCT05446714|541981702|FG000|Overall Study|Lost to Follow-up|1|||
150230338|NCT05446714|541981703|FG001|Overall Study|Lost to Follow-up|3|||
150230339|NCT05446714|541981704|FG002|Overall Study|Lost to Follow-up|2|||
150230340|NCT05446714|541981702|FG000|Overall Study|Protocol Violation|2|||
150230341|NCT05446714|541981703|FG001|Overall Study|Protocol Violation|0|||
150230342|NCT05446714|541981704|FG002|Overall Study|Protocol Violation|0|||
150230343|NCT02544113|541981712|FG000|Overall Study|Death|3|||
150230344|NCT02544113|541981713|FG001|Overall Study|Death|4|||
150230345|NCT02847637|541981715|FG000|Overall Study|Withdrawal by Subject|0|||
150230346|NCT02847637|541981716|FG001|Overall Study|Withdrawal by Subject|1|||
150230347|NCT02847637|541981717|FG002|Overall Study|Withdrawal by Subject|1|||
150230348|NCT02847637|541981718|FG003|Overall Study|Withdrawal by Subject|0|||
150230349|NCT02847637|541981715|FG000|Overall Study|Lost to Follow-up|1|||
150230350|NCT02847637|541981716|FG001|Overall Study|Lost to Follow-up|1|||
150230351|NCT02847637|541981717|FG002|Overall Study|Lost to Follow-up|0|||
150230352|NCT02847637|541981718|FG003|Overall Study|Lost to Follow-up|0|||
150230353|NCT01746108|541981719|FG000|Overall Study|Migrated /moved from study area|0|||
150230354|NCT01746108|541981720|FG001|Overall Study|Migrated /moved from study area|1|||
150230355|NCT01746108|541981721|FG002|Overall Study|Migrated /moved from study area|0|||
150230356|NCT01746108|541981719|FG000|Overall Study|Adverse event, non-fatal|0|||
150230357|NCT01746108|541981720|FG001|Overall Study|Adverse event, non-fatal|1|||
150230358|NCT01746108|541981721|FG002|Overall Study|Adverse event, non-fatal|0|||
150230359|NCT01746108|541981719|FG000|Overall Study|Withdrawal by Subject|0|||
150230360|NCT01746108|541981720|FG001|Overall Study|Withdrawal by Subject|1|||
150230361|NCT01746108|541981721|FG002|Overall Study|Withdrawal by Subject|0|||
150230362|NCT01746108|541981719|FG000|Overall Study|Lost to Follow-up|0|||
150230363|NCT01746108|541981720|FG001|Overall Study|Lost to Follow-up|1|||
150230364|NCT01746108|541981721|FG002|Overall Study|Lost to Follow-up|0|||
150230365|NCT01004185|541981722|FG000|Overall Study|Adverse Event|1|||
150230366|NCT01004185|541981723|FG001|Overall Study|Adverse Event|1|||
150230367|NCT01004185|541981722|FG000|Overall Study|Lost to Follow-up|0|||
150230368|NCT01004185|541981723|FG001|Overall Study|Lost to Follow-up|1|||
150230369|NCT01004185|541981722|FG000|Overall Study|Lack of Efficacy|2|||
150230370|NCT01004185|541981723|FG001|Overall Study|Lack of Efficacy|1|||
150230371|NCT01004185|541981722|FG000|Overall Study|Sponsor Terminated Study|4|||
150230372|NCT01004185|541981723|FG001|Overall Study|Sponsor Terminated Study|5|||
150230373|NCT01004185|541981722|FG000|Overall Study|Withdrawal by Subject|2|||
150230374|NCT01004185|541981723|FG001|Overall Study|Withdrawal by Subject|1|||
150230375|NCT03214250|541981724|FG000|Overall Study|Death|5|||
150230376|NCT03214250|541981725|FG001|Overall Study|Death|5|||
150230377|NCT03214250|541981726|FG002|Overall Study|Death|7|||
150230378|NCT03214250|541981727|FG003|Overall Study|Death|4|||
150230379|NCT03214250|541981728|FG004|Overall Study|Death|23|||
150230380|NCT03214250|541981729|FG005|Overall Study|Death|23|||
150230381|NCT03214250|541981730|FG006|Overall Study|Death|24|||
150230382|NCT03214250|541981724|FG000|Overall Study|Lost to Follow-up|0|||
150230383|NCT03214250|541981725|FG001|Overall Study|Lost to Follow-up|0|||
150230384|NCT03214250|541981726|FG002|Overall Study|Lost to Follow-up|0|||
150230385|NCT03214250|541981727|FG003|Overall Study|Lost to Follow-up|1|||
150230386|NCT03214250|541981728|FG004|Overall Study|Lost to Follow-up|1|||
150230387|NCT03214250|541981729|FG005|Overall Study|Lost to Follow-up|2|||
150230388|NCT03214250|541981730|FG006|Overall Study|Lost to Follow-up|0|||
150230389|NCT03214250|541981724|FG000|Overall Study|Other|0|||
150230390|NCT03214250|541981725|FG001|Overall Study|Other|0|||
150230391|NCT03214250|541981726|FG002|Overall Study|Other|0|||
150230392|NCT03214250|541981727|FG003|Overall Study|Other|0|||
150230393|NCT03214250|541981728|FG004|Overall Study|Other|1|||
150230394|NCT03214250|541981729|FG005|Overall Study|Other|1|||
150230395|NCT03214250|541981730|FG006|Overall Study|Other|2|||
150230396|NCT03214250|541981724|FG000|Overall Study|Remains on Study|2|||
150230397|NCT03214250|541981725|FG001|Overall Study|Remains on Study|2|||
150230398|NCT03214250|541981726|FG002|Overall Study|Remains on Study|0|||
150230399|NCT03214250|541981727|FG003|Overall Study|Remains on Study|1|||
150230400|NCT03214250|541981728|FG004|Overall Study|Remains on Study|7|||
150230401|NCT03214250|541981729|FG005|Overall Study|Remains on Study|5|||
150230402|NCT03214250|541981730|FG006|Overall Study|Remains on Study|3|||
150230403|NCT03214250|541981724|FG000|Overall Study|Withdrawal by Subject|0|||
150230404|NCT03214250|541981725|FG001|Overall Study|Withdrawal by Subject|0|||
150230405|NCT03214250|541981726|FG002|Overall Study|Withdrawal by Subject|1|||
150230406|NCT03214250|541981727|FG003|Overall Study|Withdrawal by Subject|2|||
150230407|NCT03214250|541981728|FG004|Overall Study|Withdrawal by Subject|5|||
150230408|NCT03214250|541981729|FG005|Overall Study|Withdrawal by Subject|0|||
150230409|NCT03214250|541981730|FG006|Overall Study|Withdrawal by Subject|2|||
150230410|NCT00797511|541981731|FG000|Overall Study|Withdrawal by Subject|1|||
150230411|NCT00053352|541981735|FG000|Overall Study|Lost to Follow-up|0|||
150230412|NCT00053352|541981736|FG001|Overall Study|Lost to Follow-up|1|||
150230413|NCT00053352|541981735|FG000|Overall Study|Physician Decision|11|||
150230414|NCT00053352|541981736|FG001|Overall Study|Physician Decision|1|||
150230415|NCT00053352|541981735|FG000|Overall Study|Withdrawal by Subject|1|||
150230416|NCT00053352|541981736|FG001|Overall Study|Withdrawal by Subject|0|||
150230417|NCT00053352|541981735|FG000|Overall Study|Ineligible|8|||
150230418|NCT00053352|541981736|FG001|Overall Study|Ineligible|8|||
150230419|NCT00053352|541981735|FG000|Overall Study|Disease at new site|1|||
150230420|NCT00053352|541981736|FG001|Overall Study|Disease at new site|0|||
150230421|NCT02741713|541981739|FG000|Overall Study|Surgery type changed intra-operatively|2|||
150230422|NCT02741713|541981740|FG001|Overall Study|Surgery type changed intra-operatively|1|||
150230423|NCT01388478|541981741|FG000|Overall Study|Adverse Event|4|||
150230424|NCT01388478|541981741|FG000|Overall Study|Withdrawal by Subject|1|||
150230425|NCT01037413|541981744|FG000|Part A: Skin Testing|Adverse Event|1|||
150230426|NCT01037413|541981745|FG001|Part A: Skin Testing|Adverse Event|0|||
150230427|NCT01037413|541981744|FG000|Part A: Skin Testing|Protocol Violation|1|||
150230428|NCT01037413|541981745|FG001|Part A: Skin Testing|Protocol Violation|0|||
150230429|NCT01037413|541981744|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
150230430|NCT01037413|541981745|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
150230431|NCT01037413|541981744|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
150230432|NCT01037413|541981745|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
150230433|NCT00619983|541981749|FG000|Test Drug Alone|Withdrawal by Subject|1|||
150230434|NCT00619983|541981750|FG001|Test Drug Alone|Withdrawal by Subject|0|||
150230435|NCT00619983|541981751|FG002|Test Drug Alone|Withdrawal by Subject|0|||
150230436|NCT00619983|541981752|FG003|Test Drug Alone|Withdrawal by Subject|1|||
150230437|NCT00619983|541981749|FG000|Test Drug Alone|Failure of daily diary device|1|||
150230438|NCT00619983|541981750|FG001|Test Drug Alone|Failure of daily diary device|1|||
150230439|NCT00619983|541981751|FG002|Test Drug Alone|Failure of daily diary device|2|||
150230440|NCT00619983|541981752|FG003|Test Drug Alone|Failure of daily diary device|2|||
150230441|NCT00931918|541981753|FG000|Overall Study|Adverse Event|4|||
150230442|NCT00931918|541981754|FG001|Overall Study|Adverse Event|6|||
150230443|NCT00931918|541981753|FG000|Overall Study|Progressive Disease|2|||
150230444|NCT00931918|541981754|FG001|Overall Study|Progressive Disease|1|||
150230445|NCT00931918|541981753|FG000|Overall Study|Symptomatic Deterioration|1|||
150230446|NCT00931918|541981754|FG001|Overall Study|Symptomatic Deterioration|0|||
150230447|NCT00931918|541981753|FG000|Overall Study|Withdrawal by Patient|3|||
150230448|NCT00931918|541981754|FG001|Overall Study|Withdrawal by Patient|4|||
150230449|NCT00931918|541981753|FG000|Overall Study|Other Reason not Specified|4|||
150230450|NCT00931918|541981754|FG001|Overall Study|Other Reason not Specified|4|||
150230451|NCT00931918|541981753|FG000|Overall Study|Did not receive study drug|3|||
150230452|NCT00931918|541981754|FG001|Overall Study|Did not receive study drug|2|||
150230453|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
150230454|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
150230455|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
150230456|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
150230457|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
150230458|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
150230459|NCT03201900|541981757|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
150230460|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
150230461|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
150230462|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
150230463|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
150230464|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
150230465|NCT03201900|541981757|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
150230466|NCT02971228|541981758|FG000|Overall Study|Withdrawal by Subject|1|||
150230467|NCT02971228|541981759|FG001|Overall Study|Withdrawal by Subject|1|||
150230468|NCT02971228|541981760|FG002|Overall Study|Withdrawal by Subject|0|||
150230469|NCT02971228|541981761|FG003|Overall Study|Withdrawal by Subject|0|||
150230470|NCT02971228|541981762|FG004|Overall Study|Withdrawal by Subject|0|||
150230471|NCT02971228|541981758|FG000|Overall Study|Logistical challenges|0|||
150230472|NCT02971228|541981759|FG001|Overall Study|Logistical challenges|1|||
150230473|NCT02971228|541981760|FG002|Overall Study|Logistical challenges|0|||
150230474|NCT02971228|541981761|FG003|Overall Study|Logistical challenges|0|||
150230475|NCT02971228|541981762|FG004|Overall Study|Logistical challenges|0|||
150230476|NCT02560389|541981765|FG000|Overall Study|Lost to Follow-up|1|||
150230477|NCT02560389|541981766|FG001|Overall Study|Lost to Follow-up|2|||
150230478|NCT02560389|541981767|FG002|Overall Study|Lost to Follow-up|2|||
150230479|NCT02560389|541981765|FG000|Overall Study|Tested positive for illicit substance|0|||
150230480|NCT02560389|541981766|FG001|Overall Study|Tested positive for illicit substance|1|||
150230481|NCT02560389|541981767|FG002|Overall Study|Tested positive for illicit substance|0|||
150230482|NCT02716298|541981768|FG000|First Intervention (1 Month)|Lens discomfort|1|||
150230483|NCT02716298|541981769|FG001|First Intervention (1 Month)|Lens discomfort|1|||
150230484|NCT00550446|541981770|FG000|Up To Week 12|Adverse Event|2|||
150230485|NCT00550446|541981771|FG001|Up To Week 12|Adverse Event|2|||
150230486|NCT00550446|541981772|FG002|Up To Week 12|Adverse Event|0|||
150230487|NCT00550446|541981773|FG003|Up To Week 12|Adverse Event|0|||
150230488|NCT00550446|541981774|FG004|Up To Week 12|Adverse Event|2|||
150230489|NCT00550446|541981775|FG005|Up To Week 12|Adverse Event|2|||
150230490|NCT00550446|541981776|FG006|Up To Week 12|Adverse Event|1|||
150230491|NCT00550446|541981777|FG007|Up To Week 12|Adverse Event|0|||
150230492|NCT00550446|541981778|FG008|Up To Week 12|Adverse Event|0|||
150230493|NCT00550446|541981779|FG009|Up To Week 12|Adverse Event|0|||
150230494|NCT00550446|541981780|FG010|Up To Week 12|Adverse Event|0|||
150230495|NCT00550446|541981770|FG000|Up To Week 12|Lack of Efficacy|3|||
150230496|NCT00550446|541981771|FG001|Up To Week 12|Lack of Efficacy|1|||
150230497|NCT00550446|541981772|FG002|Up To Week 12|Lack of Efficacy|0|||
150230498|NCT00550446|541981773|FG003|Up To Week 12|Lack of Efficacy|1|||
150230499|NCT00550446|541981774|FG004|Up To Week 12|Lack of Efficacy|0|||
150230500|NCT00550446|541981775|FG005|Up To Week 12|Lack of Efficacy|3|||
150230501|NCT00550446|541981776|FG006|Up To Week 12|Lack of Efficacy|3|||
150230502|NCT00550446|541981777|FG007|Up To Week 12|Lack of Efficacy|0|||
150230503|NCT00550446|541981778|FG008|Up To Week 12|Lack of Efficacy|0|||
150141903|NCT00279201|541654112|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
150141904|NCT00279201|541654113|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
150141905|NCT00279201|541654114|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
150141906|NCT00279201|541654115|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
150141907|NCT00279201|541654116|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
150141908|NCT00279201|541654117|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
150141909|NCT00279201|541654112|FG000|Maintenance|Adverse Event|4|||
150141910|NCT00279201|541654113|FG001|Maintenance|Adverse Event|4|||
150141911|NCT00279201|541654114|FG002|Maintenance|Adverse Event|0|||
150141912|NCT00279201|541654115|FG003|Maintenance|Adverse Event|0|||
150141913|NCT00279201|541654116|FG004|Maintenance|Adverse Event|0|||
150141914|NCT00279201|541654117|FG005|Maintenance|Adverse Event|0|||
150141915|NCT00279201|541654112|FG000|Maintenance|Death|4|||
150141916|NCT00279201|541654113|FG001|Maintenance|Death|4|||
150141917|NCT00279201|541654114|FG002|Maintenance|Death|0|||
150141918|NCT00279201|541654115|FG003|Maintenance|Death|0|||
150141919|NCT00279201|541654116|FG004|Maintenance|Death|0|||
150141920|NCT00279201|541654117|FG005|Maintenance|Death|0|||
150141921|NCT00279201|541654112|FG000|Maintenance|Lost to Follow-up|17|||
150141922|NCT00279201|541654113|FG001|Maintenance|Lost to Follow-up|13|||
150141923|NCT00279201|541654114|FG002|Maintenance|Lost to Follow-up|0|||
150141924|NCT00279201|541654115|FG003|Maintenance|Lost to Follow-up|0|||
150141925|NCT00279201|541654116|FG004|Maintenance|Lost to Follow-up|0|||
150141926|NCT00279201|541654117|FG005|Maintenance|Lost to Follow-up|0|||
150141927|NCT00279201|541654112|FG000|Maintenance|Entry Criteria Exclusion|1|||
150141928|NCT00279201|541654113|FG001|Maintenance|Entry Criteria Exclusion|4|||
150141929|NCT00279201|541654114|FG002|Maintenance|Entry Criteria Exclusion|0|||
150141930|NCT00279201|541654115|FG003|Maintenance|Entry Criteria Exclusion|0|||
150230504|NCT00550446|541981779|FG009|Up To Week 12|Lack of Efficacy|0|||
150141931|NCT00279201|541654116|FG004|Maintenance|Entry Criteria Exclusion|0|||
150141932|NCT00279201|541654117|FG005|Maintenance|Entry Criteria Exclusion|0|||
150141933|NCT00279201|541654112|FG000|Maintenance|Protocol Violation|16|||
150141934|NCT00279201|541654113|FG001|Maintenance|Protocol Violation|24|||
150141935|NCT00279201|541654114|FG002|Maintenance|Protocol Violation|0|||
150141936|NCT00279201|541654115|FG003|Maintenance|Protocol Violation|0|||
150141937|NCT00279201|541654116|FG004|Maintenance|Protocol Violation|0|||
150141938|NCT00279201|541654117|FG005|Maintenance|Protocol Violation|0|||
150230505|NCT00550446|541981780|FG010|Up To Week 12|Lack of Efficacy|0|||
150230506|NCT00550446|541981770|FG000|Up To Week 12|Lost to Follow-up|0|||
150230507|NCT00550446|541981771|FG001|Up To Week 12|Lost to Follow-up|1|||
150230508|NCT00550446|541981772|FG002|Up To Week 12|Lost to Follow-up|0|||
150230509|NCT00550446|541981773|FG003|Up To Week 12|Lost to Follow-up|0|||
150230510|NCT00550446|541981774|FG004|Up To Week 12|Lost to Follow-up|1|||
150230511|NCT00550446|541981775|FG005|Up To Week 12|Lost to Follow-up|1|||
150230512|NCT00550446|541981776|FG006|Up To Week 12|Lost to Follow-up|2|||
150230513|NCT00550446|541981777|FG007|Up To Week 12|Lost to Follow-up|0|||
150230514|NCT00550446|541981778|FG008|Up To Week 12|Lost to Follow-up|0|||
150230515|NCT00550446|541981779|FG009|Up To Week 12|Lost to Follow-up|0|||
150230516|NCT00550446|541981780|FG010|Up To Week 12|Lost to Follow-up|0|||
150230517|NCT00550446|541981770|FG000|Up To Week 12|Withdrawal by Subject|2|||
150230518|NCT00550446|541981771|FG001|Up To Week 12|Withdrawal by Subject|0|||
150230519|NCT00550446|541981772|FG002|Up To Week 12|Withdrawal by Subject|3|||
150230520|NCT00550446|541981773|FG003|Up To Week 12|Withdrawal by Subject|2|||
150230521|NCT00550446|541981774|FG004|Up To Week 12|Withdrawal by Subject|0|||
150230522|NCT00550446|541981775|FG005|Up To Week 12|Withdrawal by Subject|1|||
150230523|NCT00550446|541981776|FG006|Up To Week 12|Withdrawal by Subject|3|||
150230524|NCT00550446|541981777|FG007|Up To Week 12|Withdrawal by Subject|0|||
150230525|NCT00550446|541981778|FG008|Up To Week 12|Withdrawal by Subject|0|||
150230526|NCT00550446|541981779|FG009|Up To Week 12|Withdrawal by Subject|0|||
150230527|NCT00550446|541981780|FG010|Up To Week 12|Withdrawal by Subject|0|||
150230528|NCT00550446|541981770|FG000|Up To Week 12|Other|3|||
150230529|NCT00550446|541981771|FG001|Up To Week 12|Other|0|||
150230530|NCT00550446|541981772|FG002|Up To Week 12|Other|0|||
150230531|NCT00550446|541981773|FG003|Up To Week 12|Other|0|||
150230532|NCT00550446|541981774|FG004|Up To Week 12|Other|0|||
150230533|NCT00550446|541981775|FG005|Up To Week 12|Other|1|||
150230534|NCT00550446|541981776|FG006|Up To Week 12|Other|4|||
150230535|NCT00550446|541981777|FG007|Up To Week 12|Other|0|||
150230536|NCT00550446|541981778|FG008|Up To Week 12|Other|0|||
150230537|NCT00550446|541981779|FG009|Up To Week 12|Other|0|||
150230538|NCT00550446|541981780|FG010|Up To Week 12|Other|0|||
150230539|NCT00550446|541981770|FG000|Up To Week 12|Randomized not treated|0|||
150230540|NCT00550446|541981771|FG001|Up To Week 12|Randomized not treated|1|||
150230541|NCT00550446|541981772|FG002|Up To Week 12|Randomized not treated|1|||
150230542|NCT00550446|541981773|FG003|Up To Week 12|Randomized not treated|0|||
150230543|NCT00550446|541981774|FG004|Up To Week 12|Randomized not treated|0|||
150230544|NCT00550446|541981775|FG005|Up To Week 12|Randomized not treated|0|||
150230545|NCT00550446|541981776|FG006|Up To Week 12|Randomized not treated|0|||
150230546|NCT00550446|541981777|FG007|Up To Week 12|Randomized not treated|0|||
150230547|NCT00550446|541981778|FG008|Up To Week 12|Randomized not treated|0|||
150230548|NCT00550446|541981779|FG009|Up To Week 12|Randomized not treated|0|||
150230549|NCT00550446|541981780|FG010|Up To Week 12|Randomized not treated|0|||
150230550|NCT00550446|541981770|FG000|Post Week 12|Adverse Event|2|||
150230551|NCT00550446|541981771|FG001|Post Week 12|Adverse Event|1|||
150230552|NCT00550446|541981772|FG002|Post Week 12|Adverse Event|1|||
150230553|NCT00550446|541981773|FG003|Post Week 12|Adverse Event|1|||
150230554|NCT00550446|541981774|FG004|Post Week 12|Adverse Event|1|||
150230555|NCT00550446|541981775|FG005|Post Week 12|Adverse Event|1|||
150230556|NCT00550446|541981776|FG006|Post Week 12|Adverse Event|0|||
150230557|NCT00550446|541981777|FG007|Post Week 12|Adverse Event|0|||
150230558|NCT00550446|541981778|FG008|Post Week 12|Adverse Event|0|||
150230559|NCT00550446|541981779|FG009|Post Week 12|Adverse Event|4|||
150230560|NCT00550446|541981780|FG010|Post Week 12|Adverse Event|0|||
150230561|NCT00550446|541981770|FG000|Post Week 12|Lack of Efficacy|0|||
150230562|NCT00550446|541981771|FG001|Post Week 12|Lack of Efficacy|0|||
150230563|NCT00550446|541981772|FG002|Post Week 12|Lack of Efficacy|1|||
150230564|NCT00550446|541981773|FG003|Post Week 12|Lack of Efficacy|0|||
150230565|NCT00550446|541981774|FG004|Post Week 12|Lack of Efficacy|0|||
150230566|NCT00550446|541981775|FG005|Post Week 12|Lack of Efficacy|0|||
150230567|NCT00550446|541981776|FG006|Post Week 12|Lack of Efficacy|0|||
150230568|NCT00550446|541981777|FG007|Post Week 12|Lack of Efficacy|1|||
150230569|NCT00550446|541981778|FG008|Post Week 12|Lack of Efficacy|1|||
150230570|NCT00550446|541981779|FG009|Post Week 12|Lack of Efficacy|2|||
150230571|NCT00550446|541981780|FG010|Post Week 12|Lack of Efficacy|1|||
150230572|NCT00550446|541981770|FG000|Post Week 12|Lost to Follow-up|0|||
150230573|NCT00550446|541981771|FG001|Post Week 12|Lost to Follow-up|0|||
150230574|NCT00550446|541981772|FG002|Post Week 12|Lost to Follow-up|1|||
150230575|NCT00550446|541981773|FG003|Post Week 12|Lost to Follow-up|1|||
150230576|NCT00550446|541981774|FG004|Post Week 12|Lost to Follow-up|0|||
150230577|NCT00550446|541981775|FG005|Post Week 12|Lost to Follow-up|0|||
150230578|NCT00550446|541981776|FG006|Post Week 12|Lost to Follow-up|1|||
150230579|NCT00550446|541981777|FG007|Post Week 12|Lost to Follow-up|0|||
150230580|NCT00550446|541981778|FG008|Post Week 12|Lost to Follow-up|0|||
150230581|NCT00550446|541981779|FG009|Post Week 12|Lost to Follow-up|0|||
150230582|NCT00550446|541981780|FG010|Post Week 12|Lost to Follow-up|0|||
150141939|NCT00279201|541654112|FG000|Maintenance|Withdrawal by Subject|18|||
150141940|NCT00279201|541654113|FG001|Maintenance|Withdrawal by Subject|18|||
150141941|NCT00279201|541654114|FG002|Maintenance|Withdrawal by Subject|0|||
150141942|NCT00279201|541654115|FG003|Maintenance|Withdrawal by Subject|0|||
150141943|NCT00279201|541654116|FG004|Maintenance|Withdrawal by Subject|0|||
150141944|NCT00279201|541654117|FG005|Maintenance|Withdrawal by Subject|0|||
150141945|NCT00279201|541654112|FG000|Maintenance|Physician Decision|9|||
150141946|NCT00279201|541654113|FG001|Maintenance|Physician Decision|9|||
150141947|NCT00279201|541654114|FG002|Maintenance|Physician Decision|0|||
150141948|NCT00279201|541654115|FG003|Maintenance|Physician Decision|0|||
150141949|NCT00279201|541654116|FG004|Maintenance|Physician Decision|0|||
150141950|NCT00279201|541654117|FG005|Maintenance|Physician Decision|0|||
150141951|NCT00279201|541654112|FG000|Maintenance|Sponsor Decision|4|||
150141952|NCT00279201|541654113|FG001|Maintenance|Sponsor Decision|0|||
150141953|NCT00279201|541654114|FG002|Maintenance|Sponsor Decision|0|||
150141954|NCT00279201|541654115|FG003|Maintenance|Sponsor Decision|0|||
150141955|NCT00279201|541654116|FG004|Maintenance|Sponsor Decision|0|||
150141956|NCT00279201|541654117|FG005|Maintenance|Sponsor Decision|0|||
150141957|NCT00279201|541654112|FG000|Maintenance|HbA1c>7.5%|123|||
150141958|NCT00279201|541654113|FG001|Maintenance|HbA1c>7.5%|126|||
150141959|NCT00279201|541654114|FG002|Maintenance|HbA1c>7.5%|0|||
150141960|NCT00279201|541654115|FG003|Maintenance|HbA1c>7.5%|0|||
150141961|NCT00279201|541654116|FG004|Maintenance|HbA1c>7.5%|0|||
150141962|NCT00279201|541654117|FG005|Maintenance|HbA1c>7.5%|0|||
150141963|NCT00279201|541654112|FG000|Intensification Addendum|Withdrawal by Subject|0|||
150141964|NCT00279201|541654113|FG001|Intensification Addendum|Withdrawal by Subject|0|||
150141965|NCT00279201|541654114|FG002|Intensification Addendum|Withdrawal by Subject|12|||
150141966|NCT00279201|541654115|FG003|Intensification Addendum|Withdrawal by Subject|14|||
150141967|NCT00279201|541654116|FG004|Intensification Addendum|Withdrawal by Subject|9|||
150141968|NCT00279201|541654117|FG005|Intensification Addendum|Withdrawal by Subject|18|||
150141969|NCT00279201|541654112|FG000|Intensification Addendum|Lost to Follow-up|0|||
150141970|NCT00279201|541654113|FG001|Intensification Addendum|Lost to Follow-up|0|||
150141971|NCT00279201|541654114|FG002|Intensification Addendum|Lost to Follow-up|4|||
150141972|NCT00279201|541654115|FG003|Intensification Addendum|Lost to Follow-up|6|||
150141973|NCT00279201|541654116|FG004|Intensification Addendum|Lost to Follow-up|7|||
150141974|NCT00279201|541654117|FG005|Intensification Addendum|Lost to Follow-up|7|||
150141975|NCT00279201|541654112|FG000|Intensification Addendum|Protocol Violation|0|||
150141976|NCT00279201|541654113|FG001|Intensification Addendum|Protocol Violation|0|||
150141977|NCT00279201|541654114|FG002|Intensification Addendum|Protocol Violation|2|||
150141978|NCT00279201|541654115|FG003|Intensification Addendum|Protocol Violation|2|||
150141979|NCT00279201|541654116|FG004|Intensification Addendum|Protocol Violation|6|||
150141980|NCT00279201|541654117|FG005|Intensification Addendum|Protocol Violation|6|||
150141981|NCT00279201|541654112|FG000|Intensification Addendum|Adverse Event|0|||
150141982|NCT00279201|541654113|FG001|Intensification Addendum|Adverse Event|0|||
150141983|NCT00279201|541654114|FG002|Intensification Addendum|Adverse Event|0|||
150141984|NCT00279201|541654115|FG003|Intensification Addendum|Adverse Event|4|||
150141985|NCT00279201|541654116|FG004|Intensification Addendum|Adverse Event|1|||
150141986|NCT00279201|541654117|FG005|Intensification Addendum|Adverse Event|3|||
150141987|NCT00279201|541654112|FG000|Intensification Addendum|Physician Decision|0|||
150141988|NCT00279201|541654113|FG001|Intensification Addendum|Physician Decision|0|||
150141989|NCT00279201|541654114|FG002|Intensification Addendum|Physician Decision|4|||
150141990|NCT00279201|541654115|FG003|Intensification Addendum|Physician Decision|1|||
150141991|NCT00279201|541654116|FG004|Intensification Addendum|Physician Decision|3|||
150141992|NCT00279201|541654117|FG005|Intensification Addendum|Physician Decision|2|||
150141993|NCT00279201|541654112|FG000|Intensification Addendum|Sponsor Decision|0|||
150141994|NCT00279201|541654113|FG001|Intensification Addendum|Sponsor Decision|0|||
150141995|NCT00279201|541654114|FG002|Intensification Addendum|Sponsor Decision|0|||
150141996|NCT00279201|541654115|FG003|Intensification Addendum|Sponsor Decision|0|||
150141997|NCT00279201|541654116|FG004|Intensification Addendum|Sponsor Decision|1|||
150141998|NCT00279201|541654117|FG005|Intensification Addendum|Sponsor Decision|1|||
150141999|NCT00279201|541654112|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
150142000|NCT00279201|541654113|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
150142001|NCT00279201|541654114|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
150142002|NCT00279201|541654115|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
150142003|NCT00279201|541654116|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
150142004|NCT00279201|541654117|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
150142005|NCT00279201|541654112|FG000|Intensification Addendum|Lack of Efficacy|0|||
150142006|NCT00279201|541654113|FG001|Intensification Addendum|Lack of Efficacy|0|||
150142007|NCT00279201|541654114|FG002|Intensification Addendum|Lack of Efficacy|0|||
150230583|NCT00550446|541981770|FG000|Post Week 12|Withdrawal by Subject|0|||
150230584|NCT00550446|541981771|FG001|Post Week 12|Withdrawal by Subject|0|||
150230585|NCT00550446|541981772|FG002|Post Week 12|Withdrawal by Subject|0|||
150230586|NCT00550446|541981773|FG003|Post Week 12|Withdrawal by Subject|0|||
150230587|NCT00550446|541981774|FG004|Post Week 12|Withdrawal by Subject|1|||
150230588|NCT00550446|541981775|FG005|Post Week 12|Withdrawal by Subject|0|||
150230589|NCT00550446|541981776|FG006|Post Week 12|Withdrawal by Subject|0|||
150230590|NCT00550446|541981777|FG007|Post Week 12|Withdrawal by Subject|0|||
150230591|NCT00550446|541981778|FG008|Post Week 12|Withdrawal by Subject|0|||
150230592|NCT00550446|541981779|FG009|Post Week 12|Withdrawal by Subject|0|||
150230593|NCT00550446|541981780|FG010|Post Week 12|Withdrawal by Subject|0|||
150230594|NCT00550446|541981770|FG000|Post Week 12|Other|1|||
150230595|NCT00550446|541981771|FG001|Post Week 12|Other|1|||
150230596|NCT00550446|541981772|FG002|Post Week 12|Other|0|||
150230597|NCT00550446|541981773|FG003|Post Week 12|Other|1|||
150230598|NCT00550446|541981774|FG004|Post Week 12|Other|0|||
150230599|NCT00550446|541981775|FG005|Post Week 12|Other|0|||
150230600|NCT00550446|541981776|FG006|Post Week 12|Other|1|||
150230601|NCT00550446|541981777|FG007|Post Week 12|Other|0|||
150230602|NCT00550446|541981778|FG008|Post Week 12|Other|1|||
150230603|NCT00550446|541981779|FG009|Post Week 12|Other|1|||
150230604|NCT00550446|541981780|FG010|Post Week 12|Other|0|||
150230605|NCT00129649|541981783|FG000|Overall Study|Withdrawal by Subject|76|||
150230606|NCT00129649|541981784|FG001|Overall Study|Withdrawal by Subject|65|||
150230607|NCT02482935|541981785|FG000|Period 1|Withdrawal by Subject|1|||
150230608|NCT02482935|541981786|FG001|Period 1|Withdrawal by Subject|0|||
150230609|NCT04952701|541981787|FG000|Control Lens|Physician Decision|4|||
150230610|NCT04952701|541981787|FG000|Test Lens|Physician Decision|1|||
150230611|NCT04081389|541981788|FG000|Overall Study|Withdrawal by Subject|0|||
150230612|NCT04081389|541981789|FG001|Overall Study|Withdrawal by Subject|0|||
150230613|NCT04081389|541981790|FG002|Overall Study|Withdrawal by Subject|1|||
150230614|NCT04081389|541981791|FG003|Overall Study|Withdrawal by Subject|0|||
150230615|NCT00827775|541981797|FG000|Overall Study|Withdrawal by Subject|0|||
150230616|NCT00827775|541981798|FG001|Overall Study|Withdrawal by Subject|5|||
150230617|NCT00866918|541981801|FG000|Overall Study|Death|1|||
150230618|NCT00866918|541981802|FG001|Overall Study|Death|5|||
150230619|NCT00866918|541981801|FG000|Overall Study|Lack of Efficacy|1|||
150230620|NCT00866918|541981802|FG001|Overall Study|Lack of Efficacy|1|||
150230621|NCT00866918|541981801|FG000|Overall Study|Physician Decision|10|||
150230622|NCT00866918|541981802|FG001|Overall Study|Physician Decision|2|||
150230623|NCT00866918|541981801|FG000|Overall Study|Ineligible|2|||
150230624|NCT00866918|541981802|FG001|Overall Study|Ineligible|4|||
150230625|NCT00866918|541981801|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
150230626|NCT00866918|541981802|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
150230627|NCT00866918|541981801|FG000|Overall Study|Secondary malignancy|1|||
150230628|NCT00866918|541981802|FG001|Overall Study|Secondary malignancy|0|||
150230629|NCT00527514|541981804|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
150230630|NCT00527514|541981804|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
150230631|NCT00527514|541981804|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
150230632|NCT00527514|541981804|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
150230633|NCT00527514|541981804|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
150230634|NCT00527514|541981804|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
150230635|NCT00527514|541981804|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
150230636|NCT00001941|541981805|FG000|Overall Study|not treated- rapidly progressing disease|0|||
150230637|NCT00001941|541981806|FG001|Overall Study|not treated- rapidly progressing disease|0|||
150230638|NCT00001941|541981807|FG002|Overall Study|not treated- rapidly progressing disease|0|||
150230639|NCT00001941|541981808|FG003|Overall Study|not treated- rapidly progressing disease|0|||
150230640|NCT00001941|541981809|FG004|Overall Study|not treated- rapidly progressing disease|1|||
150230641|NCT00802438|541981820|FG000|Overall Study|Screen Failure|20|||
150230642|NCT00802438|541981820|FG000|Overall Study|Withdrawal by Subject|7|||
150230643|NCT00802438|541981820|FG000|Overall Study|Physician Decision|1|||
150230644|NCT01281917|541981821|FG000|Overall Study|Withdrawal by Subject|1|||
150230645|NCT02101268|541981825|FG000|Randomized Treatment Phase|Subject Decision|8|||
150230646|NCT02101268|541981826|FG001|Randomized Treatment Phase|Subject Decision|4|||
150230647|NCT02101268|541981827|FG002|Randomized Treatment Phase|Subject Decision|0|||
150230648|NCT02101268|541981828|FG003|Randomized Treatment Phase|Subject Decision|0|||
150230649|NCT02101268|541981825|FG000|Randomized Treatment Phase|Physician Decision|4|||
150230650|NCT02101268|541981826|FG001|Randomized Treatment Phase|Physician Decision|1|||
150230651|NCT02101268|541981827|FG002|Randomized Treatment Phase|Physician Decision|0|||
150230652|NCT02101268|541981828|FG003|Randomized Treatment Phase|Physician Decision|0|||
150230653|NCT02101268|541981825|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
150230654|NCT02101268|541981826|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
150230655|NCT02101268|541981827|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
150230656|NCT02101268|541981828|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
150230657|NCT02101268|541981825|FG000|Randomized Treatment Phase|Adverse Event|6|||
150230658|NCT02101268|541981826|FG001|Randomized Treatment Phase|Adverse Event|0|||
150230659|NCT02101268|541981827|FG002|Randomized Treatment Phase|Adverse Event|0|||
150230660|NCT02101268|541981828|FG003|Randomized Treatment Phase|Adverse Event|0|||
150230661|NCT02101268|541981825|FG000|Randomized Treatment Phase|Death|5|||
150230662|NCT02101268|541981826|FG001|Randomized Treatment Phase|Death|4|||
150230663|NCT02101268|541981827|FG002|Randomized Treatment Phase|Death|0|||
150230664|NCT02101268|541981828|FG003|Randomized Treatment Phase|Death|0|||
150230665|NCT02101268|541981825|FG000|Randomized Treatment Phase|Disease Progression|4|||
150230666|NCT02101268|541981826|FG001|Randomized Treatment Phase|Disease Progression|1|||
150230667|NCT02101268|541981827|FG002|Randomized Treatment Phase|Disease Progression|0|||
150230668|NCT02101268|541981828|FG003|Randomized Treatment Phase|Disease Progression|0|||
150230669|NCT02101268|541981825|FG000|Extended Treatment Phase|Subject Decision|0|||
150230670|NCT02101268|541981826|FG001|Extended Treatment Phase|Subject Decision|0|||
150230671|NCT02101268|541981827|FG002|Extended Treatment Phase|Subject Decision|3|||
150230672|NCT02101268|541981828|FG003|Extended Treatment Phase|Subject Decision|2|||
150230673|NCT02101268|541981825|FG000|Extended Treatment Phase|Physician Decision|0|||
150230674|NCT02101268|541981826|FG001|Extended Treatment Phase|Physician Decision|0|||
150230675|NCT02101268|541981827|FG002|Extended Treatment Phase|Physician Decision|5|||
150230676|NCT02101268|541981828|FG003|Extended Treatment Phase|Physician Decision|2|||
150230677|NCT02101268|541981825|FG000|Extended Treatment Phase|Adverse Event|0|||
150230678|NCT02101268|541981826|FG001|Extended Treatment Phase|Adverse Event|0|||
150230679|NCT02101268|541981827|FG002|Extended Treatment Phase|Adverse Event|14|||
150230680|NCT02101268|541981828|FG003|Extended Treatment Phase|Adverse Event|18|||
150230681|NCT02101268|541981825|FG000|Extended Treatment Phase|Death|0|||
150230682|NCT02101268|541981826|FG001|Extended Treatment Phase|Death|0|||
150230683|NCT02101268|541981827|FG002|Extended Treatment Phase|Death|5|||
150230684|NCT02101268|541981828|FG003|Extended Treatment Phase|Death|1|||
150230685|NCT02101268|541981825|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
150230686|NCT02101268|541981826|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
150230687|NCT02101268|541981827|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
150230688|NCT02101268|541981828|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
150230689|NCT02101268|541981825|FG000|Extended Treatment Phase|Disease Progression|0|||
150142008|NCT00279201|541654115|FG003|Intensification Addendum|Lack of Efficacy|1|||
150142009|NCT00279201|541654116|FG004|Intensification Addendum|Lack of Efficacy|1|||
150142010|NCT00279201|541654117|FG005|Intensification Addendum|Lack of Efficacy|0|||
150142011|NCT00279201|541654112|FG000|Intensification Addendum|Death|0|||
150142012|NCT00279201|541654113|FG001|Intensification Addendum|Death|0|||
150142013|NCT00279201|541654114|FG002|Intensification Addendum|Death|0|||
150142014|NCT00279201|541654115|FG003|Intensification Addendum|Death|0|||
150142015|NCT00279201|541654116|FG004|Intensification Addendum|Death|1|||
150142016|NCT00279201|541654117|FG005|Intensification Addendum|Death|0|||
150142017|NCT02202434|541655918|FG000|Overall Study|Death|70|||
150142018|NCT02202434|541655919|FG001|Overall Study|Death|39|||
150142019|NCT02202434|541655920|FG002|Overall Study|Death|13|||
150142020|NCT02202434|541655921|FG003|Overall Study|Death|27|||
150142021|NCT02202434|541655918|FG000|Overall Study|Lost to Follow-up|1|||
150142022|NCT02202434|541655919|FG001|Overall Study|Lost to Follow-up|1|||
150142023|NCT02202434|541655920|FG002|Overall Study|Lost to Follow-up|1|||
150142024|NCT02202434|541655921|FG003|Overall Study|Lost to Follow-up|0|||
150142025|NCT02202434|541655918|FG000|Overall Study|Physician Decision|2|||
150142026|NCT02202434|541655919|FG001|Overall Study|Physician Decision|3|||
150142027|NCT02202434|541655920|FG002|Overall Study|Physician Decision|0|||
150142028|NCT02202434|541655921|FG003|Overall Study|Physician Decision|0|||
150142029|NCT02202434|541655918|FG000|Overall Study|Withdrawal by Subject|13|||
150142030|NCT02202434|541655919|FG001|Overall Study|Withdrawal by Subject|14|||
150142031|NCT02202434|541655920|FG002|Overall Study|Withdrawal by Subject|1|||
150230690|NCT02101268|541981826|FG001|Extended Treatment Phase|Disease Progression|0|||
150230691|NCT02101268|541981827|FG002|Extended Treatment Phase|Disease Progression|13|||
150230692|NCT02101268|541981828|FG003|Extended Treatment Phase|Disease Progression|6|||
150230693|NCT02101268|541981825|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
150230694|NCT02101268|541981826|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
150230695|NCT02101268|541981827|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
150230696|NCT02101268|541981828|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
150230697|NCT01200485|541981829|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
150230698|NCT01200485|541981830|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
150230699|NCT01200485|541981831|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
150230700|NCT01200485|541981829|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
150230701|NCT01200485|541981830|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
150230702|NCT01200485|541981831|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
150230703|NCT06080438|541981832|FG000|Overall Study|Lost to Follow-up|2|||
150230704|NCT03589300|541981834|FG000|Overall Study|Adverse Event|2|||
150230705|NCT03589300|541981834|FG000|Overall Study|Death|4|||
150230706|NCT03589300|541981834|FG000|Overall Study|Lost to Follow-up|12|||
150230707|NCT03589300|541981834|FG000|Overall Study|Withdrawal by Subject|5|||
150230708|NCT02630706|541981835|FG000|Overall Study|Adverse Event|2|||
150230709|NCT02630706|541981836|FG001|Overall Study|Adverse Event|1|||
150230710|NCT02630706|541981837|FG002|Overall Study|Adverse Event|1|||
150230711|NCT02630706|541981835|FG000|Overall Study|Lost to Follow-up|0|||
150230712|NCT02630706|541981836|FG001|Overall Study|Lost to Follow-up|1|||
150230713|NCT02630706|541981837|FG002|Overall Study|Lost to Follow-up|2|||
150230714|NCT02630706|541981835|FG000|Overall Study|Physician Decision|1|||
150230715|NCT02630706|541981836|FG001|Overall Study|Physician Decision|1|||
150230716|NCT02630706|541981837|FG002|Overall Study|Physician Decision|0|||
150230717|NCT02630706|541981835|FG000|Overall Study|Pregnancy|0|||
150230718|NCT02630706|541981836|FG001|Overall Study|Pregnancy|1|||
150230719|NCT02630706|541981837|FG002|Overall Study|Pregnancy|0|||
150230720|NCT02630706|541981835|FG000|Overall Study|Withdrawal by Subject|4|||
150230721|NCT02630706|541981836|FG001|Overall Study|Withdrawal by Subject|5|||
150230722|NCT02630706|541981837|FG002|Overall Study|Withdrawal by Subject|7|||
150230723|NCT01678898|541981838|FG000|PB-102-F01|Adverse Event|0|||
150230724|NCT01678898|541981839|FG001|PB-102-F01|Adverse Event|1|||
150230725|NCT01678898|541981840|FG002|PB-102-F01|Adverse Event|0|||
150230726|NCT01678898|541981838|FG000|PB-102-F01|Physician Decision|0|||
150230727|NCT01678898|541981839|FG001|PB-102-F01|Physician Decision|1|||
150230728|NCT01678898|541981840|FG002|PB-102-F01|Physician Decision|0|||
150230729|NCT02551692|541981845|FG000|Overall Study|Lost to Follow-up|0|||
150230730|NCT02551692|541981846|FG001|Overall Study|Lost to Follow-up|1|||
150230731|NCT02551692|541981847|FG002|Overall Study|Lost to Follow-up|4|||
150230732|NCT02551692|541981845|FG000|Overall Study|Withdrawal by Subject|1|||
150230733|NCT02551692|541981846|FG001|Overall Study|Withdrawal by Subject|0|||
150230734|NCT02551692|541981847|FG002|Overall Study|Withdrawal by Subject|1|||
150230735|NCT01227928|541981848|FG000|Overall Study|Lost to Follow-up|4|||
150230736|NCT01227928|541981849|FG001|Overall Study|Lost to Follow-up|2|||
150230737|NCT01227928|541981848|FG000|Overall Study|Withdrawal by Subject|4|||
150230738|NCT01227928|541981849|FG001|Overall Study|Withdrawal by Subject|3|||
150230739|NCT01227928|541981848|FG000|Overall Study|Death|14|||
150230740|NCT01227928|541981849|FG001|Overall Study|Death|12|||
150230741|NCT04582864|541981850|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
150230742|NCT04582864|541981850|FG000|Overall Study|Death|1|||
150230743|NCT01204775|541981851|FG000|Overall Study|Poor/non-compliance|0|||
150230744|NCT01204775|541981852|FG001|Overall Study|Poor/non-compliance|1|||
150230745|NCT01204775|541981851|FG000|Overall Study|Withdrawal by Subject|1|||
150230746|NCT01204775|541981852|FG001|Overall Study|Withdrawal by Subject|0|||
150230747|NCT04380688|541981854|FG000|Overall Study|Death|2|||
150230748|NCT04380688|541981855|FG001|Overall Study|Death|2|||
150230749|NCT04380688|541981854|FG000|Overall Study|Lost to Follow-up|2|||
150230750|NCT04380688|541981855|FG001|Overall Study|Lost to Follow-up|4|||
150230751|NCT04380688|541981854|FG000|Overall Study|Withdrawal by Subject|3|||
150230752|NCT04380688|541981855|FG001|Overall Study|Withdrawal by Subject|3|||
150230753|NCT00951171|541981859|FG000|Overall Study|Adverse Event|2|||
150230754|NCT00951171|541981860|FG001|Overall Study|Adverse Event|0|||
150230755|NCT00919061|541981861|FG000|Overall Study|Adverse Event|1|||
150230756|NCT00919061|541981861|FG000|Overall Study|Withdrawal by Subject|1|||
150230757|NCT05294328|541981866|FG000|Overall Study|Adverse Event|1|||
150230758|NCT05294328|541981867|FG001|Overall Study|Adverse Event|0|||
150230759|NCT05294328|541981868|FG002|Overall Study|Adverse Event|0|||
150230760|NCT05294328|541981866|FG000|Overall Study|Physician Decision|1|||
150230761|NCT05294328|541981867|FG001|Overall Study|Physician Decision|1|||
150230762|NCT05294328|541981868|FG002|Overall Study|Physician Decision|0|||
150230763|NCT05294328|541981866|FG000|Overall Study|Withdrawal by Subject|0|||
150230764|NCT05294328|541981867|FG001|Overall Study|Withdrawal by Subject|2|||
150230765|NCT05294328|541981868|FG002|Overall Study|Withdrawal by Subject|1|||
150230766|NCT05294328|541981866|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
150230767|NCT05294328|541981867|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
150230768|NCT05294328|541981868|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
150230769|NCT04267393|541981869|FG000|Randomization|Adverse Event|1|||
150230770|NCT04267393|541981870|FG001|Randomization|Adverse Event|0|||
150230771|NCT04267393|541981871|FG002|Randomization|Adverse Event|0|||
150230772|NCT04267393|541981869|FG000|Randomization|Administrative Reasons by Sponsor|0|||
150230773|NCT04267393|541981870|FG001|Randomization|Administrative Reasons by Sponsor|1|||
150230774|NCT04267393|541981871|FG002|Randomization|Administrative Reasons by Sponsor|0|||
150230775|NCT04267393|541981869|FG000|Treatment Period|Adverse Event|0|||
150230776|NCT04267393|541981870|FG001|Treatment Period|Adverse Event|2|||
150230777|NCT04267393|541981871|FG002|Treatment Period|Adverse Event|3|||
150230778|NCT04267393|541981869|FG000|Treatment Period|Participant Withdrew Consent|0|||
150230779|NCT04267393|541981870|FG001|Treatment Period|Participant Withdrew Consent|0|||
150230780|NCT04267393|541981871|FG002|Treatment Period|Participant Withdrew Consent|1|||
150230781|NCT04267393|541981869|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
150230782|NCT04267393|541981870|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
150230783|NCT04267393|541981871|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
150230784|NCT03864341|541983259|FG000|Overall Study|Withdrawal by Subject|1|||
150230785|NCT01066936|541983260|FG000|Overall Study|Death|2|||
150230786|NCT01066936|541983260|FG000|Overall Study|Device revised/removed|1|||
150230787|NCT01066936|541983260|FG000|Overall Study|Lost to Follow-up|3|||
150230788|NCT01066936|541983260|FG000|Overall Study|Withdrawal by Subject|4|||
150230789|NCT01904136|541983261|FG000|Overall Study|Physician Decision|0|||
150230790|NCT01904136|541983262|FG001|Overall Study|Physician Decision|0|||
150230791|NCT01904136|541983263|FG002|Overall Study|Physician Decision|0|||
150230792|NCT01904136|541983264|FG003|Overall Study|Physician Decision|0|||
150230793|NCT01904136|541983265|FG004|Overall Study|Physician Decision|0|||
150230794|NCT01904136|541983266|FG005|Overall Study|Physician Decision|1|||
150230795|NCT01904136|541983267|FG006|Overall Study|Physician Decision|0|||
150230796|NCT01904136|541983268|FG007|Overall Study|Physician Decision|0|||
150230797|NCT01904136|541983269|FG008|Overall Study|Physician Decision|0|||
150230798|NCT04156399|541983274|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
150230799|NCT04156399|541983274|FG000|Overall Study|study suspension due to COVID pandemic|3|||
150230800|NCT00460564|541983280|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
150230801|NCT00460564|541983281|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
150230802|NCT00460564|541983282|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230803|NCT00460564|541983283|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230804|NCT00460564|541983284|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230805|NCT00460564|541983285|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230806|NCT00460564|541983286|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230807|NCT00460564|541983287|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
150230808|NCT00460564|541983280|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
150230809|NCT00460564|541983281|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230810|NCT00460564|541983282|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230811|NCT00460564|541983283|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230812|NCT00460564|541983284|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230813|NCT00460564|541983285|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230814|NCT00460564|541983286|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230815|NCT00460564|541983287|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
150230816|NCT00460564|541983280|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
150230817|NCT00460564|541983281|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
150230818|NCT00460564|541983282|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
150230819|NCT00460564|541983283|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
150230820|NCT00460564|541983284|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
150230821|NCT00460564|541983285|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
150230822|NCT00460564|541983286|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
150230823|NCT00460564|541983287|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
150230824|NCT00460564|541983280|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230825|NCT00460564|541983281|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230826|NCT00460564|541983282|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230827|NCT00460564|541983283|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230828|NCT00460564|541983284|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
150230829|NCT00460564|541983285|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
150230830|NCT00460564|541983286|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230831|NCT00460564|541983287|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
150230832|NCT00460564|541983280|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230833|NCT00460564|541983281|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230834|NCT00460564|541983282|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230835|NCT00460564|541983283|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230836|NCT00460564|541983284|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
150230837|NCT00460564|541983285|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230838|NCT00460564|541983286|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230839|NCT00460564|541983287|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
150230840|NCT00863798|541983288|FG000|Overall Study|Adverse Event|5|||
150230841|NCT00863798|541983289|FG001|Overall Study|Adverse Event|2|||
150230842|NCT00863798|541983290|FG002|Overall Study|Adverse Event|4|||
150230843|NCT00863798|541983288|FG000|Overall Study|Participant failed to return|2|||
150230844|NCT00863798|541983289|FG001|Overall Study|Participant failed to return|1|||
150230845|NCT00863798|541983290|FG002|Overall Study|Participant failed to return|0|||
150230846|NCT00863798|541983288|FG000|Overall Study|Investigator request|1|||
150230847|NCT00863798|541983289|FG001|Overall Study|Investigator request|2|||
150230848|NCT00863798|541983290|FG002|Overall Study|Investigator request|1|||
150230849|NCT00863798|541983288|FG000|Overall Study|Lack of Efficacy|4|||
150230850|NCT00863798|541983289|FG001|Overall Study|Lack of Efficacy|3|||
150230851|NCT00863798|541983290|FG002|Overall Study|Lack of Efficacy|6|||
150230852|NCT00863798|541983288|FG000|Overall Study|Lost to Follow-up|6|||
150230853|NCT00863798|541983289|FG001|Overall Study|Lost to Follow-up|9|||
150230854|NCT00863798|541983290|FG002|Overall Study|Lost to Follow-up|5|||
150230855|NCT00863798|541983288|FG000|Overall Study|Other|2|||
150230856|NCT00863798|541983289|FG001|Overall Study|Other|3|||
150230857|NCT00863798|541983290|FG002|Overall Study|Other|1|||
150230858|NCT00863798|541983288|FG000|Overall Study|Protocol Violation|0|||
150230859|NCT00863798|541983289|FG001|Overall Study|Protocol Violation|1|||
150230860|NCT00863798|541983290|FG002|Overall Study|Protocol Violation|1|||
150230861|NCT00863798|541983288|FG000|Overall Study|Withdrawal by Subject|8|||
150230862|NCT00863798|541983289|FG001|Overall Study|Withdrawal by Subject|7|||
150230863|NCT00863798|541983290|FG002|Overall Study|Withdrawal by Subject|4|||
150230864|NCT00863798|541983288|FG000|Overall Study|Randomized not treated|4|||
150230865|NCT00863798|541983289|FG001|Overall Study|Randomized not treated|2|||
150230866|NCT00863798|541983290|FG002|Overall Study|Randomized not treated|3|||
150230867|NCT04238520|541983291|FG000|Overall Study|Withdrawal by Subject|1|||
150230868|NCT04238520|541983292|FG001|Overall Study|Withdrawal by Subject|1|||
150230869|NCT04238520|541983291|FG000|Overall Study|Lost to Follow-up|1|||
150230870|NCT04238520|541983292|FG001|Overall Study|Lost to Follow-up|2|||
150230871|NCT04238520|541983291|FG000|Overall Study|Death|0|||
150230872|NCT04238520|541983292|FG001|Overall Study|Death|2|||
150230873|NCT04238520|541983291|FG000|Overall Study|Unsafe home environment for research staff|0|||
150230874|NCT04238520|541983292|FG001|Overall Study|Unsafe home environment for research staff|1|||
150230875|NCT01470599|541983293|FG000|Overall Study|Did not meet entrance criteria|1|||
150230876|NCT01470599|541983294|FG001|Overall Study|Did not meet entrance criteria|0|||
150230877|NCT01470599|541983293|FG000|Overall Study|Lost to Follow-up|2|||
150230878|NCT01470599|541983294|FG001|Overall Study|Lost to Follow-up|1|||
150230879|NCT01470599|541983293|FG000|Overall Study|Withdrawal by Subject|3|||
150230880|NCT01470599|541983294|FG001|Overall Study|Withdrawal by Subject|4|||
150230881|NCT01470599|541983293|FG000|Overall Study|Other|1|||
150230882|NCT01470599|541983294|FG001|Overall Study|Other|0|||
150230883|NCT01470599|541983293|FG000|Overall Study|Protocol Violation|3|||
150230884|NCT01470599|541983294|FG001|Overall Study|Protocol Violation|1|||
150230885|NCT01470599|541983293|FG000|Overall Study|Adverse event related to study drug|2|||
150230886|NCT01470599|541983294|FG001|Overall Study|Adverse event related to study drug|5|||
150230887|NCT01470599|541983293|FG000|Overall Study|Insufficient clinical response|6|||
150230888|NCT01470599|541983294|FG001|Overall Study|Insufficient clinical response|27|||
150230889|NCT01470599|541983293|FG000|Overall Study|Adverse event not related to study drug|1|||
150230890|NCT01470599|541983294|FG001|Overall Study|Adverse event not related to study drug|5|||
150230891|NCT00195442|541983295|FG000|Overall Study|Less than expected therapeutic effect|38|||
150230892|NCT00195442|541983295|FG000|Overall Study|Lost to Follow-up|27|||
150230893|NCT00195442|541983295|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
150230894|NCT00195442|541983295|FG000|Overall Study|Intermittent product shortage|21|||
150230895|NCT00195442|541983295|FG000|Overall Study|Death|7|||
150230896|NCT00195442|541983295|FG000|Overall Study|No reason specified|4|||
150230897|NCT00195442|541983295|FG000|Overall Study|Poor cooperation|2|||
150230898|NCT00195442|541983295|FG000|Overall Study|Other|14|||
150230899|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
150230900|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
150230901|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
150230902|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
150230903|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
150230904|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
150230905|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
150230906|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
150230907|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
150230908|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
150230909|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
150230910|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
150230911|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
150230912|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
150230913|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
150230914|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
150230915|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
150230916|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
150230917|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
150230918|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
150142032|NCT02202434|541655921|FG003|Overall Study|Withdrawal by Subject|4|||
150142033|NCT02202434|541655918|FG000|Overall Study|Completed Study|1|||
150142034|NCT02202434|541655919|FG001|Overall Study|Completed Study|0|||
150142035|NCT02202434|541655920|FG002|Overall Study|Completed Study|0|||
150142036|NCT02202434|541655921|FG003|Overall Study|Completed Study|0|||
150142037|NCT02202434|541655918|FG000|Overall Study|Visit Missed|21|||
150142038|NCT02202434|541655919|FG001|Overall Study|Visit Missed|12|||
150142039|NCT02202434|541655920|FG002|Overall Study|Visit Missed|0|||
150142040|NCT02202434|541655921|FG003|Overall Study|Visit Missed|5|||
150142041|NCT02202434|541655918|FG000|Overall Study|Other|1|||
150142042|NCT02202434|541655919|FG001|Overall Study|Other|0|||
150142043|NCT02202434|541655920|FG002|Overall Study|Other|0|||
150230919|NCT02637856|541983304|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
150230920|NCT02637856|541983305|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
150230921|NCT02637856|541983304|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
150230922|NCT02637856|541983305|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
150230923|NCT02637856|541983304|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
150230924|NCT02637856|541983305|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
150230925|NCT02509312|541983306|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
150230926|NCT02509312|541983307|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
150230927|NCT02509312|541983306|FG000|Overall Study|Obstetrician refusal|0|||
150230928|NCT02509312|541983307|FG001|Overall Study|Obstetrician refusal|1|||
150230929|NCT02509312|541983306|FG000|Overall Study|Patient elected for TOLAC|1|||
150142044|NCT02202434|541655921|FG003|Overall Study|Other|1|||
150142045|NCT03237858|541655922|FG000|Overall Study|Death|19|||
150142046|NCT03237858|541655922|FG000|Overall Study|Withdrawal by Subject|37|||
150142047|NCT03075501|541655925|FG000|Overall Study|Scheduling difficulties|15|||
150142048|NCT03075501|541655926|FG001|Overall Study|Scheduling difficulties|9|||
150142049|NCT00710606|541655938|FG000|Overall Study|Adverse Event|0|||
150142050|NCT00710606|541655939|FG001|Overall Study|Adverse Event|2|||
150142051|NCT05044325|541655940|FG000|Part A:Treatment Period 1|Adverse Event|0|||
150142052|NCT05044325|541655941|FG001|Part A:Treatment Period 1|Adverse Event|0|||
150142053|NCT05044325|541655942|FG002|Part A:Treatment Period 1|Adverse Event|0|||
150142054|NCT05044325|541655943|FG003|Part A:Treatment Period 1|Adverse Event|0|||
150142055|NCT05044325|541655944|FG004|Part A:Treatment Period 1|Adverse Event|0|||
150142056|NCT05044325|541655945|FG005|Part A:Treatment Period 1|Adverse Event|1|||
150142057|NCT05044325|541655946|FG006|Part A:Treatment Period 1|Adverse Event|0|||
150142058|NCT05044325|541655947|FG007|Part A:Treatment Period 1|Adverse Event|1|||
150142059|NCT05044325|541655948|FG008|Part A:Treatment Period 1|Adverse Event|0|||
150142060|NCT05044325|541655949|FG009|Part A:Treatment Period 1|Adverse Event|0|||
150142061|NCT05044325|541655940|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142062|NCT05044325|541655941|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142063|NCT05044325|541655942|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142064|NCT05044325|541655943|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
150142065|NCT05044325|541655944|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
150142066|NCT05044325|541655945|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
150142067|NCT05044325|541655946|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142068|NCT05044325|541655947|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142069|NCT05044325|541655948|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142070|NCT05044325|541655949|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
150142071|NCT05044325|541655940|FG000|Part A:Treatment Period 1|Physician Decision|0|||
150142072|NCT05044325|541655941|FG001|Part A:Treatment Period 1|Physician Decision|0|||
150142073|NCT05044325|541655942|FG002|Part A:Treatment Period 1|Physician Decision|0|||
150142074|NCT05044325|541655943|FG003|Part A:Treatment Period 1|Physician Decision|0|||
150142075|NCT05044325|541655944|FG004|Part A:Treatment Period 1|Physician Decision|0|||
150142076|NCT05044325|541655945|FG005|Part A:Treatment Period 1|Physician Decision|0|||
150142077|NCT05044325|541655946|FG006|Part A:Treatment Period 1|Physician Decision|1|||
150142078|NCT05044325|541655947|FG007|Part A:Treatment Period 1|Physician Decision|0|||
150142079|NCT05044325|541655948|FG008|Part A:Treatment Period 1|Physician Decision|0|||
150142080|NCT05044325|541655949|FG009|Part A:Treatment Period 1|Physician Decision|0|||
150142081|NCT05044325|541655940|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142082|NCT05044325|541655941|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142083|NCT05044325|541655942|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
150142084|NCT05044325|541655943|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142085|NCT05044325|541655944|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142086|NCT05044325|541655945|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142087|NCT05044325|541655946|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142088|NCT05044325|541655947|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142089|NCT05044325|541655948|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142090|NCT05044325|541655949|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
150142091|NCT05044325|541655940|FG000|Part A:Treatment Period 2|Adverse Event|0|||
150142092|NCT05044325|541655941|FG001|Part A:Treatment Period 2|Adverse Event|1|||
150230930|NCT02509312|541983307|FG001|Overall Study|Patient elected for TOLAC|0|||
150230931|NCT02509312|541983306|FG000|Overall Study|Cesarean deemed stat|1|||
150230932|NCT02509312|541983307|FG001|Overall Study|Cesarean deemed stat|0|||
150230933|NCT02509312|541983306|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
150230934|NCT02509312|541983307|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
150230935|NCT02815735|541983308|FG000|First Intervention (4 Weeks)|Discomfort|1|||
150230936|NCT02815735|541983309|FG001|First Intervention (4 Weeks)|Discomfort|0|||
150230937|NCT02815735|541983308|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
150230938|NCT02815735|541983309|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
150230939|NCT02815735|541983308|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
150230940|NCT02815735|541983309|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
150230941|NCT02815735|541983308|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
150230942|NCT02815735|541983309|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
150230943|NCT00702650|541983310|FG000|Overall Study|Withdrawal by Subject|9|||
150230944|NCT00702650|541983310|FG000|Overall Study|Non-Compliance of Study Drug|3|||
150230945|NCT00702650|541983310|FG000|Overall Study|Lost to Follow-up|2|||
150230946|NCT00702650|541983310|FG000|Overall Study|Non-Compliance with Site Directives|1|||
150230947|NCT00702650|541983310|FG000|Overall Study|Sponsor Request|1|||
150230948|NCT00702650|541983310|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
150230949|NCT00702650|541983310|FG000|Overall Study|Adverse Event|3|||
150230950|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
150230951|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
150230952|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
150230953|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
150230954|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
150230955|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
150230956|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
150230957|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
150230958|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
150230959|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
150230960|NCT01772823|541983315|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
150230961|NCT01772823|541983316|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
150230962|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
150230963|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
150230964|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
150230965|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
150230966|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
150230967|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
150230968|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
150230969|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
150230970|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
150230971|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
150230972|NCT01772823|541983315|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
150230973|NCT01772823|541983316|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
150230974|NCT01772823|541983315|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
150230975|NCT01772823|541983316|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
150230976|NCT01772823|541983315|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
150230977|NCT01772823|541983316|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
150230978|NCT01772823|541983315|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
150230979|NCT01772823|541983316|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
150230980|NCT01772823|541983315|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
150230981|NCT01772823|541983316|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
150230982|NCT01036165|541983317|FG000|Overall Study|Adverse Event|6|||
150230983|NCT01036165|541983317|FG000|Overall Study|Lost to Follow-up|2|||
150230984|NCT01036165|541983317|FG000|Overall Study|Withdrawal by Subject|3|||
150230985|NCT01036165|541983317|FG000|Overall Study|Device Related Issues|3|||
150230986|NCT01036165|541983317|FG000|Overall Study|Problems finding proper area to inject|1|||
150230987|NCT02895360|541983320|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
150230988|NCT02895360|541983321|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
150230989|NCT02895360|541983322|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
150230990|NCT02895360|541983323|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
150230991|NCT02895360|541983324|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
150230992|NCT02895360|541983325|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
150230993|NCT02895360|541983320|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
150230994|NCT02895360|541983321|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
150230995|NCT02895360|541983322|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
150230996|NCT02895360|541983323|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
150230997|NCT02895360|541983324|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
150230998|NCT02895360|541983325|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
150230999|NCT02895360|541983320|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
150231000|NCT02895360|541983321|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
150231001|NCT02895360|541983322|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
150231002|NCT02895360|541983323|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
150231003|NCT02895360|541983324|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
150231004|NCT02895360|541983325|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
150231005|NCT02895360|541983320|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
150231006|NCT02895360|541983321|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
150231007|NCT02895360|541983322|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
150231008|NCT02895360|541983323|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
150231009|NCT02895360|541983324|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
150231010|NCT02895360|541983325|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
150231011|NCT02895360|541983320|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
150231012|NCT02895360|541983321|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
150231013|NCT02895360|541983322|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
150231014|NCT02895360|541983323|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
150231015|NCT02895360|541983324|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
150231016|NCT02895360|541983325|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
150231017|NCT02895360|541983320|FG000|Phase 2a|Adverse Event|0|||
150231018|NCT02895360|541983321|FG001|Phase 2a|Adverse Event|0|||
150231019|NCT02895360|541983322|FG002|Phase 2a|Adverse Event|0|||
150231020|NCT02895360|541983323|FG003|Phase 2a|Adverse Event|0|||
150231021|NCT02895360|541983324|FG004|Phase 2a|Adverse Event|0|||
150231022|NCT02895360|541983325|FG005|Phase 2a|Adverse Event|1|||
150231023|NCT02895360|541983320|FG000|Phase 2a|Progressive disease|0|||
150231024|NCT02895360|541983321|FG001|Phase 2a|Progressive disease|0|||
150231025|NCT02895360|541983322|FG002|Phase 2a|Progressive disease|0|||
150231026|NCT02895360|541983323|FG003|Phase 2a|Progressive disease|0|||
150231027|NCT02895360|541983324|FG004|Phase 2a|Progressive disease|11|||
150231028|NCT02895360|541983325|FG005|Phase 2a|Progressive disease|11|||
150231029|NCT00307164|541983326|FG000|Overall Study|Death|1|||
150231030|NCT00307164|541983327|FG001|Overall Study|Death|0|||
150231031|NCT00307164|541983326|FG000|Overall Study|Severe debilitation, unable to continue|1|||
150231032|NCT00307164|541983327|FG001|Overall Study|Severe debilitation, unable to continue|0|||
150231033|NCT00307164|541983326|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
150231034|NCT00307164|541983327|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
150231035|NCT00307164|541983326|FG000|Overall Study|Withdrawal by Subject|1|||
150231036|NCT00307164|541983327|FG001|Overall Study|Withdrawal by Subject|8|||
150231037|NCT00307164|541983326|FG000|Overall Study|Not compliant with requirements|4|||
150231038|NCT00307164|541983327|FG001|Overall Study|Not compliant with requirements|4|||
150231039|NCT00307164|541983326|FG000|Overall Study|Lost to Follow-up|6|||
150231040|NCT00307164|541983327|FG001|Overall Study|Lost to Follow-up|1|||
150231041|NCT01649297|541983328|FG000|Overall Study|Adverse Event|5|||
150231042|NCT01649297|541983329|FG001|Overall Study|Adverse Event|5|||
150231043|NCT01649297|541983330|FG002|Overall Study|Adverse Event|4|||
150231044|NCT01649297|541983331|FG003|Overall Study|Adverse Event|13|||
150231045|NCT01649297|541983332|FG004|Overall Study|Adverse Event|1|||
150231046|NCT01649297|541983328|FG000|Overall Study|Lack of Efficacy|0|||
150231047|NCT01649297|541983329|FG001|Overall Study|Lack of Efficacy|0|||
150231048|NCT01649297|541983330|FG002|Overall Study|Lack of Efficacy|0|||
150231049|NCT01649297|541983331|FG003|Overall Study|Lack of Efficacy|0|||
150231050|NCT01649297|541983332|FG004|Overall Study|Lack of Efficacy|1|||
150231051|NCT01649297|541983328|FG000|Overall Study|Non compliant with Protocol|1|||
150231052|NCT01649297|541983329|FG001|Overall Study|Non compliant with Protocol|0|||
150231053|NCT01649297|541983330|FG002|Overall Study|Non compliant with Protocol|3|||
150231054|NCT01649297|541983331|FG003|Overall Study|Non compliant with Protocol|2|||
150231055|NCT01649297|541983332|FG004|Overall Study|Non compliant with Protocol|1|||
150231056|NCT01649297|541983328|FG000|Overall Study|Lost to Follow-up|1|||
150231057|NCT01649297|541983329|FG001|Overall Study|Lost to Follow-up|1|||
150231058|NCT01649297|541983330|FG002|Overall Study|Lost to Follow-up|4|||
150231059|NCT01649297|541983331|FG003|Overall Study|Lost to Follow-up|3|||
150231060|NCT01649297|541983332|FG004|Overall Study|Lost to Follow-up|0|||
150231061|NCT01649297|541983328|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
150231062|NCT01649297|541983329|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
150231063|NCT01649297|541983330|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
150231064|NCT01649297|541983331|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
150231065|NCT01649297|541983332|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
150231066|NCT01649297|541983328|FG000|Overall Study|For other reason|4|||
150231067|NCT01649297|541983329|FG001|Overall Study|For other reason|1|||
150231068|NCT01649297|541983330|FG002|Overall Study|For other reason|2|||
150231069|NCT01649297|541983331|FG003|Overall Study|For other reason|0|||
150231070|NCT01649297|541983332|FG004|Overall Study|For other reason|0|||
150231071|NCT01685047|541983333|FG000|Overall Study|Withdrawal by Subject|20|||
150231072|NCT01685047|541983333|FG000|Overall Study|Death|26|||
150231073|NCT01685047|541983333|FG000|Overall Study|Lost to Follow-up|8|||
150231074|NCT01685047|541983333|FG000|Overall Study|Physician Decision|25|||
150231075|NCT01685047|541983333|FG000|Overall Study|Adverse Event|5|||
150231076|NCT01685047|541983333|FG000|Overall Study|patient withdrawn by sponsor|1|||
150231077|NCT01732926|541983335|FG000|Overall Study|Study Terminated by Sponsor|168|||
150231078|NCT01732926|541983336|FG001|Overall Study|Study Terminated by Sponsor|80|||
150231079|NCT01732926|541983335|FG000|Overall Study|Withdrawal by Subject|46|||
150231080|NCT01732926|541983336|FG001|Overall Study|Withdrawal by Subject|8|||
150231081|NCT01732926|541983335|FG000|Overall Study|Physician Decision|24|||
150231082|NCT01732926|541983336|FG001|Overall Study|Physician Decision|11|||
150231083|NCT01732926|541983335|FG000|Overall Study|Other Reason|21|||
150231084|NCT01732926|541983336|FG001|Overall Study|Other Reason|4|||
150231085|NCT01732926|541983335|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
150231086|NCT01732926|541983336|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
150231087|NCT01732926|541983335|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
150231088|NCT01732926|541983336|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
150231089|NCT02262364|541983337|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
150231090|NCT01049984|541983338|FG000|Overall Study|Withdrawal by Subject|1|||
150231091|NCT01049984|541983339|FG001|Overall Study|Withdrawal by Subject|5|||
150231092|NCT01049984|541983338|FG000|Overall Study|Protocol Violation|3|||
150231093|NCT01049984|541983339|FG001|Overall Study|Protocol Violation|4|||
150231094|NCT01049984|541983338|FG000|Overall Study|Lost to Follow-up|2|||
150231095|NCT01049984|541983339|FG001|Overall Study|Lost to Follow-up|1|||
150231096|NCT01049984|541983338|FG000|Overall Study|Adverse Event|13|||
150231097|NCT01049984|541983339|FG001|Overall Study|Adverse Event|7|||
150231098|NCT01049984|541983338|FG000|Overall Study|Treatment failure|0|||
150231099|NCT01049984|541983339|FG001|Overall Study|Treatment failure|2|||
150231100|NCT00337285|541983342|FG000|Overall Study|Withdrawal by Subject|42|||
150231101|NCT00337285|541983342|FG000|Overall Study|Lost to Follow-up|41|||
150231102|NCT00337285|541983342|FG000|Overall Study|Adverse Event|28|||
150231103|NCT00337285|541983342|FG000|Overall Study|Protocol Violation|27|||
150231104|NCT00337285|541983342|FG000|Overall Study|Lack of Efficacy|11|||
150231105|NCT00337285|541983342|FG000|Overall Study|Death|1|||
150231106|NCT00337285|541983342|FG000|Overall Study|Physician Decision|1|||
150231107|NCT00337285|541983342|FG000|Overall Study|Lack of protocol compliance|7|||
150231108|NCT01321723|541983359|FG000|Overall Study|Adverse Event|3|||
150231109|NCT01321723|541983360|FG001|Overall Study|Adverse Event|5|||
150231110|NCT01321723|541983361|FG002|Overall Study|Adverse Event|2|||
150231111|NCT01321723|541983359|FG000|Overall Study|Withdrawal by Subject|2|||
150231112|NCT01321723|541983360|FG001|Overall Study|Withdrawal by Subject|0|||
150231113|NCT01321723|541983361|FG002|Overall Study|Withdrawal by Subject|2|||
150231114|NCT01670188|541983366|FG000|Overall Study|Death|0|||
150231115|NCT01670188|541983367|FG001|Overall Study|Death|1|||
150231116|NCT02212301|541983368|FG000|Period 1|Lost to Follow-up|0|||
150231117|NCT02212301|541983369|FG001|Period 1|Lost to Follow-up|1|||
150231118|NCT00578318|541983372|FG000|Overall Study|Lost to Follow-up|2|||
150231119|NCT00578318|541983373|FG001|Overall Study|Lost to Follow-up|0|||
150231120|NCT00578318|541983372|FG000|Overall Study|Physician Decision|1|||
150231121|NCT00578318|541983373|FG001|Overall Study|Physician Decision|0|||
150231122|NCT02025985|541983374|FG000|Overall Study|Consent withdrawn|0|||
150231123|NCT02025985|541983375|FG001|Overall Study|Consent withdrawn|0|||
150231124|NCT02025985|541983376|FG002|Overall Study|Consent withdrawn|1|||
150231125|NCT02025985|541983377|FG003|Overall Study|Consent withdrawn|0|||
150231126|NCT02025985|541983378|FG004|Overall Study|Consent withdrawn|0|||
150231127|NCT02025985|541983374|FG000|Overall Study|Termination of study by Sponsor|4|||
150231128|NCT02025985|541983375|FG001|Overall Study|Termination of study by Sponsor|3|||
150231129|NCT02025985|541983376|FG002|Overall Study|Termination of study by Sponsor|1|||
150231130|NCT02025985|541983377|FG003|Overall Study|Termination of study by Sponsor|1|||
150231131|NCT02025985|541983378|FG004|Overall Study|Termination of study by Sponsor|3|||
150231132|NCT02025985|541983374|FG000|Overall Study|Death|21|||
150231133|NCT02025985|541983375|FG001|Overall Study|Death|20|||
150231134|NCT02025985|541983376|FG002|Overall Study|Death|23|||
150231135|NCT02025985|541983377|FG003|Overall Study|Death|20|||
150231136|NCT02025985|541983378|FG004|Overall Study|Death|17|||
150231137|NCT03041701|541983379|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
150231138|NCT03041701|541983380|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
150231139|NCT03041701|541983381|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
150231140|NCT03041701|541983379|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
150231141|NCT03041701|541983380|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
150231142|NCT03041701|541983381|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
150231143|NCT00920699|541983382|FG000|Overall Study|Withdrawal by Subject|2|||
150231144|NCT00920699|541983383|FG001|Overall Study|Withdrawal by Subject|0|||
150231145|NCT00920699|541983384|FG002|Overall Study|Withdrawal by Subject|2|||
150231146|NCT00920699|541983382|FG000|Overall Study|no longer met eligibility|0|||
150231147|NCT00920699|541983383|FG001|Overall Study|no longer met eligibility|1|||
150231148|NCT00920699|541983384|FG002|Overall Study|no longer met eligibility|0|||
150231149|NCT00920699|541983382|FG000|Overall Study|Lost to Follow-up|0|||
150231150|NCT00920699|541983383|FG001|Overall Study|Lost to Follow-up|0|||
150231151|NCT00920699|541983384|FG002|Overall Study|Lost to Follow-up|2|||
150231152|NCT03175198|541983385|FG000|Overall Study|Adverse Event|480|||
150231153|NCT03175198|541983385|FG000|Overall Study|No actual visit|120|||
150231154|NCT03175198|541983385|FG000|Overall Study|Registration rule not followed|4|||
150231155|NCT03175198|541983385|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
150231156|NCT03175198|541983385|FG000|Overall Study|Other personal reason|509|||
150231157|NCT03175198|541983385|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
150231158|NCT03175198|541983385|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
150231159|NCT03175198|541983385|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
150231160|NCT03175198|541983385|FG000|Overall Study|To conduct invasive treatment of operation|53|||
150231161|NCT03175198|541983385|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
150231162|NCT00776984|541983391|FG000|Overall Study|Adverse Event|8|||
150231163|NCT00776984|541983392|FG001|Overall Study|Adverse Event|2|||
150231164|NCT00776984|541983391|FG000|Overall Study|Protocol Violation|4|||
150231165|NCT00776984|541983392|FG001|Overall Study|Protocol Violation|2|||
150231166|NCT00776984|541983391|FG000|Overall Study|Lost to Follow-up|2|||
150231167|NCT00776984|541983392|FG001|Overall Study|Lost to Follow-up|0|||
150231168|NCT00776984|541983391|FG000|Overall Study|Withdrawal by Subject|12|||
150231169|NCT00776984|541983392|FG001|Overall Study|Withdrawal by Subject|7|||
150231170|NCT00776984|541983391|FG000|Overall Study|Lack of Efficacy|0|||
150231171|NCT00776984|541983392|FG001|Overall Study|Lack of Efficacy|1|||
150231172|NCT00776984|541983391|FG000|Overall Study|Other|5|||
150231173|NCT00776984|541983392|FG001|Overall Study|Other|9|||
150231174|NCT01544309|541983395|FG000|Overall Study|Withdrawal by Subject|12|||
150231175|NCT01544309|541983396|FG001|Overall Study|Withdrawal by Subject|7|||
150231176|NCT01544309|541983395|FG000|Overall Study|Protocol Violation|2|||
150231177|NCT01544309|541983396|FG001|Overall Study|Protocol Violation|1|||
150231178|NCT01544309|541983395|FG000|Overall Study|Physician Decision|4|||
150231179|NCT01544309|541983396|FG001|Overall Study|Physician Decision|1|||
150231180|NCT01544309|541983395|FG000|Overall Study|Not performed pre-dose examination|1|||
150231181|NCT01544309|541983396|FG001|Overall Study|Not performed pre-dose examination|2|||
150231182|NCT01544309|541983395|FG000|Overall Study|Administered prohibit prior medication|1|||
150231183|NCT01544309|541983396|FG001|Overall Study|Administered prohibit prior medication|0|||
150231184|NCT01091519|541983397|FG000|Overall Study|Adverse Event|12|||
150231185|NCT01091519|541983398|FG001|Overall Study|Adverse Event|16|||
150231186|NCT01091519|541983397|FG000|Overall Study|Death|1|||
150231187|NCT01091519|541983398|FG001|Overall Study|Death|0|||
150231188|NCT01091519|541983397|FG000|Overall Study|Lack of Efficacy|16|||
150231189|NCT01091519|541983398|FG001|Overall Study|Lack of Efficacy|19|||
150231190|NCT01091519|541983397|FG000|Overall Study|Lost to Follow-up|14|||
150231191|NCT01091519|541983398|FG001|Overall Study|Lost to Follow-up|24|||
150231192|NCT01091519|541983397|FG000|Overall Study|Withdrawal by Subject|2|||
150231193|NCT01091519|541983398|FG001|Overall Study|Withdrawal by Subject|2|||
150231194|NCT01091519|541983397|FG000|Overall Study|Other|6|||
150231195|NCT01091519|541983398|FG001|Overall Study|Other|8|||
150231196|NCT01091519|541983397|FG000|Overall Study|Randomized not treated|4|||
150231197|NCT01091519|541983398|FG001|Overall Study|Randomized not treated|4|||
150231198|NCT01196741|541983401|FG000|Overall Study|Disease progression|34|||
150231199|NCT01196741|541983402|FG001|Overall Study|Disease progression|14|||
150231200|NCT01196741|541983401|FG000|Overall Study|Adverse Event|10|||
150231201|NCT01196741|541983402|FG001|Overall Study|Adverse Event|6|||
150231202|NCT01196741|541983401|FG000|Overall Study|Serious Adverse Event|3|||
150231203|NCT01196741|541983402|FG001|Overall Study|Serious Adverse Event|1|||
150231204|NCT01196741|541983401|FG000|Overall Study|Dose limiting Adverse Event|2|||
150231205|NCT01196741|541983402|FG001|Overall Study|Dose limiting Adverse Event|1|||
150231206|NCT01196741|541983401|FG000|Overall Study|Withdrawal by Subject|3|||
150231207|NCT01196741|541983402|FG001|Overall Study|Withdrawal by Subject|0|||
150231208|NCT01196741|541983401|FG000|Overall Study|Other reason|3|||
150231209|NCT01196741|541983402|FG001|Overall Study|Other reason|3|||
150231210|NCT01196741|541983401|FG000|Overall Study|Other|3|||
150231211|NCT01196741|541983402|FG001|Overall Study|Other|2|||
150231212|NCT01196741|541983401|FG000|Overall Study|Protocol Violation|2|||
150231213|NCT01196741|541983402|FG001|Overall Study|Protocol Violation|1|||
150231214|NCT00276016|541983405|FG000|Intervention 1|Withdrawal by Subject|0|||
150231215|NCT00276016|541983406|FG001|Intervention 1|Withdrawal by Subject|1|||
150231216|NCT00276016|541983407|FG002|Intervention 1|Withdrawal by Subject|0|||
150231217|NCT00276016|541983408|FG003|Intervention 1|Withdrawal by Subject|0|||
150231218|NCT00276016|541983409|FG004|Intervention 1|Withdrawal by Subject|0|||
150231219|NCT00276016|541983410|FG005|Intervention 1|Withdrawal by Subject|0|||
150231220|NCT02056873|541983413|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
150231221|NCT00605566|541985218|FG000|Overall Study|Adverse Event|1|||
150231222|NCT00605566|541985218|FG000|Overall Study|Clinical deterioration|1|||
150231223|NCT00605566|541985218|FG000|Overall Study|Poor compliance in run-in period|1|||
150231224|NCT01932762|541985221|FG000|Overall Study|Withdrawal by Subject|1|||
150231225|NCT01932762|541985222|FG001|Overall Study|Withdrawal by Subject|2|||
150231226|NCT01932762|541985223|FG002|Overall Study|Withdrawal by Subject|0|||
150231227|NCT01932762|541985224|FG003|Overall Study|Withdrawal by Subject|0|||
150231228|NCT01932762|541985221|FG000|Overall Study|Lost to Follow-up|4|||
150231229|NCT01932762|541985222|FG001|Overall Study|Lost to Follow-up|0|||
150231230|NCT01932762|541985223|FG002|Overall Study|Lost to Follow-up|0|||
150231231|NCT01932762|541985224|FG003|Overall Study|Lost to Follow-up|1|||
150231232|NCT01932762|541985221|FG000|Overall Study|Physician Decision|1|||
150231233|NCT01932762|541985222|FG001|Overall Study|Physician Decision|0|||
150231234|NCT01932762|541985223|FG002|Overall Study|Physician Decision|0|||
150231235|NCT01932762|541985224|FG003|Overall Study|Physician Decision|0|||
150231236|NCT00695136|541985225|FG000|Overall Study|Withdrawal by Subject|1|||
150231237|NCT00695136|541985225|FG000|Overall Study|unrelated adverse event|1|||
150231238|NCT01726049|541985227|FG000|Overall Study|Death|1|||
150231239|NCT01726049|541985228|FG001|Overall Study|Death|1|||
150231240|NCT01726049|541985227|FG000|Overall Study|Adverse Event|4|||
150231241|NCT01726049|541985228|FG001|Overall Study|Adverse Event|1|||
150231242|NCT01726049|541985227|FG000|Overall Study|refused second HC|0|||
150231243|NCT01726049|541985228|FG001|Overall Study|refused second HC|2|||
150231244|NCT02202109|541985231|FG000|Overall Study|Lost to Follow-up|88|||
150231245|NCT02202109|541985232|FG001|Overall Study|Lost to Follow-up|87|||
150231246|NCT02202109|541985231|FG000|Overall Study|Withdrawal by Subject|2|||
150231247|NCT02202109|541985232|FG001|Overall Study|Withdrawal by Subject|0|||
150231248|NCT01333111|541985237|FG000|Overall Study|patient undergoing major surgery|0|||
150231249|NCT01333111|541985238|FG001|Overall Study|patient undergoing major surgery|2|||
150231250|NCT01333111|541985239|FG002|Overall Study|patient undergoing major surgery|0|||
150231251|NCT01333111|541985237|FG000|Overall Study|personal reasons|0|||
150231252|NCT01333111|541985238|FG001|Overall Study|personal reasons|0|||
150231253|NCT01333111|541985239|FG002|Overall Study|personal reasons|1|||
150231254|NCT01333111|541985237|FG000|Overall Study|unclassified|1|||
150231255|NCT01333111|541985238|FG001|Overall Study|unclassified|0|||
150231256|NCT01333111|541985239|FG002|Overall Study|unclassified|0|||
150231257|NCT01333111|541985237|FG000|Overall Study|withdrawal criteria|0|||
150231258|NCT01333111|541985238|FG001|Overall Study|withdrawal criteria|1|||
150231259|NCT01333111|541985239|FG002|Overall Study|withdrawal criteria|0|||
150231260|NCT01333111|541985237|FG000|Overall Study|Non-compliance|1|||
150231261|NCT01333111|541985238|FG001|Overall Study|Non-compliance|0|||
150231262|NCT01333111|541985239|FG002|Overall Study|Non-compliance|0|||
150231263|NCT01333111|541985237|FG000|Overall Study|Ineffective therapy|0|||
150231264|NCT01333111|541985238|FG001|Overall Study|Ineffective therapy|0|||
150231265|NCT01333111|541985239|FG002|Overall Study|Ineffective therapy|1|||
150231266|NCT02418845|541985242|FG000|Overall Study|Lost to Follow-up|7|||
150231267|NCT02418845|541985243|FG001|Overall Study|Lost to Follow-up|2|||
150231268|NCT02418845|541985242|FG000|Overall Study|Lack of Efficacy|0|||
150231269|NCT02418845|541985243|FG001|Overall Study|Lack of Efficacy|3|||
150231270|NCT02418845|541985242|FG000|Overall Study|Physician Decision|5|||
150231271|NCT02418845|541985243|FG001|Overall Study|Physician Decision|5|||
150231272|NCT02418845|541985242|FG000|Overall Study|Protocol Violation|1|||
150231273|NCT02418845|541985243|FG001|Overall Study|Protocol Violation|0|||
150231274|NCT02418845|541985242|FG000|Overall Study|Withdrawal by Subject|3|||
150231275|NCT02418845|541985243|FG001|Overall Study|Withdrawal by Subject|2|||
150231276|NCT00487552|541985256|FG000|Overall Study|Unsuccessful magnet placements|3|||
150231277|NCT00487552|541985256|FG000|Overall Study|Death due to progressive malignancy|2|||
150231278|NCT00487552|541985256|FG000|Overall Study|Stent not placed|1|||
150231279|NCT03119688|541985257|FG000|Overall Study|Adverse Event|4|||
150231280|NCT00320398|541985258|FG000|Overall Study|Adverse Event|1|||
150231281|NCT00320398|541985259|FG001|Overall Study|Adverse Event|4|||
150231282|NCT00320398|541985258|FG000|Overall Study|Other|1|||
150231283|NCT00320398|541985259|FG001|Overall Study|Other|0|||
150231284|NCT02705625|541985260|FG000|Overall Study|Protocol Violation|1|||
150231285|NCT02705625|541985261|FG001|Overall Study|Protocol Violation|0|||
150231286|NCT02705625|541985262|FG002|Overall Study|Protocol Violation|0|||
150231287|NCT02705625|541985260|FG000|Overall Study|Adverse Event|6|||
150231288|NCT02705625|541985261|FG001|Overall Study|Adverse Event|5|||
150231289|NCT02705625|541985262|FG002|Overall Study|Adverse Event|2|||
150231290|NCT02705625|541985260|FG000|Overall Study|Death|0|||
150231291|NCT02705625|541985261|FG001|Overall Study|Death|0|||
150231292|NCT02705625|541985262|FG002|Overall Study|Death|1|||
150231293|NCT02705625|541985260|FG000|Overall Study|Withdrawal by Subject|1|||
150231294|NCT02705625|541985261|FG001|Overall Study|Withdrawal by Subject|4|||
150231295|NCT02705625|541985262|FG002|Overall Study|Withdrawal by Subject|5|||
150231296|NCT02705625|541985260|FG000|Overall Study|Lost to Follow-up|0|||
150231297|NCT02705625|541985261|FG001|Overall Study|Lost to Follow-up|0|||
150231298|NCT02705625|541985262|FG002|Overall Study|Lost to Follow-up|1|||
150231299|NCT02705625|541985260|FG000|Overall Study|Non-compliance|0|||
150231300|NCT02705625|541985261|FG001|Overall Study|Non-compliance|1|||
150231301|NCT02705625|541985262|FG002|Overall Study|Non-compliance|1|||
150231302|NCT02705625|541985260|FG000|Overall Study|Overdosing|0|||
150231303|NCT02705625|541985261|FG001|Overall Study|Overdosing|0|||
150231304|NCT02705625|541985262|FG002|Overall Study|Overdosing|1|||
150231305|NCT00847132|541985263|FG000|Overall Study|Death|1|||
150231306|NCT00847132|541985264|FG001|Overall Study|Death|1|||
150231307|NCT01057251|541985266|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
150231308|NCT01057251|541985267|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
150231309|NCT01057251|541985266|FG000|Overall Study|Adverse Event|4|||
150231310|NCT01057251|541985267|FG001|Overall Study|Adverse Event|2|||
150231311|NCT01057251|541985266|FG000|Overall Study|Lack of Efficacy|2|||
150231312|NCT01057251|541985267|FG001|Overall Study|Lack of Efficacy|11|||
150231313|NCT01057251|541985266|FG000|Overall Study|Protocol Violation|6|||
150231314|NCT01057251|541985267|FG001|Overall Study|Protocol Violation|2|||
150231315|NCT01057251|541985266|FG000|Overall Study|Withdrawal by Subject|4|||
150231316|NCT01057251|541985267|FG001|Overall Study|Withdrawal by Subject|5|||
150231317|NCT01057251|541985266|FG000|Overall Study|Lost to Follow-up|7|||
150231318|NCT01057251|541985267|FG001|Overall Study|Lost to Follow-up|6|||
150231319|NCT01057251|541985266|FG000|Overall Study|Other Reason|1|||
150231320|NCT01057251|541985267|FG001|Overall Study|Other Reason|1|||
150231321|NCT04544865|541985268|FG000|Overall Study|Death|0|||
150231322|NCT04544865|541985269|FG001|Overall Study|Death|2|||
150231323|NCT04544865|541985268|FG000|Overall Study|Lost to Follow-up|11|||
150231324|NCT04544865|541985269|FG001|Overall Study|Lost to Follow-up|7|||
150231325|NCT04544865|541985268|FG000|Overall Study|Withdrawal by Subject|0|||
150231326|NCT04544865|541985269|FG001|Overall Study|Withdrawal by Subject|1|||
150231327|NCT04544865|541985268|FG000|Overall Study|Other|0|||
150231328|NCT04544865|541985269|FG001|Overall Study|Other|1|||
150231329|NCT00943722|541985271|FG000|Base Study|Adverse Event|0|||
150231330|NCT00943722|541985272|FG001|Base Study|Adverse Event|0|||
150231331|NCT00943722|541985273|FG002|Base Study|Adverse Event|0|||
150231332|NCT00943722|541985274|FG003|Base Study|Adverse Event|1|||
150231333|NCT00943722|541985275|FG004|Base Study|Adverse Event|0|||
150231334|NCT00943722|541985276|FG005|Base Study|Adverse Event|0|||
150231335|NCT00943722|541985277|FG006|Base Study|Adverse Event|0|||
150231336|NCT00943722|541985271|FG000|Base Study|Lost to Follow-up|12|||
150231337|NCT00943722|541985272|FG001|Base Study|Lost to Follow-up|8|||
150231338|NCT00943722|541985273|FG002|Base Study|Lost to Follow-up|10|||
150231339|NCT00943722|541985274|FG003|Base Study|Lost to Follow-up|8|||
150231340|NCT00943722|541985275|FG004|Base Study|Lost to Follow-up|11|||
150231341|NCT00943722|541985276|FG005|Base Study|Lost to Follow-up|0|||
150231342|NCT00943722|541985277|FG006|Base Study|Lost to Follow-up|0|||
150231343|NCT00943722|541985271|FG000|Base Study|Physician Decision|1|||
150231344|NCT00943722|541985272|FG001|Base Study|Physician Decision|0|||
150231345|NCT00943722|541985273|FG002|Base Study|Physician Decision|0|||
150231346|NCT00943722|541985274|FG003|Base Study|Physician Decision|0|||
150231347|NCT00943722|541985275|FG004|Base Study|Physician Decision|1|||
150231348|NCT00943722|541985276|FG005|Base Study|Physician Decision|0|||
150231349|NCT00943722|541985277|FG006|Base Study|Physician Decision|0|||
150231350|NCT00943722|541985271|FG000|Base Study|Pregnancy|0|||
150231351|NCT00943722|541985272|FG001|Base Study|Pregnancy|0|||
150231352|NCT00943722|541985273|FG002|Base Study|Pregnancy|1|||
150231353|NCT00943722|541985274|FG003|Base Study|Pregnancy|0|||
150231354|NCT00943722|541985275|FG004|Base Study|Pregnancy|2|||
150231355|NCT00943722|541985276|FG005|Base Study|Pregnancy|0|||
150231356|NCT00943722|541985277|FG006|Base Study|Pregnancy|0|||
150231357|NCT00943722|541985271|FG000|Base Study|Protocol Violation|0|||
150231358|NCT00943722|541985272|FG001|Base Study|Protocol Violation|1|||
150231359|NCT00943722|541985273|FG002|Base Study|Protocol Violation|0|||
150231360|NCT00943722|541985274|FG003|Base Study|Protocol Violation|0|||
150231361|NCT00943722|541985275|FG004|Base Study|Protocol Violation|2|||
150231362|NCT00943722|541985276|FG005|Base Study|Protocol Violation|0|||
150231363|NCT00943722|541985277|FG006|Base Study|Protocol Violation|0|||
150231364|NCT00943722|541985271|FG000|Base Study|Withdrawal by Subject|12|||
150231365|NCT00943722|541985272|FG001|Base Study|Withdrawal by Subject|13|||
150231366|NCT00943722|541985273|FG002|Base Study|Withdrawal by Subject|2|||
150231367|NCT00943722|541985274|FG003|Base Study|Withdrawal by Subject|13|||
150231368|NCT00943722|541985275|FG004|Base Study|Withdrawal by Subject|8|||
150231369|NCT00943722|541985276|FG005|Base Study|Withdrawal by Subject|0|||
150231370|NCT00943722|541985277|FG006|Base Study|Withdrawal by Subject|0|||
150231371|NCT00943722|541985271|FG000|Base Study|Month 12 visit not completed|0|||
150231372|NCT00943722|541985272|FG001|Base Study|Month 12 visit not completed|0|||
150231373|NCT00943722|541985273|FG002|Base Study|Month 12 visit not completed|0|||
150231374|NCT00943722|541985274|FG003|Base Study|Month 12 visit not completed|0|||
150231375|NCT00943722|541985275|FG004|Base Study|Month 12 visit not completed|2|||
150231376|NCT00943722|541985276|FG005|Base Study|Month 12 visit not completed|0|||
150231377|NCT00943722|541985277|FG006|Base Study|Month 12 visit not completed|0|||
150231378|NCT00943722|541985271|FG000|First Extension Study: EXT 1|Adverse Event|0|||
150231379|NCT00943722|541985272|FG001|First Extension Study: EXT 1|Adverse Event|0|||
150231380|NCT00943722|541985273|FG002|First Extension Study: EXT 1|Adverse Event|0|||
150231381|NCT00943722|541985274|FG003|First Extension Study: EXT 1|Adverse Event|0|||
150231382|NCT00943722|541985275|FG004|First Extension Study: EXT 1|Adverse Event|0|||
150231383|NCT00943722|541985276|FG005|First Extension Study: EXT 1|Adverse Event|1|||
150231384|NCT00943722|541985277|FG006|First Extension Study: EXT 1|Adverse Event|0|||
150231385|NCT00943722|541985271|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
150231386|NCT00943722|541985272|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
150231387|NCT00943722|541985273|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
150231388|NCT00943722|541985274|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
150231389|NCT00943722|541985275|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
150231390|NCT00943722|541985276|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
150231391|NCT00943722|541985277|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
150231392|NCT00943722|541985271|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
150231393|NCT00943722|541985272|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
150231394|NCT00943722|541985273|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
150231395|NCT00943722|541985274|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
150231396|NCT00943722|541985275|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
150231397|NCT00943722|541985276|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
150231398|NCT00943722|541985277|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
150231399|NCT00943722|541985271|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
150231400|NCT00943722|541985272|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
150231401|NCT00943722|541985273|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
150231402|NCT00943722|541985274|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
150231403|NCT00943722|541985275|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
150231404|NCT00943722|541985276|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
150231405|NCT00943722|541985277|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
150231406|NCT00943722|541985271|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
150231407|NCT00943722|541985272|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
150231408|NCT00943722|541985273|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
150231409|NCT00943722|541985274|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
150231410|NCT00943722|541985275|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
150231411|NCT00943722|541985276|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
150231412|NCT00943722|541985277|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
150231413|NCT00943722|541985271|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
150231414|NCT00943722|541985272|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
150231415|NCT00943722|541985273|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
150231416|NCT00943722|541985274|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
150231417|NCT00943722|541985275|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
150231418|NCT00943722|541985276|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
150231419|NCT00943722|541985277|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
150231420|NCT00943722|541985271|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
150231421|NCT00943722|541985272|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
150231422|NCT00943722|541985273|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
150231423|NCT00943722|541985274|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
150231424|NCT00943722|541985275|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
150231425|NCT00943722|541985276|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
150231426|NCT00943722|541985277|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
150231427|NCT00943722|541985271|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
150231428|NCT00943722|541985272|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
150231429|NCT00943722|541985273|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
150231430|NCT00943722|541985274|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
150231431|NCT00943722|541985275|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
150231432|NCT00943722|541985276|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
150231433|NCT00943722|541985277|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
150231434|NCT00943722|541985271|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
150231435|NCT00943722|541985272|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
150231436|NCT00943722|541985273|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
150231437|NCT00943722|541985274|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
150231438|NCT00943722|541985275|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
150231439|NCT00943722|541985276|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
150231440|NCT00943722|541985277|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
150231441|NCT01040403|541985284|FG000|Overall Study|Adverse Event|10|||
150231442|NCT01040403|541985284|FG000|Overall Study|Protocol Violation|2|||
150231443|NCT01040403|541985284|FG000|Overall Study|Lost to Follow-up|1|||
150231444|NCT01040403|541985284|FG000|Overall Study|Not treated|1|||
150231445|NCT01040403|541985284|FG000|Overall Study|Other reason not defined above|6|||
150231446|NCT00594178|541985285|FG000|Overall Study|Physician Decision|5|||
150231447|NCT00496626|541985286|FG000|Overall Study|Lost to Follow-up|0|||
150231448|NCT00496626|541985287|FG001|Overall Study|Lost to Follow-up|1|||
150231449|NCT00496626|541985286|FG000|Overall Study|Protocol Violation|1|||
150231450|NCT00496626|541985287|FG001|Overall Study|Protocol Violation|0|||
150231451|NCT00496626|541985286|FG000|Overall Study|Withdrawal by Subject|5|||
150231452|NCT00496626|541985287|FG001|Overall Study|Withdrawal by Subject|4|||
150231453|NCT00496626|541985286|FG000|Overall Study|Relocated|0|||
150231454|NCT00496626|541985287|FG001|Overall Study|Relocated|1|||
150231455|NCT04191148|541985292|FG000|Overall Study|Withdrawal by Subject|1|||
150231456|NCT04191148|541985293|FG001|Overall Study|Withdrawal by Subject|0|||
150231457|NCT04191148|541985292|FG000|Overall Study|Adverse Event|1|||
150231458|NCT04191148|541985293|FG001|Overall Study|Adverse Event|0|||
150231459|NCT01874665|541985294|FG000|Overall Study|Adverse Event|6|||
150231460|NCT01874665|541985295|FG001|Overall Study|Adverse Event|2|||
150231461|NCT01874665|541985294|FG000|Overall Study|Withdrawal by Subject|4|||
150231462|NCT01874665|541985295|FG001|Overall Study|Withdrawal by Subject|1|||
150231463|NCT01874665|541985294|FG000|Overall Study|Physician Decision|3|||
150231464|NCT01874665|541985295|FG001|Overall Study|Physician Decision|0|||
150231465|NCT01874665|541985294|FG000|Overall Study|Clinical Progressive Disease|4|||
150231466|NCT01874665|541985295|FG001|Overall Study|Clinical Progressive Disease|3|||
150231467|NCT01874665|541985294|FG000|Overall Study|Study Terminated by Sponsor|0|||
150231468|NCT01874665|541985295|FG001|Overall Study|Study Terminated by Sponsor|2|||
150231469|NCT01874665|541985294|FG000|Overall Study|Documented Progressive Disease|11|||
150231470|NCT01874665|541985295|FG001|Overall Study|Documented Progressive Disease|7|||
150231471|NCT01874665|541985294|FG000|Overall Study|Other|2|||
150231472|NCT01874665|541985295|FG001|Overall Study|Other|0|||
150231473|NCT02647788|541985296|FG000|Overall Study|Lost to Follow-up|13|||
150231474|NCT02647788|541985297|FG001|Overall Study|Lost to Follow-up|11|||
150231475|NCT02647788|541985296|FG000|Overall Study|Did not want opiate|0|||
150231476|NCT02647788|541985297|FG001|Overall Study|Did not want opiate|1|||
150231477|NCT02647788|541985296|FG000|Overall Study|Withdrawal by Subject|1|||
150231478|NCT02647788|541985297|FG001|Overall Study|Withdrawal by Subject|0|||
150231479|NCT02647788|541985296|FG000|Overall Study|Felt itchy with assigned medication|1|||
150231480|NCT02647788|541985297|FG001|Overall Study|Felt itchy with assigned medication|0|||
150231481|NCT02647788|541985296|FG000|Overall Study|Felt nauseous with assigned medication|1|||
150231482|NCT02647788|541985297|FG001|Overall Study|Felt nauseous with assigned medication|1|||
150231483|NCT03245619|541985298|FG000|Part A (Up to Day 22)|Physician Decision|4|||
150231484|NCT03245619|541985299|FG001|Part A (Up to Day 22)|Physician Decision|6|||
150231485|NCT03245619|541985300|FG002|Part A (Up to Day 22)|Physician Decision|6|||
150231486|NCT03245619|541985301|FG003|Part A (Up to Day 22)|Physician Decision|0|||
150231487|NCT03245619|541985302|FG004|Part A (Up to Day 22)|Physician Decision|0|||
150231488|NCT03245619|541985303|FG005|Part A (Up to Day 22)|Physician Decision|0|||
150231489|NCT03245619|541985304|FG006|Part A (Up to Day 22)|Physician Decision|0|||
150231490|NCT03245619|541985305|FG007|Part A (Up to Day 22)|Physician Decision|0|||
150231491|NCT03245619|541985306|FG008|Part A (Up to Day 22)|Physician Decision|0|||
150231492|NCT03245619|541985307|FG009|Part A (Up to Day 22)|Physician Decision|0|||
150231493|NCT03245619|541985308|FG010|Part A (Up to Day 22)|Physician Decision|0|||
150231494|NCT03245619|541985309|FG011|Part A (Up to Day 22)|Physician Decision|0|||
150231495|NCT03245619|541985310|FG012|Part A (Up to Day 22)|Physician Decision|0|||
150231496|NCT03245619|541985311|FG013|Part A (Up to Day 22)|Physician Decision|0|||
150231497|NCT03245619|541985312|FG014|Part A (Up to Day 22)|Physician Decision|0|||
150231498|NCT03245619|541985313|FG015|Part A (Up to Day 22)|Physician Decision|0|||
150231499|NCT03245619|541985314|FG016|Part A (Up to Day 22)|Physician Decision|0|||
150231500|NCT00776659|541985330|FG000|Overall Study|Lost to Follow-up|15|||
150231501|NCT00776659|541985330|FG000|Overall Study|Withdrawal by Subject|10|||
150231502|NCT00776659|541985330|FG000|Overall Study|Study Terminated by Sponsor|1|||
150231503|NCT01233999|541985333|FG000|Overall Study|Withdrawal by Subject|1|||
150231504|NCT01233999|541985333|FG000|Overall Study|Lost to Follow-up|1|||
150231505|NCT00025506|541985334|FG000|Overall Study|Ineligible: clerical error|1|||
150231506|NCT00025506|541985334|FG000|Overall Study|Ineligible: wrong cell type|5|||
150231507|NCT00025506|541985334|FG000|Overall Study|Ineligible: inadequate pathology|2|||
150231508|NCT00025506|541985334|FG000|Overall Study|Never Treated|2|||
150231509|NCT02246218|541985335|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
150231510|NCT02246218|541985336|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
150231511|NCT02246218|541985335|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
150231512|NCT02246218|541985336|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
150231513|NCT02246218|541985335|FG000|Overall Study|Adverse Event|1|||
150231514|NCT02246218|541985336|FG001|Overall Study|Adverse Event|1|||
150231515|NCT02246218|541985335|FG000|Overall Study|Lost to Follow-up|1|||
150231516|NCT02246218|541985336|FG001|Overall Study|Lost to Follow-up|0|||
150231517|NCT02547441|541985337|FG000|Double-Blind Study Period|Adverse Event|4|||
150231518|NCT02547441|541985338|FG001|Double-Blind Study Period|Adverse Event|9|||
150231519|NCT02547441|541985337|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
150231520|NCT02547441|541985338|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
150231521|NCT02547441|541985337|FG000|Double-Blind Study Period|Physician Decision|1|||
150231522|NCT02547441|541985338|FG001|Double-Blind Study Period|Physician Decision|0|||
150231523|NCT02547441|541985337|FG000|Double-Blind Study Period|Protocol Violation|1|||
150231524|NCT02547441|541985338|FG001|Double-Blind Study Period|Protocol Violation|2|||
150231525|NCT02547441|541985337|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
150231526|NCT02547441|541985338|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
150231527|NCT02547441|541985337|FG000|Double-Blind Study Period|Sponsor Decision|1|||
150231528|NCT02547441|541985338|FG001|Double-Blind Study Period|Sponsor Decision|0|||
150231529|NCT02547441|541985337|FG000|Open-Label Study Period|Adverse Event|10|||
150231530|NCT02547441|541985338|FG001|Open-Label Study Period|Adverse Event|11|||
150231531|NCT02547441|541985337|FG000|Open-Label Study Period|Lack of Efficacy|3|||
150231532|NCT02547441|541985338|FG001|Open-Label Study Period|Lack of Efficacy|2|||
150231533|NCT02547441|541985337|FG000|Open-Label Study Period|Lost to Follow-up|7|||
150231534|NCT02547441|541985338|FG001|Open-Label Study Period|Lost to Follow-up|8|||
150231535|NCT02547441|541985337|FG000|Open-Label Study Period|Physician Decision|1|||
150231536|NCT02547441|541985338|FG001|Open-Label Study Period|Physician Decision|0|||
150231537|NCT02547441|541985337|FG000|Open-Label Study Period|Protocol Violation|2|||
150231538|NCT02547441|541985338|FG001|Open-Label Study Period|Protocol Violation|0|||
150231539|NCT02547441|541985337|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
150231540|NCT02547441|541985338|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
150231541|NCT02547441|541985337|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
150231542|NCT02547441|541985338|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
150231543|NCT01322009|541985339|FG000|Overall Study|Death|0|||
150231544|NCT01322009|541985340|FG001|Overall Study|Death|1|||
150231545|NCT01322009|541985339|FG000|Overall Study|Adverse Event|0|||
150231546|NCT01322009|541985340|FG001|Overall Study|Adverse Event|1|||
150231547|NCT01322009|541985339|FG000|Overall Study|ng tube discontinued|0|||
150231548|NCT01322009|541985340|FG001|Overall Study|ng tube discontinued|1|||
150231549|NCT01657877|541985341|FG000|Overall Study|Withdrawal by Subject|4|||
150231550|NCT01657877|541985341|FG000|Overall Study|Protocol Violation|6|||
150231551|NCT01657877|541985341|FG000|Overall Study|Adverse Event|2|||
150231552|NCT01657877|541985341|FG000|Overall Study|Other Reason|2|||
150231553|NCT00905034|541985343|FG000|Overall Study|Withdrawal by Subject|1|||
150231554|NCT00394589|541985345|FG000|Overall Study|Adverse Event|2|||
150231555|NCT00394589|541985346|FG001|Overall Study|Adverse Event|1|||
150231556|NCT00394589|541985347|FG002|Overall Study|Adverse Event|2|||
150231557|NCT00394589|541985345|FG000|Overall Study|Lack of Efficacy|2|||
150231558|NCT00394589|541985346|FG001|Overall Study|Lack of Efficacy|2|||
150231559|NCT00394589|541985347|FG002|Overall Study|Lack of Efficacy|3|||
150231560|NCT00394589|541985345|FG000|Overall Study|Protocol Violation|4|||
150231561|NCT00394589|541985346|FG001|Overall Study|Protocol Violation|0|||
150231562|NCT00394589|541985347|FG002|Overall Study|Protocol Violation|2|||
150231563|NCT03409731|541985348|FG000|Overall Study|Withdrawal by Subject|17|||
150231564|NCT03409731|541985348|FG000|Overall Study|Death|4|||
150231565|NCT01114672|541985349|FG000|Overall Study|Death|0|||
150231566|NCT01114672|541985350|FG001|Overall Study|Death|1|||
150231567|NCT01114672|541985349|FG000|Overall Study|Withdrawal by Subject|2|||
150231568|NCT01114672|541985350|FG001|Overall Study|Withdrawal by Subject|1|||
150231569|NCT01114672|541985349|FG000|Overall Study|Lost to Follow-up|1|||
150231570|NCT01114672|541985350|FG001|Overall Study|Lost to Follow-up|0|||
150231571|NCT01114672|541985349|FG000|Overall Study|transplanted|1|||
150231572|NCT01114672|541985350|FG001|Overall Study|transplanted|0|||
150231573|NCT01710800|541985353|FG000|Overall Study|Withdrawal by Subject|21|||
150231574|NCT01710800|541985353|FG000|Overall Study|Protocol Violation|1|||
150231575|NCT02427958|541985354|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
150231576|NCT02427958|541985354|FG000|Overall Study|Lost to Follow-up|6|||
150231577|NCT02427958|541985354|FG000|Overall Study|Withdrawal by Subject|14|||
150231578|NCT02427958|541985354|FG000|Overall Study|Lack of Efficacy|1|||
150231579|NCT02287883|541985362|FG000|Overall Study|Death|8|||
150231580|NCT02287883|541985363|FG001|Overall Study|Death|7|||
150231581|NCT02287883|541985362|FG000|Overall Study|No longer eligible|222|||
150231582|NCT02287883|541985363|FG001|Overall Study|No longer eligible|182|||
150231583|NCT02287883|541985362|FG000|Overall Study|Non-response to survey|229|||
150231584|NCT02287883|541985363|FG001|Overall Study|Non-response to survey|237|||
150231585|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
150231586|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
150231587|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
150231588|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
150231589|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
150231590|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
150231591|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Rejections|0|||
150231592|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Rejections|0|||
150231593|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Rejections|55|||
150231594|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
150231595|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
150231596|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
150231597|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
150231598|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
150231599|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
150231600|NCT00634920|541985364|FG000|Period 1 - Pre-Randomization|Other issues|0|||
150231601|NCT00634920|541985365|FG001|Period 1 - Pre-Randomization|Other issues|0|||
150231602|NCT00634920|541985366|FG002|Period 1 - Pre-Randomization|Other issues|6|||
150231603|NCT00634920|541985364|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
150231604|NCT00634920|541985365|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
150231605|NCT00634920|541985366|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
150231606|NCT00634920|541985364|FG000|Period 2 - Post-Randomization|Rejection|11|||
150231607|NCT00634920|541985365|FG001|Period 2 - Post-Randomization|Rejection|5|||
150231608|NCT00634920|541985366|FG002|Period 2 - Post-Randomization|Rejection|0|||
150231609|NCT00634920|541985364|FG000|Period 2 - Post-Randomization|Death|2|||
150231610|NCT00634920|541985365|FG001|Period 2 - Post-Randomization|Death|5|||
150231611|NCT00634920|541985366|FG002|Period 2 - Post-Randomization|Death|0|||
150231612|NCT00634920|541985364|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
150231613|NCT00634920|541985365|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
150231614|NCT00634920|541985366|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
150231615|NCT00634920|541985364|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
150231616|NCT00634920|541985365|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
150231617|NCT00634920|541985366|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
150231618|NCT01527500|541985368|FG000|Part A|Administrative|11|||
150231619|NCT01527500|541985369|FG001|Part A|Administrative|7|||
150231620|NCT01527500|541985368|FG000|Part A|Adverse Event|4|||
150231621|NCT01527500|541985369|FG001|Part A|Adverse Event|2|||
150231622|NCT01527500|541985368|FG000|Part A|Death|4|||
150231623|NCT01527500|541985369|FG001|Part A|Death|1|||
150231624|NCT01527500|541985368|FG000|Part A|Lost to Follow-up|0|||
150231625|NCT01527500|541985369|FG001|Part A|Lost to Follow-up|1|||
150231626|NCT01527500|541985368|FG000|Part A|Protocol Deviation|9|||
150231627|NCT01527500|541985369|FG001|Part A|Protocol Deviation|2|||
150231628|NCT01527500|541985368|FG000|Part A|Withdrawal by Subject|2|||
150231629|NCT01527500|541985369|FG001|Part A|Withdrawal by Subject|0|||
150231630|NCT01527500|541985368|FG000|Part B|Adverse Event|1|||
150231631|NCT01527500|541985369|FG001|Part B|Adverse Event|0|||
150231632|NCT00372255|541985370|FG000|Overall Study|Withdrawn for other reasons|2|||
150231633|NCT00372255|541985371|FG001|Overall Study|Withdrawn for other reasons|1|||
150231634|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
150231635|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
150231636|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
150231637|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
150231638|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
150231639|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
150231640|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
150231641|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
150231642|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
150231643|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
150231644|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
150231645|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
150231646|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
150231647|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
150231648|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
150231649|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
150231650|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
150231651|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
150231652|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
150231653|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
150231654|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
150231655|NCT01125566|541985377|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
150231656|NCT01125566|541985378|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
150231657|NCT01125566|541985379|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
150231658|NCT01125566|541985377|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
150231659|NCT01125566|541985378|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
150231660|NCT01125566|541985379|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
150231661|NCT01125566|541985377|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
150231662|NCT01125566|541985378|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
150231663|NCT01125566|541985379|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
150231664|NCT01125566|541985377|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
150231665|NCT01125566|541985378|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
150231666|NCT01125566|541985379|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
150231667|NCT01125566|541985377|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
150231668|NCT01125566|541985378|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
150231669|NCT01125566|541985379|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
150231670|NCT01560585|541985380|FG000|Overall Study|Physician Decision|3|||
150231671|NCT02970305|541985381|FG000|Overall Study|Adverse Event|10|||
150231672|NCT02970305|541985382|FG001|Overall Study|Adverse Event|6|||
150231673|NCT02970305|541985381|FG000|Overall Study|Lack of Efficacy|1|||
150231674|NCT02970305|541985382|FG001|Overall Study|Lack of Efficacy|1|||
150231675|NCT02970305|541985381|FG000|Overall Study|Noncompliance with study drug|2|||
150231676|NCT02970305|541985382|FG001|Overall Study|Noncompliance with study drug|4|||
150231677|NCT02970305|541985381|FG000|Overall Study|Protocol Violation|2|||
150231678|NCT02970305|541985382|FG001|Overall Study|Protocol Violation|2|||
150231679|NCT02970305|541985381|FG000|Overall Study|Withdrawal by Subject|12|||
150231680|NCT02970305|541985382|FG001|Overall Study|Withdrawal by Subject|11|||
150231681|NCT02970305|541985381|FG000|Overall Study|Not further specified|1|||
150231682|NCT02970305|541985382|FG001|Overall Study|Not further specified|2|||
150231683|NCT02970305|541985381|FG000|Overall Study|Lost to Follow-up|1|||
150231684|NCT02970305|541985382|FG001|Overall Study|Lost to Follow-up|2|||
150231685|NCT01813305|541985383|FG000|Overall Study|Withdrawal by Subject|12|||
150231686|NCT01813305|541985384|FG001|Overall Study|Withdrawal by Subject|5|||
150231687|NCT01813305|541985383|FG000|Overall Study|Safety Concern|4|||
150231688|NCT01813305|541985384|FG001|Overall Study|Safety Concern|0|||
150231689|NCT01813305|541985383|FG000|Overall Study|Ulcer became worse|4|||
150231690|NCT01813305|541985384|FG001|Overall Study|Ulcer became worse|0|||
150231691|NCT01813305|541985383|FG000|Overall Study|Physician Decision|4|||
150231692|NCT01813305|541985384|FG001|Overall Study|Physician Decision|0|||
150231693|NCT01813305|541985383|FG000|Overall Study|Lost to Follow-up|3|||
150231694|NCT01813305|541985384|FG001|Overall Study|Lost to Follow-up|1|||
150231695|NCT01813305|541985383|FG000|Overall Study|Protocol Violation|1|||
150231696|NCT01813305|541985384|FG001|Overall Study|Protocol Violation|0|||
150231697|NCT01813305|541985383|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
150231698|NCT01813305|541985384|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
150231699|NCT00988117|541985385|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
150231700|NCT00988117|541985385|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
150231701|NCT04088500|541985386|FG000|Overall Study|Reason unknown|1|||
150231702|NCT04088500|541985386|FG000|Overall Study|Participant withdrew consent|1|||
150231703|NCT04088500|541985386|FG000|Overall Study|Disease progression|3|||
150231704|NCT02930837|541985390|FG000|Overall Study|Adverse Event|6|||
150231705|NCT02930837|541985390|FG000|Overall Study|Lost to Follow-up|5|||
150231706|NCT02930837|541985390|FG000|Overall Study|Withdrawal by Subject|1|||
150231707|NCT02973802|541987110|FG000|Overall Study|Lost to Follow-up|1|||
150231708|NCT02973802|541987110|FG000|Overall Study|Withdrawal by Subject|1|||
150231709|NCT01850823|541987112|FG000|Overall Study|Early Visit Window|0|||
150231710|NCT01850823|541987113|FG001|Overall Study|Early Visit Window|1|||
150231711|NCT01850823|541987114|FG002|Overall Study|Early Visit Window|4|||
150231712|NCT01850823|541987112|FG000|Overall Study|Enrolled in Error|0|||
150231713|NCT01850823|541987113|FG001|Overall Study|Enrolled in Error|1|||
150231714|NCT01850823|541987114|FG002|Overall Study|Enrolled in Error|2|||
150231715|NCT01850823|541987112|FG000|Overall Study|Lack of Efficacy|1|||
150231716|NCT01850823|541987113|FG001|Overall Study|Lack of Efficacy|0|||
150231717|NCT01850823|541987114|FG002|Overall Study|Lack of Efficacy|0|||
150231718|NCT01850823|541987112|FG000|Overall Study|Lost to Follow-up|0|||
150231719|NCT01850823|541987113|FG001|Overall Study|Lost to Follow-up|0|||
150231720|NCT01850823|541987114|FG002|Overall Study|Lost to Follow-up|1|||
150231721|NCT01850823|541987112|FG000|Overall Study|Restricted Medication|0|||
150231722|NCT01850823|541987113|FG001|Overall Study|Restricted Medication|0|||
150231723|NCT01850823|541987114|FG002|Overall Study|Restricted Medication|2|||
150231724|NCT01850823|541987112|FG000|Overall Study|Significant worstening of SAR|0|||
150231725|NCT01850823|541987113|FG001|Overall Study|Significant worstening of SAR|1|||
150231726|NCT01850823|541987114|FG002|Overall Study|Significant worstening of SAR|0|||
150231727|NCT01850823|541987112|FG000|Overall Study|Withdrawal by Subject|2|||
150231728|NCT01850823|541987113|FG001|Overall Study|Withdrawal by Subject|0|||
150231729|NCT01850823|541987114|FG002|Overall Study|Withdrawal by Subject|1|||
150231730|NCT01751165|541987115|FG000|Overall Study|Adverse event, serious fatal|1|||
150231731|NCT01751165|541987116|FG001|Overall Study|Adverse event, serious fatal|0|||
150231732|NCT01751165|541987117|FG002|Overall Study|Adverse event, serious fatal|1|||
150231733|NCT01751165|541987115|FG000|Overall Study|Withdrawal by Subject|0|||
150231734|NCT01751165|541987116|FG001|Overall Study|Withdrawal by Subject|0|||
150231735|NCT01751165|541987117|FG002|Overall Study|Withdrawal by Subject|1|||
150231736|NCT01751165|541987115|FG000|Overall Study|Serious adverse event|0|||
150231737|NCT01751165|541987116|FG001|Overall Study|Serious adverse event|2|||
150231738|NCT01751165|541987117|FG002|Overall Study|Serious adverse event|0|||
150231739|NCT01751165|541987115|FG000|Overall Study|Lost to Follow-up|1|||
150231740|NCT01751165|541987116|FG001|Overall Study|Lost to Follow-up|1|||
150231741|NCT01751165|541987117|FG002|Overall Study|Lost to Follow-up|1|||
150231742|NCT00988533|541987118|FG000|Overall Study|Lost to Follow-up|3|||
150231743|NCT00913523|541987122|FG000|Overall Study|Withdrawal by Subject|3|||
150231744|NCT00913523|541987123|FG001|Overall Study|Withdrawal by Subject|2|||
150231745|NCT00913523|541987124|FG002|Overall Study|Withdrawal by Subject|2|||
150231746|NCT00913523|541987122|FG000|Overall Study|Lost to Follow-up|1|||
150231747|NCT00913523|541987123|FG001|Overall Study|Lost to Follow-up|1|||
150231748|NCT00913523|541987124|FG002|Overall Study|Lost to Follow-up|1|||
150231749|NCT00913523|541987122|FG000|Overall Study|Adverse Event|1|||
150231750|NCT00913523|541987123|FG001|Overall Study|Adverse Event|0|||
150231751|NCT00913523|541987124|FG002|Overall Study|Adverse Event|0|||
150231752|NCT00913523|541987122|FG000|Overall Study|Protocol Violation|5|||
150231753|NCT00913523|541987123|FG001|Overall Study|Protocol Violation|8|||
150231754|NCT00913523|541987124|FG002|Overall Study|Protocol Violation|8|||
150231755|NCT00913523|541987122|FG000|Overall Study|Pregnancy|1|||
150231756|NCT00913523|541987123|FG001|Overall Study|Pregnancy|3|||
150231757|NCT00913523|541987124|FG002|Overall Study|Pregnancy|0|||
150231758|NCT00913523|541987122|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
150231759|NCT00913523|541987123|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
150231760|NCT00913523|541987124|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
150231761|NCT01202409|541987125|FG000|Overall Study|Adverse Event|1|||
150231762|NCT01202409|541987125|FG000|Overall Study|Ineligible - KRAS mutants|7|||
150231763|NCT00553605|541987126|FG000|Overall Study|Did not meet entrance criteria|1|||
150231764|NCT00553605|541987127|FG001|Overall Study|Did not meet entrance criteria|3|||
150231765|NCT00553605|541987126|FG000|Overall Study|Did not receive full dose|1|||
150231766|NCT00553605|541987127|FG001|Overall Study|Did not receive full dose|0|||
150231767|NCT00553605|541987126|FG000|Overall Study|Randomized but not treated|2|||
150231768|NCT00553605|541987127|FG001|Overall Study|Randomized but not treated|0|||
150231769|NCT00292981|541987131|FG000|Overall Study|Adverse Event|1|||
150231770|NCT00292981|541987131|FG000|Overall Study|Lost to Follow-up|13|||
150231771|NCT00292981|541987131|FG000|Overall Study|Withdrawal by Subject|22|||
150231772|NCT00292981|541987131|FG000|Overall Study|Other|3|||
150231773|NCT01085812|541987132|FG000|Open-Label Period|Adverse Event|0|||
150231774|NCT01085812|541987133|FG001|Open-Label Period|Adverse Event|80|||
150231775|NCT01085812|541987132|FG000|Open-Label Period|Lack of Efficacy|0|||
150231776|NCT01085812|541987133|FG001|Open-Label Period|Lack of Efficacy|26|||
150231777|NCT01085812|541987132|FG000|Open-Label Period|Protocol Violation|0|||
150231778|NCT01085812|541987133|FG001|Open-Label Period|Protocol Violation|39|||
150231779|NCT01085812|541987132|FG000|Open-Label Period|Withdrawal by Subject|0|||
150231780|NCT01085812|541987133|FG001|Open-Label Period|Withdrawal by Subject|53|||
150231781|NCT01085812|541987132|FG000|Open-Label Period|Lost to Follow-up|0|||
150231782|NCT01085812|541987133|FG001|Open-Label Period|Lost to Follow-up|42|||
150231783|NCT01085812|541987132|FG000|Double-Blind Period|Adverse Event|3|||
150231784|NCT01085812|541987133|FG001|Double-Blind Period|Adverse Event|8|||
150231785|NCT01085812|541987132|FG000|Double-Blind Period|Protocol Violation|2|||
150231786|NCT01085812|541987133|FG001|Double-Blind Period|Protocol Violation|7|||
150231787|NCT01085812|541987132|FG000|Double-Blind Period|Withdrawal by Subject|11|||
150231788|NCT01085812|541987133|FG001|Double-Blind Period|Withdrawal by Subject|24|||
150231789|NCT01085812|541987132|FG000|Double-Blind Period|Lost to Follow-up|5|||
150231790|NCT01085812|541987133|FG001|Double-Blind Period|Lost to Follow-up|17|||
150231791|NCT01085812|541987132|FG000|Double-Blind Period|Other Reasons|0|||
150231792|NCT01085812|541987133|FG001|Double-Blind Period|Other Reasons|2|||
150231793|NCT01085812|541987132|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
150231794|NCT01085812|541987133|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
150231795|NCT01085812|541987132|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
150231796|NCT01085812|541987133|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
150231797|NCT01085812|541987132|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
150231798|NCT01085812|541987133|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
150231799|NCT01085812|541987132|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
150231800|NCT01085812|541987133|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
150231801|NCT01085812|541987132|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
150231802|NCT01085812|541987133|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
150231803|NCT04582669|541987135|FG000|Overall Study|Subject missed appointment(s).|1|||
150231804|NCT04582669|541987136|FG001|Overall Study|Subject missed appointment(s).|0|||
150231805|NCT04582669|541987137|FG002|Overall Study|Subject missed appointment(s).|1|||
150231806|NCT04582669|541987138|FG003|Overall Study|Subject missed appointment(s).|2|||
150231807|NCT04582669|541987135|FG000|Overall Study|Protocol Violation|0|||
150231808|NCT04582669|541987136|FG001|Overall Study|Protocol Violation|1|||
150231809|NCT04582669|541987137|FG002|Overall Study|Protocol Violation|1|||
150231810|NCT04582669|541987138|FG003|Overall Study|Protocol Violation|0|||
150231811|NCT01274559|541987141|FG000|Overall Study|Adverse Event|57|||
150231812|NCT01274559|541987142|FG001|Overall Study|Adverse Event|13|||
150231813|NCT01274559|541987141|FG000|Overall Study|Death|1|||
150231814|NCT01274559|541987142|FG001|Overall Study|Death|1|||
150231815|NCT01274559|541987141|FG000|Overall Study|Lost to Follow-up|3|||
150231816|NCT01274559|541987142|FG001|Overall Study|Lost to Follow-up|3|||
150231817|NCT01274559|541987141|FG000|Overall Study|Non-compliance with Study Drug|2|||
150231818|NCT01274559|541987142|FG001|Overall Study|Non-compliance with Study Drug|4|||
150231819|NCT01274559|541987141|FG000|Overall Study|Physician Decision|2|||
150231820|NCT01274559|541987142|FG001|Overall Study|Physician Decision|1|||
150231821|NCT01274559|541987141|FG000|Overall Study|Protocol Violation|28|||
150231822|NCT01274559|541987142|FG001|Overall Study|Protocol Violation|23|||
150231823|NCT01274559|541987141|FG000|Overall Study|Study Terminated by Sponsor|79|||
150231824|NCT01274559|541987142|FG001|Overall Study|Study Terminated by Sponsor|87|||
150231825|NCT01274559|541987141|FG000|Overall Study|Withdrawal by Subject|25|||
150231826|NCT01274559|541987142|FG001|Overall Study|Withdrawal by Subject|13|||
150231827|NCT03503162|541987150|FG000|Overall Study|did not meet eligibility|1|||
150231828|NCT00545571|541987154|FG000|Overall Study|Administrative Reasons|1|||
150231829|NCT00545571|541987154|FG000|Overall Study|Adverse Event|2|||
150231830|NCT00545571|541987154|FG000|Overall Study|Death|5|||
150231831|NCT00545571|541987154|FG000|Overall Study|Lack of Efficacy|1|||
150231832|NCT00545571|541987154|FG000|Overall Study|Protocol Violation|2|||
150231833|NCT00545571|541987154|FG000|Overall Study|Refused Treatment|1|||
150231834|NCT00545571|541987154|FG000|Overall Study|Screen Failure|16|||
150231835|NCT00545571|541987154|FG000|Overall Study|Transfusion|12|||
150231836|NCT00545571|541987154|FG000|Overall Study|Early Termination of Study|24|||
150231837|NCT00545571|541987154|FG000|Overall Study|Kidney Transplantation|3|||
150231838|NCT01978236|541987155|FG000|Overall Study|Discontinued due to study close|2|||
150231839|NCT01193218|541987157|FG000|0-12 Weeks|Adverse Event|6|||
150231840|NCT01193218|541987158|FG001|0-12 Weeks|Adverse Event|0|||
150231841|NCT01193218|541987159|FG002|0-12 Weeks|Adverse Event|1|||
150231842|NCT01193218|541987160|FG003|0-12 Weeks|Adverse Event|0|||
150231843|NCT01193218|541987161|FG004|0-12 Weeks|Adverse Event|0|||
150231844|NCT01193218|541987162|FG005|0-12 Weeks|Adverse Event|2|||
150231845|NCT01193218|541987163|FG006|0-12 Weeks|Adverse Event|2|||
150231846|NCT01193218|541987164|FG007|0-12 Weeks|Adverse Event|0|||
150231847|NCT01193218|541987157|FG000|0-12 Weeks|Protocol Violation|0|||
150231848|NCT01193218|541987158|FG001|0-12 Weeks|Protocol Violation|0|||
150231849|NCT01193218|541987159|FG002|0-12 Weeks|Protocol Violation|0|||
150231850|NCT01193218|541987160|FG003|0-12 Weeks|Protocol Violation|0|||
150231851|NCT01193218|541987161|FG004|0-12 Weeks|Protocol Violation|1|||
150231852|NCT01193218|541987162|FG005|0-12 Weeks|Protocol Violation|1|||
150231853|NCT01193218|541987163|FG006|0-12 Weeks|Protocol Violation|0|||
150231854|NCT01193218|541987164|FG007|0-12 Weeks|Protocol Violation|0|||
150231855|NCT01193218|541987157|FG000|0-12 Weeks|Withdrawal by Subject|3|||
150231856|NCT01193218|541987158|FG001|0-12 Weeks|Withdrawal by Subject|0|||
150231857|NCT01193218|541987159|FG002|0-12 Weeks|Withdrawal by Subject|2|||
150231858|NCT01193218|541987160|FG003|0-12 Weeks|Withdrawal by Subject|0|||
150231859|NCT01193218|541987161|FG004|0-12 Weeks|Withdrawal by Subject|0|||
150231860|NCT01193218|541987162|FG005|0-12 Weeks|Withdrawal by Subject|0|||
150231861|NCT01193218|541987163|FG006|0-12 Weeks|Withdrawal by Subject|1|||
150231862|NCT01193218|541987164|FG007|0-12 Weeks|Withdrawal by Subject|0|||
150231863|NCT01193218|541987157|FG000|12-52 Weeks|Adverse Event|1|||
150231864|NCT01193218|541987158|FG001|12-52 Weeks|Adverse Event|0|||
150231865|NCT01193218|541987159|FG002|12-52 Weeks|Adverse Event|1|||
150231866|NCT01193218|541987160|FG003|12-52 Weeks|Adverse Event|2|||
150231867|NCT01193218|541987161|FG004|12-52 Weeks|Adverse Event|3|||
150231868|NCT01193218|541987162|FG005|12-52 Weeks|Adverse Event|3|||
150231869|NCT01193218|541987163|FG006|12-52 Weeks|Adverse Event|1|||
150231870|NCT01193218|541987164|FG007|12-52 Weeks|Adverse Event|2|||
150231871|NCT01193218|541987157|FG000|12-52 Weeks|Lack of Efficacy|0|||
150231872|NCT01193218|541987158|FG001|12-52 Weeks|Lack of Efficacy|0|||
150231873|NCT01193218|541987159|FG002|12-52 Weeks|Lack of Efficacy|0|||
150231874|NCT01193218|541987160|FG003|12-52 Weeks|Lack of Efficacy|0|||
150231875|NCT01193218|541987161|FG004|12-52 Weeks|Lack of Efficacy|0|||
150231876|NCT01193218|541987162|FG005|12-52 Weeks|Lack of Efficacy|0|||
150231877|NCT01193218|541987163|FG006|12-52 Weeks|Lack of Efficacy|1|||
150231878|NCT01193218|541987164|FG007|12-52 Weeks|Lack of Efficacy|0|||
150231879|NCT01193218|541987157|FG000|12-52 Weeks|Withdrawal by Subject|3|||
150231880|NCT01193218|541987158|FG001|12-52 Weeks|Withdrawal by Subject|0|||
150231881|NCT01193218|541987159|FG002|12-52 Weeks|Withdrawal by Subject|3|||
150231882|NCT01193218|541987160|FG003|12-52 Weeks|Withdrawal by Subject|0|||
150231883|NCT01193218|541987161|FG004|12-52 Weeks|Withdrawal by Subject|0|||
150231884|NCT01193218|541987162|FG005|12-52 Weeks|Withdrawal by Subject|2|||
150231885|NCT01193218|541987163|FG006|12-52 Weeks|Withdrawal by Subject|1|||
150231886|NCT01193218|541987164|FG007|12-52 Weeks|Withdrawal by Subject|2|||
150231887|NCT01193218|541987157|FG000|12-52 Weeks|Other reason than above|1|||
150231888|NCT01193218|541987158|FG001|12-52 Weeks|Other reason than above|0|||
150231889|NCT01193218|541987159|FG002|12-52 Weeks|Other reason than above|0|||
150231890|NCT01193218|541987160|FG003|12-52 Weeks|Other reason than above|1|||
150231891|NCT01193218|541987161|FG004|12-52 Weeks|Other reason than above|1|||
150231892|NCT01193218|541987162|FG005|12-52 Weeks|Other reason than above|0|||
150231893|NCT01193218|541987163|FG006|12-52 Weeks|Other reason than above|0|||
150231894|NCT01193218|541987164|FG007|12-52 Weeks|Other reason than above|0|||
150231895|NCT00363649|541987165|FG000|Overall Study|Withdrawal by Subject|1|||
150231896|NCT00363649|541987166|FG001|Overall Study|Withdrawal by Subject|1|||
150231897|NCT00363649|541987165|FG000|Overall Study|Adverse Event|6|||
150231898|NCT00363649|541987166|FG001|Overall Study|Adverse Event|0|||
150231899|NCT01013740|541987167|FG000|Overall Study|Lost to Follow-up|3|||
150231900|NCT01013740|541987168|FG001|Overall Study|Lost to Follow-up|5|||
150231901|NCT01013740|541987167|FG000|Overall Study|Physician Decision|2|||
150231902|NCT01013740|541987168|FG001|Overall Study|Physician Decision|0|||
150231903|NCT01013740|541987167|FG000|Overall Study|Withdrawal by Subject|2|||
150231904|NCT01013740|541987168|FG001|Overall Study|Withdrawal by Subject|10|||
150231905|NCT01013740|541987167|FG000|Overall Study|study close / terminated : done in error|2|||
150231906|NCT01013740|541987168|FG001|Overall Study|study close / terminated : done in error|1|||
150231907|NCT01013740|541987167|FG000|Overall Study|Missing|2|||
150231908|NCT01013740|541987168|FG001|Overall Study|Missing|1|||
150231909|NCT01013740|541987167|FG000|Overall Study|Ongoing: Study records not completed|0|||
150231910|NCT01013740|541987168|FG001|Overall Study|Ongoing: Study records not completed|2|||
150231911|NCT03811834|541987171|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
150231912|NCT00576823|541987172|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
150231913|NCT00576823|541987173|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
150231914|NCT00576823|541987174|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
150231915|NCT00576823|541987172|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
150231916|NCT00576823|541987173|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
150231917|NCT00576823|541987174|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
150231918|NCT01242371|541987175|FG000|Overall Study|Withdrawal by Subject|2|||
150231919|NCT01242371|541987176|FG001|Overall Study|Withdrawal by Subject|2|||
150231920|NCT01242371|541987175|FG000|Overall Study|Protocol Violation|0|||
150231921|NCT01242371|541987176|FG001|Overall Study|Protocol Violation|3|||
150231922|NCT00510146|541987177|FG000|Double-Blind Treatment|Adverse Event|30|||
150231923|NCT00510146|541987178|FG001|Double-Blind Treatment|Adverse Event|13|||
150231924|NCT00510146|541987177|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
150231925|NCT00510146|541987178|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
150231926|NCT00510146|541987177|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
150231927|NCT00510146|541987178|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
150231928|NCT00510146|541987177|FG000|Double-Blind Treatment|Physician Decision|6|||
150231929|NCT00510146|541987178|FG001|Double-Blind Treatment|Physician Decision|0|||
150231930|NCT00510146|541987177|FG000|Double-Blind Treatment|Protocol Violation|1|||
150231931|NCT00510146|541987178|FG001|Double-Blind Treatment|Protocol Violation|2|||
150231932|NCT00510146|541987177|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
150231933|NCT00510146|541987178|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
150231934|NCT00510146|541987177|FG000|Double-Blind Treatment|Clinical Relapse|0|||
150231935|NCT00510146|541987178|FG001|Double-Blind Treatment|Clinical Relapse|1|||
150231936|NCT00510146|541987177|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
150231937|NCT00510146|541987178|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
150231938|NCT00510146|541987177|FG000|Open-Label Treatment|Adverse Event|22|||
150231939|NCT00510146|541987178|FG001|Open-Label Treatment|Adverse Event|8|||
150231940|NCT00510146|541987177|FG000|Open-Label Treatment|Death|1|||
150231941|NCT00510146|541987178|FG001|Open-Label Treatment|Death|1|||
150231942|NCT00510146|541987177|FG000|Open-Label Treatment|Lack of Efficacy|4|||
150231943|NCT00510146|541987178|FG001|Open-Label Treatment|Lack of Efficacy|0|||
150231944|NCT00510146|541987177|FG000|Open-Label Treatment|Lost to Follow-up|10|||
150231945|NCT00510146|541987178|FG001|Open-Label Treatment|Lost to Follow-up|1|||
150231946|NCT00510146|541987177|FG000|Open-Label Treatment|Physician Decision|3|||
150231947|NCT00510146|541987178|FG001|Open-Label Treatment|Physician Decision|1|||
150231948|NCT00510146|541987177|FG000|Open-Label Treatment|Protocol Violation|4|||
150231949|NCT00510146|541987178|FG001|Open-Label Treatment|Protocol Violation|2|||
150231950|NCT00510146|541987177|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
150231951|NCT00510146|541987178|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
150231952|NCT00510146|541987177|FG000|Open-Label Treatment|Clinical Relapse|1|||
150231953|NCT00510146|541987178|FG001|Open-Label Treatment|Clinical Relapse|1|||
150231954|NCT00510146|541987177|FG000|Open-Label Treatment|Sponsor Decision|2|||
150231955|NCT00510146|541987178|FG001|Open-Label Treatment|Sponsor Decision|0|||
150231956|NCT03188536|541987181|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
150231957|NCT03188536|541987181|FG000|Overall Study|Not participated/met inclusion criteria|1|||
150231958|NCT01930214|541987182|FG000|Overall Study|Death|4|||
150231959|NCT01930214|541987183|FG001|Overall Study|Death|4|||
150231960|NCT01930214|541987184|FG002|Overall Study|Death|11|||
150231961|NCT01930214|541987182|FG000|Overall Study|Lost to Follow-up|12|||
150231962|NCT01930214|541987183|FG001|Overall Study|Lost to Follow-up|13|||
150231963|NCT01930214|541987184|FG002|Overall Study|Lost to Follow-up|12|||
150231964|NCT01930214|541987182|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
150231965|NCT01930214|541987183|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
150231966|NCT01930214|541987184|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
150231967|NCT01930214|541987182|FG000|Overall Study|Physician Decision|2|||
150231968|NCT01930214|541987183|FG001|Overall Study|Physician Decision|0|||
150231969|NCT01930214|541987184|FG002|Overall Study|Physician Decision|0|||
150231970|NCT00025662|541987185|FG000|Overall Study|Withdrawal by Subject|2|||
150231971|NCT00025662|541987185|FG000|Overall Study|Technical failure of manipulation|1|||
150231972|NCT02132117|541987188|FG000|Overall Study|Adverse Event|6|||
150231973|NCT02132117|541987189|FG001|Overall Study|Adverse Event|1|||
150231974|NCT02132117|541987188|FG000|Overall Study|Lost to Follow-up|2|||
150231975|NCT02132117|541987189|FG001|Overall Study|Lost to Follow-up|2|||
150231976|NCT02132117|541987188|FG000|Overall Study|Personal Reasons|1|||
150231977|NCT02132117|541987189|FG001|Overall Study|Personal Reasons|2|||
150231978|NCT02132117|541987188|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150231979|NCT02132117|541987189|FG001|Overall Study|Other Miscellaneous Reasons|0|||
150231980|NCT04947436|541987190|FG000|Overall Study|Lost to Follow-up|3|||
150231981|NCT04947436|541987191|FG001|Overall Study|Lost to Follow-up|7|||
150231982|NCT04947436|541987192|FG002|Overall Study|Lost to Follow-up|5|||
150231983|NCT04947436|541987190|FG000|Overall Study|Death|1|||
150231984|NCT04947436|541987191|FG001|Overall Study|Death|1|||
150231985|NCT04947436|541987192|FG002|Overall Study|Death|1|||
150231986|NCT02161185|541987196|FG000|Treatment Phase|Administrative/Other|7|||
150231987|NCT02864342|541987200|FG000|Overall Study|Eligibility Criteria Deviation|2|||
150231988|NCT02864342|541987201|FG001|Overall Study|Eligibility Criteria Deviation|3|||
150231989|NCT02864342|541987200|FG000|Overall Study|Withdrawal by Subject|4|||
150231990|NCT02864342|541987201|FG001|Overall Study|Withdrawal by Subject|2|||
150231991|NCT02864342|541987200|FG000|Overall Study|Device Technology Issue|6|||
150231992|NCT02864342|541987201|FG001|Overall Study|Device Technology Issue|7|||
150231993|NCT02864342|541987200|FG000|Overall Study|Death|0|||
150231994|NCT02864342|541987201|FG001|Overall Study|Death|1|||
150231995|NCT02864342|541987200|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
150231996|NCT02864342|541987201|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
150231997|NCT02864342|541987200|FG000|Overall Study|Lost to Follow-up|1|||
150231998|NCT02864342|541987201|FG001|Overall Study|Lost to Follow-up|5|||
150231999|NCT02864342|541987200|FG000|Overall Study|Lost Device|1|||
150232000|NCT02864342|541987201|FG001|Overall Study|Lost Device|0|||
150232001|NCT02864342|541987200|FG000|Overall Study|Adverse Event|1|||
150232002|NCT02864342|541987201|FG001|Overall Study|Adverse Event|0|||
150232003|NCT02573883|541987202|FG000|Six Month Follow Up|Lost to Follow-up|1|||
150232004|NCT02573883|541987203|FG001|Six Month Follow Up|Lost to Follow-up|0|||
150232005|NCT02573883|541987204|FG002|Six Month Follow Up|Lost to Follow-up|0|||
150232006|NCT02573883|541987205|FG003|Six Month Follow Up|Lost to Follow-up|0|||
150232007|NCT02573883|541987202|FG000|One Year Follow Up|Lost to Follow-up|2|||
150232008|NCT02573883|541987203|FG001|One Year Follow Up|Lost to Follow-up|1|||
150232009|NCT02573883|541987204|FG002|One Year Follow Up|Lost to Follow-up|0|||
150232010|NCT02573883|541987205|FG003|One Year Follow Up|Lost to Follow-up|0|||
150232011|NCT00582114|541987206|FG000|Overall Study|Death|4|||
150232012|NCT00582114|541987207|FG001|Overall Study|Death|4|||
150232013|NCT00582114|541987206|FG000|Overall Study|Kidney Transplant|3|||
150232014|NCT00582114|541987207|FG001|Overall Study|Kidney Transplant|1|||
150232015|NCT00582114|541987206|FG000|Overall Study|Lost to Follow-up|7|||
150232016|NCT00582114|541987207|FG001|Overall Study|Lost to Follow-up|6|||
150232017|NCT00582114|541987206|FG000|Overall Study|Withdrawal by Subject|8|||
150232018|NCT00582114|541987207|FG001|Overall Study|Withdrawal by Subject|16|||
150232019|NCT00582114|541987206|FG000|Overall Study|Adverse Event|1|||
150232020|NCT00582114|541987207|FG001|Overall Study|Adverse Event|1|||
150232021|NCT00582114|541987206|FG000|Overall Study|Physician Decision|0|||
150232022|NCT00582114|541987207|FG001|Overall Study|Physician Decision|6|||
150232023|NCT00582114|541987206|FG000|Overall Study|Stopped by data safety monitoring board|19|||
150232024|NCT00582114|541987207|FG001|Overall Study|Stopped by data safety monitoring board|20|||
150232025|NCT00118703|541987208|FG000|Overall Study|Protocol Violation|1|||
150232026|NCT00118703|541987209|FG001|Overall Study|Protocol Violation|0|||
150232027|NCT00118703|541987208|FG000|Overall Study|Adverse Event|1|||
150232028|NCT00118703|541987209|FG001|Overall Study|Adverse Event|1|||
150232029|NCT00118703|541987208|FG000|Overall Study|Participant took two different treatment|0|||
150232030|NCT00118703|541987209|FG001|Overall Study|Participant took two different treatment|1|||
150232031|NCT00118703|541987208|FG000|Overall Study|Withdrawal by Subject|2|||
150232032|NCT00118703|541987209|FG001|Overall Study|Withdrawal by Subject|5|||
150232033|NCT00118703|541987208|FG000|Overall Study|Lost to Follow-up|1|||
150232034|NCT00118703|541987209|FG001|Overall Study|Lost to Follow-up|2|||
150232035|NCT00130728|541987214|FG000|Overall Study|Death|258|||
150232036|NCT00130728|541987215|FG001|Overall Study|Death|258|||
150232037|NCT00130728|541987214|FG000|Overall Study|Lost to Follow-up|4|||
150232038|NCT00130728|541987215|FG001|Overall Study|Lost to Follow-up|0|||
150232039|NCT00130728|541987214|FG000|Overall Study|Withdrawal by Subject|0|||
150232040|NCT00130728|541987215|FG001|Overall Study|Withdrawal by Subject|2|||
150232041|NCT01209286|541987217|FG000|Overall Study|Adverse Event|4|||
150232042|NCT01209286|541987218|FG001|Overall Study|Adverse Event|3|||
150232043|NCT01209286|541987219|FG002|Overall Study|Adverse Event|1|||
150232044|NCT01209286|541987217|FG000|Overall Study|Hematological Relapse After Remission|0|||
150232045|NCT01209286|541987218|FG001|Overall Study|Hematological Relapse After Remission|1|||
150232046|NCT01209286|541987219|FG002|Overall Study|Hematological Relapse After Remission|1|||
150232047|NCT01209286|541987217|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
150232048|NCT01209286|541987218|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
150232049|NCT01209286|541987219|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
150232050|NCT01209286|541987217|FG000|Overall Study|Physician Decision|0|||
150232051|NCT01209286|541987218|FG001|Overall Study|Physician Decision|2|||
150232052|NCT01209286|541987219|FG002|Overall Study|Physician Decision|0|||
150232053|NCT01209286|541987217|FG000|Overall Study|Other|0|||
150232054|NCT01209286|541987218|FG001|Overall Study|Other|1|||
150232055|NCT01209286|541987219|FG002|Overall Study|Other|0|||
150232056|NCT01349036|541987220|FG000|Overall Study|Disease progression|13|||
150232057|NCT01349036|541987221|FG001|Overall Study|Disease progression|22|||
150232058|NCT01349036|541987220|FG000|Overall Study|Other|1|||
150232059|NCT01349036|541987221|FG001|Overall Study|Other|0|||
150232060|NCT01349036|541987220|FG000|Overall Study|Withdrawal by Subject|0|||
150232061|NCT01349036|541987221|FG001|Overall Study|Withdrawal by Subject|2|||
150232062|NCT03796208|541987222|FG000|Overall Study|Withdrawal by Subject|3|||
150232063|NCT03796208|541987223|FG001|Overall Study|Withdrawal by Subject|0|||
150232064|NCT03796208|541987222|FG000|Overall Study|Loss of pregnancy|1|||
150232065|NCT03796208|541987223|FG001|Overall Study|Loss of pregnancy|1|||
150232066|NCT03796208|541987222|FG000|Overall Study|Changed prenatal clinics|0|||
150232067|NCT03796208|541987223|FG001|Overall Study|Changed prenatal clinics|5|||
150232068|NCT03796208|541987222|FG000|Overall Study|Lost to Follow-up|20|||
150232069|NCT03796208|541987223|FG001|Overall Study|Lost to Follow-up|16|||
150232070|NCT00519285|541987225|FG000|Overall Study|Adverse Event|127|||
150232071|NCT00519285|541987226|FG001|Overall Study|Adverse Event|266|||
150232072|NCT00519285|541987225|FG000|Overall Study|Disease progression|334|||
150232073|NCT00519285|541987226|FG001|Overall Study|Disease progression|186|||
150232074|NCT00519285|541987225|FG000|Overall Study|Physician Decision|75|||
150232075|NCT00519285|541987226|FG001|Overall Study|Physician Decision|47|||
150232076|NCT00519285|541987225|FG000|Overall Study|Participant's request|53|||
150232077|NCT00519285|541987226|FG001|Overall Study|Participant's request|84|||
150232078|NCT00519285|541987225|FG000|Overall Study|Consent withdrawn|4|||
150232079|NCT00519285|541987226|FG001|Overall Study|Consent withdrawn|5|||
150232080|NCT00519285|541987225|FG000|Overall Study|Poor compliance to protocol|5|||
150232081|NCT00519285|541987226|FG001|Overall Study|Poor compliance to protocol|7|||
150232082|NCT00519285|541987225|FG000|Overall Study|Reason unspecified|5|||
150232083|NCT00519285|541987226|FG001|Overall Study|Reason unspecified|8|||
150232084|NCT00519285|541987225|FG000|Overall Study|Not treated|8|||
150232085|NCT00519285|541987226|FG001|Overall Study|Not treated|7|||
150232086|NCT00519285|541987225|FG000|Overall Study|Treatment ongoing|1|||
150232087|NCT00519285|541987226|FG001|Overall Study|Treatment ongoing|2|||
150232088|NCT01020747|541987227|FG000|Overall Study|Withdrawal by Subject|1|||
150232089|NCT00006436|541987231|FG000|Overall Study|Refused further treatment|2|||
150232090|NCT00006436|541987231|FG000|Overall Study|Declined to participate (before treatment started)|1|||
150232091|NCT01071317|541987232|FG000|Overall Study|Lost to Follow-up|2|||
150232092|NCT01071317|541987233|FG001|Overall Study|Lost to Follow-up|2|||
150232093|NCT01283971|541987236|FG000|Overall Study|Adverse Event|3|||
150232094|NCT01283971|541987237|FG001|Overall Study|Adverse Event|5|||
150232095|NCT01283971|541987236|FG000|Overall Study|Insufficient therapeutic responses|3|||
150232096|NCT01283971|541987237|FG001|Overall Study|Insufficient therapeutic responses|3|||
150232097|NCT01283971|541987236|FG000|Overall Study|Protocol Violation|5|||
150232098|NCT01283971|541987237|FG001|Overall Study|Protocol Violation|1|||
150232099|NCT01283971|541987236|FG000|Overall Study|Refused treatment|3|||
150232100|NCT01283971|541987237|FG001|Overall Study|Refused treatment|1|||
150232101|NCT01283971|541987236|FG000|Overall Study|Failure to return|0|||
150232102|NCT01283971|541987237|FG001|Overall Study|Failure to return|1|||
150232103|NCT01283971|541987236|FG000|Overall Study|Administrative reasons|1|||
150232104|NCT01283971|541987237|FG001|Overall Study|Administrative reasons|1|||
150232105|NCT02598934|541987246|FG000|Overall Study|Adverse Event|11|||
150232106|NCT02598934|541987247|FG001|Overall Study|Adverse Event|13|||
150232107|NCT02598934|541987246|FG000|Overall Study|Failure to Return|3|||
150232108|NCT02598934|541987247|FG001|Overall Study|Failure to Return|3|||
150232109|NCT02598934|541987246|FG000|Overall Study|Withdrawal by Subject|2|||
150232110|NCT02598934|541987247|FG001|Overall Study|Withdrawal by Subject|3|||
150232111|NCT02598934|541987246|FG000|Overall Study|Administrative|2|||
150232112|NCT02598934|541987247|FG001|Overall Study|Administrative|1|||
150232113|NCT02598934|541987246|FG000|Overall Study|Protocol Violation|1|||
150232114|NCT02598934|541987247|FG001|Overall Study|Protocol Violation|2|||
150232115|NCT00702520|541987249|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
150232116|NCT00702520|541987250|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
150232117|NCT00702520|541987251|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
150232118|NCT00702520|541987252|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
150232119|NCT00702520|541987249|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
150232120|NCT00702520|541987250|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
150232121|NCT00702520|541987251|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
150232122|NCT00702520|541987252|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
150232123|NCT00702520|541987249|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
150232124|NCT00702520|541987250|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
150232125|NCT00702520|541987251|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
150232126|NCT00702520|541987252|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
150232127|NCT02154347|541987253|FG000|Double-blind Period|Adverse Event|1|||
150232128|NCT02154347|541987254|FG001|Double-blind Period|Adverse Event|2|||
150232129|NCT02154347|541987253|FG000|Double-blind Period|Lack of Efficacy|1|||
150232130|NCT02154347|541987254|FG001|Double-blind Period|Lack of Efficacy|0|||
150232131|NCT02154347|541987253|FG000|Double-blind Period|Physician Decision|0|||
150232132|NCT02154347|541987254|FG001|Double-blind Period|Physician Decision|1|||
150232133|NCT02154347|541987253|FG000|Double-blind Period|Withdrawal by Subject|1|||
150232134|NCT02154347|541987254|FG001|Double-blind Period|Withdrawal by Subject|1|||
150232135|NCT02154347|541987253|FG000|Open-label Period|Adverse Event|3|||
150232136|NCT02154347|541987254|FG001|Open-label Period|Adverse Event|4|||
150232137|NCT02154347|541987253|FG000|Open-label Period|Lack of Efficacy|4|||
150232138|NCT02154347|541987254|FG001|Open-label Period|Lack of Efficacy|19|||
150232139|NCT02154347|541987253|FG000|Open-label Period|Protocol Violation|0|||
150232140|NCT02154347|541987254|FG001|Open-label Period|Protocol Violation|1|||
150232141|NCT02154347|541987253|FG000|Open-label Period|Withdrawal by Subject|0|||
150232142|NCT02154347|541987254|FG001|Open-label Period|Withdrawal by Subject|1|||
150232143|NCT02481934|541987255|FG000|Overall Study|Death|2|||
150232144|NCT05041439|541987256|FG000|Overall Study|Withdrawal by Subject|1|||
150232145|NCT05041439|541987257|FG001|Overall Study|Withdrawal by Subject|1|||
150232146|NCT05041439|541987256|FG000|Overall Study|Death|1|||
150232147|NCT05041439|541987257|FG001|Overall Study|Death|0|||
150232148|NCT02210208|541989131|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
150232149|NCT02210208|541989131|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
150232150|NCT02210208|541989131|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
150232151|NCT00664105|541989132|FG000|Overall Study|Death|3|||
150232152|NCT00664105|541989132|FG000|Overall Study|Withdrawal by Subject|5|||
150232153|NCT00664105|541989132|FG000|Overall Study|Adverse Event|9|||
150232154|NCT00664105|541989132|FG000|Overall Study|Disease progression|7|||
150232155|NCT01468077|541989139|FG000|Overall Study|Adverse Event|2|||
150232156|NCT01468077|541989140|FG001|Overall Study|Adverse Event|2|||
150232157|NCT01468077|541989139|FG000|Overall Study|Lack of Efficacy|1|||
150232158|NCT01468077|541989140|FG001|Overall Study|Lack of Efficacy|1|||
150232159|NCT01468077|541989139|FG000|Overall Study|Physician Decision|1|||
150232160|NCT01468077|541989140|FG001|Overall Study|Physician Decision|0|||
150232161|NCT04843579|541989141|FG000|Overall Study|Adverse Event|1|||
150232162|NCT04843579|541989141|FG000|Overall Study|Disease Progression|1|||
150232163|NCT03834623|541989142|FG000|Overall Study|Progression|0|||
150232164|NCT03834623|541989143|FG001|Overall Study|Progression|1|||
150232165|NCT03024996|541989145|FG000|Overall Study|Death|57|||
150232166|NCT03024996|541989146|FG001|Overall Study|Death|55|||
150232167|NCT03024996|541989145|FG000|Overall Study|Disease relapse|1|||
150232168|NCT03024996|541989146|FG001|Overall Study|Disease relapse|0|||
150232169|NCT03024996|541989145|FG000|Overall Study|Lost to Follow-up|5|||
150232170|NCT03024996|541989146|FG001|Overall Study|Lost to Follow-up|10|||
150232171|NCT03024996|541989145|FG000|Overall Study|Other|3|||
150232172|NCT03024996|541989146|FG001|Overall Study|Other|3|||
150232173|NCT03024996|541989145|FG000|Overall Study|Physician Decision|0|||
150232174|NCT03024996|541989146|FG001|Overall Study|Physician Decision|1|||
150232175|NCT03024996|541989145|FG000|Overall Study|Study terminated by sponsor|303|||
150232176|NCT03024996|541989146|FG001|Overall Study|Study terminated by sponsor|283|||
150232177|NCT03024996|541989145|FG000|Overall Study|Withdrawal by Subject|21|||
150232178|NCT03024996|541989146|FG001|Overall Study|Withdrawal by Subject|36|||
150232179|NCT00478647|541989147|FG000|Overall Study|Adverse Event|1|||
150232180|NCT00478647|541989147|FG000|Overall Study|Withdrawal by Subject|1|||
150232181|NCT04333147|541989152|FG000|Overall Study|Adverse Event|43|||
150232182|NCT04333147|541989153|FG001|Overall Study|Adverse Event|40|||
150232183|NCT04333147|541989152|FG000|Overall Study|Lack of Efficacy|49|||
150232184|NCT04333147|541989153|FG001|Overall Study|Lack of Efficacy|48|||
150232185|NCT04333147|541989152|FG000|Overall Study|Lost to Follow-up|19|||
150232186|NCT04333147|541989153|FG001|Overall Study|Lost to Follow-up|16|||
150232187|NCT04333147|541989152|FG000|Overall Study|Physician Decision|17|||
150232188|NCT04333147|541989153|FG001|Overall Study|Physician Decision|20|||
150232189|NCT04333147|541989152|FG000|Overall Study|Withdrawal by Subject|65|||
150232190|NCT04333147|541989153|FG001|Overall Study|Withdrawal by Subject|68|||
150232191|NCT04333147|541989152|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
150232192|NCT04333147|541989153|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
150232193|NCT04333147|541989152|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
150232194|NCT04333147|541989153|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
150232195|NCT04333147|541989152|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
150232196|NCT04333147|541989153|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
150232197|NCT04606199|541989154|FG000|Overall Study|Withdrawal by Subject|2|||
150232198|NCT00639769|541989158|FG000|Overall Study|Death|2|||
150232199|NCT00639769|541989158|FG000|Overall Study|Adverse Event|7|||
150232200|NCT00639769|541989158|FG000|Overall Study|Lack of Efficacy|1|||
150232201|NCT00639769|541989158|FG000|Overall Study|Disease progression|26|||
150232202|NCT00639769|541989158|FG000|Overall Study|Withdrawal by Subject|4|||
150232203|NCT00784147|541989159|FG000|Overall Study|Lost to Follow-up|2|||
150232204|NCT00784147|541989160|FG001|Overall Study|Lost to Follow-up|4|||
150232205|NCT00784147|541989159|FG000|Overall Study|Withdrawal by Subject|1|||
150232206|NCT00784147|541989160|FG001|Overall Study|Withdrawal by Subject|3|||
150232207|NCT00784147|541989159|FG000|Overall Study|Physician Decision|2|||
150232208|NCT00784147|541989160|FG001|Overall Study|Physician Decision|1|||
150232209|NCT00784147|541989159|FG000|Overall Study|Protocol Violation|1|||
150232210|NCT00784147|541989160|FG001|Overall Study|Protocol Violation|1|||
150232211|NCT00784147|541989159|FG000|Overall Study|Death|2|||
150232212|NCT00784147|541989160|FG001|Overall Study|Death|0|||
150232213|NCT03596242|541989162|FG000|Overall Study|Lost to Follow-up|2|||
150232214|NCT03596242|541989163|FG001|Overall Study|Lost to Follow-up|2|||
150232215|NCT03357471|541989167|FG000|Overall Study|Adverse Event|1|||
150232216|NCT03357471|541989168|FG001|Overall Study|Adverse Event|0|||
150232217|NCT03357471|541989167|FG000|Overall Study|Lost to Follow-up|1|||
150232218|NCT03357471|541989168|FG001|Overall Study|Lost to Follow-up|0|||
150232219|NCT00706914|541989169|FG000|Overall Study|Lack of Efficacy|0|||
150232220|NCT00706914|541989170|FG001|Overall Study|Lack of Efficacy|1|||
150232221|NCT00706914|541989171|FG002|Overall Study|Lack of Efficacy|0|||
150232222|NCT00706914|541989169|FG000|Overall Study|Lost to Follow-up|1|||
150232223|NCT00706914|541989170|FG001|Overall Study|Lost to Follow-up|0|||
150232224|NCT00706914|541989171|FG002|Overall Study|Lost to Follow-up|0|||
150232225|NCT00706914|541989169|FG000|Overall Study|Adverse Event|2|||
150232226|NCT00706914|541989170|FG001|Overall Study|Adverse Event|2|||
150232227|NCT00706914|541989171|FG002|Overall Study|Adverse Event|0|||
150232228|NCT00706914|541989169|FG000|Overall Study|Protocol Violation|3|||
150232229|NCT00706914|541989170|FG001|Overall Study|Protocol Violation|1|||
150232230|NCT00706914|541989171|FG002|Overall Study|Protocol Violation|1|||
150232231|NCT03294941|541989172|FG000|Overall Study|Withdrawal by Subject|0|||
150232232|NCT03294941|541989173|FG001|Overall Study|Withdrawal by Subject|2|||
150232233|NCT01475461|541989174|FG000|Run-in Period|Not meet eligibility criteria|16|||
150232234|NCT01475461|541989175|FG001|Run-in Period|Not meet eligibility criteria|0|||
150232235|NCT01475461|541989176|FG002|Run-in Period|Not meet eligibility criteria|0|||
150232236|NCT01475461|541989177|FG003|Run-in Period|Not meet eligibility criteria|0|||
150232237|NCT01475461|541989178|FG004|Run-in Period|Not meet eligibility criteria|0|||
150232238|NCT01475461|541989179|FG005|Run-in Period|Not meet eligibility criteria|0|||
150232239|NCT01475461|541989180|FG006|Run-in Period|Not meet eligibility criteria|0|||
150232240|NCT01475461|541989174|FG000|Run-in Period|Lost to Follow-up|7|||
150232241|NCT01475461|541989175|FG001|Run-in Period|Lost to Follow-up|0|||
150232242|NCT01475461|541989176|FG002|Run-in Period|Lost to Follow-up|0|||
150232243|NCT01475461|541989177|FG003|Run-in Period|Lost to Follow-up|0|||
150232244|NCT01475461|541989178|FG004|Run-in Period|Lost to Follow-up|0|||
150232245|NCT01475461|541989179|FG005|Run-in Period|Lost to Follow-up|0|||
150232246|NCT01475461|541989180|FG006|Run-in Period|Lost to Follow-up|0|||
150232247|NCT01475461|541989174|FG000|Run-in Period|Withdrawal by Subject|11|||
150232248|NCT01475461|541989175|FG001|Run-in Period|Withdrawal by Subject|0|||
150232249|NCT01475461|541989176|FG002|Run-in Period|Withdrawal by Subject|0|||
150232250|NCT01475461|541989177|FG003|Run-in Period|Withdrawal by Subject|0|||
150232251|NCT01475461|541989178|FG004|Run-in Period|Withdrawal by Subject|0|||
150232252|NCT01475461|541989179|FG005|Run-in Period|Withdrawal by Subject|0|||
150232253|NCT01475461|541989180|FG006|Run-in Period|Withdrawal by Subject|0|||
150232254|NCT01475461|541989174|FG000|Run-in Period|Other|3|||
150232255|NCT01475461|541989175|FG001|Run-in Period|Other|0|||
150232256|NCT01475461|541989176|FG002|Run-in Period|Other|0|||
150232257|NCT01475461|541989177|FG003|Run-in Period|Other|0|||
150232258|NCT01475461|541989178|FG004|Run-in Period|Other|0|||
150232259|NCT01475461|541989179|FG005|Run-in Period|Other|0|||
150232260|NCT01475461|541989180|FG006|Run-in Period|Other|0|||
150232261|NCT01475461|541989174|FG000|Run-in Period|Protocol Violation|4|||
150232262|NCT01475461|541989175|FG001|Run-in Period|Protocol Violation|0|||
150232263|NCT01475461|541989176|FG002|Run-in Period|Protocol Violation|0|||
150232264|NCT01475461|541989177|FG003|Run-in Period|Protocol Violation|0|||
150232265|NCT01475461|541989178|FG004|Run-in Period|Protocol Violation|0|||
150232266|NCT01475461|541989179|FG005|Run-in Period|Protocol Violation|0|||
150232267|NCT01475461|541989180|FG006|Run-in Period|Protocol Violation|0|||
150232268|NCT01475461|541989174|FG000|Treatment Period|Death|0|||
150232269|NCT01475461|541989175|FG001|Treatment Period|Death|0|||
150232270|NCT01475461|541989176|FG002|Treatment Period|Death|0|||
150232271|NCT01475461|541989177|FG003|Treatment Period|Death|1|||
150232272|NCT01475461|541989178|FG004|Treatment Period|Death|0|||
150232273|NCT01475461|541989179|FG005|Treatment Period|Death|0|||
150232274|NCT01475461|541989180|FG006|Treatment Period|Death|0|||
150232275|NCT01475461|541989174|FG000|Treatment Period|Lost to Follow-up|0|||
150232276|NCT01475461|541989175|FG001|Treatment Period|Lost to Follow-up|3|||
150232277|NCT01475461|541989176|FG002|Treatment Period|Lost to Follow-up|2|||
150232278|NCT01475461|541989177|FG003|Treatment Period|Lost to Follow-up|3|||
150232279|NCT01475461|541989178|FG004|Treatment Period|Lost to Follow-up|1|||
150232280|NCT01475461|541989179|FG005|Treatment Period|Lost to Follow-up|2|||
150232281|NCT01475461|541989180|FG006|Treatment Period|Lost to Follow-up|1|||
150232282|NCT01475461|541989174|FG000|Treatment Period|Withdrawal by Subject|0|||
150232283|NCT01475461|541989175|FG001|Treatment Period|Withdrawal by Subject|2|||
150232284|NCT01475461|541989176|FG002|Treatment Period|Withdrawal by Subject|2|||
150232285|NCT01475461|541989177|FG003|Treatment Period|Withdrawal by Subject|0|||
150232286|NCT01475461|541989178|FG004|Treatment Period|Withdrawal by Subject|2|||
150232287|NCT01475461|541989179|FG005|Treatment Period|Withdrawal by Subject|2|||
150232288|NCT01475461|541989180|FG006|Treatment Period|Withdrawal by Subject|0|||
150232289|NCT01475461|541989174|FG000|Treatment Period|Other|0|||
150232290|NCT01475461|541989175|FG001|Treatment Period|Other|1|||
150232291|NCT01475461|541989176|FG002|Treatment Period|Other|0|||
150232292|NCT01475461|541989177|FG003|Treatment Period|Other|0|||
150232293|NCT01475461|541989178|FG004|Treatment Period|Other|0|||
150232294|NCT01475461|541989179|FG005|Treatment Period|Other|0|||
150232295|NCT01475461|541989180|FG006|Treatment Period|Other|0|||
150232296|NCT01475461|541989174|FG000|Treatment Period|Protocol Violation|0|||
150232297|NCT01475461|541989175|FG001|Treatment Period|Protocol Violation|1|||
150232298|NCT01475461|541989176|FG002|Treatment Period|Protocol Violation|0|||
150232299|NCT01475461|541989177|FG003|Treatment Period|Protocol Violation|0|||
150232300|NCT01475461|541989178|FG004|Treatment Period|Protocol Violation|0|||
150232301|NCT01475461|541989179|FG005|Treatment Period|Protocol Violation|0|||
150232302|NCT01475461|541989180|FG006|Treatment Period|Protocol Violation|1|||
150232303|NCT01475461|541989174|FG000|Treatment Period|Lack of Efficacy|0|||
150232304|NCT01475461|541989175|FG001|Treatment Period|Lack of Efficacy|2|||
150232305|NCT01475461|541989176|FG002|Treatment Period|Lack of Efficacy|0|||
150232306|NCT01475461|541989177|FG003|Treatment Period|Lack of Efficacy|2|||
150232307|NCT01475461|541989178|FG004|Treatment Period|Lack of Efficacy|1|||
150232308|NCT01475461|541989179|FG005|Treatment Period|Lack of Efficacy|1|||
150232309|NCT01475461|541989180|FG006|Treatment Period|Lack of Efficacy|0|||
150232310|NCT01475461|541989174|FG000|Treatment Period|Medication Error|0|||
150232311|NCT01475461|541989175|FG001|Treatment Period|Medication Error|0|||
150232312|NCT01475461|541989176|FG002|Treatment Period|Medication Error|0|||
150232313|NCT01475461|541989177|FG003|Treatment Period|Medication Error|1|||
150232314|NCT01475461|541989178|FG004|Treatment Period|Medication Error|0|||
150232315|NCT01475461|541989179|FG005|Treatment Period|Medication Error|0|||
150232316|NCT01475461|541989180|FG006|Treatment Period|Medication Error|0|||
150232317|NCT01475461|541989174|FG000|Treatment Period|Adverse Event|0|||
150232318|NCT01475461|541989175|FG001|Treatment Period|Adverse Event|0|||
150232319|NCT01475461|541989176|FG002|Treatment Period|Adverse Event|0|||
150232320|NCT01475461|541989177|FG003|Treatment Period|Adverse Event|1|||
150232321|NCT01475461|541989178|FG004|Treatment Period|Adverse Event|0|||
150232322|NCT01475461|541989179|FG005|Treatment Period|Adverse Event|0|||
150232323|NCT01475461|541989180|FG006|Treatment Period|Adverse Event|0|||
150232324|NCT01774019|541989181|FG000|Overall Study|No longer meets protocol criteria|2|||
150232325|NCT01774019|541989182|FG001|Overall Study|No longer meets protocol criteria|0|||
150232326|NCT01774019|541989181|FG000|Overall Study|Withdrawal by Subject|1|||
150232327|NCT01774019|541989182|FG001|Overall Study|Withdrawal by Subject|0|||
150232328|NCT01774019|541989181|FG000|Overall Study|Surgery delayed > 120 days|1|||
150232329|NCT01774019|541989182|FG001|Overall Study|Surgery delayed > 120 days|0|||
150232330|NCT01774019|541989181|FG000|Overall Study|Patient refused surgery|1|||
150232331|NCT01774019|541989182|FG001|Overall Study|Patient refused surgery|1|||
150232332|NCT01774019|541989181|FG000|Overall Study|Unable to implant study device|1|||
150232333|NCT01774019|541989182|FG001|Overall Study|Unable to implant study device|0|||
150232334|NCT01774019|541989181|FG000|Overall Study|Lost to Follow-up|0|||
150232335|NCT01774019|541989182|FG001|Overall Study|Lost to Follow-up|3|||
150232336|NCT01167192|541989185|FG000|Overall Study|Adverse Event|1|||
150232337|NCT01167192|541989185|FG000|Overall Study|Death|1|||
150232338|NCT01167192|541989185|FG000|Overall Study|Withdrawal by Subject|1|||
150232339|NCT01167192|541989185|FG000|Overall Study|Insurance denial|1|||
150232340|NCT02835092|541989186|FG000|Overall Study|Withdrawal by Subject|3|||
150232341|NCT02835092|541989187|FG001|Overall Study|Withdrawal by Subject|6|||
150232342|NCT02835092|541989188|FG002|Overall Study|Withdrawal by Subject|3|||
150232343|NCT02835092|541989186|FG000|Overall Study|Lost to Follow-up|0|||
150232344|NCT02835092|541989187|FG001|Overall Study|Lost to Follow-up|2|||
150232345|NCT02835092|541989188|FG002|Overall Study|Lost to Follow-up|0|||
150232346|NCT00713206|541989189|FG000|Overall Study|Lost to Follow-up|4|||
150232347|NCT00713206|541989190|FG001|Overall Study|Lost to Follow-up|4|||
150232348|NCT00713206|541989189|FG000|Overall Study|Death|1|||
150232349|NCT00713206|541989190|FG001|Overall Study|Death|0|||
150232350|NCT02561806|541989191|FG000|Induction Period|Adverse Event|0|||
150232351|NCT02561806|541989192|FG001|Induction Period|Adverse Event|2|||
150232352|NCT02561806|541989191|FG000|Induction Period|Lack of Efficacy|1|||
150232353|NCT02561806|541989192|FG001|Induction Period|Lack of Efficacy|0|||
150232354|NCT02561806|541989191|FG000|Induction Period|Withdrawal by Subject|0|||
150232355|NCT02561806|541989192|FG001|Induction Period|Withdrawal by Subject|2|||
150232356|NCT02561806|541989191|FG000|Induction Period|Site staff became unblinded|1|||
150232357|NCT02561806|541989192|FG001|Induction Period|Site staff became unblinded|0|||
150232358|NCT02561806|541989191|FG000|Induction Period|Randomized but not treated|0|||
150232359|NCT02561806|541989192|FG001|Induction Period|Randomized but not treated|1|||
150232360|NCT02561806|541989191|FG000|Maintenance Period|Adverse Event|2|||
150232361|NCT02561806|541989192|FG001|Maintenance Period|Adverse Event|1|||
150232362|NCT02561806|541989191|FG000|Maintenance Period|Lack of Efficacy|3|||
150232363|NCT02561806|541989192|FG001|Maintenance Period|Lack of Efficacy|1|||
150232364|NCT02561806|541989191|FG000|Maintenance Period|Lost to Follow-up|2|||
150232365|NCT02561806|541989192|FG001|Maintenance Period|Lost to Follow-up|2|||
150232366|NCT02561806|541989191|FG000|Maintenance Period|Protocol Violation|1|||
150232367|NCT02561806|541989192|FG001|Maintenance Period|Protocol Violation|0|||
150232368|NCT02561806|541989191|FG000|Maintenance Period|Withdrawal by Subject|5|||
150232369|NCT02561806|541989192|FG001|Maintenance Period|Withdrawal by Subject|3|||
150232370|NCT02561806|541989191|FG000|Maintenance Period|Site staff became unblinded|0|||
150232371|NCT02561806|541989192|FG001|Maintenance Period|Site staff became unblinded|1|||
150232372|NCT02561806|541989191|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
150232373|NCT02561806|541989192|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
150232374|NCT02561806|541989191|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
150232375|NCT02561806|541989192|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
150232376|NCT04545476|541989193|FG000|Overall Study|Lost to Follow-up|1|||
150232377|NCT04545476|541989194|FG001|Overall Study|Lost to Follow-up|1|||
150232378|NCT04545476|541989195|FG002|Overall Study|Lost to Follow-up|0|||
150232379|NCT04545476|541989196|FG003|Overall Study|Lost to Follow-up|0|||
150232380|NCT02175745|541989203|FG000|Overall Study|Not Eligible|1|||
150232381|NCT00983892|541989204|FG000|Overall Study|Withdrawal by Subject|10|||
150232382|NCT00983892|541989205|FG001|Overall Study|Withdrawal by Subject|12|||
150232383|NCT00808899|541989206|FG000|Overall Study|Death|1|||
150232384|NCT00808899|541989206|FG000|Overall Study|Physician Decision|3|||
150232385|NCT03028012|541989207|FG000|Overall Study|Lost to Follow-up|2|||
150232386|NCT03028012|541989208|FG001|Overall Study|Lost to Follow-up|3|||
150232387|NCT03028012|541989209|FG002|Overall Study|Lost to Follow-up|3|||
150232388|NCT03448536|541989217|FG000|Overall Study|Protocol Violation|2|||
150232389|NCT03448536|541989218|FG001|Overall Study|Protocol Violation|0|||
150232390|NCT03448536|541989217|FG000|Overall Study|Pregnancy|1|||
150232391|NCT03448536|541989218|FG001|Overall Study|Pregnancy|0|||
150232392|NCT03448536|541989217|FG000|Overall Study|Withdrawal by Subject|1|||
150232393|NCT03448536|541989218|FG001|Overall Study|Withdrawal by Subject|2|||
150232394|NCT03448536|541989217|FG000|Overall Study|Lost to Follow-up|3|||
150232395|NCT03448536|541989218|FG001|Overall Study|Lost to Follow-up|2|||
150232396|NCT03448536|541989217|FG000|Overall Study|Inadequate pain reporter|1|||
150232397|NCT03448536|541989218|FG001|Overall Study|Inadequate pain reporter|0|||
150232398|NCT03448536|541989217|FG000|Overall Study|Other|3|||
150232399|NCT03448536|541989218|FG001|Overall Study|Other|0|||
150232400|NCT03448536|541989217|FG000|Overall Study|Physician Decision|1|||
150232401|NCT03448536|541989218|FG001|Overall Study|Physician Decision|0|||
150232402|NCT01424189|541989222|FG000|Overall Study|Adverse Event|1|||
150232403|NCT01424189|541989223|FG001|Overall Study|Adverse Event|0|||
150232404|NCT01424189|541989222|FG000|Overall Study|Lost to Follow-up|4|||
150232405|NCT01424189|541989223|FG001|Overall Study|Lost to Follow-up|1|||
150232406|NCT01424189|541989222|FG000|Overall Study|Withdrawal by Subject|4|||
150232407|NCT01424189|541989223|FG001|Overall Study|Withdrawal by Subject|4|||
150232408|NCT01424189|541989222|FG000|Overall Study|Subject moved|1|||
150232409|NCT01424189|541989223|FG001|Overall Study|Subject moved|0|||
150232410|NCT01424189|541989222|FG000|Overall Study|Death|3|||
150232411|NCT01424189|541989223|FG001|Overall Study|Death|1|||
150232412|NCT03120949|541989224|FG000|Overall Study|randomized in error|1|||
150232413|NCT03120949|541989225|FG001|Overall Study|randomized in error|0|||
150232414|NCT03120949|541989224|FG000|Overall Study|Death|13|||
150232415|NCT03120949|541989225|FG001|Overall Study|Death|13|||
150232416|NCT03120949|541989224|FG000|Overall Study|Lost to Follow-up|23|||
150232417|NCT03120949|541989225|FG001|Overall Study|Lost to Follow-up|13|||
150232418|NCT03120949|541989224|FG000|Overall Study|Withdrawal by Subject|139|||
150232419|NCT03120949|541989225|FG001|Overall Study|Withdrawal by Subject|124|||
150232420|NCT03120949|541989224|FG000|Overall Study|Covid-19|43|||
150232421|NCT03120949|541989225|FG001|Overall Study|Covid-19|34|||
150232422|NCT03120949|541989224|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
150232423|NCT03120949|541989225|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
150232424|NCT03120949|541989224|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
150232425|NCT03120949|541989225|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
150232426|NCT03120949|541989224|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
150232427|NCT03120949|541989225|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
150232428|NCT03120949|541989224|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
150232429|NCT03120949|541989225|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
150232430|NCT03120949|541989224|FG000|Overall Study|Site was closed|2|||
150232431|NCT03120949|541989225|FG001|Overall Study|Site was closed|3|||
150232432|NCT03120949|541989224|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
150232433|NCT03120949|541989225|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
150232434|NCT03120949|541989224|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
150232435|NCT03120949|541989225|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
150232436|NCT03120949|541989224|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
150232437|NCT03120949|541989225|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
150232438|NCT03120949|541989224|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
150232439|NCT03120949|541989225|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
150232440|NCT03120949|541989224|FG000|Overall Study|Other: Adverse Event|0|||
150232441|NCT03120949|541989225|FG001|Overall Study|Other: Adverse Event|1|||
150232442|NCT03120949|541989224|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
150232443|NCT03120949|541989225|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
150232444|NCT03120949|541989224|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
150232445|NCT03120949|541989225|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
150232446|NCT03120949|541989224|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
150232447|NCT03120949|541989225|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
150232448|NCT03120949|541989224|FG000|Overall Study|Personal Reasons|0|||
150232449|NCT03120949|541989225|FG001|Overall Study|Personal Reasons|1|||
150232450|NCT03120949|541989224|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
150232451|NCT03120949|541989225|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
150232452|NCT03120949|541989224|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
150232453|NCT03120949|541989225|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
150232454|NCT03120949|541989224|FG000|Overall Study|Compliance With Medication|0|||
150232455|NCT03120949|541989225|FG001|Overall Study|Compliance With Medication|1|||
150232456|NCT03120949|541989224|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
150232457|NCT03120949|541989225|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
150232458|NCT03120949|541989224|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
150232459|NCT03120949|541989225|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
150232460|NCT03120949|541989224|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
150232461|NCT03120949|541989225|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
150232462|NCT01705145|541989226|FG000|Part B|Adverse Event|1|||
150232463|NCT00312845|541989227|FG000|Overall Study|Adverse Event|19|||
150232464|NCT00312845|541989228|FG001|Overall Study|Adverse Event|5|||
150232465|NCT00312845|541989227|FG000|Overall Study|Death|2|||
150232466|NCT00312845|541989228|FG001|Overall Study|Death|2|||
150232467|NCT00312845|541989227|FG000|Overall Study|Withdrawal by Subject|14|||
150232468|NCT00312845|541989228|FG001|Overall Study|Withdrawal by Subject|6|||
150232469|NCT00312845|541989227|FG000|Overall Study|Disease Progression|56|||
150232470|NCT00312845|541989228|FG001|Overall Study|Disease Progression|77|||
150232471|NCT00312845|541989227|FG000|Overall Study|Lost to Follow-up|2|||
150232472|NCT00312845|541989228|FG001|Overall Study|Lost to Follow-up|0|||
150232473|NCT00312845|541989227|FG000|Overall Study|Other|6|||
150232474|NCT00312845|541989228|FG001|Overall Study|Other|5|||
150232475|NCT01078584|541989229|FG000|Overall Study|Final Status Unknown|1073|||
150232476|NCT01078584|541989229|FG000|Overall Study|Lost to Follow-up|670|||
150232477|NCT01078584|541989229|FG000|Overall Study|Non-serious Adverse Event|577|||
150232478|NCT01078584|541989229|FG000|Overall Study|Withdrawal of Consent|244|||
150232479|NCT01078584|541989229|FG000|Overall Study|Physician Withdrew from Study|90|||
150232480|NCT01078584|541989229|FG000|Overall Study|Non-compliance|67|||
150232481|NCT01078584|541989229|FG000|Overall Study|Blood Pressure Controlled|49|||
150232482|NCT01078584|541989229|FG000|Overall Study|Physician Switched Medication|26|||
150232483|NCT01078584|541989229|FG000|Overall Study|Physician Discontinued Patient|12|||
150232484|NCT01078584|541989229|FG000|Overall Study|Lack of Efficacy|98|||
150232485|NCT01078584|541989229|FG000|Overall Study|Protocol Violation|75|||
150232486|NCT01078584|541989229|FG000|Overall Study|Serious Adverse Event|27|||
150232487|NCT01078584|541989229|FG000|Overall Study|Multiple Reasons|2|||
150232488|NCT01208870|541989230|FG000|Overall Study|Lost to Follow-up|2|||
150232489|NCT01208870|541989231|FG001|Overall Study|Lost to Follow-up|8|||
150232490|NCT01121185|541989232|FG000|Overall Study|Not infused|0|||
150232491|NCT01121185|541989233|FG001|Overall Study|Not infused|1|||
150232492|NCT01121185|541989232|FG000|Overall Study|Not transplanted|1|||
150232493|NCT01121185|541989233|FG001|Overall Study|Not transplanted|0|||
150232494|NCT01077622|541989234|FG000|Overall Study|Physician Decision|2|||
150232495|NCT01077622|541989234|FG000|Overall Study|Withdrawal by Subject|1|||
150232496|NCT00424177|541989235|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
150232497|NCT00424177|541989235|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
150232498|NCT00424177|541989235|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
150232499|NCT00424177|541989235|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
150232500|NCT00424177|541989235|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
150232501|NCT00424177|541989235|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
150232502|NCT00424177|541989235|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
150232503|NCT00424177|541989235|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
150232504|NCT00424177|541989235|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
150232505|NCT00424177|541989235|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
150232506|NCT01503164|541989240|FG000|Overall Study|Withdrawal by Subject|2|||
150232507|NCT01503164|541989241|FG001|Overall Study|Withdrawal by Subject|1|||
150232508|NCT04088136|541989244|FG000|Overall Study|Withdrawal by Subject|5|||
150232509|NCT04088136|541989245|FG001|Overall Study|Withdrawal by Subject|0|||
150232510|NCT04088136|541989244|FG000|Overall Study|Lack of Efficacy|0|||
150232511|NCT04088136|541989245|FG001|Overall Study|Lack of Efficacy|1|||
150232512|NCT01177228|541989246|FG000|Overall Study|Positive tuberculosis test|0|||
150232513|NCT01177228|541989247|FG001|Overall Study|Positive tuberculosis test|1|||
150232514|NCT01177228|541989248|FG002|Overall Study|Positive tuberculosis test|0|||
150232515|NCT01177228|541989249|FG003|Overall Study|Positive tuberculosis test|0|||
150232516|NCT01177228|541989246|FG000|Overall Study|Worsening disease activity|1|||
150232517|NCT01177228|541989247|FG001|Overall Study|Worsening disease activity|0|||
150232518|NCT01177228|541989248|FG002|Overall Study|Worsening disease activity|0|||
150232519|NCT01177228|541989249|FG003|Overall Study|Worsening disease activity|0|||
150232520|NCT01177228|541989246|FG000|Overall Study|Withdrawal by Subject|0|||
150232521|NCT01177228|541989247|FG001|Overall Study|Withdrawal by Subject|1|||
150232522|NCT01177228|541989248|FG002|Overall Study|Withdrawal by Subject|0|||
150232523|NCT01177228|541989249|FG003|Overall Study|Withdrawal by Subject|0|||
150232524|NCT04159805|541989250|FG000|Overall Study|Withdrawal by Subject|0|||
150232525|NCT04159805|541989251|FG001|Overall Study|Withdrawal by Subject|2|||
150232526|NCT04159805|541989252|FG002|Overall Study|Withdrawal by Subject|2|||
150232527|NCT01393613|541989253|FG000|Overall Study|Adverse Event|11|||
150232528|NCT01393613|541989254|FG001|Overall Study|Adverse Event|11|||
150232529|NCT01393613|541989255|FG002|Overall Study|Adverse Event|13|||
150232530|NCT01393613|541989256|FG003|Overall Study|Adverse Event|22|||
150232531|NCT01393613|541989253|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
150232532|NCT01393613|541989254|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
150232533|NCT01393613|541989255|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
150232534|NCT01393613|541989256|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
150232535|NCT01393613|541989253|FG000|Overall Study|Physician Decision|2|||
150232536|NCT01393613|541989254|FG001|Overall Study|Physician Decision|0|||
150232537|NCT01393613|541989255|FG002|Overall Study|Physician Decision|0|||
150232538|NCT01393613|541989256|FG003|Overall Study|Physician Decision|1|||
150232539|NCT01393613|541989253|FG000|Overall Study|Withdrawal by Subject|15|||
150232540|NCT01393613|541989254|FG001|Overall Study|Withdrawal by Subject|25|||
150232541|NCT01393613|541989255|FG002|Overall Study|Withdrawal by Subject|23|||
150232542|NCT01393613|541989256|FG003|Overall Study|Withdrawal by Subject|21|||
150232543|NCT01393613|541989253|FG000|Overall Study|Protocol Deviation|2|||
150232544|NCT01393613|541989254|FG001|Overall Study|Protocol Deviation|1|||
150232545|NCT01393613|541989255|FG002|Overall Study|Protocol Deviation|0|||
150232546|NCT01393613|541989256|FG003|Overall Study|Protocol Deviation|0|||
150232547|NCT01393613|541989253|FG000|Overall Study|Lack of Efficacy|9|||
150232548|NCT01393613|541989254|FG001|Overall Study|Lack of Efficacy|20|||
150232549|NCT01393613|541989255|FG002|Overall Study|Lack of Efficacy|16|||
150232550|NCT01393613|541989256|FG003|Overall Study|Lack of Efficacy|21|||
150232551|NCT00474383|541989259|FG000|Main Study|Adverse Event|11|||
150232552|NCT00474383|541989260|FG001|Main Study|Adverse Event|0|||
150232553|NCT00474383|541989259|FG000|Main Study|Symptomatic Deterioration|1|||
150232554|NCT00474383|541989260|FG001|Main Study|Symptomatic Deterioration|0|||
150232555|NCT00474383|541989259|FG000|Main Study|Progressive Disease|23|||
150232556|NCT00474383|541989260|FG001|Main Study|Progressive Disease|0|||
150232557|NCT00474383|541989259|FG000|Main Study|Other|1|||
150232558|NCT00474383|541989260|FG001|Main Study|Other|0|||
150232559|NCT00474383|541989259|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
150232560|NCT00474383|541989260|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
150232561|NCT00474383|541989259|FG000|Extension|Progressive Disease|0|||
150232562|NCT00474383|541989260|FG001|Extension|Progressive Disease|5|||
150232563|NCT00316589|541989263|FG000|Overall Study|Withdrawal by Subject|0|||
150232564|NCT00316589|541989264|FG001|Overall Study|Withdrawal by Subject|5|||
150232565|NCT00316589|541989265|FG002|Overall Study|Withdrawal by Subject|0|||
150232566|NCT00316589|541989266|FG003|Overall Study|Withdrawal by Subject|1|||
150232567|NCT00316589|541989263|FG000|Overall Study|Subject unwilling/unable to comply|0|||
150232568|NCT00316589|541989264|FG001|Overall Study|Subject unwilling/unable to comply|6|||
150232569|NCT00316589|541989265|FG002|Overall Study|Subject unwilling/unable to comply|0|||
150232570|NCT00316589|541989266|FG003|Overall Study|Subject unwilling/unable to comply|2|||
150232571|NCT00316589|541989263|FG000|Overall Study|Adverse Event|1|||
150232572|NCT00316589|541989264|FG001|Overall Study|Adverse Event|0|||
150232573|NCT00316589|541989265|FG002|Overall Study|Adverse Event|0|||
150232574|NCT00316589|541989266|FG003|Overall Study|Adverse Event|1|||
150232575|NCT00316589|541989263|FG000|Overall Study|Physician Decision|0|||
150232576|NCT00316589|541989264|FG001|Overall Study|Physician Decision|1|||
150232577|NCT00316589|541989265|FG002|Overall Study|Physician Decision|0|||
150232578|NCT00316589|541989266|FG003|Overall Study|Physician Decision|0|||
150232579|NCT00316589|541989263|FG000|Overall Study|Other reason|0|||
150232580|NCT00316589|541989264|FG001|Overall Study|Other reason|12|||
150232581|NCT00316589|541989265|FG002|Overall Study|Other reason|1|||
150232582|NCT00316589|541989266|FG003|Overall Study|Other reason|1|||
150232583|NCT01482819|541989267|FG000|Overall Study|Lost to Follow-up|2|||
150232584|NCT01502371|541989272|FG000|Overall Study|Withdrawal by Subject|1|||
150232585|NCT01502371|541989273|FG001|Overall Study|Withdrawal by Subject|2|||
150232586|NCT01502371|541989274|FG002|Overall Study|Withdrawal by Subject|1|||
150232587|NCT01502371|541989275|FG003|Overall Study|Withdrawal by Subject|1|||
150232588|NCT01502371|541989276|FG004|Overall Study|Withdrawal by Subject|1|||
150232589|NCT01502371|541989272|FG000|Overall Study|Adverse Event|2|||
150232590|NCT01502371|541989273|FG001|Overall Study|Adverse Event|1|||
150232591|NCT01502371|541989274|FG002|Overall Study|Adverse Event|0|||
150232592|NCT01502371|541989275|FG003|Overall Study|Adverse Event|4|||
150232593|NCT01502371|541989276|FG004|Overall Study|Adverse Event|3|||
150232594|NCT01502371|541989272|FG000|Overall Study|Treatment Failure|22|||
150232595|NCT01502371|541989273|FG001|Overall Study|Treatment Failure|20|||
150232596|NCT01502371|541989274|FG002|Overall Study|Treatment Failure|12|||
150232597|NCT01502371|541989275|FG003|Overall Study|Treatment Failure|19|||
150232598|NCT01502371|541989276|FG004|Overall Study|Treatment Failure|30|||
150232599|NCT01502371|541989272|FG000|Overall Study|Lack of Efficacy|3|||
150232600|NCT01502371|541989273|FG001|Overall Study|Lack of Efficacy|3|||
150232601|NCT01502371|541989274|FG002|Overall Study|Lack of Efficacy|2|||
150232602|NCT01502371|541989275|FG003|Overall Study|Lack of Efficacy|2|||
150232603|NCT01502371|541989276|FG004|Overall Study|Lack of Efficacy|4|||
150232604|NCT01502371|541989272|FG000|Overall Study|Physician Decision|3|||
150232605|NCT01502371|541989273|FG001|Overall Study|Physician Decision|0|||
150232606|NCT01502371|541989274|FG002|Overall Study|Physician Decision|0|||
150232607|NCT01502371|541989275|FG003|Overall Study|Physician Decision|0|||
150232608|NCT01502371|541989276|FG004|Overall Study|Physician Decision|1|||
150232609|NCT01502371|541989272|FG000|Overall Study|Noncompliance with Study Drug|0|||
150232610|NCT01502371|541989273|FG001|Overall Study|Noncompliance with Study Drug|0|||
150232611|NCT01502371|541989274|FG002|Overall Study|Noncompliance with Study Drug|1|||
150232612|NCT01502371|541989275|FG003|Overall Study|Noncompliance with Study Drug|2|||
150232613|NCT01502371|541989276|FG004|Overall Study|Noncompliance with Study Drug|1|||
150232614|NCT01502371|541989272|FG000|Overall Study|Technical Problems|1|||
150232615|NCT01502371|541989273|FG001|Overall Study|Technical Problems|0|||
150232616|NCT01502371|541989274|FG002|Overall Study|Technical Problems|2|||
150232617|NCT01502371|541989275|FG003|Overall Study|Technical Problems|4|||
150232618|NCT01502371|541989276|FG004|Overall Study|Technical Problems|1|||
150232619|NCT01502371|541989272|FG000|Overall Study|Protocol Violation|9|||
150232620|NCT01502371|541989273|FG001|Overall Study|Protocol Violation|5|||
150232621|NCT01502371|541989274|FG002|Overall Study|Protocol Violation|6|||
150232622|NCT01502371|541989275|FG003|Overall Study|Protocol Violation|5|||
150232623|NCT01502371|541989276|FG004|Overall Study|Protocol Violation|10|||
150232624|NCT01502371|541989272|FG000|Overall Study|Excluded Medication|0|||
150232625|NCT01502371|541989273|FG001|Overall Study|Excluded Medication|1|||
150232626|NCT01502371|541989274|FG002|Overall Study|Excluded Medication|1|||
150232627|NCT01502371|541989275|FG003|Overall Study|Excluded Medication|0|||
150232628|NCT01502371|541989276|FG004|Overall Study|Excluded Medication|1|||
150232629|NCT00562484|541989277|FG000|Overall Study|Adverse Event|6|||
150232630|NCT00562484|541989278|FG001|Overall Study|Adverse Event|1|||
150232631|NCT00562484|541989277|FG000|Overall Study|Protocol Violation|11|||
150232632|NCT00562484|541989278|FG001|Overall Study|Protocol Violation|2|||
150232633|NCT00562484|541989277|FG000|Overall Study|Withdrawal by Subject|12|||
150232634|NCT00562484|541989278|FG001|Overall Study|Withdrawal by Subject|9|||
150232635|NCT00562484|541989277|FG000|Overall Study|Moved away from the study area|20|||
150232636|NCT00562484|541989278|FG001|Overall Study|Moved away from the study area|9|||
150232637|NCT00562484|541989277|FG000|Overall Study|Lost to Follow-up|132|||
150232638|NCT00562484|541989278|FG001|Overall Study|Lost to Follow-up|71|||
150232639|NCT00562484|541989277|FG000|Overall Study|Reason not provided or not specified|25|||
150232640|NCT00562484|541989278|FG001|Overall Study|Reason not provided or not specified|12|||
150232641|NCT03325608|541989281|FG000|Overall Study|Lost to Follow-up|23|||
150232642|NCT03325608|541989282|FG001|Overall Study|Lost to Follow-up|23|||
150232643|NCT03325608|541989283|FG002|Overall Study|Lost to Follow-up|30|||
150232644|NCT03325608|541989284|FG003|Overall Study|Lost to Follow-up|30|||
150232645|NCT03325608|541989281|FG000|Overall Study|Death of Caregiver|0|||
150232646|NCT03325608|541989282|FG001|Overall Study|Death of Caregiver|0|||
150232647|NCT03325608|541989283|FG002|Overall Study|Death of Caregiver|2|||
150232648|NCT03325608|541989284|FG003|Overall Study|Death of Caregiver|2|||
150232649|NCT03325608|541989281|FG000|Overall Study|Death of Care Recipient|34|||
150232650|NCT03325608|541989282|FG001|Overall Study|Death of Care Recipient|34|||
150232651|NCT03325608|541989283|FG002|Overall Study|Death of Care Recipient|28|||
150232652|NCT03325608|541989284|FG003|Overall Study|Death of Care Recipient|28|||
150232653|NCT03325608|541989281|FG000|Overall Study|Withdrawal by Subject|49|||
150232654|NCT03325608|541989282|FG001|Overall Study|Withdrawal by Subject|49|||
150232655|NCT03325608|541989283|FG002|Overall Study|Withdrawal by Subject|35|||
150232656|NCT03325608|541989284|FG003|Overall Study|Withdrawal by Subject|35|||
150232657|NCT03325608|541989281|FG000|Overall Study|Ineligible|7|||
150232658|NCT03325608|541989282|FG001|Overall Study|Ineligible|7|||
150232659|NCT03325608|541989283|FG002|Overall Study|Ineligible|5|||
150232660|NCT03325608|541989284|FG003|Overall Study|Ineligible|5|||
150232661|NCT02188784|541989285|FG000|Overall Study|Death|3|||
150232662|NCT02188784|541989286|FG001|Overall Study|Death|1|||
150232663|NCT02188784|541989285|FG000|Overall Study|Lost to Follow-up|1|||
150232664|NCT02188784|541989286|FG001|Overall Study|Lost to Follow-up|0|||
150232665|NCT02188784|541989285|FG000|Overall Study|Withdrawal by Subject|3|||
150232666|NCT02188784|541989286|FG001|Overall Study|Withdrawal by Subject|9|||
150232667|NCT02188784|541989285|FG000|Overall Study|Physician Decision|2|||
150232668|NCT02188784|541989286|FG001|Overall Study|Physician Decision|3|||
150232669|NCT02473913|541989287|FG000|Overall Study|Lost to Follow-up|3|||
150232670|NCT02473913|541989288|FG001|Overall Study|Lost to Follow-up|3|||
150232671|NCT02250183|541989296|FG000|Overall Study|Withdrawal by Subject|2|||
150232672|NCT02250183|541989296|FG000|Overall Study|Adverse Event|5|||
150232673|NCT02250183|541989296|FG000|Overall Study|Lost to Follow-up|1|||
150232674|NCT03282799|541989297|FG000|Overall Study|Pregnancy|1|||
150232675|NCT03282799|541989298|FG001|Overall Study|Pregnancy|0|||
150232676|NCT03282799|541989297|FG000|Overall Study|Physician Decision|1|||
150232677|NCT03282799|541989298|FG001|Overall Study|Physician Decision|0|||
150232678|NCT03749616|541989299|FG000|Overall Study|Lost to Follow-up|4|||
150232679|NCT03749616|541989300|FG001|Overall Study|Lost to Follow-up|7|||
150232680|NCT03749616|541989299|FG000|Overall Study|Screen Failure|1|||
150232681|NCT03749616|541989300|FG001|Overall Study|Screen Failure|1|||
150232682|NCT03749616|541989299|FG000|Overall Study|Withdrawal by Subject|2|||
150232683|NCT03749616|541989300|FG001|Overall Study|Withdrawal by Subject|0|||
150232684|NCT03302559|541989301|FG000|Overall Study|Adverse Event|2|||
150232685|NCT03302559|541989301|FG000|Overall Study|Lost to Follow-up|1|||
150232686|NCT03302559|541989301|FG000|Overall Study|Withdrew Consent|3|||
150232687|NCT01999972|541991004|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
150232688|NCT01999972|541991005|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
150232689|NCT01999972|541991006|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
150232690|NCT01999972|541991007|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
150232691|NCT01999972|541991008|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
150232692|NCT01999972|541991009|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
150232693|NCT01999972|541991004|FG000|Dose Escalation Part|Death|0|||
150232694|NCT01999972|541991005|FG001|Dose Escalation Part|Death|1|||
150232695|NCT01999972|541991006|FG002|Dose Escalation Part|Death|0|||
150232696|NCT01999972|541991007|FG003|Dose Escalation Part|Death|0|||
150232697|NCT01999972|541991008|FG004|Dose Escalation Part|Death|0|||
150232698|NCT01999972|541991009|FG005|Dose Escalation Part|Death|0|||
150232699|NCT01999972|541991004|FG000|Dose Escalation Part|Enrolled but not treated|0|||
150232700|NCT01999972|541991005|FG001|Dose Escalation Part|Enrolled but not treated|0|||
150232701|NCT01999972|541991006|FG002|Dose Escalation Part|Enrolled but not treated|1|||
150232702|NCT01999972|541991007|FG003|Dose Escalation Part|Enrolled but not treated|1|||
150232703|NCT01999972|541991008|FG004|Dose Escalation Part|Enrolled but not treated|0|||
150232704|NCT01999972|541991009|FG005|Dose Escalation Part|Enrolled but not treated|0|||
150232705|NCT01999972|541991004|FG000|Dose Escalation Part|Disease progression|3|||
150232706|NCT01999972|541991005|FG001|Dose Escalation Part|Disease progression|2|||
150232707|NCT01999972|541991006|FG002|Dose Escalation Part|Disease progression|3|||
150232708|NCT01999972|541991007|FG003|Dose Escalation Part|Disease progression|6|||
150232709|NCT01999972|541991008|FG004|Dose Escalation Part|Disease progression|0|||
150232710|NCT01999972|541991009|FG005|Dose Escalation Part|Disease progression|0|||
150232711|NCT01999972|541991004|FG000|Dose Escalation Part|Adverse Event|0|||
150232712|NCT01999972|541991005|FG001|Dose Escalation Part|Adverse Event|0|||
150232713|NCT01999972|541991006|FG002|Dose Escalation Part|Adverse Event|0|||
150232714|NCT01999972|541991007|FG003|Dose Escalation Part|Adverse Event|2|||
150232715|NCT01999972|541991008|FG004|Dose Escalation Part|Adverse Event|0|||
150232716|NCT01999972|541991009|FG005|Dose Escalation Part|Adverse Event|0|||
150232717|NCT01999972|541991004|FG000|Dose Escalation Part|Global deterioration of health status|1|||
150232718|NCT01999972|541991005|FG001|Dose Escalation Part|Global deterioration of health status|0|||
150232719|NCT01999972|541991006|FG002|Dose Escalation Part|Global deterioration of health status|0|||
150232720|NCT01999972|541991007|FG003|Dose Escalation Part|Global deterioration of health status|1|||
150232721|NCT01999972|541991008|FG004|Dose Escalation Part|Global deterioration of health status|0|||
150232722|NCT01999972|541991009|FG005|Dose Escalation Part|Global deterioration of health status|0|||
150232723|NCT01999972|541991004|FG000|Dose Expansion Part|Death|0|||
150232724|NCT01999972|541991005|FG001|Dose Expansion Part|Death|0|||
150232725|NCT01999972|541991006|FG002|Dose Expansion Part|Death|0|||
150232726|NCT01999972|541991007|FG003|Dose Expansion Part|Death|0|||
150232727|NCT01999972|541991008|FG004|Dose Expansion Part|Death|2|||
150232728|NCT01999972|541991009|FG005|Dose Expansion Part|Death|1|||
150232729|NCT01999972|541991004|FG000|Dose Expansion Part|Disease progression|0|||
150232730|NCT01999972|541991005|FG001|Dose Expansion Part|Disease progression|0|||
150232731|NCT01999972|541991006|FG002|Dose Expansion Part|Disease progression|0|||
150232732|NCT01999972|541991007|FG003|Dose Expansion Part|Disease progression|0|||
150232733|NCT01999972|541991008|FG004|Dose Expansion Part|Disease progression|9|||
150232734|NCT01999972|541991009|FG005|Dose Expansion Part|Disease progression|3|||
150232735|NCT01999972|541991004|FG000|Dose Expansion Part|Sponsor decision|0|||
150232736|NCT01999972|541991005|FG001|Dose Expansion Part|Sponsor decision|0|||
150232737|NCT01999972|541991006|FG002|Dose Expansion Part|Sponsor decision|0|||
150232738|NCT01999972|541991007|FG003|Dose Expansion Part|Sponsor decision|0|||
150232739|NCT01999972|541991008|FG004|Dose Expansion Part|Sponsor decision|1|||
150232740|NCT01999972|541991009|FG005|Dose Expansion Part|Sponsor decision|0|||
150232741|NCT01999972|541991004|FG000|Dose Expansion Part|Adverse Event|0|||
150232742|NCT01999972|541991005|FG001|Dose Expansion Part|Adverse Event|0|||
150232743|NCT01999972|541991006|FG002|Dose Expansion Part|Adverse Event|0|||
150232744|NCT01999972|541991007|FG003|Dose Expansion Part|Adverse Event|0|||
150232745|NCT01999972|541991008|FG004|Dose Expansion Part|Adverse Event|4|||
150232746|NCT01999972|541991009|FG005|Dose Expansion Part|Adverse Event|2|||
150232747|NCT01999972|541991004|FG000|Dose Expansion Part|Participant's non-compliance|0|||
150232748|NCT01999972|541991005|FG001|Dose Expansion Part|Participant's non-compliance|0|||
150232749|NCT01999972|541991006|FG002|Dose Expansion Part|Participant's non-compliance|0|||
150232750|NCT01999972|541991007|FG003|Dose Expansion Part|Participant's non-compliance|0|||
150232751|NCT01999972|541991008|FG004|Dose Expansion Part|Participant's non-compliance|0|||
150232752|NCT01999972|541991009|FG005|Dose Expansion Part|Participant's non-compliance|1|||
150232753|NCT01999972|541991004|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
150232754|NCT01999972|541991005|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
150232755|NCT01999972|541991006|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
150232756|NCT01999972|541991007|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
150232757|NCT01999972|541991008|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
150232758|NCT01999972|541991009|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
150232759|NCT01999972|541991004|FG000|Dose Expansion Part|Changed to standard of care|0|||
150232760|NCT01999972|541991005|FG001|Dose Expansion Part|Changed to standard of care|0|||
150232761|NCT01999972|541991006|FG002|Dose Expansion Part|Changed to standard of care|0|||
150232762|NCT01999972|541991007|FG003|Dose Expansion Part|Changed to standard of care|0|||
150232763|NCT01999972|541991008|FG004|Dose Expansion Part|Changed to standard of care|1|||
150232764|NCT01999972|541991009|FG005|Dose Expansion Part|Changed to standard of care|0|||
150232765|NCT03440047|541991015|FG000|Overall Study|Withdrawal by Subject|2|||
150232766|NCT01722045|541991016|FG000|Overall Study|Adverse Event|8|||
150232767|NCT01722045|541991016|FG000|Overall Study|Death|3|||
150232768|NCT01722045|541991016|FG000|Overall Study|Withdrawal by Subject|8|||
150232769|NCT01722045|541991016|FG000|Overall Study|Lost to Follow-up|4|||
150232770|NCT01722045|541991016|FG000|Overall Study|Protocol Deviation|1|||
150232771|NCT01722045|541991016|FG000|Overall Study|Physician Decision|3|||
150232772|NCT01722045|541991016|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
150232773|NCT00612352|541991017|FG000|Overall Study|Adverse Event|1|||
150232774|NCT00612352|541991018|FG001|Overall Study|Adverse Event|0|||
150232775|NCT00612352|541991017|FG000|Overall Study|Withdrawal by Subject|3|||
150232776|NCT00612352|541991018|FG001|Overall Study|Withdrawal by Subject|5|||
150232777|NCT00612352|541991017|FG000|Overall Study|moved out of state|1|||
150232778|NCT00612352|541991018|FG001|Overall Study|moved out of state|0|||
150232779|NCT00612352|541991017|FG000|Overall Study|didn't return calls/show up on test date|4|||
150232780|NCT00612352|541991018|FG001|Overall Study|didn't return calls/show up on test date|1|||
150232781|NCT02161406|541991019|FG000|Overall Study|Death|2|||
150232782|NCT02161406|541991020|FG001|Overall Study|Death|1|||
150232783|NCT02161406|541991019|FG000|Overall Study|Lost to Follow-up|2|||
150232784|NCT02161406|541991020|FG001|Overall Study|Lost to Follow-up|1|||
150232785|NCT02161406|541991019|FG000|Overall Study|Withdrawal by Subject|2|||
150232786|NCT02161406|541991020|FG001|Overall Study|Withdrawal by Subject|4|||
150232787|NCT02161406|541991019|FG000|Overall Study|investigator withdrew subject|3|||
150232788|NCT02161406|541991020|FG001|Overall Study|investigator withdrew subject|1|||
150232789|NCT02161406|541991019|FG000|Overall Study|Lack of Efficacy|1|||
150232790|NCT02161406|541991020|FG001|Overall Study|Lack of Efficacy|1|||
150232791|NCT02161406|541991019|FG000|Overall Study|relocation|0|||
150232792|NCT02161406|541991020|FG001|Overall Study|relocation|1|||
150232793|NCT00477464|541991021|FG000|Overall Study|Lost to Follow-up|1|||
150232794|NCT00477464|541991021|FG000|Overall Study|Death|36|||
150232795|NCT00477464|541991021|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
150232796|NCT04051242|541991026|FG000|Overall Study|Withdrawal by Subject|1|||
150232797|NCT04051242|541991026|FG000|Overall Study|Physician Decision|1|||
150232798|NCT01336205|541991027|FG000|Overall Study|Other|22|||
150232799|NCT01336205|541991028|FG001|Overall Study|Other|9|||
150232800|NCT01336205|541991027|FG000|Overall Study|Lost to Follow-up|40|||
150232801|NCT01336205|541991028|FG001|Overall Study|Lost to Follow-up|20|||
150232802|NCT01336205|541991027|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
150232803|NCT01336205|541991028|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
150232804|NCT01336205|541991027|FG000|Overall Study|Lack of Efficacy|4|||
150232805|NCT01336205|541991028|FG001|Overall Study|Lack of Efficacy|0|||
150232806|NCT01336205|541991027|FG000|Overall Study|Severe noncompliance with protocol|9|||
150232807|NCT01336205|541991028|FG001|Overall Study|Severe noncompliance with protocol|2|||
150232808|NCT01336205|541991027|FG000|Overall Study|Adverse Event|56|||
150232809|NCT01336205|541991028|FG001|Overall Study|Adverse Event|6|||
150232810|NCT01336205|541991027|FG000|Overall Study|Death|1|||
150232811|NCT01336205|541991028|FG001|Overall Study|Death|1|||
150232812|NCT01336205|541991027|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
150232813|NCT01336205|541991028|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
150232814|NCT01336205|541991027|FG000|Overall Study|Withdrawal by Subject|72|||
150232815|NCT01336205|541991028|FG001|Overall Study|Withdrawal by Subject|38|||
150232816|NCT01336205|541991027|FG000|Overall Study|Did not receive treatment|4|||
150232817|NCT01336205|541991028|FG001|Overall Study|Did not receive treatment|0|||
150232818|NCT04035577|541991029|FG000|Overall Study|Lost to Follow-up|1|||
150232819|NCT04035577|541991029|FG000|Overall Study|Withdrawal by Subject|1|||
150232820|NCT00846768|541991030|FG000|Overall Study|Adverse Event|0|||
150232821|NCT00846768|541991031|FG001|Overall Study|Adverse Event|1|||
150232822|NCT00846768|541991032|FG002|Overall Study|Adverse Event|0|||
150232823|NCT00846768|541991033|FG003|Overall Study|Adverse Event|0|||
150232824|NCT04358068|541991034|FG000|Overall Study|Did not initiate study treatment|2|||
150232825|NCT04358068|541991035|FG001|Overall Study|Did not initiate study treatment|2|||
150232826|NCT04353817|541991036|FG000|Overall Study|Adverse Event|0|||
150232827|NCT04353817|541991037|FG001|Overall Study|Adverse Event|1|||
150232828|NCT00665223|541991040|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
150232829|NCT00665223|541991041|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
150232830|NCT00665223|541991042|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
150232831|NCT00665223|541991040|FG000|Randomized Phase (26 Weeks)|Death|0|||
150232832|NCT00665223|541991041|FG001|Randomized Phase (26 Weeks)|Death|0|||
150232833|NCT00665223|541991042|FG002|Randomized Phase (26 Weeks)|Death|1|||
150232834|NCT00665223|541991040|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
150232835|NCT00665223|541991041|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
150232836|NCT00665223|541991042|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
150232837|NCT00665223|541991040|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
150232838|NCT00665223|541991041|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
150232839|NCT00665223|541991042|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
150232840|NCT00665223|541991040|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
150232841|NCT00665223|541991041|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
150232842|NCT00665223|541991042|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
150232843|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
150232844|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
150232845|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
150232846|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Death|0|||
150232847|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Death|1|||
150232848|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Death|0|||
150232849|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
150232850|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
150232851|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
150232852|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
150232853|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
150232854|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
150232855|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
150232856|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
150232857|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
150232858|NCT00665223|541991040|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
150232859|NCT00665223|541991041|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
150232860|NCT00665223|541991042|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
150232861|NCT00591591|541991043|FG000|Overall Study|Withdrawal by Subject|1|||
150232862|NCT00591591|541991044|FG001|Overall Study|Withdrawal by Subject|37|||
150232863|NCT00591591|541991043|FG000|Overall Study|Lack of Efficacy|10|||
150232864|NCT00591591|541991044|FG001|Overall Study|Lack of Efficacy|2|||
150232865|NCT00002597|541991045|FG000|Overall Study|Protocol Violation|19|||
150232866|NCT00002597|541991046|FG001|Overall Study|Protocol Violation|17|||
150232867|NCT00002597|541991045|FG000|Overall Study|Withdrawal by Subject|7|||
150232868|NCT00002597|541991046|FG001|Overall Study|Withdrawal by Subject|6|||
150232869|NCT00338949|541991049|FG000|Subject Screening|Screen failures|11|||
150232870|NCT00338949|541991050|FG001|Subject Screening|Screen failures|11|||
150232871|NCT00338949|541991049|FG000|Randomization|Withdrawal by Subject|1|||
150232872|NCT00338949|541991050|FG001|Randomization|Withdrawal by Subject|0|||
150232873|NCT00338949|541991049|FG000|Randomization|Adverse Event|0|||
150232874|NCT00338949|541991050|FG001|Randomization|Adverse Event|5|||
150232875|NCT02261285|541991051|FG000|Overall Study|Disease progression|0|||
150232876|NCT02261285|541991052|FG001|Overall Study|Disease progression|0|||
150232877|NCT02261285|541991053|FG002|Overall Study|Disease progression|1|||
150232878|NCT01161628|541991054|FG000|Overall Study|Death|6|||
150232879|NCT01161628|541991054|FG000|Overall Study|Lack of Efficacy|2|||
150232880|NCT01263925|541991059|FG000|Overall Study|Protocol Violation|1|||
150232881|NCT01263925|541991060|FG001|Overall Study|Protocol Violation|0|||
150232882|NCT01263925|541991059|FG000|Overall Study|Lack of Efficacy|0|||
150232883|NCT01263925|541991060|FG001|Overall Study|Lack of Efficacy|1|||
150232884|NCT01263925|541991059|FG000|Overall Study|Adverse Event|23|||
150232885|NCT01263925|541991060|FG001|Overall Study|Adverse Event|22|||
150232886|NCT01263925|541991059|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
150232887|NCT01263925|541991060|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
150232888|NCT01263925|541991059|FG000|Overall Study|Withdrawal by Subject|6|||
150232889|NCT01263925|541991060|FG001|Overall Study|Withdrawal by Subject|8|||
150232890|NCT01263925|541991059|FG000|Overall Study|Other|4|||
150232891|NCT01263925|541991060|FG001|Overall Study|Other|4|||
150232892|NCT01263925|541991059|FG000|Overall Study|Lost to Follow-up|3|||
150232893|NCT01263925|541991060|FG001|Overall Study|Lost to Follow-up|1|||
150232894|NCT01263925|541991059|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
150232895|NCT01263925|541991060|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
150232896|NCT01263925|541991059|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
150232897|NCT01263925|541991060|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
150232898|NCT01263925|541991059|FG000|Overall Study|AE/ Withdrawal|1|||
150232899|NCT01263925|541991060|FG001|Overall Study|AE/ Withdrawal|4|||
150232900|NCT01263925|541991059|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
150232901|NCT01263925|541991060|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
150232902|NCT01263925|541991059|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
150232903|NCT01263925|541991060|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
150232904|NCT01263925|541991059|FG000|Overall Study|Withdrawal/ Not specified|0|||
150232905|NCT01263925|541991060|FG001|Overall Study|Withdrawal/ Not specified|1|||
150232906|NCT03029819|541991061|FG000|Overall Study|Lost to Follow-up|3|||
150232907|NCT03029819|541991062|FG001|Overall Study|Lost to Follow-up|5|||
150232908|NCT03029819|541991061|FG000|Overall Study|Removed due to disruptive behavior|0|||
150232909|NCT03029819|541991062|FG001|Overall Study|Removed due to disruptive behavior|1|||
150232910|NCT01215032|541991068|FG000|Overall Study|Adverse Event|3|||
150232911|NCT01215032|541991068|FG000|Overall Study|Lack of Efficacy|17|||
150232912|NCT02725008|541991069|FG000|Overall Study|Lost to Follow-up|7|||
150232913|NCT02725008|541991070|FG001|Overall Study|Lost to Follow-up|9|||
150232914|NCT02725008|541991069|FG000|Overall Study|Withdrawal by Subject|2|||
150232915|NCT02725008|541991070|FG001|Overall Study|Withdrawal by Subject|2|||
150232916|NCT02725008|541991069|FG000|Overall Study|Admitted to hospital|0|||
150232917|NCT02725008|541991070|FG001|Overall Study|Admitted to hospital|1|||
150232918|NCT01726517|541991073|FG000|Overall Study|Withdrawal by Subject|0|||
150232919|NCT01726517|541991074|FG001|Overall Study|Withdrawal by Subject|0|||
150232920|NCT01726517|541991075|FG002|Overall Study|Withdrawal by Subject|1|||
150232921|NCT01726517|541991076|FG003|Overall Study|Withdrawal by Subject|0|||
150232922|NCT01726517|541991077|FG004|Overall Study|Withdrawal by Subject|0|||
150232923|NCT00770588|541991078|FG000|Overall Study|Adverse Event|9|||
150232924|NCT00770588|541991079|FG001|Overall Study|Adverse Event|2|||
150232925|NCT00770588|541991078|FG000|Overall Study|Death caused by progression of disease|70|||
150232926|NCT00770588|541991079|FG001|Overall Study|Death caused by progression of disease|91|||
150232927|NCT00770588|541991078|FG000|Overall Study|Lost to Follow-up|1|||
150232928|NCT00770588|541991079|FG001|Overall Study|Lost to Follow-up|1|||
150232929|NCT00770588|541991078|FG000|Overall Study|Withdrawal by Subject|1|||
150232930|NCT00770588|541991079|FG001|Overall Study|Withdrawal by Subject|1|||
150232931|NCT04688086|541991080|FG000|Overall Study|Lost to Follow-up|164|||
150232932|NCT04688086|541991080|FG000|Overall Study|Imaging error;|64|||
150232933|NCT01203956|541991083|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
150232934|NCT01203956|541991084|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
150232935|NCT01329419|541991087|FG000|Overall Study|Protocol Violation|235|||
150232936|NCT04522778|541991088|FG000|Overall Study|Patient did not want to wear the device|1|||
150232937|NCT04522778|541991089|FG001|Overall Study|Patient did not want to wear the device|0|||
150232938|NCT04522778|541991088|FG000|Overall Study|Lost to Follow-up|0|||
150232939|NCT04522778|541991089|FG001|Overall Study|Lost to Follow-up|1|||
150232940|NCT00069277|541991092|FG000|Overall Study|Adverse Event|3|||
150232941|NCT00069277|541991092|FG000|Overall Study|Withdrawal by Subject|1|||
150232942|NCT00069277|541991092|FG000|Overall Study|Progressive Disease|15|||
150232943|NCT00069277|541991092|FG000|Overall Study|Physician Decision|2|||
150232944|NCT01225159|541991093|FG000|Overall Study|Change operation|1|||
150232945|NCT01225159|541991094|FG001|Overall Study|Change operation|0|||
150232946|NCT02230306|541991095|FG000|Overall Study|Did not receive study treatment|1|||
150232947|NCT00361842|541991101|FG000|Overall Study|Withdrawal by Subject|2|||
150232948|NCT00361842|541991102|FG001|Overall Study|Withdrawal by Subject|3|||
150232949|NCT00361842|541991101|FG000|Overall Study|Death|2|||
150232950|NCT00361842|541991102|FG001|Overall Study|Death|1|||
150232951|NCT00361842|541991101|FG000|Overall Study|Disease progression|19|||
150232952|NCT00361842|541991102|FG001|Overall Study|Disease progression|20|||
150232953|NCT00361842|541991101|FG000|Overall Study|Adverse Event|2|||
150232954|NCT00361842|541991102|FG001|Overall Study|Adverse Event|3|||
150232955|NCT00361842|541991101|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
150232956|NCT00361842|541991102|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
150232957|NCT00361842|541991101|FG000|Overall Study|Other|1|||
150232958|NCT00361842|541991102|FG001|Overall Study|Other|0|||
150232959|NCT00361842|541991101|FG000|Overall Study|Other|0|||
150232960|NCT00361842|541991102|FG001|Overall Study|Other|2|||
150232961|NCT01220856|541991103|FG000|Overall Study|graft loss|3|||
150232962|NCT01220856|541991104|FG001|Overall Study|graft loss|3|||
150232963|NCT01220856|541991103|FG000|Overall Study|Lost to Follow-up|1|||
150232964|NCT01220856|541991104|FG001|Overall Study|Lost to Follow-up|0|||
150232965|NCT03512288|541991105|FG000|Overall Study|Adverse Event|1|||
150232966|NCT03512288|541991106|FG001|Overall Study|Adverse Event|0|||
150232967|NCT03512288|541991105|FG000|Overall Study|Lost to Follow-up|12|||
150232968|NCT03512288|541991106|FG001|Overall Study|Lost to Follow-up|15|||
150232969|NCT03512288|541991105|FG000|Overall Study|Physician Decision|0|||
150232970|NCT03512288|541991106|FG001|Overall Study|Physician Decision|2|||
150232971|NCT03512288|541991105|FG000|Overall Study|Protocol Violation|6|||
150232972|NCT03512288|541991106|FG001|Overall Study|Protocol Violation|4|||
150232973|NCT03512288|541991105|FG000|Overall Study|Medication error without associated adverse event|1|||
150232974|NCT03512288|541991106|FG001|Overall Study|Medication error without associated adverse event|0|||
150232975|NCT03512288|541991105|FG000|Overall Study|No longer met eligibility criteria|5|||
150232976|NCT03512288|541991106|FG001|Overall Study|No longer met eligibility criteria|2|||
150232977|NCT03512288|541991105|FG000|Overall Study|Withdrawal by parent/guardian|14|||
150232978|NCT03512288|541991106|FG001|Overall Study|Withdrawal by parent/guardian|18|||
150232979|NCT03512288|541991105|FG000|Overall Study|Other|1|||
150232980|NCT03512288|541991106|FG001|Overall Study|Other|1|||
150232981|NCT03512288|541991105|FG000|Overall Study|Randomized but not treated|1|||
150232982|NCT03512288|541991106|FG001|Overall Study|Randomized but not treated|1|||
150232983|NCT04206384|541991107|FG000|Overall Study|Withdrawal by Subject|8|||
150232984|NCT04206384|541991107|FG000|Overall Study|Adverse Event|2|||
150232985|NCT02212197|541991108|FG000|Overall Study|Need for radiotherapy|1|||
150232986|NCT02212197|541991109|FG001|Overall Study|Need for radiotherapy|0|||
150232987|NCT02212197|541991110|FG002|Overall Study|Need for radiotherapy|0|||
150232988|NCT03015181|541991111|FG000|Overall Study|Enrolled, but product never administered|1|||
150232989|NCT03015181|541991112|FG001|Overall Study|Enrolled, but product never administered|0|||
150232990|NCT03015181|541991113|FG002|Overall Study|Enrolled, but product never administered|0|||
150232991|NCT03015181|541991114|FG003|Overall Study|Enrolled, but product never administered|0|||
150232992|NCT03015181|541991115|FG004|Overall Study|Enrolled, but product never administered|0|||
150232993|NCT03015181|541991116|FG005|Overall Study|Enrolled, but product never administered|0|||
150232994|NCT03015181|541991117|FG006|Overall Study|Enrolled, but product never administered|0|||
150232995|NCT03015181|541991111|FG000|Overall Study|Withdrawal by Subject|0|||
150232996|NCT03015181|541991112|FG001|Overall Study|Withdrawal by Subject|0|||
150232997|NCT03015181|541991113|FG002|Overall Study|Withdrawal by Subject|0|||
150232998|NCT03015181|541991114|FG003|Overall Study|Withdrawal by Subject|0|||
150232999|NCT03015181|541991115|FG004|Overall Study|Withdrawal by Subject|0|||
150233000|NCT03015181|541991116|FG005|Overall Study|Withdrawal by Subject|1|||
150233001|NCT03015181|541991117|FG006|Overall Study|Withdrawal by Subject|0|||
150233002|NCT03015181|541991111|FG000|Overall Study|Physician Decision|0|||
150233003|NCT03015181|541991112|FG001|Overall Study|Physician Decision|0|||
150233004|NCT03015181|541991113|FG002|Overall Study|Physician Decision|0|||
150233005|NCT03015181|541991114|FG003|Overall Study|Physician Decision|0|||
150233006|NCT03015181|541991115|FG004|Overall Study|Physician Decision|0|||
150233007|NCT03015181|541991116|FG005|Overall Study|Physician Decision|0|||
150233008|NCT03015181|541991117|FG006|Overall Study|Physician Decision|1|||
150233009|NCT01260142|541991119|FG000|Treatment Period 1|Study on hold|1|||
150233010|NCT01260142|541991120|FG001|Treatment Period 1|Study on hold|1|||
150233011|NCT01260142|541991121|FG002|Treatment Period 1|Study on hold|0|||
150233012|NCT01260142|541991122|FG003|Treatment Period 1|Study on hold|0|||
150233013|NCT01260142|541991123|FG004|Treatment Period 1|Study on hold|1|||
150233014|NCT01260142|541991124|FG005|Treatment Period 1|Study on hold|2|||
150233015|NCT01260142|541991119|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
150233016|NCT01260142|541991120|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
150233017|NCT01260142|541991121|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
150233018|NCT01260142|541991122|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
150233019|NCT01260142|541991123|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
150233020|NCT01260142|541991124|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
150233021|NCT01260142|541991119|FG000|Treatment Period 1|Withdrawal by Subject|0|||
150233022|NCT01260142|541991120|FG001|Treatment Period 1|Withdrawal by Subject|0|||
150233023|NCT01260142|541991121|FG002|Treatment Period 1|Withdrawal by Subject|0|||
150233024|NCT01260142|541991122|FG003|Treatment Period 1|Withdrawal by Subject|0|||
150233025|NCT01260142|541991123|FG004|Treatment Period 1|Withdrawal by Subject|0|||
150233026|NCT01260142|541991124|FG005|Treatment Period 1|Withdrawal by Subject|1|||
150233027|NCT00496834|541991129|FG000|Overall Study|Withdrawal by Subject|4|||
150233028|NCT00496834|541991130|FG001|Overall Study|Withdrawal by Subject|6|||
150233029|NCT00496834|541991129|FG000|Overall Study|Contraindicated medication administered|0|||
150233030|NCT00496834|541991130|FG001|Overall Study|Contraindicated medication administered|1|||
150233031|NCT00496834|541991129|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
150233032|NCT00496834|541991130|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
150233033|NCT00496834|541991129|FG000|Overall Study|Adverse Event|5|||
150233034|NCT00496834|541991130|FG001|Overall Study|Adverse Event|3|||
150233035|NCT00496834|541991129|FG000|Overall Study|IP administration violation|2|||
150233036|NCT00496834|541991130|FG001|Overall Study|IP administration violation|0|||
150233037|NCT00496834|541991129|FG000|Overall Study|Lost to Follow-up|2|||
150233038|NCT00496834|541991130|FG001|Overall Study|Lost to Follow-up|0|||
150233039|NCT00496834|541991129|FG000|Overall Study|Blood Pressure control failure|2|||
150233040|NCT00496834|541991130|FG001|Overall Study|Blood Pressure control failure|1|||
150233041|NCT00356759|541991131|FG000|Overall Study|Death|5|||
150233042|NCT00356759|541991132|FG001|Overall Study|Death|2|||
150233043|NCT00356759|541991131|FG000|Overall Study|Withdrawal by Subject|2|||
150233044|NCT00356759|541991132|FG001|Overall Study|Withdrawal by Subject|2|||
150233045|NCT00356759|541991131|FG000|Overall Study|Adverse Event|1|||
150233046|NCT00356759|541991132|FG001|Overall Study|Adverse Event|3|||
150233047|NCT00356759|541991131|FG000|Overall Study|Lost to Follow-up|1|||
150233048|NCT00356759|541991132|FG001|Overall Study|Lost to Follow-up|1|||
150233049|NCT00356759|541991131|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
150233050|NCT00356759|541991132|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
150233051|NCT01494298|541991133|FG000|Overall Study|Protocol Violation|2|||
150233052|NCT01494298|541991134|FG001|Overall Study|Protocol Violation|8|||
150233053|NCT03821064|541991135|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
150233054|NCT02998918|541991137|FG000|Overall Study|Withdrawal by Subject|1|||
150233055|NCT02998918|541991138|FG001|Overall Study|Withdrawal by Subject|0|||
150233056|NCT00942188|541991139|FG000|Overall Study|Adverse Event|0|||
150233057|NCT00942188|541991140|FG001|Overall Study|Adverse Event|3|||
150233058|NCT00942188|541991141|FG002|Overall Study|Adverse Event|2|||
150233059|NCT00942188|541991142|FG003|Overall Study|Adverse Event|0|||
150233060|NCT00942188|541991139|FG000|Overall Study|Lack of Efficacy|0|||
150233061|NCT00942188|541991140|FG001|Overall Study|Lack of Efficacy|0|||
150233062|NCT00942188|541991141|FG002|Overall Study|Lack of Efficacy|0|||
150233063|NCT00942188|541991142|FG003|Overall Study|Lack of Efficacy|1|||
150233064|NCT00942188|541991139|FG000|Overall Study|Protocol Violation|1|||
150233065|NCT00942188|541991140|FG001|Overall Study|Protocol Violation|1|||
150233066|NCT00942188|541991141|FG002|Overall Study|Protocol Violation|0|||
150233067|NCT00942188|541991142|FG003|Overall Study|Protocol Violation|0|||
150233068|NCT00942188|541991139|FG000|Overall Study|Lost to Follow-up|2|||
150233069|NCT00942188|541991140|FG001|Overall Study|Lost to Follow-up|1|||
150233070|NCT00942188|541991141|FG002|Overall Study|Lost to Follow-up|2|||
150233071|NCT00942188|541991142|FG003|Overall Study|Lost to Follow-up|0|||
150233072|NCT00942188|541991139|FG000|Overall Study|Withdrawal by Subject|1|||
150233073|NCT00942188|541991140|FG001|Overall Study|Withdrawal by Subject|3|||
150233074|NCT00942188|541991141|FG002|Overall Study|Withdrawal by Subject|4|||
150233075|NCT00942188|541991142|FG003|Overall Study|Withdrawal by Subject|2|||
150233076|NCT00942188|541991139|FG000|Overall Study|Physician Decision|0|||
150233077|NCT00942188|541991140|FG001|Overall Study|Physician Decision|0|||
150233078|NCT00942188|541991141|FG002|Overall Study|Physician Decision|1|||
150233079|NCT00942188|541991142|FG003|Overall Study|Physician Decision|0|||
150233080|NCT00942188|541991139|FG000|Overall Study|Sponsor Decision|0|||
150233081|NCT00942188|541991140|FG001|Overall Study|Sponsor Decision|2|||
150233082|NCT00942188|541991141|FG002|Overall Study|Sponsor Decision|0|||
150233083|NCT00942188|541991142|FG003|Overall Study|Sponsor Decision|1|||
150233084|NCT02979613|541991143|FG000|Double-Blind Phase|Withdrew Consent|2|||
150233085|NCT02979613|541991144|FG001|Double-Blind Phase|Withdrew Consent|4|||
150233086|NCT02979613|541991143|FG000|Double-Blind Phase|Pregnancy|2|||
150233087|NCT02979613|541991144|FG001|Double-Blind Phase|Pregnancy|2|||
150233088|NCT02979613|541991143|FG000|Double-Blind Phase|Adverse Event|2|||
150233089|NCT02979613|541991144|FG001|Double-Blind Phase|Adverse Event|0|||
150233090|NCT02979613|541991143|FG000|Double-Blind Phase|Lost to Follow-up|1|||
150233091|NCT02979613|541991144|FG001|Double-Blind Phase|Lost to Follow-up|1|||
150233092|NCT02979613|541991143|FG000|Double-Blind Phase|Protocol Violation|1|||
150233093|NCT02979613|541991144|FG001|Double-Blind Phase|Protocol Violation|1|||
150233094|NCT02979613|541991143|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
150233095|NCT02979613|541991144|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
150233096|NCT02979613|541991143|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
150233097|NCT02979613|541991144|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
150233098|NCT02979613|541991143|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
150233099|NCT02979613|541991144|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
150233100|NCT02979613|541991143|FG000|Open-Label Extension (OLE) Phase|Death|0|||
150233101|NCT02979613|541991144|FG001|Open-Label Extension (OLE) Phase|Death|1|||
150233102|NCT02979613|541991143|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
150233103|NCT02979613|541991144|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
150233104|NCT04944784|541991149|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
150233105|NCT04944784|541991150|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
150233106|NCT04944784|541991151|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
150233107|NCT04944784|541991152|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
150233108|NCT04944784|541991149|FG000|Double-blind Period|Adverse Event|20|||
150233109|NCT04944784|541991150|FG001|Double-blind Period|Adverse Event|4|||
150233110|NCT04944784|541991151|FG002|Double-blind Period|Adverse Event|0|||
150233111|NCT04944784|541991152|FG003|Double-blind Period|Adverse Event|0|||
150233112|NCT04944784|541991149|FG000|Double-blind Period|Withdrawal by Subject|15|||
150233113|NCT04944784|541991150|FG001|Double-blind Period|Withdrawal by Subject|4|||
150233114|NCT04944784|541991151|FG002|Double-blind Period|Withdrawal by Subject|0|||
150233115|NCT04944784|541991152|FG003|Double-blind Period|Withdrawal by Subject|0|||
150233116|NCT04944784|541991149|FG000|Double-blind Period|Death|7|||
150233117|NCT04944784|541991150|FG001|Double-blind Period|Death|2|||
150233118|NCT04944784|541991151|FG002|Double-blind Period|Death|0|||
150233119|NCT04944784|541991152|FG003|Double-blind Period|Death|0|||
150233120|NCT04944784|541991149|FG000|Double-blind Period|Physician Decision|2|||
150233121|NCT04944784|541991150|FG001|Double-blind Period|Physician Decision|1|||
150233122|NCT04944784|541991151|FG002|Double-blind Period|Physician Decision|0|||
150233123|NCT04944784|541991152|FG003|Double-blind Period|Physician Decision|0|||
150233124|NCT04944784|541991149|FG000|Double-blind Period|Lack of Efficacy|0|||
150233125|NCT04944784|541991150|FG001|Double-blind Period|Lack of Efficacy|1|||
150233126|NCT04944784|541991151|FG002|Double-blind Period|Lack of Efficacy|0|||
150233127|NCT04944784|541991152|FG003|Double-blind Period|Lack of Efficacy|0|||
150233128|NCT04944784|541991149|FG000|Double-blind Period|Sponsor Request|2|||
150233129|NCT04944784|541991150|FG001|Double-blind Period|Sponsor Request|1|||
150233130|NCT04944784|541991151|FG002|Double-blind Period|Sponsor Request|0|||
150233131|NCT04944784|541991152|FG003|Double-blind Period|Sponsor Request|0|||
150233132|NCT04944784|541991149|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
150233133|NCT04944784|541991150|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
150233134|NCT04944784|541991151|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
150233135|NCT04944784|541991152|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
150233136|NCT04944784|541991149|FG000|Double-blind Period|Participant Choice|1|||
150233137|NCT04944784|541991150|FG001|Double-blind Period|Participant Choice|1|||
150233138|NCT04944784|541991151|FG002|Double-blind Period|Participant Choice|0|||
150233139|NCT04944784|541991152|FG003|Double-blind Period|Participant Choice|0|||
150233140|NCT04944784|541991149|FG000|Double-blind Period|Progressive Disease|2|||
150233141|NCT04944784|541991150|FG001|Double-blind Period|Progressive Disease|2|||
150233142|NCT04944784|541991151|FG002|Double-blind Period|Progressive Disease|0|||
150233143|NCT04944784|541991152|FG003|Double-blind Period|Progressive Disease|0|||
150233144|NCT04944784|541991149|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
150233145|NCT04944784|541991150|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
150233146|NCT04944784|541991151|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
150233147|NCT04944784|541991152|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
150233148|NCT04944784|541991149|FG000|Active Drug Period|Adverse Event|0|||
150233149|NCT04944784|541991150|FG001|Active Drug Period|Adverse Event|0|||
150233150|NCT04944784|541991151|FG002|Active Drug Period|Adverse Event|3|||
150233151|NCT04944784|541991152|FG003|Active Drug Period|Adverse Event|6|||
150233152|NCT04944784|541991149|FG000|Active Drug Period|Withdrawal by Subject|0|||
150233153|NCT04944784|541991150|FG001|Active Drug Period|Withdrawal by Subject|0|||
150233154|NCT04944784|541991151|FG002|Active Drug Period|Withdrawal by Subject|4|||
150233155|NCT04944784|541991152|FG003|Active Drug Period|Withdrawal by Subject|7|||
150233156|NCT04944784|541991149|FG000|Active Drug Period|Death|0|||
150233157|NCT04944784|541991150|FG001|Active Drug Period|Death|0|||
150233158|NCT04944784|541991151|FG002|Active Drug Period|Death|3|||
150233159|NCT04944784|541991152|FG003|Active Drug Period|Death|4|||
150233160|NCT04944784|541991149|FG000|Active Drug Period|Lack of Efficacy|0|||
150233161|NCT04944784|541991150|FG001|Active Drug Period|Lack of Efficacy|0|||
150233162|NCT04944784|541991151|FG002|Active Drug Period|Lack of Efficacy|2|||
150233163|NCT04944784|541991152|FG003|Active Drug Period|Lack of Efficacy|2|||
150233164|NCT04944784|541991149|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
150233165|NCT04944784|541991150|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
150233166|NCT04944784|541991151|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
150233167|NCT04944784|541991152|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
150233168|NCT04944784|541991149|FG000|Active Drug Period|Participant Choice|0|||
150233169|NCT04944784|541991150|FG001|Active Drug Period|Participant Choice|0|||
150233170|NCT04944784|541991151|FG002|Active Drug Period|Participant Choice|0|||
150233171|NCT04944784|541991152|FG003|Active Drug Period|Participant Choice|1|||
150233172|NCT04944784|541991149|FG000|Active Drug Period|Progressive Disease|0|||
150233173|NCT04944784|541991150|FG001|Active Drug Period|Progressive Disease|0|||
150233174|NCT04944784|541991151|FG002|Active Drug Period|Progressive Disease|4|||
150233175|NCT04944784|541991152|FG003|Active Drug Period|Progressive Disease|4|||
150233176|NCT04944784|541991149|FG000|Active Drug Period|Lost to Follow-up|0|||
150233177|NCT04944784|541991150|FG001|Active Drug Period|Lost to Follow-up|0|||
150233178|NCT04944784|541991151|FG002|Active Drug Period|Lost to Follow-up|0|||
150233179|NCT04944784|541991152|FG003|Active Drug Period|Lost to Follow-up|1|||
150233180|NCT03614676|541992868|FG000|Overall Study|Delivery before planned visit|2|||
150233181|NCT03614676|541992869|FG001|Overall Study|Delivery before planned visit|0|||
150233182|NCT03614676|541992868|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
150233183|NCT03614676|541992869|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
150233184|NCT03614676|541992868|FG000|Overall Study|Migrated / moved from the study area|30|||
150233185|NCT03614676|541992869|FG001|Overall Study|Migrated / moved from the study area|22|||
150233186|NCT03614676|541992868|FG000|Overall Study|Lost to Follow-up|17|||
150233187|NCT03614676|541992869|FG001|Overall Study|Lost to Follow-up|42|||
150233188|NCT03614676|541992868|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
150233189|NCT03614676|541992869|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
150233190|NCT03614676|541992868|FG000|Overall Study|Other|16|||
150233191|NCT03614676|541992869|FG001|Overall Study|Other|47|||
150233192|NCT03614676|541992868|FG000|Overall Study|Protocol Violation|0|||
150233193|NCT03614676|541992869|FG001|Overall Study|Protocol Violation|2|||
150233194|NCT03614676|541992868|FG000|Overall Study|Neonatal event of interest|0|||
150233195|NCT03614676|541992869|FG001|Overall Study|Neonatal event of interest|6|||
150233196|NCT03614676|541992868|FG000|Overall Study|Death in infant greater than 28 days old|0|||
150233197|NCT03614676|541992869|FG001|Overall Study|Death in infant greater than 28 days old|12|||
150233198|NCT03614676|541992868|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
150233199|NCT03614676|541992869|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
150233200|NCT02388347|541992870|FG000|Overall Study|Withdrawal by Subject|0|||
150233201|NCT02388347|541992871|FG001|Overall Study|Withdrawal by Subject|0|||
150233202|NCT02388347|541992872|FG002|Overall Study|Withdrawal by Subject|1|||
150233203|NCT02388347|541992873|FG003|Overall Study|Withdrawal by Subject|0|||
150233204|NCT02388347|541992874|FG004|Overall Study|Withdrawal by Subject|0|||
150233205|NCT00497874|541992875|FG000|Overall Study|Withdrawal by Subject|48|||
150233206|NCT00497874|541992876|FG001|Overall Study|Withdrawal by Subject|17|||
150233207|NCT00497874|541992875|FG000|Overall Study|Illness|8|||
150233208|NCT00497874|541992876|FG001|Overall Study|Illness|4|||
150233209|NCT00497874|541992875|FG000|Overall Study|Death|2|||
150233210|NCT00497874|541992876|FG001|Overall Study|Death|4|||
150233211|NCT00497874|541992875|FG000|Overall Study|Unable to contact|52|||
150233212|NCT00497874|541992876|FG001|Overall Study|Unable to contact|67|||
150233213|NCT00497874|541992875|FG000|Overall Study|Unable to schedule|37|||
150233214|NCT00497874|541992876|FG001|Overall Study|Unable to schedule|24|||
150233215|NCT02080403|541992877|FG000|Overall Study|Adverse Event|5|||
150233216|NCT02080403|541992878|FG001|Overall Study|Adverse Event|1|||
150233217|NCT02080403|541992877|FG000|Overall Study|Death|0|||
150233218|NCT02080403|541992878|FG001|Overall Study|Death|2|||
150233219|NCT02080403|541992877|FG000|Overall Study|Lost to Follow-up|2|||
150233220|NCT02080403|541992878|FG001|Overall Study|Lost to Follow-up|0|||
150233221|NCT02080403|541992877|FG000|Overall Study|Pregnancy|0|||
150233222|NCT02080403|541992878|FG001|Overall Study|Pregnancy|1|||
150233223|NCT02080403|541992877|FG000|Overall Study|Protocol Violation|3|||
150233224|NCT02080403|541992878|FG001|Overall Study|Protocol Violation|7|||
150233225|NCT02080403|541992877|FG000|Overall Study|Withdrawal by Subject|5|||
150233226|NCT02080403|541992878|FG001|Overall Study|Withdrawal by Subject|1|||
150233227|NCT01171183|541992879|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
150233228|NCT01171183|541992880|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
150233229|NCT01171183|541992879|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
150233230|NCT01171183|541992880|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
150233231|NCT01171183|541992879|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
150233232|NCT01171183|541992880|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
150233233|NCT01171183|541992879|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
150233234|NCT01171183|541992880|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
150233235|NCT01171183|541992879|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
150233236|NCT01171183|541992880|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
150233237|NCT01171183|541992879|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
150233238|NCT01171183|541992880|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
150233239|NCT01101334|541992881|FG000|Overall Study|Adverse Event|9|||
150233240|NCT01101334|541992882|FG001|Overall Study|Adverse Event|4|||
150233241|NCT01101334|541992881|FG000|Overall Study|Death|7|||
150233242|NCT01101334|541992882|FG001|Overall Study|Death|1|||
150233243|NCT01101334|541992881|FG000|Overall Study|Withdrawal by Subject|4|||
150233244|NCT01101334|541992882|FG001|Overall Study|Withdrawal by Subject|3|||
150233245|NCT01101334|541992881|FG000|Overall Study|Withdrawal by Sponsor|1|||
150233246|NCT01101334|541992882|FG001|Overall Study|Withdrawal by Sponsor|1|||
150233247|NCT01101334|541992881|FG000|Overall Study|Progressive Disease|22|||
150233248|NCT01101334|541992882|FG001|Overall Study|Progressive Disease|35|||
150233249|NCT01101334|541992881|FG000|Overall Study|Other|2|||
150233250|NCT01101334|541992882|FG001|Overall Study|Other|1|||
150233251|NCT02826798|541992885|FG000|Overall Study|Withdrawal by Subject|0|||
150233252|NCT02826798|541992886|FG001|Overall Study|Withdrawal by Subject|1|||
150233253|NCT02826798|541992887|FG002|Overall Study|Withdrawal by Subject|0|||
150233254|NCT02826798|541992888|FG003|Overall Study|Withdrawal by Subject|1|||
150233255|NCT02826798|541992889|FG004|Overall Study|Withdrawal by Subject|0|||
150233256|NCT02806505|541992890|FG000|Overall Study|Adverse event/intercurrent illness|1|||
150233257|NCT02806505|541992891|FG001|Overall Study|Adverse event/intercurrent illness|3|||
150233258|NCT02806505|541992890|FG000|Overall Study|Death|4|||
150233259|NCT02806505|541992891|FG001|Overall Study|Death|0|||
150233260|NCT02806505|541992890|FG000|Overall Study|Did not cooperate/refused treatment|3|||
150233261|NCT02806505|541992891|FG001|Overall Study|Did not cooperate/refused treatment|3|||
150233262|NCT02806505|541992890|FG000|Overall Study|Failure to return|0|||
150233263|NCT02806505|541992891|FG001|Overall Study|Failure to return|1|||
150233264|NCT02806505|541992890|FG000|Overall Study|Insufficient therapeutic response|2|||
150233265|NCT02806505|541992891|FG001|Overall Study|Insufficient therapeutic response|4|||
150233266|NCT01181609|541992892|FG000|Overall Study|Adverse Event|1|||
150233267|NCT01181609|541992892|FG000|Overall Study|Withdrawal by Subject|1|||
150233268|NCT01181609|541992892|FG000|Overall Study|Lost to Follow-up|1|||
150233269|NCT01181609|541992892|FG000|Overall Study|Death|50|||
150233270|NCT00263211|541992895|FG000|Overall Study|Death|1|||
150233271|NCT00263211|541992896|FG001|Overall Study|Death|0|||
150233272|NCT00263211|541992895|FG000|Overall Study|Withdrawal by Subject|3|||
150233273|NCT00263211|541992896|FG001|Overall Study|Withdrawal by Subject|0|||
150233274|NCT00263211|541992895|FG000|Overall Study|Protocol Violation|1|||
150233275|NCT00263211|541992896|FG001|Overall Study|Protocol Violation|0|||
150233276|NCT00263211|541992895|FG000|Overall Study|Disease Progression|0|||
150233277|NCT00263211|541992896|FG001|Overall Study|Disease Progression|1|||
150233278|NCT02034162|541992897|FG000|Double-blind|Lost to Follow-up|3|||
150233279|NCT02034162|541992898|FG001|Double-blind|Lost to Follow-up|0|||
150233280|NCT02034162|541992899|FG002|Double-blind|Lost to Follow-up|0|||
150233281|NCT02034162|541992897|FG000|Double-blind|Physician Decision|1|||
150233282|NCT02034162|541992898|FG001|Double-blind|Physician Decision|0|||
150233283|NCT02034162|541992899|FG002|Double-blind|Physician Decision|0|||
150233284|NCT02034162|541992897|FG000|Double-blind|Protocol Violation|0|||
150233285|NCT02034162|541992898|FG001|Double-blind|Protocol Violation|1|||
150233286|NCT02034162|541992899|FG002|Double-blind|Protocol Violation|0|||
150233287|NCT02034162|541992897|FG000|Double-blind|Withdrawal by Subject|5|||
150233288|NCT02034162|541992898|FG001|Double-blind|Withdrawal by Subject|7|||
150233289|NCT02034162|541992899|FG002|Double-blind|Withdrawal by Subject|0|||
150233290|NCT00760513|541992900|FG000|Overall Study|Withdrawal by Subject|5|||
150233291|NCT00760513|541992901|FG001|Overall Study|Withdrawal by Subject|7|||
150233292|NCT02820597|541992907|FG000|Overall Study|Lost to Follow-up|12|||
150233293|NCT01053247|541992908|FG000|Overall Study|Withdrawal by Subject|9|||
150233294|NCT01053247|541992909|FG001|Overall Study|Withdrawal by Subject|4|||
150233295|NCT01053247|541992910|FG002|Overall Study|Withdrawal by Subject|15|||
150233296|NCT01053247|541992908|FG000|Overall Study|Lack of Efficacy|1|||
150233297|NCT01053247|541992909|FG001|Overall Study|Lack of Efficacy|0|||
150233298|NCT01053247|541992910|FG002|Overall Study|Lack of Efficacy|1|||
150233299|NCT01053247|541992908|FG000|Overall Study|Protocol Violation|2|||
150233300|NCT01053247|541992909|FG001|Overall Study|Protocol Violation|1|||
150233301|NCT01053247|541992910|FG002|Overall Study|Protocol Violation|2|||
150233302|NCT01053247|541992908|FG000|Overall Study|Lost to Follow-up|8|||
150233303|NCT01053247|541992909|FG001|Overall Study|Lost to Follow-up|5|||
150233304|NCT01053247|541992910|FG002|Overall Study|Lost to Follow-up|7|||
150233305|NCT01053247|541992908|FG000|Overall Study|Adverse Event|0|||
150233306|NCT01053247|541992909|FG001|Overall Study|Adverse Event|9|||
150233307|NCT01053247|541992910|FG002|Overall Study|Adverse Event|3|||
150233308|NCT03458728|541992911|FG000|Overall Study|Adverse Event|1|||
150233309|NCT03458728|541992912|FG001|Overall Study|Adverse Event|0|||
150233310|NCT03458728|541992911|FG000|Overall Study|Physician Decision|1|||
150233311|NCT03458728|541992912|FG001|Overall Study|Physician Decision|0|||
150233312|NCT03458728|541992911|FG000|Overall Study|Progressive disease - clinical assessment|1|||
150233313|NCT03458728|541992912|FG001|Overall Study|Progressive disease - clinical assessment|0|||
150233314|NCT03458728|541992911|FG000|Overall Study|Progressive disease - radiological progression|21|||
150233315|NCT03458728|541992912|FG001|Overall Study|Progressive disease - radiological progression|6|||
150233316|NCT03458728|541992911|FG000|Overall Study|Withdrawal by Subject|0|||
150233317|NCT03458728|541992912|FG001|Overall Study|Withdrawal by Subject|1|||
150233318|NCT04702893|541992917|FG000|Overall Study|Other reasons than listed|11|||
150233319|NCT04702893|541992917|FG000|Overall Study|Withdrawal by Subject|3|||
150233320|NCT04702893|541992917|FG000|Overall Study|Lost to Follow-up|7|||
150233321|NCT04702893|541992917|FG000|Overall Study|Death|10|||
150233322|NCT04702893|541992917|FG000|Overall Study|Not treated|6|||
150233323|NCT00408928|541992918|FG000|Overall Study|Withdrawal by Subject|1|||
150233324|NCT00408928|541992918|FG000|Overall Study|Death|1|||
150233325|NCT00408928|541992918|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
150233326|NCT01114139|541992921|FG000|Overall Study|Adverse Event|3|||
150233327|NCT01114139|541992922|FG001|Overall Study|Adverse Event|2|||
150233328|NCT01114139|541992921|FG000|Overall Study|Lost to Follow-up|15|||
150233329|NCT01114139|541992922|FG001|Overall Study|Lost to Follow-up|3|||
150233330|NCT01114139|541992921|FG000|Overall Study|Withdrawal by Subject|17|||
150233331|NCT01114139|541992922|FG001|Overall Study|Withdrawal by Subject|6|||
150233332|NCT01114139|541992921|FG000|Overall Study|Other-Missed 1 visit|1|||
150233333|NCT01114139|541992922|FG001|Overall Study|Other-Missed 1 visit|0|||
150233334|NCT01114139|541992921|FG000|Overall Study|Other-Protocol Violation|1|||
150233335|NCT01114139|541992922|FG001|Overall Study|Other-Protocol Violation|0|||
150233336|NCT01114139|541992921|FG000|Overall Study|Other-Out of window for study drug dose|1|||
150233337|NCT01114139|541992922|FG001|Overall Study|Other-Out of window for study drug dose|0|||
150233338|NCT01114139|541992921|FG000|Overall Study|Other-Participant falsified records|0|||
150233339|NCT01114139|541992922|FG001|Overall Study|Other-Participant falsified records|1|||
150233340|NCT01114139|541992921|FG000|Overall Study|Other-Participant went on hospice|0|||
150233341|NCT01114139|541992922|FG001|Overall Study|Other-Participant went on hospice|1|||
150233342|NCT01114139|541992921|FG000|Overall Study|Other-Physician changed treatment|1|||
150233343|NCT01114139|541992922|FG001|Overall Study|Other-Physician changed treatment|0|||
150233344|NCT01114139|541992921|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
150233345|NCT01114139|541992922|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
150233346|NCT02536742|541992924|FG000|Overall Study|Did not start protocol therapy|1|||
150233347|NCT02536742|541992924|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
150233348|NCT00916305|541992931|FG000|Overall Study|Lost to Follow-up|21|||
150233349|NCT00916305|541992932|FG001|Overall Study|Lost to Follow-up|27|||
150233350|NCT00916305|541992931|FG000|Overall Study|Withdrawal by Subject|0|||
150233351|NCT00916305|541992932|FG001|Overall Study|Withdrawal by Subject|1|||
150233352|NCT00858247|541992933|FG000|Baseline Assessment|Withdrawal by Subject|1|||
150233353|NCT00858247|541992934|FG001|Baseline Assessment|Withdrawal by Subject|1|||
150233354|NCT00858247|541992933|FG000|Baseline Assessment|Poor IV access|1|||
150233355|NCT00858247|541992934|FG001|Baseline Assessment|Poor IV access|0|||
150233356|NCT00858247|541992933|FG000|Baseline Assessment|Protocol Violation|0|||
150233357|NCT00858247|541992934|FG001|Baseline Assessment|Protocol Violation|1|||
150233358|NCT00858247|541992933|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
150233359|NCT00858247|541992934|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
150233360|NCT02512861|541992935|FG000|Overall Study|Protocol Violation|3|||
150233361|NCT02512861|541992936|FG001|Overall Study|Protocol Violation|7|||
150233362|NCT02512861|541992935|FG000|Overall Study|Physician Decision|3|||
150233363|NCT02512861|541992936|FG001|Overall Study|Physician Decision|1|||
150233364|NCT02512861|541992935|FG000|Overall Study|Withdrawal by Subject|0|||
150233365|NCT02512861|541992936|FG001|Overall Study|Withdrawal by Subject|1|||
150233366|NCT01172639|541992937|FG000|Overall Study|Death|1|||
150233367|NCT01172639|541992938|FG001|Overall Study|Death|1|||
150233368|NCT01172639|541992939|FG002|Overall Study|Death|0|||
150233369|NCT01172639|541992940|FG003|Overall Study|Death|0|||
150233370|NCT01172639|541992941|FG004|Overall Study|Death|0|||
150233371|NCT01172639|541992937|FG000|Overall Study|Lost to Follow-up|9|||
150233372|NCT01172639|541992938|FG001|Overall Study|Lost to Follow-up|7|||
150233373|NCT01172639|541992939|FG002|Overall Study|Lost to Follow-up|11|||
150233374|NCT01172639|541992940|FG003|Overall Study|Lost to Follow-up|6|||
150233375|NCT01172639|541992941|FG004|Overall Study|Lost to Follow-up|6|||
150233376|NCT01172639|541992937|FG000|Overall Study|Withdrawal by Subject|3|||
150233377|NCT01172639|541992938|FG001|Overall Study|Withdrawal by Subject|3|||
150233378|NCT01172639|541992939|FG002|Overall Study|Withdrawal by Subject|5|||
150233379|NCT01172639|541992940|FG003|Overall Study|Withdrawal by Subject|5|||
150233380|NCT01172639|541992941|FG004|Overall Study|Withdrawal by Subject|0|||
150233381|NCT02447432|541992942|FG000|Epoch 001|Adverse Event|1|||
150233382|NCT02447432|541992943|FG001|Epoch 001|Adverse Event|1|||
150233383|NCT02447432|541992942|FG000|Epoch 001|Withdrawal by Subject|0|||
150233384|NCT02447432|541992943|FG001|Epoch 001|Withdrawal by Subject|4|||
150233385|NCT02447432|541992942|FG000|Epoch 001|Migrated/moved from study area|3|||
150233386|NCT02447432|541992943|FG001|Epoch 001|Migrated/moved from study area|5|||
150233387|NCT02447432|541992942|FG000|Epoch 001|Lost to Follow-up|1|||
150233388|NCT02447432|541992943|FG001|Epoch 001|Lost to Follow-up|3|||
150233389|NCT01585298|541992944|FG000|Overall Study|Study completion was not documented.|1|||
150233390|NCT01585298|541992944|FG000|Overall Study|Protocol deviation|1|||
150233391|NCT01585298|541992944|FG000|Overall Study|Administrative problems|4|||
150233392|NCT01585298|541992944|FG000|Overall Study|Lost to Follow-up|2|||
150233393|NCT01585298|541992944|FG000|Overall Study|Withdrawal by Subject|4|||
150233394|NCT01585298|541992944|FG000|Overall Study|Abnormal test procedure results|1|||
150233395|NCT01585298|541992944|FG000|Overall Study|Adverse Event|24|||
150233396|NCT00874497|541992951|FG000|Overall Study|Lost to Follow-up|2|||
150233397|NCT00874497|541992952|FG001|Overall Study|Lost to Follow-up|4|||
150233398|NCT00874497|541992951|FG000|Overall Study|Adverse Event|9|||
150233399|NCT00874497|541992952|FG001|Overall Study|Adverse Event|4|||
150233400|NCT00874497|541992951|FG000|Overall Study|Sponsor Discontinued Trial|7|||
150233401|NCT00874497|541992952|FG001|Overall Study|Sponsor Discontinued Trial|3|||
150233402|NCT00874497|541992951|FG000|Overall Study|Met Withdrawal Criteria|4|||
150233403|NCT00874497|541992952|FG001|Overall Study|Met Withdrawal Criteria|2|||
150233404|NCT00874497|541992951|FG000|Overall Study|Physician Decision|1|||
150233405|NCT00874497|541992952|FG001|Overall Study|Physician Decision|1|||
150233406|NCT00874497|541992951|FG000|Overall Study|Withdrawal by Subject|5|||
150233407|NCT00874497|541992952|FG001|Overall Study|Withdrawal by Subject|4|||
150233408|NCT00505414|541992954|FG000|Titration Phase|Adverse Event|0|||
150233409|NCT00505414|541992955|FG001|Titration Phase|Adverse Event|0|||
150233410|NCT00505414|541992956|FG002|Titration Phase|Adverse Event|0|||
150233411|NCT00505414|541992957|FG003|Titration Phase|Adverse Event|8|||
150233412|NCT00505414|541992958|FG004|Titration Phase|Adverse Event|3|||
150233413|NCT00505414|541992954|FG000|Titration Phase|Death|0|||
150233414|NCT00505414|541992955|FG001|Titration Phase|Death|0|||
150233415|NCT00505414|541992956|FG002|Titration Phase|Death|0|||
150233416|NCT00505414|541992957|FG003|Titration Phase|Death|2|||
150233417|NCT00505414|541992958|FG004|Titration Phase|Death|0|||
150233418|NCT00505414|541992954|FG000|Titration Phase|Lack of Efficacy|0|||
150233419|NCT00505414|541992955|FG001|Titration Phase|Lack of Efficacy|0|||
150233420|NCT00505414|541992956|FG002|Titration Phase|Lack of Efficacy|0|||
150233421|NCT00505414|541992957|FG003|Titration Phase|Lack of Efficacy|10|||
150233422|NCT00505414|541992958|FG004|Titration Phase|Lack of Efficacy|1|||
150233423|NCT00505414|541992954|FG000|Titration Phase|Protocol Violation|0|||
150233424|NCT00505414|541992955|FG001|Titration Phase|Protocol Violation|0|||
150233425|NCT00505414|541992956|FG002|Titration Phase|Protocol Violation|0|||
150233426|NCT00505414|541992957|FG003|Titration Phase|Protocol Violation|0|||
150233427|NCT00505414|541992958|FG004|Titration Phase|Protocol Violation|1|||
150233428|NCT00505414|541992954|FG000|Titration Phase|Withdrawal by Subject|0|||
150233429|NCT00505414|541992955|FG001|Titration Phase|Withdrawal by Subject|0|||
150233430|NCT00505414|541992956|FG002|Titration Phase|Withdrawal by Subject|0|||
150233431|NCT00505414|541992957|FG003|Titration Phase|Withdrawal by Subject|3|||
150233432|NCT00505414|541992958|FG004|Titration Phase|Withdrawal by Subject|4|||
150233433|NCT00505414|541992954|FG000|Titration Phase|Underlying disease and therapy required|0|||
150233434|NCT00505414|541992955|FG001|Titration Phase|Underlying disease and therapy required|0|||
150233435|NCT00505414|541992956|FG002|Titration Phase|Underlying disease and therapy required|0|||
150233436|NCT00505414|541992957|FG003|Titration Phase|Underlying disease and therapy required|7|||
150233437|NCT00505414|541992958|FG004|Titration Phase|Underlying disease and therapy required|3|||
150233438|NCT00505414|541992954|FG000|Maintenance Phase|Adverse Event|2|||
150233439|NCT00505414|541992955|FG001|Maintenance Phase|Adverse Event|2|||
150233440|NCT00505414|541992956|FG002|Maintenance Phase|Adverse Event|3|||
150233441|NCT00505414|541992957|FG003|Maintenance Phase|Adverse Event|0|||
150233442|NCT00505414|541992958|FG004|Maintenance Phase|Adverse Event|0|||
150233443|NCT00505414|541992954|FG000|Maintenance Phase|Death|2|||
150233444|NCT00505414|541992955|FG001|Maintenance Phase|Death|0|||
150233445|NCT00505414|541992956|FG002|Maintenance Phase|Death|1|||
150233446|NCT00505414|541992957|FG003|Maintenance Phase|Death|0|||
150233447|NCT00505414|541992958|FG004|Maintenance Phase|Death|0|||
150233448|NCT00505414|541992954|FG000|Maintenance Phase|Lack of Efficacy|2|||
150233449|NCT00505414|541992955|FG001|Maintenance Phase|Lack of Efficacy|1|||
150233450|NCT00505414|541992956|FG002|Maintenance Phase|Lack of Efficacy|1|||
150233451|NCT00505414|541992957|FG003|Maintenance Phase|Lack of Efficacy|0|||
150233452|NCT00505414|541992958|FG004|Maintenance Phase|Lack of Efficacy|0|||
150233453|NCT00505414|541992954|FG000|Maintenance Phase|Withdrawal by Subject|0|||
150233454|NCT00505414|541992955|FG001|Maintenance Phase|Withdrawal by Subject|0|||
150233455|NCT00505414|541992956|FG002|Maintenance Phase|Withdrawal by Subject|1|||
150233456|NCT00505414|541992957|FG003|Maintenance Phase|Withdrawal by Subject|0|||
150233457|NCT00505414|541992958|FG004|Maintenance Phase|Withdrawal by Subject|0|||
150233458|NCT00505414|541992954|FG000|Maintenance Phase|underlying disease and therapy required|0|||
150233459|NCT00505414|541992955|FG001|Maintenance Phase|underlying disease and therapy required|2|||
150233460|NCT00505414|541992956|FG002|Maintenance Phase|underlying disease and therapy required|2|||
150233461|NCT00505414|541992957|FG003|Maintenance Phase|underlying disease and therapy required|0|||
150233462|NCT00505414|541992958|FG004|Maintenance Phase|underlying disease and therapy required|0|||
150233463|NCT00644878|541992959|FG000|Overall Study|Adverse Event|2|||
150233464|NCT00644878|541992959|FG000|Overall Study|Abnormal laboratory value|3|||
150233465|NCT00644878|541992959|FG000|Overall Study|Protocol deviation|2|||
150233466|NCT00644878|541992959|FG000|Overall Study|Treatment duration completed as per protocol|11|||
150233467|NCT01841112|541992960|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
150233468|NCT01841112|541992961|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
150233469|NCT01841112|541992962|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
150233470|NCT01841112|541992963|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
150233471|NCT01841112|541992964|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
150233472|NCT00878553|541992965|FG000|Sleep Study|Withdrawal by Subject|2|||
150233473|NCT00878553|541992966|FG001|Sleep Study|Withdrawal by Subject|0|||
150233474|NCT00878553|541992967|FG002|Sleep Study|Withdrawal by Subject|0|||
150233475|NCT00878553|541992968|FG003|Sleep Study|Withdrawal by Subject|0|||
150233476|NCT00878553|541992969|FG004|Sleep Study|Withdrawal by Subject|0|||
150233477|NCT00878553|541992965|FG000|Sleep Study|Lost to Follow-up|1|||
150233478|NCT00878553|541992966|FG001|Sleep Study|Lost to Follow-up|0|||
150233479|NCT00878553|541992967|FG002|Sleep Study|Lost to Follow-up|0|||
150233480|NCT00878553|541992968|FG003|Sleep Study|Lost to Follow-up|0|||
150233481|NCT00878553|541992969|FG004|Sleep Study|Lost to Follow-up|0|||
150233482|NCT00878553|541992965|FG000|Sleep Study|car accident|1|||
150233483|NCT00878553|541992966|FG001|Sleep Study|car accident|0|||
150233484|NCT00878553|541992967|FG002|Sleep Study|car accident|0|||
150233485|NCT00878553|541992968|FG003|Sleep Study|car accident|0|||
150233486|NCT00878553|541992969|FG004|Sleep Study|car accident|0|||
150233487|NCT00878553|541992965|FG000|Sleep Study|family emergency|1|||
150233488|NCT00878553|541992966|FG001|Sleep Study|family emergency|0|||
150233489|NCT00878553|541992967|FG002|Sleep Study|family emergency|0|||
150233490|NCT00878553|541992968|FG003|Sleep Study|family emergency|0|||
150233491|NCT00878553|541992969|FG004|Sleep Study|family emergency|0|||
150233492|NCT00878553|541992965|FG000|PK Study|Withdrawal by Subject|0|||
150233493|NCT00878553|541992966|FG001|PK Study|Withdrawal by Subject|0|||
150233494|NCT00878553|541992967|FG002|PK Study|Withdrawal by Subject|0|||
150233495|NCT00878553|541992968|FG003|PK Study|Withdrawal by Subject|1|||
150233496|NCT00878553|541992969|FG004|PK Study|Withdrawal by Subject|0|||
150233497|NCT02143063|541992970|FG000|Overall Study|Lost to Follow-up|16|||
150233498|NCT02143063|541992971|FG001|Overall Study|Lost to Follow-up|28|||
150233499|NCT02143063|541992972|FG002|Overall Study|Lost to Follow-up|29|||
150233500|NCT02143063|541992970|FG000|Overall Study|Withdrawal by Subject|0|||
150233501|NCT02143063|541992971|FG001|Overall Study|Withdrawal by Subject|1|||
150233502|NCT02143063|541992972|FG002|Overall Study|Withdrawal by Subject|0|||
150233503|NCT02143063|541992970|FG000|Overall Study|Death|0|||
150233504|NCT02143063|541992971|FG001|Overall Study|Death|1|||
150233505|NCT02143063|541992972|FG002|Overall Study|Death|1|||
150233506|NCT03517111|541992975|FG000|Enrolled|Withdrawal by Subject|0|||
150233507|NCT03517111|541992976|FG001|Enrolled|Withdrawal by Subject|1|||
150233508|NCT03517111|541992977|FG002|Enrolled|Withdrawal by Subject|0|||
150233509|NCT03517111|541992975|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
150233510|NCT03517111|541992976|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
150233511|NCT03517111|541992977|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
150233512|NCT03517111|541992975|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
150233513|NCT03517111|541992976|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
150233514|NCT03517111|541992977|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
150233515|NCT03517111|541992975|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
150233516|NCT03517111|541992976|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
150233517|NCT03517111|541992977|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
150233518|NCT03517111|541992975|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
150233519|NCT03517111|541992976|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
150233520|NCT03517111|541992977|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
150233521|NCT00912223|541992978|FG000|Overall Study|Withdrawal by Subject|1|||
150233522|NCT00912223|541992978|FG000|Overall Study|Not transplanted|1|||
150233523|NCT00912223|541992978|FG000|Overall Study|Transformed disease|1|||
150233524|NCT02719743|541992979|FG000|Overall Study|Consent withdrawal|0|||
150233525|NCT02719743|541992980|FG001|Overall Study|Consent withdrawal|2|||
150233526|NCT02719743|541992981|FG002|Overall Study|Consent withdrawal|0|||
150233527|NCT02719743|541992982|FG003|Overall Study|Consent withdrawal|1|||
150233528|NCT02719743|541992983|FG004|Overall Study|Consent withdrawal|0|||
150233529|NCT02719743|541992979|FG000|Overall Study|Migrated/moved from study area|0|||
150233530|NCT02719743|541992980|FG001|Overall Study|Migrated/moved from study area|0|||
150233531|NCT02719743|541992981|FG002|Overall Study|Migrated/moved from study area|0|||
150233532|NCT02719743|541992982|FG003|Overall Study|Migrated/moved from study area|0|||
150233533|NCT02719743|541992983|FG004|Overall Study|Migrated/moved from study area|2|||
150233534|NCT02719743|541992979|FG000|Overall Study|Lost to Follow-up|1|||
150233535|NCT02719743|541992980|FG001|Overall Study|Lost to Follow-up|1|||
150233536|NCT02719743|541992981|FG002|Overall Study|Lost to Follow-up|0|||
150233537|NCT02719743|541992982|FG003|Overall Study|Lost to Follow-up|0|||
150233538|NCT02719743|541992983|FG004|Overall Study|Lost to Follow-up|0|||
150233539|NCT01438840|541992984|FG000|Core Study|Adverse Event|0|||
150233540|NCT01438840|541992985|FG001|Core Study|Adverse Event|3|||
150233541|NCT01438840|541992986|FG002|Core Study|Adverse Event|0|||
150233542|NCT01438840|541992984|FG000|Core Study|Lack of Efficacy|15|||
150233543|NCT01438840|541992985|FG001|Core Study|Lack of Efficacy|7|||
150233544|NCT01438840|541992986|FG002|Core Study|Lack of Efficacy|0|||
150233545|NCT01438840|541992984|FG000|Core Study|Withdrawal of consent|1|||
150233546|NCT01438840|541992985|FG001|Core Study|Withdrawal of consent|0|||
150233547|NCT01438840|541992986|FG002|Core Study|Withdrawal of consent|0|||
150233548|NCT01438840|541992984|FG000|Extension Phase|Adverse Event|0|||
150233549|NCT01438840|541992985|FG001|Extension Phase|Adverse Event|0|||
150233550|NCT01438840|541992986|FG002|Extension Phase|Adverse Event|3|||
150233551|NCT01438840|541992984|FG000|Extension Phase|Lost to Follow-up|0|||
150233552|NCT01438840|541992985|FG001|Extension Phase|Lost to Follow-up|0|||
150233553|NCT01438840|541992986|FG002|Extension Phase|Lost to Follow-up|1|||
150233554|NCT01438840|541992984|FG000|Extension Phase|Withdrawal by Subject|0|||
150233555|NCT01438840|541992985|FG001|Extension Phase|Withdrawal by Subject|0|||
150233556|NCT01438840|541992986|FG002|Extension Phase|Withdrawal by Subject|3|||
150233557|NCT01438840|541992984|FG000|Extension Phase|Lack of Efficacy|0|||
150233558|NCT01438840|541992985|FG001|Extension Phase|Lack of Efficacy|0|||
150233559|NCT01438840|541992986|FG002|Extension Phase|Lack of Efficacy|2|||
150233560|NCT01438840|541992984|FG000|Extension Phase|Other|0|||
150233561|NCT01438840|541992985|FG001|Extension Phase|Other|0|||
150233562|NCT01438840|541992986|FG002|Extension Phase|Other|1|||
150233563|NCT02601209|541992987|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
150233564|NCT02601209|541992988|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
150233565|NCT02601209|541992989|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
150233566|NCT02601209|541992990|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233567|NCT02601209|541992991|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233568|NCT02601209|541992992|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233569|NCT02601209|541992993|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233570|NCT02601209|541992994|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233571|NCT02601209|541992995|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
150233572|NCT02601209|541992987|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233573|NCT02601209|541992988|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233574|NCT02601209|541992989|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233575|NCT02601209|541992990|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233576|NCT02601209|541992991|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
150233577|NCT02601209|541992992|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
150233578|NCT02601209|541992993|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
150233579|NCT02601209|541992994|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233580|NCT02601209|541992995|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
150233581|NCT02062645|541992998|FG000|Overall Study|Adverse Event|2|||
150233582|NCT02062645|541992998|FG000|Overall Study|Protocol Violation|8|||
150233583|NCT02062645|541992998|FG000|Overall Study|Lost to Follow-up|5|||
150233584|NCT00461123|541993001|FG000|Overall Study|Adverse Event|1|||
150233585|NCT00461123|541993002|FG001|Overall Study|Adverse Event|0|||
150233586|NCT00461123|541993001|FG000|Overall Study|Lost to Follow-up|1|||
150233587|NCT00461123|541993002|FG001|Overall Study|Lost to Follow-up|1|||
150233588|NCT00461123|541993001|FG000|Overall Study|Protocol Violation|3|||
150233589|NCT00461123|541993002|FG001|Overall Study|Protocol Violation|2|||
150233590|NCT00461123|541993001|FG000|Overall Study|Withdrawal by Subject|1|||
150233591|NCT00461123|541993002|FG001|Overall Study|Withdrawal by Subject|3|||
150233592|NCT02024750|541993003|FG000|Overall Study|Withdrawal by Subject|2|||
150233593|NCT02024750|541993004|FG001|Overall Study|Withdrawal by Subject|1|||
150233594|NCT00927901|541993005|FG000|Treatment Period 1|Subject withdrew consent|0|||
150233595|NCT00927901|541993006|FG001|Treatment Period 1|Subject withdrew consent|0|||
150233596|NCT00927901|541993007|FG002|Treatment Period 1|Subject withdrew consent|1|||
150233597|NCT00927901|541993008|FG003|Treatment Period 1|Subject withdrew consent|0|||
150233598|NCT00927901|541993005|FG000|Treatment Period 4|Adverse Event|0|||
150233599|NCT00927901|541993006|FG001|Treatment Period 4|Adverse Event|0|||
150233600|NCT00927901|541993007|FG002|Treatment Period 4|Adverse Event|0|||
150233601|NCT00927901|541993008|FG003|Treatment Period 4|Adverse Event|1|||
150233602|NCT00927901|541993005|FG000|Treatment Period 4|Subject withdrew consent|0|||
150233603|NCT00927901|541993006|FG001|Treatment Period 4|Subject withdrew consent|0|||
150233604|NCT00927901|541993007|FG002|Treatment Period 4|Subject withdrew consent|1|||
150233605|NCT00927901|541993008|FG003|Treatment Period 4|Subject withdrew consent|0|||
150233606|NCT02344173|541993009|FG000|Procedure|Ablation Procedure Not Performed|7|||
150233607|NCT02344173|541993009|FG000|12-month Visit|Death|8|||
150233608|NCT02344173|541993009|FG000|12-month Visit|Withdrawal by Subject|30|||
150233609|NCT02344173|541993009|FG000|12-month Visit|Lost to Follow-up|58|||
150233610|NCT01891890|541993011|FG000|Overall Study|Lost to Follow-up|0|||
150233611|NCT01891890|541993012|FG001|Overall Study|Lost to Follow-up|0|||
150233612|NCT01891890|541993013|FG002|Overall Study|Lost to Follow-up|1|||
150233613|NCT01891890|541993011|FG000|Overall Study|Study ended before endpoint reached|7|||
150233614|NCT01891890|541993012|FG001|Overall Study|Study ended before endpoint reached|3|||
150233615|NCT01891890|541993013|FG002|Overall Study|Study ended before endpoint reached|6|||
150233616|NCT00746356|541993016|FG000|Overall Study|Withdrawal by Subject|2|||
150233617|NCT00746356|541993017|FG001|Overall Study|Withdrawal by Subject|3|||
150233618|NCT00746356|541993016|FG000|Overall Study|Death|7|||
150233619|NCT00746356|541993017|FG001|Overall Study|Death|3|||
150233620|NCT00746356|541993016|FG000|Overall Study|Lost to Follow-up|1|||
150233621|NCT00746356|541993017|FG001|Overall Study|Lost to Follow-up|0|||
150233622|NCT00746356|541993016|FG000|Overall Study|Removal of Device|0|||
150233623|NCT00746356|541993017|FG001|Overall Study|Removal of Device|1|||
150233624|NCT00746356|541993016|FG000|Overall Study|Patient relocated|1|||
150233625|NCT00746356|541993017|FG001|Overall Study|Patient relocated|0|||
150233626|NCT03605368|541993018|FG000|Overall Study|Lost to Follow-up|2|||
150233627|NCT03605368|541993019|FG001|Overall Study|Lost to Follow-up|1|||
150233628|NCT03605368|541993020|FG002|Overall Study|Lost to Follow-up|3|||
150233629|NCT03605368|541993021|FG003|Overall Study|Lost to Follow-up|2|||
150233630|NCT03605368|541993018|FG000|Overall Study|Withdrawal by Subject|0|||
150233631|NCT03605368|541993019|FG001|Overall Study|Withdrawal by Subject|0|||
150233632|NCT03605368|541993020|FG002|Overall Study|Withdrawal by Subject|4|||
150233633|NCT03605368|541993021|FG003|Overall Study|Withdrawal by Subject|3|||
150233634|NCT02881047|541993022|FG000|Overall Study|Adverse Event|1|||
150233635|NCT02881047|541993022|FG000|Overall Study|Withdrawal by Subject|1|||
150233636|NCT03765164|541993023|FG000|Pre-intervention|Withdrawal by Subject|5|||
150233637|NCT03765164|541993024|FG001|Pre-intervention|Withdrawal by Subject|6|||
150233638|NCT02484547|541993025|FG000|Placebo-Controlled Period|Adverse Event|10|||
150233639|NCT02484547|541993026|FG001|Placebo-Controlled Period|Adverse Event|13|||
150233640|NCT02484547|541993027|FG002|Placebo-Controlled Period|Adverse Event|20|||
150233641|NCT02484547|541993028|FG003|Placebo-Controlled Period|Adverse Event|0|||
150233642|NCT02484547|541993029|FG004|Placebo-Controlled Period|Adverse Event|0|||
150233643|NCT02484547|541993030|FG005|Placebo-Controlled Period|Adverse Event|0|||
150233644|NCT02484547|541993031|FG006|Placebo-Controlled Period|Adverse Event|0|||
150233645|NCT02484547|541993025|FG000|Placebo-Controlled Period|Change of Treatment|0|||
150233646|NCT02484547|541993026|FG001|Placebo-Controlled Period|Change of Treatment|0|||
150233647|NCT02484547|541993027|FG002|Placebo-Controlled Period|Change of Treatment|1|||
150233648|NCT02484547|541993028|FG003|Placebo-Controlled Period|Change of Treatment|0|||
150233649|NCT02484547|541993029|FG004|Placebo-Controlled Period|Change of Treatment|0|||
150233650|NCT02484547|541993030|FG005|Placebo-Controlled Period|Change of Treatment|0|||
150233651|NCT02484547|541993031|FG006|Placebo-Controlled Period|Change of Treatment|0|||
150233652|NCT02484547|541993025|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
150233653|NCT02484547|541993026|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
150233654|NCT02484547|541993027|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
150233655|NCT02484547|541993028|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
150233656|NCT02484547|541993029|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
150233657|NCT02484547|541993030|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
150233658|NCT02484547|541993031|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
150233659|NCT02484547|541993025|FG000|Placebo-Controlled Period|Death|5|||
150233660|NCT02484547|541993026|FG001|Placebo-Controlled Period|Death|0|||
150233661|NCT02484547|541993027|FG002|Placebo-Controlled Period|Death|6|||
150233662|NCT02484547|541993028|FG003|Placebo-Controlled Period|Death|0|||
150233663|NCT02484547|541993029|FG004|Placebo-Controlled Period|Death|0|||
150233664|NCT02484547|541993030|FG005|Placebo-Controlled Period|Death|0|||
150233665|NCT02484547|541993031|FG006|Placebo-Controlled Period|Death|0|||
150233666|NCT02484547|541993025|FG000|Placebo-Controlled Period|Disease Progression|2|||
150233667|NCT02484547|541993026|FG001|Placebo-Controlled Period|Disease Progression|0|||
150233668|NCT02484547|541993027|FG002|Placebo-Controlled Period|Disease Progression|1|||
150233669|NCT02484547|541993028|FG003|Placebo-Controlled Period|Disease Progression|0|||
150233670|NCT02484547|541993029|FG004|Placebo-Controlled Period|Disease Progression|0|||
150233671|NCT02484547|541993030|FG005|Placebo-Controlled Period|Disease Progression|0|||
150233672|NCT02484547|541993031|FG006|Placebo-Controlled Period|Disease Progression|0|||
150233673|NCT02484547|541993025|FG000|Placebo-Controlled Period|Investigator Decision|2|||
150233674|NCT02484547|541993026|FG001|Placebo-Controlled Period|Investigator Decision|2|||
150233675|NCT02484547|541993027|FG002|Placebo-Controlled Period|Investigator Decision|5|||
150233676|NCT02484547|541993028|FG003|Placebo-Controlled Period|Investigator Decision|0|||
150233677|NCT02484547|541993029|FG004|Placebo-Controlled Period|Investigator Decision|0|||
150233678|NCT02484547|541993030|FG005|Placebo-Controlled Period|Investigator Decision|0|||
150233679|NCT02484547|541993031|FG006|Placebo-Controlled Period|Investigator Decision|0|||
150233680|NCT02484547|541993025|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
150233681|NCT02484547|541993026|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
150233682|NCT02484547|541993027|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
150233683|NCT02484547|541993028|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
150233684|NCT02484547|541993029|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
150233685|NCT02484547|541993030|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
150233686|NCT02484547|541993031|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
150233687|NCT02484547|541993025|FG000|Placebo-Controlled Period|Relocation|1|||
150233688|NCT02484547|541993026|FG001|Placebo-Controlled Period|Relocation|1|||
150233689|NCT02484547|541993027|FG002|Placebo-Controlled Period|Relocation|1|||
150233690|NCT02484547|541993028|FG003|Placebo-Controlled Period|Relocation|0|||
150233691|NCT02484547|541993029|FG004|Placebo-Controlled Period|Relocation|0|||
150233692|NCT02484547|541993030|FG005|Placebo-Controlled Period|Relocation|0|||
150233693|NCT02484547|541993031|FG006|Placebo-Controlled Period|Relocation|0|||
150233694|NCT02484547|541993025|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
150233695|NCT02484547|541993026|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
150233696|NCT02484547|541993027|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
150233697|NCT02484547|541993028|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
150233698|NCT02484547|541993029|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
150233699|NCT02484547|541993030|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
150233700|NCT02484547|541993031|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
150233701|NCT02484547|541993025|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
150233702|NCT02484547|541993026|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
150233703|NCT02484547|541993027|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
150233704|NCT02484547|541993028|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150233705|NCT02484547|541993029|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150233706|NCT02484547|541993030|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150233707|NCT02484547|541993031|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
150233708|NCT02484547|541993025|FG000|Placebo-Controlled Period|Reason not Specified|216|||
150233709|NCT02484547|541993026|FG001|Placebo-Controlled Period|Reason not Specified|194|||
150233710|NCT02484547|541993027|FG002|Placebo-Controlled Period|Reason not Specified|183|||
150233711|NCT02484547|541993028|FG003|Placebo-Controlled Period|Reason not Specified|0|||
150233712|NCT02484547|541993029|FG004|Placebo-Controlled Period|Reason not Specified|0|||
150233713|NCT02484547|541993030|FG005|Placebo-Controlled Period|Reason not Specified|0|||
150233714|NCT02484547|541993031|FG006|Placebo-Controlled Period|Reason not Specified|0|||
150233715|NCT02484547|541993025|FG000|Long-Term Extension Period|Adverse Event|0|||
150233716|NCT02484547|541993026|FG001|Long-Term Extension Period|Adverse Event|0|||
150233717|NCT02484547|541993027|FG002|Long-Term Extension Period|Adverse Event|0|||
150233718|NCT02484547|541993028|FG003|Long-Term Extension Period|Adverse Event|0|||
150233719|NCT02484547|541993029|FG004|Long-Term Extension Period|Adverse Event|1|||
150233720|NCT02484547|541993030|FG005|Long-Term Extension Period|Adverse Event|3|||
150233721|NCT02484547|541993031|FG006|Long-Term Extension Period|Adverse Event|2|||
150233722|NCT02484547|541993025|FG000|Long-Term Extension Period|Death|0|||
150233723|NCT02484547|541993026|FG001|Long-Term Extension Period|Death|0|||
150233724|NCT02484547|541993027|FG002|Long-Term Extension Period|Death|0|||
150233725|NCT02484547|541993028|FG003|Long-Term Extension Period|Death|0|||
150233726|NCT02484547|541993029|FG004|Long-Term Extension Period|Death|0|||
150233727|NCT02484547|541993030|FG005|Long-Term Extension Period|Death|3|||
150233728|NCT02484547|541993031|FG006|Long-Term Extension Period|Death|0|||
150233729|NCT02484547|541993025|FG000|Long-Term Extension Period|Disease Progression|0|||
150233730|NCT02484547|541993026|FG001|Long-Term Extension Period|Disease Progression|0|||
150233731|NCT02484547|541993027|FG002|Long-Term Extension Period|Disease Progression|0|||
150233732|NCT02484547|541993028|FG003|Long-Term Extension Period|Disease Progression|0|||
150233733|NCT02484547|541993029|FG004|Long-Term Extension Period|Disease Progression|2|||
150233734|NCT02484547|541993030|FG005|Long-Term Extension Period|Disease Progression|4|||
150233735|NCT02484547|541993031|FG006|Long-Term Extension Period|Disease Progression|0|||
150233736|NCT02484547|541993025|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
150233737|NCT02484547|541993026|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
150233738|NCT02484547|541993027|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
150233739|NCT02484547|541993028|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
150233740|NCT02484547|541993029|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
150233741|NCT02484547|541993030|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
150233742|NCT02484547|541993031|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
150233743|NCT02484547|541993025|FG000|Long-Term Extension Period|Loss of Capacity|0|||
150233744|NCT02484547|541993026|FG001|Long-Term Extension Period|Loss of Capacity|0|||
150233745|NCT02484547|541993027|FG002|Long-Term Extension Period|Loss of Capacity|0|||
150233746|NCT02484547|541993028|FG003|Long-Term Extension Period|Loss of Capacity|0|||
150233747|NCT02484547|541993029|FG004|Long-Term Extension Period|Loss of Capacity|1|||
150233748|NCT02484547|541993030|FG005|Long-Term Extension Period|Loss of Capacity|0|||
150233749|NCT02484547|541993031|FG006|Long-Term Extension Period|Loss of Capacity|0|||
150233750|NCT02484547|541993025|FG000|Long-Term Extension Period|Change of Treatment|0|||
150233751|NCT02484547|541993026|FG001|Long-Term Extension Period|Change of Treatment|0|||
150233752|NCT02484547|541993027|FG002|Long-Term Extension Period|Change of Treatment|0|||
150233753|NCT02484547|541993028|FG003|Long-Term Extension Period|Change of Treatment|0|||
150233754|NCT02484547|541993029|FG004|Long-Term Extension Period|Change of Treatment|0|||
150233755|NCT02484547|541993030|FG005|Long-Term Extension Period|Change of Treatment|0|||
150233756|NCT02484547|541993031|FG006|Long-Term Extension Period|Change of Treatment|1|||
150233757|NCT02484547|541993025|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
150233758|NCT02484547|541993026|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
150233759|NCT02484547|541993027|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
150233760|NCT02484547|541993028|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
150233761|NCT02484547|541993029|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
150233762|NCT02484547|541993030|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
150233763|NCT02484547|541993031|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
150233764|NCT02484547|541993025|FG000|Long-Term Extension Period|Investigator Decision|0|||
150233765|NCT02484547|541993026|FG001|Long-Term Extension Period|Investigator Decision|0|||
150233766|NCT02484547|541993027|FG002|Long-Term Extension Period|Investigator Decision|0|||
150233767|NCT02484547|541993028|FG003|Long-Term Extension Period|Investigator Decision|2|||
150233768|NCT02484547|541993029|FG004|Long-Term Extension Period|Investigator Decision|1|||
150233769|NCT02484547|541993030|FG005|Long-Term Extension Period|Investigator Decision|0|||
150233770|NCT02484547|541993031|FG006|Long-Term Extension Period|Investigator Decision|1|||
150233771|NCT02484547|541993025|FG000|Long-Term Extension Period|Relocation|0|||
150233772|NCT02484547|541993026|FG001|Long-Term Extension Period|Relocation|0|||
150233773|NCT02484547|541993027|FG002|Long-Term Extension Period|Relocation|0|||
150233774|NCT02484547|541993028|FG003|Long-Term Extension Period|Relocation|1|||
150233775|NCT02484547|541993029|FG004|Long-Term Extension Period|Relocation|1|||
150233776|NCT02484547|541993030|FG005|Long-Term Extension Period|Relocation|0|||
150233777|NCT02484547|541993031|FG006|Long-Term Extension Period|Relocation|0|||
150233778|NCT02484547|541993025|FG000|Long-Term Extension Period|Study Visit Burden|0|||
150233779|NCT02484547|541993026|FG001|Long-Term Extension Period|Study Visit Burden|0|||
150233780|NCT02484547|541993027|FG002|Long-Term Extension Period|Study Visit Burden|0|||
150233781|NCT02484547|541993028|FG003|Long-Term Extension Period|Study Visit Burden|2|||
150233782|NCT02484547|541993029|FG004|Long-Term Extension Period|Study Visit Burden|0|||
150233783|NCT02484547|541993030|FG005|Long-Term Extension Period|Study Visit Burden|0|||
150233784|NCT02484547|541993031|FG006|Long-Term Extension Period|Study Visit Burden|3|||
150233785|NCT02484547|541993025|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
150233786|NCT02484547|541993026|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
150233787|NCT02484547|541993027|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
150233788|NCT02484547|541993028|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
150233789|NCT02484547|541993029|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
150233790|NCT02484547|541993030|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
150233791|NCT02484547|541993031|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
150233792|NCT02484547|541993025|FG000|Long-Term Extension Period|Reason not Specified|0|||
150233793|NCT02484547|541993026|FG001|Long-Term Extension Period|Reason not Specified|0|||
150233794|NCT02484547|541993027|FG002|Long-Term Extension Period|Reason not Specified|0|||
150233795|NCT02484547|541993028|FG003|Long-Term Extension Period|Reason not Specified|119|||
150233796|NCT02484547|541993029|FG004|Long-Term Extension Period|Reason not Specified|117|||
150233797|NCT02484547|541993030|FG005|Long-Term Extension Period|Reason not Specified|223|||
150233798|NCT02484547|541993031|FG006|Long-Term Extension Period|Reason not Specified|231|||
150233799|NCT01665599|541993032|FG000|Overall Study|Adverse Event|1|||
150233800|NCT01665599|541993032|FG000|Overall Study|Consent Withdrawn|1|||
150233801|NCT01665599|541993032|FG000|Overall Study|Investigator/Sponsor decision|1|||
150233802|NCT01665599|541993032|FG000|Overall Study|Death|1|||
150233803|NCT01665599|541993032|FG000|Overall Study|Lost to Follow-up|2|||
150233804|NCT01665599|541993032|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
150233805|NCT01665599|541993032|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
150233806|NCT01831726|541993043|FG000|Overall Study|Adverse Event|16|||
150142093|NCT05044325|541655942|FG002|Part A:Treatment Period 2|Adverse Event|0|||
150142094|NCT05044325|541655943|FG003|Part A:Treatment Period 2|Adverse Event|0|||
150142095|NCT05044325|541655944|FG004|Part A:Treatment Period 2|Adverse Event|1|||
150142096|NCT05044325|541655945|FG005|Part A:Treatment Period 2|Adverse Event|1|||
150142097|NCT05044325|541655946|FG006|Part A:Treatment Period 2|Adverse Event|0|||
150142098|NCT05044325|541655947|FG007|Part A:Treatment Period 2|Adverse Event|0|||
150142099|NCT05044325|541655948|FG008|Part A:Treatment Period 2|Adverse Event|0|||
150142100|NCT05044325|541655949|FG009|Part A:Treatment Period 2|Adverse Event|0|||
150142101|NCT05044325|541655940|FG000|Part A:Treatment Period 2|Physician Decision|0|||
150142102|NCT05044325|541655941|FG001|Part A:Treatment Period 2|Physician Decision|0|||
150233807|NCT01831726|541993043|FG000|Overall Study|Death|7|||
150233808|NCT01831726|541993043|FG000|Overall Study|Disease Progression|49|||
150233809|NCT01831726|541993043|FG000|Overall Study|Physician Decision|1|||
150233810|NCT01831726|541993043|FG000|Overall Study|Subject/guardian decision|7|||
150233811|NCT01568112|541993044|FG000|Overall Study|Randomized But Not Treated|0|||
150233812|NCT01568112|541993045|FG001|Overall Study|Randomized But Not Treated|1|||
150233813|NCT01568112|541993046|FG002|Overall Study|Randomized But Not Treated|0|||
150233814|NCT01568112|541993047|FG003|Overall Study|Randomized But Not Treated|0|||
150142103|NCT05044325|541655942|FG002|Part A:Treatment Period 2|Physician Decision|0|||
150233815|NCT01568112|541993044|FG000|Overall Study|Withdrew due to Adverse Event|2|||
150233816|NCT01568112|541993045|FG001|Overall Study|Withdrew due to Adverse Event|4|||
150233817|NCT01568112|541993046|FG002|Overall Study|Withdrew due to Adverse Event|6|||
150233818|NCT01568112|541993047|FG003|Overall Study|Withdrew due to Adverse Event|3|||
150233819|NCT01568112|541993044|FG000|Overall Study|Lost to Follow-up|0|||
150233820|NCT01568112|541993045|FG001|Overall Study|Lost to Follow-up|0|||
150233821|NCT01568112|541993046|FG002|Overall Study|Lost to Follow-up|0|||
150233822|NCT01568112|541993047|FG003|Overall Study|Lost to Follow-up|1|||
150233823|NCT01568112|541993044|FG000|Overall Study|Withdrawal by Subject|2|||
150233824|NCT01568112|541993045|FG001|Overall Study|Withdrawal by Subject|3|||
150233825|NCT01568112|541993046|FG002|Overall Study|Withdrawal by Subject|0|||
150233826|NCT01568112|541993047|FG003|Overall Study|Withdrawal by Subject|7|||
150233827|NCT01568112|541993044|FG000|Overall Study|Withdrawal by Physician|1|||
150233828|NCT01568112|541993045|FG001|Overall Study|Withdrawal by Physician|0|||
150233829|NCT01568112|541993046|FG002|Overall Study|Withdrawal by Physician|1|||
150233830|NCT01568112|541993047|FG003|Overall Study|Withdrawal by Physician|1|||
150233831|NCT00908349|541994523|FG000|Overall Study|Adverse Event|10|||
150233832|NCT00908349|541994523|FG000|Overall Study|Withdrawal by Subject|9|||
150233833|NCT00908349|541994523|FG000|Overall Study|Physician Decision|5|||
150233834|NCT00908349|541994523|FG000|Overall Study|Lost to Follow-up|5|||
150233835|NCT00908349|541994523|FG000|Overall Study|Various|6|||
150233836|NCT00761956|541994528|FG000|Overall Study|Lost to Follow-up|6|||
150233837|NCT00761956|541994529|FG001|Overall Study|Lost to Follow-up|11|||
150233838|NCT00761956|541994528|FG000|Overall Study|Withdrawal by Subject|3|||
150233839|NCT00761956|541994529|FG001|Overall Study|Withdrawal by Subject|8|||
150233840|NCT00761956|541994528|FG000|Overall Study|Death|0|||
150233841|NCT00761956|541994529|FG001|Overall Study|Death|1|||
150233842|NCT00761956|541994528|FG000|Overall Study|Adverse Event|26|||
150233843|NCT00761956|541994529|FG001|Overall Study|Adverse Event|34|||
150233844|NCT04398368|541994532|FG000|Overall Study|Withdrawal by Subject|2|||
150233845|NCT03602586|541994533|FG000|Overall Study|Withdrawal by Subject|3|||
150233846|NCT00030823|541994536|FG000|Overall Study|Withdrawal by Subject|1|||
150233847|NCT04523207|541994537|FG000|Overall Study|Adverse Event|5|||
150233848|NCT04523207|541994538|FG001|Overall Study|Adverse Event|1|||
150233849|NCT04523207|541994537|FG000|Overall Study|Lost to Follow-up|2|||
150233850|NCT04523207|541994538|FG001|Overall Study|Lost to Follow-up|0|||
150233851|NCT04523207|541994537|FG000|Overall Study|Withdrawal by Subject|2|||
150233852|NCT04523207|541994538|FG001|Overall Study|Withdrawal by Subject|0|||
150233853|NCT04523207|541994537|FG000|Overall Study|Progressive Disease|2|||
150233854|NCT04523207|541994538|FG001|Overall Study|Progressive Disease|1|||
150233855|NCT04523207|541994537|FG000|Overall Study|Other|7|||
150233856|NCT04523207|541994538|FG001|Overall Study|Other|1|||
150233857|NCT03113383|541994539|FG000|Overall Study|Death|4|||
150233858|NCT03113383|541994540|FG001|Overall Study|Death|0|||
150233859|NCT03062449|541994542|FG000|Overall Study|Withdrawal by Subject|7|||
150233860|NCT03062449|541994543|FG001|Overall Study|Withdrawal by Subject|1|||
150233861|NCT01951378|541994545|FG000|Overall Study|Study Terminated-Not completed|23|||
150233862|NCT01951378|541994546|FG001|Overall Study|Study Terminated-Not completed|17|||
150233863|NCT03568812|541994547|FG000|Overall Study|Physician Decision|0|||
150233864|NCT03568812|541994548|FG001|Overall Study|Physician Decision|1|||
150233865|NCT03194867|541994555|FG000|Overall Study|Incorrect completion of end of study form|0|||
150233866|NCT03194867|541994556|FG001|Overall Study|Incorrect completion of end of study form|0|||
150233867|NCT03194867|541994557|FG002|Overall Study|Incorrect completion of end of study form|1|||
150233868|NCT03194867|541994558|FG003|Overall Study|Incorrect completion of end of study form|0|||
150233869|NCT00634842|541994559|FG000|Overall Study|Adverse Event|2|||
150233870|NCT00634842|541994560|FG001|Overall Study|Adverse Event|3|||
150233871|NCT00634842|541994559|FG000|Overall Study|Protocol Violation|8|||
150233872|NCT00634842|541994560|FG001|Overall Study|Protocol Violation|4|||
150233873|NCT00634842|541994559|FG000|Overall Study|Move to another state|1|||
150233874|NCT00634842|541994560|FG001|Overall Study|Move to another state|0|||
150233875|NCT00634842|541994559|FG000|Overall Study|Inclusion criteria were not met|1|||
150233876|NCT00634842|541994560|FG001|Overall Study|Inclusion criteria were not met|0|||
150233877|NCT00634842|541994559|FG000|Overall Study|Lost to Follow-up|1|||
150233878|NCT00634842|541994560|FG001|Overall Study|Lost to Follow-up|2|||
150233879|NCT00634842|541994559|FG000|Overall Study|Physician Decision|1|||
150233880|NCT00634842|541994560|FG001|Overall Study|Physician Decision|0|||
150233881|NCT00634842|541994559|FG000|Overall Study|Withdrawal by Subject|1|||
150233882|NCT00634842|541994560|FG001|Overall Study|Withdrawal by Subject|3|||
150233883|NCT00634842|541994559|FG000|Overall Study|Lack of time and intolerance to drug|0|||
150233884|NCT00634842|541994560|FG001|Overall Study|Lack of time and intolerance to drug|1|||
150233885|NCT00634842|541994559|FG000|Overall Study|Discontinued due to injection|0|||
150233886|NCT00634842|541994560|FG001|Overall Study|Discontinued due to injection|2|||
150233887|NCT00634842|541994559|FG000|Overall Study|No need of study drug to treat diabetes|0|||
150233888|NCT00634842|541994560|FG001|Overall Study|No need of study drug to treat diabetes|1|||
150233889|NCT00634842|541994559|FG000|Overall Study|No wish to keep taking Avandia|0|||
150233890|NCT00634842|541994560|FG001|Overall Study|No wish to keep taking Avandia|1|||
150233891|NCT00634842|541994559|FG000|Overall Study|Subject off study drug for too long|0|||
150233892|NCT00634842|541994560|FG001|Overall Study|Subject off study drug for too long|1|||
150233893|NCT00464945|541994561|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
150233894|NCT00464945|541994562|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
150233895|NCT00464945|541994561|FG000|Infant Series|Protocol Violation|1|||
150233896|NCT00464945|541994562|FG001|Infant Series|Protocol Violation|0|||
150233897|NCT00464945|541994561|FG000|Infant Series|Lost to Follow-up|1|||
150233898|NCT00464945|541994562|FG001|Infant Series|Lost to Follow-up|0|||
150233899|NCT00464945|541994561|FG000|After Infant Series|Withdrawal by Subject|0|||
150233900|NCT00464945|541994562|FG001|After Infant Series|Withdrawal by Subject|2|||
150233901|NCT00464945|541994561|FG000|Toddler Dose|Lost to Follow-up|0|||
150233902|NCT00464945|541994562|FG001|Toddler Dose|Lost to Follow-up|1|||
150233903|NCT00543062|541994563|FG000|Overall Study|Withdrawal by Subject|1|||
150233904|NCT00543062|541994564|FG001|Overall Study|Withdrawal by Subject|0|||
150233905|NCT00543062|541994565|FG002|Overall Study|Withdrawal by Subject|2|||
150233906|NCT00543062|541994566|FG003|Overall Study|Withdrawal by Subject|0|||
150233907|NCT00543062|541994563|FG000|Overall Study|Adverse Event|0|||
150233908|NCT00543062|541994564|FG001|Overall Study|Adverse Event|1|||
150233909|NCT00543062|541994565|FG002|Overall Study|Adverse Event|1|||
150233910|NCT00543062|541994566|FG003|Overall Study|Adverse Event|1|||
150233911|NCT00543062|541994563|FG000|Overall Study|Protocol Violation|1|||
150233912|NCT00543062|541994564|FG001|Overall Study|Protocol Violation|0|||
150233913|NCT00543062|541994565|FG002|Overall Study|Protocol Violation|0|||
150233914|NCT00543062|541994566|FG003|Overall Study|Protocol Violation|0|||
150233915|NCT04629443|541994569|FG000|Overall Study|Adverse Event|2|||
150233916|NCT04629443|541994570|FG001|Overall Study|Adverse Event|1|||
150233917|NCT04629443|541994571|FG002|Overall Study|Adverse Event|2|||
150233918|NCT04629443|541994569|FG000|Overall Study|Progressive Disease|2|||
150233919|NCT04629443|541994570|FG001|Overall Study|Progressive Disease|3|||
150233920|NCT04629443|541994571|FG002|Overall Study|Progressive Disease|3|||
150233921|NCT04629443|541994569|FG000|Overall Study|Physician Decision|1|||
150233922|NCT04629443|541994570|FG001|Overall Study|Physician Decision|3|||
150233923|NCT04629443|541994571|FG002|Overall Study|Physician Decision|0|||
150233924|NCT03463577|541994572|FG000|Overall Study|Lost to Follow-up|238|||
150233925|NCT03463577|541994573|FG001|Overall Study|Lost to Follow-up|435|||
150233926|NCT03463577|541994574|FG002|Overall Study|Lost to Follow-up|0|||
150233927|NCT03463577|541994575|FG003|Overall Study|Lost to Follow-up|0|||
150233928|NCT03463577|541994576|FG004|Overall Study|Lost to Follow-up|0|||
150233929|NCT03463577|541994577|FG005|Overall Study|Lost to Follow-up|0|||
150233930|NCT03463577|541994572|FG000|Overall Study|With unknown pregnancy outcome|0|||
150233931|NCT03463577|541994573|FG001|Overall Study|With unknown pregnancy outcome|5|||
150233932|NCT03463577|541994574|FG002|Overall Study|With unknown pregnancy outcome|0|||
150233933|NCT03463577|541994575|FG003|Overall Study|With unknown pregnancy outcome|0|||
150233934|NCT03463577|541994576|FG004|Overall Study|With unknown pregnancy outcome|0|||
150233935|NCT03463577|541994577|FG005|Overall Study|With unknown pregnancy outcome|0|||
150233936|NCT03463577|541994572|FG000|Overall Study|Maternal death|2|||
150233937|NCT03463577|541994573|FG001|Overall Study|Maternal death|0|||
150233938|NCT03463577|541994574|FG002|Overall Study|Maternal death|0|||
150233939|NCT03463577|541994575|FG003|Overall Study|Maternal death|0|||
150233940|NCT03463577|541994576|FG004|Overall Study|Maternal death|0|||
150233941|NCT03463577|541994577|FG005|Overall Study|Maternal death|0|||
150233942|NCT03463577|541994572|FG000|Overall Study|Neonatal death|0|||
150233943|NCT03463577|541994573|FG001|Overall Study|Neonatal death|0|||
150233944|NCT03463577|541994574|FG002|Overall Study|Neonatal death|0|||
150233945|NCT03463577|541994575|FG003|Overall Study|Neonatal death|15|||
150233946|NCT03463577|541994576|FG004|Overall Study|Neonatal death|17|||
150233947|NCT03463577|541994577|FG005|Overall Study|Neonatal death|0|||
150233948|NCT03974100|541994578|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
150233949|NCT03974100|541994579|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
150233950|NCT03974100|541994580|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
150233951|NCT03974100|541994581|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
150233952|NCT03974100|541994582|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
150233953|NCT03974100|541994578|FG000|TP1 - Day 1 to Week 52|Death|1|||
150233954|NCT03974100|541994579|FG001|TP1 - Day 1 to Week 52|Death|0|||
150233955|NCT03974100|541994580|FG002|TP1 - Day 1 to Week 52|Death|0|||
150233956|NCT03974100|541994581|FG003|TP1 - Day 1 to Week 52|Death|0|||
150233957|NCT03974100|541994582|FG004|TP1 - Day 1 to Week 52|Death|0|||
150233958|NCT03974100|541994578|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
150233959|NCT03974100|541994579|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
150233960|NCT03974100|541994580|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
150233961|NCT03974100|541994581|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
150233962|NCT03974100|541994582|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
150233963|NCT03974100|541994578|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
150233964|NCT03974100|541994579|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
150233965|NCT03974100|541994580|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
150233966|NCT03974100|541994581|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
150233967|NCT03974100|541994582|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
150233968|NCT03974100|541994578|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
150233969|NCT03974100|541994579|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
150233970|NCT03974100|541994580|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
150233971|NCT03974100|541994581|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
150233972|NCT03974100|541994582|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
150233973|NCT03974100|541994578|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
150233974|NCT03974100|541994579|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
150233975|NCT03974100|541994580|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
150233976|NCT03974100|541994581|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
150233977|NCT03974100|541994582|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
150233978|NCT03974100|541994578|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
150233979|NCT03974100|541994579|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
150233980|NCT03974100|541994580|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
150233981|NCT03974100|541994581|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
150233982|NCT03974100|541994582|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
150233983|NCT00690378|541994583|FG000|Overall Study|Adverse Event|1|||
150233984|NCT00690378|541994584|FG001|Overall Study|Adverse Event|0|||
150233985|NCT00690378|541994583|FG000|Overall Study|Withdrawal by Subject|2|||
150233986|NCT00690378|541994584|FG001|Overall Study|Withdrawal by Subject|0|||
150233987|NCT00690378|541994583|FG000|Overall Study|Protocol Violation|1|||
150233988|NCT00690378|541994584|FG001|Overall Study|Protocol Violation|0|||
150233989|NCT00690378|541994583|FG000|Overall Study|Lost to Follow-up|2|||
150233990|NCT00690378|541994584|FG001|Overall Study|Lost to Follow-up|3|||
150233991|NCT00690378|541994583|FG000|Overall Study|Did not meet inc/exc criteria|13|||
150233992|NCT00690378|541994584|FG001|Overall Study|Did not meet inc/exc criteria|11|||
150233993|NCT00690378|541994583|FG000|Overall Study|Social problem|1|||
150233994|NCT00690378|541994584|FG001|Overall Study|Social problem|0|||
150233995|NCT03318783|541994588|FG000|Overall Study|Withdrawal by Subject|0|||
150233996|NCT03318783|541994589|FG001|Overall Study|Withdrawal by Subject|1|||
150233997|NCT03318783|541994588|FG000|Overall Study|Death|0|||
150233998|NCT03318783|541994589|FG001|Overall Study|Death|1|||
150233999|NCT01426113|541994596|FG000|Overall Study|Study Discontinued|1|||
150234000|NCT01426113|541994597|FG001|Overall Study|Study Discontinued|1|||
150234001|NCT01426113|541994596|FG000|Overall Study|Adverse Event|0|||
150234002|NCT01426113|541994597|FG001|Overall Study|Adverse Event|1|||
150234003|NCT00468130|541994600|FG000|Overall Study|Adverse Event|2|||
150234004|NCT00468130|541994601|FG001|Overall Study|Adverse Event|1|||
150234005|NCT00468130|541994600|FG000|Overall Study|Withdrawal by Subject|0|||
150234006|NCT00468130|541994601|FG001|Overall Study|Withdrawal by Subject|1|||
150234007|NCT02485899|541994602|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
150234008|NCT02485899|541994603|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
150234009|NCT02485899|541994602|FG000|Overall Study|Withdrawal by Subject|1|||
150234010|NCT02485899|541994603|FG001|Overall Study|Withdrawal by Subject|0|||
150234011|NCT02485899|541994602|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
150234012|NCT02485899|541994603|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
150234013|NCT00436956|541994604|FG000|Overall Study|Not evaluable|1|||
150234014|NCT00436956|541994605|FG001|Overall Study|Not evaluable|0|||
150234015|NCT00623363|541994607|FG000|Overall Study|Adverse Event|2|||
150234016|NCT00623363|541994608|FG001|Overall Study|Adverse Event|2|||
150234017|NCT01174264|541994612|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
150234018|NCT01174264|541994613|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
150234019|NCT01174264|541994614|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
150234020|NCT01174264|541994612|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
150234021|NCT01174264|541994613|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
150234022|NCT01174264|541994614|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
150234023|NCT01174264|541994612|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
150234024|NCT01174264|541994613|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
150234025|NCT01174264|541994614|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
150234026|NCT02604342|541994616|FG000|Overall Study|Death|32|||
150234027|NCT02604342|541994617|FG001|Overall Study|Death|16|||
150234028|NCT02604342|541994616|FG000|Overall Study|Progression of disease|1|||
150234029|NCT02604342|541994617|FG001|Overall Study|Progression of disease|0|||
150234030|NCT02604342|541994616|FG000|Overall Study|Withdrawal by Subject|5|||
150234031|NCT02604342|541994617|FG001|Overall Study|Withdrawal by Subject|6|||
150234032|NCT02604342|541994616|FG000|Overall Study|Other|1|||
150234033|NCT02604342|541994617|FG001|Overall Study|Other|0|||
150234034|NCT02604342|541994616|FG000|Overall Study|Study Termination by Sponsor|1|||
150234035|NCT02604342|541994617|FG001|Overall Study|Study Termination by Sponsor|0|||
150234036|NCT02604342|541994616|FG000|Overall Study|Lost to Follow-up|1|||
150234037|NCT02604342|541994617|FG001|Overall Study|Lost to Follow-up|1|||
150234038|NCT02604342|541994616|FG000|Overall Study|Physician Decision|2|||
150234039|NCT02604342|541994617|FG001|Overall Study|Physician Decision|0|||
150234040|NCT01702519|541994618|FG000|Washout Period|Lost to Follow-up|1|||
150234041|NCT01702519|541994619|FG001|Washout Period|Lost to Follow-up|0|||
150234042|NCT01702519|541994618|FG000|Washout Period|Withdrawal by Subject|0|||
150234043|NCT01702519|541994619|FG001|Washout Period|Withdrawal by Subject|2|||
150234044|NCT03738397|541994620|FG000|Overall Study|Adverse Event|3|||
150234045|NCT03738397|541994621|FG001|Overall Study|Adverse Event|7|||
150234046|NCT03738397|541994620|FG000|Overall Study|Withdrawal by Subject|8|||
150234047|NCT03738397|541994621|FG001|Overall Study|Withdrawal by Subject|11|||
150234048|NCT03738397|541994620|FG000|Overall Study|Lost to Follow-up|7|||
150234049|NCT03738397|541994621|FG001|Overall Study|Lost to Follow-up|5|||
150234050|NCT03738397|541994620|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
150234051|NCT03738397|541994621|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
150234052|NCT03738397|541994620|FG000|Overall Study|Other|4|||
150234053|NCT03738397|541994621|FG001|Overall Study|Other|6|||
150234054|NCT01185171|541994624|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
150234055|NCT01185171|541994624|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
150234056|NCT01185171|541994624|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
150234057|NCT01185171|541994624|FG000|Maintenance|Elevated liver transaminases|3|||
150234058|NCT01185171|541994624|FG000|Maintenance|Rush|2|||
150234059|NCT01185171|541994624|FG000|Maintenance|Diarrhea|1|||
150234060|NCT01185171|541994624|FG000|Maintenance|Xerostomia|1|||
150234061|NCT01185171|541994624|FG000|Maintenance|Nausea|1|||
150234062|NCT01185171|541994624|FG000|Maintenance|Comorbid Illness|2|||
150234063|NCT01185171|541994624|FG000|Maintenance|Withdrawal by Subject|1|||
150234064|NCT01185171|541994624|FG000|Maintenance|Disease Recurrence|1|||
150234065|NCT00573651|541994629|FG000|Overall Study|Lost to Follow-up|3|||
150234066|NCT00573651|541994629|FG000|Overall Study|Withdrawal by Subject|1|||
150234067|NCT01837797|541994630|FG000|Period 1|Adverse Event|9|||
150234068|NCT01837797|541994631|FG001|Period 1|Adverse Event|0|||
150234069|NCT01837797|541994632|FG002|Period 1|Adverse Event|0|||
150234070|NCT01837797|541994633|FG003|Period 1|Adverse Event|0|||
150234071|NCT01837797|541994634|FG004|Period 1|Adverse Event|0|||
150234072|NCT01837797|541994630|FG000|Period 1|Withdrawal by Subject|6|||
150234073|NCT01837797|541994631|FG001|Period 1|Withdrawal by Subject|0|||
150234074|NCT01837797|541994632|FG002|Period 1|Withdrawal by Subject|0|||
150234075|NCT01837797|541994633|FG003|Period 1|Withdrawal by Subject|0|||
150234076|NCT01837797|541994634|FG004|Period 1|Withdrawal by Subject|0|||
150234077|NCT01837797|541994630|FG000|Period 1|Administrative reasons|76|||
150234078|NCT01837797|541994631|FG001|Period 1|Administrative reasons|0|||
150234079|NCT01837797|541994632|FG002|Period 1|Administrative reasons|0|||
150234080|NCT01837797|541994633|FG003|Period 1|Administrative reasons|0|||
150234081|NCT01837797|541994634|FG004|Period 1|Administrative reasons|0|||
150234082|NCT01837797|541994630|FG000|Period 1|Withdrawal of consent before treatment|1|||
150234083|NCT01837797|541994631|FG001|Period 1|Withdrawal of consent before treatment|0|||
150234084|NCT01837797|541994632|FG002|Period 1|Withdrawal of consent before treatment|0|||
150234085|NCT01837797|541994633|FG003|Period 1|Withdrawal of consent before treatment|0|||
150234086|NCT01837797|541994634|FG004|Period 1|Withdrawal of consent before treatment|0|||
150234087|NCT01837797|541994630|FG000|Period 1|Other|10|||
150234088|NCT01837797|541994631|FG001|Period 1|Other|0|||
150234089|NCT01837797|541994632|FG002|Period 1|Other|0|||
150234090|NCT01837797|541994633|FG003|Period 1|Other|0|||
150234091|NCT01837797|541994634|FG004|Period 1|Other|0|||
150234092|NCT01837797|541994630|FG000|Period 2|Administrative or other reasons|0|||
150234093|NCT01837797|541994631|FG001|Period 2|Administrative or other reasons|5|||
150234094|NCT01837797|541994632|FG002|Period 2|Administrative or other reasons|2|||
150234095|NCT01837797|541994633|FG003|Period 2|Administrative or other reasons|4|||
150234096|NCT01837797|541994634|FG004|Period 2|Administrative or other reasons|0|||
150234097|NCT01837797|541994630|FG000|Period 2|Adverse Event|0|||
150234098|NCT01837797|541994631|FG001|Period 2|Adverse Event|0|||
150234099|NCT01837797|541994632|FG002|Period 2|Adverse Event|0|||
150234100|NCT01837797|541994633|FG003|Period 2|Adverse Event|1|||
150234101|NCT01837797|541994634|FG004|Period 2|Adverse Event|0|||
150234102|NCT01837797|541994630|FG000|Period 3|Adverse Event|0|||
150234103|NCT01837797|541994631|FG001|Period 3|Adverse Event|0|||
150234104|NCT01837797|541994632|FG002|Period 3|Adverse Event|0|||
150234105|NCT01837797|541994633|FG003|Period 3|Adverse Event|0|||
150234106|NCT01837797|541994634|FG004|Period 3|Adverse Event|1|||
150234107|NCT01837797|541994630|FG000|Period 3|Administrative reasons|0|||
150234108|NCT01837797|541994631|FG001|Period 3|Administrative reasons|0|||
150234109|NCT01837797|541994632|FG002|Period 3|Administrative reasons|0|||
150234110|NCT01837797|541994633|FG003|Period 3|Administrative reasons|0|||
150234111|NCT01837797|541994634|FG004|Period 3|Administrative reasons|20|||
150234112|NCT01837797|541994630|FG000|Period 3|Other|0|||
150234113|NCT01837797|541994631|FG001|Period 3|Other|0|||
150234114|NCT01837797|541994632|FG002|Period 3|Other|0|||
150234115|NCT01837797|541994633|FG003|Period 3|Other|0|||
150234116|NCT01837797|541994634|FG004|Period 3|Other|2|||
150234117|NCT03797989|541994635|FG000|VAC069A|Withdrawal by Subject|0|||
150234118|NCT03797989|541994636|FG001|VAC069A|Withdrawal by Subject|0|||
150234119|NCT03797989|541994637|FG002|VAC069A|Withdrawal by Subject|1|||
150234120|NCT03797989|541994638|FG003|VAC069A|Withdrawal by Subject|0|||
150234121|NCT03797989|541994639|FG004|VAC069A|Withdrawal by Subject|0|||
150234122|NCT03797989|541994640|FG005|VAC069A|Withdrawal by Subject|0|||
150234123|NCT03797989|541994641|FG006|VAC069A|Withdrawal by Subject|0|||
150234124|NCT03797989|541994642|FG007|VAC069A|Withdrawal by Subject|0|||
150234125|NCT03797989|541994643|FG008|VAC069A|Withdrawal by Subject|0|||
150234126|NCT03797989|541994644|FG009|VAC069A|Withdrawal by Subject|0|||
150234127|NCT03797989|541994645|FG010|VAC069A|Withdrawal by Subject|0|||
150234128|NCT03797989|541994646|FG011|VAC069A|Withdrawal by Subject|0|||
150234129|NCT04052997|541994648|FG000|Overall Study|Withdrawal by Subject|17|||
150234130|NCT04052997|541994648|FG000|Overall Study|Physician Decision|50|||
150234131|NCT04052997|541994648|FG000|Overall Study|Death|43|||
150234132|NCT04052997|541994648|FG000|Overall Study|Lost to Follow-up|5|||
150234133|NCT04052997|541994648|FG000|Overall Study|Progression of Disease|1|||
150234134|NCT04814992|541994651|FG000|Overall Study|Withdrawal by Subject|6|||
150234135|NCT04814992|541994652|FG001|Overall Study|Withdrawal by Subject|3|||
150234136|NCT04814992|541994651|FG000|Overall Study|Lost to Follow-up|1|||
150234137|NCT04814992|541994652|FG001|Overall Study|Lost to Follow-up|4|||
150234138|NCT00514813|541994664|FG000|Overall Study|Study terminated|14|||
150234139|NCT00514813|541994665|FG001|Overall Study|Study terminated|74|||
150234140|NCT00514813|541994666|FG002|Overall Study|Study terminated|40|||
150234141|NCT00514813|541994667|FG003|Overall Study|Study terminated|2|||
150234142|NCT00514813|541994664|FG000|Overall Study|Adverse Event|0|||
150234143|NCT00514813|541994665|FG001|Overall Study|Adverse Event|2|||
150234144|NCT00514813|541994666|FG002|Overall Study|Adverse Event|2|||
150234145|NCT00514813|541994667|FG003|Overall Study|Adverse Event|0|||
150234146|NCT00514813|541994664|FG000|Overall Study|Protocol Violation|1|||
150234147|NCT00514813|541994665|FG001|Overall Study|Protocol Violation|0|||
150234148|NCT00514813|541994666|FG002|Overall Study|Protocol Violation|0|||
150234149|NCT00514813|541994667|FG003|Overall Study|Protocol Violation|0|||
150234150|NCT00514813|541994664|FG000|Overall Study|Withdrawal by Subject|0|||
150234151|NCT00514813|541994665|FG001|Overall Study|Withdrawal by Subject|1|||
150234152|NCT00514813|541994666|FG002|Overall Study|Withdrawal by Subject|0|||
150234153|NCT00514813|541994667|FG003|Overall Study|Withdrawal by Subject|0|||
150234154|NCT00514813|541994664|FG000|Overall Study|Lack of Efficacy|0|||
150234155|NCT00514813|541994665|FG001|Overall Study|Lack of Efficacy|1|||
150234156|NCT00514813|541994666|FG002|Overall Study|Lack of Efficacy|0|||
150234157|NCT00514813|541994667|FG003|Overall Study|Lack of Efficacy|0|||
150234158|NCT00514813|541994664|FG000|Overall Study|Kidney transplant|0|||
150234159|NCT00514813|541994665|FG001|Overall Study|Kidney transplant|6|||
150234160|NCT00514813|541994666|FG002|Overall Study|Kidney transplant|2|||
150234161|NCT00514813|541994667|FG003|Overall Study|Kidney transplant|0|||
150234162|NCT00514813|541994664|FG000|Overall Study|Death|0|||
150234163|NCT00514813|541994665|FG001|Overall Study|Death|2|||
150234164|NCT00514813|541994666|FG002|Overall Study|Death|3|||
150234165|NCT00514813|541994667|FG003|Overall Study|Death|2|||
150234166|NCT01075100|541994668|FG000|Overall Study|Adverse Event|15|||
150234167|NCT01075100|541994669|FG001|Overall Study|Adverse Event|18|||
150234168|NCT01075100|541994668|FG000|Overall Study|Patient Request|4|||
150234169|NCT01075100|541994669|FG001|Overall Study|Patient Request|4|||
150234170|NCT01075100|541994668|FG000|Overall Study|Investigator Request|2|||
150234171|NCT01075100|541994669|FG001|Overall Study|Investigator Request|1|||
150234172|NCT01075100|541994668|FG000|Overall Study|Disease Progression|25|||
150234173|NCT01075100|541994669|FG001|Overall Study|Disease Progression|29|||
150234174|NCT01075100|541994668|FG000|Overall Study|Other|3|||
150234175|NCT01075100|541994669|FG001|Overall Study|Other|1|||
150234176|NCT00143598|541994672|FG000|Overall Study|Lost to Follow-up|23|||
150234177|NCT00143598|541994673|FG001|Overall Study|Lost to Follow-up|21|||
150234178|NCT00143598|541994672|FG000|Overall Study|Withdrawal by Subject|33|||
150234179|NCT00143598|541994673|FG001|Overall Study|Withdrawal by Subject|37|||
150234180|NCT00143598|541994672|FG000|Overall Study|Death|36|||
150234181|NCT00143598|541994673|FG001|Overall Study|Death|36|||
150234182|NCT03900715|541994676|FG000|Overall Study|Protocol Deviation|1|||
150234183|NCT03900715|541994676|FG000|Overall Study|Lack of Efficacy|1|||
150234184|NCT03900715|541994676|FG000|Overall Study|Progressive Disease|6|||
150234185|NCT03900715|541994676|FG000|Overall Study|Adverse Event|2|||
150234186|NCT03900715|541994676|FG000|Overall Study|Other reasons|11|||
150234187|NCT03898700|541996360|FG000|Overall Study|Withdrawal by Subject|2|||
150234188|NCT00701909|541996361|FG000|Overall Study|Withdrawal by Subject|0|||
150234189|NCT00701909|541996362|FG001|Overall Study|Withdrawal by Subject|1|||
150234190|NCT00971997|541996363|FG000|Overall Study|Adverse Event|2|||
150234191|NCT00971997|541996363|FG000|Overall Study|Death|1|||
150234192|NCT00971997|541996363|FG000|Overall Study|Protocol Violation|4|||
150234193|NCT00971997|541996363|FG000|Overall Study|Withdrawal by Subject|5|||
150234194|NCT00971997|541996363|FG000|Overall Study|Physician Decision|7|||
150234195|NCT04009629|541996364|FG000|Overall Study|Withdrawal by Subject|2|||
150234196|NCT04009629|541996365|FG001|Overall Study|Withdrawal by Subject|0|||
150234197|NCT02808975|541996366|FG000|Overall Study|Adverse Event|3|||
150234198|NCT02808975|541996367|FG001|Overall Study|Adverse Event|4|||
150234199|NCT02808975|541996366|FG000|Overall Study|Withdrew consent|9|||
150234200|NCT02808975|541996367|FG001|Overall Study|Withdrew consent|8|||
150234201|NCT02808975|541996366|FG000|Overall Study|Lost to Follow-up|4|||
150234202|NCT02808975|541996367|FG001|Overall Study|Lost to Follow-up|6|||
150234203|NCT02808975|541996366|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
150234204|NCT02808975|541996367|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
150234205|NCT02808975|541996366|FG000|Overall Study|Other, not specified|5|||
150234206|NCT02808975|541996367|FG001|Overall Study|Other, not specified|1|||
150234207|NCT00511836|541996370|FG000|Double-blind Period|Lost to Follow-up|1|||
150234208|NCT00511836|541996371|FG001|Double-blind Period|Lost to Follow-up|0|||
150234209|NCT01755546|541996373|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
150234210|NCT01755546|541996373|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
150234211|NCT01755546|541996373|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
150234212|NCT01755546|541996373|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
150234213|NCT01755546|541996373|FG000|Titration Phase|Adverse Event|11|||
150234214|NCT01755546|541996373|FG000|Titration Phase|Lack of Efficacy|18|||
150234215|NCT01755546|541996373|FG000|Titration Phase|Protocol Violation|9|||
150234216|NCT01755546|541996373|FG000|Titration Phase|Lost to Follow-up|2|||
150234217|NCT01755546|541996373|FG000|Titration Phase|Other and Continuing|22|||
150234218|NCT01755546|541996373|FG000|Titration Phase|Withdrawal by Subject|8|||
150234219|NCT01755546|541996373|FG000|Long Term Treatment|Adverse Event|12|||
150234220|NCT01755546|541996373|FG000|Long Term Treatment|Lack of Efficacy|6|||
150234221|NCT01755546|541996373|FG000|Long Term Treatment|Protocol Violation|10|||
150234222|NCT01755546|541996373|FG000|Long Term Treatment|Withdrawal by Subject|35|||
150234223|NCT01755546|541996373|FG000|Long Term Treatment|Lost to Follow-up|17|||
150234224|NCT01755546|541996373|FG000|Long Term Treatment|other and ongoing|41|||
150234225|NCT00891046|541996374|FG000|Overall Study|Protocol Violation|1|||
150234226|NCT00891046|541996375|FG001|Overall Study|Protocol Violation|1|||
150234227|NCT00891046|541996376|FG002|Overall Study|Protocol Violation|0|||
150234228|NCT00891046|541996377|FG003|Overall Study|Protocol Violation|0|||
150234229|NCT00891046|541996378|FG004|Overall Study|Protocol Violation|1|||
150234230|NCT00891046|541996374|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
150234231|NCT00891046|541996375|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
150234232|NCT00891046|541996376|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
150234233|NCT00891046|541996377|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
150234234|NCT00891046|541996378|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
150234235|NCT00891046|541996374|FG000|Overall Study|Administrative problems|0|||
150234236|NCT00891046|541996375|FG001|Overall Study|Administrative problems|0|||
150234237|NCT00891046|541996376|FG002|Overall Study|Administrative problems|0|||
150234238|NCT00891046|541996377|FG003|Overall Study|Administrative problems|0|||
150234239|NCT00891046|541996378|FG004|Overall Study|Administrative problems|1|||
150234240|NCT00891046|541996374|FG000|Overall Study|Participant no longer required drug|0|||
150234241|NCT00891046|541996375|FG001|Overall Study|Participant no longer required drug|2|||
150234242|NCT00891046|541996376|FG002|Overall Study|Participant no longer required drug|0|||
150234243|NCT00891046|541996377|FG003|Overall Study|Participant no longer required drug|0|||
150234244|NCT00891046|541996378|FG004|Overall Study|Participant no longer required drug|1|||
150234245|NCT00891046|541996374|FG000|Overall Study|Adverse Event|4|||
150234246|NCT00891046|541996375|FG001|Overall Study|Adverse Event|3|||
150234247|NCT00891046|541996376|FG002|Overall Study|Adverse Event|2|||
150234248|NCT00891046|541996377|FG003|Overall Study|Adverse Event|0|||
150234249|NCT00891046|541996378|FG004|Overall Study|Adverse Event|14|||
150234250|NCT00891046|541996374|FG000|Overall Study|Withdrawal by Subject|2|||
150234251|NCT00891046|541996375|FG001|Overall Study|Withdrawal by Subject|1|||
150234252|NCT00891046|541996376|FG002|Overall Study|Withdrawal by Subject|2|||
150234253|NCT00891046|541996377|FG003|Overall Study|Withdrawal by Subject|1|||
150234254|NCT00891046|541996378|FG004|Overall Study|Withdrawal by Subject|1|||
150234255|NCT00891046|541996374|FG000|Overall Study|Lost to Follow-up|0|||
150234256|NCT00891046|541996375|FG001|Overall Study|Lost to Follow-up|0|||
150234257|NCT00891046|541996376|FG002|Overall Study|Lost to Follow-up|0|||
150234258|NCT00891046|541996377|FG003|Overall Study|Lost to Follow-up|0|||
150234259|NCT00891046|541996378|FG004|Overall Study|Lost to Follow-up|1|||
150234260|NCT00362375|541996379|FG000|Overall Study|Lost to Follow-up|40|||
150234261|NCT00362375|541996380|FG001|Overall Study|Lost to Follow-up|35|||
150234262|NCT02106195|541996381|FG000|Overall Study|Adverse Event|2|||
150234263|NCT02106195|541996381|FG000|Overall Study|Protocol Violation|1|||
150234264|NCT04984239|541996382|FG000|Overall Study|Lost to Follow-up|1|||
150234265|NCT01663506|541996385|FG000|Overall Study|Lack of Efficacy|3|||
150234266|NCT01663506|541996385|FG000|Overall Study|Consent Withdrawal by Subject|1|||
150234267|NCT01663506|541996385|FG000|Overall Study|Lost to Follow-up|1|||
150234268|NCT01663506|541996385|FG000|Overall Study|Adverse Event|1|||
150234269|NCT01663506|541996385|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
150234270|NCT02438371|541996386|FG000|Overall Study|Lost to Follow-up|3|||
150234271|NCT02438371|541996387|FG001|Overall Study|Lost to Follow-up|2|||
150234272|NCT02438371|541996386|FG000|Overall Study|Withdrawal by Subject|1|||
150234273|NCT02438371|541996387|FG001|Overall Study|Withdrawal by Subject|1|||
150234274|NCT01161446|541996388|FG000|Overall Study|Lost to Follow-up|18|||
150234275|NCT01161446|541996389|FG001|Overall Study|Lost to Follow-up|14|||
150234276|NCT01161446|541996388|FG000|Overall Study|Withdrawal by Subject|0|||
150234277|NCT01161446|541996389|FG001|Overall Study|Withdrawal by Subject|1|||
150234278|NCT01010204|541996391|FG000|Overall Study|Lost to Follow-up|2|||
150234279|NCT01010204|541996392|FG001|Overall Study|Lost to Follow-up|2|||
150234280|NCT01010204|541996391|FG000|Overall Study|Adverse Event|1|||
150234281|NCT01010204|541996392|FG001|Overall Study|Adverse Event|3|||
150234282|NCT01010204|541996391|FG000|Overall Study|Withdrawal by Subject|2|||
150234283|NCT01010204|541996392|FG001|Overall Study|Withdrawal by Subject|3|||
150234284|NCT01010204|541996391|FG000|Overall Study|psychiatric hospitalization|2|||
150234285|NCT01010204|541996392|FG001|Overall Study|psychiatric hospitalization|1|||
150234286|NCT01513330|541996393|FG000|SenSura Mio First,|Adverse Event|2|||
150234287|NCT01513330|541996394|FG001|SenSura Mio First,|Adverse Event|0|||
150234288|NCT01513330|541996393|FG000|SenSura Mio First,|Lack of Efficacy|0|||
150234289|NCT01513330|541996394|FG001|SenSura Mio First,|Lack of Efficacy|1|||
150234290|NCT01513330|541996393|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
150234291|NCT01513330|541996394|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
150234292|NCT01513330|541996393|FG000|SenSura Mio First,|Other|1|||
150234293|NCT01513330|541996394|FG001|SenSura Mio First,|Other|0|||
150234294|NCT01513330|541996393|FG000|Standard Care First,|Lack of Efficacy|2|||
150234295|NCT01513330|541996394|FG001|Standard Care First,|Lack of Efficacy|2|||
150234296|NCT01513330|541996393|FG000|Standard Care First,|Withdrawal by Subject|1|||
150234297|NCT01513330|541996394|FG001|Standard Care First,|Withdrawal by Subject|2|||
150234298|NCT01513330|541996393|FG000|Standard Care First,|Other|1|||
150234299|NCT01513330|541996394|FG001|Standard Care First,|Other|0|||
150234300|NCT01519778|541996395|FG000|Overall Study|Withdrawal by Subject|3|||
150234301|NCT01519778|541996395|FG000|Overall Study|Lost to Follow-up|10|||
150234302|NCT01519778|541996395|FG000|Overall Study|Physician Decision|1|||
150234303|NCT01547117|541996400|FG000|Overall Study|Physician Decision|0|||
150234304|NCT01547117|541996401|FG001|Overall Study|Physician Decision|1|||
150234305|NCT01547117|541996402|FG002|Overall Study|Physician Decision|1|||
150234306|NCT01547117|541996403|FG003|Overall Study|Physician Decision|3|||
150234307|NCT01547117|541996400|FG000|Overall Study|Withdrawal by Subject|1|||
150234308|NCT01547117|541996401|FG001|Overall Study|Withdrawal by Subject|2|||
150234309|NCT01547117|541996402|FG002|Overall Study|Withdrawal by Subject|1|||
150234310|NCT01547117|541996403|FG003|Overall Study|Withdrawal by Subject|2|||
150234311|NCT03927690|541996405|FG000|Overall Study|Withdrawal by Subject|3|||
150234312|NCT03927690|541996406|FG001|Overall Study|Withdrawal by Subject|1|||
150234313|NCT03927690|541996407|FG002|Overall Study|Withdrawal by Subject|1|||
150234314|NCT03927690|541996405|FG000|Overall Study|Adverse Event|1|||
150234315|NCT03927690|541996406|FG001|Overall Study|Adverse Event|0|||
150234316|NCT03927690|541996407|FG002|Overall Study|Adverse Event|0|||
150234317|NCT03927690|541996405|FG000|Overall Study|Death|1|||
150234318|NCT03927690|541996406|FG001|Overall Study|Death|0|||
150234319|NCT03927690|541996407|FG002|Overall Study|Death|0|||
150234320|NCT03927690|541996405|FG000|Overall Study|Lost to Follow-up|2|||
150234321|NCT03927690|541996406|FG001|Overall Study|Lost to Follow-up|2|||
150234322|NCT03927690|541996407|FG002|Overall Study|Lost to Follow-up|1|||
150234323|NCT01844726|541996414|FG000|Overall Study|Withdrawal by Subject|0|||
150234324|NCT01844726|541996415|FG001|Overall Study|Withdrawal by Subject|1|||
150234325|NCT01844726|541996414|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
150234326|NCT01844726|541996415|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
150234327|NCT03898960|541996418|FG000|Overall Study|Death|10|||
150234328|NCT00548847|541996419|FG000|Overall Study|Disease progression|7|||
150234329|NCT00236184|541996420|FG000|Overall Study|Adverse Event|5|||
150234330|NCT00236184|541996421|FG001|Overall Study|Adverse Event|2|||
150234331|NCT00236184|541996420|FG000|Overall Study|Lack of Efficacy|0|||
150234332|NCT00236184|541996421|FG001|Overall Study|Lack of Efficacy|1|||
150234333|NCT00236184|541996420|FG000|Overall Study|Lost to Follow-up|3|||
150234334|NCT00236184|541996421|FG001|Overall Study|Lost to Follow-up|4|||
150234335|NCT00236184|541996420|FG000|Overall Study|Physician Decision|1|||
150234336|NCT00236184|541996421|FG001|Overall Study|Physician Decision|1|||
150234337|NCT00236184|541996420|FG000|Overall Study|Withdrawal by Subject|3|||
150234338|NCT00236184|541996421|FG001|Overall Study|Withdrawal by Subject|0|||
150234339|NCT00236184|541996420|FG000|Overall Study|Protocol Violation|3|||
150234340|NCT00236184|541996421|FG001|Overall Study|Protocol Violation|0|||
150234341|NCT00236184|541996420|FG000|Overall Study|non-compliance with study drug|2|||
150234342|NCT00236184|541996421|FG001|Overall Study|non-compliance with study drug|1|||
150234343|NCT00236184|541996420|FG000|Overall Study|other|1|||
150234344|NCT00236184|541996421|FG001|Overall Study|other|2|||
150234345|NCT01101997|541996422|FG000|Overall Study|Withdrawal by Subject|2|||
150234346|NCT00469456|541996423|FG000|Overall Study|Adverse Event|4|||
150234347|NCT00469456|541996424|FG001|Overall Study|Adverse Event|3|||
150234348|NCT00469456|541996423|FG000|Overall Study|Protocol Violation|1|||
150234349|NCT00469456|541996424|FG001|Overall Study|Protocol Violation|0|||
150234350|NCT00469456|541996423|FG000|Overall Study|Withdrawal by Subject|4|||
150234351|NCT00469456|541996424|FG001|Overall Study|Withdrawal by Subject|1|||
150234352|NCT00704171|541996431|FG000|Overall Study|Withdrawal by Subject|1|||
150234353|NCT00704171|541996432|FG001|Overall Study|Withdrawal by Subject|0|||
150234354|NCT00719043|541996437|FG000|Overall Study|Adverse Event|5|||
150234355|NCT00719043|541996438|FG001|Overall Study|Adverse Event|1|||
150234356|NCT00719043|541996439|FG002|Overall Study|Adverse Event|2|||
150234357|NCT00719043|541996440|FG003|Overall Study|Adverse Event|2|||
150234358|NCT00719043|541996441|FG004|Overall Study|Adverse Event|1|||
150234359|NCT00719043|541996442|FG005|Overall Study|Adverse Event|4|||
150234360|NCT00719043|541996443|FG006|Overall Study|Adverse Event|4|||
150234361|NCT00719043|541996437|FG000|Overall Study|Lost to Follow-up|14|||
150234362|NCT00719043|541996438|FG001|Overall Study|Lost to Follow-up|10|||
150234363|NCT00719043|541996439|FG002|Overall Study|Lost to Follow-up|8|||
150234364|NCT00719043|541996440|FG003|Overall Study|Lost to Follow-up|9|||
150234365|NCT00719043|541996441|FG004|Overall Study|Lost to Follow-up|10|||
150234366|NCT00719043|541996442|FG005|Overall Study|Lost to Follow-up|9|||
150234367|NCT00719043|541996443|FG006|Overall Study|Lost to Follow-up|9|||
150234368|NCT00719043|541996437|FG000|Overall Study|Protocol Violation|0|||
150234369|NCT00719043|541996438|FG001|Overall Study|Protocol Violation|0|||
150234370|NCT00719043|541996439|FG002|Overall Study|Protocol Violation|0|||
150234371|NCT00719043|541996440|FG003|Overall Study|Protocol Violation|0|||
150234372|NCT00719043|541996441|FG004|Overall Study|Protocol Violation|0|||
150234373|NCT00719043|541996442|FG005|Overall Study|Protocol Violation|1|||
150234374|NCT00719043|541996443|FG006|Overall Study|Protocol Violation|0|||
150234375|NCT00719043|541996437|FG000|Overall Study|Other|1|||
150234376|NCT00719043|541996438|FG001|Overall Study|Other|0|||
150234377|NCT00719043|541996439|FG002|Overall Study|Other|1|||
150234378|NCT00719043|541996440|FG003|Overall Study|Other|2|||
150234379|NCT00719043|541996441|FG004|Overall Study|Other|0|||
150234380|NCT00719043|541996442|FG005|Overall Study|Other|2|||
150234381|NCT00719043|541996443|FG006|Overall Study|Other|1|||
150234382|NCT00719043|541996437|FG000|Overall Study|Withdrawal by Subject|12|||
150234383|NCT00719043|541996438|FG001|Overall Study|Withdrawal by Subject|14|||
150234384|NCT00719043|541996439|FG002|Overall Study|Withdrawal by Subject|9|||
150234385|NCT00719043|541996440|FG003|Overall Study|Withdrawal by Subject|10|||
150234386|NCT00719043|541996441|FG004|Overall Study|Withdrawal by Subject|16|||
150234387|NCT00719043|541996442|FG005|Overall Study|Withdrawal by Subject|18|||
150234388|NCT00719043|541996443|FG006|Overall Study|Withdrawal by Subject|14|||
150234389|NCT01588366|541996444|FG000|Overall Study|Adverse Event|0|||
150234390|NCT01588366|541996445|FG001|Overall Study|Adverse Event|1|||
150234391|NCT01588366|541996446|FG002|Overall Study|Adverse Event|0|||
150234392|NCT01588366|541996447|FG003|Overall Study|Adverse Event|1|||
150234393|NCT01588366|541996448|FG004|Overall Study|Adverse Event|0|||
150234394|NCT01588366|541996449|FG005|Overall Study|Adverse Event|2|||
150234395|NCT00302159|541996450|FG000|Overall Study|pt declined before treatment started|1|||
150234396|NCT00302159|541996450|FG000|Overall Study|pt started Avastin|1|||
150234397|NCT00813098|541996451|FG000|Overall Study|Adverse Event|2|||
150234398|NCT00813098|541996452|FG001|Overall Study|Adverse Event|4|||
150234399|NCT00813098|541996453|FG002|Overall Study|Adverse Event|1|||
150234400|NCT00813098|541996451|FG000|Overall Study|Withdrawal by Subject|0|||
150234401|NCT00813098|541996452|FG001|Overall Study|Withdrawal by Subject|1|||
150234402|NCT00813098|541996453|FG002|Overall Study|Withdrawal by Subject|0|||
150234403|NCT00813098|541996451|FG000|Overall Study|Inability to complete study procedures|1|||
150234404|NCT00813098|541996452|FG001|Overall Study|Inability to complete study procedures|0|||
150234405|NCT00813098|541996453|FG002|Overall Study|Inability to complete study procedures|0|||
150234406|NCT00813098|541996451|FG000|Overall Study|Lost to Follow-up|0|||
150234407|NCT00813098|541996452|FG001|Overall Study|Lost to Follow-up|1|||
150234408|NCT00813098|541996453|FG002|Overall Study|Lost to Follow-up|0|||
150234409|NCT00813098|541996451|FG000|Overall Study|Protocol Violation|0|||
150234410|NCT00813098|541996452|FG001|Overall Study|Protocol Violation|0|||
150234411|NCT00813098|541996453|FG002|Overall Study|Protocol Violation|1|||
150234412|NCT00813098|541996451|FG000|Overall Study|Principal Investigator decision|0|||
150234413|NCT00813098|541996452|FG001|Overall Study|Principal Investigator decision|1|||
150234414|NCT00813098|541996453|FG002|Overall Study|Principal Investigator decision|0|||
150234415|NCT00813098|541996451|FG000|Overall Study|Withdrew Consent|0|||
150234416|NCT00813098|541996452|FG001|Overall Study|Withdrew Consent|1|||
150234417|NCT00813098|541996453|FG002|Overall Study|Withdrew Consent|0|||
150234418|NCT03470545|541996456|FG000|Overall Study|Death|0|||
150234419|NCT03470545|541996457|FG001|Overall Study|Death|1|||
150234420|NCT03470545|541996456|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
150234421|NCT03470545|541996457|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
150234422|NCT03470545|541996456|FG000|Overall Study|Adverse Event|2|||
150234423|NCT03470545|541996457|FG001|Overall Study|Adverse Event|0|||
150234424|NCT03470545|541996456|FG000|Overall Study|Withdrawal by Subject|1|||
150234425|NCT03470545|541996457|FG001|Overall Study|Withdrawal by Subject|1|||
150234426|NCT03470545|541996456|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
150234427|NCT03470545|541996457|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
150234428|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
150234429|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
150234430|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
150234431|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
150234432|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
150234433|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
150234434|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
150234435|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
150234436|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
150234437|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
150234438|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
150234439|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
150234440|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
150234441|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
150234442|NCT01664923|541996458|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
150234443|NCT01664923|541996459|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
150234444|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
150234445|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
150234446|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
150234447|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
150234448|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
150234449|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
150234450|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
150234451|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
150234452|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
150234453|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
150234454|NCT01664923|541996458|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
150234455|NCT01664923|541996459|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
150234456|NCT03672175|541996464|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
150234457|NCT03672175|541996465|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
150234458|NCT03672175|541996466|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
150234459|NCT03672175|541996464|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
150234460|NCT03672175|541996465|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
150234461|NCT03672175|541996466|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
150234462|NCT03672175|541996464|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
150234463|NCT03672175|541996465|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
150234464|NCT03672175|541996466|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
150234465|NCT03672175|541996464|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
150234466|NCT03672175|541996465|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
150234467|NCT03672175|541996466|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
150234468|NCT03672175|541996464|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
150234469|NCT03672175|541996465|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
150234470|NCT03672175|541996466|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
150234471|NCT03672175|541996464|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
150234472|NCT03672175|541996465|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
150234473|NCT03672175|541996466|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
150234474|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
150234475|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
150234476|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
150234477|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
150234478|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
150234479|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
150234480|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
150234481|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
150234482|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
150234483|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
150234484|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
150234485|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
150234486|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
150234487|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
150234488|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
150234489|NCT03672175|541996464|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
150234490|NCT03672175|541996465|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
150234491|NCT03672175|541996466|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
150234492|NCT01772563|541996467|FG000|Cycle 1|Dose limiting toxicity|2|||
150234493|NCT01772563|541996467|FG000|Cycle 1|Progressive disease|2|||
150234494|NCT01772563|541996467|FG000|Cycle 2 and Beyond|Progressive disease|17|||
150234495|NCT01772563|541996467|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
150234496|NCT01772563|541996467|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
150234497|NCT01086384|541996469|FG000|2-week Run-in Period|Adverse Event|1|||
150234498|NCT01086384|541996470|FG001|2-week Run-in Period|Adverse Event|0|||
150234499|NCT01086384|541996471|FG002|2-week Run-in Period|Adverse Event|0|||
150234500|NCT01086384|541996469|FG000|2-week Run-in Period|Protocol Violation|1|||
150234501|NCT01086384|541996470|FG001|2-week Run-in Period|Protocol Violation|0|||
150234502|NCT01086384|541996471|FG002|2-week Run-in Period|Protocol Violation|0|||
150234503|NCT01086384|541996469|FG000|2-week Run-in Period|Lost to Follow-up|1|||
150234504|NCT01086384|541996470|FG001|2-week Run-in Period|Lost to Follow-up|0|||
150234505|NCT01086384|541996471|FG002|2-week Run-in Period|Lost to Follow-up|0|||
150234506|NCT01086384|541996469|FG000|2-week Run-in Period|Physician Decision|6|||
150234507|NCT01086384|541996470|FG001|2-week Run-in Period|Physician Decision|0|||
150234508|NCT01086384|541996471|FG002|2-week Run-in Period|Physician Decision|0|||
150234509|NCT01086384|541996469|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
150234510|NCT01086384|541996470|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
150234511|NCT01086384|541996471|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
150234512|NCT01086384|541996469|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
150234513|NCT01086384|541996470|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
150234514|NCT01086384|541996471|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
150234515|NCT01086384|541996469|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
150234516|NCT01086384|541996470|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
150234517|NCT01086384|541996471|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
150234518|NCT01086384|541996469|FG000|2-week Run-in Period|Randomized in Error|1|||
150234519|NCT01086384|541996470|FG001|2-week Run-in Period|Randomized in Error|0|||
150234520|NCT01086384|541996471|FG002|2-week Run-in Period|Randomized in Error|0|||
150234521|NCT01086384|541996469|FG000|Treatment Period|Withdrawal by Subject|0|||
150234522|NCT01086384|541996470|FG001|Treatment Period|Withdrawal by Subject|53|||
150234523|NCT01086384|541996471|FG002|Treatment Period|Withdrawal by Subject|55|||
150234524|NCT01086384|541996469|FG000|Treatment Period|Protocol Violation|0|||
150234525|NCT01086384|541996470|FG001|Treatment Period|Protocol Violation|26|||
150234526|NCT01086384|541996471|FG002|Treatment Period|Protocol Violation|17|||
150234527|NCT01086384|541996469|FG000|Treatment Period|Lack of Efficacy|0|||
150234528|NCT01086384|541996470|FG001|Treatment Period|Lack of Efficacy|22|||
150234529|NCT01086384|541996471|FG002|Treatment Period|Lack of Efficacy|13|||
150234530|NCT01086384|541996469|FG000|Treatment Period|Adverse Event|0|||
150234531|NCT01086384|541996470|FG001|Treatment Period|Adverse Event|19|||
150234532|NCT01086384|541996471|FG002|Treatment Period|Adverse Event|15|||
150234533|NCT01086384|541996469|FG000|Treatment Period|Lost to Follow-up|0|||
150234534|NCT01086384|541996470|FG001|Treatment Period|Lost to Follow-up|11|||
150234535|NCT01086384|541996471|FG002|Treatment Period|Lost to Follow-up|9|||
150234536|NCT01086384|541996469|FG000|Treatment Period|Physician Decision|0|||
150234537|NCT01086384|541996470|FG001|Treatment Period|Physician Decision|9|||
150234538|NCT01086384|541996471|FG002|Treatment Period|Physician Decision|6|||
150234539|NCT01086384|541996469|FG000|Treatment Period|Study Closed/Terminated|0|||
150234540|NCT01086384|541996470|FG001|Treatment Period|Study Closed/Terminated|7|||
150234541|NCT01086384|541996471|FG002|Treatment Period|Study Closed/Terminated|8|||
150234542|NCT01086384|541996469|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
150234543|NCT01086384|541996470|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
150234544|NCT01086384|541996471|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
150234545|NCT01086384|541996469|FG000|Treatment Period|Received Treatment in Error|0|||
150234546|NCT01086384|541996470|FG001|Treatment Period|Received Treatment in Error|1|||
150234547|NCT01086384|541996471|FG002|Treatment Period|Received Treatment in Error|0|||
150234548|NCT02586415|541996474|FG000|Overall Study|Death|13|||
150234549|NCT02586415|541996475|FG001|Overall Study|Death|23|||
150234550|NCT02586415|541996474|FG000|Overall Study|Lost to Follow-up|1|||
150234551|NCT02586415|541996475|FG001|Overall Study|Lost to Follow-up|2|||
150234552|NCT01898442|541996477|FG000|Overall Study|Hemolysis/technical problems|1|||
150234553|NCT01898442|541996478|FG001|Overall Study|Hemolysis/technical problems|2|||
150234554|NCT01898442|541996479|FG002|Overall Study|Hemolysis/technical problems|2|||
150234555|NCT01898442|541996477|FG000|Overall Study|Patient vomited pills|0|||
150234556|NCT01898442|541996478|FG001|Overall Study|Patient vomited pills|0|||
150234557|NCT01898442|541996479|FG002|Overall Study|Patient vomited pills|1|||
150234558|NCT00255944|541996480|FG000|Overall Study|Lost to Follow-up|797|||
150234559|NCT00255944|541996481|FG001|Overall Study|Lost to Follow-up|834|||
150234560|NCT01121913|541996483|FG000|First Intervention Period|Adverse Event|0|||
150234561|NCT01121913|541996484|FG001|First Intervention Period|Adverse Event|0|||
150234562|NCT01121913|541996485|FG002|First Intervention Period|Adverse Event|1|||
150234563|NCT01121913|541996486|FG003|First Intervention Period|Adverse Event|0|||
150234564|NCT01121913|541996483|FG000|First Washout Period|Withdrawal by Subject|1|||
150234565|NCT01121913|541996484|FG001|First Washout Period|Withdrawal by Subject|0|||
150234566|NCT01121913|541996485|FG002|First Washout Period|Withdrawal by Subject|0|||
150234567|NCT01121913|541996486|FG003|First Washout Period|Withdrawal by Subject|0|||
150234568|NCT01121913|541996483|FG000|Second Intervention Period|Adverse Event|0|||
150234569|NCT01121913|541996484|FG001|Second Intervention Period|Adverse Event|0|||
150234570|NCT01121913|541996485|FG002|Second Intervention Period|Adverse Event|1|||
150234571|NCT01121913|541996486|FG003|Second Intervention Period|Adverse Event|0|||
150234572|NCT01121913|541996483|FG000|Second Washout Period|Withdrawal by Subject|0|||
150234573|NCT01121913|541996484|FG001|Second Washout Period|Withdrawal by Subject|0|||
150234574|NCT01121913|541996485|FG002|Second Washout Period|Withdrawal by Subject|1|||
150234575|NCT01121913|541996486|FG003|Second Washout Period|Withdrawal by Subject|0|||
150234576|NCT01121913|541996483|FG000|Third Washout Period|Adverse Event|1|||
150234577|NCT01121913|541996484|FG001|Third Washout Period|Adverse Event|0|||
150234578|NCT01121913|541996485|FG002|Third Washout Period|Adverse Event|0|||
150234579|NCT01121913|541996486|FG003|Third Washout Period|Adverse Event|0|||
150234580|NCT00935259|541996487|FG000|Period 1|Administrative (scheduling conflict)|1|||
150234581|NCT00935259|541996488|FG001|Period 1|Administrative (scheduling conflict)|1|||
150234582|NCT03856047|541996491|FG000|Overall Study|Withdrawal by Subject|0|||
150234583|NCT03856047|541996492|FG001|Overall Study|Withdrawal by Subject|1|||
150234584|NCT03856047|541996493|FG002|Overall Study|Withdrawal by Subject|1|||
150234585|NCT03856047|541996494|FG003|Overall Study|Withdrawal by Subject|0|||
150234586|NCT03856047|541996495|FG004|Overall Study|Withdrawal by Subject|3|||
150234587|NCT03856047|541996496|FG005|Overall Study|Withdrawal by Subject|0|||
150234588|NCT03856047|541996497|FG006|Overall Study|Withdrawal by Subject|2|||
150234589|NCT03856047|541996491|FG000|Overall Study|Lost to Follow-up|4|||
150234590|NCT03856047|541996492|FG001|Overall Study|Lost to Follow-up|2|||
150234591|NCT03856047|541996493|FG002|Overall Study|Lost to Follow-up|3|||
150234592|NCT03856047|541996494|FG003|Overall Study|Lost to Follow-up|1|||
150234593|NCT03856047|541996495|FG004|Overall Study|Lost to Follow-up|4|||
150234594|NCT03856047|541996496|FG005|Overall Study|Lost to Follow-up|4|||
150234595|NCT03856047|541996497|FG006|Overall Study|Lost to Follow-up|4|||
150234596|NCT03410108|541996498|FG000|Overall Study|Ongoing|41|||
150234597|NCT03410108|541996498|FG000|Overall Study|Adverse Event|4|||
150234598|NCT03410108|541996498|FG000|Overall Study|Progressive Disease|58|||
150234599|NCT03410108|541996498|FG000|Overall Study|Withdrawal by Subject|1|||
150234600|NCT00937521|541996500|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234601|NCT00937521|541996501|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234602|NCT00937521|541996502|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
150234603|NCT00937521|541996503|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234604|NCT00937521|541996504|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234605|NCT00937521|541996505|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234606|NCT00937521|541996506|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
150234607|NCT00937521|541996507|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
150234608|NCT00937521|541996500|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
150234609|NCT00937521|541996501|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
150234610|NCT00937521|541996502|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
150234611|NCT00937521|541996503|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
150234612|NCT00937521|541996504|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
150234613|NCT00937521|541996505|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
150234614|NCT00937521|541996506|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
150234615|NCT00937521|541996507|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
150234616|NCT00937521|541996500|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234617|NCT00937521|541996501|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234618|NCT00937521|541996502|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
150234619|NCT00937521|541996503|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
150234620|NCT00937521|541996504|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234621|NCT00937521|541996505|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234622|NCT00937521|541996506|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234623|NCT00937521|541996507|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
150234624|NCT00937521|541996500|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
150234625|NCT00937521|541996501|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
150234626|NCT00937521|541996502|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
150234627|NCT00937521|541996503|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
150234628|NCT00937521|541996504|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
150234629|NCT00937521|541996505|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
150234630|NCT00937521|541996506|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
150234631|NCT00937521|541996507|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
150234632|NCT00937521|541996500|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
150234633|NCT00937521|541996501|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234634|NCT00937521|541996502|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234635|NCT00937521|541996503|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234636|NCT00937521|541996504|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234637|NCT00937521|541996505|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234638|NCT00937521|541996506|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
150234639|NCT00937521|541996507|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
150234640|NCT00937521|541996500|FG000|Booster Phase|Adverse Event|0|||
150234641|NCT00937521|541996501|FG001|Booster Phase|Adverse Event|0|||
150234642|NCT00937521|541996502|FG002|Booster Phase|Adverse Event|0|||
150234643|NCT00937521|541996503|FG003|Booster Phase|Adverse Event|0|||
150234644|NCT00937521|541996504|FG004|Booster Phase|Adverse Event|0|||
150234645|NCT00937521|541996505|FG005|Booster Phase|Adverse Event|0|||
150234646|NCT00937521|541996506|FG006|Booster Phase|Adverse Event|1|||
150234647|NCT00937521|541996507|FG007|Booster Phase|Adverse Event|0|||
150234648|NCT00937521|541996500|FG000|Booster Phase|Withdrawal by Subject|1|||
150234649|NCT00937521|541996501|FG001|Booster Phase|Withdrawal by Subject|0|||
150234650|NCT00937521|541996502|FG002|Booster Phase|Withdrawal by Subject|0|||
150234651|NCT00937521|541996503|FG003|Booster Phase|Withdrawal by Subject|1|||
150234652|NCT00937521|541996504|FG004|Booster Phase|Withdrawal by Subject|0|||
150234653|NCT00937521|541996505|FG005|Booster Phase|Withdrawal by Subject|0|||
150234654|NCT00937521|541996506|FG006|Booster Phase|Withdrawal by Subject|0|||
150234655|NCT00937521|541996507|FG007|Booster Phase|Withdrawal by Subject|2|||
150234656|NCT00937521|541996500|FG000|Booster Phase|Lost to Follow-up|2|||
150234657|NCT00937521|541996501|FG001|Booster Phase|Lost to Follow-up|2|||
150234658|NCT00937521|541996502|FG002|Booster Phase|Lost to Follow-up|4|||
150234659|NCT00937521|541996503|FG003|Booster Phase|Lost to Follow-up|2|||
150234660|NCT00937521|541996504|FG004|Booster Phase|Lost to Follow-up|4|||
150234661|NCT00937521|541996505|FG005|Booster Phase|Lost to Follow-up|4|||
150234662|NCT00937521|541996506|FG006|Booster Phase|Lost to Follow-up|3|||
150234663|NCT00937521|541996507|FG007|Booster Phase|Lost to Follow-up|0|||
150234664|NCT00937521|541996500|FG000|Booster Phase|Administrative Reason|0|||
150234665|NCT00937521|541996501|FG001|Booster Phase|Administrative Reason|0|||
150234666|NCT00937521|541996502|FG002|Booster Phase|Administrative Reason|1|||
150234667|NCT00937521|541996503|FG003|Booster Phase|Administrative Reason|0|||
150234668|NCT00937521|541996504|FG004|Booster Phase|Administrative Reason|1|||
150234669|NCT00937521|541996505|FG005|Booster Phase|Administrative Reason|1|||
150234670|NCT00937521|541996506|FG006|Booster Phase|Administrative Reason|0|||
150234671|NCT00937521|541996507|FG007|Booster Phase|Administrative Reason|0|||
150234672|NCT00937521|541996500|FG000|Booster Phase|Protocol Deviation|0|||
150234673|NCT00937521|541996501|FG001|Booster Phase|Protocol Deviation|0|||
150234674|NCT00937521|541996502|FG002|Booster Phase|Protocol Deviation|0|||
150234675|NCT00937521|541996503|FG003|Booster Phase|Protocol Deviation|0|||
150234676|NCT00937521|541996504|FG004|Booster Phase|Protocol Deviation|0|||
150234677|NCT00937521|541996505|FG005|Booster Phase|Protocol Deviation|0|||
150234678|NCT00937521|541996506|FG006|Booster Phase|Protocol Deviation|1|||
150234679|NCT00937521|541996507|FG007|Booster Phase|Protocol Deviation|0|||
150234680|NCT01721746|541996511|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
150234681|NCT01721746|541996512|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
150234682|NCT01721746|541996511|FG000|Pre-Treatment|Withdrawal by Subject|1|||
150234683|NCT01721746|541996512|FG001|Pre-Treatment|Withdrawal by Subject|16|||
150234684|NCT01721746|541996511|FG000|Pre-Treatment|Poor/Non-compliance|1|||
150234685|NCT01721746|541996512|FG001|Pre-Treatment|Poor/Non-compliance|0|||
150234686|NCT01721746|541996511|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
150234687|NCT01721746|541996512|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
150234688|NCT01721746|541996511|FG000|Treatment|Disease Progression|192|||
150234689|NCT01721746|541996512|FG001|Treatment|Disease Progression|74|||
150234690|NCT01721746|541996511|FG000|Treatment|Study Drug Toxicity|19|||
150234691|NCT01721746|541996512|FG001|Treatment|Study Drug Toxicity|11|||
150234692|NCT01721746|541996511|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
150234693|NCT01721746|541996512|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
150234694|NCT01721746|541996511|FG000|Treatment|Participant request to discontinue Study treatment|26|||
150234695|NCT01721746|541996512|FG001|Treatment|Participant request to discontinue Study treatment|7|||
150234696|NCT01721746|541996511|FG000|Treatment|Participant withdrew consent|4|||
150234697|NCT01721746|541996512|FG001|Treatment|Participant withdrew consent|2|||
150234698|NCT01721746|541996511|FG000|Treatment|Maximum Clinical Benefit|9|||
150234699|NCT01721746|541996512|FG001|Treatment|Maximum Clinical Benefit|3|||
150234700|NCT01721746|541996511|FG000|Treatment|Poor/Non-compliance|2|||
150234701|NCT01721746|541996512|FG001|Treatment|Poor/Non-compliance|0|||
150234702|NCT01721746|541996511|FG000|Treatment|Participant no longer met Study criteria|4|||
150234703|NCT01721746|541996512|FG001|Treatment|Participant no longer met Study criteria|0|||
150234704|NCT01721746|541996511|FG000|Treatment|Other reasons|6|||
150234705|NCT01721746|541996512|FG001|Treatment|Other reasons|2|||
150234706|NCT02447718|541996515|FG000|Overall Study|Lost to Follow-up|8|||
150234707|NCT02447718|541996516|FG001|Overall Study|Lost to Follow-up|0|||
150234708|NCT02447718|541996515|FG000|Overall Study|Withdrawal by Subject|3|||
150234709|NCT02447718|541996516|FG001|Overall Study|Withdrawal by Subject|0|||
150234710|NCT02447718|541996515|FG000|Overall Study|Screen Failure|1|||
150234711|NCT02447718|541996516|FG001|Overall Study|Screen Failure|0|||
150234712|NCT00239681|541996517|FG000|Overall Study|Adverse Event|100|||
150234713|NCT00239681|541996518|FG001|Overall Study|Adverse Event|99|||
150234714|NCT00239681|541996517|FG000|Overall Study|Withdrawal by Subject|458|||
150234715|NCT00239681|541996518|FG001|Overall Study|Withdrawal by Subject|489|||
150234716|NCT00239681|541996517|FG000|Overall Study|Lost to Follow-up|28|||
150234717|NCT00239681|541996518|FG001|Overall Study|Lost to Follow-up|22|||
150234718|NCT00239681|541996517|FG000|Overall Study|Protocol Violation|4|||
150234719|NCT00239681|541996518|FG001|Overall Study|Protocol Violation|4|||
150234720|NCT00239681|541996517|FG000|Overall Study|Physician Decision|13|||
150234721|NCT00239681|541996518|FG001|Overall Study|Physician Decision|17|||
150234722|NCT00239681|541996517|FG000|Overall Study|No information chacked on CaseReportForm|90|||
150234723|NCT00239681|541996518|FG001|Overall Study|No information chacked on CaseReportForm|84|||
150234724|NCT00934700|541996519|FG000|Overall Study|missing scan|5|||
150234725|NCT00934700|541996520|FG001|Overall Study|missing scan|9|||
150234726|NCT00934700|541996519|FG000|Overall Study|Death|8|||
150234727|NCT00934700|541996520|FG001|Overall Study|Death|3|||
150234728|NCT02641587|541998249|FG000|Confinement Period|Adverse Event|1|||
150234729|NCT02641587|541998250|FG001|Confinement Period|Adverse Event|0|||
150234730|NCT02641587|541998249|FG000|Confinement Period|Withdrawal by Subject|2|||
150234731|NCT02641587|541998250|FG001|Confinement Period|Withdrawal by Subject|1|||
150234732|NCT02641587|541998249|FG000|Ambulatory Period|Withdrawal by Subject|1|||
150234733|NCT02641587|541998250|FG001|Ambulatory Period|Withdrawal by Subject|0|||
150234734|NCT01150045|541998252|FG000|Overall Study|Protocol Violation|0|||
150234735|NCT01150045|541998253|FG001|Overall Study|Protocol Violation|1|||
150234736|NCT01150045|541998254|FG002|Overall Study|Protocol Violation|0|||
150234737|NCT01150045|541998255|FG003|Overall Study|Protocol Violation|1|||
150234738|NCT00328562|541998259|FG000|Overall Study|Disease progression|1|||
150234739|NCT00810342|541998260|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
150234740|NCT00810342|541998261|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
150234741|NCT00810342|541998260|FG000|Month 1 Follow-up|Pregnancy|1|||
150234742|NCT00810342|541998261|FG001|Month 1 Follow-up|Pregnancy|0|||
150234743|NCT00810342|541998260|FG000|6-month Follow-up|Lost to Follow-up|18|||
150234744|NCT00810342|541998261|FG001|6-month Follow-up|Lost to Follow-up|6|||
150234745|NCT00810342|541998260|FG000|6-month Follow-up|Pregnancy|6|||
150234746|NCT00810342|541998261|FG001|6-month Follow-up|Pregnancy|2|||
150234747|NCT00810342|541998260|FG000|12-month Followup|Pregnancy|9|||
150234748|NCT00810342|541998261|FG001|12-month Followup|Pregnancy|10|||
150234749|NCT00810342|541998260|FG000|12-month Followup|Lost to Follow-up|3|||
150234750|NCT00810342|541998261|FG001|12-month Followup|Lost to Follow-up|1|||
150234751|NCT04504630|541998262|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
150234752|NCT04504630|541998263|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
150234753|NCT04504630|541998262|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
150234754|NCT04504630|541998263|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
150234755|NCT03021551|541998266|FG000|Overall Study|Equipment Issues|2|||
150234756|NCT03021551|541998266|FG000|Overall Study|Protocol Violation|1|||
150234757|NCT00412880|541998267|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
150234758|NCT00412880|541998267|FG000|Overall Study|Consent withdrawn|1|||
150234759|NCT00412880|541998267|FG000|Overall Study|Adverse Event|1|||
150234760|NCT00412880|541998267|FG000|Overall Study|Progressive disease|20|||
150234761|NCT01288209|541998268|FG000|Overall Study|Withdrawal by Subject|1|||
150234762|NCT01288209|541998269|FG001|Overall Study|Withdrawal by Subject|3|||
150234763|NCT01288209|541998268|FG000|Overall Study|Other|1|||
150234764|NCT01288209|541998269|FG001|Overall Study|Other|0|||
150234765|NCT02232399|541998270|FG000|Overall Study|Adverse Event|1|||
150234766|NCT02232399|541998271|FG001|Overall Study|Adverse Event|0|||
150234767|NCT02232399|541998270|FG000|Overall Study|Withdrawal by Subject|0|||
150234768|NCT02232399|541998271|FG001|Overall Study|Withdrawal by Subject|1|||
150234769|NCT01660256|541998272|FG000|Overall Study|Adverse Event|4|||
150234770|NCT01660256|541998273|FG001|Overall Study|Adverse Event|0|||
150234771|NCT01660256|541998274|FG002|Overall Study|Adverse Event|2|||
150234772|NCT01660256|541998272|FG000|Overall Study|Withdrawal by Subject|1|||
150234773|NCT01660256|541998273|FG001|Overall Study|Withdrawal by Subject|0|||
150234774|NCT01660256|541998274|FG002|Overall Study|Withdrawal by Subject|2|||
150234775|NCT03491215|541998276|FG000|Overall Study|Death|6|||
150234776|NCT03491215|541998277|FG001|Overall Study|Death|2|||
150234777|NCT03491215|541998278|FG002|Overall Study|Death|1|||
150234778|NCT03491215|541998279|FG003|Overall Study|Death|0|||
150234779|NCT03491215|541998276|FG000|Overall Study|Physician Decision|1|||
150234780|NCT03491215|541998277|FG001|Overall Study|Physician Decision|0|||
150234781|NCT03491215|541998278|FG002|Overall Study|Physician Decision|0|||
150234782|NCT03491215|541998279|FG003|Overall Study|Physician Decision|0|||
150234783|NCT00551135|541998288|FG000|Overall Study|Adverse Event|1|||
150234784|NCT00551135|541998289|FG001|Overall Study|Adverse Event|0|||
150234785|NCT00551135|541998290|FG002|Overall Study|Adverse Event|1|||
150234786|NCT00551135|541998291|FG003|Overall Study|Adverse Event|1|||
150234787|NCT00551135|541998288|FG000|Overall Study|Lost to Follow-up|0|||
150234788|NCT00551135|541998289|FG001|Overall Study|Lost to Follow-up|0|||
150234789|NCT00551135|541998290|FG002|Overall Study|Lost to Follow-up|0|||
150234790|NCT00551135|541998291|FG003|Overall Study|Lost to Follow-up|1|||
150234791|NCT00551135|541998288|FG000|Overall Study|Other|3|||
150234792|NCT00551135|541998289|FG001|Overall Study|Other|2|||
150234793|NCT00551135|541998290|FG002|Overall Study|Other|1|||
150234794|NCT00551135|541998291|FG003|Overall Study|Other|2|||
150234795|NCT00551135|541998288|FG000|Overall Study|Withdrawal by Subject|1|||
150234796|NCT00551135|541998289|FG001|Overall Study|Withdrawal by Subject|0|||
150234797|NCT00551135|541998290|FG002|Overall Study|Withdrawal by Subject|3|||
150234798|NCT00551135|541998291|FG003|Overall Study|Withdrawal by Subject|1|||
150234799|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
150234800|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
150234801|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
150234802|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
150234803|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
150234804|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
150234805|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
150234806|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
150234807|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
150234808|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
150234809|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
150234810|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
150234811|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
150234812|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
150234813|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
150234814|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
150234815|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
150234816|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
150234817|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
150234818|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
150234819|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
150234820|NCT04599855|541998292|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
150234821|NCT04599855|541998293|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
150234822|NCT04599855|541998294|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
150234823|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
150234824|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
150234825|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
150234826|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
150234827|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
150234828|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
150234829|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
150234830|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
150234831|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
150234832|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
150234833|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
150234834|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
150234835|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
150234836|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
150234837|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
150234838|NCT04599855|541998292|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
150234839|NCT04599855|541998293|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
150234840|NCT04599855|541998294|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
150234841|NCT02165397|541998295|FG000|Overall Study|Death|7|||
150234842|NCT02165397|541998296|FG001|Overall Study|Death|10|||
150234843|NCT02165397|541998297|FG002|Overall Study|Death|8|||
150234844|NCT02165397|541998295|FG000|Overall Study|Lost to Follow-up|1|||
150234845|NCT02165397|541998296|FG001|Overall Study|Lost to Follow-up|3|||
150234846|NCT02165397|541998297|FG002|Overall Study|Lost to Follow-up|0|||
150234847|NCT02165397|541998295|FG000|Overall Study|Withdrawal by Subject|6|||
150234848|NCT02165397|541998296|FG001|Overall Study|Withdrawal by Subject|6|||
150234849|NCT02165397|541998297|FG002|Overall Study|Withdrawal by Subject|1|||
150234850|NCT02165397|541998295|FG000|Overall Study|Other, Not Specified|0|||
150234851|NCT02165397|541998296|FG001|Overall Study|Other, Not Specified|0|||
150234852|NCT02165397|541998297|FG002|Overall Study|Other, Not Specified|1|||
150234853|NCT04799418|541998298|FG000|Overall Study|Death|1|||
150234854|NCT04799418|541998299|FG001|Overall Study|Death|1|||
150234855|NCT04799418|541998298|FG000|Overall Study|Lack of Efficacy|14|||
150234856|NCT04799418|541998299|FG001|Overall Study|Lack of Efficacy|14|||
150234857|NCT04799418|541998298|FG000|Overall Study|Withdrawal by Subject|10|||
150234858|NCT04799418|541998299|FG001|Overall Study|Withdrawal by Subject|7|||
150234859|NCT04799418|541998298|FG000|Overall Study|Adverse Event|3|||
150234860|NCT04799418|541998299|FG001|Overall Study|Adverse Event|2|||
150234861|NCT03297398|541998300|FG000|Overall Study|Sponsor's decision|6|||
150234862|NCT03297398|541998301|FG001|Overall Study|Sponsor's decision|9|||
150234863|NCT03297398|541998302|FG002|Overall Study|Sponsor's decision|7|||
150234864|NCT03297398|541998300|FG000|Overall Study|Adverse Event|1|||
150234865|NCT03297398|541998301|FG001|Overall Study|Adverse Event|4|||
150234866|NCT03297398|541998302|FG002|Overall Study|Adverse Event|4|||
150234867|NCT03297398|541998300|FG000|Overall Study|Withdrawal by Subject|1|||
150234868|NCT03297398|541998301|FG001|Overall Study|Withdrawal by Subject|2|||
150234869|NCT03297398|541998302|FG002|Overall Study|Withdrawal by Subject|2|||
150234870|NCT03297398|541998300|FG000|Overall Study|Protocol Violation|0|||
150234871|NCT03297398|541998301|FG001|Overall Study|Protocol Violation|2|||
150234872|NCT03297398|541998302|FG002|Overall Study|Protocol Violation|0|||
150234873|NCT03297398|541998300|FG000|Overall Study|Physician Decision|0|||
150234874|NCT03297398|541998301|FG001|Overall Study|Physician Decision|0|||
150234875|NCT03297398|541998302|FG002|Overall Study|Physician Decision|1|||
150234876|NCT03297398|541998300|FG000|Overall Study|Lost to Follow-up|0|||
150234877|NCT03297398|541998301|FG001|Overall Study|Lost to Follow-up|0|||
150234878|NCT03297398|541998302|FG002|Overall Study|Lost to Follow-up|1|||
150234879|NCT01379703|541998307|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
150234880|NCT01379703|541998308|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
150234881|NCT01379703|541998309|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
150234882|NCT01379703|541998307|FG000|Study Start Through 9 Months|Adverse Event|0|||
150234883|NCT01379703|541998308|FG001|Study Start Through 9 Months|Adverse Event|14|||
150234884|NCT01379703|541998309|FG002|Study Start Through 9 Months|Adverse Event|10|||
150234885|NCT01379703|541998307|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
150234886|NCT01379703|541998308|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
150234887|NCT01379703|541998309|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
150234888|NCT01379703|541998307|FG000|Study Start Through 9 Months|Treatment Failure|0|||
150234889|NCT01379703|541998308|FG001|Study Start Through 9 Months|Treatment Failure|2|||
150234890|NCT01379703|541998309|FG002|Study Start Through 9 Months|Treatment Failure|2|||
150234891|NCT01379703|541998307|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
150234892|NCT01379703|541998308|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
150234893|NCT01379703|541998309|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
150234894|NCT01379703|541998307|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
150234895|NCT01379703|541998308|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
150234896|NCT01379703|541998309|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
150234897|NCT01379703|541998307|FG000|Study Start Through 9 Months|Medication not available|0|||
150234898|NCT01379703|541998308|FG001|Study Start Through 9 Months|Medication not available|2|||
150234899|NCT01379703|541998309|FG002|Study Start Through 9 Months|Medication not available|1|||
150234900|NCT01379703|541998307|FG000|Study Start Through 9 Months|Poor general condition|0|||
150234901|NCT01379703|541998308|FG001|Study Start Through 9 Months|Poor general condition|1|||
150234902|NCT01379703|541998309|FG002|Study Start Through 9 Months|Poor general condition|0|||
150234903|NCT01379703|541998307|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
150234904|NCT01379703|541998308|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
150234905|NCT01379703|541998309|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
150234906|NCT01379703|541998307|FG000|Study Start Through 9 Months|Reason unknown|2|||
150234907|NCT01379703|541998308|FG001|Study Start Through 9 Months|Reason unknown|31|||
150234908|NCT01379703|541998309|FG002|Study Start Through 9 Months|Reason unknown|24|||
150234909|NCT01379703|541998307|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
150234910|NCT01379703|541998308|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
150234911|NCT01379703|541998309|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
150234912|NCT01379703|541998307|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
150234913|NCT01379703|541998308|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
150234914|NCT01379703|541998309|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
150234915|NCT01379703|541998307|FG000|9 Months Through 18 Months|Adverse Event|0|||
150234916|NCT01379703|541998308|FG001|9 Months Through 18 Months|Adverse Event|6|||
150234917|NCT01379703|541998309|FG002|9 Months Through 18 Months|Adverse Event|0|||
150234918|NCT01379703|541998307|FG000|9 Months Through 18 Months|Treatment failure|0|||
150234919|NCT01379703|541998308|FG001|9 Months Through 18 Months|Treatment failure|5|||
150234920|NCT01379703|541998309|FG002|9 Months Through 18 Months|Treatment failure|0|||
150234921|NCT01379703|541998307|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
150234922|NCT01379703|541998308|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
150234923|NCT01379703|541998309|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
150234924|NCT01379703|541998307|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
150234925|NCT01379703|541998308|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
150234926|NCT01379703|541998309|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
150234927|NCT01379703|541998307|FG000|9 Months Through 18 Months|Fatigue|0|||
150234928|NCT01379703|541998308|FG001|9 Months Through 18 Months|Fatigue|1|||
150234929|NCT01379703|541998309|FG002|9 Months Through 18 Months|Fatigue|0|||
150234930|NCT01379703|541998307|FG000|9 Months Through 18 Months|Reason Unknown|0|||
150234931|NCT01379703|541998308|FG001|9 Months Through 18 Months|Reason Unknown|23|||
150234932|NCT01379703|541998309|FG002|9 Months Through 18 Months|Reason Unknown|0|||
150234933|NCT03481556|541998310|FG000|Overall Study|Adverse Event|1|||
150234934|NCT03481556|541998311|FG001|Overall Study|Adverse Event|0|||
150234935|NCT03481556|541998312|FG002|Overall Study|Adverse Event|0|||
150234936|NCT03481556|541998313|FG003|Overall Study|Adverse Event|0|||
150234937|NCT03481556|541998310|FG000|Overall Study|Death|4|||
150234938|NCT03481556|541998311|FG001|Overall Study|Death|2|||
150234939|NCT03481556|541998312|FG002|Overall Study|Death|3|||
150234940|NCT03481556|541998313|FG003|Overall Study|Death|16|||
150234941|NCT03481556|541998310|FG000|Overall Study|Study Terminated by Sponsor|10|||
150234942|NCT03481556|541998311|FG001|Overall Study|Study Terminated by Sponsor|5|||
150234943|NCT03481556|541998312|FG002|Overall Study|Study Terminated by Sponsor|2|||
150234944|NCT03481556|541998313|FG003|Overall Study|Study Terminated by Sponsor|9|||
150234945|NCT01316887|541998314|FG000|Overall Study|Adverse Event|13|||
150234946|NCT01316887|541998315|FG001|Overall Study|Adverse Event|21|||
150234947|NCT01316887|541998316|FG002|Overall Study|Adverse Event|17|||
150234948|NCT01316887|541998314|FG000|Overall Study|Lack of Efficacy|9|||
150234949|NCT01316887|541998315|FG001|Overall Study|Lack of Efficacy|3|||
150234950|NCT01316887|541998316|FG002|Overall Study|Lack of Efficacy|1|||
150234951|NCT01316887|541998314|FG000|Overall Study|Protocol Violation|2|||
150234952|NCT01316887|541998315|FG001|Overall Study|Protocol Violation|6|||
150234953|NCT01316887|541998316|FG002|Overall Study|Protocol Violation|6|||
150234954|NCT01316887|541998314|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
150234955|NCT01316887|541998315|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
150234956|NCT01316887|541998316|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
150234957|NCT01316887|541998314|FG000|Overall Study|Study Closed/Terminated|2|||
150234958|NCT01316887|541998315|FG001|Overall Study|Study Closed/Terminated|4|||
150234959|NCT01316887|541998316|FG002|Overall Study|Study Closed/Terminated|3|||
150234960|NCT01316887|541998314|FG000|Overall Study|Lost to Follow-up|1|||
150234961|NCT01316887|541998315|FG001|Overall Study|Lost to Follow-up|7|||
150234962|NCT01316887|541998316|FG002|Overall Study|Lost to Follow-up|5|||
150234963|NCT01316887|541998314|FG000|Overall Study|Withdrawal by Subject|8|||
150234964|NCT01316887|541998315|FG001|Overall Study|Withdrawal by Subject|16|||
150234965|NCT01316887|541998316|FG002|Overall Study|Withdrawal by Subject|15|||
150234966|NCT02172950|541998317|FG000|Overall Study|Physician Decision|3|||
150234967|NCT02172950|541998318|FG001|Overall Study|Physician Decision|3|||
150234968|NCT02172950|541998317|FG000|Overall Study|Lack of Efficacy|1|||
150234969|NCT02172950|541998318|FG001|Overall Study|Lack of Efficacy|0|||
150234970|NCT02172950|541998317|FG000|Overall Study|Adverse Event|4|||
150234971|NCT02172950|541998318|FG001|Overall Study|Adverse Event|1|||
150234972|NCT02172950|541998317|FG000|Overall Study|Withdrawal by Subject|10|||
150234973|NCT02172950|541998318|FG001|Overall Study|Withdrawal by Subject|0|||
150234974|NCT02172950|541998317|FG000|Overall Study|Protocol Violation|1|||
150234975|NCT02172950|541998318|FG001|Overall Study|Protocol Violation|0|||
150234976|NCT02172950|541998317|FG000|Overall Study|Lost to Follow-up|1|||
150234977|NCT02172950|541998318|FG001|Overall Study|Lost to Follow-up|0|||
150234978|NCT02172950|541998317|FG000|Overall Study|Death|1|||
150234979|NCT02172950|541998318|FG001|Overall Study|Death|0|||
150234980|NCT02172950|541998317|FG000|Overall Study|Patient traveling|1|||
150234981|NCT02172950|541998318|FG001|Overall Study|Patient traveling|0|||
150234982|NCT02172950|541998317|FG000|Overall Study|Patient went to other country|1|||
150234983|NCT02172950|541998318|FG001|Overall Study|Patient went to other country|0|||
150234984|NCT02172950|541998317|FG000|Overall Study|Patient relocated overseas|1|||
150234985|NCT02172950|541998318|FG001|Overall Study|Patient relocated overseas|1|||
150234986|NCT02172950|541998317|FG000|Overall Study|Patient moving|1|||
150234987|NCT02172950|541998318|FG001|Overall Study|Patient moving|0|||
150234988|NCT00107978|541998319|FG000|Overall Study|Adverse Event|1|||
150234989|NCT00107978|541998320|FG001|Overall Study|Adverse Event|5|||
150234990|NCT00107978|541998319|FG000|Overall Study|Death|3|||
150234991|NCT00107978|541998320|FG001|Overall Study|Death|3|||
150234992|NCT00107978|541998319|FG000|Overall Study|Lost to Follow-up|20|||
150234993|NCT00107978|541998320|FG001|Overall Study|Lost to Follow-up|28|||
150234994|NCT00107978|541998319|FG000|Overall Study|Withdrawal by Subject|4|||
150234995|NCT00107978|541998320|FG001|Overall Study|Withdrawal by Subject|9|||
150234996|NCT00107978|541998319|FG000|Overall Study|Protocol Violation|0|||
150234997|NCT00107978|541998320|FG001|Overall Study|Protocol Violation|1|||
150234998|NCT00107978|541998319|FG000|Overall Study|Other|5|||
150234999|NCT00107978|541998320|FG001|Overall Study|Other|4|||
150235000|NCT02669407|541998321|FG000|Overall Study|Physician Decision|3|||
150235001|NCT03634839|541998322|FG000|First Intervention (2 Hours)|Adverse Event|0|||
150235002|NCT03634839|541998323|FG001|First Intervention (2 Hours)|Adverse Event|2|||
150235003|NCT00350298|541998324|FG000|Overall Study|Death|7|||
150235004|NCT00350298|541998325|FG001|Overall Study|Death|8|||
150235005|NCT00350298|541998324|FG000|Overall Study|Lost to Follow-up|1|||
150235006|NCT00350298|541998325|FG001|Overall Study|Lost to Follow-up|2|||
150235007|NCT00350298|541998324|FG000|Overall Study|Withdrawal by Subject|1|||
150235008|NCT00350298|541998325|FG001|Overall Study|Withdrawal by Subject|3|||
150235009|NCT00853229|541998333|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
150235010|NCT00853229|541998334|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
150235011|NCT01777490|541998338|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
150235012|NCT01777490|541998339|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
150235013|NCT01777490|541998340|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
150235014|NCT01777490|541998341|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
150235015|NCT00832000|541998347|FG000|Overall Study|Adverse Event|2|||
150235016|NCT00832000|541998348|FG001|Overall Study|Adverse Event|0|||
150235017|NCT00832000|541998347|FG000|Overall Study|Withdrawal by Subject|1|||
150235018|NCT00832000|541998348|FG001|Overall Study|Withdrawal by Subject|0|||
150235019|NCT00832000|541998347|FG000|Overall Study|No calls to IVR in either period|1|||
150235020|NCT00832000|541998348|FG001|Overall Study|No calls to IVR in either period|1|||
150235021|NCT00832000|541998347|FG000|Overall Study|No calls to IVR in period 2|2|||
150235022|NCT00832000|541998348|FG001|Overall Study|No calls to IVR in period 2|0|||
150235023|NCT02725567|541998349|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
150235024|NCT02725567|541998350|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
150235025|NCT02725567|541998349|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
150235026|NCT02725567|541998350|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
150235027|NCT02725567|541998349|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
150235028|NCT02725567|541998350|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
150235029|NCT02777242|541998351|FG000|Overall Study|Other|2|||
150235030|NCT02777242|541998351|FG000|Overall Study|Lost to Follow-up|1|||
150235031|NCT02777242|541998351|FG000|Overall Study|Multiple|1|||
150235032|NCT02777242|541998351|FG000|Overall Study|Sponsor's request|1|||
150235033|NCT02777242|541998351|FG000|Overall Study|Withdrawal by Subject|1|||
150235034|NCT01129115|541998352|FG000|Overall Study|Adverse Event|1|||
150235035|NCT01129115|541998353|FG001|Overall Study|Adverse Event|2|||
150235036|NCT01129115|541998354|FG002|Overall Study|Adverse Event|3|||
150235037|NCT01129115|541998355|FG003|Overall Study|Adverse Event|3|||
150235038|NCT01129115|541998352|FG000|Overall Study|Withdrawal by Subject|1|||
150235039|NCT01129115|541998353|FG001|Overall Study|Withdrawal by Subject|3|||
150235040|NCT01129115|541998354|FG002|Overall Study|Withdrawal by Subject|1|||
150235041|NCT01129115|541998355|FG003|Overall Study|Withdrawal by Subject|4|||
150235042|NCT01129115|541998352|FG000|Overall Study|Protocol Violation|0|||
150235043|NCT01129115|541998353|FG001|Overall Study|Protocol Violation|2|||
150235044|NCT01129115|541998354|FG002|Overall Study|Protocol Violation|2|||
150235045|NCT01129115|541998355|FG003|Overall Study|Protocol Violation|2|||
150235046|NCT01747837|541998357|FG000|Overall Study|Lost to Follow-up|5|||
150235047|NCT01747837|541998358|FG001|Overall Study|Lost to Follow-up|2|||
150235048|NCT01747837|541998357|FG000|Overall Study|Death|4|||
150235049|NCT01747837|541998358|FG001|Overall Study|Death|4|||
150235050|NCT00817336|541998360|FG000|Overall Study|Withdrawal by Subject|1|||
150235051|NCT00817336|541998361|FG001|Overall Study|Withdrawal by Subject|1|||
150235052|NCT00511797|541998362|FG000|Overall Study|Adverse Event|1|||
150235053|NCT00511797|541998363|FG001|Overall Study|Adverse Event|2|||
150235054|NCT00511797|541998364|FG002|Overall Study|Adverse Event|2|||
150235055|NCT00511797|541998365|FG003|Overall Study|Adverse Event|2|||
150235056|NCT00511797|541998362|FG000|Overall Study|Lost to Follow-up|1|||
150235057|NCT00511797|541998363|FG001|Overall Study|Lost to Follow-up|0|||
150235058|NCT00511797|541998364|FG002|Overall Study|Lost to Follow-up|0|||
150235059|NCT00511797|541998365|FG003|Overall Study|Lost to Follow-up|1|||
150235060|NCT00511797|541998362|FG000|Overall Study|Pregnancy|0|||
150235061|NCT00511797|541998363|FG001|Overall Study|Pregnancy|0|||
150235062|NCT00511797|541998364|FG002|Overall Study|Pregnancy|0|||
150235063|NCT00511797|541998365|FG003|Overall Study|Pregnancy|1|||
150235064|NCT00511797|541998362|FG000|Overall Study|Protocol Violation|0|||
150235065|NCT00511797|541998363|FG001|Overall Study|Protocol Violation|2|||
150235066|NCT00511797|541998364|FG002|Overall Study|Protocol Violation|2|||
150235067|NCT00511797|541998365|FG003|Overall Study|Protocol Violation|3|||
150235068|NCT00511797|541998362|FG000|Overall Study|Withdrawal by Subject|3|||
150235069|NCT00511797|541998363|FG001|Overall Study|Withdrawal by Subject|3|||
150235070|NCT00511797|541998364|FG002|Overall Study|Withdrawal by Subject|4|||
150235071|NCT00511797|541998365|FG003|Overall Study|Withdrawal by Subject|2|||
150235072|NCT00511797|541998362|FG000|Overall Study|Never dispensed|1|||
150235073|NCT00511797|541998363|FG001|Overall Study|Never dispensed|0|||
150235074|NCT00511797|541998364|FG002|Overall Study|Never dispensed|1|||
150235075|NCT00511797|541998365|FG003|Overall Study|Never dispensed|3|||
150235076|NCT00511797|541998362|FG000|Overall Study|Study drug not taken|0|||
150235077|NCT00511797|541998363|FG001|Overall Study|Study drug not taken|1|||
150235078|NCT00511797|541998364|FG002|Overall Study|Study drug not taken|0|||
150235079|NCT00511797|541998365|FG003|Overall Study|Study drug not taken|1|||
150235080|NCT00511797|541998362|FG000|Overall Study|Partially missing diary|0|||
150235081|NCT00511797|541998363|FG001|Overall Study|Partially missing diary|0|||
150235082|NCT00511797|541998364|FG002|Overall Study|Partially missing diary|1|||
150235083|NCT00511797|541998365|FG003|Overall Study|Partially missing diary|0|||
150235084|NCT00511797|541998362|FG000|Overall Study|Other (moving etc)|1|||
150235085|NCT00511797|541998363|FG001|Overall Study|Other (moving etc)|0|||
150235086|NCT00511797|541998364|FG002|Overall Study|Other (moving etc)|1|||
150235087|NCT00511797|541998365|FG003|Overall Study|Other (moving etc)|2|||
150235088|NCT02019641|541998372|FG000|10-Week Follow up|Withdrawal by investigator|2|||
150235089|NCT02019641|541998373|FG001|10-Week Follow up|Withdrawal by investigator|0|||
150235090|NCT02019641|541998374|FG002|10-Week Follow up|Withdrawal by investigator|0|||
150235091|NCT02019641|541998372|FG000|10-Week Follow up|Withdrawal by Subject|1|||
150235092|NCT02019641|541998373|FG001|10-Week Follow up|Withdrawal by Subject|1|||
150235093|NCT02019641|541998374|FG002|10-Week Follow up|Withdrawal by Subject|0|||
150235094|NCT02019641|541998372|FG000|20-Week Follow up|Withdrawal by investigator|0|||
150235095|NCT02019641|541998373|FG001|20-Week Follow up|Withdrawal by investigator|0|||
150235096|NCT02019641|541998374|FG002|20-Week Follow up|Withdrawal by investigator|1|||
150235097|NCT01017263|541998375|FG000|Overall Study|not eligible|12|||
150235098|NCT02654132|541998378|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
150235099|NCT02654132|541998379|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
150235100|NCT02654132|541998378|FG000|Treatment Period|Disease progression|43|||
150235101|NCT02654132|541998379|FG001|Treatment Period|Disease progression|38|||
150235102|NCT02654132|541998378|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
150235103|NCT02654132|541998379|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
150235104|NCT02654132|541998378|FG000|Treatment Period|Other reasons|4|||
150235105|NCT02654132|541998379|FG001|Treatment Period|Other reasons|2|||
150235106|NCT02654132|541998378|FG000|Treatment Period|Study drug toxicity|2|||
150235107|NCT02654132|541998379|FG001|Treatment Period|Study drug toxicity|2|||
150235108|NCT02654132|541998378|FG000|Treatment Period|Withdrawal by Subject|2|||
150235109|NCT02654132|541998379|FG001|Treatment Period|Withdrawal by Subject|1|||
150235110|NCT02654132|541998378|FG000|Treatment Period|Maximum Clinical Benefit|0|||
150235111|NCT02654132|541998379|FG001|Treatment Period|Maximum Clinical Benefit|2|||
150235112|NCT02654132|541998378|FG000|Treatment Period|Participant request to discontinue|2|||
150235113|NCT02654132|541998379|FG001|Treatment Period|Participant request to discontinue|0|||
150235114|NCT02654132|541998378|FG000|Treatment Period|Administrative reasons by sponsor|0|||
150235115|NCT02654132|541998379|FG001|Treatment Period|Administrative reasons by sponsor|1|||
150235116|NCT02654132|541998378|FG000|Treatment Period|Death|1|||
150235117|NCT02654132|541998379|FG001|Treatment Period|Death|0|||
150235118|NCT01880437|541998382|FG000|Overall Study|Death|12|||
150235119|NCT01880437|541998383|FG001|Overall Study|Death|4|||
150235120|NCT01880437|541998384|FG002|Overall Study|Death|17|||
150235121|NCT01880437|541998382|FG000|Overall Study|Study terminated by Sponsor|3|||
150235122|NCT01880437|541998383|FG001|Overall Study|Study terminated by Sponsor|0|||
150235123|NCT01880437|541998384|FG002|Overall Study|Study terminated by Sponsor|2|||
150235124|NCT03713320|541998385|FG000|Randomized Period|Adverse Event|1|||
150235125|NCT03713320|541998386|FG001|Randomized Period|Adverse Event|5|||
150235126|NCT03713320|541998387|FG002|Randomized Period|Adverse Event|0|||
150235127|NCT03713320|541998385|FG000|Randomized Period|Physician Decision|1|||
150235128|NCT03713320|541998386|FG001|Randomized Period|Physician Decision|1|||
150235129|NCT03713320|541998387|FG002|Randomized Period|Physician Decision|0|||
150235130|NCT03713320|541998385|FG000|Randomized Period|Withdrawal by Subject|4|||
150235131|NCT03713320|541998386|FG001|Randomized Period|Withdrawal by Subject|0|||
150235132|NCT03713320|541998387|FG002|Randomized Period|Withdrawal by Subject|0|||
150235133|NCT03713320|541998385|FG000|Randomized Period|Participant decision|3|||
150235134|NCT03713320|541998386|FG001|Randomized Period|Participant decision|1|||
150235135|NCT03713320|541998387|FG002|Randomized Period|Participant decision|0|||
150235136|NCT03713320|541998385|FG000|Randomized Period|Study terminated by sponsor|6|||
150235137|NCT03713320|541998386|FG001|Randomized Period|Study terminated by sponsor|3|||
150235138|NCT03713320|541998387|FG002|Randomized Period|Study terminated by sponsor|0|||
150235139|NCT03713320|541998385|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
150235140|NCT03713320|541998386|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
150235141|NCT03713320|541998387|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
150235142|NCT03713320|541998385|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
150235143|NCT03713320|541998386|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
150235144|NCT03713320|541998387|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
150235145|NCT00909532|541998388|FG000|Overall Study|Adverse Event|4|||
150235146|NCT00909532|541998389|FG001|Overall Study|Adverse Event|1|||
150235147|NCT00909532|541998388|FG000|Overall Study|Pregnancy|0|||
150235148|NCT00909532|541998389|FG001|Overall Study|Pregnancy|1|||
150235149|NCT00909532|541998388|FG000|Overall Study|Prohibited Medication|2|||
150235150|NCT00909532|541998389|FG001|Overall Study|Prohibited Medication|1|||
150235151|NCT00909532|541998388|FG000|Overall Study|Withdrawal of Consent|1|||
150235152|NCT00909532|541998389|FG001|Overall Study|Withdrawal of Consent|1|||
150235153|NCT00909532|541998388|FG000|Overall Study|Noncompliance with Study Requirements|0|||
150235154|NCT00909532|541998389|FG001|Overall Study|Noncompliance with Study Requirements|2|||
150235155|NCT00909532|541998388|FG000|Overall Study|Physician Decision|1|||
150235156|NCT00909532|541998389|FG001|Overall Study|Physician Decision|0|||
150235157|NCT00909532|541998388|FG000|Overall Study|Wrong Genotype|1|||
150235158|NCT00909532|541998389|FG001|Overall Study|Wrong Genotype|0|||
150235159|NCT00909532|541998388|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
150235160|NCT00909532|541998389|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
150235161|NCT01209598|541998390|FG000|Overall Study|Withdrawal by Subject|1|||
150235162|NCT01209598|541998391|FG001|Overall Study|Withdrawal by Subject|0|||
150235163|NCT00085566|541998392|FG000|Overall Study|Adverse Event|0|||
150235164|NCT00085566|541998393|FG001|Overall Study|Adverse Event|0|||
150235165|NCT00085566|541998394|FG002|Overall Study|Adverse Event|10|||
150235166|NCT00085566|541998392|FG000|Overall Study|Patient Not treated|0|||
150235167|NCT00085566|541998393|FG001|Overall Study|Patient Not treated|0|||
150235168|NCT00085566|541998394|FG002|Overall Study|Patient Not treated|3|||
150235169|NCT00085566|541998392|FG000|Overall Study|Clinical progression|0|||
150235170|NCT00085566|541998393|FG001|Overall Study|Clinical progression|0|||
150235171|NCT00085566|541998394|FG002|Overall Study|Clinical progression|1|||
150235172|NCT03772613|541998396|FG000|Overall Study|Lost to Follow-up|0|||
150235173|NCT03772613|541998397|FG001|Overall Study|Lost to Follow-up|1|||
150235174|NCT03772613|541998398|FG002|Overall Study|Lost to Follow-up|1|||
150235175|NCT04594733|541998399|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
150235176|NCT04594733|541998400|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
150235177|NCT04594733|541998399|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
150235178|NCT04594733|541998400|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
150235179|NCT04594733|541998399|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
150235180|NCT04594733|541998400|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
150235181|NCT01251887|541998407|FG000|Overall Study|Scheduling conflict|1|||
150235182|NCT01251887|541998408|FG001|Overall Study|Scheduling conflict|2|||
150235183|NCT01251887|541998409|FG002|Overall Study|Scheduling conflict|2|||
150235184|NCT01251887|541998407|FG000|Overall Study|Physician Decision|0|||
150235185|NCT01251887|541998408|FG001|Overall Study|Physician Decision|1|||
150235186|NCT01251887|541998409|FG002|Overall Study|Physician Decision|0|||
150235187|NCT03049306|541998412|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
150235188|NCT03049306|541998413|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
150235189|NCT03151551|541998414|FG000|Open-Label Treatment Period|Adverse Event|0|||
150235190|NCT03151551|541998415|FG001|Open-Label Treatment Period|Adverse Event|2|||
150235191|NCT03151551|541998414|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
150235192|NCT03151551|541998415|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
150235193|NCT03151551|541998414|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
150235194|NCT03151551|541998415|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
150235195|NCT03151551|541998414|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
150235196|NCT03151551|541998415|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
150235197|NCT03151551|541998414|FG000|Open-Label Treatment Period|Physician Decision|3|||
150235198|NCT03151551|541998415|FG001|Open-Label Treatment Period|Physician Decision|0|||
150235199|NCT03151551|541998414|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
150235200|NCT03151551|541998415|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
150235201|NCT03151551|541998414|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
150235202|NCT03151551|541998415|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
150235203|NCT03151551|541998414|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
150235204|NCT03151551|541998415|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
150235205|NCT03151551|541998414|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
150235206|NCT03151551|541998415|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
150235207|NCT03151551|541998414|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
150235208|NCT03151551|541998415|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
150235209|NCT01639742|542000473|FG000|Overall Study|Study Ongoing|17|||
150235210|NCT01639742|542000473|FG000|Overall Study|Lost to Follow-up|1|||
150235211|NCT01266018|542000475|FG000|Overall Study|Physician Decision|1|||
150235212|NCT01266018|542000476|FG001|Overall Study|Physician Decision|0|||
150235213|NCT01266018|542000475|FG000|Overall Study|Progressive disease|0|||
150235214|NCT01266018|542000476|FG001|Overall Study|Progressive disease|1|||
150235215|NCT02370251|542000477|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
150235216|NCT02370251|542000477|FG000|Overall Study|Death|4|||
150235217|NCT04120376|542000478|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
150235218|NCT04120376|542000479|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
150235219|NCT02053610|542000480|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
150235220|NCT02053610|542000481|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
150235221|NCT02053610|542000480|FG000|Overall Study|Withdrew Consent|2|||
150235222|NCT02053610|542000481|FG001|Overall Study|Withdrew Consent|9|||
150235223|NCT02053610|542000480|FG000|Overall Study|Death|5|||
150235224|NCT02053610|542000481|FG001|Overall Study|Death|5|||
150235225|NCT02053610|542000480|FG000|Overall Study|Administrative/Other|1|||
150235226|NCT02053610|542000481|FG001|Overall Study|Administrative/Other|1|||
150235227|NCT02053610|542000480|FG000|Overall Study|Disease Progression|2|||
150235228|NCT02053610|542000481|FG001|Overall Study|Disease Progression|3|||
150235229|NCT02053610|542000480|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
150235230|NCT02053610|542000481|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
150235231|NCT02053610|542000480|FG000|Overall Study|Did not Receive Treatment|4|||
150235232|NCT02053610|542000481|FG001|Overall Study|Did not Receive Treatment|2|||
150235233|NCT02053610|542000480|FG000|Overall Study|Insufficient Therapeutic Response|1|||
150235234|NCT02053610|542000481|FG001|Overall Study|Insufficient Therapeutic Response|1|||
150235235|NCT02053610|542000480|FG000|Overall Study|Violation of Selection Criteria|1|||
150235236|NCT02053610|542000481|FG001|Overall Study|Violation of Selection Criteria|0|||
150235237|NCT00781937|542000483|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
150235238|NCT00781937|542000484|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
150235239|NCT00781937|542000483|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
150235240|NCT00781937|542000484|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
150235241|NCT00781937|542000483|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
150235242|NCT00781937|542000484|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
150235243|NCT00781937|542000483|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
150235244|NCT00781937|542000484|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
150235245|NCT00781937|542000483|FG000|Main Trial Period Through Week 56|Unclassified|10|||
150235246|NCT00781937|542000484|FG001|Main Trial Period Through Week 56|Unclassified|15|||
150235247|NCT00781937|542000483|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
150235248|NCT00781937|542000484|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
150235249|NCT00781937|542000483|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
150235250|NCT00781937|542000484|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
150235251|NCT02094898|542000490|FG000|Overall Study|Clinical Worsening|2|||
150235252|NCT02094898|542000490|FG000|Overall Study|Adverse Event|2|||
150235253|NCT02094898|542000490|FG000|Overall Study|Lack of Efficacy|1|||
150235254|NCT03305809|542000491|FG000|Overall Study|Adverse Event|2|||
150235255|NCT03305809|542000492|FG001|Overall Study|Adverse Event|2|||
150235256|NCT03305809|542000493|FG002|Overall Study|Adverse Event|6|||
150235257|NCT03305809|542000494|FG003|Overall Study|Adverse Event|6|||
150235258|NCT03305809|542000491|FG000|Overall Study|Death|0|||
150235259|NCT03305809|542000492|FG001|Overall Study|Death|0|||
150235260|NCT03305809|542000493|FG002|Overall Study|Death|1|||
150235261|NCT03305809|542000494|FG003|Overall Study|Death|1|||
150235262|NCT03305809|542000491|FG000|Overall Study|Lost to Follow-up|1|||
150235263|NCT03305809|542000492|FG001|Overall Study|Lost to Follow-up|2|||
150235264|NCT03305809|542000493|FG002|Overall Study|Lost to Follow-up|0|||
150235265|NCT03305809|542000494|FG003|Overall Study|Lost to Follow-up|0|||
150235266|NCT03305809|542000491|FG000|Overall Study|Sponsor Decision|1|||
150235267|NCT03305809|542000492|FG001|Overall Study|Sponsor Decision|0|||
150235268|NCT03305809|542000493|FG002|Overall Study|Sponsor Decision|1|||
150235269|NCT03305809|542000494|FG003|Overall Study|Sponsor Decision|8|||
150235270|NCT03305809|542000491|FG000|Overall Study|Physician Decision|0|||
150235271|NCT03305809|542000492|FG001|Overall Study|Physician Decision|0|||
150235272|NCT03305809|542000493|FG002|Overall Study|Physician Decision|2|||
150235273|NCT03305809|542000494|FG003|Overall Study|Physician Decision|4|||
150235274|NCT03305809|542000491|FG000|Overall Study|Progressive Disease|0|||
150235275|NCT03305809|542000492|FG001|Overall Study|Progressive Disease|0|||
150235276|NCT03305809|542000493|FG002|Overall Study|Progressive Disease|1|||
150235277|NCT03305809|542000494|FG003|Overall Study|Progressive Disease|0|||
150235278|NCT03305809|542000491|FG000|Overall Study|Protocol Violation|1|||
150235279|NCT03305809|542000492|FG001|Overall Study|Protocol Violation|0|||
150235280|NCT03305809|542000493|FG002|Overall Study|Protocol Violation|2|||
150235281|NCT03305809|542000494|FG003|Overall Study|Protocol Violation|3|||
150235282|NCT03305809|542000491|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
150235283|NCT03305809|542000492|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
150235284|NCT03305809|542000493|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
150235285|NCT03305809|542000494|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
150235286|NCT03305809|542000491|FG000|Overall Study|Withdrawal by Subject|2|||
150235287|NCT03305809|542000492|FG001|Overall Study|Withdrawal by Subject|4|||
150235288|NCT03305809|542000493|FG002|Overall Study|Withdrawal by Subject|5|||
150235289|NCT03305809|542000494|FG003|Overall Study|Withdrawal by Subject|2|||
150235290|NCT03305809|542000491|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
150235291|NCT03305809|542000492|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
150235292|NCT03305809|542000493|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
150235293|NCT03305809|542000494|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
150235294|NCT04014790|542000495|FG000|Overall Study|Death|4|||
150235295|NCT04014790|542000495|FG000|Overall Study|Adverse Event|1|||
150235296|NCT04014790|542000495|FG000|Overall Study|Withdrawal by Subject|1|||
150235297|NCT00816556|542000496|FG000|Overall Study|Adverse Event|1|||
150235298|NCT00816556|542000497|FG001|Overall Study|Adverse Event|1|||
150235299|NCT00816556|542000498|FG002|Overall Study|Adverse Event|1|||
150235300|NCT00816556|542000496|FG000|Overall Study|Withdrawal by Subject|1|||
150235301|NCT00816556|542000497|FG001|Overall Study|Withdrawal by Subject|1|||
150235302|NCT00816556|542000498|FG002|Overall Study|Withdrawal by Subject|1|||
150235303|NCT00816556|542000496|FG000|Overall Study|Lost to Follow-up|0|||
150235304|NCT00816556|542000497|FG001|Overall Study|Lost to Follow-up|0|||
150235305|NCT00816556|542000498|FG002|Overall Study|Lost to Follow-up|1|||
150235306|NCT03065933|542000499|FG000|Overall Study|study terminated|5|||
150235307|NCT02330562|542000503|FG000|Overall Study|Adverse Event|0|||
150142104|NCT05044325|541655943|FG003|Part A:Treatment Period 2|Physician Decision|0|||
150142105|NCT05044325|541655944|FG004|Part A:Treatment Period 2|Physician Decision|0|||
150142106|NCT05044325|541655945|FG005|Part A:Treatment Period 2|Physician Decision|1|||
150142107|NCT05044325|541655946|FG006|Part A:Treatment Period 2|Physician Decision|0|||
150142108|NCT05044325|541655947|FG007|Part A:Treatment Period 2|Physician Decision|0|||
150142109|NCT05044325|541655948|FG008|Part A:Treatment Period 2|Physician Decision|0|||
150142110|NCT05044325|541655949|FG009|Part A:Treatment Period 2|Physician Decision|0|||
150142111|NCT05044325|541655940|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142112|NCT05044325|541655941|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142113|NCT05044325|541655942|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142114|NCT05044325|541655943|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
150142115|NCT05044325|541655944|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
150142116|NCT05044325|541655945|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142117|NCT05044325|541655946|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142118|NCT05044325|541655947|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142119|NCT05044325|541655948|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142120|NCT05044325|541655949|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
150142121|NCT03145766|541655961|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
150142122|NCT03145766|541655962|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
150142123|NCT03145766|541655963|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
150142124|NCT03145766|541655964|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
150142125|NCT03145766|541655965|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
150142126|NCT03145766|541655961|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
150142127|NCT03145766|541655962|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
150142128|NCT03145766|541655963|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
150142129|NCT03145766|541655964|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
150142130|NCT03145766|541655965|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
150142131|NCT03145766|541655961|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
150142132|NCT03145766|541655962|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
150142133|NCT03145766|541655963|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
150142134|NCT03145766|541655964|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
150142135|NCT03145766|541655965|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
150142136|NCT03145766|541655961|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
150142137|NCT03145766|541655962|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
150142138|NCT03145766|541655963|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
150142139|NCT03145766|541655964|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
150142140|NCT03145766|541655965|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
150142141|NCT03145766|541655961|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
150142142|NCT03145766|541655962|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
150142143|NCT03145766|541655963|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
150142144|NCT03145766|541655964|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
150142145|NCT03145766|541655965|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
150142146|NCT03145766|541655961|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
150142147|NCT03145766|541655962|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
150142148|NCT03145766|541655963|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
150142149|NCT03145766|541655964|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
150142150|NCT03145766|541655965|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
150142151|NCT03145766|541655961|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
150142152|NCT03145766|541655962|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
150142153|NCT03145766|541655963|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
150142154|NCT03145766|541655964|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
150142155|NCT03145766|541655965|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
150142156|NCT02799472|541655967|FG000|Overall Study|Withdrawal by Subject|2|||
150235308|NCT02330562|542000504|FG001|Overall Study|Adverse Event|0|||
150235309|NCT02330562|542000505|FG002|Overall Study|Adverse Event|3|||
150235310|NCT02330562|542000506|FG003|Overall Study|Adverse Event|0|||
150235311|NCT02330562|542000507|FG004|Overall Study|Adverse Event|3|||
150235312|NCT02330562|542000508|FG005|Overall Study|Adverse Event|1|||
150235313|NCT02330562|542000509|FG006|Overall Study|Adverse Event|0|||
150235314|NCT02330562|542000510|FG007|Overall Study|Adverse Event|0|||
150235315|NCT02330562|542000511|FG008|Overall Study|Adverse Event|0|||
150235316|NCT02330562|542000512|FG009|Overall Study|Adverse Event|1|||
150235317|NCT02330562|542000513|FG010|Overall Study|Adverse Event|1|||
150235318|NCT02330562|542000503|FG000|Overall Study|Participant decision|1|||
150235319|NCT02330562|542000504|FG001|Overall Study|Participant decision|0|||
150235320|NCT02330562|542000505|FG002|Overall Study|Participant decision|4|||
150235321|NCT02330562|542000506|FG003|Overall Study|Participant decision|1|||
150235322|NCT02330562|542000507|FG004|Overall Study|Participant decision|5|||
150235323|NCT02330562|542000508|FG005|Overall Study|Participant decision|2|||
150235324|NCT02330562|542000509|FG006|Overall Study|Participant decision|0|||
150235325|NCT02330562|542000510|FG007|Overall Study|Participant decision|0|||
150235326|NCT02330562|542000511|FG008|Overall Study|Participant decision|0|||
150235327|NCT02330562|542000512|FG009|Overall Study|Participant decision|3|||
150235328|NCT02330562|542000513|FG010|Overall Study|Participant decision|0|||
150235329|NCT02330562|542000503|FG000|Overall Study|Disease progression|5|||
150235330|NCT02330562|542000504|FG001|Overall Study|Disease progression|3|||
150235331|NCT02330562|542000505|FG002|Overall Study|Disease progression|20|||
150235332|NCT02330562|542000506|FG003|Overall Study|Disease progression|28|||
150235333|NCT02330562|542000507|FG004|Overall Study|Disease progression|23|||
150235334|NCT02330562|542000508|FG005|Overall Study|Disease progression|7|||
150235335|NCT02330562|542000509|FG006|Overall Study|Disease progression|1|||
150235336|NCT02330562|542000510|FG007|Overall Study|Disease progression|1|||
150235337|NCT02330562|542000511|FG008|Overall Study|Disease progression|1|||
150235338|NCT02330562|542000512|FG009|Overall Study|Disease progression|0|||
150235339|NCT02330562|542000513|FG010|Overall Study|Disease progression|5|||
150235340|NCT02330562|542000503|FG000|Overall Study|Other reasons|0|||
150235341|NCT02330562|542000504|FG001|Overall Study|Other reasons|0|||
150235342|NCT02330562|542000505|FG002|Overall Study|Other reasons|0|||
150235343|NCT02330562|542000506|FG003|Overall Study|Other reasons|1|||
150235344|NCT02330562|542000507|FG004|Overall Study|Other reasons|0|||
150235345|NCT02330562|542000508|FG005|Overall Study|Other reasons|0|||
150235346|NCT02330562|542000509|FG006|Overall Study|Other reasons|0|||
150235347|NCT02330562|542000510|FG007|Overall Study|Other reasons|0|||
150235348|NCT02330562|542000511|FG008|Overall Study|Other reasons|0|||
150235349|NCT02330562|542000512|FG009|Overall Study|Other reasons|0|||
150235350|NCT02330562|542000513|FG010|Overall Study|Other reasons|0|||
150235351|NCT02330562|542000503|FG000|Overall Study|Withdrawal by Subject|0|||
150235352|NCT02330562|542000504|FG001|Overall Study|Withdrawal by Subject|0|||
150235353|NCT02330562|542000505|FG002|Overall Study|Withdrawal by Subject|0|||
150235354|NCT02330562|542000506|FG003|Overall Study|Withdrawal by Subject|0|||
150235355|NCT02330562|542000507|FG004|Overall Study|Withdrawal by Subject|0|||
150235356|NCT02330562|542000508|FG005|Overall Study|Withdrawal by Subject|0|||
150235357|NCT02330562|542000509|FG006|Overall Study|Withdrawal by Subject|0|||
150235358|NCT02330562|542000510|FG007|Overall Study|Withdrawal by Subject|0|||
150235359|NCT02330562|542000511|FG008|Overall Study|Withdrawal by Subject|0|||
150235360|NCT02330562|542000512|FG009|Overall Study|Withdrawal by Subject|1|||
150235361|NCT02330562|542000513|FG010|Overall Study|Withdrawal by Subject|0|||
150235362|NCT01496365|542000520|FG000|Overall Study|Adverse Event|2|||
150235363|NCT01496365|542000521|FG001|Overall Study|Adverse Event|3|||
150235364|NCT01496365|542000522|FG002|Overall Study|Adverse Event|3|||
150235365|NCT01496365|542000523|FG003|Overall Study|Adverse Event|2|||
150235366|NCT01496365|542000524|FG004|Overall Study|Adverse Event|5|||
150235367|NCT01496365|542000525|FG005|Overall Study|Adverse Event|6|||
150235368|NCT01496365|542000526|FG006|Overall Study|Adverse Event|4|||
150235369|NCT01496365|542000520|FG000|Overall Study|Withdrawal by Subject|6|||
150235370|NCT01496365|542000521|FG001|Overall Study|Withdrawal by Subject|6|||
150235371|NCT01496365|542000522|FG002|Overall Study|Withdrawal by Subject|0|||
150235372|NCT01496365|542000523|FG003|Overall Study|Withdrawal by Subject|1|||
150235373|NCT01496365|542000524|FG004|Overall Study|Withdrawal by Subject|3|||
150235374|NCT01496365|542000525|FG005|Overall Study|Withdrawal by Subject|2|||
150235375|NCT01496365|542000526|FG006|Overall Study|Withdrawal by Subject|1|||
150235376|NCT01496365|542000520|FG000|Overall Study|Protocol Violation|2|||
150235377|NCT01496365|542000521|FG001|Overall Study|Protocol Violation|1|||
150235378|NCT01496365|542000522|FG002|Overall Study|Protocol Violation|1|||
150235379|NCT01496365|542000523|FG003|Overall Study|Protocol Violation|0|||
150235380|NCT01496365|542000524|FG004|Overall Study|Protocol Violation|0|||
150235381|NCT01496365|542000525|FG005|Overall Study|Protocol Violation|1|||
150235382|NCT01496365|542000526|FG006|Overall Study|Protocol Violation|0|||
150235383|NCT01496365|542000520|FG000|Overall Study|Lack of Efficacy|1|||
150235384|NCT01496365|542000521|FG001|Overall Study|Lack of Efficacy|0|||
150235385|NCT01496365|542000522|FG002|Overall Study|Lack of Efficacy|0|||
150235386|NCT01496365|542000523|FG003|Overall Study|Lack of Efficacy|0|||
150235387|NCT01496365|542000524|FG004|Overall Study|Lack of Efficacy|0|||
150235388|NCT01496365|542000525|FG005|Overall Study|Lack of Efficacy|1|||
150235389|NCT01496365|542000526|FG006|Overall Study|Lack of Efficacy|0|||
150235390|NCT01496365|542000520|FG000|Overall Study|Lost to Follow-up|0|||
150235391|NCT01496365|542000521|FG001|Overall Study|Lost to Follow-up|1|||
150235392|NCT01496365|542000522|FG002|Overall Study|Lost to Follow-up|0|||
150235393|NCT01496365|542000523|FG003|Overall Study|Lost to Follow-up|0|||
150235394|NCT01496365|542000524|FG004|Overall Study|Lost to Follow-up|2|||
150235395|NCT01496365|542000525|FG005|Overall Study|Lost to Follow-up|0|||
150235396|NCT01496365|542000526|FG006|Overall Study|Lost to Follow-up|0|||
150235397|NCT01496365|542000520|FG000|Overall Study|Other|4|||
150235398|NCT01496365|542000521|FG001|Overall Study|Other|4|||
150235399|NCT01496365|542000522|FG002|Overall Study|Other|2|||
150235400|NCT01496365|542000523|FG003|Overall Study|Other|1|||
150235401|NCT01496365|542000524|FG004|Overall Study|Other|3|||
150235402|NCT01496365|542000525|FG005|Overall Study|Other|0|||
150235403|NCT01496365|542000526|FG006|Overall Study|Other|1|||
150235404|NCT01015677|542000527|FG000|Overall Study|Adverse Event|0|||
150235405|NCT01015677|542000528|FG001|Overall Study|Adverse Event|1|||
150235406|NCT01015677|542000529|FG002|Overall Study|Adverse Event|0|||
150235407|NCT01015677|542000527|FG000|Overall Study|Lack of Efficacy|0|||
150235408|NCT01015677|542000528|FG001|Overall Study|Lack of Efficacy|1|||
150235409|NCT01015677|542000529|FG002|Overall Study|Lack of Efficacy|0|||
150235410|NCT01015677|542000527|FG000|Overall Study|Protocol Violation|0|||
150235411|NCT01015677|542000528|FG001|Overall Study|Protocol Violation|1|||
150235412|NCT01015677|542000529|FG002|Overall Study|Protocol Violation|0|||
150235413|NCT01015677|542000527|FG000|Overall Study|Withdrawal by Subject|1|||
150235414|NCT01015677|542000528|FG001|Overall Study|Withdrawal by Subject|1|||
150235415|NCT01015677|542000529|FG002|Overall Study|Withdrawal by Subject|0|||
150235416|NCT01646385|542000530|FG000|Overall Study|Death|202|||
150235417|NCT01646385|542000531|FG001|Overall Study|Death|222|||
150235418|NCT01646385|542000530|FG000|Overall Study|Switched to alternate biologic|636|||
150235419|NCT01646385|542000531|FG001|Overall Study|Switched to alternate biologic|649|||
150235420|NCT02706951|542000532|FG000|Period 1|Adverse Event|1|||
150235421|NCT02706951|542000533|FG001|Period 1|Adverse Event|5|||
150235422|NCT02706951|542000534|FG002|Period 1|Adverse Event|3|||
150235423|NCT02706951|542000535|FG003|Period 1|Adverse Event|0|||
150235424|NCT02706951|542000536|FG004|Period 1|Adverse Event|0|||
150235425|NCT02706951|542000532|FG000|Period 1|Withdrawal by Subject|10|||
150235426|NCT02706951|542000533|FG001|Period 1|Withdrawal by Subject|6|||
150235427|NCT02706951|542000534|FG002|Period 1|Withdrawal by Subject|6|||
150235428|NCT02706951|542000535|FG003|Period 1|Withdrawal by Subject|0|||
150235429|NCT02706951|542000536|FG004|Period 1|Withdrawal by Subject|0|||
150235430|NCT02706951|542000532|FG000|Period 1|Lost to Follow-up|0|||
150235431|NCT02706951|542000533|FG001|Period 1|Lost to Follow-up|4|||
150235432|NCT02706951|542000534|FG002|Period 1|Lost to Follow-up|1|||
150235433|NCT02706951|542000535|FG003|Period 1|Lost to Follow-up|0|||
150235434|NCT02706951|542000536|FG004|Period 1|Lost to Follow-up|0|||
150235435|NCT02706951|542000532|FG000|Period 1|Other|2|||
150235436|NCT02706951|542000533|FG001|Period 1|Other|1|||
150235437|NCT02706951|542000534|FG002|Period 1|Other|0|||
150235438|NCT02706951|542000535|FG003|Period 1|Other|0|||
150235439|NCT02706951|542000536|FG004|Period 1|Other|0|||
150235440|NCT02706951|542000532|FG000|Period 2|Adverse Event|0|||
150235441|NCT02706951|542000533|FG001|Period 2|Adverse Event|0|||
150235442|NCT02706951|542000534|FG002|Period 2|Adverse Event|0|||
150235443|NCT02706951|542000535|FG003|Period 2|Adverse Event|25|||
150235444|NCT02706951|542000536|FG004|Period 2|Adverse Event|34|||
150235445|NCT02706951|542000532|FG000|Period 2|Withdrawal by Subject|0|||
150235446|NCT02706951|542000533|FG001|Period 2|Withdrawal by Subject|0|||
150235447|NCT02706951|542000534|FG002|Period 2|Withdrawal by Subject|0|||
150235448|NCT02706951|542000535|FG003|Period 2|Withdrawal by Subject|38|||
150235449|NCT02706951|542000536|FG004|Period 2|Withdrawal by Subject|44|||
150235450|NCT02706951|542000532|FG000|Period 2|Lost to Follow-up|0|||
150235451|NCT02706951|542000533|FG001|Period 2|Lost to Follow-up|0|||
150235452|NCT02706951|542000534|FG002|Period 2|Lost to Follow-up|0|||
150235453|NCT02706951|542000535|FG003|Period 2|Lost to Follow-up|17|||
150235454|NCT02706951|542000536|FG004|Period 2|Lost to Follow-up|9|||
150235455|NCT02706951|542000532|FG000|Period 2|COVID-19 Related|0|||
150235456|NCT02706951|542000533|FG001|Period 2|COVID-19 Related|0|||
150235457|NCT02706951|542000534|FG002|Period 2|COVID-19 Related|0|||
150235458|NCT02706951|542000535|FG003|Period 2|COVID-19 Related|1|||
150235459|NCT02706951|542000536|FG004|Period 2|COVID-19 Related|2|||
150235460|NCT02706951|542000532|FG000|Period 2|Other|0|||
150235461|NCT02706951|542000533|FG001|Period 2|Other|0|||
150235462|NCT02706951|542000534|FG002|Period 2|Other|0|||
150235463|NCT02706951|542000535|FG003|Period 2|Other|37|||
150235464|NCT02706951|542000536|FG004|Period 2|Other|31|||
150235465|NCT04294667|542000539|FG000|Overall Study|Lack of Efficacy|4|||
150235466|NCT04294667|542000540|FG001|Overall Study|Lack of Efficacy|4|||
150235467|NCT04294667|542000539|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
150235468|NCT04294667|542000540|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
150235469|NCT04294667|542000539|FG000|Overall Study|Patient has a Renal Flare|1|||
150235470|NCT04294667|542000540|FG001|Overall Study|Patient has a Renal Flare|0|||
150235471|NCT04294667|542000539|FG000|Overall Study|SLE Worsening|0|||
150235472|NCT04294667|542000540|FG001|Overall Study|SLE Worsening|1|||
150235473|NCT04294667|542000539|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
150235474|NCT04294667|542000540|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
150235475|NCT04294667|542000539|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
150235476|NCT04294667|542000540|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
150235477|NCT04294667|542000539|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
150235478|NCT04294667|542000540|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
150235479|NCT04294667|542000539|FG000|Overall Study|Subject Moved to Another State|0|||
150235480|NCT04294667|542000540|FG001|Overall Study|Subject Moved to Another State|1|||
150235481|NCT04294667|542000539|FG000|Overall Study|Adverse event, serious fatal|0|||
150235482|NCT04294667|542000540|FG001|Overall Study|Adverse event, serious fatal|1|||
150235483|NCT04294667|542000539|FG000|Overall Study|Adverse event, non-fatal|3|||
150235484|NCT04294667|542000540|FG001|Overall Study|Adverse event, non-fatal|4|||
150235485|NCT01841697|542000541|FG000|Overall Study|Death|0|||
150235486|NCT01841697|542000542|FG001|Overall Study|Death|1|||
150235487|NCT01841697|542000541|FG000|Overall Study|Lost to Follow-up|4|||
150235488|NCT01841697|542000542|FG001|Overall Study|Lost to Follow-up|1|||
150235489|NCT01841697|542000541|FG000|Overall Study|Withdrawal by Subject|16|||
150235490|NCT01841697|542000542|FG001|Overall Study|Withdrawal by Subject|16|||
150235491|NCT00233389|542000545|FG000|Overall Study|Adverse Event|5|||
150235492|NCT00233389|542000546|FG001|Overall Study|Adverse Event|5|||
150235493|NCT00233389|542000545|FG000|Overall Study|Lack of Efficacy|11|||
150235494|NCT00233389|542000546|FG001|Overall Study|Lack of Efficacy|8|||
150235495|NCT00233389|542000545|FG000|Overall Study|Lost to Follow-up|1|||
150235496|NCT00233389|542000546|FG001|Overall Study|Lost to Follow-up|1|||
150235497|NCT00233389|542000545|FG000|Overall Study|Physician Decision|1|||
150235498|NCT00233389|542000546|FG001|Overall Study|Physician Decision|0|||
150235499|NCT00233389|542000545|FG000|Overall Study|Protocol Violation|0|||
150235500|NCT00233389|542000546|FG001|Overall Study|Protocol Violation|1|||
150235501|NCT00233389|542000545|FG000|Overall Study|Withdrawal by Subject|0|||
150235502|NCT00233389|542000546|FG001|Overall Study|Withdrawal by Subject|1|||
150235503|NCT04962698|542000547|FG000|Motor Imagery|Technical difficulty|1|||
150235504|NCT04962698|542000548|FG001|Motor Imagery|Technical difficulty|0|||
150235505|NCT04962698|542000547|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
150235506|NCT04962698|542000548|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
150235507|NCT04962698|542000547|FG000|Kinesthetic MI|Technical difficulty|1|||
150235508|NCT04962698|542000548|FG001|Kinesthetic MI|Technical difficulty|0|||
150235509|NCT04962698|542000547|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
150235510|NCT04962698|542000548|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
150235511|NCT04962698|542000547|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
150235512|NCT04962698|542000548|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
150235513|NCT04962698|542000547|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
150235514|NCT04962698|542000548|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
150235515|NCT04962698|542000547|FG000|Virtual-hand Interaction|Technical difficulty|1|||
150235516|NCT04962698|542000548|FG001|Virtual-hand Interaction|Technical difficulty|0|||
150235517|NCT04962698|542000547|FG000|Robotic Action Observation|Technical difficulty|1|||
150235518|NCT04962698|542000548|FG001|Robotic Action Observation|Technical difficulty|0|||
150235519|NCT04962698|542000547|FG000|Rest|Technical difficulty|1|||
150235520|NCT04962698|542000548|FG001|Rest|Technical difficulty|0|||
150235521|NCT04962698|542000547|FG000|Rest|Exclusion criteria met after enrollment|0|||
150235522|NCT04962698|542000548|FG001|Rest|Exclusion criteria met after enrollment|2|||
150235523|NCT02312206|542000549|FG000|Overall Study|Adverse Event|3|||
150235524|NCT02312206|542000550|FG001|Overall Study|Adverse Event|6|||
150235525|NCT02312206|542000549|FG000|Overall Study|Withdrawal by Subject|6|||
150235526|NCT02312206|542000550|FG001|Overall Study|Withdrawal by Subject|6|||
150235527|NCT02312206|542000549|FG000|Overall Study|Physician Decision|7|||
150235528|NCT02312206|542000550|FG001|Overall Study|Physician Decision|6|||
150235529|NCT02312206|542000549|FG000|Overall Study|Death|31|||
150235530|NCT02312206|542000550|FG001|Overall Study|Death|36|||
150235531|NCT02312206|542000549|FG000|Overall Study|Study Terminated by Sponsor|81|||
150235532|NCT02312206|542000550|FG001|Overall Study|Study Terminated by Sponsor|74|||
150235533|NCT02312206|542000549|FG000|Overall Study|Patient transferred to hospice|0|||
150235534|NCT02312206|542000550|FG001|Overall Study|Patient transferred to hospice|1|||
150235535|NCT02312206|542000549|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
150235536|NCT02312206|542000550|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
150235537|NCT02312206|542000549|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
150235538|NCT02312206|542000550|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
150235539|NCT02312206|542000549|FG000|Overall Study|Disease Progression|1|||
150235540|NCT02312206|542000550|FG001|Overall Study|Disease Progression|0|||
150235541|NCT00585975|542000551|FG000|Overall Study|Withdrawal by Subject|3|||
150235542|NCT00585975|542000552|FG001|Overall Study|Withdrawal by Subject|3|||
150235543|NCT00585975|542000551|FG000|Overall Study|Lost to Follow-up|2|||
150235544|NCT00585975|542000552|FG001|Overall Study|Lost to Follow-up|1|||
150235545|NCT00585975|542000551|FG000|Overall Study|Enrollment met/over-enrolled|10|||
150235546|NCT00585975|542000552|FG001|Overall Study|Enrollment met/over-enrolled|9|||
150235547|NCT03082612|542000555|FG000|Overall Study|Lost to Follow-up|2|||
150235548|NCT03082612|542000556|FG001|Overall Study|Lost to Follow-up|0|||
150235549|NCT01006616|542000557|FG000|Period 1 (6 Months)|Adverse Event|10|||
150235550|NCT01006616|542000558|FG001|Period 1 (6 Months)|Adverse Event|31|||
150235551|NCT01006616|542000559|FG002|Period 1 (6 Months)|Adverse Event|37|||
150235552|NCT01006616|542000560|FG003|Period 1 (6 Months)|Adverse Event|9|||
150235553|NCT01006616|542000557|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
150235554|NCT01006616|542000558|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
150235555|NCT01006616|542000559|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
150235556|NCT01006616|542000560|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
150235557|NCT01006616|542000557|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
150235558|NCT01006616|542000558|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
150235559|NCT01006616|542000559|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
150235560|NCT01006616|542000560|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
150235561|NCT01006616|542000557|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
150235562|NCT01006616|542000558|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
150235563|NCT01006616|542000559|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
150235564|NCT01006616|542000560|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
150235565|NCT01006616|542000557|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
150235566|NCT01006616|542000558|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
150235567|NCT01006616|542000559|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
150235568|NCT01006616|542000560|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
150235569|NCT01006616|542000557|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
150235570|NCT01006616|542000558|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
150235571|NCT01006616|542000559|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
150235572|NCT01006616|542000560|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
150235573|NCT01006616|542000557|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
150235574|NCT01006616|542000558|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
150235575|NCT01006616|542000559|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
150235576|NCT01006616|542000560|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
150235577|NCT01006616|542000557|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
150235578|NCT01006616|542000558|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
150235579|NCT01006616|542000559|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
150235580|NCT01006616|542000560|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
150235581|NCT01006616|542000557|FG000|Period 1 (6 Months)|Not Treated|0|||
150235582|NCT01006616|542000558|FG001|Period 1 (6 Months)|Not Treated|0|||
150235583|NCT01006616|542000559|FG002|Period 1 (6 Months)|Not Treated|1|||
150235584|NCT01006616|542000560|FG003|Period 1 (6 Months)|Not Treated|1|||
150235585|NCT01006616|542000557|FG000|Period 2 (18 Months)|Adverse Event|6|||
150235586|NCT01006616|542000558|FG001|Period 2 (18 Months)|Adverse Event|6|||
150235587|NCT01006616|542000559|FG002|Period 2 (18 Months)|Adverse Event|6|||
150235588|NCT01006616|542000560|FG003|Period 2 (18 Months)|Adverse Event|4|||
150235589|NCT01006616|542000557|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
150235590|NCT01006616|542000558|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
150235591|NCT01006616|542000559|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
150235592|NCT01006616|542000560|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
150235593|NCT01006616|542000557|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
150235594|NCT01006616|542000558|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
150235595|NCT01006616|542000559|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
150235596|NCT01006616|542000560|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
150235597|NCT01006616|542000557|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
150235598|NCT01006616|542000558|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
150235599|NCT01006616|542000559|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
150235600|NCT01006616|542000560|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
150235601|NCT01006616|542000557|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
150235602|NCT01006616|542000558|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
150235603|NCT01006616|542000559|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
150235604|NCT01006616|542000560|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
150235605|NCT01006616|542000557|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
150235606|NCT01006616|542000558|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
150235607|NCT01006616|542000559|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
150235608|NCT01006616|542000560|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
150235609|NCT01006616|542000557|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
150235610|NCT01006616|542000558|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
150235611|NCT01006616|542000559|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
150235612|NCT01006616|542000560|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
150235613|NCT01006616|542000557|FG000|Period 2 (18 Months)|Study Terminated|63|||
150235614|NCT01006616|542000558|FG001|Period 2 (18 Months)|Study Terminated|46|||
150235615|NCT01006616|542000559|FG002|Period 2 (18 Months)|Study Terminated|44|||
150235616|NCT01006616|542000560|FG003|Period 2 (18 Months)|Study Terminated|70|||
150235617|NCT00992992|542000567|FG000|Overall Study|Lost to Follow-up|3|||
150235618|NCT00992992|542000567|FG000|Overall Study|Death|16|||
150235619|NCT00992992|542000567|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
150235620|NCT00992992|542000567|FG000|Overall Study|Sponsor Closed the Study|4|||
150235621|NCT00952848|542000568|FG000|Overall Study|Withdrawal by Subject|4|||
150235622|NCT00217022|542000569|FG000|Overall Study|Withdrawal by Subject|1|||
150235623|NCT00217022|542000570|FG001|Overall Study|Withdrawal by Subject|1|||
150235624|NCT00458393|542000571|FG000|Overall Study|Withdrawal by Subject|67|||
150235625|NCT00458393|542000572|FG001|Overall Study|Withdrawal by Subject|80|||
150235626|NCT00458393|542000571|FG000|Overall Study|Physician Decision|31|||
150235627|NCT00458393|542000572|FG001|Overall Study|Physician Decision|22|||
150235628|NCT00458393|542000571|FG000|Overall Study|Relocated|77|||
150235629|NCT00458393|542000572|FG001|Overall Study|Relocated|81|||
150235630|NCT00458393|542000571|FG000|Overall Study|Lost to Follow-up|115|||
150235631|NCT00458393|542000572|FG001|Overall Study|Lost to Follow-up|92|||
150235632|NCT00458393|542000571|FG000|Overall Study|Sites marked other on the form.|19|||
150235633|NCT00458393|542000572|FG001|Overall Study|Sites marked other on the form.|20|||
150235634|NCT05178979|542000574|FG000|Overall Study|Death|0|||
150235635|NCT05178979|542000575|FG001|Overall Study|Death|5|||
150235636|NCT05178979|542000576|FG002|Overall Study|Death|0|||
150235637|NCT05178979|542000577|FG003|Overall Study|Death|3|||
150235638|NCT05178979|542000574|FG000|Overall Study|Adverse Event|0|||
150235639|NCT05178979|542000575|FG001|Overall Study|Adverse Event|1|||
150235640|NCT05178979|542000576|FG002|Overall Study|Adverse Event|0|||
150235641|NCT05178979|542000577|FG003|Overall Study|Adverse Event|0|||
150235642|NCT05178979|542000574|FG000|Overall Study|Lost to Follow-up|1|||
150235643|NCT05178979|542000575|FG001|Overall Study|Lost to Follow-up|8|||
150235644|NCT05178979|542000576|FG002|Overall Study|Lost to Follow-up|3|||
150235645|NCT05178979|542000577|FG003|Overall Study|Lost to Follow-up|8|||
150235646|NCT02299427|542000578|FG000|Overall Study|Withdrawal by Subject|1|||
150235647|NCT02299427|542000579|FG001|Overall Study|Withdrawal by Subject|0|||
150235648|NCT02299427|542000578|FG000|Overall Study|Lost to Follow-up|1|||
150235649|NCT02299427|542000579|FG001|Overall Study|Lost to Follow-up|3|||
150235650|NCT02299427|542000578|FG000|Overall Study|not adherent to dog website use|21|||
150235651|NCT02299427|542000579|FG001|Overall Study|not adherent to dog website use|0|||
150235652|NCT03845075|542000585|FG000|Part 1 - DB|Withdrawal by Subject|1|||
150235653|NCT03845075|542000586|FG001|Part 1 - DB|Withdrawal by Subject|1|||
150235654|NCT03845075|542000587|FG002|Part 1 - DB|Withdrawal by Subject|0|||
150235655|NCT03845075|542000588|FG003|Part 1 - DB|Withdrawal by Subject|0|||
150235656|NCT03845075|542000585|FG000|Part 1 - DB|Adverse Event|0|||
150235657|NCT03845075|542000586|FG001|Part 1 - DB|Adverse Event|1|||
150235658|NCT03845075|542000587|FG002|Part 1 - DB|Adverse Event|0|||
150235659|NCT03845075|542000588|FG003|Part 1 - DB|Adverse Event|0|||
150235660|NCT03845075|542000585|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
150235661|NCT03845075|542000586|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
150235662|NCT03845075|542000587|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
150235663|NCT03845075|542000588|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
150235664|NCT02564718|542000589|FG000|Overall Study|Withdrew from treatment|0|||
150235665|NCT02564718|542000590|FG001|Overall Study|Withdrew from treatment|1|||
150235666|NCT03269695|542000591|FG000|Overall Study|Adverse Event|2|||
150235667|NCT03269695|542000592|FG001|Overall Study|Adverse Event|1|||
150235668|NCT03269695|542000591|FG000|Overall Study|Lack of Efficacy|0|||
150235669|NCT03269695|542000592|FG001|Overall Study|Lack of Efficacy|1|||
150235670|NCT03269695|542000591|FG000|Overall Study|Withdrawal by Subject|0|||
150235671|NCT03269695|542000592|FG001|Overall Study|Withdrawal by Subject|1|||
150235672|NCT00104637|542000593|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
150235673|NCT00104637|542000594|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
150235674|NCT01313624|542000595|FG000|Double-Blind Phase|Adverse Event|27|||
150235675|NCT01313624|542000596|FG001|Double-Blind Phase|Adverse Event|4|||
150235676|NCT01313624|542000595|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
150235677|NCT01313624|542000596|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
150235678|NCT01313624|542000595|FG000|Double-Blind Phase|Lost to Follow-up|0|||
150235679|NCT01313624|542000596|FG001|Double-Blind Phase|Lost to Follow-up|2|||
150235680|NCT01313624|542000595|FG000|Double-Blind Phase|Physician Decision|1|||
150235681|NCT01313624|542000596|FG001|Double-Blind Phase|Physician Decision|0|||
150235682|NCT01313624|542000595|FG000|Double-Blind Phase|Lack of Efficacy|1|||
150235683|NCT01313624|542000596|FG001|Double-Blind Phase|Lack of Efficacy|0|||
150235684|NCT01313624|542000595|FG000|Open-Label Phase|Adverse Event|1|||
150235685|NCT01313624|542000596|FG001|Open-Label Phase|Adverse Event|10|||
150235686|NCT01313624|542000595|FG000|Open-Label Phase|Withdrawal by Subject|2|||
150235687|NCT01313624|542000596|FG001|Open-Label Phase|Withdrawal by Subject|2|||
150235688|NCT01313624|542000595|FG000|Open-Label Phase|Lost to Follow-up|1|||
150235689|NCT01313624|542000596|FG001|Open-Label Phase|Lost to Follow-up|1|||
150235690|NCT00857233|542000597|FG000|Overall Study|Adverse Event|24|||
150235691|NCT00857233|542000597|FG000|Overall Study|Lack of Efficacy|1|||
150235692|NCT00857233|542000597|FG000|Overall Study|Non-compliance|1|||
150235693|NCT00857233|542000597|FG000|Overall Study|Withdrawal of Consent|9|||
150235694|NCT00857233|542000597|FG000|Overall Study|Lost to Follow-up|4|||
150235695|NCT00857233|542000597|FG000|Overall Study|Nursing Home Placement|14|||
150235696|NCT00857233|542000597|FG000|Overall Study|Other Reasons|2|||
150235697|NCT05043883|542000598|FG000|Overall Study|Minimum required measurements could not be taken|4|||
150235698|NCT02980705|542000599|FG000|Overall Study|Adverse Event|0|||
150235699|NCT02980705|542000600|FG001|Overall Study|Adverse Event|1|||
150235700|NCT02980705|542000599|FG000|Overall Study|Withdrawal by Subject|6|||
150235701|NCT02980705|542000600|FG001|Overall Study|Withdrawal by Subject|9|||
150235702|NCT02980705|542000599|FG000|Overall Study|withdrew participation|0|||
150235703|NCT02980705|542000600|FG001|Overall Study|withdrew participation|1|||
150235704|NCT02980705|542000599|FG000|Overall Study|Lost to Follow-up|2|||
150235705|NCT02980705|542000600|FG001|Overall Study|Lost to Follow-up|0|||
150235706|NCT00263575|542000601|FG000|Titration Period|Adverse Event|14|||
150235707|NCT00263575|542000601|FG000|Titration Period|Withdrawal by Subject|10|||
150235708|NCT00263575|542000601|FG000|Titration Period|Protocol Violation|9|||
150235709|NCT00263575|542000601|FG000|Titration Period|Sponsor Decision|2|||
150235710|NCT00263575|542000601|FG000|Titration Period|Other|2|||
150235711|NCT00263575|542000601|FG000|Titration Period|Lack of Efficacy|6|||
150235712|NCT00263575|542000601|FG000|Maintence Period|Adverse Event|23|||
150235713|NCT00263575|542000601|FG000|Maintence Period|Withdrawal by Subject|8|||
150235714|NCT00263575|542000601|FG000|Maintence Period|Protocol Violation|4|||
150235715|NCT00263575|542000601|FG000|Maintence Period|Lack of Efficacy|4|||
150235716|NCT00263575|542000601|FG000|Maintence Period|Physician Decision|6|||
150235717|NCT00263575|542000601|FG000|Maintence Period|Lost to Follow-up|1|||
150235718|NCT00263575|542000601|FG000|Maintence Period|Sponsor Decision|24|||
150235719|NCT00263575|542000601|FG000|Maintence Period|Other|7|||
150235720|NCT01130168|542000607|FG000|Period 1|Withdrawal by Subject|0|||
150235721|NCT01130168|542000608|FG001|Period 1|Withdrawal by Subject|1|||
150235722|NCT01130168|542000609|FG002|Period 1|Withdrawal by Subject|0|||
150235723|NCT01130168|542000610|FG003|Period 1|Withdrawal by Subject|1|||
150235724|NCT01130168|542000611|FG004|Period 1|Withdrawal by Subject|0|||
150235725|NCT01130168|542000612|FG005|Period 1|Withdrawal by Subject|0|||
150235726|NCT01130168|542000607|FG000|Period 1|Discontinued For Other Reason|0|||
150235727|NCT01130168|542000608|FG001|Period 1|Discontinued For Other Reason|0|||
150235728|NCT01130168|542000609|FG002|Period 1|Discontinued For Other Reason|1|||
150235729|NCT01130168|542000610|FG003|Period 1|Discontinued For Other Reason|1|||
150235730|NCT01130168|542000611|FG004|Period 1|Discontinued For Other Reason|0|||
150235731|NCT01130168|542000612|FG005|Period 1|Discontinued For Other Reason|0|||
150235732|NCT01130168|542000607|FG000|Period 1|Adverse Event|0|||
150235733|NCT01130168|542000608|FG001|Period 1|Adverse Event|0|||
150235734|NCT01130168|542000609|FG002|Period 1|Adverse Event|0|||
150235735|NCT01130168|542000610|FG003|Period 1|Adverse Event|1|||
150235736|NCT01130168|542000611|FG004|Period 1|Adverse Event|0|||
150235737|NCT01130168|542000612|FG005|Period 1|Adverse Event|0|||
150235738|NCT04354168|542000615|FG000|Overall Study|Lost to Follow-up|22|||
150235739|NCT01781832|542000616|FG000|Overall Study|Withdrawal by Subject|1|||
150235740|NCT00087555|542000617|FG000|Overall Study|Adverse Event|3|||
150235741|NCT00087555|542000618|FG001|Overall Study|Adverse Event|6|||
150235742|NCT00087555|542000619|FG002|Overall Study|Adverse Event|14|||
150235743|NCT00087555|542000617|FG000|Overall Study|Lost to Follow-up|0|||
150235744|NCT00087555|542000618|FG001|Overall Study|Lost to Follow-up|1|||
150235745|NCT00087555|542000619|FG002|Overall Study|Lost to Follow-up|1|||
150235746|NCT00087555|542000617|FG000|Overall Study|Non - Compliance|1|||
150235747|NCT00087555|542000618|FG001|Overall Study|Non - Compliance|0|||
150235748|NCT00087555|542000619|FG002|Overall Study|Non - Compliance|0|||
150235749|NCT00087555|542000617|FG000|Overall Study|Protocol Violation|0|||
150235750|NCT00087555|542000618|FG001|Overall Study|Protocol Violation|0|||
150235751|NCT00087555|542000619|FG002|Overall Study|Protocol Violation|2|||
150235752|NCT00087555|542000617|FG000|Overall Study|Screen Failure|1|||
150235753|NCT00087555|542000618|FG001|Overall Study|Screen Failure|1|||
150235754|NCT00087555|542000619|FG002|Overall Study|Screen Failure|0|||
150235755|NCT00087555|542000617|FG000|Overall Study|Pregnancy|0|||
150235756|NCT00087555|542000618|FG001|Overall Study|Pregnancy|1|||
150235757|NCT00087555|542000619|FG002|Overall Study|Pregnancy|1|||
150235758|NCT00087555|542000617|FG000|Overall Study|Withdrawal by Subject|3|||
150235759|NCT00087555|542000618|FG001|Overall Study|Withdrawal by Subject|2|||
150235760|NCT00087555|542000619|FG002|Overall Study|Withdrawal by Subject|1|||
150235761|NCT00087555|542000617|FG000|Overall Study|Lack of Efficacy|2|||
150235762|NCT00087555|542000618|FG001|Overall Study|Lack of Efficacy|0|||
150235763|NCT00087555|542000619|FG002|Overall Study|Lack of Efficacy|1|||
150235764|NCT00087555|542000617|FG000|Overall Study|Non Compliance|0|||
150235765|NCT00087555|542000618|FG001|Overall Study|Non Compliance|0|||
150235766|NCT00087555|542000619|FG002|Overall Study|Non Compliance|1|||
150235767|NCT00087555|542000617|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
150235768|NCT00087555|542000618|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
150235769|NCT00087555|542000619|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
150235770|NCT00087555|542000617|FG000|Overall Study|Patient wanted to go back on Med|1|||
150235771|NCT00087555|542000618|FG001|Overall Study|Patient wanted to go back on Med|0|||
150235772|NCT00087555|542000619|FG002|Overall Study|Patient wanted to go back on Med|0|||
150235773|NCT05523219|542000620|FG000|Overall Study|Wrong inclusion|1|||
150235774|NCT05523219|542000620|FG000|Overall Study|Lost to Follow-up|7|||
150235775|NCT00661713|542000621|FG000|Overall Study|Death|1|||
150235776|NCT00661713|542000622|FG001|Overall Study|Death|0|||
150235777|NCT00661713|542000623|FG002|Overall Study|Death|0|||
150235778|NCT00661713|542000624|FG003|Overall Study|Death|0|||
150235779|NCT00661713|542000625|FG004|Overall Study|Death|1|||
150235780|NCT00661713|542000626|FG005|Overall Study|Death|0|||
150235781|NCT00661713|542000627|FG006|Overall Study|Death|0|||
150235782|NCT00661713|542000628|FG007|Overall Study|Death|0|||
150235783|NCT00661713|542000621|FG000|Overall Study|Unable to Classify|1|||
150235784|NCT00661713|542000622|FG001|Overall Study|Unable to Classify|0|||
150235785|NCT00661713|542000623|FG002|Overall Study|Unable to Classify|0|||
150235786|NCT00661713|542000624|FG003|Overall Study|Unable to Classify|0|||
150235787|NCT00661713|542000625|FG004|Overall Study|Unable to Classify|0|||
150235788|NCT00661713|542000626|FG005|Overall Study|Unable to Classify|0|||
150235789|NCT00661713|542000627|FG006|Overall Study|Unable to Classify|0|||
150235790|NCT00661713|542000628|FG007|Overall Study|Unable to Classify|0|||
150235791|NCT00661713|542000621|FG000|Overall Study|Protocol Violation|1|||
150235792|NCT00661713|542000622|FG001|Overall Study|Protocol Violation|6|||
150235793|NCT00661713|542000623|FG002|Overall Study|Protocol Violation|3|||
150235794|NCT00661713|542000624|FG003|Overall Study|Protocol Violation|3|||
150235795|NCT00661713|542000625|FG004|Overall Study|Protocol Violation|0|||
150235796|NCT00661713|542000626|FG005|Overall Study|Protocol Violation|2|||
150235797|NCT00661713|542000627|FG006|Overall Study|Protocol Violation|2|||
150235798|NCT00661713|542000628|FG007|Overall Study|Protocol Violation|1|||
150235799|NCT00661713|542000621|FG000|Overall Study|Withdrawal by Subject|11|||
150235800|NCT00661713|542000622|FG001|Overall Study|Withdrawal by Subject|25|||
150235801|NCT00661713|542000623|FG002|Overall Study|Withdrawal by Subject|12|||
150235802|NCT00661713|542000624|FG003|Overall Study|Withdrawal by Subject|21|||
150235803|NCT00661713|542000625|FG004|Overall Study|Withdrawal by Subject|12|||
150235804|NCT00661713|542000626|FG005|Overall Study|Withdrawal by Subject|26|||
150235805|NCT00661713|542000627|FG006|Overall Study|Withdrawal by Subject|45|||
150235806|NCT00661713|542000628|FG007|Overall Study|Withdrawal by Subject|9|||
150235807|NCT00661713|542000621|FG000|Overall Study|Lost to Follow-up|2|||
150235808|NCT00661713|542000622|FG001|Overall Study|Lost to Follow-up|7|||
150235809|NCT00661713|542000623|FG002|Overall Study|Lost to Follow-up|2|||
150235810|NCT00661713|542000624|FG003|Overall Study|Lost to Follow-up|2|||
150235811|NCT00661713|542000625|FG004|Overall Study|Lost to Follow-up|5|||
150235812|NCT00661713|542000626|FG005|Overall Study|Lost to Follow-up|7|||
150235813|NCT00661713|542000627|FG006|Overall Study|Lost to Follow-up|14|||
150235814|NCT00661713|542000628|FG007|Overall Study|Lost to Follow-up|1|||
150235815|NCT00661713|542000621|FG000|Overall Study|Administrative Reason|0|||
150235816|NCT00661713|542000622|FG001|Overall Study|Administrative Reason|1|||
150235817|NCT00661713|542000623|FG002|Overall Study|Administrative Reason|0|||
150235818|NCT00661713|542000624|FG003|Overall Study|Administrative Reason|2|||
150235819|NCT00661713|542000625|FG004|Overall Study|Administrative Reason|2|||
150235820|NCT00661713|542000626|FG005|Overall Study|Administrative Reason|2|||
150235821|NCT00661713|542000627|FG006|Overall Study|Administrative Reason|1|||
150235822|NCT00661713|542000628|FG007|Overall Study|Administrative Reason|0|||
150235823|NCT00661713|542000621|FG000|Overall Study|Adverse Event|0|||
150235824|NCT00661713|542000622|FG001|Overall Study|Adverse Event|0|||
150235825|NCT00661713|542000623|FG002|Overall Study|Adverse Event|0|||
150235826|NCT00661713|542000624|FG003|Overall Study|Adverse Event|0|||
150235827|NCT00661713|542000625|FG004|Overall Study|Adverse Event|0|||
150235828|NCT00661713|542000626|FG005|Overall Study|Adverse Event|0|||
150235829|NCT00661713|542000627|FG006|Overall Study|Adverse Event|1|||
150235830|NCT00661713|542000628|FG007|Overall Study|Adverse Event|0|||
150235831|NCT00661713|542000621|FG000|Overall Study|Inappropriate Enrollment|0|||
150235832|NCT00661713|542000622|FG001|Overall Study|Inappropriate Enrollment|0|||
150235833|NCT00661713|542000623|FG002|Overall Study|Inappropriate Enrollment|0|||
150235834|NCT00661713|542000624|FG003|Overall Study|Inappropriate Enrollment|0|||
150235835|NCT00661713|542000625|FG004|Overall Study|Inappropriate Enrollment|0|||
150235836|NCT00661713|542000626|FG005|Overall Study|Inappropriate Enrollment|0|||
150235837|NCT00661713|542000627|FG006|Overall Study|Inappropriate Enrollment|1|||
150235838|NCT00661713|542000628|FG007|Overall Study|Inappropriate Enrollment|0|||
150235839|NCT01482429|542000629|FG000|Care Usual|Protocol Violation|0|||
150235840|NCT01482429|542000630|FG001|Care Usual|Protocol Violation|172|||
150235841|NCT01482429|542000629|FG000|Care Usual|Lost to Follow-up|0|||
150235842|NCT01482429|542000630|FG001|Care Usual|Lost to Follow-up|1|||
150235843|NCT01482429|542000629|FG000|Protocol|Protocol Violation|275|||
150235844|NCT01482429|542000630|FG001|Protocol|Protocol Violation|0|||
150235845|NCT03561597|542000632|FG000|Overall Study|Lost to Follow-up|20|||
150235846|NCT04887506|542000633|FG000|Overall Study|Death|1|||
150235847|NCT04887506|542000634|FG001|Overall Study|Death|1|||
150235848|NCT04887506|542000633|FG000|Overall Study|Withdrawal by Subject|0|||
150235849|NCT04887506|542000634|FG001|Overall Study|Withdrawal by Subject|3|||
150235850|NCT04887506|542000633|FG000|Overall Study|Adverse Event|4|||
150235851|NCT04887506|542000634|FG001|Overall Study|Adverse Event|3|||
150235852|NCT04887506|542000633|FG000|Overall Study|Other - Not Reported|1|||
150235853|NCT04887506|542000634|FG001|Overall Study|Other - Not Reported|1|||
150235854|NCT01024036|542000658|FG000|Blinded Treatment|Adverse Event|1|||
150235855|NCT01024036|542000659|FG001|Blinded Treatment|Adverse Event|1|||
150235856|NCT01024036|542000658|FG000|Blinded Treatment|Lack of Efficacy|16|||
150235857|NCT01024036|542000659|FG001|Blinded Treatment|Lack of Efficacy|14|||
150235858|NCT01024036|542000658|FG000|Blinded Treatment|Physician Decision|1|||
150235859|NCT01024036|542000659|FG001|Blinded Treatment|Physician Decision|0|||
150235860|NCT01024036|542000658|FG000|Blinded Treatment|Death|0|||
150235861|NCT01024036|542000659|FG001|Blinded Treatment|Death|2|||
150235862|NCT01024036|542000658|FG000|Blinded Treatment|Withdrawal by Subject|4|||
150235863|NCT01024036|542000659|FG001|Blinded Treatment|Withdrawal by Subject|3|||
150235864|NCT01024036|542000658|FG000|Unblinded Treatment|Adverse Event|0|||
150235865|NCT01024036|542000659|FG001|Unblinded Treatment|Adverse Event|1|||
150235866|NCT01024036|542000658|FG000|Unblinded Treatment|Lack of Efficacy|0|||
150235867|NCT01024036|542000659|FG001|Unblinded Treatment|Lack of Efficacy|2|||
150235868|NCT01024036|542000658|FG000|Follow-Up Period|Lost to Follow-up|1|||
150235869|NCT01024036|542000659|FG001|Follow-Up Period|Lost to Follow-up|1|||
150235870|NCT01024036|542000658|FG000|Follow-Up Period|Withdrawal by Subject|0|||
150235871|NCT01024036|542000659|FG001|Follow-Up Period|Withdrawal by Subject|1|||
150235872|NCT01024036|542000658|FG000|Follow-Up Period|Adverse Event|4|||
150235873|NCT01024036|542000659|FG001|Follow-Up Period|Adverse Event|1|||
150235874|NCT00691678|542000661|FG000|Overall Study|Adverse Event|5|||
150235875|NCT00691678|542000661|FG000|Overall Study|life events, pain|11|||
150235876|NCT01190449|542000662|FG000|Overall Study|Ineligible|0|||
150235877|NCT01190449|542000663|FG001|Overall Study|Ineligible|4|||
150235878|NCT04811339|542000664|FG000|Overall Study|lack of transportation not wanting to return|4|||
150235879|NCT04811339|542000665|FG001|Overall Study|lack of transportation not wanting to return|8|||
150235880|NCT04811339|542000666|FG002|Overall Study|lack of transportation not wanting to return|0|||
150235881|NCT04811339|542000664|FG000|Overall Study|Adverse Event|3|||
150235882|NCT04811339|542000665|FG001|Overall Study|Adverse Event|0|||
150235883|NCT04811339|542000666|FG002|Overall Study|Adverse Event|0|||
150235884|NCT04811339|542000664|FG000|Overall Study|Lost to Follow-up|1|||
150235885|NCT04811339|542000665|FG001|Overall Study|Lost to Follow-up|0|||
150235886|NCT04811339|542000666|FG002|Overall Study|Lost to Follow-up|0|||
150235887|NCT04811339|542000664|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
150235888|NCT04811339|542000665|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
150235889|NCT04811339|542000666|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
150235890|NCT04811339|542000664|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
150235891|NCT04811339|542000665|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
150235892|NCT04811339|542000666|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
150235893|NCT04811339|542000664|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
150235894|NCT04811339|542000665|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
150235895|NCT04811339|542000666|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
150235896|NCT04811339|542000664|FG000|Overall Study|Withdrawal by Subject|0|||
150235897|NCT04811339|542000665|FG001|Overall Study|Withdrawal by Subject|3|||
150235898|NCT04811339|542000666|FG002|Overall Study|Withdrawal by Subject|0|||
150235899|NCT04811339|542000664|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
150235900|NCT04811339|542000665|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
150235901|NCT04811339|542000666|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
150235902|NCT04811339|542000664|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
150235903|NCT04811339|542000665|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
150235904|NCT04811339|542000666|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
150235905|NCT05896696|542000669|FG000|Overall Study|Screening Failure|7|||
150235906|NCT05896696|542000669|FG000|Overall Study|Withdrawal by Subject|2|||
150235907|NCT00903760|542002584|FG000|Overall Study|Disease Progression/Death|8|||
150235908|NCT00903760|542002585|FG001|Overall Study|Disease Progression/Death|6|||
150235909|NCT00903760|542002584|FG000|Overall Study|Stem Cell Transplant|8|||
150235910|NCT00903760|542002585|FG001|Overall Study|Stem Cell Transplant|4|||
150235911|NCT00903760|542002584|FG000|Overall Study|Physician Decision|1|||
150235912|NCT00903760|542002585|FG001|Overall Study|Physician Decision|2|||
150235913|NCT00903760|542002584|FG000|Overall Study|Death|0|||
150235914|NCT00903760|542002585|FG001|Overall Study|Death|1|||
150235915|NCT00903760|542002584|FG000|Overall Study|Lost to Follow-up|1|||
150235916|NCT00903760|542002585|FG001|Overall Study|Lost to Follow-up|0|||
150235917|NCT00903760|542002584|FG000|Overall Study|Withdrawal by Subject|1|||
150235918|NCT00903760|542002585|FG001|Overall Study|Withdrawal by Subject|2|||
150235919|NCT00903760|542002584|FG000|Overall Study|Off treatment for long period|0|||
150235920|NCT00903760|542002585|FG001|Overall Study|Off treatment for long period|1|||
150235921|NCT01256671|542002590|FG000|Overall Study|Adverse Event|29|||
150235922|NCT01256671|542002590|FG000|Overall Study|Lost to Follow-up|16|||
150235923|NCT01256671|542002590|FG000|Overall Study|Withdrawal by Subject|31|||
150235924|NCT01256671|542002590|FG000|Overall Study|Physician Decision|3|||
150235925|NCT01256671|542002590|FG000|Overall Study|Lack of Efficacy|4|||
150235926|NCT01256671|542002590|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
150235927|NCT04411186|542002591|FG000|Overall Study|Withdrawn due to protocol violation|0|||
150235928|NCT04411186|542002592|FG001|Overall Study|Withdrawn due to protocol violation|1|||
150235929|NCT03167151|542002593|FG000|Overall Study|Withdrawal by Subject|1|||
150235930|NCT03167151|542002594|FG001|Overall Study|Withdrawal by Subject|0|||
150235931|NCT03167151|542002595|FG002|Overall Study|Withdrawal by Subject|0|||
150235932|NCT03167151|542002593|FG000|Overall Study|No evidence of tumour at surgery|0|||
150235933|NCT03167151|542002594|FG001|Overall Study|No evidence of tumour at surgery|1|||
150235934|NCT03167151|542002595|FG002|Overall Study|No evidence of tumour at surgery|1|||
150235935|NCT01458522|542002596|FG000|Overall Study|Withdrawal by Subject|2|||
150235936|NCT01458522|542002597|FG001|Overall Study|Withdrawal by Subject|2|||
150235937|NCT01458522|542002596|FG000|Overall Study|Physician Decision|1|||
150235938|NCT01458522|542002597|FG001|Overall Study|Physician Decision|9|||
150235939|NCT00516139|542002598|FG000|Overall Study|Adverse Event|27|||
150235940|NCT00516139|542002598|FG000|Overall Study|Lost to Follow-up|1|||
150235941|NCT00516139|542002598|FG000|Overall Study|Protocol Violation|1|||
150235942|NCT00516139|542002598|FG000|Overall Study|Withdrawal by Subject|8|||
150235943|NCT00516139|542002598|FG000|Overall Study|Lack of Efficacy|1|||
150235944|NCT00416598|542002599|FG000|Induction & Intensification|Adverse Event|38|||
150235945|NCT00416598|542002599|FG000|Induction & Intensification|Death|32|||
150235946|NCT00416598|542002599|FG000|Induction & Intensification|Withdrawal by Subject|46|||
150235947|NCT00416598|542002599|FG000|Induction & Intensification|Alternative Treatment|135|||
150235948|NCT00416598|542002599|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
150235949|NCT00416598|542002599|FG000|Induction & Intensification|Relapse/progression|29|||
150235950|NCT00416598|542002599|FG000|Induction & Intensification|Failed induction|87|||
150235951|NCT00416598|542002599|FG000|Decitabine Maintenance|Adverse Event|5|||
150235952|NCT00416598|542002599|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
150235953|NCT00416598|542002599|FG000|Decitabine Maintenance|Progression/relapse|38|||
150235954|NCT00416598|542002599|FG000|Decitabine Maintenance|Alternative treatment|2|||
150235955|NCT00416598|542002599|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
150235956|NCT02166476|542002606|FG000|Overall Study|Withdrawal by Subject|5|||
150235957|NCT02166476|542002607|FG001|Overall Study|Withdrawal by Subject|7|||
150235958|NCT02166476|542002606|FG000|Overall Study|Adverse Event|3|||
150235959|NCT02166476|542002607|FG001|Overall Study|Adverse Event|3|||
150235960|NCT02166476|542002606|FG000|Overall Study|Lost to Follow-up|5|||
150235961|NCT02166476|542002607|FG001|Overall Study|Lost to Follow-up|10|||
150235962|NCT02166476|542002606|FG000|Overall Study|Physician Decision|1|||
150235963|NCT02166476|542002607|FG001|Overall Study|Physician Decision|0|||
150235964|NCT02166476|542002606|FG000|Overall Study|Unable to Come for Visit|0|||
150235965|NCT02166476|542002607|FG001|Overall Study|Unable to Come for Visit|3|||
150235966|NCT04367480|542002614|FG000|Overall Study|Adverse Event|1|||
150235967|NCT04367480|542002615|FG001|Overall Study|Adverse Event|1|||
150235968|NCT04367480|542002614|FG000|Overall Study|Death|1|||
150235969|NCT04367480|542002615|FG001|Overall Study|Death|0|||
150235970|NCT04367480|542002614|FG000|Overall Study|Lost to Follow-up|1|||
150235971|NCT04367480|542002615|FG001|Overall Study|Lost to Follow-up|1|||
150235972|NCT04367480|542002614|FG000|Overall Study|Withdrawal by Subject|0|||
150235973|NCT04367480|542002615|FG001|Overall Study|Withdrawal by Subject|3|||
150235974|NCT04367480|542002614|FG000|Overall Study|App glitch during the study|1|||
150235975|NCT04367480|542002615|FG001|Overall Study|App glitch during the study|0|||
150235976|NCT04367480|542002614|FG000|Overall Study|Device Distribution Error|0|||
150235977|NCT04367480|542002615|FG001|Overall Study|Device Distribution Error|2|||
150235978|NCT04367480|542002614|FG000|Overall Study|Ineligible after Randomization|0|||
150235979|NCT04367480|542002615|FG001|Overall Study|Ineligible after Randomization|1|||
150235980|NCT04367480|542002614|FG000|Overall Study|Other Medical Reasons|0|||
150235981|NCT04367480|542002615|FG001|Overall Study|Other Medical Reasons|2|||
150235982|NCT03382561|542002616|FG000|Overall Study|Disease progression|47|||
150235983|NCT03382561|542002617|FG001|Overall Study|Disease progression|6|||
150235984|NCT03382561|542002616|FG000|Overall Study|Adverse Event|10|||
150235985|NCT03382561|542002617|FG001|Overall Study|Adverse Event|2|||
150235986|NCT03382561|542002616|FG000|Overall Study|Death|8|||
150235987|NCT03382561|542002617|FG001|Overall Study|Death|3|||
150235988|NCT03382561|542002616|FG000|Overall Study|Withdrawal by Subject|6|||
150235989|NCT03382561|542002617|FG001|Overall Study|Withdrawal by Subject|5|||
150235990|NCT03382561|542002616|FG000|Overall Study|Alternative therapy|2|||
150235991|NCT03382561|542002617|FG001|Overall Study|Alternative therapy|8|||
150235992|NCT03382561|542002616|FG000|Overall Study|Never started treatment|3|||
150235993|NCT03382561|542002617|FG001|Overall Study|Never started treatment|6|||
150235994|NCT03382561|542002616|FG000|Overall Study|Lack of Efficacy|0|||
150235995|NCT03382561|542002617|FG001|Overall Study|Lack of Efficacy|1|||
150235996|NCT03382561|542002616|FG000|Overall Study|Physician Decision|0|||
150235997|NCT03382561|542002617|FG001|Overall Study|Physician Decision|1|||
150235998|NCT03382561|542002616|FG000|Overall Study|Other complicating disease|0|||
150235999|NCT03382561|542002617|FG001|Overall Study|Other complicating disease|1|||
150236000|NCT01131104|542002618|FG000|Overall Study|Withdrawal by Subject|3|||
150236001|NCT01131104|542002618|FG000|Overall Study|Physician Decision|4|||
150236002|NCT01131104|542002618|FG000|Overall Study|Information Not Available|5|||
150236003|NCT01131104|542002618|FG000|Overall Study|No Information on Index Date of Onset|1|||
150236004|NCT04469465|542002620|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
150236005|NCT04469465|542002621|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
150236006|NCT04469465|542002620|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
150236007|NCT04469465|542002621|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
150236008|NCT04469465|542002620|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
150236009|NCT04469465|542002621|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
150236010|NCT04469465|542002620|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
150236011|NCT04469465|542002621|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
150236012|NCT04469465|542002620|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
150236013|NCT04469465|542002621|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
150236014|NCT04469465|542002620|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
150236015|NCT04469465|542002621|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
150236016|NCT04469465|542002620|FG000|Long-Term Extension (LTE)|Death|0|||
150236017|NCT04469465|542002621|FG001|Long-Term Extension (LTE)|Death|1|||
150236018|NCT04469465|542002620|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
150236019|NCT04469465|542002621|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
150236020|NCT01165177|542002622|FG000|Overall Study|Serious Adverse Event|227|||
150236021|NCT01165177|542002623|FG001|Overall Study|Serious Adverse Event|235|||
150236022|NCT01165177|542002622|FG000|Overall Study|Withdrawal by Subject|368|||
150236023|NCT01165177|542002623|FG001|Overall Study|Withdrawal by Subject|354|||
150236024|NCT01165177|542002622|FG000|Overall Study|Protocol Violation|19|||
150236025|NCT01165177|542002623|FG001|Overall Study|Protocol Violation|21|||
150236026|NCT01165177|542002622|FG000|Overall Study|Non-serious adverse event|30|||
150236027|NCT01165177|542002623|FG001|Overall Study|Non-serious adverse event|18|||
150236028|NCT01165177|542002622|FG000|Overall Study|Other unspecified reasons|47|||
150236029|NCT01165177|542002623|FG001|Overall Study|Other unspecified reasons|35|||
150236030|NCT01165177|542002622|FG000|Overall Study|Suspected HZ episode|0|||
150236031|NCT01165177|542002623|FG001|Overall Study|Suspected HZ episode|2|||
150236032|NCT01165177|542002622|FG000|Overall Study|Lost to Follow-up|183|||
150236033|NCT01165177|542002623|FG001|Overall Study|Lost to Follow-up|194|||
150236034|NCT01165177|542002622|FG000|Overall Study|Migrated/ moved from study area|48|||
150236035|NCT01165177|542002623|FG001|Overall Study|Migrated/ moved from study area|43|||
150236036|NCT03520075|542002624|FG000|Phase 1 (Dose Escalation)|Death|2|||
150236037|NCT03520075|542002625|FG001|Phase 1 (Dose Escalation)|Death|2|||
150236038|NCT03520075|542002626|FG002|Phase 1 (Dose Escalation)|Death|3|||
150236039|NCT03520075|542002627|FG003|Phase 1 (Dose Escalation)|Death|2|||
150236040|NCT03520075|542002628|FG004|Phase 1 (Dose Escalation)|Death|6|||
150236041|NCT03520075|542002629|FG005|Phase 1 (Dose Escalation)|Death|5|||
150236042|NCT03520075|542002630|FG006|Phase 1 (Dose Escalation)|Death|3|||
150236043|NCT03520075|542002631|FG007|Phase 1 (Dose Escalation)|Death|2|||
150236044|NCT03520075|542002632|FG008|Phase 1 (Dose Escalation)|Death|3|||
150236045|NCT03520075|542002633|FG009|Phase 1 (Dose Escalation)|Death|1|||
150236046|NCT03520075|542002634|FG010|Phase 1 (Dose Escalation)|Death|5|||
150236047|NCT03520075|542002635|FG011|Phase 1 (Dose Escalation)|Death|7|||
150236048|NCT03520075|542002636|FG012|Phase 1 (Dose Escalation)|Death|11|||
150236049|NCT03520075|542002637|FG013|Phase 1 (Dose Escalation)|Death|0|||
150236050|NCT03520075|542002638|FG014|Phase 1 (Dose Escalation)|Death|0|||
150236051|NCT03520075|542002639|FG015|Phase 1 (Dose Escalation)|Death|0|||
150236052|NCT03520075|542002640|FG016|Phase 1 (Dose Escalation)|Death|0|||
150236053|NCT03520075|542002641|FG017|Phase 1 (Dose Escalation)|Death|0|||
150236054|NCT03520075|542002642|FG018|Phase 1 (Dose Escalation)|Death|0|||
150236055|NCT03520075|542002624|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
150236056|NCT03520075|542002625|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236057|NCT03520075|542002626|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236058|NCT03520075|542002627|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
150236059|NCT03520075|542002628|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
150236060|NCT03520075|542002629|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
150236061|NCT03520075|542002630|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236062|NCT03520075|542002631|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
150236063|NCT03520075|542002632|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236064|NCT03520075|542002633|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
150236065|NCT03520075|542002634|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236066|NCT03520075|542002635|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236067|NCT03520075|542002636|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
150236068|NCT03520075|542002637|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236069|NCT03520075|542002638|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236070|NCT03520075|542002639|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236071|NCT03520075|542002640|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236072|NCT03520075|542002641|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236073|NCT03520075|542002642|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
150236074|NCT03520075|542002624|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236075|NCT03520075|542002625|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
150236076|NCT03520075|542002626|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236077|NCT03520075|542002627|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
150236078|NCT03520075|542002628|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
150236079|NCT03520075|542002629|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236080|NCT03520075|542002630|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236081|NCT03520075|542002631|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236082|NCT03520075|542002632|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236083|NCT03520075|542002633|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236084|NCT03520075|542002634|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
150236085|NCT03520075|542002635|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236086|NCT03520075|542002636|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
150236087|NCT03520075|542002637|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236088|NCT03520075|542002638|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236089|NCT03520075|542002639|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236090|NCT03520075|542002640|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236091|NCT03520075|542002641|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236092|NCT03520075|542002642|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
150236093|NCT03520075|542002624|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236094|NCT03520075|542002625|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236095|NCT03520075|542002626|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236096|NCT03520075|542002627|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236097|NCT03520075|542002628|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236098|NCT03520075|542002629|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236099|NCT03520075|542002630|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236100|NCT03520075|542002631|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236101|NCT03520075|542002632|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236102|NCT03520075|542002633|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
150236103|NCT03520075|542002634|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236104|NCT03520075|542002635|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236105|NCT03520075|542002636|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
150236106|NCT03520075|542002637|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236107|NCT03520075|542002638|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236108|NCT03520075|542002639|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236109|NCT03520075|542002640|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236110|NCT03520075|542002641|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236111|NCT03520075|542002642|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
150236112|NCT03520075|542002624|FG000|Phase 2 (Dose Expansion)|Death|0|||
150236113|NCT03520075|542002625|FG001|Phase 2 (Dose Expansion)|Death|0|||
150236114|NCT03520075|542002626|FG002|Phase 2 (Dose Expansion)|Death|0|||
150236115|NCT03520075|542002627|FG003|Phase 2 (Dose Expansion)|Death|0|||
150236116|NCT03520075|542002628|FG004|Phase 2 (Dose Expansion)|Death|0|||
150236117|NCT03520075|542002629|FG005|Phase 2 (Dose Expansion)|Death|0|||
150236118|NCT03520075|542002630|FG006|Phase 2 (Dose Expansion)|Death|0|||
150236119|NCT03520075|542002631|FG007|Phase 2 (Dose Expansion)|Death|0|||
150236120|NCT03520075|542002632|FG008|Phase 2 (Dose Expansion)|Death|0|||
150236121|NCT03520075|542002633|FG009|Phase 2 (Dose Expansion)|Death|0|||
150236122|NCT03520075|542002634|FG010|Phase 2 (Dose Expansion)|Death|0|||
150236123|NCT03520075|542002635|FG011|Phase 2 (Dose Expansion)|Death|0|||
150236124|NCT03520075|542002636|FG012|Phase 2 (Dose Expansion)|Death|0|||
150236125|NCT03520075|542002637|FG013|Phase 2 (Dose Expansion)|Death|20|||
150236126|NCT03520075|542002638|FG014|Phase 2 (Dose Expansion)|Death|13|||
150236127|NCT03520075|542002639|FG015|Phase 2 (Dose Expansion)|Death|9|||
150236128|NCT03520075|542002640|FG016|Phase 2 (Dose Expansion)|Death|5|||
150236129|NCT03520075|542002641|FG017|Phase 2 (Dose Expansion)|Death|14|||
150236130|NCT03520075|542002642|FG018|Phase 2 (Dose Expansion)|Death|12|||
150236131|NCT03520075|542002624|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236132|NCT03520075|542002625|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236133|NCT03520075|542002626|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236134|NCT03520075|542002627|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236135|NCT03520075|542002628|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236136|NCT03520075|542002629|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236137|NCT03520075|542002630|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236138|NCT03520075|542002631|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236139|NCT03520075|542002632|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236140|NCT03520075|542002633|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236141|NCT03520075|542002634|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236142|NCT03520075|542002635|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236143|NCT03520075|542002636|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236144|NCT03520075|542002637|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
150236145|NCT03520075|542002638|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
150236146|NCT03520075|542002639|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
150236147|NCT03520075|542002640|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
150236148|NCT03520075|542002641|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
150236149|NCT03520075|542002642|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
150236150|NCT03520075|542002624|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236151|NCT03520075|542002625|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236152|NCT03520075|542002626|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236153|NCT03520075|542002627|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236154|NCT03520075|542002628|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236155|NCT03520075|542002629|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236156|NCT03520075|542002630|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236157|NCT03520075|542002631|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236158|NCT03520075|542002632|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236159|NCT03520075|542002633|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236160|NCT03520075|542002634|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236161|NCT03520075|542002635|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236162|NCT03520075|542002636|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236163|NCT03520075|542002637|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236164|NCT03520075|542002638|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
150236165|NCT03520075|542002639|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
150236166|NCT03520075|542002640|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236167|NCT03520075|542002641|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
150236168|NCT03520075|542002642|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
150236169|NCT03520075|542002624|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236170|NCT03520075|542002625|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236171|NCT03520075|542002626|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236172|NCT03520075|542002627|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236173|NCT03520075|542002628|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236174|NCT03520075|542002629|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236175|NCT03520075|542002630|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236176|NCT03520075|542002631|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236177|NCT03520075|542002632|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236178|NCT03520075|542002633|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236179|NCT03520075|542002634|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236180|NCT03520075|542002635|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236181|NCT03520075|542002636|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236182|NCT03520075|542002637|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
150236183|NCT03520075|542002638|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236184|NCT03520075|542002639|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236185|NCT03520075|542002640|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
150236186|NCT03520075|542002641|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
150236187|NCT03520075|542002642|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
150236188|NCT03546816|542002645|FG000|Overall Study|Adverse Event|5|||
150236189|NCT03546816|542002646|FG001|Overall Study|Adverse Event|3|||
150236190|NCT03546816|542002645|FG000|Overall Study|Lack of Efficacy|2|||
150236191|NCT03546816|542002646|FG001|Overall Study|Lack of Efficacy|4|||
150236192|NCT03546816|542002645|FG000|Overall Study|Pregnancy|1|||
150236193|NCT03546816|542002646|FG001|Overall Study|Pregnancy|0|||
150236194|NCT03546816|542002645|FG000|Overall Study|Physician Decision|2|||
150236195|NCT03546816|542002646|FG001|Overall Study|Physician Decision|0|||
150236196|NCT03546816|542002645|FG000|Overall Study|Withdrawal by Subject|8|||
150236197|NCT03546816|542002646|FG001|Overall Study|Withdrawal by Subject|10|||
150236198|NCT03546816|542002645|FG000|Overall Study|Lost to Follow-up|3|||
150236199|NCT03546816|542002646|FG001|Overall Study|Lost to Follow-up|2|||
150236200|NCT02270671|542002647|FG000|Overall Study|Withdrawal by Subject|1|||
150236201|NCT02270671|542002648|FG001|Overall Study|Withdrawal by Subject|1|||
150236202|NCT02270671|542002647|FG000|Overall Study|Protocol Violation|0|||
150236203|NCT02270671|542002648|FG001|Overall Study|Protocol Violation|1|||
150236204|NCT02270671|542002647|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
150236205|NCT02270671|542002648|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
150236206|NCT02270671|542002647|FG000|Overall Study|Lost to Follow-up|2|||
150236207|NCT02270671|542002648|FG001|Overall Study|Lost to Follow-up|1|||
150236208|NCT01657799|542002649|FG000|Overall Study|Adverse Event Related to progression|6|||
150236209|NCT01657799|542002650|FG001|Overall Study|Adverse Event Related to progression|8|||
150236210|NCT01657799|542002651|FG002|Overall Study|Adverse Event Related to progression|12|||
150236211|NCT01657799|542002649|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
150236212|NCT01657799|542002650|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
150236213|NCT01657799|542002651|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
150236214|NCT01657799|542002649|FG000|Overall Study|Withdrawal by Subject|13|||
150236215|NCT01657799|542002650|FG001|Overall Study|Withdrawal by Subject|10|||
150236216|NCT01657799|542002651|FG002|Overall Study|Withdrawal by Subject|10|||
150236217|NCT01657799|542002649|FG000|Overall Study|Lost to Follow-up|1|||
150236218|NCT01657799|542002650|FG001|Overall Study|Lost to Follow-up|0|||
150236219|NCT01657799|542002651|FG002|Overall Study|Lost to Follow-up|1|||
150236220|NCT01657799|542002649|FG000|Overall Study|Disease Progression|2|||
150236221|NCT01657799|542002650|FG001|Overall Study|Disease Progression|4|||
150236222|NCT01657799|542002651|FG002|Overall Study|Disease Progression|4|||
150236223|NCT01657799|542002649|FG000|Overall Study|Progressive Disease Clinical|7|||
150236224|NCT01657799|542002650|FG001|Overall Study|Progressive Disease Clinical|4|||
150236225|NCT01657799|542002651|FG002|Overall Study|Progressive Disease Clinical|7|||
150236226|NCT01657799|542002649|FG000|Overall Study|Radiographic & Clinical Progression|16|||
150236227|NCT01657799|542002650|FG001|Overall Study|Radiographic & Clinical Progression|11|||
150236228|NCT01657799|542002651|FG002|Overall Study|Radiographic & Clinical Progression|15|||
150236229|NCT01657799|542002649|FG000|Overall Study|Other|52|||
150236230|NCT01657799|542002650|FG001|Overall Study|Other|62|||
150236231|NCT01657799|542002651|FG002|Overall Study|Other|49|||
150236232|NCT00611715|542002657|FG000|Overall Study|Disease Progression|24|||
150236233|NCT00611715|542002658|FG001|Overall Study|Disease Progression|4|||
150236234|NCT00611715|542002657|FG000|Overall Study|Withdrawal by Subject|5|||
150236235|NCT00611715|542002658|FG001|Overall Study|Withdrawal by Subject|1|||
150236236|NCT00611715|542002657|FG000|Overall Study|Adverse Event|9|||
150236237|NCT00611715|542002658|FG001|Overall Study|Adverse Event|1|||
150236238|NCT00611715|542002657|FG000|Overall Study|Death|1|||
150236239|NCT00611715|542002658|FG001|Overall Study|Death|0|||
150236240|NCT00611715|542002657|FG000|Overall Study|two patients are still on treatment|2|||
150236241|NCT00611715|542002658|FG001|Overall Study|two patients are still on treatment|0|||
150236242|NCT00727415|542002659|FG000|Phase I|Dose Limiting Toxicity|2|||
150236243|NCT03414047|542002668|FG000|Overall Study|Adverse Event|0|||
150236244|NCT03414047|542002669|FG001|Overall Study|Adverse Event|0|||
150236245|NCT03414047|542002670|FG002|Overall Study|Adverse Event|1|||
150236246|NCT03414047|542002671|FG003|Overall Study|Adverse Event|1|||
150236247|NCT03414047|542002668|FG000|Overall Study|Physician Decision|1|||
150236248|NCT03414047|542002669|FG001|Overall Study|Physician Decision|0|||
150236249|NCT03414047|542002670|FG002|Overall Study|Physician Decision|0|||
150236250|NCT03414047|542002671|FG003|Overall Study|Physician Decision|1|||
150236251|NCT03414047|542002668|FG000|Overall Study|Withdrawal by Subject|1|||
150236252|NCT03414047|542002669|FG001|Overall Study|Withdrawal by Subject|0|||
150236253|NCT03414047|542002670|FG002|Overall Study|Withdrawal by Subject|2|||
150236254|NCT03414047|542002671|FG003|Overall Study|Withdrawal by Subject|0|||
150236255|NCT04593823|542002672|FG000|Overall Study|Withdrawal by Subject|1|||
150236256|NCT04593823|542002673|FG001|Overall Study|Withdrawal by Subject|1|||
150236257|NCT04593823|542002672|FG000|Overall Study|Lost to Follow-up|0|||
150236258|NCT04593823|542002673|FG001|Overall Study|Lost to Follow-up|1|||
150236259|NCT02250534|542002674|FG000|Overall Study|Lost to Follow-up|18|||
150236260|NCT02250534|542002675|FG001|Overall Study|Lost to Follow-up|28|||
150236261|NCT02250534|542002676|FG002|Overall Study|Lost to Follow-up|33|||
150236262|NCT02250534|542002674|FG000|Overall Study|Personal reasons|7|||
150236263|NCT02250534|542002675|FG001|Overall Study|Personal reasons|8|||
150236264|NCT02250534|542002676|FG002|Overall Study|Personal reasons|14|||
150236265|NCT02250534|542002674|FG000|Overall Study|Adverse Event|6|||
150236266|NCT02250534|542002675|FG001|Overall Study|Adverse Event|3|||
150236267|NCT02250534|542002676|FG002|Overall Study|Adverse Event|8|||
150236268|NCT02250534|542002674|FG000|Overall Study|incarcerated|2|||
150236269|NCT02250534|542002675|FG001|Overall Study|incarcerated|1|||
150236270|NCT02250534|542002676|FG002|Overall Study|incarcerated|2|||
150236271|NCT02250534|542002674|FG000|Overall Study|Withdrawal by Subject|0|||
150236272|NCT02250534|542002675|FG001|Overall Study|Withdrawal by Subject|1|||
150236273|NCT02250534|542002676|FG002|Overall Study|Withdrawal by Subject|2|||
150236274|NCT02250534|542002674|FG000|Overall Study|Death|0|||
150236275|NCT02250534|542002675|FG001|Overall Study|Death|1|||
150236276|NCT02250534|542002676|FG002|Overall Study|Death|1|||
150236277|NCT02250534|542002674|FG000|Overall Study|Physician Decision|1|||
150236278|NCT02250534|542002675|FG001|Overall Study|Physician Decision|3|||
150236279|NCT02250534|542002676|FG002|Overall Study|Physician Decision|1|||
150236280|NCT02250534|542002674|FG000|Overall Study|Protocol Violation|1|||
150236281|NCT02250534|542002675|FG001|Overall Study|Protocol Violation|0|||
150236282|NCT02250534|542002676|FG002|Overall Study|Protocol Violation|1|||
150236283|NCT02250534|542002674|FG000|Overall Study|Reason unknown|1|||
150236284|NCT02250534|542002675|FG001|Overall Study|Reason unknown|0|||
150236285|NCT02250534|542002676|FG002|Overall Study|Reason unknown|0|||
150236286|NCT01253447|542002678|FG000|Overall Study|Adverse Event|2|||
150236287|NCT02108652|542002679|FG000|Overall Study|Death|253|||
150236288|NCT02108652|542002679|FG000|Overall Study|Lost to Follow-up|2|||
150236289|NCT02108652|542002679|FG000|Overall Study|Withdrawal by Subject|16|||
150236290|NCT02108652|542002679|FG000|Overall Study|Study Terminated By Sponsor|31|||
150236291|NCT02108652|542002679|FG000|Overall Study|Non-Compliance|1|||
150236292|NCT02108652|542002679|FG000|Overall Study|Physician Decision|6|||
150236293|NCT02108652|542002679|FG000|Overall Study|Progression Of Disease|1|||
150236294|NCT01560871|542002682|FG000|Overall Study|transportation issues|2|||
150236295|NCT01560871|542002683|FG001|Overall Study|transportation issues|1|||
150236296|NCT01560871|542002682|FG000|Overall Study|relocation|1|||
150236297|NCT01560871|542002683|FG001|Overall Study|relocation|0|||
150236298|NCT01560871|542002682|FG000|Overall Study|readmission to a hospital|2|||
150236299|NCT01560871|542002683|FG001|Overall Study|readmission to a hospital|1|||
150236300|NCT01560871|542002682|FG000|Overall Study|Lost to Follow-up|1|||
150236301|NCT01560871|542002683|FG001|Overall Study|Lost to Follow-up|0|||
150236302|NCT00537329|542002684|FG000|Overall Study|Death|10|||
150236303|NCT00537329|542002684|FG000|Overall Study|Adverse Event|3|||
150236304|NCT00537329|542002684|FG000|Overall Study|Lack of Efficacy|2|||
150236305|NCT00537329|542002684|FG000|Overall Study|Lost to Follow-up|6|||
150236306|NCT00537329|542002684|FG000|Overall Study|Withdrawal by Subject|4|||
150236307|NCT00537329|542002684|FG000|Overall Study|Other|1|||
150236308|NCT00243022|542002685|FG000|Overall Study|Withdrawal by Subject|1|||
150236309|NCT00243022|542002686|FG001|Overall Study|Withdrawal by Subject|0|||
150236310|NCT00243022|542002685|FG000|Overall Study|Death|1|||
150236311|NCT00243022|542002686|FG001|Overall Study|Death|0|||
150236312|NCT00243022|542002685|FG000|Overall Study|Difficult Travel Distance|0|||
150236313|NCT00243022|542002686|FG001|Overall Study|Difficult Travel Distance|1|||
150236314|NCT01390441|542002687|FG000|Treatment Period|Protocol Violation|0|||
150236315|NCT01390441|542002688|FG001|Treatment Period|Protocol Violation|1|||
150236316|NCT01390441|542002689|FG002|Treatment Period|Protocol Violation|0|||
150236317|NCT01390441|542002690|FG003|Treatment Period|Protocol Violation|0|||
150236318|NCT01390441|542002691|FG004|Treatment Period|Protocol Violation|0|||
150236319|NCT01390441|542002687|FG000|Treatment Period|Physician Decision|0|||
150236320|NCT01390441|542002688|FG001|Treatment Period|Physician Decision|0|||
150236321|NCT01390441|542002689|FG002|Treatment Period|Physician Decision|0|||
150236322|NCT01390441|542002690|FG003|Treatment Period|Physician Decision|1|||
150236323|NCT01390441|542002691|FG004|Treatment Period|Physician Decision|0|||
150236324|NCT01390441|542002687|FG000|Treatment Period|Lack of Efficacy|0|||
150236325|NCT01390441|542002688|FG001|Treatment Period|Lack of Efficacy|0|||
150236326|NCT01390441|542002689|FG002|Treatment Period|Lack of Efficacy|0|||
150236327|NCT01390441|542002690|FG003|Treatment Period|Lack of Efficacy|0|||
150236328|NCT01390441|542002691|FG004|Treatment Period|Lack of Efficacy|1|||
150236329|NCT01390441|542002687|FG000|Treatment Period|Unknown due to early stopping of study|0|||
150236330|NCT01390441|542002688|FG001|Treatment Period|Unknown due to early stopping of study|0|||
150236331|NCT01390441|542002689|FG002|Treatment Period|Unknown due to early stopping of study|8|||
150236332|NCT01390441|542002690|FG003|Treatment Period|Unknown due to early stopping of study|11|||
150236333|NCT01390441|542002691|FG004|Treatment Period|Unknown due to early stopping of study|7|||
150236334|NCT01390441|542002687|FG000|Treatment Period|Adverse Event|0|||
150236335|NCT01390441|542002688|FG001|Treatment Period|Adverse Event|0|||
150236336|NCT01390441|542002689|FG002|Treatment Period|Adverse Event|1|||
150236337|NCT01390441|542002690|FG003|Treatment Period|Adverse Event|1|||
150236338|NCT01390441|542002691|FG004|Treatment Period|Adverse Event|2|||
150236339|NCT01390441|542002687|FG000|Treatment Period|Withdrawal by Subject|0|||
150236340|NCT01390441|542002688|FG001|Treatment Period|Withdrawal by Subject|0|||
150236341|NCT01390441|542002689|FG002|Treatment Period|Withdrawal by Subject|1|||
150236342|NCT01390441|542002690|FG003|Treatment Period|Withdrawal by Subject|0|||
150236343|NCT01390441|542002691|FG004|Treatment Period|Withdrawal by Subject|1|||
150236344|NCT01390441|542002687|FG000|Treatment Period|Lost to Follow-up|1|||
150236345|NCT01390441|542002688|FG001|Treatment Period|Lost to Follow-up|0|||
150236346|NCT01390441|542002689|FG002|Treatment Period|Lost to Follow-up|0|||
150236347|NCT01390441|542002690|FG003|Treatment Period|Lost to Follow-up|0|||
150236348|NCT01390441|542002691|FG004|Treatment Period|Lost to Follow-up|0|||
150236349|NCT01390441|542002687|FG000|Extension Period|Protocol Violation|3|||
150236350|NCT01390441|542002688|FG001|Extension Period|Protocol Violation|1|||
150236351|NCT01390441|542002689|FG002|Extension Period|Protocol Violation|0|||
150236352|NCT01390441|542002690|FG003|Extension Period|Protocol Violation|1|||
150236353|NCT01390441|542002691|FG004|Extension Period|Protocol Violation|0|||
150236354|NCT00621192|542002692|FG000|Overall Study|Withdrawal by Subject|0|||
150236355|NCT00621192|542002693|FG001|Overall Study|Withdrawal by Subject|0|||
150236356|NCT00621192|542002694|FG002|Overall Study|Withdrawal by Subject|2|||
150236357|NCT00621192|542002695|FG003|Overall Study|Withdrawal by Subject|0|||
150236358|NCT00621192|542002692|FG000|Overall Study|Physician Decision|1|||
150236359|NCT00621192|542002693|FG001|Overall Study|Physician Decision|3|||
150236360|NCT00621192|542002694|FG002|Overall Study|Physician Decision|0|||
150236361|NCT00621192|542002695|FG003|Overall Study|Physician Decision|0|||
150236362|NCT00621192|542002692|FG000|Overall Study|Protocol Violation|1|||
150236363|NCT00621192|542002693|FG001|Overall Study|Protocol Violation|0|||
150236364|NCT00621192|542002694|FG002|Overall Study|Protocol Violation|0|||
150236365|NCT00621192|542002695|FG003|Overall Study|Protocol Violation|1|||
150236366|NCT00621192|542002692|FG000|Overall Study|Adverse Event|0|||
150236367|NCT00621192|542002693|FG001|Overall Study|Adverse Event|1|||
150236368|NCT00621192|542002694|FG002|Overall Study|Adverse Event|0|||
150236369|NCT00621192|542002695|FG003|Overall Study|Adverse Event|1|||
150236370|NCT00621192|542002692|FG000|Overall Study|Death|2|||
150236371|NCT00621192|542002693|FG001|Overall Study|Death|5|||
150236372|NCT00621192|542002694|FG002|Overall Study|Death|0|||
150236373|NCT00621192|542002695|FG003|Overall Study|Death|0|||
150236374|NCT00621192|542002692|FG000|Overall Study|Final Assessments not Completed|0|||
150236375|NCT00621192|542002693|FG001|Overall Study|Final Assessments not Completed|0|||
150236376|NCT00621192|542002694|FG002|Overall Study|Final Assessments not Completed|3|||
150236377|NCT00621192|542002695|FG003|Overall Study|Final Assessments not Completed|1|||
150236378|NCT04706793|542002696|FG000|Treatment|Disease worsening|10|||
150236379|NCT04706793|542002697|FG001|Treatment|Disease worsening|10|||
150236380|NCT04706793|542002696|FG000|Follow-up|Lack of Efficacy|1|||
150236381|NCT04706793|542002697|FG001|Follow-up|Lack of Efficacy|0|||
150236382|NCT04706793|542002696|FG000|Follow-up|Disease worsening|8|||
150236383|NCT04706793|542002697|FG001|Follow-up|Disease worsening|10|||
150236384|NCT04706793|542002696|FG000|Follow-up|Adverse Event|1|||
150236385|NCT04706793|542002697|FG001|Follow-up|Adverse Event|0|||
150236386|NCT00823836|542002698|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
150236387|NCT00823836|542002699|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
150236388|NCT00823836|542002698|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
150236389|NCT00823836|542002699|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
150236390|NCT00823836|542002698|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
150236391|NCT00823836|542002699|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
150236392|NCT00823836|542002698|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
150236393|NCT00823836|542002699|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
150236394|NCT00823836|542002698|FG000|Long-term Phase|Adverse Event|3|||
150236395|NCT00823836|542002699|FG001|Long-term Phase|Adverse Event|2|||
150236396|NCT00823836|542002698|FG000|Long-term Phase|Physician Decision|1|||
150236397|NCT00823836|542002699|FG001|Long-term Phase|Physician Decision|2|||
150236398|NCT00823836|542002698|FG000|Long-term Phase|Withdrawal by Subject|1|||
150236399|NCT00823836|542002699|FG001|Long-term Phase|Withdrawal by Subject|1|||
150236400|NCT02725528|542002700|FG000|Overall Study|Lost to Follow-up|1|||
150236401|NCT02725528|542002701|FG001|Overall Study|Lost to Follow-up|4|||
150236402|NCT02725528|542002700|FG000|Overall Study|Withdrawal by Subject|0|||
150236403|NCT02725528|542002701|FG001|Overall Study|Withdrawal by Subject|1|||
150236404|NCT02287233|542002702|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
150236405|NCT02287233|542002703|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
150236406|NCT02287233|542002704|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
150236407|NCT02287233|542002702|FG000|Overall Study|Adverse Event Related to Progression|0|||
150236408|NCT02287233|542002703|FG001|Overall Study|Adverse Event Related to Progression|2|||
150236409|NCT02287233|542002704|FG002|Overall Study|Adverse Event Related to Progression|8|||
150236410|NCT02287233|542002702|FG000|Overall Study|Physician Decision|1|||
150236411|NCT02287233|542002703|FG001|Overall Study|Physician Decision|2|||
150236412|NCT02287233|542002704|FG002|Overall Study|Physician Decision|4|||
150236413|NCT02287233|542002702|FG000|Overall Study|Progressive Disease with Death|0|||
150236414|NCT02287233|542002703|FG001|Overall Study|Progressive Disease with Death|0|||
150236415|NCT02287233|542002704|FG002|Overall Study|Progressive Disease with Death|10|||
150236416|NCT02287233|542002702|FG000|Overall Study|Progressive Disease Without Death|2|||
150236417|NCT02287233|542002703|FG001|Overall Study|Progressive Disease Without Death|3|||
150236418|NCT02287233|542002704|FG002|Overall Study|Progressive Disease Without Death|20|||
150236419|NCT02287233|542002702|FG000|Overall Study|Withdrawal by Subject|1|||
150236420|NCT02287233|542002703|FG001|Overall Study|Withdrawal by Subject|1|||
150236421|NCT02287233|542002704|FG002|Overall Study|Withdrawal by Subject|7|||
150236422|NCT02287233|542002702|FG000|Overall Study|Other|3|||
150236423|NCT02287233|542002703|FG001|Overall Study|Other|0|||
150236424|NCT02287233|542002704|FG002|Overall Study|Other|15|||
150236425|NCT02287233|542002702|FG000|Overall Study|Did Not Receive Treatment|0|||
150236426|NCT02287233|542002703|FG001|Overall Study|Did Not Receive Treatment|0|||
150236427|NCT02287233|542002704|FG002|Overall Study|Did Not Receive Treatment|2|||
150236428|NCT02804399|542002705|FG000|Period 2|Adverse Event|0|||
150236429|NCT02804399|542002706|FG001|Period 2|Adverse Event|1|||
150236430|NCT02058836|542002707|FG000|Overall Study|Withdrawal by Subject|1|||
150236431|NCT02058836|542002708|FG001|Overall Study|Withdrawal by Subject|1|||
150236432|NCT01774305|542002711|FG000|Overall Study|Physician Decision|1|||
150236433|NCT01774305|542002712|FG001|Overall Study|Physician Decision|0|||
150236434|NCT02168478|542002713|FG000|Overall Study|Withdrawal by Subject|1|||
150236435|NCT02168478|542002713|FG000|Overall Study|Did Not Consent to Participation|2|||
150236436|NCT02168478|542002713|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
150236437|NCT01157377|542002714|FG000|Overall Study|Lost to Follow-up|0|||
150236438|NCT01157377|542002715|FG001|Overall Study|Lost to Follow-up|0|||
150236439|NCT01157377|542002716|FG002|Overall Study|Lost to Follow-up|1|||
150236440|NCT01157377|542002717|FG003|Overall Study|Lost to Follow-up|0|||
150236441|NCT01157377|542002718|FG004|Overall Study|Lost to Follow-up|1|||
150236442|NCT01157377|542002719|FG005|Overall Study|Lost to Follow-up|1|||
150236443|NCT01157377|542002720|FG006|Overall Study|Lost to Follow-up|0|||
150236444|NCT01157377|542002714|FG000|Overall Study|Personal Reasons|2|||
150236445|NCT01157377|542002715|FG001|Overall Study|Personal Reasons|1|||
150236446|NCT01157377|542002716|FG002|Overall Study|Personal Reasons|0|||
150236447|NCT01157377|542002717|FG003|Overall Study|Personal Reasons|1|||
150236448|NCT01157377|542002718|FG004|Overall Study|Personal Reasons|0|||
150236449|NCT01157377|542002719|FG005|Overall Study|Personal Reasons|0|||
150236450|NCT01157377|542002720|FG006|Overall Study|Personal Reasons|0|||
150236451|NCT01157377|542002714|FG000|Overall Study|Protocol Violation|0|||
150236452|NCT01157377|542002715|FG001|Overall Study|Protocol Violation|0|||
150236453|NCT01157377|542002716|FG002|Overall Study|Protocol Violation|0|||
150236454|NCT01157377|542002717|FG003|Overall Study|Protocol Violation|0|||
150236455|NCT01157377|542002718|FG004|Overall Study|Protocol Violation|0|||
150236456|NCT01157377|542002719|FG005|Overall Study|Protocol Violation|1|||
150236457|NCT01157377|542002720|FG006|Overall Study|Protocol Violation|0|||
150236458|NCT01157377|542002714|FG000|Overall Study|Lack of Efficacy|0|||
150236459|NCT01157377|542002715|FG001|Overall Study|Lack of Efficacy|0|||
150236460|NCT01157377|542002716|FG002|Overall Study|Lack of Efficacy|0|||
150236461|NCT01157377|542002717|FG003|Overall Study|Lack of Efficacy|0|||
150236462|NCT01157377|542002718|FG004|Overall Study|Lack of Efficacy|0|||
150236463|NCT01157377|542002719|FG005|Overall Study|Lack of Efficacy|0|||
150236464|NCT01157377|542002720|FG006|Overall Study|Lack of Efficacy|1|||
150236465|NCT01157377|542002714|FG000|Overall Study|Other Miscellaneous Reasons|0|||
150236466|NCT01157377|542002715|FG001|Overall Study|Other Miscellaneous Reasons|2|||
150236467|NCT01157377|542002716|FG002|Overall Study|Other Miscellaneous Reasons|0|||
150236468|NCT01157377|542002717|FG003|Overall Study|Other Miscellaneous Reasons|0|||
150236469|NCT01157377|542002718|FG004|Overall Study|Other Miscellaneous Reasons|1|||
150236470|NCT01157377|542002719|FG005|Overall Study|Other Miscellaneous Reasons|1|||
150236471|NCT01157377|542002720|FG006|Overall Study|Other Miscellaneous Reasons|1|||
150236472|NCT00904722|542002731|FG000|Overall Study|Physician Decision|1|||
150236473|NCT01801982|542002735|FG000|Overall Study|Lost to Follow-up|1|||
150236474|NCT00727506|542002736|FG000|Overall Study|Adverse Event|0|||
150236475|NCT00727506|542002737|FG001|Overall Study|Adverse Event|0|||
150236476|NCT00727506|542002738|FG002|Overall Study|Adverse Event|4|||
150236477|NCT00727506|542002739|FG003|Overall Study|Adverse Event|4|||
150236478|NCT00727506|542002740|FG004|Overall Study|Adverse Event|1|||
150236479|NCT00727506|542002741|FG005|Overall Study|Adverse Event|8|||
150236480|NCT00727506|542002736|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
150236481|NCT00727506|542002737|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150236482|NCT00727506|542002738|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
150236483|NCT00727506|542002739|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150236484|NCT00727506|542002740|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150236485|NCT00727506|542002741|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
150236486|NCT00727506|542002736|FG000|Overall Study|Progressive disease|4|||
150236487|NCT00727506|542002737|FG001|Overall Study|Progressive disease|7|||
150236488|NCT00727506|542002738|FG002|Overall Study|Progressive disease|9|||
150236489|NCT00727506|542002739|FG003|Overall Study|Progressive disease|28|||
150236490|NCT00727506|542002740|FG004|Overall Study|Progressive disease|38|||
150236491|NCT00727506|542002741|FG005|Overall Study|Progressive disease|28|||
150236492|NCT00727506|542002736|FG000|Overall Study|Refused to continue medication|0|||
150236493|NCT00727506|542002737|FG001|Overall Study|Refused to continue medication|1|||
150236494|NCT00727506|542002738|FG002|Overall Study|Refused to continue medication|2|||
150236495|NCT00727506|542002739|FG003|Overall Study|Refused to continue medication|3|||
150236496|NCT00727506|542002740|FG004|Overall Study|Refused to continue medication|1|||
150236497|NCT00727506|542002741|FG005|Overall Study|Refused to continue medication|2|||
150236498|NCT00727506|542002736|FG000|Overall Study|Other reason not described above|0|||
150236499|NCT00727506|542002737|FG001|Overall Study|Other reason not described above|0|||
150236500|NCT00727506|542002738|FG002|Overall Study|Other reason not described above|1|||
150236501|NCT00727506|542002739|FG003|Overall Study|Other reason not described above|4|||
150236502|NCT00727506|542002740|FG004|Overall Study|Other reason not described above|1|||
150236503|NCT00727506|542002741|FG005|Overall Study|Other reason not described above|1|||
150236504|NCT02650466|542002742|FG000|Overall Study|Physician Decision|1|||
150236505|NCT02650466|542002742|FG000|Overall Study|Withdrawal by Subject|5|||
150236506|NCT02650466|542002742|FG000|Overall Study|Lost to Follow-up|1|||
150236507|NCT01214421|542002743|FG000|Overall Study|Lost to Follow-up|7|||
150236508|NCT01214421|542002744|FG001|Overall Study|Lost to Follow-up|3|||
150236509|NCT01214421|542002745|FG002|Overall Study|Lost to Follow-up|7|||
150236510|NCT01214421|542002746|FG003|Overall Study|Lost to Follow-up|3|||
150236511|NCT01214421|542002743|FG000|Overall Study|Adverse Event|16|||
150236512|NCT01214421|542002744|FG001|Overall Study|Adverse Event|35|||
150236513|NCT01214421|542002745|FG002|Overall Study|Adverse Event|14|||
150236514|NCT01214421|542002746|FG003|Overall Study|Adverse Event|3|||
150236515|NCT01214421|542002743|FG000|Overall Study|Sponsor Discontinued Site|1|||
150236516|NCT01214421|542002744|FG001|Overall Study|Sponsor Discontinued Site|2|||
150236517|NCT01214421|542002745|FG002|Overall Study|Sponsor Discontinued Site|0|||
150236518|NCT01214421|542002746|FG003|Overall Study|Sponsor Discontinued Site|0|||
150236519|NCT01214421|542002743|FG000|Overall Study|Withdrawal Criteria Met|3|||
150236520|NCT01214421|542002744|FG001|Overall Study|Withdrawal Criteria Met|0|||
150236521|NCT01214421|542002745|FG002|Overall Study|Withdrawal Criteria Met|2|||
150236522|NCT01214421|542002746|FG003|Overall Study|Withdrawal Criteria Met|1|||
150236523|NCT01214421|542002743|FG000|Overall Study|Physician Decision|2|||
150236524|NCT01214421|542002744|FG001|Overall Study|Physician Decision|0|||
150236525|NCT01214421|542002745|FG002|Overall Study|Physician Decision|4|||
150236526|NCT01214421|542002746|FG003|Overall Study|Physician Decision|0|||
150236527|NCT01214421|542002743|FG000|Overall Study|Withdrawal by Subject|21|||
150236528|NCT01214421|542002744|FG001|Overall Study|Withdrawal by Subject|18|||
150236529|NCT01214421|542002745|FG002|Overall Study|Withdrawal by Subject|11|||
150236530|NCT01214421|542002746|FG003|Overall Study|Withdrawal by Subject|2|||
150236531|NCT03783689|542002748|FG000|Overall Study|Adverse Event|2|||
150236532|NCT03783689|542002749|FG001|Overall Study|Adverse Event|0|||
150236533|NCT03783689|542002748|FG000|Overall Study|Lost to Follow-up|2|||
150236534|NCT03783689|542002749|FG001|Overall Study|Lost to Follow-up|1|||
150236535|NCT03783689|542002748|FG000|Overall Study|Physician Decision|2|||
150236536|NCT03783689|542002749|FG001|Overall Study|Physician Decision|1|||
150236537|NCT03783689|542002748|FG000|Overall Study|Withdrawal by Subject|3|||
150236538|NCT03783689|542002749|FG001|Overall Study|Withdrawal by Subject|3|||
150236539|NCT04795336|542004329|FG000|Overall Study|Withdrawal by Subject|3|||
150236540|NCT04795336|542004330|FG001|Overall Study|Withdrawal by Subject|4|||
150236541|NCT04795336|542004331|FG002|Overall Study|Withdrawal by Subject|3|||
150236542|NCT04795336|542004332|FG003|Overall Study|Withdrawal by Subject|12|||
150236543|NCT04795336|542004329|FG000|Overall Study|Lost study logs|0|||
150236544|NCT04795336|542004330|FG001|Overall Study|Lost study logs|1|||
150236545|NCT04795336|542004331|FG002|Overall Study|Lost study logs|0|||
150236546|NCT04795336|542004332|FG003|Overall Study|Lost study logs|2|||
150236547|NCT04795336|542004329|FG000|Overall Study|Did not take study medication|2|||
150236548|NCT04795336|542004330|FG001|Overall Study|Did not take study medication|0|||
150236549|NCT04795336|542004331|FG002|Overall Study|Did not take study medication|0|||
150236550|NCT04795336|542004332|FG003|Overall Study|Did not take study medication|0|||
150236551|NCT01638390|542004333|FG000|Overall Study|screening failures|21|||
150236552|NCT01536587|542004340|FG000|Overall Study|Adverse Event|2|||
150236553|NCT02666664|542004341|FG000|Overall Study|Physician Decision|0|||
150236554|NCT02666664|542004342|FG001|Overall Study|Physician Decision|1|||
150236555|NCT02666664|542004341|FG000|Overall Study|Protocol Violation|0|||
150236556|NCT02666664|542004342|FG001|Overall Study|Protocol Violation|2|||
150236557|NCT02666664|542004341|FG000|Overall Study|Other|0|||
150236558|NCT02666664|542004342|FG001|Overall Study|Other|1|||
150236559|NCT02666664|542004341|FG000|Overall Study|Adverse Event|12|||
150236560|NCT02666664|542004342|FG001|Overall Study|Adverse Event|37|||
150236561|NCT02666664|542004341|FG000|Overall Study|Withdrawal by participant|23|||
150236562|NCT02666664|542004342|FG001|Overall Study|Withdrawal by participant|40|||
150236563|NCT02666664|542004341|FG000|Overall Study|Sponsor decision|0|||
150236564|NCT02666664|542004342|FG001|Overall Study|Sponsor decision|1|||
150236565|NCT02666664|542004341|FG000|Overall Study|Lost to Follow-up|1|||
150236566|NCT02666664|542004342|FG001|Overall Study|Lost to Follow-up|2|||
150236567|NCT04596995|542004343|FG000|Overall Study|Lack of Efficacy|8|||
150236568|NCT04596995|542004343|FG000|Overall Study|Lost to Follow-up|3|||
150236569|NCT04596995|542004343|FG000|Overall Study|Withdrawal by Subject|12|||
150236570|NCT04596995|542004343|FG000|Overall Study|Sponsor decision|3|||
150236571|NCT04596995|542004343|FG000|Overall Study|Enrolled in managed access program|3|||
150236572|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
150236573|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
150236574|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
150236575|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Death|4|||
150236576|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Death|2|||
150236577|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Death|3|||
150236578|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
150236579|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
150236580|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
150236581|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
150236582|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
150236583|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
150236584|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
150236585|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
150236586|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
150236587|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
150236588|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
150236589|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
150236590|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
150236591|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
150236592|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
150236593|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
150236594|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
150236595|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
150236596|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
150236597|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
150236598|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
150236599|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
150236600|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
150236601|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
150236602|NCT02783573|542004344|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
150236603|NCT02783573|542004345|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
150236604|NCT02783573|542004346|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
150236605|NCT02783573|542004344|FG000|Delayed-Start Period|Sponsor Decision|0|||
150236606|NCT02783573|542004345|FG001|Delayed-Start Period|Sponsor Decision|17|||
150236607|NCT02783573|542004346|FG002|Delayed-Start Period|Sponsor Decision|12|||
150236608|NCT00589303|542004347|FG000|Overall Study|Withdrawal by Subject|2|||
150236609|NCT00589303|542004348|FG001|Overall Study|Withdrawal by Subject|1|||
150236610|NCT04836559|542004350|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
150236611|NCT04836559|542004351|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
150236612|NCT04836559|542004352|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
150236613|NCT04836559|542004353|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
150236614|NCT04836559|542004354|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
150236615|NCT04836559|542004355|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
150236616|NCT04836559|542004356|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
150236617|NCT04836559|542004357|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
150236618|NCT04836559|542004350|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
150236619|NCT04836559|542004351|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
150236620|NCT04836559|542004352|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
150236621|NCT04836559|542004353|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
150236622|NCT04836559|542004354|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
150236623|NCT04836559|542004355|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
150236624|NCT04836559|542004356|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
150236625|NCT04836559|542004357|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
150236626|NCT04836559|542004350|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
150236627|NCT04836559|542004351|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236628|NCT04836559|542004352|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236629|NCT04836559|542004353|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236630|NCT04836559|542004354|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236631|NCT04836559|542004355|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236632|NCT04836559|542004356|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236633|NCT04836559|542004357|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
150236634|NCT04836559|542004350|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
150236635|NCT04836559|542004351|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236636|NCT04836559|542004352|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236637|NCT04836559|542004353|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236638|NCT04836559|542004354|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236639|NCT04836559|542004355|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236640|NCT04836559|542004356|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236641|NCT04836559|542004357|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
150236642|NCT04836559|542004350|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236643|NCT04836559|542004351|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236644|NCT04836559|542004352|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236645|NCT04836559|542004353|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
150236646|NCT04836559|542004354|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236647|NCT04836559|542004355|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236648|NCT04836559|542004356|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236649|NCT04836559|542004357|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
150236650|NCT04836559|542004350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
150236651|NCT04836559|542004351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
150236652|NCT04836559|542004352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
150236653|NCT04836559|542004353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
150236654|NCT04836559|542004354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
150236655|NCT04836559|542004355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
150236656|NCT04836559|542004356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
150236657|NCT04836559|542004357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
150236658|NCT04836559|542004350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
150236659|NCT04836559|542004351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
150236660|NCT04836559|542004352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
150236661|NCT04836559|542004353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
150236662|NCT04836559|542004354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
150236663|NCT04836559|542004355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
150236664|NCT04836559|542004356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
150236665|NCT04836559|542004357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
150236666|NCT04836559|542004350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
150236667|NCT04836559|542004351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
150236668|NCT04836559|542004352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
150236669|NCT04836559|542004353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
150236670|NCT04836559|542004354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
150236671|NCT04836559|542004355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
150236672|NCT04836559|542004356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
150236673|NCT04836559|542004357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
150236674|NCT04836559|542004350|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236675|NCT04836559|542004351|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236676|NCT04836559|542004352|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236677|NCT04836559|542004353|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236678|NCT04836559|542004354|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236679|NCT04836559|542004355|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236680|NCT04836559|542004356|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
150236681|NCT04836559|542004357|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
150236682|NCT00730015|542004358|FG000|Overall Study|Adverse Event|11|||
150236683|NCT00730015|542004359|FG001|Overall Study|Adverse Event|10|||
150236684|NCT00730015|542004360|FG002|Overall Study|Adverse Event|8|||
150236685|NCT00730015|542004358|FG000|Overall Study|Protocol Violation|2|||
150236686|NCT00730015|542004359|FG001|Overall Study|Protocol Violation|6|||
150236687|NCT00730015|542004360|FG002|Overall Study|Protocol Violation|4|||
150236688|NCT00730015|542004358|FG000|Overall Study|Withdrawal by Subject|12|||
150236689|NCT00730015|542004359|FG001|Overall Study|Withdrawal by Subject|12|||
150236690|NCT00730015|542004360|FG002|Overall Study|Withdrawal by Subject|8|||
150236691|NCT00730015|542004358|FG000|Overall Study|Lost to Follow-up|4|||
150236692|NCT00730015|542004359|FG001|Overall Study|Lost to Follow-up|10|||
150236693|NCT00730015|542004360|FG002|Overall Study|Lost to Follow-up|3|||
150236694|NCT00730015|542004358|FG000|Overall Study|Lack of Efficacy|1|||
150236695|NCT00730015|542004359|FG001|Overall Study|Lack of Efficacy|2|||
150236696|NCT00730015|542004360|FG002|Overall Study|Lack of Efficacy|8|||
150236697|NCT00730015|542004358|FG000|Overall Study|Other Reason|1|||
150236698|NCT00730015|542004359|FG001|Overall Study|Other Reason|0|||
150236699|NCT00730015|542004360|FG002|Overall Study|Other Reason|1|||
150236700|NCT04978350|542004361|FG000|Overall Study|Lost to Follow-up|6|||
150236701|NCT00013611|542004362|FG000|Overall Study|Lost to Follow-up|91|||
150236702|NCT00013611|542004363|FG001|Overall Study|Lost to Follow-up|100|||
150236703|NCT05382039|542004364|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
150236704|NCT05382039|542004365|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
150236705|NCT05382039|542004366|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
150236706|NCT05382039|542004364|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
150236707|NCT05382039|542004365|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
150236708|NCT05382039|542004366|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
150236709|NCT05382039|542004364|FG000|Overall Study|waiting for confirmation|0|||
150236710|NCT05382039|542004365|FG001|Overall Study|waiting for confirmation|0|||
150236711|NCT05382039|542004366|FG002|Overall Study|waiting for confirmation|1|||
150236712|NCT01432626|542004367|FG000|Overall Study|LV function recovered|2|||
150236713|NCT01432626|542004367|FG000|Overall Study|Withdrawal by Subject|2|||
150236714|NCT01432626|542004367|FG000|Overall Study|Only 1 image competed|2|||
150236715|NCT01432626|542004367|FG000|Overall Study|Imaging agent not available|1|||
150236716|NCT02577003|542004370|FG000|Overall Study|Adverse Event|2|||
150236717|NCT02577003|542004371|FG001|Overall Study|Adverse Event|4|||
150236718|NCT02577003|542004370|FG000|Overall Study|Withdrawal by Subject|0|||
150236719|NCT02577003|542004371|FG001|Overall Study|Withdrawal by Subject|1|||
150236720|NCT02786004|542004372|FG000|Overall Study|Withdrawal by Subject|0|||
150236721|NCT02786004|542004373|FG001|Overall Study|Withdrawal by Subject|1|||
150236722|NCT04351269|542004374|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
150236723|NCT04351269|542004375|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
150236724|NCT04351269|542004376|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
150236725|NCT04351269|542004374|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
150236726|NCT04351269|542004375|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
150236727|NCT04351269|542004376|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
150236728|NCT04351269|542004374|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
150236729|NCT04351269|542004375|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
150236730|NCT04351269|542004376|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
150236731|NCT04351269|542004374|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
150236732|NCT04351269|542004375|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
150236733|NCT04351269|542004376|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
150236734|NCT04351269|542004374|FG000|Overall Study|Lost to Follow-up|1|||
150236735|NCT04351269|542004375|FG001|Overall Study|Lost to Follow-up|3|||
150236736|NCT04351269|542004376|FG002|Overall Study|Lost to Follow-up|0|||
150236737|NCT03210519|542004377|FG000|Overall Study|Adverse Event|2|||
150236738|NCT03210519|542004378|FG001|Overall Study|Adverse Event|0|||
150236739|NCT04486313|542004381|FG000|Overall Study|Lost to Follow-up|7|||
150236740|NCT04486313|542004382|FG001|Overall Study|Lost to Follow-up|9|||
150236741|NCT04486313|542004381|FG000|Overall Study|Withdrawal by Subject|8|||
150236742|NCT04486313|542004382|FG001|Overall Study|Withdrawal by Subject|6|||
150236743|NCT04486313|542004381|FG000|Overall Study|Physician Decision|1|||
150236744|NCT04486313|542004382|FG001|Overall Study|Physician Decision|1|||
150236745|NCT04486313|542004381|FG000|Overall Study|Death|2|||
150236746|NCT04486313|542004382|FG001|Overall Study|Death|0|||
150236747|NCT04486313|542004381|FG000|Overall Study|Protocol Violation|1|||
150236748|NCT04486313|542004382|FG001|Overall Study|Protocol Violation|1|||
150236749|NCT00126659|542004383|FG000|Overall Study|Adverse Event|0|||
150236750|NCT00126659|542004384|FG001|Overall Study|Adverse Event|0|||
150236751|NCT00126659|542004385|FG002|Overall Study|Adverse Event|2|||
150236752|NCT00174447|542004386|FG000|Overall Study|Adverse Event|19|||
150236753|NCT00174447|542004386|FG000|Overall Study|Withdrawal by Subject|15|||
150236754|NCT00174447|542004386|FG000|Overall Study|Protocol Violation|1|||
150236755|NCT00174447|542004386|FG000|Overall Study|Lack of Efficacy|1|||
150236756|NCT00174447|542004386|FG000|Overall Study|Administrative reason/Other|2|||
150236757|NCT01013961|542004389|FG000|Overall Study|Adverse Event|2|||
150236758|NCT01013961|542004390|FG001|Overall Study|Adverse Event|2|||
150236759|NCT01013961|542004389|FG000|Overall Study|Withdrawal by Subject|1|||
150236760|NCT01013961|542004390|FG001|Overall Study|Withdrawal by Subject|0|||
150236761|NCT01013961|542004389|FG000|Overall Study|Physician Decision|0|||
150236762|NCT01013961|542004390|FG001|Overall Study|Physician Decision|1|||
150236763|NCT03865953|542004401|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
150236764|NCT03865953|542004402|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
150236765|NCT03865953|542004401|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
150236766|NCT03865953|542004402|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
150236767|NCT03865953|542004401|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
150236768|NCT03865953|542004402|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
150236769|NCT02229578|542004403|FG000|Overall Study|Withdrawal by Subject|1|||
150236770|NCT02229578|542004404|FG001|Overall Study|Withdrawal by Subject|3|||
150236771|NCT02229578|542004403|FG000|Overall Study|Protocol Violation|2|||
150236772|NCT02229578|542004404|FG001|Overall Study|Protocol Violation|0|||
150236773|NCT00943787|542004405|FG000|Overall Study|Physician Decision|4|||
150236774|NCT00943787|542004405|FG000|Overall Study|Withdrawal by Subject|3|||
150236775|NCT01777334|542004408|FG000|Overall Study|Adverse Event|18|||
150236776|NCT01777334|542004409|FG001|Overall Study|Adverse Event|14|||
150236777|NCT01777334|542004408|FG000|Overall Study|Lack of Efficacy|15|||
150236778|NCT01777334|542004409|FG001|Overall Study|Lack of Efficacy|29|||
150236779|NCT01777334|542004408|FG000|Overall Study|Protocol Violation|3|||
150236780|NCT01777334|542004409|FG001|Overall Study|Protocol Violation|7|||
150236781|NCT01777334|542004408|FG000|Overall Study|Lost to Follow-up|3|||
150236782|NCT01777334|542004409|FG001|Overall Study|Lost to Follow-up|2|||
150236783|NCT01777334|542004408|FG000|Overall Study|Withdrawal by Subject|14|||
150236784|NCT01777334|542004409|FG001|Overall Study|Withdrawal by Subject|11|||
150236785|NCT03603639|542004410|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
150236786|NCT03603639|542004411|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
150236787|NCT03603639|542004412|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
150236788|NCT03603639|542004413|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
150236789|NCT03603639|542004414|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
150236790|NCT03603639|542004415|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
150236791|NCT03603639|542004410|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
150236792|NCT03603639|542004411|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
150236793|NCT03603639|542004412|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
150236794|NCT03603639|542004413|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
150236795|NCT03603639|542004414|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
150236796|NCT03603639|542004415|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
150236797|NCT00756457|542004417|FG000|Overall Study|Lost to Follow-up|1|||
150236798|NCT00756457|542004418|FG001|Overall Study|Lost to Follow-up|2|||
150236799|NCT02413593|542004420|FG000|Overall Study|Lost to Follow-up|3|||
150236800|NCT02413593|542004420|FG000|Overall Study|Adverse Event|1|||
150236801|NCT00409409|542004421|FG000|Overall Study|Adverse Event|7|||
150236802|NCT00409409|542004422|FG001|Overall Study|Adverse Event|2|||
150236803|NCT00409409|542004421|FG000|Overall Study|Withdrawal by Subject|1|||
150236804|NCT00409409|542004422|FG001|Overall Study|Withdrawal by Subject|1|||
150236805|NCT00409409|542004421|FG000|Overall Study|Any other reason not above-mentioned|0|||
150236806|NCT00409409|542004422|FG001|Overall Study|Any other reason not above-mentioned|1|||
150236807|NCT03599622|542004425|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
150236808|NCT03599622|542004426|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
150236809|NCT03599622|542004427|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
150236810|NCT03599622|542004428|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
150236811|NCT03599622|542004425|FG000|Pre-Treatment Period|Other reasons|1|||
150236812|NCT03599622|542004426|FG001|Pre-Treatment Period|Other reasons|1|||
150236813|NCT03599622|542004427|FG002|Pre-Treatment Period|Other reasons|1|||
150236814|NCT03599622|542004428|FG003|Pre-Treatment Period|Other reasons|0|||
150236815|NCT03599622|542004425|FG000|Treatment Period|Adverse Event|11|||
150236816|NCT03599622|542004426|FG001|Treatment Period|Adverse Event|20|||
150236817|NCT03599622|542004427|FG002|Treatment Period|Adverse Event|18|||
150236818|NCT03599622|542004428|FG003|Treatment Period|Adverse Event|2|||
150236819|NCT03599622|542004425|FG000|Treatment Period|Lack of Efficacy|18|||
150236820|NCT03599622|542004426|FG001|Treatment Period|Lack of Efficacy|12|||
150236821|NCT03599622|542004427|FG002|Treatment Period|Lack of Efficacy|13|||
150236822|NCT03599622|542004428|FG003|Treatment Period|Lack of Efficacy|2|||
150236823|NCT03599622|542004425|FG000|Treatment Period|Withdrawal by Subject|5|||
150236824|NCT03599622|542004426|FG001|Treatment Period|Withdrawal by Subject|11|||
150236825|NCT03599622|542004427|FG002|Treatment Period|Withdrawal by Subject|16|||
150236826|NCT03599622|542004428|FG003|Treatment Period|Withdrawal by Subject|1|||
150236827|NCT03599622|542004425|FG000|Treatment Period|Other reasons|4|||
150236828|NCT03599622|542004426|FG001|Treatment Period|Other reasons|6|||
150236829|NCT03599622|542004427|FG002|Treatment Period|Other reasons|7|||
150236830|NCT03599622|542004428|FG003|Treatment Period|Other reasons|0|||
150236831|NCT03599622|542004425|FG000|Treatment Period|Lost to Follow-up|1|||
150236832|NCT03599622|542004426|FG001|Treatment Period|Lost to Follow-up|0|||
150236833|NCT03599622|542004427|FG002|Treatment Period|Lost to Follow-up|0|||
150236834|NCT03599622|542004428|FG003|Treatment Period|Lost to Follow-up|0|||
150236835|NCT03599622|542004425|FG000|Treatment Period|Study terminated by sponsor|7|||
150236836|NCT03599622|542004426|FG001|Treatment Period|Study terminated by sponsor|20|||
150236837|NCT03599622|542004427|FG002|Treatment Period|Study terminated by sponsor|15|||
150236838|NCT03599622|542004428|FG003|Treatment Period|Study terminated by sponsor|0|||
150236839|NCT03599622|542004425|FG000|Treatment Period|Site terminated by sponsor|0|||
150236840|NCT03599622|542004426|FG001|Treatment Period|Site terminated by sponsor|1|||
150236841|NCT03599622|542004427|FG002|Treatment Period|Site terminated by sponsor|0|||
150236842|NCT03599622|542004428|FG003|Treatment Period|Site terminated by sponsor|0|||
150236843|NCT01278615|542004431|FG000|Overall Study|Withdrawal by Subject|2|||
150236844|NCT00905359|542004432|FG000|Overall Study|Lost to Follow-up|17|||
150236845|NCT00905359|542004433|FG001|Overall Study|Lost to Follow-up|10|||
150236846|NCT00905359|542004432|FG000|Overall Study|Death|2|||
150236847|NCT00905359|542004433|FG001|Overall Study|Death|0|||
150236848|NCT00905359|542004432|FG000|Overall Study|Withdrawal consent|5|||
150236849|NCT00905359|542004433|FG001|Overall Study|Withdrawal consent|6|||
150236850|NCT02138253|542004434|FG000|Overall Study|Adverse Event|3|||
150236851|NCT02138253|542004435|FG001|Overall Study|Adverse Event|3|||
150236852|NCT02138253|542004434|FG000|Overall Study|Lost to Follow-up|2|||
150236853|NCT02138253|542004435|FG001|Overall Study|Lost to Follow-up|1|||
150236854|NCT02138253|542004434|FG000|Overall Study|Physician Decision|2|||
150236855|NCT02138253|542004435|FG001|Overall Study|Physician Decision|0|||
150236856|NCT02138253|542004434|FG000|Overall Study|Non compliance|1|||
150236857|NCT02138253|542004435|FG001|Overall Study|Non compliance|0|||
150236858|NCT02138253|542004434|FG000|Overall Study|Withdrawal by Subject|1|||
150236859|NCT02138253|542004435|FG001|Overall Study|Withdrawal by Subject|0|||
150236860|NCT01918371|542004436|FG000|Overall Study|Missing Data|1|||
150236861|NCT01918371|542004437|FG001|Overall Study|Missing Data|1|||
150236862|NCT01006889|542004438|FG000|Overall Study|Withdrawal by Subject|3|||
150236863|NCT01099579|542004445|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
150236864|NCT01099579|542004446|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
150236865|NCT01099579|542004447|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
150236866|NCT01099579|542004445|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
150236867|NCT01099579|542004446|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
150236868|NCT01099579|542004447|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
150236869|NCT01099579|542004445|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
150236870|NCT01099579|542004446|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
150236871|NCT01099579|542004447|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
150236872|NCT01099579|542004445|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
150236873|NCT01099579|542004446|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
150236874|NCT01099579|542004447|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
150236875|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
150236876|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
150236877|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
150236878|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
150236879|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
150236880|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
150236881|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
150236882|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
150236883|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
150236884|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
150236885|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
150236886|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
150236887|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
150236888|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
150236889|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
150236890|NCT01099579|542004445|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
150236891|NCT01099579|542004446|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
150236892|NCT01099579|542004447|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
150236893|NCT02706847|542004450|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
150236894|NCT02706847|542004451|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
150236895|NCT02706847|542004452|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
150236896|NCT02706847|542004453|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
150236897|NCT02706847|542004450|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
150236898|NCT02706847|542004451|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
150236899|NCT02706847|542004452|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
150236900|NCT02706847|542004453|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
150236901|NCT02706847|542004450|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
150236902|NCT02706847|542004451|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
150236903|NCT02706847|542004452|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
150236904|NCT02706847|542004453|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
150236905|NCT02706847|542004450|FG000|Period 1: Day 1 to Week 12|Other|4|||
150236906|NCT02706847|542004451|FG001|Period 1: Day 1 to Week 12|Other|4|||
150236907|NCT02706847|542004452|FG002|Period 1: Day 1 to Week 12|Other|2|||
150236908|NCT02706847|542004453|FG003|Period 1: Day 1 to Week 12|Other|2|||
150236909|NCT02706847|542004450|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
150236910|NCT02706847|542004451|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
150236911|NCT02706847|542004452|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
150236912|NCT02706847|542004453|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
150236913|NCT02706847|542004450|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
150236914|NCT02706847|542004451|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
150236915|NCT02706847|542004452|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
150236916|NCT02706847|542004453|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
150236917|NCT02706847|542004450|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
150236918|NCT02706847|542004451|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
150236919|NCT02706847|542004452|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
150236920|NCT02706847|542004453|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
150236921|NCT02706847|542004450|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
150236922|NCT02706847|542004451|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
150236923|NCT02706847|542004452|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
150236924|NCT02706847|542004453|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
150236925|NCT02706847|542004450|FG000|Period 1: Week 12 to Week 24|Other|1|||
150236926|NCT02706847|542004451|FG001|Period 1: Week 12 to Week 24|Other|0|||
150236927|NCT02706847|542004452|FG002|Period 1: Week 12 to Week 24|Other|1|||
150236928|NCT02706847|542004453|FG003|Period 1: Week 12 to Week 24|Other|4|||
150236929|NCT02706847|542004450|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
150236930|NCT02706847|542004451|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
150236931|NCT02706847|542004452|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
150236932|NCT02706847|542004453|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
150236933|NCT02706847|542004450|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
150236934|NCT02706847|542004451|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
150236935|NCT02706847|542004452|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
150236936|NCT02706847|542004453|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
150236937|NCT02706847|542004450|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
150236938|NCT02706847|542004451|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
150236939|NCT02706847|542004452|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
150236940|NCT02706847|542004453|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
150236941|NCT02706847|542004450|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
150236942|NCT02706847|542004451|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
150236943|NCT02706847|542004452|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
150236944|NCT02706847|542004453|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
150236945|NCT02706847|542004450|FG000|Period 2: Week 24 to Week 260|Other|8|||
150236946|NCT02706847|542004451|FG001|Period 2: Week 24 to Week 260|Other|5|||
150236947|NCT02706847|542004452|FG002|Period 2: Week 24 to Week 260|Other|15|||
150236948|NCT02706847|542004453|FG003|Period 2: Week 24 to Week 260|Other|15|||
150236949|NCT03432390|542004454|FG000|Apnea Period|Protocol Violation|2|||
150236950|NCT03432390|542004455|FG001|Apnea Period|Protocol Violation|2|||
150236951|NCT01087814|542004457|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
150236952|NCT01087814|542004458|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
150236953|NCT01087814|542004457|FG000|Second Intervention (5 Days)|Physician Decision|1|||
150236954|NCT01087814|542004458|FG001|Second Intervention (5 Days)|Physician Decision|0|||
150236955|NCT01427738|542004459|FG000|Overall Study|Death|12|||
150236956|NCT01427738|542004460|FG001|Overall Study|Death|9|||
150236957|NCT01427738|542004459|FG000|Overall Study|Severe debilitation, unable to continue|0|||
150236958|NCT01427738|542004460|FG001|Overall Study|Severe debilitation, unable to continue|1|||
150236959|NCT01427738|542004459|FG000|Overall Study|Subject unable to get to clinic|5|||
150236960|NCT01427738|542004460|FG001|Overall Study|Subject unable to get to clinic|2|||
150236961|NCT01427738|542004459|FG000|Overall Study|Withdrawal by Subject|0|||
150236962|NCT01427738|542004460|FG001|Overall Study|Withdrawal by Subject|2|||
150236963|NCT01427738|542004459|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
150236964|NCT01427738|542004460|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
150236965|NCT01427738|542004459|FG000|Overall Study|Lost to Follow-up|1|||
150236966|NCT01427738|542004460|FG001|Overall Study|Lost to Follow-up|5|||
150236967|NCT05314374|542004461|FG000|Overall Study|Adverse Event|2|||
150236968|NCT05314374|542004462|FG001|Overall Study|Adverse Event|2|||
150236969|NCT02658175|542004463|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
150236970|NCT02658175|542004464|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
150236971|NCT02658175|542004465|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
150236972|NCT02658175|542004463|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
150236973|NCT02658175|542004464|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
150236974|NCT02658175|542004465|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
150236975|NCT02658175|542004463|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
150236976|NCT02658175|542004464|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
150236977|NCT02658175|542004465|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
150236978|NCT02658175|542004463|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
150236979|NCT02658175|542004464|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
150236980|NCT02658175|542004465|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
150236981|NCT02658175|542004463|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
150236982|NCT02658175|542004464|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
150236983|NCT02658175|542004465|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
150236984|NCT02658175|542004463|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
150236985|NCT02658175|542004464|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
150236986|NCT02658175|542004465|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
150236987|NCT02658175|542004463|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
150236988|NCT02658175|542004464|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
150236989|NCT02658175|542004465|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
150236990|NCT02658175|542004463|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
150236991|NCT02658175|542004464|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
150236992|NCT02658175|542004465|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
150236993|NCT02658175|542004463|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
150236994|NCT02658175|542004464|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
150236995|NCT02658175|542004465|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
150236996|NCT02658175|542004463|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
150236997|NCT02658175|542004464|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
150236998|NCT02658175|542004465|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
150236999|NCT02918292|542004468|FG000|Study Enrollment Prior to Transplant|Death|1|||
150237000|NCT02918292|542004468|FG000|Study Follow up After Transplant|Death|6|||
150237001|NCT02392104|542004470|FG000|Overall Study|discontinuation of warfarin|3|||
150237002|NCT02392104|542004470|FG000|Overall Study|bleeding event|1|||
150237003|NCT02392104|542004470|FG000|Overall Study|transferred care to another doctor|2|||
150237004|NCT02392104|542004470|FG000|Overall Study|INR goal range changed|1|||
150237005|NCT02392104|542004470|FG000|Overall Study|admitted to skilled nursing facility|3|||
150237006|NCT02392104|542004470|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
150237007|NCT02636608|542004474|FG000|Overall Study|Failure to Return|4|||
150237008|NCT02636608|542004474|FG000|Overall Study|Insufficient Virological Response|1|||
150237009|NCT02636608|542004474|FG000|Overall Study|Death|3|||
150237010|NCT02636608|542004474|FG000|Overall Study|Other|2|||
150237011|NCT02636608|542004474|FG000|Overall Study|Did Not Receive Treatment|1|||
150237012|NCT03912532|542004475|FG000|Overall Study|Adverse Event|3|||
150237013|NCT03912532|542004476|FG001|Overall Study|Adverse Event|3|||
150237014|NCT03912532|542004477|FG002|Overall Study|Adverse Event|2|||
150237015|NCT03912532|542004478|FG003|Overall Study|Adverse Event|2|||
150237016|NCT03912532|542004475|FG000|Overall Study|Lost to Follow-up|3|||
150237017|NCT03912532|542004476|FG001|Overall Study|Lost to Follow-up|2|||
150237018|NCT03912532|542004477|FG002|Overall Study|Lost to Follow-up|1|||
150237019|NCT03912532|542004478|FG003|Overall Study|Lost to Follow-up|2|||
150237020|NCT03912532|542004475|FG000|Overall Study|Withdrawal by Subject|1|||
150237021|NCT03912532|542004476|FG001|Overall Study|Withdrawal by Subject|1|||
150237022|NCT03912532|542004477|FG002|Overall Study|Withdrawal by Subject|2|||
150237023|NCT03912532|542004478|FG003|Overall Study|Withdrawal by Subject|0|||
150237024|NCT03912532|542004475|FG000|Overall Study|Physician Decision|1|||
150237025|NCT03912532|542004476|FG001|Overall Study|Physician Decision|0|||
150237026|NCT03912532|542004477|FG002|Overall Study|Physician Decision|0|||
150237027|NCT03912532|542004478|FG003|Overall Study|Physician Decision|3|||
150237028|NCT03912532|542004475|FG000|Overall Study|Other|0|||
150237029|NCT03912532|542004476|FG001|Overall Study|Other|1|||
150237030|NCT03912532|542004477|FG002|Overall Study|Other|1|||
150237031|NCT03912532|542004478|FG003|Overall Study|Other|0|||
150237032|NCT04913948|542004479|FG000|Overall Study|Withdrawal by Subject|2|||
150237033|NCT04913948|542004479|FG000|Overall Study|Sample processing issues|1|||
150237034|NCT04913948|542004479|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
150237035|NCT00815919|542004480|FG000|Overall Study|Unrelated Fungal Infection|1|||
150237036|NCT00815919|542004480|FG000|Overall Study|AML Relapse|1|||
150237037|NCT00815919|542004480|FG000|Overall Study|Lack of Efficacy|2|||
150237038|NCT03522389|542004481|FG000|Overall Study|Lost to Follow-up|1|||
150237039|NCT03522389|542004482|FG001|Overall Study|Lost to Follow-up|1|||
150237040|NCT03522389|542004483|FG002|Overall Study|Lost to Follow-up|2|||
150237041|NCT03522389|542004481|FG000|Overall Study|had herniated nucleus pulposus|0|||
150237042|NCT03522389|542004482|FG001|Overall Study|had herniated nucleus pulposus|1|||
150237043|NCT03522389|542004483|FG002|Overall Study|had herniated nucleus pulposus|0|||
150237044|NCT03522389|542004481|FG000|Overall Study|go to work in other province|1|||
150237045|NCT03522389|542004482|FG001|Overall Study|go to work in other province|0|||
150237046|NCT03522389|542004483|FG002|Overall Study|go to work in other province|0|||
150237047|NCT04599907|542004485|FG000|Overall Study|Withdrawal by Subject|1|||
150237048|NCT04599907|542004486|FG001|Overall Study|Withdrawal by Subject|7|||
150237049|NCT04599907|542004487|FG002|Overall Study|Withdrawal by Subject|6|||
150237050|NCT04599907|542004485|FG000|Overall Study|Lost to Follow-up|0|||
150237051|NCT04599907|542004486|FG001|Overall Study|Lost to Follow-up|1|||
150237052|NCT04599907|542004487|FG002|Overall Study|Lost to Follow-up|0|||
150237053|NCT00966264|542006518|FG000|Overall Study|Lost to Follow-up|4|||
150237054|NCT00966264|542006519|FG001|Overall Study|Lost to Follow-up|3|||
150237055|NCT00487825|542006520|FG000|Overall Study|Adverse Event|2|||
150237056|NCT00487825|542006521|FG001|Overall Study|Adverse Event|2|||
150237057|NCT00487825|542006520|FG000|Overall Study|Lack of Efficacy|1|||
150237058|NCT00487825|542006521|FG001|Overall Study|Lack of Efficacy|1|||
150237059|NCT00487825|542006520|FG000|Overall Study|Other|3|||
150237060|NCT00487825|542006521|FG001|Overall Study|Other|2|||
150237061|NCT01986114|542006524|FG000|Overall Study|Adverse Event|59|||
150237062|NCT01986114|542006524|FG000|Overall Study|Lack of Efficacy|23|||
150237063|NCT01986114|542006524|FG000|Overall Study|Withdrawal by Subject|58|||
150237064|NCT01986114|542006524|FG000|Overall Study|Noncompliance|3|||
150237065|NCT01986114|542006524|FG000|Overall Study|Protocol Violation|1|||
150237066|NCT01986114|542006524|FG000|Overall Study|Lost to Follow-up|5|||
150237067|NCT01986114|542006524|FG000|Overall Study|Other reason|7|||
150237068|NCT01190644|542006525|FG000|Overall Study|Death|2|||
150237069|NCT01190644|542006525|FG000|Overall Study|Disease progression|1|||
150237070|NCT02366143|542006526|FG000|Overall Study|Death|307|||
150237071|NCT02366143|542006527|FG001|Overall Study|Death|278|||
150237072|NCT02366143|542006528|FG002|Overall Study|Death|280|||
150237073|NCT02366143|542006526|FG000|Overall Study|Lost to Follow-up|2|||
150237074|NCT02366143|542006527|FG001|Overall Study|Lost to Follow-up|4|||
150237075|NCT02366143|542006528|FG002|Overall Study|Lost to Follow-up|2|||
150237076|NCT02366143|542006526|FG000|Overall Study|Physician Decision|1|||
150237077|NCT02366143|542006527|FG001|Overall Study|Physician Decision|2|||
150237078|NCT02366143|542006528|FG002|Overall Study|Physician Decision|1|||
150237079|NCT02366143|542006526|FG000|Overall Study|Protocol Violation|0|||
150237080|NCT02366143|542006527|FG001|Overall Study|Protocol Violation|0|||
150237081|NCT02366143|542006528|FG002|Overall Study|Protocol Violation|2|||
150237082|NCT02366143|542006526|FG000|Overall Study|Withdrawal by Subject|16|||
150237083|NCT02366143|542006527|FG001|Overall Study|Withdrawal by Subject|17|||
150237084|NCT02366143|542006528|FG002|Overall Study|Withdrawal by Subject|22|||
150237085|NCT02366143|542006526|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
150237086|NCT02366143|542006527|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
150237087|NCT02366143|542006528|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
150237088|NCT02366143|542006526|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
150237089|NCT02366143|542006527|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
150237090|NCT02366143|542006528|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
150237091|NCT02366143|542006526|FG000|Overall Study|Randomization Error|1|||
150237092|NCT02366143|542006527|FG001|Overall Study|Randomization Error|0|||
150237093|NCT02366143|542006528|FG002|Overall Study|Randomization Error|0|||
150237094|NCT02366143|542006526|FG000|Overall Study|PI Move and Site Closure|1|||
150237095|NCT02366143|542006527|FG001|Overall Study|PI Move and Site Closure|0|||
150237096|NCT02366143|542006528|FG002|Overall Study|PI Move and Site Closure|1|||
150237097|NCT02366143|542006526|FG000|Overall Study|Study Terminated By Sponsor|0|||
150237098|NCT02366143|542006527|FG001|Overall Study|Study Terminated By Sponsor|0|||
150237099|NCT02366143|542006528|FG002|Overall Study|Study Terminated By Sponsor|2|||
150237100|NCT02366143|542006526|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
150237101|NCT02366143|542006527|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
150237102|NCT02366143|542006528|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
150237103|NCT02366143|542006526|FG000|Overall Study|Patient moved to roll-over study|1|||
150237104|NCT02366143|542006527|FG001|Overall Study|Patient moved to roll-over study|19|||
150237105|NCT02366143|542006528|FG002|Overall Study|Patient moved to roll-over study|28|||
150237106|NCT02366143|542006526|FG000|Overall Study|Patient moved to commercial stock|0|||
150237107|NCT02366143|542006527|FG001|Overall Study|Patient moved to commercial stock|0|||
150237108|NCT02366143|542006528|FG002|Overall Study|Patient moved to commercial stock|1|||
150237109|NCT02366143|542006526|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
150237110|NCT02366143|542006527|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
150237111|NCT02366143|542006528|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
150237112|NCT02366143|542006526|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
150237113|NCT02366143|542006527|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
150237114|NCT02366143|542006528|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
150237115|NCT02366143|542006526|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
150237116|NCT02366143|542006527|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
150237117|NCT02366143|542006528|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
150237118|NCT02366143|542006526|FG000|Overall Study|Requester's instructions|1|||
150237119|NCT02366143|542006527|FG001|Overall Study|Requester's instructions|1|||
150237120|NCT02366143|542006528|FG002|Overall Study|Requester's instructions|1|||
150237121|NCT02366143|542006526|FG000|Overall Study|Uneligible|0|||
150237122|NCT02366143|542006527|FG001|Overall Study|Uneligible|1|||
150237123|NCT02366143|542006528|FG002|Overall Study|Uneligible|0|||
150237124|NCT02366143|542006526|FG000|Overall Study|Post Trial Migration|0|||
150237125|NCT02366143|542006527|FG001|Overall Study|Post Trial Migration|1|||
150237126|NCT02366143|542006528|FG002|Overall Study|Post Trial Migration|0|||
150237127|NCT02366143|542006526|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
150237128|NCT02366143|542006527|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
150237129|NCT02366143|542006528|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
150237130|NCT02366143|542006526|FG000|Overall Study|Patient switched to PTAP|0|||
150237131|NCT02366143|542006527|FG001|Overall Study|Patient switched to PTAP|1|||
150237132|NCT02366143|542006528|FG002|Overall Study|Patient switched to PTAP|0|||
150237133|NCT02366143|542006526|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
150237134|NCT02366143|542006527|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
150237135|NCT02366143|542006528|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
150237136|NCT02172911|542006529|FG000|Overall Study|Serious Adverse Event|0|||
150237137|NCT02172911|542006530|FG001|Overall Study|Serious Adverse Event|1|||
150237138|NCT02172911|542006529|FG000|Overall Study|Progression of Disease|0|||
150237139|NCT02172911|542006530|FG001|Overall Study|Progression of Disease|1|||
150237140|NCT02172911|542006529|FG000|Overall Study|Loss of insurance coverage|1|||
150237141|NCT02172911|542006530|FG001|Overall Study|Loss of insurance coverage|0|||
150237142|NCT00575042|542006533|FG000|Overall Study|Adverse Event|2|||
150237143|NCT00575042|542006533|FG000|Overall Study|Lost to Follow-up|1|||
150237144|NCT01271504|542006536|FG000|Overall Study|Death|7|||
150237145|NCT01271504|542006537|FG001|Overall Study|Death|6|||
150237146|NCT01271504|542006538|FG002|Overall Study|Death|32|||
150237147|NCT01271504|542006539|FG003|Overall Study|Death|32|||
150237148|NCT01271504|542006536|FG000|Overall Study|Lost to Follow-up|0|||
150237149|NCT01271504|542006537|FG001|Overall Study|Lost to Follow-up|1|||
150237150|NCT01271504|542006538|FG002|Overall Study|Lost to Follow-up|3|||
150237151|NCT01271504|542006539|FG003|Overall Study|Lost to Follow-up|1|||
150237152|NCT01271504|542006536|FG000|Overall Study|Protocol Violation|0|||
150237153|NCT01271504|542006537|FG001|Overall Study|Protocol Violation|0|||
150237154|NCT01271504|542006538|FG002|Overall Study|Protocol Violation|0|||
150237155|NCT01271504|542006539|FG003|Overall Study|Protocol Violation|2|||
150237156|NCT01271504|542006536|FG000|Overall Study|Administrative Reasons|0|||
150237157|NCT01271504|542006537|FG001|Overall Study|Administrative Reasons|0|||
150237158|NCT01271504|542006538|FG002|Overall Study|Administrative Reasons|6|||
150237159|NCT01271504|542006539|FG003|Overall Study|Administrative Reasons|5|||
150237160|NCT01271504|542006536|FG000|Overall Study|Withdrawal by Subject|0|||
150237161|NCT01271504|542006537|FG001|Overall Study|Withdrawal by Subject|0|||
150237162|NCT01271504|542006538|FG002|Overall Study|Withdrawal by Subject|1|||
150237163|NCT01271504|542006539|FG003|Overall Study|Withdrawal by Subject|3|||
150237164|NCT01271504|542006536|FG000|Overall Study|Other|0|||
150237165|NCT01271504|542006537|FG001|Overall Study|Other|1|||
150237166|NCT01271504|542006538|FG002|Overall Study|Other|2|||
150237167|NCT01271504|542006539|FG003|Overall Study|Other|0|||
150237168|NCT00940875|542006546|FG000|Treatment Phase|Adverse Event|9|||
150237169|NCT00940875|542006547|FG001|Treatment Phase|Adverse Event|3|||
150237170|NCT00940875|542006546|FG000|Treatment Phase|Death|3|||
150237171|NCT00940875|542006547|FG001|Treatment Phase|Death|5|||
150237172|NCT00940875|542006546|FG000|Treatment Phase|Lack of Efficacy|1|||
150237173|NCT00940875|542006547|FG001|Treatment Phase|Lack of Efficacy|0|||
150237174|NCT00940875|542006546|FG000|Treatment Phase|Withdrawal by Subject|3|||
150237175|NCT00940875|542006547|FG001|Treatment Phase|Withdrawal by Subject|0|||
150237176|NCT00940875|542006546|FG000|Treatment Phase|Disease progression|9|||
150237177|NCT00940875|542006547|FG001|Treatment Phase|Disease progression|11|||
150237178|NCT00940875|542006546|FG000|Treatment Phase|Physician Decision|1|||
150237179|NCT00940875|542006547|FG001|Treatment Phase|Physician Decision|0|||
150237180|NCT00940875|542006546|FG000|Post-Study Treatment|Death|0|||
150237181|NCT00940875|542006547|FG001|Post-Study Treatment|Death|1|||
150237182|NCT00940875|542006546|FG000|Post-Study Treatment|Disease Progression|0|||
150237183|NCT00940875|542006547|FG001|Post-Study Treatment|Disease Progression|2|||
150237184|NCT00490945|542006548|FG000|Overall Study|Adverse Event|0|||
150237185|NCT00490945|542006549|FG001|Overall Study|Adverse Event|1|||
150237186|NCT00490945|542006550|FG002|Overall Study|Adverse Event|0|||
150237187|NCT00490945|542006551|FG003|Overall Study|Adverse Event|0|||
150237188|NCT00490945|542006552|FG004|Overall Study|Adverse Event|0|||
150237189|NCT03721705|542006562|FG000|Overall Study|Adverse Event|2|||
150237190|NCT03721705|542006563|FG001|Overall Study|Adverse Event|0|||
150237191|NCT03721705|542006562|FG000|Overall Study|Withdrawal by Subject|4|||
150237192|NCT03721705|542006563|FG001|Overall Study|Withdrawal by Subject|10|||
150237193|NCT03721705|542006562|FG000|Overall Study|No Suitable Study Partner|1|||
150237194|NCT03721705|542006563|FG001|Overall Study|No Suitable Study Partner|0|||
150237195|NCT03721705|542006562|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
150237196|NCT03721705|542006563|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
150237197|NCT03721705|542006562|FG000|Overall Study|Death|0|||
150237198|NCT03721705|542006563|FG001|Overall Study|Death|1|||
150237199|NCT01162135|542006564|FG000|Overall Study|Withdrawal by Subject|1|||
150237200|NCT01162135|542006564|FG000|Overall Study|Severe back pain|1|||
150237201|NCT01162135|542006564|FG000|Overall Study|Ineligible|1|||
150237202|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
150237203|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
150237204|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
150237205|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
150237206|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
150237207|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
150237208|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
150237209|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
150237210|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
150237211|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
150237212|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
150237213|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
150237214|NCT01216072|542006572|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
150237215|NCT01216072|542006573|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
150237216|NCT01216072|542006572|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
150237217|NCT01216072|542006573|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
150237218|NCT01216072|542006572|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
150237219|NCT01216072|542006573|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
150237220|NCT01216072|542006572|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
150237221|NCT01216072|542006573|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
150237222|NCT02947100|542006579|FG000|Overall Study|study terminated early|3|||
150237223|NCT02947100|542006579|FG000|Overall Study|did not meet inclusion criteria|1|||
150237224|NCT00822770|542006580|FG000|Overall Study|Not treated|1|||
150237225|NCT00822770|542006581|FG001|Overall Study|Not treated|0|||
150237226|NCT00822770|542006580|FG000|Overall Study|Complication/Incomplete treatment|1|||
150237227|NCT00822770|542006581|FG001|Overall Study|Complication/Incomplete treatment|0|||
150237228|NCT00822770|542006580|FG000|Overall Study|Death|1|||
150237229|NCT00822770|542006581|FG001|Overall Study|Death|1|||
150237230|NCT02402322|542006582|FG000|Pretreatment|Withdrawal by Subject|3|||
150237231|NCT02402322|542006583|FG001|Pretreatment|Withdrawal by Subject|1|||
150237232|NCT02402322|542006584|FG002|Pretreatment|Withdrawal by Subject|1|||
150237233|NCT02402322|542006582|FG000|Follow-up|Withdrawal by Subject|6|||
150237234|NCT02402322|542006583|FG001|Follow-up|Withdrawal by Subject|3|||
150237235|NCT02402322|542006584|FG002|Follow-up|Withdrawal by Subject|24|||
150237236|NCT02818998|542006585|FG000|Overall Study|Adverse Event|3|||
150237237|NCT02818998|542006586|FG001|Overall Study|Adverse Event|2|||
150237238|NCT02818998|542006587|FG002|Overall Study|Adverse Event|1|||
150237239|NCT02818998|542006585|FG000|Overall Study|Lost to Follow-up|4|||
150237240|NCT02818998|542006586|FG001|Overall Study|Lost to Follow-up|1|||
150237241|NCT02818998|542006587|FG002|Overall Study|Lost to Follow-up|2|||
150237242|NCT02818998|542006585|FG000|Overall Study|Withdrawal by sponsor|0|||
150237243|NCT02818998|542006586|FG001|Overall Study|Withdrawal by sponsor|1|||
150237244|NCT02818998|542006587|FG002|Overall Study|Withdrawal by sponsor|1|||
150237245|NCT02818998|542006585|FG000|Overall Study|Death|3|||
150237246|NCT02818998|542006586|FG001|Overall Study|Death|6|||
150237247|NCT02818998|542006587|FG002|Overall Study|Death|8|||
150237248|NCT02818998|542006585|FG000|Overall Study|Withdrawal by Subject|7|||
150237249|NCT02818998|542006586|FG001|Overall Study|Withdrawal by Subject|6|||
150237250|NCT02818998|542006587|FG002|Overall Study|Withdrawal by Subject|6|||
150237251|NCT02818998|542006585|FG000|Overall Study|Physician Decision|1|||
150237252|NCT02818998|542006586|FG001|Overall Study|Physician Decision|0|||
150237253|NCT02818998|542006587|FG002|Overall Study|Physician Decision|0|||
150237254|NCT01080326|542006591|FG000|Overall Study|Patient deterioration prior to procedure|3|||
150237255|NCT01080326|542006591|FG000|Overall Study|Surgeon decision|1|||
150237256|NCT01296555|542006593|FG000|Overall Study|Adverse Event|0|||
150237257|NCT01296555|542006594|FG001|Overall Study|Adverse Event|0|||
150237258|NCT01296555|542006595|FG002|Overall Study|Adverse Event|1|||
150237259|NCT01296555|542006596|FG003|Overall Study|Adverse Event|1|||
150237260|NCT01296555|542006597|FG004|Overall Study|Adverse Event|2|||
150237261|NCT01296555|542006598|FG005|Overall Study|Adverse Event|4|||
150237262|NCT01296555|542006599|FG006|Overall Study|Adverse Event|1|||
150237263|NCT01296555|542006600|FG007|Overall Study|Adverse Event|4|||
150237264|NCT01296555|542006601|FG008|Overall Study|Adverse Event|3|||
150237265|NCT01296555|542006602|FG009|Overall Study|Adverse Event|1|||
150237266|NCT01296555|542006603|FG010|Overall Study|Adverse Event|0|||
150237267|NCT01296555|542006604|FG011|Overall Study|Adverse Event|4|||
150237268|NCT01296555|542006605|FG012|Overall Study|Adverse Event|1|||
150237269|NCT01296555|542006606|FG013|Overall Study|Adverse Event|4|||
150237270|NCT01296555|542006607|FG014|Overall Study|Adverse Event|0|||
150237271|NCT01296555|542006608|FG015|Overall Study|Adverse Event|0|||
150237272|NCT01296555|542006609|FG016|Overall Study|Adverse Event|0|||
150237273|NCT01296555|542006610|FG017|Overall Study|Adverse Event|0|||
150237274|NCT01296555|542006611|FG018|Overall Study|Adverse Event|0|||
150237275|NCT01296555|542006612|FG019|Overall Study|Adverse Event|1|||
150237276|NCT01296555|542006613|FG020|Overall Study|Adverse Event|0|||
150237277|NCT01296555|542006614|FG021|Overall Study|Adverse Event|0|||
150237278|NCT01296555|542006615|FG022|Overall Study|Adverse Event|0|||
150237279|NCT01296555|542006616|FG023|Overall Study|Adverse Event|0|||
150237280|NCT01296555|542006617|FG024|Overall Study|Adverse Event|0|||
150237281|NCT01296555|542006618|FG025|Overall Study|Adverse Event|0|||
150237282|NCT01296555|542006619|FG026|Overall Study|Adverse Event|0|||
150237283|NCT01296555|542006620|FG027|Overall Study|Adverse Event|0|||
150237284|NCT01296555|542006621|FG028|Overall Study|Adverse Event|0|||
150237285|NCT01296555|542006593|FG000|Overall Study|Reason Not Specified|0|||
150237286|NCT01296555|542006594|FG001|Overall Study|Reason Not Specified|0|||
150237287|NCT01296555|542006595|FG002|Overall Study|Reason Not Specified|0|||
150237288|NCT01296555|542006596|FG003|Overall Study|Reason Not Specified|0|||
150237289|NCT01296555|542006597|FG004|Overall Study|Reason Not Specified|0|||
150237290|NCT01296555|542006598|FG005|Overall Study|Reason Not Specified|0|||
150237291|NCT01296555|542006599|FG006|Overall Study|Reason Not Specified|0|||
150237292|NCT01296555|542006600|FG007|Overall Study|Reason Not Specified|0|||
150237293|NCT01296555|542006601|FG008|Overall Study|Reason Not Specified|0|||
150237294|NCT01296555|542006602|FG009|Overall Study|Reason Not Specified|0|||
150237295|NCT01296555|542006603|FG010|Overall Study|Reason Not Specified|0|||
150237296|NCT01296555|542006604|FG011|Overall Study|Reason Not Specified|0|||
150237297|NCT01296555|542006605|FG012|Overall Study|Reason Not Specified|0|||
150237298|NCT01296555|542006606|FG013|Overall Study|Reason Not Specified|1|||
150237299|NCT01296555|542006607|FG014|Overall Study|Reason Not Specified|2|||
150237300|NCT01296555|542006608|FG015|Overall Study|Reason Not Specified|3|||
150237301|NCT01296555|542006609|FG016|Overall Study|Reason Not Specified|7|||
150237302|NCT01296555|542006610|FG017|Overall Study|Reason Not Specified|4|||
150237303|NCT01296555|542006611|FG018|Overall Study|Reason Not Specified|3|||
150237304|NCT01296555|542006612|FG019|Overall Study|Reason Not Specified|7|||
150237305|NCT01296555|542006613|FG020|Overall Study|Reason Not Specified|11|||
150237306|NCT01296555|542006614|FG021|Overall Study|Reason Not Specified|5|||
150237307|NCT01296555|542006615|FG022|Overall Study|Reason Not Specified|5|||
150237308|NCT01296555|542006616|FG023|Overall Study|Reason Not Specified|7|||
150237309|NCT01296555|542006617|FG024|Overall Study|Reason Not Specified|2|||
150237310|NCT01296555|542006618|FG025|Overall Study|Reason Not Specified|2|||
150237311|NCT01296555|542006619|FG026|Overall Study|Reason Not Specified|19|||
150237312|NCT01296555|542006620|FG027|Overall Study|Reason Not Specified|11|||
150237313|NCT01296555|542006621|FG028|Overall Study|Reason Not Specified|9|||
150237314|NCT01296555|542006593|FG000|Overall Study|Physician Decision|0|||
150237315|NCT01296555|542006594|FG001|Overall Study|Physician Decision|0|||
150237316|NCT01296555|542006595|FG002|Overall Study|Physician Decision|0|||
150237317|NCT01296555|542006596|FG003|Overall Study|Physician Decision|0|||
150237318|NCT01296555|542006597|FG004|Overall Study|Physician Decision|1|||
150237319|NCT01296555|542006598|FG005|Overall Study|Physician Decision|0|||
150237320|NCT01296555|542006599|FG006|Overall Study|Physician Decision|0|||
150237321|NCT01296555|542006600|FG007|Overall Study|Physician Decision|0|||
150237322|NCT01296555|542006601|FG008|Overall Study|Physician Decision|0|||
150237323|NCT01296555|542006602|FG009|Overall Study|Physician Decision|0|||
150237324|NCT01296555|542006603|FG010|Overall Study|Physician Decision|0|||
150237325|NCT01296555|542006604|FG011|Overall Study|Physician Decision|0|||
150237326|NCT01296555|542006605|FG012|Overall Study|Physician Decision|0|||
150237327|NCT01296555|542006606|FG013|Overall Study|Physician Decision|1|||
150237328|NCT01296555|542006607|FG014|Overall Study|Physician Decision|0|||
150237329|NCT01296555|542006608|FG015|Overall Study|Physician Decision|0|||
150237330|NCT01296555|542006609|FG016|Overall Study|Physician Decision|0|||
150237331|NCT01296555|542006610|FG017|Overall Study|Physician Decision|0|||
150237332|NCT01296555|542006611|FG018|Overall Study|Physician Decision|0|||
150237333|NCT01296555|542006612|FG019|Overall Study|Physician Decision|1|||
150237334|NCT01296555|542006613|FG020|Overall Study|Physician Decision|0|||
150237335|NCT01296555|542006614|FG021|Overall Study|Physician Decision|0|||
150237336|NCT01296555|542006615|FG022|Overall Study|Physician Decision|0|||
150237337|NCT01296555|542006616|FG023|Overall Study|Physician Decision|0|||
150237338|NCT01296555|542006617|FG024|Overall Study|Physician Decision|0|||
150237339|NCT01296555|542006618|FG025|Overall Study|Physician Decision|0|||
150237340|NCT01296555|542006619|FG026|Overall Study|Physician Decision|0|||
150237341|NCT01296555|542006620|FG027|Overall Study|Physician Decision|0|||
150237342|NCT01296555|542006621|FG028|Overall Study|Physician Decision|0|||
150237343|NCT01296555|542006593|FG000|Overall Study|Progressive Disease|6|||
150237344|NCT01296555|542006594|FG001|Overall Study|Progressive Disease|3|||
150237345|NCT01296555|542006595|FG002|Overall Study|Progressive Disease|3|||
150237346|NCT01296555|542006596|FG003|Overall Study|Progressive Disease|7|||
150237347|NCT01296555|542006597|FG004|Overall Study|Progressive Disease|6|||
150237348|NCT01296555|542006598|FG005|Overall Study|Progressive Disease|16|||
150237349|NCT01296555|542006599|FG006|Overall Study|Progressive Disease|16|||
150237350|NCT01296555|542006600|FG007|Overall Study|Progressive Disease|8|||
150237351|NCT01296555|542006601|FG008|Overall Study|Progressive Disease|7|||
150237352|NCT01296555|542006602|FG009|Overall Study|Progressive Disease|18|||
150237353|NCT01296555|542006603|FG010|Overall Study|Progressive Disease|7|||
150237354|NCT01296555|542006604|FG011|Overall Study|Progressive Disease|14|||
150237355|NCT01296555|542006605|FG012|Overall Study|Progressive Disease|5|||
150237356|NCT01296555|542006606|FG013|Overall Study|Progressive Disease|12|||
150237357|NCT01296555|542006607|FG014|Overall Study|Progressive Disease|1|||
150237358|NCT01296555|542006608|FG015|Overall Study|Progressive Disease|1|||
150237359|NCT01296555|542006609|FG016|Overall Study|Progressive Disease|0|||
150237360|NCT01296555|542006610|FG017|Overall Study|Progressive Disease|0|||
150237361|NCT01296555|542006611|FG018|Overall Study|Progressive Disease|0|||
150237362|NCT01296555|542006612|FG019|Overall Study|Progressive Disease|1|||
150237363|NCT01296555|542006613|FG020|Overall Study|Progressive Disease|0|||
150237364|NCT01296555|542006614|FG021|Overall Study|Progressive Disease|0|||
150237365|NCT01296555|542006615|FG022|Overall Study|Progressive Disease|0|||
150237366|NCT01296555|542006616|FG023|Overall Study|Progressive Disease|0|||
150237367|NCT01296555|542006617|FG024|Overall Study|Progressive Disease|1|||
150237368|NCT01296555|542006618|FG025|Overall Study|Progressive Disease|0|||
150237369|NCT01296555|542006619|FG026|Overall Study|Progressive Disease|5|||
150237370|NCT01296555|542006620|FG027|Overall Study|Progressive Disease|1|||
150237371|NCT01296555|542006621|FG028|Overall Study|Progressive Disease|0|||
150237372|NCT01296555|542006593|FG000|Overall Study|Protocol Violation|0|||
150237373|NCT01296555|542006594|FG001|Overall Study|Protocol Violation|0|||
150237374|NCT01296555|542006595|FG002|Overall Study|Protocol Violation|0|||
150237375|NCT01296555|542006596|FG003|Overall Study|Protocol Violation|0|||
150237376|NCT01296555|542006597|FG004|Overall Study|Protocol Violation|0|||
150237377|NCT01296555|542006598|FG005|Overall Study|Protocol Violation|0|||
150237378|NCT01296555|542006599|FG006|Overall Study|Protocol Violation|0|||
150237379|NCT01296555|542006600|FG007|Overall Study|Protocol Violation|0|||
150237380|NCT01296555|542006601|FG008|Overall Study|Protocol Violation|0|||
150237381|NCT01296555|542006602|FG009|Overall Study|Protocol Violation|0|||
150237382|NCT01296555|542006603|FG010|Overall Study|Protocol Violation|0|||
150237383|NCT01296555|542006604|FG011|Overall Study|Protocol Violation|0|||
150237384|NCT01296555|542006605|FG012|Overall Study|Protocol Violation|0|||
150237385|NCT01296555|542006606|FG013|Overall Study|Protocol Violation|1|||
150237386|NCT01296555|542006607|FG014|Overall Study|Protocol Violation|0|||
150237387|NCT01296555|542006608|FG015|Overall Study|Protocol Violation|0|||
150237388|NCT01296555|542006609|FG016|Overall Study|Protocol Violation|0|||
150237389|NCT01296555|542006610|FG017|Overall Study|Protocol Violation|0|||
150237390|NCT01296555|542006611|FG018|Overall Study|Protocol Violation|0|||
150237391|NCT01296555|542006612|FG019|Overall Study|Protocol Violation|0|||
150237392|NCT01296555|542006613|FG020|Overall Study|Protocol Violation|0|||
150237393|NCT01296555|542006614|FG021|Overall Study|Protocol Violation|0|||
150237394|NCT01296555|542006615|FG022|Overall Study|Protocol Violation|0|||
150237395|NCT01296555|542006616|FG023|Overall Study|Protocol Violation|0|||
150237396|NCT01296555|542006617|FG024|Overall Study|Protocol Violation|0|||
150237397|NCT01296555|542006618|FG025|Overall Study|Protocol Violation|0|||
150237398|NCT01296555|542006619|FG026|Overall Study|Protocol Violation|0|||
150142157|NCT02799472|541655968|FG001|Overall Study|Withdrawal by Subject|4|||
150142158|NCT02799472|541655967|FG000|Overall Study|Lack of Efficacy|2|||
150142159|NCT02799472|541655968|FG001|Overall Study|Lack of Efficacy|0|||
150142160|NCT02799472|541655967|FG000|Overall Study|Lost to Follow-up|0|||
150142161|NCT02799472|541655968|FG001|Overall Study|Lost to Follow-up|1|||
150142162|NCT02801669|541655969|FG000|Overall Study|Death|66|||
150142163|NCT02801669|541655970|FG001|Overall Study|Death|69|||
150142164|NCT02801669|541655969|FG000|Overall Study|Withdrawal by Subject|81|||
150142165|NCT02801669|541655970|FG001|Overall Study|Withdrawal by Subject|77|||
150142166|NCT02801669|541655969|FG000|Overall Study|Other|4|||
150142167|NCT02801669|541655970|FG001|Overall Study|Other|6|||
150142168|NCT00615264|541655971|FG000|Overall Study|Withdrawal by Subject|17|||
150142169|NCT00615264|541655972|FG001|Overall Study|Withdrawal by Subject|19|||
150142170|NCT00615264|541655971|FG000|Overall Study|Lost to Follow-up|6|||
150142171|NCT00615264|541655972|FG001|Overall Study|Lost to Follow-up|13|||
150142172|NCT00615264|541655971|FG000|Overall Study|Adverse Event|8|||
150142173|NCT00615264|541655972|FG001|Overall Study|Adverse Event|5|||
150142174|NCT00615264|541655971|FG000|Overall Study|Death|1|||
150142175|NCT00615264|541655972|FG001|Overall Study|Death|1|||
150142176|NCT00615264|541655971|FG000|Overall Study|Protocol Violation|11|||
150142177|NCT00615264|541655972|FG001|Overall Study|Protocol Violation|7|||
150142178|NCT00615264|541655971|FG000|Overall Study|Not defined|7|||
150142179|NCT00615264|541655972|FG001|Overall Study|Not defined|4|||
150142180|NCT00615264|541655971|FG000|Overall Study|Dermal Hypersensitivity|0|||
150142181|NCT00615264|541655972|FG001|Overall Study|Dermal Hypersensitivity|3|||
150142182|NCT00058422|541655973|FG000|Overall Study|Not treated|2|||
150142183|NCT01982435|541655976|FG000|Overall Study|Adverse Event|1|||
150142184|NCT01982435|541655977|FG001|Overall Study|Adverse Event|0|||
150142185|NCT00871403|541655978|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
150142186|NCT00871403|541655979|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
150142187|NCT00871403|541655980|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
150142188|NCT00871403|541655978|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
150142189|NCT00871403|541655979|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
150142190|NCT00871403|541655980|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
150142191|NCT00871403|541655978|FG000|Combination Treatment Phase|Adverse Event|0|||
150142192|NCT00871403|541655979|FG001|Combination Treatment Phase|Adverse Event|17|||
150237399|NCT01296555|542006620|FG027|Overall Study|Protocol Violation|0|||
150142193|NCT00871403|541655980|FG002|Combination Treatment Phase|Adverse Event|2|||
150142194|NCT00871403|541655978|FG000|Combination Treatment Phase|Disease Progression|0|||
150142195|NCT00871403|541655979|FG001|Combination Treatment Phase|Disease Progression|8|||
150142196|NCT00871403|541655980|FG002|Combination Treatment Phase|Disease Progression|5|||
150142197|NCT00871403|541655978|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
150142198|NCT00871403|541655979|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
150142199|NCT00871403|541655980|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
150142200|NCT00871403|541655978|FG000|Combination Treatment Phase|Physician Decision|0|||
150142201|NCT00871403|541655979|FG001|Combination Treatment Phase|Physician Decision|1|||
150142202|NCT00871403|541655980|FG002|Combination Treatment Phase|Physician Decision|3|||
150142203|NCT00871403|541655978|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
150142204|NCT00871403|541655979|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
150142205|NCT00871403|541655980|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
150142206|NCT00871403|541655978|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
150142207|NCT00871403|541655979|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
150142208|NCT00871403|541655980|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
150142209|NCT02569437|541655984|FG000|Overall Study|Lost to Follow-up|12|||
150142210|NCT02569437|541655985|FG001|Overall Study|Lost to Follow-up|14|||
150142211|NCT00985985|541655986|FG000|Overall Study|Adverse Event|4|||
150142212|NCT00985985|541655987|FG001|Overall Study|Adverse Event|2|||
150142213|NCT00985985|541655988|FG002|Overall Study|Adverse Event|2|||
150142214|NCT00985985|541655989|FG003|Overall Study|Adverse Event|2|||
150142215|NCT00985985|541655986|FG000|Overall Study|Lost to Follow-up|4|||
150142216|NCT00985985|541655987|FG001|Overall Study|Lost to Follow-up|11|||
150142217|NCT00985985|541655988|FG002|Overall Study|Lost to Follow-up|2|||
150142218|NCT00985985|541655989|FG003|Overall Study|Lost to Follow-up|3|||
150142219|NCT00985985|541655986|FG000|Overall Study|Protocol Violation|1|||
150142220|NCT00985985|541655987|FG001|Overall Study|Protocol Violation|2|||
150142221|NCT00985985|541655988|FG002|Overall Study|Protocol Violation|0|||
150142222|NCT00985985|541655989|FG003|Overall Study|Protocol Violation|1|||
150142223|NCT00985985|541655986|FG000|Overall Study|Lack of Efficacy|5|||
150237400|NCT01296555|542006621|FG028|Overall Study|Protocol Violation|0|||
150237401|NCT01296555|542006593|FG000|Overall Study|Study Terminated By Sponsor|0|||
150237402|NCT01296555|542006594|FG001|Overall Study|Study Terminated By Sponsor|0|||
150142224|NCT00985985|541655987|FG001|Overall Study|Lack of Efficacy|6|||
150142225|NCT00985985|541655988|FG002|Overall Study|Lack of Efficacy|1|||
150142226|NCT00985985|541655989|FG003|Overall Study|Lack of Efficacy|3|||
150142227|NCT00985985|541655986|FG000|Overall Study|Withdrawal by Subject|4|||
150142228|NCT00985985|541655987|FG001|Overall Study|Withdrawal by Subject|2|||
150142229|NCT00985985|541655988|FG002|Overall Study|Withdrawal by Subject|2|||
150142230|NCT00985985|541655989|FG003|Overall Study|Withdrawal by Subject|2|||
150237403|NCT01296555|542006595|FG002|Overall Study|Study Terminated By Sponsor|0|||
150142231|NCT00985985|541655986|FG000|Overall Study|Other Reason|6|||
150142232|NCT00985985|541655987|FG001|Overall Study|Other Reason|1|||
150237404|NCT01296555|542006596|FG003|Overall Study|Study Terminated By Sponsor|0|||
150237405|NCT01296555|542006597|FG004|Overall Study|Study Terminated By Sponsor|0|||
150237406|NCT01296555|542006598|FG005|Overall Study|Study Terminated By Sponsor|0|||
150237407|NCT01296555|542006599|FG006|Overall Study|Study Terminated By Sponsor|0|||
150237408|NCT01296555|542006600|FG007|Overall Study|Study Terminated By Sponsor|0|||
150237409|NCT01296555|542006601|FG008|Overall Study|Study Terminated By Sponsor|0|||
150237410|NCT01296555|542006602|FG009|Overall Study|Study Terminated By Sponsor|0|||
150237411|NCT01296555|542006603|FG010|Overall Study|Study Terminated By Sponsor|0|||
150237412|NCT01296555|542006604|FG011|Overall Study|Study Terminated By Sponsor|0|||
150237413|NCT01296555|542006605|FG012|Overall Study|Study Terminated By Sponsor|0|||
150237414|NCT01296555|542006606|FG013|Overall Study|Study Terminated By Sponsor|0|||
150237415|NCT01296555|542006607|FG014|Overall Study|Study Terminated By Sponsor|0|||
150237416|NCT01296555|542006608|FG015|Overall Study|Study Terminated By Sponsor|0|||
150237417|NCT01296555|542006609|FG016|Overall Study|Study Terminated By Sponsor|0|||
150237418|NCT01296555|542006610|FG017|Overall Study|Study Terminated By Sponsor|0|||
150237419|NCT01296555|542006611|FG018|Overall Study|Study Terminated By Sponsor|0|||
150237420|NCT01296555|542006612|FG019|Overall Study|Study Terminated By Sponsor|0|||
150237421|NCT01296555|542006613|FG020|Overall Study|Study Terminated By Sponsor|0|||
150237422|NCT01296555|542006614|FG021|Overall Study|Study Terminated By Sponsor|0|||
150237423|NCT01296555|542006615|FG022|Overall Study|Study Terminated By Sponsor|0|||
150237424|NCT01296555|542006616|FG023|Overall Study|Study Terminated By Sponsor|0|||
150237425|NCT01296555|542006617|FG024|Overall Study|Study Terminated By Sponsor|0|||
150237426|NCT01296555|542006618|FG025|Overall Study|Study Terminated By Sponsor|1|||
150237427|NCT01296555|542006619|FG026|Overall Study|Study Terminated By Sponsor|0|||
150237428|NCT01296555|542006620|FG027|Overall Study|Study Terminated By Sponsor|0|||
150237429|NCT01296555|542006621|FG028|Overall Study|Study Terminated By Sponsor|0|||
150237430|NCT01296555|542006593|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237431|NCT01296555|542006594|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237432|NCT01296555|542006595|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237433|NCT01296555|542006596|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237434|NCT01296555|542006597|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237435|NCT01296555|542006598|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237436|NCT01296555|542006599|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237437|NCT01296555|542006600|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237438|NCT01296555|542006601|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237439|NCT01296555|542006602|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237440|NCT01296555|542006603|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237441|NCT01296555|542006604|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237442|NCT01296555|542006605|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237443|NCT01296555|542006606|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237444|NCT01296555|542006607|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237445|NCT01296555|542006608|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237446|NCT01296555|542006609|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237447|NCT01296555|542006610|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237448|NCT01296555|542006611|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237449|NCT01296555|542006612|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
150237450|NCT01296555|542006613|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237451|NCT01296555|542006614|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237452|NCT01296555|542006615|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237453|NCT01296555|542006616|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237454|NCT01296555|542006617|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237455|NCT01296555|542006618|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237456|NCT01296555|542006619|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237457|NCT01296555|542006620|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237458|NCT01296555|542006621|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
150237459|NCT01296555|542006593|FG000|Overall Study|Death|0|||
150237460|NCT01296555|542006594|FG001|Overall Study|Death|0|||
150237461|NCT01296555|542006595|FG002|Overall Study|Death|0|||
150237462|NCT01296555|542006596|FG003|Overall Study|Death|2|||
150237463|NCT01296555|542006597|FG004|Overall Study|Death|1|||
150237464|NCT01296555|542006598|FG005|Overall Study|Death|0|||
150237465|NCT01296555|542006599|FG006|Overall Study|Death|2|||
150237466|NCT01296555|542006600|FG007|Overall Study|Death|0|||
150237467|NCT01296555|542006601|FG008|Overall Study|Death|0|||
150237468|NCT01296555|542006602|FG009|Overall Study|Death|1|||
150237469|NCT01296555|542006603|FG010|Overall Study|Death|0|||
150237470|NCT01296555|542006604|FG011|Overall Study|Death|1|||
150237471|NCT01296555|542006605|FG012|Overall Study|Death|0|||
150237472|NCT01296555|542006606|FG013|Overall Study|Death|2|||
150237473|NCT01296555|542006607|FG014|Overall Study|Death|27|||
150237474|NCT01296555|542006608|FG015|Overall Study|Death|15|||
150237475|NCT01296555|542006609|FG016|Overall Study|Death|11|||
150237476|NCT01296555|542006610|FG017|Overall Study|Death|11|||
150237477|NCT01296555|542006611|FG018|Overall Study|Death|17|||
150237478|NCT01296555|542006612|FG019|Overall Study|Death|12|||
150237479|NCT01296555|542006613|FG020|Overall Study|Death|13|||
150237480|NCT01296555|542006614|FG021|Overall Study|Death|12|||
150237481|NCT01296555|542006615|FG022|Overall Study|Death|12|||
150237482|NCT01296555|542006616|FG023|Overall Study|Death|13|||
150237483|NCT01296555|542006617|FG024|Overall Study|Death|7|||
150142233|NCT00985985|541655988|FG002|Overall Study|Other Reason|4|||
150142234|NCT00985985|541655989|FG003|Overall Study|Other Reason|2|||
150142235|NCT02255357|541655992|FG000|Overall Study|Physician Decision|10|||
150142236|NCT02255357|541655993|FG001|Overall Study|Physician Decision|24|||
150142237|NCT00509236|541655994|FG000|Overall Study|Adverse Event|7|||
150142238|NCT00509236|541655995|FG001|Overall Study|Adverse Event|9|||
150142239|NCT00509236|541655994|FG000|Overall Study|Withdrawal by Subject|5|||
150142240|NCT00509236|541655995|FG001|Overall Study|Withdrawal by Subject|10|||
150142241|NCT00509236|541655994|FG000|Overall Study|Protocol Violation|3|||
150142242|NCT00509236|541655995|FG001|Overall Study|Protocol Violation|0|||
150142243|NCT00509236|541655994|FG000|Overall Study|Excluded Medication|1|||
150142244|NCT00509236|541655995|FG001|Overall Study|Excluded Medication|1|||
150142245|NCT00509236|541655994|FG000|Overall Study|Scheduled Kidney Transplant|1|||
150142246|NCT00509236|541655995|FG001|Overall Study|Scheduled Kidney Transplant|0|||
150142247|NCT00312702|541655998|FG000|Immunization Phase|Lost to Follow-up|0|||
150142248|NCT00312702|541655999|FG001|Immunization Phase|Lost to Follow-up|1|||
150142249|NCT00312702|541656000|FG002|Immunization Phase|Lost to Follow-up|0|||
150142250|NCT03056534|541656006|FG000|Overall Study|Participant withdrew consent|8|||
150142251|NCT03056534|541656006|FG000|Overall Study|Participant not able to return|6|||
150142252|NCT03056534|541656006|FG000|Overall Study|Lost to Follow-up|37|||
150142253|NCT03056534|541656006|FG000|Overall Study|Investigator judgment|1|||
150142254|NCT03056534|541656006|FG000|Overall Study|Death|4|||
150142255|NCT03056534|541656006|FG000|Overall Study|Adverse Event|1|||
150142256|NCT03056534|541656006|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
150142257|NCT04146896|541656011|FG000|Overall Study|Adverse Event|5|||
150142258|NCT04146896|541656012|FG001|Overall Study|Adverse Event|8|||
150142259|NCT04146896|541656011|FG000|Overall Study|Lack of Efficacy|3|||
150142260|NCT04146896|541656012|FG001|Overall Study|Lack of Efficacy|2|||
150142261|NCT04146896|541656011|FG000|Overall Study|Lost to Follow-up|0|||
150142262|NCT04146896|541656012|FG001|Overall Study|Lost to Follow-up|1|||
150142263|NCT04146896|541656011|FG000|Overall Study|Non-compliance|5|||
150142264|NCT04146896|541656012|FG001|Overall Study|Non-compliance|4|||
150142265|NCT04146896|541656011|FG000|Overall Study|Withdrawal by Subject|3|||
150142266|NCT04146896|541656012|FG001|Overall Study|Withdrawal by Subject|5|||
150142267|NCT04146896|541656011|FG000|Overall Study|Randomized in error|1|||
150142268|NCT04146896|541656012|FG001|Overall Study|Randomized in error|2|||
150142269|NCT01597505|541656013|FG000|Overall Study|Physician Decision|5|||
150142270|NCT01597505|541656014|FG001|Overall Study|Physician Decision|0|||
150142271|NCT01597505|541656013|FG000|Overall Study|Adverse Event|19|||
150142272|NCT01597505|541656014|FG001|Overall Study|Adverse Event|7|||
150142273|NCT01597505|541656013|FG000|Overall Study|Lost to Follow-up|4|||
150142274|NCT01597505|541656014|FG001|Overall Study|Lost to Follow-up|2|||
150237484|NCT01296555|542006618|FG025|Overall Study|Death|7|||
150237485|NCT01296555|542006619|FG026|Overall Study|Death|35|||
150237486|NCT01296555|542006620|FG027|Overall Study|Death|92|||
150237487|NCT01296555|542006621|FG028|Overall Study|Death|44|||
150237488|NCT01296555|542006593|FG000|Overall Study|Lost to Follow-up|0|||
150237489|NCT01296555|542006594|FG001|Overall Study|Lost to Follow-up|0|||
150237490|NCT01296555|542006595|FG002|Overall Study|Lost to Follow-up|0|||
150237491|NCT01296555|542006596|FG003|Overall Study|Lost to Follow-up|0|||
150237492|NCT01296555|542006597|FG004|Overall Study|Lost to Follow-up|0|||
150237493|NCT01296555|542006598|FG005|Overall Study|Lost to Follow-up|0|||
150142275|NCT01597505|541656013|FG000|Overall Study|Withdrawal by Subject|10|||
150142276|NCT01597505|541656014|FG001|Overall Study|Withdrawal by Subject|18|||
150237494|NCT01296555|542006599|FG006|Overall Study|Lost to Follow-up|0|||
150142277|NCT01597505|541656013|FG000|Overall Study|Other|5|||
150142278|NCT01597505|541656014|FG001|Overall Study|Other|6|||
150142279|NCT01597505|541656013|FG000|Overall Study|Missing|1|||
150142280|NCT01597505|541656014|FG001|Overall Study|Missing|0|||
150142281|NCT02675465|541656015|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
150237495|NCT01296555|542006600|FG007|Overall Study|Lost to Follow-up|0|||
150237496|NCT01296555|542006601|FG008|Overall Study|Lost to Follow-up|0|||
150237497|NCT01296555|542006602|FG009|Overall Study|Lost to Follow-up|0|||
150237498|NCT01296555|542006603|FG010|Overall Study|Lost to Follow-up|0|||
150237499|NCT01296555|542006604|FG011|Overall Study|Lost to Follow-up|0|||
150237500|NCT01296555|542006605|FG012|Overall Study|Lost to Follow-up|0|||
150237501|NCT01296555|542006606|FG013|Overall Study|Lost to Follow-up|0|||
150237502|NCT01296555|542006607|FG014|Overall Study|Lost to Follow-up|2|||
150237503|NCT01296555|542006608|FG015|Overall Study|Lost to Follow-up|1|||
150237504|NCT01296555|542006609|FG016|Overall Study|Lost to Follow-up|0|||
150237505|NCT01296555|542006610|FG017|Overall Study|Lost to Follow-up|2|||
150237506|NCT01296555|542006611|FG018|Overall Study|Lost to Follow-up|0|||
150237507|NCT01296555|542006612|FG019|Overall Study|Lost to Follow-up|2|||
150237508|NCT01296555|542006613|FG020|Overall Study|Lost to Follow-up|3|||
150237509|NCT01296555|542006614|FG021|Overall Study|Lost to Follow-up|2|||
150237510|NCT01296555|542006615|FG022|Overall Study|Lost to Follow-up|0|||
150237511|NCT01296555|542006616|FG023|Overall Study|Lost to Follow-up|0|||
150237512|NCT01296555|542006617|FG024|Overall Study|Lost to Follow-up|0|||
150237513|NCT01296555|542006618|FG025|Overall Study|Lost to Follow-up|0|||
150237514|NCT01296555|542006619|FG026|Overall Study|Lost to Follow-up|3|||
150237515|NCT01296555|542006620|FG027|Overall Study|Lost to Follow-up|13|||
150237516|NCT01296555|542006621|FG028|Overall Study|Lost to Follow-up|5|||
150237517|NCT01296555|542006593|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150142282|NCT02675465|541656016|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
150142283|NCT02675465|541656017|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
150142284|NCT02675465|541656018|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
150142285|NCT02675465|541656019|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
150142286|NCT02675465|541656020|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
150142287|NCT02675465|541656015|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
150142288|NCT02675465|541656016|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
150142289|NCT02675465|541656017|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
150142290|NCT02675465|541656018|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
150142291|NCT02675465|541656019|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
150142292|NCT02675465|541656020|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
150142293|NCT02675465|541656015|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
150142294|NCT02675465|541656016|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
150237518|NCT01296555|542006594|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150142295|NCT02675465|541656017|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
150142296|NCT02675465|541656018|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
150142297|NCT02675465|541656019|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
150142298|NCT02675465|541656020|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
150237519|NCT01296555|542006595|FG002|Overall Study|Non-Compliance With Study Drug|0|||
150237520|NCT01296555|542006596|FG003|Overall Study|Non-Compliance With Study Drug|0|||
150237521|NCT01296555|542006597|FG004|Overall Study|Non-Compliance With Study Drug|0|||
150142299|NCT02675465|541656015|FG000|Stage 4: Long Term Extension|Death|0|||
150142300|NCT02675465|541656016|FG001|Stage 4: Long Term Extension|Death|0|||
150142301|NCT02675465|541656017|FG002|Stage 4: Long Term Extension|Death|0|||
150142302|NCT02675465|541656018|FG003|Stage 4: Long Term Extension|Death|1|||
150142303|NCT02675465|541656019|FG004|Stage 4: Long Term Extension|Death|0|||
150142304|NCT02675465|541656020|FG005|Stage 4: Long Term Extension|Death|0|||
150142305|NCT04543188|541656028|FG000|Phase 1a|Adverse Event|0|||
150142306|NCT04543188|541656029|FG001|Phase 1a|Adverse Event|0|||
150142307|NCT04543188|541656030|FG002|Phase 1a|Adverse Event|0|||
150142308|NCT04543188|541656031|FG003|Phase 1a|Adverse Event|1|||
150142309|NCT04543188|541656032|FG004|Phase 1a|Adverse Event|0|||
150142310|NCT04543188|541656033|FG005|Phase 1a|Adverse Event|0|||
150142311|NCT04543188|541656034|FG006|Phase 1a|Adverse Event|1|||
150142312|NCT04543188|541656035|FG007|Phase 1a|Adverse Event|0|||
150142313|NCT04543188|541656036|FG008|Phase 1a|Adverse Event|0|||
150142314|NCT04543188|541656037|FG009|Phase 1a|Adverse Event|0|||
150142315|NCT04543188|541656038|FG010|Phase 1a|Adverse Event|0|||
150142316|NCT04543188|541656039|FG011|Phase 1a|Adverse Event|0|||
150142317|NCT04543188|541656040|FG012|Phase 1a|Adverse Event|0|||
150142318|NCT04543188|541656041|FG013|Phase 1a|Adverse Event|0|||
150142319|NCT04543188|541656042|FG014|Phase 1a|Adverse Event|0|||
150142320|NCT04543188|541656028|FG000|Phase 1a|Other (Death)|0|||
150142321|NCT04543188|541656029|FG001|Phase 1a|Other (Death)|1|||
150142322|NCT04543188|541656030|FG002|Phase 1a|Other (Death)|0|||
150142323|NCT04543188|541656031|FG003|Phase 1a|Other (Death)|0|||
150142324|NCT04543188|541656032|FG004|Phase 1a|Other (Death)|1|||
150142325|NCT04543188|541656033|FG005|Phase 1a|Other (Death)|0|||
150142326|NCT04543188|541656034|FG006|Phase 1a|Other (Death)|0|||
150142327|NCT04543188|541656035|FG007|Phase 1a|Other (Death)|0|||
150142328|NCT04543188|541656036|FG008|Phase 1a|Other (Death)|0|||
150142329|NCT04543188|541656037|FG009|Phase 1a|Other (Death)|1|||
150142330|NCT04543188|541656038|FG010|Phase 1a|Other (Death)|0|||
150142331|NCT04543188|541656039|FG011|Phase 1a|Other (Death)|0|||
150142332|NCT04543188|541656040|FG012|Phase 1a|Other (Death)|0|||
150142333|NCT04543188|541656041|FG013|Phase 1a|Other (Death)|0|||
150142334|NCT04543188|541656042|FG014|Phase 1a|Other (Death)|0|||
150142335|NCT04543188|541656028|FG000|Phase 1a|Lost to Follow-up|0|||
150142336|NCT04543188|541656029|FG001|Phase 1a|Lost to Follow-up|0|||
150142337|NCT04543188|541656030|FG002|Phase 1a|Lost to Follow-up|0|||
150142338|NCT04543188|541656031|FG003|Phase 1a|Lost to Follow-up|0|||
150142339|NCT04543188|541656032|FG004|Phase 1a|Lost to Follow-up|0|||
150142340|NCT04543188|541656033|FG005|Phase 1a|Lost to Follow-up|0|||
150142341|NCT04543188|541656034|FG006|Phase 1a|Lost to Follow-up|0|||
150142342|NCT04543188|541656035|FG007|Phase 1a|Lost to Follow-up|0|||
150142343|NCT04543188|541656036|FG008|Phase 1a|Lost to Follow-up|0|||
150142344|NCT04543188|541656037|FG009|Phase 1a|Lost to Follow-up|0|||
150142345|NCT04543188|541656038|FG010|Phase 1a|Lost to Follow-up|1|||
150142346|NCT04543188|541656039|FG011|Phase 1a|Lost to Follow-up|0|||
150142347|NCT04543188|541656040|FG012|Phase 1a|Lost to Follow-up|0|||
150142348|NCT04543188|541656041|FG013|Phase 1a|Lost to Follow-up|0|||
150142349|NCT04543188|541656042|FG014|Phase 1a|Lost to Follow-up|0|||
150142350|NCT04543188|541656028|FG000|Phase 1a|Progressive Disease|2|||
150142351|NCT04543188|541656029|FG001|Phase 1a|Progressive Disease|2|||
150142352|NCT04543188|541656030|FG002|Phase 1a|Progressive Disease|3|||
150142353|NCT04543188|541656031|FG003|Phase 1a|Progressive Disease|1|||
150142354|NCT04543188|541656032|FG004|Phase 1a|Progressive Disease|4|||
150142355|NCT04543188|541656033|FG005|Phase 1a|Progressive Disease|2|||
150142356|NCT04543188|541656034|FG006|Phase 1a|Progressive Disease|3|||
150142357|NCT04543188|541656035|FG007|Phase 1a|Progressive Disease|4|||
150142358|NCT04543188|541656036|FG008|Phase 1a|Progressive Disease|1|||
150142359|NCT04543188|541656037|FG009|Phase 1a|Progressive Disease|0|||
150142360|NCT04543188|541656038|FG010|Phase 1a|Progressive Disease|4|||
150142361|NCT04543188|541656039|FG011|Phase 1a|Progressive Disease|0|||
150142362|NCT04543188|541656040|FG012|Phase 1a|Progressive Disease|0|||
150237522|NCT01296555|542006598|FG005|Overall Study|Non-Compliance With Study Drug|0|||
150237523|NCT01296555|542006599|FG006|Overall Study|Non-Compliance With Study Drug|0|||
150237524|NCT01296555|542006600|FG007|Overall Study|Non-Compliance With Study Drug|1|||
150237525|NCT01296555|542006601|FG008|Overall Study|Non-Compliance With Study Drug|0|||
150237526|NCT01296555|542006602|FG009|Overall Study|Non-Compliance With Study Drug|0|||
150237527|NCT01296555|542006603|FG010|Overall Study|Non-Compliance With Study Drug|0|||
150142363|NCT04543188|541656041|FG013|Phase 1a|Progressive Disease|0|||
150142364|NCT04543188|541656042|FG014|Phase 1a|Progressive Disease|0|||
150142365|NCT04543188|541656028|FG000|Phase 1a|Study terminated by sponsor|0|||
150142366|NCT04543188|541656029|FG001|Phase 1a|Study terminated by sponsor|0|||
150142367|NCT04543188|541656030|FG002|Phase 1a|Study terminated by sponsor|0|||
150142368|NCT04543188|541656031|FG003|Phase 1a|Study terminated by sponsor|0|||
150142369|NCT04543188|541656032|FG004|Phase 1a|Study terminated by sponsor|1|||
150142370|NCT04543188|541656033|FG005|Phase 1a|Study terminated by sponsor|0|||
150142371|NCT04543188|541656034|FG006|Phase 1a|Study terminated by sponsor|0|||
150142372|NCT04543188|541656035|FG007|Phase 1a|Study terminated by sponsor|0|||
150142373|NCT04543188|541656036|FG008|Phase 1a|Study terminated by sponsor|0|||
150142374|NCT04543188|541656037|FG009|Phase 1a|Study terminated by sponsor|0|||
150142375|NCT04543188|541656038|FG010|Phase 1a|Study terminated by sponsor|1|||
150142376|NCT04543188|541656039|FG011|Phase 1a|Study terminated by sponsor|0|||
150142377|NCT04543188|541656040|FG012|Phase 1a|Study terminated by sponsor|0|||
150142378|NCT04543188|541656041|FG013|Phase 1a|Study terminated by sponsor|0|||
150142379|NCT04543188|541656042|FG014|Phase 1a|Study terminated by sponsor|0|||
150142380|NCT04543188|541656028|FG000|Phase 1a|Withdrawal by Subject|0|||
150142381|NCT04543188|541656029|FG001|Phase 1a|Withdrawal by Subject|0|||
150142382|NCT04543188|541656030|FG002|Phase 1a|Withdrawal by Subject|0|||
150142383|NCT04543188|541656031|FG003|Phase 1a|Withdrawal by Subject|0|||
150142384|NCT04543188|541656032|FG004|Phase 1a|Withdrawal by Subject|3|||
150142385|NCT04543188|541656033|FG005|Phase 1a|Withdrawal by Subject|0|||
150142386|NCT04543188|541656034|FG006|Phase 1a|Withdrawal by Subject|0|||
150142387|NCT04543188|541656035|FG007|Phase 1a|Withdrawal by Subject|0|||
150142388|NCT04543188|541656036|FG008|Phase 1a|Withdrawal by Subject|1|||
150142389|NCT04543188|541656037|FG009|Phase 1a|Withdrawal by Subject|1|||
150142390|NCT04543188|541656038|FG010|Phase 1a|Withdrawal by Subject|2|||
150142391|NCT04543188|541656039|FG011|Phase 1a|Withdrawal by Subject|0|||
150142392|NCT04543188|541656040|FG012|Phase 1a|Withdrawal by Subject|0|||
150142393|NCT04543188|541656041|FG013|Phase 1a|Withdrawal by Subject|0|||
150142394|NCT04543188|541656042|FG014|Phase 1a|Withdrawal by Subject|0|||
150142395|NCT04543188|541656028|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
150142396|NCT04543188|541656029|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
150142397|NCT04543188|541656030|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
150142398|NCT04543188|541656031|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
150142399|NCT04543188|541656032|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
150142400|NCT04543188|541656033|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
150142401|NCT04543188|541656034|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
150142402|NCT04543188|541656035|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
150142403|NCT04543188|541656036|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
150142404|NCT04543188|541656037|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
150142405|NCT04543188|541656038|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
150142406|NCT04543188|541656039|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
150142407|NCT04543188|541656040|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
150142408|NCT04543188|541656041|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
150237528|NCT01296555|542006604|FG011|Overall Study|Non-Compliance With Study Drug|0|||
150237529|NCT01296555|542006605|FG012|Overall Study|Non-Compliance With Study Drug|0|||
150237530|NCT01296555|542006606|FG013|Overall Study|Non-Compliance With Study Drug|0|||
150237531|NCT01296555|542006607|FG014|Overall Study|Non-Compliance With Study Drug|0|||
150237532|NCT01296555|542006608|FG015|Overall Study|Non-Compliance With Study Drug|0|||
150237533|NCT01296555|542006609|FG016|Overall Study|Non-Compliance With Study Drug|0|||
150237534|NCT01296555|542006610|FG017|Overall Study|Non-Compliance With Study Drug|0|||
150237535|NCT01296555|542006611|FG018|Overall Study|Non-Compliance With Study Drug|0|||
150237536|NCT01296555|542006612|FG019|Overall Study|Non-Compliance With Study Drug|0|||
150237537|NCT01296555|542006613|FG020|Overall Study|Non-Compliance With Study Drug|0|||
150237538|NCT01296555|542006614|FG021|Overall Study|Non-Compliance With Study Drug|0|||
150237539|NCT01296555|542006615|FG022|Overall Study|Non-Compliance With Study Drug|0|||
150237540|NCT01296555|542006616|FG023|Overall Study|Non-Compliance With Study Drug|0|||
150237541|NCT01296555|542006617|FG024|Overall Study|Non-Compliance With Study Drug|0|||
150237542|NCT01296555|542006618|FG025|Overall Study|Non-Compliance With Study Drug|0|||
150237543|NCT01296555|542006619|FG026|Overall Study|Non-Compliance With Study Drug|0|||
150237544|NCT01296555|542006620|FG027|Overall Study|Non-Compliance With Study Drug|0|||
150237545|NCT01296555|542006621|FG028|Overall Study|Non-Compliance With Study Drug|0|||
150237546|NCT01296555|542006593|FG000|Overall Study|Withdrawal by Subject|0|||
150237547|NCT01296555|542006594|FG001|Overall Study|Withdrawal by Subject|0|||
150237548|NCT01296555|542006595|FG002|Overall Study|Withdrawal by Subject|0|||
150237549|NCT01296555|542006596|FG003|Overall Study|Withdrawal by Subject|0|||
150237550|NCT01296555|542006597|FG004|Overall Study|Withdrawal by Subject|1|||
150237551|NCT01296555|542006598|FG005|Overall Study|Withdrawal by Subject|0|||
150237552|NCT01296555|542006599|FG006|Overall Study|Withdrawal by Subject|1|||
150237553|NCT01296555|542006600|FG007|Overall Study|Withdrawal by Subject|0|||
150237554|NCT01296555|542006601|FG008|Overall Study|Withdrawal by Subject|0|||
150237555|NCT01296555|542006602|FG009|Overall Study|Withdrawal by Subject|0|||
150237556|NCT01296555|542006603|FG010|Overall Study|Withdrawal by Subject|1|||
150237557|NCT01296555|542006604|FG011|Overall Study|Withdrawal by Subject|1|||
150237558|NCT01296555|542006605|FG012|Overall Study|Withdrawal by Subject|0|||
150142409|NCT04543188|541656042|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
150142410|NCT04543188|541656028|FG000|Phase 1a|Other|0|||
150142411|NCT04543188|541656029|FG001|Phase 1a|Other|0|||
150142412|NCT04543188|541656030|FG002|Phase 1a|Other|0|||
150142413|NCT04543188|541656031|FG003|Phase 1a|Other|0|||
150142414|NCT04543188|541656032|FG004|Phase 1a|Other|0|||
150237559|NCT01296555|542006606|FG013|Overall Study|Withdrawal by Subject|0|||
150237560|NCT01296555|542006607|FG014|Overall Study|Withdrawal by Subject|3|||
150237561|NCT01296555|542006608|FG015|Overall Study|Withdrawal by Subject|0|||
150237562|NCT01296555|542006609|FG016|Overall Study|Withdrawal by Subject|2|||
150237563|NCT01296555|542006610|FG017|Overall Study|Withdrawal by Subject|1|||
150237564|NCT01296555|542006611|FG018|Overall Study|Withdrawal by Subject|0|||
150237565|NCT01296555|542006612|FG019|Overall Study|Withdrawal by Subject|1|||
150237566|NCT01296555|542006613|FG020|Overall Study|Withdrawal by Subject|1|||
150237567|NCT01296555|542006614|FG021|Overall Study|Withdrawal by Subject|1|||
150237568|NCT01296555|542006615|FG022|Overall Study|Withdrawal by Subject|3|||
150237569|NCT01296555|542006616|FG023|Overall Study|Withdrawal by Subject|0|||
150237570|NCT01296555|542006617|FG024|Overall Study|Withdrawal by Subject|0|||
150237571|NCT01296555|542006618|FG025|Overall Study|Withdrawal by Subject|0|||
150237572|NCT01296555|542006619|FG026|Overall Study|Withdrawal by Subject|8|||
150237573|NCT01296555|542006620|FG027|Overall Study|Withdrawal by Subject|4|||
150237574|NCT01296555|542006621|FG028|Overall Study|Withdrawal by Subject|2|||
150237575|NCT01182181|542006624|FG000|First Intervention|Adverse Event|1|||
150237576|NCT01182181|542006625|FG001|First Intervention|Adverse Event|0|||
150237577|NCT01182181|542006624|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
150237578|NCT01182181|542006625|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
150237579|NCT01704547|542006626|FG000|Overall Study|Physician Decision|4|||
150237580|NCT01704547|542006626|FG000|Overall Study|Withdrawal by Subject|1|||
150237581|NCT01101061|542006627|FG000|Overall Study|Adverse Event|0|||
150237582|NCT01101061|542006628|FG001|Overall Study|Adverse Event|0|||
150237583|NCT01101061|542006629|FG002|Overall Study|Adverse Event|1|||
150237584|NCT01101061|542006630|FG003|Overall Study|Adverse Event|0|||
150237585|NCT01101061|542006631|FG004|Overall Study|Adverse Event|0|||
150237586|NCT01101061|542006632|FG005|Overall Study|Adverse Event|0|||
150237587|NCT02569957|542006637|FG000|Overall Study|Withdrawal by Subject|0|||
150237588|NCT02569957|542006638|FG001|Overall Study|Withdrawal by Subject|1|||
150237589|NCT02635386|542006639|FG000|Overall Study|Pregnancy|2|||
150237590|NCT02635386|542006640|FG001|Overall Study|Pregnancy|0|||
150237591|NCT02635386|542006641|FG002|Overall Study|Pregnancy|0|||
150237592|NCT02635386|542006642|FG003|Overall Study|Pregnancy|0|||
150237593|NCT02635386|542006643|FG004|Overall Study|Pregnancy|2|||
150237594|NCT02635386|542006639|FG000|Overall Study|Withdrawal by Subject|1|||
150237595|NCT02635386|542006640|FG001|Overall Study|Withdrawal by Subject|1|||
150237596|NCT02635386|542006641|FG002|Overall Study|Withdrawal by Subject|0|||
150237597|NCT02635386|542006642|FG003|Overall Study|Withdrawal by Subject|1|||
150237598|NCT02635386|542006643|FG004|Overall Study|Withdrawal by Subject|0|||
150237599|NCT02635386|542006639|FG000|Overall Study|Physician Decision|0|||
150142415|NCT04543188|541656033|FG005|Phase 1a|Other|0|||
150142416|NCT04543188|541656034|FG006|Phase 1a|Other|0|||
150142417|NCT04543188|541656035|FG007|Phase 1a|Other|0|||
150142418|NCT04543188|541656036|FG008|Phase 1a|Other|0|||
150142419|NCT04543188|541656037|FG009|Phase 1a|Other|1|||
150142420|NCT04543188|541656038|FG010|Phase 1a|Other|0|||
150142421|NCT04543188|541656039|FG011|Phase 1a|Other|0|||
150142422|NCT04543188|541656040|FG012|Phase 1a|Other|0|||
150142423|NCT04543188|541656041|FG013|Phase 1a|Other|0|||
150142424|NCT04543188|541656042|FG014|Phase 1a|Other|0|||
150142425|NCT04543188|541656028|FG000|Phase 1b|Adverse Event|0|||
150142426|NCT04543188|541656029|FG001|Phase 1b|Adverse Event|0|||
150142427|NCT04543188|541656030|FG002|Phase 1b|Adverse Event|0|||
150142428|NCT04543188|541656031|FG003|Phase 1b|Adverse Event|0|||
150142429|NCT04543188|541656032|FG004|Phase 1b|Adverse Event|0|||
150142430|NCT04543188|541656033|FG005|Phase 1b|Adverse Event|0|||
150142431|NCT04543188|541656034|FG006|Phase 1b|Adverse Event|0|||
150142432|NCT04543188|541656035|FG007|Phase 1b|Adverse Event|0|||
150142433|NCT04543188|541656036|FG008|Phase 1b|Adverse Event|0|||
150142434|NCT04543188|541656037|FG009|Phase 1b|Adverse Event|0|||
150142435|NCT04543188|541656038|FG010|Phase 1b|Adverse Event|0|||
150142436|NCT04543188|541656039|FG011|Phase 1b|Adverse Event|0|||
150142437|NCT04543188|541656040|FG012|Phase 1b|Adverse Event|0|||
150142438|NCT04543188|541656041|FG013|Phase 1b|Adverse Event|0|||
150142439|NCT04543188|541656042|FG014|Phase 1b|Adverse Event|2|||
150142440|NCT04543188|541656028|FG000|Phase 1b|Other (Death)|0|||
150237600|NCT02635386|542006640|FG001|Overall Study|Physician Decision|1|||
150237601|NCT02635386|542006641|FG002|Overall Study|Physician Decision|0|||
150142441|NCT04543188|541656029|FG001|Phase 1b|Other (Death)|0|||
150142442|NCT04543188|541656030|FG002|Phase 1b|Other (Death)|0|||
150237602|NCT02635386|542006642|FG003|Overall Study|Physician Decision|0|||
150237603|NCT02635386|542006643|FG004|Overall Study|Physician Decision|0|||
150237604|NCT02635386|542006639|FG000|Overall Study|Moved Out of State|0|||
150237605|NCT02635386|542006640|FG001|Overall Study|Moved Out of State|1|||
150142443|NCT04543188|541656031|FG003|Phase 1b|Other (Death)|0|||
150142444|NCT04543188|541656032|FG004|Phase 1b|Other (Death)|0|||
150142445|NCT04543188|541656033|FG005|Phase 1b|Other (Death)|0|||
150142446|NCT04543188|541656034|FG006|Phase 1b|Other (Death)|0|||
150142447|NCT04543188|541656035|FG007|Phase 1b|Other (Death)|0|||
150142448|NCT04543188|541656036|FG008|Phase 1b|Other (Death)|0|||
150237606|NCT02635386|542006641|FG002|Overall Study|Moved Out of State|0|||
150237607|NCT02635386|542006642|FG003|Overall Study|Moved Out of State|0|||
150237608|NCT02635386|542006643|FG004|Overall Study|Moved Out of State|0|||
150237609|NCT02635386|542006639|FG000|Overall Study|Noncompliant|0|||
150237610|NCT02635386|542006640|FG001|Overall Study|Noncompliant|2|||
150237611|NCT02635386|542006641|FG002|Overall Study|Noncompliant|1|||
150237612|NCT02635386|542006642|FG003|Overall Study|Noncompliant|1|||
150237613|NCT02635386|542006643|FG004|Overall Study|Noncompliant|1|||
150237614|NCT02635386|542006639|FG000|Overall Study|side effects|0|||
150237615|NCT02635386|542006640|FG001|Overall Study|side effects|0|||
150237616|NCT02635386|542006641|FG002|Overall Study|side effects|1|||
150237617|NCT02635386|542006642|FG003|Overall Study|side effects|4|||
150237618|NCT02635386|542006643|FG004|Overall Study|side effects|6|||
150237619|NCT02635386|542006639|FG000|Overall Study|needed other major surgery|0|||
150237620|NCT02635386|542006640|FG001|Overall Study|needed other major surgery|1|||
150237621|NCT02635386|542006641|FG002|Overall Study|needed other major surgery|0|||
150237622|NCT02635386|542006642|FG003|Overall Study|needed other major surgery|0|||
150237623|NCT02635386|542006643|FG004|Overall Study|needed other major surgery|0|||
150237624|NCT02635386|542006639|FG000|Overall Study|Other medical problems not drug related|0|||
150237625|NCT02635386|542006640|FG001|Overall Study|Other medical problems not drug related|0|||
150237626|NCT02635386|542006641|FG002|Overall Study|Other medical problems not drug related|0|||
150237627|NCT02635386|542006642|FG003|Overall Study|Other medical problems not drug related|1|||
150237628|NCT02635386|542006643|FG004|Overall Study|Other medical problems not drug related|0|||
150237629|NCT00745498|542006644|FG000|Overall Study|Lost to Follow-up|1|||
150237630|NCT00745498|542006645|FG001|Overall Study|Lost to Follow-up|1|||
150237631|NCT00745498|542006646|FG002|Overall Study|Lost to Follow-up|3|||
150237632|NCT00745498|542006644|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
150237633|NCT00745498|542006645|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
150237634|NCT00745498|542006646|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
150237635|NCT00745498|542006644|FG000|Overall Study|Non-PDR related VH|0|||
150237636|NCT00745498|542006645|FG001|Overall Study|Non-PDR related VH|1|||
150237637|NCT00745498|542006646|FG002|Overall Study|Non-PDR related VH|1|||
150237638|NCT00745498|542006644|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
150237639|NCT00745498|542006645|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
150237640|NCT00745498|542006646|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
150237641|NCT03174782|542006647|FG000|Overall Study|Protocol Violation|1|||
150237642|NCT03174782|542006648|FG001|Overall Study|Protocol Violation|0|||
150237643|NCT03174782|542006647|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
150237644|NCT03174782|542006648|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
150237645|NCT00778921|542006649|FG000|Overall Study|Adverse Event|9|||
150237646|NCT00778921|542006650|FG001|Overall Study|Adverse Event|10|||
150237647|NCT00778921|542006651|FG002|Overall Study|Adverse Event|14|||
150237648|NCT00778921|542006649|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
150237649|NCT00778921|542006650|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
150237650|NCT00778921|542006651|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
150237651|NCT00778921|542006649|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
150237652|NCT00778921|542006650|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
150237653|NCT00778921|542006651|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
150237654|NCT00778921|542006649|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
150237655|NCT00778921|542006650|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
150237656|NCT00778921|542006651|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
150237657|NCT00778921|542006649|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
150237658|NCT00778921|542006650|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
150237659|NCT00778921|542006651|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
150237660|NCT00778921|542006649|FG000|Overall Study|Patient withdrew request|3|||
150237661|NCT00778921|542006650|FG001|Overall Study|Patient withdrew request|1|||
150237662|NCT00778921|542006651|FG002|Overall Study|Patient withdrew request|6|||
150237663|NCT00778921|542006649|FG000|Overall Study|Lost to Follow-up|0|||
150237664|NCT00778921|542006650|FG001|Overall Study|Lost to Follow-up|2|||
150237665|NCT00778921|542006651|FG002|Overall Study|Lost to Follow-up|1|||
150237666|NCT00778921|542006649|FG000|Overall Study|Administrative Problems|1|||
150237667|NCT00778921|542006650|FG001|Overall Study|Administrative Problems|2|||
150237668|NCT00778921|542006651|FG002|Overall Study|Administrative Problems|0|||
150237669|NCT00778921|542006649|FG000|Overall Study|Protocol Violation|3|||
150237670|NCT00778921|542006650|FG001|Overall Study|Protocol Violation|0|||
150237671|NCT00778921|542006651|FG002|Overall Study|Protocol Violation|2|||
150237672|NCT00778921|542006649|FG000|Overall Study|Not treated|0|||
150237673|NCT00778921|542006650|FG001|Overall Study|Not treated|2|||
150237674|NCT00778921|542006651|FG002|Overall Study|Not treated|2|||
150237675|NCT03178045|542006652|FG000|Overall Study|Withdrawal by Subject|5|||
150237676|NCT03178045|542006653|FG001|Overall Study|Withdrawal by Subject|7|||
150237677|NCT03178045|542006652|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
150237678|NCT03178045|542006653|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
150237679|NCT03178045|542006652|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
150237680|NCT03178045|542006653|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
150237681|NCT03636373|542006654|FG000|Overall Study|Study closure due to Covid-19|1|||
150237682|NCT03636373|542006655|FG001|Overall Study|Study closure due to Covid-19|0|||
150237683|NCT00572533|542006656|FG000|Overall Study|Death|4|||
150237684|NCT00572533|542006657|FG001|Overall Study|Death|1|||
150237685|NCT00572533|542006656|FG000|Overall Study|Received Kidney Transplant|2|||
150237686|NCT00572533|542006657|FG001|Overall Study|Received Kidney Transplant|1|||
150237687|NCT00572533|542006656|FG000|Overall Study|Social Issues|1|||
150237688|NCT00572533|542006657|FG001|Overall Study|Social Issues|0|||
150142449|NCT04543188|541656037|FG009|Phase 1b|Other (Death)|0|||
150142450|NCT04543188|541656038|FG010|Phase 1b|Other (Death)|0|||
150142451|NCT04543188|541656039|FG011|Phase 1b|Other (Death)|0|||
150142452|NCT04543188|541656040|FG012|Phase 1b|Other (Death)|1|||
150142453|NCT04543188|541656041|FG013|Phase 1b|Other (Death)|0|||
150142454|NCT04543188|541656042|FG014|Phase 1b|Other (Death)|1|||
150142455|NCT04543188|541656028|FG000|Phase 1b|Progressive Disease|0|||
150142456|NCT04543188|541656029|FG001|Phase 1b|Progressive Disease|0|||
150142457|NCT04543188|541656030|FG002|Phase 1b|Progressive Disease|0|||
150142458|NCT04543188|541656031|FG003|Phase 1b|Progressive Disease|0|||
150142459|NCT04543188|541656032|FG004|Phase 1b|Progressive Disease|0|||
150142460|NCT04543188|541656033|FG005|Phase 1b|Progressive Disease|0|||
150142461|NCT04543188|541656034|FG006|Phase 1b|Progressive Disease|0|||
150142462|NCT04543188|541656035|FG007|Phase 1b|Progressive Disease|0|||
150142463|NCT04543188|541656036|FG008|Phase 1b|Progressive Disease|0|||
150142464|NCT04543188|541656037|FG009|Phase 1b|Progressive Disease|0|||
150142465|NCT04543188|541656038|FG010|Phase 1b|Progressive Disease|0|||
150142466|NCT04543188|541656039|FG011|Phase 1b|Progressive Disease|0|||
150142467|NCT04543188|541656040|FG012|Phase 1b|Progressive Disease|2|||
150142468|NCT04543188|541656041|FG013|Phase 1b|Progressive Disease|1|||
150142469|NCT04543188|541656042|FG014|Phase 1b|Progressive Disease|5|||
150142470|NCT04543188|541656028|FG000|Phase 1b|Study Terminated By Sponsor|0|||
150142471|NCT04543188|541656029|FG001|Phase 1b|Study Terminated By Sponsor|0|||
150142472|NCT04543188|541656030|FG002|Phase 1b|Study Terminated By Sponsor|0|||
150142473|NCT04543188|541656031|FG003|Phase 1b|Study Terminated By Sponsor|0|||
150142474|NCT04543188|541656032|FG004|Phase 1b|Study Terminated By Sponsor|0|||
150142475|NCT04543188|541656033|FG005|Phase 1b|Study Terminated By Sponsor|0|||
150142476|NCT04543188|541656034|FG006|Phase 1b|Study Terminated By Sponsor|0|||
150142477|NCT04543188|541656035|FG007|Phase 1b|Study Terminated By Sponsor|0|||
150142478|NCT04543188|541656036|FG008|Phase 1b|Study Terminated By Sponsor|0|||
150142479|NCT04543188|541656037|FG009|Phase 1b|Study Terminated By Sponsor|0|||
150142480|NCT04543188|541656038|FG010|Phase 1b|Study Terminated By Sponsor|0|||
150142481|NCT04543188|541656039|FG011|Phase 1b|Study Terminated By Sponsor|1|||
150142482|NCT04543188|541656040|FG012|Phase 1b|Study Terminated By Sponsor|1|||
150142483|NCT04543188|541656041|FG013|Phase 1b|Study Terminated By Sponsor|0|||
150142484|NCT04543188|541656042|FG014|Phase 1b|Study Terminated By Sponsor|1|||
150142485|NCT04543188|541656028|FG000|Phase 1b|Withdrawal by Subject|0|||
150142486|NCT04543188|541656029|FG001|Phase 1b|Withdrawal by Subject|0|||
150142487|NCT04543188|541656030|FG002|Phase 1b|Withdrawal by Subject|0|||
150142488|NCT04543188|541656031|FG003|Phase 1b|Withdrawal by Subject|0|||
150142489|NCT04543188|541656032|FG004|Phase 1b|Withdrawal by Subject|0|||
150142490|NCT04543188|541656033|FG005|Phase 1b|Withdrawal by Subject|0|||
150142491|NCT04543188|541656034|FG006|Phase 1b|Withdrawal by Subject|0|||
150142492|NCT04543188|541656035|FG007|Phase 1b|Withdrawal by Subject|0|||
150142493|NCT04543188|541656036|FG008|Phase 1b|Withdrawal by Subject|0|||
150142494|NCT04543188|541656037|FG009|Phase 1b|Withdrawal by Subject|0|||
150142495|NCT04543188|541656038|FG010|Phase 1b|Withdrawal by Subject|0|||
150142496|NCT04543188|541656039|FG011|Phase 1b|Withdrawal by Subject|0|||
150142497|NCT04543188|541656040|FG012|Phase 1b|Withdrawal by Subject|0|||
150142498|NCT04543188|541656041|FG013|Phase 1b|Withdrawal by Subject|0|||
150142499|NCT04543188|541656042|FG014|Phase 1b|Withdrawal by Subject|2|||
150142500|NCT05004688|541656045|FG000|Overall Study|Protocol Violation|7|||
150142501|NCT05004688|541656045|FG000|Overall Study|Physician Decision|2|||
150142502|NCT05004688|541656045|FG000|Overall Study|Withdrawal by Subject|2|||
150142503|NCT01313286|541656046|FG000|Period 1|Withdrawal by Subject|2|||
150142504|NCT01313286|541656047|FG001|Period 1|Withdrawal by Subject|0|||
150142505|NCT05158296|541656048|FG000|Overall Study|Sponsor Decision|2|||
150142506|NCT05158296|541656049|FG001|Overall Study|Sponsor Decision|3|||
150142507|NCT05158296|541656050|FG002|Overall Study|Sponsor Decision|2|||
150142508|NCT02552238|541656051|FG000|Overall Study|Withdrawal by Subject|2|||
150142509|NCT02552238|541656051|FG000|Overall Study|Adverse Event|2|||
150142510|NCT02036645|541656055|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142511|NCT02036645|541656056|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142512|NCT02036645|541656057|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142513|NCT02036645|541656058|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142514|NCT02036645|541656059|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142515|NCT02036645|541656060|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142516|NCT02036645|541656061|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
150142517|NCT02036645|541656062|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142518|NCT02036645|541656063|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142519|NCT02036645|541656064|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142520|NCT02036645|541656065|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142521|NCT02036645|541656066|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
150142522|NCT02036645|541656055|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142523|NCT02036645|541656056|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142524|NCT02036645|541656057|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142525|NCT02036645|541656058|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
150237689|NCT00572533|542006656|FG000|Overall Study|Transfer out of Facility|0|||
150237690|NCT00572533|542006657|FG001|Overall Study|Transfer out of Facility|1|||
150237691|NCT01078922|542006658|FG000|Overall Study|Adverse Event|1|||
150142526|NCT02036645|541656059|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142527|NCT02036645|541656060|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142528|NCT02036645|541656061|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142529|NCT02036645|541656062|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142530|NCT02036645|541656063|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142531|NCT02036645|541656064|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142532|NCT02036645|541656065|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142533|NCT02036645|541656066|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
150142534|NCT04241094|541656067|FG000|Overall Study|Dropped out of treatment|4|||
150142535|NCT04241094|541656067|FG000|Overall Study|Ineligible after clinical assessment|2|||
150142536|NCT04241094|541656067|FG000|Overall Study|Lost to Follow-up|2|||
150142537|NCT02272725|541656075|FG000|Overall Study|equipment malfunction|2|||
150142538|NCT02272725|541656076|FG001|Overall Study|equipment malfunction|0|||
150142539|NCT01061333|541656077|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
150142540|NCT01061333|541656078|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
150142541|NCT04858802|541657946|FG000|Overall Study|Lost to Follow-up|1|||
150142542|NCT04858802|541657947|FG001|Overall Study|Lost to Follow-up|1|||
150142543|NCT04858802|541657946|FG000|Overall Study|Withdrawal by Subject|1|||
150142544|NCT04858802|541657947|FG001|Overall Study|Withdrawal by Subject|1|||
150142545|NCT02026232|541657948|FG000|Overall Study|incomplete visit/missing data|3|||
150142546|NCT02026232|541657949|FG001|Overall Study|incomplete visit/missing data|2|||
150142547|NCT03610737|541657950|FG000|Overall Study|Withdrawal by Subject|1|||
150142548|NCT03610737|541657951|FG001|Overall Study|Withdrawal by Subject|5|||
150142549|NCT03610737|541657950|FG000|Overall Study|Death|1|||
150142550|NCT03610737|541657951|FG001|Overall Study|Death|0|||
150142551|NCT03610737|541657950|FG000|Overall Study|Not treated|5|||
150142552|NCT03610737|541657951|FG001|Overall Study|Not treated|2|||
150142553|NCT03610737|541657950|FG000|Overall Study|Missed Visit|1|||
150142554|NCT03610737|541657951|FG001|Overall Study|Missed Visit|2|||
150142555|NCT02714868|541657952|FG000|Overall Study|Withdrawal by Subject|3|||
150142556|NCT02714868|541657953|FG001|Overall Study|Withdrawal by Subject|0|||
150142557|NCT02714868|541657952|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
150142558|NCT02714868|541657953|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
150142559|NCT02714868|541657952|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
150142560|NCT02714868|541657953|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
150142561|NCT02013388|541657954|FG000|Overall Study|work emergency|1|||
150142562|NCT02013388|541657955|FG001|Overall Study|work emergency|0|||
150142563|NCT02013388|541657956|FG002|Overall Study|work emergency|0|||
150142564|NCT02013388|541657957|FG003|Overall Study|work emergency|0|||
150142565|NCT02013388|541657958|FG004|Overall Study|work emergency|1|||
150142566|NCT02013388|541657959|FG005|Overall Study|work emergency|0|||
150142567|NCT02013388|541657960|FG006|Overall Study|work emergency|0|||
150142568|NCT02013388|541657961|FG007|Overall Study|work emergency|0|||
150142569|NCT04461795|541657963|FG000|Overall Study|Lost to Follow-up|2|||
150142570|NCT04461795|541657963|FG000|Overall Study|Withdrawal by Subject|2|||
150142571|NCT04461795|541657963|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
150142572|NCT00185640|541657964|FG000|Overall Study|Not Eligible|4|||
150142573|NCT00185640|541657964|FG000|Overall Study|Withdrawal by Subject|3|||
150142574|NCT00185640|541657964|FG000|Overall Study|Death|138|||
150142575|NCT02396537|541657971|FG000|Overall Study|Protocol Violation|0|||
150142576|NCT02396537|541657972|FG001|Overall Study|Protocol Violation|1|||
150142577|NCT00927355|541657973|FG000|Overall Study|Adverse Event|1|||
150142578|NCT00927355|541657974|FG001|Overall Study|Adverse Event|1|||
150142579|NCT01572389|541657975|FG000|Overall Study|Death|1|||
150142580|NCT01572389|541657976|FG001|Overall Study|Death|3|||
150142581|NCT01572389|541657975|FG000|Overall Study|Withdrawal by Subject|14|||
150142582|NCT01572389|541657976|FG001|Overall Study|Withdrawal by Subject|2|||
150142583|NCT01572389|541657975|FG000|Overall Study|Lost to Follow-up|25|||
150142584|NCT01572389|541657976|FG001|Overall Study|Lost to Follow-up|14|||
150142585|NCT01572389|541657975|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
150142586|NCT01572389|541657976|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
150142587|NCT01153269|541657977|FG000|Overall Study|Withdrawal by Subject|1|||
150142588|NCT01153269|541657977|FG000|Overall Study|Antiretroviral therapy break|1|||
150142589|NCT02635724|541657988|FG000|Overall Study|Withdrawal by Subject|0|||
150237692|NCT02353468|542006659|FG000|Overall Study|Study terminated|3|||
150237693|NCT00003477|542006660|FG000|Overall Study|Not evalauable|4|||
150142590|NCT02635724|541657989|FG001|Overall Study|Withdrawal by Subject|1|||
150142591|NCT02635724|541657990|FG002|Overall Study|Withdrawal by Subject|0|||
150142592|NCT00100932|541657997|FG000|Overall Study|Adverse Event|11|||
150142593|NCT00100932|541657998|FG001|Overall Study|Adverse Event|2|||
150142594|NCT00100932|541657997|FG000|Overall Study|Withdrawal by Subject|6|||
150142595|NCT00100932|541657998|FG001|Overall Study|Withdrawal by Subject|0|||
150142596|NCT00100932|541657997|FG000|Overall Study|Progressive Disease|44|||
150237694|NCT00267098|542006661|FG000|Overall Study|Death|0|||
150237695|NCT00267098|542006662|FG001|Overall Study|Death|0|||
150237696|NCT00267098|542006663|FG002|Overall Study|Death|57|||
150237697|NCT00267098|542006664|FG003|Overall Study|Death|66|||
150237698|NCT00267098|542006665|FG004|Overall Study|Death|14|||
150237699|NCT00267098|542006666|FG005|Overall Study|Death|23|||
150237700|NCT00267098|542006667|FG006|Overall Study|Death|28|||
150237701|NCT00267098|542006668|FG007|Overall Study|Death|9|||
150237702|NCT00267098|542006661|FG000|Overall Study|Lost to Follow-up|0|||
150237703|NCT00267098|542006662|FG001|Overall Study|Lost to Follow-up|0|||
150237704|NCT00267098|542006663|FG002|Overall Study|Lost to Follow-up|6|||
150237705|NCT00267098|542006664|FG003|Overall Study|Lost to Follow-up|5|||
150237706|NCT00267098|542006665|FG004|Overall Study|Lost to Follow-up|2|||
150237707|NCT00267098|542006666|FG005|Overall Study|Lost to Follow-up|3|||
150237708|NCT00267098|542006667|FG006|Overall Study|Lost to Follow-up|1|||
150237709|NCT00267098|542006668|FG007|Overall Study|Lost to Follow-up|1|||
150237710|NCT00267098|542006661|FG000|Overall Study|Withdrawal by Subject|8|||
150237711|NCT00267098|542006662|FG001|Overall Study|Withdrawal by Subject|0|||
150237712|NCT00267098|542006663|FG002|Overall Study|Withdrawal by Subject|24|||
150237713|NCT00267098|542006664|FG003|Overall Study|Withdrawal by Subject|21|||
150237714|NCT00267098|542006665|FG004|Overall Study|Withdrawal by Subject|12|||
150237715|NCT00267098|542006666|FG005|Overall Study|Withdrawal by Subject|9|||
150237716|NCT00267098|542006667|FG006|Overall Study|Withdrawal by Subject|12|||
150237717|NCT00267098|542006668|FG007|Overall Study|Withdrawal by Subject|5|||
150237718|NCT00267098|542006661|FG000|Overall Study|Physician Decision|5|||
150237719|NCT00267098|542006662|FG001|Overall Study|Physician Decision|0|||
150237720|NCT00267098|542006663|FG002|Overall Study|Physician Decision|7|||
150237721|NCT00267098|542006664|FG003|Overall Study|Physician Decision|11|||
150237722|NCT00267098|542006665|FG004|Overall Study|Physician Decision|5|||
150237723|NCT00267098|542006666|FG005|Overall Study|Physician Decision|4|||
150237724|NCT00267098|542006667|FG006|Overall Study|Physician Decision|3|||
150237725|NCT00267098|542006668|FG007|Overall Study|Physician Decision|0|||
150237726|NCT00267098|542006661|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
150237727|NCT00267098|542006662|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237728|NCT00267098|542006663|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237729|NCT00267098|542006664|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237730|NCT00267098|542006665|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
150237731|NCT00267098|542006666|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237732|NCT00267098|542006667|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237733|NCT00267098|542006668|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
150237734|NCT00267098|542006661|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237735|NCT00267098|542006662|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
150237736|NCT00267098|542006663|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237737|NCT00267098|542006664|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237738|NCT00267098|542006665|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237739|NCT00267098|542006666|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237740|NCT00267098|542006667|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237741|NCT00267098|542006668|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
150237742|NCT00267098|542006661|FG000|Overall Study|Site closure|0|||
150237743|NCT00267098|542006662|FG001|Overall Study|Site closure|0|||
150237744|NCT00267098|542006663|FG002|Overall Study|Site closure|0|||
150237745|NCT00267098|542006664|FG003|Overall Study|Site closure|1|||
150237746|NCT00267098|542006665|FG004|Overall Study|Site closure|0|||
150237747|NCT00267098|542006666|FG005|Overall Study|Site closure|1|||
150237748|NCT00267098|542006667|FG006|Overall Study|Site closure|1|||
150237749|NCT00267098|542006668|FG007|Overall Study|Site closure|0|||
150237750|NCT00267098|542006661|FG000|Overall Study|Explanted Medtronic device|0|||
150237751|NCT00267098|542006662|FG001|Overall Study|Explanted Medtronic device|0|||
150237752|NCT00267098|542006663|FG002|Overall Study|Explanted Medtronic device|0|||
150237753|NCT00267098|542006664|FG003|Overall Study|Explanted Medtronic device|1|||
150237754|NCT00267098|542006665|FG004|Overall Study|Explanted Medtronic device|0|||
150237755|NCT00267098|542006666|FG005|Overall Study|Explanted Medtronic device|0|||
150237756|NCT00267098|542006667|FG006|Overall Study|Explanted Medtronic device|0|||
150237757|NCT00267098|542006668|FG007|Overall Study|Explanted Medtronic device|0|||
150237758|NCT00267098|542006661|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237759|NCT00267098|542006662|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237760|NCT00267098|542006663|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237761|NCT00267098|542006664|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237762|NCT00267098|542006665|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
150237763|NCT00267098|542006666|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237764|NCT00267098|542006667|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237765|NCT00267098|542006668|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
150237766|NCT00267098|542006661|FG000|Overall Study|Subject listed for heart transplant|0|||
150237767|NCT00267098|542006662|FG001|Overall Study|Subject listed for heart transplant|0|||
150237768|NCT00267098|542006663|FG002|Overall Study|Subject listed for heart transplant|0|||
150237769|NCT00267098|542006664|FG003|Overall Study|Subject listed for heart transplant|0|||
150237770|NCT00267098|542006665|FG004|Overall Study|Subject listed for heart transplant|0|||
150237771|NCT00267098|542006666|FG005|Overall Study|Subject listed for heart transplant|0|||
150237772|NCT00267098|542006667|FG006|Overall Study|Subject listed for heart transplant|1|||
150237773|NCT00267098|542006668|FG007|Overall Study|Subject listed for heart transplant|0|||
150237774|NCT00267098|542006661|FG000|Overall Study|Sponsor withdrew subject|0|||
150237775|NCT00267098|542006662|FG001|Overall Study|Sponsor withdrew subject|0|||
150237776|NCT00267098|542006663|FG002|Overall Study|Sponsor withdrew subject|0|||
150237777|NCT00267098|542006664|FG003|Overall Study|Sponsor withdrew subject|1|||
150237778|NCT00267098|542006665|FG004|Overall Study|Sponsor withdrew subject|0|||
150237779|NCT00267098|542006666|FG005|Overall Study|Sponsor withdrew subject|0|||
150237780|NCT00267098|542006667|FG006|Overall Study|Sponsor withdrew subject|0|||
150237781|NCT00267098|542006668|FG007|Overall Study|Sponsor withdrew subject|0|||
150237782|NCT01575873|542006669|FG000|Overall Study|Withdrawal by Subject|15|||
150237783|NCT01575873|542006670|FG001|Overall Study|Withdrawal by Subject|20|||
150237784|NCT01575873|542006671|FG002|Overall Study|Withdrawal by Subject|34|||
150237785|NCT01575873|542006672|FG003|Overall Study|Withdrawal by Subject|34|||
150237786|NCT01575873|542006669|FG000|Overall Study|Adverse Event|7|||
150237787|NCT01575873|542006670|FG001|Overall Study|Adverse Event|7|||
150237788|NCT01575873|542006671|FG002|Overall Study|Adverse Event|9|||
150237789|NCT01575873|542006672|FG003|Overall Study|Adverse Event|12|||
150237790|NCT01575873|542006669|FG000|Overall Study|Lost to Follow-up|1|||
150237791|NCT01575873|542006670|FG001|Overall Study|Lost to Follow-up|3|||
150237792|NCT01575873|542006671|FG002|Overall Study|Lost to Follow-up|13|||
150237793|NCT01575873|542006672|FG003|Overall Study|Lost to Follow-up|5|||
150237794|NCT01575873|542006669|FG000|Overall Study|Death|3|||
150237795|NCT01575873|542006670|FG001|Overall Study|Death|2|||
150237796|NCT01575873|542006671|FG002|Overall Study|Death|8|||
150237797|NCT01575873|542006672|FG003|Overall Study|Death|9|||
150237798|NCT01575873|542006669|FG000|Overall Study|Noncompliance|1|||
150237799|NCT01575873|542006670|FG001|Overall Study|Noncompliance|2|||
150237800|NCT01575873|542006671|FG002|Overall Study|Noncompliance|4|||
150237801|NCT01575873|542006672|FG003|Overall Study|Noncompliance|3|||
150237802|NCT01575873|542006669|FG000|Overall Study|Administrative decision|1|||
150237803|NCT01575873|542006670|FG001|Overall Study|Administrative decision|1|||
150237804|NCT01575873|542006671|FG002|Overall Study|Administrative decision|1|||
150237805|NCT01575873|542006672|FG003|Overall Study|Administrative decision|0|||
150237806|NCT01575873|542006669|FG000|Overall Study|Protocol deviation|0|||
150237807|NCT01575873|542006670|FG001|Overall Study|Protocol deviation|1|||
150237808|NCT01575873|542006671|FG002|Overall Study|Protocol deviation|0|||
150237809|NCT01575873|542006672|FG003|Overall Study|Protocol deviation|1|||
150237810|NCT01575873|542006669|FG000|Overall Study|Requirement for Alternative Therapy|0|||
150237811|NCT01575873|542006670|FG001|Overall Study|Requirement for Alternative Therapy|0|||
150237812|NCT01575873|542006671|FG002|Overall Study|Requirement for Alternative Therapy|1|||
150237813|NCT01575873|542006672|FG003|Overall Study|Requirement for Alternative Therapy|1|||
150237814|NCT01575873|542006669|FG000|Overall Study|Other|0|||
150237815|NCT01575873|542006670|FG001|Overall Study|Other|0|||
150237816|NCT01575873|542006671|FG002|Overall Study|Other|4|||
150237817|NCT01575873|542006672|FG003|Overall Study|Other|2|||
150237818|NCT00798304|542006673|FG000|Overall Study|Adverse Event|0|||
150237819|NCT00798304|542006674|FG001|Overall Study|Adverse Event|1|||
150237820|NCT00798304|542006675|FG002|Overall Study|Adverse Event|1|||
150237821|NCT00798304|542006673|FG000|Overall Study|Discontinuation by Sponsor|14|||
150237822|NCT00798304|542006674|FG001|Overall Study|Discontinuation by Sponsor|21|||
150237823|NCT00798304|542006675|FG002|Overall Study|Discontinuation by Sponsor|9|||
150237824|NCT02031536|542006676|FG000|Overall Study|ineligible|1|||
150237825|NCT02031536|542006677|FG001|Overall Study|ineligible|0|||
150237826|NCT04211389|542006679|FG000|Overall Study|Adverse Event|1|||
150237827|NCT04211389|542006680|FG001|Overall Study|Adverse Event|2|||
150237828|NCT04211389|542006679|FG000|Overall Study|Lost to Follow-up|15|||
150237829|NCT04211389|542006680|FG001|Overall Study|Lost to Follow-up|7|||
150237830|NCT04211389|542006679|FG000|Overall Study|Protocol Violation|0|||
150237831|NCT04211389|542006680|FG001|Overall Study|Protocol Violation|1|||
150237832|NCT04211389|542006679|FG000|Overall Study|Withdrawal by Subject|10|||
150237833|NCT04211389|542006680|FG001|Overall Study|Withdrawal by Subject|11|||
150237834|NCT00547534|542006683|FG000|Overall Study|Adverse Event|7|||
150237835|NCT00547534|542006683|FG000|Overall Study|Disease Progression|4|||
150237836|NCT02688530|542006690|FG000|Overall Study|Withdrawal by Subject|0|||
150237837|NCT02688530|542006691|FG001|Overall Study|Withdrawal by Subject|1|||
150237838|NCT02688530|542006692|FG002|Overall Study|Withdrawal by Subject|0|||
150237839|NCT02688530|542006693|FG003|Overall Study|Withdrawal by Subject|0|||
150237840|NCT02688530|542006690|FG000|Overall Study|Lost to Follow-up|0|||
150237841|NCT02688530|542006691|FG001|Overall Study|Lost to Follow-up|0|||
150237842|NCT02688530|542006692|FG002|Overall Study|Lost to Follow-up|2|||
150237843|NCT02688530|542006693|FG003|Overall Study|Lost to Follow-up|0|||
150237844|NCT00725543|542006694|FG000|Overall Study|Adverse Event|10|||
150237845|NCT00725543|542006694|FG000|Overall Study|Lack of Efficacy|3|||
150237846|NCT00725543|542006694|FG000|Overall Study|Withdrawal by Subject|10|||
150237847|NCT00725543|542006694|FG000|Overall Study|Physician Decision|5|||
150237848|NCT00725543|542006694|FG000|Overall Study|Lost to Follow-up|4|||
150237849|NCT00725543|542006694|FG000|Overall Study|Non-compliance|2|||
150237850|NCT00725543|542006694|FG000|Overall Study|Other|119|||
150237851|NCT01062971|542006701|FG000|Overall Study|Protocol Violation|1|||
150237852|NCT01062971|542006702|FG001|Overall Study|Protocol Violation|3|||
150237853|NCT01062971|542006701|FG000|Overall Study|Lost to Follow-up|3|||
150237854|NCT01062971|542006702|FG001|Overall Study|Lost to Follow-up|4|||
150237855|NCT01530087|542006703|FG000|Overall Study|Physician Decision|2|||
150237856|NCT01182207|542006704|FG000|First Intervention|Positive Hepatitis Results|0|||
150237857|NCT01182207|542006705|FG001|First Intervention|Positive Hepatitis Results|1|||
150237858|NCT01182207|542006704|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
150237859|NCT01182207|542006705|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
150237860|NCT03783871|542006712|FG000|Overall Study|Withdrawal by Subject|15|||
150237861|NCT03783871|542006712|FG000|Overall Study|Death|13|||
150237862|NCT03783871|542006712|FG000|Overall Study|Lost to Follow-up|2|||
150237863|NCT05990387|542006713|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
150237864|NCT05990387|542006714|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
150237865|NCT00604188|542006715|FG000|Overall Study|Adverse Event|1|||
150237866|NCT00604188|542006716|FG001|Overall Study|Adverse Event|4|||
150237867|NCT00604188|542006715|FG000|Overall Study|Lost to Follow-up|17|||
150237868|NCT00604188|542006716|FG001|Overall Study|Lost to Follow-up|15|||
150237869|NCT00604188|542006715|FG000|Overall Study|Withdrawal by Subject|5|||
150237870|NCT00604188|542006716|FG001|Overall Study|Withdrawal by Subject|1|||
150237871|NCT00604188|542006715|FG000|Overall Study|Non-compliance with protocol|4|||
150237872|NCT00604188|542006716|FG001|Overall Study|Non-compliance with protocol|4|||
150237873|NCT00604188|542006715|FG000|Overall Study|Did not receive study drug|0|||
150237874|NCT00604188|542006716|FG001|Overall Study|Did not receive study drug|1|||
150237875|NCT04680637|542006717|FG000|Overall Study|Lost to Follow-up|0|||
150237876|NCT04680637|542006718|FG001|Overall Study|Lost to Follow-up|1|||
150237877|NCT04680637|542006719|FG002|Overall Study|Lost to Follow-up|0|||
150237878|NCT04680637|542006720|FG003|Overall Study|Lost to Follow-up|1|||
150237879|NCT04680637|542006717|FG000|Overall Study|Death|1|||
150237880|NCT04680637|542006718|FG001|Overall Study|Death|0|||
150237881|NCT04680637|542006719|FG002|Overall Study|Death|0|||
150237882|NCT04680637|542006720|FG003|Overall Study|Death|0|||
150237883|NCT04680637|542006717|FG000|Overall Study|Withdrawal by Subject|7|||
150237884|NCT04680637|542006718|FG001|Overall Study|Withdrawal by Subject|10|||
150237885|NCT04680637|542006719|FG002|Overall Study|Withdrawal by Subject|17|||
150237886|NCT04680637|542006720|FG003|Overall Study|Withdrawal by Subject|15|||
150237887|NCT04680637|542006717|FG000|Overall Study|Decision by Sponsor|21|||
150237888|NCT04680637|542006718|FG001|Overall Study|Decision by Sponsor|15|||
150237889|NCT04680637|542006719|FG002|Overall Study|Decision by Sponsor|7|||
150237890|NCT04680637|542006720|FG003|Overall Study|Decision by Sponsor|32|||
150237891|NCT02242643|542006721|FG000|Overall Study|Protocol Violation|1|||
150237892|NCT02242643|542006722|FG001|Overall Study|Protocol Violation|2|||
150237893|NCT02242643|542006721|FG000|Overall Study|Withdrawal by Subject|15|||
150237894|NCT02242643|542006722|FG001|Overall Study|Withdrawal by Subject|10|||
150237895|NCT02242643|542006721|FG000|Overall Study|Migrated/moved from study area|1|||
150237896|NCT02242643|542006722|FG001|Overall Study|Migrated/moved from study area|3|||
150237897|NCT02242643|542006721|FG000|Overall Study|Lost to Follow-up|54|||
150237898|NCT02242643|542006722|FG001|Overall Study|Lost to Follow-up|61|||
150237899|NCT02242643|542006721|FG000|Overall Study|Child placed in foster care by family|0|||
150237900|NCT02242643|542006722|FG001|Overall Study|Child placed in foster care by family|1|||
150237901|NCT02242643|542006721|FG000|Overall Study|Non-compliance|1|||
150237902|NCT02242643|542006722|FG001|Overall Study|Non-compliance|0|||
150237903|NCT02242643|542006721|FG000|Overall Study|Consent withdrawal by parent|1|||
150237904|NCT02242643|542006722|FG001|Overall Study|Consent withdrawal by parent|0|||
150237905|NCT02242643|542006721|FG000|Overall Study|Protocol requirements not followed|1|||
150237906|NCT02242643|542006722|FG001|Overall Study|Protocol requirements not followed|0|||
150237907|NCT02242643|542006721|FG000|Overall Study|Language barrier|1|||
150237908|NCT02242643|542006722|FG001|Overall Study|Language barrier|0|||
150237909|NCT02242643|542006721|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
150237910|NCT02242643|542006722|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
150237911|NCT01103232|542006724|FG000|Overall Study|Withdrawal by Subject|1|||
150237912|NCT01103232|542006725|FG001|Overall Study|Withdrawal by Subject|1|||
150237913|NCT01103232|542006724|FG000|Overall Study|Protocol Violation|0|||
150237914|NCT01103232|542006725|FG001|Overall Study|Protocol Violation|1|||
150237915|NCT00443599|542006729|FG000|Overall Study|Physician Decision|2|||
150237916|NCT00443599|542006730|FG001|Overall Study|Physician Decision|1|||
150237917|NCT00443599|542006729|FG000|Overall Study|Death|1|||
150237918|NCT00443599|542006730|FG001|Overall Study|Death|1|||
150237919|NCT00443599|542006729|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
150237920|NCT00443599|542006730|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
150237921|NCT05093504|542006731|FG000|Overall Study|Death|0|||
150237922|NCT05093504|542006732|FG001|Overall Study|Death|1|||
150237923|NCT03733899|542006735|FG000|Period 1|Protocol Violation|0|||
150237924|NCT03733899|542006736|FG001|Period 1|Protocol Violation|0|||
150237925|NCT03733899|542006737|FG002|Period 1|Protocol Violation|0|||
150237926|NCT03733899|542006738|FG003|Period 1|Protocol Violation|0|||
150237927|NCT03733899|542006739|FG004|Period 1|Protocol Violation|0|||
150237928|NCT03733899|542006740|FG005|Period 1|Protocol Violation|1|||
150237929|NCT03733899|542006735|FG000|Period 2|Unscuccessful Treatment|0|||
150237930|NCT03733899|542006736|FG001|Period 2|Unscuccessful Treatment|1|||
150237931|NCT03733899|542006737|FG002|Period 2|Unscuccessful Treatment|0|||
150237932|NCT03733899|542006738|FG003|Period 2|Unscuccessful Treatment|0|||
150237933|NCT03733899|542006739|FG004|Period 2|Unscuccessful Treatment|0|||
150237934|NCT03733899|542006740|FG005|Period 2|Unscuccessful Treatment|0|||
150237935|NCT03733899|542006735|FG000|Period 3|Withdrawal by Subject|1|||
150237936|NCT03733899|542006736|FG001|Period 3|Withdrawal by Subject|0|||
150237937|NCT03733899|542006737|FG002|Period 3|Withdrawal by Subject|0|||
150237938|NCT03733899|542006738|FG003|Period 3|Withdrawal by Subject|0|||
150237939|NCT03733899|542006739|FG004|Period 3|Withdrawal by Subject|0|||
150237940|NCT03733899|542006740|FG005|Period 3|Withdrawal by Subject|0|||
150237941|NCT03526679|542007817|FG000|Overall Study|still under treatment|2|||
150237942|NCT04916002|542007820|FG000|Overall Study|Adverse Event|0|||
150237943|NCT04916002|542007821|FG001|Overall Study|Adverse Event|1|||
150237944|NCT04916002|542007822|FG002|Overall Study|Adverse Event|0|||
150237945|NCT04916002|542007823|FG003|Overall Study|Adverse Event|1|||
150237946|NCT04916002|542007824|FG004|Overall Study|Adverse Event|0|||
150237947|NCT04916002|542007820|FG000|Overall Study|Withdrawal by Subject|3|||
150237948|NCT04916002|542007821|FG001|Overall Study|Withdrawal by Subject|1|||
150237949|NCT04916002|542007822|FG002|Overall Study|Withdrawal by Subject|0|||
150237950|NCT04916002|542007823|FG003|Overall Study|Withdrawal by Subject|1|||
150237951|NCT04916002|542007824|FG004|Overall Study|Withdrawal by Subject|0|||
150237952|NCT04916002|542007820|FG000|Overall Study|Death|8|||
150237953|NCT04916002|542007821|FG001|Overall Study|Death|7|||
150237954|NCT04916002|542007822|FG002|Overall Study|Death|4|||
150237955|NCT04916002|542007823|FG003|Overall Study|Death|9|||
150237956|NCT04916002|542007824|FG004|Overall Study|Death|0|||
150237957|NCT04916002|542007820|FG000|Overall Study|Study Terminated by Sponsor|11|||
150237958|NCT04916002|542007821|FG001|Overall Study|Study Terminated by Sponsor|10|||
150237959|NCT04916002|542007822|FG002|Overall Study|Study Terminated by Sponsor|8|||
150237960|NCT04916002|542007823|FG003|Overall Study|Study Terminated by Sponsor|5|||
150237961|NCT04916002|542007824|FG004|Overall Study|Study Terminated by Sponsor|4|||
150237962|NCT04916002|542007820|FG000|Overall Study|End of trial|1|||
150237963|NCT04916002|542007821|FG001|Overall Study|End of trial|0|||
150237964|NCT04916002|542007822|FG002|Overall Study|End of trial|0|||
150237965|NCT04916002|542007823|FG003|Overall Study|End of trial|0|||
150237966|NCT04916002|542007824|FG004|Overall Study|End of trial|0|||
150237967|NCT04916002|542007820|FG000|Overall Study|Progressive disease|0|||
150237968|NCT04916002|542007821|FG001|Overall Study|Progressive disease|0|||
150237969|NCT04916002|542007822|FG002|Overall Study|Progressive disease|1|||
150237970|NCT04916002|542007823|FG003|Overall Study|Progressive disease|0|||
150237971|NCT04916002|542007824|FG004|Overall Study|Progressive disease|0|||
150237972|NCT04916002|542007820|FG000|Overall Study|Participant non-compliance|2|||
150237973|NCT04916002|542007821|FG001|Overall Study|Participant non-compliance|0|||
150237974|NCT04916002|542007822|FG002|Overall Study|Participant non-compliance|0|||
150237975|NCT04916002|542007823|FG003|Overall Study|Participant non-compliance|0|||
150237976|NCT04916002|542007824|FG004|Overall Study|Participant non-compliance|0|||
150237977|NCT05923112|542007825|FG000|Overall Study|Protocol Violation|4|||
150237978|NCT05923112|542007825|FG000|Overall Study|No informed consent on publication of study results|243|||
150237979|NCT03118050|542007826|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
150237980|NCT03118050|542007827|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
150237981|NCT03118050|542007828|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
150237982|NCT03118050|542007829|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
150237983|NCT03118050|542007830|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
150237984|NCT03118050|542007831|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
150237985|NCT03118050|542007832|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
150237986|NCT01234883|542007838|FG000|Overall Study|Early treatment release|8|||
150237987|NCT01234883|542007839|FG001|Overall Study|Early treatment release|10|||
150237988|NCT01234883|542007838|FG000|Overall Study|Parent/guardian withdrew consent|1|||
150237989|NCT01234883|542007839|FG001|Overall Study|Parent/guardian withdrew consent|2|||
150237990|NCT01234883|542007838|FG000|Overall Study|Technical difficulties with IV infusion|0|||
150237991|NCT01234883|542007839|FG001|Overall Study|Technical difficulties with IV infusion|1|||
150237992|NCT01234883|542007838|FG000|Overall Study|Inclusion/exclusion failure|1|||
150237993|NCT01234883|542007839|FG001|Overall Study|Inclusion/exclusion failure|0|||
150237994|NCT04889118|542007840|FG000|Overall Study|Death|49|||
150237995|NCT04889118|542007841|FG001|Overall Study|Death|47|||
150237996|NCT04889118|542007840|FG000|Overall Study|Sponsor Decision|15|||
150237997|NCT04889118|542007841|FG001|Overall Study|Sponsor Decision|20|||
150237998|NCT05147350|542007842|FG000|Overall Study|Death|2|||
150237999|NCT05147350|542007843|FG001|Overall Study|Death|3|||
150238000|NCT05147350|542007844|FG002|Overall Study|Death|3|||
150238001|NCT05147350|542007845|FG003|Overall Study|Death|2|||
150238002|NCT05147350|542007846|FG004|Overall Study|Death|2|||
150238003|NCT05147350|542007847|FG005|Overall Study|Death|1|||
150238004|NCT05147350|542007848|FG006|Overall Study|Death|1|||
150238005|NCT05147350|542007849|FG007|Overall Study|Death|3|||
150238006|NCT05147350|542007842|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
150238007|NCT05147350|542007843|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
150238008|NCT05147350|542007844|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
150238009|NCT05147350|542007845|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
150238010|NCT05147350|542007846|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
150238011|NCT05147350|542007847|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
150238012|NCT05147350|542007848|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
150238013|NCT05147350|542007849|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
150238014|NCT05147350|542007842|FG000|Overall Study|Withdrawal by Subject|0|||
150238015|NCT05147350|542007843|FG001|Overall Study|Withdrawal by Subject|0|||
150238016|NCT05147350|542007844|FG002|Overall Study|Withdrawal by Subject|3|||
150238017|NCT05147350|542007845|FG003|Overall Study|Withdrawal by Subject|1|||
150238018|NCT05147350|542007846|FG004|Overall Study|Withdrawal by Subject|1|||
150238019|NCT05147350|542007847|FG005|Overall Study|Withdrawal by Subject|0|||
150238020|NCT05147350|542007848|FG006|Overall Study|Withdrawal by Subject|1|||
150238021|NCT05147350|542007849|FG007|Overall Study|Withdrawal by Subject|0|||
150238022|NCT05147350|542007842|FG000|Overall Study|Other Reasons|0|||
150238023|NCT05147350|542007843|FG001|Overall Study|Other Reasons|0|||
150238024|NCT05147350|542007844|FG002|Overall Study|Other Reasons|2|||
150238025|NCT05147350|542007845|FG003|Overall Study|Other Reasons|0|||
150238026|NCT05147350|542007846|FG004|Overall Study|Other Reasons|0|||
150238027|NCT05147350|542007847|FG005|Overall Study|Other Reasons|2|||
150238028|NCT05147350|542007848|FG006|Overall Study|Other Reasons|1|||
150238029|NCT05147350|542007849|FG007|Overall Study|Other Reasons|1|||
150238030|NCT06136897|542007852|FG000|Overall Study|Ineligible|3|||
150238031|NCT06136897|542007852|FG000|Overall Study|Mutation status not confirmed|7|||
150238032|NCT06136897|542007852|FG000|Overall Study|Adverse Event|2|||
150238033|NCT06136897|542007852|FG000|Overall Study|Death|1|||
150238034|NCT06136897|542007852|FG000|Overall Study|Disease progression|18|||
150238035|NCT06136897|542007852|FG000|Overall Study|Other complicating disease|1|||
150238036|NCT06136897|542007852|FG000|Overall Study|Withdrawal by Subject|1|||
150238037|NCT06136897|542007852|FG000|Overall Study|Still on treatment|1|||
150238038|NCT06136897|542007852|FG000|Overall Study|Lost to Follow-up|1|||
150238039|NCT02472145|542007853|FG000|Overall Study|Death|10|||
150238040|NCT02472145|542007854|FG001|Overall Study|Death|101|||
150238041|NCT02472145|542007855|FG002|Overall Study|Death|99|||
150238042|NCT02472145|542007853|FG000|Overall Study|Lost to Follow-up|0|||
150238043|NCT02472145|542007854|FG001|Overall Study|Lost to Follow-up|1|||
150238044|NCT02472145|542007855|FG002|Overall Study|Lost to Follow-up|0|||
150238045|NCT02472145|542007853|FG000|Overall Study|Withdrawal by Subject|0|||
150238046|NCT02472145|542007854|FG001|Overall Study|Withdrawal by Subject|9|||
150238047|NCT02472145|542007855|FG002|Overall Study|Withdrawal by Subject|13|||
150238048|NCT02472145|542007853|FG000|Overall Study|Sponsor decision|0|||
150238049|NCT02472145|542007854|FG001|Overall Study|Sponsor decision|3|||
150238050|NCT02472145|542007855|FG002|Overall Study|Sponsor decision|2|||
150238051|NCT02472145|542007853|FG000|Overall Study|Other|0|||
150238052|NCT02472145|542007854|FG001|Overall Study|Other|45|||
150238053|NCT02472145|542007855|FG002|Overall Study|Other|43|||
150238054|NCT00632021|542007856|FG000|Overall Study|Withdrawal/death|4|||
150238055|NCT00632021|542007857|FG001|Overall Study|Withdrawal/death|7|||
150238056|NCT01628692|542007860|FG000|Overall Study|Lack of Efficacy|4|||
150238057|NCT01628692|542007861|FG001|Overall Study|Lack of Efficacy|4|||
150238058|NCT01628692|542007862|FG002|Overall Study|Lack of Efficacy|5|||
150238059|NCT01628692|542007863|FG003|Overall Study|Lack of Efficacy|1|||
150238060|NCT01628692|542007864|FG004|Overall Study|Lack of Efficacy|4|||
150238061|NCT01628692|542007865|FG005|Overall Study|Lack of Efficacy|7|||
150238062|NCT01628692|542007860|FG000|Overall Study|Adverse Event|2|||
150238063|NCT01628692|542007861|FG001|Overall Study|Adverse Event|0|||
150238064|NCT01628692|542007862|FG002|Overall Study|Adverse Event|2|||
150238065|NCT01628692|542007863|FG003|Overall Study|Adverse Event|0|||
150238066|NCT01628692|542007864|FG004|Overall Study|Adverse Event|0|||
150238067|NCT01628692|542007865|FG005|Overall Study|Adverse Event|0|||
150238068|NCT01628692|542007860|FG000|Overall Study|Withdrawal by Subject|0|||
150238069|NCT01628692|542007861|FG001|Overall Study|Withdrawal by Subject|1|||
150238070|NCT01628692|542007862|FG002|Overall Study|Withdrawal by Subject|1|||
150238071|NCT01628692|542007863|FG003|Overall Study|Withdrawal by Subject|0|||
150238072|NCT01628692|542007864|FG004|Overall Study|Withdrawal by Subject|0|||
150238073|NCT01628692|542007865|FG005|Overall Study|Withdrawal by Subject|0|||
150238074|NCT01628692|542007860|FG000|Overall Study|Death|0|||
150238075|NCT01628692|542007861|FG001|Overall Study|Death|1|||
150238076|NCT01628692|542007862|FG002|Overall Study|Death|0|||
150238077|NCT01628692|542007863|FG003|Overall Study|Death|0|||
150238078|NCT01628692|542007864|FG004|Overall Study|Death|0|||
150238079|NCT01628692|542007865|FG005|Overall Study|Death|0|||
150238080|NCT01628692|542007860|FG000|Overall Study|Poor compliance/noncompliance|1|||
150238081|NCT01628692|542007861|FG001|Overall Study|Poor compliance/noncompliance|0|||
150238082|NCT01628692|542007862|FG002|Overall Study|Poor compliance/noncompliance|0|||
150238083|NCT01628692|542007863|FG003|Overall Study|Poor compliance/noncompliance|0|||
150238084|NCT01628692|542007864|FG004|Overall Study|Poor compliance/noncompliance|0|||
150238085|NCT01628692|542007865|FG005|Overall Study|Poor compliance/noncompliance|0|||
150238086|NCT01628692|542007860|FG000|Overall Study|Administrative reason by sponsor|0|||
150238087|NCT01628692|542007861|FG001|Overall Study|Administrative reason by sponsor|0|||
150238088|NCT01628692|542007862|FG002|Overall Study|Administrative reason by sponsor|0|||
150238089|NCT01628692|542007863|FG003|Overall Study|Administrative reason by sponsor|0|||
150238090|NCT01628692|542007864|FG004|Overall Study|Administrative reason by sponsor|0|||
150238091|NCT01628692|542007865|FG005|Overall Study|Administrative reason by sponsor|1|||
150238092|NCT01628692|542007860|FG000|Overall Study|Completed 12 Week only|0|||
150238093|NCT01628692|542007861|FG001|Overall Study|Completed 12 Week only|0|||
150238094|NCT01628692|542007862|FG002|Overall Study|Completed 12 Week only|0|||
150238095|NCT01628692|542007863|FG003|Overall Study|Completed 12 Week only|0|||
150238096|NCT01628692|542007864|FG004|Overall Study|Completed 12 Week only|0|||
150142597|NCT00100932|541657998|FG001|Overall Study|Progressive Disease|18|||
150142598|NCT00100932|541657997|FG000|Overall Study|Physician Decision|7|||
150142599|NCT00100932|541657998|FG001|Overall Study|Physician Decision|5|||
150142600|NCT00100932|541657997|FG000|Overall Study|Other|5|||
150142601|NCT00100932|541657998|FG001|Overall Study|Other|2|||
150142602|NCT02387996|541658001|FG000|Overall Study|Disease Progression|167|||
150142603|NCT02387996|541658001|FG000|Overall Study|Study Drug Toxicity|31|||
150142604|NCT02387996|541658001|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
150142605|NCT02387996|541658001|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
150142606|NCT02387996|541658001|FG000|Overall Study|Subject Withdrew Consent|5|||
150142607|NCT02387996|541658001|FG000|Overall Study|Lost to Follow-up|1|||
150142608|NCT02387996|541658001|FG000|Overall Study|Poor/Non-Compliance|1|||
150238097|NCT01628692|542007865|FG005|Overall Study|Completed 12 Week only|1|||
150238098|NCT02437071|542007866|FG000|Overall Study|Withdrawal by Subject|1|||
150238099|NCT02437071|542007867|FG001|Overall Study|Withdrawal by Subject|0|||
150142609|NCT02387996|541658001|FG000|Overall Study|Other Reasons|5|||
150142610|NCT02387996|541658001|FG000|Overall Study|Death|1|||
150142611|NCT02424591|541658002|FG000|Overall Study|Protocol Violation|2|||
150142612|NCT02424591|541658003|FG001|Overall Study|Protocol Violation|3|||
150238100|NCT01587118|542007870|FG000|Overall Study|Adverse Event|3|||
150238101|NCT01587118|542007870|FG000|Overall Study|Lost to Follow-up|2|||
150142613|NCT01446796|541658004|FG000|Overall Study|Withdrawal by Subject|1|||
150142614|NCT01446796|541658005|FG001|Overall Study|Withdrawal by Subject|0|||
150142615|NCT00770432|541658008|FG000|Overall Study|Other|4|||
150142616|NCT00770432|541658009|FG001|Overall Study|Other|6|||
150142617|NCT00770432|541658008|FG000|Overall Study|Non-compliance|0|||
150142618|NCT00770432|541658009|FG001|Overall Study|Non-compliance|1|||
150142619|NCT01453348|541658010|FG000|Overall Study|Death|0|||
150142620|NCT01453348|541658011|FG001|Overall Study|Death|0|||
150142621|NCT01453348|541658012|FG002|Overall Study|Death|1|||
150142622|NCT01453348|541658010|FG000|Overall Study|Withdrawal by Subject|0|||
150142623|NCT01453348|541658011|FG001|Overall Study|Withdrawal by Subject|1|||
150142624|NCT01453348|541658012|FG002|Overall Study|Withdrawal by Subject|0|||
150142625|NCT01453348|541658010|FG000|Overall Study|Protocol Violation|1|||
150142626|NCT01453348|541658011|FG001|Overall Study|Protocol Violation|0|||
150142627|NCT01453348|541658012|FG002|Overall Study|Protocol Violation|0|||
150142628|NCT02756832|541658016|FG000|Overall Study|Lost for Observation after Baseline|6|||
150142629|NCT02756832|541658016|FG000|Overall Study|Lost for Observation|13|||
150238102|NCT01587118|542007870|FG000|Overall Study|Relocation|1|||
150238103|NCT01587118|542007870|FG000|Overall Study|nonresponse|1|||
150238104|NCT03802617|542007872|FG000|Overall Study|Adverse Event|0|||
150238105|NCT03802617|542007873|FG001|Overall Study|Adverse Event|4|||
150238106|NCT03802617|542007874|FG002|Overall Study|Adverse Event|5|||
150238107|NCT03802617|542007875|FG003|Overall Study|Adverse Event|1|||
150238108|NCT03802617|542007872|FG000|Overall Study|Lack of Efficacy|0|||
150238109|NCT03802617|542007873|FG001|Overall Study|Lack of Efficacy|1|||
150238110|NCT03802617|542007874|FG002|Overall Study|Lack of Efficacy|0|||
150238111|NCT03802617|542007875|FG003|Overall Study|Lack of Efficacy|2|||
150238112|NCT03802617|542007872|FG000|Overall Study|Protocol Violation|1|||
150238113|NCT03802617|542007873|FG001|Overall Study|Protocol Violation|1|||
150238114|NCT03802617|542007874|FG002|Overall Study|Protocol Violation|1|||
150238115|NCT03802617|542007875|FG003|Overall Study|Protocol Violation|0|||
150238116|NCT03802617|542007872|FG000|Overall Study|Withdrawal by Subject|1|||
150238117|NCT03802617|542007873|FG001|Overall Study|Withdrawal by Subject|1|||
150238118|NCT03802617|542007874|FG002|Overall Study|Withdrawal by Subject|1|||
150238119|NCT03802617|542007875|FG003|Overall Study|Withdrawal by Subject|0|||
150238120|NCT03802617|542007872|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
150238121|NCT03802617|542007873|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
150238122|NCT03802617|542007874|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
150238123|NCT03802617|542007875|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
150238124|NCT04788511|542007879|FG000|Overall Study|Withdrawal by Subject|2|||
150238125|NCT04788511|542007880|FG001|Overall Study|Withdrawal by Subject|1|||
150142630|NCT02756832|541658016|FG000|Overall Study|Patient's Unwillingness|12|||
150142631|NCT02756832|541658016|FG000|Overall Study|Insufficient Efficacy|2|||
150142632|NCT02756832|541658016|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
150142633|NCT02756832|541658016|FG000|Overall Study|Reason not Specified|9|||
150142634|NCT02756832|541658016|FG000|Overall Study|Protocol Deviation|10|||
150142635|NCT00954733|541658020|FG000|Overall Study|blood gas machine did not work|1|||
150142636|NCT03592277|541658021|FG000|Overall Study|Withdrawal by Subject|6|||
150142637|NCT03592277|541658022|FG001|Overall Study|Withdrawal by Subject|8|||
150142638|NCT03579290|541658025|FG000|Overall Study|Lost to Follow-up|9|||
150142639|NCT01781390|541658026|FG000|Overall Study|Withdrawal of Consent|0|||
150238126|NCT04788511|542007879|FG000|Overall Study|Lost to Follow-up|2|||
150238127|NCT04788511|542007880|FG001|Overall Study|Lost to Follow-up|7|||
150238128|NCT04788511|542007879|FG000|Overall Study|Death|3|||
150238129|NCT04788511|542007880|FG001|Overall Study|Death|4|||
150142640|NCT01781390|541658027|FG001|Overall Study|Withdrawal of Consent|3|||
150142641|NCT01781390|541658028|FG002|Overall Study|Withdrawal of Consent|1|||
150142642|NCT01781390|541658026|FG000|Overall Study|Lost to Follow-up|1|||
150142643|NCT01781390|541658027|FG001|Overall Study|Lost to Follow-up|1|||
150142644|NCT01781390|541658028|FG002|Overall Study|Lost to Follow-up|1|||
150142645|NCT01781390|541658026|FG000|Overall Study|Adverse Event|1|||
150142646|NCT01781390|541658027|FG001|Overall Study|Adverse Event|2|||
150142647|NCT01781390|541658028|FG002|Overall Study|Adverse Event|1|||
150142648|NCT01781390|541658026|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
150142649|NCT01781390|541658027|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
150142650|NCT01781390|541658028|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
150142651|NCT00622713|541658029|FG000|Overall Study|Adverse Event|35|||
150142652|NCT00622713|541658029|FG000|Overall Study|Administrative problems|4|||
150142653|NCT00622713|541658029|FG000|Overall Study|Withdrawal by Subject|11|||
150142654|NCT00622713|541658029|FG000|Overall Study|Lost to Follow-up|5|||
150142655|NCT00622713|541658029|FG000|Overall Study|Death|2|||
150142656|NCT00622713|541658029|FG000|Overall Study|Subject no longer required study drug|1|||
150142657|NCT00622713|541658029|FG000|Overall Study|Did not meet eligibility criteria|1|||
150142658|NCT01719237|541658033|FG000|Overall Study|Physician Decision|0|||
150142659|NCT01719237|541658034|FG001|Overall Study|Physician Decision|1|||
150142660|NCT02914314|541658035|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
150142661|NCT02914314|541658036|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
150142662|NCT02914314|541658037|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
150142663|NCT02914314|541658038|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
150142664|NCT02914314|541658035|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
150142665|NCT02914314|541658036|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
150142666|NCT02914314|541658037|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
150142667|NCT02914314|541658038|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
150142668|NCT02914314|541658035|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
150142669|NCT02914314|541658036|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
150142670|NCT02914314|541658037|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
150142671|NCT02914314|541658038|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
150142672|NCT02914314|541658035|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
150142673|NCT02914314|541658036|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
150142674|NCT02914314|541658037|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
150142675|NCT02914314|541658038|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
150142676|NCT02914314|541658035|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
150142677|NCT02914314|541658036|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
150142678|NCT02914314|541658037|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
150142679|NCT02914314|541658038|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
150142680|NCT03728972|541658041|FG000|Overall Study|Death|1|||
150142681|NCT03728972|541658042|FG001|Overall Study|Death|0|||
150142682|NCT03728972|541658041|FG000|Overall Study|Lack of Efficacy|1|||
150142683|NCT03728972|541658042|FG001|Overall Study|Lack of Efficacy|0|||
150142684|NCT03728972|541658041|FG000|Overall Study|Physician Decision|3|||
150142685|NCT03728972|541658042|FG001|Overall Study|Physician Decision|0|||
150142686|NCT03728972|541658041|FG000|Overall Study|Disease progression|4|||
150142687|NCT03728972|541658042|FG001|Overall Study|Disease progression|3|||
150142688|NCT00895622|541658043|FG000|Overall Study|Protocol Violation|5|||
150142689|NCT00895622|541658044|FG001|Overall Study|Protocol Violation|4|||
150142690|NCT00895622|541658045|FG002|Overall Study|Protocol Violation|4|||
150142691|NCT03324880|541658046|FG000|Overall Study|Adverse Event|0|||
150142692|NCT03324880|541658047|FG001|Overall Study|Adverse Event|2|||
150142693|NCT03324880|541658046|FG000|Overall Study|Withdrawal by Subject|2|||
150142694|NCT03324880|541658047|FG001|Overall Study|Withdrawal by Subject|2|||
150142695|NCT03324880|541658046|FG000|Overall Study|Lost to Follow-up|0|||
150142696|NCT03324880|541658047|FG001|Overall Study|Lost to Follow-up|1|||
150142697|NCT03324880|541658046|FG000|Overall Study|Product Recall|0|||
150142698|NCT03324880|541658047|FG001|Overall Study|Product Recall|1|||
150142699|NCT00652938|541658048|FG000|Overall Study|Adverse Event|1|||
150142700|NCT00652938|541658049|FG001|Overall Study|Adverse Event|0|||
150142701|NCT00652938|541658050|FG002|Overall Study|Adverse Event|2|||
150142702|NCT00652938|541658048|FG000|Overall Study|Withdrawal by Subject|0|||
150142703|NCT00652938|541658049|FG001|Overall Study|Withdrawal by Subject|6|||
150142704|NCT00652938|541658050|FG002|Overall Study|Withdrawal by Subject|1|||
150142705|NCT00652938|541658048|FG000|Overall Study|Lost to Follow-up|0|||
150142706|NCT00652938|541658049|FG001|Overall Study|Lost to Follow-up|0|||
150142707|NCT00652938|541658050|FG002|Overall Study|Lost to Follow-up|2|||
150142708|NCT00652938|541658048|FG000|Overall Study|fear of blood sampling|0|||
150142709|NCT00652938|541658049|FG001|Overall Study|fear of blood sampling|1|||
150142710|NCT00652938|541658050|FG002|Overall Study|fear of blood sampling|0|||
150142711|NCT01412801|541658054|FG000|Overall Study|Death|0|||
150142712|NCT01412801|541658055|FG001|Overall Study|Death|1|||
150142713|NCT01412801|541658056|FG002|Overall Study|Death|0|||
150142714|NCT01412801|541658057|FG003|Overall Study|Death|4|||
150142715|NCT01412801|541658058|FG004|Overall Study|Death|2|||
150142716|NCT01412801|541658059|FG005|Overall Study|Death|2|||
150142717|NCT01412801|541658054|FG000|Overall Study|Lost to Follow-up|1|||
150142718|NCT01412801|541658055|FG001|Overall Study|Lost to Follow-up|2|||
150142719|NCT01412801|541658056|FG002|Overall Study|Lost to Follow-up|4|||
150142720|NCT01412801|541658057|FG003|Overall Study|Lost to Follow-up|0|||
150142721|NCT01412801|541658058|FG004|Overall Study|Lost to Follow-up|1|||
150142722|NCT01412801|541658059|FG005|Overall Study|Lost to Follow-up|1|||
150142723|NCT01412801|541658054|FG000|Overall Study|Withdrawal by Subject|3|||
150142724|NCT01412801|541658055|FG001|Overall Study|Withdrawal by Subject|2|||
150142725|NCT01412801|541658056|FG002|Overall Study|Withdrawal by Subject|1|||
150142726|NCT01412801|541658057|FG003|Overall Study|Withdrawal by Subject|0|||
150142727|NCT01412801|541658058|FG004|Overall Study|Withdrawal by Subject|0|||
150142728|NCT01412801|541658059|FG005|Overall Study|Withdrawal by Subject|0|||
150142729|NCT01412801|541658054|FG000|Overall Study|Relocated to another area|0|||
150142730|NCT01412801|541658055|FG001|Overall Study|Relocated to another area|0|||
150142731|NCT01412801|541658056|FG002|Overall Study|Relocated to another area|2|||
150142732|NCT01412801|541658057|FG003|Overall Study|Relocated to another area|0|||
150142733|NCT01412801|541658058|FG004|Overall Study|Relocated to another area|0|||
150142734|NCT01412801|541658059|FG005|Overall Study|Relocated to another area|0|||
150142735|NCT01547299|541658060|FG000|Overall Study|Withdrawal by Subject|2|||
150142736|NCT01547299|541658061|FG001|Overall Study|Withdrawal by Subject|2|||
150142737|NCT00782496|541658062|FG000|Overall Study|Lost to Follow-up|14|||
150142738|NCT00782496|541658063|FG001|Overall Study|Lost to Follow-up|15|||
150142739|NCT01987817|541658065|FG000|Overall Study|Adverse Event|4|||
150142740|NCT01987817|541658066|FG001|Overall Study|Adverse Event|0|||
150142741|NCT01987817|541658065|FG000|Overall Study|Withdrawal by Subject|1|||
150142742|NCT01987817|541658066|FG001|Overall Study|Withdrawal by Subject|1|||
150142743|NCT01987817|541658065|FG000|Overall Study|Physician Decision|1|||
150142744|NCT01987817|541658066|FG001|Overall Study|Physician Decision|0|||
150142745|NCT01576718|541658069|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
150142746|NCT01576718|541658070|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142747|NCT01576718|541658071|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142748|NCT01576718|541658072|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142749|NCT01576718|541658073|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142750|NCT01576718|541658074|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142751|NCT01576718|541658075|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
150142752|NCT01576718|541658069|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
150142753|NCT01576718|541658070|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142754|NCT01576718|541658071|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142755|NCT01576718|541658072|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142756|NCT01576718|541658073|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142757|NCT01576718|541658074|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142758|NCT01576718|541658075|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
150142759|NCT01576718|541658069|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
150142760|NCT01576718|541658070|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142761|NCT01576718|541658071|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142762|NCT01576718|541658072|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142763|NCT01576718|541658073|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142764|NCT01576718|541658074|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142765|NCT01576718|541658075|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
150142766|NCT01576718|541658069|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
150142767|NCT01576718|541658070|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142768|NCT01576718|541658071|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142769|NCT01576718|541658072|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142770|NCT01576718|541658073|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142771|NCT01576718|541658074|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142772|NCT01576718|541658075|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
150142773|NCT01576718|541658069|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
150142774|NCT01576718|541658070|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142775|NCT01576718|541658071|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142776|NCT01576718|541658072|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142777|NCT01576718|541658073|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142778|NCT01576718|541658074|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142779|NCT01576718|541658075|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
150142780|NCT01576718|541658069|FG000|Treatment Period|Adverse Event|0|||
150142781|NCT01576718|541658070|FG001|Treatment Period|Adverse Event|1|||
150142782|NCT01576718|541658071|FG002|Treatment Period|Adverse Event|1|||
150142783|NCT01576718|541658072|FG003|Treatment Period|Adverse Event|1|||
150238130|NCT01658020|542007886|FG000|Overall Study|Adverse Event|3|||
150238131|NCT01658020|542007887|FG001|Overall Study|Adverse Event|3|||
150238132|NCT01658020|542007886|FG000|Overall Study|Lost to Follow-up|1|||
150238133|NCT01658020|542007887|FG001|Overall Study|Lost to Follow-up|0|||
150238134|NCT01658020|542007886|FG000|Overall Study|Withdrawal by Subject|4|||
150238135|NCT01658020|542007887|FG001|Overall Study|Withdrawal by Subject|5|||
150238136|NCT01658020|542007886|FG000|Overall Study|Protocol Violation|0|||
150238137|NCT01658020|542007887|FG001|Overall Study|Protocol Violation|1|||
150238138|NCT04206085|542007888|FG000|Overall Study|Lost to Follow-up|0|||
150238139|NCT04206085|542007889|FG001|Overall Study|Lost to Follow-up|1|||
150238140|NCT04206085|542007890|FG002|Overall Study|Lost to Follow-up|0|||
150238141|NCT04206085|542007888|FG000|Overall Study|Lost to Follow-up|0|||
150238142|NCT04206085|542007889|FG001|Overall Study|Lost to Follow-up|0|||
150238143|NCT04206085|542007890|FG002|Overall Study|Lost to Follow-up|1|||
150238144|NCT02760485|542007891|FG000|Phase 1|Death|3|||
150238145|NCT02760485|542007892|FG001|Phase 1|Death|6|||
150238146|NCT02760485|542007893|FG002|Phase 1|Death|0|||
150238147|NCT02760485|542007891|FG000|Phase 1|Withdrawal by Subject|2|||
150238148|NCT02760485|542007892|FG001|Phase 1|Withdrawal by Subject|0|||
150238149|NCT02760485|542007893|FG002|Phase 1|Withdrawal by Subject|0|||
150238150|NCT02760485|542007891|FG000|Phase 1|Progressive Disease|1|||
150238151|NCT02760485|542007892|FG001|Phase 1|Progressive Disease|0|||
150238152|NCT02760485|542007893|FG002|Phase 1|Progressive Disease|0|||
150238153|NCT02760485|542007891|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
150238154|NCT02760485|542007892|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
150238155|NCT02760485|542007893|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
150238156|NCT02760485|542007891|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
150238157|NCT02760485|542007892|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
150238158|NCT02760485|542007893|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
150238159|NCT02760485|542007891|FG000|Phase 2|Death|0|||
150238160|NCT02760485|542007892|FG001|Phase 2|Death|0|||
150238161|NCT02760485|542007893|FG002|Phase 2|Death|12|||
150142784|NCT01576718|541658073|FG004|Treatment Period|Adverse Event|1|||
150142785|NCT01576718|541658074|FG005|Treatment Period|Adverse Event|1|||
150142786|NCT01576718|541658075|FG006|Treatment Period|Adverse Event|0|||
150142787|NCT01576718|541658069|FG000|Treatment Period|Withdrawal by Subject|0|||
150142788|NCT01576718|541658070|FG001|Treatment Period|Withdrawal by Subject|1|||
150142789|NCT01576718|541658071|FG002|Treatment Period|Withdrawal by Subject|1|||
150142790|NCT01576718|541658072|FG003|Treatment Period|Withdrawal by Subject|0|||
150142791|NCT01576718|541658073|FG004|Treatment Period|Withdrawal by Subject|2|||
150142792|NCT01576718|541658074|FG005|Treatment Period|Withdrawal by Subject|4|||
150142793|NCT01576718|541658075|FG006|Treatment Period|Withdrawal by Subject|2|||
150142794|NCT01576718|541658069|FG000|Treatment Period|Physician Decision|0|||
150142795|NCT01576718|541658070|FG001|Treatment Period|Physician Decision|1|||
150142796|NCT01576718|541658071|FG002|Treatment Period|Physician Decision|1|||
150142797|NCT01576718|541658072|FG003|Treatment Period|Physician Decision|1|||
150142798|NCT01576718|541658073|FG004|Treatment Period|Physician Decision|1|||
150142799|NCT01576718|541658074|FG005|Treatment Period|Physician Decision|0|||
150142800|NCT01576718|541658075|FG006|Treatment Period|Physician Decision|0|||
150142801|NCT01576718|541658069|FG000|Treatment Period|Protocol Violation|0|||
150142802|NCT01576718|541658070|FG001|Treatment Period|Protocol Violation|5|||
150142803|NCT01576718|541658071|FG002|Treatment Period|Protocol Violation|4|||
150142804|NCT01576718|541658072|FG003|Treatment Period|Protocol Violation|10|||
150142805|NCT01576718|541658073|FG004|Treatment Period|Protocol Violation|6|||
150142806|NCT01576718|541658074|FG005|Treatment Period|Protocol Violation|8|||
150142807|NCT01576718|541658075|FG006|Treatment Period|Protocol Violation|12|||
150238162|NCT02760485|542007891|FG000|Phase 2|Withdrawal by Subject|0|||
150238163|NCT02760485|542007892|FG001|Phase 2|Withdrawal by Subject|0|||
150238164|NCT02760485|542007893|FG002|Phase 2|Withdrawal by Subject|3|||
150238165|NCT02760485|542007891|FG000|Phase 2|Progressive Disease|0|||
150238166|NCT02760485|542007892|FG001|Phase 2|Progressive Disease|0|||
150238167|NCT02760485|542007893|FG002|Phase 2|Progressive Disease|1|||
150238168|NCT02760485|542007891|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
150238169|NCT02760485|542007892|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
150142808|NCT01576718|541658069|FG000|Treatment Period|Sponsor request|0|||
150238170|NCT02760485|542007893|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
150142809|NCT01576718|541658070|FG001|Treatment Period|Sponsor request|1|||
150238171|NCT03845023|542007894|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
150238172|NCT03845023|542007895|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
150238173|NCT03845023|542007896|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
150238174|NCT03845023|542007897|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
150142810|NCT01576718|541658071|FG002|Treatment Period|Sponsor request|0|||
150142811|NCT01576718|541658072|FG003|Treatment Period|Sponsor request|0|||
150142812|NCT01576718|541658073|FG004|Treatment Period|Sponsor request|0|||
150142813|NCT01576718|541658074|FG005|Treatment Period|Sponsor request|1|||
150142814|NCT01576718|541658075|FG006|Treatment Period|Sponsor request|0|||
150142815|NCT01576718|541658069|FG000|Treatment Period|Met stopping criteria|0|||
150238175|NCT03845023|542007894|FG000|Follow-Up (14 Days)|Adverse Event|0|||
150238176|NCT03845023|542007895|FG001|Follow-Up (14 Days)|Adverse Event|0|||
150238177|NCT03845023|542007896|FG002|Follow-Up (14 Days)|Adverse Event|1|||
150238178|NCT03845023|542007897|FG003|Follow-Up (14 Days)|Adverse Event|1|||
150238179|NCT02353871|542007898|FG000|Overall Study|Protocol deviation|0|||
150238180|NCT02353871|542007899|FG001|Overall Study|Protocol deviation|1|||
150142816|NCT01576718|541658070|FG001|Treatment Period|Met stopping criteria|16|||
150142817|NCT01576718|541658071|FG002|Treatment Period|Met stopping criteria|13|||
150142818|NCT01576718|541658072|FG003|Treatment Period|Met stopping criteria|19|||
150142819|NCT01576718|541658073|FG004|Treatment Period|Met stopping criteria|16|||
150142820|NCT01576718|541658074|FG005|Treatment Period|Met stopping criteria|33|||
150142821|NCT01576718|541658075|FG006|Treatment Period|Met stopping criteria|15|||
150142822|NCT01576718|541658069|FG000|Treatment Period|Lost to Follow-up|0|||
150142823|NCT01576718|541658070|FG001|Treatment Period|Lost to Follow-up|0|||
150142824|NCT01576718|541658071|FG002|Treatment Period|Lost to Follow-up|0|||
150142825|NCT01576718|541658072|FG003|Treatment Period|Lost to Follow-up|0|||
150142826|NCT01576718|541658073|FG004|Treatment Period|Lost to Follow-up|1|||
150142827|NCT01576718|541658074|FG005|Treatment Period|Lost to Follow-up|0|||
150142828|NCT01576718|541658075|FG006|Treatment Period|Lost to Follow-up|0|||
150142829|NCT01576718|541658069|FG000|Treatment Period|Noncompliance to study medication|0|||
150142830|NCT01576718|541658070|FG001|Treatment Period|Noncompliance to study medication|0|||
150142831|NCT01576718|541658071|FG002|Treatment Period|Noncompliance to study medication|0|||
150142832|NCT01576718|541658072|FG003|Treatment Period|Noncompliance to study medication|0|||
150142833|NCT01576718|541658073|FG004|Treatment Period|Noncompliance to study medication|0|||
150142834|NCT01576718|541658074|FG005|Treatment Period|Noncompliance to study medication|1|||
150142835|NCT01576718|541658075|FG006|Treatment Period|Noncompliance to study medication|1|||
150142836|NCT01874145|541658076|FG000|Core Period|Non-compliance|1|||
150142837|NCT01874145|541658077|FG001|Core Period|Non-compliance|0|||
150142838|NCT01874145|541658076|FG000|Core Period|Protocol Violation|1|||
150142839|NCT01874145|541658077|FG001|Core Period|Protocol Violation|1|||
150142840|NCT01874145|541658076|FG000|Core Period|Physician Decision|1|||
150142841|NCT01874145|541658077|FG001|Core Period|Physician Decision|1|||
150142842|NCT01874145|541658076|FG000|Core Period|Adverse Event|0|||
150142843|NCT01874145|541658077|FG001|Core Period|Adverse Event|1|||
150142844|NCT01874145|541658076|FG000|Core Period|Withdrawal by Subject|0|||
150142845|NCT01874145|541658077|FG001|Core Period|Withdrawal by Subject|4|||
150142846|NCT01874145|541658076|FG000|Extension Period|Adverse Event|3|||
150142847|NCT01874145|541658077|FG001|Extension Period|Adverse Event|2|||
150142848|NCT01874145|541658076|FG000|Extension Period|Withdrawal by Subject|2|||
150142849|NCT01874145|541658077|FG001|Extension Period|Withdrawal by Subject|1|||
150142850|NCT01874145|541658076|FG000|Extension Period|Lost to Follow-up|1|||
150142851|NCT01874145|541658077|FG001|Extension Period|Lost to Follow-up|1|||
150142852|NCT04631705|541658078|FG000|Overall Study|Withdrawal by Subject|0|||
150142853|NCT04631705|541658079|FG001|Overall Study|Withdrawal by Subject|0|||
150142854|NCT04631705|541658080|FG002|Overall Study|Withdrawal by Subject|0|||
150142855|NCT04631705|541658081|FG003|Overall Study|Withdrawal by Subject|0|||
150142856|NCT04631705|541658082|FG004|Overall Study|Withdrawal by Subject|0|||
150142857|NCT04631705|541658083|FG005|Overall Study|Withdrawal by Subject|0|||
150142858|NCT04631705|541658084|FG006|Overall Study|Withdrawal by Subject|1|||
150142859|NCT04631705|541658085|FG007|Overall Study|Withdrawal by Subject|0|||
150142860|NCT04631705|541658086|FG008|Overall Study|Withdrawal by Subject|0|||
150142861|NCT04739761|541658104|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
150142862|NCT04739761|541658105|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
150142863|NCT04739761|541658104|FG000|Overall Study|By complete response from the participant|1|||
150142864|NCT04739761|541658105|FG001|Overall Study|By complete response from the participant|0|||
150142865|NCT04739761|541658104|FG000|Overall Study|Lost to Follow-up|3|||
150142866|NCT04739761|541658105|FG001|Overall Study|Lost to Follow-up|3|||
150142867|NCT04739761|541658104|FG000|Overall Study|Death|13|||
150238181|NCT02353871|542007898|FG000|Overall Study|Consent withdrawn|1|||
150142868|NCT04739761|541658105|FG001|Overall Study|Death|13|||
150142869|NCT04739761|541658104|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
150142870|NCT04739761|541658105|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
150238182|NCT02353871|542007899|FG001|Overall Study|Consent withdrawn|8|||
150142871|NCT04739761|541658104|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
150238183|NCT02353871|542007898|FG000|Overall Study|Lost to Follow-up|2|||
150238184|NCT02353871|542007899|FG001|Overall Study|Lost to Follow-up|0|||
150238185|NCT04750577|542007905|FG000|Overall Study|Adverse Event|2|||
150238186|NCT04750577|542007906|FG001|Overall Study|Adverse Event|10|||
150238187|NCT04750577|542007907|FG002|Overall Study|Adverse Event|8|||
150238188|NCT04750577|542007908|FG003|Overall Study|Adverse Event|1|||
150238189|NCT04750577|542007905|FG000|Overall Study|Change of residence|0|||
150238190|NCT04750577|542007906|FG001|Overall Study|Change of residence|0|||
150238191|NCT04750577|542007907|FG002|Overall Study|Change of residence|1|||
150238192|NCT04750577|542007908|FG003|Overall Study|Change of residence|0|||
150238193|NCT04750577|542007905|FG000|Overall Study|Burden of study procedures|0|||
150238194|NCT04750577|542007906|FG001|Overall Study|Burden of study procedures|2|||
150238195|NCT04750577|542007907|FG002|Overall Study|Burden of study procedures|2|||
150238196|NCT04750577|542007908|FG003|Overall Study|Burden of study procedures|0|||
150238197|NCT04750577|542007905|FG000|Overall Study|Prematurely discontinued|0|||
150238198|NCT04750577|542007906|FG001|Overall Study|Prematurely discontinued|0|||
150238199|NCT04750577|542007907|FG002|Overall Study|Prematurely discontinued|0|||
150238200|NCT04750577|542007908|FG003|Overall Study|Prematurely discontinued|2|||
150238201|NCT04750577|542007905|FG000|Overall Study|Protocol deviation|1|||
150238202|NCT04750577|542007906|FG001|Overall Study|Protocol deviation|1|||
150238203|NCT04750577|542007907|FG002|Overall Study|Protocol deviation|1|||
150238204|NCT04750577|542007908|FG003|Overall Study|Protocol deviation|1|||
150238205|NCT04750577|542007905|FG000|Overall Study|Other than listed|3|||
150238206|NCT04750577|542007906|FG001|Overall Study|Other than listed|2|||
150238207|NCT04750577|542007907|FG002|Overall Study|Other than listed|2|||
150238208|NCT04750577|542007908|FG003|Overall Study|Other than listed|1|||
150238209|NCT04750577|542007905|FG000|Overall Study|Not treated|0|||
150238210|NCT04750577|542007906|FG001|Overall Study|Not treated|0|||
150238211|NCT04750577|542007907|FG002|Overall Study|Not treated|0|||
150238212|NCT04750577|542007908|FG003|Overall Study|Not treated|2|||
150238213|NCT02647645|542007911|FG000|Overall Study|Lost to Follow-up|2|||
150238214|NCT02647645|542007912|FG001|Overall Study|Lost to Follow-up|1|||
150238215|NCT03371823|542007915|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
150238216|NCT03371823|542007916|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
150238217|NCT01466790|542007918|FG000|Overall Study|Adverse Event|1|||
150238218|NCT01466790|542007919|FG001|Overall Study|Adverse Event|0|||
150238219|NCT01466790|542007920|FG002|Overall Study|Adverse Event|0|||
150238220|NCT01466790|542007921|FG003|Overall Study|Adverse Event|0|||
150238221|NCT01466790|542007922|FG004|Overall Study|Adverse Event|2|||
150238222|NCT01466790|542007923|FG005|Overall Study|Adverse Event|0|||
150238223|NCT01466790|542007924|FG006|Overall Study|Adverse Event|0|||
150238224|NCT01466790|542007925|FG007|Overall Study|Adverse Event|0|||
150238225|NCT01466790|542007918|FG000|Overall Study|Lost to Follow-up|2|||
150238226|NCT01466790|542007919|FG001|Overall Study|Lost to Follow-up|0|||
150238227|NCT01466790|542007920|FG002|Overall Study|Lost to Follow-up|0|||
150238228|NCT01466790|542007921|FG003|Overall Study|Lost to Follow-up|0|||
150238229|NCT01466790|542007922|FG004|Overall Study|Lost to Follow-up|0|||
150238230|NCT01466790|542007923|FG005|Overall Study|Lost to Follow-up|0|||
150238231|NCT01466790|542007924|FG006|Overall Study|Lost to Follow-up|0|||
150238232|NCT01466790|542007925|FG007|Overall Study|Lost to Follow-up|0|||
150238233|NCT01466790|542007918|FG000|Overall Study|Withdrawal by Subject|1|||
150142872|NCT04739761|541658105|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
150142873|NCT04739761|541658104|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
150142874|NCT04739761|541658105|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
150142875|NCT04739761|541658104|FG000|Overall Study|Adverse Event|0|||
150142876|NCT04739761|541658105|FG001|Overall Study|Adverse Event|3|||
150142877|NCT04739761|541658104|FG000|Overall Study|Participant decision|1|||
150142878|NCT04739761|541658105|FG001|Overall Study|Participant decision|0|||
150142879|NCT04739761|541658104|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
150142880|NCT04739761|541658105|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
150142881|NCT04739761|541658104|FG000|Overall Study|Participant immediately started next line of treatment|1|||
150142882|NCT04739761|541658105|FG001|Overall Study|Participant immediately started next line of treatment|0|||
150142883|NCT04739761|541658104|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
150142884|NCT04739761|541658105|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
150238234|NCT01466790|542007919|FG001|Overall Study|Withdrawal by Subject|1|||
150238235|NCT01466790|542007920|FG002|Overall Study|Withdrawal by Subject|0|||
150238236|NCT01466790|542007921|FG003|Overall Study|Withdrawal by Subject|0|||
150238237|NCT01466790|542007922|FG004|Overall Study|Withdrawal by Subject|1|||
150238238|NCT01466790|542007923|FG005|Overall Study|Withdrawal by Subject|0|||
150238239|NCT01466790|542007924|FG006|Overall Study|Withdrawal by Subject|1|||
150238240|NCT01466790|542007925|FG007|Overall Study|Withdrawal by Subject|1|||
150238241|NCT00356811|542007926|FG000|Overall Study|Death|35|||
150238242|NCT00356811|542007926|FG000|Overall Study|Lost to Follow-up|2|||
150238243|NCT00356811|542007926|FG000|Overall Study|Withdrawal by Subject|6|||
150238244|NCT00356811|542007926|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
150238245|NCT00356811|542007926|FG000|Overall Study|Study Is Terminating|3|||
150238246|NCT00356811|542007926|FG000|Overall Study|Site Closed during Follow-up|2|||
150238247|NCT02386839|542007927|FG000|Overall Study|Death|1|||
150238248|NCT02386839|542007928|FG001|Overall Study|Death|0|||
150238249|NCT02386839|542007927|FG000|Overall Study|Withdrawal by Subject|9|||
150238250|NCT02386839|542007928|FG001|Overall Study|Withdrawal by Subject|10|||
150238251|NCT02386839|542007927|FG000|Overall Study|Lost to Follow-up|4|||
150238252|NCT02386839|542007928|FG001|Overall Study|Lost to Follow-up|4|||
150238253|NCT02386839|542007927|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
150238254|NCT02386839|542007928|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
150238255|NCT02386839|542007927|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
150238256|NCT02386839|542007928|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
150238257|NCT02386839|542007927|FG000|Overall Study|Other (unspecified)|1|||
150238258|NCT02386839|542007928|FG001|Overall Study|Other (unspecified)|0|||
150238259|NCT05347485|542007933|FG000|Overall Study|Death|14|||
150238260|NCT05347485|542007933|FG000|Overall Study|Lost to Follow-up|2|||
150238261|NCT05347485|542007933|FG000|Overall Study|Withdrawal by Subject|13|||
150238262|NCT05347485|542007933|FG000|Overall Study|Progressive Disease|1|||
150238263|NCT05347485|542007933|FG000|Overall Study|Study Terminated by Sponsor|49|||
150238264|NCT05347485|542007933|FG000|Overall Study|Other|1|||
150238265|NCT05347485|542007933|FG000|Overall Study|Enrolled (consented) but not treated|4|||
150238266|NCT05347485|542007933|FG000|Overall Study|Disease Relapse|2|||
150238267|NCT04369053|542008858|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
150238268|NCT04369053|542008858|FG000|Overall Study|Withdrawal by Subject|773|||
150238269|NCT04369053|542008858|FG000|Overall Study|Lost to Follow-up|182|||
150238270|NCT04369053|542008858|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
150238271|NCT05064488|542008859|FG000|Overall Study|Withdrawal by Subject|2|||
150238272|NCT05064488|542008860|FG001|Overall Study|Withdrawal by Subject|0|||
150238273|NCT04090528|542008863|FG000|Overall Study|participants still on study|9|||
150238274|NCT04090528|542008864|FG001|Overall Study|participants still on study|13|||
150238275|NCT04082429|542008865|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
150238276|NCT04082429|542008866|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
150238277|NCT04082429|542008867|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
150238278|NCT04082429|542008868|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
150238279|NCT04082429|542008869|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
150238280|NCT04082429|542008870|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
150238281|NCT04082429|542008871|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
150238282|NCT04082429|542008872|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
150238283|NCT04082429|542008873|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
150238284|NCT04082429|542008865|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238285|NCT04082429|542008866|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238286|NCT04082429|542008867|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238287|NCT04082429|542008868|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238288|NCT04082429|542008869|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
150238289|NCT04082429|542008870|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238290|NCT04082429|542008871|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238291|NCT04082429|542008872|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238292|NCT04082429|542008873|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
150238293|NCT04082429|542008865|FG000|Main Part (After the Treatment Pause)|Death|0|||
150238294|NCT04082429|542008866|FG001|Main Part (After the Treatment Pause)|Death|0|||
150238295|NCT04082429|542008867|FG002|Main Part (After the Treatment Pause)|Death|0|||
150238296|NCT04082429|542008868|FG003|Main Part (After the Treatment Pause)|Death|0|||
150238297|NCT04082429|542008869|FG004|Main Part (After the Treatment Pause)|Death|1|||
150238298|NCT04082429|542008870|FG005|Main Part (After the Treatment Pause)|Death|0|||
150238299|NCT04082429|542008871|FG006|Main Part (After the Treatment Pause)|Death|0|||
150238300|NCT04082429|542008872|FG007|Main Part (After the Treatment Pause)|Death|0|||
150238301|NCT04082429|542008873|FG008|Main Part (After the Treatment Pause)|Death|0|||
150238302|NCT04082429|542008865|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238303|NCT04082429|542008866|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238304|NCT04082429|542008867|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238305|NCT04082429|542008868|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
150238306|NCT04082429|542008869|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238307|NCT04082429|542008870|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
150142885|NCT04739761|541658104|FG000|Overall Study|Lack of clinical benefit|1|||
150142886|NCT04739761|541658105|FG001|Overall Study|Lack of clinical benefit|0|||
150142887|NCT04739761|541658104|FG000|Overall Study|Disease progression|5|||
150142888|NCT04739761|541658105|FG001|Overall Study|Disease progression|5|||
150142889|NCT04739761|541658104|FG000|Overall Study|Withdrawal by Subject|14|||
150238308|NCT04082429|542008871|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238309|NCT04082429|542008872|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238310|NCT04082429|542008873|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
150238311|NCT04082429|542008865|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
150238312|NCT04082429|542008866|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
150238313|NCT04082429|542008867|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
150238314|NCT04082429|542008868|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
150238315|NCT04082429|542008869|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
150238316|NCT04082429|542008870|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
150238317|NCT04082429|542008871|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
150238318|NCT04082429|542008872|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
150238319|NCT04082429|542008873|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
150238320|NCT04082429|542008865|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
150238321|NCT04082429|542008866|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238322|NCT04082429|542008867|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150142890|NCT04739761|541658105|FG001|Overall Study|Withdrawal by Subject|13|||
150142891|NCT04739761|541658104|FG000|Overall Study|Protocol Violation|1|||
150142892|NCT04739761|541658105|FG001|Overall Study|Protocol Violation|0|||
150142893|NCT04739761|541658104|FG000|Overall Study|Physician Decision|2|||
150142894|NCT04739761|541658105|FG001|Overall Study|Physician Decision|0|||
150142895|NCT03881696|541658109|FG000|Overall Study|Adverse Event|2|||
150142896|NCT03881696|541658110|FG001|Overall Study|Adverse Event|0|||
150142897|NCT03881696|541658109|FG000|Overall Study|Withdrawal by Subject|2|||
150142898|NCT03881696|541658110|FG001|Overall Study|Withdrawal by Subject|0|||
150142899|NCT03881696|541658109|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
150142900|NCT03881696|541658110|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
150142901|NCT03881696|541658109|FG000|Overall Study|Failure to meet continuation criteria|1|||
150142902|NCT03881696|541658110|FG001|Overall Study|Failure to meet continuation criteria|0|||
150238323|NCT04082429|542008868|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238324|NCT04082429|542008869|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238325|NCT04082429|542008870|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
150238326|NCT04082429|542008871|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238327|NCT04082429|542008872|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238328|NCT04082429|542008873|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
150238329|NCT04082429|542008865|FG000|Extension Part|Ongoing|0|||
150238330|NCT04082429|542008866|FG001|Extension Part|Ongoing|7|||
150238331|NCT04082429|542008867|FG002|Extension Part|Ongoing|17|||
150238332|NCT04082429|542008868|FG003|Extension Part|Ongoing|6|||
150238333|NCT04082429|542008869|FG004|Extension Part|Ongoing|45|||
150238334|NCT04082429|542008870|FG005|Extension Part|Ongoing|0|||
150238335|NCT04082429|542008871|FG006|Extension Part|Ongoing|10|||
150238336|NCT04082429|542008872|FG007|Extension Part|Ongoing|23|||
150238337|NCT04082429|542008873|FG008|Extension Part|Ongoing|25|||
150238338|NCT04991766|542008874|FG000|Overall Study|Withdrawal by Subject|2|||
150238339|NCT04991766|542008875|FG001|Overall Study|Withdrawal by Subject|0|||
150238340|NCT05499130|542008876|FG000|Overall Study|Adverse Event|2|||
150238341|NCT05499130|542008877|FG001|Overall Study|Adverse Event|0|||
150238342|NCT05499130|542008878|FG002|Overall Study|Adverse Event|1|||
150238343|NCT05499130|542008879|FG003|Overall Study|Adverse Event|0|||
150238344|NCT05499130|542008880|FG004|Overall Study|Adverse Event|1|||
150238345|NCT05499130|542008881|FG005|Overall Study|Adverse Event|4|||
150238346|NCT05499130|542008882|FG006|Overall Study|Adverse Event|1|||
150238347|NCT05499130|542008883|FG007|Overall Study|Adverse Event|0|||
150238348|NCT05499130|542008876|FG000|Overall Study|Lack of Efficacy|1|||
150238349|NCT05499130|542008877|FG001|Overall Study|Lack of Efficacy|0|||
150238350|NCT05499130|542008878|FG002|Overall Study|Lack of Efficacy|0|||
150238351|NCT05499130|542008879|FG003|Overall Study|Lack of Efficacy|0|||
150238352|NCT05499130|542008880|FG004|Overall Study|Lack of Efficacy|5|||
150238353|NCT05499130|542008881|FG005|Overall Study|Lack of Efficacy|0|||
150238354|NCT05499130|542008882|FG006|Overall Study|Lack of Efficacy|1|||
150238355|NCT05499130|542008883|FG007|Overall Study|Lack of Efficacy|0|||
150238356|NCT05499130|542008876|FG000|Overall Study|Withdrawal by Subject|2|||
150238357|NCT05499130|542008877|FG001|Overall Study|Withdrawal by Subject|0|||
150238358|NCT05499130|542008878|FG002|Overall Study|Withdrawal by Subject|0|||
150238359|NCT05499130|542008879|FG003|Overall Study|Withdrawal by Subject|0|||
150238360|NCT05499130|542008880|FG004|Overall Study|Withdrawal by Subject|1|||
150238361|NCT05499130|542008881|FG005|Overall Study|Withdrawal by Subject|2|||
150238362|NCT05499130|542008882|FG006|Overall Study|Withdrawal by Subject|0|||
150238363|NCT05499130|542008883|FG007|Overall Study|Withdrawal by Subject|0|||
150238364|NCT05499130|542008876|FG000|Overall Study|Lost to Follow-up|0|||
150238365|NCT05499130|542008877|FG001|Overall Study|Lost to Follow-up|0|||
150238366|NCT05499130|542008878|FG002|Overall Study|Lost to Follow-up|0|||
150238367|NCT05499130|542008879|FG003|Overall Study|Lost to Follow-up|0|||
150238368|NCT05499130|542008880|FG004|Overall Study|Lost to Follow-up|0|||
150238369|NCT05499130|542008881|FG005|Overall Study|Lost to Follow-up|2|||
150238370|NCT05499130|542008882|FG006|Overall Study|Lost to Follow-up|0|||
150238371|NCT05499130|542008883|FG007|Overall Study|Lost to Follow-up|0|||
150238372|NCT05499130|542008876|FG000|Overall Study|Other Than Specified|0|||
150238373|NCT05499130|542008877|FG001|Overall Study|Other Than Specified|0|||
150238374|NCT05499130|542008878|FG002|Overall Study|Other Than Specified|0|||
150238375|NCT05499130|542008879|FG003|Overall Study|Other Than Specified|0|||
150238376|NCT05499130|542008880|FG004|Overall Study|Other Than Specified|1|||
150238377|NCT05499130|542008881|FG005|Overall Study|Other Than Specified|1|||
150238378|NCT05499130|542008882|FG006|Overall Study|Other Than Specified|2|||
150238379|NCT05499130|542008883|FG007|Overall Study|Other Than Specified|0|||
150238380|NCT05499130|542008876|FG000|Overall Study|Protocol Violation|0|||
150238381|NCT05499130|542008877|FG001|Overall Study|Protocol Violation|0|||
150238382|NCT05499130|542008878|FG002|Overall Study|Protocol Violation|0|||
150238383|NCT05499130|542008879|FG003|Overall Study|Protocol Violation|0|||
150238384|NCT05499130|542008880|FG004|Overall Study|Protocol Violation|1|||
150238385|NCT05499130|542008881|FG005|Overall Study|Protocol Violation|0|||
150238386|NCT05499130|542008882|FG006|Overall Study|Protocol Violation|0|||
150238387|NCT05499130|542008883|FG007|Overall Study|Protocol Violation|0|||
150238388|NCT04464421|542008884|FG000|Overall Study|Lost to Follow-up|2|||
150238389|NCT04464421|542008885|FG001|Overall Study|Lost to Follow-up|2|||
150238390|NCT04590404|542008888|FG000|Overall Study|Death|16|||
150238391|NCT04590404|542008889|FG001|Overall Study|Death|17|||
150238392|NCT04590404|542008888|FG000|Overall Study|Withdrawal by Subject|7|||
150238393|NCT04590404|542008889|FG001|Overall Study|Withdrawal by Subject|2|||
150238394|NCT05903183|542008890|FG000|Main Trial Part (365 Days)|Death|1|||
150238395|NCT05903183|542008891|FG001|Main Trial Part (365 Days)|Death|0|||
150238396|NCT05903183|542008892|FG002|Main Trial Part (365 Days)|Death|0|||
150238397|NCT05903183|542008893|FG003|Main Trial Part (365 Days)|Death|0|||
150238398|NCT05903183|542008894|FG004|Main Trial Part (365 Days)|Death|0|||
150238399|NCT05903183|542008890|FG000|Main Trial Part (365 Days)|Other|1|||
150238400|NCT05903183|542008891|FG001|Main Trial Part (365 Days)|Other|2|||
150238401|NCT05903183|542008892|FG002|Main Trial Part (365 Days)|Other|1|||
150238402|NCT05903183|542008893|FG003|Main Trial Part (365 Days)|Other|0|||
150238403|NCT05903183|542008894|FG004|Main Trial Part (365 Days)|Other|0|||
150238404|NCT05903183|542008890|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
150238405|NCT05903183|542008891|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
150238406|NCT05903183|542008892|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
150238407|NCT05903183|542008893|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
150238408|NCT05903183|542008894|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
150238409|NCT05903183|542008890|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
150238410|NCT05903183|542008891|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
150238411|NCT05903183|542008892|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
150238412|NCT05903183|542008893|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
150238413|NCT05903183|542008894|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
150238414|NCT05903183|542008890|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
150238415|NCT05903183|542008891|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
150238416|NCT05903183|542008892|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
150238417|NCT05903183|542008893|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
150238418|NCT05903183|542008894|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
150238419|NCT03698019|542008895|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
150238420|NCT03698019|542008896|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
150238421|NCT03698019|542008895|FG000|Step 1: Registration|Withdrawal by Subject|7|||
150238422|NCT03698019|542008896|FG001|Step 1: Registration|Withdrawal by Subject|2|||
150238423|NCT03698019|542008895|FG000|Step 1: Registration|Toxicity|0|||
150238424|NCT03698019|542008896|FG001|Step 1: Registration|Toxicity|1|||
150238425|NCT03698019|542008895|FG000|Step 1: Registration|Disease Progression|0|||
150238426|NCT03698019|542008896|FG001|Step 1: Registration|Disease Progression|12|||
150238427|NCT03698019|542008895|FG000|Step 1: Registration|Co-morbidities|0|||
150238428|NCT03698019|542008896|FG001|Step 1: Registration|Co-morbidities|1|||
150238429|NCT03698019|542008895|FG000|Step 1: Registration|Scheduling Issues|1|||
150238430|NCT03698019|542008896|FG001|Step 1: Registration|Scheduling Issues|0|||
150238431|NCT03698019|542008895|FG000|Step 1: Registration|Participant Refusal|0|||
150238432|NCT03698019|542008896|FG001|Step 1: Registration|Participant Refusal|1|||
150238433|NCT03698019|542008895|FG000|Step 2: Surgery|Participant Refusal|2|||
150238434|NCT03698019|542008896|FG001|Step 2: Surgery|Participant Refusal|1|||
150238435|NCT03698019|542008895|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
150238436|NCT03698019|542008896|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
150238437|NCT03698019|542008895|FG000|Step 2: Surgery|Metastatic Disease|16|||
150238438|NCT03698019|542008896|FG001|Step 2: Surgery|Metastatic Disease|9|||
150238439|NCT03698019|542008895|FG000|Step 2: Surgery|Residual Disease|2|||
150238440|NCT03698019|542008896|FG001|Step 2: Surgery|Residual Disease|1|||
150238441|NCT03698019|542008895|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
150238442|NCT03698019|542008896|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
150238443|NCT03698019|542008895|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
150238444|NCT03698019|542008896|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
150238445|NCT03698019|542008895|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
150238446|NCT03698019|542008896|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
150238447|NCT03698019|542008895|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
150238448|NCT03698019|542008896|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
150238449|NCT03698019|542008895|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
150238450|NCT03698019|542008896|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
150238451|NCT03698019|542008895|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
150238452|NCT03698019|542008896|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
150238453|NCT03698019|542008895|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
150238454|NCT03698019|542008896|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
150238455|NCT03698019|542008895|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
150238456|NCT03698019|542008896|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
150238457|NCT00569127|542008897|FG000|Overall Study|Adverse Event|57|||
150238458|NCT00569127|542008898|FG001|Overall Study|Adverse Event|47|||
150238459|NCT00569127|542008897|FG000|Overall Study|Withdrawal by Subject|13|||
150238460|NCT00569127|542008898|FG001|Overall Study|Withdrawal by Subject|27|||
150238461|NCT00569127|542008897|FG000|Overall Study|Progression|99|||
150238462|NCT00569127|542008898|FG001|Overall Study|Progression|100|||
150238463|NCT00569127|542008897|FG000|Overall Study|Death|4|||
150238464|NCT00569127|542008898|FG001|Overall Study|Death|3|||
150238465|NCT00569127|542008897|FG000|Overall Study|Other|20|||
150238466|NCT00569127|542008898|FG001|Overall Study|Other|19|||
150238467|NCT00569127|542008897|FG000|Overall Study|Lost to Follow-up|0|||
150238468|NCT00569127|542008898|FG001|Overall Study|Lost to Follow-up|3|||
150238469|NCT00569127|542008897|FG000|Overall Study|Not Eligible|14|||
150238470|NCT00569127|542008898|FG001|Overall Study|Not Eligible|11|||
150238471|NCT00569127|542008897|FG000|Overall Study|Still on Treatment|7|||
150238472|NCT00569127|542008898|FG001|Overall Study|Still on Treatment|3|||
150238473|NCT05739994|542008919|FG000|Overall Study|Withdrawal by Subject|2|||
150238474|NCT05739994|542008920|FG001|Overall Study|Withdrawal by Subject|2|||
150238475|NCT05739994|542008921|FG002|Overall Study|Withdrawal by Subject|4|||
150238476|NCT03299959|542008922|FG000|Overall Study|Lost to Follow-up|7|||
150238477|NCT03299959|542008923|FG001|Overall Study|Lost to Follow-up|9|||
150238478|NCT03299959|542008922|FG000|Overall Study|Death|1|||
150238479|NCT03299959|542008923|FG001|Overall Study|Death|0|||
150238480|NCT03299959|542008922|FG000|Overall Study|Withdrawal by Subject|13|||
150238481|NCT03299959|542008923|FG001|Overall Study|Withdrawal by Subject|9|||
150238482|NCT03299959|542008922|FG000|Overall Study|Changes in study team and government regulations|1|||
150238483|NCT03299959|542008923|FG001|Overall Study|Changes in study team and government regulations|1|||
150238484|NCT03299959|542008922|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
150238485|NCT03299959|542008923|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
150238486|NCT03735121|542008924|FG000|Overall Study|Death|3|||
150238487|NCT03735121|542008925|FG001|Overall Study|Death|6|||
150238488|NCT03735121|542008926|FG002|Overall Study|Death|19|||
150238489|NCT03735121|542008927|FG003|Overall Study|Death|97|||
150238490|NCT03735121|542008928|FG004|Overall Study|Death|205|||
150238491|NCT03735121|542008924|FG000|Overall Study|Lost to Follow-up|0|||
150238492|NCT03735121|542008925|FG001|Overall Study|Lost to Follow-up|0|||
150238493|NCT03735121|542008926|FG002|Overall Study|Lost to Follow-up|0|||
150238494|NCT03735121|542008927|FG003|Overall Study|Lost to Follow-up|2|||
150238495|NCT03735121|542008928|FG004|Overall Study|Lost to Follow-up|3|||
150238496|NCT03735121|542008924|FG000|Overall Study|New Therapy|0|||
150238497|NCT03735121|542008925|FG001|Overall Study|New Therapy|1|||
150238498|NCT03735121|542008926|FG002|Overall Study|New Therapy|0|||
150238499|NCT03735121|542008927|FG003|Overall Study|New Therapy|0|||
150238500|NCT03735121|542008928|FG004|Overall Study|New Therapy|0|||
150238501|NCT03735121|542008924|FG000|Overall Study|Study Ended by Sponsor|1|||
150238502|NCT03735121|542008925|FG001|Overall Study|Study Ended by Sponsor|0|||
150238503|NCT03735121|542008926|FG002|Overall Study|Study Ended by Sponsor|1|||
150238504|NCT03735121|542008927|FG003|Overall Study|Study Ended by Sponsor|17|||
150238505|NCT03735121|542008928|FG004|Overall Study|Study Ended by Sponsor|28|||
150238506|NCT03735121|542008924|FG000|Overall Study|Withdrawal by Subject|1|||
150238507|NCT03735121|542008925|FG001|Overall Study|Withdrawal by Subject|1|||
150238508|NCT03735121|542008926|FG002|Overall Study|Withdrawal by Subject|6|||
150238509|NCT03735121|542008927|FG003|Overall Study|Withdrawal by Subject|8|||
150238510|NCT03735121|542008928|FG004|Overall Study|Withdrawal by Subject|11|||
150238511|NCT03725605|542008929|FG000|Overall Study|Unsuccessful TIL expansion|2|||
150238512|NCT03668223|542008930|FG000|Overall Study|Death|10|||
150238513|NCT03668223|542008931|FG001|Overall Study|Death|5|||
150238514|NCT03668223|542008930|FG000|Overall Study|Lost to Follow-up|12|||
150238515|NCT03668223|542008931|FG001|Overall Study|Lost to Follow-up|12|||
150238516|NCT03668223|542008930|FG000|Overall Study|Withdrawal by Subject|8|||
150238517|NCT03668223|542008931|FG001|Overall Study|Withdrawal by Subject|3|||
150238518|NCT01503086|542008932|FG000|Overall Study|Lost to Follow-up|0|||
150238519|NCT01503086|542008933|FG001|Overall Study|Lost to Follow-up|1|||
150238520|NCT01503086|542008934|FG002|Overall Study|Lost to Follow-up|0|||
150238521|NCT01503086|542008932|FG000|Overall Study|Did Not Start Treatment|4|||
150238522|NCT01503086|542008933|FG001|Overall Study|Did Not Start Treatment|3|||
150238523|NCT01503086|542008934|FG002|Overall Study|Did Not Start Treatment|3|||
150238524|NCT01503086|542008932|FG000|Overall Study|Progressive disease|3|||
150238525|NCT01503086|542008933|FG001|Overall Study|Progressive disease|1|||
150238526|NCT01503086|542008934|FG002|Overall Study|Progressive disease|0|||
150238527|NCT01503086|542008932|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
150238528|NCT01503086|542008933|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
150238529|NCT01503086|542008934|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
150238530|NCT01503086|542008932|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
150238531|NCT01503086|542008933|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
150238532|NCT01503086|542008934|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
150238533|NCT05502783|542008935|FG000|Overall Study|Lack of Efficacy|1|||
150238534|NCT04870957|542008936|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
150238535|NCT04870957|542008937|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
150238536|NCT04870957|542008938|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
150238537|NCT04870957|542008939|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
150238538|NCT04870957|542008940|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
150238539|NCT04870957|542008941|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
150238540|NCT04870957|542008936|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
150238541|NCT04870957|542008937|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
150238542|NCT04870957|542008938|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
150238543|NCT04870957|542008939|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
150238544|NCT04870957|542008940|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
150238545|NCT04870957|542008941|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
150238546|NCT04870957|542008936|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
150238547|NCT04870957|542008937|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
150238548|NCT04870957|542008938|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
150238549|NCT04870957|542008939|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
150238550|NCT04870957|542008940|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
150238551|NCT04870957|542008941|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
150238552|NCT04870957|542008936|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
150238553|NCT04870957|542008937|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
150238554|NCT04870957|542008938|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
150238555|NCT04870957|542008939|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
150238556|NCT04870957|542008940|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
150238557|NCT04870957|542008941|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
150238558|NCT04870957|542008936|FG000|T2 (Randomization) - T3|Adverse Event|1|||
150238559|NCT04870957|542008937|FG001|T2 (Randomization) - T3|Adverse Event|1|||
150238560|NCT04870957|542008938|FG002|T2 (Randomization) - T3|Adverse Event|0|||
150238561|NCT04870957|542008939|FG003|T2 (Randomization) - T3|Adverse Event|0|||
150238562|NCT04870957|542008940|FG004|T2 (Randomization) - T3|Adverse Event|0|||
150238563|NCT04870957|542008941|FG005|T2 (Randomization) - T3|Adverse Event|0|||
150238564|NCT04870957|542008936|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
150238565|NCT04870957|542008937|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
150238566|NCT04870957|542008938|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
150238567|NCT04870957|542008939|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
150238568|NCT04870957|542008940|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
150238569|NCT04870957|542008941|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
150238570|NCT04870957|542008936|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
150238571|NCT04870957|542008937|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
150238572|NCT04870957|542008938|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
150238573|NCT04870957|542008939|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
150238574|NCT04870957|542008940|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
150238575|NCT04870957|542008941|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
150238576|NCT04870957|542008936|FG000|T2 (Randomization) - T3|Physician Decision|0|||
150238577|NCT04870957|542008937|FG001|T2 (Randomization) - T3|Physician Decision|0|||
150238578|NCT04870957|542008938|FG002|T2 (Randomization) - T3|Physician Decision|2|||
150238579|NCT04870957|542008939|FG003|T2 (Randomization) - T3|Physician Decision|1|||
150238580|NCT04870957|542008940|FG004|T2 (Randomization) - T3|Physician Decision|0|||
150238581|NCT04870957|542008941|FG005|T2 (Randomization) - T3|Physician Decision|0|||
150238582|NCT04870957|542008936|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
150238583|NCT04870957|542008937|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
150238584|NCT04870957|542008938|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
150238585|NCT04870957|542008939|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
150238586|NCT04870957|542008940|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
150238587|NCT04870957|542008941|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
150238588|NCT04870957|542008936|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
150238589|NCT04870957|542008937|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
150238590|NCT04870957|542008938|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
150238591|NCT04870957|542008939|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
150238592|NCT04870957|542008940|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
150238593|NCT04870957|542008941|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
150238594|NCT04870957|542008936|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
150238595|NCT04870957|542008937|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
150238596|NCT04870957|542008938|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
150238597|NCT04870957|542008939|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
150238598|NCT04870957|542008940|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
150238599|NCT04870957|542008941|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
150238600|NCT04870957|542008936|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
150238601|NCT04870957|542008937|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
150238602|NCT04870957|542008938|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
150238603|NCT04870957|542008939|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
150238604|NCT04870957|542008940|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
150238605|NCT04870957|542008941|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
150238606|NCT04870957|542008936|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
150238607|NCT04870957|542008937|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
150238608|NCT04870957|542008938|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
150238609|NCT04870957|542008939|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
150238610|NCT04870957|542008940|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
150238611|NCT04870957|542008941|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
150238612|NCT04870957|542008936|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
150238613|NCT04870957|542008937|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
150238614|NCT04870957|542008938|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
150238615|NCT04870957|542008939|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
150238616|NCT04870957|542008940|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
150238617|NCT04870957|542008941|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
150238618|NCT04870957|542008936|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
150238619|NCT04870957|542008937|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
150238620|NCT04870957|542008938|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
150238621|NCT04870957|542008939|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
150238622|NCT04870957|542008940|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
150238623|NCT04870957|542008941|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
150238624|NCT04870957|542008936|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
150238625|NCT04870957|542008937|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
150238626|NCT04870957|542008938|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
150238627|NCT04870957|542008939|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
150238628|NCT04870957|542008940|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
150238629|NCT04870957|542008941|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
150238630|NCT04870957|542008936|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
150238631|NCT04870957|542008937|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
150238632|NCT04870957|542008938|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
150238633|NCT04870957|542008939|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
150238634|NCT04870957|542008940|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
150238635|NCT04870957|542008941|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
150238636|NCT05970640|542008942|FG000|Overall Study|Adverse Event|1|||
150238637|NCT05970640|542008943|FG001|Overall Study|Adverse Event|3|||
150238638|NCT05970640|542008944|FG002|Overall Study|Adverse Event|1|||
150238639|NCT05970640|542008945|FG003|Overall Study|Adverse Event|0|||
150238640|NCT05970640|542008942|FG000|Overall Study|Withdrawal by Subject|0|||
150238641|NCT05970640|542008943|FG001|Overall Study|Withdrawal by Subject|0|||
150238642|NCT05970640|542008944|FG002|Overall Study|Withdrawal by Subject|1|||
150238643|NCT05970640|542008945|FG003|Overall Study|Withdrawal by Subject|1|||
150238644|NCT05970640|542008942|FG000|Overall Study|Sponsor decision|0|||
150238645|NCT05970640|542008943|FG001|Overall Study|Sponsor decision|0|||
150238646|NCT05970640|542008944|FG002|Overall Study|Sponsor decision|1|||
150238647|NCT05970640|542008945|FG003|Overall Study|Sponsor decision|1|||
150238648|NCT04340843|542008946|FG000|Overall Study|Adverse Event|0|||
150238649|NCT04340843|542008947|FG001|Overall Study|Adverse Event|2|||
150238650|NCT04340843|542008946|FG000|Overall Study|Withdrawal by Subject|0|||
150238651|NCT04340843|542008947|FG001|Overall Study|Withdrawal by Subject|2|||
150238652|NCT01090011|542009952|FG000|Overall Study|Progressive disease|128|||
150238653|NCT01090011|542009952|FG000|Overall Study|Adverse Event|32|||
150238654|NCT01090011|542009952|FG000|Overall Study|Protocol Violation|1|||
150238655|NCT01090011|542009952|FG000|Overall Study|Refusal to start/continue medication|5|||
150238656|NCT01090011|542009952|FG000|Overall Study|Other reason not defined above|5|||
150238657|NCT00321685|542009959|FG000|Overall Study|Adverse Event|18|||
150238658|NCT00321685|542009959|FG000|Overall Study|Death|2|||
150238659|NCT00321685|542009959|FG000|Overall Study|Withdrawal by Subject|8|||
150238660|NCT00321685|542009959|FG000|Overall Study|Alternative therapy|1|||
150238661|NCT00321685|542009959|FG000|Overall Study|Complicating disese|1|||
150238662|NCT00321685|542009959|FG000|Overall Study|Other|5|||
150238663|NCT00321685|542009959|FG000|Overall Study|Not start protocol therapy|2|||
150238664|NCT00321685|542009959|FG000|Overall Study|Ineligible|2|||
150238665|NCT01730950|542009963|FG000|Overall Study|Protocol Violation|6|||
150238666|NCT01730950|542009964|FG001|Overall Study|Protocol Violation|6|||
150238667|NCT03023722|542009965|FG000|Overall Study|No follow-up assessment|4|||
150238668|NCT03616964|542009966|FG000|Overall Study|Adverse Event|15|||
150238669|NCT03616964|542009967|FG001|Overall Study|Adverse Event|10|||
150238670|NCT03616964|542009968|FG002|Overall Study|Adverse Event|16|||
150238671|NCT03616964|542009966|FG000|Overall Study|Death|3|||
150238672|NCT03616964|542009967|FG001|Overall Study|Death|0|||
150238673|NCT03616964|542009968|FG002|Overall Study|Death|4|||
150238674|NCT03616964|542009966|FG000|Overall Study|Lack of Efficacy|4|||
150238675|NCT03616964|542009967|FG001|Overall Study|Lack of Efficacy|8|||
150238676|NCT03616964|542009968|FG002|Overall Study|Lack of Efficacy|8|||
150238677|NCT03616964|542009966|FG000|Overall Study|Lost to Follow-up|2|||
150238678|NCT03616964|542009967|FG001|Overall Study|Lost to Follow-up|1|||
150238679|NCT03616964|542009968|FG002|Overall Study|Lost to Follow-up|3|||
150238680|NCT03616964|542009966|FG000|Overall Study|Withdrawal by Subject|18|||
150238681|NCT03616964|542009967|FG001|Overall Study|Withdrawal by Subject|14|||
150238682|NCT03616964|542009968|FG002|Overall Study|Withdrawal by Subject|21|||
150238683|NCT03616964|542009966|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
150238684|NCT03616964|542009967|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
150238685|NCT03616964|542009968|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
150238686|NCT03616964|542009966|FG000|Overall Study|Sponsor's Decision|1|||
150238687|NCT03616964|542009967|FG001|Overall Study|Sponsor's Decision|0|||
150238688|NCT03616964|542009968|FG002|Overall Study|Sponsor's Decision|0|||
150238689|NCT03616964|542009966|FG000|Overall Study|Physician Decision|0|||
150238690|NCT03616964|542009967|FG001|Overall Study|Physician Decision|2|||
150238691|NCT03616964|542009968|FG002|Overall Study|Physician Decision|0|||
150238692|NCT03616964|542009966|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
150238693|NCT03616964|542009967|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
150238694|NCT03616964|542009968|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
150238695|NCT03616964|542009966|FG000|Overall Study|Protocol Violation|0|||
150238696|NCT03616964|542009967|FG001|Overall Study|Protocol Violation|1|||
150238697|NCT03616964|542009968|FG002|Overall Study|Protocol Violation|0|||
150238698|NCT03616964|542009966|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
150238699|NCT03616964|542009967|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
150238700|NCT03616964|542009968|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
150238701|NCT03616964|542009966|FG000|Overall Study|Randomized but Never Treated|1|||
150238702|NCT03616964|542009967|FG001|Overall Study|Randomized but Never Treated|1|||
150238703|NCT03616964|542009968|FG002|Overall Study|Randomized but Never Treated|1|||
150238704|NCT00129935|542009969|FG000|Overall Study|Adverse Event|18|||
150238705|NCT00129935|542009970|FG001|Overall Study|Adverse Event|56|||
150238706|NCT00129935|542009969|FG000|Overall Study|Death|1|||
150238707|NCT00129935|542009970|FG001|Overall Study|Death|1|||
150238708|NCT00129935|542009969|FG000|Overall Study|Withdrawal by Subject|7|||
150238709|NCT00129935|542009970|FG001|Overall Study|Withdrawal by Subject|20|||
150238710|NCT00129935|542009969|FG000|Overall Study|Protocol Violation|0|||
150238711|NCT00129935|542009970|FG001|Overall Study|Protocol Violation|4|||
150238712|NCT00129935|542009969|FG000|Overall Study|Physician Decision|3|||
150238713|NCT00129935|542009970|FG001|Overall Study|Physician Decision|4|||
150238714|NCT00129935|542009969|FG000|Overall Study|Recurrence|1|||
150238715|NCT00129935|542009970|FG001|Overall Study|Recurrence|3|||
150238716|NCT00129935|542009969|FG000|Overall Study|Second primary|0|||
150238717|NCT00129935|542009970|FG001|Overall Study|Second primary|1|||
150238718|NCT00129935|542009969|FG000|Overall Study|Other|3|||
150238719|NCT00129935|542009970|FG001|Overall Study|Other|2|||
150238720|NCT00129935|542009969|FG000|Overall Study|Crossed to the other arm|2|||
150238721|NCT00129935|542009970|FG001|Overall Study|Crossed to the other arm|1|||
150238722|NCT00129935|542009969|FG000|Overall Study|Incorrect study treatment|1|||
150238723|NCT00129935|542009970|FG001|Overall Study|Incorrect study treatment|0|||
150238724|NCT03020069|542009972|FG000|Overall Study|Lost to Follow-up|0|||
150238725|NCT03020069|542009973|FG001|Overall Study|Lost to Follow-up|1|||
150238726|NCT02056626|542009974|FG000|Overall Study|patient did not follow directions|3|||
150238727|NCT02056626|542009975|FG001|Overall Study|patient did not follow directions|1|||
150238728|NCT02056626|542009976|FG002|Overall Study|patient did not follow directions|0|||
150238729|NCT02056626|542009977|FG003|Overall Study|patient did not follow directions|0|||
150238730|NCT05765435|542009980|FG000|Overall Study|Lost to Follow-up|0|||
150238731|NCT05765435|542009981|FG001|Overall Study|Lost to Follow-up|1|||
150238732|NCT05765435|542009982|FG002|Overall Study|Lost to Follow-up|0|||
150238733|NCT05765435|542009980|FG000|Overall Study|Withdrawal by Subject|0|||
150238734|NCT05765435|542009981|FG001|Overall Study|Withdrawal by Subject|0|||
150238735|NCT05765435|542009982|FG002|Overall Study|Withdrawal by Subject|1|||
150238736|NCT01952847|542009983|FG000|Overall Study|Ineligible|1|||
150238737|NCT01952847|542009984|FG001|Overall Study|Ineligible|0|||
150238738|NCT01952847|542009985|FG002|Overall Study|Ineligible|0|||
150238739|NCT01952847|542009986|FG003|Overall Study|Ineligible|0|||
150238740|NCT01952847|542009983|FG000|Overall Study|Lack of Insurance Coverage|0|||
150238741|NCT01952847|542009984|FG001|Overall Study|Lack of Insurance Coverage|1|||
150238742|NCT01952847|542009985|FG002|Overall Study|Lack of Insurance Coverage|0|||
150238743|NCT01952847|542009986|FG003|Overall Study|Lack of Insurance Coverage|0|||
150238744|NCT01952847|542009983|FG000|Overall Study|Withdrawal by Subject|1|||
150238745|NCT01952847|542009984|FG001|Overall Study|Withdrawal by Subject|1|||
150238746|NCT01952847|542009985|FG002|Overall Study|Withdrawal by Subject|0|||
150238747|NCT01952847|542009986|FG003|Overall Study|Withdrawal by Subject|1|||
150238748|NCT00882115|542009989|FG000|Overall Study|Withdrawal by Subject|3|||
150238749|NCT00882115|542009989|FG000|Overall Study|did not respond to DEP challe|6|||
150238750|NCT01850589|542009990|FG000|Overall Study|Withdrawal by Subject|8|||
150238751|NCT01850589|542009991|FG001|Overall Study|Withdrawal by Subject|0|||
150238752|NCT01843777|542009992|FG000|Overall Study|Withdrawal by Subject|1|||
150238753|NCT01843777|542009993|FG001|Overall Study|Withdrawal by Subject|0|||
150238754|NCT03721172|542009995|FG000|Placebo-controlled Phase|Adverse Event|7|||
150238755|NCT03721172|542009996|FG001|Placebo-controlled Phase|Adverse Event|7|||
150238756|NCT03721172|542009997|FG002|Placebo-controlled Phase|Adverse Event|0|||
150238757|NCT03721172|542009995|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
150238758|NCT03721172|542009996|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
150238759|NCT03721172|542009997|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
150238760|NCT03721172|542009995|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
150238761|NCT03721172|542009996|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
150238762|NCT03721172|542009997|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
150238763|NCT03721172|542009995|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
150238764|NCT03721172|542009996|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
150238765|NCT03721172|542009997|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
150238766|NCT03721172|542009995|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
150238767|NCT03721172|542009996|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
150238768|NCT03721172|542009997|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
150238769|NCT03721172|542009995|FG000|Placebo-controlled Phase|Other|3|||
150238770|NCT03721172|542009996|FG001|Placebo-controlled Phase|Other|0|||
150238771|NCT03721172|542009997|FG002|Placebo-controlled Phase|Other|0|||
150238772|NCT03721172|542009995|FG000|Apremilast Extension Phase|Adverse Event|0|||
150238773|NCT03721172|542009996|FG001|Apremilast Extension Phase|Adverse Event|0|||
150238774|NCT03721172|542009997|FG002|Apremilast Extension Phase|Adverse Event|10|||
150238775|NCT03721172|542009995|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
150238776|NCT03721172|542009996|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
150238777|NCT03721172|542009997|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
150238778|NCT03721172|542009995|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
150238779|NCT03721172|542009996|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
150238780|NCT03721172|542009997|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
150238781|NCT03721172|542009995|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
150238782|NCT03721172|542009996|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
150238783|NCT03721172|542009997|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
150238784|NCT03721172|542009995|FG000|Apremilast Extension Phase|Protocol Violation|0|||
150238785|NCT03721172|542009996|FG001|Apremilast Extension Phase|Protocol Violation|0|||
150238786|NCT03721172|542009997|FG002|Apremilast Extension Phase|Protocol Violation|1|||
150238787|NCT03721172|542009995|FG000|Apremilast Extension Phase|Physician Decision|0|||
150238788|NCT03721172|542009996|FG001|Apremilast Extension Phase|Physician Decision|0|||
150238789|NCT03721172|542009997|FG002|Apremilast Extension Phase|Physician Decision|1|||
150238790|NCT03721172|542009995|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
150238791|NCT03721172|542009996|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
150238792|NCT03721172|542009997|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
150238793|NCT03721172|542009995|FG000|Apremilast Extension Phase|Other|0|||
150238794|NCT03721172|542009996|FG001|Apremilast Extension Phase|Other|0|||
150238795|NCT03721172|542009997|FG002|Apremilast Extension Phase|Other|3|||
150238796|NCT03721172|542009995|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
150238797|NCT03721172|542009996|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
150238798|NCT03721172|542009997|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
150238799|NCT01318876|542009998|FG000|Day 8 Survey|email address invalid|96|||
150238800|NCT01318876|542009998|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
150238801|NCT01318876|542009998|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
150238802|NCT00224029|542010000|FG000|Overall Study|Lost to Follow-up|1|||
150238803|NCT00224029|542010000|FG000|Overall Study|Withdrawal by Subject|4|||
150238804|NCT00224029|542010000|FG000|Overall Study|Other|1|||
150238805|NCT03513068|542010001|FG000|Overall Study|Death|1|||
150238806|NCT03513068|542010002|FG001|Overall Study|Death|0|||
150238807|NCT03513068|542010001|FG000|Overall Study|Withdrawal by Subject|4|||
150238808|NCT03513068|542010002|FG001|Overall Study|Withdrawal by Subject|6|||
150238809|NCT01236352|542010006|FG000|Overall Study|Death|0|||
150238810|NCT01236352|542010007|FG001|Overall Study|Death|0|||
150238811|NCT01236352|542010008|FG002|Overall Study|Death|0|||
150238812|NCT01236352|542010009|FG003|Overall Study|Death|0|||
150238813|NCT01236352|542010010|FG004|Overall Study|Death|0|||
150238814|NCT01236352|542010011|FG005|Overall Study|Death|0|||
150238815|NCT01236352|542010012|FG006|Overall Study|Death|0|||
150238816|NCT01236352|542010013|FG007|Overall Study|Death|1|||
150238817|NCT01236352|542010014|FG008|Overall Study|Death|0|||
150238818|NCT01236352|542010015|FG009|Overall Study|Death|0|||
150238819|NCT01236352|542010016|FG010|Overall Study|Death|0|||
150238820|NCT01236352|542010006|FG000|Overall Study|Withdrawal by Subject|0|||
150238821|NCT01236352|542010007|FG001|Overall Study|Withdrawal by Subject|0|||
150238822|NCT01236352|542010008|FG002|Overall Study|Withdrawal by Subject|0|||
150238823|NCT01236352|542010009|FG003|Overall Study|Withdrawal by Subject|0|||
150238824|NCT01236352|542010010|FG004|Overall Study|Withdrawal by Subject|0|||
150238825|NCT01236352|542010011|FG005|Overall Study|Withdrawal by Subject|0|||
150238826|NCT01236352|542010012|FG006|Overall Study|Withdrawal by Subject|0|||
150238827|NCT01236352|542010013|FG007|Overall Study|Withdrawal by Subject|0|||
150238828|NCT01236352|542010014|FG008|Overall Study|Withdrawal by Subject|0|||
150238829|NCT01236352|542010015|FG009|Overall Study|Withdrawal by Subject|2|||
150238830|NCT01236352|542010016|FG010|Overall Study|Withdrawal by Subject|1|||
150238831|NCT01236352|542010006|FG000|Overall Study|Adverse Event|0|||
150238832|NCT01236352|542010007|FG001|Overall Study|Adverse Event|0|||
150238833|NCT01236352|542010008|FG002|Overall Study|Adverse Event|0|||
150238834|NCT01236352|542010009|FG003|Overall Study|Adverse Event|0|||
150238835|NCT01236352|542010010|FG004|Overall Study|Adverse Event|0|||
150238836|NCT01236352|542010011|FG005|Overall Study|Adverse Event|0|||
150238837|NCT01236352|542010012|FG006|Overall Study|Adverse Event|2|||
150238838|NCT01236352|542010013|FG007|Overall Study|Adverse Event|0|||
150238839|NCT01236352|542010014|FG008|Overall Study|Adverse Event|0|||
150238840|NCT01236352|542010015|FG009|Overall Study|Adverse Event|4|||
150238841|NCT01236352|542010016|FG010|Overall Study|Adverse Event|1|||
150238842|NCT01236352|542010006|FG000|Overall Study|Study drug toxicity|0|||
150238843|NCT01236352|542010007|FG001|Overall Study|Study drug toxicity|0|||
150238844|NCT01236352|542010008|FG002|Overall Study|Study drug toxicity|0|||
150238845|NCT01236352|542010009|FG003|Overall Study|Study drug toxicity|0|||
150238846|NCT01236352|542010010|FG004|Overall Study|Study drug toxicity|0|||
150238847|NCT01236352|542010011|FG005|Overall Study|Study drug toxicity|1|||
150238848|NCT01236352|542010012|FG006|Overall Study|Study drug toxicity|1|||
150238849|NCT01236352|542010013|FG007|Overall Study|Study drug toxicity|0|||
150238850|NCT01236352|542010014|FG008|Overall Study|Study drug toxicity|0|||
150238851|NCT01236352|542010015|FG009|Overall Study|Study drug toxicity|2|||
150238852|NCT01236352|542010016|FG010|Overall Study|Study drug toxicity|2|||
150238853|NCT01236352|542010006|FG000|Overall Study|Disease progression|1|||
150238854|NCT01236352|542010007|FG001|Overall Study|Disease progression|2|||
150238855|NCT01236352|542010008|FG002|Overall Study|Disease progression|1|||
150238856|NCT01236352|542010009|FG003|Overall Study|Disease progression|2|||
150238857|NCT01236352|542010010|FG004|Overall Study|Disease progression|2|||
150238858|NCT01236352|542010011|FG005|Overall Study|Disease progression|2|||
150238859|NCT01236352|542010012|FG006|Overall Study|Disease progression|1|||
150238860|NCT01236352|542010013|FG007|Overall Study|Disease progression|3|||
150238861|NCT01236352|542010014|FG008|Overall Study|Disease progression|2|||
150238862|NCT01236352|542010015|FG009|Overall Study|Disease progression|2|||
150238863|NCT01236352|542010016|FG010|Overall Study|Disease progression|2|||
150238864|NCT01236352|542010006|FG000|Overall Study|Poor/Non-compliance|1|||
150238865|NCT01236352|542010007|FG001|Overall Study|Poor/Non-compliance|0|||
150238866|NCT01236352|542010008|FG002|Overall Study|Poor/Non-compliance|0|||
150238867|NCT01236352|542010009|FG003|Overall Study|Poor/Non-compliance|0|||
150238868|NCT01236352|542010010|FG004|Overall Study|Poor/Non-compliance|0|||
150238869|NCT01236352|542010011|FG005|Overall Study|Poor/Non-compliance|0|||
150238870|NCT01236352|542010012|FG006|Overall Study|Poor/Non-compliance|0|||
150238871|NCT01236352|542010013|FG007|Overall Study|Poor/Non-compliance|0|||
150238872|NCT01236352|542010014|FG008|Overall Study|Poor/Non-compliance|0|||
150238873|NCT01236352|542010015|FG009|Overall Study|Poor/Non-compliance|0|||
150238874|NCT01236352|542010016|FG010|Overall Study|Poor/Non-compliance|0|||
150238875|NCT01236352|542010006|FG000|Overall Study|Maximum clinical benefit|1|||
150238876|NCT01236352|542010007|FG001|Overall Study|Maximum clinical benefit|1|||
150238877|NCT01236352|542010008|FG002|Overall Study|Maximum clinical benefit|1|||
150238878|NCT01236352|542010009|FG003|Overall Study|Maximum clinical benefit|0|||
150238879|NCT01236352|542010010|FG004|Overall Study|Maximum clinical benefit|2|||
150238880|NCT01236352|542010011|FG005|Overall Study|Maximum clinical benefit|0|||
150238881|NCT01236352|542010012|FG006|Overall Study|Maximum clinical benefit|3|||
150238882|NCT01236352|542010013|FG007|Overall Study|Maximum clinical benefit|1|||
150238883|NCT01236352|542010014|FG008|Overall Study|Maximum clinical benefit|1|||
150238884|NCT01236352|542010015|FG009|Overall Study|Maximum clinical benefit|4|||
150238885|NCT01236352|542010016|FG010|Overall Study|Maximum clinical benefit|2|||
150238886|NCT01236352|542010006|FG000|Overall Study|Subject request to discontinue treatment|0|||
150238887|NCT01236352|542010007|FG001|Overall Study|Subject request to discontinue treatment|0|||
150238888|NCT01236352|542010008|FG002|Overall Study|Subject request to discontinue treatment|1|||
150238889|NCT01236352|542010009|FG003|Overall Study|Subject request to discontinue treatment|1|||
150238890|NCT01236352|542010010|FG004|Overall Study|Subject request to discontinue treatment|0|||
150238891|NCT01236352|542010011|FG005|Overall Study|Subject request to discontinue treatment|1|||
150238892|NCT01236352|542010012|FG006|Overall Study|Subject request to discontinue treatment|0|||
150238893|NCT01236352|542010013|FG007|Overall Study|Subject request to discontinue treatment|0|||
150238894|NCT01236352|542010014|FG008|Overall Study|Subject request to discontinue treatment|0|||
150238895|NCT01236352|542010015|FG009|Overall Study|Subject request to discontinue treatment|1|||
150238896|NCT01236352|542010016|FG010|Overall Study|Subject request to discontinue treatment|4|||
150238897|NCT01236352|542010006|FG000|Overall Study|Subject to receive drug via EAP|1|||
150238898|NCT01236352|542010007|FG001|Overall Study|Subject to receive drug via EAP|1|||
150238899|NCT01236352|542010008|FG002|Overall Study|Subject to receive drug via EAP|1|||
150238900|NCT01236352|542010009|FG003|Overall Study|Subject to receive drug via EAP|0|||
150238901|NCT01236352|542010010|FG004|Overall Study|Subject to receive drug via EAP|0|||
150238902|NCT01236352|542010011|FG005|Overall Study|Subject to receive drug via EAP|0|||
150238903|NCT01236352|542010012|FG006|Overall Study|Subject to receive drug via EAP|0|||
150238904|NCT01236352|542010013|FG007|Overall Study|Subject to receive drug via EAP|2|||
150238905|NCT01236352|542010014|FG008|Overall Study|Subject to receive drug via EAP|0|||
150238906|NCT01236352|542010015|FG009|Overall Study|Subject to receive drug via EAP|4|||
150238907|NCT01236352|542010016|FG010|Overall Study|Subject to receive drug via EAP|0|||
150238908|NCT01236352|542010006|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
150238909|NCT01236352|542010007|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
150238910|NCT01236352|542010008|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
150238911|NCT01236352|542010009|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
150238912|NCT01236352|542010010|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
150238913|NCT01236352|542010011|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
150238914|NCT01236352|542010012|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
150238915|NCT01236352|542010013|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
150238916|NCT01236352|542010014|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
150238917|NCT01236352|542010015|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
150238918|NCT01236352|542010016|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
150238919|NCT01236352|542010006|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238920|NCT01236352|542010007|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238921|NCT01236352|542010008|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238922|NCT01236352|542010009|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238923|NCT01236352|542010010|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238924|NCT01236352|542010011|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238925|NCT01236352|542010012|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238926|NCT01236352|542010013|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238927|NCT01236352|542010014|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238928|NCT01236352|542010015|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
150238929|NCT01236352|542010016|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
150238930|NCT01236352|542010006|FG000|Overall Study|Lack of response to drug|0|||
150238931|NCT01236352|542010007|FG001|Overall Study|Lack of response to drug|0|||
150238932|NCT01236352|542010008|FG002|Overall Study|Lack of response to drug|0|||
150238933|NCT01236352|542010009|FG003|Overall Study|Lack of response to drug|0|||
150238934|NCT01236352|542010010|FG004|Overall Study|Lack of response to drug|0|||
150238935|NCT01236352|542010011|FG005|Overall Study|Lack of response to drug|0|||
150238936|NCT01236352|542010012|FG006|Overall Study|Lack of response to drug|0|||
150238937|NCT01236352|542010013|FG007|Overall Study|Lack of response to drug|0|||
150238938|NCT01236352|542010014|FG008|Overall Study|Lack of response to drug|0|||
150238939|NCT01236352|542010015|FG009|Overall Study|Lack of response to drug|1|||
150238940|NCT01236352|542010016|FG010|Overall Study|Lack of response to drug|1|||
150238941|NCT01236352|542010006|FG000|Overall Study|Patient transferred to IST|0|||
150238942|NCT01236352|542010007|FG001|Overall Study|Patient transferred to IST|0|||
150238943|NCT01236352|542010008|FG002|Overall Study|Patient transferred to IST|0|||
150238944|NCT01236352|542010009|FG003|Overall Study|Patient transferred to IST|0|||
150238945|NCT01236352|542010010|FG004|Overall Study|Patient transferred to IST|0|||
150238946|NCT01236352|542010011|FG005|Overall Study|Patient transferred to IST|0|||
150238947|NCT01236352|542010012|FG006|Overall Study|Patient transferred to IST|0|||
150238948|NCT01236352|542010013|FG007|Overall Study|Patient transferred to IST|0|||
150238949|NCT01236352|542010014|FG008|Overall Study|Patient transferred to IST|0|||
150238950|NCT01236352|542010015|FG009|Overall Study|Patient transferred to IST|2|||
150238951|NCT01236352|542010016|FG010|Overall Study|Patient transferred to IST|6|||
150238952|NCT01827046|542010017|FG000|Overall Study|Lost to Follow-up|1|||
150238953|NCT01827046|542010018|FG001|Overall Study|Lost to Follow-up|5|||
150238954|NCT01827046|542010017|FG000|Overall Study|Withdrawal by Subject|0|||
150238955|NCT01827046|542010018|FG001|Overall Study|Withdrawal by Subject|4|||
150238956|NCT02282917|542010022|FG000|Overall Study|Withdrawal by Subject|1|||
150238957|NCT02282917|542010022|FG000|Overall Study|Screen Failure/Not Eligible|1|||
150238958|NCT02581059|542010023|FG000|Study Treatment|Disease Progression|1|||
150238959|NCT02581059|542010024|FG001|Study Treatment|Disease Progression|1|||
150238960|NCT02581059|542010023|FG000|Study Treatment|Adverse Event|2|||
150238961|NCT02581059|542010024|FG001|Study Treatment|Adverse Event|1|||
150238962|NCT02581059|542010023|FG000|Study Treatment|Death|1|||
150238963|NCT02581059|542010024|FG001|Study Treatment|Death|1|||
150238964|NCT02581059|542010023|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
150238965|NCT02581059|542010024|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
150238966|NCT02581059|542010023|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
150238967|NCT02581059|542010024|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
150238968|NCT02581059|542010023|FG000|Follow up|Death|1|||
150238969|NCT02581059|542010024|FG001|Follow up|Death|3|||
150238970|NCT02581059|542010023|FG000|Follow up|study terminated|1|||
150238971|NCT02581059|542010024|FG001|Follow up|study terminated|1|||
150238972|NCT02581059|542010023|FG000|Follow up|screen failure|0|||
150238973|NCT02581059|542010024|FG001|Follow up|screen failure|1|||
150238974|NCT02581059|542010023|FG000|Follow up|Patient started new clinical trial|1|||
150238975|NCT02581059|542010024|FG001|Follow up|Patient started new clinical trial|0|||
150238976|NCT03149029|542010025|FG000|Overall Study|Adverse Event|2|||
150238977|NCT03149029|542010026|FG001|Overall Study|Adverse Event|0|||
150238978|NCT02176863|542010027|FG000|Overall Study|Physician Decision|1|||
150238979|NCT02176863|542010028|FG001|Overall Study|Physician Decision|0|||
150238980|NCT02176863|542010029|FG002|Overall Study|Physician Decision|0|||
150238981|NCT02176863|542010030|FG003|Overall Study|Physician Decision|0|||
150238982|NCT02176863|542010031|FG004|Overall Study|Physician Decision|0|||
150238983|NCT02176863|542010027|FG000|Overall Study|Adverse Event|10|||
150238984|NCT02176863|542010028|FG001|Overall Study|Adverse Event|4|||
150238985|NCT02176863|542010029|FG002|Overall Study|Adverse Event|4|||
150238986|NCT02176863|542010030|FG003|Overall Study|Adverse Event|1|||
150238987|NCT02176863|542010031|FG004|Overall Study|Adverse Event|1|||
150238988|NCT02176863|542010027|FG000|Overall Study|Protocol Violation|2|||
150238989|NCT02176863|542010028|FG001|Overall Study|Protocol Violation|0|||
150238990|NCT02176863|542010029|FG002|Overall Study|Protocol Violation|1|||
150238991|NCT02176863|542010030|FG003|Overall Study|Protocol Violation|1|||
150238992|NCT02176863|542010031|FG004|Overall Study|Protocol Violation|0|||
150238993|NCT02176863|542010027|FG000|Overall Study|Withdrawal by Subject|4|||
150238994|NCT02176863|542010028|FG001|Overall Study|Withdrawal by Subject|2|||
150238995|NCT02176863|542010029|FG002|Overall Study|Withdrawal by Subject|2|||
150238996|NCT02176863|542010030|FG003|Overall Study|Withdrawal by Subject|3|||
150238997|NCT02176863|542010031|FG004|Overall Study|Withdrawal by Subject|4|||
150238998|NCT02176863|542010027|FG000|Overall Study|Reason not specified|0|||
150238999|NCT02176863|542010028|FG001|Overall Study|Reason not specified|1|||
150239000|NCT02176863|542010029|FG002|Overall Study|Reason not specified|1|||
150239001|NCT02176863|542010030|FG003|Overall Study|Reason not specified|2|||
150239002|NCT02176863|542010031|FG004|Overall Study|Reason not specified|1|||
150239003|NCT02176863|542010027|FG000|Overall Study|Lost to Follow-up|0|||
150239004|NCT02176863|542010028|FG001|Overall Study|Lost to Follow-up|1|||
150239005|NCT02176863|542010029|FG002|Overall Study|Lost to Follow-up|1|||
150239006|NCT02176863|542010030|FG003|Overall Study|Lost to Follow-up|0|||
150239007|NCT02176863|542010031|FG004|Overall Study|Lost to Follow-up|0|||
150239008|NCT06077773|542010032|FG000|Overall Study|Withdrawal by Subject|1|||
150239009|NCT06077773|542010033|FG001|Overall Study|Withdrawal by Subject|0|||
150239010|NCT06077773|542010034|FG002|Overall Study|Withdrawal by Subject|1|||
150239011|NCT06077773|542010032|FG000|Overall Study|Lost to Follow-up|0|||
150239012|NCT06077773|542010033|FG001|Overall Study|Lost to Follow-up|1|||
150239013|NCT06077773|542010034|FG002|Overall Study|Lost to Follow-up|0|||
150239014|NCT06077773|542010032|FG000|Overall Study|Adverse Event|0|||
150239015|NCT06077773|542010033|FG001|Overall Study|Adverse Event|0|||
150239016|NCT06077773|542010034|FG002|Overall Study|Adverse Event|2|||
150239017|NCT02473042|542010035|FG000|Overall Study|Withdrawal by Subject|1|||
150239018|NCT02473042|542010036|FG001|Overall Study|Withdrawal by Subject|0|||
150239019|NCT02473042|542010035|FG000|Overall Study|Patient became ineligible after enrollment|2|||
150239020|NCT02473042|542010036|FG001|Overall Study|Patient became ineligible after enrollment|5|||
150239021|NCT02473042|542010035|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
150239022|NCT02473042|542010036|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
150239023|NCT02473042|542010035|FG000|Overall Study|PACU data unable to be collected|3|||
150239024|NCT02473042|542010036|FG001|Overall Study|PACU data unable to be collected|0|||
150239025|NCT02037256|542010037|FG000|Overall Study|Protocol Violation|0|||
150239026|NCT02037256|542010038|FG001|Overall Study|Protocol Violation|1|||
150239027|NCT02037256|542010037|FG000|Overall Study|Withdrawn prior to Velcade|0|||
150239028|NCT02037256|542010038|FG001|Overall Study|Withdrawn prior to Velcade|2|||
150239029|NCT03007732|542010039|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
150239030|NCT03007732|542010040|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
150239031|NCT03007732|542010041|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
150239032|NCT03007732|542010042|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
150239033|NCT02101983|542010043|FG000|Overall Study|Physician Decision|1|||
150239034|NCT02101983|542010044|FG001|Overall Study|Physician Decision|0|||
150239035|NCT03459846|542010052|FG000|Overall Study|Death|52|||
150239036|NCT03459846|542010053|FG001|Overall Study|Death|46|||
150239037|NCT03459846|542010052|FG000|Overall Study|Study terminated by sponsor|24|||
150239038|NCT03459846|542010053|FG001|Overall Study|Study terminated by sponsor|28|||
150239039|NCT03459846|542010052|FG000|Overall Study|Withdrawal by Subject|2|||
150239040|NCT03459846|542010053|FG001|Overall Study|Withdrawal by Subject|2|||
150239041|NCT00826228|542011734|FG000|Overall Study|Withdrawal by Subject|1|||
150239042|NCT01246999|542011735|FG000|Overall Study|Lost to Follow-up|0|||
150239043|NCT01246999|542011736|FG001|Overall Study|Lost to Follow-up|1|||
150239044|NCT01246999|542011737|FG002|Overall Study|Lost to Follow-up|0|||
150239045|NCT01246999|542011738|FG003|Overall Study|Lost to Follow-up|0|||
150239046|NCT01246999|542011735|FG000|Overall Study|Withdrawal by Subject|0|||
150239047|NCT01246999|542011736|FG001|Overall Study|Withdrawal by Subject|0|||
150239048|NCT01246999|542011737|FG002|Overall Study|Withdrawal by Subject|0|||
150239049|NCT01246999|542011738|FG003|Overall Study|Withdrawal by Subject|2|||
150239050|NCT04650698|542011739|FG000|Overall Study|Protocol Violation|2|||
150239051|NCT04650698|542011740|FG001|Overall Study|Protocol Violation|1|||
150239052|NCT04650698|542011739|FG000|Overall Study|Withdrawal by Subject|0|||
150239053|NCT04650698|542011740|FG001|Overall Study|Withdrawal by Subject|1|||
150239054|NCT00307047|542011741|FG000|Overall Study|Lost to Follow-up|35|||
150239055|NCT00307047|542011742|FG001|Overall Study|Lost to Follow-up|24|||
150239056|NCT00307047|542011741|FG000|Overall Study|Withdrawal by Subject|6|||
150239057|NCT00307047|542011742|FG001|Overall Study|Withdrawal by Subject|6|||
150239058|NCT00307047|542011741|FG000|Overall Study|Physician Decision|1|||
150239059|NCT00307047|542011742|FG001|Overall Study|Physician Decision|2|||
150239060|NCT00307047|542011741|FG000|Overall Study|Lost to follow-up for other reasons|0|||
150239061|NCT00307047|542011742|FG001|Overall Study|Lost to follow-up for other reasons|1|||
150239062|NCT00307047|542011741|FG000|Overall Study|All death, all MI, all Revascularization|27|||
150239063|NCT00307047|542011742|FG001|Overall Study|All death, all MI, all Revascularization|16|||
150239064|NCT00379769|542011743|FG000|Main Study|Death|57|||
150239065|NCT00379769|542011744|FG001|Main Study|Death|67|||
150239066|NCT00379769|542011745|FG002|Main Study|Death|54|||
150239067|NCT00379769|542011746|FG003|Main Study|Death|72|||
150239068|NCT00379769|542011747|FG004|Main Study|Death|0|||
150239069|NCT00379769|542011748|FG005|Main Study|Death|0|||
150239070|NCT00379769|542011743|FG000|Main Study|Adverse Event|5|||
150239071|NCT00379769|542011744|FG001|Main Study|Adverse Event|8|||
150239072|NCT00379769|542011745|FG002|Main Study|Adverse Event|10|||
150239073|NCT00379769|542011746|FG003|Main Study|Adverse Event|11|||
150239074|NCT00379769|542011747|FG004|Main Study|Adverse Event|0|||
150239075|NCT00379769|542011748|FG005|Main Study|Adverse Event|0|||
150239076|NCT00379769|542011743|FG000|Main Study|Lost to Follow-up|29|||
150239077|NCT00379769|542011744|FG001|Main Study|Lost to Follow-up|29|||
150239078|NCT00379769|542011745|FG002|Main Study|Lost to Follow-up|25|||
150239079|NCT00379769|542011746|FG003|Main Study|Lost to Follow-up|26|||
150239080|NCT00379769|542011747|FG004|Main Study|Lost to Follow-up|0|||
150239081|NCT00379769|542011748|FG005|Main Study|Lost to Follow-up|0|||
150239082|NCT00379769|542011743|FG000|Main Study|Withdrawal by Subject|46|||
150239083|NCT00379769|542011744|FG001|Main Study|Withdrawal by Subject|56|||
150239084|NCT00379769|542011745|FG002|Main Study|Withdrawal by Subject|72|||
150239085|NCT00379769|542011746|FG003|Main Study|Withdrawal by Subject|70|||
150239086|NCT00379769|542011747|FG004|Main Study|Withdrawal by Subject|0|||
150239087|NCT00379769|542011748|FG005|Main Study|Withdrawal by Subject|0|||
150239088|NCT00379769|542011743|FG000|Main Study|Moved to survival status follow-up only|27|||
150239089|NCT00379769|542011744|FG001|Main Study|Moved to survival status follow-up only|25|||
150239090|NCT00379769|542011745|FG002|Main Study|Moved to survival status follow-up only|32|||
150239091|NCT00379769|542011746|FG003|Main Study|Moved to survival status follow-up only|36|||
150239092|NCT00379769|542011747|FG004|Main Study|Moved to survival status follow-up only|0|||
150239093|NCT00379769|542011748|FG005|Main Study|Moved to survival status follow-up only|0|||
150239094|NCT00379769|542011743|FG000|Main Study|Participant moved|3|||
150239095|NCT00379769|542011744|FG001|Main Study|Participant moved|2|||
150239096|NCT00379769|542011745|FG002|Main Study|Participant moved|3|||
150239097|NCT00379769|542011746|FG003|Main Study|Participant moved|3|||
150239098|NCT00379769|542011747|FG004|Main Study|Participant moved|0|||
150239099|NCT00379769|542011748|FG005|Main Study|Participant moved|0|||
150239100|NCT00379769|542011743|FG000|Main Study|Poor compliance|3|||
150239101|NCT00379769|542011744|FG001|Main Study|Poor compliance|2|||
150239102|NCT00379769|542011745|FG002|Main Study|Poor compliance|2|||
150239103|NCT00379769|542011746|FG003|Main Study|Poor compliance|1|||
150239104|NCT00379769|542011747|FG004|Main Study|Poor compliance|0|||
150239105|NCT00379769|542011748|FG005|Main Study|Poor compliance|0|||
150239106|NCT00379769|542011743|FG000|Main Study|Prohibited glucose lowering medication|0|||
150239107|NCT00379769|542011744|FG001|Main Study|Prohibited glucose lowering medication|3|||
150239108|NCT00379769|542011745|FG002|Main Study|Prohibited glucose lowering medication|0|||
150239109|NCT00379769|542011746|FG003|Main Study|Prohibited glucose lowering medication|1|||
150239110|NCT00379769|542011747|FG004|Main Study|Prohibited glucose lowering medication|0|||
150239111|NCT00379769|542011748|FG005|Main Study|Prohibited glucose lowering medication|0|||
150239112|NCT00379769|542011743|FG000|Main Study|Site closed|4|||
150239113|NCT00379769|542011744|FG001|Main Study|Site closed|4|||
150239114|NCT00379769|542011745|FG002|Main Study|Site closed|4|||
150239115|NCT00379769|542011746|FG003|Main Study|Site closed|8|||
150239116|NCT00379769|542011747|FG004|Main Study|Site closed|0|||
150239117|NCT00379769|542011748|FG005|Main Study|Site closed|0|||
150239118|NCT00379769|542011743|FG000|Main Study|Entry criteria violation|0|||
150239119|NCT00379769|542011744|FG001|Main Study|Entry criteria violation|0|||
150239120|NCT00379769|542011745|FG002|Main Study|Entry criteria violation|1|||
150239121|NCT00379769|542011746|FG003|Main Study|Entry criteria violation|1|||
150239122|NCT00379769|542011747|FG004|Main Study|Entry criteria violation|0|||
150239123|NCT00379769|542011748|FG005|Main Study|Entry criteria violation|0|||
150239124|NCT00379769|542011743|FG000|Main Study|Participant did not take study drug|0|||
150239125|NCT00379769|542011744|FG001|Main Study|Participant did not take study drug|0|||
150239126|NCT00379769|542011745|FG002|Main Study|Participant did not take study drug|1|||
150239127|NCT00379769|542011746|FG003|Main Study|Participant did not take study drug|0|||
150239128|NCT00379769|542011747|FG004|Main Study|Participant did not take study drug|0|||
150239129|NCT00379769|542011748|FG005|Main Study|Participant did not take study drug|0|||
150239130|NCT00379769|542011743|FG000|Main Study|Physician Decision|2|||
150239131|NCT00379769|542011744|FG001|Main Study|Physician Decision|2|||
150239132|NCT00379769|542011745|FG002|Main Study|Physician Decision|1|||
150239133|NCT00379769|542011746|FG003|Main Study|Physician Decision|1|||
150239134|NCT00379769|542011747|FG004|Main Study|Physician Decision|0|||
150239135|NCT00379769|542011748|FG005|Main Study|Physician Decision|0|||
150239136|NCT00379769|542011743|FG000|Main Study|Participant completed study at visit 27|1|||
150239137|NCT00379769|542011744|FG001|Main Study|Participant completed study at visit 27|0|||
150239138|NCT00379769|542011745|FG002|Main Study|Participant completed study at visit 27|0|||
150239139|NCT00379769|542011746|FG003|Main Study|Participant completed study at visit 27|0|||
150239140|NCT00379769|542011747|FG004|Main Study|Participant completed study at visit 27|0|||
150239141|NCT00379769|542011748|FG005|Main Study|Participant completed study at visit 27|0|||
150239142|NCT00379769|542011743|FG000|Main Study|Personal reasons|1|||
150239143|NCT00379769|542011744|FG001|Main Study|Personal reasons|0|||
150239144|NCT00379769|542011745|FG002|Main Study|Personal reasons|0|||
150239145|NCT00379769|542011746|FG003|Main Study|Personal reasons|0|||
150239146|NCT00379769|542011747|FG004|Main Study|Personal reasons|0|||
150239147|NCT00379769|542011748|FG005|Main Study|Personal reasons|0|||
150239148|NCT00379769|542011743|FG000|Main Study|Risk of heart failure|0|||
150239149|NCT00379769|542011744|FG001|Main Study|Risk of heart failure|1|||
150239150|NCT00379769|542011745|FG002|Main Study|Risk of heart failure|0|||
150239151|NCT00379769|542011746|FG003|Main Study|Risk of heart failure|0|||
150239152|NCT00379769|542011747|FG004|Main Study|Risk of heart failure|0|||
150239153|NCT00379769|542011748|FG005|Main Study|Risk of heart failure|0|||
150239154|NCT00379769|542011743|FG000|Main Study|Investigator refused to log temperature|0|||
150239155|NCT00379769|542011744|FG001|Main Study|Investigator refused to log temperature|0|||
150239156|NCT00379769|542011745|FG002|Main Study|Investigator refused to log temperature|1|||
150239157|NCT00379769|542011746|FG003|Main Study|Investigator refused to log temperature|0|||
150239158|NCT00379769|542011747|FG004|Main Study|Investigator refused to log temperature|0|||
150239159|NCT00379769|542011748|FG005|Main Study|Investigator refused to log temperature|0|||
150239160|NCT00379769|542011743|FG000|Main Study|Reason unspecified|0|||
150239161|NCT00379769|542011744|FG001|Main Study|Reason unspecified|0|||
150239162|NCT00379769|542011745|FG002|Main Study|Reason unspecified|1|||
150239163|NCT00379769|542011746|FG003|Main Study|Reason unspecified|0|||
150239164|NCT00379769|542011747|FG004|Main Study|Reason unspecified|0|||
150239165|NCT00379769|542011748|FG005|Main Study|Reason unspecified|0|||
150239166|NCT00379769|542011743|FG000|Observational Follow-up|Death|0|||
150239167|NCT00379769|542011744|FG001|Observational Follow-up|Death|0|||
150239168|NCT00379769|542011745|FG002|Observational Follow-up|Death|0|||
150239169|NCT00379769|542011746|FG003|Observational Follow-up|Death|0|||
150239170|NCT00379769|542011747|FG004|Observational Follow-up|Death|78|||
150239171|NCT00379769|542011748|FG005|Observational Follow-up|Death|70|||
150239172|NCT00379769|542011743|FG000|Observational Follow-up|Adverse Event|0|||
150239173|NCT00379769|542011744|FG001|Observational Follow-up|Adverse Event|0|||
150239174|NCT00379769|542011745|FG002|Observational Follow-up|Adverse Event|0|||
150239175|NCT00379769|542011746|FG003|Observational Follow-up|Adverse Event|0|||
150239176|NCT00379769|542011747|FG004|Observational Follow-up|Adverse Event|1|||
150239177|NCT00379769|542011748|FG005|Observational Follow-up|Adverse Event|0|||
150239178|NCT00379769|542011743|FG000|Observational Follow-up|Lost to Follow-up|0|||
150239179|NCT00379769|542011744|FG001|Observational Follow-up|Lost to Follow-up|0|||
150239180|NCT00379769|542011745|FG002|Observational Follow-up|Lost to Follow-up|0|||
150239181|NCT00379769|542011746|FG003|Observational Follow-up|Lost to Follow-up|0|||
150239182|NCT00379769|542011747|FG004|Observational Follow-up|Lost to Follow-up|25|||
150239183|NCT00379769|542011748|FG005|Observational Follow-up|Lost to Follow-up|27|||
150239184|NCT00379769|542011743|FG000|Observational Follow-up|Withdrawal by Subject|0|||
150239185|NCT00379769|542011744|FG001|Observational Follow-up|Withdrawal by Subject|0|||
150239186|NCT00379769|542011745|FG002|Observational Follow-up|Withdrawal by Subject|0|||
150239187|NCT00379769|542011746|FG003|Observational Follow-up|Withdrawal by Subject|0|||
150239188|NCT00379769|542011747|FG004|Observational Follow-up|Withdrawal by Subject|12|||
150239189|NCT00379769|542011748|FG005|Observational Follow-up|Withdrawal by Subject|12|||
150239190|NCT00379769|542011743|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
150239191|NCT00379769|542011744|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
150239192|NCT00379769|542011745|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
150239193|NCT00379769|542011746|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
150239194|NCT00379769|542011747|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
150239195|NCT00379769|542011748|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
150239196|NCT00379769|542011743|FG000|Observational Follow-up|Physician Decision|0|||
150239197|NCT00379769|542011744|FG001|Observational Follow-up|Physician Decision|0|||
150239198|NCT00379769|542011745|FG002|Observational Follow-up|Physician Decision|0|||
150239199|NCT00379769|542011746|FG003|Observational Follow-up|Physician Decision|0|||
150239200|NCT00379769|542011747|FG004|Observational Follow-up|Physician Decision|8|||
150239201|NCT00379769|542011748|FG005|Observational Follow-up|Physician Decision|8|||
150239202|NCT00379769|542011743|FG000|Observational Follow-up|Site Closed Early|0|||
150239203|NCT00379769|542011744|FG001|Observational Follow-up|Site Closed Early|0|||
150239204|NCT00379769|542011745|FG002|Observational Follow-up|Site Closed Early|0|||
150239205|NCT00379769|542011746|FG003|Observational Follow-up|Site Closed Early|0|||
150239206|NCT00379769|542011747|FG004|Observational Follow-up|Site Closed Early|6|||
150239207|NCT00379769|542011748|FG005|Observational Follow-up|Site Closed Early|7|||
150239208|NCT00379769|542011743|FG000|Observational Follow-up|Participant Moved|0|||
150239209|NCT00379769|542011744|FG001|Observational Follow-up|Participant Moved|0|||
150239210|NCT00379769|542011745|FG002|Observational Follow-up|Participant Moved|0|||
150239211|NCT00379769|542011746|FG003|Observational Follow-up|Participant Moved|0|||
150239212|NCT00379769|542011747|FG004|Observational Follow-up|Participant Moved|0|||
150239213|NCT00379769|542011748|FG005|Observational Follow-up|Participant Moved|1|||
150239214|NCT00379769|542011743|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
150239215|NCT00379769|542011744|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
150239216|NCT00379769|542011745|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
150239217|NCT00379769|542011746|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
150239218|NCT00379769|542011747|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
150239219|NCT00379769|542011748|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
150239220|NCT03778294|542011749|FG000|Overall Study|Death|1|||
150239221|NCT03778294|542011749|FG000|Overall Study|Issues with insurance|1|||
150239222|NCT03778294|542011749|FG000|Overall Study|disease progression before treatment|2|||
150239223|NCT02825251|542011750|FG000|Overall Study|Adverse Event|0|||
150239224|NCT02825251|542011751|FG001|Overall Study|Adverse Event|1|||
150239225|NCT02825251|542011750|FG000|Overall Study|Lost to Follow-up|0|||
150239226|NCT02825251|542011751|FG001|Overall Study|Lost to Follow-up|1|||
150239227|NCT02825251|542011750|FG000|Overall Study|Withdrawal by Subject|1|||
150239228|NCT02825251|542011751|FG001|Overall Study|Withdrawal by Subject|4|||
150239229|NCT02825251|542011750|FG000|Overall Study|Unclassified|2|||
150239230|NCT02825251|542011751|FG001|Overall Study|Unclassified|0|||
150239231|NCT01689363|542011755|FG000|Overall Study|Protocol Violation|0|||
150239232|NCT01689363|542011756|FG001|Overall Study|Protocol Violation|1|||
150239233|NCT01689363|542011757|FG002|Overall Study|Protocol Violation|0|||
150239234|NCT01689363|542011758|FG003|Overall Study|Protocol Violation|0|||
150239235|NCT01689363|542011759|FG004|Overall Study|Protocol Violation|0|||
150239236|NCT01689363|542011760|FG005|Overall Study|Protocol Violation|0|||
150239237|NCT01689363|542011761|FG006|Overall Study|Protocol Violation|0|||
150239238|NCT01689363|542011762|FG007|Overall Study|Protocol Violation|0|||
150239239|NCT02104505|542011763|FG000|First Intervention (14 Days)|Adverse Event|2|||
150239240|NCT02104505|542011764|FG001|First Intervention (14 Days)|Adverse Event|0|||
150239241|NCT02104505|542011763|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
150239242|NCT02104505|542011764|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
150239243|NCT02104505|542011763|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
150239244|NCT02104505|542011764|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
150239245|NCT02104505|542011763|FG000|First Intervention (14 Days)|exclusionary condition|0|||
150239246|NCT02104505|542011764|FG001|First Intervention (14 Days)|exclusionary condition|1|||
150239247|NCT02104505|542011763|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
150239248|NCT02104505|542011764|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
150239249|NCT02104505|542011763|FG000|Second Intervention (14 Days)|Adverse Event|2|||
150239250|NCT02104505|542011764|FG001|Second Intervention (14 Days)|Adverse Event|0|||
150239251|NCT01845805|542011765|FG000|Overall Study|Withdrawal by Subject|1|||
150239252|NCT01845805|542011766|FG001|Overall Study|Withdrawal by Subject|2|||
150239253|NCT01845805|542011765|FG000|Overall Study|Disease Progression|13|||
150239254|NCT01845805|542011766|FG001|Overall Study|Disease Progression|14|||
150239255|NCT01845805|542011765|FG000|Overall Study|Drug-related Toxicity|4|||
150239256|NCT01845805|542011766|FG001|Overall Study|Drug-related Toxicity|0|||
150239257|NCT02859064|542011767|FG000|Overall Study|Progressive Disease|3|||
150239258|NCT02859064|542011767|FG000|Overall Study|Physician Decision|1|||
150239259|NCT02859064|542011767|FG000|Overall Study|Withdrawal by Subject|1|||
150239260|NCT02859064|542011767|FG000|Overall Study|Death|1|||
150239261|NCT00127842|542011768|FG000|Overall Study|Adverse Event|15|||
150239262|NCT00127842|542011768|FG000|Overall Study|Withdrawal by Subject|3|||
150239263|NCT00127842|542011768|FG000|Overall Study|Lost to Follow-up|1|||
150239264|NCT00127842|542011768|FG000|Overall Study|Lack of Efficacy|12|||
150239265|NCT00127842|542011768|FG000|Overall Study|Noncompliance|2|||
150239266|NCT00127842|542011768|FG000|Overall Study|Protocol Violation|1|||
150239267|NCT00127842|542011768|FG000|Overall Study|Other|5|||
150239268|NCT00667459|542011769|FG000|Overall Study|Death|0|||
150239269|NCT00667459|542011770|FG001|Overall Study|Death|2|||
150239270|NCT00667459|542011769|FG000|Overall Study|Lost to Follow-up|8|||
150239271|NCT00667459|542011770|FG001|Overall Study|Lost to Follow-up|43|||
150239272|NCT02568397|542011771|FG000|Period 2|Withdrawal by Subject|0|||
150239273|NCT02568397|542011772|FG001|Period 2|Withdrawal by Subject|1|||
150239274|NCT02568397|542011771|FG000|Period 2|Physician Decision|0|||
150239275|NCT02568397|542011772|FG001|Period 2|Physician Decision|1|||
150239276|NCT02354651|542011773|FG000|Overall Study|Withdrawal by Subject|2|||
150239277|NCT02354651|542011773|FG000|Overall Study|Physician Decision|1|||
150239278|NCT00581893|542011774|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
150239279|NCT00581893|542011775|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
150239280|NCT00590564|542011776|FG000|Overall Study|Withdrawal by Subject|4|||
150239281|NCT00590564|542011776|FG000|Overall Study|Lost to Follow-up|6|||
150239282|NCT00590564|542011776|FG000|Overall Study|Protocol Violation|1|||
150239283|NCT00590564|542011776|FG000|Overall Study|Patient Found to be Ineligible|1|||
150239284|NCT00590564|542011776|FG000|Overall Study|Patient Non-compliance|6|||
150239285|NCT01377389|542011779|FG000|Overall Study|Withdrawal by Subject|1|||
150239286|NCT01377389|542011779|FG000|Overall Study|Screen failure|2|||
150239287|NCT01434680|542011780|FG000|Overall Study|Withdrawal by Subject|1|||
150239288|NCT01434680|542011781|FG001|Overall Study|Withdrawal by Subject|0|||
150239289|NCT01434680|542011782|FG002|Overall Study|Withdrawal by Subject|2|||
150239290|NCT01434680|542011783|FG003|Overall Study|Withdrawal by Subject|0|||
150239291|NCT01434680|542011780|FG000|Overall Study|Lost to Follow-up|1|||
150239292|NCT01434680|542011781|FG001|Overall Study|Lost to Follow-up|1|||
150239293|NCT01434680|542011782|FG002|Overall Study|Lost to Follow-up|0|||
150239294|NCT01434680|542011783|FG003|Overall Study|Lost to Follow-up|0|||
150239295|NCT01434680|542011780|FG000|Overall Study|Protocol Violation|1|||
150239296|NCT01434680|542011781|FG001|Overall Study|Protocol Violation|1|||
150239297|NCT01434680|542011782|FG002|Overall Study|Protocol Violation|0|||
150239298|NCT01434680|542011783|FG003|Overall Study|Protocol Violation|0|||
150239299|NCT00725712|542011785|FG000|Overall Study|Withdrawal by Subject|2|||
150239300|NCT00725712|542011786|FG001|Overall Study|Withdrawal by Subject|1|||
150239301|NCT00725712|542011785|FG000|Overall Study|Protocol Violation|1|||
150239302|NCT00725712|542011786|FG001|Overall Study|Protocol Violation|0|||
150239303|NCT00725712|542011785|FG000|Overall Study|Progressive disease|37|||
150239304|NCT00725712|542011786|FG001|Overall Study|Progressive disease|16|||
150239305|NCT00725712|542011785|FG000|Overall Study|Clinical progression not based on RECIST|0|||
150239306|NCT00725712|542011786|FG001|Overall Study|Clinical progression not based on RECIST|3|||
150239307|NCT00725712|542011785|FG000|Overall Study|Adverse Event|5|||
150239308|NCT00725712|542011786|FG001|Overall Study|Adverse Event|5|||
150239309|NCT00725712|542011785|FG000|Overall Study|Death|2|||
150239310|NCT00725712|542011786|FG001|Overall Study|Death|0|||
150239311|NCT00725712|542011785|FG000|Overall Study|Other: Death|1|||
150239312|NCT00725712|542011786|FG001|Overall Study|Other: Death|0|||
150239313|NCT00725712|542011785|FG000|Overall Study|Hospitalized, unable to continue|0|||
150239314|NCT00725712|542011786|FG001|Overall Study|Hospitalized, unable to continue|1|||
150239315|NCT02684123|542011790|FG000|Phase 1|Lack of Efficacy|5|||
150239316|NCT02684123|542011791|FG001|Phase 1|Lack of Efficacy|0|||
150239317|NCT02684123|542011790|FG000|Phase 1|Adverse Event|3|||
150239318|NCT02684123|542011791|FG001|Phase 1|Adverse Event|0|||
150239319|NCT02684123|542011790|FG000|Phase 1|Lost to Follow-up|0|||
150239320|NCT02684123|542011791|FG001|Phase 1|Lost to Follow-up|1|||
150239321|NCT02684123|542011790|FG000|Phase 2|Lack of Efficacy|1|||
150239322|NCT02684123|542011791|FG001|Phase 2|Lack of Efficacy|8|||
150239323|NCT02037477|542011795|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
150239324|NCT02037477|542011796|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
150239325|NCT02037477|542011797|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
150239326|NCT02037477|542011798|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
150239327|NCT01245140|542011799|FG000|Overall Study|Adverse Event|1|||
150239328|NCT01245140|542011800|FG001|Overall Study|Adverse Event|3|||
150239329|NCT01245140|542011799|FG000|Overall Study|Lack of Efficacy|2|||
150239330|NCT01245140|542011800|FG001|Overall Study|Lack of Efficacy|4|||
150239331|NCT01245140|542011799|FG000|Overall Study|Protocol Violation|0|||
150239332|NCT01245140|542011800|FG001|Overall Study|Protocol Violation|1|||
150239333|NCT01245140|542011799|FG000|Overall Study|Withdrawal by Subject|0|||
150239334|NCT01245140|542011800|FG001|Overall Study|Withdrawal by Subject|1|||
150239335|NCT01245140|542011799|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
150239336|NCT01245140|542011800|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
150239337|NCT02635360|542011801|FG000|Overall Study|Adverse Event|0|||
150239338|NCT02635360|542011802|FG001|Overall Study|Adverse Event|3|||
150239339|NCT02635360|542011801|FG000|Overall Study|Withdrawal by Subject|2|||
150239340|NCT02635360|542011802|FG001|Overall Study|Withdrawal by Subject|0|||
150239341|NCT02635360|542011801|FG000|Overall Study|Non-Compliance|3|||
150239342|NCT02635360|542011802|FG001|Overall Study|Non-Compliance|1|||
150239343|NCT02635360|542011801|FG000|Overall Study|Disease Progression|0|||
150239344|NCT02635360|542011802|FG001|Overall Study|Disease Progression|2|||
150239345|NCT02635360|542011801|FG000|Overall Study|Lost to Follow-up|1|||
150239346|NCT02635360|542011802|FG001|Overall Study|Lost to Follow-up|1|||
150239347|NCT00334542|542011803|FG000|Overall Study|Adverse Event|3|||
150239348|NCT00334542|542011803|FG000|Overall Study|Withdrawal by Subject|1|||
150239349|NCT00334542|542011803|FG000|Overall Study|New cancer diagnosis|1|||
150239350|NCT00872001|542011814|FG000|Overall Study|Adverse Event|34|||
150239351|NCT00872001|542011815|FG001|Overall Study|Adverse Event|23|||
150239352|NCT00872001|542011814|FG000|Overall Study|Protocol Defined Clinical Event|5|||
150239353|NCT00872001|542011815|FG001|Overall Study|Protocol Defined Clinical Event|7|||
150239354|NCT00872001|542011814|FG000|Overall Study|Lost to Follow-up|13|||
150239355|NCT00872001|542011815|FG001|Overall Study|Lost to Follow-up|12|||
150239356|NCT00872001|542011814|FG000|Overall Study|Withdrawal by Subject|18|||
150239357|NCT00872001|542011815|FG001|Overall Study|Withdrawal by Subject|30|||
150239358|NCT00872001|542011814|FG000|Overall Study|Protocol Violation|5|||
150239359|NCT00872001|542011815|FG001|Overall Study|Protocol Violation|8|||
150239360|NCT00872001|542011814|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
150239361|NCT00872001|542011815|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
150239362|NCT00872001|542011814|FG000|Overall Study|Administrative|23|||
150239363|NCT00872001|542011815|FG001|Overall Study|Administrative|15|||
150239364|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
150239365|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
150239366|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
150239367|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
150239368|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
150239369|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
150239370|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
150239371|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
150239372|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
150239373|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
150239374|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
150239375|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
150239376|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
150239377|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
150239378|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
150239379|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
150239380|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
150239381|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
150239382|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Missing|2|||
150239383|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Missing|1|||
150239384|NCT00443209|542011820|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
150239385|NCT00443209|542011821|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
150239386|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
150239387|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
150239388|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
150239389|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
150239390|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
150239391|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
150239392|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
150239393|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
150239394|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
150239395|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
150239396|NCT00443209|542011820|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
150239397|NCT00443209|542011821|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
150239398|NCT01728623|542011822|FG000|Overall Study|Disease progression|26|||
150239399|NCT01728623|542011822|FG000|Overall Study|Adverse Event|1|||
150239400|NCT01728623|542011822|FG000|Overall Study|Withdrawal by Subject|1|||
150239401|NCT01791413|542011823|FG000|Overall Study|Lost to Follow-up|5|||
150239402|NCT01791413|542011824|FG001|Overall Study|Lost to Follow-up|1|||
150239403|NCT04016272|542011835|FG000|Overall Study|Withdrawal by Subject|1|||
150239404|NCT04016272|542011836|FG001|Overall Study|Withdrawal by Subject|2|||
150239405|NCT00825305|542011837|FG000|Overall Study|Adverse Event|1|||
150239406|NCT00825305|542011838|FG001|Overall Study|Adverse Event|1|||
150239407|NCT00825305|542011837|FG000|Overall Study|Withdrawal by Subject|6|||
150239408|NCT00825305|542011838|FG001|Overall Study|Withdrawal by Subject|12|||
150239409|NCT00825305|542011837|FG000|Overall Study|Inappropriate inclusion|1|||
150239410|NCT00825305|542011838|FG001|Overall Study|Inappropriate inclusion|0|||
150239411|NCT00825305|542011837|FG000|Overall Study|Protocol Violation|9|||
150239412|NCT00825305|542011838|FG001|Overall Study|Protocol Violation|9|||
150239413|NCT00825305|542011837|FG000|Overall Study|Can not be classified|0|||
150239414|NCT00825305|542011838|FG001|Overall Study|Can not be classified|1|||
150239415|NCT01850030|542011845|FG000|Overall Study|Adverse Event|64|||
150239416|NCT01850030|542011846|FG001|Overall Study|Adverse Event|82|||
150239417|NCT01850030|542011845|FG000|Overall Study|Lack of Efficacy|3|||
150239418|NCT01850030|542011846|FG001|Overall Study|Lack of Efficacy|1|||
150239419|NCT01850030|542011845|FG000|Overall Study|Lost to Follow-up|5|||
150239420|NCT01850030|542011846|FG001|Overall Study|Lost to Follow-up|5|||
150239421|NCT01850030|542011845|FG000|Overall Study|Withdrawal by Subject|3|||
150239422|NCT01850030|542011846|FG001|Overall Study|Withdrawal by Subject|4|||
150239423|NCT01850030|542011845|FG000|Overall Study|Protocol Violation|24|||
150239424|NCT01850030|542011846|FG001|Overall Study|Protocol Violation|28|||
150239425|NCT01850030|542011845|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
150239426|NCT01850030|542011846|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
150239427|NCT00246090|542011847|FG000|Overall Study|Adverse Event|25|||
150239428|NCT00246090|542011847|FG000|Overall Study|Withdrawal by Subject|7|||
150239429|NCT00246090|542011847|FG000|Overall Study|Progressive Disease|212|||
150239430|NCT00246090|542011847|FG000|Overall Study|Clinical Progression|30|||
150239431|NCT00246090|542011847|FG000|Overall Study|Physician Decision|11|||
150239432|NCT00246090|542011847|FG000|Overall Study|Not Otherwise Specified|10|||
150239433|NCT00763451|542011850|FG000|Overall Study|Adverse Event|4|||
150239434|NCT00763451|542011851|FG001|Overall Study|Adverse Event|6|||
150239435|NCT00763451|542011852|FG002|Overall Study|Adverse Event|19|||
150239436|NCT00763451|542011853|FG003|Overall Study|Adverse Event|14|||
150239437|NCT00763451|542011850|FG000|Overall Study|Lack of Efficacy|1|||
150239438|NCT00763451|542011851|FG001|Overall Study|Lack of Efficacy|4|||
150239439|NCT00763451|542011852|FG002|Overall Study|Lack of Efficacy|3|||
150239440|NCT00763451|542011853|FG003|Overall Study|Lack of Efficacy|2|||
150239441|NCT00763451|542011850|FG000|Overall Study|Withdrawal by Subject|1|||
150239442|NCT00763451|542011851|FG001|Overall Study|Withdrawal by Subject|6|||
150239443|NCT00763451|542011852|FG002|Overall Study|Withdrawal by Subject|9|||
150239444|NCT00763451|542011853|FG003|Overall Study|Withdrawal by Subject|7|||
150239445|NCT00763451|542011850|FG000|Overall Study|Protocol Violation|0|||
150239446|NCT00763451|542011851|FG001|Overall Study|Protocol Violation|0|||
150239447|NCT00763451|542011852|FG002|Overall Study|Protocol Violation|1|||
150239448|NCT00763451|542011853|FG003|Overall Study|Protocol Violation|0|||
150239449|NCT00763451|542011850|FG000|Overall Study|Poor Compliance to Protocol|1|||
150239450|NCT00763451|542011851|FG001|Overall Study|Poor Compliance to Protocol|1|||
150239451|NCT00763451|542011852|FG002|Overall Study|Poor Compliance to Protocol|2|||
150239452|NCT00763451|542011853|FG003|Overall Study|Poor Compliance to Protocol|2|||
150239453|NCT00763451|542011850|FG000|Overall Study|Familial and Personal Reasons|5|||
150239454|NCT00763451|542011851|FG001|Overall Study|Familial and Personal Reasons|3|||
150239455|NCT00763451|542011852|FG002|Overall Study|Familial and Personal Reasons|5|||
150239456|NCT00763451|542011853|FG003|Overall Study|Familial and Personal Reasons|4|||
150239457|NCT00763451|542011850|FG000|Overall Study|Randomized but not Treated|1|||
150239458|NCT00763451|542011851|FG001|Overall Study|Randomized but not Treated|1|||
150239459|NCT00763451|542011852|FG002|Overall Study|Randomized but not Treated|0|||
150239460|NCT00763451|542011853|FG003|Overall Study|Randomized but not Treated|0|||
150239461|NCT00763451|542011850|FG000|Overall Study|Study Site Reason|0|||
150239462|NCT00763451|542011851|FG001|Overall Study|Study Site Reason|1|||
150239463|NCT00763451|542011852|FG002|Overall Study|Study Site Reason|1|||
150239464|NCT00763451|542011853|FG003|Overall Study|Study Site Reason|1|||
150239465|NCT05594589|542011858|FG000|Overall Study|Other|0|||
150239466|NCT05594589|542011859|FG001|Overall Study|Other|1|||
150239467|NCT05594589|542011860|FG002|Overall Study|Other|0|||
150239468|NCT00115336|542011861|FG000|Overall Study|Hospital discharge before study drug|0|||
150239469|NCT00115336|542011862|FG001|Overall Study|Hospital discharge before study drug|1|||
150239470|NCT02554383|542011863|FG000|Overall Study|Ineligible|3|||
150239471|NCT02554383|542011864|FG001|Overall Study|Ineligible|2|||
150239472|NCT02554383|542011863|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
150239473|NCT02554383|542011864|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
150239474|NCT02554383|542011863|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
150239475|NCT02554383|542011864|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
150239476|NCT02554383|542011863|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
150239477|NCT02554383|542011864|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
150239478|NCT00715117|542011875|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
150239479|NCT00715117|542011876|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
150239480|NCT03569891|542011879|FG000|Lead-in|Ineligible during lead-in|8|||
150239481|NCT03569891|542011879|FG000|Lead-in|Withdrawal by Subject|3|||
150239482|NCT03569891|542011879|FG000|Lead-in|Risks related to COVID-19|2|||
150239483|NCT03569891|542011879|FG000|AMT-061|Adverse Event|1|||
150239484|NCT01310699|542011884|FG000|Overall Study|Patients did not complete tandem.|4|||
150239485|NCT01310699|542011885|FG001|Overall Study|Patients did not complete tandem.|6|||
150239486|NCT00926575|542011886|FG000|Overall Study|Adverse Event|1|||
150239487|NCT00926575|542011887|FG001|Overall Study|Adverse Event|1|||
150239488|NCT00926575|542011886|FG000|Overall Study|Death|4|||
150239489|NCT00926575|542011887|FG001|Overall Study|Death|4|||
150239490|NCT00926575|542011886|FG000|Overall Study|Lost to Follow-up|1|||
150239491|NCT00926575|542011887|FG001|Overall Study|Lost to Follow-up|1|||
150239492|NCT00926575|542011886|FG000|Overall Study|Physician Decision|1|||
150239493|NCT00926575|542011887|FG001|Overall Study|Physician Decision|2|||
150239494|NCT00926575|542011886|FG000|Overall Study|Protocol Violation|1|||
150239495|NCT00926575|542011887|FG001|Overall Study|Protocol Violation|0|||
150239496|NCT00926575|542011886|FG000|Overall Study|Withdrawal by Subject|8|||
150239497|NCT00926575|542011887|FG001|Overall Study|Withdrawal by Subject|9|||
150239498|NCT02035696|542014053|FG000|Overall Study|Lost to Follow-up|0|||
150239499|NCT02035696|542014054|FG001|Overall Study|Lost to Follow-up|3|||
150239500|NCT02035696|542014055|FG002|Overall Study|Lost to Follow-up|1|||
150239501|NCT02035696|542014056|FG003|Overall Study|Lost to Follow-up|2|||
150239502|NCT02035696|542014053|FG000|Overall Study|Withdrawal by Subject|3|||
150239503|NCT02035696|542014054|FG001|Overall Study|Withdrawal by Subject|0|||
150239504|NCT02035696|542014055|FG002|Overall Study|Withdrawal by Subject|2|||
150239505|NCT02035696|542014056|FG003|Overall Study|Withdrawal by Subject|1|||
150239506|NCT01867047|542014058|FG000|Overall Study|Lost to Follow-up|3|||
150239507|NCT01867047|542014059|FG001|Overall Study|Lost to Follow-up|3|||
150239508|NCT01867047|542014058|FG000|Overall Study|Withdrawal by Subject|2|||
150239509|NCT01867047|542014059|FG001|Overall Study|Withdrawal by Subject|0|||
150239510|NCT01867047|542014058|FG000|Overall Study|Physician Decision|2|||
150239511|NCT01867047|542014059|FG001|Overall Study|Physician Decision|0|||
150239512|NCT01867047|542014058|FG000|Overall Study|surgery not indicated in protocol|1|||
150239513|NCT01867047|542014059|FG001|Overall Study|surgery not indicated in protocol|2|||
150239514|NCT01454739|542014060|FG000|Overall Study|Protocol Violation|2|||
150239515|NCT01454739|542014061|FG001|Overall Study|Protocol Violation|3|||
150239516|NCT01454739|542014060|FG000|Overall Study|Withdrawal by Subject|2|||
150239517|NCT01454739|542014061|FG001|Overall Study|Withdrawal by Subject|6|||
150239518|NCT01454739|542014060|FG000|Overall Study|Other|3|||
150239519|NCT01454739|542014061|FG001|Overall Study|Other|5|||
150239520|NCT01454739|542014060|FG000|Overall Study|Physician Decision|0|||
150239521|NCT01454739|542014061|FG001|Overall Study|Physician Decision|5|||
150239522|NCT01454739|542014060|FG000|Overall Study|Lost to Follow-up|0|||
150239523|NCT01454739|542014061|FG001|Overall Study|Lost to Follow-up|1|||
150239524|NCT01454739|542014060|FG000|Overall Study|Adverse Event|0|||
150239525|NCT01454739|542014061|FG001|Overall Study|Adverse Event|1|||
150239526|NCT02367352|542014062|FG000|Overall Study|Progressive disease|7|||
150239527|NCT02367352|542014063|FG001|Overall Study|Progressive disease|0|||
150239528|NCT02367352|542014064|FG002|Overall Study|Progressive disease|0|||
150239529|NCT02367352|542014062|FG000|Overall Study|Participant Received Alternative Therapy|1|||
150239530|NCT02367352|542014063|FG001|Overall Study|Participant Received Alternative Therapy|0|||
150239531|NCT02367352|542014064|FG002|Overall Study|Participant Received Alternative Therapy|0|||
150239532|NCT02367352|542014062|FG000|Overall Study|Adverse Event|1|||
150239533|NCT02367352|542014063|FG001|Overall Study|Adverse Event|0|||
150239534|NCT02367352|542014064|FG002|Overall Study|Adverse Event|0|||
150239535|NCT01437423|542014069|FG000|Overall Study|Lost to Follow-up|12|||
150239536|NCT01437423|542014069|FG000|Overall Study|Off label usage|3|||
150239537|NCT01375751|542014070|FG000|Overall Study|Other|0|||
150239538|NCT01375751|542014071|FG001|Overall Study|Other|1|||
150239539|NCT01375751|542014072|FG002|Overall Study|Other|0|||
150239540|NCT02980523|542014073|FG000|Overall Study|Lost to Follow-up|1|||
150239541|NCT02980523|542014074|FG001|Overall Study|Lost to Follow-up|4|||
150239542|NCT02980523|542014075|FG002|Overall Study|Lost to Follow-up|1|||
150239543|NCT02980523|542014076|FG003|Overall Study|Lost to Follow-up|2|||
150239544|NCT02980523|542014077|FG004|Overall Study|Lost to Follow-up|1|||
150239545|NCT02980523|542014073|FG000|Overall Study|Excluded from analysis|1|||
150239546|NCT02980523|542014074|FG001|Overall Study|Excluded from analysis|3|||
150239547|NCT02980523|542014075|FG002|Overall Study|Excluded from analysis|1|||
150239548|NCT02980523|542014076|FG003|Overall Study|Excluded from analysis|1|||
150239549|NCT02980523|542014077|FG004|Overall Study|Excluded from analysis|1|||
150239550|NCT02980523|542014073|FG000|Overall Study|Lack of Efficacy|1|||
150239551|NCT02980523|542014074|FG001|Overall Study|Lack of Efficacy|4|||
150239552|NCT02980523|542014075|FG002|Overall Study|Lack of Efficacy|4|||
150239553|NCT02980523|542014076|FG003|Overall Study|Lack of Efficacy|5|||
150239554|NCT02980523|542014077|FG004|Overall Study|Lack of Efficacy|8|||
150239555|NCT02980523|542014073|FG000|Overall Study|Did not receive intervention|0|||
150239556|NCT02980523|542014074|FG001|Overall Study|Did not receive intervention|0|||
150239557|NCT02980523|542014075|FG002|Overall Study|Did not receive intervention|0|||
150239558|NCT02980523|542014076|FG003|Overall Study|Did not receive intervention|1|||
150239559|NCT02980523|542014077|FG004|Overall Study|Did not receive intervention|0|||
150239560|NCT00633945|542014078|FG000|Overall Study|Physician Decision|2|||
150239561|NCT02552147|542014079|FG000|First Intervention (7 Days)|Protocol Violation|1|||
150239562|NCT02552147|542014080|FG001|First Intervention (7 Days)|Protocol Violation|0|||
150239563|NCT02552147|542014079|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
150239564|NCT02552147|542014080|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
150239565|NCT02229227|542014084|FG000|Overall Study|Adverse Event|14|||
150239566|NCT02229227|542014085|FG001|Overall Study|Adverse Event|9|||
150239567|NCT02229227|542014084|FG000|Overall Study|Lack of Efficacy|3|||
150239568|NCT02229227|542014085|FG001|Overall Study|Lack of Efficacy|3|||
150239569|NCT02229227|542014084|FG000|Overall Study|Protocol Violation|6|||
150239570|NCT02229227|542014085|FG001|Overall Study|Protocol Violation|8|||
150239571|NCT02229227|542014084|FG000|Overall Study|Protocol defined stopping criteria|1|||
150239572|NCT02229227|542014085|FG001|Overall Study|Protocol defined stopping criteria|3|||
150239573|NCT02229227|542014084|FG000|Overall Study|Lost to Follow-up|3|||
150239574|NCT02229227|542014085|FG001|Overall Study|Lost to Follow-up|3|||
150239575|NCT02229227|542014084|FG000|Overall Study|Study terminated by sponsor|11|||
150239576|NCT02229227|542014085|FG001|Overall Study|Study terminated by sponsor|11|||
150239577|NCT02229227|542014084|FG000|Overall Study|Withdrawal by Subject|8|||
150239578|NCT02229227|542014085|FG001|Overall Study|Withdrawal by Subject|12|||
150239579|NCT02229227|542014084|FG000|Overall Study|Other|0|||
150239580|NCT02229227|542014085|FG001|Overall Study|Other|1|||
150239581|NCT02229227|542014084|FG000|Overall Study|Physician Decision|5|||
150239582|NCT02229227|542014085|FG001|Overall Study|Physician Decision|12|||
150239583|NCT01607879|542014092|FG000|Overall Study|Death|1|||
150239584|NCT01607879|542014093|FG001|Overall Study|Death|0|||
150239585|NCT04468230|542014094|FG000|Overall Study|Adverse Event|2|||
150239586|NCT03845140|542014096|FG000|Overall Study|Participant travelled outside study area|0|||
150239587|NCT03845140|542014097|FG001|Overall Study|Participant travelled outside study area|1|||
150239588|NCT03845140|542014098|FG002|Overall Study|Participant travelled outside study area|0|||
150239589|NCT03845140|542014099|FG003|Overall Study|Participant travelled outside study area|0|||
150239590|NCT03845140|542014100|FG004|Overall Study|Participant travelled outside study area|0|||
150239591|NCT03845140|542014101|FG005|Overall Study|Participant travelled outside study area|0|||
150239592|NCT01592045|542014104|FG000|Overall Study|Disease Progression|1|||
150239593|NCT01592045|542014105|FG001|Overall Study|Disease Progression|1|||
150239594|NCT01592045|542014104|FG000|Overall Study|Adverse Event|1|||
150239595|NCT01592045|542014105|FG001|Overall Study|Adverse Event|1|||
150239596|NCT01592045|542014104|FG000|Overall Study|Withdrawal by Subject|1|||
150239597|NCT01592045|542014105|FG001|Overall Study|Withdrawal by Subject|0|||
150239598|NCT01592045|542014104|FG000|Overall Study|Moved out of country|2|||
150239599|NCT01592045|542014105|FG001|Overall Study|Moved out of country|0|||
150239600|NCT00983853|542014112|FG000|Overall Study|Lost to Follow-up|1|||
150239601|NCT00983853|542014113|FG001|Overall Study|Lost to Follow-up|1|||
150239602|NCT00983853|542014114|FG002|Overall Study|Lost to Follow-up|2|||
150239603|NCT00983853|542014115|FG003|Overall Study|Lost to Follow-up|2|||
150239604|NCT00983853|542014116|FG004|Overall Study|Lost to Follow-up|2|||
150239605|NCT00983853|542014117|FG005|Overall Study|Lost to Follow-up|1|||
150239606|NCT00983853|542014112|FG000|Overall Study|Withdrawal by Subject|0|||
150239607|NCT00983853|542014113|FG001|Overall Study|Withdrawal by Subject|0|||
150239608|NCT00983853|542014114|FG002|Overall Study|Withdrawal by Subject|1|||
150239609|NCT00983853|542014115|FG003|Overall Study|Withdrawal by Subject|0|||
150239610|NCT00983853|542014116|FG004|Overall Study|Withdrawal by Subject|1|||
150239611|NCT00983853|542014117|FG005|Overall Study|Withdrawal by Subject|0|||
150239612|NCT00983853|542014112|FG000|Overall Study|Unable to come to study follow-up visits|0|||
150239613|NCT00983853|542014113|FG001|Overall Study|Unable to come to study follow-up visits|1|||
150239614|NCT00983853|542014114|FG002|Overall Study|Unable to come to study follow-up visits|0|||
150239615|NCT00983853|542014115|FG003|Overall Study|Unable to come to study follow-up visits|0|||
150239616|NCT00983853|542014116|FG004|Overall Study|Unable to come to study follow-up visits|0|||
150239617|NCT00983853|542014117|FG005|Overall Study|Unable to come to study follow-up visits|0|||
150239618|NCT02599688|542014125|FG000|Overall Study|Lack of Efficacy|1|||
150239619|NCT02599688|542014125|FG000|Overall Study|Withdrawal by Subject|1|||
150239620|NCT02599688|542014125|FG000|Overall Study|Termination by Sponsor|2|||
150239621|NCT03016598|542014126|FG000|Overall Study|Lost to Follow-up|0|||
150239622|NCT03016598|542014127|FG001|Overall Study|Lost to Follow-up|2|||
150239623|NCT02049515|542014130|FG000|Overall Study|Adverse Event|46|||
150239624|NCT02049515|542014131|FG001|Overall Study|Adverse Event|2|||
150239625|NCT02049515|542014130|FG000|Overall Study|Protocol-specified Disease Progression|23|||
150239626|NCT02049515|542014131|FG001|Overall Study|Protocol-specified Disease Progression|2|||
150239627|NCT02049515|542014130|FG000|Overall Study|Death|6|||
150239628|NCT02049515|542014131|FG001|Overall Study|Death|0|||
150239629|NCT02049515|542014130|FG000|Overall Study|Physician Decision|5|||
150239630|NCT02049515|542014131|FG001|Overall Study|Physician Decision|1|||
150239631|NCT02049515|542014130|FG000|Overall Study|Withdrawal by Subject|3|||
150239632|NCT02049515|542014131|FG001|Overall Study|Withdrawal by Subject|0|||
150239633|NCT02049515|542014130|FG000|Overall Study|Termination of the Study by Sponsor|2|||
150239634|NCT02049515|542014131|FG001|Overall Study|Termination of the Study by Sponsor|0|||
150239635|NCT02049515|542014130|FG000|Overall Study|Protocol Violation|1|||
150239636|NCT02049515|542014131|FG001|Overall Study|Protocol Violation|1|||
150239637|NCT02049515|542014130|FG000|Overall Study|Clinical Deterioration|1|||
150239638|NCT02049515|542014131|FG001|Overall Study|Clinical Deterioration|0|||
150239639|NCT02049515|542014130|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
150239640|NCT02049515|542014131|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
150239641|NCT02049515|542014130|FG000|Overall Study|Treatment Interruption >42 Days|1|||
150239642|NCT02049515|542014131|FG001|Overall Study|Treatment Interruption >42 Days|0|||
150239643|NCT02049515|542014130|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
150239644|NCT02049515|542014131|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
150239645|NCT02872012|542014135|FG000|Overall Study|Withdrawal by Subject|1|||
150239646|NCT02872012|542014136|FG001|Overall Study|Withdrawal by Subject|0|||
150239647|NCT02872012|542014137|FG002|Overall Study|Withdrawal by Subject|0|||
150239648|NCT02872012|542014138|FG003|Overall Study|Withdrawal by Subject|0|||
150239649|NCT02872012|542014139|FG004|Overall Study|Withdrawal by Subject|0|||
150239650|NCT03000348|542014140|FG000|Overall Study|Adverse Event|1|||
150239651|NCT03000348|542014141|FG001|Overall Study|Adverse Event|1|||
150239652|NCT03000348|542014142|FG002|Overall Study|Adverse Event|1|||
150239653|NCT03000348|542014143|FG003|Overall Study|Adverse Event|1|||
150239654|NCT03000348|542014144|FG004|Overall Study|Adverse Event|1|||
150239655|NCT03000348|542014145|FG005|Overall Study|Adverse Event|1|||
150239656|NCT03000348|542014140|FG000|Overall Study|Lost to Follow-up|0|||
150239657|NCT03000348|542014141|FG001|Overall Study|Lost to Follow-up|0|||
150239658|NCT03000348|542014142|FG002|Overall Study|Lost to Follow-up|1|||
150239659|NCT03000348|542014143|FG003|Overall Study|Lost to Follow-up|0|||
150239660|NCT03000348|542014144|FG004|Overall Study|Lost to Follow-up|0|||
150239661|NCT03000348|542014145|FG005|Overall Study|Lost to Follow-up|0|||
150239662|NCT03000348|542014140|FG000|Overall Study|Withdrawal by Subject|0|||
150239663|NCT03000348|542014141|FG001|Overall Study|Withdrawal by Subject|1|||
150239664|NCT03000348|542014142|FG002|Overall Study|Withdrawal by Subject|0|||
150239665|NCT03000348|542014143|FG003|Overall Study|Withdrawal by Subject|0|||
150239666|NCT03000348|542014144|FG004|Overall Study|Withdrawal by Subject|0|||
150239667|NCT03000348|542014145|FG005|Overall Study|Withdrawal by Subject|0|||
150239668|NCT03000348|542014140|FG000|Overall Study|Consent|0|||
150239669|NCT03000348|542014141|FG001|Overall Study|Consent|0|||
150239670|NCT03000348|542014142|FG002|Overall Study|Consent|0|||
150239671|NCT03000348|542014143|FG003|Overall Study|Consent|0|||
150239672|NCT03000348|542014144|FG004|Overall Study|Consent|1|||
150239673|NCT03000348|542014145|FG005|Overall Study|Consent|0|||
150239674|NCT03000348|542014140|FG000|Overall Study|Failure to expectorate sputum|1|||
150239675|NCT03000348|542014141|FG001|Overall Study|Failure to expectorate sputum|0|||
150239676|NCT03000348|542014142|FG002|Overall Study|Failure to expectorate sputum|1|||
150239677|NCT03000348|542014143|FG003|Overall Study|Failure to expectorate sputum|0|||
150239678|NCT03000348|542014144|FG004|Overall Study|Failure to expectorate sputum|1|||
150239679|NCT03000348|542014145|FG005|Overall Study|Failure to expectorate sputum|0|||
150239680|NCT03000348|542014140|FG000|Overall Study|No gram negative|1|||
150239681|NCT03000348|542014141|FG001|Overall Study|No gram negative|2|||
150239682|NCT03000348|542014142|FG002|Overall Study|No gram negative|1|||
150239683|NCT03000348|542014143|FG003|Overall Study|No gram negative|1|||
150239684|NCT03000348|542014144|FG004|Overall Study|No gram negative|1|||
150239685|NCT03000348|542014145|FG005|Overall Study|No gram negative|1|||
150239686|NCT03000348|542014140|FG000|Overall Study|Patient had no transport|0|||
150239687|NCT03000348|542014141|FG001|Overall Study|Patient had no transport|0|||
150239688|NCT03000348|542014142|FG002|Overall Study|Patient had no transport|0|||
150239689|NCT03000348|542014143|FG003|Overall Study|Patient had no transport|1|||
150239690|NCT03000348|542014144|FG004|Overall Study|Patient had no transport|0|||
150239691|NCT03000348|542014145|FG005|Overall Study|Patient had no transport|0|||
150239692|NCT03000348|542014140|FG000|Overall Study|Dosing|0|||
150239693|NCT03000348|542014141|FG001|Overall Study|Dosing|0|||
150239694|NCT03000348|542014142|FG002|Overall Study|Dosing|0|||
150239695|NCT03000348|542014143|FG003|Overall Study|Dosing|0|||
150239696|NCT03000348|542014144|FG004|Overall Study|Dosing|1|||
150239697|NCT03000348|542014145|FG005|Overall Study|Dosing|0|||
150239698|NCT01667549|542014146|FG000|Overall Study|Withdrawal by Subject|3|||
150239699|NCT01667549|542014147|FG001|Overall Study|Withdrawal by Subject|5|||
150239700|NCT01667549|542014148|FG002|Overall Study|Withdrawal by Subject|7|||
150239701|NCT01667549|542014149|FG003|Overall Study|Withdrawal by Subject|6|||
150239702|NCT01667549|542014150|FG004|Overall Study|Withdrawal by Subject|1|||
150239703|NCT01407276|542014151|FG000|Overall Study|Withdrawal by Subject|0|||
150239704|NCT01407276|542014152|FG001|Overall Study|Withdrawal by Subject|0|||
150239705|NCT01407276|542014153|FG002|Overall Study|Withdrawal by Subject|0|||
150239706|NCT01407276|542014154|FG003|Overall Study|Withdrawal by Subject|0|||
150239707|NCT01407276|542014155|FG004|Overall Study|Withdrawal by Subject|0|||
150239708|NCT01407276|542014156|FG005|Overall Study|Withdrawal by Subject|0|||
150239709|NCT01407276|542014157|FG006|Overall Study|Withdrawal by Subject|0|||
150239710|NCT01407276|542014158|FG007|Overall Study|Withdrawal by Subject|1|||
150239711|NCT01807182|542014159|FG000|Overall Study|Death|1|||
150239712|NCT01807182|542014159|FG000|Overall Study|New therapy|1|||
150239713|NCT01807182|542014159|FG000|Overall Study|Moved to hospice care|1|||
150239714|NCT00478205|542014161|FG000|Overall Study|Adverse Event|182|||
150239715|NCT00478205|542014162|FG001|Overall Study|Adverse Event|39|||
150239716|NCT00478205|542014161|FG000|Overall Study|Medication Non-compliance|9|||
150239717|NCT00478205|542014162|FG001|Overall Study|Medication Non-compliance|4|||
150239718|NCT00478205|542014161|FG000|Overall Study|Protocol Violation|15|||
150239719|NCT00478205|542014162|FG001|Overall Study|Protocol Violation|5|||
150239720|NCT00478205|542014161|FG000|Overall Study|Request of Investigator or Sponsor|4|||
150239721|NCT00478205|542014162|FG001|Overall Study|Request of Investigator or Sponsor|5|||
150239722|NCT00478205|542014161|FG000|Overall Study|Withdrawal by Subject|61|||
150239723|NCT00478205|542014162|FG001|Overall Study|Withdrawal by Subject|22|||
150239724|NCT00478205|542014161|FG000|Overall Study|Lack of Efficacy|1|||
150239725|NCT00478205|542014162|FG001|Overall Study|Lack of Efficacy|0|||
150239726|NCT00478205|542014161|FG000|Overall Study|Other|24|||
150239727|NCT00478205|542014162|FG001|Overall Study|Other|12|||
150239728|NCT04092452|542014164|FG000|Overall Study|Adverse Event|1|||
150239729|NCT04092452|542014165|FG001|Overall Study|Adverse Event|3|||
150239730|NCT04092452|542014166|FG002|Overall Study|Adverse Event|3|||
150239731|NCT04092452|542014167|FG003|Overall Study|Adverse Event|7|||
150239732|NCT04092452|542014164|FG000|Overall Study|Lack of Efficacy|1|||
150239733|NCT04092452|542014165|FG001|Overall Study|Lack of Efficacy|1|||
150239734|NCT04092452|542014166|FG002|Overall Study|Lack of Efficacy|1|||
150239735|NCT04092452|542014167|FG003|Overall Study|Lack of Efficacy|0|||
150239736|NCT04092452|542014164|FG000|Overall Study|Lost to Follow-up|4|||
150239737|NCT04092452|542014165|FG001|Overall Study|Lost to Follow-up|3|||
150239738|NCT04092452|542014166|FG002|Overall Study|Lost to Follow-up|5|||
150239739|NCT04092452|542014167|FG003|Overall Study|Lost to Follow-up|1|||
150239740|NCT04092452|542014164|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150239741|NCT04092452|542014165|FG001|Overall Study|Non-Compliance With Study Drug|0|||
150239742|NCT04092452|542014166|FG002|Overall Study|Non-Compliance With Study Drug|1|||
150239743|NCT04092452|542014167|FG003|Overall Study|Non-Compliance With Study Drug|1|||
150239744|NCT04092452|542014164|FG000|Overall Study|Physician Decision|1|||
150239745|NCT04092452|542014165|FG001|Overall Study|Physician Decision|0|||
150239746|NCT04092452|542014166|FG002|Overall Study|Physician Decision|1|||
150239747|NCT04092452|542014167|FG003|Overall Study|Physician Decision|0|||
150239748|NCT04092452|542014164|FG000|Overall Study|Pregnancy|2|||
150239749|NCT04092452|542014165|FG001|Overall Study|Pregnancy|0|||
150239750|NCT04092452|542014166|FG002|Overall Study|Pregnancy|0|||
150239751|NCT04092452|542014167|FG003|Overall Study|Pregnancy|0|||
150239752|NCT04092452|542014164|FG000|Overall Study|Protocol Deviation|1|||
150239753|NCT04092452|542014165|FG001|Overall Study|Protocol Deviation|0|||
150239754|NCT04092452|542014166|FG002|Overall Study|Protocol Deviation|0|||
150239755|NCT04092452|542014167|FG003|Overall Study|Protocol Deviation|0|||
150239756|NCT04092452|542014164|FG000|Overall Study|Withdrawal by Subject|3|||
150239757|NCT04092452|542014165|FG001|Overall Study|Withdrawal by Subject|10|||
150239758|NCT04092452|542014166|FG002|Overall Study|Withdrawal by Subject|3|||
150239759|NCT04092452|542014167|FG003|Overall Study|Withdrawal by Subject|5|||
150239760|NCT04092452|542014164|FG000|Overall Study|Other|0|||
150239761|NCT04092452|542014165|FG001|Overall Study|Other|0|||
150239762|NCT04092452|542014166|FG002|Overall Study|Other|1|||
150239763|NCT04092452|542014167|FG003|Overall Study|Other|2|||
150239764|NCT01012947|542014175|FG000|Overall Study|Lost to Follow-up|131|||
150239765|NCT01012947|542014176|FG001|Overall Study|Lost to Follow-up|135|||
150239766|NCT01012947|542014177|FG002|Overall Study|Lost to Follow-up|130|||
150239767|NCT01012947|542014178|FG003|Overall Study|Lost to Follow-up|118|||
150239768|NCT01012947|542014179|FG004|Overall Study|Lost to Follow-up|142|||
150239769|NCT02127125|542014180|FG000|Overall Study|Lost to Follow-up|0|||
150239770|NCT02127125|542014181|FG001|Overall Study|Lost to Follow-up|0|||
150239771|NCT02127125|542014182|FG002|Overall Study|Lost to Follow-up|0|||
150239772|NCT02127125|542014183|FG003|Overall Study|Lost to Follow-up|0|||
150239773|NCT02127125|542014184|FG004|Overall Study|Lost to Follow-up|2|||
150239774|NCT02127125|542014185|FG005|Overall Study|Lost to Follow-up|1|||
150239775|NCT02127125|542014186|FG006|Overall Study|Lost to Follow-up|0|||
150239776|NCT02127125|542014187|FG007|Overall Study|Lost to Follow-up|0|||
150239777|NCT02127125|542014188|FG008|Overall Study|Lost to Follow-up|0|||
150239778|NCT02127125|542014180|FG000|Overall Study|Withdrawal by Subject|0|||
150239779|NCT02127125|542014181|FG001|Overall Study|Withdrawal by Subject|0|||
150239780|NCT02127125|542014182|FG002|Overall Study|Withdrawal by Subject|0|||
150239781|NCT02127125|542014183|FG003|Overall Study|Withdrawal by Subject|1|||
150239782|NCT02127125|542014184|FG004|Overall Study|Withdrawal by Subject|0|||
150239783|NCT02127125|542014185|FG005|Overall Study|Withdrawal by Subject|0|||
150239784|NCT02127125|542014186|FG006|Overall Study|Withdrawal by Subject|0|||
150239785|NCT02127125|542014187|FG007|Overall Study|Withdrawal by Subject|0|||
150239786|NCT02127125|542014188|FG008|Overall Study|Withdrawal by Subject|0|||
150239787|NCT02127125|542014180|FG000|Overall Study|Physician Decision|0|||
150239788|NCT02127125|542014181|FG001|Overall Study|Physician Decision|0|||
150239789|NCT02127125|542014182|FG002|Overall Study|Physician Decision|1|||
150239790|NCT02127125|542014183|FG003|Overall Study|Physician Decision|0|||
150239791|NCT02127125|542014184|FG004|Overall Study|Physician Decision|1|||
150239792|NCT02127125|542014185|FG005|Overall Study|Physician Decision|2|||
150239793|NCT02127125|542014186|FG006|Overall Study|Physician Decision|0|||
150239794|NCT02127125|542014187|FG007|Overall Study|Physician Decision|0|||
150239795|NCT02127125|542014188|FG008|Overall Study|Physician Decision|0|||
150239796|NCT03332784|542014189|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239797|NCT03332784|542014190|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
150239798|NCT03332784|542014191|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239799|NCT03332784|542014192|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239800|NCT03332784|542014193|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239801|NCT03332784|542014194|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239802|NCT03332784|542014195|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239803|NCT03332784|542014196|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239804|NCT03332784|542014197|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239805|NCT03332784|542014198|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239806|NCT03332784|542014199|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239807|NCT03332784|542014200|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239808|NCT03332784|542014201|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239809|NCT03332784|542014202|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239810|NCT03332784|542014203|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
150239811|NCT03332784|542014204|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239812|NCT03332784|542014205|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239813|NCT03332784|542014206|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239814|NCT03332784|542014207|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239815|NCT03332784|542014208|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
150239816|NCT01018732|542014215|FG000|Overall Study|Lost to Follow-up|0|||
150239817|NCT01018732|542014216|FG001|Overall Study|Lost to Follow-up|0|||
150239818|NCT01018732|542014217|FG002|Overall Study|Lost to Follow-up|3|||
150239819|NCT01018732|542014215|FG000|Overall Study|Protocol Violation|1|||
150239820|NCT01018732|542014216|FG001|Overall Study|Protocol Violation|1|||
150239821|NCT01018732|542014217|FG002|Overall Study|Protocol Violation|0|||
150239822|NCT01018732|542014215|FG000|Overall Study|Inappropriate Enrollment|0|||
150239823|NCT01018732|542014216|FG001|Overall Study|Inappropriate Enrollment|1|||
150239824|NCT01018732|542014217|FG002|Overall Study|Inappropriate Enrollment|0|||
150239825|NCT01018732|542014215|FG000|Overall Study|Unable to Classify|0|||
150239826|NCT01018732|542014216|FG001|Overall Study|Unable to Classify|0|||
150239827|NCT01018732|542014217|FG002|Overall Study|Unable to Classify|1|||
150239828|NCT01536171|542014218|FG000|Overall Study|Withdrawal by Subject|1|||
150239829|NCT02165826|542014219|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
150239830|NCT02165826|542014220|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
150239831|NCT02165826|542014221|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
150239832|NCT02165826|542014219|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
150239833|NCT02165826|542014220|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
150239834|NCT02165826|542014221|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
150239835|NCT02165826|542014219|FG000|Main Treatment Period|Lost to Follow-up|4|||
150239836|NCT02165826|542014220|FG001|Main Treatment Period|Lost to Follow-up|2|||
150239837|NCT02165826|542014221|FG002|Main Treatment Period|Lost to Follow-up|1|||
150239838|NCT02165826|542014219|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
150239839|NCT02165826|542014220|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
150239840|NCT02165826|542014221|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
150239841|NCT02165826|542014219|FG000|Main Treatment Period|Lack of Efficacy|2|||
150239842|NCT02165826|542014220|FG001|Main Treatment Period|Lack of Efficacy|0|||
150239843|NCT02165826|542014221|FG002|Main Treatment Period|Lack of Efficacy|0|||
150239844|NCT02165826|542014219|FG000|Main Treatment Period|Reason Not Specified|8|||
150239845|NCT02165826|542014220|FG001|Main Treatment Period|Reason Not Specified|5|||
150239846|NCT02165826|542014221|FG002|Main Treatment Period|Reason Not Specified|16|||
150239847|NCT02165826|542014219|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
150239848|NCT02165826|542014220|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
150239849|NCT02165826|542014221|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
150239850|NCT02165826|542014219|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
150239851|NCT02165826|542014220|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
150239852|NCT02165826|542014221|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
150239853|NCT02165826|542014219|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
150239854|NCT02165826|542014220|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
150239855|NCT02165826|542014221|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
150239856|NCT02165826|542014219|FG000|Down-Titration Period|Reason Not Specified|1|||
150239857|NCT02165826|542014220|FG001|Down-Titration Period|Reason Not Specified|0|||
150239858|NCT02165826|542014221|FG002|Down-Titration Period|Reason Not Specified|2|||
150239859|NCT01191008|542014223|FG000|Overall Study|Protocol Violation|7|||
150239860|NCT01191008|542014223|FG000|Overall Study|Lost to Follow-up|8|||
150239861|NCT00978562|542014224|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
150239862|NCT02394665|542014227|FG000|Overall Study|Physician Decision|1|||
150239863|NCT02394665|542014228|FG001|Overall Study|Physician Decision|0|||
150239864|NCT02394665|542014229|FG002|Overall Study|Physician Decision|0|||
150239865|NCT00490698|542014235|FG000|Overall Study|Withdrawal by Subject|1|||
150239866|NCT00490698|542014235|FG000|Overall Study|Disease Progression|7|||
150239867|NCT00490698|542014235|FG000|Overall Study|Physician Decision|2|||
150239868|NCT02201901|542014236|FG000|Overall Study|Randomized but never treated|0|||
150239869|NCT02201901|542014237|FG001|Overall Study|Randomized but never treated|1|||
150239870|NCT02201901|542014238|FG002|Overall Study|Randomized but never treated|0|||
150239871|NCT02201901|542014236|FG000|Overall Study|Lack of Efficacy|7|||
150239872|NCT02201901|542014237|FG001|Overall Study|Lack of Efficacy|1|||
150239873|NCT02201901|542014238|FG002|Overall Study|Lack of Efficacy|6|||
150239874|NCT02201901|542014236|FG000|Overall Study|Death|3|||
150239875|NCT02201901|542014237|FG001|Overall Study|Death|3|||
150239876|NCT02201901|542014238|FG002|Overall Study|Death|3|||
150239877|NCT02201901|542014236|FG000|Overall Study|Lost to Follow-up|2|||
150239878|NCT02201901|542014237|FG001|Overall Study|Lost to Follow-up|3|||
150239879|NCT02201901|542014238|FG002|Overall Study|Lost to Follow-up|2|||
150239880|NCT02201901|542014236|FG000|Overall Study|Withdrew Consent|2|||
150239881|NCT02201901|542014237|FG001|Overall Study|Withdrew Consent|0|||
150239882|NCT02201901|542014238|FG002|Overall Study|Withdrew Consent|2|||
150239883|NCT02201901|542014236|FG000|Overall Study|Adverse Event|1|||
150239884|NCT02201901|542014237|FG001|Overall Study|Adverse Event|1|||
150239885|NCT02201901|542014238|FG002|Overall Study|Adverse Event|0|||
150239886|NCT00738283|542014242|FG000|Overall Study|Death|1|||
150239887|NCT00738283|542014242|FG000|Overall Study|Transfer to another facility|2|||
150239888|NCT00738283|542014242|FG000|Overall Study|Discharge home prior to end of study|1|||
150239889|NCT03595878|542014243|FG000|Overall Study|Death|2|||
150239890|NCT03595878|542014244|FG001|Overall Study|Death|1|||
150239891|NCT03595878|542014245|FG002|Overall Study|Death|0|||
150239892|NCT03595878|542014243|FG000|Overall Study|Disease progression|2|||
150239893|NCT03595878|542014244|FG001|Overall Study|Disease progression|1|||
150239894|NCT03595878|542014245|FG002|Overall Study|Disease progression|2|||
150239895|NCT00469859|542014246|FG000|Overall Study|Inevaluable|0|||
150239896|NCT00469859|542014247|FG001|Overall Study|Inevaluable|2|||
150239897|NCT03494985|542014248|FG000|Overall Study|Adverse Event|3|||
150239898|NCT03494985|542014249|FG001|Overall Study|Adverse Event|2|||
150239899|NCT03494985|542014250|FG002|Overall Study|Adverse Event|3|||
150239900|NCT03494985|542014251|FG003|Overall Study|Adverse Event|0|||
150239901|NCT03494985|542014248|FG000|Overall Study|Other (Withdrawal of consent)|2|||
150239902|NCT03494985|542014249|FG001|Overall Study|Other (Withdrawal of consent)|3|||
150239903|NCT03494985|542014250|FG002|Overall Study|Other (Withdrawal of consent)|2|||
150239904|NCT03494985|542014251|FG003|Overall Study|Other (Withdrawal of consent)|5|||
150239905|NCT03494985|542014248|FG000|Overall Study|Other (Not specified)|0|||
150239906|NCT03494985|542014249|FG001|Overall Study|Other (Not specified)|1|||
150239907|NCT03494985|542014250|FG002|Overall Study|Other (Not specified)|1|||
150239908|NCT03494985|542014251|FG003|Overall Study|Other (Not specified)|0|||
150239909|NCT04124471|542014252|FG000|Overall Study|screen failure|1|||
150239910|NCT02282059|542014253|FG000|Overall Study|Other|15|||
150239911|NCT02282059|542014254|FG001|Overall Study|Other|3|||
150239912|NCT02282059|542014253|FG000|Overall Study|Participant refused further follow-up|8|||
150239913|NCT02282059|542014254|FG001|Overall Study|Participant refused further follow-up|4|||
150239914|NCT02282059|542014253|FG000|Overall Study|Lost to Follow-up|19|||
150239915|NCT02282059|542014254|FG001|Overall Study|Lost to Follow-up|3|||
150239916|NCT02282059|542014253|FG000|Overall Study|Death|40|||
150239917|NCT02282059|542014254|FG001|Overall Study|Death|8|||
150239918|NCT02394925|542014255|FG000|Overall Study|Adverse Event|1|||
150239919|NCT02394925|542014255|FG000|Overall Study|Lens Discomfort|3|||
150239920|NCT02394925|542014255|FG000|Overall Study|Lens handling difficulities|5|||
150239921|NCT02394925|542014255|FG000|Overall Study|Lost to Follow-up|9|||
150239922|NCT02394925|542014255|FG000|Overall Study|Protocol Violation|5|||
150239923|NCT02394925|542014255|FG000|Overall Study|No longer meet eligibility criteria|1|||
150239924|NCT02394925|542014255|FG000|Overall Study|Unsatisfactory Visual Response|5|||
150239925|NCT04886518|542014261|FG000|Overall Study|Noncompliance with study drug|1|||
150239926|NCT04886518|542014262|FG001|Overall Study|Noncompliance with study drug|0|||
150239927|NCT04886518|542014263|FG002|Overall Study|Noncompliance with study drug|0|||
150239928|NCT04886518|542014261|FG000|Overall Study|Adverse Event|0|||
150239929|NCT04886518|542014262|FG001|Overall Study|Adverse Event|1|||
150239930|NCT04886518|542014263|FG002|Overall Study|Adverse Event|0|||
150239931|NCT04886518|542014261|FG000|Overall Study|Withdrawal by Subject|1|||
150239932|NCT04886518|542014262|FG001|Overall Study|Withdrawal by Subject|0|||
150239933|NCT04886518|542014263|FG002|Overall Study|Withdrawal by Subject|0|||
150239934|NCT02358668|542016654|FG000|Overall Study|Adverse Event|2|||
150239935|NCT02358668|542016655|FG001|Overall Study|Adverse Event|0|||
150239936|NCT02358668|542016656|FG002|Overall Study|Adverse Event|0|||
150239937|NCT02358668|542016654|FG000|Overall Study|Withdrawal by Subject|0|||
150239938|NCT02358668|542016655|FG001|Overall Study|Withdrawal by Subject|1|||
150239939|NCT02358668|542016656|FG002|Overall Study|Withdrawal by Subject|0|||
150239940|NCT02419417|542016657|FG000|Overall Study|Disease progression|5|||
150239941|NCT02419417|542016658|FG001|Overall Study|Disease progression|4|||
150239942|NCT02419417|542016659|FG002|Overall Study|Disease progression|13|||
150239943|NCT02419417|542016660|FG003|Overall Study|Disease progression|10|||
150239944|NCT02419417|542016661|FG004|Overall Study|Disease progression|10|||
150239945|NCT02419417|542016662|FG005|Overall Study|Disease progression|3|||
150239946|NCT02419417|542016663|FG006|Overall Study|Disease progression|4|||
150239947|NCT02419417|542016664|FG007|Overall Study|Disease progression|5|||
150239948|NCT02419417|542016665|FG008|Overall Study|Disease progression|13|||
150239949|NCT02419417|542016666|FG009|Overall Study|Disease progression|9|||
150239950|NCT02419417|542016667|FG010|Overall Study|Disease progression|0|||
150239951|NCT02419417|542016657|FG000|Overall Study|Study drug toxicity|0|||
150239952|NCT02419417|542016658|FG001|Overall Study|Study drug toxicity|0|||
150239953|NCT02419417|542016659|FG002|Overall Study|Study drug toxicity|0|||
150239954|NCT02419417|542016660|FG003|Overall Study|Study drug toxicity|0|||
150239955|NCT02419417|542016661|FG004|Overall Study|Study drug toxicity|1|||
150239956|NCT02419417|542016662|FG005|Overall Study|Study drug toxicity|0|||
150239957|NCT02419417|542016663|FG006|Overall Study|Study drug toxicity|0|||
150239958|NCT02419417|542016664|FG007|Overall Study|Study drug toxicity|0|||
150239959|NCT02419417|542016665|FG008|Overall Study|Study drug toxicity|0|||
150239960|NCT02419417|542016666|FG009|Overall Study|Study drug toxicity|0|||
150239961|NCT02419417|542016667|FG010|Overall Study|Study drug toxicity|0|||
150239962|NCT02419417|542016657|FG000|Overall Study|Adverse event unrelated to study drug|0|||
150239963|NCT02419417|542016658|FG001|Overall Study|Adverse event unrelated to study drug|0|||
150239964|NCT02419417|542016659|FG002|Overall Study|Adverse event unrelated to study drug|0|||
150239965|NCT02419417|542016660|FG003|Overall Study|Adverse event unrelated to study drug|0|||
150239966|NCT02419417|542016661|FG004|Overall Study|Adverse event unrelated to study drug|2|||
150239967|NCT02419417|542016662|FG005|Overall Study|Adverse event unrelated to study drug|1|||
150239968|NCT02419417|542016663|FG006|Overall Study|Adverse event unrelated to study drug|0|||
150239969|NCT02419417|542016664|FG007|Overall Study|Adverse event unrelated to study drug|1|||
150239970|NCT02419417|542016665|FG008|Overall Study|Adverse event unrelated to study drug|0|||
150239971|NCT02419417|542016666|FG009|Overall Study|Adverse event unrelated to study drug|0|||
150239972|NCT02419417|542016667|FG010|Overall Study|Adverse event unrelated to study drug|0|||
150239973|NCT02419417|542016657|FG000|Overall Study|Participant request to discontinue|0|||
150239974|NCT02419417|542016658|FG001|Overall Study|Participant request to discontinue|0|||
150239975|NCT02419417|542016659|FG002|Overall Study|Participant request to discontinue|0|||
150239976|NCT02419417|542016660|FG003|Overall Study|Participant request to discontinue|0|||
150239977|NCT02419417|542016661|FG004|Overall Study|Participant request to discontinue|0|||
150239978|NCT02419417|542016662|FG005|Overall Study|Participant request to discontinue|0|||
150239979|NCT02419417|542016663|FG006|Overall Study|Participant request to discontinue|0|||
150239980|NCT02419417|542016664|FG007|Overall Study|Participant request to discontinue|0|||
150239981|NCT02419417|542016665|FG008|Overall Study|Participant request to discontinue|0|||
150239982|NCT02419417|542016666|FG009|Overall Study|Participant request to discontinue|1|||
150239983|NCT02419417|542016667|FG010|Overall Study|Participant request to discontinue|0|||
150239984|NCT02419417|542016657|FG000|Overall Study|Withdrawal by Subject|0|||
150239985|NCT02419417|542016658|FG001|Overall Study|Withdrawal by Subject|0|||
150239986|NCT02419417|542016659|FG002|Overall Study|Withdrawal by Subject|0|||
150239987|NCT02419417|542016660|FG003|Overall Study|Withdrawal by Subject|0|||
150239988|NCT02419417|542016661|FG004|Overall Study|Withdrawal by Subject|0|||
150239989|NCT02419417|542016662|FG005|Overall Study|Withdrawal by Subject|0|||
150239990|NCT02419417|542016663|FG006|Overall Study|Withdrawal by Subject|0|||
150239991|NCT02419417|542016664|FG007|Overall Study|Withdrawal by Subject|0|||
150239992|NCT02419417|542016665|FG008|Overall Study|Withdrawal by Subject|0|||
150239993|NCT02419417|542016666|FG009|Overall Study|Withdrawal by Subject|0|||
150239994|NCT02419417|542016667|FG010|Overall Study|Withdrawal by Subject|1|||
150239995|NCT01240551|542016668|FG000|Overall Study|Refused further treatment|3|||
150239996|NCT01240551|542016669|FG001|Overall Study|Refused further treatment|2|||
150239997|NCT01240551|542016668|FG000|Overall Study|Lost to Follow-up|1|||
150239998|NCT01240551|542016669|FG001|Overall Study|Lost to Follow-up|1|||
150239999|NCT02737826|542016675|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
150240000|NCT02737826|542016676|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
150240001|NCT02737826|542016677|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
150240002|NCT00078377|542016678|FG000|Overall Study|Adverse Event|2|||
150240003|NCT00078377|542016679|FG001|Overall Study|Adverse Event|5|||
150240004|NCT00078377|542016680|FG002|Overall Study|Adverse Event|1|||
150240005|NCT00078377|542016678|FG000|Overall Study|Lack of Efficacy|2|||
150240006|NCT00078377|542016679|FG001|Overall Study|Lack of Efficacy|0|||
150240007|NCT00078377|542016680|FG002|Overall Study|Lack of Efficacy|2|||
150240008|NCT00078377|542016678|FG000|Overall Study|Lost to Follow-up|0|||
150240009|NCT00078377|542016679|FG001|Overall Study|Lost to Follow-up|1|||
150240010|NCT00078377|542016680|FG002|Overall Study|Lost to Follow-up|1|||
150240011|NCT00078377|542016678|FG000|Overall Study|Physician Decision|2|||
150240012|NCT00078377|542016679|FG001|Overall Study|Physician Decision|0|||
150240013|NCT00078377|542016680|FG002|Overall Study|Physician Decision|0|||
150240014|NCT00078377|542016678|FG000|Overall Study|Withdrawal by Subject|3|||
150240015|NCT00078377|542016679|FG001|Overall Study|Withdrawal by Subject|4|||
150240016|NCT00078377|542016680|FG002|Overall Study|Withdrawal by Subject|4|||
150240017|NCT00078377|542016678|FG000|Overall Study|Miscellaneous|2|||
150240018|NCT00078377|542016679|FG001|Overall Study|Miscellaneous|6|||
150240019|NCT00078377|542016680|FG002|Overall Study|Miscellaneous|1|||
150240020|NCT01385748|542016681|FG000|Overall Study|Withdrawal by Subject|7|||
150240021|NCT01385748|542016682|FG001|Overall Study|Withdrawal by Subject|4|||
150240022|NCT01385748|542016683|FG002|Overall Study|Withdrawal by Subject|5|||
150240023|NCT01385748|542016681|FG000|Overall Study|Noncompliance|3|||
150240024|NCT01385748|542016682|FG001|Overall Study|Noncompliance|1|||
150240025|NCT01385748|542016683|FG002|Overall Study|Noncompliance|6|||
150240026|NCT01385748|542016681|FG000|Overall Study|Other|1|||
150240027|NCT01385748|542016682|FG001|Overall Study|Other|7|||
150240028|NCT01385748|542016683|FG002|Overall Study|Other|1|||
150240029|NCT01385748|542016681|FG000|Overall Study|Adverse Event|4|||
150240030|NCT01385748|542016682|FG001|Overall Study|Adverse Event|2|||
150240031|NCT01385748|542016683|FG002|Overall Study|Adverse Event|1|||
150240032|NCT01317875|542016684|FG000|Overall Study|Other|0|||
150240033|NCT01317875|542016685|FG001|Overall Study|Other|0|||
150240034|NCT01317875|542016686|FG002|Overall Study|Other|1|||
150240035|NCT01317875|542016687|FG003|Overall Study|Other|0|||
150240036|NCT01317875|542016688|FG004|Overall Study|Other|0|||
150240037|NCT01317875|542016689|FG005|Overall Study|Other|0|||
150240038|NCT01317875|542016690|FG006|Overall Study|Other|0|||
150240039|NCT01317875|542016691|FG007|Overall Study|Other|0|||
150240040|NCT01317875|542016692|FG008|Overall Study|Other|0|||
150240041|NCT01317875|542016693|FG009|Overall Study|Other|0|||
150240042|NCT01317875|542016684|FG000|Overall Study|Noncompliance with study drug|0|||
150240043|NCT01317875|542016685|FG001|Overall Study|Noncompliance with study drug|0|||
150240044|NCT01317875|542016686|FG002|Overall Study|Noncompliance with study drug|1|||
150240045|NCT01317875|542016687|FG003|Overall Study|Noncompliance with study drug|0|||
150240046|NCT01317875|542016688|FG004|Overall Study|Noncompliance with study drug|0|||
150240047|NCT01317875|542016689|FG005|Overall Study|Noncompliance with study drug|0|||
150240048|NCT01317875|542016690|FG006|Overall Study|Noncompliance with study drug|0|||
150240049|NCT01317875|542016691|FG007|Overall Study|Noncompliance with study drug|0|||
150240050|NCT01317875|542016692|FG008|Overall Study|Noncompliance with study drug|0|||
150240051|NCT01317875|542016693|FG009|Overall Study|Noncompliance with study drug|0|||
150240052|NCT01317875|542016684|FG000|Overall Study|Progressive Disease|1|||
150240053|NCT01317875|542016685|FG001|Overall Study|Progressive Disease|0|||
150240054|NCT01317875|542016686|FG002|Overall Study|Progressive Disease|2|||
150240055|NCT01317875|542016687|FG003|Overall Study|Progressive Disease|0|||
150240056|NCT01317875|542016688|FG004|Overall Study|Progressive Disease|1|||
150240057|NCT01317875|542016689|FG005|Overall Study|Progressive Disease|0|||
150240058|NCT01317875|542016690|FG006|Overall Study|Progressive Disease|0|||
150240059|NCT01317875|542016691|FG007|Overall Study|Progressive Disease|1|||
150240060|NCT01317875|542016692|FG008|Overall Study|Progressive Disease|0|||
150240061|NCT01317875|542016693|FG009|Overall Study|Progressive Disease|0|||
150240062|NCT01317875|542016684|FG000|Overall Study|Withdrawal by Subject|0|||
150240063|NCT01317875|542016685|FG001|Overall Study|Withdrawal by Subject|0|||
150240064|NCT01317875|542016686|FG002|Overall Study|Withdrawal by Subject|0|||
150240065|NCT01317875|542016687|FG003|Overall Study|Withdrawal by Subject|0|||
150240066|NCT01317875|542016688|FG004|Overall Study|Withdrawal by Subject|1|||
150240067|NCT01317875|542016689|FG005|Overall Study|Withdrawal by Subject|0|||
150240068|NCT01317875|542016690|FG006|Overall Study|Withdrawal by Subject|0|||
150240069|NCT01317875|542016691|FG007|Overall Study|Withdrawal by Subject|3|||
150240070|NCT01317875|542016692|FG008|Overall Study|Withdrawal by Subject|0|||
150240071|NCT01317875|542016693|FG009|Overall Study|Withdrawal by Subject|0|||
150240072|NCT01317875|542016684|FG000|Overall Study|Physician Decision|0|||
150240073|NCT01317875|542016685|FG001|Overall Study|Physician Decision|1|||
150240074|NCT01317875|542016686|FG002|Overall Study|Physician Decision|1|||
150240075|NCT01317875|542016687|FG003|Overall Study|Physician Decision|0|||
150240076|NCT01317875|542016688|FG004|Overall Study|Physician Decision|2|||
150240077|NCT01317875|542016689|FG005|Overall Study|Physician Decision|0|||
150240078|NCT01317875|542016690|FG006|Overall Study|Physician Decision|0|||
150240079|NCT01317875|542016691|FG007|Overall Study|Physician Decision|2|||
150240080|NCT01317875|542016692|FG008|Overall Study|Physician Decision|0|||
150240081|NCT01317875|542016693|FG009|Overall Study|Physician Decision|0|||
150240082|NCT01317875|542016684|FG000|Overall Study|Death|0|||
150240083|NCT01317875|542016685|FG001|Overall Study|Death|0|||
150240084|NCT01317875|542016686|FG002|Overall Study|Death|2|||
150240085|NCT01317875|542016687|FG003|Overall Study|Death|1|||
150240086|NCT01317875|542016688|FG004|Overall Study|Death|0|||
150240087|NCT01317875|542016689|FG005|Overall Study|Death|1|||
150240088|NCT01317875|542016690|FG006|Overall Study|Death|0|||
150240089|NCT01317875|542016691|FG007|Overall Study|Death|4|||
150240090|NCT01317875|542016692|FG008|Overall Study|Death|0|||
150240091|NCT01317875|542016693|FG009|Overall Study|Death|0|||
150240092|NCT01317875|542016684|FG000|Overall Study|Adverse Event|2|||
150240093|NCT01317875|542016685|FG001|Overall Study|Adverse Event|1|||
150240094|NCT01317875|542016686|FG002|Overall Study|Adverse Event|2|||
150240095|NCT01317875|542016687|FG003|Overall Study|Adverse Event|1|||
150240096|NCT01317875|542016688|FG004|Overall Study|Adverse Event|5|||
150240097|NCT01317875|542016689|FG005|Overall Study|Adverse Event|1|||
150240098|NCT01317875|542016690|FG006|Overall Study|Adverse Event|2|||
150240099|NCT01317875|542016691|FG007|Overall Study|Adverse Event|5|||
150240100|NCT01317875|542016692|FG008|Overall Study|Adverse Event|0|||
150240101|NCT01317875|542016693|FG009|Overall Study|Adverse Event|0|||
150240102|NCT01381575|542016694|FG000|Overall Study|Serious Adverse Event|1|||
150240103|NCT01381575|542016695|FG001|Overall Study|Serious Adverse Event|0|||
150240104|NCT01381575|542016696|FG002|Overall Study|Serious Adverse Event|0|||
150240105|NCT01381575|542016694|FG000|Overall Study|Non-Serious Adverse Event|0|||
150240106|NCT01381575|542016695|FG001|Overall Study|Non-Serious Adverse Event|0|||
150240107|NCT01381575|542016696|FG002|Overall Study|Non-Serious Adverse Event|1|||
150240108|NCT01381575|542016694|FG000|Overall Study|Protocol Violation|0|||
150240109|NCT01381575|542016695|FG001|Overall Study|Protocol Violation|1|||
150240110|NCT01381575|542016696|FG002|Overall Study|Protocol Violation|1|||
150240111|NCT01381575|542016694|FG000|Overall Study|Withdrawal by Subject|15|||
150240112|NCT01381575|542016695|FG001|Overall Study|Withdrawal by Subject|9|||
150240113|NCT01381575|542016696|FG002|Overall Study|Withdrawal by Subject|7|||
150240114|NCT01381575|542016694|FG000|Overall Study|Migrated/moved from study area|2|||
150240115|NCT01381575|542016695|FG001|Overall Study|Migrated/moved from study area|12|||
150240116|NCT01381575|542016696|FG002|Overall Study|Migrated/moved from study area|2|||
150240117|NCT01381575|542016694|FG000|Overall Study|Lost to Follow-up|8|||
150240118|NCT01381575|542016695|FG001|Overall Study|Lost to Follow-up|17|||
150240119|NCT01381575|542016696|FG002|Overall Study|Lost to Follow-up|9|||
150240120|NCT01200342|542016703|FG000|Overall Study|Disease Progression|1|||
150240121|NCT04546217|542016706|FG000|Overall Study|Withdrawal by Subject|2|||
150240122|NCT04546217|542016707|FG001|Overall Study|Withdrawal by Subject|0|||
150240123|NCT04546217|542016706|FG000|Overall Study|Uncontrolled hypertension|1|||
150240124|NCT04546217|542016707|FG001|Overall Study|Uncontrolled hypertension|0|||
150240125|NCT02550938|542016708|FG000|Overall Study|Lost to Follow-up|8|||
150240126|NCT02550938|542016709|FG001|Overall Study|Lost to Follow-up|7|||
150240127|NCT02550938|542016710|FG002|Overall Study|Lost to Follow-up|12|||
150240128|NCT02550938|542016711|FG003|Overall Study|Lost to Follow-up|11|||
150240129|NCT01367847|542016712|FG000|Overall Study|Withdrawal by Subject|2|||
150240130|NCT01367847|542016713|FG001|Overall Study|Withdrawal by Subject|2|||
150240131|NCT01439867|542016716|FG000|Overall Study|Non-compliance|0|||
150240132|NCT01439867|542016717|FG001|Overall Study|Non-compliance|1|||
150240133|NCT01439867|542016716|FG000|Overall Study|Withdrawal by Subject|1|||
150240134|NCT01439867|542016717|FG001|Overall Study|Withdrawal by Subject|2|||
150240135|NCT01439867|542016716|FG000|Overall Study|Administrative Decision|4|||
150240136|NCT01439867|542016717|FG001|Overall Study|Administrative Decision|5|||
150240137|NCT01439867|542016716|FG000|Overall Study|Protocol-specified Criteria|1|||
150240138|NCT01439867|542016717|FG001|Overall Study|Protocol-specified Criteria|0|||
150240139|NCT00863512|542016718|FG000|Overall Study|Adverse Event|2|||
150240140|NCT00863512|542016719|FG001|Overall Study|Adverse Event|0|||
150240141|NCT00863512|542016718|FG000|Overall Study|Withdrawal by Subject|11|||
150240142|NCT00863512|542016719|FG001|Overall Study|Withdrawal by Subject|0|||
150240143|NCT00863512|542016718|FG000|Overall Study|Physician Decision|1|||
150240144|NCT00863512|542016719|FG001|Overall Study|Physician Decision|0|||
150240145|NCT00983749|542016727|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
150240146|NCT00983749|542016728|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
150240147|NCT04292470|542016729|FG000|Overall Study|Withdrawal by Subject|0|||
150240148|NCT04292470|542016730|FG001|Overall Study|Withdrawal by Subject|1|||
150240149|NCT02906020|542016748|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
150240150|NCT02906020|542016749|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
150240151|NCT02906020|542016750|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
150240152|NCT02906020|542016751|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
150240153|NCT02906020|542016752|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
150240154|NCT02906020|542016753|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
150240155|NCT02906020|542016754|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
150240156|NCT02906020|542016755|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
150240157|NCT02906020|542016756|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
150240158|NCT02906020|542016757|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
150240159|NCT02906020|542016758|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
150240160|NCT02906020|542016759|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
150240161|NCT02906020|542016760|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
150240162|NCT02906020|542016761|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
150240163|NCT02906020|542016762|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
150240164|NCT02906020|542016763|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
150240165|NCT02906020|542016748|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240166|NCT02906020|542016749|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240167|NCT02906020|542016750|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240168|NCT02906020|542016751|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240169|NCT02906020|542016752|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240170|NCT02906020|542016753|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240171|NCT02906020|542016754|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240172|NCT02906020|542016755|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240173|NCT02906020|542016756|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
150240174|NCT02906020|542016757|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
150240175|NCT02906020|542016758|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240176|NCT02906020|542016759|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240177|NCT02906020|542016760|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240178|NCT02906020|542016761|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240179|NCT02906020|542016762|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240180|NCT02906020|542016763|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
150240181|NCT02906020|542016748|FG000|Part 2: Double-blind Treatment Period|Other|0|||
150240182|NCT02906020|542016749|FG001|Part 2: Double-blind Treatment Period|Other|0|||
150240183|NCT02906020|542016750|FG002|Part 2: Double-blind Treatment Period|Other|0|||
150240184|NCT02906020|542016751|FG003|Part 2: Double-blind Treatment Period|Other|0|||
150240185|NCT02906020|542016752|FG004|Part 2: Double-blind Treatment Period|Other|0|||
150240186|NCT02906020|542016753|FG005|Part 2: Double-blind Treatment Period|Other|0|||
150240187|NCT02906020|542016754|FG006|Part 2: Double-blind Treatment Period|Other|0|||
150240188|NCT02906020|542016755|FG007|Part 2: Double-blind Treatment Period|Other|0|||
150240189|NCT02906020|542016756|FG008|Part 2: Double-blind Treatment Period|Other|6|||
150240190|NCT02906020|542016757|FG009|Part 2: Double-blind Treatment Period|Other|10|||
150240191|NCT02906020|542016758|FG010|Part 2: Double-blind Treatment Period|Other|0|||
150240192|NCT02906020|542016759|FG011|Part 2: Double-blind Treatment Period|Other|0|||
150240193|NCT02906020|542016760|FG012|Part 2: Double-blind Treatment Period|Other|0|||
150240194|NCT02906020|542016761|FG013|Part 2: Double-blind Treatment Period|Other|0|||
150240195|NCT02906020|542016762|FG014|Part 2: Double-blind Treatment Period|Other|0|||
150240196|NCT02906020|542016763|FG015|Part 2: Double-blind Treatment Period|Other|0|||
150240197|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240198|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240199|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240200|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240201|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240202|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240203|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240204|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240205|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240206|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240207|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240208|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240209|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
150240210|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
150240211|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240212|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
150240213|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240214|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240215|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240216|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240217|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240218|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240219|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240220|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240221|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240222|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240223|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240224|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240225|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
150240226|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
150240227|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
150240228|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
150240229|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240230|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240231|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240232|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240233|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240234|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240235|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240236|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240237|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240238|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240239|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240240|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240241|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
150240242|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
150240243|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240244|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
150240245|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240246|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240247|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240248|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240249|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240250|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240251|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240252|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240253|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240254|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240255|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240256|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240257|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
150240258|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
150240259|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240260|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
150240261|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240262|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240263|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240264|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240265|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240266|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240267|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240268|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240269|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240270|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240271|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240272|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
150240273|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
150240274|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
150240275|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
150240276|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
150240277|NCT02906020|542016748|FG000|Part 2: Long-term Follow-up Period|Other|0|||
150240278|NCT02906020|542016749|FG001|Part 2: Long-term Follow-up Period|Other|0|||
150240279|NCT02906020|542016750|FG002|Part 2: Long-term Follow-up Period|Other|0|||
150240280|NCT02906020|542016751|FG003|Part 2: Long-term Follow-up Period|Other|0|||
150240281|NCT02906020|542016752|FG004|Part 2: Long-term Follow-up Period|Other|0|||
150240282|NCT02906020|542016753|FG005|Part 2: Long-term Follow-up Period|Other|0|||
150240283|NCT02906020|542016754|FG006|Part 2: Long-term Follow-up Period|Other|0|||
150240284|NCT02906020|542016755|FG007|Part 2: Long-term Follow-up Period|Other|0|||
150240285|NCT02906020|542016756|FG008|Part 2: Long-term Follow-up Period|Other|0|||
150240286|NCT02906020|542016757|FG009|Part 2: Long-term Follow-up Period|Other|0|||
150240287|NCT02906020|542016758|FG010|Part 2: Long-term Follow-up Period|Other|0|||
150240288|NCT02906020|542016759|FG011|Part 2: Long-term Follow-up Period|Other|0|||
150240289|NCT02906020|542016760|FG012|Part 2: Long-term Follow-up Period|Other|13|||
150240290|NCT02906020|542016761|FG013|Part 2: Long-term Follow-up Period|Other|8|||
150240291|NCT02906020|542016762|FG014|Part 2: Long-term Follow-up Period|Other|3|||
150240292|NCT02906020|542016763|FG015|Part 2: Long-term Follow-up Period|Other|2|||
150240293|NCT01375673|542016769|FG000|Overall Study|Withdrawal by Subject|0|||
150240294|NCT01375673|542016770|FG001|Overall Study|Withdrawal by Subject|1|||
150240295|NCT04698915|542016771|FG000|Overall Study|Adverse Event|2|||
150240296|NCT04698915|542016772|FG001|Overall Study|Adverse Event|0|||
150240297|NCT04698915|542016771|FG000|Overall Study|Death|23|||
150240298|NCT04698915|542016772|FG001|Overall Study|Death|20|||
150240299|NCT04698915|542016771|FG000|Overall Study|Physician Decision|1|||
150240300|NCT04698915|542016772|FG001|Overall Study|Physician Decision|1|||
150240301|NCT04698915|542016771|FG000|Overall Study|Lost to Follow-up|1|||
150240302|NCT04698915|542016772|FG001|Overall Study|Lost to Follow-up|0|||
150240303|NCT04698915|542016771|FG000|Overall Study|Study Terminated by Sponsor|55|||
150240304|NCT04698915|542016772|FG001|Overall Study|Study Terminated by Sponsor|60|||
150240305|NCT04698915|542016771|FG000|Overall Study|Withdrawal by Subject|2|||
150240306|NCT04698915|542016772|FG001|Overall Study|Withdrawal by Subject|3|||
150240307|NCT00979953|542016773|FG000|Overall Study|Adverse Event|5|||
150240308|NCT00979953|542016774|FG001|Overall Study|Adverse Event|2|||
150240309|NCT00979953|542016775|FG002|Overall Study|Adverse Event|17|||
150240310|NCT00979953|542016776|FG003|Overall Study|Adverse Event|4|||
150240311|NCT00979953|542016773|FG000|Overall Study|Lack of Efficacy|1|||
150240312|NCT00979953|542016774|FG001|Overall Study|Lack of Efficacy|2|||
150240313|NCT00979953|542016775|FG002|Overall Study|Lack of Efficacy|0|||
150240314|NCT00979953|542016776|FG003|Overall Study|Lack of Efficacy|0|||
150240315|NCT00979953|542016773|FG000|Overall Study|Lost to Follow-up|1|||
150240316|NCT00979953|542016774|FG001|Overall Study|Lost to Follow-up|1|||
150240317|NCT00979953|542016775|FG002|Overall Study|Lost to Follow-up|1|||
150240318|NCT00979953|542016776|FG003|Overall Study|Lost to Follow-up|0|||
150240319|NCT00979953|542016773|FG000|Overall Study|Withdrawal by Subject|0|||
150240320|NCT00979953|542016774|FG001|Overall Study|Withdrawal by Subject|0|||
150240321|NCT00979953|542016775|FG002|Overall Study|Withdrawal by Subject|2|||
150240322|NCT00979953|542016776|FG003|Overall Study|Withdrawal by Subject|1|||
150240323|NCT00979953|542016773|FG000|Overall Study|Protocol Violation|1|||
150240324|NCT00979953|542016774|FG001|Overall Study|Protocol Violation|0|||
150240325|NCT00979953|542016775|FG002|Overall Study|Protocol Violation|2|||
150240326|NCT00979953|542016776|FG003|Overall Study|Protocol Violation|2|||
150240327|NCT01124097|542016777|FG000|Overall Study|Withdrawal by Subject|4|||
150240328|NCT01124097|542016778|FG001|Overall Study|Withdrawal by Subject|3|||
150240329|NCT01124097|542016779|FG002|Overall Study|Withdrawal by Subject|2|||
150240330|NCT01124097|542016780|FG003|Overall Study|Withdrawal by Subject|3|||
150240331|NCT01124097|542016777|FG000|Overall Study|Lack of Efficacy|2|||
150240332|NCT01124097|542016778|FG001|Overall Study|Lack of Efficacy|3|||
150240333|NCT01124097|542016779|FG002|Overall Study|Lack of Efficacy|1|||
150240334|NCT01124097|542016780|FG003|Overall Study|Lack of Efficacy|3|||
150240335|NCT01124097|542016777|FG000|Overall Study|Adverse Event|24|||
150240336|NCT01124097|542016778|FG001|Overall Study|Adverse Event|15|||
150240337|NCT01124097|542016779|FG002|Overall Study|Adverse Event|15|||
150240338|NCT01124097|542016780|FG003|Overall Study|Adverse Event|7|||
150240339|NCT01124097|542016777|FG000|Overall Study|Protocol Violation|2|||
150240340|NCT01124097|542016778|FG001|Overall Study|Protocol Violation|0|||
150240341|NCT01124097|542016779|FG002|Overall Study|Protocol Violation|2|||
150240342|NCT01124097|542016780|FG003|Overall Study|Protocol Violation|1|||
150240343|NCT01124097|542016777|FG000|Overall Study|Physician Decision|2|||
150240344|NCT01124097|542016778|FG001|Overall Study|Physician Decision|1|||
150240345|NCT01124097|542016779|FG002|Overall Study|Physician Decision|0|||
150240346|NCT01124097|542016780|FG003|Overall Study|Physician Decision|0|||
150240347|NCT04829747|542016786|FG000|Overall Study|Protocol Violation|1|||
150240348|NCT05878873|542016792|FG000|Overall Study|Lost to Follow-up|2|||
150240349|NCT05878873|542016793|FG001|Overall Study|Lost to Follow-up|0|||
150240350|NCT02375347|542016799|FG000|Overall Study|Protocol Violation|1|||
150240351|NCT00193479|542016800|FG000|Induction Chemotherapy|Adverse Event|2|||
150240352|NCT00193479|542016800|FG000|Induction Chemotherapy|Disease Progression|1|||
150240353|NCT00193479|542016800|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
150240354|NCT00193479|542016800|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
150240355|NCT00425607|542016801|FG000|Overall Study|Death|1|||
150240356|NCT00425607|542016801|FG000|Overall Study|Withdrawal by Subject|1|||
150240357|NCT00079339|542016802|FG000|Overall Study|Adverse Event|1|||
150240358|NCT00079339|542016803|FG001|Overall Study|Adverse Event|7|||
150240359|NCT00079339|542016804|FG002|Overall Study|Adverse Event|2|||
150240360|NCT00079339|542016802|FG000|Overall Study|Death|1|||
150240361|NCT00079339|542016803|FG001|Overall Study|Death|0|||
150240362|NCT00079339|542016804|FG002|Overall Study|Death|0|||
150240363|NCT00079339|542016802|FG000|Overall Study|Non-compliance|0|||
150240364|NCT00079339|542016803|FG001|Overall Study|Non-compliance|0|||
150240365|NCT00079339|542016804|FG002|Overall Study|Non-compliance|1|||
150240366|NCT00079339|542016802|FG000|Overall Study|Withdrawal by Subject|0|||
150240367|NCT00079339|542016803|FG001|Overall Study|Withdrawal by Subject|4|||
150240368|NCT00079339|542016804|FG002|Overall Study|Withdrawal by Subject|1|||
150240369|NCT00079339|542016802|FG000|Overall Study|Disease progression|3|||
150240370|NCT00079339|542016803|FG001|Overall Study|Disease progression|28|||
150240371|NCT00079339|542016804|FG002|Overall Study|Disease progression|2|||
150240372|NCT02563548|542016805|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
150240373|NCT02563548|542016806|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
150240374|NCT02563548|542016807|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
150240375|NCT02563548|542016808|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
150240376|NCT02563548|542016809|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
150240377|NCT02563548|542016810|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
150240378|NCT02563548|542016805|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
150240379|NCT02563548|542016806|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
150240380|NCT02563548|542016807|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
150240381|NCT02563548|542016808|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
150240382|NCT02563548|542016809|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
150240383|NCT02563548|542016810|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
150240384|NCT02563548|542016805|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
150240385|NCT02563548|542016806|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
150240386|NCT02563548|542016807|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
150240387|NCT02563548|542016808|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
150240388|NCT02563548|542016809|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
150240389|NCT02563548|542016810|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
150240390|NCT02563548|542016805|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
150240391|NCT02563548|542016806|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
150240392|NCT02563548|542016807|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
150240393|NCT02563548|542016808|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
150240394|NCT02563548|542016809|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
150240395|NCT02563548|542016810|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
150240396|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
150240397|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
150240398|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
150240399|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
150240400|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
150240401|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
150240402|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
150240403|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
150240404|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
150240405|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
150240406|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
150240407|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
150240408|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
150240409|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
150240410|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
150240411|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
150240412|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
150240413|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
150240414|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
150240415|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
150240416|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
150240417|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
150240418|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
150240419|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
150240420|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
150240421|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
150240422|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
150240423|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
150240424|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
150240425|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
150240426|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
150240427|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
150240428|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
150240429|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
150240430|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
150240431|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
150240432|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
150240433|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
150240434|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
150240435|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
150240436|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
150240437|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
150240438|NCT02563548|542016805|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
150240439|NCT02563548|542016806|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
150240440|NCT02563548|542016807|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
150240441|NCT02563548|542016808|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
150240442|NCT02563548|542016809|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
150240443|NCT02563548|542016810|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
150240444|NCT00559377|542016811|FG000|Overall Study|Withdrawal by Subject|9|||
150240445|NCT01547598|542016815|FG000|Overall Study|Withdrew consent|1|||
150240446|NCT01547598|542016816|FG001|Overall Study|Withdrew consent|1|||
150240447|NCT01547598|542016815|FG000|Overall Study|Lost to Follow-up|1|||
150240448|NCT01547598|542016816|FG001|Overall Study|Lost to Follow-up|1|||
150240449|NCT01547598|542016815|FG000|Overall Study|Adverse Event|1|||
150240450|NCT01547598|542016816|FG001|Overall Study|Adverse Event|1|||
150240451|NCT01547598|542016815|FG000|Overall Study|Protocol Violation|1|||
150240452|NCT01547598|542016816|FG001|Overall Study|Protocol Violation|1|||
150240453|NCT01547598|542016815|FG000|Overall Study|Other Miscellaneous Reasons|2|||
150240454|NCT01547598|542016816|FG001|Overall Study|Other Miscellaneous Reasons|1|||
150240455|NCT00203047|542016819|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
150240456|NCT00203047|542016820|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
150240457|NCT00203047|542016819|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
150240458|NCT00203047|542016820|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
150240459|NCT00203047|542016819|FG000|Overall Study|Withdrawal by Subject|13|||
150240460|NCT00203047|542016820|FG001|Overall Study|Withdrawal by Subject|47|||
150240461|NCT00203047|542016819|FG000|Overall Study|Teva requested participant withdrawal|1|||
150240462|NCT00203047|542016820|FG001|Overall Study|Teva requested participant withdrawal|1|||
150240463|NCT00203047|542016819|FG000|Overall Study|Physician Decision|8|||
150240464|NCT00203047|542016820|FG001|Overall Study|Physician Decision|7|||
150240465|NCT00203047|542016819|FG000|Overall Study|Non-compliance|4|||
150240466|NCT00203047|542016820|FG001|Overall Study|Non-compliance|8|||
150240467|NCT00203047|542016819|FG000|Overall Study|Protocol Violation|1|||
150240468|NCT00203047|542016820|FG001|Overall Study|Protocol Violation|0|||
150240469|NCT00203047|542016819|FG000|Overall Study|Lost to Follow-up|11|||
150240470|NCT00203047|542016820|FG001|Overall Study|Lost to Follow-up|5|||
150240471|NCT00203047|542016819|FG000|Overall Study|Adverse Event|8|||
150240472|NCT00203047|542016820|FG001|Overall Study|Adverse Event|18|||
150240473|NCT00203047|542016819|FG000|Overall Study|Death|1|||
150240474|NCT00203047|542016820|FG001|Overall Study|Death|2|||
150240475|NCT00203047|542016819|FG000|Overall Study|Pregnancy|3|||
150240476|NCT00203047|542016820|FG001|Overall Study|Pregnancy|0|||
150240477|NCT00203047|542016819|FG000|Overall Study|Other|5|||
150240478|NCT00203047|542016820|FG001|Overall Study|Other|5|||
150240479|NCT00340704|542016821|FG000|PK Study|Adverse Event|0|||
150240480|NCT00340704|542016822|FG001|PK Study|Adverse Event|1|||
150240481|NCT00340704|542016823|FG002|PK Study|Adverse Event|0|||
150240482|NCT00340704|542016824|FG003|PK Study|Adverse Event|0|||
150240483|NCT00340704|542016825|FG004|PK Study|Adverse Event|0|||
150240484|NCT00340704|542016826|FG005|PK Study|Adverse Event|0|||
150240485|NCT00340704|542016827|FG006|PK Study|Adverse Event|0|||
150240486|NCT00340704|542016828|FG007|PK Study|Adverse Event|0|||
150240487|NCT00340704|542016829|FG008|PK Study|Adverse Event|0|||
150240488|NCT00340704|542016821|FG000|PK Study|Not treated|0|||
150240489|NCT00340704|542016822|FG001|PK Study|Not treated|0|||
150240490|NCT00340704|542016823|FG002|PK Study|Not treated|1|||
150240491|NCT00340704|542016824|FG003|PK Study|Not treated|0|||
150240492|NCT00340704|542016825|FG004|PK Study|Not treated|0|||
150240493|NCT00340704|542016826|FG005|PK Study|Not treated|0|||
150240494|NCT00340704|542016827|FG006|PK Study|Not treated|0|||
150240495|NCT00340704|542016828|FG007|PK Study|Not treated|0|||
150240496|NCT00340704|542016829|FG008|PK Study|Not treated|0|||
150240497|NCT00340704|542016821|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
150240498|NCT00340704|542016822|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
150240499|NCT00340704|542016823|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
150240500|NCT00340704|542016824|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
150240501|NCT00340704|542016825|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
150240502|NCT00340704|542016826|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
150240503|NCT00340704|542016827|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
150240504|NCT00340704|542016828|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
150240505|NCT00340704|542016829|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
150240506|NCT00340704|542016821|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240507|NCT00340704|542016822|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240508|NCT00340704|542016823|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240509|NCT00340704|542016824|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240510|NCT00340704|542016825|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240511|NCT00340704|542016826|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
150240512|NCT00340704|542016827|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240513|NCT00340704|542016828|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240514|NCT00340704|542016829|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
150240515|NCT00340704|542016821|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240516|NCT00340704|542016822|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240517|NCT00340704|542016823|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240518|NCT00340704|542016824|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240519|NCT00340704|542016825|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
150240520|NCT00340704|542016826|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
150240521|NCT00340704|542016827|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240522|NCT00340704|542016828|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240523|NCT00340704|542016829|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
150240524|NCT00340704|542016821|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
150240525|NCT00340704|542016822|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
150240526|NCT00340704|542016823|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
150240527|NCT00340704|542016824|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
150240528|NCT00340704|542016825|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
150240529|NCT00340704|542016826|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
150240530|NCT00340704|542016827|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
150240531|NCT00340704|542016828|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
150240532|NCT00340704|542016829|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
150240533|NCT04071301|542016830|FG000|Overall Study|Withdrawal by Subject|6|||
150240534|NCT04071301|542016830|FG000|Overall Study|Death|1|||
150240535|NCT00121667|542016831|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
150240536|NCT00121667|542016832|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
150240537|NCT00121667|542016833|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
150240538|NCT00121667|542016834|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
150240539|NCT00121667|542016831|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
150240540|NCT00121667|542016832|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
150240541|NCT00121667|542016833|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
150240542|NCT00121667|542016834|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
150240543|NCT00121667|542016831|FG000|Short Term (ST) Period|Adverse Event|5|||
150240544|NCT00121667|542016832|FG001|Short Term (ST) Period|Adverse Event|6|||
150240545|NCT00121667|542016833|FG002|Short Term (ST) Period|Adverse Event|5|||
150240546|NCT00121667|542016834|FG003|Short Term (ST) Period|Adverse Event|3|||
150240547|NCT00121667|542016831|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
150240548|NCT00121667|542016832|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
150240549|NCT00121667|542016833|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
150240550|NCT00121667|542016834|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
150240551|NCT00121667|542016831|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
150240552|NCT00121667|542016832|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
150240553|NCT00121667|542016833|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
150240554|NCT00121667|542016834|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
150240555|NCT00121667|542016831|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
150240556|NCT00121667|542016832|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
150240557|NCT00121667|542016833|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
150240558|NCT00121667|542016834|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
150240559|NCT00121667|542016831|FG000|Short Term (ST) Period|Other Reason|3|||
150240560|NCT00121667|542016832|FG001|Short Term (ST) Period|Other Reason|0|||
150240561|NCT00121667|542016833|FG002|Short Term (ST) Period|Other Reason|0|||
150240562|NCT00121667|542016834|FG003|Short Term (ST) Period|Other Reason|0|||
150240563|NCT00121667|542016831|FG000|Short Term (ST) Period|Death|0|||
150240564|NCT00121667|542016832|FG001|Short Term (ST) Period|Death|0|||
150240565|NCT00121667|542016833|FG002|Short Term (ST) Period|Death|0|||
150240566|NCT00121667|542016834|FG003|Short Term (ST) Period|Death|1|||
150240567|NCT00121667|542016831|FG000|Short Term (ST) Period|Pregnancy|0|||
150240568|NCT00121667|542016832|FG001|Short Term (ST) Period|Pregnancy|0|||
150240569|NCT00121667|542016833|FG002|Short Term (ST) Period|Pregnancy|0|||
150240570|NCT00121667|542016834|FG003|Short Term (ST) Period|Pregnancy|1|||
150240571|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
150240572|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
150240573|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
150240574|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
150240575|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
150240576|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
150240577|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
150240578|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
150240579|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
150240580|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
150240581|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
150240582|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
150240583|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
150240584|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
150240585|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
150240586|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
150240587|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
150240588|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
150240589|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
150240590|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
150240591|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
150240592|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
150240593|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
150240594|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
150240595|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
150240596|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
150240597|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
150240598|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
150240599|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
150240600|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
150240601|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
150240602|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
150240603|NCT00121667|542016831|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
150240604|NCT00121667|542016832|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
150240605|NCT00121667|542016833|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
150240606|NCT00121667|542016834|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
150240607|NCT01453023|542016835|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
150240608|NCT01453023|542016836|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
150240609|NCT01453023|542016835|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
150240610|NCT01453023|542016836|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
150240611|NCT01453023|542016835|FG000|Treatment Period 2|Protocol Violation|0|||
150240612|NCT01453023|542016836|FG001|Treatment Period 2|Protocol Violation|1|||
150240613|NCT05186311|542016837|FG000|Part A: Serum|Withdrawal by Subject|1|||
150240614|NCT02879383|542016838|FG000|First 24 Weeks|Physician Decision|0|||
150240615|NCT02879383|542016839|FG001|First 24 Weeks|Physician Decision|1|||
150240616|NCT02879383|542016840|FG002|First 24 Weeks|Physician Decision|0|||
150240617|NCT02879383|542016841|FG003|First 24 Weeks|Physician Decision|0|||
150240618|NCT02125279|542016844|FG000|Overall Study|Lack of Efficacy|2|||
150240619|NCT02125279|542016844|FG000|Overall Study|Withdrawal by Subject|6|||
150240620|NCT02125279|542016844|FG000|Overall Study|Protocol Violation|1|||
150240621|NCT02125279|542016844|FG000|Overall Study|Lost to Follow-up|4|||
150240622|NCT01790295|542016856|FG000|Overall Study|Adverse Event|1|||
150240623|NCT01790295|542016856|FG000|Overall Study|Death|4|||
150240624|NCT01790295|542016856|FG000|Overall Study|Lack of Efficacy|2|||
150240625|NCT01790295|542016856|FG000|Overall Study|Study closure|4|||
150240626|NCT00420784|542016862|FG000|Overall Study|Adverse Event|11|||
150240627|NCT00420784|542016863|FG001|Overall Study|Adverse Event|29|||
150240628|NCT00420784|542016864|FG002|Overall Study|Adverse Event|10|||
150240629|NCT00420784|542016865|FG003|Overall Study|Adverse Event|5|||
150240630|NCT00420784|542016862|FG000|Overall Study|Withdrawal by Subject|0|||
150240631|NCT00420784|542016863|FG001|Overall Study|Withdrawal by Subject|1|||
150240632|NCT00420784|542016864|FG002|Overall Study|Withdrawal by Subject|0|||
150240633|NCT00420784|542016865|FG003|Overall Study|Withdrawal by Subject|0|||
150240634|NCT00420784|542016862|FG000|Overall Study|Lost to Follow-up|0|||
150240635|NCT00420784|542016863|FG001|Overall Study|Lost to Follow-up|0|||
150240636|NCT00420784|542016864|FG002|Overall Study|Lost to Follow-up|2|||
150240637|NCT00420784|542016865|FG003|Overall Study|Lost to Follow-up|1|||
150240638|NCT00420784|542016862|FG000|Overall Study|Virologic Stopping Rule|17|||
150240639|NCT00420784|542016863|FG001|Overall Study|Virologic Stopping Rule|26|||
150240640|NCT00420784|542016864|FG002|Overall Study|Virologic Stopping Rule|41|||
150240641|NCT00420784|542016865|FG003|Overall Study|Virologic Stopping Rule|67|||
150240642|NCT00420784|542016862|FG000|Overall Study|Other|1|||
150240643|NCT00420784|542016863|FG001|Overall Study|Other|2|||
150240644|NCT00420784|542016864|FG002|Overall Study|Other|0|||
150240645|NCT00420784|542016865|FG003|Overall Study|Other|5|||
150240646|NCT02417441|542016866|FG000|Overall Study|Inconclusive due to missing data|52|||
150240647|NCT02417441|542016867|FG001|Overall Study|Inconclusive due to missing data|19|||
150240648|NCT00723125|542016880|FG000|Overall Study|Met Dx|1|||
150240649|NCT00723125|542016881|FG001|Overall Study|Met Dx|0|||
150240650|NCT00723125|542016880|FG000|Overall Study|Withdrawal by Subject|15|||
150240651|NCT00723125|542016881|FG001|Overall Study|Withdrawal by Subject|6|||
150240652|NCT00723125|542016880|FG000|Overall Study|Adverse Event|2|||
150240653|NCT00723125|542016881|FG001|Overall Study|Adverse Event|0|||
150240654|NCT02493946|542016888|FG000|DB Period|Withdrawal by Subject|8|||
150240655|NCT02493946|542016889|FG001|DB Period|Withdrawal by Subject|5|||
150240656|NCT02493946|542016890|FG002|DB Period|Withdrawal by Subject|0|||
150240657|NCT02493946|542016888|FG000|Open Label Period|Withdrawal by Subject|0|||
150240658|NCT02493946|542016889|FG001|Open Label Period|Withdrawal by Subject|0|||
150240659|NCT02493946|542016890|FG002|Open Label Period|Withdrawal by Subject|74|||
150240660|NCT02493946|542016888|FG000|Open Label Period|Adverse Event|0|||
150240661|NCT02493946|542016889|FG001|Open Label Period|Adverse Event|0|||
150240662|NCT02493946|542016890|FG002|Open Label Period|Adverse Event|4|||
150240663|NCT02493946|542016888|FG000|Open Label Period|Lost to Follow-up|0|||
150240664|NCT02493946|542016889|FG001|Open Label Period|Lost to Follow-up|0|||
150240665|NCT02493946|542016890|FG002|Open Label Period|Lost to Follow-up|1|||
150240666|NCT02493946|542016888|FG000|Open Label Period|Investigator decision, non-compliance|0|||
150240667|NCT02493946|542016889|FG001|Open Label Period|Investigator decision, non-compliance|0|||
150240668|NCT02493946|542016890|FG002|Open Label Period|Investigator decision, non-compliance|2|||
150240669|NCT02493946|542016888|FG000|Open Label Period|Investigator decision, non-availability|0|||
150240670|NCT02493946|542016889|FG001|Open Label Period|Investigator decision, non-availability|0|||
150240671|NCT02493946|542016890|FG002|Open Label Period|Investigator decision, non-availability|1|||
150240672|NCT02493946|542016888|FG000|Open Label Period|Pregnancy|0|||
150240673|NCT02493946|542016889|FG001|Open Label Period|Pregnancy|0|||
150240674|NCT02493946|542016890|FG002|Open Label Period|Pregnancy|3|||
150240675|NCT02493946|542016888|FG000|Open Label Period|Site error|0|||
150240676|NCT02493946|542016889|FG001|Open Label Period|Site error|0|||
150240677|NCT02493946|542016890|FG002|Open Label Period|Site error|1|||
150240678|NCT02559310|542016893|FG000|Overall Study|Death|4|||
150240679|NCT02559310|542016894|FG001|Overall Study|Death|3|||
150240680|NCT02559310|542016893|FG000|Overall Study|Lost to Follow-up|5|||
150240681|NCT02559310|542016894|FG001|Overall Study|Lost to Follow-up|3|||
150240682|NCT02559310|542016893|FG000|Overall Study|Physician Decision|2|||
150240683|NCT02559310|542016894|FG001|Overall Study|Physician Decision|1|||
150240684|NCT02559310|542016893|FG000|Overall Study|Withdrawal by Subject|13|||
150240685|NCT02559310|542016894|FG001|Overall Study|Withdrawal by Subject|9|||
150240686|NCT02559310|542016893|FG000|Overall Study|Sponsor Decision|0|||
150240687|NCT02559310|542016894|FG001|Overall Study|Sponsor Decision|1|||
150240688|NCT02559310|542016893|FG000|Overall Study|Randomized but not treated|3|||
150240689|NCT02559310|542016894|FG001|Overall Study|Randomized but not treated|2|||
150240690|NCT02633397|542016895|FG000|Overall Study|Adverse Event|8|||
150240691|NCT02633397|542016896|FG001|Overall Study|Adverse Event|8|||
150240692|NCT02633397|542016895|FG000|Overall Study|Study Burden|4|||
150240693|NCT02633397|542016896|FG001|Overall Study|Study Burden|1|||
150240694|NCT02633397|542016895|FG000|Overall Study|Treatment interruption|2|||
150240695|NCT02633397|542016896|FG001|Overall Study|Treatment interruption|5|||
150240696|NCT02633397|542016895|FG000|Overall Study|Death|2|||
150240697|NCT02633397|542016896|FG001|Overall Study|Death|2|||
150240698|NCT02633397|542016895|FG000|Overall Study|Physician Decision|0|||
150240699|NCT02633397|542016896|FG001|Overall Study|Physician Decision|1|||
150240700|NCT03036124|542016897|FG000|Overall Study|Lost to Follow-up|0|||
150240701|NCT03036124|542016898|FG001|Overall Study|Lost to Follow-up|2|||
150240702|NCT03036124|542016897|FG000|Overall Study|Withdrawal by Subject|5|||
150240703|NCT03036124|542016898|FG001|Overall Study|Withdrawal by Subject|4|||
150240704|NCT04021043|542018476|FG000|Overall Study|Adverse Event|3|||
150240705|NCT04021043|542018477|FG001|Overall Study|Adverse Event|1|||
150240706|NCT04021043|542018478|FG002|Overall Study|Adverse Event|1|||
150240707|NCT04021043|542018479|FG003|Overall Study|Adverse Event|0|||
150240708|NCT04021043|542018476|FG000|Overall Study|Death|2|||
150240709|NCT04021043|542018477|FG001|Overall Study|Death|3|||
150240710|NCT04021043|542018478|FG002|Overall Study|Death|1|||
150240711|NCT04021043|542018479|FG003|Overall Study|Death|3|||
150240712|NCT04021043|542018476|FG000|Overall Study|Withdrawal by Subject|1|||
150240713|NCT04021043|542018477|FG001|Overall Study|Withdrawal by Subject|1|||
150240714|NCT04021043|542018478|FG002|Overall Study|Withdrawal by Subject|1|||
150240715|NCT04021043|542018479|FG003|Overall Study|Withdrawal by Subject|6|||
150240716|NCT04021043|542018476|FG000|Overall Study|Discontinued due to disease progression|4|||
150240717|NCT04021043|542018477|FG001|Overall Study|Discontinued due to disease progression|5|||
150240718|NCT04021043|542018478|FG002|Overall Study|Discontinued due to disease progression|7|||
150240719|NCT04021043|542018479|FG003|Overall Study|Discontinued due to disease progression|10|||
150240720|NCT04441905|542018480|FG000|Overall Study|Lost to Follow-up|1|||
150240721|NCT04441905|542018481|FG001|Overall Study|Lost to Follow-up|0|||
150240722|NCT04441905|542018482|FG002|Overall Study|Lost to Follow-up|0|||
150240723|NCT04441905|542018483|FG003|Overall Study|Lost to Follow-up|0|||
150240724|NCT04441905|542018484|FG004|Overall Study|Lost to Follow-up|0|||
150240725|NCT04441905|542018485|FG005|Overall Study|Lost to Follow-up|0|||
150240726|NCT04441905|542018480|FG000|Overall Study|Enrolled but treatment not administered|0|||
150240727|NCT04441905|542018481|FG001|Overall Study|Enrolled but treatment not administered|1|||
150240728|NCT04441905|542018482|FG002|Overall Study|Enrolled but treatment not administered|0|||
150240729|NCT04441905|542018483|FG003|Overall Study|Enrolled but treatment not administered|0|||
150240730|NCT04441905|542018484|FG004|Overall Study|Enrolled but treatment not administered|0|||
150240731|NCT04441905|542018485|FG005|Overall Study|Enrolled but treatment not administered|0|||
150240732|NCT04441905|542018480|FG000|Overall Study|Became ineligible after enrollment|0|||
150240733|NCT04441905|542018481|FG001|Overall Study|Became ineligible after enrollment|0|||
150240734|NCT04441905|542018482|FG002|Overall Study|Became ineligible after enrollment|0|||
150240735|NCT04441905|542018483|FG003|Overall Study|Became ineligible after enrollment|0|||
150240736|NCT04441905|542018484|FG004|Overall Study|Became ineligible after enrollment|1|||
150240737|NCT04441905|542018485|FG005|Overall Study|Became ineligible after enrollment|0|||
150240738|NCT02562235|542018486|FG000|Overall Study|Adverse Event|3|||
150240739|NCT03945773|542018487|FG000|Overall Study|Consent Withdrawn|1|||
150240740|NCT03945773|542018488|FG001|Overall Study|Consent Withdrawn|1|||
150240741|NCT03945773|542018487|FG000|Overall Study|Lost to Follow-up|1|||
150240742|NCT03945773|542018488|FG001|Overall Study|Lost to Follow-up|0|||
150240743|NCT03945773|542018487|FG000|Overall Study|Death|46|||
150240744|NCT03945773|542018488|FG001|Overall Study|Death|22|||
150240745|NCT03945773|542018487|FG000|Overall Study|Physician Decision|1|||
150240746|NCT03945773|542018488|FG001|Overall Study|Physician Decision|0|||
150240747|NCT03945773|542018487|FG000|Overall Study|Other|1|||
150240748|NCT03945773|542018488|FG001|Overall Study|Other|0|||
150240749|NCT03945773|542018487|FG000|Overall Study|Ongoing at the time of DCO|4|||
150240750|NCT03945773|542018488|FG001|Overall Study|Ongoing at the time of DCO|3|||
150240751|NCT01920932|542018489|FG000|Overall Study|Death|1|||
150240752|NCT01920932|542018489|FG000|Overall Study|Withdrawal of consent|1|||
150240753|NCT04024462|542018490|FG000|Overall Study|Withdrawal by Subject|6|||
150240754|NCT04024462|542018491|FG001|Overall Study|Withdrawal by Subject|7|||
150240755|NCT04024462|542018490|FG000|Overall Study|Progressive Disease|0|||
150240756|NCT04024462|542018491|FG001|Overall Study|Progressive Disease|1|||
150240757|NCT04024462|542018490|FG000|Overall Study|Adverse Event|0|||
150240758|NCT04024462|542018491|FG001|Overall Study|Adverse Event|1|||
150240759|NCT04024462|542018490|FG000|Overall Study|Death|0|||
150240760|NCT04024462|542018491|FG001|Overall Study|Death|1|||
150240761|NCT04024462|542018490|FG000|Overall Study|Lost to Follow-up|1|||
150240762|NCT04024462|542018491|FG001|Overall Study|Lost to Follow-up|0|||
150240763|NCT04024462|542018490|FG000|Overall Study|Ongoing in the Study|94|||
150240764|NCT04024462|542018491|FG001|Overall Study|Ongoing in the Study|89|||
150240765|NCT05274750|542018492|FG000|Overall Study|Adverse Event|0|||
150240766|NCT05274750|542018493|FG001|Overall Study|Adverse Event|1|||
150240767|NCT05274750|542018492|FG000|Overall Study|Lost to Follow-up|2|||
150240768|NCT05274750|542018493|FG001|Overall Study|Lost to Follow-up|3|||
150240769|NCT05274750|542018492|FG000|Overall Study|Physician Decision|3|||
150240770|NCT05274750|542018493|FG001|Overall Study|Physician Decision|0|||
150240771|NCT05274750|542018492|FG000|Overall Study|Withdrawal by Subject|10|||
150240772|NCT05274750|542018493|FG001|Overall Study|Withdrawal by Subject|9|||
150240773|NCT05274750|542018492|FG000|Overall Study|GCP Violation|0|||
150240774|NCT05274750|542018493|FG001|Overall Study|GCP Violation|4|||
150240775|NCT05274750|542018492|FG000|Overall Study|Randomized, not treated|0|||
150240776|NCT05274750|542018493|FG001|Overall Study|Randomized, not treated|1|||
150240777|NCT04328623|542018498|FG000|Overall Study|Protocol Violation|0|||
150240778|NCT04328623|542018499|FG001|Overall Study|Protocol Violation|1|||
150240779|NCT05687032|542018500|FG000|Treatment Phase|Adverse Event|13|||
150240780|NCT05687032|542018500|FG000|Treatment Phase|Death|1|||
150240781|NCT05687032|542018500|FG000|Treatment Phase|Physician Decision|3|||
150240782|NCT05687032|542018500|FG000|Treatment Phase|Progressive disease|9|||
150240783|NCT05687032|542018500|FG000|Treatment Phase|Withdrawal by Subject|5|||
150240784|NCT05687032|542018500|FG000|Follow-Up Phase|Death|16|||
150240785|NCT05687032|542018500|FG000|Follow-Up Phase|Ongoing|26|||
150240786|NCT03912662|542018503|FG000|Overall Study|Adverse Event|3|||
150240787|NCT03912662|542018503|FG000|Overall Study|Adverse Event and Death|1|||
150240788|NCT03912662|542018503|FG000|Overall Study|Death|1|||
150240789|NCT03912662|542018503|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
150240790|NCT03912662|542018503|FG000|Overall Study|Mesh Removal|1|||
150240791|NCT03912662|542018503|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
150240792|NCT03912662|542018503|FG000|Overall Study|Early study termination|20|||
150240793|NCT03880019|542018505|FG000|Overall Study|Competing disease|1|||
150240794|NCT03934099|542018506|FG000|Overall Study|Adverse Event|0|||
150240795|NCT03934099|542018507|FG001|Overall Study|Adverse Event|3|||
150240796|NCT03934099|542018508|FG002|Overall Study|Adverse Event|1|||
150240797|NCT03934099|542018509|FG003|Overall Study|Adverse Event|0|||
150240798|NCT03934099|542018506|FG000|Overall Study|Lost to Follow-up|1|||
150240799|NCT03934099|542018507|FG001|Overall Study|Lost to Follow-up|2|||
150240800|NCT03934099|542018508|FG002|Overall Study|Lost to Follow-up|1|||
150240801|NCT03934099|542018509|FG003|Overall Study|Lost to Follow-up|1|||
150240802|NCT03934099|542018506|FG000|Overall Study|Protocol Violation|1|||
150240803|NCT03934099|542018507|FG001|Overall Study|Protocol Violation|0|||
150240804|NCT03934099|542018508|FG002|Overall Study|Protocol Violation|0|||
150240805|NCT03934099|542018509|FG003|Overall Study|Protocol Violation|0|||
150240806|NCT03934099|542018506|FG000|Overall Study|Withdrawal by Subject|2|||
150240807|NCT03934099|542018507|FG001|Overall Study|Withdrawal by Subject|0|||
150240808|NCT03934099|542018508|FG002|Overall Study|Withdrawal by Subject|1|||
150240809|NCT03934099|542018509|FG003|Overall Study|Withdrawal by Subject|1|||
150240810|NCT03934099|542018506|FG000|Overall Study|Other reasons|0|||
150240811|NCT03934099|542018507|FG001|Overall Study|Other reasons|1|||
150240812|NCT03934099|542018508|FG002|Overall Study|Other reasons|0|||
150240813|NCT03934099|542018509|FG003|Overall Study|Other reasons|0|||
150240814|NCT05628285|542018510|FG000|Overall Study|Lost to Follow-up|1|||
150240815|NCT02339506|542018511|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
150240816|NCT02339506|542018512|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
150240817|NCT02339506|542018511|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
150240818|NCT02339506|542018512|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
150240819|NCT02869867|542018513|FG000|Overall Study|Protocol Violation|1|||
150240820|NCT02869867|542018514|FG001|Overall Study|Protocol Violation|0|||
150240821|NCT02869867|542018513|FG000|Overall Study|Lost to Follow-up|5|||
150240822|NCT02869867|542018514|FG001|Overall Study|Lost to Follow-up|5|||
150240823|NCT05218499|542018515|FG000|Overall Study|Not treated|1|||
150240824|NCT05218499|542018516|FG001|Overall Study|Not treated|1|||
150240825|NCT05218499|542018517|FG002|Overall Study|Not treated|8|||
150240826|NCT05218499|542018515|FG000|Overall Study|Death|2|||
150240827|NCT05218499|542018516|FG001|Overall Study|Death|0|||
150240828|NCT05218499|542018517|FG002|Overall Study|Death|0|||
150240829|NCT05218499|542018515|FG000|Overall Study|Other than listed|3|||
150240830|NCT05218499|542018516|FG001|Overall Study|Other than listed|7|||
150240831|NCT05218499|542018517|FG002|Overall Study|Other than listed|10|||
150240832|NCT05218499|542018515|FG000|Overall Study|Protocol deviation|5|||
150240833|NCT05218499|542018516|FG001|Overall Study|Protocol deviation|6|||
150240834|NCT05218499|542018517|FG002|Overall Study|Protocol deviation|4|||
150240835|NCT05218499|542018515|FG000|Overall Study|Technical problems|0|||
150240836|NCT05218499|542018516|FG001|Overall Study|Technical problems|1|||
150240837|NCT05218499|542018517|FG002|Overall Study|Technical problems|0|||
150240838|NCT05218499|542018515|FG000|Overall Study|Burden of trial procedures|0|||
150240839|NCT05218499|542018516|FG001|Overall Study|Burden of trial procedures|1|||
150240840|NCT05218499|542018517|FG002|Overall Study|Burden of trial procedures|2|||
150240841|NCT05218499|542018515|FG000|Overall Study|Clinical disease progression|6|||
150240842|NCT05218499|542018516|FG001|Overall Study|Clinical disease progression|6|||
150240843|NCT05218499|542018517|FG002|Overall Study|Clinical disease progression|11|||
150240844|NCT05218499|542018515|FG000|Overall Study|Objective disease progression|44|||
150240845|NCT05218499|542018516|FG001|Overall Study|Objective disease progression|61|||
150240846|NCT05218499|542018517|FG002|Overall Study|Objective disease progression|42|||
150240847|NCT05218499|542018515|FG000|Overall Study|Adverse Event|11|||
150240848|NCT05218499|542018516|FG001|Overall Study|Adverse Event|36|||
150240849|NCT05218499|542018517|FG002|Overall Study|Adverse Event|9|||
150240850|NCT05218499|542018515|FG000|Overall Study|On treatment at time of snapshot|18|||
150240851|NCT05218499|542018516|FG001|Overall Study|On treatment at time of snapshot|29|||
150240852|NCT05218499|542018517|FG002|Overall Study|On treatment at time of snapshot|0|||
150240853|NCT05555615|542018519|FG000|Overall Study|Adverse Event|7|||
150240854|NCT05555615|542018519|FG000|Overall Study|Lack of Efficacy|12|||
150240855|NCT05555615|542018519|FG000|Overall Study|Lost to Follow-up|10|||
150240856|NCT05555615|542018519|FG000|Overall Study|Noncompliance with study drug|5|||
150240857|NCT05555615|542018519|FG000|Overall Study|Physician Decision|2|||
150240858|NCT05555615|542018519|FG000|Overall Study|Study terminated by sponsor|80|||
150240859|NCT05555615|542018519|FG000|Overall Study|Prohibited medication use|2|||
150240860|NCT05555615|542018519|FG000|Overall Study|Withdrawal by Subject|20|||
150240861|NCT05555615|542018519|FG000|Overall Study|Not further specified|4|||
150240862|NCT03635086|542018520|FG000|Overall Study|Withdrawal of consent|0|||
150240863|NCT03635086|542018521|FG001|Overall Study|Withdrawal of consent|0|||
150240864|NCT03635086|542018522|FG002|Overall Study|Withdrawal of consent|1|||
150240865|NCT03635086|542018523|FG003|Overall Study|Withdrawal of consent|0|||
150240866|NCT03635086|542018524|FG004|Overall Study|Withdrawal of consent|0|||
150240867|NCT03635086|542018520|FG000|Overall Study|Adverse Event|0|||
150240868|NCT03635086|542018521|FG001|Overall Study|Adverse Event|1|||
150240869|NCT03635086|542018522|FG002|Overall Study|Adverse Event|0|||
150240870|NCT03635086|542018523|FG003|Overall Study|Adverse Event|0|||
150240871|NCT03635086|542018524|FG004|Overall Study|Adverse Event|0|||
150240872|NCT03635086|542018520|FG000|Overall Study|Lost to Follow-up|1|||
150240873|NCT03635086|542018521|FG001|Overall Study|Lost to Follow-up|0|||
150240874|NCT03635086|542018522|FG002|Overall Study|Lost to Follow-up|0|||
150240875|NCT03635086|542018523|FG003|Overall Study|Lost to Follow-up|0|||
150240876|NCT03635086|542018524|FG004|Overall Study|Lost to Follow-up|0|||
150240877|NCT02196077|542018525|FG000|Overall Study|Adverse Event|4|||
150240878|NCT02196077|542018525|FG000|Overall Study|Lack of Efficacy|1|||
150240879|NCT02196077|542018525|FG000|Overall Study|Withdrawal by Subject|14|||
150240880|NCT02196077|542018525|FG000|Overall Study|Physician Decision|1|||
150240881|NCT02196077|542018525|FG000|Overall Study|Lost to Follow-up|3|||
150240882|NCT02196077|542018525|FG000|Overall Study|Protocol Violation|24|||
150240883|NCT03482752|542018528|FG000|Overall Study|Withdrawal by Subject|2|||
150240884|NCT03482752|542018528|FG000|Overall Study|Lost to Follow-up|1|||
150240885|NCT03482752|542018528|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
150240886|NCT02844777|542018529|FG000|Overall Study|Withdrawal by Subject|2|||
150240887|NCT02844777|542018530|FG001|Overall Study|Withdrawal by Subject|0|||
150240888|NCT02844777|542018531|FG002|Overall Study|Withdrawal by Subject|0|||
150240889|NCT00150618|542018533|FG000|Overall Study|Adverse Event|2|||
150240890|NCT00150618|542018534|FG001|Overall Study|Adverse Event|2|||
150240891|NCT00150618|542018535|FG002|Overall Study|Adverse Event|6|||
150240892|NCT00150618|542018536|FG003|Overall Study|Adverse Event|9|||
150240893|NCT00150618|542018537|FG004|Overall Study|Adverse Event|5|||
150240894|NCT00150618|542018533|FG000|Overall Study|Withdrawal by Subject|6|||
150240895|NCT00150618|542018534|FG001|Overall Study|Withdrawal by Subject|8|||
150240896|NCT00150618|542018535|FG002|Overall Study|Withdrawal by Subject|8|||
150240897|NCT00150618|542018536|FG003|Overall Study|Withdrawal by Subject|4|||
150240898|NCT00150618|542018537|FG004|Overall Study|Withdrawal by Subject|5|||
150240899|NCT00150618|542018533|FG000|Overall Study|Lost to Follow-up|4|||
150240900|NCT00150618|542018534|FG001|Overall Study|Lost to Follow-up|1|||
150240901|NCT00150618|542018535|FG002|Overall Study|Lost to Follow-up|5|||
150240902|NCT00150618|542018536|FG003|Overall Study|Lost to Follow-up|8|||
150240903|NCT00150618|542018537|FG004|Overall Study|Lost to Follow-up|4|||
150240904|NCT00150618|542018533|FG000|Overall Study|Protocol Violation|1|||
150240905|NCT00150618|542018534|FG001|Overall Study|Protocol Violation|0|||
150240906|NCT00150618|542018535|FG002|Overall Study|Protocol Violation|0|||
150240907|NCT00150618|542018536|FG003|Overall Study|Protocol Violation|0|||
150240908|NCT00150618|542018537|FG004|Overall Study|Protocol Violation|1|||
150240909|NCT00150618|542018533|FG000|Overall Study|Lack of Efficacy|1|||
150240910|NCT00150618|542018534|FG001|Overall Study|Lack of Efficacy|4|||
150240911|NCT00150618|542018535|FG002|Overall Study|Lack of Efficacy|7|||
150240912|NCT00150618|542018536|FG003|Overall Study|Lack of Efficacy|4|||
150240913|NCT00150618|542018537|FG004|Overall Study|Lack of Efficacy|6|||
150240914|NCT00150618|542018533|FG000|Overall Study|No study meds|0|||
150240915|NCT00150618|542018534|FG001|Overall Study|No study meds|0|||
150240916|NCT00150618|542018535|FG002|Overall Study|No study meds|0|||
150240917|NCT00150618|542018536|FG003|Overall Study|No study meds|0|||
150240918|NCT00150618|542018537|FG004|Overall Study|No study meds|2|||
150240919|NCT00150618|542018533|FG000|Overall Study|Physician Decision|0|||
150240920|NCT00150618|542018534|FG001|Overall Study|Physician Decision|2|||
150240921|NCT00150618|542018535|FG002|Overall Study|Physician Decision|0|||
150240922|NCT00150618|542018536|FG003|Overall Study|Physician Decision|0|||
150240923|NCT00150618|542018537|FG004|Overall Study|Physician Decision|1|||
150240924|NCT00150618|542018533|FG000|Overall Study|Lack of compliance|2|||
150240925|NCT00150618|542018534|FG001|Overall Study|Lack of compliance|1|||
150240926|NCT00150618|542018535|FG002|Overall Study|Lack of compliance|1|||
150240927|NCT00150618|542018536|FG003|Overall Study|Lack of compliance|0|||
150240928|NCT00150618|542018537|FG004|Overall Study|Lack of compliance|1|||
150240929|NCT00150618|542018533|FG000|Overall Study|Abnormal ECG|1|||
150240930|NCT00150618|542018534|FG001|Overall Study|Abnormal ECG|0|||
150240931|NCT00150618|542018535|FG002|Overall Study|Abnormal ECG|0|||
150240932|NCT00150618|542018536|FG003|Overall Study|Abnormal ECG|0|||
150240933|NCT00150618|542018537|FG004|Overall Study|Abnormal ECG|0|||
150240934|NCT00150618|542018533|FG000|Overall Study|Sponsor's decision|0|||
150240935|NCT00150618|542018534|FG001|Overall Study|Sponsor's decision|0|||
150240936|NCT00150618|542018535|FG002|Overall Study|Sponsor's decision|0|||
150240937|NCT00150618|542018536|FG003|Overall Study|Sponsor's decision|1|||
150240938|NCT00150618|542018537|FG004|Overall Study|Sponsor's decision|0|||
150240939|NCT00762476|542018538|FG000|Overall Study|Adverse Event|7|||
150240940|NCT00762476|542018539|FG001|Overall Study|Adverse Event|1|||
150240941|NCT00762476|542018538|FG000|Overall Study|Lost to Follow-up|2|||
150240942|NCT00762476|542018539|FG001|Overall Study|Lost to Follow-up|0|||
150240943|NCT00762476|542018538|FG000|Overall Study|Protocol Violation|5|||
150240944|NCT00762476|542018539|FG001|Overall Study|Protocol Violation|6|||
150240945|NCT00762476|542018538|FG000|Overall Study|Physician Decision|2|||
150240946|NCT00762476|542018539|FG001|Overall Study|Physician Decision|14|||
150240947|NCT00762476|542018538|FG000|Overall Study|Withdrawal by Subject|6|||
150240948|NCT00762476|542018539|FG001|Overall Study|Withdrawal by Subject|12|||
150240949|NCT00762476|542018538|FG000|Overall Study|antibiotic use|0|||
150240950|NCT00762476|542018539|FG001|Overall Study|antibiotic use|1|||
150240951|NCT00762476|542018538|FG000|Overall Study|non-compliance with study visits|0|||
150240952|NCT00762476|542018539|FG001|Overall Study|non-compliance with study visits|2|||
150240953|NCT00762476|542018538|FG000|Overall Study|Seasonal allergies|1|||
150240954|NCT00762476|542018539|FG001|Overall Study|Seasonal allergies|0|||
150240955|NCT00965497|542018540|FG000|Overall Study|Physician Decision|1|||
150240956|NCT02878603|542018541|FG000|Overall Study|Lost to Follow-up|4|||
150240957|NCT02878603|542018542|FG001|Overall Study|Lost to Follow-up|1|||
150240958|NCT02878603|542018541|FG000|Overall Study|Withdrawal by Subject|1|||
150240959|NCT02878603|542018542|FG001|Overall Study|Withdrawal by Subject|1|||
150240960|NCT02878603|542018541|FG000|Overall Study|Death|1|||
150240961|NCT02878603|542018542|FG001|Overall Study|Death|0|||
150240962|NCT02878603|542018541|FG000|Overall Study|Physician Decision|0|||
150240963|NCT02878603|542018542|FG001|Overall Study|Physician Decision|3|||
150240964|NCT02781311|542018551|FG000|Overall Study|Adverse Event|2|||
150240965|NCT02781311|542018552|FG001|Overall Study|Adverse Event|6|||
150240966|NCT02781311|542018553|FG002|Overall Study|Adverse Event|1|||
150240967|NCT02781311|542018551|FG000|Overall Study|Withdrawal of Consent|11|||
150240968|NCT02781311|542018552|FG001|Overall Study|Withdrawal of Consent|12|||
150240969|NCT02781311|542018553|FG002|Overall Study|Withdrawal of Consent|2|||
150240970|NCT02781311|542018551|FG000|Overall Study|Lost to Follow-up|11|||
150240971|NCT02781311|542018552|FG001|Overall Study|Lost to Follow-up|8|||
150240972|NCT02781311|542018553|FG002|Overall Study|Lost to Follow-up|1|||
150240973|NCT02781311|542018551|FG000|Overall Study|Non-Compliance with Study Drug|2|||
150240974|NCT02781311|542018552|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150240975|NCT02781311|542018553|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150240976|NCT04547023|542018562|FG000|Overall Study|Did Not Receive Intervention|3|||
150240977|NCT04547023|542018563|FG001|Overall Study|Did Not Receive Intervention|2|||
150240978|NCT04547023|542018562|FG000|Overall Study|Lost to Follow-up|1|||
150240979|NCT04547023|542018563|FG001|Overall Study|Lost to Follow-up|1|||
150240980|NCT00250432|542018564|FG000|Overall Study|Adverse Event|25|||
150240981|NCT00250432|542018565|FG001|Overall Study|Adverse Event|29|||
150240982|NCT00250432|542018564|FG000|Overall Study|Lack of Efficacy|2|||
150240983|NCT00250432|542018565|FG001|Overall Study|Lack of Efficacy|1|||
150240984|NCT00250432|542018564|FG000|Overall Study|Lost to Follow-up|6|||
150240985|NCT00250432|542018565|FG001|Overall Study|Lost to Follow-up|5|||
150240986|NCT00250432|542018564|FG000|Overall Study|Patient Moved|0|||
150240987|NCT00250432|542018565|FG001|Overall Study|Patient Moved|1|||
150240988|NCT00250432|542018564|FG000|Overall Study|Protocol Violation|0|||
150240989|NCT00250432|542018565|FG001|Overall Study|Protocol Violation|3|||
150240990|NCT00250432|542018564|FG000|Overall Study|Withdrawal by Subject|6|||
150240991|NCT00250432|542018565|FG001|Overall Study|Withdrawal by Subject|2|||
150240992|NCT00250432|542018564|FG000|Overall Study|Pt died out of posttherapy report period|6|||
150240993|NCT00250432|542018565|FG001|Overall Study|Pt died out of posttherapy report period|5|||
150240994|NCT00250432|542018564|FG000|Overall Study|Pt was considered untreatable|0|||
150240995|NCT00250432|542018565|FG001|Overall Study|Pt was considered untreatable|1|||
150240996|NCT01011868|542018566|FG000|After Week 18 Follow-up|Adverse Event|8|||
150240997|NCT01011868|542018567|FG001|After Week 18 Follow-up|Adverse Event|6|||
150240998|NCT01011868|542018568|FG002|After Week 18 Follow-up|Adverse Event|13|||
150240999|NCT01011868|542018566|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
150241000|NCT01011868|542018567|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
150241001|NCT01011868|542018568|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
150241002|NCT01011868|542018566|FG000|After Week 18 Follow-up|Protocol Violation|1|||
150241003|NCT01011868|542018567|FG001|After Week 18 Follow-up|Protocol Violation|1|||
150241004|NCT01011868|542018568|FG002|After Week 18 Follow-up|Protocol Violation|1|||
150241005|NCT01011868|542018566|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
150241006|NCT01011868|542018567|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
150241007|NCT01011868|542018568|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
150241008|NCT01011868|542018566|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
150241009|NCT01011868|542018567|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
150241010|NCT01011868|542018568|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
150241011|NCT01011868|542018566|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
150241012|NCT01011868|542018567|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
150241013|NCT01011868|542018568|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
150241014|NCT01011868|542018566|FG000|After Week 78 Follow-up|Adverse Event|14|||
150241015|NCT01011868|542018567|FG001|After Week 78 Follow-up|Adverse Event|18|||
150241016|NCT01011868|542018568|FG002|After Week 78 Follow-up|Adverse Event|21|||
150241017|NCT01011868|542018566|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
150241018|NCT01011868|542018567|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
150241019|NCT01011868|542018568|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
150241020|NCT01011868|542018566|FG000|After Week 78 Follow-up|Protocol Violation|9|||
150241021|NCT01011868|542018567|FG001|After Week 78 Follow-up|Protocol Violation|1|||
150241022|NCT01011868|542018568|FG002|After Week 78 Follow-up|Protocol Violation|2|||
150241023|NCT01011868|542018566|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
150241024|NCT01011868|542018567|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
150241025|NCT01011868|542018568|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
150241026|NCT01011868|542018566|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
150241027|NCT01011868|542018567|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
150241028|NCT01011868|542018568|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
150241029|NCT01011868|542018566|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
150241030|NCT01011868|542018567|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
150241031|NCT01011868|542018568|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
150241032|NCT01262092|542018569|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
150241033|NCT01262092|542018570|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
150241034|NCT01262092|542018569|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
150241035|NCT01262092|542018570|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
150241036|NCT01262092|542018569|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
150241037|NCT01262092|542018570|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
150241038|NCT01262092|542018569|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
150241039|NCT01262092|542018570|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
150241040|NCT03784820|542018571|FG000|Overall Study|Lost to Follow-up|5|||
150241041|NCT03784820|542018572|FG001|Overall Study|Lost to Follow-up|5|||
150241042|NCT03784820|542018573|FG002|Overall Study|Lost to Follow-up|3|||
150241043|NCT03784820|542018574|FG003|Overall Study|Lost to Follow-up|3|||
150241044|NCT01255761|542018575|FG000|Overall Study|Adverse Event|29|||
150241045|NCT01255761|542018576|FG001|Overall Study|Adverse Event|43|||
150241046|NCT01255761|542018575|FG000|Overall Study|Lack of Efficacy|86|||
150241047|NCT01255761|542018576|FG001|Overall Study|Lack of Efficacy|74|||
150241048|NCT01255761|542018575|FG000|Overall Study|Protocol Violation|9|||
150241049|NCT01255761|542018576|FG001|Overall Study|Protocol Violation|5|||
150241050|NCT01255761|542018575|FG000|Overall Study|Lost to Follow-up|10|||
150241051|NCT01255761|542018576|FG001|Overall Study|Lost to Follow-up|8|||
150241052|NCT01255761|542018575|FG000|Overall Study|Withdrawal by Subject|11|||
150241053|NCT01255761|542018576|FG001|Overall Study|Withdrawal by Subject|27|||
150241054|NCT01255761|542018575|FG000|Overall Study|Other Reasons|37|||
150241055|NCT01255761|542018576|FG001|Overall Study|Other Reasons|18|||
150241056|NCT02336425|542018577|FG000|Overall Study|Study terminated.|2|||
150241057|NCT02336425|542018578|FG001|Overall Study|Study terminated.|2|||
150241058|NCT02336425|542018579|FG002|Overall Study|Study terminated.|3|||
150241059|NCT02336425|542018580|FG003|Overall Study|Study terminated.|3|||
150241060|NCT00658606|542018581|FG000|Overall Study|Adverse Event|2|||
150241061|NCT00658606|542018582|FG001|Overall Study|Adverse Event|1|||
150241062|NCT00658606|542018581|FG000|Overall Study|Lack of Efficacy|6|||
150241063|NCT00658606|542018582|FG001|Overall Study|Lack of Efficacy|3|||
150241064|NCT00658606|542018581|FG000|Overall Study|Lost to Follow-up|1|||
150241065|NCT00658606|542018582|FG001|Overall Study|Lost to Follow-up|0|||
150241066|NCT00658606|542018581|FG000|Overall Study|Withdrawal by Subject|7|||
150241067|NCT00658606|542018582|FG001|Overall Study|Withdrawal by Subject|16|||
150241068|NCT00658606|542018581|FG000|Overall Study|Lack of Compliance|0|||
150241069|NCT00658606|542018582|FG001|Overall Study|Lack of Compliance|3|||
150241070|NCT04905849|542018583|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
150241071|NCT04905849|542018584|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
150241072|NCT01056263|542018590|FG000|Overall Study|Adverse Event|12|||
150241073|NCT01056263|542018590|FG000|Overall Study|Death|1|||
150241074|NCT01056263|542018590|FG000|Overall Study|Withdrawal by Subject|1|||
150241075|NCT01056263|542018590|FG000|Overall Study|Lack of Efficacy|29|||
150241076|NCT01056263|542018590|FG000|Overall Study|Progressive disease|2|||
150241077|NCT01056263|542018590|FG000|Overall Study|Neoplasm progression|1|||
150241078|NCT01056263|542018590|FG000|Overall Study|Objective progression or relapse|1|||
150241079|NCT01056263|542018590|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
150241080|NCT00838929|542018592|FG000|Overall Study|Protocol Violation|0|||
150241081|NCT00838929|542018593|FG001|Overall Study|Protocol Violation|1|||
150241082|NCT00838929|542018594|FG002|Overall Study|Protocol Violation|0|||
150241083|NCT00838929|542018592|FG000|Overall Study|Disease progression|0|||
150241084|NCT00838929|542018593|FG001|Overall Study|Disease progression|2|||
150241085|NCT00838929|542018594|FG002|Overall Study|Disease progression|1|||
150241086|NCT00699842|542018599|FG000|Overall Study|Death|0|||
150241087|NCT00699842|542018600|FG001|Overall Study|Death|1|||
150241088|NCT00699842|542018601|FG002|Overall Study|Death|0|||
150241089|NCT03595124|542020150|FG000|Overall Study|Physician Decision|1|||
150241090|NCT03595124|542020151|FG001|Overall Study|Physician Decision|1|||
150241091|NCT03595124|542020152|FG002|Overall Study|Physician Decision|1|||
150241092|NCT03595124|542020150|FG000|Overall Study|Ineligible|1|||
150241093|NCT03595124|542020151|FG001|Overall Study|Ineligible|1|||
150241094|NCT03595124|542020152|FG002|Overall Study|Ineligible|0|||
150241095|NCT03595124|542020150|FG000|Overall Study|Disease Progression|4|||
150241096|NCT03595124|542020151|FG001|Overall Study|Disease Progression|1|||
150241097|NCT03595124|542020152|FG002|Overall Study|Disease Progression|4|||
150241098|NCT03607422|542020155|FG000|Overall Study|Adverse Event|7|||
150241099|NCT03607422|542020156|FG001|Overall Study|Adverse Event|3|||
150241100|NCT03607422|542020157|FG002|Overall Study|Adverse Event|2|||
150241101|NCT03607422|542020158|FG003|Overall Study|Adverse Event|0|||
150241102|NCT03607422|542020159|FG004|Overall Study|Adverse Event|2|||
150241103|NCT03607422|542020160|FG005|Overall Study|Adverse Event|0|||
150241104|NCT03607422|542020155|FG000|Overall Study|Withdrawal by Subject|11|||
150241105|NCT03607422|542020156|FG001|Overall Study|Withdrawal by Subject|3|||
150241106|NCT03607422|542020157|FG002|Overall Study|Withdrawal by Subject|6|||
150241107|NCT03607422|542020158|FG003|Overall Study|Withdrawal by Subject|2|||
150241108|NCT03607422|542020159|FG004|Overall Study|Withdrawal by Subject|0|||
150241109|NCT03607422|542020160|FG005|Overall Study|Withdrawal by Subject|0|||
150241110|NCT03607422|542020155|FG000|Overall Study|Lost to Follow-up|0|||
150241111|NCT03607422|542020156|FG001|Overall Study|Lost to Follow-up|0|||
150241112|NCT03607422|542020157|FG002|Overall Study|Lost to Follow-up|1|||
150241113|NCT03607422|542020158|FG003|Overall Study|Lost to Follow-up|0|||
150241114|NCT03607422|542020159|FG004|Overall Study|Lost to Follow-up|0|||
150241115|NCT03607422|542020160|FG005|Overall Study|Lost to Follow-up|0|||
150241116|NCT03607422|542020155|FG000|Overall Study|Other|12|||
150241117|NCT03607422|542020156|FG001|Overall Study|Other|4|||
150241118|NCT03607422|542020157|FG002|Overall Study|Other|1|||
150241119|NCT03607422|542020158|FG003|Overall Study|Other|2|||
150241120|NCT03607422|542020159|FG004|Overall Study|Other|0|||
150241121|NCT03607422|542020160|FG005|Overall Study|Other|2|||
150241122|NCT03607422|542020155|FG000|Overall Study|Ongoing at Time of Analysis|8|||
150241123|NCT03607422|542020156|FG001|Overall Study|Ongoing at Time of Analysis|0|||
150241124|NCT03607422|542020157|FG002|Overall Study|Ongoing at Time of Analysis|2|||
150241125|NCT03607422|542020158|FG003|Overall Study|Ongoing at Time of Analysis|1|||
150241126|NCT03607422|542020159|FG004|Overall Study|Ongoing at Time of Analysis|1|||
150241127|NCT03607422|542020160|FG005|Overall Study|Ongoing at Time of Analysis|1|||
150241128|NCT04832971|542020161|FG000|Double-Blind (DB) Treatment Period|Death|1|||
150241129|NCT04832971|542020162|FG001|Double-Blind (DB) Treatment Period|Death|0|||
150241130|NCT04832971|542020163|FG002|Double-Blind (DB) Treatment Period|Death|0|||
150241131|NCT04832971|542020164|FG003|Double-Blind (DB) Treatment Period|Death|0|||
150241132|NCT04832971|542020165|FG004|Double-Blind (DB) Treatment Period|Death|0|||
150241133|NCT04832971|542020166|FG005|Double-Blind (DB) Treatment Period|Death|0|||
150241134|NCT04832971|542020167|FG006|Double-Blind (DB) Treatment Period|Death|0|||
150241135|NCT04832971|542020168|FG007|Double-Blind (DB) Treatment Period|Death|0|||
150241136|NCT04832971|542020169|FG008|Double-Blind (DB) Treatment Period|Death|0|||
150241137|NCT04832971|542020170|FG009|Double-Blind (DB) Treatment Period|Death|0|||
150241138|NCT04832971|542020161|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
150241139|NCT04832971|542020162|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
150241140|NCT04832971|542020163|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
150241141|NCT04832971|542020164|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241142|NCT04832971|542020165|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241143|NCT04832971|542020166|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241144|NCT04832971|542020167|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241145|NCT04832971|542020168|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241146|NCT04832971|542020169|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241147|NCT04832971|542020170|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
150241148|NCT04832971|542020161|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
150241149|NCT04832971|542020162|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
150241150|NCT04832971|542020163|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
150241151|NCT04832971|542020164|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
150241152|NCT04832971|542020165|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241153|NCT04832971|542020166|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241154|NCT04832971|542020167|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241155|NCT04832971|542020168|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241156|NCT04832971|542020169|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241157|NCT04832971|542020170|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
150241158|NCT04832971|542020161|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241159|NCT04832971|542020162|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
150241160|NCT04832971|542020163|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241161|NCT04832971|542020164|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241162|NCT04832971|542020165|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241163|NCT04832971|542020166|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241164|NCT04832971|542020167|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241165|NCT04832971|542020168|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241166|NCT04832971|542020169|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241167|NCT04832971|542020170|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
150241168|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241169|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241170|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241171|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241172|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241173|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
150241174|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
150241175|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
150241176|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
150241177|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
150241178|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Death|0|||
150241179|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Death|0|||
150241180|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Death|0|||
150241181|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Death|0|||
150241182|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Death|0|||
150241183|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Death|0|||
150241184|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Death|0|||
150241185|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Death|1|||
150241186|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Death|0|||
150241187|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Death|0|||
150241188|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241189|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241190|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241191|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241192|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241193|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241194|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
150241195|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
150241196|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241197|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
150241198|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
150241199|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
150241200|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
150241201|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
150241202|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
150241203|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
150241204|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
150241205|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
150241206|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
150241207|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
150241208|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150241209|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150241210|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150241211|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150241212|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
150241213|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
150241214|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150241215|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
150241216|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
150241217|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
150241218|NCT04832971|542020161|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241219|NCT04832971|542020162|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241220|NCT04832971|542020163|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241221|NCT04832971|542020164|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241222|NCT04832971|542020165|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241223|NCT04832971|542020166|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241224|NCT04832971|542020167|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
150241225|NCT04832971|542020168|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
150241226|NCT04832971|542020169|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
150241227|NCT04832971|542020170|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
150241228|NCT03584152|542020171|FG000|Overall Study|Discontinued intervention|7|||
150241229|NCT03584152|542020172|FG001|Overall Study|Discontinued intervention|4|||
150241230|NCT00433511|542020177|FG000|Step 1|Adverse Event|50|||
150241231|NCT00433511|542020178|FG001|Step 1|Adverse Event|157|||
150241232|NCT00433511|542020179|FG002|Step 1|Adverse Event|153|||
150241233|NCT00433511|542020177|FG000|Step 1|Withdrawal by Subject|45|||
150241234|NCT00433511|542020178|FG001|Step 1|Withdrawal by Subject|143|||
150241235|NCT00433511|542020179|FG002|Step 1|Withdrawal by Subject|154|||
150241236|NCT00433511|542020177|FG000|Step 1|Death|3|||
150241237|NCT00433511|542020178|FG001|Step 1|Death|1|||
150241238|NCT00433511|542020179|FG002|Step 1|Death|1|||
150241239|NCT00433511|542020177|FG000|Step 1|Physician Decision|1|||
150241240|NCT00433511|542020178|FG001|Step 1|Physician Decision|4|||
150241241|NCT00433511|542020179|FG002|Step 1|Physician Decision|3|||
150241242|NCT00433511|542020177|FG000|Step 1|Never started protocol therapy|28|||
150241243|NCT00433511|542020178|FG001|Step 1|Never started protocol therapy|64|||
150241244|NCT00433511|542020179|FG002|Step 1|Never started protocol therapy|66|||
150241245|NCT00433511|542020177|FG000|Step 1|Alternative therapy|2|||
150241246|NCT00433511|542020178|FG001|Step 1|Alternative therapy|1|||
150241247|NCT00433511|542020179|FG002|Step 1|Alternative therapy|3|||
150241248|NCT00433511|542020177|FG000|Step 1|Disease progression, relapse|5|||
150241249|NCT00433511|542020178|FG001|Step 1|Disease progression, relapse|3|||
150241250|NCT00433511|542020179|FG002|Step 1|Disease progression, relapse|3|||
150241251|NCT00433511|542020177|FG000|Step 1|Other complicating disease|2|||
150241252|NCT00433511|542020178|FG001|Step 1|Other complicating disease|6|||
150241253|NCT00433511|542020179|FG002|Step 1|Other complicating disease|3|||
150241254|NCT00433511|542020177|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
150241255|NCT00433511|542020178|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
150241256|NCT00433511|542020179|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
150241257|NCT00433511|542020177|FG000|Step 1|Suspected recurrence|0|||
150241258|NCT00433511|542020178|FG001|Step 1|Suspected recurrence|1|||
150241259|NCT00433511|542020179|FG002|Step 1|Suspected recurrence|0|||
150241260|NCT00433511|542020177|FG000|Step 1|Insurance/drug distribution issues|0|||
150241261|NCT00433511|542020178|FG001|Step 1|Insurance/drug distribution issues|1|||
150241262|NCT00433511|542020179|FG002|Step 1|Insurance/drug distribution issues|2|||
150241263|NCT00433511|542020177|FG000|Step 1|Patient moved|0|||
150241264|NCT00433511|542020178|FG001|Step 1|Patient moved|0|||
150241265|NCT00433511|542020179|FG002|Step 1|Patient moved|1|||
150241266|NCT00433511|542020177|FG000|Step 2 (Arm D)|Adverse Event|0|||
150241267|NCT00433511|542020178|FG001|Step 2 (Arm D)|Adverse Event|0|||
150241268|NCT00433511|542020179|FG002|Step 2 (Arm D)|Adverse Event|135|||
150241269|NCT00433511|542020177|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
150241270|NCT00433511|542020178|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
150241271|NCT00433511|542020179|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
150241272|NCT00433511|542020177|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
150241273|NCT00433511|542020178|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
150241274|NCT00433511|542020179|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
150241275|NCT00433511|542020177|FG000|Step 2 (Arm D)|Physician Decision|0|||
150241276|NCT00433511|542020178|FG001|Step 2 (Arm D)|Physician Decision|0|||
150241277|NCT00433511|542020179|FG002|Step 2 (Arm D)|Physician Decision|9|||
150241278|NCT00433511|542020177|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
150241279|NCT00433511|542020178|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
150241280|NCT00433511|542020179|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
150241281|NCT00433511|542020177|FG000|Step 2 (Arm D)|Other complicating disease|0|||
150241282|NCT00433511|542020178|FG001|Step 2 (Arm D)|Other complicating disease|0|||
150241283|NCT00433511|542020179|FG002|Step 2 (Arm D)|Other complicating disease|3|||
150241284|NCT00433511|542020177|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
150241285|NCT00433511|542020178|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
150241286|NCT00433511|542020179|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
150241287|NCT00433511|542020177|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
150241288|NCT00433511|542020178|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
150241289|NCT00433511|542020179|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
150241290|NCT00433511|542020177|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
150241291|NCT00433511|542020178|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
150241292|NCT00433511|542020179|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
150241293|NCT00433511|542020177|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
150241294|NCT00433511|542020178|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
150241295|NCT00433511|542020179|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
150241296|NCT02312557|542020180|FG000|Overall Study|Survival follow-up|4|||
150241297|NCT00742326|542020181|FG000|Overall Study|Physician Decision|0|||
150241298|NCT00742326|542020182|FG001|Overall Study|Physician Decision|1|||
150241299|NCT03698994|542020186|FG000|Overall Study|Adverse Event|2|||
150241300|NCT03698994|542020186|FG000|Overall Study|Death|1|||
150241301|NCT03698994|542020186|FG000|Overall Study|Physician Decision|1|||
150241302|NCT03698994|542020186|FG000|Overall Study|Withdrawal by Subject|3|||
150241303|NCT03698994|542020186|FG000|Overall Study|Progressive Disease|12|||
150241304|NCT04042077|542020191|FG000|Overall Study|Adverse Event|0|||
150241305|NCT04042077|542020192|FG001|Overall Study|Adverse Event|1|||
150241306|NCT04042077|542020191|FG000|Overall Study|Death|2|||
150241307|NCT04042077|542020192|FG001|Overall Study|Death|1|||
150241308|NCT04042077|542020191|FG000|Overall Study|Physician Decision|2|||
150241309|NCT04042077|542020192|FG001|Overall Study|Physician Decision|0|||
150241310|NCT04042077|542020191|FG000|Overall Study|Withdrawal by Subject|3|||
150241311|NCT04042077|542020192|FG001|Overall Study|Withdrawal by Subject|2|||
150241312|NCT04042077|542020191|FG000|Overall Study|Lack of Efficacy|0|||
150241313|NCT04042077|542020192|FG001|Overall Study|Lack of Efficacy|1|||
150241314|NCT01080300|542020193|FG000|Overall Study|Adverse Event|49|||
150241315|NCT01080300|542020194|FG001|Overall Study|Adverse Event|35|||
150241316|NCT01080300|542020193|FG000|Overall Study|Lack of Efficacy|12|||
150241317|NCT01080300|542020194|FG001|Overall Study|Lack of Efficacy|15|||
150241318|NCT01080300|542020193|FG000|Overall Study|Protocol Violation|7|||
150241319|NCT01080300|542020194|FG001|Overall Study|Protocol Violation|13|||
150241320|NCT01080300|542020193|FG000|Overall Study|Lost to Follow-up|10|||
150241321|NCT01080300|542020194|FG001|Overall Study|Lost to Follow-up|6|||
150241322|NCT01080300|542020193|FG000|Overall Study|Death|0|||
150241323|NCT01080300|542020194|FG001|Overall Study|Death|1|||
150241324|NCT01080300|542020193|FG000|Overall Study|Withdrawal by Subject|12|||
150241325|NCT01080300|542020194|FG001|Overall Study|Withdrawal by Subject|28|||
150241326|NCT01080300|542020193|FG000|Overall Study|Reasons not specified|4|||
150241327|NCT01080300|542020194|FG001|Overall Study|Reasons not specified|6|||
150241328|NCT01776008|542020195|FG000|Overall Study|ineligible|2|||
150241329|NCT01163474|542020196|FG000|Overall Study|Withdrawal by Subject|1|||
150241330|NCT01163474|542020196|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
150241331|NCT01163474|542020196|FG000|Overall Study|Lost to Follow-up|3|||
150241332|NCT02689453|542020198|FG000|Overall Study|Progressive disease|0|||
150241333|NCT02689453|542020199|FG001|Overall Study|Progressive disease|1|||
150241334|NCT02689453|542020200|FG002|Overall Study|Progressive disease|1|||
150241335|NCT01162486|542020201|FG000|Overall Study|low ANC|1|||
150241336|NCT01162486|542020202|FG001|Overall Study|low ANC|0|||
150241337|NCT01162486|542020203|FG002|Overall Study|low ANC|0|||
150241338|NCT01162486|542020204|FG003|Overall Study|low ANC|0|||
150241339|NCT01162486|542020205|FG004|Overall Study|low ANC|0|||
150241340|NCT01162486|542020201|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
150241341|NCT01162486|542020202|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
150241342|NCT01162486|542020203|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
150241343|NCT01162486|542020204|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
150241344|NCT01162486|542020205|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
150241345|NCT01162486|542020201|FG000|Overall Study|elevated LFTs|0|||
150241346|NCT01162486|542020202|FG001|Overall Study|elevated LFTs|0|||
150241347|NCT01162486|542020203|FG002|Overall Study|elevated LFTs|1|||
150241348|NCT01162486|542020204|FG003|Overall Study|elevated LFTs|0|||
150241349|NCT01162486|542020205|FG004|Overall Study|elevated LFTs|0|||
150241350|NCT01162486|542020201|FG000|Overall Study|Pregnancy|0|||
150241351|NCT01162486|542020202|FG001|Overall Study|Pregnancy|0|||
150241352|NCT01162486|542020203|FG002|Overall Study|Pregnancy|0|||
150241353|NCT01162486|542020204|FG003|Overall Study|Pregnancy|1|||
150241354|NCT01162486|542020205|FG004|Overall Study|Pregnancy|0|||
150241355|NCT00953615|542020206|FG000|Overall Study|Adverse Event|1|||
150241356|NCT02498236|542020209|FG000|Overall Study|Did not show for testing|1|||
150241357|NCT02498236|542020210|FG001|Overall Study|Did not show for testing|0|||
150241358|NCT02498236|542020211|FG002|Overall Study|Did not show for testing|0|||
150241359|NCT02498236|542020212|FG003|Overall Study|Did not show for testing|0|||
150241360|NCT02498236|542020213|FG004|Overall Study|Did not show for testing|0|||
150241361|NCT02498236|542020214|FG005|Overall Study|Did not show for testing|0|||
150241362|NCT02498236|542020215|FG006|Overall Study|Did not show for testing|0|||
150241363|NCT02498236|542020216|FG007|Overall Study|Did not show for testing|1|||
150241364|NCT02498236|542020209|FG000|Overall Study|Equipment failure|0|||
150241365|NCT02498236|542020210|FG001|Overall Study|Equipment failure|0|||
150241366|NCT02498236|542020211|FG002|Overall Study|Equipment failure|0|||
150241367|NCT02498236|542020212|FG003|Overall Study|Equipment failure|0|||
150241368|NCT02498236|542020213|FG004|Overall Study|Equipment failure|0|||
150241369|NCT02498236|542020214|FG005|Overall Study|Equipment failure|0|||
150241370|NCT02498236|542020215|FG006|Overall Study|Equipment failure|1|||
150241371|NCT02498236|542020216|FG007|Overall Study|Equipment failure|0|||
150241372|NCT02498236|542020209|FG000|Overall Study|Withdrawal by Subject|0|||
150241373|NCT02498236|542020210|FG001|Overall Study|Withdrawal by Subject|0|||
150241374|NCT02498236|542020211|FG002|Overall Study|Withdrawal by Subject|0|||
150241375|NCT02498236|542020212|FG003|Overall Study|Withdrawal by Subject|0|||
150241376|NCT02498236|542020213|FG004|Overall Study|Withdrawal by Subject|1|||
150241377|NCT02498236|542020214|FG005|Overall Study|Withdrawal by Subject|0|||
150241378|NCT02498236|542020215|FG006|Overall Study|Withdrawal by Subject|0|||
150241379|NCT02498236|542020216|FG007|Overall Study|Withdrawal by Subject|0|||
150241380|NCT02296892|542020217|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
150241381|NCT02296892|542020218|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
150241382|NCT02296892|542020219|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
150241383|NCT02296892|542020217|FG000|Overall Study|Lost to Follow-up|5|||
150241384|NCT02296892|542020218|FG001|Overall Study|Lost to Follow-up|0|||
150241385|NCT02296892|542020219|FG002|Overall Study|Lost to Follow-up|1|||
150241386|NCT00585078|542020220|FG000|Overall Study|Withdrawal by Subject|4|||
150241387|NCT00585078|542020220|FG000|Overall Study|Poor performance status|1|||
150241388|NCT00585078|542020220|FG000|Overall Study|Disease Progression|24|||
150241389|NCT00585078|542020220|FG000|Overall Study|Adverse Event|10|||
150241390|NCT00585078|542020220|FG000|Overall Study|Death|1|||
150241391|NCT01814072|542020223|FG000|Overall Study|Lost to Follow-up|2|||
150241392|NCT01814072|542020224|FG001|Overall Study|Lost to Follow-up|2|||
150241393|NCT01814072|542020225|FG002|Overall Study|Lost to Follow-up|2|||
150241394|NCT01814072|542020226|FG003|Overall Study|Lost to Follow-up|0|||
150241395|NCT01814072|542020227|FG004|Overall Study|Lost to Follow-up|2|||
150241396|NCT01814072|542020228|FG005|Overall Study|Lost to Follow-up|3|||
150241397|NCT01814072|542020229|FG006|Overall Study|Lost to Follow-up|3|||
150241398|NCT01814072|542020230|FG007|Overall Study|Lost to Follow-up|1|||
150241399|NCT01814072|542020231|FG008|Overall Study|Lost to Follow-up|2|||
150241400|NCT01814072|542020232|FG009|Overall Study|Lost to Follow-up|3|||
150241401|NCT01814072|542020233|FG010|Overall Study|Lost to Follow-up|1|||
150241402|NCT01814072|542020234|FG011|Overall Study|Lost to Follow-up|2|||
150241403|NCT01814072|542020235|FG012|Overall Study|Lost to Follow-up|2|||
150241404|NCT01814072|542020236|FG013|Overall Study|Lost to Follow-up|1|||
150241405|NCT01814072|542020237|FG014|Overall Study|Lost to Follow-up|2|||
150241406|NCT01814072|542020238|FG015|Overall Study|Lost to Follow-up|1|||
150241407|NCT01814072|542020239|FG016|Overall Study|Lost to Follow-up|3|||
150241408|NCT01814072|542020240|FG017|Overall Study|Lost to Follow-up|1|||
150241409|NCT01814072|542020241|FG018|Overall Study|Lost to Follow-up|3|||
150241410|NCT01814072|542020242|FG019|Overall Study|Lost to Follow-up|3|||
150241411|NCT01814072|542020243|FG020|Overall Study|Lost to Follow-up|2|||
150241412|NCT01814072|542020244|FG021|Overall Study|Lost to Follow-up|1|||
150241413|NCT01814072|542020245|FG022|Overall Study|Lost to Follow-up|3|||
150241414|NCT01814072|542020246|FG023|Overall Study|Lost to Follow-up|1|||
150241415|NCT01814072|542020247|FG024|Overall Study|Lost to Follow-up|4|||
150241416|NCT01814072|542020248|FG025|Overall Study|Lost to Follow-up|1|||
150241417|NCT01814072|542020249|FG026|Overall Study|Lost to Follow-up|1|||
150241418|NCT01814072|542020250|FG027|Overall Study|Lost to Follow-up|2|||
150241419|NCT01814072|542020251|FG028|Overall Study|Lost to Follow-up|3|||
150241420|NCT01814072|542020252|FG029|Overall Study|Lost to Follow-up|3|||
150241421|NCT01814072|542020253|FG030|Overall Study|Lost to Follow-up|2|||
150241422|NCT01814072|542020254|FG031|Overall Study|Lost to Follow-up|0|||
150241423|NCT01814072|542020223|FG000|Overall Study|Withdrawal by Subject|2|||
150241424|NCT01814072|542020224|FG001|Overall Study|Withdrawal by Subject|0|||
150241425|NCT01814072|542020225|FG002|Overall Study|Withdrawal by Subject|1|||
150241426|NCT01814072|542020226|FG003|Overall Study|Withdrawal by Subject|0|||
150241427|NCT01814072|542020227|FG004|Overall Study|Withdrawal by Subject|2|||
150241428|NCT01814072|542020228|FG005|Overall Study|Withdrawal by Subject|3|||
150241429|NCT01814072|542020229|FG006|Overall Study|Withdrawal by Subject|1|||
150241430|NCT01814072|542020230|FG007|Overall Study|Withdrawal by Subject|0|||
150241431|NCT01814072|542020231|FG008|Overall Study|Withdrawal by Subject|1|||
150241432|NCT01814072|542020232|FG009|Overall Study|Withdrawal by Subject|2|||
150241433|NCT01814072|542020233|FG010|Overall Study|Withdrawal by Subject|0|||
150241434|NCT01814072|542020234|FG011|Overall Study|Withdrawal by Subject|0|||
150241435|NCT01814072|542020235|FG012|Overall Study|Withdrawal by Subject|1|||
150241436|NCT01814072|542020236|FG013|Overall Study|Withdrawal by Subject|1|||
150241437|NCT01814072|542020237|FG014|Overall Study|Withdrawal by Subject|1|||
150241438|NCT01814072|542020238|FG015|Overall Study|Withdrawal by Subject|1|||
150241439|NCT01814072|542020239|FG016|Overall Study|Withdrawal by Subject|0|||
150241440|NCT01814072|542020240|FG017|Overall Study|Withdrawal by Subject|0|||
150241441|NCT01814072|542020241|FG018|Overall Study|Withdrawal by Subject|0|||
150241442|NCT01814072|542020242|FG019|Overall Study|Withdrawal by Subject|2|||
150241443|NCT01814072|542020243|FG020|Overall Study|Withdrawal by Subject|0|||
150241444|NCT01814072|542020244|FG021|Overall Study|Withdrawal by Subject|0|||
150241445|NCT01814072|542020245|FG022|Overall Study|Withdrawal by Subject|1|||
150241446|NCT01814072|542020246|FG023|Overall Study|Withdrawal by Subject|0|||
150241447|NCT01814072|542020247|FG024|Overall Study|Withdrawal by Subject|2|||
150241448|NCT01814072|542020248|FG025|Overall Study|Withdrawal by Subject|1|||
150241449|NCT01814072|542020249|FG026|Overall Study|Withdrawal by Subject|1|||
150241450|NCT01814072|542020250|FG027|Overall Study|Withdrawal by Subject|2|||
150241451|NCT01814072|542020251|FG028|Overall Study|Withdrawal by Subject|1|||
150241452|NCT01814072|542020252|FG029|Overall Study|Withdrawal by Subject|0|||
150241453|NCT01814072|542020253|FG030|Overall Study|Withdrawal by Subject|0|||
150241454|NCT01814072|542020254|FG031|Overall Study|Withdrawal by Subject|0|||
150241455|NCT00383123|542020255|FG000|Overall Study|Adverse Event|1|||
150241456|NCT00383123|542020256|FG001|Overall Study|Adverse Event|0|||
150241457|NCT00383123|542020255|FG000|Overall Study|Lost to Follow-up|68|||
150241458|NCT00383123|542020256|FG001|Overall Study|Lost to Follow-up|61|||
150241459|NCT00383123|542020255|FG000|Overall Study|Protocol Violation|5|||
150241460|NCT00383123|542020256|FG001|Overall Study|Protocol Violation|1|||
150241461|NCT00383123|542020255|FG000|Overall Study|Withdrawal by Subject|27|||
150241462|NCT00383123|542020256|FG001|Overall Study|Withdrawal by Subject|18|||
150241463|NCT00383123|542020255|FG000|Overall Study|Other reason|10|||
150241464|NCT00383123|542020256|FG001|Overall Study|Other reason|6|||
150241465|NCT03566979|542020258|FG000|Overall Study|Withdrawal by Subject|2|||
150241466|NCT03566979|542020259|FG001|Overall Study|Withdrawal by Subject|0|||
150241467|NCT03566979|542020260|FG002|Overall Study|Withdrawal by Subject|1|||
150241468|NCT03566979|542020261|FG003|Overall Study|Withdrawal by Subject|1|||
150241469|NCT03566979|542020258|FG000|Overall Study|Lost to Follow-up|2|||
150241470|NCT03566979|542020259|FG001|Overall Study|Lost to Follow-up|7|||
150241471|NCT03566979|542020260|FG002|Overall Study|Lost to Follow-up|9|||
150241472|NCT03566979|542020261|FG003|Overall Study|Lost to Follow-up|5|||
150241473|NCT03566979|542020258|FG000|Overall Study|Adverse Event|1|||
150241474|NCT03566979|542020259|FG001|Overall Study|Adverse Event|0|||
150241475|NCT03566979|542020260|FG002|Overall Study|Adverse Event|0|||
150241476|NCT03566979|542020261|FG003|Overall Study|Adverse Event|0|||
150241477|NCT04147858|542020262|FG000|Overall Study|Adverse Event|6|||
150241478|NCT04147858|542020263|FG001|Overall Study|Adverse Event|6|||
150241479|NCT04147858|542020264|FG002|Overall Study|Adverse Event|6|||
150241480|NCT04147858|542020262|FG000|Overall Study|Lack of Efficacy|3|||
150241481|NCT04147858|542020263|FG001|Overall Study|Lack of Efficacy|3|||
150241482|NCT04147858|542020264|FG002|Overall Study|Lack of Efficacy|1|||
150241483|NCT04147858|542020262|FG000|Overall Study|Lost to Follow-up|1|||
150241484|NCT04147858|542020263|FG001|Overall Study|Lost to Follow-up|6|||
150241485|NCT04147858|542020264|FG002|Overall Study|Lost to Follow-up|2|||
150241486|NCT04147858|542020262|FG000|Overall Study|Withdrawal by Subject|3|||
150241487|NCT04147858|542020263|FG001|Overall Study|Withdrawal by Subject|4|||
150241488|NCT04147858|542020264|FG002|Overall Study|Withdrawal by Subject|10|||
150241489|NCT04147858|542020262|FG000|Overall Study|Subject Noncompliance, Other|4|||
150241490|NCT04147858|542020263|FG001|Overall Study|Subject Noncompliance, Other|3|||
150241491|NCT04147858|542020264|FG002|Overall Study|Subject Noncompliance, Other|1|||
150241492|NCT02615938|542020267|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
150241493|NCT02615938|542020268|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
150241494|NCT02615938|542020269|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
150241495|NCT02615938|542020270|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
150241496|NCT02615938|542020267|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
150241497|NCT02615938|542020268|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
150241498|NCT02615938|542020269|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
150241499|NCT02615938|542020270|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
150241500|NCT02615938|542020267|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
150241501|NCT02615938|542020268|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
150241502|NCT02615938|542020269|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
150241503|NCT02615938|542020270|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
150241504|NCT03375320|542020280|FG000|Overall Study|Adverse Event|34|||
150241505|NCT03375320|542020281|FG001|Overall Study|Adverse Event|9|||
150241506|NCT03375320|542020282|FG002|Overall Study|Adverse Event|10|||
150241507|NCT03375320|542020283|FG003|Overall Study|Adverse Event|0|||
150241508|NCT03375320|542020280|FG000|Overall Study|Death|6|||
150241509|NCT03375320|542020281|FG001|Overall Study|Death|3|||
150241510|NCT03375320|542020282|FG002|Overall Study|Death|0|||
150241511|NCT03375320|542020283|FG003|Overall Study|Death|0|||
150241512|NCT03375320|542020280|FG000|Overall Study|Withdrawal by Subject|7|||
150241513|NCT03375320|542020281|FG001|Overall Study|Withdrawal by Subject|4|||
150241514|NCT03375320|542020282|FG002|Overall Study|Withdrawal by Subject|5|||
150241515|NCT03375320|542020283|FG003|Overall Study|Withdrawal by Subject|4|||
150241516|NCT03375320|542020280|FG000|Overall Study|Progressive disease|55|||
150241517|NCT03375320|542020281|FG001|Overall Study|Progressive disease|41|||
150241518|NCT03375320|542020282|FG002|Overall Study|Progressive disease|29|||
150241519|NCT03375320|542020283|FG003|Overall Study|Progressive disease|24|||
150241520|NCT03375320|542020280|FG000|Overall Study|Alternative treatment|6|||
150241521|NCT03375320|542020281|FG001|Overall Study|Alternative treatment|1|||
150241522|NCT03375320|542020282|FG002|Overall Study|Alternative treatment|1|||
150241523|NCT03375320|542020283|FG003|Overall Study|Alternative treatment|0|||
150241524|NCT03375320|542020280|FG000|Overall Study|Other disease|1|||
150241525|NCT03375320|542020281|FG001|Overall Study|Other disease|1|||
150241526|NCT03375320|542020282|FG002|Overall Study|Other disease|3|||
150241527|NCT03375320|542020283|FG003|Overall Study|Other disease|0|||
150241528|NCT03375320|542020280|FG000|Overall Study|Withdrawal prior to initiation|2|||
150241529|NCT03375320|542020281|FG001|Overall Study|Withdrawal prior to initiation|2|||
150241530|NCT03375320|542020282|FG002|Overall Study|Withdrawal prior to initiation|1|||
150241531|NCT03375320|542020283|FG003|Overall Study|Withdrawal prior to initiation|0|||
150241532|NCT03375320|542020280|FG000|Overall Study|Physician Decision|1|||
150241533|NCT03375320|542020281|FG001|Overall Study|Physician Decision|1|||
150241534|NCT03375320|542020282|FG002|Overall Study|Physician Decision|1|||
150241535|NCT03375320|542020283|FG003|Overall Study|Physician Decision|1|||
150241536|NCT03375320|542020280|FG000|Overall Study|Non-compliance|1|||
150241537|NCT03375320|542020281|FG001|Overall Study|Non-compliance|0|||
150241538|NCT03375320|542020282|FG002|Overall Study|Non-compliance|0|||
150241539|NCT03375320|542020283|FG003|Overall Study|Non-compliance|0|||
150241540|NCT03348631|542020284|FG000|Overall Study|Not Eligible, No treatment|0|||
150241541|NCT03348631|542020285|FG001|Overall Study|Not Eligible, No treatment|1|||
150241542|NCT03348631|542020284|FG000|Overall Study|Not Eligible, Treated|2|||
150241543|NCT03348631|542020285|FG001|Overall Study|Not Eligible, Treated|0|||
150241544|NCT03348631|542020284|FG000|Overall Study|Eligible, No Treatment|1|||
150241545|NCT03348631|542020285|FG001|Overall Study|Eligible, No Treatment|0|||
150241546|NCT03388632|542020286|FG000|Triplet C|Clinical progression|0|||
150241547|NCT03388632|542020287|FG001|Triplet C|Clinical progression|0|||
150241548|NCT03388632|542020288|FG002|Triplet C|Clinical progression|0|||
150241549|NCT03388632|542020289|FG003|Triplet C|Clinical progression|0|||
150241550|NCT03388632|542020290|FG004|Triplet C|Clinical progression|1|||
150241551|NCT03388632|542020291|FG005|Triplet C|Clinical progression|0|||
150241552|NCT03388632|542020292|FG006|Triplet C|Clinical progression|0|||
150241553|NCT03388632|542020293|FG007|Triplet C|Clinical progression|0|||
150241554|NCT03388632|542020294|FG008|Triplet C|Clinical progression|0|||
150241555|NCT03388632|542020286|FG000|Triplet C|42-day lapse in tx|0|||
150241556|NCT03388632|542020287|FG001|Triplet C|42-day lapse in tx|0|||
150241557|NCT03388632|542020288|FG002|Triplet C|42-day lapse in tx|0|||
150241558|NCT03388632|542020289|FG003|Triplet C|42-day lapse in tx|0|||
150241559|NCT03388632|542020290|FG004|Triplet C|42-day lapse in tx|1|||
150241560|NCT03388632|542020291|FG005|Triplet C|42-day lapse in tx|0|||
150241561|NCT03388632|542020292|FG006|Triplet C|42-day lapse in tx|0|||
150241562|NCT03388632|542020293|FG007|Triplet C|42-day lapse in tx|0|||
150241563|NCT03388632|542020294|FG008|Triplet C|42-day lapse in tx|0|||
150241564|NCT03388632|542020286|FG000|Triplet C|Adverse Event|0|||
150241565|NCT03388632|542020287|FG001|Triplet C|Adverse Event|0|||
150241566|NCT03388632|542020288|FG002|Triplet C|Adverse Event|0|||
150241567|NCT03388632|542020289|FG003|Triplet C|Adverse Event|0|||
150241568|NCT03388632|542020290|FG004|Triplet C|Adverse Event|0|||
150241569|NCT03388632|542020291|FG005|Triplet C|Adverse Event|0|||
150241570|NCT03388632|542020292|FG006|Triplet C|Adverse Event|0|||
150241571|NCT03388632|542020293|FG007|Triplet C|Adverse Event|0|||
150241572|NCT03388632|542020294|FG008|Triplet C|Adverse Event|1|||
150241573|NCT03388632|542020286|FG000|Triplet C|Switched to alternative treatment|0|||
150241574|NCT03388632|542020287|FG001|Triplet C|Switched to alternative treatment|0|||
150241575|NCT03388632|542020288|FG002|Triplet C|Switched to alternative treatment|0|||
150241576|NCT03388632|542020289|FG003|Triplet C|Switched to alternative treatment|0|||
150241577|NCT03388632|542020290|FG004|Triplet C|Switched to alternative treatment|0|||
150241578|NCT03388632|542020291|FG005|Triplet C|Switched to alternative treatment|0|||
150241579|NCT03388632|542020292|FG006|Triplet C|Switched to alternative treatment|0|||
150241580|NCT03388632|542020293|FG007|Triplet C|Switched to alternative treatment|1|||
150241581|NCT03388632|542020294|FG008|Triplet C|Switched to alternative treatment|0|||
150241582|NCT03388632|542020286|FG000|Triplet C|Participant choice|0|||
150241583|NCT03388632|542020287|FG001|Triplet C|Participant choice|0|||
150241584|NCT03388632|542020288|FG002|Triplet C|Participant choice|0|||
150241585|NCT03388632|542020289|FG003|Triplet C|Participant choice|0|||
150241586|NCT03388632|542020290|FG004|Triplet C|Participant choice|0|||
150241587|NCT03388632|542020291|FG005|Triplet C|Participant choice|1|||
150241588|NCT03388632|542020292|FG006|Triplet C|Participant choice|0|||
150241589|NCT03388632|542020293|FG007|Triplet C|Participant choice|0|||
150241590|NCT03388632|542020294|FG008|Triplet C|Participant choice|0|||
150241591|NCT01068210|542020295|FG000|Overall Study|Lost to Follow-up|1|||
150241592|NCT01068210|542020296|FG001|Overall Study|Lost to Follow-up|2|||
150241593|NCT01068210|542020297|FG002|Overall Study|Lost to Follow-up|2|||
150241594|NCT01068210|542020298|FG003|Overall Study|Lost to Follow-up|1|||
150241595|NCT01068210|542020295|FG000|Overall Study|Second cancer|0|||
150241596|NCT01068210|542020296|FG001|Overall Study|Second cancer|1|||
150241597|NCT01068210|542020297|FG002|Overall Study|Second cancer|0|||
150241598|NCT01068210|542020298|FG003|Overall Study|Second cancer|0|||
150241599|NCT01068210|542020295|FG000|Overall Study|Disease progression|0|||
150241600|NCT01068210|542020296|FG001|Overall Study|Disease progression|0|||
150241601|NCT01068210|542020297|FG002|Overall Study|Disease progression|0|||
150241602|NCT01068210|542020298|FG003|Overall Study|Disease progression|2|||
150241603|NCT03692052|542020307|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
150241604|NCT03692052|542020307|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
150241605|NCT03692052|542020307|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
150241606|NCT03692052|542020307|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
150241607|NCT01806389|542020310|FG000|Overall Study|Withdrawal by Subject|4|||
150241608|NCT04596540|542020311|FG000|Overall Study|Withdrawal by Subject|9|||
150241609|NCT04596540|542020312|FG001|Overall Study|Withdrawal by Subject|8|||
150241610|NCT04596540|542020313|FG002|Overall Study|Withdrawal by Subject|5|||
150241611|NCT04596540|542020311|FG000|Overall Study|Lost to Follow-up|1|||
150241612|NCT04596540|542020312|FG001|Overall Study|Lost to Follow-up|2|||
150241613|NCT04596540|542020313|FG002|Overall Study|Lost to Follow-up|1|||
150241614|NCT04596540|542020311|FG000|Overall Study|Sponsor Decision|2|||
150241615|NCT04596540|542020312|FG001|Overall Study|Sponsor Decision|0|||
150241616|NCT04596540|542020313|FG002|Overall Study|Sponsor Decision|0|||
150241617|NCT04596540|542020311|FG000|Overall Study|Physician Decision|0|||
150241618|NCT04596540|542020312|FG001|Overall Study|Physician Decision|1|||
150241619|NCT04596540|542020313|FG002|Overall Study|Physician Decision|1|||
150241620|NCT04596540|542020311|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
150241621|NCT04596540|542020312|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
150241622|NCT04596540|542020313|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
150241623|NCT04596540|542020311|FG000|Overall Study|Other Than Specified|5|||
150241624|NCT04596540|542020312|FG001|Overall Study|Other Than Specified|5|||
150241625|NCT04596540|542020313|FG002|Overall Study|Other Than Specified|2|||
150241626|NCT04526665|542020316|FG000|Overall Study|Withdrawal by Subject|6|||
150241627|NCT04526665|542020317|FG001|Overall Study|Withdrawal by Subject|3|||
150241628|NCT04526665|542020316|FG000|Overall Study|Adverse Event|4|||
150241629|NCT04526665|542020317|FG001|Overall Study|Adverse Event|1|||
150241630|NCT04526665|542020316|FG000|Overall Study|Physician Decision|2|||
150241631|NCT04526665|542020317|FG001|Overall Study|Physician Decision|2|||
150241632|NCT04526665|542020316|FG000|Overall Study|Death|2|||
150241633|NCT04526665|542020317|FG001|Overall Study|Death|0|||
150241634|NCT04526665|542020316|FG000|Overall Study|Other|0|||
150241635|NCT04526665|542020317|FG001|Overall Study|Other|1|||
150241636|NCT04949802|542021784|FG000|Overall Study|Lost to Follow-up|3|||
150241637|NCT00233480|542021787|FG000|Overall Study|Underwent status II heart transplant|0|||
150241638|NCT00233480|542021788|FG001|Overall Study|Underwent status II heart transplant|1|||
150241639|NCT01443403|542021789|FG000|Overall Study|Adverse Event|1|||
150241640|NCT01443403|542021790|FG001|Overall Study|Adverse Event|1|||
150241641|NCT01443403|542021791|FG002|Overall Study|Adverse Event|4|||
150241642|NCT01443403|542021792|FG003|Overall Study|Adverse Event|5|||
150241643|NCT01443403|542021789|FG000|Overall Study|Withdrawal by Subject|0|||
150241644|NCT01443403|542021790|FG001|Overall Study|Withdrawal by Subject|1|||
150241645|NCT01443403|542021791|FG002|Overall Study|Withdrawal by Subject|2|||
150241646|NCT01443403|542021792|FG003|Overall Study|Withdrawal by Subject|1|||
150241647|NCT01443403|542021789|FG000|Overall Study|Lost to Follow-up|0|||
150241648|NCT01443403|542021790|FG001|Overall Study|Lost to Follow-up|0|||
150241649|NCT01443403|542021791|FG002|Overall Study|Lost to Follow-up|0|||
150241650|NCT01443403|542021792|FG003|Overall Study|Lost to Follow-up|1|||
150241651|NCT01443403|542021789|FG000|Overall Study|Protocol Violation|2|||
150241652|NCT01443403|542021790|FG001|Overall Study|Protocol Violation|1|||
150241653|NCT01443403|542021791|FG002|Overall Study|Protocol Violation|1|||
150241654|NCT01443403|542021792|FG003|Overall Study|Protocol Violation|1|||
150241655|NCT01443403|542021789|FG000|Overall Study|Use of Prohibited Treatment|2|||
150241656|NCT01443403|542021790|FG001|Overall Study|Use of Prohibited Treatment|3|||
150241657|NCT01443403|542021791|FG002|Overall Study|Use of Prohibited Treatment|0|||
150241658|NCT01443403|542021792|FG003|Overall Study|Use of Prohibited Treatment|0|||
150241659|NCT01443403|542021789|FG000|Overall Study|Other - Miscellaneous|1|||
150241660|NCT01443403|542021790|FG001|Overall Study|Other - Miscellaneous|0|||
150241661|NCT01443403|542021791|FG002|Overall Study|Other - Miscellaneous|0|||
150241662|NCT01443403|542021792|FG003|Overall Study|Other - Miscellaneous|1|||
150241663|NCT03258723|542021793|FG000|Overall Study|COVID Interruption of study|54|||
150241664|NCT03258723|542021793|FG000|Overall Study|Lost to Follow-up|8|||
150241665|NCT01107899|542021794|FG000|Overall Study|Physician Decision|5|||
150241666|NCT01107899|542021795|FG001|Overall Study|Physician Decision|0|||
150241667|NCT01107899|542021796|FG002|Overall Study|Physician Decision|3|||
150241668|NCT01107899|542021794|FG000|Overall Study|Withdrawal by Subject|0|||
150241669|NCT01107899|542021795|FG001|Overall Study|Withdrawal by Subject|0|||
150241670|NCT01107899|542021796|FG002|Overall Study|Withdrawal by Subject|1|||
150241671|NCT00953771|542021797|FG000|Overall Study|Death|1|||
150241672|NCT00953771|542021798|FG001|Overall Study|Death|0|||
150241673|NCT00974259|542021799|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
150241674|NCT00974259|542021800|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
150241675|NCT03377361|542021804|FG000|Pre-Treatment|Subject withdrew consent|0|||
150241676|NCT03377361|542021805|FG001|Pre-Treatment|Subject withdrew consent|0|||
150241677|NCT03377361|542021806|FG002|Pre-Treatment|Subject withdrew consent|0|||
150241678|NCT03377361|542021807|FG003|Pre-Treatment|Subject withdrew consent|0|||
150241679|NCT03377361|542021808|FG004|Pre-Treatment|Subject withdrew consent|0|||
150241680|NCT03377361|542021809|FG005|Pre-Treatment|Subject withdrew consent|0|||
150241681|NCT03377361|542021810|FG006|Pre-Treatment|Subject withdrew consent|0|||
150241682|NCT03377361|542021811|FG007|Pre-Treatment|Subject withdrew consent|3|||
150241683|NCT03377361|542021812|FG008|Pre-Treatment|Subject withdrew consent|1|||
150241684|NCT03377361|542021813|FG009|Pre-Treatment|Subject withdrew consent|0|||
150241685|NCT03377361|542021804|FG000|Pre-Treatment|Not Reported|0|||
150241686|NCT03377361|542021805|FG001|Pre-Treatment|Not Reported|0|||
150241687|NCT03377361|542021806|FG002|Pre-Treatment|Not Reported|0|||
150241688|NCT03377361|542021807|FG003|Pre-Treatment|Not Reported|0|||
150241689|NCT03377361|542021808|FG004|Pre-Treatment|Not Reported|0|||
150241690|NCT03377361|542021809|FG005|Pre-Treatment|Not Reported|0|||
150241691|NCT03377361|542021810|FG006|Pre-Treatment|Not Reported|0|||
150241692|NCT03377361|542021811|FG007|Pre-Treatment|Not Reported|0|||
150241693|NCT03377361|542021812|FG008|Pre-Treatment|Not Reported|3|||
150241694|NCT03377361|542021813|FG009|Pre-Treatment|Not Reported|0|||
150241695|NCT03377361|542021804|FG000|Treatment Period|Disease Progression|3|||
150241696|NCT03377361|542021805|FG001|Treatment Period|Disease Progression|2|||
150241697|NCT03377361|542021806|FG002|Treatment Period|Disease Progression|5|||
150241698|NCT03377361|542021807|FG003|Treatment Period|Disease Progression|3|||
150241699|NCT03377361|542021808|FG004|Treatment Period|Disease Progression|3|||
150241700|NCT03377361|542021809|FG005|Treatment Period|Disease Progression|3|||
150241701|NCT03377361|542021810|FG006|Treatment Period|Disease Progression|6|||
150241702|NCT03377361|542021811|FG007|Treatment Period|Disease Progression|106|||
150241703|NCT03377361|542021812|FG008|Treatment Period|Disease Progression|48|||
150241704|NCT03377361|542021813|FG009|Treatment Period|Disease Progression|59|||
150241705|NCT03377361|542021804|FG000|Treatment Period|Study Drug Toxicity|0|||
150241706|NCT03377361|542021805|FG001|Treatment Period|Study Drug Toxicity|0|||
150241707|NCT03377361|542021806|FG002|Treatment Period|Study Drug Toxicity|0|||
150241708|NCT03377361|542021807|FG003|Treatment Period|Study Drug Toxicity|1|||
150241709|NCT03377361|542021808|FG004|Treatment Period|Study Drug Toxicity|0|||
150241710|NCT03377361|542021809|FG005|Treatment Period|Study Drug Toxicity|0|||
150241711|NCT03377361|542021810|FG006|Treatment Period|Study Drug Toxicity|0|||
150241712|NCT03377361|542021811|FG007|Treatment Period|Study Drug Toxicity|7|||
150241713|NCT03377361|542021812|FG008|Treatment Period|Study Drug Toxicity|2|||
150241714|NCT03377361|542021813|FG009|Treatment Period|Study Drug Toxicity|16|||
150241715|NCT03377361|542021804|FG000|Treatment Period|Death|0|||
150241716|NCT03377361|542021805|FG001|Treatment Period|Death|0|||
150241717|NCT03377361|542021806|FG002|Treatment Period|Death|1|||
150241718|NCT03377361|542021807|FG003|Treatment Period|Death|0|||
150241719|NCT03377361|542021808|FG004|Treatment Period|Death|0|||
150241720|NCT03377361|542021809|FG005|Treatment Period|Death|0|||
150241721|NCT03377361|542021810|FG006|Treatment Period|Death|0|||
150241722|NCT03377361|542021811|FG007|Treatment Period|Death|2|||
150241723|NCT03377361|542021812|FG008|Treatment Period|Death|1|||
150241724|NCT03377361|542021813|FG009|Treatment Period|Death|3|||
150241725|NCT03377361|542021804|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241726|NCT03377361|542021805|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241727|NCT03377361|542021806|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241728|NCT03377361|542021807|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241729|NCT03377361|542021808|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241730|NCT03377361|542021809|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241731|NCT03377361|542021810|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
150241732|NCT03377361|542021811|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
150241733|NCT03377361|542021812|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
150241734|NCT03377361|542021813|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
150241735|NCT03377361|542021804|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
150241736|NCT03377361|542021805|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
150241737|NCT03377361|542021806|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
150241738|NCT03377361|542021807|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
150241739|NCT03377361|542021808|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
150241740|NCT03377361|542021809|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
150241741|NCT03377361|542021810|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
150241742|NCT03377361|542021811|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
150241743|NCT03377361|542021812|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
150241744|NCT03377361|542021813|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
150241745|NCT03377361|542021804|FG000|Treatment Period|Subject Withdrew Consent|0|||
150241746|NCT03377361|542021805|FG001|Treatment Period|Subject Withdrew Consent|0|||
150241747|NCT03377361|542021806|FG002|Treatment Period|Subject Withdrew Consent|0|||
150241748|NCT03377361|542021807|FG003|Treatment Period|Subject Withdrew Consent|0|||
150241749|NCT03377361|542021808|FG004|Treatment Period|Subject Withdrew Consent|0|||
150241750|NCT03377361|542021809|FG005|Treatment Period|Subject Withdrew Consent|0|||
150241751|NCT03377361|542021810|FG006|Treatment Period|Subject Withdrew Consent|0|||
150241752|NCT03377361|542021811|FG007|Treatment Period|Subject Withdrew Consent|0|||
150241753|NCT03377361|542021812|FG008|Treatment Period|Subject Withdrew Consent|2|||
150241754|NCT03377361|542021813|FG009|Treatment Period|Subject Withdrew Consent|1|||
150241755|NCT03377361|542021804|FG000|Treatment Period|No longer meets study criteria|0|||
150241756|NCT03377361|542021805|FG001|Treatment Period|No longer meets study criteria|1|||
150241757|NCT03377361|542021806|FG002|Treatment Period|No longer meets study criteria|0|||
150241758|NCT03377361|542021807|FG003|Treatment Period|No longer meets study criteria|0|||
150241759|NCT03377361|542021808|FG004|Treatment Period|No longer meets study criteria|0|||
150241760|NCT03377361|542021809|FG005|Treatment Period|No longer meets study criteria|0|||
150241761|NCT03377361|542021810|FG006|Treatment Period|No longer meets study criteria|0|||
150241762|NCT03377361|542021811|FG007|Treatment Period|No longer meets study criteria|1|||
150241763|NCT03377361|542021812|FG008|Treatment Period|No longer meets study criteria|0|||
150241764|NCT03377361|542021813|FG009|Treatment Period|No longer meets study criteria|0|||
150241765|NCT03377361|542021804|FG000|Treatment Period|Other Reasons|0|||
150241766|NCT03377361|542021805|FG001|Treatment Period|Other Reasons|0|||
150241767|NCT03377361|542021806|FG002|Treatment Period|Other Reasons|0|||
150241768|NCT03377361|542021807|FG003|Treatment Period|Other Reasons|3|||
150241769|NCT03377361|542021808|FG004|Treatment Period|Other Reasons|0|||
150241770|NCT03377361|542021809|FG005|Treatment Period|Other Reasons|0|||
150241771|NCT03377361|542021810|FG006|Treatment Period|Other Reasons|0|||
150241772|NCT03377361|542021811|FG007|Treatment Period|Other Reasons|2|||
150241773|NCT03377361|542021812|FG008|Treatment Period|Other Reasons|0|||
150241774|NCT03377361|542021813|FG009|Treatment Period|Other Reasons|1|||
150241775|NCT00794924|542021814|FG000|Overall Study|Lost to Follow-up|6|||
150241776|NCT00794924|542021815|FG001|Overall Study|Lost to Follow-up|8|||
150241777|NCT00794924|542021814|FG000|Overall Study|Withdrawal by Subject|48|||
150241778|NCT00794924|542021815|FG001|Overall Study|Withdrawal by Subject|60|||
150241779|NCT00794924|542021814|FG000|Overall Study|Adverse Event|6|||
150241780|NCT00794924|542021815|FG001|Overall Study|Adverse Event|2|||
150241781|NCT03274895|542021816|FG000|Overall Study|Lack of Efficacy|1|||
150241782|NCT03274895|542021817|FG001|Overall Study|Lack of Efficacy|0|||
150241783|NCT03274895|542021816|FG000|Overall Study|Adverse Event|8|||
150241784|NCT03274895|542021817|FG001|Overall Study|Adverse Event|7|||
150241785|NCT03274895|542021816|FG000|Overall Study|Lost to Follow-up|1|||
150241786|NCT03274895|542021817|FG001|Overall Study|Lost to Follow-up|0|||
150241787|NCT03274895|542021816|FG000|Overall Study|Diagnosis not confirmed|3|||
150241788|NCT03274895|542021817|FG001|Overall Study|Diagnosis not confirmed|4|||
150241789|NCT01294436|542021818|FG000|Overall Study|Adverse Event|10|||
150241790|NCT01294436|542021819|FG001|Overall Study|Adverse Event|17|||
150241791|NCT01294436|542021818|FG000|Overall Study|Withdrawal by Subject|11|||
150241792|NCT01294436|542021819|FG001|Overall Study|Withdrawal by Subject|28|||
150241793|NCT01294436|542021818|FG000|Overall Study|subject no longer meets study criteria|5|||
150241794|NCT01294436|542021819|FG001|Overall Study|subject no longer meets study criteria|20|||
150241795|NCT01294436|542021818|FG000|Overall Study|poor/non-compliance|2|||
150241796|NCT01294436|542021819|FG001|Overall Study|poor/non-compliance|5|||
150241797|NCT02389764|542021820|FG000|Overall Study|Lack of Efficacy|9|||
150241798|NCT04674189|542021822|FG000|Overall Study|Adverse Event|0|||
150241799|NCT04674189|542021823|FG001|Overall Study|Adverse Event|0|||
150241800|NCT04674189|542021824|FG002|Overall Study|Adverse Event|1|||
150241801|NCT04674189|542021822|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
150241802|NCT04674189|542021823|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
150241803|NCT04674189|542021824|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
150241804|NCT04674189|542021822|FG000|Overall Study|Physician Decision|1|||
150241805|NCT04674189|542021823|FG001|Overall Study|Physician Decision|0|||
150241806|NCT04674189|542021824|FG002|Overall Study|Physician Decision|0|||
150241807|NCT04674189|542021822|FG000|Overall Study|Withdrawal by Participant|83|||
150241808|NCT04674189|542021823|FG001|Overall Study|Withdrawal by Participant|71|||
150241809|NCT04674189|542021824|FG002|Overall Study|Withdrawal by Participant|142|||
150241810|NCT04674189|542021822|FG000|Overall Study|Lost to Follow-up|55|||
150241811|NCT04674189|542021823|FG001|Overall Study|Lost to Follow-up|53|||
150241812|NCT04674189|542021824|FG002|Overall Study|Lost to Follow-up|44|||
150241813|NCT04674189|542021822|FG000|Overall Study|Miscellaneous|27|||
150241814|NCT04674189|542021823|FG001|Overall Study|Miscellaneous|23|||
150241815|NCT04674189|542021824|FG002|Overall Study|Miscellaneous|207|||
150241816|NCT04674189|542021822|FG000|Overall Study|Did Not Receive Treatment|3|||
150241817|NCT04674189|542021823|FG001|Overall Study|Did Not Receive Treatment|1|||
150241818|NCT04674189|542021824|FG002|Overall Study|Did Not Receive Treatment|2|||
150241819|NCT01637077|542021825|FG000|Overall Study|Cancel|1|||
150241820|NCT01637077|542021826|FG001|Overall Study|Cancel|1|||
150241821|NCT01637077|542021825|FG000|Overall Study|Withdrawal by Subject|1|||
150241822|NCT01637077|542021826|FG001|Overall Study|Withdrawal by Subject|0|||
150241823|NCT01637077|542021825|FG000|Overall Study|No cycle 1 questionnaire data|2|||
150241824|NCT01637077|542021826|FG001|Overall Study|No cycle 1 questionnaire data|0|||
150241825|NCT02638103|542021827|FG000|Overall Study|Adverse Event|13|||
150241826|NCT02638103|542021828|FG001|Overall Study|Adverse Event|12|||
150241827|NCT02638103|542021829|FG002|Overall Study|Adverse Event|19|||
150241828|NCT02638103|542021830|FG003|Overall Study|Adverse Event|12|||
150241829|NCT02638103|542021827|FG000|Overall Study|Withdrawal by Subject|43|||
150241830|NCT02638103|542021828|FG001|Overall Study|Withdrawal by Subject|53|||
150241831|NCT02638103|542021829|FG002|Overall Study|Withdrawal by Subject|30|||
150241832|NCT02638103|542021830|FG003|Overall Study|Withdrawal by Subject|61|||
150241833|NCT02638103|542021827|FG000|Overall Study|Protocol Violation|1|||
150241834|NCT02638103|542021828|FG001|Overall Study|Protocol Violation|2|||
150241835|NCT02638103|542021829|FG002|Overall Study|Protocol Violation|1|||
150241836|NCT02638103|542021830|FG003|Overall Study|Protocol Violation|4|||
150241837|NCT02638103|542021827|FG000|Overall Study|Pregnancy|2|||
150241838|NCT02638103|542021828|FG001|Overall Study|Pregnancy|3|||
150241839|NCT02638103|542021829|FG002|Overall Study|Pregnancy|0|||
150241840|NCT02638103|542021830|FG003|Overall Study|Pregnancy|1|||
150241841|NCT02638103|542021827|FG000|Overall Study|Non-compliance to Study Procedures|2|||
150241842|NCT02638103|542021828|FG001|Overall Study|Non-compliance to Study Procedures|1|||
150241843|NCT02638103|542021829|FG002|Overall Study|Non-compliance to Study Procedures|1|||
150241844|NCT02638103|542021830|FG003|Overall Study|Non-compliance to Study Procedures|1|||
150241845|NCT02638103|542021827|FG000|Overall Study|Lost to Follow-up|26|||
150241846|NCT02638103|542021828|FG001|Overall Study|Lost to Follow-up|33|||
150241847|NCT02638103|542021829|FG002|Overall Study|Lost to Follow-up|20|||
150241848|NCT02638103|542021830|FG003|Overall Study|Lost to Follow-up|37|||
150241849|NCT02638103|542021827|FG000|Overall Study|Lack of Efficacy|14|||
150241850|NCT02638103|542021828|FG001|Overall Study|Lack of Efficacy|10|||
150241851|NCT02638103|542021829|FG002|Overall Study|Lack of Efficacy|12|||
150241852|NCT02638103|542021830|FG003|Overall Study|Lack of Efficacy|22|||
150241853|NCT02638103|542021827|FG000|Overall Study|Other than specified|5|||
150241854|NCT02638103|542021828|FG001|Overall Study|Other than specified|4|||
150241855|NCT02638103|542021829|FG002|Overall Study|Other than specified|2|||
150241856|NCT02638103|542021830|FG003|Overall Study|Other than specified|4|||
150241857|NCT01358331|542021831|FG000|Overall Study|Lost to Follow-up|0|||
150241858|NCT01358331|542021832|FG001|Overall Study|Lost to Follow-up|0|||
150241859|NCT01358331|542021833|FG002|Overall Study|Lost to Follow-up|0|||
150241860|NCT01358331|542021834|FG003|Overall Study|Lost to Follow-up|1|||
150241861|NCT01358331|542021835|FG004|Overall Study|Lost to Follow-up|0|||
150241862|NCT01358331|542021836|FG005|Overall Study|Lost to Follow-up|0|||
150241863|NCT01358331|542021831|FG000|Overall Study|Withdrawal by Subject|0|||
150241864|NCT01358331|542021832|FG001|Overall Study|Withdrawal by Subject|0|||
150241865|NCT01358331|542021833|FG002|Overall Study|Withdrawal by Subject|0|||
150241866|NCT01358331|542021834|FG003|Overall Study|Withdrawal by Subject|1|||
150241867|NCT01358331|542021835|FG004|Overall Study|Withdrawal by Subject|1|||
150241868|NCT01358331|542021836|FG005|Overall Study|Withdrawal by Subject|1|||
150241869|NCT01358331|542021831|FG000|Overall Study|Adverse Events|1|||
150241870|NCT01358331|542021832|FG001|Overall Study|Adverse Events|1|||
150241871|NCT01358331|542021833|FG002|Overall Study|Adverse Events|1|||
150241872|NCT01358331|542021834|FG003|Overall Study|Adverse Events|0|||
150241873|NCT01358331|542021835|FG004|Overall Study|Adverse Events|1|||
150241874|NCT01358331|542021836|FG005|Overall Study|Adverse Events|5|||
150241875|NCT01358331|542021831|FG000|Overall Study|Symptomatic Deterioration|0|||
150241876|NCT01358331|542021832|FG001|Overall Study|Symptomatic Deterioration|0|||
150241877|NCT01358331|542021833|FG002|Overall Study|Symptomatic Deterioration|0|||
150241878|NCT01358331|542021834|FG003|Overall Study|Symptomatic Deterioration|0|||
150241879|NCT01358331|542021835|FG004|Overall Study|Symptomatic Deterioration|1|||
150241880|NCT01358331|542021836|FG005|Overall Study|Symptomatic Deterioration|0|||
150241881|NCT01358331|542021831|FG000|Overall Study|Participants did not wish to continue|0|||
150241882|NCT01358331|542021832|FG001|Overall Study|Participants did not wish to continue|0|||
150241883|NCT01358331|542021833|FG002|Overall Study|Participants did not wish to continue|0|||
150241884|NCT01358331|542021834|FG003|Overall Study|Participants did not wish to continue|0|||
150241885|NCT01358331|542021835|FG004|Overall Study|Participants did not wish to continue|1|||
150241886|NCT01358331|542021836|FG005|Overall Study|Participants did not wish to continue|0|||
150241887|NCT01358331|542021831|FG000|Overall Study|Progress of disease under investigation|1|||
150241888|NCT01358331|542021832|FG001|Overall Study|Progress of disease under investigation|2|||
150241889|NCT01358331|542021833|FG002|Overall Study|Progress of disease under investigation|3|||
150241890|NCT01358331|542021834|FG003|Overall Study|Progress of disease under investigation|1|||
150241891|NCT01358331|542021835|FG004|Overall Study|Progress of disease under investigation|3|||
150241892|NCT01358331|542021836|FG005|Overall Study|Progress of disease under investigation|0|||
150241893|NCT04907357|542021837|FG000|Overall Study|Death|0|||
150241894|NCT04907357|542021838|FG001|Overall Study|Death|1|||
150241895|NCT04907357|542021837|FG000|Overall Study|Lost to Follow-up|9|||
150241896|NCT04907357|542021838|FG001|Overall Study|Lost to Follow-up|18|||
150241897|NCT04907357|542021837|FG000|Overall Study|Physician Decision|1|||
150241898|NCT04907357|542021838|FG001|Overall Study|Physician Decision|0|||
150241899|NCT04907357|542021837|FG000|Overall Study|Withdrawal by Subject|0|||
150241900|NCT04907357|542021838|FG001|Overall Study|Withdrawal by Subject|1|||
150241901|NCT04907357|542021837|FG000|Overall Study|Unable to attend visits|1|||
150241902|NCT04907357|542021838|FG001|Overall Study|Unable to attend visits|0|||
150241903|NCT04907357|542021837|FG000|Overall Study|Incarcerated|1|||
150241904|NCT04907357|542021838|FG001|Overall Study|Incarcerated|1|||
150241905|NCT03342196|542021839|FG000|Overall Study|Physician Decision|1|||
150241906|NCT00546078|542021840|FG000|Overall Study|Lost to Follow-up|1|||
150241907|NCT00546078|542021841|FG001|Overall Study|Lost to Follow-up|3|||
150241908|NCT00546078|542021840|FG000|Overall Study|Withdrawal by Subject|2|||
150241909|NCT00546078|542021841|FG001|Overall Study|Withdrawal by Subject|3|||
150241910|NCT00546078|542021840|FG000|Overall Study|Other reason|1|||
150241911|NCT00546078|542021841|FG001|Overall Study|Other reason|1|||
150241912|NCT03358238|542021845|FG000|Overall Study|Withdrawal by Subject|0|||
150241913|NCT03358238|542021846|FG001|Overall Study|Withdrawal by Subject|1|||
150241914|NCT01431950|542021847|FG000|Overall Study|Study Site Closed/Terminated|7|||
150241915|NCT01431950|542021848|FG001|Overall Study|Study Site Closed/Terminated|3|||
150241916|NCT01431950|542021847|FG000|Overall Study|Withdrawal by Subject|4|||
150241917|NCT01431950|542021848|FG001|Overall Study|Withdrawal by Subject|3|||
150241918|NCT01431950|542021847|FG000|Overall Study|Protocol Violation|2|||
150241919|NCT01431950|542021848|FG001|Overall Study|Protocol Violation|3|||
150241920|NCT01431950|542021847|FG000|Overall Study|Adverse Event|2|||
150241921|NCT01431950|542021848|FG001|Overall Study|Adverse Event|2|||
150241922|NCT01431950|542021847|FG000|Overall Study|Physician Decision|2|||
150241923|NCT01431950|542021848|FG001|Overall Study|Physician Decision|1|||
150241924|NCT01431950|542021847|FG000|Overall Study|Lack of Efficacy|2|||
150241925|NCT01431950|542021848|FG001|Overall Study|Lack of Efficacy|1|||
150241926|NCT01431950|542021847|FG000|Overall Study|Lost to Follow-up|0|||
150241927|NCT01431950|542021848|FG001|Overall Study|Lost to Follow-up|1|||
150241928|NCT01431950|542021847|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
150241929|NCT01431950|542021848|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
150241930|NCT01210651|542021849|FG000|Overall Study|Lost to Follow-up|1|||
150241931|NCT01210651|542021850|FG001|Overall Study|Lost to Follow-up|1|||
150241932|NCT01210651|542021849|FG000|Overall Study|schedule conflicts|1|||
150241933|NCT01210651|542021850|FG001|Overall Study|schedule conflicts|5|||
150241934|NCT01210651|542021849|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
150241935|NCT01210651|542021850|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
150241936|NCT01210651|542021849|FG000|Overall Study|Withdrawal by Subject|1|||
150241937|NCT01210651|542021850|FG001|Overall Study|Withdrawal by Subject|1|||
150241938|NCT01210651|542021849|FG000|Overall Study|Injury outside study|2|||
150241939|NCT01210651|542021850|FG001|Overall Study|Injury outside study|0|||
150241940|NCT01740154|542021851|FG000|Overall Study|Adverse Event|1|||
150241941|NCT03358472|542021855|FG000|Overall Study|Death|6|||
150241942|NCT03358472|542021856|FG001|Overall Study|Death|3|||
150241943|NCT03358472|542021857|FG002|Overall Study|Death|10|||
150241944|NCT03358472|542021855|FG000|Overall Study|Physician Decision|0|||
150241945|NCT03358472|542021856|FG001|Overall Study|Physician Decision|1|||
150241946|NCT03358472|542021857|FG002|Overall Study|Physician Decision|0|||
150241947|NCT03358472|542021855|FG000|Overall Study|Withdrawal by Subject|0|||
150241948|NCT03358472|542021856|FG001|Overall Study|Withdrawal by Subject|0|||
150241949|NCT03358472|542021857|FG002|Overall Study|Withdrawal by Subject|1|||
150241950|NCT03358472|542021855|FG000|Overall Study|On-going at clinical cut off date|9|||
150241951|NCT03358472|542021856|FG001|Overall Study|On-going at clinical cut off date|6|||
150241952|NCT03358472|542021857|FG002|Overall Study|On-going at clinical cut off date|5|||
150241953|NCT03974022|542021858|FG000|Overall Study|Death|0|||
150241954|NCT03974022|542021859|FG001|Overall Study|Death|1|||
150241955|NCT03974022|542021860|FG002|Overall Study|Death|0|||
150241956|NCT03974022|542021861|FG003|Overall Study|Death|2|||
150241957|NCT03974022|542021862|FG004|Overall Study|Death|0|||
150241958|NCT03974022|542021863|FG005|Overall Study|Death|1|||
150241959|NCT03974022|542021864|FG006|Overall Study|Death|0|||
150241960|NCT03974022|542021865|FG007|Overall Study|Death|2|||
150241961|NCT03974022|542021866|FG008|Overall Study|Death|1|||
150241962|NCT03974022|542021867|FG009|Overall Study|Death|4|||
150241963|NCT03974022|542021868|FG010|Overall Study|Death|0|||
150241964|NCT03974022|542021869|FG011|Overall Study|Death|0|||
150241965|NCT03974022|542021870|FG012|Overall Study|Death|0|||
150241966|NCT03974022|542021871|FG013|Overall Study|Death|33|||
150241967|NCT03974022|542021872|FG014|Overall Study|Death|40|||
150241968|NCT03974022|542021858|FG000|Overall Study|Withdrawal by Subject|0|||
150241969|NCT03974022|542021859|FG001|Overall Study|Withdrawal by Subject|0|||
150241970|NCT03974022|542021860|FG002|Overall Study|Withdrawal by Subject|0|||
150241971|NCT03974022|542021861|FG003|Overall Study|Withdrawal by Subject|0|||
150241972|NCT03974022|542021862|FG004|Overall Study|Withdrawal by Subject|0|||
150241973|NCT03974022|542021863|FG005|Overall Study|Withdrawal by Subject|4|||
150241974|NCT03974022|542021864|FG006|Overall Study|Withdrawal by Subject|4|||
150241975|NCT03974022|542021865|FG007|Overall Study|Withdrawal by Subject|2|||
150241976|NCT03974022|542021866|FG008|Overall Study|Withdrawal by Subject|2|||
150241977|NCT03974022|542021867|FG009|Overall Study|Withdrawal by Subject|3|||
150241978|NCT03974022|542021868|FG010|Overall Study|Withdrawal by Subject|0|||
150241979|NCT03974022|542021869|FG011|Overall Study|Withdrawal by Subject|1|||
150241980|NCT03974022|542021870|FG012|Overall Study|Withdrawal by Subject|0|||
150241981|NCT03974022|542021871|FG013|Overall Study|Withdrawal by Subject|3|||
150241982|NCT03974022|542021872|FG014|Overall Study|Withdrawal by Subject|9|||
150241983|NCT03974022|542021858|FG000|Overall Study|Lost to Follow-up|0|||
150241984|NCT03974022|542021859|FG001|Overall Study|Lost to Follow-up|0|||
150241985|NCT03974022|542021860|FG002|Overall Study|Lost to Follow-up|0|||
150241986|NCT03974022|542021861|FG003|Overall Study|Lost to Follow-up|0|||
150241987|NCT03974022|542021862|FG004|Overall Study|Lost to Follow-up|0|||
150241988|NCT03974022|542021863|FG005|Overall Study|Lost to Follow-up|0|||
150241989|NCT03974022|542021864|FG006|Overall Study|Lost to Follow-up|1|||
150241990|NCT03974022|542021865|FG007|Overall Study|Lost to Follow-up|0|||
150241991|NCT03974022|542021866|FG008|Overall Study|Lost to Follow-up|0|||
150241992|NCT03974022|542021867|FG009|Overall Study|Lost to Follow-up|0|||
150241993|NCT03974022|542021868|FG010|Overall Study|Lost to Follow-up|0|||
150241994|NCT03974022|542021869|FG011|Overall Study|Lost to Follow-up|0|||
150241995|NCT03974022|542021870|FG012|Overall Study|Lost to Follow-up|0|||
150241996|NCT03974022|542021871|FG013|Overall Study|Lost to Follow-up|1|||
150241997|NCT03974022|542021872|FG014|Overall Study|Lost to Follow-up|1|||
150241998|NCT03974022|542021858|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
150241999|NCT03974022|542021859|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
150242000|NCT03974022|542021860|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
150242001|NCT03974022|542021861|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
150242002|NCT03974022|542021862|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
150242003|NCT03974022|542021863|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
150242004|NCT03974022|542021864|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
150242005|NCT03974022|542021865|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
150242006|NCT03974022|542021866|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
150242007|NCT03974022|542021867|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
150242008|NCT03974022|542021868|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
150242009|NCT03974022|542021869|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
150242010|NCT03974022|542021870|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
150242011|NCT03974022|542021871|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
150242012|NCT03974022|542021872|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
150242013|NCT04013971|542021873|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
150242014|NCT04013971|542021874|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
150242015|NCT04013971|542021873|FG000|Overall Study|Missing biomechanical data|0|||
150242016|NCT04013971|542021874|FG001|Overall Study|Missing biomechanical data|1|||
150242017|NCT02520310|542021875|FG000|At 6 Months Clinical Follow-up|Death|1|||
150242018|NCT02520310|542021875|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
150242019|NCT02520310|542021875|FG000|AT 3 Year Clinical Follow-up|Death|2|||
150242020|NCT02520310|542021875|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
150242021|NCT02520310|542021875|FG000|AT 4 Year Clinical Follow-up|Death|1|||
150242022|NCT02520310|542021875|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
150242023|NCT01340014|542021876|FG000|Period 1, First 7 Days|Adverse Event|1|||
150242024|NCT01340014|542021877|FG001|Period 1, First 7 Days|Adverse Event|0|||
150242025|NCT01340014|542021876|FG000|Period 1, First 7 Days|Personal Reasons|1|||
150242026|NCT01340014|542021877|FG001|Period 1, First 7 Days|Personal Reasons|0|||
150242027|NCT01340014|542021876|FG000|Period 2, Second 7 Days|Adverse Event|0|||
150242028|NCT01340014|542021877|FG001|Period 2, Second 7 Days|Adverse Event|1|||
150242029|NCT05032066|542021878|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
150242030|NCT05032066|542021879|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
150242031|NCT05032066|542021880|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
150242032|NCT05032066|542021878|FG000|Part 1: Core Phase|Physician Decision|0|||
150242033|NCT05032066|542021879|FG001|Part 1: Core Phase|Physician Decision|1|||
150242034|NCT05032066|542021880|FG002|Part 1: Core Phase|Physician Decision|1|||
150242035|NCT05032066|542021878|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
150242036|NCT05032066|542021879|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
150242037|NCT05032066|542021880|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
150242038|NCT05032066|542021878|FG000|Part 1: Core Phase|Death|3|||
150242039|NCT05032066|542021879|FG001|Part 1: Core Phase|Death|4|||
150242040|NCT05032066|542021880|FG002|Part 1: Core Phase|Death|2|||
150242041|NCT05032066|542021878|FG000|Part 1: Core Phase|Adverse Event|2|||
150242042|NCT05032066|542021879|FG001|Part 1: Core Phase|Adverse Event|3|||
150242043|NCT05032066|542021880|FG002|Part 1: Core Phase|Adverse Event|0|||
150242044|NCT05032066|542021878|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
150242045|NCT05032066|542021879|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
150242046|NCT05032066|542021880|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
150242047|NCT05032066|542021878|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
150242048|NCT05032066|542021879|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
150242049|NCT05032066|542021880|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
150242050|NCT05032066|542021878|FG000|Part 2: Extension Phase|Physician Decision|1|||
150242051|NCT05032066|542021879|FG001|Part 2: Extension Phase|Physician Decision|2|||
150242052|NCT05032066|542021880|FG002|Part 2: Extension Phase|Physician Decision|0|||
150242053|NCT05032066|542021878|FG000|Part 2: Extension Phase|Death|2|||
150242054|NCT05032066|542021879|FG001|Part 2: Extension Phase|Death|4|||
150242055|NCT05032066|542021880|FG002|Part 2: Extension Phase|Death|5|||
150242056|NCT04577573|542021883|FG000|Overall Study|Technical - invalid protocol|0|||
150242057|NCT04577573|542021884|FG001|Overall Study|Technical - invalid protocol|2|||
150242058|NCT04577573|542021885|FG002|Overall Study|Technical - invalid protocol|0|||
150242059|NCT04297618|542021886|FG000|Overall Study|Adverse Event|1|||
150242060|NCT04297618|542021886|FG000|Overall Study|Withdrawal by Subject|1|||
150242061|NCT04704219|542021887|FG000|Overall Study|Screen Failure|1|||
150242062|NCT04704219|542021887|FG000|Overall Study|Withdrawal by Subject|1|||
150242063|NCT04704219|542021887|FG000|Overall Study|Death|78|||
150242064|NCT04704219|542021887|FG000|Overall Study|Participants Ongoing|80|||
150242065|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
150242066|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
150242067|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
150242068|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
150242069|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
150242070|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
150242071|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
150242072|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
150242073|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
150242074|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
150242075|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
150242076|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
150242077|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
150242078|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
150242079|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
150242080|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
150242081|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
150242082|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
150242083|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
150242084|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
150242085|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
150242086|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
150242087|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
150242088|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
150242089|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
150242090|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
150242091|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
150242092|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
150242093|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
150242094|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
150242095|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
150242096|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
150242097|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
150242098|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
150242099|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
150242100|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
150242101|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
150242102|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
150242103|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
150242104|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
150242105|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
150242106|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
150242107|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
150242108|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
150242109|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
150242110|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
150242111|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
150242112|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
150242113|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
150242114|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
150242115|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
150242116|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
150242117|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
150242118|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
150242119|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
150242120|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
150242121|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
150242122|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
150242123|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
150242124|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
150242125|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
150242126|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
150242127|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
150242128|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
150242129|NCT00217737|542021888|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
150242130|NCT00217737|542021889|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
150242131|NCT00217737|542021890|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
150242132|NCT00217737|542021891|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
150242133|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
150242134|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
150242135|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
150242136|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
150242137|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
150242138|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
150242139|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
150242140|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
150242141|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Study suspension|0|||
150242142|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Study suspension|45|||
150242143|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Study suspension|0|||
150242144|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Study suspension|0|||
150242145|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
150242146|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
150242147|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
150242148|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
150242149|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Death|2|||
150242150|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Death|3|||
150242151|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Death|0|||
150242152|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Death|0|||
150242153|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
150242154|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
150242155|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
150242156|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
150242157|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
150242158|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
150242159|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
150242160|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
150242161|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
150242162|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
150242163|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
150242164|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
150242165|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
150242166|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
150242167|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
150242168|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
150242169|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
150242170|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
150242171|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
150242172|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
150242173|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
150242174|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
150242175|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
150242176|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
150242177|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
150242178|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
150242179|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
150242180|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
150242181|NCT00217737|542021888|FG000|Step 2 Randomization/Registration|Other|1|||
150242182|NCT00217737|542021889|FG001|Step 2 Randomization/Registration|Other|2|||
150242183|NCT00217737|542021890|FG002|Step 2 Randomization/Registration|Other|0|||
150242184|NCT00217737|542021891|FG003|Step 2 Randomization/Registration|Other|0|||
150242185|NCT03213704|542021893|FG000|Overall Study|Physician Decision|3|||
150242186|NCT03213704|542021893|FG000|Overall Study|Protocol Violation|1|||
150242187|NCT03213704|542021893|FG000|Overall Study|Progressive disease|4|||
150242188|NCT01183390|542023347|FG000|First Intervention|Adverse Event|0|||
150242189|NCT01183390|542023348|FG001|First Intervention|Adverse Event|1|||
150242190|NCT00474526|542023349|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
150242191|NCT00474526|542023350|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
150242192|NCT00474526|542023351|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
150242193|NCT00474526|542023352|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
150242194|NCT00474526|542023353|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
150242195|NCT00474526|542023354|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
150242196|NCT00474526|542023355|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
150242197|NCT00474526|542023356|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
150242198|NCT00474526|542023357|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
150242199|NCT00474526|542023358|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
150242200|NCT00474526|542023359|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
150242201|NCT00474526|542023360|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
150242202|NCT00474526|542023361|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
150242203|NCT00474526|542023362|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
150242204|NCT00474526|542023363|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
150242205|NCT00474526|542023364|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
150242206|NCT00474526|542023365|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
150242207|NCT00474526|542023349|FG000|Overall Study|Adverse Event|2|||
150242208|NCT00474526|542023350|FG001|Overall Study|Adverse Event|0|||
150242209|NCT00474526|542023351|FG002|Overall Study|Adverse Event|2|||
150242210|NCT00474526|542023352|FG003|Overall Study|Adverse Event|4|||
150242211|NCT00474526|542023353|FG004|Overall Study|Adverse Event|2|||
150242212|NCT00474526|542023354|FG005|Overall Study|Adverse Event|1|||
150242213|NCT00474526|542023355|FG006|Overall Study|Adverse Event|1|||
150242214|NCT00474526|542023356|FG007|Overall Study|Adverse Event|0|||
150242215|NCT00474526|542023357|FG008|Overall Study|Adverse Event|0|||
150242216|NCT00474526|542023358|FG009|Overall Study|Adverse Event|0|||
150242217|NCT00474526|542023359|FG010|Overall Study|Adverse Event|0|||
150242218|NCT00474526|542023360|FG011|Overall Study|Adverse Event|0|||
150242219|NCT00474526|542023361|FG012|Overall Study|Adverse Event|0|||
150242220|NCT00474526|542023362|FG013|Overall Study|Adverse Event|0|||
150242221|NCT00474526|542023363|FG014|Overall Study|Adverse Event|1|||
150242222|NCT00474526|542023364|FG015|Overall Study|Adverse Event|1|||
150242223|NCT00474526|542023365|FG016|Overall Study|Adverse Event|0|||
150242224|NCT00474526|542023349|FG000|Overall Study|Death|0|||
150242225|NCT00474526|542023350|FG001|Overall Study|Death|0|||
150242226|NCT00474526|542023351|FG002|Overall Study|Death|0|||
150242227|NCT00474526|542023352|FG003|Overall Study|Death|0|||
150242228|NCT00474526|542023353|FG004|Overall Study|Death|0|||
150242229|NCT00474526|542023354|FG005|Overall Study|Death|0|||
150242230|NCT00474526|542023355|FG006|Overall Study|Death|0|||
150242231|NCT00474526|542023356|FG007|Overall Study|Death|0|||
150242232|NCT00474526|542023357|FG008|Overall Study|Death|0|||
150242233|NCT00474526|542023358|FG009|Overall Study|Death|0|||
150242234|NCT00474526|542023359|FG010|Overall Study|Death|0|||
150242235|NCT00474526|542023360|FG011|Overall Study|Death|0|||
150242236|NCT00474526|542023361|FG012|Overall Study|Death|0|||
150242237|NCT00474526|542023362|FG013|Overall Study|Death|3|||
150242238|NCT00474526|542023363|FG014|Overall Study|Death|0|||
150242239|NCT00474526|542023364|FG015|Overall Study|Death|0|||
150242240|NCT00474526|542023365|FG016|Overall Study|Death|0|||
150242241|NCT00474526|542023349|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242242|NCT00474526|542023350|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
150242243|NCT00474526|542023351|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242244|NCT00474526|542023352|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
150242245|NCT00474526|542023353|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
150242246|NCT00474526|542023354|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242247|NCT00474526|542023355|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242248|NCT00474526|542023356|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242249|NCT00474526|542023357|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242250|NCT00474526|542023358|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242251|NCT00474526|542023359|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242252|NCT00474526|542023360|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242253|NCT00474526|542023361|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242254|NCT00474526|542023362|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
150242255|NCT00474526|542023363|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
150242256|NCT00474526|542023364|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242257|NCT00474526|542023365|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
150242258|NCT00474526|542023349|FG000|Overall Study|Lost to Follow-up|8|||
150242259|NCT00474526|542023350|FG001|Overall Study|Lost to Follow-up|6|||
150242260|NCT00474526|542023351|FG002|Overall Study|Lost to Follow-up|13|||
150242261|NCT00474526|542023352|FG003|Overall Study|Lost to Follow-up|29|||
150242262|NCT00474526|542023353|FG004|Overall Study|Lost to Follow-up|11|||
150242263|NCT00474526|542023354|FG005|Overall Study|Lost to Follow-up|5|||
150242264|NCT00474526|542023355|FG006|Overall Study|Lost to Follow-up|8|||
150242265|NCT00474526|542023356|FG007|Overall Study|Lost to Follow-up|1|||
150242266|NCT00474526|542023357|FG008|Overall Study|Lost to Follow-up|0|||
150242267|NCT00474526|542023358|FG009|Overall Study|Lost to Follow-up|6|||
150242268|NCT00474526|542023359|FG010|Overall Study|Lost to Follow-up|2|||
150242269|NCT00474526|542023360|FG011|Overall Study|Lost to Follow-up|4|||
150242270|NCT00474526|542023361|FG012|Overall Study|Lost to Follow-up|6|||
150242271|NCT00474526|542023362|FG013|Overall Study|Lost to Follow-up|74|||
150242272|NCT00474526|542023363|FG014|Overall Study|Lost to Follow-up|29|||
150242273|NCT00474526|542023364|FG015|Overall Study|Lost to Follow-up|4|||
150242274|NCT00474526|542023365|FG016|Overall Study|Lost to Follow-up|5|||
150242275|NCT00474526|542023349|FG000|Overall Study|Protocol Violation|2|||
150242276|NCT00474526|542023350|FG001|Overall Study|Protocol Violation|6|||
150242277|NCT00474526|542023351|FG002|Overall Study|Protocol Violation|4|||
150242278|NCT00474526|542023352|FG003|Overall Study|Protocol Violation|12|||
150242279|NCT00474526|542023353|FG004|Overall Study|Protocol Violation|3|||
150242280|NCT00474526|542023354|FG005|Overall Study|Protocol Violation|1|||
150242281|NCT00474526|542023355|FG006|Overall Study|Protocol Violation|3|||
150242282|NCT00474526|542023356|FG007|Overall Study|Protocol Violation|0|||
150242283|NCT00474526|542023357|FG008|Overall Study|Protocol Violation|0|||
150242284|NCT00474526|542023358|FG009|Overall Study|Protocol Violation|4|||
150242285|NCT00474526|542023359|FG010|Overall Study|Protocol Violation|2|||
150242286|NCT00474526|542023360|FG011|Overall Study|Protocol Violation|2|||
150242287|NCT00474526|542023361|FG012|Overall Study|Protocol Violation|4|||
150242288|NCT00474526|542023362|FG013|Overall Study|Protocol Violation|19|||
150242289|NCT00474526|542023363|FG014|Overall Study|Protocol Violation|9|||
150242290|NCT00474526|542023364|FG015|Overall Study|Protocol Violation|6|||
150242291|NCT00474526|542023365|FG016|Overall Study|Protocol Violation|2|||
150242292|NCT00474526|542023349|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
150242293|NCT00474526|542023350|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
150242294|NCT00474526|542023351|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
150242295|NCT00474526|542023352|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
150242296|NCT00474526|542023353|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
150242297|NCT00474526|542023354|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
150242298|NCT00474526|542023355|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
150242299|NCT00474526|542023356|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
150242300|NCT00474526|542023357|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
150242301|NCT00474526|542023358|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
150242302|NCT00474526|542023359|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
150242303|NCT00474526|542023360|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
150242304|NCT00474526|542023361|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
150242305|NCT00474526|542023362|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
150242306|NCT00474526|542023363|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
150242307|NCT00474526|542023364|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
150242308|NCT00474526|542023365|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
150242309|NCT00474526|542023349|FG000|Overall Study|Withdrawal by Subject|9|||
150242310|NCT00474526|542023350|FG001|Overall Study|Withdrawal by Subject|24|||
150242311|NCT00474526|542023351|FG002|Overall Study|Withdrawal by Subject|21|||
150242312|NCT00474526|542023352|FG003|Overall Study|Withdrawal by Subject|52|||
150242313|NCT00474526|542023353|FG004|Overall Study|Withdrawal by Subject|38|||
150242314|NCT00474526|542023354|FG005|Overall Study|Withdrawal by Subject|6|||
150242315|NCT00474526|542023355|FG006|Overall Study|Withdrawal by Subject|12|||
150242316|NCT00474526|542023356|FG007|Overall Study|Withdrawal by Subject|4|||
150242317|NCT00474526|542023357|FG008|Overall Study|Withdrawal by Subject|4|||
150242318|NCT00474526|542023358|FG009|Overall Study|Withdrawal by Subject|13|||
150242319|NCT00474526|542023359|FG010|Overall Study|Withdrawal by Subject|5|||
150242320|NCT00474526|542023360|FG011|Overall Study|Withdrawal by Subject|4|||
150242321|NCT00474526|542023361|FG012|Overall Study|Withdrawal by Subject|4|||
150242322|NCT00474526|542023362|FG013|Overall Study|Withdrawal by Subject|37|||
150242323|NCT00474526|542023363|FG014|Overall Study|Withdrawal by Subject|22|||
150242324|NCT00474526|542023364|FG015|Overall Study|Withdrawal by Subject|1|||
150242325|NCT00474526|542023365|FG016|Overall Study|Withdrawal by Subject|1|||
150242326|NCT02763215|542023366|FG000|Overall Study|Participants withdrew from study|3|||
150242327|NCT02763215|542023366|FG000|Overall Study|Missed visit|1|||
150242328|NCT02763215|542023366|FG000|Overall Study|Visit outside visit-window|1|||
150242329|NCT02763215|542023366|FG000|Overall Study|Death|1|||
150242330|NCT02763215|542023366|FG000|Overall Study|Lost to Follow-up|1|||
150242331|NCT00592293|542023368|FG000|Overall Study|Withdrawal by Subject|1|||
150242332|NCT01606319|542023369|FG000|Overall Study|Lost to Follow-up|17|||
150242333|NCT01606319|542023370|FG001|Overall Study|Lost to Follow-up|14|||
150242334|NCT01606319|542023369|FG000|Overall Study|Withdrawal by Subject|9|||
150242335|NCT01606319|542023370|FG001|Overall Study|Withdrawal by Subject|12|||
150242336|NCT01606319|542023369|FG000|Overall Study|Physician Decision|1|||
150242337|NCT01606319|542023370|FG001|Overall Study|Physician Decision|2|||
150242338|NCT01606319|542023369|FG000|Overall Study|Lack of Efficacy|6|||
150242339|NCT01606319|542023370|FG001|Overall Study|Lack of Efficacy|8|||
150242340|NCT01606319|542023369|FG000|Overall Study|Adverse Event|1|||
150242341|NCT01606319|542023370|FG001|Overall Study|Adverse Event|4|||
150242342|NCT01784523|542023373|FG000|Overall Study|Study closed early|7|||
150242343|NCT01784523|542023374|FG001|Overall Study|Study closed early|4|||
150242344|NCT02179177|542023375|FG000|Overall Study|Lost to Follow-up|1|||
150242345|NCT02179177|542023376|FG001|Overall Study|Lost to Follow-up|1|||
150242346|NCT02179177|542023375|FG000|Overall Study|Withdrawal by Subject|1|||
150242347|NCT02179177|542023376|FG001|Overall Study|Withdrawal by Subject|1|||
150242348|NCT00022659|542023377|FG000|Overall Study|Ineligible: wrong primary|1|||
150242349|NCT00022659|542023377|FG000|Overall Study|Never treated|1|||
150242350|NCT04340947|542023378|FG000|7-day Washout Period|Lost to Follow-up|5|||
150242351|NCT04340947|542023379|FG001|7-day Washout Period|Lost to Follow-up|4|||
150242352|NCT01907906|542023382|FG000|Overall Study|Withdrawal by Subject|1|||
150242353|NCT01907906|542023383|FG001|Overall Study|Withdrawal by Subject|0|||
150242354|NCT01907906|542023382|FG000|Overall Study|Physician Decision|3|||
150242355|NCT01907906|542023383|FG001|Overall Study|Physician Decision|1|||
150242356|NCT00884650|542023384|FG000|Overall Study|Did not return complete pain diaries|7|||
150242357|NCT00884650|542023385|FG001|Overall Study|Did not return complete pain diaries|7|||
150242358|NCT00884650|542023384|FG000|Overall Study|Admitted Post-Op|1|||
150242359|NCT00884650|542023385|FG001|Overall Study|Admitted Post-Op|0|||
150242360|NCT00884650|542023384|FG000|Overall Study|Femoral Stress Fracture|1|||
150242361|NCT00884650|542023385|FG001|Overall Study|Femoral Stress Fracture|0|||
150242362|NCT00884650|542023384|FG000|Overall Study|Pain Pump Complication|0|||
150242363|NCT00884650|542023385|FG001|Overall Study|Pain Pump Complication|1|||
150242364|NCT04052425|542023394|FG000|24-Week Double-blind Period|Adverse Event|0|||
150242365|NCT04052425|542023395|FG001|24-Week Double-blind Period|Adverse Event|1|||
150242366|NCT04052425|542023396|FG002|24-Week Double-blind Period|Adverse Event|0|||
150242367|NCT04052425|542023397|FG003|24-Week Double-blind Period|Adverse Event|0|||
150242368|NCT04052425|542023394|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
150242369|NCT04052425|542023395|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
150242370|NCT04052425|542023396|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
150242371|NCT04052425|542023397|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
150242372|NCT04052425|542023394|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
150242373|NCT04052425|542023395|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
150242374|NCT04052425|542023396|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
150242375|NCT04052425|542023397|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
150242376|NCT04052425|542023394|FG000|24-Week Double-blind Period|Physician Decision|1|||
150242377|NCT04052425|542023395|FG001|24-Week Double-blind Period|Physician Decision|0|||
150242378|NCT04052425|542023396|FG002|24-Week Double-blind Period|Physician Decision|0|||
150242379|NCT04052425|542023397|FG003|24-Week Double-blind Period|Physician Decision|0|||
150242380|NCT04052425|542023394|FG000|24-Week Double-blind Period|Protocol Violation|1|||
150242381|NCT04052425|542023395|FG001|24-Week Double-blind Period|Protocol Violation|0|||
150242382|NCT04052425|542023396|FG002|24-Week Double-blind Period|Protocol Violation|0|||
150242383|NCT04052425|542023397|FG003|24-Week Double-blind Period|Protocol Violation|0|||
150242384|NCT04052425|542023394|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
150242385|NCT04052425|542023395|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
150242386|NCT04052425|542023396|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
150242387|NCT04052425|542023397|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
150242388|NCT04052425|542023394|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
150242389|NCT04052425|542023395|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
150242390|NCT04052425|542023396|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
150242391|NCT04052425|542023397|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
150242392|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
150242393|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
150242394|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
150242395|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
150242396|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
150242397|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
150242398|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
150242399|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
150242400|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
150242401|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
150242402|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
150242403|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
150242404|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
150242405|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
150242406|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
150242407|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
150242408|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
150242409|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
150242410|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
150242411|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
150242412|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
150242413|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
150242414|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
150242415|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
150242416|NCT04052425|542023394|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
150242417|NCT04052425|542023395|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
150242418|NCT04052425|542023396|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
150242419|NCT04052425|542023397|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
150242420|NCT04334278|542023398|FG000|Overall Study|Lost to Follow-up|0|||
150242421|NCT04334278|542023399|FG001|Overall Study|Lost to Follow-up|3|||
150242422|NCT04334278|542023398|FG000|Overall Study|Withdrawal by Subject|4|||
150242423|NCT04334278|542023399|FG001|Overall Study|Withdrawal by Subject|2|||
150242424|NCT01821937|542023400|FG000|Overall Study|Adverse Event|0|||
150242425|NCT01821937|542023401|FG001|Overall Study|Adverse Event|3|||
150242426|NCT00732992|542023402|FG000|Overall Study|Adverse Event|1|||
150242427|NCT00732992|542023403|FG001|Overall Study|Adverse Event|1|||
150242428|NCT00732992|542023402|FG000|Overall Study|Objective Progression or Relapse|3|||
150242429|NCT00732992|542023403|FG001|Overall Study|Objective Progression or Relapse|5|||
150242430|NCT00732992|542023402|FG000|Overall Study|Global Deterioration of Health Status|1|||
150242431|NCT00732992|542023403|FG001|Overall Study|Global Deterioration of Health Status|0|||
150242432|NCT00732992|542023402|FG000|Overall Study|Withdrawal by Subject|1|||
150242433|NCT00732992|542023403|FG001|Overall Study|Withdrawal by Subject|0|||
150242434|NCT02838134|542023404|FG000|Overall Study|Lost to Follow-up|1|||
150242435|NCT02838134|542023405|FG001|Overall Study|Lost to Follow-up|2|||
150242436|NCT02838134|542023404|FG000|Overall Study|logistic problems|1|||
150242437|NCT02838134|542023405|FG001|Overall Study|logistic problems|1|||
150242438|NCT01969851|542023406|FG000|Overall Study|Adverse Event|0|||
150242439|NCT01969851|542023407|FG001|Overall Study|Adverse Event|0|||
150242440|NCT01969851|542023408|FG002|Overall Study|Adverse Event|3|||
150242441|NCT01969851|542023406|FG000|Overall Study|Lack of Efficacy|0|||
150242442|NCT01969851|542023407|FG001|Overall Study|Lack of Efficacy|3|||
150242443|NCT01969851|542023408|FG002|Overall Study|Lack of Efficacy|1|||
150242444|NCT01969851|542023406|FG000|Overall Study|Withdrawal by Subject|1|||
150242445|NCT01969851|542023407|FG001|Overall Study|Withdrawal by Subject|0|||
150242446|NCT01969851|542023408|FG002|Overall Study|Withdrawal by Subject|1|||
150242447|NCT01969851|542023406|FG000|Overall Study|No effective dose in Titration period|0|||
150242448|NCT01969851|542023407|FG001|Overall Study|No effective dose in Titration period|0|||
150242449|NCT01969851|542023408|FG002|Overall Study|No effective dose in Titration period|1|||
150242450|NCT01969851|542023406|FG000|Overall Study|Sponsor decision|0|||
150242451|NCT01969851|542023407|FG001|Overall Study|Sponsor decision|0|||
150242452|NCT01969851|542023408|FG002|Overall Study|Sponsor decision|1|||
150242453|NCT01245374|542023413|FG000|Overall Study|Protocol Violation|1|||
150242454|NCT01245374|542023413|FG000|Overall Study|Withdrawal by Subject|3|||
150242455|NCT04199052|542023417|FG000|Overall Study|Lost to Follow-up|11|||
150242456|NCT04199052|542023418|FG001|Overall Study|Lost to Follow-up|18|||
150242457|NCT04946942|542023419|FG000|Overall Study|Lost to Follow-up|6|||
150242458|NCT04946942|542023420|FG001|Overall Study|Lost to Follow-up|2|||
150242459|NCT04946942|542023421|FG002|Overall Study|Lost to Follow-up|0|||
150242460|NCT00365547|542023422|FG000|Overall Study|Insurance did not cover Avastin|1|||
150242461|NCT00365547|542023422|FG000|Overall Study|Screen failure|1|||
150242462|NCT00365547|542023422|FG000|Overall Study|Withdrawal by Subject|1|||
150242463|NCT03170518|542023423|FG000|Overall Study|Lost to Follow-up|4|||
150242464|NCT03170518|542023424|FG001|Overall Study|Lost to Follow-up|1|||
150242465|NCT03170518|542023425|FG002|Overall Study|Lost to Follow-up|0|||
150242466|NCT03170518|542023423|FG000|Overall Study|Physician Decision|1|||
150242467|NCT03170518|542023424|FG001|Overall Study|Physician Decision|0|||
150242468|NCT03170518|542023425|FG002|Overall Study|Physician Decision|0|||
150242469|NCT03170518|542023423|FG000|Overall Study|Withdrawal by Subject|4|||
150242470|NCT03170518|542023424|FG001|Overall Study|Withdrawal by Subject|5|||
150242471|NCT03170518|542023425|FG002|Overall Study|Withdrawal by Subject|2|||
150242472|NCT03170518|542023423|FG000|Overall Study|Site terminated by sponsor|0|||
150242473|NCT03170518|542023424|FG001|Overall Study|Site terminated by sponsor|1|||
150242474|NCT03170518|542023425|FG002|Overall Study|Site terminated by sponsor|0|||
150242475|NCT03170518|542023423|FG000|Overall Study|Non-compliance with study drug|1|||
150242476|NCT03170518|542023424|FG001|Overall Study|Non-compliance with study drug|0|||
150242477|NCT03170518|542023425|FG002|Overall Study|Non-compliance with study drug|1|||
150242478|NCT03170518|542023423|FG000|Overall Study|Withdrawal by parent/guardian|2|||
150242479|NCT03170518|542023424|FG001|Overall Study|Withdrawal by parent/guardian|0|||
150242480|NCT03170518|542023425|FG002|Overall Study|Withdrawal by parent/guardian|0|||
150242481|NCT02257918|542023426|FG000|Overall Study|Lost to Follow-up|4|||
150242482|NCT02257918|542023427|FG001|Overall Study|Lost to Follow-up|1|||
150242483|NCT02257918|542023428|FG002|Overall Study|Lost to Follow-up|0|||
150242484|NCT02257918|542023426|FG000|Overall Study|Withdrawal by Subject|0|||
150242485|NCT02257918|542023427|FG001|Overall Study|Withdrawal by Subject|0|||
150242486|NCT02257918|542023428|FG002|Overall Study|Withdrawal by Subject|1|||
150242487|NCT02257918|542023426|FG000|Overall Study|Pregnancy|0|||
150242488|NCT02257918|542023427|FG001|Overall Study|Pregnancy|0|||
150242489|NCT02257918|542023428|FG002|Overall Study|Pregnancy|1|||
150242490|NCT03023423|542023429|FG000|Overall Study|Death|5|||
150242491|NCT03023423|542023430|FG001|Overall Study|Death|12|||
150242492|NCT03023423|542023431|FG002|Overall Study|Death|20|||
150242493|NCT03023423|542023429|FG000|Overall Study|Other|0|||
150242494|NCT03023423|542023430|FG001|Overall Study|Other|2|||
150242495|NCT03023423|542023431|FG002|Overall Study|Other|2|||
150242496|NCT03023423|542023429|FG000|Overall Study|Ongoing|2|||
150242497|NCT03023423|542023430|FG001|Overall Study|Ongoing|32|||
150242498|NCT03023423|542023431|FG002|Overall Study|Ongoing|24|||
150242499|NCT03512197|542023432|FG000|Overall Study|Guardian decision|1|||
150242500|NCT03512197|542023433|FG001|Overall Study|Guardian decision|1|||
150242501|NCT03512197|542023432|FG000|Overall Study|Lack of Efficacy|19|||
150242502|NCT03512197|542023433|FG001|Overall Study|Lack of Efficacy|11|||
150242503|NCT03512197|542023432|FG000|Overall Study|New Therapy for Study Indication|16|||
150242504|NCT03512197|542023433|FG001|Overall Study|New Therapy for Study Indication|16|||
150242505|NCT03512197|542023432|FG000|Overall Study|Physician Decision|60|||
150242506|NCT03512197|542023433|FG001|Overall Study|Physician Decision|60|||
150242507|NCT03512197|542023432|FG000|Overall Study|Protocol Violation|0|||
150242508|NCT03512197|542023433|FG001|Overall Study|Protocol Violation|2|||
150242509|NCT03512197|542023432|FG000|Overall Study|Terminated by Sponsored|46|||
150242510|NCT03512197|542023433|FG001|Overall Study|Terminated by Sponsored|50|||
150242511|NCT03512197|542023432|FG000|Overall Study|Subject Decision|15|||
150242512|NCT03512197|542023433|FG001|Overall Study|Subject Decision|12|||
150242513|NCT03512197|542023432|FG000|Overall Study|Withdrawal of informed consent|20|||
150242514|NCT03512197|542023433|FG001|Overall Study|Withdrawal of informed consent|14|||
150242515|NCT03512197|542023432|FG000|Overall Study|Adverse Event|30|||
150242516|NCT03512197|542023433|FG001|Overall Study|Adverse Event|34|||
150242517|NCT03512197|542023432|FG000|Overall Study|Death|14|||
150242518|NCT03512197|542023433|FG001|Overall Study|Death|9|||
150242519|NCT03512197|542023432|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
150242520|NCT03512197|542023433|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
150242521|NCT03512197|542023432|FG000|Overall Study|Missing|3|||
150242522|NCT03512197|542023433|FG001|Overall Study|Missing|13|||
150242523|NCT03842436|542023434|FG000|Overall Study|Lost to Follow-up|1|||
150242524|NCT01948076|542023435|FG000|Overall Study|Withdrawal by Subject|0|||
150242525|NCT01948076|542023436|FG001|Overall Study|Withdrawal by Subject|1|||
150242526|NCT01151423|542023437|FG000|Overall Study|Study terminated by Sponsor|9|||
150242527|NCT01151423|542023438|FG001|Overall Study|Study terminated by Sponsor|10|||
150242528|NCT01151423|542023437|FG000|Overall Study|Protocol Violation|0|||
150242529|NCT01151423|542023438|FG001|Overall Study|Protocol Violation|1|||
150242530|NCT01151423|542023437|FG000|Overall Study|Physician Decision|1|||
150242531|NCT01151423|542023438|FG001|Overall Study|Physician Decision|1|||
150242532|NCT01151423|542023437|FG000|Overall Study|Pregnancy|0|||
150242533|NCT01151423|542023438|FG001|Overall Study|Pregnancy|1|||
150242534|NCT01151423|542023437|FG000|Overall Study|Death|0|||
150242535|NCT01151423|542023438|FG001|Overall Study|Death|1|||
150242536|NCT01151423|542023437|FG000|Overall Study|Adverse Event|3|||
150242537|NCT01151423|542023438|FG001|Overall Study|Adverse Event|0|||
150242538|NCT01151423|542023437|FG000|Overall Study|Withdrawal by Subject|1|||
150242539|NCT01151423|542023438|FG001|Overall Study|Withdrawal by Subject|3|||
150242540|NCT01151423|542023437|FG000|Overall Study|Lost to Follow-up|1|||
150242541|NCT01151423|542023438|FG001|Overall Study|Lost to Follow-up|0|||
150242542|NCT01151423|542023437|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
150242543|NCT01151423|542023438|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
150242544|NCT01151423|542023437|FG000|Overall Study|Participated in other clinical trial|1|||
150242545|NCT01151423|542023438|FG001|Overall Study|Participated in other clinical trial|0|||
150242546|NCT01263054|542023439|FG000|Overall Study|Death|1|||
150242547|NCT01263054|542023440|FG001|Overall Study|Death|0|||
150242548|NCT01263054|542023439|FG000|Overall Study|Lost to Follow-up|2|||
150242549|NCT01263054|542023440|FG001|Overall Study|Lost to Follow-up|2|||
150242550|NCT01263054|542023439|FG000|Overall Study|Withdrawal by Subject|1|||
150242551|NCT01263054|542023440|FG001|Overall Study|Withdrawal by Subject|3|||
150242552|NCT01263054|542023439|FG000|Overall Study|Qualification Violation|1|||
150242553|NCT01263054|542023440|FG001|Overall Study|Qualification Violation|0|||
150242554|NCT01263054|542023439|FG000|Overall Study|Other|0|||
150242555|NCT01263054|542023440|FG001|Overall Study|Other|1|||
150242556|NCT00936598|542023441|FG000|Overall Study|Withdrawal by Subject|1|||
150242557|NCT00936598|542023442|FG001|Overall Study|Withdrawal by Subject|0|||
150242558|NCT00936598|542023441|FG000|Overall Study|Ineligible after consent|1|||
150242559|NCT00936598|542023442|FG001|Overall Study|Ineligible after consent|0|||
150242560|NCT00681668|542023443|FG000|Overall Study|Protocol Violation|1|||
150242561|NCT00681668|542023443|FG000|Overall Study|Withdrawal by Subject|1|||
150242562|NCT04277507|542023447|FG000|Overall Study|Lost to Follow-up|17|||
150242563|NCT04277507|542023447|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
150242564|NCT04277507|542023447|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
150242565|NCT04277507|542023447|FG000|Overall Study|Withdrawal by Subject|3|||
150242566|NCT04277507|542023447|FG000|Overall Study|Death due to COVID-19|1|||
150242567|NCT04277507|542023447|FG000|Overall Study|Data missing for full evaluation|5|||
150242568|NCT00583947|542023457|FG000|Cross-over Period|Adverse Event|2|||
150242569|NCT00583947|542023458|FG001|Cross-over Period|Adverse Event|0|||
150242570|NCT00583947|542023457|FG000|Cross-over Period|Withdrawal by Subject|2|||
150242571|NCT00583947|542023458|FG001|Cross-over Period|Withdrawal by Subject|0|||
150242572|NCT00583947|542023457|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
150242573|NCT00583947|542023458|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
150242574|NCT00583947|542023457|FG000|Cross-over Period|Other|1|||
150242575|NCT00583947|542023458|FG001|Cross-over Period|Other|1|||
150242576|NCT00486252|542023460|FG000|Overall Study|Adverse Event|7|||
150242577|NCT00486252|542023460|FG000|Overall Study|Lack of Efficacy|9|||
150242578|NCT00486252|542023460|FG000|Overall Study|Lost to Follow-up|24|||
150242579|NCT00486252|542023460|FG000|Overall Study|Other|18|||
150242580|NCT01261247|542023461|FG000|Overall Study|Ineligible|2|||
150242581|NCT05226130|542023462|FG000|Overall Study|Lost to Follow-up|0|||
150242582|NCT05226130|542023463|FG001|Overall Study|Lost to Follow-up|1|||
150242583|NCT05226130|542023462|FG000|Overall Study|Not treatment adherent|0|||
150242584|NCT05226130|542023463|FG001|Overall Study|Not treatment adherent|2|||
150242585|NCT05101993|542023472|FG000|Overall Study|Withdrawal by Subject|1|||
150242586|NCT01124838|542023473|FG000|Overall Study|Miscellaneous|4|||
150242587|NCT01124838|542023474|FG001|Overall Study|Miscellaneous|2|||
150242588|NCT01124838|542023473|FG000|Overall Study|Adverse Event|7|||
150242589|NCT01124838|542023474|FG001|Overall Study|Adverse Event|11|||
150242590|NCT01124838|542023473|FG000|Overall Study|Lack of Efficacy|2|||
150242591|NCT01124838|542023474|FG001|Overall Study|Lack of Efficacy|0|||
150242592|NCT01124838|542023473|FG000|Overall Study|Withdrawal by Subject|3|||
150242593|NCT01124838|542023474|FG001|Overall Study|Withdrawal by Subject|2|||
150242594|NCT01124838|542023473|FG000|Overall Study|Lost to Follow-up|2|||
150242595|NCT01124838|542023474|FG001|Overall Study|Lost to Follow-up|0|||
150242596|NCT02065882|542023475|FG000|Part I: PK/PD|Screening failure|5|||
150242597|NCT02065882|542023475|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
150242598|NCT02065882|542023475|FG000|Part I: PK/PD|Adverse Event|1|||
150242599|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|Screening failure|7|||
150242600|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
150242601|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
150242602|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
150242603|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
150242604|NCT02065882|542023475|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
150242605|NCT04680533|542023476|FG000|Overall Study|Screen failure|1|||
150242606|NCT03816761|542024801|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
150242607|NCT03816761|542024802|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
150242608|NCT03816761|542024803|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
150242609|NCT03816761|542024804|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
150242610|NCT03816761|542024805|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
150242611|NCT03816761|542024806|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
150242612|NCT03816761|542024801|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
150242613|NCT03816761|542024802|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
150242614|NCT03816761|542024803|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
150242615|NCT03816761|542024804|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
150242616|NCT03816761|542024805|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
150242617|NCT03816761|542024806|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
150242618|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Adverse Event|2|||
150242619|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Adverse Event|0|||
150242620|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Adverse Event|0|||
150242621|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Adverse Event|0|||
150242622|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
150242623|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
150242624|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
150242625|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
150242626|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
150242627|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
150242628|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
150242629|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
150242630|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Physician Decision|1|||
150242631|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Physician Decision|0|||
150242632|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Physician Decision|0|||
150242633|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Physician Decision|0|||
150242634|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Pregnancy|1|||
150242635|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Pregnancy|0|||
150242636|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Pregnancy|0|||
150242637|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Pregnancy|0|||
150242638|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
150242639|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
150242640|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
150242641|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
150242642|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
150242643|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
150242644|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
150242645|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
150242646|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
150242647|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
150242648|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
150242649|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
150242650|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
150242651|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
150242652|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
150242653|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
150242654|NCT04057573|542024811|FG000|24-Week Double-Blind Period|Not Treated|1|||
150242655|NCT04057573|542024812|FG001|24-Week Double-Blind Period|Not Treated|0|||
150242656|NCT04057573|542024813|FG002|24-Week Double-Blind Period|Not Treated|0|||
150242657|NCT04057573|542024814|FG003|24-Week Double-Blind Period|Not Treated|0|||
150242658|NCT04057573|542024811|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
150242659|NCT04057573|542024812|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
150242660|NCT04057573|542024813|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
150242661|NCT04057573|542024814|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
150242662|NCT04057573|542024811|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
150242663|NCT04057573|542024812|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
150242664|NCT04057573|542024813|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
150242665|NCT04057573|542024814|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
150242666|NCT04057573|542024811|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
150242667|NCT04057573|542024812|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
150242668|NCT04057573|542024813|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
150242669|NCT04057573|542024814|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
150242670|NCT04057573|542024811|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
150242671|NCT04057573|542024812|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
150242672|NCT04057573|542024813|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
150242673|NCT04057573|542024814|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
150242674|NCT04057573|542024811|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
150242675|NCT04057573|542024812|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
150242676|NCT04057573|542024813|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
150242677|NCT04057573|542024814|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
150242678|NCT04991753|542024815|FG000|Overall Study|Withdrawal by Subject|0|||
150242679|NCT04991753|542024816|FG001|Overall Study|Withdrawal by Subject|1|||
150242680|NCT02797522|542024819|FG000|Overall Study|Study Terminated by Sponsor|0|||
150242681|NCT02797522|542024820|FG001|Overall Study|Study Terminated by Sponsor|0|||
150242682|NCT02797522|542024821|FG002|Overall Study|Study Terminated by Sponsor|0|||
150242683|NCT02797522|542024822|FG003|Overall Study|Study Terminated by Sponsor|0|||
150242684|NCT02797522|542024823|FG004|Overall Study|Study Terminated by Sponsor|0|||
150242685|NCT02797522|542024824|FG005|Overall Study|Study Terminated by Sponsor|0|||
150242686|NCT02797522|542024825|FG006|Overall Study|Study Terminated by Sponsor|0|||
150242687|NCT02797522|542024826|FG007|Overall Study|Study Terminated by Sponsor|4|||
150242688|NCT02797522|542024827|FG008|Overall Study|Study Terminated by Sponsor|2|||
150242689|NCT02797522|542024828|FG009|Overall Study|Study Terminated by Sponsor|4|||
150242690|NCT02797522|542024829|FG010|Overall Study|Study Terminated by Sponsor|1|||
150242691|NCT03299049|542024830|FG000|Overall Study|On-going|486|||
150242692|NCT03299049|542024831|FG001|Overall Study|On-going|481|||
150242693|NCT03299049|542024830|FG000|Overall Study|Withdrawal by Subject|6|||
150242694|NCT03299049|542024831|FG001|Overall Study|Withdrawal by Subject|21|||
150242695|NCT03299049|542024830|FG000|Overall Study|Physician Decision|5|||
150242696|NCT03299049|542024831|FG001|Overall Study|Physician Decision|1|||
150242697|NCT03299049|542024830|FG000|Overall Study|Lost to Follow-up|2|||
150242698|NCT03299049|542024831|FG001|Overall Study|Lost to Follow-up|0|||
150242699|NCT03299049|542024830|FG000|Overall Study|Pregnancy|1|||
150242700|NCT03299049|542024831|FG001|Overall Study|Pregnancy|3|||
150242701|NCT03299049|542024830|FG000|Overall Study|Protocol Violation|1|||
150242702|NCT03299049|542024831|FG001|Overall Study|Protocol Violation|1|||
150242703|NCT03299049|542024830|FG000|Overall Study|Lack of Efficacy|9|||
150242704|NCT03299049|542024831|FG001|Overall Study|Lack of Efficacy|3|||
150242705|NCT03299049|542024830|FG000|Overall Study|Adverse Event|12|||
150242706|NCT03299049|542024831|FG001|Overall Study|Adverse Event|13|||
150242707|NCT02980042|542024834|FG000|Overall Study|Lost to Follow-up|5|||
150242708|NCT02980042|542024835|FG001|Overall Study|Lost to Follow-up|0|||
150242709|NCT02980042|542024834|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
150242710|NCT02980042|542024835|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
150242711|NCT02460575|542024840|FG000|Overall Study|Lost to Follow-up|1|||
150242712|NCT02460575|542024841|FG001|Overall Study|Lost to Follow-up|0|||
150242713|NCT02521363|542024842|FG000|Overall Study|Withdrawal by Subject|1|||
150242714|NCT02521363|542024843|FG001|Overall Study|Withdrawal by Subject|2|||
150242715|NCT04896008|542024844|FG000|Overall Study|Ongoing|70|||
150242716|NCT04896008|542024845|FG001|Overall Study|Ongoing|38|||
150242717|NCT04896008|542024844|FG000|Overall Study|Adverse Event|0|||
150242718|NCT04896008|542024845|FG001|Overall Study|Adverse Event|2|||
150242719|NCT04896008|542024844|FG000|Overall Study|Death|5|||
150242720|NCT04896008|542024845|FG001|Overall Study|Death|10|||
150242721|NCT04896008|542024844|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
150242722|NCT04896008|542024845|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
150242723|NCT04896008|542024844|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
150242724|NCT04896008|542024845|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
150242725|NCT04896008|542024844|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
150242726|NCT04896008|542024845|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
150242727|NCT04896008|542024844|FG000|Overall Study|Withdrawal by Subject|1|||
150242728|NCT04896008|542024845|FG001|Overall Study|Withdrawal by Subject|4|||
150242729|NCT04896008|542024844|FG000|Overall Study|Investigator Decision|2|||
150242730|NCT04896008|542024845|FG001|Overall Study|Investigator Decision|0|||
150242731|NCT04896008|542024844|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
150242732|NCT04896008|542024845|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
150242733|NCT04201288|542024848|FG000|Overall Study|Death|1|||
150242734|NCT04201288|542024849|FG001|Overall Study|Death|1|||
150242735|NCT04201288|542024848|FG000|Overall Study|Lost to Follow-up|5|||
150242736|NCT04201288|542024849|FG001|Overall Study|Lost to Follow-up|3|||
150242737|NCT04201288|542024848|FG000|Overall Study|Withdrawal by Subject|1|||
150242738|NCT04201288|542024849|FG001|Overall Study|Withdrawal by Subject|0|||
150242739|NCT00944229|542024850|FG000|Overall Study|Withdrawal by Subject|11|||
150242740|NCT00944229|542024850|FG000|Overall Study|Physician Decision|14|||
150242741|NCT01270828|542024851|FG000|Pregabalin CR SB|Reason Unspecified|0|||
150242742|NCT01270828|542024852|FG001|Pregabalin CR SB|Reason Unspecified|0|||
150242743|NCT01270828|542024853|FG002|Pregabalin CR SB|Reason Unspecified|8|||
150242744|NCT01270828|542024851|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
150242745|NCT01270828|542024852|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
150242746|NCT01270828|542024853|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
150242747|NCT01270828|542024851|FG000|Pregabalin CR SB|Related adverse event|0|||
150242748|NCT01270828|542024852|FG001|Pregabalin CR SB|Related adverse event|0|||
150242749|NCT01270828|542024853|FG002|Pregabalin CR SB|Related adverse event|46|||
150242750|NCT01270828|542024851|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
150242751|NCT01270828|542024852|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
150242752|NCT01270828|542024853|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
150242753|NCT01270828|542024851|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
150242754|NCT01270828|542024852|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
150242755|NCT01270828|542024853|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
150242756|NCT01270828|542024851|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
150242757|NCT01270828|542024852|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
150242758|NCT01270828|542024853|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
150242759|NCT01270828|542024851|FG000|Pregabalin CR SB|Unrelated AE|0|||
150242760|NCT01270828|542024852|FG001|Pregabalin CR SB|Unrelated AE|0|||
150242761|NCT01270828|542024853|FG002|Pregabalin CR SB|Unrelated AE|8|||
150242762|NCT01270828|542024851|FG000|Pregabalin CR SB|Protocol Violation|0|||
150242763|NCT01270828|542024852|FG001|Pregabalin CR SB|Protocol Violation|0|||
150242764|NCT01270828|542024853|FG002|Pregabalin CR SB|Protocol Violation|8|||
150242765|NCT01270828|542024851|FG000|Double Blind Phase|Death|0|||
150242766|NCT01270828|542024852|FG001|Double Blind Phase|Death|1|||
150242767|NCT01270828|542024853|FG002|Double Blind Phase|Death|0|||
150242768|NCT01270828|542024851|FG000|Double Blind Phase|Protocol Violation|0|||
150242769|NCT01270828|542024852|FG001|Double Blind Phase|Protocol Violation|1|||
150242770|NCT01270828|542024853|FG002|Double Blind Phase|Protocol Violation|0|||
150242771|NCT01270828|542024851|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
150242772|NCT01270828|542024852|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
150242773|NCT01270828|542024853|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
150242774|NCT01270828|542024851|FG000|Double Blind Phase|Reason Unspecified|7|||
150242775|NCT01270828|542024852|FG001|Double Blind Phase|Reason Unspecified|4|||
150242776|NCT01270828|542024853|FG002|Double Blind Phase|Reason Unspecified|0|||
150242777|NCT01270828|542024851|FG000|Double Blind Phase|Withdrawal by Subject|6|||
150242778|NCT01270828|542024852|FG001|Double Blind Phase|Withdrawal by Subject|15|||
150242779|NCT01270828|542024853|FG002|Double Blind Phase|Withdrawal by Subject|0|||
150242780|NCT01270828|542024851|FG000|Double Blind Phase|Lost to Follow-up|1|||
150242781|NCT01270828|542024852|FG001|Double Blind Phase|Lost to Follow-up|2|||
150242782|NCT01270828|542024853|FG002|Double Blind Phase|Lost to Follow-up|0|||
150242783|NCT01270828|542024851|FG000|Double Blind Phase|Lack of Efficacy|2|||
150242784|NCT01270828|542024852|FG001|Double Blind Phase|Lack of Efficacy|11|||
150242785|NCT01270828|542024853|FG002|Double Blind Phase|Lack of Efficacy|0|||
150242786|NCT01270828|542024851|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
150242787|NCT01270828|542024852|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
150242788|NCT01270828|542024853|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
150242789|NCT01270828|542024851|FG000|Double Blind Phase|Adverse event related to study drug|5|||
150242790|NCT01270828|542024852|FG001|Double Blind Phase|Adverse event related to study drug|7|||
150242791|NCT01270828|542024853|FG002|Double Blind Phase|Adverse event related to study drug|0|||
150242792|NCT01810939|542024856|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
150242793|NCT01810939|542024857|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
150242794|NCT01810939|542024858|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
150242795|NCT01810939|542024856|FG000|Part A Treatment Period|Protocol Violation|2|||
150242796|NCT01810939|542024857|FG001|Part A Treatment Period|Protocol Violation|0|||
150242797|NCT01810939|542024858|FG002|Part A Treatment Period|Protocol Violation|0|||
150242798|NCT01810939|542024856|FG000|Part A Treatment Period|Adverse Event|10|||
150242799|NCT01810939|542024857|FG001|Part A Treatment Period|Adverse Event|0|||
150242800|NCT01810939|542024858|FG002|Part A Treatment Period|Adverse Event|0|||
150242801|NCT01810939|542024856|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
150242802|NCT01810939|542024857|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
150242803|NCT01810939|542024858|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
150242804|NCT01810939|542024856|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
150242805|NCT01810939|542024857|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
150242806|NCT01810939|542024858|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
150242807|NCT01810939|542024856|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
150242808|NCT01810939|542024857|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
150242809|NCT01810939|542024858|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
150242810|NCT01810939|542024856|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
150242811|NCT01810939|542024857|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
150242812|NCT01810939|542024858|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
150242813|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
150242814|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
150242815|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
150242816|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
150242817|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
150242818|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
150242819|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
150242820|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
150242821|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
150242822|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
150242823|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
150242824|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
150242825|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
150242826|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
150242827|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
150242828|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
150242829|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
150242830|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
150242831|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
150242832|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
150242833|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
150242834|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
150242835|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
150242836|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
150242837|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
150242838|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
150242839|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
150242840|NCT01810939|542024856|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
150242841|NCT01810939|542024857|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
150242842|NCT01810939|542024858|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
150242843|NCT02963090|542024859|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
150242844|NCT02963090|542024860|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
150242845|NCT04400487|542024861|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
150242846|NCT04400487|542024861|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
150242847|NCT04400487|542024861|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
150242848|NCT01677299|542024862|FG000|Overall Study|Adverse Event|0|||
150242849|NCT01677299|542024863|FG001|Overall Study|Adverse Event|2|||
150242850|NCT01677299|542024864|FG002|Overall Study|Adverse Event|1|||
150242851|NCT01677299|542024865|FG003|Overall Study|Adverse Event|0|||
150242852|NCT01677299|542024862|FG000|Overall Study|Withdrawal by Subject|0|||
150242853|NCT01677299|542024863|FG001|Overall Study|Withdrawal by Subject|1|||
150242854|NCT01677299|542024864|FG002|Overall Study|Withdrawal by Subject|0|||
150242855|NCT01677299|542024865|FG003|Overall Study|Withdrawal by Subject|1|||
150242856|NCT02153905|542024866|FG000|Overall Study|Death|1|||
150242857|NCT02153905|542024867|FG001|Overall Study|Death|0|||
150242858|NCT00520845|542024868|FG000|Overall Study|Death|3|||
150242859|NCT00520845|542024868|FG000|Overall Study|Adverse Event|4|||
150242860|NCT00520845|542024868|FG000|Overall Study|Disease Progression, relapse|13|||
150242861|NCT00520845|542024868|FG000|Overall Study|Withdrawal by Subject|1|||
150242862|NCT00520845|542024868|FG000|Overall Study|Alternative Therapy|1|||
150242863|NCT00351377|542024871|FG000|Overall Study|Adverse Event|5|||
150242864|NCT00351377|542024871|FG000|Overall Study|Death|1|||
150242865|NCT00351377|542024871|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150242866|NCT01732549|542024872|FG000|Overall Study|Adverse Event|13|||
150242867|NCT01732549|542024873|FG001|Overall Study|Adverse Event|3|||
150242868|NCT01732549|542024872|FG000|Overall Study|Consent withdrawn|13|||
150242869|NCT01732549|542024873|FG001|Overall Study|Consent withdrawn|6|||
150242870|NCT01732549|542024872|FG000|Overall Study|Disease progression|37|||
150242871|NCT01732549|542024873|FG001|Overall Study|Disease progression|50|||
150242872|NCT01732549|542024872|FG000|Overall Study|Other|8|||
150242873|NCT01732549|542024873|FG001|Overall Study|Other|14|||
150242874|NCT01516749|542024874|FG000|Active Therapy|Lost to Follow-up|1|||
150242875|NCT01516749|542024874|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
150242876|NCT02030002|542024875|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
150242877|NCT02030002|542024875|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
150242878|NCT02030002|542024875|FG000|Follow-up|Lost to Follow-up|2|||
150242879|NCT03994731|542024877|FG000|Pegloticase + IMM Period|Death|2|||
150242880|NCT03994731|542024878|FG001|Pegloticase + IMM Period|Death|0|||
150242881|NCT03994731|542024877|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
150242882|NCT03994731|542024878|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
150242883|NCT03994731|542024877|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
150242884|NCT03994731|542024878|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
150242885|NCT01681992|542024881|FG000|Overall Study|Adverse Event|3|||
150242886|NCT01681992|542024882|FG001|Overall Study|Adverse Event|2|||
150242887|NCT01681992|542024883|FG002|Overall Study|Adverse Event|3|||
150242888|NCT01681992|542024881|FG000|Overall Study|Lost to Follow-up|36|||
150242889|NCT01681992|542024882|FG001|Overall Study|Lost to Follow-up|38|||
150242890|NCT01681992|542024883|FG002|Overall Study|Lost to Follow-up|53|||
150242891|NCT01681992|542024881|FG000|Overall Study|As Per Sponsor Decision|0|||
150242892|NCT01681992|542024882|FG001|Overall Study|As Per Sponsor Decision|0|||
150242893|NCT01681992|542024883|FG002|Overall Study|As Per Sponsor Decision|1|||
150242894|NCT01681992|542024881|FG000|Overall Study|Protocol Violation|0|||
150242895|NCT01681992|542024882|FG001|Overall Study|Protocol Violation|0|||
150242896|NCT01681992|542024883|FG002|Overall Study|Protocol Violation|1|||
150242897|NCT01681992|542024881|FG000|Overall Study|Withdrawal by Subject|27|||
150242898|NCT01681992|542024882|FG001|Overall Study|Withdrawal by Subject|30|||
150242899|NCT01681992|542024883|FG002|Overall Study|Withdrawal by Subject|25|||
150242900|NCT02406248|542024888|FG000|Overall Study|Death|7|||
150242901|NCT02406248|542024888|FG000|Overall Study|Withdrawal by Subject|2|||
150242902|NCT04805073|542024897|FG000|Overall Study|study personnel not available|2|||
150242903|NCT04805073|542024898|FG001|Overall Study|study personnel not available|0|||
150242904|NCT04805073|542024897|FG000|Overall Study|spinal anesthesia failure|0|||
150242905|NCT04805073|542024898|FG001|Overall Study|spinal anesthesia failure|1|||
150242906|NCT04805073|542024897|FG000|Overall Study|Lost to Follow-up|0|||
150242907|NCT04805073|542024898|FG001|Overall Study|Lost to Follow-up|2|||
150242908|NCT03017742|542024903|FG000|Overall Study|Protocol Violation|36|||
150242909|NCT03017742|542024903|FG000|Overall Study|Withdrawal by Subject|37|||
150242910|NCT01782690|542024911|FG000|Overall Study|Not reported|7|||
150242911|NCT01782690|542024911|FG000|Overall Study|Toxicity of gemcitabine|1|||
150242912|NCT01782690|542024911|FG000|Overall Study|Toxicity of erlotinib|1|||
150242913|NCT01782690|542024911|FG000|Overall Study|Lost to Follow-up|31|||
150242914|NCT01782690|542024911|FG000|Overall Study|Withdrawal of informed consent|2|||
150242915|NCT01782690|542024911|FG000|Overall Study|Absent rash|9|||
150242916|NCT01782690|542024911|FG000|Overall Study|Physician Decision|13|||
150242917|NCT01782690|542024911|FG000|Overall Study|Patient's wish|21|||
150242918|NCT01782690|542024911|FG000|Overall Study|Tumor progression|74|||
150242919|NCT01782690|542024911|FG000|Overall Study|Death|133|||
150242920|NCT01782690|542024911|FG000|Overall Study|Study completion unknown|7|||
150242921|NCT06719986|542024912|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
150242922|NCT06719986|542024913|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
150242923|NCT06719986|542024914|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
150242924|NCT06719986|542024912|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
150242925|NCT06719986|542024913|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
150242926|NCT06719986|542024914|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
150242927|NCT02473965|542027135|FG000|Overall Study|Adverse Event|6|||
150242928|NCT02473965|542027136|FG001|Overall Study|Adverse Event|4|||
150242929|NCT02473965|542027135|FG000|Overall Study|MG worsening|4|||
150242930|NCT02473965|542027136|FG001|Overall Study|MG worsening|1|||
150242931|NCT02473965|542027135|FG000|Overall Study|Withdrawal by Subject|2|||
150242932|NCT02473965|542027136|FG001|Overall Study|Withdrawal by Subject|3|||
150242933|NCT02473965|542027135|FG000|Overall Study|Physician Decision|0|||
150242934|NCT02473965|542027136|FG001|Overall Study|Physician Decision|2|||
150242935|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
150242936|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
150242937|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
150242938|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
150242939|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
150242940|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
150242941|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
150242942|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
150242943|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
150242944|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
150242945|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
150242946|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
150242947|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
150242948|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
150242949|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
150242950|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
150242951|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
150242952|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
150242953|NCT00132678|542027139|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
150242954|NCT00132678|542027140|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
150242955|NCT00132678|542027141|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
150242956|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Death|2|||
150242957|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Death|0|||
150242958|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Death|0|||
150242959|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
150242960|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
150242961|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
150242962|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
150242963|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
150242964|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
150242965|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
150242966|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
150242967|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
150242968|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
150242969|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
150242970|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
150242971|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
150242972|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
150242973|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
150242974|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
150242975|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
150242976|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
150242977|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
150242978|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
150242979|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
150242980|NCT00132678|542027139|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
150242981|NCT00132678|542027140|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
150242982|NCT00132678|542027141|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
150242983|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
150242984|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
150242985|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
150242986|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
150242987|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
150242988|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
150242989|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
150242990|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
150242991|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
150242992|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
150242993|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
150242994|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
150242995|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
150242996|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
150242997|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
150242998|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
150242999|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
150243000|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
150243001|NCT00132678|542027139|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
150243002|NCT00132678|542027140|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
150243003|NCT00132678|542027141|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
150243004|NCT00953147|542027144|FG000|Overall Study|Adverse Event|8|||
150243005|NCT00953147|542027145|FG001|Overall Study|Adverse Event|16|||
150243006|NCT00953147|542027146|FG002|Overall Study|Adverse Event|6|||
150243007|NCT00953147|542027144|FG000|Overall Study|Protocol Violation|2|||
150243008|NCT00953147|542027145|FG001|Overall Study|Protocol Violation|8|||
150243009|NCT00953147|542027146|FG002|Overall Study|Protocol Violation|4|||
150243010|NCT00953147|542027144|FG000|Overall Study|Withdrawal by Subject|13|||
150243011|NCT00953147|542027145|FG001|Overall Study|Withdrawal by Subject|15|||
150243012|NCT00953147|542027146|FG002|Overall Study|Withdrawal by Subject|12|||
150243013|NCT00953147|542027144|FG000|Overall Study|Lost to Follow-up|8|||
150243014|NCT00953147|542027145|FG001|Overall Study|Lost to Follow-up|9|||
150243015|NCT00953147|542027146|FG002|Overall Study|Lost to Follow-up|4|||
150243016|NCT00953147|542027144|FG000|Overall Study|Physician Decision|2|||
150243017|NCT00953147|542027145|FG001|Overall Study|Physician Decision|7|||
150243018|NCT00953147|542027146|FG002|Overall Study|Physician Decision|3|||
150243019|NCT00953147|542027144|FG000|Overall Study|Other|4|||
150243020|NCT00953147|542027145|FG001|Overall Study|Other|11|||
150243021|NCT00953147|542027146|FG002|Overall Study|Other|13|||
150243022|NCT01484431|542027147|FG000|Period 1: High Dose|Physician Decision|0|||
150243023|NCT01484431|542027148|FG001|Period 1: High Dose|Physician Decision|1|||
150243024|NCT01484431|542027149|FG002|Period 1: High Dose|Physician Decision|0|||
150243025|NCT01484431|542027147|FG000|Period 2|Death|0|||
150243026|NCT01484431|542027148|FG001|Period 2|Death|1|||
150243027|NCT01484431|542027149|FG002|Period 2|Death|1|||
150243028|NCT01484431|542027147|FG000|Period 2|Physician Decision|0|||
150243029|NCT01484431|542027148|FG001|Period 2|Physician Decision|0|||
150243030|NCT01484431|542027149|FG002|Period 2|Physician Decision|1|||
150243031|NCT01484431|542027147|FG000|Period 2|Non-Compliance with Study Drug|1|||
150243032|NCT01484431|542027148|FG001|Period 2|Non-Compliance with Study Drug|0|||
150243033|NCT01484431|542027149|FG002|Period 2|Non-Compliance with Study Drug|0|||
150243034|NCT01251770|542027151|FG000|Overall Study|Protocol Violation|13|||
150243035|NCT01251770|542027152|FG001|Overall Study|Protocol Violation|7|||
150243036|NCT02113124|542027153|FG000|Overall Study|Unable to retrieve blood sample|1|||
150243037|NCT02113124|542027154|FG001|Overall Study|Unable to retrieve blood sample|1|||
150243038|NCT02514239|542027155|FG000|Overall Study|Refused to continue trial medication|0|||
150243039|NCT02514239|542027156|FG001|Overall Study|Refused to continue trial medication|0|||
150243040|NCT02514239|542027157|FG002|Overall Study|Refused to continue trial medication|0|||
150243041|NCT02514239|542027158|FG003|Overall Study|Refused to continue trial medication|0|||
150243042|NCT02514239|542027159|FG004|Overall Study|Refused to continue trial medication|0|||
150243043|NCT02514239|542027160|FG005|Overall Study|Refused to continue trial medication|0|||
150243044|NCT02514239|542027161|FG006|Overall Study|Refused to continue trial medication|0|||
150243045|NCT02514239|542027162|FG007|Overall Study|Refused to continue trial medication|0|||
150243046|NCT02514239|542027163|FG008|Overall Study|Refused to continue trial medication|0|||
150243047|NCT02514239|542027164|FG009|Overall Study|Refused to continue trial medication|1|||
150243048|NCT02514239|542027155|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243049|NCT02514239|542027156|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243050|NCT02514239|542027157|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243051|NCT02514239|542027158|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243052|NCT02514239|542027159|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243053|NCT02514239|542027160|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243054|NCT02514239|542027161|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243055|NCT02514239|542027162|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
150243056|NCT02514239|542027163|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
150243057|NCT02514239|542027164|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
150243058|NCT02514239|542027155|FG000|Overall Study|Not treated|0|||
150243059|NCT02514239|542027156|FG001|Overall Study|Not treated|1|||
150243060|NCT02514239|542027157|FG002|Overall Study|Not treated|0|||
150243061|NCT02514239|542027158|FG003|Overall Study|Not treated|0|||
150243062|NCT02514239|542027159|FG004|Overall Study|Not treated|0|||
150243063|NCT02514239|542027160|FG005|Overall Study|Not treated|0|||
150243064|NCT02514239|542027161|FG006|Overall Study|Not treated|0|||
150243065|NCT02514239|542027162|FG007|Overall Study|Not treated|0|||
150243066|NCT02514239|542027163|FG008|Overall Study|Not treated|0|||
150243067|NCT02514239|542027164|FG009|Overall Study|Not treated|0|||
150243068|NCT02514239|542027155|FG000|Overall Study|Other Adverse Events|2|||
150243069|NCT02514239|542027156|FG001|Overall Study|Other Adverse Events|0|||
150243070|NCT02514239|542027157|FG002|Overall Study|Other Adverse Events|0|||
150243071|NCT02514239|542027158|FG003|Overall Study|Other Adverse Events|1|||
150243072|NCT02514239|542027159|FG004|Overall Study|Other Adverse Events|0|||
150243073|NCT02514239|542027160|FG005|Overall Study|Other Adverse Events|1|||
150243074|NCT02514239|542027161|FG006|Overall Study|Other Adverse Events|0|||
150243075|NCT02514239|542027162|FG007|Overall Study|Other Adverse Events|1|||
150243076|NCT02514239|542027163|FG008|Overall Study|Other Adverse Events|2|||
150243077|NCT02514239|542027164|FG009|Overall Study|Other Adverse Events|0|||
150243078|NCT02514239|542027155|FG000|Overall Study|Progressive disease|3|||
150243079|NCT02514239|542027156|FG001|Overall Study|Progressive disease|3|||
150243080|NCT02514239|542027157|FG002|Overall Study|Progressive disease|2|||
150243081|NCT02514239|542027158|FG003|Overall Study|Progressive disease|2|||
150243082|NCT02514239|542027159|FG004|Overall Study|Progressive disease|3|||
150243083|NCT02514239|542027160|FG005|Overall Study|Progressive disease|3|||
150243084|NCT02514239|542027161|FG006|Overall Study|Progressive disease|4|||
150243085|NCT02514239|542027162|FG007|Overall Study|Progressive disease|2|||
150243086|NCT02514239|542027163|FG008|Overall Study|Progressive disease|5|||
150243087|NCT02514239|542027164|FG009|Overall Study|Progressive disease|0|||
150243088|NCT01901419|542027165|FG000|Overall Study|Protocol Violation|2|||
150243089|NCT01901419|542027166|FG001|Overall Study|Protocol Violation|6|||
150243090|NCT01901419|542027165|FG000|Overall Study|unavailable researchers|6|||
150243091|NCT01901419|542027166|FG001|Overall Study|unavailable researchers|3|||
150243092|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
150243093|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
150243094|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
150243095|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
150243096|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
150243097|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
150243098|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
150243099|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
150243100|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
150243101|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
150243102|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
150243103|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
150243104|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
150243105|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
150243106|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243107|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243108|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243109|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243110|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243111|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
150243112|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
150243113|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
150243114|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
150243115|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
150243116|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
150243117|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
150243118|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
150243119|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
150243120|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243121|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243122|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243123|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243124|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
150243125|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243126|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
150243127|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243128|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
150243129|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243130|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243131|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243132|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243133|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
150243134|NCT01888874|542027167|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
150243135|NCT01888874|542027168|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
150243136|NCT01888874|542027169|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
150243137|NCT01888874|542027170|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
150243138|NCT01888874|542027171|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
150243139|NCT01888874|542027172|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
150243140|NCT01888874|542027173|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
150243141|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
150243142|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
150243143|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
150243144|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
150243145|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
150243146|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
150243147|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
150243148|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243149|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243150|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243151|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243152|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
150243153|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243154|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
150243155|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
150243156|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
150243157|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
150243158|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
150243159|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
150243160|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
150243161|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
150243162|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243163|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243164|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
150243165|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243166|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243167|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243168|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
150243169|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
150243170|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
150243171|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
150243172|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
150243173|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
150243174|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
150243175|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
150243176|NCT01888874|542027167|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
150243177|NCT01888874|542027168|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
150243178|NCT01888874|542027169|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
150243179|NCT01888874|542027170|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
150243180|NCT01888874|542027171|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
150243181|NCT01888874|542027172|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
150243182|NCT01888874|542027173|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
150243183|NCT00475644|542027175|FG000|Overall Study|Protocol Violation|13|||
150243184|NCT01411241|542027176|FG000|Overall Study|Protocol Violation|0|||
150243185|NCT01411241|542027177|FG001|Overall Study|Protocol Violation|5|||
150243186|NCT01411241|542027176|FG000|Overall Study|Withdrawal by Subject|9|||
150243187|NCT01411241|542027177|FG001|Overall Study|Withdrawal by Subject|10|||
150243188|NCT01411241|542027176|FG000|Overall Study|Serious Adverse Event|0|||
150243189|NCT01411241|542027177|FG001|Overall Study|Serious Adverse Event|3|||
150243190|NCT01411241|542027176|FG000|Overall Study|Lost to Follow-up|2|||
150243191|NCT01411241|542027177|FG001|Overall Study|Lost to Follow-up|4|||
150243192|NCT01020877|542027186|FG000|Second Intervention|Withdrawal by Subject|1|||
150243193|NCT01020877|542027187|FG001|Second Intervention|Withdrawal by Subject|0|||
150243194|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
150243195|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
150243196|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
150243197|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
150243198|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
150243199|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
150243200|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
150243201|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
150243202|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
150243203|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
150243204|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
150243205|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
150243206|NCT00790400|542027188|FG000|Double-blind Period (Core Phase)|Death|1|||
150243207|NCT00790400|542027189|FG001|Double-blind Period (Core Phase)|Death|0|||
150243208|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
150243209|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
150243210|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
150243211|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
150243212|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
150243213|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
150243214|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
150243215|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
150243216|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
150243217|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
150243218|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Death|1|||
150243219|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Death|0|||
150243220|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
150243221|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
150243222|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
150243223|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
150243224|NCT00790400|542027188|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
150243225|NCT00790400|542027189|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
150243226|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
150243227|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
150243228|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
150243229|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
150243230|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Death|13|||
150243231|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Death|12|||
150243232|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Progression|257|||
150243233|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Progression|218|||
150243234|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
150243235|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
150243236|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
150243237|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
150243238|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
150243239|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
150243240|NCT01006980|542027191|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
150243241|NCT01006980|542027192|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
150243242|NCT01006980|542027191|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
150243243|NCT01006980|542027192|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
150243244|NCT01006980|542027191|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
150243245|NCT01006980|542027192|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
150243246|NCT01006980|542027191|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
150243247|NCT01006980|542027192|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
150243248|NCT01006980|542027191|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
150243249|NCT01006980|542027192|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
150243250|NCT01006980|542027191|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
150243251|NCT01006980|542027192|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
150243252|NCT01483144|542027193|FG000|Overall Study|Adverse Event|9|||
150243253|NCT01483144|542027194|FG001|Overall Study|Adverse Event|4|||
150243254|NCT01483144|542027195|FG002|Overall Study|Adverse Event|6|||
150243255|NCT01483144|542027193|FG000|Overall Study|Withdrawal by Subject|0|||
150243256|NCT01483144|542027194|FG001|Overall Study|Withdrawal by Subject|2|||
150243257|NCT01483144|542027195|FG002|Overall Study|Withdrawal by Subject|5|||
150243258|NCT01483144|542027193|FG000|Overall Study|Physician Decision|1|||
150243259|NCT01483144|542027194|FG001|Overall Study|Physician Decision|0|||
150243260|NCT01483144|542027195|FG002|Overall Study|Physician Decision|0|||
150243261|NCT01483144|542027193|FG000|Overall Study|Lost to Follow-up|2|||
150243262|NCT01483144|542027194|FG001|Overall Study|Lost to Follow-up|4|||
150243263|NCT01483144|542027195|FG002|Overall Study|Lost to Follow-up|1|||
150243264|NCT01483144|542027193|FG000|Overall Study|Protocol Violation|3|||
150243265|NCT01483144|542027194|FG001|Overall Study|Protocol Violation|3|||
150243266|NCT01483144|542027195|FG002|Overall Study|Protocol Violation|3|||
150243267|NCT04307940|542027196|FG000|Overall Study|Adverse Event|1|||
150243268|NCT04307940|542027197|FG001|Overall Study|Adverse Event|0|||
150243269|NCT04307940|542027198|FG002|Overall Study|Adverse Event|0|||
150243270|NCT04307940|542027196|FG000|Overall Study|Withdrawal by Subject|2|||
150243271|NCT04307940|542027197|FG001|Overall Study|Withdrawal by Subject|3|||
150243272|NCT04307940|542027198|FG002|Overall Study|Withdrawal by Subject|1|||
150243273|NCT04307940|542027196|FG000|Overall Study|Lost to Follow-up|2|||
150243274|NCT04307940|542027197|FG001|Overall Study|Lost to Follow-up|0|||
150243275|NCT04307940|542027198|FG002|Overall Study|Lost to Follow-up|1|||
150243276|NCT05543174|542027199|FG000|Overall Study|Ongoing|7|||
150243277|NCT03104075|542027205|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
150243278|NCT03104075|542027206|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
150243279|NCT00709228|542027210|FG000|Overall Study|Not treated|14|||
150243280|NCT00709228|542027210|FG000|Overall Study|Eligibility criteria not met|281|||
150243281|NCT00709228|542027210|FG000|Overall Study|Adverse events|2|||
150243282|NCT00709228|542027210|FG000|Overall Study|Discontinued treatment|14|||
150243283|NCT00709228|542027210|FG000|Overall Study|Did not enter follow-up|4|||
150243284|NCT00709228|542027210|FG000|Overall Study|Discontinued follow-up|5|||
150243285|NCT00709228|542027210|FG000|Overall Study|Disease progression|1|||
150243286|NCT00709228|542027210|FG000|Overall Study|Lost to Follow-up|6|||
150243287|NCT00709228|542027210|FG000|Overall Study|Non-compliance|5|||
150243288|NCT02870972|542027211|FG000|Overall Study|Adverse Event|1|||
150243289|NCT02870972|542027212|FG001|Overall Study|Adverse Event|0|||
150243290|NCT02870972|542027213|FG002|Overall Study|Adverse Event|0|||
150243291|NCT02870972|542027214|FG003|Overall Study|Adverse Event|0|||
150243292|NCT02870972|542027215|FG004|Overall Study|Adverse Event|0|||
150243293|NCT04497389|542027216|FG000|Overall Study|Withdrawal by Subject|1|||
150243294|NCT04497389|542027217|FG001|Overall Study|Withdrawal by Subject|0|||
150243295|NCT01594827|542027222|FG000|Overall Study|Adverse Event|1|||
150243296|NCT01594827|542027223|FG001|Overall Study|Adverse Event|0|||
150243297|NCT01594827|542027222|FG000|Overall Study|Physician Decision|3|||
150243298|NCT01594827|542027223|FG001|Overall Study|Physician Decision|0|||
150243299|NCT03445533|542027225|FG000|Overall Study|Progressive Disease|48|||
150243300|NCT03445533|542027226|FG001|Overall Study|Progressive Disease|81|||
150243301|NCT03445533|542027225|FG000|Overall Study|Adverse Event|60|||
150243302|NCT03445533|542027226|FG001|Overall Study|Adverse Event|64|||
150243303|NCT03445533|542027225|FG000|Overall Study|Death|9|||
150243304|NCT03445533|542027226|FG001|Overall Study|Death|19|||
150243305|NCT03445533|542027225|FG000|Overall Study|Miscellaneous|0|||
150243306|NCT03445533|542027226|FG001|Overall Study|Miscellaneous|16|||
150243307|NCT03445533|542027225|FG000|Overall Study|Withdrawal by Subject|3|||
150243308|NCT03445533|542027226|FG001|Overall Study|Withdrawal by Subject|4|||
150243309|NCT03445533|542027225|FG000|Overall Study|Physician Decision|1|||
150243310|NCT03445533|542027226|FG001|Overall Study|Physician Decision|3|||
150243311|NCT03445533|542027225|FG000|Overall Study|Sponsor Decision|0|||
150243312|NCT03445533|542027226|FG001|Overall Study|Sponsor Decision|1|||
150243313|NCT03445533|542027225|FG000|Overall Study|Lost to Follow-up|0|||
150243314|NCT03445533|542027226|FG001|Overall Study|Lost to Follow-up|1|||
150243315|NCT03445533|542027225|FG000|Overall Study|Never Received any Study Treatment|7|||
150243316|NCT03445533|542027226|FG001|Overall Study|Never Received any Study Treatment|4|||
150243317|NCT02615509|542027227|FG000|Overall Study|Lost to Follow-up|134|||
150243318|NCT02615509|542027227|FG000|Overall Study|Death|4|||
150243319|NCT02615509|542027227|FG000|Overall Study|Withdrawal by Subject|8|||
150243320|NCT03334253|542027228|FG000|Overall Study|Withdrawal by Subject|1|||
150243321|NCT03334253|542027229|FG001|Overall Study|Withdrawal by Subject|0|||
150243322|NCT03334253|542027228|FG000|Overall Study|Lost to Follow-up|4|||
150243323|NCT03334253|542027229|FG001|Overall Study|Lost to Follow-up|3|||
150243324|NCT03334253|542027228|FG000|Overall Study|Moved residence|2|||
150243325|NCT03334253|542027229|FG001|Overall Study|Moved residence|2|||
150243326|NCT03274453|542027230|FG000|Overall Study|Lost to Follow-up|2|||
150243327|NCT03274453|542027231|FG001|Overall Study|Lost to Follow-up|5|||
150243328|NCT03274453|542027232|FG002|Overall Study|Lost to Follow-up|4|||
150243329|NCT03274453|542027233|FG003|Overall Study|Lost to Follow-up|1|||
150243330|NCT03274453|542027230|FG000|Overall Study|Physician Decision|2|||
150243331|NCT03274453|542027231|FG001|Overall Study|Physician Decision|0|||
150243332|NCT03274453|542027232|FG002|Overall Study|Physician Decision|0|||
150243333|NCT03274453|542027233|FG003|Overall Study|Physician Decision|3|||
150243334|NCT03274453|542027230|FG000|Overall Study|Surgery Cancelled|0|||
150243335|NCT03274453|542027231|FG001|Overall Study|Surgery Cancelled|1|||
150243336|NCT03274453|542027232|FG002|Overall Study|Surgery Cancelled|0|||
150243337|NCT03274453|542027233|FG003|Overall Study|Surgery Cancelled|0|||
150243338|NCT00945672|542027235|FG000|Overall Study|Withdrawal by Subject|0|||
150243339|NCT00945672|542027236|FG001|Overall Study|Withdrawal by Subject|0|||
150243340|NCT00945672|542027237|FG002|Overall Study|Withdrawal by Subject|0|||
150243341|NCT00945672|542027238|FG003|Overall Study|Withdrawal by Subject|1|||
150243342|NCT00968526|542027239|FG000|Overall Study|Adverse Event|2|||
150243343|NCT00968526|542027240|FG001|Overall Study|Adverse Event|0|||
150243344|NCT00968526|542027239|FG000|Overall Study|Migrated/moved from study area|1|||
150243345|NCT00968526|542027240|FG001|Overall Study|Migrated/moved from study area|0|||
150243346|NCT05569421|542027244|FG000|Overall Study|Withdrawal by Subject|1|||
150243347|NCT05569421|542027245|FG001|Overall Study|Withdrawal by Subject|0|||
150243348|NCT05569421|542027246|FG002|Overall Study|Withdrawal by Subject|0|||
150243349|NCT00874731|542027247|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
150243350|NCT00874731|542027248|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
150243351|NCT00874731|542027249|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
150243352|NCT00874731|542027247|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
150243353|NCT00874731|542027248|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
150243354|NCT00874731|542027249|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
150243355|NCT00874731|542027247|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
150243356|NCT00874731|542027248|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
150243357|NCT00874731|542027249|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
150243358|NCT01736540|542027251|FG000|Overall Study|Did not complete scan within 45 days|2|||
150243359|NCT01736540|542027251|FG000|Overall Study|Death|1|||
150243360|NCT01736540|542027251|FG000|Overall Study|Abnormal test procedure|1|||
150243361|NCT01736540|542027251|FG000|Overall Study|Withdrawal by Subject|5|||
150243362|NCT01736540|542027251|FG000|Overall Study|Protocol Violation|1|||
150243363|NCT01736540|542027251|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
150243364|NCT01736540|542027251|FG000|Overall Study|No show for MRI appointment|1|||
150243365|NCT01736540|542027251|FG000|Overall Study|Unable to make MRI appointment|3|||
150243366|NCT03812029|542027254|FG000|Overall Study|Protocol Violation|1|||
150243367|NCT03812029|542027255|FG001|Overall Study|Protocol Violation|0|||
150243368|NCT03812029|542027256|FG002|Overall Study|Protocol Violation|0|||
150243369|NCT03812029|542027257|FG003|Overall Study|Protocol Violation|1|||
150243370|NCT03812029|542027258|FG004|Overall Study|Protocol Violation|0|||
150243371|NCT03812029|542027254|FG000|Overall Study|Withdrawal by Subject|1|||
150243372|NCT03812029|542027255|FG001|Overall Study|Withdrawal by Subject|0|||
150243373|NCT03812029|542027256|FG002|Overall Study|Withdrawal by Subject|0|||
150243374|NCT03812029|542027257|FG003|Overall Study|Withdrawal by Subject|2|||
150243375|NCT03812029|542027258|FG004|Overall Study|Withdrawal by Subject|2|||
150243376|NCT03812029|542027254|FG000|Overall Study|Stopping rules|0|||
150243377|NCT03812029|542027255|FG001|Overall Study|Stopping rules|1|||
150243378|NCT03812029|542027256|FG002|Overall Study|Stopping rules|0|||
150243379|NCT03812029|542027257|FG003|Overall Study|Stopping rules|0|||
150243380|NCT03812029|542027258|FG004|Overall Study|Stopping rules|0|||
150243381|NCT03812029|542027254|FG000|Overall Study|Adverse Event|0|||
150243382|NCT03812029|542027255|FG001|Overall Study|Adverse Event|9|||
150243383|NCT03812029|542027256|FG002|Overall Study|Adverse Event|0|||
150243384|NCT03812029|542027257|FG003|Overall Study|Adverse Event|3|||
150243385|NCT03812029|542027258|FG004|Overall Study|Adverse Event|5|||
150243386|NCT03812029|542027254|FG000|Overall Study|Lost to Follow-up|0|||
150243387|NCT03812029|542027255|FG001|Overall Study|Lost to Follow-up|0|||
150243388|NCT03812029|542027256|FG002|Overall Study|Lost to Follow-up|0|||
150243389|NCT03812029|542027257|FG003|Overall Study|Lost to Follow-up|0|||
150243390|NCT03812029|542027258|FG004|Overall Study|Lost to Follow-up|3|||
150243391|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
150243392|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
150243393|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
150243394|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
150243395|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
150243396|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
150243397|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
150243398|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
150243399|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
150243400|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
150243401|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
150243402|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
150243403|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
150243404|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
150243405|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
150243406|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
150243407|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
150243408|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
150243409|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
150243410|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
150243411|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
150243412|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
150243413|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
150243414|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
150243415|NCT00479882|542027259|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
150243416|NCT00479882|542027260|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
150243417|NCT00479882|542027261|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
150243418|NCT00479882|542027262|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
150243419|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
150243420|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
150243421|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
150243422|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
150243423|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
150243424|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
150243425|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
150243426|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
150243427|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
150243428|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
150243429|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
150243430|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
150243431|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
150243432|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
150243433|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
150243434|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
150243435|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
150243436|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
150243437|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
150243438|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
150243439|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
150243440|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
150243441|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
150243442|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
150243443|NCT00479882|542027259|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
150243444|NCT00479882|542027260|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
150243445|NCT00479882|542027261|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
150243446|NCT00479882|542027262|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
150243447|NCT00581477|542027263|FG000|Overall Study|Physician Decision|2|||
150243448|NCT03106753|542027264|FG000|Overall Study|Withdrawal by Subject|0|||
150243449|NCT03106753|542027265|FG001|Overall Study|Withdrawal by Subject|1|||
150243450|NCT03933462|542027268|FG000|Overall Study|Adverse Event|2|||
150243451|NCT03933462|542027269|FG001|Overall Study|Adverse Event|0|||
150243452|NCT02975102|542027271|FG000|Overall Study|Adverse Event|2|||
150243453|NCT02975102|542027272|FG001|Overall Study|Adverse Event|1|||
150243454|NCT04148651|542027273|FG000|Overall Study|Lost to Follow-up|2|||
150243455|NCT03392168|542027276|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
150243456|NCT03392168|542027277|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
150243457|NCT03392168|542027278|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
150243458|NCT03392168|542027279|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
150243459|NCT03392168|542027276|FG000|Period 2: Cohort 2|Other|0|||
150243460|NCT03392168|542027277|FG001|Period 2: Cohort 2|Other|1|||
150243461|NCT03392168|542027278|FG002|Period 2: Cohort 2|Other|0|||
150243462|NCT03392168|542027279|FG003|Period 2: Cohort 2|Other|0|||
150243463|NCT02609672|542027280|FG000|Overall Study|Lost to Follow-up|3|||
150243464|NCT02609672|542027281|FG001|Overall Study|Lost to Follow-up|1|||
150243465|NCT03519204|542027282|FG000|Overall Study|Lost to Follow-up|3|||
150243466|NCT03519204|542027283|FG001|Overall Study|Lost to Follow-up|8|||
150243467|NCT03519204|542027282|FG000|Overall Study|Withdrawal by Subject|9|||
150243468|NCT03519204|542027283|FG001|Overall Study|Withdrawal by Subject|7|||
150243469|NCT03519204|542027282|FG000|Overall Study|Other Miscellaneous Reasons|1|||
150243470|NCT03519204|542027283|FG001|Overall Study|Other Miscellaneous Reasons|0|||
150243471|NCT02597712|542027285|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
150243472|NCT02597712|542027286|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
150243473|NCT02597712|542027285|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
150243474|NCT02597712|542027286|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
150243475|NCT02597712|542027285|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
150243476|NCT02597712|542027286|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
150243477|NCT01441635|542027290|FG000|Overall Study|Adverse Event|4|||
150243478|NCT01441635|542027291|FG001|Overall Study|Adverse Event|3|||
150243479|NCT01441635|542027292|FG002|Overall Study|Adverse Event|1|||
150243480|NCT01441635|542027293|FG003|Overall Study|Adverse Event|5|||
150243481|NCT01441635|542027294|FG004|Overall Study|Adverse Event|1|||
150243482|NCT01441635|542027295|FG005|Overall Study|Adverse Event|2|||
150243483|NCT01441635|542027296|FG006|Overall Study|Adverse Event|2|||
150243484|NCT01441635|542027297|FG007|Overall Study|Adverse Event|2|||
150243485|NCT01441635|542027298|FG008|Overall Study|Adverse Event|1|||
150243486|NCT01441635|542027299|FG009|Overall Study|Adverse Event|0|||
150243487|NCT01441635|542027290|FG000|Overall Study|Withdrawal by Subject|1|||
150243488|NCT01441635|542027291|FG001|Overall Study|Withdrawal by Subject|1|||
150243489|NCT01441635|542027292|FG002|Overall Study|Withdrawal by Subject|0|||
150243490|NCT01441635|542027293|FG003|Overall Study|Withdrawal by Subject|1|||
150243491|NCT01441635|542027294|FG004|Overall Study|Withdrawal by Subject|0|||
150243492|NCT01441635|542027295|FG005|Overall Study|Withdrawal by Subject|0|||
150243493|NCT01441635|542027296|FG006|Overall Study|Withdrawal by Subject|2|||
150243494|NCT01441635|542027297|FG007|Overall Study|Withdrawal by Subject|0|||
150243495|NCT01441635|542027298|FG008|Overall Study|Withdrawal by Subject|1|||
150243496|NCT01441635|542027299|FG009|Overall Study|Withdrawal by Subject|1|||
150243497|NCT01441635|542027290|FG000|Overall Study|Lost to Follow-up|0|||
150243498|NCT01441635|542027291|FG001|Overall Study|Lost to Follow-up|1|||
150243499|NCT01441635|542027292|FG002|Overall Study|Lost to Follow-up|1|||
150243500|NCT01441635|542027293|FG003|Overall Study|Lost to Follow-up|1|||
150243501|NCT01441635|542027294|FG004|Overall Study|Lost to Follow-up|1|||
150243502|NCT01441635|542027295|FG005|Overall Study|Lost to Follow-up|3|||
150243503|NCT01441635|542027296|FG006|Overall Study|Lost to Follow-up|1|||
150243504|NCT01441635|542027297|FG007|Overall Study|Lost to Follow-up|1|||
150243505|NCT01441635|542027298|FG008|Overall Study|Lost to Follow-up|0|||
150243506|NCT01441635|542027299|FG009|Overall Study|Lost to Follow-up|1|||
150243507|NCT01441635|542027290|FG000|Overall Study|Noncompliance|0|||
150243508|NCT01441635|542027291|FG001|Overall Study|Noncompliance|1|||
150243509|NCT01441635|542027292|FG002|Overall Study|Noncompliance|0|||
150243510|NCT01441635|542027293|FG003|Overall Study|Noncompliance|0|||
150243511|NCT01441635|542027294|FG004|Overall Study|Noncompliance|0|||
150243512|NCT01441635|542027295|FG005|Overall Study|Noncompliance|0|||
150243513|NCT01441635|542027296|FG006|Overall Study|Noncompliance|1|||
150243514|NCT01441635|542027297|FG007|Overall Study|Noncompliance|0|||
150243515|NCT01441635|542027298|FG008|Overall Study|Noncompliance|0|||
150243516|NCT01441635|542027299|FG009|Overall Study|Noncompliance|0|||
150243517|NCT01441635|542027290|FG000|Overall Study|Surgery or Invasive Intervention|0|||
150243518|NCT01441635|542027291|FG001|Overall Study|Surgery or Invasive Intervention|0|||
150243519|NCT01441635|542027292|FG002|Overall Study|Surgery or Invasive Intervention|1|||
150243520|NCT01441635|542027293|FG003|Overall Study|Surgery or Invasive Intervention|0|||
150243521|NCT01441635|542027294|FG004|Overall Study|Surgery or Invasive Intervention|0|||
150243522|NCT01441635|542027295|FG005|Overall Study|Surgery or Invasive Intervention|0|||
150243523|NCT01441635|542027296|FG006|Overall Study|Surgery or Invasive Intervention|0|||
150243524|NCT01441635|542027297|FG007|Overall Study|Surgery or Invasive Intervention|0|||
150243525|NCT01441635|542027298|FG008|Overall Study|Surgery or Invasive Intervention|0|||
150243526|NCT01441635|542027299|FG009|Overall Study|Surgery or Invasive Intervention|0|||
150243527|NCT01441635|542027290|FG000|Overall Study|Received Exclusionary Medication|1|||
150243528|NCT01441635|542027291|FG001|Overall Study|Received Exclusionary Medication|0|||
150243529|NCT01441635|542027292|FG002|Overall Study|Received Exclusionary Medication|0|||
150243530|NCT01441635|542027293|FG003|Overall Study|Received Exclusionary Medication|0|||
150243531|NCT01441635|542027294|FG004|Overall Study|Received Exclusionary Medication|0|||
150243532|NCT01441635|542027295|FG005|Overall Study|Received Exclusionary Medication|0|||
150243533|NCT01441635|542027296|FG006|Overall Study|Received Exclusionary Medication|0|||
150243534|NCT01441635|542027297|FG007|Overall Study|Received Exclusionary Medication|0|||
150243535|NCT01441635|542027298|FG008|Overall Study|Received Exclusionary Medication|0|||
150243536|NCT01441635|542027299|FG009|Overall Study|Received Exclusionary Medication|0|||
150243537|NCT01441635|542027290|FG000|Overall Study|Other|0|||
150243538|NCT01441635|542027291|FG001|Overall Study|Other|0|||
150243539|NCT01441635|542027292|FG002|Overall Study|Other|0|||
150243540|NCT01441635|542027293|FG003|Overall Study|Other|0|||
150243541|NCT01441635|542027294|FG004|Overall Study|Other|0|||
150243542|NCT01441635|542027295|FG005|Overall Study|Other|0|||
150243543|NCT01441635|542027296|FG006|Overall Study|Other|0|||
150243544|NCT01441635|542027297|FG007|Overall Study|Other|1|||
150243545|NCT01441635|542027298|FG008|Overall Study|Other|0|||
150243546|NCT01441635|542027299|FG009|Overall Study|Other|0|||
150243547|NCT02600897|542027300|FG000|Overall Study|Death|1|||
150243548|NCT02600897|542027301|FG001|Overall Study|Death|2|||
150243549|NCT02600897|542027302|FG002|Overall Study|Death|1|||
150243550|NCT02600897|542027303|FG003|Overall Study|Death|2|||
150243551|NCT02600897|542027304|FG004|Overall Study|Death|3|||
150243552|NCT02600897|542027305|FG005|Overall Study|Death|2|||
150243553|NCT02600897|542027306|FG006|Overall Study|Death|10|||
150243554|NCT02600897|542027307|FG007|Overall Study|Death|7|||
150243555|NCT02600897|542027308|FG008|Overall Study|Death|20|||
150243556|NCT02600897|542027300|FG000|Overall Study|Lost to Follow-up|1|||
150243557|NCT02600897|542027301|FG001|Overall Study|Lost to Follow-up|0|||
150243558|NCT02600897|542027302|FG002|Overall Study|Lost to Follow-up|0|||
150243559|NCT02600897|542027303|FG003|Overall Study|Lost to Follow-up|0|||
150243560|NCT02600897|542027304|FG004|Overall Study|Lost to Follow-up|0|||
150243561|NCT02600897|542027305|FG005|Overall Study|Lost to Follow-up|0|||
150243562|NCT02600897|542027306|FG006|Overall Study|Lost to Follow-up|0|||
150243563|NCT02600897|542027307|FG007|Overall Study|Lost to Follow-up|1|||
150243564|NCT02600897|542027308|FG008|Overall Study|Lost to Follow-up|0|||
150243565|NCT02600897|542027300|FG000|Overall Study|Withdrawal by Subject|0|||
150243566|NCT02600897|542027301|FG001|Overall Study|Withdrawal by Subject|0|||
150243567|NCT02600897|542027302|FG002|Overall Study|Withdrawal by Subject|0|||
150243568|NCT02600897|542027303|FG003|Overall Study|Withdrawal by Subject|0|||
150243569|NCT02600897|542027304|FG004|Overall Study|Withdrawal by Subject|0|||
150243570|NCT02600897|542027305|FG005|Overall Study|Withdrawal by Subject|0|||
150243571|NCT02600897|542027306|FG006|Overall Study|Withdrawal by Subject|0|||
150243572|NCT02600897|542027307|FG007|Overall Study|Withdrawal by Subject|4|||
150243573|NCT02600897|542027308|FG008|Overall Study|Withdrawal by Subject|2|||
150243574|NCT02600897|542027300|FG000|Overall Study|Reason Not Specified|0|||
150243575|NCT02600897|542027301|FG001|Overall Study|Reason Not Specified|0|||
150243576|NCT02600897|542027302|FG002|Overall Study|Reason Not Specified|0|||
150243577|NCT02600897|542027303|FG003|Overall Study|Reason Not Specified|0|||
150243578|NCT02600897|542027304|FG004|Overall Study|Reason Not Specified|0|||
150243579|NCT02600897|542027305|FG005|Overall Study|Reason Not Specified|0|||
150243580|NCT02600897|542027306|FG006|Overall Study|Reason Not Specified|0|||
150243581|NCT02600897|542027307|FG007|Overall Study|Reason Not Specified|0|||
150243582|NCT02600897|542027308|FG008|Overall Study|Reason Not Specified|1|||
150243583|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Adverse Event|10|||
150243584|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Adverse Event|9|||
150243585|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Adverse Event|7|||
150243586|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
150243587|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
150243588|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
150243589|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
150243590|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
150243591|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
150243592|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Physician Decision|7|||
150243593|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Physician Decision|3|||
150243594|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Physician Decision|2|||
150243595|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Pregnancy|2|||
150243596|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Pregnancy|1|||
150243597|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Pregnancy|3|||
150243598|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
150243599|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
150243600|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
150243601|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
150243602|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
150243603|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
150243604|NCT02614183|542027311|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
150243605|NCT02614183|542027312|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
150243606|NCT02614183|542027313|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
150243607|NCT02614183|542027311|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
150243608|NCT02614183|542027312|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
150243609|NCT02614183|542027313|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
150243610|NCT02614183|542027311|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
150243611|NCT02614183|542027312|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
150243612|NCT02614183|542027313|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
150243613|NCT02614183|542027311|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
150243614|NCT02614183|542027312|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
150243615|NCT02614183|542027313|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
150243616|NCT02614183|542027311|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
150243617|NCT02614183|542027312|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
150243618|NCT02614183|542027313|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
150243619|NCT05992922|542027314|FG000|Overall Study|Adverse Event|6|||
150243620|NCT05992922|542027315|FG001|Overall Study|Adverse Event|0|||
150243621|NCT05992922|542027314|FG000|Overall Study|Sponsor Termination of Study|14|||
150243622|NCT05992922|542027315|FG001|Overall Study|Sponsor Termination of Study|20|||
150243623|NCT00699153|542029505|FG000|Overall Study|Lost to Follow-up|1|||
150243624|NCT00699153|542029506|FG001|Overall Study|Lost to Follow-up|0|||
150243625|NCT00699153|542029505|FG000|Overall Study|Adverse Event|0|||
150243626|NCT00699153|542029506|FG001|Overall Study|Adverse Event|2|||
150243627|NCT00699153|542029505|FG000|Overall Study|Protocol Violation|1|||
150243628|NCT00699153|542029506|FG001|Overall Study|Protocol Violation|0|||
150243629|NCT00699153|542029505|FG000|Overall Study|Travel Problem|1|||
150243630|NCT00699153|542029506|FG001|Overall Study|Travel Problem|0|||
150243631|NCT00078338|542029509|FG000|Overall Study|Adverse Event|31|||
150243632|NCT00078338|542029510|FG001|Overall Study|Adverse Event|24|||
150243633|NCT00078338|542029509|FG000|Overall Study|Lost to Follow-up|17|||
150243634|NCT00078338|542029510|FG001|Overall Study|Lost to Follow-up|2|||
150243635|NCT00078338|542029509|FG000|Overall Study|Protocol Violation|2|||
150243636|NCT00078338|542029510|FG001|Overall Study|Protocol Violation|2|||
150243637|NCT00078338|542029509|FG000|Overall Study|Disease Progression|4|||
150243638|NCT00078338|542029510|FG001|Overall Study|Disease Progression|7|||
150243639|NCT00078338|542029509|FG000|Overall Study|Other|28|||
150243640|NCT00078338|542029510|FG001|Overall Study|Other|16|||
150243641|NCT00078338|542029509|FG000|Overall Study|Subjects randomized, but not treated|3|||
150243642|NCT00078338|542029510|FG001|Overall Study|Subjects randomized, but not treated|3|||
150243643|NCT04996004|542029511|FG000|Phase I|Death|1|||
150243644|NCT04996004|542029512|FG001|Phase I|Death|2|||
150243645|NCT04996004|542029513|FG002|Phase I|Death|1|||
150243646|NCT04996004|542029514|FG003|Phase I|Death|0|||
150243647|NCT04996004|542029515|FG004|Phase I|Death|0|||
150243648|NCT04996004|542029516|FG005|Phase I|Death|0|||
150243649|NCT04996004|542029511|FG000|Phase I|Study terminated by sponsor|2|||
150243650|NCT04996004|542029512|FG001|Phase I|Study terminated by sponsor|1|||
150243651|NCT04996004|542029513|FG002|Phase I|Study terminated by sponsor|2|||
150243652|NCT04996004|542029514|FG003|Phase I|Study terminated by sponsor|0|||
150243653|NCT04996004|542029515|FG004|Phase I|Study terminated by sponsor|0|||
150243654|NCT04996004|542029516|FG005|Phase I|Study terminated by sponsor|0|||
150243655|NCT04996004|542029511|FG000|Phase II|Study terminated by sponsor|0|||
150243656|NCT04996004|542029512|FG001|Phase II|Study terminated by sponsor|0|||
150243657|NCT04996004|542029513|FG002|Phase II|Study terminated by sponsor|0|||
150243658|NCT04996004|542029514|FG003|Phase II|Study terminated by sponsor|20|||
150243659|NCT04996004|542029515|FG004|Phase II|Study terminated by sponsor|10|||
150243660|NCT04996004|542029516|FG005|Phase II|Study terminated by sponsor|10|||
150243661|NCT04996004|542029511|FG000|Phase II|Withdrawal by Subject|0|||
150243662|NCT04996004|542029512|FG001|Phase II|Withdrawal by Subject|0|||
150243663|NCT04996004|542029513|FG002|Phase II|Withdrawal by Subject|0|||
150243664|NCT04996004|542029514|FG003|Phase II|Withdrawal by Subject|0|||
150243665|NCT04996004|542029515|FG004|Phase II|Withdrawal by Subject|1|||
150243666|NCT04996004|542029516|FG005|Phase II|Withdrawal by Subject|2|||
150243667|NCT04996004|542029511|FG000|Phase II|Death|0|||
150243668|NCT04996004|542029512|FG001|Phase II|Death|0|||
150243669|NCT04996004|542029513|FG002|Phase II|Death|0|||
150243670|NCT04996004|542029514|FG003|Phase II|Death|12|||
150243671|NCT04996004|542029515|FG004|Phase II|Death|2|||
150243672|NCT04996004|542029516|FG005|Phase II|Death|9|||
150243673|NCT04996004|542029511|FG000|Phase II|Other|0|||
150243674|NCT04996004|542029512|FG001|Phase II|Other|0|||
150243675|NCT04996004|542029513|FG002|Phase II|Other|0|||
150243676|NCT04996004|542029514|FG003|Phase II|Other|0|||
150243677|NCT04996004|542029515|FG004|Phase II|Other|0|||
150243678|NCT04996004|542029516|FG005|Phase II|Other|1|||
150243679|NCT00789360|542029526|FG000|Overall Study|Protocol Violation|3|||
150243680|NCT00789360|542029527|FG001|Overall Study|Protocol Violation|1|||
150243681|NCT03559062|542029528|FG000|Overall Study|Other|0|||
150243682|NCT03559062|542029529|FG001|Overall Study|Other|1|||
150243683|NCT03559062|542029530|FG002|Overall Study|Other|0|||
150243684|NCT03926195|542029532|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
150243685|NCT03926195|542029533|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
150243686|NCT03926195|542029532|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
150243687|NCT03926195|542029533|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
150243688|NCT03926195|542029532|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
150243689|NCT03926195|542029533|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
150243690|NCT03926195|542029532|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
150243691|NCT03926195|542029533|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
150243692|NCT03926195|542029532|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
150243693|NCT03926195|542029533|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
150243694|NCT03926195|542029532|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
150243695|NCT03926195|542029533|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
150243696|NCT00447590|542029534|FG000|Overall Study|Withdrawal by Subject|26|||
150243697|NCT00447590|542029534|FG000|Overall Study|Lost to Follow-up|24|||
150243698|NCT00447590|542029534|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
150243699|NCT01967069|542029535|FG000|Overall Study|Adverse Event|2|||
150243700|NCT01967069|542029536|FG001|Overall Study|Adverse Event|2|||
150243701|NCT01967069|542029535|FG000|Overall Study|Lost to Follow-up|5|||
150243702|NCT01967069|542029536|FG001|Overall Study|Lost to Follow-up|2|||
150243703|NCT01967069|542029535|FG000|Overall Study|Withdrawal by Subject|1|||
150243704|NCT01967069|542029536|FG001|Overall Study|Withdrawal by Subject|3|||
150243705|NCT01967069|542029535|FG000|Overall Study|Lack of Efficacy|0|||
150243706|NCT01967069|542029536|FG001|Overall Study|Lack of Efficacy|1|||
150243707|NCT00609947|542029537|FG000|Overall Study|Death|1|||
150243708|NCT00504075|542029538|FG000|Overall Study|Adverse Event|1|||
150243709|NCT00504075|542029538|FG000|Overall Study|Lost to Follow-up|5|||
150243710|NCT00504075|542029538|FG000|Overall Study|Withdrawal by Subject|1|||
150243711|NCT00504075|542029538|FG000|Overall Study|Required other therapeutic intervention|1|||
150243712|NCT01689857|542029540|FG000|Overall Study|Lost to Follow-up|5|||
150243713|NCT01689857|542029541|FG001|Overall Study|Lost to Follow-up|2|||
150243714|NCT05105087|542029542|FG000|Overall Study|Withdrawal by Subject|2|||
150243715|NCT05105087|542029542|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
150243716|NCT03149042|542029548|FG000|Overall Study|Invasive FFR not performed|21|||
150243717|NCT03149042|542029548|FG000|Overall Study|Poor CT Image Quality|1|||
150243718|NCT03149042|542029548|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
150243719|NCT01643044|542029549|FG000|Overall Study|Lost to Follow-up|1|||
150243720|NCT01643044|542029550|FG001|Overall Study|Lost to Follow-up|1|||
150243721|NCT01643044|542029549|FG000|Overall Study|Miscarried baby|2|||
150243722|NCT01643044|542029550|FG001|Overall Study|Miscarried baby|2|||
150243723|NCT01643044|542029549|FG000|Overall Study|Delivered outside of hospital|1|||
150243724|NCT01643044|542029550|FG001|Overall Study|Delivered outside of hospital|2|||
150243725|NCT00790205|542029555|FG000|Overall Study|Lost to Follow-up|61|||
150243726|NCT00790205|542029556|FG001|Overall Study|Lost to Follow-up|71|||
150243727|NCT00790205|542029555|FG000|Overall Study|Withdrawal by Subject|299|||
150243728|NCT00790205|542029556|FG001|Overall Study|Withdrawal by Subject|363|||
150243729|NCT02643628|542029557|FG000|Overall Study|Lost to Follow-up|1|||
150243730|NCT02643628|542029558|FG001|Overall Study|Lost to Follow-up|4|||
150243731|NCT02643628|542029557|FG000|Overall Study|Withdrawal by Subject|0|||
150243732|NCT02643628|542029558|FG001|Overall Study|Withdrawal by Subject|1|||
150243733|NCT02643628|542029557|FG000|Overall Study|Relocated out of state|0|||
150243734|NCT02643628|542029558|FG001|Overall Study|Relocated out of state|1|||
150243735|NCT02362503|542029559|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
150243736|NCT02362503|542029560|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
150243737|NCT02362503|542029561|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
150243738|NCT02362503|542029559|FG000|Double-blind Period-Up to 8 Days|Death|1|||
150243739|NCT02362503|542029560|FG001|Double-blind Period-Up to 8 Days|Death|0|||
150243740|NCT02362503|542029561|FG002|Double-blind Period-Up to 8 Days|Death|0|||
150243741|NCT02362503|542029559|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
150243742|NCT02362503|542029560|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
150243743|NCT02362503|542029561|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
150243744|NCT02362503|542029559|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
150243745|NCT02362503|542029560|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
150243746|NCT02362503|542029561|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
150243747|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
150243748|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
150243749|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
150243750|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
150243751|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
150243752|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
150243753|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
150243754|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
150243755|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
150243756|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
150243757|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
150243758|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
150243759|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
150243760|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
150243761|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
150243762|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
150243763|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
150243764|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
150243765|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
150243766|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
150243767|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
150243768|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
150243769|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
150243770|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
150243771|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
150243772|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
150243773|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
150243774|NCT02362503|542029559|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
150243775|NCT02362503|542029560|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
150243776|NCT02362503|542029561|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
150243777|NCT05143138|542029562|FG000|Overall Study|Death|5|||
150243778|NCT05143138|542029563|FG001|Overall Study|Death|35|||
150243779|NCT05143138|542029564|FG002|Overall Study|Death|1|||
150243780|NCT05143138|542029562|FG000|Overall Study|Lost to Follow-up|2|||
150243781|NCT05143138|542029563|FG001|Overall Study|Lost to Follow-up|4|||
150243782|NCT05143138|542029564|FG002|Overall Study|Lost to Follow-up|0|||
150243783|NCT05143138|542029562|FG000|Overall Study|withdrawal|1|||
150243784|NCT05143138|542029563|FG001|Overall Study|withdrawal|1|||
150243785|NCT05143138|542029564|FG002|Overall Study|withdrawal|0|||
150243786|NCT04245345|542029573|FG000|Overall Study|Death|1|||
150243787|NCT04245345|542029573|FG000|Overall Study|Exited prior to implant|5|||
150243788|NCT04245345|542029573|FG000|Overall Study|Exited prior to 1-month|9|||
150243789|NCT04245345|542029573|FG000|Overall Study|Missed 1-month visit|3|||
150243790|NCT04245345|542029573|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
150243791|NCT04245345|542029573|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
150243792|NCT01834586|542029574|FG000|Overall Study|Adverse Event|1|||
150243793|NCT03443414|542029575|FG000|Overall Study|Adverse Event|6|||
150243794|NCT03443414|542029576|FG001|Overall Study|Adverse Event|0|||
150243795|NCT03443414|542029577|FG002|Overall Study|Adverse Event|4|||
150243796|NCT03443414|542029578|FG003|Overall Study|Adverse Event|2|||
150243797|NCT03443414|542029579|FG004|Overall Study|Adverse Event|3|||
150243798|NCT03443414|542029575|FG000|Overall Study|Withdrawal by Subject|3|||
150243799|NCT03443414|542029576|FG001|Overall Study|Withdrawal by Subject|2|||
150243800|NCT03443414|542029577|FG002|Overall Study|Withdrawal by Subject|2|||
150243801|NCT03443414|542029578|FG003|Overall Study|Withdrawal by Subject|2|||
150243802|NCT03443414|542029579|FG004|Overall Study|Withdrawal by Subject|1|||
150243803|NCT03443414|542029575|FG000|Overall Study|Death|0|||
150243804|NCT03443414|542029576|FG001|Overall Study|Death|1|||
150243805|NCT03443414|542029577|FG002|Overall Study|Death|0|||
150243806|NCT03443414|542029578|FG003|Overall Study|Death|1|||
150243807|NCT03443414|542029579|FG004|Overall Study|Death|0|||
150243808|NCT03443414|542029575|FG000|Overall Study|Reason not specified|2|||
150243809|NCT03443414|542029576|FG001|Overall Study|Reason not specified|0|||
150243810|NCT03443414|542029577|FG002|Overall Study|Reason not specified|0|||
150243811|NCT03443414|542029578|FG003|Overall Study|Reason not specified|0|||
150243812|NCT03443414|542029579|FG004|Overall Study|Reason not specified|1|||
150243813|NCT03325777|542029582|FG000|Overall Study|Lost to Follow-up|9|||
150243814|NCT03325777|542029583|FG001|Overall Study|Lost to Follow-up|12|||
150243815|NCT01436305|542029593|FG000|Overall Study|Death|1|||
150243816|NCT01436305|542029594|FG001|Overall Study|Death|0|||
150243817|NCT01436305|542029595|FG002|Overall Study|Death|0|||
150243818|NCT01436305|542029593|FG000|Overall Study|Lost to Follow-up|0|||
150243819|NCT01436305|542029594|FG001|Overall Study|Lost to Follow-up|1|||
150243820|NCT01436305|542029595|FG002|Overall Study|Lost to Follow-up|0|||
150243821|NCT01436305|542029593|FG000|Overall Study|Withdrawal by Subject|1|||
150243822|NCT01436305|542029594|FG001|Overall Study|Withdrawal by Subject|3|||
150243823|NCT01436305|542029595|FG002|Overall Study|Withdrawal by Subject|0|||
150243824|NCT05262751|542029601|FG000|Washout Period 2|Adverse Event|1|||
150243825|NCT05262751|542029602|FG001|Washout Period 2|Adverse Event|0|||
150243826|NCT05262751|542029603|FG002|Washout Period 2|Adverse Event|0|||
150243827|NCT05262751|542029604|FG003|Washout Period 2|Adverse Event|0|||
150243828|NCT05262751|542029605|FG004|Washout Period 2|Adverse Event|0|||
150243829|NCT05262751|542029606|FG005|Washout Period 2|Adverse Event|0|||
150243830|NCT05262751|542029601|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
150243831|NCT05262751|542029602|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
150243832|NCT05262751|542029603|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
150243833|NCT05262751|542029604|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
150243834|NCT05262751|542029605|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
150243835|NCT05262751|542029606|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
150243836|NCT03690427|542029607|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
150243837|NCT03690427|542029608|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
150243838|NCT01721954|542029609|FG000|Overall Study|Death|58|||
150243839|NCT01721954|542029610|FG001|Overall Study|Death|64|||
150243840|NCT01721954|542029609|FG000|Overall Study|Withdrawal by Subject|8|||
150243841|NCT01721954|542029610|FG001|Overall Study|Withdrawal by Subject|4|||
150243842|NCT01721954|542029609|FG000|Overall Study|Adverse Event|2|||
150243843|NCT01721954|542029610|FG001|Overall Study|Adverse Event|0|||
150243844|NCT01721954|542029609|FG000|Overall Study|Lost to Follow-up|2|||
150243845|NCT01721954|542029610|FG001|Overall Study|Lost to Follow-up|1|||
150243846|NCT02956837|542029613|FG000|Overall Study|Serious Adverse Events|0|||
150243847|NCT02956837|542029614|FG001|Overall Study|Serious Adverse Events|1|||
150243848|NCT02956837|542029615|FG002|Overall Study|Serious Adverse Events|0|||
150243849|NCT02956837|542029616|FG003|Overall Study|Serious Adverse Events|0|||
150243850|NCT02956837|542029613|FG000|Overall Study|Withdrawal by Subject|0|||
150243851|NCT02956837|542029614|FG001|Overall Study|Withdrawal by Subject|1|||
150243852|NCT02956837|542029615|FG002|Overall Study|Withdrawal by Subject|0|||
150243853|NCT02956837|542029616|FG003|Overall Study|Withdrawal by Subject|3|||
150243854|NCT02956837|542029613|FG000|Overall Study|Lost to Follow-up|0|||
150243855|NCT02956837|542029614|FG001|Overall Study|Lost to Follow-up|1|||
150243856|NCT02956837|542029615|FG002|Overall Study|Lost to Follow-up|2|||
150243857|NCT02956837|542029616|FG003|Overall Study|Lost to Follow-up|0|||
150243858|NCT01727505|542029621|FG000|First 24 Hours|Adverse Event|0|||
150243859|NCT01727505|542029622|FG001|First 24 Hours|Adverse Event|1|||
150243860|NCT01727505|542029621|FG000|Second 24 Hours|Missing data|0|||
150243861|NCT01727505|542029622|FG001|Second 24 Hours|Missing data|1|||
150243862|NCT02637323|542029624|FG000|Overall Study|Lost to Follow-up|2|||
150243863|NCT02637323|542029625|FG001|Overall Study|Lost to Follow-up|0|||
150243864|NCT02637323|542029624|FG000|Overall Study|Protocol Violation|0|||
150243865|NCT02637323|542029625|FG001|Overall Study|Protocol Violation|1|||
150243866|NCT01825577|542029626|FG000|Overall Study|Physician Decision|2|||
150243867|NCT01825577|542029626|FG000|Overall Study|Withdrawal by Subject|1|||
150243868|NCT01825577|542029626|FG000|Overall Study|Withdrawn by family members|2|||
150243869|NCT01825577|542029626|FG000|Overall Study|Lack of Efficacy|3|||
150243870|NCT00358644|542029627|FG000|Overall Study|Progressive Disease|21|||
150243871|NCT00358644|542029627|FG000|Overall Study|Adverse Event|7|||
150243872|NCT00358644|542029627|FG000|Overall Study|Death|11|||
150243873|NCT00358644|542029627|FG000|Overall Study|Withdrawal by Subject|4|||
150243874|NCT00358644|542029627|FG000|Overall Study|Physician Decision|6|||
150243875|NCT00358644|542029627|FG000|Overall Study|Patient not eligible for study|1|||
150243876|NCT00513708|542029628|FG000|Overall Study|Lost to Follow-up|4|||
150243877|NCT00513708|542029629|FG001|Overall Study|Lost to Follow-up|4|||
150243878|NCT00513708|542029630|FG002|Overall Study|Lost to Follow-up|4|||
150243879|NCT03327831|542029631|FG000|Overall Study|Lost to Follow-up|2|||
150243880|NCT00368875|542029632|FG000|Overall Study|Adverse Event|0|||
150243881|NCT00368875|542029633|FG001|Overall Study|Adverse Event|12|||
150243882|NCT00368875|542029632|FG000|Overall Study|Progressive disease|3|||
150243883|NCT00368875|542029633|FG001|Overall Study|Progressive disease|27|||
150243884|NCT00368875|542029632|FG000|Overall Study|Withdrawal by Subject|2|||
150243885|NCT00368875|542029633|FG001|Overall Study|Withdrawal by Subject|6|||
150243886|NCT00368875|542029632|FG000|Overall Study|Other Reason|0|||
150243887|NCT00368875|542029633|FG001|Overall Study|Other Reason|2|||
150243888|NCT00368875|542029632|FG000|Overall Study|Alternative Therapy|1|||
150243889|NCT00368875|542029633|FG001|Overall Study|Alternative Therapy|1|||
150243890|NCT01564277|542029634|FG000|Overall Study|Protocol Violation|0|||
150243891|NCT01564277|542029635|FG001|Overall Study|Protocol Violation|1|||
150243892|NCT01564277|542029634|FG000|Overall Study|Physician Decision|1|||
150243893|NCT01564277|542029635|FG001|Overall Study|Physician Decision|0|||
150243894|NCT02595372|542029636|FG000|Overall Study|Adverse Event|6|||
150243895|NCT02595372|542029636|FG000|Overall Study|Physician Decision|2|||
150243896|NCT02595372|542029636|FG000|Overall Study|Disease Progression|1|||
150243897|NCT01594970|542029639|FG000|Overall Study|Non-Adverse Event Related|4|||
150243898|NCT01594970|542029640|FG001|Overall Study|Non-Adverse Event Related|5|||
150243899|NCT01594970|542029641|FG002|Overall Study|Non-Adverse Event Related|6|||
150243900|NCT01594970|542029639|FG000|Overall Study|Adverse Event|17|||
150243901|NCT01594970|542029640|FG001|Overall Study|Adverse Event|23|||
150243902|NCT01594970|542029641|FG002|Overall Study|Adverse Event|23|||
150243903|NCT01594970|542029639|FG000|Overall Study|Lost to Follow-up|54|||
150243904|NCT01594970|542029640|FG001|Overall Study|Lost to Follow-up|54|||
150243905|NCT01594970|542029641|FG002|Overall Study|Lost to Follow-up|37|||
150243906|NCT00401258|542029642|FG000|Overall Study|Adverse Event|7|||
150243907|NCT01427725|542029643|FG000|Overall Study|Lost to Follow-up|17|||
150243908|NCT01427725|542029643|FG000|Overall Study|Protocol Violation|1|||
150243909|NCT01427725|542029643|FG000|Overall Study|Drug not administered|1|||
150243910|NCT01427725|542029643|FG000|Overall Study|Failure to visit|7|||
150243911|NCT01427725|542029643|FG000|Overall Study|Adverse Event|46|||
150243912|NCT01427725|542029643|FG000|Overall Study|Failure to visit after administration|40|||
150243913|NCT01427725|542029643|FG000|Overall Study|Patient's rejection|27|||
150243914|NCT01427725|542029643|FG000|Overall Study|Transfer to a different hospital|17|||
150243915|NCT01427725|542029643|FG000|Overall Study|Lack of Efficacy|8|||
150243916|NCT01427725|542029643|FG000|Overall Study|Death|7|||
150243917|NCT01427725|542029643|FG000|Overall Study|Symptom improvement|6|||
150243918|NCT01427725|542029643|FG000|Overall Study|AE and Patient's rejection|5|||
150243919|NCT01427725|542029643|FG000|Overall Study|Physician Decision|5|||
150243920|NCT01427725|542029643|FG000|Overall Study|Exacerbation of underlying disease|5|||
150243921|NCT01427725|542029643|FG000|Overall Study|Oral feeding difficulty|5|||
150243922|NCT01427725|542029643|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
150243923|NCT01427725|542029643|FG000|Overall Study|Forgetting prescription|1|||
150243924|NCT01427725|542029643|FG000|Overall Study|Other|2|||
150243925|NCT01299480|542029644|FG000|Overall Study|No longer willing to participate|19|||
150243926|NCT01299480|542029645|FG001|Overall Study|No longer willing to participate|17|||
150243927|NCT01299480|542029646|FG002|Overall Study|No longer willing to participate|14|||
150243928|NCT01299480|542029647|FG003|Overall Study|No longer willing to participate|13|||
150243929|NCT01299480|542029648|FG004|Overall Study|No longer willing to participate|10|||
150243930|NCT01299480|542029644|FG000|Overall Study|Protocol Violation|7|||
150243931|NCT01299480|542029645|FG001|Overall Study|Protocol Violation|5|||
150243932|NCT01299480|542029646|FG002|Overall Study|Protocol Violation|8|||
150243933|NCT01299480|542029647|FG003|Overall Study|Protocol Violation|1|||
150243934|NCT01299480|542029648|FG004|Overall Study|Protocol Violation|1|||
150243935|NCT01299480|542029644|FG000|Overall Study|Withdrawal by Subject|3|||
150243936|NCT01299480|542029645|FG001|Overall Study|Withdrawal by Subject|4|||
150243937|NCT01299480|542029646|FG002|Overall Study|Withdrawal by Subject|7|||
150243938|NCT01299480|542029647|FG003|Overall Study|Withdrawal by Subject|3|||
150243939|NCT01299480|542029648|FG004|Overall Study|Withdrawal by Subject|4|||
150243940|NCT01299480|542029644|FG000|Overall Study|Adverse Event|6|||
150243941|NCT01299480|542029645|FG001|Overall Study|Adverse Event|4|||
150243942|NCT01299480|542029646|FG002|Overall Study|Adverse Event|5|||
150243943|NCT01299480|542029647|FG003|Overall Study|Adverse Event|4|||
150243944|NCT01299480|542029648|FG004|Overall Study|Adverse Event|0|||
150243945|NCT01299480|542029644|FG000|Overall Study|Withdrawal due to pregnancy|0|||
150243946|NCT01299480|542029645|FG001|Overall Study|Withdrawal due to pregnancy|1|||
150243947|NCT01299480|542029646|FG002|Overall Study|Withdrawal due to pregnancy|1|||
150243948|NCT01299480|542029647|FG003|Overall Study|Withdrawal due to pregnancy|0|||
150243949|NCT01299480|542029648|FG004|Overall Study|Withdrawal due to pregnancy|0|||
150243950|NCT01299480|542029644|FG000|Overall Study|Physician Decision|1|||
150243951|NCT01299480|542029645|FG001|Overall Study|Physician Decision|1|||
150243952|NCT01299480|542029646|FG002|Overall Study|Physician Decision|0|||
150243953|NCT01299480|542029647|FG003|Overall Study|Physician Decision|2|||
150243954|NCT01299480|542029648|FG004|Overall Study|Physician Decision|0|||
150243955|NCT01299480|542029644|FG000|Overall Study|Lost to Follow-up|3|||
150243956|NCT01299480|542029645|FG001|Overall Study|Lost to Follow-up|1|||
150243957|NCT01299480|542029646|FG002|Overall Study|Lost to Follow-up|2|||
150243958|NCT01299480|542029647|FG003|Overall Study|Lost to Follow-up|1|||
150243959|NCT01299480|542029648|FG004|Overall Study|Lost to Follow-up|2|||
150243960|NCT01299480|542029644|FG000|Overall Study|Other|3|||
150243961|NCT01299480|542029645|FG001|Overall Study|Other|2|||
150243962|NCT01299480|542029646|FG002|Overall Study|Other|3|||
150243963|NCT01299480|542029647|FG003|Overall Study|Other|0|||
150243964|NCT01299480|542029648|FG004|Overall Study|Other|3|||
150243965|NCT01299480|542029644|FG000|Overall Study|Started, but not vaccinated|0|||
150243966|NCT01299480|542029645|FG001|Overall Study|Started, but not vaccinated|0|||
150243967|NCT01299480|542029646|FG002|Overall Study|Started, but not vaccinated|1|||
150243968|NCT01299480|542029647|FG003|Overall Study|Started, but not vaccinated|1|||
150243969|NCT01299480|542029648|FG004|Overall Study|Started, but not vaccinated|0|||
150243970|NCT01430468|542029655|FG000|Overall Study|Physician Decision|2|||
150243971|NCT01430468|542029656|FG001|Overall Study|Physician Decision|1|||
150243972|NCT01430468|542029655|FG000|Overall Study|Withdrawal by Subject|5|||
150243973|NCT01430468|542029656|FG001|Overall Study|Withdrawal by Subject|5|||
150243974|NCT01281839|542029657|FG000|Overall Study|Lost to Follow-up|6|||
150243975|NCT01281839|542029658|FG001|Overall Study|Lost to Follow-up|3|||
150243976|NCT01281839|542029657|FG000|Overall Study|Withdrawal by Subject|4|||
150243977|NCT01281839|542029658|FG001|Overall Study|Withdrawal by Subject|10|||
150243978|NCT01281839|542029657|FG000|Overall Study|Reason not specified|0|||
150243979|NCT01281839|542029658|FG001|Overall Study|Reason not specified|1|||
150243980|NCT01305239|542029659|FG000|Overall Study|Adverse Event|22|||
150243981|NCT01305239|542029659|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
150243982|NCT01754753|542029662|FG000|Overall Study|Study close|43|||
150243983|NCT01754753|542029663|FG001|Overall Study|Study close|44|||
150243984|NCT01754753|542029662|FG000|Overall Study|Lost to Follow-up|9|||
150243985|NCT01754753|542029663|FG001|Overall Study|Lost to Follow-up|5|||
150243986|NCT00344032|542029664|FG000|Overall Study|Adverse Event|0|||
150243987|NCT00344032|542029665|FG001|Overall Study|Adverse Event|1|||
150243988|NCT00344032|542029664|FG000|Overall Study|Withdrawal by Subject|6|||
150243989|NCT00344032|542029665|FG001|Overall Study|Withdrawal by Subject|2|||
150243990|NCT00344032|542029664|FG000|Overall Study|Lost to Follow-up|4|||
150243991|NCT00344032|542029665|FG001|Overall Study|Lost to Follow-up|6|||
150243992|NCT00344032|542029664|FG000|Overall Study|Physician Decision|4|||
150243993|NCT00344032|542029665|FG001|Overall Study|Physician Decision|1|||
150243994|NCT05131477|542029672|FG000|PART 1|Withdrawal by Subject|2|||
150243995|NCT05131477|542029673|FG001|PART 1|Withdrawal by Subject|9|||
150243996|NCT05131477|542029674|FG002|PART 1|Withdrawal by Subject|6|||
150243997|NCT05131477|542029675|FG003|PART 1|Withdrawal by Subject|2|||
150243998|NCT05131477|542029676|FG004|PART 1|Withdrawal by Subject|8|||
150243999|NCT05131477|542029677|FG005|PART 1|Withdrawal by Subject|0|||
150244000|NCT05131477|542029678|FG006|PART 1|Withdrawal by Subject|0|||
150244001|NCT05131477|542029679|FG007|PART 1|Withdrawal by Subject|0|||
150244002|NCT05131477|542029680|FG008|PART 1|Withdrawal by Subject|0|||
150244003|NCT05131477|542029681|FG009|PART 1|Withdrawal by Subject|0|||
150244004|NCT05131477|542029682|FG010|PART 1|Withdrawal by Subject|0|||
150244005|NCT05131477|542029683|FG011|PART 1|Withdrawal by Subject|0|||
150244006|NCT05131477|542029684|FG012|PART 1|Withdrawal by Subject|0|||
150244007|NCT05131477|542029685|FG013|PART 1|Withdrawal by Subject|0|||
150244008|NCT05131477|542029672|FG000|PART 1|Physician Decision|1|||
150244009|NCT05131477|542029673|FG001|PART 1|Physician Decision|0|||
150244010|NCT05131477|542029674|FG002|PART 1|Physician Decision|0|||
150244011|NCT05131477|542029675|FG003|PART 1|Physician Decision|0|||
150244012|NCT05131477|542029676|FG004|PART 1|Physician Decision|0|||
150244013|NCT05131477|542029677|FG005|PART 1|Physician Decision|0|||
150244014|NCT05131477|542029678|FG006|PART 1|Physician Decision|0|||
150244015|NCT05131477|542029679|FG007|PART 1|Physician Decision|0|||
150244016|NCT05131477|542029680|FG008|PART 1|Physician Decision|0|||
150244017|NCT05131477|542029681|FG009|PART 1|Physician Decision|0|||
150244018|NCT05131477|542029682|FG010|PART 1|Physician Decision|0|||
150244019|NCT05131477|542029683|FG011|PART 1|Physician Decision|0|||
150244020|NCT05131477|542029684|FG012|PART 1|Physician Decision|0|||
150244021|NCT05131477|542029685|FG013|PART 1|Physician Decision|0|||
150244022|NCT05131477|542029672|FG000|PART 1|Adverse Event|3|||
150244023|NCT05131477|542029673|FG001|PART 1|Adverse Event|5|||
150244024|NCT05131477|542029674|FG002|PART 1|Adverse Event|1|||
150244025|NCT05131477|542029675|FG003|PART 1|Adverse Event|6|||
150244026|NCT05131477|542029676|FG004|PART 1|Adverse Event|4|||
150244027|NCT05131477|542029677|FG005|PART 1|Adverse Event|0|||
150244028|NCT05131477|542029678|FG006|PART 1|Adverse Event|0|||
150244029|NCT05131477|542029679|FG007|PART 1|Adverse Event|0|||
150244030|NCT05131477|542029680|FG008|PART 1|Adverse Event|0|||
150244031|NCT05131477|542029681|FG009|PART 1|Adverse Event|0|||
150244032|NCT05131477|542029682|FG010|PART 1|Adverse Event|0|||
150244033|NCT05131477|542029683|FG011|PART 1|Adverse Event|0|||
150244034|NCT05131477|542029684|FG012|PART 1|Adverse Event|0|||
150244035|NCT05131477|542029685|FG013|PART 1|Adverse Event|0|||
150244036|NCT05131477|542029672|FG000|PART 1|unclassified|1|||
150244037|NCT05131477|542029673|FG001|PART 1|unclassified|1|||
150244038|NCT05131477|542029674|FG002|PART 1|unclassified|0|||
150244039|NCT05131477|542029675|FG003|PART 1|unclassified|0|||
150244040|NCT05131477|542029676|FG004|PART 1|unclassified|4|||
150244041|NCT05131477|542029677|FG005|PART 1|unclassified|0|||
150244042|NCT05131477|542029678|FG006|PART 1|unclassified|0|||
150244043|NCT05131477|542029679|FG007|PART 1|unclassified|0|||
150244044|NCT05131477|542029680|FG008|PART 1|unclassified|0|||
150244045|NCT05131477|542029681|FG009|PART 1|unclassified|0|||
150244046|NCT05131477|542029682|FG010|PART 1|unclassified|0|||
150244047|NCT05131477|542029683|FG011|PART 1|unclassified|0|||
150244048|NCT05131477|542029684|FG012|PART 1|unclassified|0|||
150244049|NCT05131477|542029685|FG013|PART 1|unclassified|0|||
150244050|NCT05131477|542029672|FG000|PART 1|Randomized and not treated|0|||
150244051|NCT05131477|542029673|FG001|PART 1|Randomized and not treated|0|||
150244052|NCT05131477|542029674|FG002|PART 1|Randomized and not treated|0|||
150244053|NCT05131477|542029675|FG003|PART 1|Randomized and not treated|1|||
150244054|NCT05131477|542029676|FG004|PART 1|Randomized and not treated|1|||
150244055|NCT05131477|542029677|FG005|PART 1|Randomized and not treated|0|||
150244056|NCT05131477|542029678|FG006|PART 1|Randomized and not treated|0|||
150244057|NCT05131477|542029679|FG007|PART 1|Randomized and not treated|0|||
150244058|NCT05131477|542029680|FG008|PART 1|Randomized and not treated|0|||
150244059|NCT05131477|542029681|FG009|PART 1|Randomized and not treated|0|||
150244060|NCT05131477|542029682|FG010|PART 1|Randomized and not treated|0|||
150244061|NCT05131477|542029683|FG011|PART 1|Randomized and not treated|0|||
150244062|NCT05131477|542029684|FG012|PART 1|Randomized and not treated|0|||
150244063|NCT05131477|542029685|FG013|PART 1|Randomized and not treated|0|||
150244064|NCT05131477|542029672|FG000|PART 1|Protocol Violation|2|||
150244065|NCT05131477|542029673|FG001|PART 1|Protocol Violation|0|||
150244066|NCT05131477|542029674|FG002|PART 1|Protocol Violation|0|||
150244067|NCT05131477|542029675|FG003|PART 1|Protocol Violation|1|||
150244068|NCT05131477|542029676|FG004|PART 1|Protocol Violation|0|||
150244069|NCT05131477|542029677|FG005|PART 1|Protocol Violation|0|||
150244070|NCT05131477|542029678|FG006|PART 1|Protocol Violation|0|||
150244071|NCT05131477|542029679|FG007|PART 1|Protocol Violation|0|||
150244072|NCT05131477|542029680|FG008|PART 1|Protocol Violation|0|||
150244073|NCT05131477|542029681|FG009|PART 1|Protocol Violation|0|||
150244074|NCT05131477|542029682|FG010|PART 1|Protocol Violation|0|||
150244075|NCT05131477|542029683|FG011|PART 1|Protocol Violation|0|||
150244076|NCT05131477|542029684|FG012|PART 1|Protocol Violation|0|||
150244077|NCT05131477|542029685|FG013|PART 1|Protocol Violation|0|||
150244078|NCT05131477|542029672|FG000|PART 1|Lack of Efficacy|0|||
150244079|NCT05131477|542029673|FG001|PART 1|Lack of Efficacy|1|||
150244080|NCT05131477|542029674|FG002|PART 1|Lack of Efficacy|1|||
150244081|NCT05131477|542029675|FG003|PART 1|Lack of Efficacy|2|||
150244082|NCT05131477|542029676|FG004|PART 1|Lack of Efficacy|5|||
150244083|NCT05131477|542029677|FG005|PART 1|Lack of Efficacy|0|||
150244084|NCT05131477|542029678|FG006|PART 1|Lack of Efficacy|0|||
150244085|NCT05131477|542029679|FG007|PART 1|Lack of Efficacy|0|||
150244086|NCT05131477|542029680|FG008|PART 1|Lack of Efficacy|0|||
150244087|NCT05131477|542029681|FG009|PART 1|Lack of Efficacy|0|||
150244088|NCT05131477|542029682|FG010|PART 1|Lack of Efficacy|0|||
150244089|NCT05131477|542029683|FG011|PART 1|Lack of Efficacy|0|||
150244090|NCT05131477|542029684|FG012|PART 1|Lack of Efficacy|0|||
150244091|NCT05131477|542029685|FG013|PART 1|Lack of Efficacy|0|||
150244092|NCT05131477|542029672|FG000|PART 2|Withdrawal by Subject|0|||
150244093|NCT05131477|542029673|FG001|PART 2|Withdrawal by Subject|0|||
150244094|NCT05131477|542029674|FG002|PART 2|Withdrawal by Subject|0|||
150244095|NCT05131477|542029675|FG003|PART 2|Withdrawal by Subject|0|||
150244096|NCT05131477|542029676|FG004|PART 2|Withdrawal by Subject|0|||
150244097|NCT05131477|542029677|FG005|PART 2|Withdrawal by Subject|0|||
150244098|NCT05131477|542029678|FG006|PART 2|Withdrawal by Subject|2|||
150244099|NCT05131477|542029679|FG007|PART 2|Withdrawal by Subject|0|||
150244100|NCT05131477|542029680|FG008|PART 2|Withdrawal by Subject|0|||
150244101|NCT05131477|542029681|FG009|PART 2|Withdrawal by Subject|0|||
150244102|NCT05131477|542029682|FG010|PART 2|Withdrawal by Subject|2|||
150244103|NCT05131477|542029683|FG011|PART 2|Withdrawal by Subject|0|||
150244104|NCT05131477|542029684|FG012|PART 2|Withdrawal by Subject|2|||
150244105|NCT05131477|542029685|FG013|PART 2|Withdrawal by Subject|2|||
150244106|NCT05131477|542029672|FG000|PART 2|Other|0|||
150244107|NCT05131477|542029673|FG001|PART 2|Other|0|||
150244108|NCT05131477|542029674|FG002|PART 2|Other|0|||
150244109|NCT05131477|542029675|FG003|PART 2|Other|0|||
150244110|NCT05131477|542029676|FG004|PART 2|Other|0|||
150244111|NCT05131477|542029677|FG005|PART 2|Other|0|||
150244112|NCT05131477|542029678|FG006|PART 2|Other|0|||
150244113|NCT05131477|542029679|FG007|PART 2|Other|0|||
150244114|NCT05131477|542029680|FG008|PART 2|Other|1|||
150244115|NCT05131477|542029681|FG009|PART 2|Other|1|||
150244116|NCT05131477|542029682|FG010|PART 2|Other|0|||
150244117|NCT05131477|542029683|FG011|PART 2|Other|0|||
150244118|NCT05131477|542029684|FG012|PART 2|Other|1|||
150244119|NCT05131477|542029685|FG013|PART 2|Other|0|||
150244120|NCT05131477|542029672|FG000|PART 2|Lack of Efficacy|0|||
150244121|NCT05131477|542029673|FG001|PART 2|Lack of Efficacy|0|||
150244122|NCT05131477|542029674|FG002|PART 2|Lack of Efficacy|0|||
150244123|NCT05131477|542029675|FG003|PART 2|Lack of Efficacy|0|||
150244124|NCT05131477|542029676|FG004|PART 2|Lack of Efficacy|0|||
150244125|NCT05131477|542029677|FG005|PART 2|Lack of Efficacy|1|||
150244126|NCT05131477|542029678|FG006|PART 2|Lack of Efficacy|1|||
150244127|NCT05131477|542029679|FG007|PART 2|Lack of Efficacy|0|||
150244128|NCT05131477|542029680|FG008|PART 2|Lack of Efficacy|3|||
150244129|NCT05131477|542029681|FG009|PART 2|Lack of Efficacy|0|||
150244130|NCT05131477|542029682|FG010|PART 2|Lack of Efficacy|1|||
150244131|NCT05131477|542029683|FG011|PART 2|Lack of Efficacy|0|||
150244132|NCT05131477|542029684|FG012|PART 2|Lack of Efficacy|2|||
150244133|NCT05131477|542029685|FG013|PART 2|Lack of Efficacy|0|||
150244134|NCT05131477|542029672|FG000|PART 2|Unclassified|0|||
150244135|NCT05131477|542029673|FG001|PART 2|Unclassified|0|||
150244136|NCT05131477|542029674|FG002|PART 2|Unclassified|0|||
150244137|NCT05131477|542029675|FG003|PART 2|Unclassified|0|||
150244138|NCT05131477|542029676|FG004|PART 2|Unclassified|0|||
150244139|NCT05131477|542029677|FG005|PART 2|Unclassified|0|||
150244140|NCT05131477|542029678|FG006|PART 2|Unclassified|0|||
150244141|NCT05131477|542029679|FG007|PART 2|Unclassified|0|||
150244142|NCT05131477|542029680|FG008|PART 2|Unclassified|0|||
150244143|NCT05131477|542029681|FG009|PART 2|Unclassified|0|||
150244144|NCT05131477|542029682|FG010|PART 2|Unclassified|1|||
150244145|NCT05131477|542029683|FG011|PART 2|Unclassified|0|||
150244146|NCT05131477|542029684|FG012|PART 2|Unclassified|0|||
150244147|NCT05131477|542029685|FG013|PART 2|Unclassified|0|||
150244148|NCT05131477|542029672|FG000|PART 2|Re-randomized and not treated|0|||
150244149|NCT05131477|542029673|FG001|PART 2|Re-randomized and not treated|0|||
150244150|NCT05131477|542029674|FG002|PART 2|Re-randomized and not treated|0|||
150244151|NCT05131477|542029675|FG003|PART 2|Re-randomized and not treated|0|||
150244152|NCT05131477|542029676|FG004|PART 2|Re-randomized and not treated|0|||
150244153|NCT05131477|542029677|FG005|PART 2|Re-randomized and not treated|0|||
150244154|NCT05131477|542029678|FG006|PART 2|Re-randomized and not treated|0|||
150244155|NCT05131477|542029679|FG007|PART 2|Re-randomized and not treated|1|||
150244156|NCT05131477|542029680|FG008|PART 2|Re-randomized and not treated|0|||
150244157|NCT05131477|542029681|FG009|PART 2|Re-randomized and not treated|0|||
150244158|NCT05131477|542029682|FG010|PART 2|Re-randomized and not treated|1|||
150244159|NCT05131477|542029683|FG011|PART 2|Re-randomized and not treated|0|||
150244160|NCT05131477|542029684|FG012|PART 2|Re-randomized and not treated|1|||
150244161|NCT05131477|542029685|FG013|PART 2|Re-randomized and not treated|1|||
150244162|NCT02194829|542029686|FG000|Overall Study|Adverse Event|2|||
150244163|NCT02194829|542029687|FG001|Overall Study|Adverse Event|2|||
150244164|NCT02194829|542029686|FG000|Overall Study|Death|0|||
150244165|NCT02194829|542029687|FG001|Overall Study|Death|1|||
150244166|NCT02194829|542029686|FG000|Overall Study|Disease progression|0|||
150244167|NCT02194829|542029687|FG001|Overall Study|Disease progression|1|||
150244168|NCT02194829|542029686|FG000|Overall Study|Withdrawal by Subject|0|||
150244169|NCT02194829|542029687|FG001|Overall Study|Withdrawal by Subject|1|||
150244170|NCT02194829|542029686|FG000|Overall Study|Never started protocol therapy|0|||
150244171|NCT02194829|542029687|FG001|Overall Study|Never started protocol therapy|1|||
150244172|NCT06840769|542029689|FG000|Overall Study|Withdrawal by Subject|1|||
150244173|NCT06840769|542029690|FG001|Overall Study|Withdrawal by Subject|0|||
150244174|NCT06840769|542029691|FG002|Overall Study|Withdrawal by Subject|0|||
150244175|NCT06840769|542029692|FG003|Overall Study|Withdrawal by Subject|0|||
150244176|NCT06840769|542029693|FG004|Overall Study|Withdrawal by Subject|0|||
150244177|NCT02726945|542029694|FG000|Overall Study|Withdrawal by Subject|0|||
150244178|NCT02726945|542029695|FG001|Overall Study|Withdrawal by Subject|0|||
150244179|NCT02726945|542029696|FG002|Overall Study|Withdrawal by Subject|1|||
150244180|NCT02726945|542029694|FG000|Overall Study|Elected to have total knee replacement|0|||
150244181|NCT02726945|542029695|FG001|Overall Study|Elected to have total knee replacement|1|||
150244182|NCT02726945|542029696|FG002|Overall Study|Elected to have total knee replacement|0|||
150244183|NCT03374488|542031406|FG000|Overall Study|Death|13|||
150244184|NCT03374488|542031407|FG001|Overall Study|Death|13|||
150244185|NCT03374488|542031406|FG000|Overall Study|Withdrawal by Subject|3|||
150244186|NCT03374488|542031407|FG001|Overall Study|Withdrawal by Subject|1|||
150244187|NCT03374488|542031406|FG000|Overall Study|Physician Decision|3|||
150244188|NCT03374488|542031407|FG001|Overall Study|Physician Decision|0|||
150244189|NCT02493062|542031408|FG000|Overall Study|Physician Decision|12|||
150244190|NCT03054337|542031409|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
150244191|NCT03054337|542031410|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
150244192|NCT03054337|542031411|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
150244193|NCT03054337|542031412|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
150244194|NCT03054337|542031413|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
150244195|NCT03054337|542031414|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
150244196|NCT01327612|542031415|FG000|Overall Study|Withdrawal by Subject|0|||
150244197|NCT01327612|542031416|FG001|Overall Study|Withdrawal by Subject|0|||
150244198|NCT01327612|542031417|FG002|Overall Study|Withdrawal by Subject|0|||
150244199|NCT01327612|542031418|FG003|Overall Study|Withdrawal by Subject|0|||
150244200|NCT01327612|542031419|FG004|Overall Study|Withdrawal by Subject|0|||
150244201|NCT01327612|542031420|FG005|Overall Study|Withdrawal by Subject|1|||
150244202|NCT01327612|542031421|FG006|Overall Study|Withdrawal by Subject|0|||
150244203|NCT01327612|542031415|FG000|Overall Study|Disease Progression|1|||
150244204|NCT01327612|542031416|FG001|Overall Study|Disease Progression|1|||
150244205|NCT01327612|542031417|FG002|Overall Study|Disease Progression|1|||
150244206|NCT01327612|542031418|FG003|Overall Study|Disease Progression|0|||
150244207|NCT01327612|542031419|FG004|Overall Study|Disease Progression|1|||
150244208|NCT01327612|542031420|FG005|Overall Study|Disease Progression|2|||
150244209|NCT01327612|542031421|FG006|Overall Study|Disease Progression|2|||
150244210|NCT01327612|542031415|FG000|Overall Study|Administrative Decision|0|||
150244211|NCT01327612|542031416|FG001|Overall Study|Administrative Decision|0|||
150244212|NCT01327612|542031417|FG002|Overall Study|Administrative Decision|0|||
150244213|NCT01327612|542031418|FG003|Overall Study|Administrative Decision|1|||
150244214|NCT01327612|542031419|FG004|Overall Study|Administrative Decision|0|||
150244215|NCT01327612|542031420|FG005|Overall Study|Administrative Decision|0|||
150244216|NCT01327612|542031421|FG006|Overall Study|Administrative Decision|0|||
150244217|NCT01327612|542031415|FG000|Overall Study|Death|0|||
150244218|NCT01327612|542031416|FG001|Overall Study|Death|0|||
150244219|NCT01327612|542031417|FG002|Overall Study|Death|0|||
150244220|NCT01327612|542031418|FG003|Overall Study|Death|0|||
150244221|NCT01327612|542031419|FG004|Overall Study|Death|1|||
150244222|NCT01327612|542031420|FG005|Overall Study|Death|0|||
150244223|NCT01327612|542031421|FG006|Overall Study|Death|0|||
150244224|NCT01016262|542031429|FG000|Double-blind Phase|Adverse Event|0|||
150244225|NCT01016262|542031430|FG001|Double-blind Phase|Adverse Event|0|||
150244226|NCT01016262|542031431|FG002|Double-blind Phase|Adverse Event|1|||
150244227|NCT01016262|542031432|FG003|Double-blind Phase|Adverse Event|0|||
150244228|NCT01016262|542031433|FG004|Double-blind Phase|Adverse Event|0|||
150244229|NCT01016262|542031434|FG005|Double-blind Phase|Adverse Event|0|||
150244230|NCT01016262|542031429|FG000|Double-blind Phase|Lack of Efficacy|1|||
150244231|NCT01016262|542031430|FG001|Double-blind Phase|Lack of Efficacy|0|||
150244232|NCT01016262|542031431|FG002|Double-blind Phase|Lack of Efficacy|5|||
150244233|NCT01016262|542031432|FG003|Double-blind Phase|Lack of Efficacy|0|||
150244234|NCT01016262|542031433|FG004|Double-blind Phase|Lack of Efficacy|0|||
150244235|NCT01016262|542031434|FG005|Double-blind Phase|Lack of Efficacy|0|||
150244236|NCT01016262|542031429|FG000|Double-blind Phase|Disease Progression|0|||
150244237|NCT01016262|542031430|FG001|Double-blind Phase|Disease Progression|1|||
150244238|NCT01016262|542031431|FG002|Double-blind Phase|Disease Progression|2|||
150244239|NCT01016262|542031432|FG003|Double-blind Phase|Disease Progression|0|||
150244240|NCT01016262|542031433|FG004|Double-blind Phase|Disease Progression|0|||
150244241|NCT01016262|542031434|FG005|Double-blind Phase|Disease Progression|0|||
150244242|NCT01016262|542031429|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
150244243|NCT01016262|542031430|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
150244244|NCT01016262|542031431|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
150244245|NCT01016262|542031432|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
150244246|NCT01016262|542031433|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
150244247|NCT01016262|542031434|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
150244248|NCT01016262|542031429|FG000|Open-Label Phase|Adverse Event|0|||
150244249|NCT01016262|542031430|FG001|Open-Label Phase|Adverse Event|0|||
150244250|NCT01016262|542031431|FG002|Open-Label Phase|Adverse Event|0|||
150244251|NCT01016262|542031432|FG003|Open-Label Phase|Adverse Event|1|||
150244252|NCT01016262|542031433|FG004|Open-Label Phase|Adverse Event|0|||
150244253|NCT01016262|542031434|FG005|Open-Label Phase|Adverse Event|0|||
150244254|NCT01016262|542031429|FG000|Open-Label Phase|Lost to Follow-up|0|||
150244255|NCT01016262|542031430|FG001|Open-Label Phase|Lost to Follow-up|0|||
150244256|NCT01016262|542031431|FG002|Open-Label Phase|Lost to Follow-up|0|||
150244257|NCT01016262|542031432|FG003|Open-Label Phase|Lost to Follow-up|0|||
150244258|NCT01016262|542031433|FG004|Open-Label Phase|Lost to Follow-up|1|||
150244259|NCT01016262|542031434|FG005|Open-Label Phase|Lost to Follow-up|0|||
150244260|NCT01016262|542031429|FG000|Open-Label Phase|Lack of Efficacy|0|||
150244261|NCT01016262|542031430|FG001|Open-Label Phase|Lack of Efficacy|0|||
150244262|NCT01016262|542031431|FG002|Open-Label Phase|Lack of Efficacy|0|||
150244263|NCT01016262|542031432|FG003|Open-Label Phase|Lack of Efficacy|1|||
150244264|NCT01016262|542031433|FG004|Open-Label Phase|Lack of Efficacy|0|||
150244265|NCT01016262|542031434|FG005|Open-Label Phase|Lack of Efficacy|0|||
150244266|NCT01016262|542031429|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
150244267|NCT01016262|542031430|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
150244268|NCT01016262|542031431|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
150244269|NCT01016262|542031432|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
150244270|NCT01016262|542031433|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
150244271|NCT01016262|542031434|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
150244272|NCT01730378|542031437|FG000|Overall Study|Lost to Follow-up|1|||
150244273|NCT01730378|542031438|FG001|Overall Study|Lost to Follow-up|0|||
150244274|NCT00659880|542031441|FG000|Overall Study|Lost to Follow-up|5|||
150244275|NCT01853475|542031442|FG000|Overall Study|Withdrawal by Subject|0|||
150244276|NCT01853475|542031443|FG001|Overall Study|Withdrawal by Subject|1|||
150244277|NCT01853475|542031444|FG002|Overall Study|Withdrawal by Subject|0|||
150244278|NCT03199469|542031445|FG000|Overall Study|Randomized, not treated|0|||
150244279|NCT03199469|542031446|FG001|Overall Study|Randomized, not treated|3|||
150244280|NCT03199469|542031445|FG000|Overall Study|Withdrawal by Subject|1|||
150244281|NCT03199469|542031446|FG001|Overall Study|Withdrawal by Subject|0|||
150244282|NCT03199469|542031445|FG000|Overall Study|Death|1|||
150244283|NCT03199469|542031446|FG001|Overall Study|Death|3|||
150244284|NCT03199469|542031445|FG000|Overall Study|Ongoing|5|||
150244285|NCT03199469|542031446|FG001|Overall Study|Ongoing|14|||
150244286|NCT01023958|542031449|FG000|Overall Study|Progressive disease|48|||
150244287|NCT01023958|542031449|FG000|Overall Study|Other adverse event|1|||
150244288|NCT01023958|542031449|FG000|Overall Study|Refused to continue medication|1|||
150244289|NCT02159040|542031450|FG000|Overall Study|Death|1|||
150244290|NCT01031628|542031454|FG000|Overall Study|Study terminated early|0|||
150244291|NCT01031628|542031455|FG001|Overall Study|Study terminated early|1|||
150244292|NCT01031628|542031456|FG002|Overall Study|Study terminated early|3|||
150244293|NCT01031628|542031457|FG003|Overall Study|Study terminated early|0|||
150244294|NCT01304498|542031458|FG000|Overall Study|Adverse Event|1|||
150244295|NCT01304498|542031459|FG001|Overall Study|Adverse Event|1|||
150244296|NCT01304498|542031458|FG000|Overall Study|Withdrawal by Subject|2|||
150244297|NCT01304498|542031459|FG001|Overall Study|Withdrawal by Subject|3|||
150244298|NCT01304498|542031458|FG000|Overall Study|Protocol Violation|1|||
150244299|NCT01304498|542031459|FG001|Overall Study|Protocol Violation|0|||
150244300|NCT01304498|542031458|FG000|Overall Study|Lost to Follow-up|2|||
150244301|NCT01304498|542031459|FG001|Overall Study|Lost to Follow-up|1|||
150244302|NCT03080493|542031460|FG000|Overall Study|Did not provide NRS pain results|1|||
150244303|NCT03080493|542031461|FG001|Overall Study|Did not provide NRS pain results|0|||
150244304|NCT03080493|542031460|FG000|Overall Study|Adverse Event|0|||
150244305|NCT03080493|542031461|FG001|Overall Study|Adverse Event|1|||
150244306|NCT03080493|542031460|FG000|Overall Study|Randomization error (parity group)|0|||
150244307|NCT03080493|542031461|FG001|Overall Study|Randomization error (parity group)|1|||
150244308|NCT00755417|542031463|FG000|Overall Study|Adverse Event|28|||
150244309|NCT00755417|542031464|FG001|Overall Study|Adverse Event|20|||
150244310|NCT00755417|542031465|FG002|Overall Study|Adverse Event|7|||
150244311|NCT00755417|542031463|FG000|Overall Study|Lack of Efficacy|8|||
150244312|NCT00755417|542031464|FG001|Overall Study|Lack of Efficacy|4|||
150244313|NCT00755417|542031465|FG002|Overall Study|Lack of Efficacy|9|||
150244314|NCT00755417|542031463|FG000|Overall Study|Protocol Violation|2|||
150244315|NCT00755417|542031464|FG001|Overall Study|Protocol Violation|1|||
150244316|NCT00755417|542031465|FG002|Overall Study|Protocol Violation|1|||
150244317|NCT00755417|542031463|FG000|Overall Study|Lost to Follow-up|3|||
150244318|NCT00755417|542031464|FG001|Overall Study|Lost to Follow-up|0|||
150244319|NCT00755417|542031465|FG002|Overall Study|Lost to Follow-up|1|||
150244320|NCT00755417|542031463|FG000|Overall Study|Withdrawal by Subject|12|||
150244321|NCT00755417|542031464|FG001|Overall Study|Withdrawal by Subject|12|||
150244322|NCT00755417|542031465|FG002|Overall Study|Withdrawal by Subject|12|||
150244323|NCT00755417|542031463|FG000|Overall Study|Not specified or missing data|9|||
150244324|NCT00755417|542031464|FG001|Overall Study|Not specified or missing data|18|||
150244325|NCT00755417|542031465|FG002|Overall Study|Not specified or missing data|12|||
150244326|NCT02803593|542031467|FG000|Overall Study|Lost to Follow-up|17|||
150244327|NCT02803593|542031468|FG001|Overall Study|Lost to Follow-up|35|||
150244328|NCT03004404|542031472|FG000|Period 2|Adverse Event|0|||
150244329|NCT03004404|542031473|FG001|Period 2|Adverse Event|0|||
150244330|NCT03004404|542031474|FG002|Period 2|Adverse Event|0|||
150244331|NCT03004404|542031475|FG003|Period 2|Adverse Event|0|||
150244332|NCT03004404|542031476|FG004|Period 2|Adverse Event|0|||
150244333|NCT03004404|542031477|FG005|Period 2|Adverse Event|0|||
150244334|NCT03004404|542031478|FG006|Period 2|Adverse Event|0|||
150244335|NCT03004404|542031479|FG007|Period 2|Adverse Event|0|||
150244336|NCT03004404|542031480|FG008|Period 2|Adverse Event|1|||
150244337|NCT03004404|542031481|FG009|Period 2|Adverse Event|0|||
150244338|NCT03004404|542031482|FG010|Period 2|Adverse Event|0|||
150244339|NCT03004404|542031483|FG011|Period 2|Adverse Event|0|||
150244340|NCT03004404|542031484|FG012|Period 2|Adverse Event|0|||
150244341|NCT03004404|542031485|FG013|Period 2|Adverse Event|0|||
150244342|NCT03004404|542031486|FG014|Period 2|Adverse Event|0|||
150244343|NCT03004404|542031487|FG015|Period 2|Adverse Event|1|||
150244344|NCT02522728|542031491|FG000|Overall Study|Withdrawal by Subject|6|||
150244345|NCT02522728|542031492|FG001|Overall Study|Withdrawal by Subject|6|||
150244346|NCT02522728|542031491|FG000|Overall Study|Death|4|||
150244347|NCT02522728|542031492|FG001|Overall Study|Death|3|||
150244348|NCT02522728|542031491|FG000|Overall Study|Adverse Event|2|||
150244349|NCT02522728|542031492|FG001|Overall Study|Adverse Event|1|||
150244350|NCT02522728|542031491|FG000|Overall Study|Did not receive randomized study device|0|||
150244351|NCT02522728|542031492|FG001|Overall Study|Did not receive randomized study device|1|||
150244352|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
150244353|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
150244354|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
150244355|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
150244356|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
150244357|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
150244358|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
150244359|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
150244360|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
150244361|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
150244362|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
150244363|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
150244364|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
150244365|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
150244366|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
150244367|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
150244368|NCT04210843|542031494|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
150244369|NCT04210843|542031495|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
150244370|NCT04210843|542031494|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
150244371|NCT04210843|542031495|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
150244372|NCT04210843|542031494|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
150244373|NCT04210843|542031495|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
150244374|NCT04210843|542031494|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
150244375|NCT04210843|542031495|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
150244376|NCT04210843|542031494|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
150244377|NCT04210843|542031495|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
150244378|NCT04210843|542031494|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
150244379|NCT04210843|542031495|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
150244380|NCT04210843|542031494|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
150244381|NCT04210843|542031495|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
150244382|NCT04210843|542031494|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
150244383|NCT04210843|542031495|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
150244384|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
150244385|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
150244386|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
150244387|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
150244388|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
150244389|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
150244390|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
150244391|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
150244392|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
150244393|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
150244394|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
150244395|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
150244396|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
150244397|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
150244398|NCT04210843|542031494|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
150244399|NCT04210843|542031495|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
150244400|NCT01099917|542031496|FG000|Overall Study|Adverse Event|3|||
150244401|NCT01099917|542031496|FG000|Overall Study|Not Treated|24|||
150244402|NCT01266161|542031497|FG000|Overall Study|Ineligible|1|||
150244403|NCT01266161|542031498|FG001|Overall Study|Ineligible|0|||
150244404|NCT01266161|542031497|FG000|Overall Study|Lack of Efficacy|0|||
150244405|NCT01266161|542031498|FG001|Overall Study|Lack of Efficacy|1|||
150244406|NCT01266161|542031497|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
150244407|NCT01266161|542031498|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
150244408|NCT02990468|542031499|FG000|Phase 2: MTD|Change in treatment|0|||
150244409|NCT02990468|542031500|FG001|Phase 2: MTD|Change in treatment|0|||
150244410|NCT02990468|542031501|FG002|Phase 2: MTD|Change in treatment|1|||
150244411|NCT03355209|542031505|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
150244412|NCT03355209|542031506|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
150244413|NCT03355209|542031507|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
150244414|NCT03355209|542031508|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
150244415|NCT03355209|542031509|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
150244416|NCT03355209|542031510|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
150244417|NCT03355209|542031505|FG000|Part 1: Double-Blind Period|Death|0|||
150244418|NCT03355209|542031506|FG001|Part 1: Double-Blind Period|Death|0|||
150244419|NCT03355209|542031507|FG002|Part 1: Double-Blind Period|Death|1|||
150244420|NCT03355209|542031508|FG003|Part 1: Double-Blind Period|Death|0|||
150244421|NCT03355209|542031509|FG004|Part 1: Double-Blind Period|Death|0|||
150244422|NCT03355209|542031510|FG005|Part 1: Double-Blind Period|Death|0|||
150244423|NCT03355209|542031505|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
150244424|NCT03355209|542031506|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
150244425|NCT03355209|542031507|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
150244426|NCT03355209|542031508|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
150244427|NCT03355209|542031509|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
150244428|NCT03355209|542031510|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
150244429|NCT03355209|542031505|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
150244430|NCT03355209|542031506|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
150244431|NCT03355209|542031507|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
150244432|NCT03355209|542031508|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150244433|NCT03355209|542031509|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150244434|NCT03355209|542031510|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
150244435|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
150244436|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
150244437|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
150244438|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
150244439|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
150244440|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
150244441|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
150244442|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
150244443|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
150244444|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
150244445|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
150244446|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
150244447|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
150244448|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
150244449|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
150244450|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
150244451|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
150244452|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
150244453|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
150244454|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
150244455|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
150244456|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
150244457|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
150244458|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
150244459|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
150244460|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
150244461|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
150244462|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150244463|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
150244464|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
150244465|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
150244466|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
150244467|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
150244468|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
150244469|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
150244470|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
150244471|NCT03355209|542031505|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
150244472|NCT03355209|542031506|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
150244473|NCT03355209|542031507|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
150244474|NCT03355209|542031508|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
150244475|NCT03355209|542031509|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
150244476|NCT03355209|542031510|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
150244477|NCT01081886|542031511|FG000|Overall Study|Study termination|11|||
150244478|NCT01081886|542031512|FG001|Overall Study|Study termination|13|||
150244479|NCT02567708|542031513|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
150244480|NCT02567708|542031514|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
150244481|NCT02567708|542031513|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
150244482|NCT02567708|542031514|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
150244483|NCT02567708|542031513|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
150244484|NCT02567708|542031514|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
150244485|NCT02567708|542031513|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
150244486|NCT02567708|542031514|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
150244487|NCT00706654|542031515|FG000|Conversion Phase|Lost to Follow-up|4|||
150244488|NCT00706654|542031516|FG001|Conversion Phase|Lost to Follow-up|0|||
150244489|NCT00706654|542031517|FG002|Conversion Phase|Lost to Follow-up|0|||
150244490|NCT00706654|542031518|FG003|Conversion Phase|Lost to Follow-up|0|||
150244491|NCT00706654|542031515|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
150244492|NCT00706654|542031516|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
150244493|NCT00706654|542031517|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
150244494|NCT00706654|542031518|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
150244495|NCT00706654|542031515|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
150244496|NCT00706654|542031516|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
150244497|NCT00706654|542031517|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
150244498|NCT00706654|542031518|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
150244499|NCT00706654|542031515|FG000|Conversion Phase|Withdrawn by Investigator|14|||
150244500|NCT00706654|542031516|FG001|Conversion Phase|Withdrawn by Investigator|0|||
150244501|NCT00706654|542031517|FG002|Conversion Phase|Withdrawn by Investigator|0|||
150244502|NCT00706654|542031518|FG003|Conversion Phase|Withdrawn by Investigator|0|||
150244503|NCT00706654|542031515|FG000|Conversion Phase|Withdrew Consent|38|||
150244504|NCT00706654|542031516|FG001|Conversion Phase|Withdrew Consent|0|||
150244505|NCT00706654|542031517|FG002|Conversion Phase|Withdrew Consent|0|||
150244506|NCT00706654|542031518|FG003|Conversion Phase|Withdrew Consent|0|||
150244507|NCT00706654|542031515|FG000|Conversion Phase|Adverse Event|18|||
150244508|NCT00706654|542031516|FG001|Conversion Phase|Adverse Event|0|||
150244509|NCT00706654|542031517|FG002|Conversion Phase|Adverse Event|0|||
150244510|NCT00706654|542031518|FG003|Conversion Phase|Adverse Event|0|||
150244511|NCT00706654|542031515|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
150244512|NCT00706654|542031516|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
150244513|NCT00706654|542031517|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
150244514|NCT00706654|542031518|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
150244515|NCT00706654|542031515|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
150244516|NCT00706654|542031516|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
150244517|NCT00706654|542031517|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
150244518|NCT00706654|542031518|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
150244519|NCT00706654|542031515|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
150244520|NCT00706654|542031516|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
150244521|NCT00706654|542031517|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
150244522|NCT00706654|542031518|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
150244523|NCT00706654|542031515|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
150244524|NCT00706654|542031516|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
150244525|NCT00706654|542031517|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
150244526|NCT00706654|542031518|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
150244527|NCT00706654|542031515|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
150244528|NCT00706654|542031516|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
150244529|NCT00706654|542031517|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
150244530|NCT00706654|542031518|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
150244531|NCT00706654|542031515|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
150244532|NCT00706654|542031516|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
150244533|NCT00706654|542031517|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
150244534|NCT00706654|542031518|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
150244535|NCT00706654|542031515|FG000|Oral Stabilization Phase|Withdrew consent|55|||
150244536|NCT00706654|542031516|FG001|Oral Stabilization Phase|Withdrew consent|0|||
150244537|NCT00706654|542031517|FG002|Oral Stabilization Phase|Withdrew consent|0|||
150244538|NCT00706654|542031518|FG003|Oral Stabilization Phase|Withdrew consent|0|||
150244539|NCT00706654|542031515|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
150244540|NCT00706654|542031516|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
150244541|NCT00706654|542031517|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
150244542|NCT00706654|542031518|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
150244543|NCT00706654|542031515|FG000|Oral Stabilization Phase|Adverse Event|21|||
150244544|NCT00706654|542031516|FG001|Oral Stabilization Phase|Adverse Event|0|||
150244545|NCT00706654|542031517|FG002|Oral Stabilization Phase|Adverse Event|0|||
150244546|NCT00706654|542031518|FG003|Oral Stabilization Phase|Adverse Event|0|||
150244547|NCT00706654|542031515|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
150244548|NCT00706654|542031516|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150244549|NCT00706654|542031517|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150244550|NCT00706654|542031518|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
150244551|NCT00706654|542031515|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
150244552|NCT00706654|542031516|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150244553|NCT00706654|542031517|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150244554|NCT00706654|542031518|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
150244555|NCT00706654|542031515|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
150244556|NCT00706654|542031516|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
150244557|NCT00706654|542031517|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
150244558|NCT00706654|542031518|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
150244559|NCT00706654|542031515|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
150244560|NCT00706654|542031516|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
150244561|NCT00706654|542031517|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
150244562|NCT00706654|542031518|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
150244563|NCT00706654|542031515|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
150244564|NCT00706654|542031516|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
150244565|NCT00706654|542031517|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
150244566|NCT00706654|542031518|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
150244567|NCT00706654|542031515|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
150244568|NCT00706654|542031516|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
150244569|NCT00706654|542031517|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
150244570|NCT00706654|542031518|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
150244571|NCT00706654|542031515|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
150244572|NCT00706654|542031516|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
150244573|NCT00706654|542031517|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
150244574|NCT00706654|542031518|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
150244575|NCT00706654|542031515|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
150244576|NCT00706654|542031516|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
150244577|NCT00706654|542031517|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
150244578|NCT00706654|542031518|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
150244579|NCT00706654|542031515|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
150244580|NCT00706654|542031516|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
150244581|NCT00706654|542031517|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
150244582|NCT00706654|542031518|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
150244583|NCT00706654|542031515|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
150244584|NCT00706654|542031516|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
150244585|NCT00706654|542031517|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
150244586|NCT00706654|542031518|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
150244587|NCT01151215|542031519|FG000|Overall Study|Worsening of condition under study|1|||
150244588|NCT01151215|542031520|FG001|Overall Study|Worsening of condition under study|1|||
150244589|NCT01151215|542031521|FG002|Overall Study|Worsening of condition under study|1|||
150244590|NCT01151215|542031519|FG000|Overall Study|Death|16|||
150244591|NCT01151215|542031520|FG001|Overall Study|Death|20|||
150244592|NCT01151215|542031521|FG002|Overall Study|Death|11|||
150244593|NCT01151215|542031519|FG000|Overall Study|Lost to Follow-up|0|||
150244594|NCT01151215|542031520|FG001|Overall Study|Lost to Follow-up|0|||
150244595|NCT01151215|542031521|FG002|Overall Study|Lost to Follow-up|3|||
150244596|NCT01151215|542031519|FG000|Overall Study|Withdrawal by Subject|3|||
150244597|NCT01151215|542031520|FG001|Overall Study|Withdrawal by Subject|1|||
150244598|NCT01151215|542031521|FG002|Overall Study|Withdrawal by Subject|2|||
150244599|NCT01151215|542031519|FG000|Overall Study|Disease progression|0|||
150244600|NCT01151215|542031520|FG001|Overall Study|Disease progression|1|||
150244601|NCT01151215|542031521|FG002|Overall Study|Disease progression|1|||
150244602|NCT01151215|542031519|FG000|Overall Study|Safety as judged by the investigator|0|||
150244603|NCT01151215|542031520|FG001|Overall Study|Safety as judged by the investigator|0|||
150244604|NCT01151215|542031521|FG002|Overall Study|Safety as judged by the investigator|1|||
150244605|NCT01154140|542031525|FG000|Overall Study|Death|71|||
150244606|NCT01154140|542031526|FG001|Overall Study|Death|81|||
150244607|NCT01154140|542031525|FG000|Overall Study|Lost to Follow-up|4|||
150244608|NCT01154140|542031526|FG001|Overall Study|Lost to Follow-up|5|||
150244609|NCT01154140|542031525|FG000|Overall Study|Withdrawal by Subject|12|||
150244610|NCT01154140|542031526|FG001|Overall Study|Withdrawal by Subject|13|||
150244611|NCT01154140|542031525|FG000|Overall Study|Other|3|||
150244612|NCT01154140|542031526|FG001|Overall Study|Other|1|||
150244613|NCT01154140|542031525|FG000|Overall Study|Randomized but not treated|1|||
150244614|NCT01154140|542031526|FG001|Overall Study|Randomized but not treated|2|||
150244615|NCT04276051|542031531|FG000|Overall Study|Lost to Follow-up|0|||
150244616|NCT04276051|542031532|FG001|Overall Study|Lost to Follow-up|1|||
150244617|NCT04276051|542031531|FG000|Overall Study|Physician Decision|0|||
150244618|NCT04276051|542031532|FG001|Overall Study|Physician Decision|1|||
150244619|NCT04276051|542031531|FG000|Overall Study|Withdrawal by Subject|1|||
150244620|NCT04276051|542031532|FG001|Overall Study|Withdrawal by Subject|1|||
150244621|NCT01374568|542031533|FG000|Overall Study|Lab unable to analyze BTM|0|||
150244622|NCT01374568|542031534|FG001|Overall Study|Lab unable to analyze BTM|2|||
150244623|NCT01912404|542031535|FG000|Overall Study|Due to personal reasons|1|||
150244624|NCT01912404|542031536|FG001|Overall Study|Due to personal reasons|0|||
150244625|NCT02269423|542031537|FG000|Overall Study|Discontinued due to change in residence|0|||
150244626|NCT02269423|542031538|FG001|Overall Study|Discontinued due to change in residence|1|||
150244627|NCT02269423|542031539|FG002|Overall Study|Discontinued due to change in residence|0|||
150244628|NCT02269423|542031540|FG003|Overall Study|Discontinued due to change in residence|1|||
150244629|NCT00617929|542031543|FG000|Overall Study|Physician Decision|1|||
150244630|NCT03229486|542031544|FG000|Overall Study|Protocol Violation|0|||
150244631|NCT03229486|542031545|FG001|Overall Study|Protocol Violation|1|||
150244632|NCT00856245|542031549|FG000|Overall Study|Was not transplanted|5|||
150244633|NCT00760747|542031556|FG000|Study Period II|Adverse Event|3|||
150244634|NCT00760747|542031557|FG001|Study Period II|Adverse Event|4|||
150244635|NCT00760747|542031556|FG000|Study Period II|Lack of Efficacy|0|||
150244636|NCT00760747|542031557|FG001|Study Period II|Lack of Efficacy|6|||
150244637|NCT00760747|542031556|FG000|Study Period II|Parent/Caregiver Decision|3|||
150244638|NCT00760747|542031557|FG001|Study Period II|Parent/Caregiver Decision|0|||
150244639|NCT00760747|542031556|FG000|Study Period II|Protocol Violation|6|||
150244640|NCT00760747|542031557|FG001|Study Period II|Protocol Violation|3|||
150244641|NCT00760747|542031556|FG000|Study Period II|Withdrawal by Subject|1|||
150244642|NCT00760747|542031557|FG001|Study Period II|Withdrawal by Subject|0|||
150244643|NCT00760747|542031556|FG000|Study Period II|No drug administered|0|||
150244644|NCT00760747|542031557|FG001|Study Period II|No drug administered|1|||
150244645|NCT00760747|542031556|FG000|Study Period III|Adverse Event|1|||
150244646|NCT00760747|542031557|FG001|Study Period III|Adverse Event|0|||
150244647|NCT00760747|542031556|FG000|Study Period III|Lack of Efficacy|1|||
150244648|NCT00760747|542031557|FG001|Study Period III|Lack of Efficacy|0|||
150244649|NCT00760747|542031556|FG000|Study Period III|Parent/Caregiver Decision|0|||
150244650|NCT00760747|542031557|FG001|Study Period III|Parent/Caregiver Decision|1|||
150244651|NCT00760747|542031556|FG000|Study Period III|Protocol Violation|1|||
150244652|NCT00760747|542031557|FG001|Study Period III|Protocol Violation|1|||
150244653|NCT00760747|542031556|FG000|Study Period III|Physician Decision|0|||
150244654|NCT00760747|542031557|FG001|Study Period III|Physician Decision|1|||
150244655|NCT01443923|542031558|FG000|Overall Study|Adverse Event|1|||
150244656|NCT01443923|542031559|FG001|Overall Study|Adverse Event|0|||
150244657|NCT00844597|542031562|FG000|Overall Study|Adverse Event|0|||
150244658|NCT00844597|542031563|FG001|Overall Study|Adverse Event|0|||
150244659|NCT00844597|542031564|FG002|Overall Study|Adverse Event|0|||
150244660|NCT00844597|542031565|FG003|Overall Study|Adverse Event|1|||
150244661|NCT00844597|542031566|FG004|Overall Study|Adverse Event|0|||
150244662|NCT00844597|542031567|FG005|Overall Study|Adverse Event|0|||
150244663|NCT04160988|542031568|FG000|Overall Study|poor image quality|28|||
150244664|NCT01250509|542031569|FG000|Overall Study|Lost to Follow-up|5|||
150244665|NCT01250509|542031570|FG001|Overall Study|Lost to Follow-up|2|||
150244666|NCT01228175|542031571|FG000|Overall Study|Lost to Follow-up|64|||
150244667|NCT01228175|542031572|FG001|Overall Study|Lost to Follow-up|50|||
150244668|NCT01228175|542031571|FG000|Overall Study|Withdrawal by Subject|1|||
150244669|NCT01228175|542031572|FG001|Overall Study|Withdrawal by Subject|2|||
150244670|NCT01228175|542031571|FG000|Overall Study|Physician Decision|1|||
150244671|NCT01228175|542031572|FG001|Overall Study|Physician Decision|1|||
150244672|NCT00243074|542031574|FG000|Overall Study|Ineligible|6|||
150244673|NCT00243074|542031574|FG000|Overall Study|Adverse Event|6|||
150244674|NCT00243074|542031574|FG000|Overall Study|Withdrawal by Subject|2|||
150244675|NCT00243074|542031574|FG000|Overall Study|Lack of Efficacy|36|||
150244676|NCT00243074|542031574|FG000|Overall Study|Death|2|||
150244677|NCT00243074|542031574|FG000|Overall Study|not protocol specified|1|||
150244678|NCT00243074|542031574|FG000|Overall Study|Did not receive any treatment|1|||
150244679|NCT03939689|542033298|FG000|Overall Study|Radiographic progression|14|||
150244680|NCT03939689|542033299|FG001|Overall Study|Radiographic progression|17|||
150244681|NCT03939689|542033298|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
150244682|NCT03939689|542033299|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
150244683|NCT03939689|542033298|FG000|Overall Study|Adverse Event|1|||
150244684|NCT03939689|542033299|FG001|Overall Study|Adverse Event|8|||
150244685|NCT03939689|542033298|FG000|Overall Study|Unequivocal clinical progression|2|||
150244686|NCT03939689|542033299|FG001|Overall Study|Unequivocal clinical progression|5|||
150244687|NCT03939689|542033298|FG000|Overall Study|Other|1|||
150244688|NCT03939689|542033299|FG001|Overall Study|Other|4|||
150244689|NCT03939689|542033298|FG000|Overall Study|Death|0|||
150244690|NCT03939689|542033299|FG001|Overall Study|Death|3|||
150244691|NCT03939689|542033298|FG000|Overall Study|Participant decision|0|||
150244692|NCT03939689|542033299|FG001|Overall Study|Participant decision|3|||
150244693|NCT03939689|542033298|FG000|Overall Study|Withdrawal of consent|2|||
150244694|NCT03939689|542033299|FG001|Overall Study|Withdrawal of consent|1|||
150244695|NCT03939689|542033298|FG000|Overall Study|Investigator decision|1|||
150244696|NCT03939689|542033299|FG001|Overall Study|Investigator decision|0|||
150244697|NCT04427280|542033300|FG000|Overall Study|Withdrawal by Subject|0|||
150244698|NCT04427280|542033301|FG001|Overall Study|Withdrawal by Subject|2|||
150244699|NCT02412735|542033312|FG000|Overall Study|Adverse Event|0|||
150244700|NCT02412735|542033313|FG001|Overall Study|Adverse Event|1|||
150244701|NCT02412735|542033314|FG002|Overall Study|Adverse Event|2|||
150244702|NCT02412735|542033312|FG000|Overall Study|Withdrawal by Subject|23|||
150244703|NCT02412735|542033313|FG001|Overall Study|Withdrawal by Subject|27|||
150244704|NCT02412735|542033314|FG002|Overall Study|Withdrawal by Subject|22|||
150244705|NCT02412735|542033312|FG000|Overall Study|Investigator Decision|3|||
150244706|NCT02412735|542033313|FG001|Overall Study|Investigator Decision|3|||
150244707|NCT02412735|542033314|FG002|Overall Study|Investigator Decision|2|||
150244708|NCT02412735|542033312|FG000|Overall Study|Lost to Follow-up|17|||
150244709|NCT02412735|542033313|FG001|Overall Study|Lost to Follow-up|11|||
150244710|NCT02412735|542033314|FG002|Overall Study|Lost to Follow-up|18|||
150244711|NCT02412735|542033312|FG000|Overall Study|Reason not Specified|3|||
150244712|NCT02412735|542033313|FG001|Overall Study|Reason not Specified|2|||
150244713|NCT02412735|542033314|FG002|Overall Study|Reason not Specified|2|||
150244714|NCT01228318|542033315|FG000|Overall Study|Clinic no show to receive intervention|1|||
150244715|NCT01228318|542033316|FG001|Overall Study|Clinic no show to receive intervention|0|||
150244716|NCT01228318|542033315|FG000|Overall Study|Unable to contact|2|||
150244717|NCT01228318|542033316|FG001|Overall Study|Unable to contact|5|||
150244718|NCT01228318|542033315|FG000|Overall Study|Moved|0|||
150244719|NCT01228318|542033316|FG001|Overall Study|Moved|2|||
150244720|NCT01228318|542033315|FG000|Overall Study|Incarcerated|1|||
150244721|NCT01228318|542033316|FG001|Overall Study|Incarcerated|0|||
150244722|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
150244723|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
150244724|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
150244725|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
150244726|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
150244727|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
150244728|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
150244729|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
150244730|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
150244731|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
150244732|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
150244733|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
150244734|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
150244735|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
150244736|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
150244737|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
150244738|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
150244739|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
150244740|NCT00603525|542033321|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
150244741|NCT00603525|542033322|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
150244742|NCT00603525|542033323|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
150244743|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
150244744|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
150244745|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
150244746|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
150244747|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
150244748|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
150244749|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
150244750|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
150244751|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
150244752|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
150244753|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
150244754|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
150244755|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
150244756|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
150244757|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
150244758|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
150244759|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
150244760|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
150244761|NCT00603525|542033321|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
150244762|NCT00603525|542033322|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
150244763|NCT00603525|542033323|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
150244764|NCT00603525|542033321|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
150244765|NCT00603525|542033322|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
150244766|NCT00603525|542033323|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
150244767|NCT00770029|542033324|FG000|Overall Study|Lost to Follow-up|2|||
150244768|NCT00770029|542033325|FG001|Overall Study|Lost to Follow-up|0|||
150244769|NCT00770029|542033324|FG000|Overall Study|Withdrawal by Subject|3|||
150244770|NCT00770029|542033325|FG001|Overall Study|Withdrawal by Subject|3|||
150244771|NCT00770029|542033324|FG000|Overall Study|Adverse Event|1|||
150244772|NCT00770029|542033325|FG001|Overall Study|Adverse Event|0|||
150244773|NCT02124811|542033326|FG000|Overall Study|Early termination|2|||
150244774|NCT02124811|542033327|FG001|Overall Study|Early termination|2|||
150244775|NCT02124811|542033326|FG000|Overall Study|Withdrawal by Subject|1|||
150244776|NCT02124811|542033327|FG001|Overall Study|Withdrawal by Subject|0|||
150244777|NCT04043143|542033328|FG000|Overall Study|Lost to Follow-up|5|||
150244778|NCT04043143|542033329|FG001|Overall Study|Lost to Follow-up|5|||
150244779|NCT04043143|542033328|FG000|Overall Study|screen failure|1|||
150244780|NCT04043143|542033329|FG001|Overall Study|screen failure|0|||
150244781|NCT03480932|542033330|FG000|Overall Study|Death|1|||
150244782|NCT03480932|542033331|FG001|Overall Study|Death|1|||
150244783|NCT03480932|542033332|FG002|Overall Study|Death|0|||
150244784|NCT03480932|542033330|FG000|Overall Study|Lost to Follow-up|0|||
150244785|NCT03480932|542033331|FG001|Overall Study|Lost to Follow-up|2|||
150244786|NCT03480932|542033332|FG002|Overall Study|Lost to Follow-up|3|||
150244787|NCT03480932|542033330|FG000|Overall Study|Incarcerated|2|||
150244788|NCT03480932|542033331|FG001|Overall Study|Incarcerated|2|||
150244789|NCT03480932|542033332|FG002|Overall Study|Incarcerated|2|||
150244790|NCT04624243|542033336|FG000|Overall Study|Death|0|||
150244791|NCT04624243|542033337|FG001|Overall Study|Death|1|||
150244792|NCT04624243|542033338|FG002|Overall Study|Death|0|||
150244793|NCT04624243|542033339|FG003|Overall Study|Death|0|||
150244794|NCT04624243|542033340|FG004|Overall Study|Death|0|||
150244795|NCT04624243|542033336|FG000|Overall Study|Lost to Follow-up|2|||
150244796|NCT04624243|542033337|FG001|Overall Study|Lost to Follow-up|3|||
150244797|NCT04624243|542033338|FG002|Overall Study|Lost to Follow-up|7|||
150244798|NCT04624243|542033339|FG003|Overall Study|Lost to Follow-up|1|||
150244799|NCT04624243|542033340|FG004|Overall Study|Lost to Follow-up|3|||
150244800|NCT04624243|542033336|FG000|Overall Study|Physician Decision|3|||
150244801|NCT04624243|542033337|FG001|Overall Study|Physician Decision|8|||
150244802|NCT04624243|542033338|FG002|Overall Study|Physician Decision|15|||
150244803|NCT04624243|542033339|FG003|Overall Study|Physician Decision|2|||
150244804|NCT04624243|542033340|FG004|Overall Study|Physician Decision|11|||
150244805|NCT04624243|542033336|FG000|Overall Study|Withdrawal by Subject|19|||
150244806|NCT04624243|542033337|FG001|Overall Study|Withdrawal by Subject|44|||
150244807|NCT04624243|542033338|FG002|Overall Study|Withdrawal by Subject|40|||
150244808|NCT04624243|542033339|FG003|Overall Study|Withdrawal by Subject|21|||
150244809|NCT04624243|542033340|FG004|Overall Study|Withdrawal by Subject|39|||
150244810|NCT04624243|542033336|FG000|Overall Study|Miscellaneous|3|||
150244811|NCT04624243|542033337|FG001|Overall Study|Miscellaneous|12|||
150244812|NCT04624243|542033338|FG002|Overall Study|Miscellaneous|9|||
150244813|NCT04624243|542033339|FG003|Overall Study|Miscellaneous|4|||
150244814|NCT04624243|542033340|FG004|Overall Study|Miscellaneous|6|||
150244815|NCT03322540|542033343|FG000|Overall Study|Death|21|||
150244816|NCT03322540|542033344|FG001|Overall Study|Death|28|||
150244817|NCT03322540|542033343|FG000|Overall Study|Lost to Follow-up|0|||
150244818|NCT03322540|542033344|FG001|Overall Study|Lost to Follow-up|1|||
150244819|NCT03322540|542033343|FG000|Overall Study|Physician Decision|7|||
150244820|NCT03322540|542033344|FG001|Overall Study|Physician Decision|6|||
150244821|NCT03322540|542033343|FG000|Overall Study|Withdrawal by Subject|3|||
150244822|NCT03322540|542033344|FG001|Overall Study|Withdrawal by Subject|1|||
150244823|NCT03322540|542033343|FG000|Overall Study|Study terminated by sponsor|0|||
150244824|NCT03322540|542033344|FG001|Overall Study|Study terminated by sponsor|1|||
150244825|NCT01294397|542033349|FG000|Overall Study|Withdrawal by Subject|1|||
150244826|NCT01294397|542033349|FG000|Overall Study|Administrative Decision|1|||
150244827|NCT01661205|542033350|FG000|Overall Study|Physician Decision|2|||
150244828|NCT00426127|542033351|FG000|Overall Study|Adverse Event|1|||
150244829|NCT00426127|542033351|FG000|Overall Study|Removed due to disease progression|1|||
150244830|NCT03111095|542033355|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
150244831|NCT03111095|542033356|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
150244832|NCT03111095|542033355|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
150244833|NCT03111095|542033356|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
150244834|NCT00955708|542033362|FG000|Overall Study|Death|269|||
150244835|NCT00955708|542033362|FG000|Overall Study|Lost to Follow-up|72|||
150244836|NCT00955708|542033362|FG000|Overall Study|Physician Decision|36|||
150244837|NCT00955708|542033362|FG000|Overall Study|Protocol Violation|134|||
150244838|NCT00955708|542033362|FG000|Overall Study|Registry Conclusion|186|||
150244839|NCT00955708|542033362|FG000|Overall Study|Product removed from service|94|||
150244840|NCT00955708|542033362|FG000|Overall Study|Patient Refused to participate further|116|||
150244841|NCT00955708|542033362|FG000|Overall Study|Closure of study location|60|||
150244842|NCT00955708|542033362|FG000|Overall Study|Patient changed care provider/moved|91|||
150244843|NCT03738475|542033363|FG000|Overall Study|Participant Non-Compliance|1|||
150244844|NCT03738475|542033364|FG001|Overall Study|Participant Non-Compliance|0|||
150244845|NCT00737477|542033365|FG000|Overall Study|Adverse Event|9|||
150244846|NCT00737477|542033365|FG000|Overall Study|Death|9|||
150244847|NCT00737477|542033365|FG000|Overall Study|Treatment Refusal|1|||
150244848|NCT00737477|542033365|FG000|Overall Study|Withdrawal by Subject|1|||
150244849|NCT00737477|542033365|FG000|Overall Study|Renal Transplantation|10|||
150244850|NCT00737477|542033365|FG000|Overall Study|Other|4|||
150244851|NCT01132820|542033366|FG000|Overall Study|Ineligible: wrong cell type|1|||
150244852|NCT01132820|542033366|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
150244853|NCT01132820|542033366|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
150244854|NCT01132820|542033366|FG000|Overall Study|Never treated|1|||
150244855|NCT01132820|542033366|FG000|Overall Study|Inadequate data|1|||
150244856|NCT01370655|542033367|FG000|Period 1|Adverse Event|2|||
150244857|NCT01370655|542033368|FG001|Period 1|Adverse Event|0|||
150244858|NCT01370655|542033369|FG002|Period 1|Adverse Event|0|||
150244859|NCT01370655|542033370|FG003|Period 1|Adverse Event|0|||
150244860|NCT01370655|542033371|FG004|Period 1|Adverse Event|0|||
150244861|NCT01370655|542033372|FG005|Period 1|Adverse Event|0|||
150244862|NCT01370655|542033373|FG006|Period 1|Adverse Event|1|||
150244863|NCT01370655|542033374|FG007|Period 1|Adverse Event|0|||
150244864|NCT01370655|542033375|FG008|Period 1|Adverse Event|0|||
150244865|NCT01370655|542033376|FG009|Period 1|Adverse Event|0|||
150244866|NCT01370655|542033377|FG010|Period 1|Adverse Event|0|||
150244867|NCT01370655|542033378|FG011|Period 1|Adverse Event|0|||
150244868|NCT01370655|542033367|FG000|Period 2|Adverse Event|0|||
150244869|NCT01370655|542033368|FG001|Period 2|Adverse Event|0|||
150244870|NCT01370655|542033369|FG002|Period 2|Adverse Event|1|||
150244871|NCT01370655|542033370|FG003|Period 2|Adverse Event|0|||
150244872|NCT01370655|542033371|FG004|Period 2|Adverse Event|1|||
150244873|NCT01370655|542033372|FG005|Period 2|Adverse Event|0|||
150244874|NCT01370655|542033373|FG006|Period 2|Adverse Event|0|||
150244875|NCT01370655|542033374|FG007|Period 2|Adverse Event|1|||
150244876|NCT01370655|542033375|FG008|Period 2|Adverse Event|0|||
150244877|NCT01370655|542033376|FG009|Period 2|Adverse Event|0|||
150244878|NCT01370655|542033377|FG010|Period 2|Adverse Event|0|||
150244879|NCT01370655|542033378|FG011|Period 2|Adverse Event|0|||
150244880|NCT01370655|542033367|FG000|Period 2|met protocol specified stopping criteria|0|||
150244881|NCT01370655|542033368|FG001|Period 2|met protocol specified stopping criteria|0|||
150244882|NCT01370655|542033369|FG002|Period 2|met protocol specified stopping criteria|1|||
150244883|NCT01370655|542033370|FG003|Period 2|met protocol specified stopping criteria|0|||
150244884|NCT01370655|542033371|FG004|Period 2|met protocol specified stopping criteria|0|||
150244885|NCT01370655|542033372|FG005|Period 2|met protocol specified stopping criteria|0|||
150244886|NCT01370655|542033373|FG006|Period 2|met protocol specified stopping criteria|1|||
150244887|NCT01370655|542033374|FG007|Period 2|met protocol specified stopping criteria|0|||
150244888|NCT01370655|542033375|FG008|Period 2|met protocol specified stopping criteria|1|||
150244889|NCT01370655|542033376|FG009|Period 2|met protocol specified stopping criteria|0|||
150244890|NCT01370655|542033377|FG010|Period 2|met protocol specified stopping criteria|1|||
150244891|NCT01370655|542033378|FG011|Period 2|met protocol specified stopping criteria|0|||
150244892|NCT01370655|542033367|FG000|Period 2|Withdrawal by Subject|0|||
150244893|NCT01370655|542033368|FG001|Period 2|Withdrawal by Subject|0|||
150244894|NCT01370655|542033369|FG002|Period 2|Withdrawal by Subject|0|||
150244895|NCT01370655|542033370|FG003|Period 2|Withdrawal by Subject|0|||
150244896|NCT01370655|542033371|FG004|Period 2|Withdrawal by Subject|0|||
150244897|NCT01370655|542033372|FG005|Period 2|Withdrawal by Subject|0|||
150244898|NCT01370655|542033373|FG006|Period 2|Withdrawal by Subject|0|||
150244899|NCT01370655|542033374|FG007|Period 2|Withdrawal by Subject|0|||
150244900|NCT01370655|542033375|FG008|Period 2|Withdrawal by Subject|1|||
150244901|NCT01370655|542033376|FG009|Period 2|Withdrawal by Subject|0|||
150244902|NCT01370655|542033377|FG010|Period 2|Withdrawal by Subject|0|||
150244903|NCT01370655|542033378|FG011|Period 2|Withdrawal by Subject|0|||
150244904|NCT01735175|542033381|FG000|Overall Study|Withdrawal by Subject|9|||
150244905|NCT01735175|542033382|FG001|Overall Study|Withdrawal by Subject|2|||
150244906|NCT01735175|542033381|FG000|Overall Study|Lost to Follow-up|4|||
150244907|NCT01735175|542033382|FG001|Overall Study|Lost to Follow-up|2|||
150244908|NCT01735175|542033381|FG000|Overall Study|Death|3|||
150244909|NCT01735175|542033382|FG001|Overall Study|Death|2|||
150244910|NCT01735175|542033381|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
150244911|NCT01735175|542033382|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
150244912|NCT01485120|542033385|FG000|Overall Study|Withdrawal by Subject|2|||
150244913|NCT00422734|542033386|FG000|Overall Study|Physician Decision|1|||
150244914|NCT00422734|542033387|FG001|Overall Study|Physician Decision|1|||
150244915|NCT00422734|542033386|FG000|Overall Study|Protocol Violation|1|||
150244916|NCT00422734|542033387|FG001|Overall Study|Protocol Violation|6|||
150244917|NCT00422734|542033386|FG000|Overall Study|Withdrawal by Subject|12|||
150244918|NCT00422734|542033387|FG001|Overall Study|Withdrawal by Subject|8|||
150244919|NCT00422734|542033386|FG000|Overall Study|Adverse Event|0|||
150244920|NCT00422734|542033387|FG001|Overall Study|Adverse Event|3|||
150244921|NCT00422734|542033386|FG000|Overall Study|Partner Decision|0|||
150244922|NCT00422734|542033387|FG001|Overall Study|Partner Decision|3|||
150244923|NCT02344342|542033388|FG000|Overall Study|Industry partner dropped out|11|||
150244924|NCT02344342|542033389|FG001|Overall Study|Industry partner dropped out|9|||
150244925|NCT02344342|542033390|FG002|Overall Study|Industry partner dropped out|14|||
150244926|NCT02344342|542033391|FG003|Overall Study|Industry partner dropped out|10|||
150244927|NCT00848484|542033392|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
150244928|NCT00848484|542033393|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
150244929|NCT00848484|542033392|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
150244930|NCT00848484|542033393|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
150244931|NCT00848484|542033392|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
150244932|NCT00848484|542033393|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
150244933|NCT00848484|542033392|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
150244934|NCT00848484|542033393|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
150244935|NCT00848484|542033392|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
150244936|NCT00848484|542033393|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
150244937|NCT02670122|542033397|FG000|Overall Study|Lost to Follow-up|4|||
150244938|NCT02762903|542033403|FG000|Overall Study|Lost to Follow-up|0|||
150244939|NCT02762903|542033404|FG001|Overall Study|Lost to Follow-up|1|||
150244940|NCT01889069|542033405|FG000|Overall Study|Death|18|||
150244941|NCT01889069|542033405|FG000|Overall Study|Progression of Disease|14|||
150244942|NCT01889069|542033405|FG000|Overall Study|Lost to Follow-up|6|||
150244943|NCT01889069|542033405|FG000|Overall Study|Other|4|||
150244944|NCT01889069|542033405|FG000|Overall Study|Consent Withdrawal|3|||
150244945|NCT00108745|542033406|FG000|Overall Study|Withdrawal by Subject|19|||
150244946|NCT00108745|542033407|FG001|Overall Study|Withdrawal by Subject|12|||
150244947|NCT00108745|542033408|FG002|Overall Study|Withdrawal by Subject|12|||
150244948|NCT00108745|542033406|FG000|Overall Study|Never Treated|8|||
150244949|NCT00108745|542033407|FG001|Overall Study|Never Treated|10|||
150244950|NCT00108745|542033408|FG002|Overall Study|Never Treated|12|||
150244951|NCT00108745|542033406|FG000|Overall Study|Ineligible|7|||
150244952|NCT00108745|542033407|FG001|Overall Study|Ineligible|13|||
150244953|NCT00108745|542033408|FG002|Overall Study|Ineligible|13|||
150244954|NCT01426347|542033413|FG000|Overall Study|Lost to Follow-up|0|||
150244955|NCT01426347|542033414|FG001|Overall Study|Lost to Follow-up|3|||
150244956|NCT01426347|542033413|FG000|Overall Study|Protocol Violation|2|||
150244957|NCT01426347|542033414|FG001|Overall Study|Protocol Violation|0|||
150244958|NCT01426347|542033413|FG000|Overall Study|Withdrawal by Subject|5|||
150244959|NCT01426347|542033414|FG001|Overall Study|Withdrawal by Subject|0|||
150244960|NCT00664534|542033415|FG000|Overall Study|Adverse Event|2|||
150244961|NCT00664534|542033416|FG001|Overall Study|Adverse Event|3|||
150244962|NCT00664534|542033415|FG000|Overall Study|Lost to Follow-up|6|||
150244963|NCT00664534|542033416|FG001|Overall Study|Lost to Follow-up|10|||
150244964|NCT00664534|542033415|FG000|Overall Study|Protocol Violation|10|||
150244965|NCT00664534|542033416|FG001|Overall Study|Protocol Violation|8|||
150244966|NCT00664534|542033415|FG000|Overall Study|Withdrawal by Subject|7|||
150244967|NCT00664534|542033416|FG001|Overall Study|Withdrawal by Subject|6|||
150244968|NCT00664534|542033415|FG000|Overall Study|Physician Decision|8|||
150244969|NCT00664534|542033416|FG001|Overall Study|Physician Decision|0|||
150244970|NCT00664534|542033415|FG000|Overall Study|Sponsor decision|8|||
150244971|NCT00664534|542033416|FG001|Overall Study|Sponsor decision|6|||
150244972|NCT03041792|542033417|FG000|Overall Study|Adverse Event|4|||
150244973|NCT03041792|542033418|FG001|Overall Study|Adverse Event|0|||
150244974|NCT03041792|542033417|FG000|Overall Study|Death in the family|0|||
150244975|NCT03041792|542033418|FG001|Overall Study|Death in the family|2|||
150244976|NCT03041792|542033417|FG000|Overall Study|Randomized but not treated|0|||
150244977|NCT03041792|542033418|FG001|Overall Study|Randomized but not treated|1|||
150244978|NCT00402051|542033425|FG000|Overall Study|Progressive Disease|13|||
150244979|NCT00402051|542033426|FG001|Overall Study|Progressive Disease|20|||
150244980|NCT00402051|542033425|FG000|Overall Study|Adverse Event|11|||
150244981|NCT00402051|542033426|FG001|Overall Study|Adverse Event|4|||
150244982|NCT00402051|542033425|FG000|Overall Study|Physician Decision|7|||
150244983|NCT00402051|542033426|FG001|Overall Study|Physician Decision|3|||
150244984|NCT00402051|542033425|FG000|Overall Study|Withdrawal by Subject|3|||
150244985|NCT00402051|542033426|FG001|Overall Study|Withdrawal by Subject|3|||
150244986|NCT00402051|542033425|FG000|Overall Study|Death - Related to Study Drug|1|||
150244987|NCT00402051|542033426|FG001|Overall Study|Death - Related to Study Drug|2|||
150244988|NCT00402051|542033425|FG000|Overall Study|Death Due to Study Disease|2|||
150244989|NCT00402051|542033426|FG001|Overall Study|Death Due to Study Disease|1|||
150244990|NCT00402051|542033425|FG000|Overall Study|Death Due to Adverse Event|0|||
150244991|NCT00402051|542033426|FG001|Overall Study|Death Due to Adverse Event|2|||
150244992|NCT00402051|542033425|FG000|Overall Study|Lost to Follow-up|1|||
150244993|NCT00402051|542033426|FG001|Overall Study|Lost to Follow-up|0|||
150244994|NCT00277095|542033428|FG000|Overall Study|Death|2|||
150244995|NCT00277095|542033428|FG000|Overall Study|Explanted|7|||
150244996|NCT00277095|542033428|FG000|Overall Study|Lost to Follow-up|2|||
150244997|NCT00277095|542033428|FG000|Overall Study|Missed Follow-up|9|||
150244998|NCT00277095|542033428|FG000|Overall Study|Physician Decision|1|||
150244999|NCT05415748|542033432|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
150245000|NCT05415748|542033433|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
150245001|NCT05415748|542033434|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
150245002|NCT05415748|542033435|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
150245003|NCT05415748|542033432|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
150245004|NCT05415748|542033433|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
150245005|NCT05415748|542033434|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
150245006|NCT05415748|542033435|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
150245007|NCT03075527|542033436|FG000|Overall Study|Death|1|||
150245008|NCT03075527|542033436|FG000|Overall Study|Withdrawal by Subject|1|||
150245009|NCT03075527|542033436|FG000|Overall Study|Physician Decision|3|||
150245010|NCT03075527|542033436|FG000|Overall Study|Progression/Relapse|14|||
150245011|NCT02209181|542033444|FG000|Overall Study|Adverse Event|1|||
150245012|NCT02209181|542033445|FG001|Overall Study|Adverse Event|0|||
150245013|NCT02209181|542033446|FG002|Overall Study|Adverse Event|1|||
150245014|NCT02209181|542033447|FG003|Overall Study|Adverse Event|0|||
150245015|NCT02209181|542033444|FG000|Overall Study|Withdrawal by Subject|0|||
150245016|NCT02209181|542033445|FG001|Overall Study|Withdrawal by Subject|1|||
150245017|NCT02209181|542033446|FG002|Overall Study|Withdrawal by Subject|0|||
150245018|NCT02209181|542033447|FG003|Overall Study|Withdrawal by Subject|0|||
150245019|NCT04463680|542033454|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
150245020|NCT04463680|542033454|FG000|Overall Study|Not eligible due to implant duration of use|1|||
150245021|NCT04463680|542033454|FG000|Overall Study|Withdrawal by Subject|3|||
150245022|NCT02592707|542033455|FG000|Overall Study|Consent Withdrawn|0|||
150245023|NCT02592707|542033456|FG001|Overall Study|Consent Withdrawn|1|||
150245024|NCT02592707|542033457|FG002|Overall Study|Consent Withdrawn|2|||
150245025|NCT02592707|542033458|FG003|Overall Study|Consent Withdrawn|0|||
150245026|NCT02592707|542033455|FG000|Overall Study|Death|1|||
150245027|NCT02592707|542033456|FG001|Overall Study|Death|0|||
150245028|NCT02592707|542033457|FG002|Overall Study|Death|0|||
150245029|NCT02592707|542033458|FG003|Overall Study|Death|0|||
150245030|NCT02592707|542033455|FG000|Overall Study|Progressive Disease|4|||
150245031|NCT02592707|542033456|FG001|Overall Study|Progressive Disease|4|||
150245032|NCT02592707|542033457|FG002|Overall Study|Progressive Disease|3|||
150245033|NCT02592707|542033458|FG003|Overall Study|Progressive Disease|3|||
150245034|NCT02592707|542033455|FG000|Overall Study|Other|0|||
150245035|NCT02592707|542033456|FG001|Overall Study|Other|0|||
150245036|NCT02592707|542033457|FG002|Overall Study|Other|1|||
150245037|NCT02592707|542033458|FG003|Overall Study|Other|2|||
150245038|NCT02592707|542033455|FG000|Overall Study|Never entered LTFU period|1|||
150245039|NCT02592707|542033456|FG001|Overall Study|Never entered LTFU period|0|||
150245040|NCT02592707|542033457|FG002|Overall Study|Never entered LTFU period|0|||
150245041|NCT02592707|542033458|FG003|Overall Study|Never entered LTFU period|2|||
150245042|NCT02998476|542033459|FG000|Overall Study|Lost to Follow-up|1|||
150245043|NCT02998476|542033460|FG001|Overall Study|Lost to Follow-up|0|||
150245044|NCT02998476|542033459|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
150245045|NCT02998476|542033460|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
150245046|NCT02998476|542033459|FG000|Overall Study|Withdrawal by Subject|1|||
150245047|NCT02998476|542033460|FG001|Overall Study|Withdrawal by Subject|2|||
150245048|NCT02998476|542033459|FG000|Overall Study|Death|45|||
150245049|NCT02998476|542033460|FG001|Overall Study|Death|2|||
150245050|NCT02998476|542033459|FG000|Overall Study|Other|6|||
150245051|NCT02998476|542033460|FG001|Overall Study|Other|1|||
150245052|NCT04855734|542033461|FG000|Overall Study|Lost to Follow-up|2|||
150245053|NCT04855734|542033462|FG001|Overall Study|Lost to Follow-up|2|||
150245054|NCT03832595|542033463|FG000|Overall Study|Death|142|||
150245055|NCT03832595|542033464|FG001|Overall Study|Death|130|||
150245056|NCT03832595|542033463|FG000|Overall Study|Medical management without dialysis|37|||
150245057|NCT03832595|542033464|FG001|Overall Study|Medical management without dialysis|1|||
150245058|NCT03277352|542033465|FG000|Overall Study|Study Terminated By Sponsor|2|||
150245059|NCT03277352|542033465|FG000|Overall Study|Withdrawal by Subject|4|||
150245060|NCT03277352|542033465|FG000|Overall Study|Death|4|||
150245061|NCT04535544|542033468|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
150245062|NCT04535544|542033469|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
150245063|NCT04535544|542033470|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
150245064|NCT04535544|542033471|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
150245065|NCT04535544|542033468|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
150245066|NCT04535544|542033469|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
150245067|NCT04535544|542033470|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
150245068|NCT04535544|542033471|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
150245069|NCT04535544|542033468|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
150245070|NCT04535544|542033469|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
150245071|NCT04535544|542033470|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
150245072|NCT04535544|542033471|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
150245073|NCT04535544|542033468|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
150245074|NCT04535544|542033469|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
150245075|NCT04535544|542033470|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
150245076|NCT04535544|542033471|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
150245077|NCT04535544|542033468|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
150245078|NCT04535544|542033469|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
150245079|NCT04535544|542033470|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
150245080|NCT04535544|542033471|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
150245081|NCT04535544|542033468|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
150245082|NCT04535544|542033469|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
150245083|NCT04535544|542033470|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
150245084|NCT04535544|542033471|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
150245085|NCT04535544|542033468|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
150245086|NCT04535544|542033469|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
150245087|NCT04535544|542033470|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
150245088|NCT04535544|542033471|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
150245089|NCT04535544|542033468|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
150245090|NCT04535544|542033469|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
150245091|NCT04535544|542033470|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
150245092|NCT04535544|542033471|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
150245093|NCT01920477|542036150|FG000|Overall Study|Adverse Event|0|||
150245094|NCT01920477|542036151|FG001|Overall Study|Adverse Event|1|||
150245095|NCT01920477|542036150|FG000|Overall Study|Lack of Efficacy|1|||
150245096|NCT01920477|542036151|FG001|Overall Study|Lack of Efficacy|0|||
150245097|NCT01920477|542036150|FG000|Overall Study|Study closed/terminated|14|||
150245098|NCT01920477|542036151|FG001|Overall Study|Study closed/terminated|15|||
150245099|NCT01920477|542036150|FG000|Overall Study|Withdrawal by Subject|0|||
150245100|NCT01920477|542036151|FG001|Overall Study|Withdrawal by Subject|1|||
150245101|NCT01681277|542036152|FG000|Overall Study|Adverse Event|1|||
150245102|NCT01681277|542036153|FG001|Overall Study|Adverse Event|0|||
150245103|NCT01681277|542036154|FG002|Overall Study|Adverse Event|0|||
150245104|NCT01681277|542036155|FG003|Overall Study|Adverse Event|0|||
150245105|NCT01681277|542036156|FG004|Overall Study|Adverse Event|0|||
150245106|NCT01667926|542036157|FG000|Overall Study|Withdrawal by Subject|1|||
150245107|NCT01667926|542036158|FG001|Overall Study|Withdrawal by Subject|2|||
150245108|NCT01667926|542036159|FG002|Overall Study|Withdrawal by Subject|2|||
150245109|NCT01667926|542036157|FG000|Overall Study|Physician Decision|0|||
150245110|NCT01667926|542036158|FG001|Overall Study|Physician Decision|0|||
150245111|NCT01667926|542036159|FG002|Overall Study|Physician Decision|1|||
150245112|NCT01667926|542036157|FG000|Overall Study|Time committment|0|||
150245113|NCT01667926|542036158|FG001|Overall Study|Time committment|0|||
150245114|NCT01667926|542036159|FG002|Overall Study|Time committment|2|||
150245115|NCT01667926|542036157|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
150245116|NCT01667926|542036158|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
150245117|NCT01667926|542036159|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
150245118|NCT01667926|542036157|FG000|Overall Study|Lost to Follow-up|1|||
150245119|NCT01667926|542036158|FG001|Overall Study|Lost to Follow-up|2|||
150245120|NCT01667926|542036159|FG002|Overall Study|Lost to Follow-up|1|||
150245121|NCT01667926|542036157|FG000|Overall Study|Side effects|3|||
150245122|NCT01667926|542036158|FG001|Overall Study|Side effects|0|||
150245123|NCT01667926|542036159|FG002|Overall Study|Side effects|0|||
150245124|NCT03838731|542036160|FG000|Overall Study|Pregnancy|0|||
150245125|NCT03838731|542036161|FG001|Overall Study|Pregnancy|1|||
150245126|NCT03838731|542036160|FG000|Overall Study|Withdrawal of consent|1|||
150245127|NCT03838731|542036161|FG001|Overall Study|Withdrawal of consent|0|||
150245128|NCT02271984|542036164|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245129|NCT02271984|542036165|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245130|NCT02271984|542036166|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245131|NCT02271984|542036167|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245132|NCT02271984|542036168|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245133|NCT02271984|542036169|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
150245134|NCT02271984|542036170|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245135|NCT02271984|542036171|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
150245136|NCT02271984|542036172|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245137|NCT02271984|542036173|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245138|NCT02271984|542036174|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245139|NCT02271984|542036175|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
150245140|NCT01088984|542036176|FG000|Phase 1|Death|2|||
150245141|NCT01088984|542036177|FG001|Phase 1|Death|1|||
150245142|NCT01088984|542036176|FG000|Phase 1|Disease Progression|2|||
150245143|NCT01088984|542036177|FG001|Phase 1|Disease Progression|4|||
150245144|NCT01088984|542036176|FG000|Phase 1|Other|1|||
150245145|NCT01088984|542036177|FG001|Phase 1|Other|1|||
150245146|NCT01088984|542036176|FG000|Phase 2|Death|0|||
150245147|NCT01088984|542036177|FG001|Phase 2|Death|5|||
150245148|NCT01088984|542036176|FG000|Phase 2|Withdrawal by Subject|0|||
150245149|NCT01088984|542036177|FG001|Phase 2|Withdrawal by Subject|1|||
150245150|NCT01088984|542036176|FG000|Phase 2|DIsease Progression|0|||
150245151|NCT01088984|542036177|FG001|Phase 2|DIsease Progression|25|||
150245152|NCT01088984|542036176|FG000|Phase 2|Other|0|||
150245153|NCT01088984|542036177|FG001|Phase 2|Other|1|||
150245154|NCT01182441|542036182|FG000|Overall Study|Patient Still in Follow-up|152|||
150245155|NCT01182441|542036183|FG001|Overall Study|Patient Still in Follow-up|72|||
150245156|NCT01182441|542036182|FG000|Overall Study|Death|37|||
150245157|NCT01182441|542036183|FG001|Overall Study|Death|25|||
150245158|NCT01182441|542036182|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
150245159|NCT01182441|542036183|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
150245160|NCT01182441|542036182|FG000|Overall Study|Lost to Follow-up|5|||
150245161|NCT01182441|542036183|FG001|Overall Study|Lost to Follow-up|8|||
150245162|NCT01182441|542036182|FG000|Overall Study|Withdrawal by Subject|6|||
150245163|NCT01182441|542036183|FG001|Overall Study|Withdrawal by Subject|13|||
150245164|NCT01182441|542036182|FG000|Overall Study|Implant Not Attempted|4|||
150245165|NCT01182441|542036183|FG001|Overall Study|Implant Not Attempted|0|||
150245166|NCT01182441|542036182|FG000|Overall Study|Adverse Event|2|||
150245167|NCT01182441|542036183|FG001|Overall Study|Adverse Event|0|||
150245168|NCT01182441|542036182|FG000|Overall Study|Physician Decision|1|||
150245169|NCT01182441|542036183|FG001|Overall Study|Physician Decision|1|||
150245170|NCT04079868|542036184|FG000|Overall Study|Lost to Follow-up|100|||
150245171|NCT04079868|542036185|FG001|Overall Study|Lost to Follow-up|200|||
150245172|NCT04079868|542036184|FG000|Overall Study|Physician Decision|100|||
150245173|NCT04079868|542036185|FG001|Overall Study|Physician Decision|0|||
150245174|NCT05620108|542036186|FG000|Overall Study|Physician Decision|1|||
150245175|NCT05620108|542036187|FG001|Overall Study|Physician Decision|2|||
150245176|NCT02038842|542036188|FG000|Overall Study|Withdrawal by Subject|2|||
150245177|NCT02038842|542036189|FG001|Overall Study|Withdrawal by Subject|2|||
150245178|NCT02038842|542036190|FG002|Overall Study|Withdrawal by Subject|0|||
150245179|NCT02038842|542036191|FG003|Overall Study|Withdrawal by Subject|0|||
150245180|NCT02038842|542036188|FG000|Overall Study|Participant decision|0|||
150245181|NCT02038842|542036189|FG001|Overall Study|Participant decision|0|||
150245182|NCT02038842|542036190|FG002|Overall Study|Participant decision|2|||
150245183|NCT02038842|542036191|FG003|Overall Study|Participant decision|1|||
150245184|NCT02038842|542036188|FG000|Overall Study|Adverse Event|0|||
150245185|NCT02038842|542036189|FG001|Overall Study|Adverse Event|0|||
150245186|NCT02038842|542036190|FG002|Overall Study|Adverse Event|3|||
150245187|NCT02038842|542036191|FG003|Overall Study|Adverse Event|1|||
150245188|NCT02038842|542036188|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
150245189|NCT02038842|542036189|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
150245190|NCT02038842|542036190|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
150245191|NCT02038842|542036191|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
150245192|NCT01757197|542036194|FG000|Overall Study|Death|2|||
150245193|NCT05332912|542036195|FG000|Overall Study|Withdrawal by Subject|0|||
150245194|NCT05332912|542036196|FG001|Overall Study|Withdrawal by Subject|1|||
150245195|NCT05332912|542036197|FG002|Overall Study|Withdrawal by Subject|2|||
150245196|NCT05332912|542036198|FG003|Overall Study|Withdrawal by Subject|0|||
150245197|NCT05332912|542036195|FG000|Overall Study|Lost to Follow-up|0|||
150245198|NCT05332912|542036196|FG001|Overall Study|Lost to Follow-up|0|||
150245199|NCT05332912|542036197|FG002|Overall Study|Lost to Follow-up|1|||
150245200|NCT05332912|542036198|FG003|Overall Study|Lost to Follow-up|0|||
150245201|NCT01174446|542036199|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
150245202|NCT01174446|542036200|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
150245203|NCT01174446|542036201|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
150245204|NCT01174446|542036202|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
150245205|NCT01174446|542036199|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
150245206|NCT01174446|542036200|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
150245207|NCT01174446|542036201|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
150245208|NCT01174446|542036202|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
150245209|NCT01174446|542036199|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
150245210|NCT01174446|542036200|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
150245211|NCT01174446|542036201|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
150245212|NCT01174446|542036202|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
150245213|NCT01174446|542036199|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
150245214|NCT01174446|542036200|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
150245215|NCT01174446|542036201|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
150245216|NCT01174446|542036202|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
150245217|NCT05000216|542036204|FG000|Stage 1|Lost to Follow-up|0|||
150245218|NCT05000216|542036205|FG001|Stage 1|Lost to Follow-up|0|||
150245219|NCT05000216|542036206|FG002|Stage 1|Lost to Follow-up|0|||
150245220|NCT05000216|542036207|FG003|Stage 1|Lost to Follow-up|0|||
150245221|NCT05000216|542036208|FG004|Stage 1|Lost to Follow-up|0|||
150245222|NCT05000216|542036209|FG005|Stage 1|Lost to Follow-up|0|||
150245223|NCT05000216|542036210|FG006|Stage 1|Lost to Follow-up|1|||
150245224|NCT05000216|542036211|FG007|Stage 1|Lost to Follow-up|1|||
150245225|NCT05000216|542036212|FG008|Stage 1|Lost to Follow-up|0|||
150245226|NCT05000216|542036213|FG009|Stage 1|Lost to Follow-up|2|||
150245227|NCT05000216|542036214|FG010|Stage 1|Lost to Follow-up|3|||
150245228|NCT05000216|542036215|FG011|Stage 1|Lost to Follow-up|0|||
150245229|NCT05000216|542036216|FG012|Stage 1|Lost to Follow-up|0|||
150245230|NCT05000216|542036217|FG013|Stage 1|Lost to Follow-up|0|||
150245231|NCT05000216|542036218|FG014|Stage 1|Lost to Follow-up|0|||
150245232|NCT05000216|542036219|FG015|Stage 1|Lost to Follow-up|0|||
150245233|NCT05000216|542036220|FG016|Stage 1|Lost to Follow-up|0|||
150245234|NCT05000216|542036221|FG017|Stage 1|Lost to Follow-up|0|||
150245235|NCT05000216|542036222|FG018|Stage 1|Lost to Follow-up|0|||
150245236|NCT05000216|542036223|FG019|Stage 1|Lost to Follow-up|0|||
150245237|NCT05000216|542036224|FG020|Stage 1|Lost to Follow-up|0|||
150245238|NCT05000216|542036225|FG021|Stage 1|Lost to Follow-up|0|||
150245239|NCT05000216|542036204|FG000|Stage 1|Physician Decision|0|||
150245240|NCT05000216|542036205|FG001|Stage 1|Physician Decision|0|||
150245241|NCT05000216|542036206|FG002|Stage 1|Physician Decision|0|||
150245242|NCT05000216|542036207|FG003|Stage 1|Physician Decision|0|||
150245243|NCT05000216|542036208|FG004|Stage 1|Physician Decision|0|||
150245244|NCT05000216|542036209|FG005|Stage 1|Physician Decision|0|||
150245245|NCT05000216|542036210|FG006|Stage 1|Physician Decision|0|||
150245246|NCT05000216|542036211|FG007|Stage 1|Physician Decision|1|||
150245247|NCT05000216|542036212|FG008|Stage 1|Physician Decision|1|||
150245248|NCT05000216|542036213|FG009|Stage 1|Physician Decision|0|||
150245249|NCT05000216|542036214|FG010|Stage 1|Physician Decision|0|||
150245250|NCT05000216|542036215|FG011|Stage 1|Physician Decision|0|||
150245251|NCT05000216|542036216|FG012|Stage 1|Physician Decision|0|||
150245252|NCT05000216|542036217|FG013|Stage 1|Physician Decision|0|||
150245253|NCT05000216|542036218|FG014|Stage 1|Physician Decision|0|||
150245254|NCT05000216|542036219|FG015|Stage 1|Physician Decision|0|||
150245255|NCT05000216|542036220|FG016|Stage 1|Physician Decision|0|||
150245256|NCT05000216|542036221|FG017|Stage 1|Physician Decision|0|||
150245257|NCT05000216|542036222|FG018|Stage 1|Physician Decision|0|||
150245258|NCT05000216|542036223|FG019|Stage 1|Physician Decision|0|||
150245259|NCT05000216|542036224|FG020|Stage 1|Physician Decision|0|||
150245260|NCT05000216|542036225|FG021|Stage 1|Physician Decision|0|||
150245261|NCT05000216|542036204|FG000|Stage 1|Withdrawal by Subject|0|||
150245262|NCT05000216|542036205|FG001|Stage 1|Withdrawal by Subject|1|||
150245263|NCT05000216|542036206|FG002|Stage 1|Withdrawal by Subject|0|||
150245264|NCT05000216|542036207|FG003|Stage 1|Withdrawal by Subject|0|||
150245265|NCT05000216|542036208|FG004|Stage 1|Withdrawal by Subject|0|||
150245266|NCT05000216|542036209|FG005|Stage 1|Withdrawal by Subject|0|||
150245267|NCT05000216|542036210|FG006|Stage 1|Withdrawal by Subject|0|||
150245268|NCT05000216|542036211|FG007|Stage 1|Withdrawal by Subject|0|||
150245269|NCT05000216|542036212|FG008|Stage 1|Withdrawal by Subject|0|||
150245270|NCT05000216|542036213|FG009|Stage 1|Withdrawal by Subject|3|||
150245271|NCT05000216|542036214|FG010|Stage 1|Withdrawal by Subject|10|||
150245272|NCT05000216|542036215|FG011|Stage 1|Withdrawal by Subject|0|||
150245273|NCT05000216|542036216|FG012|Stage 1|Withdrawal by Subject|0|||
150245274|NCT05000216|542036217|FG013|Stage 1|Withdrawal by Subject|0|||
150245275|NCT05000216|542036218|FG014|Stage 1|Withdrawal by Subject|0|||
150245276|NCT05000216|542036219|FG015|Stage 1|Withdrawal by Subject|0|||
150245277|NCT05000216|542036220|FG016|Stage 1|Withdrawal by Subject|0|||
150245278|NCT05000216|542036221|FG017|Stage 1|Withdrawal by Subject|0|||
150245279|NCT05000216|542036222|FG018|Stage 1|Withdrawal by Subject|0|||
150245280|NCT05000216|542036223|FG019|Stage 1|Withdrawal by Subject|0|||
150245281|NCT05000216|542036224|FG020|Stage 1|Withdrawal by Subject|0|||
150245282|NCT05000216|542036225|FG021|Stage 1|Withdrawal by Subject|0|||
150245283|NCT05000216|542036204|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
150245284|NCT05000216|542036205|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
150245285|NCT05000216|542036206|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
150245286|NCT05000216|542036207|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
150245287|NCT05000216|542036208|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
150245288|NCT05000216|542036209|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
150245289|NCT05000216|542036210|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
150245290|NCT05000216|542036211|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
150245291|NCT05000216|542036212|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
150245292|NCT05000216|542036213|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
150245293|NCT05000216|542036214|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
150245294|NCT05000216|542036215|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
150245295|NCT05000216|542036216|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
150245296|NCT05000216|542036217|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
150245297|NCT05000216|542036218|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
150245298|NCT05000216|542036219|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
150245299|NCT05000216|542036220|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
150245300|NCT05000216|542036221|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
150245301|NCT05000216|542036222|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
150245302|NCT05000216|542036223|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
150245303|NCT05000216|542036224|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
150245304|NCT05000216|542036225|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
150245305|NCT05000216|542036204|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245306|NCT05000216|542036205|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245307|NCT05000216|542036206|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245308|NCT05000216|542036207|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245309|NCT05000216|542036208|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245310|NCT05000216|542036209|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245311|NCT05000216|542036210|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245312|NCT05000216|542036211|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245313|NCT05000216|542036212|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
150245314|NCT05000216|542036213|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245315|NCT05000216|542036214|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245316|NCT05000216|542036215|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245317|NCT05000216|542036216|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245318|NCT05000216|542036217|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245319|NCT05000216|542036218|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245320|NCT05000216|542036219|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245321|NCT05000216|542036220|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245322|NCT05000216|542036221|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245323|NCT05000216|542036222|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245324|NCT05000216|542036223|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245325|NCT05000216|542036224|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245326|NCT05000216|542036225|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
150245327|NCT05000216|542036204|FG000|Stage 1|Other|0|||
150245328|NCT05000216|542036205|FG001|Stage 1|Other|0|||
150245329|NCT05000216|542036206|FG002|Stage 1|Other|0|||
150245330|NCT05000216|542036207|FG003|Stage 1|Other|0|||
150245331|NCT05000216|542036208|FG004|Stage 1|Other|1|||
150245332|NCT05000216|542036209|FG005|Stage 1|Other|0|||
150245333|NCT05000216|542036210|FG006|Stage 1|Other|0|||
150245334|NCT05000216|542036211|FG007|Stage 1|Other|2|||
150245335|NCT05000216|542036212|FG008|Stage 1|Other|0|||
150245336|NCT05000216|542036213|FG009|Stage 1|Other|0|||
150245337|NCT05000216|542036214|FG010|Stage 1|Other|1|||
150245338|NCT05000216|542036215|FG011|Stage 1|Other|1|||
150245339|NCT05000216|542036216|FG012|Stage 1|Other|0|||
150245340|NCT05000216|542036217|FG013|Stage 1|Other|0|||
150245341|NCT05000216|542036218|FG014|Stage 1|Other|0|||
150245342|NCT05000216|542036219|FG015|Stage 1|Other|0|||
150245343|NCT05000216|542036220|FG016|Stage 1|Other|0|||
150245344|NCT05000216|542036221|FG017|Stage 1|Other|0|||
150245345|NCT05000216|542036222|FG018|Stage 1|Other|0|||
150245346|NCT05000216|542036223|FG019|Stage 1|Other|0|||
150245347|NCT05000216|542036224|FG020|Stage 1|Other|0|||
150245348|NCT05000216|542036225|FG021|Stage 1|Other|0|||
150245349|NCT05000216|542036204|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
150245350|NCT05000216|542036205|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
150245351|NCT05000216|542036206|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
150245352|NCT05000216|542036207|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
150245353|NCT05000216|542036208|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
150245354|NCT05000216|542036209|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
150245355|NCT05000216|542036210|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
150245356|NCT05000216|542036211|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
150245357|NCT05000216|542036212|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
150245358|NCT05000216|542036213|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
150245359|NCT05000216|542036214|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
150245360|NCT05000216|542036215|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
150245361|NCT05000216|542036216|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
150245362|NCT05000216|542036217|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
150245363|NCT05000216|542036218|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
150245364|NCT05000216|542036219|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
150245365|NCT05000216|542036220|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
150245366|NCT05000216|542036221|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
150245367|NCT05000216|542036222|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
150245368|NCT05000216|542036223|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
150245369|NCT05000216|542036224|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
150245370|NCT05000216|542036225|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
150245371|NCT05000216|542036204|FG000|Stage 2|Lost to Follow-up|0|||
150245372|NCT05000216|542036205|FG001|Stage 2|Lost to Follow-up|0|||
150245373|NCT05000216|542036206|FG002|Stage 2|Lost to Follow-up|0|||
150245374|NCT05000216|542036207|FG003|Stage 2|Lost to Follow-up|0|||
150245375|NCT05000216|542036208|FG004|Stage 2|Lost to Follow-up|0|||
150245376|NCT05000216|542036209|FG005|Stage 2|Lost to Follow-up|0|||
150245377|NCT05000216|542036210|FG006|Stage 2|Lost to Follow-up|0|||
150245378|NCT05000216|542036211|FG007|Stage 2|Lost to Follow-up|0|||
150245379|NCT05000216|542036212|FG008|Stage 2|Lost to Follow-up|0|||
150245380|NCT05000216|542036213|FG009|Stage 2|Lost to Follow-up|0|||
150245381|NCT05000216|542036214|FG010|Stage 2|Lost to Follow-up|0|||
150245382|NCT05000216|542036215|FG011|Stage 2|Lost to Follow-up|0|||
150245383|NCT05000216|542036216|FG012|Stage 2|Lost to Follow-up|0|||
150245384|NCT05000216|542036217|FG013|Stage 2|Lost to Follow-up|0|||
150245385|NCT05000216|542036218|FG014|Stage 2|Lost to Follow-up|0|||
150245386|NCT05000216|542036219|FG015|Stage 2|Lost to Follow-up|0|||
150245387|NCT05000216|542036220|FG016|Stage 2|Lost to Follow-up|4|||
150245388|NCT05000216|542036221|FG017|Stage 2|Lost to Follow-up|0|||
150245389|NCT05000216|542036222|FG018|Stage 2|Lost to Follow-up|0|||
150245390|NCT05000216|542036223|FG019|Stage 2|Lost to Follow-up|0|||
150245391|NCT05000216|542036224|FG020|Stage 2|Lost to Follow-up|0|||
150245392|NCT05000216|542036225|FG021|Stage 2|Lost to Follow-up|0|||
150245393|NCT05000216|542036204|FG000|Stage 2|Physician Decision|0|||
150245394|NCT05000216|542036205|FG001|Stage 2|Physician Decision|0|||
150245395|NCT05000216|542036206|FG002|Stage 2|Physician Decision|0|||
150245396|NCT05000216|542036207|FG003|Stage 2|Physician Decision|0|||
150245397|NCT05000216|542036208|FG004|Stage 2|Physician Decision|0|||
150245398|NCT05000216|542036209|FG005|Stage 2|Physician Decision|0|||
150245399|NCT05000216|542036210|FG006|Stage 2|Physician Decision|0|||
150245400|NCT05000216|542036211|FG007|Stage 2|Physician Decision|0|||
150245401|NCT05000216|542036212|FG008|Stage 2|Physician Decision|0|||
150245402|NCT05000216|542036213|FG009|Stage 2|Physician Decision|0|||
150245403|NCT05000216|542036214|FG010|Stage 2|Physician Decision|0|||
150245404|NCT05000216|542036215|FG011|Stage 2|Physician Decision|0|||
150245405|NCT05000216|542036216|FG012|Stage 2|Physician Decision|1|||
150245406|NCT05000216|542036217|FG013|Stage 2|Physician Decision|0|||
150245407|NCT05000216|542036218|FG014|Stage 2|Physician Decision|0|||
150245408|NCT05000216|542036219|FG015|Stage 2|Physician Decision|0|||
150245409|NCT05000216|542036220|FG016|Stage 2|Physician Decision|0|||
150245410|NCT05000216|542036221|FG017|Stage 2|Physician Decision|0|||
150245411|NCT05000216|542036222|FG018|Stage 2|Physician Decision|0|||
150245412|NCT05000216|542036223|FG019|Stage 2|Physician Decision|0|||
150245413|NCT05000216|542036224|FG020|Stage 2|Physician Decision|0|||
150245414|NCT05000216|542036225|FG021|Stage 2|Physician Decision|0|||
150245415|NCT05000216|542036204|FG000|Stage 2|Withdrawal by Subject|0|||
150245416|NCT05000216|542036205|FG001|Stage 2|Withdrawal by Subject|0|||
150245417|NCT05000216|542036206|FG002|Stage 2|Withdrawal by Subject|0|||
150245418|NCT05000216|542036207|FG003|Stage 2|Withdrawal by Subject|0|||
150245419|NCT05000216|542036208|FG004|Stage 2|Withdrawal by Subject|0|||
150245420|NCT05000216|542036209|FG005|Stage 2|Withdrawal by Subject|0|||
150245421|NCT05000216|542036210|FG006|Stage 2|Withdrawal by Subject|0|||
150245422|NCT05000216|542036211|FG007|Stage 2|Withdrawal by Subject|0|||
150245423|NCT05000216|542036212|FG008|Stage 2|Withdrawal by Subject|0|||
150245424|NCT05000216|542036213|FG009|Stage 2|Withdrawal by Subject|0|||
150245425|NCT05000216|542036214|FG010|Stage 2|Withdrawal by Subject|0|||
150245426|NCT05000216|542036215|FG011|Stage 2|Withdrawal by Subject|0|||
150245427|NCT05000216|542036216|FG012|Stage 2|Withdrawal by Subject|0|||
150245428|NCT05000216|542036217|FG013|Stage 2|Withdrawal by Subject|0|||
150245429|NCT05000216|542036218|FG014|Stage 2|Withdrawal by Subject|2|||
150245430|NCT05000216|542036219|FG015|Stage 2|Withdrawal by Subject|0|||
150245431|NCT05000216|542036220|FG016|Stage 2|Withdrawal by Subject|9|||
150245432|NCT05000216|542036221|FG017|Stage 2|Withdrawal by Subject|0|||
150245433|NCT05000216|542036222|FG018|Stage 2|Withdrawal by Subject|0|||
150245434|NCT05000216|542036223|FG019|Stage 2|Withdrawal by Subject|0|||
150245435|NCT05000216|542036224|FG020|Stage 2|Withdrawal by Subject|0|||
150245436|NCT05000216|542036225|FG021|Stage 2|Withdrawal by Subject|0|||
150245437|NCT05000216|542036204|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
150245438|NCT05000216|542036205|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
150245439|NCT05000216|542036206|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
150245440|NCT05000216|542036207|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
150245441|NCT05000216|542036208|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
150245442|NCT05000216|542036209|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
150245443|NCT05000216|542036210|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
150245444|NCT05000216|542036211|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
150245445|NCT05000216|542036212|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
150245446|NCT05000216|542036213|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
150245447|NCT05000216|542036214|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
150245448|NCT05000216|542036215|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
150245449|NCT05000216|542036216|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
150245450|NCT05000216|542036217|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
150245451|NCT05000216|542036218|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
150245452|NCT05000216|542036219|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
150245453|NCT05000216|542036220|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
150245454|NCT05000216|542036221|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
150245455|NCT05000216|542036222|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
150245456|NCT05000216|542036223|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
150245457|NCT05000216|542036224|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
150245458|NCT05000216|542036225|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
150245459|NCT05000216|542036204|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245460|NCT05000216|542036205|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245461|NCT05000216|542036206|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245462|NCT05000216|542036207|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245463|NCT05000216|542036208|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245464|NCT05000216|542036209|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245465|NCT05000216|542036210|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245466|NCT05000216|542036211|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245467|NCT05000216|542036212|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245468|NCT05000216|542036213|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245469|NCT05000216|542036214|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245470|NCT05000216|542036215|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245471|NCT05000216|542036216|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245472|NCT05000216|542036217|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245473|NCT05000216|542036218|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
150245474|NCT05000216|542036219|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245475|NCT05000216|542036220|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
150245476|NCT05000216|542036221|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245477|NCT05000216|542036222|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245478|NCT05000216|542036223|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245479|NCT05000216|542036224|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245480|NCT05000216|542036225|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
150245481|NCT05000216|542036204|FG000|Stage 2|Other reason|0|||
150245482|NCT05000216|542036205|FG001|Stage 2|Other reason|0|||
150245483|NCT05000216|542036206|FG002|Stage 2|Other reason|0|||
150245484|NCT05000216|542036207|FG003|Stage 2|Other reason|0|||
150245485|NCT05000216|542036208|FG004|Stage 2|Other reason|0|||
150245486|NCT05000216|542036209|FG005|Stage 2|Other reason|0|||
150245487|NCT05000216|542036210|FG006|Stage 2|Other reason|0|||
150245488|NCT05000216|542036211|FG007|Stage 2|Other reason|0|||
150245489|NCT05000216|542036212|FG008|Stage 2|Other reason|0|||
150245490|NCT05000216|542036213|FG009|Stage 2|Other reason|0|||
150245491|NCT05000216|542036214|FG010|Stage 2|Other reason|0|||
150245492|NCT05000216|542036215|FG011|Stage 2|Other reason|0|||
150245493|NCT05000216|542036216|FG012|Stage 2|Other reason|0|||
150245494|NCT05000216|542036217|FG013|Stage 2|Other reason|0|||
150245495|NCT05000216|542036218|FG014|Stage 2|Other reason|0|||
150245496|NCT05000216|542036219|FG015|Stage 2|Other reason|0|||
150245497|NCT05000216|542036220|FG016|Stage 2|Other reason|1|||
150245498|NCT05000216|542036221|FG017|Stage 2|Other reason|0|||
150245499|NCT05000216|542036222|FG018|Stage 2|Other reason|0|||
150245500|NCT05000216|542036223|FG019|Stage 2|Other reason|0|||
150245501|NCT05000216|542036224|FG020|Stage 2|Other reason|0|||
150245502|NCT05000216|542036225|FG021|Stage 2|Other reason|0|||
150245503|NCT05000216|542036204|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
150245504|NCT05000216|542036205|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
150245505|NCT05000216|542036206|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
150245506|NCT05000216|542036207|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
150245507|NCT05000216|542036208|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
150245508|NCT05000216|542036209|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
150245509|NCT05000216|542036210|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
150245510|NCT05000216|542036211|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
150245511|NCT05000216|542036212|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
150245512|NCT05000216|542036213|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
150245513|NCT05000216|542036214|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
150245514|NCT05000216|542036215|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
150245515|NCT05000216|542036216|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
150245516|NCT05000216|542036217|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
150245517|NCT05000216|542036218|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
150245518|NCT05000216|542036219|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
150245519|NCT05000216|542036220|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
150245520|NCT05000216|542036221|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
150245521|NCT05000216|542036222|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
150245522|NCT05000216|542036223|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
150245523|NCT05000216|542036224|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
150245524|NCT05000216|542036225|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
150245525|NCT05000216|542036204|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245526|NCT05000216|542036205|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245527|NCT05000216|542036206|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245528|NCT05000216|542036207|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245529|NCT05000216|542036208|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245530|NCT05000216|542036209|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245531|NCT05000216|542036210|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245532|NCT05000216|542036211|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245533|NCT05000216|542036212|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245534|NCT05000216|542036213|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245535|NCT05000216|542036214|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245536|NCT05000216|542036215|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245537|NCT05000216|542036216|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245538|NCT05000216|542036217|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245539|NCT05000216|542036218|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245540|NCT05000216|542036219|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
150245541|NCT05000216|542036220|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245542|NCT05000216|542036221|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245543|NCT05000216|542036222|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245544|NCT05000216|542036223|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245545|NCT05000216|542036224|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245546|NCT05000216|542036225|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
150245547|NCT05000216|542036204|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245548|NCT05000216|542036205|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245549|NCT05000216|542036206|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245550|NCT05000216|542036207|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245551|NCT05000216|542036208|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245552|NCT05000216|542036209|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245553|NCT05000216|542036210|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245554|NCT05000216|542036211|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245555|NCT05000216|542036212|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245556|NCT05000216|542036213|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245557|NCT05000216|542036214|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245558|NCT05000216|542036215|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245559|NCT05000216|542036216|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245560|NCT05000216|542036217|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
150245561|NCT05000216|542036218|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245562|NCT05000216|542036219|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
150245563|NCT05000216|542036220|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245564|NCT05000216|542036221|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245565|NCT05000216|542036222|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
150245566|NCT05000216|542036223|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245567|NCT05000216|542036224|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245568|NCT05000216|542036225|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
150245569|NCT04076943|542036226|FG000|Overall Study|Withdrawal by Subject|12|||
150245570|NCT04076943|542036226|FG000|Overall Study|Adverse Event|1|||
150245571|NCT04076943|542036226|FG000|Overall Study|Progressive Disease|2|||
150245572|NCT04076943|542036226|FG000|Overall Study|Death|13|||
150245573|NCT04076943|542036226|FG000|Overall Study|Other than specified|6|||
150245574|NCT02224703|542036229|FG000|Overall Study|Adverse Event|0|||
150245575|NCT02224703|542036230|FG001|Overall Study|Adverse Event|5|||
150245576|NCT02224703|542036231|FG002|Overall Study|Adverse Event|0|||
150245577|NCT02224703|542036229|FG000|Overall Study|Withdrawn by investigator|1|||
150245578|NCT02224703|542036230|FG001|Overall Study|Withdrawn by investigator|0|||
150245579|NCT02224703|542036231|FG002|Overall Study|Withdrawn by investigator|0|||
150245580|NCT02224703|542036229|FG000|Overall Study|Advised by medical monitor|1|||
150245581|NCT02224703|542036230|FG001|Overall Study|Advised by medical monitor|0|||
150245582|NCT02224703|542036231|FG002|Overall Study|Advised by medical monitor|0|||
150245583|NCT02224703|542036229|FG000|Overall Study|Withdrawn by parent/guardian|0|||
150245584|NCT02224703|542036230|FG001|Overall Study|Withdrawn by parent/guardian|1|||
150245585|NCT02224703|542036231|FG002|Overall Study|Withdrawn by parent/guardian|0|||
150245586|NCT02224703|542036229|FG000|Overall Study|Lack of Efficacy|1|||
150245587|NCT02224703|542036230|FG001|Overall Study|Lack of Efficacy|0|||
150245588|NCT02224703|542036231|FG002|Overall Study|Lack of Efficacy|0|||
150245589|NCT02057575|542036232|FG000|Overall Study|Adverse Event|0|||
150245590|NCT02057575|542036233|FG001|Overall Study|Adverse Event|2|||
150245591|NCT02057575|542036234|FG002|Overall Study|Adverse Event|0|||
150245592|NCT02057575|542036235|FG003|Overall Study|Adverse Event|1|||
150245593|NCT02057575|542036232|FG000|Overall Study|Withdrawal by Subject|1|||
150245594|NCT02057575|542036233|FG001|Overall Study|Withdrawal by Subject|0|||
150245595|NCT02057575|542036234|FG002|Overall Study|Withdrawal by Subject|0|||
150245596|NCT02057575|542036235|FG003|Overall Study|Withdrawal by Subject|0|||
150245597|NCT02057575|542036232|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
150245598|NCT02057575|542036233|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
150245599|NCT02057575|542036234|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
150245600|NCT02057575|542036235|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
150245601|NCT02057575|542036232|FG000|Overall Study|Protocol Violation|0|||
150245602|NCT02057575|542036233|FG001|Overall Study|Protocol Violation|1|||
150245603|NCT02057575|542036234|FG002|Overall Study|Protocol Violation|0|||
150245604|NCT02057575|542036235|FG003|Overall Study|Protocol Violation|0|||
150245605|NCT00863681|542036236|FG000|Overall Study|Other|2|||
150245606|NCT00863681|542036237|FG001|Overall Study|Other|0|||
150245607|NCT00863681|542036238|FG002|Overall Study|Other|0|||
150245608|NCT00863681|542036236|FG000|Overall Study|Missing|1|||
150245609|NCT00863681|542036237|FG001|Overall Study|Missing|0|||
150245610|NCT00863681|542036238|FG002|Overall Study|Missing|0|||
150245611|NCT00863681|542036236|FG000|Overall Study|Death|40|||
150245612|NCT00863681|542036237|FG001|Overall Study|Death|23|||
150245613|NCT00863681|542036238|FG002|Overall Study|Death|6|||
150245614|NCT00863681|542036236|FG000|Overall Study|Withdrawal by Subject|12|||
150245615|NCT00863681|542036237|FG001|Overall Study|Withdrawal by Subject|5|||
150245616|NCT00863681|542036238|FG002|Overall Study|Withdrawal by Subject|2|||
150245617|NCT00863681|542036236|FG000|Overall Study|Protocol Violation|2|||
150245618|NCT00863681|542036237|FG001|Overall Study|Protocol Violation|0|||
150245619|NCT00863681|542036238|FG002|Overall Study|Protocol Violation|0|||
150245620|NCT00863681|542036236|FG000|Overall Study|Lost to Follow-up|3|||
150245621|NCT00863681|542036237|FG001|Overall Study|Lost to Follow-up|0|||
150245622|NCT00863681|542036238|FG002|Overall Study|Lost to Follow-up|3|||
150245623|NCT00863681|542036236|FG000|Overall Study|Adverse Event|28|||
150245624|NCT00863681|542036237|FG001|Overall Study|Adverse Event|10|||
150245625|NCT00863681|542036238|FG002|Overall Study|Adverse Event|6|||
150245626|NCT00863681|542036236|FG000|Overall Study|Lack of Efficacy|2|||
150245627|NCT00863681|542036237|FG001|Overall Study|Lack of Efficacy|2|||
150245628|NCT00863681|542036238|FG002|Overall Study|Lack of Efficacy|1|||
150245629|NCT00863681|542036236|FG000|Overall Study|Non-compliance with study drug|1|||
150245630|NCT00863681|542036237|FG001|Overall Study|Non-compliance with study drug|3|||
150245631|NCT00863681|542036238|FG002|Overall Study|Non-compliance with study drug|0|||
150245632|NCT03596762|542036239|FG000|Overall Study|Protocol Violation|0|||
150245633|NCT03596762|542036240|FG001|Overall Study|Protocol Violation|0|||
150245634|NCT03596762|542036241|FG002|Overall Study|Protocol Violation|0|||
150245635|NCT03596762|542036242|FG003|Overall Study|Protocol Violation|0|||
150245636|NCT03596762|542036243|FG004|Overall Study|Protocol Violation|1|||
150245637|NCT03596762|542036239|FG000|Overall Study|Adverse Event|2|||
150245638|NCT03596762|542036240|FG001|Overall Study|Adverse Event|0|||
150245639|NCT03596762|542036241|FG002|Overall Study|Adverse Event|1|||
150245640|NCT03596762|542036242|FG003|Overall Study|Adverse Event|0|||
150245641|NCT03596762|542036243|FG004|Overall Study|Adverse Event|5|||
150245642|NCT03596762|542036239|FG000|Overall Study|Withdrawal by Subject|2|||
150245643|NCT03596762|542036240|FG001|Overall Study|Withdrawal by Subject|1|||
150245644|NCT03596762|542036241|FG002|Overall Study|Withdrawal by Subject|0|||
150245645|NCT03596762|542036242|FG003|Overall Study|Withdrawal by Subject|1|||
150245646|NCT03596762|542036243|FG004|Overall Study|Withdrawal by Subject|1|||
150245647|NCT03842228|542036244|FG000|Overall Study|Adverse Event|1|||
150245648|NCT03842228|542036245|FG001|Overall Study|Adverse Event|1|||
150245649|NCT03842228|542036246|FG002|Overall Study|Adverse Event|1|||
150245650|NCT03842228|542036247|FG003|Overall Study|Adverse Event|0|||
150245651|NCT03842228|542036248|FG004|Overall Study|Adverse Event|0|||
150245652|NCT03842228|542036249|FG005|Overall Study|Adverse Event|0|||
150245653|NCT03842228|542036250|FG006|Overall Study|Adverse Event|0|||
150245654|NCT03842228|542036244|FG000|Overall Study|Death|0|||
150245655|NCT03842228|542036245|FG001|Overall Study|Death|1|||
150245656|NCT03842228|542036246|FG002|Overall Study|Death|0|||
150245657|NCT03842228|542036247|FG003|Overall Study|Death|0|||
150245658|NCT03842228|542036248|FG004|Overall Study|Death|0|||
150245659|NCT03842228|542036249|FG005|Overall Study|Death|0|||
150245660|NCT03842228|542036250|FG006|Overall Study|Death|0|||
150245661|NCT03842228|542036244|FG000|Overall Study|Withdrawal by Subject|0|||
150245662|NCT03842228|542036245|FG001|Overall Study|Withdrawal by Subject|0|||
150245663|NCT03842228|542036246|FG002|Overall Study|Withdrawal by Subject|2|||
150245664|NCT03842228|542036247|FG003|Overall Study|Withdrawal by Subject|1|||
150245665|NCT03842228|542036248|FG004|Overall Study|Withdrawal by Subject|0|||
150245666|NCT03842228|542036249|FG005|Overall Study|Withdrawal by Subject|0|||
150245667|NCT03842228|542036250|FG006|Overall Study|Withdrawal by Subject|2|||
150245668|NCT03842228|542036244|FG000|Overall Study|Progression|8|||
150245669|NCT03842228|542036245|FG001|Overall Study|Progression|1|||
150245670|NCT03842228|542036246|FG002|Overall Study|Progression|7|||
150245671|NCT03842228|542036247|FG003|Overall Study|Progression|5|||
150245672|NCT03842228|542036248|FG004|Overall Study|Progression|4|||
150245673|NCT03842228|542036249|FG005|Overall Study|Progression|2|||
150245674|NCT03842228|542036250|FG006|Overall Study|Progression|3|||
150245675|NCT02195479|542036251|FG000|Overall Study|Lost to Follow-up|18|||
150245676|NCT02195479|542036252|FG001|Overall Study|Lost to Follow-up|15|||
150245677|NCT02195479|542036251|FG000|Overall Study|Death|217|||
150245678|NCT02195479|542036252|FG001|Overall Study|Death|171|||
150245679|NCT02195479|542036251|FG000|Overall Study|Physician Decision|1|||
150245680|NCT02195479|542036252|FG001|Overall Study|Physician Decision|0|||
150245681|NCT02195479|542036251|FG000|Overall Study|Withdrawal by Subject|30|||
150245682|NCT02195479|542036252|FG001|Overall Study|Withdrawal by Subject|30|||
150245683|NCT02195479|542036251|FG000|Overall Study|Other|3|||
150245684|NCT02195479|542036252|FG001|Overall Study|Other|4|||
150245685|NCT02195479|542036251|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
150245686|NCT02195479|542036252|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
150245687|NCT01263509|542036253|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
150245688|NCT01263509|542036254|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
150245689|NCT01263509|542036255|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
150245690|NCT01263509|542036256|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
150245691|NCT01263509|542036253|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
150245692|NCT01263509|542036254|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
150245693|NCT01263509|542036255|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
150245694|NCT01263509|542036256|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
150245695|NCT01263509|542036253|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
150245696|NCT01263509|542036254|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
150245697|NCT01263509|542036255|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
150245698|NCT01263509|542036256|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
150245699|NCT01263509|542036253|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
150245700|NCT01263509|542036254|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
150245701|NCT01263509|542036255|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150245702|NCT01263509|542036256|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
150245703|NCT01263509|542036253|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
150245704|NCT01263509|542036254|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
150245705|NCT01263509|542036255|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
150245706|NCT01263509|542036256|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
150245707|NCT05071053|542036257|FG000|Overall Study|Progressive disease|30|||
150245708|NCT05071053|542036257|FG000|Overall Study|Adverse Event|5|||
150245709|NCT01602510|542036265|FG000|Open Label Phase|Adverse Event|46|||
150245710|NCT01602510|542036266|FG001|Open Label Phase|Adverse Event|0|||
150245711|NCT01602510|542036267|FG002|Open Label Phase|Adverse Event|0|||
150245712|NCT01602510|542036265|FG000|Open Label Phase|Lack of Efficacy|22|||
150245713|NCT01602510|542036266|FG001|Open Label Phase|Lack of Efficacy|0|||
150245714|NCT01602510|542036267|FG002|Open Label Phase|Lack of Efficacy|0|||
150245715|NCT01602510|542036265|FG000|Open Label Phase|Protocol Violation|15|||
150245716|NCT01602510|542036266|FG001|Open Label Phase|Protocol Violation|0|||
150245717|NCT01602510|542036267|FG002|Open Label Phase|Protocol Violation|0|||
150245718|NCT01602510|542036265|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
150245719|NCT01602510|542036266|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
150245720|NCT01602510|542036267|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
150245721|NCT01602510|542036265|FG000|Open Label Phase|Lost to Follow-up|22|||
150245722|NCT01602510|542036266|FG001|Open Label Phase|Lost to Follow-up|0|||
150245723|NCT01602510|542036267|FG002|Open Label Phase|Lost to Follow-up|0|||
150245724|NCT01602510|542036265|FG000|Open Label Phase|Physician Decision|19|||
150245725|NCT01602510|542036266|FG001|Open Label Phase|Physician Decision|0|||
150245726|NCT01602510|542036267|FG002|Open Label Phase|Physician Decision|0|||
150245727|NCT01602510|542036265|FG000|Open Label Phase|Withdrawal by Subject|57|||
150245728|NCT01602510|542036266|FG001|Open Label Phase|Withdrawal by Subject|0|||
150245729|NCT01602510|542036267|FG002|Open Label Phase|Withdrawal by Subject|0|||
150245730|NCT01602510|542036265|FG000|Randomized Phase|Adverse Event|0|||
150245731|NCT01602510|542036266|FG001|Randomized Phase|Adverse Event|2|||
150245732|NCT01602510|542036267|FG002|Randomized Phase|Adverse Event|6|||
150245733|NCT01602510|542036265|FG000|Randomized Phase|Lack of Efficacy|0|||
150245734|NCT01602510|542036266|FG001|Randomized Phase|Lack of Efficacy|4|||
150245735|NCT01602510|542036267|FG002|Randomized Phase|Lack of Efficacy|4|||
150245736|NCT01602510|542036265|FG000|Randomized Phase|Protocol Violation|0|||
150245737|NCT01602510|542036266|FG001|Randomized Phase|Protocol Violation|3|||
150245738|NCT01602510|542036267|FG002|Randomized Phase|Protocol Violation|3|||
150245739|NCT01602510|542036265|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
150245740|NCT01602510|542036266|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
150245741|NCT01602510|542036267|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
150245742|NCT01602510|542036265|FG000|Randomized Phase|Lost to Follow-up|0|||
150245743|NCT01602510|542036266|FG001|Randomized Phase|Lost to Follow-up|1|||
150245744|NCT01602510|542036267|FG002|Randomized Phase|Lost to Follow-up|3|||
150245745|NCT01602510|542036265|FG000|Randomized Phase|Physician Decision|0|||
150245746|NCT01602510|542036266|FG001|Randomized Phase|Physician Decision|0|||
150245747|NCT01602510|542036267|FG002|Randomized Phase|Physician Decision|2|||
150245748|NCT01602510|542036265|FG000|Randomized Phase|Withdrawal by Subject|0|||
150245749|NCT01602510|542036266|FG001|Randomized Phase|Withdrawal by Subject|6|||
150245750|NCT01602510|542036267|FG002|Randomized Phase|Withdrawal by Subject|7|||
150245751|NCT01001390|542036268|FG000|Overall Study|Failure to wear AFO device|2|||
150245752|NCT01001390|542036269|FG001|Overall Study|Failure to wear AFO device|0|||
150245753|NCT00895895|542036270|FG000|Period 1|Adverse Event|7|||
150245754|NCT00895895|542036271|FG001|Period 1|Adverse Event|6|||
150245755|NCT00895895|542036272|FG002|Period 1|Adverse Event|4|||
150245756|NCT00895895|542036273|FG003|Period 1|Adverse Event|6|||
150245757|NCT00895895|542036274|FG004|Period 1|Adverse Event|7|||
150245758|NCT00895895|542036270|FG000|Period 1|Death|0|||
150245759|NCT00895895|542036271|FG001|Period 1|Death|0|||
150245760|NCT00895895|542036272|FG002|Period 1|Death|0|||
150245761|NCT00895895|542036273|FG003|Period 1|Death|0|||
150245762|NCT00895895|542036274|FG004|Period 1|Death|1|||
150245763|NCT00895895|542036270|FG000|Period 1|discontinued by sponsor|2|||
150245764|NCT00895895|542036271|FG001|Period 1|discontinued by sponsor|1|||
150245765|NCT00895895|542036272|FG002|Period 1|discontinued by sponsor|2|||
150245766|NCT00895895|542036273|FG003|Period 1|discontinued by sponsor|1|||
150245767|NCT00895895|542036274|FG004|Period 1|discontinued by sponsor|1|||
150245768|NCT00895895|542036270|FG000|Period 1|failed to return|0|||
150245769|NCT00895895|542036271|FG001|Period 1|failed to return|0|||
150245770|NCT00895895|542036272|FG002|Period 1|failed to return|1|||
150245771|NCT00895895|542036273|FG003|Period 1|failed to return|0|||
150245772|NCT00895895|542036274|FG004|Period 1|failed to return|1|||
150245773|NCT00895895|542036270|FG000|Period 1|investigator request|0|||
150245774|NCT00895895|542036271|FG001|Period 1|investigator request|1|||
150245775|NCT00895895|542036272|FG002|Period 1|investigator request|0|||
150245776|NCT00895895|542036273|FG003|Period 1|investigator request|0|||
150245777|NCT00895895|542036274|FG004|Period 1|investigator request|0|||
150245778|NCT00895895|542036270|FG000|Period 1|Lost to Follow-up|2|||
150245779|NCT00895895|542036271|FG001|Period 1|Lost to Follow-up|1|||
150245780|NCT00895895|542036272|FG002|Period 1|Lost to Follow-up|3|||
150245781|NCT00895895|542036273|FG003|Period 1|Lost to Follow-up|2|||
150245782|NCT00895895|542036274|FG004|Period 1|Lost to Follow-up|3|||
150245783|NCT00895895|542036270|FG000|Period 1|Other|1|||
150245784|NCT00895895|542036271|FG001|Period 1|Other|2|||
150245785|NCT00895895|542036272|FG002|Period 1|Other|1|||
150245786|NCT00895895|542036273|FG003|Period 1|Other|1|||
150245787|NCT00895895|542036274|FG004|Period 1|Other|1|||
150245788|NCT00895895|542036270|FG000|Period 1|Protocol Violation|0|||
150245789|NCT00895895|542036271|FG001|Period 1|Protocol Violation|1|||
150245790|NCT00895895|542036272|FG002|Period 1|Protocol Violation|0|||
150245791|NCT00895895|542036273|FG003|Period 1|Protocol Violation|0|||
150245792|NCT00895895|542036274|FG004|Period 1|Protocol Violation|0|||
150245793|NCT00895895|542036270|FG000|Period 1|Withdrawal by Subject|6|||
150245794|NCT00895895|542036271|FG001|Period 1|Withdrawal by Subject|6|||
150245795|NCT00895895|542036272|FG002|Period 1|Withdrawal by Subject|8|||
150245796|NCT00895895|542036273|FG003|Period 1|Withdrawal by Subject|2|||
150245797|NCT00895895|542036274|FG004|Period 1|Withdrawal by Subject|4|||
150245798|NCT00895895|542036270|FG000|Period 1|unsatisfactory response-efficacy|2|||
150245799|NCT00895895|542036271|FG001|Period 1|unsatisfactory response-efficacy|0|||
150245800|NCT00895895|542036272|FG002|Period 1|unsatisfactory response-efficacy|0|||
150245801|NCT00895895|542036273|FG003|Period 1|unsatisfactory response-efficacy|0|||
150245802|NCT00895895|542036274|FG004|Period 1|unsatisfactory response-efficacy|0|||
150245803|NCT00895895|542036270|FG000|Period 1|randomized and not treated|1|||
150245804|NCT00895895|542036271|FG001|Period 1|randomized and not treated|3|||
150245805|NCT00895895|542036272|FG002|Period 1|randomized and not treated|1|||
150245806|NCT00895895|542036273|FG003|Period 1|randomized and not treated|1|||
150245807|NCT00895895|542036274|FG004|Period 1|randomized and not treated|2|||
150245808|NCT00895895|542036270|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
150245809|NCT00895895|542036271|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
150245810|NCT00895895|542036272|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
150245811|NCT00895895|542036273|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
150245812|NCT00895895|542036274|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
150245813|NCT00895895|542036270|FG000|After Period 1, Prior to Period 2|Other|0|||
150245814|NCT00895895|542036271|FG001|After Period 1, Prior to Period 2|Other|0|||
150245815|NCT00895895|542036272|FG002|After Period 1, Prior to Period 2|Other|1|||
150245816|NCT00895895|542036273|FG003|After Period 1, Prior to Period 2|Other|0|||
150245817|NCT00895895|542036274|FG004|After Period 1, Prior to Period 2|Other|0|||
150245818|NCT00895895|542036270|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
150245819|NCT00895895|542036271|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
150245820|NCT00895895|542036272|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
150245821|NCT00895895|542036273|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
150245822|NCT00895895|542036274|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
150245823|NCT00895895|542036270|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
150245824|NCT00895895|542036271|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
150245825|NCT00895895|542036272|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
150245826|NCT00895895|542036273|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
150245827|NCT00895895|542036274|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
150245828|NCT00895895|542036270|FG000|Period 2|Adverse Event|3|||
150245829|NCT00895895|542036271|FG001|Period 2|Adverse Event|3|||
150245830|NCT00895895|542036272|FG002|Period 2|Adverse Event|5|||
150245831|NCT00895895|542036273|FG003|Period 2|Adverse Event|2|||
150245832|NCT00895895|542036274|FG004|Period 2|Adverse Event|5|||
150245833|NCT00895895|542036270|FG000|Period 2|Death|0|||
150245834|NCT00895895|542036271|FG001|Period 2|Death|0|||
150245835|NCT00895895|542036272|FG002|Period 2|Death|1|||
150245836|NCT00895895|542036273|FG003|Period 2|Death|0|||
150245837|NCT00895895|542036274|FG004|Period 2|Death|0|||
150245838|NCT00895895|542036270|FG000|Period 2|discontinued by sponsor|44|||
150245839|NCT00895895|542036271|FG001|Period 2|discontinued by sponsor|44|||
150245840|NCT00895895|542036272|FG002|Period 2|discontinued by sponsor|38|||
150245841|NCT00895895|542036273|FG003|Period 2|discontinued by sponsor|46|||
150245842|NCT00895895|542036274|FG004|Period 2|discontinued by sponsor|37|||
150245843|NCT00895895|542036270|FG000|Period 2|failed to return|2|||
150245844|NCT00895895|542036271|FG001|Period 2|failed to return|0|||
150245845|NCT00895895|542036272|FG002|Period 2|failed to return|0|||
150245846|NCT00895895|542036273|FG003|Period 2|failed to return|0|||
150245847|NCT00895895|542036274|FG004|Period 2|failed to return|0|||
150245848|NCT00895895|542036270|FG000|Period 2|investigator request|2|||
150245849|NCT00895895|542036271|FG001|Period 2|investigator request|0|||
150245850|NCT00895895|542036272|FG002|Period 2|investigator request|0|||
150245851|NCT00895895|542036273|FG003|Period 2|investigator request|0|||
150245852|NCT00895895|542036274|FG004|Period 2|investigator request|0|||
150245853|NCT00895895|542036270|FG000|Period 2|Lost to Follow-up|1|||
150245854|NCT00895895|542036271|FG001|Period 2|Lost to Follow-up|2|||
150245855|NCT00895895|542036272|FG002|Period 2|Lost to Follow-up|1|||
150245856|NCT00895895|542036273|FG003|Period 2|Lost to Follow-up|1|||
150245857|NCT00895895|542036274|FG004|Period 2|Lost to Follow-up|0|||
150245858|NCT00895895|542036270|FG000|Period 2|Other|1|||
150245859|NCT00895895|542036271|FG001|Period 2|Other|1|||
150245860|NCT00895895|542036272|FG002|Period 2|Other|3|||
150245861|NCT00895895|542036273|FG003|Period 2|Other|1|||
150245862|NCT00895895|542036274|FG004|Period 2|Other|1|||
150245863|NCT00895895|542036270|FG000|Period 2|Protocol Violation|1|||
150245864|NCT00895895|542036271|FG001|Period 2|Protocol Violation|0|||
150245865|NCT00895895|542036272|FG002|Period 2|Protocol Violation|1|||
150245866|NCT00895895|542036273|FG003|Period 2|Protocol Violation|1|||
150245867|NCT00895895|542036274|FG004|Period 2|Protocol Violation|1|||
150245868|NCT00895895|542036270|FG000|Period 2|Withdrawal by Subject|0|||
150245869|NCT00895895|542036271|FG001|Period 2|Withdrawal by Subject|2|||
150245870|NCT00895895|542036272|FG002|Period 2|Withdrawal by Subject|0|||
150245871|NCT00895895|542036273|FG003|Period 2|Withdrawal by Subject|3|||
150245872|NCT00895895|542036274|FG004|Period 2|Withdrawal by Subject|5|||
150245873|NCT00895895|542036270|FG000|Period 2|unsatisfactory response-efficacy|2|||
150245874|NCT00895895|542036271|FG001|Period 2|unsatisfactory response-efficacy|1|||
150245875|NCT00895895|542036272|FG002|Period 2|unsatisfactory response-efficacy|0|||
150245876|NCT00895895|542036273|FG003|Period 2|unsatisfactory response-efficacy|0|||
150245877|NCT00895895|542036274|FG004|Period 2|unsatisfactory response-efficacy|0|||
150245878|NCT01261000|542036275|FG000|Overall Study|Screen failure|1|||
150245879|NCT03019640|542036276|FG000|Overall Study|Screen Failures|4|||
150245880|NCT03019640|542036276|FG000|Overall Study|Adverse Event|3|||
150245881|NCT03019640|542036276|FG000|Overall Study|Participant Relapsed|1|||
150245882|NCT04916730|542036284|FG000|Overall Study|Withdrawal by Subject|4|||
150245883|NCT04916730|542036285|FG001|Overall Study|Withdrawal by Subject|2|||
150245884|NCT04916730|542036284|FG000|Overall Study|Lost to Follow-up|0|||
150245885|NCT04916730|542036285|FG001|Overall Study|Lost to Follow-up|2|||
150245886|NCT04916730|542036284|FG000|Overall Study|Physician Decision|1|||
150245887|NCT04916730|542036285|FG001|Overall Study|Physician Decision|0|||
150245888|NCT00455741|542036286|FG000|Overall Study|Physician Decision|0|||
150245889|NCT00455741|542036287|FG001|Overall Study|Physician Decision|1|||
150245890|NCT04978090|542036290|FG000|Overall Study|unable to adequately fit device|2|||
150245891|NCT00935532|542036295|FG000|Overall Study|Adverse Event|11|||
150245892|NCT00935532|542036296|FG001|Overall Study|Adverse Event|6|||
150245893|NCT00935532|542036295|FG000|Overall Study|Death|1|||
150245894|NCT00935532|542036296|FG001|Overall Study|Death|0|||
150245895|NCT00935532|542036295|FG000|Overall Study|Lost to Follow-up|1|||
150245896|NCT00935532|542036296|FG001|Overall Study|Lost to Follow-up|0|||
150245897|NCT00935532|542036295|FG000|Overall Study|Physician Decision|1|||
150245898|NCT00935532|542036296|FG001|Overall Study|Physician Decision|2|||
150245899|NCT00935532|542036295|FG000|Overall Study|Protocol Violation|2|||
150245900|NCT00935532|542036296|FG001|Overall Study|Protocol Violation|1|||
150245901|NCT00935532|542036295|FG000|Overall Study|Subject Decision|2|||
150245902|NCT00935532|542036296|FG001|Overall Study|Subject Decision|1|||
150245903|NCT00935532|542036295|FG000|Overall Study|Sponsor Decision|0|||
150245904|NCT00935532|542036296|FG001|Overall Study|Sponsor Decision|1|||
150245905|NCT00935532|542036295|FG000|Overall Study|Loss Glucose Control|4|||
150245906|NCT00935532|542036296|FG001|Overall Study|Loss Glucose Control|0|||
150245907|NCT02227992|542036297|FG000|Overall Study|Lost to Follow-up|1|||
150245908|NCT02227992|542036298|FG001|Overall Study|Lost to Follow-up|1|||
150245909|NCT00996606|542036299|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
150245910|NCT00996606|542036299|FG000|Overall Study|Insufficient Therapeutic Response|2|||
150245911|NCT00996606|542036299|FG000|Overall Study|Protocol Violation|1|||
150245912|NCT00996606|542036299|FG000|Overall Study|Withdrawal by Subject|3|||
150245913|NCT00281320|542036300|FG000|Overall Study|Adverse Event|12|||
150245914|NCT00281320|542036301|FG001|Overall Study|Adverse Event|9|||
150245915|NCT00281320|542036300|FG000|Overall Study|Lack of Efficacy|4|||
150245916|NCT00281320|542036301|FG001|Overall Study|Lack of Efficacy|3|||
150245917|NCT00281320|542036300|FG000|Overall Study|Withdrawal by Subject|5|||
150245918|NCT00281320|542036301|FG001|Overall Study|Withdrawal by Subject|6|||
150245919|NCT00281320|542036300|FG000|Overall Study|Lost to Follow-up|1|||
150245920|NCT00281320|542036301|FG001|Overall Study|Lost to Follow-up|2|||
150245921|NCT00281320|542036300|FG000|Overall Study|Other|3|||
150245922|NCT00281320|542036301|FG001|Overall Study|Other|1|||
150245923|NCT00475228|542036302|FG000|Overall Study|Lost to Follow-up|17|||
150245924|NCT00475228|542036303|FG001|Overall Study|Lost to Follow-up|17|||
150245925|NCT01447576|542036304|FG000|Overall Study|Lost to Follow-up|52|||
150245926|NCT01447576|542036304|FG000|Overall Study|Adverse Event|127|||
150245927|NCT01447576|542036304|FG000|Overall Study|Participant met withdrawal criteria|40|||
150245928|NCT01447576|542036304|FG000|Overall Study|Withdrawal by Subject|100|||
150245929|NCT01447576|542036304|FG000|Overall Study|Protocol deviation|83|||
150245930|NCT01447576|542036304|FG000|Overall Study|Lack of Efficacy|68|||
150245931|NCT01447576|542036304|FG000|Overall Study|Physician Decision|6|||
150245932|NCT00975676|542036306|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
150245933|NCT00975676|542036307|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
150245934|NCT02548078|542036308|FG000|Overall Study|Serious adverse event/Adverse event|1|||
150245935|NCT02548078|542036309|FG001|Overall Study|Serious adverse event/Adverse event|0|||
150245936|NCT02548078|542036308|FG000|Overall Study|Moved from study area|3|||
150245937|NCT02548078|542036309|FG001|Overall Study|Moved from study area|3|||
150245938|NCT02548078|542036308|FG000|Overall Study|Lost to Follow-up|1|||
150245939|NCT02548078|542036309|FG001|Overall Study|Lost to Follow-up|3|||
150245940|NCT02579772|542036310|FG000|Overall Study|Withdrawal by Subject|0|||
150245941|NCT02579772|542036311|FG001|Overall Study|Withdrawal by Subject|1|||
150245942|NCT02579772|542036310|FG000|Overall Study|Usage of additional antioxidants|1|||
150245943|NCT02579772|542036311|FG001|Overall Study|Usage of additional antioxidants|0|||
150245944|NCT02579772|542036310|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
150245945|NCT02579772|542036311|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
150245946|NCT03128671|542036312|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
150245947|NCT03128671|542036313|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
150245948|NCT03128671|542036312|FG000|Allocation|Death|1|||
150245949|NCT03128671|542036313|FG001|Allocation|Death|0|||
150245950|NCT03128671|542036312|FG000|Allocation|Withdrawal by Subject|4|||
150245951|NCT03128671|542036313|FG001|Allocation|Withdrawal by Subject|0|||
150245952|NCT03128671|542036312|FG000|Intervention|Withdrawal by Subject|11|||
150245953|NCT03128671|542036313|FG001|Intervention|Withdrawal by Subject|10|||
150245954|NCT03128671|542036312|FG000|Intervention|Palliative/hospice care initiated|9|||
150245955|NCT03128671|542036313|FG001|Intervention|Palliative/hospice care initiated|10|||
150245956|NCT03128671|542036312|FG000|Intervention|Death|13|||
150245957|NCT03128671|542036313|FG001|Intervention|Death|11|||
150245958|NCT03128671|542036312|FG000|Intervention|Interrupted by hurricane|1|||
150245959|NCT03128671|542036313|FG001|Intervention|Interrupted by hurricane|0|||
150245960|NCT03128671|542036312|FG000|Intervention|Physician Decision|2|||
150245961|NCT03128671|542036313|FG001|Intervention|Physician Decision|3|||
150245962|NCT04641962|542036315|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
150245963|NCT04641962|542036316|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
150245964|NCT04641962|542036317|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
150245965|NCT04641962|542036318|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
150245966|NCT04641962|542036319|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
150245967|NCT04641962|542036315|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
150245968|NCT04641962|542036316|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
150245969|NCT04641962|542036317|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
150245970|NCT04641962|542036318|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
150245971|NCT04641962|542036319|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
150245972|NCT04641962|542036315|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
150245973|NCT04641962|542036316|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
150245974|NCT04641962|542036317|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
150245975|NCT04641962|542036318|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
150245976|NCT04641962|542036319|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
150245977|NCT04641962|542036315|FG000|DBT Period: Up to 52 Weeks|Death|1|||
150245978|NCT04641962|542036316|FG001|DBT Period: Up to 52 Weeks|Death|0|||
150245979|NCT04641962|542036317|FG002|DBT Period: Up to 52 Weeks|Death|0|||
150245980|NCT04641962|542036318|FG003|DBT Period: Up to 52 Weeks|Death|0|||
150245981|NCT04641962|542036319|FG004|DBT Period: Up to 52 Weeks|Death|0|||
150245982|NCT04641962|542036315|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
150245983|NCT04641962|542036316|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
150245984|NCT04641962|542036317|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
150245985|NCT04641962|542036318|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
150245986|NCT04641962|542036319|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
150245987|NCT04641962|542036315|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
150245988|NCT04641962|542036316|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
150245989|NCT04641962|542036317|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
150245990|NCT04641962|542036318|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
150245991|NCT04641962|542036319|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
150245992|NCT04641962|542036315|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
150245993|NCT04641962|542036316|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
150245994|NCT04641962|542036317|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
150245995|NCT04641962|542036318|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
150245996|NCT04641962|542036319|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
150245997|NCT00862836|542036320|FG000|Overall Study|Withdrawal by Subject|1|||
150245998|NCT02942004|542037786|FG000|Overall Study|Withdrawal by Subject|0|||
150245999|NCT02942004|542037787|FG001|Overall Study|Withdrawal by Subject|2|||
150246000|NCT02942004|542037788|FG002|Overall Study|Withdrawal by Subject|3|||
150246001|NCT02942004|542037786|FG000|Overall Study|Lost to Follow-up|1|||
150246002|NCT02942004|542037787|FG001|Overall Study|Lost to Follow-up|1|||
150246003|NCT02942004|542037788|FG002|Overall Study|Lost to Follow-up|2|||
150246004|NCT02942004|542037786|FG000|Overall Study|Randomized but not dosed|3|||
150246005|NCT02942004|542037787|FG001|Overall Study|Randomized but not dosed|9|||
150246006|NCT02942004|542037788|FG002|Overall Study|Randomized but not dosed|4|||
150246007|NCT05627258|542037789|FG000|Overall Study|Lost to Follow-up|1|||
150246008|NCT05627258|542037790|FG001|Overall Study|Lost to Follow-up|0|||
150246009|NCT05627258|542037791|FG002|Overall Study|Lost to Follow-up|0|||
150246010|NCT05627258|542037792|FG003|Overall Study|Lost to Follow-up|0|||
150246011|NCT05627258|542037793|FG004|Overall Study|Lost to Follow-up|0|||
150246012|NCT05627258|542037794|FG005|Overall Study|Lost to Follow-up|0|||
150246013|NCT05627258|542037789|FG000|Overall Study|Withdrawal by Subject|0|||
150246014|NCT05627258|542037790|FG001|Overall Study|Withdrawal by Subject|0|||
150246015|NCT05627258|542037791|FG002|Overall Study|Withdrawal by Subject|0|||
150246016|NCT05627258|542037792|FG003|Overall Study|Withdrawal by Subject|0|||
149737502|NCT02601950|540170380|FG003|Overall Study|Participant refused further study treatment|0|||
149737503|NCT02601950|540170381|FG004|Overall Study|Participant refused further study treatment|2|||
149737504|NCT02601950|540170382|FG005|Overall Study|Participant refused further study treatment|2|||
149737505|NCT02601950|540170383|FG006|Overall Study|Participant refused further study treatment|2|||
149737506|NCT02601950|540170384|FG007|Overall Study|Participant refused further study treatment|1|||
149737507|NCT02601950|540170377|FG000|Overall Study|Investigator discretion|1|||
149737508|NCT02601950|540170378|FG001|Overall Study|Investigator discretion|0|||
149737509|NCT02601950|540170379|FG002|Overall Study|Investigator discretion|1|||
149737510|NCT02601950|540170380|FG003|Overall Study|Investigator discretion|0|||
149737511|NCT02601950|540170381|FG004|Overall Study|Investigator discretion|1|||
149737512|NCT02601950|540170382|FG005|Overall Study|Investigator discretion|1|||
149737513|NCT02601950|540170383|FG006|Overall Study|Investigator discretion|1|||
149737514|NCT02601950|540170384|FG007|Overall Study|Investigator discretion|0|||
149737515|NCT02601950|540170377|FG000|Overall Study|Other|0|||
149737516|NCT02601950|540170378|FG001|Overall Study|Other|0|||
149737517|NCT02601950|540170379|FG002|Overall Study|Other|0|||
149737518|NCT02601950|540170380|FG003|Overall Study|Other|0|||
149737519|NCT02601950|540170381|FG004|Overall Study|Other|2|||
149737520|NCT02601950|540170382|FG005|Overall Study|Other|2|||
149737521|NCT02601950|540170383|FG006|Overall Study|Other|1|||
149737522|NCT02601950|540170384|FG007|Overall Study|Other|0|||
149737523|NCT00408005|540170385|FG000|Induction|Adverse Event|19|||
149737524|NCT00408005|540170386|FG001|Induction|Adverse Event|3|||
149737525|NCT00408005|540170387|FG002|Induction|Adverse Event|0|||
149737526|NCT00408005|540170388|FG003|Induction|Adverse Event|0|||
149737527|NCT00408005|540170389|FG004|Induction|Adverse Event|0|||
149737528|NCT00408005|540170390|FG005|Induction|Adverse Event|0|||
149737529|NCT00408005|540170391|FG006|Induction|Adverse Event|0|||
149737530|NCT00408005|540170392|FG007|Induction|Adverse Event|0|||
149737531|NCT00408005|540170385|FG000|Induction|Death|6|||
149737532|NCT00408005|540170386|FG001|Induction|Death|0|||
149737533|NCT00408005|540170387|FG002|Induction|Death|0|||
149737534|NCT00408005|540170388|FG003|Induction|Death|0|||
149737535|NCT00408005|540170389|FG004|Induction|Death|0|||
149737536|NCT00408005|540170390|FG005|Induction|Death|0|||
149737537|NCT00408005|540170391|FG006|Induction|Death|0|||
149737538|NCT00408005|540170392|FG007|Induction|Death|0|||
149737539|NCT00408005|540170385|FG000|Induction|Physician Decision|83|||
149737540|NCT00408005|540170386|FG001|Induction|Physician Decision|9|||
149737541|NCT00408005|540170387|FG002|Induction|Physician Decision|0|||
149737542|NCT00408005|540170388|FG003|Induction|Physician Decision|0|||
149737543|NCT00408005|540170389|FG004|Induction|Physician Decision|0|||
149737544|NCT00408005|540170390|FG005|Induction|Physician Decision|0|||
150246017|NCT05627258|542037793|FG004|Overall Study|Withdrawal by Subject|2|||
150246018|NCT05627258|542037794|FG005|Overall Study|Withdrawal by Subject|0|||
150246019|NCT05627258|542037789|FG000|Overall Study|Enrolled, but product not administered|1|||
150246020|NCT05627258|542037790|FG001|Overall Study|Enrolled, but product not administered|0|||
150246021|NCT05627258|542037791|FG002|Overall Study|Enrolled, but product not administered|0|||
150246022|NCT05627258|542037792|FG003|Overall Study|Enrolled, but product not administered|0|||
150246023|NCT05627258|542037793|FG004|Overall Study|Enrolled, but product not administered|0|||
150246024|NCT05627258|542037794|FG005|Overall Study|Enrolled, but product not administered|0|||
150246025|NCT05627258|542037789|FG000|Overall Study|Other subject illness/injury|1|||
150246026|NCT05627258|542037790|FG001|Overall Study|Other subject illness/injury|0|||
150246027|NCT05627258|542037791|FG002|Overall Study|Other subject illness/injury|0|||
150246028|NCT05627258|542037792|FG003|Overall Study|Other subject illness/injury|0|||
150246029|NCT05627258|542037793|FG004|Overall Study|Other subject illness/injury|0|||
150246030|NCT05627258|542037794|FG005|Overall Study|Other subject illness/injury|0|||
150246031|NCT05627258|542037789|FG000|Overall Study|Subject moved from area|0|||
150246032|NCT05627258|542037790|FG001|Overall Study|Subject moved from area|0|||
150246033|NCT05627258|542037791|FG002|Overall Study|Subject moved from area|1|||
150246034|NCT05627258|542037792|FG003|Overall Study|Subject moved from area|0|||
150246035|NCT05627258|542037793|FG004|Overall Study|Subject moved from area|0|||
149737545|NCT00408005|540170391|FG006|Induction|Physician Decision|0|||
149737546|NCT00408005|540170392|FG007|Induction|Physician Decision|0|||
149737547|NCT00408005|540170385|FG000|Induction|Withdrawal by Subject|2|||
150246036|NCT05627258|542037794|FG005|Overall Study|Subject moved from area|0|||
149737548|NCT00408005|540170386|FG001|Induction|Withdrawal by Subject|4|||
149737549|NCT00408005|540170387|FG002|Induction|Withdrawal by Subject|0|||
149737550|NCT00408005|540170388|FG003|Induction|Withdrawal by Subject|0|||
149737551|NCT00408005|540170389|FG004|Induction|Withdrawal by Subject|0|||
149737552|NCT00408005|540170390|FG005|Induction|Withdrawal by Subject|0|||
150246037|NCT04517669|542037795|FG000|Overall Study|Lost to Follow-up|2|||
150246038|NCT04517669|542037795|FG000|Overall Study|Withdrawal by Subject|3|||
150246039|NCT04517669|542037795|FG000|Overall Study|Drug withdrawn|44|||
150246040|NCT04517669|542037795|FG000|Overall Study|Other|1|||
150246041|NCT04517669|542037795|FG000|Overall Study|Eligibility criteria not met|4|||
150246042|NCT04517669|542037795|FG000|Overall Study|Did not receive treatment|3|||
150246043|NCT02138786|542037796|FG000|Overall Study|Adverse Event|0|||
150246044|NCT02138786|542037797|FG001|Overall Study|Adverse Event|2|||
150246045|NCT02138786|542037798|FG002|Overall Study|Adverse Event|1|||
150246046|NCT02138786|542037796|FG000|Overall Study|Death|1|||
150246047|NCT02138786|542037797|FG001|Overall Study|Death|7|||
150246048|NCT02138786|542037798|FG002|Overall Study|Death|2|||
150246049|NCT02138786|542037796|FG000|Overall Study|Disease Progression|1|||
150246050|NCT02138786|542037797|FG001|Overall Study|Disease Progression|1|||
150246051|NCT02138786|542037798|FG002|Overall Study|Disease Progression|3|||
150246052|NCT02138786|542037796|FG000|Overall Study|Withdrawal by Subject|1|||
150246053|NCT02138786|542037797|FG001|Overall Study|Withdrawal by Subject|2|||
150246054|NCT02138786|542037798|FG002|Overall Study|Withdrawal by Subject|0|||
150246055|NCT02138786|542037796|FG000|Overall Study|Patient's Wish|0|||
150246056|NCT02138786|542037797|FG001|Overall Study|Patient's Wish|2|||
150246057|NCT02138786|542037798|FG002|Overall Study|Patient's Wish|0|||
150246058|NCT02138786|542037796|FG000|Overall Study|Sponsor Terminated Study|0|||
150246059|NCT02138786|542037797|FG001|Overall Study|Sponsor Terminated Study|1|||
150246060|NCT02138786|542037798|FG002|Overall Study|Sponsor Terminated Study|1|||
150246061|NCT02138786|542037796|FG000|Overall Study|Non-Compliance|0|||
150246062|NCT02138786|542037797|FG001|Overall Study|Non-Compliance|0|||
150246063|NCT02138786|542037798|FG002|Overall Study|Non-Compliance|1|||
150246064|NCT02088957|542037799|FG000|Overall Study|Lack of Efficacy|1|||
150246065|NCT02088957|542037800|FG001|Overall Study|Lack of Efficacy|0|||
150246066|NCT01923662|542037804|FG000|Overall Study|Withdrawal by Subject|1|||
150246067|NCT00677534|542037808|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
150246068|NCT00677534|542037808|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
150246069|NCT00677534|542037808|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
150246070|NCT02687035|542037809|FG000|Overall Study|Withdrawal by Subject|1|||
150246071|NCT02687035|542037809|FG000|Overall Study|Death|87|||
150246072|NCT02687035|542037809|FG000|Overall Study|Lost to Follow-up|1|||
150246073|NCT02687035|542037809|FG000|Overall Study|Missed Visit|87|||
150246074|NCT02687035|542037809|FG000|Overall Study|Did not receive Study Device|8|||
150246075|NCT00667394|542037812|FG000|Overall Study|Adverse Event|3|||
150246076|NCT00667394|542037813|FG001|Overall Study|Adverse Event|0|||
150246077|NCT00667394|542037812|FG000|Overall Study|Progressive disease|1|||
150246078|NCT00667394|542037813|FG001|Overall Study|Progressive disease|0|||
150246079|NCT04638660|542037818|FG000|Overall Study|Withdrawal by Subject|2|||
150246080|NCT04638660|542037819|FG001|Overall Study|Withdrawal by Subject|0|||
150246081|NCT04638660|542037818|FG000|Overall Study|Lost to Follow-up|1|||
150246082|NCT04638660|542037819|FG001|Overall Study|Lost to Follow-up|0|||
150246083|NCT04481373|542037824|FG000|Overall Study|Protocol Violation|1|||
150246084|NCT04481373|542037825|FG001|Overall Study|Protocol Violation|0|||
150246085|NCT04481373|542037824|FG000|Overall Study|Viral load in hospital not over 1000|2|||
150246086|NCT04481373|542037825|FG001|Overall Study|Viral load in hospital not over 1000|1|||
150246087|NCT04481373|542037824|FG000|Overall Study|Death before hospital discharge|1|||
150246088|NCT04481373|542037825|FG001|Overall Study|Death before hospital discharge|0|||
150246089|NCT00332462|542037826|FG000|Overall Study|Adverse Event|5|||
150246090|NCT00332462|542037826|FG000|Overall Study|Abnormal Lab Value|1|||
149737553|NCT00408005|540170391|FG006|Induction|Withdrawal by Subject|0|||
150246091|NCT00332462|542037826|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
150246092|NCT00332462|542037826|FG000|Overall Study|no longer requires study drug|1|||
150246093|NCT00332462|542037826|FG000|Overall Study|Death|3|||
150246094|NCT00332462|542037826|FG000|Overall Study|Graft Loss|2|||
150246095|NCT02922023|542037829|FG000|Overall Study|Lost to Follow-up|2|||
150246096|NCT02922023|542037830|FG001|Overall Study|Lost to Follow-up|0|||
150246097|NCT02766777|542037843|FG000|Overall Study|Adverse Event|12|||
150246098|NCT02766777|542037843|FG000|Overall Study|Lost to Follow-up|16|||
150246099|NCT02766777|542037843|FG000|Overall Study|Non-Compliance With Study Drug|1|||
150246100|NCT02766777|542037843|FG000|Overall Study|Protocol Violation|1|||
150246101|NCT02766777|542037843|FG000|Overall Study|Withdrawal by Subject|4|||
150246102|NCT01886287|542037844|FG000|Overall Study|Radiographic disease progression|1|||
150246103|NCT01886287|542037844|FG000|Overall Study|Clinical progression due to disease|1|||
150246104|NCT02593123|542037845|FG000|Overall Study|Physician Decision|2|||
150246105|NCT02593123|542037846|FG001|Overall Study|Physician Decision|1|||
150246106|NCT02593123|542037845|FG000|Overall Study|Relapse|1|||
150246107|NCT02593123|542037846|FG001|Overall Study|Relapse|1|||
150246108|NCT00504777|542037847|FG000|Overall Study|Adverse Event|1|||
150246109|NCT01195623|542037851|FG000|Overall Study|Lost to Follow-up|35|||
150246110|NCT01195623|542037852|FG001|Overall Study|Lost to Follow-up|37|||
150246111|NCT00534495|542037854|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
150246112|NCT00534495|542037855|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
150246113|NCT00534495|542037856|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
150246114|NCT00534495|542037854|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
150246115|NCT00534495|542037855|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
150246116|NCT00534495|542037856|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
150246117|NCT00534495|542037854|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
150246118|NCT00534495|542037855|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
150246119|NCT00534495|542037856|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
150246120|NCT00534495|542037854|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
150246121|NCT00534495|542037855|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
150246122|NCT00534495|542037856|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
150246123|NCT00534495|542037854|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
150246124|NCT00534495|542037855|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
150246125|NCT00534495|542037856|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
150246126|NCT00534495|542037854|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
150246127|NCT00534495|542037855|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
150246128|NCT00534495|542037856|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
150246129|NCT00534495|542037854|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
150246130|NCT00534495|542037855|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
150246131|NCT00534495|542037856|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
150246132|NCT00534495|542037854|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
150246133|NCT00534495|542037855|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
150246134|NCT00534495|542037856|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
150246135|NCT00534495|542037854|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
150246136|NCT00534495|542037855|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
150246137|NCT00534495|542037856|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
150246138|NCT01572740|542037857|FG000|Overall Study|Adverse Event|1|||
150246139|NCT01572740|542037858|FG001|Overall Study|Adverse Event|1|||
150246140|NCT01572740|542037857|FG000|Overall Study|Withdrawal by Subject|1|||
150246141|NCT01572740|542037858|FG001|Overall Study|Withdrawal by Subject|1|||
150246142|NCT01572740|542037857|FG000|Overall Study|unclassified|4|||
150246143|NCT01572740|542037858|FG001|Overall Study|unclassified|3|||
150246144|NCT00214019|542037862|FG000|Overall Study|Lost to Follow-up|11|||
150246145|NCT00214019|542037862|FG000|Overall Study|Withdrawal by Subject|2|||
150246146|NCT00214019|542037862|FG000|Overall Study|Screen Failed prior to randomization|17|||
150246147|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
150246148|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
150246149|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
150246150|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
150246151|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
150246152|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
150246153|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
150246154|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
149737554|NCT00408005|540170392|FG007|Induction|Withdrawal by Subject|0|||
150246155|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
150246156|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
150246157|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246158|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246159|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
150246160|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
150246161|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246162|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246163|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246164|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
150246165|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
150246166|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246167|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246168|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246169|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
150246170|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
149737555|NCT00408005|540170385|FG000|Induction|Ineligible|33|||
150246171|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246172|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246173|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
150246174|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
150246175|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
150246176|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
150246177|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
150246178|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
150246179|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
150246180|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
149737556|NCT00408005|540170386|FG001|Induction|Ineligible|14|||
150246181|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
150246182|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
150246183|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
150246184|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
150246185|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
150246186|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
150246187|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
150246188|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
150246189|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
150246190|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
150246191|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
150246192|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
150246193|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
150246194|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
150246195|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
150246196|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
150246197|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
150246198|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
150246199|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
150246200|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
150246201|NCT00477490|542037863|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
150246202|NCT00477490|542037864|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
150246203|NCT00477490|542037865|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
150246204|NCT00477490|542037866|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
150246205|NCT00477490|542037867|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
150246206|NCT00477490|542037868|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
150246207|NCT00477490|542037869|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
150246208|NCT00477490|542037870|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
150246209|NCT00477490|542037871|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
150246210|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
150246211|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
150246212|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
150246213|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
150246214|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
150246215|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
150246216|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
150246217|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
150246218|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
150246219|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
150246220|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
150246221|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
150246222|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
150246223|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
150246224|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
150246225|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
150246226|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
150246227|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
150246228|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
150246229|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
150246230|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
150246231|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
150246232|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
150246233|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
150246234|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
150246235|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
150246236|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
150246237|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246238|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246239|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246240|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246241|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
150246242|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246243|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
150246244|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
150246245|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
150246246|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246247|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
150246248|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246249|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246250|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246251|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246252|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246253|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246254|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
150246255|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
150246256|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
150246257|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
150246258|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
150246259|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
150246260|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
150246261|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
150246262|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
150246263|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
150246264|NCT00477490|542037863|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246265|NCT00477490|542037864|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
150246266|NCT00477490|542037865|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
150246267|NCT00477490|542037866|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246268|NCT00477490|542037867|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
150246269|NCT00477490|542037868|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246270|NCT00477490|542037869|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246271|NCT00477490|542037870|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246272|NCT00477490|542037871|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
150246273|NCT01465763|542037876|FG000|Overall Study|Withdrawal by Subject|4|||
150246274|NCT01465763|542037877|FG001|Overall Study|Withdrawal by Subject|0|||
150246275|NCT01465763|542037878|FG002|Overall Study|Withdrawal by Subject|1|||
150246276|NCT01465763|542037876|FG000|Overall Study|Insufficient Clinical Response|11|||
150246277|NCT01465763|542037877|FG001|Overall Study|Insufficient Clinical Response|0|||
150246278|NCT01465763|542037878|FG002|Overall Study|Insufficient Clinical Response|1|||
150246279|NCT01465763|542037876|FG000|Overall Study|Adverse Event|9|||
150246280|NCT01465763|542037877|FG001|Overall Study|Adverse Event|0|||
150246281|NCT01465763|542037878|FG002|Overall Study|Adverse Event|1|||
150246282|NCT01465763|542037876|FG000|Overall Study|Other|2|||
150246283|NCT01465763|542037877|FG001|Overall Study|Other|0|||
150246284|NCT01465763|542037878|FG002|Overall Study|Other|0|||
150246285|NCT01465763|542037876|FG000|Overall Study|Protocol Violation|4|||
150246286|NCT01465763|542037877|FG001|Overall Study|Protocol Violation|1|||
150246287|NCT01465763|542037878|FG002|Overall Study|Protocol Violation|1|||
150246288|NCT01465763|542037876|FG000|Overall Study|Death|1|||
150246289|NCT01465763|542037877|FG001|Overall Study|Death|0|||
150246290|NCT01465763|542037878|FG002|Overall Study|Death|0|||
150246291|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
150246292|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
150246293|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
150246294|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
150246295|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246296|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246297|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246298|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246299|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246300|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246301|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246302|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
150246303|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
150246304|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
150246305|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
150246306|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
150246307|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246308|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246309|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246310|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246311|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246312|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246313|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246314|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
150246315|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
150246316|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
150246317|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
150246318|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
150246319|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246320|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246321|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246322|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246323|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246324|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246325|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246326|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
150246327|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
150246328|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
150246329|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
150246330|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
150246331|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246332|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246333|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246334|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246335|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246336|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246337|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246338|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
150246339|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246340|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246341|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
150246342|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
150246343|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246344|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246345|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246346|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246347|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246348|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246349|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246350|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
150246351|NCT01646177|542037879|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
150246352|NCT01646177|542037880|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
150246353|NCT01646177|542037881|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
150246354|NCT01646177|542037882|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246355|NCT01646177|542037883|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246356|NCT01646177|542037884|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246357|NCT01646177|542037885|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246358|NCT01646177|542037886|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246359|NCT01646177|542037887|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246360|NCT01646177|542037888|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246361|NCT01646177|542037889|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246362|NCT01646177|542037890|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
150246363|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246364|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246365|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246366|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246367|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
150246368|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
150246369|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
150246370|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
150246371|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246372|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246373|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246374|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
150246375|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246376|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246377|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246378|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246379|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
150246380|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
150246381|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
150246382|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
150246383|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246384|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246385|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246386|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
150246387|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246388|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246389|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246390|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246391|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
150246392|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
150246393|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
150246394|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
150246395|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246396|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246397|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246398|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
150246399|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246400|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246401|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246402|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246403|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
150246404|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
150246405|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
150246406|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
150246407|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246408|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246409|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246410|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
150246411|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246412|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246413|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246414|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246415|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
150246416|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
150246417|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
150246418|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
150246419|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246420|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246421|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246422|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
150246423|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246424|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246425|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246426|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246427|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
150246428|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
150246429|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246430|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
150246431|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246432|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246433|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246434|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
150246435|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246436|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246437|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246438|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246439|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
150246440|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
150246441|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
150246442|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
150246443|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246444|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246445|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246446|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
150246447|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
150246448|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
150246449|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
150246450|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
150246451|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
150246452|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
150246453|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
150246454|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
150246455|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
150246456|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
150246457|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
150246458|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
150246459|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246460|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246461|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246462|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246463|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
150246464|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
150246465|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
150246466|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
150246467|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246468|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246469|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246470|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
150246471|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246472|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246473|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246474|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246475|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246476|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246477|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246478|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
150246479|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246480|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246481|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246482|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
150246483|NCT01646177|542037879|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246484|NCT01646177|542037880|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246485|NCT01646177|542037881|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246486|NCT01646177|542037882|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246487|NCT01646177|542037883|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246488|NCT01646177|542037884|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
150246489|NCT01646177|542037885|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
150246490|NCT01646177|542037886|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
150246491|NCT01646177|542037887|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246492|NCT01646177|542037888|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246493|NCT01646177|542037889|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246494|NCT01646177|542037890|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
150246495|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246496|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246497|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246498|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246499|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246500|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246501|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246502|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
150246503|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
150246504|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
150246505|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
150246506|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
150246507|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246508|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246509|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246510|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246511|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246512|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246513|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246514|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
150246515|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
150246516|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
150246517|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
150246518|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
150246519|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246520|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246521|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246522|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246523|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246524|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246525|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246526|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
150246527|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
150246528|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
150246529|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
150246530|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
150246531|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246532|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246533|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246534|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246535|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246536|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246537|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246538|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
150246539|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
150246540|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
150246541|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
150246542|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
150246543|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246544|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246545|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246546|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246547|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246548|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246549|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246550|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
150246551|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
150246552|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
150246553|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
150246554|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
150246555|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246556|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246557|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246558|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246559|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246560|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246561|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246562|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
150246563|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
150246564|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
150246565|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
150246566|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
149737557|NCT00408005|540170387|FG002|Induction|Ineligible|0|||
150246567|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246568|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246569|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246570|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246571|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246572|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246573|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246574|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246575|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
150246576|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
150246577|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
150246578|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
150246579|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246580|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246581|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246582|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246583|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246584|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246585|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246586|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246587|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
150246588|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
150246589|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
150246590|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
150246591|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246592|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246593|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246594|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246595|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246596|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246597|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246598|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246599|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
150246600|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
150246601|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
150246602|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
150246603|NCT01646177|542037879|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246604|NCT01646177|542037880|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246605|NCT01646177|542037881|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246606|NCT01646177|542037882|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246607|NCT01646177|542037883|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246608|NCT01646177|542037884|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246609|NCT01646177|542037885|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246610|NCT01646177|542037886|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246611|NCT01646177|542037887|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246612|NCT01646177|542037888|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
150246613|NCT01646177|542037889|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
150246614|NCT01646177|542037890|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
150246615|NCT02920970|542037893|FG000|First Intervention|Protocol Violation|0|||
150246616|NCT02920970|542037894|FG001|First Intervention|Protocol Violation|1|||
150246617|NCT02920970|542037893|FG000|First Intervention|Adverse Event|0|||
150246618|NCT02920970|542037894|FG001|First Intervention|Adverse Event|1|||
150246619|NCT02920970|542037893|FG000|Second Intervention|Poor Lens Fit|1|||
150246620|NCT02920970|542037894|FG001|Second Intervention|Poor Lens Fit|0|||
150246621|NCT01711853|542037895|FG000|Overall Study|Not treated|3|||
150246622|NCT04191616|542037896|FG000|Pre-assignment Period|Did not receive study treatment|2|||
150246623|NCT04191616|542037896|FG000|Treatment Period|Death|37|||
150246624|NCT04191616|542037896|FG000|Treatment Period|Sponsor decision|11|||
150246625|NCT04191616|542037896|FG000|Treatment Period|Withdrawal by Subject|4|||
150246626|NCT04230122|542037897|FG000|Overall Study|Lost to Follow-up|1|||
150246627|NCT04230122|542037898|FG001|Overall Study|Lost to Follow-up|0|||
150246628|NCT00604708|542037900|FG000|Overall Study|Withdrawal by Subject|9|||
150246629|NCT00604708|542037901|FG001|Overall Study|Withdrawal by Subject|10|||
150246630|NCT00604708|542037900|FG000|Overall Study|Protocol Violation|2|||
150246631|NCT00604708|542037901|FG001|Overall Study|Protocol Violation|8|||
150246632|NCT00604708|542037900|FG000|Overall Study|Lost to Follow-up|5|||
150246633|NCT00604708|542037901|FG001|Overall Study|Lost to Follow-up|5|||
150246634|NCT00604708|542037900|FG000|Overall Study|administrative reasons|9|||
150246635|NCT00604708|542037901|FG001|Overall Study|administrative reasons|11|||
150246636|NCT00604708|542037900|FG000|Overall Study|Adverse Event|6|||
150246637|NCT00604708|542037901|FG001|Overall Study|Adverse Event|6|||
150246638|NCT01277887|542037903|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
150246639|NCT01277887|542037904|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
150246640|NCT01277887|542037903|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
150246641|NCT01277887|542037904|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
150246642|NCT01277887|542037903|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
150246643|NCT01277887|542037904|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
150246644|NCT01371708|542037905|FG000|Overall Study|Insufficient clinical response|3|||
150246645|NCT01371708|542037906|FG001|Overall Study|Insufficient clinical response|2|||
150246646|NCT01371708|542037907|FG002|Overall Study|Insufficient clinical response|0|||
150246647|NCT01371708|542037905|FG000|Overall Study|Lost to Follow-up|5|||
150246648|NCT01371708|542037906|FG001|Overall Study|Lost to Follow-up|9|||
150246649|NCT01371708|542037907|FG002|Overall Study|Lost to Follow-up|7|||
150246650|NCT01371708|542037905|FG000|Overall Study|Protocol Violation|2|||
150246651|NCT01371708|542037906|FG001|Overall Study|Protocol Violation|1|||
150246652|NCT01371708|542037907|FG002|Overall Study|Protocol Violation|2|||
150246653|NCT01371708|542037905|FG000|Overall Study|No longer willing to participate|7|||
150246654|NCT01371708|542037906|FG001|Overall Study|No longer willing to participate|7|||
150246655|NCT01371708|542037907|FG002|Overall Study|No longer willing to participate|13|||
150246656|NCT01371708|542037905|FG000|Overall Study|Medication error/not related to AE|0|||
150246657|NCT01371708|542037906|FG001|Overall Study|Medication error/not related to AE|1|||
150246658|NCT01371708|542037907|FG002|Overall Study|Medication error/not related to AE|0|||
150246659|NCT01371708|542037905|FG000|Overall Study|Other|3|||
150246660|NCT01371708|542037906|FG001|Overall Study|Other|2|||
150246661|NCT01371708|542037907|FG002|Overall Study|Other|4|||
150246662|NCT01371708|542037905|FG000|Overall Study|Adverse Event|5|||
150246663|NCT01371708|542037906|FG001|Overall Study|Adverse Event|8|||
150246664|NCT01371708|542037907|FG002|Overall Study|Adverse Event|12|||
150246665|NCT01371708|542037905|FG000|Overall Study|Started but did not receive treatment|1|||
150246666|NCT01371708|542037906|FG001|Overall Study|Started but did not receive treatment|0|||
150246667|NCT01371708|542037907|FG002|Overall Study|Started but did not receive treatment|1|||
150246668|NCT02514551|542037908|FG000|Overall Study|Lost to Follow-up|0|||
150246669|NCT02514551|542037909|FG001|Overall Study|Lost to Follow-up|1|||
150246670|NCT02514551|542037908|FG000|Overall Study|Participant Never Treated|0|||
150246671|NCT02514551|542037909|FG001|Overall Study|Participant Never Treated|2|||
150246672|NCT00632502|542037923|FG000|Overall Study|Adverse Event|0|||
150246673|NCT00632502|542037924|FG001|Overall Study|Adverse Event|1|||
150246674|NCT00632502|542037923|FG000|Overall Study|Randomized not treated|3|||
150246675|NCT00632502|542037924|FG001|Overall Study|Randomized not treated|0|||
150246676|NCT04954326|542037925|FG000|Overall Study|Protocol Violation|0|||
150246677|NCT04954326|542037926|FG001|Overall Study|Protocol Violation|1|||
150246678|NCT04954326|542037925|FG000|Overall Study|Death|0|||
150246679|NCT04954326|542037926|FG001|Overall Study|Death|2|||
150246680|NCT04954326|542037925|FG000|Overall Study|Physician Decision|0|||
150246681|NCT04954326|542037926|FG001|Overall Study|Physician Decision|1|||
150246682|NCT01213524|542037927|FG000|Baseline|Withdrawal by Subject|5|||
150246683|NCT01213524|542037927|FG000|Baseline|high breath alcohol levels|1|||
150246684|NCT01213524|542037927|FG000|Baseline|Physician Decision|1|||
150246685|NCT01213524|542037927|FG000|Session 2|Withdrawal by Subject|5|||
150246686|NCT01213524|542037927|FG000|Session 3|Withdrawal by Subject|4|||
150246687|NCT01213524|542037927|FG000|Session 4|Physician Decision|1|||
150246688|NCT01213524|542037927|FG000|Session 4|Withdrawal by Subject|2|||
150246689|NCT02519348|542037933|FG000|Overall Study|Death|31|||
150246690|NCT02519348|542037934|FG001|Overall Study|Death|74|||
150246691|NCT02519348|542037935|FG002|Overall Study|Death|47|||
150246692|NCT02519348|542037936|FG003|Overall Study|Death|54|||
150246693|NCT02519348|542037937|FG004|Overall Study|Death|63|||
150246694|NCT02519348|542037938|FG005|Overall Study|Death|18|||
150246695|NCT02519348|542037939|FG006|Overall Study|Death|2|||
150246696|NCT02519348|542037940|FG007|Overall Study|Death|5|||
150246697|NCT02519348|542037941|FG008|Overall Study|Death|5|||
150246698|NCT02519348|542037933|FG000|Overall Study|Withdrawal by Subject|4|||
150246699|NCT02519348|542037934|FG001|Overall Study|Withdrawal by Subject|7|||
150246700|NCT02519348|542037935|FG002|Overall Study|Withdrawal by Subject|4|||
150246701|NCT02519348|542037936|FG003|Overall Study|Withdrawal by Subject|3|||
150246702|NCT02519348|542037937|FG004|Overall Study|Withdrawal by Subject|3|||
150246703|NCT02519348|542037938|FG005|Overall Study|Withdrawal by Subject|2|||
150246704|NCT02519348|542037939|FG006|Overall Study|Withdrawal by Subject|0|||
150246705|NCT02519348|542037940|FG007|Overall Study|Withdrawal by Subject|0|||
150246706|NCT02519348|542037941|FG008|Overall Study|Withdrawal by Subject|1|||
150246707|NCT02519348|542037933|FG000|Overall Study|Lost to Follow-up|0|||
150246708|NCT02519348|542037934|FG001|Overall Study|Lost to Follow-up|0|||
150246709|NCT02519348|542037935|FG002|Overall Study|Lost to Follow-up|1|||
150246710|NCT02519348|542037936|FG003|Overall Study|Lost to Follow-up|0|||
150246711|NCT02519348|542037937|FG004|Overall Study|Lost to Follow-up|2|||
150246712|NCT02519348|542037938|FG005|Overall Study|Lost to Follow-up|1|||
150246713|NCT02519348|542037939|FG006|Overall Study|Lost to Follow-up|1|||
150246714|NCT02519348|542037940|FG007|Overall Study|Lost to Follow-up|0|||
150246715|NCT02519348|542037941|FG008|Overall Study|Lost to Follow-up|0|||
150246716|NCT02519348|542037933|FG000|Overall Study|Other|0|||
150246717|NCT02519348|542037934|FG001|Overall Study|Other|3|||
150246718|NCT02519348|542037935|FG002|Overall Study|Other|0|||
150246719|NCT02519348|542037936|FG003|Overall Study|Other|0|||
150246720|NCT02519348|542037937|FG004|Overall Study|Other|1|||
150246721|NCT02519348|542037938|FG005|Overall Study|Other|0|||
150246722|NCT02519348|542037939|FG006|Overall Study|Other|0|||
150246723|NCT02519348|542037940|FG007|Overall Study|Other|0|||
150246724|NCT02519348|542037941|FG008|Overall Study|Other|0|||
150246725|NCT02519348|542037933|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
150246726|NCT02519348|542037934|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
150246727|NCT02519348|542037935|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
150246728|NCT02519348|542037936|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
150246729|NCT02519348|542037937|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
150246730|NCT02519348|542037938|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
150246731|NCT02519348|542037939|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
150246732|NCT02519348|542037940|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
150246733|NCT02519348|542037941|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
150246734|NCT05239598|542037942|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
150246735|NCT05239598|542037943|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
150246736|NCT05239598|542037942|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
150246737|NCT05239598|542037943|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
150246738|NCT05855967|542037944|FG000|Overall Study|Withdrawal by Subject|7|||
150246739|NCT05855967|542037945|FG001|Overall Study|Withdrawal by Subject|5|||
150246740|NCT05855967|542037944|FG000|Overall Study|Lost to Follow-up|2|||
150246741|NCT05855967|542037945|FG001|Overall Study|Lost to Follow-up|1|||
150246742|NCT04147195|542037946|FG000|Overall Study|Adverse Event|0|||
150246743|NCT04147195|542037947|FG001|Overall Study|Adverse Event|3|||
150246744|NCT04147195|542037946|FG000|Overall Study|Study Terminated by Sponsor|4|||
150246745|NCT04147195|542037947|FG001|Overall Study|Study Terminated by Sponsor|2|||
150246746|NCT04147195|542037946|FG000|Overall Study|Withdrawal by Subject|0|||
150246747|NCT04147195|542037947|FG001|Overall Study|Withdrawal by Subject|1|||
150246748|NCT04707664|542039885|FG000|Overall Study|Adverse Event|2|||
150246749|NCT04707664|542039886|FG001|Overall Study|Adverse Event|0|||
150246750|NCT04707664|542039885|FG000|Overall Study|Death|1|||
150246751|NCT04707664|542039886|FG001|Overall Study|Death|2|||
150246752|NCT04707664|542039885|FG000|Overall Study|Withdrawal by Subject|13|||
150246753|NCT04707664|542039886|FG001|Overall Study|Withdrawal by Subject|21|||
150246754|NCT04707664|542039885|FG000|Overall Study|Lost to Follow-up|11|||
150246755|NCT04707664|542039886|FG001|Overall Study|Lost to Follow-up|13|||
150246756|NCT04707664|542039885|FG000|Overall Study|Not treated|2|||
150246757|NCT04707664|542039886|FG001|Overall Study|Not treated|0|||
150246758|NCT02706405|542039891|FG000|Overall Study|Death|3|||
150246759|NCT02706405|542039892|FG001|Overall Study|Death|2|||
150246760|NCT02706405|542039893|FG002|Overall Study|Death|0|||
150246761|NCT02706405|542039894|FG003|Overall Study|Death|1|||
150246762|NCT02706405|542039895|FG004|Overall Study|Death|0|||
150246763|NCT02706405|542039896|FG005|Overall Study|Death|0|||
150246764|NCT02706405|542039897|FG006|Overall Study|Death|3|||
150246765|NCT02706405|542039898|FG007|Overall Study|Death|4|||
150246766|NCT02706405|542039891|FG000|Overall Study|Disease progression|0|||
150246767|NCT02706405|542039892|FG001|Overall Study|Disease progression|0|||
150246768|NCT02706405|542039893|FG002|Overall Study|Disease progression|0|||
150246769|NCT02706405|542039894|FG003|Overall Study|Disease progression|0|||
150246770|NCT02706405|542039895|FG004|Overall Study|Disease progression|0|||
150246771|NCT02706405|542039896|FG005|Overall Study|Disease progression|0|||
150246772|NCT02706405|542039897|FG006|Overall Study|Disease progression|0|||
150246773|NCT02706405|542039898|FG007|Overall Study|Disease progression|1|||
150246774|NCT02706405|542039891|FG000|Overall Study|Pt moved to new therapy|0|||
150246775|NCT02706405|542039892|FG001|Overall Study|Pt moved to new therapy|0|||
150246776|NCT02706405|542039893|FG002|Overall Study|Pt moved to new therapy|0|||
150246777|NCT02706405|542039894|FG003|Overall Study|Pt moved to new therapy|0|||
150246778|NCT02706405|542039895|FG004|Overall Study|Pt moved to new therapy|0|||
150246779|NCT02706405|542039896|FG005|Overall Study|Pt moved to new therapy|1|||
150246780|NCT02706405|542039897|FG006|Overall Study|Pt moved to new therapy|0|||
150246781|NCT02706405|542039898|FG007|Overall Study|Pt moved to new therapy|1|||
150246782|NCT02706405|542039891|FG000|Overall Study|Physician Decision|1|||
150246783|NCT02706405|542039892|FG001|Overall Study|Physician Decision|0|||
150246784|NCT02706405|542039893|FG002|Overall Study|Physician Decision|0|||
150246785|NCT02706405|542039894|FG003|Overall Study|Physician Decision|0|||
150246786|NCT02706405|542039895|FG004|Overall Study|Physician Decision|0|||
150246787|NCT02706405|542039896|FG005|Overall Study|Physician Decision|0|||
150246788|NCT02706405|542039897|FG006|Overall Study|Physician Decision|0|||
150246789|NCT02706405|542039898|FG007|Overall Study|Physician Decision|0|||
150246790|NCT02304705|542039899|FG000|Overall Study|Withdrawal by Subject|2|||
150246791|NCT02304705|542039900|FG001|Overall Study|Withdrawal by Subject|0|||
150246792|NCT02304705|542039899|FG000|Overall Study|Physician Decision|2|||
150246793|NCT02304705|542039900|FG001|Overall Study|Physician Decision|4|||
150246794|NCT02304705|542039899|FG000|Overall Study|Death|0|||
150246795|NCT02304705|542039900|FG001|Overall Study|Death|1|||
150246796|NCT02304705|542039899|FG000|Overall Study|Lost to Follow-up|0|||
150246797|NCT02304705|542039900|FG001|Overall Study|Lost to Follow-up|2|||
150246798|NCT01195948|542039901|FG000|Overall Study|Lost to Follow-up|0|||
150246799|NCT01195948|542039902|FG001|Overall Study|Lost to Follow-up|1|||
150246800|NCT01195948|542039903|FG002|Overall Study|Lost to Follow-up|2|||
150246801|NCT03140280|542039904|FG000|Overall Study|Physician Decision|5|||
150246802|NCT05577715|542039915|FG000|Overall Study|Withdrawal by Subject|1|||
150246803|NCT05577715|542039915|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
150246804|NCT05577715|542039915|FG000|Overall Study|Lost to Follow-up|1|||
150246805|NCT05577715|542039915|FG000|Overall Study|Death|6|||
150246806|NCT03412773|542039916|FG000|Overall Study|Lost to Follow-up|0|||
150246807|NCT03412773|542039917|FG001|Overall Study|Lost to Follow-up|7|||
150246808|NCT03412773|542039918|FG002|Overall Study|Lost to Follow-up|6|||
150246809|NCT03412773|542039916|FG000|Overall Study|Withdrawal by Subject|0|||
150246810|NCT03412773|542039917|FG001|Overall Study|Withdrawal by Subject|15|||
150246811|NCT03412773|542039918|FG002|Overall Study|Withdrawal by Subject|19|||
150246812|NCT03412773|542039916|FG000|Overall Study|Study Closed By Sponsor|3|||
150246813|NCT03412773|542039917|FG001|Overall Study|Study Closed By Sponsor|46|||
150246814|NCT03412773|542039918|FG002|Overall Study|Study Closed By Sponsor|33|||
150246815|NCT03412773|542039916|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
150246816|NCT03412773|542039917|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
150246817|NCT03412773|542039918|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
150246818|NCT03412773|542039916|FG000|Overall Study|Death|7|||
150246819|NCT03412773|542039917|FG001|Overall Study|Death|259|||
150246820|NCT03412773|542039918|FG002|Overall Study|Death|273|||
150246821|NCT03412773|542039916|FG000|Overall Study|Physician Decision|0|||
150246822|NCT03412773|542039917|FG001|Overall Study|Physician Decision|0|||
150246823|NCT03412773|542039918|FG002|Overall Study|Physician Decision|1|||
150246824|NCT02643303|542039922|FG000|Overall Study|Progressive Disease|4|||
150246825|NCT02643303|542039923|FG001|Overall Study|Progressive Disease|4|||
150246826|NCT02643303|542039924|FG002|Overall Study|Progressive Disease|1|||
150246827|NCT02643303|542039925|FG003|Overall Study|Progressive Disease|12|||
150246828|NCT02643303|542039926|FG004|Overall Study|Progressive Disease|6|||
150246829|NCT02643303|542039927|FG005|Overall Study|Progressive Disease|4|||
150246830|NCT02643303|542039928|FG006|Overall Study|Progressive Disease|8|||
150246831|NCT02643303|542039929|FG007|Overall Study|Progressive Disease|2|||
150246832|NCT02643303|542039930|FG008|Overall Study|Progressive Disease|6|||
150246833|NCT02643303|542039922|FG000|Overall Study|Adverse Event|0|||
150246834|NCT02643303|542039923|FG001|Overall Study|Adverse Event|1|||
150246835|NCT02643303|542039924|FG002|Overall Study|Adverse Event|0|||
150246836|NCT02643303|542039925|FG003|Overall Study|Adverse Event|0|||
150246837|NCT02643303|542039926|FG004|Overall Study|Adverse Event|1|||
150246838|NCT02643303|542039927|FG005|Overall Study|Adverse Event|0|||
150246839|NCT02643303|542039928|FG006|Overall Study|Adverse Event|0|||
150246840|NCT02643303|542039929|FG007|Overall Study|Adverse Event|0|||
150246841|NCT02643303|542039930|FG008|Overall Study|Adverse Event|0|||
150246842|NCT02643303|542039922|FG000|Overall Study|Withdrawal by Subject|0|||
150246843|NCT02643303|542039923|FG001|Overall Study|Withdrawal by Subject|0|||
150246844|NCT02643303|542039924|FG002|Overall Study|Withdrawal by Subject|0|||
150246845|NCT02643303|542039925|FG003|Overall Study|Withdrawal by Subject|1|||
150246846|NCT02643303|542039926|FG004|Overall Study|Withdrawal by Subject|0|||
150246847|NCT02643303|542039927|FG005|Overall Study|Withdrawal by Subject|0|||
150246848|NCT02643303|542039928|FG006|Overall Study|Withdrawal by Subject|1|||
150246849|NCT02643303|542039929|FG007|Overall Study|Withdrawal by Subject|1|||
150246850|NCT02643303|542039930|FG008|Overall Study|Withdrawal by Subject|1|||
150246851|NCT03057847|542039937|FG000|Overall Study|Lost to Follow-up|16|||
150246852|NCT03301155|542039939|FG000|Overall Study|Сompliance with exclusion criteria|8|||
150246853|NCT03301155|542039940|FG001|Overall Study|Сompliance with exclusion criteria|7|||
150246854|NCT01706705|542039943|FG000|Overall Study|Death|1|||
150246855|NCT01706705|542039943|FG000|Overall Study|Lack of Efficacy|13|||
150246856|NCT01706705|542039943|FG000|Overall Study|Non-clinical|6|||
150246857|NCT03510455|542039944|FG000|Overall Study|Physician Decision|1|||
150246858|NCT04958642|542039945|FG000|Overall Study|Transferred to OLEX program|3|||
150246859|NCT04958642|542039946|FG001|Overall Study|Transferred to OLEX program|0|||
150246860|NCT04958642|542039947|FG002|Overall Study|Transferred to OLEX program|5|||
150246861|NCT04958642|542039945|FG000|Overall Study|Death|0|||
150246862|NCT04958642|542039946|FG001|Overall Study|Death|0|||
150246863|NCT04958642|542039947|FG002|Overall Study|Death|1|||
150246864|NCT04958642|542039945|FG000|Overall Study|Withdrawal by Subject|4|||
150246865|NCT04958642|542039946|FG001|Overall Study|Withdrawal by Subject|9|||
150246866|NCT04958642|542039947|FG002|Overall Study|Withdrawal by Subject|13|||
150246867|NCT04958642|542039945|FG000|Overall Study|Investigator's Decision|0|||
150246868|NCT04958642|542039946|FG001|Overall Study|Investigator's Decision|0|||
150246869|NCT04958642|542039947|FG002|Overall Study|Investigator's Decision|1|||
150246870|NCT04958642|542039945|FG000|Overall Study|Adverse Event|1|||
150246871|NCT04958642|542039946|FG001|Overall Study|Adverse Event|0|||
150246872|NCT04958642|542039947|FG002|Overall Study|Adverse Event|1|||
150246873|NCT04958642|542039945|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
150246874|NCT04958642|542039946|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
150246875|NCT04958642|542039947|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
150246876|NCT04958642|542039945|FG000|Overall Study|Lost to Follow-up|1|||
150246877|NCT04958642|542039946|FG001|Overall Study|Lost to Follow-up|0|||
150246878|NCT04958642|542039947|FG002|Overall Study|Lost to Follow-up|0|||
150246879|NCT04958642|542039945|FG000|Overall Study|Transferred to EAP following study termination|0|||
150246880|NCT04958642|542039946|FG001|Overall Study|Transferred to EAP following study termination|0|||
150246881|NCT04958642|542039947|FG002|Overall Study|Transferred to EAP following study termination|1|||
150246882|NCT04958642|542039945|FG000|Overall Study|Transferred to Expanded Access Program|1|||
150246883|NCT04958642|542039946|FG001|Overall Study|Transferred to Expanded Access Program|0|||
150246884|NCT04958642|542039947|FG002|Overall Study|Transferred to Expanded Access Program|0|||
150246885|NCT01199068|542039948|FG000|Overall Study|Unacceptable toxicity|0|||
150246886|NCT01199068|542039949|FG001|Overall Study|Unacceptable toxicity|0|||
150246887|NCT01199068|542039950|FG002|Overall Study|Unacceptable toxicity|2|||
150246888|NCT01199068|542039948|FG000|Overall Study|Progressive disease|3|||
150246889|NCT01199068|542039949|FG001|Overall Study|Progressive disease|3|||
150246890|NCT01199068|542039950|FG002|Overall Study|Progressive disease|6|||
150246891|NCT01199068|542039948|FG000|Overall Study|Withdrawal by Subject|0|||
150246892|NCT01199068|542039949|FG001|Overall Study|Withdrawal by Subject|0|||
150246893|NCT01199068|542039950|FG002|Overall Study|Withdrawal by Subject|1|||
150246894|NCT01250925|542039951|FG000|Overall Study|Lost to Follow-up|1|||
150246895|NCT01250925|542039952|FG001|Overall Study|Lost to Follow-up|1|||
150246896|NCT01250925|542039953|FG002|Overall Study|Lost to Follow-up|0|||
150246897|NCT01250925|542039951|FG000|Overall Study|Withdrawal by Subject|2|||
150246898|NCT01250925|542039952|FG001|Overall Study|Withdrawal by Subject|0|||
150246899|NCT01250925|542039953|FG002|Overall Study|Withdrawal by Subject|0|||
150246900|NCT01250925|542039951|FG000|Overall Study|Protocol Violation|2|||
150246901|NCT01250925|542039952|FG001|Overall Study|Protocol Violation|0|||
150246902|NCT01250925|542039953|FG002|Overall Study|Protocol Violation|0|||
150246903|NCT01250925|542039951|FG000|Overall Study|Physician Decision|0|||
150246904|NCT01250925|542039952|FG001|Overall Study|Physician Decision|2|||
150246905|NCT01250925|542039953|FG002|Overall Study|Physician Decision|1|||
150246906|NCT01250925|542039951|FG000|Overall Study|Adverse Event|0|||
150246907|NCT01250925|542039952|FG001|Overall Study|Adverse Event|0|||
150246908|NCT01250925|542039953|FG002|Overall Study|Adverse Event|1|||
150246909|NCT00678301|542039954|FG000|Overall Study|Non-compliance with study procedures|0|||
150246910|NCT00678301|542039955|FG001|Overall Study|Non-compliance with study procedures|1|||
150246911|NCT00678301|542039954|FG000|Overall Study|Adverse Event|1|||
150246912|NCT00678301|542039955|FG001|Overall Study|Adverse Event|0|||
150246913|NCT00678301|542039954|FG000|Overall Study|Withdrawal by Subject|4|||
150246914|NCT00678301|542039955|FG001|Overall Study|Withdrawal by Subject|0|||
150246915|NCT00678301|542039954|FG000|Overall Study|Lost to Follow-up|3|||
150246916|NCT00678301|542039955|FG001|Overall Study|Lost to Follow-up|1|||
150246917|NCT03338296|542039956|FG000|Overall Study|Adverse Event|0|||
150246918|NCT03338296|542039957|FG001|Overall Study|Adverse Event|1|||
150246919|NCT03338296|542039956|FG000|Overall Study|Withdrawal by Subject|14|||
150246920|NCT03338296|542039957|FG001|Overall Study|Withdrawal by Subject|13|||
150246921|NCT03338296|542039956|FG000|Overall Study|Lost to Follow-up|10|||
150246922|NCT03338296|542039957|FG001|Overall Study|Lost to Follow-up|10|||
150246923|NCT03338296|542039956|FG000|Overall Study|Study Terminated by Sponsor|77|||
150246924|NCT03338296|542039957|FG001|Overall Study|Study Terminated by Sponsor|76|||
150246925|NCT03338296|542039956|FG000|Overall Study|Other|2|||
150246926|NCT03338296|542039957|FG001|Overall Study|Other|7|||
150246927|NCT03338296|542039956|FG000|Overall Study|Missing|0|||
150246928|NCT03338296|542039957|FG001|Overall Study|Missing|1|||
150246929|NCT01939353|542039958|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
150246930|NCT01939353|542039958|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
150246931|NCT01939353|542039958|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
150246932|NCT01939353|542039958|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
150246933|NCT01939353|542039958|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
150246934|NCT04421950|542039964|FG000|Overall Study|Dropped or lost to follow up|4|||
150246935|NCT04421950|542039965|FG001|Overall Study|Dropped or lost to follow up|2|||
150246936|NCT05048238|542039966|FG000|Overall Study|Withdrawal by Subject|1|||
150246937|NCT00335140|542039971|FG000|Overall Study|Ineligible|1|||
150246938|NCT01038427|542039974|FG000|Overall Study|Lost to follow up|1|||
150246939|NCT01038427|542039975|FG001|Overall Study|Lost to follow up|1|||
150246940|NCT01038427|542039976|FG002|Overall Study|Lost to follow up|0|||
150246941|NCT01038427|542039974|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
150246942|NCT01038427|542039975|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
150246943|NCT01038427|542039976|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
150246944|NCT01038427|542039974|FG000|Overall Study|Withdrew consent|0|||
150246945|NCT01038427|542039975|FG001|Overall Study|Withdrew consent|0|||
150246946|NCT01038427|542039976|FG002|Overall Study|Withdrew consent|1|||
150246947|NCT01038427|542039974|FG000|Overall Study|Adverse Event|2|||
150246948|NCT01038427|542039975|FG001|Overall Study|Adverse Event|2|||
150246949|NCT01038427|542039976|FG002|Overall Study|Adverse Event|1|||
150246950|NCT01038427|542039974|FG000|Overall Study|Enrolled in error|0|||
150246951|NCT01038427|542039975|FG001|Overall Study|Enrolled in error|1|||
150246952|NCT01038427|542039976|FG002|Overall Study|Enrolled in error|1|||
150246953|NCT01038427|542039974|FG000|Overall Study|Other|0|||
150246954|NCT01038427|542039975|FG001|Overall Study|Other|2|||
150246955|NCT01038427|542039976|FG002|Overall Study|Other|0|||
150246956|NCT01137578|542039980|FG000|Overall Study|Participant requested to Discontinue|3|||
150246957|NCT01137578|542039981|FG001|Overall Study|Participant requested to Discontinue|0|||
150246958|NCT01137578|542039982|FG002|Overall Study|Participant requested to Discontinue|0|||
150246959|NCT01137578|542039980|FG000|Overall Study|Withdrawal by Subject|1|||
150246960|NCT01137578|542039981|FG001|Overall Study|Withdrawal by Subject|0|||
150246961|NCT01137578|542039982|FG002|Overall Study|Withdrawal by Subject|0|||
150246962|NCT01137578|542039980|FG000|Overall Study|Other|12|||
150246963|NCT01137578|542039981|FG001|Overall Study|Other|2|||
150246964|NCT01137578|542039982|FG002|Overall Study|Other|6|||
150246965|NCT01361594|542039983|FG000|Overall Study|Withdrawal by Subject|1|||
150246966|NCT01361594|542039984|FG001|Overall Study|Withdrawal by Subject|2|||
150246967|NCT00415051|542039985|FG000|Overall Study|Protocol Violation|1|||
150246968|NCT03651700|542039986|FG000|Overall Study|Withdrawal by Subject|1|||
150246969|NCT03651700|542039987|FG001|Overall Study|Withdrawal by Subject|0|||
150246970|NCT05479734|542039990|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
150246971|NCT05479734|542039991|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
150246972|NCT05479734|542039990|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
150246973|NCT05479734|542039991|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
150246974|NCT05479734|542039990|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
150246975|NCT05479734|542039991|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
150246976|NCT05479734|542039990|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
150246977|NCT05479734|542039991|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
150246978|NCT03945825|542039992|FG000|Overall Study|Enrolled but treatment not administered|0|||
150246979|NCT03945825|542039993|FG001|Overall Study|Enrolled but treatment not administered|0|||
150246980|NCT03945825|542039994|FG002|Overall Study|Enrolled but treatment not administered|0|||
150246981|NCT03945825|542039995|FG003|Overall Study|Enrolled but treatment not administered|0|||
150246982|NCT03945825|542039996|FG004|Overall Study|Enrolled but treatment not administered|1|||
150246983|NCT03945825|542039997|FG005|Overall Study|Enrolled but treatment not administered|0|||
150246984|NCT03945825|542039992|FG000|Overall Study|Lost to Follow-up|1|||
150246985|NCT03945825|542039993|FG001|Overall Study|Lost to Follow-up|5|||
150246986|NCT03945825|542039994|FG002|Overall Study|Lost to Follow-up|0|||
150246987|NCT03945825|542039995|FG003|Overall Study|Lost to Follow-up|1|||
150246988|NCT03945825|542039996|FG004|Overall Study|Lost to Follow-up|2|||
150246989|NCT03945825|542039997|FG005|Overall Study|Lost to Follow-up|2|||
150246990|NCT03945825|542039992|FG000|Overall Study|Withdrawal by Subject|1|||
150246991|NCT03945825|542039993|FG001|Overall Study|Withdrawal by Subject|0|||
150246992|NCT03945825|542039994|FG002|Overall Study|Withdrawal by Subject|1|||
150246993|NCT03945825|542039995|FG003|Overall Study|Withdrawal by Subject|1|||
150246994|NCT03945825|542039996|FG004|Overall Study|Withdrawal by Subject|0|||
150246995|NCT03945825|542039997|FG005|Overall Study|Withdrawal by Subject|1|||
150246996|NCT00600613|542039998|FG000|Overall Study|Protocol Deviation|1|||
150246997|NCT01509547|542040001|FG000|Overall Study|Lost to Follow-up|24|||
150246998|NCT01509547|542040002|FG001|Overall Study|Lost to Follow-up|14|||
150246999|NCT01509547|542040001|FG000|Overall Study|Withdrawal by Subject|11|||
150247000|NCT01509547|542040002|FG001|Overall Study|Withdrawal by Subject|24|||
150247001|NCT01509547|542040001|FG000|Overall Study|Physician Decision|0|||
150247002|NCT01509547|542040002|FG001|Overall Study|Physician Decision|1|||
150247003|NCT01399918|542040003|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
150247004|NCT03197766|542040004|FG000|Overall Study|Withdrawal by Subject|2|||
150247005|NCT03197766|542040005|FG001|Overall Study|Withdrawal by Subject|0|||
150247006|NCT00570908|542040006|FG000|Overall Study|Adverse Event|5|||
150247007|NCT00570908|542040006|FG000|Overall Study|Withdrawal by Subject|2|||
150247008|NCT01110408|542040007|FG000|Overall Study|Protocol Violation|1|||
150247009|NCT01110408|542040008|FG001|Overall Study|Protocol Violation|0|||
150247010|NCT00669877|542040009|FG000|Overall Study|Disease Progression/Death|4|||
150247011|NCT03635099|542040010|FG000|Period 1|Adverse Event|1|||
150247012|NCT03635099|542040011|FG001|Period 1|Adverse Event|0|||
150247013|NCT03635099|542040012|FG002|Period 1|Adverse Event|0|||
150247014|NCT03635099|542040013|FG003|Period 1|Adverse Event|1|||
150247015|NCT03635099|542040014|FG004|Period 1|Adverse Event|0|||
150247016|NCT03635099|542040015|FG005|Period 1|Adverse Event|0|||
150247017|NCT03635099|542040016|FG006|Period 1|Adverse Event|0|||
150247018|NCT03635099|542040017|FG007|Period 1|Adverse Event|0|||
150247019|NCT03635099|542040010|FG000|Period 1|Protocol Violation|0|||
150247020|NCT03635099|542040011|FG001|Period 1|Protocol Violation|0|||
150247021|NCT03635099|542040012|FG002|Period 1|Protocol Violation|1|||
150247022|NCT03635099|542040013|FG003|Period 1|Protocol Violation|0|||
150247023|NCT03635099|542040014|FG004|Period 1|Protocol Violation|0|||
150247024|NCT03635099|542040015|FG005|Period 1|Protocol Violation|0|||
150247025|NCT03635099|542040016|FG006|Period 1|Protocol Violation|0|||
150247026|NCT03635099|542040017|FG007|Period 1|Protocol Violation|0|||
150247027|NCT03635099|542040010|FG000|Period 1|Lost to Follow-up|0|||
150247028|NCT03635099|542040011|FG001|Period 1|Lost to Follow-up|0|||
150247029|NCT03635099|542040012|FG002|Period 1|Lost to Follow-up|1|||
150247030|NCT03635099|542040013|FG003|Period 1|Lost to Follow-up|2|||
150247031|NCT03635099|542040014|FG004|Period 1|Lost to Follow-up|1|||
150247032|NCT03635099|542040015|FG005|Period 1|Lost to Follow-up|0|||
150247033|NCT03635099|542040016|FG006|Period 1|Lost to Follow-up|1|||
150247034|NCT03635099|542040017|FG007|Period 1|Lost to Follow-up|2|||
150247035|NCT03635099|542040010|FG000|Period 1|Withdrawal by Subject|3|||
150247036|NCT03635099|542040011|FG001|Period 1|Withdrawal by Subject|3|||
150247037|NCT03635099|542040012|FG002|Period 1|Withdrawal by Subject|5|||
150247038|NCT03635099|542040013|FG003|Period 1|Withdrawal by Subject|2|||
150247039|NCT03635099|542040014|FG004|Period 1|Withdrawal by Subject|2|||
150247040|NCT03635099|542040015|FG005|Period 1|Withdrawal by Subject|0|||
150247041|NCT03635099|542040016|FG006|Period 1|Withdrawal by Subject|3|||
150247042|NCT03635099|542040017|FG007|Period 1|Withdrawal by Subject|0|||
150247043|NCT03635099|542040010|FG000|Period 1|History of suicidal ideation|0|||
150247044|NCT03635099|542040011|FG001|Period 1|History of suicidal ideation|0|||
150247045|NCT03635099|542040012|FG002|Period 1|History of suicidal ideation|1|||
150247046|NCT03635099|542040013|FG003|Period 1|History of suicidal ideation|0|||
150247047|NCT03635099|542040014|FG004|Period 1|History of suicidal ideation|0|||
150247048|NCT03635099|542040015|FG005|Period 1|History of suicidal ideation|0|||
150247049|NCT03635099|542040016|FG006|Period 1|History of suicidal ideation|0|||
150247050|NCT03635099|542040017|FG007|Period 1|History of suicidal ideation|0|||
150247051|NCT03635099|542040010|FG000|Period 1|pursue other treatment options|0|||
150247052|NCT03635099|542040011|FG001|Period 1|pursue other treatment options|0|||
150247053|NCT03635099|542040012|FG002|Period 1|pursue other treatment options|0|||
150247054|NCT03635099|542040013|FG003|Period 1|pursue other treatment options|0|||
150247055|NCT03635099|542040014|FG004|Period 1|pursue other treatment options|0|||
150247056|NCT03635099|542040015|FG005|Period 1|pursue other treatment options|1|||
150247057|NCT03635099|542040016|FG006|Period 1|pursue other treatment options|0|||
150247058|NCT03635099|542040017|FG007|Period 1|pursue other treatment options|0|||
150247059|NCT03635099|542040010|FG000|Not Eligible for Period 2|Pregnancy|0|||
150247060|NCT03635099|542040011|FG001|Not Eligible for Period 2|Pregnancy|0|||
150247061|NCT03635099|542040012|FG002|Not Eligible for Period 2|Pregnancy|0|||
150247062|NCT03635099|542040013|FG003|Not Eligible for Period 2|Pregnancy|1|||
150247063|NCT03635099|542040014|FG004|Not Eligible for Period 2|Pregnancy|0|||
150247064|NCT03635099|542040015|FG005|Not Eligible for Period 2|Pregnancy|0|||
150247065|NCT03635099|542040016|FG006|Not Eligible for Period 2|Pregnancy|0|||
150247066|NCT03635099|542040017|FG007|Not Eligible for Period 2|Pregnancy|0|||
150247067|NCT03635099|542040010|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
150247068|NCT03635099|542040011|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247069|NCT03635099|542040012|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247070|NCT03635099|542040013|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247071|NCT03635099|542040014|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247072|NCT03635099|542040015|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247073|NCT03635099|542040016|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247074|NCT03635099|542040017|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
150247075|NCT03635099|542040010|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
150247076|NCT03635099|542040011|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
150247077|NCT03635099|542040012|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
150247078|NCT03635099|542040013|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
150247079|NCT03635099|542040014|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
150247080|NCT03635099|542040015|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
150247081|NCT03635099|542040016|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
150247082|NCT03635099|542040017|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
150247083|NCT03635099|542040010|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
150247084|NCT03635099|542040011|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
150247085|NCT03635099|542040012|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
150247086|NCT03635099|542040013|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
150247087|NCT03635099|542040014|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
150247088|NCT03635099|542040015|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
150247089|NCT03635099|542040016|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
150247090|NCT03635099|542040017|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
150247091|NCT03635099|542040010|FG000|Period 2|Adverse Event|0|||
150247092|NCT03635099|542040011|FG001|Period 2|Adverse Event|0|||
150247093|NCT03635099|542040012|FG002|Period 2|Adverse Event|1|||
150247094|NCT03635099|542040013|FG003|Period 2|Adverse Event|0|||
150247095|NCT03635099|542040014|FG004|Period 2|Adverse Event|1|||
150247096|NCT03635099|542040015|FG005|Period 2|Adverse Event|0|||
150247097|NCT03635099|542040016|FG006|Period 2|Adverse Event|0|||
150247098|NCT03635099|542040017|FG007|Period 2|Adverse Event|0|||
150247099|NCT03635099|542040010|FG000|Period 2|Lost to Follow-up|0|||
150247100|NCT03635099|542040011|FG001|Period 2|Lost to Follow-up|0|||
150247101|NCT03635099|542040012|FG002|Period 2|Lost to Follow-up|1|||
150247102|NCT03635099|542040013|FG003|Period 2|Lost to Follow-up|0|||
150247103|NCT03635099|542040014|FG004|Period 2|Lost to Follow-up|4|||
150247104|NCT03635099|542040015|FG005|Period 2|Lost to Follow-up|0|||
150247105|NCT03635099|542040016|FG006|Period 2|Lost to Follow-up|0|||
150247106|NCT03635099|542040017|FG007|Period 2|Lost to Follow-up|0|||
150247107|NCT03635099|542040010|FG000|Period 2|Withdrawal by Subject|0|||
150247108|NCT03635099|542040011|FG001|Period 2|Withdrawal by Subject|0|||
150247109|NCT03635099|542040012|FG002|Period 2|Withdrawal by Subject|7|||
150247110|NCT03635099|542040013|FG003|Period 2|Withdrawal by Subject|4|||
150247111|NCT03635099|542040014|FG004|Period 2|Withdrawal by Subject|7|||
150247112|NCT03635099|542040015|FG005|Period 2|Withdrawal by Subject|0|||
150247113|NCT03635099|542040016|FG006|Period 2|Withdrawal by Subject|0|||
150247114|NCT03635099|542040017|FG007|Period 2|Withdrawal by Subject|0|||
150247115|NCT04103892|542040018|FG000|Overall Study|Adverse Event|0|||
150247116|NCT04103892|542040019|FG001|Overall Study|Adverse Event|0|||
150247117|NCT04103892|542040020|FG002|Overall Study|Adverse Event|0|||
150247118|NCT04103892|542040021|FG003|Overall Study|Adverse Event|3|||
150247119|NCT04103892|542040018|FG000|Overall Study|Lost to Follow-up|0|||
150247120|NCT04103892|542040019|FG001|Overall Study|Lost to Follow-up|0|||
150247121|NCT04103892|542040020|FG002|Overall Study|Lost to Follow-up|2|||
150247122|NCT04103892|542040021|FG003|Overall Study|Lost to Follow-up|0|||
150247123|NCT04103892|542040018|FG000|Overall Study|Protocol Violation|0|||
150247124|NCT04103892|542040019|FG001|Overall Study|Protocol Violation|0|||
150247125|NCT04103892|542040020|FG002|Overall Study|Protocol Violation|1|||
150247126|NCT04103892|542040021|FG003|Overall Study|Protocol Violation|1|||
150247127|NCT04103892|542040018|FG000|Overall Study|Withdrawal by Subject|1|||
150247128|NCT04103892|542040019|FG001|Overall Study|Withdrawal by Subject|0|||
150247129|NCT04103892|542040020|FG002|Overall Study|Withdrawal by Subject|2|||
150247130|NCT04103892|542040021|FG003|Overall Study|Withdrawal by Subject|5|||
150247131|NCT04103892|542040018|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
150247132|NCT04103892|542040019|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
150247133|NCT04103892|542040020|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
150247134|NCT04103892|542040021|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
150247135|NCT03008005|542040022|FG000|Overall Study|Physician Decision|1|||
150247136|NCT03008005|542040023|FG001|Overall Study|Physician Decision|0|||
150247137|NCT03008005|542040024|FG002|Overall Study|Physician Decision|0|||
150247138|NCT03008005|542040022|FG000|Overall Study|Withdrawal by Subject|1|||
150247139|NCT03008005|542040023|FG001|Overall Study|Withdrawal by Subject|0|||
150247140|NCT03008005|542040024|FG002|Overall Study|Withdrawal by Subject|0|||
150247141|NCT03008005|542040022|FG000|Overall Study|Ineligible|0|||
150247142|NCT03008005|542040023|FG001|Overall Study|Ineligible|1|||
150247143|NCT03008005|542040024|FG002|Overall Study|Ineligible|0|||
150247144|NCT01435772|542040026|FG000|Overall Study|Adverse Event|1|||
150247145|NCT01435772|542040027|FG001|Overall Study|Adverse Event|0|||
150247146|NCT01435772|542040028|FG002|Overall Study|Adverse Event|2|||
150247147|NCT01435772|542040026|FG000|Overall Study|Withdrawal by Subject|0|||
150247148|NCT01435772|542040027|FG001|Overall Study|Withdrawal by Subject|1|||
150247149|NCT01435772|542040028|FG002|Overall Study|Withdrawal by Subject|3|||
150247150|NCT01435772|542040026|FG000|Overall Study|Other - study termination|2|||
150247151|NCT01435772|542040027|FG001|Overall Study|Other - study termination|2|||
150247152|NCT01435772|542040028|FG002|Overall Study|Other - study termination|10|||
150247153|NCT03238963|542040029|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
150247154|NCT03238963|542040030|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
150247155|NCT03238963|542040029|FG000|Overall Study|Withdrawal by Subject|1|||
150247156|NCT03238963|542040030|FG001|Overall Study|Withdrawal by Subject|1|||
150247157|NCT03238963|542040029|FG000|Overall Study|Lost to Follow-up|1|||
150247158|NCT03238963|542040030|FG001|Overall Study|Lost to Follow-up|0|||
150247159|NCT03238963|542040029|FG000|Overall Study|Protocol Violation|1|||
150247160|NCT03238963|542040030|FG001|Overall Study|Protocol Violation|1|||
150247161|NCT03238963|542040029|FG000|Overall Study|Adverse Event|1|||
150247162|NCT03238963|542040030|FG001|Overall Study|Adverse Event|0|||
150247163|NCT06926673|542040031|FG000|Overall Study|Lost to Follow-up|0|||
150247164|NCT06926673|542040032|FG001|Overall Study|Lost to Follow-up|0|||
150247165|NCT06926673|542040033|FG002|Overall Study|Lost to Follow-up|0|||
150247166|NCT06926673|542040034|FG003|Overall Study|Lost to Follow-up|1|||
150247167|NCT06926673|542040035|FG004|Overall Study|Lost to Follow-up|0|||
150247168|NCT06926673|542040036|FG005|Overall Study|Lost to Follow-up|0|||
150247169|NCT06926673|542040037|FG006|Overall Study|Lost to Follow-up|0|||
150247170|NCT06926673|542040031|FG000|Overall Study|Physician Decision|0|||
150247171|NCT06926673|542040032|FG001|Overall Study|Physician Decision|0|||
150247172|NCT06926673|542040033|FG002|Overall Study|Physician Decision|0|||
150247173|NCT06926673|542040034|FG003|Overall Study|Physician Decision|0|||
150247174|NCT06926673|542040035|FG004|Overall Study|Physician Decision|0|||
150247175|NCT06926673|542040036|FG005|Overall Study|Physician Decision|0|||
150247176|NCT06926673|542040037|FG006|Overall Study|Physician Decision|1|||
150247177|NCT06926673|542040031|FG000|Overall Study|Withdrawal by Subject|0|||
150247178|NCT06926673|542040032|FG001|Overall Study|Withdrawal by Subject|3|||
150247179|NCT06926673|542040033|FG002|Overall Study|Withdrawal by Subject|2|||
150247180|NCT06926673|542040034|FG003|Overall Study|Withdrawal by Subject|1|||
150247181|NCT06926673|542040035|FG004|Overall Study|Withdrawal by Subject|0|||
150247182|NCT06926673|542040036|FG005|Overall Study|Withdrawal by Subject|2|||
150247183|NCT06926673|542040037|FG006|Overall Study|Withdrawal by Subject|0|||
150247184|NCT05823012|542040038|FG000|Titration Period|Adverse Event|1|||
150247185|NCT05823012|542040038|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
150247186|NCT05823012|542040038|FG000|Maintenance Period|Adverse Event|1|||
150247187|NCT05823012|542040038|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
150247188|NCT05823012|542040038|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
150247189|NCT01424813|542040039|FG000|Overall Study|Withdrawal by Subject|3|||
150247190|NCT01424813|542040040|FG001|Overall Study|Withdrawal by Subject|0|||
150247191|NCT01424813|542040039|FG000|Overall Study|Protocol Violation|1|||
150247192|NCT01424813|542040040|FG001|Overall Study|Protocol Violation|0|||
150247193|NCT01424813|542040039|FG000|Overall Study|Other|1|||
150247194|NCT01424813|542040040|FG001|Overall Study|Other|2|||
150247195|NCT07149155|542040044|FG000|Overall Study|Lost to Follow-up|10|||
150247196|NCT03345576|542040045|FG000|Overall Study|Withdrawal by Subject|2|||
150247197|NCT03345576|542040046|FG001|Overall Study|Withdrawal by Subject|2|||
150247198|NCT03345576|542040045|FG000|Overall Study|Adverse Event|1|||
150247199|NCT03345576|542040046|FG001|Overall Study|Adverse Event|0|||
150247200|NCT00626197|542042212|FG000|Overall Study|Did not cooperate|2|||
150247201|NCT00626197|542042213|FG001|Overall Study|Did not cooperate|6|||
150247202|NCT00626197|542042214|FG002|Overall Study|Did not cooperate|1|||
150247203|NCT00626197|542042212|FG000|Overall Study|Failure to return|6|||
150247204|NCT00626197|542042213|FG001|Overall Study|Failure to return|5|||
150247205|NCT00626197|542042214|FG002|Overall Study|Failure to return|6|||
150247206|NCT00626197|542042212|FG000|Overall Study|Adverse event, serious fatal|3|||
150247207|NCT00626197|542042213|FG001|Overall Study|Adverse event, serious fatal|6|||
150247208|NCT00626197|542042214|FG002|Overall Study|Adverse event, serious fatal|6|||
150247209|NCT00626197|542042212|FG000|Overall Study|Adverse Event|1|||
150247210|NCT00626197|542042213|FG001|Overall Study|Adverse Event|1|||
150247211|NCT00626197|542042214|FG002|Overall Study|Adverse Event|2|||
150247212|NCT00626197|542042212|FG000|Overall Study|Withdrawal by Subject|17|||
150247213|NCT00626197|542042213|FG001|Overall Study|Withdrawal by Subject|17|||
150247214|NCT00626197|542042214|FG002|Overall Study|Withdrawal by Subject|7|||
150247215|NCT00626197|542042212|FG000|Overall Study|Administrative reasons|15|||
150247216|NCT00626197|542042213|FG001|Overall Study|Administrative reasons|19|||
150247217|NCT00626197|542042214|FG002|Overall Study|Administrative reasons|55|||
150247218|NCT04833127|542042215|FG000|Overall Study|Lost to Follow-up|1|||
150247219|NCT04833127|542042216|FG001|Overall Study|Lost to Follow-up|1|||
150247220|NCT04335591|542042221|FG000|Overall Study|Adverse Event|5|||
150247221|NCT04335591|542042222|FG001|Overall Study|Adverse Event|2|||
150247222|NCT04335591|542042223|FG002|Overall Study|Adverse Event|3|||
150247223|NCT04335591|542042224|FG003|Overall Study|Adverse Event|2|||
150247224|NCT04335591|542042221|FG000|Overall Study|Protocol Violation|1|||
150247225|NCT04335591|542042222|FG001|Overall Study|Protocol Violation|0|||
150247226|NCT04335591|542042223|FG002|Overall Study|Protocol Violation|0|||
150247227|NCT04335591|542042224|FG003|Overall Study|Protocol Violation|0|||
150247228|NCT04335591|542042221|FG000|Overall Study|Withdrawal by Subject|8|||
150247229|NCT04335591|542042222|FG001|Overall Study|Withdrawal by Subject|4|||
150247230|NCT04335591|542042223|FG002|Overall Study|Withdrawal by Subject|4|||
150247231|NCT04335591|542042224|FG003|Overall Study|Withdrawal by Subject|5|||
150247232|NCT04335591|542042221|FG000|Overall Study|Subject planning pregnancy|0|||
150247233|NCT04335591|542042222|FG001|Overall Study|Subject planning pregnancy|1|||
150247234|NCT04335591|542042223|FG002|Overall Study|Subject planning pregnancy|0|||
150247235|NCT04335591|542042224|FG003|Overall Study|Subject planning pregnancy|0|||
150247236|NCT04335591|542042221|FG000|Overall Study|Ukrainian Russian war conflict|4|||
150247237|NCT04335591|542042222|FG001|Overall Study|Ukrainian Russian war conflict|5|||
150247238|NCT04335591|542042223|FG002|Overall Study|Ukrainian Russian war conflict|2|||
150247239|NCT04335591|542042224|FG003|Overall Study|Ukrainian Russian war conflict|0|||
150247240|NCT05282121|542042225|FG000|Overall Study|Adverse Event|1|||
150247241|NCT05282121|542042226|FG001|Overall Study|Adverse Event|1|||
150247242|NCT05282121|542042227|FG002|Overall Study|Adverse Event|4|||
150247243|NCT05282121|542042228|FG003|Overall Study|Adverse Event|1|||
150247244|NCT05282121|542042225|FG000|Overall Study|Study Terminated by Sponsor|1|||
150247245|NCT05282121|542042226|FG001|Overall Study|Study Terminated by Sponsor|2|||
150247246|NCT05282121|542042227|FG002|Overall Study|Study Terminated by Sponsor|2|||
150247247|NCT05282121|542042228|FG003|Overall Study|Study Terminated by Sponsor|2|||
150247248|NCT05282121|542042225|FG000|Overall Study|Other than listed|0|||
150247249|NCT05282121|542042226|FG001|Overall Study|Other than listed|0|||
150247250|NCT05282121|542042227|FG002|Overall Study|Other than listed|1|||
150247251|NCT05282121|542042228|FG003|Overall Study|Other than listed|0|||
150247252|NCT05282121|542042225|FG000|Overall Study|No reason available|0|||
150247253|NCT05282121|542042226|FG001|Overall Study|No reason available|0|||
150247254|NCT05282121|542042227|FG002|Overall Study|No reason available|1|||
150247255|NCT05282121|542042228|FG003|Overall Study|No reason available|0|||
150247256|NCT01077128|542042238|FG000|Overall Study|Adverse Event|8|||
150247257|NCT01077128|542042238|FG000|Overall Study|Lack of Efficacy|1|||
150247258|NCT01077128|542042238|FG000|Overall Study|Disease exacerbation|1|||
150247259|NCT01077128|542042238|FG000|Overall Study|Adverse event and consent withdrawal|1|||
150247260|NCT01077128|542042238|FG000|Overall Study|Adverse event and disease exacerbation|1|||
150247261|NCT01077128|542042238|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
150247262|NCT01077128|542042238|FG000|Overall Study|Other|54|||
150247263|NCT00847626|542042239|FG000|Overall Study|Adverse Event|10|||
150247264|NCT00847626|542042240|FG001|Overall Study|Adverse Event|10|||
150247265|NCT00847626|542042241|FG002|Overall Study|Adverse Event|6|||
150247266|NCT00847626|542042242|FG003|Overall Study|Adverse Event|19|||
150247267|NCT00847626|542042243|FG004|Overall Study|Adverse Event|11|||
150247268|NCT00847626|542042244|FG005|Overall Study|Adverse Event|22|||
150247269|NCT00847626|542042245|FG006|Overall Study|Adverse Event|4|||
150247270|NCT00847626|542042246|FG007|Overall Study|Adverse Event|6|||
150247271|NCT00847626|542042247|FG008|Overall Study|Adverse Event|3|||
150247272|NCT00847626|542042248|FG009|Overall Study|Adverse Event|6|||
150247273|NCT00847626|542042249|FG010|Overall Study|Adverse Event|6|||
150247274|NCT00847626|542042239|FG000|Overall Study|Protocol Violation|2|||
150247275|NCT00847626|542042240|FG001|Overall Study|Protocol Violation|1|||
150247276|NCT00847626|542042241|FG002|Overall Study|Protocol Violation|2|||
150247277|NCT00847626|542042242|FG003|Overall Study|Protocol Violation|1|||
150247278|NCT00847626|542042243|FG004|Overall Study|Protocol Violation|1|||
150247279|NCT00847626|542042244|FG005|Overall Study|Protocol Violation|1|||
150247280|NCT00847626|542042245|FG006|Overall Study|Protocol Violation|1|||
150247281|NCT00847626|542042246|FG007|Overall Study|Protocol Violation|1|||
150247282|NCT00847626|542042247|FG008|Overall Study|Protocol Violation|0|||
150247283|NCT00847626|542042248|FG009|Overall Study|Protocol Violation|1|||
150247284|NCT00847626|542042249|FG010|Overall Study|Protocol Violation|1|||
150247285|NCT00847626|542042239|FG000|Overall Study|Lost to Follow-up|0|||
150247286|NCT00847626|542042240|FG001|Overall Study|Lost to Follow-up|1|||
150247287|NCT00847626|542042241|FG002|Overall Study|Lost to Follow-up|1|||
150247288|NCT00847626|542042242|FG003|Overall Study|Lost to Follow-up|1|||
150247289|NCT00847626|542042243|FG004|Overall Study|Lost to Follow-up|0|||
150247290|NCT00847626|542042244|FG005|Overall Study|Lost to Follow-up|3|||
150247291|NCT00847626|542042245|FG006|Overall Study|Lost to Follow-up|1|||
150247292|NCT00847626|542042246|FG007|Overall Study|Lost to Follow-up|3|||
150247293|NCT00847626|542042247|FG008|Overall Study|Lost to Follow-up|1|||
150247294|NCT00847626|542042248|FG009|Overall Study|Lost to Follow-up|0|||
150247295|NCT00847626|542042249|FG010|Overall Study|Lost to Follow-up|1|||
150247296|NCT00847626|542042239|FG000|Overall Study|Withdrawal by Subject|5|||
150247297|NCT00847626|542042240|FG001|Overall Study|Withdrawal by Subject|5|||
150247298|NCT00847626|542042241|FG002|Overall Study|Withdrawal by Subject|3|||
150247299|NCT00847626|542042242|FG003|Overall Study|Withdrawal by Subject|8|||
150247300|NCT00847626|542042243|FG004|Overall Study|Withdrawal by Subject|12|||
150247301|NCT00847626|542042244|FG005|Overall Study|Withdrawal by Subject|9|||
150247302|NCT00847626|542042245|FG006|Overall Study|Withdrawal by Subject|8|||
150247303|NCT00847626|542042246|FG007|Overall Study|Withdrawal by Subject|4|||
150247304|NCT00847626|542042247|FG008|Overall Study|Withdrawal by Subject|4|||
150247305|NCT00847626|542042248|FG009|Overall Study|Withdrawal by Subject|5|||
150247306|NCT00847626|542042249|FG010|Overall Study|Withdrawal by Subject|2|||
150247307|NCT00847626|542042239|FG000|Overall Study|Lack of Efficacy|3|||
150247308|NCT00847626|542042240|FG001|Overall Study|Lack of Efficacy|1|||
150247309|NCT00847626|542042241|FG002|Overall Study|Lack of Efficacy|0|||
150247310|NCT00847626|542042242|FG003|Overall Study|Lack of Efficacy|1|||
150247311|NCT00847626|542042243|FG004|Overall Study|Lack of Efficacy|2|||
150247312|NCT00847626|542042244|FG005|Overall Study|Lack of Efficacy|0|||
150247313|NCT00847626|542042245|FG006|Overall Study|Lack of Efficacy|6|||
150247314|NCT00847626|542042246|FG007|Overall Study|Lack of Efficacy|2|||
150247315|NCT00847626|542042247|FG008|Overall Study|Lack of Efficacy|5|||
150247316|NCT00847626|542042248|FG009|Overall Study|Lack of Efficacy|1|||
150247317|NCT00847626|542042249|FG010|Overall Study|Lack of Efficacy|7|||
150247318|NCT00847626|542042239|FG000|Overall Study|Other|1|||
150247319|NCT00847626|542042240|FG001|Overall Study|Other|5|||
150247320|NCT00847626|542042241|FG002|Overall Study|Other|4|||
150247321|NCT00847626|542042242|FG003|Overall Study|Other|1|||
150247322|NCT00847626|542042243|FG004|Overall Study|Other|2|||
150247323|NCT00847626|542042244|FG005|Overall Study|Other|2|||
150247324|NCT00847626|542042245|FG006|Overall Study|Other|2|||
150247325|NCT00847626|542042246|FG007|Overall Study|Other|3|||
150247326|NCT00847626|542042247|FG008|Overall Study|Other|1|||
150247327|NCT00847626|542042248|FG009|Overall Study|Other|1|||
150247328|NCT00847626|542042249|FG010|Overall Study|Other|3|||
150247329|NCT00384189|542042252|FG000|Overall Study|Reason Not Specified|50|||
150247330|NCT00384189|542042253|FG001|Overall Study|Reason Not Specified|57|||
150247331|NCT00384189|542042254|FG002|Overall Study|Reason Not Specified|58|||
150247332|NCT00384189|542042255|FG003|Overall Study|Reason Not Specified|40|||
150247333|NCT04546425|542042256|FG000|Overall Study|Protocol Violation|1|||
150247334|NCT04546425|542042257|FG001|Overall Study|Protocol Violation|1|||
150247335|NCT04546425|542042258|FG002|Overall Study|Protocol Violation|0|||
150247336|NCT04546425|542042259|FG003|Overall Study|Protocol Violation|0|||
150247337|NCT04546425|542042256|FG000|Overall Study|Adverse Event|3|||
150247338|NCT04546425|542042257|FG001|Overall Study|Adverse Event|0|||
150247339|NCT04546425|542042258|FG002|Overall Study|Adverse Event|0|||
150247340|NCT04546425|542042259|FG003|Overall Study|Adverse Event|0|||
150247341|NCT04546425|542042256|FG000|Overall Study|Lost to Follow-up|5|||
150247342|NCT04546425|542042257|FG001|Overall Study|Lost to Follow-up|4|||
150247343|NCT04546425|542042258|FG002|Overall Study|Lost to Follow-up|0|||
150247344|NCT04546425|542042259|FG003|Overall Study|Lost to Follow-up|0|||
150247345|NCT04546425|542042256|FG000|Overall Study|No Longer met eligibility criteria|3|||
150247346|NCT04546425|542042257|FG001|Overall Study|No Longer met eligibility criteria|3|||
150247347|NCT04546425|542042258|FG002|Overall Study|No Longer met eligibility criteria|1|||
150247348|NCT04546425|542042259|FG003|Overall Study|No Longer met eligibility criteria|1|||
150247349|NCT04546425|542042256|FG000|Overall Study|Withdrawal by parent/guardian|6|||
150247350|NCT04546425|542042257|FG001|Overall Study|Withdrawal by parent/guardian|5|||
150247351|NCT04546425|542042258|FG002|Overall Study|Withdrawal by parent/guardian|1|||
150247352|NCT04546425|542042259|FG003|Overall Study|Withdrawal by parent/guardian|1|||
150247353|NCT02979249|542042265|FG000|Overall Study|Lost to Follow-up|2|||
150247354|NCT02979249|542042265|FG000|Overall Study|Withdrawal by Subject|4|||
150247355|NCT01125046|542042266|FG000|First 6 Months of Treatment|Death|1|||
150247356|NCT01125046|542042266|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
150247357|NCT01125046|542042266|FG000|First 6 Months of Treatment|Non-compliance|1|||
150247358|NCT01125046|542042266|FG000|First 6 Months of Treatment|Surgery|1|||
150247359|NCT01125046|542042266|FG000|First 6 Months of Treatment|Progressive Disease|7|||
150247360|NCT01125046|542042266|FG000|First 6 Months of Treatment|Adverse Event|2|||
150247361|NCT01125046|542042266|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
150247362|NCT01125046|542042266|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
150247363|NCT01125046|542042266|FG000|Follow-up/Data Cut Off Point|Death|29|||
150247364|NCT01125046|542042266|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
150247365|NCT01685229|542042267|FG000|Overall Study|Subjects missing Study Exit form|3|||
150247366|NCT01685229|542042268|FG001|Overall Study|Subjects missing Study Exit form|1|||
150247367|NCT01685229|542042267|FG000|Overall Study|Lost to Follow-up|16|||
150247368|NCT01685229|542042268|FG001|Overall Study|Lost to Follow-up|10|||
150247369|NCT01685229|542042267|FG000|Overall Study|Withdrawal by Subject|6|||
150247370|NCT01685229|542042268|FG001|Overall Study|Withdrawal by Subject|5|||
150247371|NCT01685229|542042267|FG000|Overall Study|Death|1|||
150247372|NCT01685229|542042268|FG001|Overall Study|Death|0|||
150247373|NCT01399697|542042274|FG000|Overall Study|Adverse Event|13|||
150247374|NCT01399697|542042275|FG001|Overall Study|Adverse Event|3|||
150247375|NCT01399697|542042276|FG002|Overall Study|Adverse Event|1|||
150247376|NCT01399697|542042274|FG000|Overall Study|Lost to Follow-up|2|||
150247377|NCT01399697|542042275|FG001|Overall Study|Lost to Follow-up|0|||
150247378|NCT01399697|542042276|FG002|Overall Study|Lost to Follow-up|0|||
150247379|NCT01399697|542042274|FG000|Overall Study|Withdrawal by Subject|8|||
150247380|NCT01399697|542042275|FG001|Overall Study|Withdrawal by Subject|0|||
150247381|NCT01399697|542042276|FG002|Overall Study|Withdrawal by Subject|0|||
150247382|NCT01399697|542042274|FG000|Overall Study|Investigator Decisión|1|||
150247383|NCT01399697|542042275|FG001|Overall Study|Investigator Decisión|0|||
150247384|NCT01399697|542042276|FG002|Overall Study|Investigator Decisión|2|||
150247385|NCT01399697|542042274|FG000|Overall Study|Lack of Efficacy|9|||
150247386|NCT01399697|542042275|FG001|Overall Study|Lack of Efficacy|0|||
150247387|NCT01399697|542042276|FG002|Overall Study|Lack of Efficacy|1|||
150247388|NCT01399697|542042274|FG000|Overall Study|Protocol Violation|2|||
150247389|NCT01399697|542042275|FG001|Overall Study|Protocol Violation|0|||
150247390|NCT01399697|542042276|FG002|Overall Study|Protocol Violation|0|||
150247391|NCT01399697|542042274|FG000|Overall Study|Non-Compliant|1|||
150247392|NCT01399697|542042275|FG001|Overall Study|Non-Compliant|0|||
150247393|NCT01399697|542042276|FG002|Overall Study|Non-Compliant|0|||
150247394|NCT01399697|542042274|FG000|Overall Study|Inclusion Error|2|||
150247395|NCT01399697|542042275|FG001|Overall Study|Inclusion Error|0|||
150247396|NCT01399697|542042276|FG002|Overall Study|Inclusion Error|0|||
150247397|NCT01399697|542042274|FG000|Overall Study|Positive result for hepatitis B|1|||
150247398|NCT01399697|542042275|FG001|Overall Study|Positive result for hepatitis B|0|||
150247399|NCT01399697|542042276|FG002|Overall Study|Positive result for hepatitis B|0|||
150247400|NCT01399697|542042274|FG000|Overall Study|Clinical RA remission|1|||
150247401|NCT01399697|542042275|FG001|Overall Study|Clinical RA remission|0|||
150247402|NCT01399697|542042276|FG002|Overall Study|Clinical RA remission|0|||
150247403|NCT01399697|542042274|FG000|Overall Study|Sponsor Decision|1|||
150247404|NCT01399697|542042275|FG001|Overall Study|Sponsor Decision|0|||
150247405|NCT01399697|542042276|FG002|Overall Study|Sponsor Decision|0|||
150247406|NCT02964325|542042277|FG000|Overall Study|Lost to Follow-up|3|||
150247407|NCT02964325|542042278|FG001|Overall Study|Lost to Follow-up|3|||
150247408|NCT02964325|542042277|FG000|Overall Study|Physician Decision|5|||
150247409|NCT02964325|542042278|FG001|Overall Study|Physician Decision|4|||
150247410|NCT02964325|542042277|FG000|Overall Study|Death|1|||
150247411|NCT02964325|542042278|FG001|Overall Study|Death|3|||
150247412|NCT02964325|542042277|FG000|Overall Study|Withdrawal by Subject|2|||
150247413|NCT02964325|542042278|FG001|Overall Study|Withdrawal by Subject|1|||
150247414|NCT02964325|542042277|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
150247415|NCT02964325|542042278|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
150247416|NCT00967005|542042284|FG000|Overall Study|Lost to Follow-up|7|||
150247417|NCT00967005|542042285|FG001|Overall Study|Lost to Follow-up|10|||
150247418|NCT01371825|542042286|FG000|Overall Study|Death|4|||
150247419|NCT04868539|542042289|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
150247420|NCT04868539|542042290|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
150247421|NCT01401153|542042291|FG000|First Test Day|Learning disabilities; illness|1|||
150247422|NCT01401153|542042292|FG001|First Test Day|Learning disabilities; illness|10|||
150247423|NCT01401153|542042291|FG000|Second Test Day|illness|0|||
150247424|NCT01401153|542042292|FG001|Second Test Day|illness|5|||
150247425|NCT01818531|542042295|FG000|Overall Study|Withdrawn for case delay after block|1|||
150247426|NCT01818531|542042296|FG001|Overall Study|Withdrawn for case delay after block|0|||
150247427|NCT01818531|542042295|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
150247428|NCT01818531|542042296|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
150247429|NCT01818531|542042295|FG000|Overall Study|Withdrawn for failure to place block|0|||
150247430|NCT01818531|542042296|FG001|Overall Study|Withdrawn for failure to place block|1|||
150247431|NCT01677767|542042297|FG000|Overall Study|Adverse Event|1|||
150247432|NCT01677767|542042297|FG000|Overall Study|Death|4|||
150247433|NCT01677767|542042297|FG000|Overall Study|Protocol Violation|4|||
150247434|NCT01677767|542042297|FG000|Overall Study|Withdrawal by Subject|10|||
150247435|NCT01677767|542042297|FG000|Overall Study|Non-compliance by the participants|3|||
150247436|NCT02807272|542042298|FG000|Overall Study|Death|9|||
150247437|NCT02807272|542042299|FG001|Overall Study|Death|5|||
150247438|NCT02807272|542042300|FG002|Overall Study|Death|2|||
150247439|NCT02807272|542042301|FG003|Overall Study|Death|0|||
150247440|NCT02807272|542042302|FG004|Overall Study|Death|1|||
150247441|NCT02807272|542042298|FG000|Overall Study|Lost to Follow-up|1|||
150247442|NCT02807272|542042299|FG001|Overall Study|Lost to Follow-up|0|||
150247443|NCT02807272|542042300|FG002|Overall Study|Lost to Follow-up|0|||
150247444|NCT02807272|542042301|FG003|Overall Study|Lost to Follow-up|0|||
150247445|NCT02807272|542042302|FG004|Overall Study|Lost to Follow-up|0|||
150247446|NCT02807272|542042298|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
150247447|NCT02807272|542042299|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
150247448|NCT02807272|542042300|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
150247449|NCT02807272|542042301|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
150247450|NCT02807272|542042302|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
150247451|NCT02807272|542042298|FG000|Overall Study|Protocol-defined Disease Progression|0|||
150247452|NCT02807272|542042299|FG001|Overall Study|Protocol-defined Disease Progression|1|||
150247453|NCT02807272|542042300|FG002|Overall Study|Protocol-defined Disease Progression|0|||
150247454|NCT02807272|542042301|FG003|Overall Study|Protocol-defined Disease Progression|0|||
150247455|NCT02807272|542042302|FG004|Overall Study|Protocol-defined Disease Progression|1|||
150247456|NCT02807272|542042298|FG000|Overall Study|Study Terminated by Sponsor|1|||
150247457|NCT02807272|542042299|FG001|Overall Study|Study Terminated by Sponsor|0|||
150247458|NCT02807272|542042300|FG002|Overall Study|Study Terminated by Sponsor|0|||
150247459|NCT02807272|542042301|FG003|Overall Study|Study Terminated by Sponsor|1|||
150247460|NCT02807272|542042302|FG004|Overall Study|Study Terminated by Sponsor|0|||
150247461|NCT02807272|542042298|FG000|Overall Study|Other|1|||
150247462|NCT02807272|542042299|FG001|Overall Study|Other|0|||
150247463|NCT02807272|542042300|FG002|Overall Study|Other|0|||
150247464|NCT02807272|542042301|FG003|Overall Study|Other|0|||
150247465|NCT02807272|542042302|FG004|Overall Study|Other|1|||
150247466|NCT01162863|542042303|FG000|Overall Study|Lack of Efficacy|1|||
150247467|NCT01162863|542042304|FG001|Overall Study|Lack of Efficacy|0|||
150247468|NCT01162863|542042305|FG002|Overall Study|Lack of Efficacy|0|||
150247469|NCT01162863|542042303|FG000|Overall Study|Adverse Event|0|||
150247470|NCT01162863|542042304|FG001|Overall Study|Adverse Event|1|||
150247471|NCT01162863|542042305|FG002|Overall Study|Adverse Event|0|||
150247472|NCT00588692|542042306|FG000|Overall Study|Withdrawal by Subject|4|||
150247473|NCT00588692|542042307|FG001|Overall Study|Withdrawal by Subject|2|||
150247474|NCT00588692|542042306|FG000|Overall Study|Hip Surgery|0|||
150247475|NCT00588692|542042307|FG001|Overall Study|Hip Surgery|1|||
150247476|NCT00588692|542042306|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
150247477|NCT00588692|542042307|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
150247478|NCT00588692|542042306|FG000|Overall Study|Cancer|1|||
150247479|NCT00588692|542042307|FG001|Overall Study|Cancer|0|||
150247480|NCT00588692|542042306|FG000|Overall Study|Death|1|||
150247481|NCT00588692|542042307|FG001|Overall Study|Death|0|||
150247482|NCT00820170|542042308|FG000|Overall Study|Adverse Event|0|||
150247483|NCT00820170|542042309|FG001|Overall Study|Adverse Event|0|||
150247484|NCT00820170|542042310|FG002|Overall Study|Adverse Event|0|||
150247485|NCT00820170|542042311|FG003|Overall Study|Adverse Event|0|||
150247486|NCT00820170|542042312|FG004|Overall Study|Adverse Event|2|||
150247487|NCT00820170|542042308|FG000|Overall Study|Progressive Disease|0|||
150247488|NCT00820170|542042309|FG001|Overall Study|Progressive Disease|0|||
150247489|NCT00820170|542042310|FG002|Overall Study|Progressive Disease|0|||
150247490|NCT00820170|542042311|FG003|Overall Study|Progressive Disease|0|||
150247491|NCT00820170|542042312|FG004|Overall Study|Progressive Disease|2|||
150247492|NCT03995316|542042313|FG000|Overall Study|Lost to Follow-up|10|||
150247493|NCT03995316|542042314|FG001|Overall Study|Lost to Follow-up|3|||
150247494|NCT02202785|542042315|FG000|Overall Study|Study Terminated by Sponsor|1|||
150247495|NCT02202785|542042316|FG001|Overall Study|Study Terminated by Sponsor|6|||
150247496|NCT02202785|542042317|FG002|Overall Study|Study Terminated by Sponsor|4|||
150247497|NCT02202785|542042315|FG000|Overall Study|Withdrawal by Subject|0|||
150247498|NCT02202785|542042316|FG001|Overall Study|Withdrawal by Subject|1|||
150247499|NCT02202785|542042317|FG002|Overall Study|Withdrawal by Subject|0|||
150247500|NCT02202785|542042315|FG000|Overall Study|Lost to Follow-up|0|||
150247501|NCT02202785|542042316|FG001|Overall Study|Lost to Follow-up|1|||
150247502|NCT02202785|542042317|FG002|Overall Study|Lost to Follow-up|0|||
150247503|NCT02202785|542042315|FG000|Overall Study|Reason not Specified|10|||
150247504|NCT02202785|542042316|FG001|Overall Study|Reason not Specified|7|||
150247505|NCT02202785|542042317|FG002|Overall Study|Reason not Specified|13|||
150247506|NCT02180243|542042318|FG000|Overall Study|Withdrawal by Subject|12|||
150247507|NCT02180243|542042319|FG001|Overall Study|Withdrawal by Subject|12|||
150247508|NCT02180243|542042318|FG000|Overall Study|Lost to Follow-up|12|||
150247509|NCT02180243|542042319|FG001|Overall Study|Lost to Follow-up|2|||
150247510|NCT01461005|542042320|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
150247511|NCT01436253|542042321|FG000|Overall Study|Lost to Follow-up|182|||
150247512|NCT01436253|542042321|FG000|Overall Study|Not meeting all eligibility criteria|117|||
150247513|NCT06285240|542042322|FG000|Overall Study|Withdrawal by Subject|2|||
150247514|NCT06285240|542042323|FG001|Overall Study|Withdrawal by Subject|0|||
150247515|NCT06285240|542042324|FG002|Overall Study|Withdrawal by Subject|0|||
150247516|NCT06285240|542042325|FG003|Overall Study|Withdrawal by Subject|0|||
150247517|NCT06285240|542042322|FG000|Overall Study|Serious Adverse Event|0|||
150247518|NCT06285240|542042323|FG001|Overall Study|Serious Adverse Event|0|||
150247519|NCT06285240|542042324|FG002|Overall Study|Serious Adverse Event|1|||
150247520|NCT06285240|542042325|FG003|Overall Study|Serious Adverse Event|0|||
150247521|NCT04844879|542042328|FG000|Overall Study|Death|1|||
150247522|NCT04844879|542042328|FG000|Overall Study|Withdrawal by Subject|1|||
150247523|NCT04844879|542042328|FG000|Overall Study|Adverse Event|1|||
150247524|NCT05140915|542042329|FG000|Overall Study|Lost to Follow-up|2|||
150247525|NCT05140915|542042330|FG001|Overall Study|Lost to Follow-up|1|||
150247526|NCT04520659|542042331|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
150247527|NCT04520659|542042332|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
150247528|NCT04520659|542042333|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
150247529|NCT04520659|542042334|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
150247530|NCT04485611|542042339|FG000|Prehabilitation|Physician Decision|1|||
150247531|NCT04879849|542042340|FG000|Overall Study|Lost to Follow-up|0|||
150247532|NCT04879849|542042341|FG001|Overall Study|Lost to Follow-up|0|||
150247533|NCT04879849|542042342|FG002|Overall Study|Lost to Follow-up|0|||
150247534|NCT04879849|542042343|FG003|Overall Study|Lost to Follow-up|1|||
150247535|NCT04879849|542042344|FG004|Overall Study|Lost to Follow-up|0|||
150247536|NCT04879849|542042345|FG005|Overall Study|Lost to Follow-up|0|||
150247537|NCT04879849|542042346|FG006|Overall Study|Lost to Follow-up|0|||
150247538|NCT04879849|542042347|FG007|Overall Study|Lost to Follow-up|0|||
150247539|NCT04879849|542042340|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
150247540|NCT04879849|542042341|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
150247541|NCT04879849|542042342|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
150247542|NCT04879849|542042343|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
150247543|NCT04879849|542042344|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
150247544|NCT04879849|542042345|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
150247545|NCT04879849|542042346|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
150247546|NCT04879849|542042347|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
150247547|NCT04879849|542042340|FG000|Overall Study|Withdrawal by Subject|0|||
150247548|NCT04879849|542042341|FG001|Overall Study|Withdrawal by Subject|0|||
150247549|NCT04879849|542042342|FG002|Overall Study|Withdrawal by Subject|0|||
150247550|NCT04879849|542042343|FG003|Overall Study|Withdrawal by Subject|0|||
150247551|NCT04879849|542042344|FG004|Overall Study|Withdrawal by Subject|2|||
150247552|NCT04879849|542042345|FG005|Overall Study|Withdrawal by Subject|0|||
150247553|NCT04879849|542042346|FG006|Overall Study|Withdrawal by Subject|1|||
150247554|NCT04879849|542042347|FG007|Overall Study|Withdrawal by Subject|0|||
150247555|NCT04879849|542042340|FG000|Overall Study|Progressive Disease|0|||
150247556|NCT04879849|542042341|FG001|Overall Study|Progressive Disease|0|||
150247557|NCT04879849|542042342|FG002|Overall Study|Progressive Disease|1|||
150247558|NCT04879849|542042343|FG003|Overall Study|Progressive Disease|0|||
150247559|NCT04879849|542042344|FG004|Overall Study|Progressive Disease|0|||
150247560|NCT04879849|542042345|FG005|Overall Study|Progressive Disease|0|||
150247561|NCT04879849|542042346|FG006|Overall Study|Progressive Disease|0|||
150247562|NCT04879849|542042347|FG007|Overall Study|Progressive Disease|0|||
150247563|NCT04879849|542042340|FG000|Overall Study|Death|0|||
150247564|NCT04879849|542042341|FG001|Overall Study|Death|0|||
150247565|NCT04879849|542042342|FG002|Overall Study|Death|1|||
150247566|NCT04879849|542042343|FG003|Overall Study|Death|1|||
150247567|NCT04879849|542042344|FG004|Overall Study|Death|1|||
150247568|NCT04879849|542042345|FG005|Overall Study|Death|2|||
150247569|NCT04879849|542042346|FG006|Overall Study|Death|1|||
150247570|NCT04879849|542042347|FG007|Overall Study|Death|2|||
150247571|NCT04879849|542042340|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
150247572|NCT04879849|542042341|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
150247573|NCT04879849|542042342|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
150247574|NCT04879849|542042343|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
150247575|NCT04879849|542042344|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
150247576|NCT04879849|542042345|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
150247577|NCT04879849|542042346|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
150247578|NCT04879849|542042347|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
150247579|NCT04879849|542042340|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247580|NCT04879849|542042341|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247581|NCT04879849|542042342|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247582|NCT04879849|542042343|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247583|NCT04879849|542042344|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247584|NCT04879849|542042345|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247585|NCT04879849|542042346|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
150247586|NCT04879849|542042347|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
150247587|NCT04879849|542042340|FG000|Overall Study|Reason Not Specified|1|||
150247588|NCT04879849|542042341|FG001|Overall Study|Reason Not Specified|0|||
150247589|NCT04879849|542042342|FG002|Overall Study|Reason Not Specified|0|||
150247590|NCT04879849|542042343|FG003|Overall Study|Reason Not Specified|0|||
150247591|NCT04879849|542042344|FG004|Overall Study|Reason Not Specified|0|||
150247592|NCT04879849|542042345|FG005|Overall Study|Reason Not Specified|0|||
150247593|NCT04879849|542042346|FG006|Overall Study|Reason Not Specified|0|||
150247594|NCT04879849|542042347|FG007|Overall Study|Reason Not Specified|0|||
150247595|NCT03361865|542042348|FG000|Overall Study|Death|17|||
150247596|NCT03361865|542042349|FG001|Overall Study|Death|18|||
150247597|NCT03361865|542042348|FG000|Overall Study|Physician Decision|1|||
150247598|NCT03361865|542042349|FG001|Overall Study|Physician Decision|9|||
150247599|NCT03361865|542042348|FG000|Overall Study|Withdrawal by Subject|1|||
150247600|NCT03361865|542042349|FG001|Overall Study|Withdrawal by Subject|0|||
150247601|NCT03852719|542042351|FG000|Overall Study|Withdrawal of consent|8|||
150247602|NCT03852719|542042352|FG001|Overall Study|Withdrawal of consent|8|||
150247603|NCT03852719|542042353|FG002|Overall Study|Withdrawal of consent|9|||
150247604|NCT03852719|542042351|FG000|Overall Study|Physician Decision|5|||
150247605|NCT03852719|542042352|FG001|Overall Study|Physician Decision|4|||
150247606|NCT03852719|542042353|FG002|Overall Study|Physician Decision|1|||
150247607|NCT03852719|542042351|FG000|Overall Study|Pregnancy|2|||
150247608|NCT03852719|542042352|FG001|Overall Study|Pregnancy|1|||
150247609|NCT03852719|542042353|FG002|Overall Study|Pregnancy|0|||
150247610|NCT03852719|542042351|FG000|Overall Study|Death|1|||
150247611|NCT03852719|542042352|FG001|Overall Study|Death|0|||
150247612|NCT03852719|542042353|FG002|Overall Study|Death|0|||
150247613|NCT03852719|542042351|FG000|Overall Study|Reason not Specified|3|||
150247614|NCT03852719|542042352|FG001|Overall Study|Reason not Specified|3|||
150247615|NCT03852719|542042353|FG002|Overall Study|Reason not Specified|5|||
150247616|NCT03852719|542042351|FG000|Overall Study|Adverse Event|2|||
150247617|NCT03852719|542042352|FG001|Overall Study|Adverse Event|1|||
150247618|NCT03852719|542042353|FG002|Overall Study|Adverse Event|4|||
150247619|NCT03852719|542042351|FG000|Overall Study|Progressive disease|1|||
150247620|NCT03852719|542042352|FG001|Overall Study|Progressive disease|4|||
150247621|NCT03852719|542042353|FG002|Overall Study|Progressive disease|1|||
150247622|NCT03852719|542042351|FG000|Overall Study|Lost to Follow-up|1|||
150247623|NCT03852719|542042352|FG001|Overall Study|Lost to Follow-up|0|||
150247624|NCT03852719|542042353|FG002|Overall Study|Lost to Follow-up|0|||
150247625|NCT04201262|542042354|FG000|Primary Treatment Period|Adverse Event|1|||
150247626|NCT04201262|542042355|FG001|Primary Treatment Period|Adverse Event|2|||
150247627|NCT04201262|542042354|FG000|Primary Treatment Period|Physician Decision|1|||
150247628|NCT04201262|542042355|FG001|Primary Treatment Period|Physician Decision|1|||
150247629|NCT04201262|542042354|FG000|Long-term Extension Period|Death|1|||
150247630|NCT04201262|542042355|FG001|Long-term Extension Period|Death|0|||
150247631|NCT01647542|542042357|FG000|Overall Study|Major Protocol Deviation|1|||
150247632|NCT01647542|542042358|FG001|Overall Study|Major Protocol Deviation|0|||
150247633|NCT01647542|542042359|FG002|Overall Study|Major Protocol Deviation|0|||
150247634|NCT01647542|542042357|FG000|Overall Study|Adverse Event|4|||
150247635|NCT01647542|542042358|FG001|Overall Study|Adverse Event|5|||
150247636|NCT01647542|542042359|FG002|Overall Study|Adverse Event|4|||
150247637|NCT01647542|542042357|FG000|Overall Study|Lost to Follow-up|0|||
150247638|NCT01647542|542042358|FG001|Overall Study|Lost to Follow-up|2|||
150247639|NCT01647542|542042359|FG002|Overall Study|Lost to Follow-up|2|||
150247640|NCT01647542|542042357|FG000|Overall Study|Withdrawal by Subject|6|||
150247641|NCT01647542|542042358|FG001|Overall Study|Withdrawal by Subject|4|||
150247642|NCT01647542|542042359|FG002|Overall Study|Withdrawal by Subject|0|||
150247643|NCT01647542|542042357|FG000|Overall Study|Study Termination|64|||
150247644|NCT01647542|542042358|FG001|Overall Study|Study Termination|61|||
150247645|NCT01647542|542042359|FG002|Overall Study|Study Termination|65|||
150247646|NCT01647542|542042357|FG000|Overall Study|Lack of Efficacy|1|||
150247647|NCT01647542|542042358|FG001|Overall Study|Lack of Efficacy|1|||
150247648|NCT01647542|542042359|FG002|Overall Study|Lack of Efficacy|0|||
150247649|NCT01647542|542042357|FG000|Overall Study|Death|0|||
150247650|NCT01647542|542042358|FG001|Overall Study|Death|0|||
150247651|NCT01647542|542042359|FG002|Overall Study|Death|1|||
150247652|NCT02819024|542042360|FG000|Overall Study|Withdrawal by Subject|1|||
150247653|NCT05576662|542042361|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
150247654|NCT05576662|542042362|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
150247655|NCT05576662|542042361|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
150247656|NCT05576662|542042362|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
150247657|NCT05576662|542042361|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
150247658|NCT05576662|542042362|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
150247659|NCT05576662|542042361|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
150247660|NCT05576662|542042362|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
150247661|NCT05217641|542042366|FG000|Overall Study|Lost to Follow-up|1|||
150247662|NCT05217641|542042367|FG001|Overall Study|Lost to Follow-up|1|||
150247663|NCT05217641|542042368|FG002|Overall Study|Lost to Follow-up|0|||
150247664|NCT05217641|542042369|FG003|Overall Study|Lost to Follow-up|1|||
150247665|NCT05217641|542042370|FG004|Overall Study|Lost to Follow-up|1|||
150247666|NCT05217641|542042371|FG005|Overall Study|Lost to Follow-up|0|||
150247667|NCT05217641|542042366|FG000|Overall Study|Withdrawal by Subject|0|||
150247668|NCT05217641|542042367|FG001|Overall Study|Withdrawal by Subject|0|||
150247669|NCT05217641|542042368|FG002|Overall Study|Withdrawal by Subject|0|||
150247670|NCT05217641|542042369|FG003|Overall Study|Withdrawal by Subject|3|||
150247671|NCT05217641|542042370|FG004|Overall Study|Withdrawal by Subject|1|||
150247672|NCT05217641|542042371|FG005|Overall Study|Withdrawal by Subject|0|||
150247673|NCT05217641|542042366|FG000|Overall Study|Other: participant did not specify reason|0|||
150247674|NCT05217641|542042367|FG001|Overall Study|Other: participant did not specify reason|0|||
150247675|NCT05217641|542042368|FG002|Overall Study|Other: participant did not specify reason|0|||
150247676|NCT05217641|542042369|FG003|Overall Study|Other: participant did not specify reason|0|||
150247677|NCT05217641|542042370|FG004|Overall Study|Other: participant did not specify reason|1|||
150247678|NCT05217641|542042371|FG005|Overall Study|Other: participant did not specify reason|0|||
150247679|NCT05217641|542042366|FG000|Overall Study|Extended Follow up|1|||
150247680|NCT05217641|542042367|FG001|Overall Study|Extended Follow up|1|||
150247681|NCT05217641|542042368|FG002|Overall Study|Extended Follow up|0|||
150247682|NCT05217641|542042369|FG003|Overall Study|Extended Follow up|0|||
150247683|NCT05217641|542042370|FG004|Overall Study|Extended Follow up|1|||
150247684|NCT05217641|542042371|FG005|Overall Study|Extended Follow up|0|||
150247685|NCT05292586|542042372|FG000|Overall Study|Withdrawal by Subject|3|||
150247686|NCT05292586|542042373|FG001|Overall Study|Withdrawal by Subject|10|||
150247687|NCT05292586|542042372|FG000|Overall Study|Randomization error|3|||
150247688|NCT05292586|542042373|FG001|Overall Study|Randomization error|7|||
150247689|NCT05292586|542042372|FG000|Overall Study|Adverse Event|3|||
150247690|NCT05292586|542042373|FG001|Overall Study|Adverse Event|0|||
150247691|NCT05292586|542042372|FG000|Overall Study|Lost to Follow-up|0|||
150247692|NCT05292586|542042373|FG001|Overall Study|Lost to Follow-up|1|||
150247693|NCT05292586|542042372|FG000|Overall Study|Patient refused treatment|1|||
150247694|NCT05292586|542042373|FG001|Overall Study|Patient refused treatment|0|||
150247695|NCT05292586|542042372|FG000|Overall Study|Patient could not travel to the study site|1|||
150247696|NCT05292586|542042373|FG001|Overall Study|Patient could not travel to the study site|0|||
150247697|NCT05292586|542042372|FG000|Overall Study|Technical issues with the masterscope|0|||
150247698|NCT05292586|542042373|FG001|Overall Study|Technical issues with the masterscope|3|||
150247699|NCT05292586|542042372|FG000|Overall Study|Patient moved to a different state|0|||
150247700|NCT05292586|542042373|FG001|Overall Study|Patient moved to a different state|1|||
150247701|NCT03633799|542042378|FG000|Overall Study|Adverse Event|349|||
150247702|NCT03633799|542042378|FG000|Overall Study|Withdrawal by Subject|288|||
150247703|NCT03633799|542042378|FG000|Overall Study|Lost to Follow-up|97|||
150247704|NCT03633799|542042378|FG000|Overall Study|Physician Decision|9|||
150247705|NCT03633799|542042378|FG000|Overall Study|Protocol Violation|4|||
150247706|NCT03633799|542042378|FG000|Overall Study|Pregnancy|20|||
150247707|NCT03633799|542042378|FG000|Overall Study|other|39|||
150247708|NCT03633799|542042378|FG000|Overall Study|ongoing within third year of study|106|||
150247709|NCT03633799|542042378|FG000|Overall Study|unsuccessful study drug placement|19|||
150247710|NCT02397447|542042381|FG000|Overall Study|Lost to Follow-up|2|||
150247711|NCT02397447|542042382|FG001|Overall Study|Lost to Follow-up|2|||
150247712|NCT02994069|542042383|FG000|Overall Study|Death|7|||
150247713|NCT02994069|542042384|FG001|Overall Study|Death|13|||
150247714|NCT02994069|542042383|FG000|Overall Study|Adverse Event|1|||
150247715|NCT02994069|542042384|FG001|Overall Study|Adverse Event|0|||
150247716|NCT02994069|542042383|FG000|Overall Study|Other|2|||
150247717|NCT02994069|542042384|FG001|Overall Study|Other|0|||
150247718|NCT02994069|542042383|FG000|Overall Study|still on follow up/treatment|5|||
150247719|NCT02994069|542042384|FG001|Overall Study|still on follow up/treatment|6|||
150247720|NCT01876082|542044093|FG000|Overall Study|Withdrawal by Subject|0|||
150247721|NCT01876082|542044094|FG001|Overall Study|Withdrawal by Subject|2|||
150247722|NCT01876082|542044093|FG000|Overall Study|Protocol Violation|1|||
150247723|NCT01876082|542044094|FG001|Overall Study|Protocol Violation|0|||
150247724|NCT01876082|542044093|FG000|Overall Study|Adverse Event|1|||
150247725|NCT01876082|542044094|FG001|Overall Study|Adverse Event|1|||
150247726|NCT01876082|542044093|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
150247727|NCT01876082|542044094|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
150247728|NCT03829501|542044095|FG000|Overall Study|Withdrawal of Consent|2|||
150247729|NCT03829501|542044096|FG001|Overall Study|Withdrawal of Consent|0|||
150247730|NCT03829501|542044097|FG002|Overall Study|Withdrawal of Consent|3|||
150247731|NCT03829501|542044098|FG003|Overall Study|Withdrawal of Consent|0|||
150247732|NCT03829501|542044099|FG004|Overall Study|Withdrawal of Consent|1|||
150247733|NCT03829501|542044100|FG005|Overall Study|Withdrawal of Consent|1|||
150247734|NCT03829501|542044101|FG006|Overall Study|Withdrawal of Consent|0|||
150247735|NCT03829501|542044102|FG007|Overall Study|Withdrawal of Consent|10|||
150247736|NCT03829501|542044103|FG008|Overall Study|Withdrawal of Consent|10|||
150247737|NCT03829501|542044104|FG009|Overall Study|Withdrawal of Consent|3|||
150247738|NCT03829501|542044105|FG010|Overall Study|Withdrawal of Consent|4|||
150247739|NCT03829501|542044106|FG011|Overall Study|Withdrawal of Consent|4|||
150247740|NCT03829501|542044107|FG012|Overall Study|Withdrawal of Consent|4|||
150247741|NCT03829501|542044108|FG013|Overall Study|Withdrawal of Consent|0|||
150247742|NCT03829501|542044109|FG014|Overall Study|Withdrawal of Consent|3|||
150247743|NCT03829501|542044110|FG015|Overall Study|Withdrawal of Consent|0|||
150247744|NCT03829501|542044111|FG016|Overall Study|Withdrawal of Consent|1|||
150247745|NCT03829501|542044112|FG017|Overall Study|Withdrawal of Consent|1|||
150247746|NCT03829501|542044113|FG018|Overall Study|Withdrawal of Consent|0|||
150247747|NCT03829501|542044114|FG019|Overall Study|Withdrawal of Consent|0|||
150247748|NCT03829501|542044115|FG020|Overall Study|Withdrawal of Consent|3|||
150247749|NCT03829501|542044116|FG021|Overall Study|Withdrawal of Consent|0|||
150247750|NCT03829501|542044117|FG022|Overall Study|Withdrawal of Consent|1|||
150247751|NCT03829501|542044095|FG000|Overall Study|PD|0|||
150247752|NCT03829501|542044096|FG001|Overall Study|PD|0|||
150247753|NCT03829501|542044097|FG002|Overall Study|PD|0|||
150247754|NCT03829501|542044098|FG003|Overall Study|PD|2|||
150247755|NCT03829501|542044099|FG004|Overall Study|PD|0|||
150247756|NCT03829501|542044100|FG005|Overall Study|PD|0|||
150247757|NCT03829501|542044101|FG006|Overall Study|PD|0|||
150247758|NCT03829501|542044102|FG007|Overall Study|PD|0|||
150247759|NCT03829501|542044103|FG008|Overall Study|PD|0|||
150247760|NCT03829501|542044104|FG009|Overall Study|PD|0|||
150247761|NCT03829501|542044105|FG010|Overall Study|PD|0|||
150247762|NCT03829501|542044106|FG011|Overall Study|PD|0|||
150247763|NCT03829501|542044107|FG012|Overall Study|PD|0|||
150247764|NCT03829501|542044108|FG013|Overall Study|PD|0|||
150247765|NCT03829501|542044109|FG014|Overall Study|PD|0|||
150247766|NCT03829501|542044110|FG015|Overall Study|PD|1|||
150247767|NCT03829501|542044111|FG016|Overall Study|PD|0|||
150247768|NCT03829501|542044112|FG017|Overall Study|PD|0|||
150247769|NCT03829501|542044113|FG018|Overall Study|PD|0|||
150247770|NCT03829501|542044114|FG019|Overall Study|PD|0|||
150247771|NCT03829501|542044115|FG020|Overall Study|PD|1|||
150247772|NCT03829501|542044116|FG021|Overall Study|PD|0|||
150247773|NCT03829501|542044117|FG022|Overall Study|PD|0|||
150247774|NCT03829501|542044095|FG000|Overall Study|Study Terminated by Sponsor|0|||
150247775|NCT03829501|542044096|FG001|Overall Study|Study Terminated by Sponsor|0|||
150247776|NCT03829501|542044097|FG002|Overall Study|Study Terminated by Sponsor|0|||
150247777|NCT03829501|542044098|FG003|Overall Study|Study Terminated by Sponsor|0|||
150247778|NCT03829501|542044099|FG004|Overall Study|Study Terminated by Sponsor|0|||
150247779|NCT03829501|542044100|FG005|Overall Study|Study Terminated by Sponsor|0|||
150247780|NCT03829501|542044101|FG006|Overall Study|Study Terminated by Sponsor|0|||
150247781|NCT03829501|542044102|FG007|Overall Study|Study Terminated by Sponsor|3|||
150247782|NCT03829501|542044103|FG008|Overall Study|Study Terminated by Sponsor|1|||
150247783|NCT03829501|542044104|FG009|Overall Study|Study Terminated by Sponsor|0|||
150247784|NCT03829501|542044105|FG010|Overall Study|Study Terminated by Sponsor|0|||
150247785|NCT03829501|542044106|FG011|Overall Study|Study Terminated by Sponsor|0|||
150247786|NCT03829501|542044107|FG012|Overall Study|Study Terminated by Sponsor|0|||
150247787|NCT03829501|542044108|FG013|Overall Study|Study Terminated by Sponsor|0|||
150247788|NCT03829501|542044109|FG014|Overall Study|Study Terminated by Sponsor|3|||
150247789|NCT03829501|542044110|FG015|Overall Study|Study Terminated by Sponsor|2|||
150247790|NCT03829501|542044111|FG016|Overall Study|Study Terminated by Sponsor|2|||
150247791|NCT03829501|542044112|FG017|Overall Study|Study Terminated by Sponsor|0|||
150247792|NCT03829501|542044113|FG018|Overall Study|Study Terminated by Sponsor|0|||
150247793|NCT03829501|542044114|FG019|Overall Study|Study Terminated by Sponsor|0|||
150247794|NCT03829501|542044115|FG020|Overall Study|Study Terminated by Sponsor|1|||
150247795|NCT03829501|542044116|FG021|Overall Study|Study Terminated by Sponsor|0|||
150247796|NCT03829501|542044117|FG022|Overall Study|Study Terminated by Sponsor|3|||
150247797|NCT03829501|542044095|FG000|Overall Study|Lost to Follow Up|0|||
150247798|NCT03829501|542044096|FG001|Overall Study|Lost to Follow Up|0|||
150247799|NCT03829501|542044097|FG002|Overall Study|Lost to Follow Up|0|||
150247800|NCT03829501|542044098|FG003|Overall Study|Lost to Follow Up|0|||
150247801|NCT03829501|542044099|FG004|Overall Study|Lost to Follow Up|1|||
150247802|NCT03829501|542044100|FG005|Overall Study|Lost to Follow Up|0|||
150247803|NCT03829501|542044101|FG006|Overall Study|Lost to Follow Up|0|||
150247804|NCT03829501|542044102|FG007|Overall Study|Lost to Follow Up|2|||
150247805|NCT03829501|542044103|FG008|Overall Study|Lost to Follow Up|2|||
150247806|NCT03829501|542044104|FG009|Overall Study|Lost to Follow Up|0|||
150247807|NCT03829501|542044105|FG010|Overall Study|Lost to Follow Up|2|||
150247808|NCT03829501|542044106|FG011|Overall Study|Lost to Follow Up|1|||
150247809|NCT03829501|542044107|FG012|Overall Study|Lost to Follow Up|0|||
150247810|NCT03829501|542044108|FG013|Overall Study|Lost to Follow Up|1|||
150247811|NCT03829501|542044109|FG014|Overall Study|Lost to Follow Up|1|||
150247812|NCT03829501|542044110|FG015|Overall Study|Lost to Follow Up|0|||
150247813|NCT03829501|542044111|FG016|Overall Study|Lost to Follow Up|0|||
150247814|NCT03829501|542044112|FG017|Overall Study|Lost to Follow Up|0|||
150247815|NCT03829501|542044113|FG018|Overall Study|Lost to Follow Up|0|||
150247816|NCT03829501|542044114|FG019|Overall Study|Lost to Follow Up|0|||
150247817|NCT03829501|542044115|FG020|Overall Study|Lost to Follow Up|0|||
150247818|NCT03829501|542044116|FG021|Overall Study|Lost to Follow Up|0|||
150247819|NCT03829501|542044117|FG022|Overall Study|Lost to Follow Up|1|||
150247820|NCT03829501|542044095|FG000|Overall Study|Death|2|||
150247821|NCT03829501|542044096|FG001|Overall Study|Death|4|||
150247822|NCT03829501|542044097|FG002|Overall Study|Death|5|||
150247823|NCT03829501|542044098|FG003|Overall Study|Death|6|||
150247824|NCT03829501|542044099|FG004|Overall Study|Death|5|||
150247825|NCT03829501|542044100|FG005|Overall Study|Death|4|||
150247826|NCT03829501|542044101|FG006|Overall Study|Death|5|||
150247827|NCT03829501|542044102|FG007|Overall Study|Death|24|||
150247828|NCT03829501|542044103|FG008|Overall Study|Death|22|||
150247829|NCT03829501|542044104|FG009|Overall Study|Death|6|||
150247830|NCT03829501|542044105|FG010|Overall Study|Death|3|||
150247831|NCT03829501|542044106|FG011|Overall Study|Death|10|||
150247832|NCT03829501|542044107|FG012|Overall Study|Death|10|||
150247833|NCT03829501|542044108|FG013|Overall Study|Death|5|||
150247834|NCT03829501|542044109|FG014|Overall Study|Death|7|||
150247835|NCT03829501|542044110|FG015|Overall Study|Death|2|||
150247836|NCT03829501|542044111|FG016|Overall Study|Death|2|||
150247837|NCT03829501|542044112|FG017|Overall Study|Death|1|||
150247838|NCT03829501|542044113|FG018|Overall Study|Death|1|||
150247839|NCT03829501|542044114|FG019|Overall Study|Death|1|||
150247840|NCT03829501|542044115|FG020|Overall Study|Death|1|||
150247841|NCT03829501|542044116|FG021|Overall Study|Death|2|||
150247842|NCT03829501|542044117|FG022|Overall Study|Death|3|||
150247843|NCT03829501|542044095|FG000|Overall Study|Miscellaneous|0|||
150247844|NCT03829501|542044096|FG001|Overall Study|Miscellaneous|0|||
150247845|NCT03829501|542044097|FG002|Overall Study|Miscellaneous|1|||
150247846|NCT03829501|542044098|FG003|Overall Study|Miscellaneous|0|||
150247847|NCT03829501|542044099|FG004|Overall Study|Miscellaneous|0|||
150247848|NCT03829501|542044100|FG005|Overall Study|Miscellaneous|0|||
150247849|NCT03829501|542044101|FG006|Overall Study|Miscellaneous|0|||
150247850|NCT03829501|542044102|FG007|Overall Study|Miscellaneous|1|||
150247851|NCT03829501|542044103|FG008|Overall Study|Miscellaneous|0|||
150247852|NCT03829501|542044104|FG009|Overall Study|Miscellaneous|0|||
150247853|NCT03829501|542044105|FG010|Overall Study|Miscellaneous|0|||
150247854|NCT03829501|542044106|FG011|Overall Study|Miscellaneous|0|||
150247855|NCT03829501|542044107|FG012|Overall Study|Miscellaneous|0|||
150247856|NCT03829501|542044108|FG013|Overall Study|Miscellaneous|0|||
150247857|NCT03829501|542044109|FG014|Overall Study|Miscellaneous|0|||
150247858|NCT03829501|542044110|FG015|Overall Study|Miscellaneous|0|||
150247859|NCT03829501|542044111|FG016|Overall Study|Miscellaneous|0|||
150247860|NCT03829501|542044112|FG017|Overall Study|Miscellaneous|0|||
150247861|NCT03829501|542044113|FG018|Overall Study|Miscellaneous|0|||
150247862|NCT03829501|542044114|FG019|Overall Study|Miscellaneous|0|||
150247863|NCT03829501|542044115|FG020|Overall Study|Miscellaneous|0|||
150247864|NCT03829501|542044116|FG021|Overall Study|Miscellaneous|0|||
150247865|NCT03829501|542044117|FG022|Overall Study|Miscellaneous|1|||
150247866|NCT02964013|542044118|FG000|Overall Study|Death|58|||
150247867|NCT02964013|542044119|FG001|Overall Study|Death|239|||
150247868|NCT02964013|542044120|FG002|Overall Study|Death|38|||
150247869|NCT02964013|542044121|FG003|Overall Study|Death|10|||
150247870|NCT02964013|542044122|FG004|Overall Study|Death|33|||
150247871|NCT02964013|542044118|FG000|Overall Study|Lost to Follow-up|1|||
150247872|NCT02964013|542044119|FG001|Overall Study|Lost to Follow-up|4|||
150247873|NCT02964013|542044120|FG002|Overall Study|Lost to Follow-up|2|||
150247874|NCT02964013|542044121|FG003|Overall Study|Lost to Follow-up|0|||
150247875|NCT02964013|542044122|FG004|Overall Study|Lost to Follow-up|0|||
150247876|NCT02964013|542044118|FG000|Overall Study|Physician Decision|0|||
150247877|NCT02964013|542044119|FG001|Overall Study|Physician Decision|1|||
150247878|NCT02964013|542044120|FG002|Overall Study|Physician Decision|0|||
150247879|NCT02964013|542044121|FG003|Overall Study|Physician Decision|0|||
150247880|NCT02964013|542044122|FG004|Overall Study|Physician Decision|0|||
150247881|NCT02964013|542044118|FG000|Overall Study|Sponsor Decision|3|||
150247882|NCT02964013|542044119|FG001|Overall Study|Sponsor Decision|22|||
150247883|NCT02964013|542044120|FG002|Overall Study|Sponsor Decision|11|||
150247884|NCT02964013|542044121|FG003|Overall Study|Sponsor Decision|0|||
150247885|NCT02964013|542044122|FG004|Overall Study|Sponsor Decision|7|||
150247886|NCT02964013|542044118|FG000|Overall Study|Withdrawal by Subject|6|||
150247887|NCT02964013|542044119|FG001|Overall Study|Withdrawal by Subject|27|||
150247888|NCT02964013|542044120|FG002|Overall Study|Withdrawal by Subject|9|||
150247889|NCT02964013|542044121|FG003|Overall Study|Withdrawal by Subject|0|||
150247890|NCT02964013|542044122|FG004|Overall Study|Withdrawal by Subject|0|||
150247891|NCT02964013|542044118|FG000|Overall Study|Not Treated|0|||
150247892|NCT02964013|542044119|FG001|Overall Study|Not Treated|2|||
150247893|NCT02964013|542044120|FG002|Overall Study|Not Treated|0|||
150247894|NCT02964013|542044121|FG003|Overall Study|Not Treated|1|||
150247895|NCT02964013|542044122|FG004|Overall Study|Not Treated|0|||
150247896|NCT01123070|542044123|FG000|Part B Double Blind Period|Protocol Violation|0|||
150247897|NCT01123070|542044124|FG001|Part B Double Blind Period|Protocol Violation|0|||
150247898|NCT01123070|542044125|FG002|Part B Double Blind Period|Protocol Violation|0|||
150247899|NCT01123070|542044126|FG003|Part B Double Blind Period|Protocol Violation|1|||
150247900|NCT01123070|542044123|FG000|Part B Double Blind Period|Adverse Event|0|||
150247901|NCT01123070|542044124|FG001|Part B Double Blind Period|Adverse Event|0|||
150247902|NCT01123070|542044125|FG002|Part B Double Blind Period|Adverse Event|2|||
150247903|NCT01123070|542044126|FG003|Part B Double Blind Period|Adverse Event|0|||
150247904|NCT01123070|542044123|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
150247905|NCT01123070|542044124|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
150247906|NCT01123070|542044125|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
150247907|NCT01123070|542044126|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
150247908|NCT04942366|542044127|FG000|Overall Study|Withdrawal by Subject|5|||
150247909|NCT04942366|542044128|FG001|Overall Study|Withdrawal by Subject|5|||
150247910|NCT03284229|542044129|FG000|Overall Study|Lost to Follow-up|3|||
150247911|NCT03554629|542044130|FG000|Overall Study|Inadequate data|6|||
150247912|NCT00663702|542044131|FG000|Overall Study|Adverse Event|8|||
150247913|NCT00663702|542044132|FG001|Overall Study|Adverse Event|4|||
150247914|NCT00663702|542044131|FG000|Overall Study|Withdrawal by Subject|3|||
150247915|NCT00663702|542044132|FG001|Overall Study|Withdrawal by Subject|1|||
150247916|NCT00663702|542044131|FG000|Overall Study|Pregnancy|0|||
150247917|NCT00663702|542044132|FG001|Overall Study|Pregnancy|1|||
150247918|NCT00663702|542044131|FG000|Overall Study|Lost to Follow-up|3|||
150247919|NCT00663702|542044132|FG001|Overall Study|Lost to Follow-up|0|||
150247920|NCT00663702|542044131|FG000|Overall Study|Death|1|||
150247921|NCT00663702|542044132|FG001|Overall Study|Death|1|||
150247922|NCT00663702|542044131|FG000|Overall Study|Lack of Efficacy|3|||
150247923|NCT00663702|542044132|FG001|Overall Study|Lack of Efficacy|3|||
150247924|NCT01977677|542044133|FG000|Overall Study|Unrelated Adverse Event|0|||
150247925|NCT01977677|542044134|FG001|Overall Study|Unrelated Adverse Event|0|||
150247926|NCT01977677|542044135|FG002|Overall Study|Unrelated Adverse Event|1|||
150247927|NCT01498887|542044136|FG000|Overall Study|Administrative problems|1|||
150247928|NCT01498887|542044137|FG001|Overall Study|Administrative problems|0|||
150247929|NCT01498887|542044136|FG000|Overall Study|Lost to Follow-up|1|||
150247930|NCT01498887|542044137|FG001|Overall Study|Lost to Follow-up|1|||
150247931|NCT01498887|542044136|FG000|Overall Study|Withdrawal by Subject|1|||
150247932|NCT01498887|542044137|FG001|Overall Study|Withdrawal by Subject|0|||
150247933|NCT01498887|542044136|FG000|Overall Study|Protocol Violation|1|||
150247934|NCT01498887|542044137|FG001|Overall Study|Protocol Violation|3|||
150247935|NCT01498887|542044136|FG000|Overall Study|Lack of Efficacy|5|||
150247936|NCT01498887|542044137|FG001|Overall Study|Lack of Efficacy|3|||
150247937|NCT01498887|542044136|FG000|Overall Study|Abnormal result from test procedure|1|||
150247938|NCT01498887|542044137|FG001|Overall Study|Abnormal result from test procedure|1|||
150247939|NCT01498887|542044136|FG000|Overall Study|Abnormal laboratory value|2|||
150247940|NCT01498887|542044137|FG001|Overall Study|Abnormal laboratory value|2|||
150247941|NCT01498887|542044136|FG000|Overall Study|Adverse Event|4|||
150247942|NCT01498887|542044137|FG001|Overall Study|Adverse Event|1|||
150247943|NCT00667225|542044142|FG000|Overall Study|Subject had no more lesions to treat.|1|||
150247944|NCT00667225|542044143|FG001|Overall Study|Subject had no more lesions to treat.|0|||
150247945|NCT00667225|542044142|FG000|Overall Study|Lost to Follow-up|0|||
150247946|NCT00667225|542044143|FG001|Overall Study|Lost to Follow-up|1|||
150247947|NCT03056300|542044144|FG000|Overall Study|Surgical reason per study protocol|3|||
150247948|NCT05262517|542044151|FG000|Overall Study|Randomized but not treated|5|||
150247949|NCT05262517|542044152|FG001|Overall Study|Randomized but not treated|11|||
150247950|NCT05602727|542044153|FG000|Overall Study|Physician Decision|0|||
150247951|NCT05602727|542044154|FG001|Overall Study|Physician Decision|1|||
150247952|NCT05602727|542044155|FG002|Overall Study|Physician Decision|0|||
150247953|NCT05602727|542044153|FG000|Overall Study|Randomized by mistake without study medication|1|||
150247954|NCT05602727|542044154|FG001|Overall Study|Randomized by mistake without study medication|0|||
150247955|NCT05602727|542044155|FG002|Overall Study|Randomized by mistake without study medication|0|||
150247956|NCT05602727|542044153|FG000|Overall Study|Study termination by Sponsor|18|||
150247957|NCT05602727|542044154|FG001|Overall Study|Study termination by Sponsor|15|||
150247958|NCT05602727|542044155|FG002|Overall Study|Study termination by Sponsor|19|||
150247959|NCT05602727|542044153|FG000|Overall Study|Withdrawal by Subject|2|||
150247960|NCT05602727|542044154|FG001|Overall Study|Withdrawal by Subject|1|||
150247961|NCT05602727|542044155|FG002|Overall Study|Withdrawal by Subject|1|||
150247962|NCT05602727|542044153|FG000|Overall Study|Various reasons|1|||
150247963|NCT05602727|542044154|FG001|Overall Study|Various reasons|6|||
150247964|NCT05602727|542044155|FG002|Overall Study|Various reasons|1|||
150247965|NCT02187159|542044156|FG000|Overall Study|Protocol Violation|4|||
150247966|NCT02187159|542044157|FG001|Overall Study|Protocol Violation|6|||
150247967|NCT02187159|542044158|FG002|Overall Study|Protocol Violation|3|||
150247968|NCT02187159|542044159|FG003|Overall Study|Protocol Violation|4|||
150247969|NCT02187159|542044156|FG000|Overall Study|Lack of Efficacy|10|||
150247970|NCT02187159|542044157|FG001|Overall Study|Lack of Efficacy|5|||
150247971|NCT02187159|542044158|FG002|Overall Study|Lack of Efficacy|4|||
150247972|NCT02187159|542044159|FG003|Overall Study|Lack of Efficacy|7|||
150247973|NCT02187159|542044156|FG000|Overall Study|Adverse Event|28|||
150247974|NCT02187159|542044157|FG001|Overall Study|Adverse Event|33|||
150247975|NCT02187159|542044158|FG002|Overall Study|Adverse Event|42|||
150247976|NCT02187159|542044159|FG003|Overall Study|Adverse Event|50|||
150247977|NCT02187159|542044156|FG000|Overall Study|Withdrawal by Subject|24|||
150247978|NCT02187159|542044157|FG001|Overall Study|Withdrawal by Subject|28|||
150247979|NCT02187159|542044158|FG002|Overall Study|Withdrawal by Subject|25|||
150247980|NCT02187159|542044159|FG003|Overall Study|Withdrawal by Subject|26|||
150247981|NCT02187159|542044156|FG000|Overall Study|Other|3|||
150247982|NCT02187159|542044157|FG001|Overall Study|Other|7|||
150247983|NCT02187159|542044158|FG002|Overall Study|Other|3|||
150247984|NCT02187159|542044159|FG003|Overall Study|Other|9|||
150247985|NCT04325282|542044160|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
150247986|NCT04325282|542044161|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
150247987|NCT04325282|542044160|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
150247988|NCT04325282|542044161|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
150247989|NCT04020185|542044165|FG000|Overall Study|Death|0|||
150247990|NCT04020185|542044166|FG001|Overall Study|Death|0|||
150247991|NCT04020185|542044167|FG002|Overall Study|Death|1|||
150247992|NCT04020185|542044168|FG003|Overall Study|Death|2|||
150247993|NCT04020185|542044169|FG004|Overall Study|Death|1|||
150247994|NCT04020185|542044170|FG005|Overall Study|Death|0|||
150247995|NCT04020185|542044171|FG006|Overall Study|Death|1|||
150247996|NCT04020185|542044172|FG007|Overall Study|Death|0|||
150247997|NCT04020185|542044165|FG000|Overall Study|Consent withdrawn|1|||
150247998|NCT04020185|542044166|FG001|Overall Study|Consent withdrawn|0|||
150247999|NCT04020185|542044167|FG002|Overall Study|Consent withdrawn|0|||
150248000|NCT04020185|542044168|FG003|Overall Study|Consent withdrawn|0|||
150248001|NCT04020185|542044169|FG004|Overall Study|Consent withdrawn|2|||
150248002|NCT04020185|542044170|FG005|Overall Study|Consent withdrawn|0|||
150248003|NCT04020185|542044171|FG006|Overall Study|Consent withdrawn|1|||
150248004|NCT04020185|542044172|FG007|Overall Study|Consent withdrawn|1|||
150248005|NCT04020185|542044165|FG000|Overall Study|Patient in hospice|0|||
150248006|NCT04020185|542044166|FG001|Overall Study|Patient in hospice|1|||
150248007|NCT04020185|542044167|FG002|Overall Study|Patient in hospice|0|||
150248008|NCT04020185|542044168|FG003|Overall Study|Patient in hospice|0|||
150248009|NCT04020185|542044169|FG004|Overall Study|Patient in hospice|0|||
150248010|NCT04020185|542044170|FG005|Overall Study|Patient in hospice|0|||
150248011|NCT04020185|542044171|FG006|Overall Study|Patient in hospice|0|||
150248012|NCT04020185|542044172|FG007|Overall Study|Patient in hospice|0|||
150248013|NCT04020185|542044165|FG000|Overall Study|Continuing on expanded access|0|||
150248014|NCT04020185|542044166|FG001|Overall Study|Continuing on expanded access|0|||
150248015|NCT04020185|542044167|FG002|Overall Study|Continuing on expanded access|0|||
150248016|NCT04020185|542044168|FG003|Overall Study|Continuing on expanded access|0|||
150248017|NCT04020185|542044169|FG004|Overall Study|Continuing on expanded access|0|||
150248018|NCT04020185|542044170|FG005|Overall Study|Continuing on expanded access|0|||
150248019|NCT04020185|542044171|FG006|Overall Study|Continuing on expanded access|1|||
150248020|NCT04020185|542044172|FG007|Overall Study|Continuing on expanded access|1|||
150248021|NCT00527787|542044175|FG000|Overall Study|Adverse Event|14|||
150248022|NCT00527787|542044176|FG001|Overall Study|Adverse Event|24|||
150248023|NCT00527787|542044175|FG000|Overall Study|Withdrawal by Subject|13|||
150248024|NCT00527787|542044176|FG001|Overall Study|Withdrawal by Subject|25|||
150248025|NCT00527787|542044175|FG000|Overall Study|Lost to Follow-up|5|||
150248026|NCT00527787|542044176|FG001|Overall Study|Lost to Follow-up|2|||
150248027|NCT00527787|542044175|FG000|Overall Study|Duodenal Ulcer|1|||
150248028|NCT00527787|542044176|FG001|Overall Study|Duodenal Ulcer|10|||
150248029|NCT00527787|542044175|FG000|Overall Study|misc|5|||
150248030|NCT00527787|542044176|FG001|Overall Study|misc|2|||
150248031|NCT01840410|542044183|FG000|Overall Study|Physician Decision|1|||
150248032|NCT01840410|542044184|FG001|Overall Study|Physician Decision|2|||
150248033|NCT01840410|542044183|FG000|Overall Study|Pregnancy|1|||
150248034|NCT01840410|542044184|FG001|Overall Study|Pregnancy|0|||
150248035|NCT01840410|542044183|FG000|Overall Study|Protocol deviation|1|||
150248036|NCT01840410|542044184|FG001|Overall Study|Protocol deviation|0|||
150248037|NCT01840410|542044183|FG000|Overall Study|Lost to Follow-up|1|||
150248038|NCT01840410|542044184|FG001|Overall Study|Lost to Follow-up|0|||
150248039|NCT01840410|542044183|FG000|Overall Study|Withdrawal by Subject|2|||
150248040|NCT01840410|542044184|FG001|Overall Study|Withdrawal by Subject|1|||
150248041|NCT01840410|542044183|FG000|Overall Study|Adverse Event|1|||
150248042|NCT01840410|542044184|FG001|Overall Study|Adverse Event|1|||
150248043|NCT00839956|542044185|FG000|Overall Study|Adverse Event|2|||
150248044|NCT00839956|542044185|FG000|Overall Study|Lack of Efficacy|6|||
150248045|NCT00839956|542044185|FG000|Overall Study|Physician Decision|1|||
150248046|NCT00839956|542044185|FG000|Overall Study|Withdrawal by Subject|3|||
150248047|NCT01495598|542044188|FG000|Overall Study|Death during follow up period|2|||
150248048|NCT01495598|542044188|FG000|Overall Study|Death on study|1|||
150248049|NCT01495598|542044188|FG000|Overall Study|Lost to Follow-up|3|||
150248050|NCT01495598|542044188|FG000|Overall Study|Physician Decision|8|||
150248051|NCT03083665|542044189|FG000|Double-Blind Period|Adverse Event|5|||
150248052|NCT03083665|542044190|FG001|Double-Blind Period|Adverse Event|4|||
150248053|NCT03083665|542044191|FG002|Double-Blind Period|Adverse Event|5|||
150248054|NCT03083665|542044192|FG003|Double-Blind Period|Adverse Event|0|||
150248055|NCT03083665|542044193|FG004|Double-Blind Period|Adverse Event|0|||
150248056|NCT03083665|542044194|FG005|Double-Blind Period|Adverse Event|0|||
150248057|NCT03083665|542044189|FG000|Double-Blind Period|Lack of Efficacy|0|||
150248058|NCT03083665|542044190|FG001|Double-Blind Period|Lack of Efficacy|0|||
150248059|NCT03083665|542044191|FG002|Double-Blind Period|Lack of Efficacy|1|||
150248060|NCT03083665|542044192|FG003|Double-Blind Period|Lack of Efficacy|0|||
150248061|NCT03083665|542044193|FG004|Double-Blind Period|Lack of Efficacy|0|||
150248062|NCT03083665|542044194|FG005|Double-Blind Period|Lack of Efficacy|0|||
150248063|NCT03083665|542044189|FG000|Double-Blind Period|Protocol Violation|1|||
150248064|NCT03083665|542044190|FG001|Double-Blind Period|Protocol Violation|0|||
150248065|NCT03083665|542044191|FG002|Double-Blind Period|Protocol Violation|1|||
150248066|NCT03083665|542044192|FG003|Double-Blind Period|Protocol Violation|0|||
150248067|NCT03083665|542044193|FG004|Double-Blind Period|Protocol Violation|0|||
150248068|NCT03083665|542044194|FG005|Double-Blind Period|Protocol Violation|0|||
150248069|NCT03083665|542044189|FG000|Double-Blind Period|Lost to Follow-up|1|||
150248070|NCT03083665|542044190|FG001|Double-Blind Period|Lost to Follow-up|0|||
150248071|NCT03083665|542044191|FG002|Double-Blind Period|Lost to Follow-up|1|||
150248072|NCT03083665|542044192|FG003|Double-Blind Period|Lost to Follow-up|0|||
150248073|NCT03083665|542044193|FG004|Double-Blind Period|Lost to Follow-up|0|||
150248074|NCT03083665|542044194|FG005|Double-Blind Period|Lost to Follow-up|0|||
150248075|NCT03083665|542044189|FG000|Double-Blind Period|Withdrawal by Subject|3|||
150248076|NCT03083665|542044190|FG001|Double-Blind Period|Withdrawal by Subject|0|||
150248077|NCT03083665|542044191|FG002|Double-Blind Period|Withdrawal by Subject|0|||
150248078|NCT03083665|542044192|FG003|Double-Blind Period|Withdrawal by Subject|0|||
150248079|NCT03083665|542044193|FG004|Double-Blind Period|Withdrawal by Subject|0|||
150248080|NCT03083665|542044194|FG005|Double-Blind Period|Withdrawal by Subject|0|||
150248081|NCT03083665|542044189|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
150248082|NCT03083665|542044190|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
150248083|NCT03083665|542044191|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
150248084|NCT03083665|542044192|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
150248085|NCT03083665|542044193|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
150248086|NCT03083665|542044194|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
150248087|NCT03083665|542044189|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
150248088|NCT03083665|542044190|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
150248089|NCT03083665|542044191|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
150248090|NCT03083665|542044192|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
150248091|NCT03083665|542044193|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
150248092|NCT03083665|542044194|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
150248093|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
150248094|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
150248095|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
150248096|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
150248097|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
150248098|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
150248099|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
150248100|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
150248101|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
150248102|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
150248103|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
150248104|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
150248105|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
150248106|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
150248107|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
150248108|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
150248109|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
150248110|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
150248111|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
150248112|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
150248113|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
150248114|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149737558|NCT00408005|540170388|FG003|Induction|Ineligible|0|||
150248115|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
150248116|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
150248117|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
150248118|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
150248119|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
150248120|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
150248121|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
150248122|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
150248123|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
150248124|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
150248125|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
150248126|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
150248127|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
150248128|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
150248129|NCT03083665|542044189|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
150248130|NCT03083665|542044190|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
150248131|NCT03083665|542044191|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
150248132|NCT03083665|542044192|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
150248133|NCT03083665|542044193|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
150248134|NCT03083665|542044194|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
150248135|NCT01289210|542044195|FG000|Overall Study|Adverse Event|1|||
150248136|NCT01040169|542044212|FG000|Overall Study|Lost to Follow-up|3|||
150248137|NCT01040169|542044213|FG001|Overall Study|Lost to Follow-up|8|||
150248138|NCT00350727|542044214|FG000|Phase I: Dose Escalation|Adverse Event|4|||
150248139|NCT00350727|542044215|FG001|Phase I: Dose Escalation|Adverse Event|0|||
150248140|NCT00350727|542044216|FG002|Phase I: Dose Escalation|Adverse Event|0|||
150248141|NCT00350727|542044214|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
150248142|NCT00350727|542044215|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
150248143|NCT00350727|542044216|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
150248144|NCT00350727|542044214|FG000|Phase I: Dose Escalation|Death|1|||
150248145|NCT00350727|542044215|FG001|Phase I: Dose Escalation|Death|0|||
150248146|NCT00350727|542044216|FG002|Phase I: Dose Escalation|Death|0|||
150248147|NCT00350727|542044214|FG000|Phase I: Dose Escalation|Physician Decision|1|||
150248148|NCT00350727|542044215|FG001|Phase I: Dose Escalation|Physician Decision|0|||
150248149|NCT00350727|542044216|FG002|Phase I: Dose Escalation|Physician Decision|0|||
150248150|NCT00350727|542044214|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
150248151|NCT00350727|542044215|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
150248152|NCT00350727|542044216|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
150248153|NCT00350727|542044214|FG000|Phase II|Disease Progression|0|||
150248154|NCT00350727|542044215|FG001|Phase II|Disease Progression|15|||
150248155|NCT00350727|542044216|FG002|Phase II|Disease Progression|16|||
150248156|NCT00350727|542044214|FG000|Phase II|Clinical Deterioration|0|||
150248157|NCT00350727|542044215|FG001|Phase II|Clinical Deterioration|1|||
150248158|NCT00350727|542044216|FG002|Phase II|Clinical Deterioration|0|||
150248159|NCT00350727|542044214|FG000|Phase II|Withdrawal by Subject|0|||
150248160|NCT00350727|542044215|FG001|Phase II|Withdrawal by Subject|2|||
150248161|NCT00350727|542044216|FG002|Phase II|Withdrawal by Subject|1|||
150248162|NCT00350727|542044214|FG000|Phase II|Adverse Event|0|||
150248163|NCT00350727|542044215|FG001|Phase II|Adverse Event|1|||
150248164|NCT00350727|542044216|FG002|Phase II|Adverse Event|1|||
150248165|NCT00350727|542044214|FG000|Phase II|Death|0|||
150248166|NCT00350727|542044215|FG001|Phase II|Death|0|||
150248167|NCT00350727|542044216|FG002|Phase II|Death|2|||
150248168|NCT00350727|542044214|FG000|Phase II|Sponsor Terminated Study|0|||
150248169|NCT00350727|542044215|FG001|Phase II|Sponsor Terminated Study|0|||
150248170|NCT00350727|542044216|FG002|Phase II|Sponsor Terminated Study|1|||
150248171|NCT00350727|542044214|FG000|Phase II|Enrolled in Rollover Study|0|||
150248172|NCT00350727|542044215|FG001|Phase II|Enrolled in Rollover Study|0|||
150248173|NCT00350727|542044216|FG002|Phase II|Enrolled in Rollover Study|1|||
150248174|NCT03551691|542044222|FG000|Overall Study|Withdrawal by Subject|3|||
150248175|NCT03551691|542044223|FG001|Overall Study|Withdrawal by Subject|3|||
150248176|NCT02367040|542044224|FG000|Overall Study|Lost to Follow-up|1|||
150248177|NCT02367040|542044225|FG001|Overall Study|Lost to Follow-up|1|||
150248178|NCT02367040|542044224|FG000|Overall Study|Lack of Efficacy|1|||
150248179|NCT02367040|542044225|FG001|Overall Study|Lack of Efficacy|0|||
150248180|NCT02367040|542044224|FG000|Overall Study|Additional primary malignancy|1|||
150248181|NCT02367040|542044225|FG001|Overall Study|Additional primary malignancy|1|||
150248182|NCT02367040|542044224|FG000|Overall Study|AE not associated with clinical disease progression|117|||
150248183|NCT02367040|542044225|FG001|Overall Study|AE not associated with clinical disease progression|12|||
150248184|NCT02367040|542044224|FG000|Overall Study|AE associated with clinical disease progression|1|||
150248185|NCT02367040|542044225|FG001|Overall Study|AE associated with clinical disease progression|4|||
150248186|NCT02367040|542044224|FG000|Overall Study|Physician Decision|2|||
150248187|NCT02367040|542044225|FG001|Overall Study|Physician Decision|8|||
150248188|NCT02367040|542044224|FG000|Overall Study|Non-compliance to study drug|1|||
150248189|NCT02367040|542044225|FG001|Overall Study|Non-compliance to study drug|0|||
150248190|NCT02367040|542044224|FG000|Overall Study|Failure to meet continuation criteria|1|||
150248191|NCT02367040|542044225|FG001|Overall Study|Failure to meet continuation criteria|0|||
150248192|NCT02367040|542044224|FG000|Overall Study|Switching to other therapy|2|||
150248193|NCT02367040|542044225|FG001|Overall Study|Switching to other therapy|0|||
150248194|NCT02367040|542044224|FG000|Overall Study|Withdrawal by Subject|51|||
150248195|NCT02367040|542044225|FG001|Overall Study|Withdrawal by Subject|16|||
150248196|NCT02367040|542044224|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
150248197|NCT02367040|542044225|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150248198|NCT02367040|542044224|FG000|Overall Study|Patient decision|40|||
150248199|NCT02367040|542044225|FG001|Overall Study|Patient decision|14|||
150248200|NCT02367040|542044224|FG000|Overall Study|Required procedure failed|1|||
150248201|NCT02367040|542044225|FG001|Overall Study|Required procedure failed|0|||
150248202|NCT02367040|542044224|FG000|Overall Study|Randomized by mistake with study treatment|1|||
150248203|NCT02367040|542044225|FG001|Overall Study|Randomized by mistake with study treatment|0|||
150248204|NCT02367040|542044224|FG000|Overall Study|Protocol Violation|1|||
150248205|NCT02367040|542044225|FG001|Overall Study|Protocol Violation|0|||
150248206|NCT02367040|542044224|FG000|Overall Study|Progressive disease - radiological progression|54|||
150248207|NCT02367040|542044225|FG001|Overall Study|Progressive disease - radiological progression|80|||
150248208|NCT02367040|542044224|FG000|Overall Study|Progressive disease - clinical progression|6|||
150248209|NCT02367040|542044225|FG001|Overall Study|Progressive disease - clinical progression|6|||
150248210|NCT02367040|542044224|FG000|Overall Study|Drug not administered|3|||
150248211|NCT02367040|542044225|FG001|Overall Study|Drug not administered|2|||
150248212|NCT02367040|542044224|FG000|Overall Study|Progressive disease|0|||
150248213|NCT02367040|542044225|FG001|Overall Study|Progressive disease|1|||
150248214|NCT02367040|542044224|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
150248215|NCT02367040|542044225|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
150248216|NCT02367040|542044224|FG000|Overall Study|Death|2|||
150248217|NCT02367040|542044225|FG001|Overall Study|Death|0|||
150248218|NCT02367040|542044224|FG000|Overall Study|Study terminated by sponsor|19|||
150248219|NCT02367040|542044225|FG001|Overall Study|Study terminated by sponsor|2|||
150248220|NCT02477618|542044226|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
150248221|NCT02477618|542044227|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
150248222|NCT02477618|542044226|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
150248223|NCT02477618|542044227|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
150248224|NCT02477618|542044226|FG000|Overall Study|Adverse Event|1|||
150248225|NCT02477618|542044227|FG001|Overall Study|Adverse Event|1|||
150248226|NCT02477618|542044226|FG000|Overall Study|Transferred Away from Study Site|1|||
150248227|NCT02477618|542044227|FG001|Overall Study|Transferred Away from Study Site|0|||
150248228|NCT02477618|542044226|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
150248229|NCT02477618|542044227|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
150248230|NCT02446821|542044228|FG000|Overall Study|Adverse Event|28|||
150248231|NCT02446821|542044228|FG000|Overall Study|Withdrawal by Subject|6|||
150248232|NCT02446821|542044228|FG000|Overall Study|Lost to Follow-up|22|||
150248233|NCT02446821|542044228|FG000|Overall Study|other|9|||
150248234|NCT02446821|542044228|FG000|Overall Study|insertion failure|3|||
150248235|NCT03007420|542044229|FG000|Overall Study|Withdrawal by Subject|0|||
150248236|NCT03007420|542044230|FG001|Overall Study|Withdrawal by Subject|2|||
150248237|NCT03007420|542044229|FG000|Overall Study|Physician Decision|0|||
150248238|NCT03007420|542044230|FG001|Overall Study|Physician Decision|1|||
150248239|NCT02284009|542044234|FG000|Overall Study|Adverse Event|3|||
150248240|NCT02284009|542044235|FG001|Overall Study|Adverse Event|0|||
150248241|NCT02284009|542044234|FG000|Overall Study|Lost to Follow-up|1|||
150248242|NCT02284009|542044235|FG001|Overall Study|Lost to Follow-up|3|||
150248243|NCT02284009|542044234|FG000|Overall Study|Physician Decision|0|||
150248244|NCT02284009|542044235|FG001|Overall Study|Physician Decision|2|||
150248245|NCT02284009|542044234|FG000|Overall Study|Withdrawal by Subject|2|||
150248246|NCT02284009|542044235|FG001|Overall Study|Withdrawal by Subject|5|||
150248247|NCT00747227|542045610|FG000|Overall Study|Death|3|||
150248248|NCT00747227|542045611|FG001|Overall Study|Death|1|||
150248249|NCT00747227|542045610|FG000|Overall Study|Withdrawal by Subject|1|||
150248250|NCT00747227|542045611|FG001|Overall Study|Withdrawal by Subject|0|||
150248251|NCT00747227|542045610|FG000|Overall Study|Lost to Follow-up|1|||
150248252|NCT00747227|542045611|FG001|Overall Study|Lost to Follow-up|2|||
150248253|NCT00747227|542045610|FG000|Overall Study|Illness|1|||
150248254|NCT00747227|542045611|FG001|Overall Study|Illness|1|||
150248255|NCT02993406|542045626|FG000|Overall Study|Withdrawal by Subject|170|||
150248256|NCT02993406|542045627|FG001|Overall Study|Withdrawal by Subject|196|||
150248257|NCT02993406|542045626|FG000|Overall Study|Physician Decision|3|||
150248258|NCT02993406|542045627|FG001|Overall Study|Physician Decision|5|||
150248259|NCT02993406|542045626|FG000|Overall Study|Lost to Follow-up|12|||
150248260|NCT02993406|542045627|FG001|Overall Study|Lost to Follow-up|13|||
150248261|NCT02993406|542045626|FG000|Overall Study|Unclassifiable Response|105|||
150248262|NCT02993406|542045627|FG001|Overall Study|Unclassifiable Response|139|||
150248263|NCT02993406|542045626|FG000|Overall Study|Administrative decision|1|||
150248264|NCT02993406|542045627|FG001|Overall Study|Administrative decision|0|||
150248265|NCT02993406|542045626|FG000|Overall Study|Sponsor decision|4|||
150248266|NCT02993406|542045627|FG001|Overall Study|Sponsor decision|5|||
150248267|NCT03563157|542045628|FG000|Overall Study|Progressive Disease|2|||
150248268|NCT02248818|542045629|FG000|Screening|Protocol Violation|0|||
150248269|NCT02248818|542045630|FG001|Screening|Protocol Violation|0|||
150248270|NCT02248818|542045631|FG002|Screening|Protocol Violation|0|||
150248271|NCT02248818|542045632|FG003|Screening|Protocol Violation|0|||
150248272|NCT02248818|542045633|FG004|Screening|Protocol Violation|0|||
150248273|NCT02248818|542045634|FG005|Screening|Protocol Violation|0|||
150248274|NCT02248818|542045635|FG006|Screening|Protocol Violation|0|||
150248275|NCT02248818|542045636|FG007|Screening|Protocol Violation|0|||
150248276|NCT02248818|542045637|FG008|Screening|Protocol Violation|7|||
150248277|NCT02248818|542045629|FG000|Screening|Study fully enrolled|0|||
150248278|NCT02248818|542045630|FG001|Screening|Study fully enrolled|0|||
150248279|NCT02248818|542045631|FG002|Screening|Study fully enrolled|0|||
150248280|NCT02248818|542045632|FG003|Screening|Study fully enrolled|0|||
150248281|NCT02248818|542045633|FG004|Screening|Study fully enrolled|0|||
150248282|NCT02248818|542045634|FG005|Screening|Study fully enrolled|0|||
150248283|NCT02248818|542045635|FG006|Screening|Study fully enrolled|0|||
150248284|NCT02248818|542045636|FG007|Screening|Study fully enrolled|0|||
150248285|NCT02248818|542045637|FG008|Screening|Study fully enrolled|14|||
150248286|NCT02248818|542045629|FG000|Screening|Physician Decision|0|||
150248287|NCT02248818|542045630|FG001|Screening|Physician Decision|0|||
150248288|NCT02248818|542045631|FG002|Screening|Physician Decision|0|||
150248289|NCT02248818|542045632|FG003|Screening|Physician Decision|0|||
150248290|NCT02248818|542045633|FG004|Screening|Physician Decision|0|||
150248291|NCT02248818|542045634|FG005|Screening|Physician Decision|0|||
150248292|NCT02248818|542045635|FG006|Screening|Physician Decision|0|||
150248293|NCT02248818|542045636|FG007|Screening|Physician Decision|0|||
150248294|NCT02248818|542045637|FG008|Screening|Physician Decision|73|||
150248295|NCT02248818|542045629|FG000|Screening|Withdrawal by Subject|0|||
150248296|NCT02248818|542045630|FG001|Screening|Withdrawal by Subject|0|||
150248297|NCT02248818|542045631|FG002|Screening|Withdrawal by Subject|0|||
150248298|NCT02248818|542045632|FG003|Screening|Withdrawal by Subject|0|||
150248299|NCT02248818|542045633|FG004|Screening|Withdrawal by Subject|0|||
150248300|NCT02248818|542045634|FG005|Screening|Withdrawal by Subject|0|||
150248301|NCT02248818|542045635|FG006|Screening|Withdrawal by Subject|0|||
150248302|NCT02248818|542045636|FG007|Screening|Withdrawal by Subject|0|||
150248303|NCT02248818|542045637|FG008|Screening|Withdrawal by Subject|6|||
150248304|NCT02248818|542045629|FG000|Screening|Lost to Follow-up|0|||
150248305|NCT02248818|542045630|FG001|Screening|Lost to Follow-up|0|||
150248306|NCT02248818|542045631|FG002|Screening|Lost to Follow-up|0|||
150248307|NCT02248818|542045632|FG003|Screening|Lost to Follow-up|0|||
150248308|NCT02248818|542045633|FG004|Screening|Lost to Follow-up|0|||
150248309|NCT02248818|542045634|FG005|Screening|Lost to Follow-up|0|||
150248310|NCT02248818|542045635|FG006|Screening|Lost to Follow-up|0|||
150248311|NCT02248818|542045636|FG007|Screening|Lost to Follow-up|0|||
150248312|NCT02248818|542045637|FG008|Screening|Lost to Follow-up|7|||
150248313|NCT02248818|542045629|FG000|Randomised Study|Administrative - randomization error|0|||
150248314|NCT02248818|542045630|FG001|Randomised Study|Administrative - randomization error|0|||
150248315|NCT02248818|542045631|FG002|Randomised Study|Administrative - randomization error|0|||
150248316|NCT02248818|542045632|FG003|Randomised Study|Administrative - randomization error|0|||
150248317|NCT02248818|542045633|FG004|Randomised Study|Administrative - randomization error|0|||
150248318|NCT02248818|542045634|FG005|Randomised Study|Administrative - randomization error|8|||
150248319|NCT02248818|542045635|FG006|Randomised Study|Administrative - randomization error|0|||
150248320|NCT02248818|542045636|FG007|Randomised Study|Administrative - randomization error|0|||
150248321|NCT02248818|542045637|FG008|Randomised Study|Administrative - randomization error|0|||
150248322|NCT02942277|542045638|FG000|Year 1|Withdrawal by Subject|0|||
150248323|NCT02942277|542045639|FG001|Year 1|Withdrawal by Subject|0|||
150248324|NCT02942277|542045640|FG002|Year 1|Withdrawal by Subject|0|||
150248325|NCT02942277|542045641|FG003|Year 1|Withdrawal by Subject|0|||
150248326|NCT02942277|542045642|FG004|Year 1|Withdrawal by Subject|1|||
150248327|NCT02942277|542045643|FG005|Year 1|Withdrawal by Subject|3|||
150248328|NCT02942277|542045644|FG006|Year 1|Withdrawal by Subject|0|||
150248329|NCT02942277|542045645|FG007|Year 1|Withdrawal by Subject|1|||
150248330|NCT02942277|542045646|FG008|Year 1|Withdrawal by Subject|0|||
150248331|NCT02942277|542045647|FG009|Year 1|Withdrawal by Subject|0|||
150248332|NCT02942277|542045648|FG010|Year 1|Withdrawal by Subject|3|||
150248333|NCT02942277|542045638|FG000|Year 1|Travel|0|||
150248334|NCT02942277|542045639|FG001|Year 1|Travel|1|||
150248335|NCT02942277|542045640|FG002|Year 1|Travel|0|||
150248336|NCT02942277|542045641|FG003|Year 1|Travel|0|||
150248337|NCT02942277|542045642|FG004|Year 1|Travel|4|||
150248338|NCT02942277|542045643|FG005|Year 1|Travel|5|||
149737559|NCT00408005|540170389|FG004|Induction|Ineligible|0|||
150248339|NCT02942277|542045644|FG006|Year 1|Travel|0|||
150248340|NCT02942277|542045645|FG007|Year 1|Travel|0|||
150248341|NCT02942277|542045646|FG008|Year 1|Travel|0|||
150248342|NCT02942277|542045647|FG009|Year 1|Travel|0|||
150248343|NCT02942277|542045648|FG010|Year 1|Travel|8|||
150248344|NCT02942277|542045638|FG000|Year 1|Joined Army|0|||
150248345|NCT02942277|542045639|FG001|Year 1|Joined Army|1|||
150248346|NCT02942277|542045640|FG002|Year 1|Joined Army|0|||
150248347|NCT02942277|542045641|FG003|Year 1|Joined Army|0|||
150248348|NCT02942277|542045642|FG004|Year 1|Joined Army|0|||
150248349|NCT02942277|542045643|FG005|Year 1|Joined Army|0|||
150248350|NCT02942277|542045644|FG006|Year 1|Joined Army|0|||
150248351|NCT02942277|542045645|FG007|Year 1|Joined Army|0|||
150248352|NCT02942277|542045646|FG008|Year 1|Joined Army|0|||
150248353|NCT02942277|542045647|FG009|Year 1|Joined Army|0|||
150248354|NCT02942277|542045648|FG010|Year 1|Joined Army|0|||
150248355|NCT02942277|542045638|FG000|Year 1|Subject met withdrawal criteria|0|||
150248356|NCT02942277|542045639|FG001|Year 1|Subject met withdrawal criteria|0|||
150248357|NCT02942277|542045640|FG002|Year 1|Subject met withdrawal criteria|0|||
150248358|NCT02942277|542045641|FG003|Year 1|Subject met withdrawal criteria|1|||
150248359|NCT02942277|542045642|FG004|Year 1|Subject met withdrawal criteria|0|||
150248360|NCT02942277|542045643|FG005|Year 1|Subject met withdrawal criteria|0|||
150248361|NCT02942277|542045644|FG006|Year 1|Subject met withdrawal criteria|0|||
150248362|NCT02942277|542045645|FG007|Year 1|Subject met withdrawal criteria|0|||
150248363|NCT02942277|542045646|FG008|Year 1|Subject met withdrawal criteria|0|||
150248364|NCT02942277|542045647|FG009|Year 1|Subject met withdrawal criteria|0|||
150248365|NCT02942277|542045648|FG010|Year 1|Subject met withdrawal criteria|0|||
150248366|NCT02942277|542045638|FG000|Year 1|Lost to Follow-up|0|||
150248367|NCT02942277|542045639|FG001|Year 1|Lost to Follow-up|0|||
150248368|NCT02942277|542045640|FG002|Year 1|Lost to Follow-up|0|||
150248369|NCT02942277|542045641|FG003|Year 1|Lost to Follow-up|0|||
150248370|NCT02942277|542045642|FG004|Year 1|Lost to Follow-up|1|||
150248371|NCT02942277|542045643|FG005|Year 1|Lost to Follow-up|0|||
150248372|NCT02942277|542045644|FG006|Year 1|Lost to Follow-up|0|||
150248373|NCT02942277|542045645|FG007|Year 1|Lost to Follow-up|0|||
150248374|NCT02942277|542045646|FG008|Year 1|Lost to Follow-up|0|||
150248375|NCT02942277|542045647|FG009|Year 1|Lost to Follow-up|0|||
150248376|NCT02942277|542045648|FG010|Year 1|Lost to Follow-up|2|||
150248377|NCT02942277|542045638|FG000|Year 1|Protocol Violation|0|||
150248378|NCT02942277|542045639|FG001|Year 1|Protocol Violation|0|||
150248379|NCT02942277|542045640|FG002|Year 1|Protocol Violation|0|||
150248380|NCT02942277|542045641|FG003|Year 1|Protocol Violation|0|||
150248381|NCT02942277|542045642|FG004|Year 1|Protocol Violation|1|||
150248382|NCT02942277|542045643|FG005|Year 1|Protocol Violation|1|||
150248383|NCT02942277|542045644|FG006|Year 1|Protocol Violation|0|||
150248384|NCT02942277|542045645|FG007|Year 1|Protocol Violation|0|||
150248385|NCT02942277|542045646|FG008|Year 1|Protocol Violation|0|||
150248386|NCT02942277|542045647|FG009|Year 1|Protocol Violation|0|||
150248387|NCT02942277|542045648|FG010|Year 1|Protocol Violation|2|||
150248388|NCT02942277|542045638|FG000|Year 1|Pregnancy|0|||
150248389|NCT02942277|542045639|FG001|Year 1|Pregnancy|0|||
150248390|NCT02942277|542045640|FG002|Year 1|Pregnancy|0|||
150248391|NCT02942277|542045641|FG003|Year 1|Pregnancy|0|||
150248392|NCT02942277|542045642|FG004|Year 1|Pregnancy|0|||
150248393|NCT02942277|542045643|FG005|Year 1|Pregnancy|1|||
150248394|NCT02942277|542045644|FG006|Year 1|Pregnancy|0|||
150248395|NCT02942277|542045645|FG007|Year 1|Pregnancy|0|||
150248396|NCT02942277|542045646|FG008|Year 1|Pregnancy|0|||
150248397|NCT02942277|542045647|FG009|Year 1|Pregnancy|0|||
150248398|NCT02942277|542045648|FG010|Year 1|Pregnancy|0|||
150248399|NCT02942277|542045638|FG000|Year 2|Lost to Follow-up|0|||
150248400|NCT02942277|542045639|FG001|Year 2|Lost to Follow-up|0|||
150248401|NCT02942277|542045640|FG002|Year 2|Lost to Follow-up|0|||
150248402|NCT02942277|542045641|FG003|Year 2|Lost to Follow-up|0|||
150248403|NCT02942277|542045642|FG004|Year 2|Lost to Follow-up|2|||
150248404|NCT02942277|542045643|FG005|Year 2|Lost to Follow-up|1|||
150248405|NCT02942277|542045644|FG006|Year 2|Lost to Follow-up|0|||
150248406|NCT02942277|542045645|FG007|Year 2|Lost to Follow-up|0|||
150248407|NCT02942277|542045646|FG008|Year 2|Lost to Follow-up|0|||
150248408|NCT02942277|542045647|FG009|Year 2|Lost to Follow-up|0|||
150248409|NCT02942277|542045648|FG010|Year 2|Lost to Follow-up|0|||
150248410|NCT02942277|542045638|FG000|Year 2|Did not rescreen|0|||
150248411|NCT02942277|542045639|FG001|Year 2|Did not rescreen|0|||
150248412|NCT02942277|542045640|FG002|Year 2|Did not rescreen|1|||
150248413|NCT02942277|542045641|FG003|Year 2|Did not rescreen|1|||
150248414|NCT02942277|542045642|FG004|Year 2|Did not rescreen|9|||
150248415|NCT02942277|542045643|FG005|Year 2|Did not rescreen|6|||
150248416|NCT02942277|542045644|FG006|Year 2|Did not rescreen|0|||
150248417|NCT02942277|542045645|FG007|Year 2|Did not rescreen|1|||
150248418|NCT02942277|542045646|FG008|Year 2|Did not rescreen|0|||
150248419|NCT02942277|542045647|FG009|Year 2|Did not rescreen|0|||
150248420|NCT02942277|542045648|FG010|Year 2|Did not rescreen|21|||
150248421|NCT02942277|542045638|FG000|Year 2|Met withdrawal criteria|0|||
150248422|NCT02942277|542045639|FG001|Year 2|Met withdrawal criteria|0|||
150248423|NCT02942277|542045640|FG002|Year 2|Met withdrawal criteria|0|||
150248424|NCT02942277|542045641|FG003|Year 2|Met withdrawal criteria|0|||
150248425|NCT02942277|542045642|FG004|Year 2|Met withdrawal criteria|1|||
150248426|NCT02942277|542045643|FG005|Year 2|Met withdrawal criteria|2|||
150248427|NCT02942277|542045644|FG006|Year 2|Met withdrawal criteria|0|||
150248428|NCT02942277|542045645|FG007|Year 2|Met withdrawal criteria|0|||
150248429|NCT02942277|542045646|FG008|Year 2|Met withdrawal criteria|0|||
150248430|NCT02942277|542045647|FG009|Year 2|Met withdrawal criteria|0|||
150248431|NCT02942277|542045648|FG010|Year 2|Met withdrawal criteria|1|||
150248432|NCT02942277|542045638|FG000|Year 2|Travel|0|||
150248433|NCT02942277|542045639|FG001|Year 2|Travel|1|||
150248434|NCT02942277|542045640|FG002|Year 2|Travel|0|||
150248435|NCT02942277|542045641|FG003|Year 2|Travel|0|||
150248436|NCT02942277|542045642|FG004|Year 2|Travel|0|||
150248437|NCT02942277|542045643|FG005|Year 2|Travel|1|||
150248438|NCT02942277|542045644|FG006|Year 2|Travel|0|||
150248439|NCT02942277|542045645|FG007|Year 2|Travel|0|||
150248440|NCT02942277|542045646|FG008|Year 2|Travel|0|||
150248441|NCT02942277|542045647|FG009|Year 2|Travel|1|||
150248442|NCT02942277|542045648|FG010|Year 2|Travel|3|||
150248443|NCT02942277|542045638|FG000|Year 2|Non-compliant|0|||
150248444|NCT02942277|542045639|FG001|Year 2|Non-compliant|0|||
150248445|NCT02942277|542045640|FG002|Year 2|Non-compliant|0|||
150248446|NCT02942277|542045641|FG003|Year 2|Non-compliant|0|||
150248447|NCT02942277|542045642|FG004|Year 2|Non-compliant|1|||
150248448|NCT02942277|542045643|FG005|Year 2|Non-compliant|1|||
150248449|NCT02942277|542045644|FG006|Year 2|Non-compliant|0|||
150248450|NCT02942277|542045645|FG007|Year 2|Non-compliant|0|||
150248451|NCT02942277|542045646|FG008|Year 2|Non-compliant|0|||
150248452|NCT02942277|542045647|FG009|Year 2|Non-compliant|0|||
150248453|NCT02942277|542045648|FG010|Year 2|Non-compliant|0|||
150248454|NCT02942277|542045638|FG000|Year 2|Withdrawal by Subject|0|||
150248455|NCT02942277|542045639|FG001|Year 2|Withdrawal by Subject|0|||
150248456|NCT02942277|542045640|FG002|Year 2|Withdrawal by Subject|0|||
150248457|NCT02942277|542045641|FG003|Year 2|Withdrawal by Subject|0|||
150248458|NCT02942277|542045642|FG004|Year 2|Withdrawal by Subject|0|||
150248459|NCT02942277|542045643|FG005|Year 2|Withdrawal by Subject|0|||
150248460|NCT02942277|542045644|FG006|Year 2|Withdrawal by Subject|1|||
150248461|NCT02942277|542045645|FG007|Year 2|Withdrawal by Subject|0|||
150248462|NCT02942277|542045646|FG008|Year 2|Withdrawal by Subject|0|||
150248463|NCT02942277|542045647|FG009|Year 2|Withdrawal by Subject|0|||
150248464|NCT02942277|542045648|FG010|Year 2|Withdrawal by Subject|0|||
150248465|NCT00461981|542045653|FG000|Overall Study|Lost to Follow-up|9|||
150248466|NCT00461981|542045654|FG001|Overall Study|Lost to Follow-up|6|||
150248467|NCT00461981|542045653|FG000|Overall Study|Withdrawal by Subject|2|||
150248468|NCT00461981|542045654|FG001|Overall Study|Withdrawal by Subject|3|||
150248469|NCT01876901|542045656|FG000|Overall Study|Protocol Violation|10|||
150248470|NCT01876901|542045657|FG001|Overall Study|Protocol Violation|2|||
150248471|NCT01876901|542045656|FG000|Overall Study|No or other surgical intervention|7|||
150248472|NCT01876901|542045657|FG001|Overall Study|No or other surgical intervention|5|||
150248473|NCT03031496|542045659|FG000|Period 1|Adverse Event|2|||
150248474|NCT03031496|542045660|FG001|Period 1|Adverse Event|0|||
150248475|NCT03031496|542045659|FG000|Period 1|Withdrawal by Subject|0|||
150248476|NCT03031496|542045660|FG001|Period 1|Withdrawal by Subject|2|||
150248477|NCT03868787|542045662|FG000|Overall Study|Withdrawal by Subject|2|||
150248478|NCT03868787|542045663|FG001|Overall Study|Withdrawal by Subject|1|||
150248479|NCT04313608|542045664|FG000|Overall Study|Death|12|||
150248480|NCT04313608|542045665|FG001|Overall Study|Death|3|||
150248481|NCT02510040|542045666|FG000|Overall Study|Deemed no longer eligible|18|||
150248482|NCT02510040|542045667|FG001|Overall Study|Deemed no longer eligible|3|||
150248483|NCT02510040|542045668|FG002|Overall Study|Deemed no longer eligible|1|||
150248484|NCT01712061|542045669|FG000|Overall Study|Adverse Event|4|||
150248485|NCT01712061|542045670|FG001|Overall Study|Adverse Event|9|||
150248486|NCT01712061|542045671|FG002|Overall Study|Adverse Event|5|||
150248487|NCT01712061|542045669|FG000|Overall Study|Death|0|||
150248488|NCT01712061|542045670|FG001|Overall Study|Death|0|||
150248489|NCT01712061|542045671|FG002|Overall Study|Death|1|||
150248490|NCT01712061|542045669|FG000|Overall Study|Lost to Follow-up|1|||
150248491|NCT01712061|542045670|FG001|Overall Study|Lost to Follow-up|0|||
150248492|NCT01712061|542045671|FG002|Overall Study|Lost to Follow-up|1|||
150248493|NCT01712061|542045669|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
150248494|NCT01712061|542045670|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
150248495|NCT01712061|542045671|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
150248496|NCT01712061|542045669|FG000|Overall Study|Medication Error Without Associated AE|0|||
150248497|NCT01712061|542045670|FG001|Overall Study|Medication Error Without Associated AE|1|||
150248498|NCT01712061|542045671|FG002|Overall Study|Medication Error Without Associated AE|0|||
150248499|NCT01712061|542045669|FG000|Overall Study|Withdrawal by Subject|1|||
150248500|NCT01712061|542045670|FG001|Overall Study|Withdrawal by Subject|7|||
150248501|NCT01712061|542045671|FG002|Overall Study|Withdrawal by Subject|1|||
150248502|NCT01712061|542045669|FG000|Overall Study|Other|0|||
150248503|NCT01712061|542045670|FG001|Overall Study|Other|3|||
150248504|NCT01712061|542045671|FG002|Overall Study|Other|0|||
150248505|NCT00879775|542045674|FG000|Overall Study|Lost to Follow-up|2|||
150248506|NCT00879775|542045675|FG001|Overall Study|Lost to Follow-up|1|||
150248507|NCT00842244|542045676|FG000|Overall Study|Death|3|||
150248508|NCT00842244|542045676|FG000|Overall Study|Withdrawal by Subject|1|||
150248509|NCT00842244|542045676|FG000|Overall Study|Other|17|||
150248510|NCT01068665|542045677|FG000|Overall Study|Adverse Event|5|||
150248511|NCT01068665|542045678|FG001|Overall Study|Adverse Event|4|||
150248512|NCT01068665|542045677|FG000|Overall Study|Lack of Efficacy|0|||
150248513|NCT01068665|542045678|FG001|Overall Study|Lack of Efficacy|2|||
150248514|NCT01068665|542045677|FG000|Overall Study|Protocol Violation|5|||
150248515|NCT01068665|542045678|FG001|Overall Study|Protocol Violation|2|||
150248516|NCT01068665|542045677|FG000|Overall Study|Withdrawal Criteria|3|||
150248517|NCT01068665|542045678|FG001|Overall Study|Withdrawal Criteria|9|||
150248518|NCT01068665|542045677|FG000|Overall Study|Other|17|||
150248519|NCT01068665|542045678|FG001|Overall Study|Other|12|||
150248520|NCT02992691|542045681|FG000|Overall Study|Adverse Event|2|||
150248521|NCT02992691|542045681|FG000|Overall Study|Withdrawal by Subject|1|||
150248522|NCT00392925|542045683|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
150248523|NCT00392925|542045684|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
150248524|NCT00392925|542045685|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
150248525|NCT00392925|542045686|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
150248526|NCT00392925|542045683|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
150248527|NCT00392925|542045684|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
150248528|NCT00392925|542045685|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
150248529|NCT00392925|542045686|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
150248530|NCT00392925|542045683|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
150248531|NCT00392925|542045684|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
150248532|NCT00392925|542045685|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
150248533|NCT00392925|542045686|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
150248534|NCT00392925|542045683|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
150248535|NCT00392925|542045684|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
150248536|NCT00392925|542045685|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
150248537|NCT00392925|542045686|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
150248538|NCT00392925|542045683|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
150248539|NCT00392925|542045684|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
150248540|NCT00392925|542045685|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
150248541|NCT00392925|542045686|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
150248542|NCT00392925|542045683|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
150248543|NCT00392925|542045684|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
150248544|NCT00392925|542045685|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
150248545|NCT00392925|542045686|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
150248546|NCT00392925|542045683|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
150248547|NCT00392925|542045684|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
150248548|NCT00392925|542045685|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
150248549|NCT00392925|542045686|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
150248550|NCT00392925|542045683|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
150248551|NCT00392925|542045684|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
150248552|NCT00392925|542045685|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
150248553|NCT00392925|542045686|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
150248554|NCT00392925|542045683|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
150248555|NCT00392925|542045684|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
150248556|NCT00392925|542045685|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
150248557|NCT00392925|542045686|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
150248558|NCT03552523|542045687|FG000|Overall Study|Withdrawal by Subject|1|||
150248559|NCT03552523|542045688|FG001|Overall Study|Withdrawal by Subject|1|||
150248560|NCT03538938|542045689|FG000|Overall Study|Death|0|||
150248561|NCT03538938|542045690|FG001|Overall Study|Death|0|||
150248562|NCT03538938|542045691|FG002|Overall Study|Death|2|||
150248563|NCT03538938|542045692|FG003|Overall Study|Death|0|||
150248564|NCT03538938|542045693|FG004|Overall Study|Death|0|||
150248565|NCT03538938|542045694|FG005|Overall Study|Death|1|||
150248566|NCT03538938|542045695|FG006|Overall Study|Death|0|||
150248567|NCT03538938|542045696|FG007|Overall Study|Death|1|||
150248568|NCT03538938|542045697|FG008|Overall Study|Death|1|||
150248569|NCT03538938|542045698|FG009|Overall Study|Death|1|||
150248570|NCT03538938|542045699|FG010|Overall Study|Death|0|||
150248571|NCT03538938|542045700|FG011|Overall Study|Death|0|||
150248572|NCT03538938|542045701|FG012|Overall Study|Death|1|||
150248573|NCT03538938|542045702|FG013|Overall Study|Death|1|||
150248574|NCT03538938|542045703|FG014|Overall Study|Death|0|||
150248575|NCT03538938|542045704|FG015|Overall Study|Death|1|||
150248576|NCT03538938|542045689|FG000|Overall Study|Withdrawal by Subject|4|||
150248577|NCT03538938|542045690|FG001|Overall Study|Withdrawal by Subject|6|||
150248578|NCT03538938|542045691|FG002|Overall Study|Withdrawal by Subject|5|||
150248579|NCT03538938|542045692|FG003|Overall Study|Withdrawal by Subject|3|||
150248580|NCT03538938|542045693|FG004|Overall Study|Withdrawal by Subject|0|||
150248581|NCT03538938|542045694|FG005|Overall Study|Withdrawal by Subject|0|||
150248582|NCT03538938|542045695|FG006|Overall Study|Withdrawal by Subject|3|||
150248583|NCT03538938|542045696|FG007|Overall Study|Withdrawal by Subject|1|||
150248584|NCT03538938|542045697|FG008|Overall Study|Withdrawal by Subject|5|||
150248585|NCT03538938|542045698|FG009|Overall Study|Withdrawal by Subject|1|||
150248586|NCT03538938|542045699|FG010|Overall Study|Withdrawal by Subject|2|||
150248587|NCT03538938|542045700|FG011|Overall Study|Withdrawal by Subject|1|||
150248588|NCT03538938|542045701|FG012|Overall Study|Withdrawal by Subject|3|||
150248589|NCT03538938|542045702|FG013|Overall Study|Withdrawal by Subject|0|||
150248590|NCT03538938|542045703|FG014|Overall Study|Withdrawal by Subject|2|||
150248591|NCT03538938|542045704|FG015|Overall Study|Withdrawal by Subject|4|||
150248592|NCT03538938|542045689|FG000|Overall Study|Incarcerated|0|||
150248593|NCT03538938|542045690|FG001|Overall Study|Incarcerated|0|||
150248594|NCT03538938|542045691|FG002|Overall Study|Incarcerated|0|||
150248595|NCT03538938|542045692|FG003|Overall Study|Incarcerated|0|||
150248596|NCT03538938|542045693|FG004|Overall Study|Incarcerated|0|||
150248597|NCT03538938|542045694|FG005|Overall Study|Incarcerated|0|||
150248598|NCT03538938|542045695|FG006|Overall Study|Incarcerated|0|||
150248599|NCT03538938|542045696|FG007|Overall Study|Incarcerated|0|||
150248600|NCT03538938|542045697|FG008|Overall Study|Incarcerated|0|||
150248601|NCT03538938|542045698|FG009|Overall Study|Incarcerated|0|||
150248602|NCT03538938|542045699|FG010|Overall Study|Incarcerated|0|||
150248603|NCT03538938|542045700|FG011|Overall Study|Incarcerated|1|||
150248604|NCT03538938|542045701|FG012|Overall Study|Incarcerated|0|||
150248605|NCT03538938|542045702|FG013|Overall Study|Incarcerated|0|||
150248606|NCT03538938|542045703|FG014|Overall Study|Incarcerated|0|||
150248607|NCT03538938|542045704|FG015|Overall Study|Incarcerated|0|||
150248608|NCT00755105|542045705|FG000|Overall Study|Withdrawal by Subject|9|||
150248609|NCT00755105|542045706|FG001|Overall Study|Withdrawal by Subject|11|||
150248610|NCT00755105|542045707|FG002|Overall Study|Withdrawal by Subject|4|||
150248611|NCT04145700|542045710|FG000|Overall Study|Withdrawal by Subject|8|||
150248612|NCT04145700|542045711|FG001|Overall Study|Withdrawal by Subject|3|||
150248613|NCT01518153|542045714|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
150248614|NCT01518153|542045715|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
150248615|NCT01518153|542045716|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
150248616|NCT01518153|542045714|FG000|Stem Cell Transplant|Death|2|||
150248617|NCT01518153|542045715|FG001|Stem Cell Transplant|Death|0|||
150248618|NCT01518153|542045716|FG002|Stem Cell Transplant|Death|0|||
150248619|NCT01518153|542045714|FG000|Stem Cell Transplant|Secondary graft failure|1|||
150248620|NCT01518153|542045715|FG001|Stem Cell Transplant|Secondary graft failure|0|||
150248621|NCT01518153|542045716|FG002|Stem Cell Transplant|Secondary graft failure|0|||
150248622|NCT01518153|542045714|FG000|Stem Cell Transplant|Adverse Event|1|||
150248623|NCT01518153|542045715|FG001|Stem Cell Transplant|Adverse Event|0|||
150248624|NCT01518153|542045716|FG002|Stem Cell Transplant|Adverse Event|0|||
150248625|NCT01518153|542045714|FG000|Donor Lymphocyte Infusion|Death|0|||
150248626|NCT01518153|542045715|FG001|Donor Lymphocyte Infusion|Death|2|||
150248627|NCT01518153|542045716|FG002|Donor Lymphocyte Infusion|Death|1|||
150248628|NCT01327846|542045718|FG000|Core Phase|Subject decision (vital status: missing)|1|||
150248629|NCT01327846|542045719|FG001|Core Phase|Subject decision (vital status: missing)|2|||
150248630|NCT01327846|542045720|FG002|Core Phase|Subject decision (vital status: missing)|2|||
150248631|NCT01327846|542045721|FG003|Core Phase|Subject decision (vital status: missing)|1|||
150248632|NCT01327846|542045718|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
150248633|NCT01327846|542045719|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
150248634|NCT01327846|542045720|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
150248635|NCT01327846|542045721|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
150248636|NCT01327846|542045718|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
150248637|NCT01327846|542045719|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
150248638|NCT01327846|542045720|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
149737560|NCT00408005|540170390|FG005|Induction|Ineligible|0|||
150248639|NCT01327846|542045721|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
150248640|NCT01327846|542045718|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
150248641|NCT01327846|542045719|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
150248642|NCT01327846|542045720|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
150248643|NCT01327846|542045721|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
150248644|NCT01327846|542045718|FG000|Core Phase|Lost to Follow-up|3|||
150248645|NCT01327846|542045719|FG001|Core Phase|Lost to Follow-up|3|||
150248646|NCT01327846|542045720|FG002|Core Phase|Lost to Follow-up|4|||
150248647|NCT01327846|542045721|FG003|Core Phase|Lost to Follow-up|5|||
150248648|NCT01327846|542045718|FG000|Extension Phase|Study terminated by sponsor|1073|||
150248649|NCT01327846|542045719|FG001|Extension Phase|Study terminated by sponsor|1124|||
150248650|NCT01327846|542045720|FG002|Extension Phase|Study terminated by sponsor|1067|||
150248651|NCT01327846|542045721|FG003|Extension Phase|Study terminated by sponsor|1660|||
150248652|NCT01327846|542045718|FG000|Extension Phase|Withdrawal by Subject|20|||
150248653|NCT01327846|542045719|FG001|Extension Phase|Withdrawal by Subject|13|||
150248654|NCT01327846|542045720|FG002|Extension Phase|Withdrawal by Subject|19|||
150248655|NCT01327846|542045721|FG003|Extension Phase|Withdrawal by Subject|37|||
150248656|NCT01327846|542045718|FG000|Extension Phase|Lost to Follow-up|4|||
150248657|NCT01327846|542045719|FG001|Extension Phase|Lost to Follow-up|3|||
150248658|NCT01327846|542045720|FG002|Extension Phase|Lost to Follow-up|4|||
150248659|NCT01327846|542045721|FG003|Extension Phase|Lost to Follow-up|7|||
150248660|NCT01327846|542045718|FG000|Extension Phase|Technical Problems|2|||
150248661|NCT01327846|542045719|FG001|Extension Phase|Technical Problems|4|||
150248662|NCT01327846|542045720|FG002|Extension Phase|Technical Problems|2|||
150248663|NCT01327846|542045721|FG003|Extension Phase|Technical Problems|2|||
150248664|NCT00203268|542045722|FG000|Early Treatment|only treated one headache|2|||
150248665|NCT00203268|542045722|FG000|Early Treatment|Lost to Follow-up|1|||
150248666|NCT00203268|542045722|FG000|Early Treatment|Withdrawal by Subject|1|||
150248667|NCT00594880|542045724|FG000|Overall Study|Withdrawal by Subject|1|||
150248668|NCT00594880|542045725|FG001|Overall Study|Withdrawal by Subject|1|||
150248669|NCT00594880|542045724|FG000|Overall Study|Lost to Follow-up|1|||
150248670|NCT00594880|542045725|FG001|Overall Study|Lost to Follow-up|0|||
150248671|NCT01254747|542045728|FG000|Overall Study|Unacceptable subjective vision|0|||
150248672|NCT01254747|542045729|FG001|Overall Study|Unacceptable subjective vision|0|||
150248673|NCT01254747|542045730|FG002|Overall Study|Unacceptable subjective vision|0|||
150248674|NCT01254747|542045731|FG003|Overall Study|Unacceptable subjective vision|2|||
150248675|NCT01254747|542045728|FG000|Overall Study|Difficult removal handling|0|||
150248676|NCT01254747|542045729|FG001|Overall Study|Difficult removal handling|0|||
150248677|NCT01254747|542045730|FG002|Overall Study|Difficult removal handling|1|||
150248678|NCT01254747|542045731|FG003|Overall Study|Difficult removal handling|0|||
150248679|NCT01254747|542045728|FG000|Overall Study|Symptoms and problems|0|||
150248680|NCT01254747|542045729|FG001|Overall Study|Symptoms and problems|2|||
150248681|NCT01254747|542045730|FG002|Overall Study|Symptoms and problems|1|||
150248682|NCT01254747|542045731|FG003|Overall Study|Symptoms and problems|0|||
150248683|NCT01254747|542045728|FG000|Overall Study|Lost to Follow-up|0|||
150248684|NCT01254747|542045729|FG001|Overall Study|Lost to Follow-up|0|||
150248685|NCT01254747|542045730|FG002|Overall Study|Lost to Follow-up|1|||
150248686|NCT01254747|542045731|FG003|Overall Study|Lost to Follow-up|0|||
150248687|NCT01254747|542045728|FG000|Overall Study|Biomicroscopy|0|||
150248688|NCT01254747|542045729|FG001|Overall Study|Biomicroscopy|0|||
150248689|NCT01254747|542045730|FG002|Overall Study|Biomicroscopy|1|||
150248690|NCT01254747|542045731|FG003|Overall Study|Biomicroscopy|0|||
150248691|NCT01254747|542045728|FG000|Overall Study|Discomfort|0|||
150248692|NCT01254747|542045729|FG001|Overall Study|Discomfort|4|||
150248693|NCT01254747|542045730|FG002|Overall Study|Discomfort|0|||
150248694|NCT01254747|542045731|FG003|Overall Study|Discomfort|0|||
150248695|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
150248696|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
150248697|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
150248698|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
150248699|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
150248700|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
150248701|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
150248702|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
150248703|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
150248704|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
150248705|NCT00245960|542045732|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
150248706|NCT00245960|542045733|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
150248707|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
150248708|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
150248709|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
150248710|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
150248711|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
150248712|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
150248713|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
150248714|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
150248715|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
150248716|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
150248717|NCT00245960|542045732|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
150248718|NCT00245960|542045733|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
150248719|NCT00737698|542045734|FG000|Overall Study|Withdrawal by Subject|6|||
150248720|NCT00737698|542045735|FG001|Overall Study|Withdrawal by Subject|5|||
150248721|NCT00737698|542045736|FG002|Overall Study|Withdrawal by Subject|3|||
150248722|NCT00737698|542045734|FG000|Overall Study|Death|0|||
150248723|NCT00737698|542045735|FG001|Overall Study|Death|0|||
150248724|NCT00737698|542045736|FG002|Overall Study|Death|1|||
150248725|NCT01067846|542045737|FG000|Overall Study|Lost to Follow-up|17|||
150248726|NCT01067846|542045738|FG001|Overall Study|Lost to Follow-up|19|||
150248727|NCT01067846|542045737|FG000|Overall Study|Withdrawal by Subject|1|||
150248728|NCT01067846|542045738|FG001|Overall Study|Withdrawal by Subject|0|||
150248729|NCT01067846|542045737|FG000|Overall Study|participation in other tx study|1|||
150248730|NCT01067846|542045738|FG001|Overall Study|participation in other tx study|0|||
150248731|NCT02817906|542045739|FG000|Overall Study|Adverse Event|3|||
150248732|NCT02817906|542045740|FG001|Overall Study|Adverse Event|0|||
150248733|NCT02817906|542045739|FG000|Overall Study|Lack of Efficacy|1|||
150248734|NCT02817906|542045740|FG001|Overall Study|Lack of Efficacy|0|||
150248735|NCT02817906|542045739|FG000|Overall Study|Protocol Violation|1|||
150248736|NCT02817906|542045740|FG001|Overall Study|Protocol Violation|1|||
150248737|NCT02817906|542045739|FG000|Overall Study|Study Terminated by Sponsor|2|||
150248738|NCT02817906|542045740|FG001|Overall Study|Study Terminated by Sponsor|2|||
150248739|NCT02817906|542045739|FG000|Overall Study|Withdrawal by Subject|7|||
150248740|NCT02817906|542045740|FG001|Overall Study|Withdrawal by Subject|0|||
150248741|NCT02817906|542045739|FG000|Overall Study|Other|2|||
150248742|NCT02817906|542045740|FG001|Overall Study|Other|2|||
150248743|NCT00972322|542045746|FG000|Overall Study|Adverse Event|2|||
150248744|NCT00972322|542045747|FG001|Overall Study|Adverse Event|1|||
150248745|NCT00972322|542045746|FG000|Overall Study|Positive drug screen|0|||
150248746|NCT00972322|542045747|FG001|Overall Study|Positive drug screen|1|||
150248747|NCT00972322|542045746|FG000|Overall Study|Lost to Follow-up|0|||
150248748|NCT00972322|542045747|FG001|Overall Study|Lost to Follow-up|1|||
150248749|NCT00972322|542045746|FG000|Overall Study|Consistently high glucose values|1|||
150248750|NCT00972322|542045747|FG001|Overall Study|Consistently high glucose values|0|||
150248751|NCT04958200|542045748|FG000|Overall Study|Withdrawal by Subject|0|||
150248752|NCT04958200|542045749|FG001|Overall Study|Withdrawal by Subject|2|||
150248753|NCT04958200|542045748|FG000|Overall Study|Lost to Follow-up|3|||
150248754|NCT04958200|542045749|FG001|Overall Study|Lost to Follow-up|2|||
150248755|NCT02387970|542045750|FG000|Overall Study|Did not complete 1-year follow up|1|||
150248756|NCT02387970|542045751|FG001|Overall Study|Did not complete 1-year follow up|2|||
150248757|NCT03086655|542045758|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
150248758|NCT03086655|542045759|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
150248759|NCT03086655|542045758|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
150248760|NCT03086655|542045759|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
150248761|NCT03086655|542045758|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
150248762|NCT03086655|542045759|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
150248763|NCT03086655|542045758|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
150248764|NCT03086655|542045759|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
150248765|NCT03086655|542045758|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
150248766|NCT03086655|542045759|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
150248767|NCT03086655|542045758|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
150248768|NCT03086655|542045759|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
150248769|NCT03086655|542045758|FG000|12 Month Follow-up = Final Assessment|Death|0|||
150248770|NCT03086655|542045759|FG001|12 Month Follow-up = Final Assessment|Death|1|||
150248771|NCT03841526|542045760|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
150248772|NCT03841526|542045761|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
150248773|NCT03841526|542045762|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
150248774|NCT03841526|542045763|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
150248775|NCT03841526|542045764|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
150248776|NCT03841526|542045765|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
150248777|NCT03841526|542045760|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
150248778|NCT03841526|542045761|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
150248779|NCT03841526|542045762|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
150248780|NCT03841526|542045763|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
150248781|NCT03841526|542045764|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
150248782|NCT03841526|542045765|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
150248783|NCT03841526|542045760|FG000|Outpatient Phase Treatment|Physician Decision|0|||
150248784|NCT03841526|542045761|FG001|Outpatient Phase Treatment|Physician Decision|1|||
150248785|NCT03841526|542045762|FG002|Outpatient Phase Treatment|Physician Decision|0|||
150248786|NCT03841526|542045763|FG003|Outpatient Phase Treatment|Physician Decision|0|||
150248787|NCT03841526|542045764|FG004|Outpatient Phase Treatment|Physician Decision|0|||
150248788|NCT03841526|542045765|FG005|Outpatient Phase Treatment|Physician Decision|0|||
150248789|NCT03841526|542045760|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
150248790|NCT03841526|542045761|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
150248791|NCT03841526|542045762|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
150248792|NCT03841526|542045763|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
150248793|NCT03841526|542045764|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
150248794|NCT03841526|542045765|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
150248795|NCT00918879|542046750|FG000|Overall Study|Withdrawal by Subject|4|||
150248796|NCT00918879|542046751|FG001|Overall Study|Withdrawal by Subject|4|||
150248797|NCT00918879|542046750|FG000|Overall Study|Lost to Follow-up|1|||
150248798|NCT00918879|542046751|FG001|Overall Study|Lost to Follow-up|1|||
150248799|NCT00918879|542046750|FG000|Overall Study|Severe non-compliance to protocol|1|||
150248800|NCT00918879|542046751|FG001|Overall Study|Severe non-compliance to protocol|1|||
150248801|NCT00357110|542046752|FG000|Overall Study|Early study termination|5|||
150248802|NCT00357110|542046753|FG001|Overall Study|Early study termination|5|||
149737561|NCT00408005|540170391|FG006|Induction|Ineligible|0|||
150248803|NCT03339245|542046756|FG000|Overall Study|Adverse Event|1|||
150248804|NCT03339245|542046757|FG001|Overall Study|Adverse Event|1|||
150248805|NCT03339245|542046756|FG000|Overall Study|Withdrawal by Subject|1|||
150248806|NCT03339245|542046757|FG001|Overall Study|Withdrawal by Subject|0|||
150248807|NCT00515671|542046758|FG000|Overall Study|Lost to Follow-up|13|||
150248808|NCT00515671|542046759|FG001|Overall Study|Lost to Follow-up|10|||
150248809|NCT00515671|542046758|FG000|Overall Study|Withdrawal by Subject|3|||
150248810|NCT00515671|542046759|FG001|Overall Study|Withdrawal by Subject|5|||
150248811|NCT00515671|542046758|FG000|Overall Study|incarcerated|1|||
150248812|NCT00515671|542046759|FG001|Overall Study|incarcerated|2|||
150248813|NCT00288639|542046760|FG000|Overall Study|Adverse Event|5|||
150248814|NCT00288639|542046760|FG000|Overall Study|Lack of Efficacy|4|||
150248815|NCT00288639|542046760|FG000|Overall Study|Withdrawal by Subject|2|||
150248816|NCT00288639|542046760|FG000|Overall Study|Other|1|||
150248817|NCT01283152|542046761|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
150248818|NCT01283152|542046762|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
150248819|NCT01283152|542046761|FG000|Overall Study|Refused HESA|1|||
150248820|NCT01283152|542046762|FG001|Overall Study|Refused HESA|0|||
150248821|NCT00567567|542046763|FG000|Overall Study|Adverse Event|0|||
150248822|NCT00567567|542046764|FG001|Overall Study|Adverse Event|2|||
150248823|NCT00567567|542046765|FG002|Overall Study|Adverse Event|5|||
150248824|NCT00567567|542046763|FG000|Overall Study|Death|8|||
150248825|NCT00567567|542046764|FG001|Overall Study|Death|1|||
150248826|NCT00567567|542046765|FG002|Overall Study|Death|5|||
150248827|NCT00567567|542046763|FG000|Overall Study|Lack of Efficacy|16|||
150248828|NCT00567567|542046764|FG001|Overall Study|Lack of Efficacy|17|||
150248829|NCT00567567|542046765|FG002|Overall Study|Lack of Efficacy|48|||
150248830|NCT00567567|542046763|FG000|Overall Study|Lost to Follow-up|0|||
150248831|NCT00567567|542046764|FG001|Overall Study|Lost to Follow-up|0|||
150248832|NCT00567567|542046765|FG002|Overall Study|Lost to Follow-up|1|||
150248833|NCT00567567|542046763|FG000|Overall Study|Physician Decision|16|||
150248834|NCT00567567|542046764|FG001|Overall Study|Physician Decision|18|||
150248835|NCT00567567|542046765|FG002|Overall Study|Physician Decision|84|||
150248836|NCT00567567|542046763|FG000|Overall Study|Withdrawal by Subject|0|||
150248837|NCT00567567|542046764|FG001|Overall Study|Withdrawal by Subject|0|||
150248838|NCT00567567|542046765|FG002|Overall Study|Withdrawal by Subject|2|||
150248839|NCT00567567|542046763|FG000|Overall Study|Ineligible|4|||
150248840|NCT00567567|542046764|FG001|Overall Study|Ineligible|0|||
150248841|NCT00567567|542046765|FG002|Overall Study|Ineligible|9|||
150248842|NCT00567567|542046763|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
150248843|NCT00567567|542046764|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
150248844|NCT00567567|542046765|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
150248845|NCT00567567|542046763|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
150248846|NCT00567567|542046764|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
150248847|NCT00567567|542046765|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
150248848|NCT00567567|542046763|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
150248849|NCT00567567|542046764|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
150248850|NCT00567567|542046765|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
150248851|NCT03433677|542046766|FG000|Period 1|Protocol Violation|1|||
150248852|NCT03433677|542046767|FG001|Period 1|Protocol Violation|0|||
150248853|NCT03433677|542046766|FG000|Period 2|Withdrawal by Subject|1|||
150248854|NCT03433677|542046767|FG001|Period 2|Withdrawal by Subject|1|||
150248855|NCT03330405|542046768|FG000|Overall Study|Other|1|||
150248856|NCT03330405|542046769|FG001|Overall Study|Other|3|||
150248857|NCT03330405|542046770|FG002|Overall Study|Other|1|||
150248858|NCT03330405|542046771|FG003|Overall Study|Other|0|||
150248859|NCT03330405|542046772|FG004|Overall Study|Other|2|||
150248860|NCT03330405|542046773|FG005|Overall Study|Other|0|||
150248861|NCT03330405|542046774|FG006|Overall Study|Other|1|||
150248862|NCT03330405|542046775|FG007|Overall Study|Other|0|||
150248863|NCT03330405|542046776|FG008|Overall Study|Other|0|||
150248864|NCT03330405|542046777|FG009|Overall Study|Other|0|||
150248865|NCT03330405|542046778|FG010|Overall Study|Other|0|||
150248866|NCT03330405|542046768|FG000|Overall Study|Progressive disease|8|||
150248867|NCT03330405|542046769|FG001|Overall Study|Progressive disease|27|||
150248868|NCT03330405|542046770|FG002|Overall Study|Progressive disease|4|||
150248869|NCT03330405|542046771|FG003|Overall Study|Progressive disease|18|||
150248870|NCT03330405|542046772|FG004|Overall Study|Progressive disease|16|||
150248871|NCT03330405|542046773|FG005|Overall Study|Progressive disease|14|||
150248872|NCT03330405|542046774|FG006|Overall Study|Progressive disease|7|||
150248873|NCT03330405|542046775|FG007|Overall Study|Progressive disease|29|||
150248874|NCT03330405|542046776|FG008|Overall Study|Progressive disease|9|||
150248875|NCT03330405|542046777|FG009|Overall Study|Progressive disease|11|||
150248876|NCT03330405|542046778|FG010|Overall Study|Progressive disease|5|||
150248877|NCT03330405|542046768|FG000|Overall Study|Withdrawal by Subject|1|||
150248878|NCT03330405|542046769|FG001|Overall Study|Withdrawal by Subject|4|||
150248879|NCT03330405|542046770|FG002|Overall Study|Withdrawal by Subject|0|||
150248880|NCT03330405|542046771|FG003|Overall Study|Withdrawal by Subject|1|||
150248881|NCT03330405|542046772|FG004|Overall Study|Withdrawal by Subject|1|||
150248882|NCT03330405|542046773|FG005|Overall Study|Withdrawal by Subject|1|||
150248883|NCT03330405|542046774|FG006|Overall Study|Withdrawal by Subject|0|||
150248884|NCT03330405|542046775|FG007|Overall Study|Withdrawal by Subject|2|||
150248885|NCT03330405|542046776|FG008|Overall Study|Withdrawal by Subject|2|||
150248886|NCT03330405|542046777|FG009|Overall Study|Withdrawal by Subject|1|||
150248887|NCT03330405|542046778|FG010|Overall Study|Withdrawal by Subject|1|||
150248888|NCT03330405|542046768|FG000|Overall Study|Global deterioration of health status|2|||
150248889|NCT03330405|542046769|FG001|Overall Study|Global deterioration of health status|3|||
150248890|NCT03330405|542046770|FG002|Overall Study|Global deterioration of health status|0|||
150248891|NCT03330405|542046771|FG003|Overall Study|Global deterioration of health status|2|||
150248892|NCT03330405|542046772|FG004|Overall Study|Global deterioration of health status|3|||
150248893|NCT03330405|542046773|FG005|Overall Study|Global deterioration of health status|3|||
150248894|NCT03330405|542046774|FG006|Overall Study|Global deterioration of health status|0|||
150248895|NCT03330405|542046775|FG007|Overall Study|Global deterioration of health status|2|||
150248896|NCT03330405|542046776|FG008|Overall Study|Global deterioration of health status|8|||
150248897|NCT03330405|542046777|FG009|Overall Study|Global deterioration of health status|4|||
150248898|NCT03330405|542046778|FG010|Overall Study|Global deterioration of health status|1|||
150248899|NCT03330405|542046768|FG000|Overall Study|Adverse Event|0|||
150248900|NCT03330405|542046769|FG001|Overall Study|Adverse Event|1|||
150248901|NCT03330405|542046770|FG002|Overall Study|Adverse Event|0|||
150248902|NCT03330405|542046771|FG003|Overall Study|Adverse Event|1|||
150248903|NCT03330405|542046772|FG004|Overall Study|Adverse Event|1|||
150248904|NCT03330405|542046773|FG005|Overall Study|Adverse Event|1|||
150248905|NCT03330405|542046774|FG006|Overall Study|Adverse Event|3|||
150248906|NCT03330405|542046775|FG007|Overall Study|Adverse Event|4|||
150248907|NCT03330405|542046776|FG008|Overall Study|Adverse Event|2|||
150248908|NCT03330405|542046777|FG009|Overall Study|Adverse Event|2|||
150248909|NCT03330405|542046778|FG010|Overall Study|Adverse Event|2|||
150248910|NCT03330405|542046768|FG000|Overall Study|Death|0|||
150248911|NCT03330405|542046769|FG001|Overall Study|Death|4|||
150248912|NCT03330405|542046770|FG002|Overall Study|Death|0|||
150248913|NCT03330405|542046771|FG003|Overall Study|Death|0|||
150248914|NCT03330405|542046772|FG004|Overall Study|Death|0|||
150248915|NCT03330405|542046773|FG005|Overall Study|Death|1|||
150248916|NCT03330405|542046774|FG006|Overall Study|Death|0|||
150248917|NCT03330405|542046775|FG007|Overall Study|Death|2|||
150248918|NCT03330405|542046776|FG008|Overall Study|Death|0|||
150248919|NCT03330405|542046777|FG009|Overall Study|Death|0|||
150248920|NCT03330405|542046778|FG010|Overall Study|Death|0|||
150248921|NCT03330405|542046768|FG000|Overall Study|Physician Decision|0|||
150248922|NCT03330405|542046769|FG001|Overall Study|Physician Decision|0|||
150248923|NCT03330405|542046770|FG002|Overall Study|Physician Decision|0|||
150248924|NCT03330405|542046771|FG003|Overall Study|Physician Decision|0|||
150248925|NCT03330405|542046772|FG004|Overall Study|Physician Decision|0|||
150248926|NCT03330405|542046773|FG005|Overall Study|Physician Decision|0|||
150248927|NCT03330405|542046774|FG006|Overall Study|Physician Decision|0|||
150248928|NCT03330405|542046775|FG007|Overall Study|Physician Decision|1|||
150248929|NCT03330405|542046776|FG008|Overall Study|Physician Decision|0|||
150248930|NCT03330405|542046777|FG009|Overall Study|Physician Decision|0|||
150248931|NCT03330405|542046778|FG010|Overall Study|Physician Decision|0|||
150248932|NCT01736189|542046779|FG000|Overall Study|Violation of registration criteria|41|||
150248933|NCT01736189|542046779|FG000|Overall Study|Protocol Violation|4|||
150248934|NCT01736189|542046779|FG000|Overall Study|Criteria and protocol violations|1|||
150248935|NCT01499303|542046782|FG000|Overall Study|Ongoing|2|||
150248936|NCT01499303|542046783|FG001|Overall Study|Ongoing|1|||
150248937|NCT01499303|542046782|FG000|Overall Study|Withdrawal by Subject|0|||
150248938|NCT01499303|542046783|FG001|Overall Study|Withdrawal by Subject|1|||
150248939|NCT01499303|542046782|FG000|Overall Study|Adverse Event|1|||
150248940|NCT01499303|542046783|FG001|Overall Study|Adverse Event|4|||
150248941|NCT01499303|542046782|FG000|Overall Study|Other|0|||
150248942|NCT01499303|542046783|FG001|Overall Study|Other|1|||
150248943|NCT00608868|542046784|FG000|Overall Study|Withdrawal by Subject|7|||
150248944|NCT00608868|542046784|FG000|Overall Study|Protocol Violation|3|||
150248945|NCT00608868|542046784|FG000|Overall Study|Lost to Follow-up|2|||
150248946|NCT00608868|542046784|FG000|Overall Study|Adverse Event|1|||
150248947|NCT00608868|542046784|FG000|Overall Study|Physician Decision|2|||
150248948|NCT00702962|542046787|FG000|Overall Study|Progressive disease|0|||
150248949|NCT00702962|542046788|FG001|Overall Study|Progressive disease|1|||
150248950|NCT00702962|542046787|FG000|Overall Study|Hospitalized for other health disorder|1|||
150248951|NCT00702962|542046788|FG001|Overall Study|Hospitalized for other health disorder|0|||
150248952|NCT02476175|542046789|FG000|Overall Study|Adverse Event|2|||
150248953|NCT01252355|542046790|FG000|Overall Study|Adverse Event|9|||
150248954|NCT01252355|542046791|FG001|Overall Study|Adverse Event|17|||
150248955|NCT01252355|542046792|FG002|Overall Study|Adverse Event|22|||
150248956|NCT01252355|542046790|FG000|Overall Study|Lack of Efficacy|6|||
150248957|NCT01252355|542046791|FG001|Overall Study|Lack of Efficacy|4|||
150248958|NCT01252355|542046792|FG002|Overall Study|Lack of Efficacy|2|||
150248959|NCT01252355|542046790|FG000|Overall Study|Lost to Follow-up|0|||
150248960|NCT01252355|542046791|FG001|Overall Study|Lost to Follow-up|0|||
150248961|NCT01252355|542046792|FG002|Overall Study|Lost to Follow-up|1|||
150248962|NCT01252355|542046790|FG000|Overall Study|Poor Compliance to Protocol|1|||
150248963|NCT01252355|542046791|FG001|Overall Study|Poor Compliance to Protocol|1|||
150248964|NCT01252355|542046792|FG002|Overall Study|Poor Compliance to Protocol|1|||
150248965|NCT01252355|542046790|FG000|Overall Study|Progressive Disease|2|||
150248966|NCT01252355|542046791|FG001|Overall Study|Progressive Disease|0|||
150248967|NCT01252355|542046792|FG002|Overall Study|Progressive Disease|0|||
150248968|NCT01252355|542046790|FG000|Overall Study|Sponsor Early Termination of Study|149|||
150248969|NCT01252355|542046791|FG001|Overall Study|Sponsor Early Termination of Study|149|||
150248970|NCT01252355|542046792|FG002|Overall Study|Sponsor Early Termination of Study|146|||
150248971|NCT01252355|542046790|FG000|Overall Study|Randomized but not Treated|2|||
150248972|NCT01252355|542046791|FG001|Overall Study|Randomized but not Treated|0|||
150248973|NCT01252355|542046792|FG002|Overall Study|Randomized but not Treated|0|||
150248974|NCT01252355|542046790|FG000|Overall Study|Other Than Above|8|||
150248975|NCT01252355|542046791|FG001|Overall Study|Other Than Above|7|||
150248976|NCT01252355|542046792|FG002|Overall Study|Other Than Above|7|||
150248977|NCT02175641|542046793|FG000|Overall Study|Death|3|||
150248978|NCT02175641|542046794|FG001|Overall Study|Death|4|||
150248979|NCT02175641|542046793|FG000|Overall Study|Lost to Follow-up|4|||
150248980|NCT02175641|542046794|FG001|Overall Study|Lost to Follow-up|4|||
150248981|NCT02175641|542046793|FG000|Overall Study|Withdrawal by Subject|7|||
150248982|NCT02175641|542046794|FG001|Overall Study|Withdrawal by Subject|4|||
150248983|NCT02175641|542046793|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
150248984|NCT02175641|542046794|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
150248985|NCT02175641|542046793|FG000|Overall Study|Developed Contraindicated Condition|8|||
150248986|NCT02175641|542046794|FG001|Overall Study|Developed Contraindicated Condition|0|||
150248987|NCT01923467|542046799|FG000|Overall Study|Lost to Follow-up|62|||
150248988|NCT01923467|542046799|FG000|Overall Study|Subject non-interest|479|||
150248989|NCT02242097|542046800|FG000|Ibrutinib Treatment|Adverse Event|16|||
150248990|NCT02242097|542046800|FG000|Ibrutinib Treatment|Physician Decision|1|||
150248991|NCT02242097|542046800|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
150248992|NCT02242097|542046800|FG000|Ibrutinib Treatment|Death|1|||
150248993|NCT02242097|542046800|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
150248994|NCT02242097|542046800|FG000|Post Therapy Follow Up|Death|3|||
149737562|NCT00408005|540170392|FG007|Induction|Ineligible|0|||
150248995|NCT02242097|542046800|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
150248996|NCT03435692|542046801|FG000|Overall Study|Lack of Efficacy|2|||
150248997|NCT03435692|542046802|FG001|Overall Study|Lack of Efficacy|2|||
150248998|NCT03435692|542046803|FG002|Overall Study|Lack of Efficacy|0|||
150248999|NCT01145898|542046804|FG000|3-year Treatment|medication change by treating physician|3|||
150249000|NCT01145898|542046805|FG001|3-year Treatment|medication change by treating physician|16|||
150249001|NCT02440425|542046806|FG000|Overall Study|Death likely due to disease progression|1|||
150249002|NCT02440425|542046806|FG000|Overall Study|Withdrawal by Subject|2|||
150249003|NCT02440425|542046806|FG000|Overall Study|Adverse Event|1|||
150249004|NCT02440425|542046806|FG000|Overall Study|Adverse Event/Ineligible|1|||
150249005|NCT00780559|542046813|FG000|Overall Study|Lost to Follow-up|2|||
150249006|NCT00780559|542046814|FG001|Overall Study|Lost to Follow-up|7|||
150249007|NCT00780559|542046813|FG000|Overall Study|Death|1|||
150249008|NCT00780559|542046814|FG001|Overall Study|Death|0|||
150249009|NCT04462289|542046815|FG000|Overall Study|Lost to Follow-up|4|||
150249010|NCT04462289|542046816|FG001|Overall Study|Lost to Follow-up|5|||
150249011|NCT04462289|542046815|FG000|Overall Study|Death|0|||
150249012|NCT04462289|542046816|FG001|Overall Study|Death|3|||
150249013|NCT04462289|542046815|FG000|Overall Study|Withdrawal by Subject|1|||
150249014|NCT04462289|542046816|FG001|Overall Study|Withdrawal by Subject|3|||
150249015|NCT04343976|542046822|FG000|Overall Study|Withdrawal by Subject|0|||
150249016|NCT04343976|542046823|FG001|Overall Study|Withdrawal by Subject|1|||
150249017|NCT02807883|542046824|FG000|Overall Study|Withdrawal by Subject|2|||
150249018|NCT00694109|542046825|FG000|Overall Study|Physician Decision|3|||
150249019|NCT00694109|542046825|FG000|Overall Study|Adverse Event|74|||
150249020|NCT00694109|542046825|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
150249021|NCT00694109|542046825|FG000|Overall Study|Lack of Efficacy|2|||
150249022|NCT00694109|542046825|FG000|Overall Study|Withdrawal by Subject|13|||
150249023|NCT00694109|542046825|FG000|Overall Study|Pregnancy|1|||
150249024|NCT00694109|542046825|FG000|Overall Study|Enrolled but not treated|1|||
150249025|NCT00694109|542046825|FG000|Overall Study|Other|2|||
150249026|NCT00694109|542046825|FG000|Overall Study|Consented but no additional treatment|3|||
150249027|NCT00846807|542046826|FG000|Overall Study|Adverse Event|270|||
150249028|NCT00846807|542046826|FG000|Overall Study|Lost to Follow-up|94|||
150249029|NCT00846807|542046826|FG000|Overall Study|Withdrawal by Subject|56|||
150249030|NCT00846807|542046826|FG000|Overall Study|Non compliant with European label|7|||
150249031|NCT00846807|542046826|FG000|Overall Study|Switch to other anticoagulants|89|||
150249032|NCT00846807|542046826|FG000|Overall Study|No prescription after hospital discharge|56|||
150249033|NCT00846807|542046826|FG000|Overall Study|Other|60|||
150249034|NCT03686423|542046832|FG000|Overall Study|Withdrawal by Subject|9|||
150249035|NCT03686423|542046832|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
150249036|NCT04608773|542046833|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
150249037|NCT04608773|542046834|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
150249038|NCT04608773|542046833|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
150249039|NCT04608773|542046834|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
150249040|NCT04608773|542046833|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
150249041|NCT04608773|542046834|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
150249042|NCT04608773|542046833|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
150249043|NCT04608773|542046834|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
150249044|NCT04608773|542046833|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
150249045|NCT04608773|542046834|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
150249046|NCT02833077|542046835|FG000|Overall Study|Adverse Event|1|||
150249047|NCT02833077|542046836|FG001|Overall Study|Adverse Event|2|||
150249048|NCT02833077|542046835|FG000|Overall Study|Lost to Follow-up|10|||
150249049|NCT02833077|542046836|FG001|Overall Study|Lost to Follow-up|1|||
150249050|NCT02833077|542046835|FG000|Overall Study|Personal Reasons|6|||
150249051|NCT02833077|542046836|FG001|Overall Study|Personal Reasons|4|||
150249052|NCT02833077|542046835|FG000|Overall Study|Protocol Deviation|0|||
150249053|NCT02833077|542046836|FG001|Overall Study|Protocol Deviation|1|||
150249054|NCT01077518|542046837|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
150249055|NCT01077518|542046838|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
150249056|NCT01077518|542046839|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
150249057|NCT01077518|542046837|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
150249058|NCT01077518|542046838|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
150249059|NCT01077518|542046839|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
150249060|NCT01077518|542046837|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
150249061|NCT01077518|542046838|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
150249062|NCT01077518|542046839|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
150249063|NCT01077518|542046837|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
150249064|NCT01077518|542046838|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
150249065|NCT01077518|542046839|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
150249066|NCT01077518|542046837|FG000|Optional Ofa Phase|Physician Decision|0|||
150249067|NCT01077518|542046838|FG001|Optional Ofa Phase|Physician Decision|0|||
150249068|NCT01077518|542046839|FG002|Optional Ofa Phase|Physician Decision|1|||
150249069|NCT01077518|542046837|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
150249070|NCT01077518|542046838|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
150249071|NCT01077518|542046839|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
150249072|NCT01077518|542046837|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
150249073|NCT01077518|542046838|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
150249074|NCT01077518|542046839|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
150249075|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
150249076|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
150249077|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
150249078|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
150249079|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
150249080|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
150249081|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
150249082|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
150249083|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
150249084|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
150249085|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
150249086|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
150249087|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
150249088|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
150249089|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
150249090|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
150249091|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
150249092|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
150249093|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
150249094|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
150249095|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
150249096|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
150249097|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
150249098|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
150249099|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
150249100|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
150249101|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
150249102|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
150249103|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
150249104|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
150249105|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
150249106|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
150249107|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
150249108|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
150249109|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
150249110|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
150249111|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
150249112|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
150249113|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
150249114|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
150249115|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
150249116|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
150249117|NCT03524092|542046840|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
150249118|NCT03524092|542046841|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
150249119|NCT03524092|542046842|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
150249120|NCT03524092|542046843|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
150249121|NCT03524092|542046844|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
150249122|NCT03524092|542046845|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
150249123|NCT03524092|542046840|FG000|Loss of Response Rescue Period|Adverse Event|0|||
150249124|NCT03524092|542046841|FG001|Loss of Response Rescue Period|Adverse Event|0|||
150249125|NCT03524092|542046842|FG002|Loss of Response Rescue Period|Adverse Event|0|||
150249126|NCT03524092|542046843|FG003|Loss of Response Rescue Period|Adverse Event|2|||
150249127|NCT03524092|542046844|FG004|Loss of Response Rescue Period|Adverse Event|0|||
150249128|NCT03524092|542046845|FG005|Loss of Response Rescue Period|Adverse Event|0|||
150249129|NCT03524092|542046840|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
150249130|NCT03524092|542046841|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
150249131|NCT03524092|542046842|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
150249132|NCT03524092|542046843|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
150249133|NCT03524092|542046844|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
150249134|NCT03524092|542046845|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
150249135|NCT03524092|542046840|FG000|Loss of Response Rescue Period|Pregnancy|0|||
150249136|NCT03524092|542046841|FG001|Loss of Response Rescue Period|Pregnancy|0|||
150249137|NCT03524092|542046842|FG002|Loss of Response Rescue Period|Pregnancy|0|||
150249138|NCT03524092|542046843|FG003|Loss of Response Rescue Period|Pregnancy|1|||
150249139|NCT03524092|542046844|FG004|Loss of Response Rescue Period|Pregnancy|0|||
150249140|NCT03524092|542046845|FG005|Loss of Response Rescue Period|Pregnancy|0|||
150249141|NCT03524092|542046840|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
150249142|NCT03524092|542046841|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
150249143|NCT03524092|542046842|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
150249144|NCT03524092|542046843|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
150249145|NCT03524092|542046844|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
150249146|NCT03524092|542046845|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
150249147|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
150249148|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
150249149|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
150249150|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
150249151|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
150249152|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
150249153|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
150249154|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
150249155|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
150249156|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
150249157|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
150249158|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
150249159|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
150249160|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
150249161|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
150249162|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
150249163|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
150249164|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
150249165|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
150249166|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
150249167|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
150249168|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
150249169|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
150249170|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
150249171|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
150249172|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
150249173|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
150249174|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
150249175|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
150249176|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
150249177|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
150249178|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
150249179|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
150249180|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
150249181|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
150249182|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
150249183|NCT03524092|542046840|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
150249184|NCT03524092|542046841|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
150249185|NCT03524092|542046842|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
150249186|NCT03524092|542046843|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
150249187|NCT03524092|542046844|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
150249188|NCT03524092|542046845|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
150249189|NCT03524092|542046840|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
150249190|NCT03524092|542046841|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
150249191|NCT03524092|542046842|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
150249192|NCT03524092|542046843|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
150249193|NCT03524092|542046844|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
150249194|NCT03524092|542046845|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
150249195|NCT03524092|542046840|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
150249196|NCT03524092|542046841|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
150249197|NCT03524092|542046842|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
150249198|NCT03524092|542046843|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
150249199|NCT03524092|542046844|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
150249200|NCT03524092|542046845|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
150249201|NCT03524092|542046840|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
150249202|NCT03524092|542046841|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
150249203|NCT03524092|542046842|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
150249204|NCT03524092|542046843|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
150249205|NCT03524092|542046844|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
150249206|NCT03524092|542046845|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
150249207|NCT03524092|542046840|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
150249208|NCT03524092|542046841|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
150249209|NCT03524092|542046842|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
150249210|NCT03524092|542046843|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
150249211|NCT03524092|542046844|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
150249212|NCT03524092|542046845|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
150249213|NCT04303780|542046846|FG000|Overall Study|Death|104|||
150249214|NCT04303780|542046847|FG001|Overall Study|Death|85|||
150249215|NCT04303780|542046846|FG000|Overall Study|Lost to Follow-up|5|||
150249216|NCT04303780|542046847|FG001|Overall Study|Lost to Follow-up|2|||
150249217|NCT04303780|542046846|FG000|Overall Study|Withdrawal by Subject|12|||
150249218|NCT04303780|542046847|FG001|Overall Study|Withdrawal by Subject|39|||
150249219|NCT04303780|542046846|FG000|Overall Study|Ongoing in study|50|||
150249220|NCT04303780|542046847|FG001|Overall Study|Ongoing in study|45|||
150249221|NCT05718466|542048542|FG000|Overall Study|Withdrawal by Subject|1|||
150249222|NCT05718466|542048543|FG001|Overall Study|Withdrawal by Subject|2|||
150249223|NCT05718466|542048542|FG000|Overall Study|Death|0|||
150249224|NCT05718466|542048543|FG001|Overall Study|Death|1|||
150249225|NCT00387426|542048544|FG000|Overall Study|Lack of Response|7|||
150249226|NCT00387426|542048544|FG000|Overall Study|Toxicities|4|||
150249227|NCT00387426|542048544|FG000|Overall Study|Disease Progression|3|||
150249228|NCT01253135|542048545|FG000|Original Protocol|Protocol Amendment|15|||
150249229|NCT01253135|542048545|FG000|Amended Protocol|Non-compliance|1|||
150249230|NCT01901432|542048546|FG000|Overall Study|Adverse Event|0|||
150249231|NCT01901432|542048547|FG001|Overall Study|Adverse Event|1|||
150249232|NCT01901432|542048548|FG002|Overall Study|Adverse Event|1|||
150249233|NCT01901432|542048549|FG003|Overall Study|Adverse Event|0|||
150249234|NCT01901432|542048550|FG004|Overall Study|Adverse Event|1|||
150249235|NCT01901432|542048546|FG000|Overall Study|Withdrawal by Subject|0|||
150249236|NCT01901432|542048547|FG001|Overall Study|Withdrawal by Subject|0|||
150249237|NCT01901432|542048548|FG002|Overall Study|Withdrawal by Subject|1|||
150249238|NCT01901432|542048549|FG003|Overall Study|Withdrawal by Subject|0|||
150249239|NCT01901432|542048550|FG004|Overall Study|Withdrawal by Subject|5|||
150249240|NCT01901432|542048546|FG000|Overall Study|Physician Decision|0|||
150249241|NCT01901432|542048547|FG001|Overall Study|Physician Decision|0|||
150249242|NCT01901432|542048548|FG002|Overall Study|Physician Decision|0|||
150249243|NCT01901432|542048549|FG003|Overall Study|Physician Decision|0|||
150249244|NCT01901432|542048550|FG004|Overall Study|Physician Decision|2|||
150249245|NCT01901432|542048546|FG000|Overall Study|Patient decision to stop study drug|0|||
150249246|NCT01901432|542048547|FG001|Overall Study|Patient decision to stop study drug|0|||
150249247|NCT01901432|542048548|FG002|Overall Study|Patient decision to stop study drug|0|||
150249248|NCT01901432|542048549|FG003|Overall Study|Patient decision to stop study drug|0|||
150249249|NCT01901432|542048550|FG004|Overall Study|Patient decision to stop study drug|1|||
150249250|NCT00379288|542048551|FG000|Overall Study|Adverse Event|5|||
150249251|NCT00379288|542048552|FG001|Overall Study|Adverse Event|6|||
150249252|NCT00379288|542048553|FG002|Overall Study|Adverse Event|2|||
150249253|NCT00379288|542048554|FG003|Overall Study|Adverse Event|0|||
150249254|NCT00379288|542048551|FG000|Overall Study|Treatment Failure|0|||
150249255|NCT00379288|542048552|FG001|Overall Study|Treatment Failure|1|||
150249256|NCT00379288|542048553|FG002|Overall Study|Treatment Failure|0|||
150249257|NCT00379288|542048554|FG003|Overall Study|Treatment Failure|1|||
150249258|NCT00379288|542048551|FG000|Overall Study|Lost to Follow-up|3|||
150249259|NCT00379288|542048552|FG001|Overall Study|Lost to Follow-up|3|||
150249260|NCT00379288|542048553|FG002|Overall Study|Lost to Follow-up|2|||
150249261|NCT00379288|542048554|FG003|Overall Study|Lost to Follow-up|0|||
150249262|NCT00379288|542048551|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
150249263|NCT00379288|542048552|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
150249264|NCT00379288|542048553|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
150249265|NCT00379288|542048554|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
150249266|NCT00379288|542048551|FG000|Overall Study|Subject withdrew-related to study drug|1|||
150249267|NCT00379288|542048552|FG001|Overall Study|Subject withdrew-related to study drug|0|||
150249268|NCT00379288|542048553|FG002|Overall Study|Subject withdrew-related to study drug|0|||
150249269|NCT00379288|542048554|FG003|Overall Study|Subject withdrew-related to study drug|1|||
150249270|NCT00379288|542048551|FG000|Overall Study|Noncompliance with protocol|8|||
150249271|NCT00379288|542048552|FG001|Overall Study|Noncompliance with protocol|6|||
150249272|NCT00379288|542048553|FG002|Overall Study|Noncompliance with protocol|2|||
150249273|NCT00379288|542048554|FG003|Overall Study|Noncompliance with protocol|1|||
150249274|NCT00379288|542048551|FG000|Overall Study|Did not meet protocol eligibility|0|||
150249275|NCT00379288|542048552|FG001|Overall Study|Did not meet protocol eligibility|1|||
150249276|NCT00379288|542048553|FG002|Overall Study|Did not meet protocol eligibility|0|||
150249277|NCT00379288|542048554|FG003|Overall Study|Did not meet protocol eligibility|2|||
150249278|NCT00379288|542048551|FG000|Overall Study|Administrative|2|||
150249279|NCT00379288|542048552|FG001|Overall Study|Administrative|2|||
150249280|NCT00379288|542048553|FG002|Overall Study|Administrative|0|||
150249281|NCT00379288|542048554|FG003|Overall Study|Administrative|1|||
150249282|NCT01015560|542048555|FG000|Overall Study|Adverse Event|1|||
150249283|NCT01015560|542048555|FG000|Overall Study|Not protocol specified|1|||
150249284|NCT01015560|542048555|FG000|Overall Study|Withdrawal by Subject|1|||
150249285|NCT01255631|542048563|FG000|Overall Study|poor enrollment, no data analyzed|9|||
150249286|NCT01255631|542048564|FG001|Overall Study|poor enrollment, no data analyzed|6|||
150249287|NCT02815579|542048572|FG000|Overall Study|Non-payment of loan down-payment|16|||
150249288|NCT02815579|542048573|FG001|Overall Study|Non-payment of loan down-payment|0|||
150249289|NCT02815579|542048572|FG000|Overall Study|Withdrawal by Subject|7|||
150249290|NCT02815579|542048573|FG001|Overall Study|Withdrawal by Subject|1|||
150249291|NCT02815579|542048572|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
150249292|NCT02815579|542048573|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
150249293|NCT02815579|542048572|FG000|Overall Study|Lost to Follow-up|7|||
150249294|NCT02815579|542048573|FG001|Overall Study|Lost to Follow-up|4|||
150249295|NCT02815579|542048572|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
150249296|NCT02815579|542048573|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
150249297|NCT02815579|542048572|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
150249298|NCT02815579|542048573|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
150249299|NCT02815579|542048572|FG000|Overall Study|Death|5|||
150249300|NCT02815579|542048573|FG001|Overall Study|Death|4|||
150249301|NCT02815579|542048572|FG000|Overall Study|Imprisoned|0|||
150249302|NCT02815579|542048573|FG001|Overall Study|Imprisoned|2|||
150249303|NCT02815579|542048572|FG000|Overall Study|Did not meet enrollment criteria|0|||
150249304|NCT02815579|542048573|FG001|Overall Study|Did not meet enrollment criteria|1|||
150249305|NCT00264303|542048574|FG000|Overall Study|Adverse Event|4|||
150249306|NCT00264303|542048575|FG001|Overall Study|Adverse Event|3|||
150249307|NCT00264303|542048574|FG000|Overall Study|Lack of Efficacy|10|||
150249308|NCT00264303|542048575|FG001|Overall Study|Lack of Efficacy|13|||
150249309|NCT00264303|542048574|FG000|Overall Study|Lost to Follow-up|3|||
150249310|NCT00264303|542048575|FG001|Overall Study|Lost to Follow-up|3|||
150249311|NCT00264303|542048574|FG000|Overall Study|Withdrawal by Subject|2|||
150249312|NCT00264303|542048575|FG001|Overall Study|Withdrawal by Subject|3|||
150249313|NCT00264303|542048574|FG000|Overall Study|Various reasons listed in study report|6|||
150249314|NCT00264303|542048575|FG001|Overall Study|Various reasons listed in study report|7|||
150249315|NCT02389452|542048576|FG000|Overall Study|Lost to Follow-up|13|||
150249316|NCT02389452|542048576|FG000|Overall Study|Adverse Event|1|||
150249317|NCT02389452|542048576|FG000|Overall Study|Withdrawal by Subject|5|||
150249318|NCT02389452|542048576|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
150249319|NCT02311673|542048577|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
150249320|NCT02311673|542048578|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
150249321|NCT02311673|542048579|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
150249322|NCT02311673|542048580|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
150249323|NCT01014208|542048586|FG000|Overall Study|Lost to Follow-up|2|||
150249324|NCT01014208|542048587|FG001|Overall Study|Lost to Follow-up|5|||
150249325|NCT01014208|542048586|FG000|Overall Study|Participant Withdrew Consent|12|||
150249326|NCT01014208|542048587|FG001|Overall Study|Participant Withdrew Consent|12|||
150249327|NCT01014208|542048586|FG000|Overall Study|Did Not Receive Study Drug|2|||
150249328|NCT01014208|542048587|FG001|Overall Study|Did Not Receive Study Drug|0|||
150249329|NCT01014208|542048586|FG000|Overall Study|Study Closed/terminated|78|||
150249330|NCT01014208|542048587|FG001|Overall Study|Study Closed/terminated|83|||
150249331|NCT00414908|542048595|FG000|Overall Study|Protocol Violation|1|||
150249332|NCT00414908|542048596|FG001|Overall Study|Protocol Violation|1|||
150249333|NCT01076153|542048597|FG000|Overall Study|Symptoms improved/resolved|10|||
150249334|NCT01076153|542048597|FG000|Overall Study|Adverse Event|1|||
150249335|NCT04165031|542048598|FG000|Overall Study|Adverse Event|1|||
150249336|NCT04165031|542048599|FG001|Overall Study|Adverse Event|1|||
150249337|NCT04165031|542048600|FG002|Overall Study|Adverse Event|0|||
150249338|NCT04165031|542048601|FG003|Overall Study|Adverse Event|0|||
150249339|NCT04165031|542048602|FG004|Overall Study|Adverse Event|0|||
150249340|NCT04165031|542048603|FG005|Overall Study|Adverse Event|0|||
150249341|NCT04165031|542048598|FG000|Overall Study|Withdrawal by Subject|0|||
150249342|NCT04165031|542048599|FG001|Overall Study|Withdrawal by Subject|0|||
150249343|NCT04165031|542048600|FG002|Overall Study|Withdrawal by Subject|1|||
150249344|NCT04165031|542048601|FG003|Overall Study|Withdrawal by Subject|0|||
150249345|NCT04165031|542048602|FG004|Overall Study|Withdrawal by Subject|0|||
150249346|NCT04165031|542048603|FG005|Overall Study|Withdrawal by Subject|0|||
150249347|NCT00818168|542048604|FG000|Overall Study|Lack of Efficacy|18|||
150249348|NCT00818168|542048604|FG000|Overall Study|Pregnancy|2|||
150249349|NCT00818168|542048604|FG000|Overall Study|Withdrawal by Subject|16|||
150249350|NCT00818168|542048604|FG000|Overall Study|Lost to Follow-up|7|||
150249351|NCT00818168|542048604|FG000|Overall Study|Adverse Event|19|||
150249352|NCT00818168|542048604|FG000|Overall Study|Reason for Non-completion Not reported|6|||
150249353|NCT00818168|542048604|FG000|Overall Study|Participant Moved|2|||
150249354|NCT03809039|542048607|FG000|Part 1|Withdrawal by Subject|1|||
150249355|NCT03809039|542048608|FG001|Part 1|Withdrawal by Subject|0|||
150249356|NCT03809039|542048609|FG002|Part 1|Withdrawal by Subject|0|||
150249357|NCT03809039|542048610|FG003|Part 1|Withdrawal by Subject|1|||
150249358|NCT03809039|542048611|FG004|Part 1|Withdrawal by Subject|0|||
150249359|NCT03809039|542048612|FG005|Part 1|Withdrawal by Subject|0|||
150249360|NCT03809039|542048613|FG006|Part 1|Withdrawal by Subject|0|||
150249361|NCT03809039|542048614|FG007|Part 1|Withdrawal by Subject|0|||
150249362|NCT03809039|542048615|FG008|Part 1|Withdrawal by Subject|0|||
150249363|NCT03809039|542048607|FG000|Part 3|Withdrawn by study termination|0|||
150249364|NCT03809039|542048608|FG001|Part 3|Withdrawn by study termination|0|||
150249365|NCT03809039|542048609|FG002|Part 3|Withdrawn by study termination|0|||
150249366|NCT03809039|542048610|FG003|Part 3|Withdrawn by study termination|0|||
150249367|NCT03809039|542048611|FG004|Part 3|Withdrawn by study termination|0|||
150249368|NCT03809039|542048612|FG005|Part 3|Withdrawn by study termination|0|||
150249369|NCT03809039|542048613|FG006|Part 3|Withdrawn by study termination|0|||
150249370|NCT03809039|542048614|FG007|Part 3|Withdrawn by study termination|2|||
150249371|NCT03809039|542048615|FG008|Part 3|Withdrawn by study termination|6|||
150249372|NCT03853551|542048618|FG000|Overall Study|Death|2|||
150249373|NCT03853551|542048618|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
150249374|NCT00818779|542048620|FG000|Overall Study|Protocol Violation|1|||
150249375|NCT00818779|542048621|FG001|Overall Study|Protocol Violation|0|||
150249376|NCT00818779|542048620|FG000|Overall Study|Lost to Follow-up|1|||
150249377|NCT00818779|542048621|FG001|Overall Study|Lost to Follow-up|0|||
150249378|NCT00818779|542048620|FG000|Overall Study|Adverse Event|4|||
150249379|NCT00818779|542048621|FG001|Overall Study|Adverse Event|1|||
150249380|NCT00743431|542048622|FG000|Overall Study|Toxicity|6|||
150249381|NCT00743431|542048622|FG000|Overall Study|Tumor progression|56|||
150249382|NCT00743431|542048622|FG000|Overall Study|Withdrawal by Subject|13|||
150249383|NCT00743431|542048622|FG000|Overall Study|Death|9|||
150249384|NCT00743431|542048622|FG000|Overall Study|Reason for discontinuation not specified|29|||
150249385|NCT00743431|542048622|FG000|Overall Study|No documentation available|13|||
150249386|NCT03309813|542048623|FG000|Main Randomized Study|Withdrawal by Subject|1|||
150249387|NCT03309813|542048624|FG001|Main Randomized Study|Withdrawal by Subject|0|||
150249388|NCT04978493|542048625|FG000|Overall Study|No reason available|0|||
150249389|NCT04978493|542048626|FG001|Overall Study|No reason available|1|||
150249390|NCT04978493|542048625|FG000|Overall Study|Adverse Event|1|||
150249391|NCT04978493|542048626|FG001|Overall Study|Adverse Event|0|||
150249392|NCT01128114|542048627|FG000|Overall Study|Treatment Withdrawn|6|||
150249393|NCT01128114|542048627|FG000|Overall Study|Screening Failed|2|||
150249394|NCT02206061|542048628|FG000|Overall Study|Withdrawal by Subject|4|||
150249395|NCT02206061|542048629|FG001|Overall Study|Withdrawal by Subject|7|||
150249396|NCT02206061|542048630|FG002|Overall Study|Withdrawal by Subject|1|||
150249397|NCT02206061|542048628|FG000|Overall Study|Lost to Follow-up|14|||
150249398|NCT02206061|542048629|FG001|Overall Study|Lost to Follow-up|7|||
150249399|NCT02206061|542048630|FG002|Overall Study|Lost to Follow-up|20|||
150249400|NCT04187326|542048631|FG000|Overall Study|Lost to Follow-up|2|||
150249401|NCT04187326|542048632|FG001|Overall Study|Lost to Follow-up|1|||
150249402|NCT04187326|542048631|FG000|Overall Study|Computer error- task was only partially completed.|0|||
150249403|NCT04187326|542048632|FG001|Overall Study|Computer error- task was only partially completed.|1|||
150249404|NCT02738853|542048635|FG000|Enrollment|Inclusion/Exclusion not met|21|||
150249405|NCT02738853|542048635|FG000|Enrollment|Withdrawal by Subject|3|||
150249406|NCT02738853|542048635|FG000|Enrollment|Subject treated with commercially available device|6|||
150249407|NCT02738853|542048635|FG000|Enrollment|Study Enrollment Closed|3|||
150249408|NCT02738853|542048635|FG000|Procedure|Death|1|||
150249409|NCT02738853|542048635|FG000|1 Month|Death|2|||
150249410|NCT02738853|542048635|FG000|6 Month|Death|4|||
150249411|NCT02738853|542048635|FG000|6 Month|Withdrawal by Subject|2|||
150249412|NCT02738853|542048635|FG000|1 Year|Death|6|||
150249413|NCT02738853|542048635|FG000|1 Year|Withdrawal by Subject|1|||
150249414|NCT02738853|542048635|FG000|2 Year|Death|2|||
150249415|NCT02738853|542048635|FG000|2 Year|Lost to Follow-up|1|||
150249416|NCT02738853|542048635|FG000|3 Year|Death|2|||
150249417|NCT02738853|542048635|FG000|3 Year|Withdrawal by Subject|1|||
150249418|NCT02738853|542048635|FG000|4 Year|Death|9|||
150249419|NCT02738853|542048635|FG000|5 Year|Lost to Follow-up|4|||
150249420|NCT00316017|542048637|FG000|Overall Study|Protocol Violation|11|||
150249421|NCT00316017|542048638|FG001|Overall Study|Protocol Violation|13|||
150249422|NCT00316017|542048639|FG002|Overall Study|Protocol Violation|19|||
150249423|NCT04157400|542048640|FG000|Overall Study|Withdrawal by Subject|1|||
150249424|NCT04157400|542048640|FG000|Overall Study|Lost to Follow-up|3|||
150249425|NCT01803282|542048653|FG000|Overall Study|Progressive Disease|4|||
150249426|NCT01803282|542048654|FG001|Overall Study|Progressive Disease|3|||
150249427|NCT01803282|542048655|FG002|Overall Study|Progressive Disease|6|||
150249428|NCT01803282|542048656|FG003|Overall Study|Progressive Disease|22|||
150249429|NCT01803282|542048657|FG004|Overall Study|Progressive Disease|5|||
150249430|NCT01803282|542048658|FG005|Overall Study|Progressive Disease|8|||
150249431|NCT01803282|542048659|FG006|Overall Study|Progressive Disease|23|||
150249432|NCT01803282|542048660|FG007|Overall Study|Progressive Disease|24|||
150249433|NCT01803282|542048661|FG008|Overall Study|Progressive Disease|3|||
150249434|NCT01803282|542048662|FG009|Overall Study|Progressive Disease|29|||
150249435|NCT01803282|542048663|FG010|Overall Study|Progressive Disease|6|||
150249436|NCT01803282|542048664|FG011|Overall Study|Progressive Disease|11|||
150249437|NCT01803282|542048653|FG000|Overall Study|Death|0|||
150249438|NCT01803282|542048654|FG001|Overall Study|Death|0|||
150249439|NCT01803282|542048655|FG002|Overall Study|Death|0|||
150249440|NCT01803282|542048656|FG003|Overall Study|Death|0|||
150249441|NCT01803282|542048657|FG004|Overall Study|Death|2|||
150249442|NCT01803282|542048658|FG005|Overall Study|Death|1|||
150249443|NCT01803282|542048659|FG006|Overall Study|Death|1|||
150249444|NCT01803282|542048660|FG007|Overall Study|Death|5|||
150249445|NCT01803282|542048661|FG008|Overall Study|Death|1|||
150249446|NCT01803282|542048662|FG009|Overall Study|Death|1|||
150249447|NCT01803282|542048663|FG010|Overall Study|Death|0|||
150249448|NCT01803282|542048664|FG011|Overall Study|Death|0|||
150249449|NCT01803282|542048653|FG000|Overall Study|Withdrew Consent|0|||
150249450|NCT01803282|542048654|FG001|Overall Study|Withdrew Consent|0|||
150249451|NCT01803282|542048655|FG002|Overall Study|Withdrew Consent|0|||
150249452|NCT01803282|542048656|FG003|Overall Study|Withdrew Consent|6|||
150249453|NCT01803282|542048657|FG004|Overall Study|Withdrew Consent|1|||
150249454|NCT01803282|542048658|FG005|Overall Study|Withdrew Consent|0|||
150249455|NCT01803282|542048659|FG006|Overall Study|Withdrew Consent|8|||
150249456|NCT01803282|542048660|FG007|Overall Study|Withdrew Consent|3|||
150249457|NCT01803282|542048661|FG008|Overall Study|Withdrew Consent|1|||
150249458|NCT01803282|542048662|FG009|Overall Study|Withdrew Consent|5|||
150249459|NCT01803282|542048663|FG010|Overall Study|Withdrew Consent|0|||
150249460|NCT01803282|542048664|FG011|Overall Study|Withdrew Consent|1|||
150249461|NCT01803282|542048653|FG000|Overall Study|Investigator's Discretion|0|||
150249462|NCT01803282|542048654|FG001|Overall Study|Investigator's Discretion|0|||
150249463|NCT01803282|542048655|FG002|Overall Study|Investigator's Discretion|0|||
150249464|NCT01803282|542048656|FG003|Overall Study|Investigator's Discretion|7|||
150249465|NCT01803282|542048657|FG004|Overall Study|Investigator's Discretion|2|||
150249466|NCT01803282|542048658|FG005|Overall Study|Investigator's Discretion|1|||
150249467|NCT01803282|542048659|FG006|Overall Study|Investigator's Discretion|7|||
150249468|NCT01803282|542048660|FG007|Overall Study|Investigator's Discretion|10|||
150249469|NCT01803282|542048661|FG008|Overall Study|Investigator's Discretion|6|||
150249470|NCT01803282|542048662|FG009|Overall Study|Investigator's Discretion|7|||
150249471|NCT01803282|542048663|FG010|Overall Study|Investigator's Discretion|1|||
150249472|NCT01803282|542048664|FG011|Overall Study|Investigator's Discretion|0|||
150249473|NCT01803282|542048653|FG000|Overall Study|Adverse Event|0|||
150249474|NCT01803282|542048654|FG001|Overall Study|Adverse Event|0|||
150249475|NCT01803282|542048655|FG002|Overall Study|Adverse Event|0|||
150249476|NCT01803282|542048656|FG003|Overall Study|Adverse Event|0|||
150249477|NCT01803282|542048657|FG004|Overall Study|Adverse Event|0|||
150249478|NCT01803282|542048658|FG005|Overall Study|Adverse Event|0|||
150249479|NCT01803282|542048659|FG006|Overall Study|Adverse Event|1|||
150249480|NCT01803282|542048660|FG007|Overall Study|Adverse Event|2|||
150249481|NCT01803282|542048661|FG008|Overall Study|Adverse Event|0|||
150249482|NCT01803282|542048662|FG009|Overall Study|Adverse Event|1|||
150249483|NCT01803282|542048663|FG010|Overall Study|Adverse Event|0|||
150249484|NCT01803282|542048664|FG011|Overall Study|Adverse Event|3|||
150249485|NCT01803282|542048653|FG000|Overall Study|Non-Compliance with Study Drug|0|||
150249486|NCT01803282|542048654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
150249487|NCT01803282|542048655|FG002|Overall Study|Non-Compliance with Study Drug|0|||
150249488|NCT01803282|542048656|FG003|Overall Study|Non-Compliance with Study Drug|1|||
150249489|NCT01803282|542048657|FG004|Overall Study|Non-Compliance with Study Drug|0|||
150249490|NCT01803282|542048658|FG005|Overall Study|Non-Compliance with Study Drug|0|||
150249491|NCT01803282|542048659|FG006|Overall Study|Non-Compliance with Study Drug|0|||
150249492|NCT01803282|542048660|FG007|Overall Study|Non-Compliance with Study Drug|0|||
150249493|NCT01803282|542048661|FG008|Overall Study|Non-Compliance with Study Drug|0|||
150249494|NCT01803282|542048662|FG009|Overall Study|Non-Compliance with Study Drug|0|||
150249495|NCT01803282|542048663|FG010|Overall Study|Non-Compliance with Study Drug|0|||
150249496|NCT01803282|542048664|FG011|Overall Study|Non-Compliance with Study Drug|0|||
150249497|NCT01803282|542048653|FG000|Overall Study|Unknown Reason|0|||
150249498|NCT01803282|542048654|FG001|Overall Study|Unknown Reason|0|||
150249499|NCT01803282|542048655|FG002|Overall Study|Unknown Reason|0|||
150249500|NCT01803282|542048656|FG003|Overall Study|Unknown Reason|0|||
150249501|NCT01803282|542048657|FG004|Overall Study|Unknown Reason|0|||
150249502|NCT01803282|542048658|FG005|Overall Study|Unknown Reason|0|||
150249503|NCT01803282|542048659|FG006|Overall Study|Unknown Reason|0|||
150249504|NCT01803282|542048660|FG007|Overall Study|Unknown Reason|1|||
150249505|NCT01803282|542048661|FG008|Overall Study|Unknown Reason|0|||
150249506|NCT01803282|542048662|FG009|Overall Study|Unknown Reason|0|||
150249507|NCT01803282|542048663|FG010|Overall Study|Unknown Reason|0|||
150249508|NCT01803282|542048664|FG011|Overall Study|Unknown Reason|0|||
150249509|NCT01803282|542048653|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
150249510|NCT01803282|542048654|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
150249511|NCT01803282|542048655|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
150249512|NCT01803282|542048656|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
150249513|NCT01803282|542048657|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
150249514|NCT01803282|542048658|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
150249515|NCT01803282|542048659|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
150249516|NCT01803282|542048660|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
150249517|NCT01803282|542048661|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
150249518|NCT01803282|542048662|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
150249519|NCT01803282|542048663|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
150249520|NCT01803282|542048664|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
150249521|NCT01803282|542048653|FG000|Overall Study|Enrolled but Never Treated|0|||
150249522|NCT01803282|542048654|FG001|Overall Study|Enrolled but Never Treated|0|||
150249523|NCT01803282|542048655|FG002|Overall Study|Enrolled but Never Treated|0|||
150249524|NCT01803282|542048656|FG003|Overall Study|Enrolled but Never Treated|0|||
150249525|NCT01803282|542048657|FG004|Overall Study|Enrolled but Never Treated|1|||
150249526|NCT01803282|542048658|FG005|Overall Study|Enrolled but Never Treated|0|||
150249527|NCT01803282|542048659|FG006|Overall Study|Enrolled but Never Treated|1|||
150249528|NCT01803282|542048660|FG007|Overall Study|Enrolled but Never Treated|1|||
150249529|NCT01803282|542048661|FG008|Overall Study|Enrolled but Never Treated|0|||
150249530|NCT01803282|542048662|FG009|Overall Study|Enrolled but Never Treated|1|||
150249531|NCT01803282|542048663|FG010|Overall Study|Enrolled but Never Treated|0|||
150249532|NCT01803282|542048664|FG011|Overall Study|Enrolled but Never Treated|0|||
150249533|NCT02671500|542048666|FG000|Overall Study|Lack of Efficacy|12|||
150249534|NCT02671500|542048666|FG000|Overall Study|Lost to Follow-up|2|||
150249535|NCT05235269|542048674|FG000|Overall Study|Adverse Event|1|||
150249536|NCT05235269|542048674|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
150249537|NCT05235269|542048674|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
150249538|NCT05511038|542048675|FG000|Overall|Withdrawal by Subject|5|||
150249539|NCT05511038|542048676|FG001|Overall|Withdrawal by Subject|3|||
150249540|NCT05511038|542048675|FG000|Overall|Screen Failure|20|||
150249541|NCT05511038|542048676|FG001|Overall|Screen Failure|1|||
150249542|NCT05511038|542048675|FG000|Overall|Physician Decision|3|||
150249543|NCT05511038|542048676|FG001|Overall|Physician Decision|0|||
150249544|NCT05511038|542048675|FG000|Overall|Lost to Follow-up|3|||
150249545|NCT05511038|542048676|FG001|Overall|Lost to Follow-up|0|||
150249546|NCT05511038|542048675|FG000|Overall|Death|1|||
150249547|NCT05511038|542048676|FG001|Overall|Death|0|||
150249548|NCT05511038|542048675|FG000|Screening|Withdrawal by Subject|1|||
150249549|NCT05511038|542048676|FG001|Screening|Withdrawal by Subject|0|||
150249550|NCT05511038|542048675|FG000|Screening|Lost to Follow Up (1 participant)|1|||
150249551|NCT05511038|542048676|FG001|Screening|Lost to Follow Up (1 participant)|0|||
150249552|NCT05511038|542048675|FG000|Screening|Screen Failure|3|||
150249553|NCT05511038|542048676|FG001|Screening|Screen Failure|0|||
150249554|NCT05511038|542048675|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
150249555|NCT05511038|542048676|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
150249556|NCT05511038|542048675|FG000|Treatment|Withdrawal by Subject|5|||
150249557|NCT05511038|542048676|FG001|Treatment|Withdrawal by Subject|3|||
150249558|NCT05511038|542048675|FG000|Treatment|Physician Decision|4|||
150249559|NCT05511038|542048676|FG001|Treatment|Physician Decision|0|||
150249560|NCT05511038|542048675|FG000|Treatment|Lost to Follow-up|2|||
150249561|NCT05511038|542048676|FG001|Treatment|Lost to Follow-up|0|||
150249562|NCT05511038|542048675|FG000|Treatment|Death|1|||
150249563|NCT05511038|542048676|FG001|Treatment|Death|0|||
150249564|NCT05511038|542048675|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
150249565|NCT05511038|542048676|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
150249566|NCT05511038|542048675|FG000|Treatment|Refuse by subject|1|||
150249567|NCT05511038|542048676|FG001|Treatment|Refuse by subject|0|||
150249568|NCT05511038|542048675|FG000|Treatment|Subject did not go to the site for visit|1|||
150249569|NCT05511038|542048676|FG001|Treatment|Subject did not go to the site for visit|0|||
150249570|NCT05543187|542048679|FG000|Overall Study|Ongoing|3|||
150249571|NCT05543187|542048680|FG001|Overall Study|Ongoing|2|||
150249572|NCT03810235|542048681|FG000|Overall Study|Withdrawal by Subject|2|||
150249573|NCT03810235|542048682|FG001|Overall Study|Withdrawal by Subject|0|||
150249574|NCT04777864|542048683|FG000|Overall Study|Lost to Follow-up|8|||
150249575|NCT04777864|542048684|FG001|Overall Study|Lost to Follow-up|19|||
150249576|NCT00798434|542048687|FG000|Double-Blind|Adverse Event|22|||
150249577|NCT00798434|542048688|FG001|Double-Blind|Adverse Event|46|||
150249578|NCT00798434|542048687|FG000|Double-Blind|Death|0|||
150249579|NCT00798434|542048688|FG001|Double-Blind|Death|1|||
150249580|NCT00798434|542048687|FG000|Double-Blind|Lost to Follow-up|1|||
150249581|NCT00798434|542048688|FG001|Double-Blind|Lost to Follow-up|0|||
150249582|NCT00798434|542048687|FG000|Double-Blind|Lack of Efficacy|8|||
150249583|NCT00798434|542048688|FG001|Double-Blind|Lack of Efficacy|12|||
150249584|NCT00798434|542048687|FG000|Double-Blind|Withdrawal by Subject|17|||
150249585|NCT00798434|542048688|FG001|Double-Blind|Withdrawal by Subject|14|||
150249586|NCT00798434|542048687|FG000|Double-Blind|Protocol Violation|1|||
150249587|NCT00798434|542048688|FG001|Double-Blind|Protocol Violation|4|||
150249588|NCT00798434|542048687|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
150249589|NCT00798434|542048688|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
150249590|NCT00798434|542048687|FG000|Double-Blind|Other|1|||
150249591|NCT00798434|542048688|FG001|Double-Blind|Other|0|||
150249592|NCT00798434|542048687|FG000|Double-Blind|Not Treated|3|||
150249593|NCT00798434|542048688|FG001|Double-Blind|Not Treated|6|||
150249594|NCT00798434|542048687|FG000|Open-Label|Adverse Event|33|||
150249595|NCT00798434|542048688|FG001|Open-Label|Adverse Event|11|||
150249596|NCT00798434|542048687|FG000|Open-Label|Lack of Efficacy|5|||
150249597|NCT00798434|542048688|FG001|Open-Label|Lack of Efficacy|11|||
150249598|NCT00798434|542048687|FG000|Open-Label|Withdrawal by Subject|2|||
150249599|NCT00798434|542048688|FG001|Open-Label|Withdrawal by Subject|7|||
150249600|NCT00798434|542048687|FG000|Open-Label|Protocol Violation|1|||
150249601|NCT00798434|542048688|FG001|Open-Label|Protocol Violation|0|||
150249602|NCT00798434|542048687|FG000|Open-Label|Other|1|||
150249603|NCT00798434|542048688|FG001|Open-Label|Other|2|||
150249604|NCT00798434|542048687|FG000|Open-Label|Not Treated|0|||
150249605|NCT00798434|542048688|FG001|Open-Label|Not Treated|1|||
150249606|NCT01217437|542048692|FG000|Overall Study|Adverse Event|0|||
150249607|NCT01217437|542048693|FG001|Overall Study|Adverse Event|8|||
150249608|NCT01217437|542048692|FG000|Overall Study|Death|5|||
150249609|NCT01217437|542048693|FG001|Overall Study|Death|0|||
150249610|NCT01217437|542048692|FG000|Overall Study|Lack of Efficacy|29|||
150249611|NCT01217437|542048693|FG001|Overall Study|Lack of Efficacy|25|||
150249612|NCT01217437|542048692|FG000|Overall Study|Physician Decision|8|||
150249613|NCT01217437|542048693|FG001|Overall Study|Physician Decision|5|||
150249614|NCT01217437|542048692|FG000|Overall Study|Withdrawal by Subject|0|||
150249615|NCT01217437|542048693|FG001|Overall Study|Withdrawal by Subject|2|||
150249616|NCT01217437|542048692|FG000|Overall Study|Ineligible|1|||
150249617|NCT01217437|542048693|FG001|Overall Study|Ineligible|1|||
150249618|NCT03682185|542048696|FG000|Overall Study|Lost to Follow-up|4|||
150249619|NCT03682185|542048697|FG001|Overall Study|Lost to Follow-up|7|||
150249620|NCT03682185|542048698|FG002|Overall Study|Lost to Follow-up|4|||
150249621|NCT03682185|542048699|FG003|Overall Study|Lost to Follow-up|7|||
150249622|NCT03682185|542048700|FG004|Overall Study|Lost to Follow-up|1|||
150249623|NCT03682185|542048696|FG000|Overall Study|Withdrawal by Subject|7|||
150249624|NCT03682185|542048697|FG001|Overall Study|Withdrawal by Subject|3|||
150249625|NCT03682185|542048698|FG002|Overall Study|Withdrawal by Subject|7|||
150249626|NCT03682185|542048699|FG003|Overall Study|Withdrawal by Subject|3|||
150249627|NCT03682185|542048700|FG004|Overall Study|Withdrawal by Subject|0|||
150249628|NCT04908631|542048701|FG000|Overall Study|Lost to Follow-up|1|||
150249629|NCT04908631|542048701|FG000|Overall Study|Physician Decision|1|||
150249630|NCT04908631|542048701|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
150249631|NCT02336451|542048705|FG000|Overall Study|Adverse Event|1|||
150249632|NCT02336451|542048706|FG001|Overall Study|Adverse Event|2|||
150249633|NCT02336451|542048707|FG002|Overall Study|Adverse Event|0|||
150249634|NCT02336451|542048708|FG003|Overall Study|Adverse Event|6|||
150249635|NCT02336451|542048709|FG004|Overall Study|Adverse Event|4|||
150249636|NCT02336451|542048705|FG000|Overall Study|Death|6|||
150249637|NCT02336451|542048706|FG001|Overall Study|Death|2|||
150249638|NCT02336451|542048707|FG002|Overall Study|Death|3|||
150249639|NCT02336451|542048708|FG003|Overall Study|Death|6|||
150249640|NCT02336451|542048709|FG004|Overall Study|Death|6|||
150249641|NCT02336451|542048705|FG000|Overall Study|Physician Decision|9|||
150249642|NCT02336451|542048706|FG001|Overall Study|Physician Decision|6|||
150249643|NCT02336451|542048707|FG002|Overall Study|Physician Decision|7|||
150249644|NCT02336451|542048708|FG003|Overall Study|Physician Decision|16|||
150249645|NCT02336451|542048709|FG004|Overall Study|Physician Decision|3|||
150249646|NCT02336451|542048705|FG000|Overall Study|Progressive disease|23|||
150249647|NCT02336451|542048706|FG001|Overall Study|Progressive disease|26|||
150249648|NCT02336451|542048707|FG002|Overall Study|Progressive disease|2|||
150249649|NCT02336451|542048708|FG003|Overall Study|Progressive disease|14|||
150249650|NCT02336451|542048709|FG004|Overall Study|Progressive disease|4|||
150249651|NCT02336451|542048705|FG000|Overall Study|Protocol Violation|1|||
150249652|NCT02336451|542048706|FG001|Overall Study|Protocol Violation|0|||
150249653|NCT02336451|542048707|FG002|Overall Study|Protocol Violation|0|||
150249654|NCT02336451|542048708|FG003|Overall Study|Protocol Violation|0|||
150249655|NCT02336451|542048709|FG004|Overall Study|Protocol Violation|0|||
150249656|NCT02336451|542048705|FG000|Overall Study|Patient/guardian decision|2|||
150249657|NCT02336451|542048706|FG001|Overall Study|Patient/guardian decision|4|||
150249658|NCT02336451|542048707|FG002|Overall Study|Patient/guardian decision|0|||
150249659|NCT02336451|542048708|FG003|Overall Study|Patient/guardian decision|2|||
150249660|NCT02336451|542048709|FG004|Overall Study|Patient/guardian decision|1|||
150249661|NCT03548220|542048711|FG000|Overall Study|Lost to Follow-up|1|||
150249662|NCT03548220|542048712|FG001|Overall Study|Lost to Follow-up|0|||
150249663|NCT03548220|542048713|FG002|Overall Study|Lost to Follow-up|0|||
150249664|NCT03548220|542048714|FG003|Overall Study|Lost to Follow-up|0|||
150249665|NCT00890695|542050343|FG000|Overall Study|Protocol Violation|1|||
150249666|NCT00890695|542050344|FG001|Overall Study|Protocol Violation|0|||
150249667|NCT00833261|542050353|FG000|Overall Study|Withdrawal by Subject|4|||
150249668|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
150249669|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
150249670|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
150249671|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
150249672|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
150249673|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
150249674|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
150249675|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
150249676|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
150249677|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
150249678|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
150249679|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
150249680|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Death|1|||
150249681|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Death|2|||
150249682|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Death|2|||
150249683|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Death|0|||
150249684|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Death|0|||
150249685|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Death|0|||
150249686|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
150249687|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
150249688|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
150249689|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
150249690|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
150249691|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
150249692|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
150249693|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
150249694|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
150249695|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
150249696|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
150249697|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
150249698|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
150249699|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
150249700|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
150249701|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
150249702|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
150249703|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
150249704|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
150249705|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
150249706|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
150249707|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
150249708|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
150249709|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
150249710|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
150249711|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
150249712|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
150249713|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
150249714|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
150249715|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
150249716|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
150249717|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
150249718|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
150249719|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
150249720|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
150249721|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
150249722|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
150249723|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
150249724|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
150249725|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
150249726|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
150249727|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
150249728|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Site closure|0|||
150249729|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Site closure|0|||
150249730|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Site closure|1|||
150249731|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Site closure|0|||
150249732|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Site closure|0|||
150249733|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Site closure|0|||
150249734|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
150249735|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
150249736|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
150249737|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
150249738|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
150249739|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
150249740|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
150249741|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
150249742|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
150249743|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
150249744|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
150249745|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
150249746|NCT03439254|542050354|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
150249747|NCT03439254|542050355|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
150249748|NCT03439254|542050356|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
150249749|NCT03439254|542050357|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
150249750|NCT03439254|542050358|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
150249751|NCT03439254|542050359|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
150249752|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
150249753|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
150249754|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
150249755|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
150249756|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
150249757|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
150249758|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
150249759|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
150249760|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
150249761|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
150249762|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
150249763|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
150249764|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
150249765|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
150249766|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
150249767|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
150249768|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
150249769|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
150249770|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
150249771|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
150249772|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
150249773|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
150249774|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
150249775|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
150249776|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
150249777|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
150249778|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
150249779|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
150249780|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
150249781|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
150249782|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
150249783|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
150249784|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
150249785|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
150249786|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
150249787|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
150249788|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
150249789|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
150249790|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
150249791|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
150249792|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
150249793|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
150249794|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
150249795|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
150249796|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
150249797|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
150249798|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
150249799|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
150249800|NCT03439254|542050354|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
150249801|NCT03439254|542050355|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
150249802|NCT03439254|542050356|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
150249803|NCT03439254|542050357|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
150249804|NCT03439254|542050358|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
150249805|NCT03439254|542050359|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
150249806|NCT00837694|542050360|FG000|Overall Study|Lost to Follow-up|2|||
150249807|NCT00837694|542050361|FG001|Overall Study|Lost to Follow-up|0|||
150249808|NCT00837694|542050362|FG002|Overall Study|Lost to Follow-up|2|||
150249809|NCT00837694|542050363|FG003|Overall Study|Lost to Follow-up|1|||
150249810|NCT00837694|542050364|FG004|Overall Study|Lost to Follow-up|1|||
150249811|NCT00837694|542050365|FG005|Overall Study|Lost to Follow-up|1|||
150249812|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Physician Decision|2|||
150249813|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Physician Decision|0|||
150249814|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Physician Decision|0|||
150249815|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Adverse Event|33|||
150249816|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Adverse Event|0|||
150249817|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Adverse Event|0|||
150249818|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
150249819|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
150249820|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
150249821|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
150249822|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
150249823|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
150249824|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
150249825|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
150249826|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
150249827|NCT01008553|542050366|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
150249828|NCT01008553|542050367|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
150249829|NCT01008553|542050368|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
150249830|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
150249831|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
150249832|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
150249833|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
150249834|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
150249835|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
150249836|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
150249837|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
150249838|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
150249839|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
150249840|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
150249841|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
150249842|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
150249843|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
150249844|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
150249845|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
150249846|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
150249847|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
150249848|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
150249849|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
150249850|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
150249851|NCT01008553|542050366|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
150249852|NCT01008553|542050367|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
150249853|NCT01008553|542050368|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
150249854|NCT03482466|542050372|FG000|Overall Study|Protocol Violation|2|||
150249855|NCT04552899|542050373|FG000|Overall Study|Adverse Event|4|||
150249856|NCT04552899|542050374|FG001|Overall Study|Adverse Event|3|||
150249857|NCT04552899|542050373|FG000|Overall Study|Death|4|||
150249858|NCT04552899|542050374|FG001|Overall Study|Death|4|||
150249859|NCT04552899|542050373|FG000|Overall Study|Lost to Follow-up|8|||
150249860|NCT04552899|542050374|FG001|Overall Study|Lost to Follow-up|13|||
150249861|NCT04552899|542050373|FG000|Overall Study|Lung Transplant|4|||
150249862|NCT04552899|542050374|FG001|Overall Study|Lung Transplant|3|||
150249863|NCT04552899|542050373|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
150249864|NCT04552899|542050374|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
150249865|NCT04552899|542050373|FG000|Overall Study|Physician Decision|3|||
150249866|NCT04552899|542050374|FG001|Overall Study|Physician Decision|4|||
150249867|NCT04552899|542050373|FG000|Overall Study|Study Terminated By Sponsor|237|||
150249868|NCT04552899|542050374|FG001|Overall Study|Study Terminated By Sponsor|239|||
150249869|NCT04552899|542050373|FG000|Overall Study|Withdrawal by Subject|15|||
150249870|NCT04552899|542050374|FG001|Overall Study|Withdrawal by Subject|17|||
150249871|NCT00731133|542050377|FG000|Overall Study|Withdrawal by Subject|10|||
150249872|NCT02383940|542050378|FG000|Overall Study|Adverse Event|1|||
150249873|NCT02383940|542050379|FG001|Overall Study|Adverse Event|0|||
150249874|NCT02383940|542050378|FG000|Overall Study|Lost to Follow-up|2|||
150249875|NCT02383940|542050379|FG001|Overall Study|Lost to Follow-up|2|||
150249876|NCT02383940|542050378|FG000|Overall Study|Physician Decision|2|||
150249877|NCT02383940|542050379|FG001|Overall Study|Physician Decision|0|||
150249878|NCT02383940|542050378|FG000|Overall Study|Withdrawal by Subject|1|||
150249879|NCT02383940|542050379|FG001|Overall Study|Withdrawal by Subject|1|||
150249880|NCT02383940|542050378|FG000|Overall Study|Randomized but not treated|2|||
150249881|NCT02383940|542050379|FG001|Overall Study|Randomized but not treated|0|||
150249882|NCT02383940|542050378|FG000|Overall Study|Other than specified above|1|||
150249883|NCT02383940|542050379|FG001|Overall Study|Other than specified above|0|||
150249884|NCT01240915|542050381|FG000|Overall Study|Adverse Event|0|||
150249885|NCT01240915|542050382|FG001|Overall Study|Adverse Event|0|||
150249886|NCT01240915|542050383|FG002|Overall Study|Adverse Event|0|||
150249887|NCT01240915|542050384|FG003|Overall Study|Adverse Event|1|||
150249888|NCT01240915|542050385|FG004|Overall Study|Adverse Event|0|||
150249889|NCT01240915|542050386|FG005|Overall Study|Adverse Event|2|||
150249890|NCT01240915|542050387|FG006|Overall Study|Adverse Event|0|||
150249891|NCT01240915|542050388|FG007|Overall Study|Adverse Event|0|||
150249892|NCT01240915|542050389|FG008|Overall Study|Adverse Event|1|||
150249893|NCT01240915|542050381|FG000|Overall Study|Lost to Follow-up|0|||
150249894|NCT01240915|542050382|FG001|Overall Study|Lost to Follow-up|0|||
150249895|NCT01240915|542050383|FG002|Overall Study|Lost to Follow-up|0|||
150249896|NCT01240915|542050384|FG003|Overall Study|Lost to Follow-up|0|||
150249897|NCT01240915|542050385|FG004|Overall Study|Lost to Follow-up|1|||
150249898|NCT01240915|542050386|FG005|Overall Study|Lost to Follow-up|1|||
150249899|NCT01240915|542050387|FG006|Overall Study|Lost to Follow-up|0|||
150249900|NCT01240915|542050388|FG007|Overall Study|Lost to Follow-up|1|||
150249901|NCT01240915|542050389|FG008|Overall Study|Lost to Follow-up|1|||
150249902|NCT01240915|542050381|FG000|Overall Study|Withdrawal by Subject|2|||
150249903|NCT01240915|542050382|FG001|Overall Study|Withdrawal by Subject|1|||
150249904|NCT01240915|542050383|FG002|Overall Study|Withdrawal by Subject|0|||
150249905|NCT01240915|542050384|FG003|Overall Study|Withdrawal by Subject|2|||
150249906|NCT01240915|542050385|FG004|Overall Study|Withdrawal by Subject|0|||
150249907|NCT01240915|542050386|FG005|Overall Study|Withdrawal by Subject|4|||
150249908|NCT01240915|542050387|FG006|Overall Study|Withdrawal by Subject|2|||
150249909|NCT01240915|542050388|FG007|Overall Study|Withdrawal by Subject|3|||
150249910|NCT01240915|542050389|FG008|Overall Study|Withdrawal by Subject|3|||
150249911|NCT01240915|542050381|FG000|Overall Study|Other|0|||
150249912|NCT01240915|542050382|FG001|Overall Study|Other|0|||
150249913|NCT01240915|542050383|FG002|Overall Study|Other|0|||
150249914|NCT01240915|542050384|FG003|Overall Study|Other|0|||
150249915|NCT01240915|542050385|FG004|Overall Study|Other|2|||
150249916|NCT01240915|542050386|FG005|Overall Study|Other|0|||
150249917|NCT01240915|542050387|FG006|Overall Study|Other|0|||
150249918|NCT01240915|542050388|FG007|Overall Study|Other|0|||
150249919|NCT01240915|542050389|FG008|Overall Study|Other|0|||
150249920|NCT01240915|542050381|FG000|Overall Study|Insufficient Clinical Response|0|||
150249921|NCT01240915|542050382|FG001|Overall Study|Insufficient Clinical Response|0|||
150249922|NCT01240915|542050383|FG002|Overall Study|Insufficient Clinical Response|0|||
150249923|NCT01240915|542050384|FG003|Overall Study|Insufficient Clinical Response|0|||
150249924|NCT01240915|542050385|FG004|Overall Study|Insufficient Clinical Response|1|||
150249925|NCT01240915|542050386|FG005|Overall Study|Insufficient Clinical Response|3|||
150249926|NCT01240915|542050387|FG006|Overall Study|Insufficient Clinical Response|6|||
150249927|NCT01240915|542050388|FG007|Overall Study|Insufficient Clinical Response|0|||
150249928|NCT01240915|542050389|FG008|Overall Study|Insufficient Clinical Response|3|||
150249929|NCT01598662|542050391|FG000|Overall Study|Lost to Follow-up|10|||
150249930|NCT01598662|542050392|FG001|Overall Study|Lost to Follow-up|17|||
150249931|NCT01598662|542050391|FG000|Overall Study|Physician Decision|1|||
150249932|NCT01598662|542050392|FG001|Overall Study|Physician Decision|2|||
150249933|NCT01598662|542050391|FG000|Overall Study|IUD expelled before month 6|0|||
150249934|NCT01598662|542050392|FG001|Overall Study|IUD expelled before month 6|2|||
150249935|NCT02574845|542050395|FG000|Overall Study|Consent withdrawn further participation|0|||
150249936|NCT02574845|542050396|FG001|Overall Study|Consent withdrawn further participation|0|||
150249937|NCT02574845|542050397|FG002|Overall Study|Consent withdrawn further participation|0|||
150249938|NCT02574845|542050398|FG003|Overall Study|Consent withdrawn further participation|0|||
150249939|NCT02574845|542050399|FG004|Overall Study|Consent withdrawn further participation|1|||
150249940|NCT02574845|542050400|FG005|Overall Study|Consent withdrawn further participation|0|||
150249941|NCT02574845|542050395|FG000|Overall Study|Adverse Event|0|||
150249942|NCT02574845|542050396|FG001|Overall Study|Adverse Event|1|||
150249943|NCT02574845|542050397|FG002|Overall Study|Adverse Event|0|||
150249944|NCT02574845|542050398|FG003|Overall Study|Adverse Event|0|||
150249945|NCT02574845|542050399|FG004|Overall Study|Adverse Event|0|||
150249946|NCT02574845|542050400|FG005|Overall Study|Adverse Event|1|||
150249947|NCT01867333|542050401|FG000|Overall Study|Withdrawal by Subject|1|||
150249948|NCT01867333|542050402|FG001|Overall Study|Withdrawal by Subject|0|||
150249949|NCT01867333|542050401|FG000|Overall Study|Adverse Event|1|||
150249950|NCT01867333|542050402|FG001|Overall Study|Adverse Event|0|||
150249951|NCT01867333|542050401|FG000|Overall Study|Participant choice|1|||
150249952|NCT01867333|542050402|FG001|Overall Study|Participant choice|2|||
150249953|NCT01867333|542050401|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
150249954|NCT01867333|542050402|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
150249955|NCT01867333|542050401|FG000|Overall Study|Death|0|||
150249956|NCT01867333|542050402|FG001|Overall Study|Death|1|||
150249957|NCT01867333|542050401|FG000|Overall Study|Physician Decision|3|||
150249958|NCT01867333|542050402|FG001|Overall Study|Physician Decision|2|||
150249959|NCT01867333|542050401|FG000|Overall Study|Switched to alternative treatment|1|||
150249960|NCT01867333|542050402|FG001|Overall Study|Switched to alternative treatment|0|||
150249961|NCT01696045|542050406|FG000|Overall Study|Study drug toxicity|1|||
150249962|NCT01696045|542050407|FG001|Overall Study|Study drug toxicity|5|||
150249963|NCT01696045|542050406|FG000|Overall Study|Disease progression|2|||
150249964|NCT01696045|542050407|FG001|Overall Study|Disease progression|2|||
150249965|NCT01559129|542050408|FG000|Treatment Phase|Adverse Event|0|||
150249966|NCT01559129|542050409|FG001|Treatment Phase|Adverse Event|2|||
150249967|NCT01559129|542050408|FG000|Treatment Phase|Progressive Disease|1|||
150249968|NCT01559129|542050409|FG001|Treatment Phase|Progressive Disease|1|||
150249969|NCT01559129|542050408|FG000|Treatment Phase|Lack of Efficacy|0|||
150249970|NCT01559129|542050409|FG001|Treatment Phase|Lack of Efficacy|1|||
150249971|NCT01559129|542050408|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
150249972|NCT01559129|542050409|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
150249973|NCT01559129|542050408|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
150249974|NCT01559129|542050409|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
150249975|NCT01559129|542050408|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
150249976|NCT01559129|542050409|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
150249977|NCT01559129|542050408|FG000|Open-label Extension Period|Adverse Event|1|||
150249978|NCT01559129|542050409|FG001|Open-label Extension Period|Adverse Event|0|||
150249979|NCT01559129|542050408|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
150249980|NCT01559129|542050409|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
150249981|NCT03525392|542050410|FG000|Overall Study|Adverse Event|1|||
150249982|NCT03525392|542050411|FG001|Overall Study|Adverse Event|0|||
150249983|NCT03525392|542050412|FG002|Overall Study|Adverse Event|2|||
150249984|NCT03525392|542050413|FG003|Overall Study|Adverse Event|0|||
150249985|NCT03525392|542050414|FG004|Overall Study|Adverse Event|0|||
150249986|NCT03525392|542050410|FG000|Overall Study|Progressive disease|0|||
150249987|NCT03525392|542050411|FG001|Overall Study|Progressive disease|1|||
150249988|NCT03525392|542050412|FG002|Overall Study|Progressive disease|1|||
150249989|NCT03525392|542050413|FG003|Overall Study|Progressive disease|3|||
150249990|NCT03525392|542050414|FG004|Overall Study|Progressive disease|1|||
150249991|NCT00831129|542050417|FG000|Overall Study|Adverse Event|0|||
150249992|NCT00831129|542050418|FG001|Overall Study|Adverse Event|1|||
150249993|NCT00831129|542050417|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
150249994|NCT00831129|542050418|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
150249995|NCT03291288|542050422|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
150249996|NCT03291288|542050423|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
150249997|NCT03291288|542050422|FG000|Drug-drug Interaction Phase|Disease progression|1|||
150249998|NCT03291288|542050423|FG001|Drug-drug Interaction Phase|Disease progression|0|||
150249999|NCT03291288|542050422|FG000|Drug-drug Interaction Phase|Other|3|||
150250000|NCT03291288|542050423|FG001|Drug-drug Interaction Phase|Other|0|||
150250001|NCT03291288|542050422|FG000|Pexidartinib Only|Ongoing|0|||
150250002|NCT03291288|542050423|FG001|Pexidartinib Only|Ongoing|2|||
150250003|NCT04276415|542050424|FG000|Overall Study|Adverse Event|0|||
150250004|NCT04276415|542050425|FG001|Overall Study|Adverse Event|0|||
150250005|NCT04276415|542050426|FG002|Overall Study|Adverse Event|0|||
150250006|NCT04276415|542050427|FG003|Overall Study|Adverse Event|3|||
150250007|NCT04276415|542050428|FG004|Overall Study|Adverse Event|0|||
150250008|NCT04276415|542050429|FG005|Overall Study|Adverse Event|0|||
150250009|NCT04276415|542050424|FG000|Overall Study|Clinical progression|1|||
150250010|NCT04276415|542050425|FG001|Overall Study|Clinical progression|1|||
150250011|NCT04276415|542050426|FG002|Overall Study|Clinical progression|0|||
150250012|NCT04276415|542050427|FG003|Overall Study|Clinical progression|0|||
150250013|NCT04276415|542050428|FG004|Overall Study|Clinical progression|1|||
150250014|NCT04276415|542050429|FG005|Overall Study|Clinical progression|0|||
150250015|NCT04276415|542050424|FG000|Overall Study|Other|0|||
150250016|NCT04276415|542050425|FG001|Overall Study|Other|0|||
150250017|NCT04276415|542050426|FG002|Overall Study|Other|0|||
150250018|NCT04276415|542050427|FG003|Overall Study|Other|1|||
150250019|NCT04276415|542050428|FG004|Overall Study|Other|0|||
150250020|NCT04276415|542050429|FG005|Overall Study|Other|0|||
150250021|NCT04276415|542050424|FG000|Overall Study|Physician Decision|0|||
150250022|NCT04276415|542050425|FG001|Overall Study|Physician Decision|0|||
150250023|NCT04276415|542050426|FG002|Overall Study|Physician Decision|1|||
150250024|NCT04276415|542050427|FG003|Overall Study|Physician Decision|3|||
150250025|NCT04276415|542050428|FG004|Overall Study|Physician Decision|2|||
150250026|NCT04276415|542050429|FG005|Overall Study|Physician Decision|0|||
150250027|NCT04276415|542050424|FG000|Overall Study|Progressive disease|3|||
150250028|NCT04276415|542050425|FG001|Overall Study|Progressive disease|3|||
150250029|NCT04276415|542050426|FG002|Overall Study|Progressive disease|4|||
150250030|NCT04276415|542050427|FG003|Overall Study|Progressive disease|5|||
150250031|NCT04276415|542050428|FG004|Overall Study|Progressive disease|1|||
150250032|NCT04276415|542050429|FG005|Overall Study|Progressive disease|2|||
150250033|NCT04276415|542050424|FG000|Overall Study|Withdrawal by patient|0|||
150250034|NCT04276415|542050425|FG001|Overall Study|Withdrawal by patient|0|||
150250035|NCT04276415|542050426|FG002|Overall Study|Withdrawal by patient|0|||
150250036|NCT04276415|542050427|FG003|Overall Study|Withdrawal by patient|1|||
150250037|NCT04276415|542050428|FG004|Overall Study|Withdrawal by patient|2|||
150250038|NCT04276415|542050429|FG005|Overall Study|Withdrawal by patient|0|||
150250039|NCT00208325|542050430|FG000|Overall Study|Death|18|||
150250040|NCT00208325|542050431|FG001|Overall Study|Death|19|||
150250041|NCT00208325|542050432|FG002|Overall Study|Death|7|||
150250042|NCT00208325|542050433|FG003|Overall Study|Death|5|||
150250043|NCT00208325|542050430|FG000|Overall Study|Withdrawal by Subject|0|||
150250044|NCT00208325|542050431|FG001|Overall Study|Withdrawal by Subject|1|||
150250045|NCT00208325|542050432|FG002|Overall Study|Withdrawal by Subject|0|||
150250046|NCT00208325|542050433|FG003|Overall Study|Withdrawal by Subject|0|||
150250047|NCT00208325|542050430|FG000|Overall Study|Revision|4|||
150250048|NCT00208325|542050431|FG001|Overall Study|Revision|1|||
150250049|NCT00208325|542050432|FG002|Overall Study|Revision|0|||
150250050|NCT00208325|542050433|FG003|Overall Study|Revision|4|||
150250051|NCT00208325|542050430|FG000|Overall Study|Lost to Follow-up|1|||
150250052|NCT00208325|542050431|FG001|Overall Study|Lost to Follow-up|0|||
150250053|NCT00208325|542050432|FG002|Overall Study|Lost to Follow-up|2|||
150250054|NCT00208325|542050433|FG003|Overall Study|Lost to Follow-up|0|||
150250055|NCT00208325|542050430|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
150250056|NCT00208325|542050431|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
150250057|NCT00208325|542050432|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
150250058|NCT00208325|542050433|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
150250059|NCT00208325|542050430|FG000|Overall Study|Does not wish to Continue in Study|5|||
150250060|NCT00208325|542050431|FG001|Overall Study|Does not wish to Continue in Study|8|||
150250061|NCT00208325|542050432|FG002|Overall Study|Does not wish to Continue in Study|3|||
150250062|NCT00208325|542050433|FG003|Overall Study|Does not wish to Continue in Study|2|||
150250063|NCT00208325|542050430|FG000|Overall Study|Other|2|||
150250064|NCT00208325|542050431|FG001|Overall Study|Other|1|||
150250065|NCT00208325|542050432|FG002|Overall Study|Other|1|||
150250066|NCT00208325|542050433|FG003|Overall Study|Other|0|||
150250067|NCT00208325|542050430|FG000|Overall Study|Mis-Randomized|17|||
150250068|NCT00208325|542050431|FG001|Overall Study|Mis-Randomized|20|||
150250069|NCT00208325|542050432|FG002|Overall Study|Mis-Randomized|0|||
150250070|NCT00208325|542050433|FG003|Overall Study|Mis-Randomized|0|||
150250071|NCT02145468|542050434|FG000|Overall Study|Withdrawal by Subject|5|||
150250072|NCT02145468|542050435|FG001|Overall Study|Withdrawal by Subject|8|||
150250073|NCT00586612|542050436|FG000|Primary Phase|Protocol Violation|1|||
150250074|NCT00586612|542050437|FG001|Primary Phase|Protocol Violation|0|||
150250075|NCT00586612|542050436|FG000|Primary Phase|Lost to Follow-up|0|||
150250076|NCT00586612|542050437|FG001|Primary Phase|Lost to Follow-up|1|||
150250077|NCT00586612|542050436|FG000|Primary Phase|Withdrawal by Subject|0|||
150250078|NCT00586612|542050437|FG001|Primary Phase|Withdrawal by Subject|2|||
150250079|NCT00586612|542050436|FG000|Booster Phase|Lost to Follow-up|3|||
150250080|NCT00586612|542050437|FG001|Booster Phase|Lost to Follow-up|1|||
150250081|NCT00623805|542050442|FG000|Overall Study|Adverse Event|9|||
150250082|NCT00623805|542050443|FG001|Overall Study|Adverse Event|6|||
150250083|NCT00623805|542050442|FG000|Overall Study|Death|2|||
150250084|NCT00623805|542050443|FG001|Overall Study|Death|0|||
150250085|NCT00623805|542050442|FG000|Overall Study|Lack of Efficacy|3|||
150250086|NCT00623805|542050443|FG001|Overall Study|Lack of Efficacy|7|||
150250087|NCT00623805|542050442|FG000|Overall Study|Lost to Follow-up|2|||
150250088|NCT00623805|542050443|FG001|Overall Study|Lost to Follow-up|2|||
150250089|NCT00623805|542050442|FG000|Overall Study|Protocol Violation|1|||
150250090|NCT00623805|542050443|FG001|Overall Study|Protocol Violation|1|||
150250091|NCT00623805|542050442|FG000|Overall Study|Reason not Specified|3|||
150250092|NCT00623805|542050443|FG001|Overall Study|Reason not Specified|6|||
150250093|NCT02906007|542050446|FG000|Overall Study|Physician Decision|0|||
150250094|NCT02906007|542050447|FG001|Overall Study|Physician Decision|0|||
150250095|NCT02906007|542050448|FG002|Overall Study|Physician Decision|1|||
150250096|NCT02906007|542050446|FG000|Overall Study|Died|1|||
150250097|NCT02906007|542050447|FG001|Overall Study|Died|0|||
150250098|NCT02906007|542050448|FG002|Overall Study|Died|0|||
150250099|NCT03520712|542050449|FG000|Overall Study|Early termination of the study by Sponsor|2|||
150250100|NCT04531982|542050452|FG000|Overall Study|Withdrawal by Subject|10|||
150250101|NCT04531982|542050453|FG001|Overall Study|Withdrawal by Subject|11|||
150250102|NCT04531982|542050452|FG000|Overall Study|Adverse Event|6|||
150250103|NCT04531982|542050453|FG001|Overall Study|Adverse Event|14|||
150250104|NCT04531982|542050452|FG000|Overall Study|Protocol Violation|6|||
150250105|NCT04531982|542050453|FG001|Overall Study|Protocol Violation|9|||
150250106|NCT04531982|542050452|FG000|Overall Study|Non-compliance with study drug|3|||
150250107|NCT04531982|542050453|FG001|Overall Study|Non-compliance with study drug|2|||
150250108|NCT04531982|542050452|FG000|Overall Study|Use of prohibited medication|2|||
150250109|NCT04531982|542050453|FG001|Overall Study|Use of prohibited medication|0|||
150250110|NCT04531982|542050452|FG000|Overall Study|Lost to Follow-up|0|||
150250111|NCT04531982|542050453|FG001|Overall Study|Lost to Follow-up|1|||
150250112|NCT04531982|542050452|FG000|Overall Study|Geopolitical conflict|2|||
150250113|NCT04531982|542050453|FG001|Overall Study|Geopolitical conflict|0|||
150250114|NCT04531982|542050452|FG000|Overall Study|Lack of Efficacy|3|||
150250115|NCT04531982|542050453|FG001|Overall Study|Lack of Efficacy|1|||
150250116|NCT06655558|542050454|FG000|Overall Study|Protocol Violation|1|||
150250117|NCT02344290|542050462|FG000|Overall Study|Withdrawal by Subject|315|||
150250118|NCT02344290|542050463|FG001|Overall Study|Withdrawal by Subject|324|||
150250119|NCT02344290|542050462|FG000|Overall Study|Lost to Follow-up|258|||
150250120|NCT02344290|542050463|FG001|Overall Study|Lost to Follow-up|249|||
150250121|NCT02344290|542050462|FG000|Overall Study|Unable to get to clinic|69|||
150250122|NCT02344290|542050463|FG001|Overall Study|Unable to get to clinic|60|||
150250123|NCT02344290|542050462|FG000|Overall Study|Physician Decision|25|||
150250124|NCT02344290|542050463|FG001|Overall Study|Physician Decision|25|||
150250125|NCT02344290|542050462|FG000|Overall Study|Site Closure|15|||
150250126|NCT02344290|542050463|FG001|Overall Study|Site Closure|19|||
150250127|NCT02344290|542050462|FG000|Overall Study|Other|5|||
150250128|NCT02344290|542050463|FG001|Overall Study|Other|3|||
150250129|NCT04998812|542050464|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
150250130|NCT04998812|542050465|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
150250131|NCT04998812|542050464|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
150250132|NCT04998812|542050465|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
150250133|NCT04998812|542050464|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
150250134|NCT04998812|542050465|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
150250135|NCT04998812|542050464|FG000|Vaccination Period|Ongoing in study|23|||
150250136|NCT04998812|542050465|FG001|Vaccination Period|Ongoing in study|23|||
150250137|NCT04893460|542050467|FG000|Overall Study|Lost to Follow-up|18|||
150250138|NCT03578887|542050469|FG000|Overall Study|Withdrawal by Subject|7|||
150250139|NCT03578887|542050470|FG001|Overall Study|Withdrawal by Subject|2|||
150250140|NCT03578887|542050471|FG002|Overall Study|Withdrawal by Subject|1|||
150250141|NCT03578887|542050469|FG000|Overall Study|Lost to Follow-up|13|||
150250142|NCT03578887|542050470|FG001|Overall Study|Lost to Follow-up|1|||
150250143|NCT03578887|542050471|FG002|Overall Study|Lost to Follow-up|4|||
150250144|NCT03578887|542050469|FG000|Overall Study|Physician Decision|0|||
150250145|NCT03578887|542050470|FG001|Overall Study|Physician Decision|1|||
150250146|NCT03578887|542050471|FG002|Overall Study|Physician Decision|1|||
150250147|NCT04500769|542052167|FG000|Overall Study|Withdrawal by Subject|5|||
150250148|NCT00568178|542052168|FG000|Double Blind Base Study|Adverse Event|0|||
150250149|NCT00568178|542052169|FG001|Double Blind Base Study|Adverse Event|2|||
150250150|NCT00568178|542052170|FG002|Double Blind Base Study|Adverse Event|1|||
150250151|NCT00568178|542052171|FG003|Double Blind Base Study|Adverse Event|2|||
150250152|NCT00568178|542052172|FG004|Double Blind Base Study|Adverse Event|0|||
150250153|NCT00568178|542052173|FG005|Double Blind Base Study|Adverse Event|0|||
150250154|NCT00568178|542052168|FG000|Double Blind Base Study|Lost to Follow-up|1|||
150250155|NCT00568178|542052169|FG001|Double Blind Base Study|Lost to Follow-up|0|||
150250156|NCT00568178|542052170|FG002|Double Blind Base Study|Lost to Follow-up|0|||
150250157|NCT00568178|542052171|FG003|Double Blind Base Study|Lost to Follow-up|1|||
150250158|NCT00568178|542052172|FG004|Double Blind Base Study|Lost to Follow-up|0|||
150250159|NCT00568178|542052173|FG005|Double Blind Base Study|Lost to Follow-up|0|||
150250160|NCT00568178|542052168|FG000|Double Blind Base Study|Physician Decision|1|||
150250161|NCT00568178|542052169|FG001|Double Blind Base Study|Physician Decision|1|||
150250162|NCT00568178|542052170|FG002|Double Blind Base Study|Physician Decision|0|||
150250163|NCT00568178|542052171|FG003|Double Blind Base Study|Physician Decision|1|||
150250164|NCT00568178|542052172|FG004|Double Blind Base Study|Physician Decision|0|||
150250165|NCT00568178|542052173|FG005|Double Blind Base Study|Physician Decision|0|||
150250166|NCT00568178|542052168|FG000|Double Blind Base Study|Protocol Violation|3|||
150250167|NCT00568178|542052169|FG001|Double Blind Base Study|Protocol Violation|2|||
150250168|NCT00568178|542052170|FG002|Double Blind Base Study|Protocol Violation|0|||
150250169|NCT00568178|542052171|FG003|Double Blind Base Study|Protocol Violation|0|||
150250170|NCT00568178|542052172|FG004|Double Blind Base Study|Protocol Violation|0|||
150250171|NCT00568178|542052173|FG005|Double Blind Base Study|Protocol Violation|0|||
150250172|NCT00568178|542052168|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
150250173|NCT00568178|542052169|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
150250174|NCT00568178|542052170|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
150250175|NCT00568178|542052171|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
150250176|NCT00568178|542052172|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
150250177|NCT00568178|542052173|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
150250178|NCT00568178|542052168|FG000|Double Blind Base Study|Progressive Disease|0|||
150250179|NCT00568178|542052169|FG001|Double Blind Base Study|Progressive Disease|0|||
150250180|NCT00568178|542052170|FG002|Double Blind Base Study|Progressive Disease|0|||
150250181|NCT00568178|542052171|FG003|Double Blind Base Study|Progressive Disease|1|||
150250182|NCT00568178|542052172|FG004|Double Blind Base Study|Progressive Disease|0|||
150250183|NCT00568178|542052173|FG005|Double Blind Base Study|Progressive Disease|0|||
150250184|NCT00568178|542052168|FG000|Open Label Extension|Adverse Event|0|||
150250185|NCT00568178|542052169|FG001|Open Label Extension|Adverse Event|0|||
150250186|NCT00568178|542052170|FG002|Open Label Extension|Adverse Event|0|||
150250187|NCT00568178|542052171|FG003|Open Label Extension|Adverse Event|0|||
150250188|NCT00568178|542052172|FG004|Open Label Extension|Adverse Event|11|||
150250189|NCT00568178|542052173|FG005|Open Label Extension|Adverse Event|8|||
150250190|NCT00568178|542052168|FG000|Open Label Extension|Protocol Violation|0|||
150250191|NCT00568178|542052169|FG001|Open Label Extension|Protocol Violation|0|||
150250192|NCT00568178|542052170|FG002|Open Label Extension|Protocol Violation|0|||
150250193|NCT00568178|542052171|FG003|Open Label Extension|Protocol Violation|0|||
150250194|NCT00568178|542052172|FG004|Open Label Extension|Protocol Violation|1|||
150250195|NCT00568178|542052173|FG005|Open Label Extension|Protocol Violation|0|||
150250196|NCT00568178|542052168|FG000|Open Label Extension|Lost to Follow-up|0|||
150250197|NCT00568178|542052169|FG001|Open Label Extension|Lost to Follow-up|0|||
150250198|NCT00568178|542052170|FG002|Open Label Extension|Lost to Follow-up|0|||
150250199|NCT00568178|542052171|FG003|Open Label Extension|Lost to Follow-up|0|||
150250200|NCT00568178|542052172|FG004|Open Label Extension|Lost to Follow-up|6|||
150250201|NCT00568178|542052173|FG005|Open Label Extension|Lost to Follow-up|11|||
150250202|NCT00568178|542052168|FG000|Open Label Extension|Physician Decision|0|||
150250203|NCT00568178|542052169|FG001|Open Label Extension|Physician Decision|0|||
150250204|NCT00568178|542052170|FG002|Open Label Extension|Physician Decision|0|||
150250205|NCT00568178|542052171|FG003|Open Label Extension|Physician Decision|0|||
150250206|NCT00568178|542052172|FG004|Open Label Extension|Physician Decision|9|||
150250207|NCT00568178|542052173|FG005|Open Label Extension|Physician Decision|8|||
150250208|NCT00568178|542052168|FG000|Open Label Extension|Pregnancy|0|||
150250209|NCT00568178|542052169|FG001|Open Label Extension|Pregnancy|0|||
150250210|NCT00568178|542052170|FG002|Open Label Extension|Pregnancy|0|||
150250211|NCT00568178|542052171|FG003|Open Label Extension|Pregnancy|0|||
150250212|NCT00568178|542052172|FG004|Open Label Extension|Pregnancy|0|||
150250213|NCT00568178|542052173|FG005|Open Label Extension|Pregnancy|1|||
150250214|NCT00568178|542052168|FG000|Open Label Extension|Progressive Disease|0|||
150250215|NCT00568178|542052169|FG001|Open Label Extension|Progressive Disease|0|||
150250216|NCT00568178|542052170|FG002|Open Label Extension|Progressive Disease|0|||
150250217|NCT00568178|542052171|FG003|Open Label Extension|Progressive Disease|0|||
150250218|NCT00568178|542052172|FG004|Open Label Extension|Progressive Disease|3|||
150250219|NCT00568178|542052173|FG005|Open Label Extension|Progressive Disease|1|||
150250220|NCT00568178|542052168|FG000|Open Label Extension|Termination of Trial|0|||
150250221|NCT00568178|542052169|FG001|Open Label Extension|Termination of Trial|0|||
150250222|NCT00568178|542052170|FG002|Open Label Extension|Termination of Trial|0|||
150250223|NCT00568178|542052171|FG003|Open Label Extension|Termination of Trial|0|||
150250224|NCT00568178|542052172|FG004|Open Label Extension|Termination of Trial|45|||
150250225|NCT00568178|542052173|FG005|Open Label Extension|Termination of Trial|47|||
150250226|NCT00568178|542052168|FG000|Open Label Extension|Withdrawal by Subject|0|||
150250227|NCT00568178|542052169|FG001|Open Label Extension|Withdrawal by Subject|0|||
150250228|NCT00568178|542052170|FG002|Open Label Extension|Withdrawal by Subject|0|||
150250229|NCT00568178|542052171|FG003|Open Label Extension|Withdrawal by Subject|0|||
150250230|NCT00568178|542052172|FG004|Open Label Extension|Withdrawal by Subject|4|||
150250231|NCT00568178|542052173|FG005|Open Label Extension|Withdrawal by Subject|4|||
150250232|NCT01332630|542052174|FG000|Overall Study|Withdrawal by Subject|3|||
150250233|NCT01008410|542052176|FG000|Overall Study|Adverse Event|13|||
150250234|NCT01008410|542052177|FG001|Overall Study|Adverse Event|7|||
150250235|NCT01008410|542052176|FG000|Overall Study|Withdrawal by Subject|6|||
150250236|NCT01008410|542052177|FG001|Overall Study|Withdrawal by Subject|2|||
150250237|NCT01008410|542052176|FG000|Overall Study|Lost to Follow-up|1|||
150250238|NCT01008410|542052177|FG001|Overall Study|Lost to Follow-up|0|||
150250239|NCT01008410|542052176|FG000|Overall Study|Noncompliance|1|||
150250240|NCT01008410|542052177|FG001|Overall Study|Noncompliance|0|||
150250241|NCT01008410|542052176|FG000|Overall Study|Low Cortisol|2|||
150250242|NCT01008410|542052177|FG001|Overall Study|Low Cortisol|0|||
150250243|NCT01008410|542052176|FG000|Overall Study|Lack of Efficacy|2|||
150250244|NCT01008410|542052177|FG001|Overall Study|Lack of Efficacy|6|||
150250245|NCT01008410|542052176|FG000|Overall Study|Met Exclusion Criterion|0|||
150250246|NCT01008410|542052177|FG001|Overall Study|Met Exclusion Criterion|1|||
150250247|NCT02787044|542052184|FG000|Overall Study|Lost to Follow-up|15|||
150250248|NCT02787044|542052185|FG001|Overall Study|Lost to Follow-up|19|||
150250249|NCT03889704|542052186|FG000|Overall Study|Study terminated due to pandemic|1|||
150250250|NCT02591953|542052187|FG000|Overall Study|Lost to Follow-up|6|||
150250251|NCT02591953|542052188|FG001|Overall Study|Lost to Follow-up|6|||
150250252|NCT01517295|542052189|FG000|Overall Study|Physician Decision|1|||
150250253|NCT01517295|542052190|FG001|Overall Study|Physician Decision|0|||
150250254|NCT02672852|542052191|FG000|Part A1|Disease Worsening|1|||
150250255|NCT02672852|542052192|FG001|Part A1|Disease Worsening|0|||
150250256|NCT02672852|542052193|FG002|Part A1|Disease Worsening|0|||
150250257|NCT02672852|542052194|FG003|Part A1|Disease Worsening|0|||
150250258|NCT02672852|542052195|FG004|Part A1|Disease Worsening|0|||
150250259|NCT02672852|542052196|FG005|Part A1|Disease Worsening|0|||
150250260|NCT02672852|542052197|FG006|Part A1|Disease Worsening|0|||
150250261|NCT02672852|542052191|FG000|Part A1|Adverse Event|0|||
150250262|NCT02672852|542052192|FG001|Part A1|Adverse Event|1|||
150250263|NCT02672852|542052193|FG002|Part A1|Adverse Event|0|||
150250264|NCT02672852|542052194|FG003|Part A1|Adverse Event|0|||
150250265|NCT02672852|542052195|FG004|Part A1|Adverse Event|0|||
150250266|NCT02672852|542052196|FG005|Part A1|Adverse Event|0|||
150250267|NCT02672852|542052197|FG006|Part A1|Adverse Event|0|||
150250268|NCT02672852|542052191|FG000|Part A1|Lost to Follow-up|1|||
150250269|NCT02672852|542052192|FG001|Part A1|Lost to Follow-up|2|||
150250270|NCT02672852|542052193|FG002|Part A1|Lost to Follow-up|0|||
150250271|NCT02672852|542052194|FG003|Part A1|Lost to Follow-up|0|||
150250272|NCT02672852|542052195|FG004|Part A1|Lost to Follow-up|0|||
150250273|NCT02672852|542052196|FG005|Part A1|Lost to Follow-up|0|||
150250274|NCT02672852|542052197|FG006|Part A1|Lost to Follow-up|0|||
150250275|NCT02672852|542052191|FG000|Part A1|Withdrawal by Subject|1|||
150250276|NCT02672852|542052192|FG001|Part A1|Withdrawal by Subject|1|||
150250277|NCT02672852|542052193|FG002|Part A1|Withdrawal by Subject|0|||
150250278|NCT02672852|542052194|FG003|Part A1|Withdrawal by Subject|0|||
150250279|NCT02672852|542052195|FG004|Part A1|Withdrawal by Subject|0|||
150250280|NCT02672852|542052196|FG005|Part A1|Withdrawal by Subject|0|||
150250281|NCT02672852|542052197|FG006|Part A1|Withdrawal by Subject|0|||
150250282|NCT02672852|542052191|FG000|Part A2|Disease worsening|0|||
150250283|NCT02672852|542052192|FG001|Part A2|Disease worsening|0|||
150250284|NCT02672852|542052193|FG002|Part A2|Disease worsening|1|||
150250285|NCT02672852|542052194|FG003|Part A2|Disease worsening|0|||
150250286|NCT02672852|542052195|FG004|Part A2|Disease worsening|0|||
150250287|NCT02672852|542052196|FG005|Part A2|Disease worsening|0|||
150250288|NCT02672852|542052197|FG006|Part A2|Disease worsening|0|||
150250289|NCT02672852|542052191|FG000|Part A2|Adverse Event|0|||
150250290|NCT02672852|542052192|FG001|Part A2|Adverse Event|0|||
150250291|NCT02672852|542052193|FG002|Part A2|Adverse Event|3|||
150250292|NCT02672852|542052194|FG003|Part A2|Adverse Event|0|||
150250293|NCT02672852|542052195|FG004|Part A2|Adverse Event|0|||
150250294|NCT02672852|542052196|FG005|Part A2|Adverse Event|0|||
150250295|NCT02672852|542052197|FG006|Part A2|Adverse Event|0|||
150250296|NCT02672852|542052191|FG000|Part A2|Lost to Follow-up|0|||
150250297|NCT02672852|542052192|FG001|Part A2|Lost to Follow-up|0|||
150250298|NCT02672852|542052193|FG002|Part A2|Lost to Follow-up|2|||
150250299|NCT02672852|542052194|FG003|Part A2|Lost to Follow-up|0|||
150250300|NCT02672852|542052195|FG004|Part A2|Lost to Follow-up|0|||
150250301|NCT02672852|542052196|FG005|Part A2|Lost to Follow-up|0|||
150250302|NCT02672852|542052197|FG006|Part A2|Lost to Follow-up|0|||
150250303|NCT02672852|542052191|FG000|Part A2|Withdrawal by Subject|0|||
150250304|NCT02672852|542052192|FG001|Part A2|Withdrawal by Subject|0|||
150250305|NCT02672852|542052193|FG002|Part A2|Withdrawal by Subject|1|||
150250306|NCT02672852|542052194|FG003|Part A2|Withdrawal by Subject|0|||
150250307|NCT02672852|542052195|FG004|Part A2|Withdrawal by Subject|0|||
150250308|NCT02672852|542052196|FG005|Part A2|Withdrawal by Subject|0|||
150250309|NCT02672852|542052197|FG006|Part A2|Withdrawal by Subject|0|||
150250310|NCT02672852|542052191|FG000|Part A2|Other|0|||
150250311|NCT02672852|542052192|FG001|Part A2|Other|0|||
150250312|NCT02672852|542052193|FG002|Part A2|Other|3|||
150250313|NCT02672852|542052194|FG003|Part A2|Other|0|||
150250314|NCT02672852|542052195|FG004|Part A2|Other|0|||
150250315|NCT02672852|542052196|FG005|Part A2|Other|0|||
150250316|NCT02672852|542052197|FG006|Part A2|Other|0|||
150250317|NCT02672852|542052191|FG000|Part A2|Not entered in Part B|0|||
150250318|NCT02672852|542052192|FG001|Part A2|Not entered in Part B|0|||
150250319|NCT02672852|542052193|FG002|Part A2|Not entered in Part B|0|||
150250320|NCT02672852|542052194|FG003|Part A2|Not entered in Part B|4|||
150250321|NCT02672852|542052195|FG004|Part A2|Not entered in Part B|0|||
150250322|NCT02672852|542052196|FG005|Part A2|Not entered in Part B|0|||
150250323|NCT02672852|542052197|FG006|Part A2|Not entered in Part B|0|||
150250324|NCT02672852|542052191|FG000|Part B|Disease worsening|0|||
150250325|NCT02672852|542052192|FG001|Part B|Disease worsening|0|||
150250326|NCT02672852|542052193|FG002|Part B|Disease worsening|0|||
150250327|NCT02672852|542052194|FG003|Part B|Disease worsening|0|||
150250328|NCT02672852|542052195|FG004|Part B|Disease worsening|1|||
150250329|NCT02672852|542052196|FG005|Part B|Disease worsening|0|||
150250330|NCT02672852|542052197|FG006|Part B|Disease worsening|1|||
150250331|NCT02672852|542052191|FG000|Part B|Worsening pre-existing condition|0|||
150250332|NCT02672852|542052192|FG001|Part B|Worsening pre-existing condition|0|||
150250333|NCT02672852|542052193|FG002|Part B|Worsening pre-existing condition|0|||
150250334|NCT02672852|542052194|FG003|Part B|Worsening pre-existing condition|0|||
150250335|NCT02672852|542052195|FG004|Part B|Worsening pre-existing condition|0|||
150250336|NCT02672852|542052196|FG005|Part B|Worsening pre-existing condition|1|||
150250337|NCT02672852|542052197|FG006|Part B|Worsening pre-existing condition|0|||
150250338|NCT02672852|542052191|FG000|Part B|Other adverse event|0|||
150250339|NCT02672852|542052192|FG001|Part B|Other adverse event|0|||
150250340|NCT02672852|542052193|FG002|Part B|Other adverse event|0|||
150250341|NCT02672852|542052194|FG003|Part B|Other adverse event|0|||
150250342|NCT02672852|542052195|FG004|Part B|Other adverse event|3|||
150250343|NCT02672852|542052196|FG005|Part B|Other adverse event|5|||
150250344|NCT02672852|542052197|FG006|Part B|Other adverse event|1|||
150250345|NCT02672852|542052191|FG000|Part B|Lost to Follow-up|0|||
150250346|NCT02672852|542052192|FG001|Part B|Lost to Follow-up|0|||
150250347|NCT02672852|542052193|FG002|Part B|Lost to Follow-up|0|||
150250348|NCT02672852|542052194|FG003|Part B|Lost to Follow-up|0|||
150250349|NCT02672852|542052195|FG004|Part B|Lost to Follow-up|3|||
150250350|NCT02672852|542052196|FG005|Part B|Lost to Follow-up|4|||
150250351|NCT02672852|542052197|FG006|Part B|Lost to Follow-up|1|||
150250352|NCT02672852|542052191|FG000|Part B|Withdrawal by Subject|0|||
150250353|NCT02672852|542052192|FG001|Part B|Withdrawal by Subject|0|||
150250354|NCT02672852|542052193|FG002|Part B|Withdrawal by Subject|0|||
150250355|NCT02672852|542052194|FG003|Part B|Withdrawal by Subject|0|||
150250356|NCT02672852|542052195|FG004|Part B|Withdrawal by Subject|5|||
150250357|NCT02672852|542052196|FG005|Part B|Withdrawal by Subject|0|||
150250358|NCT02672852|542052197|FG006|Part B|Withdrawal by Subject|7|||
150250359|NCT02672852|542052191|FG000|Part B|Other|0|||
150250360|NCT02672852|542052192|FG001|Part B|Other|0|||
150250361|NCT02672852|542052193|FG002|Part B|Other|0|||
150250362|NCT02672852|542052194|FG003|Part B|Other|0|||
150250363|NCT02672852|542052195|FG004|Part B|Other|4|||
150250364|NCT02672852|542052196|FG005|Part B|Other|1|||
150250365|NCT02672852|542052197|FG006|Part B|Other|2|||
150250366|NCT03248882|542052198|FG000|Overall Study|Adverse Event|3|||
150250367|NCT03248882|542052199|FG001|Overall Study|Adverse Event|3|||
150250368|NCT03248882|542052200|FG002|Overall Study|Adverse Event|2|||
150250369|NCT03248882|542052201|FG003|Overall Study|Adverse Event|6|||
150250370|NCT03248882|542052202|FG004|Overall Study|Adverse Event|9|||
150250371|NCT03248882|542052198|FG000|Overall Study|Lost to Follow-up|0|||
150250372|NCT03248882|542052199|FG001|Overall Study|Lost to Follow-up|0|||
150250373|NCT03248882|542052200|FG002|Overall Study|Lost to Follow-up|0|||
150250374|NCT03248882|542052201|FG003|Overall Study|Lost to Follow-up|0|||
150250375|NCT03248882|542052202|FG004|Overall Study|Lost to Follow-up|1|||
150250376|NCT03248882|542052198|FG000|Overall Study|Protocol Violation|2|||
150250377|NCT03248882|542052199|FG001|Overall Study|Protocol Violation|0|||
150250378|NCT03248882|542052200|FG002|Overall Study|Protocol Violation|2|||
150250379|NCT03248882|542052201|FG003|Overall Study|Protocol Violation|0|||
150250380|NCT03248882|542052202|FG004|Overall Study|Protocol Violation|1|||
150250381|NCT03248882|542052198|FG000|Overall Study|Withdrawal by Subject|2|||
150250382|NCT03248882|542052199|FG001|Overall Study|Withdrawal by Subject|2|||
150250383|NCT03248882|542052200|FG002|Overall Study|Withdrawal by Subject|3|||
150250384|NCT03248882|542052201|FG003|Overall Study|Withdrawal by Subject|4|||
150250385|NCT03248882|542052202|FG004|Overall Study|Withdrawal by Subject|2|||
150250386|NCT04308590|542052203|FG000|Overall Study|Adverse Event|12|||
150250387|NCT04308590|542052204|FG001|Overall Study|Adverse Event|2|||
150250388|NCT04308590|542052203|FG000|Overall Study|Withdrawal by Subject|10|||
150250389|NCT04308590|542052204|FG001|Overall Study|Withdrawal by Subject|4|||
150250390|NCT04308590|542052203|FG000|Overall Study|Death|1|||
150250391|NCT04308590|542052204|FG001|Overall Study|Death|0|||
150250392|NCT04308590|542052203|FG000|Overall Study|Lost to Follow-up|1|||
150250393|NCT04308590|542052204|FG001|Overall Study|Lost to Follow-up|1|||
150250394|NCT04308590|542052203|FG000|Overall Study|Physician Decision|1|||
150250395|NCT04308590|542052204|FG001|Overall Study|Physician Decision|0|||
150250396|NCT04308590|542052203|FG000|Overall Study|Subject does not want to continue with Pi|0|||
150250397|NCT04308590|542052204|FG001|Overall Study|Subject does not want to continue with Pi|1|||
150250398|NCT01156376|542052206|FG000|Overall Study|Adverse Event|1|||
150250399|NCT01156376|542052207|FG001|Overall Study|Adverse Event|0|||
150250400|NCT01156376|542052208|FG002|Overall Study|Adverse Event|1|||
150250401|NCT01156376|542052206|FG000|Overall Study|Withdrawal by Subject|0|||
150250402|NCT01156376|542052207|FG001|Overall Study|Withdrawal by Subject|0|||
150250403|NCT01156376|542052208|FG002|Overall Study|Withdrawal by Subject|3|||
150250404|NCT01493427|542052209|FG000|Overall Study|Adverse Event|10|||
150250405|NCT01493427|542052209|FG000|Overall Study|Personal Reasons|4|||
150250406|NCT01493427|542052209|FG000|Overall Study|Lost to Follow-up|2|||
150250407|NCT01493427|542052209|FG000|Overall Study|Inability to Follow Instructions|2|||
150250408|NCT01493427|542052209|FG000|Overall Study|Other|2|||
150250409|NCT00565773|542052210|FG000|Overall Study|Withdrawal by Subject|1|||
150250410|NCT00565773|542052210|FG000|Overall Study|Physician Decision|1|||
150250411|NCT01725126|542052211|FG000|Overall Study|Protocol Violation|0|||
150250412|NCT01725126|542052212|FG001|Overall Study|Protocol Violation|1|||
150250413|NCT01725126|542052213|FG002|Overall Study|Protocol Violation|0|||
150250414|NCT01725126|542052214|FG003|Overall Study|Protocol Violation|0|||
150250415|NCT01725126|542052215|FG004|Overall Study|Protocol Violation|0|||
150250416|NCT01725126|542052216|FG005|Overall Study|Protocol Violation|0|||
150250417|NCT01725126|542052211|FG000|Overall Study|Withdrawal by Subject|0|||
150250418|NCT01725126|542052212|FG001|Overall Study|Withdrawal by Subject|0|||
150250419|NCT01725126|542052213|FG002|Overall Study|Withdrawal by Subject|0|||
150250420|NCT01725126|542052214|FG003|Overall Study|Withdrawal by Subject|1|||
150250421|NCT01725126|542052215|FG004|Overall Study|Withdrawal by Subject|0|||
150250422|NCT01725126|542052216|FG005|Overall Study|Withdrawal by Subject|0|||
150250423|NCT01075958|542052219|FG000|Overall Study|Blood sample could not be obtained|44|||
150250424|NCT02781090|542052224|FG000|3-Month Follow-Up|Missed Visit|20|||
150250425|NCT02781090|542052225|FG001|3-Month Follow-Up|Missed Visit|20|||
150250426|NCT02781090|542052224|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
150250427|NCT02781090|542052225|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
150250428|NCT02781090|542052224|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
150250429|NCT02781090|542052225|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
150250430|NCT02781090|542052224|FG000|3-Month Follow-Up|Death|1|||
150250431|NCT02781090|542052225|FG001|3-Month Follow-Up|Death|0|||
150250432|NCT02781090|542052224|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
150250433|NCT02781090|542052225|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
150250434|NCT02781090|542052224|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
150250435|NCT02781090|542052225|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
150250436|NCT02781090|542052224|FG000|6-Month Follow-Up|Death|0|||
150250437|NCT02781090|542052225|FG001|6-Month Follow-Up|Death|1|||
150250438|NCT02075073|542052226|FG000|Overall Study|Withdrawal by Subject|0|||
150250439|NCT02075073|542052227|FG001|Overall Study|Withdrawal by Subject|1|||
150250440|NCT02075073|542052228|FG002|Overall Study|Withdrawal by Subject|0|||
150250441|NCT00416195|542052231|FG000|Overall Study|Adverse Event|1|||
150250442|NCT00416195|542052232|FG001|Overall Study|Adverse Event|2|||
150250443|NCT00416195|542052231|FG000|Overall Study|Protocol Violation|1|||
150250444|NCT00416195|542052232|FG001|Overall Study|Protocol Violation|1|||
150250445|NCT00416195|542052231|FG000|Overall Study|Other|0|||
150250446|NCT00416195|542052232|FG001|Overall Study|Other|1|||
150250447|NCT03101462|542052237|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
150250448|NCT03101462|542052238|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
150250449|NCT02530970|542052241|FG000|Overall Study|Adverse Event|8|||
150250450|NCT02530970|542052241|FG000|Overall Study|Lost to Follow-up|88|||
150250451|NCT02530970|542052241|FG000|Overall Study|Physician Decision|5|||
150250452|NCT02530970|542052241|FG000|Overall Study|Withdrawal by Subject|14|||
150250453|NCT02530970|542052241|FG000|Overall Study|Death|6|||
150250454|NCT02530970|542052241|FG000|Overall Study|Hospitalization|1|||
150250455|NCT02530970|542052241|FG000|Overall Study|Insurance|2|||
150250456|NCT02530970|542052241|FG000|Overall Study|Explant|2|||
150250457|NCT02530970|542052241|FG000|Overall Study|Change in Provider|5|||
150250458|NCT02530970|542052241|FG000|Overall Study|Relocation|3|||
150250459|NCT03846453|542052244|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
150250460|NCT03846453|542052245|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
150250461|NCT03846453|542052246|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
150250462|NCT03846453|542052244|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
150250463|NCT03846453|542052245|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
150250464|NCT03846453|542052246|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
150250465|NCT03846453|542052244|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
150250466|NCT03846453|542052245|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
150250467|NCT03846453|542052246|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
150250468|NCT03846453|542052244|FG000|Placebo Run-in (14 Days)|Other|2|||
150250469|NCT03846453|542052245|FG001|Placebo Run-in (14 Days)|Other|0|||
150250470|NCT03846453|542052246|FG002|Placebo Run-in (14 Days)|Other|0|||
150250471|NCT03846453|542052244|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
150250472|NCT03846453|542052245|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
150250473|NCT03846453|542052246|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
150250474|NCT03846453|542052244|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
150250475|NCT03846453|542052245|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
150250476|NCT03846453|542052246|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
150250477|NCT03846453|542052244|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
150250478|NCT03846453|542052245|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
150250479|NCT03846453|542052246|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
150250480|NCT03846453|542052244|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
150250481|NCT03846453|542052245|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
150250482|NCT03846453|542052246|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
150250483|NCT03846453|542052244|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
150250484|NCT03846453|542052245|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
150250485|NCT03846453|542052246|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
150250486|NCT00468143|542052247|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
150250487|NCT00468143|542052248|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
150250488|NCT00468143|542052247|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
150250489|NCT00468143|542052248|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
150250490|NCT00886795|542052252|FG000|Overall Study|Lack of Efficacy|1|||
150250491|NCT01669577|542052255|FG000|Overall Study|Death|22|||
150250492|NCT01669577|542052255|FG000|Overall Study|Lost to Follow-up|78|||
150250493|NCT01669577|542052255|FG000|Overall Study|Physician Decision|34|||
150250494|NCT01283516|542052256|FG000|Overall Study|Adverse Event|0|||
150250495|NCT01283516|542052257|FG001|Overall Study|Adverse Event|0|||
150250496|NCT01283516|542052258|FG002|Overall Study|Adverse Event|0|||
150250497|NCT01283516|542052259|FG003|Overall Study|Adverse Event|0|||
150250498|NCT01283516|542052260|FG004|Overall Study|Adverse Event|0|||
150250499|NCT01283516|542052261|FG005|Overall Study|Adverse Event|0|||
150250500|NCT01283516|542052262|FG006|Overall Study|Adverse Event|2|||
150250501|NCT01283516|542052263|FG007|Overall Study|Adverse Event|0|||
150250502|NCT01283516|542052264|FG008|Overall Study|Adverse Event|28|||
150250503|NCT01283516|542052256|FG000|Overall Study|Death|0|||
150250504|NCT01283516|542052257|FG001|Overall Study|Death|0|||
150250505|NCT01283516|542052258|FG002|Overall Study|Death|0|||
150250506|NCT01283516|542052259|FG003|Overall Study|Death|0|||
150250507|NCT01283516|542052260|FG004|Overall Study|Death|0|||
150250508|NCT01283516|542052261|FG005|Overall Study|Death|1|||
150250509|NCT01283516|542052262|FG006|Overall Study|Death|0|||
150250510|NCT01283516|542052263|FG007|Overall Study|Death|1|||
150250511|NCT01283516|542052264|FG008|Overall Study|Death|12|||
150250512|NCT01283516|542052256|FG000|Overall Study|Disease Progression|2|||
150250513|NCT01283516|542052257|FG001|Overall Study|Disease Progression|2|||
150250514|NCT01283516|542052258|FG002|Overall Study|Disease Progression|3|||
150250515|NCT01283516|542052259|FG003|Overall Study|Disease Progression|3|||
150250516|NCT01283516|542052260|FG004|Overall Study|Disease Progression|13|||
150250517|NCT01283516|542052261|FG005|Overall Study|Disease Progression|8|||
150250518|NCT01283516|542052262|FG006|Overall Study|Disease Progression|6|||
150250519|NCT01283516|542052263|FG007|Overall Study|Disease Progression|3|||
150250520|NCT01283516|542052264|FG008|Overall Study|Disease Progression|139|||
150250521|NCT01283516|542052256|FG000|Overall Study|Withdrawal by Subject|0|||
150250522|NCT01283516|542052257|FG001|Overall Study|Withdrawal by Subject|0|||
150250523|NCT01283516|542052258|FG002|Overall Study|Withdrawal by Subject|0|||
150250524|NCT01283516|542052259|FG003|Overall Study|Withdrawal by Subject|0|||
150250525|NCT01283516|542052260|FG004|Overall Study|Withdrawal by Subject|1|||
150250526|NCT01283516|542052261|FG005|Overall Study|Withdrawal by Subject|0|||
150250527|NCT01283516|542052262|FG006|Overall Study|Withdrawal by Subject|1|||
150250528|NCT01283516|542052263|FG007|Overall Study|Withdrawal by Subject|0|||
150250529|NCT01283516|542052264|FG008|Overall Study|Withdrawal by Subject|36|||
150250530|NCT01283516|542052256|FG000|Overall Study|Administrative problems|0|||
150250531|NCT01283516|542052257|FG001|Overall Study|Administrative problems|0|||
150250532|NCT01283516|542052258|FG002|Overall Study|Administrative problems|0|||
150250533|NCT01283516|542052259|FG003|Overall Study|Administrative problems|0|||
150250534|NCT01283516|542052260|FG004|Overall Study|Administrative problems|0|||
150250535|NCT01283516|542052261|FG005|Overall Study|Administrative problems|1|||
150250536|NCT01283516|542052262|FG006|Overall Study|Administrative problems|1|||
150250537|NCT01283516|542052263|FG007|Overall Study|Administrative problems|1|||
150250538|NCT01283516|542052264|FG008|Overall Study|Administrative problems|39|||
150250539|NCT01283516|542052256|FG000|Overall Study|Lost to Follow-up|0|||
150250540|NCT01283516|542052257|FG001|Overall Study|Lost to Follow-up|0|||
150250541|NCT01283516|542052258|FG002|Overall Study|Lost to Follow-up|0|||
150250542|NCT01283516|542052259|FG003|Overall Study|Lost to Follow-up|0|||
150250543|NCT01283516|542052260|FG004|Overall Study|Lost to Follow-up|0|||
150250544|NCT01283516|542052261|FG005|Overall Study|Lost to Follow-up|0|||
150250545|NCT01283516|542052262|FG006|Overall Study|Lost to Follow-up|0|||
150250546|NCT01283516|542052263|FG007|Overall Study|Lost to Follow-up|0|||
150250547|NCT01283516|542052264|FG008|Overall Study|Lost to Follow-up|1|||
150250548|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
150250549|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
150250550|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
150250551|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
150250552|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
150250553|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
150250554|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
150250555|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
150250556|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
150250557|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
150250558|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Adverse Event|0|||
150250559|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Adverse Event|0|||
150250560|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Adverse Event|3|||
150250561|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Adverse Event|2|||
150250562|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Adverse Event|13|||
150250563|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
150250564|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
150250565|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
150250566|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
150250567|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
150250568|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Patient's wish|0|||
150250569|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Patient's wish|0|||
150250570|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Patient's wish|19|||
150250571|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Patient's wish|9|||
150250572|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Patient's wish|20|||
150250573|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
150250574|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
150250575|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
150250576|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
150250577|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
150250578|NCT00444275|542052270|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
150250579|NCT00444275|542052271|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
150250580|NCT00444275|542052272|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
150250581|NCT00444275|542052273|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
150250582|NCT00444275|542052274|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
150250583|NCT00132873|542052275|FG000|Overall Study|Adverse Event|3|||
150250584|NCT00132873|542052275|FG000|Overall Study|Lost to Follow-up|1|||
150250585|NCT00132873|542052275|FG000|Overall Study|Lack of Efficacy|1|||
150250586|NCT00132873|542052275|FG000|Overall Study|Withdrawal by Subject|3|||
150250587|NCT00132873|542052275|FG000|Overall Study|Planned Pregnancy|1|||
150250588|NCT01204710|542052279|FG000|Randomization Treatment|Lost to Follow-up|1|||
150250589|NCT01204710|542052280|FG001|Randomization Treatment|Lost to Follow-up|0|||
150250590|NCT01204710|542052279|FG000|Randomization Treatment|Withdrawal by Subject|6|||
150250591|NCT01204710|542052280|FG001|Randomization Treatment|Withdrawal by Subject|5|||
150250592|NCT01204710|542052279|FG000|Randomization Treatment|Physician Decision|3|||
150250593|NCT01204710|542052280|FG001|Randomization Treatment|Physician Decision|2|||
150250594|NCT01204710|542052279|FG000|Randomization Treatment|Entry criteria not met|0|||
150250595|NCT01204710|542052280|FG001|Randomization Treatment|Entry criteria not met|1|||
150250596|NCT01204710|542052279|FG000|Randomization Treatment|Adverse Event|4|||
150250597|NCT01204710|542052280|FG001|Randomization Treatment|Adverse Event|2|||
150250598|NCT01204710|542052279|FG000|Randomization Treatment|Sponsor Decision|0|||
150250599|NCT01204710|542052280|FG001|Randomization Treatment|Sponsor Decision|1|||
150250600|NCT01204710|542052279|FG000|Randomization Treatment|Worsening of General condition|0|||
150250601|NCT01204710|542052280|FG001|Randomization Treatment|Worsening of General condition|1|||
150250602|NCT01204710|542052279|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
150250603|NCT01204710|542052280|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
150250604|NCT01204710|542052279|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
150250605|NCT01204710|542052280|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
150250606|NCT01204710|542052279|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
150250607|NCT01204710|542052280|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
150250608|NCT01204710|542052279|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
150250609|NCT01204710|542052280|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
150250610|NCT01896726|542052281|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
150250611|NCT01896726|542052281|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
150250612|NCT05543707|542052285|FG000|Overall Study|Study drug non-compliance/|5|||
150250613|NCT05543707|542052286|FG001|Overall Study|Study drug non-compliance/|0|||
150250614|NCT05543707|542052285|FG000|Overall Study|Withdrawal by Subject|1|||
150250615|NCT05543707|542052286|FG001|Overall Study|Withdrawal by Subject|1|||
150250616|NCT05543707|542052285|FG000|Overall Study|Adverse Event|1|||
150250617|NCT05543707|542052286|FG001|Overall Study|Adverse Event|0|||
150250618|NCT05543707|542052285|FG000|Overall Study|concurrent illness|0|||
150250619|NCT05543707|542052286|FG001|Overall Study|concurrent illness|1|||
150250620|NCT05543707|542052285|FG000|Overall Study|Pregnancy|1|||
150250621|NCT05543707|542052286|FG001|Overall Study|Pregnancy|1|||
150250622|NCT04047862|542052291|FG000|Overall Study|Death|0|||
150250623|NCT04047862|542052292|FG001|Overall Study|Death|0|||
150250624|NCT04047862|542052293|FG002|Overall Study|Death|4|||
150250625|NCT04047862|542052294|FG003|Overall Study|Death|7|||
150250626|NCT04047862|542052295|FG004|Overall Study|Death|2|||
150250627|NCT04047862|542052296|FG005|Overall Study|Death|4|||
150250628|NCT04047862|542052297|FG006|Overall Study|Death|3|||
150250629|NCT04047862|542052298|FG007|Overall Study|Death|24|||
150250630|NCT04047862|542052299|FG008|Overall Study|Death|24|||
150250631|NCT04047862|542052300|FG009|Overall Study|Death|22|||
150250632|NCT04047862|542052301|FG010|Overall Study|Death|35|||
150250633|NCT04047862|542052302|FG011|Overall Study|Death|18|||
150250634|NCT04047862|542052303|FG012|Overall Study|Death|14|||
150250635|NCT04047862|542052304|FG013|Overall Study|Death|6|||
150250636|NCT04047862|542052305|FG014|Overall Study|Death|19|||
150250637|NCT04047862|542052306|FG015|Overall Study|Death|42|||
150250638|NCT04047862|542052307|FG016|Overall Study|Death|9|||
150250639|NCT04047862|542052308|FG017|Overall Study|Death|8|||
150250640|NCT04047862|542052309|FG018|Overall Study|Death|10|||
150250641|NCT04047862|542052291|FG000|Overall Study|Withdrawal by Subject|0|||
150250642|NCT04047862|542052292|FG001|Overall Study|Withdrawal by Subject|0|||
150250643|NCT04047862|542052293|FG002|Overall Study|Withdrawal by Subject|0|||
150250644|NCT04047862|542052294|FG003|Overall Study|Withdrawal by Subject|5|||
150250645|NCT04047862|542052295|FG004|Overall Study|Withdrawal by Subject|2|||
150250646|NCT04047862|542052296|FG005|Overall Study|Withdrawal by Subject|0|||
150250647|NCT04047862|542052297|FG006|Overall Study|Withdrawal by Subject|1|||
150250648|NCT04047862|542052298|FG007|Overall Study|Withdrawal by Subject|0|||
150250649|NCT04047862|542052299|FG008|Overall Study|Withdrawal by Subject|4|||
150250650|NCT04047862|542052300|FG009|Overall Study|Withdrawal by Subject|4|||
150250651|NCT04047862|542052301|FG010|Overall Study|Withdrawal by Subject|4|||
150250652|NCT04047862|542052302|FG011|Overall Study|Withdrawal by Subject|2|||
150250653|NCT04047862|542052303|FG012|Overall Study|Withdrawal by Subject|3|||
150250654|NCT04047862|542052304|FG013|Overall Study|Withdrawal by Subject|0|||
150250655|NCT04047862|542052305|FG014|Overall Study|Withdrawal by Subject|9|||
150250656|NCT04047862|542052306|FG015|Overall Study|Withdrawal by Subject|5|||
150250657|NCT04047862|542052307|FG016|Overall Study|Withdrawal by Subject|1|||
150250658|NCT04047862|542052308|FG017|Overall Study|Withdrawal by Subject|3|||
150250659|NCT04047862|542052309|FG018|Overall Study|Withdrawal by Subject|1|||
150250660|NCT04047862|542052291|FG000|Overall Study|Lost to Follow-up|0|||
150250661|NCT04047862|542052292|FG001|Overall Study|Lost to Follow-up|0|||
150250662|NCT04047862|542052293|FG002|Overall Study|Lost to Follow-up|1|||
150250663|NCT04047862|542052294|FG003|Overall Study|Lost to Follow-up|0|||
150250664|NCT04047862|542052295|FG004|Overall Study|Lost to Follow-up|0|||
150250665|NCT04047862|542052296|FG005|Overall Study|Lost to Follow-up|0|||
150250666|NCT04047862|542052297|FG006|Overall Study|Lost to Follow-up|0|||
150250667|NCT04047862|542052298|FG007|Overall Study|Lost to Follow-up|1|||
150250668|NCT04047862|542052299|FG008|Overall Study|Lost to Follow-up|0|||
150250669|NCT04047862|542052300|FG009|Overall Study|Lost to Follow-up|1|||
150250670|NCT04047862|542052301|FG010|Overall Study|Lost to Follow-up|0|||
150250671|NCT04047862|542052302|FG011|Overall Study|Lost to Follow-up|3|||
150250672|NCT04047862|542052303|FG012|Overall Study|Lost to Follow-up|0|||
150250673|NCT04047862|542052304|FG013|Overall Study|Lost to Follow-up|0|||
150250674|NCT04047862|542052305|FG014|Overall Study|Lost to Follow-up|2|||
150250675|NCT04047862|542052306|FG015|Overall Study|Lost to Follow-up|2|||
150250676|NCT04047862|542052307|FG016|Overall Study|Lost to Follow-up|1|||
150250677|NCT04047862|542052308|FG017|Overall Study|Lost to Follow-up|0|||
150250678|NCT04047862|542052309|FG018|Overall Study|Lost to Follow-up|0|||
150250679|NCT04047862|542052291|FG000|Overall Study|Physician Decision|0|||
150250680|NCT04047862|542052292|FG001|Overall Study|Physician Decision|0|||
150250681|NCT04047862|542052293|FG002|Overall Study|Physician Decision|0|||
150250682|NCT04047862|542052294|FG003|Overall Study|Physician Decision|1|||
150250683|NCT04047862|542052295|FG004|Overall Study|Physician Decision|0|||
150250684|NCT04047862|542052296|FG005|Overall Study|Physician Decision|0|||
150250685|NCT04047862|542052297|FG006|Overall Study|Physician Decision|0|||
150250686|NCT04047862|542052298|FG007|Overall Study|Physician Decision|0|||
150250687|NCT04047862|542052299|FG008|Overall Study|Physician Decision|0|||
150250688|NCT04047862|542052300|FG009|Overall Study|Physician Decision|0|||
150250689|NCT04047862|542052301|FG010|Overall Study|Physician Decision|0|||
150250690|NCT04047862|542052302|FG011|Overall Study|Physician Decision|0|||
150250691|NCT04047862|542052303|FG012|Overall Study|Physician Decision|0|||
150250692|NCT04047862|542052304|FG013|Overall Study|Physician Decision|0|||
150250693|NCT04047862|542052305|FG014|Overall Study|Physician Decision|1|||
150250694|NCT04047862|542052306|FG015|Overall Study|Physician Decision|0|||
150250695|NCT04047862|542052307|FG016|Overall Study|Physician Decision|1|||
150250696|NCT04047862|542052308|FG017|Overall Study|Physician Decision|0|||
150250697|NCT04047862|542052309|FG018|Overall Study|Physician Decision|0|||
150250698|NCT04047862|542052291|FG000|Overall Study|Completed all Assessments|1|||
150250699|NCT04047862|542052292|FG001|Overall Study|Completed all Assessments|3|||
150250700|NCT04047862|542052293|FG002|Overall Study|Completed all Assessments|1|||
150250701|NCT04047862|542052294|FG003|Overall Study|Completed all Assessments|3|||
150250702|NCT04047862|542052295|FG004|Overall Study|Completed all Assessments|2|||
150250703|NCT04047862|542052296|FG005|Overall Study|Completed all Assessments|5|||
150250704|NCT04047862|542052297|FG006|Overall Study|Completed all Assessments|7|||
150250705|NCT04047862|542052298|FG007|Overall Study|Completed all Assessments|0|||
150250706|NCT04047862|542052299|FG008|Overall Study|Completed all Assessments|0|||
150250707|NCT04047862|542052300|FG009|Overall Study|Completed all Assessments|0|||
150250708|NCT04047862|542052301|FG010|Overall Study|Completed all Assessments|0|||
150250709|NCT04047862|542052302|FG011|Overall Study|Completed all Assessments|0|||
150250710|NCT04047862|542052303|FG012|Overall Study|Completed all Assessments|0|||
150250711|NCT04047862|542052304|FG013|Overall Study|Completed all Assessments|0|||
150250712|NCT04047862|542052305|FG014|Overall Study|Completed all Assessments|0|||
150250713|NCT04047862|542052306|FG015|Overall Study|Completed all Assessments|0|||
150250714|NCT04047862|542052307|FG016|Overall Study|Completed all Assessments|0|||
150250715|NCT04047862|542052308|FG017|Overall Study|Completed all Assessments|0|||
150250716|NCT04047862|542052309|FG018|Overall Study|Completed all Assessments|0|||
150250717|NCT04047862|542052291|FG000|Overall Study|Sponsor Decision|0|||
150250718|NCT04047862|542052292|FG001|Overall Study|Sponsor Decision|0|||
150250719|NCT04047862|542052293|FG002|Overall Study|Sponsor Decision|0|||
150250720|NCT04047862|542052294|FG003|Overall Study|Sponsor Decision|0|||
150250721|NCT04047862|542052295|FG004|Overall Study|Sponsor Decision|0|||
150250722|NCT04047862|542052296|FG005|Overall Study|Sponsor Decision|0|||
150250723|NCT04047862|542052297|FG006|Overall Study|Sponsor Decision|0|||
150250724|NCT04047862|542052298|FG007|Overall Study|Sponsor Decision|13|||
150250725|NCT04047862|542052299|FG008|Overall Study|Sponsor Decision|10|||
150250726|NCT04047862|542052300|FG009|Overall Study|Sponsor Decision|18|||
150250727|NCT04047862|542052301|FG010|Overall Study|Sponsor Decision|3|||
150250728|NCT04047862|542052302|FG011|Overall Study|Sponsor Decision|3|||
150250729|NCT04047862|542052303|FG012|Overall Study|Sponsor Decision|4|||
150250730|NCT04047862|542052304|FG013|Overall Study|Sponsor Decision|0|||
150250731|NCT04047862|542052305|FG014|Overall Study|Sponsor Decision|7|||
150250732|NCT04047862|542052306|FG015|Overall Study|Sponsor Decision|8|||
150250733|NCT04047862|542052307|FG016|Overall Study|Sponsor Decision|9|||
150250734|NCT04047862|542052308|FG017|Overall Study|Sponsor Decision|7|||
150250735|NCT04047862|542052309|FG018|Overall Study|Sponsor Decision|8|||
150250736|NCT04047862|542052291|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250737|NCT04047862|542052292|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250738|NCT04047862|542052293|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250739|NCT04047862|542052294|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250740|NCT04047862|542052295|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250741|NCT04047862|542052296|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250742|NCT04047862|542052297|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250743|NCT04047862|542052298|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
150250744|NCT04047862|542052299|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
150250745|NCT04047862|542052300|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250746|NCT04047862|542052301|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
150250747|NCT04047862|542052302|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250748|NCT04047862|542052303|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250749|NCT04047862|542052304|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
150250750|NCT04047862|542052305|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
150250751|NCT04047862|542052306|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
150250752|NCT04047862|542052307|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
150250753|NCT04047862|542052308|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
150250754|NCT04047862|542052309|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
150250755|NCT04047862|542052291|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250756|NCT04047862|542052292|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250757|NCT04047862|542052293|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250758|NCT04047862|542052294|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250759|NCT04047862|542052295|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250760|NCT04047862|542052296|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250761|NCT04047862|542052297|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250762|NCT04047862|542052298|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250763|NCT04047862|542052299|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250764|NCT04047862|542052300|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250765|NCT04047862|542052301|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250766|NCT04047862|542052302|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250767|NCT04047862|542052303|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250768|NCT04047862|542052304|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250769|NCT04047862|542052305|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250770|NCT04047862|542052306|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
150250771|NCT04047862|542052307|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250772|NCT04047862|542052308|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
150250773|NCT04047862|542052309|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
150250774|NCT04047862|542052291|FG000|Overall Study|Other|0|||
150250775|NCT04047862|542052292|FG001|Overall Study|Other|0|||
150250776|NCT04047862|542052293|FG002|Overall Study|Other|0|||
150250777|NCT04047862|542052294|FG003|Overall Study|Other|0|||
150250778|NCT04047862|542052295|FG004|Overall Study|Other|0|||
150250779|NCT04047862|542052296|FG005|Overall Study|Other|0|||
150250780|NCT04047862|542052297|FG006|Overall Study|Other|0|||
150250781|NCT04047862|542052298|FG007|Overall Study|Other|0|||
150250782|NCT04047862|542052299|FG008|Overall Study|Other|0|||
150250783|NCT04047862|542052300|FG009|Overall Study|Other|0|||
150250784|NCT04047862|542052301|FG010|Overall Study|Other|0|||
150250785|NCT04047862|542052302|FG011|Overall Study|Other|0|||
150250786|NCT04047862|542052303|FG012|Overall Study|Other|0|||
150250787|NCT04047862|542052304|FG013|Overall Study|Other|0|||
150250788|NCT04047862|542052305|FG014|Overall Study|Other|2|||
150250789|NCT04047862|542052306|FG015|Overall Study|Other|1|||
150250790|NCT04047862|542052307|FG016|Overall Study|Other|1|||
150250791|NCT04047862|542052308|FG017|Overall Study|Other|1|||
150250792|NCT04047862|542052309|FG018|Overall Study|Other|0|||
150250793|NCT03826030|542052310|FG000|Overall Study|Withdrawal by Subject|2|||
150250794|NCT03826030|542052311|FG001|Overall Study|Withdrawal by Subject|0|||
150250795|NCT03826030|542052312|FG002|Overall Study|Withdrawal by Subject|1|||
150250796|NCT03826030|542052310|FG000|Overall Study|Lost to Follow-up|1|||
150250797|NCT03826030|542052311|FG001|Overall Study|Lost to Follow-up|1|||
150250798|NCT03826030|542052312|FG002|Overall Study|Lost to Follow-up|1|||
150250799|NCT03826030|542052310|FG000|Overall Study|Too busy to return for visits|1|||
150250800|NCT03826030|542052311|FG001|Overall Study|Too busy to return for visits|0|||
150250801|NCT03826030|542052312|FG002|Overall Study|Too busy to return for visits|0|||
150250802|NCT06748729|542052317|FG000|Overall Study|Withdrawal by Subject|1|||
150250803|NCT03986944|542054342|FG000|Overall Study|Adverse Event|1|||
150250804|NCT03986944|542054343|FG001|Overall Study|Adverse Event|2|||
150250805|NCT03986944|542054344|FG002|Overall Study|Adverse Event|3|||
150250806|NCT03986944|542054342|FG000|Overall Study|Protocol Violation|0|||
150250807|NCT03986944|542054343|FG001|Overall Study|Protocol Violation|1|||
150250808|NCT03986944|542054344|FG002|Overall Study|Protocol Violation|1|||
150250809|NCT03986944|542054342|FG000|Overall Study|Withdrawal by Subject|3|||
150250810|NCT03986944|542054343|FG001|Overall Study|Withdrawal by Subject|5|||
150250811|NCT03986944|542054344|FG002|Overall Study|Withdrawal by Subject|5|||
150250812|NCT03986944|542054342|FG000|Overall Study|Study termination|10|||
150250813|NCT03986944|542054343|FG001|Overall Study|Study termination|10|||
150250814|NCT03986944|542054344|FG002|Overall Study|Study termination|10|||
150250815|NCT03986944|542054342|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
150250816|NCT03986944|542054343|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
150250817|NCT03986944|542054344|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
150250818|NCT03986944|542054342|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
150250819|NCT03986944|542054343|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
150250820|NCT03986944|542054344|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
150250821|NCT03002220|542054345|FG000|Overall Study|Lack of Efficacy|2|||
150250822|NCT03002220|542054345|FG000|Overall Study|Withdrawal by Subject|3|||
150250823|NCT03002220|542054345|FG000|Overall Study|Adverse Event|2|||
150250824|NCT03002220|542054345|FG000|Overall Study|Disease progression|13|||
150250825|NCT03002220|542054345|FG000|Overall Study|Physician Decision|1|||
150250826|NCT01202903|542054349|FG000|Overall Study|Administrative Probelms|1|||
150250827|NCT01202903|542054350|FG001|Overall Study|Administrative Probelms|4|||
150250828|NCT01202903|542054349|FG000|Overall Study|Protocol Violation|0|||
150250829|NCT01202903|542054350|FG001|Overall Study|Protocol Violation|1|||
150250830|NCT01202903|542054349|FG000|Overall Study|Death|1|||
150250831|NCT01202903|542054350|FG001|Overall Study|Death|0|||
150250832|NCT01202903|542054349|FG000|Overall Study|Lost to Follow-up|1|||
150250833|NCT01202903|542054350|FG001|Overall Study|Lost to Follow-up|1|||
150250834|NCT01202903|542054349|FG000|Overall Study|Lack of Efficacy|1|||
150250835|NCT01202903|542054350|FG001|Overall Study|Lack of Efficacy|3|||
150250836|NCT01202903|542054349|FG000|Overall Study|Adverse Event|3|||
150250837|NCT01202903|542054350|FG001|Overall Study|Adverse Event|3|||
150250838|NCT01202903|542054349|FG000|Overall Study|Withdrawal by Subject|4|||
150250839|NCT01202903|542054350|FG001|Overall Study|Withdrawal by Subject|4|||
150250840|NCT01302080|542054351|FG000|Overall Study|Withdrew Consent|92|||
150250841|NCT01302080|542054352|FG001|Overall Study|Withdrew Consent|39|||
150250842|NCT01302080|542054351|FG000|Overall Study|Patient/Family Moved|28|||
150250843|NCT01302080|542054352|FG001|Overall Study|Patient/Family Moved|3|||
150250844|NCT01302080|542054351|FG000|Overall Study|Lost to Follow-up|192|||
150250845|NCT01302080|542054352|FG001|Overall Study|Lost to Follow-up|93|||
150250846|NCT01302080|542054351|FG000|Overall Study|Death|1|||
150250847|NCT01302080|542054352|FG001|Overall Study|Death|0|||
150250848|NCT01302080|542054351|FG000|Overall Study|Other|52|||
150250849|NCT01302080|542054352|FG001|Overall Study|Other|8|||
150250850|NCT01302080|542054351|FG000|Overall Study|Reason Missing For Discontinuation|1|||
150250851|NCT01302080|542054352|FG001|Overall Study|Reason Missing For Discontinuation|0|||
150250852|NCT00297427|542054369|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
150250853|NCT00297427|542054370|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
150250854|NCT00297427|542054369|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
150250855|NCT00297427|542054370|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
150250856|NCT00297427|542054369|FG000|Phase 1: Initial Intervention|Death|0|||
150250857|NCT00297427|542054370|FG001|Phase 1: Initial Intervention|Death|1|||
150250858|NCT00297427|542054369|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
150250859|NCT00297427|542054370|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
150250860|NCT00297427|542054369|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
150250861|NCT00297427|542054370|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
150250862|NCT00297427|542054369|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
150250863|NCT00297427|542054370|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
150250864|NCT00297427|542054369|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
150250865|NCT00297427|542054370|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
150250866|NCT00297427|542054369|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
150250867|NCT00297427|542054370|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
150250868|NCT01127893|542054371|FG000|Overall Study|Study Termination by the Sponsor|1|||
150250869|NCT01262677|542054372|FG000|Overall Study|Does not meet entrance criteria|0|||
150250870|NCT01262677|542054373|FG001|Overall Study|Does not meet entrance criteria|2|||
150250871|NCT01262677|542054374|FG002|Overall Study|Does not meet entrance criteria|0|||
150250872|NCT01262677|542054372|FG000|Overall Study|Insufficient clinical response|0|||
150250873|NCT01262677|542054373|FG001|Overall Study|Insufficient clinical response|0|||
150250874|NCT01262677|542054374|FG002|Overall Study|Insufficient clinical response|1|||
150250875|NCT01262677|542054372|FG000|Overall Study|Lost to Follow-up|1|||
150250876|NCT01262677|542054373|FG001|Overall Study|Lost to Follow-up|0|||
150250877|NCT01262677|542054374|FG002|Overall Study|Lost to Follow-up|2|||
150250878|NCT01262677|542054372|FG000|Overall Study|No longer willing to participate|3|||
150250879|NCT01262677|542054373|FG001|Overall Study|No longer willing to participate|3|||
150250880|NCT01262677|542054374|FG002|Overall Study|No longer willing to participate|2|||
150250881|NCT01262677|542054372|FG000|Overall Study|Reason not provided|2|||
150250882|NCT01262677|542054373|FG001|Overall Study|Reason not provided|1|||
150250883|NCT01262677|542054374|FG002|Overall Study|Reason not provided|3|||
150250884|NCT01262677|542054372|FG000|Overall Study|Protocol Violation|0|||
150250885|NCT01262677|542054373|FG001|Overall Study|Protocol Violation|1|||
150250886|NCT01262677|542054374|FG002|Overall Study|Protocol Violation|1|||
150250887|NCT01262677|542054372|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
150250888|NCT01262677|542054373|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
150250889|NCT01262677|542054374|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
150250890|NCT02060370|542054383|FG000|Overall Study|Physician Decision|1|||
150250891|NCT01896557|542054384|FG000|Clopidogrel Alone|Adverse Event|1|||
150250892|NCT01896557|542054385|FG001|Clopidogrel Alone|Adverse Event|0|||
150250893|NCT01896557|542054384|FG000|Clopidogrel + GI Protector|low adherence|1|||
150250894|NCT01896557|542054385|FG001|Clopidogrel + GI Protector|low adherence|1|||
150250895|NCT01896557|542054384|FG000|Clopidogrel + GI Protector|Reading error|1|||
150250896|NCT01896557|542054385|FG001|Clopidogrel + GI Protector|Reading error|3|||
150250897|NCT02182947|542054390|FG000|Overall Study|Withdrawal by Subject|7|||
150250898|NCT02182947|542054390|FG000|Overall Study|Lost to Follow-up|3|||
150250899|NCT02182947|542054390|FG000|Overall Study|Failed screening activities|8|||
150250900|NCT00356408|542054391|FG000|Overall Study|Adverse Event|9|||
150250901|NCT00356408|542054391|FG000|Overall Study|Lack of Efficacy|36|||
150250902|NCT00356408|542054391|FG000|Overall Study|Lost to Follow-up|2|||
150250903|NCT00356408|542054391|FG000|Overall Study|Withdrawal by Subject|6|||
150250904|NCT00356408|542054391|FG000|Overall Study|Other: Principal investigator discretion|3|||
150250905|NCT00356408|542054391|FG000|Overall Study|Other: Sponsor request|1|||
150250906|NCT00356408|542054391|FG000|Overall Study|Other: Azathioprine stopped|1|||
150250907|NCT00356408|542054391|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
150250908|NCT00356408|542054391|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
150250909|NCT05487586|542054392|FG000|Overall Study|Death|22|||
150250910|NCT05487586|542054392|FG000|Overall Study|Physician Decision|1|||
150250911|NCT05487586|542054392|FG000|Overall Study|Transfer to another hospital|4|||
150250912|NCT05487586|542054392|FG000|Overall Study|Other|1|||
150250913|NCT01072630|542054398|FG000|Overall Study|Adverse Event|11|||
150250914|NCT01072630|542054399|FG001|Overall Study|Adverse Event|19|||
150250915|NCT01072630|542054400|FG002|Overall Study|Adverse Event|2|||
150250916|NCT01072630|542054398|FG000|Overall Study|Lack of Efficacy|10|||
150250917|NCT01072630|542054399|FG001|Overall Study|Lack of Efficacy|10|||
150250918|NCT01072630|542054400|FG002|Overall Study|Lack of Efficacy|1|||
150250919|NCT01072630|542054398|FG000|Overall Study|Withdrawal by Subject|8|||
150250920|NCT01072630|542054399|FG001|Overall Study|Withdrawal by Subject|7|||
150250921|NCT01072630|542054400|FG002|Overall Study|Withdrawal by Subject|2|||
150250922|NCT01072630|542054398|FG000|Overall Study|Protocol Violation|10|||
150250923|NCT01072630|542054399|FG001|Overall Study|Protocol Violation|8|||
150250924|NCT01072630|542054400|FG002|Overall Study|Protocol Violation|4|||
150250925|NCT01072630|542054398|FG000|Overall Study|Lost to Follow-up|11|||
150250926|NCT01072630|542054399|FG001|Overall Study|Lost to Follow-up|11|||
150250927|NCT01072630|542054400|FG002|Overall Study|Lost to Follow-up|1|||
150250928|NCT01072630|542054398|FG000|Overall Study|Noncompliance with study medication|1|||
150250929|NCT01072630|542054399|FG001|Overall Study|Noncompliance with study medication|1|||
150250930|NCT01072630|542054400|FG002|Overall Study|Noncompliance with study medication|1|||
150250931|NCT01072630|542054398|FG000|Overall Study|Noncompliance with study procedures|1|||
150250932|NCT01072630|542054399|FG001|Overall Study|Noncompliance with study procedures|2|||
150250933|NCT01072630|542054400|FG002|Overall Study|Noncompliance with study procedures|1|||
150250934|NCT01072630|542054398|FG000|Overall Study|Other|3|||
150250935|NCT01072630|542054399|FG001|Overall Study|Other|2|||
150250936|NCT01072630|542054400|FG002|Overall Study|Other|1|||
150250937|NCT00643617|542054402|FG000|Overall Study|Death|6|||
150250938|NCT00643617|542054403|FG001|Overall Study|Death|9|||
150250939|NCT00643617|542054402|FG000|Overall Study|Lost to Follow-up|42|||
150250940|NCT00643617|542054403|FG001|Overall Study|Lost to Follow-up|51|||
150250941|NCT02683785|542054421|FG000|Overall Study|Withdrawal by Subject|1|||
150250942|NCT02683785|542054422|FG001|Overall Study|Withdrawal by Subject|1|||
150250943|NCT02683785|542054421|FG000|Overall Study|Lost to Follow-up|0|||
150250944|NCT02683785|542054422|FG001|Overall Study|Lost to Follow-up|1|||
150250945|NCT02683785|542054421|FG000|Overall Study|Adverse Event|0|||
150250946|NCT02683785|542054422|FG001|Overall Study|Adverse Event|2|||
150250947|NCT01305408|542054423|FG000|Overall Study|Adverse Event|10|||
150250948|NCT01305408|542054424|FG001|Overall Study|Adverse Event|7|||
150250949|NCT01305408|542054423|FG000|Overall Study|Lack of Efficacy|3|||
150250950|NCT01305408|542054424|FG001|Overall Study|Lack of Efficacy|4|||
150250951|NCT01305408|542054423|FG000|Overall Study|Withdrawal by Subject|9|||
150250952|NCT01305408|542054424|FG001|Overall Study|Withdrawal by Subject|9|||
150250953|NCT01305408|542054423|FG000|Overall Study|Protocol Violation|4|||
150250954|NCT01305408|542054424|FG001|Overall Study|Protocol Violation|6|||
150250955|NCT01305408|542054423|FG000|Overall Study|Lost to Follow-up|5|||
150250956|NCT01305408|542054424|FG001|Overall Study|Lost to Follow-up|3|||
150250957|NCT01305408|542054423|FG000|Overall Study|Noncompliance with study medication|0|||
150250958|NCT01305408|542054424|FG001|Overall Study|Noncompliance with study medication|1|||
150250959|NCT01305408|542054423|FG000|Overall Study|Noncompliance with study procedures|0|||
150250960|NCT01305408|542054424|FG001|Overall Study|Noncompliance with study procedures|1|||
150250961|NCT01305408|542054423|FG000|Overall Study|Other|1|||
150250962|NCT01305408|542054424|FG001|Overall Study|Other|0|||
150250963|NCT02770612|542054425|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
150250964|NCT02233803|542054426|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
150250965|NCT02233803|542054427|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
150250966|NCT02233803|542054426|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
150250967|NCT02233803|542054427|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
150250968|NCT02233803|542054426|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
150250969|NCT02233803|542054427|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
150250970|NCT02233803|542054426|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
150250971|NCT02233803|542054427|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
150250972|NCT02233803|542054426|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
150250973|NCT02233803|542054427|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
150250974|NCT02233803|542054426|FG000|Washout Period (4-Wks)|Physician Decision|1|||
150250975|NCT02233803|542054427|FG001|Washout Period (4-Wks)|Physician Decision|0|||
150250976|NCT02233803|542054426|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
150250977|NCT02233803|542054427|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
150250978|NCT02233803|542054426|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
150250979|NCT02233803|542054427|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
150250980|NCT02233803|542054426|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
150250981|NCT02233803|542054427|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
150250982|NCT01606670|542054428|FG000|Overall Study|Adverse Event|6|||
150250983|NCT01606670|542054428|FG000|Overall Study|Lack of Efficacy|2|||
150250984|NCT01606670|542054428|FG000|Overall Study|Lost to Follow-up|3|||
150250985|NCT01606670|542054428|FG000|Overall Study|Withdrawal by Subject|3|||
150250986|NCT01606670|542054428|FG000|Overall Study|Other Reason|2|||
150250987|NCT02636725|542054429|FG000|Overall Study|Adverse Event|1|||
150250988|NCT03653208|542054432|FG000|Overall Study|Withdrawal by Subject|0|||
150250989|NCT03653208|542054433|FG001|Overall Study|Withdrawal by Subject|0|||
150250990|NCT03653208|542054434|FG002|Overall Study|Withdrawal by Subject|0|||
150250991|NCT03653208|542054435|FG003|Overall Study|Withdrawal by Subject|0|||
150250992|NCT03653208|542054436|FG004|Overall Study|Withdrawal by Subject|1|||
150250993|NCT03653208|542054437|FG005|Overall Study|Withdrawal by Subject|0|||
150250994|NCT03653208|542054438|FG006|Overall Study|Withdrawal by Subject|0|||
150250995|NCT03653208|542054439|FG007|Overall Study|Withdrawal by Subject|1|||
150250996|NCT03653208|542054440|FG008|Overall Study|Withdrawal by Subject|1|||
150250997|NCT00368927|542054441|FG000|Overall Study|Lost to Follow-up|2|||
150250998|NCT00368927|542054442|FG001|Overall Study|Lost to Follow-up|0|||
150250999|NCT00368927|542054441|FG000|Overall Study|Adverse Event|1|||
150251000|NCT00368927|542054442|FG001|Overall Study|Adverse Event|1|||
150251001|NCT00368927|542054441|FG000|Overall Study|Withdrawal by Subject|1|||
150251002|NCT00368927|542054442|FG001|Overall Study|Withdrawal by Subject|2|||
150251003|NCT00368927|542054441|FG000|Overall Study|Physician Decision|1|||
150251004|NCT00368927|542054442|FG001|Overall Study|Physician Decision|0|||
150251005|NCT01152814|542054443|FG000|Overall Study|Lost to Follow-up|2|||
150251006|NCT03284203|542054444|FG000|Overall Study|Lost to Follow-up|3|||
150251007|NCT01877239|542054445|FG000|Overall Study|Adverse Event|4|||
150251008|NCT01877239|542054445|FG000|Overall Study|Disease Remission|1|||
150251009|NCT01877239|542054445|FG000|Overall Study|Withdrawal by Subject|4|||
150251010|NCT01877239|542054445|FG000|Overall Study|Other|2|||
150251011|NCT01877239|542054445|FG000|Overall Study|Lack of Efficacy|4|||
150251012|NCT01877239|542054445|FG000|Overall Study|Data not available|35|||
150251013|NCT04662931|542054451|FG000|Overall Study|Withdrawal by Subject|17|||
150251014|NCT04662931|542054451|FG000|Overall Study|Death|3|||
150251015|NCT04662931|542054451|FG000|Overall Study|Lost to Follow-up|3|||
150251016|NCT04662931|542054451|FG000|Overall Study|Guardian Decision|1|||
150251017|NCT02406677|542054452|FG000|Overall Study|Death|16|||
150251018|NCT02406677|542054453|FG001|Overall Study|Death|8|||
150251019|NCT02406677|542054452|FG000|Overall Study|Discharged without P2Y12|1|||
150251020|NCT02406677|542054453|FG001|Overall Study|Discharged without P2Y12|3|||
150251021|NCT02406677|542054452|FG000|Overall Study|Discharged on prasugrel|283|||
150251022|NCT02406677|542054453|FG001|Overall Study|Discharged on prasugrel|587|||
150251023|NCT02406677|542054452|FG000|Overall Study|Withdrawal by Subject|1|||
150251024|NCT02406677|542054453|FG001|Overall Study|Withdrawal by Subject|0|||
150251025|NCT01114880|542054454|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
150251026|NCT01114880|542054455|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
150251027|NCT01114880|542054454|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
150251028|NCT01114880|542054455|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
150251029|NCT01114880|542054454|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
150251030|NCT01114880|542054455|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
150251031|NCT01114880|542054454|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
150251032|NCT01114880|542054455|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
150251033|NCT01114880|542054454|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
150251034|NCT01114880|542054455|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
150251035|NCT01114880|542054454|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
150251036|NCT01114880|542054455|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
150251037|NCT04531098|542054458|FG000|Stage I|Adverse Event|0|||
150251038|NCT04531098|542054459|FG001|Stage I|Adverse Event|0|||
150251039|NCT04531098|542054460|FG002|Stage I|Adverse Event|3|||
150251040|NCT04531098|542054458|FG000|Stage I|Protocol Violation|0|||
150251041|NCT04531098|542054459|FG001|Stage I|Protocol Violation|0|||
150251042|NCT04531098|542054460|FG002|Stage I|Protocol Violation|5|||
150251043|NCT04531098|542054458|FG000|Stage I|Withdrawal by Subject|0|||
150251044|NCT04531098|542054459|FG001|Stage I|Withdrawal by Subject|5|||
150251045|NCT04531098|542054460|FG002|Stage I|Withdrawal by Subject|10|||
150251046|NCT04531098|542054458|FG000|Stage II|Adverse Event|1|||
150251047|NCT04531098|542054459|FG001|Stage II|Adverse Event|2|||
150251048|NCT04531098|542054460|FG002|Stage II|Adverse Event|0|||
150251049|NCT04531098|542054458|FG000|Stage II|Protocol Violation|1|||
150251050|NCT04531098|542054459|FG001|Stage II|Protocol Violation|2|||
150251051|NCT04531098|542054460|FG002|Stage II|Protocol Violation|0|||
150251052|NCT04531098|542054458|FG000|Stage II|Withdrawal by Subject|3|||
150251053|NCT04531098|542054459|FG001|Stage II|Withdrawal by Subject|1|||
150251054|NCT04531098|542054460|FG002|Stage II|Withdrawal by Subject|0|||
150251055|NCT04531098|542054458|FG000|Stage II|Moved from study area|8|||
150251056|NCT04531098|542054459|FG001|Stage II|Moved from study area|5|||
150251057|NCT04531098|542054460|FG002|Stage II|Moved from study area|0|||
150251058|NCT04531904|542054461|FG000|Overall Study|Lost to Follow-up|1|||
150251059|NCT04531904|542054461|FG000|Overall Study|Death|14|||
150251060|NCT00283244|542054462|FG000|Overall Study|Adverse Event|0|||
150251061|NCT00283244|542054463|FG001|Overall Study|Adverse Event|8|||
150251062|NCT00283244|542054464|FG002|Overall Study|Adverse Event|11|||
150251063|NCT00283244|542054462|FG000|Overall Study|Death|4|||
150251064|NCT00283244|542054463|FG001|Overall Study|Death|3|||
150251065|NCT00283244|542054464|FG002|Overall Study|Death|2|||
150251066|NCT00283244|542054462|FG000|Overall Study|Lack of Efficacy|8|||
150251067|NCT00283244|542054463|FG001|Overall Study|Lack of Efficacy|32|||
150251068|NCT00283244|542054464|FG002|Overall Study|Lack of Efficacy|26|||
150251069|NCT00283244|542054462|FG000|Overall Study|Withdrawal by Subject|1|||
150251070|NCT00283244|542054463|FG001|Overall Study|Withdrawal by Subject|2|||
150251071|NCT00283244|542054464|FG002|Overall Study|Withdrawal by Subject|2|||
150251072|NCT00283244|542054462|FG000|Overall Study|Physician Decision|0|||
150251073|NCT00283244|542054463|FG001|Overall Study|Physician Decision|0|||
150251074|NCT00283244|542054464|FG002|Overall Study|Physician Decision|1|||
150251075|NCT00283244|542054462|FG000|Overall Study|Medical illness (other complicating dz)|4|||
150251076|NCT00283244|542054463|FG001|Overall Study|Medical illness (other complicating dz)|3|||
150251077|NCT00283244|542054464|FG002|Overall Study|Medical illness (other complicating dz)|6|||
150251078|NCT00283244|542054462|FG000|Overall Study|Clinical deterioration|1|||
150251079|NCT00283244|542054463|FG001|Overall Study|Clinical deterioration|3|||
150251080|NCT00283244|542054464|FG002|Overall Study|Clinical deterioration|3|||
150251081|NCT02628028|542054465|FG000|Dosing Period|Withdrawal by Subject|0|||
150251082|NCT02628028|542054466|FG001|Dosing Period|Withdrawal by Subject|0|||
150251083|NCT02628028|542054467|FG002|Dosing Period|Withdrawal by Subject|1|||
150251084|NCT02628028|542054468|FG003|Dosing Period|Withdrawal by Subject|0|||
150251085|NCT02628028|542054469|FG004|Dosing Period|Withdrawal by Subject|2|||
150251086|NCT02628028|542054470|FG005|Dosing Period|Withdrawal by Subject|4|||
150251087|NCT02628028|542054471|FG006|Dosing Period|Withdrawal by Subject|1|||
150251088|NCT02628028|542054472|FG007|Dosing Period|Withdrawal by Subject|1|||
150251089|NCT02628028|542054465|FG000|Dosing Period|Adverse Event|0|||
150251090|NCT02628028|542054466|FG001|Dosing Period|Adverse Event|0|||
150251091|NCT02628028|542054467|FG002|Dosing Period|Adverse Event|0|||
150251092|NCT02628028|542054468|FG003|Dosing Period|Adverse Event|0|||
150251093|NCT02628028|542054469|FG004|Dosing Period|Adverse Event|2|||
150251094|NCT02628028|542054470|FG005|Dosing Period|Adverse Event|1|||
150251095|NCT02628028|542054471|FG006|Dosing Period|Adverse Event|3|||
150251096|NCT02628028|542054472|FG007|Dosing Period|Adverse Event|2|||
150251097|NCT02628028|542054465|FG000|Dosing Period|Death|0|||
150251098|NCT02628028|542054466|FG001|Dosing Period|Death|0|||
150251099|NCT02628028|542054467|FG002|Dosing Period|Death|0|||
150251100|NCT02628028|542054468|FG003|Dosing Period|Death|0|||
150251101|NCT02628028|542054469|FG004|Dosing Period|Death|0|||
150251102|NCT02628028|542054470|FG005|Dosing Period|Death|0|||
150251103|NCT02628028|542054471|FG006|Dosing Period|Death|0|||
150251104|NCT02628028|542054472|FG007|Dosing Period|Death|1|||
150251105|NCT02628028|542054465|FG000|Dosing Period|Lack of Efficacy|0|||
150251106|NCT02628028|542054466|FG001|Dosing Period|Lack of Efficacy|0|||
150251107|NCT02628028|542054467|FG002|Dosing Period|Lack of Efficacy|0|||
150251108|NCT02628028|542054468|FG003|Dosing Period|Lack of Efficacy|0|||
150251109|NCT02628028|542054469|FG004|Dosing Period|Lack of Efficacy|3|||
150251110|NCT02628028|542054470|FG005|Dosing Period|Lack of Efficacy|0|||
150251111|NCT02628028|542054471|FG006|Dosing Period|Lack of Efficacy|1|||
150251112|NCT02628028|542054472|FG007|Dosing Period|Lack of Efficacy|0|||
150251113|NCT02628028|542054465|FG000|Dosing Period|Study Terminated by Sponsor|0|||
150251114|NCT02628028|542054466|FG001|Dosing Period|Study Terminated by Sponsor|0|||
150251115|NCT02628028|542054467|FG002|Dosing Period|Study Terminated by Sponsor|0|||
150251116|NCT02628028|542054468|FG003|Dosing Period|Study Terminated by Sponsor|0|||
150251117|NCT02628028|542054469|FG004|Dosing Period|Study Terminated by Sponsor|7|||
150251118|NCT02628028|542054470|FG005|Dosing Period|Study Terminated by Sponsor|6|||
150251119|NCT02628028|542054471|FG006|Dosing Period|Study Terminated by Sponsor|7|||
150251120|NCT02628028|542054472|FG007|Dosing Period|Study Terminated by Sponsor|7|||
150251121|NCT02628028|542054465|FG000|Dosing Period|Physician Decision|0|||
150251122|NCT02628028|542054466|FG001|Dosing Period|Physician Decision|0|||
150251123|NCT02628028|542054467|FG002|Dosing Period|Physician Decision|0|||
150251124|NCT02628028|542054468|FG003|Dosing Period|Physician Decision|0|||
150251125|NCT02628028|542054469|FG004|Dosing Period|Physician Decision|0|||
150251126|NCT02628028|542054470|FG005|Dosing Period|Physician Decision|1|||
150251127|NCT02628028|542054471|FG006|Dosing Period|Physician Decision|0|||
150251128|NCT02628028|542054472|FG007|Dosing Period|Physician Decision|0|||
150251129|NCT02628028|542054465|FG000|Dosing Period|Site Terminated by Sponsor|0|||
150251130|NCT02628028|542054466|FG001|Dosing Period|Site Terminated by Sponsor|0|||
150251131|NCT02628028|542054467|FG002|Dosing Period|Site Terminated by Sponsor|0|||
150251132|NCT02628028|542054468|FG003|Dosing Period|Site Terminated by Sponsor|0|||
150251133|NCT02628028|542054469|FG004|Dosing Period|Site Terminated by Sponsor|0|||
150251134|NCT02628028|542054470|FG005|Dosing Period|Site Terminated by Sponsor|1|||
150251135|NCT02628028|542054471|FG006|Dosing Period|Site Terminated by Sponsor|1|||
150251136|NCT02628028|542054472|FG007|Dosing Period|Site Terminated by Sponsor|0|||
150251137|NCT02628028|542054465|FG000|Dosing Period|Lost to Follow-up|0|||
150251138|NCT02628028|542054466|FG001|Dosing Period|Lost to Follow-up|0|||
150251139|NCT02628028|542054467|FG002|Dosing Period|Lost to Follow-up|0|||
150251140|NCT02628028|542054468|FG003|Dosing Period|Lost to Follow-up|0|||
150251141|NCT02628028|542054469|FG004|Dosing Period|Lost to Follow-up|0|||
150251142|NCT02628028|542054470|FG005|Dosing Period|Lost to Follow-up|0|||
150251143|NCT02628028|542054471|FG006|Dosing Period|Lost to Follow-up|1|||
150251144|NCT02628028|542054472|FG007|Dosing Period|Lost to Follow-up|0|||
150251145|NCT02628028|542054465|FG000|Dosing Period|Other|0|||
150251146|NCT02628028|542054466|FG001|Dosing Period|Other|0|||
150251147|NCT02628028|542054467|FG002|Dosing Period|Other|0|||
150251148|NCT02628028|542054468|FG003|Dosing Period|Other|0|||
150251149|NCT02628028|542054469|FG004|Dosing Period|Other|2|||
150251150|NCT02628028|542054470|FG005|Dosing Period|Other|1|||
150251151|NCT02628028|542054471|FG006|Dosing Period|Other|2|||
150251152|NCT02628028|542054472|FG007|Dosing Period|Other|4|||
150251153|NCT02628028|542054465|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
150251154|NCT02628028|542054466|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
150251155|NCT02628028|542054467|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
150251156|NCT02628028|542054468|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
150251157|NCT02628028|542054469|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
150251158|NCT02628028|542054470|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
150251159|NCT02628028|542054471|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
150251160|NCT02628028|542054472|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
150251161|NCT02628028|542054465|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251162|NCT02628028|542054466|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251163|NCT02628028|542054467|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251164|NCT02628028|542054468|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251165|NCT02628028|542054469|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251166|NCT02628028|542054470|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
150251167|NCT02628028|542054471|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
150251168|NCT02628028|542054472|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
150251169|NCT02628028|542054465|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
150251170|NCT02628028|542054466|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
150251171|NCT02628028|542054467|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
150251172|NCT02628028|542054468|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
150251173|NCT02628028|542054469|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
150251174|NCT02628028|542054470|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
150251175|NCT02628028|542054471|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
150251176|NCT02628028|542054472|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
150251177|NCT02628028|542054465|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
150251178|NCT02628028|542054466|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
150251179|NCT02628028|542054467|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
150251180|NCT02628028|542054468|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
150251181|NCT02628028|542054469|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
150251182|NCT02628028|542054470|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
150251183|NCT02628028|542054471|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
150251184|NCT02628028|542054472|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
150251185|NCT02628028|542054465|FG000|Long-term Extension (LTE) Period|Other|0|||
150251186|NCT02628028|542054466|FG001|Long-term Extension (LTE) Period|Other|0|||
150251187|NCT02628028|542054467|FG002|Long-term Extension (LTE) Period|Other|0|||
150251188|NCT02628028|542054468|FG003|Long-term Extension (LTE) Period|Other|0|||
150251189|NCT02628028|542054469|FG004|Long-term Extension (LTE) Period|Other|0|||
150251190|NCT02628028|542054470|FG005|Long-term Extension (LTE) Period|Other|3|||
150251191|NCT02628028|542054471|FG006|Long-term Extension (LTE) Period|Other|4|||
150251192|NCT02628028|542054472|FG007|Long-term Extension (LTE) Period|Other|3|||
150251193|NCT03519997|542054475|FG000|Overall Study|Adverse Event|4|||
150251194|NCT03519997|542054475|FG000|Overall Study|Withdrawal by Subject|2|||
150251195|NCT03519997|542054475|FG000|Overall Study|Protocol Violation|1|||
150251196|NCT03361605|542054476|FG000|Overall Study|Analyzable data not available|3|||
150251197|NCT00186888|542054477|FG000|Overall Study|Toxicity|0|||
150251198|NCT00186888|542054478|FG001|Overall Study|Toxicity|1|||
150251199|NCT00186888|542054479|FG002|Overall Study|Toxicity|0|||
150251200|NCT00186888|542054477|FG000|Overall Study|Relapse or progression of disease|4|||
150251201|NCT00186888|542054478|FG001|Overall Study|Relapse or progression of disease|2|||
150251202|NCT00186888|542054479|FG002|Overall Study|Relapse or progression of disease|0|||
150251203|NCT02108964|542054480|FG000|Overall Study|Progressive disease|15|||
150251204|NCT02108964|542054481|FG001|Overall Study|Progressive disease|31|||
150251205|NCT02108964|542054482|FG002|Overall Study|Progressive disease|54|||
150251206|NCT02108964|542054483|FG003|Overall Study|Progressive disease|7|||
150251207|NCT02108964|542054484|FG004|Overall Study|Progressive disease|20|||
150251208|NCT02108964|542054485|FG005|Overall Study|Progressive disease|4|||
150251209|NCT02108964|542054486|FG006|Overall Study|Progressive disease|6|||
150251210|NCT02108964|542054487|FG007|Overall Study|Progressive disease|33|||
150251211|NCT02108964|542054480|FG000|Overall Study|Physician Decision|1|||
150251212|NCT02108964|542054481|FG001|Overall Study|Physician Decision|5|||
150251213|NCT02108964|542054482|FG002|Overall Study|Physician Decision|7|||
150251214|NCT02108964|542054483|FG003|Overall Study|Physician Decision|1|||
150251215|NCT02108964|542054484|FG004|Overall Study|Physician Decision|2|||
150251216|NCT02108964|542054485|FG005|Overall Study|Physician Decision|1|||
150251217|NCT02108964|542054486|FG006|Overall Study|Physician Decision|1|||
150251218|NCT02108964|542054487|FG007|Overall Study|Physician Decision|3|||
150251219|NCT02108964|542054480|FG000|Overall Study|Adverse Event|0|||
150251220|NCT02108964|542054481|FG001|Overall Study|Adverse Event|0|||
150251221|NCT02108964|542054482|FG002|Overall Study|Adverse Event|4|||
150251222|NCT02108964|542054483|FG003|Overall Study|Adverse Event|0|||
150251223|NCT02108964|542054484|FG004|Overall Study|Adverse Event|1|||
150251224|NCT02108964|542054485|FG005|Overall Study|Adverse Event|0|||
150251225|NCT02108964|542054486|FG006|Overall Study|Adverse Event|3|||
150251226|NCT02108964|542054487|FG007|Overall Study|Adverse Event|2|||
150251227|NCT02108964|542054480|FG000|Overall Study|Death|1|||
150251228|NCT02108964|542054481|FG001|Overall Study|Death|1|||
150251229|NCT02108964|542054482|FG002|Overall Study|Death|4|||
150251230|NCT02108964|542054483|FG003|Overall Study|Death|0|||
150251231|NCT02108964|542054484|FG004|Overall Study|Death|3|||
150251232|NCT02108964|542054485|FG005|Overall Study|Death|0|||
150251233|NCT02108964|542054486|FG006|Overall Study|Death|0|||
150251234|NCT02108964|542054487|FG007|Overall Study|Death|2|||
150251235|NCT02108964|542054480|FG000|Overall Study|Subject/Guardian decision|0|||
150251236|NCT02108964|542054481|FG001|Overall Study|Subject/Guardian decision|1|||
150251237|NCT02108964|542054482|FG002|Overall Study|Subject/Guardian decision|4|||
150251238|NCT02108964|542054483|FG003|Overall Study|Subject/Guardian decision|0|||
150251239|NCT02108964|542054484|FG004|Overall Study|Subject/Guardian decision|2|||
150251240|NCT02108964|542054485|FG005|Overall Study|Subject/Guardian decision|0|||
150251241|NCT02108964|542054486|FG006|Overall Study|Subject/Guardian decision|1|||
150251242|NCT02108964|542054487|FG007|Overall Study|Subject/Guardian decision|2|||
150251243|NCT02108964|542054480|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150251244|NCT02108964|542054481|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150251245|NCT02108964|542054482|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150251246|NCT02108964|542054483|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150255334|NCT00700427|542070610|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
150251247|NCT02108964|542054484|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150251248|NCT02108964|542054485|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150251249|NCT02108964|542054486|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
150255335|NCT00700427|542070611|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
150255336|NCT00700427|542070612|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
150251250|NCT02108964|542054487|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
150251251|NCT03006848|542054488|FG000|Overall Study|Adverse Event|1|||
150251252|NCT03006848|542054488|FG000|Overall Study|Physician Decision|1|||
150251253|NCT03006848|542054488|FG000|Overall Study|Lack of Efficacy|16|||
150251254|NCT04372121|542054489|FG000|Overall Study|Lost to Follow-up|0|||
150251255|NCT04372121|542054490|FG001|Overall Study|Lost to Follow-up|0|||
150251256|NCT04372121|542054491|FG002|Overall Study|Lost to Follow-up|0|||
150251257|NCT04372121|542054492|FG003|Overall Study|Lost to Follow-up|1|||
150251258|NCT04372121|542054489|FG000|Overall Study|Protocol Violation|0|||
150251259|NCT04372121|542054490|FG001|Overall Study|Protocol Violation|0|||
150251260|NCT04372121|542054491|FG002|Overall Study|Protocol Violation|1|||
150251261|NCT04372121|542054492|FG003|Overall Study|Protocol Violation|0|||
150251262|NCT04372121|542054489|FG000|Overall Study|Withdrawal by Subject|3|||
150251263|NCT04372121|542054490|FG001|Overall Study|Withdrawal by Subject|1|||
150251264|NCT04372121|542054491|FG002|Overall Study|Withdrawal by Subject|0|||
150251265|NCT04372121|542054492|FG003|Overall Study|Withdrawal by Subject|0|||
150251266|NCT04372121|542054489|FG000|Overall Study|Study termination|6|||
150251267|NCT04372121|542054490|FG001|Overall Study|Study termination|5|||
150251268|NCT04372121|542054491|FG002|Overall Study|Study termination|1|||
150251269|NCT04372121|542054492|FG003|Overall Study|Study termination|1|||
150251270|NCT04372121|542054489|FG000|Overall Study|Hysterectomy planned|1|||
150251271|NCT04372121|542054490|FG001|Overall Study|Hysterectomy planned|0|||
150251272|NCT04372121|542054491|FG002|Overall Study|Hysterectomy planned|0|||
150251273|NCT04372121|542054492|FG003|Overall Study|Hysterectomy planned|0|||
150251274|NCT03820947|542054497|FG000|Overall Study|Physician Decision|0|||
150251275|NCT03820947|542054498|FG001|Overall Study|Physician Decision|1|||
150251276|NCT03820947|542054499|FG002|Overall Study|Physician Decision|1|||
150251277|NCT03820947|542054500|FG003|Overall Study|Physician Decision|0|||
150251278|NCT03820947|542054501|FG004|Overall Study|Physician Decision|3|||
150251279|NCT03820947|542054497|FG000|Overall Study|Withdrawal by Subject|6|||
150251280|NCT03820947|542054498|FG001|Overall Study|Withdrawal by Subject|10|||
150251281|NCT03820947|542054499|FG002|Overall Study|Withdrawal by Subject|3|||
150251282|NCT03820947|542054500|FG003|Overall Study|Withdrawal by Subject|8|||
150251283|NCT03820947|542054501|FG004|Overall Study|Withdrawal by Subject|5|||
150251284|NCT03820947|542054497|FG000|Overall Study|Procedure Not Attempted|0|||
150251285|NCT03820947|542054498|FG001|Overall Study|Procedure Not Attempted|2|||
150251286|NCT03820947|542054499|FG002|Overall Study|Procedure Not Attempted|1|||
150251287|NCT03820947|542054500|FG003|Overall Study|Procedure Not Attempted|0|||
150251288|NCT03820947|542054501|FG004|Overall Study|Procedure Not Attempted|0|||
150251289|NCT03820947|542054497|FG000|Overall Study|Other Exit|1|||
150251290|NCT03820947|542054498|FG001|Overall Study|Other Exit|3|||
150251291|NCT03820947|542054499|FG002|Overall Study|Other Exit|3|||
149723453|NCT00984204|540124789|FG000|Overall Study|Death|1|||
149723454|NCT00984204|540124789|FG000|Overall Study|Lost to Follow-up|4|||
149723455|NCT00984204|540124789|FG000|Overall Study|Lack of Efficacy|10|||
149723469|NCT02787863|540124793|FG000|Overall Study|Death|1|||
149723470|NCT02787863|540124794|FG001|Overall Study|Death|0|||
149723471|NCT02787863|540124795|FG002|Overall Study|Death|1|||
149723472|NCT02787863|540124796|FG003|Overall Study|Death|0|||
149723473|NCT02787863|540124797|FG004|Overall Study|Death|0|||
149723474|NCT02787863|540124798|FG005|Overall Study|Death|0|||
149723475|NCT02787863|540124799|FG006|Overall Study|Death|0|||
149723476|NCT02787863|540124800|FG007|Overall Study|Death|0|||
149723477|NCT02787863|540124793|FG000|Overall Study|Withdrawal by Subject|0|||
149723478|NCT02787863|540124794|FG001|Overall Study|Withdrawal by Subject|1|||
149723479|NCT02787863|540124795|FG002|Overall Study|Withdrawal by Subject|1|||
149723480|NCT02787863|540124796|FG003|Overall Study|Withdrawal by Subject|0|||
149723481|NCT02787863|540124797|FG004|Overall Study|Withdrawal by Subject|0|||
149723482|NCT02787863|540124798|FG005|Overall Study|Withdrawal by Subject|0|||
149723483|NCT02787863|540124799|FG006|Overall Study|Withdrawal by Subject|0|||
149723484|NCT02787863|540124800|FG007|Overall Study|Withdrawal by Subject|0|||
150251292|NCT03820947|542054500|FG003|Overall Study|Other Exit|3|||
150251293|NCT03820947|542054501|FG004|Overall Study|Other Exit|0|||
150251294|NCT03820947|542054497|FG000|Overall Study|Follow-up Not Done|10|||
150251295|NCT03820947|542054498|FG001|Overall Study|Follow-up Not Done|13|||
150251296|NCT03820947|542054499|FG002|Overall Study|Follow-up Not Done|2|||
150251297|NCT03820947|542054500|FG003|Overall Study|Follow-up Not Done|3|||
149723501|NCT00252057|540124808|FG000|Overall Study|Withdrawal by Subject|2|||
149723502|NCT00252057|540124809|FG001|Overall Study|Withdrawal by Subject|5|||
149723503|NCT00252057|540124808|FG000|Overall Study|Death|1|||
149723504|NCT00252057|540124809|FG001|Overall Study|Death|2|||
149723505|NCT00252057|540124808|FG000|Overall Study|Participant previously enrolled|0|||
149723506|NCT00252057|540124809|FG001|Overall Study|Participant previously enrolled|1|||
150251298|NCT03820947|542054501|FG004|Overall Study|Follow-up Not Done|12|||
150251299|NCT03820947|542054497|FG000|Overall Study|Death|0|||
150251300|NCT03820947|542054498|FG001|Overall Study|Death|0|||
150251301|NCT03820947|542054499|FG002|Overall Study|Death|0|||
150251302|NCT03820947|542054500|FG003|Overall Study|Death|0|||
150251303|NCT03820947|542054501|FG004|Overall Study|Death|9|||
149723767|NCT00511355|540124861|FG000|Overall Study|Adverse Event|4|||
149723768|NCT00511355|540124862|FG001|Overall Study|Adverse Event|4|||
149723769|NCT00511355|540124861|FG000|Overall Study|Pregnancy Wish|1|||
149723770|NCT00511355|540124862|FG001|Overall Study|Pregnancy Wish|0|||
149723771|NCT00511355|540124861|FG000|Overall Study|Lost to Follow-up|2|||
150251304|NCT03820947|542054497|FG000|Overall Study|Lost to Follow-up|4|||
150251305|NCT03820947|542054498|FG001|Overall Study|Lost to Follow-up|6|||
150251306|NCT03820947|542054499|FG002|Overall Study|Lost to Follow-up|0|||
149723772|NCT00511355|540124862|FG001|Overall Study|Lost to Follow-up|1|||
149723773|NCT00511355|540124861|FG000|Overall Study|Other Reason|0|||
149723774|NCT00511355|540124862|FG001|Overall Study|Other Reason|1|||
150251307|NCT03820947|542054500|FG003|Overall Study|Lost to Follow-up|0|||
150251308|NCT03820947|542054501|FG004|Overall Study|Lost to Follow-up|9|||
149723775|NCT00511355|540124861|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
149723776|NCT00511355|540124862|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
149723777|NCT00511355|540124861|FG000|Overall Study|Withdrawal of informed consent|0|||
149723778|NCT00511355|540124862|FG001|Overall Study|Withdrawal of informed consent|1|||
149723779|NCT00511355|540124861|FG000|Overall Study|Other reason pre-treatment|0|||
149723780|NCT00511355|540124862|FG001|Overall Study|Other reason pre-treatment|1|||
149723781|NCT01632566|540124864|FG000|Overall Study|Withdrawal by Subject|0|||
149723782|NCT01632566|540124865|FG001|Overall Study|Withdrawal by Subject|1|||
149723783|NCT01632566|540124866|FG002|Overall Study|Withdrawal by Subject|0|||
149723784|NCT01632566|540124867|FG003|Overall Study|Withdrawal by Subject|0|||
149723785|NCT01632566|540124868|FG004|Overall Study|Withdrawal by Subject|0|||
149723786|NCT01632566|540124864|FG000|Overall Study|Sponsor Decision|0|||
149723787|NCT01632566|540124865|FG001|Overall Study|Sponsor Decision|2|||
149723788|NCT01632566|540124866|FG002|Overall Study|Sponsor Decision|9|||
149723789|NCT01632566|540124867|FG003|Overall Study|Sponsor Decision|2|||
149723790|NCT01632566|540124868|FG004|Overall Study|Sponsor Decision|2|||
149723803|NCT02158091|540124875|FG000|Overall Study|DLT|2|||
149723804|NCT02158091|540124876|FG001|Overall Study|DLT|1|||
149723805|NCT02158091|540124877|FG002|Overall Study|DLT|0|||
149723806|NCT03977467|540124878|FG000|Overall Study|Disease Progression|1|||
149723807|NCT03977467|540124879|FG001|Overall Study|Disease Progression|1|||
149723808|NCT03977467|540124880|FG002|Overall Study|Disease Progression|30|||
149723809|NCT03977467|540124881|FG003|Overall Study|Disease Progression|0|||
149723810|NCT03977467|540124878|FG000|Overall Study|Adverse Event|0|||
149723811|NCT03977467|540124879|FG001|Overall Study|Adverse Event|1|||
149723812|NCT03977467|540124880|FG002|Overall Study|Adverse Event|0|||
149723813|NCT03977467|540124881|FG003|Overall Study|Adverse Event|0|||
149723814|NCT03977467|540124878|FG000|Overall Study|Death|0|||
149723815|NCT03977467|540124879|FG001|Overall Study|Death|0|||
149723816|NCT03977467|540124880|FG002|Overall Study|Death|3|||
149723817|NCT03977467|540124881|FG003|Overall Study|Death|0|||
149723818|NCT03977467|540124878|FG000|Overall Study|Lack of Efficacy|0|||
149723819|NCT03977467|540124879|FG001|Overall Study|Lack of Efficacy|0|||
149723820|NCT03977467|540124880|FG002|Overall Study|Lack of Efficacy|1|||
149723821|NCT03977467|540124881|FG003|Overall Study|Lack of Efficacy|0|||
149723822|NCT03977467|540124878|FG000|Overall Study|Withdrawal by Subject|2|||
149723823|NCT03977467|540124879|FG001|Overall Study|Withdrawal by Subject|1|||
149723824|NCT03977467|540124880|FG002|Overall Study|Withdrawal by Subject|4|||
149723825|NCT03977467|540124881|FG003|Overall Study|Withdrawal by Subject|0|||
149723826|NCT03977467|540124878|FG000|Overall Study|Study Terminated|1|||
149723827|NCT03977467|540124879|FG001|Overall Study|Study Terminated|0|||
149723828|NCT03977467|540124880|FG002|Overall Study|Study Terminated|0|||
149723829|NCT03977467|540124881|FG003|Overall Study|Study Terminated|1|||
150251309|NCT01967147|542056110|FG000|Overall Study|Adverse Event|5|||
150251310|NCT01967147|542056111|FG001|Overall Study|Adverse Event|2|||
150251311|NCT01967147|542056110|FG000|Overall Study|Lack of Efficacy|1|||
150251312|NCT01967147|542056111|FG001|Overall Study|Lack of Efficacy|4|||
150251313|NCT01967147|542056110|FG000|Overall Study|Lost to Follow-up|1|||
150251314|NCT01967147|542056111|FG001|Overall Study|Lost to Follow-up|2|||
150251315|NCT01967147|542056110|FG000|Overall Study|Withdrawal by Subject|2|||
150251316|NCT01967147|542056111|FG001|Overall Study|Withdrawal by Subject|4|||
150251317|NCT01967147|542056110|FG000|Overall Study|Non-compliance with Study Drug|0|||
150251318|NCT01967147|542056111|FG001|Overall Study|Non-compliance with Study Drug|3|||
150251319|NCT01967147|542056110|FG000|Overall Study|Other|4|||
150251320|NCT01967147|542056111|FG001|Overall Study|Other|5|||
150251321|NCT03843554|542056112|FG000|Overall Study|Physician Decision|0|||
149724296|NCT05593016|540127122|FG000|Overall Study|Death|1|||
149724297|NCT05593016|540127123|FG001|Overall Study|Death|1|||
149724298|NCT05593016|540127124|FG002|Overall Study|Death|1|||
149724299|NCT05593016|540127125|FG003|Overall Study|Death|0|||
149724300|NCT05593016|540127126|FG004|Overall Study|Death|0|||
149724301|NCT05593016|540127122|FG000|Overall Study|Lost to Follow-up|1|||
149724302|NCT05593016|540127123|FG001|Overall Study|Lost to Follow-up|1|||
149724303|NCT05593016|540127124|FG002|Overall Study|Lost to Follow-up|1|||
149724304|NCT05593016|540127125|FG003|Overall Study|Lost to Follow-up|2|||
149724305|NCT05593016|540127126|FG004|Overall Study|Lost to Follow-up|0|||
149724306|NCT00598975|540127130|FG000|Overall Study|Adverse Event|1|||
149724307|NCT00598975|540127131|FG001|Overall Study|Adverse Event|1|||
149724308|NCT00598975|540127130|FG000|Overall Study|Brain metastases|1|||
149724309|NCT00598975|540127131|FG001|Overall Study|Brain metastases|0|||
149724310|NCT00598975|540127130|FG000|Overall Study|Withdrawal by Subject|1|||
149724311|NCT00598975|540127131|FG001|Overall Study|Withdrawal by Subject|1|||
149724312|NCT00598975|540127130|FG000|Overall Study|Withdrawal of consent|0|||
149724313|NCT00598975|540127131|FG001|Overall Study|Withdrawal of consent|1|||
149724314|NCT00598975|540127130|FG000|Overall Study|Disease progression|8|||
149724315|NCT00598975|540127131|FG001|Overall Study|Disease progression|3|||
149724316|NCT00598975|540127130|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
149724317|NCT00598975|540127131|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
149724318|NCT01790503|540127134|FG000|Overall Study|Adverse Event|1|||
149724319|NCT01790503|540127135|FG001|Overall Study|Adverse Event|0|||
149724320|NCT01790503|540127136|FG002|Overall Study|Adverse Event|0|||
149724321|NCT01790503|540127137|FG003|Overall Study|Adverse Event|0|||
149724322|NCT01790503|540127138|FG004|Overall Study|Adverse Event|0|||
149724323|NCT01790503|540127139|FG005|Overall Study|Adverse Event|2|||
149724324|NCT01790503|540127140|FG006|Overall Study|Adverse Event|0|||
149724325|NCT01790503|540127141|FG007|Overall Study|Adverse Event|0|||
149724326|NCT01790503|540127142|FG008|Overall Study|Adverse Event|2|||
149724327|NCT01790503|540127143|FG009|Overall Study|Adverse Event|4|||
150251322|NCT03843554|542056113|FG001|Overall Study|Physician Decision|2|||
150251323|NCT02218606|542056115|FG000|Overall Study|Adverse Event|1|||
149724328|NCT01790503|540127144|FG010|Overall Study|Adverse Event|7|||
149724329|NCT01790503|540127134|FG000|Overall Study|Withdrawal by Subject|0|||
149724330|NCT01790503|540127135|FG001|Overall Study|Withdrawal by Subject|0|||
149724331|NCT01790503|540127136|FG002|Overall Study|Withdrawal by Subject|1|||
149724332|NCT01790503|540127137|FG003|Overall Study|Withdrawal by Subject|1|||
149724333|NCT01790503|540127138|FG004|Overall Study|Withdrawal by Subject|1|||
149724334|NCT01790503|540127139|FG005|Overall Study|Withdrawal by Subject|2|||
149724335|NCT01790503|540127140|FG006|Overall Study|Withdrawal by Subject|1|||
149724336|NCT01790503|540127141|FG007|Overall Study|Withdrawal by Subject|0|||
149724337|NCT01790503|540127142|FG008|Overall Study|Withdrawal by Subject|0|||
149724338|NCT01790503|540127143|FG009|Overall Study|Withdrawal by Subject|0|||
149724339|NCT01790503|540127144|FG010|Overall Study|Withdrawal by Subject|1|||
150251324|NCT02218606|542056116|FG001|Overall Study|Adverse Event|1|||
149724340|NCT01790503|540127134|FG000|Overall Study|Disease progression|2|||
149724341|NCT01790503|540127135|FG001|Overall Study|Disease progression|1|||
149724342|NCT01790503|540127136|FG002|Overall Study|Disease progression|0|||
149724343|NCT01790503|540127137|FG003|Overall Study|Disease progression|1|||
149724344|NCT01790503|540127138|FG004|Overall Study|Disease progression|2|||
149724345|NCT01790503|540127139|FG005|Overall Study|Disease progression|1|||
149724346|NCT01790503|540127140|FG006|Overall Study|Disease progression|0|||
149724347|NCT01790503|540127141|FG007|Overall Study|Disease progression|1|||
149724348|NCT01790503|540127142|FG008|Overall Study|Disease progression|0|||
149724349|NCT01790503|540127143|FG009|Overall Study|Disease progression|17|||
149724350|NCT01790503|540127144|FG010|Overall Study|Disease progression|7|||
149724351|NCT01790503|540127134|FG000|Overall Study|Protocol Violation|0|||
149724352|NCT01790503|540127135|FG001|Overall Study|Protocol Violation|0|||
149724353|NCT01790503|540127136|FG002|Overall Study|Protocol Violation|0|||
149724354|NCT01790503|540127137|FG003|Overall Study|Protocol Violation|0|||
149724355|NCT01790503|540127138|FG004|Overall Study|Protocol Violation|0|||
149724356|NCT01790503|540127139|FG005|Overall Study|Protocol Violation|0|||
149724357|NCT01790503|540127140|FG006|Overall Study|Protocol Violation|0|||
149724358|NCT01790503|540127141|FG007|Overall Study|Protocol Violation|0|||
149724359|NCT01790503|540127142|FG008|Overall Study|Protocol Violation|0|||
149724360|NCT01790503|540127143|FG009|Overall Study|Protocol Violation|1|||
149724361|NCT01790503|540127144|FG010|Overall Study|Protocol Violation|0|||
149724362|NCT01790503|540127134|FG000|Overall Study|Physician Decision|0|||
149724363|NCT01790503|540127135|FG001|Overall Study|Physician Decision|0|||
149724364|NCT01790503|540127136|FG002|Overall Study|Physician Decision|0|||
149724365|NCT01790503|540127137|FG003|Overall Study|Physician Decision|0|||
149724366|NCT01790503|540127138|FG004|Overall Study|Physician Decision|0|||
149724367|NCT01790503|540127139|FG005|Overall Study|Physician Decision|0|||
149724368|NCT01790503|540127140|FG006|Overall Study|Physician Decision|0|||
149724369|NCT01790503|540127141|FG007|Overall Study|Physician Decision|0|||
149724370|NCT01790503|540127142|FG008|Overall Study|Physician Decision|0|||
149724371|NCT01790503|540127143|FG009|Overall Study|Physician Decision|1|||
149724372|NCT01790503|540127144|FG010|Overall Study|Physician Decision|1|||
149724373|NCT01790503|540127134|FG000|Overall Study|Death|0|||
149724374|NCT01790503|540127135|FG001|Overall Study|Death|0|||
149724375|NCT01790503|540127136|FG002|Overall Study|Death|0|||
149724376|NCT01790503|540127137|FG003|Overall Study|Death|0|||
149724377|NCT01790503|540127138|FG004|Overall Study|Death|0|||
149724378|NCT01790503|540127139|FG005|Overall Study|Death|0|||
149724379|NCT01790503|540127140|FG006|Overall Study|Death|0|||
149724380|NCT01790503|540127141|FG007|Overall Study|Death|0|||
149724381|NCT01790503|540127142|FG008|Overall Study|Death|0|||
149724382|NCT01790503|540127143|FG009|Overall Study|Death|1|||
149724383|NCT01790503|540127144|FG010|Overall Study|Death|0|||
149724384|NCT01790503|540127134|FG000|Overall Study|Non Compliance|0|||
149724385|NCT01790503|540127135|FG001|Overall Study|Non Compliance|0|||
149724386|NCT01790503|540127136|FG002|Overall Study|Non Compliance|0|||
149724387|NCT01790503|540127137|FG003|Overall Study|Non Compliance|0|||
149724388|NCT01790503|540127138|FG004|Overall Study|Non Compliance|1|||
149724389|NCT01790503|540127139|FG005|Overall Study|Non Compliance|0|||
149724390|NCT01790503|540127140|FG006|Overall Study|Non Compliance|0|||
149724391|NCT01790503|540127141|FG007|Overall Study|Non Compliance|0|||
149724392|NCT01790503|540127142|FG008|Overall Study|Non Compliance|0|||
149724393|NCT01790503|540127143|FG009|Overall Study|Non Compliance|0|||
149724394|NCT01790503|540127144|FG010|Overall Study|Non Compliance|0|||
149724395|NCT01790503|540127134|FG000|Overall Study|Other|0|||
149724396|NCT01790503|540127135|FG001|Overall Study|Other|0|||
149724397|NCT01790503|540127136|FG002|Overall Study|Other|0|||
149724398|NCT01790503|540127137|FG003|Overall Study|Other|0|||
149724399|NCT01790503|540127138|FG004|Overall Study|Other|1|||
149724400|NCT01790503|540127139|FG005|Overall Study|Other|0|||
149724401|NCT01790503|540127140|FG006|Overall Study|Other|0|||
149724402|NCT01790503|540127141|FG007|Overall Study|Other|0|||
149724403|NCT01790503|540127142|FG008|Overall Study|Other|1|||
149724404|NCT01790503|540127143|FG009|Overall Study|Other|2|||
149724405|NCT01790503|540127144|FG010|Overall Study|Other|0|||
150251325|NCT02218606|542056115|FG000|Overall Study|Death|15|||
150251326|NCT02218606|542056116|FG001|Overall Study|Death|28|||
150251327|NCT02218606|542056115|FG000|Overall Study|Physician Decision|0|||
149724406|NCT02322710|540127147|FG000|Overall Study|No efficacy assessment post-baseline|0|||
149724407|NCT02322710|540127148|FG001|Overall Study|No efficacy assessment post-baseline|1|||
149724408|NCT02322710|540127147|FG000|Overall Study|Protocol Violation|20|||
149724409|NCT02322710|540127148|FG001|Overall Study|Protocol Violation|25|||
149724410|NCT00122135|540127150|FG000|Overall Study|Withdrawal by Subject|3|||
149724411|NCT00122135|540127151|FG001|Overall Study|Withdrawal by Subject|0|||
149724412|NCT02770326|540127155|FG000|Overall Study|Death|3|||
149724413|NCT02770326|540127155|FG000|Overall Study|Lost to Follow-up|1|||
149724414|NCT02479802|540127161|FG000|Overall Study|Lost to Follow-up|1|||
149724415|NCT02479802|540127161|FG000|Overall Study|Adverse Event|1|||
149724416|NCT03124784|540127162|FG000|Overall Study|Adverse Event|1|||
149724417|NCT03124784|540127162|FG000|Overall Study|Computer/Equip Malfunction|1|||
149737563|NCT00408005|540170385|FG000|Induction|Refusal of Further Protocol Therapy|225|||
149724418|NCT05702515|540127163|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
149724419|NCT02162732|540127164|FG000|Overall Study|Biopsy not performed.|18|||
149724420|NCT03757988|540127165|FG000|Overall Study|Withdrawal by Subject|1|||
149724421|NCT01121393|540127170|FG000|Overall Study|Progressive disease|201|||
149724422|NCT01121393|540127171|FG001|Overall Study|Progressive disease|20|||
149724423|NCT01121393|540127170|FG000|Overall Study|Other Adverse events|24|||
149724424|NCT01121393|540127171|FG001|Overall Study|Other Adverse events|45|||
149724425|NCT01121393|540127170|FG000|Overall Study|Non-compliant with protocol|0|||
149724426|NCT01121393|540127171|FG001|Overall Study|Non-compliant with protocol|3|||
149724427|NCT01121393|540127170|FG000|Overall Study|Lost to Follow-up|1|||
149724428|NCT01121393|540127171|FG001|Overall Study|Lost to Follow-up|0|||
149724429|NCT01121393|540127170|FG000|Overall Study|Refused cont. medication|7|||
149724430|NCT01121393|540127171|FG001|Overall Study|Refused cont. medication|7|||
149724431|NCT01121393|540127170|FG000|Overall Study|Not treated|3|||
149724432|NCT01121393|540127171|FG001|Overall Study|Not treated|9|||
149724433|NCT01121393|540127170|FG000|Overall Study|Other than listed|6|||
149724434|NCT01121393|540127171|FG001|Overall Study|Other than listed|0|||
149724435|NCT04372927|540127172|FG000|Overall Study|Death|1|||
149724436|NCT00577993|540127173|FG000|Overall Study|Adverse Event|1|||
149724437|NCT00577993|540127174|FG001|Overall Study|Adverse Event|0|||
149724438|NCT00577993|540127175|FG002|Overall Study|Adverse Event|0|||
149724439|NCT00577993|540127173|FG000|Overall Study|Death|0|||
149724440|NCT00577993|540127174|FG001|Overall Study|Death|1|||
149724441|NCT00577993|540127175|FG002|Overall Study|Death|1|||
149724442|NCT00577993|540127173|FG000|Overall Study|Lack of Efficacy|0|||
149724443|NCT00577993|540127174|FG001|Overall Study|Lack of Efficacy|1|||
149724444|NCT00577993|540127175|FG002|Overall Study|Lack of Efficacy|0|||
149724445|NCT00577993|540127173|FG000|Overall Study|Protocol Violation|2|||
149724446|NCT00577993|540127174|FG001|Overall Study|Protocol Violation|3|||
149724447|NCT00577993|540127175|FG002|Overall Study|Protocol Violation|0|||
149724448|NCT00577993|540127173|FG000|Overall Study|Withdrawal by Subject|1|||
149724449|NCT00577993|540127174|FG001|Overall Study|Withdrawal by Subject|0|||
149724450|NCT00577993|540127175|FG002|Overall Study|Withdrawal by Subject|2|||
149724451|NCT00577993|540127173|FG000|Overall Study|Conversion|2|||
149724452|NCT00577993|540127174|FG001|Overall Study|Conversion|5|||
149724453|NCT00577993|540127175|FG002|Overall Study|Conversion|0|||
149724454|NCT00577993|540127173|FG000|Overall Study|Uninsured|1|||
149724455|NCT00577993|540127174|FG001|Overall Study|Uninsured|0|||
149724456|NCT00577993|540127175|FG002|Overall Study|Uninsured|0|||
149724457|NCT00608985|540127183|FG000|Overall Study|Adverse Event|2|||
149724458|NCT00608985|540127184|FG001|Overall Study|Adverse Event|7|||
149724459|NCT00608985|540127185|FG002|Overall Study|Adverse Event|4|||
149724460|NCT00608985|540127186|FG003|Overall Study|Adverse Event|6|||
149724461|NCT00608985|540127183|FG000|Overall Study|Administrative/Other|7|||
149724462|NCT00608985|540127184|FG001|Overall Study|Administrative/Other|4|||
149724463|NCT00608985|540127185|FG002|Overall Study|Administrative/Other|1|||
149724464|NCT00608985|540127186|FG003|Overall Study|Administrative/Other|2|||
149724465|NCT00608985|540127183|FG000|Overall Study|Withdrawal of Consent|5|||
149724466|NCT00608985|540127184|FG001|Overall Study|Withdrawal of Consent|1|||
149724467|NCT00608985|540127185|FG002|Overall Study|Withdrawal of Consent|1|||
149724468|NCT00608985|540127186|FG003|Overall Study|Withdrawal of Consent|1|||
149724469|NCT00608985|540127183|FG000|Overall Study|Lost to Follow-up|2|||
149724470|NCT00608985|540127184|FG001|Overall Study|Lost to Follow-up|1|||
149724471|NCT00608985|540127185|FG002|Overall Study|Lost to Follow-up|0|||
149724472|NCT00608985|540127186|FG003|Overall Study|Lost to Follow-up|0|||
149724473|NCT03033745|540127187|FG000|Overall Study|Protocol Violation|0|||
149724474|NCT03033745|540127188|FG001|Overall Study|Protocol Violation|0|||
150251328|NCT02218606|542056116|FG001|Overall Study|Physician Decision|1|||
150251329|NCT02218606|542056115|FG000|Overall Study|Withdrawal by Subject|4|||
150251330|NCT02218606|542056116|FG001|Overall Study|Withdrawal by Subject|0|||
150251331|NCT02218606|542056115|FG000|Overall Study|Noncompliance|1|||
150251332|NCT02218606|542056116|FG001|Overall Study|Noncompliance|0|||
150251333|NCT02218606|542056115|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
150251334|NCT02218606|542056116|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
150251335|NCT02218606|542056115|FG000|Overall Study|Other|2|||
150251336|NCT02218606|542056116|FG001|Overall Study|Other|1|||
150251337|NCT02218606|542056115|FG000|Overall Study|Never started treatment|0|||
150251338|NCT02218606|542056116|FG001|Overall Study|Never started treatment|1|||
150251339|NCT03203473|542056117|FG000|Induction Phase|Never started primary treatment|2|||
150251340|NCT03203473|542056118|FG001|Induction Phase|Never started primary treatment|0|||
150251341|NCT03203473|542056119|FG002|Induction Phase|Never started primary treatment|0|||
150251342|NCT03203473|542056117|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
150251343|NCT03203473|542056118|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
149724475|NCT03033745|540127189|FG002|Overall Study|Protocol Violation|1|||
150251344|NCT03203473|542056119|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
150251345|NCT03203473|542056117|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
149724476|NCT03033745|540127187|FG000|Overall Study|Adverse Event|1|||
149724477|NCT03033745|540127188|FG001|Overall Study|Adverse Event|0|||
149724478|NCT03033745|540127189|FG002|Overall Study|Adverse Event|1|||
149724479|NCT03033745|540127187|FG000|Overall Study|Withdrawal by Subject|0|||
149724480|NCT03033745|540127188|FG001|Overall Study|Withdrawal by Subject|1|||
149724481|NCT03033745|540127189|FG002|Overall Study|Withdrawal by Subject|0|||
149724482|NCT02706730|540127190|FG000|Overall Study|Adverse Event|3|||
149724483|NCT02706730|540127190|FG000|Overall Study|Lack of Efficacy|5|||
149724484|NCT02706730|540127190|FG000|Overall Study|Withdrawal by Subject|11|||
149724485|NCT02706730|540127190|FG000|Overall Study|Study Terminated by Sponsor|11|||
149724486|NCT02706730|540127190|FG000|Overall Study|Subject chose not to receive injection|3|||
149724487|NCT02499029|540127191|FG000|Overall Study|Lost to Follow-up|2|||
149724488|NCT02499029|540127192|FG001|Overall Study|Lost to Follow-up|2|||
149724489|NCT02499029|540127191|FG000|Overall Study|Physician Decision|2|||
149724490|NCT02499029|540127192|FG001|Overall Study|Physician Decision|1|||
149724491|NCT02499029|540127191|FG000|Overall Study|Death|1|||
149724492|NCT02499029|540127192|FG001|Overall Study|Death|0|||
149724493|NCT01999582|540127193|FG000|Overall Study|Withdrawal by Subject|0|||
149724494|NCT01999582|540127194|FG001|Overall Study|Withdrawal by Subject|0|||
149724495|NCT01999582|540127195|FG002|Overall Study|Withdrawal by Subject|0|||
149724496|NCT01999582|540127196|FG003|Overall Study|Withdrawal by Subject|1|||
149724497|NCT01999582|540127197|FG004|Overall Study|Withdrawal by Subject|0|||
149724498|NCT01999582|540127198|FG005|Overall Study|Withdrawal by Subject|0|||
149724499|NCT01999582|540127193|FG000|Overall Study|Adverse Event|0|||
149724500|NCT01999582|540127194|FG001|Overall Study|Adverse Event|0|||
149724501|NCT01999582|540127195|FG002|Overall Study|Adverse Event|3|||
149724502|NCT01999582|540127196|FG003|Overall Study|Adverse Event|0|||
149724503|NCT01999582|540127197|FG004|Overall Study|Adverse Event|1|||
149724504|NCT01999582|540127198|FG005|Overall Study|Adverse Event|0|||
149724505|NCT01999582|540127193|FG000|Overall Study|Other Reasons|1|||
149724506|NCT01999582|540127194|FG001|Overall Study|Other Reasons|0|||
149724507|NCT01999582|540127195|FG002|Overall Study|Other Reasons|3|||
149724508|NCT01999582|540127196|FG003|Overall Study|Other Reasons|1|||
149724509|NCT01999582|540127197|FG004|Overall Study|Other Reasons|1|||
149724510|NCT01999582|540127198|FG005|Overall Study|Other Reasons|2|||
149724511|NCT01999582|540127193|FG000|Overall Study|Protocol Violation|1|||
149724512|NCT01999582|540127194|FG001|Overall Study|Protocol Violation|0|||
149724513|NCT01999582|540127195|FG002|Overall Study|Protocol Violation|0|||
149724514|NCT01999582|540127196|FG003|Overall Study|Protocol Violation|0|||
149724515|NCT01999582|540127197|FG004|Overall Study|Protocol Violation|0|||
149724516|NCT01999582|540127198|FG005|Overall Study|Protocol Violation|1|||
149724517|NCT01999582|540127193|FG000|Overall Study|Lack of Efficacy|1|||
149724518|NCT01999582|540127194|FG001|Overall Study|Lack of Efficacy|3|||
149724519|NCT01999582|540127195|FG002|Overall Study|Lack of Efficacy|0|||
149724520|NCT01999582|540127196|FG003|Overall Study|Lack of Efficacy|1|||
149724521|NCT01999582|540127197|FG004|Overall Study|Lack of Efficacy|0|||
149724522|NCT01999582|540127198|FG005|Overall Study|Lack of Efficacy|0|||
149724523|NCT01081795|540127201|FG000|Overall Study|Adverse Event|18|||
149724524|NCT01081795|540127202|FG001|Overall Study|Adverse Event|23|||
149724525|NCT01081795|540127203|FG002|Overall Study|Adverse Event|6|||
149724526|NCT01081795|540127201|FG000|Overall Study|Lack of Efficacy|7|||
149724527|NCT01081795|540127202|FG001|Overall Study|Lack of Efficacy|5|||
149724528|NCT01081795|540127203|FG002|Overall Study|Lack of Efficacy|19|||
149724529|NCT01081795|540127201|FG000|Overall Study|Subject's schedule|1|||
149724530|NCT01081795|540127202|FG001|Overall Study|Subject's schedule|1|||
149724531|NCT01081795|540127203|FG002|Overall Study|Subject's schedule|2|||
149724532|NCT01081795|540127201|FG000|Overall Study|Revocation of informed consent|2|||
149724533|NCT01081795|540127202|FG001|Overall Study|Revocation of informed consent|0|||
149724534|NCT01081795|540127203|FG002|Overall Study|Revocation of informed consent|0|||
149724535|NCT01081795|540127201|FG000|Overall Study|Ineligible for participation|1|||
149724536|NCT01081795|540127202|FG001|Overall Study|Ineligible for participation|0|||
150251346|NCT03203473|542056118|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
150251347|NCT03203473|542056119|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
150251348|NCT03203473|542056117|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
150251349|NCT03203473|542056118|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
150251350|NCT03203473|542056119|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
150251351|NCT03203473|542056117|FG000|Arm Allocation Phase|started salvage therapy|0|||
150251352|NCT03203473|542056118|FG001|Arm Allocation Phase|started salvage therapy|5|||
150251353|NCT03203473|542056119|FG002|Arm Allocation Phase|started salvage therapy|0|||
150251354|NCT03203473|542056117|FG000|Arm Allocation Phase|Disease progression|0|||
150251355|NCT03203473|542056118|FG001|Arm Allocation Phase|Disease progression|0|||
150251356|NCT03203473|542056119|FG002|Arm Allocation Phase|Disease progression|37|||
149724537|NCT01081795|540127203|FG002|Overall Study|Ineligible for participation|0|||
149724538|NCT01081795|540127201|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
149724539|NCT01081795|540127202|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
149724540|NCT01081795|540127203|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
149724541|NCT01081795|540127201|FG000|Overall Study|Using drug with restricted days of use|2|||
149724542|NCT01081795|540127202|FG001|Overall Study|Using drug with restricted days of use|3|||
150251357|NCT03203473|542056117|FG000|Arm Allocation Phase|Adverse Event|0|||
150251358|NCT03203473|542056118|FG001|Arm Allocation Phase|Adverse Event|0|||
150251359|NCT03203473|542056119|FG002|Arm Allocation Phase|Adverse Event|11|||
150251360|NCT03203473|542056117|FG000|Arm Allocation Phase|Physician Decision|0|||
150251361|NCT03203473|542056118|FG001|Arm Allocation Phase|Physician Decision|0|||
150251362|NCT03203473|542056119|FG002|Arm Allocation Phase|Physician Decision|3|||
150251363|NCT03203473|542056117|FG000|Arm Allocation Phase|Death|0|||
150251364|NCT03203473|542056118|FG001|Arm Allocation Phase|Death|0|||
150251365|NCT03203473|542056119|FG002|Arm Allocation Phase|Death|1|||
150251366|NCT03203473|542056117|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
150251367|NCT03203473|542056118|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
150251368|NCT03203473|542056119|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
150251369|NCT03203473|542056117|FG000|Arm Allocation Phase|Intercurrent illness|0|||
150251370|NCT03203473|542056118|FG001|Arm Allocation Phase|Intercurrent illness|0|||
150251371|NCT03203473|542056119|FG002|Arm Allocation Phase|Intercurrent illness|1|||
150251372|NCT03203473|542056117|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
150251373|NCT03203473|542056118|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
150251374|NCT03203473|542056119|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
150251375|NCT02314780|542056126|FG000|Overall Study|organizational reasons|0|||
150251376|NCT02314780|542056127|FG001|Overall Study|organizational reasons|2|||
150251377|NCT02314780|542056128|FG002|Overall Study|organizational reasons|0|||
150251378|NCT02314780|542056126|FG000|Overall Study|Adverse Event|0|||
150251379|NCT02314780|542056127|FG001|Overall Study|Adverse Event|1|||
150251380|NCT02314780|542056128|FG002|Overall Study|Adverse Event|0|||
150251381|NCT01077271|542056132|FG000|Overall Study|Parental desire|8|||
150251382|NCT01077271|542056132|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
150251383|NCT01077271|542056132|FG000|Overall Study|Noncompliance|2|||
150251384|NCT01077271|542056132|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
150251385|NCT01077271|542056132|FG000|Overall Study|Changed doctors|2|||
150251386|NCT01077271|542056132|FG000|Overall Study|Parents thought too many injections|2|||
150251387|NCT01077271|542056132|FG000|Overall Study|End of RSV season nearly reached|1|||
150251388|NCT01077271|542056132|FG000|Overall Study|Mother unconvinced of the necessity|1|||
150251389|NCT04396366|542056135|FG000|Overall Study|Adverse Event|1|||
150251390|NCT04396366|542056136|FG001|Overall Study|Adverse Event|0|||
150251391|NCT00166712|542056138|FG000|Overall Study|Death|0|||
150251392|NCT00166712|542056139|FG001|Overall Study|Death|1|||
150251393|NCT00166712|542056138|FG000|Overall Study|Adverse Event|1|||
150251394|NCT00166712|542056139|FG001|Overall Study|Adverse Event|0|||
150251395|NCT00166712|542056138|FG000|Overall Study|Withdrawal by Subject|1|||
150251396|NCT00166712|542056139|FG001|Overall Study|Withdrawal by Subject|2|||
150251397|NCT00166712|542056138|FG000|Overall Study|Physician Decision|0|||
150251398|NCT00166712|542056139|FG001|Overall Study|Physician Decision|2|||
150251399|NCT04684394|542056140|FG000|Overall Study|Death|1|||
150251400|NCT04684394|542056141|FG001|Overall Study|Death|2|||
150251401|NCT04684394|542056140|FG000|Overall Study|Lost to Follow-up|1|||
150251402|NCT04684394|542056141|FG001|Overall Study|Lost to Follow-up|0|||
150251403|NCT04684394|542056140|FG000|Overall Study|Withdrawal by Subject|2|||
150251404|NCT04684394|542056141|FG001|Overall Study|Withdrawal by Subject|0|||
150251405|NCT04684394|542056140|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
150251406|NCT04684394|542056141|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
150251407|NCT00640133|542056144|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
150251408|NCT00640133|542056145|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
150251409|NCT00640133|542056144|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
150251410|NCT00640133|542056145|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
150251411|NCT00640133|542056144|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
150251412|NCT00640133|542056145|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
150251413|NCT01183260|542056146|FG000|Overall Study|Intraop screen failure|2|||
150251414|NCT01183260|542056147|FG001|Overall Study|Intraop screen failure|0|||
150251415|NCT01183260|542056146|FG000|Overall Study|Withdrawal by Subject|1|||
150251416|NCT01183260|542056147|FG001|Overall Study|Withdrawal by Subject|1|||
150251417|NCT01183260|542056146|FG000|Overall Study|Revised within 30 days|0|||
150251418|NCT01183260|542056147|FG001|Overall Study|Revised within 30 days|1|||
150251419|NCT01183260|542056146|FG000|Overall Study|Death|1|||
150251420|NCT01183260|542056147|FG001|Overall Study|Death|0|||
149724543|NCT01081795|540127203|FG002|Overall Study|Using drug with restricted days of use|2|||
149724544|NCT01081795|540127201|FG000|Overall Study|Other|1|||
149724545|NCT01081795|540127202|FG001|Overall Study|Other|2|||
150251421|NCT00128102|542056148|FG000|Overall Study|Site Discontinued|3|||
150251422|NCT00128102|542056149|FG001|Overall Study|Site Discontinued|6|||
149724546|NCT01081795|540127203|FG002|Overall Study|Other|0|||
149724547|NCT02462473|540127204|FG000|Overall Study|Death|1|||
149724548|NCT02462473|540127204|FG000|Overall Study|Other|3|||
149724549|NCT00661271|540127205|FG000|Overall Study|Lost to Follow-up|28|||
150251423|NCT00128102|542056148|FG000|Overall Study|Other|0|||
150251424|NCT00128102|542056149|FG001|Overall Study|Other|1|||
150251425|NCT00128102|542056148|FG000|Overall Study|Progressive Disease|255|||
149724550|NCT00661271|540127206|FG001|Overall Study|Lost to Follow-up|25|||
149724551|NCT00953758|540127208|FG000|Overall Study|Death|2|||
149724552|NCT00953758|540127209|FG001|Overall Study|Death|0|||
149724553|NCT00953758|540127210|FG002|Overall Study|Death|1|||
149724554|NCT00953758|540127211|FG003|Overall Study|Death|1|||
149724555|NCT00953758|540127212|FG004|Overall Study|Death|1|||
149724556|NCT00953758|540127213|FG005|Overall Study|Death|1|||
149724557|NCT00953758|540127214|FG006|Overall Study|Death|1|||
149724558|NCT00953758|540127215|FG007|Overall Study|Death|3|||
149724559|NCT00953758|540127216|FG008|Overall Study|Death|1|||
149724560|NCT00953758|540127217|FG009|Overall Study|Death|0|||
149724561|NCT00953758|540127208|FG000|Overall Study|Participant refused further follow-up|0|||
149724562|NCT00953758|540127209|FG001|Overall Study|Participant refused further follow-up|0|||
149724563|NCT00953758|540127210|FG002|Overall Study|Participant refused further follow-up|1|||
149724564|NCT00953758|540127211|FG003|Overall Study|Participant refused further follow-up|0|||
149724565|NCT00953758|540127212|FG004|Overall Study|Participant refused further follow-up|3|||
149724566|NCT00953758|540127213|FG005|Overall Study|Participant refused further follow-up|0|||
149724567|NCT00953758|540127214|FG006|Overall Study|Participant refused further follow-up|0|||
149724568|NCT00953758|540127215|FG007|Overall Study|Participant refused further follow-up|0|||
149724569|NCT00953758|540127216|FG008|Overall Study|Participant refused further follow-up|1|||
149724570|NCT00953758|540127217|FG009|Overall Study|Participant refused further follow-up|0|||
149724571|NCT00953758|540127208|FG000|Overall Study|Lost to Follow-up|0|||
149724572|NCT00953758|540127209|FG001|Overall Study|Lost to Follow-up|0|||
149724573|NCT00953758|540127210|FG002|Overall Study|Lost to Follow-up|0|||
149724574|NCT00953758|540127211|FG003|Overall Study|Lost to Follow-up|1|||
149724575|NCT00953758|540127212|FG004|Overall Study|Lost to Follow-up|0|||
149724576|NCT00953758|540127213|FG005|Overall Study|Lost to Follow-up|0|||
149724577|NCT00953758|540127214|FG006|Overall Study|Lost to Follow-up|0|||
149724578|NCT00953758|540127215|FG007|Overall Study|Lost to Follow-up|1|||
149724579|NCT00953758|540127216|FG008|Overall Study|Lost to Follow-up|0|||
149724580|NCT00953758|540127217|FG009|Overall Study|Lost to Follow-up|1|||
149724581|NCT00953758|540127208|FG000|Overall Study|Physician Decision|0|||
149724582|NCT00953758|540127209|FG001|Overall Study|Physician Decision|0|||
149724583|NCT00953758|540127210|FG002|Overall Study|Physician Decision|0|||
149724584|NCT00953758|540127211|FG003|Overall Study|Physician Decision|0|||
149724585|NCT00953758|540127212|FG004|Overall Study|Physician Decision|1|||
149724586|NCT00953758|540127213|FG005|Overall Study|Physician Decision|0|||
149724587|NCT00953758|540127214|FG006|Overall Study|Physician Decision|0|||
149724588|NCT00953758|540127215|FG007|Overall Study|Physician Decision|0|||
149724589|NCT00953758|540127216|FG008|Overall Study|Physician Decision|0|||
149724590|NCT00953758|540127217|FG009|Overall Study|Physician Decision|0|||
149724591|NCT00953758|540127208|FG000|Overall Study|Disease progression|0|||
149724592|NCT00953758|540127209|FG001|Overall Study|Disease progression|0|||
149724593|NCT00953758|540127210|FG002|Overall Study|Disease progression|0|||
149724594|NCT00953758|540127211|FG003|Overall Study|Disease progression|0|||
149724595|NCT00953758|540127212|FG004|Overall Study|Disease progression|1|||
149724596|NCT00953758|540127213|FG005|Overall Study|Disease progression|0|||
149724597|NCT00953758|540127214|FG006|Overall Study|Disease progression|0|||
149724598|NCT00953758|540127215|FG007|Overall Study|Disease progression|0|||
149724599|NCT00953758|540127216|FG008|Overall Study|Disease progression|0|||
149724600|NCT00953758|540127217|FG009|Overall Study|Disease progression|0|||
149724601|NCT00953758|540127208|FG000|Overall Study|Participant went for transplant|0|||
149724602|NCT00953758|540127209|FG001|Overall Study|Participant went for transplant|0|||
149724603|NCT00953758|540127210|FG002|Overall Study|Participant went for transplant|0|||
149724604|NCT00953758|540127211|FG003|Overall Study|Participant went for transplant|0|||
149724605|NCT00953758|540127212|FG004|Overall Study|Participant went for transplant|0|||
149724606|NCT00953758|540127213|FG005|Overall Study|Participant went for transplant|0|||
149724607|NCT00953758|540127214|FG006|Overall Study|Participant went for transplant|0|||
149724608|NCT00953758|540127215|FG007|Overall Study|Participant went for transplant|0|||
149724609|NCT00953758|540127216|FG008|Overall Study|Participant went for transplant|1|||
149724610|NCT00953758|540127217|FG009|Overall Study|Participant went for transplant|0|||
149724611|NCT01707693|540127218|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
149724612|NCT01707693|540127219|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
149724613|NCT01707693|540127218|FG000|Overall Study Allocation|Protocol Violation|4|||
149724614|NCT01707693|540127219|FG001|Overall Study Allocation|Protocol Violation|3|||
149724615|NCT01707693|540127218|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
149724616|NCT01707693|540127219|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
149724617|NCT01707693|540127218|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
149724618|NCT01707693|540127219|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
149724619|NCT03115151|540127221|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
149724620|NCT03115151|540127222|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
149724621|NCT03115151|540127221|FG000|Overall Study|Epidural catheter removal|1|||
149724622|NCT03115151|540127222|FG001|Overall Study|Epidural catheter removal|0|||
149724623|NCT03115151|540127221|FG000|Overall Study|Withdrawal by Subject|0|||
149724624|NCT03115151|540127222|FG001|Overall Study|Withdrawal by Subject|1|||
149724625|NCT03115151|540127221|FG000|Overall Study|Intervention not received according to the protocol.|1|||
150251426|NCT00128102|542056149|FG001|Overall Study|Progressive Disease|285|||
149724626|NCT03115151|540127222|FG001|Overall Study|Intervention not received according to the protocol.|1|||
149724627|NCT03115151|540127221|FG000|Overall Study|Physician Decision|1|||
149724628|NCT03115151|540127222|FG001|Overall Study|Physician Decision|0|||
149724629|NCT03115151|540127221|FG000|Overall Study|Randomization not applied|1|||
149724630|NCT03115151|540127222|FG001|Overall Study|Randomization not applied|1|||
149724631|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
149724632|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
149724633|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
149724634|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
149724635|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149724636|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149724637|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
149724638|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149724639|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
149724640|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149724641|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149724642|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149724643|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
149724644|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
149724645|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
149724646|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
149724647|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
149724648|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
149724649|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
149724650|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
149724651|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149724652|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149724653|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149724654|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149724655|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
149724656|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149724657|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149724658|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149724659|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149724660|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149724661|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149724662|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
149724663|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149724664|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149724665|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149724666|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149724667|NCT03403205|540127223|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
149724668|NCT03403205|540127224|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149724669|NCT03403205|540127225|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
149724670|NCT03403205|540127226|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
149724671|NCT03403205|540127227|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149724672|NCT03403205|540127228|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149724673|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
149724674|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
149724675|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
149724676|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
149724677|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
149724678|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
149724679|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
149724680|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
149724681|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
149724682|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
149724683|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
149724684|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
149724685|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Death|1|||
149724686|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Death|0|||
149724687|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Death|0|||
149724688|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Death|0|||
149724689|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Death|0|||
149724690|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Death|0|||
149724691|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
149724692|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149724693|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149724694|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149724695|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149724696|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149724697|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
149724698|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
149724699|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
149724700|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
149724701|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
149724702|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
149724703|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
149724704|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149724705|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149724706|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149724707|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149724708|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149724709|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
149724710|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
149724711|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
149724712|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
149724713|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
149724714|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
149724715|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
149724716|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
149724717|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
149724718|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
149724719|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
149724720|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
149724721|NCT03403205|540127223|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
149724722|NCT03403205|540127224|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
149724723|NCT03403205|540127225|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
149724724|NCT03403205|540127226|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
149724725|NCT03403205|540127227|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
149724726|NCT03403205|540127228|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
149724727|NCT00706030|540127229|FG000|Overall Study|Disease Progression|4|||
149724728|NCT00706030|540127230|FG001|Overall Study|Disease Progression|6|||
149724729|NCT00706030|540127231|FG002|Overall Study|Disease Progression|46|||
149724730|NCT00706030|540127232|FG003|Overall Study|Disease Progression|12|||
149724731|NCT00706030|540127229|FG000|Overall Study|Adverse Event|1|||
149724732|NCT00706030|540127230|FG001|Overall Study|Adverse Event|0|||
149724733|NCT00706030|540127231|FG002|Overall Study|Adverse Event|4|||
149724734|NCT00706030|540127232|FG003|Overall Study|Adverse Event|2|||
149724735|NCT00706030|540127229|FG000|Overall Study|Withdrawal by Subject|1|||
149724736|NCT00706030|540127230|FG001|Overall Study|Withdrawal by Subject|0|||
149724737|NCT00706030|540127231|FG002|Overall Study|Withdrawal by Subject|2|||
149724738|NCT00706030|540127232|FG003|Overall Study|Withdrawal by Subject|0|||
149724739|NCT00706030|540127229|FG000|Overall Study|Physician Decision|0|||
149724740|NCT00706030|540127230|FG001|Overall Study|Physician Decision|0|||
149724741|NCT00706030|540127231|FG002|Overall Study|Physician Decision|2|||
149724742|NCT00706030|540127232|FG003|Overall Study|Physician Decision|0|||
149724743|NCT00706030|540127229|FG000|Overall Study|Not recorded|0|||
149724744|NCT00706030|540127230|FG001|Overall Study|Not recorded|0|||
149724745|NCT00706030|540127231|FG002|Overall Study|Not recorded|2|||
149724746|NCT00706030|540127232|FG003|Overall Study|Not recorded|0|||
149724747|NCT00706030|540127229|FG000|Overall Study|Protocol Violation|0|||
149724748|NCT00706030|540127230|FG001|Overall Study|Protocol Violation|0|||
149724749|NCT00706030|540127231|FG002|Overall Study|Protocol Violation|1|||
149724750|NCT00706030|540127232|FG003|Overall Study|Protocol Violation|1|||
149724751|NCT00706030|540127229|FG000|Overall Study|Failed to return|0|||
149724752|NCT00706030|540127230|FG001|Overall Study|Failed to return|0|||
149724753|NCT00706030|540127231|FG002|Overall Study|Failed to return|1|||
149724754|NCT00706030|540127232|FG003|Overall Study|Failed to return|0|||
149724755|NCT00706030|540127229|FG000|Overall Study|Symptomatic Deterioration|0|||
149724756|NCT00706030|540127230|FG001|Overall Study|Symptomatic Deterioration|0|||
149724757|NCT00706030|540127231|FG002|Overall Study|Symptomatic Deterioration|1|||
149724758|NCT00706030|540127232|FG003|Overall Study|Symptomatic Deterioration|0|||
149724759|NCT00706030|540127229|FG000|Overall Study|No treatment received|0|||
149724760|NCT00706030|540127230|FG001|Overall Study|No treatment received|0|||
149724761|NCT00706030|540127231|FG002|Overall Study|No treatment received|0|||
149724762|NCT00706030|540127232|FG003|Overall Study|No treatment received|1|||
149724763|NCT00706030|540127229|FG000|Overall Study|Death|0|||
149724764|NCT00706030|540127230|FG001|Overall Study|Death|0|||
149724765|NCT00706030|540127231|FG002|Overall Study|Death|1|||
149724766|NCT00706030|540127232|FG003|Overall Study|Death|0|||
149724767|NCT05779072|540127233|FG000|Overall Study|Lost to Follow-up|0|||
149724768|NCT05779072|540127234|FG001|Overall Study|Lost to Follow-up|1|||
149724769|NCT05779072|540127233|FG000|Overall Study|Withdrawal by Subject|1|||
149724770|NCT05779072|540127234|FG001|Overall Study|Withdrawal by Subject|5|||
149724771|NCT03713944|540127235|FG000|Study Treatment|Patient non-compliance|1|||
149724772|NCT03713944|540127235|FG000|Study Treatment|Alternative Cancer Therapy|3|||
149724773|NCT03713944|540127235|FG000|Study Treatment|Disease Progression|18|||
149724774|NCT03713944|540127235|FG000|Study Treatment|AE/Side Effects/Complications|2|||
149724775|NCT03713944|540127235|FG000|Study Treatment|Death|2|||
149724776|NCT03713944|540127235|FG000|Study Treatment|Withdrawal by Subject|1|||
149724777|NCT03713944|540127235|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
149724778|NCT03713944|540127235|FG000|Study Treatment|Symptomatic Deterioration|2|||
149724779|NCT03713944|540127235|FG000|Follow up|Withdrawal by Subject|2|||
149724780|NCT03713944|540127235|FG000|Follow up|Death|11|||
149724781|NCT03713944|540127235|FG000|Follow up|Study Terminated|3|||
149724782|NCT03847610|540127236|FG000|Overall Study|Withdrawal by Subject|1|||
149724783|NCT03298022|540127237|FG000|Overall Study|Lack of Efficacy|4|||
149724784|NCT03298022|540127237|FG000|Overall Study|Withdrawal by Subject|7|||
149724785|NCT03298022|540127237|FG000|Overall Study|Adverse Event|1|||
149724786|NCT03298022|540127237|FG000|Overall Study|disease relapse|1|||
149724787|NCT01445769|540127238|FG000|Overall Study|Consent Withdrawn|2|||
149724788|NCT01445769|540127238|FG000|Overall Study|Disease Progression|1|||
150251427|NCT00128102|542056148|FG000|Overall Study|Adverse Event|34|||
150251428|NCT00128102|542056149|FG001|Overall Study|Adverse Event|11|||
150251429|NCT00128102|542056148|FG000|Overall Study|Death|12|||
150251430|NCT00128102|542056149|FG001|Overall Study|Death|13|||
150251431|NCT00128102|542056148|FG000|Overall Study|Physician Decision|3|||
150251432|NCT00128102|542056149|FG001|Overall Study|Physician Decision|3|||
150251433|NCT00128102|542056148|FG000|Overall Study|Withdrawal by Subject|19|||
149724789|NCT01445769|540127238|FG000|Overall Study|Lost to Follow-up|5|||
149724790|NCT00487539|540127243|FG000|Overall Study|Adverse Event|3|||
149724791|NCT00487539|540127244|FG001|Overall Study|Adverse Event|2|||
149724792|NCT00487539|540127245|FG002|Overall Study|Adverse Event|1|||
149724793|NCT00487539|540127246|FG003|Overall Study|Adverse Event|1|||
149724794|NCT00487539|540127243|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149724795|NCT00487539|540127244|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149724796|NCT00487539|540127245|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149724797|NCT00487539|540127246|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
149724798|NCT00487539|540127243|FG000|Overall Study|Other|3|||
149724799|NCT00487539|540127244|FG001|Overall Study|Other|1|||
149724800|NCT00487539|540127245|FG002|Overall Study|Other|2|||
149724801|NCT00487539|540127246|FG003|Overall Study|Other|2|||
149724802|NCT02695628|540127247|FG000|Overall Study|Withdrawal by Subject|1|||
149724803|NCT02751502|540127248|FG000|Overall Study|Lack of funding|4|||
149724804|NCT02678390|540127249|FG000|AE (1 Day)|Withdrawal by Subject|0|||
149724805|NCT02678390|540127250|FG001|AE (1 Day)|Withdrawal by Subject|1|||
149724806|NCT00852995|540127251|FG000|Overall Study|Adverse Event|1|||
149724807|NCT00852995|540127252|FG001|Overall Study|Adverse Event|0|||
149724808|NCT00852995|540127253|FG002|Overall Study|Adverse Event|4|||
149724809|NCT00852995|540127254|FG003|Overall Study|Adverse Event|0|||
149724810|NCT00852995|540127255|FG004|Overall Study|Adverse Event|0|||
149724811|NCT00852995|540127251|FG000|Overall Study|Lost to Follow-up|0|||
149724812|NCT00852995|540127252|FG001|Overall Study|Lost to Follow-up|1|||
149724813|NCT00852995|540127253|FG002|Overall Study|Lost to Follow-up|1|||
149724814|NCT00852995|540127254|FG003|Overall Study|Lost to Follow-up|0|||
149724815|NCT00852995|540127255|FG004|Overall Study|Lost to Follow-up|0|||
149724816|NCT00852995|540127251|FG000|Overall Study|Withdrawal by Subject|4|||
149724817|NCT00852995|540127252|FG001|Overall Study|Withdrawal by Subject|0|||
149724818|NCT00852995|540127253|FG002|Overall Study|Withdrawal by Subject|0|||
149724819|NCT00852995|540127254|FG003|Overall Study|Withdrawal by Subject|1|||
149724820|NCT00852995|540127255|FG004|Overall Study|Withdrawal by Subject|2|||
149724821|NCT00852995|540127251|FG000|Overall Study|Non-Compliance|0|||
149724822|NCT00852995|540127252|FG001|Overall Study|Non-Compliance|0|||
149724823|NCT00852995|540127253|FG002|Overall Study|Non-Compliance|0|||
149724824|NCT00852995|540127254|FG003|Overall Study|Non-Compliance|2|||
149724825|NCT00852995|540127255|FG004|Overall Study|Non-Compliance|0|||
149724826|NCT00852995|540127251|FG000|Overall Study|Progressive Disease|1|||
149724827|NCT00852995|540127252|FG001|Overall Study|Progressive Disease|0|||
149724828|NCT00852995|540127253|FG002|Overall Study|Progressive Disease|0|||
149724829|NCT00852995|540127254|FG003|Overall Study|Progressive Disease|2|||
149724830|NCT00852995|540127255|FG004|Overall Study|Progressive Disease|1|||
149724831|NCT00852995|540127251|FG000|Overall Study|Physician Decision|1|||
149724832|NCT00852995|540127252|FG001|Overall Study|Physician Decision|0|||
149724833|NCT00852995|540127253|FG002|Overall Study|Physician Decision|0|||
149724834|NCT00852995|540127254|FG003|Overall Study|Physician Decision|0|||
150251434|NCT00128102|542056149|FG001|Overall Study|Withdrawal by Subject|11|||
150251435|NCT00128102|542056148|FG000|Overall Study|Protocol Violation|2|||
149724835|NCT00852995|540127255|FG004|Overall Study|Physician Decision|0|||
149724836|NCT00852995|540127251|FG000|Overall Study|Protocol Violation|0|||
149724837|NCT00852995|540127252|FG001|Overall Study|Protocol Violation|0|||
149724838|NCT00852995|540127253|FG002|Overall Study|Protocol Violation|0|||
149724839|NCT00852995|540127254|FG003|Overall Study|Protocol Violation|0|||
149724840|NCT00852995|540127255|FG004|Overall Study|Protocol Violation|1|||
149724841|NCT00852995|540127251|FG000|Overall Study|Moved Out of Area|1|||
149724842|NCT00852995|540127252|FG001|Overall Study|Moved Out of Area|0|||
149724843|NCT00852995|540127253|FG002|Overall Study|Moved Out of Area|0|||
149724844|NCT00852995|540127254|FG003|Overall Study|Moved Out of Area|0|||
149724845|NCT00852995|540127255|FG004|Overall Study|Moved Out of Area|0|||
149724846|NCT00720109|540127256|FG000|Induction Period|Did not meet eligibility criteria|3|||
149724847|NCT00720109|540127257|FG001|Induction Period|Did not meet eligibility criteria|0|||
149724848|NCT00720109|540127258|FG002|Induction Period|Did not meet eligibility criteria|0|||
149724849|NCT00720109|540127256|FG000|Induction Period|Bone Marrow Transplant|2|||
149724850|NCT00720109|540127257|FG001|Induction Period|Bone Marrow Transplant|0|||
149724851|NCT00720109|540127258|FG002|Induction Period|Bone Marrow Transplant|0|||
149724852|NCT00720109|540127256|FG000|Induction Period|Physician Decision|1|||
149724853|NCT00720109|540127257|FG001|Induction Period|Physician Decision|0|||
149724854|NCT00720109|540127258|FG002|Induction Period|Physician Decision|0|||
149724855|NCT00720109|540127256|FG000|Risk Stratification Period|Adverse Event|0|||
149724856|NCT00720109|540127257|FG001|Risk Stratification Period|Adverse Event|1|||
149724857|NCT00720109|540127258|FG002|Risk Stratification Period|Adverse Event|0|||
149724858|NCT00720109|540127256|FG000|Risk Stratification Period|Physician Decision|0|||
149724859|NCT00720109|540127257|FG001|Risk Stratification Period|Physician Decision|2|||
149724860|NCT00720109|540127258|FG002|Risk Stratification Period|Physician Decision|1|||
149724861|NCT00720109|540127256|FG000|Risk Stratification Period|Bone marrow transplant|0|||
149724862|NCT00720109|540127257|FG001|Risk Stratification Period|Bone marrow transplant|9|||
149724863|NCT00720109|540127258|FG002|Risk Stratification Period|Bone marrow transplant|7|||
149724864|NCT00720109|540127256|FG000|Risk Stratification Period|Disease progression or relapse|0|||
149724865|NCT00720109|540127257|FG001|Risk Stratification Period|Disease progression or relapse|2|||
149724866|NCT00720109|540127258|FG002|Risk Stratification Period|Disease progression or relapse|0|||
149724867|NCT00720109|540127256|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
149724868|NCT00720109|540127257|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
149724869|NCT00720109|540127258|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
149724870|NCT03595553|540127259|FG000|Overall Study|Withdrawal by Subject|20|||
149724871|NCT03595553|540127260|FG001|Overall Study|Withdrawal by Subject|8|||
149724872|NCT03595553|540127259|FG000|Overall Study|Physician Decision|3|||
149724873|NCT03595553|540127260|FG001|Overall Study|Physician Decision|2|||
149724874|NCT03595553|540127259|FG000|Overall Study|Adverse Event|2|||
149724875|NCT03595553|540127260|FG001|Overall Study|Adverse Event|5|||
149724876|NCT03595553|540127259|FG000|Overall Study|Death|24|||
149724877|NCT03595553|540127260|FG001|Overall Study|Death|22|||
149724878|NCT03595553|540127259|FG000|Overall Study|Lost to Follow-up|6|||
149724879|NCT03595553|540127260|FG001|Overall Study|Lost to Follow-up|7|||
149724880|NCT03595553|540127259|FG000|Overall Study|Other as indicated in CSR|3|||
149724881|NCT03595553|540127260|FG001|Overall Study|Other as indicated in CSR|3|||
149724882|NCT03595553|540127259|FG000|Overall Study|Sponsor Decision|0|||
149724883|NCT03595553|540127260|FG001|Overall Study|Sponsor Decision|1|||
149724884|NCT03467958|540127261|FG000|Overall Study|Adverse Event|20|||
149724885|NCT03467958|540127262|FG001|Overall Study|Adverse Event|32|||
149724886|NCT03467958|540127263|FG002|Overall Study|Adverse Event|5|||
149724887|NCT03467958|540127264|FG003|Overall Study|Adverse Event|3|||
149724888|NCT03467958|540127265|FG004|Overall Study|Adverse Event|3|||
149724889|NCT03467958|540127266|FG005|Overall Study|Adverse Event|3|||
149724890|NCT03467958|540127267|FG006|Overall Study|Adverse Event|6|||
149724891|NCT03467958|540127268|FG007|Overall Study|Adverse Event|5|||
149724892|NCT03467958|540127269|FG008|Overall Study|Adverse Event|0|||
149724893|NCT03467958|540127261|FG000|Overall Study|Lack of Efficacy|59|||
149724894|NCT03467958|540127262|FG001|Overall Study|Lack of Efficacy|120|||
149724895|NCT03467958|540127263|FG002|Overall Study|Lack of Efficacy|6|||
149724896|NCT03467958|540127264|FG003|Overall Study|Lack of Efficacy|9|||
149724897|NCT03467958|540127265|FG004|Overall Study|Lack of Efficacy|8|||
149724898|NCT03467958|540127266|FG005|Overall Study|Lack of Efficacy|9|||
149724899|NCT03467958|540127267|FG006|Overall Study|Lack of Efficacy|11|||
149724900|NCT03467958|540127268|FG007|Overall Study|Lack of Efficacy|9|||
149724901|NCT03467958|540127269|FG008|Overall Study|Lack of Efficacy|3|||
149724902|NCT03467958|540127261|FG000|Overall Study|Lost to Follow-up|1|||
149724903|NCT03467958|540127262|FG001|Overall Study|Lost to Follow-up|2|||
149724904|NCT03467958|540127263|FG002|Overall Study|Lost to Follow-up|1|||
149724905|NCT03467958|540127264|FG003|Overall Study|Lost to Follow-up|0|||
149724906|NCT03467958|540127265|FG004|Overall Study|Lost to Follow-up|4|||
149724907|NCT03467958|540127266|FG005|Overall Study|Lost to Follow-up|0|||
149724908|NCT03467958|540127267|FG006|Overall Study|Lost to Follow-up|0|||
149724909|NCT03467958|540127268|FG007|Overall Study|Lost to Follow-up|0|||
149724910|NCT03467958|540127269|FG008|Overall Study|Lost to Follow-up|0|||
149724911|NCT03467958|540127261|FG000|Overall Study|Other reasons|8|||
149724912|NCT03467958|540127262|FG001|Overall Study|Other reasons|14|||
149724913|NCT03467958|540127263|FG002|Overall Study|Other reasons|2|||
149724914|NCT03467958|540127264|FG003|Overall Study|Other reasons|1|||
149724915|NCT03467958|540127265|FG004|Overall Study|Other reasons|4|||
149724916|NCT03467958|540127266|FG005|Overall Study|Other reasons|0|||
149724917|NCT03467958|540127267|FG006|Overall Study|Other reasons|1|||
149724918|NCT03467958|540127268|FG007|Overall Study|Other reasons|0|||
149724919|NCT03467958|540127269|FG008|Overall Study|Other reasons|1|||
149724920|NCT03467958|540127261|FG000|Overall Study|Pregnancy|1|||
149724921|NCT03467958|540127262|FG001|Overall Study|Pregnancy|0|||
149724922|NCT03467958|540127263|FG002|Overall Study|Pregnancy|0|||
149724923|NCT03467958|540127264|FG003|Overall Study|Pregnancy|0|||
149724924|NCT03467958|540127265|FG004|Overall Study|Pregnancy|0|||
149724925|NCT03467958|540127266|FG005|Overall Study|Pregnancy|1|||
149724926|NCT03467958|540127267|FG006|Overall Study|Pregnancy|0|||
149724927|NCT03467958|540127268|FG007|Overall Study|Pregnancy|0|||
149724928|NCT03467958|540127269|FG008|Overall Study|Pregnancy|0|||
149724929|NCT03467958|540127261|FG000|Overall Study|Study terminated by sponsor|65|||
149724930|NCT03467958|540127262|FG001|Overall Study|Study terminated by sponsor|117|||
149724931|NCT03467958|540127263|FG002|Overall Study|Study terminated by sponsor|45|||
149724932|NCT03467958|540127264|FG003|Overall Study|Study terminated by sponsor|64|||
149724933|NCT03467958|540127265|FG004|Overall Study|Study terminated by sponsor|66|||
149724934|NCT03467958|540127266|FG005|Overall Study|Study terminated by sponsor|17|||
149724935|NCT03467958|540127267|FG006|Overall Study|Study terminated by sponsor|11|||
149724936|NCT03467958|540127268|FG007|Overall Study|Study terminated by sponsor|5|||
149724937|NCT03467958|540127269|FG008|Overall Study|Study terminated by sponsor|5|||
149724938|NCT03467958|540127261|FG000|Overall Study|Withdrawal by Subject|25|||
149724939|NCT03467958|540127262|FG001|Overall Study|Withdrawal by Subject|44|||
149724940|NCT03467958|540127263|FG002|Overall Study|Withdrawal by Subject|7|||
149724941|NCT03467958|540127264|FG003|Overall Study|Withdrawal by Subject|8|||
149724942|NCT03467958|540127265|FG004|Overall Study|Withdrawal by Subject|6|||
149724943|NCT03467958|540127266|FG005|Overall Study|Withdrawal by Subject|8|||
149724944|NCT03467958|540127267|FG006|Overall Study|Withdrawal by Subject|4|||
149724945|NCT03467958|540127268|FG007|Overall Study|Withdrawal by Subject|1|||
149724946|NCT03467958|540127269|FG008|Overall Study|Withdrawal by Subject|4|||
149724947|NCT02925156|540127271|FG000|Overall Study|Lost to Follow-up|27|||
150251436|NCT00128102|542056149|FG001|Overall Study|Protocol Violation|2|||
150251437|NCT01531673|542056150|FG000|Overall Study|Non-Compliance|0|||
149724948|NCT02925156|540127272|FG001|Overall Study|Lost to Follow-up|53|||
149724949|NCT02925156|540127273|FG002|Overall Study|Lost to Follow-up|51|||
149724950|NCT02925156|540127274|FG003|Overall Study|Lost to Follow-up|59|||
149724951|NCT02925156|540127275|FG004|Overall Study|Lost to Follow-up|89|||
149724952|NCT02925156|540127276|FG005|Overall Study|Lost to Follow-up|107|||
149724953|NCT02925156|540127277|FG006|Overall Study|Lost to Follow-up|34|||
149724954|NCT02925156|540127278|FG007|Overall Study|Lost to Follow-up|36|||
149724955|NCT02925156|540127279|FG008|Overall Study|Lost to Follow-up|73|||
149724956|NCT02925156|540127280|FG009|Overall Study|Lost to Follow-up|34|||
149724957|NCT01844895|540127283|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
149724958|NCT01844895|540127283|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
149724959|NCT01844895|540127283|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
149724960|NCT01844895|540127283|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
149724961|NCT01844895|540127283|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
149724962|NCT01844895|540127283|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
149724963|NCT01844895|540127283|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
149724964|NCT03208231|540127286|FG000|Overall Study|Death|1|||
149724965|NCT03208231|540127287|FG001|Overall Study|Death|2|||
149724966|NCT03208231|540127286|FG000|Overall Study|Moved and unable to get to clinic|1|||
149724967|NCT03208231|540127287|FG001|Overall Study|Moved and unable to get to clinic|0|||
149724968|NCT03208231|540127286|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
149724969|NCT03208231|540127287|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
149724970|NCT04947800|540127293|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
149724971|NCT04947800|540127294|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
149724972|NCT04947800|540127295|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
149724973|NCT04982250|540127303|FG000|Overall Study|Lost to Follow-up|0|||
149724974|NCT04982250|540127304|FG001|Overall Study|Lost to Follow-up|26|||
149724975|NCT04982250|540127305|FG002|Overall Study|Lost to Follow-up|0|||
149724976|NCT04982250|540127306|FG003|Overall Study|Lost to Follow-up|0|||
149724977|NCT04982250|540127307|FG004|Overall Study|Lost to Follow-up|72|||
149724978|NCT04982250|540127308|FG005|Overall Study|Lost to Follow-up|69|||
149724979|NCT04982250|540127303|FG000|Overall Study|Not Eligible to Enroll|0|||
149724980|NCT04982250|540127304|FG001|Overall Study|Not Eligible to Enroll|0|||
149724981|NCT04982250|540127305|FG002|Overall Study|Not Eligible to Enroll|0|||
149724982|NCT04982250|540127306|FG003|Overall Study|Not Eligible to Enroll|0|||
149724983|NCT04982250|540127307|FG004|Overall Study|Not Eligible to Enroll|10|||
149724984|NCT04982250|540127308|FG005|Overall Study|Not Eligible to Enroll|7|||
150251438|NCT01531673|542056151|FG001|Overall Study|Non-Compliance|0|||
149724985|NCT01489527|540127310|FG000|Overall Study|Pregnancy|9|||
149724986|NCT01489527|540127311|FG001|Overall Study|Pregnancy|14|||
149724987|NCT01489527|540127310|FG000|Overall Study|Participant moved|6|||
149724988|NCT01489527|540127311|FG001|Overall Study|Participant moved|7|||
149724989|NCT01489527|540127310|FG000|Overall Study|Withdrawal by Subject|0|||
149724990|NCT01489527|540127311|FG001|Overall Study|Withdrawal by Subject|4|||
149724991|NCT01489527|540127310|FG000|Overall Study|Lost to Follow-up|5|||
149724992|NCT01489527|540127311|FG001|Overall Study|Lost to Follow-up|1|||
149724993|NCT01489527|540127310|FG000|Overall Study|Procedures|1|||
149724994|NCT01489527|540127311|FG001|Overall Study|Procedures|0|||
149724995|NCT01489527|540127310|FG000|Overall Study|Not compliant|1|||
149724996|NCT01489527|540127311|FG001|Overall Study|Not compliant|0|||
149724997|NCT00700271|540127312|FG000|Overall Study|Adverse Event|4|||
149724998|NCT00700271|540127313|FG001|Overall Study|Adverse Event|6|||
149724999|NCT00700271|540127312|FG000|Overall Study|Protocol Violation|1|||
149725000|NCT00700271|540127313|FG001|Overall Study|Protocol Violation|0|||
149725001|NCT00700271|540127312|FG000|Overall Study|Administrative Reasons|1|||
149725002|NCT00700271|540127313|FG001|Overall Study|Administrative Reasons|0|||
149725003|NCT00700271|540127312|FG000|Overall Study|Withdrawal by Subject|6|||
149725004|NCT00700271|540127313|FG001|Overall Study|Withdrawal by Subject|4|||
149725005|NCT00700271|540127312|FG000|Overall Study|Lost to Follow-up|2|||
149725006|NCT00700271|540127313|FG001|Overall Study|Lost to Follow-up|2|||
149725007|NCT01411085|540127314|FG000|Overall Study|Physician Decision|1|||
149725008|NCT01411085|540127314|FG000|Overall Study|Protocol Violation|1|||
149725009|NCT01411085|540127314|FG000|Overall Study|Adverse Event|1|||
149725010|NCT04440592|540127322|FG000|Overall Study|Adverse Event|8|||
149725011|NCT04440592|540127323|FG001|Overall Study|Adverse Event|0|||
149725012|NCT04440592|540127322|FG000|Overall Study|Lost to Follow-up|1|||
149725013|NCT04440592|540127323|FG001|Overall Study|Lost to Follow-up|0|||
149725014|NCT04440592|540127322|FG000|Overall Study|Withdrawal by Subject|1|||
149725015|NCT04440592|540127323|FG001|Overall Study|Withdrawal by Subject|1|||
150251439|NCT01531673|542056152|FG002|Overall Study|Non-Compliance|0|||
150251440|NCT01531673|542056153|FG003|Overall Study|Non-Compliance|0|||
150251441|NCT01531673|542056154|FG004|Overall Study|Non-Compliance|0|||
149725016|NCT04440592|540127322|FG000|Overall Study|Other therapy needed|0|||
149725017|NCT04440592|540127323|FG001|Overall Study|Other therapy needed|1|||
149725018|NCT02028455|540127326|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725019|NCT02028455|540127327|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725020|NCT02028455|540127328|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725021|NCT02028455|540127329|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725022|NCT02028455|540127330|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725023|NCT02028455|540127331|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149725024|NCT02028455|540127332|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
149725025|NCT02028455|540127333|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
149725026|NCT02028455|540127326|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
149725027|NCT02028455|540127327|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
149725028|NCT02028455|540127328|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
149725029|NCT02028455|540127329|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
149725030|NCT02028455|540127330|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
149725031|NCT02028455|540127331|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
149725032|NCT02028455|540127332|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
149725033|NCT02028455|540127333|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
149725034|NCT02028455|540127326|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149725035|NCT02028455|540127327|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149725036|NCT02028455|540127328|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
150251442|NCT01531673|542056155|FG005|Overall Study|Non-Compliance|1|||
150251443|NCT01531673|542056156|FG006|Overall Study|Non-Compliance|0|||
150251444|NCT01531673|542056157|FG007|Overall Study|Non-Compliance|0|||
149725037|NCT02028455|540127329|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149725038|NCT02028455|540127330|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149725039|NCT02028455|540127331|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
149725040|NCT02028455|540127332|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149725041|NCT02028455|540127333|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
150251445|NCT01531673|542056158|FG008|Overall Study|Non-Compliance|0|||
149725042|NCT02028455|540127326|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149725043|NCT02028455|540127327|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149725044|NCT02028455|540127328|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
149725045|NCT02028455|540127329|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
150251446|NCT01531673|542056159|FG009|Overall Study|Non-Compliance|0|||
150251447|NCT01531673|542056160|FG010|Overall Study|Non-Compliance|0|||
149725046|NCT02028455|540127330|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149725047|NCT02028455|540127331|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149725048|NCT02028455|540127332|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
149725049|NCT02028455|540127333|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
149725050|NCT02396589|540127334|FG000|Intervention|Lost to Follow-up|1|||
149725051|NCT02396589|540127335|FG001|Intervention|Lost to Follow-up|0|||
149725052|NCT02396589|540127334|FG000|6 Month Follow-up|change in health status|0|||
149725053|NCT02396589|540127335|FG001|6 Month Follow-up|change in health status|1|||
149725054|NCT02396589|540127334|FG000|9 Month Follow-up|Death|0|||
149725055|NCT02396589|540127335|FG001|9 Month Follow-up|Death|1|||
149725056|NCT02396589|540127334|FG000|12 Month Follow up|Lost to Follow-up|0|||
149725057|NCT02396589|540127335|FG001|12 Month Follow up|Lost to Follow-up|2|||
149725058|NCT04705051|540129350|FG000|Overall Study|Enrolled but not treated|1|||
149725059|NCT04705051|540129350|FG000|Overall Study|Study terminated by sponsor|23|||
149725060|NCT01178138|540129351|FG000|Overall Study|Lost to Follow-up|8|||
149725061|NCT01178138|540129351|FG000|Overall Study|Withdrawal by Subject|7|||
149725062|NCT01178138|540129351|FG000|Overall Study|Physician Decision|8|||
149725063|NCT01241708|540129352|FG000|Overall Study|Withdrawal by Subject|6|||
149725064|NCT01241708|540129352|FG000|Overall Study|Screen Failure|6|||
149725065|NCT01241708|540129352|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
149725066|NCT01241708|540129352|FG000|Overall Study|Lost to Follow-up|5|||
149725067|NCT02968810|540129353|FG000|Overall Study|Lost to Follow-up|1|||
149725068|NCT02968810|540129354|FG001|Overall Study|Lost to Follow-up|0|||
149725069|NCT02968810|540129353|FG000|Overall Study|Physician Decision|1|||
149725070|NCT02968810|540129354|FG001|Overall Study|Physician Decision|0|||
149725071|NCT02968810|540129353|FG000|Overall Study|Withdrawal by Subject|1|||
149725072|NCT02968810|540129354|FG001|Overall Study|Withdrawal by Subject|3|||
149725073|NCT02968810|540129353|FG000|Overall Study|Disease Progression|0|||
149725074|NCT02968810|540129354|FG001|Overall Study|Disease Progression|1|||
149725075|NCT04183335|540129357|FG000|Overall Study|Adverse Event|1|||
149725076|NCT04183335|540129358|FG001|Overall Study|Adverse Event|0|||
149725077|NCT04183335|540129357|FG000|Overall Study|Withdrawal by Subject|12|||
149725078|NCT04183335|540129358|FG001|Overall Study|Withdrawal by Subject|3|||
149725079|NCT00049673|540129359|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
149725080|NCT00049673|540129360|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
149725081|NCT01535729|540129361|FG000|Overall Study|Withdrawal by Subject|2|||
149725082|NCT01535729|540129361|FG000|Overall Study|Disease progression|230|||
149725083|NCT01535729|540129361|FG000|Overall Study|Discontinued treatment|25|||
149725084|NCT01535729|540129361|FG000|Overall Study|Lost to Follow-up|8|||
149725085|NCT01535729|540129361|FG000|Overall Study|Death|52|||
149725086|NCT01535729|540129361|FG000|Overall Study|Other|19|||
149725087|NCT01535729|540129361|FG000|Overall Study|Did not sign informed consent|1|||
149725088|NCT01535729|540129361|FG000|Overall Study|No previous chemotherapy|33|||
149725089|NCT01535729|540129361|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
149725090|NCT01535729|540129361|FG000|Overall Study|Protocol Violation|11|||
149725091|NCT01535729|540129361|FG000|Overall Study|Screening failure|1|||
149725092|NCT01535729|540129361|FG000|Overall Study|Not treated|9|||
149725093|NCT01535729|540129361|FG000|Overall Study|No participant record available|5|||
149725094|NCT02787850|540129362|FG000|Overall Study|Withdrawal by Subject|0|||
149725095|NCT02787850|540129363|FG001|Overall Study|Withdrawal by Subject|1|||
149725096|NCT03733392|540129366|FG000|Overall Study|Withdrawal by Subject|11|||
149725097|NCT03733392|540129367|FG001|Overall Study|Withdrawal by Subject|1|||
149725098|NCT03733392|540129366|FG000|Overall Study|Death|1|||
149725099|NCT03733392|540129367|FG001|Overall Study|Death|0|||
149725100|NCT03733392|540129366|FG000|Overall Study|Lost to Follow-up|5|||
150251448|NCT01531673|542056161|FG011|Overall Study|Non-Compliance|0|||
150251449|NCT01531673|542056162|FG012|Overall Study|Non-Compliance|0|||
150251450|NCT01531673|542056150|FG000|Overall Study|Adverse Event|0|||
150251451|NCT01531673|542056151|FG001|Overall Study|Adverse Event|1|||
150251452|NCT01531673|542056152|FG002|Overall Study|Adverse Event|0|||
150251453|NCT01531673|542056153|FG003|Overall Study|Adverse Event|0|||
150251454|NCT01531673|542056154|FG004|Overall Study|Adverse Event|0|||
149725101|NCT03733392|540129367|FG001|Overall Study|Lost to Follow-up|0|||
149725102|NCT03733392|540129366|FG000|Overall Study|Protocol Violation|0|||
149725103|NCT03733392|540129367|FG001|Overall Study|Protocol Violation|1|||
149725104|NCT03733392|540129366|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
149725105|NCT03733392|540129367|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
149725106|NCT03733392|540129366|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
149725107|NCT03733392|540129367|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
149725108|NCT03733392|540129366|FG000|Overall Study|Patient Non-Compliance|2|||
149725109|NCT03733392|540129367|FG001|Overall Study|Patient Non-Compliance|1|||
149725110|NCT03733392|540129366|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
149725111|NCT03733392|540129367|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
150251455|NCT01531673|542056155|FG005|Overall Study|Adverse Event|0|||
150251456|NCT01531673|542056156|FG006|Overall Study|Adverse Event|0|||
149725112|NCT03733392|540129366|FG000|Overall Study|Withdrawal prior to procedure|5|||
149725113|NCT03733392|540129367|FG001|Overall Study|Withdrawal prior to procedure|2|||
149725114|NCT00808444|540129375|FG000|Overall Study|Withdrawal by Subject|1|||
149725115|NCT00808444|540129376|FG001|Overall Study|Withdrawal by Subject|0|||
149725116|NCT00808444|540129375|FG000|Overall Study|Lost to Follow-up|0|||
149725117|NCT00808444|540129376|FG001|Overall Study|Lost to Follow-up|1|||
149725118|NCT00618748|540129377|FG000|Overall Study|Adverse Event|4|||
149725119|NCT00618748|540129378|FG001|Overall Study|Adverse Event|3|||
149725120|NCT00618748|540129379|FG002|Overall Study|Adverse Event|8|||
149725121|NCT00618748|540129377|FG000|Overall Study|Physician Decision|3|||
149725122|NCT00618748|540129378|FG001|Overall Study|Physician Decision|1|||
149725123|NCT00618748|540129379|FG002|Overall Study|Physician Decision|1|||
149725124|NCT00618748|540129377|FG000|Overall Study|Withdrawal by Subject|4|||
149725125|NCT00618748|540129378|FG001|Overall Study|Withdrawal by Subject|1|||
149725126|NCT00618748|540129379|FG002|Overall Study|Withdrawal by Subject|5|||
149725127|NCT03269344|540129380|FG000|Overall Study|Protocol Violation|4|||
149725128|NCT03269344|540129381|FG001|Overall Study|Protocol Violation|3|||
149725129|NCT04401267|540129382|FG000|Overall Study|Death|0|||
149725130|NCT04401267|540129383|FG001|Overall Study|Death|1|||
149725131|NCT04401267|540129382|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
149725132|NCT04401267|540129383|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
149725133|NCT04401267|540129382|FG000|Overall Study|Found to be Ineligible|1|||
149725134|NCT04401267|540129383|FG001|Overall Study|Found to be Ineligible|0|||
149725135|NCT01449708|540129389|FG000|Overall Study|Protocol Violation|0|||
149725136|NCT01449708|540129390|FG001|Overall Study|Protocol Violation|1|||
149725137|NCT01449708|540129389|FG000|Overall Study|surgical complication|1|||
149725138|NCT01449708|540129390|FG001|Overall Study|surgical complication|2|||
149725139|NCT01449708|540129389|FG000|Overall Study|respiratory failure|1|||
149725140|NCT01449708|540129390|FG001|Overall Study|respiratory failure|0|||
149725141|NCT04294459|540129393|FG000|Overall Study|Adverse Event|0|||
149725142|NCT04294459|540129394|FG001|Overall Study|Adverse Event|1|||
149725143|NCT04033367|540129395|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
149725144|NCT04033367|540129396|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
149725145|NCT04033367|540129395|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
149725146|NCT04033367|540129396|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
149725147|NCT04033367|540129395|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
149725148|NCT04033367|540129396|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
149725149|NCT04033367|540129395|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
149725150|NCT04033367|540129396|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
149725151|NCT01191697|540129397|FG000|Overall Study|Death|1|||
149725152|NCT01191697|540129397|FG000|Overall Study|Physician Decision|2|||
150251457|NCT01531673|542056157|FG007|Overall Study|Adverse Event|0|||
150251458|NCT01531673|542056158|FG008|Overall Study|Adverse Event|0|||
150251459|NCT01531673|542056159|FG009|Overall Study|Adverse Event|0|||
150251460|NCT01531673|542056160|FG010|Overall Study|Adverse Event|0|||
150251461|NCT01531673|542056161|FG011|Overall Study|Adverse Event|0|||
150251462|NCT01531673|542056162|FG012|Overall Study|Adverse Event|0|||
150251463|NCT01531673|542056150|FG000|Overall Study|Lost to Follow-up|0|||
150251464|NCT01531673|542056151|FG001|Overall Study|Lost to Follow-up|0|||
150251465|NCT01531673|542056152|FG002|Overall Study|Lost to Follow-up|0|||
150251466|NCT01531673|542056153|FG003|Overall Study|Lost to Follow-up|0|||
150251467|NCT01531673|542056154|FG004|Overall Study|Lost to Follow-up|1|||
150251468|NCT01531673|542056155|FG005|Overall Study|Lost to Follow-up|0|||
150251469|NCT01531673|542056156|FG006|Overall Study|Lost to Follow-up|0|||
150251470|NCT01531673|542056157|FG007|Overall Study|Lost to Follow-up|0|||
149725153|NCT01191697|540129397|FG000|Overall Study|Pursue chemoradiation|2|||
149725154|NCT01191697|540129397|FG000|Overall Study|Break from chemotherapy|2|||
149725155|NCT01191697|540129397|FG000|Overall Study|Withdrawal by Subject|1|||
149725156|NCT01191697|540129397|FG000|Overall Study|Surveillance|1|||
149725157|NCT01191697|540129397|FG000|Overall Study|Adverse Event|2|||
149725158|NCT01191697|540129397|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
149725159|NCT01191697|540129397|FG000|Overall Study|Not completed but analyzed|25|||
149725160|NCT01882907|540129398|FG000|Overall Study|Adverse Event|3|||
149725161|NCT01882907|540129399|FG001|Overall Study|Adverse Event|1|||
149725162|NCT01882907|540129398|FG000|Overall Study|Lack of Efficacy|0|||
149725163|NCT01882907|540129399|FG001|Overall Study|Lack of Efficacy|3|||
149725164|NCT01882907|540129398|FG000|Overall Study|Lost to Follow-up|1|||
149725165|NCT01882907|540129399|FG001|Overall Study|Lost to Follow-up|4|||
149725166|NCT01882907|540129398|FG000|Overall Study|Protocol Violation|10|||
149725167|NCT01882907|540129399|FG001|Overall Study|Protocol Violation|14|||
149725168|NCT01882907|540129398|FG000|Overall Study|Withdrawal by Subject|0|||
149725169|NCT01882907|540129399|FG001|Overall Study|Withdrawal by Subject|6|||
149725170|NCT01784965|540129400|FG000|Overall Study|Withdrawal by Subject|6|||
149725171|NCT01784965|540129401|FG001|Overall Study|Withdrawal by Subject|3|||
150251471|NCT01531673|542056158|FG008|Overall Study|Lost to Follow-up|0|||
150251472|NCT01531673|542056159|FG009|Overall Study|Lost to Follow-up|0|||
150251473|NCT01531673|542056160|FG010|Overall Study|Lost to Follow-up|0|||
150251474|NCT01531673|542056161|FG011|Overall Study|Lost to Follow-up|0|||
149725172|NCT01784965|540129400|FG000|Overall Study|Adverse Event|0|||
149725173|NCT01784965|540129401|FG001|Overall Study|Adverse Event|8|||
149725174|NCT01467492|540129404|FG000|Overall Study|Withdrawal by Subject|6|||
149725175|NCT01467492|540129405|FG001|Overall Study|Withdrawal by Subject|4|||
149725176|NCT01467492|540129404|FG000|Overall Study|Study Terminated by Sponsor|6|||
149725177|NCT01467492|540129405|FG001|Overall Study|Study Terminated by Sponsor|4|||
149725178|NCT01467492|540129404|FG000|Overall Study|Adverse Event|4|||
149725179|NCT01467492|540129405|FG001|Overall Study|Adverse Event|3|||
149725180|NCT01467492|540129404|FG000|Overall Study|Lost to Follow-up|3|||
149725181|NCT01467492|540129405|FG001|Overall Study|Lost to Follow-up|2|||
149725182|NCT01467492|540129404|FG000|Overall Study|Undefined|2|||
149725183|NCT01467492|540129405|FG001|Overall Study|Undefined|0|||
149725184|NCT01467492|540129404|FG000|Overall Study|Enrolled But Not Treated|1|||
149725185|NCT01467492|540129405|FG001|Overall Study|Enrolled But Not Treated|0|||
149725186|NCT02450487|540129406|FG000|Overall Study|Lost to Follow-up|3|||
149725187|NCT01491178|540129407|FG000|Overall Study|Adverse Event|1016|||
149725188|NCT01491178|540129407|FG000|Overall Study|Improvement of NVAF|210|||
149725189|NCT01491178|540129407|FG000|Overall Study|To conduct invasive treatment|59|||
149725190|NCT01491178|540129407|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
149725191|NCT01491178|540129407|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
149725192|NCT01491178|540129407|FG000|Overall Study|To take a contraindication|20|||
149725193|NCT01491178|540129407|FG000|Overall Study|Other than specified above|657|||
149725194|NCT03132636|540129408|FG000|Overall Study|Adverse Event|1|||
149725195|NCT03132636|540129409|FG001|Overall Study|Adverse Event|2|||
149725196|NCT03132636|540129408|FG000|Overall Study|Death|4|||
149725197|NCT03132636|540129409|FG001|Overall Study|Death|7|||
149725198|NCT03132636|540129408|FG000|Overall Study|Lost to Follow-up|3|||
149725199|NCT03132636|540129409|FG001|Overall Study|Lost to Follow-up|2|||
149725200|NCT03132636|540129408|FG000|Overall Study|Non compliance with protocol by participant|1|||
149725201|NCT03132636|540129409|FG001|Overall Study|Non compliance with protocol by participant|1|||
149725202|NCT03132636|540129408|FG000|Overall Study|Subject decision|1|||
149725203|NCT03132636|540129409|FG001|Overall Study|Subject decision|9|||
149725204|NCT03132636|540129408|FG000|Overall Study|Sponsor decision|0|||
149725205|NCT03132636|540129409|FG001|Overall Study|Sponsor decision|1|||
149725206|NCT03132636|540129408|FG000|Overall Study|Physician Decision|1|||
149725207|NCT03132636|540129409|FG001|Overall Study|Physician Decision|0|||
149725208|NCT03132636|540129408|FG000|Overall Study|Progressive disease|33|||
149725209|NCT03132636|540129409|FG001|Overall Study|Progressive disease|36|||
149725210|NCT03132636|540129408|FG000|Overall Study|Withdrawal of consent|2|||
149725211|NCT03132636|540129409|FG001|Overall Study|Withdrawal of consent|5|||
149725212|NCT03132636|540129408|FG000|Overall Study|Did not re-consent|1|||
149725213|NCT03132636|540129409|FG001|Overall Study|Did not re-consent|0|||
149725214|NCT03132636|540129408|FG000|Overall Study|Lost insurance coverage|1|||
149725215|NCT03132636|540129409|FG001|Overall Study|Lost insurance coverage|0|||
149725216|NCT03132636|540129408|FG000|Overall Study|Related to radiological outcomes|0|||
149725217|NCT03132636|540129409|FG001|Overall Study|Related to radiological outcomes|1|||
149725218|NCT03132636|540129408|FG000|Overall Study|Unable to come to site for continued visits|0|||
149725219|NCT03132636|540129409|FG001|Overall Study|Unable to come to site for continued visits|1|||
149725220|NCT01415752|540129410|FG000|Induction (Step 1)|Ineligible|4|||
149725221|NCT01415752|540129411|FG001|Induction (Step 1)|Ineligible|3|||
149725222|NCT01415752|540129412|FG002|Induction (Step 1)|Ineligible|4|||
149725223|NCT01415752|540129413|FG003|Induction (Step 1)|Ineligible|4|||
149725224|NCT01415752|540129410|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
149725225|NCT01415752|540129411|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
149725226|NCT01415752|540129412|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
149725227|NCT01415752|540129413|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
149725228|NCT01415752|540129410|FG000|Maintenance (Step 2)|Adverse Event|3|||
149725229|NCT01415752|540129411|FG001|Maintenance (Step 2)|Adverse Event|4|||
149725230|NCT01415752|540129412|FG002|Maintenance (Step 2)|Adverse Event|9|||
149725231|NCT01415752|540129413|FG003|Maintenance (Step 2)|Adverse Event|6|||
150251475|NCT01531673|542056162|FG012|Overall Study|Lost to Follow-up|0|||
149725232|NCT01415752|540129410|FG000|Maintenance (Step 2)|Death|1|||
149725233|NCT01415752|540129411|FG001|Maintenance (Step 2)|Death|1|||
149725234|NCT01415752|540129412|FG002|Maintenance (Step 2)|Death|2|||
149725235|NCT01415752|540129413|FG003|Maintenance (Step 2)|Death|0|||
149725236|NCT01415752|540129410|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
149725237|NCT01415752|540129411|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
149725238|NCT01415752|540129412|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
149725239|NCT01415752|540129413|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
149725240|NCT01415752|540129410|FG000|Maintenance (Step 2)|Alternative therapy|0|||
149725241|NCT01415752|540129411|FG001|Maintenance (Step 2)|Alternative therapy|1|||
149725242|NCT01415752|540129412|FG002|Maintenance (Step 2)|Alternative therapy|0|||
149725243|NCT01415752|540129413|FG003|Maintenance (Step 2)|Alternative therapy|0|||
149725244|NCT01415752|540129410|FG000|Maintenance (Step 2)|Other reasons|3|||
149725245|NCT01415752|540129411|FG001|Maintenance (Step 2)|Other reasons|6|||
149725246|NCT01415752|540129412|FG002|Maintenance (Step 2)|Other reasons|4|||
149725247|NCT01415752|540129413|FG003|Maintenance (Step 2)|Other reasons|6|||
149725248|NCT01415752|540129410|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
149725249|NCT01415752|540129411|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
149725250|NCT01415752|540129412|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
149725251|NCT01415752|540129413|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
149725252|NCT01415752|540129410|FG000|Maintenance (Step 2)|ineligible|1|||
149725253|NCT01415752|540129411|FG001|Maintenance (Step 2)|ineligible|1|||
149725254|NCT01415752|540129412|FG002|Maintenance (Step 2)|ineligible|1|||
149725255|NCT01415752|540129413|FG003|Maintenance (Step 2)|ineligible|0|||
149725256|NCT01415752|540129410|FG000|Maintenance (Step 2)|Missing|4|||
149725257|NCT01415752|540129411|FG001|Maintenance (Step 2)|Missing|1|||
149725258|NCT01415752|540129412|FG002|Maintenance (Step 2)|Missing|4|||
149725259|NCT01415752|540129413|FG003|Maintenance (Step 2)|Missing|3|||
149725260|NCT03286842|540129414|FG000|Overall Study|Patients rolled over to another study|80|||
149725261|NCT01391507|540129415|FG000|Overall Study|Death|0|||
149725262|NCT01391507|540129416|FG001|Overall Study|Death|0|||
149725263|NCT01391507|540129417|FG002|Overall Study|Death|0|||
149725264|NCT01391507|540129418|FG003|Overall Study|Death|1|||
149725265|NCT01391507|540129415|FG000|Overall Study|Adverse Event|1|||
149725266|NCT01391507|540129416|FG001|Overall Study|Adverse Event|1|||
149725267|NCT01391507|540129417|FG002|Overall Study|Adverse Event|2|||
149725268|NCT01391507|540129418|FG003|Overall Study|Adverse Event|2|||
149725269|NCT01391507|540129415|FG000|Overall Study|Withdrawal by Subject|1|||
149725270|NCT01391507|540129416|FG001|Overall Study|Withdrawal by Subject|2|||
149725271|NCT01391507|540129417|FG002|Overall Study|Withdrawal by Subject|1|||
149725272|NCT01391507|540129418|FG003|Overall Study|Withdrawal by Subject|1|||
149725273|NCT01391507|540129415|FG000|Overall Study|Lack of Efficacy|0|||
149725274|NCT01391507|540129416|FG001|Overall Study|Lack of Efficacy|0|||
149725275|NCT01391507|540129417|FG002|Overall Study|Lack of Efficacy|0|||
149725276|NCT01391507|540129418|FG003|Overall Study|Lack of Efficacy|1|||
149725277|NCT01391507|540129415|FG000|Overall Study|Protocol Violation|2|||
149725278|NCT01391507|540129416|FG001|Overall Study|Protocol Violation|1|||
149725279|NCT01391507|540129417|FG002|Overall Study|Protocol Violation|1|||
149725280|NCT01391507|540129418|FG003|Overall Study|Protocol Violation|2|||
149725281|NCT01285908|540129423|FG000|Baseline Measurement|unable to insert catheter|1|||
149725282|NCT01285908|540129424|FG001|Baseline Measurement|unable to insert catheter|0|||
149725283|NCT01285908|540129425|FG002|Baseline Measurement|unable to insert catheter|0|||
149725284|NCT01285908|540129423|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
149725285|NCT01285908|540129424|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
149725286|NCT01285908|540129425|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
149725287|NCT01285908|540129423|FG000|Baseline Measurement|unable to tolerate procedure|1|||
149725288|NCT01285908|540129424|FG001|Baseline Measurement|unable to tolerate procedure|0|||
149725289|NCT01285908|540129425|FG002|Baseline Measurement|unable to tolerate procedure|0|||
149725290|NCT01562548|540129426|FG000|Overall Study|Lost to Follow-up|0|||
149725291|NCT01562548|540129427|FG001|Overall Study|Lost to Follow-up|0|||
149725292|NCT01562548|540129428|FG002|Overall Study|Lost to Follow-up|1|||
149725293|NCT01562548|540129429|FG003|Overall Study|Lost to Follow-up|0|||
149725294|NCT02926209|540129430|FG000|Study Cohort|Poor Bowel Preparation|1|||
149725295|NCT02926209|540129431|FG001|Study Cohort|Poor Bowel Preparation|0|||
149725296|NCT01239160|540129432|FG000|Overall Study|Lost to Follow-up|3|||
149725297|NCT01239160|540129433|FG001|Overall Study|Lost to Follow-up|5|||
149725298|NCT01239160|540129434|FG002|Overall Study|Lost to Follow-up|0|||
149725299|NCT01239160|540129432|FG000|Overall Study|Withdrawal by Subject|17|||
149725300|NCT01239160|540129433|FG001|Overall Study|Withdrawal by Subject|6|||
149725301|NCT01239160|540129434|FG002|Overall Study|Withdrawal by Subject|2|||
149725302|NCT01239160|540129432|FG000|Overall Study|Physician Decision|5|||
149725303|NCT01239160|540129433|FG001|Overall Study|Physician Decision|7|||
149725304|NCT01239160|540129434|FG002|Overall Study|Physician Decision|2|||
149725305|NCT01239160|540129432|FG000|Overall Study|Early Termination Due to Study Closure|0|||
149725306|NCT01239160|540129433|FG001|Overall Study|Early Termination Due to Study Closure|1|||
149725307|NCT01239160|540129434|FG002|Overall Study|Early Termination Due to Study Closure|6|||
149725308|NCT04781816|540129440|FG000|Overall Study|Adverse Event|0|||
149725309|NCT04781816|540129441|FG001|Overall Study|Adverse Event|1|||
149725310|NCT04781816|540129440|FG000|Overall Study|Withdrawal by Subject|1|||
149725311|NCT04781816|540129441|FG001|Overall Study|Withdrawal by Subject|1|||
149725312|NCT04781816|540129440|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
149725313|NCT04781816|540129441|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
149725314|NCT01789970|540129442|FG000|Open-label Titration Period|Adverse Event|68|||
149725315|NCT01789970|540129443|FG001|Open-label Titration Period|Adverse Event|0|||
149725316|NCT01789970|540129444|FG002|Open-label Titration Period|Adverse Event|0|||
149725317|NCT01789970|540129442|FG000|Open-label Titration Period|Lack of Efficacy|31|||
149725318|NCT01789970|540129443|FG001|Open-label Titration Period|Lack of Efficacy|0|||
149725319|NCT01789970|540129444|FG002|Open-label Titration Period|Lack of Efficacy|0|||
149725320|NCT01789970|540129442|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
149725321|NCT01789970|540129443|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
149725322|NCT01789970|540129444|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
150251476|NCT01531673|542056150|FG000|Overall Study|Other|0|||
149725323|NCT01789970|540129442|FG000|Open-label Titration Period|Protocol Violation|18|||
149725324|NCT01789970|540129443|FG001|Open-label Titration Period|Protocol Violation|0|||
149725325|NCT01789970|540129444|FG002|Open-label Titration Period|Protocol Violation|0|||
149725326|NCT01789970|540129442|FG000|Open-label Titration Period|Lost to Follow-up|5|||
149725327|NCT01789970|540129443|FG001|Open-label Titration Period|Lost to Follow-up|0|||
149725328|NCT01789970|540129444|FG002|Open-label Titration Period|Lost to Follow-up|0|||
149725329|NCT01789970|540129442|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
149725330|NCT01789970|540129443|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
149725331|NCT01789970|540129444|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
149725332|NCT01789970|540129442|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
149725333|NCT01789970|540129443|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
149725334|NCT01789970|540129444|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
149725335|NCT01789970|540129442|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
149725336|NCT01789970|540129443|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
149725337|NCT01789970|540129444|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
149725338|NCT01789970|540129442|FG000|Open-label Titration Period|Pregnancy|2|||
149725339|NCT01789970|540129443|FG001|Open-label Titration Period|Pregnancy|0|||
149725340|NCT01789970|540129444|FG002|Open-label Titration Period|Pregnancy|0|||
149725341|NCT01789970|540129442|FG000|Open-label Titration Period|Other|76|||
149725342|NCT01789970|540129443|FG001|Open-label Titration Period|Other|0|||
149725343|NCT01789970|540129444|FG002|Open-label Titration Period|Other|0|||
149725344|NCT01789970|540129442|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
149725345|NCT01789970|540129443|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
149725346|NCT01789970|540129444|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
149725347|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
149725348|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
149725349|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
149725350|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149725351|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
149725352|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
149725353|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149725354|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
149725355|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
149725356|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
149725357|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
149725358|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
149725359|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
149725360|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
149725361|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
149725362|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
149725363|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
149725364|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
149725365|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
149725366|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
149725367|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
149725368|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
149725369|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
149725370|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
149725371|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
149725372|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
149725373|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
149725374|NCT01789970|540129442|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
149725375|NCT01789970|540129443|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
149725376|NCT01789970|540129444|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
149725377|NCT02574637|540129451|FG000|Double-blind Period|Adverse Event|1|||
149725378|NCT02574637|540129452|FG001|Double-blind Period|Adverse Event|0|||
149725379|NCT02574637|540129453|FG002|Double-blind Period|Adverse Event|0|||
149725380|NCT02574637|540129454|FG003|Double-blind Period|Adverse Event|0|||
149725381|NCT02574637|540129455|FG004|Double-blind Period|Adverse Event|0|||
150251477|NCT01531673|542056151|FG001|Overall Study|Other|0|||
150251478|NCT01531673|542056152|FG002|Overall Study|Other|0|||
150251479|NCT01531673|542056153|FG003|Overall Study|Other|1|||
150251480|NCT01531673|542056154|FG004|Overall Study|Other|0|||
150251481|NCT01531673|542056155|FG005|Overall Study|Other|0|||
150251482|NCT01531673|542056156|FG006|Overall Study|Other|0|||
150251483|NCT01531673|542056157|FG007|Overall Study|Other|0|||
150251484|NCT01531673|542056158|FG008|Overall Study|Other|0|||
149725382|NCT02574637|540129456|FG005|Double-blind Period|Adverse Event|0|||
149725383|NCT02574637|540129457|FG006|Double-blind Period|Adverse Event|0|||
149725384|NCT02574637|540129458|FG007|Double-blind Period|Adverse Event|0|||
149725385|NCT02574637|540129459|FG008|Double-blind Period|Adverse Event|0|||
149725386|NCT02574637|540129460|FG009|Double-blind Period|Adverse Event|0|||
149725387|NCT02574637|540129451|FG000|Double-blind Period|Lack of Efficacy|0|||
149725388|NCT02574637|540129452|FG001|Double-blind Period|Lack of Efficacy|0|||
149725389|NCT02574637|540129453|FG002|Double-blind Period|Lack of Efficacy|2|||
149725390|NCT02574637|540129454|FG003|Double-blind Period|Lack of Efficacy|0|||
149725391|NCT02574637|540129455|FG004|Double-blind Period|Lack of Efficacy|0|||
149725392|NCT02574637|540129456|FG005|Double-blind Period|Lack of Efficacy|0|||
149725393|NCT02574637|540129457|FG006|Double-blind Period|Lack of Efficacy|0|||
149725394|NCT02574637|540129458|FG007|Double-blind Period|Lack of Efficacy|0|||
149725395|NCT02574637|540129459|FG008|Double-blind Period|Lack of Efficacy|0|||
149725396|NCT02574637|540129460|FG009|Double-blind Period|Lack of Efficacy|0|||
149725397|NCT02574637|540129451|FG000|Double-blind Period|Protocol Deviation|1|||
149725398|NCT02574637|540129452|FG001|Double-blind Period|Protocol Deviation|0|||
149725399|NCT02574637|540129453|FG002|Double-blind Period|Protocol Deviation|0|||
149725400|NCT02574637|540129454|FG003|Double-blind Period|Protocol Deviation|0|||
149725401|NCT02574637|540129455|FG004|Double-blind Period|Protocol Deviation|0|||
149725402|NCT02574637|540129456|FG005|Double-blind Period|Protocol Deviation|0|||
149725403|NCT02574637|540129457|FG006|Double-blind Period|Protocol Deviation|0|||
149725404|NCT02574637|540129458|FG007|Double-blind Period|Protocol Deviation|0|||
149725405|NCT02574637|540129459|FG008|Double-blind Period|Protocol Deviation|0|||
149725406|NCT02574637|540129460|FG009|Double-blind Period|Protocol Deviation|0|||
149725407|NCT02574637|540129451|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
149725408|NCT02574637|540129452|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
149725409|NCT02574637|540129453|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
149725410|NCT02574637|540129454|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
149725411|NCT02574637|540129455|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
149725412|NCT02574637|540129456|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
149725413|NCT02574637|540129457|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
149725414|NCT02574637|540129458|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
149725415|NCT02574637|540129459|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
149725416|NCT02574637|540129460|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
149725417|NCT02574637|540129451|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
149725418|NCT02574637|540129452|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
149725419|NCT02574637|540129453|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
149725420|NCT02574637|540129454|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
149725421|NCT02574637|540129455|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
149725422|NCT02574637|540129456|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
149725423|NCT02574637|540129457|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
149725424|NCT02574637|540129458|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
149725425|NCT02574637|540129459|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
149725426|NCT02574637|540129460|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
149725427|NCT02574637|540129451|FG000|Double-blind Period|Reason Not Specified|0|||
149725428|NCT02574637|540129452|FG001|Double-blind Period|Reason Not Specified|0|||
149725429|NCT02574637|540129453|FG002|Double-blind Period|Reason Not Specified|0|||
149725430|NCT02574637|540129454|FG003|Double-blind Period|Reason Not Specified|1|||
149725431|NCT02574637|540129455|FG004|Double-blind Period|Reason Not Specified|0|||
149725432|NCT02574637|540129456|FG005|Double-blind Period|Reason Not Specified|0|||
149725433|NCT02574637|540129457|FG006|Double-blind Period|Reason Not Specified|0|||
149725434|NCT02574637|540129458|FG007|Double-blind Period|Reason Not Specified|0|||
149725435|NCT02574637|540129459|FG008|Double-blind Period|Reason Not Specified|0|||
149725436|NCT02574637|540129460|FG009|Double-blind Period|Reason Not Specified|0|||
149725437|NCT02574637|540129451|FG000|Open-label (OL) Period|Adverse Event|0|||
149725438|NCT02574637|540129452|FG001|Open-label (OL) Period|Adverse Event|0|||
149725439|NCT02574637|540129453|FG002|Open-label (OL) Period|Adverse Event|0|||
149725440|NCT02574637|540129454|FG003|Open-label (OL) Period|Adverse Event|0|||
149725441|NCT02574637|540129455|FG004|Open-label (OL) Period|Adverse Event|0|||
149725442|NCT02574637|540129456|FG005|Open-label (OL) Period|Adverse Event|0|||
149725443|NCT02574637|540129457|FG006|Open-label (OL) Period|Adverse Event|0|||
149725444|NCT02574637|540129458|FG007|Open-label (OL) Period|Adverse Event|0|||
149725445|NCT02574637|540129459|FG008|Open-label (OL) Period|Adverse Event|1|||
149725446|NCT02574637|540129460|FG009|Open-label (OL) Period|Adverse Event|0|||
149725447|NCT02574637|540129451|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
149725448|NCT02574637|540129452|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
149725449|NCT02574637|540129453|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
149725450|NCT02574637|540129454|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
149725451|NCT02574637|540129455|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
149725452|NCT02574637|540129456|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
149725453|NCT02574637|540129457|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
149725454|NCT02574637|540129458|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
149725455|NCT02574637|540129459|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
149725456|NCT02574637|540129460|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
149725457|NCT02574637|540129451|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725458|NCT02574637|540129452|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725459|NCT02574637|540129453|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725460|NCT02574637|540129454|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725461|NCT02574637|540129455|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725462|NCT02574637|540129456|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149725463|NCT02574637|540129457|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
149725464|NCT02574637|540129458|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149725465|NCT02574637|540129459|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149725466|NCT02574637|540129460|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149725467|NCT01536860|540129461|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
149725468|NCT01536860|540129462|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
149725469|NCT01536860|540129463|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
149725470|NCT01164722|540129464|FG000|Overall Study|Adverse Event|0|||
149725471|NCT01164722|540129465|FG001|Overall Study|Adverse Event|1|||
149725472|NCT01164722|540129464|FG000|Overall Study|Withdrawal by Subject|3|||
149725473|NCT01164722|540129465|FG001|Overall Study|Withdrawal by Subject|4|||
149725474|NCT01164722|540129464|FG000|Overall Study|Lost to Follow-up|3|||
149725475|NCT01164722|540129465|FG001|Overall Study|Lost to Follow-up|6|||
149725476|NCT01164722|540129464|FG000|Overall Study|met protocol criteria for non-treatment|11|||
149725477|NCT01164722|540129465|FG001|Overall Study|met protocol criteria for non-treatment|1|||
149725478|NCT01164722|540129464|FG000|Overall Study|enrolled on other study, concomitant med|1|||
149725479|NCT01164722|540129465|FG001|Overall Study|enrolled on other study, concomitant med|3|||
149725480|NCT02682901|540129467|FG000|Overall Study|Adverse Event|10|||
149725481|NCT02682901|540129468|FG001|Overall Study|Adverse Event|3|||
149725482|NCT02682901|540129467|FG000|Overall Study|Lack of Efficacy|0|||
149725483|NCT02682901|540129468|FG001|Overall Study|Lack of Efficacy|1|||
149725484|NCT03870555|540129469|FG000|Period 3 (2 Days)|Adverse Event|1|||
149725485|NCT03870555|540129470|FG001|Period 3 (2 Days)|Adverse Event|0|||
149725486|NCT03870555|540129471|FG002|Period 3 (2 Days)|Adverse Event|0|||
149725487|NCT02902120|540129473|FG000|Overall Study|Lack of Efficacy|1|||
149725488|NCT03694925|540129476|FG000|Overall Study|Inadequate laboratory testing|0|||
149725489|NCT03694925|540129477|FG001|Overall Study|Inadequate laboratory testing|3|||
149725490|NCT03694925|540129478|FG002|Overall Study|Inadequate laboratory testing|0|||
149725491|NCT01422239|540129481|FG000|Overall Study|Lost to Follow-up|4|||
149725492|NCT01422239|540129482|FG001|Overall Study|Lost to Follow-up|3|||
149725493|NCT02799069|540129485|FG000|Overall Study|Adverse Event|0|||
149725494|NCT02799069|540129486|FG001|Overall Study|Adverse Event|2|||
149725495|NCT02799069|540129487|FG002|Overall Study|Adverse Event|2|||
149725496|NCT02799069|540129485|FG000|Overall Study|Lack of Efficacy|2|||
149725497|NCT02799069|540129486|FG001|Overall Study|Lack of Efficacy|0|||
149725498|NCT02799069|540129487|FG002|Overall Study|Lack of Efficacy|0|||
149725499|NCT02799069|540129485|FG000|Overall Study|Lost to Follow-up|1|||
149725500|NCT02799069|540129486|FG001|Overall Study|Lost to Follow-up|1|||
149725501|NCT02799069|540129487|FG002|Overall Study|Lost to Follow-up|0|||
149725502|NCT02799069|540129485|FG000|Overall Study|Withdrawal by Subject|4|||
149725503|NCT02799069|540129486|FG001|Overall Study|Withdrawal by Subject|4|||
149725504|NCT02799069|540129487|FG002|Overall Study|Withdrawal by Subject|3|||
149725505|NCT02799069|540129485|FG000|Overall Study|Protocol Violation|1|||
149725506|NCT02799069|540129486|FG001|Overall Study|Protocol Violation|0|||
149725507|NCT02799069|540129487|FG002|Overall Study|Protocol Violation|2|||
149725508|NCT03652662|540129495|FG000|Overall Study|Withdrawal by Subject|2|||
149725509|NCT03652662|540129496|FG001|Overall Study|Withdrawal by Subject|1|||
149725510|NCT03652662|540129495|FG000|Overall Study|Lost to Follow-up|1|||
149725511|NCT03652662|540129496|FG001|Overall Study|Lost to Follow-up|0|||
149725512|NCT03499028|540129497|FG000|Overall Study|Lost to Follow-up|12|||
149725513|NCT03499028|540129498|FG001|Overall Study|Lost to Follow-up|9|||
150251485|NCT01531673|542056159|FG009|Overall Study|Other|1|||
150251486|NCT01531673|542056160|FG010|Overall Study|Other|0|||
150251487|NCT01531673|542056161|FG011|Overall Study|Other|0|||
150251488|NCT01531673|542056162|FG012|Overall Study|Other|0|||
150251489|NCT04476251|542056165|FG000|Overall Study|Not treated|1|||
149725514|NCT03499028|540129497|FG000|Overall Study|Withdrawal by Subject|5|||
149725515|NCT03499028|540129498|FG001|Overall Study|Withdrawal by Subject|8|||
149725516|NCT03499028|540129497|FG000|Overall Study|Unplanned SNF discharge|5|||
149725517|NCT03499028|540129498|FG001|Overall Study|Unplanned SNF discharge|8|||
149725518|NCT01110200|540129499|FG000|Overall Study|Adverse Event|28|||
149725519|NCT01110200|540129500|FG001|Overall Study|Adverse Event|28|||
150251490|NCT03446781|542056166|FG000|Overall Study|Lost to Follow-up|11|||
149725520|NCT01110200|540129499|FG000|Overall Study|Withdrawal by Subject|25|||
149725521|NCT01110200|540129500|FG001|Overall Study|Withdrawal by Subject|32|||
149725522|NCT01110200|540129499|FG000|Overall Study|Lack of Efficacy|16|||
150251491|NCT03446781|542056167|FG001|Overall Study|Lost to Follow-up|5|||
150251492|NCT03446781|542056166|FG000|Overall Study|Withdrawal by Subject|9|||
149725523|NCT01110200|540129500|FG001|Overall Study|Lack of Efficacy|25|||
149725524|NCT01110200|540129499|FG000|Overall Study|Protocol Violation|14|||
149725525|NCT01110200|540129500|FG001|Overall Study|Protocol Violation|12|||
149725526|NCT01110200|540129499|FG000|Overall Study|Physician Decision|13|||
149725527|NCT01110200|540129500|FG001|Overall Study|Physician Decision|17|||
149725528|NCT01110200|540129499|FG000|Overall Study|Lost to Follow-up|10|||
149725529|NCT01110200|540129500|FG001|Overall Study|Lost to Follow-up|7|||
149725530|NCT01681433|540129501|FG000|Overall Study|Lack of Efficacy|23|||
149725531|NCT01681433|540129502|FG001|Overall Study|Lack of Efficacy|23|||
149725532|NCT01681433|540129501|FG000|Overall Study|Withdrawal by Subject|5|||
149725533|NCT01681433|540129502|FG001|Overall Study|Withdrawal by Subject|5|||
149725534|NCT01681433|540129501|FG000|Overall Study|Protocol Violation|2|||
149725535|NCT01681433|540129502|FG001|Overall Study|Protocol Violation|0|||
149725536|NCT01681433|540129501|FG000|Overall Study|Adverse Event|2|||
149725537|NCT01681433|540129502|FG001|Overall Study|Adverse Event|4|||
149725538|NCT01681433|540129501|FG000|Overall Study|Lost to Follow-up|0|||
149725539|NCT01681433|540129502|FG001|Overall Study|Lost to Follow-up|1|||
149725540|NCT00730639|540129503|FG000|Overall Study|Adverse Event|3|||
149725541|NCT00730639|540129504|FG001|Overall Study|Adverse Event|0|||
149725542|NCT00730639|540129505|FG002|Overall Study|Adverse Event|9|||
149725543|NCT00730639|540129506|FG003|Overall Study|Adverse Event|8|||
149725544|NCT00730639|540129507|FG004|Overall Study|Adverse Event|23|||
149725545|NCT00730639|540129503|FG000|Overall Study|Complete Response|0|||
149725546|NCT00730639|540129504|FG001|Overall Study|Complete Response|0|||
149725547|NCT00730639|540129505|FG002|Overall Study|Complete Response|2|||
149725548|NCT00730639|540129506|FG003|Overall Study|Complete Response|2|||
149725549|NCT00730639|540129507|FG004|Overall Study|Complete Response|1|||
149725550|NCT00730639|540129503|FG000|Overall Study|Completed Maximum Cycles|0|||
149725551|NCT00730639|540129504|FG001|Overall Study|Completed Maximum Cycles|0|||
149725552|NCT00730639|540129505|FG002|Overall Study|Completed Maximum Cycles|11|||
149725553|NCT00730639|540129506|FG003|Overall Study|Completed Maximum Cycles|3|||
149725554|NCT00730639|540129507|FG004|Overall Study|Completed Maximum Cycles|6|||
149725555|NCT00730639|540129503|FG000|Overall Study|Death|0|||
149725556|NCT00730639|540129504|FG001|Overall Study|Death|0|||
149725557|NCT00730639|540129505|FG002|Overall Study|Death|0|||
149725558|NCT00730639|540129506|FG003|Overall Study|Death|0|||
149725559|NCT00730639|540129507|FG004|Overall Study|Death|2|||
149725560|NCT00730639|540129503|FG000|Overall Study|Disease Progression|12|||
149725561|NCT00730639|540129504|FG001|Overall Study|Disease Progression|13|||
149725562|NCT00730639|540129505|FG002|Overall Study|Disease Progression|48|||
149725563|NCT00730639|540129506|FG003|Overall Study|Disease Progression|32|||
149725564|NCT00730639|540129507|FG004|Overall Study|Disease Progression|88|||
149725565|NCT00730639|540129503|FG000|Overall Study|non-specified|0|||
149725566|NCT00730639|540129504|FG001|Overall Study|non-specified|0|||
149725567|NCT00730639|540129505|FG002|Overall Study|non-specified|4|||
149725568|NCT00730639|540129506|FG003|Overall Study|non-specified|2|||
149725569|NCT00730639|540129507|FG004|Overall Study|non-specified|3|||
149725570|NCT00730639|540129503|FG000|Overall Study|Protocol Violation|0|||
149725571|NCT00730639|540129504|FG001|Overall Study|Protocol Violation|0|||
149725572|NCT00730639|540129505|FG002|Overall Study|Protocol Violation|1|||
149725573|NCT00730639|540129506|FG003|Overall Study|Protocol Violation|0|||
149725574|NCT00730639|540129507|FG004|Overall Study|Protocol Violation|0|||
149725575|NCT00730639|540129503|FG000|Overall Study|Withdrawal by Subject|0|||
149725576|NCT00730639|540129504|FG001|Overall Study|Withdrawal by Subject|0|||
149725577|NCT00730639|540129505|FG002|Overall Study|Withdrawal by Subject|6|||
149725578|NCT00730639|540129506|FG003|Overall Study|Withdrawal by Subject|3|||
149725579|NCT00730639|540129507|FG004|Overall Study|Withdrawal by Subject|4|||
149725580|NCT00730639|540129503|FG000|Overall Study|Treatment on-going|2|||
149725581|NCT00730639|540129504|FG001|Overall Study|Treatment on-going|5|||
149725582|NCT00730639|540129505|FG002|Overall Study|Treatment on-going|5|||
149725583|NCT00730639|540129506|FG003|Overall Study|Treatment on-going|4|||
149725584|NCT00730639|540129507|FG004|Overall Study|Treatment on-going|4|||
149725585|NCT00903929|540129508|FG000|Overall Study|Withdrawal by Subject|0|||
149725586|NCT00903929|540129509|FG001|Overall Study|Withdrawal by Subject|0|||
149725587|NCT00903929|540129510|FG002|Overall Study|Withdrawal by Subject|1|||
149725588|NCT00903929|540129511|FG003|Overall Study|Withdrawal by Subject|2|||
149725589|NCT00903929|540129508|FG000|Overall Study|Adverse Event|0|||
149725590|NCT00903929|540129509|FG001|Overall Study|Adverse Event|0|||
149725591|NCT00903929|540129510|FG002|Overall Study|Adverse Event|0|||
149725592|NCT00903929|540129511|FG003|Overall Study|Adverse Event|1|||
149725593|NCT02665286|540129512|FG000|Overall Study|Lost to Follow-up|3|||
150251493|NCT03446781|542056167|FG001|Overall Study|Withdrawal by Subject|7|||
149725594|NCT02665286|540129513|FG001|Overall Study|Lost to Follow-up|2|||
149725595|NCT02665286|540129514|FG002|Overall Study|Lost to Follow-up|1|||
149725596|NCT01318109|540129517|FG000|Overall Study|Adverse Event|0|||
149725597|NCT01318109|540129518|FG001|Overall Study|Adverse Event|2|||
149725598|NCT01318109|540129519|FG002|Overall Study|Adverse Event|0|||
149725599|NCT01318109|540129517|FG000|Overall Study|Withdrawal by Subject|1|||
149725600|NCT01318109|540129518|FG001|Overall Study|Withdrawal by Subject|0|||
149725601|NCT01318109|540129519|FG002|Overall Study|Withdrawal by Subject|0|||
149725602|NCT01318109|540129517|FG000|Overall Study|Schedule Conflict|0|||
149725603|NCT01318109|540129518|FG001|Overall Study|Schedule Conflict|1|||
149725604|NCT01318109|540129519|FG002|Overall Study|Schedule Conflict|0|||
149725605|NCT01250379|540129524|FG000|Overall Study|Death|141|||
149725606|NCT01250379|540129525|FG001|Overall Study|Death|148|||
149725607|NCT01250379|540129524|FG000|Overall Study|Withdrawal by Subject|32|||
149725608|NCT01250379|540129525|FG001|Overall Study|Withdrawal by Subject|20|||
149725609|NCT01250379|540129524|FG000|Overall Study|Physician Decision|11|||
149725610|NCT01250379|540129525|FG001|Overall Study|Physician Decision|3|||
149725611|NCT01250379|540129524|FG000|Overall Study|Protocol Violation|2|||
149725612|NCT01250379|540129525|FG001|Overall Study|Protocol Violation|8|||
149725613|NCT01250379|540129524|FG000|Overall Study|Lost to Follow-up|9|||
149725614|NCT01250379|540129525|FG001|Overall Study|Lost to Follow-up|6|||
149725615|NCT01250379|540129524|FG000|Overall Study|Adverse Event|5|||
149725616|NCT01250379|540129525|FG001|Overall Study|Adverse Event|4|||
149725617|NCT01250379|540129524|FG000|Overall Study|Other|0|||
149725618|NCT01250379|540129525|FG001|Overall Study|Other|4|||
149725619|NCT01250379|540129524|FG000|Overall Study|Participant noncompliance|2|||
149725620|NCT01250379|540129525|FG001|Overall Study|Participant noncompliance|0|||
149725621|NCT04899232|540129526|FG000|Screening Period|Physician Decision|1|||
149725622|NCT04899232|540129527|FG001|Screening Period|Physician Decision|0|||
149725623|NCT04899232|540129528|FG002|Screening Period|Physician Decision|0|||
149725624|NCT04899232|540129526|FG000|Screening Period|Withdrawal by Subject|1|||
149725625|NCT04899232|540129527|FG001|Screening Period|Withdrawal by Subject|0|||
149725626|NCT04899232|540129528|FG002|Screening Period|Withdrawal by Subject|0|||
149725627|NCT04899232|540129526|FG000|Screening Period|Participant discharged before receiving intervention|3|||
149725628|NCT04899232|540129527|FG001|Screening Period|Participant discharged before receiving intervention|0|||
149725629|NCT04899232|540129528|FG002|Screening Period|Participant discharged before receiving intervention|0|||
149725630|NCT01314716|540129529|FG000|Double-Blind Phase|Randomized but not treated|1|||
149725631|NCT01314716|540129530|FG001|Double-Blind Phase|Randomized but not treated|1|||
149725632|NCT01314716|540129529|FG000|Double-Blind Phase|Adverse Event|10|||
149725633|NCT01314716|540129530|FG001|Double-Blind Phase|Adverse Event|4|||
149725634|NCT01314716|540129529|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
149725635|NCT01314716|540129530|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
149725636|NCT01314716|540129529|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149725637|NCT01314716|540129530|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149725638|NCT01314716|540129529|FG000|Double-Blind Phase|Sponsor request|1|||
149725639|NCT01314716|540129530|FG001|Double-Blind Phase|Sponsor request|2|||
149725640|NCT01314716|540129529|FG000|Double-Blind Phase|Physician Decision|0|||
149725641|NCT01314716|540129530|FG001|Double-Blind Phase|Physician Decision|1|||
149725642|NCT01314716|540129529|FG000|Open-Label Phase|Adverse Event|4|||
149725643|NCT01314716|540129530|FG001|Open-Label Phase|Adverse Event|6|||
149725644|NCT01314716|540129529|FG000|Open-Label Phase|Withdrawal by Subject|1|||
149725645|NCT01314716|540129530|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149725646|NCT01314716|540129529|FG000|Open-Label Phase|Physician Decision|5|||
149725647|NCT01314716|540129530|FG001|Open-Label Phase|Physician Decision|4|||
149725648|NCT02926950|540129534|FG000|Overall Study|Adverse Event|4|||
149725649|NCT02926950|540129535|FG001|Overall Study|Adverse Event|6|||
149725650|NCT02926950|540129534|FG000|Overall Study|At the participant's own request|21|||
149725651|NCT02926950|540129535|FG001|Overall Study|At the participant's own request|25|||
149725652|NCT02926950|540129534|FG000|Overall Study|Reason not Specified|17|||
149725653|NCT02926950|540129535|FG001|Overall Study|Reason not Specified|9|||
149725654|NCT02926950|540129534|FG000|Overall Study|Lost to Follow-up|7|||
149725655|NCT02926950|540129535|FG001|Overall Study|Lost to Follow-up|8|||
149725656|NCT05036083|540129536|FG000|Overall Study|Physician Decision|1|||
149725657|NCT05036083|540129536|FG000|Overall Study|Withdrawal by Subject|1|||
149725658|NCT05036083|540129536|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
149725659|NCT05036083|540129536|FG000|Overall Study|IV not sustainable|1|||
149725660|NCT03087955|540131260|FG000|Overall Study|Death|4|||
149725661|NCT03087955|540131261|FG001|Overall Study|Death|0|||
149725662|NCT03087955|540131260|FG000|Overall Study|Lack of Efficacy|2|||
149725663|NCT03087955|540131261|FG001|Overall Study|Lack of Efficacy|0|||
149725664|NCT03087955|540131260|FG000|Overall Study|Lost to Follow-up|1|||
149725665|NCT03087955|540131261|FG001|Overall Study|Lost to Follow-up|0|||
149725666|NCT02392429|540131262|FG000|Screening|Screen failure|15|||
149725667|NCT02392429|540131262|FG000|Enrolled Participants|Ineligible due to disease|3|||
149725668|NCT02392429|540131262|FG000|Enrolled Participants|Withdrawal by Subject|4|||
149725669|NCT02392429|540131262|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
149725670|NCT02392429|540131262|FG000|Evaluable|Death|5|||
149725671|NCT02392429|540131262|FG000|Evaluable|Withdrawal by Subject|1|||
149725672|NCT02392429|540131262|FG000|Evaluable|Adverse Event|1|||
149725673|NCT02392429|540131262|FG000|Evaluable|remission bone marrow biopsy|3|||
149725674|NCT00482014|540131263|FG000|Overall Study|Withdrawal by Subject|1|||
149725675|NCT00482014|540131264|FG001|Overall Study|Withdrawal by Subject|2|||
149725676|NCT00482014|540131265|FG002|Overall Study|Withdrawal by Subject|3|||
149725677|NCT00482014|540131266|FG003|Overall Study|Withdrawal by Subject|4|||
149725678|NCT00482014|540131263|FG000|Overall Study|Adverse Event|3|||
149725679|NCT00482014|540131264|FG001|Overall Study|Adverse Event|0|||
149725680|NCT00482014|540131265|FG002|Overall Study|Adverse Event|2|||
149725681|NCT00482014|540131266|FG003|Overall Study|Adverse Event|8|||
149725682|NCT00482014|540131263|FG000|Overall Study|Death|1|||
149725683|NCT00482014|540131264|FG001|Overall Study|Death|2|||
149725684|NCT00482014|540131265|FG002|Overall Study|Death|1|||
149725685|NCT00482014|540131266|FG003|Overall Study|Death|4|||
149725686|NCT00482014|540131263|FG000|Overall Study|Lack of Efficacy|1|||
149725687|NCT00482014|540131264|FG001|Overall Study|Lack of Efficacy|0|||
149725688|NCT00482014|540131265|FG002|Overall Study|Lack of Efficacy|4|||
149725689|NCT00482014|540131266|FG003|Overall Study|Lack of Efficacy|6|||
149725690|NCT00482014|540131263|FG000|Overall Study|Sponsor Decision|1|||
149725691|NCT00482014|540131264|FG001|Overall Study|Sponsor Decision|2|||
149725692|NCT00482014|540131265|FG002|Overall Study|Sponsor Decision|1|||
149725693|NCT00482014|540131266|FG003|Overall Study|Sponsor Decision|1|||
149725694|NCT03686397|540131267|FG000|Overall Study|Lack of Efficacy|3|||
149725695|NCT03686397|540131268|FG001|Overall Study|Lack of Efficacy|5|||
149725696|NCT03686397|540131267|FG000|Overall Study|Adverse Event|0|||
149725697|NCT03686397|540131268|FG001|Overall Study|Adverse Event|1|||
149725698|NCT03686397|540131267|FG000|Overall Study|Protocol Violation|0|||
149725699|NCT03686397|540131268|FG001|Overall Study|Protocol Violation|1|||
149725700|NCT03686397|540131267|FG000|Overall Study|Withdrawal by Subject|0|||
149725701|NCT03686397|540131268|FG001|Overall Study|Withdrawal by Subject|1|||
149725702|NCT03686397|540131267|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
149725703|NCT03686397|540131268|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
149725704|NCT04137887|540131271|FG000|Overall Study|Death|102|||
149725705|NCT04137887|540131272|FG001|Overall Study|Death|92|||
149725706|NCT04137887|540131271|FG000|Overall Study|Withdrawal by Subject|2|||
149725707|NCT04137887|540131272|FG001|Overall Study|Withdrawal by Subject|3|||
149725708|NCT04137887|540131271|FG000|Overall Study|Randomized but not treated|0|||
149725709|NCT04137887|540131272|FG001|Overall Study|Randomized but not treated|1|||
149725710|NCT05064059|540131275|FG000|Overall Study|Death|199|||
149725711|NCT05064059|540131276|FG001|Overall Study|Death|196|||
149725712|NCT05064059|540131275|FG000|Overall Study|Physician Decision|4|||
149725713|NCT05064059|540131276|FG001|Overall Study|Physician Decision|2|||
149725714|NCT05064059|540131275|FG000|Overall Study|Sponsor Decision|14|||
149725715|NCT05064059|540131276|FG001|Overall Study|Sponsor Decision|11|||
149725716|NCT05064059|540131275|FG000|Overall Study|Withdrawal by Subject|4|||
149725717|NCT05064059|540131276|FG001|Overall Study|Withdrawal by Subject|11|||
149725718|NCT02740478|540131277|FG000|Overall Study|Withdrawal by Subject|1|||
149725719|NCT02615990|540131279|FG000|Overall Study|study terminated|1|||
149725720|NCT02615990|540131280|FG001|Overall Study|study terminated|1|||
149725721|NCT04316585|540131281|FG000|Overall Study|Adverse Event|2|||
149725722|NCT04316585|540131282|FG001|Overall Study|Adverse Event|1|||
149725723|NCT04316585|540131281|FG000|Overall Study|Lost to Follow-up|1|||
149725724|NCT04316585|540131282|FG001|Overall Study|Lost to Follow-up|0|||
149725725|NCT04316585|540131281|FG000|Overall Study|Withdrawal by Subject|2|||
149725726|NCT04316585|540131282|FG001|Overall Study|Withdrawal by Subject|3|||
149725727|NCT04316585|540131281|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
149725728|NCT04316585|540131282|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
149725729|NCT04316585|540131281|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
149725730|NCT04316585|540131282|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
149725731|NCT03905863|540131283|FG000|Overall Study|Adverse Event|2|||
149725732|NCT03905863|540131284|FG001|Overall Study|Adverse Event|4|||
149725733|NCT03905863|540131283|FG000|Overall Study|Withdrawal by Subject|2|||
149725734|NCT03905863|540131284|FG001|Overall Study|Withdrawal by Subject|2|||
149725735|NCT03905863|540131283|FG000|Overall Study|Physician Decision|0|||
149725736|NCT03905863|540131284|FG001|Overall Study|Physician Decision|3|||
149725737|NCT03905863|540131283|FG000|Overall Study|Lost to Follow-up|1|||
149725738|NCT03905863|540131284|FG001|Overall Study|Lost to Follow-up|0|||
149725739|NCT03905863|540131283|FG000|Overall Study|Protocol Violation|0|||
149725740|NCT03905863|540131284|FG001|Overall Study|Protocol Violation|2|||
149725741|NCT03905863|540131283|FG000|Overall Study|Death|0|||
149725742|NCT03905863|540131284|FG001|Overall Study|Death|1|||
149725743|NCT01072344|540131286|FG000|Overall Study|Relasped-reached end point|7|||
149725744|NCT01072344|540131287|FG001|Overall Study|Relasped-reached end point|12|||
149725745|NCT01072344|540131286|FG000|Overall Study|Protocol Violation|1|||
149725746|NCT01072344|540131287|FG001|Overall Study|Protocol Violation|2|||
149725747|NCT01072344|540131286|FG000|Overall Study|Lost to Follow-up|3|||
149725748|NCT01072344|540131287|FG001|Overall Study|Lost to Follow-up|4|||
150251494|NCT03446781|542056166|FG000|Overall Study|Adverse Event|8|||
149725749|NCT01934140|540131294|FG000|Persistence Phase (Year 6-10)|Other|24|||
149725750|NCT01934140|540131295|FG001|Persistence Phase (Year 6-10)|Other|6|||
149725751|NCT01934140|540131294|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
149725752|NCT01934140|540131295|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
149725753|NCT01934140|540131294|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
149725754|NCT01934140|540131295|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
149725755|NCT01934140|540131294|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
149725756|NCT01934140|540131295|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
149725757|NCT01934140|540131294|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
149725758|NCT01934140|540131295|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
149725759|NCT01934140|540131294|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
149725760|NCT01934140|540131295|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
149725761|NCT01934140|540131294|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
149725762|NCT01934140|540131295|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
149725763|NCT01934140|540131294|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
149725764|NCT01934140|540131295|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
149725765|NCT02944448|540131299|FG000|Overall Study|Adverse Event|37|||
149725766|NCT02944448|540131300|FG001|Overall Study|Adverse Event|6|||
149725767|NCT02944448|540131299|FG000|Overall Study|Lack of Efficacy|8|||
149725768|NCT02944448|540131300|FG001|Overall Study|Lack of Efficacy|5|||
149725769|NCT02944448|540131299|FG000|Overall Study|Lost to Follow-up|3|||
149725770|NCT02944448|540131300|FG001|Overall Study|Lost to Follow-up|1|||
149725771|NCT02944448|540131299|FG000|Overall Study|Protocol Violation|25|||
149725772|NCT02944448|540131300|FG001|Overall Study|Protocol Violation|7|||
149725773|NCT02944448|540131299|FG000|Overall Study|Withdrawal by Subject|14|||
149725774|NCT02944448|540131300|FG001|Overall Study|Withdrawal by Subject|4|||
149725775|NCT02944448|540131299|FG000|Overall Study|Sponsor did not supply drug in time|0|||
149725776|NCT02944448|540131300|FG001|Overall Study|Sponsor did not supply drug in time|1|||
149725777|NCT02944448|540131299|FG000|Overall Study|Noncompliant with dosing|1|||
149725778|NCT02944448|540131300|FG001|Overall Study|Noncompliant with dosing|0|||
149725779|NCT02944448|540131299|FG000|Overall Study|Abnormal laboratory values|1|||
149725780|NCT02944448|540131300|FG001|Overall Study|Abnormal laboratory values|0|||
149725781|NCT01461044|540131301|FG000|Overall Study|Death|58|||
149725782|NCT01461044|540131302|FG001|Overall Study|Death|35|||
149725783|NCT01461044|540131301|FG000|Overall Study|Lost to Follow-up|12|||
149725784|NCT01461044|540131302|FG001|Overall Study|Lost to Follow-up|5|||
149725785|NCT00716976|540131303|FG000|Overall Study|Adverse Event|2|||
149725786|NCT00716976|540131304|FG001|Overall Study|Adverse Event|0|||
149725787|NCT00716976|540131303|FG000|Overall Study|Death|1|||
149725788|NCT00716976|540131304|FG001|Overall Study|Death|0|||
149725789|NCT00716976|540131303|FG000|Overall Study|Physician Decision|2|||
149725790|NCT00716976|540131304|FG001|Overall Study|Physician Decision|2|||
149725791|NCT00716976|540131303|FG000|Overall Study|Withdrawal by Subject|5|||
149725792|NCT00716976|540131304|FG001|Overall Study|Withdrawal by Subject|1|||
149725793|NCT00716976|540131303|FG000|Overall Study|Premature discontinuation cisplatin|5|||
149725794|NCT00716976|540131304|FG001|Overall Study|Premature discontinuation cisplatin|4|||
149725795|NCT00716976|540131303|FG000|Overall Study|Radiation during protocol|1|||
149725796|NCT00716976|540131304|FG001|Overall Study|Radiation during protocol|0|||
149725797|NCT00716976|540131303|FG000|Overall Study|Ineligibles|4|||
149725798|NCT00716976|540131304|FG001|Overall Study|Ineligibles|2|||
149725799|NCT00200850|540131305|FG000|Overall Study|relocation|1|||
149725800|NCT00200850|540131306|FG001|Overall Study|relocation|0|||
149725801|NCT00200850|540131307|FG002|Overall Study|relocation|1|||
149725802|NCT00200850|540131305|FG000|Overall Study|too busy|1|||
149725803|NCT00200850|540131306|FG001|Overall Study|too busy|0|||
149725804|NCT00200850|540131307|FG002|Overall Study|too busy|0|||
149725805|NCT00200850|540131305|FG000|Overall Study|Pregnancy|0|||
149725806|NCT00200850|540131306|FG001|Overall Study|Pregnancy|0|||
149725807|NCT00200850|540131307|FG002|Overall Study|Pregnancy|1|||
149725808|NCT00200850|540131305|FG000|Overall Study|Poor adherence|0|||
149725809|NCT00200850|540131306|FG001|Overall Study|Poor adherence|0|||
149725810|NCT00200850|540131307|FG002|Overall Study|Poor adherence|1|||
149725811|NCT00200850|540131305|FG000|Overall Study|optic neuritis|0|||
149725812|NCT00200850|540131306|FG001|Overall Study|optic neuritis|0|||
149725813|NCT00200850|540131307|FG002|Overall Study|optic neuritis|1|||
150251495|NCT03446781|542056167|FG001|Overall Study|Adverse Event|2|||
150251496|NCT03446781|542056166|FG000|Overall Study|Protocol Violation|0|||
150251497|NCT03446781|542056167|FG001|Overall Study|Protocol Violation|3|||
150251498|NCT01638429|542056174|FG000|Overall Study|Withdrawal by Subject|1|||
150251499|NCT01470001|542056175|FG000|Overall Study|Lost to Follow-up|1|||
150251500|NCT01470001|542056176|FG001|Overall Study|Lost to Follow-up|1|||
149725814|NCT00200850|540131305|FG000|Overall Study|Adverse Event|1|||
150251501|NCT01470001|542056175|FG000|Overall Study|Physician Decision|2|||
150251502|NCT01470001|542056176|FG001|Overall Study|Physician Decision|0|||
150251503|NCT01470001|542056175|FG000|Overall Study|Withdrawal by Subject|2|||
150251504|NCT01470001|542056176|FG001|Overall Study|Withdrawal by Subject|1|||
149725815|NCT00200850|540131306|FG001|Overall Study|Adverse Event|1|||
149725816|NCT00200850|540131307|FG002|Overall Study|Adverse Event|2|||
149725817|NCT02889796|540131312|FG000|Overall Study|Withdrew Consent|18|||
149725818|NCT02889796|540131313|FG001|Overall Study|Withdrew Consent|29|||
149725819|NCT02889796|540131314|FG002|Overall Study|Withdrew Consent|20|||
149725820|NCT02889796|540131315|FG003|Overall Study|Withdrew Consent|1|||
149725821|NCT02889796|540131316|FG004|Overall Study|Withdrew Consent|2|||
149725822|NCT02889796|540131317|FG005|Overall Study|Withdrew Consent|35|||
149725823|NCT02889796|540131312|FG000|Overall Study|Investigator's Discretion|10|||
149725824|NCT02889796|540131313|FG001|Overall Study|Investigator's Discretion|9|||
149725825|NCT02889796|540131314|FG002|Overall Study|Investigator's Discretion|10|||
149725826|NCT02889796|540131315|FG003|Overall Study|Investigator's Discretion|3|||
149725827|NCT02889796|540131316|FG004|Overall Study|Investigator's Discretion|0|||
149725828|NCT02889796|540131317|FG005|Overall Study|Investigator's Discretion|15|||
149725829|NCT02889796|540131312|FG000|Overall Study|Adverse Event|17|||
149725830|NCT02889796|540131313|FG001|Overall Study|Adverse Event|8|||
149725831|NCT02889796|540131314|FG002|Overall Study|Adverse Event|8|||
149725832|NCT02889796|540131315|FG003|Overall Study|Adverse Event|4|||
149725833|NCT02889796|540131316|FG004|Overall Study|Adverse Event|1|||
149725834|NCT02889796|540131317|FG005|Overall Study|Adverse Event|7|||
149725835|NCT02889796|540131312|FG000|Overall Study|Lost to Follow-up|5|||
149725836|NCT02889796|540131313|FG001|Overall Study|Lost to Follow-up|7|||
149725837|NCT02889796|540131314|FG002|Overall Study|Lost to Follow-up|2|||
149725838|NCT02889796|540131315|FG003|Overall Study|Lost to Follow-up|0|||
149725839|NCT02889796|540131316|FG004|Overall Study|Lost to Follow-up|2|||
149725840|NCT02889796|540131317|FG005|Overall Study|Lost to Follow-up|6|||
149725841|NCT02889796|540131312|FG000|Overall Study|Protocol Violation|0|||
149725842|NCT02889796|540131313|FG001|Overall Study|Protocol Violation|1|||
149725843|NCT02889796|540131314|FG002|Overall Study|Protocol Violation|3|||
149725844|NCT02889796|540131315|FG003|Overall Study|Protocol Violation|0|||
149725845|NCT02889796|540131316|FG004|Overall Study|Protocol Violation|0|||
149725846|NCT02889796|540131317|FG005|Overall Study|Protocol Violation|4|||
149725847|NCT02889796|540131312|FG000|Overall Study|Non-compliance With Study Drug|0|||
149725848|NCT02889796|540131313|FG001|Overall Study|Non-compliance With Study Drug|2|||
149725849|NCT02889796|540131314|FG002|Overall Study|Non-compliance With Study Drug|0|||
149725850|NCT02889796|540131315|FG003|Overall Study|Non-compliance With Study Drug|0|||
149725851|NCT02889796|540131316|FG004|Overall Study|Non-compliance With Study Drug|1|||
149725852|NCT02889796|540131317|FG005|Overall Study|Non-compliance With Study Drug|2|||
149725853|NCT02889796|540131312|FG000|Overall Study|Death|1|||
149725854|NCT02889796|540131313|FG001|Overall Study|Death|1|||
149725855|NCT02889796|540131314|FG002|Overall Study|Death|0|||
149725856|NCT02889796|540131315|FG003|Overall Study|Death|1|||
149725857|NCT02889796|540131316|FG004|Overall Study|Death|0|||
149725858|NCT02889796|540131317|FG005|Overall Study|Death|1|||
149725859|NCT02889796|540131312|FG000|Overall Study|Pregnancy|0|||
149725860|NCT02889796|540131313|FG001|Overall Study|Pregnancy|1|||
149725861|NCT02889796|540131314|FG002|Overall Study|Pregnancy|1|||
149725862|NCT02889796|540131315|FG003|Overall Study|Pregnancy|0|||
149725863|NCT02889796|540131316|FG004|Overall Study|Pregnancy|0|||
149725864|NCT02889796|540131317|FG005|Overall Study|Pregnancy|0|||
149725865|NCT02889796|540131312|FG000|Overall Study|Randomized but not Dosed|2|||
149725866|NCT02889796|540131313|FG001|Overall Study|Randomized but not Dosed|0|||
149725867|NCT02889796|540131314|FG002|Overall Study|Randomized but not Dosed|0|||
149725868|NCT02889796|540131315|FG003|Overall Study|Randomized but not Dosed|0|||
149725869|NCT02889796|540131316|FG004|Overall Study|Randomized but not Dosed|0|||
149725870|NCT02889796|540131317|FG005|Overall Study|Randomized but not Dosed|2|||
149725871|NCT02421887|540131318|FG000|Overall Study|Lost to Follow-up|5|||
149725872|NCT02421887|540131319|FG001|Overall Study|Lost to Follow-up|0|||
149725873|NCT02421887|540131318|FG000|Overall Study|Withdrawal by Subject|8|||
149725874|NCT02421887|540131319|FG001|Overall Study|Withdrawal by Subject|5|||
149725875|NCT02421887|540131318|FG000|Overall Study|Physician Decision|2|||
149725876|NCT02421887|540131319|FG001|Overall Study|Physician Decision|4|||
149725877|NCT02421887|540131318|FG000|Overall Study|Adverse Event|2|||
149725878|NCT02421887|540131319|FG001|Overall Study|Adverse Event|0|||
149725879|NCT04269395|540131320|FG000|Overall Study|Lost to Follow-up|1|||
149725880|NCT04269395|540131321|FG001|Overall Study|Lost to Follow-up|0|||
149725881|NCT04269395|540131320|FG000|Overall Study|Study terminated by Sponsor|13|||
149725882|NCT04269395|540131321|FG001|Overall Study|Study terminated by Sponsor|10|||
149725883|NCT01764633|540131322|FG000|Overall Study|Withdrawal by Subject|105|||
149725884|NCT01764633|540131323|FG001|Overall Study|Withdrawal by Subject|88|||
149725885|NCT01764633|540131322|FG000|Overall Study|Lost to Follow-up|13|||
149725886|NCT01764633|540131323|FG001|Overall Study|Lost to Follow-up|5|||
149725887|NCT02268058|540131324|FG000|Overall Study|Protocol Violation|1|||
149725888|NCT02268058|540131325|FG001|Overall Study|Protocol Violation|0|||
149725889|NCT02268058|540131326|FG002|Overall Study|Protocol Violation|0|||
149725890|NCT02268058|540131327|FG003|Overall Study|Protocol Violation|0|||
149725891|NCT04142983|540131328|FG000|Overall Study|Lost to Follow-up|73|||
149725892|NCT04142983|540131328|FG000|Overall Study|Withdrawal by Subject|10|||
149725893|NCT04142983|540131328|FG000|Overall Study|Physician Decision|1|||
150251505|NCT03268603|542056177|FG000|Overall Study|Withdrawal by Subject|6|||
149725894|NCT04142983|540131328|FG000|Overall Study|Adverse Event|1|||
149725895|NCT04142983|540131328|FG000|Overall Study|No longer eligible|4|||
149725896|NCT04142983|540131328|FG000|Overall Study|Screen Failure|10|||
149725897|NCT02062658|540131330|FG000|Overall Study|Withdrawal by Subject|1|||
149725898|NCT02062658|540131330|FG000|Overall Study|Lack of Efficacy|1|||
149725899|NCT00643994|540131331|FG000|Overall Study|Death|24|||
149725900|NCT00643994|540131331|FG000|Overall Study|Lost to Follow-up|72|||
149725901|NCT01847885|540131335|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
149725902|NCT01847885|540131336|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
149725903|NCT01847885|540131337|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
149725904|NCT01847885|540131335|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
149725905|NCT01847885|540131336|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
149725906|NCT01847885|540131337|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
149725907|NCT01847885|540131335|FG000|Initial Enrollment (Consented)|Screen failure|39|||
149725908|NCT01847885|540131336|FG001|Initial Enrollment (Consented)|Screen failure|0|||
149725909|NCT01847885|540131337|FG002|Initial Enrollment (Consented)|Screen failure|0|||
150251506|NCT03268603|542056177|FG000|Overall Study|Physician Decision|1|||
150251507|NCT03268603|542056177|FG000|Overall Study|Withdrawn due to disease progression|2|||
150251508|NCT03896152|542056183|FG000|Overall Study|Patient/guardian decision|1|||
149725910|NCT01847885|540131335|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
149725911|NCT01847885|540131336|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
149725912|NCT01847885|540131337|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
149725913|NCT01847885|540131335|FG000|Randomization|Protocol Violation|0|||
149725914|NCT01847885|540131336|FG001|Randomization|Protocol Violation|1|||
149725915|NCT01847885|540131337|FG002|Randomization|Protocol Violation|0|||
149725916|NCT01847885|540131335|FG000|Randomization|Withdrawal by Subject|0|||
149725917|NCT01847885|540131336|FG001|Randomization|Withdrawal by Subject|0|||
149725918|NCT01847885|540131337|FG002|Randomization|Withdrawal by Subject|2|||
149725919|NCT01847885|540131335|FG000|Randomization|Screen Failure|0|||
149725920|NCT01847885|540131336|FG001|Randomization|Screen Failure|3|||
149725921|NCT01847885|540131337|FG002|Randomization|Screen Failure|0|||
149725922|NCT04016311|540131341|FG000|Overall Study|Withdrawal by Subject|1|||
149725923|NCT04016311|540131342|FG001|Overall Study|Withdrawal by Subject|0|||
149725924|NCT04029519|540131344|FG000|Overall Study|Protocol Violation|1|||
149725925|NCT04029519|540131344|FG000|Overall Study|Withdrawal by Subject|3|||
149725926|NCT04029519|540131344|FG000|Overall Study|Lost to Follow-up|1|||
149725927|NCT00756938|540131351|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
149725928|NCT00756938|540131352|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
149725929|NCT00756938|540131353|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
149725930|NCT00756938|540131354|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
149725931|NCT00756938|540131351|FG000|12-week Base Study|Protocol Violation|0|||
149725932|NCT00756938|540131352|FG001|12-week Base Study|Protocol Violation|0|||
149725933|NCT00756938|540131353|FG002|12-week Base Study|Protocol Violation|1|||
149725934|NCT00756938|540131354|FG003|12-week Base Study|Protocol Violation|0|||
149725935|NCT00756938|540131351|FG000|12-week Base Study|Lost to Follow-up|1|||
149725936|NCT00756938|540131352|FG001|12-week Base Study|Lost to Follow-up|0|||
149725937|NCT00756938|540131353|FG002|12-week Base Study|Lost to Follow-up|0|||
149725938|NCT00756938|540131354|FG003|12-week Base Study|Lost to Follow-up|0|||
149725939|NCT00756938|540131351|FG000|Optional Extension|Lack of Efficacy|0|||
149725940|NCT00756938|540131352|FG001|Optional Extension|Lack of Efficacy|0|||
149725941|NCT00756938|540131353|FG002|Optional Extension|Lack of Efficacy|0|||
149725942|NCT00756938|540131354|FG003|Optional Extension|Lack of Efficacy|1|||
149725943|NCT00756938|540131351|FG000|Optional Extension|End of Study|0|||
149725944|NCT00756938|540131352|FG001|Optional Extension|End of Study|0|||
149725945|NCT00756938|540131353|FG002|Optional Extension|End of Study|0|||
149725946|NCT00756938|540131354|FG003|Optional Extension|End of Study|11|||
149725947|NCT00756938|540131351|FG000|Optional Extension|Protocol-specific criteria met|0|||
149725948|NCT00756938|540131352|FG001|Optional Extension|Protocol-specific criteria met|0|||
149725949|NCT00756938|540131353|FG002|Optional Extension|Protocol-specific criteria met|0|||
149725950|NCT00756938|540131354|FG003|Optional Extension|Protocol-specific criteria met|9|||
149725951|NCT00756938|540131351|FG000|Optional Extension|Physician Decision|0|||
149725952|NCT00756938|540131352|FG001|Optional Extension|Physician Decision|0|||
149725953|NCT00756938|540131353|FG002|Optional Extension|Physician Decision|0|||
149725954|NCT00756938|540131354|FG003|Optional Extension|Physician Decision|3|||
149725955|NCT00756938|540131351|FG000|Optional Extension|Lost to Follow-up|0|||
149725956|NCT00756938|540131352|FG001|Optional Extension|Lost to Follow-up|0|||
149725957|NCT00756938|540131353|FG002|Optional Extension|Lost to Follow-up|0|||
149725958|NCT00756938|540131354|FG003|Optional Extension|Lost to Follow-up|1|||
149725959|NCT00756938|540131351|FG000|Optional Extension|Protocol Violation|0|||
149725960|NCT00756938|540131352|FG001|Optional Extension|Protocol Violation|0|||
149725961|NCT00756938|540131353|FG002|Optional Extension|Protocol Violation|0|||
149725962|NCT00756938|540131354|FG003|Optional Extension|Protocol Violation|1|||
149725963|NCT00756938|540131351|FG000|Optional Extension|Withdrawal by Subject|0|||
149725964|NCT00756938|540131352|FG001|Optional Extension|Withdrawal by Subject|0|||
149725965|NCT00756938|540131353|FG002|Optional Extension|Withdrawal by Subject|0|||
149725966|NCT00756938|540131354|FG003|Optional Extension|Withdrawal by Subject|10|||
149725967|NCT00756938|540131351|FG000|Optional Extension|Adverse Event|0|||
149725968|NCT00756938|540131352|FG001|Optional Extension|Adverse Event|0|||
149725969|NCT00756938|540131353|FG002|Optional Extension|Adverse Event|0|||
149725970|NCT00756938|540131354|FG003|Optional Extension|Adverse Event|1|||
149725971|NCT04823949|540131355|FG000|Overall Study|Withdrawal by Subject|0|||
150251509|NCT03896152|542056184|FG001|Overall Study|Patient/guardian decision|1|||
149725972|NCT04823949|540131356|FG001|Overall Study|Withdrawal by Subject|4|||
149725973|NCT04823949|540131355|FG000|Overall Study|Physician Decision|0|||
149725974|NCT04823949|540131356|FG001|Overall Study|Physician Decision|1|||
149725975|NCT00094055|540131357|FG000|Overall Study|Adverse Event|11|||
149725976|NCT00094055|540131357|FG000|Overall Study|Death|4|||
149725977|NCT00094055|540131357|FG000|Overall Study|Lack of Efficacy|17|||
149725978|NCT00094055|540131357|FG000|Overall Study|Lost to Follow-up|2|||
149725979|NCT00094055|540131357|FG000|Overall Study|progressive disease|2|||
149725980|NCT00094055|540131357|FG000|Overall Study|clinical progression|1|||
149725981|NCT00094055|540131357|FG000|Overall Study|roll-over to another study|14|||
149725982|NCT00094055|540131357|FG000|Overall Study|Withdrawal by Subject|9|||
149725983|NCT02347176|540131360|FG000|Overall Study|Lost to Follow-up|2|||
149725984|NCT02347176|540131361|FG001|Overall Study|Lost to Follow-up|3|||
149725985|NCT02347176|540131362|FG002|Overall Study|Lost to Follow-up|1|||
149725986|NCT02347176|540131363|FG003|Overall Study|Lost to Follow-up|1|||
149725987|NCT02347176|540131360|FG000|Overall Study|Withdrawal by Subject|9|||
149725988|NCT02347176|540131361|FG001|Overall Study|Withdrawal by Subject|5|||
149725989|NCT02347176|540131362|FG002|Overall Study|Withdrawal by Subject|5|||
149725990|NCT02347176|540131363|FG003|Overall Study|Withdrawal by Subject|3|||
149725991|NCT02347176|540131360|FG000|Overall Study|Other|1|||
149725992|NCT02347176|540131361|FG001|Overall Study|Other|2|||
149725993|NCT02347176|540131362|FG002|Overall Study|Other|2|||
149725994|NCT02347176|540131363|FG003|Overall Study|Other|0|||
149725995|NCT00411554|540131364|FG000|Overall Study|Adverse Event|2|||
149725996|NCT00411554|540131365|FG001|Overall Study|Adverse Event|4|||
149725997|NCT00411554|540131364|FG000|Overall Study|Lack of Efficacy|2|||
149725998|NCT00411554|540131365|FG001|Overall Study|Lack of Efficacy|5|||
149725999|NCT00411554|540131364|FG000|Overall Study|Withdrawal by Subject|3|||
149726000|NCT00411554|540131365|FG001|Overall Study|Withdrawal by Subject|0|||
149726001|NCT00411554|540131364|FG000|Overall Study|Patient Moved|1|||
149726002|NCT00411554|540131365|FG001|Overall Study|Patient Moved|0|||
149726003|NCT02556255|540131366|FG000|Overall Study|Lost to Follow-up|4|||
149726004|NCT01543087|540131367|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
149726005|NCT01543087|540131368|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
149726006|NCT01543087|540131369|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
149726007|NCT01543087|540131370|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
149726008|NCT01543087|540131371|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
149726009|NCT01543087|540131372|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
149726010|NCT01543087|540131367|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
149726011|NCT01543087|540131368|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
149726012|NCT01543087|540131369|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
149726013|NCT01543087|540131370|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
149726014|NCT01543087|540131371|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
149726015|NCT01543087|540131372|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
149726016|NCT01543087|540131367|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
149726017|NCT01543087|540131368|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
149726018|NCT01543087|540131369|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
149726019|NCT01543087|540131370|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
149726020|NCT01543087|540131371|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
149726021|NCT01543087|540131372|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
149726022|NCT01543087|540131367|FG000|Stage 1 (48 Months)|Other than specified|5|||
149726023|NCT01543087|540131368|FG001|Stage 1 (48 Months)|Other than specified|0|||
149726024|NCT01543087|540131369|FG002|Stage 1 (48 Months)|Other than specified|9|||
149726025|NCT01543087|540131370|FG003|Stage 1 (48 Months)|Other than specified|0|||
149726026|NCT01543087|540131371|FG004|Stage 1 (48 Months)|Other than specified|0|||
149726027|NCT01543087|540131372|FG005|Stage 1 (48 Months)|Other than specified|0|||
149726028|NCT01543087|540131367|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
150251510|NCT03896152|542056183|FG000|Overall Study|Adverse Event|0|||
150251511|NCT03896152|542056184|FG001|Overall Study|Adverse Event|1|||
150251512|NCT03896152|542056183|FG000|Overall Study|Physician Decision|1|||
150251513|NCT03896152|542056184|FG001|Overall Study|Physician Decision|0|||
149726029|NCT01543087|540131368|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
149726030|NCT01543087|540131369|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
149726031|NCT01543087|540131370|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
149726032|NCT01543087|540131371|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
149726033|NCT01543087|540131372|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
149726034|NCT01543087|540131367|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149726035|NCT01543087|540131368|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
149726036|NCT01543087|540131369|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149726037|NCT01543087|540131370|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149726038|NCT01543087|540131371|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
149726039|NCT01543087|540131372|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149726040|NCT01543087|540131367|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
150251514|NCT03896152|542056183|FG000|Overall Study|Technical problems|1|||
149726041|NCT01543087|540131368|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
149726042|NCT01543087|540131369|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
149726043|NCT01543087|540131370|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
149726044|NCT01543087|540131371|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
149726045|NCT01543087|540131372|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
149726046|NCT04673786|540131373|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
149726047|NCT04673786|540131374|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
149726048|NCT04673786|540131375|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
149726049|NCT04673786|540131373|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
149726050|NCT04673786|540131374|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
149726051|NCT04673786|540131375|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
149726052|NCT04673786|540131373|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
149726053|NCT04673786|540131374|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
149726054|NCT04673786|540131375|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
149726055|NCT04673786|540131373|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
149726056|NCT04673786|540131374|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
149726057|NCT04673786|540131375|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
150251515|NCT03896152|542056184|FG001|Overall Study|Technical problems|0|||
150251516|NCT04939701|542056185|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
150251517|NCT04939701|542056186|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
150251518|NCT04939701|542056187|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
150251519|NCT04939701|542056185|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
150251520|NCT04939701|542056186|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
150251521|NCT04939701|542056187|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
150251522|NCT04939701|542056185|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
150251523|NCT04939701|542056186|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
150251524|NCT04939701|542056187|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
150251525|NCT04939701|542056185|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
150251526|NCT04939701|542056186|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
150251527|NCT04939701|542056187|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
150251528|NCT04939701|542056185|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
150251529|NCT04939701|542056186|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
150251530|NCT04939701|542056187|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
150251531|NCT04939701|542056185|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
150251532|NCT04939701|542056186|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
150251533|NCT04939701|542056187|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
150251534|NCT04939701|542056185|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
150251535|NCT04939701|542056186|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
150251536|NCT04939701|542056187|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
150251537|NCT02236988|542056188|FG000|Overall Study|Lost to Follow-up|0|||
150251538|NCT02236988|542056189|FG001|Overall Study|Lost to Follow-up|0|||
150251539|NCT02236988|542056190|FG002|Overall Study|Lost to Follow-up|0|||
150251540|NCT02236988|542056191|FG003|Overall Study|Lost to Follow-up|1|||
150251541|NCT02236988|542056188|FG000|Overall Study|Unable to Comply with Study Visits|0|||
150251542|NCT02236988|542056189|FG001|Overall Study|Unable to Comply with Study Visits|0|||
150251543|NCT02236988|542056190|FG002|Overall Study|Unable to Comply with Study Visits|0|||
150251544|NCT02236988|542056191|FG003|Overall Study|Unable to Comply with Study Visits|2|||
150251545|NCT05775991|542056192|FG000|Overall Study|Withdrawal by Subject|0|||
150251546|NCT05775991|542056193|FG001|Overall Study|Withdrawal by Subject|0|||
150251547|NCT05775991|542056194|FG002|Overall Study|Withdrawal by Subject|2|||
150251548|NCT01461811|542056195|FG000|Overall Study|Adverse Event|2|||
150251549|NCT01461811|542056196|FG001|Overall Study|Adverse Event|1|||
150251550|NCT01461811|542056195|FG000|Overall Study|Subject decision unrelated to an AE|1|||
150251551|NCT01461811|542056196|FG001|Overall Study|Subject decision unrelated to an AE|1|||
149726058|NCT04673786|540131373|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
149726059|NCT04673786|540131374|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
149726060|NCT04673786|540131375|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
150251552|NCT01461811|542056195|FG000|Overall Study|Noncompliance|1|||
149726061|NCT04673786|540131373|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
149726062|NCT04673786|540131374|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
149726063|NCT04673786|540131375|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
149726064|NCT00143455|540131376|FG000|Cohort 1|Adverse Event|8|||
149726065|NCT00143455|540131377|FG001|Cohort 1|Adverse Event|4|||
150251553|NCT01461811|542056196|FG001|Overall Study|Noncompliance|1|||
150251554|NCT03733314|542056197|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
150251555|NCT03733314|542056198|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
150251556|NCT03733314|542056197|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
149726066|NCT00143455|540131378|FG002|Cohort 1|Adverse Event|0|||
149726067|NCT00143455|540131379|FG003|Cohort 1|Adverse Event|0|||
149726068|NCT00143455|540131376|FG000|Cohort 1|Death|5|||
150251557|NCT03733314|542056198|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
150251558|NCT03733314|542056197|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
150251559|NCT03733314|542056198|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
149726069|NCT00143455|540131377|FG001|Cohort 1|Death|2|||
149726070|NCT00143455|540131378|FG002|Cohort 1|Death|0|||
149726071|NCT00143455|540131379|FG003|Cohort 1|Death|0|||
149726072|NCT00143455|540131376|FG000|Cohort 1|Progressive Disease|0|||
149726073|NCT00143455|540131377|FG001|Cohort 1|Progressive Disease|6|||
149726074|NCT00143455|540131378|FG002|Cohort 1|Progressive Disease|0|||
149726075|NCT00143455|540131379|FG003|Cohort 1|Progressive Disease|0|||
149726076|NCT00143455|540131376|FG000|Cohort 1|Withdrawal by Subject|1|||
149726077|NCT00143455|540131377|FG001|Cohort 1|Withdrawal by Subject|4|||
149726078|NCT00143455|540131378|FG002|Cohort 1|Withdrawal by Subject|0|||
149726079|NCT00143455|540131379|FG003|Cohort 1|Withdrawal by Subject|0|||
149726080|NCT00143455|540131376|FG000|Cohort 1|Randomized But Not Treated|0|||
149726081|NCT00143455|540131377|FG001|Cohort 1|Randomized But Not Treated|1|||
149726082|NCT00143455|540131378|FG002|Cohort 1|Randomized But Not Treated|0|||
149726083|NCT00143455|540131379|FG003|Cohort 1|Randomized But Not Treated|0|||
149726084|NCT00143455|540131376|FG000|Cohort 2|Adverse Event|0|||
149726085|NCT00143455|540131377|FG001|Cohort 2|Adverse Event|0|||
149726086|NCT00143455|540131378|FG002|Cohort 2|Adverse Event|42|||
149726087|NCT00143455|540131379|FG003|Cohort 2|Adverse Event|30|||
149726088|NCT00143455|540131376|FG000|Cohort 2|No Longer Required Study Treatment|0|||
149726089|NCT00143455|540131377|FG001|Cohort 2|No Longer Required Study Treatment|0|||
149726090|NCT00143455|540131378|FG002|Cohort 2|No Longer Required Study Treatment|1|||
149726091|NCT00143455|540131379|FG003|Cohort 2|No Longer Required Study Treatment|0|||
149726092|NCT00143455|540131376|FG000|Cohort 2|Protocol Violation|0|||
149726093|NCT00143455|540131377|FG001|Cohort 2|Protocol Violation|0|||
149726094|NCT00143455|540131378|FG002|Cohort 2|Protocol Violation|1|||
149726095|NCT00143455|540131379|FG003|Cohort 2|Protocol Violation|1|||
149726096|NCT00143455|540131376|FG000|Cohort 2|Lost to Follow-up|0|||
149726097|NCT00143455|540131377|FG001|Cohort 2|Lost to Follow-up|0|||
149726098|NCT00143455|540131378|FG002|Cohort 2|Lost to Follow-up|1|||
149726099|NCT00143455|540131379|FG003|Cohort 2|Lost to Follow-up|4|||
149726100|NCT00143455|540131376|FG000|Cohort 2|Death|0|||
149726101|NCT00143455|540131377|FG001|Cohort 2|Death|0|||
149726102|NCT00143455|540131378|FG002|Cohort 2|Death|20|||
149726103|NCT00143455|540131379|FG003|Cohort 2|Death|12|||
149726104|NCT00143455|540131376|FG000|Cohort 2|Progressive Disease|0|||
149726105|NCT00143455|540131377|FG001|Cohort 2|Progressive Disease|0|||
149726106|NCT00143455|540131378|FG002|Cohort 2|Progressive Disease|20|||
149726107|NCT00143455|540131379|FG003|Cohort 2|Progressive Disease|27|||
149726108|NCT00143455|540131376|FG000|Cohort 2|Withdrawal by Subject|0|||
149726109|NCT00143455|540131377|FG001|Cohort 2|Withdrawal by Subject|0|||
149726110|NCT00143455|540131378|FG002|Cohort 2|Withdrawal by Subject|13|||
149726111|NCT00143455|540131379|FG003|Cohort 2|Withdrawal by Subject|12|||
149726112|NCT00143455|540131376|FG000|Cohort 2|Other|0|||
149726113|NCT00143455|540131377|FG001|Cohort 2|Other|0|||
149726114|NCT00143455|540131378|FG002|Cohort 2|Other|7|||
149726115|NCT00143455|540131379|FG003|Cohort 2|Other|6|||
149726116|NCT00143455|540131376|FG000|Cohort 2|Randomized But Not Treated|0|||
149726117|NCT00143455|540131377|FG001|Cohort 2|Randomized But Not Treated|0|||
149726118|NCT00143455|540131378|FG002|Cohort 2|Randomized But Not Treated|1|||
149726119|NCT00143455|540131379|FG003|Cohort 2|Randomized But Not Treated|1|||
149726120|NCT01325428|540131380|FG000|Part A|Progressive disease according to RECIST|9|||
149726121|NCT01325428|540131380|FG000|Part A|Clinical signs, symptoms of progression|2|||
149726122|NCT01325428|540131380|FG000|Part A|Other adverse event|1|||
149726123|NCT01325428|540131380|FG000|Part A|Refused continue taking trial medication|2|||
149726124|NCT01325428|540131380|FG000|Part A|Other reason not defined above|2|||
149726125|NCT01325428|540131380|FG000|Part B|Refused continue taking trial medication|2|||
149726126|NCT01325428|540131380|FG000|Part B|Other reason not defined above|1|||
149726127|NCT01298492|540131381|FG000|Overall Study|Death|2|||
149726128|NCT01298492|540131381|FG000|Overall Study|Insufficient Clinical Response|22|||
149726129|NCT01298492|540131381|FG000|Overall Study|Lost to Follow-up|12|||
149726130|NCT01298492|540131381|FG000|Overall Study|Withdrawal by Subject|47|||
149726131|NCT01298492|540131381|FG000|Overall Study|Other (Unspecified)|7|||
149726132|NCT01298492|540131381|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
149726133|NCT01298492|540131381|FG000|Overall Study|Protocol Violation|2|||
149726134|NCT01298492|540131381|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
149726135|NCT01298492|540131381|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
149726136|NCT02004873|540131382|FG000|Overall Study|Implant unsuccessful|6|||
149726137|NCT02004873|540131382|FG000|Overall Study|Awaiting 6-month visit|390|||
149726138|NCT02004873|540131382|FG000|Overall Study|Missed 6-month visit|4|||
149726139|NCT02004873|540131382|FG000|Overall Study|Death|23|||
149726140|NCT02004873|540131382|FG000|Overall Study|Withdrawal by Subject|1|||
149726141|NCT01353703|540131383|FG000|Overall Study|Migrated/moved from study area|1|||
149726142|NCT01353703|540131384|FG001|Overall Study|Migrated/moved from study area|0|||
149726143|NCT01687712|540131386|FG000|Cycle 1|Not Biochemically Pregnant|386|||
149726144|NCT01687712|540131387|FG001|Cycle 1|Not Biochemically Pregnant|348|||
149726145|NCT01687712|540131386|FG000|Cycle 1|Early Pregnancy Loss|43|||
149726146|NCT01687712|540131387|FG001|Cycle 1|Early Pregnancy Loss|60|||
149726147|NCT01687712|540131386|FG000|Cycle 1|Ectopic Pregnancy|5|||
149726148|NCT01687712|540131387|FG001|Cycle 1|Ectopic Pregnancy|5|||
149726149|NCT01687712|540131386|FG000|Cycle 1|Heterotropic Pregnancy|1|||
149726150|NCT01687712|540131387|FG001|Cycle 1|Heterotropic Pregnancy|0|||
149726151|NCT01687712|540131386|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
149726152|NCT01687712|540131387|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
149726153|NCT01687712|540131386|FG000|Cycle 1|Abortion|3|||
149726154|NCT01687712|540131387|FG001|Cycle 1|Abortion|0|||
149726155|NCT01687712|540131386|FG000|Cycle 1|Intrauterine Fetal Death|0|||
149726156|NCT01687712|540131387|FG001|Cycle 1|Intrauterine Fetal Death|1|||
149726157|NCT01687712|540131386|FG000|Cycle 1|Lost to Follow-up|1|||
149726158|NCT01687712|540131387|FG001|Cycle 1|Lost to Follow-up|1|||
149726159|NCT01687712|540131386|FG000|Cycle 2|Not Biochemically Pregnant|74|||
149726160|NCT01687712|540131387|FG001|Cycle 2|Not Biochemically Pregnant|77|||
149726161|NCT01687712|540131386|FG000|Cycle 2|Early Pregnancy Loss|18|||
149726162|NCT01687712|540131387|FG001|Cycle 2|Early Pregnancy Loss|16|||
149726163|NCT01687712|540131386|FG000|Cycle 2|Ectopic Pregnancy|0|||
149726164|NCT01687712|540131387|FG001|Cycle 2|Ectopic Pregnancy|1|||
149726165|NCT01687712|540131386|FG000|Cycle 2|Still Birth|1|||
149726166|NCT01687712|540131387|FG001|Cycle 2|Still Birth|0|||
149726167|NCT01687712|540131386|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
149726168|NCT01687712|540131387|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
149726169|NCT01687712|540131386|FG000|Cycle 3|Not Biochemically Pregnant|21|||
149726170|NCT01687712|540131387|FG001|Cycle 3|Not Biochemically Pregnant|22|||
149726171|NCT01687712|540131386|FG000|Cycle 3|Early Pregnancy Loss|1|||
149726172|NCT01687712|540131387|FG001|Cycle 3|Early Pregnancy Loss|2|||
149726173|NCT01687712|540131386|FG000|Cycle 3|Ectopic Pregnancy|1|||
149726174|NCT01687712|540131387|FG001|Cycle 3|Ectopic Pregnancy|0|||
149726175|NCT01687712|540131386|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
149726176|NCT01687712|540131387|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
149726177|NCT00512798|540131388|FG000|Overall Study|Death|0|||
149726178|NCT00512798|540131389|FG001|Overall Study|Death|3|||
149726179|NCT00512798|540131388|FG000|Overall Study|Adverse Event|2|||
149726180|NCT00512798|540131389|FG001|Overall Study|Adverse Event|4|||
149726181|NCT00512798|540131388|FG000|Overall Study|Progression of disease|14|||
149726182|NCT00512798|540131389|FG001|Overall Study|Progression of disease|20|||
149726183|NCT00512798|540131388|FG000|Overall Study|Withdrawal by Subject|3|||
149726184|NCT00512798|540131389|FG001|Overall Study|Withdrawal by Subject|0|||
149726185|NCT01984268|540131398|FG000|Overall Study|Study Terminated|15|||
149726186|NCT03505021|540131399|FG000|Overall Study|Protocol Violation|1|||
149726187|NCT03505021|540131400|FG001|Overall Study|Protocol Violation|0|||
149726188|NCT03505021|540131399|FG000|Overall Study|Death|9|||
150251560|NCT03733314|542056197|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
150251561|NCT03733314|542056198|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
150251562|NCT03733314|542056197|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
150251563|NCT03733314|542056198|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
150251564|NCT03733314|542056197|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
150251565|NCT03733314|542056198|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
150251566|NCT04514510|542056199|FG000|Overall Study|Lost to Follow-up|0|||
150251567|NCT04514510|542056200|FG001|Overall Study|Lost to Follow-up|1|||
150251568|NCT04514510|542056199|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
150251569|NCT04514510|542056200|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
150251570|NCT00864253|542056205|FG000|Overall Study|Adverse Event|56|||
150251571|NCT00864253|542056206|FG001|Overall Study|Adverse Event|11|||
150251572|NCT00864253|542056205|FG000|Overall Study|Unrelated Adverse Event|3|||
150251573|NCT00864253|542056206|FG001|Overall Study|Unrelated Adverse Event|1|||
149726189|NCT03505021|540131400|FG001|Overall Study|Death|8|||
149726190|NCT03505021|540131399|FG000|Overall Study|Consent withdrawn by subject|6|||
149726191|NCT03505021|540131400|FG001|Overall Study|Consent withdrawn by subject|1|||
149726192|NCT03505021|540131399|FG000|Overall Study|Lost to Follow-up|5|||
149726193|NCT03505021|540131400|FG001|Overall Study|Lost to Follow-up|3|||
149726194|NCT03505021|540131399|FG000|Overall Study|Adverse Event|26|||
149726195|NCT03505021|540131400|FG001|Overall Study|Adverse Event|9|||
149726196|NCT03505021|540131399|FG000|Overall Study|Disease progression|33|||
149726197|NCT03505021|540131400|FG001|Overall Study|Disease progression|17|||
149726198|NCT03505021|540131399|FG000|Overall Study|Other|11|||
149726199|NCT03505021|540131400|FG001|Overall Study|Other|5|||
149726200|NCT03505021|540131399|FG000|Overall Study|Personal reason|21|||
149726201|NCT03505021|540131400|FG001|Overall Study|Personal reason|12|||
149726202|NCT00403260|540133627|FG000|Overall Study|Adverse Event|5|||
149726203|NCT00403260|540133628|FG001|Overall Study|Adverse Event|4|||
149726204|NCT00403260|540133627|FG000|Overall Study|Withdrawal by Subject|5|||
149726205|NCT00403260|540133628|FG001|Overall Study|Withdrawal by Subject|6|||
149726206|NCT00403260|540133627|FG000|Overall Study|Lost to Follow-up|49|||
149726207|NCT00403260|540133628|FG001|Overall Study|Lost to Follow-up|25|||
149726208|NCT00403260|540133627|FG000|Overall Study|Re-appearance of P. falciparum|34|||
149726209|NCT00403260|540133628|FG001|Overall Study|Re-appearance of P. falciparum|25|||
149726210|NCT00403260|540133627|FG000|Overall Study|P. vivax infection|26|||
149726211|NCT00403260|540133628|FG001|Overall Study|P. vivax infection|4|||
149726212|NCT00403260|540133627|FG000|Overall Study|Mixed infection with P. vivax|2|||
149726213|NCT00403260|540133628|FG001|Overall Study|Mixed infection with P. vivax|0|||
149726214|NCT00403260|540133627|FG000|Overall Study|Mixed infection with P. falciparum|1|||
149726215|NCT00403260|540133628|FG001|Overall Study|Mixed infection with P. falciparum|0|||
149726216|NCT00403260|540133627|FG000|Overall Study|P. vivax infection at screening|1|||
149726217|NCT00403260|540133628|FG001|Overall Study|P. vivax infection at screening|0|||
149726218|NCT00403260|540133627|FG000|Overall Study|P. ovale infection|1|||
149726219|NCT00403260|540133628|FG001|Overall Study|P. ovale infection|0|||
149726220|NCT00403260|540133627|FG000|Overall Study|Gametocyte re-appearance|1|||
149726221|NCT00403260|540133628|FG001|Overall Study|Gametocyte re-appearance|1|||
149726222|NCT00403260|540133627|FG000|Overall Study|Withdrawn from study accidentally|0|||
149726223|NCT00403260|540133628|FG001|Overall Study|Withdrawn from study accidentally|1|||
149726224|NCT03718143|540133632|FG000|Overall Study|Death|1|||
149726225|NCT03718143|540133633|FG001|Overall Study|Death|0|||
149726226|NCT03718143|540133634|FG002|Overall Study|Death|0|||
149726227|NCT03718143|540133632|FG000|Overall Study|Progression of Disease|1|||
149726228|NCT03718143|540133633|FG001|Overall Study|Progression of Disease|0|||
149726229|NCT03718143|540133634|FG002|Overall Study|Progression of Disease|0|||
149726230|NCT03718143|540133632|FG000|Overall Study|Withdrawal of Informed Consent|1|||
149726231|NCT03718143|540133633|FG001|Overall Study|Withdrawal of Informed Consent|2|||
149726232|NCT03718143|540133634|FG002|Overall Study|Withdrawal of Informed Consent|1|||
150251574|NCT00864253|542056205|FG000|Overall Study|Physician Decision|11|||
150251575|NCT00864253|542056206|FG001|Overall Study|Physician Decision|15|||
150251576|NCT00864253|542056205|FG000|Overall Study|Protocol Violation|0|||
150251577|NCT00864253|542056206|FG001|Overall Study|Protocol Violation|2|||
150251578|NCT00864253|542056205|FG000|Overall Study|Lost to Follow-up|1|||
150251579|NCT00864253|542056206|FG001|Overall Study|Lost to Follow-up|1|||
150251580|NCT00864253|542056205|FG000|Overall Study|Withdrawal by Subject|18|||
150251581|NCT00864253|542056206|FG001|Overall Study|Withdrawal by Subject|18|||
149726233|NCT00805740|540133635|FG000|Overall Study|Death|7|||
149726234|NCT00805740|540133636|FG001|Overall Study|Death|4|||
149726235|NCT00805740|540133635|FG000|Overall Study|Withdrawal by Subject|1|||
149726236|NCT00805740|540133636|FG001|Overall Study|Withdrawal by Subject|0|||
149726237|NCT00805740|540133635|FG000|Overall Study|Lost to Follow-up|1|||
149726238|NCT00805740|540133636|FG001|Overall Study|Lost to Follow-up|0|||
149726239|NCT00805740|540133635|FG000|Overall Study|Randomized, but not treated|2|||
149726240|NCT00805740|540133636|FG001|Overall Study|Randomized, but not treated|0|||
149726241|NCT05227690|540133646|FG000|Overall Study|Adverse Event|5|||
149726242|NCT05227690|540133647|FG001|Overall Study|Adverse Event|6|||
149726243|NCT05227690|540133648|FG002|Overall Study|Adverse Event|10|||
149726244|NCT05227690|540133646|FG000|Overall Study|Lack of Efficacy|2|||
149726245|NCT05227690|540133647|FG001|Overall Study|Lack of Efficacy|4|||
149726246|NCT05227690|540133648|FG002|Overall Study|Lack of Efficacy|1|||
149726247|NCT05227690|540133646|FG000|Overall Study|Physician Decision|6|||
149726248|NCT05227690|540133647|FG001|Overall Study|Physician Decision|0|||
149726249|NCT05227690|540133648|FG002|Overall Study|Physician Decision|4|||
149726250|NCT05227690|540133646|FG000|Overall Study|Withdrawal of consent|28|||
149726251|NCT05227690|540133647|FG001|Overall Study|Withdrawal of consent|27|||
149726252|NCT05227690|540133648|FG002|Overall Study|Withdrawal of consent|21|||
149726253|NCT05227690|540133646|FG000|Overall Study|Other, not specified|2|||
149726254|NCT05227690|540133647|FG001|Overall Study|Other, not specified|2|||
149726255|NCT05227690|540133648|FG002|Overall Study|Other, not specified|1|||
149726256|NCT05499559|540133649|FG000|Overall Study|Lost to Follow-up|467|||
149726257|NCT00223496|540133652|FG000|Overall Study|screen failure|9|||
149726258|NCT00223496|540133652|FG000|Overall Study|Lost to Follow-up|4|||
149726259|NCT00223496|540133652|FG000|Overall Study|Lack of Efficacy|6|||
149726260|NCT00223496|540133652|FG000|Overall Study|Withdrawal by Subject|1|||
149726261|NCT00223496|540133652|FG000|Overall Study|Physician Decision|2|||
149726262|NCT02971202|540133655|FG000|Overall Study|Pregnancy|1|||
149726263|NCT02971202|540133656|FG001|Overall Study|Pregnancy|0|||
149726264|NCT02971202|540133657|FG002|Overall Study|Pregnancy|0|||
149726265|NCT02971202|540133655|FG000|Overall Study|screen fail after consent|1|||
149726266|NCT02971202|540133656|FG001|Overall Study|screen fail after consent|0|||
149726267|NCT02971202|540133657|FG002|Overall Study|screen fail after consent|1|||
149726268|NCT02723201|540133658|FG000|Second Intervention Period|Protocol Violation|1|||
149726269|NCT02723201|540133659|FG001|Second Intervention Period|Protocol Violation|0|||
149726270|NCT02723201|540133660|FG002|Second Intervention Period|Protocol Violation|0|||
149726271|NCT02723201|540133658|FG000|Second Intervention Period|Adverse Event|1|||
149726272|NCT02723201|540133659|FG001|Second Intervention Period|Adverse Event|0|||
149726273|NCT02723201|540133660|FG002|Second Intervention Period|Adverse Event|0|||
149726274|NCT01414257|540133666|FG000|Overall Study|No Visit After First Day of Treatment|12|||
149726275|NCT01414257|540133666|FG000|Overall Study|Protocol Violation|10|||
149726276|NCT01534676|540133667|FG000|Overall Study|Study closed due to poor enrollment|2|||
149726277|NCT01534676|540133668|FG001|Overall Study|Study closed due to poor enrollment|1|||
150251582|NCT00864253|542056205|FG000|Overall Study|Death|1|||
149726278|NCT02634580|540133669|FG000|Double-blind Treatment Period|Subject Request|1|||
149726279|NCT02634580|540133670|FG001|Double-blind Treatment Period|Subject Request|0|||
149726280|NCT02634580|540133671|FG002|Double-blind Treatment Period|Subject Request|1|||
149726281|NCT02634580|540133672|FG003|Double-blind Treatment Period|Subject Request|1|||
149726282|NCT02634580|540133669|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
149726283|NCT02634580|540133670|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
149726284|NCT02634580|540133671|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
149726285|NCT02634580|540133672|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
149726286|NCT02908880|540133674|FG000|Overall Study|Lost to Follow-up|4|||
149726287|NCT02908880|540133674|FG000|Overall Study|Explantation of the device|1|||
149726288|NCT02908880|540133674|FG000|Overall Study|Withdrawal by Subject|17|||
149726289|NCT02908880|540133674|FG000|Overall Study|Death|5|||
149726290|NCT01396005|540133677|FG000|Overall Study|Withdrawal by Subject|0|||
149726291|NCT01396005|540133678|FG001|Overall Study|Withdrawal by Subject|1|||
149726292|NCT01396005|540133677|FG000|Overall Study|Non-compliance with protocol|0|||
149726293|NCT01396005|540133678|FG001|Overall Study|Non-compliance with protocol|1|||
149726294|NCT05689047|540133683|FG000|Overall Study|Lost to Follow-up|0|||
149726295|NCT05689047|540133684|FG001|Overall Study|Lost to Follow-up|1|||
149726296|NCT05689047|540133683|FG000|Overall Study|Protocol Deviation|1|||
149726297|NCT05689047|540133684|FG001|Overall Study|Protocol Deviation|0|||
149726298|NCT01604512|540133685|FG000|Overall Study|Withdrawal by Subject|3|||
149726299|NCT01604512|540133685|FG000|Overall Study|Not treated|4|||
149726300|NCT03083886|540133686|FG000|Overall Study|Withdrawal by Subject|51|||
149726301|NCT03083886|540133687|FG001|Overall Study|Withdrawal by Subject|73|||
149726302|NCT03083886|540133688|FG002|Overall Study|Withdrawal by Subject|104|||
149726303|NCT03083886|540133686|FG000|Overall Study|Missing Baseline data|43|||
149726304|NCT03083886|540133687|FG001|Overall Study|Missing Baseline data|42|||
149726305|NCT03083886|540133688|FG002|Overall Study|Missing Baseline data|31|||
149726306|NCT03083886|540133686|FG000|Overall Study|Investigator terminated|1|||
149726307|NCT03083886|540133687|FG001|Overall Study|Investigator terminated|6|||
149726308|NCT03083886|540133688|FG002|Overall Study|Investigator terminated|3|||
149726309|NCT03178487|540133692|FG000|Period 1|Adverse Event|1|||
149726310|NCT03178487|540133693|FG001|Period 1|Adverse Event|2|||
149726311|NCT03178487|540133692|FG000|Period 1|Withdrawal by Subject|2|||
149726312|NCT03178487|540133693|FG001|Period 1|Withdrawal by Subject|1|||
149726313|NCT03178487|540133692|FG000|Period 1|Lost to Follow-up|1|||
149726314|NCT03178487|540133693|FG001|Period 1|Lost to Follow-up|0|||
149726315|NCT03178487|540133692|FG000|Period 1|Other|0|||
149726316|NCT03178487|540133693|FG001|Period 1|Other|1|||
149726317|NCT03178487|540133692|FG000|Period 2|Adverse Event|4|||
149726318|NCT03178487|540133693|FG001|Period 2|Adverse Event|4|||
149726319|NCT03178487|540133692|FG000|Period 2|Withdrawal by Subject|6|||
149726320|NCT03178487|540133693|FG001|Period 2|Withdrawal by Subject|6|||
149726321|NCT03178487|540133692|FG000|Period 2|Lost to Follow-up|2|||
149726322|NCT03178487|540133693|FG001|Period 2|Lost to Follow-up|2|||
149726323|NCT03178487|540133692|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
149726324|NCT03178487|540133693|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
149726325|NCT03178487|540133692|FG000|Period 2|Other|8|||
149726326|NCT03178487|540133693|FG001|Period 2|Other|7|||
149726327|NCT01453855|540133694|FG000|Overall Study|Adverse Event|3|||
149726328|NCT01453855|540133695|FG001|Overall Study|Adverse Event|4|||
149726329|NCT01453855|540133694|FG000|Overall Study|Lost to Follow-up|2|||
149726330|NCT01453855|540133695|FG001|Overall Study|Lost to Follow-up|1|||
149726331|NCT01453855|540133694|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
149726332|NCT01453855|540133695|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
149726333|NCT01453855|540133694|FG000|Overall Study|Noncompliance|1|||
149726334|NCT01453855|540133695|FG001|Overall Study|Noncompliance|0|||
149726335|NCT01453855|540133694|FG000|Overall Study|Inadequate Control of IOP|1|||
149726336|NCT01453855|540133695|FG001|Overall Study|Inadequate Control of IOP|5|||
149726337|NCT01453855|540133694|FG000|Overall Study|Other|0|||
149726338|NCT01453855|540133695|FG001|Overall Study|Other|1|||
149726339|NCT04161495|540133696|FG000|Overall Study|Withdrawal by Subject|3|||
149726340|NCT04161495|540133697|FG001|Overall Study|Withdrawal by Subject|0|||
149726341|NCT04161495|540133696|FG000|Overall Study|Protocol Violation|1|||
149726342|NCT04161495|540133697|FG001|Overall Study|Protocol Violation|0|||
149726343|NCT04161495|540133696|FG000|Overall Study|Prohibited concomitant medication|3|||
149726344|NCT04161495|540133697|FG001|Overall Study|Prohibited concomitant medication|0|||
149726345|NCT04161495|540133696|FG000|Overall Study|Adverse Event|1|||
149726346|NCT04161495|540133697|FG001|Overall Study|Adverse Event|0|||
149726347|NCT04161495|540133696|FG000|Overall Study|Other - Unspecified|1|||
149726348|NCT04161495|540133697|FG001|Overall Study|Other - Unspecified|0|||
149726349|NCT04161495|540133696|FG000|Overall Study|Death|0|||
149726350|NCT04161495|540133697|FG001|Overall Study|Death|1|||
149726351|NCT03529773|540133700|FG000|Overall Study|Adverse Event|0|||
149726352|NCT03529773|540133701|FG001|Overall Study|Adverse Event|0|||
149726353|NCT03529773|540133702|FG002|Overall Study|Adverse Event|0|||
149726354|NCT03529773|540133703|FG003|Overall Study|Adverse Event|0|||
149726355|NCT03529773|540133704|FG004|Overall Study|Adverse Event|0|||
149726356|NCT03529773|540133705|FG005|Overall Study|Adverse Event|0|||
149726357|NCT03529773|540133706|FG006|Overall Study|Adverse Event|0|||
149726358|NCT03529773|540133707|FG007|Overall Study|Adverse Event|0|||
149726359|NCT03529773|540133708|FG008|Overall Study|Adverse Event|0|||
149726360|NCT03529773|540133709|FG009|Overall Study|Adverse Event|0|||
149726361|NCT03529773|540133710|FG010|Overall Study|Adverse Event|0|||
149726362|NCT03529773|540133711|FG011|Overall Study|Adverse Event|0|||
149726363|NCT03529773|540133712|FG012|Overall Study|Adverse Event|0|||
149726364|NCT03529773|540133713|FG013|Overall Study|Adverse Event|0|||
149726365|NCT03529773|540133714|FG014|Overall Study|Adverse Event|0|||
149726366|NCT03529773|540133715|FG015|Overall Study|Adverse Event|0|||
149726367|NCT03529773|540133716|FG016|Overall Study|Adverse Event|0|||
149726368|NCT03529773|540133717|FG017|Overall Study|Adverse Event|0|||
149726369|NCT03529773|540133718|FG018|Overall Study|Adverse Event|0|||
149726370|NCT03529773|540133719|FG019|Overall Study|Adverse Event|0|||
149726371|NCT03529773|540133720|FG020|Overall Study|Adverse Event|0|||
149726372|NCT03529773|540133721|FG021|Overall Study|Adverse Event|0|||
149726373|NCT03529773|540133722|FG022|Overall Study|Adverse Event|0|||
149726374|NCT03529773|540133723|FG023|Overall Study|Adverse Event|0|||
149726375|NCT03529773|540133724|FG024|Overall Study|Adverse Event|0|||
149726376|NCT03529773|540133725|FG025|Overall Study|Adverse Event|0|||
149726377|NCT03529773|540133726|FG026|Overall Study|Adverse Event|0|||
149726378|NCT03529773|540133727|FG027|Overall Study|Adverse Event|0|||
149726379|NCT03529773|540133728|FG028|Overall Study|Adverse Event|0|||
149726380|NCT03529773|540133729|FG029|Overall Study|Adverse Event|0|||
149726381|NCT03529773|540133730|FG030|Overall Study|Adverse Event|1|||
149726382|NCT03529773|540133731|FG031|Overall Study|Adverse Event|0|||
149726383|NCT03529773|540133732|FG032|Overall Study|Adverse Event|0|||
149726384|NCT03529773|540133733|FG033|Overall Study|Adverse Event|0|||
149726385|NCT03529773|540133734|FG034|Overall Study|Adverse Event|0|||
149726386|NCT03529773|540133735|FG035|Overall Study|Adverse Event|1|||
149726387|NCT03529773|540133736|FG036|Overall Study|Adverse Event|0|||
149726388|NCT03529773|540133737|FG037|Overall Study|Adverse Event|0|||
149726389|NCT03529773|540133738|FG038|Overall Study|Adverse Event|1|||
149726390|NCT03529773|540133739|FG039|Overall Study|Adverse Event|1|||
149726391|NCT03529773|540133700|FG000|Overall Study|Death|0|||
149726392|NCT03529773|540133701|FG001|Overall Study|Death|0|||
149726393|NCT03529773|540133702|FG002|Overall Study|Death|0|||
149726394|NCT03529773|540133703|FG003|Overall Study|Death|0|||
149726395|NCT03529773|540133704|FG004|Overall Study|Death|0|||
149726396|NCT03529773|540133705|FG005|Overall Study|Death|0|||
149726397|NCT03529773|540133706|FG006|Overall Study|Death|0|||
149726398|NCT03529773|540133707|FG007|Overall Study|Death|0|||
149726399|NCT03529773|540133708|FG008|Overall Study|Death|0|||
149726400|NCT03529773|540133709|FG009|Overall Study|Death|0|||
149726401|NCT03529773|540133710|FG010|Overall Study|Death|0|||
149726402|NCT03529773|540133711|FG011|Overall Study|Death|0|||
149726403|NCT03529773|540133712|FG012|Overall Study|Death|1|||
149726404|NCT03529773|540133713|FG013|Overall Study|Death|0|||
149726405|NCT03529773|540133714|FG014|Overall Study|Death|0|||
149726406|NCT03529773|540133715|FG015|Overall Study|Death|0|||
149726407|NCT03529773|540133716|FG016|Overall Study|Death|0|||
149726408|NCT03529773|540133717|FG017|Overall Study|Death|0|||
149726409|NCT03529773|540133718|FG018|Overall Study|Death|0|||
149726410|NCT03529773|540133719|FG019|Overall Study|Death|1|||
149726411|NCT03529773|540133720|FG020|Overall Study|Death|0|||
149726412|NCT03529773|540133721|FG021|Overall Study|Death|0|||
149726413|NCT03529773|540133722|FG022|Overall Study|Death|1|||
149726414|NCT03529773|540133723|FG023|Overall Study|Death|0|||
149726415|NCT03529773|540133724|FG024|Overall Study|Death|0|||
149726416|NCT03529773|540133725|FG025|Overall Study|Death|0|||
149726417|NCT03529773|540133726|FG026|Overall Study|Death|0|||
149726418|NCT03529773|540133727|FG027|Overall Study|Death|0|||
149726419|NCT03529773|540133728|FG028|Overall Study|Death|0|||
149726420|NCT03529773|540133729|FG029|Overall Study|Death|0|||
150251583|NCT00864253|542056206|FG001|Overall Study|Death|0|||
149726421|NCT03529773|540133730|FG030|Overall Study|Death|0|||
149726422|NCT03529773|540133731|FG031|Overall Study|Death|0|||
149726423|NCT03529773|540133732|FG032|Overall Study|Death|0|||
149726424|NCT03529773|540133733|FG033|Overall Study|Death|1|||
149726425|NCT03529773|540133734|FG034|Overall Study|Death|1|||
149726426|NCT03529773|540133735|FG035|Overall Study|Death|0|||
149726427|NCT03529773|540133736|FG036|Overall Study|Death|1|||
149726428|NCT03529773|540133737|FG037|Overall Study|Death|0|||
149726429|NCT03529773|540133738|FG038|Overall Study|Death|0|||
149726430|NCT03529773|540133739|FG039|Overall Study|Death|0|||
149726431|NCT03529773|540133700|FG000|Overall Study|Lost to Follow-up|0|||
149726432|NCT03529773|540133701|FG001|Overall Study|Lost to Follow-up|0|||
149726433|NCT03529773|540133702|FG002|Overall Study|Lost to Follow-up|1|||
149726434|NCT03529773|540133703|FG003|Overall Study|Lost to Follow-up|0|||
149726435|NCT03529773|540133704|FG004|Overall Study|Lost to Follow-up|1|||
149726436|NCT03529773|540133705|FG005|Overall Study|Lost to Follow-up|1|||
149726437|NCT03529773|540133706|FG006|Overall Study|Lost to Follow-up|0|||
149726438|NCT03529773|540133707|FG007|Overall Study|Lost to Follow-up|0|||
150251584|NCT00864253|542056205|FG000|Overall Study|Ongoing|2|||
149726439|NCT03529773|540133708|FG008|Overall Study|Lost to Follow-up|0|||
149726440|NCT03529773|540133709|FG009|Overall Study|Lost to Follow-up|0|||
149726441|NCT03529773|540133710|FG010|Overall Study|Lost to Follow-up|0|||
149726442|NCT03529773|540133711|FG011|Overall Study|Lost to Follow-up|0|||
149726443|NCT03529773|540133712|FG012|Overall Study|Lost to Follow-up|0|||
149726444|NCT03529773|540133713|FG013|Overall Study|Lost to Follow-up|1|||
149726445|NCT03529773|540133714|FG014|Overall Study|Lost to Follow-up|4|||
149726446|NCT03529773|540133715|FG015|Overall Study|Lost to Follow-up|1|||
149726447|NCT03529773|540133716|FG016|Overall Study|Lost to Follow-up|1|||
149726448|NCT03529773|540133717|FG017|Overall Study|Lost to Follow-up|0|||
149726449|NCT03529773|540133718|FG018|Overall Study|Lost to Follow-up|1|||
149726450|NCT03529773|540133719|FG019|Overall Study|Lost to Follow-up|1|||
149726451|NCT03529773|540133720|FG020|Overall Study|Lost to Follow-up|2|||
149726452|NCT03529773|540133721|FG021|Overall Study|Lost to Follow-up|4|||
149726453|NCT03529773|540133722|FG022|Overall Study|Lost to Follow-up|3|||
149726454|NCT03529773|540133723|FG023|Overall Study|Lost to Follow-up|4|||
149726455|NCT03529773|540133724|FG024|Overall Study|Lost to Follow-up|3|||
149726456|NCT03529773|540133725|FG025|Overall Study|Lost to Follow-up|5|||
149726457|NCT03529773|540133726|FG026|Overall Study|Lost to Follow-up|5|||
149726458|NCT03529773|540133727|FG027|Overall Study|Lost to Follow-up|0|||
149726459|NCT03529773|540133728|FG028|Overall Study|Lost to Follow-up|0|||
149726460|NCT03529773|540133729|FG029|Overall Study|Lost to Follow-up|0|||
149726461|NCT03529773|540133730|FG030|Overall Study|Lost to Follow-up|1|||
149726462|NCT03529773|540133731|FG031|Overall Study|Lost to Follow-up|0|||
149726463|NCT03529773|540133732|FG032|Overall Study|Lost to Follow-up|0|||
149726464|NCT03529773|540133733|FG033|Overall Study|Lost to Follow-up|1|||
149726465|NCT03529773|540133734|FG034|Overall Study|Lost to Follow-up|1|||
149726466|NCT03529773|540133735|FG035|Overall Study|Lost to Follow-up|0|||
149726467|NCT03529773|540133736|FG036|Overall Study|Lost to Follow-up|0|||
149726468|NCT03529773|540133737|FG037|Overall Study|Lost to Follow-up|3|||
149726469|NCT03529773|540133738|FG038|Overall Study|Lost to Follow-up|1|||
149726470|NCT03529773|540133739|FG039|Overall Study|Lost to Follow-up|1|||
149726471|NCT03529773|540133700|FG000|Overall Study|No longer meets eligibility criteria|0|||
149726472|NCT03529773|540133701|FG001|Overall Study|No longer meets eligibility criteria|0|||
149726473|NCT03529773|540133702|FG002|Overall Study|No longer meets eligibility criteria|0|||
149726474|NCT03529773|540133703|FG003|Overall Study|No longer meets eligibility criteria|0|||
149726475|NCT03529773|540133704|FG004|Overall Study|No longer meets eligibility criteria|0|||
149726476|NCT03529773|540133705|FG005|Overall Study|No longer meets eligibility criteria|0|||
149726477|NCT03529773|540133706|FG006|Overall Study|No longer meets eligibility criteria|0|||
149726478|NCT03529773|540133707|FG007|Overall Study|No longer meets eligibility criteria|0|||
149726479|NCT03529773|540133708|FG008|Overall Study|No longer meets eligibility criteria|0|||
149726480|NCT03529773|540133709|FG009|Overall Study|No longer meets eligibility criteria|0|||
149726481|NCT03529773|540133710|FG010|Overall Study|No longer meets eligibility criteria|0|||
149726482|NCT03529773|540133711|FG011|Overall Study|No longer meets eligibility criteria|0|||
149726483|NCT03529773|540133712|FG012|Overall Study|No longer meets eligibility criteria|0|||
149726484|NCT03529773|540133713|FG013|Overall Study|No longer meets eligibility criteria|0|||
149726485|NCT03529773|540133714|FG014|Overall Study|No longer meets eligibility criteria|0|||
149726486|NCT03529773|540133715|FG015|Overall Study|No longer meets eligibility criteria|0|||
149726487|NCT03529773|540133716|FG016|Overall Study|No longer meets eligibility criteria|0|||
149726488|NCT03529773|540133717|FG017|Overall Study|No longer meets eligibility criteria|0|||
149726489|NCT03529773|540133718|FG018|Overall Study|No longer meets eligibility criteria|0|||
149726490|NCT03529773|540133719|FG019|Overall Study|No longer meets eligibility criteria|0|||
149726491|NCT03529773|540133720|FG020|Overall Study|No longer meets eligibility criteria|0|||
149726492|NCT03529773|540133721|FG021|Overall Study|No longer meets eligibility criteria|0|||
149726493|NCT03529773|540133722|FG022|Overall Study|No longer meets eligibility criteria|1|||
149726494|NCT03529773|540133723|FG023|Overall Study|No longer meets eligibility criteria|0|||
149726495|NCT03529773|540133724|FG024|Overall Study|No longer meets eligibility criteria|0|||
149726496|NCT03529773|540133725|FG025|Overall Study|No longer meets eligibility criteria|0|||
149726497|NCT03529773|540133726|FG026|Overall Study|No longer meets eligibility criteria|0|||
149726498|NCT03529773|540133727|FG027|Overall Study|No longer meets eligibility criteria|0|||
149726499|NCT03529773|540133728|FG028|Overall Study|No longer meets eligibility criteria|0|||
149726500|NCT03529773|540133729|FG029|Overall Study|No longer meets eligibility criteria|0|||
150251585|NCT00864253|542056206|FG001|Overall Study|Ongoing|3|||
150251586|NCT00864253|542056205|FG000|Overall Study|Untreated|7|||
149726501|NCT03529773|540133730|FG030|Overall Study|No longer meets eligibility criteria|0|||
149726502|NCT03529773|540133731|FG031|Overall Study|No longer meets eligibility criteria|0|||
149726503|NCT03529773|540133732|FG032|Overall Study|No longer meets eligibility criteria|0|||
149726504|NCT03529773|540133733|FG033|Overall Study|No longer meets eligibility criteria|0|||
149726505|NCT03529773|540133734|FG034|Overall Study|No longer meets eligibility criteria|0|||
149726506|NCT03529773|540133735|FG035|Overall Study|No longer meets eligibility criteria|0|||
149726507|NCT03529773|540133736|FG036|Overall Study|No longer meets eligibility criteria|0|||
150251587|NCT00864253|542056206|FG001|Overall Study|Untreated|7|||
150251588|NCT01111240|542056207|FG000|Overall Study|Adverse Event|190|||
149726508|NCT03529773|540133737|FG037|Overall Study|No longer meets eligibility criteria|0|||
149726509|NCT03529773|540133738|FG038|Overall Study|No longer meets eligibility criteria|1|||
149726510|NCT03529773|540133739|FG039|Overall Study|No longer meets eligibility criteria|0|||
149726511|NCT03529773|540133700|FG000|Overall Study|Other|0|||
149726512|NCT03529773|540133701|FG001|Overall Study|Other|0|||
149726513|NCT03529773|540133702|FG002|Overall Study|Other|0|||
149726514|NCT03529773|540133703|FG003|Overall Study|Other|0|||
149726515|NCT03529773|540133704|FG004|Overall Study|Other|0|||
149726516|NCT03529773|540133705|FG005|Overall Study|Other|0|||
149726517|NCT03529773|540133706|FG006|Overall Study|Other|0|||
149726518|NCT03529773|540133707|FG007|Overall Study|Other|0|||
149726519|NCT03529773|540133708|FG008|Overall Study|Other|0|||
150251589|NCT01111240|542056207|FG000|Overall Study|Lack of Efficacy|545|||
150251590|NCT01111240|542056207|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
150251591|NCT01111240|542056207|FG000|Overall Study|Other|312|||
150251592|NCT01989169|542056208|FG000|Period 2|Adverse Event|0|||
150251593|NCT01989169|542056209|FG001|Period 2|Adverse Event|1|||
150251594|NCT01585155|542056210|FG000|Overall Study|Adverse Event|1|||
150251595|NCT01585155|542056210|FG000|Overall Study|Lack of Efficacy|2|||
150251596|NCT01585155|542056210|FG000|Overall Study|Worsening ulcerative colitis|2|||
150251597|NCT02235311|542056215|FG000|Overall Study|Lost to Follow-up|0|||
150251598|NCT02235311|542056216|FG001|Overall Study|Lost to Follow-up|1|||
150251599|NCT02235311|542056215|FG000|Overall Study|Protocol Violation|0|||
150251600|NCT02235311|542056216|FG001|Overall Study|Protocol Violation|1|||
150251601|NCT04655027|542056217|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
150251602|NCT04655027|542056218|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
150251603|NCT00658788|542056219|FG000|Overall Study|Adverse Event|11|||
150251604|NCT00658788|542056219|FG000|Overall Study|Withdrawal by Subject|13|||
150251605|NCT00658788|542056219|FG000|Overall Study|Lost to Follow-up|18|||
150251606|NCT00658788|542056219|FG000|Overall Study|Treatment Discontinuation|32|||
150251607|NCT00653523|542056220|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
150251608|NCT00653523|542056220|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
150251609|NCT00653523|542056220|FG000|Overall Study|Adverse Event|7|||
150251610|NCT00653523|542056220|FG000|Overall Study|Withdrawal by Subject|6|||
150251611|NCT00653523|542056220|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
150251612|NCT00653523|542056220|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
150251613|NCT03898167|542056221|FG000|Overall Study|Terminated phone call early|7|||
150251614|NCT03898167|542056222|FG001|Overall Study|Terminated phone call early|0|||
150251615|NCT03898167|542056223|FG002|Overall Study|Terminated phone call early|0|||
150251616|NCT03898167|542056221|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
150251617|NCT03898167|542056222|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
150251618|NCT03898167|542056223|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
150251619|NCT04696653|542056227|FG000|Overall Study|left organization|18|||
150251620|NCT04696653|542056227|FG000|Overall Study|Lost to Follow-up|3|||
150251621|NCT01099215|542058255|FG000|Overall Study|Withdrawal by Subject|1|||
150251622|NCT01099215|542058256|FG001|Overall Study|Withdrawal by Subject|0|||
150251623|NCT01099215|542058255|FG000|Overall Study|Adverse Event|0|||
150251624|NCT01099215|542058256|FG001|Overall Study|Adverse Event|1|||
150251625|NCT01732822|542058257|FG000|Overall Study|Withdrawal by Subject|123|||
150251626|NCT01732822|542058258|FG001|Overall Study|Withdrawal by Subject|113|||
149726520|NCT03529773|540133709|FG009|Overall Study|Other|0|||
149726521|NCT03529773|540133710|FG010|Overall Study|Other|0|||
149726522|NCT03529773|540133711|FG011|Overall Study|Other|0|||
149726523|NCT03529773|540133712|FG012|Overall Study|Other|1|||
149726524|NCT03529773|540133713|FG013|Overall Study|Other|0|||
150251627|NCT00215137|542058259|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
150251628|NCT00215137|542058260|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
150251629|NCT00215137|542058261|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
150251630|NCT00215137|542058259|FG000|Randomization Period|Lost to Follow-up|0|||
150251631|NCT00215137|542058260|FG001|Randomization Period|Lost to Follow-up|1|||
150251632|NCT00215137|542058261|FG002|Randomization Period|Lost to Follow-up|0|||
150251633|NCT00215137|542058259|FG000|Randomization Period|Withdrawal by Subject|0|||
150251634|NCT00215137|542058260|FG001|Randomization Period|Withdrawal by Subject|1|||
150251635|NCT00215137|542058261|FG002|Randomization Period|Withdrawal by Subject|0|||
150251636|NCT03333876|542058262|FG000|Screening Period|Screen Failure|4|||
150251637|NCT03333876|542058262|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
150251638|NCT03333876|542058262|FG000|Mandibular Advancement|Adverse Event|2|||
150251639|NCT03333876|542058262|FG000|Mandibular Advancement|Product Damage|2|||
150251640|NCT00095498|542058264|FG000|Overall Study|Physician Decision|9|||
150251641|NCT00095498|542058265|FG001|Overall Study|Physician Decision|10|||
150251642|NCT00095498|542058266|FG002|Overall Study|Physician Decision|8|||
150251643|NCT00095498|542058264|FG000|Overall Study|Adverse Event|1|||
150251644|NCT00095498|542058265|FG001|Overall Study|Adverse Event|0|||
149726525|NCT03529773|540133714|FG014|Overall Study|Other|2|||
149726526|NCT03529773|540133715|FG015|Overall Study|Other|0|||
149726527|NCT03529773|540133716|FG016|Overall Study|Other|0|||
149726528|NCT03529773|540133717|FG017|Overall Study|Other|3|||
149726529|NCT03529773|540133718|FG018|Overall Study|Other|0|||
149726530|NCT03529773|540133719|FG019|Overall Study|Other|0|||
149726531|NCT03529773|540133720|FG020|Overall Study|Other|1|||
149726532|NCT03529773|540133721|FG021|Overall Study|Other|0|||
149726533|NCT03529773|540133722|FG022|Overall Study|Other|1|||
149726534|NCT03529773|540133723|FG023|Overall Study|Other|0|||
149726535|NCT03529773|540133724|FG024|Overall Study|Other|3|||
149726536|NCT03529773|540133725|FG025|Overall Study|Other|2|||
149726537|NCT03529773|540133726|FG026|Overall Study|Other|2|||
149726538|NCT03529773|540133727|FG027|Overall Study|Other|0|||
149726539|NCT03529773|540133728|FG028|Overall Study|Other|0|||
149726540|NCT03529773|540133729|FG029|Overall Study|Other|0|||
149726541|NCT03529773|540133730|FG030|Overall Study|Other|0|||
149726542|NCT03529773|540133731|FG031|Overall Study|Other|0|||
149726543|NCT03529773|540133732|FG032|Overall Study|Other|0|||
149726544|NCT03529773|540133733|FG033|Overall Study|Other|0|||
149726545|NCT03529773|540133734|FG034|Overall Study|Other|1|||
149726546|NCT03529773|540133735|FG035|Overall Study|Other|1|||
149726547|NCT03529773|540133736|FG036|Overall Study|Other|0|||
149726548|NCT03529773|540133737|FG037|Overall Study|Other|0|||
149726549|NCT03529773|540133738|FG038|Overall Study|Other|0|||
149726550|NCT03529773|540133739|FG039|Overall Study|Other|0|||
149726551|NCT03529773|540133700|FG000|Overall Study|Physician Decision|0|||
149726552|NCT03529773|540133701|FG001|Overall Study|Physician Decision|0|||
149726553|NCT03529773|540133702|FG002|Overall Study|Physician Decision|0|||
149726554|NCT03529773|540133703|FG003|Overall Study|Physician Decision|0|||
149726555|NCT03529773|540133704|FG004|Overall Study|Physician Decision|0|||
149726556|NCT03529773|540133705|FG005|Overall Study|Physician Decision|0|||
149726557|NCT03529773|540133706|FG006|Overall Study|Physician Decision|0|||
149726558|NCT03529773|540133707|FG007|Overall Study|Physician Decision|0|||
149726559|NCT03529773|540133708|FG008|Overall Study|Physician Decision|0|||
149726560|NCT03529773|540133709|FG009|Overall Study|Physician Decision|0|||
149726561|NCT03529773|540133710|FG010|Overall Study|Physician Decision|0|||
149726562|NCT03529773|540133711|FG011|Overall Study|Physician Decision|0|||
149726563|NCT03529773|540133712|FG012|Overall Study|Physician Decision|0|||
149726564|NCT03529773|540133713|FG013|Overall Study|Physician Decision|0|||
149726565|NCT03529773|540133714|FG014|Overall Study|Physician Decision|0|||
149726566|NCT03529773|540133715|FG015|Overall Study|Physician Decision|0|||
149726567|NCT03529773|540133716|FG016|Overall Study|Physician Decision|0|||
149726568|NCT03529773|540133717|FG017|Overall Study|Physician Decision|0|||
149726569|NCT03529773|540133718|FG018|Overall Study|Physician Decision|0|||
149726570|NCT03529773|540133719|FG019|Overall Study|Physician Decision|1|||
149726571|NCT03529773|540133720|FG020|Overall Study|Physician Decision|1|||
149726572|NCT03529773|540133721|FG021|Overall Study|Physician Decision|0|||
149726573|NCT03529773|540133722|FG022|Overall Study|Physician Decision|0|||
149726574|NCT03529773|540133723|FG023|Overall Study|Physician Decision|0|||
149726575|NCT03529773|540133724|FG024|Overall Study|Physician Decision|0|||
150251645|NCT00095498|542058266|FG002|Overall Study|Adverse Event|1|||
150251646|NCT00095498|542058264|FG000|Overall Study|Withdrawal by Subject|15|||
150251647|NCT00095498|542058265|FG001|Overall Study|Withdrawal by Subject|16|||
150251648|NCT00095498|542058266|FG002|Overall Study|Withdrawal by Subject|15|||
150251649|NCT00095498|542058264|FG000|Overall Study|Disease progression|0|||
150251650|NCT00095498|542058265|FG001|Overall Study|Disease progression|1|||
150251651|NCT00095498|542058266|FG002|Overall Study|Disease progression|1|||
150251652|NCT00095498|542058264|FG000|Overall Study|Ineligibility determined|3|||
150251653|NCT00095498|542058265|FG001|Overall Study|Ineligibility determined|0|||
150251654|NCT00095498|542058266|FG002|Overall Study|Ineligibility determined|2|||
150251655|NCT00095498|542058264|FG000|Overall Study|Lost to Follow-up|1|||
150251656|NCT00095498|542058265|FG001|Overall Study|Lost to Follow-up|1|||
150251657|NCT00095498|542058266|FG002|Overall Study|Lost to Follow-up|2|||
150251658|NCT00095498|542058264|FG000|Overall Study|Noncompliance|1|||
150251659|NCT00095498|542058265|FG001|Overall Study|Noncompliance|0|||
150251660|NCT00095498|542058266|FG002|Overall Study|Noncompliance|1|||
150251661|NCT00095498|542058264|FG000|Overall Study|Other|6|||
150251662|NCT00095498|542058265|FG001|Overall Study|Other|7|||
150251663|NCT00095498|542058266|FG002|Overall Study|Other|6|||
150251664|NCT00095498|542058264|FG000|Overall Study|Protocol Violation|0|||
150251665|NCT00095498|542058265|FG001|Overall Study|Protocol Violation|0|||
150251666|NCT00095498|542058266|FG002|Overall Study|Protocol Violation|1|||
150251667|NCT00095498|542058264|FG000|Overall Study|Requirement for alternative therapy|1|||
150251668|NCT00095498|542058265|FG001|Overall Study|Requirement for alternative therapy|0|||
150251669|NCT00095498|542058266|FG002|Overall Study|Requirement for alternative therapy|2|||
149726576|NCT03529773|540133725|FG025|Overall Study|Physician Decision|0|||
149726577|NCT03529773|540133726|FG026|Overall Study|Physician Decision|0|||
149726578|NCT03529773|540133727|FG027|Overall Study|Physician Decision|0|||
149726579|NCT03529773|540133728|FG028|Overall Study|Physician Decision|0|||
149726580|NCT03529773|540133729|FG029|Overall Study|Physician Decision|0|||
149726581|NCT03529773|540133730|FG030|Overall Study|Physician Decision|0|||
149726582|NCT03529773|540133731|FG031|Overall Study|Physician Decision|0|||
149726583|NCT03529773|540133732|FG032|Overall Study|Physician Decision|0|||
149726584|NCT03529773|540133733|FG033|Overall Study|Physician Decision|0|||
149726585|NCT03529773|540133734|FG034|Overall Study|Physician Decision|0|||
149726586|NCT03529773|540133735|FG035|Overall Study|Physician Decision|0|||
149726587|NCT03529773|540133736|FG036|Overall Study|Physician Decision|0|||
149726588|NCT03529773|540133737|FG037|Overall Study|Physician Decision|0|||
149726589|NCT03529773|540133738|FG038|Overall Study|Physician Decision|0|||
149726590|NCT03529773|540133739|FG039|Overall Study|Physician Decision|0|||
149726591|NCT03529773|540133700|FG000|Overall Study|Protocol Violation|0|||
149726592|NCT03529773|540133701|FG001|Overall Study|Protocol Violation|0|||
149726593|NCT03529773|540133702|FG002|Overall Study|Protocol Violation|0|||
149726594|NCT03529773|540133703|FG003|Overall Study|Protocol Violation|0|||
149726595|NCT03529773|540133704|FG004|Overall Study|Protocol Violation|0|||
149726596|NCT03529773|540133705|FG005|Overall Study|Protocol Violation|0|||
149726597|NCT03529773|540133706|FG006|Overall Study|Protocol Violation|0|||
149726598|NCT03529773|540133707|FG007|Overall Study|Protocol Violation|0|||
149726599|NCT03529773|540133708|FG008|Overall Study|Protocol Violation|0|||
149726600|NCT03529773|540133709|FG009|Overall Study|Protocol Violation|0|||
149726601|NCT03529773|540133710|FG010|Overall Study|Protocol Violation|0|||
149726602|NCT03529773|540133711|FG011|Overall Study|Protocol Violation|0|||
149726603|NCT03529773|540133712|FG012|Overall Study|Protocol Violation|0|||
149726604|NCT03529773|540133713|FG013|Overall Study|Protocol Violation|0|||
149726605|NCT03529773|540133714|FG014|Overall Study|Protocol Violation|0|||
149726606|NCT03529773|540133715|FG015|Overall Study|Protocol Violation|0|||
149726607|NCT03529773|540133716|FG016|Overall Study|Protocol Violation|0|||
149726608|NCT03529773|540133717|FG017|Overall Study|Protocol Violation|0|||
149726609|NCT03529773|540133718|FG018|Overall Study|Protocol Violation|0|||
149726610|NCT03529773|540133719|FG019|Overall Study|Protocol Violation|0|||
149726611|NCT03529773|540133720|FG020|Overall Study|Protocol Violation|0|||
149726612|NCT03529773|540133721|FG021|Overall Study|Protocol Violation|0|||
149726613|NCT03529773|540133722|FG022|Overall Study|Protocol Violation|0|||
149726614|NCT03529773|540133723|FG023|Overall Study|Protocol Violation|0|||
149726615|NCT03529773|540133724|FG024|Overall Study|Protocol Violation|0|||
149726616|NCT03529773|540133725|FG025|Overall Study|Protocol Violation|0|||
149726617|NCT03529773|540133726|FG026|Overall Study|Protocol Violation|0|||
149726618|NCT03529773|540133727|FG027|Overall Study|Protocol Violation|0|||
149726619|NCT03529773|540133728|FG028|Overall Study|Protocol Violation|0|||
149726620|NCT03529773|540133729|FG029|Overall Study|Protocol Violation|0|||
149726621|NCT03529773|540133730|FG030|Overall Study|Protocol Violation|1|||
149726622|NCT03529773|540133731|FG031|Overall Study|Protocol Violation|0|||
149726623|NCT03529773|540133732|FG032|Overall Study|Protocol Violation|0|||
149726624|NCT03529773|540133733|FG033|Overall Study|Protocol Violation|0|||
149726625|NCT03529773|540133734|FG034|Overall Study|Protocol Violation|0|||
149726626|NCT03529773|540133735|FG035|Overall Study|Protocol Violation|0|||
149726627|NCT03529773|540133736|FG036|Overall Study|Protocol Violation|0|||
149726628|NCT03529773|540133737|FG037|Overall Study|Protocol Violation|0|||
149726629|NCT03529773|540133738|FG038|Overall Study|Protocol Violation|0|||
149726630|NCT03529773|540133739|FG039|Overall Study|Protocol Violation|0|||
149726631|NCT03529773|540133700|FG000|Overall Study|Withdrawal by Subject|0|||
149726632|NCT03529773|540133701|FG001|Overall Study|Withdrawal by Subject|0|||
149726633|NCT03529773|540133702|FG002|Overall Study|Withdrawal by Subject|0|||
149726634|NCT03529773|540133703|FG003|Overall Study|Withdrawal by Subject|0|||
149726635|NCT03529773|540133704|FG004|Overall Study|Withdrawal by Subject|0|||
149726636|NCT03529773|540133705|FG005|Overall Study|Withdrawal by Subject|0|||
149726637|NCT03529773|540133706|FG006|Overall Study|Withdrawal by Subject|0|||
149726638|NCT03529773|540133707|FG007|Overall Study|Withdrawal by Subject|1|||
149726639|NCT03529773|540133708|FG008|Overall Study|Withdrawal by Subject|0|||
149726640|NCT03529773|540133709|FG009|Overall Study|Withdrawal by Subject|1|||
149726641|NCT03529773|540133710|FG010|Overall Study|Withdrawal by Subject|1|||
149726642|NCT03529773|540133711|FG011|Overall Study|Withdrawal by Subject|0|||
149726643|NCT03529773|540133712|FG012|Overall Study|Withdrawal by Subject|0|||
149726644|NCT03529773|540133713|FG013|Overall Study|Withdrawal by Subject|0|||
149726645|NCT03529773|540133714|FG014|Overall Study|Withdrawal by Subject|0|||
149726646|NCT03529773|540133715|FG015|Overall Study|Withdrawal by Subject|3|||
149726647|NCT03529773|540133716|FG016|Overall Study|Withdrawal by Subject|0|||
149726648|NCT03529773|540133717|FG017|Overall Study|Withdrawal by Subject|2|||
149726649|NCT03529773|540133718|FG018|Overall Study|Withdrawal by Subject|3|||
149726650|NCT03529773|540133719|FG019|Overall Study|Withdrawal by Subject|1|||
149726651|NCT03529773|540133720|FG020|Overall Study|Withdrawal by Subject|3|||
149726652|NCT03529773|540133721|FG021|Overall Study|Withdrawal by Subject|1|||
149726653|NCT03529773|540133722|FG022|Overall Study|Withdrawal by Subject|1|||
149726654|NCT03529773|540133723|FG023|Overall Study|Withdrawal by Subject|2|||
149726655|NCT03529773|540133724|FG024|Overall Study|Withdrawal by Subject|2|||
149726656|NCT03529773|540133725|FG025|Overall Study|Withdrawal by Subject|4|||
149726657|NCT03529773|540133726|FG026|Overall Study|Withdrawal by Subject|2|||
149726658|NCT03529773|540133727|FG027|Overall Study|Withdrawal by Subject|1|||
149726659|NCT03529773|540133728|FG028|Overall Study|Withdrawal by Subject|1|||
149726660|NCT03529773|540133729|FG029|Overall Study|Withdrawal by Subject|0|||
149726661|NCT03529773|540133730|FG030|Overall Study|Withdrawal by Subject|0|||
149726662|NCT03529773|540133731|FG031|Overall Study|Withdrawal by Subject|0|||
149726663|NCT03529773|540133732|FG032|Overall Study|Withdrawal by Subject|0|||
149726664|NCT03529773|540133733|FG033|Overall Study|Withdrawal by Subject|0|||
149726665|NCT03529773|540133734|FG034|Overall Study|Withdrawal by Subject|1|||
149726666|NCT03529773|540133735|FG035|Overall Study|Withdrawal by Subject|2|||
149726667|NCT03529773|540133736|FG036|Overall Study|Withdrawal by Subject|0|||
149726668|NCT03529773|540133737|FG037|Overall Study|Withdrawal by Subject|2|||
149726669|NCT03529773|540133738|FG038|Overall Study|Withdrawal by Subject|1|||
149726670|NCT03529773|540133739|FG039|Overall Study|Withdrawal by Subject|1|||
149726671|NCT03529773|540133700|FG000|Overall Study|Screen Failure|0|||
149726672|NCT03529773|540133701|FG001|Overall Study|Screen Failure|0|||
149726673|NCT03529773|540133702|FG002|Overall Study|Screen Failure|0|||
149726674|NCT03529773|540133703|FG003|Overall Study|Screen Failure|0|||
149726675|NCT03529773|540133704|FG004|Overall Study|Screen Failure|0|||
149726676|NCT03529773|540133705|FG005|Overall Study|Screen Failure|0|||
149726677|NCT03529773|540133706|FG006|Overall Study|Screen Failure|0|||
149726678|NCT03529773|540133707|FG007|Overall Study|Screen Failure|0|||
149726679|NCT03529773|540133708|FG008|Overall Study|Screen Failure|0|||
149726680|NCT03529773|540133709|FG009|Overall Study|Screen Failure|0|||
149726681|NCT03529773|540133710|FG010|Overall Study|Screen Failure|0|||
149726682|NCT03529773|540133711|FG011|Overall Study|Screen Failure|0|||
149726683|NCT03529773|540133712|FG012|Overall Study|Screen Failure|0|||
149726684|NCT03529773|540133713|FG013|Overall Study|Screen Failure|0|||
149726685|NCT03529773|540133714|FG014|Overall Study|Screen Failure|0|||
149726686|NCT03529773|540133715|FG015|Overall Study|Screen Failure|0|||
149726687|NCT03529773|540133716|FG016|Overall Study|Screen Failure|0|||
149726688|NCT03529773|540133717|FG017|Overall Study|Screen Failure|0|||
149726689|NCT03529773|540133718|FG018|Overall Study|Screen Failure|0|||
149726690|NCT03529773|540133719|FG019|Overall Study|Screen Failure|0|||
149726691|NCT03529773|540133720|FG020|Overall Study|Screen Failure|0|||
149726692|NCT03529773|540133721|FG021|Overall Study|Screen Failure|0|||
149726693|NCT03529773|540133722|FG022|Overall Study|Screen Failure|0|||
149726694|NCT03529773|540133723|FG023|Overall Study|Screen Failure|0|||
149726695|NCT03529773|540133724|FG024|Overall Study|Screen Failure|0|||
149726696|NCT03529773|540133725|FG025|Overall Study|Screen Failure|0|||
149726697|NCT03529773|540133726|FG026|Overall Study|Screen Failure|0|||
149726698|NCT03529773|540133727|FG027|Overall Study|Screen Failure|0|||
149726699|NCT03529773|540133728|FG028|Overall Study|Screen Failure|0|||
149726700|NCT03529773|540133729|FG029|Overall Study|Screen Failure|0|||
149726701|NCT03529773|540133730|FG030|Overall Study|Screen Failure|0|||
149726702|NCT03529773|540133731|FG031|Overall Study|Screen Failure|0|||
149726703|NCT03529773|540133732|FG032|Overall Study|Screen Failure|0|||
149726704|NCT03529773|540133733|FG033|Overall Study|Screen Failure|0|||
149726705|NCT03529773|540133734|FG034|Overall Study|Screen Failure|0|||
149726706|NCT03529773|540133735|FG035|Overall Study|Screen Failure|0|||
149726707|NCT03529773|540133736|FG036|Overall Study|Screen Failure|1|||
149726708|NCT03529773|540133737|FG037|Overall Study|Screen Failure|1|||
149726709|NCT03529773|540133738|FG038|Overall Study|Screen Failure|0|||
149726710|NCT03529773|540133739|FG039|Overall Study|Screen Failure|1|||
149726711|NCT03529773|540133700|FG000|Overall Study|Randomized but not vaccinated|0|||
149726712|NCT03529773|540133701|FG001|Overall Study|Randomized but not vaccinated|0|||
149726713|NCT03529773|540133702|FG002|Overall Study|Randomized but not vaccinated|0|||
149726714|NCT03529773|540133703|FG003|Overall Study|Randomized but not vaccinated|0|||
149726715|NCT03529773|540133704|FG004|Overall Study|Randomized but not vaccinated|0|||
149726716|NCT03529773|540133705|FG005|Overall Study|Randomized but not vaccinated|0|||
149726717|NCT03529773|540133706|FG006|Overall Study|Randomized but not vaccinated|0|||
149726718|NCT03529773|540133707|FG007|Overall Study|Randomized but not vaccinated|0|||
149726719|NCT03529773|540133708|FG008|Overall Study|Randomized but not vaccinated|0|||
149726720|NCT03529773|540133709|FG009|Overall Study|Randomized but not vaccinated|0|||
149726721|NCT03529773|540133710|FG010|Overall Study|Randomized but not vaccinated|0|||
149726722|NCT03529773|540133711|FG011|Overall Study|Randomized but not vaccinated|0|||
149726723|NCT03529773|540133712|FG012|Overall Study|Randomized but not vaccinated|0|||
149726724|NCT03529773|540133713|FG013|Overall Study|Randomized but not vaccinated|0|||
149726725|NCT03529773|540133714|FG014|Overall Study|Randomized but not vaccinated|0|||
149726726|NCT03529773|540133715|FG015|Overall Study|Randomized but not vaccinated|0|||
149726727|NCT03529773|540133716|FG016|Overall Study|Randomized but not vaccinated|0|||
149726728|NCT03529773|540133717|FG017|Overall Study|Randomized but not vaccinated|1|||
149726729|NCT03529773|540133718|FG018|Overall Study|Randomized but not vaccinated|0|||
149726730|NCT03529773|540133719|FG019|Overall Study|Randomized but not vaccinated|0|||
149726731|NCT03529773|540133720|FG020|Overall Study|Randomized but not vaccinated|0|||
149726732|NCT03529773|540133721|FG021|Overall Study|Randomized but not vaccinated|0|||
149726733|NCT03529773|540133722|FG022|Overall Study|Randomized but not vaccinated|0|||
149726734|NCT03529773|540133723|FG023|Overall Study|Randomized but not vaccinated|0|||
149726735|NCT03529773|540133724|FG024|Overall Study|Randomized but not vaccinated|0|||
149726736|NCT03529773|540133725|FG025|Overall Study|Randomized but not vaccinated|0|||
149726737|NCT03529773|540133726|FG026|Overall Study|Randomized but not vaccinated|0|||
149726738|NCT03529773|540133727|FG027|Overall Study|Randomized but not vaccinated|1|||
149726739|NCT03529773|540133728|FG028|Overall Study|Randomized but not vaccinated|0|||
149726740|NCT03529773|540133729|FG029|Overall Study|Randomized but not vaccinated|0|||
149726741|NCT03529773|540133730|FG030|Overall Study|Randomized but not vaccinated|0|||
149726742|NCT03529773|540133731|FG031|Overall Study|Randomized but not vaccinated|0|||
149726743|NCT03529773|540133732|FG032|Overall Study|Randomized but not vaccinated|0|||
149726744|NCT03529773|540133733|FG033|Overall Study|Randomized but not vaccinated|0|||
149726745|NCT03529773|540133734|FG034|Overall Study|Randomized but not vaccinated|0|||
149726746|NCT03529773|540133735|FG035|Overall Study|Randomized but not vaccinated|0|||
149726747|NCT03529773|540133736|FG036|Overall Study|Randomized but not vaccinated|0|||
149726748|NCT03529773|540133737|FG037|Overall Study|Randomized but not vaccinated|0|||
149726749|NCT03529773|540133738|FG038|Overall Study|Randomized but not vaccinated|0|||
149726750|NCT03529773|540133739|FG039|Overall Study|Randomized but not vaccinated|0|||
149726751|NCT01496066|540133741|FG000|Overall Study|Lost to Follow-up|8|||
149726752|NCT01496066|540133742|FG001|Overall Study|Lost to Follow-up|5|||
149726753|NCT01496066|540133741|FG000|Overall Study|Explant|3|||
149726754|NCT01496066|540133742|FG001|Overall Study|Explant|0|||
149726755|NCT01496066|540133741|FG000|Overall Study|Death|1|||
149726756|NCT01496066|540133742|FG001|Overall Study|Death|4|||
149726757|NCT00253630|540133743|FG000|Overall Study|ineligible|2|||
149726758|NCT00209339|540133746|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
149726759|NCT00209339|540133746|FG000|At 12 Months Follow-up|Death|1|||
149726760|NCT00209339|540133746|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
149726761|NCT00209339|540133746|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
149726762|NCT00209339|540133746|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
149726763|NCT00209339|540133746|FG000|At 24 Months Follow-up|Death|1|||
149726764|NCT00209339|540133746|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
149726765|NCT00209339|540133746|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
149726766|NCT00209339|540133746|FG000|At 4 Years Follow-up|Death|1|||
149726767|NCT00209339|540133746|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
149726768|NCT00209339|540133746|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
149726769|NCT00209339|540133746|FG000|At 5 Years Follow-up|Death|1|||
149726770|NCT00429858|540133747|FG000|Overall Study|Withdrawal by Subject|1|||
149726771|NCT00429858|540133747|FG000|Overall Study|Study Termination|1|||
149726772|NCT01587079|540133748|FG000|Overall Study|Protocol-specified criteria|9|||
149726773|NCT01587079|540133748|FG000|Overall Study|Protocol Violation|5|||
149726774|NCT01587079|540133748|FG000|Overall Study|Lost to Follow-up|2|||
149726775|NCT01587079|540133748|FG000|Overall Study|Physician Decision|2|||
149726776|NCT01587079|540133748|FG000|Overall Study|Withdrawal by Subject|7|||
149726777|NCT01587079|540133748|FG000|Overall Study|Adverse Event|14|||
149726778|NCT02475655|540133750|FG000|Overall Study|Lost to Follow-up|0|||
149726779|NCT02475655|540133751|FG001|Overall Study|Lost to Follow-up|1|||
149726780|NCT00257010|540133752|FG000|Overall Study|Lack of Efficacy|11|||
149726781|NCT00257010|540133752|FG000|Overall Study|Lost to Follow-up|53|||
149726782|NCT00257010|540133752|FG000|Overall Study|Withdrawal by Subject|34|||
149726783|NCT00257010|540133752|FG000|Overall Study|Adverse Event|10|||
149726784|NCT00257010|540133752|FG000|Overall Study|various|11|||
149726785|NCT00257010|540133752|FG000|Overall Study|no headache reported|9|||
149726786|NCT00441545|540133756|FG000|First Intervention|Adverse Event|6|||
149726787|NCT00441545|540133757|FG001|First Intervention|Adverse Event|5|||
149726788|NCT00441545|540133756|FG000|First Intervention|Protocol Violation|2|||
149726789|NCT00441545|540133757|FG001|First Intervention|Protocol Violation|2|||
149726790|NCT00441545|540133756|FG000|First Intervention|Withdrawal by Subject|3|||
149726791|NCT00441545|540133757|FG001|First Intervention|Withdrawal by Subject|3|||
149726792|NCT00441545|540133756|FG000|First Intervention|Kidney transplant|1|||
149726793|NCT00441545|540133757|FG001|First Intervention|Kidney transplant|1|||
149726794|NCT00441545|540133756|FG000|First Intervention|Lack of Efficacy|2|||
149726795|NCT00441545|540133757|FG001|First Intervention|Lack of Efficacy|0|||
149726796|NCT00441545|540133756|FG000|First Intervention|Subject exceeded safety criteria|0|||
149726797|NCT00441545|540133757|FG001|First Intervention|Subject exceeded safety criteria|1|||
149726798|NCT00441545|540133756|FG000|First Intervention|Subject met an exclusionary criteria|1|||
149726799|NCT00441545|540133757|FG001|First Intervention|Subject met an exclusionary criteria|0|||
149726800|NCT00441545|540133756|FG000|First Intervention|Extended hospitalization|1|||
149726801|NCT00441545|540133757|FG001|First Intervention|Extended hospitalization|0|||
149726802|NCT00441545|540133756|FG000|First Intervention|Site error|1|||
150251670|NCT05020327|542058267|FG000|Overall Study|Physician Decision|3|||
150251671|NCT05020327|542058268|FG001|Overall Study|Physician Decision|0|||
149726803|NCT00441545|540133757|FG001|First Intervention|Site error|0|||
149726804|NCT00441545|540133756|FG000|First Intervention|Sponsor's request|1|||
149726805|NCT00441545|540133757|FG001|First Intervention|Sponsor's request|0|||
149726806|NCT00441545|540133756|FG000|Second Intervention|Adverse Event|5|||
149726807|NCT00441545|540133757|FG001|Second Intervention|Adverse Event|2|||
149726808|NCT00441545|540133756|FG000|Second Intervention|Protocol Violation|4|||
149726809|NCT00441545|540133757|FG001|Second Intervention|Protocol Violation|1|||
149726810|NCT00441545|540133756|FG000|Second Intervention|Withdrawal by Subject|1|||
149726811|NCT00441545|540133757|FG001|Second Intervention|Withdrawal by Subject|1|||
149726812|NCT00441545|540133756|FG000|Second Intervention|Kidney Transplant|1|||
149726813|NCT00441545|540133757|FG001|Second Intervention|Kidney Transplant|1|||
149726814|NCT00441545|540133756|FG000|Second Intervention|Lack of Efficacy|0|||
149726815|NCT00441545|540133757|FG001|Second Intervention|Lack of Efficacy|1|||
149726816|NCT00441545|540133756|FG000|Second Intervention|Subject exceeded safety criteria|1|||
149726817|NCT00441545|540133757|FG001|Second Intervention|Subject exceeded safety criteria|0|||
149726818|NCT00441545|540133756|FG000|Second Intervention|Subject moved|0|||
149726819|NCT00441545|540133757|FG001|Second Intervention|Subject moved|1|||
149726820|NCT00939692|540133764|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
149726821|NCT00939692|540133765|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
149726822|NCT00939692|540133764|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
149726823|NCT00939692|540133765|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
149726824|NCT00699907|540133770|FG000|Overall Study|Withdrawal by Subject|2|||
149726825|NCT00699907|540133771|FG001|Overall Study|Withdrawal by Subject|1|||
149726826|NCT00699907|540133772|FG002|Overall Study|Withdrawal by Subject|0|||
149726827|NCT00699907|540133770|FG000|Overall Study|No usable sample|0|||
149726828|NCT00699907|540133771|FG001|Overall Study|No usable sample|9|||
149726829|NCT00699907|540133772|FG002|Overall Study|No usable sample|8|||
149726830|NCT00430508|540133773|FG000|Overall Study|Adverse Event|2|||
149726831|NCT00430508|540133774|FG001|Overall Study|Adverse Event|3|||
149726832|NCT00430508|540133775|FG002|Overall Study|Adverse Event|5|||
149726833|NCT00430508|540133776|FG003|Overall Study|Adverse Event|3|||
149726834|NCT00430508|540133773|FG000|Overall Study|Withdrawal by Subject|0|||
149726835|NCT00430508|540133774|FG001|Overall Study|Withdrawal by Subject|1|||
149726836|NCT00430508|540133775|FG002|Overall Study|Withdrawal by Subject|1|||
149726837|NCT00430508|540133776|FG003|Overall Study|Withdrawal by Subject|1|||
149726838|NCT00430508|540133773|FG000|Overall Study|responder at visit 4|0|||
149726839|NCT00430508|540133774|FG001|Overall Study|responder at visit 4|0|||
149726840|NCT00430508|540133775|FG002|Overall Study|responder at visit 4|2|||
149726841|NCT00430508|540133776|FG003|Overall Study|responder at visit 4|0|||
149726842|NCT00430508|540133773|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
149726843|NCT00430508|540133774|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
149726844|NCT00430508|540133775|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
149726845|NCT00430508|540133776|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
149726846|NCT00430508|540133773|FG000|Overall Study|Other|1|||
149726847|NCT00430508|540133774|FG001|Overall Study|Other|1|||
149726848|NCT00430508|540133775|FG002|Overall Study|Other|3|||
149726849|NCT00430508|540133776|FG003|Overall Study|Other|0|||
149726850|NCT03889639|540133779|FG000|Overall Study|Withdrawal by Subject|0|||
149726851|NCT03889639|540133780|FG001|Overall Study|Withdrawal by Subject|0|||
149726852|NCT03889639|540133781|FG002|Overall Study|Withdrawal by Subject|0|||
149726853|NCT03889639|540133782|FG003|Overall Study|Withdrawal by Subject|0|||
149726854|NCT03889639|540133783|FG004|Overall Study|Withdrawal by Subject|0|||
149726855|NCT03889639|540133784|FG005|Overall Study|Withdrawal by Subject|0|||
149726856|NCT03889639|540133785|FG006|Overall Study|Withdrawal by Subject|0|||
149726857|NCT03889639|540133786|FG007|Overall Study|Withdrawal by Subject|1|||
149726858|NCT01703858|540133787|FG000|Overall Study|Withdrawal by Subject|0|||
149726859|NCT01703858|540133788|FG001|Overall Study|Withdrawal by Subject|1|||
149726860|NCT01703858|540133789|FG002|Overall Study|Withdrawal by Subject|0|||
149726861|NCT02340663|540133796|FG000|Overall Study|Lost to Follow-up|1|||
149726862|NCT02340663|540133797|FG001|Overall Study|Lost to Follow-up|0|||
149726863|NCT02340663|540133796|FG000|Overall Study|Protocol Violation|1|||
149726864|NCT02340663|540133797|FG001|Overall Study|Protocol Violation|0|||
149726865|NCT02340663|540133796|FG000|Overall Study|Withdrawal by Subject|3|||
149726866|NCT02340663|540133797|FG001|Overall Study|Withdrawal by Subject|1|||
149726867|NCT00516737|540133820|FG000|Overall Study|Lost to Follow-up|2|||
149726868|NCT00516737|540133821|FG001|Overall Study|Lost to Follow-up|0|||
149726869|NCT00516737|540133820|FG000|Overall Study|Physician Decision|0|||
149726870|NCT00516737|540133821|FG001|Overall Study|Physician Decision|1|||
149726871|NCT00516737|540133820|FG000|Overall Study|Withdrawal by Subject|0|||
149726872|NCT00516737|540133821|FG001|Overall Study|Withdrawal by Subject|1|||
149726873|NCT00516737|540133820|FG000|Overall Study|Lack of Qualifying Event|9|||
149726874|NCT00516737|540133821|FG001|Overall Study|Lack of Qualifying Event|6|||
149726875|NCT00848354|540133822|FG000|Phase 1|Adverse Event|5|||
149726876|NCT00848354|540133823|FG001|Phase 1|Adverse Event|4|||
149726877|NCT00848354|540133822|FG000|Phase 1|Discontinuation of study by sponsor|2|||
150251672|NCT05020327|542058269|FG002|Overall Study|Physician Decision|0|||
150251673|NCT05020327|542058267|FG000|Overall Study|Withdrawal by Subject|1|||
149726878|NCT00848354|540133823|FG001|Phase 1|Discontinuation of study by sponsor|1|||
149726879|NCT00848354|540133822|FG000|Phase 1|Failed to return|0|||
149726880|NCT00848354|540133823|FG001|Phase 1|Failed to return|1|||
149726881|NCT00848354|540133822|FG000|Phase 1|Lost to Follow-up|1|||
149726882|NCT00848354|540133823|FG001|Phase 1|Lost to Follow-up|1|||
149726883|NCT00848354|540133822|FG000|Phase 1|Unspecified Reason|1|||
149726884|NCT00848354|540133823|FG001|Phase 1|Unspecified Reason|1|||
149726885|NCT00848354|540133822|FG000|Phase 1|Protocol Violation|1|||
149726886|NCT00848354|540133823|FG001|Phase 1|Protocol Violation|1|||
149726887|NCT00848354|540133822|FG000|Phase 1|Withdrawal by Subject|2|||
149726888|NCT00848354|540133823|FG001|Phase 1|Withdrawal by Subject|4|||
149726889|NCT00848354|540133822|FG000|Phase 1|Lack of Efficacy|0|||
149726890|NCT00848354|540133823|FG001|Phase 1|Lack of Efficacy|1|||
149726891|NCT00848354|540133822|FG000|Phase 2 Year 1|Adverse Event|7|||
149726892|NCT00848354|540133823|FG001|Phase 2 Year 1|Adverse Event|2|||
149726893|NCT00848354|540133822|FG000|Phase 2 Year 1|Death|1|||
149726894|NCT00848354|540133823|FG001|Phase 2 Year 1|Death|0|||
149726895|NCT00848354|540133822|FG000|Phase 2 Year 1|Failed to Return|1|||
149726896|NCT00848354|540133823|FG001|Phase 2 Year 1|Failed to Return|1|||
149726897|NCT00848354|540133822|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
149726898|NCT00848354|540133823|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
149726899|NCT00848354|540133822|FG000|Phase 2 Year 1|Unspecified Reason|3|||
149726900|NCT00848354|540133823|FG001|Phase 2 Year 1|Unspecified Reason|0|||
149726901|NCT00848354|540133822|FG000|Phase 2 Year 1|Protocol Violation|4|||
149726902|NCT00848354|540133823|FG001|Phase 2 Year 1|Protocol Violation|1|||
149726903|NCT00848354|540133822|FG000|Phase 2 Year 1|Subject Request|1|||
149726904|NCT00848354|540133823|FG001|Phase 2 Year 1|Subject Request|2|||
149726905|NCT00848354|540133822|FG000|Phase 2 Year 2|Adverse Event|12|||
149726906|NCT00848354|540133823|FG001|Phase 2 Year 2|Adverse Event|2|||
149726907|NCT00848354|540133822|FG000|Phase 2 Year 2|Death|2|||
149726908|NCT00848354|540133823|FG001|Phase 2 Year 2|Death|0|||
149726909|NCT00848354|540133822|FG000|Phase 2 Year 2|Failed to return|3|||
149726910|NCT00848354|540133823|FG001|Phase 2 Year 2|Failed to return|0|||
149726911|NCT00848354|540133822|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
149726912|NCT00848354|540133823|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
149726913|NCT00848354|540133822|FG000|Phase 2 Year 2|Unspecified Reason|1|||
149726914|NCT00848354|540133823|FG001|Phase 2 Year 2|Unspecified Reason|0|||
149726915|NCT00848354|540133822|FG000|Phase 2 Year 2|Protocol Violation|1|||
149726916|NCT00848354|540133823|FG001|Phase 2 Year 2|Protocol Violation|1|||
149726917|NCT00848354|540133822|FG000|Phase 2 Year 2|Subject Request|1|||
149726918|NCT00848354|540133823|FG001|Phase 2 Year 2|Subject Request|1|||
149726919|NCT00848354|540133822|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
149726920|NCT00848354|540133823|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
149726921|NCT00915343|540133826|FG000|Part B - Open Label Period|Treatment switch|0|||
149726922|NCT00915343|540133827|FG001|Part B - Open Label Period|Treatment switch|0|||
149726923|NCT00915343|540133828|FG002|Part B - Open Label Period|Treatment switch|1|||
149726924|NCT00915343|540133826|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
149726925|NCT00915343|540133827|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
149726926|NCT00915343|540133828|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
149726927|NCT00626093|540133830|FG000|Overall Study|Lost to Follow-up|5|||
149726928|NCT00626093|540133830|FG000|Overall Study|Death|1|||
149726929|NCT00626093|540133830|FG000|Overall Study|Physician Decision|4|||
149726930|NCT00626093|540133830|FG000|Overall Study|Withdrawal by Subject|6|||
149726931|NCT00626093|540133830|FG000|Overall Study|Protocol Violation|1|||
149726932|NCT00626093|540133830|FG000|Overall Study|One of the required devices not implante|6|||
149726933|NCT00911989|540133831|FG000|Overall Study|Adverse Event|1|||
149726934|NCT03434977|540133832|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
149726935|NCT03434977|540133833|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
149726936|NCT03064841|540133834|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
149726937|NCT03064841|540133834|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
149726938|NCT03064841|540133834|FG000|Overall Study|Screen failure|2|||
149726939|NCT04622046|540133835|FG000|Intervention Period|Adverse Event|1|||
149726940|NCT04622046|540133835|FG000|Intervention Period|Withdrawal by Subject|2|||
149726941|NCT04622046|540133835|FG000|Extension Period|Ongoing in the Extension Period|21|||
149726942|NCT04341948|540133836|FG000|Overall Study|Adverse Event|0|||
149726943|NCT04341948|540133837|FG001|Overall Study|Adverse Event|1|||
149726944|NCT04341948|540133836|FG000|Overall Study|Lost to Follow-up|6|||
149726945|NCT04341948|540133837|FG001|Overall Study|Lost to Follow-up|1|||
149726946|NCT04341948|540133836|FG000|Overall Study|Physician Decision|1|||
149726947|NCT04341948|540133837|FG001|Overall Study|Physician Decision|2|||
149726948|NCT04341948|540133836|FG000|Overall Study|Withdrawal by Participant|6|||
149726949|NCT04341948|540133837|FG001|Overall Study|Withdrawal by Participant|3|||
149726950|NCT04341948|540133836|FG000|Overall Study|Lack of compliance by Participant|1|||
149726951|NCT04341948|540133837|FG001|Overall Study|Lack of compliance by Participant|0|||
149726952|NCT03266016|540135375|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
149726953|NCT03266016|540135376|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149726954|NCT03266016|540135377|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149726955|NCT03266016|540135378|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149726956|NCT03266016|540135375|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
149726957|NCT03266016|540135376|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
149726958|NCT03266016|540135377|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
149726959|NCT03266016|540135378|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
149726960|NCT03160560|540135379|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
149726961|NCT03160560|540135380|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149726962|NCT03160560|540135381|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149726963|NCT03160560|540135382|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
149726964|NCT03160560|540135379|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
149726965|NCT03160560|540135380|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149726966|NCT03160560|540135381|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149726967|NCT03160560|540135382|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149726968|NCT01978093|540135383|FG000|Overall Study|Death|1|||
149726969|NCT01978093|540135384|FG001|Overall Study|Death|0|||
149726970|NCT01978093|540135383|FG000|Overall Study|Adverse Event|0|||
149726971|NCT01978093|540135384|FG001|Overall Study|Adverse Event|5|||
149726972|NCT01978093|540135383|FG000|Overall Study|Protocol Violation|8|||
149726973|NCT01978093|540135384|FG001|Overall Study|Protocol Violation|2|||
149726974|NCT01978093|540135383|FG000|Overall Study|Withdrawal by Subject|29|||
149726975|NCT01978093|540135384|FG001|Overall Study|Withdrawal by Subject|25|||
149726976|NCT01978093|540135383|FG000|Overall Study|Lost to Follow-up|11|||
149726977|NCT01978093|540135384|FG001|Overall Study|Lost to Follow-up|15|||
149726978|NCT01978093|540135383|FG000|Overall Study|Migrated/moved from study area|11|||
149726979|NCT01978093|540135384|FG001|Overall Study|Migrated/moved from study area|13|||
149726980|NCT01978093|540135383|FG000|Overall Study|Loss of kaiser coverage|4|||
149726981|NCT01978093|540135384|FG001|Overall Study|Loss of kaiser coverage|10|||
149726982|NCT01978093|540135383|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
149726983|NCT01978093|540135384|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
149726984|NCT01978093|540135383|FG000|Overall Study|Mother lost custody of child|0|||
149726985|NCT01978093|540135384|FG001|Overall Study|Mother lost custody of child|1|||
149726986|NCT01978093|540135383|FG000|Overall Study|Child was in care of grandmother|0|||
149726987|NCT01978093|540135384|FG001|Overall Study|Child was in care of grandmother|1|||
149726988|NCT01978093|540135383|FG000|Overall Study|N/A for vaccine administration|0|||
149726989|NCT01978093|540135384|FG001|Overall Study|N/A for vaccine administration|1|||
149726990|NCT00424827|540135389|FG000|Overall Study|Adverse Event|1|||
149726991|NCT00491179|540135390|FG000|Overall Study|Adverse Event|5|||
149726992|NCT00491179|540135391|FG001|Overall Study|Adverse Event|1|||
149726993|NCT00491179|540135390|FG000|Overall Study|Withdrawal by Subject|2|||
149726994|NCT00491179|540135391|FG001|Overall Study|Withdrawal by Subject|1|||
149726995|NCT02009878|540135393|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
149726996|NCT02009878|540135394|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
149726997|NCT02009878|540135395|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
149726998|NCT01790048|540135397|FG000|Overall Study|Incorrect Age|9|||
149726999|NCT01790048|540135398|FG001|Overall Study|Incorrect Age|14|||
149727000|NCT01790048|540135397|FG000|Overall Study|data entry error|0|||
149727001|NCT01790048|540135398|FG001|Overall Study|data entry error|1|||
149727002|NCT01790048|540135397|FG000|Overall Study|Other|0|||
149727003|NCT01790048|540135398|FG001|Overall Study|Other|2|||
149727004|NCT01790048|540135397|FG000|Overall Study|SAM at Enrollment|2|||
149727005|NCT01790048|540135398|FG001|Overall Study|SAM at Enrollment|0|||
149727006|NCT01790048|540135397|FG000|Overall Study|Measurement error|1|||
149727007|NCT01790048|540135398|FG001|Overall Study|Measurement error|0|||
149727008|NCT00584233|540135399|FG000|Overall Study|Withdrawal by Subject|5|||
149727009|NCT00584233|540135399|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
149727010|NCT00159432|540135400|FG000|Overall Study|Adverse Event|1|||
149727011|NCT00159432|540135400|FG000|Overall Study|Death|1|||
149727012|NCT00159432|540135400|FG000|Overall Study|Lack of Efficacy|8|||
149727013|NCT04537208|540135403|FG000|Overall Study|Adverse Event|0|||
149727014|NCT04537208|540135404|FG001|Overall Study|Adverse Event|0|||
149727015|NCT04537208|540135405|FG002|Overall Study|Adverse Event|0|||
149727016|NCT04537208|540135406|FG003|Overall Study|Adverse Event|0|||
149727017|NCT04537208|540135407|FG004|Overall Study|Adverse Event|0|||
149727018|NCT04537208|540135408|FG005|Overall Study|Adverse Event|0|||
149727019|NCT04537208|540135409|FG006|Overall Study|Adverse Event|0|||
149727020|NCT04537208|540135410|FG007|Overall Study|Adverse Event|0|||
149727021|NCT04537208|540135411|FG008|Overall Study|Adverse Event|1|||
149727022|NCT04537208|540135412|FG009|Overall Study|Adverse Event|0|||
149727023|NCT04537208|540135413|FG010|Overall Study|Adverse Event|0|||
149727024|NCT04537208|540135403|FG000|Overall Study|Protocol deviation|0|||
149727025|NCT04537208|540135404|FG001|Overall Study|Protocol deviation|0|||
149727026|NCT04537208|540135405|FG002|Overall Study|Protocol deviation|2|||
149727027|NCT04537208|540135406|FG003|Overall Study|Protocol deviation|0|||
149727028|NCT04537208|540135407|FG004|Overall Study|Protocol deviation|0|||
149727029|NCT04537208|540135408|FG005|Overall Study|Protocol deviation|2|||
149727030|NCT04537208|540135409|FG006|Overall Study|Protocol deviation|4|||
149727031|NCT04537208|540135410|FG007|Overall Study|Protocol deviation|0|||
149727032|NCT04537208|540135411|FG008|Overall Study|Protocol deviation|1|||
149727033|NCT04537208|540135412|FG009|Overall Study|Protocol deviation|0|||
149727034|NCT04537208|540135413|FG010|Overall Study|Protocol deviation|2|||
149727035|NCT04537208|540135403|FG000|Overall Study|Withdrawal by Subject|4|||
149727036|NCT04537208|540135404|FG001|Overall Study|Withdrawal by Subject|2|||
149727037|NCT04537208|540135405|FG002|Overall Study|Withdrawal by Subject|1|||
149727038|NCT04537208|540135406|FG003|Overall Study|Withdrawal by Subject|3|||
149727039|NCT04537208|540135407|FG004|Overall Study|Withdrawal by Subject|5|||
149727040|NCT04537208|540135408|FG005|Overall Study|Withdrawal by Subject|1|||
149727041|NCT04537208|540135409|FG006|Overall Study|Withdrawal by Subject|6|||
149727042|NCT04537208|540135410|FG007|Overall Study|Withdrawal by Subject|1|||
149727043|NCT04537208|540135411|FG008|Overall Study|Withdrawal by Subject|7|||
149727044|NCT04537208|540135412|FG009|Overall Study|Withdrawal by Subject|2|||
149727045|NCT04537208|540135413|FG010|Overall Study|Withdrawal by Subject|4|||
149727046|NCT04537208|540135403|FG000|Overall Study|Lost to Follow-up|4|||
149727047|NCT04537208|540135404|FG001|Overall Study|Lost to Follow-up|1|||
149727048|NCT04537208|540135405|FG002|Overall Study|Lost to Follow-up|3|||
149727049|NCT04537208|540135406|FG003|Overall Study|Lost to Follow-up|4|||
149727050|NCT04537208|540135407|FG004|Overall Study|Lost to Follow-up|3|||
149727051|NCT04537208|540135408|FG005|Overall Study|Lost to Follow-up|2|||
149727052|NCT04537208|540135409|FG006|Overall Study|Lost to Follow-up|3|||
149727053|NCT04537208|540135410|FG007|Overall Study|Lost to Follow-up|2|||
149727054|NCT04537208|540135411|FG008|Overall Study|Lost to Follow-up|7|||
149727055|NCT04537208|540135412|FG009|Overall Study|Lost to Follow-up|2|||
149727056|NCT04537208|540135413|FG010|Overall Study|Lost to Follow-up|2|||
149727057|NCT03655756|540135414|FG000|Overall Study|Death|1|||
149727058|NCT03237065|540135415|FG000|Overall Study|Adverse Event|0|||
149727059|NCT03237065|540135416|FG001|Overall Study|Adverse Event|2|||
149727060|NCT03237065|540135415|FG000|Overall Study|Protocol Violation|0|||
149727061|NCT03237065|540135416|FG001|Overall Study|Protocol Violation|1|||
149727062|NCT03237065|540135415|FG000|Overall Study|Withdrawal by Subject|3|||
149727063|NCT03237065|540135416|FG001|Overall Study|Withdrawal by Subject|0|||
149727064|NCT03237065|540135415|FG000|Overall Study|Lost to Follow-up|1|||
149727065|NCT03237065|540135416|FG001|Overall Study|Lost to Follow-up|0|||
149727066|NCT03237065|540135415|FG000|Overall Study|Unable to obtain venous access|0|||
149727067|NCT03237065|540135416|FG001|Overall Study|Unable to obtain venous access|1|||
149727068|NCT00704964|540135418|FG000|Overall Study|Not completed on time|328|||
149727069|NCT04317274|540135419|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
149727070|NCT04317274|540135420|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
149727071|NCT04317274|540135421|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
149727072|NCT04317274|540135422|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
149727073|NCT02161211|540135425|FG000|Overall Study|Lost to Follow-up|21|||
149727074|NCT02161211|540135426|FG001|Overall Study|Lost to Follow-up|27|||
149727075|NCT02161211|540135427|FG002|Overall Study|Lost to Follow-up|21|||
149727076|NCT02161211|540135425|FG000|Overall Study|Dropped|12|||
149727077|NCT02161211|540135426|FG001|Overall Study|Dropped|5|||
149727078|NCT02161211|540135427|FG002|Overall Study|Dropped|9|||
149727079|NCT00993031|540135440|FG000|Overall Study|Death|0|||
149727080|NCT00993031|540135441|FG001|Overall Study|Death|1|||
149727081|NCT00993031|540135440|FG000|Overall Study|Physician Decision|0|||
149727082|NCT00993031|540135441|FG001|Overall Study|Physician Decision|2|||
149727083|NCT00993031|540135440|FG000|Overall Study|Withdrawal by Subject|3|||
149727084|NCT00993031|540135441|FG001|Overall Study|Withdrawal by Subject|3|||
149727085|NCT00993031|540135440|FG000|Overall Study|Lost to Follow-up|19|||
149727086|NCT00993031|540135441|FG001|Overall Study|Lost to Follow-up|13|||
149727087|NCT01834729|540135444|FG000|Overall Study|Did not return bowel diaries|0|||
149727088|NCT01834729|540135445|FG001|Overall Study|Did not return bowel diaries|0|||
149727089|NCT01834729|540135446|FG002|Overall Study|Did not return bowel diaries|3|||
149727090|NCT01834729|540135447|FG003|Overall Study|Did not return bowel diaries|0|||
149727091|NCT01834729|540135444|FG000|Overall Study|Withdrawal by Subject|1|||
149727092|NCT01834729|540135445|FG001|Overall Study|Withdrawal by Subject|1|||
149727093|NCT01834729|540135446|FG002|Overall Study|Withdrawal by Subject|0|||
149727094|NCT01834729|540135447|FG003|Overall Study|Withdrawal by Subject|0|||
149727095|NCT01834729|540135444|FG000|Overall Study|Adverse Event|0|||
149727096|NCT01834729|540135445|FG001|Overall Study|Adverse Event|0|||
149727097|NCT01834729|540135446|FG002|Overall Study|Adverse Event|0|||
149727098|NCT01834729|540135447|FG003|Overall Study|Adverse Event|2|||
149727099|NCT00288080|540135448|FG000|Overall Study|Withdrawal by Subject|1|||
149727100|NCT00288080|540135449|FG001|Overall Study|Withdrawal by Subject|3|||
149727101|NCT00288080|540135448|FG000|Overall Study|Protocol Violation|25|||
149727102|NCT00288080|540135449|FG001|Overall Study|Protocol Violation|20|||
149727103|NCT03403192|540135450|FG000|Overall Study|Lost to Follow-up|1|||
149727104|NCT03403192|540135451|FG001|Overall Study|Lost to Follow-up|2|||
149727105|NCT03403192|540135452|FG002|Overall Study|Lost to Follow-up|0|||
149727106|NCT03403192|540135453|FG003|Overall Study|Lost to Follow-up|0|||
149727107|NCT03403192|540135450|FG000|Overall Study|Unable to respond|0|||
149727108|NCT03403192|540135451|FG001|Overall Study|Unable to respond|1|||
149727109|NCT03403192|540135452|FG002|Overall Study|Unable to respond|0|||
149727110|NCT03403192|540135453|FG003|Overall Study|Unable to respond|0|||
149727111|NCT03403192|540135450|FG000|Overall Study|Incomplete|3|||
149727112|NCT03403192|540135451|FG001|Overall Study|Incomplete|1|||
149727113|NCT03403192|540135452|FG002|Overall Study|Incomplete|3|||
150251674|NCT05020327|542058268|FG001|Overall Study|Withdrawal by Subject|1|||
150251675|NCT05020327|542058269|FG002|Overall Study|Withdrawal by Subject|0|||
149727114|NCT03403192|540135453|FG003|Overall Study|Incomplete|6|||
149727115|NCT02387580|540135455|FG000|Overall Study|Withdrawal by Subject|0|||
149727116|NCT02387580|540135456|FG001|Overall Study|Withdrawal by Subject|0|||
149727117|NCT02387580|540135457|FG002|Overall Study|Withdrawal by Subject|0|||
149727118|NCT02387580|540135458|FG003|Overall Study|Withdrawal by Subject|1|||
149727119|NCT02387580|540135459|FG004|Overall Study|Withdrawal by Subject|0|||
149727120|NCT02387580|540135460|FG005|Overall Study|Withdrawal by Subject|0|||
149727121|NCT00087646|540135461|FG000|Overall Study|Adverse Event|37|||
149727122|NCT00087646|540135462|FG001|Overall Study|Adverse Event|6|||
149727123|NCT00087646|540135463|FG002|Overall Study|Adverse Event|18|||
149727124|NCT00087646|540135464|FG003|Overall Study|Adverse Event|20|||
149727125|NCT00087646|540135461|FG000|Overall Study|Death|0|||
149727126|NCT00087646|540135462|FG001|Overall Study|Death|1|||
149727127|NCT00087646|540135463|FG002|Overall Study|Death|0|||
149727128|NCT00087646|540135464|FG003|Overall Study|Death|0|||
149727129|NCT00087646|540135461|FG000|Overall Study|Withdrawal by Subject|6|||
149727130|NCT00087646|540135462|FG001|Overall Study|Withdrawal by Subject|1|||
149727131|NCT00087646|540135463|FG002|Overall Study|Withdrawal by Subject|2|||
149727132|NCT00087646|540135464|FG003|Overall Study|Withdrawal by Subject|2|||
149727133|NCT00087646|540135461|FG000|Overall Study|Insufficient therapeutic response|64|||
149727134|NCT00087646|540135462|FG001|Overall Study|Insufficient therapeutic response|24|||
149727135|NCT00087646|540135463|FG002|Overall Study|Insufficient therapeutic response|38|||
149727136|NCT00087646|540135464|FG003|Overall Study|Insufficient therapeutic response|51|||
149727137|NCT00087646|540135461|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
149727138|NCT00087646|540135462|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
149727139|NCT00087646|540135463|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
149727140|NCT00087646|540135464|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
149727141|NCT00087646|540135461|FG000|Overall Study|Failure to Return|5|||
149727142|NCT00087646|540135462|FG001|Overall Study|Failure to Return|2|||
149727143|NCT00087646|540135463|FG002|Overall Study|Failure to Return|2|||
149727144|NCT00087646|540135464|FG003|Overall Study|Failure to Return|3|||
149727145|NCT00087646|540135461|FG000|Overall Study|Administrative/Other|6|||
149727146|NCT00087646|540135462|FG001|Overall Study|Administrative/Other|1|||
149727147|NCT00087646|540135463|FG002|Overall Study|Administrative/Other|1|||
149727148|NCT00087646|540135464|FG003|Overall Study|Administrative/Other|2|||
149727149|NCT00087646|540135461|FG000|Overall Study|Other Protocol Violation|3|||
149727150|NCT00087646|540135462|FG001|Overall Study|Other Protocol Violation|1|||
149727151|NCT00087646|540135463|FG002|Overall Study|Other Protocol Violation|0|||
149727152|NCT00087646|540135464|FG003|Overall Study|Other Protocol Violation|0|||
149727153|NCT00087646|540135461|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
149727154|NCT00087646|540135462|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
149727155|NCT00087646|540135463|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
149727156|NCT00087646|540135464|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
149727157|NCT03033875|540135468|FG000|Overall Study|Withdrawal by Subject|5|||
149727158|NCT03033875|540135469|FG001|Overall Study|Withdrawal by Subject|9|||
149727159|NCT03033875|540135470|FG002|Overall Study|Withdrawal by Subject|4|||
149727160|NCT03033875|540135468|FG000|Overall Study|Other|14|||
149727161|NCT03033875|540135469|FG001|Overall Study|Other|15|||
149727162|NCT03033875|540135470|FG002|Overall Study|Other|8|||
149727163|NCT04925752|540135472|FG000|Overall Study|Still on Study|1826|||
149727164|NCT04925752|540135473|FG001|Overall Study|Still on Study|926|||
149727165|NCT04925752|540135472|FG000|Overall Study|Withdrew Consent|128|||
149727166|NCT04925752|540135473|FG001|Overall Study|Withdrew Consent|59|||
149727167|NCT04925752|540135472|FG000|Overall Study|Lost to Follow-up|73|||
149727168|NCT04925752|540135473|FG001|Overall Study|Lost to Follow-up|47|||
149727169|NCT04925752|540135472|FG000|Overall Study|Randomized but Never Treated|12|||
149727170|NCT04925752|540135473|FG001|Overall Study|Randomized but Never Treated|9|||
149727171|NCT04925752|540135472|FG000|Overall Study|Hiv-1 Infection|6|||
149727172|NCT04925752|540135473|FG001|Overall Study|Hiv-1 Infection|7|||
149727173|NCT04925752|540135472|FG000|Overall Study|Investigator's discretion|8|||
149727174|NCT04925752|540135473|FG001|Overall Study|Investigator's discretion|5|||
149727175|NCT04925752|540135472|FG000|Overall Study|Non-compliance with Study Drug|8|||
149727176|NCT04925752|540135473|FG001|Overall Study|Non-compliance with Study Drug|5|||
149727177|NCT04925752|540135472|FG000|Overall Study|Adverse Event|5|||
149727178|NCT04925752|540135473|FG001|Overall Study|Adverse Event|2|||
149727179|NCT04925752|540135472|FG000|Overall Study|Death|4|||
150251676|NCT05020327|542058267|FG000|Overall Study|personal/cultural, ineligible|12|||
150251677|NCT05020327|542058268|FG001|Overall Study|personal/cultural, ineligible|0|||
149727180|NCT04925752|540135473|FG001|Overall Study|Death|2|||
149727181|NCT04925752|540135472|FG000|Overall Study|Protocol Violation|1|||
149727182|NCT04925752|540135473|FG001|Overall Study|Protocol Violation|3|||
149727183|NCT04925752|540135472|FG000|Overall Study|Withdrew Assent|1|||
149727184|NCT04925752|540135473|FG001|Overall Study|Withdrew Assent|0|||
149727185|NCT02286947|540135476|FG000|Overall Study|Withdrawal by Subject|2|||
149727186|NCT01145066|540135477|FG000|Overall Study|To resume NSAIDs|2|||
149727187|NCT01145066|540135478|FG001|Overall Study|To resume NSAIDs|2|||
149727188|NCT01145066|540135479|FG002|Overall Study|To resume NSAIDs|1|||
149727189|NCT01145066|540135477|FG000|Overall Study|Non-related surgery|0|||
149727190|NCT01145066|540135478|FG001|Overall Study|Non-related surgery|0|||
149727191|NCT01145066|540135479|FG002|Overall Study|Non-related surgery|1|||
149727192|NCT01145066|540135477|FG000|Overall Study|Withdrawal by Subject|0|||
149727193|NCT01145066|540135478|FG001|Overall Study|Withdrawal by Subject|0|||
149727194|NCT01145066|540135479|FG002|Overall Study|Withdrawal by Subject|2|||
149727195|NCT01145066|540135477|FG000|Overall Study|To start new med|1|||
149727196|NCT01145066|540135478|FG001|Overall Study|To start new med|0|||
149727197|NCT01145066|540135479|FG002|Overall Study|To start new med|0|||
150251678|NCT05020327|542058269|FG002|Overall Study|personal/cultural, ineligible|0|||
150251679|NCT00591370|542058270|FG000|Overall Study|Not Treated|2|||
150251680|NCT00095056|542058272|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
150251681|NCT00095056|542058273|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
150251682|NCT00095056|542058272|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
150251683|NCT00095056|542058273|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
150251684|NCT00095056|542058272|FG000|Phase A (Weeks 0-12)|Death|1|||
150251685|NCT00095056|542058273|FG001|Phase A (Weeks 0-12)|Death|0|||
150251686|NCT00095056|542058272|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
150251687|NCT00095056|542058273|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
150251688|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
150251689|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
150251690|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
150251691|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
150251692|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
149727198|NCT01145066|540135477|FG000|Overall Study|problems swallowing capsule|1|||
149727199|NCT01145066|540135478|FG001|Overall Study|problems swallowing capsule|0|||
149727200|NCT01145066|540135479|FG002|Overall Study|problems swallowing capsule|0|||
149727201|NCT01145066|540135477|FG000|Overall Study|Abdominal discomfort|0|||
149727202|NCT01145066|540135478|FG001|Overall Study|Abdominal discomfort|1|||
149727203|NCT01145066|540135479|FG002|Overall Study|Abdominal discomfort|0|||
149727204|NCT01145066|540135477|FG000|Overall Study|Low platelet count|0|||
149727205|NCT01145066|540135478|FG001|Overall Study|Low platelet count|1|||
149727206|NCT01145066|540135479|FG002|Overall Study|Low platelet count|0|||
149727207|NCT03920670|540135480|FG000|Overall Study|Protocol Violation|2|||
149727208|NCT03920670|540135481|FG001|Overall Study|Protocol Violation|2|||
149727209|NCT03920670|540135480|FG000|Overall Study|Adverse Event|1|||
149727210|NCT03920670|540135481|FG001|Overall Study|Adverse Event|0|||
149727211|NCT00573794|540135487|FG000|Overall Study|Adverse Event|81|||
149727212|NCT00573794|540135487|FG000|Overall Study|Withdrew Consent|90|||
149727213|NCT00573794|540135487|FG000|Overall Study|Lost to Follow-up|13|||
149727214|NCT00573794|540135487|FG000|Overall Study|Protocol Violation|6|||
149727215|NCT00573794|540135487|FG000|Overall Study|Lack of Efficacy|94|||
149727216|NCT00573794|540135487|FG000|Overall Study|Other|46|||
149727217|NCT04202679|540135493|FG000|Overall Study|Adverse Event|2|||
149727218|NCT04202679|540135494|FG001|Overall Study|Adverse Event|0|||
149727219|NCT04202679|540135493|FG000|Overall Study|Poor compliance to protocol|1|||
149727220|NCT04202679|540135494|FG001|Overall Study|Poor compliance to protocol|0|||
149727221|NCT04202679|540135493|FG000|Overall Study|Withdrawal by Subject|23|||
149727222|NCT04202679|540135494|FG001|Overall Study|Withdrawal by Subject|6|||
149727223|NCT05902364|540135495|FG000|Overall Study|Adverse Event|1|||
149727224|NCT05902364|540135496|FG001|Overall Study|Adverse Event|0|||
149727225|NCT02270242|540135497|FG000|Overall Study|Withdrawal by Subject|18|||
149727226|NCT02270242|540135498|FG001|Overall Study|Withdrawal by Subject|25|||
149727227|NCT02270242|540135497|FG000|Overall Study|Lost to Follow-up|41|||
149727228|NCT02270242|540135498|FG001|Overall Study|Lost to Follow-up|27|||
149727229|NCT02270242|540135497|FG000|Overall Study|Physician Decision|0|||
149727230|NCT02270242|540135498|FG001|Overall Study|Physician Decision|1|||
149727231|NCT02482129|540135499|FG000|Overall Study|Adverse Event-prior to treatment|0|||
149727232|NCT02482129|540135500|FG001|Overall Study|Adverse Event-prior to treatment|1|||
149727233|NCT02482129|540135499|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
150251693|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
150251694|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
150251695|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
150251696|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Death|3|||
150251697|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Death|1|||
150251698|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
149727234|NCT02482129|540135500|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
149727235|NCT02482129|540135499|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
149727236|NCT02482129|540135500|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
149727237|NCT02482129|540135499|FG000|Overall Study|Criteria not met-prior to treatment|1|||
149727238|NCT02482129|540135500|FG001|Overall Study|Criteria not met-prior to treatment|0|||
149727239|NCT02482129|540135499|FG000|Overall Study|Adverse Event|1|||
149727240|NCT02482129|540135500|FG001|Overall Study|Adverse Event|0|||
149727241|NCT02482129|540135499|FG000|Overall Study|Withdrawal by Subject|2|||
149727242|NCT02482129|540135500|FG001|Overall Study|Withdrawal by Subject|0|||
149727243|NCT02482129|540135499|FG000|Overall Study|Criteria not met|1|||
149727244|NCT02482129|540135500|FG001|Overall Study|Criteria not met|0|||
149727245|NCT01877083|540135501|FG000|Treatment Phase|Disease Progression|10|||
149727246|NCT01877083|540135501|FG000|Treatment Phase|Clinical Progression|1|||
149727247|NCT01877083|540135501|FG000|Treatment Phase|Adverse Event|6|||
149727248|NCT01877083|540135501|FG000|Treatment Phase|Withdrawal by Subject|2|||
149727249|NCT01877083|540135501|FG000|Treatment Phase|Lost to Follow-up|1|||
149727250|NCT01877083|540135501|FG000|Extension Phase|Disease Progression|3|||
149727251|NCT01877083|540135501|FG000|Extension Phase|Adverse Event|2|||
149727252|NCT00429585|540135504|FG000|Overall Study|Death|1|||
149727253|NCT00429585|540135505|FG001|Overall Study|Death|0|||
149727254|NCT00429585|540135504|FG000|Overall Study|Lost to Follow-up|27|||
149727255|NCT00429585|540135505|FG001|Overall Study|Lost to Follow-up|20|||
149727256|NCT00429585|540135504|FG000|Overall Study|Physician Decision|2|||
149727257|NCT00429585|540135505|FG001|Overall Study|Physician Decision|0|||
149727258|NCT01582308|540135506|FG000|Period 1|Withdrawal by Subject|0|||
149727259|NCT01582308|540135507|FG001|Period 1|Withdrawal by Subject|0|||
149727260|NCT01582308|540135508|FG002|Period 1|Withdrawal by Subject|0|||
149727261|NCT01582308|540135509|FG003|Period 1|Withdrawal by Subject|0|||
149727262|NCT01582308|540135510|FG004|Period 1|Withdrawal by Subject|0|||
149727263|NCT01582308|540135511|FG005|Period 1|Withdrawal by Subject|0|||
149727264|NCT01582308|540135512|FG006|Period 1|Withdrawal by Subject|1|||
149727265|NCT01582308|540135513|FG007|Period 1|Withdrawal by Subject|0|||
149727266|NCT01582308|540135514|FG008|Period 1|Withdrawal by Subject|0|||
149727267|NCT01582308|540135515|FG009|Period 1|Withdrawal by Subject|0|||
149727268|NCT01582308|540135506|FG000|10-day Washout Following Period 1|Physician Decision|0|||
149727269|NCT01582308|540135507|FG001|10-day Washout Following Period 1|Physician Decision|0|||
149727270|NCT01582308|540135508|FG002|10-day Washout Following Period 1|Physician Decision|0|||
149727271|NCT01582308|540135509|FG003|10-day Washout Following Period 1|Physician Decision|0|||
149727272|NCT01582308|540135510|FG004|10-day Washout Following Period 1|Physician Decision|1|||
149727273|NCT01582308|540135511|FG005|10-day Washout Following Period 1|Physician Decision|0|||
149727274|NCT01582308|540135512|FG006|10-day Washout Following Period 1|Physician Decision|0|||
149727275|NCT01582308|540135513|FG007|10-day Washout Following Period 1|Physician Decision|0|||
149727276|NCT01582308|540135514|FG008|10-day Washout Following Period 1|Physician Decision|0|||
149727277|NCT01582308|540135515|FG009|10-day Washout Following Period 1|Physician Decision|0|||
149727278|NCT01582308|540135506|FG000|Period 4|Physician Decision|1|||
149727279|NCT01582308|540135507|FG001|Period 4|Physician Decision|0|||
149727280|NCT01582308|540135508|FG002|Period 4|Physician Decision|0|||
149727281|NCT01582308|540135509|FG003|Period 4|Physician Decision|0|||
149727282|NCT01582308|540135510|FG004|Period 4|Physician Decision|0|||
149727283|NCT01582308|540135511|FG005|Period 4|Physician Decision|1|||
149727284|NCT01582308|540135512|FG006|Period 4|Physician Decision|0|||
149727285|NCT01582308|540135513|FG007|Period 4|Physician Decision|0|||
149727286|NCT01582308|540135514|FG008|Period 4|Physician Decision|0|||
149727287|NCT01582308|540135515|FG009|Period 4|Physician Decision|1|||
149727288|NCT03631706|540135522|FG000|Overall Study|Randomized, not treated|1|||
150251699|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
150251700|NCT00095056|542058272|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
150251701|NCT00095056|542058273|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
150251702|NCT00306670|542058277|FG000|Overall Study|patients recruited; Genentech, the st|0|||
150251703|NCT00306670|542058278|FG001|Overall Study|patients recruited; Genentech, the st|2|||
150251704|NCT00503139|542058279|FG000|Overall Study|Case Report Forms were not collected|4|||
150251705|NCT00503139|542058279|FG000|Overall Study|Protocol Violation|4|||
150251706|NCT02735577|542058283|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
150251707|NCT02735577|542058283|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
150251708|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
150251709|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
150251710|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
150251711|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
150251712|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
150251713|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
150251714|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
150251715|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
150251716|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
150251717|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
150251718|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
149727289|NCT03631706|540135523|FG001|Overall Study|Randomized, not treated|0|||
149727290|NCT01354028|540137573|FG000|Overall Study|Physician Decision|0|||
149727291|NCT01354028|540137574|FG001|Overall Study|Physician Decision|2|||
149727292|NCT01354028|540137573|FG000|Overall Study|Discharged before study start|2|||
149727293|NCT01354028|540137574|FG001|Overall Study|Discharged before study start|2|||
149727294|NCT01354028|540137573|FG000|Overall Study|No quiet alert state|0|||
149727295|NCT01354028|540137574|FG001|Overall Study|No quiet alert state|1|||
149727296|NCT00975156|540137575|FG000|Overall Study|Protocol Violation|0|||
150251719|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
149727297|NCT00975156|540137576|FG001|Overall Study|Protocol Violation|1|||
149727298|NCT03472560|540137579|FG000|Overall Study|Subject transfer to continuation protocol|0|||
149727299|NCT03472560|540137580|FG001|Overall Study|Subject transfer to continuation protocol|1|||
149727300|NCT03472560|540137579|FG000|Overall Study|Withdrawal by Subject|4|||
149727301|NCT03472560|540137580|FG001|Overall Study|Withdrawal by Subject|0|||
149727302|NCT03472560|540137579|FG000|Overall Study|Progressive disease|24|||
149727303|NCT03472560|540137580|FG001|Overall Study|Progressive disease|8|||
149727304|NCT03472560|540137579|FG000|Overall Study|Physician Decision|1|||
149727305|NCT03472560|540137580|FG001|Overall Study|Physician Decision|0|||
149727306|NCT03472560|540137579|FG000|Overall Study|Death|7|||
149727307|NCT03472560|540137580|FG001|Overall Study|Death|4|||
149727308|NCT03472560|540137579|FG000|Overall Study|Adverse Event|5|||
149727309|NCT03472560|540137580|FG001|Overall Study|Adverse Event|3|||
149727310|NCT03472560|540137579|FG000|Overall Study|Global deterioration of health status|0|||
149727311|NCT03472560|540137580|FG001|Overall Study|Global deterioration of health status|4|||
149727312|NCT01946178|540137581|FG000|Overall Study|Pregnancy|1|||
149727313|NCT01946178|540137581|FG000|Overall Study|Lost to Follow-up|1|||
149727314|NCT05425563|540137582|FG000|Overall Study|Withdrawal by Subject|17|||
149727315|NCT02494596|540137585|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149727316|NCT02494596|540137586|FG001|Overall Study|Insufficient Therapeutic Response|3|||
149727317|NCT02494596|540137587|FG002|Overall Study|Insufficient Therapeutic Response|1|||
149727318|NCT02494596|540137585|FG000|Overall Study|Adverse Event|0|||
149727319|NCT02494596|540137586|FG001|Overall Study|Adverse Event|1|||
149727320|NCT02494596|540137587|FG002|Overall Study|Adverse Event|0|||
149727321|NCT02494596|540137585|FG000|Overall Study|Refused Treatment|0|||
149727322|NCT02494596|540137586|FG001|Overall Study|Refused Treatment|1|||
149727323|NCT02494596|540137587|FG002|Overall Study|Refused Treatment|0|||
149727324|NCT02222714|540137588|FG000|Overall Study|Death|0|||
149727325|NCT02222714|540137589|FG001|Overall Study|Death|2|||
149727326|NCT02222714|540137590|FG002|Overall Study|Death|3|||
149727327|NCT02222714|540137591|FG003|Overall Study|Death|4|||
149727328|NCT02222714|540137592|FG004|Overall Study|Death|6|||
149727329|NCT02222714|540137588|FG000|Overall Study|Withdrawal by Subject|0|||
149727330|NCT02222714|540137589|FG001|Overall Study|Withdrawal by Subject|0|||
149727331|NCT02222714|540137590|FG002|Overall Study|Withdrawal by Subject|1|||
149727332|NCT02222714|540137591|FG003|Overall Study|Withdrawal by Subject|0|||
149727333|NCT02222714|540137592|FG004|Overall Study|Withdrawal by Subject|1|||
149727334|NCT01340209|540137595|FG000|Overall Study|Adverse Event|1|||
149727335|NCT01340209|540137596|FG001|Overall Study|Adverse Event|1|||
149727336|NCT01340209|540137597|FG002|Overall Study|Adverse Event|2|||
149727337|NCT01340209|540137595|FG000|Overall Study|Protocol Violation|1|||
149727338|NCT01340209|540137596|FG001|Overall Study|Protocol Violation|2|||
149727339|NCT01340209|540137597|FG002|Overall Study|Protocol Violation|1|||
149727340|NCT01340209|540137595|FG000|Overall Study|Withdrawal by Subject|0|||
149727341|NCT01340209|540137596|FG001|Overall Study|Withdrawal by Subject|0|||
149727342|NCT01340209|540137597|FG002|Overall Study|Withdrawal by Subject|1|||
149727343|NCT01340209|540137595|FG000|Overall Study|Other reason not defined above|3|||
149727344|NCT01340209|540137596|FG001|Overall Study|Other reason not defined above|5|||
149727345|NCT01340209|540137597|FG002|Overall Study|Other reason not defined above|4|||
149727346|NCT01537211|540137598|FG000|Overall Study|Lost to Follow-up|0|||
149727347|NCT01537211|540137599|FG001|Overall Study|Lost to Follow-up|1|||
149727348|NCT02161562|540137601|FG000|Overall Study|Withdrawal by Subject|5|||
150251720|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
150251721|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
150251722|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
150251723|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
150251724|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
150251725|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
150251726|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
150251727|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
150251728|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
150251729|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
150251730|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
150251731|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
149727349|NCT02161562|540137602|FG001|Overall Study|Withdrawal by Subject|8|||
149727350|NCT02161562|540137601|FG000|Overall Study|Protocol Violation|9|||
149727351|NCT02161562|540137602|FG001|Overall Study|Protocol Violation|4|||
149727352|NCT02161562|540137601|FG000|Overall Study|Pregnancy|1|||
149727353|NCT02161562|540137602|FG001|Overall Study|Pregnancy|2|||
149727354|NCT02161562|540137601|FG000|Overall Study|Lost to Follow-up|3|||
149727355|NCT02161562|540137602|FG001|Overall Study|Lost to Follow-up|1|||
149727356|NCT02161562|540137601|FG000|Overall Study|Lack of Efficacy|4|||
149727357|NCT02161562|540137602|FG001|Overall Study|Lack of Efficacy|1|||
150251732|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
149727358|NCT02161562|540137601|FG000|Overall Study|Adverse Event|1|||
149727359|NCT02161562|540137602|FG001|Overall Study|Adverse Event|1|||
150251733|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251734|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
150251735|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251736|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251737|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251738|NCT00833833|542058284|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
150251739|NCT00833833|542058285|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
150251740|NCT00833833|542058286|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
150251741|NCT00833833|542058287|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
150251742|NCT00833833|542058288|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
150251743|NCT00833833|542058289|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
149727360|NCT02161562|540137601|FG000|Overall Study|Participant moved back to home country|1|||
149727361|NCT02161562|540137602|FG001|Overall Study|Participant moved back to home country|0|||
149727362|NCT02161562|540137601|FG000|Overall Study|Withdrew due to being out of the country|1|||
149727363|NCT02161562|540137602|FG001|Overall Study|Withdrew due to being out of the country|0|||
149727364|NCT02161562|540137601|FG000|Overall Study|Participant moved out of province|1|||
149727365|NCT02161562|540137602|FG001|Overall Study|Participant moved out of province|0|||
149727366|NCT02450578|540137621|FG000|Overall Study|ECG abnormality so not treated|1|||
149727367|NCT02450578|540137622|FG001|Overall Study|ECG abnormality so not treated|0|||
149727368|NCT02450578|540137623|FG002|Overall Study|ECG abnormality so not treated|0|||
149727369|NCT02450578|540137624|FG003|Overall Study|ECG abnormality so not treated|0|||
149727370|NCT04428411|540137625|FG000|Overall Study|Lost to Follow-up|114|||
149727371|NCT02918019|540137626|FG000|Overall Study|Death|0|||
149727372|NCT02918019|540137627|FG001|Overall Study|Death|0|||
149727373|NCT02918019|540137628|FG002|Overall Study|Death|1|||
149727374|NCT02918019|540137629|FG003|Overall Study|Death|0|||
149727375|NCT02918019|540137626|FG000|Overall Study|Lost to Follow-up|1|||
149727376|NCT02918019|540137627|FG001|Overall Study|Lost to Follow-up|1|||
149727377|NCT02918019|540137628|FG002|Overall Study|Lost to Follow-up|0|||
149727378|NCT02918019|540137629|FG003|Overall Study|Lost to Follow-up|1|||
149727379|NCT02918019|540137626|FG000|Overall Study|Principal investigator request|0|||
149727380|NCT02918019|540137627|FG001|Overall Study|Principal investigator request|0|||
149727381|NCT02918019|540137628|FG002|Overall Study|Principal investigator request|0|||
149727382|NCT02918019|540137629|FG003|Overall Study|Principal investigator request|1|||
149727383|NCT02918019|540137626|FG000|Overall Study|Physician Decision|1|||
149727384|NCT02918019|540137627|FG001|Overall Study|Physician Decision|3|||
149727385|NCT02918019|540137628|FG002|Overall Study|Physician Decision|2|||
149727386|NCT02918019|540137629|FG003|Overall Study|Physician Decision|0|||
149727387|NCT02918019|540137626|FG000|Overall Study|Protocol deviation|1|||
149727388|NCT02918019|540137627|FG001|Overall Study|Protocol deviation|1|||
149727389|NCT02918019|540137628|FG002|Overall Study|Protocol deviation|0|||
149727390|NCT02918019|540137629|FG003|Overall Study|Protocol deviation|2|||
149727391|NCT02918019|540137626|FG000|Overall Study|Withdrawal by Subject|3|||
149727392|NCT02918019|540137627|FG001|Overall Study|Withdrawal by Subject|4|||
149727393|NCT02918019|540137628|FG002|Overall Study|Withdrawal by Subject|6|||
149727394|NCT02918019|540137629|FG003|Overall Study|Withdrawal by Subject|4|||
149727395|NCT02918019|540137626|FG000|Overall Study|Adverse Event|0|||
149727396|NCT02918019|540137627|FG001|Overall Study|Adverse Event|1|||
149727397|NCT02918019|540137628|FG002|Overall Study|Adverse Event|0|||
149727398|NCT02918019|540137629|FG003|Overall Study|Adverse Event|1|||
149727399|NCT00662792|540137630|FG000|Period 1|Personal Reasons|0|||
149727400|NCT00662792|540137631|FG001|Period 1|Personal Reasons|0|||
149727401|NCT00662792|540137632|FG002|Period 1|Personal Reasons|1|||
149727402|NCT00662792|540137633|FG003|Period 1|Personal Reasons|0|||
149727403|NCT00662792|540137630|FG000|Period 1|Refused continuing medication|0|||
149727404|NCT00662792|540137631|FG001|Period 1|Refused continuing medication|1|||
149727405|NCT00662792|540137632|FG002|Period 1|Refused continuing medication|1|||
149727406|NCT00662792|540137633|FG003|Period 1|Refused continuing medication|0|||
149727407|NCT00662792|540137630|FG000|Period 1|Lost to Follow-up|1|||
149727408|NCT00662792|540137631|FG001|Period 1|Lost to Follow-up|0|||
149727409|NCT00662792|540137632|FG002|Period 1|Lost to Follow-up|0|||
149727410|NCT00662792|540137633|FG003|Period 1|Lost to Follow-up|0|||
149727411|NCT00662792|540137630|FG000|Period 1|Other adverse event (AE)|0|||
149727412|NCT00662792|540137631|FG001|Period 1|Other adverse event (AE)|2|||
149727413|NCT00662792|540137632|FG002|Period 1|Other adverse event (AE)|0|||
149727414|NCT00662792|540137633|FG003|Period 1|Other adverse event (AE)|0|||
149727415|NCT00662792|540137630|FG000|Period 1|Worsening of disease under study (AE)|1|||
149727416|NCT00662792|540137631|FG001|Period 1|Worsening of disease under study (AE)|3|||
149727417|NCT00662792|540137632|FG002|Period 1|Worsening of disease under study (AE)|2|||
149727418|NCT00662792|540137633|FG003|Period 1|Worsening of disease under study (AE)|0|||
149727419|NCT00662792|540137630|FG000|Period 1|Not treated|0|||
149727420|NCT00662792|540137631|FG001|Period 1|Not treated|1|||
149727421|NCT00662792|540137632|FG002|Period 1|Not treated|0|||
149727422|NCT00662792|540137633|FG003|Period 1|Not treated|0|||
149727423|NCT00662792|540137630|FG000|Period 2|Worsening of disease under study|1|||
149727424|NCT00662792|540137631|FG001|Period 2|Worsening of disease under study|0|||
149727425|NCT00662792|540137632|FG002|Period 2|Worsening of disease under study|0|||
149727426|NCT00662792|540137633|FG003|Period 2|Worsening of disease under study|3|||
150251744|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
150251745|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
150251746|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
149727427|NCT00662792|540137630|FG000|Period 3|Refused continuing medication|1|||
149727428|NCT00662792|540137631|FG001|Period 3|Refused continuing medication|0|||
149727429|NCT00662792|540137632|FG002|Period 3|Refused continuing medication|1|||
149727430|NCT00662792|540137633|FG003|Period 3|Refused continuing medication|0|||
149727431|NCT00662792|540137630|FG000|Period 3|Other adverse event (AE)|0|||
149727432|NCT00662792|540137631|FG001|Period 3|Other adverse event (AE)|0|||
149727433|NCT00662792|540137632|FG002|Period 3|Other adverse event (AE)|1|||
149727434|NCT00662792|540137633|FG003|Period 3|Other adverse event (AE)|1|||
149727435|NCT00662792|540137630|FG000|Period 4|Refused continuing medication|0|||
149727436|NCT00662792|540137631|FG001|Period 4|Refused continuing medication|1|||
149727437|NCT00662792|540137632|FG002|Period 4|Refused continuing medication|0|||
149727438|NCT00662792|540137633|FG003|Period 4|Refused continuing medication|0|||
149727439|NCT00662792|540137630|FG000|Period 4|Other adverse event (AE)|1|||
149727440|NCT00662792|540137631|FG001|Period 4|Other adverse event (AE)|0|||
149727441|NCT00662792|540137632|FG002|Period 4|Other adverse event (AE)|0|||
149727442|NCT00662792|540137633|FG003|Period 4|Other adverse event (AE)|0|||
149727443|NCT00662792|540137630|FG000|Period 4|Worsening of disease under study (AE)|0|||
149727444|NCT00662792|540137631|FG001|Period 4|Worsening of disease under study (AE)|0|||
149727445|NCT00662792|540137632|FG002|Period 4|Worsening of disease under study (AE)|0|||
149727446|NCT00662792|540137633|FG003|Period 4|Worsening of disease under study (AE)|1|||
149727447|NCT01699087|540137634|FG000|Overall Study|Lost to Follow-up|7|||
149727448|NCT01699087|540137634|FG000|Overall Study|Screen failure (prior to treatment)|15|||
149727449|NCT01699087|540137634|FG000|Overall Study|Unable to make future visits|2|||
149727450|NCT00094757|540137637|FG000|Overall Study|Adverse Event|11|||
149727451|NCT00094757|540137638|FG001|Overall Study|Adverse Event|9|||
149727452|NCT00094757|540137639|FG002|Overall Study|Adverse Event|6|||
149727453|NCT00094757|540137637|FG000|Overall Study|Lack of Efficacy|11|||
149727454|NCT00094757|540137638|FG001|Overall Study|Lack of Efficacy|15|||
149727455|NCT00094757|540137639|FG002|Overall Study|Lack of Efficacy|8|||
149727456|NCT00094757|540137637|FG000|Overall Study|Lost to Follow-up|3|||
149727457|NCT00094757|540137638|FG001|Overall Study|Lost to Follow-up|5|||
149727458|NCT00094757|540137639|FG002|Overall Study|Lost to Follow-up|6|||
149727459|NCT00094757|540137637|FG000|Overall Study|Patient Moved|2|||
149727460|NCT00094757|540137638|FG001|Overall Study|Patient Moved|1|||
149727461|NCT00094757|540137639|FG002|Overall Study|Patient Moved|1|||
149727462|NCT00094757|540137637|FG000|Overall Study|Protocol Violation|8|||
149727463|NCT00094757|540137638|FG001|Overall Study|Protocol Violation|5|||
149727464|NCT00094757|540137639|FG002|Overall Study|Protocol Violation|3|||
149727465|NCT00094757|540137637|FG000|Overall Study|Withdrawal by Subject|14|||
149727466|NCT00094757|540137638|FG001|Overall Study|Withdrawal by Subject|21|||
149727467|NCT00094757|540137639|FG002|Overall Study|Withdrawal by Subject|5|||
149727468|NCT00094757|540137637|FG000|Overall Study|Other|3|||
149727469|NCT00094757|540137638|FG001|Overall Study|Other|3|||
149727470|NCT00094757|540137639|FG002|Overall Study|Other|1|||
149727471|NCT00094757|540137637|FG000|Overall Study|Protocol specified discontinuation|1|||
149727472|NCT00094757|540137638|FG001|Overall Study|Protocol specified discontinuation|3|||
149727473|NCT00094757|540137639|FG002|Overall Study|Protocol specified discontinuation|0|||
149727474|NCT03021642|540137640|FG000|Washout Period (21 Days)|Adverse Event|1|||
149727475|NCT03021642|540137641|FG001|Washout Period (21 Days)|Adverse Event|1|||
149727476|NCT00090545|540137645|FG000|Overall Study|Disease progression on study|21|||
149727477|NCT00090545|540137646|FG001|Overall Study|Disease progression on study|17|||
149727478|NCT00090545|540137645|FG000|Overall Study|Refused further treatment|1|||
149727479|NCT00090545|540137646|FG001|Overall Study|Refused further treatment|4|||
149727480|NCT00090545|540137645|FG000|Overall Study|Death|0|||
149727481|NCT00090545|540137646|FG001|Overall Study|Death|1|||
149727482|NCT00090545|540137645|FG000|Overall Study|Adverse Event|0|||
149727483|NCT00090545|540137646|FG001|Overall Study|Adverse Event|2|||
149727484|NCT02474082|540137647|FG000|Overall Study|Adverse Event|2|||
149727485|NCT02474082|540137648|FG001|Overall Study|Adverse Event|32|||
149727486|NCT02474082|540137647|FG000|Overall Study|Withdrawal of informed consent|1|||
149727487|NCT02474082|540137648|FG001|Overall Study|Withdrawal of informed consent|11|||
149727488|NCT02474082|540137647|FG000|Overall Study|Lost to Follow-up|2|||
149727489|NCT02474082|540137648|FG001|Overall Study|Lost to Follow-up|2|||
149727490|NCT02474082|540137647|FG000|Overall Study|Dose tapering not achieved|0|||
149727491|NCT02474082|540137648|FG001|Overall Study|Dose tapering not achieved|4|||
149727492|NCT02474082|540137647|FG000|Overall Study|Participant/guardian decision|1|||
149727493|NCT02474082|540137648|FG001|Overall Study|Participant/guardian decision|2|||
149727494|NCT02474082|540137647|FG000|Overall Study|Non-compliance with study treatment|0|||
149727495|NCT02474082|540137648|FG001|Overall Study|Non-compliance with study treatment|2|||
149727496|NCT02474082|540137647|FG000|Overall Study|Protocol deviation|0|||
149727497|NCT02474082|540137648|FG001|Overall Study|Protocol deviation|1|||
149727498|NCT01463098|540137649|FG000|Part A (11 Days)|Participant Choice|2|||
149727499|NCT01463098|540137650|FG001|Part A (11 Days)|Participant Choice|0|||
149727500|NCT01463098|540137651|FG002|Part A (11 Days)|Participant Choice|0|||
149727501|NCT01463098|540137652|FG003|Part A (11 Days)|Participant Choice|0|||
149727502|NCT01463098|540137653|FG004|Part A (11 Days)|Participant Choice|0|||
149727503|NCT01463098|540137654|FG005|Part A (11 Days)|Participant Choice|0|||
149727504|NCT01463098|540137655|FG006|Part A (11 Days)|Participant Choice|0|||
149727505|NCT01463098|540137656|FG007|Part A (11 Days)|Participant Choice|0|||
149727506|NCT01463098|540137657|FG008|Part A (11 Days)|Participant Choice|1|||
149727507|NCT01463098|540137658|FG009|Part A (11 Days)|Participant Choice|0|||
149727508|NCT01463098|540137659|FG010|Part A (11 Days)|Participant Choice|0|||
149727509|NCT01463098|540137660|FG011|Part A (11 Days)|Participant Choice|0|||
149727510|NCT01463098|540137661|FG012|Part A (11 Days)|Participant Choice|0|||
149727511|NCT01463098|540137662|FG013|Part A (11 Days)|Participant Choice|0|||
149727512|NCT01463098|540137649|FG000|Part A (11 Days)|Lost to Follow-up|0|||
149727513|NCT01463098|540137650|FG001|Part A (11 Days)|Lost to Follow-up|0|||
149727514|NCT01463098|540137651|FG002|Part A (11 Days)|Lost to Follow-up|0|||
149727515|NCT01463098|540137652|FG003|Part A (11 Days)|Lost to Follow-up|0|||
149727516|NCT01463098|540137653|FG004|Part A (11 Days)|Lost to Follow-up|1|||
149727517|NCT01463098|540137654|FG005|Part A (11 Days)|Lost to Follow-up|0|||
149727518|NCT01463098|540137655|FG006|Part A (11 Days)|Lost to Follow-up|0|||
149727519|NCT01463098|540137656|FG007|Part A (11 Days)|Lost to Follow-up|0|||
149727520|NCT01463098|540137657|FG008|Part A (11 Days)|Lost to Follow-up|0|||
149727521|NCT01463098|540137658|FG009|Part A (11 Days)|Lost to Follow-up|0|||
149727522|NCT01463098|540137659|FG010|Part A (11 Days)|Lost to Follow-up|0|||
149727523|NCT01463098|540137660|FG011|Part A (11 Days)|Lost to Follow-up|0|||
149727524|NCT01463098|540137661|FG012|Part A (11 Days)|Lost to Follow-up|0|||
149727525|NCT01463098|540137662|FG013|Part A (11 Days)|Lost to Follow-up|0|||
149727526|NCT01463098|540137649|FG000|Part B (11 Days)|Participant Choice|0|||
149727527|NCT01463098|540137650|FG001|Part B (11 Days)|Participant Choice|0|||
149727528|NCT01463098|540137651|FG002|Part B (11 Days)|Participant Choice|0|||
149727529|NCT01463098|540137652|FG003|Part B (11 Days)|Participant Choice|0|||
149727530|NCT01463098|540137653|FG004|Part B (11 Days)|Participant Choice|0|||
149727531|NCT01463098|540137654|FG005|Part B (11 Days)|Participant Choice|0|||
149727532|NCT01463098|540137655|FG006|Part B (11 Days)|Participant Choice|0|||
149727533|NCT01463098|540137656|FG007|Part B (11 Days)|Participant Choice|0|||
149727534|NCT01463098|540137657|FG008|Part B (11 Days)|Participant Choice|0|||
149727535|NCT01463098|540137658|FG009|Part B (11 Days)|Participant Choice|0|||
149727536|NCT01463098|540137659|FG010|Part B (11 Days)|Participant Choice|0|||
149727537|NCT01463098|540137660|FG011|Part B (11 Days)|Participant Choice|1|||
149727538|NCT01463098|540137661|FG012|Part B (11 Days)|Participant Choice|0|||
149727539|NCT01463098|540137662|FG013|Part B (11 Days)|Participant Choice|0|||
149727540|NCT01528787|540137665|FG000|Overall Study|Withdrawal by Subject|0|||
149727541|NCT01528787|540137666|FG001|Overall Study|Withdrawal by Subject|0|||
149727542|NCT01528787|540137667|FG002|Overall Study|Withdrawal by Subject|0|||
149727543|NCT01528787|540137668|FG003|Overall Study|Withdrawal by Subject|1|||
149727544|NCT01528787|540137665|FG000|Overall Study|Family Emergency|0|||
149727545|NCT01528787|540137666|FG001|Overall Study|Family Emergency|0|||
149727546|NCT01528787|540137667|FG002|Overall Study|Family Emergency|1|||
149727547|NCT01528787|540137668|FG003|Overall Study|Family Emergency|0|||
149727548|NCT03433781|540137669|FG000|Overall Study|Progression of Disease|1|||
149727549|NCT03433781|540137670|FG001|Overall Study|Progression of Disease|0|||
149727550|NCT03433781|540137671|FG002|Overall Study|Progression of Disease|0|||
149727551|NCT03433781|540137669|FG000|Overall Study|Physician Decision|0|||
149727552|NCT03433781|540137670|FG001|Overall Study|Physician Decision|1|||
149727553|NCT03433781|540137671|FG002|Overall Study|Physician Decision|0|||
149727554|NCT00797823|540137672|FG000|First Period (Initial Randomization)|Physician Decision|1|||
149727555|NCT00797823|540137673|FG001|First Period (Initial Randomization)|Physician Decision|0|||
149727556|NCT00797823|540137674|FG002|First Period (Initial Randomization)|Physician Decision|0|||
149727557|NCT02809833|540137675|FG000|Overall Study|Death|3|||
149727558|NCT02809833|540137675|FG000|Overall Study|Intolerance|54|||
149727559|NCT02809833|540137675|FG000|Overall Study|Lack of Efficacy|89|||
149727560|NCT02809833|540137675|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
149727561|NCT02809833|540137675|FG000|Overall Study|Noncompliance|1|||
149727562|NCT02809833|540137675|FG000|Overall Study|Withdrawal by Subject|34|||
149727563|NCT02809833|540137675|FG000|Overall Study|Lost to Follow-up|35|||
149727564|NCT02809833|540137675|FG000|Overall Study|Adverse Event (AE)|24|||
149727565|NCT02809833|540137675|FG000|Overall Study|Other|5|||
149727566|NCT02809833|540137675|FG000|Overall Study|Missing Information|52|||
149727567|NCT02971670|540137678|FG000|Overall Study|Withdrawal by Subject|4|||
149727568|NCT02971670|540137679|FG001|Overall Study|Withdrawal by Subject|1|||
149727569|NCT02971670|540137680|FG002|Overall Study|Withdrawal by Subject|1|||
149727570|NCT02971670|540137681|FG003|Overall Study|Withdrawal by Subject|2|||
149727571|NCT02793232|540137682|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727572|NCT02793232|540137683|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727573|NCT02793232|540137684|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727574|NCT02793232|540137685|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727575|NCT02793232|540137686|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
149727576|NCT02793232|540137687|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727577|NCT02793232|540137688|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
149727578|NCT02793232|540137689|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727579|NCT02793232|540137690|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149727580|NCT04849780|540137691|FG000|Period 1|Covid-19 Related|1|||
149727581|NCT04849780|540137692|FG001|Period 1|Covid-19 Related|0|||
149727582|NCT04849780|540137691|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
149727583|NCT04849780|540137692|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
150251747|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
150251748|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
150251749|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
150251750|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
150251751|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
150251752|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
150251753|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
149727584|NCT04849780|540137691|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
149727585|NCT04849780|540137692|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
149727586|NCT03979274|540137699|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149727587|NCT03979274|540137700|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149727588|NCT02302963|540137701|FG000|Overall Study|Withdrawal by Subject|2|||
149727589|NCT02302963|540137702|FG001|Overall Study|Withdrawal by Subject|1|||
149727590|NCT02302963|540137701|FG000|Overall Study|Steroid injection|0|||
149727591|NCT02302963|540137702|FG001|Overall Study|Steroid injection|1|||
149727592|NCT02302963|540137701|FG000|Overall Study|Physician Decision|1|||
149727593|NCT02302963|540137702|FG001|Overall Study|Physician Decision|0|||
149727594|NCT00603915|540137708|FG000|Overall Study|Physician Decision|1|||
149727595|NCT03687502|540137709|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
149727596|NCT03687502|540137709|FG000|Overall Study|Lumason not available|1|||
149727597|NCT01724528|540137710|FG000|Overall Study|Death|3|||
149727598|NCT01724528|540137711|FG001|Overall Study|Death|0|||
149727599|NCT01724528|540137710|FG000|Overall Study|Withdrawal by Subject|0|||
149727600|NCT01724528|540137711|FG001|Overall Study|Withdrawal by Subject|2|||
150251754|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
149727601|NCT01724528|540137710|FG000|Overall Study|Protocol Violation|0|||
149727602|NCT01724528|540137711|FG001|Overall Study|Protocol Violation|1|||
149727603|NCT01724528|540137710|FG000|Overall Study|Patient refused to attend last visit|1|||
149727604|NCT01724528|540137711|FG001|Overall Study|Patient refused to attend last visit|0|||
149727605|NCT05574062|540137715|FG000|Pre Run-In|Screening failure|3|||
149727606|NCT05574062|540137716|FG001|Pre Run-In|Screening failure|0|||
149727607|NCT05574062|540137717|FG002|Pre Run-In|Screening failure|0|||
149727608|NCT05574062|540137718|FG003|Pre Run-In|Screening failure|0|||
149727609|NCT05574062|540137719|FG004|Pre Run-In|Screening failure|0|||
149727610|NCT05574062|540137715|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
149727611|NCT05574062|540137716|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
149727612|NCT05574062|540137717|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
149727613|NCT05574062|540137718|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
149727614|NCT05574062|540137719|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
149727615|NCT05574062|540137715|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
149727616|NCT05574062|540137716|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
149727617|NCT05574062|540137717|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
149727618|NCT05574062|540137718|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
149727619|NCT05574062|540137719|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
149727620|NCT05574062|540137715|FG000|Continuation Phase Period 1|Physician Decision|1|||
149727621|NCT05574062|540137716|FG001|Continuation Phase Period 1|Physician Decision|0|||
149727622|NCT05574062|540137717|FG002|Continuation Phase Period 1|Physician Decision|0|||
149727623|NCT05574062|540137718|FG003|Continuation Phase Period 1|Physician Decision|0|||
149727624|NCT05574062|540137719|FG004|Continuation Phase Period 1|Physician Decision|0|||
149727625|NCT05574062|540137715|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
149727626|NCT05574062|540137716|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
149727627|NCT05574062|540137717|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
149727628|NCT05574062|540137718|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
149727629|NCT05574062|540137719|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
149727630|NCT05574062|540137715|FG000|Continuation Phase Period 1|Adverse Event|1|||
149727631|NCT05574062|540137716|FG001|Continuation Phase Period 1|Adverse Event|0|||
149727632|NCT05574062|540137717|FG002|Continuation Phase Period 1|Adverse Event|0|||
149727633|NCT05574062|540137718|FG003|Continuation Phase Period 1|Adverse Event|0|||
149727634|NCT05574062|540137719|FG004|Continuation Phase Period 1|Adverse Event|0|||
149727635|NCT05574062|540137715|FG000|Continuation Phase Period 1|Death|1|||
149727636|NCT05574062|540137716|FG001|Continuation Phase Period 1|Death|0|||
149727637|NCT05574062|540137717|FG002|Continuation Phase Period 1|Death|0|||
149727638|NCT05574062|540137718|FG003|Continuation Phase Period 1|Death|0|||
149727639|NCT05574062|540137719|FG004|Continuation Phase Period 1|Death|0|||
149727640|NCT05574062|540137715|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
149727641|NCT05574062|540137716|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
149727642|NCT05574062|540137717|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
149727643|NCT05574062|540137718|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
149727644|NCT05574062|540137719|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
149727645|NCT04820309|540137722|FG000|Overall Study|Adverse Event|96|||
149727646|NCT04820309|540137722|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
149727647|NCT04820309|540137722|FG000|Overall Study|Consent Withdrawn|93|||
149727648|NCT04820309|540137722|FG000|Overall Study|failure to adhere to protocol|32|||
149727649|NCT04820309|540137722|FG000|Overall Study|alcohol or drug use|6|||
149727650|NCT04820309|540137722|FG000|Overall Study|Lost to Follow-up|46|||
149727651|NCT04820309|540137722|FG000|Overall Study|Death|2|||
149727652|NCT04820309|540137722|FG000|Overall Study|Pregnancy|1|||
149727653|NCT04820309|540137722|FG000|Overall Study|Other reasons|12|||
149727654|NCT04811716|540137727|FG000|Overall Study|Withdrawal by Subject|2|||
149727655|NCT04811716|540137728|FG001|Overall Study|Withdrawal by Subject|0|||
149727656|NCT03864653|540137729|FG000|Overall Study|Withdrawal by Subject|1|||
149727657|NCT03048422|540137730|FG000|Overall Study|Death|1|||
149727658|NCT03048422|540137731|FG001|Overall Study|Death|0|||
149727659|NCT03048422|540137732|FG002|Overall Study|Death|0|||
149727660|NCT03048422|540137730|FG000|Overall Study|Lost to Follow-up|5|||
149727661|NCT03048422|540137731|FG001|Overall Study|Lost to Follow-up|0|||
149727662|NCT03048422|540137732|FG002|Overall Study|Lost to Follow-up|1|||
149727663|NCT03048422|540137730|FG000|Overall Study|Withdrawal by Subject|5|||
149727664|NCT03048422|540137731|FG001|Overall Study|Withdrawal by Subject|7|||
149727665|NCT03048422|540137732|FG002|Overall Study|Withdrawal by Subject|4|||
149727666|NCT03048422|540137730|FG000|Overall Study|Moved|3|||
149727667|NCT03048422|540137731|FG001|Overall Study|Moved|2|||
149727668|NCT03048422|540137732|FG002|Overall Study|Moved|2|||
149727669|NCT03048422|540137730|FG000|Overall Study|Noncompliant with Study Requirements|2|||
149727670|NCT03048422|540137731|FG001|Overall Study|Noncompliant with Study Requirements|1|||
149727671|NCT03048422|540137732|FG002|Overall Study|Noncompliant with Study Requirements|2|||
149727672|NCT03048422|540137730|FG000|Overall Study|Not Able to Get to Clinic|1|||
149727673|NCT03048422|540137731|FG001|Overall Study|Not Able to Get to Clinic|0|||
149727674|NCT03048422|540137732|FG002|Overall Study|Not Able to Get to Clinic|0|||
149727675|NCT01928381|540137733|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
149727676|NCT01928381|540137734|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727677|NCT01928381|540137735|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727678|NCT01928381|540137736|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727679|NCT01928381|540137737|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727680|NCT01928381|540137738|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727681|NCT01928381|540137739|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149727682|NCT01928381|540137733|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
149727683|NCT01928381|540137734|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
149727684|NCT01928381|540137735|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
149727685|NCT01928381|540137736|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
149727686|NCT01928381|540137737|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
149727687|NCT01928381|540137738|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
149727688|NCT01928381|540137739|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
149727689|NCT01928381|540137733|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
149727690|NCT01928381|540137734|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727691|NCT01928381|540137735|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727692|NCT01928381|540137736|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727693|NCT01928381|540137737|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727694|NCT01928381|540137738|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727695|NCT01928381|540137739|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
149727696|NCT01928381|540137733|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
149727697|NCT01928381|540137734|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
149727698|NCT01928381|540137735|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
149727699|NCT01928381|540137736|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
149727700|NCT01928381|540137737|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
149727701|NCT01928381|540137738|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
149727702|NCT01928381|540137739|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
149727703|NCT01928381|540137733|FG000|Part 1 - Pain Training|Protocol Violation|1|||
149727704|NCT01928381|540137734|FG001|Part 1 - Pain Training|Protocol Violation|0|||
149727705|NCT01928381|540137735|FG002|Part 1 - Pain Training|Protocol Violation|0|||
149727706|NCT01928381|540137736|FG003|Part 1 - Pain Training|Protocol Violation|0|||
149727707|NCT01928381|540137737|FG004|Part 1 - Pain Training|Protocol Violation|0|||
149727708|NCT01928381|540137738|FG005|Part 1 - Pain Training|Protocol Violation|0|||
149727709|NCT01928381|540137739|FG006|Part 1 - Pain Training|Protocol Violation|0|||
149727710|NCT01928381|540137733|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
149727711|NCT01928381|540137734|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727712|NCT01928381|540137735|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727713|NCT01928381|540137736|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727714|NCT01928381|540137737|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727715|NCT01928381|540137738|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727716|NCT01928381|540137739|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149727717|NCT01928381|540137733|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
149727718|NCT01928381|540137734|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727719|NCT01928381|540137735|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727720|NCT01928381|540137736|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727721|NCT01928381|540137737|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727722|NCT01928381|540137738|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727723|NCT01928381|540137739|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149727724|NCT01928381|540137733|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
149727725|NCT01928381|540137734|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727726|NCT01928381|540137735|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727727|NCT01928381|540137736|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727728|NCT01928381|540137737|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727729|NCT01928381|540137738|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727730|NCT01928381|540137739|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149727731|NCT01928381|540137733|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
149727732|NCT01928381|540137734|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727733|NCT01928381|540137735|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727734|NCT01928381|540137736|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727735|NCT01928381|540137737|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727736|NCT01928381|540137738|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727737|NCT01928381|540137739|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149727738|NCT01928381|540137733|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727739|NCT01928381|540137734|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727740|NCT01928381|540137735|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
149727741|NCT01928381|540137736|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727742|NCT01928381|540137737|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727743|NCT01928381|540137738|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727744|NCT01928381|540137739|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
149727745|NCT01928381|540137733|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727746|NCT01928381|540137734|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727747|NCT01928381|540137735|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
149727748|NCT01928381|540137736|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727749|NCT01928381|540137737|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727750|NCT01928381|540137738|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727751|NCT01928381|540137739|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149727752|NCT01928381|540137733|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
149727753|NCT01928381|540137734|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
149727754|NCT01928381|540137735|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
149727755|NCT01928381|540137736|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
149727756|NCT01928381|540137737|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
149727757|NCT01928381|540137738|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
149727758|NCT01928381|540137739|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
149727759|NCT01928381|540137733|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
149727760|NCT01928381|540137734|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
149727761|NCT01928381|540137735|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
149727762|NCT01928381|540137736|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
149727763|NCT01928381|540137737|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
149727764|NCT01928381|540137738|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
149727765|NCT01928381|540137739|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
149727766|NCT01928381|540137733|FG000|Washout First Intervention|Protocol Violation|0|||
149727767|NCT01928381|540137734|FG001|Washout First Intervention|Protocol Violation|0|||
150251755|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
150251756|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
150251757|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
150251758|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
150251759|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
150251760|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
149727768|NCT01928381|540137735|FG002|Washout First Intervention|Protocol Violation|0|||
149727769|NCT01928381|540137736|FG003|Washout First Intervention|Protocol Violation|0|||
150251761|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
149727770|NCT01928381|540137737|FG004|Washout First Intervention|Protocol Violation|1|||
149727771|NCT01928381|540137738|FG005|Washout First Intervention|Protocol Violation|0|||
149727772|NCT01928381|540137739|FG006|Washout First Intervention|Protocol Violation|0|||
149727773|NCT01928381|540137733|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
149727774|NCT01928381|540137734|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
149727775|NCT01928381|540137735|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
149727776|NCT01928381|540137736|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
149727777|NCT01928381|540137737|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
150251762|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251763|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251764|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149727778|NCT01928381|540137738|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
149727779|NCT01928381|540137739|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
149727780|NCT01928381|540137733|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727781|NCT01928381|540137734|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727782|NCT01928381|540137735|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
149727783|NCT01928381|540137736|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727784|NCT01928381|540137737|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727785|NCT01928381|540137738|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727786|NCT01928381|540137739|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
149727787|NCT03406897|540137740|FG000|Overall Study|Lost to Follow-up|1|||
149727788|NCT03406897|540137741|FG001|Overall Study|Lost to Follow-up|2|||
149727789|NCT03406897|540137740|FG000|Overall Study|Withdrawal by Subject|4|||
149727790|NCT03406897|540137741|FG001|Overall Study|Withdrawal by Subject|4|||
149727791|NCT03406897|540137740|FG000|Overall Study|Physician Decision|0|||
149727792|NCT03406897|540137741|FG001|Overall Study|Physician Decision|1|||
149727793|NCT04484285|540139163|FG000|Overall Study|Unable to operate stimulator|3|||
149727794|NCT04484285|540139164|FG001|Overall Study|Unable to operate stimulator|0|||
149727795|NCT01227902|540139166|FG000|Overall Study|Adverse Event|12|||
149727796|NCT01227902|540139167|FG001|Overall Study|Adverse Event|8|||
149727797|NCT01227902|540139168|FG002|Overall Study|Adverse Event|11|||
149727798|NCT01227902|540139169|FG003|Overall Study|Adverse Event|4|||
149727799|NCT01227902|540139166|FG000|Overall Study|Lack of Efficacy|1|||
149727800|NCT01227902|540139167|FG001|Overall Study|Lack of Efficacy|2|||
149727801|NCT01227902|540139168|FG002|Overall Study|Lack of Efficacy|2|||
149727802|NCT01227902|540139169|FG003|Overall Study|Lack of Efficacy|1|||
149727803|NCT01227902|540139166|FG000|Overall Study|Protocol Violation|1|||
149727804|NCT01227902|540139167|FG001|Overall Study|Protocol Violation|0|||
149727805|NCT01227902|540139168|FG002|Overall Study|Protocol Violation|0|||
149727806|NCT01227902|540139169|FG003|Overall Study|Protocol Violation|0|||
149727807|NCT01227902|540139166|FG000|Overall Study|Lost to Follow-up|0|||
149727808|NCT01227902|540139167|FG001|Overall Study|Lost to Follow-up|0|||
149727809|NCT01227902|540139168|FG002|Overall Study|Lost to Follow-up|1|||
149727810|NCT01227902|540139169|FG003|Overall Study|Lost to Follow-up|2|||
149727811|NCT01227902|540139166|FG000|Overall Study|Physician Decision|0|||
149727812|NCT01227902|540139167|FG001|Overall Study|Physician Decision|1|||
149727813|NCT01227902|540139168|FG002|Overall Study|Physician Decision|1|||
149727814|NCT01227902|540139169|FG003|Overall Study|Physician Decision|0|||
149727815|NCT01227902|540139166|FG000|Overall Study|Withdrawal by Subject|4|||
149727816|NCT01227902|540139167|FG001|Overall Study|Withdrawal by Subject|2|||
149727817|NCT01227902|540139168|FG002|Overall Study|Withdrawal by Subject|4|||
149727818|NCT01227902|540139169|FG003|Overall Study|Withdrawal by Subject|3|||
149727819|NCT05280756|540139170|FG000|Overall Study|Lost to Follow-up|1|||
149727820|NCT05280756|540139171|FG001|Overall Study|Lost to Follow-up|1|||
149727821|NCT02363478|540139172|FG000|Overall Study|Lost to Follow-up|4|||
149727822|NCT02363478|540139172|FG000|Overall Study|Adverse Event|4|||
149727823|NCT00768898|540139173|FG000|Overall Study|Unrelated injury|1|||
149727824|NCT00768898|540139173|FG000|Overall Study|Headache|1|||
149727825|NCT02527707|540139174|FG000|Overall Study|Adverse Event|1|||
149727826|NCT02527707|540139174|FG000|Overall Study|Adverse Event|1|||
149727827|NCT00930059|540139175|FG000|Overall Study|Death|1|||
149727828|NCT00930059|540139176|FG001|Overall Study|Death|0|||
149727829|NCT00930059|540139175|FG000|Overall Study|Did not meet entrance criteria|1|||
149727830|NCT00930059|540139176|FG001|Overall Study|Did not meet entrance criteria|1|||
149727831|NCT00930059|540139175|FG000|Overall Study|Withdrawal by Subject|3|||
149727832|NCT00930059|540139176|FG001|Overall Study|Withdrawal by Subject|4|||
149727833|NCT00930059|540139175|FG000|Overall Study|Other|1|||
149727834|NCT00930059|540139176|FG001|Overall Study|Other|0|||
149727835|NCT00930059|540139175|FG000|Overall Study|1 site terminated by sponsor|1|||
149727836|NCT00930059|540139176|FG001|Overall Study|1 site terminated by sponsor|1|||
149727837|NCT00930059|540139175|FG000|Overall Study|Adverse Event|1|||
149727838|NCT00930059|540139176|FG001|Overall Study|Adverse Event|6|||
149727839|NCT01299766|540139177|FG000|Overall Study|Death|5|||
149727840|NCT01299766|540139178|FG001|Overall Study|Death|4|||
149727841|NCT01299766|540139177|FG000|Overall Study|Withdrawal by Subject|29|||
149727842|NCT01299766|540139178|FG001|Overall Study|Withdrawal by Subject|19|||
149727843|NCT04002310|540139179|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
149727844|NCT04002310|540139180|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
149727845|NCT04002310|540139181|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
149727846|NCT04002310|540139182|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
149727847|NCT04002310|540139183|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
149727848|NCT00542997|540139184|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
149727849|NCT00542997|540139184|FG000|Wash in / Wash Out Period|Adverse Event|3|||
149727850|NCT00542997|540139184|FG000|Efficacy Period|Adverse Event|3|||
149727851|NCT00352534|540139185|FG000|Initial Staging|Ineligible|8|||
149727852|NCT00352534|540139186|FG001|Initial Staging|Ineligible|9|||
149727853|NCT00352534|540139187|FG002|Initial Staging|Ineligible|0|||
149727854|NCT00352534|540139188|FG003|Initial Staging|Ineligible|0|||
149727855|NCT00352534|540139189|FG004|Initial Staging|Ineligible|0|||
149727856|NCT00352534|540139190|FG005|Initial Staging|Ineligible|0|||
149727857|NCT00352534|540139191|FG006|Initial Staging|Ineligible|0|||
149727858|NCT00352534|540139185|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
149727859|NCT00352534|540139186|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
149727860|NCT00352534|540139187|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
149727861|NCT00352534|540139188|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
149727862|NCT00352534|540139189|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
149727863|NCT00352534|540139190|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
149727864|NCT00352534|540139191|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
149727865|NCT00352534|540139185|FG000|Final Risk Group Assignment|Physician Decision|0|||
149727866|NCT00352534|540139186|FG001|Final Risk Group Assignment|Physician Decision|0|||
149727867|NCT00352534|540139187|FG002|Final Risk Group Assignment|Physician Decision|0|||
149727868|NCT00352534|540139188|FG003|Final Risk Group Assignment|Physician Decision|0|||
149727869|NCT00352534|540139189|FG004|Final Risk Group Assignment|Physician Decision|0|||
149727870|NCT00352534|540139190|FG005|Final Risk Group Assignment|Physician Decision|8|||
149727871|NCT00352534|540139191|FG006|Final Risk Group Assignment|Physician Decision|0|||
149727872|NCT00352534|540139185|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727873|NCT00352534|540139186|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727874|NCT00352534|540139187|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727875|NCT00352534|540139188|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727876|NCT00352534|540139189|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727877|NCT00352534|540139190|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
149727878|NCT00352534|540139191|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
149727879|NCT00352534|540139185|FG000|Final Risk Group Assignment|Ineligible|0|||
149727880|NCT00352534|540139186|FG001|Final Risk Group Assignment|Ineligible|0|||
149727881|NCT00352534|540139187|FG002|Final Risk Group Assignment|Ineligible|3|||
149727882|NCT00352534|540139188|FG003|Final Risk Group Assignment|Ineligible|1|||
149727883|NCT00352534|540139189|FG004|Final Risk Group Assignment|Ineligible|0|||
149727884|NCT00352534|540139190|FG005|Final Risk Group Assignment|Ineligible|13|||
149727885|NCT00352534|540139191|FG006|Final Risk Group Assignment|Ineligible|0|||
149727886|NCT00352534|540139185|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727887|NCT00352534|540139186|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727888|NCT00352534|540139187|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727889|NCT00352534|540139188|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727890|NCT00352534|540139189|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727891|NCT00352534|540139190|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149727892|NCT00352534|540139191|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
149727893|NCT00352534|540139185|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727894|NCT00352534|540139186|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727895|NCT00352534|540139187|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727896|NCT00352534|540139188|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727897|NCT00352534|540139189|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727898|NCT00352534|540139190|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149727899|NCT00352534|540139191|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
149727900|NCT00352534|540139185|FG000|Final Risk Group Assignment|Death|0|||
149727901|NCT00352534|540139186|FG001|Final Risk Group Assignment|Death|0|||
149727902|NCT00352534|540139187|FG002|Final Risk Group Assignment|Death|0|||
149727903|NCT00352534|540139188|FG003|Final Risk Group Assignment|Death|0|||
149727904|NCT00352534|540139189|FG004|Final Risk Group Assignment|Death|0|||
149727905|NCT00352534|540139190|FG005|Final Risk Group Assignment|Death|2|||
149727906|NCT00352534|540139191|FG006|Final Risk Group Assignment|Death|0|||
149727907|NCT00544869|540139194|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
149727908|NCT00544869|540139195|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
149727909|NCT00544869|540139196|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
149727910|NCT00544869|540139194|FG000|Overall Study|Adverse Event|6|||
149727911|NCT00544869|540139195|FG001|Overall Study|Adverse Event|1|||
149727912|NCT00544869|540139196|FG002|Overall Study|Adverse Event|0|||
149727913|NCT00544869|540139194|FG000|Overall Study|Lack of Efficacy|1|||
149727914|NCT00544869|540139195|FG001|Overall Study|Lack of Efficacy|1|||
149727915|NCT00544869|540139196|FG002|Overall Study|Lack of Efficacy|0|||
149727916|NCT00544869|540139194|FG000|Overall Study|Physician Decision|2|||
149727917|NCT00544869|540139195|FG001|Overall Study|Physician Decision|0|||
149727918|NCT00544869|540139196|FG002|Overall Study|Physician Decision|0|||
149727919|NCT00619502|540139207|FG000|Overall Study|Lost to Follow-up|8|||
149727920|NCT00619502|540139208|FG001|Overall Study|Lost to Follow-up|10|||
149727921|NCT01777763|540139209|FG000|Overall Study|Adverse Event|2|||
149727922|NCT01777763|540139210|FG001|Overall Study|Adverse Event|32|||
149727923|NCT01777763|540139209|FG000|Overall Study|Protocol Violation|1|||
149727924|NCT01777763|540139210|FG001|Overall Study|Protocol Violation|7|||
149727925|NCT01777763|540139209|FG000|Overall Study|Withdrawal by Subject|0|||
149727926|NCT01777763|540139210|FG001|Overall Study|Withdrawal by Subject|2|||
149727927|NCT01777763|540139209|FG000|Overall Study|Treatment Failure|1|||
149727928|NCT01777763|540139210|FG001|Overall Study|Treatment Failure|6|||
149727929|NCT03968419|540139211|FG000|Treatment Period|Adverse Event|0|||
149727930|NCT03968419|540139212|FG001|Treatment Period|Adverse Event|0|||
149727931|NCT03968419|540139213|FG002|Treatment Period|Adverse Event|1|||
149727932|NCT03968419|540139211|FG000|Safety Follow-up Period|Death|3|||
149727933|NCT03968419|540139212|FG001|Safety Follow-up Period|Death|2|||
149727934|NCT03968419|540139213|FG002|Safety Follow-up Period|Death|1|||
149727935|NCT03968419|540139211|FG000|Safety Follow-up Period|Subject Decision|2|||
149727936|NCT03968419|540139212|FG001|Safety Follow-up Period|Subject Decision|1|||
149727937|NCT03968419|540139213|FG002|Safety Follow-up Period|Subject Decision|0|||
149727938|NCT00935883|540139216|FG000|Treatment Period|Physician Decision|1|||
150251765|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
150251766|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
150251767|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
150251768|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
150251769|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
150251770|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
150251771|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
150251772|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
150251773|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
150251774|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
150251775|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
150251776|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
150251777|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
150251778|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
150251779|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
149727939|NCT00935883|540139217|FG001|Treatment Period|Physician Decision|0|||
149727940|NCT00935883|540139216|FG000|Treatment Period|Withdrawal by Subject|0|||
149727941|NCT00935883|540139217|FG001|Treatment Period|Withdrawal by Subject|2|||
149727942|NCT01641939|540139220|FG000|Overall Study|Death|90|||
149727943|NCT01641939|540139221|FG001|Overall Study|Death|187|||
149727944|NCT01641939|540139222|FG002|Overall Study|Death|61|||
149727945|NCT01641939|540139220|FG000|Overall Study|Lost to Follow-up|3|||
149727946|NCT01641939|540139221|FG001|Overall Study|Lost to Follow-up|2|||
149727947|NCT01641939|540139222|FG002|Overall Study|Lost to Follow-up|1|||
149727948|NCT01641939|540139220|FG000|Overall Study|Withdrawal by Subject|14|||
149727949|NCT01641939|540139221|FG001|Overall Study|Withdrawal by Subject|11|||
149727950|NCT01641939|540139222|FG002|Overall Study|Withdrawal by Subject|5|||
149727951|NCT01641939|540139220|FG000|Overall Study|Study Terminated by Sponsor|10|||
149727952|NCT01641939|540139221|FG001|Overall Study|Study Terminated by Sponsor|28|||
149727953|NCT01641939|540139222|FG002|Overall Study|Study Terminated by Sponsor|3|||
149727954|NCT02894840|540139223|FG000|Overall Study|Lost to Follow-up|1|||
149727955|NCT02894840|540139224|FG001|Overall Study|Lost to Follow-up|0|||
149727956|NCT02894840|540139225|FG002|Overall Study|Lost to Follow-up|3|||
149727957|NCT02894840|540139226|FG003|Overall Study|Lost to Follow-up|0|||
149727958|NCT00804687|540139230|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
149727959|NCT00804687|540139231|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
149727960|NCT00804687|540139232|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
149727961|NCT00804687|540139233|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
149727962|NCT00804687|540139234|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
149727963|NCT00804687|540139235|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
149727964|NCT00804687|540139230|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
149727965|NCT00804687|540139231|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
149727966|NCT00804687|540139232|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
149727967|NCT00804687|540139233|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
149727968|NCT00804687|540139234|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
149727969|NCT00804687|540139235|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
149727970|NCT00804687|540139230|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
150251780|NCT00833833|542058284|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
150251781|NCT00833833|542058285|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149727971|NCT00804687|540139231|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
149727972|NCT00804687|540139232|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
149727973|NCT00804687|540139233|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
149727974|NCT00804687|540139234|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
149727975|NCT00804687|540139235|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
149727976|NCT00804687|540139230|FG000|Period 5: Treatment Period|Positive drug test|1|||
149727977|NCT00804687|540139231|FG001|Period 5: Treatment Period|Positive drug test|0|||
149727978|NCT00804687|540139232|FG002|Period 5: Treatment Period|Positive drug test|0|||
149727979|NCT00804687|540139233|FG003|Period 5: Treatment Period|Positive drug test|0|||
149727980|NCT00804687|540139234|FG004|Period 5: Treatment Period|Positive drug test|0|||
149727981|NCT00804687|540139235|FG005|Period 5: Treatment Period|Positive drug test|0|||
149727982|NCT02397473|540139241|FG000|Treatment Phase|Adverse Event|1|||
149727983|NCT02397473|540139242|FG001|Treatment Phase|Adverse Event|2|||
149727984|NCT02397473|540139241|FG000|Treatment Phase|Lack of Efficacy|8|||
149727985|NCT02397473|540139242|FG001|Treatment Phase|Lack of Efficacy|1|||
149727986|NCT02397473|540139241|FG000|Treatment Phase|Lost to Follow-up|1|||
149727987|NCT02397473|540139242|FG001|Treatment Phase|Lost to Follow-up|0|||
149727988|NCT02397473|540139241|FG000|Treatment Phase|Withdrawal by Subject|2|||
149727989|NCT02397473|540139242|FG001|Treatment Phase|Withdrawal by Subject|1|||
149727990|NCT02397473|540139241|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
149727991|NCT02397473|540139242|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
149727992|NCT02397473|540139241|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
149727993|NCT02397473|540139242|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
149727994|NCT02397473|540139241|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
149727995|NCT02397473|540139242|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
149727996|NCT02397473|540139241|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
149727997|NCT02397473|540139242|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
149727998|NCT02397473|540139241|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
149727999|NCT02397473|540139242|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
149728000|NCT00343512|540139249|FG000|Overall Study|Withdrawal by Subject|2|||
149728001|NCT00323557|540139250|FG000|Overall Study|Physician Decision|1|||
149728002|NCT00323557|540139251|FG001|Overall Study|Physician Decision|0|||
149728003|NCT00197054|540139252|FG000|Overall Study|Withdrawal by Subject|9|||
149728004|NCT00197054|540139253|FG001|Overall Study|Withdrawal by Subject|3|||
149728005|NCT00197054|540139254|FG002|Overall Study|Withdrawal by Subject|3|||
149728006|NCT00197054|540139252|FG000|Overall Study|Moved from area|7|||
149728007|NCT00197054|540139253|FG001|Overall Study|Moved from area|14|||
149728008|NCT00197054|540139254|FG002|Overall Study|Moved from area|9|||
149728009|NCT00197054|540139252|FG000|Overall Study|Lost to Follow-up|1|||
149728010|NCT00197054|540139253|FG001|Overall Study|Lost to Follow-up|4|||
149728011|NCT00197054|540139254|FG002|Overall Study|Lost to Follow-up|0|||
149728012|NCT00684515|540139255|FG000|Overall Study|Adverse Event|3|||
149728013|NCT00684515|540139256|FG001|Overall Study|Adverse Event|3|||
149728014|NCT00684515|540139257|FG002|Overall Study|Adverse Event|1|||
149728015|NCT00684515|540139255|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
149728016|NCT00684515|540139256|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
149728017|NCT00684515|540139257|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
149728018|NCT01580397|540139258|FG000|Overall Study|Lack of Efficacy|14|||
149728019|NCT01405053|540139261|FG000|Overall Study|Adverse Event|3|||
149728020|NCT01405053|540139262|FG001|Overall Study|Adverse Event|0|||
149728021|NCT01405053|540139261|FG000|Overall Study|Lost to Follow-up|0|||
149728022|NCT01405053|540139262|FG001|Overall Study|Lost to Follow-up|1|||
149728023|NCT01405053|540139261|FG000|Overall Study|Participant choice|2|||
149728024|NCT01405053|540139262|FG001|Overall Study|Participant choice|1|||
149728025|NCT01405053|540139261|FG000|Overall Study|Inadequate therapeutic effect|2|||
149728026|NCT01405053|540139262|FG001|Overall Study|Inadequate therapeutic effect|1|||
149728027|NCT01405053|540139261|FG000|Overall Study|Withdrawal by Subject|3|||
149728028|NCT01405053|540139262|FG001|Overall Study|Withdrawal by Subject|4|||
149728029|NCT01405053|540139261|FG000|Overall Study|Other|0|||
149728030|NCT01405053|540139262|FG001|Overall Study|Other|1|||
149728031|NCT00357500|540139276|FG000|Overall Study|Adverse Event|3|||
149728032|NCT00357500|540139276|FG000|Overall Study|Withdrawal by Subject|5|||
149728033|NCT00357500|540139276|FG000|Overall Study|Progressive Disease|65|||
149728034|NCT00357500|540139276|FG000|Overall Study|Not Started Protocol Therapy|4|||
149728035|NCT02301403|540139277|FG000|Overall Study|Withdrawal by Subject|28|||
149728036|NCT02301403|540139278|FG001|Overall Study|Withdrawal by Subject|41|||
149728037|NCT01060059|540139281|FG000|Overall Study|Adverse Event|1|||
149728038|NCT01060059|540139282|FG001|Overall Study|Adverse Event|1|||
149728039|NCT01060059|540139281|FG000|Overall Study|Death|2|||
149728040|NCT01060059|540139282|FG001|Overall Study|Death|3|||
149728041|NCT01060059|540139281|FG000|Overall Study|Lost to Follow-up|18|||
149728042|NCT01060059|540139282|FG001|Overall Study|Lost to Follow-up|34|||
149728043|NCT01060059|540139281|FG000|Overall Study|entry criteria not met|4|||
150251782|NCT00833833|542058286|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149728044|NCT01060059|540139282|FG001|Overall Study|entry criteria not met|3|||
149728045|NCT01060059|540139281|FG000|Overall Study|Withdrawal by Subject|35|||
149728046|NCT01060059|540139282|FG001|Overall Study|Withdrawal by Subject|23|||
149728047|NCT01060059|540139281|FG000|Overall Study|lack of glycemic control|2|||
149728048|NCT01060059|540139282|FG001|Overall Study|lack of glycemic control|1|||
149728049|NCT01060059|540139281|FG000|Overall Study|lack of compliance|5|||
149728050|NCT01060059|540139282|FG001|Overall Study|lack of compliance|2|||
149728051|NCT01614093|540139285|FG000|Overall Study|Withdrawal by Subject|1|||
149728052|NCT01816243|540139286|FG000|Overall Study|Adverse Event|6|||
149728053|NCT01816243|540139286|FG000|Overall Study|Lost to Follow-up|1|||
149728054|NCT01816243|540139286|FG000|Overall Study|Lack of Efficacy|1|||
149728055|NCT01816243|540139286|FG000|Overall Study|Not eligible for the study|1|||
149728056|NCT01816243|540139286|FG000|Overall Study|Amputation|3|||
149728057|NCT01920711|540139287|FG000|Overall Study|Death|347|||
149728058|NCT01920711|540139288|FG001|Overall Study|Death|356|||
149728059|NCT01920711|540139287|FG000|Overall Study|Lost to Follow-up|13|||
149728060|NCT01920711|540139288|FG001|Overall Study|Lost to Follow-up|14|||
149728061|NCT01920711|540139287|FG000|Overall Study|Withdrawal by Subject|4|||
149728062|NCT01920711|540139288|FG001|Overall Study|Withdrawal by Subject|3|||
149728063|NCT01777581|540139294|FG000|Overall Study|Lost to Follow-up|1|||
149728064|NCT01777581|540139295|FG001|Overall Study|Lost to Follow-up|1|||
149728065|NCT01777581|540139294|FG000|Overall Study|Adverse Event|2|||
149728066|NCT01777581|540139295|FG001|Overall Study|Adverse Event|0|||
149728067|NCT01777581|540139294|FG000|Overall Study|Lack of Efficacy|0|||
149728068|NCT01777581|540139295|FG001|Overall Study|Lack of Efficacy|1|||
149728069|NCT05702736|540139296|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
149728070|NCT05702736|540139297|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
149728071|NCT05702736|540139296|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
149728072|NCT05702736|540139297|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
149728073|NCT02321436|540139298|FG000|Overall Study|Withdrawal by Subject|1|||
149728074|NCT02321436|540139299|FG001|Overall Study|Withdrawal by Subject|0|||
149728075|NCT02321436|540139298|FG000|Overall Study|Lost to Follow-up|0|||
149728076|NCT02321436|540139299|FG001|Overall Study|Lost to Follow-up|1|||
149728077|NCT00546052|540139300|FG000|Overall Study|Adverse Event|47|||
149728078|NCT00546052|540139300|FG000|Overall Study|Lost to Follow-up|144|||
149728079|NCT00546052|540139300|FG000|Overall Study|Protocol Violation|9|||
149728080|NCT00546052|540139300|FG000|Overall Study|Withdrawal by Subject|20|||
149728081|NCT00546052|540139300|FG000|Overall Study|Non Compliance|7|||
149728082|NCT00772668|540139303|FG000|Overall Study|Physician Decision|3|||
149728083|NCT00865020|540139309|FG000|Overall Study|Withdrawal by Subject|22|||
149728084|NCT00865020|540139310|FG001|Overall Study|Withdrawal by Subject|16|||
149728085|NCT00865020|540139309|FG000|Overall Study|Adverse Event|9|||
149728086|NCT00865020|540139310|FG001|Overall Study|Adverse Event|14|||
149728087|NCT00865020|540139309|FG000|Overall Study|Abnormal test procedure result(s)|6|||
149728088|NCT00865020|540139310|FG001|Overall Study|Abnormal test procedure result(s)|8|||
149728089|NCT00865020|540139309|FG000|Overall Study|Lost to Follow-up|6|||
149728090|NCT00865020|540139310|FG001|Overall Study|Lost to Follow-up|4|||
149728091|NCT00865020|540139309|FG000|Overall Study|Protocol deviation|4|||
149728092|NCT00865020|540139310|FG001|Overall Study|Protocol deviation|1|||
149728093|NCT00865020|540139309|FG000|Overall Study|Administrative problems|0|||
149728094|NCT00865020|540139310|FG001|Overall Study|Administrative problems|2|||
149728095|NCT00865020|540139309|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149728096|NCT00865020|540139310|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149728097|NCT00865020|540139309|FG000|Overall Study|Death|0|||
149728098|NCT00865020|540139310|FG001|Overall Study|Death|1|||
149728099|NCT00865020|540139309|FG000|Overall Study|Randomized but discontinued|2|||
149728100|NCT00865020|540139310|FG001|Overall Study|Randomized but discontinued|4|||
149728101|NCT01001702|540140922|FG000|Overall Study|Lost to Follow-up|7|||
149728102|NCT01001702|540140922|FG000|Overall Study|Adverse Event|7|||
149728103|NCT01001702|540140922|FG000|Overall Study|Sponsor Discontinued Study|4|||
149728104|NCT01001702|540140922|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
149728105|NCT01001702|540140922|FG000|Overall Study|Investigator withdrew Subject|10|||
149728106|NCT01001702|540140922|FG000|Overall Study|Withdrawal by Subject|19|||
149728107|NCT01001702|540140922|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
149728108|NCT02624492|540140924|FG000|Overall Study|Adverse Event|2|||
149728109|NCT02624492|540140925|FG001|Overall Study|Adverse Event|2|||
149728110|NCT02624492|540140926|FG002|Overall Study|Adverse Event|2|||
149728111|NCT02624492|540140924|FG000|Overall Study|Progressive disease|0|||
149728112|NCT02624492|540140925|FG001|Overall Study|Progressive disease|2|||
149728113|NCT02624492|540140926|FG002|Overall Study|Progressive disease|3|||
149728114|NCT01163786|540140929|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
149728115|NCT01163786|540140929|FG000|Treatment With Bortezomib|Adverse Event|2|||
149728116|NCT01163786|540140929|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
149728117|NCT00634569|540140930|FG000|Overall Study|Withdrawal by Subject|0|||
149728118|NCT00634569|540140931|FG001|Overall Study|Withdrawal by Subject|4|||
149728119|NCT00634569|540140930|FG000|Overall Study|Physician Decision|0|||
149728120|NCT00634569|540140931|FG001|Overall Study|Physician Decision|1|||
149728121|NCT01212185|540140932|FG000|Overall Study|Protocol Violation|2|||
149728122|NCT01212185|540140933|FG001|Overall Study|Protocol Violation|1|||
149728123|NCT02167945|540140934|FG000|Overall Study|Adverse Event|16|||
149728124|NCT02167945|540140934|FG000|Overall Study|Withdrew Consent|42|||
149728125|NCT02167945|540140934|FG000|Overall Study|Lost to Follow-up|122|||
149728126|NCT02167945|540140934|FG000|Overall Study|COVID-19 logistical restrictions|6|||
149728127|NCT02167945|540140934|FG000|Overall Study|Other, not specified|63|||
149728128|NCT01192347|540140935|FG000|Overall Study|Death|3|||
149728129|NCT01192347|540140935|FG000|Overall Study|Lost to Follow-up|3|||
149728130|NCT01192347|540140935|FG000|Overall Study|Withdrawal by Subject|1|||
149728131|NCT01192347|540140935|FG000|Overall Study|Adverse Event|1|||
149728132|NCT01192347|540140935|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
149728133|NCT01192347|540140935|FG000|Overall Study|Patient seen in different hospital|1|||
149728134|NCT01192347|540140935|FG000|Overall Study|Patient not visiting hospital regularly|1|||
149728135|NCT01192347|540140935|FG000|Overall Study|Patient did not show up for visits|1|||
149728136|NCT02623335|540140936|FG000|Overall Study|Death|8|||
149728137|NCT02623335|540140937|FG001|Overall Study|Death|7|||
149728138|NCT02623335|540140936|FG000|Overall Study|Lost to Follow-up|15|||
149728139|NCT02623335|540140937|FG001|Overall Study|Lost to Follow-up|23|||
149728140|NCT02623335|540140936|FG000|Overall Study|Withdrawal by Subject|2|||
149728141|NCT02623335|540140937|FG001|Overall Study|Withdrawal by Subject|5|||
149728142|NCT02623335|540140936|FG000|Overall Study|Protocol Violation|2|||
149728143|NCT02623335|540140937|FG001|Overall Study|Protocol Violation|1|||
149728144|NCT00395967|540140938|FG000|Treatment Period|Failed Mobilization|1|||
149728145|NCT00395967|540140938|FG000|Follow-up Period|Death|1|||
149728146|NCT00395967|540140938|FG000|Follow-up Period|Lost to Follow-up|1|||
149728147|NCT02400255|540140939|FG000|Overall Study|Relapse|4|||
149728148|NCT02400255|540140940|FG001|Overall Study|Relapse|1|||
149728149|NCT02400255|540140941|FG002|Overall Study|Relapse|1|||
149728150|NCT02400255|540140942|FG003|Overall Study|Relapse|2|||
149728151|NCT02400255|540140939|FG000|Overall Study|Adverse Event|6|||
149728152|NCT02400255|540140940|FG001|Overall Study|Adverse Event|3|||
149728153|NCT02400255|540140941|FG002|Overall Study|Adverse Event|0|||
149728154|NCT02400255|540140942|FG003|Overall Study|Adverse Event|0|||
149728155|NCT02400255|540140939|FG000|Overall Study|Physician Decision|6|||
149728156|NCT02400255|540140940|FG001|Overall Study|Physician Decision|0|||
149728157|NCT02400255|540140941|FG002|Overall Study|Physician Decision|0|||
149728158|NCT02400255|540140942|FG003|Overall Study|Physician Decision|0|||
149728159|NCT02400255|540140939|FG000|Overall Study|Loss of insurance|1|||
149728160|NCT02400255|540140940|FG001|Overall Study|Loss of insurance|0|||
149728161|NCT02400255|540140941|FG002|Overall Study|Loss of insurance|0|||
149728162|NCT02400255|540140942|FG003|Overall Study|Loss of insurance|0|||
149728163|NCT02568046|540140943|FG000|Overall Study|Adverse Event|0|||
149728164|NCT02568046|540140944|FG001|Overall Study|Adverse Event|1|||
149728165|NCT02568046|540140943|FG000|Overall Study|Death|2|||
149728166|NCT02568046|540140944|FG001|Overall Study|Death|0|||
149728167|NCT02568046|540140943|FG000|Overall Study|Progressive Disease|1|||
149728168|NCT02568046|540140944|FG001|Overall Study|Progressive Disease|0|||
149728169|NCT02568046|540140943|FG000|Overall Study|Withdrawal by Subject|2|||
149728170|NCT02568046|540140944|FG001|Overall Study|Withdrawal by Subject|1|||
149728171|NCT02568046|540140943|FG000|Overall Study|Other Events|0|||
149728172|NCT02568046|540140944|FG001|Overall Study|Other Events|1|||
150251783|NCT00833833|542058287|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149728173|NCT00523991|540140945|FG000|Overall Study|Adverse Event|6|||
149728174|NCT00523991|540140946|FG001|Overall Study|Adverse Event|5|||
149728175|NCT00523991|540140945|FG000|Overall Study|Protocol Violation|1|||
149728176|NCT00523991|540140946|FG001|Overall Study|Protocol Violation|4|||
149728177|NCT00523991|540140945|FG000|Overall Study|Lost to Follow-up|4|||
149728178|NCT00523991|540140946|FG001|Overall Study|Lost to Follow-up|1|||
149728179|NCT00523991|540140945|FG000|Overall Study|Withdrawal by Subject|7|||
149728180|NCT00523991|540140946|FG001|Overall Study|Withdrawal by Subject|17|||
149728181|NCT00523991|540140945|FG000|Overall Study|Other reason (not specified)|3|||
149728182|NCT00523991|540140946|FG001|Overall Study|Other reason (not specified)|0|||
149728183|NCT03261531|540140947|FG000|Overall Study|Withdrawal by Subject|4|||
149728184|NCT01700192|540140948|FG000|Overall Study|Adverse Event|73|||
149728185|NCT01700192|540140949|FG001|Overall Study|Adverse Event|18|||
149728186|NCT01700192|540140948|FG000|Overall Study|Lack of Efficacy|1|||
149728187|NCT01700192|540140949|FG001|Overall Study|Lack of Efficacy|0|||
149728188|NCT01700192|540140948|FG000|Overall Study|Lost to Follow-up|42|||
149728189|NCT01700192|540140949|FG001|Overall Study|Lost to Follow-up|29|||
149728190|NCT01700192|540140948|FG000|Overall Study|Noncompliance with study drug|0|||
149728191|NCT01700192|540140949|FG001|Overall Study|Noncompliance with study drug|5|||
149728192|NCT01700192|540140948|FG000|Overall Study|Physician Decision|2|||
149728193|NCT01700192|540140949|FG001|Overall Study|Physician Decision|3|||
149728194|NCT01700192|540140948|FG000|Overall Study|Pregnancy|1|||
149728195|NCT01700192|540140949|FG001|Overall Study|Pregnancy|4|||
149728196|NCT01700192|540140948|FG000|Overall Study|Progressive disease|1|||
149728197|NCT01700192|540140949|FG001|Overall Study|Progressive disease|0|||
149728198|NCT01700192|540140948|FG000|Overall Study|Protocol Violation|3|||
149728199|NCT01700192|540140949|FG001|Overall Study|Protocol Violation|4|||
149728200|NCT01700192|540140948|FG000|Overall Study|Technical problems|0|||
149728201|NCT01700192|540140949|FG001|Overall Study|Technical problems|1|||
149728202|NCT01700192|540140948|FG000|Overall Study|Withdrawal by Subject|56|||
149728203|NCT01700192|540140949|FG001|Overall Study|Withdrawal by Subject|64|||
149728204|NCT01700192|540140948|FG000|Overall Study|Never received study drug|1|||
149728205|NCT01700192|540140949|FG001|Overall Study|Never received study drug|0|||
149728206|NCT00744874|540140951|FG000|Overall Study|Lost to Follow-up|1|||
149728207|NCT00744874|540140951|FG000|Overall Study|Withdrawal by Subject|1|||
149728208|NCT00744874|540140951|FG000|Overall Study|Study Device not available at procedure|1|||
149728209|NCT00744874|540140951|FG000|Overall Study|Unable to accomodate schedule|1|||
149728210|NCT00379795|540140957|FG000|Overall Study|Death|31|||
149728211|NCT00379795|540140958|FG001|Overall Study|Death|8|||
149728212|NCT00379795|540140959|FG002|Overall Study|Death|6|||
149728213|NCT00379795|540140960|FG003|Overall Study|Death|4|||
149728214|NCT00379795|540140961|FG004|Overall Study|Death|7|||
149728215|NCT00379795|540140957|FG000|Overall Study|Adverse Event|17|||
149728216|NCT00379795|540140958|FG001|Overall Study|Adverse Event|3|||
149728217|NCT00379795|540140959|FG002|Overall Study|Adverse Event|3|||
149728218|NCT00379795|540140960|FG003|Overall Study|Adverse Event|1|||
149728219|NCT00379795|540140961|FG004|Overall Study|Adverse Event|4|||
149728220|NCT00379795|540140957|FG000|Overall Study|Lost to Follow-up|8|||
149728221|NCT00379795|540140958|FG001|Overall Study|Lost to Follow-up|1|||
149728222|NCT00379795|540140959|FG002|Overall Study|Lost to Follow-up|2|||
149728223|NCT00379795|540140960|FG003|Overall Study|Lost to Follow-up|1|||
149728224|NCT00379795|540140961|FG004|Overall Study|Lost to Follow-up|4|||
149728225|NCT00379795|540140957|FG000|Overall Study|Physician Decision|25|||
149728226|NCT00379795|540140958|FG001|Overall Study|Physician Decision|0|||
149728227|NCT00379795|540140959|FG002|Overall Study|Physician Decision|2|||
149728228|NCT00379795|540140960|FG003|Overall Study|Physician Decision|2|||
149728229|NCT00379795|540140961|FG004|Overall Study|Physician Decision|2|||
149728230|NCT00379795|540140957|FG000|Overall Study|Withdrawal by Subject|94|||
149728231|NCT00379795|540140958|FG001|Overall Study|Withdrawal by Subject|11|||
149728232|NCT00379795|540140959|FG002|Overall Study|Withdrawal by Subject|19|||
149728233|NCT00379795|540140960|FG003|Overall Study|Withdrawal by Subject|7|||
149728234|NCT00379795|540140961|FG004|Overall Study|Withdrawal by Subject|14|||
149728235|NCT00379795|540140957|FG000|Overall Study|Subject non-compliance|7|||
149728236|NCT00379795|540140958|FG001|Overall Study|Subject non-compliance|2|||
149728237|NCT00379795|540140959|FG002|Overall Study|Subject non-compliance|0|||
149728238|NCT00379795|540140960|FG003|Overall Study|Subject non-compliance|0|||
149728239|NCT00379795|540140961|FG004|Overall Study|Subject non-compliance|1|||
149728240|NCT00379795|540140957|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
149728241|NCT00379795|540140958|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149728242|NCT00379795|540140959|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149728243|NCT00379795|540140960|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
149728244|NCT00379795|540140961|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149728245|NCT00379795|540140957|FG000|Overall Study|Subjects condition mandated intervention|34|||
149728246|NCT00379795|540140958|FG001|Overall Study|Subjects condition mandated intervention|9|||
149728247|NCT00379795|540140959|FG002|Overall Study|Subjects condition mandated intervention|7|||
149728248|NCT00379795|540140960|FG003|Overall Study|Subjects condition mandated intervention|5|||
149728249|NCT00379795|540140961|FG004|Overall Study|Subjects condition mandated intervention|7|||
149728250|NCT00379795|540140957|FG000|Overall Study|Sponsor's decision|257|||
149728251|NCT00379795|540140958|FG001|Overall Study|Sponsor's decision|17|||
149728252|NCT00379795|540140959|FG002|Overall Study|Sponsor's decision|54|||
149728253|NCT00379795|540140960|FG003|Overall Study|Sponsor's decision|47|||
149728254|NCT00379795|540140961|FG004|Overall Study|Sponsor's decision|10|||
149728255|NCT00763321|540140962|FG000|Open-label Period|Adverse Event|24|||
149728256|NCT00763321|540140963|FG001|Open-label Period|Adverse Event|0|||
149728257|NCT00763321|540140964|FG002|Open-label Period|Adverse Event|0|||
149728258|NCT00763321|540140962|FG000|Open-label Period|Lost to Follow-up|14|||
150251784|NCT00833833|542058288|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149728259|NCT00763321|540140963|FG001|Open-label Period|Lost to Follow-up|0|||
149728260|NCT00763321|540140964|FG002|Open-label Period|Lost to Follow-up|0|||
149728261|NCT00763321|540140962|FG000|Open-label Period|Withdrawal by Subject|7|||
149728262|NCT00763321|540140963|FG001|Open-label Period|Withdrawal by Subject|0|||
149728263|NCT00763321|540140964|FG002|Open-label Period|Withdrawal by Subject|0|||
149728264|NCT00763321|540140962|FG000|Open-label Period|Subject noncompliant|7|||
149728265|NCT00763321|540140963|FG001|Open-label Period|Subject noncompliant|0|||
149728266|NCT00763321|540140964|FG002|Open-label Period|Subject noncompliant|0|||
149728267|NCT00763321|540140962|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
149728268|NCT00763321|540140963|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
149728269|NCT00763321|540140964|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
149728270|NCT00763321|540140962|FG000|Open-label Period|Lack of Efficacy|2|||
149728271|NCT00763321|540140963|FG001|Open-label Period|Lack of Efficacy|0|||
149728272|NCT00763321|540140964|FG002|Open-label Period|Lack of Efficacy|0|||
149728273|NCT00763321|540140962|FG000|Open-label Period|Other|4|||
149728274|NCT00763321|540140963|FG001|Open-label Period|Other|0|||
149728275|NCT00763321|540140964|FG002|Open-label Period|Other|0|||
149728276|NCT00763321|540140962|FG000|Double-blind Period|Lack of Efficacy|0|||
149728277|NCT00763321|540140963|FG001|Double-blind Period|Lack of Efficacy|9|||
149728278|NCT00763321|540140964|FG002|Double-blind Period|Lack of Efficacy|17|||
149728279|NCT00763321|540140962|FG000|Double-blind Period|Adverse Event|0|||
149728280|NCT00763321|540140963|FG001|Double-blind Period|Adverse Event|4|||
149728281|NCT00763321|540140964|FG002|Double-blind Period|Adverse Event|4|||
149728282|NCT00763321|540140962|FG000|Double-blind Period|Lost to Follow-up|0|||
149728283|NCT00763321|540140963|FG001|Double-blind Period|Lost to Follow-up|4|||
149728284|NCT00763321|540140964|FG002|Double-blind Period|Lost to Follow-up|2|||
149728285|NCT00763321|540140962|FG000|Double-blind Period|Withdrawal by Subject|0|||
149728286|NCT00763321|540140963|FG001|Double-blind Period|Withdrawal by Subject|2|||
149728287|NCT00763321|540140964|FG002|Double-blind Period|Withdrawal by Subject|3|||
149728288|NCT00763321|540140962|FG000|Double-blind Period|Other|0|||
149728289|NCT00763321|540140963|FG001|Double-blind Period|Other|2|||
149728290|NCT00763321|540140964|FG002|Double-blind Period|Other|3|||
149728291|NCT03175549|540140965|FG000|Overall Study|Lost to Follow-up|2|||
149728292|NCT03175549|540140966|FG001|Overall Study|Lost to Follow-up|2|||
149728293|NCT03175549|540140965|FG000|Overall Study|Medication non-compliance|2|||
149728294|NCT03175549|540140966|FG001|Overall Study|Medication non-compliance|2|||
149728295|NCT02435849|540140967|FG000|Overall Study|Death|23|||
149728296|NCT02435849|540140968|FG001|Overall Study|Death|0|||
149728297|NCT02435849|540140967|FG000|Overall Study|Lack of Efficacy|10|||
149728298|NCT02435849|540140968|FG001|Overall Study|Lack of Efficacy|0|||
149728299|NCT02435849|540140967|FG000|Overall Study|New therapy for study indication|8|||
149728300|NCT02435849|540140968|FG001|Overall Study|New therapy for study indication|0|||
149728301|NCT02435849|540140967|FG000|Overall Study|Subject/guardian decision|5|||
149728302|NCT02435849|540140968|FG001|Overall Study|Subject/guardian decision|1|||
149728303|NCT02435849|540140967|FG000|Overall Study|Lost to Follow-up|1|||
149728304|NCT02435849|540140968|FG001|Overall Study|Lost to Follow-up|0|||
149728305|NCT02435849|540140967|FG000|Overall Study|Physician Decision|1|||
149728306|NCT02435849|540140968|FG001|Overall Study|Physician Decision|0|||
149728307|NCT02486757|540140969|FG000|Overall Study|Lost to Follow-up|1|||
149728308|NCT00725075|540140970|FG000|Overall Study|Use of Excluded Medication|0|||
149728309|NCT00725075|540140971|FG001|Overall Study|Use of Excluded Medication|1|||
149728310|NCT00725075|540140972|FG002|Overall Study|Use of Excluded Medication|0|||
149728311|NCT00725075|540140970|FG000|Overall Study|Protocol Violation|0|||
149728312|NCT00725075|540140971|FG001|Overall Study|Protocol Violation|0|||
149728313|NCT00725075|540140972|FG002|Overall Study|Protocol Violation|1|||
149728314|NCT00725075|540140970|FG000|Overall Study|Lost to Follow-up|1|||
149728315|NCT00725075|540140971|FG001|Overall Study|Lost to Follow-up|0|||
149728316|NCT00725075|540140972|FG002|Overall Study|Lost to Follow-up|0|||
149728317|NCT00725075|540140970|FG000|Overall Study|Withdrawal by Subject|4|||
149728318|NCT00725075|540140971|FG001|Overall Study|Withdrawal by Subject|5|||
149728319|NCT00725075|540140972|FG002|Overall Study|Withdrawal by Subject|4|||
149728320|NCT00725075|540140970|FG000|Overall Study|Adverse Event|2|||
149728321|NCT00725075|540140971|FG001|Overall Study|Adverse Event|1|||
149728322|NCT00725075|540140972|FG002|Overall Study|Adverse Event|1|||
149728323|NCT00725075|540140970|FG000|Overall Study|Worsening of Disease|2|||
149728324|NCT00725075|540140971|FG001|Overall Study|Worsening of Disease|1|||
149728325|NCT00725075|540140972|FG002|Overall Study|Worsening of Disease|2|||
149728326|NCT00725075|540140970|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
149728327|NCT00725075|540140971|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
149728328|NCT00725075|540140972|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
149728329|NCT00725075|540140970|FG000|Overall Study|Other|1|||
149728330|NCT00725075|540140971|FG001|Overall Study|Other|0|||
149728331|NCT00725075|540140972|FG002|Overall Study|Other|0|||
149728332|NCT00352105|540140973|FG000|Overall Study|Death|5|||
149728333|NCT00352105|540140973|FG000|Overall Study|Withdrawal by Subject|5|||
149728334|NCT00352105|540140973|FG000|Overall Study|Lack of Efficacy|9|||
149728335|NCT00352105|540140973|FG000|Overall Study|Adverse Event|19|||
149728336|NCT00352105|540140973|FG000|Overall Study|Protocol Violation|2|||
149728337|NCT02979431|540140974|FG000|Overall Study|Parent/guardian withdrew consent|2|||
149728338|NCT02979431|540140975|FG001|Overall Study|Parent/guardian withdrew consent|1|||
149728339|NCT02979431|540140976|FG002|Overall Study|Parent/guardian withdrew consent|1|||
149728340|NCT02979431|540140977|FG003|Overall Study|Parent/guardian withdrew consent|1|||
149728341|NCT02979431|540140974|FG000|Overall Study|Randomized but received no study drug|1|||
149728342|NCT02979431|540140975|FG001|Overall Study|Randomized but received no study drug|1|||
149728343|NCT02979431|540140976|FG002|Overall Study|Randomized but received no study drug|0|||
149728344|NCT02979431|540140977|FG003|Overall Study|Randomized but received no study drug|0|||
149728345|NCT02979431|540140974|FG000|Overall Study|Adverse Event|0|||
149728346|NCT02979431|540140975|FG001|Overall Study|Adverse Event|0|||
149728347|NCT02979431|540140976|FG002|Overall Study|Adverse Event|1|||
149728348|NCT02979431|540140977|FG003|Overall Study|Adverse Event|0|||
149728349|NCT02979431|540140974|FG000|Overall Study|Subject left country after Day14|1|||
149728350|NCT02979431|540140975|FG001|Overall Study|Subject left country after Day14|0|||
149728351|NCT02979431|540140976|FG002|Overall Study|Subject left country after Day14|0|||
149728352|NCT02979431|540140977|FG003|Overall Study|Subject left country after Day14|0|||
149728353|NCT01656434|540140978|FG000|Overall Study|Adverse Event|199|||
149728354|NCT01656434|540140979|FG001|Overall Study|Adverse Event|63|||
149728355|NCT01656434|540140978|FG000|Overall Study|Enrollment terminated at trial site|2|||
149728356|NCT01656434|540140979|FG001|Overall Study|Enrollment terminated at trial site|0|||
149728357|NCT01656434|540140978|FG000|Overall Study|Lost to Follow-up|309|||
149728358|NCT01656434|540140979|FG001|Overall Study|Lost to Follow-up|76|||
149728359|NCT01656434|540140978|FG000|Overall Study|Site discontinued study participation|24|||
149728360|NCT01656434|540140979|FG001|Overall Study|Site discontinued study participation|9|||
149728361|NCT01656434|540140978|FG000|Overall Study|Screen failure|2|||
149728362|NCT01656434|540140979|FG001|Overall Study|Screen failure|0|||
149728363|NCT01656434|540140978|FG000|Overall Study|Protocol Violation|7|||
149728364|NCT01656434|540140979|FG001|Overall Study|Protocol Violation|0|||
149728365|NCT01656434|540140978|FG000|Overall Study|Pregnancy wish|18|||
149728366|NCT01656434|540140979|FG001|Overall Study|Pregnancy wish|6|||
149728367|NCT01656434|540140978|FG000|Overall Study|Pregnancy|45|||
149728368|NCT01656434|540140979|FG001|Overall Study|Pregnancy|10|||
149728369|NCT01656434|540140978|FG000|Overall Study|Physician Decision|7|||
149728370|NCT01656434|540140979|FG001|Overall Study|Physician Decision|2|||
149728371|NCT01656434|540140978|FG000|Overall Study|Non-compliance with study drug|48|||
149728372|NCT01656434|540140979|FG001|Overall Study|Non-compliance with study drug|9|||
149728373|NCT01656434|540140978|FG000|Overall Study|Study terminated by sponsor|1501|||
149728374|NCT01656434|540140979|FG001|Overall Study|Study terminated by sponsor|348|||
149728375|NCT01656434|540140978|FG000|Overall Study|Participant discontinued; drug related|13|||
149728376|NCT01656434|540140979|FG001|Overall Study|Participant discontinued; drug related|4|||
149728377|NCT01656434|540140978|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
149728378|NCT01656434|540140979|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
149728379|NCT01656434|540140978|FG000|Overall Study|Non-compliance with protocol|39|||
149728380|NCT01656434|540140979|FG001|Overall Study|Non-compliance with protocol|15|||
149728381|NCT01656434|540140978|FG000|Overall Study|Participant moved|40|||
149728382|NCT01656434|540140979|FG001|Overall Study|Participant moved|12|||
149728383|NCT01656434|540140978|FG000|Overall Study|Participant withdrew consent|28|||
149728384|NCT01656434|540140979|FG001|Overall Study|Participant withdrew consent|9|||
149728385|NCT01656434|540140978|FG000|Overall Study|Withdrawal by Subject|64|||
149728386|NCT01656434|540140979|FG001|Overall Study|Withdrawal by Subject|7|||
149728387|NCT01235962|540140980|FG000|Overall Study|Withdrawal by Subject|20|||
149728388|NCT01235962|540140981|FG001|Overall Study|Withdrawal by Subject|19|||
149728389|NCT01235962|540140982|FG002|Overall Study|Withdrawal by Subject|62|||
149728390|NCT01235962|540140983|FG003|Overall Study|Withdrawal by Subject|49|||
149728391|NCT01235962|540140980|FG000|Overall Study|Lost to Follow-up|21|||
150251785|NCT00833833|542058289|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
149728392|NCT01235962|540140981|FG001|Overall Study|Lost to Follow-up|16|||
149728393|NCT01235962|540140982|FG002|Overall Study|Lost to Follow-up|47|||
149728394|NCT01235962|540140983|FG003|Overall Study|Lost to Follow-up|32|||
149728395|NCT01235962|540140980|FG000|Overall Study|Physician Decision|5|||
149728396|NCT01235962|540140981|FG001|Overall Study|Physician Decision|0|||
149728397|NCT01235962|540140982|FG002|Overall Study|Physician Decision|9|||
149728398|NCT01235962|540140983|FG003|Overall Study|Physician Decision|5|||
149728399|NCT02883244|540140984|FG000|Overall Study|Lost to Follow-up|0|||
149728400|NCT02883244|540140985|FG001|Overall Study|Lost to Follow-up|1|||
149728401|NCT01727258|540140986|FG000|Overall Study|Adverse Event|0|||
149728402|NCT01727258|540140987|FG001|Overall Study|Adverse Event|2|||
149728403|NCT01727258|540140988|FG002|Overall Study|Adverse Event|0|||
149728404|NCT01727258|540140986|FG000|Overall Study|Noncompliance with Study Drug|0|||
149728405|NCT01727258|540140987|FG001|Overall Study|Noncompliance with Study Drug|0|||
149728406|NCT01727258|540140988|FG002|Overall Study|Noncompliance with Study Drug|1|||
149728407|NCT01727258|540140986|FG000|Overall Study|Withdrawal by Subject|1|||
149728408|NCT01727258|540140987|FG001|Overall Study|Withdrawal by Subject|1|||
149728409|NCT01727258|540140988|FG002|Overall Study|Withdrawal by Subject|0|||
149728410|NCT01727258|540140986|FG000|Overall Study|Lost to Follow-up|1|||
149728411|NCT01727258|540140987|FG001|Overall Study|Lost to Follow-up|0|||
149728412|NCT01727258|540140988|FG002|Overall Study|Lost to Follow-up|0|||
149728413|NCT06098729|540140995|FG000|Overall Study|Withdrawal by Subject|1|||
149728414|NCT00993928|540141004|FG000|Overall Study|Withdrawal by Subject|4|||
149728415|NCT00993928|540141005|FG001|Overall Study|Withdrawal by Subject|7|||
149728416|NCT00993928|540141004|FG000|Overall Study|ineligible|1|||
149728417|NCT00993928|540141005|FG001|Overall Study|ineligible|0|||
149728418|NCT01665144|540141006|FG000|Core Part|Withdrawal by Subject|96|||
149728419|NCT01665144|540141007|FG001|Core Part|Withdrawal by Subject|77|||
149728420|NCT01665144|540141008|FG002|Core Part|Withdrawal by Subject|0|||
149728421|NCT01665144|540141006|FG000|Core Part|Adverse Event|45|||
149728422|NCT01665144|540141007|FG001|Core Part|Adverse Event|18|||
149728423|NCT01665144|540141008|FG002|Core Part|Adverse Event|0|||
149728424|NCT01665144|540141006|FG000|Core Part|Lack of Efficacy|16|||
149728425|NCT01665144|540141007|FG001|Core Part|Lack of Efficacy|11|||
149728426|NCT01665144|540141008|FG002|Core Part|Lack of Efficacy|0|||
149728427|NCT01665144|540141006|FG000|Core Part|Lost to Follow-up|9|||
149728428|NCT01665144|540141007|FG001|Core Part|Lost to Follow-up|8|||
149728429|NCT01665144|540141008|FG002|Core Part|Lost to Follow-up|0|||
149728430|NCT01665144|540141006|FG000|Core Part|Physician Decision|13|||
149728431|NCT01665144|540141007|FG001|Core Part|Physician Decision|1|||
149728432|NCT01665144|540141008|FG002|Core Part|Physician Decision|0|||
149728433|NCT01665144|540141006|FG000|Core Part|Progressive disease|8|||
149728434|NCT01665144|540141007|FG001|Core Part|Progressive disease|4|||
149728435|NCT01665144|540141008|FG002|Core Part|Progressive disease|0|||
149728436|NCT01665144|540141006|FG000|Core Part|Non-compliance with study treatment|5|||
149728437|NCT01665144|540141007|FG001|Core Part|Non-compliance with study treatment|0|||
149728438|NCT01665144|540141008|FG002|Core Part|Non-compliance with study treatment|0|||
149728439|NCT01665144|540141006|FG000|Core Part|Death|3|||
149728440|NCT01665144|540141007|FG001|Core Part|Death|1|||
149728441|NCT01665144|540141008|FG002|Core Part|Death|0|||
149728442|NCT01665144|540141006|FG000|Core Part|Protocol deviation|3|||
149728443|NCT01665144|540141007|FG001|Core Part|Protocol deviation|1|||
149728444|NCT01665144|540141008|FG002|Core Part|Protocol deviation|0|||
149728445|NCT01665144|540141006|FG000|Core Part|New therapy for study indication|2|||
149728446|NCT01665144|540141007|FG001|Core Part|New therapy for study indication|1|||
149728447|NCT01665144|540141008|FG002|Core Part|New therapy for study indication|0|||
149728448|NCT01665144|540141006|FG000|Core Part|Technical problems|2|||
149728449|NCT01665144|540141007|FG001|Core Part|Technical problems|0|||
149728450|NCT01665144|540141008|FG002|Core Part|Technical problems|0|||
149728451|NCT01665144|540141006|FG000|Extension Part|Patient/guardian decision|180|||
149728452|NCT01665144|540141007|FG001|Extension Part|Patient/guardian decision|0|||
149728453|NCT01665144|540141008|FG002|Extension Part|Patient/guardian decision|98|||
149728454|NCT01665144|540141006|FG000|Extension Part|Adverse Event|104|||
149728455|NCT01665144|540141007|FG001|Extension Part|Adverse Event|0|||
149728456|NCT01665144|540141008|FG002|Extension Part|Adverse Event|59|||
149728457|NCT01665144|540141006|FG000|Extension Part|Study closed early|42|||
149728458|NCT01665144|540141007|FG001|Extension Part|Study closed early|0|||
149728459|NCT01665144|540141008|FG002|Extension Part|Study closed early|19|||
149728460|NCT01665144|540141006|FG000|Extension Part|Progressive disease|36|||
149728461|NCT01665144|540141007|FG001|Extension Part|Progressive disease|0|||
149728462|NCT01665144|540141008|FG002|Extension Part|Progressive disease|14|||
149728463|NCT01665144|540141006|FG000|Extension Part|Lack of Efficacy|37|||
149728464|NCT01665144|540141007|FG001|Extension Part|Lack of Efficacy|0|||
149728465|NCT01665144|540141008|FG002|Extension Part|Lack of Efficacy|12|||
149728466|NCT01665144|540141006|FG000|Extension Part|Physician Decision|29|||
149728467|NCT01665144|540141007|FG001|Extension Part|Physician Decision|0|||
149728468|NCT01665144|540141008|FG002|Extension Part|Physician Decision|13|||
149728469|NCT01665144|540141006|FG000|Extension Part|Technical problems|20|||
149728470|NCT01665144|540141007|FG001|Extension Part|Technical problems|0|||
149728471|NCT01665144|540141008|FG002|Extension Part|Technical problems|8|||
149728472|NCT01665144|540141006|FG000|Extension Part|Death|20|||
149728473|NCT01665144|540141007|FG001|Extension Part|Death|0|||
149728474|NCT01665144|540141008|FG002|Extension Part|Death|4|||
149728475|NCT01665144|540141006|FG000|Extension Part|Missing|12|||
149728476|NCT01665144|540141007|FG001|Extension Part|Missing|0|||
149728477|NCT01665144|540141008|FG002|Extension Part|Missing|6|||
149728478|NCT01665144|540141006|FG000|Extension Part|Lost to Follow-up|9|||
149728479|NCT01665144|540141007|FG001|Extension Part|Lost to Follow-up|0|||
149728480|NCT01665144|540141008|FG002|Extension Part|Lost to Follow-up|5|||
149728481|NCT01665144|540141006|FG000|Extension Part|New therapy for study indication|3|||
149728482|NCT01665144|540141007|FG001|Extension Part|New therapy for study indication|0|||
149728483|NCT01665144|540141008|FG002|Extension Part|New therapy for study indication|2|||
149728484|NCT01665144|540141006|FG000|Extension Part|Protocol deviation|3|||
149728485|NCT01665144|540141007|FG001|Extension Part|Protocol deviation|0|||
149728486|NCT01665144|540141008|FG002|Extension Part|Protocol deviation|0|||
149728487|NCT01972074|540141011|FG000|Overall Study|Adverse Event|4|||
149728488|NCT01972074|540141012|FG001|Overall Study|Adverse Event|1|||
149728489|NCT01972074|540141013|FG002|Overall Study|Adverse Event|0|||
149728490|NCT01972074|540141011|FG000|Overall Study|Lack of Efficacy|1|||
149728491|NCT01972074|540141012|FG001|Overall Study|Lack of Efficacy|1|||
149728492|NCT01972074|540141013|FG002|Overall Study|Lack of Efficacy|0|||
150251786|NCT02040259|542058290|FG000|Overall Study|Death|280|||
149728493|NCT01972074|540141011|FG000|Overall Study|Lost to Follow-up|0|||
149728494|NCT01972074|540141012|FG001|Overall Study|Lost to Follow-up|1|||
149728495|NCT01972074|540141013|FG002|Overall Study|Lost to Follow-up|1|||
149728496|NCT01972074|540141011|FG000|Overall Study|Withdrawal by Subject|1|||
149728497|NCT01972074|540141012|FG001|Overall Study|Withdrawal by Subject|1|||
149728498|NCT01972074|540141013|FG002|Overall Study|Withdrawal by Subject|1|||
149728499|NCT01972074|540141011|FG000|Overall Study|Scanner Unavailable|0|||
149728500|NCT01972074|540141012|FG001|Overall Study|Scanner Unavailable|0|||
149728501|NCT01972074|540141013|FG002|Overall Study|Scanner Unavailable|1|||
149728502|NCT02317562|540141014|FG000|Overall Study|Physician Decision|1|||
149728503|NCT02317562|540141014|FG000|Overall Study|early termination of the study|8|||
149728504|NCT02317562|540141014|FG000|Overall Study|Lack of Efficacy|4|||
149728505|NCT02317562|540141014|FG000|Overall Study|Withdrawal by Subject|1|||
150251787|NCT02040259|542058290|FG000|Overall Study|Lost to Follow-up|76|||
149728506|NCT02319044|540141015|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
149728507|NCT02319044|540141016|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
149728508|NCT02319044|540141017|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
149728509|NCT02319044|540141015|FG000|Overall Study|Withdrawal by Subject|3|||
149728510|NCT02319044|540141016|FG001|Overall Study|Withdrawal by Subject|3|||
149728511|NCT02319044|540141017|FG002|Overall Study|Withdrawal by Subject|6|||
149728512|NCT02319044|540141015|FG000|Overall Study|Condition under investigation worsened|100|||
149728513|NCT02319044|540141016|FG001|Overall Study|Condition under investigation worsened|50|||
149728514|NCT02319044|540141017|FG002|Overall Study|Condition under investigation worsened|46|||
149728515|NCT02319044|540141015|FG000|Overall Study|Adverse Event|17|||
149728516|NCT02319044|540141016|FG001|Overall Study|Adverse Event|2|||
149728517|NCT02319044|540141017|FG002|Overall Study|Adverse Event|8|||
149728518|NCT02319044|540141015|FG000|Overall Study|Study specific discontinuation criteria|2|||
149728519|NCT02319044|540141016|FG001|Overall Study|Study specific discontinuation criteria|2|||
149728520|NCT02319044|540141017|FG002|Overall Study|Study specific discontinuation criteria|1|||
149728521|NCT02319044|540141015|FG000|Overall Study|Not treated|0|||
149728522|NCT02319044|540141016|FG001|Overall Study|Not treated|2|||
149728523|NCT02319044|540141017|FG002|Overall Study|Not treated|2|||
149728524|NCT03551743|540141018|FG000|Overall Study|Adverse Event|1|||
149728525|NCT03551743|540141019|FG001|Overall Study|Adverse Event|0|||
149728526|NCT03551743|540141020|FG002|Overall Study|Adverse Event|0|||
149728527|NCT03551743|540141021|FG003|Overall Study|Adverse Event|0|||
149728528|NCT03551743|540141018|FG000|Overall Study|Withdrawal by Subject|1|||
149728529|NCT03551743|540141019|FG001|Overall Study|Withdrawal by Subject|0|||
149728530|NCT03551743|540141020|FG002|Overall Study|Withdrawal by Subject|0|||
149728531|NCT03551743|540141021|FG003|Overall Study|Withdrawal by Subject|0|||
149728532|NCT03891901|540141022|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
149728533|NCT03891901|540141023|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728534|NCT03891901|540141024|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728535|NCT03891901|540141025|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728536|NCT03891901|540141026|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728537|NCT03891901|540141027|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728538|NCT03891901|540141028|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728539|NCT03891901|540141029|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728540|NCT03891901|540141030|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149728541|NCT03891901|540141022|FG000|Overall Study|Adverse Event|2|||
149728542|NCT03891901|540141023|FG001|Overall Study|Adverse Event|2|||
149728543|NCT03891901|540141024|FG002|Overall Study|Adverse Event|0|||
149728544|NCT03891901|540141025|FG003|Overall Study|Adverse Event|0|||
149728545|NCT03891901|540141026|FG004|Overall Study|Adverse Event|0|||
149728546|NCT03891901|540141027|FG005|Overall Study|Adverse Event|0|||
149728547|NCT03891901|540141028|FG006|Overall Study|Adverse Event|0|||
149728548|NCT03891901|540141029|FG007|Overall Study|Adverse Event|0|||
149728549|NCT03891901|540141030|FG008|Overall Study|Adverse Event|0|||
149728550|NCT03891901|540141022|FG000|Overall Study|Poor venous access|1|||
149728551|NCT03891901|540141023|FG001|Overall Study|Poor venous access|0|||
149728552|NCT03891901|540141024|FG002|Overall Study|Poor venous access|0|||
149728553|NCT03891901|540141025|FG003|Overall Study|Poor venous access|0|||
149728554|NCT03891901|540141026|FG004|Overall Study|Poor venous access|0|||
149728555|NCT03891901|540141027|FG005|Overall Study|Poor venous access|0|||
149728556|NCT03891901|540141028|FG006|Overall Study|Poor venous access|0|||
149728557|NCT03891901|540141029|FG007|Overall Study|Poor venous access|0|||
149728558|NCT03891901|540141030|FG008|Overall Study|Poor venous access|0|||
149728559|NCT03891901|540141022|FG000|Overall Study|Withdrawal by Subject|0|||
149728560|NCT03891901|540141023|FG001|Overall Study|Withdrawal by Subject|2|||
149728561|NCT03891901|540141024|FG002|Overall Study|Withdrawal by Subject|0|||
149728562|NCT03891901|540141025|FG003|Overall Study|Withdrawal by Subject|0|||
149728563|NCT03891901|540141026|FG004|Overall Study|Withdrawal by Subject|0|||
149728564|NCT03891901|540141027|FG005|Overall Study|Withdrawal by Subject|0|||
149728565|NCT03891901|540141028|FG006|Overall Study|Withdrawal by Subject|0|||
149728566|NCT03891901|540141029|FG007|Overall Study|Withdrawal by Subject|0|||
149728567|NCT03891901|540141030|FG008|Overall Study|Withdrawal by Subject|0|||
149728568|NCT02154087|540141033|FG000|Overall Study|Study Termination|1|||
149728569|NCT04949841|540141036|FG000|Overall Study|Adverse Event|7|||
149728570|NCT04949841|540141036|FG000|Overall Study|Death|1|||
150251788|NCT02040259|542058290|FG000|Overall Study|Assessment not completed|3|||
150251789|NCT02040259|542058290|FG000|Overall Study|Withdrawal by Subject|4|||
150251790|NCT00316602|542058291|FG000|Overall Study|Withdrawal by Subject|3|||
150251791|NCT00316602|542058292|FG001|Overall Study|Withdrawal by Subject|2|||
149728571|NCT04949841|540141036|FG000|Overall Study|Withdrawal by Subject|52|||
149728572|NCT04949841|540141036|FG000|Overall Study|Pregnancy|4|||
149728573|NCT04949841|540141036|FG000|Overall Study|Lost to Follow-up|9|||
149728574|NCT04949841|540141036|FG000|Overall Study|Lack of Efficacy|55|||
149728575|NCT04949841|540141036|FG000|Overall Study|Various reasons|9|||
150251792|NCT00316602|542058291|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
149728576|NCT03110900|540141042|FG000|Overall Study|Sponsor withdrew|1|||
149728577|NCT03110900|540141043|FG001|Overall Study|Sponsor withdrew|1|||
149728578|NCT00644787|540141044|FG000|Period 1: Titration Phase|Adverse Event|11|||
149728579|NCT00644787|540141045|FG001|Period 1: Titration Phase|Adverse Event|0|||
149728580|NCT00644787|540141046|FG002|Period 1: Titration Phase|Adverse Event|0|||
149728581|NCT00644787|540141044|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
149728582|NCT00644787|540141045|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
149728583|NCT00644787|540141046|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
149728584|NCT00644787|540141044|FG000|Period 1: Titration Phase|Physician Decision|1|||
149728585|NCT00644787|540141045|FG001|Period 1: Titration Phase|Physician Decision|0|||
149728586|NCT00644787|540141046|FG002|Period 1: Titration Phase|Physician Decision|0|||
149728587|NCT00644787|540141044|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
149728588|NCT00644787|540141045|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
149728589|NCT00644787|540141046|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
149728590|NCT00644787|540141044|FG000|Period 1: Titration Phase|Worsening of complications|1|||
150251793|NCT00316602|542058292|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
150251794|NCT00316602|542058291|FG000|Overall Study|Adverse Event|1|||
150251795|NCT00316602|542058292|FG001|Overall Study|Adverse Event|0|||
150251796|NCT00316602|542058291|FG000|Overall Study|Other|3|||
150251797|NCT00316602|542058292|FG001|Overall Study|Other|6|||
150251798|NCT01142232|542058293|FG000|Overall Study|Adverse Event|1|||
150251799|NCT01142232|542058294|FG001|Overall Study|Adverse Event|2|||
150251800|NCT01142232|542058295|FG002|Overall Study|Adverse Event|1|||
150251801|NCT01142232|542058296|FG003|Overall Study|Adverse Event|0|||
150251802|NCT01142232|542058297|FG004|Overall Study|Adverse Event|4|||
150251803|NCT01142232|542058293|FG000|Overall Study|Death|0|||
150251804|NCT01142232|542058294|FG001|Overall Study|Death|0|||
149728591|NCT00644787|540141045|FG001|Period 1: Titration Phase|Worsening of complications|0|||
149728592|NCT00644787|540141046|FG002|Period 1: Titration Phase|Worsening of complications|0|||
149728593|NCT00644787|540141044|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
149728594|NCT00644787|540141045|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
149728595|NCT00644787|540141046|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
149728596|NCT00644787|540141044|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
149728597|NCT00644787|540141045|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
149728598|NCT00644787|540141046|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
149728599|NCT00644787|540141044|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
149728600|NCT00644787|540141045|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
149728601|NCT00644787|540141046|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
149728602|NCT00644787|540141044|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
149728603|NCT00644787|540141045|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
149728604|NCT00644787|540141046|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
149728605|NCT00644787|540141044|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
149728606|NCT00644787|540141045|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
149728607|NCT00644787|540141046|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
149728608|NCT00644787|540141044|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
149728609|NCT00644787|540141045|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
149728610|NCT00644787|540141046|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
149728611|NCT00644787|540141044|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
149728612|NCT00644787|540141045|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
149728613|NCT00644787|540141046|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
149728614|NCT03355300|540141047|FG000|Overall Study|Physician Decision|0|||
149728615|NCT03355300|540141048|FG001|Overall Study|Physician Decision|1|||
149728616|NCT03355300|540141047|FG000|Overall Study|Lack of Efficacy|2|||
149728617|NCT03355300|540141048|FG001|Overall Study|Lack of Efficacy|1|||
149728618|NCT03355300|540141047|FG000|Overall Study|Other reason|1|||
149728619|NCT03355300|540141048|FG001|Overall Study|Other reason|0|||
149728620|NCT01031446|540141054|FG000|Overall Study|Disease Progression|38|||
149728621|NCT01031446|540141054|FG000|Overall Study|Adverse Event|9|||
149728622|NCT01031446|540141054|FG000|Overall Study|Physician Decision|4|||
149728623|NCT01031446|540141054|FG000|Overall Study|Withdrawal by Subject|3|||
149728624|NCT01031446|540141054|FG000|Overall Study|Still on treatment|1|||
150251805|NCT01142232|542058295|FG002|Overall Study|Death|0|||
150251806|NCT01142232|542058296|FG003|Overall Study|Death|0|||
150251807|NCT01142232|542058297|FG004|Overall Study|Death|1|||
150251808|NCT01142232|542058293|FG000|Overall Study|Disease Progression|2|||
149728625|NCT00500682|540141055|FG000|Overall Study|Adverse Event|37|||
150251809|NCT01142232|542058294|FG001|Overall Study|Disease Progression|0|||
150251810|NCT01142232|542058295|FG002|Overall Study|Disease Progression|1|||
150251811|NCT01142232|542058296|FG003|Overall Study|Disease Progression|2|||
150251812|NCT01142232|542058297|FG004|Overall Study|Disease Progression|12|||
149728626|NCT00500682|540141056|FG001|Overall Study|Adverse Event|29|||
150251813|NCT01142232|542058293|FG000|Overall Study|Withdrawal by Subject|0|||
150251814|NCT01142232|542058294|FG001|Overall Study|Withdrawal by Subject|0|||
149728627|NCT00500682|540141055|FG000|Overall Study|Death|25|||
149728628|NCT00500682|540141056|FG001|Overall Study|Death|16|||
149728629|NCT00500682|540141055|FG000|Overall Study|Lost to Follow-up|11|||
149728630|NCT00500682|540141056|FG001|Overall Study|Lost to Follow-up|11|||
149728631|NCT00500682|540141055|FG000|Overall Study|Physician Decision|6|||
149728632|NCT00500682|540141056|FG001|Overall Study|Physician Decision|10|||
149728633|NCT00500682|540141055|FG000|Overall Study|Pregnancy|2|||
149728634|NCT00500682|540141056|FG001|Overall Study|Pregnancy|0|||
149728635|NCT00500682|540141055|FG000|Overall Study|Protocol Violation|1|||
149728636|NCT00500682|540141056|FG001|Overall Study|Protocol Violation|3|||
149728637|NCT00500682|540141055|FG000|Overall Study|Withdrawal by Subject|80|||
149728638|NCT00500682|540141056|FG001|Overall Study|Withdrawal by Subject|74|||
149728639|NCT00500682|540141055|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
149728640|NCT00500682|540141056|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
149728641|NCT02531646|540141059|FG000|Overall Study|equip. image processing issue|5|||
149728642|NCT02531646|540141060|FG001|Overall Study|equip. image processing issue|1|||
149728643|NCT02531646|540141061|FG002|Overall Study|equip. image processing issue|0|||
149728644|NCT03344003|540141065|FG000|Overall Study|Switched to alternative treatment|1|||
149728645|NCT03344003|540141066|FG001|Overall Study|Switched to alternative treatment|0|||
149728646|NCT03344003|540141065|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
149728647|NCT03344003|540141066|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
149728648|NCT01182428|540141067|FG000|Overall Study|Physician Decision|1|||
149728649|NCT01182428|540141068|FG001|Overall Study|Physician Decision|0|||
149728650|NCT01182428|540141067|FG000|Overall Study|Lost to Follow-up|9|||
149728651|NCT01182428|540141068|FG001|Overall Study|Lost to Follow-up|1|||
149728652|NCT01182428|540141067|FG000|Overall Study|Withdrawal by Subject|1|||
149728653|NCT01182428|540141068|FG001|Overall Study|Withdrawal by Subject|0|||
149728654|NCT00684957|540141072|FG000|Overall Study|Withdrawal by Subject|1|||
149728655|NCT00684957|540141073|FG001|Overall Study|Withdrawal by Subject|1|||
149728656|NCT00684957|540141072|FG000|Overall Study|Lost to Follow-up|1|||
149728657|NCT00684957|540141073|FG001|Overall Study|Lost to Follow-up|0|||
149728658|NCT06272370|540142382|FG000|Overall Study|Lost to Follow-up|0|||
149728659|NCT06272370|540142383|FG001|Overall Study|Lost to Follow-up|3|||
149728660|NCT06272370|540142384|FG002|Overall Study|Lost to Follow-up|1|||
149728661|NCT06272370|540142385|FG003|Overall Study|Lost to Follow-up|1|||
149728662|NCT03064763|540142388|FG000|Overall Study|Lost to Follow-up|1|||
149728663|NCT03064763|540142388|FG000|Overall Study|Death|8|||
149728664|NCT00680836|540142389|FG000|Overall Study|Withdrawal by Subject|3|||
149728665|NCT00680836|540142390|FG001|Overall Study|Withdrawal by Subject|0|||
149728666|NCT00680836|540142389|FG000|Overall Study|Lost to Follow-up|3|||
149728667|NCT00680836|540142390|FG001|Overall Study|Lost to Follow-up|1|||
149728668|NCT00680836|540142389|FG000|Overall Study|Physician Decision|2|||
149728669|NCT00680836|540142390|FG001|Overall Study|Physician Decision|1|||
149728670|NCT03038308|540142391|FG000|Overall Study|Surgical resection|1|||
149728671|NCT03038308|540142391|FG000|Overall Study|Withdrawal by Subject|2|||
149728672|NCT03038308|540142391|FG000|Overall Study|Lost to Follow-up|1|||
149728673|NCT01583179|540142392|FG000|Overall Study|Screen failure|1|||
149728674|NCT01583179|540142393|FG001|Overall Study|Screen failure|2|||
149728675|NCT01220414|540142394|FG000|Overall Study|Withdrawal by Subject|1|||
149728676|NCT01220414|540142395|FG001|Overall Study|Withdrawal by Subject|0|||
149728677|NCT01220414|540142396|FG002|Overall Study|Withdrawal by Subject|0|||
149728678|NCT01220414|540142397|FG003|Overall Study|Withdrawal by Subject|1|||
149728679|NCT00623831|540142398|FG000|Overall Study|Withdrawal by Subject|1|||
149728680|NCT00623831|540142399|FG001|Overall Study|Withdrawal by Subject|0|||
149728681|NCT00623831|540142398|FG000|Overall Study|Progressive Disease|0|||
149728682|NCT00623831|540142399|FG001|Overall Study|Progressive Disease|1|||
149728683|NCT03555266|540142405|FG000|Overall Study|Protocol Violation|6|||
149728684|NCT03555266|540142406|FG001|Overall Study|Protocol Violation|4|||
149728685|NCT03370770|540142410|FG000|Overall Study|Patient was followed in another hospital center|1|||
149728686|NCT03370770|540142410|FG000|Overall Study|Progressive Disease|98|||
149728687|NCT03370770|540142410|FG000|Overall Study|Adverse Event|2|||
149728688|NCT03370770|540142410|FG000|Overall Study|Death|5|||
149728689|NCT00132730|540142411|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
150251815|NCT01142232|542058295|FG002|Overall Study|Withdrawal by Subject|0|||
150251816|NCT01142232|542058296|FG003|Overall Study|Withdrawal by Subject|1|||
150251817|NCT01142232|542058297|FG004|Overall Study|Withdrawal by Subject|3|||
149728690|NCT00132730|540142412|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
149728691|NCT00132730|540142413|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
149728692|NCT00132730|540142414|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
149728693|NCT00132730|540142415|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
149728694|NCT00132730|540142416|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
149728695|NCT00132730|540142411|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
150251818|NCT01142232|542058293|FG000|Overall Study|Physician Decision|0|||
149728696|NCT00132730|540142412|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
150251819|NCT01142232|542058294|FG001|Overall Study|Physician Decision|1|||
149728697|NCT00132730|540142413|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149728698|NCT00132730|540142414|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149728699|NCT00132730|540142415|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149728700|NCT00132730|540142416|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149728701|NCT00132730|540142411|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
149728702|NCT00132730|540142412|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
149728703|NCT00132730|540142413|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
149728704|NCT00132730|540142414|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
149728705|NCT00132730|540142415|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
149728706|NCT00132730|540142416|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
149728707|NCT00132730|540142411|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149728708|NCT00132730|540142412|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149728709|NCT00132730|540142413|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
149728710|NCT00132730|540142414|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
149728711|NCT00132730|540142415|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149728712|NCT00132730|540142416|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149728713|NCT00132730|540142411|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149728714|NCT00132730|540142412|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149728715|NCT00132730|540142413|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
149728716|NCT00132730|540142414|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
149728717|NCT00132730|540142415|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
150251820|NCT01142232|542058295|FG002|Overall Study|Physician Decision|0|||
150251821|NCT01142232|542058296|FG003|Overall Study|Physician Decision|2|||
150251822|NCT01142232|542058297|FG004|Overall Study|Physician Decision|10|||
150251823|NCT01142232|542058293|FG000|Overall Study|Alternative Therapy|0|||
149728718|NCT00132730|540142416|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149728719|NCT00132730|540142411|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149728720|NCT00132730|540142412|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149728721|NCT00132730|540142413|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149728722|NCT00132730|540142414|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
149728723|NCT00132730|540142415|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149728724|NCT00132730|540142416|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149728725|NCT00132730|540142411|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149728726|NCT00132730|540142412|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149728727|NCT00132730|540142413|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
149728728|NCT00132730|540142414|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
149728729|NCT00132730|540142415|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149728730|NCT00132730|540142416|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149728731|NCT00132730|540142411|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149728732|NCT00132730|540142412|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149728733|NCT00132730|540142413|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149728734|NCT00132730|540142414|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149728735|NCT00132730|540142415|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
149728736|NCT00132730|540142416|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
149728737|NCT00132730|540142411|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149728738|NCT00132730|540142412|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149728739|NCT00132730|540142413|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149728740|NCT00132730|540142414|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149728741|NCT00132730|540142415|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
149728742|NCT00132730|540142416|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149728743|NCT00132730|540142411|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149728744|NCT00132730|540142412|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149728745|NCT00132730|540142413|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149728746|NCT00132730|540142414|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149728747|NCT00132730|540142415|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
149728748|NCT00132730|540142416|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149728749|NCT00132730|540142411|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149728750|NCT00132730|540142412|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149728751|NCT00132730|540142413|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149728752|NCT00132730|540142414|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
150251824|NCT01142232|542058294|FG001|Overall Study|Alternative Therapy|1|||
150251825|NCT01142232|542058295|FG002|Overall Study|Alternative Therapy|1|||
150251826|NCT01142232|542058296|FG003|Overall Study|Alternative Therapy|0|||
150251827|NCT01142232|542058297|FG004|Overall Study|Alternative Therapy|1|||
149728753|NCT00132730|540142415|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
149728754|NCT00132730|540142416|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149728755|NCT00132730|540142411|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149728756|NCT00132730|540142412|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149728757|NCT00132730|540142413|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149728758|NCT00132730|540142414|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149728759|NCT00132730|540142415|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
149728760|NCT00132730|540142416|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
149728761|NCT00179959|540142417|FG000|Overall Study|Lost to Follow-up|3|||
149728762|NCT00179959|540142418|FG001|Overall Study|Lost to Follow-up|1|||
149728763|NCT00179959|540142417|FG000|Overall Study|Withdrawal by Subject|3|||
150251828|NCT01142232|542058293|FG000|Overall Study|Off Trt for other complicating disease|0|||
150251829|NCT01142232|542058294|FG001|Overall Study|Off Trt for other complicating disease|0|||
150251830|NCT01142232|542058295|FG002|Overall Study|Off Trt for other complicating disease|0|||
150251831|NCT01142232|542058296|FG003|Overall Study|Off Trt for other complicating disease|0|||
150251832|NCT01142232|542058297|FG004|Overall Study|Off Trt for other complicating disease|1|||
150251833|NCT01142232|542058293|FG000|Overall Study|Noncompliance|0|||
150251834|NCT01142232|542058294|FG001|Overall Study|Noncompliance|0|||
150251835|NCT01142232|542058295|FG002|Overall Study|Noncompliance|0|||
150251836|NCT01142232|542058296|FG003|Overall Study|Noncompliance|0|||
150251837|NCT01142232|542058297|FG004|Overall Study|Noncompliance|2|||
150251838|NCT00626990|542058298|FG000|Overall Study|Lack of Efficacy|6|||
150251839|NCT00626990|542058299|FG001|Overall Study|Lack of Efficacy|7|||
149728764|NCT00179959|540142418|FG001|Overall Study|Withdrawal by Subject|2|||
149728765|NCT01262976|540142419|FG000|Up to Month 2|Serious Adverse Event|0|||
149728766|NCT01262976|540142420|FG001|Up to Month 2|Serious Adverse Event|0|||
149728767|NCT01262976|540142421|FG002|Up to Month 2|Serious Adverse Event|1|||
149728768|NCT01262976|540142422|FG003|Up to Month 2|Serious Adverse Event|0|||
149728769|NCT01262976|540142423|FG004|Up to Month 2|Serious Adverse Event|0|||
149728770|NCT01262976|540142424|FG005|Up to Month 2|Serious Adverse Event|0|||
149728771|NCT01262976|540142419|FG000|Up to Month 2|Withdrawal by Subject|1|||
149728772|NCT01262976|540142420|FG001|Up to Month 2|Withdrawal by Subject|0|||
149728773|NCT01262976|540142421|FG002|Up to Month 2|Withdrawal by Subject|0|||
149728774|NCT01262976|540142422|FG003|Up to Month 2|Withdrawal by Subject|0|||
149728775|NCT01262976|540142423|FG004|Up to Month 2|Withdrawal by Subject|0|||
149728776|NCT01262976|540142424|FG005|Up to Month 2|Withdrawal by Subject|0|||
149728777|NCT01262976|540142419|FG000|Up to Month 2|Migrated/moved from study area|0|||
149728778|NCT01262976|540142420|FG001|Up to Month 2|Migrated/moved from study area|1|||
149728779|NCT01262976|540142421|FG002|Up to Month 2|Migrated/moved from study area|0|||
149728780|NCT01262976|540142422|FG003|Up to Month 2|Migrated/moved from study area|0|||
149728781|NCT01262976|540142423|FG004|Up to Month 2|Migrated/moved from study area|1|||
149728782|NCT01262976|540142424|FG005|Up to Month 2|Migrated/moved from study area|1|||
149728783|NCT01262976|540142419|FG000|Up to Month 2|Lost to Follow-up|1|||
149728784|NCT01262976|540142420|FG001|Up to Month 2|Lost to Follow-up|0|||
149728785|NCT01262976|540142421|FG002|Up to Month 2|Lost to Follow-up|0|||
149728786|NCT01262976|540142422|FG003|Up to Month 2|Lost to Follow-up|1|||
149728787|NCT01262976|540142423|FG004|Up to Month 2|Lost to Follow-up|1|||
149728788|NCT01262976|540142424|FG005|Up to Month 2|Lost to Follow-up|1|||
149728789|NCT01262976|540142419|FG000|Up to Month 2|Other|1|||
149728790|NCT01262976|540142420|FG001|Up to Month 2|Other|0|||
149728791|NCT01262976|540142421|FG002|Up to Month 2|Other|0|||
149728792|NCT01262976|540142422|FG003|Up to Month 2|Other|1|||
149728793|NCT01262976|540142423|FG004|Up to Month 2|Other|0|||
149728794|NCT01262976|540142424|FG005|Up to Month 2|Other|2|||
149728795|NCT01262976|540142419|FG000|Up to Month 7|Serious Adverse Event|0|||
149728796|NCT01262976|540142420|FG001|Up to Month 7|Serious Adverse Event|0|||
149728797|NCT01262976|540142421|FG002|Up to Month 7|Serious Adverse Event|2|||
149728798|NCT01262976|540142422|FG003|Up to Month 7|Serious Adverse Event|0|||
149728799|NCT01262976|540142423|FG004|Up to Month 7|Serious Adverse Event|0|||
149728800|NCT01262976|540142424|FG005|Up to Month 7|Serious Adverse Event|0|||
149728801|NCT01262976|540142419|FG000|Up to Month 7|Withdrawal by Subject|1|||
149728802|NCT01262976|540142420|FG001|Up to Month 7|Withdrawal by Subject|0|||
149728803|NCT01262976|540142421|FG002|Up to Month 7|Withdrawal by Subject|0|||
149728804|NCT01262976|540142422|FG003|Up to Month 7|Withdrawal by Subject|0|||
149728805|NCT01262976|540142423|FG004|Up to Month 7|Withdrawal by Subject|0|||
149728806|NCT01262976|540142424|FG005|Up to Month 7|Withdrawal by Subject|0|||
149728807|NCT01262976|540142419|FG000|Up to Month 7|Migrated/moved from study area|0|||
149728808|NCT01262976|540142420|FG001|Up to Month 7|Migrated/moved from study area|0|||
149728809|NCT01262976|540142421|FG002|Up to Month 7|Migrated/moved from study area|1|||
149728810|NCT01262976|540142422|FG003|Up to Month 7|Migrated/moved from study area|3|||
149728811|NCT01262976|540142423|FG004|Up to Month 7|Migrated/moved from study area|1|||
149728812|NCT01262976|540142424|FG005|Up to Month 7|Migrated/moved from study area|1|||
149728813|NCT01262976|540142419|FG000|Up to Month 7|Lost to Follow-up|1|||
149728814|NCT01262976|540142420|FG001|Up to Month 7|Lost to Follow-up|0|||
149728815|NCT01262976|540142421|FG002|Up to Month 7|Lost to Follow-up|1|||
149728816|NCT01262976|540142422|FG003|Up to Month 7|Lost to Follow-up|3|||
149728817|NCT01262976|540142423|FG004|Up to Month 7|Lost to Follow-up|1|||
149728818|NCT01262976|540142424|FG005|Up to Month 7|Lost to Follow-up|3|||
149728819|NCT01262976|540142419|FG000|Up to Month 7|Other|3|||
149728820|NCT01262976|540142420|FG001|Up to Month 7|Other|0|||
149728821|NCT01262976|540142421|FG002|Up to Month 7|Other|2|||
149728822|NCT01262976|540142422|FG003|Up to Month 7|Other|0|||
149728823|NCT01262976|540142423|FG004|Up to Month 7|Other|0|||
149728824|NCT01262976|540142424|FG005|Up to Month 7|Other|0|||
149728825|NCT01262976|540142419|FG000|Up to Year 1|Serious Adverse Event|0|||
149728826|NCT01262976|540142420|FG001|Up to Year 1|Serious Adverse Event|0|||
149728827|NCT01262976|540142421|FG002|Up to Year 1|Serious Adverse Event|2|||
149728828|NCT01262976|540142422|FG003|Up to Year 1|Serious Adverse Event|0|||
149728829|NCT01262976|540142423|FG004|Up to Year 1|Serious Adverse Event|0|||
149728830|NCT01262976|540142424|FG005|Up to Year 1|Serious Adverse Event|0|||
149728831|NCT01262976|540142419|FG000|Up to Year 1|Withdrawal by Subject|1|||
149728832|NCT01262976|540142420|FG001|Up to Year 1|Withdrawal by Subject|0|||
149728833|NCT01262976|540142421|FG002|Up to Year 1|Withdrawal by Subject|0|||
149728834|NCT01262976|540142422|FG003|Up to Year 1|Withdrawal by Subject|0|||
149728835|NCT01262976|540142423|FG004|Up to Year 1|Withdrawal by Subject|0|||
149728836|NCT01262976|540142424|FG005|Up to Year 1|Withdrawal by Subject|0|||
149728837|NCT01262976|540142419|FG000|Up to Year 1|Migrated/moved from study area|1|||
149728838|NCT01262976|540142420|FG001|Up to Year 1|Migrated/moved from study area|0|||
149728839|NCT01262976|540142421|FG002|Up to Year 1|Migrated/moved from study area|0|||
149728840|NCT01262976|540142422|FG003|Up to Year 1|Migrated/moved from study area|3|||
149728841|NCT01262976|540142423|FG004|Up to Year 1|Migrated/moved from study area|3|||
149728842|NCT01262976|540142424|FG005|Up to Year 1|Migrated/moved from study area|2|||
149728843|NCT01262976|540142419|FG000|Up to Year 1|Lost to Follow-up|4|||
149728844|NCT01262976|540142420|FG001|Up to Year 1|Lost to Follow-up|0|||
149728845|NCT01262976|540142421|FG002|Up to Year 1|Lost to Follow-up|0|||
149728846|NCT01262976|540142422|FG003|Up to Year 1|Lost to Follow-up|1|||
149728847|NCT01262976|540142423|FG004|Up to Year 1|Lost to Follow-up|6|||
149728848|NCT01262976|540142424|FG005|Up to Year 1|Lost to Follow-up|5|||
149728849|NCT01262976|540142419|FG000|Up to Year 1|Other|3|||
149728850|NCT01262976|540142420|FG001|Up to Year 1|Other|1|||
149728851|NCT01262976|540142421|FG002|Up to Year 1|Other|0|||
149728852|NCT01262976|540142422|FG003|Up to Year 1|Other|0|||
149728853|NCT01262976|540142423|FG004|Up to Year 1|Other|2|||
149728854|NCT01262976|540142424|FG005|Up to Year 1|Other|1|||
149728855|NCT01262976|540142419|FG000|Up to Year 1|Subjects with unknown completion status|0|||
149728856|NCT01262976|540142420|FG001|Up to Year 1|Subjects with unknown completion status|0|||
149728857|NCT01262976|540142421|FG002|Up to Year 1|Subjects with unknown completion status|1|||
149728858|NCT01262976|540142422|FG003|Up to Year 1|Subjects with unknown completion status|0|||
149728859|NCT01262976|540142423|FG004|Up to Year 1|Subjects with unknown completion status|0|||
149728860|NCT01262976|540142424|FG005|Up to Year 1|Subjects with unknown completion status|1|||
149728861|NCT01262976|540142419|FG000|Up to Year 2|Serious Adverse Event|0|||
149728862|NCT01262976|540142420|FG001|Up to Year 2|Serious Adverse Event|0|||
149728863|NCT01262976|540142421|FG002|Up to Year 2|Serious Adverse Event|2|||
149728864|NCT01262976|540142422|FG003|Up to Year 2|Serious Adverse Event|0|||
149728865|NCT01262976|540142423|FG004|Up to Year 2|Serious Adverse Event|0|||
149728866|NCT01262976|540142424|FG005|Up to Year 2|Serious Adverse Event|0|||
149728867|NCT01262976|540142419|FG000|Up to Year 2|Withdrawal by Subject|1|||
149728868|NCT01262976|540142420|FG001|Up to Year 2|Withdrawal by Subject|0|||
149728869|NCT01262976|540142421|FG002|Up to Year 2|Withdrawal by Subject|0|||
149728870|NCT01262976|540142422|FG003|Up to Year 2|Withdrawal by Subject|0|||
149728871|NCT01262976|540142423|FG004|Up to Year 2|Withdrawal by Subject|0|||
149728872|NCT01262976|540142424|FG005|Up to Year 2|Withdrawal by Subject|0|||
149728873|NCT01262976|540142419|FG000|Up to Year 2|Migrated/moved from study area|0|||
149728874|NCT01262976|540142420|FG001|Up to Year 2|Migrated/moved from study area|0|||
149728875|NCT01262976|540142421|FG002|Up to Year 2|Migrated/moved from study area|0|||
149728876|NCT01262976|540142422|FG003|Up to Year 2|Migrated/moved from study area|2|||
149728877|NCT01262976|540142423|FG004|Up to Year 2|Migrated/moved from study area|1|||
149728878|NCT01262976|540142424|FG005|Up to Year 2|Migrated/moved from study area|2|||
149728879|NCT01262976|540142419|FG000|Up to Year 2|Lost to Follow-up|1|||
149728880|NCT01262976|540142420|FG001|Up to Year 2|Lost to Follow-up|1|||
149728881|NCT01262976|540142421|FG002|Up to Year 2|Lost to Follow-up|2|||
149728882|NCT01262976|540142422|FG003|Up to Year 2|Lost to Follow-up|2|||
149728883|NCT01262976|540142423|FG004|Up to Year 2|Lost to Follow-up|3|||
149728884|NCT01262976|540142424|FG005|Up to Year 2|Lost to Follow-up|3|||
149728885|NCT01262976|540142419|FG000|Up to Year 2|Subjects with unknown completion status|0|||
149728886|NCT01262976|540142420|FG001|Up to Year 2|Subjects with unknown completion status|0|||
149728887|NCT01262976|540142421|FG002|Up to Year 2|Subjects with unknown completion status|1|||
149728888|NCT01262976|540142422|FG003|Up to Year 2|Subjects with unknown completion status|0|||
149728889|NCT01262976|540142423|FG004|Up to Year 2|Subjects with unknown completion status|0|||
149728890|NCT01262976|540142424|FG005|Up to Year 2|Subjects with unknown completion status|0|||
149728891|NCT01262976|540142419|FG000|Up to Year 2|Other|3|||
149728892|NCT01262976|540142420|FG001|Up to Year 2|Other|0|||
149728893|NCT01262976|540142421|FG002|Up to Year 2|Other|0|||
149728894|NCT01262976|540142422|FG003|Up to Year 2|Other|0|||
149728895|NCT01262976|540142423|FG004|Up to Year 2|Other|0|||
149728896|NCT01262976|540142424|FG005|Up to Year 2|Other|0|||
149728897|NCT01262976|540142419|FG000|Up to Year 3|Serious Adverse Event|0|||
149728898|NCT01262976|540142420|FG001|Up to Year 3|Serious Adverse Event|0|||
149728899|NCT01262976|540142421|FG002|Up to Year 3|Serious Adverse Event|2|||
149728900|NCT01262976|540142422|FG003|Up to Year 3|Serious Adverse Event|0|||
149728901|NCT01262976|540142423|FG004|Up to Year 3|Serious Adverse Event|0|||
149728902|NCT01262976|540142424|FG005|Up to Year 3|Serious Adverse Event|0|||
149728903|NCT01262976|540142419|FG000|Up to Year 3|Withdrawal by Subject|1|||
149728904|NCT01262976|540142420|FG001|Up to Year 3|Withdrawal by Subject|0|||
149728905|NCT01262976|540142421|FG002|Up to Year 3|Withdrawal by Subject|0|||
149728906|NCT01262976|540142422|FG003|Up to Year 3|Withdrawal by Subject|0|||
149728907|NCT01262976|540142423|FG004|Up to Year 3|Withdrawal by Subject|0|||
149728908|NCT01262976|540142424|FG005|Up to Year 3|Withdrawal by Subject|0|||
149728909|NCT01262976|540142419|FG000|Up to Year 3|Migrated/moved from study area|0|||
149728910|NCT01262976|540142420|FG001|Up to Year 3|Migrated/moved from study area|0|||
149728911|NCT01262976|540142421|FG002|Up to Year 3|Migrated/moved from study area|0|||
149728912|NCT01262976|540142422|FG003|Up to Year 3|Migrated/moved from study area|2|||
149728913|NCT01262976|540142423|FG004|Up to Year 3|Migrated/moved from study area|1|||
149728914|NCT01262976|540142424|FG005|Up to Year 3|Migrated/moved from study area|1|||
149728915|NCT01262976|540142419|FG000|Up to Year 3|Lost to Follow-up|2|||
149728916|NCT01262976|540142420|FG001|Up to Year 3|Lost to Follow-up|2|||
149728917|NCT01262976|540142421|FG002|Up to Year 3|Lost to Follow-up|4|||
149728918|NCT01262976|540142422|FG003|Up to Year 3|Lost to Follow-up|3|||
149728919|NCT01262976|540142423|FG004|Up to Year 3|Lost to Follow-up|1|||
149728920|NCT01262976|540142424|FG005|Up to Year 3|Lost to Follow-up|3|||
149728921|NCT01262976|540142419|FG000|Up to Year 3|Subjects with unknown completion status|0|||
149728922|NCT01262976|540142420|FG001|Up to Year 3|Subjects with unknown completion status|0|||
149728923|NCT01262976|540142421|FG002|Up to Year 3|Subjects with unknown completion status|1|||
149728924|NCT01262976|540142422|FG003|Up to Year 3|Subjects with unknown completion status|0|||
149728925|NCT01262976|540142423|FG004|Up to Year 3|Subjects with unknown completion status|0|||
149728926|NCT01262976|540142424|FG005|Up to Year 3|Subjects with unknown completion status|0|||
149728927|NCT01262976|540142419|FG000|Up to Year 3|Other|3|||
149728928|NCT01262976|540142420|FG001|Up to Year 3|Other|0|||
149728929|NCT01262976|540142421|FG002|Up to Year 3|Other|0|||
149728930|NCT01262976|540142422|FG003|Up to Year 3|Other|0|||
149728931|NCT01262976|540142423|FG004|Up to Year 3|Other|0|||
149728932|NCT01262976|540142424|FG005|Up to Year 3|Other|0|||
149728933|NCT00236080|540142425|FG000|Overall Study|Adverse Event|0|||
149728934|NCT00236080|540142426|FG001|Overall Study|Adverse Event|0|||
149728935|NCT00236080|540142427|FG002|Overall Study|Adverse Event|3|||
149728936|NCT00236080|540142428|FG003|Overall Study|Adverse Event|1|||
149728937|NCT00236080|540142429|FG004|Overall Study|Adverse Event|0|||
149728938|NCT00236080|540142425|FG000|Overall Study|Lost to Follow-up|0|||
149728939|NCT00236080|540142426|FG001|Overall Study|Lost to Follow-up|1|||
149728940|NCT00236080|540142427|FG002|Overall Study|Lost to Follow-up|0|||
149728941|NCT00236080|540142428|FG003|Overall Study|Lost to Follow-up|0|||
149728942|NCT00236080|540142429|FG004|Overall Study|Lost to Follow-up|0|||
149728943|NCT00236080|540142425|FG000|Overall Study|Physician Decision|1|||
149728944|NCT00236080|540142426|FG001|Overall Study|Physician Decision|0|||
149728945|NCT00236080|540142427|FG002|Overall Study|Physician Decision|1|||
149728946|NCT00236080|540142428|FG003|Overall Study|Physician Decision|1|||
149728947|NCT00236080|540142429|FG004|Overall Study|Physician Decision|1|||
149728948|NCT00236080|540142425|FG000|Overall Study|Withdrawal by Subject|1|||
149728949|NCT00236080|540142426|FG001|Overall Study|Withdrawal by Subject|0|||
149728950|NCT00236080|540142427|FG002|Overall Study|Withdrawal by Subject|0|||
149728951|NCT00236080|540142428|FG003|Overall Study|Withdrawal by Subject|0|||
149728952|NCT00236080|540142429|FG004|Overall Study|Withdrawal by Subject|0|||
149728953|NCT00236080|540142425|FG000|Overall Study|Miscellaneous|0|||
149728954|NCT00236080|540142426|FG001|Overall Study|Miscellaneous|0|||
149728955|NCT00236080|540142427|FG002|Overall Study|Miscellaneous|1|||
149728956|NCT00236080|540142428|FG003|Overall Study|Miscellaneous|0|||
149728957|NCT00236080|540142429|FG004|Overall Study|Miscellaneous|0|||
149728958|NCT01214044|540142430|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
149728959|NCT01214044|540142430|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
149728960|NCT01214044|540142430|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
149728961|NCT01214044|540142430|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
149728962|NCT01214044|540142430|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
149728963|NCT01214044|540142430|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
149728964|NCT00408694|540142431|FG000|Overall Study|Ineligible|1|||
149728965|NCT00408694|540142431|FG000|Overall Study|No protocol treatment|1|||
149728966|NCT01961544|540142432|FG000|Overall Study|Protocol Violation|1|||
149728967|NCT01961544|540142432|FG000|Overall Study|Withdrawal by Subject|7|||
149728968|NCT01961544|540142432|FG000|Overall Study|Adverse Event|1|||
149728969|NCT01961544|540142432|FG000|Overall Study|Physician Decision|2|||
149728970|NCT01961544|540142432|FG000|Overall Study|Poor Tolerance|1|||
149728971|NCT01961544|540142432|FG000|Overall Study|Aggravation of Steral Pain|1|||
149728972|NCT00193063|540142433|FG000|Overall Study|Lack of Efficacy|3|||
149728973|NCT00193063|540142433|FG000|Overall Study|Adverse Event|1|||
150251840|NCT00626990|542058300|FG002|Overall Study|Lack of Efficacy|49|||
150251841|NCT00626990|542058301|FG003|Overall Study|Lack of Efficacy|40|||
150251842|NCT00626990|542058298|FG000|Overall Study|Adverse Event|1|||
150251843|NCT00626990|542058299|FG001|Overall Study|Adverse Event|7|||
150251844|NCT00626990|542058300|FG002|Overall Study|Adverse Event|14|||
150251845|NCT00626990|542058301|FG003|Overall Study|Adverse Event|28|||
150251846|NCT00626990|542058298|FG000|Overall Study|Death|0|||
150251847|NCT00626990|542058299|FG001|Overall Study|Death|1|||
150251848|NCT00626990|542058300|FG002|Overall Study|Death|0|||
150251849|NCT00626990|542058301|FG003|Overall Study|Death|0|||
150251850|NCT00626990|542058298|FG000|Overall Study|Withdrawal by Subject|3|||
150251851|NCT00626990|542058299|FG001|Overall Study|Withdrawal by Subject|1|||
150251852|NCT00626990|542058300|FG002|Overall Study|Withdrawal by Subject|5|||
150251853|NCT00626990|542058301|FG003|Overall Study|Withdrawal by Subject|11|||
149728974|NCT01127165|540142434|FG000|Overall Study|Adverse Event|2|||
149728975|NCT01127165|540142435|FG001|Overall Study|Adverse Event|2|||
149728976|NCT01127165|540142434|FG000|Overall Study|Lack of Efficacy|10|||
149728977|NCT01127165|540142435|FG001|Overall Study|Lack of Efficacy|8|||
149728978|NCT01127165|540142434|FG000|Overall Study|Lost to Follow-up|3|||
150251854|NCT00626990|542058298|FG000|Overall Study|Protocol Violation|0|||
149728979|NCT01127165|540142435|FG001|Overall Study|Lost to Follow-up|5|||
149728980|NCT01127165|540142434|FG000|Overall Study|Withdrawal by Subject|1|||
149728981|NCT01127165|540142435|FG001|Overall Study|Withdrawal by Subject|3|||
149728982|NCT01127165|540142434|FG000|Overall Study|Protocol Violation|0|||
149728983|NCT01127165|540142435|FG001|Overall Study|Protocol Violation|1|||
149728984|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
149728985|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149728986|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149728987|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149728988|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149728989|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
149728990|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
149728991|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
149728992|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
149728993|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
149728994|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
149728995|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149728996|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149728997|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149728998|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149728999|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
149729000|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149729001|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149729002|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149729003|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149729004|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
149729005|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
149729006|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
149729007|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
149729008|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
149729009|NCT01017952|540142436|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
149729010|NCT01017952|540142437|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149729011|NCT01017952|540142438|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149729012|NCT01017952|540142439|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149729013|NCT01017952|540142440|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149729014|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
149729015|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
149729016|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
149729017|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
149729018|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
149729019|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149729020|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
149729021|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
149729022|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
149729023|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
149729024|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149729025|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
149729026|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
149729027|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
149729028|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
149729029|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
149729030|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149729031|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
149729032|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
149729033|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
149729034|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149729035|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
149729036|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
149729037|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
149729038|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
149729039|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149729040|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149729041|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149729042|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
150251855|NCT00626990|542058299|FG001|Overall Study|Protocol Violation|1|||
149729043|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149729044|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149729045|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
149729046|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
149729047|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
149729048|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
149729049|NCT01017952|540142436|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
149729050|NCT01017952|540142437|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
149729051|NCT01017952|540142438|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
149729052|NCT01017952|540142439|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
149729053|NCT01017952|540142440|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
149729054|NCT01064167|540142441|FG000|Overall Study|Protocol Violation|14|||
149729055|NCT01064167|540142442|FG001|Overall Study|Protocol Violation|15|||
149729056|NCT03984305|540142445|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
150251856|NCT00626990|542058300|FG002|Overall Study|Protocol Violation|1|||
150251857|NCT00626990|542058301|FG003|Overall Study|Protocol Violation|0|||
150251858|NCT00626990|542058298|FG000|Overall Study|Various different reasons/missing|4|||
150251859|NCT00626990|542058299|FG001|Overall Study|Various different reasons/missing|8|||
149729057|NCT03984305|540142446|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
149729058|NCT03984305|540142445|FG000|Overall Study|Withdrawal by Subject|3|||
149729059|NCT03984305|540142446|FG001|Overall Study|Withdrawal by Subject|3|||
149729060|NCT03984305|540142445|FG000|Overall Study|Lost to Follow-up|1|||
149729061|NCT03984305|540142446|FG001|Overall Study|Lost to Follow-up|0|||
149729062|NCT03543410|540142449|FG000|Overall Study|Adverse Event|10|||
149729063|NCT03543410|540142450|FG001|Overall Study|Adverse Event|8|||
149729064|NCT03543410|540142451|FG002|Overall Study|Adverse Event|2|||
149729065|NCT03543410|540142449|FG000|Overall Study|Lack of Efficacy|0|||
149729066|NCT03543410|540142450|FG001|Overall Study|Lack of Efficacy|1|||
149729067|NCT03543410|540142451|FG002|Overall Study|Lack of Efficacy|0|||
149729068|NCT03543410|540142449|FG000|Overall Study|Lost to Follow-up|0|||
149729069|NCT03543410|540142450|FG001|Overall Study|Lost to Follow-up|1|||
149729070|NCT03543410|540142451|FG002|Overall Study|Lost to Follow-up|0|||
149729071|NCT03543410|540142449|FG000|Overall Study|Withdrawal by Subject|5|||
149729072|NCT03543410|540142450|FG001|Overall Study|Withdrawal by Subject|2|||
149729073|NCT03543410|540142451|FG002|Overall Study|Withdrawal by Subject|8|||
149729074|NCT03543410|540142449|FG000|Overall Study|Protocol Violation|0|||
149729075|NCT03543410|540142450|FG001|Overall Study|Protocol Violation|1|||
149729076|NCT03543410|540142451|FG002|Overall Study|Protocol Violation|0|||
149729077|NCT03543410|540142449|FG000|Overall Study|Due to COVID-19|4|||
149729078|NCT03543410|540142450|FG001|Overall Study|Due to COVID-19|0|||
149729079|NCT03543410|540142451|FG002|Overall Study|Due to COVID-19|2|||
149729080|NCT03543410|540142449|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
149729081|NCT03543410|540142450|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
149729082|NCT03543410|540142451|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
149729083|NCT03543410|540142449|FG000|Overall Study|Not Due to COVID-19|2|||
149729084|NCT03543410|540142450|FG001|Overall Study|Not Due to COVID-19|0|||
149729085|NCT03543410|540142451|FG002|Overall Study|Not Due to COVID-19|1|||
149729086|NCT02435914|540142452|FG000|Overall Study|Ocular Adverse Event|1|||
149729087|NCT02435914|540142453|FG001|Overall Study|Ocular Adverse Event|0|||
149729088|NCT02435914|540142454|FG002|Overall Study|Ocular Adverse Event|0|||
149729089|NCT02435914|540142455|FG003|Overall Study|Ocular Adverse Event|0|||
149729090|NCT02435914|540142452|FG000|Overall Study|Withdrawal by Subject|0|||
149729091|NCT02435914|540142453|FG001|Overall Study|Withdrawal by Subject|1|||
149729092|NCT02435914|540142454|FG002|Overall Study|Withdrawal by Subject|0|||
149729093|NCT02435914|540142455|FG003|Overall Study|Withdrawal by Subject|0|||
149729094|NCT02435914|540142452|FG000|Overall Study|Other Miscellaneous Reason|0|||
149729095|NCT02435914|540142453|FG001|Overall Study|Other Miscellaneous Reason|0|||
149729096|NCT02435914|540142454|FG002|Overall Study|Other Miscellaneous Reason|1|||
149729097|NCT02435914|540142455|FG003|Overall Study|Other Miscellaneous Reason|0|||
149729098|NCT01818726|540142458|FG000|Overall Study|Administrative reasons|5|||
149729099|NCT01818726|540142459|FG001|Overall Study|Administrative reasons|1|||
149729100|NCT01818726|540142458|FG000|Overall Study|Withdrawal by Subject|0|||
149729101|NCT01818726|540142459|FG001|Overall Study|Withdrawal by Subject|1|||
150251860|NCT00626990|542058300|FG002|Overall Study|Various different reasons/missing|8|||
150251861|NCT00626990|542058301|FG003|Overall Study|Various different reasons/missing|16|||
149729102|NCT01818726|540142458|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
149729103|NCT01818726|540142459|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
149729104|NCT04871711|540142460|FG000|Overall Study|Withdrawal by Subject|11|||
149729105|NCT04871711|540142461|FG001|Overall Study|Withdrawal by Subject|5|||
149729106|NCT04871711|540142460|FG000|Overall Study|Lack of Efficacy|5|||
149729107|NCT04871711|540142461|FG001|Overall Study|Lack of Efficacy|7|||
149729108|NCT04871711|540142460|FG000|Overall Study|Adverse Event|2|||
149729109|NCT04871711|540142461|FG001|Overall Study|Adverse Event|6|||
149729110|NCT04871711|540142460|FG000|Overall Study|Various reasons|2|||
149729111|NCT04871711|540142461|FG001|Overall Study|Various reasons|1|||
149729112|NCT04871711|540142460|FG000|Overall Study|Lost to Follow-up|0|||
149729113|NCT04871711|540142461|FG001|Overall Study|Lost to Follow-up|2|||
149729114|NCT01913483|540142462|FG000|Overall Study|Withdrawal by Subject|1|||
149729115|NCT01913483|540142463|FG001|Overall Study|Withdrawal by Subject|2|||
149729116|NCT01913483|540142462|FG000|Overall Study|Lost to Follow-up|6|||
149729117|NCT01913483|540142463|FG001|Overall Study|Lost to Follow-up|3|||
149729118|NCT01913483|540142462|FG000|Overall Study|Death|14|||
149729119|NCT01913483|540142463|FG001|Overall Study|Death|17|||
149729120|NCT01469000|540142467|FG000|Overall Study|Withdrawal by Subject|16|||
149729121|NCT01469000|540142468|FG001|Overall Study|Withdrawal by Subject|3|||
149729122|NCT01469000|540142467|FG000|Overall Study|Sponsor Decision|4|||
149729123|NCT01469000|540142468|FG001|Overall Study|Sponsor Decision|1|||
149729124|NCT02026063|540142473|FG000|Overall Study|Physician Decision|0|||
149729125|NCT02026063|540142474|FG001|Overall Study|Physician Decision|10|||
149729126|NCT02026063|540142473|FG000|Overall Study|Noncompliance with Study Drug|1|||
149729127|NCT02026063|540142474|FG001|Overall Study|Noncompliance with Study Drug|1|||
149729128|NCT02026063|540142473|FG000|Overall Study|Withdrawal of Consent|1|||
149729129|NCT02026063|540142474|FG001|Overall Study|Withdrawal of Consent|6|||
149729130|NCT02026063|540142473|FG000|Overall Study|Adverse Event|5|||
149729131|NCT02026063|540142474|FG001|Overall Study|Adverse Event|20|||
149729132|NCT02026063|540142473|FG000|Overall Study|Lack of Efficacy|0|||
149729133|NCT02026063|540142474|FG001|Overall Study|Lack of Efficacy|4|||
149729134|NCT02026063|540142473|FG000|Overall Study|Lost to Follow-up|0|||
149729135|NCT02026063|540142474|FG001|Overall Study|Lost to Follow-up|1|||
149729136|NCT02026063|540142473|FG000|Overall Study|Reason not Specified|2|||
149729137|NCT02026063|540142474|FG001|Overall Study|Reason not Specified|7|||
149729138|NCT00486278|540142481|FG000|Overall Study|Adverse Event|5|||
149729139|NCT00486278|540142481|FG000|Overall Study|Withdrawal by Subject|2|||
149729140|NCT00486278|540142481|FG000|Overall Study|Physician Decision|2|||
149729141|NCT02183519|540142487|FG000|Overall Study|computer error|3|||
149729142|NCT02183519|540142488|FG001|Overall Study|computer error|0|||
149729143|NCT02183519|540142487|FG000|Overall Study|Did not respond to cough inducter|0|||
149729144|NCT02183519|540142488|FG001|Overall Study|Did not respond to cough inducter|3|||
149729145|NCT04556617|540142489|FG000|Overall Study|progressive disease|0|||
149729146|NCT04556617|540142490|FG001|Overall Study|progressive disease|2|||
149729147|NCT04556617|540142491|FG002|Overall Study|progressive disease|2|||
149729148|NCT04556617|540142492|FG003|Overall Study|progressive disease|1|||
149729149|NCT04556617|540142493|FG004|Overall Study|progressive disease|1|||
149729150|NCT04556617|540142489|FG000|Overall Study|Physician Decision|0|||
149729151|NCT04556617|540142490|FG001|Overall Study|Physician Decision|0|||
149729152|NCT04556617|540142491|FG002|Overall Study|Physician Decision|2|||
149729153|NCT04556617|540142492|FG003|Overall Study|Physician Decision|0|||
149729154|NCT04556617|540142493|FG004|Overall Study|Physician Decision|0|||
149729155|NCT04556617|540142489|FG000|Overall Study|Adverse Event|0|||
149729156|NCT04556617|540142490|FG001|Overall Study|Adverse Event|0|||
149729157|NCT04556617|540142491|FG002|Overall Study|Adverse Event|2|||
149729158|NCT04556617|540142492|FG003|Overall Study|Adverse Event|3|||
149729159|NCT04556617|540142493|FG004|Overall Study|Adverse Event|0|||
149729160|NCT04556617|540142489|FG000|Overall Study|Withdrawal by Subject|0|||
149729161|NCT04556617|540142490|FG001|Overall Study|Withdrawal by Subject|2|||
150251862|NCT04138576|542058302|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
150251863|NCT01994837|542058303|FG000|Overall Study|Progressive disease per protocol|23|||
149729162|NCT04556617|540142491|FG002|Overall Study|Withdrawal by Subject|1|||
149729163|NCT04556617|540142492|FG003|Overall Study|Withdrawal by Subject|1|||
149729164|NCT04556617|540142493|FG004|Overall Study|Withdrawal by Subject|0|||
149729165|NCT04556617|540142489|FG000|Overall Study|PSA increase|0|||
149729166|NCT04556617|540142490|FG001|Overall Study|PSA increase|1|||
149729167|NCT04556617|540142491|FG002|Overall Study|PSA increase|0|||
149729168|NCT04556617|540142492|FG003|Overall Study|PSA increase|0|||
149729169|NCT04556617|540142493|FG004|Overall Study|PSA increase|0|||
149729170|NCT04556617|540142489|FG000|Overall Study|Sponsor study termination|1|||
149729171|NCT04556617|540142490|FG001|Overall Study|Sponsor study termination|0|||
149729172|NCT04556617|540142491|FG002|Overall Study|Sponsor study termination|0|||
149729173|NCT04556617|540142492|FG003|Overall Study|Sponsor study termination|0|||
149729174|NCT04556617|540142493|FG004|Overall Study|Sponsor study termination|0|||
149729175|NCT05168267|540142496|FG000|Overall Study|Withdrawal by Subject|2|||
149729176|NCT05168267|540142497|FG001|Overall Study|Withdrawal by Subject|1|||
149729177|NCT05168267|540142496|FG000|Overall Study|Withdrawn by Therapist|1|||
149729178|NCT05168267|540142497|FG001|Overall Study|Withdrawn by Therapist|1|||
149729179|NCT05168267|540142496|FG000|Overall Study|Left Facility|1|||
149729180|NCT05168267|540142497|FG001|Overall Study|Left Facility|0|||
149729181|NCT02937350|540142498|FG000|Overall Study|Withdrawal by Subject|0|||
149729182|NCT02937350|540142499|FG001|Overall Study|Withdrawal by Subject|1|||
149729183|NCT02937350|540142500|FG002|Overall Study|Withdrawal by Subject|0|||
149729184|NCT00695565|540142501|FG000|Overall Study|Lost to Follow-up|4|||
149729185|NCT00695565|540142502|FG001|Overall Study|Lost to Follow-up|4|||
149729186|NCT00695565|540142501|FG000|Overall Study|Adverse Event|3|||
149729187|NCT00695565|540142502|FG001|Overall Study|Adverse Event|1|||
149729188|NCT00695565|540142501|FG000|Overall Study|Protocol Violation|3|||
149729189|NCT00695565|540142502|FG001|Overall Study|Protocol Violation|1|||
149729190|NCT00695565|540142501|FG000|Overall Study|Withdrawal by Subject|1|||
149729191|NCT00695565|540142502|FG001|Overall Study|Withdrawal by Subject|1|||
149729192|NCT00695565|540142501|FG000|Overall Study|Lack of Efficacy|1|||
149729193|NCT00695565|540142502|FG001|Overall Study|Lack of Efficacy|1|||
149729194|NCT00695565|540142501|FG000|Overall Study|Subject did not follow instructions|1|||
149729195|NCT00695565|540142502|FG001|Overall Study|Subject did not follow instructions|1|||
149729196|NCT01462266|540142503|FG000|Overall Study|Adverse Event|7|||
149729197|NCT01462266|540142504|FG001|Overall Study|Adverse Event|6|||
149729198|NCT01462266|540142503|FG000|Overall Study|Death|2|||
149729199|NCT01462266|540142504|FG001|Overall Study|Death|1|||
149729200|NCT01462266|540142503|FG000|Overall Study|Lack of Efficacy|0|||
149729201|NCT01462266|540142504|FG001|Overall Study|Lack of Efficacy|2|||
149729202|NCT01462266|540142503|FG000|Overall Study|Lost to Follow-up|4|||
149729203|NCT01462266|540142504|FG001|Overall Study|Lost to Follow-up|3|||
149729204|NCT01462266|540142503|FG000|Overall Study|Non-compliance with study drug|3|||
149729205|NCT01462266|540142504|FG001|Overall Study|Non-compliance with study drug|0|||
149729206|NCT01462266|540142503|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
149729207|NCT01462266|540142504|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
149729208|NCT01462266|540142503|FG000|Overall Study|Physician Decision|2|||
149729209|NCT01462266|540142504|FG001|Overall Study|Physician Decision|5|||
149729210|NCT01462266|540142503|FG000|Overall Study|Protocol Violation|1|||
149729211|NCT01462266|540142504|FG001|Overall Study|Protocol Violation|3|||
149729212|NCT01462266|540142503|FG000|Overall Study|Withdrawal by Subject|7|||
149729213|NCT01462266|540142504|FG001|Overall Study|Withdrawal by Subject|2|||
149729214|NCT01462266|540142503|FG000|Overall Study|Screen failure|1|||
149729215|NCT01462266|540142504|FG001|Overall Study|Screen failure|1|||
149729216|NCT01106846|540142505|FG000|Overall Study|Change in surgical procedure|0|||
149729217|NCT01106846|540142506|FG001|Overall Study|Change in surgical procedure|1|||
149729218|NCT04698629|540142520|FG000|Overall Study|Adverse Event|1|||
149729219|NCT02320487|540142521|FG000|Overall Study|Reason not Specified|1|||
149729220|NCT02320487|540142521|FG000|Overall Study|Physician Decision|5|||
149729221|NCT02320487|540142521|FG000|Overall Study|Withdrawal by Subject|1|||
149729222|NCT02320487|540142521|FG000|Overall Study|Death|3|||
149729223|NCT02320487|540142521|FG000|Overall Study|Adverse Event|11|||
149729224|NCT06228586|540142522|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
149729225|NCT06228586|540142523|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
149729226|NCT05888103|540144136|FG000|Overall Study|Participant decision|3|||
149729227|NCT05888103|540144137|FG001|Overall Study|Participant decision|3|||
149729228|NCT05900115|540144138|FG000|Overall Study|Lost to Follow-up|129|||
149729229|NCT05900115|540144139|FG001|Overall Study|Lost to Follow-up|98|||
149729230|NCT02949128|540144140|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
149729231|NCT02949128|540144140|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
149729232|NCT02949128|540144140|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
149729233|NCT02949128|540144140|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
149729234|NCT02949128|540144140|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
149729235|NCT02949128|540144140|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
150251864|NCT01994837|542058303|FG000|Overall Study|Adv event related to progressive disease|3|||
149729236|NCT02949128|540144140|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
149729237|NCT02949128|540144140|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
149729238|NCT02949128|540144140|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
149729239|NCT02949128|540144140|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
149729240|NCT01602341|540144141|FG000|Overall Study|Adverse Event|0|||
149729241|NCT01602341|540144142|FG001|Overall Study|Adverse Event|1|||
149729242|NCT02152345|540144143|FG000|Overall Study|Case Cancellations|2|||
149729243|NCT02152345|540144144|FG001|Overall Study|Case Cancellations|4|||
149729244|NCT02152345|540144143|FG000|Overall Study|Withdrawal by Subject|2|||
149729245|NCT02152345|540144144|FG001|Overall Study|Withdrawal by Subject|1|||
149729246|NCT02554929|540144146|FG000|Overall Study|Lost to Follow-up|4|||
149729247|NCT02554929|540144147|FG001|Overall Study|Lost to Follow-up|4|||
149729248|NCT02554929|540144146|FG000|Overall Study|Withdrawal by Subject|2|||
149729249|NCT02554929|540144147|FG001|Overall Study|Withdrawal by Subject|8|||
149729250|NCT01916980|540144148|FG000|Overall Study|Adverse Event|4|||
149729251|NCT01916980|540144149|FG001|Overall Study|Adverse Event|2|||
149729252|NCT01916980|540144148|FG000|Overall Study|Lack of Efficacy|2|||
149729253|NCT01916980|540144149|FG001|Overall Study|Lack of Efficacy|2|||
149729254|NCT01916980|540144148|FG000|Overall Study|Withdrawal by Subject|1|||
149729255|NCT01916980|540144149|FG001|Overall Study|Withdrawal by Subject|0|||
149729256|NCT02324270|540144150|FG000|Overall Study|Withdrawal by Subject|0|||
149729257|NCT02324270|540144151|FG001|Overall Study|Withdrawal by Subject|1|||
149729258|NCT02324270|540144152|FG002|Overall Study|Withdrawal by Subject|0|||
149729259|NCT02324270|540144150|FG000|Overall Study|Lost to Follow-up|4|||
149729260|NCT02324270|540144151|FG001|Overall Study|Lost to Follow-up|3|||
149729261|NCT02324270|540144152|FG002|Overall Study|Lost to Follow-up|4|||
149729262|NCT02324270|540144150|FG000|Overall Study|Protocol Violation|0|||
149729263|NCT02324270|540144151|FG001|Overall Study|Protocol Violation|1|||
149729264|NCT02324270|540144152|FG002|Overall Study|Protocol Violation|1|||
149729265|NCT02324270|540144150|FG000|Overall Study|Non Compliance with Study Drug|1|||
149729266|NCT02324270|540144151|FG001|Overall Study|Non Compliance with Study Drug|2|||
149729267|NCT02324270|540144152|FG002|Overall Study|Non Compliance with Study Drug|0|||
149729268|NCT00546364|540144153|FG000|Overall Study|Disease progression|5|||
149729269|NCT00546364|540144154|FG001|Overall Study|Disease progression|11|||
149729270|NCT00546364|540144155|FG002|Overall Study|Disease progression|8|||
149729271|NCT00546364|540144153|FG000|Overall Study|Completed and off treatment|1|||
149729272|NCT00546364|540144154|FG001|Overall Study|Completed and off treatment|0|||
149729273|NCT00546364|540144155|FG002|Overall Study|Completed and off treatment|2|||
149729274|NCT00546364|540144153|FG000|Overall Study|Administrative reason by sponsor|1|||
149729275|NCT00546364|540144154|FG001|Overall Study|Administrative reason by sponsor|0|||
149729276|NCT00546364|540144155|FG002|Overall Study|Administrative reason by sponsor|0|||
149729277|NCT00546364|540144153|FG000|Overall Study|Poor compliance/noncompliance|0|||
149729278|NCT00546364|540144154|FG001|Overall Study|Poor compliance/noncompliance|0|||
149729279|NCT00546364|540144155|FG002|Overall Study|Poor compliance/noncompliance|1|||
149729280|NCT00546364|540144153|FG000|Overall Study|No longer meets study criteria|1|||
149729281|NCT00546364|540144154|FG001|Overall Study|No longer meets study criteria|1|||
149729282|NCT00546364|540144155|FG002|Overall Study|No longer meets study criteria|0|||
149729283|NCT00546364|540144153|FG000|Overall Study|Withdrawal by Subject|5|||
149729284|NCT00546364|540144154|FG001|Overall Study|Withdrawal by Subject|6|||
149729285|NCT00546364|540144155|FG002|Overall Study|Withdrawal by Subject|3|||
149729286|NCT00546364|540144153|FG000|Overall Study|Prior taxotere|1|||
149729287|NCT00546364|540144154|FG001|Overall Study|Prior taxotere|0|||
149729288|NCT00546364|540144155|FG002|Overall Study|Prior taxotere|0|||
149729289|NCT00546364|540144153|FG000|Overall Study|Mixed response|1|||
149729290|NCT00546364|540144154|FG001|Overall Study|Mixed response|0|||
149729291|NCT00546364|540144155|FG002|Overall Study|Mixed response|0|||
149729292|NCT00546364|540144153|FG000|Overall Study|Palliative treatment|1|||
149729293|NCT00546364|540144154|FG001|Overall Study|Palliative treatment|0|||
149729294|NCT00546364|540144155|FG002|Overall Study|Palliative treatment|1|||
149729295|NCT00546364|540144153|FG000|Overall Study|Target lesions resected|1|||
149729296|NCT00546364|540144154|FG001|Overall Study|Target lesions resected|0|||
149729297|NCT00546364|540144155|FG002|Overall Study|Target lesions resected|0|||
149729298|NCT00546364|540144153|FG000|Overall Study|Physician Decision|0|||
149729299|NCT00546364|540144154|FG001|Overall Study|Physician Decision|0|||
149729300|NCT00546364|540144155|FG002|Overall Study|Physician Decision|1|||
149729301|NCT00546364|540144153|FG000|Overall Study|Sponsor decision|0|||
149729302|NCT00546364|540144154|FG001|Overall Study|Sponsor decision|0|||
149729303|NCT00546364|540144155|FG002|Overall Study|Sponsor decision|1|||
149729304|NCT03521791|540144156|FG000|Overall Study|Protocol Violation|7|||
149729305|NCT03521791|540144157|FG001|Overall Study|Protocol Violation|17|||
149729306|NCT02090855|540144158|FG000|Overall Study|no evaluable Standard of Truth results|2|||
149729307|NCT03786432|540144160|FG000|Overall Study|Screen Failure after consent|1|||
149729308|NCT03786432|540144160|FG000|Overall Study|Lost to Follow-up|4|||
149729309|NCT03786432|540144160|FG000|Overall Study|did not complete 12 month CT scan|1|||
149729310|NCT00388947|540144161|FG000|Overall Study|Protocol Violation|47|||
149729311|NCT04187092|540144162|FG000|Overall Study|Lost to Follow-up|1|||
149729312|NCT04187092|540144163|FG001|Overall Study|Lost to Follow-up|1|||
149729313|NCT04187092|540144162|FG000|Overall Study|Withdrawal by Subject|1|||
149729314|NCT04187092|540144163|FG001|Overall Study|Withdrawal by Subject|1|||
149729315|NCT04187092|540144162|FG000|Overall Study|Adverse Event|0|||
149729316|NCT04187092|540144163|FG001|Overall Study|Adverse Event|1|||
149729317|NCT01475734|540144165|FG000|Overall Study|Withdrawal by Subject|1|||
149729318|NCT01475734|540144166|FG001|Overall Study|Withdrawal by Subject|0|||
149729319|NCT01475734|540144165|FG000|Overall Study|Protocol Violation|1|||
149729320|NCT01475734|540144166|FG001|Overall Study|Protocol Violation|0|||
149729321|NCT01475734|540144165|FG000|Overall Study|Physician Decision|0|||
149729322|NCT01475734|540144166|FG001|Overall Study|Physician Decision|1|||
149729323|NCT00771472|540144167|FG000|Overall Study|Physician Decision|2|||
149729324|NCT00771472|540144168|FG001|Overall Study|Physician Decision|3|||
149729325|NCT00771472|540144167|FG000|Overall Study|Progressive Disease|3|||
150251865|NCT01994837|542058303|FG000|Overall Study|Fatal progressive disease|2|||
150251866|NCT01994837|542058303|FG000|Overall Study|Adverse event not related to progression|1|||
150251867|NCT01994837|542058303|FG000|Overall Study|Chose palliative care|1|||
150251868|NCT01994837|542058303|FG000|Overall Study|Proceeded to transplant|1|||
150251869|NCT01994837|542058303|FG000|Overall Study|Removed from study due to no response|1|||
150251870|NCT00574873|542058305|FG000|Overall Study|Withdrawal by Subject|18|||
150251871|NCT00574873|542058306|FG001|Overall Study|Withdrawal by Subject|19|||
150251872|NCT00574873|542058305|FG000|Overall Study|Investigator request|18|||
150251873|NCT00574873|542058306|FG001|Overall Study|Investigator request|8|||
150251874|NCT00574873|542058305|FG000|Overall Study|Death|15|||
150251875|NCT00574873|542058306|FG001|Overall Study|Death|14|||
150251876|NCT00574873|542058305|FG000|Overall Study|Lost to Follow-up|14|||
150251877|NCT00574873|542058306|FG001|Overall Study|Lost to Follow-up|5|||
150251878|NCT00574873|542058305|FG000|Overall Study|Other|40|||
150251879|NCT00574873|542058306|FG001|Overall Study|Other|4|||
150251880|NCT00574873|542058305|FG000|Overall Study|Discontinuation of study by sponsor|5|||
150251881|NCT00574873|542058306|FG001|Overall Study|Discontinuation of study by sponsor|199|||
150251882|NCT00574873|542058305|FG000|Overall Study|Blank, site closed per local regulations|2|||
150251883|NCT00574873|542058306|FG001|Overall Study|Blank, site closed per local regulations|2|||
150251884|NCT00574873|542058305|FG000|Overall Study|Extension Study|126|||
150251885|NCT00574873|542058306|FG001|Overall Study|Extension Study|0|||
150251886|NCT00581555|542058307|FG000|Overall Study|Adverse Event|4|||
150251887|NCT00581555|542058308|FG001|Overall Study|Adverse Event|3|||
150251888|NCT00581555|542058307|FG000|Overall Study|Physician Decision|3|||
150251889|NCT00581555|542058308|FG001|Overall Study|Physician Decision|2|||
150251890|NCT00581555|542058307|FG000|Overall Study|Withdrawal by Subject|18|||
150251891|NCT00581555|542058308|FG001|Overall Study|Withdrawal by Subject|9|||
150251892|NCT00581555|542058307|FG000|Overall Study|Lost to Follow-up|2|||
150251893|NCT00581555|542058308|FG001|Overall Study|Lost to Follow-up|2|||
150251894|NCT00581555|542058307|FG000|Overall Study|Other reasons|16|||
150251895|NCT00581555|542058308|FG001|Overall Study|Other reasons|4|||
150251896|NCT05816330|542058309|FG000|Overall Study|Withdrawal by Subject|4|||
150251897|NCT05816330|542058310|FG001|Overall Study|Withdrawal by Subject|1|||
150251898|NCT00201643|542058311|FG000|Overall Study|Withdrawal by Subject|5|||
150251899|NCT00201643|542058312|FG001|Overall Study|Withdrawal by Subject|4|||
150251900|NCT01802567|542058314|FG000|Overall Study|Withdrawal by Subject|2|||
150251901|NCT01802567|542058314|FG000|Overall Study|Physician Decision|1|||
150251902|NCT01802567|542058314|FG000|Overall Study|Lack of Efficacy|7|||
150251903|NCT01802567|542058314|FG000|Overall Study|Consented but did not start therapy|7|||
150251904|NCT01802567|542058314|FG000|Overall Study|Protocol Violation|1|||
150251905|NCT01940939|542058315|FG000|Overall Study|Withdrawal by Subject|2|||
150251906|NCT01940939|542058316|FG001|Overall Study|Withdrawal by Subject|8|||
150251907|NCT01895101|542058317|FG000|Overall Study|OPCAB procedure|1|||
150251908|NCT01895101|542058318|FG001|Overall Study|OPCAB procedure|1|||
150251909|NCT01895101|542058319|FG002|Overall Study|OPCAB procedure|3|||
150251910|NCT01895101|542058317|FG000|Overall Study|Withdrawal by Subject|0|||
150251911|NCT01895101|542058318|FG001|Overall Study|Withdrawal by Subject|1|||
150251912|NCT01895101|542058319|FG002|Overall Study|Withdrawal by Subject|2|||
150251913|NCT01895101|542058317|FG000|Overall Study|another study, enrolled in other study|0|||
150251914|NCT01895101|542058318|FG001|Overall Study|another study, enrolled in other study|1|||
150251915|NCT01895101|542058319|FG002|Overall Study|another study, enrolled in other study|0|||
150251916|NCT01895101|542058317|FG000|Overall Study|Death|0|||
150251917|NCT01895101|542058318|FG001|Overall Study|Death|1|||
150251918|NCT01895101|542058319|FG002|Overall Study|Death|0|||
150251919|NCT01895101|542058317|FG000|Overall Study|coagulation disorder|0|||
150251920|NCT01895101|542058318|FG001|Overall Study|coagulation disorder|1|||
150251921|NCT01895101|542058319|FG002|Overall Study|coagulation disorder|0|||
150251922|NCT00370682|542058320|FG000|Overall Study|Moved from area|0|||
150251923|NCT00370682|542058321|FG001|Overall Study|Moved from area|2|||
150251924|NCT00370682|542058322|FG002|Overall Study|Moved from area|0|||
150251925|NCT00370682|542058320|FG000|Overall Study|Lost to Follow-up|0|||
150251926|NCT00370682|542058321|FG001|Overall Study|Lost to Follow-up|1|||
150251927|NCT00370682|542058322|FG002|Overall Study|Lost to Follow-up|1|||
150251928|NCT03167359|542058323|FG000|Overall Study|Physician Decision|1|||
150251929|NCT03167359|542058323|FG000|Overall Study|Lost to Follow-up|1|||
150251930|NCT03339583|542058324|FG000|First Intervention (14 Days)|Adverse Event|1|||
150251931|NCT03339583|542058325|FG001|First Intervention (14 Days)|Adverse Event|0|||
150251932|NCT03339583|542058324|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
150251933|NCT03339583|542058325|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
150251934|NCT03339583|542058324|FG000|Second Intervention (14 Days)|Adverse Event|0|||
150251935|NCT03339583|542058325|FG001|Second Intervention (14 Days)|Adverse Event|1|||
150251936|NCT03339583|542058324|FG000|Follow-up (14 Days)|Physician Decision|6|||
150251937|NCT03339583|542058325|FG001|Follow-up (14 Days)|Physician Decision|3|||
150251938|NCT00943852|542058326|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149729326|NCT00771472|540144168|FG001|Overall Study|Progressive Disease|1|||
149729327|NCT00771472|540144167|FG000|Overall Study|Protocol Violation|1|||
149729328|NCT00771472|540144168|FG001|Overall Study|Protocol Violation|0|||
149729329|NCT00880750|540144174|FG000|First Intervention|Adverse Event|1|||
149729330|NCT00880750|540144175|FG001|First Intervention|Adverse Event|0|||
149729331|NCT00880750|540144174|FG000|First Intervention|Unable to collect urine|4|||
149729332|NCT00880750|540144175|FG001|First Intervention|Unable to collect urine|0|||
149729333|NCT00880750|540144174|FG000|First Intervention|Non-compliance with meals|0|||
150251939|NCT00943852|542058327|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251940|NCT00943852|542058328|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251941|NCT00943852|542058329|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
150251942|NCT00943852|542058330|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149729334|NCT00880750|540144175|FG001|First Intervention|Non-compliance with meals|1|||
149729335|NCT00880750|540144174|FG000|First Intervention|Withdrawal by Subject|2|||
149729336|NCT00880750|540144175|FG001|First Intervention|Withdrawal by Subject|0|||
149729337|NCT00880750|540144174|FG000|First Intervention|Lost to Follow-up|2|||
149729338|NCT00880750|540144175|FG001|First Intervention|Lost to Follow-up|0|||
149729339|NCT00880750|540144174|FG000|Second Intervention|Withdrawal by Subject|2|||
149729340|NCT00880750|540144175|FG001|Second Intervention|Withdrawal by Subject|2|||
149729341|NCT00880750|540144174|FG000|Second Intervention|Protocol Violation|1|||
149729342|NCT00880750|540144175|FG001|Second Intervention|Protocol Violation|0|||
149729343|NCT00880750|540144174|FG000|Second Intervention|Unable to collect urine|1|||
149729344|NCT00880750|540144175|FG001|Second Intervention|Unable to collect urine|0|||
149729345|NCT00483327|540144180|FG000|Overall Study|Adverse Event|1|||
149729346|NCT00483327|540144180|FG000|Overall Study|Withdrawal by Subject|3|||
149729347|NCT00483327|540144180|FG000|Overall Study|Lost to Follow-up|4|||
149729348|NCT00483327|540144180|FG000|Overall Study|Patient Non Compliance|2|||
149729349|NCT01390389|540144181|FG000|Overall Study|Withdrawal by Subject|2|||
149729350|NCT01390389|540144182|FG001|Overall Study|Withdrawal by Subject|0|||
149729351|NCT01390389|540144181|FG000|Overall Study|Screen Fail|2|||
149729352|NCT01390389|540144182|FG001|Overall Study|Screen Fail|1|||
149729353|NCT03593915|540144183|FG000|Overall Study|Adverse Event|0|||
149729354|NCT03593915|540144184|FG001|Overall Study|Adverse Event|0|||
149729355|NCT03593915|540144185|FG002|Overall Study|Adverse Event|0|||
149729356|NCT03593915|540144186|FG003|Overall Study|Adverse Event|1|||
149729357|NCT03593915|540144187|FG004|Overall Study|Adverse Event|0|||
149729358|NCT03593915|540144188|FG005|Overall Study|Adverse Event|0|||
149729359|NCT03593915|540144183|FG000|Overall Study|Physician Decision|0|||
149729360|NCT03593915|540144184|FG001|Overall Study|Physician Decision|0|||
149729361|NCT03593915|540144185|FG002|Overall Study|Physician Decision|0|||
149729362|NCT03593915|540144186|FG003|Overall Study|Physician Decision|0|||
149729363|NCT03593915|540144187|FG004|Overall Study|Physician Decision|0|||
149729364|NCT03593915|540144188|FG005|Overall Study|Physician Decision|1|||
149729365|NCT01246206|540144189|FG000|Overall Study|Patient did not receive study regiments.|1|||
149729366|NCT02002975|540144190|FG000|Overall Study|Case Report Forms Uncollected|135|||
149729367|NCT02002975|540144190|FG000|Overall Study|Protocol Deviation|437|||
149729368|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
149729369|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
149729370|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
149729371|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
149729372|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
149729373|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
149729374|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
149729375|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
149729376|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
149729377|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
149729378|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
149729379|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
149729380|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
149729381|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
149729382|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
149729383|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
149729384|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
149729385|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
149729386|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
149729387|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
149729388|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
149729389|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
149729390|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
149729391|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
149729392|NCT04660643|540144191|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
149729393|NCT04660643|540144192|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
149729394|NCT04660643|540144193|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
149729395|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
149729396|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
149729397|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
149729398|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
149729399|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
149729400|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
149729401|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
149729402|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
150251943|NCT00943852|542058331|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149729403|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
149729404|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
149729405|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
149729406|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
149729407|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
149729408|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
149729409|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
149729410|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
149729411|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
149729412|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
149729413|NCT04660643|540144191|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
149729414|NCT04660643|540144192|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
149729415|NCT04660643|540144193|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
149729416|NCT03988907|540144194|FG000|Overall Study|Unable to complete visit|0|||
149729417|NCT03988907|540144195|FG001|Overall Study|Unable to complete visit|1|||
149729418|NCT03609619|540144201|FG000|Overall Study|Adverse Event|1|||
149729419|NCT03609619|540144202|FG001|Overall Study|Adverse Event|0|||
149729420|NCT03609619|540144201|FG000|Overall Study|Lack of Efficacy|1|||
149729421|NCT03609619|540144202|FG001|Overall Study|Lack of Efficacy|2|||
149729422|NCT03609619|540144201|FG000|Overall Study|Protocol Violation|5|||
149729423|NCT03609619|540144202|FG001|Overall Study|Protocol Violation|0|||
149729424|NCT03609619|540144201|FG000|Overall Study|Withdrawal by Subject|2|||
149729425|NCT03609619|540144202|FG001|Overall Study|Withdrawal by Subject|3|||
149729426|NCT03609619|540144201|FG000|Overall Study|Lost to Follow-up|1|||
149729427|NCT03609619|540144202|FG001|Overall Study|Lost to Follow-up|1|||
149729428|NCT05162066|540144203|FG000|Overall Study|Adverse Event|1|||
149729429|NCT05162066|540144204|FG001|Overall Study|Adverse Event|0|||
149729430|NCT05162066|540144205|FG002|Overall Study|Adverse Event|0|||
149729431|NCT05162066|540144203|FG000|Overall Study|Perceived lack of efficacy|1|||
149729432|NCT05162066|540144204|FG001|Overall Study|Perceived lack of efficacy|0|||
149729433|NCT05162066|540144205|FG002|Overall Study|Perceived lack of efficacy|0|||
149729434|NCT00167245|540144206|FG000|Overall Study|Lost to Follow-up|20|||
149729435|NCT00167245|540144207|FG001|Overall Study|Lost to Follow-up|31|||
149729436|NCT00167245|540144206|FG000|Overall Study|Withdrawal by Subject|5|||
149729437|NCT00167245|540144207|FG001|Overall Study|Withdrawal by Subject|8|||
149729438|NCT00167245|540144206|FG000|Overall Study|Incarcerated|3|||
149729439|NCT00167245|540144207|FG001|Overall Study|Incarcerated|2|||
149729440|NCT00167245|540144206|FG000|Overall Study|Drowsy|1|||
149729441|NCT00167245|540144207|FG001|Overall Study|Drowsy|0|||
149729442|NCT00568555|540144208|FG000|Overall Study|Withdrawal by Subject|1|||
149729443|NCT00568555|540144209|FG001|Overall Study|Withdrawal by Subject|1|||
149729444|NCT01871090|540144210|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
149729445|NCT01871090|540144211|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
149729446|NCT01871090|540144210|FG000|Overall Study|Interrogation not completed correctly|1|||
149729447|NCT01871090|540144211|FG001|Overall Study|Interrogation not completed correctly|0|||
149729448|NCT01871090|540144210|FG000|Overall Study|Subject Non-Compliance|0|||
149729449|NCT01871090|540144211|FG001|Overall Study|Subject Non-Compliance|1|||
149729450|NCT01231555|540144212|FG000|Overall Study|Study terminated|8|||
149729451|NCT01231555|540144213|FG001|Overall Study|Study terminated|5|||
149729452|NCT01231555|540144214|FG002|Overall Study|Study terminated|8|||
149729453|NCT01231555|540144212|FG000|Overall Study|Withdrawal by Subject|0|||
149729454|NCT01231555|540144213|FG001|Overall Study|Withdrawal by Subject|2|||
149729455|NCT01231555|540144214|FG002|Overall Study|Withdrawal by Subject|0|||
149729456|NCT01773421|540144217|FG000|Treatment Phase|Other|0|||
149729457|NCT01773421|540144218|FG001|Treatment Phase|Other|0|||
149729458|NCT01773421|540144219|FG002|Treatment Phase|Other|2|||
149729459|NCT01773421|540144220|FG003|Treatment Phase|Other|0|||
149729460|NCT01773421|540144221|FG004|Treatment Phase|Other|0|||
149729461|NCT01773421|540144222|FG005|Treatment Phase|Other|0|||
149729462|NCT01773421|540144223|FG006|Treatment Phase|Other|0|||
149729463|NCT01773421|540144217|FG000|Treatment Phase|Adverse Event|0|||
149729464|NCT01773421|540144218|FG001|Treatment Phase|Adverse Event|0|||
149729465|NCT01773421|540144219|FG002|Treatment Phase|Adverse Event|3|||
149729466|NCT01773421|540144220|FG003|Treatment Phase|Adverse Event|1|||
149729467|NCT01773421|540144221|FG004|Treatment Phase|Adverse Event|0|||
149729468|NCT01773421|540144222|FG005|Treatment Phase|Adverse Event|0|||
149729469|NCT01773421|540144223|FG006|Treatment Phase|Adverse Event|0|||
149729470|NCT01773421|540144217|FG000|Treatment Phase|Withdrawal by Subject|0|||
149729471|NCT01773421|540144218|FG001|Treatment Phase|Withdrawal by Subject|0|||
149729472|NCT01773421|540144219|FG002|Treatment Phase|Withdrawal by Subject|1|||
149729473|NCT01773421|540144220|FG003|Treatment Phase|Withdrawal by Subject|1|||
149729474|NCT01773421|540144221|FG004|Treatment Phase|Withdrawal by Subject|0|||
149729475|NCT01773421|540144222|FG005|Treatment Phase|Withdrawal by Subject|0|||
149729476|NCT01773421|540144223|FG006|Treatment Phase|Withdrawal by Subject|0|||
149729477|NCT01773421|540144217|FG000|Extension Phase|Other|0|||
149729478|NCT01773421|540144218|FG001|Extension Phase|Other|0|||
149729479|NCT01773421|540144219|FG002|Extension Phase|Other|0|||
149729480|NCT01773421|540144220|FG003|Extension Phase|Other|0|||
149729481|NCT01773421|540144221|FG004|Extension Phase|Other|1|||
149729482|NCT01773421|540144222|FG005|Extension Phase|Other|2|||
149729483|NCT01773421|540144223|FG006|Extension Phase|Other|0|||
149729484|NCT01773421|540144217|FG000|Extension Phase|Adverse Event|0|||
149729485|NCT01773421|540144218|FG001|Extension Phase|Adverse Event|0|||
149729486|NCT01773421|540144219|FG002|Extension Phase|Adverse Event|0|||
149729487|NCT01773421|540144220|FG003|Extension Phase|Adverse Event|0|||
149729488|NCT01773421|540144221|FG004|Extension Phase|Adverse Event|2|||
149729489|NCT01773421|540144222|FG005|Extension Phase|Adverse Event|0|||
149729490|NCT01773421|540144223|FG006|Extension Phase|Adverse Event|0|||
149729491|NCT00688909|540144224|FG000|Overall Study|Adverse Event|28|||
149729492|NCT00688909|540144224|FG000|Overall Study|Patient withdrew consent|2|||
149729493|NCT00688909|540144224|FG000|Overall Study|Administrative problems|1|||
149729494|NCT00688909|540144224|FG000|Overall Study|Protocol Violation|2|||
149729495|NCT03502330|540144225|FG000|Overall Study|Adverse Event|2|||
149729496|NCT03502330|540144226|FG001|Overall Study|Adverse Event|1|||
149729497|NCT03502330|540144227|FG002|Overall Study|Adverse Event|0|||
149729498|NCT03502330|540144228|FG003|Overall Study|Adverse Event|0|||
149729499|NCT03502330|540144229|FG004|Overall Study|Adverse Event|1|||
149729500|NCT03502330|540144230|FG005|Overall Study|Adverse Event|0|||
149729501|NCT03502330|540144231|FG006|Overall Study|Adverse Event|1|||
149729502|NCT03502330|540144232|FG007|Overall Study|Adverse Event|1|||
149729503|NCT03502330|540144233|FG008|Overall Study|Adverse Event|0|||
149729504|NCT03502330|540144225|FG000|Overall Study|Lack of Efficacy|1|||
149729505|NCT03502330|540144226|FG001|Overall Study|Lack of Efficacy|5|||
149729506|NCT03502330|540144227|FG002|Overall Study|Lack of Efficacy|3|||
149729507|NCT03502330|540144228|FG003|Overall Study|Lack of Efficacy|5|||
149729508|NCT03502330|540144229|FG004|Overall Study|Lack of Efficacy|1|||
149729509|NCT03502330|540144230|FG005|Overall Study|Lack of Efficacy|5|||
149729510|NCT03502330|540144231|FG006|Overall Study|Lack of Efficacy|5|||
149729511|NCT03502330|540144232|FG007|Overall Study|Lack of Efficacy|6|||
149729512|NCT03502330|540144233|FG008|Overall Study|Lack of Efficacy|0|||
149729513|NCT03502330|540144225|FG000|Overall Study|Physician Decision|0|||
149729514|NCT03502330|540144226|FG001|Overall Study|Physician Decision|0|||
149729515|NCT03502330|540144227|FG002|Overall Study|Physician Decision|0|||
149729516|NCT03502330|540144228|FG003|Overall Study|Physician Decision|0|||
149729517|NCT03502330|540144229|FG004|Overall Study|Physician Decision|1|||
149729518|NCT03502330|540144230|FG005|Overall Study|Physician Decision|0|||
149729519|NCT03502330|540144231|FG006|Overall Study|Physician Decision|0|||
149729520|NCT03502330|540144232|FG007|Overall Study|Physician Decision|0|||
149729521|NCT03502330|540144233|FG008|Overall Study|Physician Decision|0|||
149729522|NCT03502330|540144225|FG000|Overall Study|Withdrawal by Subject|0|||
149729523|NCT03502330|540144226|FG001|Overall Study|Withdrawal by Subject|0|||
149729524|NCT03502330|540144227|FG002|Overall Study|Withdrawal by Subject|0|||
149729525|NCT03502330|540144228|FG003|Overall Study|Withdrawal by Subject|0|||
149729526|NCT03502330|540144229|FG004|Overall Study|Withdrawal by Subject|0|||
149729527|NCT03502330|540144230|FG005|Overall Study|Withdrawal by Subject|1|||
149729528|NCT03502330|540144231|FG006|Overall Study|Withdrawal by Subject|0|||
149729529|NCT03502330|540144232|FG007|Overall Study|Withdrawal by Subject|1|||
149729530|NCT03502330|540144233|FG008|Overall Study|Withdrawal by Subject|0|||
149729531|NCT03502330|540144225|FG000|Overall Study|Death|0|||
149729532|NCT03502330|540144226|FG001|Overall Study|Death|0|||
149729533|NCT03502330|540144227|FG002|Overall Study|Death|0|||
149729534|NCT03502330|540144228|FG003|Overall Study|Death|0|||
149729535|NCT03502330|540144229|FG004|Overall Study|Death|0|||
149729536|NCT03502330|540144230|FG005|Overall Study|Death|0|||
149729537|NCT03502330|540144231|FG006|Overall Study|Death|2|||
149729538|NCT03502330|540144232|FG007|Overall Study|Death|0|||
149729539|NCT03502330|540144233|FG008|Overall Study|Death|0|||
149729540|NCT02472847|540144242|FG000|Overall Study|Withdrawal by Subject|1|||
149729541|NCT02472847|540144243|FG001|Overall Study|Withdrawal by Subject|5|||
149729542|NCT00669617|540144245|FG000|Period 1|Withdrawal by Subject|0|||
149729543|NCT00669617|540144246|FG001|Period 1|Withdrawal by Subject|0|||
149729544|NCT00669617|540144247|FG002|Period 1|Withdrawal by Subject|1|||
149729545|NCT00669617|540144248|FG003|Period 1|Withdrawal by Subject|0|||
149729546|NCT00669617|540144249|FG004|Period 1|Withdrawal by Subject|0|||
149729547|NCT00669617|540144245|FG000|Period 1|Protocol Deviation|0|||
149729548|NCT00669617|540144246|FG001|Period 1|Protocol Deviation|0|||
149729549|NCT00669617|540144247|FG002|Period 1|Protocol Deviation|0|||
149729550|NCT00669617|540144248|FG003|Period 1|Protocol Deviation|0|||
149729551|NCT00669617|540144249|FG004|Period 1|Protocol Deviation|1|||
149729552|NCT00669617|540144245|FG000|Period 3|Lost to Follow-up|1|||
149729553|NCT00669617|540144246|FG001|Period 3|Lost to Follow-up|0|||
149729554|NCT00669617|540144247|FG002|Period 3|Lost to Follow-up|0|||
149729555|NCT00669617|540144248|FG003|Period 3|Lost to Follow-up|0|||
149729556|NCT00669617|540144249|FG004|Period 3|Lost to Follow-up|0|||
149729557|NCT01276821|540144250|FG000|Overall Study|Protocol Violation|0|||
149729558|NCT01276821|540144251|FG001|Overall Study|Protocol Violation|1|||
149729559|NCT03980938|540144252|FG000|Treatment Period 1|Study Terminated|1|||
149729560|NCT03980938|540144253|FG001|Treatment Period 1|Study Terminated|1|||
149729561|NCT03980938|540144252|FG000|Treatment Period 2|Study Terminated|2|||
149729562|NCT03980938|540144253|FG001|Treatment Period 2|Study Terminated|2|||
149729563|NCT02939131|540144254|FG000|Overall Study|Unable to get to clinic|6|||
149729564|NCT02939131|540144255|FG001|Overall Study|Unable to get to clinic|4|||
149729565|NCT02939131|540144254|FG000|Overall Study|Lost to Follow-up|2|||
149729566|NCT02939131|540144255|FG001|Overall Study|Lost to Follow-up|4|||
149729567|NCT02939131|540144254|FG000|Overall Study|severe debilitation|1|||
149729568|NCT02939131|540144255|FG001|Overall Study|severe debilitation|0|||
149729569|NCT02939131|540144254|FG000|Overall Study|Other|0|||
149729570|NCT02939131|540144255|FG001|Overall Study|Other|1|||
149729571|NCT02939131|540144254|FG000|Overall Study|not willing to adhere to protocol|2|||
149729572|NCT02939131|540144255|FG001|Overall Study|not willing to adhere to protocol|0|||
149729573|NCT03569202|540144259|FG000|Part 3|Physician Decision|1|||
149729574|NCT03569202|540144260|FG001|Part 3|Physician Decision|0|||
149729575|NCT03569202|540144259|FG000|Part 3|Other|1|||
149729576|NCT03569202|540144260|FG001|Part 3|Other|1|||
149729577|NCT00420511|540144261|FG000|Overall Study|Adverse Event|1|||
149729578|NCT00420511|540144262|FG001|Overall Study|Adverse Event|1|||
149729579|NCT00420511|540144261|FG000|Overall Study|Lost to Follow-up|1|||
149729580|NCT00420511|540144262|FG001|Overall Study|Lost to Follow-up|0|||
149729581|NCT02415712|540144263|FG000|Overall Study|Protocol Violation|16|||
149729582|NCT01668654|540144264|FG000|Overall Study|Study Closed/Terminated|3|||
149729583|NCT01668654|540144264|FG000|Overall Study|Withdrawal by Subject|1|||
149729584|NCT00454779|540144266|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
149729585|NCT00454779|540144267|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
149729586|NCT00454779|540144266|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
149729587|NCT00454779|540144267|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
149729588|NCT00454779|540144266|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
149729589|NCT00454779|540144267|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
149729590|NCT00454779|540144266|FG000|First-line Treatment Phase|Protocol Violation|0|||
149729591|NCT00454779|540144267|FG001|First-line Treatment Phase|Protocol Violation|1|||
149729592|NCT00454779|540144266|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
149729593|NCT00454779|540144267|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
149729594|NCT00454779|540144266|FG000|First-line Treatment Phase|Ongoing|1|||
149729595|NCT00454779|540144267|FG001|First-line Treatment Phase|Ongoing|0|||
149729596|NCT00454779|540144266|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
149729597|NCT00454779|540144267|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
149729598|NCT00454779|540144266|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
149729599|NCT00454779|540144267|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
149729600|NCT00454779|540144266|FG000|Second-line Treatment Phase|Ongoing|0|||
149729601|NCT00454779|540144267|FG001|Second-line Treatment Phase|Ongoing|1|||
149729602|NCT01337973|540144268|FG000|Overall Study|Lost to Follow-up|2|||
150251944|NCT00943852|542058332|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251945|NCT00943852|542058333|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251946|NCT00943852|542058334|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251947|NCT00943852|542058335|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
150251948|NCT00943852|542058326|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251949|NCT00943852|542058327|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251950|NCT00943852|542058328|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251951|NCT00943852|542058329|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251952|NCT00943852|542058330|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251953|NCT00943852|542058331|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
150251954|NCT00943852|542058332|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251955|NCT00943852|542058333|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251956|NCT00943852|542058334|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
150251957|NCT00943852|542058335|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149729603|NCT01337973|540144269|FG001|Overall Study|Lost to Follow-up|4|||
149729604|NCT01337973|540144270|FG002|Overall Study|Lost to Follow-up|3|||
149729605|NCT01337973|540144268|FG000|Overall Study|Death|1|||
149729606|NCT01337973|540144269|FG001|Overall Study|Death|2|||
149729607|NCT01337973|540144270|FG002|Overall Study|Death|1|||
149729608|NCT01337973|540144268|FG000|Overall Study|Withdrawal by Subject|10|||
149729609|NCT01337973|540144269|FG001|Overall Study|Withdrawal by Subject|8|||
149729610|NCT01337973|540144270|FG002|Overall Study|Withdrawal by Subject|4|||
149729611|NCT01337973|540144268|FG000|Overall Study|missing data on primary outcome|3|||
149729612|NCT01337973|540144269|FG001|Overall Study|missing data on primary outcome|1|||
149729613|NCT01337973|540144270|FG002|Overall Study|missing data on primary outcome|3|||
149729614|NCT02522767|540144273|FG000|Double-blind|Withdrawal by Subject|8|||
150251958|NCT00943852|542058326|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251959|NCT00943852|542058327|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251960|NCT00943852|542058328|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251961|NCT00943852|542058329|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251962|NCT00943852|542058330|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251963|NCT00943852|542058331|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251964|NCT00943852|542058332|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
150251965|NCT00943852|542058333|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251966|NCT00943852|542058334|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251967|NCT00943852|542058335|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
150251968|NCT00943852|542058326|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251969|NCT00943852|542058327|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251970|NCT00943852|542058328|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149729615|NCT02522767|540144274|FG001|Double-blind|Withdrawal by Subject|11|||
149729616|NCT02522767|540144273|FG000|Double-blind|Lost to Follow-up|1|||
149729617|NCT02522767|540144274|FG001|Double-blind|Lost to Follow-up|0|||
149729618|NCT02522767|540144273|FG000|Double-blind|Adverse Event|1|||
149729619|NCT02522767|540144274|FG001|Double-blind|Adverse Event|10|||
149729620|NCT02522767|540144273|FG000|Double-blind|Protocol Violation|0|||
149729621|NCT02522767|540144274|FG001|Double-blind|Protocol Violation|1|||
149729622|NCT02522767|540144273|FG000|Double-blind|Lack of Efficacy|0|||
149729623|NCT02522767|540144274|FG001|Double-blind|Lack of Efficacy|2|||
149729624|NCT02522767|540144273|FG000|Double-blind|Protocol Deviation|1|||
149729625|NCT02522767|540144274|FG001|Double-blind|Protocol Deviation|0|||
149729626|NCT02522767|540144273|FG000|Open-label|Withdrawal by Subject|2|||
149729627|NCT02522767|540144274|FG001|Open-label|Withdrawal by Subject|3|||
149729628|NCT02522767|540144273|FG000|Open-label|Lost to Follow-up|0|||
149729629|NCT02522767|540144274|FG001|Open-label|Lost to Follow-up|1|||
149729630|NCT02522767|540144273|FG000|Open-label|Adverse Event|2|||
149729631|NCT02522767|540144274|FG001|Open-label|Adverse Event|1|||
149729632|NCT02522767|540144273|FG000|Open-label|Lack of Efficacy|1|||
149729633|NCT02522767|540144274|FG001|Open-label|Lack of Efficacy|1|||
149729634|NCT02522767|540144273|FG000|Open-label|Protocol Violation|0|||
149729635|NCT02522767|540144274|FG001|Open-label|Protocol Violation|1|||
149729636|NCT00254566|540144276|FG000|Overall Study|Death|1|||
149729637|NCT00254566|540144277|FG001|Overall Study|Death|0|||
149729638|NCT00254566|540144276|FG000|Overall Study|Adverse Event|5|||
149729639|NCT00254566|540144277|FG001|Overall Study|Adverse Event|4|||
149729640|NCT00254566|540144276|FG000|Overall Study|Lack of Efficacy|12|||
149729641|NCT00254566|540144277|FG001|Overall Study|Lack of Efficacy|9|||
149729642|NCT00254566|540144276|FG000|Overall Study|Other|1|||
149729643|NCT00254566|540144277|FG001|Overall Study|Other|5|||
149729644|NCT00254566|540144276|FG000|Overall Study|Withdrawal by Subject|5|||
149729645|NCT00254566|540144277|FG001|Overall Study|Withdrawal by Subject|6|||
149729646|NCT00254566|540144276|FG000|Overall Study|Lost to Follow-up|7|||
149729647|NCT00254566|540144277|FG001|Overall Study|Lost to Follow-up|2|||
149729648|NCT00548548|540144278|FG000|Overall Study|Death|345|||
149729649|NCT00548548|540144279|FG001|Overall Study|Death|348|||
149729650|NCT00548548|540144278|FG000|Overall Study|Lost to Follow-up|17|||
149729651|NCT00548548|540144279|FG001|Overall Study|Lost to Follow-up|18|||
149729652|NCT01940484|540144280|FG000|Overall Study|Withdrawal by Subject|3|||
149729653|NCT01940484|540144280|FG000|Overall Study|Underwent transplantation|4|||
149729654|NCT01940484|540144280|FG000|Overall Study|Death|2|||
149729655|NCT01940484|540144280|FG000|Overall Study|Adverse Event|1|||
149729656|NCT01705691|540144283|FG000|Overall Study|Death|1|||
149729657|NCT01705691|540144284|FG001|Overall Study|Death|2|||
149729658|NCT01705691|540144283|FG000|Overall Study|Withdrawal by Subject|1|||
149729659|NCT01705691|540144284|FG001|Overall Study|Withdrawal by Subject|2|||
149729660|NCT01705691|540144283|FG000|Overall Study|Lost to Follow-up|1|||
149729661|NCT01705691|540144284|FG001|Overall Study|Lost to Follow-up|1|||
149729662|NCT01705691|540144283|FG000|Overall Study|Other|0|||
150251971|NCT00943852|542058329|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149729663|NCT01705691|540144284|FG001|Overall Study|Other|1|||
149729664|NCT02658448|540144285|FG000|Overall Study|Lost to Follow-up|1|||
149729665|NCT00841763|540144286|FG000|Overall Study|Withdrawal by Subject|60|||
149729666|NCT00841763|540144287|FG001|Overall Study|Withdrawal by Subject|17|||
149729667|NCT00841763|540144288|FG002|Overall Study|Withdrawal by Subject|4|||
149729668|NCT00841763|540144289|FG003|Overall Study|Withdrawal by Subject|1|||
149729669|NCT00841763|540144286|FG000|Overall Study|Adverse Event|9|||
149729670|NCT00841763|540144287|FG001|Overall Study|Adverse Event|10|||
149729671|NCT00841763|540144288|FG002|Overall Study|Adverse Event|3|||
149729672|NCT00841763|540144289|FG003|Overall Study|Adverse Event|2|||
149729673|NCT00841763|540144286|FG000|Overall Study|Lost to Follow-up|63|||
149729674|NCT00841763|540144287|FG001|Overall Study|Lost to Follow-up|25|||
149729675|NCT00841763|540144288|FG002|Overall Study|Lost to Follow-up|0|||
149729676|NCT00841763|540144289|FG003|Overall Study|Lost to Follow-up|0|||
149729677|NCT00841763|540144286|FG000|Overall Study|Protocol Violation|20|||
149729678|NCT00841763|540144287|FG001|Overall Study|Protocol Violation|3|||
149729679|NCT00841763|540144288|FG002|Overall Study|Protocol Violation|1|||
149729680|NCT00841763|540144289|FG003|Overall Study|Protocol Violation|0|||
149729681|NCT00841763|540144286|FG000|Overall Study|Administrative Reasons|3|||
149729682|NCT00841763|540144287|FG001|Overall Study|Administrative Reasons|1|||
149729683|NCT00841763|540144288|FG002|Overall Study|Administrative Reasons|0|||
149729684|NCT00841763|540144289|FG003|Overall Study|Administrative Reasons|0|||
149729685|NCT00841763|540144286|FG000|Overall Study|Unable to Classify|7|||
149729686|NCT00841763|540144287|FG001|Overall Study|Unable to Classify|1|||
149729687|NCT00841763|540144288|FG002|Overall Study|Unable to Classify|0|||
149729688|NCT00841763|540144289|FG003|Overall Study|Unable to Classify|0|||
149729689|NCT03634800|540144290|FG000|Overall Study|Adverse Event|1|||
149729690|NCT03634800|540144290|FG000|Overall Study|Disease Progression|4|||
149729691|NCT03634800|540144290|FG000|Overall Study|Withdrawal by Subject|1|||
149729692|NCT00272987|540144293|FG000|Overall Study|Adverse Event|1|||
149729693|NCT00272987|540144294|FG001|Overall Study|Adverse Event|0|||
149729694|NCT00272987|540144295|FG002|Overall Study|Adverse Event|0|||
149729695|NCT00272987|540144293|FG000|Overall Study|Lost to Follow-up|3|||
149729696|NCT00272987|540144294|FG001|Overall Study|Lost to Follow-up|1|||
149729697|NCT00272987|540144295|FG002|Overall Study|Lost to Follow-up|1|||
149729698|NCT00272987|540144293|FG000|Overall Study|Withdrawal by Subject|1|||
149729699|NCT00272987|540144294|FG001|Overall Study|Withdrawal by Subject|0|||
149729700|NCT00272987|540144295|FG002|Overall Study|Withdrawal by Subject|3|||
149729701|NCT00272987|540144293|FG000|Overall Study|Sponsor Terminated study|0|||
149729702|NCT00272987|540144294|FG001|Overall Study|Sponsor Terminated study|1|||
149729703|NCT00272987|540144295|FG002|Overall Study|Sponsor Terminated study|1|||
149729704|NCT00272987|540144293|FG000|Overall Study|Disease progression|1|||
149729705|NCT00272987|540144294|FG001|Overall Study|Disease progression|1|||
149729706|NCT00272987|540144295|FG002|Overall Study|Disease progression|2|||
149729707|NCT00272987|540144293|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
149729708|NCT00272987|540144294|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
149729709|NCT00272987|540144295|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
149729710|NCT00272987|540144293|FG000|Overall Study|Death|1|||
149729711|NCT00272987|540144294|FG001|Overall Study|Death|0|||
149729712|NCT00272987|540144295|FG002|Overall Study|Death|0|||
149729713|NCT03739528|540144302|FG000|Overall Study|Not treated|8|||
149729714|NCT03739528|540144303|FG001|Overall Study|Not treated|12|||
149729715|NCT03739528|540144302|FG000|Overall Study|Treatment and study discontinued|6|||
149729716|NCT03739528|540144303|FG001|Overall Study|Treatment and study discontinued|2|||
149729717|NCT03739528|540144302|FG000|Overall Study|Treatment discontinued + study completed|1|||
149729718|NCT03739528|540144303|FG001|Overall Study|Treatment discontinued + study completed|3|||
149729719|NCT01109940|540144304|FG000|Overall Study|Administrative problems|2|||
149729720|NCT01109940|540144305|FG001|Overall Study|Administrative problems|0|||
149729721|NCT01109940|540144306|FG002|Overall Study|Administrative problems|0|||
149729722|NCT01109940|540144307|FG003|Overall Study|Administrative problems|0|||
149729723|NCT01109940|540144304|FG000|Overall Study|Serious Adverse Event|2|||
149729724|NCT01109940|540144305|FG001|Overall Study|Serious Adverse Event|1|||
149729725|NCT01109940|540144306|FG002|Overall Study|Serious Adverse Event|0|||
149729726|NCT01109940|540144307|FG003|Overall Study|Serious Adverse Event|0|||
149729727|NCT01109940|540144304|FG000|Overall Study|Lost to Follow-up|1|||
149729728|NCT01109940|540144305|FG001|Overall Study|Lost to Follow-up|0|||
149729729|NCT01109940|540144306|FG002|Overall Study|Lost to Follow-up|0|||
149729730|NCT01109940|540144307|FG003|Overall Study|Lost to Follow-up|0|||
149729731|NCT01109940|540144304|FG000|Overall Study|Patient withdrew consent|1|||
149729732|NCT01109940|540144305|FG001|Overall Study|Patient withdrew consent|1|||
149729733|NCT01109940|540144306|FG002|Overall Study|Patient withdrew consent|0|||
149729734|NCT01109940|540144307|FG003|Overall Study|Patient withdrew consent|0|||
149729735|NCT01109940|540144304|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149729736|NCT01109940|540144305|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149729737|NCT01109940|540144306|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
149729738|NCT01109940|540144307|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149729739|NCT02419508|540144308|FG000|Overall Study|Adverse Event|9|||
149729740|NCT02419508|540144309|FG001|Overall Study|Adverse Event|3|||
149729741|NCT02419508|540144308|FG000|Overall Study|Withdrawal by Subject|1|||
149729742|NCT02419508|540144309|FG001|Overall Study|Withdrawal by Subject|0|||
149729743|NCT02419508|540144308|FG000|Overall Study|Other - Reason not specified|0|||
149729744|NCT02419508|540144309|FG001|Overall Study|Other - Reason not specified|1|||
149729745|NCT01748071|540146315|FG000|Overall Study|Adverse Event|2|||
149729746|NCT01748071|540146316|FG001|Overall Study|Adverse Event|2|||
149729747|NCT01748071|540146317|FG002|Overall Study|Adverse Event|0|||
149729748|NCT03068325|540146318|FG000|Overall Study|Lost to Follow-up|5|||
149729749|NCT00066690|540146319|FG000|Overall Study|Adverse Event|145|||
149729750|NCT00066690|540146320|FG001|Overall Study|Adverse Event|58|||
149729751|NCT00066690|540146321|FG002|Overall Study|Adverse Event|126|||
150251972|NCT00943852|542058330|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251973|NCT00943852|542058331|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251974|NCT00943852|542058332|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251975|NCT00943852|542058333|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
150251976|NCT00943852|542058334|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
150251977|NCT00943852|542058335|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149729752|NCT00066690|540146319|FG000|Overall Study|Death|3|||
149729753|NCT00066690|540146320|FG001|Overall Study|Death|0|||
149729754|NCT00066690|540146321|FG002|Overall Study|Death|2|||
149729755|NCT00066690|540146319|FG000|Overall Study|Lack of Efficacy|114|||
149729756|NCT00066690|540146320|FG001|Overall Study|Lack of Efficacy|110|||
149729757|NCT00066690|540146321|FG002|Overall Study|Lack of Efficacy|76|||
149729758|NCT00066690|540146319|FG000|Overall Study|Lost to Follow-up|40|||
149729759|NCT00066690|540146320|FG001|Overall Study|Lost to Follow-up|21|||
149729760|NCT00066690|540146321|FG002|Overall Study|Lost to Follow-up|29|||
149729761|NCT00066690|540146319|FG000|Overall Study|Withdrawal by Subject|50|||
149729762|NCT00066690|540146320|FG001|Overall Study|Withdrawal by Subject|55|||
149729763|NCT00066690|540146321|FG002|Overall Study|Withdrawal by Subject|49|||
149729764|NCT00066690|540146319|FG000|Overall Study|Treatment Ongoing|246|||
149729765|NCT00066690|540146320|FG001|Overall Study|Treatment Ongoing|278|||
149729766|NCT00066690|540146321|FG002|Overall Study|Treatment Ongoing|282|||
149729767|NCT00700180|540146322|FG000|Overall Study|Death|99|||
149729768|NCT00700180|540146323|FG001|Overall Study|Death|114|||
149729769|NCT00700180|540146322|FG000|Overall Study|Alive on treatment|5|||
149729770|NCT00700180|540146323|FG001|Overall Study|Alive on treatment|3|||
149729771|NCT00700180|540146322|FG000|Overall Study|Alive in follow-up|46|||
149729772|NCT00700180|540146323|FG001|Overall Study|Alive in follow-up|27|||
149729773|NCT00700180|540146322|FG000|Overall Study|Lost to Follow-up|4|||
149729774|NCT00700180|540146323|FG001|Overall Study|Lost to Follow-up|5|||
149729775|NCT01613326|540146324|FG000|Overall Study|Adverse Event|7|||
149729776|NCT01613326|540146325|FG001|Overall Study|Adverse Event|5|||
149729777|NCT01613326|540146324|FG000|Overall Study|Withdrawal by Subject|3|||
149729778|NCT01613326|540146325|FG001|Overall Study|Withdrawal by Subject|4|||
149729779|NCT01613326|540146324|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149729780|NCT01613326|540146325|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149729781|NCT01613326|540146324|FG000|Overall Study|inability to use device|1|||
149729782|NCT01613326|540146325|FG001|Overall Study|inability to use device|0|||
149729783|NCT01613326|540146324|FG000|Overall Study|Lack of Efficacy|0|||
149729784|NCT01613326|540146325|FG001|Overall Study|Lack of Efficacy|1|||
149729785|NCT01613326|540146324|FG000|Overall Study|Lost to Follow-up|0|||
149729786|NCT01613326|540146325|FG001|Overall Study|Lost to Follow-up|1|||
149729787|NCT01613326|540146324|FG000|Overall Study|Administrative|0|||
149729788|NCT01613326|540146325|FG001|Overall Study|Administrative|2|||
149729789|NCT01613326|540146324|FG000|Overall Study|Protocol Violation|0|||
149729790|NCT01613326|540146325|FG001|Overall Study|Protocol Violation|1|||
149729791|NCT00605267|540146328|FG000|Overall Study|Adverse Event|0|||
149729792|NCT00605267|540146329|FG001|Overall Study|Adverse Event|1|||
149729793|NCT00605267|540146328|FG000|Overall Study|Lack of Efficacy|1|||
149729794|NCT00605267|540146329|FG001|Overall Study|Lack of Efficacy|5|||
149729795|NCT00605267|540146328|FG000|Overall Study|Withdrawal by Subject|2|||
149729796|NCT00605267|540146329|FG001|Overall Study|Withdrawal by Subject|3|||
149729797|NCT04557384|540146330|FG000|Overall Study|Study Terminated by Sponsor|1|||
149729798|NCT04557384|540146330|FG000|Overall Study|Death|1|||
149729799|NCT00168831|540146332|FG000|Overall Study|Adverse Event|36|||
149729800|NCT00168831|540146333|FG001|Overall Study|Adverse Event|47|||
149729801|NCT00168831|540146334|FG002|Overall Study|Adverse Event|74|||
149729802|NCT00168831|540146332|FG000|Overall Study|Lost to Follow-up|5|||
149729803|NCT00168831|540146333|FG001|Overall Study|Lost to Follow-up|6|||
149729804|NCT00168831|540146334|FG002|Overall Study|Lost to Follow-up|4|||
149729805|NCT00168831|540146332|FG000|Overall Study|Withdrawal by Subject|7|||
149729806|NCT00168831|540146333|FG001|Overall Study|Withdrawal by Subject|14|||
149729807|NCT00168831|540146334|FG002|Overall Study|Withdrawal by Subject|19|||
149729808|NCT00168831|540146332|FG000|Overall Study|Protocol Violation|6|||
149729809|NCT00168831|540146333|FG001|Overall Study|Protocol Violation|11|||
149729810|NCT00168831|540146334|FG002|Overall Study|Protocol Violation|11|||
149729811|NCT00168831|540146332|FG000|Overall Study|Other|6|||
149729812|NCT00168831|540146333|FG001|Overall Study|Other|3|||
149729813|NCT00168831|540146334|FG002|Overall Study|Other|6|||
149729814|NCT01505894|540146335|FG000|Overall Study|Adverse Event|1|||
149729815|NCT01505894|540146336|FG001|Overall Study|Adverse Event|0|||
149729816|NCT01505894|540146337|FG002|Overall Study|Adverse Event|0|||
149729817|NCT01505894|540146338|FG003|Overall Study|Adverse Event|0|||
149729818|NCT01505894|540146339|FG004|Overall Study|Adverse Event|0|||
149729819|NCT01505894|540146340|FG005|Overall Study|Adverse Event|0|||
149729820|NCT01505894|540146341|FG006|Overall Study|Adverse Event|0|||
149729821|NCT01505894|540146342|FG007|Overall Study|Adverse Event|0|||
149729822|NCT01505894|540146343|FG008|Overall Study|Adverse Event|0|||
149729823|NCT01505894|540146335|FG000|Overall Study|Other than specified|0|||
149729824|NCT01505894|540146336|FG001|Overall Study|Other than specified|0|||
149729825|NCT01505894|540146337|FG002|Overall Study|Other than specified|0|||
149729826|NCT01505894|540146338|FG003|Overall Study|Other than specified|0|||
149729827|NCT01505894|540146339|FG004|Overall Study|Other than specified|1|||
149729828|NCT01505894|540146340|FG005|Overall Study|Other than specified|0|||
149729829|NCT01505894|540146341|FG006|Overall Study|Other than specified|0|||
149729830|NCT01505894|540146342|FG007|Overall Study|Other than specified|0|||
149729831|NCT01505894|540146343|FG008|Overall Study|Other than specified|0|||
149729832|NCT01622569|540146344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
149729833|NCT01622569|540146345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
149729834|NCT01622569|540146346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
149729835|NCT01622569|540146347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
149729836|NCT01622569|540146344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149729837|NCT01622569|540146345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149729838|NCT01622569|540146346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
149729839|NCT01622569|540146347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149729840|NCT01622569|540146344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
149729841|NCT01622569|540146345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
149729842|NCT01622569|540146346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
149729843|NCT01622569|540146347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
149729844|NCT01622569|540146344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149729845|NCT01622569|540146345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
149729846|NCT01622569|540146346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149729847|NCT01622569|540146347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
149729848|NCT01622569|540146344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149729849|NCT01622569|540146345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149729850|NCT01622569|540146346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149729851|NCT01622569|540146347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
149729852|NCT01622569|540146344|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
149729853|NCT01622569|540146345|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
149729854|NCT01622569|540146346|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
149729855|NCT01622569|540146347|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
149729856|NCT01622569|540146344|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
149729857|NCT01622569|540146345|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
149729858|NCT01622569|540146346|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
149729859|NCT01622569|540146347|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
149729860|NCT01622569|540146344|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149729861|NCT01622569|540146345|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149729862|NCT01622569|540146346|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149729863|NCT01622569|540146347|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
149729864|NCT04173741|540146348|FG000|Overall Study|IVC measurement cannot be done|1|||
149729865|NCT04173741|540146349|FG001|Overall Study|IVC measurement cannot be done|1|||
149729866|NCT00059202|540146350|FG000|Overall Study|Withdrawal by Subject|5|||
149729867|NCT00059202|540146351|FG001|Overall Study|Withdrawal by Subject|9|||
149729868|NCT00059202|540146350|FG000|Overall Study|Protocol Violation|1|||
149729869|NCT00059202|540146351|FG001|Overall Study|Protocol Violation|3|||
149729870|NCT00059202|540146350|FG000|Overall Study|drug toxicity|0|||
149729871|NCT00059202|540146351|FG001|Overall Study|drug toxicity|3|||
149729872|NCT03106779|540146354|FG000|Overall Study|Lack of Efficacy|33|||
149729873|NCT03106779|540146355|FG001|Overall Study|Lack of Efficacy|24|||
149729874|NCT03106779|540146354|FG000|Overall Study|Adverse Event|8|||
149729875|NCT03106779|540146355|FG001|Overall Study|Adverse Event|16|||
149729876|NCT03106779|540146354|FG000|Overall Study|Physician Decision|10|||
149729877|NCT03106779|540146355|FG001|Overall Study|Physician Decision|6|||
149729878|NCT03106779|540146354|FG000|Overall Study|Patient/guardian decision|4|||
149729879|NCT03106779|540146355|FG001|Overall Study|Patient/guardian decision|3|||
149729880|NCT03106779|540146354|FG000|Overall Study|Progressive disease|1|||
150251978|NCT00943852|542058326|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
150251979|NCT00943852|542058327|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
150251980|NCT00943852|542058328|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
150251981|NCT00943852|542058329|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
149729881|NCT03106779|540146355|FG001|Overall Study|Progressive disease|3|||
149729882|NCT03106779|540146354|FG000|Overall Study|Lost to Follow-up|1|||
149729883|NCT03106779|540146355|FG001|Overall Study|Lost to Follow-up|2|||
149729884|NCT03106779|540146354|FG000|Overall Study|Death|1|||
149729885|NCT03106779|540146355|FG001|Overall Study|Death|0|||
149729886|NCT03106779|540146354|FG000|Overall Study|Protocol Violation|1|||
149729887|NCT03106779|540146355|FG001|Overall Study|Protocol Violation|0|||
149729888|NCT03106779|540146354|FG000|Overall Study|Not treated|1|||
150251982|NCT00943852|542058330|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
150251983|NCT00943852|542058331|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
150251984|NCT00943852|542058332|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
150251985|NCT00943852|542058333|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
150251986|NCT00943852|542058334|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149729889|NCT03106779|540146355|FG001|Overall Study|Not treated|0|||
149729890|NCT04088409|540146356|FG000|Part A|Withdrawal by Subject|2|||
149729891|NCT04088409|540146357|FG001|Part A|Withdrawal by Subject|1|||
149729892|NCT04088409|540146356|FG000|Part A|Did Not Meet Randomization Criteria|2|||
149729893|NCT04088409|540146357|FG001|Part A|Did Not Meet Randomization Criteria|0|||
149729894|NCT04088409|540146356|FG000|Part A|Lack of Efficacy|9|||
149729895|NCT04088409|540146357|FG001|Part A|Lack of Efficacy|0|||
149729896|NCT04088409|540146356|FG000|Part A|Lost to Follow-up|1|||
149729897|NCT04088409|540146357|FG001|Part A|Lost to Follow-up|0|||
149729898|NCT04088409|540146356|FG000|Part A|Adverse Event|1|||
149729899|NCT04088409|540146357|FG001|Part A|Adverse Event|0|||
149729900|NCT04088409|540146356|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
149729901|NCT04088409|540146357|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
149729902|NCT04088409|540146356|FG000|Part B|Ongoing Treatment|10|||
149729903|NCT04088409|540146357|FG001|Part B|Ongoing Treatment|0|||
149729904|NCT04233229|540146358|FG000|Overall Study|Withdrawal by Subject|0|||
149729905|NCT04233229|540146359|FG001|Overall Study|Withdrawal by Subject|1|||
149729906|NCT04233229|540146358|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
149729907|NCT04233229|540146359|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
149729908|NCT04233229|540146358|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
149729909|NCT04233229|540146359|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
149729910|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
149729911|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
149729912|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
149729913|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
149729914|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
149729915|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
149729916|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
149729917|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
149729918|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
149729919|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
149729920|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
149729921|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
149729922|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
149729923|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
149729924|NCT02288247|540146360|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
149729925|NCT02288247|540146361|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
149729926|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
149729927|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
149729928|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
149729929|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
149729930|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
149729931|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
149729932|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
149729933|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
149729934|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
149729935|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
149729936|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
149729937|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
149729938|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
149729939|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
149729940|NCT02288247|540146360|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
149729941|NCT02288247|540146361|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
149729942|NCT04652804|540146362|FG000|Overall Study|Ineligible post randomization|1|||
149729943|NCT04652804|540146363|FG001|Overall Study|Ineligible post randomization|0|||
149729944|NCT04652804|540146364|FG002|Overall Study|Ineligible post randomization|1|||
149729945|NCT04652804|540146365|FG003|Overall Study|Ineligible post randomization|0|||
149729946|NCT04652804|540146366|FG004|Overall Study|Ineligible post randomization|1|||
149729947|NCT04652804|540146367|FG005|Overall Study|Ineligible post randomization|1|||
149729948|NCT04652804|540146362|FG000|Overall Study|Missing SVR lab results|2|||
149729949|NCT04652804|540146363|FG001|Overall Study|Missing SVR lab results|0|||
149729950|NCT04652804|540146364|FG002|Overall Study|Missing SVR lab results|0|||
149729951|NCT04652804|540146365|FG003|Overall Study|Missing SVR lab results|0|||
149729952|NCT04652804|540146366|FG004|Overall Study|Missing SVR lab results|0|||
149729953|NCT04652804|540146367|FG005|Overall Study|Missing SVR lab results|0|||
149729954|NCT00584194|540146368|FG000|Overall Study|Other|135|||
149729955|NCT04093531|540146369|FG000|Overall Study|failed screening|4|||
149729956|NCT00927368|540146372|FG000|Overall Study|enrollment in another study|1|||
149729957|NCT00927368|540146373|FG001|Overall Study|enrollment in another study|1|||
149729958|NCT00927368|540146374|FG002|Overall Study|enrollment in another study|2|||
149729959|NCT00927368|540146372|FG000|Overall Study|Lost to Follow-up|4|||
149729960|NCT00927368|540146373|FG001|Overall Study|Lost to Follow-up|0|||
149729961|NCT00927368|540146374|FG002|Overall Study|Lost to Follow-up|0|||
149729962|NCT00927368|540146372|FG000|Overall Study|equipment failure|1|||
149729963|NCT00927368|540146373|FG001|Overall Study|equipment failure|0|||
149729964|NCT00927368|540146374|FG002|Overall Study|equipment failure|0|||
149729965|NCT00927368|540146372|FG000|Overall Study|ineligible post randomization|0|||
149729966|NCT00927368|540146373|FG001|Overall Study|ineligible post randomization|3|||
149729967|NCT00927368|540146374|FG002|Overall Study|ineligible post randomization|1|||
149729968|NCT00927368|540146372|FG000|Overall Study|cancellation of surgery|0|||
149729969|NCT00927368|540146373|FG001|Overall Study|cancellation of surgery|1|||
149729970|NCT00927368|540146374|FG002|Overall Study|cancellation of surgery|2|||
149729971|NCT00191451|540146376|FG000|Overall Study|Withdrawal by Subject|2|||
149729972|NCT00191451|540146377|FG001|Overall Study|Withdrawal by Subject|3|||
149729973|NCT00191451|540146378|FG002|Overall Study|Withdrawal by Subject|5|||
149729974|NCT00191451|540146376|FG000|Overall Study|Physician Decision|2|||
149729975|NCT00191451|540146377|FG001|Overall Study|Physician Decision|9|||
149729976|NCT00191451|540146378|FG002|Overall Study|Physician Decision|6|||
149729977|NCT00191451|540146376|FG000|Overall Study|Sponsor Decision|1|||
149729978|NCT00191451|540146377|FG001|Overall Study|Sponsor Decision|0|||
149729979|NCT00191451|540146378|FG002|Overall Study|Sponsor Decision|0|||
149729980|NCT00191451|540146376|FG000|Overall Study|Ineligible|0|||
149729981|NCT00191451|540146377|FG001|Overall Study|Ineligible|1|||
149729982|NCT00191451|540146378|FG002|Overall Study|Ineligible|0|||
149729983|NCT00191451|540146376|FG000|Overall Study|Reason Not Specified|2|||
149729984|NCT00191451|540146377|FG001|Overall Study|Reason Not Specified|1|||
149729985|NCT00191451|540146378|FG002|Overall Study|Reason Not Specified|3|||
149729986|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
149729987|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
149729988|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
149729989|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
149729990|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
149729991|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
149729992|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
149729993|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
149729994|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
149729995|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
149729996|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
149729997|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
149729998|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149729999|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149730000|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149730001|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
149730002|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
149730003|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
149730004|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
149730005|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
149730006|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
149730007|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
149730008|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
149730009|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
150251987|NCT00943852|542058335|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
150251988|NCT00734591|542058336|FG000|Screening for Prospective Period|Site did not participate|1604|||
150251989|NCT00734591|542058337|FG001|Screening for Prospective Period|Site did not participate|1488|||
150251990|NCT00734591|542058336|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
150251991|NCT00734591|542058337|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
150251992|NCT00734591|542058336|FG000|Prospective Period|Withdrawal by Subject|11|||
149730010|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Death|2|||
149730011|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Death|1|||
149730012|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Death|2|||
149730013|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Graft loss|0|||
149730014|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Graft loss|2|||
149730015|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Graft loss|0|||
149730016|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
149730017|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
149730018|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
149730019|NCT01114529|540146383|FG000|Completed Study Medication at Month 24|Missing|2|||
149730020|NCT01114529|540146384|FG001|Completed Study Medication at Month 24|Missing|0|||
149730021|NCT01114529|540146385|FG002|Completed Study Medication at Month 24|Missing|0|||
149730022|NCT01114529|540146383|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
149730023|NCT01114529|540146384|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
149730024|NCT01114529|540146385|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
149730025|NCT01114529|540146383|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
149730026|NCT01114529|540146384|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
149730027|NCT01114529|540146385|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
149730028|NCT01114529|540146383|FG000|Completed Study Phase at Month 24|Death|8|||
149730029|NCT01114529|540146384|FG001|Completed Study Phase at Month 24|Death|5|||
149730030|NCT01114529|540146385|FG002|Completed Study Phase at Month 24|Death|4|||
149730031|NCT01114529|540146383|FG000|Completed Study Phase at Month 24|Other|2|||
149730032|NCT01114529|540146384|FG001|Completed Study Phase at Month 24|Other|0|||
149730033|NCT01114529|540146385|FG002|Completed Study Phase at Month 24|Other|0|||
150251993|NCT00734591|542058337|FG001|Prospective Period|Withdrawal by Subject|9|||
150251994|NCT00734591|542058336|FG000|Prospective Period|Lost to Follow-up|37|||
150251995|NCT00734591|542058337|FG001|Prospective Period|Lost to Follow-up|33|||
150251996|NCT00734591|542058336|FG000|Prospective Period|Study Terminated|1|||
150251997|NCT00734591|542058337|FG001|Prospective Period|Study Terminated|0|||
150251998|NCT00734591|542058336|FG000|Prospective Period|Other|2|||
150251999|NCT00734591|542058337|FG001|Prospective Period|Other|2|||
150252000|NCT01656200|542058338|FG000|Overall Study|Withdrawal by Subject|1|||
150252001|NCT00730275|542058339|FG000|Overall Study|Withdrawal by Subject|0|||
150252002|NCT00730275|542058340|FG001|Overall Study|Withdrawal by Subject|0|||
150252003|NCT00730275|542058341|FG002|Overall Study|Withdrawal by Subject|0|||
150252004|NCT00730275|542058342|FG003|Overall Study|Withdrawal by Subject|1|||
150252005|NCT00338962|542058347|FG000|Overall Study|Lost to Follow-up|3|||
149730034|NCT01114529|540146383|FG000|Completed Study Phase at Month 24|Missing|2|||
149730035|NCT01114529|540146384|FG001|Completed Study Phase at Month 24|Missing|0|||
149730036|NCT01114529|540146385|FG002|Completed Study Phase at Month 24|Missing|0|||
149730037|NCT02614079|540146387|FG000|Overall Study|Withdrawal by Subject|1|||
149730038|NCT03072160|540146388|FG000|Overall Study|Adverse Event|3|||
149730039|NCT03072160|540146389|FG001|Overall Study|Adverse Event|1|||
149730040|NCT03072160|540146388|FG000|Overall Study|Refused further treatment|6|||
149730041|NCT03072160|540146389|FG001|Overall Study|Refused further treatment|1|||
149730042|NCT03072160|540146388|FG000|Overall Study|Physician Decision|1|||
149730043|NCT03072160|540146389|FG001|Overall Study|Physician Decision|0|||
149730044|NCT03072160|540146388|FG000|Overall Study|Disease progression on study|1|||
149730045|NCT03072160|540146389|FG001|Overall Study|Disease progression on study|1|||
149730046|NCT03072160|540146388|FG000|Overall Study|No contact|0|||
150252006|NCT00338962|542058348|FG001|Overall Study|Lost to Follow-up|3|||
150252007|NCT00338962|542058349|FG002|Overall Study|Lost to Follow-up|2|||
149730047|NCT03072160|540146389|FG001|Overall Study|No contact|1|||
149730048|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
149730049|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
149730050|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
150252008|NCT00338962|542058350|FG003|Overall Study|Lost to Follow-up|3|||
150252009|NCT00338962|542058347|FG000|Overall Study|Withdrawal by Subject|1|||
150252010|NCT00338962|542058348|FG001|Overall Study|Withdrawal by Subject|0|||
150252011|NCT00338962|542058349|FG002|Overall Study|Withdrawal by Subject|0|||
150252012|NCT00338962|542058350|FG003|Overall Study|Withdrawal by Subject|0|||
150252013|NCT00338962|542058347|FG000|Overall Study|No Transportation|2|||
150252014|NCT00338962|542058348|FG001|Overall Study|No Transportation|0|||
149730051|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Death|28|||
149730052|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Death|0|||
149730053|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Death|0|||
149730054|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
149730055|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
149730056|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
149730057|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
149730058|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
149730059|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
149730060|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
149730061|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
149730062|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
149730063|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
149730064|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
149730065|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
149730066|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
149730067|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
149730068|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
149730069|NCT00820755|540146390|FG000|Period 1: Combination Therapy Phase|Other|11|||
149730070|NCT00820755|540146391|FG001|Period 1: Combination Therapy Phase|Other|0|||
149730071|NCT00820755|540146392|FG002|Period 1: Combination Therapy Phase|Other|0|||
149730072|NCT00820755|540146390|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
149730073|NCT00820755|540146391|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
149730074|NCT00820755|540146392|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
149730075|NCT02211261|540146393|FG000|Overall Study|Withdrawal by Subject|0|||
149730076|NCT02211261|540146394|FG001|Overall Study|Withdrawal by Subject|0|||
149730077|NCT02211261|540146395|FG002|Overall Study|Withdrawal by Subject|1|||
149730078|NCT02211261|540146396|FG003|Overall Study|Withdrawal by Subject|0|||
149730079|NCT02211261|540146397|FG004|Overall Study|Withdrawal by Subject|2|||
149730080|NCT02211261|540146398|FG005|Overall Study|Withdrawal by Subject|0|||
149730081|NCT02211261|540146399|FG006|Overall Study|Withdrawal by Subject|0|||
149730082|NCT02211261|540146400|FG007|Overall Study|Withdrawal by Subject|0|||
149730083|NCT02211261|540146401|FG008|Overall Study|Withdrawal by Subject|0|||
149730084|NCT02211261|540146402|FG009|Overall Study|Withdrawal by Subject|0|||
149730085|NCT02211261|540146403|FG010|Overall Study|Withdrawal by Subject|0|||
149730086|NCT02211261|540146393|FG000|Overall Study|Other|0|||
149730087|NCT02211261|540146394|FG001|Overall Study|Other|0|||
149730088|NCT02211261|540146395|FG002|Overall Study|Other|0|||
149730089|NCT02211261|540146396|FG003|Overall Study|Other|0|||
149730090|NCT02211261|540146397|FG004|Overall Study|Other|0|||
149730091|NCT02211261|540146398|FG005|Overall Study|Other|1|||
149730092|NCT02211261|540146399|FG006|Overall Study|Other|0|||
149730093|NCT02211261|540146400|FG007|Overall Study|Other|0|||
149730094|NCT02211261|540146401|FG008|Overall Study|Other|0|||
149730095|NCT02211261|540146402|FG009|Overall Study|Other|2|||
149730096|NCT02211261|540146403|FG010|Overall Study|Other|0|||
149730097|NCT02211261|540146393|FG000|Overall Study|Lost to Follow-up|0|||
149730098|NCT02211261|540146394|FG001|Overall Study|Lost to Follow-up|0|||
149730099|NCT02211261|540146395|FG002|Overall Study|Lost to Follow-up|0|||
149730100|NCT02211261|540146396|FG003|Overall Study|Lost to Follow-up|0|||
149730101|NCT02211261|540146397|FG004|Overall Study|Lost to Follow-up|0|||
149730102|NCT02211261|540146398|FG005|Overall Study|Lost to Follow-up|0|||
149730103|NCT02211261|540146399|FG006|Overall Study|Lost to Follow-up|0|||
149730104|NCT02211261|540146400|FG007|Overall Study|Lost to Follow-up|1|||
149730105|NCT02211261|540146401|FG008|Overall Study|Lost to Follow-up|0|||
149730106|NCT02211261|540146402|FG009|Overall Study|Lost to Follow-up|0|||
149730107|NCT02211261|540146403|FG010|Overall Study|Lost to Follow-up|0|||
149730108|NCT02817087|540146404|FG000|Overall Study|Withdrawal by Subject|2|||
149730109|NCT02817087|540146405|FG001|Overall Study|Withdrawal by Subject|0|||
150252015|NCT00338962|542058349|FG002|Overall Study|No Transportation|0|||
149730110|NCT02251912|540146407|FG000|Overall Study|Withdrawal by Subject|2|||
149730111|NCT02251912|540146408|FG001|Overall Study|Withdrawal by Subject|3|||
150252016|NCT00338962|542058350|FG003|Overall Study|No Transportation|0|||
149730112|NCT02251912|540146407|FG000|Overall Study|Adverse Event|0|||
149730113|NCT02251912|540146408|FG001|Overall Study|Adverse Event|2|||
149730114|NCT00480857|540146409|FG000|Overall Study|Lack of Efficacy|2|||
149730115|NCT02551159|540146410|FG000|Overall Study|Death|352|||
150252017|NCT00338962|542058347|FG000|Overall Study|Time Constraint|2|||
150252018|NCT00338962|542058348|FG001|Overall Study|Time Constraint|0|||
149730116|NCT02551159|540146411|FG001|Overall Study|Death|174|||
149730117|NCT02551159|540146412|FG002|Overall Study|Death|161|||
149730118|NCT02551159|540146410|FG000|Overall Study|Withdrawal by Subject|8|||
149730119|NCT02551159|540146411|FG001|Overall Study|Withdrawal by Subject|5|||
150252019|NCT00338962|542058349|FG002|Overall Study|Time Constraint|0|||
150252020|NCT00338962|542058350|FG003|Overall Study|Time Constraint|0|||
150252021|NCT00338962|542058347|FG000|Overall Study|Moved|0|||
150252022|NCT00338962|542058348|FG001|Overall Study|Moved|1|||
150252023|NCT00338962|542058349|FG002|Overall Study|Moved|0|||
150252024|NCT00338962|542058350|FG003|Overall Study|Moved|0|||
150252025|NCT00338962|542058347|FG000|Overall Study|Adverse Event|0|||
150252026|NCT00338962|542058348|FG001|Overall Study|Adverse Event|0|||
150252027|NCT00338962|542058349|FG002|Overall Study|Adverse Event|2|||
149730120|NCT02551159|540146412|FG002|Overall Study|Withdrawal by Subject|16|||
149730121|NCT02551159|540146410|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
149730122|NCT02551159|540146411|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
149730123|NCT02551159|540146412|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
149730124|NCT00243659|540146413|FG000|Overall Study|Withdrawal by Subject|1|||
149730125|NCT00243659|540146414|FG001|Overall Study|Withdrawal by Subject|1|||
149730126|NCT00243659|540146413|FG000|Overall Study|Protocol Violation|1|||
149730127|NCT00243659|540146414|FG001|Overall Study|Protocol Violation|2|||
149730128|NCT00268242|540146415|FG000|Overall Study|Death|1|||
149730129|NCT02175680|540146416|FG000|Overall Study|non-compliance|1|||
149730130|NCT02175680|540146416|FG000|Overall Study|other non-medical reason|1|||
149730131|NCT00464178|540146417|FG000|Overall Study|Protocol Violation|1|||
149730132|NCT00464178|540146417|FG000|Overall Study|Withdrawal by Subject|1|||
149730133|NCT04506294|540146420|FG000|Overall Study|Lost to Follow-up|70|||
149730134|NCT04506294|540146421|FG001|Overall Study|Lost to Follow-up|20|||
149730135|NCT04506294|540146420|FG000|Overall Study|Withdrawal by Subject|16|||
149730136|NCT04506294|540146421|FG001|Overall Study|Withdrawal by Subject|2|||
149730137|NCT01465659|540146422|FG000|Completed 1 Cycle of Treatment|Death|0|||
149730138|NCT01465659|540146423|FG001|Completed 1 Cycle of Treatment|Death|1|||
149730139|NCT01465659|540146424|FG002|Completed 1 Cycle of Treatment|Death|0|||
149730140|NCT01465659|540146425|FG003|Completed 1 Cycle of Treatment|Death|0|||
149730141|NCT01465659|540146422|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
149730142|NCT01465659|540146423|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
149730143|NCT01465659|540146424|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
149730144|NCT01465659|540146425|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
149730145|NCT01465659|540146422|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149730146|NCT01465659|540146423|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
149730147|NCT01465659|540146424|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149730148|NCT01465659|540146425|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149730149|NCT01465659|540146422|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
149730150|NCT01465659|540146423|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
149730151|NCT01465659|540146424|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
149730152|NCT01465659|540146425|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
149730153|NCT01465659|540146422|FG000|Completed Follow for 1 Year|Death|6|||
149730154|NCT01465659|540146423|FG001|Completed Follow for 1 Year|Death|3|||
149730155|NCT01465659|540146424|FG002|Completed Follow for 1 Year|Death|2|||
149730156|NCT01465659|540146425|FG003|Completed Follow for 1 Year|Death|4|||
149730157|NCT03434379|540146426|FG000|Global Period|Lost to Follow-up|3|||
149730158|NCT03434379|540146427|FG001|Global Period|Lost to Follow-up|6|||
149730159|NCT03434379|540146428|FG002|Global Period|Lost to Follow-up|0|||
149730160|NCT03434379|540146429|FG003|Global Period|Lost to Follow-up|0|||
149730161|NCT03434379|540146426|FG000|Global Period|Death|115|||
149730162|NCT03434379|540146427|FG001|Global Period|Death|228|||
149730163|NCT03434379|540146428|FG002|Global Period|Death|0|||
149730164|NCT03434379|540146429|FG003|Global Period|Death|0|||
149730165|NCT03434379|540146426|FG000|Global Period|Withdrawal by Subject|20|||
149730166|NCT03434379|540146427|FG001|Global Period|Withdrawal by Subject|21|||
149730167|NCT03434379|540146428|FG002|Global Period|Withdrawal by Subject|0|||
149730168|NCT03434379|540146429|FG003|Global Period|Withdrawal by Subject|0|||
149730169|NCT03434379|540146426|FG000|Global Period|Reason Unspecified|0|||
149730170|NCT03434379|540146427|FG001|Global Period|Reason Unspecified|1|||
150252028|NCT00338962|542058350|FG003|Overall Study|Adverse Event|0|||
150252029|NCT00338962|542058347|FG000|Overall Study|Poor Compliance|0|||
150252030|NCT00338962|542058348|FG001|Overall Study|Poor Compliance|0|||
149730171|NCT03434379|540146428|FG002|Global Period|Reason Unspecified|0|||
149730172|NCT03434379|540146429|FG003|Global Period|Reason Unspecified|0|||
149730173|NCT03434379|540146426|FG000|Global Period|Study Ended by Sponsor|26|||
149730174|NCT03434379|540146427|FG001|Global Period|Study Ended by Sponsor|80|||
149730175|NCT03434379|540146428|FG002|Global Period|Study Ended by Sponsor|0|||
149730176|NCT03434379|540146429|FG003|Global Period|Study Ended by Sponsor|0|||
149730177|NCT03434379|540146426|FG000|Global Period|Physician Decision|1|||
149730178|NCT03434379|540146427|FG001|Global Period|Physician Decision|0|||
149730179|NCT03434379|540146428|FG002|Global Period|Physician Decision|0|||
149730180|NCT03434379|540146429|FG003|Global Period|Physician Decision|0|||
149730181|NCT03434379|540146426|FG000|China Extension Period|Lost to Follow-up|0|||
149730182|NCT03434379|540146427|FG001|China Extension Period|Lost to Follow-up|0|||
149730183|NCT03434379|540146428|FG002|China Extension Period|Lost to Follow-up|2|||
149730184|NCT03434379|540146429|FG003|China Extension Period|Lost to Follow-up|3|||
150252031|NCT00338962|542058349|FG002|Overall Study|Poor Compliance|2|||
150252032|NCT00338962|542058350|FG003|Overall Study|Poor Compliance|0|||
150252033|NCT03046121|542058351|FG000|Overall Study|Death|32|||
150252034|NCT03046121|542058352|FG001|Overall Study|Death|60|||
150252035|NCT03046121|542058351|FG000|Overall Study|Withdrawal by Subject|14|||
150252036|NCT03046121|542058352|FG001|Overall Study|Withdrawal by Subject|12|||
150252037|NCT03214640|542058353|FG000|Overall Study|Protocol Violation|1|||
150252038|NCT03214640|542058354|FG001|Overall Study|Protocol Violation|2|||
150252039|NCT03214640|542058355|FG002|Overall Study|Protocol Violation|1|||
150252040|NCT03214640|542058356|FG003|Overall Study|Protocol Violation|4|||
150252041|NCT04155047|542058357|FG000|Overall Study|Adverse Event|1|||
150252042|NCT04155047|542058358|FG001|Overall Study|Adverse Event|0|||
150252043|NCT04155047|542058357|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
150252044|NCT04155047|542058358|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
150252045|NCT00821587|542058363|FG000|Overall Study|Physician Decision|0|||
150252046|NCT00821587|542058364|FG001|Overall Study|Physician Decision|1|||
150252047|NCT04488770|542058365|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149730185|NCT03434379|540146426|FG000|China Extension Period|Death|0|||
149730186|NCT03434379|540146427|FG001|China Extension Period|Death|0|||
149730187|NCT03434379|540146428|FG002|China Extension Period|Death|46|||
149730188|NCT03434379|540146429|FG003|China Extension Period|Death|88|||
149730189|NCT03434379|540146426|FG000|China Extension Period|Withdrawal by Subject|0|||
149730190|NCT03434379|540146427|FG001|China Extension Period|Withdrawal by Subject|0|||
149730191|NCT03434379|540146428|FG002|China Extension Period|Withdrawal by Subject|8|||
149730192|NCT03434379|540146429|FG003|China Extension Period|Withdrawal by Subject|6|||
149730193|NCT03434379|540146426|FG000|China Extension Period|Study Ended by Sponsor|0|||
149730194|NCT03434379|540146427|FG001|China Extension Period|Study Ended by Sponsor|0|||
149730195|NCT03434379|540146428|FG002|China Extension Period|Study Ended by Sponsor|5|||
149730196|NCT03434379|540146429|FG003|China Extension Period|Study Ended by Sponsor|36|||
149730197|NCT00769119|540146437|FG000|Overall Study|Voluntary discontinuation|0|||
149730198|NCT00769119|540146438|FG001|Overall Study|Voluntary discontinuation|2|||
149730199|NCT00769119|540146437|FG000|Overall Study|Adverse Event|1|||
149730200|NCT00769119|540146438|FG001|Overall Study|Adverse Event|1|||
149730201|NCT00769119|540146437|FG000|Overall Study|Disallowed medication|1|||
149730202|NCT00769119|540146438|FG001|Overall Study|Disallowed medication|0|||
149730203|NCT00686647|540146439|FG000|Overall Study|Lost to Follow-up|1|||
149730204|NCT00686647|540146439|FG000|Overall Study|Death|1|||
149730205|NCT01116544|540146443|FG000|Overall Study|Protocol Violation|1|||
149730206|NCT01116544|540146444|FG001|Overall Study|Protocol Violation|0|||
149730207|NCT01116544|540146443|FG000|Overall Study|Withdrawal by Subject|1|||
149730208|NCT01116544|540146444|FG001|Overall Study|Withdrawal by Subject|1|||
149730209|NCT00578643|540146445|FG000|Overall Study|Death|1|||
149730210|NCT00578643|540146445|FG000|Overall Study|Lost to Follow-up|1|||
149730211|NCT01725750|540146446|FG000|Overall Study|Adverse Event|1|||
149730212|NCT01725750|540146447|FG001|Overall Study|Adverse Event|0|||
149730213|NCT01725750|540146446|FG000|Overall Study|Lost to Follow-up|1|||
149730214|NCT01725750|540146447|FG001|Overall Study|Lost to Follow-up|1|||
149730215|NCT01725750|540146446|FG000|Overall Study|Withdrawal by Subject|0|||
149730216|NCT01725750|540146447|FG001|Overall Study|Withdrawal by Subject|9|||
149730217|NCT03828487|540146450|FG000|Overall Study|Physician Decision|1|||
149730218|NCT03179436|540146453|FG000|Overall Study|Withdrawal by Subject|1|||
149730219|NCT03179436|540146454|FG001|Overall Study|Withdrawal by Subject|0|||
149730220|NCT03179436|540146455|FG002|Overall Study|Withdrawal by Subject|0|||
149730221|NCT03179436|540146456|FG003|Overall Study|Withdrawal by Subject|4|||
149730222|NCT03179436|540146457|FG004|Overall Study|Withdrawal by Subject|2|||
149730223|NCT03179436|540146458|FG005|Overall Study|Withdrawal by Subject|2|||
149730224|NCT03179436|540146459|FG006|Overall Study|Withdrawal by Subject|5|||
149730225|NCT03179436|540146460|FG007|Overall Study|Withdrawal by Subject|0|||
149730226|NCT03179436|540146461|FG008|Overall Study|Withdrawal by Subject|3|||
149730227|NCT03179436|540146462|FG009|Overall Study|Withdrawal by Subject|0|||
149730228|NCT03179436|540146463|FG010|Overall Study|Withdrawal by Subject|0|||
149730229|NCT03179436|540146464|FG011|Overall Study|Withdrawal by Subject|0|||
149730230|NCT03179436|540146453|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149730231|NCT03179436|540146454|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149730232|NCT03179436|540146455|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149730233|NCT03179436|540146456|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149730234|NCT03179436|540146457|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149730235|NCT03179436|540146458|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149730236|NCT03179436|540146459|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
149730237|NCT03179436|540146460|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
149730238|NCT03179436|540146461|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
149730239|NCT03179436|540146462|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
149730240|NCT03179436|540146463|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
149730241|NCT03179436|540146464|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
149730242|NCT03179436|540146453|FG000|Overall Study|Sponsor Decision|0|||
150252048|NCT04488770|542058366|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252049|NCT04488770|542058367|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149730243|NCT03179436|540146454|FG001|Overall Study|Sponsor Decision|0|||
149730244|NCT03179436|540146455|FG002|Overall Study|Sponsor Decision|1|||
149730245|NCT03179436|540146456|FG003|Overall Study|Sponsor Decision|3|||
149730246|NCT03179436|540146457|FG004|Overall Study|Sponsor Decision|9|||
149730247|NCT03179436|540146458|FG005|Overall Study|Sponsor Decision|7|||
149730248|NCT03179436|540146459|FG006|Overall Study|Sponsor Decision|2|||
149730249|NCT03179436|540146460|FG007|Overall Study|Sponsor Decision|4|||
149730250|NCT03179436|540146461|FG008|Overall Study|Sponsor Decision|23|||
149730251|NCT03179436|540146462|FG009|Overall Study|Sponsor Decision|6|||
150252050|NCT04488770|542058368|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
149730252|NCT03179436|540146463|FG010|Overall Study|Sponsor Decision|7|||
149730253|NCT03179436|540146464|FG011|Overall Study|Sponsor Decision|5|||
149730254|NCT03179436|540146453|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730255|NCT03179436|540146454|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
149730256|NCT03179436|540146455|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730257|NCT03179436|540146456|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730258|NCT03179436|540146457|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730259|NCT03179436|540146458|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
149730260|NCT03179436|540146459|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730261|NCT03179436|540146460|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730262|NCT03179436|540146461|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730263|NCT03179436|540146462|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730264|NCT03179436|540146463|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730265|NCT03179436|540146464|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
149730266|NCT03179436|540146453|FG000|Overall Study|Lost to Follow-up|1|||
149730267|NCT03179436|540146454|FG001|Overall Study|Lost to Follow-up|0|||
149730268|NCT03179436|540146455|FG002|Overall Study|Lost to Follow-up|0|||
149730269|NCT03179436|540146456|FG003|Overall Study|Lost to Follow-up|1|||
149730270|NCT03179436|540146457|FG004|Overall Study|Lost to Follow-up|0|||
149730271|NCT03179436|540146458|FG005|Overall Study|Lost to Follow-up|1|||
149730272|NCT03179436|540146459|FG006|Overall Study|Lost to Follow-up|0|||
149730273|NCT03179436|540146460|FG007|Overall Study|Lost to Follow-up|0|||
149730274|NCT03179436|540146461|FG008|Overall Study|Lost to Follow-up|1|||
149730275|NCT03179436|540146462|FG009|Overall Study|Lost to Follow-up|1|||
149730276|NCT03179436|540146463|FG010|Overall Study|Lost to Follow-up|0|||
149730277|NCT03179436|540146464|FG011|Overall Study|Lost to Follow-up|0|||
149730278|NCT03179436|540146453|FG000|Overall Study|Death|12|||
149730279|NCT03179436|540146454|FG001|Overall Study|Death|17|||
149730280|NCT03179436|540146455|FG002|Overall Study|Death|7|||
149730281|NCT03179436|540146456|FG003|Overall Study|Death|32|||
149730282|NCT03179436|540146457|FG004|Overall Study|Death|29|||
149730283|NCT03179436|540146458|FG005|Overall Study|Death|30|||
149730284|NCT03179436|540146459|FG006|Overall Study|Death|33|||
149730285|NCT03179436|540146460|FG007|Overall Study|Death|9|||
149730286|NCT03179436|540146461|FG008|Overall Study|Death|84|||
149730287|NCT03179436|540146462|FG009|Overall Study|Death|33|||
149730288|NCT03179436|540146463|FG010|Overall Study|Death|22|||
149730289|NCT03179436|540146464|FG011|Overall Study|Death|15|||
149730290|NCT02887521|540146465|FG000|Overall Study|Withdrawal by Subject|0|||
149730291|NCT02887521|540146466|FG001|Overall Study|Withdrawal by Subject|3|||
149730292|NCT01634555|540146477|FG000|Overall Study|Adverse Event|3|||
149730293|NCT01634555|540146477|FG000|Overall Study|Physician Decision|1|||
149730294|NCT01738971|540146480|FG000|Overall Study|Lost to Follow-up|19|||
149730295|NCT01738971|540146481|FG001|Overall Study|Lost to Follow-up|30|||
149730296|NCT01738971|540146482|FG002|Overall Study|Lost to Follow-up|17|||
149730297|NCT00618722|540148790|FG000|Overall Study|Refusal of Treatment|0|||
149730298|NCT00618722|540148791|FG001|Overall Study|Refusal of Treatment|0|||
149730299|NCT00618722|540148792|FG002|Overall Study|Refusal of Treatment|1|||
149730300|NCT00618722|540148793|FG003|Overall Study|Refusal of Treatment|0|||
149730301|NCT00618722|540148790|FG000|Overall Study|Patient Request|1|||
149730302|NCT00618722|540148791|FG001|Overall Study|Patient Request|1|||
149730303|NCT00618722|540148792|FG002|Overall Study|Patient Request|1|||
149730304|NCT00618722|540148793|FG003|Overall Study|Patient Request|1|||
149730305|NCT00618722|540148790|FG000|Overall Study|Inability to Complete Study Procedure|0|||
149730306|NCT00618722|540148791|FG001|Overall Study|Inability to Complete Study Procedure|1|||
149730307|NCT00618722|540148792|FG002|Overall Study|Inability to Complete Study Procedure|0|||
149730308|NCT00618722|540148793|FG003|Overall Study|Inability to Complete Study Procedure|0|||
149730309|NCT00618722|540148790|FG000|Overall Study|Lost to Follow-up|2|||
149730310|NCT00618722|540148791|FG001|Overall Study|Lost to Follow-up|0|||
149730311|NCT00618722|540148792|FG002|Overall Study|Lost to Follow-up|0|||
149730312|NCT00618722|540148793|FG003|Overall Study|Lost to Follow-up|2|||
149730313|NCT00618722|540148790|FG000|Overall Study|Miscellaneous Reasons|0|||
149730314|NCT00618722|540148791|FG001|Overall Study|Miscellaneous Reasons|0|||
149730315|NCT00618722|540148792|FG002|Overall Study|Miscellaneous Reasons|1|||
149730316|NCT00618722|540148793|FG003|Overall Study|Miscellaneous Reasons|1|||
149730317|NCT00200057|540148794|FG000|Overall Study|Lack of Efficacy|3|||
149730318|NCT00200057|540148794|FG000|Overall Study|Exited due to terminal illness of PI|2|||
149730319|NCT00200057|540148794|FG000|Overall Study|Withdrawal by Subject|1|||
149730320|NCT00200057|540148794|FG000|Overall Study|Change in medical condition|1|||
149730321|NCT00200057|540148794|FG000|Overall Study|Infection|1|||
149730322|NCT00200057|540148794|FG000|Overall Study|Death|1|||
149730323|NCT05512949|540148795|FG000|Overall Study|Lost to Follow-up|4|||
149730324|NCT05512949|540148796|FG001|Overall Study|Lost to Follow-up|6|||
149730325|NCT05512949|540148797|FG002|Overall Study|Lost to Follow-up|2|||
149730326|NCT05512949|540148795|FG000|Overall Study|Protocol Violation|0|||
149730327|NCT05512949|540148796|FG001|Overall Study|Protocol Violation|0|||
149730328|NCT05512949|540148797|FG002|Overall Study|Protocol Violation|1|||
149730329|NCT05512949|540148795|FG000|Overall Study|Withdrawal by Subject|1|||
149730330|NCT05512949|540148796|FG001|Overall Study|Withdrawal by Subject|1|||
149730331|NCT05512949|540148797|FG002|Overall Study|Withdrawal by Subject|2|||
149730332|NCT05512949|540148795|FG000|Overall Study|Completion status unknown|1|||
149730333|NCT05512949|540148796|FG001|Overall Study|Completion status unknown|3|||
149730334|NCT05512949|540148797|FG002|Overall Study|Completion status unknown|0|||
149730335|NCT02810964|540148798|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
149730336|NCT02810964|540148799|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
149730337|NCT02810964|540148798|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
149730338|NCT02810964|540148799|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
149730339|NCT02810964|540148798|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
149730340|NCT02810964|540148799|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
149730341|NCT02810964|540148798|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
149730342|NCT02810964|540148799|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
149730343|NCT03523351|540148800|FG000|Overall Study|Death|13|||
149730344|NCT03523351|540148801|FG001|Overall Study|Death|11|||
149730345|NCT03523351|540148800|FG000|Overall Study|Lost to Follow-up|2|||
149730346|NCT03523351|540148801|FG001|Overall Study|Lost to Follow-up|3|||
149730347|NCT03523351|540148800|FG000|Overall Study|Withdrawal by Subject|4|||
149730348|NCT03523351|540148801|FG001|Overall Study|Withdrawal by Subject|0|||
149730349|NCT03523351|540148800|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
149730350|NCT03523351|540148801|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
149730351|NCT01430442|540148802|FG000|Overall Study|Subject Withdrew Consent|3|||
149730352|NCT01430442|540148803|FG001|Overall Study|Subject Withdrew Consent|0|||
149730353|NCT01430442|540148804|FG002|Overall Study|Subject Withdrew Consent|1|||
149730354|NCT01430442|540148805|FG003|Overall Study|Subject Withdrew Consent|0|||
149730355|NCT01430442|540148806|FG004|Overall Study|Subject Withdrew Consent|2|||
149730356|NCT01430442|540148807|FG005|Overall Study|Subject Withdrew Consent|1|||
149730357|NCT01430442|540148808|FG006|Overall Study|Subject Withdrew Consent|5|||
149730358|NCT01430442|540148809|FG007|Overall Study|Subject Withdrew Consent|2|||
149730359|NCT01430442|540148802|FG000|Overall Study|Lost to Follow-up|2|||
149730360|NCT01430442|540148803|FG001|Overall Study|Lost to Follow-up|0|||
149730361|NCT01430442|540148804|FG002|Overall Study|Lost to Follow-up|1|||
149730362|NCT01430442|540148805|FG003|Overall Study|Lost to Follow-up|2|||
149730363|NCT01430442|540148806|FG004|Overall Study|Lost to Follow-up|2|||
149730364|NCT01430442|540148807|FG005|Overall Study|Lost to Follow-up|1|||
149730365|NCT01430442|540148808|FG006|Overall Study|Lost to Follow-up|5|||
149730366|NCT01430442|540148809|FG007|Overall Study|Lost to Follow-up|1|||
149730367|NCT01430442|540148802|FG000|Overall Study|Pregnancy|1|||
149730368|NCT01430442|540148803|FG001|Overall Study|Pregnancy|0|||
149730369|NCT01430442|540148804|FG002|Overall Study|Pregnancy|0|||
149730370|NCT01430442|540148805|FG003|Overall Study|Pregnancy|0|||
149730371|NCT01430442|540148806|FG004|Overall Study|Pregnancy|0|||
149730372|NCT01430442|540148807|FG005|Overall Study|Pregnancy|1|||
149730373|NCT01430442|540148808|FG006|Overall Study|Pregnancy|0|||
149730374|NCT01430442|540148809|FG007|Overall Study|Pregnancy|0|||
149730375|NCT01430442|540148802|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
149730376|NCT01430442|540148803|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
149730377|NCT01430442|540148804|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
149730378|NCT01430442|540148805|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
149730379|NCT01430442|540148806|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
149730380|NCT01430442|540148807|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
149730381|NCT01430442|540148808|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
149730382|NCT01430442|540148809|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
149730383|NCT00772629|540148811|FG000|Overall Study|Subject was not vaccinated|1|||
149730384|NCT00772629|540148812|FG001|Overall Study|Subject was not vaccinated|0|||
149730385|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
149730386|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
149730387|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
149730388|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149730389|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149730390|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149730391|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149730392|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149730393|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
149730394|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
149730395|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
149730396|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149730397|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149730398|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149730399|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149730400|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149730401|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
149730402|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
149730403|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
149730404|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149730405|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149730406|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149730407|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149730408|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149730409|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
149730410|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
149730411|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149730412|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149730413|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149730414|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149730415|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149730416|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149730417|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
149730418|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
149730419|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
149730420|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149730421|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149730422|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149730423|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149730424|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149730425|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
149730426|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
149730427|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730428|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730429|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730430|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730431|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730432|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149730433|NCT01097629|540148816|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
149730434|NCT01097629|540148817|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
149730435|NCT01097629|540148818|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
149730436|NCT01097629|540148819|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149730437|NCT01097629|540148820|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149730438|NCT01097629|540148821|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149730439|NCT01097629|540148822|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149730440|NCT01097629|540148823|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149730441|NCT01097629|540148816|FG000|DB RO Phase|Withdrawal by Subject|0|||
149730442|NCT01097629|540148817|FG001|DB RO Phase|Withdrawal by Subject|0|||
149730443|NCT01097629|540148818|FG002|DB RO Phase|Withdrawal by Subject|0|||
149730444|NCT01097629|540148819|FG003|DB RO Phase|Withdrawal by Subject|0|||
149730445|NCT01097629|540148820|FG004|DB RO Phase|Withdrawal by Subject|0|||
149730446|NCT01097629|540148821|FG005|DB RO Phase|Withdrawal by Subject|0|||
149730447|NCT01097629|540148822|FG006|DB RO Phase|Withdrawal by Subject|0|||
149730448|NCT01097629|540148823|FG007|DB RO Phase|Withdrawal by Subject|1|||
149730449|NCT01097629|540148816|FG000|DB RO Phase|Protocol Violation|0|||
149730450|NCT01097629|540148817|FG001|DB RO Phase|Protocol Violation|0|||
149730451|NCT01097629|540148818|FG002|DB RO Phase|Protocol Violation|0|||
149730452|NCT01097629|540148819|FG003|DB RO Phase|Protocol Violation|1|||
149730453|NCT01097629|540148820|FG004|DB RO Phase|Protocol Violation|0|||
149730454|NCT01097629|540148821|FG005|DB RO Phase|Protocol Violation|1|||
149730455|NCT01097629|540148822|FG006|DB RO Phase|Protocol Violation|1|||
149730456|NCT01097629|540148823|FG007|DB RO Phase|Protocol Violation|0|||
149730457|NCT01097629|540148816|FG000|DB RO Phase|Lost to Follow-up|0|||
150252051|NCT04488770|542058369|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252052|NCT04488770|542058370|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252053|NCT04488770|542058371|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252054|NCT04488770|542058372|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252055|NCT04488770|542058373|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252056|NCT04488770|542058374|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252057|NCT04488770|542058375|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149730458|NCT01097629|540148817|FG001|DB RO Phase|Lost to Follow-up|0|||
149730459|NCT01097629|540148818|FG002|DB RO Phase|Lost to Follow-up|0|||
149730460|NCT01097629|540148819|FG003|DB RO Phase|Lost to Follow-up|0|||
149730461|NCT01097629|540148820|FG004|DB RO Phase|Lost to Follow-up|0|||
149730462|NCT01097629|540148821|FG005|DB RO Phase|Lost to Follow-up|0|||
149730463|NCT01097629|540148822|FG006|DB RO Phase|Lost to Follow-up|2|||
149730464|NCT01097629|540148823|FG007|DB RO Phase|Lost to Follow-up|0|||
150252058|NCT04488770|542058376|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252059|NCT04488770|542058377|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
150252060|NCT04488770|542058365|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
150252061|NCT04488770|542058366|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252062|NCT04488770|542058367|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252063|NCT04488770|542058368|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252064|NCT04488770|542058369|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252065|NCT04488770|542058370|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252066|NCT04488770|542058371|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252067|NCT04488770|542058372|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252068|NCT04488770|542058373|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252069|NCT04488770|542058374|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252070|NCT04488770|542058375|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252071|NCT04488770|542058376|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252072|NCT04488770|542058377|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
150252073|NCT04488770|542058365|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252074|NCT04488770|542058366|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252075|NCT04488770|542058367|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149730465|NCT00132041|540148826|FG000|Baseline|Ineligible|6|||
149730466|NCT00132041|540148826|FG000|3 Months Post Ablation|Transplant|1|||
149730467|NCT00132041|540148826|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
149730468|NCT00132041|540148826|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
149730469|NCT00132041|540148826|FG000|6 Months Post Ablation|Death|2|||
149730470|NCT00132041|540148826|FG000|6 Months Post Ablation|Transplant|6|||
149730471|NCT00132041|540148826|FG000|9 Months Post Ablation|Death|1|||
149730472|NCT00132041|540148826|FG000|9 Months Post Ablation|Transplant|1|||
149730473|NCT00132041|540148826|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
149730474|NCT00132041|540148826|FG000|12 Months Post Ablation|Death|1|||
149730475|NCT00132041|540148826|FG000|12 Months Post Ablation|Transplant|1|||
149730476|NCT00132041|540148826|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
149730477|NCT00132041|540148826|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
149730478|NCT00132041|540148826|FG000|15 Months Post Ablation|Death|1|||
149730479|NCT00132041|540148826|FG000|15 Months Post Ablation|Transplant|5|||
149730480|NCT00132041|540148826|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
149730481|NCT00132041|540148826|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
149730482|NCT00132041|540148826|FG000|18 Months Post Ablation|Transplant|1|||
149730483|NCT00132041|540148826|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
149730484|NCT00132041|540148826|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
149730485|NCT01171820|540148827|FG000|Overall Study|Death|3|||
149730486|NCT01171820|540148828|FG001|Overall Study|Death|3|||
149730487|NCT01171820|540148827|FG000|Overall Study|Lost to Follow-up|0|||
149730488|NCT01171820|540148828|FG001|Overall Study|Lost to Follow-up|1|||
149730489|NCT01171820|540148827|FG000|Overall Study|Withdrawal by Subject|2|||
149730490|NCT01171820|540148828|FG001|Overall Study|Withdrawal by Subject|0|||
149730491|NCT01171820|540148827|FG000|Overall Study|Physician Decision|0|||
149730492|NCT01171820|540148828|FG001|Overall Study|Physician Decision|1|||
149730493|NCT01171820|540148827|FG000|Overall Study|1-Year Missed Visit|1|||
149730494|NCT01171820|540148828|FG001|Overall Study|1-Year Missed Visit|1|||
149730495|NCT03969875|540148829|FG000|Overall Study|did not receive allocated intervention|3|||
149730496|NCT03969875|540148830|FG001|Overall Study|did not receive allocated intervention|3|||
149730497|NCT03969875|540148831|FG002|Overall Study|did not receive allocated intervention|4|||
149730498|NCT03969875|540148829|FG000|Overall Study|Protocol Violation|4|||
149730499|NCT03969875|540148830|FG001|Overall Study|Protocol Violation|2|||
149730500|NCT03969875|540148831|FG002|Overall Study|Protocol Violation|2|||
149730501|NCT02327260|540148833|FG000|Overall Study|Lost to Follow-up|2|||
149730502|NCT02327260|540148834|FG001|Overall Study|Lost to Follow-up|3|||
149730503|NCT02327260|540148835|FG002|Overall Study|Lost to Follow-up|2|||
150252076|NCT04488770|542058368|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252077|NCT04488770|542058369|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252078|NCT04488770|542058370|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
149730504|NCT02327260|540148833|FG000|Overall Study|invalid phone number|1|||
149730505|NCT02327260|540148834|FG001|Overall Study|invalid phone number|1|||
149730506|NCT02327260|540148835|FG002|Overall Study|invalid phone number|0|||
149730507|NCT02327260|540148833|FG000|Overall Study|non-adherence to protocol|2|||
149730508|NCT02327260|540148834|FG001|Overall Study|non-adherence to protocol|0|||
149730509|NCT02327260|540148835|FG002|Overall Study|non-adherence to protocol|0|||
149730510|NCT02327260|540148833|FG000|Overall Study|cognitive concerns|1|||
149730511|NCT02327260|540148834|FG001|Overall Study|cognitive concerns|0|||
149730512|NCT02327260|540148835|FG002|Overall Study|cognitive concerns|0|||
149730513|NCT02804763|540148838|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
149730514|NCT02804763|540148839|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149730515|NCT02804763|540148840|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149730516|NCT02804763|540148841|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149730517|NCT02804763|540148838|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
149730518|NCT02804763|540148839|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
149730519|NCT02804763|540148840|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
149730520|NCT02804763|540148841|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
149730521|NCT02804763|540148838|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149730522|NCT02804763|540148839|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
149730523|NCT02804763|540148840|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149730524|NCT02804763|540148841|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149730525|NCT02804763|540148838|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
149730526|NCT02804763|540148839|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
149730527|NCT02804763|540148840|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
149730528|NCT02804763|540148841|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
149730529|NCT02804763|540148838|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
149730530|NCT02804763|540148839|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
149730531|NCT02804763|540148840|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
149730532|NCT02804763|540148841|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
149730533|NCT02804763|540148838|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149730534|NCT02804763|540148839|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
149730535|NCT02804763|540148840|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149730536|NCT02804763|540148841|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149730537|NCT00793793|540148842|FG000|Overall Study|Adverse Event|0|||
149730538|NCT00793793|540148843|FG001|Overall Study|Adverse Event|0|||
149730539|NCT00793793|540148844|FG002|Overall Study|Adverse Event|1|||
149730540|NCT00793793|540148845|FG003|Overall Study|Adverse Event|1|||
149730541|NCT00793793|540148846|FG004|Overall Study|Adverse Event|0|||
149730542|NCT00793793|540148847|FG005|Overall Study|Adverse Event|1|||
149730543|NCT00793793|540148848|FG006|Overall Study|Adverse Event|2|||
149730544|NCT00793793|540148849|FG007|Overall Study|Adverse Event|0|||
149730545|NCT00793793|540148850|FG008|Overall Study|Adverse Event|0|||
149730546|NCT00793793|540148851|FG009|Overall Study|Adverse Event|0|||
149730547|NCT00793793|540148852|FG010|Overall Study|Adverse Event|0|||
149730548|NCT00793793|540148853|FG011|Overall Study|Adverse Event|2|||
149730549|NCT00793793|540148842|FG000|Overall Study|Protocol Violation|0|||
149730550|NCT00793793|540148843|FG001|Overall Study|Protocol Violation|0|||
149730551|NCT00793793|540148844|FG002|Overall Study|Protocol Violation|0|||
149730552|NCT00793793|540148845|FG003|Overall Study|Protocol Violation|1|||
149730553|NCT00793793|540148846|FG004|Overall Study|Protocol Violation|0|||
149730554|NCT00793793|540148847|FG005|Overall Study|Protocol Violation|0|||
149730555|NCT00793793|540148848|FG006|Overall Study|Protocol Violation|0|||
149730556|NCT00793793|540148849|FG007|Overall Study|Protocol Violation|0|||
150252079|NCT04488770|542058371|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
150252080|NCT04488770|542058372|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252081|NCT04488770|542058373|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252082|NCT04488770|542058374|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252083|NCT04488770|542058375|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252084|NCT04488770|542058376|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252085|NCT04488770|542058377|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
150252086|NCT04488770|542058365|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252087|NCT04488770|542058366|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252088|NCT04488770|542058367|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252089|NCT04488770|542058368|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252090|NCT04488770|542058369|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
150252091|NCT04488770|542058370|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252092|NCT04488770|542058371|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252093|NCT04488770|542058372|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252094|NCT04488770|542058373|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252095|NCT04488770|542058374|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149730557|NCT00793793|540148850|FG008|Overall Study|Protocol Violation|0|||
149730558|NCT00793793|540148851|FG009|Overall Study|Protocol Violation|0|||
149730559|NCT00793793|540148852|FG010|Overall Study|Protocol Violation|0|||
149730560|NCT00793793|540148853|FG011|Overall Study|Protocol Violation|0|||
149730561|NCT00793793|540148842|FG000|Overall Study|Lost to Follow-up|0|||
149730562|NCT00793793|540148843|FG001|Overall Study|Lost to Follow-up|0|||
150252096|NCT04488770|542058375|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252097|NCT04488770|542058376|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252098|NCT04488770|542058377|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
150252099|NCT03547739|542058378|FG000|Overall Study|Death|0|||
150252100|NCT03547739|542058379|FG001|Overall Study|Death|1|||
150252101|NCT03547739|542058380|FG002|Overall Study|Death|5|||
150252102|NCT03547739|542058378|FG000|Overall Study|Adverse Event|24|||
150252103|NCT03547739|542058379|FG001|Overall Study|Adverse Event|11|||
150252104|NCT03547739|542058380|FG002|Overall Study|Adverse Event|13|||
150252105|NCT03547739|542058378|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
150252106|NCT03547739|542058379|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
150252107|NCT03547739|542058380|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
150252108|NCT03547739|542058378|FG000|Overall Study|Lost to Follow-up|80|||
150252109|NCT03547739|542058379|FG001|Overall Study|Lost to Follow-up|84|||
150252110|NCT03547739|542058380|FG002|Overall Study|Lost to Follow-up|116|||
150252111|NCT01208103|542058381|FG000|Overall Study|Adverse Event|1|||
150252112|NCT01208103|542058381|FG000|Overall Study|Withdrawal by Subject|1|||
150252113|NCT00403767|542058387|FG000|Overall Study|Adverse Event|993|||
150252114|NCT00403767|542058388|FG001|Overall Study|Adverse Event|919|||
150252115|NCT00403767|542058387|FG000|Overall Study|Non-compliant with study medication|134|||
150252116|NCT00403767|542058388|FG001|Overall Study|Non-compliant with study medication|164|||
150252117|NCT00403767|542058387|FG000|Overall Study|Consent withdrawn|671|||
150252118|NCT00403767|542058388|FG001|Overall Study|Consent withdrawn|673|||
150252119|NCT00403767|542058387|FG000|Overall Study|Investigator dec./not protocol-related|191|||
150252120|NCT00403767|542058388|FG001|Overall Study|Investigator dec./not protocol-related|178|||
150252121|NCT00403767|542058387|FG000|Overall Study|Lost to Follow-up|6|||
150252122|NCT00403767|542058388|FG001|Overall Study|Lost to Follow-up|8|||
150252123|NCT00403767|542058387|FG000|Overall Study|Protocol Violation|142|||
150252124|NCT00403767|542058388|FG001|Overall Study|Protocol Violation|124|||
150252125|NCT00403767|542058387|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
150252126|NCT00403767|542058388|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
150252127|NCT00403767|542058387|FG000|Overall Study|Study terminated by sponsor|82|||
150252128|NCT00403767|542058388|FG001|Overall Study|Study terminated by sponsor|69|||
150252129|NCT00403767|542058387|FG000|Overall Study|Missing/incomplete data|1|||
150252130|NCT00403767|542058388|FG001|Overall Study|Missing/incomplete data|1|||
150252131|NCT05330676|542058389|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
150252132|NCT05330676|542058390|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
150252133|NCT02045875|542058393|FG000|Overall Study|Lost to Follow-up|3|||
150252134|NCT02045875|542058394|FG001|Overall Study|Lost to Follow-up|0|||
150252135|NCT02045875|542058393|FG000|Overall Study|Withdrawal by Subject|4|||
150252136|NCT02045875|542058394|FG001|Overall Study|Withdrawal by Subject|3|||
150252137|NCT01276379|542058395|FG000|Overall Study|Screening failure|40|||
150252138|NCT01743989|542058396|FG000|Treatment Phase|Unstable MR4.0|0|||
150252139|NCT01743989|542058397|FG001|Treatment Phase|Unstable MR4.0|6|||
150252140|NCT01743989|542058398|FG002|Treatment Phase|Unstable MR4.0|263|||
150252141|NCT01743989|542058396|FG000|Treatment Phase|Adverse Event|0|||
150252142|NCT01743989|542058397|FG001|Treatment Phase|Adverse Event|4|||
150252143|NCT01743989|542058398|FG002|Treatment Phase|Adverse Event|67|||
150252144|NCT01743989|542058396|FG000|Treatment Phase|Withdrawal by Subject|1|||
150252145|NCT01743989|542058397|FG001|Treatment Phase|Withdrawal by Subject|3|||
150252146|NCT01743989|542058398|FG002|Treatment Phase|Withdrawal by Subject|28|||
150252147|NCT01743989|542058396|FG000|Treatment Phase|Death|0|||
150252148|NCT01743989|542058397|FG001|Treatment Phase|Death|1|||
150252149|NCT01743989|542058398|FG002|Treatment Phase|Death|3|||
150252150|NCT01743989|542058396|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
150252151|NCT01743989|542058397|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
150252152|NCT01743989|542058398|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
150252153|NCT01743989|542058396|FG000|Treatment Phase|Protocol deviation|0|||
150252154|NCT01743989|542058397|FG001|Treatment Phase|Protocol deviation|0|||
149730563|NCT00793793|540148844|FG002|Overall Study|Lost to Follow-up|1|||
149730564|NCT00793793|540148845|FG003|Overall Study|Lost to Follow-up|0|||
149730565|NCT00793793|540148846|FG004|Overall Study|Lost to Follow-up|0|||
149730566|NCT00793793|540148847|FG005|Overall Study|Lost to Follow-up|0|||
150252155|NCT01743989|542058398|FG002|Treatment Phase|Protocol deviation|3|||
149730567|NCT00793793|540148848|FG006|Overall Study|Lost to Follow-up|0|||
150252156|NCT01743989|542058396|FG000|Treatment Phase|Pregnancy|0|||
150252157|NCT01743989|542058397|FG001|Treatment Phase|Pregnancy|0|||
150252158|NCT01743989|542058398|FG002|Treatment Phase|Pregnancy|2|||
150252159|NCT01743989|542058396|FG000|Treatment Phase|Lost to Follow-up|0|||
150252160|NCT01743989|542058397|FG001|Treatment Phase|Lost to Follow-up|0|||
150252161|NCT01743989|542058398|FG002|Treatment Phase|Lost to Follow-up|2|||
150252162|NCT01743989|542058396|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
150252163|NCT01743989|542058397|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
150252164|NCT01743989|542058398|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
150252165|NCT01743989|542058396|FG000|Treatment Phase|Administrative problems|0|||
150252166|NCT01743989|542058397|FG001|Treatment Phase|Administrative problems|0|||
150252167|NCT01743989|542058398|FG002|Treatment Phase|Administrative problems|1|||
150252168|NCT01743989|542058396|FG000|Treatment Phase|New cancer (CML) therapy|0|||
150252169|NCT01743989|542058397|FG001|Treatment Phase|New cancer (CML) therapy|1|||
150252170|NCT01743989|542058398|FG002|Treatment Phase|New cancer (CML) therapy|0|||
150252171|NCT01743989|542058396|FG000|Treatment Phase|Physician Decision|0|||
150252172|NCT01743989|542058397|FG001|Treatment Phase|Physician Decision|0|||
150252173|NCT01743989|542058398|FG002|Treatment Phase|Physician Decision|3|||
150252174|NCT01743989|542058396|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
150252175|NCT01743989|542058397|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
150252176|NCT01743989|542058398|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
150252177|NCT01743989|542058396|FG000|Treatment Phase|Not randomized by mistake|0|||
150252178|NCT01743989|542058397|FG001|Treatment Phase|Not randomized by mistake|0|||
150252179|NCT01743989|542058398|FG002|Treatment Phase|Not randomized by mistake|1|||
150252180|NCT01743989|542058396|FG000|Treatment Phase|Included by mistake|0|||
150252181|NCT01743989|542058397|FG001|Treatment Phase|Included by mistake|0|||
150252182|NCT01743989|542058398|FG002|Treatment Phase|Included by mistake|1|||
150252183|NCT01743989|542058396|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
150252184|NCT01743989|542058397|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
150252185|NCT01743989|542058398|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
150252186|NCT01743989|542058396|FG000|TFR Phase|Adverse Event|0|||
150252187|NCT01743989|542058397|FG001|TFR Phase|Adverse Event|1|||
150252188|NCT01743989|542058398|FG002|TFR Phase|Adverse Event|0|||
150252189|NCT01743989|542058396|FG000|TFR Phase|Lost to Follow-up|0|||
150252190|NCT01743989|542058397|FG001|TFR Phase|Lost to Follow-up|2|||
150252191|NCT01743989|542058398|FG002|TFR Phase|Lost to Follow-up|0|||
150252192|NCT01743989|542058396|FG000|TFR Phase|Physician Decision|0|||
150252193|NCT01743989|542058397|FG001|TFR Phase|Physician Decision|1|||
150252194|NCT01743989|542058398|FG002|TFR Phase|Physician Decision|0|||
150252195|NCT01743989|542058396|FG000|TFR Phase|Logistical problems|0|||
150252196|NCT01743989|542058397|FG001|TFR Phase|Logistical problems|2|||
150252197|NCT01743989|542058398|FG002|TFR Phase|Logistical problems|0|||
150252198|NCT01743989|542058396|FG000|TFR Phase|Protocol deviation|0|||
150252199|NCT01743989|542058397|FG001|TFR Phase|Protocol deviation|1|||
150252200|NCT01743989|542058398|FG002|TFR Phase|Protocol deviation|0|||
150252201|NCT01743989|542058396|FG000|TFR Phase|Withdrawal by Subject|0|||
150252202|NCT01743989|542058397|FG001|TFR Phase|Withdrawal by Subject|2|||
150252203|NCT01743989|542058398|FG002|TFR Phase|Withdrawal by Subject|0|||
150252204|NCT01743989|542058396|FG000|Re-treatment Phase|Adverse Event|8|||
150252205|NCT01743989|542058397|FG001|Re-treatment Phase|Adverse Event|4|||
150252206|NCT01743989|542058398|FG002|Re-treatment Phase|Adverse Event|0|||
150252207|NCT01743989|542058396|FG000|Re-treatment Phase|Death|1|||
150252208|NCT01743989|542058397|FG001|Re-treatment Phase|Death|1|||
150252209|NCT01743989|542058398|FG002|Re-treatment Phase|Death|0|||
150252210|NCT01743989|542058396|FG000|Re-treatment Phase|Administrative problems|1|||
150252211|NCT01743989|542058397|FG001|Re-treatment Phase|Administrative problems|1|||
150252212|NCT01743989|542058398|FG002|Re-treatment Phase|Administrative problems|0|||
150252213|NCT01743989|542058396|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
150252214|NCT01743989|542058397|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
150252215|NCT01743989|542058398|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
150252216|NCT01743989|542058396|FG000|Re-treatment Phase|Unstable MR|1|||
150252217|NCT01743989|542058397|FG001|Re-treatment Phase|Unstable MR|0|||
150252218|NCT01743989|542058398|FG002|Re-treatment Phase|Unstable MR|0|||
150252219|NCT01743989|542058396|FG000|Re-treatment Phase|Physician Decision|0|||
150252220|NCT01743989|542058397|FG001|Re-treatment Phase|Physician Decision|1|||
150252221|NCT01743989|542058398|FG002|Re-treatment Phase|Physician Decision|0|||
150252222|NCT01743989|542058396|FG000|Re-treatment Phase|Lost to Follow-up|0|||
150252223|NCT01743989|542058397|FG001|Re-treatment Phase|Lost to Follow-up|1|||
150252224|NCT01743989|542058398|FG002|Re-treatment Phase|Lost to Follow-up|0|||
150252225|NCT05384938|542058401|FG000|Overall Study|Withdrawal by Subject|8|||
150252226|NCT05384938|542058401|FG000|Overall Study|Lost to Follow-up|6|||
150252227|NCT05384938|542058401|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
150252228|NCT00384397|542058403|FG000|Overall Study|Adverse Event|0|||
150252229|NCT00384397|542058404|FG001|Overall Study|Adverse Event|1|||
150252230|NCT00384397|542058405|FG002|Overall Study|Adverse Event|2|||
149730568|NCT00793793|540148849|FG007|Overall Study|Lost to Follow-up|0|||
150252231|NCT00384397|542058403|FG000|Overall Study|Protocol Violation|7|||
150252232|NCT00384397|542058404|FG001|Overall Study|Protocol Violation|15|||
150252233|NCT00384397|542058405|FG002|Overall Study|Protocol Violation|13|||
150252234|NCT00384397|542058403|FG000|Overall Study|Lost to Follow-up|11|||
150252235|NCT00384397|542058404|FG001|Overall Study|Lost to Follow-up|13|||
150252236|NCT00384397|542058405|FG002|Overall Study|Lost to Follow-up|3|||
150252237|NCT00384397|542058403|FG000|Overall Study|Withdrawal by Subject|14|||
150252238|NCT00384397|542058404|FG001|Overall Study|Withdrawal by Subject|17|||
150252239|NCT00384397|542058405|FG002|Overall Study|Withdrawal by Subject|15|||
150252240|NCT01525238|542058406|FG000|Overall Study|Withdrawal by Subject|1|||
150252241|NCT01525238|542058407|FG001|Overall Study|Withdrawal by Subject|0|||
150252242|NCT01525238|542058408|FG002|Overall Study|Withdrawal by Subject|0|||
150252243|NCT01214642|542058409|FG000|Overall Study|Progressive Disease|3|||
150252244|NCT01214642|542058410|FG001|Overall Study|Progressive Disease|2|||
150252245|NCT01214642|542058411|FG002|Overall Study|Progressive Disease|3|||
150252246|NCT01214642|542058412|FG003|Overall Study|Progressive Disease|5|||
150252247|NCT01214642|542058413|FG004|Overall Study|Progressive Disease|5|||
150252248|NCT01214642|542058414|FG005|Overall Study|Progressive Disease|3|||
150252249|NCT01214642|542058415|FG006|Overall Study|Progressive Disease|5|||
150252250|NCT01214642|542058416|FG007|Overall Study|Progressive Disease|3|||
150252251|NCT01214642|542058417|FG008|Overall Study|Progressive Disease|10|||
150252252|NCT01214642|542058418|FG009|Overall Study|Progressive Disease|2|||
150252253|NCT01214642|542058419|FG010|Overall Study|Progressive Disease|1|||
150252254|NCT01214642|542058420|FG011|Overall Study|Progressive Disease|4|||
150252255|NCT01214642|542058409|FG000|Overall Study|Adverse Event|0|||
150252256|NCT01214642|542058410|FG001|Overall Study|Adverse Event|1|||
150252257|NCT01214642|542058411|FG002|Overall Study|Adverse Event|0|||
150252258|NCT01214642|542058412|FG003|Overall Study|Adverse Event|0|||
150252259|NCT01214642|542058413|FG004|Overall Study|Adverse Event|0|||
150252260|NCT01214642|542058414|FG005|Overall Study|Adverse Event|0|||
150252261|NCT01214642|542058415|FG006|Overall Study|Adverse Event|1|||
150252262|NCT01214642|542058416|FG007|Overall Study|Adverse Event|0|||
150252263|NCT01214642|542058417|FG008|Overall Study|Adverse Event|0|||
150252264|NCT01214642|542058418|FG009|Overall Study|Adverse Event|1|||
150252265|NCT01214642|542058419|FG010|Overall Study|Adverse Event|1|||
150252266|NCT01214642|542058420|FG011|Overall Study|Adverse Event|0|||
150252267|NCT01214642|542058409|FG000|Overall Study|Death|0|||
150252268|NCT01214642|542058410|FG001|Overall Study|Death|0|||
150252269|NCT01214642|542058411|FG002|Overall Study|Death|1|||
150252270|NCT01214642|542058412|FG003|Overall Study|Death|0|||
150252271|NCT01214642|542058413|FG004|Overall Study|Death|0|||
150252272|NCT01214642|542058414|FG005|Overall Study|Death|0|||
150252273|NCT01214642|542058415|FG006|Overall Study|Death|0|||
150252274|NCT01214642|542058416|FG007|Overall Study|Death|0|||
150252275|NCT01214642|542058417|FG008|Overall Study|Death|0|||
150252276|NCT01214642|542058418|FG009|Overall Study|Death|0|||
150252277|NCT01214642|542058419|FG010|Overall Study|Death|1|||
150252278|NCT01214642|542058420|FG011|Overall Study|Death|0|||
150252279|NCT01214642|542058409|FG000|Overall Study|Withdrawal by Subject|0|||
150252280|NCT01214642|542058410|FG001|Overall Study|Withdrawal by Subject|0|||
150252281|NCT01214642|542058411|FG002|Overall Study|Withdrawal by Subject|1|||
150252282|NCT01214642|542058412|FG003|Overall Study|Withdrawal by Subject|0|||
150252283|NCT01214642|542058413|FG004|Overall Study|Withdrawal by Subject|0|||
150252284|NCT01214642|542058414|FG005|Overall Study|Withdrawal by Subject|0|||
150252285|NCT01214642|542058415|FG006|Overall Study|Withdrawal by Subject|0|||
150252286|NCT01214642|542058416|FG007|Overall Study|Withdrawal by Subject|0|||
150252287|NCT01214642|542058417|FG008|Overall Study|Withdrawal by Subject|3|||
150252288|NCT01214642|542058418|FG009|Overall Study|Withdrawal by Subject|1|||
150252289|NCT01214642|542058419|FG010|Overall Study|Withdrawal by Subject|1|||
150252290|NCT01214642|542058420|FG011|Overall Study|Withdrawal by Subject|0|||
150252291|NCT01214642|542058409|FG000|Overall Study|Physician Decision|0|||
150252292|NCT01214642|542058410|FG001|Overall Study|Physician Decision|0|||
150252293|NCT01214642|542058411|FG002|Overall Study|Physician Decision|1|||
150252294|NCT01214642|542058412|FG003|Overall Study|Physician Decision|1|||
150252295|NCT01214642|542058413|FG004|Overall Study|Physician Decision|1|||
150252296|NCT01214642|542058414|FG005|Overall Study|Physician Decision|0|||
150252297|NCT01214642|542058415|FG006|Overall Study|Physician Decision|0|||
150252298|NCT01214642|542058416|FG007|Overall Study|Physician Decision|0|||
150252299|NCT01214642|542058417|FG008|Overall Study|Physician Decision|0|||
150252300|NCT01214642|542058418|FG009|Overall Study|Physician Decision|0|||
150252301|NCT01214642|542058419|FG010|Overall Study|Physician Decision|0|||
150252302|NCT01214642|542058420|FG011|Overall Study|Physician Decision|2|||
150252303|NCT01946529|542058421|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
150252304|NCT01946529|542058422|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
150252305|NCT01946529|542058423|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
150252306|NCT01946529|542058421|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
150252307|NCT01946529|542058422|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
150252308|NCT01946529|542058423|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
150252309|NCT02731690|542060132|FG000|Overall Study|Adverse Event|1|||
150252310|NCT02731690|542060132|FG000|Overall Study|Withdrawal by Subject|3|||
150252311|NCT02731690|542060132|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
150252312|NCT03568318|542060136|FG000|Overall Study|Adverse Event|3|||
150252313|NCT03568318|542060137|FG001|Overall Study|Adverse Event|1|||
150252314|NCT03568318|542060138|FG002|Overall Study|Adverse Event|1|||
150252315|NCT03568318|542060139|FG003|Overall Study|Adverse Event|0|||
150252316|NCT03568318|542060140|FG004|Overall Study|Adverse Event|1|||
150252317|NCT03568318|542060141|FG005|Overall Study|Adverse Event|0|||
150252318|NCT03568318|542060136|FG000|Overall Study|Withdrawal by Subject|6|||
150252319|NCT03568318|542060137|FG001|Overall Study|Withdrawal by Subject|5|||
150252320|NCT03568318|542060138|FG002|Overall Study|Withdrawal by Subject|2|||
150252321|NCT03568318|542060139|FG003|Overall Study|Withdrawal by Subject|1|||
150252322|NCT03568318|542060140|FG004|Overall Study|Withdrawal by Subject|0|||
150252323|NCT03568318|542060141|FG005|Overall Study|Withdrawal by Subject|0|||
150252324|NCT03568318|542060136|FG000|Overall Study|Lost to Follow-up|3|||
150252325|NCT03568318|542060137|FG001|Overall Study|Lost to Follow-up|2|||
150252326|NCT03568318|542060138|FG002|Overall Study|Lost to Follow-up|2|||
150252327|NCT03568318|542060139|FG003|Overall Study|Lost to Follow-up|2|||
150252328|NCT03568318|542060140|FG004|Overall Study|Lost to Follow-up|1|||
150252329|NCT03568318|542060141|FG005|Overall Study|Lost to Follow-up|0|||
150252330|NCT03568318|542060136|FG000|Overall Study|Other|3|||
150252331|NCT03568318|542060137|FG001|Overall Study|Other|1|||
150252332|NCT03568318|542060138|FG002|Overall Study|Other|3|||
150252333|NCT03568318|542060139|FG003|Overall Study|Other|0|||
150252334|NCT03568318|542060140|FG004|Overall Study|Other|0|||
150252335|NCT03568318|542060141|FG005|Overall Study|Other|0|||
150252336|NCT03568318|542060136|FG000|Overall Study|Ongoing at Time of Analysis|5|||
150252337|NCT03568318|542060137|FG001|Overall Study|Ongoing at Time of Analysis|3|||
150252338|NCT03568318|542060138|FG002|Overall Study|Ongoing at Time of Analysis|2|||
150252339|NCT03568318|542060139|FG003|Overall Study|Ongoing at Time of Analysis|1|||
150252340|NCT03568318|542060140|FG004|Overall Study|Ongoing at Time of Analysis|0|||
150252341|NCT03568318|542060141|FG005|Overall Study|Ongoing at Time of Analysis|0|||
150252342|NCT02898077|542060142|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
150252343|NCT02898077|542060143|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
150252344|NCT02898077|542060142|FG000|Overall Study|Lost to Follow-up|4|||
150252345|NCT02898077|542060143|FG001|Overall Study|Lost to Follow-up|3|||
150252346|NCT02898077|542060142|FG000|Overall Study|Physician Decision|0|||
150252347|NCT02898077|542060143|FG001|Overall Study|Physician Decision|2|||
150252348|NCT02898077|542060142|FG000|Overall Study|Sponsor Decision|32|||
150252349|NCT02898077|542060143|FG001|Overall Study|Sponsor Decision|13|||
150252350|NCT02898077|542060142|FG000|Overall Study|Withdrawal by Subject|6|||
150252351|NCT02898077|542060143|FG001|Overall Study|Withdrawal by Subject|3|||
150252352|NCT02898077|542060142|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
150252353|NCT02898077|542060143|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
150252354|NCT02898077|542060142|FG000|Overall Study|Ended extension period|3|||
150252355|NCT02898077|542060143|FG001|Overall Study|Ended extension period|0|||
150252356|NCT04410523|542060144|FG000|Overall Study|Study terminated by sponsor|1|||
150252357|NCT04410523|542060145|FG001|Overall Study|Study terminated by sponsor|3|||
150252358|NCT04410523|542060146|FG002|Overall Study|Study terminated by sponsor|2|||
150252359|NCT04410523|542060147|FG003|Overall Study|Study terminated by sponsor|6|||
150252360|NCT04410523|542060148|FG004|Overall Study|Study terminated by sponsor|3|||
150252361|NCT04410523|542060149|FG005|Overall Study|Study terminated by sponsor|4|||
150252362|NCT04410523|542060144|FG000|Overall Study|Adverse Event|1|||
150252363|NCT04410523|542060145|FG001|Overall Study|Adverse Event|0|||
150252364|NCT04410523|542060146|FG002|Overall Study|Adverse Event|0|||
150252365|NCT04410523|542060147|FG003|Overall Study|Adverse Event|0|||
150252366|NCT04410523|542060148|FG004|Overall Study|Adverse Event|0|||
150252367|NCT04410523|542060149|FG005|Overall Study|Adverse Event|2|||
150252368|NCT04410523|542060144|FG000|Overall Study|Lost to Follow-up|0|||
150252369|NCT04410523|542060145|FG001|Overall Study|Lost to Follow-up|1|||
150252370|NCT04410523|542060146|FG002|Overall Study|Lost to Follow-up|0|||
150252371|NCT04410523|542060147|FG003|Overall Study|Lost to Follow-up|0|||
150252372|NCT04410523|542060148|FG004|Overall Study|Lost to Follow-up|0|||
150252373|NCT04410523|542060149|FG005|Overall Study|Lost to Follow-up|0|||
150252374|NCT04410523|542060144|FG000|Overall Study|Physician Decision|0|||
150252375|NCT04410523|542060145|FG001|Overall Study|Physician Decision|1|||
150252376|NCT04410523|542060146|FG002|Overall Study|Physician Decision|0|||
150252377|NCT04410523|542060147|FG003|Overall Study|Physician Decision|0|||
150252378|NCT04410523|542060148|FG004|Overall Study|Physician Decision|0|||
150252379|NCT04410523|542060149|FG005|Overall Study|Physician Decision|0|||
150252380|NCT04410523|542060144|FG000|Overall Study|Pregnancy|0|||
150252381|NCT04410523|542060145|FG001|Overall Study|Pregnancy|0|||
150252382|NCT04410523|542060146|FG002|Overall Study|Pregnancy|0|||
150252383|NCT04410523|542060147|FG003|Overall Study|Pregnancy|0|||
150252384|NCT04410523|542060148|FG004|Overall Study|Pregnancy|0|||
150252385|NCT04410523|542060149|FG005|Overall Study|Pregnancy|1|||
150252386|NCT04410523|542060144|FG000|Overall Study|Protocol deviation|0|||
150252387|NCT04410523|542060145|FG001|Overall Study|Protocol deviation|0|||
150252388|NCT04410523|542060146|FG002|Overall Study|Protocol deviation|0|||
150252389|NCT04410523|542060147|FG003|Overall Study|Protocol deviation|0|||
150252390|NCT04410523|542060148|FG004|Overall Study|Protocol deviation|0|||
150252391|NCT04410523|542060149|FG005|Overall Study|Protocol deviation|2|||
150252392|NCT04410523|542060144|FG000|Overall Study|Subject decision|2|||
150252393|NCT04410523|542060145|FG001|Overall Study|Subject decision|0|||
150252394|NCT04410523|542060146|FG002|Overall Study|Subject decision|0|||
150252395|NCT04410523|542060147|FG003|Overall Study|Subject decision|1|||
150252396|NCT04410523|542060148|FG004|Overall Study|Subject decision|0|||
150252397|NCT04410523|542060149|FG005|Overall Study|Subject decision|1|||
150252398|NCT00490490|542060152|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
150252399|NCT00490490|542060152|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
150252400|NCT03207451|542060153|FG000|Overall Study|scheduling conflict|1|||
150252401|NCT03207451|542060154|FG001|Overall Study|scheduling conflict|0|||
150252402|NCT03207451|542060155|FG002|Overall Study|scheduling conflict|2|||
150252403|NCT03207451|542060156|FG003|Overall Study|scheduling conflict|2|||
150252404|NCT03207451|542060153|FG000|Overall Study|Adverse Event|0|||
150252405|NCT03207451|542060154|FG001|Overall Study|Adverse Event|0|||
150252406|NCT03207451|542060155|FG002|Overall Study|Adverse Event|0|||
150252407|NCT03207451|542060156|FG003|Overall Study|Adverse Event|1|||
150252408|NCT02040584|542060157|FG000|Overall Study|Adverse Event|13|||
150252409|NCT02040584|542060158|FG001|Overall Study|Adverse Event|6|||
150252410|NCT02040584|542060157|FG000|Overall Study|Protocol Violation|9|||
150252411|NCT02040584|542060158|FG001|Overall Study|Protocol Violation|11|||
150252412|NCT02040584|542060157|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150252413|NCT02040584|542060158|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150252414|NCT02040584|542060157|FG000|Overall Study|Death|6|||
150252415|NCT02040584|542060158|FG001|Overall Study|Death|3|||
150252416|NCT02040584|542060157|FG000|Overall Study|Transplant rejection/retransplant|0|||
150252417|NCT02040584|542060158|FG001|Overall Study|Transplant rejection/retransplant|1|||
150252418|NCT02040584|542060157|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
150252419|NCT02040584|542060158|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
150252420|NCT00996476|542060159|FG000|Overall Study|Withdrawal by Subject|1|||
150252421|NCT00996476|542060160|FG001|Overall Study|Withdrawal by Subject|2|||
150252422|NCT00996476|542060161|FG002|Overall Study|Withdrawal by Subject|1|||
150252423|NCT00996476|542060162|FG003|Overall Study|Withdrawal by Subject|0|||
150252424|NCT00996476|542060163|FG004|Overall Study|Withdrawal by Subject|1|||
150252425|NCT00996476|542060159|FG000|Overall Study|Adverse Event|0|||
150252426|NCT00996476|542060160|FG001|Overall Study|Adverse Event|1|||
150252427|NCT00996476|542060161|FG002|Overall Study|Adverse Event|0|||
150252428|NCT00996476|542060162|FG003|Overall Study|Adverse Event|0|||
150252429|NCT00996476|542060163|FG004|Overall Study|Adverse Event|1|||
150252430|NCT00436852|542060164|FG000|Overall Study|Death|23|||
150252431|NCT00436852|542060165|FG001|Overall Study|Death|34|||
150252432|NCT00436852|542060164|FG000|Overall Study|Lack of Efficacy|9|||
150252433|NCT00436852|542060165|FG001|Overall Study|Lack of Efficacy|7|||
150252434|NCT00436852|542060164|FG000|Overall Study|Withdrawal by Subject|2|||
150252435|NCT00436852|542060165|FG001|Overall Study|Withdrawal by Subject|4|||
150252436|NCT00436852|542060164|FG000|Overall Study|Ineligible|1|||
150252437|NCT00436852|542060165|FG001|Overall Study|Ineligible|0|||
150252438|NCT02141620|542060166|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
150252439|NCT02141620|542060167|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
150252440|NCT01519089|542060168|FG000|Overall Study|Adverse Event|4|||
150252441|NCT01519089|542060169|FG001|Overall Study|Adverse Event|4|||
150252442|NCT01519089|542060168|FG000|Overall Study|Lack of Efficacy|0|||
150252443|NCT01519089|542060169|FG001|Overall Study|Lack of Efficacy|2|||
150252444|NCT01519089|542060168|FG000|Overall Study|Lost to Follow-up|1|||
150252445|NCT01519089|542060169|FG001|Overall Study|Lost to Follow-up|0|||
150252446|NCT01519089|542060168|FG000|Overall Study|Withdrawal by Subject|0|||
150252447|NCT01519089|542060169|FG001|Overall Study|Withdrawal by Subject|2|||
150252448|NCT01519089|542060168|FG000|Overall Study|Other|2|||
150252449|NCT01519089|542060169|FG001|Overall Study|Other|6|||
150252450|NCT01519089|542060168|FG000|Overall Study|Not received study drug|0|||
150252451|NCT01519089|542060169|FG001|Overall Study|Not received study drug|1|||
150252452|NCT01353859|542060172|FG000|Overall Study|Adverse Event|3|||
150252453|NCT01353859|542060172|FG000|Overall Study|Lack of Efficacy|1|||
150252454|NCT01659853|542060173|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
150252455|NCT01659853|542060174|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
150252456|NCT01659853|542060173|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
150252457|NCT01659853|542060174|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
150252458|NCT03921723|542060177|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
150252459|NCT03921723|542060177|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
150252460|NCT03015129|542060178|FG000|Overall Study|Death|2|||
150252461|NCT03015129|542060179|FG001|Overall Study|Death|2|||
150252462|NCT03015129|542060178|FG000|Overall Study|Lost to Follow-up|0|||
150252463|NCT03015129|542060179|FG001|Overall Study|Lost to Follow-up|1|||
150252464|NCT03015129|542060178|FG000|Overall Study|Progression of disease|38|||
150252465|NCT03015129|542060179|FG001|Overall Study|Progression of disease|33|||
150252466|NCT03015129|542060178|FG000|Overall Study|Adverse Event|0|||
150252467|NCT03015129|542060179|FG001|Overall Study|Adverse Event|4|||
150252468|NCT05032872|542060180|FG000|Overall Study|Adverse Event|1|||
150252469|NCT05032872|542060181|FG001|Overall Study|Adverse Event|0|||
150252470|NCT05032872|542060180|FG000|Overall Study|Lost to Follow-up|2|||
150252471|NCT05032872|542060181|FG001|Overall Study|Lost to Follow-up|4|||
150252472|NCT05032872|542060180|FG000|Overall Study|Withdrawal by Subject|4|||
150252473|NCT05032872|542060181|FG001|Overall Study|Withdrawal by Subject|3|||
150252474|NCT00910039|542060182|FG000|Overall Study|Physician Decision|1|||
150252475|NCT00406692|542060183|FG000|Overall Study|Withdrawal by Subject|4|||
150252476|NCT00406692|542060183|FG000|Overall Study|Physician Decision|1|||
150252477|NCT00406692|542060183|FG000|Overall Study|Adverse Event|1|||
150252478|NCT00406692|542060183|FG000|Overall Study|Lack of Efficacy|1|||
150252479|NCT01744392|542060186|FG000|Overall Study|Physician Decision|1|||
150252480|NCT01696955|542060194|FG000|Main Study|Protocol Violation|1|||
150252481|NCT01696955|542060195|FG001|Main Study|Protocol Violation|0|||
150252482|NCT01696955|542060194|FG000|Main Study|Withdrawal by Subject|1|||
150252483|NCT01696955|542060195|FG001|Main Study|Withdrawal by Subject|1|||
150252484|NCT01641159|542060202|FG000|Overall Study|Lost to Follow-up|2|||
150252485|NCT01641159|542060203|FG001|Overall Study|Lost to Follow-up|1|||
150252486|NCT01641159|542060202|FG000|Overall Study|Withdrawal by Subject|0|||
150252487|NCT01641159|542060203|FG001|Overall Study|Withdrawal by Subject|1|||
150252488|NCT00798590|542060204|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
150252489|NCT00798590|542060205|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
150252490|NCT01280357|542060208|FG000|Overall Study|Excluded no internal monitoring|14|||
150252491|NCT01280357|542060208|FG000|Overall Study|IInsufficient data/No data supplied|12|||
150252492|NCT00688870|542060209|FG000|Infant Series|Parent or legal guardian request|4|||
150252493|NCT00688870|542060210|FG001|Infant Series|Parent or legal guardian request|0|||
150252494|NCT00992225|542060211|FG000|Overall Study|Entry Criteria Not Met|8|||
150252495|NCT00992225|542060211|FG000|Overall Study|Adverse Event|2|||
150252496|NCT03466073|542060212|FG000|Overall Study|Death|1|||
150252497|NCT03466073|542060213|FG001|Overall Study|Death|0|||
150252498|NCT03466073|542060214|FG002|Overall Study|Death|0|||
150252499|NCT03466073|542060215|FG003|Overall Study|Death|0|||
150252500|NCT03466073|542060216|FG004|Overall Study|Death|0|||
150252501|NCT03466073|542060217|FG005|Overall Study|Death|1|||
150252502|NCT00744757|542060218|FG000|Overall Study|Objective disease progression|7|||
150252503|NCT00744757|542060218|FG000|Overall Study|Physician Decision|5|||
150252504|NCT00744757|542060218|FG000|Overall Study|Withdrawal by Subject|1|||
150252505|NCT00744757|542060218|FG000|Overall Study|Death|6|||
150252506|NCT00744757|542060218|FG000|Overall Study|Adverse Event|2|||
150252507|NCT00532493|542060219|FG000|Overall Study|Death|1|||
150252508|NCT00532493|542060220|FG001|Overall Study|Death|1|||
150252509|NCT00532493|542060219|FG000|Overall Study|Lost to Follow-up|10|||
150252510|NCT00532493|542060220|FG001|Overall Study|Lost to Follow-up|7|||
150252511|NCT00532493|542060219|FG000|Overall Study|Withdrawal by Subject|7|||
150252512|NCT00532493|542060220|FG001|Overall Study|Withdrawal by Subject|9|||
150252513|NCT00532493|542060219|FG000|Overall Study|Physician Decision|1|||
150252514|NCT00532493|542060220|FG001|Overall Study|Physician Decision|6|||
150252515|NCT00532493|542060219|FG000|Overall Study|Adverse Event|6|||
150252516|NCT00532493|542060220|FG001|Overall Study|Adverse Event|5|||
150252517|NCT00532493|542060219|FG000|Overall Study|Protocol Deviation|1|||
150252518|NCT00532493|542060220|FG001|Overall Study|Protocol Deviation|0|||
150252519|NCT00532493|542060219|FG000|Overall Study|Subject Moved Away|3|||
150252520|NCT00532493|542060220|FG001|Overall Study|Subject Moved Away|1|||
150252521|NCT00532493|542060219|FG000|Overall Study|Contraindicative Medication|1|||
150252522|NCT00532493|542060220|FG001|Overall Study|Contraindicative Medication|0|||
150252523|NCT03459443|542060229|FG000|Overall Study|Lack of Efficacy|3|||
150252524|NCT03459443|542060229|FG000|Overall Study|Adverse Event|1|||
150252525|NCT03459443|542060229|FG000|Overall Study|Sponsor's decision to close the study|18|||
150252526|NCT00888927|542060230|FG000|Overall Study|Adverse Event|0|||
150252527|NCT00888927|542060231|FG001|Overall Study|Adverse Event|0|||
150252528|NCT00888927|542060232|FG002|Overall Study|Adverse Event|0|||
150252529|NCT00888927|542060233|FG003|Overall Study|Adverse Event|1|||
150252530|NCT00888927|542060230|FG000|Overall Study|Withdrawal of consent|0|||
149730569|NCT00793793|540148850|FG008|Overall Study|Lost to Follow-up|1|||
149730570|NCT00793793|540148851|FG009|Overall Study|Lost to Follow-up|3|||
149730571|NCT00793793|540148852|FG010|Overall Study|Lost to Follow-up|1|||
149730572|NCT00793793|540148853|FG011|Overall Study|Lost to Follow-up|0|||
150252531|NCT00888927|542060231|FG001|Overall Study|Withdrawal of consent|0|||
150252532|NCT00888927|542060232|FG002|Overall Study|Withdrawal of consent|0|||
149730573|NCT00793793|540148842|FG000|Overall Study|Withdrawal by Subject|0|||
149730574|NCT00793793|540148843|FG001|Overall Study|Withdrawal by Subject|0|||
149730575|NCT00793793|540148844|FG002|Overall Study|Withdrawal by Subject|0|||
149730576|NCT00793793|540148845|FG003|Overall Study|Withdrawal by Subject|0|||
149730577|NCT00793793|540148846|FG004|Overall Study|Withdrawal by Subject|1|||
149730578|NCT00793793|540148847|FG005|Overall Study|Withdrawal by Subject|0|||
149730579|NCT00793793|540148848|FG006|Overall Study|Withdrawal by Subject|0|||
150252533|NCT00888927|542060233|FG003|Overall Study|Withdrawal of consent|1|||
150252534|NCT02153073|542060234|FG000|Overall Study|Case Report Forms Uncollected|230|||
150252535|NCT02153073|542060234|FG000|Overall Study|Protocol Deviation|68|||
150252536|NCT03702231|542060235|FG000|Overall Study|Withdrawal by Subject|1|||
150252537|NCT03702231|542060236|FG001|Overall Study|Withdrawal by Subject|0|||
150252538|NCT03702231|542060237|FG002|Overall Study|Withdrawal by Subject|0|||
150252539|NCT03702231|542060235|FG000|Overall Study|Protocol Violation|0|||
149730580|NCT00793793|540148849|FG007|Overall Study|Withdrawal by Subject|0|||
149730581|NCT00793793|540148850|FG008|Overall Study|Withdrawal by Subject|1|||
150252540|NCT03702231|542060236|FG001|Overall Study|Protocol Violation|0|||
150252541|NCT03702231|542060237|FG002|Overall Study|Protocol Violation|1|||
150252542|NCT03702231|542060235|FG000|Overall Study|Change in CLL Treatment|0|||
150252543|NCT03702231|542060236|FG001|Overall Study|Change in CLL Treatment|0|||
150252544|NCT03702231|542060237|FG002|Overall Study|Change in CLL Treatment|1|||
150252545|NCT03702231|542060235|FG000|Overall Study|COVID Pandemic|1|||
150252546|NCT03702231|542060236|FG001|Overall Study|COVID Pandemic|4|||
150252547|NCT03702231|542060237|FG002|Overall Study|COVID Pandemic|1|||
150252548|NCT03702231|542060235|FG000|Overall Study|Non-compliance|0|||
150252549|NCT03702231|542060236|FG001|Overall Study|Non-compliance|0|||
150252550|NCT03702231|542060237|FG002|Overall Study|Non-compliance|1|||
150252551|NCT01607476|542060239|FG000|Overall Study|Withdrawal by Subject|1|||
150252552|NCT01607476|542060240|FG001|Overall Study|Withdrawal by Subject|0|||
150252553|NCT01607476|542060241|FG002|Overall Study|Withdrawal by Subject|1|||
150252554|NCT01607476|542060239|FG000|Overall Study|Lost to Follow-up|0|||
150252555|NCT01607476|542060240|FG001|Overall Study|Lost to Follow-up|0|||
150252556|NCT01607476|542060241|FG002|Overall Study|Lost to Follow-up|2|||
150252557|NCT04445987|542060242|FG000|Overall Study|Adverse Event|0|||
150252558|NCT04445987|542060243|FG001|Overall Study|Adverse Event|0|||
150252559|NCT04445987|542060244|FG002|Overall Study|Adverse Event|1|||
150252560|NCT04445987|542060245|FG003|Overall Study|Adverse Event|0|||
150252561|NCT04445987|542060246|FG004|Overall Study|Adverse Event|4|||
150252562|NCT04445987|542060247|FG005|Overall Study|Adverse Event|0|||
150252563|NCT04445987|542060242|FG000|Overall Study|Lost to Follow-up|4|||
150252564|NCT04445987|542060243|FG001|Overall Study|Lost to Follow-up|3|||
150252565|NCT04445987|542060244|FG002|Overall Study|Lost to Follow-up|1|||
150252566|NCT04445987|542060245|FG003|Overall Study|Lost to Follow-up|1|||
150252567|NCT04445987|542060246|FG004|Overall Study|Lost to Follow-up|29|||
150252568|NCT04445987|542060247|FG005|Overall Study|Lost to Follow-up|0|||
150252569|NCT04445987|542060242|FG000|Overall Study|Physician Decision|0|||
150252570|NCT04445987|542060243|FG001|Overall Study|Physician Decision|0|||
150252571|NCT04445987|542060244|FG002|Overall Study|Physician Decision|0|||
150252572|NCT04445987|542060245|FG003|Overall Study|Physician Decision|0|||
150252573|NCT04445987|542060246|FG004|Overall Study|Physician Decision|1|||
150252574|NCT04445987|542060247|FG005|Overall Study|Physician Decision|0|||
150252575|NCT04445987|542060242|FG000|Overall Study|Protocol Violation|1|||
150252576|NCT04445987|542060243|FG001|Overall Study|Protocol Violation|0|||
150252577|NCT04445987|542060244|FG002|Overall Study|Protocol Violation|0|||
150252578|NCT04445987|542060245|FG003|Overall Study|Protocol Violation|0|||
150252579|NCT04445987|542060246|FG004|Overall Study|Protocol Violation|2|||
150252580|NCT04445987|542060247|FG005|Overall Study|Protocol Violation|0|||
150252581|NCT04445987|542060242|FG000|Overall Study|Withdrawal by Subject|4|||
150252582|NCT04445987|542060243|FG001|Overall Study|Withdrawal by Subject|0|||
150252583|NCT04445987|542060244|FG002|Overall Study|Withdrawal by Subject|1|||
150252584|NCT04445987|542060245|FG003|Overall Study|Withdrawal by Subject|0|||
150252585|NCT04445987|542060246|FG004|Overall Study|Withdrawal by Subject|18|||
150252586|NCT04445987|542060247|FG005|Overall Study|Withdrawal by Subject|1|||
150252587|NCT04445987|542060242|FG000|Overall Study|Other reason|0|||
150252588|NCT04445987|542060243|FG001|Overall Study|Other reason|0|||
150252589|NCT04445987|542060244|FG002|Overall Study|Other reason|1|||
150252590|NCT04445987|542060245|FG003|Overall Study|Other reason|0|||
150252591|NCT04445987|542060246|FG004|Overall Study|Other reason|2|||
150252592|NCT04445987|542060247|FG005|Overall Study|Other reason|0|||
150252593|NCT00680992|542060253|FG000|Overall Study|Complete Resection (as per protocol)|25|||
150252594|NCT00680992|542060254|FG001|Overall Study|Complete Resection (as per protocol)|121|||
150252595|NCT00680992|542060255|FG002|Overall Study|Complete Resection (as per protocol)|0|||
150252596|NCT00680992|542060253|FG000|Overall Study|Administrative Decision|83|||
150252597|NCT00680992|542060254|FG001|Overall Study|Administrative Decision|42|||
150252598|NCT00680992|542060255|FG002|Overall Study|Administrative Decision|5|||
150252599|NCT00680992|542060253|FG000|Overall Study|End of Trial|32|||
150252600|NCT00680992|542060254|FG001|Overall Study|End of Trial|12|||
150252601|NCT00680992|542060255|FG002|Overall Study|End of Trial|3|||
150252602|NCT00680992|542060253|FG000|Overall Study|Withdrawal by Subject|33|||
150252603|NCT00680992|542060254|FG001|Overall Study|Withdrawal by Subject|11|||
150252604|NCT00680992|542060255|FG002|Overall Study|Withdrawal by Subject|1|||
150252605|NCT00680992|542060253|FG000|Overall Study|Adverse Event|21|||
150252606|NCT00680992|542060254|FG001|Overall Study|Adverse Event|19|||
150252607|NCT00680992|542060255|FG002|Overall Study|Adverse Event|1|||
150252608|NCT00680992|542060253|FG000|Overall Study|Other|19|||
150252609|NCT00680992|542060254|FG001|Overall Study|Other|14|||
150252610|NCT00680992|542060255|FG002|Overall Study|Other|1|||
150252611|NCT00680992|542060253|FG000|Overall Study|Disease Progression|21|||
150252612|NCT00680992|542060254|FG001|Overall Study|Disease Progression|9|||
150252613|NCT00680992|542060255|FG002|Overall Study|Disease Progression|0|||
150252614|NCT00680992|542060253|FG000|Overall Study|Lost to Follow-up|12|||
150252615|NCT00680992|542060254|FG001|Overall Study|Lost to Follow-up|14|||
150252616|NCT00680992|542060255|FG002|Overall Study|Lost to Follow-up|0|||
150252617|NCT00680992|542060253|FG000|Overall Study|Noncompliance|4|||
150252618|NCT00680992|542060254|FG001|Overall Study|Noncompliance|6|||
150252619|NCT00680992|542060255|FG002|Overall Study|Noncompliance|0|||
150252620|NCT00680992|542060253|FG000|Overall Study|Requirement for Alternative Therapy|8|||
150252621|NCT00680992|542060254|FG001|Overall Study|Requirement for Alternative Therapy|2|||
150252622|NCT00680992|542060255|FG002|Overall Study|Requirement for Alternative Therapy|0|||
150252623|NCT00680992|542060253|FG000|Overall Study|Pregnancy|5|||
150252624|NCT00680992|542060254|FG001|Overall Study|Pregnancy|0|||
150252625|NCT00680992|542060255|FG002|Overall Study|Pregnancy|1|||
150252626|NCT00680992|542060253|FG000|Overall Study|Death|5|||
150252627|NCT00680992|542060254|FG001|Overall Study|Death|1|||
150252628|NCT00680992|542060255|FG002|Overall Study|Death|0|||
150252629|NCT00680992|542060253|FG000|Overall Study|Ineligibility Determined|0|||
150252630|NCT00680992|542060254|FG001|Overall Study|Ineligibility Determined|1|||
150252631|NCT00680992|542060255|FG002|Overall Study|Ineligibility Determined|0|||
150252632|NCT02425904|542060258|FG000|Overall Study|Lost to Follow-up|1|||
150252633|NCT02425904|542060259|FG001|Overall Study|Lost to Follow-up|0|||
150252634|NCT02425904|542060258|FG000|Overall Study|Withdrawal by Subject|2|||
150252635|NCT02425904|542060259|FG001|Overall Study|Withdrawal by Subject|0|||
150252636|NCT02425904|542060258|FG000|Overall Study|Death|0|||
150252637|NCT02425904|542060259|FG001|Overall Study|Death|3|||
150252638|NCT03842358|542060260|FG000|Overall Study|Poor DOT probe contact with breast|2|||
150252639|NCT03842358|542060260|FG000|Overall Study|DOT system problem|1|||
149730582|NCT00793793|540148851|FG009|Overall Study|Withdrawal by Subject|0|||
149730583|NCT00793793|540148852|FG010|Overall Study|Withdrawal by Subject|0|||
149730584|NCT00793793|540148853|FG011|Overall Study|Withdrawal by Subject|0|||
149730585|NCT00793793|540148842|FG000|Overall Study|reason not specified|0|||
149730586|NCT00793793|540148843|FG001|Overall Study|reason not specified|1|||
149730587|NCT00793793|540148844|FG002|Overall Study|reason not specified|0|||
149730588|NCT00793793|540148845|FG003|Overall Study|reason not specified|1|||
150252640|NCT03842358|542060260|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
150252641|NCT03842358|542060260|FG000|Overall Study|No biopsy after physician review|4|||
150252642|NCT03842358|542060260|FG000|Overall Study|Patient withdrew|2|||
150252643|NCT02626455|542060261|FG000|Overall Study|Other|1|||
150252644|NCT02626455|542060262|FG001|Overall Study|Other|1|||
150252645|NCT02626455|542060263|FG002|Overall Study|Other|0|||
150252646|NCT02626455|542060264|FG003|Overall Study|Other|0|||
150252647|NCT02626455|542060265|FG004|Overall Study|Other|0|||
150252648|NCT02626455|542060266|FG005|Overall Study|Other|17|||
150252649|NCT02626455|542060267|FG006|Overall Study|Other|23|||
150252650|NCT02626455|542060261|FG000|Overall Study|Withdrawal by Subject|1|||
150252651|NCT02626455|542060262|FG001|Overall Study|Withdrawal by Subject|0|||
150252652|NCT02626455|542060263|FG002|Overall Study|Withdrawal by Subject|0|||
150252653|NCT02626455|542060264|FG003|Overall Study|Withdrawal by Subject|0|||
150252654|NCT02626455|542060265|FG004|Overall Study|Withdrawal by Subject|0|||
150252655|NCT02626455|542060266|FG005|Overall Study|Withdrawal by Subject|10|||
150252656|NCT02626455|542060267|FG006|Overall Study|Withdrawal by Subject|6|||
150252657|NCT02626455|542060261|FG000|Overall Study|Physician Decision|0|||
150252658|NCT02626455|542060262|FG001|Overall Study|Physician Decision|2|||
150252659|NCT02626455|542060263|FG002|Overall Study|Physician Decision|2|||
150252660|NCT02626455|542060264|FG003|Overall Study|Physician Decision|2|||
150252661|NCT02626455|542060265|FG004|Overall Study|Physician Decision|1|||
150252662|NCT02626455|542060266|FG005|Overall Study|Physician Decision|10|||
150252663|NCT02626455|542060267|FG006|Overall Study|Physician Decision|3|||
150252664|NCT02626455|542060261|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252665|NCT02626455|542060262|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252666|NCT02626455|542060263|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252667|NCT02626455|542060264|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252668|NCT02626455|542060265|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252669|NCT02626455|542060266|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
150252670|NCT02626455|542060267|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
150252671|NCT02626455|542060261|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
150252672|NCT02626455|542060262|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
150252673|NCT02626455|542060263|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
150252674|NCT02626455|542060264|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
150252675|NCT02626455|542060265|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
150252676|NCT02626455|542060266|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149730589|NCT00793793|540148846|FG004|Overall Study|reason not specified|1|||
150252677|NCT02626455|542060267|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
150252678|NCT02626455|542060261|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
150252679|NCT02626455|542060262|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
150252680|NCT02626455|542060263|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149730590|NCT00793793|540148847|FG005|Overall Study|reason not specified|1|||
150252681|NCT02626455|542060264|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
150252682|NCT02626455|542060265|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
150252683|NCT02626455|542060266|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
150252684|NCT02626455|542060267|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
150252685|NCT02626455|542060261|FG000|Overall Study|Patient decision|0|||
149730591|NCT00793793|540148848|FG006|Overall Study|reason not specified|2|||
149730592|NCT00793793|540148849|FG007|Overall Study|reason not specified|0|||
150252686|NCT02626455|542060262|FG001|Overall Study|Patient decision|1|||
150252687|NCT02626455|542060263|FG002|Overall Study|Patient decision|0|||
150252688|NCT02626455|542060264|FG003|Overall Study|Patient decision|0|||
150252689|NCT02626455|542060265|FG004|Overall Study|Patient decision|1|||
150252690|NCT02626455|542060266|FG005|Overall Study|Patient decision|36|||
150252691|NCT02626455|542060267|FG006|Overall Study|Patient decision|22|||
150252692|NCT02626455|542060261|FG000|Overall Study|Protocol Violation|0|||
150252693|NCT02626455|542060262|FG001|Overall Study|Protocol Violation|0|||
150252694|NCT02626455|542060263|FG002|Overall Study|Protocol Violation|0|||
150252695|NCT02626455|542060264|FG003|Overall Study|Protocol Violation|0|||
150252696|NCT02626455|542060265|FG004|Overall Study|Protocol Violation|0|||
150252697|NCT02626455|542060266|FG005|Overall Study|Protocol Violation|0|||
150252698|NCT02626455|542060267|FG006|Overall Study|Protocol Violation|1|||
150252699|NCT02626455|542060261|FG000|Overall Study|Progressive disease - radiological progression|0|||
150252700|NCT02626455|542060262|FG001|Overall Study|Progressive disease - radiological progression|0|||
150252701|NCT02626455|542060263|FG002|Overall Study|Progressive disease - radiological progression|0|||
150252702|NCT02626455|542060264|FG003|Overall Study|Progressive disease - radiological progression|0|||
150252703|NCT02626455|542060265|FG004|Overall Study|Progressive disease - radiological progression|0|||
150252704|NCT02626455|542060266|FG005|Overall Study|Progressive disease - radiological progression|11|||
150252705|NCT02626455|542060267|FG006|Overall Study|Progressive disease - radiological progression|22|||
150252706|NCT02626455|542060261|FG000|Overall Study|Progressive disease - clinical progression|0|||
150252707|NCT02626455|542060262|FG001|Overall Study|Progressive disease - clinical progression|0|||
150252708|NCT02626455|542060263|FG002|Overall Study|Progressive disease - clinical progression|0|||
150252709|NCT02626455|542060264|FG003|Overall Study|Progressive disease - clinical progression|0|||
150252710|NCT02626455|542060265|FG004|Overall Study|Progressive disease - clinical progression|0|||
150252711|NCT02626455|542060266|FG005|Overall Study|Progressive disease - clinical progression|1|||
150252712|NCT02626455|542060267|FG006|Overall Study|Progressive disease - clinical progression|2|||
150252713|NCT02626455|542060261|FG000|Overall Study|Lost to Follow-up|0|||
150252714|NCT02626455|542060262|FG001|Overall Study|Lost to Follow-up|0|||
150252715|NCT02626455|542060263|FG002|Overall Study|Lost to Follow-up|0|||
150252716|NCT02626455|542060264|FG003|Overall Study|Lost to Follow-up|0|||
150252717|NCT02626455|542060265|FG004|Overall Study|Lost to Follow-up|0|||
150252718|NCT02626455|542060266|FG005|Overall Study|Lost to Follow-up|1|||
150252719|NCT02626455|542060267|FG006|Overall Study|Lost to Follow-up|0|||
150252720|NCT02626455|542060261|FG000|Overall Study|AE not associated with clinical disease progression|1|||
150252721|NCT02626455|542060262|FG001|Overall Study|AE not associated with clinical disease progression|1|||
150252722|NCT02626455|542060263|FG002|Overall Study|AE not associated with clinical disease progression|0|||
150252723|NCT02626455|542060264|FG003|Overall Study|AE not associated with clinical disease progression|2|||
150252724|NCT02626455|542060265|FG004|Overall Study|AE not associated with clinical disease progression|1|||
150252725|NCT02626455|542060266|FG005|Overall Study|AE not associated with clinical disease progression|65|||
150252726|NCT02626455|542060267|FG006|Overall Study|AE not associated with clinical disease progression|21|||
150252727|NCT02626455|542060261|FG000|Overall Study|AE associated with clinical disease progression|0|||
150252728|NCT02626455|542060262|FG001|Overall Study|AE associated with clinical disease progression|0|||
150252729|NCT02626455|542060263|FG002|Overall Study|AE associated with clinical disease progression|0|||
150252730|NCT02626455|542060264|FG003|Overall Study|AE associated with clinical disease progression|0|||
150252731|NCT02626455|542060265|FG004|Overall Study|AE associated with clinical disease progression|0|||
150252732|NCT02626455|542060266|FG005|Overall Study|AE associated with clinical disease progression|1|||
150252733|NCT02626455|542060267|FG006|Overall Study|AE associated with clinical disease progression|2|||
150252734|NCT02626455|542060261|FG000|Overall Study|Study intervention never administered|0|||
150252735|NCT02626455|542060262|FG001|Overall Study|Study intervention never administered|0|||
149730593|NCT00793793|540148850|FG008|Overall Study|reason not specified|7|||
149730594|NCT00793793|540148851|FG009|Overall Study|reason not specified|6|||
149730595|NCT00793793|540148852|FG010|Overall Study|reason not specified|2|||
149730596|NCT00793793|540148853|FG011|Overall Study|reason not specified|4|||
149730597|NCT00840827|540148855|FG000|Overall Study|Adverse Event|1|||
149730598|NCT00840827|540148855|FG000|Overall Study|Lack of Efficacy|4|||
149730599|NCT00840827|540148855|FG000|Overall Study|Physician Decision|1|||
149730600|NCT01445535|540148856|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
150252736|NCT02626455|542060263|FG002|Overall Study|Study intervention never administered|0|||
150252737|NCT02626455|542060264|FG003|Overall Study|Study intervention never administered|0|||
150252738|NCT02626455|542060265|FG004|Overall Study|Study intervention never administered|0|||
150252739|NCT02626455|542060266|FG005|Overall Study|Study intervention never administered|1|||
149730601|NCT01445535|540148857|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
149730602|NCT01445535|540148858|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
150252740|NCT02626455|542060267|FG006|Overall Study|Study intervention never administered|3|||
149730603|NCT01445535|540148859|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
150252741|NCT05148962|542060268|FG000|Overall Study|Withdrawal by Subject|1|||
150252742|NCT05148962|542060269|FG001|Overall Study|Withdrawal by Subject|1|||
149730604|NCT01445535|540148856|FG000|Overall Study|Disease progression|1|||
150252743|NCT05148962|542060270|FG002|Overall Study|Withdrawal by Subject|0|||
150252744|NCT05148962|542060271|FG003|Overall Study|Withdrawal by Subject|1|||
150252745|NCT05148962|542060272|FG004|Overall Study|Withdrawal by Subject|0|||
150252746|NCT05148962|542060268|FG000|Overall Study|Participant was early terminated per protocol|0|||
150252747|NCT05148962|542060269|FG001|Overall Study|Participant was early terminated per protocol|0|||
150252748|NCT05148962|542060270|FG002|Overall Study|Participant was early terminated per protocol|3|||
150252749|NCT05148962|542060271|FG003|Overall Study|Participant was early terminated per protocol|5|||
150252750|NCT05148962|542060272|FG004|Overall Study|Participant was early terminated per protocol|2|||
150252751|NCT05148962|542060268|FG000|Overall Study|Miscellaneous|0|||
150252752|NCT05148962|542060269|FG001|Overall Study|Miscellaneous|0|||
150252753|NCT05148962|542060270|FG002|Overall Study|Miscellaneous|0|||
150252754|NCT05148962|542060271|FG003|Overall Study|Miscellaneous|1|||
150252755|NCT05148962|542060272|FG004|Overall Study|Miscellaneous|0|||
150252756|NCT06665919|542060273|FG000|Overall Study|Withdrawal by Subject|4|||
150252757|NCT06665919|542060274|FG001|Overall Study|Withdrawal by Subject|4|||
150252758|NCT06665919|542060275|FG002|Overall Study|Withdrawal by Subject|4|||
150252759|NCT06665919|542060273|FG000|Overall Study|Non-compliance to Treatment|4|||
150252760|NCT06665919|542060274|FG001|Overall Study|Non-compliance to Treatment|1|||
150252761|NCT06665919|542060275|FG002|Overall Study|Non-compliance to Treatment|6|||
150252762|NCT06665919|542060273|FG000|Overall Study|Lost to Follow-up|3|||
150252763|NCT06665919|542060274|FG001|Overall Study|Lost to Follow-up|0|||
150252764|NCT06665919|542060275|FG002|Overall Study|Lost to Follow-up|2|||
150252765|NCT06665919|542060273|FG000|Overall Study|Physician Decision|4|||
150252766|NCT06665919|542060274|FG001|Overall Study|Physician Decision|0|||
150252767|NCT06665919|542060275|FG002|Overall Study|Physician Decision|1|||
150252768|NCT01200290|542060276|FG000|Treatment Period|Adverse Event|1|||
150252769|NCT01200290|542060276|FG000|Post-Treatment Follow-Up Period|Death|2|||
150252770|NCT01144377|542060277|FG000|52 Week Treatment Period|Adverse Event|0|||
150252771|NCT01144377|542060278|FG001|52 Week Treatment Period|Adverse Event|0|||
150252772|NCT01144377|542060279|FG002|52 Week Treatment Period|Adverse Event|3|||
150252773|NCT01144377|542060280|FG003|52 Week Treatment Period|Adverse Event|2|||
150252774|NCT01144377|542060281|FG004|52 Week Treatment Period|Adverse Event|1|||
150252775|NCT01144377|542060277|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
150252776|NCT01144377|542060278|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
150252777|NCT01144377|542060279|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
150252778|NCT01144377|542060280|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
150252779|NCT01144377|542060281|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
150252780|NCT01144377|542060277|FG000|52 Week Treatment Period|Protocol Violation|0|||
150252781|NCT01144377|542060278|FG001|52 Week Treatment Period|Protocol Violation|0|||
150252782|NCT01144377|542060279|FG002|52 Week Treatment Period|Protocol Violation|0|||
150252783|NCT01144377|542060280|FG003|52 Week Treatment Period|Protocol Violation|0|||
150252784|NCT01144377|542060281|FG004|52 Week Treatment Period|Protocol Violation|1|||
150252785|NCT01144377|542060277|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
150252786|NCT01144377|542060278|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
150252787|NCT01144377|542060279|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
150252788|NCT01144377|542060280|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
150252789|NCT01144377|542060281|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
150252790|NCT01144377|542060277|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
150252791|NCT01144377|542060278|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
150252792|NCT01144377|542060279|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
150252793|NCT01144377|542060280|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
150252794|NCT01144377|542060281|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
149730605|NCT01445535|540148857|FG001|Overall Study|Disease progression|0|||
149730606|NCT01445535|540148858|FG002|Overall Study|Disease progression|1|||
149730607|NCT01445535|540148859|FG003|Overall Study|Disease progression|0|||
149730608|NCT01445535|540148856|FG000|Overall Study|PI discretion|0|||
149730609|NCT01445535|540148857|FG001|Overall Study|PI discretion|0|||
149730610|NCT01445535|540148858|FG002|Overall Study|PI discretion|0|||
149730611|NCT01445535|540148859|FG003|Overall Study|PI discretion|1|||
149730612|NCT00364689|540148864|FG000|Overall Study|Lost to Follow-up|1|||
149730613|NCT00331409|540148870|FG000|Overall Study|Lack of Efficacy|4|||
149730614|NCT01482910|540148871|FG000|Overall Study|Adverse Event|6|||
150252795|NCT01144377|542060277|FG000|52 Week Treatment Period|Sponsor Decision|0|||
149730615|NCT01482910|540148872|FG001|Overall Study|Adverse Event|5|||
149730616|NCT01482910|540148871|FG000|Overall Study|Lost to Follow-up|0|||
149730617|NCT01482910|540148872|FG001|Overall Study|Lost to Follow-up|1|||
149730618|NCT01482910|540148871|FG000|Overall Study|Protocol Violation|1|||
149730619|NCT01482910|540148872|FG001|Overall Study|Protocol Violation|1|||
150252796|NCT01144377|542060278|FG001|52 Week Treatment Period|Sponsor Decision|0|||
149730620|NCT01482910|540148871|FG000|Overall Study|Withdrawal by Subject|7|||
150252797|NCT01144377|542060279|FG002|52 Week Treatment Period|Sponsor Decision|0|||
149730621|NCT01482910|540148872|FG001|Overall Study|Withdrawal by Subject|2|||
149730622|NCT01482910|540148871|FG000|Overall Study|Death|1|||
149730623|NCT01482910|540148872|FG001|Overall Study|Death|0|||
149730624|NCT03222349|540148876|FG000|Overall Study|Treatment B not done|5|||
150252798|NCT01144377|542060280|FG003|52 Week Treatment Period|Sponsor Decision|0|||
150252799|NCT01144377|542060281|FG004|52 Week Treatment Period|Sponsor Decision|1|||
150252800|NCT01144377|542060277|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
150252801|NCT01144377|542060278|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
150252802|NCT01144377|542060279|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
150252803|NCT01144377|542060280|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
150252804|NCT01144377|542060281|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
150252805|NCT01144377|542060277|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
150252806|NCT01144377|542060278|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
150252807|NCT01144377|542060279|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
150252808|NCT01144377|542060280|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
150252809|NCT01144377|542060281|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
150252810|NCT01144377|542060277|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
150252811|NCT01144377|542060278|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
150252812|NCT01144377|542060279|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
150252813|NCT01144377|542060280|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
150252814|NCT01144377|542060281|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
150252815|NCT02980731|542062293|FG000|Overall Study|Death|63|||
150252816|NCT02980731|542062293|FG000|Overall Study|Withdrawal by Subject|6|||
150252817|NCT02980731|542062293|FG000|Overall Study|Lost to Follow-up|5|||
150252818|NCT02980731|542062293|FG000|Overall Study|Study terminated by Sponsor|4|||
150252819|NCT02980731|542062293|FG000|Overall Study|Completed survival follow-up period|65|||
150252820|NCT02980731|542062293|FG000|Overall Study|COVID-19 infection|1|||
150252821|NCT02980731|542062293|FG000|Overall Study|Other, not specified|66|||
150252822|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Adverse Event|6|||
150252823|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Adverse Event|6|||
150252824|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Death|1|||
150252825|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Death|1|||
150252826|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
150252827|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
150252828|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
150252829|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
150252830|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Physician Decision|1|||
150252831|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Physician Decision|4|||
150252832|NCT03828747|542062295|FG000|Double-Blind Treatment Period|Various reasons|5|||
150252833|NCT03828747|542062296|FG001|Double-Blind Treatment Period|Various reasons|3|||
150252834|NCT03828747|542062295|FG000|Open-Label Extension|Adverse Event|9|||
150252835|NCT03828747|542062296|FG001|Open-Label Extension|Adverse Event|7|||
150252836|NCT03828747|542062295|FG000|Open-Label Extension|Death|0|||
150252837|NCT03828747|542062296|FG001|Open-Label Extension|Death|2|||
150252838|NCT03828747|542062295|FG000|Open-Label Extension|Lost to Follow-up|4|||
150252839|NCT03828747|542062296|FG001|Open-Label Extension|Lost to Follow-up|0|||
150252840|NCT03828747|542062295|FG000|Open-Label Extension|Withdrawal by Subject|31|||
150252841|NCT03828747|542062296|FG001|Open-Label Extension|Withdrawal by Subject|30|||
150252842|NCT03828747|542062295|FG000|Open-Label Extension|Various reasons|4|||
150252843|NCT03828747|542062296|FG001|Open-Label Extension|Various reasons|4|||
150252844|NCT03828747|542062295|FG000|Open-Label Extension|Physician Decision|6|||
150252845|NCT03828747|542062296|FG001|Open-Label Extension|Physician Decision|2|||
150252846|NCT00772330|542062297|FG000|Overall Study|Lost to Follow-up|3|||
150252847|NCT00127205|542062298|FG000|Overall Study|Adverse Event|228|||
150252848|NCT00127205|542062299|FG001|Overall Study|Adverse Event|387|||
150252849|NCT00127205|542062300|FG002|Overall Study|Adverse Event|273|||
150252850|NCT00127205|542062298|FG000|Overall Study|Death|8|||
150252851|NCT00127205|542062299|FG001|Overall Study|Death|6|||
150252852|NCT00127205|542062300|FG002|Overall Study|Death|5|||
150252853|NCT00127205|542062298|FG000|Overall Study|Withdrawal by Subject|318|||
150252854|NCT00127205|542062299|FG001|Overall Study|Withdrawal by Subject|310|||
150252855|NCT00127205|542062300|FG002|Overall Study|Withdrawal by Subject|172|||
150252856|NCT00127205|542062298|FG000|Overall Study|Other-non protocol specified|142|||
150252857|NCT00127205|542062299|FG001|Overall Study|Other-non protocol specified|129|||
150252858|NCT00127205|542062300|FG002|Overall Study|Other-non protocol specified|77|||
150252859|NCT00127205|542062298|FG000|Overall Study|Data not reported|6|||
150252860|NCT00127205|542062299|FG001|Overall Study|Data not reported|10|||
150252861|NCT00127205|542062300|FG002|Overall Study|Data not reported|1|||
150252862|NCT00127205|542062298|FG000|Overall Study|Progression|127|||
150252863|NCT00127205|542062299|FG001|Overall Study|Progression|131|||
150252864|NCT00127205|542062300|FG002|Overall Study|Progression|84|||
150252865|NCT00307684|542062301|FG000|Open Label Phase|Lack of Efficacy|0|||
150252866|NCT00307684|542062302|FG001|Open Label Phase|Lack of Efficacy|0|||
150252867|NCT00307684|542062303|FG002|Open Label Phase|Lack of Efficacy|3|||
150252868|NCT00307684|542062301|FG000|Open Label Phase|Adverse Event|0|||
150252869|NCT00307684|542062302|FG001|Open Label Phase|Adverse Event|0|||
150252870|NCT00307684|542062303|FG002|Open Label Phase|Adverse Event|16|||
150252871|NCT00307684|542062301|FG000|Open Label Phase|Withdrawal by Subject|0|||
150252872|NCT00307684|542062302|FG001|Open Label Phase|Withdrawal by Subject|0|||
150252873|NCT00307684|542062303|FG002|Open Label Phase|Withdrawal by Subject|15|||
150252874|NCT00307684|542062301|FG000|Open Label Phase|Lost to Follow-up|0|||
150252875|NCT00307684|542062302|FG001|Open Label Phase|Lost to Follow-up|0|||
150252876|NCT00307684|542062303|FG002|Open Label Phase|Lost to Follow-up|11|||
150252877|NCT00307684|542062301|FG000|Open Label Phase|non compliance|0|||
150252878|NCT00307684|542062302|FG001|Open Label Phase|non compliance|0|||
150252879|NCT00307684|542062303|FG002|Open Label Phase|non compliance|5|||
150252880|NCT00307684|542062301|FG000|Open Label Phase|other|0|||
150252881|NCT00307684|542062302|FG001|Open Label Phase|other|0|||
150252882|NCT00307684|542062303|FG002|Open Label Phase|other|6|||
150252883|NCT00307684|542062301|FG000|Double Blind Phase|Lack of Efficacy|2|||
150252884|NCT00307684|542062302|FG001|Double Blind Phase|Lack of Efficacy|5|||
150252885|NCT00307684|542062303|FG002|Double Blind Phase|Lack of Efficacy|0|||
150252886|NCT02580305|542062304|FG000|Overall Study|Adverse Event|15|||
150252887|NCT02580305|542062305|FG001|Overall Study|Adverse Event|19|||
150252888|NCT02580305|542062306|FG002|Overall Study|Adverse Event|10|||
150252889|NCT02580305|542062304|FG000|Overall Study|Lack of Efficacy|5|||
150252890|NCT02580305|542062305|FG001|Overall Study|Lack of Efficacy|0|||
150252891|NCT02580305|542062306|FG002|Overall Study|Lack of Efficacy|2|||
150252892|NCT02580305|542062304|FG000|Overall Study|Protocol Violation|4|||
150252893|NCT02580305|542062305|FG001|Overall Study|Protocol Violation|9|||
150252894|NCT02580305|542062306|FG002|Overall Study|Protocol Violation|6|||
150252895|NCT02580305|542062304|FG000|Overall Study|Lost to Follow-up|4|||
150252896|NCT02580305|542062305|FG001|Overall Study|Lost to Follow-up|4|||
150252897|NCT02580305|542062306|FG002|Overall Study|Lost to Follow-up|2|||
150252898|NCT02580305|542062304|FG000|Overall Study|Withdrawal by Subject|11|||
150252899|NCT02580305|542062305|FG001|Overall Study|Withdrawal by Subject|9|||
150252900|NCT02580305|542062306|FG002|Overall Study|Withdrawal by Subject|7|||
150252901|NCT02580305|542062304|FG000|Overall Study|Randomized in error and never treated|4|||
150252902|NCT02580305|542062305|FG001|Overall Study|Randomized in error and never treated|8|||
150252903|NCT02580305|542062306|FG002|Overall Study|Randomized in error and never treated|5|||
150252904|NCT00224887|542062307|FG000|Overall Study|Pregnancy|6|||
150252905|NCT00224887|542062308|FG001|Overall Study|Pregnancy|6|||
150252906|NCT03527550|542062311|FG000|Overall Study|Lost to Follow-up|4|||
150252907|NCT03527550|542062312|FG001|Overall Study|Lost to Follow-up|2|||
150252908|NCT03527550|542062311|FG000|Overall Study|Withdrawal by Subject|4|||
150252909|NCT03527550|542062312|FG001|Overall Study|Withdrawal by Subject|1|||
150252910|NCT03527550|542062311|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
150252911|NCT03527550|542062312|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
150252912|NCT03053518|542062315|FG000|Overall Study|Withdrawal by Subject|3|||
150252913|NCT03053518|542062315|FG000|Overall Study|Lost to Follow-up|2|||
150252914|NCT03053518|542062315|FG000|Overall Study|Ineligible|5|||
150252915|NCT02683876|542062316|FG000|Overall Study|samples damaged during shipping|2|||
150252916|NCT02683876|542062317|FG001|Overall Study|samples damaged during shipping|0|||
150252917|NCT00939822|542062318|FG000|Overall Study|Lost to Follow-up|1|||
150252918|NCT00939822|542062319|FG001|Overall Study|Lost to Follow-up|0|||
150252919|NCT00939822|542062318|FG000|Overall Study|withdrew from study due to busy schedule|1|||
150252920|NCT00939822|542062319|FG001|Overall Study|withdrew from study due to busy schedule|1|||
150252921|NCT00939822|542062318|FG000|Overall Study|Mental health issues|0|||
150252922|NCT00939822|542062319|FG001|Overall Study|Mental health issues|2|||
150252923|NCT00400725|542062330|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
150252924|NCT00400725|542062331|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
150252925|NCT00400725|542062332|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
150252926|NCT00400725|542062330|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
150252927|NCT00400725|542062331|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
150252928|NCT00400725|542062332|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
150252929|NCT00400725|542062330|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
150252930|NCT00400725|542062331|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
150252931|NCT00400725|542062332|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
150252932|NCT00400725|542062330|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
150252933|NCT00400725|542062331|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
150252934|NCT00400725|542062332|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
150252935|NCT00400725|542062330|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
150252936|NCT00400725|542062331|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
150252937|NCT00400725|542062332|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
150252938|NCT00400725|542062330|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
150252939|NCT00400725|542062331|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
150252940|NCT00400725|542062332|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
150252941|NCT00400725|542062330|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
150252942|NCT00400725|542062331|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
150252943|NCT00400725|542062332|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
150252944|NCT00400725|542062330|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
150252945|NCT00400725|542062331|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
150252946|NCT00400725|542062332|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
150252947|NCT00400725|542062330|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
150252948|NCT00400725|542062331|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
150252949|NCT00400725|542062332|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
150252950|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Adverse Event|1|||
150252951|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Adverse Event|1|||
150252952|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Adverse Event|2|||
150252953|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Adverse Event|5|||
150252954|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Adverse Event|0|||
150252955|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
150252956|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
150252957|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
150252958|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
150252959|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
150252960|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
150252961|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
150252962|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
150252963|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
150252964|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
150252965|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
150252966|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
150252967|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
150252968|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
150252969|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
150252970|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
150252971|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
150252972|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
150252973|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
150252974|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
150252975|NCT00951015|542062342|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
150252976|NCT00951015|542062343|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
150252977|NCT00951015|542062344|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
150252978|NCT00951015|542062345|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
150252979|NCT00951015|542062346|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
150252980|NCT00951015|542062342|FG000|Open-label Phase|Adverse Event|0|||
150252981|NCT00951015|542062343|FG001|Open-label Phase|Adverse Event|0|||
150252982|NCT00951015|542062344|FG002|Open-label Phase|Adverse Event|0|||
150252983|NCT00951015|542062345|FG003|Open-label Phase|Adverse Event|0|||
150252984|NCT00951015|542062346|FG004|Open-label Phase|Adverse Event|3|||
150252985|NCT00951015|542062342|FG000|Open-label Phase|Lack of Efficacy|0|||
150252986|NCT00951015|542062343|FG001|Open-label Phase|Lack of Efficacy|0|||
150252987|NCT00951015|542062344|FG002|Open-label Phase|Lack of Efficacy|0|||
150252988|NCT00951015|542062345|FG003|Open-label Phase|Lack of Efficacy|0|||
150252989|NCT00951015|542062346|FG004|Open-label Phase|Lack of Efficacy|1|||
150252990|NCT00951015|542062342|FG000|Open-label Phase|Protocol Violation|0|||
150252991|NCT00951015|542062343|FG001|Open-label Phase|Protocol Violation|0|||
150252992|NCT00951015|542062344|FG002|Open-label Phase|Protocol Violation|0|||
150252993|NCT00951015|542062345|FG003|Open-label Phase|Protocol Violation|0|||
150252994|NCT00951015|542062346|FG004|Open-label Phase|Protocol Violation|12|||
150252995|NCT00951015|542062342|FG000|Open-label Phase|Lost to Follow-up|0|||
150252996|NCT00951015|542062343|FG001|Open-label Phase|Lost to Follow-up|0|||
150252997|NCT00951015|542062344|FG002|Open-label Phase|Lost to Follow-up|0|||
150252998|NCT00951015|542062345|FG003|Open-label Phase|Lost to Follow-up|0|||
150252999|NCT00951015|542062346|FG004|Open-label Phase|Lost to Follow-up|12|||
150253000|NCT00951015|542062342|FG000|Open-label Phase|Withdrawal by Subject|0|||
150253001|NCT00951015|542062343|FG001|Open-label Phase|Withdrawal by Subject|0|||
150253002|NCT00951015|542062344|FG002|Open-label Phase|Withdrawal by Subject|0|||
150253003|NCT00951015|542062345|FG003|Open-label Phase|Withdrawal by Subject|0|||
150253004|NCT00951015|542062346|FG004|Open-label Phase|Withdrawal by Subject|14|||
150253005|NCT00951015|542062342|FG000|Open-label Phase|Physician Decision|0|||
150253006|NCT00951015|542062343|FG001|Open-label Phase|Physician Decision|0|||
150253007|NCT00951015|542062344|FG002|Open-label Phase|Physician Decision|0|||
150253008|NCT00951015|542062345|FG003|Open-label Phase|Physician Decision|0|||
150253009|NCT00951015|542062346|FG004|Open-label Phase|Physician Decision|8|||
150253010|NCT03819634|542062348|FG000|Overall Study|Physician Decision|2|||
150253011|NCT00757627|542062349|FG000|Overall Study|Adverse Event|15|||
150253012|NCT00757627|542062349|FG000|Overall Study|Lack of Efficacy|10|||
150253013|NCT00757627|542062349|FG000|Overall Study|Lost to Follow-up|28|||
150253014|NCT00757627|542062349|FG000|Overall Study|Withdrawal by Subject|27|||
150253015|NCT00757627|542062349|FG000|Overall Study|Other|1|||
150253016|NCT00635661|542062350|FG000|Overall Study|Withdrawal by Subject|4|||
150253017|NCT03192475|542062351|FG000|Overall Study|Death|0|||
150253018|NCT03192475|542062352|FG001|Overall Study|Death|1|||
150253019|NCT03192475|542062351|FG000|Overall Study|Lost to Follow-up|13|||
150253020|NCT03192475|542062352|FG001|Overall Study|Lost to Follow-up|8|||
150253021|NCT00573859|542062355|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
150253022|NCT00573859|542062355|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
150253023|NCT02229851|542062360|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
150253024|NCT02229851|542062361|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
150253025|NCT02229851|542062362|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
150253026|NCT02229851|542062363|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
150253027|NCT02229851|542062364|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
150253028|NCT02229851|542062365|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
150253029|NCT02229851|542062366|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
150253030|NCT02229851|542062360|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253031|NCT02229851|542062361|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
150253032|NCT02229851|542062362|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253033|NCT02229851|542062363|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253034|NCT02229851|542062364|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253035|NCT02229851|542062365|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253036|NCT02229851|542062366|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
150253037|NCT02229851|542062360|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
150253038|NCT02229851|542062361|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
150253039|NCT02229851|542062362|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
150253040|NCT02229851|542062363|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
150253041|NCT02229851|542062364|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
150253042|NCT02229851|542062365|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
150253043|NCT02229851|542062366|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
150253044|NCT02229851|542062360|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149730625|NCT03222349|540148877|FG001|Overall Study|Treatment B not done|0|||
149730626|NCT03222349|540148876|FG000|Overall Study|Lost to Follow-up|1|||
149730627|NCT03222349|540148877|FG001|Overall Study|Lost to Follow-up|2|||
149730628|NCT03222349|540148876|FG000|Overall Study|Withdrawal by Subject|1|||
149730629|NCT03222349|540148877|FG001|Overall Study|Withdrawal by Subject|0|||
149730630|NCT03222349|540148876|FG000|Overall Study|Treatment A not done|0|||
149730631|NCT03222349|540148877|FG001|Overall Study|Treatment A not done|5|||
149730632|NCT03222349|540148876|FG000|Overall Study|Study terminated by sponsor|1|||
149730633|NCT03222349|540148877|FG001|Overall Study|Study terminated by sponsor|0|||
149730634|NCT02769624|540148878|FG000|Overall Study|Lost to Follow-up|0|||
150253045|NCT02229851|542062361|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
150253046|NCT02229851|542062362|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
150253047|NCT02229851|542062363|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
150253048|NCT02229851|542062364|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
150253049|NCT02229851|542062365|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
150253050|NCT02229851|542062366|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
150253051|NCT02229851|542062360|FG000|Main Phase (Double-blind Phase)|Death|1|||
150253052|NCT02229851|542062361|FG001|Main Phase (Double-blind Phase)|Death|1|||
150253053|NCT02229851|542062362|FG002|Main Phase (Double-blind Phase)|Death|0|||
150253054|NCT02229851|542062363|FG003|Main Phase (Double-blind Phase)|Death|0|||
150253055|NCT02229851|542062364|FG004|Main Phase (Double-blind Phase)|Death|0|||
150253056|NCT02229851|542062365|FG005|Main Phase (Double-blind Phase)|Death|0|||
150253057|NCT02229851|542062366|FG006|Main Phase (Double-blind Phase)|Death|0|||
150253058|NCT02229851|542062360|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
150253059|NCT02229851|542062361|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
150253060|NCT02229851|542062362|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
150253061|NCT02229851|542062363|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
150253062|NCT02229851|542062364|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
150253063|NCT02229851|542062365|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
150253064|NCT02229851|542062366|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
150253065|NCT02229851|542062360|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
149730635|NCT02769624|540148879|FG001|Overall Study|Lost to Follow-up|1|||
150253066|NCT02229851|542062361|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
149730636|NCT01552681|540148880|FG000|Overall Study|Withdrawal by Subject|4|||
149730637|NCT01552681|540148881|FG001|Overall Study|Withdrawal by Subject|0|||
149730638|NCT01552681|540148880|FG000|Overall Study|Physician Decision|1|||
150253067|NCT02229851|542062362|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
150253068|NCT02229851|542062363|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
149730639|NCT01552681|540148881|FG001|Overall Study|Physician Decision|0|||
149730640|NCT01552681|540148880|FG000|Overall Study|Subject moved away|0|||
150253069|NCT02229851|542062364|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
150253070|NCT02229851|542062365|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
150253071|NCT02229851|542062366|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
150253072|NCT02229851|542062360|FG000|Extension Phase (Open-label Phase)|Death|0|||
150253073|NCT02229851|542062361|FG001|Extension Phase (Open-label Phase)|Death|0|||
150253074|NCT02229851|542062362|FG002|Extension Phase (Open-label Phase)|Death|0|||
150253075|NCT02229851|542062363|FG003|Extension Phase (Open-label Phase)|Death|1|||
150253076|NCT02229851|542062364|FG004|Extension Phase (Open-label Phase)|Death|0|||
150253077|NCT02229851|542062365|FG005|Extension Phase (Open-label Phase)|Death|1|||
150253078|NCT02229851|542062366|FG006|Extension Phase (Open-label Phase)|Death|1|||
150253079|NCT03541200|542062367|FG000|Overall Study|Adverse Event|19|||
150253080|NCT03541200|542062367|FG000|Overall Study|Death|1|||
150253081|NCT03541200|542062367|FG000|Overall Study|Lost to Follow-up|10|||
150253082|NCT03541200|542062367|FG000|Overall Study|Physician Decision|1|||
150253083|NCT03541200|542062367|FG000|Overall Study|Protocol Violation|51|||
150253084|NCT03541200|542062367|FG000|Overall Study|Withdrawal by Subject|23|||
150253085|NCT03541200|542062367|FG000|Overall Study|other|8|||
150253086|NCT03682302|542062368|FG000|Overall Study|Lost to Follow-up|1|||
150253087|NCT03682302|542062369|FG001|Overall Study|Lost to Follow-up|2|||
150253088|NCT03682302|542062370|FG002|Overall Study|Lost to Follow-up|0|||
150253089|NCT03682302|542062371|FG003|Overall Study|Lost to Follow-up|1|||
150253090|NCT03682302|542062368|FG000|Overall Study|Study drug was not administered|0|||
150253091|NCT03682302|542062369|FG001|Overall Study|Study drug was not administered|0|||
150253092|NCT03682302|542062370|FG002|Overall Study|Study drug was not administered|1|||
150253093|NCT03682302|542062371|FG003|Overall Study|Study drug was not administered|1|||
150253094|NCT01769326|542062372|FG000|Overall Study|Lost to Follow-up|1|||
150253095|NCT01769326|542062373|FG001|Overall Study|Lost to Follow-up|2|||
150253096|NCT01769326|542062374|FG002|Overall Study|Lost to Follow-up|0|||
150253097|NCT01769326|542062375|FG003|Overall Study|Lost to Follow-up|0|||
150253098|NCT01769326|542062372|FG000|Overall Study|unrelated injry|1|||
150253099|NCT01769326|542062373|FG001|Overall Study|unrelated injry|1|||
150253100|NCT01769326|542062374|FG002|Overall Study|unrelated injry|0|||
150253101|NCT01769326|542062375|FG003|Overall Study|unrelated injry|0|||
150253102|NCT01769326|542062372|FG000|Overall Study|got a job|0|||
150253103|NCT01769326|542062373|FG001|Overall Study|got a job|1|||
150253104|NCT01769326|542062374|FG002|Overall Study|got a job|0|||
150253105|NCT01769326|542062375|FG003|Overall Study|got a job|0|||
150253106|NCT01769326|542062372|FG000|Overall Study|Got sick and could not complete study|0|||
150253107|NCT01769326|542062373|FG001|Overall Study|Got sick and could not complete study|0|||
150253108|NCT01769326|542062374|FG002|Overall Study|Got sick and could not complete study|1|||
150253109|NCT01769326|542062375|FG003|Overall Study|Got sick and could not complete study|0|||
150253110|NCT01413503|542062376|FG000|Overall Study|Lost to Follow-up|1|||
150253111|NCT00293059|542062377|FG000|Overall Study|Adverse Event|12|||
150253112|NCT00293059|542062378|FG001|Overall Study|Adverse Event|4|||
150253113|NCT00293059|542062377|FG000|Overall Study|Lack of Efficacy|2|||
150253114|NCT00293059|542062378|FG001|Overall Study|Lack of Efficacy|0|||
150253115|NCT00293059|542062377|FG000|Overall Study|Lost to Follow-up|2|||
150253116|NCT00293059|542062378|FG001|Overall Study|Lost to Follow-up|3|||
150253117|NCT00293059|542062377|FG000|Overall Study|Pregnancy|1|||
150253118|NCT00293059|542062378|FG001|Overall Study|Pregnancy|1|||
150253119|NCT00293059|542062377|FG000|Overall Study|Protocol Violation|2|||
150253120|NCT00293059|542062378|FG001|Overall Study|Protocol Violation|0|||
150253121|NCT00293059|542062377|FG000|Overall Study|Withdrawal by Subject|11|||
150253122|NCT00293059|542062378|FG001|Overall Study|Withdrawal by Subject|5|||
150253123|NCT00293059|542062377|FG000|Overall Study|Participant moved out of state|1|||
150253124|NCT00293059|542062378|FG001|Overall Study|Participant moved out of state|0|||
150253125|NCT00293059|542062377|FG000|Overall Study|Participant stopped study drug|1|||
150253126|NCT00293059|542062378|FG001|Overall Study|Participant stopped study drug|0|||
150253127|NCT00293059|542062377|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
149730641|NCT01552681|540148881|FG001|Overall Study|Subject moved away|1|||
149730642|NCT01987908|540148891|FG000|Placebo Lead-in Period|Adverse Event|2|||
149730643|NCT01987908|540148892|FG001|Placebo Lead-in Period|Adverse Event|0|||
149730644|NCT01987908|540148893|FG002|Placebo Lead-in Period|Adverse Event|0|||
149730645|NCT01987908|540148891|FG000|Placebo Lead-in Period|Physician Decision|2|||
150253128|NCT00293059|542062378|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
150253129|NCT00293059|542062377|FG000|Overall Study|missing|3|||
150253130|NCT00293059|542062378|FG001|Overall Study|missing|5|||
150253131|NCT02001064|542062379|FG000|Overall Study|Withdrawal by Subject|2|||
150253132|NCT02001064|542062380|FG001|Overall Study|Withdrawal by Subject|1|||
150253133|NCT01609062|542062381|FG000|Extension Phase|Terminated by Sponsor|14|||
150253134|NCT01609062|542062382|FG001|Extension Phase|Terminated by Sponsor|9|||
150253135|NCT01609062|542062381|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
149730646|NCT01987908|540148892|FG001|Placebo Lead-in Period|Physician Decision|0|||
150253136|NCT01609062|542062382|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
149730647|NCT01987908|540148893|FG002|Placebo Lead-in Period|Physician Decision|0|||
150253137|NCT01609062|542062381|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
150253138|NCT01609062|542062382|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
150253139|NCT03772587|542062383|FG000|Overall Study|COVID-19|0|||
150253140|NCT03772587|542062384|FG001|Overall Study|COVID-19|0|||
150253141|NCT03772587|542062385|FG002|Overall Study|COVID-19|1|||
150253142|NCT03772587|542062386|FG003|Overall Study|COVID-19|1|||
150253143|NCT03772587|542062387|FG004|Overall Study|COVID-19|0|||
150253144|NCT03772587|542062383|FG000|Overall Study|Withdrawal by Subject|1|||
150253145|NCT03772587|542062384|FG001|Overall Study|Withdrawal by Subject|0|||
150253146|NCT03772587|542062385|FG002|Overall Study|Withdrawal by Subject|0|||
150253147|NCT03772587|542062386|FG003|Overall Study|Withdrawal by Subject|0|||
150253148|NCT03772587|542062387|FG004|Overall Study|Withdrawal by Subject|0|||
150253149|NCT05260021|542062390|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
150253150|NCT05260021|542062391|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
150253151|NCT05260021|542062392|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
150253152|NCT05260021|542062390|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
150253153|NCT05260021|542062391|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
150253154|NCT05260021|542062392|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
150253155|NCT05260021|542062390|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
150253156|NCT05260021|542062391|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
150253157|NCT05260021|542062392|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
150253158|NCT05260021|542062390|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
150253159|NCT05260021|542062391|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
150253160|NCT05260021|542062392|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
150253161|NCT05260021|542062390|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
150253162|NCT05260021|542062391|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
150253163|NCT05260021|542062392|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
150253164|NCT00607724|542062393|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
150253165|NCT00607724|542062394|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
150253166|NCT00607724|542062395|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
150253167|NCT00607724|542062396|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
150253168|NCT00607724|542062397|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
150253169|NCT00607724|542062398|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
150253170|NCT00607724|542062399|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
150253171|NCT00607724|542062393|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
150253172|NCT00607724|542062394|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
150253173|NCT00607724|542062395|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
150253174|NCT00607724|542062396|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
150253175|NCT00607724|542062397|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
150253176|NCT00607724|542062398|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
150253177|NCT00607724|542062399|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
150253178|NCT00607724|542062393|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
150253179|NCT00607724|542062394|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
149730648|NCT01987908|540148891|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
149730649|NCT01987908|540148892|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
149730650|NCT01987908|540148893|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
149730651|NCT01987908|540148891|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
149730652|NCT01987908|540148892|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
149730653|NCT01987908|540148893|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
149730654|NCT01987908|540148891|FG000|Treatment Period|Adverse Event|0|||
149730655|NCT01987908|540148892|FG001|Treatment Period|Adverse Event|1|||
149730656|NCT01987908|540148893|FG002|Treatment Period|Adverse Event|1|||
149730657|NCT01987908|540148891|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
149730658|NCT01987908|540148892|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
149730659|NCT01987908|540148893|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
149730660|NCT01987908|540148891|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
149730661|NCT01987908|540148892|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
149730662|NCT01987908|540148893|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
150253180|NCT00607724|542062395|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
150253181|NCT00607724|542062396|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
149730663|NCT01869348|540148894|FG000|Overall Study|Withdrawal by Subject|1|||
149730664|NCT01869348|540148895|FG001|Overall Study|Withdrawal by Subject|1|||
150253182|NCT00607724|542062397|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
150253183|NCT00607724|542062398|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
150253184|NCT00607724|542062399|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
150253185|NCT00607724|542062393|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
149730665|NCT02789657|540148897|FG000|Overall Study|Withdrawal by Subject|2|||
149730666|NCT02789657|540148898|FG001|Overall Study|Withdrawal by Subject|0|||
149730667|NCT02789657|540148899|FG002|Overall Study|Withdrawal by Subject|0|||
149730668|NCT02789657|540148900|FG003|Overall Study|Withdrawal by Subject|0|||
149730669|NCT00448708|540148901|FG000|Overall Study|Death|21|||
149730670|NCT00448708|540148902|FG001|Overall Study|Death|17|||
149730671|NCT00448708|540148901|FG000|Overall Study|Withdrawal by Subject|8|||
149730672|NCT00448708|540148902|FG001|Overall Study|Withdrawal by Subject|4|||
149730673|NCT00448708|540148901|FG000|Overall Study|Lost to Follow-up|6|||
149730674|NCT00448708|540148902|FG001|Overall Study|Lost to Follow-up|8|||
149730675|NCT00448708|540148901|FG000|Overall Study|not listed|0|||
149730676|NCT00448708|540148902|FG001|Overall Study|not listed|2|||
149730677|NCT04698525|540148903|FG000|Overall Study|Lost to Follow-up|1|||
149730678|NCT04698525|540148904|FG001|Overall Study|Lost to Follow-up|2|||
149730679|NCT04698525|540148903|FG000|Overall Study|Three suffered of Covid-19|2|||
149730680|NCT04698525|540148904|FG001|Overall Study|Three suffered of Covid-19|1|||
149730681|NCT01731678|540148907|FG000|Overall Study|Withdrawal by Subject|3|||
149730682|NCT01731678|540148907|FG000|Overall Study|Did not meet inclusion criteria|1|||
149730683|NCT01731678|540148907|FG000|Overall Study|RMT too high, making TMS difficult|3|||
149730684|NCT03665285|540148910|FG000|Overall Study|Started New Anticancer Treatment|1|||
149730685|NCT03665285|540148911|FG001|Overall Study|Started New Anticancer Treatment|1|||
149730686|NCT03665285|540148912|FG002|Overall Study|Started New Anticancer Treatment|2|||
149730687|NCT03665285|540148913|FG003|Overall Study|Started New Anticancer Treatment|4|||
149730688|NCT03665285|540148914|FG004|Overall Study|Started New Anticancer Treatment|1|||
149730689|NCT03665285|540148915|FG005|Overall Study|Started New Anticancer Treatment|1|||
149730690|NCT03665285|540148916|FG006|Overall Study|Started New Anticancer Treatment|2|||
149730691|NCT03665285|540148917|FG007|Overall Study|Started New Anticancer Treatment|15|||
149730692|NCT03665285|540148918|FG008|Overall Study|Started New Anticancer Treatment|1|||
149730693|NCT03665285|540148910|FG000|Overall Study|Disease Progression|0|||
149730694|NCT03665285|540148911|FG001|Overall Study|Disease Progression|0|||
149730695|NCT03665285|540148912|FG002|Overall Study|Disease Progression|3|||
150253186|NCT00607724|542062394|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
150253187|NCT00607724|542062395|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
150253188|NCT00607724|542062396|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
150253189|NCT00607724|542062397|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
150253190|NCT00607724|542062398|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
150253191|NCT00607724|542062399|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
150253192|NCT00607724|542062393|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253193|NCT00607724|542062394|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253194|NCT00607724|542062395|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253195|NCT00607724|542062396|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
150253196|NCT00607724|542062397|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253197|NCT00607724|542062398|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253198|NCT00607724|542062399|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
150253199|NCT00151281|542062400|FG000|Overall Study|Not evaluable|3|||
150253200|NCT04150068|542062403|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
150253201|NCT04150068|542062404|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
150253202|NCT04150068|542062405|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
150253203|NCT04150068|542062403|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
150253204|NCT04150068|542062404|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
150253205|NCT04150068|542062405|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
150253206|NCT05316701|542062406|FG000|Overall Study|Adverse Event|0|||
150253207|NCT05316701|542062407|FG001|Overall Study|Adverse Event|1|||
150253208|NCT05316701|542062406|FG000|Overall Study|Death|3|||
150253209|NCT05316701|542062407|FG001|Overall Study|Death|9|||
150253210|NCT05316701|542062406|FG000|Overall Study|Lost to Follow-up|1|||
150253211|NCT05316701|542062407|FG001|Overall Study|Lost to Follow-up|0|||
150253212|NCT05316701|542062406|FG000|Overall Study|Physician Decision|1|||
150253213|NCT05316701|542062407|FG001|Overall Study|Physician Decision|4|||
150253214|NCT05316701|542062406|FG000|Overall Study|Withdrawal by Subject|3|||
150253215|NCT05316701|542062407|FG001|Overall Study|Withdrawal by Subject|5|||
150253216|NCT05316701|542062406|FG000|Overall Study|Progression/Relapse|14|||
150253217|NCT05316701|542062407|FG001|Overall Study|Progression/Relapse|9|||
150253218|NCT05316701|542062406|FG000|Overall Study|Received Standard of Care|1|||
150253219|NCT05316701|542062407|FG001|Overall Study|Received Standard of Care|0|||
150253220|NCT05316701|542062406|FG000|Overall Study|Ongoing|70|||
150253221|NCT05316701|542062407|FG001|Overall Study|Ongoing|64|||
149730696|NCT03665285|540148913|FG003|Overall Study|Disease Progression|1|||
149730697|NCT03665285|540148914|FG004|Overall Study|Disease Progression|0|||
149730698|NCT03665285|540148915|FG005|Overall Study|Disease Progression|0|||
149730699|NCT03665285|540148916|FG006|Overall Study|Disease Progression|0|||
149730700|NCT03665285|540148917|FG007|Overall Study|Disease Progression|7|||
149730701|NCT03665285|540148918|FG008|Overall Study|Disease Progression|1|||
149730702|NCT03665285|540148910|FG000|Overall Study|Hospice|0|||
149730703|NCT03665285|540148911|FG001|Overall Study|Hospice|0|||
150253222|NCT04679935|542062408|FG000|Overall Study|Death|0|||
150253223|NCT04679935|542062409|FG001|Overall Study|Death|1|||
150253224|NCT04362189|542062413|FG000|Overall Study|Lost to Follow-up|0|||
149730704|NCT03665285|540148912|FG002|Overall Study|Hospice|0|||
150253225|NCT04362189|542062414|FG001|Overall Study|Lost to Follow-up|1|||
150253226|NCT04362189|542062413|FG000|Overall Study|Withdrawal by Subject|1|||
150253227|NCT04362189|542062414|FG001|Overall Study|Withdrawal by Subject|0|||
150253228|NCT04362189|542062413|FG000|Overall Study|FDA Clinical Hold|7|||
150253229|NCT04362189|542062414|FG001|Overall Study|FDA Clinical Hold|2|||
150253230|NCT04362189|542062413|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
150253231|NCT04362189|542062414|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
150253232|NCT04362189|542062413|FG000|Overall Study|Adverse Event|0|||
150253233|NCT04362189|542062414|FG001|Overall Study|Adverse Event|2|||
150253234|NCT04362189|542062413|FG000|Overall Study|Death|4|||
150253235|NCT04362189|542062414|FG001|Overall Study|Death|1|||
150253236|NCT02111681|542062415|FG000|Overall Study|Death|5|||
150253237|NCT02111681|542062415|FG000|Overall Study|Lack of Efficacy|2|||
150253238|NCT02111681|542062415|FG000|Overall Study|Progression of disease|4|||
150253239|NCT04349631|542062418|FG000|Overall Study|Lost to Follow-up|3|||
150253240|NCT04349631|542062418|FG000|Overall Study|Withdrawal by Subject|7|||
150253241|NCT00775463|542063835|FG000|Overall Study|Withdrawal by Subject|0|||
150253242|NCT00775463|542063836|FG001|Overall Study|Withdrawal by Subject|1|||
150253243|NCT00775463|542063835|FG000|Overall Study|Adverse Event|7|||
150253244|NCT00775463|542063836|FG001|Overall Study|Adverse Event|9|||
150253245|NCT00775463|542063835|FG000|Overall Study|Protocol Violation|2|||
150253246|NCT00775463|542063836|FG001|Overall Study|Protocol Violation|2|||
150253247|NCT00775463|542063835|FG000|Overall Study|Lost to Follow-up|1|||
150253248|NCT00775463|542063836|FG001|Overall Study|Lost to Follow-up|0|||
150253249|NCT00775463|542063835|FG000|Overall Study|Lack of Efficacy|1|||
150253250|NCT00775463|542063836|FG001|Overall Study|Lack of Efficacy|1|||
150253251|NCT00091169|542063837|FG000|Overall Study|Disease progression|3|||
150253252|NCT00091169|542063838|FG001|Overall Study|Disease progression|1|||
150253253|NCT00091169|542063837|FG000|Overall Study|Adverse Event|11|||
150253254|NCT00091169|542063838|FG001|Overall Study|Adverse Event|17|||
150253255|NCT00091169|542063837|FG000|Overall Study|Death|4|||
150253256|NCT00091169|542063838|FG001|Overall Study|Death|1|||
150253257|NCT00091169|542063837|FG000|Overall Study|Withdrawal by Subject|10|||
150253258|NCT00091169|542063838|FG001|Overall Study|Withdrawal by Subject|13|||
150253259|NCT00091169|542063837|FG000|Overall Study|Other|3|||
150253260|NCT00091169|542063838|FG001|Overall Study|Other|4|||
150253261|NCT00091169|542063837|FG000|Overall Study|Not start protocol therapy|26|||
150253262|NCT00091169|542063838|FG001|Overall Study|Not start protocol therapy|17|||
150253263|NCT02366468|542063848|FG000|Overall Study|Adverse Event|2|||
150253264|NCT02366468|542063849|FG001|Overall Study|Adverse Event|0|||
150253265|NCT02366468|542063848|FG000|Overall Study|Withdrawal by Subject|1|||
150253266|NCT02366468|542063849|FG001|Overall Study|Withdrawal by Subject|5|||
150253267|NCT02366468|542063848|FG000|Overall Study|Lost to Follow-up|2|||
150253268|NCT02366468|542063849|FG001|Overall Study|Lost to Follow-up|0|||
150253269|NCT02366468|542063848|FG000|Overall Study|Death|1|||
150253270|NCT02366468|542063849|FG001|Overall Study|Death|2|||
150253271|NCT02366468|542063848|FG000|Overall Study|Other|0|||
150253272|NCT02366468|542063849|FG001|Overall Study|Other|2|||
150253273|NCT03651622|542063850|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
150253274|NCT03651622|542063851|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
150253275|NCT03651622|542063852|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
150253276|NCT03651622|542063850|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
150253277|NCT03651622|542063851|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
150253278|NCT03651622|542063852|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
150253279|NCT03651622|542063850|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
150253280|NCT03651622|542063851|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
150253281|NCT03651622|542063852|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
149730705|NCT03665285|540148913|FG003|Overall Study|Hospice|0|||
150253282|NCT03651622|542063850|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
150253283|NCT03651622|542063851|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
150253284|NCT03651622|542063852|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
150253285|NCT03651622|542063850|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
150253286|NCT03651622|542063851|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
150253287|NCT03651622|542063852|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
150253288|NCT03582943|542063853|FG000|Allocated to Groups|Withdrawal by Subject|1|||
150253289|NCT03582943|542063854|FG001|Allocated to Groups|Withdrawal by Subject|1|||
150253290|NCT03582943|542063853|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
150253291|NCT03582943|542063854|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
150253292|NCT03582943|542063853|FG000|Analyzed|Protocol Violation|4|||
149730706|NCT03665285|540148914|FG004|Overall Study|Hospice|0|||
149730707|NCT03665285|540148915|FG005|Overall Study|Hospice|0|||
150253293|NCT03582943|542063854|FG001|Analyzed|Protocol Violation|1|||
150253294|NCT01153321|542063855|FG000|Overall Study|Development of study withdrawal criteria|0|||
150253295|NCT01153321|542063856|FG001|Overall Study|Development of study withdrawal criteria|1|||
150253296|NCT01153321|542063855|FG000|Overall Study|Withdrawal by Subject|0|||
150253297|NCT01153321|542063856|FG001|Overall Study|Withdrawal by Subject|1|||
150253298|NCT01153321|542063855|FG000|Overall Study|Adverse Event|1|||
150253299|NCT01153321|542063856|FG001|Overall Study|Adverse Event|1|||
150253300|NCT02071290|542063857|FG000|Overall Study|Death|1|||
150253301|NCT02071290|542063858|FG001|Overall Study|Death|0|||
150253302|NCT02071290|542063857|FG000|Overall Study|Withdrawal by Subject|0|||
150253303|NCT02071290|542063858|FG001|Overall Study|Withdrawal by Subject|1|||
150253304|NCT02071290|542063857|FG000|Overall Study|Protocol Violation|3|||
150253305|NCT02071290|542063858|FG001|Overall Study|Protocol Violation|5|||
150253306|NCT02071290|542063857|FG000|Overall Study|Physician Decision|0|||
150253307|NCT02071290|542063858|FG001|Overall Study|Physician Decision|1|||
150253308|NCT01232738|542063859|FG000|Overall Study|Death|3|||
150253309|NCT01232738|542063859|FG000|Overall Study|Physician Decision|2|||
150253310|NCT01232738|542063859|FG000|Overall Study|Lost to Follow-up|1|||
150253311|NCT01232738|542063859|FG000|Overall Study|Withdrawal by Subject|2|||
150253312|NCT01232738|542063859|FG000|Overall Study|Adverse Event|5|||
150253313|NCT00488475|542063860|FG000|Overall Study|Other|1754|||
150253314|NCT02797080|542063875|FG000|Overall Study|Lost to Follow-up|1|||
150253315|NCT02797080|542063875|FG000|Overall Study|Withdrawal by Subject|1|||
150253316|NCT00299494|542063876|FG000|Overall Study|Withdrawal by Subject|0|||
150253317|NCT00299494|542063877|FG001|Overall Study|Withdrawal by Subject|0|||
150253318|NCT00299494|542063878|FG002|Overall Study|Withdrawal by Subject|0|||
150253319|NCT00299494|542063879|FG003|Overall Study|Withdrawal by Subject|3|||
150253320|NCT00299494|542063880|FG004|Overall Study|Withdrawal by Subject|1|||
150253321|NCT00299494|542063881|FG005|Overall Study|Withdrawal by Subject|4|||
150253322|NCT00299494|542063876|FG000|Overall Study|Physician Decision|0|||
150253323|NCT00299494|542063877|FG001|Overall Study|Physician Decision|0|||
150253324|NCT00299494|542063878|FG002|Overall Study|Physician Decision|0|||
150253325|NCT00299494|542063879|FG003|Overall Study|Physician Decision|0|||
150253326|NCT00299494|542063880|FG004|Overall Study|Physician Decision|1|||
150253327|NCT00299494|542063881|FG005|Overall Study|Physician Decision|0|||
150253328|NCT00299494|542063876|FG000|Overall Study|Death|3|||
150253329|NCT00299494|542063877|FG001|Overall Study|Death|1|||
150253330|NCT00299494|542063878|FG002|Overall Study|Death|4|||
150253331|NCT00299494|542063879|FG003|Overall Study|Death|6|||
150253332|NCT00299494|542063880|FG004|Overall Study|Death|18|||
150253333|NCT00299494|542063881|FG005|Overall Study|Death|19|||
150253334|NCT00299494|542063876|FG000|Overall Study|Lost to Follow-up|0|||
150253335|NCT00299494|542063877|FG001|Overall Study|Lost to Follow-up|0|||
150253336|NCT00299494|542063878|FG002|Overall Study|Lost to Follow-up|0|||
150253337|NCT00299494|542063879|FG003|Overall Study|Lost to Follow-up|0|||
150253338|NCT00299494|542063880|FG004|Overall Study|Lost to Follow-up|3|||
150253339|NCT00299494|542063881|FG005|Overall Study|Lost to Follow-up|1|||
150253340|NCT00299494|542063876|FG000|Overall Study|Other - Unspecified|0|||
150253341|NCT00299494|542063877|FG001|Overall Study|Other - Unspecified|0|||
150253342|NCT00299494|542063878|FG002|Overall Study|Other - Unspecified|0|||
150253343|NCT00299494|542063879|FG003|Overall Study|Other - Unspecified|0|||
150253344|NCT00299494|542063880|FG004|Overall Study|Other - Unspecified|3|||
150253345|NCT00299494|542063881|FG005|Overall Study|Other - Unspecified|1|||
150253346|NCT00299494|542063876|FG000|Overall Study|Other - site closure|0|||
150253347|NCT00299494|542063877|FG001|Overall Study|Other - site closure|0|||
150253348|NCT00299494|542063878|FG002|Overall Study|Other - site closure|0|||
150253349|NCT00299494|542063879|FG003|Overall Study|Other - site closure|1|||
150253350|NCT00299494|542063880|FG004|Overall Study|Other - site closure|1|||
150253351|NCT00299494|542063881|FG005|Overall Study|Other - site closure|1|||
150253352|NCT01417104|542063885|FG000|Overall Study|Withdrawal by Subject|5|||
150253353|NCT01417104|542063886|FG001|Overall Study|Withdrawal by Subject|1|||
150253354|NCT01417104|542063885|FG000|Overall Study|Failure to make contact|0|||
150253355|NCT01417104|542063886|FG001|Overall Study|Failure to make contact|1|||
150253356|NCT01417104|542063885|FG000|Overall Study|Adverse Event|1|||
150253357|NCT01417104|542063886|FG001|Overall Study|Adverse Event|0|||
150253358|NCT01416389|542063887|FG000|Overall Study|Lost to Follow-up|1|||
150253359|NCT01416389|542063888|FG001|Overall Study|Lost to Follow-up|0|||
150253360|NCT01416389|542063887|FG000|Overall Study|Started New Therapy|2|||
150253361|NCT01416389|542063888|FG001|Overall Study|Started New Therapy|0|||
150253362|NCT01365481|542063889|FG000|Overall Study|Adverse Event|6|||
150253363|NCT01365481|542063890|FG001|Overall Study|Adverse Event|9|||
150253364|NCT01365481|542063891|FG002|Overall Study|Adverse Event|0|||
150253365|NCT01365481|542063892|FG003|Overall Study|Adverse Event|2|||
150253366|NCT01365481|542063889|FG000|Overall Study|Withdrawal by Subject|0|||
150253367|NCT01365481|542063890|FG001|Overall Study|Withdrawal by Subject|2|||
150253368|NCT01365481|542063891|FG002|Overall Study|Withdrawal by Subject|1|||
150253369|NCT01365481|542063892|FG003|Overall Study|Withdrawal by Subject|1|||
150253370|NCT01365481|542063889|FG000|Overall Study|Lost to Follow-up|1|||
150253371|NCT01365481|542063890|FG001|Overall Study|Lost to Follow-up|1|||
150253372|NCT01365481|542063891|FG002|Overall Study|Lost to Follow-up|2|||
150253373|NCT01365481|542063892|FG003|Overall Study|Lost to Follow-up|3|||
150253374|NCT01365481|542063889|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150253375|NCT01365481|542063890|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150253376|NCT01365481|542063891|FG002|Overall Study|Abnormal laboratory value(s)|0|||
150253377|NCT01365481|542063892|FG003|Overall Study|Abnormal laboratory value(s)|0|||
150253378|NCT01365481|542063889|FG000|Overall Study|Administrative problems|0|||
150253379|NCT01365481|542063890|FG001|Overall Study|Administrative problems|1|||
150253380|NCT01365481|542063891|FG002|Overall Study|Administrative problems|0|||
150253381|NCT01365481|542063892|FG003|Overall Study|Administrative problems|0|||
150253382|NCT01365481|542063889|FG000|Overall Study|Protocol deviation|0|||
150253383|NCT01365481|542063890|FG001|Overall Study|Protocol deviation|1|||
150253384|NCT01365481|542063891|FG002|Overall Study|Protocol deviation|0|||
150253385|NCT01365481|542063892|FG003|Overall Study|Protocol deviation|1|||
150253386|NCT01365481|542063889|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
150253387|NCT01365481|542063890|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
150253388|NCT01365481|542063891|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
150253389|NCT01365481|542063892|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
150253390|NCT00958841|542063897|FG000|Overall Study|Abnormal laboratory value(s)|1|||
150253391|NCT00958841|542063897|FG000|Overall Study|Abnormal test procedure result(s)|3|||
150253392|NCT00958841|542063897|FG000|Overall Study|Administrative problems|1|||
150253393|NCT00958841|542063897|FG000|Overall Study|Adverse Event|8|||
150253394|NCT00958841|542063897|FG000|Overall Study|New cancer therapy|5|||
150253395|NCT00958841|542063897|FG000|Overall Study|Withdrawal by Subject|1|||
150253396|NCT00958841|542063897|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
150253397|NCT00958841|542063897|FG000|Overall Study|Completed M6/did not enter extension|27|||
150253398|NCT00958841|542063897|FG000|Overall Study|Discontinued prior to M*|28|||
150253399|NCT01125514|542063899|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
150253400|NCT01125514|542063899|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
150253401|NCT01125514|542063899|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
150253402|NCT01125514|542063899|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
150253403|NCT01125514|542063899|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
150253404|NCT01125514|542063899|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
150253405|NCT00858364|542063900|FG000|Overall Study|Administrative Decision|3|||
150253406|NCT00858364|542063901|FG001|Overall Study|Administrative Decision|2|||
150253407|NCT00858364|542063900|FG000|Overall Study|Adverse Event|5|||
150253408|NCT00858364|542063901|FG001|Overall Study|Adverse Event|2|||
150253409|NCT00858364|542063900|FG000|Overall Study|Withdrawal by Subject|44|||
150253410|NCT00858364|542063901|FG001|Overall Study|Withdrawal by Subject|118|||
150253411|NCT00858364|542063900|FG000|Overall Study|Ineligibility Determined|1|||
150253412|NCT00858364|542063901|FG001|Overall Study|Ineligibility Determined|10|||
150253413|NCT00858364|542063900|FG000|Overall Study|Lost to Follow-up|24|||
150253414|NCT00858364|542063901|FG001|Overall Study|Lost to Follow-up|54|||
150253415|NCT00858364|542063900|FG000|Overall Study|Noncompliance|3|||
150253416|NCT00858364|542063901|FG001|Overall Study|Noncompliance|4|||
150253417|NCT00858364|542063900|FG000|Overall Study|Protocol Deviation|0|||
150253418|NCT00858364|542063901|FG001|Overall Study|Protocol Deviation|2|||
150253419|NCT00858364|542063900|FG000|Overall Study|Other|9|||
150253420|NCT00858364|542063901|FG001|Overall Study|Other|17|||
150253421|NCT00858364|542063900|FG000|Overall Study|Missing|1|||
150253422|NCT00858364|542063901|FG001|Overall Study|Missing|1|||
150253423|NCT00858364|542063900|FG000|Overall Study|Still on-study|114|||
150253424|NCT00858364|542063901|FG001|Overall Study|Still on-study|247|||
150253425|NCT03980808|542063902|FG000|Overall Study|Lost to Follow-up|2|||
150253426|NCT03980808|542063903|FG001|Overall Study|Lost to Follow-up|2|||
150253427|NCT00436605|542063907|FG000|Overall Study|Protocol Violation|3|||
150253428|NCT03014011|542063908|FG000|First Intervention|Withdrawal by Subject|1|||
150253429|NCT03014011|542063909|FG001|First Intervention|Withdrawal by Subject|0|||
150253430|NCT03014011|542063908|FG000|Washout|Withdrawal by Subject|1|||
150253431|NCT03014011|542063909|FG001|Washout|Withdrawal by Subject|0|||
150253432|NCT02755818|542063910|FG000|Overall Study|Withdrawal by Subject|0|||
150253433|NCT02755818|542063911|FG001|Overall Study|Withdrawal by Subject|0|||
150253434|NCT02755818|542063912|FG002|Overall Study|Withdrawal by Subject|0|||
150253435|NCT02755818|542063913|FG003|Overall Study|Withdrawal by Subject|2|||
150253436|NCT02755818|542063910|FG000|Overall Study|withdrawal by PI|0|||
150253437|NCT02755818|542063911|FG001|Overall Study|withdrawal by PI|0|||
150253438|NCT02755818|542063912|FG002|Overall Study|withdrawal by PI|1|||
150253439|NCT02755818|542063913|FG003|Overall Study|withdrawal by PI|1|||
150253440|NCT00929110|542063914|FG000|Overall Study|Adverse Event|40|||
150253441|NCT00929110|542063915|FG001|Overall Study|Adverse Event|29|||
150253442|NCT00929110|542063916|FG002|Overall Study|Adverse Event|18|||
150253443|NCT00929110|542063914|FG000|Overall Study|Subject withdrew consent|40|||
150253444|NCT00929110|542063915|FG001|Overall Study|Subject withdrew consent|23|||
150253445|NCT00929110|542063916|FG002|Overall Study|Subject withdrew consent|26|||
150253446|NCT00929110|542063914|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
150253447|NCT00929110|542063915|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
150253448|NCT00929110|542063916|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
149730708|NCT03665285|540148916|FG006|Overall Study|Hospice|0|||
150253449|NCT00929110|542063914|FG000|Overall Study|Lost to Follow-up|7|||
150253450|NCT00929110|542063915|FG001|Overall Study|Lost to Follow-up|7|||
150253451|NCT00929110|542063916|FG002|Overall Study|Lost to Follow-up|3|||
150253452|NCT00929110|542063914|FG000|Overall Study|Protocol deviation|5|||
150253453|NCT00929110|542063915|FG001|Overall Study|Protocol deviation|2|||
150253454|NCT00929110|542063916|FG002|Overall Study|Protocol deviation|4|||
150253455|NCT00929110|542063914|FG000|Overall Study|Administrative problems|4|||
150253456|NCT00929110|542063915|FG001|Overall Study|Administrative problems|1|||
150253457|NCT00929110|542063916|FG002|Overall Study|Administrative problems|2|||
150253458|NCT00929110|542063914|FG000|Overall Study|Death|2|||
150253459|NCT00929110|542063915|FG001|Overall Study|Death|2|||
150253460|NCT00929110|542063916|FG002|Overall Study|Death|2|||
150253461|NCT00929110|542063914|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150253462|NCT00929110|542063915|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150253463|NCT00929110|542063916|FG002|Overall Study|Abnormal laboratory value(s)|0|||
150253464|NCT00929110|542063914|FG000|Overall Study|Abnormal test procedure result(s)|0|||
150253465|NCT00929110|542063915|FG001|Overall Study|Abnormal test procedure result(s)|1|||
150253466|NCT00929110|542063916|FG002|Overall Study|Abnormal test procedure result(s)|1|||
150253467|NCT00929110|542063914|FG000|Overall Study|Patient inability to use the device|0|||
150253468|NCT00929110|542063915|FG001|Overall Study|Patient inability to use the device|1|||
150253469|NCT00929110|542063916|FG002|Overall Study|Patient inability to use the device|0|||
150253470|NCT02416453|542063919|FG000|Overall Study|Adverse Event|0|||
150253471|NCT02416453|542063920|FG001|Overall Study|Adverse Event|0|||
150253472|NCT02416453|542063921|FG002|Overall Study|Adverse Event|0|||
150253473|NCT02416453|542063922|FG003|Overall Study|Adverse Event|2|||
150253474|NCT02416453|542063923|FG004|Overall Study|Adverse Event|0|||
150253475|NCT02416453|542063924|FG005|Overall Study|Adverse Event|1|||
150253476|NCT02416453|542063925|FG006|Overall Study|Adverse Event|0|||
150253477|NCT02416453|542063926|FG007|Overall Study|Adverse Event|0|||
150253478|NCT02416453|542063927|FG008|Overall Study|Adverse Event|0|||
150253479|NCT02416453|542063928|FG009|Overall Study|Adverse Event|0|||
150253480|NCT02416453|542063929|FG010|Overall Study|Adverse Event|0|||
150253481|NCT02416453|542063919|FG000|Overall Study|Lost to Follow-up|1|||
150253482|NCT02416453|542063920|FG001|Overall Study|Lost to Follow-up|3|||
150253483|NCT02416453|542063921|FG002|Overall Study|Lost to Follow-up|0|||
150253484|NCT02416453|542063922|FG003|Overall Study|Lost to Follow-up|8|||
150253485|NCT02416453|542063923|FG004|Overall Study|Lost to Follow-up|0|||
150253486|NCT02416453|542063924|FG005|Overall Study|Lost to Follow-up|5|||
150253487|NCT02416453|542063925|FG006|Overall Study|Lost to Follow-up|1|||
150253488|NCT02416453|542063926|FG007|Overall Study|Lost to Follow-up|3|||
150253489|NCT02416453|542063927|FG008|Overall Study|Lost to Follow-up|1|||
150253490|NCT02416453|542063928|FG009|Overall Study|Lost to Follow-up|0|||
150253491|NCT02416453|542063929|FG010|Overall Study|Lost to Follow-up|0|||
150253492|NCT02416453|542063919|FG000|Overall Study|Physician Decision|0|||
150253493|NCT02416453|542063920|FG001|Overall Study|Physician Decision|0|||
150253494|NCT02416453|542063921|FG002|Overall Study|Physician Decision|0|||
150253495|NCT02416453|542063922|FG003|Overall Study|Physician Decision|0|||
150253496|NCT02416453|542063923|FG004|Overall Study|Physician Decision|0|||
150253497|NCT02416453|542063924|FG005|Overall Study|Physician Decision|1|||
150253498|NCT02416453|542063925|FG006|Overall Study|Physician Decision|1|||
150253499|NCT02416453|542063926|FG007|Overall Study|Physician Decision|1|||
150253500|NCT02416453|542063927|FG008|Overall Study|Physician Decision|0|||
150253501|NCT02416453|542063928|FG009|Overall Study|Physician Decision|0|||
150253502|NCT02416453|542063929|FG010|Overall Study|Physician Decision|0|||
150253503|NCT02416453|542063919|FG000|Overall Study|Withdrawal by Subject|2|||
150253504|NCT02416453|542063920|FG001|Overall Study|Withdrawal by Subject|0|||
150253505|NCT02416453|542063921|FG002|Overall Study|Withdrawal by Subject|0|||
150253506|NCT02416453|542063922|FG003|Overall Study|Withdrawal by Subject|5|||
150253507|NCT02416453|542063923|FG004|Overall Study|Withdrawal by Subject|1|||
150253508|NCT02416453|542063924|FG005|Overall Study|Withdrawal by Subject|8|||
150253509|NCT02416453|542063925|FG006|Overall Study|Withdrawal by Subject|0|||
150253510|NCT02416453|542063926|FG007|Overall Study|Withdrawal by Subject|8|||
150253511|NCT02416453|542063927|FG008|Overall Study|Withdrawal by Subject|4|||
150253512|NCT02416453|542063928|FG009|Overall Study|Withdrawal by Subject|0|||
150253513|NCT02416453|542063929|FG010|Overall Study|Withdrawal by Subject|0|||
150253514|NCT02416453|542063919|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253515|NCT02416453|542063920|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253516|NCT02416453|542063921|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
150253517|NCT02416453|542063922|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253518|NCT02416453|542063923|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253519|NCT02416453|542063924|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253520|NCT02416453|542063925|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253521|NCT02416453|542063926|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253522|NCT02416453|542063927|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253523|NCT02416453|542063928|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253524|NCT02416453|542063929|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
150253525|NCT02416453|542063919|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253526|NCT02416453|542063920|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253527|NCT02416453|542063921|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253528|NCT02416453|542063922|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253529|NCT02416453|542063923|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253530|NCT02416453|542063924|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
150253531|NCT02416453|542063925|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253532|NCT02416453|542063926|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253533|NCT02416453|542063927|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253534|NCT02416453|542063928|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253535|NCT02416453|542063929|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
150253536|NCT01163292|542063930|FG000|Overall Study|Lack of Efficacy|9|||
150253537|NCT01163292|542063931|FG001|Overall Study|Lack of Efficacy|0|||
150253538|NCT01163292|542063930|FG000|Overall Study|Adverse Event|6|||
150253539|NCT01163292|542063931|FG001|Overall Study|Adverse Event|0|||
150253540|NCT01163292|542063930|FG000|Overall Study|Initiation of biological therapy|0|||
150253541|NCT01163292|542063931|FG001|Overall Study|Initiation of biological therapy|15|||
150253542|NCT01163292|542063930|FG000|Overall Study|Sufficient response to adalimumab|8|||
150253543|NCT01163292|542063931|FG001|Overall Study|Sufficient response to adalimumab|0|||
150253544|NCT01163292|542063930|FG000|Overall Study|Refusal to receive adalimumab|7|||
150253545|NCT01163292|542063931|FG001|Overall Study|Refusal to receive adalimumab|0|||
150253546|NCT01163292|542063930|FG000|Overall Study|Economic reasons|6|||
150253547|NCT01163292|542063931|FG001|Overall Study|Economic reasons|0|||
150253548|NCT01163292|542063930|FG000|Overall Study|No further visits|5|||
150253549|NCT01163292|542063931|FG001|Overall Study|No further visits|7|||
150253550|NCT02535091|542063932|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
150253551|NCT02535091|542063933|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
150253552|NCT02535091|542063934|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
150253553|NCT02535091|542063932|FG000|Overall Study|Withdrawal by Subject|14|||
150253554|NCT02535091|542063933|FG001|Overall Study|Withdrawal by Subject|5|||
150253555|NCT02535091|542063934|FG002|Overall Study|Withdrawal by Subject|121|||
150253556|NCT02535091|542063932|FG000|Overall Study|Adverse Event|9|||
150253557|NCT02535091|542063933|FG001|Overall Study|Adverse Event|4|||
150253558|NCT02535091|542063934|FG002|Overall Study|Adverse Event|170|||
150253559|NCT02535091|542063932|FG000|Overall Study|Other|4|||
150253560|NCT02535091|542063933|FG001|Overall Study|Other|3|||
150253561|NCT02535091|542063934|FG002|Overall Study|Other|81|||
150253562|NCT02535091|542063932|FG000|Overall Study|Lost to Follow-up|0|||
150253563|NCT02535091|542063933|FG001|Overall Study|Lost to Follow-up|1|||
150253564|NCT02535091|542063934|FG002|Overall Study|Lost to Follow-up|19|||
150253565|NCT02535091|542063932|FG000|Overall Study|Protocol Violation|0|||
150253566|NCT02535091|542063933|FG001|Overall Study|Protocol Violation|1|||
150253567|NCT02535091|542063934|FG002|Overall Study|Protocol Violation|11|||
150253568|NCT02535091|542063932|FG000|Overall Study|Pregnancy|0|||
150253569|NCT02535091|542063933|FG001|Overall Study|Pregnancy|0|||
150253570|NCT02535091|542063934|FG002|Overall Study|Pregnancy|7|||
150253571|NCT03223662|542063945|FG000|Overall Study|Physician Decision|1|||
150253572|NCT03223662|542063945|FG000|Overall Study|Study closure|1|||
150253573|NCT01259089|542063946|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
150253574|NCT01259089|542063947|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
150253575|NCT01259089|542063948|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
150253576|NCT01259089|542063949|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
150253577|NCT01259089|542063950|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
150253578|NCT01259089|542063951|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
150253579|NCT01259089|542063946|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
150253580|NCT01259089|542063947|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
150253581|NCT01259089|542063948|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
150253582|NCT01259089|542063949|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
150253583|NCT01259089|542063950|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
150253584|NCT01259089|542063951|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
150253585|NCT01259089|542063946|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
150253586|NCT01259089|542063947|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
150253587|NCT01259089|542063948|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
150253588|NCT01259089|542063949|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
150253589|NCT01259089|542063950|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
150253590|NCT01259089|542063951|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
150253591|NCT01259089|542063946|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
150253592|NCT01259089|542063947|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
149730709|NCT03665285|540148917|FG007|Overall Study|Hospice|2|||
150253593|NCT01259089|542063948|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
150253594|NCT01259089|542063949|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
150253595|NCT01259089|542063950|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
150253596|NCT01259089|542063951|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
150253597|NCT01259089|542063946|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
150253598|NCT01259089|542063947|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
150253599|NCT01259089|542063948|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
150253600|NCT01259089|542063949|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
150253601|NCT01259089|542063950|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
150253602|NCT01259089|542063951|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
150253603|NCT01259089|542063946|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
150253604|NCT01259089|542063947|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
150253605|NCT01259089|542063948|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
150253606|NCT01259089|542063949|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
150253607|NCT01259089|542063950|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
150253608|NCT01259089|542063951|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
150253609|NCT01259089|542063946|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
150253610|NCT01259089|542063947|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
150253611|NCT01259089|542063948|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
150253612|NCT01259089|542063949|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
150253613|NCT01259089|542063950|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
150253614|NCT01259089|542063951|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
150253615|NCT01259089|542063946|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
150253616|NCT01259089|542063947|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
150253617|NCT01259089|542063948|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
150253618|NCT01259089|542063949|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
150253619|NCT01259089|542063950|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
150253620|NCT01259089|542063951|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
150253621|NCT01259089|542063946|FG000|Survival Follow up for Two Years|Death|3|||
150253622|NCT01259089|542063947|FG001|Survival Follow up for Two Years|Death|2|||
150253623|NCT01259089|542063948|FG002|Survival Follow up for Two Years|Death|2|||
150253624|NCT01259089|542063949|FG003|Survival Follow up for Two Years|Death|3|||
150253625|NCT01259089|542063950|FG004|Survival Follow up for Two Years|Death|6|||
150253626|NCT01259089|542063951|FG005|Survival Follow up for Two Years|Death|13|||
150253627|NCT01259089|542063946|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
150253628|NCT01259089|542063947|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
150253629|NCT01259089|542063948|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
150253630|NCT01259089|542063949|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
150253631|NCT01259089|542063950|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
150253632|NCT01259089|542063951|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
150253633|NCT01259089|542063946|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
150253634|NCT01259089|542063947|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
150253635|NCT01259089|542063948|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
150253636|NCT01259089|542063949|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
150253637|NCT01259089|542063950|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
150253638|NCT01259089|542063951|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
150253639|NCT01258595|542063952|FG000|Overall Study|Lost to Follow-up|1|||
150253640|NCT01258595|542063953|FG001|Overall Study|Lost to Follow-up|0|||
150253641|NCT01258595|542063952|FG000|Overall Study|Withdrawal by Subject|0|||
150253642|NCT01258595|542063953|FG001|Overall Study|Withdrawal by Subject|1|||
150253643|NCT01489891|542063956|FG000|Overall Study|Endoscopy failure|1|||
150253644|NCT01489891|542063957|FG001|Overall Study|Endoscopy failure|0|||
150253645|NCT00948766|542063958|FG000|Core Study|Adverse Event|73|||
150253646|NCT00948766|542063959|FG001|Core Study|Adverse Event|51|||
150253647|NCT00948766|542063958|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
150253648|NCT00948766|542063959|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
150253649|NCT00948766|542063958|FG000|Core Study|Patient Withdrew Consent|27|||
150253650|NCT00948766|542063959|FG001|Core Study|Patient Withdrew Consent|46|||
150253651|NCT00948766|542063958|FG000|Core Study|Lost to Follow-up|3|||
150253652|NCT00948766|542063959|FG001|Core Study|Lost to Follow-up|2|||
150253653|NCT00948766|542063958|FG000|Core Study|Administrative Problems|2|||
150253654|NCT00948766|542063959|FG001|Core Study|Administrative Problems|2|||
150253655|NCT00948766|542063958|FG000|Core Study|Death|1|||
150253656|NCT00948766|542063959|FG001|Core Study|Death|1|||
150253657|NCT00948766|542063958|FG000|Core Study|Protocol Deviation|8|||
150253658|NCT00948766|542063959|FG001|Core Study|Protocol Deviation|10|||
150253659|NCT00948766|542063958|FG000|Extension Study|Adverse Event|43|||
150253660|NCT00948766|542063959|FG001|Extension Study|Adverse Event|0|||
150253661|NCT00948766|542063958|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
150253662|NCT00948766|542063959|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
150253663|NCT00948766|542063958|FG000|Extension Study|Study Drug No Longer Required|1|||
150253664|NCT00948766|542063959|FG001|Extension Study|Study Drug No Longer Required|0|||
150253665|NCT00948766|542063958|FG000|Extension Study|Patient Withdrew Consent|32|||
150253666|NCT00948766|542063959|FG001|Extension Study|Patient Withdrew Consent|0|||
150253667|NCT00948766|542063958|FG000|Extension Study|Lost to Follow-up|8|||
150253668|NCT00948766|542063959|FG001|Extension Study|Lost to Follow-up|0|||
149730710|NCT03665285|540148918|FG008|Overall Study|Hospice|0|||
149730711|NCT03665285|540148910|FG000|Overall Study|Withdrawal by Subject|0|||
149730712|NCT03665285|540148911|FG001|Overall Study|Withdrawal by Subject|0|||
149730713|NCT03665285|540148912|FG002|Overall Study|Withdrawal by Subject|0|||
149730714|NCT03665285|540148913|FG003|Overall Study|Withdrawal by Subject|0|||
149730715|NCT03665285|540148914|FG004|Overall Study|Withdrawal by Subject|1|||
149730716|NCT03665285|540148915|FG005|Overall Study|Withdrawal by Subject|0|||
149730717|NCT03665285|540148916|FG006|Overall Study|Withdrawal by Subject|0|||
149730718|NCT03665285|540148917|FG007|Overall Study|Withdrawal by Subject|2|||
149730719|NCT03665285|540148918|FG008|Overall Study|Withdrawal by Subject|0|||
149730720|NCT03665285|540148910|FG000|Overall Study|Physician Decision|0|||
149730721|NCT03665285|540148911|FG001|Overall Study|Physician Decision|0|||
149730722|NCT03665285|540148912|FG002|Overall Study|Physician Decision|0|||
149730723|NCT03665285|540148913|FG003|Overall Study|Physician Decision|0|||
149730724|NCT03665285|540148914|FG004|Overall Study|Physician Decision|0|||
149730725|NCT03665285|540148915|FG005|Overall Study|Physician Decision|0|||
149730726|NCT03665285|540148916|FG006|Overall Study|Physician Decision|0|||
149730727|NCT03665285|540148917|FG007|Overall Study|Physician Decision|2|||
149730728|NCT03665285|540148918|FG008|Overall Study|Physician Decision|0|||
149730729|NCT00354601|540148919|FG000|Overall Study|Protocol Violation|1|||
149730730|NCT00354601|540148919|FG000|Overall Study|progression|1|||
149730731|NCT03603652|540148920|FG000|Overall Study|Death|2|||
149730732|NCT02058147|540148921|FG000|Overall Study|Randomized but not treated|0|||
149730733|NCT02058147|540148922|FG001|Overall Study|Randomized but not treated|0|||
149730734|NCT02058147|540148923|FG002|Overall Study|Randomized but not treated|1|||
149730735|NCT02058147|540148921|FG000|Overall Study|Adverse Event|12|||
149730736|NCT02058147|540148922|FG001|Overall Study|Adverse Event|9|||
149730737|NCT02058147|540148923|FG002|Overall Study|Adverse Event|21|||
149730738|NCT02058147|540148921|FG000|Overall Study|Lack of Efficacy|1|||
149730739|NCT02058147|540148922|FG001|Overall Study|Lack of Efficacy|0|||
149730740|NCT02058147|540148923|FG002|Overall Study|Lack of Efficacy|3|||
149730741|NCT02058147|540148921|FG000|Overall Study|Poor compliance to protocol|8|||
149730742|NCT02058147|540148922|FG001|Overall Study|Poor compliance to protocol|9|||
149730743|NCT02058147|540148923|FG002|Overall Study|Poor compliance to protocol|4|||
149730744|NCT02058147|540148921|FG000|Overall Study|Other than specified|8|||
149730745|NCT02058147|540148922|FG001|Overall Study|Other than specified|9|||
149730746|NCT02058147|540148923|FG002|Overall Study|Other than specified|0|||
149730747|NCT01486199|540148926|FG000|Two Year Period Between Study Days|Physician Decision|1|||
149730748|NCT01486199|540148927|FG001|Two Year Period Between Study Days|Physician Decision|0|||
149730749|NCT00130286|540148931|FG000|Overall Study|Withdrawal by Subject|0|||
149730750|NCT00130286|540148932|FG001|Overall Study|Withdrawal by Subject|1|||
149730751|NCT00130286|540148933|FG002|Overall Study|Withdrawal by Subject|2|||
149730752|NCT00130286|540148934|FG003|Overall Study|Withdrawal by Subject|2|||
149730753|NCT00130286|540148931|FG000|Overall Study|Adverse Event|0|||
149730754|NCT00130286|540148932|FG001|Overall Study|Adverse Event|0|||
149730755|NCT00130286|540148933|FG002|Overall Study|Adverse Event|2|||
149730756|NCT00130286|540148934|FG003|Overall Study|Adverse Event|0|||
149730757|NCT00130286|540148931|FG000|Overall Study|Missing lab specimens|0|||
149730758|NCT00130286|540148932|FG001|Overall Study|Missing lab specimens|2|||
149730759|NCT00130286|540148933|FG002|Overall Study|Missing lab specimens|0|||
149730760|NCT00130286|540148934|FG003|Overall Study|Missing lab specimens|0|||
149730761|NCT03604445|540148935|FG000|Overall Study|Death|0|||
149730762|NCT03604445|540148936|FG001|Overall Study|Death|0|||
149730763|NCT03604445|540148937|FG002|Overall Study|Death|0|||
149730764|NCT03604445|540148938|FG003|Overall Study|Death|0|||
149730765|NCT03604445|540148939|FG004|Overall Study|Death|0|||
149730766|NCT03604445|540148940|FG005|Overall Study|Death|0|||
149730767|NCT03604445|540148941|FG006|Overall Study|Death|0|||
149730768|NCT03604445|540148942|FG007|Overall Study|Death|0|||
149730769|NCT03604445|540148943|FG008|Overall Study|Death|1|||
149730770|NCT03604445|540148935|FG000|Overall Study|Withdrawal by Subject|0|||
149730771|NCT03604445|540148936|FG001|Overall Study|Withdrawal by Subject|0|||
149730772|NCT03604445|540148937|FG002|Overall Study|Withdrawal by Subject|0|||
149730773|NCT03604445|540148938|FG003|Overall Study|Withdrawal by Subject|0|||
149730774|NCT03604445|540148939|FG004|Overall Study|Withdrawal by Subject|0|||
149730775|NCT03604445|540148940|FG005|Overall Study|Withdrawal by Subject|0|||
149730776|NCT03604445|540148941|FG006|Overall Study|Withdrawal by Subject|1|||
149730777|NCT03604445|540148942|FG007|Overall Study|Withdrawal by Subject|0|||
149730778|NCT03604445|540148943|FG008|Overall Study|Withdrawal by Subject|0|||
149730779|NCT03604445|540148935|FG000|Overall Study|Missing visit|0|||
149730780|NCT03604445|540148936|FG001|Overall Study|Missing visit|0|||
149730781|NCT03604445|540148937|FG002|Overall Study|Missing visit|0|||
149730782|NCT03604445|540148938|FG003|Overall Study|Missing visit|0|||
149730783|NCT03604445|540148939|FG004|Overall Study|Missing visit|0|||
149730784|NCT03604445|540148940|FG005|Overall Study|Missing visit|1|||
149730785|NCT03604445|540148941|FG006|Overall Study|Missing visit|0|||
149730786|NCT03604445|540148942|FG007|Overall Study|Missing visit|1|||
149730787|NCT03604445|540148943|FG008|Overall Study|Missing visit|0|||
149730788|NCT03604445|540148935|FG000|Overall Study|Adverse Event|0|||
149730789|NCT03604445|540148936|FG001|Overall Study|Adverse Event|0|||
149730790|NCT03604445|540148937|FG002|Overall Study|Adverse Event|0|||
149730791|NCT03604445|540148938|FG003|Overall Study|Adverse Event|1|||
149730792|NCT03604445|540148939|FG004|Overall Study|Adverse Event|0|||
149730793|NCT03604445|540148940|FG005|Overall Study|Adverse Event|0|||
149730794|NCT03604445|540148941|FG006|Overall Study|Adverse Event|0|||
149730795|NCT03604445|540148942|FG007|Overall Study|Adverse Event|0|||
149730796|NCT03604445|540148943|FG008|Overall Study|Adverse Event|1|||
149730797|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
149730798|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
149730799|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
149730800|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
149730801|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
149730802|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149730803|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149730804|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149730805|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
149730806|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149730807|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149730808|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149730809|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
149730810|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149730811|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149730812|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149730813|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
149730814|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149730815|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149730816|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149730817|NCT01360645|540148944|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
149730818|NCT01360645|540148945|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149730819|NCT01360645|540148946|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149730820|NCT01360645|540148947|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149730821|NCT01360645|540148944|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
149730822|NCT01360645|540148945|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
149730823|NCT01360645|540148946|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
149730824|NCT01360645|540148947|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
149730825|NCT01360645|540148944|FG000|Phase B (6 Weeks)|Adverse Event|0|||
149730826|NCT01360645|540148945|FG001|Phase B (6 Weeks)|Adverse Event|6|||
149730827|NCT01360645|540148946|FG002|Phase B (6 Weeks)|Adverse Event|0|||
149730828|NCT01360645|540148947|FG003|Phase B (6 Weeks)|Adverse Event|0|||
149730829|NCT01360645|540148944|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149730830|NCT01360645|540148945|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
149730831|NCT01360645|540148946|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
149730832|NCT01360645|540148947|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149730833|NCT01360645|540148944|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149730834|NCT01360645|540148945|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
149730835|NCT01360645|540148946|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
149730836|NCT01360645|540148947|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149730837|NCT01360645|540148944|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
149730838|NCT01360645|540148945|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
149730839|NCT01360645|540148946|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
149730840|NCT01360645|540148947|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
149730841|NCT01360645|540148944|FG000|Phase A+|Lost to Follow-up|0|||
149730842|NCT01360645|540148945|FG001|Phase A+|Lost to Follow-up|0|||
149730843|NCT01360645|540148946|FG002|Phase A+|Lost to Follow-up|0|||
149730844|NCT01360645|540148947|FG003|Phase A+|Lost to Follow-up|7|||
149730845|NCT01360645|540148944|FG000|Phase A+|Adverse Event|0|||
149730846|NCT01360645|540148945|FG001|Phase A+|Adverse Event|0|||
149730847|NCT01360645|540148946|FG002|Phase A+|Adverse Event|0|||
149730848|NCT01360645|540148947|FG003|Phase A+|Adverse Event|2|||
149730849|NCT01360645|540148944|FG000|Phase A+|Met Withdrawal Criteria|0|||
149730850|NCT01360645|540148945|FG001|Phase A+|Met Withdrawal Criteria|0|||
149730851|NCT01360645|540148946|FG002|Phase A+|Met Withdrawal Criteria|0|||
149730852|NCT01360645|540148947|FG003|Phase A+|Met Withdrawal Criteria|4|||
149730853|NCT01360645|540148944|FG000|Phase A+|Physician Decision|0|||
149730854|NCT01360645|540148945|FG001|Phase A+|Physician Decision|0|||
149730855|NCT01360645|540148946|FG002|Phase A+|Physician Decision|0|||
149730856|NCT01360645|540148947|FG003|Phase A+|Physician Decision|2|||
149730857|NCT01360645|540148944|FG000|Phase A+|Withdrawal by Subject|0|||
149730858|NCT01360645|540148945|FG001|Phase A+|Withdrawal by Subject|0|||
149730859|NCT01360645|540148946|FG002|Phase A+|Withdrawal by Subject|0|||
149730860|NCT01360645|540148947|FG003|Phase A+|Withdrawal by Subject|5|||
149730861|NCT01360645|540148944|FG000|Phase A+|Protocol Deviation|0|||
149730862|NCT01360645|540148945|FG001|Phase A+|Protocol Deviation|0|||
149730863|NCT01360645|540148946|FG002|Phase A+|Protocol Deviation|0|||
149730864|NCT01360645|540148947|FG003|Phase A+|Protocol Deviation|4|||
149730865|NCT00773279|540148948|FG000|Period 1|Adverse Event|2|||
149730866|NCT00773279|540148949|FG001|Period 1|Adverse Event|1|||
149730867|NCT00773279|540148948|FG000|Period 1|Lack of Efficacy|0|||
149730868|NCT00773279|540148949|FG001|Period 1|Lack of Efficacy|2|||
149730869|NCT00773279|540148948|FG000|Period 1|Unclassified|5|||
149730870|NCT00773279|540148949|FG001|Period 1|Unclassified|1|||
149730871|NCT00773279|540148948|FG000|Period 2|Adverse Event|0|||
149730872|NCT00773279|540148949|FG001|Period 2|Adverse Event|1|||
149730873|NCT00773279|540148948|FG000|Period 2|Lack of Efficacy|1|||
149730874|NCT00773279|540148949|FG001|Period 2|Lack of Efficacy|0|||
149730875|NCT00773279|540148948|FG000|Period 2|Protocol Violation|0|||
149730876|NCT00773279|540148949|FG001|Period 2|Protocol Violation|3|||
149730877|NCT00773279|540148948|FG000|Period 2|Unclassified|2|||
149730878|NCT00773279|540148949|FG001|Period 2|Unclassified|2|||
149730879|NCT00611247|540148954|FG000|Overall Study|Death|1|||
149730880|NCT00611247|540148955|FG001|Overall Study|Death|5|||
149730881|NCT00611247|540148954|FG000|Overall Study|Lack of Efficacy|1|||
149730882|NCT00611247|540148955|FG001|Overall Study|Lack of Efficacy|16|||
149730883|NCT01890421|540148956|FG000|Overall Study|Adverse Event|1|||
149730884|NCT01890421|540148956|FG000|Overall Study|Other reason|10|||
149730885|NCT03969888|540148958|FG000|Overall Study|Never Received Study Drug|0|||
149730886|NCT03969888|540148959|FG001|Overall Study|Never Received Study Drug|0|||
149730887|NCT03969888|540148960|FG002|Overall Study|Never Received Study Drug|1|||
149730888|NCT03969888|540148961|FG003|Overall Study|Never Received Study Drug|0|||
149730889|NCT03969888|540148962|FG004|Overall Study|Never Received Study Drug|0|||
149730890|NCT03969888|540148963|FG005|Overall Study|Never Received Study Drug|0|||
149730891|NCT03969888|540148964|FG006|Overall Study|Never Received Study Drug|1|||
149730892|NCT03969888|540148965|FG007|Overall Study|Never Received Study Drug|0|||
149730893|NCT03969888|540148958|FG000|Overall Study|Reason Not Specified|0|||
149730894|NCT03969888|540148959|FG001|Overall Study|Reason Not Specified|0|||
149730895|NCT03969888|540148960|FG002|Overall Study|Reason Not Specified|0|||
149730896|NCT03969888|540148961|FG003|Overall Study|Reason Not Specified|0|||
149730897|NCT03969888|540148962|FG004|Overall Study|Reason Not Specified|0|||
150253669|NCT00948766|542063958|FG000|Extension Study|Administrative Problems|1|||
150253670|NCT00948766|542063959|FG001|Extension Study|Administrative Problems|0|||
150253671|NCT00948766|542063958|FG000|Extension Study|Death|4|||
149730898|NCT03969888|540148963|FG005|Overall Study|Reason Not Specified|0|||
149730899|NCT03969888|540148964|FG006|Overall Study|Reason Not Specified|0|||
149730900|NCT03969888|540148965|FG007|Overall Study|Reason Not Specified|1|||
149730901|NCT00946309|540148968|FG000|Overall Study|Protocol Violation|1|||
150253672|NCT00948766|542063959|FG001|Extension Study|Death|0|||
149730902|NCT00946309|540148969|FG001|Overall Study|Protocol Violation|0|||
149730903|NCT00946309|540148968|FG000|Overall Study|Lost to Follow-up|0|||
150253673|NCT01036438|542063960|FG000|Overall Study|Adverse Event|7|||
150253674|NCT01036438|542063961|FG001|Overall Study|Adverse Event|8|||
150253675|NCT01036438|542063960|FG000|Overall Study|Death|0|||
150253676|NCT01036438|542063961|FG001|Overall Study|Death|1|||
150253677|NCT01036438|542063960|FG000|Overall Study|No effect of study treatment|3|||
150253678|NCT01036438|542063961|FG001|Overall Study|No effect of study treatment|1|||
150253679|NCT00777088|542063962|FG000|Overall Study|PED Treatment not attempted|1|||
150253680|NCT01278173|542063963|FG000|Overall Study|Lack of Efficacy|13|||
150253681|NCT01278173|542063963|FG000|Overall Study|Adverse Event|8|||
150253682|NCT01278173|542063963|FG000|Overall Study|Administrative or other reason|4|||
150253683|NCT01278173|542063963|FG000|Overall Study|Protocol Violation|1|||
150253684|NCT01278173|542063963|FG000|Overall Study|Withdrawal by Subject|1|||
150253685|NCT03592745|542063964|FG000|Overall Study|Adverse Event|0|||
149730904|NCT00946309|540148969|FG001|Overall Study|Lost to Follow-up|1|||
149730905|NCT00946309|540148968|FG000|Overall Study|Procedure cancelled/discontinued|0|||
149730906|NCT00946309|540148969|FG001|Overall Study|Procedure cancelled/discontinued|3|||
149730907|NCT00428597|540148975|FG000|Overall Study|Randomized but not treated|3|||
149730908|NCT00428597|540148976|FG001|Overall Study|Randomized but not treated|3|||
149730909|NCT00428597|540148975|FG000|Overall Study|Objective Progression or Relapse|19|||
149730910|NCT00428597|540148976|FG001|Overall Study|Objective Progression or Relapse|47|||
149730911|NCT00428597|540148975|FG000|Overall Study|Study Terminated by Sponsor|41|||
149730912|NCT00428597|540148976|FG001|Overall Study|Study Terminated by Sponsor|16|||
149730913|NCT00428597|540148975|FG000|Overall Study|Adverse Event|15|||
149730914|NCT00428597|540148976|FG001|Overall Study|Adverse Event|7|||
149730915|NCT00428597|540148975|FG000|Overall Study|Global Deterioration of Health Status|1|||
149730916|NCT00428597|540148976|FG001|Overall Study|Global Deterioration of Health Status|5|||
149730917|NCT00428597|540148975|FG000|Overall Study|Protocol Violation|2|||
149730918|NCT00428597|540148976|FG001|Overall Study|Protocol Violation|1|||
149730919|NCT00428597|540148975|FG000|Overall Study|Withdrawal by Subject|2|||
149730920|NCT00428597|540148976|FG001|Overall Study|Withdrawal by Subject|1|||
149730921|NCT00428597|540148975|FG000|Overall Study|Other|1|||
149730922|NCT00428597|540148976|FG001|Overall Study|Other|1|||
149730923|NCT00428597|540148975|FG000|Overall Study|Lost to Follow-up|0|||
149730924|NCT00428597|540148976|FG001|Overall Study|Lost to Follow-up|1|||
149730925|NCT00428597|540148975|FG000|Overall Study|Pregnancy|1|||
149730926|NCT00428597|540148976|FG001|Overall Study|Pregnancy|0|||
149730927|NCT00428597|540148975|FG000|Overall Study|Death|1|||
149730928|NCT00428597|540148976|FG001|Overall Study|Death|3|||
149730929|NCT02447848|540148977|FG000|Overall Study|Patient discharged|3|||
149730930|NCT02447848|540148977|FG000|Overall Study|Lack of Efficacy|4|||
149730931|NCT02447848|540148977|FG000|Overall Study|Withdrawal by Subject|4|||
149730932|NCT02307370|540148978|FG000|Overall Study|Death|5|||
149730933|NCT02307370|540148978|FG000|Overall Study|Lost to Follow-up|1|||
149730934|NCT02307370|540148978|FG000|Overall Study|Withdrawal by Subject|1|||
149730935|NCT02307370|540148978|FG000|Overall Study|Declined Addendum ICF|6|||
149730936|NCT02307370|540148978|FG000|Overall Study|No response during telephone contact|5|||
149730937|NCT02307370|540148978|FG000|Overall Study|Protocol Violation|1|||
149730938|NCT01506882|540148979|FG000|Overall Study|Lack of Efficacy|4|||
149730939|NCT01506882|540148980|FG001|Overall Study|Lack of Efficacy|3|||
149730940|NCT01506882|540148979|FG000|Overall Study|Lost to Follow-up|1|||
149730941|NCT01506882|540148980|FG001|Overall Study|Lost to Follow-up|0|||
149730942|NCT01506882|540148979|FG000|Overall Study|Withdrawal by Subject|9|||
149730943|NCT01506882|540148980|FG001|Overall Study|Withdrawal by Subject|3|||
149730944|NCT01506882|540148979|FG000|Overall Study|SAE, non-fatal|2|||
149730945|NCT01506882|540148980|FG001|Overall Study|SAE, non-fatal|0|||
149730946|NCT01506882|540148979|FG000|Overall Study|AE, non-serious non-fatal|3|||
149730947|NCT01506882|540148980|FG001|Overall Study|AE, non-serious non-fatal|1|||
149730948|NCT01506882|540148979|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
149730949|NCT01506882|540148980|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
149730950|NCT01506882|540148979|FG000|Overall Study|Other Reason|2|||
149730951|NCT01506882|540148980|FG001|Overall Study|Other Reason|0|||
149730952|NCT00667576|540150941|FG000|Overall Study|Withdrawal by Subject|1|||
149730953|NCT00667576|540150942|FG001|Overall Study|Withdrawal by Subject|0|||
149730954|NCT00667576|540150943|FG002|Overall Study|Withdrawal by Subject|1|||
149730955|NCT00667576|540150944|FG003|Overall Study|Withdrawal by Subject|1|||
149730956|NCT00667576|540150945|FG004|Overall Study|Withdrawal by Subject|1|||
149730957|NCT00667576|540150941|FG000|Overall Study|Adverse Event|1|||
149730958|NCT00667576|540150942|FG001|Overall Study|Adverse Event|1|||
149730959|NCT00667576|540150943|FG002|Overall Study|Adverse Event|0|||
149730960|NCT00667576|540150944|FG003|Overall Study|Adverse Event|0|||
149730961|NCT00667576|540150945|FG004|Overall Study|Adverse Event|0|||
149730962|NCT00667576|540150941|FG000|Overall Study|Lost to Follow-up|0|||
149730963|NCT00667576|540150942|FG001|Overall Study|Lost to Follow-up|0|||
149730964|NCT00667576|540150943|FG002|Overall Study|Lost to Follow-up|1|||
149730965|NCT00667576|540150944|FG003|Overall Study|Lost to Follow-up|0|||
149730966|NCT00667576|540150945|FG004|Overall Study|Lost to Follow-up|0|||
149730967|NCT00667576|540150941|FG000|Overall Study|Protocol Violation|0|||
149730968|NCT00667576|540150942|FG001|Overall Study|Protocol Violation|0|||
149730969|NCT00667576|540150943|FG002|Overall Study|Protocol Violation|0|||
149730970|NCT00667576|540150944|FG003|Overall Study|Protocol Violation|1|||
149730971|NCT00667576|540150945|FG004|Overall Study|Protocol Violation|0|||
149730972|NCT00667576|540150941|FG000|Overall Study|Physician Decision|0|||
149730973|NCT00667576|540150942|FG001|Overall Study|Physician Decision|0|||
149730974|NCT00667576|540150943|FG002|Overall Study|Physician Decision|0|||
149730975|NCT00667576|540150944|FG003|Overall Study|Physician Decision|1|||
149730976|NCT00667576|540150945|FG004|Overall Study|Physician Decision|0|||
149730977|NCT00667576|540150941|FG000|Overall Study|Missed Visit|0|||
149730978|NCT00667576|540150942|FG001|Overall Study|Missed Visit|0|||
149730979|NCT00667576|540150943|FG002|Overall Study|Missed Visit|0|||
149730980|NCT00667576|540150944|FG003|Overall Study|Missed Visit|1|||
149730981|NCT00667576|540150945|FG004|Overall Study|Missed Visit|0|||
149730982|NCT00778830|540150949|FG000|Overall Study|Ongoing at data cut-off|0|||
149730983|NCT00778830|540150950|FG001|Overall Study|Ongoing at data cut-off|1|||
149730984|NCT01891643|540150951|FG000|Overall Study|Adverse event unrelated to study drug|2|||
149730985|NCT01891643|540150952|FG001|Overall Study|Adverse event unrelated to study drug|5|||
149730986|NCT01891643|540150951|FG000|Overall Study|Disease Progression|4|||
149730987|NCT01891643|540150952|FG001|Overall Study|Disease Progression|3|||
149730988|NCT01891643|540150951|FG000|Overall Study|Study Drug Toxicity|3|||
149730989|NCT01891643|540150952|FG001|Overall Study|Study Drug Toxicity|0|||
149730990|NCT01891643|540150951|FG000|Overall Study|Maximum Clinical Benefit|0|||
149730991|NCT01891643|540150952|FG001|Overall Study|Maximum Clinical Benefit|1|||
149730992|NCT01891643|540150951|FG000|Overall Study|Poor/Non-compliance|0|||
149730993|NCT01891643|540150952|FG001|Overall Study|Poor/Non-compliance|1|||
149730994|NCT01891643|540150951|FG000|Overall Study|Participant request to discontinue|1|||
149730995|NCT01891643|540150952|FG001|Overall Study|Participant request to discontinue|0|||
149730996|NCT01307033|540150956|FG000|8-week Double-blind Period|Adverse Event|2|||
149730997|NCT01307033|540150957|FG001|8-week Double-blind Period|Adverse Event|0|||
149730998|NCT01307033|540150958|FG002|8-week Double-blind Period|Adverse Event|0|||
149730999|NCT01307033|540150959|FG003|8-week Double-blind Period|Adverse Event|0|||
149731000|NCT01307033|540150956|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
149731001|NCT01307033|540150957|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
149731002|NCT01307033|540150958|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
149731003|NCT01307033|540150959|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
149731004|NCT01307033|540150956|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
149731005|NCT01307033|540150957|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
149731006|NCT01307033|540150958|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
149731007|NCT01307033|540150959|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
149731008|NCT01307033|540150956|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
149731009|NCT01307033|540150957|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
149731010|NCT01307033|540150958|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
149731011|NCT01307033|540150959|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
149731012|NCT01307033|540150956|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
149731013|NCT01307033|540150957|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
149731014|NCT01307033|540150958|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
149731015|NCT01307033|540150959|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
149731016|NCT01307033|540150956|FG000|44-week Open-label Extension|Adverse Event|0|||
149731017|NCT01307033|540150957|FG001|44-week Open-label Extension|Adverse Event|0|||
149731018|NCT01307033|540150958|FG002|44-week Open-label Extension|Adverse Event|2|||
149731019|NCT01307033|540150959|FG003|44-week Open-label Extension|Adverse Event|1|||
149731020|NCT01307033|540150956|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
149731021|NCT01307033|540150957|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
149731022|NCT01307033|540150958|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
149731023|NCT01307033|540150959|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
149731024|NCT01307033|540150956|FG000|44-week Open-label Extension|Physician Decision|0|||
149731025|NCT01307033|540150957|FG001|44-week Open-label Extension|Physician Decision|0|||
149731026|NCT01307033|540150958|FG002|44-week Open-label Extension|Physician Decision|1|||
149731027|NCT01307033|540150959|FG003|44-week Open-label Extension|Physician Decision|0|||
149731028|NCT01307033|540150956|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149731029|NCT01307033|540150957|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149731030|NCT01307033|540150958|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149731031|NCT01307033|540150959|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
149731032|NCT01307033|540150956|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
149731033|NCT01307033|540150957|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
149731034|NCT01307033|540150958|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
149731035|NCT01307033|540150959|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
149731036|NCT01307033|540150956|FG000|44-week Open-label Extension|Death|0|||
149731037|NCT01307033|540150957|FG001|44-week Open-label Extension|Death|0|||
149731038|NCT01307033|540150958|FG002|44-week Open-label Extension|Death|0|||
149731039|NCT01307033|540150959|FG003|44-week Open-label Extension|Death|1|||
149731040|NCT01400932|540150962|FG000|Overall Study|Adverse Event|10|||
149731041|NCT01400932|540150963|FG001|Overall Study|Adverse Event|5|||
149731042|NCT01400932|540150962|FG000|Overall Study|Lack of Efficacy|0|||
149731043|NCT01400932|540150963|FG001|Overall Study|Lack of Efficacy|3|||
149731044|NCT01400932|540150962|FG000|Overall Study|Withdrawal by Subject|2|||
149731045|NCT01400932|540150963|FG001|Overall Study|Withdrawal by Subject|6|||
149731046|NCT01400932|540150962|FG000|Overall Study|Lost to Follow-up|1|||
149731047|NCT01400932|540150963|FG001|Overall Study|Lost to Follow-up|0|||
149731048|NCT01400932|540150962|FG000|Overall Study|Protocol Deviation|0|||
149731049|NCT01400932|540150963|FG001|Overall Study|Protocol Deviation|1|||
149731050|NCT01400932|540150962|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149731051|NCT01400932|540150963|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149731052|NCT00860158|540150964|FG000|Overall Study|Study Terminated|1|||
149731053|NCT04656990|540150965|FG000|Baseline|pandemic|20|||
149731054|NCT04656990|540150966|FG001|Baseline|pandemic|24|||
149731055|NCT04656990|540150965|FG000|Follow Up Period|Lost to Follow-up|61|||
149731056|NCT04656990|540150966|FG001|Follow Up Period|Lost to Follow-up|73|||
149731057|NCT03244059|540150967|FG000|Specific Aim 1|Physician Decision|1|||
149731058|NCT03244059|540150968|FG001|Specific Aim 1|Physician Decision|0|||
149731059|NCT03244059|540150967|FG000|Specific Aim 2|Physician Decision|1|||
149731060|NCT03244059|540150968|FG001|Specific Aim 2|Physician Decision|0|||
149731061|NCT05499520|540150970|FG000|Overall Study|Lost to Follow-up|0|||
149731062|NCT05499520|540150971|FG001|Overall Study|Lost to Follow-up|0|||
149731063|NCT05499520|540150972|FG002|Overall Study|Lost to Follow-up|38|||
149731064|NCT05499520|540150973|FG003|Overall Study|Lost to Follow-up|41|||
149731065|NCT05499520|540150974|FG004|Overall Study|Lost to Follow-up|46|||
149731066|NCT05499520|540150975|FG005|Overall Study|Lost to Follow-up|0|||
149731067|NCT05499520|540150976|FG006|Overall Study|Lost to Follow-up|31|||
149731068|NCT05499520|540150977|FG007|Overall Study|Lost to Follow-up|45|||
149731069|NCT05499520|540150978|FG008|Overall Study|Lost to Follow-up|42|||
149731070|NCT05499520|540150979|FG009|Overall Study|Lost to Follow-up|0|||
149731071|NCT05499520|540150980|FG010|Overall Study|Lost to Follow-up|0|||
149731072|NCT05499520|540150981|FG011|Overall Study|Lost to Follow-up|37|||
149731073|NCT05499520|540150982|FG012|Overall Study|Lost to Follow-up|53|||
149731074|NCT05499520|540150983|FG013|Overall Study|Lost to Follow-up|49|||
149731075|NCT05499520|540150984|FG014|Overall Study|Lost to Follow-up|0|||
149731076|NCT05499520|540150985|FG015|Overall Study|Lost to Follow-up|36|||
149731077|NCT05499520|540150986|FG016|Overall Study|Lost to Follow-up|58|||
149731078|NCT05499520|540150987|FG017|Overall Study|Lost to Follow-up|53|||
149731079|NCT00282243|540150988|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
149731080|NCT00282243|540150988|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
149731081|NCT00282243|540150988|FG000|Extension Treatment Period|Adverse Event|15|||
149731082|NCT00282243|540150988|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
149731083|NCT00282243|540150988|FG000|Extension Treatment Period|Non-compliance|2|||
149731084|NCT00282243|540150988|FG000|Extension Treatment Period|Physician Decision|1|||
149731085|NCT00686127|540150989|FG000|Overall Study|Withdrawal by Subject|14|||
149731086|NCT00686127|540150990|FG001|Overall Study|Withdrawal by Subject|6|||
149731087|NCT03588741|540150993|FG000|Overall Study|Withdrawal by Subject|1|||
149731088|NCT02487108|540150995|FG000|Overall Study|Adverse Event|1|||
149731089|NCT02487108|540150996|FG001|Overall Study|Adverse Event|6|||
149731090|NCT02487108|540150997|FG002|Overall Study|Adverse Event|12|||
149731091|NCT02487108|540150998|FG003|Overall Study|Adverse Event|6|||
149731092|NCT02487108|540150995|FG000|Overall Study|Withdrawal by Subject|8|||
149731093|NCT02487108|540150996|FG001|Overall Study|Withdrawal by Subject|5|||
149731094|NCT02487108|540150997|FG002|Overall Study|Withdrawal by Subject|5|||
149731095|NCT02487108|540150998|FG003|Overall Study|Withdrawal by Subject|0|||
149731096|NCT02487108|540150995|FG000|Overall Study|Non-compliance to study medication|3|||
149731097|NCT02487108|540150996|FG001|Overall Study|Non-compliance to study medication|2|||
149731098|NCT02487108|540150997|FG002|Overall Study|Non-compliance to study medication|5|||
149731099|NCT02487108|540150998|FG003|Overall Study|Non-compliance to study medication|4|||
149731100|NCT02487108|540150995|FG000|Overall Study|Protocol Violation|1|||
149731101|NCT02487108|540150996|FG001|Overall Study|Protocol Violation|1|||
149731102|NCT02487108|540150997|FG002|Overall Study|Protocol Violation|2|||
149731103|NCT02487108|540150998|FG003|Overall Study|Protocol Violation|0|||
149731104|NCT02487108|540150995|FG000|Overall Study|Non-compliance to study procedures|0|||
149731105|NCT02487108|540150996|FG001|Overall Study|Non-compliance to study procedures|0|||
149731106|NCT02487108|540150997|FG002|Overall Study|Non-compliance to study procedures|0|||
149731107|NCT02487108|540150998|FG003|Overall Study|Non-compliance to study procedures|1|||
149731108|NCT02487108|540150995|FG000|Overall Study|Other than specified|3|||
149731109|NCT02487108|540150996|FG001|Overall Study|Other than specified|2|||
149731110|NCT02487108|540150997|FG002|Overall Study|Other than specified|2|||
149731111|NCT02487108|540150998|FG003|Overall Study|Other than specified|0|||
149731112|NCT00883493|540150999|FG000|Overall Study|Adverse Event|11|||
149731113|NCT00883493|540151000|FG001|Overall Study|Adverse Event|12|||
149731114|NCT00883493|540150999|FG000|Overall Study|Lack of Efficacy|4|||
149731115|NCT00883493|540151000|FG001|Overall Study|Lack of Efficacy|3|||
149731116|NCT00883493|540150999|FG000|Overall Study|Lost to Follow-up|7|||
149731117|NCT00883493|540151000|FG001|Overall Study|Lost to Follow-up|6|||
149731118|NCT00883493|540150999|FG000|Overall Study|Withdrawal by Subject|11|||
149731119|NCT00883493|540151000|FG001|Overall Study|Withdrawal by Subject|20|||
149731120|NCT00883493|540150999|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
149731121|NCT00883493|540151000|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
149731122|NCT00883493|540150999|FG000|Overall Study|Study specific disc. criteria|2|||
149731123|NCT00883493|540151000|FG001|Overall Study|Study specific disc. criteria|0|||
149731124|NCT00883493|540150999|FG000|Overall Study|Other|5|||
149731125|NCT00883493|540151000|FG001|Overall Study|Other|3|||
149731126|NCT00400400|540151001|FG000|Overall Study|Adverse Event|9|||
149731127|NCT00400400|540151002|FG001|Overall Study|Adverse Event|8|||
149731128|NCT00400400|540151001|FG000|Overall Study|Protocol Violation|2|||
149731129|NCT00400400|540151002|FG001|Overall Study|Protocol Violation|0|||
149731130|NCT00400400|540151001|FG000|Overall Study|Withdrawal by Subject|1|||
149731131|NCT00400400|540151002|FG001|Overall Study|Withdrawal by Subject|3|||
149731132|NCT00400400|540151001|FG000|Overall Study|Administrative Problem|1|||
149731133|NCT00400400|540151002|FG001|Overall Study|Administrative Problem|0|||
149731134|NCT00400400|540151001|FG000|Overall Study|Lost to Follow-up|0|||
149731135|NCT00400400|540151002|FG001|Overall Study|Lost to Follow-up|1|||
149731136|NCT00400400|540151001|FG000|Overall Study|Did not receive study drug|1|||
149731137|NCT00400400|540151002|FG001|Overall Study|Did not receive study drug|3|||
149731138|NCT00648167|540151003|FG000|Overall Study|Adverse Event|6|||
149731139|NCT00648167|540151003|FG000|Overall Study|unable to swallow tablets|1|||
149731140|NCT01688050|540151004|FG000|Overall Study|Death|7|||
149731141|NCT01688050|540151004|FG000|Overall Study|Conversion to open repair|1|||
149731142|NCT01688050|540151004|FG000|Overall Study|Lost to Follow-up|13|||
149731143|NCT01688050|540151004|FG000|Overall Study|Withdrawal by Subject|10|||
149731144|NCT05099640|540151010|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
149731145|NCT05099640|540151011|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
149731146|NCT05099640|540151012|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
149731147|NCT05099640|540151010|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
149731148|NCT05099640|540151011|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
149731149|NCT05099640|540151012|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
149731150|NCT05099640|540151010|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
149731151|NCT05099640|540151011|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
149731152|NCT05099640|540151012|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
149731153|NCT05099640|540151010|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
149731154|NCT05099640|540151011|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
149731155|NCT05099640|540151012|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
149731156|NCT05099640|540151010|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
149731157|NCT05099640|540151011|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
149731158|NCT05099640|540151012|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
149731159|NCT05099640|540151010|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
149731160|NCT05099640|540151011|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
149731161|NCT05099640|540151012|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
149731162|NCT00189462|540151016|FG000|Overall Study|Lack of Efficacy|5|||
149731163|NCT00189462|540151017|FG001|Overall Study|Lack of Efficacy|1|||
149731164|NCT00189462|540151016|FG000|Overall Study|Lost to Follow-up|18|||
149731165|NCT00189462|540151017|FG001|Overall Study|Lost to Follow-up|20|||
149731166|NCT00849667|540151018|FG000|Overall Study|Withdrawal by Subject|16|||
149731167|NCT00849667|540151019|FG001|Overall Study|Withdrawal by Subject|33|||
149731168|NCT00849667|540151020|FG002|Overall Study|Withdrawal by Subject|35|||
149731169|NCT00849667|540151018|FG000|Overall Study|Lost to Follow-up|8|||
149731170|NCT00849667|540151019|FG001|Overall Study|Lost to Follow-up|8|||
149731171|NCT00849667|540151020|FG002|Overall Study|Lost to Follow-up|8|||
149731172|NCT00849667|540151018|FG000|Overall Study|Adverse Event|1|||
149731173|NCT00849667|540151019|FG001|Overall Study|Adverse Event|2|||
149731174|NCT00849667|540151020|FG002|Overall Study|Adverse Event|0|||
149731175|NCT00849667|540151018|FG000|Overall Study|Other|18|||
149731176|NCT00849667|540151019|FG001|Overall Study|Other|19|||
149731177|NCT00849667|540151020|FG002|Overall Study|Other|18|||
149731178|NCT00849667|540151018|FG000|Overall Study|Progressive disease|119|||
149731179|NCT00849667|540151019|FG001|Overall Study|Progressive disease|100|||
149731180|NCT00849667|540151020|FG002|Overall Study|Progressive disease|112|||
149731181|NCT00849667|540151018|FG000|Overall Study|Sponsor decision|208|||
149731182|NCT00849667|540151019|FG001|Overall Study|Sponsor decision|204|||
149731183|NCT00849667|540151020|FG002|Overall Study|Sponsor decision|190|||
149731184|NCT00849667|540151018|FG000|Overall Study|Investigator discretion|0|||
149731185|NCT00849667|540151019|FG001|Overall Study|Investigator discretion|0|||
149731186|NCT00849667|540151020|FG002|Overall Study|Investigator discretion|1|||
149731187|NCT00553462|540151021|FG000|Overall Study|Adverse Event|4|||
149731188|NCT00553462|540151021|FG000|Overall Study|Progression|4|||
149731189|NCT00553462|540151021|FG000|Overall Study|Withdrawal by Subject|5|||
149731190|NCT00553462|540151021|FG000|Overall Study|Physician Decision|1|||
149731191|NCT01262625|540151022|FG000|Overall Study|Administrative Error|1|||
149731192|NCT01262625|540151023|FG001|Overall Study|Administrative Error|1|||
149731193|NCT01262625|540151022|FG000|Overall Study|Site Closed|1|||
149731194|NCT01262625|540151023|FG001|Overall Study|Site Closed|0|||
149731195|NCT03075163|540151024|FG000|Overall Study|not eligible for treatment limb|138|||
149731196|NCT03075163|540151025|FG001|Overall Study|not eligible for treatment limb|138|||
150253686|NCT03592745|542063965|FG001|Overall Study|Adverse Event|2|||
149731197|NCT04398732|540151026|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
149731198|NCT03882424|540151029|FG000|Overall Study|Lost to Follow-up|3|||
149731199|NCT03882424|540151030|FG001|Overall Study|Lost to Follow-up|0|||
149731200|NCT03882424|540151031|FG002|Overall Study|Lost to Follow-up|0|||
149731201|NCT03882424|540151029|FG000|Overall Study|schedule conflict|1|||
149731202|NCT03882424|540151030|FG001|Overall Study|schedule conflict|0|||
149731203|NCT03882424|540151031|FG002|Overall Study|schedule conflict|0|||
150253687|NCT03592745|542063964|FG000|Overall Study|Lost to Follow-up|2|||
149731204|NCT02772757|540151037|FG000|Overall Study|Withdrawal by Subject|1|||
149731205|NCT02772757|540151038|FG001|Overall Study|Withdrawal by Subject|0|||
149731206|NCT02772757|540151039|FG002|Overall Study|Withdrawal by Subject|1|||
149731207|NCT02772757|540151037|FG000|Overall Study|Protocol Violation|0|||
149731208|NCT02772757|540151038|FG001|Overall Study|Protocol Violation|0|||
149731209|NCT02772757|540151039|FG002|Overall Study|Protocol Violation|1|||
149731210|NCT02772757|540151037|FG000|Overall Study|Physician Decision|0|||
149731211|NCT02772757|540151038|FG001|Overall Study|Physician Decision|3|||
149731212|NCT02772757|540151039|FG002|Overall Study|Physician Decision|3|||
149731213|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Adverse Event|21|||
149731214|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Adverse Event|6|||
149731215|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
149731216|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
149731217|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
149731218|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
149731219|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
149731220|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
149731221|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Physician Decision|0|||
149731222|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Physician Decision|3|||
149731223|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
149731224|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
149731225|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
149731226|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
149731227|NCT00510276|540151041|FG000|Acute Double-Blind Phase|Subject Decision|26|||
149731228|NCT00510276|540151042|FG001|Acute Double-Blind Phase|Subject Decision|28|||
149731229|NCT00510276|540151041|FG000|Extension Open-Label Phase|Adverse Event|9|||
149731230|NCT00510276|540151042|FG001|Extension Open-Label Phase|Adverse Event|18|||
149731231|NCT00510276|540151041|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
149731232|NCT00510276|540151042|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
149731233|NCT00510276|540151041|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
149731234|NCT00510276|540151042|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
149731235|NCT00510276|540151041|FG000|Extension Open-Label Phase|Physician Decision|2|||
149731236|NCT00510276|540151042|FG001|Extension Open-Label Phase|Physician Decision|3|||
149731237|NCT00510276|540151041|FG000|Extension Open-Label Phase|Protocol Violation|0|||
149731238|NCT00510276|540151042|FG001|Extension Open-Label Phase|Protocol Violation|1|||
149731239|NCT00510276|540151041|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
149731240|NCT00510276|540151042|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
149731241|NCT00510276|540151041|FG000|Extension Open-Label Phase|Subject Decision|7|||
149731242|NCT00510276|540151042|FG001|Extension Open-Label Phase|Subject Decision|9|||
149731243|NCT03486392|540151045|FG000|Overall Study|Lost to Follow-up|0|||
149731244|NCT03486392|540151046|FG001|Overall Study|Lost to Follow-up|0|||
149731245|NCT03486392|540151047|FG002|Overall Study|Lost to Follow-up|8|||
149731246|NCT03486392|540151048|FG003|Overall Study|Lost to Follow-up|5|||
149731247|NCT03486392|540151049|FG004|Overall Study|Lost to Follow-up|2|||
149731248|NCT03486392|540151045|FG000|Overall Study|Withdrawal by Subject|3|||
149731249|NCT03486392|540151046|FG001|Overall Study|Withdrawal by Subject|0|||
149731250|NCT03486392|540151047|FG002|Overall Study|Withdrawal by Subject|6|||
149731251|NCT03486392|540151048|FG003|Overall Study|Withdrawal by Subject|4|||
149731252|NCT03486392|540151049|FG004|Overall Study|Withdrawal by Subject|1|||
149731253|NCT03486392|540151045|FG000|Overall Study|Death|0|||
149731254|NCT03486392|540151046|FG001|Overall Study|Death|0|||
149731255|NCT03486392|540151047|FG002|Overall Study|Death|0|||
149731256|NCT03486392|540151048|FG003|Overall Study|Death|0|||
149731257|NCT03486392|540151049|FG004|Overall Study|Death|1|||
149731258|NCT01500057|540151050|FG000|Overall Study|Lost to Follow-up|6|||
149731259|NCT01500057|540151051|FG001|Overall Study|Lost to Follow-up|4|||
149731260|NCT00441792|540151052|FG000|Overall Study|Lost to Follow-up|0|||
149731261|NCT00441792|540151053|FG001|Overall Study|Lost to Follow-up|2|||
149731262|NCT00888355|540151056|FG000|Overall Study|Adverse Event|10|||
149731263|NCT00888355|540151057|FG001|Overall Study|Adverse Event|0|||
149731264|NCT00888355|540151058|FG002|Overall Study|Adverse Event|3|||
149731265|NCT00888355|540151059|FG003|Overall Study|Adverse Event|3|||
149731266|NCT00888355|540151056|FG000|Overall Study|Lack of Efficacy|9|||
149731267|NCT00888355|540151057|FG001|Overall Study|Lack of Efficacy|2|||
150253688|NCT03592745|542063965|FG001|Overall Study|Lost to Follow-up|0|||
149731268|NCT00888355|540151058|FG002|Overall Study|Lack of Efficacy|5|||
149731269|NCT00888355|540151059|FG003|Overall Study|Lack of Efficacy|2|||
149731270|NCT00888355|540151056|FG000|Overall Study|Lost to Follow-up|0|||
149731271|NCT00888355|540151057|FG001|Overall Study|Lost to Follow-up|2|||
149731272|NCT00888355|540151058|FG002|Overall Study|Lost to Follow-up|2|||
149731273|NCT00888355|540151059|FG003|Overall Study|Lost to Follow-up|0|||
149731274|NCT00888355|540151056|FG000|Overall Study|Protocol Violation|3|||
149731275|NCT00888355|540151057|FG001|Overall Study|Protocol Violation|2|||
149731276|NCT00888355|540151058|FG002|Overall Study|Protocol Violation|1|||
149731277|NCT00888355|540151059|FG003|Overall Study|Protocol Violation|2|||
149731278|NCT00888355|540151056|FG000|Overall Study|Withdrawal by Subject|0|||
149731279|NCT00888355|540151057|FG001|Overall Study|Withdrawal by Subject|3|||
149731280|NCT00888355|540151058|FG002|Overall Study|Withdrawal by Subject|1|||
149731281|NCT00888355|540151059|FG003|Overall Study|Withdrawal by Subject|3|||
149731282|NCT00666926|540151061|FG000|Overall Study|Adverse Event|0|||
149731283|NCT00666926|540151062|FG001|Overall Study|Adverse Event|0|||
149731284|NCT00666926|540151063|FG002|Overall Study|Adverse Event|0|||
149731285|NCT00666926|540151064|FG003|Overall Study|Adverse Event|0|||
149731286|NCT00666926|540151065|FG004|Overall Study|Adverse Event|0|||
149731287|NCT00666926|540151066|FG005|Overall Study|Adverse Event|0|||
149731288|NCT00666926|540151067|FG006|Overall Study|Adverse Event|0|||
149731289|NCT00666926|540151068|FG007|Overall Study|Adverse Event|0|||
149731290|NCT00666926|540151069|FG008|Overall Study|Adverse Event|0|||
149731291|NCT00666926|540151070|FG009|Overall Study|Adverse Event|2|||
149731292|NCT00666926|540151071|FG010|Overall Study|Adverse Event|2|||
149731293|NCT00666926|540151072|FG011|Overall Study|Adverse Event|2|||
149731294|NCT00666926|540151073|FG012|Overall Study|Adverse Event|0|||
149731295|NCT00666926|540151074|FG013|Overall Study|Adverse Event|1|||
149731296|NCT00666926|540151075|FG014|Overall Study|Adverse Event|0|||
149731297|NCT00666926|540151076|FG015|Overall Study|Adverse Event|0|||
149731298|NCT00666926|540151061|FG000|Overall Study|Laboratory abnormality|0|||
149731299|NCT00666926|540151062|FG001|Overall Study|Laboratory abnormality|0|||
149731300|NCT00666926|540151063|FG002|Overall Study|Laboratory abnormality|0|||
149731301|NCT00666926|540151064|FG003|Overall Study|Laboratory abnormality|0|||
149731302|NCT00666926|540151065|FG004|Overall Study|Laboratory abnormality|0|||
149731303|NCT00666926|540151066|FG005|Overall Study|Laboratory abnormality|0|||
149731304|NCT00666926|540151067|FG006|Overall Study|Laboratory abnormality|0|||
149731305|NCT00666926|540151068|FG007|Overall Study|Laboratory abnormality|0|||
149731306|NCT00666926|540151069|FG008|Overall Study|Laboratory abnormality|0|||
149731307|NCT00666926|540151070|FG009|Overall Study|Laboratory abnormality|0|||
149731308|NCT00666926|540151071|FG010|Overall Study|Laboratory abnormality|1|||
149731309|NCT00666926|540151072|FG011|Overall Study|Laboratory abnormality|0|||
149731310|NCT00666926|540151073|FG012|Overall Study|Laboratory abnormality|0|||
149731311|NCT00666926|540151074|FG013|Overall Study|Laboratory abnormality|0|||
149731312|NCT00666926|540151075|FG014|Overall Study|Laboratory abnormality|0|||
149731313|NCT00666926|540151076|FG015|Overall Study|Laboratory abnormality|1|||
149731314|NCT00666926|540151061|FG000|Overall Study|Lack of Efficacy|0|||
149731315|NCT00666926|540151062|FG001|Overall Study|Lack of Efficacy|0|||
149731316|NCT00666926|540151063|FG002|Overall Study|Lack of Efficacy|0|||
149731317|NCT00666926|540151064|FG003|Overall Study|Lack of Efficacy|0|||
149731318|NCT00666926|540151065|FG004|Overall Study|Lack of Efficacy|0|||
149731319|NCT00666926|540151066|FG005|Overall Study|Lack of Efficacy|1|||
149731320|NCT00666926|540151067|FG006|Overall Study|Lack of Efficacy|0|||
149731321|NCT00666926|540151068|FG007|Overall Study|Lack of Efficacy|0|||
149731322|NCT00666926|540151069|FG008|Overall Study|Lack of Efficacy|0|||
149731323|NCT00666926|540151070|FG009|Overall Study|Lack of Efficacy|0|||
149731324|NCT00666926|540151071|FG010|Overall Study|Lack of Efficacy|0|||
149731325|NCT00666926|540151072|FG011|Overall Study|Lack of Efficacy|1|||
149731326|NCT00666926|540151073|FG012|Overall Study|Lack of Efficacy|0|||
149731327|NCT00666926|540151074|FG013|Overall Study|Lack of Efficacy|0|||
149731328|NCT00666926|540151075|FG014|Overall Study|Lack of Efficacy|0|||
149731329|NCT00666926|540151076|FG015|Overall Study|Lack of Efficacy|0|||
149731330|NCT00666926|540151061|FG000|Overall Study|Lost to Follow-up|0|||
150253689|NCT03592745|542063964|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
149731331|NCT00666926|540151062|FG001|Overall Study|Lost to Follow-up|0|||
149731332|NCT00666926|540151063|FG002|Overall Study|Lost to Follow-up|0|||
149731333|NCT00666926|540151064|FG003|Overall Study|Lost to Follow-up|1|||
149731334|NCT00666926|540151065|FG004|Overall Study|Lost to Follow-up|0|||
149731335|NCT00666926|540151066|FG005|Overall Study|Lost to Follow-up|0|||
149731336|NCT00666926|540151067|FG006|Overall Study|Lost to Follow-up|0|||
149731337|NCT00666926|540151068|FG007|Overall Study|Lost to Follow-up|0|||
149731338|NCT00666926|540151069|FG008|Overall Study|Lost to Follow-up|0|||
149731339|NCT00666926|540151070|FG009|Overall Study|Lost to Follow-up|0|||
149731340|NCT00666926|540151071|FG010|Overall Study|Lost to Follow-up|0|||
149731341|NCT00666926|540151072|FG011|Overall Study|Lost to Follow-up|0|||
149731342|NCT00666926|540151073|FG012|Overall Study|Lost to Follow-up|0|||
149731343|NCT00666926|540151074|FG013|Overall Study|Lost to Follow-up|0|||
149731344|NCT00666926|540151075|FG014|Overall Study|Lost to Follow-up|0|||
149731345|NCT00666926|540151076|FG015|Overall Study|Lost to Follow-up|0|||
149731346|NCT00666926|540151061|FG000|Overall Study|Other|2|||
149731347|NCT00666926|540151062|FG001|Overall Study|Other|4|||
149731348|NCT00666926|540151063|FG002|Overall Study|Other|3|||
149731349|NCT00666926|540151064|FG003|Overall Study|Other|3|||
149731350|NCT00666926|540151065|FG004|Overall Study|Other|3|||
149731351|NCT00666926|540151066|FG005|Overall Study|Other|3|||
149731352|NCT00666926|540151067|FG006|Overall Study|Other|4|||
149731353|NCT00666926|540151068|FG007|Overall Study|Other|0|||
149731354|NCT00666926|540151069|FG008|Overall Study|Other|3|||
149731355|NCT00666926|540151070|FG009|Overall Study|Other|5|||
149731356|NCT00666926|540151071|FG010|Overall Study|Other|3|||
149731357|NCT00666926|540151072|FG011|Overall Study|Other|26|||
149731358|NCT00666926|540151073|FG012|Overall Study|Other|3|||
149731359|NCT00666926|540151074|FG013|Overall Study|Other|2|||
149731360|NCT00666926|540151075|FG014|Overall Study|Other|4|||
150253690|NCT03592745|542063965|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
150253691|NCT02729831|542063967|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
150253692|NCT02729831|542063968|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
150253693|NCT02729831|542063969|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
150253694|NCT02729831|542063970|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
150253695|NCT02729831|542063967|FG000|1 Week Post-visit|Lost to Follow-up|43|||
150253696|NCT02729831|542063968|FG001|1 Week Post-visit|Lost to Follow-up|40|||
150253697|NCT02729831|542063969|FG002|1 Week Post-visit|Lost to Follow-up|38|||
150253698|NCT02729831|542063970|FG003|1 Week Post-visit|Lost to Follow-up|36|||
150253699|NCT02729831|542063967|FG000|6 Month Follow-up|Lost to Follow-up|54|||
150253700|NCT02729831|542063968|FG001|6 Month Follow-up|Lost to Follow-up|51|||
150253701|NCT02729831|542063969|FG002|6 Month Follow-up|Lost to Follow-up|48|||
150253702|NCT02729831|542063970|FG003|6 Month Follow-up|Lost to Follow-up|42|||
150253703|NCT02729831|542063967|FG000|6 Month Follow-up|Death|1|||
150253704|NCT02729831|542063968|FG001|6 Month Follow-up|Death|3|||
150253705|NCT02729831|542063969|FG002|6 Month Follow-up|Death|0|||
150253706|NCT02729831|542063970|FG003|6 Month Follow-up|Death|1|||
150253707|NCT02091206|542063971|FG000|Treatment Period|Adverse Event|0|||
150253708|NCT02091206|542063972|FG001|Treatment Period|Adverse Event|1|||
150253709|NCT02091206|542063973|FG002|Treatment Period|Adverse Event|0|||
150253710|NCT02091206|542063974|FG003|Treatment Period|Adverse Event|0|||
150253711|NCT02091206|542063971|FG000|Treatment Period|Met withdrawal criteria|0|||
150253712|NCT02091206|542063972|FG001|Treatment Period|Met withdrawal criteria|0|||
150253713|NCT02091206|542063973|FG002|Treatment Period|Met withdrawal criteria|1|||
150253714|NCT02091206|542063974|FG003|Treatment Period|Met withdrawal criteria|0|||
150253715|NCT02091206|542063971|FG000|Taper Period|Participant refused study drug|1|||
150253716|NCT02091206|542063972|FG001|Taper Period|Participant refused study drug|0|||
150253717|NCT02091206|542063973|FG002|Taper Period|Participant refused study drug|0|||
150253718|NCT02091206|542063974|FG003|Taper Period|Participant refused study drug|1|||
150253719|NCT02091206|542063971|FG000|Taper Period|Lost to Follow-up|0|||
150253720|NCT02091206|542063972|FG001|Taper Period|Lost to Follow-up|0|||
150253721|NCT02091206|542063973|FG002|Taper Period|Lost to Follow-up|0|||
150253722|NCT02091206|542063974|FG003|Taper Period|Lost to Follow-up|1|||
150253723|NCT05597787|542063976|FG000|Overall Study|Withdrawal by Subject|0|||
150253724|NCT05597787|542063977|FG001|Overall Study|Withdrawal by Subject|0|||
150253725|NCT05597787|542063978|FG002|Overall Study|Withdrawal by Subject|1|||
150253726|NCT01241604|542063979|FG000|Screening Period|Screen Failure|3|||
150253727|NCT01241604|542063980|FG001|Screening Period|Screen Failure|0|||
149731361|NCT00666926|540151076|FG015|Overall Study|Other|4|||
149731362|NCT00666926|540151061|FG000|Overall Study|Withdrawal by Subject|0|||
149731363|NCT00666926|540151062|FG001|Overall Study|Withdrawal by Subject|0|||
149731364|NCT00666926|540151063|FG002|Overall Study|Withdrawal by Subject|0|||
149731365|NCT00666926|540151064|FG003|Overall Study|Withdrawal by Subject|0|||
149731366|NCT00666926|540151065|FG004|Overall Study|Withdrawal by Subject|0|||
149731367|NCT00666926|540151066|FG005|Overall Study|Withdrawal by Subject|0|||
149731368|NCT00666926|540151067|FG006|Overall Study|Withdrawal by Subject|0|||
149731369|NCT00666926|540151068|FG007|Overall Study|Withdrawal by Subject|1|||
149731370|NCT00666926|540151069|FG008|Overall Study|Withdrawal by Subject|0|||
149731371|NCT00666926|540151070|FG009|Overall Study|Withdrawal by Subject|3|||
149731372|NCT00666926|540151071|FG010|Overall Study|Withdrawal by Subject|0|||
149731373|NCT00666926|540151072|FG011|Overall Study|Withdrawal by Subject|3|||
149731374|NCT00666926|540151073|FG012|Overall Study|Withdrawal by Subject|0|||
149731375|NCT00666926|540151074|FG013|Overall Study|Withdrawal by Subject|1|||
149731376|NCT00666926|540151075|FG014|Overall Study|Withdrawal by Subject|3|||
149731377|NCT00666926|540151076|FG015|Overall Study|Withdrawal by Subject|3|||
149731378|NCT00666926|540151061|FG000|Overall Study|Death|0|||
149731379|NCT00666926|540151062|FG001|Overall Study|Death|0|||
150253728|NCT01241604|542063981|FG002|Screening Period|Screen Failure|0|||
150253729|NCT01593787|542063982|FG000|Overall Study|Adverse Event|1|||
150253730|NCT01593787|542063983|FG001|Overall Study|Adverse Event|0|||
150253731|NCT01593787|542063984|FG002|Overall Study|Adverse Event|0|||
150253732|NCT01133418|542063985|FG000|Overall Study|Lost to Follow-up|5|||
150253733|NCT01133418|542063986|FG001|Overall Study|Lost to Follow-up|6|||
149731380|NCT00666926|540151063|FG002|Overall Study|Death|0|||
149731381|NCT00666926|540151064|FG003|Overall Study|Death|0|||
149731382|NCT00666926|540151065|FG004|Overall Study|Death|0|||
149731383|NCT00666926|540151066|FG005|Overall Study|Death|0|||
149731384|NCT00666926|540151067|FG006|Overall Study|Death|0|||
149731385|NCT00666926|540151068|FG007|Overall Study|Death|0|||
149731386|NCT00666926|540151069|FG008|Overall Study|Death|0|||
150253734|NCT00969709|542065706|FG000|Overall Study|Adverse Event|3|||
150253735|NCT00969709|542065707|FG001|Overall Study|Adverse Event|13|||
150253736|NCT00969709|542065708|FG002|Overall Study|Adverse Event|26|||
150253737|NCT00969709|542065709|FG003|Overall Study|Adverse Event|12|||
149731387|NCT00666926|540151070|FG009|Overall Study|Death|0|||
149731388|NCT00666926|540151071|FG010|Overall Study|Death|0|||
149731389|NCT00666926|540151072|FG011|Overall Study|Death|1|||
150253738|NCT00969709|542065706|FG000|Overall Study|Lack of Efficacy|7|||
150253739|NCT00969709|542065707|FG001|Overall Study|Lack of Efficacy|4|||
150253740|NCT00969709|542065708|FG002|Overall Study|Lack of Efficacy|1|||
150253741|NCT00969709|542065709|FG003|Overall Study|Lack of Efficacy|3|||
150253742|NCT00969709|542065706|FG000|Overall Study|Protocol Violation|9|||
150253743|NCT00969709|542065707|FG001|Overall Study|Protocol Violation|5|||
150253744|NCT00969709|542065708|FG002|Overall Study|Protocol Violation|9|||
150253745|NCT00969709|542065709|FG003|Overall Study|Protocol Violation|10|||
150253746|NCT00969709|542065706|FG000|Overall Study|Withdrawal by Subject|9|||
150253747|NCT00969709|542065707|FG001|Overall Study|Withdrawal by Subject|12|||
150253748|NCT00969709|542065708|FG002|Overall Study|Withdrawal by Subject|11|||
150253749|NCT00969709|542065709|FG003|Overall Study|Withdrawal by Subject|23|||
150253750|NCT00969709|542065706|FG000|Overall Study|Lost to Follow-up|10|||
150253751|NCT00969709|542065707|FG001|Overall Study|Lost to Follow-up|14|||
150253752|NCT00969709|542065708|FG002|Overall Study|Lost to Follow-up|8|||
150253753|NCT00969709|542065709|FG003|Overall Study|Lost to Follow-up|15|||
150253754|NCT00969709|542065706|FG000|Overall Study|Other reasons|0|||
150253755|NCT00969709|542065707|FG001|Overall Study|Other reasons|0|||
150253756|NCT00969709|542065708|FG002|Overall Study|Other reasons|3|||
150253757|NCT00969709|542065709|FG003|Overall Study|Other reasons|0|||
150253758|NCT03037931|542065710|FG000|Overall Study|Death|354|||
150253759|NCT03037931|542065711|FG001|Overall Study|Death|367|||
150253760|NCT03037931|542065710|FG000|Overall Study|Lost to Follow-up|7|||
150253761|NCT03037931|542065711|FG001|Overall Study|Lost to Follow-up|4|||
150253762|NCT03037931|542065710|FG000|Overall Study|Withdrawal by Subject|48|||
150253763|NCT03037931|542065711|FG001|Overall Study|Withdrawal by Subject|41|||
150253764|NCT02075476|542065712|FG000|Overall Study|Death|2|||
150253765|NCT02075476|542065713|FG001|Overall Study|Death|2|||
150253766|NCT02075476|542065712|FG000|Overall Study|Lost to Follow-up|1|||
150253767|NCT02075476|542065713|FG001|Overall Study|Lost to Follow-up|3|||
150253768|NCT01789567|542065716|FG000|Overall Study|Death|6|||
150253769|NCT02914275|542065717|FG000|Overall Study|Lost to Follow-up|84|||
150253770|NCT02914275|542065718|FG001|Overall Study|Lost to Follow-up|29|||
150253771|NCT02914275|542065717|FG000|Overall Study|Withdrawal by Subject|26|||
150253772|NCT02914275|542065718|FG001|Overall Study|Withdrawal by Subject|10|||
150253773|NCT02914275|542065717|FG000|Overall Study|Protocol Violation|1|||
150253774|NCT02914275|542065718|FG001|Overall Study|Protocol Violation|1|||
150253775|NCT02914275|542065717|FG000|Overall Study|Physician Decision|3|||
150253776|NCT02914275|542065718|FG001|Overall Study|Physician Decision|1|||
150253777|NCT02914275|542065717|FG000|Overall Study|Other|4|||
150253778|NCT02914275|542065718|FG001|Overall Study|Other|1|||
150253779|NCT02914275|542065717|FG000|Overall Study|Excluded due to invalid informed consent|3|||
150253780|NCT02914275|542065718|FG001|Overall Study|Excluded due to invalid informed consent|0|||
150253781|NCT00872989|542065719|FG000|Overall Study|Adverse Event|7|||
150253782|NCT00872989|542065720|FG001|Overall Study|Adverse Event|15|||
150253783|NCT00872989|542065719|FG000|Overall Study|Withdrawal by Subject|8|||
150253784|NCT00872989|542065720|FG001|Overall Study|Withdrawal by Subject|5|||
150253785|NCT00872989|542065719|FG000|Overall Study|Progression/relapse|47|||
150253786|NCT00872989|542065720|FG001|Overall Study|Progression/relapse|35|||
150253787|NCT00872989|542065719|FG000|Overall Study|Not protocol specified|3|||
150253788|NCT00872989|542065720|FG001|Overall Study|Not protocol specified|8|||
150253789|NCT02407990|542065721|FG000|Overall Study|Death|2|||
150253790|NCT02407990|542065722|FG001|Overall Study|Death|22|||
150253791|NCT02407990|542065723|FG002|Overall Study|Death|23|||
150253792|NCT02407990|542065724|FG003|Overall Study|Death|7|||
150253793|NCT02407990|542065725|FG004|Overall Study|Death|17|||
150253794|NCT02407990|542065726|FG005|Overall Study|Death|16|||
150253795|NCT02407990|542065727|FG006|Overall Study|Death|10|||
149731390|NCT00666926|540151073|FG012|Overall Study|Death|0|||
149731391|NCT00666926|540151074|FG013|Overall Study|Death|0|||
149731392|NCT00666926|540151075|FG014|Overall Study|Death|0|||
149731393|NCT00666926|540151076|FG015|Overall Study|Death|0|||
149731394|NCT01960855|540151077|FG000|Overall Study|Subject noncompliant|1|||
149731395|NCT01960855|540151078|FG001|Overall Study|Subject noncompliant|0|||
149731396|NCT01960855|540151079|FG002|Overall Study|Subject noncompliant|0|||
149731397|NCT01960855|540151080|FG003|Overall Study|Subject noncompliant|0|||
150253796|NCT02407990|542065728|FG007|Overall Study|Death|248|||
150253797|NCT02407990|542065721|FG000|Overall Study|Lost to Follow-up|0|||
150253798|NCT02407990|542065722|FG001|Overall Study|Lost to Follow-up|1|||
150253799|NCT02407990|542065723|FG002|Overall Study|Lost to Follow-up|0|||
150253800|NCT02407990|542065724|FG003|Overall Study|Lost to Follow-up|0|||
150253801|NCT02407990|542065725|FG004|Overall Study|Lost to Follow-up|0|||
150253802|NCT02407990|542065726|FG005|Overall Study|Lost to Follow-up|0|||
150253803|NCT02407990|542065727|FG006|Overall Study|Lost to Follow-up|0|||
150253804|NCT02407990|542065728|FG007|Overall Study|Lost to Follow-up|17|||
150253805|NCT02407990|542065721|FG000|Overall Study|Progressive Disease|0|||
149731398|NCT01960855|540151081|FG004|Overall Study|Subject noncompliant|0|||
149731399|NCT01960855|540151077|FG000|Overall Study|Adverse Event|2|||
150253806|NCT02407990|542065722|FG001|Overall Study|Progressive Disease|0|||
150253807|NCT02407990|542065723|FG002|Overall Study|Progressive Disease|0|||
150253808|NCT02407990|542065724|FG003|Overall Study|Progressive Disease|0|||
150253809|NCT02407990|542065725|FG004|Overall Study|Progressive Disease|0|||
150253810|NCT02407990|542065726|FG005|Overall Study|Progressive Disease|0|||
150253811|NCT02407990|542065727|FG006|Overall Study|Progressive Disease|0|||
150253812|NCT02407990|542065728|FG007|Overall Study|Progressive Disease|1|||
150253813|NCT02407990|542065721|FG000|Overall Study|Withdrawal by Subject|0|||
150253814|NCT02407990|542065722|FG001|Overall Study|Withdrawal by Subject|0|||
150253815|NCT02407990|542065723|FG002|Overall Study|Withdrawal by Subject|0|||
150253816|NCT02407990|542065724|FG003|Overall Study|Withdrawal by Subject|0|||
150253817|NCT02407990|542065725|FG004|Overall Study|Withdrawal by Subject|1|||
150253818|NCT02407990|542065726|FG005|Overall Study|Withdrawal by Subject|0|||
150253819|NCT02407990|542065727|FG006|Overall Study|Withdrawal by Subject|0|||
150253820|NCT02407990|542065728|FG007|Overall Study|Withdrawal by Subject|30|||
150253821|NCT02407990|542065721|FG000|Overall Study|Study Terminated by Sponsor|1|||
149731400|NCT01960855|540151078|FG001|Overall Study|Adverse Event|0|||
149731401|NCT01960855|540151079|FG002|Overall Study|Adverse Event|6|||
149731402|NCT01960855|540151080|FG003|Overall Study|Adverse Event|2|||
149731403|NCT01960855|540151081|FG004|Overall Study|Adverse Event|2|||
149731404|NCT01960855|540151077|FG000|Overall Study|Lack of Efficacy|1|||
149731405|NCT01960855|540151078|FG001|Overall Study|Lack of Efficacy|1|||
149731406|NCT01960855|540151079|FG002|Overall Study|Lack of Efficacy|0|||
149731407|NCT01960855|540151080|FG003|Overall Study|Lack of Efficacy|0|||
149731408|NCT01960855|540151081|FG004|Overall Study|Lack of Efficacy|0|||
149731409|NCT01960855|540151077|FG000|Overall Study|Other|2|||
149731410|NCT01960855|540151078|FG001|Overall Study|Other|1|||
149731411|NCT01960855|540151079|FG002|Overall Study|Other|1|||
149731412|NCT01960855|540151080|FG003|Overall Study|Other|1|||
149731413|NCT01960855|540151081|FG004|Overall Study|Other|0|||
149731414|NCT01960855|540151077|FG000|Overall Study|Consent withdrawn by subject|3|||
149731415|NCT01960855|540151078|FG001|Overall Study|Consent withdrawn by subject|1|||
149731416|NCT01960855|540151079|FG002|Overall Study|Consent withdrawn by subject|2|||
149731417|NCT01960855|540151080|FG003|Overall Study|Consent withdrawn by subject|1|||
149731418|NCT01960855|540151081|FG004|Overall Study|Consent withdrawn by subject|1|||
149731419|NCT01960855|540151077|FG000|Overall Study|Lost to Follow-up|2|||
149731420|NCT01960855|540151078|FG001|Overall Study|Lost to Follow-up|1|||
149731421|NCT01960855|540151079|FG002|Overall Study|Lost to Follow-up|0|||
149731422|NCT01960855|540151080|FG003|Overall Study|Lost to Follow-up|0|||
149731423|NCT01960855|540151081|FG004|Overall Study|Lost to Follow-up|2|||
149731424|NCT01318122|540151082|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149731425|NCT01318122|540151083|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149731426|NCT01318122|540151084|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
149731427|NCT01318122|540151085|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
149731428|NCT01318122|540151082|FG000|Enrolled - Long-Term Extension Study|Other|1|||
149731429|NCT01318122|540151083|FG001|Enrolled - Long-Term Extension Study|Other|0|||
149731430|NCT01318122|540151084|FG002|Enrolled - Long-Term Extension Study|Other|0|||
149731431|NCT01318122|540151085|FG003|Enrolled - Long-Term Extension Study|Other|0|||
149731432|NCT01318122|540151082|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
149731433|NCT01318122|540151083|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
149731434|NCT01318122|540151084|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
149731435|NCT01318122|540151085|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
149731436|NCT01318122|540151082|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
149731437|NCT01318122|540151083|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149731438|NCT01318122|540151084|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
150253822|NCT02407990|542065722|FG001|Overall Study|Study Terminated by Sponsor|3|||
150253823|NCT02407990|542065723|FG002|Overall Study|Study Terminated by Sponsor|3|||
150253824|NCT02407990|542065724|FG003|Overall Study|Study Terminated by Sponsor|0|||
150253825|NCT02407990|542065725|FG004|Overall Study|Study Terminated by Sponsor|3|||
150253826|NCT02407990|542065726|FG005|Overall Study|Study Terminated by Sponsor|4|||
150253827|NCT02407990|542065727|FG006|Overall Study|Study Terminated by Sponsor|3|||
150253828|NCT02407990|542065728|FG007|Overall Study|Study Terminated by Sponsor|37|||
150253829|NCT02407990|542065721|FG000|Overall Study|Logistics|0|||
149731439|NCT01318122|540151085|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149731440|NCT01318122|540151082|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149731441|NCT01318122|540151083|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
149731442|NCT01318122|540151084|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149731443|NCT01318122|540151085|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149731444|NCT01318122|540151082|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149731445|NCT01318122|540151083|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
149731446|NCT01318122|540151084|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
149731447|NCT01318122|540151085|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149731448|NCT02471716|540151086|FG000|Overall Study|Withdrawal by Subject|0|||
149731449|NCT02471716|540151087|FG001|Overall Study|Withdrawal by Subject|1|||
149731450|NCT02471716|540151088|FG002|Overall Study|Withdrawal by Subject|0|||
149731451|NCT02471716|540151089|FG003|Overall Study|Withdrawal by Subject|2|||
149731452|NCT02471716|540151090|FG004|Overall Study|Withdrawal by Subject|5|||
149731453|NCT02471716|540151086|FG000|Overall Study|Study Terminiated by sponsor|0|||
149731454|NCT02471716|540151087|FG001|Overall Study|Study Terminiated by sponsor|0|||
149731455|NCT02471716|540151088|FG002|Overall Study|Study Terminiated by sponsor|0|||
149731456|NCT02471716|540151089|FG003|Overall Study|Study Terminiated by sponsor|1|||
149731457|NCT02471716|540151090|FG004|Overall Study|Study Terminiated by sponsor|0|||
149731458|NCT02471716|540151086|FG000|Overall Study|Lost to Follow-up|0|||
149731459|NCT02471716|540151087|FG001|Overall Study|Lost to Follow-up|0|||
149731460|NCT02471716|540151088|FG002|Overall Study|Lost to Follow-up|0|||
149731461|NCT02471716|540151089|FG003|Overall Study|Lost to Follow-up|3|||
149731462|NCT02471716|540151090|FG004|Overall Study|Lost to Follow-up|2|||
149731463|NCT02471716|540151086|FG000|Overall Study|Death|0|||
149731464|NCT02471716|540151087|FG001|Overall Study|Death|0|||
149731465|NCT02471716|540151088|FG002|Overall Study|Death|0|||
149731466|NCT02471716|540151089|FG003|Overall Study|Death|1|||
149731467|NCT02471716|540151090|FG004|Overall Study|Death|0|||
149731468|NCT02471716|540151086|FG000|Overall Study|Other|0|||
149731469|NCT02471716|540151087|FG001|Overall Study|Other|0|||
149731470|NCT02471716|540151088|FG002|Overall Study|Other|0|||
149731471|NCT02471716|540151089|FG003|Overall Study|Other|8|||
149731472|NCT02471716|540151090|FG004|Overall Study|Other|9|||
149731473|NCT01014585|540151096|FG000|Overall Study|Adverse Event|0|||
149731474|NCT01014585|540151097|FG001|Overall Study|Adverse Event|2|||
149731475|NCT01014585|540151098|FG002|Overall Study|Adverse Event|0|||
149731476|NCT01014585|540151099|FG003|Overall Study|Adverse Event|3|||
149731477|NCT01014585|540151096|FG000|Overall Study|Withdrawal by Subject|2|||
149731478|NCT01014585|540151097|FG001|Overall Study|Withdrawal by Subject|0|||
149731479|NCT01014585|540151098|FG002|Overall Study|Withdrawal by Subject|1|||
149731480|NCT01014585|540151099|FG003|Overall Study|Withdrawal by Subject|3|||
149731481|NCT01014585|540151096|FG000|Overall Study|Lost to Follow-up|0|||
149731482|NCT01014585|540151097|FG001|Overall Study|Lost to Follow-up|0|||
149731483|NCT01014585|540151098|FG002|Overall Study|Lost to Follow-up|0|||
149731484|NCT01014585|540151099|FG003|Overall Study|Lost to Follow-up|2|||
149731485|NCT01014585|540151096|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
149731486|NCT01014585|540151097|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
149731487|NCT01014585|540151098|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
149731488|NCT01014585|540151099|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
149731489|NCT02154425|540151100|FG000|Screening Period|Adverse Event|1|||
149731490|NCT01481896|540151101|FG000|Overall Study|Lost to Follow-up|12|||
149731491|NCT01162421|540151104|FG000|Overall Study|Did not receive study drug|2|||
149731492|NCT01162421|540151105|FG001|Overall Study|Did not receive study drug|1|||
149731493|NCT01162421|540151104|FG000|Overall Study|Adverse Event|2|||
149731494|NCT01162421|540151105|FG001|Overall Study|Adverse Event|5|||
149731495|NCT01162421|540151104|FG000|Overall Study|Lost to Follow-up|0|||
149731496|NCT01162421|540151105|FG001|Overall Study|Lost to Follow-up|2|||
149731497|NCT01162421|540151104|FG000|Overall Study|Lack of Efficacy|2|||
149731498|NCT01162421|540151105|FG001|Overall Study|Lack of Efficacy|2|||
149731499|NCT01162421|540151104|FG000|Overall Study|Other|2|||
149731500|NCT01162421|540151105|FG001|Overall Study|Other|3|||
149731501|NCT03336502|540151106|FG000|Overall Study|Physician Decision|0|||
149731502|NCT03336502|540151107|FG001|Overall Study|Physician Decision|1|||
149731503|NCT03336502|540151106|FG000|Overall Study|Prohibited Drugs|1|||
149731504|NCT03336502|540151107|FG001|Overall Study|Prohibited Drugs|1|||
149731505|NCT03336502|540151106|FG000|Overall Study|Death|1|||
149731506|NCT03336502|540151107|FG001|Overall Study|Death|2|||
149731507|NCT03336502|540151106|FG000|Overall Study|Adverse Event|2|||
149731508|NCT03336502|540151107|FG001|Overall Study|Adverse Event|5|||
149731509|NCT01133171|540151111|FG000|Overall Study|Withdrawal by Subject|1|||
149731510|NCT01133171|540151112|FG001|Overall Study|Withdrawal by Subject|2|||
149731511|NCT01133171|540151113|FG002|Overall Study|Withdrawal by Subject|0|||
149731512|NCT01446419|540151114|FG000|Overall Study|Death|1|||
149731513|NCT01446419|540151115|FG001|Overall Study|Death|0|||
149731514|NCT01446419|540151114|FG000|Overall Study|Withdrawal by Subject|1|||
149731515|NCT01446419|540151115|FG001|Overall Study|Withdrawal by Subject|1|||
149731516|NCT01446419|540151114|FG000|Overall Study|Terminated per protocol|3|||
149731517|NCT01446419|540151115|FG001|Overall Study|Terminated per protocol|0|||
149731518|NCT01557166|540151116|FG000|Overall Study|Adverse Event|20|||
149731519|NCT01557166|540151117|FG001|Overall Study|Adverse Event|6|||
149731520|NCT01557166|540151116|FG000|Overall Study|Lack of Efficacy|2|||
149731521|NCT01557166|540151117|FG001|Overall Study|Lack of Efficacy|1|||
149731522|NCT01557166|540151116|FG000|Overall Study|Protocol Violation|8|||
149731523|NCT01557166|540151117|FG001|Overall Study|Protocol Violation|5|||
149731524|NCT01557166|540151116|FG000|Overall Study|Withdrawn consent|12|||
149731525|NCT01557166|540151117|FG001|Overall Study|Withdrawn consent|20|||
149731526|NCT01557166|540151116|FG000|Overall Study|Target dose not tolerated|1|||
149731527|NCT01557166|540151117|FG001|Overall Study|Target dose not tolerated|0|||
149731528|NCT01557166|540151116|FG000|Overall Study|Psychiatric disorder|1|||
149731529|NCT01557166|540151117|FG001|Overall Study|Psychiatric disorder|0|||
149731530|NCT01557166|540151116|FG000|Overall Study|Unclassified|2|||
149731531|NCT01557166|540151117|FG001|Overall Study|Unclassified|5|||
149731532|NCT02445586|540151120|FG000|Overall Study|Death|14|||
149731533|NCT02445586|540151120|FG000|Overall Study|Withdrawal by Subject|13|||
149731534|NCT02445586|540151120|FG000|Overall Study|Disease Progression|10|||
149731535|NCT02445586|540151120|FG000|Overall Study|Protocol Violation|1|||
149731536|NCT02445586|540151120|FG000|Overall Study|Medical Condition|1|||
149731537|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
149731538|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
149731539|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
149731540|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731541|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731542|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731543|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731544|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731545|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149731546|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
149731547|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
149731548|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
149731549|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731550|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731551|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731552|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731553|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731554|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149731555|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
149731556|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
149731557|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731558|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731559|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731560|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731561|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731562|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731563|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149731564|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
149731565|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
149731566|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
149731567|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731568|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731569|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731570|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731571|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731572|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149731573|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
149731574|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
149731575|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731576|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731577|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731578|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731579|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731580|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731581|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149731582|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731583|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731584|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
149731585|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731586|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731587|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
150253830|NCT02407990|542065722|FG001|Overall Study|Logistics|0|||
150253831|NCT02407990|542065723|FG002|Overall Study|Logistics|0|||
150253832|NCT02407990|542065724|FG003|Overall Study|Logistics|0|||
150253833|NCT02407990|542065725|FG004|Overall Study|Logistics|0|||
150253834|NCT02407990|542065726|FG005|Overall Study|Logistics|0|||
150253835|NCT02407990|542065727|FG006|Overall Study|Logistics|0|||
150253836|NCT02407990|542065728|FG007|Overall Study|Logistics|1|||
150253837|NCT02407990|542065721|FG000|Overall Study|Rolled into long-term extension study|0|||
150253838|NCT02407990|542065722|FG001|Overall Study|Rolled into long-term extension study|0|||
150253839|NCT02407990|542065723|FG002|Overall Study|Rolled into long-term extension study|0|||
149731588|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731589|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731590|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149731591|NCT01583374|540151121|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731592|NCT01583374|540151122|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
149731593|NCT01583374|540151123|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731594|NCT01583374|540151124|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731595|NCT01583374|540151125|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731596|NCT01583374|540151126|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731597|NCT01583374|540151127|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731598|NCT01583374|540151128|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731599|NCT01583374|540151129|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
149731600|NCT01583374|540151121|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731601|NCT01583374|540151122|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731602|NCT01583374|540151123|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731603|NCT01583374|540151124|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731604|NCT01583374|540151125|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731605|NCT01583374|540151126|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731606|NCT01583374|540151127|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731607|NCT01583374|540151128|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
149731608|NCT01583374|540151129|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149731609|NCT01583374|540151121|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149731610|NCT01583374|540151122|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149731611|NCT01583374|540151123|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
149731612|NCT01583374|540151124|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149731613|NCT01583374|540151125|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149731614|NCT01583374|540151126|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149731615|NCT01583374|540151127|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149731616|NCT01583374|540151128|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149731617|NCT01583374|540151129|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149731618|NCT01583374|540151121|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
149731619|NCT01583374|540151122|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149731620|NCT01583374|540151123|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
149731621|NCT01583374|540151124|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
149731622|NCT01583374|540151125|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
149731623|NCT01583374|540151126|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149731624|NCT01583374|540151127|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
149731625|NCT01583374|540151128|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
149731626|NCT01583374|540151129|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149731627|NCT01583374|540151121|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731628|NCT01583374|540151122|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
149731629|NCT01583374|540151123|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
149731630|NCT01583374|540151124|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731631|NCT01583374|540151125|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
149731632|NCT01583374|540151126|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731633|NCT01583374|540151127|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731634|NCT01583374|540151128|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731635|NCT01583374|540151129|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149731636|NCT01583374|540151121|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731637|NCT01583374|540151122|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731638|NCT01583374|540151123|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
149731639|NCT01583374|540151124|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731640|NCT01583374|540151125|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
149731641|NCT01583374|540151126|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
149731642|NCT01583374|540151127|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731643|NCT01583374|540151128|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731644|NCT01583374|540151129|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149731645|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
149731646|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
149731647|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149731648|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149731649|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
149731650|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149731651|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149731652|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
149731653|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
149731654|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
149731655|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149731656|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
149731657|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
149731658|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
149731659|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
149731660|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149731661|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
149731662|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149731663|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731664|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731665|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731666|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731667|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
149731668|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731669|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149731670|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
149731671|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
149731672|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
149731673|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
149731674|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
149731675|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
149731676|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
149731677|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
149731678|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
149731679|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
149731680|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
149731681|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731682|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731683|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731684|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731685|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
149731686|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731687|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
149731688|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731689|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
149731690|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149731691|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149731692|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149731693|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149731694|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149731695|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149731696|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149731697|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149731698|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149731699|NCT01583374|540151121|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149731700|NCT01583374|540151122|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
149731701|NCT01583374|540151123|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149731702|NCT01583374|540151124|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
149731703|NCT01583374|540151125|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149731704|NCT01583374|540151126|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149731705|NCT01583374|540151127|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
149731706|NCT01583374|540151128|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149731707|NCT01583374|540151129|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149731708|NCT00670007|540153050|FG000|Overall Study|Drug abuse|1|||
149731709|NCT00670007|540153050|FG000|Overall Study|Lung transplant|1|||
149731710|NCT00670007|540153050|FG000|Overall Study|Travel/Vacation|1|||
149731711|NCT00670007|540153050|FG000|Overall Study|Adverse event, serious fatal|1|||
149731712|NCT00670007|540153050|FG000|Overall Study|Adverse Event|1|||
149731713|NCT00670007|540153050|FG000|Overall Study|Withdrawal by Subject|4|||
149731714|NCT00127127|540153053|FG000|Overall Study|Adverse Event|0|||
149731715|NCT00127127|540153054|FG001|Overall Study|Adverse Event|2|||
149731716|NCT00127127|540153055|FG002|Overall Study|Adverse Event|0|||
149731717|NCT00127127|540153056|FG003|Overall Study|Adverse Event|1|||
149731718|NCT00127127|540153053|FG000|Overall Study|Lack of Efficacy|1|||
149731719|NCT00127127|540153054|FG001|Overall Study|Lack of Efficacy|3|||
149731720|NCT00127127|540153055|FG002|Overall Study|Lack of Efficacy|0|||
149731721|NCT00127127|540153056|FG003|Overall Study|Lack of Efficacy|2|||
149731722|NCT01059448|540153058|FG000|Overall Study|Adverse Event|1|||
149731723|NCT01059448|540153059|FG001|Overall Study|Adverse Event|3|||
149731724|NCT01059448|540153060|FG002|Overall Study|Adverse Event|0|||
149731725|NCT01059448|540153061|FG003|Overall Study|Adverse Event|1|||
149731726|NCT01059448|540153058|FG000|Overall Study|Withdrawal by Subject|2|||
149731727|NCT01059448|540153059|FG001|Overall Study|Withdrawal by Subject|0|||
149731728|NCT01059448|540153060|FG002|Overall Study|Withdrawal by Subject|2|||
149731729|NCT01059448|540153061|FG003|Overall Study|Withdrawal by Subject|4|||
149731730|NCT01059448|540153058|FG000|Overall Study|Disease Progression|2|||
149731731|NCT01059448|540153059|FG001|Overall Study|Disease Progression|1|||
149731732|NCT01059448|540153060|FG002|Overall Study|Disease Progression|4|||
149731733|NCT01059448|540153061|FG003|Overall Study|Disease Progression|2|||
149731734|NCT01059448|540153058|FG000|Overall Study|Administrative Decision|43|||
149731735|NCT01059448|540153059|FG001|Overall Study|Administrative Decision|49|||
149731736|NCT01059448|540153060|FG002|Overall Study|Administrative Decision|45|||
149731737|NCT01059448|540153061|FG003|Overall Study|Administrative Decision|46|||
149731738|NCT01059448|540153058|FG000|Overall Study|Lost to Follow-up|0|||
150253840|NCT02407990|542065724|FG003|Overall Study|Rolled into long-term extension study|0|||
150253841|NCT02407990|542065725|FG004|Overall Study|Rolled into long-term extension study|0|||
149731739|NCT01059448|540153059|FG001|Overall Study|Lost to Follow-up|0|||
149731740|NCT01059448|540153060|FG002|Overall Study|Lost to Follow-up|2|||
149731741|NCT01059448|540153061|FG003|Overall Study|Lost to Follow-up|0|||
149731742|NCT01059448|540153058|FG000|Overall Study|Death|0|||
149731743|NCT01059448|540153059|FG001|Overall Study|Death|1|||
149731744|NCT01059448|540153060|FG002|Overall Study|Death|0|||
149731745|NCT01059448|540153061|FG003|Overall Study|Death|0|||
149731746|NCT01059448|540153058|FG000|Overall Study|Other|1|||
149731747|NCT01059448|540153059|FG001|Overall Study|Other|1|||
149731748|NCT01059448|540153060|FG002|Overall Study|Other|0|||
149731749|NCT01059448|540153061|FG003|Overall Study|Other|1|||
149731750|NCT02591615|540153064|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149731751|NCT02591615|540153065|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149731752|NCT02591615|540153066|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
149731753|NCT02591615|540153067|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149731754|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149731755|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
149731756|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149731757|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149731758|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
149731759|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
149731760|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
149731761|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
149731762|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
149731763|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
149731764|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
149731765|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
149731766|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
149731767|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
149731768|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
149731769|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
149731770|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149731771|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
149731772|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149731773|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149731774|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
149731775|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
150253842|NCT02407990|542065726|FG005|Overall Study|Rolled into long-term extension study|0|||
149731776|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
149731777|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
149731778|NCT02591615|540153064|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
149731779|NCT02591615|540153065|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149731780|NCT02591615|540153066|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149731781|NCT02591615|540153067|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149731782|NCT02591615|540153064|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
149731783|NCT02591615|540153065|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
149731784|NCT02591615|540153066|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
149731785|NCT02591615|540153067|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
149731786|NCT02591615|540153064|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
149731787|NCT02591615|540153065|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
149731788|NCT02591615|540153066|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
149731789|NCT02591615|540153067|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
149731790|NCT02591615|540153064|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
149731791|NCT02591615|540153065|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
149731792|NCT02591615|540153066|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
150253843|NCT02407990|542065727|FG006|Overall Study|Rolled into long-term extension study|0|||
150253844|NCT02407990|542065728|FG007|Overall Study|Rolled into long-term extension study|1|||
150253845|NCT00923260|542065729|FG000|Overall Study|Lost to Follow-up|1|||
150253846|NCT00923260|542065730|FG001|Overall Study|Lost to Follow-up|1|||
150253847|NCT03900416|542065733|FG000|Six Week Follow-up|Lost to Follow-up|1|||
150253848|NCT03900416|542065734|FG001|Six Week Follow-up|Lost to Follow-up|0|||
150253849|NCT03900416|542065733|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
150253850|NCT03900416|542065734|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
150253851|NCT03900416|542065733|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
150253852|NCT03900416|542065734|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
150253853|NCT03900416|542065733|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
150253854|NCT03900416|542065734|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
150253855|NCT03900416|542065733|FG000|Twelve Week Follow-up|Adverse Event|1|||
150253856|NCT03900416|542065734|FG001|Twelve Week Follow-up|Adverse Event|1|||
150253857|NCT03900416|542065733|FG000|Six Month Follow-up|Lost to Follow-up|4|||
149731793|NCT02591615|540153067|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
149731794|NCT02591615|540153064|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149731795|NCT02591615|540153065|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149731796|NCT02591615|540153066|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
149731797|NCT02591615|540153067|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149731798|NCT02591615|540153064|FG000|Maintenance MK-3475|Adverse Event|0|||
149731799|NCT02591615|540153065|FG001|Maintenance MK-3475|Adverse Event|3|||
149731800|NCT02591615|540153066|FG002|Maintenance MK-3475|Adverse Event|1|||
149731801|NCT02591615|540153067|FG003|Maintenance MK-3475|Adverse Event|2|||
150253858|NCT03900416|542065734|FG001|Six Month Follow-up|Lost to Follow-up|3|||
150253859|NCT03900416|542065733|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
149731802|NCT02591615|540153064|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
149731803|NCT02591615|540153065|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
149731804|NCT02591615|540153066|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
149731805|NCT02591615|540153067|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
149731806|NCT02591615|540153064|FG000|Maintenance MK-3475|Death|0|||
149731807|NCT02591615|540153065|FG001|Maintenance MK-3475|Death|1|||
149731808|NCT02591615|540153066|FG002|Maintenance MK-3475|Death|1|||
149731809|NCT02591615|540153067|FG003|Maintenance MK-3475|Death|0|||
149731810|NCT02591615|540153064|FG000|Maintenance MK-3475|Physician discretion|0|||
149731811|NCT02591615|540153065|FG001|Maintenance MK-3475|Physician discretion|0|||
149731812|NCT02591615|540153066|FG002|Maintenance MK-3475|Physician discretion|1|||
149731813|NCT02591615|540153067|FG003|Maintenance MK-3475|Physician discretion|0|||
149731814|NCT02591615|540153064|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
149731815|NCT02591615|540153065|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
149731816|NCT02591615|540153066|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
149731817|NCT02591615|540153067|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
149731818|NCT02591615|540153064|FG000|Maintenance MK-3475|In active treatment|2|||
149731819|NCT02591615|540153065|FG001|Maintenance MK-3475|In active treatment|0|||
149731820|NCT02591615|540153066|FG002|Maintenance MK-3475|In active treatment|0|||
149731821|NCT02591615|540153067|FG003|Maintenance MK-3475|In active treatment|1|||
149731822|NCT04188197|540153068|FG000|Overall Study|Lost to Follow-up|4|||
149731823|NCT04188197|540153069|FG001|Overall Study|Lost to Follow-up|1|||
149731824|NCT04188197|540153068|FG000|Overall Study|Withdrawal by Subject|1|||
149731825|NCT04188197|540153069|FG001|Overall Study|Withdrawal by Subject|1|||
149731826|NCT04188197|540153068|FG000|Overall Study|Pregnancy|0|||
149731827|NCT04188197|540153069|FG001|Overall Study|Pregnancy|1|||
149731828|NCT00956943|540153075|FG000|Overall Study|Lost to Follow-up|9|||
149731829|NCT00956943|540153076|FG001|Overall Study|Lost to Follow-up|10|||
149731830|NCT02613208|540153077|FG000|Overall Study|Withdrawal by Subject|1|||
149731831|NCT02613208|540153077|FG000|Overall Study|Change of address|2|||
149731832|NCT02613208|540153077|FG000|Overall Study|Physician Decision|2|||
149731833|NCT02613208|540153077|FG000|Overall Study|Lost to Follow-up|5|||
149731834|NCT02613208|540153077|FG000|Overall Study|Death|37|||
149731835|NCT02663895|540153078|FG000|Overall Study|Adverse Event|3|||
149731836|NCT02663895|540153078|FG000|Overall Study|Physician Decision|2|||
149731837|NCT02663895|540153078|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
149731838|NCT02663895|540153078|FG000|Overall Study|Withdrawal by Subject|1|||
149731839|NCT00809328|540153082|FG000|Overall Study|Lack of Efficacy|18|||
149731840|NCT00809328|540153082|FG000|Overall Study|Adverse Event|6|||
149731841|NCT00809328|540153082|FG000|Overall Study|Protocol Violation|3|||
149731842|NCT00809328|540153082|FG000|Overall Study|Withdrawal by Subject|2|||
149731843|NCT02911688|540153085|FG000|Washout|Lost to Follow-up|1|||
149731844|NCT02911688|540153086|FG001|Washout|Lost to Follow-up|1|||
149731845|NCT02911688|540153085|FG000|Washout|Withdrawal by Subject|0|||
149731846|NCT02911688|540153086|FG001|Washout|Withdrawal by Subject|1|||
149731847|NCT00947531|540153087|FG000|Overall Study|Withdrawal by Subject|10|||
149731848|NCT00947531|540153088|FG001|Overall Study|Withdrawal by Subject|7|||
149731849|NCT00947531|540153087|FG000|Overall Study|Administrative Reason|0|||
149731850|NCT00947531|540153088|FG001|Overall Study|Administrative Reason|1|||
149731851|NCT00947531|540153087|FG000|Overall Study|Adverse Event|2|||
149731852|NCT00947531|540153088|FG001|Overall Study|Adverse Event|2|||
149731853|NCT00947531|540153087|FG000|Overall Study|Lack of Efficacy|1|||
150253860|NCT03900416|542065734|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
150253861|NCT00836745|542065735|FG000|Overall Study|Death|2|||
150253862|NCT00836745|542065735|FG000|Overall Study|Lost to Follow-up|10|||
150253863|NCT00836745|542065735|FG000|Overall Study|Adverse Event|3|||
150253864|NCT00836745|542065735|FG000|Overall Study|Objective progression or relapse|4|||
150253865|NCT00836745|542065735|FG000|Overall Study|Other|2|||
150253866|NCT05540717|542065736|FG000|Overall Study|Lost to Follow-up|2|||
150253867|NCT05540717|542065737|FG001|Overall Study|Lost to Follow-up|5|||
149731854|NCT00947531|540153088|FG001|Overall Study|Lack of Efficacy|0|||
149731855|NCT00947531|540153087|FG000|Overall Study|Other|1|||
149731856|NCT00947531|540153088|FG001|Overall Study|Other|1|||
149731857|NCT06441877|540153089|FG000|Overall Study|Withdrawal by Subject|0|||
149731858|NCT06441877|540153090|FG001|Overall Study|Withdrawal by Subject|2|||
149731859|NCT06441877|540153091|FG002|Overall Study|Withdrawal by Subject|0|||
149731860|NCT06441877|540153092|FG003|Overall Study|Withdrawal by Subject|0|||
149731861|NCT03706365|540153097|FG000|Overall Study|Lost to Follow-up|7|||
149731862|NCT03706365|540153098|FG001|Overall Study|Lost to Follow-up|0|||
149731863|NCT03706365|540153097|FG000|Overall Study|Withdrawal by Subject|17|||
149731864|NCT03706365|540153098|FG001|Overall Study|Withdrawal by Subject|15|||
150253868|NCT05540717|542065736|FG000|Overall Study|Withdrawal by Subject|6|||
149731865|NCT03706365|540153097|FG000|Overall Study|On Study Treatment|51|||
149731866|NCT03706365|540153098|FG001|Overall Study|On Study Treatment|51|||
150253869|NCT05540717|542065737|FG001|Overall Study|Withdrawal by Subject|6|||
150253870|NCT05540717|542065736|FG000|Overall Study|Sponsor request|1|||
149731867|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
149731868|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
150253871|NCT05540717|542065737|FG001|Overall Study|Sponsor request|0|||
149731869|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
149731870|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
149731871|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
149731872|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
149731873|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
149731874|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
149731875|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149731876|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149731877|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149731878|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
149731879|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
149731880|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149731881|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149731882|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
149731883|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
149731884|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
149731885|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149731886|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149731887|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
149731888|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149731889|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149731890|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149731891|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149731892|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
149731893|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
149731894|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
149731895|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
149731896|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
149731897|NCT05195528|540153099|FG000|Placebo-controlled Treatment Period|Other|0|||
149731898|NCT05195528|540153100|FG001|Placebo-controlled Treatment Period|Other|0|||
149731899|NCT05195528|540153101|FG002|Placebo-controlled Treatment Period|Other|1|||
149731900|NCT05195528|540153102|FG003|Placebo-controlled Treatment Period|Other|0|||
149731901|NCT05195528|540153103|FG004|Placebo-controlled Treatment Period|Other|0|||
149731902|NCT05195528|540153099|FG000|Extension Period|PTE or AE or SAE|0|||
149731903|NCT05195528|540153100|FG001|Extension Period|PTE or AE or SAE|4|||
149731904|NCT05195528|540153101|FG002|Extension Period|PTE or AE or SAE|5|||
149731905|NCT05195528|540153102|FG003|Extension Period|PTE or AE or SAE|4|||
149731906|NCT05195528|540153103|FG004|Extension Period|PTE or AE or SAE|4|||
149731907|NCT05195528|540153099|FG000|Extension Period|Protocol Violation|0|||
149731908|NCT05195528|540153100|FG001|Extension Period|Protocol Violation|2|||
149731909|NCT05195528|540153101|FG002|Extension Period|Protocol Violation|1|||
149731910|NCT05195528|540153102|FG003|Extension Period|Protocol Violation|0|||
149731911|NCT05195528|540153103|FG004|Extension Period|Protocol Violation|1|||
149731912|NCT05195528|540153099|FG000|Extension Period|Lost to Follow-up|0|||
149731913|NCT05195528|540153100|FG001|Extension Period|Lost to Follow-up|6|||
149731914|NCT05195528|540153101|FG002|Extension Period|Lost to Follow-up|13|||
149731915|NCT05195528|540153102|FG003|Extension Period|Lost to Follow-up|3|||
149731916|NCT05195528|540153103|FG004|Extension Period|Lost to Follow-up|7|||
149731917|NCT05195528|540153099|FG000|Extension Period|Withdrawal by Subject|0|||
149731918|NCT05195528|540153100|FG001|Extension Period|Withdrawal by Subject|12|||
149731919|NCT05195528|540153101|FG002|Extension Period|Withdrawal by Subject|9|||
149731920|NCT05195528|540153102|FG003|Extension Period|Withdrawal by Subject|6|||
149731921|NCT05195528|540153103|FG004|Extension Period|Withdrawal by Subject|5|||
149731922|NCT05195528|540153099|FG000|Extension Period|Lack of Efficacy|0|||
149731923|NCT05195528|540153100|FG001|Extension Period|Lack of Efficacy|3|||
149731924|NCT05195528|540153101|FG002|Extension Period|Lack of Efficacy|0|||
149731925|NCT05195528|540153102|FG003|Extension Period|Lack of Efficacy|0|||
149731926|NCT05195528|540153103|FG004|Extension Period|Lack of Efficacy|2|||
149731927|NCT05195528|540153099|FG000|Extension Period|Not Treated|0|||
149731928|NCT05195528|540153100|FG001|Extension Period|Not Treated|0|||
149731929|NCT05195528|540153101|FG002|Extension Period|Not Treated|2|||
149731930|NCT05195528|540153102|FG003|Extension Period|Not Treated|3|||
149731931|NCT05195528|540153103|FG004|Extension Period|Not Treated|0|||
149731932|NCT05195528|540153099|FG000|Extension Period|Other|0|||
149731933|NCT05195528|540153100|FG001|Extension Period|Other|1|||
149731934|NCT05195528|540153101|FG002|Extension Period|Other|1|||
149731935|NCT05195528|540153102|FG003|Extension Period|Other|0|||
149731936|NCT05195528|540153103|FG004|Extension Period|Other|0|||
149731937|NCT01552902|540153104|FG000|Overall Study|Adverse Event|1|||
149731938|NCT01552902|540153105|FG001|Overall Study|Adverse Event|15|||
149731939|NCT01552902|540153106|FG002|Overall Study|Adverse Event|14|||
149731940|NCT01552902|540153104|FG000|Overall Study|Protocol Violation|3|||
149731941|NCT01552902|540153105|FG001|Overall Study|Protocol Violation|3|||
149731942|NCT01552902|540153106|FG002|Overall Study|Protocol Violation|3|||
149731943|NCT01552902|540153104|FG000|Overall Study|Lack of Efficacy|4|||
149731944|NCT01552902|540153105|FG001|Overall Study|Lack of Efficacy|3|||
149731945|NCT01552902|540153106|FG002|Overall Study|Lack of Efficacy|1|||
149731946|NCT01552902|540153104|FG000|Overall Study|Withdrawal by Subject|1|||
149731947|NCT01552902|540153105|FG001|Overall Study|Withdrawal by Subject|9|||
149731948|NCT01552902|540153106|FG002|Overall Study|Withdrawal by Subject|6|||
149731949|NCT01552902|540153104|FG000|Overall Study|Lost to Follow-up|1|||
149731950|NCT01552902|540153105|FG001|Overall Study|Lost to Follow-up|3|||
149731951|NCT01552902|540153106|FG002|Overall Study|Lost to Follow-up|6|||
149731952|NCT01552902|540153104|FG000|Overall Study|Other|3|||
149731953|NCT01552902|540153105|FG001|Overall Study|Other|4|||
149731954|NCT01552902|540153106|FG002|Overall Study|Other|3|||
149731955|NCT02720757|540153107|FG000|Overall Study|Other reason|5|||
149731956|NCT02720757|540153107|FG000|Overall Study|Loss of contact|4|||
149731957|NCT02720757|540153107|FG000|Overall Study|Informed consent withdrawal|1|||
149731958|NCT02720757|540153107|FG000|Overall Study|Patients wish to withdraw|2|||
149731959|NCT02720757|540153107|FG000|Overall Study|Missing|3|||
149731960|NCT02720757|540153107|FG000|Overall Study|General exclusion|3|||
149731961|NCT02631538|540153108|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
149731962|NCT02631538|540153109|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
149731963|NCT02631538|540153110|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
149731964|NCT02631538|540153111|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
150253872|NCT05540717|542065736|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
150253873|NCT05540717|542065737|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
150253874|NCT05540717|542065736|FG000|Overall Study|Other|0|||
150253875|NCT05540717|542065737|FG001|Overall Study|Other|1|||
150253876|NCT03377699|542065738|FG000|Overall Study|Withdrawal by Subject|2|||
150253877|NCT03377699|542065739|FG001|Overall Study|Withdrawal by Subject|9|||
150253878|NCT03377699|542065738|FG000|Overall Study|Lost to Follow-up|1|||
150253879|NCT03377699|542065739|FG001|Overall Study|Lost to Follow-up|1|||
150253880|NCT03377699|542065738|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
150253881|NCT03377699|542065739|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
150253882|NCT03377699|542065738|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
150253883|NCT03377699|542065739|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
149731965|NCT02631538|540153108|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
149731966|NCT02631538|540153109|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
149731967|NCT02631538|540153110|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
149731968|NCT02631538|540153111|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
149731969|NCT02631538|540153108|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
149731970|NCT02631538|540153109|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
149731971|NCT02631538|540153110|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
149731972|NCT02631538|540153111|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
149731973|NCT02631538|540153108|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
149731974|NCT02631538|540153109|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
149731975|NCT02631538|540153110|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
149731976|NCT02631538|540153111|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
149731977|NCT02631538|540153108|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149731978|NCT02631538|540153109|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149731979|NCT02631538|540153110|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
149731980|NCT02631538|540153111|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149731981|NCT02631538|540153108|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
149731982|NCT02631538|540153109|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
149731983|NCT02631538|540153110|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
149731984|NCT02631538|540153111|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
149731985|NCT01554579|540153112|FG000|Overall Study|Adverse Event|6|||
149731986|NCT01554579|540153113|FG001|Overall Study|Adverse Event|25|||
149731987|NCT01554579|540153112|FG000|Overall Study|Lack of Efficacy|2|||
149731988|NCT01554579|540153113|FG001|Overall Study|Lack of Efficacy|1|||
149731989|NCT01554579|540153112|FG000|Overall Study|Withdrawal by Subject|2|||
149731990|NCT01554579|540153113|FG001|Overall Study|Withdrawal by Subject|1|||
149731991|NCT00234039|540153114|FG000|Overall Study|Adverse Event|2|||
149731992|NCT00234039|540153114|FG000|Overall Study|Progression/relapse|34|||
149731993|NCT00234039|540153114|FG000|Overall Study|Other - Not Protocol Specified|3|||
149731994|NCT00234039|540153114|FG000|Overall Study|Ineligible|9|||
149731995|NCT00234039|540153114|FG000|Overall Study|No Protocol Treatment Received|2|||
149731996|NCT00110019|540153115|FG000|Overall Study|Lack of Efficacy|253|||
149731997|NCT00110019|540153116|FG001|Overall Study|Lack of Efficacy|285|||
150253884|NCT03377699|542065738|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
150253885|NCT03377699|542065739|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
150253886|NCT03377699|542065738|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
149731998|NCT00110019|540153115|FG000|Overall Study|Adverse Event|61|||
149731999|NCT00110019|540153116|FG001|Overall Study|Adverse Event|40|||
149732000|NCT00110019|540153115|FG000|Overall Study|Death|13|||
149732001|NCT00110019|540153116|FG001|Overall Study|Death|15|||
149732002|NCT00110019|540153115|FG000|Overall Study|Withdrawal by Subject|21|||
149732003|NCT00110019|540153116|FG001|Overall Study|Withdrawal by Subject|9|||
149732004|NCT00110019|540153115|FG000|Overall Study|alternative therapy|5|||
149732005|NCT00110019|540153116|FG001|Overall Study|alternative therapy|1|||
149732006|NCT00110019|540153115|FG000|Overall Study|complicating disease|1|||
149732007|NCT00110019|540153116|FG001|Overall Study|complicating disease|1|||
149732008|NCT00110019|540153115|FG000|Overall Study|symptom deterioration|13|||
149732009|NCT00110019|540153116|FG001|Overall Study|symptom deterioration|16|||
149732010|NCT00110019|540153115|FG000|Overall Study|Not start protocol therapy|17|||
149732011|NCT00110019|540153116|FG001|Overall Study|Not start protocol therapy|16|||
149732012|NCT00110019|540153115|FG000|Overall Study|other reasons|22|||
149732013|NCT00110019|540153116|FG001|Overall Study|other reasons|30|||
149732014|NCT01046695|540153119|FG000|Overall Study|Subject had a pacemaker|0|||
149732015|NCT01046695|540153120|FG001|Overall Study|Subject had a pacemaker|1|||
149732016|NCT01046695|540153119|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
149732017|NCT01046695|540153120|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
149732018|NCT02239263|540153121|FG000|Overall Study|Protocol Violation|6|||
149732019|NCT04426695|540153122|FG000|Overall Study|Death|2|||
149732020|NCT04426695|540153123|FG001|Overall Study|Death|0|||
149732021|NCT04426695|540153124|FG002|Overall Study|Death|1|||
149732022|NCT04426695|540153125|FG003|Overall Study|Death|27|||
149732023|NCT04426695|540153126|FG004|Overall Study|Death|25|||
149732024|NCT04426695|540153127|FG005|Overall Study|Death|21|||
149732025|NCT04426695|540153128|FG006|Overall Study|Death|42|||
149732026|NCT04426695|540153129|FG007|Overall Study|Death|23|||
149732027|NCT04426695|540153130|FG008|Overall Study|Death|37|||
149732028|NCT04426695|540153131|FG009|Overall Study|Death|14|||
149732029|NCT04426695|540153132|FG010|Overall Study|Death|8|||
149732030|NCT04426695|540153133|FG011|Overall Study|Death|7|||
149732031|NCT04426695|540153134|FG012|Overall Study|Death|13|||
149732032|NCT04426695|540153135|FG013|Overall Study|Death|25|||
149732033|NCT04426695|540153136|FG014|Overall Study|Death|19|||
149732034|NCT04426695|540153137|FG015|Overall Study|Death|7|||
149732035|NCT04426695|540153138|FG016|Overall Study|Death|8|||
149732036|NCT04426695|540153139|FG017|Overall Study|Death|4|||
149732037|NCT04426695|540153122|FG000|Overall Study|Lost to Follow-up|2|||
149732038|NCT04426695|540153123|FG001|Overall Study|Lost to Follow-up|4|||
149732039|NCT04426695|540153124|FG002|Overall Study|Lost to Follow-up|1|||
149732040|NCT04426695|540153125|FG003|Overall Study|Lost to Follow-up|19|||
149732041|NCT04426695|540153126|FG004|Overall Study|Lost to Follow-up|10|||
149732042|NCT04426695|540153127|FG005|Overall Study|Lost to Follow-up|14|||
149732043|NCT04426695|540153128|FG006|Overall Study|Lost to Follow-up|5|||
149732044|NCT04426695|540153129|FG007|Overall Study|Lost to Follow-up|14|||
149732045|NCT04426695|540153130|FG008|Overall Study|Lost to Follow-up|10|||
149732046|NCT04426695|540153131|FG009|Overall Study|Lost to Follow-up|11|||
150253887|NCT03377699|542065739|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
150253888|NCT00774930|542065745|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
150253889|NCT00774930|542065746|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
150253890|NCT00774930|542065745|FG000|DB Phase|Adverse Event|1|||
149732047|NCT04426695|540153132|FG010|Overall Study|Lost to Follow-up|12|||
149732048|NCT04426695|540153133|FG011|Overall Study|Lost to Follow-up|6|||
150253891|NCT00774930|542065746|FG001|DB Phase|Adverse Event|2|||
150253892|NCT00774930|542065745|FG000|DB Phase|Subject Decision|1|||
150253893|NCT00774930|542065746|FG001|DB Phase|Subject Decision|5|||
150253894|NCT00774930|542065745|FG000|DB Phase|Sponsor Decision|0|||
150253895|NCT00774930|542065746|FG001|DB Phase|Sponsor Decision|1|||
150253896|NCT00774930|542065745|FG000|DB Phase|Disease Progression|1|||
150253897|NCT00774930|542065746|FG001|DB Phase|Disease Progression|1|||
150253898|NCT00774930|542065745|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
150253899|NCT00774930|542065746|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
150253900|NCT00774930|542065745|FG000|IOL Phase|Adverse Event|1|||
150253901|NCT00774930|542065746|FG001|IOL Phase|Adverse Event|1|||
150253902|NCT00774930|542065745|FG000|IOL Phase|Subject Decision|4|||
150253903|NCT00774930|542065746|FG001|IOL Phase|Subject Decision|3|||
150253904|NCT00774930|542065745|FG000|IOL Phase|Physician Decision|3|||
150253905|NCT00774930|542065746|FG001|IOL Phase|Physician Decision|2|||
150253906|NCT00774930|542065745|FG000|IOL Phase|Sponsor Decision|1|||
150253907|NCT00774930|542065746|FG001|IOL Phase|Sponsor Decision|0|||
150253908|NCT00774930|542065745|FG000|IOL Phase|Disease Progression|2|||
150253909|NCT00774930|542065746|FG001|IOL Phase|Disease Progression|1|||
150253910|NCT00774930|542065745|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
149732049|NCT04426695|540153134|FG012|Overall Study|Lost to Follow-up|2|||
149732050|NCT04426695|540153135|FG013|Overall Study|Lost to Follow-up|2|||
149732051|NCT04426695|540153136|FG014|Overall Study|Lost to Follow-up|2|||
149732052|NCT04426695|540153137|FG015|Overall Study|Lost to Follow-up|0|||
149732053|NCT04426695|540153138|FG016|Overall Study|Lost to Follow-up|0|||
149732054|NCT04426695|540153139|FG017|Overall Study|Lost to Follow-up|0|||
149732055|NCT04426695|540153122|FG000|Overall Study|Participant Decision|1|||
149732056|NCT04426695|540153123|FG001|Overall Study|Participant Decision|2|||
149732057|NCT04426695|540153124|FG002|Overall Study|Participant Decision|2|||
149732058|NCT04426695|540153125|FG003|Overall Study|Participant Decision|12|||
149732059|NCT04426695|540153126|FG004|Overall Study|Participant Decision|18|||
149732060|NCT04426695|540153127|FG005|Overall Study|Participant Decision|22|||
149732061|NCT04426695|540153128|FG006|Overall Study|Participant Decision|13|||
149732062|NCT04426695|540153129|FG007|Overall Study|Participant Decision|13|||
149732063|NCT04426695|540153130|FG008|Overall Study|Participant Decision|10|||
149732064|NCT04426695|540153131|FG009|Overall Study|Participant Decision|15|||
149732065|NCT04426695|540153132|FG010|Overall Study|Participant Decision|16|||
149732066|NCT04426695|540153133|FG011|Overall Study|Participant Decision|17|||
149732067|NCT04426695|540153134|FG012|Overall Study|Participant Decision|2|||
149732068|NCT04426695|540153135|FG013|Overall Study|Participant Decision|1|||
149732069|NCT04426695|540153136|FG014|Overall Study|Participant Decision|2|||
149732070|NCT04426695|540153137|FG015|Overall Study|Participant Decision|0|||
149732071|NCT04426695|540153138|FG016|Overall Study|Participant Decision|0|||
149732072|NCT04426695|540153139|FG017|Overall Study|Participant Decision|0|||
149732073|NCT04426695|540153122|FG000|Overall Study|Adverse Event|0|||
149732074|NCT04426695|540153123|FG001|Overall Study|Adverse Event|0|||
149732075|NCT04426695|540153124|FG002|Overall Study|Adverse Event|0|||
149732076|NCT04426695|540153125|FG003|Overall Study|Adverse Event|0|||
149732077|NCT04426695|540153126|FG004|Overall Study|Adverse Event|0|||
149732078|NCT04426695|540153127|FG005|Overall Study|Adverse Event|0|||
149732079|NCT04426695|540153128|FG006|Overall Study|Adverse Event|0|||
149732080|NCT04426695|540153129|FG007|Overall Study|Adverse Event|1|||
149732081|NCT04426695|540153130|FG008|Overall Study|Adverse Event|0|||
149732082|NCT04426695|540153131|FG009|Overall Study|Adverse Event|0|||
149732083|NCT04426695|540153132|FG010|Overall Study|Adverse Event|1|||
149732084|NCT04426695|540153133|FG011|Overall Study|Adverse Event|1|||
149732085|NCT04426695|540153134|FG012|Overall Study|Adverse Event|0|||
149732086|NCT04426695|540153135|FG013|Overall Study|Adverse Event|0|||
149732087|NCT04426695|540153136|FG014|Overall Study|Adverse Event|0|||
149732088|NCT04426695|540153137|FG015|Overall Study|Adverse Event|0|||
149732089|NCT04426695|540153138|FG016|Overall Study|Adverse Event|0|||
149732090|NCT04426695|540153139|FG017|Overall Study|Adverse Event|0|||
149732091|NCT04426695|540153122|FG000|Overall Study|Sponsor Request|0|||
149732092|NCT04426695|540153123|FG001|Overall Study|Sponsor Request|0|||
149732093|NCT04426695|540153124|FG002|Overall Study|Sponsor Request|0|||
149732094|NCT04426695|540153125|FG003|Overall Study|Sponsor Request|0|||
149732095|NCT04426695|540153126|FG004|Overall Study|Sponsor Request|0|||
150253911|NCT00774930|542065746|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
150253912|NCT00774930|542065745|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
150253913|NCT00774930|542065746|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
150253914|NCT00774930|542065745|FG000|IOL Phase|Other|1|||
150253915|NCT00774930|542065746|FG001|IOL Phase|Other|0|||
150253916|NCT00774930|542065745|FG000|IOL Phase|Brain radiation|0|||
150253917|NCT00774930|542065746|FG001|IOL Phase|Brain radiation|1|||
150253918|NCT00774930|542065745|FG000|LTOLE Phase|Adverse Event|7|||
150253919|NCT00774930|542065746|FG001|LTOLE Phase|Adverse Event|3|||
150253920|NCT00774930|542065745|FG000|LTOLE Phase|Subject decision|0|||
149732096|NCT04426695|540153127|FG005|Overall Study|Sponsor Request|0|||
149732097|NCT04426695|540153128|FG006|Overall Study|Sponsor Request|1|||
149732098|NCT04426695|540153129|FG007|Overall Study|Sponsor Request|0|||
150253921|NCT00774930|542065746|FG001|LTOLE Phase|Subject decision|5|||
150253922|NCT00774930|542065745|FG000|LTOLE Phase|Physician Decision|4|||
150253923|NCT00774930|542065746|FG001|LTOLE Phase|Physician Decision|1|||
150253924|NCT00774930|542065745|FG000|LTOLE Phase|Sponsor decision|2|||
150253925|NCT00774930|542065746|FG001|LTOLE Phase|Sponsor decision|1|||
150253926|NCT00774930|542065745|FG000|LTOLE Phase|Disease Progression|2|||
150253927|NCT00774930|542065746|FG001|LTOLE Phase|Disease Progression|5|||
149732099|NCT04426695|540153130|FG008|Overall Study|Sponsor Request|0|||
149732100|NCT04426695|540153131|FG009|Overall Study|Sponsor Request|0|||
149732101|NCT04426695|540153132|FG010|Overall Study|Sponsor Request|0|||
149732102|NCT04426695|540153133|FG011|Overall Study|Sponsor Request|0|||
149732103|NCT04426695|540153134|FG012|Overall Study|Sponsor Request|0|||
149732104|NCT04426695|540153135|FG013|Overall Study|Sponsor Request|0|||
149732105|NCT04426695|540153136|FG014|Overall Study|Sponsor Request|0|||
149732106|NCT04426695|540153137|FG015|Overall Study|Sponsor Request|0|||
149732107|NCT04426695|540153138|FG016|Overall Study|Sponsor Request|0|||
149732108|NCT04426695|540153139|FG017|Overall Study|Sponsor Request|0|||
149732109|NCT04426695|540153122|FG000|Overall Study|Physician Decision|0|||
150253928|NCT00774930|542065745|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
149732110|NCT04426695|540153123|FG001|Overall Study|Physician Decision|0|||
149732111|NCT04426695|540153124|FG002|Overall Study|Physician Decision|0|||
149732112|NCT04426695|540153125|FG003|Overall Study|Physician Decision|0|||
149732113|NCT04426695|540153126|FG004|Overall Study|Physician Decision|0|||
149732114|NCT04426695|540153127|FG005|Overall Study|Physician Decision|0|||
149732115|NCT04426695|540153128|FG006|Overall Study|Physician Decision|0|||
149732116|NCT04426695|540153129|FG007|Overall Study|Physician Decision|0|||
149732117|NCT04426695|540153130|FG008|Overall Study|Physician Decision|0|||
149732118|NCT04426695|540153131|FG009|Overall Study|Physician Decision|1|||
149732119|NCT04426695|540153132|FG010|Overall Study|Physician Decision|0|||
149732120|NCT04426695|540153133|FG011|Overall Study|Physician Decision|0|||
149732121|NCT04426695|540153134|FG012|Overall Study|Physician Decision|1|||
149732122|NCT04426695|540153135|FG013|Overall Study|Physician Decision|0|||
149732123|NCT04426695|540153136|FG014|Overall Study|Physician Decision|0|||
149732124|NCT04426695|540153137|FG015|Overall Study|Physician Decision|0|||
149732125|NCT04426695|540153138|FG016|Overall Study|Physician Decision|0|||
149732126|NCT04426695|540153139|FG017|Overall Study|Physician Decision|0|||
149732127|NCT04426695|540153122|FG000|Overall Study|Randomized but Never Treated|3|||
149732128|NCT04426695|540153123|FG001|Overall Study|Randomized but Never Treated|1|||
149732129|NCT04426695|540153124|FG002|Overall Study|Randomized but Never Treated|0|||
149732130|NCT04426695|540153125|FG003|Overall Study|Randomized but Never Treated|4|||
149732131|NCT04426695|540153126|FG004|Overall Study|Randomized but Never Treated|5|||
149732132|NCT04426695|540153127|FG005|Overall Study|Randomized but Never Treated|5|||
149732133|NCT04426695|540153128|FG006|Overall Study|Randomized but Never Treated|4|||
149732134|NCT04426695|540153129|FG007|Overall Study|Randomized but Never Treated|6|||
149732135|NCT04426695|540153130|FG008|Overall Study|Randomized but Never Treated|6|||
149732136|NCT04426695|540153131|FG009|Overall Study|Randomized but Never Treated|3|||
149732137|NCT04426695|540153132|FG010|Overall Study|Randomized but Never Treated|3|||
149732138|NCT04426695|540153133|FG011|Overall Study|Randomized but Never Treated|6|||
149732139|NCT04426695|540153134|FG012|Overall Study|Randomized but Never Treated|1|||
149732140|NCT04426695|540153135|FG013|Overall Study|Randomized but Never Treated|2|||
149732141|NCT04426695|540153136|FG014|Overall Study|Randomized but Never Treated|0|||
149732142|NCT04426695|540153137|FG015|Overall Study|Randomized but Never Treated|0|||
149732143|NCT04426695|540153138|FG016|Overall Study|Randomized but Never Treated|0|||
149732144|NCT04426695|540153139|FG017|Overall Study|Randomized but Never Treated|0|||
149732145|NCT04303000|540153140|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
149732146|NCT04303000|540153141|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
149732147|NCT04303000|540153142|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
149732148|NCT05655377|540153144|FG000|Overall Study|Withdrawal by Subject|2|||
149732149|NCT03653390|540153145|FG000|Overall Study|Lost to Follow-up|12|||
149732150|NCT03653390|540153146|FG001|Overall Study|Lost to Follow-up|8|||
149732151|NCT03653390|540153147|FG002|Overall Study|Lost to Follow-up|7|||
149732152|NCT03653390|540153145|FG000|Overall Study|Withdrawal by Subject|6|||
149732153|NCT03653390|540153146|FG001|Overall Study|Withdrawal by Subject|1|||
149732154|NCT03653390|540153147|FG002|Overall Study|Withdrawal by Subject|1|||
149732155|NCT03653390|540153145|FG000|Overall Study|Death|1|||
149732156|NCT03653390|540153146|FG001|Overall Study|Death|0|||
149732157|NCT03653390|540153147|FG002|Overall Study|Death|0|||
149732158|NCT03653390|540153145|FG000|Overall Study|Paper Survey Lost|1|||
149732159|NCT03653390|540153146|FG001|Overall Study|Paper Survey Lost|0|||
149732160|NCT03653390|540153147|FG002|Overall Study|Paper Survey Lost|0|||
149732161|NCT03118947|540153148|FG000|Overall Study|Adverse Event|7|||
149732162|NCT03118947|540153148|FG000|Overall Study|Death|3|||
149732163|NCT03118947|540153148|FG000|Overall Study|Lack of Efficacy|4|||
149732164|NCT03118947|540153148|FG000|Overall Study|Non-compliance with study drug|1|||
149732165|NCT03118947|540153148|FG000|Overall Study|Protocol Violation|2|||
149732166|NCT03118947|540153148|FG000|Overall Study|Withdrawal by Subject|3|||
149732167|NCT03118947|540153148|FG000|Overall Study|Withdrawal by caregiver|3|||
149732168|NCT03118947|540153148|FG000|Overall Study|Change in patient's living situation|4|||
149732169|NCT03118947|540153148|FG000|Overall Study|Lost to Follow-up|2|||
149732170|NCT00531960|540153151|FG000|Overall Study|Adverse Event|5|||
149732171|NCT00531960|540153152|FG001|Overall Study|Adverse Event|4|||
149732172|NCT00531960|540153151|FG000|Overall Study|Death|3|||
149732173|NCT00531960|540153152|FG001|Overall Study|Death|2|||
149732174|NCT00531960|540153151|FG000|Overall Study|Lack of Efficacy|42|||
149732175|NCT00531960|540153152|FG001|Overall Study|Lack of Efficacy|41|||
149732176|NCT00531960|540153151|FG000|Overall Study|Violation of Selection Criteria|2|||
149732177|NCT00531960|540153152|FG001|Overall Study|Violation of Selection Criteria|0|||
149732178|NCT00531960|540153151|FG000|Overall Study|Refused Treatment|5|||
149732179|NCT00531960|540153152|FG001|Overall Study|Refused Treatment|6|||
149732180|NCT00531960|540153151|FG000|Overall Study|Other|4|||
149732181|NCT00531960|540153152|FG001|Overall Study|Other|10|||
149732182|NCT02532855|540153160|FG000|Overall Study|Lost to Follow-up|4|||
149732183|NCT02532855|540153161|FG001|Overall Study|Lost to Follow-up|3|||
149732184|NCT02532855|540153160|FG000|Overall Study|Withdrawal by Subject|4|||
149732185|NCT02532855|540153161|FG001|Overall Study|Withdrawal by Subject|8|||
149732186|NCT04178772|540153172|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
149732187|NCT04178772|540153172|FG000|Overall Study|study terminated early due to COVID-19|7|||
149732188|NCT04897867|540153184|FG000|Overall Study|Withdrawal of Consent|1|||
149732189|NCT04897867|540153184|FG000|Overall Study|Pregnancy|1|||
149732190|NCT04897867|540153184|FG000|Overall Study|Lost to Follow-up|7|||
149732191|NCT04897867|540153184|FG000|Overall Study|Reason not Specified|2|||
149732192|NCT00508391|540153185|FG000|First Treatment|Withdrawal by Subject|6|||
149732193|NCT00508391|540153186|FG001|First Treatment|Withdrawal by Subject|3|||
149732194|NCT00508391|540153185|FG000|Second Treatment|Withdrawal by Subject|2|||
149732195|NCT00508391|540153186|FG001|Second Treatment|Withdrawal by Subject|0|||
149732196|NCT00880256|540153187|FG000|Overall Study|Lost to Follow-up|28|||
149732197|NCT00802360|540153188|FG000|Overall Study|Stimulation failure|4|||
149732198|NCT00802360|540153189|FG001|Overall Study|Stimulation failure|0|||
149732199|NCT00802360|540153190|FG002|Overall Study|Stimulation failure|3|||
149732200|NCT00802360|540153191|FG003|Overall Study|Stimulation failure|3|||
149732201|NCT00802360|540153188|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
149732202|NCT00802360|540153189|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
149732203|NCT00802360|540153190|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
149732204|NCT00802360|540153191|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
149732205|NCT00802360|540153188|FG000|Overall Study|Cycle cancelled|0|||
149732206|NCT00802360|540153189|FG001|Overall Study|Cycle cancelled|1|||
149732207|NCT00802360|540153190|FG002|Overall Study|Cycle cancelled|1|||
149732208|NCT00802360|540153191|FG003|Overall Study|Cycle cancelled|1|||
149732209|NCT00802360|540153188|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149732210|NCT00802360|540153189|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149732211|NCT00802360|540153190|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149732212|NCT00802360|540153191|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
149732213|NCT00802360|540153188|FG000|Overall Study|No positive serum pregnancy|17|||
149732214|NCT00802360|540153189|FG001|Overall Study|No positive serum pregnancy|20|||
149732215|NCT00802360|540153190|FG002|Overall Study|No positive serum pregnancy|14|||
149732216|NCT00802360|540153191|FG003|Overall Study|No positive serum pregnancy|10|||
149732217|NCT00802360|540153188|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
149732218|NCT00802360|540153189|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
149732219|NCT00802360|540153190|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
149732220|NCT00802360|540153191|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
149732221|NCT00802360|540153188|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
149732222|NCT00802360|540153189|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
149732223|NCT00802360|540153190|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
149732224|NCT00802360|540153191|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
149732225|NCT00802360|540153188|FG000|Overall Study|Other|2|||
149732226|NCT00802360|540153189|FG001|Overall Study|Other|3|||
149732227|NCT00802360|540153190|FG002|Overall Study|Other|6|||
149732228|NCT00802360|540153191|FG003|Overall Study|Other|3|||
149732229|NCT02041962|540153192|FG000|Overall Study|Lost Aetna Coverage|43|||
149732230|NCT02041962|540153193|FG001|Overall Study|Lost Aetna Coverage|40|||
149732231|NCT02041962|540153192|FG000|Overall Study|Death|1|||
149732232|NCT02041962|540153193|FG001|Overall Study|Death|1|||
149732233|NCT02041962|540153192|FG000|Overall Study|Lost to Follow-up|37|||
149732234|NCT02041962|540153193|FG001|Overall Study|Lost to Follow-up|32|||
149732235|NCT02041962|540153192|FG000|Overall Study|Withdrawal by Subject|0|||
149732236|NCT02041962|540153193|FG001|Overall Study|Withdrawal by Subject|11|||
149732237|NCT00330187|540153196|FG000|Overall Study|Lost to Follow-up|12|||
149732238|NCT00330187|540153197|FG001|Overall Study|Lost to Follow-up|13|||
149732239|NCT00330187|540153198|FG002|Overall Study|Lost to Follow-up|14|||
149732240|NCT00330187|540153199|FG003|Overall Study|Lost to Follow-up|10|||
149732241|NCT00330187|540153196|FG000|Overall Study|Withdrawal by Subject|8|||
149732242|NCT00330187|540153197|FG001|Overall Study|Withdrawal by Subject|5|||
149732243|NCT00330187|540153198|FG002|Overall Study|Withdrawal by Subject|4|||
149732244|NCT00330187|540153199|FG003|Overall Study|Withdrawal by Subject|4|||
149732245|NCT02908516|540153200|FG000|Overall Study|Study Terminated|3|||
149732246|NCT02908516|540153201|FG001|Overall Study|Study Terminated|3|||
149732247|NCT01225562|540153202|FG000|Overall Study|Withdrawal by Subject|52|||
149732248|NCT01225562|540153203|FG001|Overall Study|Withdrawal by Subject|50|||
149732249|NCT01225562|540153204|FG002|Overall Study|Withdrawal by Subject|52|||
150253929|NCT00774930|542065746|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
150253930|NCT00774930|542065745|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
149732250|NCT01225562|540153202|FG000|Overall Study|Lost to Follow-up|3|||
149732251|NCT01225562|540153203|FG001|Overall Study|Lost to Follow-up|6|||
150253931|NCT00774930|542065746|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
150253932|NCT01177800|542065751|FG000|Overall Study|Adverse Event|9|||
150253933|NCT01177800|542065752|FG001|Overall Study|Adverse Event|3|||
149732252|NCT01225562|540153204|FG002|Overall Study|Lost to Follow-up|1|||
149732253|NCT02601573|540153207|FG000|Overall Study|Lost to Follow-up|0|||
149732254|NCT02601573|540153208|FG001|Overall Study|Lost to Follow-up|3|||
149732255|NCT02601573|540153209|FG002|Overall Study|Lost to Follow-up|1|||
149732256|NCT02601573|540153210|FG003|Overall Study|Lost to Follow-up|0|||
149732257|NCT02601573|540153211|FG004|Overall Study|Lost to Follow-up|2|||
149732258|NCT02601573|540153207|FG000|Overall Study|Withdrawal by Subject|0|||
149732259|NCT02601573|540153208|FG001|Overall Study|Withdrawal by Subject|1|||
149732260|NCT02601573|540153209|FG002|Overall Study|Withdrawal by Subject|0|||
149732261|NCT02601573|540153210|FG003|Overall Study|Withdrawal by Subject|1|||
149732262|NCT02601573|540153211|FG004|Overall Study|Withdrawal by Subject|0|||
149732263|NCT01107444|540153212|FG000|Overall Study|Withdrawal by Subject|8|||
149732264|NCT01107444|540153213|FG001|Overall Study|Withdrawal by Subject|12|||
149732265|NCT01107444|540153212|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
149732266|NCT01107444|540153213|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
149732267|NCT01948830|540153214|FG000|Overall Study|Physician Decision|1|||
149732268|NCT01948830|540153215|FG001|Overall Study|Physician Decision|3|||
149732269|NCT01948830|540153214|FG000|Overall Study|Protocol deviation|1|||
149732270|NCT01948830|540153215|FG001|Overall Study|Protocol deviation|2|||
149732271|NCT01948830|540153214|FG000|Overall Study|Lost to Follow-up|5|||
149732272|NCT01948830|540153215|FG001|Overall Study|Lost to Follow-up|4|||
149732273|NCT01948830|540153214|FG000|Overall Study|Withdrawal by Subject|14|||
149732274|NCT01948830|540153215|FG001|Overall Study|Withdrawal by Subject|17|||
149732275|NCT01948830|540153214|FG000|Overall Study|Adverse Event|9|||
149732276|NCT01948830|540153215|FG001|Overall Study|Adverse Event|2|||
149732277|NCT01948830|540153214|FG000|Overall Study|Death|3|||
149732278|NCT01948830|540153215|FG001|Overall Study|Death|4|||
149732279|NCT03310970|540153217|FG000|Overall Study|Withdrawal by Subject|0|||
149732280|NCT03310970|540153218|FG001|Overall Study|Withdrawal by Subject|1|||
149732281|NCT02526550|540153219|FG000|Overall Study|Lost to Follow-up|1|||
149732282|NCT04062214|540153223|FG000|Week 12|Death|1|||
149732283|NCT04062214|540153224|FG001|Week 12|Death|1|||
149732284|NCT04062214|540153223|FG000|Week 12|Withdrawal by Subject|14|||
149732285|NCT04062214|540153224|FG001|Week 12|Withdrawal by Subject|13|||
149732286|NCT04062214|540153223|FG000|Week 12|Lost to Follow-up|55|||
149732287|NCT04062214|540153224|FG001|Week 12|Lost to Follow-up|68|||
149732288|NCT04062214|540153223|FG000|Week 12|Intermittent missing|31|||
149732289|NCT04062214|540153224|FG001|Week 12|Intermittent missing|29|||
149732290|NCT04062214|540153223|FG000|Week 36|Withdrawal by Subject|4|||
149732291|NCT04062214|540153224|FG001|Week 36|Withdrawal by Subject|5|||
149732292|NCT04062214|540153223|FG000|Week 36|Lost to Follow-up|50|||
149732293|NCT04062214|540153224|FG001|Week 36|Lost to Follow-up|46|||
149732294|NCT04062214|540153223|FG000|Week 36|Death|0|||
149732295|NCT04062214|540153224|FG001|Week 36|Death|1|||
149732296|NCT00091832|540153225|FG000|Overall Study|Physician Decision|1|||
149732297|NCT00091832|540153226|FG001|Overall Study|Physician Decision|0|||
149732298|NCT00091832|540153227|FG002|Overall Study|Physician Decision|0|||
149732299|NCT00091832|540153228|FG003|Overall Study|Physician Decision|0|||
149732300|NCT00091832|540153229|FG004|Overall Study|Physician Decision|0|||
149732301|NCT00091832|540153230|FG005|Overall Study|Physician Decision|0|||
149732302|NCT00091832|540153225|FG000|Overall Study|Adverse Event|0|||
149732303|NCT00091832|540153226|FG001|Overall Study|Adverse Event|0|||
149732304|NCT00091832|540153227|FG002|Overall Study|Adverse Event|0|||
149732305|NCT00091832|540153228|FG003|Overall Study|Adverse Event|1|||
149732306|NCT00091832|540153229|FG004|Overall Study|Adverse Event|3|||
149732307|NCT00091832|540153230|FG005|Overall Study|Adverse Event|0|||
149732308|NCT00091832|540153225|FG000|Overall Study|Withdrawal by Subject|4|||
149732309|NCT00091832|540153226|FG001|Overall Study|Withdrawal by Subject|5|||
149732310|NCT00091832|540153227|FG002|Overall Study|Withdrawal by Subject|0|||
149732311|NCT00091832|540153228|FG003|Overall Study|Withdrawal by Subject|1|||
149732312|NCT00091832|540153229|FG004|Overall Study|Withdrawal by Subject|3|||
149732313|NCT00091832|540153230|FG005|Overall Study|Withdrawal by Subject|1|||
149732314|NCT00091832|540153225|FG000|Overall Study|Death|6|||
149732315|NCT00091832|540153226|FG001|Overall Study|Death|4|||
149732316|NCT00091832|540153227|FG002|Overall Study|Death|5|||
149732317|NCT00091832|540153228|FG003|Overall Study|Death|8|||
149732318|NCT00091832|540153229|FG004|Overall Study|Death|5|||
149732319|NCT00091832|540153230|FG005|Overall Study|Death|6|||
149732320|NCT00091832|540153225|FG000|Overall Study|Disease Progression|2|||
149732321|NCT00091832|540153226|FG001|Overall Study|Disease Progression|0|||
149732322|NCT00091832|540153227|FG002|Overall Study|Disease Progression|0|||
149732323|NCT00091832|540153228|FG003|Overall Study|Disease Progression|1|||
149732324|NCT00091832|540153229|FG004|Overall Study|Disease Progression|1|||
149732325|NCT00091832|540153230|FG005|Overall Study|Disease Progression|2|||
149732326|NCT00091832|540153225|FG000|Overall Study|Ineligibility Determined|0|||
149732327|NCT00091832|540153226|FG001|Overall Study|Ineligibility Determined|0|||
149732328|NCT00091832|540153227|FG002|Overall Study|Ineligibility Determined|1|||
149732329|NCT00091832|540153228|FG003|Overall Study|Ineligibility Determined|0|||
149732330|NCT00091832|540153229|FG004|Overall Study|Ineligibility Determined|1|||
149732331|NCT00091832|540153230|FG005|Overall Study|Ineligibility Determined|0|||
149732332|NCT00091832|540153225|FG000|Overall Study|Lost to Follow-up|1|||
149732333|NCT00091832|540153226|FG001|Overall Study|Lost to Follow-up|0|||
149732334|NCT00091832|540153227|FG002|Overall Study|Lost to Follow-up|3|||
149732335|NCT00091832|540153228|FG003|Overall Study|Lost to Follow-up|3|||
149732336|NCT00091832|540153229|FG004|Overall Study|Lost to Follow-up|2|||
149732337|NCT00091832|540153230|FG005|Overall Study|Lost to Follow-up|1|||
149732338|NCT00091832|540153225|FG000|Overall Study|Noncompliance|0|||
149732339|NCT00091832|540153226|FG001|Overall Study|Noncompliance|1|||
149732340|NCT00091832|540153227|FG002|Overall Study|Noncompliance|0|||
149732341|NCT00091832|540153228|FG003|Overall Study|Noncompliance|0|||
149732342|NCT00091832|540153229|FG004|Overall Study|Noncompliance|0|||
149732343|NCT00091832|540153230|FG005|Overall Study|Noncompliance|0|||
149732344|NCT00091832|540153225|FG000|Overall Study|Other|0|||
149732345|NCT00091832|540153226|FG001|Overall Study|Other|1|||
149732346|NCT00091832|540153227|FG002|Overall Study|Other|2|||
149732347|NCT00091832|540153228|FG003|Overall Study|Other|0|||
149732348|NCT00091832|540153229|FG004|Overall Study|Other|0|||
149732349|NCT00091832|540153230|FG005|Overall Study|Other|0|||
149732350|NCT00091832|540153225|FG000|Overall Study|Protocol Violation|0|||
149732351|NCT00091832|540153226|FG001|Overall Study|Protocol Violation|0|||
149732352|NCT00091832|540153227|FG002|Overall Study|Protocol Violation|1|||
149732353|NCT00091832|540153228|FG003|Overall Study|Protocol Violation|0|||
149732354|NCT00091832|540153229|FG004|Overall Study|Protocol Violation|0|||
149732355|NCT00091832|540153230|FG005|Overall Study|Protocol Violation|1|||
149732356|NCT02542072|540153237|FG000|First Intervention (1 Month)|Adverse Event|1|||
149732357|NCT02542072|540153238|FG001|First Intervention (1 Month)|Adverse Event|1|||
149732358|NCT02542072|540153237|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
149732359|NCT02542072|540153238|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
149732360|NCT02542072|540153237|FG000|First Intervention (1 Month)|Lens discomfort|1|||
149732361|NCT02542072|540153238|FG001|First Intervention (1 Month)|Lens discomfort|2|||
149732362|NCT02542072|540153237|FG000|First Intervention (1 Month)|Protocol Violation|1|||
149732363|NCT02542072|540153238|FG001|First Intervention (1 Month)|Protocol Violation|0|||
149732364|NCT02542072|540153237|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
149732365|NCT02542072|540153238|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
149732366|NCT02542072|540153237|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
149732367|NCT02542072|540153238|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
149732368|NCT00654498|540153241|FG000|Overall Study|Not Treated|1|||
149732369|NCT00654498|540153242|FG001|Overall Study|Not Treated|0|||
149732370|NCT00654498|540153241|FG000|Overall Study|Adverse Event|6|||
149732371|NCT00654498|540153242|FG001|Overall Study|Adverse Event|1|||
149732372|NCT00654498|540153241|FG000|Overall Study|Protocol Violation|1|||
149732373|NCT00654498|540153242|FG001|Overall Study|Protocol Violation|1|||
149732374|NCT00654498|540153241|FG000|Overall Study|Lost to Follow-up|1|||
149732375|NCT00654498|540153242|FG001|Overall Study|Lost to Follow-up|5|||
149732376|NCT00654498|540153241|FG000|Overall Study|Withdrawal by Subject|1|||
149732377|NCT00654498|540153242|FG001|Overall Study|Withdrawal by Subject|0|||
149732378|NCT00654498|540153241|FG000|Overall Study|Other reason not defined above|4|||
149732379|NCT00654498|540153242|FG001|Overall Study|Other reason not defined above|5|||
149732380|NCT01990261|540153243|FG000|Overall Study|Death Before Treatment Start|2|||
149732381|NCT01990261|540153243|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
149732382|NCT01990261|540153243|FG000|Overall Study|Death From other Causes|1|||
149732383|NCT01990261|540153243|FG000|Overall Study|Disease Progression (PD)|8|||
149732384|NCT01990261|540153243|FG000|Overall Study|PD Before Treatment Start|1|||
149732385|NCT01990261|540153243|FG000|Overall Study|Dossier not Approved|1|||
149732386|NCT01990261|540153243|FG000|Overall Study|Lost to Follow-up|2|||
149732387|NCT01609842|540153244|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
149732388|NCT01609842|540153245|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
149732389|NCT02474329|540153247|FG000|Overall Study|Withdraw or did not contribute data.|13|||
149732390|NCT01356589|540153248|FG000|Overall Study|Enrolled, but not treated|3|||
149732391|NCT01356589|540153248|FG000|Overall Study|Dose data not recorded|2|||
149732392|NCT04343651|540153249|FG000|Overall Study|Physician Decision|2|||
149732393|NCT04343651|540153250|FG001|Overall Study|Physician Decision|1|||
149732394|NCT04343651|540153249|FG000|Overall Study|Lost to Follow-up|2|||
149732395|NCT04343651|540153250|FG001|Overall Study|Lost to Follow-up|1|||
149732396|NCT04343651|540153249|FG000|Overall Study|Protocol Violation|4|||
149732397|NCT04343651|540153250|FG001|Overall Study|Protocol Violation|6|||
149732398|NCT04343651|540153249|FG000|Overall Study|Missing|3|||
149732399|NCT04343651|540153250|FG001|Overall Study|Missing|9|||
149732400|NCT04343651|540153249|FG000|Overall Study|Withdrawal by Subject|0|||
149732401|NCT04343651|540153250|FG001|Overall Study|Withdrawal by Subject|4|||
149732402|NCT04343651|540153249|FG000|Overall Study|Death|0|||
149732403|NCT04343651|540153250|FG001|Overall Study|Death|1|||
149732404|NCT04343651|540153249|FG000|Overall Study|Did not start treatment|1|||
149732405|NCT04343651|540153250|FG001|Overall Study|Did not start treatment|1|||
149732406|NCT04343651|540153249|FG000|Overall Study|Patient did not complete visits 3-6|0|||
149732407|NCT04343651|540153250|FG001|Overall Study|Patient did not complete visits 3-6|1|||
149732408|NCT04025632|540154830|FG000|Overall Study|Adverse Event|1|||
149732409|NCT04025632|540154831|FG001|Overall Study|Adverse Event|1|||
149732410|NCT04025632|540154830|FG000|Overall Study|Withdrawal by Subject|1|||
149732411|NCT04025632|540154831|FG001|Overall Study|Withdrawal by Subject|1|||
149732412|NCT04025632|540154830|FG000|Overall Study|Study Terminated by Sponsor|10|||
149732413|NCT04025632|540154831|FG001|Overall Study|Study Terminated by Sponsor|9|||
149732414|NCT04025632|540154830|FG000|Overall Study|Physician Decision|3|||
149732415|NCT04025632|540154831|FG001|Overall Study|Physician Decision|1|||
149732416|NCT00376961|540154832|FG000|Initial Registration|Adverse Event|1|||
149732417|NCT00376961|540154833|FG001|Initial Registration|Adverse Event|0|||
149732418|NCT00376961|540154832|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
149732419|NCT00376961|540154833|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149732420|NCT00376961|540154832|FG000|Initial Registration|Progression/relapse|1|||
149732421|NCT00376961|540154833|FG001|Initial Registration|Progression/relapse|0|||
149732422|NCT00376961|540154832|FG000|Initial Registration|Ineligible|3|||
149732423|NCT00376961|540154833|FG001|Initial Registration|Ineligible|0|||
149732424|NCT00376961|540154832|FG000|Maintenance|Adverse Event|0|||
149732425|NCT00376961|540154833|FG001|Maintenance|Adverse Event|1|||
149732426|NCT00376961|540154832|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
149732427|NCT00376961|540154833|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
149732428|NCT00376961|540154832|FG000|Maintenance|Progression/relapse|0|||
149732429|NCT00376961|540154833|FG001|Maintenance|Progression/relapse|18|||
149732430|NCT00376961|540154832|FG000|Maintenance|Ineligible|0|||
149732431|NCT00376961|540154833|FG001|Maintenance|Ineligible|3|||
149732432|NCT00925600|540154834|FG000|Overall Study|Withdrawal by Subject|16|||
149732433|NCT00925600|540154835|FG001|Overall Study|Withdrawal by Subject|14|||
149732434|NCT00925600|540154834|FG000|Overall Study|Death|4|||
149732435|NCT00925600|540154835|FG001|Overall Study|Death|3|||
149732436|NCT00925600|540154834|FG000|Overall Study|Lost to Follow-up|2|||
149732437|NCT00925600|540154835|FG001|Overall Study|Lost to Follow-up|2|||
149732438|NCT00925600|540154834|FG000|Overall Study|Disease Progression|1|||
149732439|NCT00925600|540154835|FG001|Overall Study|Disease Progression|3|||
149732440|NCT00925600|540154834|FG000|Overall Study|Administrative Decision|1|||
149732441|NCT00925600|540154835|FG001|Overall Study|Administrative Decision|1|||
149732442|NCT00925600|540154834|FG000|Overall Study|Noncompliance|2|||
149732443|NCT00925600|540154835|FG001|Overall Study|Noncompliance|0|||
149732444|NCT00925600|540154834|FG000|Overall Study|Ineligibility Determined|2|||
149732445|NCT00925600|540154835|FG001|Overall Study|Ineligibility Determined|0|||
149732446|NCT00925600|540154834|FG000|Overall Study|Protocol Deviation|0|||
149732447|NCT00925600|540154835|FG001|Overall Study|Protocol Deviation|1|||
149732448|NCT00925600|540154834|FG000|Overall Study|Requirement for Alternative Therapy|0|||
149732449|NCT00925600|540154835|FG001|Overall Study|Requirement for Alternative Therapy|1|||
149732450|NCT00925600|540154834|FG000|Overall Study|Other|3|||
149732451|NCT00925600|540154835|FG001|Overall Study|Other|1|||
149732452|NCT00925600|540154834|FG000|Overall Study|Adverse Event|1|||
149732453|NCT00925600|540154835|FG001|Overall Study|Adverse Event|2|||
149732454|NCT04047797|540154838|FG000|Overall Study|Progressive Disease|1|||
149732455|NCT01793792|540154843|FG000|Overall Study|Death|5|||
149732456|NCT01793792|540154843|FG000|Overall Study|Lost to Follow-up|5|||
149732457|NCT01793792|540154843|FG000|Overall Study|Withdrawal by Subject|1|||
149732458|NCT01793792|540154843|FG000|Overall Study|Device Not Implanted|1|||
149732459|NCT00851903|540154846|FG000|Overall Study|Withdrawal by Subject|2|||
149732460|NCT00270894|540154847|FG000|Overall Study|Adverse Event|1|||
149732461|NCT00270894|540154847|FG000|Overall Study|Withdrawal by Subject|1|||
149732462|NCT01070329|540154848|FG000|Overall Study|Adverse Event|13|||
149732463|NCT01070329|540154849|FG001|Overall Study|Adverse Event|10|||
149732464|NCT01070329|540154848|FG000|Overall Study|Lost to Follow-up|22|||
149732465|NCT01070329|540154849|FG001|Overall Study|Lost to Follow-up|12|||
149732466|NCT01070329|540154848|FG000|Overall Study|Withdrawal by Subject|9|||
149732467|NCT01070329|540154849|FG001|Overall Study|Withdrawal by Subject|11|||
149732468|NCT01070329|540154848|FG000|Overall Study|Protocol Violation|3|||
149732469|NCT01070329|540154849|FG001|Overall Study|Protocol Violation|8|||
149732470|NCT01070329|540154848|FG000|Overall Study|Lack of Efficacy|2|||
149732471|NCT01070329|540154849|FG001|Overall Study|Lack of Efficacy|6|||
149732472|NCT01070329|540154848|FG000|Overall Study|Physician Decision|2|||
149732473|NCT01070329|540154849|FG001|Overall Study|Physician Decision|1|||
149732474|NCT01070329|540154848|FG000|Overall Study|Entry Criteria Not Met|1|||
149732475|NCT01070329|540154849|FG001|Overall Study|Entry Criteria Not Met|0|||
149732476|NCT01070329|540154848|FG000|Overall Study|Sponsor Decision|0|||
149732477|NCT01070329|540154849|FG001|Overall Study|Sponsor Decision|1|||
149732478|NCT02863848|540154850|FG000|Overall Study|Lost to Follow-up|1|||
149732479|NCT02863848|540154851|FG001|Overall Study|Lost to Follow-up|1|||
149732480|NCT02863848|540154850|FG000|Overall Study|Protocol Violation|1|||
149732481|NCT02863848|540154851|FG001|Overall Study|Protocol Violation|2|||
150253934|NCT01177800|542065751|FG000|Overall Study|Protocol Violation|0|||
149732482|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732483|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149732484|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732485|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732486|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732487|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
149732488|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149732489|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149732490|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149732491|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
149732492|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149732493|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149732494|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732495|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149732496|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149732497|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149732498|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149732499|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149732500|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149732501|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
149732502|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732503|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732504|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732505|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149732506|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732507|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
149732508|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
149732509|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149732510|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149732511|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149732512|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
149732513|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
149732514|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
149732515|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
149732516|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
149732517|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149732518|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
149732519|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
149732520|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
149732521|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149732522|NCT00289913|540154854|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
149732523|NCT00289913|540154855|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732524|NCT00289913|540154856|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
149732525|NCT00289913|540154857|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732526|NCT00289913|540154858|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732527|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732528|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732529|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149732530|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732531|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732532|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
149732533|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
149732534|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
149732535|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
149732536|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
149732537|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149732538|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
149732539|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149732540|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149732541|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149732542|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
149732543|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149732544|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
149732545|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732546|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732547|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149732548|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732549|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149732550|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732551|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732552|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149732553|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
149732554|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
149732555|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
149732556|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149732557|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
149732558|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
149732559|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
149732560|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
149732561|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
149732562|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149732563|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
149732564|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
149732565|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149732566|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149732567|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
149732568|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149732569|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149732570|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149732571|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149732572|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149732573|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149732574|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149732575|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149732576|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
149732577|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149732578|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149732579|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149732580|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149732581|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
149732582|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149732583|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149732584|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149732585|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149732586|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
149732587|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149732588|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149732589|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149732590|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149732591|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
149732592|NCT00289913|540154854|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149732593|NCT00289913|540154855|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149732594|NCT00289913|540154856|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149732595|NCT00289913|540154857|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149732596|NCT00289913|540154858|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
149732597|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732598|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149732599|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732600|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732601|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149732602|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
149732603|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
149732604|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
150253935|NCT01177800|542065752|FG001|Overall Study|Protocol Violation|1|||
150253936|NCT01177800|542065751|FG000|Overall Study|Physician Decision|1|||
150253937|NCT01177800|542065752|FG001|Overall Study|Physician Decision|0|||
149732605|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
149732606|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
149732607|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732608|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732609|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732610|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
149732611|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149732612|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732613|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732614|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732615|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149732616|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149732617|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
149732618|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
149732619|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
149732620|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
149732621|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
149732622|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149732623|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
149732624|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
149732625|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149732626|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149732627|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149732628|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149732629|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149732630|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149732631|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
149732632|NCT00289913|540154854|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732633|NCT00289913|540154855|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
149732634|NCT00289913|540154856|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732635|NCT00289913|540154857|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732636|NCT00289913|540154858|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149732637|NCT03822884|540154859|FG000|Overall Study|Withdrawal by Subject|0|||
149732638|NCT03822884|540154860|FG001|Overall Study|Withdrawal by Subject|0|||
149732639|NCT03822884|540154861|FG002|Overall Study|Withdrawal by Subject|0|||
149732640|NCT03822884|540154862|FG003|Overall Study|Withdrawal by Subject|0|||
149732641|NCT03822884|540154863|FG004|Overall Study|Withdrawal by Subject|1|||
149732642|NCT03822884|540154864|FG005|Overall Study|Withdrawal by Subject|0|||
149732643|NCT02357420|540154868|FG000|Overall Study|Adverse Event|3|||
149732644|NCT02357420|540154869|FG001|Overall Study|Adverse Event|3|||
149732645|NCT02357420|540154870|FG002|Overall Study|Adverse Event|8|||
149732646|NCT02357420|540154871|FG003|Overall Study|Adverse Event|9|||
149732647|NCT02357420|540154868|FG000|Overall Study|Investigator Decision|1|||
149732648|NCT02357420|540154869|FG001|Overall Study|Investigator Decision|0|||
149732649|NCT02357420|540154870|FG002|Overall Study|Investigator Decision|0|||
149732650|NCT02357420|540154871|FG003|Overall Study|Investigator Decision|0|||
149732651|NCT02357420|540154868|FG000|Overall Study|Prohibited Medication|1|||
149732652|NCT02357420|540154869|FG001|Overall Study|Prohibited Medication|1|||
149732653|NCT02357420|540154870|FG002|Overall Study|Prohibited Medication|0|||
149732654|NCT02357420|540154871|FG003|Overall Study|Prohibited Medication|0|||
149732655|NCT02357420|540154868|FG000|Overall Study|Protocol Non-compliance|0|||
149732656|NCT02357420|540154869|FG001|Overall Study|Protocol Non-compliance|0|||
149732657|NCT02357420|540154870|FG002|Overall Study|Protocol Non-compliance|0|||
149732658|NCT02357420|540154871|FG003|Overall Study|Protocol Non-compliance|1|||
149732659|NCT02357420|540154868|FG000|Overall Study|Withdrawn Consent|4|||
149732660|NCT02357420|540154869|FG001|Overall Study|Withdrawn Consent|8|||
149732661|NCT02357420|540154870|FG002|Overall Study|Withdrawn Consent|6|||
149732662|NCT02357420|540154871|FG003|Overall Study|Withdrawn Consent|6|||
149732663|NCT02357420|540154868|FG000|Overall Study|Lost to Follow-up|3|||
149732664|NCT02357420|540154869|FG001|Overall Study|Lost to Follow-up|0|||
149732665|NCT02357420|540154870|FG002|Overall Study|Lost to Follow-up|2|||
149732666|NCT02357420|540154871|FG003|Overall Study|Lost to Follow-up|3|||
149732667|NCT03617705|540154872|FG000|Overall Study|Withdrawal by Subject|2|||
149732668|NCT03617705|540154872|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
149732669|NCT03617705|540154872|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
149732670|NCT00214461|540154873|FG000|Overall Study|Adverse Event|0|||
149732671|NCT00214461|540154874|FG001|Overall Study|Adverse Event|0|||
149732672|NCT00214461|540154875|FG002|Overall Study|Adverse Event|1|||
149732673|NCT00214461|540154876|FG003|Overall Study|Adverse Event|1|||
149732674|NCT00214461|540154873|FG000|Overall Study|Withdrawal by Subject|0|||
150253938|NCT01177800|542065751|FG000|Overall Study|Withdrawal of informed consent|0|||
150253939|NCT01177800|542065752|FG001|Overall Study|Withdrawal of informed consent|1|||
150253940|NCT04032613|542065753|FG000|Overall Study|Did not complete post-program assessment|5|||
150253941|NCT04032613|542065754|FG001|Overall Study|Did not complete post-program assessment|2|||
150253942|NCT00424385|542065755|FG000|Cohort 0|Withdrawal by Subject|5|||
150253943|NCT00424385|542065755|FG000|Cohort 0|Physician Decision|1|||
150253944|NCT00424385|542065755|FG000|Cohort 1|Withdrawal by Subject|1|||
150253945|NCT05560243|542065760|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
150253946|NCT05870228|542065761|FG000|Overall Study|Lost to Follow-up|2|||
150253947|NCT05870228|542065762|FG001|Overall Study|Lost to Follow-up|0|||
150253948|NCT05870228|542065761|FG000|Overall Study|Withdrawal by Subject|1|||
150253949|NCT05870228|542065762|FG001|Overall Study|Withdrawal by Subject|0|||
150253950|NCT03231800|542065767|FG000|Overall Study|Lost to Follow-up|0|||
150253951|NCT03231800|542065768|FG001|Overall Study|Lost to Follow-up|2|||
150253952|NCT03231800|542065767|FG000|Overall Study|Protocol Violation|1|||
150253953|NCT03231800|542065768|FG001|Overall Study|Protocol Violation|1|||
150253954|NCT03231800|542065767|FG000|Overall Study|reason not provided|2|||
150253955|NCT03231800|542065768|FG001|Overall Study|reason not provided|0|||
150253956|NCT00859222|542065769|FG000|Overall Study|Adverse Event|2|||
150253957|NCT00859222|542065770|FG001|Overall Study|Adverse Event|3|||
150253958|NCT00859222|542065771|FG002|Overall Study|Adverse Event|6|||
150253959|NCT00859222|542065772|FG003|Overall Study|Adverse Event|24|||
150253960|NCT00859222|542065773|FG004|Overall Study|Adverse Event|15|||
150253961|NCT00859222|542065769|FG000|Overall Study|DLT|1|||
150253962|NCT00859222|542065770|FG001|Overall Study|DLT|0|||
150253963|NCT00859222|542065771|FG002|Overall Study|DLT|0|||
150253964|NCT00859222|542065772|FG003|Overall Study|DLT|0|||
150253965|NCT00859222|542065773|FG004|Overall Study|DLT|0|||
150253966|NCT04075994|542065774|FG000|Overall Study|Withdrawal by Subject|8|||
150253967|NCT04075994|542065775|FG001|Overall Study|Withdrawal by Subject|9|||
150253968|NCT04075994|542065774|FG000|Overall Study|Adverse Event|2|||
150253969|NCT04075994|542065775|FG001|Overall Study|Adverse Event|2|||
150253970|NCT04075994|542065774|FG000|Overall Study|Investigator withdrew|3|||
150253971|NCT04075994|542065775|FG001|Overall Study|Investigator withdrew|1|||
150253972|NCT01941719|542065779|FG000|Overall Study|Lost to Follow-up|20|||
150253973|NCT01941719|542065780|FG001|Overall Study|Lost to Follow-up|19|||
150253974|NCT04035499|542065781|FG000|Overall Study|Death|2|||
150253975|NCT04035499|542065781|FG000|Overall Study|Withdrawal by Subject|1|||
150253976|NCT02643472|542065788|FG000|Overall Study|Death|2|||
150253977|NCT02643472|542065789|FG001|Overall Study|Death|5|||
150253978|NCT02643472|542065788|FG000|Overall Study|Withdrawal by Subject|3|||
150253979|NCT02643472|542065789|FG001|Overall Study|Withdrawal by Subject|2|||
150253980|NCT02643472|542065788|FG000|Overall Study|Protocol Violation|0|||
150253981|NCT02643472|542065789|FG001|Overall Study|Protocol Violation|1|||
150253982|NCT02643472|542065788|FG000|Overall Study|Lost to Follow-up|22|||
150253983|NCT02643472|542065789|FG001|Overall Study|Lost to Follow-up|26|||
150253984|NCT01215188|542065790|FG000|Overall Study|Lost to Follow-up|22|||
150253985|NCT01215188|542065791|FG001|Overall Study|Lost to Follow-up|22|||
150253986|NCT01215188|542065792|FG002|Overall Study|Lost to Follow-up|16|||
150253987|NCT01215188|542065790|FG000|Overall Study|Adverse Event|1|||
150253988|NCT01215188|542065791|FG001|Overall Study|Adverse Event|1|||
150253989|NCT01215188|542065792|FG002|Overall Study|Adverse Event|3|||
150253990|NCT01215188|542065790|FG000|Overall Study|Physician Decision|2|||
149732675|NCT00214461|540154874|FG001|Overall Study|Withdrawal by Subject|0|||
149732676|NCT00214461|540154875|FG002|Overall Study|Withdrawal by Subject|1|||
149732677|NCT00214461|540154876|FG003|Overall Study|Withdrawal by Subject|0|||
149732678|NCT01061008|540154877|FG000|Overall Study|Badiocephalic fistula failed|3|||
149732679|NCT01061008|540154878|FG001|Overall Study|Badiocephalic fistula failed|2|||
149732680|NCT01061008|540154877|FG000|Overall Study|Death|1|||
149732681|NCT01061008|540154878|FG001|Overall Study|Death|0|||
149732682|NCT01061008|540154877|FG000|Overall Study|Withdrawal by Subject|1|||
149732683|NCT01061008|540154878|FG001|Overall Study|Withdrawal by Subject|3|||
149732684|NCT01061008|540154877|FG000|Overall Study|Unable to exercise following surgery|1|||
149732685|NCT01061008|540154878|FG001|Overall Study|Unable to exercise following surgery|0|||
149732686|NCT01061008|540154877|FG000|Overall Study|Adverse Event|0|||
149732687|NCT01061008|540154878|FG001|Overall Study|Adverse Event|1|||
149732688|NCT02024971|540154880|FG000|Overall Study|Data Not Available|30|||
149732689|NCT02024971|540154880|FG000|Overall Study|Lost to Follow-up|6|||
149732690|NCT02908100|540154881|FG000|Overall Study|Adverse Event|7|||
149732691|NCT02908100|540154882|FG001|Overall Study|Adverse Event|6|||
149732692|NCT02908100|540154883|FG002|Overall Study|Adverse Event|9|||
149732693|NCT02908100|540154881|FG000|Overall Study|Death|2|||
149732694|NCT02908100|540154882|FG001|Overall Study|Death|0|||
149732695|NCT02908100|540154883|FG002|Overall Study|Death|0|||
149732696|NCT02908100|540154881|FG000|Overall Study|Lack of Efficacy|2|||
149732697|NCT02908100|540154882|FG001|Overall Study|Lack of Efficacy|3|||
149732698|NCT02908100|540154883|FG002|Overall Study|Lack of Efficacy|3|||
149732699|NCT02908100|540154881|FG000|Overall Study|Lost to Follow-up|0|||
149732700|NCT02908100|540154882|FG001|Overall Study|Lost to Follow-up|1|||
149732701|NCT02908100|540154883|FG002|Overall Study|Lost to Follow-up|2|||
149732702|NCT02908100|540154881|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149732703|NCT02908100|540154882|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149732704|NCT02908100|540154883|FG002|Overall Study|Non-Compliance With Study Drug|2|||
149732705|NCT02908100|540154881|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
149732706|NCT02908100|540154882|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
149732707|NCT02908100|540154883|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
149732708|NCT02908100|540154881|FG000|Overall Study|Physician Decision|0|||
149732709|NCT02908100|540154882|FG001|Overall Study|Physician Decision|1|||
149732710|NCT02908100|540154883|FG002|Overall Study|Physician Decision|0|||
149732711|NCT02908100|540154881|FG000|Overall Study|Pregnancy|1|||
149732712|NCT02908100|540154882|FG001|Overall Study|Pregnancy|2|||
149732713|NCT02908100|540154883|FG002|Overall Study|Pregnancy|0|||
149732714|NCT02908100|540154881|FG000|Overall Study|Withdrawal by Subject|8|||
149732715|NCT02908100|540154882|FG001|Overall Study|Withdrawal by Subject|7|||
149732716|NCT02908100|540154883|FG002|Overall Study|Withdrawal by Subject|5|||
149732717|NCT02908100|540154881|FG000|Overall Study|Randomised in Error|1|||
149732718|NCT02908100|540154882|FG001|Overall Study|Randomised in Error|0|||
149732719|NCT02908100|540154883|FG002|Overall Study|Randomised in Error|0|||
149732720|NCT05254418|540154885|FG000|Overall Study|Adverse Event|2|||
149732721|NCT00440726|540154886|FG000|Phase 1|Dose-Limiting Toxicity|0|||
149732722|NCT00440726|540154887|FG001|Phase 1|Dose-Limiting Toxicity|1|||
149732723|NCT00440726|540154888|FG002|Phase 1|Dose-Limiting Toxicity|0|||
149732724|NCT00440726|540154886|FG000|Phase 1|Physician Decision|1|||
149732725|NCT00440726|540154887|FG001|Phase 1|Physician Decision|0|||
149732726|NCT00440726|540154888|FG002|Phase 1|Physician Decision|0|||
149732727|NCT00440726|540154886|FG000|Phase 2|Death|0|||
149732728|NCT00440726|540154887|FG001|Phase 2|Death|0|||
149732729|NCT00440726|540154888|FG002|Phase 2|Death|1|||
149732730|NCT00440726|540154886|FG000|Phase 2|Adverse Event|0|||
149732731|NCT00440726|540154887|FG001|Phase 2|Adverse Event|0|||
149732732|NCT00440726|540154888|FG002|Phase 2|Adverse Event|1|||
149732733|NCT01808612|540154889|FG000|Treatment Period|Adverse Event|8|||
149732734|NCT01808612|540154890|FG001|Treatment Period|Adverse Event|4|||
149732735|NCT01808612|540154891|FG002|Treatment Period|Adverse Event|3|||
149732736|NCT01808612|540154889|FG000|Treatment Period|Lost to Follow-up|2|||
149732737|NCT01808612|540154890|FG001|Treatment Period|Lost to Follow-up|2|||
149732738|NCT01808612|540154891|FG002|Treatment Period|Lost to Follow-up|1|||
149732739|NCT01808612|540154889|FG000|Treatment Period|Protocol Violation|1|||
149732740|NCT01808612|540154890|FG001|Treatment Period|Protocol Violation|0|||
149732741|NCT01808612|540154891|FG002|Treatment Period|Protocol Violation|0|||
149732742|NCT01808612|540154889|FG000|Treatment Period|Withdrawal by Subject|1|||
149732743|NCT01808612|540154890|FG001|Treatment Period|Withdrawal by Subject|0|||
149732744|NCT01808612|540154891|FG002|Treatment Period|Withdrawal by Subject|4|||
149732745|NCT01808612|540154889|FG000|Treatment Period|Physician Decision|1|||
149732746|NCT01808612|540154890|FG001|Treatment Period|Physician Decision|0|||
149732747|NCT01808612|540154891|FG002|Treatment Period|Physician Decision|4|||
149732748|NCT01808612|540154889|FG000|Treatment Period|Sponsor Decision|1|||
150253991|NCT01215188|542065791|FG001|Overall Study|Physician Decision|1|||
150253992|NCT01215188|542065792|FG002|Overall Study|Physician Decision|0|||
149732749|NCT01808612|540154890|FG001|Treatment Period|Sponsor Decision|0|||
149732750|NCT01808612|540154891|FG002|Treatment Period|Sponsor Decision|0|||
149732751|NCT01808612|540154889|FG000|Treatment Period|Lack of Efficacy|1|||
149732752|NCT01808612|540154890|FG001|Treatment Period|Lack of Efficacy|1|||
149732753|NCT01808612|540154891|FG002|Treatment Period|Lack of Efficacy|2|||
149732754|NCT01808612|540154889|FG000|Discontinuation Period|Adverse Event|1|||
149732755|NCT01808612|540154890|FG001|Discontinuation Period|Adverse Event|0|||
149732756|NCT01808612|540154891|FG002|Discontinuation Period|Adverse Event|0|||
149732757|NCT01808612|540154889|FG000|Discontinuation Period|Physician Decision|1|||
149732758|NCT01808612|540154890|FG001|Discontinuation Period|Physician Decision|0|||
149732759|NCT01808612|540154891|FG002|Discontinuation Period|Physician Decision|0|||
149732760|NCT01808612|540154889|FG000|Discontinuation Period|Lost to Follow-up|0|||
149732761|NCT01808612|540154890|FG001|Discontinuation Period|Lost to Follow-up|1|||
149732762|NCT01808612|540154891|FG002|Discontinuation Period|Lost to Follow-up|0|||
149732763|NCT03683394|540154892|FG000|Overall Study|Withdrawal by Subject|4|||
149732764|NCT03683394|540154893|FG001|Overall Study|Withdrawal by Subject|8|||
149732765|NCT03683394|540154892|FG000|Overall Study|Lost to Follow-up|7|||
149732766|NCT03683394|540154893|FG001|Overall Study|Lost to Follow-up|0|||
149732767|NCT03683394|540154892|FG000|Overall Study|Death|3|||
149732768|NCT03683394|540154893|FG001|Overall Study|Death|1|||
149732769|NCT00559273|540154894|FG000|Correction Period (20 Weeks)|Death|3|||
149732770|NCT00559273|540154895|FG001|Correction Period (20 Weeks)|Death|4|||
149732771|NCT00559273|540154894|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
149732772|NCT00559273|540154895|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
149732773|NCT00559273|540154894|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
149732774|NCT00559273|540154895|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
149732775|NCT00559273|540154894|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
149732776|NCT00559273|540154895|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
149732777|NCT00559273|540154894|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
149732778|NCT00559273|540154895|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
149732779|NCT00559273|540154894|FG000|Evaluation Period (8 Weeks)|Death|1|||
149732780|NCT00559273|540154895|FG001|Evaluation Period (8 Weeks)|Death|3|||
149732781|NCT00559273|540154894|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
149732782|NCT00559273|540154895|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
149732783|NCT00559273|540154894|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
149732784|NCT00559273|540154895|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
149732785|NCT00559273|540154894|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
149732786|NCT00559273|540154895|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
149732787|NCT04276207|540154896|FG000|Period 1|Withdrawal by Subject|0|||
149732788|NCT04276207|540154897|FG001|Period 1|Withdrawal by Subject|1|||
149732789|NCT01256177|540154898|FG000|Overall Study|Withdrawal by Subject|23|||
149732790|NCT01256177|540154899|FG001|Overall Study|Withdrawal by Subject|22|||
149732791|NCT01256177|540154898|FG000|Overall Study|Lost to Follow-up|2|||
149732792|NCT01256177|540154899|FG001|Overall Study|Lost to Follow-up|2|||
149732793|NCT01256177|540154898|FG000|Overall Study|Adverse Event|8|||
149732794|NCT01256177|540154899|FG001|Overall Study|Adverse Event|9|||
149732795|NCT01256177|540154898|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
149732796|NCT01256177|540154899|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149732797|NCT01256177|540154898|FG000|Overall Study|Condition under Investigation Worsened|1|||
149732798|NCT01256177|540154899|FG001|Overall Study|Condition under Investigation Worsened|0|||
149732799|NCT01256177|540154898|FG000|Overall Study|Lack of Efficacy|11|||
149732800|NCT01256177|540154899|FG001|Overall Study|Lack of Efficacy|2|||
149732801|NCT01256177|540154898|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
149732802|NCT01256177|540154899|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
149732803|NCT04451330|540154902|FG000|Overall Study|Adverse Event|1|||
149732804|NCT04451330|540154903|FG001|Overall Study|Adverse Event|2|||
149732805|NCT04451330|540154902|FG000|Overall Study|Lost to Follow-up|5|||
149732806|NCT04451330|540154903|FG001|Overall Study|Lost to Follow-up|0|||
149732807|NCT04451330|540154902|FG000|Overall Study|Withdrawal by Subject|3|||
149732808|NCT04451330|540154903|FG001|Overall Study|Withdrawal by Subject|1|||
149732809|NCT04451330|540154902|FG000|Overall Study|Withdrawal by parent/guardian|1|||
150253993|NCT01215188|542065790|FG000|Overall Study|Lack of Efficacy|0|||
150253994|NCT01215188|542065791|FG001|Overall Study|Lack of Efficacy|0|||
149732810|NCT04451330|540154903|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149732811|NCT04451330|540154902|FG000|Overall Study|Other than specified|0|||
149732812|NCT04451330|540154903|FG001|Overall Study|Other than specified|1|||
149732813|NCT01925209|540154906|FG000|Treatment Epoch|Physician Decision|1|||
149732814|NCT01925209|540154907|FG001|Treatment Epoch|Physician Decision|0|||
149732815|NCT01925209|540154908|FG002|Treatment Epoch|Physician Decision|0|||
149732816|NCT01925209|540154909|FG003|Treatment Epoch|Physician Decision|0|||
149732817|NCT01925209|540154906|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
149732818|NCT01925209|540154907|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
149732819|NCT01925209|540154908|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
150253995|NCT01215188|542065792|FG002|Overall Study|Lack of Efficacy|1|||
149732820|NCT01925209|540154909|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
149732821|NCT01925209|540154906|FG000|Treatment Epoch|Death|1|||
149732822|NCT01925209|540154907|FG001|Treatment Epoch|Death|0|||
149732823|NCT01925209|540154908|FG002|Treatment Epoch|Death|0|||
149732824|NCT01925209|540154909|FG003|Treatment Epoch|Death|0|||
149732825|NCT01925209|540154906|FG000|Treatment Epoch|Protocol deviation|0|||
149732826|NCT01925209|540154907|FG001|Treatment Epoch|Protocol deviation|0|||
149732827|NCT01925209|540154908|FG002|Treatment Epoch|Protocol deviation|1|||
149732828|NCT01925209|540154909|FG003|Treatment Epoch|Protocol deviation|1|||
149732829|NCT01925209|540154906|FG000|Treatment Epoch|Withdrawal by Subject|4|||
149732830|NCT01925209|540154907|FG001|Treatment Epoch|Withdrawal by Subject|3|||
149732831|NCT01925209|540154908|FG002|Treatment Epoch|Withdrawal by Subject|3|||
149732832|NCT01925209|540154909|FG003|Treatment Epoch|Withdrawal by Subject|2|||
149732833|NCT01925209|540154906|FG000|Treatment Epoch|Adverse Event|3|||
149732834|NCT01925209|540154907|FG001|Treatment Epoch|Adverse Event|5|||
149732835|NCT01925209|540154908|FG002|Treatment Epoch|Adverse Event|3|||
149732836|NCT01925209|540154909|FG003|Treatment Epoch|Adverse Event|1|||
149732837|NCT01925209|540154906|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
149732838|NCT01925209|540154907|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
149732839|NCT01925209|540154908|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
149732840|NCT01925209|540154909|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
149732841|NCT01925209|540154906|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
149732842|NCT01925209|540154907|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
149732843|NCT01925209|540154908|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
149732844|NCT01925209|540154909|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
149732845|NCT01925209|540154906|FG000|Follow-up|Adverse Event|1|||
149732846|NCT01925209|540154907|FG001|Follow-up|Adverse Event|4|||
149732847|NCT01925209|540154908|FG002|Follow-up|Adverse Event|0|||
149732848|NCT01925209|540154909|FG003|Follow-up|Adverse Event|1|||
149732849|NCT01925209|540154906|FG000|Follow-up|Physician Decision|0|||
149732850|NCT01925209|540154907|FG001|Follow-up|Physician Decision|0|||
149732851|NCT01925209|540154908|FG002|Follow-up|Physician Decision|1|||
149732852|NCT01925209|540154909|FG003|Follow-up|Physician Decision|0|||
149732853|NCT01925209|540154906|FG000|Follow-up|Non-compliance with study treatment|0|||
149732854|NCT01925209|540154907|FG001|Follow-up|Non-compliance with study treatment|0|||
149732855|NCT01925209|540154908|FG002|Follow-up|Non-compliance with study treatment|0|||
149732856|NCT01925209|540154909|FG003|Follow-up|Non-compliance with study treatment|1|||
149732857|NCT01925209|540154906|FG000|Follow-up|Withdrawal by Subject|0|||
149732858|NCT01925209|540154907|FG001|Follow-up|Withdrawal by Subject|2|||
149732859|NCT01925209|540154908|FG002|Follow-up|Withdrawal by Subject|0|||
149732860|NCT01925209|540154909|FG003|Follow-up|Withdrawal by Subject|2|||
149732861|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
149732862|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
149732863|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|Death|1|||
149732864|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|Death|0|||
149732865|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
149732866|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
149732867|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
149732868|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
149732869|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
149732870|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
149732871|NCT00110994|540154910|FG000|Double-blind (DB) Treatment|other reasons|2|||
149732872|NCT00110994|540154911|FG001|Double-blind (DB) Treatment|other reasons|3|||
149732873|NCT00110994|540154910|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
149732874|NCT00110994|540154911|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
149732875|NCT00110994|540154910|FG000|Active Follow-up|Other reasons|0|||
149732876|NCT00110994|540154911|FG001|Active Follow-up|Other reasons|2|||
149732877|NCT00110994|540154910|FG000|Long Term Follow-up|Death|19|||
149732878|NCT00110994|540154911|FG001|Long Term Follow-up|Death|17|||
149732879|NCT01299727|540154912|FG000|Overall Study|Withdrawal by Subject|1|||
149732880|NCT01299727|540154913|FG001|Overall Study|Withdrawal by Subject|0|||
149732881|NCT01299727|540154914|FG002|Overall Study|Withdrawal by Subject|0|||
149732882|NCT01299727|540154912|FG000|Overall Study|Adverse Event|0|||
149732883|NCT01299727|540154913|FG001|Overall Study|Adverse Event|0|||
149732884|NCT01299727|540154914|FG002|Overall Study|Adverse Event|1|||
149732885|NCT01299727|540154912|FG000|Overall Study|Completed the Treatment Period|3|||
149732886|NCT01299727|540154913|FG001|Overall Study|Completed the Treatment Period|4|||
149732887|NCT01299727|540154914|FG002|Overall Study|Completed the Treatment Period|3|||
149732888|NCT03157531|540154927|FG000|Overall Study|Death|2|||
149732889|NCT03157531|540154927|FG000|Overall Study|Lost to Follow-up|4|||
149732890|NCT00331006|540154928|FG000|Screening Phase|Withdrawal by Subject|1|||
149732891|NCT00331006|540154928|FG000|Screening Phase|enrollment halted|1|||
149732892|NCT00331006|540154928|FG000|Screening Phase|Lost to Follow-up|1|||
149732893|NCT00331006|540154928|FG000|Screening Phase|Ineligible for treatment phase|4|||
149732894|NCT00331006|540154928|FG000|Treatment Phase|Withdrawal by Subject|1|||
149732895|NCT00331006|540154928|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
149732896|NCT00331006|540154928|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
149732897|NCT03213366|540154933|FG000|Overall Study|Lost to Follow-up|9|||
149732898|NCT03213366|540154934|FG001|Overall Study|Lost to Follow-up|4|||
149732899|NCT01879410|540154935|FG000|Overall Study|Adverse Event|9|||
149732900|NCT01879410|540154936|FG001|Overall Study|Adverse Event|14|||
149732901|NCT01879410|540154935|FG000|Overall Study|Lack of Efficacy|4|||
149732902|NCT01879410|540154936|FG001|Overall Study|Lack of Efficacy|6|||
149732903|NCT01879410|540154935|FG000|Overall Study|Protocol Violation|1|||
149732904|NCT01879410|540154936|FG001|Overall Study|Protocol Violation|7|||
149732905|NCT01879410|540154935|FG000|Overall Study|Lost to Follow-up|2|||
149732906|NCT01879410|540154936|FG001|Overall Study|Lost to Follow-up|1|||
149732907|NCT01879410|540154935|FG000|Overall Study|Withdrawal by Subject|7|||
149732908|NCT01879410|540154936|FG001|Overall Study|Withdrawal by Subject|8|||
149732909|NCT01879410|540154935|FG000|Overall Study|Randomised in Error|1|||
149732910|NCT01879410|540154936|FG001|Overall Study|Randomised in Error|2|||
149732911|NCT01737931|540154941|FG000|Overall Study|Withdrawal by Subject|0|||
149732912|NCT01737931|540154942|FG001|Overall Study|Withdrawal by Subject|1|||
149732913|NCT01737931|540154943|FG002|Overall Study|Withdrawal by Subject|1|||
149732914|NCT01737931|540154941|FG000|Overall Study|Physician Decision|0|||
149732915|NCT01737931|540154942|FG001|Overall Study|Physician Decision|1|||
149732916|NCT01737931|540154943|FG002|Overall Study|Physician Decision|0|||
149732917|NCT01573910|540154944|FG000|Overall Study|Adverse Event|4|||
149732918|NCT01573910|540154945|FG001|Overall Study|Adverse Event|4|||
149732919|NCT01573910|540154944|FG000|Overall Study|Lost to Follow-up|2|||
149732920|NCT01573910|540154945|FG001|Overall Study|Lost to Follow-up|1|||
149732921|NCT01573910|540154944|FG000|Overall Study|Withdrawal by Subject|0|||
149732922|NCT01573910|540154945|FG001|Overall Study|Withdrawal by Subject|1|||
149732923|NCT01573910|540154944|FG000|Overall Study|Protocol Violation|3|||
149732924|NCT01573910|540154945|FG001|Overall Study|Protocol Violation|0|||
149732925|NCT01573910|540154944|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
149732926|NCT01573910|540154945|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
149732927|NCT00364182|540154946|FG000|First Intervention|Secondary prophylaxis|1|||
149732928|NCT00364182|540154947|FG001|First Intervention|Secondary prophylaxis|0|||
149732929|NCT00364182|540154948|FG002|First Intervention|Secondary prophylaxis|0|||
149732930|NCT00364182|540154946|FG000|First Intervention|Withdrawal by Subject|2|||
149732931|NCT00364182|540154947|FG001|First Intervention|Withdrawal by Subject|0|||
149732932|NCT00364182|540154948|FG002|First Intervention|Withdrawal by Subject|0|||
149732933|NCT00364182|540154946|FG000|Second Intervention|non-compliance|0|||
149732934|NCT00364182|540154947|FG001|Second Intervention|non-compliance|1|||
149732935|NCT00364182|540154948|FG002|Second Intervention|non-compliance|1|||
149732936|NCT00364182|540154946|FG000|Second Intervention|Protocol Violation|0|||
149732937|NCT00364182|540154947|FG001|Second Intervention|Protocol Violation|1|||
149732938|NCT00364182|540154948|FG002|Second Intervention|Protocol Violation|0|||
149732939|NCT00364182|540154946|FG000|Second Intervention|Adverse Event|0|||
149732940|NCT00364182|540154947|FG001|Second Intervention|Adverse Event|0|||
149732941|NCT00364182|540154948|FG002|Second Intervention|Adverse Event|1|||
149732942|NCT00364182|540154946|FG000|Third Intervention|non-compliance|0|||
149732943|NCT00364182|540154947|FG001|Third Intervention|non-compliance|1|||
149732944|NCT00364182|540154948|FG002|Third Intervention|non-compliance|0|||
149732945|NCT00364182|540154946|FG000|Third Intervention|Lost to Follow-up|0|||
149732946|NCT00364182|540154947|FG001|Third Intervention|Lost to Follow-up|0|||
149732947|NCT00364182|540154948|FG002|Third Intervention|Lost to Follow-up|1|||
149732948|NCT01439945|540154972|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149732949|NCT01439945|540154973|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149732950|NCT01439945|540154974|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149732951|NCT01439945|540154975|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
149732952|NCT01439945|540154972|FG000|Double-Blind Treatment Phase|Ineligible|1|||
149732953|NCT01439945|540154973|FG001|Double-Blind Treatment Phase|Ineligible|2|||
149732954|NCT01439945|540154974|FG002|Double-Blind Treatment Phase|Ineligible|0|||
149732955|NCT01439945|540154975|FG003|Double-Blind Treatment Phase|Ineligible|1|||
149732956|NCT04082663|540154976|FG000|Overall Study|Adverse Event|6|||
149732957|NCT04082663|540154976|FG000|Overall Study|Lost to Follow-up|1|||
149732958|NCT00705263|540154979|FG000|Overall Study|Withdrawal by Subject|2|||
149732959|NCT05501119|540154980|FG000|Overall Study|Withdrawal by Subject|2|||
149732960|NCT05501119|540154980|FG000|Overall Study|Lost to Follow-up|5|||
149732961|NCT05032950|540154984|FG000|Overall Study|Adverse Event|0|||
149732962|NCT05032950|540154985|FG001|Overall Study|Adverse Event|0|||
149732963|NCT05032950|540154986|FG002|Overall Study|Adverse Event|1|||
149732964|NCT05032950|540154987|FG003|Overall Study|Adverse Event|1|||
149732965|NCT05032950|540154988|FG004|Overall Study|Adverse Event|0|||
149732966|NCT05032950|540154989|FG005|Overall Study|Adverse Event|0|||
149732967|NCT02959814|540154990|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
149732968|NCT02959814|540154990|FG000|Overall Study|Excluded based on anatomical criteria|2|||
149732969|NCT02959814|540154990|FG000|Overall Study|Protocol Violation|7|||
149732970|NCT02959814|540154990|FG000|Overall Study|FFR not measured|2|||
149732971|NCT02959814|540154990|FG000|Overall Study|In-procedure QFR not computed|6|||
149732972|NCT02959814|540154990|FG000|Overall Study|Excluded by FFR core-lab|24|||
149732973|NCT01078805|540155000|FG000|Overall Study|Clinically significant abnormal lab|5|||
149732974|NCT01078805|540155000|FG000|Overall Study|Death|134|||
149732975|NCT01078805|540155000|FG000|Overall Study|Lost to Follow-up|676|||
149732976|NCT01078805|540155000|FG000|Overall Study|Physician Decision|169|||
149732977|NCT01078805|540155000|FG000|Overall Study|Serious adverse event|26|||
149732978|NCT01078805|540155000|FG000|Overall Study|Sponsor decision|46|||
149732979|NCT01078805|540155000|FG000|Overall Study|Withdrawal by Subject|739|||
149732980|NCT01078805|540155000|FG000|Overall Study|Other|173|||
149732981|NCT01078805|540155000|FG000|Overall Study|Didn't take study drug|82|||
149732982|NCT01445678|540155001|FG000|Overall Study|Adverse Event|12|||
149732983|NCT01445678|540155002|FG001|Overall Study|Adverse Event|8|||
149732984|NCT01445678|540155001|FG000|Overall Study|Lack of Efficacy|0|||
149732985|NCT01445678|540155002|FG001|Overall Study|Lack of Efficacy|2|||
149732986|NCT01445678|540155001|FG000|Overall Study|Lost to Follow-up|8|||
149732987|NCT01445678|540155002|FG001|Overall Study|Lost to Follow-up|5|||
149732988|NCT01445678|540155001|FG000|Overall Study|Protocol Violation|1|||
149732989|NCT01445678|540155002|FG001|Overall Study|Protocol Violation|1|||
149732990|NCT01445678|540155001|FG000|Overall Study|Withdrawal by Subject|9|||
149732991|NCT01445678|540155002|FG001|Overall Study|Withdrawal by Subject|5|||
149732992|NCT03116113|540157218|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732993|NCT03116113|540157219|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732994|NCT03116113|540157220|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732995|NCT03116113|540157221|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732996|NCT03116113|540157222|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732997|NCT03116113|540157223|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732998|NCT03116113|540157224|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149732999|NCT03116113|540157225|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
149733000|NCT03116113|540157226|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
149733001|NCT02159807|540157227|FG000|Overall Study|Adverse Event|0|||
149733002|NCT02159807|540157228|FG001|Overall Study|Adverse Event|0|||
149733003|NCT02159807|540157229|FG002|Overall Study|Adverse Event|1|||
149733004|NCT02159807|540157227|FG000|Overall Study|No CSF|1|||
149733005|NCT02159807|540157228|FG001|Overall Study|No CSF|1|||
149733006|NCT02159807|540157229|FG002|Overall Study|No CSF|1|||
149733007|NCT02159807|540157227|FG000|Overall Study|elevated blood pressure|0|||
149733008|NCT02159807|540157228|FG001|Overall Study|elevated blood pressure|0|||
149733009|NCT02159807|540157229|FG002|Overall Study|elevated blood pressure|1|||
149733010|NCT00950170|540157230|FG000|Overall Study|Parent/Legal Guardian Request|1|||
149733011|NCT00950170|540157230|FG000|Overall Study|Adverse Event|2|||
149733012|NCT00950170|540157230|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
149733013|NCT01254669|540157233|FG000|Overall Study|Withdrawal by Subject|0|||
149733014|NCT01254669|540157234|FG001|Overall Study|Withdrawal by Subject|1|||
149733015|NCT01254669|540157233|FG000|Overall Study|time constraint|2|||
149733016|NCT01254669|540157234|FG001|Overall Study|time constraint|2|||
149733017|NCT01254669|540157233|FG000|Overall Study|called to clinic during intervention|1|||
149733018|NCT01254669|540157234|FG001|Overall Study|called to clinic during intervention|1|||
149733019|NCT00600171|540157235|FG000|Overall Study|Adverse Event|0|||
149733020|NCT00600171|540157236|FG001|Overall Study|Adverse Event|1|||
149733021|NCT00600171|540157237|FG002|Overall Study|Adverse Event|0|||
149733022|NCT00600171|540157238|FG003|Overall Study|Adverse Event|0|||
149733023|NCT00600171|540157239|FG004|Overall Study|Adverse Event|1|||
149733024|NCT00600171|540157240|FG005|Overall Study|Adverse Event|0|||
149733025|NCT00600171|540157235|FG000|Overall Study|Lack of Efficacy|9|||
149733026|NCT00600171|540157236|FG001|Overall Study|Lack of Efficacy|12|||
149733027|NCT00600171|540157237|FG002|Overall Study|Lack of Efficacy|3|||
149733028|NCT00600171|540157238|FG003|Overall Study|Lack of Efficacy|5|||
149733029|NCT00600171|540157239|FG004|Overall Study|Lack of Efficacy|4|||
149733030|NCT00600171|540157240|FG005|Overall Study|Lack of Efficacy|0|||
149733031|NCT00600171|540157235|FG000|Overall Study|Protocol Violation|1|||
149733032|NCT00600171|540157236|FG001|Overall Study|Protocol Violation|2|||
150253996|NCT01215188|542065790|FG000|Overall Study|Protocol Violation|1|||
150253997|NCT01215188|542065791|FG001|Overall Study|Protocol Violation|1|||
150253998|NCT01215188|542065792|FG002|Overall Study|Protocol Violation|1|||
149733033|NCT00600171|540157237|FG002|Overall Study|Protocol Violation|0|||
150253999|NCT01215188|542065790|FG000|Overall Study|Withdrawal by Subject|32|||
149733034|NCT00600171|540157238|FG003|Overall Study|Protocol Violation|1|||
149733035|NCT00600171|540157239|FG004|Overall Study|Protocol Violation|0|||
149733036|NCT00600171|540157240|FG005|Overall Study|Protocol Violation|0|||
149733037|NCT00600171|540157235|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
149733038|NCT00600171|540157236|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149733039|NCT00600171|540157237|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
149733040|NCT00600171|540157238|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
149733041|NCT00600171|540157239|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
150254000|NCT01215188|542065791|FG001|Overall Study|Withdrawal by Subject|34|||
150254001|NCT01215188|542065792|FG002|Overall Study|Withdrawal by Subject|31|||
149733042|NCT00600171|540157240|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
149733043|NCT00600171|540157235|FG000|Overall Study|Withdrawal by Subject|3|||
149733044|NCT00600171|540157236|FG001|Overall Study|Withdrawal by Subject|0|||
149733045|NCT00600171|540157237|FG002|Overall Study|Withdrawal by Subject|0|||
149733046|NCT00600171|540157238|FG003|Overall Study|Withdrawal by Subject|1|||
149733047|NCT00600171|540157239|FG004|Overall Study|Withdrawal by Subject|1|||
149733048|NCT00600171|540157240|FG005|Overall Study|Withdrawal by Subject|1|||
149733049|NCT00600171|540157235|FG000|Overall Study|Physician Decision|0|||
149733050|NCT00600171|540157236|FG001|Overall Study|Physician Decision|1|||
149733051|NCT00600171|540157237|FG002|Overall Study|Physician Decision|0|||
149733052|NCT00600171|540157238|FG003|Overall Study|Physician Decision|1|||
149733053|NCT00600171|540157239|FG004|Overall Study|Physician Decision|0|||
149733054|NCT00600171|540157240|FG005|Overall Study|Physician Decision|2|||
149733055|NCT00600171|540157235|FG000|Overall Study|Lost to Follow-up|0|||
149733056|NCT00600171|540157236|FG001|Overall Study|Lost to Follow-up|0|||
149733057|NCT00600171|540157237|FG002|Overall Study|Lost to Follow-up|0|||
149733058|NCT00600171|540157238|FG003|Overall Study|Lost to Follow-up|1|||
149733059|NCT00600171|540157239|FG004|Overall Study|Lost to Follow-up|0|||
149733060|NCT00600171|540157240|FG005|Overall Study|Lost to Follow-up|0|||
149733061|NCT02367521|540157241|FG000|Overall Study|severe headache after intervention|2|||
149733062|NCT02367521|540157242|FG001|Overall Study|severe headache after intervention|0|||
149733063|NCT02367521|540157241|FG000|Overall Study|unable to find transportation|2|||
149733064|NCT02367521|540157242|FG001|Overall Study|unable to find transportation|0|||
149733065|NCT00542191|540157246|FG000|Overall Study|Death|3|||
149733066|NCT00469612|540157247|FG000|Overall Study|Study terminated before data collected|2|||
149733067|NCT00469612|540157248|FG001|Overall Study|Study terminated before data collected|0|||
149733068|NCT01279057|540157256|FG000|Overall Study|Adverse Event|1|||
149733069|NCT01279057|540157257|FG001|Overall Study|Adverse Event|0|||
149733070|NCT01279057|540157258|FG002|Overall Study|Adverse Event|1|||
149733071|NCT01279057|540157256|FG000|Overall Study|Insufficient therapeutic response|0|||
149733072|NCT01279057|540157257|FG001|Overall Study|Insufficient therapeutic response|0|||
149733073|NCT01279057|540157258|FG002|Overall Study|Insufficient therapeutic response|1|||
149733074|NCT01279057|540157256|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149733075|NCT01279057|540157257|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
149733076|NCT01279057|540157258|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149733077|NCT01279057|540157256|FG000|Overall Study|Withdrew consent|2|||
149733078|NCT01279057|540157257|FG001|Overall Study|Withdrew consent|0|||
149733079|NCT01279057|540157258|FG002|Overall Study|Withdrew consent|1|||
149733080|NCT01279057|540157256|FG000|Overall Study|Pregnancy|0|||
149733081|NCT01279057|540157257|FG001|Overall Study|Pregnancy|1|||
149733082|NCT01279057|540157258|FG002|Overall Study|Pregnancy|0|||
149733083|NCT01279057|540157256|FG000|Overall Study|Other|3|||
149733084|NCT01279057|540157257|FG001|Overall Study|Other|3|||
149733085|NCT01279057|540157258|FG002|Overall Study|Other|0|||
149733086|NCT01427309|540157260|FG000|Overall Study|Lost to Follow-up|130|||
149733087|NCT01427309|540157261|FG001|Overall Study|Lost to Follow-up|145|||
149733088|NCT01427309|540157262|FG002|Overall Study|Lost to Follow-up|122|||
149733089|NCT01427309|540157263|FG003|Overall Study|Lost to Follow-up|135|||
149733090|NCT01427309|540157260|FG000|Overall Study|Protocol Violation|42|||
149733091|NCT01427309|540157261|FG001|Overall Study|Protocol Violation|69|||
149733092|NCT01427309|540157262|FG002|Overall Study|Protocol Violation|125|||
149733093|NCT01427309|540157263|FG003|Overall Study|Protocol Violation|124|||
149733094|NCT01427309|540157260|FG000|Overall Study|Adverse Event|0|||
149733095|NCT01427309|540157261|FG001|Overall Study|Adverse Event|0|||
149733096|NCT01427309|540157262|FG002|Overall Study|Adverse Event|3|||
149733097|NCT01427309|540157263|FG003|Overall Study|Adverse Event|1|||
149733098|NCT01427309|540157260|FG000|Overall Study|Serious adverse event|52|||
149733099|NCT01427309|540157261|FG001|Overall Study|Serious adverse event|45|||
149733100|NCT01427309|540157262|FG002|Overall Study|Serious adverse event|50|||
149733101|NCT01427309|540157263|FG003|Overall Study|Serious adverse event|61|||
149733102|NCT01427309|540157260|FG000|Overall Study|Withdrawal by Subject|148|||
149733103|NCT01427309|540157261|FG001|Overall Study|Withdrawal by Subject|148|||
150254002|NCT01012414|542065793|FG000|Overall Study|Withdrawal by Subject|2|||
150254003|NCT01012414|542065793|FG000|Overall Study|Lost to Follow-up|1|||
150254004|NCT01012414|542065793|FG000|Overall Study|Trial was stopped before completed|7|||
150254005|NCT02601300|542065794|FG000|Induction Phase|Lack of Efficacy|2|||
150254006|NCT02601300|542065794|FG000|Induction Phase|Protocol Violation|1|||
150254007|NCT02601300|542065794|FG000|Extension Phase|Withdrawal by Subject|3|||
149733104|NCT01427309|540157262|FG002|Overall Study|Withdrawal by Subject|61|||
149733105|NCT01427309|540157263|FG003|Overall Study|Withdrawal by Subject|55|||
149733106|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
149733107|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
149733108|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
149733109|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
149733110|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
149733111|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
149733112|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
149733113|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
149733114|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
149733115|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
149733116|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
149733117|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
149733118|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
149733119|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
149733120|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
149733121|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
149733122|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
149733123|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
149733124|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
149733125|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
149733126|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
149733127|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
149733128|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
149733129|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
149733130|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
149733131|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
149733132|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
149733133|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
149733134|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
149733135|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
149733136|NCT00849017|540157264|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
149733137|NCT00849017|540157265|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
149733138|NCT00849017|540157266|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
149733139|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
149733140|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
149733141|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
149733142|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
149733143|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
149733144|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
149733145|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
149733146|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
149733147|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
149733148|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
149733149|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
149733150|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
149733151|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
149733152|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
149733153|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
149733154|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
149733155|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
149733156|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
149733157|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
149733158|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
149733159|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
149733160|NCT00849017|540157264|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
149733161|NCT00849017|540157265|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
149733162|NCT00849017|540157266|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
149733163|NCT02913313|540157267|FG000|Overall Study|DISEASE PROGRESSION|1|||
149733164|NCT02913313|540157268|FG001|Overall Study|DISEASE PROGRESSION|2|||
149733165|NCT02913313|540157269|FG002|Overall Study|DISEASE PROGRESSION|2|||
149733166|NCT02913313|540157270|FG003|Overall Study|DISEASE PROGRESSION|4|||
149733167|NCT02913313|540157271|FG004|Overall Study|DISEASE PROGRESSION|6|||
149733168|NCT02913313|540157272|FG005|Overall Study|DISEASE PROGRESSION|4|||
149733169|NCT02913313|540157273|FG006|Overall Study|DISEASE PROGRESSION|19|||
149733170|NCT02913313|540157274|FG007|Overall Study|DISEASE PROGRESSION|3|||
149733171|NCT02913313|540157275|FG008|Overall Study|DISEASE PROGRESSION|4|||
149733172|NCT02913313|540157276|FG009|Overall Study|DISEASE PROGRESSION|4|||
149733173|NCT02913313|540157277|FG010|Overall Study|DISEASE PROGRESSION|11|||
149733174|NCT02913313|540157278|FG011|Overall Study|DISEASE PROGRESSION|5|||
149733175|NCT02913313|540157279|FG012|Overall Study|DISEASE PROGRESSION|14|||
149733176|NCT02913313|540157280|FG013|Overall Study|DISEASE PROGRESSION|3|||
149733177|NCT02913313|540157267|FG000|Overall Study|Not Reported|0|||
149733178|NCT02913313|540157268|FG001|Overall Study|Not Reported|0|||
149733179|NCT02913313|540157269|FG002|Overall Study|Not Reported|0|||
149733180|NCT02913313|540157270|FG003|Overall Study|Not Reported|0|||
149733181|NCT02913313|540157271|FG004|Overall Study|Not Reported|1|||
149733182|NCT02913313|540157272|FG005|Overall Study|Not Reported|0|||
149733183|NCT02913313|540157273|FG006|Overall Study|Not Reported|0|||
149733184|NCT02913313|540157274|FG007|Overall Study|Not Reported|0|||
149733185|NCT02913313|540157275|FG008|Overall Study|Not Reported|0|||
149733186|NCT02913313|540157276|FG009|Overall Study|Not Reported|0|||
149733187|NCT02913313|540157277|FG010|Overall Study|Not Reported|4|||
149733188|NCT02913313|540157278|FG011|Overall Study|Not Reported|0|||
149733189|NCT02913313|540157279|FG012|Overall Study|Not Reported|0|||
149733190|NCT02913313|540157280|FG013|Overall Study|Not Reported|0|||
149733191|NCT02913313|540157267|FG000|Overall Study|Other reasons|0|||
149733192|NCT02913313|540157268|FG001|Overall Study|Other reasons|0|||
149733193|NCT02913313|540157269|FG002|Overall Study|Other reasons|0|||
149733194|NCT02913313|540157270|FG003|Overall Study|Other reasons|0|||
149733195|NCT02913313|540157271|FG004|Overall Study|Other reasons|1|||
149733196|NCT02913313|540157272|FG005|Overall Study|Other reasons|0|||
149733197|NCT02913313|540157273|FG006|Overall Study|Other reasons|0|||
149733198|NCT02913313|540157274|FG007|Overall Study|Other reasons|0|||
149733199|NCT02913313|540157275|FG008|Overall Study|Other reasons|0|||
149733200|NCT02913313|540157276|FG009|Overall Study|Other reasons|0|||
149733201|NCT02913313|540157277|FG010|Overall Study|Other reasons|1|||
149733202|NCT02913313|540157278|FG011|Overall Study|Other reasons|0|||
149733203|NCT02913313|540157279|FG012|Overall Study|Other reasons|0|||
149733204|NCT02913313|540157280|FG013|Overall Study|Other reasons|0|||
149733205|NCT02913313|540157267|FG000|Overall Study|Withdrawal by Subject|0|||
149733206|NCT02913313|540157268|FG001|Overall Study|Withdrawal by Subject|0|||
149733207|NCT02913313|540157269|FG002|Overall Study|Withdrawal by Subject|1|||
149733208|NCT02913313|540157270|FG003|Overall Study|Withdrawal by Subject|0|||
149733209|NCT02913313|540157271|FG004|Overall Study|Withdrawal by Subject|0|||
149733210|NCT02913313|540157272|FG005|Overall Study|Withdrawal by Subject|0|||
149733211|NCT02913313|540157273|FG006|Overall Study|Withdrawal by Subject|1|||
149733212|NCT02913313|540157274|FG007|Overall Study|Withdrawal by Subject|1|||
149733213|NCT02913313|540157275|FG008|Overall Study|Withdrawal by Subject|0|||
149733214|NCT02913313|540157276|FG009|Overall Study|Withdrawal by Subject|0|||
149733215|NCT02913313|540157277|FG010|Overall Study|Withdrawal by Subject|1|||
149733216|NCT02913313|540157278|FG011|Overall Study|Withdrawal by Subject|0|||
149733217|NCT02913313|540157279|FG012|Overall Study|Withdrawal by Subject|0|||
149733218|NCT02913313|540157280|FG013|Overall Study|Withdrawal by Subject|0|||
149733219|NCT02913313|540157267|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733220|NCT02913313|540157268|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733221|NCT02913313|540157269|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733222|NCT02913313|540157270|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733223|NCT02913313|540157271|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733224|NCT02913313|540157272|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733225|NCT02913313|540157273|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733226|NCT02913313|540157274|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733227|NCT02913313|540157275|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733228|NCT02913313|540157276|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733229|NCT02913313|540157277|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149733230|NCT02913313|540157278|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149733231|NCT02913313|540157279|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149733232|NCT02913313|540157280|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149733233|NCT02913313|540157267|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
149733234|NCT02913313|540157268|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
149733235|NCT02913313|540157269|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
149733236|NCT02913313|540157270|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
149733237|NCT02913313|540157271|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
149733238|NCT02913313|540157272|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
149733239|NCT02913313|540157273|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
149733240|NCT02913313|540157274|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
149733241|NCT02913313|540157275|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
149733242|NCT02913313|540157276|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
149733243|NCT02913313|540157277|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
149733244|NCT02913313|540157278|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
149733245|NCT02913313|540157279|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
149733246|NCT02913313|540157280|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
149733247|NCT06118385|540157282|FG000|Overall Study|Protocol Violation|0|||
149733248|NCT06118385|540157283|FG001|Overall Study|Protocol Violation|0|||
149733249|NCT06118385|540157284|FG002|Overall Study|Protocol Violation|0|||
149733250|NCT06118385|540157285|FG003|Overall Study|Protocol Violation|0|||
149733251|NCT06118385|540157286|FG004|Overall Study|Protocol Violation|0|||
149733252|NCT06118385|540157287|FG005|Overall Study|Protocol Violation|0|||
149733253|NCT06118385|540157288|FG006|Overall Study|Protocol Violation|0|||
149733254|NCT06118385|540157289|FG007|Overall Study|Protocol Violation|0|||
149733255|NCT06118385|540157290|FG008|Overall Study|Protocol Violation|1|||
149733256|NCT06118385|540157291|FG009|Overall Study|Protocol Violation|0|||
149733257|NCT06118385|540157292|FG010|Overall Study|Protocol Violation|0|||
149733258|NCT06118385|540157293|FG011|Overall Study|Protocol Violation|0|||
149733259|NCT06118385|540157282|FG000|Overall Study|Out-of-range blood tests|0|||
149733260|NCT06118385|540157283|FG001|Overall Study|Out-of-range blood tests|0|||
149733261|NCT06118385|540157284|FG002|Overall Study|Out-of-range blood tests|0|||
150254008|NCT02601300|542065794|FG000|Extension Phase|Adverse Event|4|||
150254009|NCT02601300|542065794|FG000|Extension Phase|Lack of Efficacy|10|||
150254010|NCT02310100|542065795|FG000|Overall Study|Physician Decision|3|||
150254011|NCT02310100|542065795|FG000|Overall Study|Withdrawal by Subject|10|||
150254012|NCT02310100|542065795|FG000|Overall Study|Enrollment closure|1|||
150254013|NCT02310100|542065795|FG000|Overall Study|Unapproved ablation operator|1|||
150254014|NCT02310100|542065795|FG000|Overall Study|Visit compliance|1|||
150254015|NCT02310100|542065795|FG000|Overall Study|Lost to Follow-up|2|||
150254016|NCT01127763|542065796|FG000|Overall Study|Adverse Event|2|||
150254017|NCT01127763|542065796|FG000|Overall Study|Withdrawal by Subject|1|||
150254018|NCT01127763|542065796|FG000|Overall Study|Physician Decision|2|||
150254019|NCT00528931|542065797|FG000|Overall Study|Lost to Follow-up|1|||
150254020|NCT01253018|542065804|FG000|Overall Study|Lost to Follow-up|1|||
150254021|NCT01253018|542065805|FG001|Overall Study|Lost to Follow-up|1|||
150254022|NCT01253018|542065804|FG000|Overall Study|Robot Repair Issues|2|||
150254023|NCT01253018|542065805|FG001|Overall Study|Robot Repair Issues|0|||
150254024|NCT01253018|542065804|FG000|Overall Study|Withdrawal by Subject|1|||
150254025|NCT01253018|542065805|FG001|Overall Study|Withdrawal by Subject|1|||
149733262|NCT06118385|540157285|FG003|Overall Study|Out-of-range blood tests|0|||
149733263|NCT06118385|540157286|FG004|Overall Study|Out-of-range blood tests|0|||
149733264|NCT06118385|540157287|FG005|Overall Study|Out-of-range blood tests|0|||
149733265|NCT06118385|540157288|FG006|Overall Study|Out-of-range blood tests|0|||
149733266|NCT06118385|540157289|FG007|Overall Study|Out-of-range blood tests|0|||
149733267|NCT06118385|540157290|FG008|Overall Study|Out-of-range blood tests|1|||
149733268|NCT06118385|540157291|FG009|Overall Study|Out-of-range blood tests|0|||
149733269|NCT06118385|540157292|FG010|Overall Study|Out-of-range blood tests|0|||
149733270|NCT06118385|540157293|FG011|Overall Study|Out-of-range blood tests|0|||
149733271|NCT02411448|540157294|FG000|Overall Study|Withdrawal by Subject|1|||
149733272|NCT02411448|540157295|FG001|Overall Study|Withdrawal by Subject|14|||
149733273|NCT02411448|540157296|FG002|Overall Study|Withdrawal by Subject|9|||
149733274|NCT02411448|540157294|FG000|Overall Study|Other|0|||
149733275|NCT02411448|540157295|FG001|Overall Study|Other|2|||
149733276|NCT02411448|540157296|FG002|Overall Study|Other|0|||
149733277|NCT02411448|540157294|FG000|Overall Study|Did not receive study treatment|0|||
149733278|NCT02411448|540157295|FG001|Overall Study|Did not receive study treatment|3|||
149733279|NCT02411448|540157296|FG002|Overall Study|Did not receive study treatment|0|||
149733280|NCT02411448|540157294|FG000|Overall Study|Alive on study treatment|3|||
149733281|NCT02411448|540157295|FG001|Overall Study|Alive on study treatment|64|||
149733282|NCT02411448|540157296|FG002|Overall Study|Alive on study treatment|43|||
149733283|NCT01848145|540157297|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
149733284|NCT01848145|540157297|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
149733285|NCT01848145|540157297|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
149733286|NCT01848145|540157297|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
149733287|NCT01848145|540157297|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
149733288|NCT01848145|540157297|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
149733289|NCT01848145|540157297|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
149733290|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Adverse Event|11|||
149733291|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Adverse Event|15|||
149733292|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
149733293|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
149733294|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
149733295|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
149733296|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
149733297|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
149733298|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
149733299|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
149733300|NCT01058096|540157300|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
149733301|NCT01058096|540157301|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
149733302|NCT02690194|540157306|FG000|Overall Study|Withdrawal by Subject|1|||
149733303|NCT02690194|540157307|FG001|Overall Study|Withdrawal by Subject|4|||
149733304|NCT02690194|540157308|FG002|Overall Study|Withdrawal by Subject|0|||
150254026|NCT00291642|542065807|FG000|Overall Study|Adverse Event|1|||
150254027|NCT00291642|542065808|FG001|Overall Study|Adverse Event|0|||
149733305|NCT03624946|540157309|FG000|Overall Study|Lost to Follow-up|0|||
149733306|NCT03624946|540157310|FG001|Overall Study|Lost to Follow-up|1|||
149733307|NCT01728779|540157311|FG000|Overall Study|Withdrawal by Subject|1|||
149733308|NCT00624520|540157312|FG000|Overall Study|Withdrawal by Subject|12|||
149733309|NCT00624520|540157313|FG001|Overall Study|Withdrawal by Subject|7|||
149733310|NCT00624520|540157312|FG000|Overall Study|Death|0|||
150254028|NCT00291642|542065809|FG002|Overall Study|Adverse Event|1|||
150254029|NCT00291642|542065810|FG003|Overall Study|Adverse Event|0|||
150254030|NCT00291642|542065811|FG004|Overall Study|Adverse Event|1|||
149733311|NCT00624520|540157313|FG001|Overall Study|Death|1|||
149733312|NCT00675025|540157314|FG000|Overall Study|Study Terminated by Sponsor|38|||
149733313|NCT00675025|540157315|FG001|Overall Study|Study Terminated by Sponsor|42|||
149733314|NCT00675025|540157314|FG000|Overall Study|Adverse Event|6|||
149733315|NCT00675025|540157315|FG001|Overall Study|Adverse Event|11|||
149733316|NCT00675025|540157314|FG000|Overall Study|Lost to Follow-up|6|||
149733317|NCT00675025|540157315|FG001|Overall Study|Lost to Follow-up|4|||
149733318|NCT00675025|540157314|FG000|Overall Study|Withdrawal by Subject|4|||
149733319|NCT00675025|540157315|FG001|Overall Study|Withdrawal by Subject|6|||
149733320|NCT00944034|540157320|FG000|Overall Study|Inappropriate enrollment|0|||
149733321|NCT00944034|540157321|FG001|Overall Study|Inappropriate enrollment|1|||
149733322|NCT00944034|540157322|FG002|Overall Study|Inappropriate enrollment|0|||
149733323|NCT00944034|540157323|FG003|Overall Study|Inappropriate enrollment|1|||
149733324|NCT00944034|540157324|FG004|Overall Study|Inappropriate enrollment|2|||
149733325|NCT00944034|540157325|FG005|Overall Study|Inappropriate enrollment|1|||
149733326|NCT00944034|540157326|FG006|Overall Study|Inappropriate enrollment|0|||
149733327|NCT00944034|540157327|FG007|Overall Study|Inappropriate enrollment|0|||
149733328|NCT00944034|540157328|FG008|Overall Study|Inappropriate enrollment|1|||
149733329|NCT00944034|540157329|FG009|Overall Study|Inappropriate enrollment|1|||
149733330|NCT00944034|540157330|FG010|Overall Study|Inappropriate enrollment|0|||
149733331|NCT00944034|540157331|FG011|Overall Study|Inappropriate enrollment|0|||
149733332|NCT00944034|540157320|FG000|Overall Study|Withdrawal by Subject|3|||
149733333|NCT00944034|540157321|FG001|Overall Study|Withdrawal by Subject|2|||
149733334|NCT00944034|540157322|FG002|Overall Study|Withdrawal by Subject|6|||
149733335|NCT00944034|540157323|FG003|Overall Study|Withdrawal by Subject|2|||
149733336|NCT00944034|540157324|FG004|Overall Study|Withdrawal by Subject|5|||
149733337|NCT00944034|540157325|FG005|Overall Study|Withdrawal by Subject|8|||
149733338|NCT00944034|540157326|FG006|Overall Study|Withdrawal by Subject|2|||
149733339|NCT00944034|540157327|FG007|Overall Study|Withdrawal by Subject|2|||
149733340|NCT00944034|540157328|FG008|Overall Study|Withdrawal by Subject|3|||
149733341|NCT00944034|540157329|FG009|Overall Study|Withdrawal by Subject|4|||
149733342|NCT00944034|540157330|FG010|Overall Study|Withdrawal by Subject|0|||
149733343|NCT00944034|540157331|FG011|Overall Study|Withdrawal by Subject|4|||
149733344|NCT00944034|540157320|FG000|Overall Study|Lost to Follow-up|0|||
149733345|NCT00944034|540157321|FG001|Overall Study|Lost to Follow-up|4|||
149733346|NCT00944034|540157322|FG002|Overall Study|Lost to Follow-up|2|||
149733347|NCT00944034|540157323|FG003|Overall Study|Lost to Follow-up|0|||
149733348|NCT00944034|540157324|FG004|Overall Study|Lost to Follow-up|5|||
149733349|NCT00944034|540157325|FG005|Overall Study|Lost to Follow-up|7|||
149733350|NCT00944034|540157326|FG006|Overall Study|Lost to Follow-up|0|||
149733351|NCT00944034|540157327|FG007|Overall Study|Lost to Follow-up|1|||
149733352|NCT00944034|540157328|FG008|Overall Study|Lost to Follow-up|5|||
149733353|NCT00944034|540157329|FG009|Overall Study|Lost to Follow-up|1|||
149733354|NCT00944034|540157330|FG010|Overall Study|Lost to Follow-up|1|||
149733355|NCT00944034|540157331|FG011|Overall Study|Lost to Follow-up|0|||
149733356|NCT00944034|540157320|FG000|Overall Study|Death|0|||
150254031|NCT00291642|542065807|FG000|Overall Study|Patient missed visit|0|||
150254032|NCT00291642|542065808|FG001|Overall Study|Patient missed visit|0|||
150254033|NCT00291642|542065809|FG002|Overall Study|Patient missed visit|1|||
150254034|NCT00291642|542065810|FG003|Overall Study|Patient missed visit|0|||
150254035|NCT00291642|542065811|FG004|Overall Study|Patient missed visit|0|||
150254036|NCT00291642|542065807|FG000|Overall Study|Intake of prohibited medication|1|||
150254037|NCT00291642|542065808|FG001|Overall Study|Intake of prohibited medication|0|||
150254038|NCT00291642|542065809|FG002|Overall Study|Intake of prohibited medication|0|||
150254039|NCT00291642|542065810|FG003|Overall Study|Intake of prohibited medication|0|||
150254040|NCT00291642|542065811|FG004|Overall Study|Intake of prohibited medication|0|||
150254041|NCT00735475|542065812|FG000|Overall Study|Adverse Event|0|||
150254042|NCT00735475|542065813|FG001|Overall Study|Adverse Event|1|||
150254043|NCT00735475|542065812|FG000|Overall Study|Death|1|||
150254044|NCT00735475|542065813|FG001|Overall Study|Death|1|||
150254045|NCT00735475|542065812|FG000|Overall Study|Lost to Follow-up|3|||
150254046|NCT00735475|542065813|FG001|Overall Study|Lost to Follow-up|3|||
150254047|NCT00735475|542065812|FG000|Overall Study|Physician Decision|0|||
150254048|NCT00735475|542065813|FG001|Overall Study|Physician Decision|1|||
150254049|NCT00735475|542065812|FG000|Overall Study|Withdrawal by Subject|4|||
150254050|NCT00735475|542065813|FG001|Overall Study|Withdrawal by Subject|5|||
150254051|NCT03189745|542065819|FG000|Overall Study|Conflict in work schedule of participant|1|||
150254052|NCT03189745|542065820|FG001|Overall Study|Conflict in work schedule of participant|1|||
150254053|NCT05086276|542065821|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
150254054|NCT05086276|542065822|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
150254055|NCT05051462|542065828|FG000|Overall Study|Lost to Follow-up|1|||
150254056|NCT05051462|542065829|FG001|Overall Study|Lost to Follow-up|8|||
150254057|NCT05051462|542065828|FG000|Overall Study|Withdrawal by Subject|1|||
149733357|NCT00944034|540157321|FG001|Overall Study|Death|0|||
149733358|NCT00944034|540157322|FG002|Overall Study|Death|1|||
149733359|NCT00944034|540157323|FG003|Overall Study|Death|0|||
149733360|NCT00944034|540157324|FG004|Overall Study|Death|0|||
149733361|NCT00944034|540157325|FG005|Overall Study|Death|0|||
149733362|NCT00944034|540157326|FG006|Overall Study|Death|0|||
149733363|NCT00944034|540157327|FG007|Overall Study|Death|0|||
149733364|NCT00944034|540157328|FG008|Overall Study|Death|0|||
149733365|NCT00944034|540157329|FG009|Overall Study|Death|0|||
149733366|NCT00944034|540157330|FG010|Overall Study|Death|0|||
149733367|NCT00944034|540157331|FG011|Overall Study|Death|0|||
149733368|NCT00944034|540157320|FG000|Overall Study|Protocol Violation|2|||
149733369|NCT00944034|540157321|FG001|Overall Study|Protocol Violation|0|||
149733370|NCT00944034|540157322|FG002|Overall Study|Protocol Violation|0|||
149733371|NCT00944034|540157323|FG003|Overall Study|Protocol Violation|1|||
149733372|NCT00944034|540157324|FG004|Overall Study|Protocol Violation|2|||
149733373|NCT00944034|540157325|FG005|Overall Study|Protocol Violation|3|||
149733374|NCT00944034|540157326|FG006|Overall Study|Protocol Violation|0|||
149733375|NCT00944034|540157327|FG007|Overall Study|Protocol Violation|1|||
149733376|NCT00944034|540157328|FG008|Overall Study|Protocol Violation|1|||
149733377|NCT00944034|540157329|FG009|Overall Study|Protocol Violation|4|||
149733378|NCT00944034|540157330|FG010|Overall Study|Protocol Violation|0|||
149733379|NCT00944034|540157331|FG011|Overall Study|Protocol Violation|0|||
149733380|NCT00944034|540157320|FG000|Overall Study|Unable to classify|0|||
149733381|NCT00944034|540157321|FG001|Overall Study|Unable to classify|0|||
149733382|NCT00944034|540157322|FG002|Overall Study|Unable to classify|0|||
149733383|NCT00944034|540157323|FG003|Overall Study|Unable to classify|0|||
149733384|NCT00944034|540157324|FG004|Overall Study|Unable to classify|0|||
149733385|NCT00944034|540157325|FG005|Overall Study|Unable to classify|1|||
149733386|NCT00944034|540157326|FG006|Overall Study|Unable to classify|1|||
149733387|NCT00944034|540157327|FG007|Overall Study|Unable to classify|1|||
149733388|NCT00944034|540157328|FG008|Overall Study|Unable to classify|0|||
149733389|NCT00944034|540157329|FG009|Overall Study|Unable to classify|0|||
149733390|NCT00944034|540157330|FG010|Overall Study|Unable to classify|0|||
149733391|NCT00944034|540157331|FG011|Overall Study|Unable to classify|0|||
149733392|NCT00944034|540157320|FG000|Overall Study|Administrative reason|0|||
149733393|NCT00944034|540157321|FG001|Overall Study|Administrative reason|0|||
149733394|NCT00944034|540157322|FG002|Overall Study|Administrative reason|0|||
149733395|NCT00944034|540157323|FG003|Overall Study|Administrative reason|0|||
149733396|NCT00944034|540157324|FG004|Overall Study|Administrative reason|0|||
149733397|NCT00944034|540157325|FG005|Overall Study|Administrative reason|0|||
149733398|NCT00944034|540157326|FG006|Overall Study|Administrative reason|1|||
149733399|NCT00944034|540157327|FG007|Overall Study|Administrative reason|0|||
149733400|NCT00944034|540157328|FG008|Overall Study|Administrative reason|0|||
149733401|NCT00944034|540157329|FG009|Overall Study|Administrative reason|0|||
149733402|NCT00944034|540157330|FG010|Overall Study|Administrative reason|0|||
149733403|NCT00944034|540157331|FG011|Overall Study|Administrative reason|0|||
149733404|NCT01596257|540157332|FG000|Overall Study|Inadequate Collection|23|||
149733405|NCT01596257|540157333|FG001|Overall Study|Inadequate Collection|19|||
149733406|NCT01570244|540157334|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
149733407|NCT00238264|540157341|FG000|Overall Study|Death|7|||
149733408|NCT00238264|540157341|FG000|Overall Study|Lost to Follow-up|18|||
149733409|NCT00238264|540157341|FG000|Overall Study|Withdrawal by Subject|4|||
149733410|NCT00238264|540157341|FG000|Overall Study|Ineligible|7|||
149733411|NCT00713219|540157342|FG000|Overall Study|Death|1|||
149733412|NCT00713219|540157342|FG000|Overall Study|Protocol Violation|1|||
149733413|NCT03183128|540157348|FG000|Overall Study|Adverse Event|1|||
149733414|NCT03183128|540157349|FG001|Overall Study|Adverse Event|2|||
149733415|NCT03183128|540157348|FG000|Overall Study|Withdrawal by Subject|1|||
149733416|NCT03183128|540157349|FG001|Overall Study|Withdrawal by Subject|8|||
149733417|NCT03183128|540157348|FG000|Overall Study|Protocol Violation|2|||
149733418|NCT03183128|540157349|FG001|Overall Study|Protocol Violation|0|||
149733419|NCT03183128|540157348|FG000|Overall Study|Lack of Efficacy|4|||
149733420|NCT03183128|540157349|FG001|Overall Study|Lack of Efficacy|27|||
149733421|NCT03183128|540157348|FG000|Overall Study|Lost to Follow-up|1|||
149733422|NCT03183128|540157349|FG001|Overall Study|Lost to Follow-up|0|||
149733423|NCT03183128|540157348|FG000|Overall Study|Death|2|||
149733424|NCT03183128|540157349|FG001|Overall Study|Death|0|||
149733425|NCT03183128|540157348|FG000|Overall Study|Physician Decision|1|||
149733426|NCT03183128|540157349|FG001|Overall Study|Physician Decision|0|||
149733427|NCT02978222|540157352|FG000|Overall Study|Withdrawal by Subject|2|||
149733428|NCT02978222|540157353|FG001|Overall Study|Withdrawal by Subject|2|||
149733429|NCT02978222|540157352|FG000|Overall Study|Physician Decision|2|||
149733430|NCT02978222|540157353|FG001|Overall Study|Physician Decision|0|||
149733431|NCT02978222|540157352|FG000|Overall Study|Adverse Event|0|||
149733432|NCT02978222|540157353|FG001|Overall Study|Adverse Event|1|||
149733433|NCT02978222|540157352|FG000|Overall Study|Death|1|||
149733434|NCT02978222|540157353|FG001|Overall Study|Death|0|||
149733435|NCT02978222|540157352|FG000|Overall Study|Disease Progression|32|||
149733436|NCT02978222|540157353|FG001|Overall Study|Disease Progression|32|||
149733437|NCT02978222|540157352|FG000|Overall Study|Early Study Termination|24|||
149733438|NCT02978222|540157353|FG001|Overall Study|Early Study Termination|21|||
149733439|NCT01686568|540157354|FG000|Main Study|Withdrawal by Subject|1|||
149733440|NCT01686568|540157355|FG001|Main Study|Withdrawal by Subject|3|||
149733441|NCT01686568|540157354|FG000|Main Study|Noncompliance with protocol|0|||
149733442|NCT01686568|540157355|FG001|Main Study|Noncompliance with protocol|1|||
149733443|NCT01686568|540157354|FG000|Main Study|Liver enzymes above range of exclusion|1|||
149733444|NCT01686568|540157355|FG001|Main Study|Liver enzymes above range of exclusion|0|||
149733445|NCT01686568|540157354|FG000|Sub-Study|Not consented for sub-study|2|||
149733446|NCT01686568|540157355|FG001|Sub-Study|Not consented for sub-study|2|||
149733447|NCT03258814|540157356|FG000|Overall Study|Early Termination|4|||
149733448|NCT03258814|540157357|FG001|Overall Study|Early Termination|3|||
149733449|NCT03258814|540157358|FG002|Overall Study|Early Termination|10|||
150254058|NCT05051462|542065829|FG001|Overall Study|Withdrawal by Subject|0|||
150254059|NCT05051462|542065828|FG000|Overall Study|Protocol Violation|0|||
150254060|NCT05051462|542065829|FG001|Overall Study|Protocol Violation|2|||
150254061|NCT01022112|542065835|FG000|Overall Study|Adverse Event|1|||
150254062|NCT01022112|542065836|FG001|Overall Study|Adverse Event|2|||
150254063|NCT01022112|542065837|FG002|Overall Study|Adverse Event|0|||
150254064|NCT01022112|542065838|FG003|Overall Study|Adverse Event|1|||
150254065|NCT01022112|542065839|FG004|Overall Study|Adverse Event|0|||
150254066|NCT01022112|542065835|FG000|Overall Study|Lack of Efficacy|1|||
150254067|NCT01022112|542065836|FG001|Overall Study|Lack of Efficacy|0|||
150254068|NCT01022112|542065837|FG002|Overall Study|Lack of Efficacy|0|||
150254069|NCT01022112|542065838|FG003|Overall Study|Lack of Efficacy|0|||
150254070|NCT01022112|542065839|FG004|Overall Study|Lack of Efficacy|1|||
150254071|NCT01022112|542065835|FG000|Overall Study|Physician Decision|0|||
150254072|NCT01022112|542065836|FG001|Overall Study|Physician Decision|0|||
150254073|NCT01022112|542065837|FG002|Overall Study|Physician Decision|1|||
150254074|NCT01022112|542065838|FG003|Overall Study|Physician Decision|0|||
150254075|NCT01022112|542065839|FG004|Overall Study|Physician Decision|1|||
150254076|NCT01022112|542065835|FG000|Overall Study|Withdrawal by Subject|0|||
150254077|NCT01022112|542065836|FG001|Overall Study|Withdrawal by Subject|1|||
150254078|NCT01022112|542065837|FG002|Overall Study|Withdrawal by Subject|2|||
150254079|NCT01022112|542065838|FG003|Overall Study|Withdrawal by Subject|2|||
150254080|NCT01022112|542065839|FG004|Overall Study|Withdrawal by Subject|1|||
150254081|NCT01022112|542065835|FG000|Overall Study|Fasting plasma glucose level increased|1|||
150254082|NCT01022112|542065836|FG001|Overall Study|Fasting plasma glucose level increased|0|||
150254083|NCT01022112|542065837|FG002|Overall Study|Fasting plasma glucose level increased|0|||
150254084|NCT01022112|542065838|FG003|Overall Study|Fasting plasma glucose level increased|0|||
150254085|NCT01022112|542065839|FG004|Overall Study|Fasting plasma glucose level increased|7|||
150254086|NCT01238900|542067266|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
150254087|NCT01238900|542067266|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
150254088|NCT03241927|542067267|FG000|Overall Study|study terminated|1|||
150254089|NCT03241927|542067268|FG001|Overall Study|study terminated|0|||
150254090|NCT01198756|542067269|FG000|Overall Study|Adverse Event|0|||
150254091|NCT01198756|542067270|FG001|Overall Study|Adverse Event|0|||
150254092|NCT01198756|542067271|FG002|Overall Study|Adverse Event|0|||
150254093|NCT01198756|542067272|FG003|Overall Study|Adverse Event|1|||
150254094|NCT01198756|542067269|FG000|Overall Study|Protocol Violation|0|||
150254095|NCT01198756|542067270|FG001|Overall Study|Protocol Violation|0|||
150254096|NCT01198756|542067271|FG002|Overall Study|Protocol Violation|0|||
150254097|NCT01198756|542067272|FG003|Overall Study|Protocol Violation|2|||
150254098|NCT01198756|542067269|FG000|Overall Study|Withdrawal by Subject|9|||
150254099|NCT01198756|542067270|FG001|Overall Study|Withdrawal by Subject|4|||
150254100|NCT01198756|542067271|FG002|Overall Study|Withdrawal by Subject|7|||
150254101|NCT01198756|542067272|FG003|Overall Study|Withdrawal by Subject|5|||
150254102|NCT01198756|542067269|FG000|Overall Study|Lost to Follow-up|29|||
150254103|NCT01198756|542067270|FG001|Overall Study|Lost to Follow-up|36|||
150254104|NCT01198756|542067271|FG002|Overall Study|Lost to Follow-up|23|||
150254105|NCT01198756|542067272|FG003|Overall Study|Lost to Follow-up|18|||
150254106|NCT02915302|542067275|FG000|Overall Study|Adverse Event|3|||
150254107|NCT02915302|542067276|FG001|Overall Study|Adverse Event|0|||
150254108|NCT02915302|542067275|FG000|Overall Study|Protocol Violation|20|||
149733450|NCT01413958|540157359|FG000|Overall Study|Lost to Follow-up|0|||
150254109|NCT02915302|542067276|FG001|Overall Study|Protocol Violation|27|||
150254110|NCT02915302|542067275|FG000|Overall Study|Lost to Follow-up|19|||
149733451|NCT01413958|540157360|FG001|Overall Study|Lost to Follow-up|1|||
149733452|NCT01900002|540157361|FG000|Overall Study|Withdrawal by Subject|2|||
149733453|NCT01900002|540157361|FG000|Overall Study|ineligible for Y-90|4|||
149733454|NCT00706628|540157368|FG000|Overall Study|Other Adverse Event|16|||
149733455|NCT00706628|540157369|FG001|Overall Study|Other Adverse Event|5|||
150254111|NCT02915302|542067276|FG001|Overall Study|Lost to Follow-up|22|||
150254112|NCT02915302|542067275|FG000|Overall Study|Withdrawal by Subject|22|||
150254113|NCT02915302|542067276|FG001|Overall Study|Withdrawal by Subject|29|||
150254114|NCT02915302|542067275|FG000|Overall Study|Other|1|||
150254115|NCT02915302|542067276|FG001|Overall Study|Other|0|||
150254116|NCT00591721|542067279|FG000|Overall Study|Withdrawal by Subject|10|||
150254117|NCT00591721|542067280|FG001|Overall Study|Withdrawal by Subject|10|||
150254118|NCT00591721|542067279|FG000|Overall Study|Lost to Follow-up|1|||
150254119|NCT00591721|542067280|FG001|Overall Study|Lost to Follow-up|4|||
150254120|NCT00591721|542067279|FG000|Overall Study|Intervention not received|10|||
150254121|NCT00591721|542067280|FG001|Overall Study|Intervention not received|8|||
150254122|NCT03809429|542067281|FG000|Overall Study|Withdrawal by Subject|7|||
150254123|NCT03809429|542067282|FG001|Overall Study|Withdrawal by Subject|3|||
150254124|NCT03809429|542067281|FG000|Overall Study|Adverse Event|6|||
150254125|NCT03809429|542067282|FG001|Overall Study|Adverse Event|9|||
150254126|NCT03809429|542067281|FG000|Overall Study|COVID-19|3|||
150254127|NCT03809429|542067282|FG001|Overall Study|COVID-19|1|||
150254128|NCT03809429|542067281|FG000|Overall Study|Participant was discontinued by investigator|12|||
150254129|NCT03809429|542067282|FG001|Overall Study|Participant was discontinued by investigator|7|||
150254130|NCT00941070|542067284|FG000|Overall Study|Patient non-compliant|1|||
150254131|NCT03174431|542067285|FG000|Overall Study|Withdrawal by Subject|14|||
150254132|NCT03174431|542067286|FG001|Overall Study|Withdrawal by Subject|11|||
150254133|NCT03174431|542067285|FG000|Overall Study|alternative treatment|2|||
150254134|NCT03174431|542067286|FG001|Overall Study|alternative treatment|0|||
150254135|NCT03174431|542067285|FG000|Overall Study|Lost to Follow-up|1|||
150254136|NCT03174431|542067286|FG001|Overall Study|Lost to Follow-up|5|||
150254137|NCT00252577|542067289|FG000|Overall Study|Lost to Follow-up|20|||
150254138|NCT01655693|542067290|FG000|Overall Study|Progression of Disease|92|||
150254139|NCT01655693|542067291|FG001|Overall Study|Progression of Disease|76|||
150254140|NCT01655693|542067292|FG002|Overall Study|Progression of Disease|58|||
150254141|NCT01655693|542067290|FG000|Overall Study|Death|8|||
150254142|NCT01655693|542067291|FG001|Overall Study|Death|9|||
150254143|NCT01655693|542067292|FG002|Overall Study|Death|12|||
150254144|NCT01655693|542067290|FG000|Overall Study|Serious Adverse Event|3|||
150254145|NCT01655693|542067291|FG001|Overall Study|Serious Adverse Event|15|||
150254146|NCT01655693|542067292|FG002|Overall Study|Serious Adverse Event|11|||
150254147|NCT01655693|542067290|FG000|Overall Study|Withdrawal by Subject|3|||
150254148|NCT01655693|542067291|FG001|Overall Study|Withdrawal by Subject|2|||
150254149|NCT01655693|542067292|FG002|Overall Study|Withdrawal by Subject|20|||
150254150|NCT01655693|542067290|FG000|Overall Study|Adverse Event|3|||
150254151|NCT01655693|542067291|FG001|Overall Study|Adverse Event|11|||
150254152|NCT01655693|542067292|FG002|Overall Study|Adverse Event|3|||
150254153|NCT01655693|542067290|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
150254154|NCT01655693|542067291|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
150254155|NCT01655693|542067292|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
150254156|NCT01655693|542067290|FG000|Overall Study|Non-Compliance|0|||
150254157|NCT01655693|542067291|FG001|Overall Study|Non-Compliance|0|||
150254158|NCT01655693|542067292|FG002|Overall Study|Non-Compliance|7|||
150254159|NCT01655693|542067290|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
150254160|NCT01655693|542067291|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
150254161|NCT01655693|542067292|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
150254162|NCT01655693|542067290|FG000|Overall Study|Protocol Violation|1|||
150254163|NCT01655693|542067291|FG001|Overall Study|Protocol Violation|0|||
150254164|NCT01655693|542067292|FG002|Overall Study|Protocol Violation|3|||
150254165|NCT01655693|542067290|FG000|Overall Study|Lost to Follow-up|1|||
150254166|NCT01655693|542067291|FG001|Overall Study|Lost to Follow-up|0|||
150254167|NCT01655693|542067292|FG002|Overall Study|Lost to Follow-up|1|||
150254168|NCT01655693|542067290|FG000|Overall Study|Screening Failure|1|||
150254169|NCT01655693|542067291|FG001|Overall Study|Screening Failure|0|||
150254170|NCT01655693|542067292|FG002|Overall Study|Screening Failure|0|||
150254171|NCT01655693|542067290|FG000|Overall Study|Other|8|||
150254172|NCT01655693|542067291|FG001|Overall Study|Other|6|||
150254173|NCT01655693|542067292|FG002|Overall Study|Other|15|||
150254174|NCT03122223|542067295|FG000|Overall Study|Withdrawal by Subject|2|||
150254175|NCT03122223|542067296|FG001|Overall Study|Withdrawal by Subject|2|||
150254176|NCT03122223|542067297|FG002|Overall Study|Withdrawal by Subject|1|||
150254177|NCT03122223|542067298|FG003|Overall Study|Withdrawal by Subject|0|||
150254178|NCT03122223|542067295|FG000|Overall Study|Lost to Follow-up|0|||
150254179|NCT03122223|542067296|FG001|Overall Study|Lost to Follow-up|2|||
150254180|NCT03122223|542067297|FG002|Overall Study|Lost to Follow-up|2|||
150254181|NCT03122223|542067298|FG003|Overall Study|Lost to Follow-up|0|||
150254182|NCT03122223|542067295|FG000|Overall Study|Participant unable to adhere|1|||
150254183|NCT03122223|542067296|FG001|Overall Study|Participant unable to adhere|1|||
150254184|NCT03122223|542067297|FG002|Overall Study|Participant unable to adhere|1|||
150254185|NCT03122223|542067298|FG003|Overall Study|Participant unable to adhere|0|||
150254186|NCT01820585|542067299|FG000|Overall Study|Adverse Event|9|||
150254187|NCT01820585|542067300|FG001|Overall Study|Adverse Event|13|||
150254188|NCT01820585|542067301|FG002|Overall Study|Adverse Event|23|||
150254189|NCT01820585|542067302|FG003|Overall Study|Adverse Event|34|||
150254190|NCT01820585|542067299|FG000|Overall Study|Lack of Efficacy|9|||
150254191|NCT01820585|542067300|FG001|Overall Study|Lack of Efficacy|7|||
150254192|NCT01820585|542067301|FG002|Overall Study|Lack of Efficacy|5|||
150254193|NCT01820585|542067302|FG003|Overall Study|Lack of Efficacy|1|||
150254194|NCT01820585|542067299|FG000|Overall Study|Withdrawal by Subject|3|||
150254195|NCT01820585|542067300|FG001|Overall Study|Withdrawal by Subject|7|||
150254196|NCT01820585|542067301|FG002|Overall Study|Withdrawal by Subject|3|||
150254197|NCT01820585|542067302|FG003|Overall Study|Withdrawal by Subject|8|||
150254198|NCT01820585|542067299|FG000|Overall Study|Lost to Follow-up|3|||
150254199|NCT01820585|542067300|FG001|Overall Study|Lost to Follow-up|3|||
150254200|NCT01820585|542067301|FG002|Overall Study|Lost to Follow-up|0|||
150254201|NCT01820585|542067302|FG003|Overall Study|Lost to Follow-up|3|||
150254202|NCT01820585|542067299|FG000|Overall Study|Protocol Violation|3|||
150254203|NCT01820585|542067300|FG001|Overall Study|Protocol Violation|1|||
150254204|NCT01820585|542067301|FG002|Overall Study|Protocol Violation|1|||
150254205|NCT01820585|542067302|FG003|Overall Study|Protocol Violation|1|||
150254206|NCT01820585|542067299|FG000|Overall Study|Subject non-compliance|0|||
150254207|NCT01820585|542067300|FG001|Overall Study|Subject non-compliance|0|||
150254208|NCT01820585|542067301|FG002|Overall Study|Subject non-compliance|1|||
150254209|NCT01820585|542067302|FG003|Overall Study|Subject non-compliance|2|||
150254210|NCT01820585|542067299|FG000|Overall Study|at sponsor request|0|||
150254211|NCT01820585|542067300|FG001|Overall Study|at sponsor request|0|||
149733456|NCT00706628|540157370|FG002|Overall Study|Other Adverse Event|5|||
150254212|NCT01820585|542067301|FG002|Overall Study|at sponsor request|1|||
150254213|NCT01820585|542067302|FG003|Overall Study|at sponsor request|0|||
150254214|NCT01820585|542067299|FG000|Overall Study|Pregnancy|0|||
150254215|NCT01820585|542067300|FG001|Overall Study|Pregnancy|1|||
150254216|NCT01820585|542067301|FG002|Overall Study|Pregnancy|0|||
149733457|NCT00706628|540157371|FG003|Overall Study|Other Adverse Event|2|||
150254217|NCT01820585|542067302|FG003|Overall Study|Pregnancy|0|||
150254218|NCT00548262|542067303|FG000|Overall Study|Death|21|||
150254219|NCT00548262|542067303|FG000|Overall Study|Adverse Event|2|||
150254220|NCT00548262|542067303|FG000|Overall Study|Lack of Efficacy|4|||
150254221|NCT00548262|542067303|FG000|Overall Study|Lost to Follow-up|1|||
150254222|NCT00548262|542067303|FG000|Overall Study|Other|3|||
149733458|NCT00706628|540157368|FG000|Overall Study|Non compliant with protocol|0|||
150254223|NCT00548262|542067303|FG000|Overall Study|Withdrawal by Subject|1|||
150254224|NCT02285153|542067304|FG000|Overall Study|Adverse Event|1|||
150254225|NCT02285153|542067305|FG001|Overall Study|Adverse Event|0|||
150254226|NCT02544451|542067309|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
150254227|NCT02544451|542067310|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
149733459|NCT00706628|540157369|FG001|Overall Study|Non compliant with protocol|1|||
149733460|NCT00706628|540157370|FG002|Overall Study|Non compliant with protocol|0|||
149733461|NCT00706628|540157371|FG003|Overall Study|Non compliant with protocol|0|||
149733462|NCT00706628|540157368|FG000|Overall Study|Consent withdrawn|6|||
149733463|NCT00706628|540157369|FG001|Overall Study|Consent withdrawn|1|||
149733464|NCT00706628|540157370|FG002|Overall Study|Consent withdrawn|3|||
149733465|NCT00706628|540157371|FG003|Overall Study|Consent withdrawn|0|||
149733466|NCT00706628|540157368|FG000|Overall Study|Progressive disease|20|||
149733467|NCT00706628|540157369|FG001|Overall Study|Progressive disease|13|||
149733468|NCT00706628|540157370|FG002|Overall Study|Progressive disease|8|||
149733469|NCT00706628|540157371|FG003|Overall Study|Progressive disease|1|||
149733470|NCT00706628|540157368|FG000|Overall Study|Other than those stated above|4|||
149733471|NCT00706628|540157369|FG001|Overall Study|Other than those stated above|0|||
149733472|NCT00706628|540157370|FG002|Overall Study|Other than those stated above|0|||
149733473|NCT00706628|540157371|FG003|Overall Study|Other than those stated above|0|||
150254228|NCT02544451|542067311|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
150254229|NCT02544451|542067312|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
150254230|NCT02544451|542067309|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
150254231|NCT02544451|542067310|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
150254232|NCT02544451|542067311|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
149733474|NCT00706628|540157368|FG000|Overall Study|Not treated|1|||
149733475|NCT00706628|540157369|FG001|Overall Study|Not treated|1|||
149733476|NCT00706628|540157370|FG002|Overall Study|Not treated|0|||
149733477|NCT00706628|540157371|FG003|Overall Study|Not treated|0|||
149733478|NCT02921425|540157372|FG000|Overall Study|Protocol Violation|9|||
149733479|NCT01145560|540157373|FG000|Overall Study|Withdrawal by Subject|2|||
149733480|NCT01145560|540157374|FG001|Overall Study|Withdrawal by Subject|1|||
149733481|NCT01145560|540157375|FG002|Overall Study|Withdrawal by Subject|0|||
150254233|NCT02544451|542067312|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
150254234|NCT02544451|542067309|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
149733482|NCT01145560|540157373|FG000|Overall Study|Lost to Follow-up|1|||
149733483|NCT01145560|540157374|FG001|Overall Study|Lost to Follow-up|1|||
149733484|NCT01145560|540157375|FG002|Overall Study|Lost to Follow-up|1|||
149733485|NCT01145560|540157373|FG000|Overall Study|No study drug by 24h after organ failure|1|||
149733486|NCT01145560|540157374|FG001|Overall Study|No study drug by 24h after organ failure|0|||
149733487|NCT01145560|540157375|FG002|Overall Study|No study drug by 24h after organ failure|0|||
149733488|NCT01145560|540157373|FG000|Overall Study|Accidental unblinding of study treatment|0|||
149733489|NCT01145560|540157374|FG001|Overall Study|Accidental unblinding of study treatment|1|||
149733490|NCT01145560|540157375|FG002|Overall Study|Accidental unblinding of study treatment|0|||
149733491|NCT01145560|540157373|FG000|Overall Study|False insurance information|0|||
149733492|NCT01145560|540157374|FG001|Overall Study|False insurance information|1|||
149733493|NCT01145560|540157375|FG002|Overall Study|False insurance information|0|||
149733494|NCT01145560|540157373|FG000|Overall Study|Withdrawal of therapy|0|||
149733495|NCT01145560|540157374|FG001|Overall Study|Withdrawal of therapy|0|||
149733496|NCT01145560|540157375|FG002|Overall Study|Withdrawal of therapy|1|||
149733497|NCT00712348|540157376|FG000|Overall Study|Withdrawal by Subject|1|||
149733498|NCT01375764|540157382|FG000|Overall Study|Lost to Follow-up|0|||
149733499|NCT01375764|540157383|FG001|Overall Study|Lost to Follow-up|1|||
149733500|NCT01375764|540157384|FG002|Overall Study|Lost to Follow-up|0|||
149733501|NCT01375764|540157385|FG003|Overall Study|Lost to Follow-up|0|||
149733502|NCT01375764|540157386|FG004|Overall Study|Lost to Follow-up|0|||
149733503|NCT01375764|540157382|FG000|Overall Study|Withdrawal by Subject|2|||
149733504|NCT01375764|540157383|FG001|Overall Study|Withdrawal by Subject|0|||
149733505|NCT01375764|540157384|FG002|Overall Study|Withdrawal by Subject|0|||
149733506|NCT01375764|540157385|FG003|Overall Study|Withdrawal by Subject|0|||
150254235|NCT02544451|542067310|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
150254236|NCT02544451|542067311|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
150254237|NCT02544451|542067312|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
149733507|NCT01375764|540157386|FG004|Overall Study|Withdrawal by Subject|1|||
149733508|NCT01375764|540157382|FG000|Overall Study|Other|0|||
149733509|NCT01375764|540157383|FG001|Overall Study|Other|0|||
150254238|NCT02544451|542067309|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
150254239|NCT02544451|542067310|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
150254240|NCT02544451|542067311|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
149733510|NCT01375764|540157384|FG002|Overall Study|Other|0|||
149733511|NCT01375764|540157385|FG003|Overall Study|Other|1|||
149733512|NCT01375764|540157386|FG004|Overall Study|Other|0|||
149733513|NCT02867761|540157387|FG000|Overall Study|Participant withdrawn by investigator|0|||
149733514|NCT02867761|540157388|FG001|Overall Study|Participant withdrawn by investigator|1|||
149733515|NCT02867761|540157387|FG000|Overall Study|Lost to Follow-up|25|||
149733516|NCT02867761|540157388|FG001|Overall Study|Lost to Follow-up|18|||
149733517|NCT02867761|540157387|FG000|Overall Study|Unable to complete protocol|3|||
149733518|NCT02867761|540157388|FG001|Overall Study|Unable to complete protocol|7|||
150254241|NCT02544451|542067312|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
150254242|NCT02544451|542067309|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
150254243|NCT02544451|542067310|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
150254244|NCT02544451|542067311|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
150254245|NCT02544451|542067312|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
150254246|NCT02544451|542067309|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
150254247|NCT02544451|542067310|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
150254248|NCT02544451|542067311|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
150254249|NCT02544451|542067312|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
150254250|NCT03590366|542067316|FG000|Overall Study|Adverse Event|0|||
150254251|NCT03590366|542067317|FG001|Overall Study|Adverse Event|3|||
150254252|NCT03590366|542067316|FG000|Overall Study|Lost to Follow-up|3|||
150254253|NCT03590366|542067317|FG001|Overall Study|Lost to Follow-up|3|||
150254254|NCT03590366|542067316|FG000|Overall Study|Withdrawal by Subject|0|||
150254255|NCT03590366|542067317|FG001|Overall Study|Withdrawal by Subject|2|||
150254256|NCT05017103|542067319|FG000|Overall Study|Death|2|||
150254257|NCT02656329|542067320|FG000|Overall Study|Lost to Follow-up|2|||
150254258|NCT02656329|542067321|FG001|Overall Study|Lost to Follow-up|3|||
150254259|NCT02656329|542067320|FG000|Overall Study|Withdrawal by Subject|7|||
150254260|NCT02656329|542067321|FG001|Overall Study|Withdrawal by Subject|6|||
150254261|NCT02656329|542067320|FG000|Overall Study|Study termination by Sponsor|150|||
150254262|NCT02656329|542067321|FG001|Overall Study|Study termination by Sponsor|142|||
150254263|NCT02656329|542067320|FG000|Overall Study|Other than specified above|5|||
150254264|NCT02656329|542067321|FG001|Overall Study|Other than specified above|6|||
150254265|NCT01081665|542067323|FG000|Overall Study|Death|41|||
150254266|NCT01081665|542067323|FG000|Overall Study|Lost to Follow-up|18|||
149733519|NCT03595280|540157389|FG000|Overall Study|Lost to Follow-up|6|||
149733520|NCT03595280|540157390|FG001|Overall Study|Lost to Follow-up|9|||
149733521|NCT03595280|540157391|FG002|Overall Study|Lost to Follow-up|15|||
149733522|NCT02292212|540157392|FG000|ViE Phase|Withdrawal by Subject|1|||
149733523|NCT02292212|540157392|FG000|ViE Phase|Protocol Violation|2|||
149733524|NCT02675075|540157393|FG000|Overall Study|Lost to Follow-up|3|||
149733525|NCT02675075|540157394|FG001|Overall Study|Lost to Follow-up|0|||
149733526|NCT02411747|540157395|FG000|Overall Study|Withdrawal by Subject|1|||
149733527|NCT02411747|540157396|FG001|Overall Study|Withdrawal by Subject|0|||
149733528|NCT02411747|540157395|FG000|Overall Study|Protocol Violation|2|||
149733529|NCT02411747|540157396|FG001|Overall Study|Protocol Violation|4|||
149733530|NCT02149810|540157397|FG000|Overall Study|Physician Decision|1|||
149733531|NCT02149810|540157398|FG001|Overall Study|Physician Decision|2|||
150254267|NCT01081665|542067323|FG000|Overall Study|Withdrawal by Subject|17|||
150254268|NCT01081665|542067323|FG000|Overall Study|Change of dialysis unit|10|||
150254269|NCT01081665|542067323|FG000|Overall Study|Regulation of iPTH|5|||
150254270|NCT01081665|542067323|FG000|Overall Study|Change in renal replacement therapy|2|||
150254271|NCT01081665|542067323|FG000|Overall Study|Adverse Event|1|||
150254272|NCT01081665|542067323|FG000|Overall Study|Lack of Efficacy|1|||
150254273|NCT01747551|542067336|FG000|Overall Study|Progressive Disease|24|||
150254274|NCT01747551|542067337|FG001|Overall Study|Progressive Disease|17|||
150254275|NCT01747551|542067336|FG000|Overall Study|Death|3|||
150254276|NCT01747551|542067337|FG001|Overall Study|Death|1|||
150254277|NCT01747551|542067336|FG000|Overall Study|Adverse Event|7|||
150254278|NCT01747551|542067337|FG001|Overall Study|Adverse Event|1|||
150254279|NCT01747551|542067336|FG000|Overall Study|Prolonged Treatment Delay|2|||
150254280|NCT01747551|542067337|FG001|Overall Study|Prolonged Treatment Delay|0|||
150254281|NCT01747551|542067336|FG000|Overall Study|Withdrawal by Subject|3|||
150254282|NCT01747551|542067337|FG001|Overall Study|Withdrawal by Subject|1|||
150254283|NCT01747551|542067336|FG000|Overall Study|Physician Decision|2|||
150254284|NCT01747551|542067337|FG001|Overall Study|Physician Decision|1|||
150254285|NCT01747551|542067336|FG000|Overall Study|Other|2|||
150254286|NCT01747551|542067337|FG001|Overall Study|Other|0|||
150254287|NCT02546921|542067339|FG000|Overall Study|Adverse Event|0|||
150254288|NCT02546921|542067340|FG001|Overall Study|Adverse Event|5|||
150254289|NCT02546921|542067341|FG002|Overall Study|Adverse Event|2|||
150254290|NCT02546921|542067342|FG003|Overall Study|Adverse Event|0|||
150254291|NCT02546921|542067343|FG004|Overall Study|Adverse Event|0|||
150254292|NCT02546921|542067344|FG005|Overall Study|Adverse Event|0|||
150254293|NCT02546921|542067345|FG006|Overall Study|Adverse Event|0|||
150254294|NCT02546921|542067339|FG000|Overall Study|Evidence of Disease Progression|1|||
150254295|NCT02546921|542067340|FG001|Overall Study|Evidence of Disease Progression|0|||
150254296|NCT02546921|542067341|FG002|Overall Study|Evidence of Disease Progression|0|||
150254297|NCT02546921|542067342|FG003|Overall Study|Evidence of Disease Progression|0|||
150254298|NCT02546921|542067343|FG004|Overall Study|Evidence of Disease Progression|1|||
150254299|NCT02546921|542067344|FG005|Overall Study|Evidence of Disease Progression|0|||
150254300|NCT02546921|542067345|FG006|Overall Study|Evidence of Disease Progression|0|||
150254301|NCT02546921|542067339|FG000|Overall Study|Patient Choice|0|||
150254302|NCT02546921|542067340|FG001|Overall Study|Patient Choice|1|||
149733532|NCT02149810|540157397|FG000|Overall Study|Lost to Follow-up|2|||
149733533|NCT02149810|540157398|FG001|Overall Study|Lost to Follow-up|1|||
150254303|NCT02546921|542067341|FG002|Overall Study|Patient Choice|0|||
150254304|NCT02546921|542067342|FG003|Overall Study|Patient Choice|0|||
150254305|NCT02546921|542067343|FG004|Overall Study|Patient Choice|0|||
150254306|NCT02546921|542067344|FG005|Overall Study|Patient Choice|1|||
150254307|NCT02546921|542067345|FG006|Overall Study|Patient Choice|0|||
150254308|NCT01373151|542067346|FG000|Period 1|Lack of Efficacy|3|||
150254309|NCT01373151|542067347|FG001|Period 1|Lack of Efficacy|0|||
150254310|NCT01373151|542067348|FG002|Period 1|Lack of Efficacy|0|||
150254311|NCT01373151|542067349|FG003|Period 1|Lack of Efficacy|0|||
150254312|NCT01373151|542067350|FG004|Period 1|Lack of Efficacy|1|||
150254313|NCT01373151|542067351|FG005|Period 1|Lack of Efficacy|0|||
150254314|NCT01373151|542067352|FG006|Period 1|Lack of Efficacy|0|||
150254315|NCT01373151|542067346|FG000|Period 1|Adverse Event|0|||
150254316|NCT01373151|542067347|FG001|Period 1|Adverse Event|0|||
150254317|NCT01373151|542067348|FG002|Period 1|Adverse Event|1|||
150254318|NCT01373151|542067349|FG003|Period 1|Adverse Event|0|||
150254319|NCT01373151|542067350|FG004|Period 1|Adverse Event|4|||
150254320|NCT01373151|542067351|FG005|Period 1|Adverse Event|3|||
150254321|NCT01373151|542067352|FG006|Period 1|Adverse Event|0|||
149733534|NCT02149810|540157397|FG000|Overall Study|Withdrawal by Subject|5|||
149733535|NCT02149810|540157398|FG001|Overall Study|Withdrawal by Subject|1|||
149733536|NCT01176916|540157399|FG000|Overall Study|Adverse Event|61|||
149733537|NCT01176916|540157399|FG000|Overall Study|Death|1|||
149733538|NCT01176916|540157399|FG000|Overall Study|Lost to Follow-up|15|||
149733539|NCT01176916|540157399|FG000|Overall Study|Objective progression or relapse|17|||
149733540|NCT01176916|540157399|FG000|Overall Study|Protocol Violation|24|||
149733541|NCT01176916|540157399|FG000|Overall Study|Withdrawal by Subject|37|||
149733542|NCT01176916|540157399|FG000|Overall Study|Other|6|||
149733543|NCT01176916|540157399|FG000|Overall Study|Withdrawal prior to Treatment|6|||
149733544|NCT00675597|540157400|FG000|Overall Study|Withdrawal by Subject|3|||
149733545|NCT03158220|540157403|FG000|Overall Study|Screen Failure|0|||
149733546|NCT03158220|540157404|FG001|Overall Study|Screen Failure|1|||
149733547|NCT03158220|540157403|FG000|Overall Study|Withdrawal by Subject|8|||
149733548|NCT03158220|540157404|FG001|Overall Study|Withdrawal by Subject|9|||
149733549|NCT03158220|540157403|FG000|Overall Study|Status unknown|0|||
149733550|NCT03158220|540157404|FG001|Overall Study|Status unknown|1|||
149733551|NCT03158220|540157403|FG000|Overall Study|Lost to Follow-up|8|||
149733552|NCT03158220|540157404|FG001|Overall Study|Lost to Follow-up|5|||
149733553|NCT03158220|540157403|FG000|Overall Study|Physician Decision|1|||
149733554|NCT03158220|540157404|FG001|Overall Study|Physician Decision|0|||
149733555|NCT01974817|540158843|FG000|Overall Study|Death|4|||
149733556|NCT01974817|540158843|FG000|Overall Study|Lost to Follow-up|2|||
149733557|NCT01974817|540158843|FG000|Overall Study|Protocol Violation|2|||
149733558|NCT00224016|540158849|FG000|Titration Period|Withdrawal by Subject|0|||
149733559|NCT00224016|540158850|FG001|Titration Period|Withdrawal by Subject|1|||
149733560|NCT00224016|540158849|FG000|Titration Period|Lost to Follow-up|1|||
149733561|NCT00224016|540158850|FG001|Titration Period|Lost to Follow-up|0|||
149733562|NCT00224016|540158849|FG000|Maintenance Period|Withdrawal by Subject|2|||
149733563|NCT00224016|540158850|FG001|Maintenance Period|Withdrawal by Subject|0|||
149733564|NCT00224016|540158849|FG000|Maintenance Period|Lost to Follow-up|0|||
149733565|NCT00224016|540158850|FG001|Maintenance Period|Lost to Follow-up|1|||
149733566|NCT01524991|540158853|FG000|Overall Study|Adverse Event|12|||
150254322|NCT01373151|542067346|FG000|Period 1|Withdrawal by Subject|2|||
150254323|NCT01373151|542067347|FG001|Period 1|Withdrawal by Subject|0|||
150254324|NCT01373151|542067348|FG002|Period 1|Withdrawal by Subject|3|||
150254325|NCT01373151|542067349|FG003|Period 1|Withdrawal by Subject|1|||
150254326|NCT01373151|542067350|FG004|Period 1|Withdrawal by Subject|0|||
150254327|NCT01373151|542067351|FG005|Period 1|Withdrawal by Subject|1|||
150254328|NCT01373151|542067352|FG006|Period 1|Withdrawal by Subject|0|||
150254329|NCT01373151|542067346|FG000|Period 2|Lack of Efficacy|9|||
150254330|NCT01373151|542067347|FG001|Period 2|Lack of Efficacy|0|||
150254331|NCT01373151|542067348|FG002|Period 2|Lack of Efficacy|0|||
150254332|NCT01373151|542067349|FG003|Period 2|Lack of Efficacy|1|||
150254333|NCT01373151|542067350|FG004|Period 2|Lack of Efficacy|2|||
150254334|NCT01373151|542067351|FG005|Period 2|Lack of Efficacy|0|||
150254335|NCT01373151|542067352|FG006|Period 2|Lack of Efficacy|3|||
150254336|NCT01373151|542067346|FG000|Period 2|Adverse Event|0|||
150254337|NCT01373151|542067347|FG001|Period 2|Adverse Event|0|||
150254338|NCT01373151|542067348|FG002|Period 2|Adverse Event|3|||
150254339|NCT01373151|542067349|FG003|Period 2|Adverse Event|3|||
149733567|NCT01524991|540158853|FG000|Overall Study|Death|1|||
149733568|NCT01524991|540158853|FG000|Overall Study|Disease ProgressionDu|17|||
149733569|NCT01524991|540158853|FG000|Overall Study|Other complicating disease|1|||
149733570|NCT01524991|540158853|FG000|Overall Study|Withdrawal by Subject|2|||
149733571|NCT01524991|540158853|FG000|Overall Study|Symptomatic Deterioration|1|||
149733572|NCT05742984|540158856|FG000|Overall Study|Adverse Event|0|||
149733573|NCT05742984|540158857|FG001|Overall Study|Adverse Event|0|||
149733574|NCT05742984|540158858|FG002|Overall Study|Adverse Event|1|||
149733575|NCT05742984|540158859|FG003|Overall Study|Adverse Event|0|||
150254340|NCT01373151|542067350|FG004|Period 2|Adverse Event|0|||
150254341|NCT01373151|542067351|FG005|Period 2|Adverse Event|0|||
150254342|NCT01373151|542067352|FG006|Period 2|Adverse Event|1|||
150254343|NCT01373151|542067346|FG000|Period 2|subject request to discontinue|0|||
150254344|NCT01373151|542067347|FG001|Period 2|subject request to discontinue|1|||
150254345|NCT01373151|542067348|FG002|Period 2|subject request to discontinue|0|||
150254346|NCT01373151|542067349|FG003|Period 2|subject request to discontinue|0|||
150254347|NCT01373151|542067350|FG004|Period 2|subject request to discontinue|0|||
150254348|NCT01373151|542067351|FG005|Period 2|subject request to discontinue|0|||
150254349|NCT01373151|542067352|FG006|Period 2|subject request to discontinue|0|||
150254350|NCT01373151|542067346|FG000|Period 2|Withdrawal by Subject|0|||
150254351|NCT01373151|542067347|FG001|Period 2|Withdrawal by Subject|0|||
150254352|NCT01373151|542067348|FG002|Period 2|Withdrawal by Subject|0|||
150254353|NCT01373151|542067349|FG003|Period 2|Withdrawal by Subject|1|||
150254354|NCT01373151|542067350|FG004|Period 2|Withdrawal by Subject|0|||
150254355|NCT01373151|542067351|FG005|Period 2|Withdrawal by Subject|0|||
150254356|NCT01373151|542067352|FG006|Period 2|Withdrawal by Subject|0|||
150254357|NCT01373151|542067346|FG000|Period 2|Other|0|||
150254358|NCT01373151|542067347|FG001|Period 2|Other|0|||
150254359|NCT01373151|542067348|FG002|Period 2|Other|1|||
150254360|NCT01373151|542067349|FG003|Period 2|Other|0|||
150254361|NCT01373151|542067350|FG004|Period 2|Other|0|||
150254362|NCT01373151|542067351|FG005|Period 2|Other|0|||
150254363|NCT01373151|542067352|FG006|Period 2|Other|1|||
150254364|NCT03381339|542067359|FG000|Overall Study|Protocol Violation|4|||
150254365|NCT03381339|542067360|FG001|Overall Study|Protocol Violation|3|||
150254366|NCT03381339|542067359|FG000|Overall Study|Lost to Follow-up|0|||
150254367|NCT03381339|542067360|FG001|Overall Study|Lost to Follow-up|1|||
150254368|NCT03117998|542067364|FG000|Overall Study|Adverse Event|1|||
150254369|NCT03117998|542067365|FG001|Overall Study|Adverse Event|0|||
150254370|NCT03117998|542067366|FG002|Overall Study|Adverse Event|0|||
150254371|NCT03117998|542067367|FG003|Overall Study|Adverse Event|0|||
150254372|NCT03117998|542067368|FG004|Overall Study|Adverse Event|0|||
150254373|NCT03117998|542067369|FG005|Overall Study|Adverse Event|0|||
150254374|NCT03117998|542067364|FG000|Overall Study|Withdrawal by Subject|0|||
150254375|NCT03117998|542067365|FG001|Overall Study|Withdrawal by Subject|0|||
150254376|NCT03117998|542067366|FG002|Overall Study|Withdrawal by Subject|2|||
150254377|NCT03117998|542067367|FG003|Overall Study|Withdrawal by Subject|3|||
150254378|NCT03117998|542067368|FG004|Overall Study|Withdrawal by Subject|3|||
150254379|NCT03117998|542067369|FG005|Overall Study|Withdrawal by Subject|0|||
150254380|NCT03117998|542067364|FG000|Overall Study|Physician Decision|0|||
150254381|NCT03117998|542067365|FG001|Overall Study|Physician Decision|1|||
150254382|NCT03117998|542067366|FG002|Overall Study|Physician Decision|1|||
150254383|NCT03117998|542067367|FG003|Overall Study|Physician Decision|0|||
150254384|NCT03117998|542067368|FG004|Overall Study|Physician Decision|0|||
150254385|NCT03117998|542067369|FG005|Overall Study|Physician Decision|0|||
150254386|NCT03117998|542067364|FG000|Overall Study|Lost to Follow-up|0|||
150254387|NCT03117998|542067365|FG001|Overall Study|Lost to Follow-up|0|||
150254388|NCT03117998|542067366|FG002|Overall Study|Lost to Follow-up|0|||
150254389|NCT03117998|542067367|FG003|Overall Study|Lost to Follow-up|1|||
150254390|NCT03117998|542067368|FG004|Overall Study|Lost to Follow-up|4|||
149733576|NCT05742984|540158860|FG004|Overall Study|Adverse Event|1|||
149733577|NCT05742984|540158861|FG005|Overall Study|Adverse Event|1|||
149733578|NCT05742984|540158856|FG000|Overall Study|Withdrawal by Subject|0|||
149733579|NCT05742984|540158857|FG001|Overall Study|Withdrawal by Subject|1|||
149733580|NCT05742984|540158858|FG002|Overall Study|Withdrawal by Subject|0|||
149733581|NCT05742984|540158859|FG003|Overall Study|Withdrawal by Subject|0|||
149733582|NCT05742984|540158860|FG004|Overall Study|Withdrawal by Subject|0|||
149733583|NCT05742984|540158861|FG005|Overall Study|Withdrawal by Subject|2|||
149733584|NCT02162862|540158862|FG000|Overall Study|Lost to Follow-up|0|||
149733585|NCT02162862|540158863|FG001|Overall Study|Lost to Follow-up|11|||
149733586|NCT02162862|540158864|FG002|Overall Study|Lost to Follow-up|0|||
149733587|NCT02162862|540158862|FG000|Overall Study|Subject did not feel the med was needed|0|||
149733588|NCT02162862|540158863|FG001|Overall Study|Subject did not feel the med was needed|0|||
149733589|NCT02162862|540158864|FG002|Overall Study|Subject did not feel the med was needed|4|||
149733590|NCT01409928|540158866|FG000|Overall Study|Physician Decision|12|||
149733591|NCT03502187|540158867|FG000|Overall Study|Withdrawal by Subject|4|||
149733592|NCT03502187|540158868|FG001|Overall Study|Withdrawal by Subject|3|||
149733593|NCT03502187|540158869|FG002|Overall Study|Withdrawal by Subject|3|||
149733594|NCT03502187|540158867|FG000|Overall Study|Lost to Follow-up|5|||
150254391|NCT03117998|542067369|FG005|Overall Study|Lost to Follow-up|0|||
150254392|NCT03117998|542067364|FG000|Overall Study|Subject noncompliance|0|||
150254393|NCT03117998|542067365|FG001|Overall Study|Subject noncompliance|0|||
150254394|NCT03117998|542067366|FG002|Overall Study|Subject noncompliance|1|||
150254395|NCT03117998|542067367|FG003|Overall Study|Subject noncompliance|0|||
150254396|NCT03117998|542067368|FG004|Overall Study|Subject noncompliance|0|||
150254397|NCT03117998|542067369|FG005|Overall Study|Subject noncompliance|2|||
149733595|NCT03502187|540158868|FG001|Overall Study|Lost to Follow-up|4|||
149733596|NCT03502187|540158869|FG002|Overall Study|Lost to Follow-up|5|||
150254398|NCT03117998|542067364|FG000|Overall Study|Protocol Violation|0|||
150254399|NCT03117998|542067365|FG001|Overall Study|Protocol Violation|0|||
150254400|NCT03117998|542067366|FG002|Overall Study|Protocol Violation|0|||
150254401|NCT03117998|542067367|FG003|Overall Study|Protocol Violation|0|||
150254402|NCT03117998|542067368|FG004|Overall Study|Protocol Violation|0|||
150254403|NCT03117998|542067369|FG005|Overall Study|Protocol Violation|1|||
150254404|NCT01468181|542067371|FG000|Overall Study|Adverse Event|8|||
150254405|NCT01468181|542067372|FG001|Overall Study|Adverse Event|1|||
150254406|NCT01468181|542067373|FG002|Overall Study|Adverse Event|6|||
150254407|NCT01468181|542067374|FG003|Overall Study|Adverse Event|2|||
150254408|NCT01468181|542067375|FG004|Overall Study|Adverse Event|2|||
150254409|NCT01468181|542067371|FG000|Overall Study|Protocol Violation|2|||
150254410|NCT01468181|542067372|FG001|Overall Study|Protocol Violation|0|||
150254411|NCT01468181|542067373|FG002|Overall Study|Protocol Violation|1|||
150254412|NCT01468181|542067374|FG003|Overall Study|Protocol Violation|0|||
150254413|NCT01468181|542067375|FG004|Overall Study|Protocol Violation|1|||
150254414|NCT01468181|542067371|FG000|Overall Study|Physician Decision|0|||
150254415|NCT01468181|542067372|FG001|Overall Study|Physician Decision|0|||
150254416|NCT01468181|542067373|FG002|Overall Study|Physician Decision|0|||
150254417|NCT01468181|542067374|FG003|Overall Study|Physician Decision|1|||
150254418|NCT01468181|542067375|FG004|Overall Study|Physician Decision|1|||
150254419|NCT01468181|542067371|FG000|Overall Study|Lost to Follow-up|0|||
150254420|NCT01468181|542067372|FG001|Overall Study|Lost to Follow-up|0|||
150254421|NCT01468181|542067373|FG002|Overall Study|Lost to Follow-up|1|||
150254422|NCT01468181|542067374|FG003|Overall Study|Lost to Follow-up|0|||
150254423|NCT01468181|542067375|FG004|Overall Study|Lost to Follow-up|1|||
150254424|NCT01468181|542067371|FG000|Overall Study|Withdrawal by Subject|0|||
150254425|NCT01468181|542067372|FG001|Overall Study|Withdrawal by Subject|1|||
150254426|NCT01468181|542067373|FG002|Overall Study|Withdrawal by Subject|0|||
150254427|NCT01468181|542067374|FG003|Overall Study|Withdrawal by Subject|0|||
150254428|NCT01468181|542067375|FG004|Overall Study|Withdrawal by Subject|0|||
150254429|NCT04828837|542067376|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
150254430|NCT04828837|542067377|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
150254431|NCT04828837|542067376|FG000|Overall Study|Lost to Follow-up|2|||
150254432|NCT04828837|542067377|FG001|Overall Study|Lost to Follow-up|6|||
150254433|NCT04828837|542067376|FG000|Overall Study|Lack of Efficacy|1|||
150254434|NCT04828837|542067377|FG001|Overall Study|Lack of Efficacy|0|||
150254435|NCT04828837|542067376|FG000|Overall Study|Admitted due to pneumothorax.|1|||
150254436|NCT04828837|542067377|FG001|Overall Study|Admitted due to pneumothorax.|0|||
150254437|NCT04828837|542067376|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
150254438|NCT04828837|542067377|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
150254439|NCT01397422|542067378|FG000|Overall Study|Adverse Event|0|||
150254440|NCT01397422|542067379|FG001|Overall Study|Adverse Event|3|||
150254441|NCT01397422|542067380|FG002|Overall Study|Adverse Event|3|||
150254442|NCT01397422|542067381|FG003|Overall Study|Adverse Event|8|||
150254443|NCT01397422|542067378|FG000|Overall Study|Withdrawal by Subject|1|||
150254444|NCT01397422|542067379|FG001|Overall Study|Withdrawal by Subject|0|||
150254445|NCT01397422|542067380|FG002|Overall Study|Withdrawal by Subject|0|||
150254446|NCT01397422|542067381|FG003|Overall Study|Withdrawal by Subject|0|||
150254447|NCT01397422|542067378|FG000|Overall Study|Increased bradykinesia related to PD|1|||
150254448|NCT01397422|542067379|FG001|Overall Study|Increased bradykinesia related to PD|0|||
150254449|NCT01397422|542067380|FG002|Overall Study|Increased bradykinesia related to PD|0|||
150254450|NCT01397422|542067381|FG003|Overall Study|Increased bradykinesia related to PD|0|||
150254451|NCT00545753|542067382|FG000|Overall Study|Withdrawal by Subject|0|||
150254452|NCT00545753|542067383|FG001|Overall Study|Withdrawal by Subject|1|||
150254453|NCT00545753|542067384|FG002|Overall Study|Withdrawal by Subject|10|||
150254454|NCT00545753|542067382|FG000|Overall Study|Lost to Follow-up|13|||
150254455|NCT00545753|542067383|FG001|Overall Study|Lost to Follow-up|3|||
150254456|NCT00545753|542067384|FG002|Overall Study|Lost to Follow-up|12|||
150254457|NCT00545753|542067382|FG000|Overall Study|Protocol Violation|3|||
150254458|NCT00545753|542067383|FG001|Overall Study|Protocol Violation|1|||
150254459|NCT00545753|542067384|FG002|Overall Study|Protocol Violation|4|||
150254460|NCT04664400|542067385|FG000|Overall Study|Withdrawal by Subject|2|||
150254461|NCT01011153|542067390|FG000|Overall Study|Less than 78 cases completed|8|||
150254462|NCT01011153|542067391|FG001|Overall Study|Less than 78 cases completed|11|||
150254463|NCT01011153|542067392|FG002|Overall Study|Less than 78 cases completed|9|||
150254464|NCT01081132|542067397|FG000|Overall Study|Lack of Efficacy|25|||
150254465|NCT01081132|542067398|FG001|Overall Study|Lack of Efficacy|9|||
150254466|NCT01081132|542067397|FG000|Overall Study|Withdrawal by Subject|13|||
150254467|NCT01081132|542067398|FG001|Overall Study|Withdrawal by Subject|16|||
150254468|NCT01081132|542067397|FG000|Overall Study|Lost to Follow-up|4|||
150254469|NCT01081132|542067398|FG001|Overall Study|Lost to Follow-up|11|||
150254470|NCT01081132|542067397|FG000|Overall Study|Adverse Event|3|||
150254471|NCT01081132|542067398|FG001|Overall Study|Adverse Event|9|||
150254472|NCT01081132|542067397|FG000|Overall Study|Non Compliance|4|||
150254473|NCT01081132|542067398|FG001|Overall Study|Non Compliance|2|||
150254474|NCT01081132|542067397|FG000|Overall Study|Lack Of Compliance|0|||
150254475|NCT01081132|542067398|FG001|Overall Study|Lack Of Compliance|1|||
150254476|NCT01081132|542067397|FG000|Overall Study|Missed Visits|1|||
150254477|NCT01081132|542067398|FG001|Overall Study|Missed Visits|1|||
150254478|NCT01081132|542067397|FG000|Overall Study|Stopped Taking Meds|2|||
150254479|NCT01081132|542067398|FG001|Overall Study|Stopped Taking Meds|0|||
150254480|NCT01081132|542067397|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
150254481|NCT01081132|542067398|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
150254482|NCT01081132|542067397|FG000|Overall Study|Declined Taper Phase|0|||
150254483|NCT01081132|542067398|FG001|Overall Study|Declined Taper Phase|1|||
150254484|NCT01081132|542067397|FG000|Overall Study|Protocol Violation|3|||
150254485|NCT01081132|542067398|FG001|Overall Study|Protocol Violation|1|||
150254486|NCT02297139|542067399|FG000|Overall Study|Disease progression|0|||
150254487|NCT02297139|542067400|FG001|Overall Study|Disease progression|1|||
150254488|NCT02297139|542067399|FG000|Overall Study|Study drug toxicity|0|||
150254489|NCT02297139|542067400|FG001|Overall Study|Study drug toxicity|4|||
150254490|NCT02297139|542067399|FG000|Overall Study|Participant request to discontinue study treatment|0|||
150254491|NCT02297139|542067400|FG001|Overall Study|Participant request to discontinue study treatment|1|||
150254492|NCT02297139|542067399|FG000|Overall Study|Maximum clinical benefit|1|||
150254493|NCT02297139|542067400|FG001|Overall Study|Maximum clinical benefit|0|||
150254494|NCT02297139|542067399|FG000|Overall Study|Administrative reason by sponsor|0|||
150254495|NCT02297139|542067400|FG001|Overall Study|Administrative reason by sponsor|2|||
150254496|NCT02297139|542067399|FG000|Overall Study|Other reasons|0|||
150254497|NCT02297139|542067400|FG001|Overall Study|Other reasons|8|||
150254498|NCT02101385|542067403|FG000|Study Treatment|Disease Progression|9|||
150254499|NCT02101385|542067404|FG001|Study Treatment|Disease Progression|3|||
150254500|NCT02101385|542067403|FG000|Study Treatment|Alternative therapy|0|||
150254501|NCT02101385|542067404|FG001|Study Treatment|Alternative therapy|1|||
150254502|NCT02101385|542067403|FG000|Study Treatment|No treatment, per protocol criteria|0|||
150254503|NCT02101385|542067404|FG001|Study Treatment|No treatment, per protocol criteria|4|||
150254504|NCT02101385|542067403|FG000|Study Treatment|Patient Non compliance|0|||
150254505|NCT02101385|542067404|FG001|Study Treatment|Patient Non compliance|2|||
150254506|NCT02101385|542067403|FG000|Study Treatment|Withdrawal by Subject|5|||
150254507|NCT02101385|542067404|FG001|Study Treatment|Withdrawal by Subject|2|||
150254508|NCT02101385|542067403|FG000|Study Treatment|screen failure|1|||
150254509|NCT02101385|542067404|FG001|Study Treatment|screen failure|0|||
150254510|NCT02101385|542067403|FG000|Study Treatment|AE/Side Effects/Complications|8|||
150254511|NCT02101385|542067404|FG001|Study Treatment|AE/Side Effects/Complications|0|||
150254512|NCT02101385|542067403|FG000|Study Treatment|Lost to Follow-up|1|||
150254513|NCT02101385|542067404|FG001|Study Treatment|Lost to Follow-up|0|||
150254514|NCT02101385|542067403|FG000|Study Treatment|Disease Progression before treatment|1|||
150254515|NCT02101385|542067404|FG001|Study Treatment|Disease Progression before treatment|0|||
150254516|NCT02101385|542067403|FG000|Study Treatment|Death|1|||
150254517|NCT02101385|542067404|FG001|Study Treatment|Death|0|||
150254518|NCT02101385|542067403|FG000|Follow up|Lost to Follow-up|4|||
150254519|NCT02101385|542067404|FG001|Follow up|Lost to Follow-up|9|||
150254520|NCT02101385|542067403|FG000|Follow up|Refused to follow up|5|||
150254521|NCT02101385|542067404|FG001|Follow up|Refused to follow up|4|||
150254522|NCT02101385|542067403|FG000|Follow up|Death|21|||
150254523|NCT02101385|542067404|FG001|Follow up|Death|39|||
150254524|NCT02101385|542067403|FG000|Follow up|study completed|33|||
150254525|NCT02101385|542067404|FG001|Follow up|study completed|52|||
150254526|NCT02101385|542067403|FG000|Follow up|screen failure|2|||
150254527|NCT02101385|542067404|FG001|Follow up|screen failure|0|||
150254528|NCT02101385|542067403|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
150254529|NCT02101385|542067404|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
150254530|NCT02101385|542067403|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
150254531|NCT02101385|542067404|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
150254532|NCT02101385|542067403|FG000|Follow up|Withdrawal by Subject|2|||
150254533|NCT02101385|542067404|FG001|Follow up|Withdrawal by Subject|2|||
150254534|NCT02101385|542067403|FG000|Follow up|PI requested closure of site|0|||
150254535|NCT02101385|542067404|FG001|Follow up|PI requested closure of site|5|||
150254536|NCT01982448|542067406|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
150254537|NCT01982448|542067407|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
150254538|NCT01982448|542067406|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
150254539|NCT01982448|542067407|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
150254540|NCT01982448|542067406|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
150254541|NCT01982448|542067407|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
150254542|NCT01982448|542067406|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
150254543|NCT01982448|542067407|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
150254544|NCT03695237|542068746|FG000|Overall Study|Withdrawal by Subject|1|||
150254545|NCT03695237|542068747|FG001|Overall Study|Withdrawal by Subject|3|||
150254546|NCT03695237|542068746|FG000|Overall Study|Lost to Follow-up|1|||
150254547|NCT03695237|542068747|FG001|Overall Study|Lost to Follow-up|2|||
150254548|NCT03695237|542068746|FG000|Overall Study|Other, Not Specified|8|||
150254549|NCT03695237|542068747|FG001|Overall Study|Other, Not Specified|2|||
150254550|NCT00055601|542068748|FG000|Overall Study|Protocol Violation|1|||
149733597|NCT01950819|540158873|FG000|Overall Study|Graft Loss|35|||
149733598|NCT01950819|540158874|FG001|Overall Study|Graft Loss|30|||
149733599|NCT01950819|540158873|FG000|Overall Study|Death|29|||
149733600|NCT01950819|540158874|FG001|Overall Study|Death|34|||
149733601|NCT01950819|540158873|FG000|Overall Study|Subject / Gardian decision|54|||
149733602|NCT01950819|540158874|FG001|Overall Study|Subject / Gardian decision|51|||
149733603|NCT01950819|540158873|FG000|Overall Study|technical problems|2|||
149733604|NCT01950819|540158874|FG001|Overall Study|technical problems|0|||
149733605|NCT01950819|540158873|FG000|Overall Study|Pregnancy|0|||
149733606|NCT01950819|540158874|FG001|Overall Study|Pregnancy|2|||
149733607|NCT01950819|540158873|FG000|Overall Study|Lost to Follow-up|9|||
149733608|NCT01950819|540158874|FG001|Overall Study|Lost to Follow-up|17|||
149733609|NCT00781365|540158875|FG000|Overall Study|Withdrawal by Subject|13|||
149733610|NCT00781365|540158876|FG001|Overall Study|Withdrawal by Subject|8|||
149733611|NCT00781365|540158875|FG000|Overall Study|Did Not Attend Visit|20|||
149733612|NCT00781365|540158876|FG001|Overall Study|Did Not Attend Visit|28|||
149733613|NCT00781365|540158875|FG000|Overall Study|Language barrier|1|||
149733614|NCT00781365|540158876|FG001|Overall Study|Language barrier|0|||
149733615|NCT02649634|540158877|FG000|Overall Study|Withdrawal by Subject|3|||
149733616|NCT02649634|540158878|FG001|Overall Study|Withdrawal by Subject|5|||
149733617|NCT02649634|540158877|FG000|Overall Study|Lost to Follow-up|0|||
149733618|NCT02649634|540158878|FG001|Overall Study|Lost to Follow-up|1|||
149733619|NCT01662648|540158879|FG000|Overall Study|Death|1|||
149733620|NCT01662648|540158880|FG001|Overall Study|Death|3|||
149733621|NCT01662648|540158879|FG000|Overall Study|Adverse Event|40|||
149733622|NCT01662648|540158880|FG001|Overall Study|Adverse Event|37|||
149733623|NCT01662648|540158879|FG000|Overall Study|Lack of Efficacy|17|||
149733624|NCT01662648|540158880|FG001|Overall Study|Lack of Efficacy|16|||
149733625|NCT01662648|540158879|FG000|Overall Study|Participant ineligible to continue trial|1|||
149733626|NCT01662648|540158880|FG001|Overall Study|Participant ineligible to continue trial|1|||
149733627|NCT01662648|540158879|FG000|Overall Study|Lost to Follow-up|24|||
149733628|NCT01662648|540158880|FG001|Overall Study|Lost to Follow-up|36|||
149733629|NCT01662648|540158879|FG000|Overall Study|Withdrawal by Subject|36|||
149733630|NCT01662648|540158880|FG001|Overall Study|Withdrawal by Subject|53|||
149733631|NCT01662648|540158879|FG000|Overall Study|Participant non-compliant|16|||
149733632|NCT01662648|540158880|FG001|Overall Study|Participant non-compliant|20|||
149733633|NCT01662648|540158879|FG000|Overall Study|Other|8|||
149733634|NCT01662648|540158880|FG001|Overall Study|Other|11|||
149733635|NCT01662648|540158879|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
149733636|NCT01662648|540158880|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
149733637|NCT01662648|540158879|FG000|Overall Study|LOE and other reason unspecified|1|||
150254551|NCT00055601|542068749|FG001|Overall Study|Protocol Violation|1|||
150254552|NCT00055601|542068748|FG000|Overall Study|No protocol treatment received|1|||
150254553|NCT00055601|542068749|FG001|Overall Study|No protocol treatment received|1|||
150254554|NCT02217332|542068756|FG000|Overall Study|Adverse Event|3|||
150254555|NCT02217332|542068756|FG000|Overall Study|Dose interruption >1 month|1|||
150254556|NCT02217332|542068756|FG000|Overall Study|Protocol Violation (eligibility)|1|||
150254557|NCT02217332|542068756|FG000|Overall Study|Withdrawal by Subject|1|||
150254558|NCT02217332|542068756|FG000|Overall Study|Lost to Follow-up|1|||
150254559|NCT04343872|542068757|FG000|Overall Study|Lost to Follow-up|6|||
150254560|NCT04343872|542068758|FG001|Overall Study|Lost to Follow-up|3|||
150254561|NCT01850446|542068759|FG000|Overall Study|Lack of Efficacy|1|||
150254562|NCT01850446|542068760|FG001|Overall Study|Lack of Efficacy|0|||
150254563|NCT01850446|542068759|FG000|Overall Study|Withdrawal by Subject|4|||
150254564|NCT01850446|542068760|FG001|Overall Study|Withdrawal by Subject|0|||
150254565|NCT01850446|542068759|FG000|Overall Study|Protocol Violation|0|||
150254566|NCT01850446|542068760|FG001|Overall Study|Protocol Violation|2|||
150254567|NCT03725085|542068761|FG000|Overall Study|Lost to Follow-up|2|||
150254568|NCT02704754|542068762|FG000|Overall Study|Lost to Follow-up|1|||
150254569|NCT02704754|542068763|FG001|Overall Study|Lost to Follow-up|1|||
150254570|NCT02704754|542068762|FG000|Overall Study|Lack of Efficacy|1|||
150254571|NCT02704754|542068763|FG001|Overall Study|Lack of Efficacy|0|||
149733638|NCT01662648|540158880|FG001|Overall Study|LOE and other reason unspecified|0|||
149733639|NCT01662648|540158879|FG000|Overall Study|LOE and Participant non-compliant|0|||
149733640|NCT01662648|540158880|FG001|Overall Study|LOE and Participant non-compliant|1|||
149733641|NCT02928952|540158883|FG000|Overall Study|Lost to Follow-up|5|||
149733642|NCT02928952|540158884|FG001|Overall Study|Lost to Follow-up|5|||
149733643|NCT02928952|540158883|FG000|Overall Study|Withdrawal by Subject|5|||
149733644|NCT02928952|540158884|FG001|Overall Study|Withdrawal by Subject|1|||
149733645|NCT02928952|540158883|FG000|Overall Study|Physician Decision|0|||
149733646|NCT02928952|540158884|FG001|Overall Study|Physician Decision|1|||
149733647|NCT01850615|540158885|FG000|Overall Study|Protocol Violation|4|||
149733648|NCT01850615|540158886|FG001|Overall Study|Protocol Violation|1|||
150254572|NCT02704754|542068762|FG000|Overall Study|Withdrawal by Subject|1|||
150254573|NCT02704754|542068763|FG001|Overall Study|Withdrawal by Subject|0|||
150254574|NCT03646656|542068768|FG000|Overall Study|Lost to Follow-up|1|||
150254575|NCT03646656|542068769|FG001|Overall Study|Lost to Follow-up|0|||
150254576|NCT03646656|542068768|FG000|Overall Study|Withdrawal by Subject|2|||
150254577|NCT03646656|542068769|FG001|Overall Study|Withdrawal by Subject|0|||
150254578|NCT03507777|542068770|FG000|Overall Study|Lost to Follow-up|5|||
150254579|NCT03507777|542068771|FG001|Overall Study|Lost to Follow-up|7|||
150254580|NCT03507777|542068770|FG000|Overall Study|Withdrawal by Subject|6|||
150254581|NCT03507777|542068771|FG001|Overall Study|Withdrawal by Subject|11|||
149733649|NCT01850615|540158885|FG000|Overall Study|Adverse Event|2|||
149733650|NCT01850615|540158886|FG001|Overall Study|Adverse Event|1|||
150254582|NCT03507777|542068770|FG000|Overall Study|Death|30|||
150254583|NCT03507777|542068771|FG001|Overall Study|Death|44|||
150254584|NCT03507777|542068770|FG000|Overall Study|Other Reasons|3|||
150254585|NCT03507777|542068771|FG001|Overall Study|Other Reasons|8|||
150254586|NCT02245737|542068772|FG000|Overall Study|Adverse Event|23|||
150254587|NCT02245737|542068773|FG001|Overall Study|Adverse Event|26|||
150254588|NCT02245737|542068774|FG002|Overall Study|Adverse Event|33|||
150254589|NCT02245737|542068772|FG000|Overall Study|Condition Worsened|9|||
150254590|NCT02245737|542068773|FG001|Overall Study|Condition Worsened|10|||
150254591|NCT02245737|542068774|FG002|Overall Study|Condition Worsened|9|||
150254592|NCT02245737|542068772|FG000|Overall Study|Death|2|||
150254593|NCT02245737|542068773|FG001|Overall Study|Death|4|||
150254594|NCT02245737|542068774|FG002|Overall Study|Death|4|||
150254595|NCT02245737|542068772|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
150254596|NCT02245737|542068773|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
150254597|NCT02245737|542068774|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
150254598|NCT02245737|542068772|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
150254599|NCT02245737|542068773|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
150254600|NCT02245737|542068774|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
150254601|NCT02245737|542068772|FG000|Overall Study|Lost to Follow-up|2|||
150254602|NCT02245737|542068773|FG001|Overall Study|Lost to Follow-up|5|||
150254603|NCT02245737|542068774|FG002|Overall Study|Lost to Follow-up|4|||
150254604|NCT02245737|542068772|FG000|Overall Study|Other-determined by Investigator|9|||
150254605|NCT02245737|542068773|FG001|Overall Study|Other-determined by Investigator|10|||
150254606|NCT02245737|542068774|FG002|Overall Study|Other-determined by Investigator|10|||
150254607|NCT02245737|542068772|FG000|Overall Study|Physician Decision|6|||
150254608|NCT02245737|542068773|FG001|Overall Study|Physician Decision|3|||
150254609|NCT02245737|542068774|FG002|Overall Study|Physician Decision|6|||
150254610|NCT02245737|542068772|FG000|Overall Study|Protocol Violation|3|||
150254611|NCT02245737|542068773|FG001|Overall Study|Protocol Violation|2|||
150254612|NCT02245737|542068774|FG002|Overall Study|Protocol Violation|3|||
150254613|NCT02245737|542068772|FG000|Overall Study|Withdrawal by Subject|40|||
150254614|NCT02245737|542068773|FG001|Overall Study|Withdrawal by Subject|41|||
150254615|NCT02245737|542068774|FG002|Overall Study|Withdrawal by Subject|44|||
150254616|NCT02245737|542068772|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
150254617|NCT02245737|542068773|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
150254618|NCT02245737|542068774|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
150254619|NCT02245737|542068772|FG000|Overall Study|Sponsor Decision|445|||
150254620|NCT02245737|542068773|FG001|Overall Study|Sponsor Decision|430|||
150254621|NCT02245737|542068774|FG002|Overall Study|Sponsor Decision|432|||
150254622|NCT00446043|542068777|FG000|Overall Study|Adverse Event|9|||
150254623|NCT00446043|542068777|FG000|Overall Study|Withdrawal by Subject|70|||
150254624|NCT00446043|542068777|FG000|Overall Study|Protocol Violation|2|||
150254625|NCT00446043|542068777|FG000|Overall Study|Lost to Follow-up|42|||
149733651|NCT01850615|540158885|FG000|Overall Study|Withdrawal by Subject|3|||
149733652|NCT01850615|540158886|FG001|Overall Study|Withdrawal by Subject|1|||
149733653|NCT01850615|540158885|FG000|Overall Study|Lost to Follow-up|0|||
149733654|NCT01850615|540158886|FG001|Overall Study|Lost to Follow-up|1|||
150254626|NCT00446043|542068777|FG000|Overall Study|Pregnancy|2|||
150254627|NCT01144052|542068785|FG000|Overall Study|Withdrawal by Subject|1|||
150254628|NCT01144052|542068786|FG001|Overall Study|Withdrawal by Subject|1|||
150254629|NCT03836716|542068790|FG000|Overall Study|Adverse Event|3|||
150254630|NCT03836716|542068790|FG000|Overall Study|Death|22|||
150254631|NCT03836716|542068790|FG000|Overall Study|Withdrawal by Subject|8|||
150254632|NCT03836716|542068790|FG000|Overall Study|Study terminated by sponsor|87|||
150254633|NCT01879722|542068791|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149733655|NCT01850615|540158885|FG000|Overall Study|Unclassified|0|||
149733656|NCT01850615|540158886|FG001|Overall Study|Unclassified|1|||
149733657|NCT00974220|540158887|FG000|Treatment Period 1|Adverse Event|2|||
149733658|NCT00974220|540158888|FG001|Treatment Period 1|Adverse Event|1|||
149733659|NCT00974220|540158887|FG000|Treatment Period 1|noncompliant subjects|0|||
150254634|NCT01879722|542068792|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
150254635|NCT01879722|542068793|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
150254636|NCT01879722|542068794|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
150254637|NCT01879722|542068795|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
150254638|NCT01879722|542068796|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
149733660|NCT00974220|540158888|FG001|Treatment Period 1|noncompliant subjects|1|||
150254639|NCT01879722|542068797|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
150254640|NCT01879722|542068798|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
149733661|NCT01227967|540158889|FG000|Overall Study|Protocol Violation|3|||
149733662|NCT01227967|540158890|FG001|Overall Study|Protocol Violation|1|||
149733663|NCT01227967|540158889|FG000|Overall Study|Death|0|||
149733664|NCT01227967|540158890|FG001|Overall Study|Death|1|||
149733665|NCT01227967|540158889|FG000|Overall Study|Lost to Follow-up|8|||
149733666|NCT01227967|540158890|FG001|Overall Study|Lost to Follow-up|3|||
149733667|NCT01227967|540158889|FG000|Overall Study|Withdrawal by Subject|4|||
149733668|NCT01227967|540158890|FG001|Overall Study|Withdrawal by Subject|3|||
149733669|NCT01227967|540158889|FG000|Overall Study|Physician Decision|0|||
149733670|NCT01227967|540158890|FG001|Overall Study|Physician Decision|1|||
149733671|NCT01227967|540158889|FG000|Overall Study|Never Started Treatment|0|||
149733672|NCT01227967|540158890|FG001|Overall Study|Never Started Treatment|4|||
149733673|NCT01227967|540158889|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
149733674|NCT01227967|540158890|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
149733675|NCT03403400|540158891|FG000|Overall Study|Lost to Follow-up|1|||
149733676|NCT03403400|540158892|FG001|Overall Study|Lost to Follow-up|0|||
149733677|NCT03403400|540158893|FG002|Overall Study|Lost to Follow-up|1|||
149733678|NCT03403400|540158891|FG000|Overall Study|Hospitalization|1|||
149733679|NCT03403400|540158892|FG001|Overall Study|Hospitalization|0|||
149733680|NCT03403400|540158893|FG002|Overall Study|Hospitalization|0|||
149733681|NCT03403400|540158891|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
149733682|NCT03403400|540158892|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
149733683|NCT03403400|540158893|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
149733684|NCT02266433|540158894|FG000|Overall Study|Lost to Follow-up|54|||
149733685|NCT02266433|540158895|FG001|Overall Study|Lost to Follow-up|46|||
149733686|NCT02266433|540158894|FG000|Overall Study|Withdrawal by Subject|5|||
149733687|NCT02266433|540158895|FG001|Overall Study|Withdrawal by Subject|7|||
149733688|NCT01273064|540158896|FG000|Overall Study|Adverse Event|5|||
149733689|NCT01273064|540158897|FG001|Overall Study|Adverse Event|1|||
149733690|NCT01273064|540158898|FG002|Overall Study|Adverse Event|3|||
149733691|NCT01273064|540158899|FG003|Overall Study|Adverse Event|2|||
149733692|NCT01273064|540158900|FG004|Overall Study|Adverse Event|1|||
149733693|NCT01273064|540158896|FG000|Overall Study|Withdrawal by Subject|4|||
149733694|NCT01273064|540158897|FG001|Overall Study|Withdrawal by Subject|2|||
149733695|NCT01273064|540158898|FG002|Overall Study|Withdrawal by Subject|2|||
149733696|NCT01273064|540158899|FG003|Overall Study|Withdrawal by Subject|2|||
149733697|NCT01273064|540158900|FG004|Overall Study|Withdrawal by Subject|0|||
149733698|NCT01273064|540158896|FG000|Overall Study|Study Termination|13|||
149733699|NCT01273064|540158897|FG001|Overall Study|Study Termination|27|||
149733700|NCT01273064|540158898|FG002|Overall Study|Study Termination|26|||
149733701|NCT01273064|540158899|FG003|Overall Study|Study Termination|16|||
149733702|NCT01273064|540158900|FG004|Overall Study|Study Termination|8|||
149733703|NCT01273064|540158896|FG000|Overall Study|Lost to Follow-up|1|||
150254641|NCT01879722|542068799|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
150254642|NCT01879722|542068800|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
150254643|NCT01879722|542068791|FG000|Overall Study|Voluntary Withdrawal|0|||
150254644|NCT01879722|542068792|FG001|Overall Study|Voluntary Withdrawal|0|||
150254645|NCT01879722|542068793|FG002|Overall Study|Voluntary Withdrawal|0|||
150254646|NCT01879722|542068794|FG003|Overall Study|Voluntary Withdrawal|0|||
150254647|NCT01879722|542068795|FG004|Overall Study|Voluntary Withdrawal|0|||
150254648|NCT01879722|542068796|FG005|Overall Study|Voluntary Withdrawal|0|||
150254649|NCT01879722|542068797|FG006|Overall Study|Voluntary Withdrawal|0|||
150254650|NCT01879722|542068798|FG007|Overall Study|Voluntary Withdrawal|0|||
150254651|NCT01879722|542068799|FG008|Overall Study|Voluntary Withdrawal|1|||
150254652|NCT01879722|542068800|FG009|Overall Study|Voluntary Withdrawal|0|||
150254653|NCT04988867|542068803|FG000|Overall Study|Study terminated by Sponsor|12|||
150254654|NCT04988867|542068803|FG000|Overall Study|Adverse Event|2|||
150254655|NCT04988867|542068803|FG000|Overall Study|Study drug noncompliance|1|||
150254656|NCT01327495|542068804|FG000|Overall Study|Adverse Event|2|||
150254657|NCT01327495|542068805|FG001|Overall Study|Adverse Event|1|||
150254658|NCT01327495|542068806|FG002|Overall Study|Adverse Event|1|||
150254659|NCT01327495|542068807|FG003|Overall Study|Adverse Event|0|||
150254660|NCT01327495|542068808|FG004|Overall Study|Adverse Event|0|||
150254661|NCT01327495|542068809|FG005|Overall Study|Adverse Event|2|||
150254662|NCT01327495|542068804|FG000|Overall Study|Withdrawal by Subject|0|||
150254663|NCT01327495|542068805|FG001|Overall Study|Withdrawal by Subject|1|||
150254664|NCT01327495|542068806|FG002|Overall Study|Withdrawal by Subject|1|||
150254665|NCT01327495|542068807|FG003|Overall Study|Withdrawal by Subject|0|||
150254666|NCT01327495|542068808|FG004|Overall Study|Withdrawal by Subject|1|||
150254667|NCT01327495|542068809|FG005|Overall Study|Withdrawal by Subject|0|||
150254668|NCT01327495|542068804|FG000|Overall Study|Physician Decision|0|||
150254669|NCT01327495|542068805|FG001|Overall Study|Physician Decision|0|||
149733704|NCT01273064|540158897|FG001|Overall Study|Lost to Follow-up|0|||
149733705|NCT01273064|540158898|FG002|Overall Study|Lost to Follow-up|0|||
149733706|NCT01273064|540158899|FG003|Overall Study|Lost to Follow-up|0|||
150254670|NCT01327495|542068806|FG002|Overall Study|Physician Decision|0|||
149733707|NCT01273064|540158900|FG004|Overall Study|Lost to Follow-up|0|||
150254671|NCT01327495|542068807|FG003|Overall Study|Physician Decision|0|||
150254672|NCT01327495|542068808|FG004|Overall Study|Physician Decision|2|||
150254673|NCT01327495|542068809|FG005|Overall Study|Physician Decision|0|||
150254674|NCT00560066|542068815|FG000|Overall Study|Death|2|||
150254675|NCT00560066|542068816|FG001|Overall Study|Death|1|||
150254676|NCT00560066|542068815|FG000|Overall Study|Withdrawal by Subject|0|||
150254677|NCT00560066|542068816|FG001|Overall Study|Withdrawal by Subject|3|||
150254678|NCT00560066|542068815|FG000|Overall Study|Lost to Follow-up|4|||
150254679|NCT00560066|542068816|FG001|Overall Study|Lost to Follow-up|10|||
150254680|NCT00560066|542068815|FG000|Overall Study|Protocol Violation|0|||
150254681|NCT00560066|542068816|FG001|Overall Study|Protocol Violation|1|||
150254682|NCT00560066|542068815|FG000|Overall Study|Administrative reason|0|||
150254683|NCT00560066|542068816|FG001|Overall Study|Administrative reason|5|||
150254684|NCT00560066|542068815|FG000|Overall Study|Missing primary reason|0|||
150254685|NCT00560066|542068816|FG001|Overall Study|Missing primary reason|2|||
150254686|NCT00506441|542068817|FG000|Period 1; Open-label Period|Adverse Event|21|||
150254687|NCT00506441|542068818|FG001|Period 1; Open-label Period|Adverse Event|0|||
150254688|NCT00506441|542068817|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
150254689|NCT00506441|542068818|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
150254690|NCT00506441|542068817|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
150254691|NCT00506441|542068818|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
150254692|NCT00506441|542068817|FG000|Period 1; Open-label Period|Physician Decision|5|||
150254693|NCT00506441|542068818|FG001|Period 1; Open-label Period|Physician Decision|0|||
150254694|NCT00506441|542068817|FG000|Period 1; Open-label Period|Protocol Violation|9|||
150254695|NCT00506441|542068818|FG001|Period 1; Open-label Period|Protocol Violation|0|||
150254696|NCT00506441|542068817|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
150254697|NCT00506441|542068818|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
150254698|NCT00506441|542068817|FG000|Period 1; Open-label Period|Other Reasons|13|||
150254699|NCT00506441|542068818|FG001|Period 1; Open-label Period|Other Reasons|0|||
150254700|NCT00506441|542068817|FG000|Period 2; Double-blind Period|Adverse Event|0|||
150254701|NCT00506441|542068818|FG001|Period 2; Double-blind Period|Adverse Event|1|||
150254702|NCT00506441|542068817|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
150254703|NCT00506441|542068818|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
150254704|NCT00506441|542068817|FG000|Period 2; Double-blind Period|Physician Decision|1|||
150254705|NCT00506441|542068818|FG001|Period 2; Double-blind Period|Physician Decision|1|||
150254706|NCT00506441|542068817|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
150254707|NCT00506441|542068818|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
150254708|NCT00506441|542068817|FG000|Period 2; Double-blind Period|Other Reason|1|||
150254709|NCT00506441|542068818|FG001|Period 2; Double-blind Period|Other Reason|1|||
150254710|NCT01151410|542068820|FG000|Overall Study|Withdrawal by Subject|3|||
150254711|NCT01151410|542068821|FG001|Overall Study|Withdrawal by Subject|5|||
149733708|NCT01273064|540158896|FG000|Overall Study|Physician Decision|0|||
149733709|NCT01273064|540158897|FG001|Overall Study|Physician Decision|0|||
149733710|NCT01273064|540158898|FG002|Overall Study|Physician Decision|0|||
149733711|NCT01273064|540158899|FG003|Overall Study|Physician Decision|0|||
149733712|NCT01273064|540158900|FG004|Overall Study|Physician Decision|1|||
149733713|NCT00560755|540158902|FG000|Overall Study|Protocol Violation|15|||
149733714|NCT00560755|540158902|FG000|Overall Study|Withdrawal by Subject|26|||
149733715|NCT00560755|540158902|FG000|Overall Study|Lost to Follow-up|9|||
149733716|NCT00560755|540158902|FG000|Overall Study|Adverse Event|8|||
149733717|NCT00560755|540158902|FG000|Overall Study|Physician Decision|2|||
149733718|NCT00848120|540158903|FG000|Overall Study|Adverse Event|1|||
149733719|NCT01988090|540158912|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
149733720|NCT01988090|540158913|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
149733721|NCT01988090|540158912|FG000|Start Treament After Randomization|Protocol Violation|0|||
149733722|NCT01988090|540158913|FG001|Start Treament After Randomization|Protocol Violation|1|||
149733723|NCT01988090|540158912|FG000|Complete Study After Start|Withdrawal by Subject|2|||
149733724|NCT01988090|540158913|FG001|Complete Study After Start|Withdrawal by Subject|0|||
149733725|NCT01988090|540158912|FG000|Complete Study After Start|Protocol Violation|1|||
149733726|NCT01988090|540158913|FG001|Complete Study After Start|Protocol Violation|1|||
149733727|NCT01961115|540158917|FG000|Overall Study|Disease Progression|1|||
149733728|NCT01961115|540158918|FG001|Overall Study|Disease Progression|0|||
149733729|NCT01961115|540158919|FG002|Overall Study|Disease Progression|3|||
149733730|NCT01961115|540158917|FG000|Overall Study|Adverse Event|1|||
149733731|NCT01961115|540158918|FG001|Overall Study|Adverse Event|0|||
149733732|NCT01961115|540158919|FG002|Overall Study|Adverse Event|1|||
149733733|NCT03887130|540158924|FG000|Overall Study|Progressive disease|23|||
149733734|NCT03887130|540158925|FG001|Overall Study|Progressive disease|14|||
149733735|NCT03887130|540158926|FG002|Overall Study|Progressive disease|7|||
149733736|NCT03887130|540158924|FG000|Overall Study|Protocol Violation|3|||
150254712|NCT01151410|542068820|FG000|Overall Study|Lost to Follow-up|3|||
150254713|NCT01151410|542068821|FG001|Overall Study|Lost to Follow-up|4|||
149733737|NCT03887130|540158925|FG001|Overall Study|Protocol Violation|1|||
149733738|NCT03887130|540158926|FG002|Overall Study|Protocol Violation|2|||
149733739|NCT03887130|540158924|FG000|Overall Study|Drug related toxicity|7|||
149733740|NCT03887130|540158925|FG001|Overall Study|Drug related toxicity|7|||
150254714|NCT01151410|542068820|FG000|Overall Study|Adverse Event|1|||
150254715|NCT01151410|542068821|FG001|Overall Study|Adverse Event|2|||
150254716|NCT01151410|542068820|FG000|Overall Study|Protocol deviation|2|||
150254717|NCT01151410|542068821|FG001|Overall Study|Protocol deviation|1|||
150254718|NCT01151410|542068820|FG000|Overall Study|Administrative problems|1|||
150254719|NCT01151410|542068821|FG001|Overall Study|Administrative problems|1|||
150254720|NCT01151410|542068820|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
150254721|NCT01151410|542068821|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
150254722|NCT01151410|542068820|FG000|Overall Study|Abnormal laboratory value(s)|0|||
150254723|NCT01151410|542068821|FG001|Overall Study|Abnormal laboratory value(s)|1|||
150254724|NCT01712659|542068822|FG000|Dose Escalation|Physician Decision|0|||
150254725|NCT01712659|542068823|FG001|Dose Escalation|Physician Decision|1|||
150254726|NCT01712659|542068824|FG002|Dose Escalation|Physician Decision|0|||
150254727|NCT01712659|542068825|FG003|Dose Escalation|Physician Decision|0|||
150254728|NCT01712659|542068826|FG004|Dose Escalation|Physician Decision|0|||
150254729|NCT01712659|542068822|FG000|Dose Escalation|Unable to take study drug|0|||
150254730|NCT01712659|542068823|FG001|Dose Escalation|Unable to take study drug|1|||
150254731|NCT01712659|542068824|FG002|Dose Escalation|Unable to take study drug|0|||
150254732|NCT01712659|542068825|FG003|Dose Escalation|Unable to take study drug|0|||
150254733|NCT01712659|542068826|FG004|Dose Escalation|Unable to take study drug|0|||
150254734|NCT01712659|542068822|FG000|Dose Expansion|Early disease progression|1|||
150254735|NCT01712659|542068823|FG001|Dose Expansion|Early disease progression|0|||
150254736|NCT01712659|542068824|FG002|Dose Expansion|Early disease progression|0|||
150254737|NCT01712659|542068825|FG003|Dose Expansion|Early disease progression|0|||
150254738|NCT01712659|542068826|FG004|Dose Expansion|Early disease progression|0|||
150254739|NCT01712659|542068822|FG000|Dose Expansion|Physician Decision|1|||
150254740|NCT01712659|542068823|FG001|Dose Expansion|Physician Decision|0|||
150254741|NCT01712659|542068824|FG002|Dose Expansion|Physician Decision|0|||
150254742|NCT01712659|542068825|FG003|Dose Expansion|Physician Decision|0|||
150254743|NCT01712659|542068826|FG004|Dose Expansion|Physician Decision|0|||
150254744|NCT00844532|542068827|FG000|Overall Study|Death|16|||
150254745|NCT00844532|542068827|FG000|Overall Study|Withdrawal by Subject|16|||
150254746|NCT00844532|542068827|FG000|Overall Study|Lost to Follow-up|7|||
150254747|NCT02270515|542068828|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
150254748|NCT02270515|542068828|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
150254749|NCT02270515|542068828|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
150254750|NCT02270515|542068828|FG000|Intervention Period 1: 0-6 Months|Death|7|||
150254751|NCT02270515|542068828|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
150254752|NCT02270515|542068828|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
150254753|NCT02270515|542068828|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
150254754|NCT02270515|542068828|FG000|Intervention Period 2: 6-12 Months|Death|5|||
150254755|NCT02270515|542068828|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
150254756|NCT02270515|542068828|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
150254757|NCT02270515|542068828|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
150254758|NCT02270515|542068828|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
150254759|NCT02270515|542068828|FG000|Intervention Period 3: 12-18 Months|Death|3|||
150254760|NCT02270515|542068828|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
150254761|NCT00738894|542068829|FG000|Overall Study|Lost to Follow-up|23|||
150254762|NCT00738894|542068830|FG001|Overall Study|Lost to Follow-up|13|||
150254763|NCT00738894|542068829|FG000|Overall Study|Withdrawal by Subject|10|||
150254764|NCT00738894|542068830|FG001|Overall Study|Withdrawal by Subject|15|||
150254765|NCT00738894|542068829|FG000|Overall Study|Physician Decision|4|||
150254766|NCT00738894|542068830|FG001|Overall Study|Physician Decision|5|||
150254767|NCT00738894|542068829|FG000|Overall Study|Death|2|||
150254768|NCT00738894|542068830|FG001|Overall Study|Death|0|||
150254769|NCT03026075|542068831|FG000|Overall Study|Physician Decision|1|||
150254770|NCT04927247|542068832|FG000|Overall Study|Other|2|||
150254771|NCT04927247|542068833|FG001|Overall Study|Other|1|||
150254772|NCT04927247|542068832|FG000|Overall Study|Physician Decision|0|||
150254773|NCT04927247|542068833|FG001|Overall Study|Physician Decision|1|||
149733741|NCT03887130|540158926|FG002|Overall Study|Drug related toxicity|13|||
149733742|NCT03887130|540158924|FG000|Overall Study|Non drug related toxicity|3|||
149733743|NCT03887130|540158925|FG001|Overall Study|Non drug related toxicity|0|||
149733744|NCT03887130|540158926|FG002|Overall Study|Non drug related toxicity|0|||
149733745|NCT03887130|540158924|FG000|Overall Study|Death|2|||
149733746|NCT03887130|540158925|FG001|Overall Study|Death|2|||
149733747|NCT03887130|540158926|FG002|Overall Study|Death|1|||
149733748|NCT03887130|540158924|FG000|Overall Study|Withdrawal by Subject|7|||
149733749|NCT03887130|540158925|FG001|Overall Study|Withdrawal by Subject|6|||
149733750|NCT03887130|540158926|FG002|Overall Study|Withdrawal by Subject|11|||
149733751|NCT03887130|540158924|FG000|Overall Study|other reason|6|||
150254774|NCT04927247|542068832|FG000|Overall Study|Adverse Event|1|||
150254775|NCT04927247|542068833|FG001|Overall Study|Adverse Event|0|||
150254776|NCT04540887|542068837|FG000|Overall Study|Withdrawal by Subject|2|||
150254777|NCT02489968|542068847|FG000|Open-label Treatment Period|Adverse Event|14|||
150254778|NCT02489968|542068848|FG001|Open-label Treatment Period|Adverse Event|7|||
150254779|NCT02489968|542068849|FG002|Open-label Treatment Period|Adverse Event|0|||
150254780|NCT02489968|542068850|FG003|Open-label Treatment Period|Adverse Event|0|||
150254781|NCT02489968|542068851|FG004|Open-label Treatment Period|Adverse Event|0|||
150254782|NCT02489968|542068852|FG005|Open-label Treatment Period|Adverse Event|0|||
150254783|NCT02489968|542068847|FG000|Open-label Treatment Period|Protocol Violation|2|||
150254784|NCT02489968|542068848|FG001|Open-label Treatment Period|Protocol Violation|2|||
150254785|NCT02489968|542068849|FG002|Open-label Treatment Period|Protocol Violation|0|||
150254786|NCT02489968|542068850|FG003|Open-label Treatment Period|Protocol Violation|0|||
149733752|NCT03887130|540158925|FG001|Overall Study|other reason|20|||
149733753|NCT03887130|540158926|FG002|Overall Study|other reason|17|||
149733754|NCT02497001|540158927|FG000|Overall Study|Lost to Follow-up|10|||
149733755|NCT02497001|540158928|FG001|Overall Study|Lost to Follow-up|2|||
149733756|NCT02497001|540158929|FG002|Overall Study|Lost to Follow-up|0|||
149733757|NCT02497001|540158930|FG003|Overall Study|Lost to Follow-up|2|||
150254787|NCT02489968|542068851|FG004|Open-label Treatment Period|Protocol Violation|0|||
150254788|NCT02489968|542068852|FG005|Open-label Treatment Period|Protocol Violation|0|||
150254789|NCT02489968|542068847|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
150254790|NCT02489968|542068848|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
150254791|NCT02489968|542068849|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
150254792|NCT02489968|542068850|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
150254793|NCT02489968|542068851|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
150254794|NCT02489968|542068852|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
149733758|NCT02497001|540158927|FG000|Overall Study|Adverse Event|28|||
149733759|NCT02497001|540158928|FG001|Overall Study|Adverse Event|30|||
149733760|NCT02497001|540158929|FG002|Overall Study|Adverse Event|11|||
149733761|NCT02497001|540158930|FG003|Overall Study|Adverse Event|11|||
149733762|NCT02497001|540158927|FG000|Overall Study|Withdrawal by Subject|14|||
149733763|NCT02497001|540158928|FG001|Overall Study|Withdrawal by Subject|37|||
150254795|NCT02489968|542068847|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
150254796|NCT02489968|542068848|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
150254797|NCT02489968|542068849|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
150254798|NCT02489968|542068850|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
150254799|NCT02489968|542068851|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
150254800|NCT02489968|542068852|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
150254801|NCT02489968|542068847|FG000|Open-label Treatment Period|Other than specified above|204|||
150254802|NCT02489968|542068848|FG001|Open-label Treatment Period|Other than specified above|189|||
150254803|NCT02489968|542068849|FG002|Open-label Treatment Period|Other than specified above|0|||
150254804|NCT02489968|542068850|FG003|Open-label Treatment Period|Other than specified above|0|||
150254805|NCT02489968|542068851|FG004|Open-label Treatment Period|Other than specified above|0|||
150254806|NCT02489968|542068852|FG005|Open-label Treatment Period|Other than specified above|0|||
150254807|NCT02489968|542068847|FG000|Double-blind Treatment Period|Adverse Event|0|||
150254808|NCT02489968|542068848|FG001|Double-blind Treatment Period|Adverse Event|0|||
150254809|NCT02489968|542068849|FG002|Double-blind Treatment Period|Adverse Event|2|||
150254810|NCT02489968|542068850|FG003|Double-blind Treatment Period|Adverse Event|6|||
150254811|NCT02489968|542068851|FG004|Double-blind Treatment Period|Adverse Event|4|||
149733764|NCT02497001|540158929|FG002|Overall Study|Withdrawal by Subject|19|||
149733765|NCT02497001|540158930|FG003|Overall Study|Withdrawal by Subject|15|||
149733766|NCT02497001|540158927|FG000|Overall Study|Physician Decision|5|||
149733767|NCT02497001|540158928|FG001|Overall Study|Physician Decision|11|||
149733768|NCT02497001|540158929|FG002|Overall Study|Physician Decision|5|||
149733769|NCT02497001|540158930|FG003|Overall Study|Physician Decision|1|||
149733770|NCT02497001|540158927|FG000|Overall Study|subjects that were not treated|1|||
149733771|NCT02497001|540158928|FG001|Overall Study|subjects that were not treated|2|||
149733772|NCT02497001|540158929|FG002|Overall Study|subjects that were not treated|2|||
149733773|NCT02497001|540158930|FG003|Overall Study|subjects that were not treated|1|||
149733774|NCT02497001|540158927|FG000|Overall Study|Major Protocol Deviation|3|||
150254812|NCT02489968|542068852|FG005|Double-blind Treatment Period|Adverse Event|5|||
150254813|NCT02489968|542068847|FG000|Double-blind Treatment Period|Protocol Violation|0|||
150254814|NCT02489968|542068848|FG001|Double-blind Treatment Period|Protocol Violation|0|||
149733775|NCT02497001|540158928|FG001|Overall Study|Major Protocol Deviation|4|||
149733776|NCT02497001|540158929|FG002|Overall Study|Major Protocol Deviation|4|||
149733777|NCT02497001|540158930|FG003|Overall Study|Major Protocol Deviation|4|||
149733778|NCT02497001|540158927|FG000|Overall Study|Lack of Efficacy|10|||
149733779|NCT02497001|540158928|FG001|Overall Study|Lack of Efficacy|16|||
149733780|NCT02497001|540158929|FG002|Overall Study|Lack of Efficacy|6|||
150254815|NCT02489968|542068849|FG002|Double-blind Treatment Period|Protocol Violation|0|||
150254816|NCT02489968|542068850|FG003|Double-blind Treatment Period|Protocol Violation|0|||
150254817|NCT02489968|542068851|FG004|Double-blind Treatment Period|Protocol Violation|1|||
150254818|NCT02489968|542068852|FG005|Double-blind Treatment Period|Protocol Violation|1|||
149733781|NCT02497001|540158930|FG003|Overall Study|Lack of Efficacy|6|||
149733782|NCT02497001|540158927|FG000|Overall Study|Protocol Violation|3|||
149733783|NCT02497001|540158928|FG001|Overall Study|Protocol Violation|1|||
150254819|NCT02489968|542068847|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
150254820|NCT02489968|542068848|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
150254821|NCT02489968|542068849|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
150254822|NCT02489968|542068850|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
150254823|NCT02489968|542068851|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
150254824|NCT02489968|542068852|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
150254825|NCT02489968|542068847|FG000|Double-blind Treatment Period|Other than specified above|0|||
150254826|NCT02489968|542068848|FG001|Double-blind Treatment Period|Other than specified above|0|||
150254827|NCT02489968|542068849|FG002|Double-blind Treatment Period|Other than specified above|0|||
150254828|NCT02489968|542068850|FG003|Double-blind Treatment Period|Other than specified above|0|||
150254829|NCT02489968|542068851|FG004|Double-blind Treatment Period|Other than specified above|1|||
150254830|NCT02489968|542068852|FG005|Double-blind Treatment Period|Other than specified above|0|||
150254831|NCT03738423|542068853|FG000|Overall Study|Withdrawal by Subject|9|||
150254832|NCT03738423|542068854|FG001|Overall Study|Withdrawal by Subject|12|||
150254833|NCT03738423|542068855|FG002|Overall Study|Withdrawal by Subject|9|||
150254834|NCT03738423|542068856|FG003|Overall Study|Withdrawal by Subject|12|||
150254835|NCT03738423|542068857|FG004|Overall Study|Withdrawal by Subject|10|||
150254836|NCT03738423|542068853|FG000|Overall Study|Lack of Efficacy|3|||
150254837|NCT03738423|542068854|FG001|Overall Study|Lack of Efficacy|1|||
150254838|NCT03738423|542068855|FG002|Overall Study|Lack of Efficacy|1|||
150254839|NCT03738423|542068856|FG003|Overall Study|Lack of Efficacy|1|||
150254840|NCT03738423|542068857|FG004|Overall Study|Lack of Efficacy|2|||
150254841|NCT03738423|542068853|FG000|Overall Study|Lost to Follow-up|1|||
150254842|NCT03738423|542068854|FG001|Overall Study|Lost to Follow-up|0|||
150254843|NCT03738423|542068855|FG002|Overall Study|Lost to Follow-up|1|||
150254844|NCT03738423|542068856|FG003|Overall Study|Lost to Follow-up|1|||
150254845|NCT03738423|542068857|FG004|Overall Study|Lost to Follow-up|0|||
150254846|NCT03738423|542068853|FG000|Overall Study|Protocol Violation|1|||
150254847|NCT03738423|542068854|FG001|Overall Study|Protocol Violation|0|||
150254848|NCT03738423|542068855|FG002|Overall Study|Protocol Violation|0|||
150254849|NCT03738423|542068856|FG003|Overall Study|Protocol Violation|0|||
150254850|NCT03738423|542068857|FG004|Overall Study|Protocol Violation|1|||
150254851|NCT03738423|542068853|FG000|Overall Study|Physician Decision|0|||
150254852|NCT03738423|542068854|FG001|Overall Study|Physician Decision|0|||
150254853|NCT03738423|542068855|FG002|Overall Study|Physician Decision|1|||
150254854|NCT03738423|542068856|FG003|Overall Study|Physician Decision|0|||
150254855|NCT03738423|542068857|FG004|Overall Study|Physician Decision|1|||
150254856|NCT03738423|542068853|FG000|Overall Study|Death|0|||
149733784|NCT02497001|540158929|FG002|Overall Study|Protocol Violation|3|||
149733785|NCT02497001|540158930|FG003|Overall Study|Protocol Violation|1|||
149733786|NCT01752023|540158931|FG000|Overall Study|Physician Decision|2|||
149733787|NCT01752023|540158932|FG001|Overall Study|Physician Decision|1|||
149733788|NCT02440581|540158933|FG000|Overall Study|Death|0|||
149733789|NCT02440581|540158934|FG001|Overall Study|Death|0|||
149733790|NCT02440581|540158935|FG002|Overall Study|Death|7|||
149733791|NCT02440581|540158936|FG003|Overall Study|Death|5|||
149733792|NCT02440581|540158933|FG000|Overall Study|Transplanted|1|||
149733793|NCT02440581|540158934|FG001|Overall Study|Transplanted|0|||
149733794|NCT02440581|540158935|FG002|Overall Study|Transplanted|3|||
149733795|NCT02440581|540158936|FG003|Overall Study|Transplanted|2|||
149733796|NCT02440581|540158933|FG000|Overall Study|Withdrawal by Subject|4|||
149733797|NCT02440581|540158934|FG001|Overall Study|Withdrawal by Subject|11|||
149733798|NCT02440581|540158935|FG002|Overall Study|Withdrawal by Subject|3|||
149733799|NCT02440581|540158936|FG003|Overall Study|Withdrawal by Subject|7|||
149733800|NCT01889602|540158938|FG000|First Intervention|Adverse Event|1|||
149733801|NCT01889602|540158939|FG001|First Intervention|Adverse Event|1|||
149733802|NCT01889602|540158940|FG002|First Intervention|Adverse Event|1|||
149733803|NCT01889602|540158938|FG000|First Intervention|Protocol Violation|0|||
149733804|NCT01889602|540158939|FG001|First Intervention|Protocol Violation|1|||
149733805|NCT01889602|540158940|FG002|First Intervention|Protocol Violation|1|||
150254857|NCT03738423|542068854|FG001|Overall Study|Death|0|||
150254858|NCT03738423|542068855|FG002|Overall Study|Death|0|||
150254859|NCT03738423|542068856|FG003|Overall Study|Death|0|||
150254860|NCT03738423|542068857|FG004|Overall Study|Death|1|||
149733806|NCT01889602|540158938|FG000|First Intervention|Study ending|0|||
149733807|NCT01889602|540158939|FG001|First Intervention|Study ending|1|||
149733808|NCT01889602|540158940|FG002|First Intervention|Study ending|0|||
150254861|NCT03738423|542068853|FG000|Overall Study|Randomized but never treated|0|||
150254862|NCT03738423|542068854|FG001|Overall Study|Randomized but never treated|0|||
150254863|NCT03738423|542068855|FG002|Overall Study|Randomized but never treated|1|||
149733809|NCT01889602|540158938|FG000|Second Intervention|Adverse Event|0|||
149733810|NCT01889602|540158939|FG001|Second Intervention|Adverse Event|0|||
149733811|NCT01889602|540158940|FG002|Second Intervention|Adverse Event|1|||
149733812|NCT01889602|540158938|FG000|Second Intervention|Study ending|1|||
150254864|NCT03738423|542068856|FG003|Overall Study|Randomized but never treated|1|||
150254865|NCT03738423|542068857|FG004|Overall Study|Randomized but never treated|0|||
150254866|NCT04577001|542068858|FG000|Overall Study|Subject became ineligible|0|||
150254867|NCT04577001|542068859|FG001|Overall Study|Subject became ineligible|1|||
150254868|NCT01865747|542068867|FG000|Overall Study (ITT)|Adverse Event|32|||
150254869|NCT01865747|542068868|FG001|Overall Study (ITT)|Adverse Event|31|||
150254870|NCT01865747|542068867|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
150254871|NCT01865747|542068868|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
150254872|NCT01865747|542068867|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
150254873|NCT01865747|542068868|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
150254874|NCT01865747|542068867|FG000|Overall Study (ITT)|Protocol Violation|1|||
150254875|NCT01865747|542068868|FG001|Overall Study (ITT)|Protocol Violation|1|||
150254876|NCT01865747|542068867|FG000|Overall Study (ITT)|Physician Decision|5|||
150254877|NCT01865747|542068868|FG001|Overall Study (ITT)|Physician Decision|2|||
150254878|NCT01865747|542068867|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
150254879|NCT01865747|542068868|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
150254880|NCT01865747|542068867|FG000|Overall Study (ITT)|Sponsor Decision|0|||
150254881|NCT01865747|542068868|FG001|Overall Study (ITT)|Sponsor Decision|1|||
150254882|NCT01865747|542068867|FG000|Overall Study (ITT)|Progressive Disease|122|||
150254883|NCT01865747|542068868|FG001|Overall Study (ITT)|Progressive Disease|158|||
150254884|NCT01865747|542068867|FG000|Overall Study (ITT)|Reason Not Provided|0|||
150254885|NCT01865747|542068868|FG001|Overall Study (ITT)|Reason Not Provided|1|||
150254886|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
150254887|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
150254888|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
150254889|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
150254890|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
150254891|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
150254892|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
150254893|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
150254894|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
150254895|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
150254896|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
150254897|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
150254898|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
150254899|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
150254900|NCT01865747|542068867|FG000|Primary Intent to Treat (PITT)|Other|0|||
150254901|NCT01865747|542068868|FG001|Primary Intent to Treat (PITT)|Other|1|||
150254902|NCT04625413|542068869|FG000|Overall Study|Hospice|2|||
150254903|NCT04625413|542068869|FG000|Overall Study|Distress|1|||
150254904|NCT04625413|542068869|FG000|Overall Study|Not feeling well|1|||
150254905|NCT03981861|542068870|FG000|Overall Study|Withdrawal by Subject|3|||
150254906|NCT05618912|542068871|FG000|Overall Study|Lost to Follow-up|14|||
150254907|NCT05618912|542068872|FG001|Overall Study|Lost to Follow-up|19|||
150254908|NCT03973931|542068873|FG000|Overall Study|Lost to Follow-up|47|||
150254909|NCT03973931|542068874|FG001|Overall Study|Lost to Follow-up|63|||
150254910|NCT03973931|542068875|FG002|Overall Study|Lost to Follow-up|51|||
150254911|NCT03973931|542068876|FG003|Overall Study|Lost to Follow-up|54|||
150254912|NCT03973931|542068873|FG000|Overall Study|opted out|6|||
150254913|NCT03973931|542068874|FG001|Overall Study|opted out|5|||
150254914|NCT03973931|542068875|FG002|Overall Study|opted out|5|||
150254915|NCT03973931|542068876|FG003|Overall Study|opted out|1|||
150254916|NCT00925353|542068877|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
150254917|NCT02516332|542070520|FG000|Overall Study|Withdrawal by Subject|2|||
150254918|NCT02516332|542070521|FG001|Overall Study|Withdrawal by Subject|1|||
150254919|NCT02516332|542070522|FG002|Overall Study|Withdrawal by Subject|2|||
150254920|NCT03541174|542070525|FG000|Part 1 Double-Blind|Adverse Event|6|||
150254921|NCT03541174|542070526|FG001|Part 1 Double-Blind|Adverse Event|5|||
150254922|NCT03541174|542070527|FG002|Part 1 Double-Blind|Adverse Event|2|||
150254923|NCT03541174|542070528|FG003|Part 1 Double-Blind|Adverse Event|0|||
150254924|NCT03541174|542070529|FG004|Part 1 Double-Blind|Adverse Event|0|||
150254925|NCT03541174|542070530|FG005|Part 1 Double-Blind|Adverse Event|0|||
150254926|NCT03541174|542070525|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
150254927|NCT03541174|542070526|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
150254928|NCT03541174|542070527|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
150254929|NCT03541174|542070528|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
150254930|NCT03541174|542070529|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
150254931|NCT03541174|542070530|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
150254932|NCT03541174|542070525|FG000|Part 1 Double-Blind|Other reasons|3|||
150254933|NCT03541174|542070526|FG001|Part 1 Double-Blind|Other reasons|2|||
150254934|NCT03541174|542070527|FG002|Part 1 Double-Blind|Other reasons|3|||
150254935|NCT03541174|542070528|FG003|Part 1 Double-Blind|Other reasons|0|||
150254936|NCT03541174|542070529|FG004|Part 1 Double-Blind|Other reasons|0|||
150254937|NCT03541174|542070530|FG005|Part 1 Double-Blind|Other reasons|0|||
150254938|NCT03541174|542070525|FG000|Part 2 Single-Blind|Adverse Event|0|||
150254939|NCT03541174|542070526|FG001|Part 2 Single-Blind|Adverse Event|0|||
150254940|NCT03541174|542070527|FG002|Part 2 Single-Blind|Adverse Event|0|||
150254941|NCT03541174|542070528|FG003|Part 2 Single-Blind|Adverse Event|25|||
150254942|NCT03541174|542070529|FG004|Part 2 Single-Blind|Adverse Event|0|||
150254943|NCT03541174|542070530|FG005|Part 2 Single-Blind|Adverse Event|0|||
150254944|NCT03541174|542070525|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
150254945|NCT03541174|542070526|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
150254946|NCT03541174|542070527|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
150254947|NCT03541174|542070528|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
150254948|NCT03541174|542070529|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
150254949|NCT03541174|542070530|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
150254950|NCT03541174|542070525|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
150254951|NCT03541174|542070526|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
150254952|NCT03541174|542070527|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
150254953|NCT03541174|542070528|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
150254954|NCT03541174|542070529|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
150254955|NCT03541174|542070530|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
150254956|NCT03541174|542070525|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
150254957|NCT03541174|542070526|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
150254958|NCT03541174|542070527|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
150254959|NCT03541174|542070528|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
150254960|NCT03541174|542070529|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
150254961|NCT03541174|542070530|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
150254962|NCT03541174|542070525|FG000|Part 2 Single-Blind|Death|0|||
150254963|NCT03541174|542070526|FG001|Part 2 Single-Blind|Death|0|||
150254964|NCT03541174|542070527|FG002|Part 2 Single-Blind|Death|0|||
149733813|NCT01889602|540158939|FG001|Second Intervention|Study ending|0|||
149733814|NCT01889602|540158940|FG002|Second Intervention|Study ending|0|||
149733815|NCT01889602|540158938|FG000|Second Intervention|Withdrawal by Subject|0|||
149733816|NCT01889602|540158939|FG001|Second Intervention|Withdrawal by Subject|0|||
149733817|NCT01889602|540158940|FG002|Second Intervention|Withdrawal by Subject|1|||
149733818|NCT01889602|540158938|FG000|Third Intervention|Protocol Violation|1|||
149733819|NCT01889602|540158939|FG001|Third Intervention|Protocol Violation|0|||
149733820|NCT01889602|540158940|FG002|Third Intervention|Protocol Violation|0|||
149733821|NCT01889602|540158938|FG000|Third Intervention|Withdrawal by Subject|2|||
149733822|NCT01889602|540158939|FG001|Third Intervention|Withdrawal by Subject|2|||
149733823|NCT01889602|540158940|FG002|Third Intervention|Withdrawal by Subject|0|||
149733824|NCT00961961|540158941|FG000|Phase I|Withdrawal by Subject|7|||
149733825|NCT00961961|540158942|FG001|Phase I|Withdrawal by Subject|0|||
149733826|NCT00961961|540158943|FG002|Phase I|Withdrawal by Subject|0|||
149733827|NCT00961961|540158944|FG003|Phase I|Withdrawal by Subject|0|||
149733828|NCT00961961|540158941|FG000|Phase I|Lost to Follow-up|10|||
149733829|NCT00961961|540158942|FG001|Phase I|Lost to Follow-up|0|||
149733830|NCT00961961|540158943|FG002|Phase I|Lost to Follow-up|0|||
149733831|NCT00961961|540158944|FG003|Phase I|Lost to Follow-up|0|||
149733832|NCT00961961|540158941|FG000|Phase I|Lack of Efficacy|94|||
149733833|NCT00961961|540158942|FG001|Phase I|Lack of Efficacy|0|||
149733834|NCT00961961|540158943|FG002|Phase I|Lack of Efficacy|0|||
149733835|NCT00961961|540158944|FG003|Phase I|Lack of Efficacy|0|||
149733836|NCT00961961|540158941|FG000|Phase I|Adverse Event|7|||
149733837|NCT00961961|540158942|FG001|Phase I|Adverse Event|0|||
149733838|NCT00961961|540158943|FG002|Phase I|Adverse Event|0|||
149733839|NCT00961961|540158944|FG003|Phase I|Adverse Event|0|||
149733840|NCT00961961|540158941|FG000|Phase I|Physician Decision|8|||
149733841|NCT00961961|540158942|FG001|Phase I|Physician Decision|0|||
149733842|NCT00961961|540158943|FG002|Phase I|Physician Decision|0|||
149733843|NCT00961961|540158944|FG003|Phase I|Physician Decision|0|||
149733844|NCT00961961|540158941|FG000|Phase II|Lost to Follow-up|0|||
149733845|NCT00961961|540158942|FG001|Phase II|Lost to Follow-up|0|||
149733846|NCT00961961|540158943|FG002|Phase II|Lost to Follow-up|10|||
149733847|NCT00961961|540158944|FG003|Phase II|Lost to Follow-up|7|||
149733848|NCT00961961|540158941|FG000|Phase II|Adverse Event|0|||
149733849|NCT00961961|540158942|FG001|Phase II|Adverse Event|0|||
149733850|NCT00961961|540158943|FG002|Phase II|Adverse Event|0|||
149733851|NCT00961961|540158944|FG003|Phase II|Adverse Event|1|||
149733852|NCT00961961|540158941|FG000|Phase II|Physician Decision|0|||
149733853|NCT00961961|540158942|FG001|Phase II|Physician Decision|0|||
149733854|NCT00961961|540158943|FG002|Phase II|Physician Decision|1|||
149733855|NCT00961961|540158944|FG003|Phase II|Physician Decision|0|||
149733856|NCT00961961|540158941|FG000|Phase II|Withdrawal by Subject|0|||
149733857|NCT00961961|540158942|FG001|Phase II|Withdrawal by Subject|0|||
149733858|NCT00961961|540158943|FG002|Phase II|Withdrawal by Subject|1|||
149733859|NCT00961961|540158944|FG003|Phase II|Withdrawal by Subject|0|||
149733860|NCT01245673|540158945|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
149733861|NCT04722991|540158946|FG000|Overall Study|Adverse Event|12|||
149733862|NCT04722991|540158947|FG001|Overall Study|Adverse Event|4|||
149733863|NCT04722991|540158946|FG000|Overall Study|Death|2|||
149733864|NCT04722991|540158947|FG001|Overall Study|Death|0|||
149733865|NCT04722991|540158946|FG000|Overall Study|Lost to Follow-up|1|||
149733866|NCT04722991|540158947|FG001|Overall Study|Lost to Follow-up|1|||
149733867|NCT04722991|540158946|FG000|Overall Study|Withdrawal cirterion met|2|||
149733868|NCT04722991|540158947|FG001|Overall Study|Withdrawal cirterion met|2|||
149733869|NCT04722991|540158946|FG000|Overall Study|Other|1|||
149733870|NCT04722991|540158947|FG001|Overall Study|Other|0|||
149733871|NCT04722991|540158946|FG000|Overall Study|Non-compliance|0|||
149733872|NCT04722991|540158947|FG001|Overall Study|Non-compliance|1|||
149733873|NCT04722991|540158946|FG000|Overall Study|Withdrawal by Subject|0|||
149733874|NCT04722991|540158947|FG001|Overall Study|Withdrawal by Subject|1|||
149733875|NCT03186989|540158948|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733876|NCT03186989|540158949|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733877|NCT03186989|540158950|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
149733878|NCT03186989|540158951|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
149733879|NCT03186989|540158952|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
149733880|NCT03186989|540158953|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733881|NCT03186989|540158954|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733882|NCT03186989|540158955|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733883|NCT03186989|540158956|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733884|NCT03186989|540158957|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733885|NCT03186989|540158958|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149733886|NCT03186989|540158948|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733887|NCT03186989|540158949|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733888|NCT03186989|540158950|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733889|NCT03186989|540158951|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
150254965|NCT03541174|542070528|FG003|Part 2 Single-Blind|Death|5|||
149733890|NCT03186989|540158952|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733891|NCT03186989|540158953|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
149733892|NCT03186989|540158954|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733893|NCT03186989|540158955|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733894|NCT03186989|540158956|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733895|NCT03186989|540158957|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733896|NCT03186989|540158958|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149733897|NCT03186989|540158948|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733898|NCT03186989|540158949|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733899|NCT03186989|540158950|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733900|NCT03186989|540158951|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733901|NCT03186989|540158952|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733902|NCT03186989|540158953|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733903|NCT03186989|540158954|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
149733904|NCT03186989|540158955|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733905|NCT03186989|540158956|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733906|NCT03186989|540158957|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733907|NCT03186989|540158958|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149733908|NCT03186989|540158948|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733909|NCT03186989|540158949|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733910|NCT03186989|540158950|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733911|NCT03186989|540158951|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733912|NCT03186989|540158952|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733913|NCT03186989|540158953|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149733914|NCT03186989|540158954|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149733915|NCT03186989|540158955|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733916|NCT03186989|540158956|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149733917|NCT03186989|540158957|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733918|NCT03186989|540158958|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149733919|NCT02246621|540158960|FG000|Overall Study|Withdrawal by Subject|28|||
149733920|NCT02246621|540158961|FG001|Overall Study|Withdrawal by Subject|16|||
149733921|NCT02246621|540158960|FG000|Overall Study|Lost to Follow-up|1|||
149733922|NCT02246621|540158961|FG001|Overall Study|Lost to Follow-up|0|||
149733923|NCT02246621|540158960|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
149733924|NCT02246621|540158961|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
149733925|NCT01292057|540158962|FG000|Overall Study|Protocol Violation|1|||
149733926|NCT01292057|540158963|FG001|Overall Study|Protocol Violation|1|||
149733927|NCT01292057|540158962|FG000|Overall Study|Lost to Follow-up|1|||
149733928|NCT01292057|540158963|FG001|Overall Study|Lost to Follow-up|1|||
149733929|NCT01459614|540158964|FG000|Overall Study|Adverse Event|1|||
149733930|NCT01459614|540158965|FG001|Overall Study|Adverse Event|0|||
149733931|NCT00630331|540158969|FG000|Overall Study|Death|2|||
149733932|NCT00630331|540158970|FG001|Overall Study|Death|1|||
149733933|NCT00630331|540158971|FG002|Overall Study|Death|1|||
149733934|NCT00630331|540158969|FG000|Overall Study|Adverse Event|1|||
149733935|NCT00630331|540158970|FG001|Overall Study|Adverse Event|0|||
149733936|NCT00630331|540158971|FG002|Overall Study|Adverse Event|0|||
149733937|NCT00630331|540158969|FG000|Overall Study|Withdrawal by Subject|12|||
149733938|NCT00630331|540158970|FG001|Overall Study|Withdrawal by Subject|7|||
149733939|NCT00630331|540158971|FG002|Overall Study|Withdrawal by Subject|5|||
149733940|NCT00630331|540158969|FG000|Overall Study|Lost to Follow-up|175|||
149733941|NCT00630331|540158970|FG001|Overall Study|Lost to Follow-up|143|||
149733942|NCT00630331|540158971|FG002|Overall Study|Lost to Follow-up|170|||
149733943|NCT00630331|540158969|FG000|Overall Study|Inappropriate enrollment|3|||
149733944|NCT00630331|540158970|FG001|Overall Study|Inappropriate enrollment|6|||
149733945|NCT00630331|540158971|FG002|Overall Study|Inappropriate enrollment|3|||
149733946|NCT00630331|540158969|FG000|Overall Study|Unable to classify|9|||
149733947|NCT00630331|540158970|FG001|Overall Study|Unable to classify|4|||
149733948|NCT00630331|540158971|FG002|Overall Study|Unable to classify|3|||
149733949|NCT00630331|540158969|FG000|Overall Study|Protocol Violation|4|||
149733950|NCT00630331|540158970|FG001|Overall Study|Protocol Violation|5|||
149733951|NCT00630331|540158971|FG002|Overall Study|Protocol Violation|6|||
149733952|NCT02425098|540158978|FG000|Overall Study|Lost to Follow-up|7|||
149733953|NCT02425098|540158979|FG001|Overall Study|Lost to Follow-up|7|||
149733954|NCT02425098|540158978|FG000|Overall Study|Withdrawal by Subject|4|||
149733955|NCT02425098|540158979|FG001|Overall Study|Withdrawal by Subject|8|||
149733956|NCT02425098|540158978|FG000|Overall Study|Pregnancy|2|||
149733957|NCT02425098|540158979|FG001|Overall Study|Pregnancy|0|||
149733958|NCT02425098|540158978|FG000|Overall Study|Reason not Specified|0|||
149733959|NCT02425098|540158979|FG001|Overall Study|Reason not Specified|1|||
149733960|NCT00821678|540158980|FG000|Overall Study|Withdrawal by Subject|8|||
149733961|NCT00821678|540158981|FG001|Overall Study|Withdrawal by Subject|0|||
149733962|NCT00821678|540158980|FG000|Overall Study|Lost to Follow-up|13|||
149733963|NCT00821678|540158981|FG001|Overall Study|Lost to Follow-up|12|||
149733964|NCT00821678|540158980|FG000|Overall Study|Death|0|||
149733965|NCT00821678|540158981|FG001|Overall Study|Death|2|||
149733966|NCT02078219|540158982|FG000|Overall Study|Other|2|||
149733967|NCT02078219|540158983|FG001|Overall Study|Other|2|||
149733968|NCT02078219|540158984|FG002|Overall Study|Other|3|||
149733969|NCT02078219|540158985|FG003|Overall Study|Other|0|||
149733970|NCT02078219|540158986|FG004|Overall Study|Other|1|||
149733971|NCT02078219|540158982|FG000|Overall Study|Withdrawal by Subject|0|||
149733972|NCT02078219|540158983|FG001|Overall Study|Withdrawal by Subject|1|||
149733973|NCT02078219|540158984|FG002|Overall Study|Withdrawal by Subject|0|||
149733974|NCT02078219|540158985|FG003|Overall Study|Withdrawal by Subject|1|||
149733975|NCT02078219|540158986|FG004|Overall Study|Withdrawal by Subject|1|||
149733976|NCT02078219|540158982|FG000|Overall Study|Protocol Violation|0|||
149733977|NCT02078219|540158983|FG001|Overall Study|Protocol Violation|0|||
149733978|NCT02078219|540158984|FG002|Overall Study|Protocol Violation|0|||
149733979|NCT02078219|540158985|FG003|Overall Study|Protocol Violation|1|||
149733980|NCT02078219|540158986|FG004|Overall Study|Protocol Violation|0|||
149733981|NCT02078219|540158982|FG000|Overall Study|Death|0|||
149733982|NCT02078219|540158983|FG001|Overall Study|Death|0|||
149733983|NCT02078219|540158984|FG002|Overall Study|Death|0|||
149733984|NCT02078219|540158985|FG003|Overall Study|Death|1|||
149733985|NCT02078219|540158986|FG004|Overall Study|Death|0|||
149733986|NCT02078219|540158982|FG000|Overall Study|Adverse Event|1|||
149733987|NCT02078219|540158983|FG001|Overall Study|Adverse Event|1|||
149733988|NCT02078219|540158984|FG002|Overall Study|Adverse Event|3|||
149733989|NCT02078219|540158985|FG003|Overall Study|Adverse Event|1|||
149733990|NCT02078219|540158986|FG004|Overall Study|Adverse Event|0|||
149733991|NCT03136107|540158993|FG000|Overall Study|Other (Not specified)|1|||
149733992|NCT03641560|540158998|FG000|Overall Study|Withdrawal by Subject|6|||
149733993|NCT03641560|540158998|FG000|Overall Study|Progressive disease|40|||
149733994|NCT03641560|540158998|FG000|Overall Study|Death|6|||
149733995|NCT03219164|540161508|FG000|Overall Study|Study Terminated by Sponsor|16|||
149733996|NCT03219164|540161509|FG001|Overall Study|Study Terminated by Sponsor|12|||
149733997|NCT03219164|540161508|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
149733998|NCT03219164|540161509|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
149733999|NCT03219164|540161508|FG000|Overall Study|Lost to Follow-up|1|||
149734000|NCT03219164|540161509|FG001|Overall Study|Lost to Follow-up|1|||
149734001|NCT03219164|540161508|FG000|Overall Study|Adverse Event|1|||
149734002|NCT03219164|540161509|FG001|Overall Study|Adverse Event|0|||
149734003|NCT03219164|540161508|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149734004|NCT03219164|540161509|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149734005|NCT03219164|540161508|FG000|Overall Study|Protocol Violation|0|||
149734006|NCT03219164|540161509|FG001|Overall Study|Protocol Violation|1|||
149734007|NCT03219164|540161508|FG000|Overall Study|Withdrew Assent|1|||
149734008|NCT03219164|540161509|FG001|Overall Study|Withdrew Assent|0|||
149734009|NCT02689492|540161510|FG000|Overall Study|Lost to Follow-up|61|||
149734010|NCT02689492|540161510|FG000|Overall Study|Withdrawal by Subject|11|||
149734011|NCT02689492|540161510|FG000|Overall Study|Death|9|||
149734012|NCT02689492|540161510|FG000|Overall Study|Physician Decision|2|||
149734013|NCT02689492|540161510|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
149734014|NCT02689492|540161510|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
149734015|NCT02689492|540161510|FG000|Overall Study|Other than listed|1|||
149734016|NCT02732951|540161511|FG000|Overall Study|Other than listed|1|||
149734017|NCT02732951|540161512|FG001|Overall Study|Other than listed|0|||
149734018|NCT02732951|540161511|FG000|Overall Study|Lost to Follow-up|0|||
149734019|NCT02732951|540161512|FG001|Overall Study|Lost to Follow-up|1|||
149734020|NCT02732951|540161511|FG000|Overall Study|Adverse Event|4|||
150254966|NCT03541174|542070529|FG004|Part 2 Single-Blind|Death|0|||
150254967|NCT03541174|542070530|FG005|Part 2 Single-Blind|Death|0|||
150254968|NCT03541174|542070525|FG000|Part 2 Single-Blind|Pregnancy|0|||
149734021|NCT02732951|540161512|FG001|Overall Study|Adverse Event|4|||
149734022|NCT02732951|540161511|FG000|Overall Study|Protocol Violation|0|||
149734023|NCT02732951|540161512|FG001|Overall Study|Protocol Violation|1|||
149734024|NCT01750918|540161513|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
149734025|NCT01750918|540161514|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
149734026|NCT01750918|540161515|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
149734027|NCT01750918|540161516|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
149734028|NCT01750918|540161517|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
149734029|NCT01750918|540161518|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
149734030|NCT01750918|540161519|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
149734031|NCT01750918|540161520|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
149734032|NCT01750918|540161513|FG000|Overall Study|Lost to Follow-up|0|||
149734033|NCT01750918|540161514|FG001|Overall Study|Lost to Follow-up|0|||
149734034|NCT01750918|540161515|FG002|Overall Study|Lost to Follow-up|2|||
149734035|NCT01750918|540161516|FG003|Overall Study|Lost to Follow-up|2|||
149734036|NCT01750918|540161517|FG004|Overall Study|Lost to Follow-up|0|||
149734037|NCT01750918|540161518|FG005|Overall Study|Lost to Follow-up|0|||
149734038|NCT01750918|540161519|FG006|Overall Study|Lost to Follow-up|0|||
149734039|NCT01750918|540161520|FG007|Overall Study|Lost to Follow-up|1|||
149734040|NCT01750918|540161513|FG000|Overall Study|Withdrawal by Subject|0|||
149734041|NCT01750918|540161514|FG001|Overall Study|Withdrawal by Subject|0|||
149734042|NCT01750918|540161515|FG002|Overall Study|Withdrawal by Subject|1|||
149734043|NCT01750918|540161516|FG003|Overall Study|Withdrawal by Subject|2|||
149734044|NCT01750918|540161517|FG004|Overall Study|Withdrawal by Subject|1|||
149734045|NCT01750918|540161518|FG005|Overall Study|Withdrawal by Subject|1|||
149734046|NCT01750918|540161519|FG006|Overall Study|Withdrawal by Subject|2|||
149734047|NCT01750918|540161520|FG007|Overall Study|Withdrawal by Subject|2|||
149734048|NCT04840667|540161528|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
149734049|NCT00110305|540161534|FG000|Overall Study|Adverse Event|46|||
149734050|NCT00110305|540161535|FG001|Overall Study|Adverse Event|13|||
149734051|NCT00110305|540161534|FG000|Overall Study|Sponsors Decision|1|||
149734052|NCT00110305|540161535|FG001|Overall Study|Sponsors Decision|0|||
149734053|NCT00110305|540161534|FG000|Overall Study|Subject Non-Compliant|9|||
149734054|NCT00110305|540161535|FG001|Overall Study|Subject Non-Compliant|2|||
149734055|NCT00110305|540161534|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
149734056|NCT00110305|540161535|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
149734057|NCT00110305|540161534|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
149734058|NCT00110305|540161535|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
149734059|NCT00110305|540161534|FG000|Overall Study|Protocol Violation|0|||
149734060|NCT00110305|540161535|FG001|Overall Study|Protocol Violation|1|||
149734061|NCT00110305|540161534|FG000|Overall Study|Withdrawal by Subject|7|||
149734062|NCT00110305|540161535|FG001|Overall Study|Withdrawal by Subject|7|||
149734063|NCT00110305|540161534|FG000|Overall Study|Lost to Follow-up|20|||
149734064|NCT00110305|540161535|FG001|Overall Study|Lost to Follow-up|3|||
149734065|NCT00110305|540161534|FG000|Overall Study|Other|8|||
149734066|NCT00110305|540161535|FG001|Overall Study|Other|2|||
149734067|NCT01805180|540161547|FG000|Lead-in Donor Phase|screen failure|1|||
149734068|NCT01805180|540161548|FG001|Lead-in Donor Phase|screen failure|0|||
149734069|NCT01805180|540161549|FG002|Lead-in Donor Phase|screen failure|0|||
149734070|NCT04574999|540161552|FG000|Overall Study|Adverse Event|1|||
149734071|NCT04574999|540161553|FG001|Overall Study|Adverse Event|0|||
149734072|NCT04574999|540161552|FG000|Overall Study|Lack of Efficacy|2|||
149734073|NCT04574999|540161553|FG001|Overall Study|Lack of Efficacy|3|||
149734074|NCT04574999|540161552|FG000|Overall Study|Protocol Violation|1|||
149734075|NCT04574999|540161553|FG001|Overall Study|Protocol Violation|0|||
149734076|NCT04574999|540161552|FG000|Overall Study|Withdrawal by Subject|2|||
149734077|NCT04574999|540161553|FG001|Overall Study|Withdrawal by Subject|2|||
149734078|NCT04574999|540161552|FG000|Overall Study|Lost to Follow-up|1|||
149734079|NCT04574999|540161553|FG001|Overall Study|Lost to Follow-up|0|||
149734080|NCT04574999|540161552|FG000|Overall Study|Personal problems|1|||
149734081|NCT04574999|540161553|FG001|Overall Study|Personal problems|0|||
149734082|NCT04574999|540161552|FG000|Overall Study|Previous planned surgery|1|||
149734083|NCT04574999|540161553|FG001|Overall Study|Previous planned surgery|0|||
149734084|NCT00206726|540161557|FG000|Overall Study|Delayed recovery of blood counts|1|||
149734085|NCT00206726|540161557|FG000|Overall Study|Progressive disease or relapsed disease|18|||
149734086|NCT00206726|540161557|FG000|Overall Study|Placed on new protocol|1|||
149734087|NCT00206726|540161557|FG000|Overall Study|Bone marrow transplant|1|||
149734088|NCT00206726|540161557|FG000|Overall Study|Adverse Event|17|||
149734089|NCT00206726|540161557|FG000|Overall Study|Death|4|||
149734090|NCT00206726|540161557|FG000|Overall Study|Protocol Violation|1|||
149734091|NCT00206726|540161557|FG000|Overall Study|Withdrawal by Subject|8|||
149734092|NCT00008385|540161558|FG000|Overall Study|Off treatment reasons not reported|79|||
149734093|NCT00008385|540161559|FG001|Overall Study|Off treatment reasons not reported|70|||
149734094|NCT00008385|540161558|FG000|Overall Study|Progressive disease|52|||
149734095|NCT00008385|540161559|FG001|Overall Study|Progressive disease|117|||
149734096|NCT00008385|540161558|FG000|Overall Study|Adverse Event|8|||
149734097|NCT00008385|540161559|FG001|Overall Study|Adverse Event|20|||
149734098|NCT00008385|540161558|FG000|Overall Study|Death|12|||
149734099|NCT00008385|540161559|FG001|Overall Study|Death|18|||
149734100|NCT00008385|540161558|FG000|Overall Study|Withdrawal by Subject|67|||
149734101|NCT00008385|540161559|FG001|Overall Study|Withdrawal by Subject|157|||
149734102|NCT00008385|540161558|FG000|Overall Study|Start non-protocol therapy|3|||
149734103|NCT00008385|540161559|FG001|Overall Study|Start non-protocol therapy|1|||
149734104|NCT00008385|540161558|FG000|Overall Study|Other complicating disease|17|||
149734105|NCT00008385|540161559|FG001|Overall Study|Other complicating disease|30|||
149734106|NCT00008385|540161558|FG000|Overall Study|Maximum dose reached|0|||
149734107|NCT00008385|540161559|FG001|Overall Study|Maximum dose reached|2|||
149734108|NCT00008385|540161558|FG000|Overall Study|Other|105|||
149734109|NCT00008385|540161559|FG001|Overall Study|Other|212|||
149734110|NCT00008385|540161558|FG000|Overall Study|Not start protocol therapy|44|||
149734111|NCT00008385|540161559|FG001|Overall Study|Not start protocol therapy|175|||
149734112|NCT05148884|540161560|FG000|Overall Study|Withdrawal by Subject|3|||
149734113|NCT05148884|540161561|FG001|Overall Study|Withdrawal by Subject|0|||
149734114|NCT05148884|540161560|FG000|Overall Study|Deep brain stimulation operation|0|||
149734115|NCT05148884|540161561|FG001|Overall Study|Deep brain stimulation operation|1|||
149734116|NCT00582556|540161562|FG000|Overall Study|Withdrawal by Subject|0|||
149734117|NCT00582556|540161563|FG001|Overall Study|Withdrawal by Subject|1|||
149734118|NCT00582556|540161564|FG002|Overall Study|Withdrawal by Subject|1|||
149734119|NCT00582556|540161562|FG000|Overall Study|Physician Decision|0|||
149734120|NCT00582556|540161563|FG001|Overall Study|Physician Decision|0|||
149734121|NCT00582556|540161564|FG002|Overall Study|Physician Decision|1|||
149734122|NCT01993888|540161567|FG000|Overall Study|Death|1|||
149734123|NCT01993888|540161568|FG001|Overall Study|Death|1|||
149734124|NCT01993888|540161567|FG000|Overall Study|Lost to Follow-up|1|||
149734125|NCT01993888|540161568|FG001|Overall Study|Lost to Follow-up|1|||
149734126|NCT01993888|540161567|FG000|Overall Study|Withdrawal by Subject|0|||
149734127|NCT01993888|540161568|FG001|Overall Study|Withdrawal by Subject|1|||
149734128|NCT01341457|540161569|FG000|Overall Study|Adverse Event|2|||
149734129|NCT01341457|540161570|FG001|Overall Study|Adverse Event|0|||
149734130|NCT00365989|540161571|FG000|Overall Study|Withdrawal by Subject|1|||
149734131|NCT00365989|540161571|FG000|Overall Study|Non-compliance|1|||
149734132|NCT00832819|540161574|FG000|Overall Study|Adverse Event|0|||
149734133|NCT00832819|540161575|FG001|Overall Study|Adverse Event|1|||
149734134|NCT00832819|540161576|FG002|Overall Study|Adverse Event|0|||
149734135|NCT00832819|540161574|FG000|Overall Study|Protocol Violation|0|||
149734136|NCT00832819|540161575|FG001|Overall Study|Protocol Violation|0|||
149734137|NCT00832819|540161576|FG002|Overall Study|Protocol Violation|1|||
149734138|NCT00317044|540161577|FG000|Overall Study|Protocol Violation|28|||
149734139|NCT00317044|540161578|FG001|Overall Study|Protocol Violation|22|||
149734140|NCT00317044|540161579|FG002|Overall Study|Protocol Violation|20|||
149734141|NCT00317044|540161577|FG000|Overall Study|Adverse Event|4|||
149734142|NCT00317044|540161578|FG001|Overall Study|Adverse Event|7|||
149734143|NCT00317044|540161579|FG002|Overall Study|Adverse Event|4|||
149734144|NCT00317044|540161577|FG000|Overall Study|Withdrawal by Subject|10|||
149734145|NCT00317044|540161578|FG001|Overall Study|Withdrawal by Subject|7|||
149734146|NCT00317044|540161579|FG002|Overall Study|Withdrawal by Subject|12|||
149734147|NCT00317044|540161577|FG000|Overall Study|Lost to Follow-up|0|||
149734148|NCT00317044|540161578|FG001|Overall Study|Lost to Follow-up|2|||
149734149|NCT00317044|540161579|FG002|Overall Study|Lost to Follow-up|3|||
149734150|NCT00317044|540161577|FG000|Overall Study|Multiple Reasons|6|||
149734151|NCT00317044|540161578|FG001|Overall Study|Multiple Reasons|2|||
149734152|NCT00317044|540161579|FG002|Overall Study|Multiple Reasons|6|||
149734153|NCT04317690|540161582|FG000|Overall Study|did not have complete information for primary outcome|0|||
149734154|NCT04317690|540161583|FG001|Overall Study|did not have complete information for primary outcome|4|||
149734155|NCT04317690|540161584|FG002|Overall Study|did not have complete information for primary outcome|0|||
149734156|NCT04317690|540161585|FG003|Overall Study|did not have complete information for primary outcome|2|||
149734157|NCT04317690|540161586|FG004|Overall Study|did not have complete information for primary outcome|0|||
149734158|NCT02318095|540161587|FG000|Overall Study|Adverse Event|1|||
149734159|NCT01717638|540161588|FG000|Overall Study|Lost to Follow-up|0|||
149734160|NCT01717638|540161589|FG001|Overall Study|Lost to Follow-up|0|||
149734161|NCT01717638|540161590|FG002|Overall Study|Lost to Follow-up|0|||
149734162|NCT01717638|540161591|FG003|Overall Study|Lost to Follow-up|0|||
149734163|NCT01717638|540161592|FG004|Overall Study|Lost to Follow-up|0|||
149734164|NCT01717638|540161593|FG005|Overall Study|Lost to Follow-up|1|||
149734165|NCT01717638|540161594|FG006|Overall Study|Lost to Follow-up|0|||
149734166|NCT01717638|540161595|FG007|Overall Study|Lost to Follow-up|0|||
149734167|NCT01717638|540161596|FG008|Overall Study|Lost to Follow-up|0|||
149734168|NCT01717638|540161597|FG009|Overall Study|Lost to Follow-up|0|||
149734169|NCT01717638|540161598|FG010|Overall Study|Lost to Follow-up|0|||
149734170|NCT01717638|540161599|FG011|Overall Study|Lost to Follow-up|0|||
149734171|NCT01717638|540161600|FG012|Overall Study|Lost to Follow-up|0|||
149734172|NCT01717638|540161588|FG000|Overall Study|Father in hospital|0|||
149734173|NCT01717638|540161589|FG001|Overall Study|Father in hospital|0|||
149734174|NCT01717638|540161590|FG002|Overall Study|Father in hospital|0|||
149734175|NCT01717638|540161591|FG003|Overall Study|Father in hospital|0|||
149734176|NCT01717638|540161592|FG004|Overall Study|Father in hospital|0|||
150254969|NCT03541174|542070526|FG001|Part 2 Single-Blind|Pregnancy|0|||
150254970|NCT03541174|542070527|FG002|Part 2 Single-Blind|Pregnancy|0|||
150254971|NCT03541174|542070528|FG003|Part 2 Single-Blind|Pregnancy|1|||
150254972|NCT03541174|542070529|FG004|Part 2 Single-Blind|Pregnancy|0|||
150254973|NCT03541174|542070530|FG005|Part 2 Single-Blind|Pregnancy|0|||
149734177|NCT01717638|540161593|FG005|Overall Study|Father in hospital|0|||
149734178|NCT01717638|540161594|FG006|Overall Study|Father in hospital|0|||
149734179|NCT01717638|540161595|FG007|Overall Study|Father in hospital|0|||
149734180|NCT01717638|540161596|FG008|Overall Study|Father in hospital|0|||
149734181|NCT01717638|540161597|FG009|Overall Study|Father in hospital|0|||
149734182|NCT01717638|540161598|FG010|Overall Study|Father in hospital|0|||
149734183|NCT01717638|540161599|FG011|Overall Study|Father in hospital|0|||
149734184|NCT01717638|540161600|FG012|Overall Study|Father in hospital|1|||
149734185|NCT01717638|540161588|FG000|Overall Study|Withdrawal by Subject|0|||
150254974|NCT03541174|542070525|FG000|Part 2 Single-Blind|Other reasons|0|||
150254975|NCT03541174|542070526|FG001|Part 2 Single-Blind|Other reasons|0|||
150254976|NCT03541174|542070527|FG002|Part 2 Single-Blind|Other reasons|0|||
150254977|NCT03541174|542070528|FG003|Part 2 Single-Blind|Other reasons|32|||
149734186|NCT01717638|540161589|FG001|Overall Study|Withdrawal by Subject|1|||
149734187|NCT01717638|540161590|FG002|Overall Study|Withdrawal by Subject|1|||
149734188|NCT01717638|540161591|FG003|Overall Study|Withdrawal by Subject|0|||
149734189|NCT01717638|540161592|FG004|Overall Study|Withdrawal by Subject|1|||
149734190|NCT01717638|540161593|FG005|Overall Study|Withdrawal by Subject|0|||
149734191|NCT01717638|540161594|FG006|Overall Study|Withdrawal by Subject|2|||
149734192|NCT01717638|540161595|FG007|Overall Study|Withdrawal by Subject|1|||
149734193|NCT01717638|540161596|FG008|Overall Study|Withdrawal by Subject|2|||
149734194|NCT01717638|540161597|FG009|Overall Study|Withdrawal by Subject|1|||
149734195|NCT01717638|540161598|FG010|Overall Study|Withdrawal by Subject|0|||
149734196|NCT01717638|540161599|FG011|Overall Study|Withdrawal by Subject|0|||
149734197|NCT01717638|540161600|FG012|Overall Study|Withdrawal by Subject|18|||
149734198|NCT01719757|540161602|FG000|Overall Study|Adverse Event|38|||
149734199|NCT01719757|540161602|FG000|Overall Study|Withdrawal by Subject|15|||
149734200|NCT01719757|540161602|FG000|Overall Study|Lost to Follow-up|20|||
149734201|NCT01719757|540161602|FG000|Overall Study|Protocol Violation|1|||
149734202|NCT01719757|540161602|FG000|Overall Study|well controlled pain|27|||
149734203|NCT02626338|540161603|FG000|Overall Study|Lack of Efficacy|3|||
149734204|NCT02626338|540161604|FG001|Overall Study|Lack of Efficacy|2|||
149734205|NCT02626338|540161605|FG002|Overall Study|Lack of Efficacy|0|||
149734206|NCT03312218|540161611|FG000|Overall Study|Never signed in to access the app|54|||
149734207|NCT03312218|540161612|FG001|Overall Study|Never signed in to access the app|58|||
149734208|NCT01901224|540161613|FG000|Overall Study|study was not funded and terminated|2|||
149734209|NCT00103012|540161617|FG000|Overall Study|Withdrawal by Subject|2|||
149734210|NCT00103012|540161618|FG001|Overall Study|Withdrawal by Subject|1|||
149734211|NCT00103012|540161619|FG002|Overall Study|Withdrawal by Subject|2|||
149734212|NCT00103012|540161617|FG000|Overall Study|Pregnancy|1|||
149734213|NCT00103012|540161618|FG001|Overall Study|Pregnancy|0|||
149734214|NCT00103012|540161619|FG002|Overall Study|Pregnancy|0|||
149734215|NCT00103012|540161617|FG000|Overall Study|Adverse Event|0|||
149734216|NCT00103012|540161618|FG001|Overall Study|Adverse Event|0|||
149734217|NCT00103012|540161619|FG002|Overall Study|Adverse Event|1|||
149734218|NCT00103012|540161617|FG000|Overall Study|Subject non-compliant with medications|0|||
149734219|NCT00103012|540161618|FG001|Overall Study|Subject non-compliant with medications|0|||
149734220|NCT00103012|540161619|FG002|Overall Study|Subject non-compliant with medications|1|||
149734221|NCT05211336|540161622|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
149734222|NCT05211336|540161623|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
149734223|NCT05211336|540161622|FG000|Overall Study|Progressive disease|0|||
149734224|NCT05211336|540161623|FG001|Overall Study|Progressive disease|4|||
149734225|NCT05211336|540161622|FG000|Overall Study|Death due to myocardial infarction|0|||
149734226|NCT05211336|540161623|FG001|Overall Study|Death due to myocardial infarction|1|||
149734227|NCT05211336|540161622|FG000|Overall Study|Death due to unknown cause|0|||
149734228|NCT05211336|540161623|FG001|Overall Study|Death due to unknown cause|1|||
149734229|NCT05211336|540161622|FG000|Overall Study|Worsening kidney function and quality of response|0|||
149734230|NCT05211336|540161623|FG001|Overall Study|Worsening kidney function and quality of response|1|||
149734231|NCT00393718|540161627|FG000|Overall Study|Adverse Event|20|||
149734232|NCT00393718|540161628|FG001|Overall Study|Adverse Event|8|||
149734233|NCT00393718|540161627|FG000|Overall Study|Protocol Violation|1|||
149734234|NCT00393718|540161628|FG001|Overall Study|Protocol Violation|2|||
149734235|NCT00393718|540161627|FG000|Overall Study|Lack of Efficacy|10|||
149734236|NCT00393718|540161628|FG001|Overall Study|Lack of Efficacy|9|||
149734237|NCT00393718|540161627|FG000|Overall Study|Hypoglycaemia|3|||
149734238|NCT00393718|540161628|FG001|Overall Study|Hypoglycaemia|2|||
149734239|NCT00393718|540161627|FG000|Overall Study|Subject decision|5|||
149734240|NCT00393718|540161628|FG001|Overall Study|Subject decision|0|||
149734241|NCT00393718|540161627|FG000|Overall Study|Withdrawal of consent|2|||
149734242|NCT00393718|540161628|FG001|Overall Study|Withdrawal of consent|1|||
149734243|NCT00393718|540161627|FG000|Overall Study|Missed measurement|1|||
150254978|NCT03541174|542070529|FG004|Part 2 Single-Blind|Other reasons|0|||
150254979|NCT03541174|542070530|FG005|Part 2 Single-Blind|Other reasons|0|||
150254980|NCT03541174|542070525|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149734244|NCT00393718|540161628|FG001|Overall Study|Missed measurement|0|||
149734245|NCT00393718|540161627|FG000|Overall Study|Move|1|||
149734246|NCT00393718|540161628|FG001|Overall Study|Move|0|||
149734247|NCT01084551|540161630|FG000|Overall Study|Adverse Event|2|||
149734248|NCT01084551|540161631|FG001|Overall Study|Adverse Event|9|||
149734249|NCT01084551|540161632|FG002|Overall Study|Adverse Event|4|||
149734250|NCT01084551|540161630|FG000|Overall Study|Lack of Efficacy|2|||
149734251|NCT01084551|540161631|FG001|Overall Study|Lack of Efficacy|0|||
149734252|NCT01084551|540161632|FG002|Overall Study|Lack of Efficacy|1|||
149734253|NCT01084551|540161630|FG000|Overall Study|Withdrawal by Subject|2|||
149734254|NCT01084551|540161631|FG001|Overall Study|Withdrawal by Subject|1|||
149734255|NCT01084551|540161632|FG002|Overall Study|Withdrawal by Subject|0|||
149734256|NCT01084551|540161630|FG000|Overall Study|Protocol Violation|2|||
149734257|NCT01084551|540161631|FG001|Overall Study|Protocol Violation|4|||
149734258|NCT01084551|540161632|FG002|Overall Study|Protocol Violation|0|||
149734259|NCT01084551|540161630|FG000|Overall Study|Lost to Follow-up|0|||
149734260|NCT01084551|540161631|FG001|Overall Study|Lost to Follow-up|0|||
149734261|NCT01084551|540161632|FG002|Overall Study|Lost to Follow-up|3|||
149734262|NCT01084551|540161630|FG000|Overall Study|Physician Decision|1|||
149734263|NCT01084551|540161631|FG001|Overall Study|Physician Decision|0|||
149734264|NCT01084551|540161632|FG002|Overall Study|Physician Decision|0|||
149734265|NCT04684420|540161633|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149734266|NCT04684420|540161634|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149734267|NCT04684420|540161635|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
149734268|NCT04684420|540161636|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
149734269|NCT04684420|540161633|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
149734270|NCT04684420|540161634|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
149734271|NCT04684420|540161635|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
149734272|NCT04684420|540161636|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
149734273|NCT00463476|540161637|FG000|Overall Study|Withdrawal by Subject|1|||
149734274|NCT00463476|540161638|FG001|Overall Study|Withdrawal by Subject|2|||
149734275|NCT00463476|540161637|FG000|Overall Study|Lost to Follow-up|1|||
149734276|NCT00463476|540161638|FG001|Overall Study|Lost to Follow-up|1|||
149734277|NCT00988247|540161640|FG000|Overall Study|Adverse Event|17|||
149734278|NCT00988247|540161641|FG001|Overall Study|Adverse Event|3|||
149734279|NCT00988247|540161640|FG000|Overall Study|Withdrawal by Subject|44|||
149734280|NCT00988247|540161641|FG001|Overall Study|Withdrawal by Subject|13|||
149734281|NCT00988247|540161640|FG000|Overall Study|Pregnancy|1|||
149734282|NCT00988247|540161641|FG001|Overall Study|Pregnancy|2|||
149734283|NCT00988247|540161640|FG000|Overall Study|Lost to Follow-up|11|||
149734284|NCT00988247|540161641|FG001|Overall Study|Lost to Follow-up|2|||
149734285|NCT00988247|540161640|FG000|Overall Study|Protocol Violation|4|||
149734286|NCT00988247|540161641|FG001|Overall Study|Protocol Violation|5|||
149734287|NCT00988247|540161640|FG000|Overall Study|Sponsor requested withdrawal|3|||
149734288|NCT00988247|540161641|FG001|Overall Study|Sponsor requested withdrawal|1|||
149734289|NCT00988247|540161640|FG000|Overall Study|Other|3|||
149734290|NCT00988247|540161641|FG001|Overall Study|Other|0|||
149734291|NCT01703000|540161642|FG000|Overall Study|Death|1|||
149734292|NCT00434967|540161643|FG000|Overall Study|Adverse Event|2|||
149734293|NCT00434967|540161644|FG001|Overall Study|Adverse Event|4|||
149734294|NCT00434967|540161645|FG002|Overall Study|Adverse Event|3|||
149734295|NCT00434967|540161646|FG003|Overall Study|Adverse Event|3|||
149734296|NCT00434967|540161643|FG000|Overall Study|Lost to Follow-up|0|||
149734297|NCT00434967|540161644|FG001|Overall Study|Lost to Follow-up|0|||
149734298|NCT00434967|540161645|FG002|Overall Study|Lost to Follow-up|1|||
149734299|NCT00434967|540161646|FG003|Overall Study|Lost to Follow-up|0|||
149734300|NCT00434967|540161643|FG000|Overall Study|Withdrawal by Subject|2|||
149734301|NCT00434967|540161644|FG001|Overall Study|Withdrawal by Subject|2|||
149734302|NCT00434967|540161645|FG002|Overall Study|Withdrawal by Subject|4|||
149734303|NCT00434967|540161646|FG003|Overall Study|Withdrawal by Subject|6|||
149734304|NCT00434967|540161643|FG000|Overall Study|Randomized in error|0|||
149734305|NCT00434967|540161644|FG001|Overall Study|Randomized in error|0|||
149734306|NCT00434967|540161645|FG002|Overall Study|Randomized in error|0|||
149734307|NCT00434967|540161646|FG003|Overall Study|Randomized in error|1|||
149734308|NCT00434967|540161643|FG000|Overall Study|Protocol Violation|0|||
149734309|NCT00434967|540161644|FG001|Overall Study|Protocol Violation|1|||
149734310|NCT00434967|540161645|FG002|Overall Study|Protocol Violation|0|||
149734311|NCT00434967|540161646|FG003|Overall Study|Protocol Violation|1|||
149734312|NCT00434967|540161643|FG000|Overall Study|Physician Decision|1|||
149734313|NCT00434967|540161644|FG001|Overall Study|Physician Decision|1|||
149734314|NCT00434967|540161645|FG002|Overall Study|Physician Decision|1|||
149734315|NCT00434967|540161646|FG003|Overall Study|Physician Decision|0|||
149734316|NCT00434967|540161643|FG000|Overall Study|Patient Disposition Challenges|2|||
149734317|NCT00434967|540161644|FG001|Overall Study|Patient Disposition Challenges|0|||
149734318|NCT00434967|540161645|FG002|Overall Study|Patient Disposition Challenges|0|||
149734319|NCT00434967|540161646|FG003|Overall Study|Patient Disposition Challenges|3|||
150254981|NCT03541174|542070526|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149734320|NCT01551693|540161651|FG000|Overall Study|Disease Progression|1|||
149734321|NCT01551693|540161652|FG001|Overall Study|Disease Progression|0|||
149734322|NCT01551693|540161651|FG000|Overall Study|Adverse Event|0|||
149734323|NCT01551693|540161652|FG001|Overall Study|Adverse Event|1|||
149734324|NCT01551693|540161651|FG000|Overall Study|Withdrawal by Subject|0|||
149734325|NCT01551693|540161652|FG001|Overall Study|Withdrawal by Subject|1|||
149734326|NCT01838044|540161653|FG000|Overall Study|Adverse Event|4|||
149734327|NCT01838044|540161654|FG001|Overall Study|Adverse Event|6|||
149734328|NCT01838044|540161653|FG000|Overall Study|Protocol Violation|3|||
149734329|NCT01838044|540161654|FG001|Overall Study|Protocol Violation|3|||
149734330|NCT01838044|540161653|FG000|Overall Study|Withdrawal by Subject|0|||
149734331|NCT01838044|540161654|FG001|Overall Study|Withdrawal by Subject|2|||
149734332|NCT01838044|540161653|FG000|Overall Study|Insufficient clinical response|1|||
149734333|NCT01838044|540161654|FG001|Overall Study|Insufficient clinical response|2|||
149734334|NCT01838044|540161653|FG000|Overall Study|Medication error without associated AE|0|||
149734335|NCT01838044|540161654|FG001|Overall Study|Medication error without associated AE|1|||
149734336|NCT01838044|540161653|FG000|Overall Study|Lost to Follow-up|0|||
149734337|NCT01838044|540161654|FG001|Overall Study|Lost to Follow-up|2|||
149734338|NCT00737529|540161659|FG000|Overall Study|Disease Progression|95|||
149734339|NCT00737529|540161659|FG000|Overall Study|Adverse Event|24|||
149734340|NCT00737529|540161659|FG000|Overall Study|Withdrawal by Subject|5|||
149734341|NCT00737529|540161659|FG000|Overall Study|Death|4|||
149734342|NCT00737529|540161659|FG000|Overall Study|Protocol Violation|1|||
149734343|NCT00737529|540161659|FG000|Overall Study|Other|4|||
149734344|NCT00565617|540161660|FG000|Overall Study|Withdrawal by Subject|1|||
149734345|NCT04666038|540161663|FG000|Overall Study|Progressive Disease|2|||
149734346|NCT04666038|540161664|FG001|Overall Study|Progressive Disease|0|||
149734347|NCT04666038|540161663|FG000|Overall Study|Death|38|||
149734348|NCT04666038|540161664|FG001|Overall Study|Death|32|||
149734349|NCT04666038|540161663|FG000|Overall Study|Withdrawal by Subject|10|||
149734350|NCT04666038|540161664|FG001|Overall Study|Withdrawal by Subject|19|||
149734351|NCT04666038|540161663|FG000|Overall Study|Lost to Follow-up|0|||
149734352|NCT04666038|540161664|FG001|Overall Study|Lost to Follow-up|2|||
149734353|NCT04666038|540161663|FG000|Overall Study|On Study Treatment|46|||
149734354|NCT04666038|540161664|FG001|Overall Study|On Study Treatment|5|||
149734355|NCT04666038|540161663|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
149734356|NCT04666038|540161664|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
149734357|NCT02658812|540161665|FG000|Overall Study|Disease Progression|7|||
149734358|NCT02658812|540161665|FG000|Overall Study|Unrelated to study treatment|1|||
149734359|NCT02658812|540161665|FG000|Overall Study|Adverse Event|1|||
149734360|NCT01512264|540161668|FG000|Overall Study|Lost to Follow-up|0|||
149734361|NCT01512264|540161669|FG001|Overall Study|Lost to Follow-up|0|||
149734362|NCT01512264|540161670|FG002|Overall Study|Lost to Follow-up|0|||
149734363|NCT01512264|540161671|FG003|Overall Study|Lost to Follow-up|1|||
149734364|NCT01194440|540161672|FG000|Baseline (First Dose)|Reason not specified|4|||
149734365|NCT01194440|540161672|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
149734366|NCT01194440|540161672|FG000|Baseline (First Dose)|Change in therapy|1|||
149734367|NCT01194440|540161672|FG000|Baseline (First Dose)|Adverse Event|1|||
149734368|NCT01194440|540161672|FG000|6-months (2nd Dose)|Change in therapy|4|||
149734369|NCT01931059|540161673|FG000|Day 1|Pregnancy|0|||
149734370|NCT01931059|540161674|FG001|Day 1|Pregnancy|1|||
149734371|NCT01931059|540161673|FG000|Day3|Lost to Follow-up|1|||
149734372|NCT01931059|540161674|FG001|Day3|Lost to Follow-up|0|||
149734373|NCT04957290|540161684|FG000|Overall Study|Progressive disease|3|||
149734374|NCT04957290|540161685|FG001|Overall Study|Progressive disease|3|||
149734375|NCT04957290|540161686|FG002|Overall Study|Progressive disease|2|||
149734376|NCT04957290|540161687|FG003|Overall Study|Progressive disease|0|||
149734377|NCT04957290|540161688|FG004|Overall Study|Progressive disease|0|||
149734378|NCT04957290|540161689|FG005|Overall Study|Progressive disease|0|||
149734379|NCT04957290|540161684|FG000|Overall Study|Withdrawal by Subject|1|||
149734380|NCT04957290|540161685|FG001|Overall Study|Withdrawal by Subject|0|||
149734381|NCT04957290|540161686|FG002|Overall Study|Withdrawal by Subject|1|||
149734382|NCT04957290|540161687|FG003|Overall Study|Withdrawal by Subject|0|||
149734383|NCT04957290|540161688|FG004|Overall Study|Withdrawal by Subject|0|||
149734384|NCT04957290|540161689|FG005|Overall Study|Withdrawal by Subject|0|||
149734385|NCT04957290|540161684|FG000|Overall Study|Death|0|||
149734386|NCT04957290|540161685|FG001|Overall Study|Death|2|||
149734387|NCT04957290|540161686|FG002|Overall Study|Death|1|||
149734388|NCT04957290|540161687|FG003|Overall Study|Death|0|||
149734389|NCT04957290|540161688|FG004|Overall Study|Death|0|||
149734390|NCT04957290|540161689|FG005|Overall Study|Death|0|||
149734391|NCT04957290|540161684|FG000|Overall Study|non compliance with study drug|0|||
149734392|NCT04957290|540161685|FG001|Overall Study|non compliance with study drug|1|||
149734393|NCT04957290|540161686|FG002|Overall Study|non compliance with study drug|0|||
149734394|NCT04957290|540161687|FG003|Overall Study|non compliance with study drug|0|||
149734395|NCT04957290|540161688|FG004|Overall Study|non compliance with study drug|0|||
149734396|NCT04957290|540161689|FG005|Overall Study|non compliance with study drug|0|||
149734397|NCT04957290|540161684|FG000|Overall Study|none specified.|0|||
149734398|NCT04957290|540161685|FG001|Overall Study|none specified.|1|||
149734399|NCT04957290|540161686|FG002|Overall Study|none specified.|2|||
149734400|NCT04957290|540161687|FG003|Overall Study|none specified.|0|||
149734401|NCT04957290|540161688|FG004|Overall Study|none specified.|0|||
149734402|NCT04957290|540161689|FG005|Overall Study|none specified.|0|||
149734403|NCT04957290|540161684|FG000|Overall Study|unacceptable toxicity|0|||
149734404|NCT04957290|540161685|FG001|Overall Study|unacceptable toxicity|0|||
149734405|NCT04957290|540161686|FG002|Overall Study|unacceptable toxicity|1|||
149734406|NCT04957290|540161687|FG003|Overall Study|unacceptable toxicity|0|||
149734407|NCT04957290|540161688|FG004|Overall Study|unacceptable toxicity|0|||
149734408|NCT04957290|540161689|FG005|Overall Study|unacceptable toxicity|0|||
149734409|NCT04957290|540161684|FG000|Overall Study|Adverse Event|0|||
149734410|NCT04957290|540161685|FG001|Overall Study|Adverse Event|0|||
149734411|NCT04957290|540161686|FG002|Overall Study|Adverse Event|1|||
149734412|NCT04957290|540161687|FG003|Overall Study|Adverse Event|0|||
149734413|NCT04957290|540161688|FG004|Overall Study|Adverse Event|0|||
149734414|NCT04957290|540161689|FG005|Overall Study|Adverse Event|0|||
149734415|NCT04957290|540161684|FG000|Overall Study|study terminated by sponsor|0|||
149734416|NCT04957290|540161685|FG001|Overall Study|study terminated by sponsor|0|||
149734417|NCT04957290|540161686|FG002|Overall Study|study terminated by sponsor|2|||
149734418|NCT04957290|540161687|FG003|Overall Study|study terminated by sponsor|0|||
149734419|NCT04957290|540161688|FG004|Overall Study|study terminated by sponsor|0|||
149734420|NCT04957290|540161689|FG005|Overall Study|study terminated by sponsor|0|||
149734421|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734422|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734423|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734424|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
149734425|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734426|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
149734427|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734428|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734429|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734430|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734431|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734432|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734433|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734434|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734435|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734436|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734437|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734438|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734439|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734440|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734441|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734442|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734443|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149734444|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149734445|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
149734446|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149734447|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
149734448|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149734449|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149734450|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149734451|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734452|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734453|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734454|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734455|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734456|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734457|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734458|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734459|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734460|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734461|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734462|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734463|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734464|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734465|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734466|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149734467|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149734468|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
149734469|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149734470|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
149734471|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
149734472|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
149734473|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149734474|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149734475|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734476|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734477|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734478|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734479|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734480|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734481|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734482|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734483|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734484|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734485|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734486|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734487|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734488|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734489|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149734490|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734491|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734492|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
149734493|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734494|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
149734495|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734496|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734497|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734498|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734499|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734500|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734501|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734502|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734503|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734504|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734505|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734506|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734507|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734508|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734509|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734510|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734511|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734512|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149734513|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
149734514|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734515|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734516|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
149734517|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734518|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734519|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734520|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734521|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734522|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734523|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734524|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734525|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734526|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734527|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734528|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734529|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734530|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734531|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734532|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734533|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734534|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734535|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149734536|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734537|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734538|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
149734539|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734540|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734541|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734542|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734543|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734544|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734545|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734546|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734547|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734548|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734549|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734550|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734551|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734552|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734553|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734554|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734555|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734556|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734557|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734558|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149734559|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734560|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734561|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
149734562|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734563|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734564|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734565|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734566|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734567|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734568|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734569|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734570|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734571|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734572|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734573|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734574|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734575|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734576|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734577|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734578|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734579|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734580|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734581|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149734582|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734583|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734584|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734585|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
149734586|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734587|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734588|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734589|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734590|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734591|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734592|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734593|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734594|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734595|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734596|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734597|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734598|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734599|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
150254982|NCT03541174|542070527|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
150254983|NCT03541174|542070528|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149734600|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734601|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734602|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734603|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734604|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149734605|NCT00896532|540161690|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734606|NCT00896532|540161691|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149734607|NCT00896532|540161692|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734608|NCT00896532|540161693|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149734609|NCT00896532|540161694|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149734610|NCT00896532|540161695|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734611|NCT00896532|540161696|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734612|NCT00896532|540161697|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734613|NCT00896532|540161698|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734614|NCT00896532|540161699|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734615|NCT00896532|540161700|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734616|NCT00896532|540161701|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734617|NCT00896532|540161702|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734618|NCT00896532|540161703|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734619|NCT00896532|540161704|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734620|NCT00896532|540161705|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734621|NCT00896532|540161706|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734622|NCT00896532|540161707|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734623|NCT00896532|540161708|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734624|NCT00896532|540161709|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734625|NCT00896532|540161710|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734626|NCT00896532|540161711|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734627|NCT00896532|540161712|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149734628|NCT00896532|540161690|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734629|NCT00896532|540161691|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734630|NCT00896532|540161692|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734631|NCT00896532|540161693|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734632|NCT00896532|540161694|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734633|NCT00896532|540161695|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734634|NCT00896532|540161696|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734635|NCT00896532|540161697|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734636|NCT00896532|540161698|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
149734637|NCT00896532|540161699|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734638|NCT00896532|540161700|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734639|NCT00896532|540161701|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734640|NCT00896532|540161702|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734641|NCT00896532|540161703|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734642|NCT00896532|540161704|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734643|NCT00896532|540161705|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734644|NCT00896532|540161706|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734645|NCT00896532|540161707|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734646|NCT00896532|540161708|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734647|NCT00896532|540161709|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734648|NCT00896532|540161710|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734649|NCT00896532|540161711|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734650|NCT00896532|540161712|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149734651|NCT00896532|540161690|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734652|NCT00896532|540161691|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734653|NCT00896532|540161692|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734654|NCT00896532|540161693|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734655|NCT00896532|540161694|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734656|NCT00896532|540161695|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734657|NCT00896532|540161696|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734658|NCT00896532|540161697|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734659|NCT00896532|540161698|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734660|NCT00896532|540161699|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734661|NCT00896532|540161700|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
150254984|NCT03541174|542070529|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
150254985|NCT03541174|542070530|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
150254986|NCT03541174|542070525|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149734662|NCT00896532|540161701|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734663|NCT00896532|540161702|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
149734664|NCT00896532|540161703|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734665|NCT00896532|540161704|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734666|NCT00896532|540161705|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734667|NCT00896532|540161706|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734668|NCT00896532|540161707|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734669|NCT00896532|540161708|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734670|NCT00896532|540161709|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734671|NCT00896532|540161710|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734672|NCT00896532|540161711|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734673|NCT00896532|540161712|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149734674|NCT00896532|540161690|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734675|NCT00896532|540161691|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734676|NCT00896532|540161692|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734677|NCT00896532|540161693|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734678|NCT00896532|540161694|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734679|NCT00896532|540161695|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734680|NCT00896532|540161696|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734681|NCT00896532|540161697|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734682|NCT00896532|540161698|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734683|NCT00896532|540161699|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734684|NCT00896532|540161700|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
149734685|NCT00896532|540161701|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734686|NCT00896532|540161702|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
149734687|NCT00896532|540161703|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734688|NCT00896532|540161704|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734689|NCT00896532|540161705|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734690|NCT00896532|540161706|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734691|NCT00896532|540161707|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734692|NCT00896532|540161708|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734693|NCT00896532|540161709|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734694|NCT00896532|540161710|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734695|NCT00896532|540161711|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734696|NCT00896532|540161712|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149734697|NCT00896532|540161690|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734698|NCT00896532|540161691|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734699|NCT00896532|540161692|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734700|NCT00896532|540161693|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734701|NCT00896532|540161694|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734702|NCT00896532|540161695|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734703|NCT00896532|540161696|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734704|NCT00896532|540161697|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734705|NCT00896532|540161698|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734706|NCT00896532|540161699|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734707|NCT00896532|540161700|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734708|NCT00896532|540161701|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734709|NCT00896532|540161702|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
149734710|NCT00896532|540161703|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
149734711|NCT00896532|540161704|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734712|NCT00896532|540161705|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734713|NCT00896532|540161706|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734714|NCT00896532|540161707|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734715|NCT00896532|540161708|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734716|NCT00896532|540161709|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734717|NCT00896532|540161710|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734718|NCT00896532|540161711|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734719|NCT00896532|540161712|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149734720|NCT00896532|540161690|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
149734721|NCT00896532|540161691|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
149734722|NCT00896532|540161692|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
150254987|NCT03541174|542070526|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
150254988|NCT03541174|542070527|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
150254989|NCT03541174|542070528|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149734723|NCT00896532|540161693|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
149734724|NCT00896532|540161694|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
149734725|NCT00896532|540161695|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
149734726|NCT00896532|540161696|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
149734727|NCT00896532|540161697|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
149734728|NCT00896532|540161698|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
149734729|NCT00896532|540161699|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
149734730|NCT00896532|540161700|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
149734731|NCT00896532|540161701|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
149734732|NCT00896532|540161702|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
149734733|NCT00896532|540161703|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
149734734|NCT00896532|540161704|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
149734735|NCT00896532|540161705|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
149734736|NCT00896532|540161706|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
149734737|NCT00896532|540161707|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
149734738|NCT00896532|540161708|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
149734739|NCT00896532|540161709|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
149734740|NCT00896532|540161710|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
149734741|NCT00896532|540161711|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
149734742|NCT00896532|540161712|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
149734743|NCT00896532|540161690|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734744|NCT00896532|540161691|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734745|NCT00896532|540161692|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734746|NCT00896532|540161693|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734747|NCT00896532|540161694|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734748|NCT00896532|540161695|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734749|NCT00896532|540161696|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
150254990|NCT03541174|542070529|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
150254991|NCT03541174|542070530|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
150254992|NCT03541174|542070525|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
150254993|NCT03541174|542070526|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
150254994|NCT03541174|542070527|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
150254995|NCT03541174|542070528|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149734750|NCT00896532|540161697|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734751|NCT00896532|540161698|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734752|NCT00896532|540161699|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734753|NCT00896532|540161700|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734754|NCT00896532|540161701|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734755|NCT00896532|540161702|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734756|NCT00896532|540161703|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734757|NCT00896532|540161704|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734758|NCT00896532|540161705|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
149734759|NCT00896532|540161706|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
149734760|NCT00896532|540161707|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734761|NCT00896532|540161708|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734762|NCT00896532|540161709|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734763|NCT00896532|540161710|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734764|NCT00896532|540161711|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734765|NCT00896532|540161712|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149734766|NCT00896532|540161690|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734767|NCT00896532|540161691|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734768|NCT00896532|540161692|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
150254996|NCT03541174|542070529|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
150254997|NCT03541174|542070530|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
150254998|NCT03541174|542070525|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
150254999|NCT03541174|542070526|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
150255000|NCT03541174|542070527|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
150255001|NCT03541174|542070528|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
150255002|NCT03541174|542070529|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
150255003|NCT03541174|542070530|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
150255004|NCT03541174|542070525|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
150255005|NCT03541174|542070526|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
150255006|NCT03541174|542070527|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
150255007|NCT03541174|542070528|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
150255008|NCT03541174|542070529|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
150255009|NCT03541174|542070530|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149734769|NCT00896532|540161693|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734770|NCT00896532|540161694|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734771|NCT00896532|540161695|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734772|NCT00896532|540161696|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734773|NCT00896532|540161697|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734774|NCT00896532|540161698|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734775|NCT00896532|540161699|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734776|NCT00896532|540161700|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734777|NCT00896532|540161701|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734778|NCT00896532|540161702|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734779|NCT00896532|540161703|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734780|NCT00896532|540161704|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734781|NCT00896532|540161705|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
149734782|NCT00896532|540161706|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
149734783|NCT00896532|540161707|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
149734784|NCT00896532|540161708|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734785|NCT00896532|540161709|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734786|NCT00896532|540161710|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734787|NCT00896532|540161711|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734788|NCT00896532|540161712|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149734789|NCT00896532|540161690|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734790|NCT00896532|540161691|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734791|NCT00896532|540161692|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734792|NCT00896532|540161693|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734793|NCT00896532|540161694|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734794|NCT00896532|540161695|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734795|NCT00896532|540161696|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734796|NCT00896532|540161697|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734797|NCT00896532|540161698|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734798|NCT00896532|540161699|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734799|NCT00896532|540161700|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734800|NCT00896532|540161701|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734801|NCT00896532|540161702|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734802|NCT00896532|540161703|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734803|NCT00896532|540161704|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734804|NCT00896532|540161705|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734805|NCT00896532|540161706|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
149734806|NCT00896532|540161707|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734807|NCT00896532|540161708|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734808|NCT00896532|540161709|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734809|NCT00896532|540161710|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734810|NCT00896532|540161711|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734811|NCT00896532|540161712|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149734812|NCT00896532|540161690|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
149734813|NCT00896532|540161691|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
149734814|NCT00896532|540161692|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
149734815|NCT00896532|540161693|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
149734816|NCT00896532|540161694|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
149734817|NCT00896532|540161695|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
149734818|NCT00896532|540161696|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
149734819|NCT00896532|540161697|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
149734820|NCT00896532|540161698|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
149734821|NCT00896532|540161699|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
149734822|NCT00896532|540161700|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
149734823|NCT00896532|540161701|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
149734824|NCT00896532|540161702|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
149734825|NCT00896532|540161703|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
149734826|NCT00896532|540161704|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
149734827|NCT00896532|540161705|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
149734828|NCT00896532|540161706|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
149734829|NCT00896532|540161707|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
149734830|NCT00896532|540161708|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
149734831|NCT00896532|540161709|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
149734832|NCT00896532|540161710|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
149734833|NCT00896532|540161711|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
149734834|NCT00896532|540161712|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
149734835|NCT00896532|540161690|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734836|NCT00896532|540161691|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734837|NCT00896532|540161692|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734838|NCT00896532|540161693|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734839|NCT00896532|540161694|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734840|NCT00896532|540161695|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734841|NCT00896532|540161696|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734842|NCT00896532|540161697|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734843|NCT00896532|540161698|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734844|NCT00896532|540161699|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734845|NCT00896532|540161700|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734846|NCT00896532|540161701|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734847|NCT00896532|540161702|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734848|NCT00896532|540161703|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734849|NCT00896532|540161704|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734850|NCT00896532|540161705|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734851|NCT00896532|540161706|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
149734852|NCT00896532|540161707|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734853|NCT00896532|540161708|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734854|NCT00896532|540161709|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734855|NCT00896532|540161710|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734856|NCT00896532|540161711|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734857|NCT00896532|540161712|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149734858|NCT00896532|540161690|FG000|Months 48-72: Follow-on Phase|Death|0|||
149734859|NCT00896532|540161691|FG001|Months 48-72: Follow-on Phase|Death|0|||
149734860|NCT00896532|540161692|FG002|Months 48-72: Follow-on Phase|Death|0|||
149734861|NCT00896532|540161693|FG003|Months 48-72: Follow-on Phase|Death|0|||
149734862|NCT00896532|540161694|FG004|Months 48-72: Follow-on Phase|Death|0|||
149734863|NCT00896532|540161695|FG005|Months 48-72: Follow-on Phase|Death|0|||
149734864|NCT00896532|540161696|FG006|Months 48-72: Follow-on Phase|Death|0|||
149734865|NCT00896532|540161697|FG007|Months 48-72: Follow-on Phase|Death|0|||
149734866|NCT00896532|540161698|FG008|Months 48-72: Follow-on Phase|Death|0|||
149734867|NCT00896532|540161699|FG009|Months 48-72: Follow-on Phase|Death|0|||
149734868|NCT00896532|540161700|FG010|Months 48-72: Follow-on Phase|Death|0|||
149734869|NCT00896532|540161701|FG011|Months 48-72: Follow-on Phase|Death|0|||
149734870|NCT00896532|540161702|FG012|Months 48-72: Follow-on Phase|Death|0|||
149734871|NCT00896532|540161703|FG013|Months 48-72: Follow-on Phase|Death|0|||
149734872|NCT00896532|540161704|FG014|Months 48-72: Follow-on Phase|Death|0|||
149734873|NCT00896532|540161705|FG015|Months 48-72: Follow-on Phase|Death|0|||
149734874|NCT00896532|540161706|FG016|Months 48-72: Follow-on Phase|Death|0|||
149734875|NCT00896532|540161707|FG017|Months 48-72: Follow-on Phase|Death|0|||
149734876|NCT00896532|540161708|FG018|Months 48-72: Follow-on Phase|Death|1|||
149734877|NCT00896532|540161709|FG019|Months 48-72: Follow-on Phase|Death|0|||
149734878|NCT00896532|540161710|FG020|Months 48-72: Follow-on Phase|Death|0|||
149734879|NCT00896532|540161711|FG021|Months 48-72: Follow-on Phase|Death|0|||
149734880|NCT00896532|540161712|FG022|Months 48-72: Follow-on Phase|Death|0|||
149734881|NCT00896532|540161690|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734882|NCT00896532|540161691|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734883|NCT00896532|540161692|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734884|NCT00896532|540161693|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734885|NCT00896532|540161694|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734886|NCT00896532|540161695|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734887|NCT00896532|540161696|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734888|NCT00896532|540161697|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734889|NCT00896532|540161698|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734890|NCT00896532|540161699|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734891|NCT00896532|540161700|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734892|NCT00896532|540161701|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734893|NCT00896532|540161702|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734894|NCT00896532|540161703|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734895|NCT00896532|540161704|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734896|NCT00896532|540161705|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734897|NCT00896532|540161706|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734898|NCT00896532|540161707|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734899|NCT00896532|540161708|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
150255010|NCT00605215|542070531|FG000|Overall Study|Death|0|||
149734900|NCT00896532|540161709|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734901|NCT00896532|540161710|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734902|NCT00896532|540161711|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
149734903|NCT00896532|540161712|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149734904|NCT00896532|540161690|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734905|NCT00896532|540161691|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734906|NCT00896532|540161692|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734907|NCT00896532|540161693|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734908|NCT00896532|540161694|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734909|NCT00896532|540161695|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734910|NCT00896532|540161696|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734911|NCT00896532|540161697|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734912|NCT00896532|540161698|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734913|NCT00896532|540161699|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734914|NCT00896532|540161700|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734915|NCT00896532|540161701|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734916|NCT00896532|540161702|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734917|NCT00896532|540161703|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734918|NCT00896532|540161704|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734919|NCT00896532|540161705|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734920|NCT00896532|540161706|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734921|NCT00896532|540161707|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734922|NCT00896532|540161708|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734923|NCT00896532|540161709|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734924|NCT00896532|540161710|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734925|NCT00896532|540161711|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
149734926|NCT00896532|540161712|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149734927|NCT03686969|540161713|FG000|Overall Study|Study terminated|1|||
149734928|NCT03686969|540161714|FG001|Overall Study|Study terminated|0|||
149734929|NCT02899156|540161717|FG000|Overall Study|Death|1|||
149734930|NCT02899156|540161718|FG001|Overall Study|Death|0|||
149734931|NCT02899156|540161717|FG000|Overall Study|Physician Decision|0|||
149734932|NCT02899156|540161718|FG001|Overall Study|Physician Decision|1|||
149734933|NCT01468987|540161719|FG000|Overall Study|Adverse Event|12|||
149734934|NCT01468987|540161720|FG001|Overall Study|Adverse Event|9|||
149734935|NCT01468987|540161719|FG000|Overall Study|Death|4|||
149734936|NCT01468987|540161720|FG001|Overall Study|Death|1|||
149734937|NCT01468987|540161719|FG000|Overall Study|Lost to Follow-up|10|||
149734938|NCT01468987|540161720|FG001|Overall Study|Lost to Follow-up|5|||
149734939|NCT01468987|540161719|FG000|Overall Study|Protocol Violation|8|||
149734940|NCT01468987|540161720|FG001|Overall Study|Protocol Violation|2|||
149734941|NCT01468987|540161719|FG000|Overall Study|Withdrawal by Subject|28|||
149734942|NCT01468987|540161720|FG001|Overall Study|Withdrawal by Subject|28|||
149734943|NCT01468987|540161719|FG000|Overall Study|Physician Decision|8|||
149734944|NCT01468987|540161720|FG001|Overall Study|Physician Decision|15|||
149734945|NCT01468987|540161719|FG000|Overall Study|Sponsor Decision|1|||
149734946|NCT01468987|540161720|FG001|Overall Study|Sponsor Decision|0|||
149734947|NCT03430986|540161721|FG000|24-week Control Period|Adverse Event|1|||
149734948|NCT03430986|540161722|FG001|24-week Control Period|Adverse Event|0|||
149734949|NCT03430986|540161721|FG000|24-week Control Period|Lost to Follow-up|2|||
149734950|NCT03430986|540161722|FG001|24-week Control Period|Lost to Follow-up|2|||
149734951|NCT03430986|540161721|FG000|24-week Control Period|Withdrawal by Participant|5|||
149734952|NCT03430986|540161722|FG001|24-week Control Period|Withdrawal by Participant|0|||
149734953|NCT03430986|540161721|FG000|24-week Control Period|Protocol Deviation|0|||
149734954|NCT03430986|540161722|FG001|24-week Control Period|Protocol Deviation|2|||
149734955|NCT03430986|540161721|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
149734956|NCT03430986|540161722|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
149734957|NCT03430986|540161721|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
149734958|NCT03430986|540161722|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
149734959|NCT00484315|540161726|FG000|12-Month Clinical Follow-up|Death|6|||
149734960|NCT00484315|540161727|FG001|12-Month Clinical Follow-up|Death|2|||
149734961|NCT00484315|540161726|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
149734962|NCT00484315|540161727|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
150255011|NCT00605215|542070532|FG001|Overall Study|Death|0|||
150255012|NCT00605215|542070533|FG002|Overall Study|Death|1|||
149734963|NCT00484315|540161726|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
149734964|NCT00484315|540161727|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
150255013|NCT00605215|542070531|FG000|Overall Study|Adverse Event|19|||
149734965|NCT00484315|540161726|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
149734966|NCT00484315|540161727|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
149734967|NCT00484315|540161726|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
149734968|NCT00484315|540161727|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
149734969|NCT00484315|540161726|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
149734970|NCT00484315|540161727|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
149734971|NCT00484315|540161726|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
149734972|NCT00484315|540161727|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
149734973|NCT00943683|540161728|FG000|Overall Study|Adverse Event|3|||
149734974|NCT00943683|540161729|FG001|Overall Study|Adverse Event|3|||
149734975|NCT00943683|540161728|FG000|Overall Study|Lost to Follow-up|1|||
149734976|NCT00943683|540161729|FG001|Overall Study|Lost to Follow-up|1|||
149734977|NCT00943683|540161728|FG000|Overall Study|Protocol Violation|1|||
149734978|NCT00943683|540161729|FG001|Overall Study|Protocol Violation|2|||
149734979|NCT00943683|540161728|FG000|Overall Study|Withdrawal by Subject|1|||
149734980|NCT00943683|540161729|FG001|Overall Study|Withdrawal by Subject|0|||
149734981|NCT00943683|540161728|FG000|Overall Study|Patient Moved|1|||
149734982|NCT00943683|540161729|FG001|Overall Study|Patient Moved|0|||
149734983|NCT03283085|540161748|FG000|Overall Study|Adverse Event|18|||
149734984|NCT03283085|540161749|FG001|Overall Study|Adverse Event|3|||
149734985|NCT03283085|540161750|FG002|Overall Study|Adverse Event|13|||
149734986|NCT03283085|540161751|FG003|Overall Study|Adverse Event|0|||
149734987|NCT03283085|540161752|FG004|Overall Study|Adverse Event|0|||
149734988|NCT03283085|540161753|FG005|Overall Study|Adverse Event|5|||
149734989|NCT03283085|540161748|FG000|Overall Study|Death|0|||
149734990|NCT03283085|540161749|FG001|Overall Study|Death|0|||
149734991|NCT03283085|540161750|FG002|Overall Study|Death|3|||
149734992|NCT03283085|540161751|FG003|Overall Study|Death|1|||
149734993|NCT03283085|540161752|FG004|Overall Study|Death|0|||
149734994|NCT03283085|540161753|FG005|Overall Study|Death|0|||
149734995|NCT03283085|540161748|FG000|Overall Study|Withdrawal by Subject|42|||
149734996|NCT03283085|540161749|FG001|Overall Study|Withdrawal by Subject|21|||
149734997|NCT03283085|540161750|FG002|Overall Study|Withdrawal by Subject|66|||
149734998|NCT03283085|540161751|FG003|Overall Study|Withdrawal by Subject|3|||
149734999|NCT03283085|540161752|FG004|Overall Study|Withdrawal by Subject|3|||
149735000|NCT03283085|540161753|FG005|Overall Study|Withdrawal by Subject|5|||
149735001|NCT03283085|540161748|FG000|Overall Study|Physician Decision|14|||
149735002|NCT03283085|540161749|FG001|Overall Study|Physician Decision|8|||
149735003|NCT03283085|540161750|FG002|Overall Study|Physician Decision|19|||
149735004|NCT03283085|540161751|FG003|Overall Study|Physician Decision|0|||
149735005|NCT03283085|540161752|FG004|Overall Study|Physician Decision|0|||
149735006|NCT03283085|540161753|FG005|Overall Study|Physician Decision|2|||
149735007|NCT03283085|540161748|FG000|Overall Study|Site Terminated by Sponsor|1|||
149735008|NCT03283085|540161749|FG001|Overall Study|Site Terminated by Sponsor|0|||
149735009|NCT03283085|540161750|FG002|Overall Study|Site Terminated by Sponsor|3|||
149735010|NCT03283085|540161751|FG003|Overall Study|Site Terminated by Sponsor|0|||
149735011|NCT03283085|540161752|FG004|Overall Study|Site Terminated by Sponsor|0|||
149735012|NCT03283085|540161753|FG005|Overall Study|Site Terminated by Sponsor|0|||
149735013|NCT03283085|540161748|FG000|Overall Study|Lost to Follow-up|2|||
149735014|NCT03283085|540161749|FG001|Overall Study|Lost to Follow-up|0|||
149735015|NCT03283085|540161750|FG002|Overall Study|Lost to Follow-up|2|||
149735016|NCT03283085|540161751|FG003|Overall Study|Lost to Follow-up|0|||
149735017|NCT03283085|540161752|FG004|Overall Study|Lost to Follow-up|0|||
149735018|NCT03283085|540161753|FG005|Overall Study|Lost to Follow-up|1|||
149735019|NCT03283085|540161748|FG000|Overall Study|Pregnancy|0|||
149735020|NCT03283085|540161749|FG001|Overall Study|Pregnancy|0|||
149735021|NCT03283085|540161750|FG002|Overall Study|Pregnancy|1|||
149735022|NCT03283085|540161751|FG003|Overall Study|Pregnancy|0|||
149735023|NCT03283085|540161752|FG004|Overall Study|Pregnancy|0|||
149735024|NCT03283085|540161753|FG005|Overall Study|Pregnancy|0|||
149735025|NCT03283085|540161748|FG000|Overall Study|Lack of Efficacy|12|||
149735026|NCT03283085|540161749|FG001|Overall Study|Lack of Efficacy|6|||
149735027|NCT03283085|540161750|FG002|Overall Study|Lack of Efficacy|24|||
149735028|NCT03283085|540161751|FG003|Overall Study|Lack of Efficacy|1|||
149735029|NCT03283085|540161752|FG004|Overall Study|Lack of Efficacy|1|||
149735030|NCT03283085|540161753|FG005|Overall Study|Lack of Efficacy|0|||
149735031|NCT03283085|540161748|FG000|Overall Study|Reason not Specified|0|||
149735032|NCT03283085|540161749|FG001|Overall Study|Reason not Specified|4|||
149735033|NCT03283085|540161750|FG002|Overall Study|Reason not Specified|8|||
149735034|NCT03283085|540161751|FG003|Overall Study|Reason not Specified|0|||
149735035|NCT03283085|540161752|FG004|Overall Study|Reason not Specified|0|||
149735036|NCT03283085|540161753|FG005|Overall Study|Reason not Specified|1|||
149735037|NCT02292771|540161754|FG000|Overall Study|Withdrawal by Subject|2|||
149735038|NCT02292771|540161755|FG001|Overall Study|Withdrawal by Subject|1|||
149735039|NCT02292771|540161754|FG000|Overall Study|Lost to Follow-up|2|||
149735040|NCT02292771|540161755|FG001|Overall Study|Lost to Follow-up|1|||
149735041|NCT01468311|540161756|FG000|Overall Study|mobilization failure|1|||
149735042|NCT01468311|540161756|FG000|Overall Study|Withdrawal by Subject|1|||
149735043|NCT05047523|540163750|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149735044|NCT05047523|540163751|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149735045|NCT05047523|540163752|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
149735046|NCT05047523|540163753|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149735047|NCT05047523|540163754|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149735048|NCT05047523|540163755|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149735049|NCT05047523|540163750|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149735050|NCT05047523|540163751|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
149735051|NCT05047523|540163752|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149735052|NCT05047523|540163753|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149735053|NCT05047523|540163754|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149735054|NCT05047523|540163755|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149735055|NCT05047523|540163750|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
149735056|NCT05047523|540163751|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
149735057|NCT05047523|540163752|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
149735058|NCT05047523|540163753|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
149735059|NCT05047523|540163754|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
149735060|NCT05047523|540163755|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
149735061|NCT05047523|540163750|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
149735062|NCT05047523|540163751|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149735063|NCT05047523|540163752|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149735064|NCT05047523|540163753|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149735065|NCT05047523|540163754|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149735066|NCT05047523|540163755|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149735067|NCT05047523|540163750|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149735068|NCT05047523|540163751|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149735069|NCT05047523|540163752|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149735070|NCT05047523|540163753|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149735071|NCT05047523|540163754|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
149735072|NCT05047523|540163755|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
149735073|NCT05047523|540163750|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
149735074|NCT05047523|540163751|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
149735075|NCT05047523|540163752|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
149735076|NCT05047523|540163753|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
149735077|NCT05047523|540163754|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
149735078|NCT05047523|540163755|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
149735079|NCT03658889|540163756|FG000|Overall Study|Protocol Violation|2|||
149735080|NCT03658889|540163757|FG001|Overall Study|Protocol Violation|0|||
149735081|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
149735082|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
149735083|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
149735084|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
149735085|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
149735086|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
149735087|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
149735088|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
149735089|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
149735090|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
149735091|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
149735092|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
149735093|NCT02747927|540163777|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
149735094|NCT02747927|540163778|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
149735095|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
149735096|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
149735097|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
149735098|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
149735099|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
149735100|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
149735101|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
149735102|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
149735103|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
149735104|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
149735105|NCT02747927|540163777|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
149735106|NCT02747927|540163778|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
149735107|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
149735108|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
150255014|NCT00605215|542070532|FG001|Overall Study|Adverse Event|21|||
149735109|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
149735110|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
149735111|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
149735112|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
149735113|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
149735114|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
149735115|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
149735116|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
149735117|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
149735118|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
149735119|NCT02747927|540163777|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
149735120|NCT02747927|540163778|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
149735121|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
149735122|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
149735123|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
149735124|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
149735125|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
149735126|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
149735127|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
149735128|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
149735129|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
149735130|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
149735131|NCT02747927|540163777|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
149735132|NCT02747927|540163778|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
149735133|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
149735134|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
149735135|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
149735136|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
149735137|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
149735138|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
149735139|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
149735140|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
149735141|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
149735142|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
149735143|NCT02747927|540163777|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
149735144|NCT02747927|540163778|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
149735145|NCT00522392|540163782|FG000|Overall Study|Disease progression|0|||
149735146|NCT00522392|540163783|FG001|Overall Study|Disease progression|3|||
149735147|NCT00522392|540163782|FG000|Overall Study|Adverse Event|7|||
149735148|NCT00522392|540163783|FG001|Overall Study|Adverse Event|7|||
149735149|NCT00522392|540163782|FG000|Overall Study|Withdrawal by Subject|1|||
149735150|NCT00522392|540163783|FG001|Overall Study|Withdrawal by Subject|1|||
149735151|NCT00522392|540163782|FG000|Overall Study|Physician Decision|0|||
149735152|NCT00522392|540163783|FG001|Overall Study|Physician Decision|1|||
149735153|NCT00522392|540163782|FG000|Overall Study|Non-compliance|0|||
149735154|NCT00522392|540163783|FG001|Overall Study|Non-compliance|1|||
149735155|NCT00430755|540163786|FG000|Overall Study|Withdrawal by Subject|53|||
149735156|NCT03902080|540163793|FG000|Overall Study|Adverse Event|17|||
149735157|NCT03902080|540163794|FG001|Overall Study|Adverse Event|15|||
149735158|NCT03902080|540163793|FG000|Overall Study|Withdrawal by Subject|28|||
149735159|NCT03902080|540163794|FG001|Overall Study|Withdrawal by Subject|35|||
149735160|NCT03902080|540163793|FG000|Overall Study|Lost to Follow-up|6|||
149735161|NCT03902080|540163794|FG001|Overall Study|Lost to Follow-up|7|||
149735162|NCT03902080|540163793|FG000|Overall Study|Other|3|||
149735163|NCT03902080|540163794|FG001|Overall Study|Other|5|||
149735164|NCT03902080|540163793|FG000|Overall Study|Non compliance|4|||
149735165|NCT03902080|540163794|FG001|Overall Study|Non compliance|3|||
149735166|NCT03902080|540163793|FG000|Overall Study|Physician Decision|5|||
149735167|NCT03902080|540163794|FG001|Overall Study|Physician Decision|1|||
149735168|NCT03902080|540163793|FG000|Overall Study|Protocol Violation|3|||
149735169|NCT03902080|540163794|FG001|Overall Study|Protocol Violation|3|||
149735170|NCT03902080|540163793|FG000|Overall Study|Lack of Efficacy|1|||
149735171|NCT03902080|540163794|FG001|Overall Study|Lack of Efficacy|3|||
149735172|NCT03902080|540163793|FG000|Overall Study|Withdrawn prior to dosing|0|||
149735173|NCT03902080|540163794|FG001|Overall Study|Withdrawn prior to dosing|1|||
149735174|NCT03575104|540163795|FG000|Overall Study|Adverse Event|4|||
149735175|NCT03575104|540163796|FG001|Overall Study|Adverse Event|3|||
149735176|NCT03575104|540163797|FG002|Overall Study|Adverse Event|4|||
149735177|NCT03575104|540163795|FG000|Overall Study|Withdrawal by Subject|13|||
149735178|NCT03575104|540163796|FG001|Overall Study|Withdrawal by Subject|16|||
149735179|NCT03575104|540163797|FG002|Overall Study|Withdrawal by Subject|11|||
149735180|NCT03575104|540163795|FG000|Overall Study|Other reasons|6|||
149735181|NCT03575104|540163796|FG001|Overall Study|Other reasons|8|||
149735182|NCT03575104|540163797|FG002|Overall Study|Other reasons|6|||
149735183|NCT03575104|540163795|FG000|Overall Study|Lost to Follow-up|1|||
149735184|NCT03575104|540163796|FG001|Overall Study|Lost to Follow-up|2|||
149735185|NCT03575104|540163797|FG002|Overall Study|Lost to Follow-up|1|||
149735186|NCT02661594|540163798|FG000|Overall Study|Protocol Violation|1|||
149735187|NCT02661594|540163799|FG001|Overall Study|Protocol Violation|0|||
149735188|NCT02661594|540163800|FG002|Overall Study|Protocol Violation|1|||
149735189|NCT02661594|540163801|FG003|Overall Study|Protocol Violation|0|||
149735190|NCT01169779|540163804|FG000|Overall Study|Adverse Event|3|||
149735191|NCT01169779|540163805|FG001|Overall Study|Adverse Event|11|||
149735192|NCT01169779|540163804|FG000|Overall Study|Lack of Efficacy|1|||
149735193|NCT01169779|540163805|FG001|Overall Study|Lack of Efficacy|0|||
149735194|NCT01169779|540163804|FG000|Overall Study|Protocol Violation|1|||
149735195|NCT01169779|540163805|FG001|Overall Study|Protocol Violation|1|||
149735196|NCT01169779|540163804|FG000|Overall Study|Withdrawal by Subject|3|||
149735197|NCT01169779|540163805|FG001|Overall Study|Withdrawal by Subject|2|||
149735198|NCT01169779|540163804|FG000|Overall Study|Familial and personal reasons|3|||
149735199|NCT01169779|540163805|FG001|Overall Study|Familial and personal reasons|3|||
149735200|NCT01354132|540163806|FG000|Randomization|Physician Decision|1|||
149735201|NCT01354132|540163807|FG001|Randomization|Physician Decision|0|||
149735202|NCT01354132|540163806|FG000|Randomization|Withdrawal by Subject|0|||
149735203|NCT01354132|540163807|FG001|Randomization|Withdrawal by Subject|1|||
149735204|NCT01354132|540163806|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
149735205|NCT01354132|540163807|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
149735206|NCT01354132|540163806|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
149735207|NCT01354132|540163807|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
149735208|NCT01354132|540163806|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
149735209|NCT01354132|540163807|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
149735210|NCT00928070|540163810|FG000|Overall Study|Lost to Follow-up|1|||
149735211|NCT00928070|540163811|FG001|Overall Study|Lost to Follow-up|2|||
149735212|NCT00928070|540163810|FG000|Overall Study|Withdrawal by Subject|10|||
149735213|NCT00928070|540163811|FG001|Overall Study|Withdrawal by Subject|3|||
149735214|NCT00928070|540163810|FG000|Overall Study|Adverse Event|14|||
149735215|NCT00928070|540163811|FG001|Overall Study|Adverse Event|26|||
149735216|NCT00928070|540163810|FG000|Overall Study|Lack of Efficacy|9|||
149735217|NCT00928070|540163811|FG001|Overall Study|Lack of Efficacy|5|||
149735218|NCT00928070|540163810|FG000|Overall Study|Did not meet entrance criteria|16|||
149735219|NCT00928070|540163811|FG001|Overall Study|Did not meet entrance criteria|9|||
149735220|NCT00928070|540163810|FG000|Overall Study|Protocol Violation|6|||
149735221|NCT00928070|540163811|FG001|Overall Study|Protocol Violation|5|||
149735222|NCT00928070|540163810|FG000|Overall Study|Randomized but not treated|2|||
149735223|NCT00928070|540163811|FG001|Overall Study|Randomized but not treated|2|||
149735224|NCT00928070|540163810|FG000|Overall Study|Other|5|||
149735225|NCT00928070|540163811|FG001|Overall Study|Other|5|||
149735226|NCT00191854|540163812|FG000|Overall Study|Death|26|||
149735227|NCT00191854|540163813|FG001|Overall Study|Death|23|||
149735228|NCT00191854|540163814|FG002|Overall Study|Death|29|||
149735229|NCT00191854|540163812|FG000|Overall Study|Lost to Follow-up|7|||
149735230|NCT00191854|540163813|FG001|Overall Study|Lost to Follow-up|5|||
149735231|NCT00191854|540163814|FG002|Overall Study|Lost to Follow-up|5|||
149735232|NCT00191854|540163812|FG000|Overall Study|Withdrawal by Subject|4|||
149735233|NCT00191854|540163813|FG001|Overall Study|Withdrawal by Subject|2|||
149735234|NCT00191854|540163814|FG002|Overall Study|Withdrawal by Subject|3|||
149735235|NCT00191854|540163812|FG000|Overall Study|Sponsor Decision|0|||
149735236|NCT00191854|540163813|FG001|Overall Study|Sponsor Decision|0|||
149735237|NCT00191854|540163814|FG002|Overall Study|Sponsor Decision|1|||
149735238|NCT00191854|540163812|FG000|Overall Study|Screen Failure|0|||
150255015|NCT00605215|542070533|FG002|Overall Study|Adverse Event|26|||
149735239|NCT00191854|540163813|FG001|Overall Study|Screen Failure|0|||
149735240|NCT00191854|540163814|FG002|Overall Study|Screen Failure|1|||
149735241|NCT02360098|540163815|FG000|Overall Study|Physician Decision|7|||
149735242|NCT00862251|540163819|FG000|Overall Study|Adverse Event|8|||
149735243|NCT00862251|540163820|FG001|Overall Study|Adverse Event|3|||
149735244|NCT00862251|540163821|FG002|Overall Study|Adverse Event|1|||
149735245|NCT00862251|540163819|FG000|Overall Study|Lost to Follow-up|0|||
149735246|NCT00862251|540163820|FG001|Overall Study|Lost to Follow-up|0|||
149735247|NCT00862251|540163821|FG002|Overall Study|Lost to Follow-up|1|||
149735248|NCT00862251|540163819|FG000|Overall Study|Protocol Violation|2|||
149735249|NCT00862251|540163820|FG001|Overall Study|Protocol Violation|0|||
149735250|NCT00862251|540163821|FG002|Overall Study|Protocol Violation|1|||
149735251|NCT00862251|540163819|FG000|Overall Study|Withdrawal by Subject|9|||
149735252|NCT00862251|540163820|FG001|Overall Study|Withdrawal by Subject|2|||
149735253|NCT00862251|540163821|FG002|Overall Study|Withdrawal by Subject|6|||
149735254|NCT02796755|540163822|FG000|Overall Study|Adverse Event|2|||
149735255|NCT02796755|540163823|FG001|Overall Study|Adverse Event|0|||
149735256|NCT00556426|540163824|FG000|Overall Study|Withdrawal by Subject|3|||
149735257|NCT00556426|540163824|FG000|Overall Study|Death|6|||
149735258|NCT02347631|540163826|FG000|First Intervention (2 Months)|Adverse Event|1|||
149735259|NCT02347631|540163827|FG001|First Intervention (2 Months)|Adverse Event|1|||
149735260|NCT02347631|540163826|FG000|First Intervention (2 Months)|Pregnancy|1|||
149735261|NCT02347631|540163827|FG001|First Intervention (2 Months)|Pregnancy|0|||
149735262|NCT02347631|540163826|FG000|First Intervention (2 Months)|Moved out of area|0|||
149735263|NCT02347631|540163827|FG001|First Intervention (2 Months)|Moved out of area|2|||
149735264|NCT02347631|540163826|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
149735265|NCT02347631|540163827|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
149735266|NCT02347631|540163826|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
149735267|NCT02347631|540163827|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
149735268|NCT02347631|540163826|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
149735269|NCT02347631|540163827|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
149735270|NCT02347631|540163826|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
149735271|NCT02347631|540163827|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
149735272|NCT02347631|540163826|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
149735273|NCT02347631|540163827|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
149735274|NCT02318784|540163829|FG000|Overall Study|Adverse Event|13|||
149735275|NCT02318784|540163829|FG000|Overall Study|Death|2|||
149735276|NCT02318784|540163829|FG000|Overall Study|Progressive Disease|37|||
149735277|NCT02318784|540163829|FG000|Overall Study|Withdrawal by Subject|10|||
149735278|NCT02304926|540163830|FG000|Overall Study|Lost to Follow-up|2|||
149735279|NCT02304926|540163831|FG001|Overall Study|Lost to Follow-up|1|||
149735280|NCT02388295|540163832|FG000|Dose Escalation Week 1|Adverse Event|1|||
149735281|NCT02388295|540163833|FG001|Dose Escalation Week 1|Adverse Event|2|||
149735282|NCT02388295|540163834|FG002|Dose Escalation Week 1|Adverse Event|1|||
149735283|NCT02388295|540163832|FG000|Dose Escalation Week 1|Determined not eligible|1|||
149735284|NCT02388295|540163833|FG001|Dose Escalation Week 1|Determined not eligible|1|||
149735285|NCT02388295|540163834|FG002|Dose Escalation Week 1|Determined not eligible|1|||
149735286|NCT02388295|540163832|FG000|Dose Escalation Week 2|Protocol Violation|0|||
149735287|NCT02388295|540163833|FG001|Dose Escalation Week 2|Protocol Violation|1|||
149735288|NCT02388295|540163834|FG002|Dose Escalation Week 2|Protocol Violation|0|||
149735289|NCT02388295|540163832|FG000|Dose Escalation Week 2|Determined not eligible|1|||
149735290|NCT02388295|540163833|FG001|Dose Escalation Week 2|Determined not eligible|1|||
149735291|NCT02388295|540163834|FG002|Dose Escalation Week 2|Determined not eligible|1|||
149735292|NCT02388295|540163832|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
149735293|NCT02388295|540163833|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
149735294|NCT02388295|540163834|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
149735295|NCT03804684|540163836|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
149735296|NCT03804684|540163837|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
149735297|NCT02429856|540163838|FG000|Overall Study|Death|12|||
149735298|NCT02429856|540163839|FG001|Overall Study|Death|13|||
149735299|NCT02429856|540163838|FG000|Overall Study|Lost to Follow-up|6|||
149735300|NCT02429856|540163839|FG001|Overall Study|Lost to Follow-up|5|||
149735301|NCT02429856|540163838|FG000|Overall Study|Withdrawal by Subject|1|||
149735302|NCT02429856|540163839|FG001|Overall Study|Withdrawal by Subject|1|||
149735303|NCT04134494|540163844|FG000|Overall Study|Lost to Follow-up|2|||
149735304|NCT00763009|540163845|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
149735305|NCT01111604|540163846|FG000|Overall Study|Lost to Follow-up|0|||
149735306|NCT01111604|540163847|FG001|Overall Study|Lost to Follow-up|0|||
149735307|NCT01111604|540163848|FG002|Overall Study|Lost to Follow-up|1|||
149735308|NCT01111604|540163846|FG000|Overall Study|Withdrew Consent|3|||
149735309|NCT01111604|540163847|FG001|Overall Study|Withdrew Consent|0|||
149735310|NCT01111604|540163848|FG002|Overall Study|Withdrew Consent|2|||
149735311|NCT01111604|540163846|FG000|Overall Study|Withdrawal by Subject|2|||
149735312|NCT01111604|540163847|FG001|Overall Study|Withdrawal by Subject|0|||
149735313|NCT01111604|540163848|FG002|Overall Study|Withdrawal by Subject|0|||
149735314|NCT01111604|540163846|FG000|Overall Study|Death|1|||
149735315|NCT01111604|540163847|FG001|Overall Study|Death|0|||
149735316|NCT01111604|540163848|FG002|Overall Study|Death|0|||
149735317|NCT01111604|540163846|FG000|Overall Study|Met Exclusion Criteria|2|||
149735318|NCT01111604|540163847|FG001|Overall Study|Met Exclusion Criteria|0|||
149735319|NCT01111604|540163848|FG002|Overall Study|Met Exclusion Criteria|0|||
149735320|NCT01355289|540163849|FG000|Core Study|Adverse Event, Non-Fatal|1|||
149735321|NCT01355289|540163850|FG001|Core Study|Adverse Event, Non-Fatal|0|||
149735322|NCT01355289|540163851|FG002|Core Study|Adverse Event, Non-Fatal|0|||
149735323|NCT01355289|540163852|FG003|Core Study|Adverse Event, Non-Fatal|0|||
149735324|NCT01355289|540163853|FG004|Core Study|Adverse Event, Non-Fatal|0|||
149735325|NCT01355289|540163849|FG000|Core Study|Inadequate Therapeutic Effect|0|||
149735326|NCT01355289|540163850|FG001|Core Study|Inadequate Therapeutic Effect|0|||
149735327|NCT01355289|540163851|FG002|Core Study|Inadequate Therapeutic Effect|0|||
149735328|NCT01355289|540163852|FG003|Core Study|Inadequate Therapeutic Effect|1|||
149735329|NCT01355289|540163853|FG004|Core Study|Inadequate Therapeutic Effect|0|||
149735330|NCT01355289|540163849|FG000|Core Study|Other|0|||
149735331|NCT01355289|540163850|FG001|Core Study|Other|0|||
150255016|NCT00605215|542070531|FG000|Overall Study|Refusal to sign the re-consent form|8|||
149735332|NCT01355289|540163851|FG002|Core Study|Other|0|||
149735333|NCT01355289|540163852|FG003|Core Study|Other|1|||
149735334|NCT01355289|540163853|FG004|Core Study|Other|0|||
149735335|NCT01355289|540163849|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
149735336|NCT01355289|540163850|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
149735337|NCT01355289|540163851|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
149735338|NCT01355289|540163852|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
149735339|NCT01355289|540163853|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
149735340|NCT01355289|540163849|FG000|Open Label Extension|Lost to Follow-up|0|||
149735341|NCT01355289|540163850|FG001|Open Label Extension|Lost to Follow-up|0|||
149735342|NCT01355289|540163851|FG002|Open Label Extension|Lost to Follow-up|0|||
149735343|NCT01355289|540163852|FG003|Open Label Extension|Lost to Follow-up|0|||
149735344|NCT01355289|540163853|FG004|Open Label Extension|Lost to Follow-up|1|||
149735345|NCT01355289|540163849|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
149735346|NCT01355289|540163850|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
149735347|NCT01355289|540163851|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
149735348|NCT01355289|540163852|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
149735349|NCT01355289|540163853|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
149735350|NCT01355289|540163849|FG000|Open Label Extension|Other|0|||
149735351|NCT01355289|540163850|FG001|Open Label Extension|Other|0|||
149735352|NCT01355289|540163851|FG002|Open Label Extension|Other|0|||
149735353|NCT01355289|540163852|FG003|Open Label Extension|Other|0|||
149735354|NCT01355289|540163853|FG004|Open Label Extension|Other|3|||
149735355|NCT02706938|540163857|FG000|First Period, 6 Weeks|Adverse Event|8|||
149735356|NCT02706938|540163858|FG001|First Period, 6 Weeks|Adverse Event|0|||
149735357|NCT02706938|540163857|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
149735358|NCT02706938|540163858|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
149735359|NCT02706938|540163857|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
149735360|NCT02706938|540163858|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
149735361|NCT02706938|540163857|FG000|Second Period, 6 Weeks|Adverse Event|0|||
149735362|NCT02706938|540163858|FG001|Second Period, 6 Weeks|Adverse Event|7|||
149735363|NCT02706938|540163857|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
149735364|NCT02706938|540163858|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
149735365|NCT02507349|540163859|FG000|Overall Study|Death|12|||
149735366|NCT02507349|540163860|FG001|Overall Study|Death|16|||
149735367|NCT02507349|540163859|FG000|Overall Study|Withdrawal by Subject|1|||
149735368|NCT02507349|540163860|FG001|Overall Study|Withdrawal by Subject|1|||
149735369|NCT02507349|540163859|FG000|Overall Study|Lost to Follow-up|174|||
149735370|NCT02507349|540163860|FG001|Overall Study|Lost to Follow-up|144|||
149735371|NCT01614964|540163863|FG000|Overall Study|Withdrawal by Subject|2|||
149735372|NCT01614964|540163864|FG001|Overall Study|Withdrawal by Subject|0|||
149735373|NCT01614964|540163863|FG000|Overall Study|Lost to Follow-up|3|||
149735374|NCT01614964|540163864|FG001|Overall Study|Lost to Follow-up|0|||
149735375|NCT00860470|540163865|FG000|Overall Study|Death|6|||
149735376|NCT00860470|540163866|FG001|Overall Study|Death|10|||
149735377|NCT00860470|540163865|FG000|Overall Study|Moved away|8|||
149735378|NCT00860470|540163866|FG001|Overall Study|Moved away|10|||
149735379|NCT00860470|540163865|FG000|Overall Study|Lost to Follow-up|34|||
149735380|NCT00860470|540163866|FG001|Overall Study|Lost to Follow-up|39|||
149735381|NCT00348140|540163867|FG000|Overall Study|Adverse Event|46|||
149735382|NCT00348140|540163868|FG001|Overall Study|Adverse Event|49|||
149735383|NCT00348140|540163869|FG002|Overall Study|Adverse Event|78|||
149735384|NCT00348140|540163867|FG000|Overall Study|Lost to Follow-up|4|||
149735385|NCT00348140|540163868|FG001|Overall Study|Lost to Follow-up|4|||
149735386|NCT00348140|540163869|FG002|Overall Study|Lost to Follow-up|4|||
149735387|NCT00348140|540163867|FG000|Overall Study|Protocol Violation|12|||
149735388|NCT00348140|540163868|FG001|Overall Study|Protocol Violation|13|||
149735389|NCT00348140|540163869|FG002|Overall Study|Protocol Violation|14|||
149735390|NCT00348140|540163867|FG000|Overall Study|Withdrawal by Subject|32|||
149735391|NCT00348140|540163868|FG001|Overall Study|Withdrawal by Subject|40|||
149735392|NCT00348140|540163869|FG002|Overall Study|Withdrawal by Subject|40|||
149735393|NCT00348140|540163867|FG000|Overall Study|Non-compliance|8|||
149735394|NCT00348140|540163868|FG001|Overall Study|Non-compliance|13|||
149735395|NCT00348140|540163869|FG002|Overall Study|Non-compliance|5|||
149735396|NCT00348140|540163867|FG000|Overall Study|Participant at risk due to study drug|2|||
149735397|NCT00348140|540163868|FG001|Overall Study|Participant at risk due to study drug|0|||
149735398|NCT00348140|540163869|FG002|Overall Study|Participant at risk due to study drug|0|||
149735399|NCT00348140|540163867|FG000|Overall Study|Conditional medication increased dose|1|||
149735400|NCT00348140|540163868|FG001|Overall Study|Conditional medication increased dose|0|||
149735401|NCT00348140|540163869|FG002|Overall Study|Conditional medication increased dose|0|||
149735402|NCT00348140|540163867|FG000|Overall Study|Caregiver related|4|||
149735403|NCT00348140|540163868|FG001|Overall Study|Caregiver related|7|||
149735404|NCT00348140|540163869|FG002|Overall Study|Caregiver related|3|||
149735405|NCT00348140|540163867|FG000|Overall Study|Participant hospitalised|3|||
149735406|NCT00348140|540163868|FG001|Overall Study|Participant hospitalised|0|||
149735407|NCT00348140|540163869|FG002|Overall Study|Participant hospitalised|0|||
149735408|NCT00348140|540163867|FG000|Overall Study|Efficacy related|1|||
149735409|NCT00348140|540163868|FG001|Overall Study|Efficacy related|1|||
149735410|NCT00348140|540163869|FG002|Overall Study|Efficacy related|0|||
149735411|NCT00348140|540163867|FG000|Overall Study|Administration related|3|||
149735412|NCT00348140|540163868|FG001|Overall Study|Administration related|1|||
149735413|NCT00348140|540163869|FG002|Overall Study|Administration related|1|||
149735414|NCT00348140|540163867|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
149735415|NCT00348140|540163868|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
149735416|NCT00348140|540163869|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
149735417|NCT00348140|540163867|FG000|Overall Study|Participant unwell|1|||
149735418|NCT00348140|540163868|FG001|Overall Study|Participant unwell|0|||
149735419|NCT00348140|540163869|FG002|Overall Study|Participant unwell|0|||
149735420|NCT00348140|540163867|FG000|Overall Study|Screen failure|1|||
149735421|NCT00348140|540163868|FG001|Overall Study|Screen failure|0|||
149735422|NCT00348140|540163869|FG002|Overall Study|Screen failure|0|||
149735423|NCT00348140|540163867|FG000|Overall Study|Investigator decided to discontinue|4|||
149735424|NCT00348140|540163868|FG001|Overall Study|Investigator decided to discontinue|1|||
149735425|NCT00348140|540163869|FG002|Overall Study|Investigator decided to discontinue|4|||
149735426|NCT00348140|540163867|FG000|Overall Study|Decided to discontinue on their own|1|||
149735427|NCT00348140|540163868|FG001|Overall Study|Decided to discontinue on their own|4|||
149735428|NCT00348140|540163869|FG002|Overall Study|Decided to discontinue on their own|1|||
149735429|NCT00348140|540163867|FG000|Overall Study|Use of prohibited drug|1|||
149735430|NCT00348140|540163868|FG001|Overall Study|Use of prohibited drug|0|||
149735431|NCT00348140|540163869|FG002|Overall Study|Use of prohibited drug|2|||
149735432|NCT00348140|540163867|FG000|Overall Study|Disease progression|1|||
149735433|NCT00348140|540163868|FG001|Overall Study|Disease progression|2|||
149735434|NCT00348140|540163869|FG002|Overall Study|Disease progression|5|||
149735435|NCT00348140|540163867|FG000|Overall Study|Increased risk of cardiac infarction|0|||
149735436|NCT00348140|540163868|FG001|Overall Study|Increased risk of cardiac infarction|1|||
149735437|NCT00348140|540163869|FG002|Overall Study|Increased risk of cardiac infarction|0|||
149735438|NCT00348140|540163867|FG000|Overall Study|Serious adverse event|0|||
149735439|NCT00348140|540163868|FG001|Overall Study|Serious adverse event|1|||
149735440|NCT00348140|540163869|FG002|Overall Study|Serious adverse event|0|||
149735441|NCT00348140|540163867|FG000|Overall Study|Abnormal ECG|0|||
149735442|NCT00348140|540163868|FG001|Overall Study|Abnormal ECG|1|||
149735443|NCT00348140|540163869|FG002|Overall Study|Abnormal ECG|3|||
149735444|NCT00348140|540163867|FG000|Overall Study|Participant died|0|||
149735445|NCT00348140|540163868|FG001|Overall Study|Participant died|1|||
149735446|NCT00348140|540163869|FG002|Overall Study|Participant died|0|||
149735447|NCT00348140|540163867|FG000|Overall Study|Exclusion criteria met|0|||
149735448|NCT00348140|540163868|FG001|Overall Study|Exclusion criteria met|0|||
149735449|NCT00348140|540163869|FG002|Overall Study|Exclusion criteria met|1|||
149735450|NCT00348140|540163867|FG000|Overall Study|Memory declined|0|||
149735451|NCT00348140|540163868|FG001|Overall Study|Memory declined|0|||
149735452|NCT00348140|540163869|FG002|Overall Study|Memory declined|1|||
149735453|NCT00619957|540163870|FG000|Month 24 Double-Blind|Adverse Event|9|||
149735454|NCT00619957|540163871|FG001|Month 24 Double-Blind|Adverse Event|7|||
149735455|NCT00619957|540163870|FG000|Month 24 Double-Blind|Protocol Violation|1|||
149735456|NCT00619957|540163871|FG001|Month 24 Double-Blind|Protocol Violation|0|||
149735457|NCT00619957|540163870|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
149735458|NCT00619957|540163871|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
149735459|NCT00619957|540163870|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
149735460|NCT00619957|540163871|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
149735461|NCT00619957|540163870|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
149735462|NCT00619957|540163871|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
149735463|NCT00619957|540163870|FG000|Month 48 Open-Label|Adverse Event|4|||
149735464|NCT00619957|540163871|FG001|Month 48 Open-Label|Adverse Event|4|||
149735465|NCT00619957|540163870|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
149735466|NCT00619957|540163871|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
149735467|NCT00619957|540163870|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
149735468|NCT00619957|540163871|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
150255017|NCT00605215|542070532|FG001|Overall Study|Refusal to sign the re-consent form|3|||
149735469|NCT00868790|540163872|FG000|Period 1|Adverse Event|1|||
149735470|NCT00868790|540163873|FG001|Period 1|Adverse Event|0|||
149735471|NCT00868790|540163874|FG002|Period 1|Adverse Event|0|||
150255018|NCT00605215|542070533|FG002|Overall Study|Refusal to sign the re-consent form|3|||
149735472|NCT00868790|540163875|FG003|Period 1|Adverse Event|0|||
149735473|NCT00868790|540163876|FG004|Period 1|Adverse Event|0|||
149735474|NCT00868790|540163877|FG005|Period 1|Adverse Event|0|||
149735475|NCT00868790|540163878|FG006|Period 1|Adverse Event|0|||
149735476|NCT00868790|540163879|FG007|Period 1|Adverse Event|3|||
149735477|NCT00868790|540163880|FG008|Period 1|Adverse Event|1|||
149735478|NCT00868790|540163881|FG009|Period 1|Adverse Event|0|||
150255019|NCT00605215|542070531|FG000|Overall Study|Withdrawal by Subject|39|||
149735479|NCT00868790|540163882|FG010|Period 1|Adverse Event|0|||
149735480|NCT00868790|540163883|FG011|Period 1|Adverse Event|0|||
149735481|NCT00868790|540163884|FG012|Period 1|Adverse Event|0|||
149735482|NCT00868790|540163885|FG013|Period 1|Adverse Event|1|||
149735483|NCT00868790|540163872|FG000|Period 1|Protocol Violation|1|||
149735484|NCT00868790|540163873|FG001|Period 1|Protocol Violation|0|||
149735485|NCT00868790|540163874|FG002|Period 1|Protocol Violation|0|||
149735486|NCT00868790|540163875|FG003|Period 1|Protocol Violation|0|||
149735487|NCT00868790|540163876|FG004|Period 1|Protocol Violation|0|||
149735488|NCT00868790|540163877|FG005|Period 1|Protocol Violation|0|||
149735489|NCT00868790|540163878|FG006|Period 1|Protocol Violation|0|||
149735490|NCT00868790|540163879|FG007|Period 1|Protocol Violation|0|||
149735491|NCT00868790|540163880|FG008|Period 1|Protocol Violation|0|||
149735492|NCT00868790|540163881|FG009|Period 1|Protocol Violation|0|||
149735493|NCT00868790|540163882|FG010|Period 1|Protocol Violation|0|||
149735494|NCT00868790|540163883|FG011|Period 1|Protocol Violation|0|||
149735495|NCT00868790|540163884|FG012|Period 1|Protocol Violation|0|||
149735496|NCT00868790|540163885|FG013|Period 1|Protocol Violation|0|||
149735497|NCT00868790|540163872|FG000|Period 1|Withdrawal by Subject|0|||
149735498|NCT00868790|540163873|FG001|Period 1|Withdrawal by Subject|1|||
149735499|NCT00868790|540163874|FG002|Period 1|Withdrawal by Subject|0|||
149735500|NCT00868790|540163875|FG003|Period 1|Withdrawal by Subject|0|||
149735501|NCT00868790|540163876|FG004|Period 1|Withdrawal by Subject|0|||
149735502|NCT00868790|540163877|FG005|Period 1|Withdrawal by Subject|0|||
149735503|NCT00868790|540163878|FG006|Period 1|Withdrawal by Subject|0|||
149735504|NCT00868790|540163879|FG007|Period 1|Withdrawal by Subject|0|||
149735505|NCT00868790|540163880|FG008|Period 1|Withdrawal by Subject|0|||
149735506|NCT00868790|540163881|FG009|Period 1|Withdrawal by Subject|0|||
149735507|NCT00868790|540163882|FG010|Period 1|Withdrawal by Subject|0|||
149735508|NCT00868790|540163883|FG011|Period 1|Withdrawal by Subject|0|||
149735509|NCT00868790|540163884|FG012|Period 1|Withdrawal by Subject|0|||
149735510|NCT00868790|540163885|FG013|Period 1|Withdrawal by Subject|1|||
149735511|NCT00868790|540163872|FG000|Period 1|Abnormal Triglycerides|0|||
149735512|NCT00868790|540163873|FG001|Period 1|Abnormal Triglycerides|0|||
149735513|NCT00868790|540163874|FG002|Period 1|Abnormal Triglycerides|0|||
149735514|NCT00868790|540163875|FG003|Period 1|Abnormal Triglycerides|0|||
149735515|NCT00868790|540163876|FG004|Period 1|Abnormal Triglycerides|1|||
149735516|NCT00868790|540163877|FG005|Period 1|Abnormal Triglycerides|0|||
149735517|NCT00868790|540163878|FG006|Period 1|Abnormal Triglycerides|0|||
149735518|NCT00868790|540163879|FG007|Period 1|Abnormal Triglycerides|0|||
149735519|NCT00868790|540163880|FG008|Period 1|Abnormal Triglycerides|0|||
149735520|NCT00868790|540163881|FG009|Period 1|Abnormal Triglycerides|0|||
149735521|NCT00868790|540163882|FG010|Period 1|Abnormal Triglycerides|0|||
149735522|NCT00868790|540163883|FG011|Period 1|Abnormal Triglycerides|0|||
149735523|NCT00868790|540163884|FG012|Period 1|Abnormal Triglycerides|0|||
149735524|NCT00868790|540163885|FG013|Period 1|Abnormal Triglycerides|0|||
149735525|NCT00868790|540163872|FG000|Period 1|Lost to Follow-up|0|||
149735526|NCT00868790|540163873|FG001|Period 1|Lost to Follow-up|0|||
149735527|NCT00868790|540163874|FG002|Period 1|Lost to Follow-up|0|||
149735528|NCT00868790|540163875|FG003|Period 1|Lost to Follow-up|0|||
149735529|NCT00868790|540163876|FG004|Period 1|Lost to Follow-up|0|||
149735530|NCT00868790|540163877|FG005|Period 1|Lost to Follow-up|1|||
149735531|NCT00868790|540163878|FG006|Period 1|Lost to Follow-up|0|||
149735532|NCT00868790|540163879|FG007|Period 1|Lost to Follow-up|0|||
149735533|NCT00868790|540163880|FG008|Period 1|Lost to Follow-up|0|||
149735534|NCT00868790|540163881|FG009|Period 1|Lost to Follow-up|0|||
149735535|NCT00868790|540163882|FG010|Period 1|Lost to Follow-up|0|||
149735536|NCT00868790|540163883|FG011|Period 1|Lost to Follow-up|0|||
149735537|NCT00868790|540163884|FG012|Period 1|Lost to Follow-up|0|||
149735538|NCT00868790|540163885|FG013|Period 1|Lost to Follow-up|0|||
149735539|NCT00868790|540163872|FG000|Period 2|Adverse Event|0|||
149735540|NCT00868790|540163873|FG001|Period 2|Adverse Event|0|||
149735541|NCT00868790|540163874|FG002|Period 2|Adverse Event|0|||
149735542|NCT00868790|540163875|FG003|Period 2|Adverse Event|0|||
149735543|NCT00868790|540163876|FG004|Period 2|Adverse Event|0|||
149735544|NCT00868790|540163877|FG005|Period 2|Adverse Event|0|||
149735545|NCT00868790|540163878|FG006|Period 2|Adverse Event|0|||
149735546|NCT00868790|540163879|FG007|Period 2|Adverse Event|0|||
149735547|NCT00868790|540163880|FG008|Period 2|Adverse Event|1|||
149735548|NCT00868790|540163881|FG009|Period 2|Adverse Event|0|||
149735549|NCT00868790|540163882|FG010|Period 2|Adverse Event|0|||
149735550|NCT00868790|540163883|FG011|Period 2|Adverse Event|0|||
149735551|NCT00868790|540163884|FG012|Period 2|Adverse Event|0|||
149735552|NCT00868790|540163885|FG013|Period 2|Adverse Event|0|||
149735553|NCT00868790|540163872|FG000|Period 2|Lost to Follow-up|0|||
149735554|NCT00868790|540163873|FG001|Period 2|Lost to Follow-up|1|||
149735555|NCT00868790|540163874|FG002|Period 2|Lost to Follow-up|0|||
149735556|NCT00868790|540163875|FG003|Period 2|Lost to Follow-up|0|||
149735557|NCT00868790|540163876|FG004|Period 2|Lost to Follow-up|0|||
149735558|NCT00868790|540163877|FG005|Period 2|Lost to Follow-up|1|||
149735559|NCT00868790|540163878|FG006|Period 2|Lost to Follow-up|0|||
149735560|NCT00868790|540163879|FG007|Period 2|Lost to Follow-up|0|||
149735561|NCT00868790|540163880|FG008|Period 2|Lost to Follow-up|0|||
149735562|NCT00868790|540163881|FG009|Period 2|Lost to Follow-up|0|||
149735563|NCT00868790|540163882|FG010|Period 2|Lost to Follow-up|0|||
149735564|NCT00868790|540163883|FG011|Period 2|Lost to Follow-up|0|||
149735565|NCT00868790|540163884|FG012|Period 2|Lost to Follow-up|0|||
149735566|NCT00868790|540163885|FG013|Period 2|Lost to Follow-up|0|||
149735567|NCT00868790|540163872|FG000|Period 2|Withdrawal by Subject|0|||
149735568|NCT00868790|540163873|FG001|Period 2|Withdrawal by Subject|0|||
149735569|NCT00868790|540163874|FG002|Period 2|Withdrawal by Subject|0|||
149735570|NCT00868790|540163875|FG003|Period 2|Withdrawal by Subject|0|||
149735571|NCT00868790|540163876|FG004|Period 2|Withdrawal by Subject|0|||
149735572|NCT00868790|540163877|FG005|Period 2|Withdrawal by Subject|0|||
149735573|NCT00868790|540163878|FG006|Period 2|Withdrawal by Subject|0|||
149735574|NCT00868790|540163879|FG007|Period 2|Withdrawal by Subject|0|||
149735575|NCT00868790|540163880|FG008|Period 2|Withdrawal by Subject|1|||
149735576|NCT00868790|540163881|FG009|Period 2|Withdrawal by Subject|0|||
149735577|NCT00868790|540163882|FG010|Period 2|Withdrawal by Subject|0|||
149735578|NCT00868790|540163883|FG011|Period 2|Withdrawal by Subject|0|||
149735579|NCT00868790|540163884|FG012|Period 2|Withdrawal by Subject|0|||
149735580|NCT00868790|540163885|FG013|Period 2|Withdrawal by Subject|1|||
149735581|NCT00868790|540163872|FG000|Period 3|Adverse Event|0|||
149735582|NCT00868790|540163873|FG001|Period 3|Adverse Event|0|||
149735583|NCT00868790|540163874|FG002|Period 3|Adverse Event|0|||
149735584|NCT00868790|540163875|FG003|Period 3|Adverse Event|0|||
149735585|NCT00868790|540163876|FG004|Period 3|Adverse Event|0|||
149735586|NCT00868790|540163877|FG005|Period 3|Adverse Event|0|||
149735587|NCT00868790|540163878|FG006|Period 3|Adverse Event|0|||
149735588|NCT00868790|540163879|FG007|Period 3|Adverse Event|0|||
149735589|NCT00868790|540163880|FG008|Period 3|Adverse Event|0|||
149735590|NCT00868790|540163881|FG009|Period 3|Adverse Event|1|||
149735591|NCT00868790|540163882|FG010|Period 3|Adverse Event|0|||
149735592|NCT00868790|540163883|FG011|Period 3|Adverse Event|0|||
149735593|NCT00868790|540163884|FG012|Period 3|Adverse Event|0|||
149735594|NCT00868790|540163885|FG013|Period 3|Adverse Event|0|||
149735595|NCT00868790|540163872|FG000|Period 3|Protocol Violation|0|||
149735596|NCT00868790|540163873|FG001|Period 3|Protocol Violation|0|||
149735597|NCT00868790|540163874|FG002|Period 3|Protocol Violation|0|||
149735598|NCT00868790|540163875|FG003|Period 3|Protocol Violation|0|||
149735599|NCT00868790|540163876|FG004|Period 3|Protocol Violation|0|||
149735600|NCT00868790|540163877|FG005|Period 3|Protocol Violation|0|||
149735601|NCT00868790|540163878|FG006|Period 3|Protocol Violation|0|||
149735602|NCT00868790|540163879|FG007|Period 3|Protocol Violation|0|||
149735603|NCT00868790|540163880|FG008|Period 3|Protocol Violation|0|||
149735604|NCT00868790|540163881|FG009|Period 3|Protocol Violation|0|||
149735605|NCT00868790|540163882|FG010|Period 3|Protocol Violation|1|||
149735606|NCT00868790|540163883|FG011|Period 3|Protocol Violation|0|||
149735607|NCT00868790|540163884|FG012|Period 3|Protocol Violation|0|||
149735608|NCT00868790|540163885|FG013|Period 3|Protocol Violation|0|||
149735609|NCT00868790|540163872|FG000|Period 3|Study Terminated by Sponsor|0|||
149735610|NCT00868790|540163873|FG001|Period 3|Study Terminated by Sponsor|0|||
149735611|NCT00868790|540163874|FG002|Period 3|Study Terminated by Sponsor|0|||
149735612|NCT00868790|540163875|FG003|Period 3|Study Terminated by Sponsor|1|||
149735613|NCT00868790|540163876|FG004|Period 3|Study Terminated by Sponsor|0|||
149735614|NCT00868790|540163877|FG005|Period 3|Study Terminated by Sponsor|0|||
149735615|NCT00868790|540163878|FG006|Period 3|Study Terminated by Sponsor|0|||
149735616|NCT00868790|540163879|FG007|Period 3|Study Terminated by Sponsor|0|||
149735617|NCT00868790|540163880|FG008|Period 3|Study Terminated by Sponsor|0|||
149735618|NCT00868790|540163881|FG009|Period 3|Study Terminated by Sponsor|0|||
149735619|NCT00868790|540163882|FG010|Period 3|Study Terminated by Sponsor|0|||
149735620|NCT00868790|540163883|FG011|Period 3|Study Terminated by Sponsor|0|||
149735621|NCT00868790|540163884|FG012|Period 3|Study Terminated by Sponsor|0|||
149735622|NCT00868790|540163885|FG013|Period 3|Study Terminated by Sponsor|0|||
149735623|NCT00868790|540163872|FG000|Period 4|Adverse Event|0|||
149735624|NCT00868790|540163873|FG001|Period 4|Adverse Event|0|||
149735625|NCT00868790|540163874|FG002|Period 4|Adverse Event|0|||
149735626|NCT00868790|540163875|FG003|Period 4|Adverse Event|0|||
149735627|NCT00868790|540163876|FG004|Period 4|Adverse Event|0|||
149735628|NCT00868790|540163877|FG005|Period 4|Adverse Event|0|||
149735629|NCT00868790|540163878|FG006|Period 4|Adverse Event|0|||
149735630|NCT00868790|540163879|FG007|Period 4|Adverse Event|1|||
149735631|NCT00868790|540163880|FG008|Period 4|Adverse Event|0|||
149735632|NCT00868790|540163881|FG009|Period 4|Adverse Event|0|||
149735633|NCT00868790|540163882|FG010|Period 4|Adverse Event|1|||
149735634|NCT00868790|540163883|FG011|Period 4|Adverse Event|0|||
149735635|NCT00868790|540163884|FG012|Period 4|Adverse Event|1|||
149735636|NCT00868790|540163885|FG013|Period 4|Adverse Event|0|||
149735637|NCT00868790|540163872|FG000|Period 4|Lost to Follow-up|0|||
149735638|NCT00868790|540163873|FG001|Period 4|Lost to Follow-up|0|||
149735639|NCT00868790|540163874|FG002|Period 4|Lost to Follow-up|0|||
149735640|NCT00868790|540163875|FG003|Period 4|Lost to Follow-up|0|||
149735641|NCT00868790|540163876|FG004|Period 4|Lost to Follow-up|0|||
149735642|NCT00868790|540163877|FG005|Period 4|Lost to Follow-up|0|||
149735643|NCT00868790|540163878|FG006|Period 4|Lost to Follow-up|0|||
149735644|NCT00868790|540163879|FG007|Period 4|Lost to Follow-up|1|||
149735645|NCT00868790|540163880|FG008|Period 4|Lost to Follow-up|0|||
149735646|NCT00868790|540163881|FG009|Period 4|Lost to Follow-up|0|||
149735647|NCT00868790|540163882|FG010|Period 4|Lost to Follow-up|0|||
149735648|NCT00868790|540163883|FG011|Period 4|Lost to Follow-up|0|||
149735649|NCT00868790|540163884|FG012|Period 4|Lost to Follow-up|0|||
149735650|NCT00868790|540163885|FG013|Period 4|Lost to Follow-up|0|||
149735651|NCT00868790|540163872|FG000|Period 4|Study Terminated by Sponsor|2|||
149735652|NCT00868790|540163873|FG001|Period 4|Study Terminated by Sponsor|0|||
149735653|NCT00868790|540163874|FG002|Period 4|Study Terminated by Sponsor|0|||
149735654|NCT00868790|540163875|FG003|Period 4|Study Terminated by Sponsor|0|||
149735655|NCT00868790|540163876|FG004|Period 4|Study Terminated by Sponsor|0|||
149735656|NCT00868790|540163877|FG005|Period 4|Study Terminated by Sponsor|0|||
149735657|NCT00868790|540163878|FG006|Period 4|Study Terminated by Sponsor|0|||
149735658|NCT00868790|540163879|FG007|Period 4|Study Terminated by Sponsor|1|||
149735659|NCT00868790|540163880|FG008|Period 4|Study Terminated by Sponsor|2|||
149735660|NCT00868790|540163881|FG009|Period 4|Study Terminated by Sponsor|0|||
149735661|NCT00868790|540163882|FG010|Period 4|Study Terminated by Sponsor|2|||
149735662|NCT00868790|540163883|FG011|Period 4|Study Terminated by Sponsor|1|||
149735663|NCT00868790|540163884|FG012|Period 4|Study Terminated by Sponsor|0|||
149735664|NCT00868790|540163885|FG013|Period 4|Study Terminated by Sponsor|1|||
149735665|NCT00868790|540163872|FG000|Period 4|Abnormal ALT/AST|0|||
149735666|NCT00868790|540163873|FG001|Period 4|Abnormal ALT/AST|0|||
149735667|NCT00868790|540163874|FG002|Period 4|Abnormal ALT/AST|1|||
149735668|NCT00868790|540163875|FG003|Period 4|Abnormal ALT/AST|0|||
149735669|NCT00868790|540163876|FG004|Period 4|Abnormal ALT/AST|0|||
149735670|NCT00868790|540163877|FG005|Period 4|Abnormal ALT/AST|0|||
149735671|NCT00868790|540163878|FG006|Period 4|Abnormal ALT/AST|0|||
149735672|NCT00868790|540163879|FG007|Period 4|Abnormal ALT/AST|0|||
149735673|NCT00868790|540163880|FG008|Period 4|Abnormal ALT/AST|0|||
149735674|NCT00868790|540163881|FG009|Period 4|Abnormal ALT/AST|0|||
149735675|NCT00868790|540163882|FG010|Period 4|Abnormal ALT/AST|0|||
149735676|NCT00868790|540163883|FG011|Period 4|Abnormal ALT/AST|0|||
149735677|NCT00868790|540163884|FG012|Period 4|Abnormal ALT/AST|0|||
149735678|NCT00868790|540163885|FG013|Period 4|Abnormal ALT/AST|0|||
149735679|NCT00868790|540163872|FG000|Post-study|Withdrawal by Subject|0|||
149735680|NCT00868790|540163873|FG001|Post-study|Withdrawal by Subject|0|||
149735681|NCT00868790|540163874|FG002|Post-study|Withdrawal by Subject|0|||
149735682|NCT00868790|540163875|FG003|Post-study|Withdrawal by Subject|0|||
149735683|NCT00868790|540163876|FG004|Post-study|Withdrawal by Subject|1|||
149735684|NCT00868790|540163877|FG005|Post-study|Withdrawal by Subject|0|||
149735685|NCT00868790|540163878|FG006|Post-study|Withdrawal by Subject|0|||
149735686|NCT00868790|540163879|FG007|Post-study|Withdrawal by Subject|0|||
149735687|NCT00868790|540163880|FG008|Post-study|Withdrawal by Subject|0|||
149735688|NCT00868790|540163881|FG009|Post-study|Withdrawal by Subject|0|||
149735689|NCT00868790|540163882|FG010|Post-study|Withdrawal by Subject|0|||
149735690|NCT00868790|540163883|FG011|Post-study|Withdrawal by Subject|0|||
149735691|NCT00868790|540163884|FG012|Post-study|Withdrawal by Subject|0|||
149735692|NCT00868790|540163885|FG013|Post-study|Withdrawal by Subject|0|||
149735693|NCT00868790|540163872|FG000|Post-study|Excluded Medication|0|||
149735694|NCT00868790|540163873|FG001|Post-study|Excluded Medication|0|||
149735695|NCT00868790|540163874|FG002|Post-study|Excluded Medication|0|||
149735696|NCT00868790|540163875|FG003|Post-study|Excluded Medication|0|||
149735697|NCT00868790|540163876|FG004|Post-study|Excluded Medication|0|||
149735698|NCT00868790|540163877|FG005|Post-study|Excluded Medication|0|||
149735699|NCT00868790|540163878|FG006|Post-study|Excluded Medication|0|||
150255020|NCT00605215|542070532|FG001|Overall Study|Withdrawal by Subject|37|||
150255021|NCT00605215|542070533|FG002|Overall Study|Withdrawal by Subject|27|||
150255022|NCT00605215|542070531|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
150255023|NCT00605215|542070532|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
150255024|NCT00605215|542070533|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
150255025|NCT00605215|542070531|FG000|Overall Study|Protocol Violation|3|||
150255026|NCT00605215|542070532|FG001|Overall Study|Protocol Violation|4|||
150255027|NCT00605215|542070533|FG002|Overall Study|Protocol Violation|1|||
149735700|NCT00868790|540163879|FG007|Post-study|Excluded Medication|2|||
149735701|NCT00868790|540163880|FG008|Post-study|Excluded Medication|0|||
149735702|NCT00868790|540163881|FG009|Post-study|Excluded Medication|1|||
149735703|NCT00868790|540163882|FG010|Post-study|Excluded Medication|0|||
149735704|NCT00868790|540163883|FG011|Post-study|Excluded Medication|0|||
149735705|NCT00868790|540163884|FG012|Post-study|Excluded Medication|0|||
149735706|NCT00868790|540163885|FG013|Post-study|Excluded Medication|0|||
149735707|NCT01763164|540163886|FG000|Treatment Phase|Participant/Guardian decision|26|||
149735708|NCT01763164|540163887|FG001|Treatment Phase|Participant/Guardian decision|14|||
149735709|NCT01763164|540163886|FG000|Treatment Phase|Protocol Violation|1|||
149735710|NCT01763164|540163887|FG001|Treatment Phase|Protocol Violation|1|||
149735711|NCT01763164|540163886|FG000|Treatment Phase|Progressive Disease|142|||
149735712|NCT01763164|540163887|FG001|Treatment Phase|Progressive Disease|76|||
149735713|NCT01763164|540163886|FG000|Treatment Phase|Physician Decision|24|||
149735714|NCT01763164|540163887|FG001|Treatment Phase|Physician Decision|13|||
149735715|NCT01763164|540163886|FG000|Treatment Phase|Death|10|||
149735716|NCT01763164|540163887|FG001|Treatment Phase|Death|1|||
149735717|NCT01763164|540163886|FG000|Treatment Phase|Adverse Event|66|||
149735718|NCT01763164|540163887|FG001|Treatment Phase|Adverse Event|8|||
149735719|NCT01763164|540163886|FG000|Treatment Phase|Randomized but not Treated|0|||
149735720|NCT01763164|540163887|FG001|Treatment Phase|Randomized but not Treated|19|||
149735721|NCT01763164|540163886|FG000|Treatment Phase|Other|0|||
149735722|NCT01763164|540163887|FG001|Treatment Phase|Other|1|||
149735723|NCT01763164|540163886|FG000|Follow up Phase|New therapy for study indication|12|||
149735724|NCT01763164|540163887|FG001|Follow up Phase|New therapy for study indication|3|||
149735725|NCT01763164|540163886|FG000|Follow up Phase|Death|21|||
149735726|NCT01763164|540163887|FG001|Follow up Phase|Death|4|||
149735727|NCT01763164|540163886|FG000|Follow up Phase|Subject/guardian decision|9|||
149735728|NCT01763164|540163887|FG001|Follow up Phase|Subject/guardian decision|2|||
149735729|NCT01763164|540163886|FG000|Follow up Phase|Progressive disease|127|||
149735730|NCT01763164|540163887|FG001|Follow up Phase|Progressive disease|62|||
149735731|NCT01763164|540163886|FG000|Follow up Phase|Physician Decision|10|||
149735732|NCT01763164|540163887|FG001|Follow up Phase|Physician Decision|3|||
149735733|NCT01763164|540163886|FG000|Follow up Phase|Lost to Follow-up|1|||
149735734|NCT01763164|540163887|FG001|Follow up Phase|Lost to Follow-up|0|||
149735735|NCT01763164|540163886|FG000|Follow up Phase|Adverse Event|17|||
149735736|NCT01763164|540163887|FG001|Follow up Phase|Adverse Event|1|||
149735737|NCT03377634|540163888|FG000|Study Period|Adverse Event|1|||
149735738|NCT03377634|540163889|FG001|Study Period|Adverse Event|0|||
149735739|NCT03377634|540163888|FG000|Study Period|Withdrawal by Subject|1|||
149735740|NCT03377634|540163889|FG001|Study Period|Withdrawal by Subject|0|||
149735741|NCT01264939|540163890|FG000|Overall Study|Adverse Event|1|||
149735742|NCT01264939|540163891|FG001|Overall Study|Adverse Event|3|||
149735743|NCT01264939|540163890|FG000|Overall Study|Lost to Follow-up|0|||
149735744|NCT01264939|540163891|FG001|Overall Study|Lost to Follow-up|3|||
149735745|NCT01264939|540163890|FG000|Overall Study|Physician Decision|1|||
149735746|NCT01264939|540163891|FG001|Overall Study|Physician Decision|1|||
149735747|NCT01264939|540163890|FG000|Overall Study|Patient/Guardian Decision|8|||
149735748|NCT01264939|540163891|FG001|Overall Study|Patient/Guardian Decision|10|||
149735749|NCT01264939|540163890|FG000|Overall Study|Disease Progression|8|||
149735750|NCT01264939|540163891|FG001|Overall Study|Disease Progression|11|||
149735751|NCT01384292|540163899|FG000|Part B|Severe non-compliance to protocol|1|||
149735752|NCT01384292|540163900|FG001|Part B|Severe non-compliance to protocol|0|||
149735753|NCT01384292|540163901|FG002|Part B|Severe non-compliance to protocol|0|||
149735754|NCT01171612|540163902|FG000|Overall Study|Lost to Follow-up|51|||
149735755|NCT00854828|540163903|FG000|Overall Study|Death|1|||
149735756|NCT00854828|540163904|FG001|Overall Study|Death|0|||
149735757|NCT00854828|540163905|FG002|Overall Study|Death|0|||
149735758|NCT00854828|540163906|FG003|Overall Study|Death|0|||
149735759|NCT00854828|540163903|FG000|Overall Study|Withdrawal by Subject|1|||
149735760|NCT00854828|540163904|FG001|Overall Study|Withdrawal by Subject|1|||
149735761|NCT00854828|540163905|FG002|Overall Study|Withdrawal by Subject|0|||
149735762|NCT00854828|540163906|FG003|Overall Study|Withdrawal by Subject|9|||
149735763|NCT00854828|540163903|FG000|Overall Study|Missed 24mo visit|1|||
149735764|NCT00854828|540163904|FG001|Overall Study|Missed 24mo visit|1|||
149735765|NCT00854828|540163905|FG002|Overall Study|Missed 24mo visit|8|||
149735766|NCT00854828|540163906|FG003|Overall Study|Missed 24mo visit|8|||
149735767|NCT01282229|540163907|FG000|Overall Study|Protocol Violation|2|||
149735768|NCT00996203|540163908|FG000|Overall Study|Adverse Event|3|||
149735769|NCT00996203|540163908|FG000|Overall Study|Lost to Follow-up|1|||
149735770|NCT00996203|540163908|FG000|Overall Study|Lack of Efficacy|1|||
149735771|NCT00996203|540163908|FG000|Overall Study|Protocol Violation|2|||
149735772|NCT01671280|540163909|FG000|Overall Study|Withdrawal by Subject|2|||
149735773|NCT01959165|540163910|FG000|Overall Study|Adverse Event|0|||
149735774|NCT01959165|540163911|FG001|Overall Study|Adverse Event|0|||
149735775|NCT01959165|540163912|FG002|Overall Study|Adverse Event|0|||
149735776|NCT01959165|540163913|FG003|Overall Study|Adverse Event|1|||
149735777|NCT01959165|540163910|FG000|Overall Study|Lack of Efficacy|1|||
149735778|NCT01959165|540163911|FG001|Overall Study|Lack of Efficacy|0|||
149735779|NCT01959165|540163912|FG002|Overall Study|Lack of Efficacy|0|||
149735780|NCT01959165|540163913|FG003|Overall Study|Lack of Efficacy|0|||
149735781|NCT01959165|540163910|FG000|Overall Study|overdose|0|||
149735782|NCT01959165|540163911|FG001|Overall Study|overdose|0|||
149735783|NCT01959165|540163912|FG002|Overall Study|overdose|0|||
149735784|NCT01959165|540163913|FG003|Overall Study|overdose|1|||
149735785|NCT01959165|540163910|FG000|Overall Study|Welfare recipient|0|||
149735786|NCT01959165|540163911|FG001|Overall Study|Welfare recipient|1|||
149735787|NCT01959165|540163912|FG002|Overall Study|Welfare recipient|0|||
149735788|NCT01959165|540163913|FG003|Overall Study|Welfare recipient|0|||
149735789|NCT03094195|540163914|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
150255028|NCT00605215|542070531|FG000|Overall Study|Pregnancy|8|||
150255029|NCT00605215|542070532|FG001|Overall Study|Pregnancy|5|||
150255030|NCT00605215|542070533|FG002|Overall Study|Pregnancy|4|||
150255031|NCT00605215|542070531|FG000|Overall Study|Lost to Follow-up|8|||
150255032|NCT00605215|542070532|FG001|Overall Study|Lost to Follow-up|5|||
150255033|NCT00605215|542070533|FG002|Overall Study|Lost to Follow-up|2|||
150255034|NCT00605215|542070531|FG000|Overall Study|Other than specified|0|||
149735790|NCT03094195|540163915|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
149735791|NCT03094195|540163916|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
149735792|NCT03094195|540163917|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149735793|NCT03094195|540163918|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149735794|NCT03094195|540163919|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149735795|NCT03094195|540163920|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149735796|NCT03094195|540163921|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149735797|NCT03094195|540163914|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
149735798|NCT03094195|540163915|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
149735799|NCT03094195|540163916|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
149735800|NCT03094195|540163917|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149735801|NCT03094195|540163918|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149735802|NCT03094195|540163919|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149735803|NCT03094195|540163920|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149735804|NCT03094195|540163921|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149735805|NCT03094195|540163914|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735806|NCT03094195|540163915|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735807|NCT03094195|540163916|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
149735808|NCT03094195|540163917|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735809|NCT03094195|540163918|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735810|NCT03094195|540163919|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735811|NCT03094195|540163920|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735812|NCT03094195|540163921|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149735813|NCT03094195|540163914|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735814|NCT03094195|540163915|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
149735815|NCT03094195|540163916|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
149735816|NCT03094195|540163917|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735817|NCT03094195|540163918|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735818|NCT03094195|540163919|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735819|NCT03094195|540163920|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735820|NCT03094195|540163921|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149735821|NCT00927563|540163922|FG000|Overall Study|Lost to Follow-up|1|||
149735822|NCT00927563|540163922|FG000|Overall Study|Withdrawal by Subject|1|||
149735823|NCT00787787|540163926|FG000|Overall Study|Lack of Efficacy|4|||
149735824|NCT00787787|540163926|FG000|Overall Study|Adverse Event|3|||
149735825|NCT02116621|540163927|FG000|Baseline|Withdrawal by Subject|0|||
149735826|NCT02116621|540163928|FG001|Baseline|Withdrawal by Subject|4|||
149735827|NCT02116621|540163927|FG000|Three Month Follow-up|Death|1|||
149735828|NCT02116621|540163928|FG001|Three Month Follow-up|Death|1|||
149735829|NCT02116621|540163927|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
149735830|NCT02116621|540163928|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
149735831|NCT02116621|540163927|FG000|Three Month Follow-up|Lost to Follow-up|0|||
149735832|NCT02116621|540163928|FG001|Three Month Follow-up|Lost to Follow-up|1|||
149735833|NCT02116621|540163927|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
149735834|NCT02116621|540163928|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
149735835|NCT02116621|540163927|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
149735836|NCT02116621|540163928|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
149735837|NCT02116621|540163927|FG000|Six Month Follow-up|Lost to Follow-up|2|||
149735838|NCT02116621|540163928|FG001|Six Month Follow-up|Lost to Follow-up|1|||
149735839|NCT02116621|540163927|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
149735840|NCT02116621|540163928|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
149735841|NCT02116621|540163927|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
149735842|NCT02116621|540163928|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
149735843|NCT02116621|540163927|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
149735844|NCT02116621|540163928|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
150255035|NCT00605215|542070532|FG001|Overall Study|Other than specified|2|||
149735845|NCT02116621|540163927|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
150255036|NCT00605215|542070533|FG002|Overall Study|Other than specified|1|||
150255037|NCT00275262|542070534|FG000|Overall Study|Adverse Event|2|||
149735846|NCT02116621|540163928|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
149735847|NCT02116621|540163927|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
149735848|NCT02116621|540163928|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
149735849|NCT01412957|540163929|FG000|Overall Study|Withdrawal by Subject|6|||
149735850|NCT01412957|540163930|FG001|Overall Study|Withdrawal by Subject|22|||
149735851|NCT01412957|540163929|FG000|Overall Study|Lost to Follow-up|7|||
149735852|NCT01412957|540163930|FG001|Overall Study|Lost to Follow-up|2|||
149735853|NCT01412957|540163929|FG000|Overall Study|Death|136|||
149735854|NCT01412957|540163930|FG001|Overall Study|Death|133|||
149735855|NCT01870739|540163932|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
149735856|NCT01870739|540163933|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
149735857|NCT01870739|540163932|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
149735858|NCT01870739|540163933|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
149735859|NCT01870739|540163932|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
149735860|NCT01870739|540163933|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
149735861|NCT01870739|540163932|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
149735862|NCT01870739|540163933|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
149735863|NCT01870739|540163932|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
149735864|NCT01870739|540163933|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
149735865|NCT01870739|540163932|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
149735866|NCT01870739|540163933|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
149735867|NCT01870739|540163932|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
149735868|NCT01870739|540163933|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
149735869|NCT01986062|540163934|FG000|Overall Study|Lost to Follow-up|1|||
149735870|NCT01986062|540163935|FG001|Overall Study|Lost to Follow-up|0|||
149735871|NCT01986062|540163934|FG000|Overall Study|Withdrawal by Subject|0|||
149735872|NCT01986062|540163935|FG001|Overall Study|Withdrawal by Subject|1|||
149735873|NCT03538743|540163936|FG000|Overall Study|Adverse Event|0|||
149735874|NCT03538743|540163937|FG001|Overall Study|Adverse Event|0|||
149735875|NCT03538743|540163938|FG002|Overall Study|Adverse Event|1|||
149735876|NCT03538743|540163939|FG003|Overall Study|Adverse Event|1|||
149735877|NCT03538743|540163940|FG004|Overall Study|Adverse Event|0|||
149735878|NCT03538743|540163941|FG005|Overall Study|Adverse Event|0|||
149735879|NCT03538743|540163942|FG006|Overall Study|Adverse Event|0|||
149735880|NCT03538743|540163943|FG007|Overall Study|Adverse Event|0|||
149735881|NCT03538743|540163944|FG008|Overall Study|Adverse Event|0|||
149735882|NCT03538743|540163936|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
149735883|NCT03538743|540163937|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
149735884|NCT03538743|540163938|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
149735885|NCT03538743|540163939|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
149735886|NCT03538743|540163940|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
149735887|NCT03538743|540163941|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
149735888|NCT03538743|540163942|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
149735889|NCT03538743|540163943|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
149735890|NCT03538743|540163944|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
149735891|NCT03538743|540163936|FG000|Overall Study|Withdrawal by Subject|0|||
149735892|NCT03538743|540163937|FG001|Overall Study|Withdrawal by Subject|0|||
149735893|NCT03538743|540163938|FG002|Overall Study|Withdrawal by Subject|0|||
149735894|NCT03538743|540163939|FG003|Overall Study|Withdrawal by Subject|1|||
149735895|NCT03538743|540163940|FG004|Overall Study|Withdrawal by Subject|0|||
149735896|NCT03538743|540163941|FG005|Overall Study|Withdrawal by Subject|0|||
149735897|NCT03538743|540163942|FG006|Overall Study|Withdrawal by Subject|0|||
149735898|NCT03538743|540163943|FG007|Overall Study|Withdrawal by Subject|0|||
149735899|NCT03538743|540163944|FG008|Overall Study|Withdrawal by Subject|0|||
149735900|NCT01565980|540163946|FG000|Overall Study|Death|1|||
149735901|NCT01565980|540163947|FG001|Overall Study|Death|0|||
149735902|NCT01565980|540163946|FG000|Overall Study|Lost to Follow-up|1|||
149735903|NCT01565980|540163947|FG001|Overall Study|Lost to Follow-up|0|||
149735904|NCT01565980|540163946|FG000|Overall Study|health complications|1|||
149735905|NCT01565980|540163947|FG001|Overall Study|health complications|1|||
149735906|NCT01565980|540163946|FG000|Overall Study|stopped medical treatment|1|||
149735907|NCT01565980|540163947|FG001|Overall Study|stopped medical treatment|0|||
149735908|NCT01565980|540163946|FG000|Overall Study|Withdrawal by Subject|0|||
149735909|NCT01565980|540163947|FG001|Overall Study|Withdrawal by Subject|3|||
149735910|NCT01929135|540163954|FG000|Overall Study|Lost to Follow-up|1|||
149735911|NCT01929135|540163955|FG001|Overall Study|Lost to Follow-up|1|||
149735912|NCT01926626|540163956|FG000|Overall Study|Withdrawal by Subject|15|||
149735913|NCT01926626|540163956|FG000|Overall Study|Lost to Follow-up|7|||
149735914|NCT04439279|540165537|FG000|Overall Study|Adverse Event|7|||
149735915|NCT04439279|540165537|FG000|Overall Study|Death|4|||
149735916|NCT04439279|540165537|FG000|Overall Study|Disease progression|17|||
149735917|NCT04439279|540165537|FG000|Overall Study|Complicating disease|3|||
149735918|NCT04439279|540165537|FG000|Overall Study|Withdrawal by Subject|2|||
149735919|NCT04439279|540165537|FG000|Overall Study|Ineligible|1|||
149735920|NCT04439279|540165537|FG000|Overall Study|Treatment still ongoing|1|||
149735921|NCT02031679|540165538|FG000|Overall Study|Protocol Violation|0|||
149735922|NCT02031679|540165539|FG001|Overall Study|Protocol Violation|1|||
149735923|NCT02031679|540165538|FG000|Overall Study|Lack of Efficacy|0|||
149735924|NCT02031679|540165539|FG001|Overall Study|Lack of Efficacy|1|||
149735925|NCT02338843|540165540|FG000|Overall Study|Adverse Event|2|||
149735926|NCT02338843|540165541|FG001|Overall Study|Adverse Event|1|||
149735927|NCT02338843|540165540|FG000|Overall Study|Death|40|||
149735928|NCT02338843|540165541|FG001|Overall Study|Death|53|||
149735929|NCT02338843|540165540|FG000|Overall Study|Physician Decision|1|||
149735930|NCT02338843|540165541|FG001|Overall Study|Physician Decision|0|||
149735931|NCT02338843|540165540|FG000|Overall Study|Withdrawal by Subject|0|||
149735932|NCT02338843|540165541|FG001|Overall Study|Withdrawal by Subject|2|||
149735933|NCT02338843|540165540|FG000|Overall Study|Subject Recovered|0|||
149735934|NCT02338843|540165541|FG001|Overall Study|Subject Recovered|2|||
149735935|NCT02338843|540165540|FG000|Overall Study|Discontinued prior to randomizat|1|||
149735936|NCT02338843|540165541|FG001|Overall Study|Discontinued prior to randomizat|0|||
149735937|NCT00023322|540165542|FG000|Overall Study|Lost to Follow-up|1|||
150255038|NCT00275262|542070535|FG001|Overall Study|Adverse Event|0|||
150255039|NCT00275262|542070534|FG000|Overall Study|Disease progression|2|||
149735938|NCT01609933|540165543|FG000|Overall Study|Adverse Event|1|||
150255040|NCT00275262|542070535|FG001|Overall Study|Disease progression|5|||
150255041|NCT00275262|542070534|FG000|Overall Study|Lost to Follow-up|0|||
150255042|NCT00275262|542070535|FG001|Overall Study|Lost to Follow-up|2|||
150255043|NCT00275262|542070534|FG000|Overall Study|Protocol Violation|0|||
150255044|NCT00275262|542070535|FG001|Overall Study|Protocol Violation|2|||
149735939|NCT01609933|540165543|FG000|Overall Study|Withdrawal by Subject|3|||
150255045|NCT00275262|542070534|FG000|Overall Study|Death|1|||
149735940|NCT02300129|540165545|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
149735941|NCT02300129|540165546|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
149735942|NCT02300129|540165547|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
149735943|NCT02300129|540165548|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
149735944|NCT02300129|540165545|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
149735945|NCT02300129|540165546|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
149735946|NCT02300129|540165547|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
150255046|NCT00275262|542070535|FG001|Overall Study|Death|0|||
150255047|NCT00275262|542070534|FG000|Overall Study|Started Chemotherapy|1|||
150255048|NCT00275262|542070535|FG001|Overall Study|Started Chemotherapy|0|||
149735947|NCT02300129|540165548|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
149735948|NCT02300129|540165545|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
149735949|NCT02300129|540165546|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149735950|NCT02300129|540165547|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149735951|NCT02300129|540165548|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149735952|NCT01887912|540165549|FG000|Overall Study|Serious adverse event|400|||
149735953|NCT01887912|540165550|FG001|Overall Study|Serious adverse event|198|||
149735954|NCT01887912|540165549|FG000|Overall Study|Other Adverse Event|34|||
149735955|NCT01887912|540165550|FG001|Overall Study|Other Adverse Event|15|||
149735956|NCT01887912|540165549|FG000|Overall Study|Protocol Violation|67|||
149735957|NCT01887912|540165550|FG001|Overall Study|Protocol Violation|37|||
149735958|NCT01887912|540165549|FG000|Overall Study|Lost to Follow-up|163|||
149735959|NCT01887912|540165550|FG001|Overall Study|Lost to Follow-up|74|||
149735960|NCT01887912|540165549|FG000|Overall Study|Withdrawal by Subject|606|||
149735961|NCT01887912|540165550|FG001|Overall Study|Withdrawal by Subject|349|||
149735962|NCT01887912|540165549|FG000|Overall Study|Other|122|||
149735963|NCT01887912|540165550|FG001|Overall Study|Other|58|||
149735964|NCT01154101|540165554|FG000|Overall Study|Adverse Event|0|||
149735965|NCT01154101|540165555|FG001|Overall Study|Adverse Event|2|||
149735966|NCT01154101|540165556|FG002|Overall Study|Adverse Event|1|||
149735967|NCT01154101|540165557|FG003|Overall Study|Adverse Event|1|||
149735968|NCT01154101|540165558|FG004|Overall Study|Adverse Event|0|||
149735969|NCT01154101|540165554|FG000|Overall Study|Lost to Follow-up|0|||
149735970|NCT01154101|540165555|FG001|Overall Study|Lost to Follow-up|1|||
149735971|NCT01154101|540165556|FG002|Overall Study|Lost to Follow-up|0|||
149735972|NCT01154101|540165557|FG003|Overall Study|Lost to Follow-up|1|||
149735973|NCT01154101|540165558|FG004|Overall Study|Lost to Follow-up|0|||
149735974|NCT01154101|540165554|FG000|Overall Study|Withdrawal by Subject|0|||
149735975|NCT01154101|540165555|FG001|Overall Study|Withdrawal by Subject|1|||
149735976|NCT01154101|540165556|FG002|Overall Study|Withdrawal by Subject|2|||
149735977|NCT01154101|540165557|FG003|Overall Study|Withdrawal by Subject|0|||
149735978|NCT01154101|540165558|FG004|Overall Study|Withdrawal by Subject|1|||
149735979|NCT05019131|540165559|FG000|Overall Study|Lost to Follow-up|0|||
149735980|NCT05019131|540165560|FG001|Overall Study|Lost to Follow-up|3|||
149735981|NCT00432237|540165561|FG000|Overall Study|Adverse Event|0|||
149735982|NCT00432237|540165562|FG001|Overall Study|Adverse Event|0|||
149735983|NCT00432237|540165563|FG002|Overall Study|Adverse Event|0|||
149735984|NCT00432237|540165564|FG003|Overall Study|Adverse Event|1|||
149735985|NCT00432237|540165561|FG000|Overall Study|Lack of Efficacy|0|||
149735986|NCT00432237|540165562|FG001|Overall Study|Lack of Efficacy|0|||
149735987|NCT00432237|540165563|FG002|Overall Study|Lack of Efficacy|0|||
149735988|NCT00432237|540165564|FG003|Overall Study|Lack of Efficacy|1|||
149735989|NCT00432237|540165561|FG000|Overall Study|Lost to Follow-up|10|||
149735990|NCT00432237|540165562|FG001|Overall Study|Lost to Follow-up|10|||
149735991|NCT00432237|540165563|FG002|Overall Study|Lost to Follow-up|18|||
149735992|NCT00432237|540165564|FG003|Overall Study|Lost to Follow-up|18|||
149735993|NCT00432237|540165561|FG000|Overall Study|Physician Decision|1|||
149735994|NCT00432237|540165562|FG001|Overall Study|Physician Decision|3|||
149735995|NCT00432237|540165563|FG002|Overall Study|Physician Decision|2|||
149735996|NCT00432237|540165564|FG003|Overall Study|Physician Decision|1|||
149735997|NCT00432237|540165561|FG000|Overall Study|Pregnancy|0|||
149735998|NCT00432237|540165562|FG001|Overall Study|Pregnancy|1|||
149735999|NCT00432237|540165563|FG002|Overall Study|Pregnancy|0|||
149736000|NCT00432237|540165564|FG003|Overall Study|Pregnancy|0|||
149736001|NCT00432237|540165561|FG000|Overall Study|Protocol Violation|13|||
149736002|NCT00432237|540165562|FG001|Overall Study|Protocol Violation|10|||
149736003|NCT00432237|540165563|FG002|Overall Study|Protocol Violation|11|||
149736004|NCT00432237|540165564|FG003|Overall Study|Protocol Violation|8|||
149736005|NCT00432237|540165561|FG000|Overall Study|Withdrawal by Subject|5|||
149736006|NCT00432237|540165562|FG001|Overall Study|Withdrawal by Subject|6|||
149736007|NCT00432237|540165563|FG002|Overall Study|Withdrawal by Subject|9|||
150255049|NCT01302067|542070542|FG000|Overall Study|Death|0|||
150255050|NCT01302067|542070543|FG001|Overall Study|Death|0|||
149736008|NCT00432237|540165564|FG003|Overall Study|Withdrawal by Subject|11|||
149736009|NCT00432237|540165561|FG000|Overall Study|Lack of Qualifying Event|38|||
149736010|NCT00432237|540165562|FG001|Overall Study|Lack of Qualifying Event|71|||
149736011|NCT00432237|540165563|FG002|Overall Study|Lack of Qualifying Event|69|||
149736012|NCT00432237|540165564|FG003|Overall Study|Lack of Qualifying Event|84|||
149736013|NCT01919307|540165567|FG000|Overall Study|Withdrawal by Subject|9|||
149736014|NCT02157883|540165571|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
149736015|NCT02157883|540165571|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
149736016|NCT02157883|540165571|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
149736017|NCT02157883|540165571|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
149736018|NCT02157883|540165571|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
149736019|NCT03155997|540165572|FG000|Overall Study|Withdrawal by Subject|119|||
150255051|NCT01302067|542070544|FG002|Overall Study|Death|1|||
149736020|NCT03155997|540165573|FG001|Overall Study|Withdrawal by Subject|134|||
149736021|NCT03155997|540165572|FG000|Overall Study|Lost to Follow-up|12|||
149736022|NCT03155997|540165573|FG001|Overall Study|Lost to Follow-up|13|||
149736023|NCT03155997|540165572|FG000|Overall Study|Missing disposition data|0|||
149736024|NCT03155997|540165573|FG001|Overall Study|Missing disposition data|1|||
149736025|NCT03155997|540165572|FG000|Overall Study|On study treatment|2027|||
149736026|NCT03155997|540165573|FG001|Overall Study|On study treatment|2074|||
149736027|NCT04067518|540165576|FG000|Overall Study|Adverse Event|1|||
149736028|NCT04067518|540165577|FG001|Overall Study|Adverse Event|3|||
149736029|NCT04067518|540165576|FG000|Overall Study|Screen failures|0|||
149736030|NCT04067518|540165577|FG001|Overall Study|Screen failures|1|||
149736031|NCT04067518|540165576|FG000|Overall Study|Enrolled but not treated|0|||
149736032|NCT04067518|540165577|FG001|Overall Study|Enrolled but not treated|1|||
149736033|NCT02771522|540165578|FG000|Overall Study|Lost to Follow-up|3|||
149736034|NCT02771522|540165578|FG000|Overall Study|Withdrawal by Subject|2|||
149736035|NCT02771522|540165578|FG000|Overall Study|No white spot lesions|3|||
149736036|NCT00934102|540165582|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
149736037|NCT00934102|540165583|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
149736038|NCT00934102|540165584|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
149736039|NCT04258579|540165585|FG000|Overall Study|Withdrawal by Subject|7|||
149736040|NCT04258579|540165585|FG000|Overall Study|Lost to Follow-up|3|||
149736041|NCT04258579|540165585|FG000|Overall Study|Protocol Violation|2|||
149736042|NCT04258579|540165585|FG000|Overall Study|Adverse Event|1|||
149736043|NCT04007159|540165586|FG000|Induction Phase|(missed study visits)|16|||
149736044|NCT04007159|540165586|FG000|Induction Phase|Withdrawal by Subject|4|||
149736045|NCT04007159|540165586|FG000|Induction Phase|Adverse Event|2|||
149736046|NCT04007159|540165586|FG000|Challenge Phase|missed study visits|3|||
149736047|NCT02076165|540165587|FG000|Overall Study|Lost to Follow-up|7|||
149736048|NCT02076165|540165588|FG001|Overall Study|Lost to Follow-up|5|||
149736049|NCT02076165|540165587|FG000|Overall Study|Refused follow-up assessment|1|||
149736050|NCT02076165|540165588|FG001|Overall Study|Refused follow-up assessment|1|||
149736051|NCT00486603|540165589|FG000|Overall Study|Withdrawal by Subject|1|||
149736052|NCT00486603|540165590|FG001|Overall Study|Withdrawal by Subject|0|||
149736053|NCT00486603|540165591|FG002|Overall Study|Withdrawal by Subject|0|||
149736054|NCT00486603|540165592|FG003|Overall Study|Withdrawal by Subject|0|||
149736055|NCT00486603|540165593|FG004|Overall Study|Withdrawal by Subject|0|||
149736056|NCT00486603|540165589|FG000|Overall Study|Physician Decision|0|||
149736057|NCT00486603|540165590|FG001|Overall Study|Physician Decision|1|||
149736058|NCT00486603|540165591|FG002|Overall Study|Physician Decision|0|||
149736059|NCT00486603|540165592|FG003|Overall Study|Physician Decision|0|||
149736060|NCT00486603|540165593|FG004|Overall Study|Physician Decision|0|||
149736061|NCT01756456|540165598|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149736062|NCT01756456|540165599|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149736063|NCT01756456|540165600|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149736064|NCT01756456|540165601|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
149736065|NCT01756456|540165602|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
149736066|NCT01756456|540165603|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
149736067|NCT01756456|540165598|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149736068|NCT01756456|540165599|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149736069|NCT01756456|540165600|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149736070|NCT01756456|540165601|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
149736071|NCT01756456|540165602|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
149736072|NCT01756456|540165603|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149736073|NCT01756456|540165598|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149736074|NCT01756456|540165599|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
149736075|NCT01756456|540165600|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149736076|NCT01756456|540165601|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149736077|NCT01756456|540165602|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149736078|NCT01756456|540165603|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149736079|NCT01756456|540165598|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
149736080|NCT01756456|540165599|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
149736081|NCT01756456|540165600|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
149736082|NCT01756456|540165601|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
149736083|NCT01756456|540165602|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
149736084|NCT01756456|540165603|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
149736085|NCT01756456|540165598|FG000|Treatment Period: Phase I/II|Other causes|0|||
149736086|NCT01756456|540165599|FG001|Treatment Period: Phase I/II|Other causes|0|||
149736087|NCT01756456|540165600|FG002|Treatment Period: Phase I/II|Other causes|0|||
149736088|NCT01756456|540165601|FG003|Treatment Period: Phase I/II|Other causes|1|||
149736089|NCT01756456|540165602|FG004|Treatment Period: Phase I/II|Other causes|2|||
149736090|NCT01756456|540165603|FG005|Treatment Period: Phase I/II|Other causes|2|||
149736091|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
149736092|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
149736093|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
150255052|NCT01302067|542070542|FG000|Overall Study|Physician Decision|9|||
149736094|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
149736095|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
149736096|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
149736097|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149736098|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
149736099|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149736100|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149736101|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149736102|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149736103|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149736104|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149736105|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149736106|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149736107|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149736108|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
149736109|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
149736110|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
149736111|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
149736112|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
149736113|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
149736114|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
149736115|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149736116|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149736117|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
149736118|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
149736119|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149736120|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
149736121|NCT01756456|540165598|FG000|Follow Up Period Phase I/II|Other causes|0|||
149736122|NCT01756456|540165599|FG001|Follow Up Period Phase I/II|Other causes|0|||
149736123|NCT01756456|540165600|FG002|Follow Up Period Phase I/II|Other causes|0|||
149736124|NCT01756456|540165601|FG003|Follow Up Period Phase I/II|Other causes|1|||
149736125|NCT01756456|540165602|FG004|Follow Up Period Phase I/II|Other causes|3|||
149736126|NCT01756456|540165603|FG005|Follow Up Period Phase I/II|Other causes|5|||
149736127|NCT00813995|540165611|FG000|Overall Study|Clinical adverse event|9|||
149736128|NCT00813995|540165612|FG001|Overall Study|Clinical adverse event|3|||
149736129|NCT00813995|540165611|FG000|Overall Study|Laboratory adverse event|0|||
149736130|NCT00813995|540165612|FG001|Overall Study|Laboratory adverse event|2|||
149736131|NCT00813995|540165611|FG000|Overall Study|Lack of Efficacy|1|||
149736132|NCT00813995|540165612|FG001|Overall Study|Lack of Efficacy|0|||
149736133|NCT00813995|540165611|FG000|Overall Study|Lost to Follow-up|4|||
149736134|NCT00813995|540165612|FG001|Overall Study|Lost to Follow-up|2|||
149736135|NCT00813995|540165611|FG000|Overall Study|Other reason|2|||
149736136|NCT00813995|540165612|FG001|Overall Study|Other reason|2|||
149736137|NCT00813995|540165611|FG000|Overall Study|Protocol Violation|3|||
149736138|NCT00813995|540165612|FG001|Overall Study|Protocol Violation|2|||
149736139|NCT00813995|540165611|FG000|Overall Study|Subject moved|4|||
149736140|NCT00813995|540165612|FG001|Overall Study|Subject moved|0|||
149736141|NCT00813995|540165611|FG000|Overall Study|Withdrawal by Subject|0|||
149736142|NCT00813995|540165612|FG001|Overall Study|Withdrawal by Subject|5|||
149736143|NCT00888238|540165622|FG000|Washout Period After Period 2|Adverse Event|0|||
149736144|NCT00888238|540165623|FG001|Washout Period After Period 2|Adverse Event|0|||
149736145|NCT00888238|540165624|FG002|Washout Period After Period 2|Adverse Event|1|||
149736146|NCT02700984|540165625|FG000|Overall Study|Death|2|||
149736147|NCT02700984|540165626|FG001|Overall Study|Death|1|||
149736148|NCT02700984|540165625|FG000|Overall Study|Lost to Follow-up|2|||
149736149|NCT02700984|540165626|FG001|Overall Study|Lost to Follow-up|1|||
149736150|NCT02700984|540165625|FG000|Overall Study|Physician Decision|0|||
149736151|NCT02700984|540165626|FG001|Overall Study|Physician Decision|1|||
149736152|NCT02700984|540165625|FG000|Overall Study|Withdrawal by Subject|8|||
149736153|NCT02700984|540165626|FG001|Overall Study|Withdrawal by Subject|9|||
149736154|NCT02700984|540165625|FG000|Overall Study|Reason not specified|3|||
149736155|NCT02700984|540165626|FG001|Overall Study|Reason not specified|2|||
149736156|NCT01032629|540165628|FG000|Overall Study|Closed Site|21|||
149736157|NCT01032629|540165629|FG001|Overall Study|Closed Site|18|||
149736158|NCT01032629|540165630|FG002|Overall Study|Closed Site|16|||
149736159|NCT01032629|540165628|FG000|Overall Study|Withdrawal by Subject|50|||
149736160|NCT01032629|540165629|FG001|Overall Study|Withdrawal by Subject|36|||
149736161|NCT01032629|540165630|FG002|Overall Study|Withdrawal by Subject|35|||
149736162|NCT01032629|540165628|FG000|Overall Study|Lost to Follow-up|74|||
149736163|NCT01032629|540165629|FG001|Overall Study|Lost to Follow-up|47|||
149736164|NCT01032629|540165630|FG002|Overall Study|Lost to Follow-up|37|||
149736165|NCT02868892|540165633|FG000|Overall Study|Investigator left site and no follow-up|6|||
149736166|NCT00723957|540165634|FG000|Overall Study|Adverse event unrelated to study drug|1|||
150255053|NCT01302067|542070543|FG001|Overall Study|Physician Decision|5|||
149736167|NCT00723957|540165635|FG001|Overall Study|Adverse event unrelated to study drug|4|||
149736168|NCT00723957|540165634|FG000|Overall Study|Death|3|||
149736169|NCT00723957|540165635|FG001|Overall Study|Death|4|||
149736170|NCT00723957|540165634|FG000|Overall Study|Disease progression|27|||
149736171|NCT00723957|540165635|FG001|Overall Study|Disease progression|25|||
149736172|NCT00723957|540165634|FG000|Overall Study|Maximum clinical benefit|4|||
149736173|NCT00723957|540165635|FG001|Overall Study|Maximum clinical benefit|5|||
149736174|NCT00723957|540165634|FG000|Overall Study|Investigator decision|1|||
149736175|NCT00723957|540165635|FG001|Overall Study|Investigator decision|1|||
149736176|NCT00723957|540165634|FG000|Overall Study|Study drug toxicity|4|||
149736177|NCT00723957|540165635|FG001|Overall Study|Study drug toxicity|6|||
149736178|NCT00723957|540165634|FG000|Overall Study|Withdrawal by Subject|7|||
149736179|NCT00723957|540165635|FG001|Overall Study|Withdrawal by Subject|5|||
149736180|NCT00723957|540165634|FG000|Overall Study|Reason not analyzed|1|||
149736181|NCT00723957|540165635|FG001|Overall Study|Reason not analyzed|0|||
149736182|NCT00723957|540165634|FG000|Overall Study|Never received treatment|3|||
149736183|NCT00723957|540165635|FG001|Overall Study|Never received treatment|3|||
149736184|NCT01360996|540165637|FG000|Overall Study|Withdrawal by Subject|4|||
149736185|NCT01360996|540165638|FG001|Overall Study|Withdrawal by Subject|3|||
149736186|NCT01360996|540165639|FG002|Overall Study|Withdrawal by Subject|2|||
149736187|NCT01360996|540165637|FG000|Overall Study|Noncompliant|2|||
149736188|NCT01360996|540165638|FG001|Overall Study|Noncompliant|0|||
149736189|NCT01360996|540165639|FG002|Overall Study|Noncompliant|0|||
149736190|NCT01454076|540165640|FG000|Overall Study|Other|2|||
149736191|NCT01454076|540165641|FG001|Overall Study|Other|0|||
149736192|NCT01454076|540165642|FG002|Overall Study|Other|0|||
149736193|NCT01454076|540165643|FG003|Overall Study|Other|1|||
149736194|NCT01454076|540165644|FG004|Overall Study|Other|2|||
149736195|NCT01454076|540165640|FG000|Overall Study|Withdrawal by Subject|3|||
149736196|NCT01454076|540165641|FG001|Overall Study|Withdrawal by Subject|4|||
149736197|NCT01454076|540165642|FG002|Overall Study|Withdrawal by Subject|2|||
149736198|NCT01454076|540165643|FG003|Overall Study|Withdrawal by Subject|1|||
149736199|NCT01454076|540165644|FG004|Overall Study|Withdrawal by Subject|2|||
149736200|NCT01454076|540165640|FG000|Overall Study|Adverse Event|8|||
149736201|NCT01454076|540165641|FG001|Overall Study|Adverse Event|2|||
149736202|NCT01454076|540165642|FG002|Overall Study|Adverse Event|7|||
149736203|NCT01454076|540165643|FG003|Overall Study|Adverse Event|0|||
149736204|NCT01454076|540165644|FG004|Overall Study|Adverse Event|2|||
149736205|NCT00291551|540165645|FG000|Overall Study|Death|7|||
149736206|NCT00291551|540165645|FG000|Overall Study|Withdrawal by Subject|6|||
149736207|NCT01015833|540165646|FG000|Overall Study|Death|1|||
149736208|NCT01015833|540165647|FG001|Overall Study|Death|0|||
149736209|NCT01015833|540165646|FG000|Overall Study|Withdrawal by Subject|3|||
149736210|NCT01015833|540165647|FG001|Overall Study|Withdrawal by Subject|2|||
149736211|NCT01015833|540165646|FG000|Overall Study|Adverse Event|0|||
149736212|NCT01015833|540165647|FG001|Overall Study|Adverse Event|1|||
149736213|NCT01015833|540165646|FG000|Overall Study|Physician Decision|2|||
149736214|NCT01015833|540165647|FG001|Overall Study|Physician Decision|0|||
149736215|NCT01015833|540165646|FG000|Overall Study|Symptomatic deterioration|0|||
149736216|NCT01015833|540165647|FG001|Overall Study|Symptomatic deterioration|1|||
149736217|NCT01015833|540165646|FG000|Overall Study|Other|5|||
149736218|NCT01015833|540165647|FG001|Overall Study|Other|1|||
149736219|NCT01015833|540165646|FG000|Overall Study|Motor Vehicle Accidents|1|||
149736220|NCT01015833|540165647|FG001|Overall Study|Motor Vehicle Accidents|0|||
149736221|NCT01015833|540165646|FG000|Overall Study|Did not start treatment|1|||
149736222|NCT01015833|540165647|FG001|Overall Study|Did not start treatment|0|||
149736223|NCT01651780|540165653|FG000|Overall Study|Physician decision: No 30-day visit|2|||
149736224|NCT01651780|540165654|FG001|Overall Study|Physician decision: No 30-day visit|1|||
149736225|NCT01651780|540165653|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
149736226|NCT01651780|540165654|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
149736227|NCT01651780|540165653|FG000|Overall Study|Withdrawal by Subject|2|||
149736228|NCT01651780|540165654|FG001|Overall Study|Withdrawal by Subject|0|||
149736229|NCT01651780|540165653|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
149736230|NCT01651780|540165654|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149736231|NCT01651780|540165653|FG000|Overall Study|Lost to Follow-up|1|||
149736232|NCT01651780|540165654|FG001|Overall Study|Lost to Follow-up|2|||
149736233|NCT01651780|540165653|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
149736234|NCT01651780|540165654|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
149736235|NCT03898063|540165655|FG000|Overall Study|Withdrawal by Subject|10|||
149736236|NCT03898063|540165656|FG001|Overall Study|Withdrawal by Subject|8|||
149736237|NCT02949830|540165657|FG000|Overall Study|Adverse Event|1|||
149736238|NCT02949830|540165657|FG000|Overall Study|Withdrawal by Subject|1|||
149736239|NCT01290887|540165658|FG000|Overall Study|Adverse Event|6|||
149736240|NCT01290887|540165659|FG001|Overall Study|Adverse Event|11|||
149736241|NCT01290887|540165658|FG000|Overall Study|Lack of Efficacy|4|||
149736242|NCT01290887|540165659|FG001|Overall Study|Lack of Efficacy|5|||
149736243|NCT01290887|540165658|FG000|Overall Study|Withdrawal by Subject|26|||
149736244|NCT01290887|540165659|FG001|Overall Study|Withdrawal by Subject|32|||
149736245|NCT01290887|540165658|FG000|Overall Study|Protocol Violation|2|||
149736246|NCT01290887|540165659|FG001|Overall Study|Protocol Violation|1|||
149736247|NCT01290887|540165658|FG000|Overall Study|Lost to Follow-up|4|||
149736248|NCT01290887|540165659|FG001|Overall Study|Lost to Follow-up|4|||
149736249|NCT01290887|540165658|FG000|Overall Study|Non-compliance to study procedures|0|||
149736250|NCT01290887|540165659|FG001|Overall Study|Non-compliance to study procedures|1|||
149736251|NCT01290887|540165658|FG000|Overall Study|Non-compliance to study medications|1|||
149736252|NCT01290887|540165659|FG001|Overall Study|Non-compliance to study medications|0|||
149736253|NCT01290887|540165658|FG000|Overall Study|Sponsor closure of study|420|||
149736254|NCT01290887|540165659|FG001|Overall Study|Sponsor closure of study|476|||
149736255|NCT01290887|540165658|FG000|Overall Study|Other|3|||
149736256|NCT01290887|540165659|FG001|Overall Study|Other|6|||
149736257|NCT01628926|540165660|FG000|Overall Study|Adverse Event|13|||
149736258|NCT01628926|540165661|FG001|Overall Study|Adverse Event|11|||
149736259|NCT01628926|540165662|FG002|Overall Study|Adverse Event|9|||
149736260|NCT01628926|540165660|FG000|Overall Study|Lack of Efficacy|2|||
149736261|NCT01628926|540165661|FG001|Overall Study|Lack of Efficacy|1|||
149736262|NCT01628926|540165662|FG002|Overall Study|Lack of Efficacy|5|||
149736263|NCT01628926|540165660|FG000|Overall Study|Withdrawal by Subject|6|||
149736264|NCT01628926|540165661|FG001|Overall Study|Withdrawal by Subject|4|||
149736265|NCT01628926|540165662|FG002|Overall Study|Withdrawal by Subject|2|||
149736266|NCT01628926|540165660|FG000|Overall Study|Protocol Violation|0|||
149736267|NCT01628926|540165661|FG001|Overall Study|Protocol Violation|1|||
149736268|NCT01628926|540165662|FG002|Overall Study|Protocol Violation|0|||
149736269|NCT01628926|540165660|FG000|Overall Study|Discontinuation criteria|3|||
149736270|NCT01628926|540165661|FG001|Overall Study|Discontinuation criteria|4|||
149736271|NCT01628926|540165662|FG002|Overall Study|Discontinuation criteria|0|||
149736272|NCT01628926|540165660|FG000|Overall Study|Physician Decision|2|||
149736273|NCT01628926|540165661|FG001|Overall Study|Physician Decision|2|||
149736274|NCT01628926|540165662|FG002|Overall Study|Physician Decision|1|||
149736275|NCT03437447|540165663|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149736276|NCT03437447|540165664|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149736277|NCT03437447|540165665|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149736278|NCT02040142|540165666|FG000|Overall Study|Lost to Follow-up|5|||
149736279|NCT02040142|540165666|FG000|Overall Study|Death|17|||
149736280|NCT02040142|540165666|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
149736281|NCT04752384|540165667|FG000|Overall Study|Withdrawal by Subject|1|||
149736282|NCT04752384|540165667|FG000|Overall Study|Death|1|||
149736283|NCT00413959|540165668|FG000|Overall Study|Pt had only one cycle.|1|||
149736284|NCT01817790|540165674|FG000|Overall Study|Adverse Event|0|||
149736285|NCT01817790|540165675|FG001|Overall Study|Adverse Event|2|||
149736286|NCT01817790|540165674|FG000|Overall Study|Lost to Follow-up|0|||
149736287|NCT01817790|540165675|FG001|Overall Study|Lost to Follow-up|1|||
149736288|NCT01817790|540165674|FG000|Overall Study|Protocol Violation|2|||
149736289|NCT01817790|540165675|FG001|Overall Study|Protocol Violation|1|||
149736290|NCT01817790|540165674|FG000|Overall Study|Withdrawal by Subject|1|||
149736291|NCT01817790|540165675|FG001|Overall Study|Withdrawal by Subject|3|||
149736292|NCT01817790|540165674|FG000|Overall Study|Other: Could not attend appointment|1|||
149736293|NCT01817790|540165675|FG001|Overall Study|Other: Could not attend appointment|1|||
149736294|NCT01671345|540165676|FG000|Overall Study|Lost to Follow-up|10|||
149736295|NCT01671345|540165677|FG001|Overall Study|Lost to Follow-up|6|||
149736296|NCT01671345|540165676|FG000|Overall Study|visit with non-participating physician|3|||
149736297|NCT01671345|540165677|FG001|Overall Study|visit with non-participating physician|3|||
149736298|NCT03636906|540165678|FG000|Overall Study|Adverse Event|0|||
149736299|NCT03636906|540165679|FG001|Overall Study|Adverse Event|0|||
149736300|NCT03636906|540165680|FG002|Overall Study|Adverse Event|1|||
149736301|NCT03636906|540165678|FG000|Overall Study|Lost to Follow-up|1|||
149736302|NCT03636906|540165679|FG001|Overall Study|Lost to Follow-up|0|||
149736303|NCT03636906|540165680|FG002|Overall Study|Lost to Follow-up|0|||
149736304|NCT03636906|540165678|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
149736305|NCT03636906|540165679|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
149736306|NCT03636906|540165680|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
149736307|NCT03636906|540165678|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
149736308|NCT03636906|540165679|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149736309|NCT03636906|540165680|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
149736310|NCT03636906|540165678|FG000|Overall Study|Other|0|||
149736311|NCT03636906|540165679|FG001|Overall Study|Other|0|||
149736312|NCT03636906|540165680|FG002|Overall Study|Other|1|||
149736313|NCT00891202|540165681|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
149736314|NCT00891202|540165682|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149736315|NCT00891202|540165683|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149736316|NCT00891202|540165684|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149736317|NCT00891202|540165681|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149736318|NCT00891202|540165682|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149736319|NCT00891202|540165683|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
149736320|NCT00891202|540165684|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149736321|NCT00891202|540165681|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149736322|NCT00891202|540165682|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149736323|NCT00891202|540165683|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
149736324|NCT00891202|540165684|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149736325|NCT00891202|540165681|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
149736326|NCT00891202|540165682|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
149736327|NCT00891202|540165683|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
149736328|NCT00891202|540165684|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
149736329|NCT03690869|540165689|FG000|Overall Study|Adverse Event|0|||
149736330|NCT03690869|540165690|FG001|Overall Study|Adverse Event|0|||
149736331|NCT03690869|540165691|FG002|Overall Study|Adverse Event|0|||
149736332|NCT03690869|540165692|FG003|Overall Study|Adverse Event|1|||
149736333|NCT03690869|540165693|FG004|Overall Study|Adverse Event|0|||
149736334|NCT03690869|540165694|FG005|Overall Study|Adverse Event|0|||
149736335|NCT03690869|540165695|FG006|Overall Study|Adverse Event|0|||
149736336|NCT03690869|540165696|FG007|Overall Study|Adverse Event|1|||
149736337|NCT03690869|540165697|FG008|Overall Study|Adverse Event|0|||
149736338|NCT03690869|540165698|FG009|Overall Study|Adverse Event|1|||
149736339|NCT03690869|540165689|FG000|Overall Study|Death|1|||
149736340|NCT03690869|540165690|FG001|Overall Study|Death|1|||
149736341|NCT03690869|540165691|FG002|Overall Study|Death|1|||
149736342|NCT03690869|540165692|FG003|Overall Study|Death|4|||
149736343|NCT03690869|540165693|FG004|Overall Study|Death|2|||
149736344|NCT03690869|540165694|FG005|Overall Study|Death|5|||
149736345|NCT03690869|540165695|FG006|Overall Study|Death|3|||
149736346|NCT03690869|540165696|FG007|Overall Study|Death|2|||
149736347|NCT03690869|540165697|FG008|Overall Study|Death|0|||
149736348|NCT03690869|540165698|FG009|Overall Study|Death|3|||
149736349|NCT03690869|540165689|FG000|Overall Study|Lost to Follow-up|0|||
149736350|NCT03690869|540165690|FG001|Overall Study|Lost to Follow-up|0|||
149736351|NCT03690869|540165691|FG002|Overall Study|Lost to Follow-up|1|||
149736352|NCT03690869|540165692|FG003|Overall Study|Lost to Follow-up|0|||
149736353|NCT03690869|540165693|FG004|Overall Study|Lost to Follow-up|0|||
149736354|NCT03690869|540165694|FG005|Overall Study|Lost to Follow-up|0|||
149736355|NCT03690869|540165695|FG006|Overall Study|Lost to Follow-up|0|||
149736356|NCT03690869|540165696|FG007|Overall Study|Lost to Follow-up|0|||
149736357|NCT03690869|540165697|FG008|Overall Study|Lost to Follow-up|0|||
149736358|NCT03690869|540165698|FG009|Overall Study|Lost to Follow-up|0|||
149736359|NCT03690869|540165689|FG000|Overall Study|Other Treatment|1|||
149736360|NCT03690869|540165690|FG001|Overall Study|Other Treatment|1|||
149736361|NCT03690869|540165691|FG002|Overall Study|Other Treatment|1|||
149736362|NCT03690869|540165692|FG003|Overall Study|Other Treatment|2|||
149736363|NCT03690869|540165693|FG004|Overall Study|Other Treatment|3|||
149736364|NCT03690869|540165694|FG005|Overall Study|Other Treatment|1|||
149736365|NCT03690869|540165695|FG006|Overall Study|Other Treatment|2|||
149736366|NCT03690869|540165696|FG007|Overall Study|Other Treatment|7|||
149736367|NCT03690869|540165697|FG008|Overall Study|Other Treatment|0|||
149736368|NCT03690869|540165698|FG009|Overall Study|Other Treatment|3|||
149736369|NCT03690869|540165689|FG000|Overall Study|Physician Decision|0|||
149736370|NCT03690869|540165690|FG001|Overall Study|Physician Decision|1|||
149736371|NCT03690869|540165691|FG002|Overall Study|Physician Decision|0|||
149736372|NCT03690869|540165692|FG003|Overall Study|Physician Decision|0|||
150255054|NCT01302067|542070544|FG002|Overall Study|Physician Decision|14|||
150255055|NCT01302067|542070542|FG000|Overall Study|Lack of Efficacy|8|||
150255056|NCT01302067|542070543|FG001|Overall Study|Lack of Efficacy|4|||
149736373|NCT03690869|540165693|FG004|Overall Study|Physician Decision|0|||
149736374|NCT03690869|540165694|FG005|Overall Study|Physician Decision|0|||
149736375|NCT03690869|540165695|FG006|Overall Study|Physician Decision|0|||
150255057|NCT01302067|542070544|FG002|Overall Study|Lack of Efficacy|2|||
150255058|NCT01302067|542070542|FG000|Overall Study|Lost to Follow-up|9|||
150255059|NCT01302067|542070543|FG001|Overall Study|Lost to Follow-up|4|||
150255060|NCT01302067|542070544|FG002|Overall Study|Lost to Follow-up|15|||
150255061|NCT01302067|542070542|FG000|Overall Study|Withdrawal by Subject|13|||
150255062|NCT01302067|542070543|FG001|Overall Study|Withdrawal by Subject|6|||
150255063|NCT01302067|542070544|FG002|Overall Study|Withdrawal by Subject|10|||
149736376|NCT03690869|540165696|FG007|Overall Study|Physician Decision|0|||
149736377|NCT03690869|540165697|FG008|Overall Study|Physician Decision|0|||
149736378|NCT03690869|540165698|FG009|Overall Study|Physician Decision|0|||
149736379|NCT03690869|540165689|FG000|Overall Study|Progressive Disease|1|||
149736380|NCT03690869|540165690|FG001|Overall Study|Progressive Disease|2|||
149736381|NCT03690869|540165691|FG002|Overall Study|Progressive Disease|0|||
149736382|NCT03690869|540165692|FG003|Overall Study|Progressive Disease|1|||
150255064|NCT01302067|542070542|FG000|Overall Study|Other|1|||
149736383|NCT03690869|540165693|FG004|Overall Study|Progressive Disease|0|||
149736384|NCT03690869|540165694|FG005|Overall Study|Progressive Disease|0|||
149736385|NCT03690869|540165695|FG006|Overall Study|Progressive Disease|0|||
149736386|NCT03690869|540165696|FG007|Overall Study|Progressive Disease|0|||
149736387|NCT03690869|540165697|FG008|Overall Study|Progressive Disease|1|||
149736388|NCT03690869|540165698|FG009|Overall Study|Progressive Disease|1|||
149736389|NCT03690869|540165689|FG000|Overall Study|Subject Decision|0|||
149736390|NCT03690869|540165690|FG001|Overall Study|Subject Decision|0|||
149736391|NCT03690869|540165691|FG002|Overall Study|Subject Decision|0|||
149736392|NCT03690869|540165692|FG003|Overall Study|Subject Decision|1|||
149736393|NCT03690869|540165693|FG004|Overall Study|Subject Decision|0|||
149736394|NCT03690869|540165694|FG005|Overall Study|Subject Decision|0|||
149736395|NCT03690869|540165695|FG006|Overall Study|Subject Decision|0|||
149736396|NCT03690869|540165696|FG007|Overall Study|Subject Decision|1|||
149736397|NCT03690869|540165697|FG008|Overall Study|Subject Decision|0|||
149736398|NCT03690869|540165698|FG009|Overall Study|Subject Decision|0|||
149736399|NCT06001307|540167185|FG000|Overall Study|Lost to Follow-up|1|||
149736400|NCT06001307|540167186|FG001|Overall Study|Lost to Follow-up|2|||
149736401|NCT03532100|540167187|FG000|Overall Study|Intervention malfunction|1|||
149736402|NCT03263806|540167188|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
149736403|NCT03263806|540167189|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
149736404|NCT03263806|540167188|FG000|Overall Study|Withdrawal by Subject|0|||
149736405|NCT03263806|540167189|FG001|Overall Study|Withdrawal by Subject|1|||
149736406|NCT03263806|540167188|FG000|Overall Study|Study Termination|5|||
149736407|NCT03263806|540167189|FG001|Overall Study|Study Termination|6|||
149736408|NCT01252966|540167200|FG000|Overall Study|Lost to Follow-up|16|||
149736409|NCT01252966|540167201|FG001|Overall Study|Lost to Follow-up|10|||
149736410|NCT01252966|540167200|FG000|Overall Study|Withdrawal by Subject|7|||
149736411|NCT01252966|540167201|FG001|Overall Study|Withdrawal by Subject|3|||
149736412|NCT05194345|540167206|FG000|Overall Study|Withdrawal by Subject|6|||
149736413|NCT05194345|540167207|FG001|Overall Study|Withdrawal by Subject|4|||
149736414|NCT05194345|540167208|FG002|Overall Study|Withdrawal by Subject|0|||
149736415|NCT05194345|540167206|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
149736416|NCT05194345|540167207|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
149736417|NCT05194345|540167208|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
149736418|NCT04854499|540167210|FG000|Overall Study|Study Terminated by Sponsor|5|||
149736419|NCT04854499|540167211|FG001|Overall Study|Study Terminated by Sponsor|27|||
149736420|NCT04854499|540167212|FG002|Overall Study|Study Terminated by Sponsor|28|||
149736421|NCT04854499|540167213|FG003|Overall Study|Study Terminated by Sponsor|19|||
149736422|NCT04854499|540167214|FG004|Overall Study|Study Terminated by Sponsor|1|||
149736423|NCT04854499|540167215|FG005|Overall Study|Study Terminated by Sponsor|10|||
149736424|NCT04854499|540167210|FG000|Overall Study|Death|1|||
149736425|NCT04854499|540167211|FG001|Overall Study|Death|23|||
149736426|NCT04854499|540167212|FG002|Overall Study|Death|21|||
149736427|NCT04854499|540167213|FG003|Overall Study|Death|7|||
149736428|NCT04854499|540167214|FG004|Overall Study|Death|6|||
149736429|NCT04854499|540167215|FG005|Overall Study|Death|24|||
149736430|NCT04854499|540167210|FG000|Overall Study|Investigator's Discretion|0|||
149736431|NCT04854499|540167211|FG001|Overall Study|Investigator's Discretion|1|||
149736432|NCT04854499|540167212|FG002|Overall Study|Investigator's Discretion|3|||
149736433|NCT04854499|540167213|FG003|Overall Study|Investigator's Discretion|4|||
149736434|NCT04854499|540167214|FG004|Overall Study|Investigator's Discretion|1|||
149736435|NCT04854499|540167215|FG005|Overall Study|Investigator's Discretion|5|||
149736436|NCT04854499|540167210|FG000|Overall Study|Withdrew Consent|0|||
149736437|NCT04854499|540167211|FG001|Overall Study|Withdrew Consent|1|||
149736438|NCT04854499|540167212|FG002|Overall Study|Withdrew Consent|2|||
149736439|NCT04854499|540167213|FG003|Overall Study|Withdrew Consent|2|||
149736440|NCT04854499|540167214|FG004|Overall Study|Withdrew Consent|0|||
149736441|NCT04854499|540167215|FG005|Overall Study|Withdrew Consent|1|||
149736442|NCT04854499|540167210|FG000|Overall Study|Lost to Follow-up|0|||
149736443|NCT04854499|540167211|FG001|Overall Study|Lost to Follow-up|0|||
149736444|NCT04854499|540167212|FG002|Overall Study|Lost to Follow-up|0|||
149736445|NCT04854499|540167213|FG003|Overall Study|Lost to Follow-up|0|||
149736446|NCT04854499|540167214|FG004|Overall Study|Lost to Follow-up|0|||
149736447|NCT04854499|540167215|FG005|Overall Study|Lost to Follow-up|1|||
149736448|NCT05415449|540167216|FG000|Overall Study|Lost to Follow-up|2|||
149736449|NCT05415449|540167216|FG000|Overall Study|Withdrawal by Subject|4|||
149736450|NCT02185521|540167220|FG000|Overall Study|Withdrawal by Subject|1|||
149736451|NCT02185521|540167220|FG000|Overall Study|Protocol Violation|1|||
149736452|NCT00398112|540167221|FG000|Overall Study|Adverse Event|4|||
149736453|NCT00398112|540167221|FG000|Overall Study|Disease progression|9|||
149736454|NCT00398112|540167221|FG000|Overall Study|Alternative treatment|1|||
149736455|NCT00398112|540167221|FG000|Overall Study|Withdrawal by Subject|3|||
149736456|NCT00398112|540167221|FG000|Overall Study|Death|1|||
149736457|NCT03932812|540167222|FG000|Overall Study|Lost to Follow-up|12|||
149736458|NCT03932812|540167223|FG001|Overall Study|Lost to Follow-up|14|||
149736459|NCT03932812|540167222|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
149736460|NCT03932812|540167223|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
149736461|NCT00332709|540167224|FG000|Overall Study|Adverse Event|11|||
149736462|NCT00332709|540167225|FG001|Overall Study|Adverse Event|14|||
149736463|NCT00332709|540167224|FG000|Overall Study|Withdrawal by Subject|2|||
149736464|NCT00332709|540167225|FG001|Overall Study|Withdrawal by Subject|3|||
149736465|NCT00332709|540167224|FG000|Overall Study|Lost to Follow-up|2|||
149736466|NCT00332709|540167225|FG001|Overall Study|Lost to Follow-up|0|||
149736467|NCT00332709|540167224|FG000|Overall Study|Administrative Problems|0|||
149736468|NCT00332709|540167225|FG001|Overall Study|Administrative Problems|3|||
149736469|NCT00332709|540167224|FG000|Overall Study|Abnormal test procedure result|1|||
149736470|NCT00332709|540167225|FG001|Overall Study|Abnormal test procedure result|0|||
149736471|NCT03293654|540167226|FG000|Overall Study|Lost to Follow-up|0|||
149736472|NCT03293654|540167227|FG001|Overall Study|Lost to Follow-up|1|||
149736473|NCT03293654|540167228|FG002|Overall Study|Lost to Follow-up|0|||
149736474|NCT01933932|540167229|FG000|Overall Study|Death|173|||
149736475|NCT01933932|540167230|FG001|Overall Study|Death|163|||
149736476|NCT01933932|540167229|FG000|Overall Study|Withdrawal by Subject|11|||
149736477|NCT01933932|540167230|FG001|Overall Study|Withdrawal by Subject|14|||
149736478|NCT01933932|540167229|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149736479|NCT01933932|540167230|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149736480|NCT04454489|540167233|FG000|Overall Study|Disease progression|12|||
149736481|NCT04454489|540167233|FG000|Overall Study|Death|4|||
149736482|NCT04454489|540167233|FG000|Overall Study|Adverse Event|1|||
149736483|NCT04454489|540167233|FG000|Overall Study|Physician Decision|1|||
149736484|NCT01323478|540167234|FG000|Overall Study|Adverse Event|7|||
149736485|NCT01323478|540167234|FG000|Overall Study|Lack of Efficacy|4|||
149736486|NCT01323478|540167234|FG000|Overall Study|Non-compliance With Study Product|3|||
149736487|NCT01323478|540167234|FG000|Overall Study|Protocol Violation|1|||
149736488|NCT01323478|540167234|FG000|Overall Study|Withdrawal of Consent|1|||
149736489|NCT01323478|540167234|FG000|Overall Study|Administrative or Other Reasons|8|||
149736490|NCT02054702|540167239|FG000|Overall Study|Lost to Follow-up|3|||
149736491|NCT02054702|540167240|FG001|Overall Study|Lost to Follow-up|5|||
149736492|NCT02054702|540167239|FG000|Overall Study|Adverse Event|3|||
149736493|NCT02054702|540167240|FG001|Overall Study|Adverse Event|1|||
149736494|NCT02054702|540167239|FG000|Overall Study|Met Withdrawal Criteria|4|||
149736495|NCT02054702|540167240|FG001|Overall Study|Met Withdrawal Criteria|1|||
149736496|NCT02054702|540167239|FG000|Overall Study|Physician Decision|0|||
149736497|NCT02054702|540167240|FG001|Overall Study|Physician Decision|1|||
149736498|NCT02054702|540167239|FG000|Overall Study|Withdrawal by Subject|14|||
149736499|NCT02054702|540167240|FG001|Overall Study|Withdrawal by Subject|4|||
149736500|NCT01262898|540167241|FG000|Overall Study|Protocol Violation|1|||
149736501|NCT01262898|540167242|FG001|Overall Study|Protocol Violation|1|||
149736502|NCT01262898|540167243|FG002|Overall Study|Protocol Violation|0|||
149736503|NCT01262898|540167244|FG003|Overall Study|Protocol Violation|0|||
149736504|NCT01262898|540167241|FG000|Overall Study|Lost to Follow-up|1|||
149736505|NCT01262898|540167242|FG001|Overall Study|Lost to Follow-up|0|||
149736506|NCT01262898|540167243|FG002|Overall Study|Lost to Follow-up|0|||
149736507|NCT01262898|540167244|FG003|Overall Study|Lost to Follow-up|0|||
149736508|NCT01262898|540167241|FG000|Overall Study|Withdrawal by Subject|1|||
149736509|NCT01262898|540167242|FG001|Overall Study|Withdrawal by Subject|1|||
149736510|NCT01262898|540167243|FG002|Overall Study|Withdrawal by Subject|0|||
149736511|NCT01262898|540167244|FG003|Overall Study|Withdrawal by Subject|0|||
149736512|NCT01295125|540167247|FG000|Overall Study|Study stopped prematurely|9|||
149736513|NCT03838484|540167248|FG000|Overall Study|Lost to Follow-up|0|||
149736514|NCT03838484|540167249|FG001|Overall Study|Lost to Follow-up|1|||
149736515|NCT03838484|540167250|FG002|Overall Study|Lost to Follow-up|0|||
149736516|NCT03838484|540167251|FG003|Overall Study|Lost to Follow-up|0|||
149736517|NCT04964258|540167259|FG000|Overall Study|Lost to Follow-up|1|||
149736518|NCT04964258|540167260|FG001|Overall Study|Lost to Follow-up|0|||
149736519|NCT04964258|540167261|FG002|Overall Study|Lost to Follow-up|0|||
149736520|NCT04964258|540167262|FG003|Overall Study|Lost to Follow-up|0|||
149736521|NCT04964258|540167263|FG004|Overall Study|Lost to Follow-up|0|||
149736522|NCT04964258|540167264|FG005|Overall Study|Lost to Follow-up|1|||
149736523|NCT04964258|540167265|FG006|Overall Study|Lost to Follow-up|0|||
149736524|NCT04964258|540167266|FG007|Overall Study|Lost to Follow-up|0|||
149736525|NCT04964258|540167267|FG008|Overall Study|Lost to Follow-up|0|||
149736526|NCT04964258|540167268|FG009|Overall Study|Lost to Follow-up|0|||
149736527|NCT04964258|540167269|FG010|Overall Study|Lost to Follow-up|0|||
149736528|NCT04525703|540167270|FG000|Overall Study|Lost to Follow-up|6|||
149736529|NCT04525703|540167271|FG001|Overall Study|Lost to Follow-up|15|||
149736530|NCT04525703|540167272|FG002|Overall Study|Lost to Follow-up|8|||
149736531|NCT01285349|540167273|FG000|Overall Study|Lost to Follow-up|27|||
149736532|NCT01285349|540167274|FG001|Overall Study|Lost to Follow-up|20|||
149736533|NCT01285349|540167275|FG002|Overall Study|Lost to Follow-up|27|||
149736534|NCT03040024|540167276|FG000|Overall Study|Adverse Event|0|||
149736535|NCT03040024|540167277|FG001|Overall Study|Adverse Event|1|||
149736536|NCT03040024|540167278|FG002|Overall Study|Adverse Event|0|||
149736537|NCT03040024|540167276|FG000|Overall Study|Death|0|||
149736538|NCT03040024|540167277|FG001|Overall Study|Death|1|||
149736539|NCT03040024|540167278|FG002|Overall Study|Death|0|||
149736540|NCT03040024|540167276|FG000|Overall Study|Physician Decision|0|||
149736541|NCT03040024|540167277|FG001|Overall Study|Physician Decision|0|||
149736542|NCT03040024|540167278|FG002|Overall Study|Physician Decision|1|||
149736543|NCT02452762|540167283|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
149736544|NCT02452762|540167284|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
149736545|NCT02452762|540167283|FG000|Overall Study|Withdrawal by Subject|1|||
149736546|NCT02452762|540167284|FG001|Overall Study|Withdrawal by Subject|0|||
149736547|NCT03682120|540167285|FG000|Overall Study|Lost to Follow-up|11|||
149736548|NCT03682120|540167286|FG001|Overall Study|Lost to Follow-up|4|||
149736549|NCT03682120|540167287|FG002|Overall Study|Lost to Follow-up|5|||
149736550|NCT03682120|540167288|FG003|Overall Study|Lost to Follow-up|2|||
149736551|NCT03682120|540167285|FG000|Overall Study|Physician Decision|1|||
149736552|NCT03682120|540167286|FG001|Overall Study|Physician Decision|0|||
149736553|NCT03682120|540167287|FG002|Overall Study|Physician Decision|0|||
149736554|NCT03682120|540167288|FG003|Overall Study|Physician Decision|0|||
149736555|NCT03682120|540167285|FG000|Overall Study|Withdrawal by Subject|1|||
149736556|NCT03682120|540167286|FG001|Overall Study|Withdrawal by Subject|2|||
149736557|NCT03682120|540167287|FG002|Overall Study|Withdrawal by Subject|3|||
149736558|NCT03682120|540167288|FG003|Overall Study|Withdrawal by Subject|0|||
149736559|NCT03682120|540167285|FG000|Overall Study|Death|0|||
149736560|NCT03682120|540167286|FG001|Overall Study|Death|1|||
149736561|NCT03682120|540167287|FG002|Overall Study|Death|0|||
149736562|NCT03682120|540167288|FG003|Overall Study|Death|0|||
149736563|NCT03682120|540167285|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
149736564|NCT03682120|540167286|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
149736565|NCT03682120|540167287|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
149736566|NCT03682120|540167288|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
149736567|NCT01957137|540167297|FG000|Randomized Portion|Adverse Event|1|||
149736568|NCT01957137|540167297|FG000|Randomized Portion|Withdrawal by Subject|1|||
149736569|NCT00054132|540167298|FG000|Overall Study|Not Treated|1|||
149736570|NCT02330419|540167306|FG000|Overall Study|Lost to Follow-up|3|||
149736571|NCT02330419|540167307|FG001|Overall Study|Lost to Follow-up|7|||
149736572|NCT02875223|540167308|FG000|Overall Study|Other reasons|0|||
149736573|NCT02875223|540167309|FG001|Overall Study|Other reasons|0|||
149736574|NCT02875223|540167310|FG002|Overall Study|Other reasons|1|||
149736575|NCT02875223|540167311|FG003|Overall Study|Other reasons|0|||
149736576|NCT02875223|540167312|FG004|Overall Study|Other reasons|1|||
149736577|NCT02875223|540167313|FG005|Overall Study|Other reasons|2|||
149736578|NCT02875223|540167314|FG006|Overall Study|Other reasons|0|||
149736579|NCT02875223|540167315|FG007|Overall Study|Other reasons|2|||
149736580|NCT02875223|540167316|FG008|Overall Study|Other reasons|0|||
149736581|NCT02875223|540167317|FG009|Overall Study|Other reasons|0|||
149736582|NCT02875223|540167318|FG010|Overall Study|Other reasons|0|||
149736583|NCT02875223|540167319|FG011|Overall Study|Other reasons|0|||
149736584|NCT02875223|540167320|FG012|Overall Study|Other reasons|0|||
149736585|NCT02875223|540167308|FG000|Overall Study|Withdrawal by Subject|0|||
149736586|NCT02875223|540167309|FG001|Overall Study|Withdrawal by Subject|0|||
149736587|NCT02875223|540167310|FG002|Overall Study|Withdrawal by Subject|0|||
149736588|NCT02875223|540167311|FG003|Overall Study|Withdrawal by Subject|0|||
149736589|NCT02875223|540167312|FG004|Overall Study|Withdrawal by Subject|1|||
149736590|NCT02875223|540167313|FG005|Overall Study|Withdrawal by Subject|1|||
149736591|NCT02875223|540167314|FG006|Overall Study|Withdrawal by Subject|0|||
149736592|NCT02875223|540167315|FG007|Overall Study|Withdrawal by Subject|0|||
149736593|NCT02875223|540167316|FG008|Overall Study|Withdrawal by Subject|1|||
149736594|NCT02875223|540167317|FG009|Overall Study|Withdrawal by Subject|0|||
149736595|NCT02875223|540167318|FG010|Overall Study|Withdrawal by Subject|0|||
149736596|NCT02875223|540167319|FG011|Overall Study|Withdrawal by Subject|0|||
149736597|NCT02875223|540167320|FG012|Overall Study|Withdrawal by Subject|0|||
149736598|NCT02875223|540167308|FG000|Overall Study|Progressive disease|0|||
149736599|NCT02875223|540167309|FG001|Overall Study|Progressive disease|0|||
149736600|NCT02875223|540167310|FG002|Overall Study|Progressive disease|1|||
149736601|NCT02875223|540167311|FG003|Overall Study|Progressive disease|0|||
149736602|NCT02875223|540167312|FG004|Overall Study|Progressive disease|0|||
149736603|NCT02875223|540167313|FG005|Overall Study|Progressive disease|0|||
149736604|NCT02875223|540167314|FG006|Overall Study|Progressive disease|0|||
149736605|NCT02875223|540167315|FG007|Overall Study|Progressive disease|0|||
149736606|NCT02875223|540167316|FG008|Overall Study|Progressive disease|0|||
149736607|NCT02875223|540167317|FG009|Overall Study|Progressive disease|12|||
149736608|NCT02875223|540167318|FG010|Overall Study|Progressive disease|2|||
149736609|NCT02875223|540167319|FG011|Overall Study|Progressive disease|3|||
149736610|NCT02875223|540167320|FG012|Overall Study|Progressive disease|6|||
149736611|NCT02875223|540167308|FG000|Overall Study|Death|4|||
149736612|NCT02875223|540167309|FG001|Overall Study|Death|4|||
149736613|NCT02875223|540167310|FG002|Overall Study|Death|3|||
149736614|NCT02875223|540167311|FG003|Overall Study|Death|4|||
149736615|NCT02875223|540167312|FG004|Overall Study|Death|2|||
149736616|NCT02875223|540167313|FG005|Overall Study|Death|3|||
149736617|NCT02875223|540167314|FG006|Overall Study|Death|5|||
149736618|NCT02875223|540167315|FG007|Overall Study|Death|7|||
149736619|NCT02875223|540167316|FG008|Overall Study|Death|3|||
149736620|NCT02875223|540167317|FG009|Overall Study|Death|2|||
149736621|NCT02875223|540167318|FG010|Overall Study|Death|0|||
149736622|NCT02875223|540167319|FG011|Overall Study|Death|0|||
149736623|NCT02875223|540167320|FG012|Overall Study|Death|0|||
149736624|NCT02875223|540167308|FG000|Overall Study|Lost to Follow-up|0|||
149736625|NCT02875223|540167309|FG001|Overall Study|Lost to Follow-up|1|||
149736626|NCT02875223|540167310|FG002|Overall Study|Lost to Follow-up|1|||
149736627|NCT02875223|540167311|FG003|Overall Study|Lost to Follow-up|0|||
149736628|NCT02875223|540167312|FG004|Overall Study|Lost to Follow-up|1|||
149736629|NCT02875223|540167313|FG005|Overall Study|Lost to Follow-up|0|||
149736630|NCT02875223|540167314|FG006|Overall Study|Lost to Follow-up|1|||
149736631|NCT02875223|540167315|FG007|Overall Study|Lost to Follow-up|1|||
149736632|NCT02875223|540167316|FG008|Overall Study|Lost to Follow-up|0|||
149736633|NCT02875223|540167317|FG009|Overall Study|Lost to Follow-up|0|||
149736634|NCT02875223|540167318|FG010|Overall Study|Lost to Follow-up|0|||
149736635|NCT02875223|540167319|FG011|Overall Study|Lost to Follow-up|0|||
149736636|NCT02875223|540167320|FG012|Overall Study|Lost to Follow-up|0|||
149736637|NCT01955707|540167325|FG000|Overall Study|Adverse Event|1|||
149736638|NCT01955707|540167326|FG001|Overall Study|Adverse Event|2|||
149736639|NCT01955707|540167325|FG000|Overall Study|Lost to Follow-up|2|||
149736640|NCT01955707|540167326|FG001|Overall Study|Lost to Follow-up|1|||
149736641|NCT01955707|540167325|FG000|Overall Study|Withdrawal by Subject|0|||
149736642|NCT01955707|540167326|FG001|Overall Study|Withdrawal by Subject|3|||
149736643|NCT01955707|540167325|FG000|Overall Study|Death|13|||
149736644|NCT01955707|540167326|FG001|Overall Study|Death|14|||
149736645|NCT01955707|540167325|FG000|Overall Study|Other|4|||
149736646|NCT01955707|540167326|FG001|Overall Study|Other|2|||
149736647|NCT04280081|540167331|FG000|Overall Study|Adverse Event|4|||
149736648|NCT04280081|540167331|FG000|Overall Study|Death|2|||
149736649|NCT04280081|540167331|FG000|Overall Study|Progressive Disease|6|||
149736650|NCT03896581|540169135|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
149736651|NCT03896581|540169136|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
149736652|NCT03896581|540169135|FG000|Overall Study|Withdrawal by Subject|4|||
149736653|NCT03896581|540169136|FG001|Overall Study|Withdrawal by Subject|1|||
149736654|NCT03896581|540169135|FG000|Overall Study|Lost to Follow-up|1|||
149736655|NCT03896581|540169136|FG001|Overall Study|Lost to Follow-up|0|||
149736656|NCT03896581|540169135|FG000|Overall Study|Lack of Efficacy|2|||
149736657|NCT03896581|540169136|FG001|Overall Study|Lack of Efficacy|1|||
149736658|NCT03896581|540169135|FG000|Overall Study|Adverse event, non-fatal|0|||
149736659|NCT03896581|540169136|FG001|Overall Study|Adverse event, non-fatal|2|||
149736660|NCT02029976|540169138|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
149736661|NCT02029976|540169139|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
149736662|NCT02029976|540169138|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
149736663|NCT02029976|540169139|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
149736664|NCT02029976|540169138|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
149736665|NCT02029976|540169139|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
149736666|NCT02029976|540169138|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
149736667|NCT02029976|540169139|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
149736668|NCT01445171|540169140|FG000|Overall Study|Lost to Follow-up|11|||
149736669|NCT01445171|540169140|FG000|Overall Study|Withdrawal by Subject|16|||
149736670|NCT01445171|540169140|FG000|Overall Study|Death|51|||
149736671|NCT01445171|540169140|FG000|Overall Study|Subjects declined to return for followup|9|||
149736672|NCT01445171|540169140|FG000|Overall Study|Consented but did not receive device|8|||
149736673|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
149736674|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
149736675|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
149736676|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
149736677|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
149736678|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
149736679|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
149736680|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
149736681|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
149736682|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
149736683|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
149736684|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149736685|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149736686|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149736687|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149736688|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149736689|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
149736690|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149736691|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149736692|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149736693|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
149736694|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
149736695|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
149736696|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
150255065|NCT01302067|542070543|FG001|Overall Study|Other|1|||
149736697|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
149736698|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
149736699|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
149736700|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149736701|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149736702|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149736703|NCT02660580|540169141|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
149736704|NCT02660580|540169142|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
149736705|NCT02660580|540169143|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149736706|NCT02660580|540169144|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149736707|NCT02660580|540169145|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149736708|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149736709|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149736710|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
149736711|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149736712|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
149736713|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149736714|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149736715|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
149736716|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149736717|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
149736718|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
149736719|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
149736720|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
149736721|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
149736722|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
149736723|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
149736724|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
149736725|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
149736726|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
149736727|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
149736728|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
149736729|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
149736730|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
149736731|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
149736732|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
149736733|NCT02660580|540169141|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149736734|NCT02660580|540169142|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149736735|NCT02660580|540169143|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149736736|NCT02660580|540169144|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
149736737|NCT02660580|540169145|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
149736738|NCT04462536|540169146|FG000|Overall Study|Withdrawal by Subject|3|||
149736739|NCT04462536|540169147|FG001|Overall Study|Withdrawal by Subject|9|||
149736740|NCT04462536|540169146|FG000|Overall Study|Lost to Follow-up|2|||
149736741|NCT04462536|540169147|FG001|Overall Study|Lost to Follow-up|4|||
149736742|NCT00450580|540169150|FG000|Overall Study|Adverse Event|5|||
149736743|NCT00450580|540169151|FG001|Overall Study|Adverse Event|7|||
149736744|NCT00450580|540169150|FG000|Overall Study|Lost to Follow-up|4|||
149736745|NCT00450580|540169151|FG001|Overall Study|Lost to Follow-up|5|||
149736746|NCT00450580|540169150|FG000|Overall Study|Withdrawal by Subject|2|||
149736747|NCT00450580|540169151|FG001|Overall Study|Withdrawal by Subject|2|||
149736748|NCT00450580|540169150|FG000|Overall Study|Protocol Violation|1|||
149736749|NCT00450580|540169151|FG001|Overall Study|Protocol Violation|1|||
149736750|NCT00450580|540169150|FG000|Overall Study|Protocol-defined virologic failure|1|||
149736751|NCT00450580|540169151|FG001|Overall Study|Protocol-defined virologic failure|0|||
149736752|NCT00450580|540169150|FG000|Overall Study|Could not comply with scheduled visits|1|||
149736753|NCT00450580|540169151|FG001|Overall Study|Could not comply with scheduled visits|0|||
149736754|NCT00450580|540169150|FG000|Overall Study|Patient went to Brazil|1|||
149736755|NCT00450580|540169151|FG001|Overall Study|Patient went to Brazil|0|||
149736756|NCT00450580|540169150|FG000|Overall Study|Patient could not swallow Norvir|1|||
149736757|NCT00450580|540169151|FG001|Overall Study|Patient could not swallow Norvir|0|||
149736758|NCT00450580|540169150|FG000|Overall Study|Withdrawal due to pregnancy|0|||
149736759|NCT00450580|540169151|FG001|Overall Study|Withdrawal due to pregnancy|1|||
149736760|NCT04572633|540169160|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
149736761|NCT03480802|540169161|FG000|Overall Study|Lost to Follow-up|5|||
149736762|NCT03480802|540169162|FG001|Overall Study|Lost to Follow-up|1|||
149736763|NCT03480802|540169161|FG000|Overall Study|Withdrawal by Subject|2|||
149736764|NCT03480802|540169162|FG001|Overall Study|Withdrawal by Subject|1|||
149736765|NCT03480802|540169161|FG000|Overall Study|Relocated|0|||
149736766|NCT03480802|540169162|FG001|Overall Study|Relocated|1|||
149736767|NCT04439266|540169165|FG000|Overall Study|Ineligible|1|||
149736768|NCT04439266|540169165|FG000|Overall Study|Adverse Event|1|||
149736769|NCT04439266|540169165|FG000|Overall Study|Death|1|||
149736770|NCT04439266|540169165|FG000|Overall Study|Disease progression|1|||
149736771|NCT04439266|540169165|FG000|Overall Study|Still on treatment|1|||
149736772|NCT05424276|540169168|FG000|Overall Study|Adverse Event|1|||
149736773|NCT05424276|540169169|FG001|Overall Study|Adverse Event|0|||
149736774|NCT05424276|540169170|FG002|Overall Study|Adverse Event|0|||
149736775|NCT05424276|540169171|FG003|Overall Study|Adverse Event|2|||
149736776|NCT05424276|540169168|FG000|Overall Study|Withdrawal by Subject|0|||
149736777|NCT05424276|540169169|FG001|Overall Study|Withdrawal by Subject|0|||
149736778|NCT05424276|540169170|FG002|Overall Study|Withdrawal by Subject|2|||
149736779|NCT05424276|540169171|FG003|Overall Study|Withdrawal by Subject|0|||
149736780|NCT05424276|540169168|FG000|Overall Study|Protocol Violation|0|||
149736781|NCT05424276|540169169|FG001|Overall Study|Protocol Violation|1|||
149736782|NCT05424276|540169170|FG002|Overall Study|Protocol Violation|0|||
149736783|NCT05424276|540169171|FG003|Overall Study|Protocol Violation|0|||
149736784|NCT05424276|540169168|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149736785|NCT05424276|540169169|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
149736786|NCT05424276|540169170|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149736787|NCT05424276|540169171|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149736788|NCT03049449|540169173|FG000|Overall Study|Did not receive treatment.|0|||
149736789|NCT03049449|540169174|FG001|Overall Study|Did not receive treatment.|0|||
149736790|NCT03049449|540169175|FG002|Overall Study|Did not receive treatment.|0|||
149736791|NCT03049449|540169176|FG003|Overall Study|Did not receive treatment.|0|||
149736792|NCT03049449|540169177|FG004|Overall Study|Did not receive treatment.|0|||
149736793|NCT03049449|540169178|FG005|Overall Study|Did not receive treatment.|0|||
149736794|NCT03049449|540169179|FG006|Overall Study|Did not receive treatment.|0|||
149736795|NCT03049449|540169180|FG007|Overall Study|Did not receive treatment.|0|||
149736796|NCT03049449|540169181|FG008|Overall Study|Did not receive treatment.|1|||
149736797|NCT03049449|540169182|FG009|Overall Study|Did not receive treatment.|0|||
149736798|NCT03049449|540169173|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
149736799|NCT03049449|540169174|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
149736800|NCT03049449|540169175|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
149736801|NCT03049449|540169176|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
149736802|NCT03049449|540169177|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
149736803|NCT03049449|540169178|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
149736804|NCT03049449|540169179|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
149736805|NCT03049449|540169180|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
149736806|NCT03049449|540169181|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
149736807|NCT03049449|540169182|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
149736808|NCT03049449|540169173|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736809|NCT03049449|540169174|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736810|NCT03049449|540169175|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736811|NCT03049449|540169176|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736812|NCT03049449|540169177|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736813|NCT03049449|540169178|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
150255066|NCT01302067|542070544|FG002|Overall Study|Other|3|||
149736814|NCT03049449|540169179|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736815|NCT03049449|540169180|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
149736816|NCT03049449|540169181|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149736817|NCT03049449|540169182|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
149736818|NCT00792298|540169184|FG000|Treatment Period 1|Adverse Event|0|||
149736819|NCT00792298|540169185|FG001|Treatment Period 1|Adverse Event|1|||
149736820|NCT00792298|540169186|FG002|Treatment Period 1|Adverse Event|0|||
149736821|NCT00792298|540169187|FG003|Treatment Period 1|Adverse Event|1|||
149736822|NCT00792298|540169188|FG004|Treatment Period 1|Adverse Event|0|||
149736823|NCT00792298|540169189|FG005|Treatment Period 1|Adverse Event|1|||
149736824|NCT00792298|540169190|FG006|Treatment Period 1|Adverse Event|1|||
149736825|NCT00792298|540169191|FG007|Treatment Period 1|Adverse Event|0|||
149736826|NCT00792298|540169184|FG000|Treatment Period 1|Lack of Efficacy|0|||
149736827|NCT00792298|540169185|FG001|Treatment Period 1|Lack of Efficacy|0|||
149736828|NCT00792298|540169186|FG002|Treatment Period 1|Lack of Efficacy|1|||
149736829|NCT00792298|540169187|FG003|Treatment Period 1|Lack of Efficacy|0|||
149736830|NCT00792298|540169188|FG004|Treatment Period 1|Lack of Efficacy|0|||
149736831|NCT00792298|540169189|FG005|Treatment Period 1|Lack of Efficacy|0|||
149736832|NCT00792298|540169190|FG006|Treatment Period 1|Lack of Efficacy|0|||
149736833|NCT00792298|540169191|FG007|Treatment Period 1|Lack of Efficacy|0|||
149736834|NCT00792298|540169184|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149736835|NCT00792298|540169185|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149736836|NCT00792298|540169186|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149736837|NCT00792298|540169187|FG003|Treatment Period 1|Withdrawal by Subject|2|||
149736838|NCT00792298|540169188|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149736839|NCT00792298|540169189|FG005|Treatment Period 1|Withdrawal by Subject|2|||
149736840|NCT00792298|540169190|FG006|Treatment Period 1|Withdrawal by Subject|1|||
149736841|NCT00792298|540169191|FG007|Treatment Period 1|Withdrawal by Subject|0|||
149736842|NCT00792298|540169184|FG000|Treatment Period 1|Lost to Follow-up|0|||
149736843|NCT00792298|540169185|FG001|Treatment Period 1|Lost to Follow-up|0|||
149736844|NCT00792298|540169186|FG002|Treatment Period 1|Lost to Follow-up|0|||
149736845|NCT00792298|540169187|FG003|Treatment Period 1|Lost to Follow-up|0|||
149736846|NCT00792298|540169188|FG004|Treatment Period 1|Lost to Follow-up|0|||
149736847|NCT00792298|540169189|FG005|Treatment Period 1|Lost to Follow-up|0|||
149736848|NCT00792298|540169190|FG006|Treatment Period 1|Lost to Follow-up|1|||
149736849|NCT00792298|540169191|FG007|Treatment Period 1|Lost to Follow-up|0|||
149736850|NCT00792298|540169184|FG000|Treatment Period 1|Physician Decision|0|||
149736851|NCT00792298|540169185|FG001|Treatment Period 1|Physician Decision|0|||
149736852|NCT00792298|540169186|FG002|Treatment Period 1|Physician Decision|0|||
149736853|NCT00792298|540169187|FG003|Treatment Period 1|Physician Decision|1|||
149736854|NCT00792298|540169188|FG004|Treatment Period 1|Physician Decision|0|||
149736855|NCT00792298|540169189|FG005|Treatment Period 1|Physician Decision|0|||
149736856|NCT00792298|540169190|FG006|Treatment Period 1|Physician Decision|1|||
149736857|NCT00792298|540169191|FG007|Treatment Period 1|Physician Decision|0|||
149736858|NCT00792298|540169184|FG000|Treatment Period 1|Protocol Violation|0|||
149736859|NCT00792298|540169185|FG001|Treatment Period 1|Protocol Violation|0|||
149736860|NCT00792298|540169186|FG002|Treatment Period 1|Protocol Violation|0|||
149736861|NCT00792298|540169187|FG003|Treatment Period 1|Protocol Violation|0|||
149736862|NCT00792298|540169188|FG004|Treatment Period 1|Protocol Violation|0|||
149736863|NCT00792298|540169189|FG005|Treatment Period 1|Protocol Violation|0|||
149736864|NCT00792298|540169190|FG006|Treatment Period 1|Protocol Violation|0|||
149736865|NCT00792298|540169191|FG007|Treatment Period 1|Protocol Violation|1|||
149736866|NCT00792298|540169184|FG000|Washout|Adverse Event|0|||
149736867|NCT00792298|540169185|FG001|Washout|Adverse Event|0|||
149736868|NCT00792298|540169186|FG002|Washout|Adverse Event|0|||
149736869|NCT00792298|540169187|FG003|Washout|Adverse Event|0|||
149736870|NCT00792298|540169188|FG004|Washout|Adverse Event|0|||
149736871|NCT00792298|540169189|FG005|Washout|Adverse Event|1|||
149736872|NCT00792298|540169190|FG006|Washout|Adverse Event|0|||
149736873|NCT00792298|540169191|FG007|Washout|Adverse Event|0|||
149736874|NCT00792298|540169184|FG000|Washout|Withdrawal by Subject|0|||
149736875|NCT00792298|540169185|FG001|Washout|Withdrawal by Subject|0|||
149736876|NCT00792298|540169186|FG002|Washout|Withdrawal by Subject|1|||
149736877|NCT00792298|540169187|FG003|Washout|Withdrawal by Subject|0|||
149736878|NCT00792298|540169188|FG004|Washout|Withdrawal by Subject|0|||
149736879|NCT00792298|540169189|FG005|Washout|Withdrawal by Subject|1|||
149736880|NCT00792298|540169190|FG006|Washout|Withdrawal by Subject|0|||
149736881|NCT00792298|540169191|FG007|Washout|Withdrawal by Subject|0|||
149736882|NCT00792298|540169184|FG000|Treatment Period 2|Lack of Efficacy|0|||
149736883|NCT00792298|540169185|FG001|Treatment Period 2|Lack of Efficacy|0|||
149736884|NCT00792298|540169186|FG002|Treatment Period 2|Lack of Efficacy|0|||
149736885|NCT00792298|540169187|FG003|Treatment Period 2|Lack of Efficacy|0|||
149736886|NCT00792298|540169188|FG004|Treatment Period 2|Lack of Efficacy|1|||
149736887|NCT00792298|540169189|FG005|Treatment Period 2|Lack of Efficacy|0|||
149736888|NCT00792298|540169190|FG006|Treatment Period 2|Lack of Efficacy|0|||
149736889|NCT00792298|540169191|FG007|Treatment Period 2|Lack of Efficacy|0|||
149736890|NCT00792298|540169184|FG000|Treatment Period 2|Physician Decision|0|||
149736891|NCT00792298|540169185|FG001|Treatment Period 2|Physician Decision|0|||
149736892|NCT00792298|540169186|FG002|Treatment Period 2|Physician Decision|0|||
149736893|NCT00792298|540169187|FG003|Treatment Period 2|Physician Decision|0|||
149736894|NCT00792298|540169188|FG004|Treatment Period 2|Physician Decision|0|||
149736895|NCT00792298|540169189|FG005|Treatment Period 2|Physician Decision|0|||
149736896|NCT00792298|540169190|FG006|Treatment Period 2|Physician Decision|1|||
149736897|NCT00792298|540169191|FG007|Treatment Period 2|Physician Decision|0|||
149736898|NCT00792298|540169184|FG000|Treatment Period 2|Pregnancy|0|||
149736899|NCT00792298|540169185|FG001|Treatment Period 2|Pregnancy|0|||
149736900|NCT00792298|540169186|FG002|Treatment Period 2|Pregnancy|1|||
149736901|NCT00792298|540169187|FG003|Treatment Period 2|Pregnancy|0|||
149736902|NCT00792298|540169188|FG004|Treatment Period 2|Pregnancy|0|||
149736903|NCT00792298|540169189|FG005|Treatment Period 2|Pregnancy|0|||
149736904|NCT00792298|540169190|FG006|Treatment Period 2|Pregnancy|0|||
149736905|NCT00792298|540169191|FG007|Treatment Period 2|Pregnancy|0|||
149736906|NCT00792298|540169184|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149736907|NCT00792298|540169185|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149736908|NCT00792298|540169186|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149736909|NCT00792298|540169187|FG003|Treatment Period 2|Withdrawal by Subject|2|||
149736910|NCT00792298|540169188|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149736911|NCT00792298|540169189|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149736912|NCT00792298|540169190|FG006|Treatment Period 2|Withdrawal by Subject|0|||
149736913|NCT00792298|540169191|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149736914|NCT03304522|540169199|FG000|Overall Study|Adverse Event|0|||
149736915|NCT03304522|540169200|FG001|Overall Study|Adverse Event|4|||
149736916|NCT03304522|540169199|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
149736917|NCT03304522|540169200|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
149736918|NCT03304522|540169199|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
149736919|NCT03304522|540169200|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
149736920|NCT03304522|540169199|FG000|Overall Study|Other|0|||
149736921|NCT03304522|540169200|FG001|Overall Study|Other|1|||
149736922|NCT03371355|540169205|FG000|Overall Study|Investigator judgment|0|||
149736923|NCT03371355|540169206|FG001|Overall Study|Investigator judgment|0|||
149736924|NCT03371355|540169207|FG002|Overall Study|Investigator judgment|1|||
149736925|NCT03371355|540169208|FG003|Overall Study|Investigator judgment|1|||
149736926|NCT03371355|540169205|FG000|Overall Study|Voluntary withdrawal|1|||
149736927|NCT03371355|540169206|FG001|Overall Study|Voluntary withdrawal|0|||
149736928|NCT03371355|540169207|FG002|Overall Study|Voluntary withdrawal|1|||
149736929|NCT03371355|540169208|FG003|Overall Study|Voluntary withdrawal|2|||
149736930|NCT03371355|540169205|FG000|Overall Study|Adverse Event|0|||
149736931|NCT03371355|540169206|FG001|Overall Study|Adverse Event|1|||
149736932|NCT03371355|540169207|FG002|Overall Study|Adverse Event|2|||
149736933|NCT03371355|540169208|FG003|Overall Study|Adverse Event|3|||
149736934|NCT03371355|540169205|FG000|Overall Study|Reason not Specified|0|||
149736935|NCT03371355|540169206|FG001|Overall Study|Reason not Specified|1|||
149736936|NCT03371355|540169207|FG002|Overall Study|Reason not Specified|0|||
149736937|NCT03371355|540169208|FG003|Overall Study|Reason not Specified|1|||
149736938|NCT02965378|540169210|FG000|Overall Study|Progression|16|||
149736939|NCT02965378|540169211|FG001|Overall Study|Progression|4|||
149736940|NCT02965378|540169210|FG000|Overall Study|Adverse Event|5|||
149736941|NCT02965378|540169211|FG001|Overall Study|Adverse Event|2|||
149736942|NCT02965378|540169210|FG000|Overall Study|Death|2|||
149736943|NCT02965378|540169211|FG001|Overall Study|Death|0|||
149736944|NCT02965378|540169210|FG000|Overall Study|Refusal|2|||
149736945|NCT02965378|540169211|FG001|Overall Study|Refusal|1|||
149736946|NCT02965378|540169210|FG000|Overall Study|Not protocol specified|0|||
149736947|NCT02965378|540169211|FG001|Overall Study|Not protocol specified|2|||
149736948|NCT02909153|540169212|FG000|Overall Study|Withdrawal by Subject|0|||
149736949|NCT02909153|540169213|FG001|Overall Study|Withdrawal by Subject|1|||
149736950|NCT02909153|540169214|FG002|Overall Study|Withdrawal by Subject|0|||
149736951|NCT02909153|540169215|FG003|Overall Study|Withdrawal by Subject|0|||
149736952|NCT02909153|540169216|FG004|Overall Study|Withdrawal by Subject|0|||
149736953|NCT01526148|540169219|FG000|Overall Study|Adverse Event|6|||
149736954|NCT01526148|540169220|FG001|Overall Study|Adverse Event|5|||
149736955|NCT01526148|540169219|FG000|Overall Study|Lost to Follow-up|3|||
149736956|NCT01526148|540169220|FG001|Overall Study|Lost to Follow-up|6|||
149736957|NCT01526148|540169219|FG000|Overall Study|Withdrawal by Subject|2|||
149736958|NCT01526148|540169220|FG001|Overall Study|Withdrawal by Subject|0|||
149736959|NCT01526148|540169219|FG000|Overall Study|Unstable Medical Condition|1|||
149736960|NCT01526148|540169220|FG001|Overall Study|Unstable Medical Condition|0|||
149736961|NCT01526148|540169219|FG000|Overall Study|Unable to discontinue concomitant med|1|||
149736962|NCT01526148|540169220|FG001|Overall Study|Unable to discontinue concomitant med|0|||
149736963|NCT01526148|540169219|FG000|Overall Study|Moved out of state|1|||
149736964|NCT01526148|540169220|FG001|Overall Study|Moved out of state|0|||
149736965|NCT01526148|540169219|FG000|Overall Study|Incarcerated|0|||
149736966|NCT01526148|540169220|FG001|Overall Study|Incarcerated|2|||
149736967|NCT01173653|540169221|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
149736968|NCT01173653|540169222|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
149736969|NCT00584870|540169223|FG000|Overall Study|Adverse Event|4|||
149736970|NCT00584870|540169224|FG001|Overall Study|Adverse Event|3|||
149736971|NCT00584870|540169225|FG002|Overall Study|Adverse Event|2|||
149736972|NCT00584870|540169223|FG000|Overall Study|Lost to Follow-up|4|||
149736973|NCT00584870|540169224|FG001|Overall Study|Lost to Follow-up|1|||
149736974|NCT00584870|540169225|FG002|Overall Study|Lost to Follow-up|1|||
149736975|NCT00584870|540169223|FG000|Overall Study|Lack of Efficacy|7|||
149736976|NCT00584870|540169224|FG001|Overall Study|Lack of Efficacy|14|||
149736977|NCT00584870|540169225|FG002|Overall Study|Lack of Efficacy|8|||
149736978|NCT00584870|540169223|FG000|Overall Study|Withdrawal by Subject|10|||
149736979|NCT00584870|540169224|FG001|Overall Study|Withdrawal by Subject|5|||
149736980|NCT00584870|540169225|FG002|Overall Study|Withdrawal by Subject|3|||
149736981|NCT00584870|540169223|FG000|Overall Study|Protocol Violation|1|||
149736982|NCT00584870|540169224|FG001|Overall Study|Protocol Violation|1|||
149736983|NCT00584870|540169225|FG002|Overall Study|Protocol Violation|2|||
149736984|NCT00584870|540169223|FG000|Overall Study|Did not met entrance criteria|1|||
149736985|NCT00584870|540169224|FG001|Overall Study|Did not met entrance criteria|0|||
149736986|NCT00584870|540169225|FG002|Overall Study|Did not met entrance criteria|0|||
149736987|NCT00584870|540169223|FG000|Overall Study|Other|2|||
149736988|NCT00584870|540169224|FG001|Overall Study|Other|0|||
149736989|NCT00584870|540169225|FG002|Overall Study|Other|0|||
149736990|NCT00584870|540169223|FG000|Overall Study|Randomized but not treated|0|||
149736991|NCT00584870|540169224|FG001|Overall Study|Randomized but not treated|1|||
149736992|NCT00584870|540169225|FG002|Overall Study|Randomized but not treated|2|||
149736993|NCT00631137|540169226|FG000|Overall Study|Withdrawal by Subject|1|||
149736994|NCT00631137|540169227|FG001|Overall Study|Withdrawal by Subject|0|||
149736995|NCT03308188|540169228|FG000|Overall Study|Withdrawal by Subject|0|||
149736996|NCT03308188|540169229|FG001|Overall Study|Withdrawal by Subject|3|||
149736997|NCT03308188|540169228|FG000|Overall Study|Death|0|||
149736998|NCT03308188|540169229|FG001|Overall Study|Death|1|||
149736999|NCT00481065|540169230|FG000|Overall Study|Adverse event or death|1|||
149737000|NCT00481065|540169231|FG001|Overall Study|Adverse event or death|1|||
149737001|NCT00481065|540169232|FG002|Overall Study|Adverse event or death|3|||
149737002|NCT00481065|540169233|FG003|Overall Study|Adverse event or death|0|||
149737003|NCT00481065|540169234|FG004|Overall Study|Adverse event or death|2|||
149737004|NCT00481065|540169235|FG005|Overall Study|Adverse event or death|0|||
149737005|NCT00481065|540169236|FG006|Overall Study|Adverse event or death|1|||
149737006|NCT00481065|540169237|FG007|Overall Study|Adverse event or death|1|||
149737007|NCT00481065|540169230|FG000|Overall Study|Withdrawal by Subject|11|||
149737008|NCT00481065|540169231|FG001|Overall Study|Withdrawal by Subject|12|||
149737009|NCT00481065|540169232|FG002|Overall Study|Withdrawal by Subject|7|||
149737010|NCT00481065|540169233|FG003|Overall Study|Withdrawal by Subject|11|||
149737011|NCT00481065|540169234|FG004|Overall Study|Withdrawal by Subject|13|||
149737012|NCT00481065|540169235|FG005|Overall Study|Withdrawal by Subject|12|||
149737013|NCT00481065|540169236|FG006|Overall Study|Withdrawal by Subject|9|||
149737014|NCT00481065|540169237|FG007|Overall Study|Withdrawal by Subject|10|||
149737015|NCT00481065|540169230|FG000|Overall Study|Lost to Follow-up|4|||
149737016|NCT00481065|540169231|FG001|Overall Study|Lost to Follow-up|2|||
149737017|NCT00481065|540169232|FG002|Overall Study|Lost to Follow-up|4|||
149737018|NCT00481065|540169233|FG003|Overall Study|Lost to Follow-up|3|||
149737019|NCT00481065|540169234|FG004|Overall Study|Lost to Follow-up|3|||
149737020|NCT00481065|540169235|FG005|Overall Study|Lost to Follow-up|3|||
149737021|NCT00481065|540169236|FG006|Overall Study|Lost to Follow-up|2|||
149737022|NCT00481065|540169237|FG007|Overall Study|Lost to Follow-up|5|||
149737023|NCT00481065|540169230|FG000|Overall Study|Inappropriate enrollment|4|||
149737024|NCT00481065|540169231|FG001|Overall Study|Inappropriate enrollment|0|||
149737025|NCT00481065|540169232|FG002|Overall Study|Inappropriate enrollment|2|||
149737026|NCT00481065|540169233|FG003|Overall Study|Inappropriate enrollment|0|||
149737027|NCT00481065|540169234|FG004|Overall Study|Inappropriate enrollment|2|||
149737028|NCT00481065|540169235|FG005|Overall Study|Inappropriate enrollment|1|||
149737029|NCT00481065|540169236|FG006|Overall Study|Inappropriate enrollment|0|||
149737030|NCT00481065|540169237|FG007|Overall Study|Inappropriate enrollment|1|||
149737031|NCT00481065|540169230|FG000|Overall Study|Administrative reason|0|||
149737032|NCT00481065|540169231|FG001|Overall Study|Administrative reason|0|||
149737033|NCT00481065|540169232|FG002|Overall Study|Administrative reason|0|||
149737034|NCT00481065|540169233|FG003|Overall Study|Administrative reason|0|||
149737035|NCT00481065|540169234|FG004|Overall Study|Administrative reason|0|||
149737036|NCT00481065|540169235|FG005|Overall Study|Administrative reason|2|||
149737037|NCT00481065|540169236|FG006|Overall Study|Administrative reason|1|||
149737038|NCT00481065|540169237|FG007|Overall Study|Administrative reason|0|||
149737039|NCT00481065|540169230|FG000|Overall Study|Protocol Violation|2|||
149737040|NCT00481065|540169231|FG001|Overall Study|Protocol Violation|1|||
149737041|NCT00481065|540169232|FG002|Overall Study|Protocol Violation|1|||
149737042|NCT00481065|540169233|FG003|Overall Study|Protocol Violation|1|||
149737043|NCT00481065|540169234|FG004|Overall Study|Protocol Violation|2|||
149737044|NCT00481065|540169235|FG005|Overall Study|Protocol Violation|6|||
149737045|NCT00481065|540169236|FG006|Overall Study|Protocol Violation|3|||
149737046|NCT00481065|540169237|FG007|Overall Study|Protocol Violation|2|||
149737047|NCT00481065|540169230|FG000|Overall Study|Unable to classify|0|||
149737048|NCT00481065|540169231|FG001|Overall Study|Unable to classify|1|||
149737049|NCT00481065|540169232|FG002|Overall Study|Unable to classify|2|||
149737050|NCT00481065|540169233|FG003|Overall Study|Unable to classify|0|||
149737051|NCT00481065|540169234|FG004|Overall Study|Unable to classify|1|||
149737052|NCT00481065|540169235|FG005|Overall Study|Unable to classify|0|||
149737053|NCT00481065|540169236|FG006|Overall Study|Unable to classify|0|||
149737054|NCT00481065|540169237|FG007|Overall Study|Unable to classify|0|||
149737055|NCT00772447|540169238|FG000|Overall Study|Withdrawal by Subject|9|||
149737056|NCT00772447|540169239|FG001|Overall Study|Withdrawal by Subject|5|||
149737057|NCT00772447|540169238|FG000|Overall Study|Physician Decision|4|||
149737058|NCT00772447|540169239|FG001|Overall Study|Physician Decision|8|||
149737059|NCT00772447|540169238|FG000|Overall Study|Lost to Follow-up|2|||
149737060|NCT00772447|540169239|FG001|Overall Study|Lost to Follow-up|4|||
149737061|NCT00772447|540169238|FG000|Overall Study|incorrect enrolment|3|||
149737062|NCT00772447|540169239|FG001|Overall Study|incorrect enrolment|4|||
149737063|NCT00772447|540169238|FG000|Overall Study|Protocol Violation|0|||
149737064|NCT00772447|540169239|FG001|Overall Study|Protocol Violation|1|||
149737065|NCT00772447|540169238|FG000|Overall Study|all others|2|||
149737066|NCT00772447|540169239|FG001|Overall Study|all others|2|||
149737067|NCT03529409|540169242|FG000|Randomized|Lost to Follow-up|0|||
149737068|NCT03529409|540169243|FG001|Randomized|Lost to Follow-up|0|||
149737069|NCT03529409|540169244|FG002|Randomized|Lost to Follow-up|4|||
149737070|NCT03529409|540169242|FG000|Randomized|Excluded|0|||
149737071|NCT03529409|540169243|FG001|Randomized|Excluded|0|||
149737072|NCT03529409|540169244|FG002|Randomized|Excluded|1|||
149737073|NCT03529409|540169242|FG000|Post-treatment Assessment|Death|1|||
149737074|NCT03529409|540169243|FG001|Post-treatment Assessment|Death|0|||
149737075|NCT03529409|540169244|FG002|Post-treatment Assessment|Death|0|||
149737076|NCT03529409|540169242|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
149737077|NCT03529409|540169243|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
149737078|NCT03529409|540169244|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
149737079|NCT03529409|540169242|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
149737080|NCT03529409|540169243|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
149737081|NCT03529409|540169244|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
149737082|NCT03529409|540169242|FG000|Follow-up Assessment|Death|1|||
149737083|NCT03529409|540169243|FG001|Follow-up Assessment|Death|0|||
149737084|NCT03529409|540169244|FG002|Follow-up Assessment|Death|0|||
149737085|NCT03529409|540169242|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
149737086|NCT03529409|540169243|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
149737087|NCT03529409|540169244|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
149737088|NCT01497262|540169245|FG000|Overall Study|Abnormal Lab Values|4|||
149737089|NCT01497262|540169245|FG000|Overall Study|Abnormal Test Procedure Result|1|||
149737090|NCT01497262|540169245|FG000|Overall Study|Physician Decision|1|||
149737091|NCT01497262|540169245|FG000|Overall Study|Withdrawal by Subject|2|||
149737092|NCT01497262|540169245|FG000|Overall Study|Adverse Event|2|||
149737093|NCT01497262|540169245|FG000|Overall Study|Protocol Violation|1|||
149737094|NCT00454207|540169246|FG000|Overall Study|Adverse Event|3|||
149737095|NCT00454207|540169247|FG001|Overall Study|Adverse Event|1|||
149737096|NCT00454207|540169246|FG000|Overall Study|Lack of Efficacy|1|||
149737097|NCT00454207|540169247|FG001|Overall Study|Lack of Efficacy|0|||
149737098|NCT00454207|540169246|FG000|Overall Study|Protocol Violation|0|||
149737099|NCT00454207|540169247|FG001|Overall Study|Protocol Violation|1|||
149737100|NCT01795547|540169248|FG000|Overall Study|Adverse Event|16|||
149737101|NCT01795547|540169249|FG001|Overall Study|Adverse Event|27|||
149737102|NCT01795547|540169248|FG000|Overall Study|Lack of Efficacy|8|||
149737103|NCT01795547|540169249|FG001|Overall Study|Lack of Efficacy|3|||
149737104|NCT01795547|540169248|FG000|Overall Study|Protocol Violation|6|||
149737105|NCT01795547|540169249|FG001|Overall Study|Protocol Violation|4|||
149737106|NCT01795547|540169248|FG000|Overall Study|Lost to Follow-up|2|||
149737107|NCT01795547|540169249|FG001|Overall Study|Lost to Follow-up|5|||
149737108|NCT01795547|540169248|FG000|Overall Study|Withdrawal of consent|7|||
149737109|NCT01795547|540169249|FG001|Overall Study|Withdrawal of consent|12|||
149737110|NCT01795547|540169248|FG000|Overall Study|Not Treated|4|||
149737111|NCT01795547|540169249|FG001|Overall Study|Not Treated|10|||
149737112|NCT01795547|540169248|FG000|Overall Study|Non-compliance with IMP|1|||
149737113|NCT01795547|540169249|FG001|Overall Study|Non-compliance with IMP|1|||
149737114|NCT01795547|540169248|FG000|Overall Study|Others|4|||
149737115|NCT01795547|540169249|FG001|Overall Study|Others|1|||
149737116|NCT01795547|540169248|FG000|Overall Study|Not stated|0|||
149737117|NCT01795547|540169249|FG001|Overall Study|Not stated|1|||
149737118|NCT00151892|540169250|FG000|Overall Study|Lack of Efficacy|50|||
149737119|NCT00151892|540169251|FG001|Overall Study|Lack of Efficacy|57|||
149737120|NCT00151892|540169250|FG000|Overall Study|Patient request|10|||
149737121|NCT00151892|540169251|FG001|Overall Study|Patient request|7|||
149737122|NCT00151892|540169250|FG000|Overall Study|Lost to Follow-up|5|||
149737123|NCT00151892|540169251|FG001|Overall Study|Lost to Follow-up|10|||
149737124|NCT00151892|540169250|FG000|Overall Study|Adverse Event|6|||
149737125|NCT00151892|540169251|FG001|Overall Study|Adverse Event|3|||
149737126|NCT00151892|540169250|FG000|Overall Study|Protocol Violation|3|||
149737127|NCT00151892|540169251|FG001|Overall Study|Protocol Violation|3|||
149737128|NCT00151892|540169250|FG000|Overall Study|Non-compliance|0|||
149737129|NCT00151892|540169251|FG001|Overall Study|Non-compliance|1|||
149737130|NCT00151892|540169250|FG000|Overall Study|Pregnancy|0|||
149737131|NCT00151892|540169251|FG001|Overall Study|Pregnancy|1|||
149737132|NCT00151892|540169250|FG000|Overall Study|Did not return for a visit|1|||
149737133|NCT00151892|540169251|FG001|Overall Study|Did not return for a visit|0|||
149737134|NCT00151892|540169250|FG000|Overall Study|Used prohibited corticosteroids|1|||
149737135|NCT00151892|540169251|FG001|Overall Study|Used prohibited corticosteroids|0|||
149737136|NCT00151892|540169250|FG000|Overall Study|Lack of study medication at center|0|||
149737137|NCT00151892|540169251|FG001|Overall Study|Lack of study medication at center|1|||
149737138|NCT01551745|540169254|FG000|Overall Study|Withdrawal by Subject|1|||
149737139|NCT01551745|540169254|FG000|Overall Study|Disease Progression|2|||
149737140|NCT02764541|540169255|FG000|Overall Study|Withdrawal by Subject|0|||
149737141|NCT02764541|540169256|FG001|Overall Study|Withdrawal by Subject|0|||
149737142|NCT02764541|540169257|FG002|Overall Study|Withdrawal by Subject|0|||
149737143|NCT02764541|540169258|FG003|Overall Study|Withdrawal by Subject|0|||
149737144|NCT02764541|540169259|FG004|Overall Study|Withdrawal by Subject|1|||
149737145|NCT02764541|540169260|FG005|Overall Study|Withdrawal by Subject|1|||
149737146|NCT02764541|540169261|FG006|Overall Study|Withdrawal by Subject|0|||
149737147|NCT02764541|540169262|FG007|Overall Study|Withdrawal by Subject|1|||
149737148|NCT02764541|540169255|FG000|Overall Study|Adverse Event|1|||
149737149|NCT02764541|540169256|FG001|Overall Study|Adverse Event|0|||
149737150|NCT02764541|540169257|FG002|Overall Study|Adverse Event|0|||
149737151|NCT02764541|540169258|FG003|Overall Study|Adverse Event|0|||
149737152|NCT02764541|540169259|FG004|Overall Study|Adverse Event|0|||
149737153|NCT02764541|540169260|FG005|Overall Study|Adverse Event|0|||
149737154|NCT02764541|540169261|FG006|Overall Study|Adverse Event|1|||
149737155|NCT02764541|540169262|FG007|Overall Study|Adverse Event|0|||
149737156|NCT02764541|540169255|FG000|Overall Study|Metastasis|1|||
149737157|NCT02764541|540169256|FG001|Overall Study|Metastasis|0|||
149737158|NCT02764541|540169257|FG002|Overall Study|Metastasis|0|||
149737159|NCT02764541|540169258|FG003|Overall Study|Metastasis|0|||
149737160|NCT02764541|540169259|FG004|Overall Study|Metastasis|0|||
149737161|NCT02764541|540169260|FG005|Overall Study|Metastasis|0|||
149737162|NCT02764541|540169261|FG006|Overall Study|Metastasis|0|||
149737163|NCT02764541|540169262|FG007|Overall Study|Metastasis|0|||
149737164|NCT02764541|540169255|FG000|Overall Study|Disease progression|1|||
149737165|NCT02764541|540169256|FG001|Overall Study|Disease progression|1|||
149737166|NCT02764541|540169257|FG002|Overall Study|Disease progression|0|||
149737167|NCT02764541|540169258|FG003|Overall Study|Disease progression|0|||
149737168|NCT02764541|540169259|FG004|Overall Study|Disease progression|0|||
149737169|NCT02764541|540169260|FG005|Overall Study|Disease progression|0|||
149737170|NCT02764541|540169261|FG006|Overall Study|Disease progression|0|||
149737171|NCT02764541|540169262|FG007|Overall Study|Disease progression|1|||
149737172|NCT02764541|540169255|FG000|Overall Study|Protocol Violation|0|||
149737173|NCT02764541|540169256|FG001|Overall Study|Protocol Violation|0|||
149737174|NCT02764541|540169257|FG002|Overall Study|Protocol Violation|0|||
149737175|NCT02764541|540169258|FG003|Overall Study|Protocol Violation|1|||
149737176|NCT02764541|540169259|FG004|Overall Study|Protocol Violation|0|||
149737177|NCT02764541|540169260|FG005|Overall Study|Protocol Violation|1|||
149737178|NCT02764541|540169261|FG006|Overall Study|Protocol Violation|0|||
149737179|NCT02764541|540169262|FG007|Overall Study|Protocol Violation|0|||
149737180|NCT02764541|540169255|FG000|Overall Study|Physician Decision|0|||
149737181|NCT02764541|540169256|FG001|Overall Study|Physician Decision|0|||
149737182|NCT02764541|540169257|FG002|Overall Study|Physician Decision|0|||
149737183|NCT02764541|540169258|FG003|Overall Study|Physician Decision|1|||
149737184|NCT02764541|540169259|FG004|Overall Study|Physician Decision|0|||
149737185|NCT02764541|540169260|FG005|Overall Study|Physician Decision|0|||
149737186|NCT02764541|540169261|FG006|Overall Study|Physician Decision|0|||
149737187|NCT02764541|540169262|FG007|Overall Study|Physician Decision|1|||
149737188|NCT02764541|540169255|FG000|Overall Study|Three Cycles completed before surgery|0|||
149737189|NCT02764541|540169256|FG001|Overall Study|Three Cycles completed before surgery|0|||
149737190|NCT02764541|540169257|FG002|Overall Study|Three Cycles completed before surgery|0|||
149737191|NCT02764541|540169258|FG003|Overall Study|Three Cycles completed before surgery|1|||
149737192|NCT02764541|540169259|FG004|Overall Study|Three Cycles completed before surgery|0|||
149737193|NCT02764541|540169260|FG005|Overall Study|Three Cycles completed before surgery|0|||
149737194|NCT02764541|540169261|FG006|Overall Study|Three Cycles completed before surgery|0|||
149737195|NCT02764541|540169262|FG007|Overall Study|Three Cycles completed before surgery|0|||
149737196|NCT02764541|540169255|FG000|Overall Study|Patient Compliance|0|||
149737197|NCT02764541|540169256|FG001|Overall Study|Patient Compliance|0|||
149737198|NCT02764541|540169257|FG002|Overall Study|Patient Compliance|1|||
150255067|NCT01302067|542070542|FG000|Overall Study|Protocol Violation|11|||
149737199|NCT02764541|540169258|FG003|Overall Study|Patient Compliance|0|||
149737200|NCT02764541|540169259|FG004|Overall Study|Patient Compliance|0|||
149737201|NCT02764541|540169260|FG005|Overall Study|Patient Compliance|0|||
149737202|NCT02764541|540169261|FG006|Overall Study|Patient Compliance|0|||
149737203|NCT02764541|540169262|FG007|Overall Study|Patient Compliance|0|||
149737204|NCT02764541|540169255|FG000|Overall Study|Death|0|||
149737205|NCT02764541|540169256|FG001|Overall Study|Death|0|||
149737206|NCT02764541|540169257|FG002|Overall Study|Death|0|||
149737207|NCT02764541|540169258|FG003|Overall Study|Death|0|||
149737208|NCT02764541|540169259|FG004|Overall Study|Death|0|||
149737209|NCT02764541|540169260|FG005|Overall Study|Death|0|||
149737210|NCT02764541|540169261|FG006|Overall Study|Death|1|||
149737211|NCT02764541|540169262|FG007|Overall Study|Death|0|||
149737212|NCT02764541|540169255|FG000|Overall Study|Insurance reasons|0|||
149737213|NCT02764541|540169256|FG001|Overall Study|Insurance reasons|0|||
149737214|NCT02764541|540169257|FG002|Overall Study|Insurance reasons|0|||
149737215|NCT02764541|540169258|FG003|Overall Study|Insurance reasons|0|||
149737216|NCT02764541|540169259|FG004|Overall Study|Insurance reasons|0|||
149737217|NCT02764541|540169260|FG005|Overall Study|Insurance reasons|0|||
149737218|NCT02764541|540169261|FG006|Overall Study|Insurance reasons|1|||
149737219|NCT02764541|540169262|FG007|Overall Study|Insurance reasons|0|||
149737220|NCT00749190|540169265|FG000|Overall Study|Adverse Event|0|||
149737221|NCT00749190|540169266|FG001|Overall Study|Adverse Event|2|||
149737222|NCT00749190|540169267|FG002|Overall Study|Adverse Event|0|||
149737223|NCT00749190|540169268|FG003|Overall Study|Adverse Event|4|||
149737224|NCT00749190|540169269|FG004|Overall Study|Adverse Event|0|||
149737225|NCT00749190|540169270|FG005|Overall Study|Adverse Event|3|||
149737226|NCT00749190|540169271|FG006|Overall Study|Adverse Event|0|||
149737227|NCT00749190|540169265|FG000|Overall Study|Lack of Efficacy|3|||
149737228|NCT00749190|540169266|FG001|Overall Study|Lack of Efficacy|1|||
149737229|NCT00749190|540169267|FG002|Overall Study|Lack of Efficacy|1|||
149737230|NCT00749190|540169268|FG003|Overall Study|Lack of Efficacy|0|||
149737231|NCT00749190|540169269|FG004|Overall Study|Lack of Efficacy|0|||
149737232|NCT00749190|540169270|FG005|Overall Study|Lack of Efficacy|1|||
149737233|NCT00749190|540169271|FG006|Overall Study|Lack of Efficacy|0|||
149737234|NCT00749190|540169265|FG000|Overall Study|Withdrawal by Subject|2|||
149737235|NCT00749190|540169266|FG001|Overall Study|Withdrawal by Subject|1|||
149737236|NCT00749190|540169267|FG002|Overall Study|Withdrawal by Subject|0|||
149737237|NCT00749190|540169268|FG003|Overall Study|Withdrawal by Subject|0|||
149737238|NCT00749190|540169269|FG004|Overall Study|Withdrawal by Subject|0|||
149737239|NCT00749190|540169270|FG005|Overall Study|Withdrawal by Subject|1|||
149737240|NCT00749190|540169271|FG006|Overall Study|Withdrawal by Subject|0|||
149737241|NCT00749190|540169265|FG000|Overall Study|Protocol Violation|0|||
149737242|NCT00749190|540169266|FG001|Overall Study|Protocol Violation|1|||
149737243|NCT00749190|540169267|FG002|Overall Study|Protocol Violation|0|||
149737244|NCT00749190|540169268|FG003|Overall Study|Protocol Violation|0|||
149737245|NCT00749190|540169269|FG004|Overall Study|Protocol Violation|0|||
149737246|NCT00749190|540169270|FG005|Overall Study|Protocol Violation|0|||
149737247|NCT00749190|540169271|FG006|Overall Study|Protocol Violation|1|||
149737248|NCT00749190|540169265|FG000|Overall Study|Other reason not defined above|0|||
149737249|NCT00749190|540169266|FG001|Overall Study|Other reason not defined above|0|||
149737250|NCT00749190|540169267|FG002|Overall Study|Other reason not defined above|0|||
149737251|NCT00749190|540169268|FG003|Overall Study|Other reason not defined above|1|||
149737252|NCT00749190|540169269|FG004|Overall Study|Other reason not defined above|0|||
149737253|NCT00749190|540169270|FG005|Overall Study|Other reason not defined above|0|||
149737254|NCT00749190|540169271|FG006|Overall Study|Other reason not defined above|0|||
149737255|NCT00784758|540169272|FG000|Overall Study|Withdrawal by Subject|3|||
149737256|NCT00784758|540169273|FG001|Overall Study|Withdrawal by Subject|0|||
149737257|NCT00784758|540169272|FG000|Overall Study|Adverse Event|1|||
149737258|NCT00784758|540169273|FG001|Overall Study|Adverse Event|0|||
149737259|NCT04439331|540169280|FG000|Overall Study|Never Start Protocol Therapy|2|||
149737260|NCT04439331|540169280|FG000|Overall Study|Ineligible|2|||
149737261|NCT04439331|540169280|FG000|Overall Study|Mutation Status Not Confirmed|1|||
149737262|NCT04439331|540169280|FG000|Overall Study|Adverse Event|1|||
149737263|NCT04439331|540169280|FG000|Overall Study|Death|1|||
149737264|NCT04439331|540169280|FG000|Overall Study|Disease Progression|20|||
149737265|NCT04439331|540169280|FG000|Overall Study|Withdrawal by Subject|6|||
149737266|NCT04439331|540169280|FG000|Overall Study|Physician Decision|1|||
149737267|NCT04439331|540169280|FG000|Overall Study|Other Complicating Disease|1|||
149737268|NCT03726268|540169282|FG000|Overall Study|Physician Decision|2|||
149737269|NCT03726268|540169283|FG001|Overall Study|Physician Decision|8|||
149737270|NCT03726268|540169284|FG002|Overall Study|Physician Decision|6|||
149737271|NCT03726268|540169285|FG003|Overall Study|Physician Decision|3|||
149737272|NCT03726268|540169282|FG000|Overall Study|Withdrawal by Subject|11|||
149737273|NCT03726268|540169283|FG001|Overall Study|Withdrawal by Subject|5|||
149737274|NCT03726268|540169284|FG002|Overall Study|Withdrawal by Subject|9|||
149737275|NCT03726268|540169285|FG003|Overall Study|Withdrawal by Subject|8|||
149737276|NCT04696861|540169286|FG000|Overall Study|Death|1|||
149737277|NCT04696861|540169287|FG001|Overall Study|Death|0|||
149737278|NCT04696861|540169286|FG000|Overall Study|Lost to Follow-up|3|||
149737279|NCT04696861|540169287|FG001|Overall Study|Lost to Follow-up|0|||
149737280|NCT03952559|540169288|FG000|Double Blind Treatment Period|Adverse Event|0|||
149737281|NCT03952559|540169289|FG001|Double Blind Treatment Period|Adverse Event|2|||
149737282|NCT03952559|540169290|FG002|Double Blind Treatment Period|Adverse Event|1|||
149737283|NCT03952559|540169291|FG003|Double Blind Treatment Period|Adverse Event|0|||
149737284|NCT03952559|540169292|FG004|Double Blind Treatment Period|Adverse Event|1|||
149737285|NCT03952559|540169288|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
149737286|NCT03952559|540169289|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
149737287|NCT03952559|540169290|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
149737288|NCT03952559|540169291|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
149737289|NCT03952559|540169292|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
149737290|NCT03952559|540169288|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
149737291|NCT03952559|540169289|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
149737292|NCT03952559|540169290|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
149737293|NCT03952559|540169291|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
149737294|NCT03952559|540169292|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149737295|NCT03952559|540169288|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
149737296|NCT03952559|540169289|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
149737297|NCT03952559|540169290|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
149737298|NCT03952559|540169291|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
149737299|NCT03952559|540169292|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
149737300|NCT01827384|540169293|FG000|Overall Study|Switched to alternative treatment|0|||
149737301|NCT01827384|540169294|FG001|Overall Study|Switched to alternative treatment|0|||
149737302|NCT01827384|540169295|FG002|Overall Study|Switched to alternative treatment|0|||
149737303|NCT01827384|540169296|FG003|Overall Study|Switched to alternative treatment|0|||
149737304|NCT01827384|540169297|FG004|Overall Study|Switched to alternative treatment|0|||
149737305|NCT01827384|540169298|FG005|Overall Study|Switched to alternative treatment|0|||
149737306|NCT01827384|540169299|FG006|Overall Study|Switched to alternative treatment|0|||
149737307|NCT01827384|540169300|FG007|Overall Study|Switched to alternative treatment|0|||
149737308|NCT01827384|540169301|FG008|Overall Study|Switched to alternative treatment|0|||
149737309|NCT01827384|540169302|FG009|Overall Study|Switched to alternative treatment|0|||
149737310|NCT01827384|540169303|FG010|Overall Study|Switched to alternative treatment|0|||
149737311|NCT01827384|540169304|FG011|Overall Study|Switched to alternative treatment|0|||
149737312|NCT01827384|540169305|FG012|Overall Study|Switched to alternative treatment|0|||
149737313|NCT01827384|540169306|FG013|Overall Study|Switched to alternative treatment|2|||
149737314|NCT01827384|540169293|FG000|Overall Study|Disease progression before treatment|0|||
149737315|NCT01827384|540169294|FG001|Overall Study|Disease progression before treatment|0|||
149737316|NCT01827384|540169295|FG002|Overall Study|Disease progression before treatment|0|||
149737317|NCT01827384|540169296|FG003|Overall Study|Disease progression before treatment|0|||
149737318|NCT01827384|540169297|FG004|Overall Study|Disease progression before treatment|0|||
149737319|NCT01827384|540169298|FG005|Overall Study|Disease progression before treatment|0|||
149737320|NCT01827384|540169299|FG006|Overall Study|Disease progression before treatment|0|||
149737321|NCT01827384|540169300|FG007|Overall Study|Disease progression before treatment|0|||
149737322|NCT01827384|540169301|FG008|Overall Study|Disease progression before treatment|0|||
149737323|NCT01827384|540169302|FG009|Overall Study|Disease progression before treatment|0|||
149737324|NCT01827384|540169303|FG010|Overall Study|Disease progression before treatment|0|||
149737325|NCT01827384|540169304|FG011|Overall Study|Disease progression before treatment|0|||
149737326|NCT01827384|540169305|FG012|Overall Study|Disease progression before treatment|0|||
149737327|NCT01827384|540169306|FG013|Overall Study|Disease progression before treatment|4|||
149737328|NCT01827384|540169293|FG000|Overall Study|Ineligible|0|||
149737329|NCT01827384|540169294|FG001|Overall Study|Ineligible|0|||
149737330|NCT01827384|540169295|FG002|Overall Study|Ineligible|0|||
149737331|NCT01827384|540169296|FG003|Overall Study|Ineligible|0|||
149737332|NCT01827384|540169297|FG004|Overall Study|Ineligible|0|||
149737333|NCT01827384|540169298|FG005|Overall Study|Ineligible|0|||
149737334|NCT01827384|540169299|FG006|Overall Study|Ineligible|0|||
149737335|NCT01827384|540169300|FG007|Overall Study|Ineligible|0|||
149737336|NCT01827384|540169301|FG008|Overall Study|Ineligible|0|||
149737337|NCT01827384|540169302|FG009|Overall Study|Ineligible|0|||
149737338|NCT01827384|540169303|FG010|Overall Study|Ineligible|0|||
149737339|NCT01827384|540169304|FG011|Overall Study|Ineligible|0|||
149737340|NCT01827384|540169305|FG012|Overall Study|Ineligible|0|||
149737341|NCT01827384|540169306|FG013|Overall Study|Ineligible|19|||
149737342|NCT01827384|540169293|FG000|Overall Study|Participant died before treatment|0|||
149737343|NCT01827384|540169294|FG001|Overall Study|Participant died before treatment|0|||
149737344|NCT01827384|540169295|FG002|Overall Study|Participant died before treatment|0|||
149737345|NCT01827384|540169296|FG003|Overall Study|Participant died before treatment|0|||
149737346|NCT01827384|540169297|FG004|Overall Study|Participant died before treatment|0|||
149737347|NCT01827384|540169298|FG005|Overall Study|Participant died before treatment|0|||
149737348|NCT01827384|540169299|FG006|Overall Study|Participant died before treatment|0|||
149737349|NCT01827384|540169300|FG007|Overall Study|Participant died before treatment|0|||
149737350|NCT01827384|540169301|FG008|Overall Study|Participant died before treatment|0|||
149737351|NCT01827384|540169302|FG009|Overall Study|Participant died before treatment|0|||
149737352|NCT01827384|540169303|FG010|Overall Study|Participant died before treatment|0|||
149737353|NCT01827384|540169304|FG011|Overall Study|Participant died before treatment|0|||
150255068|NCT01302067|542070543|FG001|Overall Study|Protocol Violation|0|||
149737354|NCT01827384|540169305|FG012|Overall Study|Participant died before treatment|0|||
149737355|NCT01827384|540169306|FG013|Overall Study|Participant died before treatment|5|||
149737356|NCT01827384|540169293|FG000|Overall Study|Insufficient tumor cells|0|||
149737357|NCT01827384|540169294|FG001|Overall Study|Insufficient tumor cells|0|||
149737358|NCT01827384|540169295|FG002|Overall Study|Insufficient tumor cells|0|||
149737359|NCT01827384|540169296|FG003|Overall Study|Insufficient tumor cells|0|||
149737360|NCT01827384|540169297|FG004|Overall Study|Insufficient tumor cells|0|||
149737361|NCT01827384|540169298|FG005|Overall Study|Insufficient tumor cells|0|||
149737362|NCT01827384|540169299|FG006|Overall Study|Insufficient tumor cells|0|||
149737363|NCT01827384|540169300|FG007|Overall Study|Insufficient tumor cells|0|||
149737364|NCT01827384|540169301|FG008|Overall Study|Insufficient tumor cells|0|||
149737365|NCT01827384|540169302|FG009|Overall Study|Insufficient tumor cells|0|||
149737366|NCT01827384|540169303|FG010|Overall Study|Insufficient tumor cells|0|||
149737367|NCT01827384|540169304|FG011|Overall Study|Insufficient tumor cells|0|||
149737368|NCT01827384|540169305|FG012|Overall Study|Insufficient tumor cells|0|||
149737369|NCT01827384|540169306|FG013|Overall Study|Insufficient tumor cells|13|||
149737370|NCT01827384|540169293|FG000|Overall Study|No actionable mutation|0|||
149737371|NCT01827384|540169294|FG001|Overall Study|No actionable mutation|0|||
149737372|NCT01827384|540169295|FG002|Overall Study|No actionable mutation|0|||
149737373|NCT01827384|540169296|FG003|Overall Study|No actionable mutation|0|||
149737374|NCT01827384|540169297|FG004|Overall Study|No actionable mutation|0|||
149737375|NCT01827384|540169298|FG005|Overall Study|No actionable mutation|0|||
149737376|NCT01827384|540169299|FG006|Overall Study|No actionable mutation|0|||
149737377|NCT01827384|540169300|FG007|Overall Study|No actionable mutation|0|||
149737378|NCT01827384|540169301|FG008|Overall Study|No actionable mutation|0|||
149737379|NCT01827384|540169302|FG009|Overall Study|No actionable mutation|0|||
149737380|NCT01827384|540169303|FG010|Overall Study|No actionable mutation|0|||
149737381|NCT01827384|540169304|FG011|Overall Study|No actionable mutation|0|||
149737382|NCT01827384|540169305|FG012|Overall Study|No actionable mutation|0|||
149737383|NCT01827384|540169306|FG013|Overall Study|No actionable mutation|73|||
149737384|NCT01827384|540169293|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
149737385|NCT01827384|540169294|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
149737386|NCT01827384|540169295|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
149737387|NCT01827384|540169296|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
149737388|NCT01827384|540169297|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
149737389|NCT01827384|540169298|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
149737390|NCT01827384|540169299|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
149737391|NCT01827384|540169300|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
149737392|NCT01827384|540169301|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
149737393|NCT01827384|540169302|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
149737394|NCT01827384|540169303|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
149737395|NCT01827384|540169304|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
149737396|NCT01827384|540169305|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
149737397|NCT01827384|540169306|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
149737398|NCT03498521|540169311|FG000|Overall Study|Death|227|||
149737399|NCT03498521|540169312|FG001|Overall Study|Death|79|||
149737400|NCT03498521|540169313|FG002|Overall Study|Death|84|||
149737401|NCT03498521|540169311|FG000|Overall Study|Exclusion criteria|1|||
149737402|NCT03498521|540169312|FG001|Overall Study|Exclusion criteria|0|||
149737403|NCT03498521|540169313|FG002|Overall Study|Exclusion criteria|0|||
149737404|NCT03498521|540169311|FG000|Overall Study|Lost to Follow-up|4|||
149737405|NCT03498521|540169312|FG001|Overall Study|Lost to Follow-up|3|||
149737406|NCT03498521|540169313|FG002|Overall Study|Lost to Follow-up|3|||
149737407|NCT03498521|540169311|FG000|Overall Study|No profile due to technical failure|1|||
149737408|NCT03498521|540169312|FG001|Overall Study|No profile due to technical failure|0|||
149737409|NCT03498521|540169313|FG002|Overall Study|No profile due to technical failure|0|||
149737410|NCT03498521|540169311|FG000|Overall Study|Physician Decision|3|||
149737411|NCT03498521|540169312|FG001|Overall Study|Physician Decision|1|||
149737412|NCT03498521|540169313|FG002|Overall Study|Physician Decision|0|||
149737413|NCT03498521|540169311|FG000|Overall Study|Withdrawal by Subject|11|||
149737414|NCT03498521|540169312|FG001|Overall Study|Withdrawal by Subject|6|||
149737415|NCT03498521|540169313|FG002|Overall Study|Withdrawal by Subject|2|||
150255069|NCT01302067|542070544|FG002|Overall Study|Protocol Violation|8|||
150255070|NCT01302067|542070542|FG000|Overall Study|Adverse Event|27|||
150255071|NCT01302067|542070543|FG001|Overall Study|Adverse Event|14|||
149737416|NCT03498521|540169311|FG000|Overall Study|Study terminated by sponsor|79|||
149737417|NCT03498521|540169312|FG001|Overall Study|Study terminated by sponsor|21|||
149737418|NCT03498521|540169313|FG002|Overall Study|Study terminated by sponsor|4|||
149737419|NCT04167345|540169314|FG000|Overall Study|Other|1|||
149737420|NCT04167345|540169315|FG001|Overall Study|Other|1|||
149737421|NCT04167345|540169316|FG002|Overall Study|Other|0|||
149737422|NCT04167345|540169317|FG003|Overall Study|Other|0|||
149737423|NCT04167345|540169318|FG004|Overall Study|Other|0|||
149737424|NCT00960076|540170367|FG000|Overall Study|Adverse Event|1|||
149737425|NCT00960076|540170368|FG001|Overall Study|Adverse Event|7|||
149737426|NCT00960076|540170367|FG000|Overall Study|No longer met study criteria|1|||
149737427|NCT00960076|540170368|FG001|Overall Study|No longer met study criteria|5|||
149737428|NCT00960076|540170367|FG000|Overall Study|Withdrawal by Subject|1|||
149737429|NCT00960076|540170368|FG001|Overall Study|Withdrawal by Subject|2|||
149737430|NCT00960076|540170367|FG000|Overall Study|Lost to Follow-up|3|||
149737431|NCT00960076|540170368|FG001|Overall Study|Lost to Follow-up|3|||
149737432|NCT00960076|540170367|FG000|Overall Study|Severe non-compliance to protocol|1|||
149737433|NCT00960076|540170368|FG001|Overall Study|Severe non-compliance to protocol|2|||
149737434|NCT00960076|540170367|FG000|Overall Study|Hyperglycemia|1|||
149737435|NCT00960076|540170368|FG001|Overall Study|Hyperglycemia|5|||
149737436|NCT00960076|540170367|FG000|Overall Study|Did not attend the termination visit|0|||
149737437|NCT00960076|540170368|FG001|Overall Study|Did not attend the termination visit|1|||
149737438|NCT01028352|540170371|FG000|Overall Study|Ineligible due to baseline average pain|5|||
149737439|NCT01028352|540170371|FG000|Overall Study|Withdrawal by Subject|1|||
149737440|NCT05052723|540170374|FG000|Overall Study|Death|19|||
149737441|NCT06161012|540170375|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
149737442|NCT06161012|540170376|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
149737443|NCT02601950|540170377|FG000|Overall Study|Participant enrolled in rollover study|0|||
149737444|NCT02601950|540170378|FG001|Overall Study|Participant enrolled in rollover study|0|||
149737445|NCT02601950|540170379|FG002|Overall Study|Participant enrolled in rollover study|1|||
149737446|NCT02601950|540170380|FG003|Overall Study|Participant enrolled in rollover study|0|||
149737447|NCT02601950|540170381|FG004|Overall Study|Participant enrolled in rollover study|1|||
149737448|NCT02601950|540170382|FG005|Overall Study|Participant enrolled in rollover study|1|||
149737449|NCT02601950|540170383|FG006|Overall Study|Participant enrolled in rollover study|1|||
149737450|NCT02601950|540170384|FG007|Overall Study|Participant enrolled in rollover study|0|||
149737451|NCT02601950|540170377|FG000|Overall Study|Disease progression - radiological|21|||
149737452|NCT02601950|540170378|FG001|Overall Study|Disease progression - radiological|26|||
149737453|NCT02601950|540170379|FG002|Overall Study|Disease progression - radiological|22|||
149737454|NCT02601950|540170380|FG003|Overall Study|Disease progression - radiological|11|||
149737455|NCT02601950|540170381|FG004|Overall Study|Disease progression - radiological|46|||
149737456|NCT02601950|540170382|FG005|Overall Study|Disease progression - radiological|52|||
149737457|NCT02601950|540170383|FG006|Overall Study|Disease progression - radiological|7|||
149737458|NCT02601950|540170384|FG007|Overall Study|Disease progression - radiological|5|||
149737459|NCT02601950|540170377|FG000|Overall Study|Disease progression - clinical|3|||
149737460|NCT02601950|540170378|FG001|Overall Study|Disease progression - clinical|5|||
149737461|NCT02601950|540170379|FG002|Overall Study|Disease progression - clinical|4|||
149737462|NCT02601950|540170380|FG003|Overall Study|Disease progression - clinical|2|||
149737463|NCT02601950|540170381|FG004|Overall Study|Disease progression - clinical|6|||
149737464|NCT02601950|540170382|FG005|Overall Study|Disease progression - clinical|6|||
149737465|NCT02601950|540170383|FG006|Overall Study|Disease progression - clinical|5|||
149737466|NCT02601950|540170384|FG007|Overall Study|Disease progression - clinical|1|||
149737467|NCT02601950|540170377|FG000|Overall Study|Death|6|||
149737468|NCT02601950|540170378|FG001|Overall Study|Death|0|||
149737469|NCT02601950|540170379|FG002|Overall Study|Death|3|||
149737470|NCT02601950|540170380|FG003|Overall Study|Death|1|||
149737471|NCT02601950|540170381|FG004|Overall Study|Death|4|||
149737472|NCT02601950|540170382|FG005|Overall Study|Death|1|||
149737473|NCT02601950|540170383|FG006|Overall Study|Death|0|||
149737474|NCT02601950|540170384|FG007|Overall Study|Death|0|||
149737475|NCT02601950|540170377|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737476|NCT02601950|540170378|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737477|NCT02601950|540170379|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737478|NCT02601950|540170380|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737479|NCT02601950|540170381|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737480|NCT02601950|540170382|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
149737481|NCT02601950|540170383|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737482|NCT02601950|540170384|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149737483|NCT02601950|540170377|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
149737484|NCT02601950|540170378|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
149737485|NCT02601950|540170379|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
149737486|NCT02601950|540170380|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
149737487|NCT02601950|540170381|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
149737488|NCT02601950|540170382|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
149737489|NCT02601950|540170383|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
149737490|NCT02601950|540170384|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
149737491|NCT02601950|540170377|FG000|Overall Study|Non-compliance|0|||
149737564|NCT00408005|540170386|FG001|Induction|Refusal of Further Protocol Therapy|44|||
149737565|NCT00408005|540170387|FG002|Induction|Refusal of Further Protocol Therapy|0|||
149737566|NCT00408005|540170388|FG003|Induction|Refusal of Further Protocol Therapy|0|||
149737567|NCT00408005|540170389|FG004|Induction|Refusal of Further Protocol Therapy|0|||
149737568|NCT00408005|540170390|FG005|Induction|Refusal of Further Protocol Therapy|0|||
149737569|NCT00408005|540170391|FG006|Induction|Refusal of Further Protocol Therapy|0|||
149737570|NCT00408005|540170392|FG007|Induction|Refusal of Further Protocol Therapy|0|||
149737571|NCT00408005|540170385|FG000|Induction|Entered another COG therapeutic protocol|4|||
149737572|NCT00408005|540170386|FG001|Induction|Entered another COG therapeutic protocol|0|||
149737573|NCT00408005|540170387|FG002|Induction|Entered another COG therapeutic protocol|0|||
149737574|NCT00408005|540170388|FG003|Induction|Entered another COG therapeutic protocol|0|||
149737575|NCT00408005|540170389|FG004|Induction|Entered another COG therapeutic protocol|0|||
149737576|NCT00408005|540170390|FG005|Induction|Entered another COG therapeutic protocol|0|||
149737577|NCT00408005|540170391|FG006|Induction|Entered another COG therapeutic protocol|0|||
149737578|NCT00408005|540170392|FG007|Induction|Entered another COG therapeutic protocol|0|||
149737579|NCT00408005|540170385|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
149737580|NCT00408005|540170386|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
149737581|NCT00408005|540170387|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
149737582|NCT00408005|540170388|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
149737583|NCT00408005|540170389|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
149737584|NCT00408005|540170390|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
149737585|NCT00408005|540170391|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
149737586|NCT00408005|540170392|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
149737587|NCT00408005|540170385|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
149737588|NCT00408005|540170386|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
149737589|NCT00408005|540170387|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
149737590|NCT00408005|540170388|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
149737591|NCT00408005|540170389|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
149737592|NCT00408005|540170390|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
149737593|NCT00408005|540170391|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
149737594|NCT00408005|540170392|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
149737595|NCT00408005|540170385|FG000|Induction|Progressive Disease|0|||
149737596|NCT00408005|540170386|FG001|Induction|Progressive Disease|1|||
149737597|NCT00408005|540170387|FG002|Induction|Progressive Disease|0|||
149737598|NCT00408005|540170388|FG003|Induction|Progressive Disease|0|||
149737599|NCT00408005|540170389|FG004|Induction|Progressive Disease|0|||
149737600|NCT00408005|540170390|FG005|Induction|Progressive Disease|0|||
149737601|NCT00408005|540170391|FG006|Induction|Progressive Disease|0|||
149737602|NCT00408005|540170392|FG007|Induction|Progressive Disease|0|||
149737603|NCT00408005|540170385|FG000|Induction|Inevaluable|18|||
149737604|NCT00408005|540170386|FG001|Induction|Inevaluable|14|||
149737605|NCT00408005|540170387|FG002|Induction|Inevaluable|0|||
149737606|NCT00408005|540170388|FG003|Induction|Inevaluable|0|||
149737607|NCT00408005|540170389|FG004|Induction|Inevaluable|0|||
149737608|NCT00408005|540170390|FG005|Induction|Inevaluable|0|||
149737609|NCT00408005|540170391|FG006|Induction|Inevaluable|0|||
149737610|NCT00408005|540170392|FG007|Induction|Inevaluable|0|||
149737611|NCT00408005|540170385|FG000|Induction|Failed to Complete Randomization|3|||
149737612|NCT00408005|540170386|FG001|Induction|Failed to Complete Randomization|2|||
149737613|NCT00408005|540170387|FG002|Induction|Failed to Complete Randomization|0|||
149737614|NCT00408005|540170388|FG003|Induction|Failed to Complete Randomization|0|||
149737615|NCT00408005|540170389|FG004|Induction|Failed to Complete Randomization|0|||
149737616|NCT00408005|540170390|FG005|Induction|Failed to Complete Randomization|0|||
149737617|NCT00408005|540170391|FG006|Induction|Failed to Complete Randomization|0|||
149737618|NCT00408005|540170392|FG007|Induction|Failed to Complete Randomization|0|||
149737619|NCT00408005|540170385|FG000|Induction|Protocol Deviation|3|||
149737620|NCT00408005|540170386|FG001|Induction|Protocol Deviation|1|||
149737621|NCT00408005|540170387|FG002|Induction|Protocol Deviation|0|||
149737622|NCT00408005|540170388|FG003|Induction|Protocol Deviation|0|||
149737623|NCT00408005|540170389|FG004|Induction|Protocol Deviation|0|||
149737624|NCT00408005|540170390|FG005|Induction|Protocol Deviation|0|||
149737625|NCT00408005|540170391|FG006|Induction|Protocol Deviation|0|||
149737626|NCT00408005|540170392|FG007|Induction|Protocol Deviation|0|||
149737627|NCT00408005|540170385|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
149737628|NCT00408005|540170386|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737629|NCT00408005|540170387|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737630|NCT00408005|540170388|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737631|NCT00408005|540170389|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737632|NCT00408005|540170390|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737633|NCT00408005|540170391|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737634|NCT00408005|540170392|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
149737635|NCT00408005|540170385|FG000|Induction|Recurrent leukemia|1|||
149737636|NCT00408005|540170386|FG001|Induction|Recurrent leukemia|0|||
150255444|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
150255445|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
150255446|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
150255447|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
150255448|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
149737637|NCT00408005|540170387|FG002|Induction|Recurrent leukemia|0|||
149737638|NCT00408005|540170388|FG003|Induction|Recurrent leukemia|0|||
149737639|NCT00408005|540170389|FG004|Induction|Recurrent leukemia|0|||
149737640|NCT00408005|540170390|FG005|Induction|Recurrent leukemia|0|||
149737641|NCT00408005|540170391|FG006|Induction|Recurrent leukemia|0|||
149737642|NCT00408005|540170392|FG007|Induction|Recurrent leukemia|0|||
149737643|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149737644|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149737645|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
149737646|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
149737647|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
149737648|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
149737649|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
149737650|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149737651|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
149737652|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
149737653|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
149737654|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
149737655|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
149737656|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
149737657|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
149737658|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
149737659|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737660|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737661|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
149737662|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737663|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
149737664|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737665|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737666|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149737667|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
149737668|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
149737669|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
149737670|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
149737671|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
149737672|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
149737673|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
149737674|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
149737675|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149737676|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149737677|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
149737678|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
149737679|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149737680|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
149737681|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149737682|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149737683|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
149737684|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
149737685|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
149737686|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
149737687|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
149737688|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
149737689|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
149737690|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
149737691|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737692|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
150255449|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
150255450|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
150255451|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
149737693|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737694|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737695|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
149737696|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737697|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737698|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149737699|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149737700|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149737701|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
149737702|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149737703|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149737704|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149737705|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149737706|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149737707|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149737708|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149737709|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149737710|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149737711|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
149737712|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149737713|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
149737714|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
149737715|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737716|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737717|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737718|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737719|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737720|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
149737721|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737722|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149737723|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149737724|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149737725|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
149737726|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
149737727|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
149737728|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
149737729|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149737730|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149737731|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737732|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737733|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737734|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737735|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
149737736|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
149737737|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737738|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149737739|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149737740|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149737741|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
149737742|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
149737743|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
149737744|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
149737745|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
149737746|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149737747|NCT00408005|540170385|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149737748|NCT00408005|540170386|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149737749|NCT00408005|540170387|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
149801747|NCT01049360|540402425|FG011|Period 4|Withdrawal by Subject|0|||
149737750|NCT00408005|540170388|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149737751|NCT00408005|540170389|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149737752|NCT00408005|540170390|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149737753|NCT00408005|540170391|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149737754|NCT00408005|540170392|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149737755|NCT05113940|540170393|FG000|Part A (18 Days)|Adverse Event|0|||
149737756|NCT05113940|540170394|FG001|Part A (18 Days)|Adverse Event|0|||
149737757|NCT05113940|540170395|FG002|Part A (18 Days)|Adverse Event|1|||
149737758|NCT05113940|540170396|FG003|Part A (18 Days)|Adverse Event|1|||
149737759|NCT05113940|540170397|FG004|Part A (18 Days)|Adverse Event|1|||
149737760|NCT05113940|540170398|FG005|Part A (18 Days)|Adverse Event|0|||
149737761|NCT05113940|540170399|FG006|Part A (18 Days)|Adverse Event|0|||
149737762|NCT05113940|540170400|FG007|Part A (18 Days)|Adverse Event|0|||
149737763|NCT05113940|540170401|FG008|Part A (18 Days)|Adverse Event|0|||
149737764|NCT05113940|540170402|FG009|Part A (18 Days)|Adverse Event|0|||
149737765|NCT05113940|540170403|FG010|Part A (18 Days)|Adverse Event|0|||
149737766|NCT05113940|540170404|FG011|Part A (18 Days)|Adverse Event|2|||
149737767|NCT05113940|540170405|FG012|Part A (18 Days)|Adverse Event|0|||
149737768|NCT05113940|540170406|FG013|Part A (18 Days)|Adverse Event|0|||
150255452|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
150255453|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
150255454|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
150255455|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
150255456|NCT03412747|542070635|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
150255457|NCT03412747|542070636|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
150255458|NCT03412747|542070637|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
150255459|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
150255460|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
150255461|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
150255462|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
150255463|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
150255464|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
150255465|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
150255466|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
150255467|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
150255468|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
150255469|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
150255470|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
150255471|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
150255472|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
150255473|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
150255474|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
150255475|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
150255476|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
150255477|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
150255478|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
150255479|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
150255480|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
150255481|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
150255482|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
150255483|NCT03412747|542070635|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
150255484|NCT03412747|542070636|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
150255485|NCT03412747|542070637|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
150255486|NCT03484273|542070638|FG000|Overall Study|Equipment Malfunction|1|||
150255487|NCT03484273|542070638|FG000|Overall Study|Data excluded from analysis|1|||
150255488|NCT00468104|542070642|FG000|First Intervention|Protocol Violation|2|||
150255489|NCT00468104|542070643|FG001|First Intervention|Protocol Violation|1|||
150255490|NCT00468104|542070642|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
150255491|NCT00468104|542070643|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
150255492|NCT00468104|542070642|FG000|First Intervention|died within 3 weeks|1|||
150255493|NCT00468104|542070643|FG001|First Intervention|died within 3 weeks|0|||
150255494|NCT00468104|542070642|FG000|First Intervention|malposition/blocked chest tube tube|2|||
150255495|NCT00468104|542070643|FG001|First Intervention|malposition/blocked chest tube tube|0|||
150255496|NCT00468104|542070642|FG000|First Intervention|large lung mass with minimal effusion|1|||
149737769|NCT05113940|540170407|FG014|Part A (18 Days)|Adverse Event|0|||
149737770|NCT05113940|540170393|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737771|NCT05113940|540170394|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737772|NCT05113940|540170395|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
150255497|NCT00468104|542070643|FG001|First Intervention|large lung mass with minimal effusion|0|||
150255498|NCT00468104|542070642|FG000|First Intervention|associated prolonged pneumothorax|1|||
150255499|NCT00468104|542070643|FG001|First Intervention|associated prolonged pneumothorax|0|||
150255500|NCT00468104|542070642|FG000|First Intervention|trapped lung|1|||
150255501|NCT00468104|542070643|FG001|First Intervention|trapped lung|0|||
150255502|NCT00468104|542070642|FG000|Second Intervention|Withdrawal by Subject|5|||
150255503|NCT00468104|542070643|FG001|Second Intervention|Withdrawal by Subject|2|||
150255504|NCT00468104|542070642|FG000|Second Intervention|discarded for malposition of chest tube|0|||
150255505|NCT00468104|542070643|FG001|Second Intervention|discarded for malposition of chest tube|2|||
150255506|NCT01263665|542070644|FG000|Overall Study|Withdrew Consent|1|||
150255507|NCT01263665|542070644|FG000|Overall Study|Lost to Follow-up|3|||
150255508|NCT01263665|542070644|FG000|Overall Study|Death|2|||
150255509|NCT01263665|542070644|FG000|Overall Study|Amputation above the ankle|1|||
150255510|NCT01263665|542070644|FG000|Overall Study|Surgical Bypass|2|||
150255511|NCT02706899|542070647|FG000|Overall Study|Withdrawal by Subject|1|||
150255512|NCT02706899|542070648|FG001|Overall Study|Withdrawal by Subject|0|||
150255513|NCT02706899|542070647|FG000|Overall Study|Death|8|||
150255514|NCT02706899|542070648|FG001|Overall Study|Death|0|||
150255515|NCT02706899|542070647|FG000|Overall Study|Study Termination by Sponsor|4|||
150255516|NCT02706899|542070648|FG001|Overall Study|Study Termination by Sponsor|6|||
150255517|NCT00324675|542070649|FG000|Overall Study|Adverse Event|1|||
150255518|NCT00324675|542070650|FG001|Overall Study|Adverse Event|0|||
150255519|NCT00381615|542070651|FG000|Overall Study|Withdrawal by Subject|1|||
150255520|NCT00381615|542070652|FG001|Overall Study|Withdrawal by Subject|3|||
150255521|NCT00381615|542070653|FG002|Overall Study|Withdrawal by Subject|0|||
150255522|NCT00381615|542070654|FG003|Overall Study|Withdrawal by Subject|1|||
150255523|NCT00381615|542070651|FG000|Overall Study|Lost to Follow-up|3|||
150255524|NCT00381615|542070652|FG001|Overall Study|Lost to Follow-up|2|||
150255525|NCT00381615|542070653|FG002|Overall Study|Lost to Follow-up|0|||
150255526|NCT00381615|542070654|FG003|Overall Study|Lost to Follow-up|1|||
150255527|NCT00381615|542070651|FG000|Overall Study|Protocol Violation|0|||
150255528|NCT00381615|542070652|FG001|Overall Study|Protocol Violation|0|||
150255529|NCT00381615|542070653|FG002|Overall Study|Protocol Violation|1|||
150255530|NCT00381615|542070654|FG003|Overall Study|Protocol Violation|0|||
150255531|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|Death|1|||
150255532|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|Death|1|||
150255533|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
150255534|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
150255535|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
150255536|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
150255537|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
150255538|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
150255539|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
150255540|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
150255541|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
150255542|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
150255543|NCT00371683|542070655|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
150255544|NCT00371683|542070656|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
150255545|NCT00371683|542070655|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
150255546|NCT00371683|542070656|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
150255547|NCT00371683|542070655|FG000|Follow-Up Period - Randomized Patients|Death|0|||
150255548|NCT00371683|542070656|FG001|Follow-Up Period - Randomized Patients|Death|2|||
150255549|NCT00371683|542070655|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
150255550|NCT00371683|542070656|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
150255551|NCT00371683|542070655|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
150255552|NCT00371683|542070656|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
150255553|NCT03181789|542070658|FG000|Overall Study|Withdrawal by Subject|0|||
150255554|NCT03181789|542070659|FG001|Overall Study|Withdrawal by Subject|1|||
150255555|NCT03181789|542070660|FG002|Overall Study|Withdrawal by Subject|1|||
150255556|NCT03181789|542070661|FG003|Overall Study|Withdrawal by Subject|0|||
150255557|NCT03181789|542070658|FG000|Overall Study|Lost to Follow-up|7|||
150255558|NCT03181789|542070659|FG001|Overall Study|Lost to Follow-up|1|||
150255559|NCT03181789|542070660|FG002|Overall Study|Lost to Follow-up|0|||
150255560|NCT03181789|542070661|FG003|Overall Study|Lost to Follow-up|0|||
150255561|NCT03181789|542070658|FG000|Overall Study|Participant unable to adhere to visit|0|||
150255562|NCT03181789|542070659|FG001|Overall Study|Participant unable to adhere to visit|1|||
150255563|NCT03181789|542070660|FG002|Overall Study|Participant unable to adhere to visit|0|||
150255564|NCT03181789|542070661|FG003|Overall Study|Participant unable to adhere to visit|0|||
149737773|NCT05113940|540170396|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737774|NCT05113940|540170397|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
150255565|NCT01131182|542070662|FG000|Overall Study|Withdrawal by Subject|1|||
150255566|NCT01131182|542070663|FG001|Overall Study|Withdrawal by Subject|1|||
149737775|NCT05113940|540170398|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737776|NCT05113940|540170399|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737777|NCT05113940|540170400|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737778|NCT05113940|540170401|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737779|NCT05113940|540170402|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737780|NCT05113940|540170403|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737781|NCT05113940|540170404|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737782|NCT05113940|540170405|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737783|NCT05113940|540170406|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
149737784|NCT05113940|540170407|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
149737785|NCT01701258|540170408|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
149737786|NCT01701258|540170409|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
149737787|NCT01701258|540170410|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
149737788|NCT01701258|540170411|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
149737789|NCT01701258|540170412|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
149737790|NCT01701258|540170413|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
149737791|NCT01701258|540170414|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
149737792|NCT01701258|540170415|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
149737793|NCT01701258|540170416|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
149737794|NCT01701258|540170417|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
149737795|NCT01701258|540170418|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
149737796|NCT01701258|540170419|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
149737797|NCT01701258|540170420|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
149737798|NCT01701258|540170408|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
149737799|NCT01701258|540170409|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
149737800|NCT01701258|540170410|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
149737801|NCT01701258|540170411|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
149737802|NCT01701258|540170412|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
149737803|NCT01701258|540170413|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
149737804|NCT01701258|540170414|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
149737805|NCT01701258|540170415|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
149737806|NCT01701258|540170416|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
149737807|NCT01701258|540170417|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
149737808|NCT01701258|540170418|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
149737809|NCT01701258|540170419|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
149737810|NCT01701258|540170420|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
149737811|NCT01701258|540170408|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
149737812|NCT01701258|540170409|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
149737813|NCT01701258|540170410|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
149737814|NCT01701258|540170411|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
149737815|NCT01701258|540170412|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
149737816|NCT01701258|540170413|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
149737817|NCT01701258|540170414|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
149737818|NCT01701258|540170415|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
149737819|NCT01701258|540170416|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
149737820|NCT01701258|540170417|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
149737821|NCT01701258|540170418|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
149737822|NCT01701258|540170419|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
149737823|NCT01701258|540170420|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
149737824|NCT01701258|540170408|FG000|Assessment and Scheduling|Investigator Terminated|2|||
149737825|NCT01701258|540170409|FG001|Assessment and Scheduling|Investigator Terminated|0|||
149737826|NCT01701258|540170410|FG002|Assessment and Scheduling|Investigator Terminated|0|||
149737827|NCT01701258|540170411|FG003|Assessment and Scheduling|Investigator Terminated|0|||
149737828|NCT01701258|540170412|FG004|Assessment and Scheduling|Investigator Terminated|0|||
149737829|NCT01701258|540170413|FG005|Assessment and Scheduling|Investigator Terminated|0|||
149737830|NCT01701258|540170414|FG006|Assessment and Scheduling|Investigator Terminated|0|||
149737831|NCT01701258|540170415|FG007|Assessment and Scheduling|Investigator Terminated|0|||
149737832|NCT01701258|540170416|FG008|Assessment and Scheduling|Investigator Terminated|0|||
149737833|NCT01701258|540170417|FG009|Assessment and Scheduling|Investigator Terminated|0|||
149737834|NCT01701258|540170418|FG010|Assessment and Scheduling|Investigator Terminated|0|||
149737835|NCT01701258|540170419|FG011|Assessment and Scheduling|Investigator Terminated|0|||
149737836|NCT01701258|540170420|FG012|Assessment and Scheduling|Investigator Terminated|0|||
149737837|NCT02542267|540170421|FG000|Overall Study|Withdrawal by Subject|10|||
149737838|NCT02542267|540170421|FG000|Overall Study|Physician Decision|6|||
149737839|NCT02542267|540170421|FG000|Overall Study|Lost to Follow-up|4|||
149737840|NCT02542267|540170421|FG000|Overall Study|Death|13|||
149737841|NCT02542267|540170421|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
149737842|NCT02542267|540170421|FG000|Overall Study|Other|9|||
149737843|NCT00442598|540170424|FG000|Overall Study|Adverse Event|1|||
149737844|NCT00442598|540170425|FG001|Overall Study|Adverse Event|0|||
149737845|NCT00442598|540170426|FG002|Overall Study|Adverse Event|0|||
149737846|NCT00442598|540170424|FG000|Overall Study|Tumor progression|3|||
149737847|NCT00442598|540170425|FG001|Overall Study|Tumor progression|4|||
149737848|NCT00442598|540170426|FG002|Overall Study|Tumor progression|0|||
150255567|NCT01131182|542070662|FG000|Overall Study|Lost to Follow-up|14|||
150255568|NCT01131182|542070663|FG001|Overall Study|Lost to Follow-up|15|||
150255569|NCT01131182|542070662|FG000|Overall Study|Other Reason|1|||
150255570|NCT01131182|542070663|FG001|Overall Study|Other Reason|0|||
150255571|NCT04602221|542070664|FG000|Overall Study|Discontinuation of trial treatment|0|||
150255572|NCT04602221|542070665|FG001|Overall Study|Discontinuation of trial treatment|0|||
150255573|NCT04602221|542070666|FG002|Overall Study|Discontinuation of trial treatment|1|||
150255574|NCT04602221|542070667|FG003|Overall Study|Discontinuation of trial treatment|0|||
150255575|NCT04602221|542070668|FG004|Overall Study|Discontinuation of trial treatment|0|||
150255576|NCT04602221|542070669|FG005|Overall Study|Discontinuation of trial treatment|0|||
150255577|NCT04602221|542070670|FG006|Overall Study|Discontinuation of trial treatment|0|||
150255578|NCT04602221|542070671|FG007|Overall Study|Discontinuation of trial treatment|0|||
150255579|NCT04602221|542070672|FG008|Overall Study|Discontinuation of trial treatment|0|||
150255580|NCT04602221|542070673|FG009|Overall Study|Discontinuation of trial treatment|0|||
150255581|NCT04602221|542070674|FG010|Overall Study|Discontinuation of trial treatment|0|||
150255582|NCT04602221|542070675|FG011|Overall Study|Discontinuation of trial treatment|0|||
149737849|NCT00442598|540170424|FG000|Overall Study|Clinical deterioration|1|||
149737850|NCT00442598|540170425|FG001|Overall Study|Clinical deterioration|2|||
149737851|NCT00442598|540170426|FG002|Overall Study|Clinical deterioration|0|||
149737852|NCT00442598|540170424|FG000|Overall Study|CA125 progression|0|||
149737853|NCT00442598|540170425|FG001|Overall Study|CA125 progression|1|||
149737854|NCT00442598|540170426|FG002|Overall Study|CA125 progression|0|||
149737855|NCT00442598|540170424|FG000|Overall Study|Reduced creatinine clearance|1|||
149737856|NCT00442598|540170425|FG001|Overall Study|Reduced creatinine clearance|0|||
149737857|NCT00442598|540170426|FG002|Overall Study|Reduced creatinine clearance|0|||
149737858|NCT00442598|540170424|FG000|Overall Study|Death|0|||
149737859|NCT00442598|540170425|FG001|Overall Study|Death|1|||
149737860|NCT00442598|540170426|FG002|Overall Study|Death|0|||
149737861|NCT00501228|540170429|FG000|Overall Study|Withdrawal by Subject|1|||
149737862|NCT01756274|540170432|FG000|Overall Study|Protocol Violation|2|||
149737863|NCT01756274|540170432|FG000|Overall Study|Laboratory error|1|||
149737864|NCT01147926|540170433|FG000|Overall Study|Subject Withdrew Consent|9|||
149737865|NCT01147926|540170434|FG001|Overall Study|Subject Withdrew Consent|10|||
149737866|NCT01147926|540170433|FG000|Overall Study|Adverse Event|7|||
149737867|NCT01147926|540170434|FG001|Overall Study|Adverse Event|6|||
149737868|NCT01147926|540170433|FG000|Overall Study|Subject Non-Compliant|5|||
149737869|NCT01147926|540170434|FG001|Overall Study|Subject Non-Compliant|4|||
149737870|NCT01147926|540170433|FG000|Overall Study|Principal investigator left hospital|1|||
149737871|NCT01147926|540170434|FG001|Overall Study|Principal investigator left hospital|3|||
149737872|NCT01147926|540170433|FG000|Overall Study|Selection criteria not met|3|||
149737873|NCT01147926|540170434|FG001|Overall Study|Selection criteria not met|1|||
149737874|NCT01147926|540170433|FG000|Overall Study|Lost to Follow-up|0|||
149737875|NCT01147926|540170434|FG001|Overall Study|Lost to Follow-up|2|||
149737876|NCT01147926|540170433|FG000|Overall Study|Sponsor's Decision|0|||
149737877|NCT01147926|540170434|FG001|Overall Study|Sponsor's Decision|1|||
149737878|NCT01147926|540170433|FG000|Overall Study|Lack of Efficacy|1|||
149737879|NCT01147926|540170434|FG001|Overall Study|Lack of Efficacy|0|||
149737880|NCT01147926|540170433|FG000|Overall Study|Too busy, no time for study|1|||
149737881|NCT01147926|540170434|FG001|Overall Study|Too busy, no time for study|0|||
149737882|NCT01147926|540170433|FG000|Overall Study|Went on holiday|0|||
149737883|NCT01147926|540170434|FG001|Overall Study|Went on holiday|1|||
149737884|NCT01147926|540170433|FG000|Overall Study|Colonoscopy result|0|||
149737885|NCT01147926|540170434|FG001|Overall Study|Colonoscopy result|1|||
149737886|NCT01670994|540170437|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
149737887|NCT01670994|540170438|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
149737888|NCT01670994|540170437|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
149737889|NCT01670994|540170438|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
150255583|NCT04602221|542070676|FG012|Overall Study|Discontinuation of trial treatment|0|||
149737890|NCT01670994|540170437|FG000|Overall Study|Patient experienced DLT|0|||
149737891|NCT01670994|540170438|FG001|Overall Study|Patient experienced DLT|1|||
149737892|NCT00891735|540170440|FG000|Overall Study|Adverse Event|2|||
149737893|NCT00891735|540170441|FG001|Overall Study|Adverse Event|0|||
149737894|NCT00891735|540170442|FG002|Overall Study|Adverse Event|2|||
149737895|NCT00891735|540170443|FG003|Overall Study|Adverse Event|0|||
149737896|NCT00891735|540170440|FG000|Overall Study|Death|8|||
150255584|NCT04602221|542070677|FG013|Overall Study|Discontinuation of trial treatment|0|||
150255585|NCT04602221|542070678|FG014|Overall Study|Discontinuation of trial treatment|0|||
150255586|NCT04602221|542070679|FG015|Overall Study|Discontinuation of trial treatment|0|||
150255587|NCT04602221|542070680|FG016|Overall Study|Discontinuation of trial treatment|0|||
149737897|NCT00891735|540170441|FG001|Overall Study|Death|5|||
150255588|NCT04602221|542070681|FG017|Overall Study|Discontinuation of trial treatment|0|||
149737898|NCT00891735|540170442|FG002|Overall Study|Death|4|||
149737899|NCT00891735|540170443|FG003|Overall Study|Death|5|||
150255589|NCT04602221|542070664|FG000|Overall Study|Other than listed|0|||
150255590|NCT04602221|542070665|FG001|Overall Study|Other than listed|0|||
150255591|NCT04602221|542070666|FG002|Overall Study|Other than listed|0|||
150255592|NCT04602221|542070667|FG003|Overall Study|Other than listed|0|||
150255593|NCT04602221|542070668|FG004|Overall Study|Other than listed|0|||
150255594|NCT04602221|542070669|FG005|Overall Study|Other than listed|0|||
150255595|NCT04602221|542070670|FG006|Overall Study|Other than listed|0|||
150255596|NCT04602221|542070671|FG007|Overall Study|Other than listed|0|||
150255597|NCT04602221|542070672|FG008|Overall Study|Other than listed|0|||
150255598|NCT04602221|542070673|FG009|Overall Study|Other than listed|0|||
150255599|NCT04602221|542070674|FG010|Overall Study|Other than listed|0|||
150255600|NCT04602221|542070675|FG011|Overall Study|Other than listed|0|||
150255601|NCT04602221|542070676|FG012|Overall Study|Other than listed|0|||
150255602|NCT04602221|542070677|FG013|Overall Study|Other than listed|0|||
150255603|NCT04602221|542070678|FG014|Overall Study|Other than listed|0|||
150255604|NCT04602221|542070679|FG015|Overall Study|Other than listed|1|||
150255605|NCT04602221|542070680|FG016|Overall Study|Other than listed|0|||
150255606|NCT04602221|542070681|FG017|Overall Study|Other than listed|1|||
150255607|NCT04602221|542070664|FG000|Overall Study|Withdrawal by Subject|0|||
150255608|NCT04602221|542070665|FG001|Overall Study|Withdrawal by Subject|0|||
150255609|NCT04602221|542070666|FG002|Overall Study|Withdrawal by Subject|0|||
150255610|NCT04602221|542070667|FG003|Overall Study|Withdrawal by Subject|0|||
150255611|NCT04602221|542070668|FG004|Overall Study|Withdrawal by Subject|0|||
150255612|NCT04602221|542070669|FG005|Overall Study|Withdrawal by Subject|0|||
150255613|NCT04602221|542070670|FG006|Overall Study|Withdrawal by Subject|0|||
150255614|NCT04602221|542070671|FG007|Overall Study|Withdrawal by Subject|0|||
150255615|NCT04602221|542070672|FG008|Overall Study|Withdrawal by Subject|0|||
150255616|NCT04602221|542070673|FG009|Overall Study|Withdrawal by Subject|0|||
150255617|NCT04602221|542070674|FG010|Overall Study|Withdrawal by Subject|0|||
150255618|NCT04602221|542070675|FG011|Overall Study|Withdrawal by Subject|0|||
150255619|NCT04602221|542070676|FG012|Overall Study|Withdrawal by Subject|1|||
150255620|NCT04602221|542070677|FG013|Overall Study|Withdrawal by Subject|0|||
150255621|NCT04602221|542070678|FG014|Overall Study|Withdrawal by Subject|0|||
150255622|NCT04602221|542070679|FG015|Overall Study|Withdrawal by Subject|0|||
150255623|NCT04602221|542070680|FG016|Overall Study|Withdrawal by Subject|0|||
150255624|NCT04602221|542070681|FG017|Overall Study|Withdrawal by Subject|0|||
150255625|NCT04602221|542070664|FG000|Overall Study|Lost to Follow-up|0|||
150255626|NCT04602221|542070665|FG001|Overall Study|Lost to Follow-up|0|||
150255627|NCT04602221|542070666|FG002|Overall Study|Lost to Follow-up|0|||
150255628|NCT04602221|542070667|FG003|Overall Study|Lost to Follow-up|0|||
150255629|NCT04602221|542070668|FG004|Overall Study|Lost to Follow-up|0|||
150255630|NCT04602221|542070669|FG005|Overall Study|Lost to Follow-up|1|||
150255631|NCT04602221|542070670|FG006|Overall Study|Lost to Follow-up|0|||
150255632|NCT04602221|542070671|FG007|Overall Study|Lost to Follow-up|0|||
150255633|NCT04602221|542070672|FG008|Overall Study|Lost to Follow-up|0|||
150255634|NCT04602221|542070673|FG009|Overall Study|Lost to Follow-up|0|||
150255635|NCT04602221|542070674|FG010|Overall Study|Lost to Follow-up|0|||
150255636|NCT04602221|542070675|FG011|Overall Study|Lost to Follow-up|0|||
150255637|NCT04602221|542070676|FG012|Overall Study|Lost to Follow-up|0|||
150255638|NCT04602221|542070677|FG013|Overall Study|Lost to Follow-up|0|||
150255639|NCT04602221|542070678|FG014|Overall Study|Lost to Follow-up|0|||
150255640|NCT04602221|542070679|FG015|Overall Study|Lost to Follow-up|0|||
150255641|NCT04602221|542070680|FG016|Overall Study|Lost to Follow-up|0|||
150255642|NCT04602221|542070681|FG017|Overall Study|Lost to Follow-up|0|||
150255643|NCT03001076|542070682|FG000|Overall Study|Withdrawal by patient|2|||
150255644|NCT03001076|542070683|FG001|Overall Study|Withdrawal by patient|0|||
149737900|NCT00891735|540170440|FG000|Overall Study|Lost to Follow-up|2|||
149737901|NCT00891735|540170441|FG001|Overall Study|Lost to Follow-up|2|||
149737902|NCT00891735|540170442|FG002|Overall Study|Lost to Follow-up|2|||
149737903|NCT00891735|540170443|FG003|Overall Study|Lost to Follow-up|2|||
149737904|NCT00891735|540170440|FG000|Overall Study|Physician's decision to withdraw patient|1|||
150255645|NCT03001076|542070682|FG000|Overall Study|Other|1|||
149737905|NCT00891735|540170441|FG001|Overall Study|Physician's decision to withdraw patient|0|||
150255646|NCT03001076|542070683|FG001|Overall Study|Other|0|||
150255647|NCT03001076|542070682|FG000|Overall Study|Adverse Event|3|||
150255648|NCT03001076|542070683|FG001|Overall Study|Adverse Event|3|||
150255649|NCT03001076|542070682|FG000|Overall Study|Sponsor decision|1|||
150255650|NCT03001076|542070683|FG001|Overall Study|Sponsor decision|0|||
150255651|NCT03001076|542070682|FG000|Overall Study|Lost to Follow-up|0|||
150255652|NCT03001076|542070683|FG001|Overall Study|Lost to Follow-up|2|||
149737906|NCT00891735|540170442|FG002|Overall Study|Physician's decision to withdraw patient|0|||
150255653|NCT02576587|542070684|FG000|Baseline|Equipment failure|0|||
150255654|NCT02576587|542070685|FG001|Baseline|Equipment failure|1|||
149737907|NCT00891735|540170443|FG003|Overall Study|Physician's decision to withdraw patient|0|||
150255655|NCT02576587|542070684|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
150255656|NCT02576587|542070685|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
150255657|NCT02576587|542070684|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
150255658|NCT02576587|542070685|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
150255659|NCT02576587|542070684|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
150255660|NCT02576587|542070685|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
150255661|NCT01080716|542070686|FG000|Part 1|Physician Decision|1|||
150255662|NCT01080716|542070687|FG001|Part 1|Physician Decision|0|||
150255663|NCT01080716|542070688|FG002|Part 1|Physician Decision|0|||
150255664|NCT01080716|542070689|FG003|Part 1|Physician Decision|0|||
150255665|NCT01056718|542070690|FG000|Overall Study|Withdrawal by Subject|2|||
150255666|NCT01056718|542070690|FG000|Overall Study|Ischemia on baseline stress test|1|||
150255667|NCT01139580|542070691|FG000|Overall Study|Adverse Event|5|||
150255668|NCT01139580|542070692|FG001|Overall Study|Adverse Event|4|||
150255669|NCT01139580|542070691|FG000|Overall Study|Lost to Follow-up|9|||
150255670|NCT01139580|542070692|FG001|Overall Study|Lost to Follow-up|1|||
150255671|NCT01139580|542070691|FG000|Overall Study|Lack of Efficacy|0|||
150255672|NCT01139580|542070692|FG001|Overall Study|Lack of Efficacy|2|||
150255673|NCT01139580|542070691|FG000|Overall Study|Withdrawal by Subject|6|||
150255674|NCT01139580|542070692|FG001|Overall Study|Withdrawal by Subject|9|||
150255675|NCT01139580|542070691|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
150255676|NCT01139580|542070692|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
150255677|NCT01139580|542070691|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
150255678|NCT01139580|542070692|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
150255679|NCT01139580|542070691|FG000|Overall Study|Misrandomized|1|||
150255680|NCT01139580|542070692|FG001|Overall Study|Misrandomized|0|||
150255681|NCT01139580|542070691|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
150255682|NCT01139580|542070692|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
150255683|NCT01139580|542070691|FG000|Overall Study|Participant Randomization in Error|0|||
150255684|NCT01139580|542070692|FG001|Overall Study|Participant Randomization in Error|1|||
150255685|NCT00633880|542070693|FG000|Open Label Titration|Lack of Efficacy|1|||
150255686|NCT00633880|542070694|FG001|Open Label Titration|Lack of Efficacy|0|||
150255687|NCT00633880|542070695|FG002|Open Label Titration|Lack of Efficacy|0|||
150255688|NCT00633880|542070693|FG000|Open Label Titration|Adverse Event|13|||
150255689|NCT00633880|542070694|FG001|Open Label Titration|Adverse Event|0|||
150255690|NCT00633880|542070695|FG002|Open Label Titration|Adverse Event|0|||
150255691|NCT00633880|542070693|FG000|Open Label Titration|Treatment Failure|55|||
150255692|NCT00633880|542070694|FG001|Open Label Titration|Treatment Failure|0|||
150255693|NCT00633880|542070695|FG002|Open Label Titration|Treatment Failure|0|||
150255694|NCT00633880|542070693|FG000|Open Label Titration|Protocol Violation|6|||
150255695|NCT00633880|542070694|FG001|Open Label Titration|Protocol Violation|0|||
150255696|NCT00633880|542070695|FG002|Open Label Titration|Protocol Violation|0|||
150255697|NCT00633880|542070693|FG000|Open Label Titration|Physician Decision|1|||
150255698|NCT00633880|542070694|FG001|Open Label Titration|Physician Decision|0|||
150255699|NCT00633880|542070695|FG002|Open Label Titration|Physician Decision|0|||
150255700|NCT00633880|542070693|FG000|Open Label Titration|Withdrawal by Subject|4|||
150255701|NCT00633880|542070694|FG001|Open Label Titration|Withdrawal by Subject|0|||
150255702|NCT00633880|542070695|FG002|Open Label Titration|Withdrawal by Subject|0|||
150255703|NCT00700778|542070696|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
150255704|NCT00350103|542070697|FG000|Overall Study|Adverse Event|12|||
150255705|NCT00350103|542070698|FG001|Overall Study|Adverse Event|29|||
150255706|NCT00350103|542070699|FG002|Overall Study|Adverse Event|17|||
150255707|NCT00350103|542070697|FG000|Overall Study|Lack of Efficacy|5|||
150255708|NCT00350103|542070698|FG001|Overall Study|Lack of Efficacy|1|||
150255709|NCT00350103|542070699|FG002|Overall Study|Lack of Efficacy|3|||
150255710|NCT00350103|542070697|FG000|Overall Study|Withdrawal by Subject|6|||
150255711|NCT00350103|542070698|FG001|Overall Study|Withdrawal by Subject|6|||
150255712|NCT00350103|542070699|FG002|Overall Study|Withdrawal by Subject|8|||
150255713|NCT00350103|542070697|FG000|Overall Study|Protocol Violation|0|||
150255714|NCT00350103|542070698|FG001|Overall Study|Protocol Violation|0|||
150255715|NCT00350103|542070699|FG002|Overall Study|Protocol Violation|1|||
150255716|NCT00350103|542070697|FG000|Overall Study|Unsatisfactory Compliance|2|||
150255717|NCT00350103|542070698|FG001|Overall Study|Unsatisfactory Compliance|2|||
150255718|NCT00350103|542070699|FG002|Overall Study|Unsatisfactory Compliance|1|||
150255719|NCT00350103|542070697|FG000|Overall Study|Investigator´s decision|1|||
150255720|NCT00350103|542070698|FG001|Overall Study|Investigator´s decision|1|||
149801748|NCT01049360|540402426|FG012|Period 4|Withdrawal by Subject|0|||
150255721|NCT00350103|542070699|FG002|Overall Study|Investigator´s decision|0|||
150255722|NCT00350103|542070697|FG000|Overall Study|Exclusion criteria met|0|||
150255723|NCT00350103|542070698|FG001|Overall Study|Exclusion criteria met|0|||
150255724|NCT00350103|542070699|FG002|Overall Study|Exclusion criteria met|1|||
150255725|NCT00350103|542070697|FG000|Overall Study|Patient relocated|0|||
150255726|NCT00350103|542070698|FG001|Overall Study|Patient relocated|0|||
150255727|NCT00350103|542070699|FG002|Overall Study|Patient relocated|1|||
150255728|NCT00350103|542070697|FG000|Overall Study|Need for prohibited medication|1|||
150255729|NCT00350103|542070698|FG001|Overall Study|Need for prohibited medication|0|||
150255730|NCT00350103|542070699|FG002|Overall Study|Need for prohibited medication|0|||
150255731|NCT00350103|542070697|FG000|Overall Study|Personal reasons|0|||
150255732|NCT00350103|542070698|FG001|Overall Study|Personal reasons|0|||
150255733|NCT00350103|542070699|FG002|Overall Study|Personal reasons|1|||
149737908|NCT00891735|540170440|FG000|Overall Study|Patient's decision to withdraw|4|||
149737909|NCT00891735|540170441|FG001|Overall Study|Patient's decision to withdraw|9|||
149737910|NCT00891735|540170442|FG002|Overall Study|Patient's decision to withdraw|4|||
149737911|NCT00891735|540170443|FG003|Overall Study|Patient's decision to withdraw|8|||
149737912|NCT00885365|540170446|FG000|4 Weeks ON Treatment|Adverse Event|2|||
149737913|NCT00885365|540170447|FG001|4 Weeks ON Treatment|Adverse Event|4|||
149737914|NCT00885365|540170446|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
149737915|NCT00885365|540170447|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
149737916|NCT00885365|540170446|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
149737917|NCT00885365|540170447|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
149737918|NCT01824979|540170448|FG000|Overall Study|Withdrawal by Subject|5|||
149737919|NCT01824979|540170449|FG001|Overall Study|Withdrawal by Subject|0|||
149737920|NCT01824979|540170448|FG000|Overall Study|Physician Decision|2|||
149737921|NCT01824979|540170449|FG001|Overall Study|Physician Decision|0|||
149737922|NCT01824979|540170448|FG000|Overall Study|Protocol Violation|6|||
149737923|NCT01824979|540170449|FG001|Overall Study|Protocol Violation|13|||
149737924|NCT03751111|540170456|FG000|Overall Study|Lack of Efficacy|9|||
149737925|NCT03751111|540170457|FG001|Overall Study|Lack of Efficacy|30|||
149737926|NCT03751111|540170456|FG000|Overall Study|Adverse Event|3|||
149737927|NCT03751111|540170457|FG001|Overall Study|Adverse Event|2|||
149737928|NCT03406962|540170462|FG000|Overall Study|Death|2|||
149737929|NCT03406962|540170462|FG000|Overall Study|Adverse Event|1|||
149737930|NCT03853694|540170463|FG000|Overall Study|Protocol Violation|3|||
149737931|NCT03853694|540170464|FG001|Overall Study|Protocol Violation|5|||
149737932|NCT03853694|540170465|FG002|Overall Study|Protocol Violation|3|||
149737933|NCT03853694|540170463|FG000|Overall Study|Delivered early|0|||
149737934|NCT03853694|540170464|FG001|Overall Study|Delivered early|1|||
149737935|NCT03853694|540170465|FG002|Overall Study|Delivered early|0|||
149737936|NCT03853694|540170463|FG000|Overall Study|not suitable to proceed|0|||
149737937|NCT03853694|540170464|FG001|Overall Study|not suitable to proceed|1|||
149737938|NCT03853694|540170465|FG002|Overall Study|not suitable to proceed|0|||
149737939|NCT03853694|540170463|FG000|Overall Study|difficult surgery|0|||
149737940|NCT03853694|540170464|FG001|Overall Study|difficult surgery|0|||
149737941|NCT03853694|540170465|FG002|Overall Study|difficult surgery|1|||
149737942|NCT03853694|540170463|FG000|Overall Study|Lost to Follow-up|0|||
149737943|NCT03853694|540170464|FG001|Overall Study|Lost to Follow-up|1|||
149737944|NCT03853694|540170465|FG002|Overall Study|Lost to Follow-up|0|||
149737945|NCT03853694|540170463|FG000|Overall Study|Withdrawal by Subject|0|||
149737946|NCT03853694|540170464|FG001|Overall Study|Withdrawal by Subject|1|||
149737947|NCT03853694|540170465|FG002|Overall Study|Withdrawal by Subject|0|||
149737948|NCT01791855|540170466|FG000|Overall Study|Adverse Event|0|||
149737949|NCT01791855|540170467|FG001|Overall Study|Adverse Event|0|||
149737950|NCT01791855|540170468|FG002|Overall Study|Adverse Event|0|||
149737951|NCT01791855|540170469|FG003|Overall Study|Adverse Event|1|||
149737952|NCT01791855|540170466|FG000|Overall Study|Randomized, not treated|0|||
149737953|NCT01791855|540170467|FG001|Overall Study|Randomized, not treated|1|||
149737954|NCT01791855|540170468|FG002|Overall Study|Randomized, not treated|0|||
149737955|NCT01791855|540170469|FG003|Overall Study|Randomized, not treated|0|||
149737956|NCT01672957|540170470|FG000|Overall Study|Protocol Violation|48|||
149737957|NCT01672957|540170470|FG000|Overall Study|Death|2|||
149737958|NCT01672957|540170470|FG000|Overall Study|ICF Signed After Transplantation|5|||
149737959|NCT00591734|540170471|FG000|Overall Study|Lack of Efficacy|35|||
149737960|NCT00591734|540170471|FG000|Overall Study|Adverse Event|5|||
149737961|NCT00591734|540170471|FG000|Overall Study|Physician Decision|5|||
149737962|NCT00591734|540170471|FG000|Overall Study|Intercurrent Illness|8|||
149737963|NCT04370509|540170475|FG000|Overall Study|Adverse Event|1|||
149737964|NCT04370509|540170476|FG001|Overall Study|Adverse Event|0|||
149737965|NCT04370509|540170475|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
149737966|NCT04370509|540170476|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
149737967|NCT02612909|540171806|FG000|Phase 2|Withdrawal by Subject|2|||
149737968|NCT02612909|540171807|FG001|Phase 2|Withdrawal by Subject|5|||
149737969|NCT02612909|540171808|FG002|Phase 2|Withdrawal by Subject|0|||
149737970|NCT02612909|540171809|FG003|Phase 2|Withdrawal by Subject|0|||
149737971|NCT02612909|540171810|FG004|Phase 2|Withdrawal by Subject|0|||
149737972|NCT02612909|540171806|FG000|Phase 2|Pregnancy|0|||
149737973|NCT02612909|540171807|FG001|Phase 2|Pregnancy|0|||
149737974|NCT02612909|540171808|FG002|Phase 2|Pregnancy|1|||
149737975|NCT02612909|540171809|FG003|Phase 2|Pregnancy|0|||
149737976|NCT02612909|540171810|FG004|Phase 2|Pregnancy|0|||
149737977|NCT02612909|540171806|FG000|Phase 3|Withdrawal by Subject|0|||
149737978|NCT02612909|540171807|FG001|Phase 3|Withdrawal by Subject|0|||
149737979|NCT02612909|540171808|FG002|Phase 3|Withdrawal by Subject|0|||
149737980|NCT02612909|540171809|FG003|Phase 3|Withdrawal by Subject|1|||
149737981|NCT02612909|540171810|FG004|Phase 3|Withdrawal by Subject|0|||
149737982|NCT00826748|540171813|FG000|Overall Study|Withdrawal by Subject|0|||
149737983|NCT00826748|540171814|FG001|Overall Study|Withdrawal by Subject|0|||
149737984|NCT00826748|540171815|FG002|Overall Study|Withdrawal by Subject|2|||
149737985|NCT00826748|540171813|FG000|Overall Study|Physician Decision|0|||
149737986|NCT00826748|540171814|FG001|Overall Study|Physician Decision|0|||
149737987|NCT00826748|540171815|FG002|Overall Study|Physician Decision|1|||
149737988|NCT00826748|540171813|FG000|Overall Study|Samples Did Not pass QC|0|||
149737989|NCT00826748|540171814|FG001|Overall Study|Samples Did Not pass QC|0|||
149737990|NCT00826748|540171815|FG002|Overall Study|Samples Did Not pass QC|1|||
149737991|NCT05224258|540171816|FG000|Overall Study|Withdrawal by Subject|1|||
149737992|NCT05224258|540171817|FG001|Overall Study|Withdrawal by Subject|1|||
149737993|NCT05224258|540171816|FG000|Overall Study|Physician Decision|1|||
149737994|NCT05224258|540171817|FG001|Overall Study|Physician Decision|1|||
149737995|NCT05224258|540171816|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149737996|NCT05224258|540171817|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149737997|NCT05224258|540171816|FG000|Overall Study|Study Product No Longer in Use|1|||
149737998|NCT05224258|540171817|FG001|Overall Study|Study Product No Longer in Use|0|||
149737999|NCT05224258|540171816|FG000|Overall Study|Adverse Event|0|||
149738000|NCT05224258|540171817|FG001|Overall Study|Adverse Event|1|||
149738001|NCT05224258|540171816|FG000|Overall Study|Protocol Deviation|0|||
149738002|NCT05224258|540171817|FG001|Overall Study|Protocol Deviation|1|||
149738003|NCT05067127|540171818|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149738004|NCT05067127|540171819|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
149738005|NCT05067127|540171820|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149738006|NCT05067127|540171821|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149738007|NCT05067127|540171818|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149738008|NCT05067127|540171819|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
149738009|NCT05067127|540171820|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149738010|NCT05067127|540171821|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149738011|NCT05067127|540171818|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
149738012|NCT05067127|540171819|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149738013|NCT05067127|540171820|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149738014|NCT05067127|540171821|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149738015|NCT05067127|540171818|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149738016|NCT05067127|540171819|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
149738017|NCT05067127|540171820|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149738018|NCT05067127|540171821|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149738019|NCT05067127|540171818|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
149738020|NCT05067127|540171819|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
149738021|NCT05067127|540171820|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
149738022|NCT05067127|540171821|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
149738023|NCT05067127|540171818|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149738024|NCT05067127|540171819|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149738025|NCT05067127|540171820|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149738026|NCT05067127|540171821|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
149738027|NCT05067127|540171818|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149738028|NCT05067127|540171819|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149738029|NCT05067127|540171820|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
149738030|NCT05067127|540171821|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
149738031|NCT05540652|540171822|FG000|Overall Study|Withdrawal by Subject|1|||
149738032|NCT03367871|540171823|FG000|Overall Study|Lost to Follow-up|1|||
149738033|NCT02013544|540171825|FG000|Overall Study|Adverse Event|5|||
149738034|NCT02013544|540171826|FG001|Overall Study|Adverse Event|5|||
149738035|NCT02013544|540171825|FG000|Overall Study|Lost to Follow-up|2|||
149738036|NCT02013544|540171826|FG001|Overall Study|Lost to Follow-up|3|||
149738037|NCT02013544|540171825|FG000|Overall Study|Withdrawal by Subject|2|||
149738038|NCT02013544|540171826|FG001|Overall Study|Withdrawal by Subject|8|||
149738039|NCT02013544|540171825|FG000|Overall Study|Physician Decision|0|||
149738040|NCT02013544|540171826|FG001|Overall Study|Physician Decision|1|||
149738041|NCT02013544|540171825|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
149738042|NCT02013544|540171826|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
149738043|NCT03514914|540171827|FG000|Overall Study|Death|3|||
149738044|NCT03514914|540171828|FG001|Overall Study|Death|3|||
149738045|NCT03514914|540171827|FG000|Overall Study|Lost to Follow-up|117|||
149738046|NCT03514914|540171828|FG001|Overall Study|Lost to Follow-up|89|||
149738047|NCT00473876|540171829|FG000|Overall Study|Lost to Follow-up|3|||
149738048|NCT00473876|540171830|FG001|Overall Study|Lost to Follow-up|1|||
149738049|NCT00755079|540171834|FG000|Overall Study|Lost to Follow-up|1|||
149738050|NCT00755079|540171835|FG001|Overall Study|Lost to Follow-up|3|||
149738051|NCT00755079|540171834|FG000|Overall Study|Adverse Event|0|||
149738052|NCT00755079|540171835|FG001|Overall Study|Adverse Event|1|||
149738053|NCT00755079|540171834|FG000|Overall Study|Withdrawal by Subject|0|||
149738054|NCT00755079|540171835|FG001|Overall Study|Withdrawal by Subject|2|||
149738055|NCT01276288|540171836|FG000|Overall Study|Adverse Event|1|||
149738056|NCT01276288|540171837|FG001|Overall Study|Adverse Event|1|||
149738057|NCT01276288|540171838|FG002|Overall Study|Adverse Event|0|||
149738058|NCT01276288|540171839|FG003|Overall Study|Adverse Event|0|||
149738059|NCT01276288|540171836|FG000|Overall Study|not treated|1|||
149738060|NCT01276288|540171837|FG001|Overall Study|not treated|0|||
149738061|NCT01276288|540171838|FG002|Overall Study|not treated|0|||
149738062|NCT01276288|540171839|FG003|Overall Study|not treated|0|||
149738063|NCT00629083|540171846|FG000|Overall Study|Adverse Event|0|||
149738064|NCT00629083|540171847|FG001|Overall Study|Adverse Event|2|||
149738065|NCT00629083|540171846|FG000|Overall Study|Lack of Efficacy|3|||
149738066|NCT00629083|540171847|FG001|Overall Study|Lack of Efficacy|1|||
149738067|NCT00629083|540171846|FG000|Overall Study|Withdrawal by Subject|10|||
149738068|NCT00629083|540171847|FG001|Overall Study|Withdrawal by Subject|2|||
149738069|NCT00629083|540171846|FG000|Overall Study|Lost to Follow-up|12|||
149738070|NCT00629083|540171847|FG001|Overall Study|Lost to Follow-up|8|||
149738071|NCT00629083|540171846|FG000|Overall Study|Moved out of country/state|2|||
149738072|NCT00629083|540171847|FG001|Overall Study|Moved out of country/state|1|||
149738073|NCT00629083|540171846|FG000|Overall Study|Refused to return for 12 month visit|1|||
149738074|NCT00629083|540171847|FG001|Overall Study|Refused to return for 12 month visit|0|||
149738075|NCT03401749|540171848|FG000|Overall Study|Lost to Follow-up|20|||
149738076|NCT03401749|540171849|FG001|Overall Study|Lost to Follow-up|16|||
149738077|NCT03401749|540171850|FG002|Overall Study|Lost to Follow-up|26|||
149738078|NCT01193686|540171851|FG000|Overall Study|Withdrawal by Subject|4|||
149738079|NCT01193686|540171852|FG001|Overall Study|Withdrawal by Subject|1|||
149738080|NCT01193686|540171851|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
149738081|NCT01193686|540171852|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
149738082|NCT01818297|540171854|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
149738083|NCT01818297|540171855|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
149738084|NCT01818297|540171854|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
149738085|NCT01818297|540171855|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
149738086|NCT01818297|540171854|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
149738087|NCT01818297|540171855|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
149738088|NCT04439344|540171856|FG000|Overall Study|Never started threapy|3|||
149738089|NCT04439344|540171856|FG000|Overall Study|Ineligible|3|||
149738090|NCT04439344|540171856|FG000|Overall Study|Adverse Event|13|||
149738091|NCT04439344|540171856|FG000|Overall Study|Death|2|||
149738092|NCT04439344|540171856|FG000|Overall Study|Disease progression|29|||
149738093|NCT04439344|540171856|FG000|Overall Study|Withdrawal by Subject|2|||
149738094|NCT04439344|540171856|FG000|Overall Study|Alternative therapy|1|||
149738095|NCT03770403|540171857|FG000|Overall Study|Adverse Event|8|||
149738096|NCT03770403|540171857|FG000|Overall Study|Death|5|||
149738097|NCT03770403|540171857|FG000|Overall Study|Physician Decision|1|||
149738098|NCT03770403|540171857|FG000|Overall Study|Sponsor decision|1|||
149738099|NCT03770403|540171857|FG000|Overall Study|Study terminated by Sponsor|1|||
149738100|NCT03770403|540171857|FG000|Overall Study|Withdrawal by Subject|13|||
149738101|NCT03770403|540171857|FG000|Overall Study|Other|88|||
149738102|NCT03896295|540171858|FG000|Overall Study|Adverse Event|0|||
149738103|NCT03896295|540171859|FG001|Overall Study|Adverse Event|1|||
149738104|NCT03896295|540171858|FG000|Overall Study|COVID-19|7|||
149738105|NCT03896295|540171859|FG001|Overall Study|COVID-19|29|||
149738106|NCT00552110|540171860|FG000|Overall Study|Serious or Life-Threatening AE|0|||
149738107|NCT00552110|540171861|FG001|Overall Study|Serious or Life-Threatening AE|0|||
149738108|NCT00552110|540171862|FG002|Overall Study|Serious or Life-Threatening AE|1|||
150255734|NCT00350103|542070697|FG000|Overall Study|Patient stopped feeling pain|1|||
149738109|NCT00552110|540171863|FG003|Overall Study|Serious or Life-Threatening AE|0|||
149738110|NCT00552110|540171864|FG004|Overall Study|Serious or Life-Threatening AE|0|||
149738111|NCT00552110|540171860|FG000|Overall Study|Lack of Efficacy|1|||
149738112|NCT00552110|540171861|FG001|Overall Study|Lack of Efficacy|0|||
150255735|NCT00350103|542070698|FG001|Overall Study|Patient stopped feeling pain|0|||
149738113|NCT00552110|540171862|FG002|Overall Study|Lack of Efficacy|0|||
150255736|NCT00350103|542070699|FG002|Overall Study|Patient stopped feeling pain|0|||
150255737|NCT00350103|542070697|FG000|Overall Study|PR greater than 250ms|0|||
150255738|NCT00350103|542070698|FG001|Overall Study|PR greater than 250ms|0|||
150255739|NCT00350103|542070699|FG002|Overall Study|PR greater than 250ms|1|||
150255740|NCT00350103|542070697|FG000|Overall Study|Wrong calculation of QT interval|0|||
150255741|NCT00350103|542070698|FG001|Overall Study|Wrong calculation of QT interval|0|||
150255742|NCT00350103|542070699|FG002|Overall Study|Wrong calculation of QT interval|1|||
150255743|NCT00350103|542070697|FG000|Overall Study|Sponsor mistake|1|||
150255744|NCT00350103|542070698|FG001|Overall Study|Sponsor mistake|0|||
149738114|NCT00552110|540171863|FG003|Overall Study|Lack of Efficacy|1|||
149738115|NCT00552110|540171864|FG004|Overall Study|Lack of Efficacy|4|||
149738116|NCT00552110|540171860|FG000|Overall Study|Withdrawal by Subject|0|||
149738117|NCT00552110|540171861|FG001|Overall Study|Withdrawal by Subject|2|||
149738118|NCT00552110|540171862|FG002|Overall Study|Withdrawal by Subject|0|||
149738119|NCT00552110|540171863|FG003|Overall Study|Withdrawal by Subject|3|||
149738120|NCT00552110|540171864|FG004|Overall Study|Withdrawal by Subject|2|||
149738121|NCT00552110|540171860|FG000|Overall Study|Lost to Follow-up|0|||
149738122|NCT00552110|540171861|FG001|Overall Study|Lost to Follow-up|0|||
150255745|NCT00350103|542070699|FG002|Overall Study|Sponsor mistake|0|||
149738123|NCT00552110|540171862|FG002|Overall Study|Lost to Follow-up|0|||
150255746|NCT00350103|542070697|FG000|Overall Study|Randomization mistake|0|||
150255747|NCT00350103|542070698|FG001|Overall Study|Randomization mistake|1|||
150255748|NCT00350103|542070699|FG002|Overall Study|Randomization mistake|1|||
150255749|NCT00350103|542070697|FG000|Overall Study|Sponsor´s decision|0|||
150255750|NCT00350103|542070698|FG001|Overall Study|Sponsor´s decision|1|||
150255751|NCT00350103|542070699|FG002|Overall Study|Sponsor´s decision|0|||
150255752|NCT00350103|542070697|FG000|Overall Study|Lost, Reason unknown|1|||
150255753|NCT00350103|542070698|FG001|Overall Study|Lost, Reason unknown|1|||
150255754|NCT00350103|542070699|FG002|Overall Study|Lost, Reason unknown|0|||
150255755|NCT02842151|542070700|FG000|Overall Study|Adverse Event|1|||
150255756|NCT02842151|542070700|FG000|Overall Study|Subject moved too far away|1|||
150255757|NCT02559895|542070701|FG000|Overall Study|Adverse Event|3|||
150255758|NCT02559895|542070702|FG001|Overall Study|Adverse Event|3|||
150255759|NCT02559895|542070703|FG002|Overall Study|Adverse Event|2|||
150255760|NCT02559895|542070704|FG003|Overall Study|Adverse Event|1|||
149738124|NCT00552110|540171863|FG003|Overall Study|Lost to Follow-up|1|||
149738125|NCT00552110|540171864|FG004|Overall Study|Lost to Follow-up|1|||
149738126|NCT00552110|540171860|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
149738127|NCT00552110|540171861|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
149738128|NCT00552110|540171862|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
150255761|NCT02559895|542070701|FG000|Overall Study|Lack of Efficacy|2|||
150255762|NCT02559895|542070702|FG001|Overall Study|Lack of Efficacy|3|||
150255763|NCT02559895|542070703|FG002|Overall Study|Lack of Efficacy|2|||
150255764|NCT02559895|542070704|FG003|Overall Study|Lack of Efficacy|8|||
150255765|NCT02559895|542070701|FG000|Overall Study|Lost to Follow-up|22|||
150255766|NCT02559895|542070702|FG001|Overall Study|Lost to Follow-up|16|||
150255767|NCT02559895|542070703|FG002|Overall Study|Lost to Follow-up|12|||
150255768|NCT02559895|542070704|FG003|Overall Study|Lost to Follow-up|17|||
150255769|NCT02559895|542070701|FG000|Overall Study|Physician Decision|1|||
150255770|NCT02559895|542070702|FG001|Overall Study|Physician Decision|1|||
150255771|NCT02559895|542070703|FG002|Overall Study|Physician Decision|3|||
150255772|NCT02559895|542070704|FG003|Overall Study|Physician Decision|0|||
150255773|NCT02559895|542070701|FG000|Overall Study|Withdrawal by Subject|16|||
150255774|NCT02559895|542070702|FG001|Overall Study|Withdrawal by Subject|9|||
150255775|NCT02559895|542070703|FG002|Overall Study|Withdrawal by Subject|20|||
150255776|NCT02559895|542070704|FG003|Overall Study|Withdrawal by Subject|9|||
150255777|NCT02559895|542070701|FG000|Overall Study|Study Burden|10|||
150255778|NCT02559895|542070702|FG001|Overall Study|Study Burden|16|||
150255779|NCT02559895|542070703|FG002|Overall Study|Study Burden|12|||
149738129|NCT00552110|540171863|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
149738130|NCT00552110|540171864|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
150255780|NCT02559895|542070704|FG003|Overall Study|Study Burden|22|||
150255781|NCT02559895|542070701|FG000|Overall Study|Other|1|||
150255782|NCT02559895|542070702|FG001|Overall Study|Other|5|||
150255783|NCT02559895|542070703|FG002|Overall Study|Other|3|||
150255784|NCT02559895|542070704|FG003|Overall Study|Other|3|||
150255785|NCT01305200|542070705|FG000|Overall Study|Physician Decision|4|||
150255786|NCT01305200|542070706|FG001|Overall Study|Physician Decision|6|||
150255787|NCT01305200|542070707|FG002|Overall Study|Physician Decision|1|||
150255788|NCT01305200|542070705|FG000|Overall Study|Withdrawal by Subject|24|||
150255789|NCT01305200|542070706|FG001|Overall Study|Withdrawal by Subject|21|||
150255790|NCT01305200|542070707|FG002|Overall Study|Withdrawal by Subject|1|||
150255791|NCT01305200|542070705|FG000|Overall Study|Ineligible|1|||
150255792|NCT01305200|542070706|FG001|Overall Study|Ineligible|2|||
150255793|NCT01305200|542070707|FG002|Overall Study|Ineligible|1|||
150255794|NCT01305200|542070705|FG000|Overall Study|Death|0|||
150255795|NCT01305200|542070706|FG001|Overall Study|Death|2|||
150255796|NCT01305200|542070707|FG002|Overall Study|Death|0|||
150255797|NCT00432666|542072621|FG000|Main Period|Adverse Event|1|||
150255798|NCT00432666|542072622|FG001|Main Period|Adverse Event|1|||
150255799|NCT00432666|542072621|FG000|Main Period|Consent Withdrawn|1|||
150255800|NCT00432666|542072622|FG001|Main Period|Consent Withdrawn|0|||
150255801|NCT00432666|542072621|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
150255802|NCT00432666|542072622|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
150255803|NCT00432666|542072621|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
150255804|NCT00432666|542072622|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
150255805|NCT00432666|542072621|FG000|Open-Label Extension Period|Adverse Event|5|||
150255806|NCT00432666|542072622|FG001|Open-Label Extension Period|Adverse Event|0|||
150255807|NCT00432666|542072621|FG000|Open-Label Extension Period|Consent withdrawn|10|||
150255808|NCT00432666|542072622|FG001|Open-Label Extension Period|Consent withdrawn|0|||
150255809|NCT00432666|542072621|FG000|Open-Label Extension Period|Physician Decision|3|||
150255810|NCT00432666|542072622|FG001|Open-Label Extension Period|Physician Decision|0|||
150255811|NCT00978627|542072623|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
150255812|NCT00978627|542072624|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
150255813|NCT00978627|542072623|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
150255814|NCT00978627|542072624|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
150255815|NCT00978627|542072623|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
150255816|NCT00978627|542072624|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
150255817|NCT00978627|542072623|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
150255818|NCT00978627|542072624|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
150255819|NCT00978627|542072623|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
150255820|NCT00978627|542072624|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
150255821|NCT00978627|542072623|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
150255822|NCT00978627|542072624|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
150255823|NCT00978627|542072623|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
150255824|NCT00978627|542072624|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
150255825|NCT00978627|542072623|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
150255826|NCT00978627|542072624|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
150255827|NCT00978627|542072623|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
150255828|NCT00978627|542072624|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
149738131|NCT00552110|540171860|FG000|Overall Study|Withdrawn per Sponsor|0|||
149738132|NCT00552110|540171861|FG001|Overall Study|Withdrawn per Sponsor|1|||
149738133|NCT00552110|540171862|FG002|Overall Study|Withdrawn per Sponsor|0|||
149738134|NCT00552110|540171863|FG003|Overall Study|Withdrawn per Sponsor|0|||
149738135|NCT00552110|540171864|FG004|Overall Study|Withdrawn per Sponsor|1|||
149738136|NCT00552110|540171860|FG000|Overall Study|Use of Prohibited Medication|1|||
149738137|NCT00552110|540171861|FG001|Overall Study|Use of Prohibited Medication|1|||
149738138|NCT00552110|540171862|FG002|Overall Study|Use of Prohibited Medication|0|||
149738139|NCT00552110|540171863|FG003|Overall Study|Use of Prohibited Medication|0|||
149738140|NCT00552110|540171864|FG004|Overall Study|Use of Prohibited Medication|0|||
149738141|NCT00552110|540171860|FG000|Overall Study|Delay of Study due to Relabeling|0|||
149738142|NCT00552110|540171861|FG001|Overall Study|Delay of Study due to Relabeling|0|||
149738143|NCT00552110|540171862|FG002|Overall Study|Delay of Study due to Relabeling|0|||
149738144|NCT00552110|540171863|FG003|Overall Study|Delay of Study due to Relabeling|1|||
149738145|NCT00552110|540171864|FG004|Overall Study|Delay of Study due to Relabeling|0|||
149738146|NCT00552110|540171860|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
149738147|NCT00552110|540171861|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
149738148|NCT00552110|540171862|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
149738149|NCT00552110|540171863|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
149738150|NCT00552110|540171864|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
149738151|NCT00552110|540171860|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
149738152|NCT00552110|540171861|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
149738153|NCT00552110|540171862|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
149738154|NCT00552110|540171863|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
149738155|NCT00552110|540171864|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
149738156|NCT03029832|540171874|FG000|Overall Study|Safety Follow-Up Completed|2|||
149738157|NCT03029832|540171875|FG001|Overall Study|Safety Follow-Up Completed|0|||
149738158|NCT03029832|540171874|FG000|Overall Study|Death due to Disease Progression|1|||
149738159|NCT03029832|540171875|FG001|Overall Study|Death due to Disease Progression|0|||
149738160|NCT03029832|540171874|FG000|Overall Study|Study Terminated By Sponsor|1|||
149738161|NCT03029832|540171875|FG001|Overall Study|Study Terminated By Sponsor|1|||
149738162|NCT01412229|540171876|FG000|Overall Study|Physician Decision|1|||
149738163|NCT04373460|540171877|FG000|Overall Study|Did not receive tranfusion|18|||
149738164|NCT04373460|540171878|FG001|Overall Study|Did not receive tranfusion|26|||
149738165|NCT00700804|540171881|FG000|Overall Study|Withdrawal by Subject|1|||
149738166|NCT00700804|540171882|FG001|Overall Study|Withdrawal by Subject|2|||
149738167|NCT00700804|540171881|FG000|Overall Study|Protocol Violation|1|||
149738168|NCT00700804|540171882|FG001|Overall Study|Protocol Violation|1|||
149738169|NCT00700804|540171881|FG000|Overall Study|Loose Stools|1|||
149738170|NCT00700804|540171882|FG001|Overall Study|Loose Stools|1|||
149738171|NCT02901431|540171883|FG000|PK Part|Adverse Event|0|||
149738172|NCT02901431|540171884|FG001|PK Part|Adverse Event|1|||
149738173|NCT02901431|540171885|FG002|PK Part|Adverse Event|0|||
149738174|NCT02901431|540171886|FG003|PK Part|Adverse Event|0|||
149738175|NCT02901431|540171887|FG004|PK Part|Adverse Event|0|||
149738176|NCT02901431|540171888|FG005|PK Part|Adverse Event|0|||
149738177|NCT02901431|540171889|FG006|PK Part|Adverse Event|0|||
149738178|NCT02901431|540171890|FG007|PK Part|Adverse Event|0|||
149738179|NCT02901431|540171891|FG008|PK Part|Adverse Event|0|||
149738180|NCT02901431|540171892|FG009|PK Part|Adverse Event|0|||
149738181|NCT02901431|540171893|FG010|PK Part|Adverse Event|0|||
149738182|NCT02901431|540171894|FG011|PK Part|Adverse Event|0|||
149738183|NCT02901431|540171895|FG012|PK Part|Adverse Event|0|||
149738184|NCT02901431|540171883|FG000|PK Part|Lost to Follow-up|0|||
149738185|NCT02901431|540171884|FG001|PK Part|Lost to Follow-up|0|||
149738186|NCT02901431|540171885|FG002|PK Part|Lost to Follow-up|1|||
149738187|NCT02901431|540171886|FG003|PK Part|Lost to Follow-up|0|||
149738188|NCT02901431|540171887|FG004|PK Part|Lost to Follow-up|0|||
149738189|NCT02901431|540171888|FG005|PK Part|Lost to Follow-up|0|||
149738190|NCT02901431|540171889|FG006|PK Part|Lost to Follow-up|0|||
149738191|NCT02901431|540171890|FG007|PK Part|Lost to Follow-up|0|||
149738192|NCT02901431|540171891|FG008|PK Part|Lost to Follow-up|0|||
149738193|NCT02901431|540171892|FG009|PK Part|Lost to Follow-up|0|||
149738194|NCT02901431|540171893|FG010|PK Part|Lost to Follow-up|0|||
149738195|NCT02901431|540171894|FG011|PK Part|Lost to Follow-up|0|||
149738196|NCT02901431|540171895|FG012|PK Part|Lost to Follow-up|0|||
149738197|NCT02901431|540171883|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
149738198|NCT02901431|540171884|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738199|NCT02901431|540171885|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738200|NCT02901431|540171886|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738201|NCT02901431|540171887|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738202|NCT02901431|540171888|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738203|NCT02901431|540171889|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738204|NCT02901431|540171890|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738205|NCT02901431|540171891|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738206|NCT02901431|540171892|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738207|NCT02901431|540171893|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738208|NCT02901431|540171894|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738209|NCT02901431|540171895|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149738210|NCT02901431|540171883|FG000|PK Part|Pending dose confirmation|0|||
149738211|NCT02901431|540171884|FG001|PK Part|Pending dose confirmation|1|||
149738212|NCT02901431|540171885|FG002|PK Part|Pending dose confirmation|0|||
149738213|NCT02901431|540171886|FG003|PK Part|Pending dose confirmation|0|||
149738214|NCT02901431|540171887|FG004|PK Part|Pending dose confirmation|0|||
149738215|NCT02901431|540171888|FG005|PK Part|Pending dose confirmation|0|||
149738216|NCT02901431|540171889|FG006|PK Part|Pending dose confirmation|0|||
149738217|NCT02901431|540171890|FG007|PK Part|Pending dose confirmation|0|||
149738218|NCT02901431|540171891|FG008|PK Part|Pending dose confirmation|0|||
149738219|NCT02901431|540171892|FG009|PK Part|Pending dose confirmation|0|||
149738220|NCT02901431|540171893|FG010|PK Part|Pending dose confirmation|0|||
149738221|NCT02901431|540171894|FG011|PK Part|Pending dose confirmation|0|||
149738222|NCT02901431|540171895|FG012|PK Part|Pending dose confirmation|0|||
149738223|NCT02901431|540171883|FG000|PK Part|8 weeks of treatment ran out|2|||
149738224|NCT02901431|540171884|FG001|PK Part|8 weeks of treatment ran out|0|||
149738225|NCT02901431|540171885|FG002|PK Part|8 weeks of treatment ran out|0|||
149738226|NCT02901431|540171886|FG003|PK Part|8 weeks of treatment ran out|0|||
149738227|NCT02901431|540171887|FG004|PK Part|8 weeks of treatment ran out|0|||
149738228|NCT02901431|540171888|FG005|PK Part|8 weeks of treatment ran out|0|||
149738229|NCT02901431|540171889|FG006|PK Part|8 weeks of treatment ran out|0|||
149738230|NCT02901431|540171890|FG007|PK Part|8 weeks of treatment ran out|0|||
149738231|NCT02901431|540171891|FG008|PK Part|8 weeks of treatment ran out|0|||
149738232|NCT02901431|540171892|FG009|PK Part|8 weeks of treatment ran out|0|||
149738233|NCT02901431|540171893|FG010|PK Part|8 weeks of treatment ran out|0|||
149738234|NCT02901431|540171894|FG011|PK Part|8 weeks of treatment ran out|0|||
149738235|NCT02901431|540171895|FG012|PK Part|8 weeks of treatment ran out|0|||
149738236|NCT02901431|540171883|FG000|PK Part|Stopped treatment after 8 weeks|1|||
149738237|NCT02901431|540171884|FG001|PK Part|Stopped treatment after 8 weeks|0|||
149738238|NCT02901431|540171885|FG002|PK Part|Stopped treatment after 8 weeks|1|||
149738239|NCT02901431|540171886|FG003|PK Part|Stopped treatment after 8 weeks|0|||
149738240|NCT02901431|540171887|FG004|PK Part|Stopped treatment after 8 weeks|0|||
149738241|NCT02901431|540171888|FG005|PK Part|Stopped treatment after 8 weeks|0|||
149738242|NCT02901431|540171889|FG006|PK Part|Stopped treatment after 8 weeks|0|||
149738243|NCT02901431|540171890|FG007|PK Part|Stopped treatment after 8 weeks|0|||
149738244|NCT02901431|540171891|FG008|PK Part|Stopped treatment after 8 weeks|0|||
149738245|NCT02901431|540171892|FG009|PK Part|Stopped treatment after 8 weeks|0|||
149738246|NCT02901431|540171893|FG010|PK Part|Stopped treatment after 8 weeks|0|||
149738247|NCT02901431|540171894|FG011|PK Part|Stopped treatment after 8 weeks|0|||
149738248|NCT02901431|540171895|FG012|PK Part|Stopped treatment after 8 weeks|0|||
149738249|NCT02901431|540171883|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
149738250|NCT02901431|540171884|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738251|NCT02901431|540171885|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
149738252|NCT02901431|540171886|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738253|NCT02901431|540171887|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738254|NCT02901431|540171888|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738255|NCT02901431|540171889|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738256|NCT02901431|540171890|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738257|NCT02901431|540171891|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738258|NCT02901431|540171892|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738259|NCT02901431|540171893|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738260|NCT02901431|540171894|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738261|NCT02901431|540171895|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149738262|NCT02901431|540171883|FG000|PK Part|Discontinued per Sponsor|0|||
149738263|NCT02901431|540171884|FG001|PK Part|Discontinued per Sponsor|3|||
149738264|NCT02901431|540171885|FG002|PK Part|Discontinued per Sponsor|0|||
149738265|NCT02901431|540171886|FG003|PK Part|Discontinued per Sponsor|0|||
149738266|NCT02901431|540171887|FG004|PK Part|Discontinued per Sponsor|0|||
149738267|NCT02901431|540171888|FG005|PK Part|Discontinued per Sponsor|0|||
149738268|NCT02901431|540171889|FG006|PK Part|Discontinued per Sponsor|0|||
149738269|NCT02901431|540171890|FG007|PK Part|Discontinued per Sponsor|0|||
149738270|NCT02901431|540171891|FG008|PK Part|Discontinued per Sponsor|0|||
149738271|NCT02901431|540171892|FG009|PK Part|Discontinued per Sponsor|0|||
149738272|NCT02901431|540171893|FG010|PK Part|Discontinued per Sponsor|0|||
149738273|NCT02901431|540171894|FG011|PK Part|Discontinued per Sponsor|0|||
149738274|NCT02901431|540171895|FG012|PK Part|Discontinued per Sponsor|0|||
149738275|NCT02901431|540171883|FG000|PK Part|Withdrawal by Subject|1|||
149738276|NCT02901431|540171884|FG001|PK Part|Withdrawal by Subject|1|||
149738277|NCT02901431|540171885|FG002|PK Part|Withdrawal by Subject|3|||
149738278|NCT02901431|540171886|FG003|PK Part|Withdrawal by Subject|0|||
149738279|NCT02901431|540171887|FG004|PK Part|Withdrawal by Subject|0|||
149738280|NCT02901431|540171888|FG005|PK Part|Withdrawal by Subject|0|||
149738281|NCT02901431|540171889|FG006|PK Part|Withdrawal by Subject|0|||
149738282|NCT02901431|540171890|FG007|PK Part|Withdrawal by Subject|0|||
149738283|NCT02901431|540171891|FG008|PK Part|Withdrawal by Subject|0|||
149738284|NCT02901431|540171892|FG009|PK Part|Withdrawal by Subject|0|||
149738285|NCT02901431|540171893|FG010|PK Part|Withdrawal by Subject|0|||
149738286|NCT02901431|540171894|FG011|PK Part|Withdrawal by Subject|0|||
149738287|NCT02901431|540171895|FG012|PK Part|Withdrawal by Subject|0|||
149738288|NCT02901431|540171883|FG000|Main Treatment Part|Adverse Event|0|||
149738289|NCT02901431|540171884|FG001|Main Treatment Part|Adverse Event|0|||
149738290|NCT02901431|540171885|FG002|Main Treatment Part|Adverse Event|0|||
149738291|NCT02901431|540171886|FG003|Main Treatment Part|Adverse Event|3|||
149738292|NCT02901431|540171887|FG004|Main Treatment Part|Adverse Event|3|||
149738293|NCT02901431|540171888|FG005|Main Treatment Part|Adverse Event|4|||
149738294|NCT02901431|540171889|FG006|Main Treatment Part|Adverse Event|1|||
149738295|NCT02901431|540171890|FG007|Main Treatment Part|Adverse Event|0|||
149738296|NCT02901431|540171891|FG008|Main Treatment Part|Adverse Event|0|||
149738297|NCT02901431|540171892|FG009|Main Treatment Part|Adverse Event|0|||
149738298|NCT02901431|540171893|FG010|Main Treatment Part|Adverse Event|0|||
149738299|NCT02901431|540171894|FG011|Main Treatment Part|Adverse Event|0|||
149738300|NCT02901431|540171895|FG012|Main Treatment Part|Adverse Event|0|||
149738301|NCT02901431|540171883|FG000|Main Treatment Part|Lack of Efficacy|0|||
149738302|NCT02901431|540171884|FG001|Main Treatment Part|Lack of Efficacy|0|||
149738303|NCT02901431|540171885|FG002|Main Treatment Part|Lack of Efficacy|0|||
149738304|NCT02901431|540171886|FG003|Main Treatment Part|Lack of Efficacy|1|||
149738305|NCT02901431|540171887|FG004|Main Treatment Part|Lack of Efficacy|0|||
149738306|NCT02901431|540171888|FG005|Main Treatment Part|Lack of Efficacy|0|||
149738307|NCT02901431|540171889|FG006|Main Treatment Part|Lack of Efficacy|0|||
149738308|NCT02901431|540171890|FG007|Main Treatment Part|Lack of Efficacy|0|||
149738309|NCT02901431|540171891|FG008|Main Treatment Part|Lack of Efficacy|0|||
149738310|NCT02901431|540171892|FG009|Main Treatment Part|Lack of Efficacy|0|||
149738311|NCT02901431|540171893|FG010|Main Treatment Part|Lack of Efficacy|0|||
149738312|NCT02901431|540171894|FG011|Main Treatment Part|Lack of Efficacy|0|||
149738313|NCT02901431|540171895|FG012|Main Treatment Part|Lack of Efficacy|0|||
149738314|NCT02901431|540171883|FG000|Main Treatment Part|Lost to Follow-up|0|||
149738315|NCT02901431|540171884|FG001|Main Treatment Part|Lost to Follow-up|0|||
149738316|NCT02901431|540171885|FG002|Main Treatment Part|Lost to Follow-up|0|||
149738317|NCT02901431|540171886|FG003|Main Treatment Part|Lost to Follow-up|3|||
149738318|NCT02901431|540171887|FG004|Main Treatment Part|Lost to Follow-up|1|||
149738319|NCT02901431|540171888|FG005|Main Treatment Part|Lost to Follow-up|2|||
149738320|NCT02901431|540171889|FG006|Main Treatment Part|Lost to Follow-up|3|||
149738321|NCT02901431|540171890|FG007|Main Treatment Part|Lost to Follow-up|0|||
149738322|NCT02901431|540171891|FG008|Main Treatment Part|Lost to Follow-up|0|||
149738323|NCT02901431|540171892|FG009|Main Treatment Part|Lost to Follow-up|0|||
149738324|NCT02901431|540171893|FG010|Main Treatment Part|Lost to Follow-up|0|||
149738325|NCT02901431|540171894|FG011|Main Treatment Part|Lost to Follow-up|0|||
149738326|NCT02901431|540171895|FG012|Main Treatment Part|Lost to Follow-up|0|||
149738327|NCT02901431|540171883|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
149738328|NCT02901431|540171884|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
149738329|NCT02901431|540171885|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
149738330|NCT02901431|540171886|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
149738331|NCT02901431|540171887|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
149738332|NCT02901431|540171888|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
149738333|NCT02901431|540171889|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
149738334|NCT02901431|540171890|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
149738335|NCT02901431|540171891|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
149738336|NCT02901431|540171892|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
149738337|NCT02901431|540171893|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
149738338|NCT02901431|540171894|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
149738339|NCT02901431|540171895|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
149738340|NCT02901431|540171883|FG000|Main Treatment Part|Physician Decision|0|||
149738341|NCT02901431|540171884|FG001|Main Treatment Part|Physician Decision|0|||
149738342|NCT02901431|540171885|FG002|Main Treatment Part|Physician Decision|0|||
149738343|NCT02901431|540171886|FG003|Main Treatment Part|Physician Decision|1|||
149738344|NCT02901431|540171887|FG004|Main Treatment Part|Physician Decision|0|||
149738345|NCT02901431|540171888|FG005|Main Treatment Part|Physician Decision|0|||
149738346|NCT02901431|540171889|FG006|Main Treatment Part|Physician Decision|1|||
149738347|NCT02901431|540171890|FG007|Main Treatment Part|Physician Decision|0|||
149738348|NCT02901431|540171891|FG008|Main Treatment Part|Physician Decision|0|||
149738349|NCT02901431|540171892|FG009|Main Treatment Part|Physician Decision|0|||
149738350|NCT02901431|540171893|FG010|Main Treatment Part|Physician Decision|0|||
149738351|NCT02901431|540171894|FG011|Main Treatment Part|Physician Decision|0|||
150255829|NCT00565851|542072625|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
149738352|NCT02901431|540171895|FG012|Main Treatment Part|Physician Decision|0|||
149738353|NCT02901431|540171883|FG000|Main Treatment Part|Withdrawal by Subject|0|||
149738354|NCT02901431|540171884|FG001|Main Treatment Part|Withdrawal by Subject|0|||
149738355|NCT02901431|540171885|FG002|Main Treatment Part|Withdrawal by Subject|0|||
149738356|NCT02901431|540171886|FG003|Main Treatment Part|Withdrawal by Subject|18|||
149801749|NCT01049360|540402427|FG013|Period 4|Withdrawal by Subject|0|||
149738357|NCT02901431|540171887|FG004|Main Treatment Part|Withdrawal by Subject|3|||
149738358|NCT02901431|540171888|FG005|Main Treatment Part|Withdrawal by Subject|5|||
149738359|NCT02901431|540171889|FG006|Main Treatment Part|Withdrawal by Subject|6|||
149738360|NCT02901431|540171890|FG007|Main Treatment Part|Withdrawal by Subject|0|||
149738361|NCT02901431|540171891|FG008|Main Treatment Part|Withdrawal by Subject|0|||
149738362|NCT02901431|540171892|FG009|Main Treatment Part|Withdrawal by Subject|0|||
149738363|NCT02901431|540171893|FG010|Main Treatment Part|Withdrawal by Subject|0|||
149738364|NCT02901431|540171894|FG011|Main Treatment Part|Withdrawal by Subject|0|||
149738365|NCT02901431|540171895|FG012|Main Treatment Part|Withdrawal by Subject|0|||
149738366|NCT02901431|540171883|FG000|Open Label Part|Adverse Event|0|||
149738367|NCT02901431|540171884|FG001|Open Label Part|Adverse Event|0|||
149738368|NCT02901431|540171885|FG002|Open Label Part|Adverse Event|0|||
149738369|NCT02901431|540171886|FG003|Open Label Part|Adverse Event|0|||
149738370|NCT02901431|540171887|FG004|Open Label Part|Adverse Event|0|||
149738371|NCT02901431|540171888|FG005|Open Label Part|Adverse Event|0|||
149738372|NCT02901431|540171889|FG006|Open Label Part|Adverse Event|0|||
149738373|NCT02901431|540171890|FG007|Open Label Part|Adverse Event|0|||
149738374|NCT02901431|540171891|FG008|Open Label Part|Adverse Event|4|||
149738375|NCT02901431|540171892|FG009|Open Label Part|Adverse Event|4|||
149738376|NCT02901431|540171893|FG010|Open Label Part|Adverse Event|0|||
149738377|NCT02901431|540171894|FG011|Open Label Part|Adverse Event|4|||
149738378|NCT02901431|540171895|FG012|Open Label Part|Adverse Event|1|||
149738379|NCT02901431|540171883|FG000|Open Label Part|Lost to Follow-up|0|||
149738380|NCT02901431|540171884|FG001|Open Label Part|Lost to Follow-up|0|||
149738381|NCT02901431|540171885|FG002|Open Label Part|Lost to Follow-up|0|||
149738382|NCT02901431|540171886|FG003|Open Label Part|Lost to Follow-up|0|||
149738383|NCT02901431|540171887|FG004|Open Label Part|Lost to Follow-up|0|||
149738384|NCT02901431|540171888|FG005|Open Label Part|Lost to Follow-up|0|||
149738385|NCT02901431|540171889|FG006|Open Label Part|Lost to Follow-up|0|||
149738386|NCT02901431|540171890|FG007|Open Label Part|Lost to Follow-up|0|||
149738387|NCT02901431|540171891|FG008|Open Label Part|Lost to Follow-up|2|||
149738388|NCT02901431|540171892|FG009|Open Label Part|Lost to Follow-up|2|||
149738389|NCT02901431|540171893|FG010|Open Label Part|Lost to Follow-up|1|||
149738390|NCT02901431|540171894|FG011|Open Label Part|Lost to Follow-up|1|||
149738391|NCT02901431|540171895|FG012|Open Label Part|Lost to Follow-up|1|||
149738392|NCT02901431|540171883|FG000|Open Label Part|Physician Decision|0|||
149738393|NCT02901431|540171884|FG001|Open Label Part|Physician Decision|0|||
149738394|NCT02901431|540171885|FG002|Open Label Part|Physician Decision|0|||
149738395|NCT02901431|540171886|FG003|Open Label Part|Physician Decision|0|||
149738396|NCT02901431|540171887|FG004|Open Label Part|Physician Decision|0|||
149738397|NCT02901431|540171888|FG005|Open Label Part|Physician Decision|0|||
149738398|NCT02901431|540171889|FG006|Open Label Part|Physician Decision|0|||
149738399|NCT02901431|540171890|FG007|Open Label Part|Physician Decision|0|||
149738400|NCT02901431|540171891|FG008|Open Label Part|Physician Decision|1|||
149738401|NCT02901431|540171892|FG009|Open Label Part|Physician Decision|1|||
149738402|NCT02901431|540171893|FG010|Open Label Part|Physician Decision|0|||
149738403|NCT02901431|540171894|FG011|Open Label Part|Physician Decision|0|||
149738404|NCT02901431|540171895|FG012|Open Label Part|Physician Decision|0|||
149738405|NCT02901431|540171883|FG000|Open Label Part|Study Terminated By Sponsor|0|||
149738406|NCT02901431|540171884|FG001|Open Label Part|Study Terminated By Sponsor|0|||
149738407|NCT02901431|540171885|FG002|Open Label Part|Study Terminated By Sponsor|0|||
149738408|NCT02901431|540171886|FG003|Open Label Part|Study Terminated By Sponsor|0|||
149738409|NCT02901431|540171887|FG004|Open Label Part|Study Terminated By Sponsor|0|||
149738410|NCT02901431|540171888|FG005|Open Label Part|Study Terminated By Sponsor|0|||
149738411|NCT02901431|540171889|FG006|Open Label Part|Study Terminated By Sponsor|0|||
150255830|NCT00565851|542072626|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
150255831|NCT00565851|542072627|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
150255832|NCT00565851|542072628|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
150255833|NCT00565851|542072629|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
149738412|NCT02901431|540171890|FG007|Open Label Part|Study Terminated By Sponsor|0|||
149738413|NCT02901431|540171891|FG008|Open Label Part|Study Terminated By Sponsor|35|||
149738414|NCT02901431|540171892|FG009|Open Label Part|Study Terminated By Sponsor|12|||
149738415|NCT02901431|540171893|FG010|Open Label Part|Study Terminated By Sponsor|21|||
149738416|NCT02901431|540171894|FG011|Open Label Part|Study Terminated By Sponsor|31|||
149738417|NCT02901431|540171895|FG012|Open Label Part|Study Terminated By Sponsor|0|||
150255834|NCT00565851|542072630|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
149738418|NCT02901431|540171883|FG000|Open Label Part|Withdrawal by Subject|0|||
149738419|NCT02901431|540171884|FG001|Open Label Part|Withdrawal by Subject|0|||
149738420|NCT02901431|540171885|FG002|Open Label Part|Withdrawal by Subject|0|||
149738421|NCT02901431|540171886|FG003|Open Label Part|Withdrawal by Subject|0|||
150255835|NCT00565851|542072631|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
149738422|NCT02901431|540171887|FG004|Open Label Part|Withdrawal by Subject|0|||
149738423|NCT02901431|540171888|FG005|Open Label Part|Withdrawal by Subject|0|||
149738424|NCT02901431|540171889|FG006|Open Label Part|Withdrawal by Subject|0|||
149738425|NCT02901431|540171890|FG007|Open Label Part|Withdrawal by Subject|0|||
149738426|NCT02901431|540171891|FG008|Open Label Part|Withdrawal by Subject|6|||
149738427|NCT02901431|540171892|FG009|Open Label Part|Withdrawal by Subject|5|||
149738428|NCT02901431|540171893|FG010|Open Label Part|Withdrawal by Subject|7|||
149738429|NCT02901431|540171894|FG011|Open Label Part|Withdrawal by Subject|3|||
149738430|NCT02901431|540171895|FG012|Open Label Part|Withdrawal by Subject|1|||
149738431|NCT03440944|540171896|FG000|Overall Study|Physician Decision|1|||
149738432|NCT03440944|540171897|FG001|Overall Study|Physician Decision|0|||
149738433|NCT03440944|540171896|FG000|Overall Study|No Acceptable Vasculature|0|||
149738434|NCT03440944|540171897|FG001|Overall Study|No Acceptable Vasculature|1|||
149738435|NCT04672083|540171898|FG000|Overall Study|Lost to Follow-up|1|||
149738436|NCT04672083|540171899|FG001|Overall Study|Lost to Follow-up|0|||
149738437|NCT04672083|540171900|FG002|Overall Study|Lost to Follow-up|0|||
149738438|NCT04672083|540171901|FG003|Overall Study|Lost to Follow-up|0|||
149738439|NCT04672083|540171902|FG004|Overall Study|Lost to Follow-up|0|||
149738440|NCT01661790|540171903|FG000|Overall Study|Lost to Follow-up|0|||
149738441|NCT01661790|540171904|FG001|Overall Study|Lost to Follow-up|2|||
149738442|NCT02048904|540171907|FG000|Overall Study|Withdrawal by Subject|7|||
149738443|NCT02048904|540171907|FG000|Overall Study|Physician Decision|70|||
149738444|NCT03832387|540171910|FG000|Overall Study|Protocol Violation|2|||
149738445|NCT03832387|540171911|FG001|Overall Study|Protocol Violation|6|||
149738446|NCT03832387|540171910|FG000|Overall Study|EXCLUSION CRITERIA|3|||
149738447|NCT03832387|540171911|FG001|Overall Study|EXCLUSION CRITERIA|1|||
149738448|NCT05775289|540171912|FG000|Overall Study|Study Ongoing|20|||
150255836|NCT00565851|542072632|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
150255837|NCT00565851|542072625|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
150255838|NCT00565851|542072626|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
150255839|NCT00565851|542072627|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
150255840|NCT00565851|542072628|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
150255841|NCT00565851|542072629|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
150255842|NCT00565851|542072630|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
150255843|NCT00565851|542072631|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
150255844|NCT00565851|542072632|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
150255845|NCT04058366|542072633|FG000|Overall Study|Adverse Event|14|||
150255846|NCT04058366|542072633|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
150255847|NCT04058366|542072633|FG000|Overall Study|Commercial drug is available for participants|6|||
150255848|NCT04058366|542072633|FG000|Overall Study|Death|1|||
150255849|NCT04058366|542072633|FG000|Overall Study|Other non-compliance|2|||
150255850|NCT04058366|542072633|FG000|Overall Study|Other|6|||
150255851|NCT01342341|542072634|FG000|Overall Study|Lost to Follow-up|4|||
150255852|NCT01342341|542072635|FG001|Overall Study|Lost to Follow-up|4|||
150255853|NCT00705679|542072636|FG000|Overall Study|Adverse Event|1|||
150255854|NCT00705679|542072637|FG001|Overall Study|Adverse Event|1|||
150255855|NCT00705679|542072638|FG002|Overall Study|Adverse Event|0|||
150255856|NCT00705679|542072639|FG003|Overall Study|Adverse Event|0|||
150255857|NCT00705679|542072640|FG004|Overall Study|Adverse Event|0|||
150255858|NCT00705679|542072636|FG000|Overall Study|Death|0|||
150255859|NCT00705679|542072637|FG001|Overall Study|Death|0|||
150255860|NCT00705679|542072638|FG002|Overall Study|Death|3|||
149738449|NCT05775289|540171913|FG001|Overall Study|Study Ongoing|53|||
149738450|NCT05775289|540171914|FG002|Overall Study|Study Ongoing|15|||
149738451|NCT05775289|540171915|FG003|Overall Study|Study Ongoing|55|||
149738452|NCT05775289|540171912|FG000|Overall Study|Death|4|||
149738453|NCT05775289|540171913|FG001|Overall Study|Death|11|||
149738454|NCT05775289|540171914|FG002|Overall Study|Death|8|||
149738455|NCT05775289|540171915|FG003|Overall Study|Death|12|||
149738456|NCT05775289|540171912|FG000|Overall Study|Lost to Follow-up|0|||
149738457|NCT05775289|540171913|FG001|Overall Study|Lost to Follow-up|1|||
149738458|NCT05775289|540171914|FG002|Overall Study|Lost to Follow-up|0|||
149738459|NCT05775289|540171915|FG003|Overall Study|Lost to Follow-up|0|||
149738460|NCT05775289|540171912|FG000|Overall Study|Progressive Disease|0|||
149738461|NCT05775289|540171913|FG001|Overall Study|Progressive Disease|0|||
149738462|NCT05775289|540171914|FG002|Overall Study|Progressive Disease|1|||
149738463|NCT05775289|540171915|FG003|Overall Study|Progressive Disease|0|||
149738464|NCT05775289|540171912|FG000|Overall Study|Withdrawal by Subject|1|||
149738465|NCT05775289|540171913|FG001|Overall Study|Withdrawal by Subject|1|||
149738466|NCT05775289|540171914|FG002|Overall Study|Withdrawal by Subject|0|||
149738467|NCT05775289|540171915|FG003|Overall Study|Withdrawal by Subject|0|||
149738468|NCT00490542|540171917|FG000|Overall Study|Lost to Follow-up|3|||
149738469|NCT00490542|540171918|FG001|Overall Study|Lost to Follow-up|0|||
149738470|NCT00490542|540171917|FG000|Overall Study|Adverse Event|3|||
149738471|NCT00490542|540171918|FG001|Overall Study|Adverse Event|3|||
150255861|NCT00705679|542072639|FG003|Overall Study|Death|2|||
150255862|NCT00705679|542072640|FG004|Overall Study|Death|1|||
149738472|NCT00490542|540171917|FG000|Overall Study|Lack of Efficacy|1|||
149738473|NCT00490542|540171918|FG001|Overall Study|Lack of Efficacy|1|||
149738474|NCT04743856|540171919|FG000|Overall Study|Lost to Follow-up|6|||
150255863|NCT00705679|542072636|FG000|Overall Study|Lost to Follow-up|32|||
150255864|NCT00705679|542072637|FG001|Overall Study|Lost to Follow-up|60|||
150255865|NCT00705679|542072638|FG002|Overall Study|Lost to Follow-up|44|||
149738475|NCT04743856|540171920|FG001|Overall Study|Lost to Follow-up|7|||
149738476|NCT04743856|540171919|FG000|Overall Study|Withdrawal by Subject|1|||
149738477|NCT04743856|540171920|FG001|Overall Study|Withdrawal by Subject|0|||
149738478|NCT04439188|540171921|FG000|Overall Study|Ineligible|3|||
149738479|NCT04439188|540171921|FG000|Overall Study|Adverse Event|4|||
149738480|NCT04439188|540171921|FG000|Overall Study|Death|1|||
149738481|NCT04439188|540171921|FG000|Overall Study|Disease Progression|25|||
149738482|NCT04439188|540171921|FG000|Overall Study|Withdrawal by Subject|2|||
149738483|NCT01813890|540171924|FG000|Overall Study|Adverse Event|0|||
149738484|NCT01813890|540171925|FG001|Overall Study|Adverse Event|3|||
149738485|NCT01813890|540171926|FG002|Overall Study|Adverse Event|4|||
149738486|NCT01813890|540171924|FG000|Overall Study|Lack of Efficacy|9|||
149738487|NCT01813890|540171925|FG001|Overall Study|Lack of Efficacy|1|||
149738488|NCT01813890|540171926|FG002|Overall Study|Lack of Efficacy|2|||
149738489|NCT04482647|540171927|FG000|Overall Study|Time constraints|2|||
149738490|NCT04482647|540171927|FG000|Overall Study|Health issues|1|||
149738491|NCT04482647|540171927|FG000|Overall Study|Death in the family|1|||
149738492|NCT04482647|540171927|FG000|Overall Study|Disliked the intervention|1|||
149738493|NCT04482647|540171927|FG000|Overall Study|No reasons specified|7|||
149738494|NCT00655928|540171932|FG000|Overall Study|Withdrawal by Subject|2|||
149738495|NCT00655928|540171933|FG001|Overall Study|Withdrawal by Subject|1|||
149738496|NCT00655928|540171932|FG000|Overall Study|Physician Decision|1|||
149738497|NCT00655928|540171933|FG001|Overall Study|Physician Decision|1|||
149738498|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
149738499|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
149738500|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
149738501|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149738502|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149738503|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149738504|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
149738505|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
149738506|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
149738507|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149738508|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149738509|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149738510|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
149738511|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
149738512|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
149738513|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149738514|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149738515|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149738516|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
149738517|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149738518|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149738519|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149738520|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149738521|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149738522|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
149738523|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
149738524|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
149738525|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149738526|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149738527|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149738528|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
149738529|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
149738530|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
149738531|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149738532|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149738533|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149738534|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
149738535|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
149738536|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
149738537|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
149738538|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
149738539|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
149738540|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
149738541|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
149738542|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
149738543|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149738544|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149738545|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149738546|NCT01707992|540171934|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
149738547|NCT01707992|540171935|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
149738548|NCT01707992|540171936|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
149738549|NCT01707992|540171937|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149738550|NCT01707992|540171938|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149738551|NCT01707992|540171939|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149738552|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
149738553|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
149738554|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
149738555|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
149738556|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
149738557|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
149738558|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149738559|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149738560|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149738561|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
149738562|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
149738563|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
149738564|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149738565|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149738566|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149738567|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
149738568|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
149738569|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
149738570|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
149738571|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
149738572|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
149738573|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
149738574|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
149738575|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
149738576|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149738577|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149738578|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149738579|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
149738580|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
149738581|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
149738582|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Death|0|||
149738583|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Death|0|||
149738584|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Death|0|||
149738585|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Death|2|||
149738586|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Death|0|||
149738587|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Death|0|||
149738588|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
149738589|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
149738590|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
149738591|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
149738592|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
149738593|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
149738594|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
149738595|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
149738596|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
149738597|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
149738598|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
149738599|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
149738600|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149738601|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149738602|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149738603|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
149738604|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
149738605|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
149738606|NCT01707992|540171934|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149738607|NCT01707992|540171935|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149738608|NCT01707992|540171936|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149738609|NCT01707992|540171937|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149738610|NCT01707992|540171938|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
149738611|NCT01707992|540171939|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149738612|NCT00998738|540171941|FG000|Overall Study|Uknown|1|||
149738613|NCT04211337|540171942|FG000|Overall Study|On Treatment|175|||
149738614|NCT04211337|540171943|FG001|Overall Study|On Treatment|40|||
149738615|NCT04211337|540171942|FG000|Overall Study|Withdrawal by Subject|0|||
149738616|NCT04211337|540171943|FG001|Overall Study|Withdrawal by Subject|2|||
149738617|NCT04980391|540171946|FG000|Overall Study|Death|0|||
149738618|NCT04980391|540171947|FG001|Overall Study|Death|0|||
149738619|NCT04980391|540171948|FG002|Overall Study|Death|1|||
149738620|NCT04980391|540171949|FG003|Overall Study|Death|1|||
149738621|NCT04980391|540171946|FG000|Overall Study|Lost to Follow-up|3|||
149738622|NCT04980391|540171947|FG001|Overall Study|Lost to Follow-up|3|||
149738623|NCT04980391|540171948|FG002|Overall Study|Lost to Follow-up|2|||
149738624|NCT04980391|540171949|FG003|Overall Study|Lost to Follow-up|3|||
149738625|NCT04980391|540171946|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
149738626|NCT04980391|540171947|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149738627|NCT04980391|540171948|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149738628|NCT04980391|540171949|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149738629|NCT04980391|540171946|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149738630|NCT04980391|540171947|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149738631|NCT04980391|540171948|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149738632|NCT04980391|540171949|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149738633|NCT04980391|540171946|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149738634|NCT04980391|540171947|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149738635|NCT04980391|540171948|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
149738636|NCT04980391|540171949|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149738637|NCT00162773|540173804|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
149738638|NCT00215150|540173807|FG000|Open Label Phase|Lost to Follow-up|7|||
149738639|NCT00215150|540173807|FG000|Open Label Phase|Withdrawal by Subject|1|||
149738640|NCT00215150|540173807|FG000|Open Label Phase|Did not complete a post base visit|13|||
149738641|NCT00215150|540173807|FG000|Open Label Phase|Did not meet randomization criteria|9|||
149738642|NCT00215150|540173807|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
149738643|NCT00215150|540173807|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
149738644|NCT00215150|540173807|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
149738645|NCT03124459|540173813|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149738646|NCT03124459|540173814|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149738647|NCT03124459|540173815|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149738648|NCT03124459|540173816|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149738649|NCT03124459|540173817|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
149738650|NCT03124459|540173818|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149738651|NCT03124459|540173813|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149738652|NCT03124459|540173814|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149738653|NCT03124459|540173815|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149738654|NCT03124459|540173816|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149738655|NCT03124459|540173817|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
149738656|NCT03124459|540173818|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149738657|NCT03124459|540173813|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149738658|NCT03124459|540173814|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149738659|NCT03124459|540173815|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149738660|NCT03124459|540173816|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
149738661|NCT03124459|540173817|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
149738662|NCT03124459|540173818|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149738663|NCT03124459|540173813|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149738664|NCT03124459|540173814|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149738665|NCT03124459|540173815|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149738666|NCT03124459|540173816|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
149738667|NCT03124459|540173817|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
149738668|NCT03124459|540173818|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149738669|NCT03124459|540173813|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149738670|NCT03124459|540173814|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149738671|NCT03124459|540173815|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149738672|NCT03124459|540173816|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149738673|NCT03124459|540173817|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149738674|NCT03124459|540173818|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
149738675|NCT03124459|540173813|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149738676|NCT03124459|540173814|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149738677|NCT03124459|540173815|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149738678|NCT03124459|540173816|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149738679|NCT03124459|540173817|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149738680|NCT03124459|540173818|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
149738681|NCT01903876|540173819|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
149738682|NCT01903876|540173820|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
149738683|NCT01903876|540173819|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
149738684|NCT01903876|540173820|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
149738685|NCT00278629|540173828|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
149738686|NCT00603239|540173833|FG000|Overall Study|Adverse Event|4|||
149738687|NCT00603239|540173834|FG001|Overall Study|Adverse Event|1|||
149738688|NCT00603239|540173833|FG000|Overall Study|Entry criteria not met|0|||
149738689|NCT00603239|540173834|FG001|Overall Study|Entry criteria not met|1|||
149738690|NCT00603239|540173833|FG000|Overall Study|Loss of glucose control|3|||
149738691|NCT00603239|540173834|FG001|Overall Study|Loss of glucose control|0|||
149738692|NCT00603239|540173833|FG000|Overall Study|Lost to Follow-up|2|||
149738693|NCT00603239|540173834|FG001|Overall Study|Lost to Follow-up|1|||
149738694|NCT00603239|540173833|FG000|Overall Study|Physician Decision|2|||
149738695|NCT00603239|540173834|FG001|Overall Study|Physician Decision|0|||
149738696|NCT00603239|540173833|FG000|Overall Study|Protocol Violation|2|||
149738697|NCT00603239|540173834|FG001|Overall Study|Protocol Violation|0|||
149738698|NCT00603239|540173833|FG000|Overall Study|Subject decision|2|||
149738699|NCT00603239|540173834|FG001|Overall Study|Subject decision|1|||
149738700|NCT01562028|540173836|FG000|Overall Study|Withdrawal by Subject|1|||
149738701|NCT01562028|540173837|FG001|Overall Study|Withdrawal by Subject|1|||
149738702|NCT01562028|540173836|FG000|Overall Study|Lost to Follow-up|2|||
149738703|NCT01562028|540173837|FG001|Overall Study|Lost to Follow-up|1|||
149738704|NCT03093402|540173840|FG000|Overall Study|Lost to Follow-up|1|||
149738705|NCT03093402|540173841|FG001|Overall Study|Lost to Follow-up|0|||
149738706|NCT03093402|540173842|FG002|Overall Study|Lost to Follow-up|0|||
149738707|NCT03093402|540173843|FG003|Overall Study|Lost to Follow-up|0|||
149738708|NCT03093402|540173840|FG000|Overall Study|Withdrawal by Subject|3|||
149738709|NCT03093402|540173841|FG001|Overall Study|Withdrawal by Subject|3|||
149738710|NCT03093402|540173842|FG002|Overall Study|Withdrawal by Subject|0|||
149738711|NCT03093402|540173843|FG003|Overall Study|Withdrawal by Subject|1|||
149738712|NCT03093402|540173840|FG000|Overall Study|Withdrew prior to dosing|2|||
149738713|NCT03093402|540173841|FG001|Overall Study|Withdrew prior to dosing|1|||
149738714|NCT03093402|540173842|FG002|Overall Study|Withdrew prior to dosing|2|||
149738715|NCT03093402|540173843|FG003|Overall Study|Withdrew prior to dosing|3|||
149738716|NCT03093402|540173840|FG000|Overall Study|Ineligible for study|1|||
149738717|NCT03093402|540173841|FG001|Overall Study|Ineligible for study|0|||
149738718|NCT03093402|540173842|FG002|Overall Study|Ineligible for study|0|||
149738719|NCT03093402|540173843|FG003|Overall Study|Ineligible for study|0|||
149738720|NCT03093402|540173840|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
149738721|NCT03093402|540173841|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
149738722|NCT03093402|540173842|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
149738723|NCT03093402|540173843|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
149738724|NCT02731742|540173846|FG000|Overall Study|Death|1|||
149738725|NCT02731742|540173847|FG001|Overall Study|Death|2|||
149738726|NCT02731742|540173848|FG002|Overall Study|Death|5|||
149738727|NCT02731742|540173849|FG003|Overall Study|Death|0|||
149738728|NCT02731742|540173846|FG000|Overall Study|Physician Decision|0|||
149738729|NCT02731742|540173847|FG001|Overall Study|Physician Decision|0|||
149738730|NCT02731742|540173848|FG002|Overall Study|Physician Decision|0|||
149738731|NCT02731742|540173849|FG003|Overall Study|Physician Decision|1|||
149738732|NCT02731742|540173846|FG000|Overall Study|Study Terminated by Sponsor|2|||
149738733|NCT02731742|540173847|FG001|Overall Study|Study Terminated by Sponsor|1|||
149738734|NCT02731742|540173848|FG002|Overall Study|Study Terminated by Sponsor|1|||
149738735|NCT02731742|540173849|FG003|Overall Study|Study Terminated by Sponsor|1|||
149738736|NCT00461175|540173852|FG000|Overall Study|Protocol Violation|522|||
149738737|NCT00461175|540173853|FG001|Overall Study|Protocol Violation|365|||
149738738|NCT03093155|540173854|FG000|Overall Study|Not Eligible|1|||
149738739|NCT03093155|540173855|FG001|Overall Study|Not Eligible|0|||
149738740|NCT03093155|540173854|FG000|Overall Study|Withdrawal by Subject|0|||
149738741|NCT03093155|540173855|FG001|Overall Study|Withdrawal by Subject|1|||
149738742|NCT04336163|540173856|FG000|Overall Study|Lost to Follow-up|55|||
149738743|NCT04336163|540173857|FG001|Overall Study|Lost to Follow-up|0|||
149738744|NCT01773473|540173858|FG000|Overall Study|Adverse Event|3|||
149738745|NCT01773473|540173859|FG001|Overall Study|Adverse Event|2|||
149738746|NCT01773473|540173858|FG000|Overall Study|Protocol Violation|0|||
149738747|NCT01773473|540173859|FG001|Overall Study|Protocol Violation|4|||
149738748|NCT01773473|540173858|FG000|Overall Study|Physician Decision|3|||
149738749|NCT01773473|540173859|FG001|Overall Study|Physician Decision|5|||
149738750|NCT01773473|540173858|FG000|Overall Study|Sponsor Decision|2|||
149738751|NCT01773473|540173859|FG001|Overall Study|Sponsor Decision|0|||
149738752|NCT01773473|540173858|FG000|Overall Study|Lack of Efficacy|0|||
149738753|NCT01773473|540173859|FG001|Overall Study|Lack of Efficacy|1|||
149738754|NCT01773473|540173858|FG000|Overall Study|Non-Compliance with study drug|1|||
149738755|NCT01773473|540173859|FG001|Overall Study|Non-Compliance with study drug|4|||
149738756|NCT01773473|540173858|FG000|Overall Study|Withdrawal by Subject|5|||
149738757|NCT01773473|540173859|FG001|Overall Study|Withdrawal by Subject|3|||
149738758|NCT01773473|540173858|FG000|Overall Study|Lost to Follow-up|2|||
149738759|NCT01773473|540173859|FG001|Overall Study|Lost to Follow-up|0|||
149738760|NCT00826514|540173860|FG000|Overall Study|Adverse Event|1|||
149738761|NCT00826514|540173861|FG001|Overall Study|Adverse Event|1|||
149738762|NCT00826514|540173860|FG000|Overall Study|Lack of Efficacy|0|||
149738763|NCT00826514|540173861|FG001|Overall Study|Lack of Efficacy|1|||
149738764|NCT00826514|540173860|FG000|Overall Study|Withdrawal by Subject|2|||
149738765|NCT00826514|540173861|FG001|Overall Study|Withdrawal by Subject|3|||
149738766|NCT01085682|540173862|FG000|Overall Study|Withdrawal by Subject|25|||
149738767|NCT01085682|540173863|FG001|Overall Study|Withdrawal by Subject|25|||
149738768|NCT03926143|540173864|FG000|Overall Study|Physician Decision|3|||
149738769|NCT03926143|540173864|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
149738770|NCT03926143|540173864|FG000|Overall Study|Adverse Event|2|||
149738771|NCT03926143|540173864|FG000|Overall Study|Progressive disease|3|||
149738772|NCT02207907|540173875|FG000|Overall Study|Lost to Follow-up|3|||
149738773|NCT02207907|540173876|FG001|Overall Study|Lost to Follow-up|1|||
149738774|NCT02207907|540173875|FG000|Overall Study|Withdrawal by Subject|5|||
149738775|NCT02207907|540173876|FG001|Overall Study|Withdrawal by Subject|6|||
149738776|NCT02207907|540173875|FG000|Overall Study|Did not meet study criteria|3|||
149738777|NCT02207907|540173876|FG001|Overall Study|Did not meet study criteria|0|||
149738778|NCT02207907|540173875|FG000|Overall Study|Pregnancy|0|||
149738779|NCT02207907|540173876|FG001|Overall Study|Pregnancy|1|||
149738780|NCT01025635|540173882|FG000|Overall Study|Withdrawal by Subject|6|||
149738781|NCT01025635|540173883|FG001|Overall Study|Withdrawal by Subject|7|||
149738782|NCT01025635|540173882|FG000|Overall Study|Protocol Violation|4|||
149738783|NCT01025635|540173883|FG001|Overall Study|Protocol Violation|2|||
149738784|NCT01025635|540173882|FG000|Overall Study|Lack of Efficacy|0|||
149738785|NCT01025635|540173883|FG001|Overall Study|Lack of Efficacy|1|||
149738786|NCT01025635|540173882|FG000|Overall Study|Lost to Follow-up|9|||
149738787|NCT01025635|540173883|FG001|Overall Study|Lost to Follow-up|13|||
149738788|NCT01025635|540173882|FG000|Overall Study|Reason not known|4|||
149738789|NCT01025635|540173883|FG001|Overall Study|Reason not known|2|||
149738790|NCT02209506|540173884|FG000|Overall Study|Withdrawal by Subject|0|||
149738791|NCT02209506|540173885|FG001|Overall Study|Withdrawal by Subject|0|||
149738792|NCT02209506|540173886|FG002|Overall Study|Withdrawal by Subject|0|||
149738793|NCT02209506|540173887|FG003|Overall Study|Withdrawal by Subject|0|||
149738794|NCT02209506|540173888|FG004|Overall Study|Withdrawal by Subject|1|||
149738795|NCT01499290|540173895|FG000|Overall Study|Withdrawal by Subject|22|||
149738796|NCT01499290|540173896|FG001|Overall Study|Withdrawal by Subject|15|||
149738797|NCT01499290|540173895|FG000|Overall Study|Not specified in study report|11|||
149738798|NCT01499290|540173896|FG001|Overall Study|Not specified in study report|5|||
149738799|NCT01499290|540173895|FG000|Overall Study|Condition improved/subject recovered|1|||
149738800|NCT01499290|540173896|FG001|Overall Study|Condition improved/subject recovered|0|||
149738801|NCT01499290|540173895|FG000|Overall Study|Lack of Efficacy|7|||
149738802|NCT01499290|540173896|FG001|Overall Study|Lack of Efficacy|8|||
149738803|NCT01499290|540173895|FG000|Overall Study|Adverse Event|14|||
149738804|NCT01499290|540173896|FG001|Overall Study|Adverse Event|7|||
149738805|NCT02209766|540173897|FG000|Overall Study|Withdrawal by Subject|0|||
149738806|NCT02209766|540173898|FG001|Overall Study|Withdrawal by Subject|0|||
149738807|NCT02209766|540173899|FG002|Overall Study|Withdrawal by Subject|0|||
149738808|NCT02209766|540173900|FG003|Overall Study|Withdrawal by Subject|1|||
149738809|NCT02209766|540173901|FG004|Overall Study|Withdrawal by Subject|0|||
149738810|NCT00327444|540173902|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
150255866|NCT00705679|542072639|FG003|Overall Study|Lost to Follow-up|30|||
149738811|NCT00327444|540173903|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
149738812|NCT00327444|540173902|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
149738813|NCT00327444|540173903|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
149738814|NCT00327444|540173902|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
149738815|NCT00327444|540173903|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
149738816|NCT00327444|540173902|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
149738817|NCT00327444|540173903|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
149738818|NCT00327444|540173902|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
149738819|NCT00327444|540173903|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
149738820|NCT00327444|540173902|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
149738821|NCT00327444|540173903|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
149738822|NCT00327444|540173902|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
149738823|NCT00327444|540173903|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
149738824|NCT00327444|540173902|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
149738825|NCT00327444|540173903|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
149738826|NCT00805207|540173904|FG000|Overall Study|Protocol Violation|0|||
149738827|NCT00805207|540173905|FG001|Overall Study|Protocol Violation|0|||
149738828|NCT00805207|540173906|FG002|Overall Study|Protocol Violation|1|||
149738829|NCT00805207|540173907|FG003|Overall Study|Protocol Violation|0|||
149738830|NCT00805207|540173908|FG004|Overall Study|Protocol Violation|0|||
149738831|NCT00805207|540173909|FG005|Overall Study|Protocol Violation|0|||
149738832|NCT00805207|540173910|FG006|Overall Study|Protocol Violation|0|||
149738833|NCT00805207|540173911|FG007|Overall Study|Protocol Violation|0|||
149738834|NCT00805207|540173912|FG008|Overall Study|Protocol Violation|0|||
149738835|NCT00805207|540173904|FG000|Overall Study|Physician Decision|0|||
149738836|NCT00805207|540173905|FG001|Overall Study|Physician Decision|1|||
149738837|NCT00805207|540173906|FG002|Overall Study|Physician Decision|0|||
149738838|NCT00805207|540173907|FG003|Overall Study|Physician Decision|0|||
149738839|NCT00805207|540173908|FG004|Overall Study|Physician Decision|0|||
149738840|NCT00805207|540173909|FG005|Overall Study|Physician Decision|1|||
149738841|NCT00805207|540173910|FG006|Overall Study|Physician Decision|0|||
149738842|NCT00805207|540173911|FG007|Overall Study|Physician Decision|0|||
149738843|NCT00805207|540173912|FG008|Overall Study|Physician Decision|0|||
149738844|NCT00805207|540173904|FG000|Overall Study|Withdrawal by Subject|0|||
149738845|NCT00805207|540173905|FG001|Overall Study|Withdrawal by Subject|1|||
149738846|NCT00805207|540173906|FG002|Overall Study|Withdrawal by Subject|0|||
149738847|NCT00805207|540173907|FG003|Overall Study|Withdrawal by Subject|0|||
149738848|NCT00805207|540173908|FG004|Overall Study|Withdrawal by Subject|1|||
149738849|NCT00805207|540173909|FG005|Overall Study|Withdrawal by Subject|2|||
149738850|NCT00805207|540173910|FG006|Overall Study|Withdrawal by Subject|0|||
149738851|NCT00805207|540173911|FG007|Overall Study|Withdrawal by Subject|0|||
149738852|NCT00805207|540173912|FG008|Overall Study|Withdrawal by Subject|0|||
149738853|NCT00064701|540173913|FG000|One Year Post-transplant|Did not receive study drug|7|||
149738854|NCT00064701|540173914|FG001|One Year Post-transplant|Did not receive study drug|12|||
149738855|NCT00064701|540173915|FG002|One Year Post-transplant|Did not receive study drug|11|||
149738856|NCT00064701|540173913|FG000|One Year Post-transplant|Adverse Event|23|||
149738857|NCT00064701|540173914|FG001|One Year Post-transplant|Adverse Event|19|||
149738858|NCT00064701|540173915|FG002|One Year Post-transplant|Adverse Event|37|||
149738859|NCT00064701|540173913|FG000|One Year Post-transplant|Rejection|0|||
149738860|NCT00064701|540173914|FG001|One Year Post-transplant|Rejection|1|||
150255867|NCT00705679|542072640|FG004|Overall Study|Lost to Follow-up|35|||
150255868|NCT00705679|542072636|FG000|Overall Study|Physician Decision|0|||
150255869|NCT00705679|542072637|FG001|Overall Study|Physician Decision|1|||
150255870|NCT00705679|542072638|FG002|Overall Study|Physician Decision|0|||
150255871|NCT00705679|542072639|FG003|Overall Study|Physician Decision|1|||
150255872|NCT00705679|542072640|FG004|Overall Study|Physician Decision|0|||
150255873|NCT00705679|542072636|FG000|Overall Study|Withdrawal by Subject|32|||
150255874|NCT00705679|542072637|FG001|Overall Study|Withdrawal by Subject|77|||
150255875|NCT00705679|542072638|FG002|Overall Study|Withdrawal by Subject|68|||
150255876|NCT00705679|542072639|FG003|Overall Study|Withdrawal by Subject|47|||
150255877|NCT00705679|542072640|FG004|Overall Study|Withdrawal by Subject|33|||
150255878|NCT03730480|542072641|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
150255879|NCT00621777|542072647|FG000|Open Phase|Adverse Event|20|||
150255880|NCT00621777|542072648|FG001|Open Phase|Adverse Event|0|||
150255881|NCT00621777|542072647|FG000|Open Phase|Did not abstain during open phase|56|||
150255882|NCT00621777|542072648|FG001|Open Phase|Did not abstain during open phase|0|||
150255883|NCT00621777|542072647|FG000|Open Phase|Withdrawal by Subject|17|||
150255884|NCT00621777|542072648|FG001|Open Phase|Withdrawal by Subject|0|||
150255885|NCT00621777|542072647|FG000|Open Phase|administrative|13|||
150255886|NCT00621777|542072648|FG001|Open Phase|administrative|0|||
150255887|NCT00621777|542072647|FG000|Open Phase|Lost to Follow-up|10|||
150255888|NCT00621777|542072648|FG001|Open Phase|Lost to Follow-up|0|||
150255889|NCT00621777|542072647|FG000|Randomized Phase|Adverse Event|3|||
150255890|NCT00621777|542072648|FG001|Randomized Phase|Adverse Event|3|||
150255891|NCT00621777|542072647|FG000|Randomized Phase|Lost to Follow-up|3|||
150255892|NCT00621777|542072648|FG001|Randomized Phase|Lost to Follow-up|3|||
150255893|NCT00621777|542072647|FG000|Randomized Phase|Withdrawal by Subject|1|||
150255894|NCT00621777|542072648|FG001|Randomized Phase|Withdrawal by Subject|9|||
150255895|NCT00621777|542072647|FG000|Randomized Phase|administrative|0|||
150255896|NCT00621777|542072648|FG001|Randomized Phase|administrative|3|||
150255897|NCT00621777|542072647|FG000|Randomized Phase|Death|0|||
150255898|NCT00621777|542072648|FG001|Randomized Phase|Death|1|||
149738861|NCT00064701|540173915|FG002|One Year Post-transplant|Rejection|16|||
149738862|NCT00064701|540173913|FG000|One Year Post-transplant|Non-compliance|4|||
149738863|NCT00064701|540173914|FG001|One Year Post-transplant|Non-compliance|2|||
149738864|NCT00064701|540173915|FG002|One Year Post-transplant|Non-compliance|5|||
149738865|NCT00064701|540173913|FG000|One Year Post-transplant|Graft Failure|3|||
149738866|NCT00064701|540173914|FG001|One Year Post-transplant|Graft Failure|2|||
150255899|NCT02663518|542072655|FG000|Part 1: Phase 1a Escalation|Death|0|||
150255900|NCT02663518|542072656|FG001|Part 1: Phase 1a Escalation|Death|0|||
150255901|NCT02663518|542072657|FG002|Part 1: Phase 1a Escalation|Death|1|||
150255902|NCT02663518|542072658|FG003|Part 1: Phase 1a Escalation|Death|0|||
150255903|NCT02663518|542072659|FG004|Part 1: Phase 1a Escalation|Death|0|||
150255904|NCT02663518|542072660|FG005|Part 1: Phase 1a Escalation|Death|0|||
150255905|NCT02663518|542072661|FG006|Part 1: Phase 1a Escalation|Death|0|||
149738867|NCT00064701|540173915|FG002|One Year Post-transplant|Graft Failure|1|||
149738868|NCT00064701|540173913|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
149738869|NCT00064701|540173914|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
149738870|NCT00064701|540173915|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
149738871|NCT00064701|540173913|FG000|One Year Post-transplant|Lost to Follow-up|1|||
149738872|NCT00064701|540173914|FG001|One Year Post-transplant|Lost to Follow-up|0|||
149738873|NCT00064701|540173915|FG002|One Year Post-transplant|Lost to Follow-up|0|||
149738874|NCT00064701|540173913|FG000|One Year Post-transplant|Converted to rapamycin|1|||
149738875|NCT00064701|540173914|FG001|One Year Post-transplant|Converted to rapamycin|0|||
149738876|NCT00064701|540173915|FG002|One Year Post-transplant|Converted to rapamycin|0|||
149738877|NCT00064701|540173913|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
149738878|NCT00064701|540173914|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
149738879|NCT00064701|540173915|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
149738880|NCT00064701|540173913|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
149738881|NCT00064701|540173914|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
149738882|NCT00064701|540173915|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
149738883|NCT00064701|540173913|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
149738884|NCT00064701|540173914|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
149738885|NCT00064701|540173915|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
149738886|NCT00064701|540173913|FG000|One Year Post-transplant|Poor absorption|0|||
149738887|NCT00064701|540173914|FG001|One Year Post-transplant|Poor absorption|1|||
149738888|NCT00064701|540173915|FG002|One Year Post-transplant|Poor absorption|0|||
149738889|NCT00064701|540173913|FG000|One Year Post-transplant|Pancreas transplant|0|||
149738890|NCT00064701|540173914|FG001|One Year Post-transplant|Pancreas transplant|0|||
149738891|NCT00064701|540173915|FG002|One Year Post-transplant|Pancreas transplant|1|||
149738892|NCT00064701|540173913|FG000|Clinical Continuation Phase|Adverse Event|12|||
149738893|NCT00064701|540173914|FG001|Clinical Continuation Phase|Adverse Event|21|||
149738894|NCT00064701|540173915|FG002|Clinical Continuation Phase|Adverse Event|14|||
149738895|NCT00064701|540173913|FG000|Clinical Continuation Phase|Non-compliance|8|||
149738896|NCT00064701|540173914|FG001|Clinical Continuation Phase|Non-compliance|6|||
149738897|NCT00064701|540173915|FG002|Clinical Continuation Phase|Non-compliance|7|||
149738898|NCT00064701|540173913|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
149738899|NCT00064701|540173914|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
149738900|NCT00064701|540173915|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
149738901|NCT00064701|540173913|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
149738902|NCT00064701|540173914|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
149738903|NCT00064701|540173915|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
149738904|NCT00064701|540173913|FG000|Clinical Continuation Phase|Graft Failure|5|||
149738905|NCT00064701|540173914|FG001|Clinical Continuation Phase|Graft Failure|5|||
149738906|NCT00064701|540173915|FG002|Clinical Continuation Phase|Graft Failure|2|||
149738907|NCT00064701|540173913|FG000|Clinical Continuation Phase|Rejection|1|||
149738908|NCT00064701|540173914|FG001|Clinical Continuation Phase|Rejection|2|||
149738909|NCT00064701|540173915|FG002|Clinical Continuation Phase|Rejection|2|||
149738910|NCT00064701|540173913|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
149738911|NCT00064701|540173914|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
149738912|NCT00064701|540173915|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
149738913|NCT00064701|540173913|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
149738914|NCT00064701|540173914|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
149738915|NCT00064701|540173915|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
149738916|NCT00064701|540173913|FG000|Clinical Continuation Phase|Physician Decision|1|||
149738917|NCT00064701|540173914|FG001|Clinical Continuation Phase|Physician Decision|3|||
149738918|NCT00064701|540173915|FG002|Clinical Continuation Phase|Physician Decision|0|||
149738919|NCT00064701|540173913|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
149738920|NCT00064701|540173914|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
149738921|NCT00064701|540173915|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
149738922|NCT00064701|540173913|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
149738923|NCT00064701|540173914|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
149738924|NCT00064701|540173915|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
149738925|NCT00064701|540173913|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
149738926|NCT00064701|540173914|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
149738927|NCT00064701|540173915|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
149738928|NCT00064701|540173913|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
149738929|NCT00064701|540173914|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
149738930|NCT00064701|540173915|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
149738931|NCT00064701|540173913|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
149738932|NCT00064701|540173914|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
149738933|NCT00064701|540173915|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
149738934|NCT00064701|540173913|FG000|Clinical Continuation Phase|Patient opted out|0|||
149738935|NCT00064701|540173914|FG001|Clinical Continuation Phase|Patient opted out|0|||
149738936|NCT00064701|540173915|FG002|Clinical Continuation Phase|Patient opted out|1|||
149738937|NCT04223609|540173917|FG000|Overall Study|Adverse Event|0|||
149738938|NCT04223609|540173918|FG001|Overall Study|Adverse Event|1|||
149738939|NCT04223609|540173917|FG000|Overall Study|Missed last visit|0|||
149738940|NCT04223609|540173918|FG001|Overall Study|Missed last visit|1|||
149738941|NCT00355121|540173919|FG000|Overall Study|Did not receive study vaccine|1|||
149738942|NCT00355121|540173920|FG001|Overall Study|Did not receive study vaccine|0|||
149738943|NCT00355121|540173921|FG002|Overall Study|Did not receive study vaccine|1|||
149738944|NCT00355121|540173919|FG000|Overall Study|Adverse Event|0|||
149738945|NCT00355121|540173920|FG001|Overall Study|Adverse Event|1|||
149738946|NCT00355121|540173921|FG002|Overall Study|Adverse Event|0|||
149738947|NCT00355121|540173919|FG000|Overall Study|Protocol Violation|7|||
149738948|NCT00355121|540173920|FG001|Overall Study|Protocol Violation|9|||
149738949|NCT00355121|540173921|FG002|Overall Study|Protocol Violation|1|||
149738950|NCT00355121|540173919|FG000|Overall Study|Lost to Follow-up|4|||
149738951|NCT00355121|540173920|FG001|Overall Study|Lost to Follow-up|7|||
149738952|NCT00355121|540173921|FG002|Overall Study|Lost to Follow-up|1|||
149738953|NCT00355121|540173919|FG000|Overall Study|Withdrawal by Subject|9|||
149738954|NCT00355121|540173920|FG001|Overall Study|Withdrawal by Subject|10|||
149738955|NCT00355121|540173921|FG002|Overall Study|Withdrawal by Subject|2|||
149738956|NCT00355121|540173919|FG000|Overall Study|Serious adverse events|0|||
149738957|NCT00355121|540173920|FG001|Overall Study|Serious adverse events|2|||
149738958|NCT00355121|540173921|FG002|Overall Study|Serious adverse events|0|||
149738959|NCT03313050|540173922|FG000|Stage 2: 12 Months|Adverse Event|0|||
149738960|NCT03313050|540173923|FG001|Stage 2: 12 Months|Adverse Event|0|||
149738961|NCT03313050|540173924|FG002|Stage 2: 12 Months|Adverse Event|0|||
149738962|NCT03313050|540173925|FG003|Stage 2: 12 Months|Adverse Event|1|||
149738963|NCT03313050|540173922|FG000|Stage 2: 12 Months|Death|0|||
149738964|NCT03313050|540173923|FG001|Stage 2: 12 Months|Death|0|||
149738965|NCT03313050|540173924|FG002|Stage 2: 12 Months|Death|3|||
149738966|NCT03313050|540173925|FG003|Stage 2: 12 Months|Death|0|||
149738967|NCT03313050|540173922|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
149738968|NCT03313050|540173923|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
149738969|NCT03313050|540173924|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
149738970|NCT03313050|540173925|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
149738971|NCT03313050|540173922|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149738972|NCT03313050|540173923|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149738973|NCT03313050|540173924|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149738974|NCT03313050|540173925|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
149738975|NCT03313050|540173922|FG000|Stage 2: 12 Months|Protocol deviation|0|||
149738976|NCT03313050|540173923|FG001|Stage 2: 12 Months|Protocol deviation|0|||
149738977|NCT03313050|540173924|FG002|Stage 2: 12 Months|Protocol deviation|7|||
149738978|NCT03313050|540173925|FG003|Stage 2: 12 Months|Protocol deviation|7|||
149738979|NCT03313050|540173922|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
149738980|NCT03313050|540173923|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
149738981|NCT03313050|540173924|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
149738982|NCT03313050|540173925|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
149738983|NCT03313050|540173922|FG000|Stage 2: 12 Months|Other|0|||
149738984|NCT03313050|540173923|FG001|Stage 2: 12 Months|Other|0|||
149738985|NCT03313050|540173924|FG002|Stage 2: 12 Months|Other|0|||
149738986|NCT03313050|540173925|FG003|Stage 2: 12 Months|Other|1|||
149738987|NCT01291017|540173932|FG000|Overall Study|Lost to Follow-up|2|||
149738988|NCT01291017|540173932|FG000|Overall Study|Withdrawal by Subject|3|||
149738989|NCT02847598|540173933|FG000|Overall Study|Adverse Event|0|||
149738990|NCT02847598|540173934|FG001|Overall Study|Adverse Event|0|||
149738991|NCT02847598|540173935|FG002|Overall Study|Adverse Event|0|||
149738992|NCT02847598|540173936|FG003|Overall Study|Adverse Event|0|||
149738993|NCT02847598|540173937|FG004|Overall Study|Adverse Event|0|||
149738994|NCT02847598|540173938|FG005|Overall Study|Adverse Event|0|||
149738995|NCT02847598|540173939|FG006|Overall Study|Adverse Event|0|||
149738996|NCT02847598|540173940|FG007|Overall Study|Adverse Event|1|||
150255906|NCT02663518|542072662|FG007|Part 1: Phase 1a Escalation|Death|0|||
150255907|NCT02663518|542072663|FG008|Part 1: Phase 1a Escalation|Death|0|||
149738997|NCT02847598|540173933|FG000|Overall Study|Consent withdrawn|2|||
149738998|NCT02847598|540173934|FG001|Overall Study|Consent withdrawn|0|||
149738999|NCT02847598|540173935|FG002|Overall Study|Consent withdrawn|0|||
149739000|NCT02847598|540173936|FG003|Overall Study|Consent withdrawn|4|||
149739001|NCT02847598|540173937|FG004|Overall Study|Consent withdrawn|3|||
149739002|NCT02847598|540173938|FG005|Overall Study|Consent withdrawn|2|||
149739003|NCT02847598|540173939|FG006|Overall Study|Consent withdrawn|1|||
149739004|NCT02847598|540173940|FG007|Overall Study|Consent withdrawn|3|||
149739005|NCT02847598|540173933|FG000|Overall Study|Death|3|||
149739006|NCT02847598|540173934|FG001|Overall Study|Death|0|||
149739007|NCT02847598|540173935|FG002|Overall Study|Death|0|||
149739008|NCT02847598|540173936|FG003|Overall Study|Death|0|||
149739009|NCT02847598|540173937|FG004|Overall Study|Death|0|||
149739010|NCT02847598|540173938|FG005|Overall Study|Death|0|||
149739011|NCT02847598|540173939|FG006|Overall Study|Death|0|||
149739012|NCT02847598|540173940|FG007|Overall Study|Death|0|||
149739013|NCT02847598|540173933|FG000|Overall Study|Lost to Follow-up|0|||
149739014|NCT02847598|540173934|FG001|Overall Study|Lost to Follow-up|0|||
149739015|NCT02847598|540173935|FG002|Overall Study|Lost to Follow-up|0|||
149739016|NCT02847598|540173936|FG003|Overall Study|Lost to Follow-up|0|||
149739017|NCT02847598|540173937|FG004|Overall Study|Lost to Follow-up|0|||
149739018|NCT02847598|540173938|FG005|Overall Study|Lost to Follow-up|1|||
149739019|NCT02847598|540173939|FG006|Overall Study|Lost to Follow-up|1|||
149739020|NCT02847598|540173940|FG007|Overall Study|Lost to Follow-up|0|||
149739021|NCT02848833|540173941|FG000|Overall Study|subject who are duplicated|1|||
149739022|NCT02848833|540173941|FG000|Overall Study|have not taken the study drug|11|||
149739023|NCT02848833|540173941|FG000|Overall Study|follow-up failure|6|||
149739024|NCT02848833|540173941|FG000|Overall Study|Protocol Violation|119|||
149739025|NCT04375761|540176209|FG000|Overall Study|Death|1|||
149739026|NCT04375761|540176210|FG001|Overall Study|Death|2|||
149739027|NCT04375761|540176209|FG000|Overall Study|Lost to Follow-up|203|||
149739028|NCT04375761|540176210|FG001|Overall Study|Lost to Follow-up|380|||
149739029|NCT04375761|540176209|FG000|Overall Study|Withdrawal by Subject|47|||
149739030|NCT04375761|540176210|FG001|Overall Study|Withdrawal by Subject|98|||
149739031|NCT04375761|540176209|FG000|Overall Study|Noncompliance with study procedure|121|||
149739032|NCT04375761|540176210|FG001|Overall Study|Noncompliance with study procedure|251|||
149739033|NCT04375761|540176209|FG000|Overall Study|Reimbursement not enough|1|||
149739034|NCT04375761|540176210|FG001|Overall Study|Reimbursement not enough|2|||
149739035|NCT04375761|540176209|FG000|Overall Study|Unforeseen family circumstances|1|||
149739036|NCT04375761|540176210|FG001|Overall Study|Unforeseen family circumstances|3|||
149739037|NCT04375761|540176209|FG000|Overall Study|Test too painful|1|||
149739038|NCT04375761|540176210|FG001|Overall Study|Test too painful|1|||
149739039|NCT04375761|540176209|FG000|Overall Study|Moved|0|||
149739040|NCT04375761|540176210|FG001|Overall Study|Moved|2|||
149739041|NCT04375761|540176209|FG000|Overall Study|Nonresponsive|0|||
149739042|NCT04375761|540176210|FG001|Overall Study|Nonresponsive|5|||
149739043|NCT03797001|540176211|FG000|Overall Study|Withdrawn due to COVID19|4|||
149739044|NCT03797001|540176212|FG001|Overall Study|Withdrawn due to COVID19|0|||
149739045|NCT03797001|540176211|FG000|Overall Study|Withdrawal by Subject|7|||
149739046|NCT03797001|540176212|FG001|Overall Study|Withdrawal by Subject|6|||
149739047|NCT03797001|540176211|FG000|Overall Study|Adverse Event|0|||
149739048|NCT03797001|540176212|FG001|Overall Study|Adverse Event|1|||
149739049|NCT05556616|540176215|FG000|Overall Study|Withdrawal by Subject|1|||
149739050|NCT05556616|540176216|FG001|Overall Study|Withdrawal by Subject|0|||
149739051|NCT05556616|540176217|FG002|Overall Study|Withdrawal by Subject|0|||
149739052|NCT05556616|540176218|FG003|Overall Study|Withdrawal by Subject|0|||
149739053|NCT05556616|540176219|FG004|Overall Study|Withdrawal by Subject|0|||
149739054|NCT05556616|540176220|FG005|Overall Study|Withdrawal by Subject|0|||
149739055|NCT05556616|540176221|FG006|Overall Study|Withdrawal by Subject|0|||
149739056|NCT05556616|540176215|FG000|Overall Study|Death|0|||
149739057|NCT05556616|540176216|FG001|Overall Study|Death|0|||
149739058|NCT05556616|540176217|FG002|Overall Study|Death|2|||
149739059|NCT05556616|540176218|FG003|Overall Study|Death|1|||
149739060|NCT05556616|540176219|FG004|Overall Study|Death|0|||
149739061|NCT05556616|540176220|FG005|Overall Study|Death|0|||
149739062|NCT05556616|540176221|FG006|Overall Study|Death|0|||
149739063|NCT05556616|540176215|FG000|Overall Study|Study Terminated by Sponsor|0|||
149739064|NCT05556616|540176216|FG001|Overall Study|Study Terminated by Sponsor|3|||
149739065|NCT05556616|540176217|FG002|Overall Study|Study Terminated by Sponsor|0|||
149739066|NCT05556616|540176218|FG003|Overall Study|Study Terminated by Sponsor|0|||
149739067|NCT05556616|540176219|FG004|Overall Study|Study Terminated by Sponsor|0|||
149739068|NCT05556616|540176220|FG005|Overall Study|Study Terminated by Sponsor|0|||
149739069|NCT05556616|540176221|FG006|Overall Study|Study Terminated by Sponsor|0|||
149739070|NCT00500266|540176223|FG000|Overall Study|Death|3|||
150255908|NCT02663518|542072664|FG009|Part 1: Phase 1a Escalation|Death|0|||
150255909|NCT02663518|542072665|FG010|Part 1: Phase 1a Escalation|Death|0|||
149739071|NCT00500266|540176223|FG000|Overall Study|Lost to Follow-up|3|||
149739072|NCT00500266|540176223|FG000|Overall Study|Withdrawal by Subject|3|||
149739073|NCT00500266|540176223|FG000|Overall Study|Assigned, not treated|4|||
149739074|NCT01431287|540176224|FG000|Overall Study|not treated|0|||
149739075|NCT01431287|540176225|FG001|Overall Study|not treated|0|||
150255910|NCT02663518|542072666|FG011|Part 1: Phase 1a Escalation|Death|0|||
150255911|NCT02663518|542072667|FG012|Part 1: Phase 1a Escalation|Death|0|||
149739076|NCT01431287|540176226|FG002|Overall Study|not treated|1|||
149739077|NCT01431287|540176227|FG003|Overall Study|not treated|0|||
149739078|NCT01431287|540176228|FG004|Overall Study|not treated|0|||
149739079|NCT01431287|540176224|FG000|Overall Study|Adverse Event|59|||
149739080|NCT01431287|540176225|FG001|Overall Study|Adverse Event|57|||
149739081|NCT01431287|540176226|FG002|Overall Study|Adverse Event|53|||
149739082|NCT01431287|540176227|FG003|Overall Study|Adverse Event|33|||
149739083|NCT01431287|540176228|FG004|Overall Study|Adverse Event|41|||
149739084|NCT01431287|540176224|FG000|Overall Study|Non compliant with protocol|6|||
149739085|NCT01431287|540176225|FG001|Overall Study|Non compliant with protocol|6|||
149739086|NCT01431287|540176226|FG002|Overall Study|Non compliant with protocol|5|||
150255912|NCT02663518|542072668|FG013|Part 1: Phase 1a Escalation|Death|0|||
149739087|NCT01431287|540176227|FG003|Overall Study|Non compliant with protocol|6|||
149739088|NCT01431287|540176228|FG004|Overall Study|Non compliant with protocol|5|||
149739089|NCT01431287|540176224|FG000|Overall Study|Lost to Follow-up|0|||
149739090|NCT01431287|540176225|FG001|Overall Study|Lost to Follow-up|3|||
149739091|NCT01431287|540176226|FG002|Overall Study|Lost to Follow-up|2|||
149739092|NCT01431287|540176227|FG003|Overall Study|Lost to Follow-up|3|||
149739093|NCT01431287|540176228|FG004|Overall Study|Lost to Follow-up|1|||
149739094|NCT01431287|540176224|FG000|Overall Study|Consent withdrawn not due to AE|29|||
149739095|NCT01431287|540176225|FG001|Overall Study|Consent withdrawn not due to AE|30|||
149739096|NCT01431287|540176226|FG002|Overall Study|Consent withdrawn not due to AE|34|||
149739097|NCT01431287|540176227|FG003|Overall Study|Consent withdrawn not due to AE|19|||
149739098|NCT01431287|540176228|FG004|Overall Study|Consent withdrawn not due to AE|29|||
149739099|NCT01431287|540176224|FG000|Overall Study|not stated above|4|||
149739100|NCT01431287|540176225|FG001|Overall Study|not stated above|2|||
149739101|NCT01431287|540176226|FG002|Overall Study|not stated above|2|||
149739102|NCT01431287|540176227|FG003|Overall Study|not stated above|2|||
149739103|NCT01431287|540176228|FG004|Overall Study|not stated above|1|||
149739104|NCT02251743|540176229|FG000|Overall Study|Withdrawal by Subject|1|||
149739105|NCT02251743|540176230|FG001|Overall Study|Withdrawal by Subject|1|||
149739106|NCT03615222|540176241|FG000|Overall Study|Ineligible|26|||
149739107|NCT03615222|540176241|FG000|Overall Study|Withdrawal by Subject|7|||
149739108|NCT03615222|540176241|FG000|Overall Study|Death|1|||
149739109|NCT01552057|540176242|FG000|Overall Study|Adverse Event|14|||
149739110|NCT01552057|540176243|FG001|Overall Study|Adverse Event|15|||
149739111|NCT01552057|540176242|FG000|Overall Study|Lack of Efficacy|8|||
149739112|NCT01552057|540176243|FG001|Overall Study|Lack of Efficacy|23|||
149739113|NCT01552057|540176242|FG000|Overall Study|Withdrawal by Subject|5|||
149739114|NCT01552057|540176243|FG001|Overall Study|Withdrawal by Subject|8|||
149739115|NCT01552057|540176242|FG000|Overall Study|Entry Criteria Not Met|2|||
149739116|NCT01552057|540176243|FG001|Overall Study|Entry Criteria Not Met|2|||
149739117|NCT01552057|540176242|FG000|Overall Study|Physician Decision|1|||
149739118|NCT01552057|540176243|FG001|Overall Study|Physician Decision|0|||
149739119|NCT00476086|540176244|FG000|Overall Study|Alternative therapy|1|||
149739120|NCT00476086|540176244|FG000|Overall Study|Progressive Disease|4|||
149739121|NCT02900092|540176245|FG000|Overall Study|Adverse Event|1|||
149739122|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
149739123|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
149739124|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
149739125|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149739126|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149739127|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149739128|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
149739129|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149739130|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149739131|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149739132|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149739133|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149739134|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
149739135|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149739136|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149739137|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149739138|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149739139|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149739140|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
149739141|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
149739142|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
149739143|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149739144|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149739145|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149739146|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149739147|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
149739148|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149739149|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149739150|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149739151|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149739152|NCT03895203|540176246|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149739153|NCT03895203|540176247|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
149739154|NCT03895203|540176248|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149739155|NCT03895203|540176249|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149739156|NCT03895203|540176250|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149739157|NCT03895203|540176251|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149739158|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149739159|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149739160|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149739161|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
149739162|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149739163|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149739164|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149739165|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149739166|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149739167|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
149739168|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
149739169|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
149739170|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149739171|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149739172|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149739173|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
149739174|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
149739175|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
149739176|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149739177|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149739178|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149739179|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
149739180|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
149739181|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149739182|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
149739183|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
149739184|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
149739185|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
149739186|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
149739187|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
149739188|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149739189|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149739190|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149739191|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
149739192|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149739193|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149739194|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149739195|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149739196|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149739197|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
149739198|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149739199|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149739200|NCT03895203|540176246|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149739201|NCT03895203|540176247|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149739202|NCT03895203|540176248|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149739203|NCT03895203|540176249|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149739204|NCT03895203|540176250|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
150255913|NCT02663518|542072655|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255914|NCT02663518|542072656|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255915|NCT02663518|542072657|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
150255916|NCT02663518|542072658|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255917|NCT02663518|542072659|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255918|NCT02663518|542072660|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255919|NCT02663518|542072661|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255920|NCT02663518|542072662|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255921|NCT02663518|542072663|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255922|NCT02663518|542072664|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255923|NCT02663518|542072665|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255924|NCT02663518|542072666|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255925|NCT02663518|542072667|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255926|NCT02663518|542072668|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
150255927|NCT02663518|542072655|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
150255928|NCT02663518|542072656|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
149739205|NCT03895203|540176251|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
149739206|NCT01389245|540176252|FG000|Overall Study|Protocol Violation|10|||
149739207|NCT01389245|540176252|FG000|Overall Study|Lost to Follow-up|3|||
149739208|NCT01389245|540176252|FG000|Overall Study|Withdrawal by Subject|2|||
149739209|NCT02292849|540176253|FG000|Overall Study|Lost to Follow-up|0|||
149739210|NCT02292849|540176254|FG001|Overall Study|Lost to Follow-up|2|||
149739211|NCT02292849|540176255|FG002|Overall Study|Lost to Follow-up|2|||
149739212|NCT02292849|540176253|FG000|Overall Study|Physician Decision|4|||
149739213|NCT02292849|540176254|FG001|Overall Study|Physician Decision|0|||
149739214|NCT02292849|540176255|FG002|Overall Study|Physician Decision|0|||
149739215|NCT04125680|540176256|FG000|Overall Study|Lost to Follow-up|15|||
149739216|NCT00097539|540176257|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
149739217|NCT00097539|540176258|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
149739218|NCT00097539|540176259|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
149739219|NCT00097539|540176260|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
149739220|NCT00097539|540176261|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
149739221|NCT00097539|540176262|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
149739222|NCT00097539|540176263|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
149739223|NCT00097539|540176257|FG000|Overall Study|Withdrawal by Subject|925|||
149739224|NCT00097539|540176258|FG001|Overall Study|Withdrawal by Subject|323|||
149739225|NCT00097539|540176259|FG002|Overall Study|Withdrawal by Subject|346|||
149739226|NCT00097539|540176260|FG003|Overall Study|Withdrawal by Subject|217|||
149739227|NCT00097539|540176261|FG004|Overall Study|Withdrawal by Subject|68|||
149739228|NCT00097539|540176262|FG005|Overall Study|Withdrawal by Subject|229|||
149739229|NCT00097539|540176263|FG006|Overall Study|Withdrawal by Subject|3|||
149739230|NCT00097539|540176257|FG000|Overall Study|Participant Non-compliant|2140|||
149739231|NCT00097539|540176258|FG001|Overall Study|Participant Non-compliant|567|||
149739232|NCT00097539|540176259|FG002|Overall Study|Participant Non-compliant|1067|||
149739233|NCT00097539|540176260|FG003|Overall Study|Participant Non-compliant|353|||
149739234|NCT00097539|540176261|FG004|Overall Study|Participant Non-compliant|136|||
149739235|NCT00097539|540176262|FG005|Overall Study|Participant Non-compliant|543|||
149739236|NCT00097539|540176263|FG006|Overall Study|Participant Non-compliant|18|||
149739237|NCT00097539|540176257|FG000|Overall Study|Lack of Efficacy|249|||
149739238|NCT00097539|540176258|FG001|Overall Study|Lack of Efficacy|122|||
149739239|NCT00097539|540176259|FG002|Overall Study|Lack of Efficacy|202|||
149739240|NCT00097539|540176260|FG003|Overall Study|Lack of Efficacy|105|||
149739241|NCT00097539|540176261|FG004|Overall Study|Lack of Efficacy|45|||
149739242|NCT00097539|540176262|FG005|Overall Study|Lack of Efficacy|228|||
149739243|NCT00097539|540176263|FG006|Overall Study|Lack of Efficacy|5|||
149739244|NCT00097539|540176257|FG000|Overall Study|Adverse Event|78|||
149739245|NCT00097539|540176258|FG001|Overall Study|Adverse Event|133|||
149739246|NCT00097539|540176259|FG002|Overall Study|Adverse Event|37|||
149739247|NCT00097539|540176260|FG003|Overall Study|Adverse Event|27|||
149739248|NCT00097539|540176261|FG004|Overall Study|Adverse Event|30|||
149739249|NCT00097539|540176262|FG005|Overall Study|Adverse Event|59|||
149739250|NCT00097539|540176263|FG006|Overall Study|Adverse Event|1|||
149739251|NCT00097539|540176257|FG000|Overall Study|Death|2|||
149739252|NCT00097539|540176258|FG001|Overall Study|Death|7|||
149739253|NCT00097539|540176259|FG002|Overall Study|Death|0|||
149739254|NCT00097539|540176260|FG003|Overall Study|Death|0|||
149739255|NCT00097539|540176261|FG004|Overall Study|Death|1|||
149739256|NCT00097539|540176262|FG005|Overall Study|Death|3|||
149739257|NCT00097539|540176263|FG006|Overall Study|Death|0|||
149739258|NCT00097539|540176257|FG000|Overall Study|Reasons Other Than Above|3602|||
149739259|NCT00097539|540176258|FG001|Overall Study|Reasons Other Than Above|1382|||
149739260|NCT00097539|540176259|FG002|Overall Study|Reasons Other Than Above|1757|||
149739261|NCT00097539|540176260|FG003|Overall Study|Reasons Other Than Above|692|||
149739262|NCT00097539|540176261|FG004|Overall Study|Reasons Other Than Above|361|||
149739263|NCT00097539|540176262|FG005|Overall Study|Reasons Other Than Above|1244|||
149739264|NCT00097539|540176263|FG006|Overall Study|Reasons Other Than Above|34|||
149739265|NCT00097539|540176257|FG000|Overall Study|Reason not Specified|111|||
149739266|NCT00097539|540176258|FG001|Overall Study|Reason not Specified|49|||
149739267|NCT00097539|540176259|FG002|Overall Study|Reason not Specified|53|||
149739268|NCT00097539|540176260|FG003|Overall Study|Reason not Specified|21|||
149739269|NCT00097539|540176261|FG004|Overall Study|Reason not Specified|11|||
149739270|NCT00097539|540176262|FG005|Overall Study|Reason not Specified|40|||
149739271|NCT00097539|540176263|FG006|Overall Study|Reason not Specified|2|||
149739272|NCT04938648|540176264|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
149739273|NCT04938648|540176265|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
149739274|NCT04938648|540176264|FG000|Overall Study|Patient too ill|0|||
149739275|NCT04938648|540176265|FG001|Overall Study|Patient too ill|1|||
149739276|NCT04938648|540176264|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
149739277|NCT04938648|540176265|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
149739278|NCT04938648|540176264|FG000|Overall Study|Patient did not have memory problems|1|||
149739279|NCT04938648|540176265|FG001|Overall Study|Patient did not have memory problems|1|||
149739280|NCT04938648|540176264|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
150255929|NCT02663518|542072657|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
150255930|NCT02663518|542072658|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
150255931|NCT02663518|542072659|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255932|NCT02663518|542072660|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255933|NCT02663518|542072661|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255934|NCT02663518|542072662|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255935|NCT02663518|542072663|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255936|NCT02663518|542072664|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255937|NCT02663518|542072665|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255938|NCT02663518|542072666|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255939|NCT02663518|542072667|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255940|NCT02663518|542072668|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
150255941|NCT02663518|542072655|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
150255942|NCT02663518|542072656|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255943|NCT02663518|542072657|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
150255944|NCT02663518|542072658|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
150255945|NCT02663518|542072659|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255946|NCT02663518|542072660|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255947|NCT02663518|542072661|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255948|NCT02663518|542072662|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255949|NCT02663518|542072663|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255950|NCT02663518|542072664|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255951|NCT02663518|542072665|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255952|NCT02663518|542072666|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255953|NCT02663518|542072667|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255954|NCT02663518|542072668|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
150255955|NCT02663518|542072655|FG000|Part 1: Phase 1a Escalation|Other|0|||
150255956|NCT02663518|542072656|FG001|Part 1: Phase 1a Escalation|Other|0|||
150255957|NCT02663518|542072657|FG002|Part 1: Phase 1a Escalation|Other|2|||
150255958|NCT02663518|542072658|FG003|Part 1: Phase 1a Escalation|Other|0|||
150255959|NCT02663518|542072659|FG004|Part 1: Phase 1a Escalation|Other|0|||
150255960|NCT02663518|542072660|FG005|Part 1: Phase 1a Escalation|Other|0|||
150255961|NCT02663518|542072661|FG006|Part 1: Phase 1a Escalation|Other|0|||
150255962|NCT02663518|542072662|FG007|Part 1: Phase 1a Escalation|Other|0|||
150255963|NCT02663518|542072663|FG008|Part 1: Phase 1a Escalation|Other|0|||
150255964|NCT02663518|542072664|FG009|Part 1: Phase 1a Escalation|Other|0|||
149739281|NCT04938648|540176265|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
149739282|NCT04938648|540176264|FG000|Overall Study|Care partner could not be reached|0|||
149739283|NCT04938648|540176265|FG001|Overall Study|Care partner could not be reached|1|||
149739284|NCT04938648|540176264|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
149739285|NCT04938648|540176265|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
149739286|NCT04938648|540176264|FG000|Overall Study|Withdrawal by Subject|2|||
149739287|NCT04938648|540176265|FG001|Overall Study|Withdrawal by Subject|1|||
149739288|NCT00364793|540176266|FG000|Overall Study|Adverse Event|2|||
149739289|NCT00364793|540176267|FG001|Overall Study|Adverse Event|0|||
149739290|NCT00364793|540176268|FG002|Overall Study|Adverse Event|0|||
149739291|NCT00364793|540176269|FG003|Overall Study|Adverse Event|0|||
149739292|NCT00364793|540176266|FG000|Overall Study|Death|1|||
149739293|NCT00364793|540176267|FG001|Overall Study|Death|0|||
149739294|NCT00364793|540176268|FG002|Overall Study|Death|1|||
149739295|NCT00364793|540176269|FG003|Overall Study|Death|0|||
149739296|NCT00364793|540176266|FG000|Overall Study|Lack of Efficacy|3|||
149739297|NCT00364793|540176267|FG001|Overall Study|Lack of Efficacy|3|||
149739298|NCT00364793|540176268|FG002|Overall Study|Lack of Efficacy|1|||
149739299|NCT00364793|540176269|FG003|Overall Study|Lack of Efficacy|1|||
149739300|NCT00364793|540176266|FG000|Overall Study|Lost to Follow-up|1|||
149739301|NCT00364793|540176267|FG001|Overall Study|Lost to Follow-up|0|||
149739302|NCT00364793|540176268|FG002|Overall Study|Lost to Follow-up|2|||
149739303|NCT00364793|540176269|FG003|Overall Study|Lost to Follow-up|0|||
149739304|NCT00364793|540176266|FG000|Overall Study|Poor or non-compliance|1|||
149739305|NCT00364793|540176267|FG001|Overall Study|Poor or non-compliance|1|||
149739306|NCT00364793|540176268|FG002|Overall Study|Poor or non-compliance|0|||
149739307|NCT00364793|540176269|FG003|Overall Study|Poor or non-compliance|1|||
149739308|NCT00364793|540176266|FG000|Overall Study|No longer meets criteria|0|||
149739309|NCT00364793|540176267|FG001|Overall Study|No longer meets criteria|0|||
149739310|NCT00364793|540176268|FG002|Overall Study|No longer meets criteria|0|||
149739311|NCT00364793|540176269|FG003|Overall Study|No longer meets criteria|1|||
150255965|NCT02663518|542072665|FG010|Part 1: Phase 1a Escalation|Other|0|||
150255966|NCT02663518|542072666|FG011|Part 1: Phase 1a Escalation|Other|0|||
150255967|NCT02663518|542072667|FG012|Part 1: Phase 1a Escalation|Other|0|||
149739312|NCT00364793|540176266|FG000|Overall Study|Withdrawal by Subject|0|||
149739313|NCT00364793|540176267|FG001|Overall Study|Withdrawal by Subject|1|||
149739314|NCT00364793|540176268|FG002|Overall Study|Withdrawal by Subject|0|||
149739315|NCT00364793|540176269|FG003|Overall Study|Withdrawal by Subject|0|||
149739316|NCT00391976|540176270|FG000|Overall Study|Adverse Event|0|||
149739317|NCT00391976|540176271|FG001|Overall Study|Adverse Event|0|||
149739318|NCT00391976|540176272|FG002|Overall Study|Adverse Event|1|||
149739319|NCT00391976|540176270|FG000|Overall Study|Withdrawal of consent|0|||
149739320|NCT00391976|540176271|FG001|Overall Study|Withdrawal of consent|1|||
149739321|NCT00391976|540176272|FG002|Overall Study|Withdrawal of consent|1|||
149739322|NCT00391976|540176270|FG000|Overall Study|Lost to Follow-up|1|||
149739323|NCT00391976|540176271|FG001|Overall Study|Lost to Follow-up|2|||
149739324|NCT00391976|540176272|FG002|Overall Study|Lost to Follow-up|0|||
149739325|NCT00391976|540176270|FG000|Overall Study|Inappropriate enrollment|1|||
149739326|NCT00391976|540176271|FG001|Overall Study|Inappropriate enrollment|1|||
149739327|NCT00391976|540176272|FG002|Overall Study|Inappropriate enrollment|0|||
149739328|NCT00391976|540176270|FG000|Overall Study|Protocol deviation/violation|4|||
149739329|NCT00391976|540176271|FG001|Overall Study|Protocol deviation/violation|2|||
149739330|NCT00391976|540176272|FG002|Overall Study|Protocol deviation/violation|1|||
149739331|NCT00391976|540176270|FG000|Overall Study|Recurrence/no eradication of infection|21|||
149739332|NCT00391976|540176271|FG001|Overall Study|Recurrence/no eradication of infection|19|||
149739333|NCT00391976|540176272|FG002|Overall Study|Recurrence/no eradication of infection|0|||
149739334|NCT00391976|540176270|FG000|Overall Study|Unable to classify|0|||
149739335|NCT00391976|540176271|FG001|Overall Study|Unable to classify|0|||
149739336|NCT00391976|540176272|FG002|Overall Study|Unable to classify|1|||
149739337|NCT00391976|540176270|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
149739338|NCT00391976|540176271|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
149739339|NCT00391976|540176272|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
149739340|NCT05127486|540176273|FG000|Overall Study|Adverse Event|2|||
149739341|NCT05127486|540176274|FG001|Overall Study|Adverse Event|4|||
149739342|NCT05127486|540176273|FG000|Overall Study|Lack of Efficacy|1|||
149739343|NCT05127486|540176274|FG001|Overall Study|Lack of Efficacy|0|||
149739344|NCT05127486|540176273|FG000|Overall Study|Pregnancy|0|||
149739345|NCT05127486|540176274|FG001|Overall Study|Pregnancy|1|||
149739346|NCT05127486|540176273|FG000|Overall Study|Physician Decision|4|||
149739347|NCT05127486|540176274|FG001|Overall Study|Physician Decision|1|||
149739348|NCT05127486|540176273|FG000|Overall Study|Withdrawal by Subject|14|||
149739349|NCT05127486|540176274|FG001|Overall Study|Withdrawal by Subject|13|||
149739350|NCT05127486|540176273|FG000|Overall Study|Lost to Follow-up|5|||
149739351|NCT05127486|540176274|FG001|Overall Study|Lost to Follow-up|8|||
149739352|NCT00049127|540176275|FG000|Overall Study|Withdrawal by Subject|0|||
149739353|NCT00049127|540176276|FG001|Overall Study|Withdrawal by Subject|0|||
149739354|NCT00049127|540176277|FG002|Overall Study|Withdrawal by Subject|1|||
149739355|NCT00049127|540176278|FG003|Overall Study|Withdrawal by Subject|0|||
149739356|NCT00049127|540176279|FG004|Overall Study|Withdrawal by Subject|0|||
149739357|NCT02582515|540176282|FG000|Overall Study|Withdrawal by Subject|0|||
149739358|NCT02582515|540176283|FG001|Overall Study|Withdrawal by Subject|1|||
149739359|NCT01287754|540176287|FG000|Overall Study|Death|2|||
149739360|NCT01287754|540176288|FG001|Overall Study|Death|12|||
149739361|NCT01287754|540176287|FG000|Overall Study|Lost to Follow-up|1|||
149739362|NCT01287754|540176288|FG001|Overall Study|Lost to Follow-up|6|||
149739363|NCT01287754|540176287|FG000|Overall Study|Protocol Violation|0|||
149739364|NCT01287754|540176288|FG001|Overall Study|Protocol Violation|3|||
150255968|NCT02663518|542072668|FG013|Part 1: Phase 1a Escalation|Other|0|||
150255969|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255970|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255971|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255972|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255973|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
149739365|NCT05027802|540176299|FG000|Overall Study|Adverse Event|2|||
149739366|NCT05027802|540176299|FG000|Overall Study|Withdrawal by Subject|18|||
149739367|NCT05027802|540176299|FG000|Overall Study|Death|2|||
149739368|NCT05027802|540176299|FG000|Overall Study|Other|1|||
149739369|NCT00001337|540176300|FG000|Overall Study|Switched to alternate treatment|2|||
149739370|NCT00001337|540176301|FG001|Overall Study|Switched to alternate treatment|2|||
149739371|NCT00001337|540176302|FG002|Overall Study|Switched to alternate treatment|0|||
149739372|NCT00001337|540176300|FG000|Overall Study|Refused further treatment|2|||
149739373|NCT00001337|540176301|FG001|Overall Study|Refused further treatment|1|||
149739374|NCT00001337|540176302|FG002|Overall Study|Refused further treatment|0|||
149739375|NCT00001337|540176300|FG000|Overall Study|Began other Tx|1|||
149739376|NCT00001337|540176301|FG001|Overall Study|Began other Tx|0|||
150255974|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255975|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
149739377|NCT00001337|540176302|FG002|Overall Study|Began other Tx|0|||
149739378|NCT00001337|540176300|FG000|Overall Study|Physician Decision|3|||
149739379|NCT00001337|540176301|FG001|Overall Study|Physician Decision|1|||
149739380|NCT00001337|540176302|FG002|Overall Study|Physician Decision|0|||
149739381|NCT00001337|540176300|FG000|Overall Study|Doesn't have NHL|0|||
149739382|NCT00001337|540176301|FG001|Overall Study|Doesn't have NHL|1|||
149739383|NCT00001337|540176302|FG002|Overall Study|Doesn't have NHL|0|||
150255976|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
149739384|NCT00001337|540176300|FG000|Overall Study|Non protocol tx needed|3|||
149739385|NCT00001337|540176301|FG001|Overall Study|Non protocol tx needed|1|||
149739386|NCT00001337|540176302|FG002|Overall Study|Non protocol tx needed|0|||
149739387|NCT00001337|540176300|FG000|Overall Study|Protocol change|1|||
149739388|NCT00001337|540176301|FG001|Overall Study|Protocol change|0|||
149739389|NCT00001337|540176302|FG002|Overall Study|Protocol change|0|||
149739390|NCT00001337|540176300|FG000|Overall Study|2nd primary disease|0|||
149739391|NCT00001337|540176301|FG001|Overall Study|2nd primary disease|0|||
149739392|NCT00001337|540176302|FG002|Overall Study|2nd primary disease|1|||
149739393|NCT00001337|540176300|FG000|Overall Study|Death during follow up period|9|||
149739394|NCT00001337|540176301|FG001|Overall Study|Death during follow up period|4|||
149739395|NCT00001337|540176302|FG002|Overall Study|Death during follow up period|0|||
149739396|NCT00001337|540176300|FG000|Overall Study|Death on study|19|||
149739397|NCT00001337|540176301|FG001|Overall Study|Death on study|9|||
149739398|NCT00001337|540176302|FG002|Overall Study|Death on study|0|||
149739399|NCT00001337|540176300|FG000|Overall Study|Disease progression during follow-up period|3|||
149739400|NCT00001337|540176301|FG001|Overall Study|Disease progression during follow-up period|1|||
149739401|NCT00001337|540176302|FG002|Overall Study|Disease progression during follow-up period|0|||
149739402|NCT00001337|540176300|FG000|Overall Study|Disease progression on study|33|||
149739403|NCT00001337|540176301|FG001|Overall Study|Disease progression on study|41|||
149739404|NCT00001337|540176302|FG002|Overall Study|Disease progression on study|0|||
149739405|NCT00001337|540176300|FG000|Overall Study|Lost to further follow-up|10|||
149739406|NCT00001337|540176301|FG001|Overall Study|Lost to further follow-up|6|||
149739407|NCT00001337|540176302|FG002|Overall Study|Lost to further follow-up|0|||
149739408|NCT00001337|540176300|FG000|Overall Study|2nd malignancy|1|||
149739409|NCT00001337|540176301|FG001|Overall Study|2nd malignancy|0|||
149739410|NCT00001337|540176302|FG002|Overall Study|2nd malignancy|0|||
149739411|NCT00001337|540176300|FG000|Overall Study|Treatment for second lymphoma|0|||
149739412|NCT00001337|540176301|FG001|Overall Study|Treatment for second lymphoma|1|||
149739413|NCT00001337|540176302|FG002|Overall Study|Treatment for second lymphoma|0|||
149739414|NCT00001337|540176300|FG000|Overall Study|Transfer to transplant|0|||
149739415|NCT00001337|540176301|FG001|Overall Study|Transfer to transplant|1|||
149739416|NCT00001337|540176302|FG002|Overall Study|Transfer to transplant|0|||
149739417|NCT05817045|540176307|FG000|Overall Study|Protocol Violation|0|||
149739418|NCT05817045|540176308|FG001|Overall Study|Protocol Violation|3|||
149739419|NCT05817045|540176307|FG000|Overall Study|Withdrawal by Subject|10|||
149739420|NCT05817045|540176308|FG001|Overall Study|Withdrawal by Subject|7|||
149739421|NCT05817045|540176307|FG000|Overall Study|Physician Decision|3|||
149739422|NCT05817045|540176308|FG001|Overall Study|Physician Decision|0|||
149739423|NCT05817045|540176307|FG000|Overall Study|Lost to Follow-up|0|||
149739424|NCT05817045|540176308|FG001|Overall Study|Lost to Follow-up|1|||
149739425|NCT05817045|540176307|FG000|Overall Study|Device Deficiency|1|||
149739426|NCT05817045|540176308|FG001|Overall Study|Device Deficiency|0|||
149739427|NCT05817045|540176307|FG000|Overall Study|System Error|1|||
149739428|NCT05817045|540176308|FG001|Overall Study|System Error|0|||
149739429|NCT02688647|540176309|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
149739430|NCT02688647|540176310|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
149739431|NCT02688647|540176309|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
149739432|NCT02688647|540176310|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
149739433|NCT02688647|540176309|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
149739434|NCT02688647|540176310|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
149739435|NCT02688647|540176309|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
149739436|NCT02688647|540176310|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
149739437|NCT02688647|540176309|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
149739438|NCT02688647|540176310|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
149739439|NCT02688647|540176309|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
149739440|NCT02688647|540176310|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
149739441|NCT02688647|540176309|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
149739442|NCT02688647|540176310|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
149739443|NCT03619213|540176311|FG000|Overall Study|Lost to Follow-up|2|||
149739444|NCT03619213|540176312|FG001|Overall Study|Lost to Follow-up|1|||
149739445|NCT03619213|540176311|FG000|Overall Study|Withdrawal by Subject|8|||
149739446|NCT03619213|540176312|FG001|Overall Study|Withdrawal by Subject|10|||
149739447|NCT02886702|540176313|FG000|Overall Study|Other|4|||
149739448|NCT02886702|540176314|FG001|Overall Study|Other|3|||
149739449|NCT02886702|540176315|FG002|Overall Study|Other|9|||
149739450|NCT02886702|540176313|FG000|Overall Study|Withdrawal by Subject|24|||
149739451|NCT02886702|540176314|FG001|Overall Study|Withdrawal by Subject|18|||
149739452|NCT02886702|540176315|FG002|Overall Study|Withdrawal by Subject|22|||
149739453|NCT02886702|540176313|FG000|Overall Study|Significant Worsening of Condition|0|||
149739454|NCT02886702|540176314|FG001|Overall Study|Significant Worsening of Condition|1|||
149739455|NCT02886702|540176315|FG002|Overall Study|Significant Worsening of Condition|0|||
149739456|NCT02886702|540176313|FG000|Overall Study|Protocol Violation|2|||
149739457|NCT02886702|540176314|FG001|Overall Study|Protocol Violation|2|||
149739458|NCT02886702|540176315|FG002|Overall Study|Protocol Violation|1|||
149739459|NCT02886702|540176313|FG000|Overall Study|Non-Compliance With Study Drug|0|||
150255977|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255978|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
149739460|NCT02886702|540176314|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149739461|NCT02886702|540176315|FG002|Overall Study|Non-Compliance With Study Drug|4|||
149739462|NCT02886702|540176313|FG000|Overall Study|Lost to Follow-up|11|||
149739463|NCT02886702|540176314|FG001|Overall Study|Lost to Follow-up|13|||
149739464|NCT02886702|540176315|FG002|Overall Study|Lost to Follow-up|8|||
149739465|NCT02886702|540176313|FG000|Overall Study|Lack of Efficacy|3|||
149739466|NCT02886702|540176314|FG001|Overall Study|Lack of Efficacy|4|||
149739467|NCT02886702|540176315|FG002|Overall Study|Lack of Efficacy|5|||
149739468|NCT02886702|540176313|FG000|Overall Study|Adverse Event|4|||
149739469|NCT02886702|540176314|FG001|Overall Study|Adverse Event|9|||
149739470|NCT02886702|540176315|FG002|Overall Study|Adverse Event|3|||
149739471|NCT02886702|540176313|FG000|Overall Study|Administrative Reasons|0|||
149739472|NCT02886702|540176314|FG001|Overall Study|Administrative Reasons|0|||
149739473|NCT02886702|540176315|FG002|Overall Study|Administrative Reasons|1|||
149739474|NCT01147497|540176319|FG000|Overall Study|failed insertion|2|||
149739475|NCT01147497|540176320|FG001|Overall Study|failed insertion|0|||
149739476|NCT04026568|540176323|FG000|Overall Study|study terminated|0|||
149739477|NCT04026568|540176324|FG001|Overall Study|study terminated|1|||
149739478|NCT00331760|540176325|FG000|Overall Study|Ineligible / no protocol treatment|15|||
149739479|NCT00331760|540176326|FG001|Overall Study|Ineligible / no protocol treatment|8|||
149739480|NCT03417440|540176328|FG000|Overall Study|Lost to Follow-up|0|||
149739481|NCT03417440|540176329|FG001|Overall Study|Lost to Follow-up|1|||
149739482|NCT03417440|540176330|FG002|Overall Study|Lost to Follow-up|0|||
149739483|NCT03417440|540176331|FG003|Overall Study|Lost to Follow-up|0|||
149739484|NCT03417440|540176332|FG004|Overall Study|Lost to Follow-up|1|||
149739485|NCT03417440|540176333|FG005|Overall Study|Lost to Follow-up|0|||
149739486|NCT03417440|540176334|FG006|Overall Study|Lost to Follow-up|0|||
149739487|NCT03417440|540176335|FG007|Overall Study|Lost to Follow-up|0|||
149739488|NCT03417440|540176328|FG000|Overall Study|Withdrawal by Subject|2|||
149739489|NCT03417440|540176329|FG001|Overall Study|Withdrawal by Subject|0|||
149739490|NCT03417440|540176330|FG002|Overall Study|Withdrawal by Subject|2|||
149739491|NCT03417440|540176331|FG003|Overall Study|Withdrawal by Subject|1|||
149739492|NCT03417440|540176332|FG004|Overall Study|Withdrawal by Subject|1|||
149739493|NCT03417440|540176333|FG005|Overall Study|Withdrawal by Subject|0|||
149739494|NCT03417440|540176334|FG006|Overall Study|Withdrawal by Subject|0|||
149739495|NCT03417440|540176335|FG007|Overall Study|Withdrawal by Subject|1|||
149739496|NCT02786901|540176336|FG000|Overall Study|Adverse Event|1|||
149739497|NCT02786901|540176337|FG001|Overall Study|Adverse Event|1|||
149739498|NCT02786901|540176338|FG002|Overall Study|Adverse Event|2|||
149739499|NCT02786901|540176336|FG000|Overall Study|Physician Decision|1|||
149739500|NCT02786901|540176337|FG001|Overall Study|Physician Decision|0|||
149739501|NCT02786901|540176338|FG002|Overall Study|Physician Decision|0|||
149739502|NCT02786901|540176336|FG000|Overall Study|Rescue Therapy Use|71|||
149739503|NCT02786901|540176337|FG001|Overall Study|Rescue Therapy Use|49|||
149739504|NCT02786901|540176338|FG002|Overall Study|Rescue Therapy Use|33|||
150255979|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255980|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255981|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
149739505|NCT02786901|540176336|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
149739506|NCT02786901|540176337|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
149739507|NCT02786901|540176338|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
149739508|NCT02786901|540176336|FG000|Overall Study|Disallowed medication|1|||
149739509|NCT02786901|540176337|FG001|Overall Study|Disallowed medication|1|||
149739510|NCT02786901|540176338|FG002|Overall Study|Disallowed medication|0|||
149739511|NCT02786901|540176336|FG000|Overall Study|Randomized in error|2|||
149739512|NCT02786901|540176337|FG001|Overall Study|Randomized in error|0|||
149739513|NCT02786901|540176338|FG002|Overall Study|Randomized in error|1|||
149739514|NCT00607048|540176340|FG000|Overall Study|Adverse Event|0|||
149739515|NCT00607048|540176341|FG001|Overall Study|Adverse Event|1|||
150255982|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
150255983|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255984|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255985|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255986|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255987|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
150255988|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255989|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
150255990|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
150255991|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255992|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255993|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149739516|NCT00607048|540176342|FG002|Overall Study|Adverse Event|0|||
149739517|NCT00607048|540176343|FG003|Overall Study|Adverse Event|0|||
149739518|NCT00607048|540176344|FG004|Overall Study|Adverse Event|4|||
149739519|NCT00607048|540176345|FG005|Overall Study|Adverse Event|0|||
149739520|NCT00607048|540176340|FG000|Overall Study|Global deterioration of health|1|||
149739521|NCT00607048|540176341|FG001|Overall Study|Global deterioration of health|0|||
149739522|NCT00607048|540176342|FG002|Overall Study|Global deterioration of health|0|||
149739523|NCT00607048|540176343|FG003|Overall Study|Global deterioration of health|0|||
149739524|NCT00607048|540176344|FG004|Overall Study|Global deterioration of health|0|||
149739525|NCT00607048|540176345|FG005|Overall Study|Global deterioration of health|0|||
149739526|NCT00607048|540176340|FG000|Overall Study|Objective disease progression - relapse|1|||
149739527|NCT00607048|540176341|FG001|Overall Study|Objective disease progression - relapse|2|||
149739528|NCT00607048|540176342|FG002|Overall Study|Objective disease progression - relapse|4|||
149739529|NCT00607048|540176343|FG003|Overall Study|Objective disease progression - relapse|2|||
149739530|NCT00607048|540176344|FG004|Overall Study|Objective disease progression - relapse|2|||
149739531|NCT00607048|540176345|FG005|Overall Study|Objective disease progression - relapse|2|||
149739532|NCT00607048|540176340|FG000|Overall Study|Withdrawal by Subject|0|||
149739533|NCT00607048|540176341|FG001|Overall Study|Withdrawal by Subject|0|||
149739534|NCT00607048|540176342|FG002|Overall Study|Withdrawal by Subject|0|||
149739535|NCT00607048|540176343|FG003|Overall Study|Withdrawal by Subject|1|||
149739536|NCT00607048|540176344|FG004|Overall Study|Withdrawal by Subject|0|||
149739537|NCT00607048|540176345|FG005|Overall Study|Withdrawal by Subject|2|||
149739538|NCT00607048|540176340|FG000|Overall Study|Other|1|||
149739539|NCT00607048|540176341|FG001|Overall Study|Other|1|||
149739540|NCT00607048|540176342|FG002|Overall Study|Other|0|||
149739541|NCT00607048|540176343|FG003|Overall Study|Other|0|||
149739542|NCT00607048|540176344|FG004|Overall Study|Other|0|||
149739543|NCT00607048|540176345|FG005|Overall Study|Other|1|||
149739544|NCT01451645|540176348|FG000|Overall Study|Protocol Violation|1|||
149739545|NCT01451645|540176349|FG001|Overall Study|Protocol Violation|0|||
149739546|NCT01451645|540176348|FG000|Overall Study|Adverse Event|0|||
149739547|NCT01451645|540176349|FG001|Overall Study|Adverse Event|3|||
149739548|NCT01451645|540176348|FG000|Overall Study|Withdrawal by Subject|4|||
149739549|NCT01451645|540176349|FG001|Overall Study|Withdrawal by Subject|2|||
149739550|NCT01451645|540176348|FG000|Overall Study|Lost to Follow-up|4|||
149739551|NCT01451645|540176349|FG001|Overall Study|Lost to Follow-up|3|||
149739552|NCT03663166|540176350|FG000|Overall Study|Withdrawal by Subject|1|||
149739553|NCT02561156|540176357|FG000|Part 2|Adverse Event|0|||
149739554|NCT02561156|540176358|FG001|Part 2|Adverse Event|0|||
149739555|NCT02561156|540176359|FG002|Part 2|Adverse Event|0|||
149739556|NCT02561156|540176360|FG003|Part 2|Adverse Event|0|||
149739557|NCT02561156|540176361|FG004|Part 2|Adverse Event|0|||
149739558|NCT02561156|540176362|FG005|Part 2|Adverse Event|0|||
149739559|NCT02561156|540176363|FG006|Part 2|Adverse Event|0|||
149739560|NCT02561156|540176364|FG007|Part 2|Adverse Event|0|||
149739561|NCT02561156|540176365|FG008|Part 2|Adverse Event|0|||
149739562|NCT02561156|540176366|FG009|Part 2|Adverse Event|0|||
149739563|NCT02561156|540176367|FG010|Part 2|Adverse Event|0|||
149739564|NCT02561156|540176368|FG011|Part 2|Adverse Event|1|||
149739565|NCT02561156|540176369|FG012|Part 2|Adverse Event|0|||
149739566|NCT01071070|540176370|FG000|Overall Study|Adverse Event|0|||
149739567|NCT01071070|540176371|FG001|Overall Study|Adverse Event|3|||
149739568|NCT01071070|540176370|FG000|Overall Study|Withdrawal by Subject|1|||
149739569|NCT01071070|540176371|FG001|Overall Study|Withdrawal by Subject|0|||
149739570|NCT01071070|540176370|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
149739571|NCT01071070|540176371|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
149739572|NCT01071070|540176370|FG000|Overall Study|Hypercalcemia|1|||
149739573|NCT01071070|540176371|FG001|Overall Study|Hypercalcemia|0|||
149739574|NCT00158184|540176372|FG000|Overall Study|personal issues|3|||
149739575|NCT00158184|540176373|FG001|Overall Study|personal issues|1|||
149739576|NCT00158184|540176372|FG000|Overall Study|failed for follow unit/study rules|2|||
150255994|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149739577|NCT00158184|540176373|FG001|Overall Study|failed for follow unit/study rules|0|||
149739578|NCT00158184|540176372|FG000|Overall Study|Adverse Event|1|||
149739579|NCT00158184|540176373|FG001|Overall Study|Adverse Event|1|||
149739580|NCT02393209|540176374|FG000|Overall Study|Study Terminated by Sponsor|1|||
149739581|NCT02393209|540176375|FG001|Overall Study|Study Terminated by Sponsor|1|||
150255995|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149739582|NCT02393209|540176376|FG002|Overall Study|Study Terminated by Sponsor|0|||
149739583|NCT02393209|540176377|FG003|Overall Study|Study Terminated by Sponsor|0|||
149739584|NCT02393209|540176374|FG000|Overall Study|Withdrawal by Patient|1|||
149739585|NCT02393209|540176375|FG001|Overall Study|Withdrawal by Patient|0|||
149739586|NCT02393209|540176376|FG002|Overall Study|Withdrawal by Patient|0|||
149739587|NCT02393209|540176377|FG003|Overall Study|Withdrawal by Patient|0|||
149739588|NCT02393209|540176374|FG000|Overall Study|Death|2|||
149739589|NCT02393209|540176375|FG001|Overall Study|Death|2|||
149739590|NCT02393209|540176376|FG002|Overall Study|Death|0|||
149739591|NCT02393209|540176377|FG003|Overall Study|Death|0|||
149739592|NCT02393209|540176374|FG000|Overall Study|Death due to Disease Progression|2|||
149739593|NCT02393209|540176375|FG001|Overall Study|Death due to Disease Progression|2|||
149739594|NCT02393209|540176376|FG002|Overall Study|Death due to Disease Progression|0|||
149739595|NCT02393209|540176377|FG003|Overall Study|Death due to Disease Progression|0|||
149739596|NCT02393209|540176374|FG000|Overall Study|Death from Legionella Infection|0|||
149739597|NCT02393209|540176375|FG001|Overall Study|Death from Legionella Infection|1|||
149739598|NCT02393209|540176376|FG002|Overall Study|Death from Legionella Infection|0|||
149739599|NCT02393209|540176377|FG003|Overall Study|Death from Legionella Infection|0|||
149739600|NCT02393209|540176374|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
149739601|NCT02393209|540176375|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
149739602|NCT02393209|540176376|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
149739603|NCT02393209|540176377|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
149739604|NCT02393209|540176374|FG000|Overall Study|Lost to Follow-up|0|||
149739605|NCT02393209|540176375|FG001|Overall Study|Lost to Follow-up|1|||
149739606|NCT02393209|540176376|FG002|Overall Study|Lost to Follow-up|0|||
149739607|NCT02393209|540176377|FG003|Overall Study|Lost to Follow-up|0|||
149739608|NCT00727402|540176378|FG000|Overall Study|Physician Decision|116|||
149739609|NCT03545282|540176379|FG000|Overall Study|Lost to Follow-up|15|||
149739610|NCT03545282|540176380|FG001|Overall Study|Lost to Follow-up|10|||
149739611|NCT03545282|540176379|FG000|Overall Study|Withdrawal by Subject|2|||
149739612|NCT03545282|540176380|FG001|Overall Study|Withdrawal by Subject|2|||
149739613|NCT02582671|540176381|FG000|Overall Study|Failure to return|1|||
149739614|NCT02582671|540176381|FG000|Overall Study|Other, not specified|1|||
149739615|NCT02537678|540176382|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
149739616|NCT02537678|540176383|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
149739617|NCT02537678|540176382|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
149739618|NCT02537678|540176383|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
149739619|NCT02537678|540176382|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
149739620|NCT02537678|540176383|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
149739621|NCT02537678|540176382|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
149739622|NCT02537678|540176383|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
149739623|NCT02537678|540176382|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
149739624|NCT02537678|540176383|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
149739625|NCT02537678|540176382|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
149739626|NCT02537678|540176383|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
149739627|NCT02537678|540176382|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
149739628|NCT02537678|540176383|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
149739629|NCT01147809|540176384|FG000|Phase I (168 Days)|Adverse Event|0|||
149739630|NCT01147809|540176385|FG001|Phase I (168 Days)|Adverse Event|0|||
149739631|NCT01147809|540176386|FG002|Phase I (168 Days)|Adverse Event|0|||
149739632|NCT01147809|540176387|FG003|Phase I (168 Days)|Adverse Event|1|||
149739633|NCT01147809|540176388|FG004|Phase I (168 Days)|Adverse Event|0|||
149739634|NCT01147809|540176389|FG005|Phase I (168 Days)|Adverse Event|0|||
149739635|NCT01147809|540176384|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
149739636|NCT01147809|540176385|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
149739637|NCT01147809|540176386|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
149739638|NCT01147809|540176387|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
149739639|NCT01147809|540176388|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
149739640|NCT01147809|540176389|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
149739641|NCT01147809|540176384|FG000|Phase I (168 Days)|Physician Decision|0|||
149739642|NCT01147809|540176385|FG001|Phase I (168 Days)|Physician Decision|1|||
149739643|NCT01147809|540176386|FG002|Phase I (168 Days)|Physician Decision|2|||
149739644|NCT01147809|540176387|FG003|Phase I (168 Days)|Physician Decision|0|||
149739645|NCT01147809|540176388|FG004|Phase I (168 Days)|Physician Decision|0|||
149739646|NCT01147809|540176389|FG005|Phase I (168 Days)|Physician Decision|0|||
149739647|NCT01147809|540176384|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
149739648|NCT01147809|540176385|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
149739649|NCT01147809|540176386|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
149739650|NCT01147809|540176387|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
149739651|NCT01147809|540176388|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
149739652|NCT01147809|540176389|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
149739653|NCT01147809|540176384|FG000|Phase II (168 Days)|Adverse Event|0|||
149739654|NCT01147809|540176385|FG001|Phase II (168 Days)|Adverse Event|0|||
149739655|NCT01147809|540176386|FG002|Phase II (168 Days)|Adverse Event|0|||
149739656|NCT01147809|540176387|FG003|Phase II (168 Days)|Adverse Event|0|||
149739657|NCT01147809|540176388|FG004|Phase II (168 Days)|Adverse Event|3|||
149739658|NCT01147809|540176389|FG005|Phase II (168 Days)|Adverse Event|6|||
149739659|NCT01147809|540176384|FG000|Phase II (168 Days)|Protocol Violation|0|||
149739660|NCT01147809|540176385|FG001|Phase II (168 Days)|Protocol Violation|0|||
149739661|NCT01147809|540176386|FG002|Phase II (168 Days)|Protocol Violation|0|||
149739662|NCT01147809|540176387|FG003|Phase II (168 Days)|Protocol Violation|0|||
149739663|NCT01147809|540176388|FG004|Phase II (168 Days)|Protocol Violation|0|||
149739664|NCT01147809|540176389|FG005|Phase II (168 Days)|Protocol Violation|1|||
149739665|NCT01147809|540176384|FG000|Phase II (168 Days)|Physician Decision|0|||
149739666|NCT01147809|540176385|FG001|Phase II (168 Days)|Physician Decision|0|||
149739667|NCT01147809|540176386|FG002|Phase II (168 Days)|Physician Decision|0|||
149739668|NCT01147809|540176387|FG003|Phase II (168 Days)|Physician Decision|0|||
149739669|NCT01147809|540176388|FG004|Phase II (168 Days)|Physician Decision|5|||
149739670|NCT01147809|540176389|FG005|Phase II (168 Days)|Physician Decision|11|||
149739671|NCT01147809|540176384|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
149739672|NCT01147809|540176385|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
149739673|NCT01147809|540176386|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
149739674|NCT01147809|540176387|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
149739675|NCT01147809|540176388|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
149739676|NCT01147809|540176389|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
149739677|NCT01147809|540176384|FG000|Phase II (168 Days)|Ongoing|0|||
149739678|NCT01147809|540176385|FG001|Phase II (168 Days)|Ongoing|0|||
149739679|NCT01147809|540176386|FG002|Phase II (168 Days)|Ongoing|0|||
149739680|NCT01147809|540176387|FG003|Phase II (168 Days)|Ongoing|0|||
149739681|NCT01147809|540176388|FG004|Phase II (168 Days)|Ongoing|1|||
149739682|NCT01147809|540176389|FG005|Phase II (168 Days)|Ongoing|0|||
149739683|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
149739684|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
149739685|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
149739686|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739687|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739688|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739689|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739690|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739691|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149739692|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
149739693|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
149739694|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
149739695|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739696|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739697|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739698|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739699|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739700|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149739701|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
149739702|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
149739703|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
149739704|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739705|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739706|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739707|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739708|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739709|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149739710|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739711|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739712|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
149739713|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739714|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739715|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739716|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739717|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739718|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149739719|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
149739720|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
149739721|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
149739722|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739723|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739724|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739725|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739726|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739727|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149739728|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
149739729|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739730|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739731|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739732|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739733|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739734|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739735|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739736|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149739737|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
149739738|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
149739739|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739740|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739741|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739742|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739743|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739744|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739745|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149739746|NCT01307423|540176390|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739747|NCT01307423|540176391|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
149739748|NCT01307423|540176392|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
149739749|NCT01307423|540176393|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739750|NCT01307423|540176394|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739751|NCT01307423|540176395|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739752|NCT01307423|540176396|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739753|NCT01307423|540176397|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739754|NCT01307423|540176398|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149739755|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149739756|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
149739757|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
149739758|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
149739759|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
149739760|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149739761|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149739762|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149739763|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149739764|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149739765|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
149739766|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
149739767|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
149739768|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
149739769|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149739770|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149739771|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149739772|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149739773|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739774|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739775|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739776|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739777|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739778|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
149739779|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739780|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739781|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149739782|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149739783|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
149739784|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
149739785|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149739786|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149739787|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
149739788|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
149739789|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149739790|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149739791|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739792|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739793|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739794|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
149739795|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739796|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739797|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739798|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739799|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149739800|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
149739801|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
149739802|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
149739803|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
149739804|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
149739805|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
149739806|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
149739807|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
149739808|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
149739809|NCT01307423|540176390|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739810|NCT01307423|540176391|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739811|NCT01307423|540176392|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739812|NCT01307423|540176393|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739813|NCT01307423|540176394|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739814|NCT01307423|540176395|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
149739815|NCT01307423|540176396|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739816|NCT01307423|540176397|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739817|NCT01307423|540176398|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149739818|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149739819|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
149739820|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
149739821|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149739822|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149739823|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149739824|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149739825|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
149739826|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
149739827|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149739828|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
149739829|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
149739830|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149739831|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149739832|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149739833|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149739834|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
149739835|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
149739836|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739837|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739838|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
149739839|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739840|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739841|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739842|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739843|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739844|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149739845|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149739846|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
149739847|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
149739848|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149739849|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149739850|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149739851|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149739852|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
149739853|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
149739854|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149739855|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149739856|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149739857|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149739858|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149739859|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
150255996|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
150255997|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150255998|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149739860|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149739861|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149739862|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149739863|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149739864|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
149739865|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
149739866|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149739867|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149739868|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149739869|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149739870|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
149739871|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
149739872|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149739873|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
149739874|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
149739875|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149739876|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149739877|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149739878|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149739879|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
149739880|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
149739881|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739882|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
149739883|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
149739884|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739885|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739886|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739887|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739888|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739889|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149739890|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149739891|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
149739892|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
149739893|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149739894|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149739895|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149739896|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149739897|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
149739898|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
149739899|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149739900|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
149739901|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
149739902|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149739903|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149739904|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149739905|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149739906|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
149739907|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
149739908|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739909|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
149739910|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739911|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739912|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739913|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739914|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739915|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
149739916|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149739917|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739918|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
149739919|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739920|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739921|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739922|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739923|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739924|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739925|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149739926|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739927|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
149739928|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739929|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739930|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739931|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739932|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739933|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149739934|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
149739935|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149739936|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
149739937|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
149739938|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149739939|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149739940|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149739941|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149739942|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
149739943|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
149739944|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739945|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739946|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
149739947|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739948|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739949|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739950|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739951|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739952|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149739953|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739954|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739955|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739956|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739957|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739958|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739959|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739960|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
149739961|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149739962|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739963|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149739964|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149739965|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739966|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739967|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739968|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739969|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149739970|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149739971|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739972|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
149739973|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
149739974|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739975|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739976|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739977|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739978|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739979|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149739980|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739981|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
149739982|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
149739983|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739984|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739985|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739986|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739987|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149739988|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
149739989|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739990|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
149739991|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739992|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739993|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739994|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739995|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739996|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739997|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149739998|NCT01307423|540176390|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149739999|NCT01307423|540176391|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149740000|NCT01307423|540176392|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
149740001|NCT01307423|540176393|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149740002|NCT01307423|540176394|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149740003|NCT01307423|540176395|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149740004|NCT01307423|540176396|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149740005|NCT01307423|540176397|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
149740006|NCT01307423|540176398|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
149740007|NCT02500537|540176399|FG000|Overall Study|Death|2|||
149740008|NCT02500537|540176400|FG001|Overall Study|Death|0|||
149740009|NCT02500537|540176399|FG000|Overall Study|Lost to Follow-up|0|||
149740010|NCT02500537|540176400|FG001|Overall Study|Lost to Follow-up|1|||
149740011|NCT02500537|540176399|FG000|Overall Study|Withdrawal by Subject|1|||
149740012|NCT02500537|540176400|FG001|Overall Study|Withdrawal by Subject|0|||
149740013|NCT01587989|540176401|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
149740014|NCT01587989|540176402|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
149740015|NCT01587989|540176403|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
149740016|NCT01587989|540176401|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
149740017|NCT01587989|540176402|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
149740018|NCT01587989|540176403|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
149740019|NCT01587989|540176401|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
149740020|NCT01587989|540176402|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
149740021|NCT01587989|540176403|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
149740022|NCT01587989|540176401|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
149740023|NCT01587989|540176402|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
149740024|NCT01587989|540176403|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
149740025|NCT01587989|540176401|FG000|Randomized Study Treatment|Screening failure|0|||
149740026|NCT01587989|540176402|FG001|Randomized Study Treatment|Screening failure|1|||
149740027|NCT01587989|540176403|FG002|Randomized Study Treatment|Screening failure|0|||
149740028|NCT01587989|540176401|FG000|Randomized Study Treatment|Physician Decision|0|||
149740029|NCT01587989|540176402|FG001|Randomized Study Treatment|Physician Decision|0|||
149740030|NCT01587989|540176403|FG002|Randomized Study Treatment|Physician Decision|1|||
149740031|NCT06119191|540176404|FG000|Overall Study|Adverse Event|0|||
149740032|NCT06119191|540176405|FG001|Overall Study|Adverse Event|1|||
149740033|NCT06119191|540176404|FG000|Overall Study|Protocol Violation|1|||
149740034|NCT06119191|540176405|FG001|Overall Study|Protocol Violation|0|||
149740035|NCT05630846|540178996|FG000|Overall Study|Death|1|||
149740036|NCT05630846|540178997|FG001|Overall Study|Death|0|||
149740037|NCT05630846|540178998|FG002|Overall Study|Death|0|||
149740038|NCT05630846|540178999|FG003|Overall Study|Death|0|||
149740039|NCT05630846|540178996|FG000|Overall Study|Withdrawal by Subject|3|||
149740040|NCT05630846|540178997|FG001|Overall Study|Withdrawal by Subject|3|||
149740041|NCT05630846|540178998|FG002|Overall Study|Withdrawal by Subject|4|||
149740042|NCT05630846|540178999|FG003|Overall Study|Withdrawal by Subject|1|||
149740043|NCT05630846|540178996|FG000|Overall Study|Lost to Follow-up|6|||
149740044|NCT05630846|540178997|FG001|Overall Study|Lost to Follow-up|5|||
149740045|NCT05630846|540178998|FG002|Overall Study|Lost to Follow-up|2|||
149740046|NCT05630846|540178999|FG003|Overall Study|Lost to Follow-up|5|||
149740047|NCT05630846|540178996|FG000|Overall Study|Other|1|||
149740048|NCT05630846|540178997|FG001|Overall Study|Other|0|||
149740049|NCT05630846|540178998|FG002|Overall Study|Other|0|||
149740050|NCT05630846|540178999|FG003|Overall Study|Other|0|||
149740051|NCT01056107|540179001|FG000|Overall Study|Withdrawal by Subject|0|||
149740052|NCT01056107|540179002|FG001|Overall Study|Withdrawal by Subject|1|||
149740053|NCT01056107|540179003|FG002|Overall Study|Withdrawal by Subject|3|||
149740054|NCT01056107|540179004|FG003|Overall Study|Withdrawal by Subject|0|||
149740055|NCT00496366|540179011|FG000|Overall Study|Death|1|||
149740056|NCT00260208|540179015|FG000|Overall Study|Subject withdrew consent|11|||
149740057|NCT00260208|540179016|FG001|Overall Study|Subject withdrew consent|7|||
149740058|NCT00260208|540179015|FG000|Overall Study|Lost to Follow-up|6|||
149740059|NCT00260208|540179016|FG001|Overall Study|Lost to Follow-up|1|||
149740060|NCT00260208|540179015|FG000|Overall Study|Death|12|||
149740061|NCT00260208|540179016|FG001|Overall Study|Death|10|||
149740062|NCT00260208|540179015|FG000|Overall Study|Missing|18|||
149740063|NCT00260208|540179016|FG001|Overall Study|Missing|16|||
149740064|NCT02091440|540179017|FG000|Overall Study|Death|2|||
149740065|NCT00768222|540179018|FG000|Overall Study|Lost to Follow-up|1|||
149740066|NCT00768222|540179019|FG001|Overall Study|Lost to Follow-up|1|||
149740067|NCT00768222|540179018|FG000|Overall Study|Withdrawal by Subject|3|||
149740068|NCT00768222|540179019|FG001|Overall Study|Withdrawal by Subject|1|||
149740069|NCT00768222|540179018|FG000|Overall Study|Protocol Violation|0|||
149740070|NCT00768222|540179019|FG001|Overall Study|Protocol Violation|2|||
149740071|NCT03323749|540179026|FG000|Double-blind Period|Lost to Follow-up|4|||
149740072|NCT03323749|540179027|FG001|Double-blind Period|Lost to Follow-up|5|||
149740073|NCT03323749|540179026|FG000|Double-blind Period|Adverse Event|3|||
149740074|NCT03323749|540179027|FG001|Double-blind Period|Adverse Event|1|||
149740075|NCT03323749|540179026|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
149740076|NCT03323749|540179027|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
149740077|NCT03323749|540179026|FG000|Open-Label Period|Adverse Event|3|||
149740078|NCT03323749|540179027|FG001|Open-Label Period|Adverse Event|10|||
149740079|NCT03323749|540179026|FG000|Open-Label Period|Withdrawal by Subject|7|||
149740080|NCT03323749|540179027|FG001|Open-Label Period|Withdrawal by Subject|5|||
149740081|NCT03263091|540179029|FG000|OL Component|Withdrawal by Subject|1|||
149740082|NCT03263091|540179030|FG001|OL Component|Withdrawal by Subject|1|||
149740083|NCT03263091|540179031|FG002|OL Component|Withdrawal by Subject|0|||
149740084|NCT03263091|540179032|FG003|OL Component|Withdrawal by Subject|0|||
149740085|NCT03263091|540179033|FG004|OL Component|Withdrawal by Subject|0|||
149740086|NCT03263091|540179034|FG005|OL Component|Withdrawal by Subject|0|||
149740087|NCT03263091|540179029|FG000|OL Component|Physician Decision|0|||
149740088|NCT03263091|540179030|FG001|OL Component|Physician Decision|1|||
149740089|NCT03263091|540179031|FG002|OL Component|Physician Decision|2|||
149740090|NCT03263091|540179032|FG003|OL Component|Physician Decision|0|||
149740091|NCT03263091|540179033|FG004|OL Component|Physician Decision|0|||
149740092|NCT03263091|540179034|FG005|OL Component|Physician Decision|0|||
149740093|NCT03263091|540179029|FG000|OL Component|Death|1|||
149740094|NCT03263091|540179030|FG001|OL Component|Death|0|||
149740095|NCT03263091|540179031|FG002|OL Component|Death|0|||
149740096|NCT03263091|540179032|FG003|OL Component|Death|0|||
149740097|NCT03263091|540179033|FG004|OL Component|Death|0|||
149740098|NCT03263091|540179034|FG005|OL Component|Death|0|||
149740099|NCT03263091|540179029|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
149740100|NCT03263091|540179030|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
149740101|NCT03263091|540179031|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
149740102|NCT03263091|540179032|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
149740103|NCT03263091|540179033|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
149740104|NCT03263091|540179034|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
149740105|NCT03263091|540179029|FG000|OL High-EPO Component|Physician Decision|0|||
149740106|NCT03263091|540179030|FG001|OL High-EPO Component|Physician Decision|0|||
149740107|NCT03263091|540179031|FG002|OL High-EPO Component|Physician Decision|0|||
149740108|NCT03263091|540179032|FG003|OL High-EPO Component|Physician Decision|1|||
149740109|NCT03263091|540179033|FG004|OL High-EPO Component|Physician Decision|0|||
149740110|NCT03263091|540179034|FG005|OL High-EPO Component|Physician Decision|0|||
149740111|NCT03263091|540179029|FG000|OL High-EPO Component|Death|0|||
149740112|NCT03263091|540179030|FG001|OL High-EPO Component|Death|0|||
149740113|NCT03263091|540179031|FG002|OL High-EPO Component|Death|0|||
149740114|NCT03263091|540179032|FG003|OL High-EPO Component|Death|3|||
149740115|NCT03263091|540179033|FG004|OL High-EPO Component|Death|0|||
149740116|NCT03263091|540179034|FG005|OL High-EPO Component|Death|0|||
149740117|NCT03263091|540179029|FG000|DB Component|Withdrawal by Subject|0|||
149740118|NCT03263091|540179030|FG001|DB Component|Withdrawal by Subject|0|||
149740119|NCT03263091|540179031|FG002|DB Component|Withdrawal by Subject|0|||
149740120|NCT03263091|540179032|FG003|DB Component|Withdrawal by Subject|0|||
149740121|NCT03263091|540179033|FG004|DB Component|Withdrawal by Subject|22|||
149740122|NCT03263091|540179034|FG005|DB Component|Withdrawal by Subject|8|||
149740123|NCT03263091|540179029|FG000|DB Component|Physician Decision|0|||
149740124|NCT03263091|540179030|FG001|DB Component|Physician Decision|0|||
149740125|NCT03263091|540179031|FG002|DB Component|Physician Decision|0|||
149740126|NCT03263091|540179032|FG003|DB Component|Physician Decision|0|||
149740127|NCT03263091|540179033|FG004|DB Component|Physician Decision|3|||
149740128|NCT03263091|540179034|FG005|DB Component|Physician Decision|1|||
149740129|NCT03263091|540179029|FG000|DB Component|Adverse Event|0|||
149740130|NCT03263091|540179030|FG001|DB Component|Adverse Event|0|||
149740131|NCT03263091|540179031|FG002|DB Component|Adverse Event|0|||
149740132|NCT03263091|540179032|FG003|DB Component|Adverse Event|0|||
149740133|NCT03263091|540179033|FG004|DB Component|Adverse Event|2|||
149740134|NCT03263091|540179034|FG005|DB Component|Adverse Event|1|||
149740135|NCT03263091|540179029|FG000|DB Component|Lost to Follow-up|0|||
149740136|NCT03263091|540179030|FG001|DB Component|Lost to Follow-up|0|||
150255999|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149740137|NCT03263091|540179031|FG002|DB Component|Lost to Follow-up|0|||
149740138|NCT03263091|540179032|FG003|DB Component|Lost to Follow-up|0|||
149740139|NCT03263091|540179033|FG004|DB Component|Lost to Follow-up|2|||
149740140|NCT03263091|540179034|FG005|DB Component|Lost to Follow-up|1|||
149740141|NCT03263091|540179029|FG000|DB Component|Death|0|||
149740142|NCT03263091|540179030|FG001|DB Component|Death|0|||
149740143|NCT03263091|540179031|FG002|DB Component|Death|0|||
149740144|NCT03263091|540179032|FG003|DB Component|Death|0|||
149740145|NCT03263091|540179033|FG004|DB Component|Death|7|||
149740146|NCT03263091|540179034|FG005|DB Component|Death|4|||
149740147|NCT03263091|540179029|FG000|DB Component|Other than specified|0|||
149740148|NCT03263091|540179030|FG001|DB Component|Other than specified|0|||
149740149|NCT03263091|540179031|FG002|DB Component|Other than specified|0|||
149740150|NCT03263091|540179032|FG003|DB Component|Other than specified|0|||
149740151|NCT03263091|540179033|FG004|DB Component|Other than specified|8|||
149740152|NCT03263091|540179034|FG005|DB Component|Other than specified|6|||
149740153|NCT01821963|540179036|FG000|Overall Study|Adverse Event|1|||
149740154|NCT00783289|540179037|FG000|Overall Study|Protocol Violation|0|||
149740155|NCT00783289|540179038|FG001|Overall Study|Protocol Violation|1|||
149740156|NCT00783289|540179039|FG002|Overall Study|Protocol Violation|0|||
149740157|NCT00783289|540179040|FG003|Overall Study|Protocol Violation|0|||
149740158|NCT00506389|540179041|FG000|In-treatment Period|Other|3|||
149740159|NCT00506389|540179042|FG001|In-treatment Period|Other|3|||
149740160|NCT00506389|540179043|FG002|In-treatment Period|Other|4|||
149740161|NCT00506389|540179041|FG000|In-treatment Period|Lost to Follow-up|0|||
149740162|NCT00506389|540179042|FG001|In-treatment Period|Lost to Follow-up|0|||
149740163|NCT00506389|540179043|FG002|In-treatment Period|Lost to Follow-up|1|||
149740164|NCT00506389|540179041|FG000|In-treatment Period|Lack of compliance|1|||
149740165|NCT00506389|540179042|FG001|In-treatment Period|Lack of compliance|0|||
149740166|NCT00506389|540179043|FG002|In-treatment Period|Lack of compliance|0|||
149740167|NCT00506389|540179041|FG000|In-treatment Period|Reasons not related to trial|4|||
149740168|NCT00506389|540179042|FG001|In-treatment Period|Reasons not related to trial|1|||
149740169|NCT00506389|540179043|FG002|In-treatment Period|Reasons not related to trial|0|||
149740170|NCT00506389|540179041|FG000|In-treatment Period|Withdrawal by Subject|3|||
149740171|NCT00506389|540179042|FG001|In-treatment Period|Withdrawal by Subject|3|||
149740172|NCT00506389|540179043|FG002|In-treatment Period|Withdrawal by Subject|4|||
149740173|NCT00506389|540179041|FG000|In-treatment Period|Lack of Efficacy|0|||
149740174|NCT00506389|540179042|FG001|In-treatment Period|Lack of Efficacy|2|||
149740175|NCT00506389|540179043|FG002|In-treatment Period|Lack of Efficacy|0|||
149740176|NCT00506389|540179041|FG000|In-treatment Period|Adverse Event|11|||
149740177|NCT00506389|540179042|FG001|In-treatment Period|Adverse Event|5|||
149740178|NCT00506389|540179043|FG002|In-treatment Period|Adverse Event|2|||
149740179|NCT00506389|540179041|FG000|In-treatment Period|Randomized but not treated|4|||
149740180|NCT00506389|540179042|FG001|In-treatment Period|Randomized but not treated|1|||
149740181|NCT00506389|540179043|FG002|In-treatment Period|Randomized but not treated|1|||
149740182|NCT03095703|540179046|FG000|Overall Study|Withdrawal by Subject|1|||
149740183|NCT03539432|540179047|FG000|Overall Study|Lost to Follow-up|0|||
149740184|NCT03539432|540179048|FG001|Overall Study|Lost to Follow-up|1|||
149740185|NCT01381094|540179049|FG000|Overall Study|Adverse Event|1|||
149740186|NCT01381094|540179050|FG001|Overall Study|Adverse Event|2|||
149740187|NCT01381094|540179051|FG002|Overall Study|Adverse Event|0|||
149740188|NCT01381094|540179052|FG003|Overall Study|Adverse Event|1|||
149740189|NCT01381094|540179053|FG004|Overall Study|Adverse Event|0|||
149740190|NCT01381094|540179049|FG000|Overall Study|Lost to Follow-up|0|||
149740191|NCT01381094|540179050|FG001|Overall Study|Lost to Follow-up|0|||
149740192|NCT01381094|540179051|FG002|Overall Study|Lost to Follow-up|0|||
149740193|NCT01381094|540179052|FG003|Overall Study|Lost to Follow-up|0|||
149740194|NCT01381094|540179053|FG004|Overall Study|Lost to Follow-up|1|||
149740195|NCT01381094|540179049|FG000|Overall Study|Withdrawal of informed consent|0|||
149740196|NCT01381094|540179050|FG001|Overall Study|Withdrawal of informed consent|1|||
149740197|NCT01381094|540179051|FG002|Overall Study|Withdrawal of informed consent|0|||
149740198|NCT01381094|540179052|FG003|Overall Study|Withdrawal of informed consent|0|||
149740199|NCT01381094|540179053|FG004|Overall Study|Withdrawal of informed consent|0|||
149740200|NCT01381094|540179049|FG000|Overall Study|Participant given Aranesp injection|1|||
149740201|NCT01381094|540179050|FG001|Overall Study|Participant given Aranesp injection|0|||
149740202|NCT01381094|540179051|FG002|Overall Study|Participant given Aranesp injection|0|||
149740203|NCT01381094|540179052|FG003|Overall Study|Participant given Aranesp injection|0|||
149740204|NCT01381094|540179053|FG004|Overall Study|Participant given Aranesp injection|0|||
149740205|NCT02443402|540179058|FG000|Overall Study|Withdrawal by Subject|3|||
149740206|NCT02443402|540179059|FG001|Overall Study|Withdrawal by Subject|1|||
149740207|NCT02443402|540179058|FG000|Overall Study|Screen Failure|1|||
149740208|NCT02443402|540179059|FG001|Overall Study|Screen Failure|2|||
149740209|NCT01934504|540179063|FG000|Overall Study|Protocol Deviation|0|||
149740210|NCT01934504|540179064|FG001|Overall Study|Protocol Deviation|0|||
149740211|NCT01934504|540179065|FG002|Overall Study|Protocol Deviation|0|||
149740212|NCT01934504|540179066|FG003|Overall Study|Protocol Deviation|2|||
149740213|NCT01934504|540179063|FG000|Overall Study|Study Terminated by Sponsor|1|||
150256000|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256001|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
150256002|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256003|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256004|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256005|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256006|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149740214|NCT01934504|540179064|FG001|Overall Study|Study Terminated by Sponsor|0|||
149740215|NCT01934504|540179065|FG002|Overall Study|Study Terminated by Sponsor|5|||
149740216|NCT01934504|540179066|FG003|Overall Study|Study Terminated by Sponsor|5|||
149740217|NCT02665689|540179073|FG000|Overall Study|Adverse Event|1|||
149740218|NCT02665689|540179074|FG001|Overall Study|Adverse Event|0|||
149740219|NCT02665689|540179073|FG000|Overall Study|Trial termination|1|||
149740220|NCT02665689|540179074|FG001|Overall Study|Trial termination|1|||
149740221|NCT02665689|540179073|FG000|Overall Study|Lost to Follow-up|0|||
149740222|NCT02665689|540179074|FG001|Overall Study|Lost to Follow-up|1|||
149740223|NCT00824564|540179075|FG000|Overall Study|Lost to Follow-up|5|||
149740224|NCT00824564|540179076|FG001|Overall Study|Lost to Follow-up|7|||
149740225|NCT00824564|540179075|FG000|Overall Study|Withdrawal by Subject|1|||
149740226|NCT00824564|540179076|FG001|Overall Study|Withdrawal by Subject|1|||
149740227|NCT00824564|540179075|FG000|Overall Study|Other|1|||
149740228|NCT00824564|540179076|FG001|Overall Study|Other|2|||
149740229|NCT00824564|540179075|FG000|Overall Study|Randomized, but not treated|1|||
149740230|NCT00824564|540179076|FG001|Overall Study|Randomized, but not treated|0|||
149740231|NCT00775021|540179077|FG000|First Intervention|Lost to Follow-up|1|||
149740232|NCT00775021|540179078|FG001|First Intervention|Lost to Follow-up|0|||
149740233|NCT00775021|540179077|FG000|Second Intervention|Adverse Event|0|||
149740234|NCT00775021|540179078|FG001|Second Intervention|Adverse Event|1|||
149740235|NCT00363415|540179079|FG000|Overall Study|Progressive Disease|196|||
149740236|NCT00363415|540179080|FG001|Overall Study|Progressive Disease|107|||
149740237|NCT00363415|540179079|FG000|Overall Study|Sponsor Decision|67|||
149740238|NCT00363415|540179080|FG001|Overall Study|Sponsor Decision|31|||
149740239|NCT00363415|540179079|FG000|Overall Study|Death|32|||
149740240|NCT00363415|540179080|FG001|Overall Study|Death|29|||
149740241|NCT00363415|540179079|FG000|Overall Study|Adverse Event|24|||
149740242|NCT00363415|540179080|FG001|Overall Study|Adverse Event|15|||
149740243|NCT00363415|540179079|FG000|Overall Study|Physician Decision|18|||
149740244|NCT00363415|540179080|FG001|Overall Study|Physician Decision|35|||
149740245|NCT00363415|540179079|FG000|Overall Study|Entry Criteria Not Met|11|||
149740246|NCT00363415|540179080|FG001|Overall Study|Entry Criteria Not Met|10|||
149740247|NCT00363415|540179079|FG000|Overall Study|Withdrawal by Subject|9|||
149740248|NCT00363415|540179080|FG001|Overall Study|Withdrawal by Subject|15|||
149740249|NCT00363415|540179079|FG000|Overall Study|Lost to Follow-up|3|||
149740250|NCT00363415|540179080|FG001|Overall Study|Lost to Follow-up|3|||
149740251|NCT00363415|540179079|FG000|Overall Study|Protocol Violation|1|||
149740252|NCT00363415|540179080|FG001|Overall Study|Protocol Violation|4|||
149740253|NCT01506141|540179091|FG000|Overall Study|Adverse Event|0|||
149740254|NCT01506141|540179092|FG001|Overall Study|Adverse Event|2|||
149740255|NCT01506141|540179091|FG000|Overall Study|Participation Terminated by Investigator|1|||
149740256|NCT01506141|540179092|FG001|Overall Study|Participation Terminated by Investigator|1|||
149740257|NCT01506141|540179091|FG000|Overall Study|Site Terminated by Sponsor|2|||
149740258|NCT01506141|540179092|FG001|Overall Study|Site Terminated by Sponsor|0|||
149740259|NCT01506141|540179091|FG000|Overall Study|Reason Not Specified|4|||
149740260|NCT01506141|540179092|FG001|Overall Study|Reason Not Specified|2|||
149740261|NCT04889209|540179093|FG000|All Cohorts Except 15E|Adverse Event|0|||
149740262|NCT04889209|540179094|FG001|All Cohorts Except 15E|Adverse Event|0|||
149740263|NCT04889209|540179095|FG002|All Cohorts Except 15E|Adverse Event|0|||
149740264|NCT04889209|540179096|FG003|All Cohorts Except 15E|Adverse Event|0|||
149740265|NCT04889209|540179097|FG004|All Cohorts Except 15E|Adverse Event|0|||
149740266|NCT04889209|540179098|FG005|All Cohorts Except 15E|Adverse Event|0|||
149740267|NCT04889209|540179099|FG006|All Cohorts Except 15E|Adverse Event|1|||
149740268|NCT04889209|540179100|FG007|All Cohorts Except 15E|Adverse Event|0|||
149740269|NCT04889209|540179101|FG008|All Cohorts Except 15E|Adverse Event|0|||
149740270|NCT04889209|540179102|FG009|All Cohorts Except 15E|Adverse Event|0|||
149740271|NCT04889209|540179103|FG010|All Cohorts Except 15E|Adverse Event|0|||
149740272|NCT04889209|540179104|FG011|All Cohorts Except 15E|Adverse Event|0|||
149740273|NCT04889209|540179105|FG012|All Cohorts Except 15E|Adverse Event|0|||
149740274|NCT04889209|540179106|FG013|All Cohorts Except 15E|Adverse Event|0|||
149740275|NCT04889209|540179107|FG014|All Cohorts Except 15E|Adverse Event|0|||
149740276|NCT04889209|540179108|FG015|All Cohorts Except 15E|Adverse Event|0|||
149740277|NCT04889209|540179109|FG016|All Cohorts Except 15E|Adverse Event|0|||
149740278|NCT04889209|540179110|FG017|All Cohorts Except 15E|Adverse Event|0|||
149740279|NCT04889209|540179093|FG000|All Cohorts Except 15E|Death|0|||
149740280|NCT04889209|540179094|FG001|All Cohorts Except 15E|Death|1|||
149740281|NCT04889209|540179095|FG002|All Cohorts Except 15E|Death|0|||
149740282|NCT04889209|540179096|FG003|All Cohorts Except 15E|Death|0|||
149740283|NCT04889209|540179097|FG004|All Cohorts Except 15E|Death|0|||
149740284|NCT04889209|540179098|FG005|All Cohorts Except 15E|Death|0|||
149740285|NCT04889209|540179099|FG006|All Cohorts Except 15E|Death|0|||
149740286|NCT04889209|540179100|FG007|All Cohorts Except 15E|Death|0|||
149740287|NCT04889209|540179101|FG008|All Cohorts Except 15E|Death|0|||
149740288|NCT04889209|540179102|FG009|All Cohorts Except 15E|Death|0|||
149740289|NCT04889209|540179103|FG010|All Cohorts Except 15E|Death|0|||
149740290|NCT04889209|540179104|FG011|All Cohorts Except 15E|Death|0|||
149740291|NCT04889209|540179105|FG012|All Cohorts Except 15E|Death|0|||
149740292|NCT04889209|540179106|FG013|All Cohorts Except 15E|Death|0|||
149740293|NCT04889209|540179107|FG014|All Cohorts Except 15E|Death|0|||
149740294|NCT04889209|540179108|FG015|All Cohorts Except 15E|Death|0|||
149740295|NCT04889209|540179109|FG016|All Cohorts Except 15E|Death|0|||
149740296|NCT04889209|540179110|FG017|All Cohorts Except 15E|Death|0|||
149740297|NCT04889209|540179093|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
149740298|NCT04889209|540179094|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
149740299|NCT04889209|540179095|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
149740300|NCT04889209|540179096|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
149740301|NCT04889209|540179097|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
149740302|NCT04889209|540179098|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
149740303|NCT04889209|540179099|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
149740304|NCT04889209|540179100|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
149740305|NCT04889209|540179101|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
149740306|NCT04889209|540179102|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
149740307|NCT04889209|540179103|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
149740308|NCT04889209|540179104|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
149740309|NCT04889209|540179105|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
149740310|NCT04889209|540179106|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
149740311|NCT04889209|540179107|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
149740312|NCT04889209|540179108|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
149740313|NCT04889209|540179109|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
149740314|NCT04889209|540179110|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
149740315|NCT04889209|540179093|FG000|All Cohorts Except 15E|Physician Decision|0|||
149740316|NCT04889209|540179094|FG001|All Cohorts Except 15E|Physician Decision|0|||
149740317|NCT04889209|540179095|FG002|All Cohorts Except 15E|Physician Decision|0|||
149740318|NCT04889209|540179096|FG003|All Cohorts Except 15E|Physician Decision|0|||
149740319|NCT04889209|540179097|FG004|All Cohorts Except 15E|Physician Decision|1|||
149740320|NCT04889209|540179098|FG005|All Cohorts Except 15E|Physician Decision|0|||
149740321|NCT04889209|540179099|FG006|All Cohorts Except 15E|Physician Decision|0|||
149740322|NCT04889209|540179100|FG007|All Cohorts Except 15E|Physician Decision|1|||
149740323|NCT04889209|540179101|FG008|All Cohorts Except 15E|Physician Decision|0|||
149740324|NCT04889209|540179102|FG009|All Cohorts Except 15E|Physician Decision|1|||
149740325|NCT04889209|540179103|FG010|All Cohorts Except 15E|Physician Decision|0|||
149740326|NCT04889209|540179104|FG011|All Cohorts Except 15E|Physician Decision|1|||
149740327|NCT04889209|540179105|FG012|All Cohorts Except 15E|Physician Decision|1|||
149740328|NCT04889209|540179106|FG013|All Cohorts Except 15E|Physician Decision|0|||
149740329|NCT04889209|540179107|FG014|All Cohorts Except 15E|Physician Decision|0|||
149740330|NCT04889209|540179108|FG015|All Cohorts Except 15E|Physician Decision|0|||
149740331|NCT04889209|540179109|FG016|All Cohorts Except 15E|Physician Decision|0|||
149740332|NCT04889209|540179110|FG017|All Cohorts Except 15E|Physician Decision|0|||
149740333|NCT04889209|540179093|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
149740334|NCT04889209|540179094|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
149740335|NCT04889209|540179095|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
149740336|NCT04889209|540179096|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
149740337|NCT04889209|540179097|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
149740338|NCT04889209|540179098|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740339|NCT04889209|540179099|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740340|NCT04889209|540179100|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
149740341|NCT04889209|540179101|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740342|NCT04889209|540179102|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740343|NCT04889209|540179103|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740344|NCT04889209|540179104|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740345|NCT04889209|540179105|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740346|NCT04889209|540179106|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
149740347|NCT04889209|540179107|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
149740348|NCT04889209|540179108|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
149740349|NCT04889209|540179109|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
149740350|NCT04889209|540179110|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
149740351|NCT04889209|540179093|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
149740352|NCT04889209|540179094|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
149740353|NCT04889209|540179095|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740354|NCT04889209|540179096|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740355|NCT04889209|540179097|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740356|NCT04889209|540179098|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149740357|NCT04889209|540179099|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740358|NCT04889209|540179100|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149740359|NCT04889209|540179101|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740360|NCT04889209|540179102|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149740361|NCT04889209|540179103|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740362|NCT04889209|540179104|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740363|NCT04889209|540179105|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740364|NCT04889209|540179106|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740365|NCT04889209|540179107|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740366|NCT04889209|540179108|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149740367|NCT04889209|540179109|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149801750|NCT01049360|540402428|FG014|Period 4|Withdrawal by Subject|0|||
150256007|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256008|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256009|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256010|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
150256011|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256012|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256013|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256014|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256015|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
150256016|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
150256017|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
150256018|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
150256019|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256020|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256021|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256022|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256023|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256024|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
150256025|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256026|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256027|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256028|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256029|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
150256030|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256031|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
150256032|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256033|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256034|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256035|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256036|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256037|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256038|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
150256039|NCT02663518|542072655|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256040|NCT02663518|542072656|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256041|NCT02663518|542072657|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256042|NCT02663518|542072658|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256043|NCT02663518|542072659|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256044|NCT02663518|542072660|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256045|NCT02663518|542072661|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
150256046|NCT02663518|542072662|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256047|NCT02663518|542072663|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256048|NCT02663518|542072664|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256049|NCT02663518|542072665|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256050|NCT02663518|542072666|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256051|NCT02663518|542072667|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256052|NCT02663518|542072668|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
150256053|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
150256054|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
150256055|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
150256056|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
150256057|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
150256058|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
149740368|NCT04889209|540179110|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149740369|NCT04889209|540179093|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740370|NCT04889209|540179094|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740371|NCT04889209|540179095|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740372|NCT04889209|540179096|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
149740373|NCT04889209|540179097|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740374|NCT04889209|540179098|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740375|NCT04889209|540179099|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740376|NCT04889209|540179100|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740377|NCT04889209|540179101|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740378|NCT04889209|540179102|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740379|NCT04889209|540179103|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740380|NCT04889209|540179104|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740381|NCT04889209|540179105|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740382|NCT04889209|540179106|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740383|NCT04889209|540179107|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740384|NCT04889209|540179108|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740385|NCT04889209|540179109|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740386|NCT04889209|540179110|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149740387|NCT04889209|540179093|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740388|NCT04889209|540179094|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740389|NCT04889209|540179095|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740390|NCT04889209|540179096|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740391|NCT04889209|540179097|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740392|NCT04889209|540179098|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740393|NCT04889209|540179099|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740394|NCT04889209|540179100|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740395|NCT04889209|540179101|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740396|NCT04889209|540179102|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740397|NCT04889209|540179103|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740398|NCT04889209|540179104|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740399|NCT04889209|540179105|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740400|NCT04889209|540179106|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740401|NCT04889209|540179107|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740402|NCT04889209|540179108|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740403|NCT04889209|540179109|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149740404|NCT04889209|540179110|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149740405|NCT04889209|540179093|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740406|NCT04889209|540179094|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740407|NCT04889209|540179095|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740408|NCT04889209|540179096|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740409|NCT04889209|540179097|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740410|NCT04889209|540179098|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740411|NCT04889209|540179099|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740412|NCT04889209|540179100|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740413|NCT04889209|540179101|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740414|NCT04889209|540179102|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740415|NCT04889209|540179103|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740416|NCT04889209|540179104|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740417|NCT04889209|540179105|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740418|NCT04889209|540179106|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740419|NCT04889209|540179107|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740420|NCT04889209|540179108|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740421|NCT04889209|540179109|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149740422|NCT04889209|540179110|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
149740423|NCT04889209|540179093|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740424|NCT04889209|540179094|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740425|NCT04889209|540179095|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740426|NCT04889209|540179096|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740427|NCT04889209|540179097|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740428|NCT04889209|540179098|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740429|NCT04889209|540179099|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740430|NCT04889209|540179100|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740431|NCT04889209|540179101|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740432|NCT04889209|540179102|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740433|NCT04889209|540179103|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740434|NCT04889209|540179104|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740435|NCT04889209|540179105|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740436|NCT04889209|540179106|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740437|NCT04889209|540179107|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740438|NCT04889209|540179108|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740439|NCT04889209|540179109|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149740440|NCT04889209|540179110|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
149740441|NCT04889209|540179093|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740442|NCT04889209|540179094|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740443|NCT04889209|540179095|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740444|NCT04889209|540179096|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740445|NCT04889209|540179097|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740446|NCT04889209|540179098|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740447|NCT04889209|540179099|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740448|NCT04889209|540179100|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740449|NCT04889209|540179101|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740450|NCT04889209|540179102|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740451|NCT04889209|540179103|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740452|NCT04889209|540179104|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740453|NCT04889209|540179105|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740454|NCT04889209|540179106|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740455|NCT04889209|540179107|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
149740456|NCT04889209|540179108|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740457|NCT04889209|540179109|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740458|NCT04889209|540179110|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149740459|NCT04607408|540179111|FG000|Overall Study|Lost to Follow-up|0|||
149740460|NCT04607408|540179112|FG001|Overall Study|Lost to Follow-up|0|||
149740461|NCT04607408|540179113|FG002|Overall Study|Lost to Follow-up|0|||
149740462|NCT04607408|540179114|FG003|Overall Study|Lost to Follow-up|1|||
149740463|NCT04607408|540179115|FG004|Overall Study|Lost to Follow-up|0|||
149740464|NCT04607408|540179111|FG000|Overall Study|Withdrawal by Subject|0|||
149740465|NCT04607408|540179112|FG001|Overall Study|Withdrawal by Subject|1|||
149740466|NCT04607408|540179113|FG002|Overall Study|Withdrawal by Subject|0|||
149740467|NCT04607408|540179114|FG003|Overall Study|Withdrawal by Subject|1|||
149740468|NCT04607408|540179115|FG004|Overall Study|Withdrawal by Subject|0|||
149740469|NCT01725165|540179126|FG000|Overall Study|Death|11|||
149740470|NCT01725165|540179127|FG001|Overall Study|Death|18|||
149740471|NCT02725788|540179130|FG000|Overall Study|Lost to Follow-up|1|||
149740472|NCT02725788|540179131|FG001|Overall Study|Lost to Follow-up|1|||
149740473|NCT02725788|540179130|FG000|Overall Study|Protocol Violation|0|||
149740474|NCT02725788|540179131|FG001|Overall Study|Protocol Violation|1|||
149740475|NCT05590377|540179132|FG000|Overall Study|Death|1|||
149740476|NCT05590377|540179133|FG001|Overall Study|Death|1|||
149740477|NCT05590377|540179134|FG002|Overall Study|Death|2|||
149740478|NCT05590377|540179135|FG003|Overall Study|Death|0|||
149740479|NCT05590377|540179136|FG004|Overall Study|Death|0|||
149740480|NCT05590377|540179132|FG000|Overall Study|Study Terminated by Sponsor|1|||
149740481|NCT05590377|540179133|FG001|Overall Study|Study Terminated by Sponsor|5|||
149740482|NCT05590377|540179134|FG002|Overall Study|Study Terminated by Sponsor|4|||
149740483|NCT05590377|540179135|FG003|Overall Study|Study Terminated by Sponsor|0|||
149740484|NCT05590377|540179136|FG004|Overall Study|Study Terminated by Sponsor|0|||
149740485|NCT05590377|540179132|FG000|Overall Study|Withdrawal by Subject|1|||
149740486|NCT05590377|540179133|FG001|Overall Study|Withdrawal by Subject|0|||
149740487|NCT05590377|540179134|FG002|Overall Study|Withdrawal by Subject|0|||
149740488|NCT05590377|540179135|FG003|Overall Study|Withdrawal by Subject|0|||
149740489|NCT05590377|540179136|FG004|Overall Study|Withdrawal by Subject|0|||
149740490|NCT00382967|540179137|FG000|Overall Study|Protocol Violation|1|||
149740491|NCT00382967|540179138|FG001|Overall Study|Protocol Violation|1|||
149740492|NCT02620020|540179149|FG000|Overall Study|Adverse Event|8|||
149740493|NCT02620020|540179150|FG001|Overall Study|Adverse Event|4|||
149740494|NCT02620020|540179151|FG002|Overall Study|Adverse Event|3|||
149740495|NCT02620020|540179152|FG003|Overall Study|Adverse Event|5|||
149740496|NCT02620020|540179149|FG000|Overall Study|Lost to Follow-up|4|||
149740497|NCT02620020|540179150|FG001|Overall Study|Lost to Follow-up|8|||
149740498|NCT02620020|540179151|FG002|Overall Study|Lost to Follow-up|1|||
149740499|NCT02620020|540179152|FG003|Overall Study|Lost to Follow-up|4|||
149740500|NCT02620020|540179149|FG000|Overall Study|Physician Decision|7|||
149740501|NCT02620020|540179150|FG001|Overall Study|Physician Decision|4|||
149740502|NCT02620020|540179151|FG002|Overall Study|Physician Decision|3|||
149740503|NCT02620020|540179152|FG003|Overall Study|Physician Decision|4|||
149740504|NCT02620020|540179149|FG000|Overall Study|Protocol Violation|5|||
149740505|NCT02620020|540179150|FG001|Overall Study|Protocol Violation|2|||
149740506|NCT02620020|540179151|FG002|Overall Study|Protocol Violation|1|||
149740507|NCT02620020|540179152|FG003|Overall Study|Protocol Violation|1|||
149740508|NCT02620020|540179149|FG000|Overall Study|Withdrawal by Subject|20|||
149740509|NCT02620020|540179150|FG001|Overall Study|Withdrawal by Subject|16|||
149740510|NCT02620020|540179151|FG002|Overall Study|Withdrawal by Subject|17|||
149740511|NCT02620020|540179152|FG003|Overall Study|Withdrawal by Subject|12|||
149740512|NCT02620020|540179149|FG000|Overall Study|Death|0|||
149740513|NCT02620020|540179150|FG001|Overall Study|Death|1|||
149740514|NCT02620020|540179151|FG002|Overall Study|Death|0|||
149740515|NCT02620020|540179152|FG003|Overall Study|Death|0|||
149740516|NCT00195650|540179153|FG000|Overall Study|Adverse Event|194|||
149740517|NCT00195650|540179153|FG000|Overall Study|Lack of Efficacy|99|||
149740518|NCT00195650|540179153|FG000|Overall Study|Withdrawal by Subject|67|||
149740519|NCT00195650|540179153|FG000|Overall Study|Lost to Follow-up|44|||
149740520|NCT00195650|540179153|FG000|Overall Study|Death|23|||
149740521|NCT00195650|540179153|FG000|Overall Study|Protocol Violation|15|||
149740522|NCT00195650|540179153|FG000|Overall Study|Administrative reasons|83|||
149740523|NCT01478958|540179154|FG000|Overall Study|Withdrawal by Subject|1|||
149740524|NCT01478958|540179155|FG001|Overall Study|Withdrawal by Subject|1|||
149740525|NCT01478958|540179156|FG002|Overall Study|Withdrawal by Subject|1|||
149740526|NCT01478958|540179154|FG000|Overall Study|Weight loss|1|||
149740527|NCT01478958|540179155|FG001|Overall Study|Weight loss|0|||
149740528|NCT01478958|540179156|FG002|Overall Study|Weight loss|0|||
149740529|NCT01478958|540179154|FG000|Overall Study|Re-located|0|||
149740530|NCT01478958|540179155|FG001|Overall Study|Re-located|1|||
149740531|NCT01478958|540179156|FG002|Overall Study|Re-located|0|||
149740532|NCT01478958|540179154|FG000|Overall Study|Unable to comply|0|||
149740533|NCT01478958|540179155|FG001|Overall Study|Unable to comply|0|||
149740534|NCT01478958|540179156|FG002|Overall Study|Unable to comply|2|||
149740535|NCT01709331|540179157|FG000|Overall Study|Adverse Event|1|||
149740536|NCT02305563|540179158|FG000|Treatment Period|Disease progression|0|||
149740537|NCT02305563|540179159|FG001|Treatment Period|Disease progression|0|||
149740538|NCT02305563|540179160|FG002|Treatment Period|Disease progression|15|||
149740539|NCT02305563|540179161|FG003|Treatment Period|Disease progression|6|||
149740540|NCT02305563|540179162|FG004|Treatment Period|Disease progression|6|||
149740541|NCT02305563|540179158|FG000|Treatment Period|Study drug toxicity|0|||
149740542|NCT02305563|540179159|FG001|Treatment Period|Study drug toxicity|0|||
149740543|NCT02305563|540179160|FG002|Treatment Period|Study drug toxicity|0|||
149740544|NCT02305563|540179161|FG003|Treatment Period|Study drug toxicity|1|||
149740545|NCT02305563|540179162|FG004|Treatment Period|Study drug toxicity|2|||
149740546|NCT02305563|540179158|FG000|Treatment Period|Death|0|||
149740547|NCT02305563|540179159|FG001|Treatment Period|Death|0|||
149740548|NCT02305563|540179160|FG002|Treatment Period|Death|1|||
149740549|NCT02305563|540179161|FG003|Treatment Period|Death|2|||
149740550|NCT02305563|540179162|FG004|Treatment Period|Death|1|||
149740551|NCT02305563|540179158|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
149740552|NCT02305563|540179159|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
149740553|NCT02305563|540179160|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
149740554|NCT02305563|540179161|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
149740555|NCT02305563|540179162|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
149740556|NCT02305563|540179158|FG000|Treatment Period|Participant request to stop therapy|0|||
149740557|NCT02305563|540179159|FG001|Treatment Period|Participant request to stop therapy|2|||
149740558|NCT02305563|540179160|FG002|Treatment Period|Participant request to stop therapy|0|||
149740559|NCT02305563|540179161|FG003|Treatment Period|Participant request to stop therapy|1|||
149740560|NCT02305563|540179162|FG004|Treatment Period|Participant request to stop therapy|0|||
149740561|NCT02305563|540179158|FG000|Treatment Period|Participant withdrew consent|0|||
149740562|NCT02305563|540179159|FG001|Treatment Period|Participant withdrew consent|0|||
149740563|NCT02305563|540179160|FG002|Treatment Period|Participant withdrew consent|1|||
149740564|NCT02305563|540179161|FG003|Treatment Period|Participant withdrew consent|1|||
149740565|NCT02305563|540179162|FG004|Treatment Period|Participant withdrew consent|1|||
149740566|NCT02305563|540179158|FG000|Treatment Period|Maximum clinical benefit|0|||
149740567|NCT02305563|540179159|FG001|Treatment Period|Maximum clinical benefit|0|||
149740568|NCT02305563|540179160|FG002|Treatment Period|Maximum clinical benefit|0|||
149740569|NCT02305563|540179161|FG003|Treatment Period|Maximum clinical benefit|0|||
149740570|NCT02305563|540179162|FG004|Treatment Period|Maximum clinical benefit|1|||
149740571|NCT02305563|540179158|FG000|Treatment Period|Poor/non-compliance|0|||
149740572|NCT02305563|540179159|FG001|Treatment Period|Poor/non-compliance|0|||
149740573|NCT02305563|540179160|FG002|Treatment Period|Poor/non-compliance|0|||
149740574|NCT02305563|540179161|FG003|Treatment Period|Poor/non-compliance|0|||
149740575|NCT02305563|540179162|FG004|Treatment Period|Poor/non-compliance|1|||
149740576|NCT02305563|540179158|FG000|Treatment Period|Administrative reason by Sponsor|0|||
149740577|NCT02305563|540179159|FG001|Treatment Period|Administrative reason by Sponsor|0|||
149740578|NCT02305563|540179160|FG002|Treatment Period|Administrative reason by Sponsor|0|||
149740579|NCT02305563|540179161|FG003|Treatment Period|Administrative reason by Sponsor|0|||
149740580|NCT02305563|540179162|FG004|Treatment Period|Administrative reason by Sponsor|1|||
149740581|NCT02305563|540179158|FG000|Treatment Period|other reason|2|||
149740582|NCT02305563|540179159|FG001|Treatment Period|other reason|0|||
149740583|NCT02305563|540179160|FG002|Treatment Period|other reason|2|||
149740584|NCT02305563|540179161|FG003|Treatment Period|other reason|2|||
149740585|NCT02305563|540179162|FG004|Treatment Period|other reason|1|||
149740586|NCT02305563|540179158|FG000|Treatment Period|Randomized but not treated|0|||
149740587|NCT02305563|540179159|FG001|Treatment Period|Randomized but not treated|0|||
149740588|NCT02305563|540179160|FG002|Treatment Period|Randomized but not treated|0|||
149740589|NCT02305563|540179161|FG003|Treatment Period|Randomized but not treated|0|||
149740590|NCT02305563|540179162|FG004|Treatment Period|Randomized but not treated|2|||
149740591|NCT02305563|540179158|FG000|Treatment Period|added ULO, then disease progression|0|||
149740592|NCT02305563|540179159|FG001|Treatment Period|added ULO, then disease progression|0|||
149740593|NCT02305563|540179160|FG002|Treatment Period|added ULO, then disease progression|0|||
149740594|NCT02305563|540179161|FG003|Treatment Period|added ULO, then disease progression|0|||
149740595|NCT02305563|540179162|FG004|Treatment Period|added ULO, then disease progression|4|||
149740596|NCT02305563|540179158|FG000|Treatment Period|added ULO; then other reason|0|||
149740597|NCT02305563|540179159|FG001|Treatment Period|added ULO; then other reason|0|||
149740598|NCT02305563|540179160|FG002|Treatment Period|added ULO; then other reason|0|||
149740599|NCT02305563|540179161|FG003|Treatment Period|added ULO; then other reason|0|||
149740600|NCT02305563|540179162|FG004|Treatment Period|added ULO; then other reason|1|||
149740601|NCT02305563|540179158|FG000|Treatment Period|added ULO, then request to stop|0|||
149740602|NCT02305563|540179159|FG001|Treatment Period|added ULO, then request to stop|0|||
149740603|NCT02305563|540179160|FG002|Treatment Period|added ULO, then request to stop|0|||
149740604|NCT02305563|540179161|FG003|Treatment Period|added ULO, then request to stop|0|||
149740605|NCT02305563|540179162|FG004|Treatment Period|added ULO, then request to stop|1|||
149740606|NCT02305563|540179158|FG000|Follow-up Period|Death|0|||
149740607|NCT02305563|540179159|FG001|Follow-up Period|Death|0|||
149740608|NCT02305563|540179160|FG002|Follow-up Period|Death|5|||
149740609|NCT02305563|540179161|FG003|Follow-up Period|Death|4|||
149740610|NCT02305563|540179162|FG004|Follow-up Period|Death|7|||
149740611|NCT02305563|540179158|FG000|Follow-up Period|Participant withdrew consent|0|||
149740612|NCT02305563|540179159|FG001|Follow-up Period|Participant withdrew consent|0|||
149740613|NCT02305563|540179160|FG002|Follow-up Period|Participant withdrew consent|2|||
149740614|NCT02305563|540179161|FG003|Follow-up Period|Participant withdrew consent|1|||
149740615|NCT02305563|540179162|FG004|Follow-up Period|Participant withdrew consent|0|||
149740616|NCT02305563|540179158|FG000|Follow-up Period|other reason|0|||
149740617|NCT02305563|540179159|FG001|Follow-up Period|other reason|0|||
149740618|NCT02305563|540179160|FG002|Follow-up Period|other reason|0|||
149740619|NCT02305563|540179161|FG003|Follow-up Period|other reason|0|||
149740620|NCT02305563|540179162|FG004|Follow-up Period|other reason|1|||
149740621|NCT02305563|540179158|FG000|Follow-up Period|Followup no longer required per protocol|3|||
149740622|NCT02305563|540179159|FG001|Follow-up Period|Followup no longer required per protocol|3|||
149740623|NCT02305563|540179160|FG002|Follow-up Period|Followup no longer required per protocol|4|||
149740624|NCT02305563|540179161|FG003|Follow-up Period|Followup no longer required per protocol|1|||
149740625|NCT02305563|540179162|FG004|Follow-up Period|Followup no longer required per protocol|4|||
149740626|NCT04640766|540179166|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
149740627|NCT04906707|540179167|FG000|Overall Study|Withdrawal by Subject|2|||
149740628|NCT04906707|540179168|FG001|Overall Study|Withdrawal by Subject|0|||
149740629|NCT04906707|540179167|FG000|Overall Study|Withdrawal due to PI decision|1|||
149740630|NCT04906707|540179168|FG001|Overall Study|Withdrawal due to PI decision|0|||
149740631|NCT04906707|540179167|FG000|Overall Study|Lost to Follow-up|0|||
149740632|NCT04906707|540179168|FG001|Overall Study|Lost to Follow-up|1|||
149740633|NCT01976806|540179169|FG000|Overall Study|Lost to Follow-up|1|||
149740634|NCT01976806|540179170|FG001|Overall Study|Lost to Follow-up|4|||
149740635|NCT01976806|540179169|FG000|Overall Study|Adverse Event|1|||
149740636|NCT01976806|540179170|FG001|Overall Study|Adverse Event|1|||
149740637|NCT01976806|540179169|FG000|Overall Study|Withdrawal by Subject|1|||
149740638|NCT01976806|540179170|FG001|Overall Study|Withdrawal by Subject|1|||
149740639|NCT02654002|540179175|FG000|Overall Study|Adverse Event|0|||
149740640|NCT02654002|540179176|FG001|Overall Study|Adverse Event|0|||
149740641|NCT02654002|540179177|FG002|Overall Study|Adverse Event|0|||
149740642|NCT02654002|540179178|FG003|Overall Study|Adverse Event|0|||
149740643|NCT02654002|540179179|FG004|Overall Study|Adverse Event|0|||
149740644|NCT02654002|540179180|FG005|Overall Study|Adverse Event|0|||
149740645|NCT02654002|540179181|FG006|Overall Study|Adverse Event|1|||
149740646|NCT02654002|540179182|FG007|Overall Study|Adverse Event|0|||
150256059|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
150256060|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
150256061|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
150256062|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
149740647|NCT02654002|540179183|FG008|Overall Study|Adverse Event|0|||
149740648|NCT02654002|540179175|FG000|Overall Study|Withdrew Consent|0|||
149740649|NCT02654002|540179176|FG001|Overall Study|Withdrew Consent|0|||
149740650|NCT02654002|540179177|FG002|Overall Study|Withdrew Consent|0|||
149740651|NCT02654002|540179178|FG003|Overall Study|Withdrew Consent|0|||
149740652|NCT02654002|540179179|FG004|Overall Study|Withdrew Consent|0|||
149740653|NCT02654002|540179180|FG005|Overall Study|Withdrew Consent|1|||
149740654|NCT02654002|540179181|FG006|Overall Study|Withdrew Consent|0|||
149740655|NCT02654002|540179182|FG007|Overall Study|Withdrew Consent|1|||
149740656|NCT02654002|540179183|FG008|Overall Study|Withdrew Consent|0|||
149740657|NCT00963807|540179185|FG000|Overall Study|Physician Decision|2|||
149740658|NCT00963807|540179185|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
150256063|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
149740659|NCT00963807|540179185|FG000|Overall Study|Disease progression|15|||
149740660|NCT00684177|540179188|FG000|Overall Study|Adverse Event|4|||
149740661|NCT00684177|540179189|FG001|Overall Study|Adverse Event|3|||
149740662|NCT00684177|540179188|FG000|Overall Study|Lack of Efficacy|10|||
149740663|NCT00684177|540179189|FG001|Overall Study|Lack of Efficacy|15|||
149740664|NCT00684177|540179188|FG000|Overall Study|Protocol Violation|1|||
149740665|NCT00684177|540179189|FG001|Overall Study|Protocol Violation|0|||
149740666|NCT00684177|540179188|FG000|Overall Study|Lost to Follow-up|2|||
149740667|NCT00684177|540179189|FG001|Overall Study|Lost to Follow-up|1|||
149740668|NCT00684177|540179188|FG000|Overall Study|Physician Decision|2|||
149740669|NCT00684177|540179189|FG001|Overall Study|Physician Decision|0|||
149740670|NCT00684177|540179188|FG000|Overall Study|Withdrawal by Subject|1|||
149740671|NCT00684177|540179189|FG001|Overall Study|Withdrawal by Subject|2|||
149740672|NCT00684177|540179188|FG000|Overall Study|Other|1|||
149740673|NCT00684177|540179189|FG001|Overall Study|Other|2|||
149740674|NCT00075881|540181432|FG000|Overall Study|Lack of Efficacy|18|||
149740675|NCT00075881|540181432|FG000|Overall Study|Adverse Event|7|||
149740676|NCT00075881|540181432|FG000|Overall Study|Death|1|||
149740677|NCT00075881|540181432|FG000|Overall Study|Withdrawal by Subject|2|||
149740678|NCT00075881|540181432|FG000|Overall Study|Protocol Violation|4|||
149740679|NCT00075881|540181432|FG000|Overall Study|other complicating disease|3|||
149740680|NCT00075881|540181432|FG000|Overall Study|other|4|||
149740681|NCT00075881|540181432|FG000|Overall Study|missing data|2|||
149740682|NCT00075881|540181432|FG000|Overall Study|Ineligible|1|||
149740683|NCT00075881|540181432|FG000|Overall Study|never start protocol therapy|1|||
149740684|NCT02224664|540181433|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
149740685|NCT02224664|540181434|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149740686|NCT02224664|540181435|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149740687|NCT02224664|540181436|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149740688|NCT02224664|540181437|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
150256064|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
150256065|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
150256066|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
149740689|NCT02224664|540181433|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
149740690|NCT02224664|540181434|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
149740691|NCT02224664|540181435|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
149740692|NCT02224664|540181436|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
149740693|NCT02224664|540181437|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
149740694|NCT02224664|540181433|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149740695|NCT02224664|540181434|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149740696|NCT02224664|540181435|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149740697|NCT02224664|540181436|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
149740698|NCT02224664|540181437|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
149740699|NCT03019549|540181438|FG000|Washout|DId not meet genotype criteria|11|||
149740700|NCT03019549|540181438|FG000|Period 2|Adverse Event|2|||
149740701|NCT03019549|540181438|FG000|Period 2|Physician Decision|2|||
149740702|NCT03019549|540181438|FG000|Period 2|Withdrawal by Subject|1|||
149740703|NCT04030195|540181441|FG000|Overall Study|Withdrawal by Subject|2|||
149740704|NCT04030195|540181442|FG001|Overall Study|Withdrawal by Subject|0|||
149740705|NCT04030195|540181443|FG002|Overall Study|Withdrawal by Subject|0|||
149740706|NCT01412879|540181444|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
149740707|NCT01412879|540181445|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
149740708|NCT01412879|540181446|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
149740709|NCT01412879|540181444|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
149740710|NCT01412879|540181445|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
149740711|NCT01412879|540181446|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
149740712|NCT01412879|540181444|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
149740713|NCT01412879|540181445|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
149740714|NCT01412879|540181446|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
149740715|NCT01412879|540181444|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
149740716|NCT01412879|540181445|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
149740717|NCT01412879|540181446|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
149740718|NCT01412879|540181444|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
149740719|NCT01412879|540181445|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
149740720|NCT01412879|540181446|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
149740721|NCT02109029|540181447|FG000|Part B|Adverse Event|0|||
149740722|NCT02109029|540181448|FG001|Part B|Adverse Event|0|||
149740723|NCT02109029|540181449|FG002|Part B|Adverse Event|0|||
149740724|NCT02109029|540181450|FG003|Part B|Adverse Event|0|||
150256067|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149740725|NCT02109029|540181451|FG004|Part B|Adverse Event|1|||
149740726|NCT02109029|540181452|FG005|Part B|Adverse Event|1|||
149740727|NCT03195894|540181453|FG000|Overall Study|"An example is Started other treatment."|4|||
149740728|NCT03195894|540181454|FG001|Overall Study|"An example is Started other treatment."|5|||
149740729|NCT03195894|540181453|FG000|Overall Study|Withdrawal by Subject|15|||
149740730|NCT03195894|540181454|FG001|Overall Study|Withdrawal by Subject|4|||
149740731|NCT03195894|540181453|FG000|Overall Study|Lost to Follow-up|14|||
149740732|NCT03195894|540181454|FG001|Overall Study|Lost to Follow-up|19|||
149740733|NCT00486902|540181458|FG000|Overall Study|Withdrawal by Subject|1|||
149740734|NCT00486902|540181459|FG001|Overall Study|Withdrawal by Subject|2|||
149740735|NCT00486902|540181458|FG000|Overall Study|decision for postpartum tubal ligation|3|||
149740736|NCT00486902|540181459|FG001|Overall Study|decision for postpartum tubal ligation|1|||
149740737|NCT00486902|540181458|FG000|Overall Study|spinal anesthetic protocal violation|1|||
149740738|NCT00486902|540181459|FG001|Overall Study|spinal anesthetic protocal violation|1|||
149740739|NCT00486902|540181458|FG000|Overall Study|Did not meet inclusion criteria|1|||
149740740|NCT00486902|540181459|FG001|Overall Study|Did not meet inclusion criteria|0|||
149740741|NCT00486902|540181458|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
149740742|NCT00486902|540181459|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
149740743|NCT01217606|540181462|FG000|Initial Treatment Phase|Other Reasons|0|||
149740744|NCT01217606|540181463|FG001|Initial Treatment Phase|Other Reasons|2|||
149740745|NCT01217606|540181462|FG000|Initial Treatment Phase|Protocol Violation|3|||
149740746|NCT01217606|540181463|FG001|Initial Treatment Phase|Protocol Violation|2|||
149740747|NCT01217606|540181462|FG000|Initial Treatment Phase|Personal Reasons|0|||
149740748|NCT01217606|540181463|FG001|Initial Treatment Phase|Personal Reasons|2|||
149740749|NCT01217606|540181462|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
149740750|NCT01217606|540181463|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
149740751|NCT01217606|540181462|FG000|Initial Treatment Phase|Adverse Event|10|||
149740752|NCT01217606|540181463|FG001|Initial Treatment Phase|Adverse Event|6|||
149740753|NCT01217606|540181462|FG000|9-Month Masked Extension|Adverse Event|3|||
149740754|NCT01217606|540181463|FG001|9-Month Masked Extension|Adverse Event|6|||
149740755|NCT01217606|540181462|FG000|9-Month Masked Extension|Other Reasons|4|||
149740756|NCT01217606|540181463|FG001|9-Month Masked Extension|Other Reasons|4|||
149740757|NCT01217606|540181462|FG000|9-Month Masked Extension|Personal Reasons|2|||
149740758|NCT01217606|540181463|FG001|9-Month Masked Extension|Personal Reasons|1|||
149740759|NCT01217606|540181462|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
149740760|NCT01217606|540181463|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
149740761|NCT01217606|540181462|FG000|9-Month Masked Extension|Pregnancy|1|||
149740762|NCT01217606|540181463|FG001|9-Month Masked Extension|Pregnancy|0|||
149740763|NCT01217606|540181462|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
149740764|NCT01217606|540181463|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
149740765|NCT04178590|540181464|FG000|Overall Study|Pregnancy|1|||
149740766|NCT04178590|540181464|FG000|Overall Study|Lost to Follow-up|1|||
149740767|NCT00996840|540181465|FG000|Overall Study|Adverse Event|0|||
149740768|NCT00996840|540181466|FG001|Overall Study|Adverse Event|1|||
149740769|NCT00996840|540181467|FG002|Overall Study|Adverse Event|0|||
149740770|NCT00996840|540181468|FG003|Overall Study|Adverse Event|0|||
149740771|NCT00996840|540181469|FG004|Overall Study|Adverse Event|0|||
149740772|NCT00996840|540181465|FG000|Overall Study|Physician Decision|0|||
149740773|NCT00996840|540181466|FG001|Overall Study|Physician Decision|0|||
149740774|NCT00996840|540181467|FG002|Overall Study|Physician Decision|1|||
149740775|NCT00996840|540181468|FG003|Overall Study|Physician Decision|1|||
149740776|NCT00996840|540181469|FG004|Overall Study|Physician Decision|2|||
149740777|NCT00996840|540181465|FG000|Overall Study|Withdrawal by Subject|1|||
149740778|NCT00996840|540181466|FG001|Overall Study|Withdrawal by Subject|1|||
149740779|NCT00996840|540181467|FG002|Overall Study|Withdrawal by Subject|0|||
149740780|NCT00996840|540181468|FG003|Overall Study|Withdrawal by Subject|0|||
149740781|NCT00996840|540181469|FG004|Overall Study|Withdrawal by Subject|0|||
149740782|NCT00474240|540181470|FG000|Overall Study|Withdrawal by Subject|1|||
149740783|NCT00474240|540181471|FG001|Overall Study|Withdrawal by Subject|1|||
149740784|NCT00474240|540181472|FG002|Overall Study|Withdrawal by Subject|0|||
149740785|NCT00474240|540181473|FG003|Overall Study|Withdrawal by Subject|2|||
149740786|NCT00474240|540181474|FG004|Overall Study|Withdrawal by Subject|3|||
149740787|NCT00474240|540181475|FG005|Overall Study|Withdrawal by Subject|1|||
149740788|NCT00474240|540181470|FG000|Overall Study|Adverse Event|0|||
149740789|NCT00474240|540181471|FG001|Overall Study|Adverse Event|0|||
149740790|NCT00474240|540181472|FG002|Overall Study|Adverse Event|9|||
149740791|NCT00474240|540181473|FG003|Overall Study|Adverse Event|14|||
149740792|NCT00474240|540181474|FG004|Overall Study|Adverse Event|5|||
149740793|NCT00474240|540181475|FG005|Overall Study|Adverse Event|16|||
149740794|NCT00474240|540181470|FG000|Overall Study|Removed due to lab value|0|||
149740795|NCT00474240|540181471|FG001|Overall Study|Removed due to lab value|0|||
149740796|NCT00474240|540181472|FG002|Overall Study|Removed due to lab value|0|||
149740797|NCT00474240|540181473|FG003|Overall Study|Removed due to lab value|0|||
149740798|NCT00474240|540181474|FG004|Overall Study|Removed due to lab value|0|||
149740799|NCT00474240|540181475|FG005|Overall Study|Removed due to lab value|1|||
149740800|NCT00809133|540181476|FG000|Overall Study|Progressive disease|2|||
149740801|NCT00809133|540181477|FG001|Overall Study|Progressive disease|5|||
149740802|NCT00809133|540181478|FG002|Overall Study|Progressive disease|5|||
149740803|NCT00809133|540181479|FG003|Overall Study|Progressive disease|3|||
149740804|NCT00809133|540181480|FG004|Overall Study|Progressive disease|4|||
149740805|NCT00809133|540181481|FG005|Overall Study|Progressive disease|1|||
149740806|NCT00809133|540181482|FG006|Overall Study|Progressive disease|3|||
149740807|NCT00809133|540181483|FG007|Overall Study|Progressive disease|3|||
149740808|NCT00809133|540181484|FG008|Overall Study|Progressive disease|3|||
149740809|NCT00809133|540181485|FG009|Overall Study|Progressive disease|9|||
149740810|NCT00809133|540181486|FG010|Overall Study|Progressive disease|5|||
149740811|NCT00809133|540181487|FG011|Overall Study|Progressive disease|7|||
149740812|NCT00809133|540181488|FG012|Overall Study|Progressive disease|5|||
149740813|NCT00809133|540181489|FG013|Overall Study|Progressive disease|4|||
149740814|NCT00809133|540181476|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740815|NCT00809133|540181477|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740816|NCT00809133|540181478|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740817|NCT00809133|540181479|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740818|NCT00809133|540181480|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740819|NCT00809133|540181481|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149740820|NCT00809133|540181482|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149740821|NCT00809133|540181483|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149740822|NCT00809133|540181484|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740823|NCT00809133|540181485|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740824|NCT00809133|540181486|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740825|NCT00809133|540181487|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740826|NCT00809133|540181488|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149740827|NCT00809133|540181489|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
149740828|NCT00809133|540181476|FG000|Overall Study|Other adverse event|1|||
149740829|NCT00809133|540181477|FG001|Overall Study|Other adverse event|1|||
149740830|NCT00809133|540181478|FG002|Overall Study|Other adverse event|1|||
149740831|NCT00809133|540181479|FG003|Overall Study|Other adverse event|0|||
149740832|NCT00809133|540181480|FG004|Overall Study|Other adverse event|0|||
149740833|NCT00809133|540181481|FG005|Overall Study|Other adverse event|3|||
149740834|NCT00809133|540181482|FG006|Overall Study|Other adverse event|2|||
149740835|NCT00809133|540181483|FG007|Overall Study|Other adverse event|4|||
149740836|NCT00809133|540181484|FG008|Overall Study|Other adverse event|0|||
149740837|NCT00809133|540181485|FG009|Overall Study|Other adverse event|0|||
149740838|NCT00809133|540181486|FG010|Overall Study|Other adverse event|1|||
149740839|NCT00809133|540181487|FG011|Overall Study|Other adverse event|1|||
149740840|NCT00809133|540181488|FG012|Overall Study|Other adverse event|0|||
149740841|NCT00809133|540181489|FG013|Overall Study|Other adverse event|1|||
149740842|NCT00809133|540181476|FG000|Overall Study|Lost to Follow-up|0|||
149740843|NCT00809133|540181477|FG001|Overall Study|Lost to Follow-up|0|||
149740844|NCT00809133|540181478|FG002|Overall Study|Lost to Follow-up|0|||
149740845|NCT00809133|540181479|FG003|Overall Study|Lost to Follow-up|0|||
149740846|NCT00809133|540181480|FG004|Overall Study|Lost to Follow-up|0|||
149740847|NCT00809133|540181481|FG005|Overall Study|Lost to Follow-up|1|||
149740848|NCT00809133|540181482|FG006|Overall Study|Lost to Follow-up|0|||
149740849|NCT00809133|540181483|FG007|Overall Study|Lost to Follow-up|0|||
149740850|NCT00809133|540181484|FG008|Overall Study|Lost to Follow-up|0|||
149740851|NCT00809133|540181485|FG009|Overall Study|Lost to Follow-up|0|||
149740852|NCT00809133|540181486|FG010|Overall Study|Lost to Follow-up|0|||
149740853|NCT00809133|540181487|FG011|Overall Study|Lost to Follow-up|0|||
149740854|NCT00809133|540181488|FG012|Overall Study|Lost to Follow-up|0|||
149740855|NCT00809133|540181489|FG013|Overall Study|Lost to Follow-up|0|||
149740856|NCT00809133|540181476|FG000|Overall Study|Consent withdrawn|0|||
149740857|NCT00809133|540181477|FG001|Overall Study|Consent withdrawn|0|||
149740858|NCT00809133|540181478|FG002|Overall Study|Consent withdrawn|0|||
149740859|NCT00809133|540181479|FG003|Overall Study|Consent withdrawn|0|||
149740860|NCT00809133|540181480|FG004|Overall Study|Consent withdrawn|1|||
149740861|NCT00809133|540181481|FG005|Overall Study|Consent withdrawn|0|||
149740862|NCT00809133|540181482|FG006|Overall Study|Consent withdrawn|0|||
149740863|NCT00809133|540181483|FG007|Overall Study|Consent withdrawn|0|||
149740864|NCT00809133|540181484|FG008|Overall Study|Consent withdrawn|0|||
149740865|NCT00809133|540181485|FG009|Overall Study|Consent withdrawn|0|||
149740866|NCT00809133|540181486|FG010|Overall Study|Consent withdrawn|0|||
149740867|NCT00809133|540181487|FG011|Overall Study|Consent withdrawn|0|||
149740868|NCT00809133|540181488|FG012|Overall Study|Consent withdrawn|0|||
149740869|NCT00809133|540181489|FG013|Overall Study|Consent withdrawn|0|||
149740870|NCT00809133|540181476|FG000|Overall Study|Other not mentioned above|0|||
149740871|NCT00809133|540181477|FG001|Overall Study|Other not mentioned above|1|||
149740872|NCT00809133|540181478|FG002|Overall Study|Other not mentioned above|0|||
149740873|NCT00809133|540181479|FG003|Overall Study|Other not mentioned above|0|||
149740874|NCT00809133|540181480|FG004|Overall Study|Other not mentioned above|0|||
149740875|NCT00809133|540181481|FG005|Overall Study|Other not mentioned above|1|||
149740876|NCT00809133|540181482|FG006|Overall Study|Other not mentioned above|0|||
149740877|NCT00809133|540181483|FG007|Overall Study|Other not mentioned above|0|||
149740878|NCT00809133|540181484|FG008|Overall Study|Other not mentioned above|0|||
149740879|NCT00809133|540181485|FG009|Overall Study|Other not mentioned above|0|||
149740880|NCT00809133|540181486|FG010|Overall Study|Other not mentioned above|0|||
149740881|NCT00809133|540181487|FG011|Overall Study|Other not mentioned above|0|||
149740882|NCT00809133|540181488|FG012|Overall Study|Other not mentioned above|0|||
149740883|NCT00809133|540181489|FG013|Overall Study|Other not mentioned above|0|||
149740884|NCT00833092|540181490|FG000|Overall Study|Withdrawal by Subject|2|||
149740885|NCT00833092|540181491|FG001|Overall Study|Withdrawal by Subject|3|||
149740886|NCT00833092|540181490|FG000|Overall Study|Protocol Violation|2|||
149740887|NCT00833092|540181491|FG001|Overall Study|Protocol Violation|1|||
149740888|NCT00833092|540181490|FG000|Overall Study|Diarrhea|0|||
149740889|NCT00833092|540181491|FG001|Overall Study|Diarrhea|2|||
149740890|NCT00833092|540181490|FG000|Overall Study|constipation|0|||
149740891|NCT00833092|540181491|FG001|Overall Study|constipation|1|||
149740892|NCT00619229|540181492|FG000|Overall Study|Withdrawal by Subject|1|||
149740893|NCT00619229|540181493|FG001|Overall Study|Withdrawal by Subject|1|||
149740894|NCT00619229|540181492|FG000|Overall Study|Lost to Follow-up|1|||
149740895|NCT00619229|540181493|FG001|Overall Study|Lost to Follow-up|0|||
149740896|NCT00619229|540181492|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
149740897|NCT00619229|540181493|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
149740898|NCT00619229|540181492|FG000|Overall Study|Investigator planned Cataract Operation|1|||
149740899|NCT00619229|540181493|FG001|Overall Study|Investigator planned Cataract Operation|0|||
149740900|NCT01700829|540181494|FG000|Overall Study|Withdrawal by Subject|1|||
149740901|NCT01700829|540181495|FG001|Overall Study|Withdrawal by Subject|1|||
149740902|NCT01075178|540181496|FG000|Subject Matching|eligible but not matched|130|||
149740903|NCT01075178|540181497|FG001|Subject Matching|eligible but not matched|403|||
149740904|NCT01075178|540181496|FG000|Subject Chart Review|died before chart review period|0|||
149740905|NCT01075178|540181497|FG001|Subject Chart Review|died before chart review period|2|||
149740906|NCT01075178|540181496|FG000|Subject Chart Review|no data collected due to site closure|3|||
149740907|NCT01075178|540181497|FG001|Subject Chart Review|no data collected due to site closure|4|||
149740908|NCT01075178|540181496|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
149740909|NCT01075178|540181497|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
149740910|NCT02983604|540181498|FG000|Overall Study|Enrolled but not Treated|0|||
149740911|NCT02983604|540181499|FG001|Overall Study|Enrolled but not Treated|0|||
149740912|NCT02983604|540181500|FG002|Overall Study|Enrolled but not Treated|1|||
149740913|NCT02983604|540181501|FG003|Overall Study|Enrolled but not Treated|0|||
149740914|NCT00316264|540181502|FG000|Overall Study|Lost to Follow-up|0|||
149740915|NCT00316264|540181503|FG001|Overall Study|Lost to Follow-up|1|||
149740916|NCT00316264|540181504|FG002|Overall Study|Lost to Follow-up|0|||
149740917|NCT00316264|540181502|FG000|Overall Study|Withdrawal of Consent|3|||
149740918|NCT00316264|540181503|FG001|Overall Study|Withdrawal of Consent|5|||
149740919|NCT00316264|540181504|FG002|Overall Study|Withdrawal of Consent|6|||
149740920|NCT00316264|540181502|FG000|Overall Study|Death|2|||
149740921|NCT00316264|540181503|FG001|Overall Study|Death|0|||
149740922|NCT00316264|540181504|FG002|Overall Study|Death|0|||
149740923|NCT00316264|540181502|FG000|Overall Study|Other|1|||
149740924|NCT00316264|540181503|FG001|Overall Study|Other|1|||
149740925|NCT00316264|540181504|FG002|Overall Study|Other|0|||
149740926|NCT00355264|540181505|FG000|Extension (Variable Duration)|Adverse Event|1|||
149740927|NCT00355264|540181505|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
149740928|NCT00699192|540181506|FG000|Overall Study|Missing|1|||
149740929|NCT00699192|540181507|FG001|Overall Study|Missing|1|||
149740930|NCT00699192|540181508|FG002|Overall Study|Missing|1|||
149740931|NCT00699192|540181506|FG000|Overall Study|Adverse Event|9|||
149740932|NCT00699192|540181507|FG001|Overall Study|Adverse Event|4|||
149740933|NCT00699192|540181508|FG002|Overall Study|Adverse Event|3|||
149740934|NCT00699192|540181506|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149740935|NCT00699192|540181507|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149740936|NCT00699192|540181508|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149740937|NCT00699192|540181506|FG000|Overall Study|Lack of Efficacy|0|||
149740938|NCT00699192|540181507|FG001|Overall Study|Lack of Efficacy|0|||
149740939|NCT00699192|540181508|FG002|Overall Study|Lack of Efficacy|1|||
149740940|NCT00699192|540181506|FG000|Overall Study|Withdrawal by Subject|3|||
149740941|NCT00699192|540181507|FG001|Overall Study|Withdrawal by Subject|2|||
149740942|NCT00699192|540181508|FG002|Overall Study|Withdrawal by Subject|4|||
149740943|NCT00699192|540181506|FG000|Overall Study|Administrative problems|1|||
149740944|NCT00699192|540181507|FG001|Overall Study|Administrative problems|3|||
149740945|NCT00699192|540181508|FG002|Overall Study|Administrative problems|1|||
150256068|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149740946|NCT00699192|540181506|FG000|Overall Study|Protocol Violation|2|||
149740947|NCT00699192|540181507|FG001|Overall Study|Protocol Violation|2|||
149740948|NCT00699192|540181508|FG002|Overall Study|Protocol Violation|0|||
149740949|NCT04927312|540181509|FG000|Overall Study|Adverse Event|1|||
149740950|NCT04927312|540181509|FG000|Overall Study|Death|1|||
149740951|NCT04927312|540181509|FG000|Overall Study|Withdrawal by Subject|1|||
149740952|NCT04927312|540181509|FG000|Overall Study|Other|1|||
149740953|NCT04919564|540181511|FG000|Overall Study|Lost to Follow-up|1|||
149740954|NCT04919564|540181512|FG001|Overall Study|Lost to Follow-up|0|||
149740955|NCT04919564|540181511|FG000|Overall Study|Physician Decision|1|||
149740956|NCT04919564|540181512|FG001|Overall Study|Physician Decision|1|||
149740957|NCT00929240|540181515|FG000|Initial Treatment Phase|Adverse Event|31|||
149740958|NCT00929240|540181516|FG001|Initial Treatment Phase|Adverse Event|0|||
149740959|NCT00929240|540181517|FG002|Initial Treatment Phase|Adverse Event|0|||
149740960|NCT00929240|540181515|FG000|Initial Treatment Phase|Disease progression|41|||
149740961|NCT00929240|540181516|FG001|Initial Treatment Phase|Disease progression|0|||
149740962|NCT00929240|540181517|FG002|Initial Treatment Phase|Disease progression|0|||
149740963|NCT00929240|540181515|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
149740964|NCT00929240|540181516|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
149740965|NCT00929240|540181517|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
149740966|NCT00929240|540181515|FG000|Initial Treatment Phase|Protocol Violation|5|||
149740967|NCT00929240|540181516|FG001|Initial Treatment Phase|Protocol Violation|0|||
149740968|NCT00929240|540181517|FG002|Initial Treatment Phase|Protocol Violation|0|||
149740969|NCT00929240|540181515|FG000|Initial Treatment Phase|Death|2|||
149740970|NCT00929240|540181516|FG001|Initial Treatment Phase|Death|0|||
149740971|NCT00929240|540181517|FG002|Initial Treatment Phase|Death|0|||
149740972|NCT00929240|540181515|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
149740973|NCT00929240|540181516|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
149740974|NCT00929240|540181517|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
149740975|NCT00929240|540181515|FG000|Initial Treatment Phase|Physician Decision|4|||
149740976|NCT00929240|540181516|FG001|Initial Treatment Phase|Physician Decision|0|||
149740977|NCT00929240|540181517|FG002|Initial Treatment Phase|Physician Decision|0|||
149740978|NCT00929240|540181515|FG000|Maintenance Phase|Disease progression|0|||
149740979|NCT00929240|540181516|FG001|Maintenance Phase|Disease progression|73|||
149740980|NCT00929240|540181517|FG002|Maintenance Phase|Disease progression|60|||
149740981|NCT00929240|540181515|FG000|Maintenance Phase|Adverse Event|0|||
149740982|NCT00929240|540181516|FG001|Maintenance Phase|Adverse Event|9|||
149740983|NCT00929240|540181517|FG002|Maintenance Phase|Adverse Event|12|||
149740984|NCT00929240|540181515|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149740985|NCT00929240|540181516|FG001|Maintenance Phase|Withdrawal by Subject|2|||
149740986|NCT00929240|540181517|FG002|Maintenance Phase|Withdrawal by Subject|6|||
149740987|NCT00929240|540181515|FG000|Maintenance Phase|Protocol Violation|0|||
149740988|NCT00929240|540181516|FG001|Maintenance Phase|Protocol Violation|1|||
149740989|NCT00929240|540181517|FG002|Maintenance Phase|Protocol Violation|0|||
149740990|NCT00929240|540181515|FG000|Maintenance Phase|Health authority/Study termination|0|||
149740991|NCT00929240|540181516|FG001|Maintenance Phase|Health authority/Study termination|1|||
149740992|NCT00929240|540181517|FG002|Maintenance Phase|Health authority/Study termination|2|||
149740993|NCT00929240|540181515|FG000|Maintenance Phase|Physician Decision|0|||
149740994|NCT00929240|540181516|FG001|Maintenance Phase|Physician Decision|2|||
149740995|NCT00929240|540181517|FG002|Maintenance Phase|Physician Decision|1|||
149740996|NCT00929240|540181515|FG000|Maintenance Phase|Change of treatment|0|||
149740997|NCT00929240|540181516|FG001|Maintenance Phase|Change of treatment|4|||
149740998|NCT00929240|540181517|FG002|Maintenance Phase|Change of treatment|0|||
149740999|NCT00929240|540181515|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
149741000|NCT00929240|540181516|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
149741001|NCT00929240|540181517|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
149741002|NCT00929240|540181515|FG000|Maintenance Phase|Participant not treated|0|||
149741003|NCT00929240|540181516|FG001|Maintenance Phase|Participant not treated|2|||
149741004|NCT00929240|540181517|FG002|Maintenance Phase|Participant not treated|0|||
149741005|NCT01287104|540181518|FG000|Overall Study|Patient developed progressive disease|1|||
149741006|NCT01287104|540181519|FG001|Overall Study|Patient developed progressive disease|1|||
149741007|NCT01287104|540181520|FG002|Overall Study|Patient developed progressive disease|3|||
149741008|NCT01287104|540181521|FG003|Overall Study|Patient developed progressive disease|2|||
149741009|NCT01287104|540181518|FG000|Overall Study|Donor anaphylaxis|0|||
149741010|NCT01287104|540181519|FG001|Overall Study|Donor anaphylaxis|1|||
149741011|NCT01287104|540181520|FG002|Overall Study|Donor anaphylaxis|0|||
149741012|NCT01287104|540181521|FG003|Overall Study|Donor anaphylaxis|1|||
149741013|NCT01287104|540181518|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
149741014|NCT01287104|540181519|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
149741015|NCT01287104|540181520|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
149741016|NCT01287104|540181521|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
149741017|NCT01287104|540181518|FG000|Overall Study|Low donor chimerism|0|||
149741018|NCT01287104|540181519|FG001|Overall Study|Low donor chimerism|1|||
149741019|NCT01287104|540181520|FG002|Overall Study|Low donor chimerism|0|||
150256069|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256070|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149741020|NCT01287104|540181521|FG003|Overall Study|Low donor chimerism|0|||
149741021|NCT01287104|540181518|FG000|Overall Study|NK cells did not meet release criteria|0|||
149741022|NCT01287104|540181519|FG001|Overall Study|NK cells did not meet release criteria|1|||
149741023|NCT01287104|540181520|FG002|Overall Study|NK cells did not meet release criteria|0|||
149741024|NCT01287104|540181521|FG003|Overall Study|NK cells did not meet release criteria|0|||
149741025|NCT00098787|540181524|FG000|Overall Study|Never started treatment|3|||
149741026|NCT00098787|540181525|FG001|Overall Study|Never started treatment|2|||
149741027|NCT00098787|540181526|FG002|Overall Study|Never started treatment|1|||
149741028|NCT00098787|540181524|FG000|Overall Study|Ineligible|9|||
149741029|NCT00098787|540181525|FG001|Overall Study|Ineligible|7|||
149741030|NCT00098787|540181526|FG002|Overall Study|Ineligible|3|||
149741031|NCT00098787|540181524|FG000|Overall Study|Disease progression|28|||
149741032|NCT00098787|540181525|FG001|Overall Study|Disease progression|17|||
149741033|NCT00098787|540181526|FG002|Overall Study|Disease progression|23|||
149741034|NCT00098787|540181524|FG000|Overall Study|Adverse Event|8|||
149741035|NCT00098787|540181525|FG001|Overall Study|Adverse Event|17|||
149741036|NCT00098787|540181526|FG002|Overall Study|Adverse Event|8|||
149741037|NCT00098787|540181524|FG000|Overall Study|Death|6|||
149741038|NCT00098787|540181525|FG001|Overall Study|Death|1|||
149741039|NCT00098787|540181526|FG002|Overall Study|Death|0|||
149741040|NCT00098787|540181524|FG000|Overall Study|Withdrawal by Subject|4|||
149741041|NCT00098787|540181525|FG001|Overall Study|Withdrawal by Subject|12|||
149741042|NCT00098787|540181526|FG002|Overall Study|Withdrawal by Subject|6|||
149741043|NCT00098787|540181524|FG000|Overall Study|Alternative therapy|8|||
149741044|NCT00098787|540181525|FG001|Overall Study|Alternative therapy|13|||
149741045|NCT00098787|540181526|FG002|Overall Study|Alternative therapy|13|||
149741046|NCT00098787|540181524|FG000|Overall Study|Other|7|||
149741047|NCT00098787|540181525|FG001|Overall Study|Other|6|||
149741048|NCT00098787|540181526|FG002|Overall Study|Other|9|||
149741049|NCT02203149|540181527|FG000|Part 1|Adverse Event|0|||
149741050|NCT02203149|540181528|FG001|Part 1|Adverse Event|1|||
149741051|NCT02203149|540181529|FG002|Part 1|Adverse Event|0|||
149741052|NCT02203149|540181530|FG003|Part 1|Adverse Event|0|||
149741053|NCT02203149|540181531|FG004|Part 1|Adverse Event|0|||
149741054|NCT02203149|540181527|FG000|Part 2|Death|0|||
149741055|NCT02203149|540181528|FG001|Part 2|Death|0|||
149741056|NCT02203149|540181529|FG002|Part 2|Death|1|||
149741057|NCT02203149|540181530|FG003|Part 2|Death|1|||
149741058|NCT02203149|540181531|FG004|Part 2|Death|0|||
149741059|NCT02203149|540181527|FG000|Part 2|Withdrawal by Subject|0|||
149741060|NCT02203149|540181528|FG001|Part 2|Withdrawal by Subject|0|||
149741061|NCT02203149|540181529|FG002|Part 2|Withdrawal by Subject|0|||
149741062|NCT02203149|540181530|FG003|Part 2|Withdrawal by Subject|1|||
149741063|NCT02203149|540181531|FG004|Part 2|Withdrawal by Subject|0|||
149741064|NCT02203149|540181527|FG000|Part 2|Adverse Event|0|||
149741065|NCT02203149|540181528|FG001|Part 2|Adverse Event|0|||
149741066|NCT02203149|540181529|FG002|Part 2|Adverse Event|0|||
149741067|NCT02203149|540181530|FG003|Part 2|Adverse Event|1|||
149741068|NCT02203149|540181531|FG004|Part 2|Adverse Event|1|||
149741069|NCT00684814|540181534|FG000|Washout Period of 7 Days|Adverse Event|1|||
149741070|NCT00684814|540181535|FG001|Washout Period of 7 Days|Adverse Event|2|||
149741071|NCT00684814|540181534|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149741072|NCT00684814|540181535|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
149741073|NCT00684814|540181534|FG000|Second Intervention|Adverse Event|1|||
149741074|NCT00684814|540181535|FG001|Second Intervention|Adverse Event|0|||
149741075|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
149741076|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
149741077|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
149741078|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
149741079|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
149741080|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
149741081|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
149741082|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
149741083|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
149741084|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
149741085|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
149741086|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
149741087|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
149741088|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
149741089|NCT00446030|540181536|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
149741090|NCT00446030|540181537|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
149741091|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
149741092|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
149741093|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
150256071|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149741094|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
149741095|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
149741096|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
149741097|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
149741098|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
149741099|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
149741100|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
149741101|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
149741102|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
149741103|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
149741104|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
149741105|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
149741106|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
149741107|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
149741108|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
149741109|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
149741110|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
149741111|NCT00446030|540181536|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
149741112|NCT00446030|540181537|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
149741113|NCT03168867|540181540|FG000|Overall Study|Withdrawal by Subject|1|||
149741114|NCT03168867|540181541|FG001|Overall Study|Withdrawal by Subject|5|||
149741115|NCT04348851|540181542|FG000|Post-Test 1|Withdrawal by Subject|0|||
149741116|NCT04348851|540181543|FG001|Post-Test 1|Withdrawal by Subject|1|||
149741117|NCT04348851|540181544|FG002|Post-Test 1|Withdrawal by Subject|0|||
149741118|NCT04348851|540181545|FG003|Post-Test 1|Withdrawal by Subject|0|||
149741119|NCT04348851|540181542|FG000|Post-Test 1|Lost to Follow-up|0|||
149741120|NCT04348851|540181543|FG001|Post-Test 1|Lost to Follow-up|1|||
149741121|NCT04348851|540181544|FG002|Post-Test 1|Lost to Follow-up|0|||
149741122|NCT04348851|540181545|FG003|Post-Test 1|Lost to Follow-up|0|||
149741123|NCT04348851|540181542|FG000|Post-Test 2|Stroke survivor death|0|||
149741124|NCT04348851|540181543|FG001|Post-Test 2|Stroke survivor death|1|||
149741125|NCT04348851|540181544|FG002|Post-Test 2|Stroke survivor death|0|||
149741126|NCT04348851|540181545|FG003|Post-Test 2|Stroke survivor death|1|||
149741127|NCT00858832|540181546|FG000|Overall Study|became ineligible: delivered vaginally|1|||
149741128|NCT00858832|540181547|FG001|Overall Study|became ineligible: delivered vaginally|0|||
149741129|NCT00858832|540181546|FG000|Overall Study|Adverse Event|0|||
149741130|NCT00858832|540181547|FG001|Overall Study|Adverse Event|1|||
149741131|NCT05292755|540181548|FG000|Overall Study|Lost to Follow-up|5|||
149741132|NCT05292755|540181549|FG001|Overall Study|Lost to Follow-up|9|||
149741133|NCT00432809|540181550|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
149741134|NCT00432809|540181551|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
149741135|NCT00432809|540181552|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
149741136|NCT00432809|540181550|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
149741137|NCT00432809|540181551|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
149741138|NCT00432809|540181552|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
149741139|NCT04052139|540181553|FG000|Overall Study|Lost to Follow-up|2|||
149741140|NCT04052139|540181554|FG001|Overall Study|Lost to Follow-up|0|||
149741141|NCT04052139|540181555|FG002|Overall Study|Lost to Follow-up|0|||
149741142|NCT04052139|540181553|FG000|Overall Study|Withdrawal by Subject|1|||
149741143|NCT04052139|540181554|FG001|Overall Study|Withdrawal by Subject|0|||
149741144|NCT04052139|540181555|FG002|Overall Study|Withdrawal by Subject|0|||
149741145|NCT04433117|540181556|FG000|Overall Study|Withdrawal by Subject|1|||
149741146|NCT04433117|540181557|FG001|Overall Study|Withdrawal by Subject|0|||
149741147|NCT00707577|540181558|FG000|Overall Study|Withdrawal by Subject|3|||
149741148|NCT00707577|540181559|FG001|Overall Study|Withdrawal by Subject|2|||
149741149|NCT00707577|540181558|FG000|Overall Study|Lost to Follow-up|34|||
149741150|NCT00707577|540181559|FG001|Overall Study|Lost to Follow-up|25|||
149741151|NCT00707577|540181558|FG000|Overall Study|Left employment|13|||
149741152|NCT00707577|540181559|FG001|Overall Study|Left employment|10|||
149741153|NCT00707577|540181558|FG000|Overall Study|Pregnancy|4|||
149741154|NCT00707577|540181559|FG001|Overall Study|Pregnancy|1|||
149741155|NCT00190775|540181560|FG000|Overall Study|Adverse Event|57|||
149741156|NCT00190775|540181561|FG001|Overall Study|Adverse Event|22|||
149741157|NCT00190775|540181560|FG000|Overall Study|Satisfactory Response|1|||
149741158|NCT00190775|540181561|FG001|Overall Study|Satisfactory Response|0|||
149741159|NCT00190775|540181560|FG000|Overall Study|Lack of Efficacy|28|||
149741160|NCT00190775|540181561|FG001|Overall Study|Lack of Efficacy|32|||
149741161|NCT00190775|540181560|FG000|Overall Study|Lost to Follow-up|31|||
149741162|NCT00190775|540181561|FG001|Overall Study|Lost to Follow-up|23|||
149741163|NCT00190775|540181560|FG000|Overall Study|Participant Moved|0|||
149741164|NCT00190775|540181561|FG001|Overall Study|Participant Moved|1|||
149741165|NCT00190775|540181560|FG000|Overall Study|Withdrawal by Subject|24|||
149741166|NCT00190775|540181561|FG001|Overall Study|Withdrawal by Subject|13|||
149741167|NCT00190775|540181560|FG000|Overall Study|Sponsor Decision|1|||
149741168|NCT00190775|540181561|FG001|Overall Study|Sponsor Decision|0|||
149741169|NCT00190775|540181560|FG000|Overall Study|Physician Decision|3|||
149741170|NCT00190775|540181561|FG001|Overall Study|Physician Decision|0|||
149741171|NCT00190775|540181560|FG000|Overall Study|Noncompliance|3|||
149741172|NCT00190775|540181561|FG001|Overall Study|Noncompliance|5|||
149741173|NCT00190775|540181560|FG000|Overall Study|Protocol Violation|0|||
149741174|NCT00190775|540181561|FG001|Overall Study|Protocol Violation|1|||
149741175|NCT00190775|540181560|FG000|Overall Study|Exclusion Criteria Met|1|||
149741176|NCT00190775|540181561|FG001|Overall Study|Exclusion Criteria Met|3|||
149741177|NCT01794780|540181562|FG000|Overall Study|Adverse Event|0|||
149741178|NCT01794780|540181563|FG001|Overall Study|Adverse Event|1|||
149741179|NCT01794780|540181564|FG002|Overall Study|Adverse Event|2|||
149741180|NCT01794780|540181565|FG003|Overall Study|Adverse Event|0|||
149741181|NCT01794780|540181566|FG004|Overall Study|Adverse Event|0|||
149741182|NCT01794780|540181567|FG005|Overall Study|Adverse Event|0|||
149741183|NCT01794780|540181568|FG006|Overall Study|Adverse Event|0|||
149741184|NCT01794780|540181569|FG007|Overall Study|Adverse Event|0|||
149741185|NCT01794780|540181562|FG000|Overall Study|Death|0|||
149741186|NCT01794780|540181563|FG001|Overall Study|Death|2|||
149741187|NCT01794780|540181564|FG002|Overall Study|Death|14|||
149741188|NCT01794780|540181565|FG003|Overall Study|Death|1|||
149741189|NCT01794780|540181566|FG004|Overall Study|Death|0|||
149741190|NCT01794780|540181567|FG005|Overall Study|Death|9|||
149741191|NCT01794780|540181568|FG006|Overall Study|Death|4|||
149741192|NCT01794780|540181569|FG007|Overall Study|Death|0|||
149741193|NCT01794780|540181562|FG000|Overall Study|Lost to Follow-up|10|||
149741194|NCT01794780|540181563|FG001|Overall Study|Lost to Follow-up|64|||
149741195|NCT01794780|540181564|FG002|Overall Study|Lost to Follow-up|165|||
149741196|NCT01794780|540181565|FG003|Overall Study|Lost to Follow-up|53|||
149741197|NCT01794780|540181566|FG004|Overall Study|Lost to Follow-up|2|||
149741198|NCT01794780|540181567|FG005|Overall Study|Lost to Follow-up|99|||
149741199|NCT01794780|540181568|FG006|Overall Study|Lost to Follow-up|30|||
149741200|NCT01794780|540181569|FG007|Overall Study|Lost to Follow-up|5|||
149741201|NCT01794780|540181562|FG000|Overall Study|Withdrew informed consent|7|||
149741202|NCT01794780|540181563|FG001|Overall Study|Withdrew informed consent|17|||
149741203|NCT01794780|540181564|FG002|Overall Study|Withdrew informed consent|36|||
149741204|NCT01794780|540181565|FG003|Overall Study|Withdrew informed consent|9|||
149741205|NCT01794780|540181566|FG004|Overall Study|Withdrew informed consent|0|||
149741206|NCT01794780|540181567|FG005|Overall Study|Withdrew informed consent|48|||
149741207|NCT01794780|540181568|FG006|Overall Study|Withdrew informed consent|4|||
149741208|NCT01794780|540181569|FG007|Overall Study|Withdrew informed consent|3|||
149741209|NCT01794780|540181562|FG000|Overall Study|Other|0|||
149741210|NCT01794780|540181563|FG001|Overall Study|Other|12|||
149741211|NCT01794780|540181564|FG002|Overall Study|Other|25|||
149741212|NCT01794780|540181565|FG003|Overall Study|Other|20|||
149741213|NCT01794780|540181566|FG004|Overall Study|Other|1|||
149741214|NCT01794780|540181567|FG005|Overall Study|Other|24|||
149741215|NCT01794780|540181568|FG006|Overall Study|Other|4|||
149741216|NCT01794780|540181569|FG007|Overall Study|Other|1|||
149741217|NCT00519077|540181570|FG000|Overall Study|Death|6|||
149741218|NCT00519077|540181570|FG000|Overall Study|Other|2|||
149741219|NCT01967225|540181571|FG000|Overall Study|Adverse Event|3|||
149741220|NCT01967225|540181572|FG001|Overall Study|Adverse Event|1|||
149741221|NCT01967225|540181571|FG000|Overall Study|Withdrawal by Subject|2|||
149741222|NCT01967225|540181572|FG001|Overall Study|Withdrawal by Subject|1|||
149741223|NCT01967225|540181571|FG000|Overall Study|Lack of Efficacy|1|||
149741224|NCT01967225|540181572|FG001|Overall Study|Lack of Efficacy|1|||
149741225|NCT01967225|540181571|FG000|Overall Study|Switching to other therapy|2|||
149741226|NCT01967225|540181572|FG001|Overall Study|Switching to other therapy|0|||
149741227|NCT01967225|540181571|FG000|Overall Study|Protocol driven decision point|1|||
149741228|NCT01967225|540181572|FG001|Overall Study|Protocol driven decision point|0|||
149741229|NCT01967225|540181571|FG000|Overall Study|Logistical difficulties|1|||
149741230|NCT01967225|540181572|FG001|Overall Study|Logistical difficulties|0|||
149741231|NCT01967225|540181571|FG000|Overall Study|Protocol Violation|2|||
149741232|NCT01967225|540181572|FG001|Overall Study|Protocol Violation|0|||
149741233|NCT00642642|540181575|FG000|Treatment & Follow Up|Adverse Event|2|||
149741234|NCT00642642|540181575|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
149741235|NCT00642642|540181575|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
149741236|NCT00332202|540181576|FG000|Overall Study|Adverse Event|72|||
150256072|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256073|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256074|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256075|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256076|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256077|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256078|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256079|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
150256080|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
150256081|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256082|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256083|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149741237|NCT00332202|540181577|FG001|Overall Study|Adverse Event|28|||
149741238|NCT00332202|540181576|FG000|Overall Study|Lost to Follow-up|2|||
149741239|NCT00332202|540181577|FG001|Overall Study|Lost to Follow-up|1|||
149741240|NCT00332202|540181576|FG000|Overall Study|Physician Decision|6|||
149741241|NCT00332202|540181577|FG001|Overall Study|Physician Decision|8|||
149741242|NCT00332202|540181576|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
149741243|NCT00332202|540181577|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
149741244|NCT00332202|540181576|FG000|Overall Study|Protocol Violation|7|||
149741245|NCT00332202|540181577|FG001|Overall Study|Protocol Violation|2|||
149741246|NCT00332202|540181576|FG000|Overall Study|Sponsor Decision|1|||
149741247|NCT00332202|540181577|FG001|Overall Study|Sponsor Decision|2|||
149741248|NCT00332202|540181576|FG000|Overall Study|Withdrawal by Subject|36|||
149741249|NCT00332202|540181577|FG001|Overall Study|Withdrawal by Subject|17|||
149741250|NCT00332202|540181576|FG000|Overall Study|Progressive Disease|106|||
149741251|NCT00332202|540181577|FG001|Overall Study|Progressive Disease|60|||
149741252|NCT00332202|540181576|FG000|Overall Study|Death|5|||
149741253|NCT00332202|540181577|FG001|Overall Study|Death|2|||
149741254|NCT00957853|540181578|FG000|Overall Study|Withdrawal by Subject|1|||
149741255|NCT00957853|540181579|FG001|Overall Study|Withdrawal by Subject|0|||
149741256|NCT00957853|540181580|FG002|Overall Study|Withdrawal by Subject|0|||
149741257|NCT02495948|540181583|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
149741258|NCT02495948|540181584|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
149741259|NCT02495948|540181583|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
149741260|NCT02495948|540181584|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
149741261|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
150256084|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149741262|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149741263|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149741264|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149741265|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149741266|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
149741267|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149741268|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
149741269|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
149741270|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149741271|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149741272|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
149741273|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
149741274|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
149741275|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149741276|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149741277|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149741278|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
149741279|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
149741280|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
149741281|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
149741282|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
149741283|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
149741284|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
149741285|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
149741286|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
149741287|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
149741288|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
149741289|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
149741290|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
149741291|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
149741292|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
149741293|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
149741294|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
149741295|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
149741296|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
149741297|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
149741298|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
149741299|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
149741300|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
149741301|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
150256085|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256086|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256087|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149741302|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
149741303|NCT00100048|540181585|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149801751|NCT01049360|540402429|FG015|Period 4|Withdrawal by Subject|0|||
149741304|NCT00100048|540181586|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149741305|NCT00100048|540181587|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149741306|NCT00100048|540181588|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
149741307|NCT00100048|540181589|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149741308|NCT00100048|540181590|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149741309|NCT01822561|540181592|FG000|Overall Study|Withdrawal by Subject|2|||
149741310|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
149741311|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
149741312|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149741313|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149741314|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149741315|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
149741316|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
149741317|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149741318|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149741319|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149741320|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
149741321|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149741322|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149741323|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149741324|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149741325|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
149741326|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149741327|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149741328|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149741329|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149741330|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Death|0|||
149741331|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Death|1|||
149741332|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Death|0|||
149741333|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Death|0|||
149741334|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Death|0|||
149741335|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149741336|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
149741337|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149741338|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149741339|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149741340|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
149741341|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149741342|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149741343|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149741344|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149741345|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
149741346|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149741347|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149741348|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149741349|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149741350|NCT05087030|540181593|FG000|Main Period (Week 0 to Week 52)|Other|1|||
149741351|NCT05087030|540181594|FG001|Main Period (Week 0 to Week 52)|Other|2|||
149741352|NCT05087030|540181595|FG002|Main Period (Week 0 to Week 52)|Other|0|||
149741353|NCT05087030|540181596|FG003|Main Period (Week 0 to Week 52)|Other|0|||
149741354|NCT05087030|540181597|FG004|Main Period (Week 0 to Week 52)|Other|0|||
149741355|NCT05087030|540181593|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149741356|NCT05087030|540181594|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149741357|NCT05087030|540181595|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149741358|NCT05087030|540181596|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149741359|NCT05087030|540181597|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
149741360|NCT02722044|540181598|FG000|Overall Study|Adverse Event|2|||
149741361|NCT02722044|540181598|FG000|Overall Study|Physician Decision|1|||
149741362|NCT02722044|540181598|FG000|Overall Study|Withdrawal by Subject|1|||
149741363|NCT02722044|540181598|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
149741364|NCT00818259|540181602|FG000|Part I|Withdrawal by Subject|1|||
149741365|NCT00818259|540181603|FG001|Part I|Withdrawal by Subject|0|||
149741366|NCT00818259|540181604|FG002|Part I|Withdrawal by Subject|0|||
149741367|NCT00818259|540181605|FG003|Part I|Withdrawal by Subject|0|||
149741368|NCT00818259|540181606|FG004|Part I|Withdrawal by Subject|0|||
149741369|NCT00818259|540181607|FG005|Part I|Withdrawal by Subject|0|||
149741370|NCT00818259|540181608|FG006|Part I|Withdrawal by Subject|0|||
149741371|NCT00818259|540181609|FG007|Part I|Withdrawal by Subject|0|||
149741372|NCT00818259|540181610|FG008|Part I|Withdrawal by Subject|0|||
149741373|NCT00818259|540181602|FG000|Part II|Physician Decision|0|||
149741374|NCT00818259|540181603|FG001|Part II|Physician Decision|0|||
149741375|NCT00818259|540181604|FG002|Part II|Physician Decision|1|||
149741376|NCT00818259|540181605|FG003|Part II|Physician Decision|0|||
149741377|NCT00818259|540181606|FG004|Part II|Physician Decision|0|||
149741378|NCT00818259|540181607|FG005|Part II|Physician Decision|0|||
149741379|NCT00818259|540181608|FG006|Part II|Physician Decision|0|||
149741380|NCT00818259|540181609|FG007|Part II|Physician Decision|0|||
149741381|NCT00818259|540181610|FG008|Part II|Physician Decision|0|||
149741382|NCT00818259|540181602|FG000|Part II|Lack of Efficacy|0|||
149741383|NCT00818259|540181603|FG001|Part II|Lack of Efficacy|0|||
149741384|NCT00818259|540181604|FG002|Part II|Lack of Efficacy|0|||
149741385|NCT00818259|540181605|FG003|Part II|Lack of Efficacy|1|||
149741386|NCT00818259|540181606|FG004|Part II|Lack of Efficacy|0|||
149741387|NCT00818259|540181607|FG005|Part II|Lack of Efficacy|0|||
149741388|NCT00818259|540181608|FG006|Part II|Lack of Efficacy|0|||
149741389|NCT00818259|540181609|FG007|Part II|Lack of Efficacy|0|||
149741390|NCT00818259|540181610|FG008|Part II|Lack of Efficacy|0|||
149741391|NCT00818259|540181602|FG000|Part II|Not Treated|0|||
149741392|NCT00818259|540181603|FG001|Part II|Not Treated|0|||
149741393|NCT00818259|540181604|FG002|Part II|Not Treated|0|||
149741394|NCT00818259|540181605|FG003|Part II|Not Treated|1|||
149741395|NCT00818259|540181606|FG004|Part II|Not Treated|0|||
149741396|NCT00818259|540181607|FG005|Part II|Not Treated|0|||
149741397|NCT00818259|540181608|FG006|Part II|Not Treated|0|||
149741398|NCT00818259|540181609|FG007|Part II|Not Treated|0|||
149741399|NCT00818259|540181610|FG008|Part II|Not Treated|0|||
149741400|NCT00818259|540181602|FG000|Part IV|Physician Decision|0|||
149741401|NCT00818259|540181603|FG001|Part IV|Physician Decision|0|||
149741402|NCT00818259|540181604|FG002|Part IV|Physician Decision|0|||
149741403|NCT00818259|540181605|FG003|Part IV|Physician Decision|0|||
149741404|NCT00818259|540181606|FG004|Part IV|Physician Decision|0|||
149741405|NCT00818259|540181607|FG005|Part IV|Physician Decision|1|||
149741406|NCT00818259|540181608|FG006|Part IV|Physician Decision|0|||
149741407|NCT00818259|540181609|FG007|Part IV|Physician Decision|0|||
149741408|NCT00818259|540181610|FG008|Part IV|Physician Decision|0|||
149741409|NCT00818259|540181602|FG000|Part V|Adverse Event|0|||
149741410|NCT00818259|540181603|FG001|Part V|Adverse Event|0|||
149741411|NCT00818259|540181604|FG002|Part V|Adverse Event|0|||
149741412|NCT00818259|540181605|FG003|Part V|Adverse Event|0|||
149741413|NCT00818259|540181606|FG004|Part V|Adverse Event|0|||
149741414|NCT00818259|540181607|FG005|Part V|Adverse Event|0|||
149741415|NCT00818259|540181608|FG006|Part V|Adverse Event|0|||
149741416|NCT00818259|540181609|FG007|Part V|Adverse Event|1|||
149741417|NCT00818259|540181610|FG008|Part V|Adverse Event|0|||
149741418|NCT00741819|540181611|FG000|Overall Study|Adverse Event|3|||
149741419|NCT00741819|540181611|FG000|Overall Study|Withdrawal by Subject|3|||
149741420|NCT00741819|540181611|FG000|Overall Study|Death|1|||
149741421|NCT00741819|540181611|FG000|Overall Study|Disease progression|1|||
149741422|NCT00609622|540181614|FG000|Overall Study|Adverse Event|14|||
149741423|NCT00609622|540181615|FG001|Overall Study|Adverse Event|10|||
149741424|NCT00609622|540181614|FG000|Overall Study|Withdrawal by Subject|4|||
149741425|NCT00609622|540181615|FG001|Overall Study|Withdrawal by Subject|20|||
149741426|NCT00609622|540181614|FG000|Overall Study|Death|1|||
149741427|NCT00609622|540181615|FG001|Overall Study|Death|4|||
149741428|NCT00609622|540181614|FG000|Overall Study|Protocol Violation|1|||
149741429|NCT00609622|540181615|FG001|Overall Study|Protocol Violation|1|||
149741430|NCT00609622|540181614|FG000|Overall Study|Objective progression or relapse|47|||
149741431|NCT00609622|540181615|FG001|Overall Study|Objective progression or relapse|41|||
149741432|NCT00609622|540181614|FG000|Overall Study|Study terminated by sponsor|16|||
149741433|NCT00609622|540181615|FG001|Overall Study|Study terminated by sponsor|3|||
149741434|NCT00609622|540181614|FG000|Overall Study|Other|7|||
149741435|NCT00609622|540181615|FG001|Overall Study|Other|14|||
149741436|NCT00609622|540181614|FG000|Overall Study|Global deterioration of health status|6|||
149741437|NCT00609622|540181615|FG001|Overall Study|Global deterioration of health status|2|||
149741438|NCT00686543|540181616|FG000|Overall Study|Adverse Event|9|||
149741439|NCT00686543|540181617|FG001|Overall Study|Adverse Event|1|||
149741440|NCT00686543|540181618|FG002|Overall Study|Adverse Event|3|||
149741441|NCT00686543|540181619|FG003|Overall Study|Adverse Event|2|||
149741442|NCT00686543|540181616|FG000|Overall Study|Withdrawal by Subject|2|||
149741443|NCT00686543|540181617|FG001|Overall Study|Withdrawal by Subject|0|||
149741444|NCT00686543|540181618|FG002|Overall Study|Withdrawal by Subject|0|||
149741445|NCT00686543|540181619|FG003|Overall Study|Withdrawal by Subject|0|||
149741446|NCT00686543|540181616|FG000|Overall Study|Protocol Violation|3|||
149741447|NCT00686543|540181617|FG001|Overall Study|Protocol Violation|0|||
149741448|NCT00686543|540181618|FG002|Overall Study|Protocol Violation|2|||
149741449|NCT00686543|540181619|FG003|Overall Study|Protocol Violation|1|||
149741450|NCT01237951|540181622|FG000|Overall Study|Death|1|||
149741451|NCT00924703|540181628|FG000|Overall Study|Withdrawal by Subject|11|||
149741452|NCT00924703|540181628|FG000|Overall Study|Physician Decision|5|||
149741453|NCT00924703|540181628|FG000|Overall Study|Lost to Follow-up|3|||
149741454|NCT00924703|540181628|FG000|Overall Study|Adverse Event|2|||
149741455|NCT00924703|540181628|FG000|Overall Study|Withdrawal by Sponsor|1|||
149741456|NCT00666562|540181629|FG000|Overall Study|Withdrawal by Subject|0|||
149741457|NCT00666562|540181630|FG001|Overall Study|Withdrawal by Subject|1|||
149741458|NCT00666562|540181631|FG002|Overall Study|Withdrawal by Subject|0|||
149741459|NCT00666562|540181629|FG000|Overall Study|Concomitant Medication|0|||
149741460|NCT00666562|540181630|FG001|Overall Study|Concomitant Medication|1|||
149741461|NCT00666562|540181631|FG002|Overall Study|Concomitant Medication|0|||
149741462|NCT01523873|540181632|FG000|Overall Study|Protocol Violation|422|||
149741463|NCT04429022|540181635|FG000|Overall Study|Protocol Violation|18|||
149741464|NCT04429022|540181636|FG001|Overall Study|Protocol Violation|1|||
149741465|NCT00275561|540181637|FG000|Overall Study|Withdrawal by Subject|0|||
149741466|NCT00275561|540181638|FG001|Overall Study|Withdrawal by Subject|1|||
149741467|NCT00275561|540181637|FG000|Overall Study|Travel|1|||
149741468|NCT00275561|540181638|FG001|Overall Study|Travel|1|||
149741469|NCT00275561|540181637|FG000|Overall Study|Scheduling|1|||
149741470|NCT00275561|540181638|FG001|Overall Study|Scheduling|2|||
149741471|NCT00275561|540181637|FG000|Overall Study|Family Issues|0|||
149741472|NCT00275561|540181638|FG001|Overall Study|Family Issues|2|||
149741473|NCT01769105|540181643|FG000|First Intervention|Protocol Violation|2|||
149741474|NCT01769105|540181644|FG001|First Intervention|Protocol Violation|2|||
149741475|NCT01769105|540181643|FG000|Cross-over|Lost to Follow-up|5|||
149741476|NCT01769105|540181644|FG001|Cross-over|Lost to Follow-up|0|||
149741477|NCT00377962|540182791|FG000|Core Study: 0-12 Months|Adverse Event|18|||
149741478|NCT00377962|540182792|FG001|Core Study: 0-12 Months|Adverse Event|2|||
149741479|NCT00377962|540182791|FG000|Core Study: 0-12 Months|Death|3|||
149741480|NCT00377962|540182792|FG001|Core Study: 0-12 Months|Death|0|||
149741481|NCT00377962|540182791|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
149741482|NCT00377962|540182792|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
149741483|NCT00377962|540182791|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
149741484|NCT00377962|540182792|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
149741485|NCT00377962|540182791|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
149741486|NCT00377962|540182792|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
149741487|NCT00377962|540182791|FG000|Extension Study: 12-24 Months|Death|1|||
149741488|NCT00377962|540182792|FG001|Extension Study: 12-24 Months|Death|1|||
149741489|NCT00377962|540182791|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
149741490|NCT00377962|540182792|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
149741491|NCT00377962|540182791|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
149741492|NCT00377962|540182792|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
149741493|NCT00377962|540182791|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
149741494|NCT00377962|540182792|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
149741495|NCT00686205|540182793|FG000|Overall Study|Protocol Violation|127|||
149741496|NCT00686205|540182794|FG001|Overall Study|Protocol Violation|0|||
149741497|NCT00686205|540182793|FG000|Overall Study|Withdrawal by Subject|2|||
149741498|NCT00686205|540182794|FG001|Overall Study|Withdrawal by Subject|0|||
149741499|NCT00686205|540182793|FG000|Overall Study|Specimen handling procedure altered|5878|||
149741500|NCT00686205|540182794|FG001|Overall Study|Specimen handling procedure altered|0|||
149741501|NCT00686205|540182793|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
149741502|NCT00686205|540182794|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
149741503|NCT02635204|540182801|FG000|Overall Study|Adverse Event|1|||
149741504|NCT02635204|540182802|FG001|Overall Study|Adverse Event|0|||
149741505|NCT02635204|540182801|FG000|Overall Study|Lost to Follow-up|1|||
149741506|NCT02635204|540182802|FG001|Overall Study|Lost to Follow-up|1|||
149741507|NCT03075839|540182809|FG000|Overall Study|Lost to Follow-up|4|||
149741508|NCT02469246|540182810|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
149741509|NCT02469246|540182811|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
149741510|NCT02469246|540182810|FG000|Double-Blind Phase|Adverse Event|12|||
149741511|NCT02469246|540182811|FG001|Double-Blind Phase|Adverse Event|9|||
149741512|NCT02469246|540182810|FG000|Double-Blind Phase|Death|2|||
149741513|NCT02469246|540182811|FG001|Double-Blind Phase|Death|0|||
149741514|NCT02469246|540182810|FG000|Double-Blind Phase|Lack of Efficacy|2|||
149741515|NCT02469246|540182811|FG001|Double-Blind Phase|Lack of Efficacy|1|||
149741516|NCT02469246|540182810|FG000|Double-Blind Phase|Investigator's Discretion|8|||
149741517|NCT02469246|540182811|FG001|Double-Blind Phase|Investigator's Discretion|8|||
149741518|NCT02469246|540182810|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
149741519|NCT02469246|540182811|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
149741520|NCT02469246|540182810|FG000|Double-Blind Phase|Protocol Violation|1|||
149741521|NCT02469246|540182811|FG001|Double-Blind Phase|Protocol Violation|1|||
149741522|NCT02469246|540182810|FG000|Double-Blind Phase|Withdrew Consent|25|||
149741523|NCT02469246|540182811|FG001|Double-Blind Phase|Withdrew Consent|25|||
149741524|NCT02469246|540182810|FG000|Double-Blind Phase|Lost to Follow-up|9|||
149741525|NCT02469246|540182811|FG001|Double-Blind Phase|Lost to Follow-up|5|||
149741526|NCT01658514|540182819|FG000|Overall Study|Protocol Violation|1|||
149741527|NCT01658514|540182820|FG001|Overall Study|Protocol Violation|0|||
149741528|NCT01658514|540182821|FG002|Overall Study|Protocol Violation|2|||
149741529|NCT01275222|540182822|FG000|Phase l by Treatment|Adverse Event|1|||
149741530|NCT01275222|540182823|FG001|Phase l by Treatment|Adverse Event|4|||
149741531|NCT01275222|540182824|FG002|Phase l by Treatment|Adverse Event|2|||
149741532|NCT01275222|540182825|FG003|Phase l by Treatment|Adverse Event|3|||
149741533|NCT01275222|540182826|FG004|Phase l by Treatment|Adverse Event|0|||
149741534|NCT01275222|540182827|FG005|Phase l by Treatment|Adverse Event|0|||
149741535|NCT01275222|540182822|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149741536|NCT01275222|540182823|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149741537|NCT01275222|540182824|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
149741538|NCT01275222|540182825|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149741539|NCT01275222|540182826|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149741540|NCT01275222|540182827|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149741541|NCT01275222|540182822|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149741542|NCT01275222|540182823|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149741543|NCT01275222|540182824|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149741544|NCT01275222|540182825|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
149741545|NCT01275222|540182826|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149741546|NCT01275222|540182827|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149741547|NCT01275222|540182822|FG000|Phase l by Treatment|Disease progression|12|||
149741548|NCT01275222|540182823|FG001|Phase l by Treatment|Disease progression|8|||
149741549|NCT01275222|540182824|FG002|Phase l by Treatment|Disease progression|2|||
149741550|NCT01275222|540182825|FG003|Phase l by Treatment|Disease progression|5|||
149741551|NCT01275222|540182826|FG004|Phase l by Treatment|Disease progression|0|||
149741552|NCT01275222|540182827|FG005|Phase l by Treatment|Disease progression|0|||
149741553|NCT01275222|540182822|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
149741554|NCT01275222|540182823|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
149741555|NCT01275222|540182824|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
149741556|NCT01275222|540182825|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
149741557|NCT01275222|540182826|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
149741558|NCT01275222|540182827|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
149741559|NCT01275222|540182822|FG000|Phase l by Treatment|Death|0|||
149741560|NCT01275222|540182823|FG001|Phase l by Treatment|Death|1|||
149741561|NCT01275222|540182824|FG002|Phase l by Treatment|Death|0|||
149741562|NCT01275222|540182825|FG003|Phase l by Treatment|Death|1|||
149741563|NCT01275222|540182826|FG004|Phase l by Treatment|Death|0|||
149741564|NCT01275222|540182827|FG005|Phase l by Treatment|Death|0|||
149741565|NCT01275222|540182822|FG000|Phase ll by Stratum|Adverse Event|0|||
149741566|NCT01275222|540182823|FG001|Phase ll by Stratum|Adverse Event|0|||
149741567|NCT01275222|540182824|FG002|Phase ll by Stratum|Adverse Event|0|||
149741568|NCT01275222|540182825|FG003|Phase ll by Stratum|Adverse Event|0|||
149741569|NCT01275222|540182826|FG004|Phase ll by Stratum|Adverse Event|2|||
149741570|NCT01275222|540182827|FG005|Phase ll by Stratum|Adverse Event|10|||
149741571|NCT01275222|540182822|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
149741572|NCT01275222|540182823|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
149741573|NCT01275222|540182824|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
149741574|NCT01275222|540182825|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
149741575|NCT01275222|540182826|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
149741576|NCT01275222|540182827|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
149741577|NCT01275222|540182822|FG000|Phase ll by Stratum|Disease progression|0|||
149741578|NCT01275222|540182823|FG001|Phase ll by Stratum|Disease progression|0|||
149741579|NCT01275222|540182824|FG002|Phase ll by Stratum|Disease progression|0|||
149741580|NCT01275222|540182825|FG003|Phase ll by Stratum|Disease progression|0|||
150256088|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256089|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256090|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256091|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256092|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
150256093|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256094|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
150256095|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256096|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256097|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256098|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149741581|NCT01275222|540182826|FG004|Phase ll by Stratum|Disease progression|23|||
149741582|NCT01275222|540182827|FG005|Phase ll by Stratum|Disease progression|31|||
149741583|NCT01275222|540182822|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
149741584|NCT01275222|540182823|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
149741585|NCT01275222|540182824|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
149741586|NCT01275222|540182825|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
149741587|NCT01275222|540182826|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
149741588|NCT01275222|540182827|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
149741589|NCT01275222|540182822|FG000|Phase ll by Stratum|Death|0|||
149741590|NCT01275222|540182823|FG001|Phase ll by Stratum|Death|0|||
149741591|NCT01275222|540182824|FG002|Phase ll by Stratum|Death|0|||
149741592|NCT01275222|540182825|FG003|Phase ll by Stratum|Death|0|||
149741593|NCT01275222|540182826|FG004|Phase ll by Stratum|Death|1|||
149741594|NCT01275222|540182827|FG005|Phase ll by Stratum|Death|1|||
149741595|NCT00144170|540182829|FG000|Overall Study|Adverse Event|84|||
149741596|NCT00144170|540182830|FG001|Overall Study|Adverse Event|41|||
149741597|NCT00144170|540182829|FG000|Overall Study|Protocol Violation|23|||
149741598|NCT00144170|540182830|FG001|Overall Study|Protocol Violation|16|||
149741599|NCT00144170|540182829|FG000|Overall Study|Lost to Follow-up|5|||
149741600|NCT00144170|540182830|FG001|Overall Study|Lost to Follow-up|10|||
149741601|NCT00144170|540182829|FG000|Overall Study|Withdrawal by Subject|29|||
149741602|NCT00144170|540182830|FG001|Overall Study|Withdrawal by Subject|13|||
149741603|NCT00144170|540182829|FG000|Overall Study|Other reason not defined above|211|||
149741604|NCT00144170|540182830|FG001|Overall Study|Other reason not defined above|316|||
149741605|NCT03871491|540182833|FG000|Overall Study|Withdrawal by Subject|14|||
149741606|NCT03871491|540182834|FG001|Overall Study|Withdrawal by Subject|14|||
149741607|NCT03871491|540182835|FG002|Overall Study|Withdrawal by Subject|14|||
149741608|NCT03871491|540182836|FG003|Overall Study|Withdrawal by Subject|14|||
149741609|NCT03871491|540182833|FG000|Overall Study|Physician Decision|0|||
149741610|NCT03871491|540182834|FG001|Overall Study|Physician Decision|0|||
149741611|NCT03871491|540182835|FG002|Overall Study|Physician Decision|1|||
149741612|NCT03871491|540182836|FG003|Overall Study|Physician Decision|1|||
149741613|NCT03871491|540182833|FG000|Overall Study|Lost to Follow-up|50|||
149741614|NCT03871491|540182834|FG001|Overall Study|Lost to Follow-up|15|||
149741615|NCT03871491|540182835|FG002|Overall Study|Lost to Follow-up|36|||
149741616|NCT03871491|540182836|FG003|Overall Study|Lost to Follow-up|11|||
149741617|NCT05202808|540182837|FG000|Overall Study|Lost to Follow-up|3|||
149741618|NCT05202808|540182838|FG001|Overall Study|Lost to Follow-up|1|||
149741619|NCT04996797|540182839|FG000|Overall Study|Adverse Event|0|||
149741620|NCT04996797|540182840|FG001|Overall Study|Adverse Event|2|||
149741621|NCT04996797|540182841|FG002|Overall Study|Adverse Event|0|||
149741622|NCT04996797|540182842|FG003|Overall Study|Adverse Event|1|||
149741623|NCT04996797|540182839|FG000|Overall Study|Lack of Efficacy|0|||
149741624|NCT04996797|540182840|FG001|Overall Study|Lack of Efficacy|2|||
149741625|NCT04996797|540182841|FG002|Overall Study|Lack of Efficacy|0|||
149741626|NCT04996797|540182842|FG003|Overall Study|Lack of Efficacy|0|||
149741627|NCT04996797|540182839|FG000|Overall Study|Prohibited Medication|0|||
149741628|NCT04996797|540182840|FG001|Overall Study|Prohibited Medication|1|||
149741629|NCT04996797|540182841|FG002|Overall Study|Prohibited Medication|0|||
149741630|NCT04996797|540182842|FG003|Overall Study|Prohibited Medication|0|||
149741631|NCT04996797|540182839|FG000|Overall Study|Ongoing|68|||
149741632|NCT04996797|540182840|FG001|Overall Study|Ongoing|60|||
149741633|NCT04996797|540182841|FG002|Overall Study|Ongoing|22|||
149741634|NCT04996797|540182842|FG003|Overall Study|Ongoing|20|||
149741635|NCT04996797|540182839|FG000|Overall Study|Withdrawal by Subject|0|||
149741636|NCT04996797|540182840|FG001|Overall Study|Withdrawal by Subject|2|||
149741637|NCT04996797|540182841|FG002|Overall Study|Withdrawal by Subject|0|||
149741638|NCT04996797|540182842|FG003|Overall Study|Withdrawal by Subject|0|||
149741639|NCT04091217|540182843|FG000|Overall Study|Lost to Follow-up|2|||
149741640|NCT02747004|540182845|FG000|Overall Study|Withdrawal by Subject|8|||
149741641|NCT02747004|540182846|FG001|Overall Study|Withdrawal by Subject|5|||
149741642|NCT02747004|540182847|FG002|Overall Study|Withdrawal by Subject|4|||
149741643|NCT02747004|540182845|FG000|Overall Study|Lost to Follow-up|1|||
149741644|NCT02747004|540182846|FG001|Overall Study|Lost to Follow-up|2|||
149741645|NCT02747004|540182847|FG002|Overall Study|Lost to Follow-up|2|||
149741646|NCT02747004|540182845|FG000|Overall Study|on study treatment/follow-up|48|||
149741647|NCT02747004|540182846|FG001|Overall Study|on study treatment/follow-up|42|||
149741648|NCT02747004|540182847|FG002|Overall Study|on study treatment/follow-up|41|||
149741649|NCT01444300|540182848|FG000|Overall Study|Adverse Event|4|||
149741650|NCT01444300|540182849|FG001|Overall Study|Adverse Event|0|||
149741651|NCT04826900|540182850|FG000|Overall Study|Family factor|1|||
149741652|NCT04826900|540182851|FG001|Overall Study|Family factor|1|||
149741653|NCT04885257|540182852|FG000|Overall Study|Withdrawal by Subject|1|||
149741654|NCT04885257|540182853|FG001|Overall Study|Withdrawal by Subject|0|||
149741655|NCT02597062|540182854|FG000|Overall Study|Ineligible|1|||
149741656|NCT03372941|540182855|FG000|Overall Study|Lost to Follow-up|2|||
149741657|NCT03372941|540182856|FG001|Overall Study|Lost to Follow-up|4|||
149741658|NCT01708057|540182857|FG000|Overall Study|Withdrawal due to study termination.|1|||
149741659|NCT01708057|540182858|FG001|Overall Study|Withdrawal due to study termination.|1|||
149741660|NCT01708057|540182859|FG002|Overall Study|Withdrawal due to study termination.|1|||
149741661|NCT01697345|540182860|FG000|Overall Study|Withdrawal by Subject|1|||
149741662|NCT02970929|540182861|FG000|Overall Study|Adverse Event|18|||
149741663|NCT02970929|540182861|FG000|Overall Study|Lack of Efficacy|8|||
149741664|NCT02970929|540182861|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
149741665|NCT02970929|540182861|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
149741666|NCT02970929|540182861|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
149741667|NCT02970929|540182861|FG000|Overall Study|LOST TO FOLLOWUP|6|||
149741668|NCT02970929|540182861|FG000|Overall Study|MOVED OUT OF STATE|1|||
149741669|NCT02970929|540182861|FG000|Overall Study|Withdrawal by Subject|16|||
149741670|NCT02370121|540182870|FG000|Overall Study|Lost to Follow-up|1|||
149741671|NCT02370121|540182871|FG001|Overall Study|Lost to Follow-up|1|||
149741672|NCT03929250|540182876|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
149741673|NCT03929250|540182877|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
149741674|NCT05262764|540182879|FG000|Overall Study|Case report form not collected|9|||
149741675|NCT05262764|540182879|FG000|Overall Study|No patient visits after entry|23|||
149741676|NCT05262764|540182879|FG000|Overall Study|Registration rule not followed|2|||
149741677|NCT05262764|540182879|FG000|Overall Study|Patient of non-chronic heart failure|1|||
149741678|NCT01392183|540182880|FG000|First Drug Administration|Adverse Event|3|||
149741679|NCT01392183|540182881|FG001|First Drug Administration|Adverse Event|2|||
149741680|NCT01392183|540182880|FG000|First Drug Administration|Death|1|||
149741681|NCT01392183|540182881|FG001|First Drug Administration|Death|0|||
149741682|NCT01392183|540182880|FG000|First Drug Administration|Withdrawal by Subject|10|||
149741683|NCT01392183|540182881|FG001|First Drug Administration|Withdrawal by Subject|17|||
149741684|NCT01024244|540184456|FG000|Overall Study|Adverse Event|1|||
149741685|NCT01024244|540184457|FG001|Overall Study|Adverse Event|2|||
149741686|NCT01024244|540184458|FG002|Overall Study|Adverse Event|0|||
149741687|NCT01024244|540184459|FG003|Overall Study|Adverse Event|1|||
149741688|NCT01024244|540184460|FG004|Overall Study|Adverse Event|2|||
149741689|NCT01024244|540184456|FG000|Overall Study|Entry Criteria Not Met|0|||
149741690|NCT01024244|540184457|FG001|Overall Study|Entry Criteria Not Met|1|||
149741691|NCT01024244|540184458|FG002|Overall Study|Entry Criteria Not Met|0|||
149741692|NCT01024244|540184459|FG003|Overall Study|Entry Criteria Not Met|0|||
149741693|NCT01024244|540184460|FG004|Overall Study|Entry Criteria Not Met|0|||
149741694|NCT01024244|540184456|FG000|Overall Study|Lack of Efficacy|1|||
149741695|NCT01024244|540184457|FG001|Overall Study|Lack of Efficacy|0|||
149741696|NCT01024244|540184458|FG002|Overall Study|Lack of Efficacy|0|||
149741697|NCT01024244|540184459|FG003|Overall Study|Lack of Efficacy|0|||
149741698|NCT01024244|540184460|FG004|Overall Study|Lack of Efficacy|0|||
149741699|NCT01024244|540184456|FG000|Overall Study|Protocol Violation|1|||
149741700|NCT01024244|540184457|FG001|Overall Study|Protocol Violation|0|||
149741701|NCT01024244|540184458|FG002|Overall Study|Protocol Violation|0|||
149741702|NCT01024244|540184459|FG003|Overall Study|Protocol Violation|0|||
149741703|NCT01024244|540184460|FG004|Overall Study|Protocol Violation|2|||
149741704|NCT01024244|540184456|FG000|Overall Study|Sponsor Decision|14|||
149741705|NCT01024244|540184457|FG001|Overall Study|Sponsor Decision|7|||
149741706|NCT01024244|540184458|FG002|Overall Study|Sponsor Decision|14|||
149741707|NCT01024244|540184459|FG003|Overall Study|Sponsor Decision|12|||
149741708|NCT01024244|540184460|FG004|Overall Study|Sponsor Decision|10|||
149741709|NCT01024244|540184456|FG000|Overall Study|Withdrawal by Subject|0|||
149741710|NCT01024244|540184457|FG001|Overall Study|Withdrawal by Subject|1|||
149741711|NCT01024244|540184458|FG002|Overall Study|Withdrawal by Subject|0|||
149741712|NCT01024244|540184459|FG003|Overall Study|Withdrawal by Subject|0|||
149741713|NCT01024244|540184460|FG004|Overall Study|Withdrawal by Subject|0|||
149741714|NCT00265941|540184466|FG000|Overall Study|Protocol Violation|22|||
149741715|NCT00265941|540184467|FG001|Overall Study|Protocol Violation|25|||
149741716|NCT00265941|540184466|FG000|Overall Study|Lost to Follow-up|1|||
149741717|NCT00265941|540184467|FG001|Overall Study|Lost to Follow-up|1|||
149741718|NCT02432807|540184470|FG000|Overall Study|Adverse Event|0|||
149741719|NCT02432807|540184471|FG001|Overall Study|Adverse Event|2|||
149741720|NCT02432807|540184470|FG000|Overall Study|Lost to Follow-up|1|||
149741721|NCT02432807|540184471|FG001|Overall Study|Lost to Follow-up|0|||
149741722|NCT02432807|540184470|FG000|Overall Study|Withdrawal by Subject|1|||
149741723|NCT02432807|540184471|FG001|Overall Study|Withdrawal by Subject|1|||
149741724|NCT02432807|540184470|FG000|Overall Study|Other|1|||
149741725|NCT02432807|540184471|FG001|Overall Study|Other|1|||
149741726|NCT03976401|540184472|FG000|Overall Study|Adverse Event|2|||
149741727|NCT03976401|540184473|FG001|Overall Study|Adverse Event|0|||
149741728|NCT03976401|540184474|FG002|Overall Study|Adverse Event|4|||
149741729|NCT03976401|540184475|FG003|Overall Study|Adverse Event|1|||
149741730|NCT03976401|540184476|FG004|Overall Study|Adverse Event|1|||
149741731|NCT03976401|540184477|FG005|Overall Study|Adverse Event|0|||
149741732|NCT03976401|540184472|FG000|Overall Study|Withdrawal by Subject|0|||
149741733|NCT03976401|540184473|FG001|Overall Study|Withdrawal by Subject|1|||
149741734|NCT03976401|540184474|FG002|Overall Study|Withdrawal by Subject|0|||
149741735|NCT03976401|540184475|FG003|Overall Study|Withdrawal by Subject|0|||
149741736|NCT03976401|540184476|FG004|Overall Study|Withdrawal by Subject|0|||
149741737|NCT03976401|540184477|FG005|Overall Study|Withdrawal by Subject|1|||
149741738|NCT03976401|540184472|FG000|Overall Study|Physician Decision|0|||
149741739|NCT03976401|540184473|FG001|Overall Study|Physician Decision|0|||
149741740|NCT03976401|540184474|FG002|Overall Study|Physician Decision|1|||
149741741|NCT03976401|540184475|FG003|Overall Study|Physician Decision|0|||
149741742|NCT03976401|540184476|FG004|Overall Study|Physician Decision|0|||
149741743|NCT03976401|540184477|FG005|Overall Study|Physician Decision|0|||
149741744|NCT03976401|540184472|FG000|Overall Study|Lost to Follow-up|1|||
149741745|NCT03976401|540184473|FG001|Overall Study|Lost to Follow-up|2|||
149741746|NCT03976401|540184474|FG002|Overall Study|Lost to Follow-up|0|||
149741747|NCT03976401|540184475|FG003|Overall Study|Lost to Follow-up|0|||
149741748|NCT03976401|540184476|FG004|Overall Study|Lost to Follow-up|0|||
149741749|NCT03976401|540184477|FG005|Overall Study|Lost to Follow-up|0|||
149741750|NCT03976401|540184472|FG000|Overall Study|Protocol Violation|0|||
149741751|NCT03976401|540184473|FG001|Overall Study|Protocol Violation|1|||
149741752|NCT03976401|540184474|FG002|Overall Study|Protocol Violation|0|||
149741753|NCT03976401|540184475|FG003|Overall Study|Protocol Violation|0|||
149741754|NCT03976401|540184476|FG004|Overall Study|Protocol Violation|0|||
149741755|NCT03976401|540184477|FG005|Overall Study|Protocol Violation|0|||
149741756|NCT03976401|540184472|FG000|Overall Study|Withdrew Consent|0|||
149741757|NCT03976401|540184473|FG001|Overall Study|Withdrew Consent|0|||
149741758|NCT03976401|540184474|FG002|Overall Study|Withdrew Consent|0|||
149741759|NCT03976401|540184475|FG003|Overall Study|Withdrew Consent|1|||
149741760|NCT03976401|540184476|FG004|Overall Study|Withdrew Consent|0|||
149741761|NCT03976401|540184477|FG005|Overall Study|Withdrew Consent|0|||
149741762|NCT02966314|540184478|FG000|Overall Study|Lost to Follow-up|1|||
149741763|NCT02966314|540184479|FG001|Overall Study|Lost to Follow-up|0|||
149741764|NCT00828464|540184480|FG000|Overall Study|Withdrawal by Subject|1|||
149741765|NCT00502840|540184481|FG000|Overall Study|Adverse Event|5|||
149741766|NCT00502840|540184481|FG000|Overall Study|Additional or changed therapy|48|||
149741767|NCT00502840|540184481|FG000|Overall Study|Lack of Efficacy|11|||
149741768|NCT00502840|540184481|FG000|Overall Study|Protocol Violation|4|||
149741769|NCT00502840|540184481|FG000|Overall Study|Withdrawal by Subject|5|||
149741770|NCT00502840|540184481|FG000|Overall Study|Lost to Follow-up|6|||
149741771|NCT00502840|540184481|FG000|Overall Study|Administrative problems|1|||
149741772|NCT00502840|540184481|FG000|Overall Study|Other|20|||
149741773|NCT02197377|540184482|FG000|Overall Study|Insertion Failure|0|||
149741774|NCT02197377|540184483|FG001|Overall Study|Insertion Failure|3|||
149741775|NCT01974323|540184484|FG000|Overall Study|Other Reasons|25|||
149741776|NCT01974323|540184485|FG001|Overall Study|Other Reasons|28|||
149741777|NCT01974323|540184484|FG000|Overall Study|Protocol Violation|2|||
149741778|NCT01974323|540184485|FG001|Overall Study|Protocol Violation|2|||
149741779|NCT01974323|540184484|FG000|Overall Study|Personal Reasons|15|||
149741780|NCT01974323|540184485|FG001|Overall Study|Personal Reasons|19|||
149741781|NCT01974323|540184484|FG000|Overall Study|Lost to Follow-up|45|||
149741782|NCT01974323|540184485|FG001|Overall Study|Lost to Follow-up|40|||
149741783|NCT01974323|540184484|FG000|Overall Study|Pregnancy|2|||
149741784|NCT01974323|540184485|FG001|Overall Study|Pregnancy|1|||
149741785|NCT01974323|540184484|FG000|Overall Study|Lack of Efficacy|1|||
149741786|NCT01974323|540184485|FG001|Overall Study|Lack of Efficacy|1|||
149741787|NCT01974323|540184484|FG000|Overall Study|Adverse Event|2|||
149741788|NCT01974323|540184485|FG001|Overall Study|Adverse Event|2|||
149741789|NCT00466505|540184487|FG000|Overall Study|disease progression|13|||
149741790|NCT00466505|540184487|FG000|Overall Study|Adverse Event|4|||
149741791|NCT01241786|540184495|FG000|Overall Study|Lack of Efficacy|5|||
149741792|NCT02886715|540184496|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149741793|NCT02886715|540184497|FG001|Overall Study|Non-Compliance With Study Drug|2|||
149741794|NCT02886715|540184498|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149741795|NCT02886715|540184496|FG000|Overall Study|Adverse Event|4|||
149741796|NCT02886715|540184497|FG001|Overall Study|Adverse Event|2|||
149741797|NCT02886715|540184498|FG002|Overall Study|Adverse Event|0|||
149741798|NCT02886715|540184496|FG000|Overall Study|Lack of Efficacy|0|||
149741799|NCT02886715|540184497|FG001|Overall Study|Lack of Efficacy|2|||
149741800|NCT02886715|540184498|FG002|Overall Study|Lack of Efficacy|1|||
149741801|NCT02886715|540184496|FG000|Overall Study|Lost to Follow-up|29|||
149741802|NCT02886715|540184497|FG001|Overall Study|Lost to Follow-up|26|||
149741803|NCT02886715|540184498|FG002|Overall Study|Lost to Follow-up|10|||
149741804|NCT02886715|540184496|FG000|Overall Study|Pregnancy|1|||
149741805|NCT02886715|540184497|FG001|Overall Study|Pregnancy|1|||
149741806|NCT02886715|540184498|FG002|Overall Study|Pregnancy|1|||
149741807|NCT02886715|540184496|FG000|Overall Study|Protocol Violation|3|||
149741808|NCT02886715|540184497|FG001|Overall Study|Protocol Violation|2|||
149741809|NCT02886715|540184498|FG002|Overall Study|Protocol Violation|1|||
149741810|NCT02886715|540184496|FG000|Overall Study|Withdrawal by Subject|20|||
149741811|NCT02886715|540184497|FG001|Overall Study|Withdrawal by Subject|18|||
149741812|NCT02886715|540184498|FG002|Overall Study|Withdrawal by Subject|5|||
149741813|NCT02886715|540184496|FG000|Overall Study|missing|7|||
149741814|NCT02886715|540184497|FG001|Overall Study|missing|2|||
149741815|NCT02886715|540184498|FG002|Overall Study|missing|2|||
149741816|NCT00503399|540184499|FG000|Overall Study|Death|2|||
149741817|NCT00503399|540184500|FG001|Overall Study|Death|1|||
149741818|NCT00503399|540184499|FG000|Overall Study|Protocol Violation|1|||
149741819|NCT00503399|540184500|FG001|Overall Study|Protocol Violation|0|||
149741820|NCT00503399|540184499|FG000|Overall Study|Withdrawal by Subject|4|||
149741821|NCT00503399|540184500|FG001|Overall Study|Withdrawal by Subject|2|||
149741822|NCT00503399|540184499|FG000|Overall Study|Adverse Event|0|||
149741823|NCT00503399|540184500|FG001|Overall Study|Adverse Event|3|||
149741824|NCT00503399|540184499|FG000|Overall Study|Lost to Follow-up|0|||
149741825|NCT00503399|540184500|FG001|Overall Study|Lost to Follow-up|2|||
149741826|NCT01676961|540184501|FG000|Overall Study|Death|3|||
149741827|NCT01676961|540184501|FG000|Overall Study|Lost to Follow-up|1|||
149741828|NCT01676961|540184501|FG000|Overall Study|Withdrawal by Subject|1|||
149741829|NCT03812510|540184502|FG000|Overall Study|Lost to Follow-up|39|||
149741830|NCT03812510|540184502|FG000|Overall Study|Withdrawal by Subject|42|||
149741831|NCT03812510|540184502|FG000|Overall Study|Physician Decision|2|||
149741832|NCT03812510|540184502|FG000|Overall Study|Study Terminated by Sponsor|9|||
149741833|NCT03812510|540184502|FG000|Overall Study|Did Not Start Study Medication|55|||
149741834|NCT03812510|540184502|FG000|Overall Study|Adverse Event|5|||
149741835|NCT00768560|540184505|FG000|Intervention Set 1|Adverse Event|0|||
149741836|NCT00768560|540184506|FG001|Intervention Set 1|Adverse Event|1|||
149741837|NCT00768560|540184507|FG002|Intervention Set 1|Adverse Event|0|||
149741838|NCT00768560|540184508|FG003|Intervention Set 1|Adverse Event|0|||
149741839|NCT00768560|540184509|FG004|Intervention Set 1|Adverse Event|0|||
149741840|NCT00768560|540184510|FG005|Intervention Set 1|Adverse Event|0|||
149741841|NCT00117312|540184511|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
149741842|NCT00117312|540184512|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
149741843|NCT00117312|540184513|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
149741844|NCT00117312|540184514|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
149741845|NCT00117312|540184511|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
149741846|NCT00117312|540184512|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
149741847|NCT00117312|540184513|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
149741848|NCT00117312|540184514|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
149741849|NCT00117312|540184511|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
149741850|NCT00117312|540184512|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
149741851|NCT00117312|540184513|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
149741852|NCT00117312|540184514|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
149741853|NCT00117312|540184511|FG000|Overall Study|Other|0|||
149741854|NCT00117312|540184512|FG001|Overall Study|Other|1|||
149741855|NCT00117312|540184513|FG002|Overall Study|Other|3|||
149741856|NCT00117312|540184514|FG003|Overall Study|Other|1|||
149741857|NCT00117312|540184511|FG000|Overall Study|Patient choice|0|||
149741858|NCT00117312|540184512|FG001|Overall Study|Patient choice|0|||
149741859|NCT00117312|540184513|FG002|Overall Study|Patient choice|2|||
149741860|NCT00117312|540184514|FG003|Overall Study|Patient choice|1|||
149741861|NCT00117312|540184511|FG000|Overall Study|Adverse Event|0|||
149741862|NCT00117312|540184512|FG001|Overall Study|Adverse Event|2|||
149741863|NCT00117312|540184513|FG002|Overall Study|Adverse Event|0|||
149741864|NCT00117312|540184514|FG003|Overall Study|Adverse Event|0|||
149741865|NCT00117312|540184511|FG000|Overall Study|Protocol Violation|0|||
149741866|NCT00117312|540184512|FG001|Overall Study|Protocol Violation|1|||
149741867|NCT00117312|540184513|FG002|Overall Study|Protocol Violation|3|||
149741868|NCT00117312|540184514|FG003|Overall Study|Protocol Violation|0|||
149741869|NCT00117312|540184511|FG000|Overall Study|PSA decrease <=50%|0|||
149741870|NCT00117312|540184512|FG001|Overall Study|PSA decrease <=50%|2|||
149741871|NCT00117312|540184513|FG002|Overall Study|PSA decrease <=50%|2|||
149741872|NCT00117312|540184514|FG003|Overall Study|PSA decrease <=50%|4|||
149741873|NCT00117312|540184511|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
149741874|NCT00117312|540184512|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
149741875|NCT00117312|540184513|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
149741876|NCT00117312|540184514|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
149741877|NCT00117312|540184511|FG000|Overall Study|Hepatic abnormality|0|||
149741878|NCT00117312|540184512|FG001|Overall Study|Hepatic abnormality|1|||
149741879|NCT00117312|540184513|FG002|Overall Study|Hepatic abnormality|0|||
149741880|NCT00117312|540184514|FG003|Overall Study|Hepatic abnormality|1|||
149741881|NCT00117312|540184511|FG000|Overall Study|Withdrawal by Subject|0|||
150256099|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149741882|NCT00117312|540184512|FG001|Overall Study|Withdrawal by Subject|2|||
149741883|NCT00117312|540184513|FG002|Overall Study|Withdrawal by Subject|0|||
149741884|NCT00117312|540184514|FG003|Overall Study|Withdrawal by Subject|0|||
149741885|NCT01128387|540184515|FG000|Overall Study|Physician Decision|0|||
149741886|NCT01128387|540184516|FG001|Overall Study|Physician Decision|1|||
149741887|NCT01535235|540184518|FG000|Overall Study|Adverse Event|1|||
149741888|NCT01535235|540184519|FG001|Overall Study|Adverse Event|0|||
149741889|NCT00824421|540184521|FG000|Overall Study|Adverse Event|6|||
149741890|NCT00824421|540184522|FG001|Overall Study|Adverse Event|6|||
149741891|NCT00824421|540184523|FG002|Overall Study|Adverse Event|6|||
149741892|NCT00824421|540184521|FG000|Overall Study|Death|0|||
149741893|NCT00824421|540184522|FG001|Overall Study|Death|1|||
149741894|NCT00824421|540184523|FG002|Overall Study|Death|0|||
149741895|NCT00824421|540184521|FG000|Overall Study|Lack of Efficacy|5|||
149741896|NCT00824421|540184522|FG001|Overall Study|Lack of Efficacy|7|||
149741897|NCT00824421|540184523|FG002|Overall Study|Lack of Efficacy|4|||
149741898|NCT00824421|540184521|FG000|Overall Study|Lost to Follow-up|2|||
149741899|NCT00824421|540184522|FG001|Overall Study|Lost to Follow-up|3|||
149741900|NCT00824421|540184523|FG002|Overall Study|Lost to Follow-up|0|||
149741901|NCT00824421|540184521|FG000|Overall Study|Pregnancy|1|||
149741902|NCT00824421|540184522|FG001|Overall Study|Pregnancy|0|||
149741903|NCT00824421|540184523|FG002|Overall Study|Pregnancy|1|||
149741904|NCT00824421|540184521|FG000|Overall Study|Withdrawal by Subject|2|||
149741905|NCT00824421|540184522|FG001|Overall Study|Withdrawal by Subject|3|||
149741906|NCT00824421|540184523|FG002|Overall Study|Withdrawal by Subject|3|||
149741907|NCT00824421|540184521|FG000|Overall Study|Randomized but not Treated|1|||
149741908|NCT00824421|540184522|FG001|Overall Study|Randomized but not Treated|1|||
149741909|NCT00824421|540184523|FG002|Overall Study|Randomized but not Treated|0|||
149741910|NCT00824421|540184521|FG000|Overall Study|Other|0|||
149741911|NCT00824421|540184522|FG001|Overall Study|Other|1|||
149741912|NCT00824421|540184523|FG002|Overall Study|Other|0|||
149741913|NCT05089708|540184525|FG000|Overall Study|Lost to Follow-up|9|||
149741914|NCT05089708|540184526|FG001|Overall Study|Lost to Follow-up|7|||
149741915|NCT05089708|540184525|FG000|Overall Study|Withdrawal by Subject|3|||
149741916|NCT05089708|540184526|FG001|Overall Study|Withdrawal by Subject|1|||
149741917|NCT05089708|540184525|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
149741918|NCT05089708|540184526|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
149741919|NCT05089708|540184525|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
149741920|NCT05089708|540184526|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
149741921|NCT02120417|540184527|FG000|Overall Study|Death|5|||
149741922|NCT02120417|540184528|FG001|Overall Study|Death|1|||
149741923|NCT02120417|540184527|FG000|Overall Study|Adverse Event|3|||
149741924|NCT02120417|540184528|FG001|Overall Study|Adverse Event|9|||
149741925|NCT02120417|540184527|FG000|Overall Study|Participant decision|4|||
149741926|NCT02120417|540184528|FG001|Overall Study|Participant decision|4|||
149741927|NCT02120417|540184527|FG000|Overall Study|Disease progression|41|||
149741928|NCT02120417|540184528|FG001|Overall Study|Disease progression|45|||
149741929|NCT02120417|540184527|FG000|Overall Study|Noncompliance with study treatment|0|||
149741930|NCT02120417|540184528|FG001|Overall Study|Noncompliance with study treatment|2|||
149741931|NCT02120417|540184527|FG000|Overall Study|Physician Decision|2|||
149741932|NCT02120417|540184528|FG001|Overall Study|Physician Decision|3|||
149741933|NCT02120417|540184527|FG000|Overall Study|Other unspecified|5|||
149741934|NCT02120417|540184528|FG001|Overall Study|Other unspecified|4|||
149741935|NCT00927485|540184529|FG000|Overall Study|Adverse Event|4|||
149741936|NCT00927485|540184530|FG001|Overall Study|Adverse Event|2|||
149741937|NCT00927485|540184529|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
149741938|NCT00927485|540184530|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
149741939|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
149741940|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
149741941|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
149741942|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
149741943|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
149741944|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
149741945|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Personal issues|2|||
149741946|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Personal issues|0|||
149741947|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Personal issues|0|||
149741948|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Too busy|7|||
149741949|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Too busy|1|||
149741950|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Too busy|0|||
149741951|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Pain|2|||
149741952|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Pain|0|||
149741953|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Pain|0|||
149741954|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Moved|1|||
149741955|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Moved|0|||
149741956|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Moved|0|||
149741957|NCT00594399|540184531|FG000|Initial 3 Month Counseling|Family illness|1|||
149741958|NCT00594399|540184532|FG001|Initial 3 Month Counseling|Family illness|0|||
149741959|NCT00594399|540184533|FG002|Initial 3 Month Counseling|Family illness|0|||
149741960|NCT00594399|540184531|FG000|Rerandomization Arm 1 Only|Death|2|||
149741961|NCT00594399|540184532|FG001|Rerandomization Arm 1 Only|Death|1|||
149741962|NCT00594399|540184533|FG002|Rerandomization Arm 1 Only|Death|0|||
149741963|NCT00594399|540184531|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
149741964|NCT00594399|540184532|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
149741965|NCT00594399|540184533|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
149741966|NCT01440101|540184534|FG000|Overall Study|Adverse Event|2|||
149741967|NCT01440101|540184535|FG001|Overall Study|Adverse Event|0|||
149741968|NCT01440101|540184536|FG002|Overall Study|Adverse Event|0|||
149741969|NCT01440101|540184534|FG000|Overall Study|Withdrawal by Subject|0|||
149741970|NCT01440101|540184535|FG001|Overall Study|Withdrawal by Subject|3|||
149741971|NCT01440101|540184536|FG002|Overall Study|Withdrawal by Subject|1|||
149741972|NCT01440101|540184534|FG000|Overall Study|Other|0|||
149741973|NCT01440101|540184535|FG001|Overall Study|Other|1|||
149741974|NCT01440101|540184536|FG002|Overall Study|Other|0|||
149741975|NCT00659438|540184537|FG000|Overall Study|Withdrawal by Subject|2|||
149741976|NCT00659438|540184538|FG001|Overall Study|Withdrawal by Subject|2|||
149741977|NCT00659438|540184537|FG000|Overall Study|Death|11|||
149741978|NCT00659438|540184538|FG001|Overall Study|Death|6|||
149741979|NCT00659438|540184537|FG000|Overall Study|Lost to Follow-up|1|||
149741980|NCT00659438|540184538|FG001|Overall Study|Lost to Follow-up|0|||
149741981|NCT01491945|540184542|FG000|Overall Study|Death|30|||
149741982|NCT01491945|540184542|FG000|Overall Study|Withdrwan/LTF|16|||
149741983|NCT01491945|540184542|FG000|Overall Study|Conversion|4|||
149741984|NCT01491945|540184542|FG000|Overall Study|Missed Visit|1|||
149741985|NCT02700451|540184543|FG000|Overall Study|Protocol Violation|2|||
149741986|NCT02700451|540184544|FG001|Overall Study|Protocol Violation|2|||
149741987|NCT02700451|540184545|FG002|Overall Study|Protocol Violation|3|||
149741988|NCT02700451|540184543|FG000|Overall Study|Discontinued intervention|14|||
149741989|NCT02700451|540184544|FG001|Overall Study|Discontinued intervention|15|||
149741990|NCT02700451|540184545|FG002|Overall Study|Discontinued intervention|14|||
149741991|NCT00404092|540184551|FG000|Overall Study|Death|1|||
149741992|NCT00404092|540184552|FG001|Overall Study|Death|0|||
149741993|NCT00404092|540184553|FG002|Overall Study|Death|0|||
149741994|NCT00404092|540184554|FG003|Overall Study|Death|0|||
149741995|NCT00404092|540184551|FG000|Overall Study|Adverse Event|0|||
149741996|NCT00404092|540184552|FG001|Overall Study|Adverse Event|0|||
149741997|NCT00404092|540184553|FG002|Overall Study|Adverse Event|1|||
149741998|NCT00404092|540184554|FG003|Overall Study|Adverse Event|0|||
149741999|NCT01511445|540184555|FG000|Overall Study|Lost to Follow-up|3|||
149742000|NCT01511445|540184556|FG001|Overall Study|Lost to Follow-up|1|||
149742001|NCT01511445|540184555|FG000|Overall Study|Protocol Violation|1|||
149742002|NCT01511445|540184556|FG001|Overall Study|Protocol Violation|3|||
149742003|NCT01511445|540184555|FG000|Overall Study|Protocol Violation|1|||
149742004|NCT01511445|540184556|FG001|Overall Study|Protocol Violation|0|||
149742005|NCT02344576|540184560|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
149742006|NCT02344576|540184561|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
149742007|NCT02344576|540184562|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
149742008|NCT02344576|540184563|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
149742009|NCT02344576|540184560|FG000|1-Month Follow-Up|Death|13|||
149742010|NCT02344576|540184561|FG001|1-Month Follow-Up|Death|8|||
149742011|NCT02344576|540184562|FG002|1-Month Follow-Up|Death|0|||
149742012|NCT02344576|540184563|FG003|1-Month Follow-Up|Death|0|||
149742013|NCT02344576|540184560|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
149742014|NCT02344576|540184561|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
149742015|NCT02344576|540184562|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
149742016|NCT02344576|540184563|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
149742017|NCT02344576|540184560|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
149742018|NCT02344576|540184561|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
149742019|NCT02344576|540184562|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
149742020|NCT02344576|540184563|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
149742021|NCT02344576|540184560|FG000|6-Month Follow-Up|Death|14|||
149742022|NCT02344576|540184561|FG001|6-Month Follow-Up|Death|14|||
149742023|NCT02344576|540184562|FG002|6-Month Follow-Up|Death|0|||
149742024|NCT02344576|540184563|FG003|6-Month Follow-Up|Death|0|||
149742025|NCT02344576|540184560|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
149742026|NCT02344576|540184561|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
149742027|NCT02344576|540184562|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
149742028|NCT02344576|540184563|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
149742029|NCT02344576|540184560|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
149742030|NCT02344576|540184561|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
149742031|NCT02344576|540184562|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
149742032|NCT02344576|540184563|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
149742033|NCT04233424|540184565|FG000|Overall Study|Death|15|||
149742034|NCT04233424|540184566|FG001|Overall Study|Death|16|||
149742035|NCT04233424|540184565|FG000|Overall Study|Withdrawal by Subject|2|||
149742036|NCT04233424|540184566|FG001|Overall Study|Withdrawal by Subject|8|||
149742037|NCT04233424|540184565|FG000|Overall Study|Physician Decision|1|||
149742038|NCT04233424|540184566|FG001|Overall Study|Physician Decision|3|||
149742039|NCT04233424|540184565|FG000|Overall Study|Protocol Violation|3|||
150256100|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256101|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149742040|NCT04233424|540184566|FG001|Overall Study|Protocol Violation|1|||
149742041|NCT04233424|540184565|FG000|Overall Study|Lost to Follow-up|1|||
149742042|NCT04233424|540184566|FG001|Overall Study|Lost to Follow-up|3|||
149742043|NCT04233424|540184565|FG000|Overall Study|subject refuse to visit site|2|||
149742044|NCT04233424|540184566|FG001|Overall Study|subject refuse to visit site|0|||
149742045|NCT04325503|540184567|FG000|Overall Study|Withdrawal by Subject|1|||
149742046|NCT04325503|540184567|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
149742047|NCT02337387|540184568|FG000|Overall Study|Adverse Event|0|||
149742048|NCT02337387|540184569|FG001|Overall Study|Adverse Event|1|||
149742049|NCT02337387|540184570|FG002|Overall Study|Adverse Event|0|||
149742050|NCT02337387|540184571|FG003|Overall Study|Adverse Event|0|||
149742051|NCT02337387|540184568|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
149742052|NCT02337387|540184569|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
149742053|NCT02337387|540184570|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
149742054|NCT02337387|540184571|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
149742055|NCT01856114|540184572|FG000|Overall Study|Withdrawal by Subject|1|||
149742056|NCT01856114|540184573|FG001|Overall Study|Withdrawal by Subject|0|||
149742057|NCT01856114|540184572|FG000|Overall Study|Adverse Event|1|||
149742058|NCT01856114|540184573|FG001|Overall Study|Adverse Event|0|||
149742059|NCT02853760|540184574|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
149742060|NCT02853760|540184575|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
149742061|NCT02853760|540184576|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
149742062|NCT02853760|540184577|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
149742063|NCT02853760|540184578|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
149742064|NCT02853760|540184579|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
149742065|NCT01642212|540184580|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
149742066|NCT01642212|540184581|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149742067|NCT01642212|540184582|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149742068|NCT01642212|540184583|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149742069|NCT01642212|540184584|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149742070|NCT01642212|540184580|FG000|Double-blind Treatment|Other|0|||
149742071|NCT01642212|540184581|FG001|Double-blind Treatment|Other|2|||
149742072|NCT01642212|540184582|FG002|Double-blind Treatment|Other|1|||
149742073|NCT01642212|540184583|FG003|Double-blind Treatment|Other|0|||
149742074|NCT01642212|540184584|FG004|Double-blind Treatment|Other|0|||
149742075|NCT01642212|540184580|FG000|Double-blind Treatment|Non-compliance|0|||
149742076|NCT01642212|540184581|FG001|Double-blind Treatment|Non-compliance|1|||
149742077|NCT01642212|540184582|FG002|Double-blind Treatment|Non-compliance|0|||
149742078|NCT01642212|540184583|FG003|Double-blind Treatment|Non-compliance|0|||
149742079|NCT01642212|540184584|FG004|Double-blind Treatment|Non-compliance|0|||
149742080|NCT01642212|540184580|FG000|Double-blind Treatment|Adverse Event|0|||
149742081|NCT01642212|540184581|FG001|Double-blind Treatment|Adverse Event|0|||
149742082|NCT01642212|540184582|FG002|Double-blind Treatment|Adverse Event|1|||
149742083|NCT01642212|540184583|FG003|Double-blind Treatment|Adverse Event|0|||
149742084|NCT01642212|540184584|FG004|Double-blind Treatment|Adverse Event|0|||
149742085|NCT01642212|540184580|FG000|Open-label Extension|Adverse Event|0|||
149742086|NCT01642212|540184581|FG001|Open-label Extension|Adverse Event|0|||
149742087|NCT01642212|540184582|FG002|Open-label Extension|Adverse Event|0|||
149742088|NCT01642212|540184583|FG003|Open-label Extension|Adverse Event|3|||
149742089|NCT01642212|540184584|FG004|Open-label Extension|Adverse Event|0|||
149742090|NCT01642212|540184580|FG000|Open-label Extension|Sponsor Decision|0|||
149742091|NCT01642212|540184581|FG001|Open-label Extension|Sponsor Decision|0|||
149742092|NCT01642212|540184582|FG002|Open-label Extension|Sponsor Decision|0|||
149742093|NCT01642212|540184583|FG003|Open-label Extension|Sponsor Decision|7|||
149742094|NCT01642212|540184584|FG004|Open-label Extension|Sponsor Decision|4|||
149742095|NCT01642212|540184580|FG000|Open-label Extension|Consent Withdrawn|0|||
149742096|NCT01642212|540184581|FG001|Open-label Extension|Consent Withdrawn|0|||
149742097|NCT01642212|540184582|FG002|Open-label Extension|Consent Withdrawn|0|||
149742098|NCT01642212|540184583|FG003|Open-label Extension|Consent Withdrawn|0|||
149742099|NCT01642212|540184584|FG004|Open-label Extension|Consent Withdrawn|2|||
149742100|NCT01642212|540184580|FG000|Open-label Extension|Lost to Follow-up|0|||
149742101|NCT01642212|540184581|FG001|Open-label Extension|Lost to Follow-up|0|||
149742102|NCT01642212|540184582|FG002|Open-label Extension|Lost to Follow-up|0|||
149742103|NCT01642212|540184583|FG003|Open-label Extension|Lost to Follow-up|0|||
149742104|NCT01642212|540184584|FG004|Open-label Extension|Lost to Follow-up|1|||
149742105|NCT01642212|540184580|FG000|Open-label Extension|Other|0|||
149742106|NCT01642212|540184581|FG001|Open-label Extension|Other|0|||
149742107|NCT01642212|540184582|FG002|Open-label Extension|Other|0|||
149742108|NCT01642212|540184583|FG003|Open-label Extension|Other|0|||
149742109|NCT01642212|540184584|FG004|Open-label Extension|Other|1|||
149742110|NCT00981526|540184585|FG000|Overall Study|Withdrawal by Subject|0|||
149742111|NCT00981526|540184586|FG001|Overall Study|Withdrawal by Subject|2|||
149742112|NCT00981526|540184585|FG000|Overall Study|Physician Decision|4|||
149742113|NCT00981526|540184586|FG001|Overall Study|Physician Decision|4|||
149742114|NCT01243268|540184587|FG000|Overall Study|Lost to Follow-up|4|||
149742115|NCT01243268|540184587|FG000|Overall Study|Protocol Violation|51|||
149742116|NCT01243268|540184587|FG000|Overall Study|Deviation with contract date|7|||
149742117|NCT01243268|540184587|FG000|Overall Study|Duplicate subject|2|||
149742118|NCT02272790|540184588|FG000|Overall Study|Physician Decision|0|||
149742119|NCT02272790|540184589|FG001|Overall Study|Physician Decision|1|||
150256102|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256103|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149742120|NCT02272790|540184590|FG002|Overall Study|Physician Decision|0|||
149742121|NCT02272790|540184591|FG003|Overall Study|Physician Decision|0|||
149742122|NCT02272790|540184592|FG004|Overall Study|Physician Decision|0|||
149742123|NCT02272790|540184593|FG005|Overall Study|Physician Decision|0|||
149742124|NCT00702143|540184594|FG000|Overall Study|Lost to Follow-up|0|||
149742125|NCT00702143|540184595|FG001|Overall Study|Lost to Follow-up|0|||
149742126|NCT00702143|540184596|FG002|Overall Study|Lost to Follow-up|1|||
149742127|NCT02793544|540184597|FG000|Overall Study|Death|10|||
149742128|NCT02793544|540184598|FG001|Overall Study|Death|8|||
149742129|NCT02793544|540184597|FG000|Overall Study|Lost to Follow-up|2|||
149742130|NCT02793544|540184598|FG001|Overall Study|Lost to Follow-up|0|||
149742131|NCT02793544|540184597|FG000|Overall Study|Withdrawal by Subject|1|||
149742132|NCT02793544|540184598|FG001|Overall Study|Withdrawal by Subject|0|||
149742133|NCT00752986|540184601|FG000|Overall Study|Withdrawal by Subject|2|||
149742134|NCT00752986|540184602|FG001|Overall Study|Withdrawal by Subject|1|||
149742135|NCT00752986|540184603|FG002|Overall Study|Withdrawal by Subject|2|||
149742136|NCT00752986|540184601|FG000|Overall Study|Protocol Violation|3|||
149742137|NCT00752986|540184602|FG001|Overall Study|Protocol Violation|0|||
149742138|NCT00752986|540184603|FG002|Overall Study|Protocol Violation|0|||
149742139|NCT02382133|540184604|FG000|Overall Study|Death|22|||
149742140|NCT02382133|540184604|FG000|Overall Study|transfer out of ICU|4|||
149742141|NCT02382133|540184604|FG000|Overall Study|Physician Decision|2|||
149742142|NCT02382133|540184604|FG000|Overall Study|arterial catheter loss|4|||
149742143|NCT02382133|540184604|FG000|Overall Study|pressure injury both sites|1|||
149742144|NCT00045032|540184609|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
149742145|NCT00045032|540184610|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
149742146|NCT00045032|540184611|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
149742147|NCT00045032|540184609|FG000|Overall Study|Death|22|||
149742148|NCT00045032|540184610|FG001|Overall Study|Death|24|||
149742149|NCT00045032|540184611|FG002|Overall Study|Death|17|||
149742150|NCT00045032|540184609|FG000|Overall Study|Insufficient Therapeutic Response|542|||
149742151|NCT00045032|540184610|FG001|Overall Study|Insufficient Therapeutic Response|437|||
149742152|NCT00045032|540184611|FG002|Overall Study|Insufficient Therapeutic Response|445|||
149742153|NCT00045032|540184609|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
149742154|NCT00045032|540184610|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
149742155|NCT00045032|540184611|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
149742156|NCT00045032|540184609|FG000|Overall Study|Other Protocol Violation|2|||
149742157|NCT00045032|540184610|FG001|Overall Study|Other Protocol Violation|0|||
149742158|NCT00045032|540184611|FG002|Overall Study|Other Protocol Violation|1|||
149742159|NCT00045032|540184609|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
149742160|NCT00045032|540184610|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
149742161|NCT00045032|540184611|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
149742162|NCT00045032|540184609|FG000|Overall Study|Failure to Return|57|||
149742163|NCT00045032|540184610|FG001|Overall Study|Failure to Return|62|||
149742164|NCT00045032|540184611|FG002|Overall Study|Failure to Return|61|||
149742165|NCT00045032|540184609|FG000|Overall Study|Other|93|||
149742166|NCT00045032|540184610|FG001|Overall Study|Other|84|||
149742167|NCT00045032|540184611|FG002|Overall Study|Other|105|||
149742168|NCT02582658|540184612|FG000|Overall Study|Failure to Return|10|||
149742169|NCT02582658|540184612|FG000|Overall Study|Insufficient Virological Response|2|||
149742170|NCT02582658|540184612|FG000|Overall Study|Withdrawn Consent|1|||
149742171|NCT02582658|540184612|FG000|Overall Study|Death|1|||
149742172|NCT02582658|540184612|FG000|Overall Study|Not further specified|11|||
149742173|NCT03277196|540184616|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
149742174|NCT03277196|540184616|FG000|Overall Study|Lost to Follow-up|3|||
149742175|NCT03277196|540184616|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
149742176|NCT03277196|540184616|FG000|Overall Study|Other|2|||
149742177|NCT00473694|540185978|FG000|Overall Study|Adverse Event|0|||
149742178|NCT00473694|540185979|FG001|Overall Study|Adverse Event|1|||
149742179|NCT00473694|540185980|FG002|Overall Study|Adverse Event|0|||
149742180|NCT00473694|540185981|FG003|Overall Study|Adverse Event|0|||
149742181|NCT00473694|540185978|FG000|Overall Study|Participants did not receive treatment|11|||
149742182|NCT00473694|540185979|FG001|Overall Study|Participants did not receive treatment|3|||
149742183|NCT00473694|540185980|FG002|Overall Study|Participants did not receive treatment|5|||
149742184|NCT00473694|540185981|FG003|Overall Study|Participants did not receive treatment|6|||
149742185|NCT00473694|540185978|FG000|Overall Study|Lost to Follow-up|0|||
149742186|NCT00473694|540185979|FG001|Overall Study|Lost to Follow-up|0|||
149742187|NCT00473694|540185980|FG002|Overall Study|Lost to Follow-up|0|||
149742188|NCT00473694|540185981|FG003|Overall Study|Lost to Follow-up|1|||
149742189|NCT02468193|540185984|FG000|Overall Study|Adverse Event|4|||
149742190|NCT02468193|540185984|FG000|Overall Study|Subject/ Guardian decision|2|||
149742191|NCT00742781|540185985|FG000|Overall Study|Withdrawal by Subject|3|||
149742192|NCT04723537|540185988|FG000|Overall Study|Withdrawal by Subject|3|||
149742193|NCT04723537|540185989|FG001|Overall Study|Withdrawal by Subject|0|||
149742194|NCT04723537|540185990|FG002|Overall Study|Withdrawal by Subject|0|||
149742195|NCT04723537|540185988|FG000|Overall Study|Physician Decision|0|||
149742196|NCT04723537|540185989|FG001|Overall Study|Physician Decision|0|||
149742197|NCT04723537|540185990|FG002|Overall Study|Physician Decision|1|||
149742198|NCT04723537|540185988|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149742199|NCT04723537|540185989|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149742200|NCT04723537|540185990|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149742201|NCT04645797|540185997|FG000|Overall Study|Disease Progression|3|||
149742202|NCT04645797|540185998|FG001|Overall Study|Disease Progression|3|||
149742203|NCT04645797|540185999|FG002|Overall Study|Disease Progression|1|||
149742204|NCT04645797|540186000|FG003|Overall Study|Disease Progression|0|||
149742205|NCT04645797|540186001|FG004|Overall Study|Disease Progression|0|||
149742206|NCT04645797|540186002|FG005|Overall Study|Disease Progression|0|||
149742207|NCT04645797|540186003|FG006|Overall Study|Disease Progression|0|||
149742208|NCT04645797|540185997|FG000|Overall Study|Death|3|||
149742209|NCT04645797|540185998|FG001|Overall Study|Death|1|||
149742210|NCT04645797|540185999|FG002|Overall Study|Death|0|||
149742211|NCT04645797|540186000|FG003|Overall Study|Death|0|||
149742212|NCT04645797|540186001|FG004|Overall Study|Death|0|||
149742213|NCT04645797|540186002|FG005|Overall Study|Death|0|||
149742214|NCT04645797|540186003|FG006|Overall Study|Death|0|||
149742215|NCT00942409|540186006|FG000|Overall Study|Lack of Efficacy|1|||
149742216|NCT00942409|540186006|FG000|Overall Study|study drug unavailable|2|||
149742217|NCT02015819|540186007|FG000|Overall Study|Rickham catheter was misaligned|0|||
149742218|NCT02015819|540186008|FG001|Overall Study|Rickham catheter was misaligned|0|||
149742219|NCT02015819|540186009|FG002|Overall Study|Rickham catheter was misaligned|0|||
149742220|NCT02015819|540186010|FG003|Overall Study|Rickham catheter was misaligned|1|||
149742221|NCT01697215|540186013|FG000|Overall Study|Physician Decision|5|||
149742222|NCT01697215|540186013|FG000|Overall Study|Malfunction|9|||
149742223|NCT01697215|540186013|FG000|Overall Study|CXR not available|9|||
149742224|NCT02599402|540186014|FG000|Overall Study|Disease progression|153|||
149742225|NCT02599402|540186014|FG000|Overall Study|Study drug toxicity|201|||
149742226|NCT02599402|540186014|FG000|Overall Study|Death|26|||
149742227|NCT02599402|540186014|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
149742228|NCT02599402|540186014|FG000|Overall Study|Participant request to discontinue study treatment|13|||
149742229|NCT02599402|540186014|FG000|Overall Study|Participant withdrew consent|5|||
149742230|NCT02599402|540186014|FG000|Overall Study|Lost to Follow-up|1|||
149742231|NCT02599402|540186014|FG000|Overall Study|Maximum Clinical Benefit|7|||
149742232|NCT02599402|540186014|FG000|Overall Study|Poor/non-compliance|1|||
149742233|NCT02599402|540186014|FG000|Overall Study|Pregnancy|1|||
149742234|NCT02599402|540186014|FG000|Overall Study|Participant no longer met study criteria|7|||
149742235|NCT02599402|540186014|FG000|Overall Study|Other Reasons|95|||
149742236|NCT05340504|540186019|FG000|Overall Study|Withdrawal by Subject|1|||
149742237|NCT05340504|540186020|FG001|Overall Study|Withdrawal by Subject|0|||
149742238|NCT03068715|540186021|FG000|Overall Study|No longer met inclusion criteria|1|||
149742239|NCT03068715|540186022|FG001|Overall Study|No longer met inclusion criteria|0|||
149742240|NCT02499952|540186025|FG000|Overall Study|Lost to Follow-up|1|||
149742241|NCT02499952|540186025|FG000|Overall Study|Death|9|||
149742242|NCT02286102|540186026|FG000|Overall Study|Screen Failure|1|||
149742243|NCT02286102|540186027|FG001|Overall Study|Screen Failure|1|||
149742244|NCT03830281|540186028|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
149742245|NCT03830281|540186029|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
149742246|NCT03830281|540186028|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
149742247|NCT03830281|540186029|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
149742248|NCT03830281|540186028|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
149742249|NCT03830281|540186029|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
149742250|NCT03830281|540186028|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
149742251|NCT03830281|540186029|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
149742252|NCT03830281|540186028|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
149742253|NCT03830281|540186029|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
149742254|NCT03830281|540186028|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
149742255|NCT03830281|540186029|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
149742256|NCT03830281|540186028|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
149742257|NCT03830281|540186029|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
149742258|NCT03830281|540186028|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
149742259|NCT03830281|540186029|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
149742260|NCT03830281|540186028|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
149742261|NCT03830281|540186029|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
149742262|NCT00201851|540186031|FG000|Overall Study|Lost to Follow-up|2|||
149742263|NCT00201851|540186032|FG001|Overall Study|Lost to Follow-up|1|||
149742264|NCT00201851|540186033|FG002|Overall Study|Lost to Follow-up|0|||
149742265|NCT00201851|540186031|FG000|Overall Study|Ineligible post enrollment|6|||
149742266|NCT00201851|540186032|FG001|Overall Study|Ineligible post enrollment|1|||
149742267|NCT00201851|540186033|FG002|Overall Study|Ineligible post enrollment|1|||
149742268|NCT03293680|540186034|FG000|Overall Study|Death|1|||
149742269|NCT03293680|540186034|FG000|Overall Study|Did not meet inclusion criteria|8|||
149742270|NCT00922935|540186035|FG000|Overall Study|Protocol Violation|0|||
149742271|NCT00922935|540186036|FG001|Overall Study|Protocol Violation|3|||
149742272|NCT00922935|540186037|FG002|Overall Study|Protocol Violation|0|||
149742273|NCT00922935|540186035|FG000|Overall Study|Physician Decision|1|||
149742274|NCT00922935|540186036|FG001|Overall Study|Physician Decision|1|||
149742275|NCT00922935|540186037|FG002|Overall Study|Physician Decision|0|||
149742276|NCT00922935|540186035|FG000|Overall Study|Lost to Follow-up|0|||
149742277|NCT00922935|540186036|FG001|Overall Study|Lost to Follow-up|1|||
149742278|NCT00922935|540186037|FG002|Overall Study|Lost to Follow-up|0|||
149742279|NCT02201940|540186038|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
149742280|NCT02201940|540186039|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
149742281|NCT02201940|540186038|FG000|Overall Study|Lack of Efficacy|2|||
149742282|NCT02201940|540186039|FG001|Overall Study|Lack of Efficacy|113|||
149742283|NCT02201940|540186038|FG000|Overall Study|Lost to Follow-up|5|||
149742284|NCT02201940|540186039|FG001|Overall Study|Lost to Follow-up|0|||
149742285|NCT02201940|540186038|FG000|Overall Study|Withdrew Consent|2|||
149742286|NCT02201940|540186039|FG001|Overall Study|Withdrew Consent|1|||
149742287|NCT02201940|540186038|FG000|Overall Study|Investigator's Discretion|1|||
149742288|NCT02201940|540186039|FG001|Overall Study|Investigator's Discretion|1|||
149742289|NCT02201940|540186038|FG000|Overall Study|Death|1|||
149742290|NCT02201940|540186039|FG001|Overall Study|Death|0|||
149742291|NCT02201940|540186038|FG000|Overall Study|Adverse Event|0|||
149742292|NCT02201940|540186039|FG001|Overall Study|Adverse Event|1|||
149742293|NCT00636818|540186040|FG000|Overall Study|Adverse Event|1|||
149742294|NCT00636818|540186040|FG000|Overall Study|Lost to Follow-up|2|||
149742295|NCT00636818|540186040|FG000|Overall Study|Entry Criteria Exclusion|3|||
149742296|NCT00636818|540186040|FG000|Overall Study|Protocol Violation|1|||
149742297|NCT00636818|540186040|FG000|Overall Study|Withdrawal by Subject|4|||
149742298|NCT00074958|540186042|FG000|Overall Study|Adverse Event|1|||
149742299|NCT02690701|540186046|FG000|Treatment Period 1|Adverse Event|2|||
149742300|NCT02690701|540186047|FG001|Treatment Period 1|Adverse Event|2|||
149742301|NCT02690701|540186046|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149742302|NCT02690701|540186047|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149742303|NCT02690701|540186046|FG000|Treatment Period 2|Adverse Event|2|||
149742304|NCT02690701|540186047|FG001|Treatment Period 2|Adverse Event|0|||
149742305|NCT02690701|540186046|FG000|Treatment Period 2|Lack of Efficacy|1|||
149742306|NCT02690701|540186047|FG001|Treatment Period 2|Lack of Efficacy|0|||
149742307|NCT02690701|540186046|FG000|Treatment Period 2|Lost to Follow-up|0|||
149742308|NCT02690701|540186047|FG001|Treatment Period 2|Lost to Follow-up|2|||
149742309|NCT02690701|540186046|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149742310|NCT02690701|540186047|FG001|Treatment Period 2|Withdrawal by Subject|2|||
149742311|NCT02690701|540186046|FG000|Treatment Period 2|Protocol Violation|0|||
149742312|NCT02690701|540186047|FG001|Treatment Period 2|Protocol Violation|1|||
149742313|NCT02115308|540186048|FG000|Overall Study|Safety Screening|2|||
149742314|NCT02115308|540186049|FG001|Overall Study|Safety Screening|2|||
149742315|NCT00749203|540186050|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
149742316|NCT00749203|540186051|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
149742317|NCT00749203|540186050|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
149742318|NCT00749203|540186051|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
149742319|NCT00749203|540186050|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
149742320|NCT00749203|540186051|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
149742321|NCT00749203|540186050|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
149742322|NCT00749203|540186051|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
149742323|NCT00749203|540186050|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
149742324|NCT00749203|540186051|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
149742325|NCT00749203|540186050|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
149742326|NCT00749203|540186051|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
150256104|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
150256105|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
150256106|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
150256107|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
150256108|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
150256109|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
150256110|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
150256111|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
150256112|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
150256113|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
150256114|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
150256115|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
150256116|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
150256117|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
150256118|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
150256119|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
150256120|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
150256121|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
149742327|NCT02698189|540186052|FG000|Overall Study|Physician Decision|3|||
149742328|NCT02698189|540186053|FG001|Overall Study|Physician Decision|0|||
149742329|NCT02698189|540186052|FG000|Overall Study|Progressive disease|0|||
149742330|NCT02698189|540186053|FG001|Overall Study|Progressive disease|5|||
149742331|NCT02698189|540186052|FG000|Overall Study|Study terminated by sponsor|0|||
149742332|NCT02698189|540186053|FG001|Overall Study|Study terminated by sponsor|1|||
149742333|NCT01564784|540186067|FG000|Overall Study|Other|1|||
149742334|NCT01564784|540186068|FG001|Overall Study|Other|0|||
149742335|NCT01564784|540186067|FG000|Overall Study|Subject refused further follow-up|1|||
149742336|NCT01564784|540186068|FG001|Overall Study|Subject refused further follow-up|6|||
149742337|NCT01564784|540186067|FG000|Overall Study|Lost to Follow-up|1|||
149742338|NCT01564784|540186068|FG001|Overall Study|Lost to Follow-up|1|||
149742339|NCT01564784|540186067|FG000|Overall Study|Death|131|||
149742340|NCT01564784|540186068|FG001|Overall Study|Death|126|||
149742341|NCT01624142|540186069|FG000|Overall Study|Withdrawal by Subject|14|||
149742342|NCT01624142|540186070|FG001|Overall Study|Withdrawal by Subject|4|||
149742343|NCT01624142|540186069|FG000|Overall Study|Death|3|||
149742344|NCT01624142|540186070|FG001|Overall Study|Death|6|||
149742345|NCT01624142|540186069|FG000|Overall Study|Study Closure|12|||
149742346|NCT01624142|540186070|FG001|Overall Study|Study Closure|6|||
149742347|NCT01624142|540186069|FG000|Overall Study|Lost to Follow-up|2|||
149742348|NCT01624142|540186070|FG001|Overall Study|Lost to Follow-up|0|||
149742349|NCT01624142|540186069|FG000|Overall Study|Other|1|||
149742350|NCT01624142|540186070|FG001|Overall Study|Other|0|||
149742351|NCT01053429|540186071|FG000|Overall Study|Adverse Event|64|||
149742352|NCT01053429|540186071|FG000|Overall Study|Other|309|||
149742353|NCT00947349|540186072|FG000|Triple Treatment Combination Period|Adverse Event|0|||
149742354|NCT00947349|540186073|FG001|Triple Treatment Combination Period|Adverse Event|1|||
149742355|NCT00947349|540186074|FG002|Triple Treatment Combination Period|Adverse Event|0|||
149742356|NCT00947349|540186075|FG003|Triple Treatment Combination Period|Adverse Event|0|||
149742357|NCT00947349|540186072|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
149742358|NCT00947349|540186073|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
149742359|NCT00947349|540186074|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
149742360|NCT00947349|540186075|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
149742361|NCT00947349|540186072|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
149742362|NCT00947349|540186073|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
149742363|NCT00947349|540186074|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
149742364|NCT00947349|540186075|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
149742365|NCT00947349|540186072|FG000|Overall Study Standard of Care|Other|0|||
149742366|NCT00947349|540186073|FG001|Overall Study Standard of Care|Other|0|||
149742367|NCT00947349|540186074|FG002|Overall Study Standard of Care|Other|0|||
149742368|NCT00947349|540186075|FG003|Overall Study Standard of Care|Other|1|||
149742369|NCT03430310|540186076|FG000|Overall Study|Protocol Violation|2|||
149742370|NCT03430310|540186077|FG001|Overall Study|Protocol Violation|0|||
149742371|NCT03430310|540186076|FG000|Overall Study|Withdrawal by Subject|3|||
149742372|NCT03430310|540186077|FG001|Overall Study|Withdrawal by Subject|2|||
149742373|NCT03430310|540186076|FG000|Overall Study|COVID shutdown March 2020|0|||
149742374|NCT03430310|540186077|FG001|Overall Study|COVID shutdown March 2020|1|||
149742375|NCT01446809|540186078|FG000|Overall Study|Adverse Event|0|||
149742376|NCT01446809|540186079|FG001|Overall Study|Adverse Event|0|||
149742377|NCT01446809|540186080|FG002|Overall Study|Adverse Event|1|||
149742378|NCT01446809|540186078|FG000|Overall Study|Failure to complete study procedures|0|||
149742379|NCT01446809|540186079|FG001|Overall Study|Failure to complete study procedures|0|||
149742380|NCT01446809|540186080|FG002|Overall Study|Failure to complete study procedures|1|||
149742381|NCT01331161|540186081|FG000|Overall Study|Physician Decision|1|||
149742382|NCT01331161|540186082|FG001|Overall Study|Physician Decision|0|||
149742383|NCT01331161|540186081|FG000|Overall Study|Lost to Follow-up|0|||
149742384|NCT01331161|540186082|FG001|Overall Study|Lost to Follow-up|1|||
149742385|NCT01331161|540186081|FG000|Overall Study|Pregnancy|0|||
149742386|NCT01331161|540186082|FG001|Overall Study|Pregnancy|1|||
149742387|NCT03972488|540186083|FG000|Overall Study|Progressive disease|42|||
149742388|NCT03972488|540186084|FG001|Overall Study|Progressive disease|44|||
149742389|NCT03972488|540186083|FG000|Overall Study|Physician Decision|13|||
149742390|NCT03972488|540186084|FG001|Overall Study|Physician Decision|7|||
149742391|NCT03972488|540186083|FG000|Overall Study|Adverse Event|8|||
149742392|NCT03972488|540186084|FG001|Overall Study|Adverse Event|1|||
149742393|NCT03972488|540186083|FG000|Overall Study|Death|4|||
149742394|NCT03972488|540186084|FG001|Overall Study|Death|4|||
149742395|NCT03972488|540186083|FG000|Overall Study|Withdrawal by Subject|3|||
149742396|NCT03972488|540186084|FG001|Overall Study|Withdrawal by Subject|4|||
149742397|NCT03972488|540186083|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
149742398|NCT03972488|540186084|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
149742399|NCT02770807|540186090|FG000|Overall Study|Adverse Event|3|||
149742400|NCT02770807|540186091|FG001|Overall Study|Adverse Event|3|||
149742401|NCT02770807|540186092|FG002|Overall Study|Adverse Event|1|||
149742402|NCT02770807|540186090|FG000|Overall Study|Withdrawal by Subject|7|||
149742403|NCT02770807|540186091|FG001|Overall Study|Withdrawal by Subject|3|||
149742404|NCT02770807|540186092|FG002|Overall Study|Withdrawal by Subject|4|||
149742405|NCT02770807|540186090|FG000|Overall Study|Other|0|||
149742406|NCT02770807|540186091|FG001|Overall Study|Other|1|||
149742407|NCT02770807|540186092|FG002|Overall Study|Other|0|||
149742408|NCT02770807|540186090|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
149742409|NCT02770807|540186091|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
149742410|NCT02770807|540186092|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
149742411|NCT02770807|540186090|FG000|Overall Study|Physician Decision|0|||
149742412|NCT02770807|540186091|FG001|Overall Study|Physician Decision|0|||
149742413|NCT02770807|540186092|FG002|Overall Study|Physician Decision|1|||
149742414|NCT00222105|540186095|FG000|Overall Study|Removed due to wrong diagnosis|1|||
149742415|NCT00222105|540186095|FG000|Overall Study|Withdrawal by Subject|1|||
149742416|NCT00222105|540186095|FG000|Overall Study|Adverse Event|8|||
149742417|NCT00222105|540186095|FG000|Overall Study|Treatment delays|2|||
149742418|NCT00222105|540186095|FG000|Overall Study|Death|2|||
149742419|NCT00374556|540188239|FG000|Overall Study|Lost to Follow-up|1|||
149742420|NCT00374556|540188240|FG001|Overall Study|Lost to Follow-up|0|||
149742421|NCT00374556|540188239|FG000|Overall Study|Removed at baseline due to medical cond|0|||
149742422|NCT00374556|540188240|FG001|Overall Study|Removed at baseline due to medical cond|1|||
149742423|NCT01416181|540188241|FG000|Part 1|Other|10|||
149742424|NCT01416181|540188242|FG001|Part 1|Other|24|||
149742425|NCT01416181|540188241|FG000|Part 1|Death|0|||
149742426|NCT01416181|540188242|FG001|Part 1|Death|1|||
149742427|NCT01416181|540188241|FG000|Part 1|Investigator Decision|7|||
149742428|NCT01416181|540188242|FG001|Part 1|Investigator Decision|6|||
149742429|NCT01416181|540188241|FG000|Part 1|Withdrawal by Subject|74|||
149742430|NCT01416181|540188242|FG001|Part 1|Withdrawal by Subject|48|||
149742431|NCT01416181|540188241|FG000|Part 1|Lack of Efficacy|16|||
149742432|NCT01416181|540188242|FG001|Part 1|Lack of Efficacy|8|||
149742433|NCT01416181|540188241|FG000|Part 1|Lost to Follow-up|1|||
149742434|NCT01416181|540188242|FG001|Part 1|Lost to Follow-up|1|||
149742435|NCT01416181|540188241|FG000|Part 1|Adverse Event|15|||
149742436|NCT01416181|540188242|FG001|Part 1|Adverse Event|18|||
149742437|NCT01416181|540188241|FG000|Part 1|Ongoing in Follow-Up|14|||
149742438|NCT01416181|540188242|FG001|Part 1|Ongoing in Follow-Up|8|||
149742439|NCT01416181|540188241|FG000|Part 2|Adverse Event|11|||
149742440|NCT01416181|540188242|FG001|Part 2|Adverse Event|4|||
149742441|NCT01416181|540188241|FG000|Part 2|Other|234|||
149742442|NCT01416181|540188242|FG001|Part 2|Other|267|||
149742443|NCT01416181|540188241|FG000|Part 2|Investigator Decision|6|||
149742444|NCT01416181|540188242|FG001|Part 2|Investigator Decision|7|||
149742445|NCT01416181|540188241|FG000|Part 2|Withdrawal by Subject|14|||
149742446|NCT01416181|540188242|FG001|Part 2|Withdrawal by Subject|5|||
149742447|NCT01416181|540188241|FG000|Part 2|Lack of Efficacy|4|||
149742448|NCT01416181|540188242|FG001|Part 2|Lack of Efficacy|1|||
149742449|NCT01416181|540188241|FG000|Part 2|Lost to Follow-up|2|||
149742450|NCT01416181|540188242|FG001|Part 2|Lost to Follow-up|2|||
149742451|NCT03874234|540188243|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742452|NCT03874234|540188244|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742453|NCT03874234|540188245|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742454|NCT03874234|540188246|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
149742455|NCT03874234|540188247|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742456|NCT03874234|540188248|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742457|NCT03874234|540188249|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742458|NCT03874234|540188250|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742459|NCT03874234|540188251|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742460|NCT03874234|540188252|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742461|NCT03874234|540188253|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742462|NCT03874234|540188254|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742463|NCT03874234|540188255|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149742464|NCT03874234|540188243|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
149742465|NCT03874234|540188244|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742466|NCT03874234|540188245|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742467|NCT03874234|540188246|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742468|NCT03874234|540188247|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742469|NCT03874234|540188248|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742470|NCT03874234|540188249|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742471|NCT03874234|540188250|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742472|NCT03874234|540188251|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742473|NCT03874234|540188252|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742474|NCT03874234|540188253|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742475|NCT03874234|540188254|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742476|NCT03874234|540188255|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149742477|NCT03874234|540188243|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742478|NCT03874234|540188244|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742479|NCT03874234|540188245|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742480|NCT03874234|540188246|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
149742481|NCT03874234|540188247|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742482|NCT03874234|540188248|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742483|NCT03874234|540188249|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742484|NCT03874234|540188250|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742485|NCT03874234|540188251|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742486|NCT03874234|540188252|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742487|NCT03874234|540188253|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742488|NCT03874234|540188254|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742489|NCT03874234|540188255|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149742490|NCT03874234|540188243|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742491|NCT03874234|540188244|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742492|NCT03874234|540188245|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742493|NCT03874234|540188246|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742494|NCT03874234|540188247|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
149742495|NCT03874234|540188248|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742496|NCT03874234|540188249|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742497|NCT03874234|540188250|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742498|NCT03874234|540188251|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742499|NCT03874234|540188252|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742500|NCT03874234|540188253|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742501|NCT03874234|540188254|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742502|NCT03874234|540188255|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149742503|NCT03874234|540188243|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742504|NCT03874234|540188244|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742505|NCT03874234|540188245|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742506|NCT03874234|540188246|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742507|NCT03874234|540188247|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742508|NCT03874234|540188248|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742509|NCT03874234|540188249|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742510|NCT03874234|540188250|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
149742511|NCT03874234|540188251|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742512|NCT03874234|540188252|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742513|NCT03874234|540188253|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742514|NCT03874234|540188254|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742515|NCT03874234|540188255|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149742516|NCT03874234|540188243|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742517|NCT03874234|540188244|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742518|NCT03874234|540188245|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742519|NCT03874234|540188246|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742520|NCT03874234|540188247|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
149742521|NCT03874234|540188248|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
149742522|NCT03874234|540188249|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742523|NCT03874234|540188250|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742524|NCT03874234|540188251|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742525|NCT03874234|540188252|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742526|NCT03874234|540188253|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742527|NCT03874234|540188254|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742528|NCT03874234|540188255|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149742529|NCT03874234|540188243|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742530|NCT03874234|540188244|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742531|NCT03874234|540188245|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742532|NCT03874234|540188246|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742533|NCT03874234|540188247|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742534|NCT03874234|540188248|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742535|NCT03874234|540188249|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
149742536|NCT03874234|540188250|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742537|NCT03874234|540188251|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742538|NCT03874234|540188252|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742539|NCT03874234|540188253|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742540|NCT03874234|540188254|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742541|NCT03874234|540188255|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149742542|NCT03874234|540188243|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742543|NCT03874234|540188244|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742544|NCT03874234|540188245|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742545|NCT03874234|540188246|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742546|NCT03874234|540188247|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
149742547|NCT03874234|540188248|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742548|NCT03874234|540188249|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742549|NCT03874234|540188250|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742550|NCT03874234|540188251|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742551|NCT03874234|540188252|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742552|NCT03874234|540188253|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742553|NCT03874234|540188254|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742554|NCT03874234|540188255|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149742555|NCT01896232|540188258|FG000|Overall Study|Death|6|||
149742556|NCT01896232|540188259|FG001|Overall Study|Death|10|||
149742557|NCT01896232|540188258|FG000|Overall Study|Withdrawal by Subject|32|||
149742558|NCT01896232|540188259|FG001|Overall Study|Withdrawal by Subject|31|||
149742559|NCT01896232|540188258|FG000|Overall Study|Sponsor Decision|2|||
149742560|NCT01896232|540188259|FG001|Overall Study|Sponsor Decision|0|||
149742561|NCT01896232|540188258|FG000|Overall Study|Lost to Follow-up|9|||
149742562|NCT01896232|540188259|FG001|Overall Study|Lost to Follow-up|12|||
149742563|NCT03816995|540188270|FG000|Overall Study|Withdrawal by Subject|3|||
149742564|NCT03816995|540188271|FG001|Overall Study|Withdrawal by Subject|1|||
149742565|NCT03816995|540188270|FG000|Overall Study|Cancelled Surgery|8|||
149742566|NCT03816995|540188271|FG001|Overall Study|Cancelled Surgery|12|||
149742567|NCT03816995|540188270|FG000|Overall Study|No wound protector used|11|||
149742568|NCT03816995|540188271|FG001|Overall Study|No wound protector used|17|||
149742569|NCT03816995|540188270|FG000|Overall Study|Protocol Violation|2|||
149742570|NCT03816995|540188271|FG001|Overall Study|Protocol Violation|3|||
149742571|NCT00541307|540188272|FG000|Overall Study|Death|5|||
149742572|NCT00541307|540188272|FG000|Overall Study|Physician Decision|3|||
149742573|NCT00541307|540188272|FG000|Overall Study|Withdrawal by Subject|6|||
149742574|NCT00541307|540188272|FG000|Overall Study|Lost to Follow-up|4|||
149742575|NCT00541307|540188272|FG000|Overall Study|Subject returned early (outside window)|1|||
149742576|NCT00541307|540188272|FG000|Overall Study|Surgical Bypass|5|||
149742577|NCT01324830|540188273|FG000|Overall Study|Progressive Disease|3|||
149742578|NCT01324830|540188274|FG001|Overall Study|Progressive Disease|2|||
149742579|NCT01324830|540188275|FG002|Overall Study|Progressive Disease|3|||
149742580|NCT01324830|540188276|FG003|Overall Study|Progressive Disease|3|||
149742581|NCT01324830|540188277|FG004|Overall Study|Progressive Disease|6|||
149742582|NCT01324830|540188278|FG005|Overall Study|Progressive Disease|6|||
149742583|NCT01324830|540188279|FG006|Overall Study|Progressive Disease|3|||
149742584|NCT01324830|540188280|FG007|Overall Study|Progressive Disease|3|||
149742585|NCT01324830|540188281|FG008|Overall Study|Progressive Disease|3|||
149742586|NCT01324830|540188282|FG009|Overall Study|Progressive Disease|6|||
149742587|NCT01324830|540188283|FG010|Overall Study|Progressive Disease|2|||
149742588|NCT01324830|540188284|FG011|Overall Study|Progressive Disease|1|||
149742589|NCT01324830|540188285|FG012|Overall Study|Progressive Disease|1|||
149742590|NCT01324830|540188286|FG013|Overall Study|Progressive Disease|1|||
149742591|NCT01324830|540188287|FG014|Overall Study|Progressive Disease|1|||
149742592|NCT01324830|540188288|FG015|Overall Study|Progressive Disease|3|||
149742593|NCT01324830|540188289|FG016|Overall Study|Progressive Disease|2|||
149742594|NCT01324830|540188290|FG017|Overall Study|Progressive Disease|3|||
149742595|NCT01324830|540188291|FG018|Overall Study|Progressive Disease|4|||
149742596|NCT01324830|540188273|FG000|Overall Study|Dose limiting toxicity|0|||
149742597|NCT01324830|540188274|FG001|Overall Study|Dose limiting toxicity|0|||
149742598|NCT01324830|540188275|FG002|Overall Study|Dose limiting toxicity|0|||
149742599|NCT01324830|540188276|FG003|Overall Study|Dose limiting toxicity|0|||
149742600|NCT01324830|540188277|FG004|Overall Study|Dose limiting toxicity|1|||
149742601|NCT01324830|540188278|FG005|Overall Study|Dose limiting toxicity|0|||
149742602|NCT01324830|540188279|FG006|Overall Study|Dose limiting toxicity|0|||
149742603|NCT01324830|540188280|FG007|Overall Study|Dose limiting toxicity|0|||
149742604|NCT01324830|540188281|FG008|Overall Study|Dose limiting toxicity|0|||
149742605|NCT01324830|540188282|FG009|Overall Study|Dose limiting toxicity|0|||
149742606|NCT01324830|540188283|FG010|Overall Study|Dose limiting toxicity|0|||
149742607|NCT01324830|540188284|FG011|Overall Study|Dose limiting toxicity|0|||
149742608|NCT01324830|540188285|FG012|Overall Study|Dose limiting toxicity|0|||
149742609|NCT01324830|540188286|FG013|Overall Study|Dose limiting toxicity|0|||
149742610|NCT01324830|540188287|FG014|Overall Study|Dose limiting toxicity|0|||
149742611|NCT01324830|540188288|FG015|Overall Study|Dose limiting toxicity|0|||
149742612|NCT01324830|540188289|FG016|Overall Study|Dose limiting toxicity|1|||
149742613|NCT01324830|540188290|FG017|Overall Study|Dose limiting toxicity|1|||
149742614|NCT01324830|540188291|FG018|Overall Study|Dose limiting toxicity|1|||
149742615|NCT01324830|540188273|FG000|Overall Study|Reason not mentioned above|0|||
149742616|NCT01324830|540188274|FG001|Overall Study|Reason not mentioned above|0|||
149742617|NCT01324830|540188275|FG002|Overall Study|Reason not mentioned above|0|||
149742618|NCT01324830|540188276|FG003|Overall Study|Reason not mentioned above|0|||
149742619|NCT01324830|540188277|FG004|Overall Study|Reason not mentioned above|0|||
149742620|NCT01324830|540188278|FG005|Overall Study|Reason not mentioned above|0|||
149742621|NCT01324830|540188279|FG006|Overall Study|Reason not mentioned above|0|||
149742622|NCT01324830|540188280|FG007|Overall Study|Reason not mentioned above|0|||
149742623|NCT01324830|540188281|FG008|Overall Study|Reason not mentioned above|0|||
149742624|NCT01324830|540188282|FG009|Overall Study|Reason not mentioned above|0|||
149742625|NCT01324830|540188283|FG010|Overall Study|Reason not mentioned above|0|||
149742626|NCT01324830|540188284|FG011|Overall Study|Reason not mentioned above|0|||
149742627|NCT01324830|540188285|FG012|Overall Study|Reason not mentioned above|0|||
149742628|NCT01324830|540188286|FG013|Overall Study|Reason not mentioned above|0|||
149742629|NCT01324830|540188287|FG014|Overall Study|Reason not mentioned above|0|||
149742630|NCT01324830|540188288|FG015|Overall Study|Reason not mentioned above|0|||
149742631|NCT01324830|540188289|FG016|Overall Study|Reason not mentioned above|0|||
149742632|NCT01324830|540188290|FG017|Overall Study|Reason not mentioned above|1|||
149742633|NCT01324830|540188291|FG018|Overall Study|Reason not mentioned above|0|||
149742634|NCT01324830|540188273|FG000|Overall Study|Adverse Event, serious fatal|0|||
149742635|NCT01324830|540188274|FG001|Overall Study|Adverse Event, serious fatal|1|||
149742636|NCT01324830|540188275|FG002|Overall Study|Adverse Event, serious fatal|0|||
149742637|NCT01324830|540188276|FG003|Overall Study|Adverse Event, serious fatal|0|||
149742638|NCT01324830|540188277|FG004|Overall Study|Adverse Event, serious fatal|0|||
149742639|NCT01324830|540188278|FG005|Overall Study|Adverse Event, serious fatal|0|||
149742640|NCT01324830|540188279|FG006|Overall Study|Adverse Event, serious fatal|0|||
149742641|NCT01324830|540188280|FG007|Overall Study|Adverse Event, serious fatal|0|||
149742642|NCT01324830|540188281|FG008|Overall Study|Adverse Event, serious fatal|0|||
149742643|NCT01324830|540188282|FG009|Overall Study|Adverse Event, serious fatal|0|||
149742644|NCT01324830|540188283|FG010|Overall Study|Adverse Event, serious fatal|0|||
149742645|NCT01324830|540188284|FG011|Overall Study|Adverse Event, serious fatal|0|||
149742646|NCT01324830|540188285|FG012|Overall Study|Adverse Event, serious fatal|0|||
149742647|NCT01324830|540188286|FG013|Overall Study|Adverse Event, serious fatal|0|||
149742648|NCT01324830|540188287|FG014|Overall Study|Adverse Event, serious fatal|0|||
149742649|NCT01324830|540188288|FG015|Overall Study|Adverse Event, serious fatal|0|||
149742650|NCT01324830|540188289|FG016|Overall Study|Adverse Event, serious fatal|0|||
149742651|NCT01324830|540188290|FG017|Overall Study|Adverse Event, serious fatal|0|||
149742652|NCT01324830|540188291|FG018|Overall Study|Adverse Event, serious fatal|0|||
149742653|NCT01324830|540188273|FG000|Overall Study|Adverse Event, non-fatal|0|||
149742654|NCT01324830|540188274|FG001|Overall Study|Adverse Event, non-fatal|0|||
149742655|NCT01324830|540188275|FG002|Overall Study|Adverse Event, non-fatal|0|||
149742656|NCT01324830|540188276|FG003|Overall Study|Adverse Event, non-fatal|0|||
149742657|NCT01324830|540188277|FG004|Overall Study|Adverse Event, non-fatal|0|||
149742658|NCT01324830|540188278|FG005|Overall Study|Adverse Event, non-fatal|0|||
149742659|NCT01324830|540188279|FG006|Overall Study|Adverse Event, non-fatal|0|||
149742660|NCT01324830|540188280|FG007|Overall Study|Adverse Event, non-fatal|0|||
149742661|NCT01324830|540188281|FG008|Overall Study|Adverse Event, non-fatal|2|||
149742662|NCT01324830|540188282|FG009|Overall Study|Adverse Event, non-fatal|0|||
149742663|NCT01324830|540188283|FG010|Overall Study|Adverse Event, non-fatal|1|||
149742664|NCT01324830|540188284|FG011|Overall Study|Adverse Event, non-fatal|0|||
149742665|NCT01324830|540188285|FG012|Overall Study|Adverse Event, non-fatal|0|||
149742666|NCT01324830|540188286|FG013|Overall Study|Adverse Event, non-fatal|0|||
149742667|NCT01324830|540188287|FG014|Overall Study|Adverse Event, non-fatal|0|||
149742668|NCT01324830|540188288|FG015|Overall Study|Adverse Event, non-fatal|0|||
149742669|NCT01324830|540188289|FG016|Overall Study|Adverse Event, non-fatal|0|||
149742670|NCT01324830|540188290|FG017|Overall Study|Adverse Event, non-fatal|1|||
149742671|NCT01324830|540188291|FG018|Overall Study|Adverse Event, non-fatal|0|||
149742672|NCT01324830|540188273|FG000|Overall Study|Withdrawal by Subject|0|||
149742673|NCT01324830|540188274|FG001|Overall Study|Withdrawal by Subject|0|||
149742674|NCT01324830|540188275|FG002|Overall Study|Withdrawal by Subject|0|||
149742675|NCT01324830|540188276|FG003|Overall Study|Withdrawal by Subject|0|||
149742676|NCT01324830|540188277|FG004|Overall Study|Withdrawal by Subject|0|||
149742677|NCT01324830|540188278|FG005|Overall Study|Withdrawal by Subject|1|||
149742678|NCT01324830|540188279|FG006|Overall Study|Withdrawal by Subject|0|||
149742679|NCT01324830|540188280|FG007|Overall Study|Withdrawal by Subject|0|||
149742680|NCT01324830|540188281|FG008|Overall Study|Withdrawal by Subject|0|||
149742681|NCT01324830|540188282|FG009|Overall Study|Withdrawal by Subject|0|||
149742682|NCT01324830|540188283|FG010|Overall Study|Withdrawal by Subject|1|||
149742683|NCT01324830|540188284|FG011|Overall Study|Withdrawal by Subject|0|||
149742684|NCT01324830|540188285|FG012|Overall Study|Withdrawal by Subject|0|||
149742685|NCT01324830|540188286|FG013|Overall Study|Withdrawal by Subject|0|||
149742686|NCT01324830|540188287|FG014|Overall Study|Withdrawal by Subject|0|||
149742687|NCT01324830|540188288|FG015|Overall Study|Withdrawal by Subject|0|||
149742688|NCT01324830|540188289|FG016|Overall Study|Withdrawal by Subject|0|||
149742689|NCT01324830|540188290|FG017|Overall Study|Withdrawal by Subject|0|||
149742690|NCT01324830|540188291|FG018|Overall Study|Withdrawal by Subject|1|||
149742691|NCT01485614|540188292|FG000|Randomization|Not Treated|1|||
149742692|NCT01485614|540188293|FG001|Randomization|Not Treated|0|||
149742693|NCT01485614|540188294|FG002|Randomization|Not Treated|0|||
149742694|NCT01485614|540188295|FG003|Randomization|Not Treated|0|||
149742695|NCT01485614|540188292|FG000|Weeks 0-20|Lost to Follow-up|2|||
149742696|NCT01485614|540188293|FG001|Weeks 0-20|Lost to Follow-up|0|||
149742697|NCT01485614|540188294|FG002|Weeks 0-20|Lost to Follow-up|0|||
149742698|NCT01485614|540188295|FG003|Weeks 0-20|Lost to Follow-up|0|||
149742699|NCT01485614|540188292|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
149742700|NCT01485614|540188293|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
149742701|NCT01485614|540188294|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
149742702|NCT01485614|540188295|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
149742703|NCT01485614|540188292|FG000|Weeks 0-20|Withdrawal by Subject|3|||
149742704|NCT01485614|540188293|FG001|Weeks 0-20|Withdrawal by Subject|2|||
149742705|NCT01485614|540188294|FG002|Weeks 0-20|Withdrawal by Subject|1|||
149742706|NCT01485614|540188295|FG003|Weeks 0-20|Withdrawal by Subject|0|||
149742707|NCT01485614|540188292|FG000|Weeks 20-54|Lost to Follow-up|4|||
149742708|NCT01485614|540188293|FG001|Weeks 20-54|Lost to Follow-up|3|||
149742709|NCT01485614|540188294|FG002|Weeks 20-54|Lost to Follow-up|1|||
149742710|NCT01485614|540188295|FG003|Weeks 20-54|Lost to Follow-up|0|||
149742711|NCT01485614|540188292|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
149742712|NCT01485614|540188293|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
149742713|NCT01485614|540188294|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
149742714|NCT01485614|540188295|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
149742715|NCT01485614|540188292|FG000|Weeks 20-54|Withdrawal by Subject|5|||
149742716|NCT01485614|540188293|FG001|Weeks 20-54|Withdrawal by Subject|3|||
149742717|NCT01485614|540188294|FG002|Weeks 20-54|Withdrawal by Subject|0|||
149742718|NCT01485614|540188295|FG003|Weeks 20-54|Withdrawal by Subject|0|||
149742719|NCT00733902|540188296|FG000|Overall Study|Death|0|||
149742720|NCT00733902|540188297|FG001|Overall Study|Death|0|||
149742721|NCT00733902|540188298|FG002|Overall Study|Death|0|||
149742722|NCT00733902|540188299|FG003|Overall Study|Death|1|||
149742723|NCT00733902|540188296|FG000|Overall Study|Adverse Event|3|||
149742724|NCT00733902|540188297|FG001|Overall Study|Adverse Event|4|||
149742725|NCT00733902|540188298|FG002|Overall Study|Adverse Event|7|||
149742726|NCT00733902|540188299|FG003|Overall Study|Adverse Event|11|||
149742727|NCT00733902|540188296|FG000|Overall Study|Lack of Efficacy|56|||
149742728|NCT00733902|540188297|FG001|Overall Study|Lack of Efficacy|21|||
149742729|NCT00733902|540188298|FG002|Overall Study|Lack of Efficacy|34|||
149742730|NCT00733902|540188299|FG003|Overall Study|Lack of Efficacy|23|||
149742731|NCT00733902|540188296|FG000|Overall Study|Protocol Violation|4|||
149742732|NCT00733902|540188297|FG001|Overall Study|Protocol Violation|6|||
149742733|NCT00733902|540188298|FG002|Overall Study|Protocol Violation|3|||
149742734|NCT00733902|540188299|FG003|Overall Study|Protocol Violation|3|||
149742735|NCT00733902|540188296|FG000|Overall Study|Withdrawal by Subject|10|||
149742736|NCT00733902|540188297|FG001|Overall Study|Withdrawal by Subject|5|||
149742737|NCT00733902|540188298|FG002|Overall Study|Withdrawal by Subject|4|||
149742738|NCT00733902|540188299|FG003|Overall Study|Withdrawal by Subject|16|||
149742739|NCT00733902|540188296|FG000|Overall Study|Entered extension study|89|||
149742740|NCT00733902|540188297|FG001|Overall Study|Entered extension study|124|||
149742741|NCT00733902|540188298|FG002|Overall Study|Entered extension study|111|||
149742742|NCT00733902|540188299|FG003|Overall Study|Entered extension study|109|||
149742743|NCT00733902|540188296|FG000|Overall Study|Randomized but not treated|2|||
149742744|NCT00733902|540188297|FG001|Overall Study|Randomized but not treated|2|||
149742745|NCT00733902|540188298|FG002|Overall Study|Randomized but not treated|2|||
149742746|NCT00733902|540188299|FG003|Overall Study|Randomized but not treated|1|||
149742747|NCT02210780|540188300|FG000|Overall Study|Adverse Event|0|||
149742748|NCT02210780|540188301|FG001|Overall Study|Adverse Event|5|||
149742749|NCT02210780|540188300|FG000|Overall Study|Lost to Follow-up|2|||
149742750|NCT02210780|540188301|FG001|Overall Study|Lost to Follow-up|1|||
149742751|NCT02210780|540188300|FG000|Overall Study|Withdrawal by Subject|1|||
149742752|NCT02210780|540188301|FG001|Overall Study|Withdrawal by Subject|1|||
149742753|NCT02210780|540188300|FG000|Overall Study|Physician Decision|1|||
149742754|NCT02210780|540188301|FG001|Overall Study|Physician Decision|0|||
149742755|NCT02210780|540188300|FG000|Overall Study|Protocol Violation|1|||
149742756|NCT02210780|540188301|FG001|Overall Study|Protocol Violation|0|||
149742757|NCT02210780|540188300|FG000|Overall Study|Other than specified above|0|||
149742758|NCT02210780|540188301|FG001|Overall Study|Other than specified above|1|||
149742759|NCT01503021|540188308|FG000|Overall Study|Adverse Event|7|||
149742760|NCT01503021|540188309|FG001|Overall Study|Adverse Event|6|||
149742761|NCT01503021|540188308|FG000|Overall Study|Death|0|||
149742762|NCT01503021|540188309|FG001|Overall Study|Death|2|||
149742763|NCT01503021|540188308|FG000|Overall Study|Lost to Follow-up|2|||
149742764|NCT01503021|540188309|FG001|Overall Study|Lost to Follow-up|0|||
149742765|NCT01503021|540188308|FG000|Overall Study|Physician Decision|3|||
149742766|NCT01503021|540188309|FG001|Overall Study|Physician Decision|0|||
149742767|NCT01503021|540188308|FG000|Overall Study|Protocol Violation|1|||
149742768|NCT01503021|540188309|FG001|Overall Study|Protocol Violation|3|||
149742769|NCT01503021|540188308|FG000|Overall Study|Withdrawal by Subject|9|||
149742770|NCT01503021|540188309|FG001|Overall Study|Withdrawal by Subject|8|||
149742771|NCT01503021|540188308|FG000|Overall Study|Moved, received transplant, etc.|5|||
149742772|NCT01503021|540188309|FG001|Overall Study|Moved, received transplant, etc.|7|||
149742773|NCT03941548|540188310|FG000|Overall Study|Adverse Event|0|||
149742774|NCT03941548|540188311|FG001|Overall Study|Adverse Event|1|||
149742775|NCT03941548|540188310|FG000|Overall Study|Lost to Follow-up|0|||
149742776|NCT03941548|540188311|FG001|Overall Study|Lost to Follow-up|1|||
149742777|NCT03941548|540188310|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
149742778|NCT03941548|540188311|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
149742779|NCT01242111|540188314|FG000|Overall Study|Adverse Event|1|||
149742780|NCT01242111|540188314|FG000|Overall Study|Withdrawal by Subject|1|||
149742781|NCT01242111|540188314|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
149742782|NCT00870688|540188315|FG000|Overall Study|Lost to Follow-up|2|||
149742783|NCT00870688|540188315|FG000|Overall Study|Death, Unrelated|1|||
149742784|NCT00870688|540188315|FG000|Overall Study|Granules in the Stools|1|||
149742785|NCT01929083|540188318|FG000|Intervention 1|Lost to Follow-up|2|||
149742786|NCT01929083|540188319|FG001|Intervention 1|Lost to Follow-up|0|||
149742787|NCT01929083|540188318|FG000|Intervention 1|Nonadherent to study medications|1|||
149742788|NCT01929083|540188319|FG001|Intervention 1|Nonadherent to study medications|0|||
149742789|NCT01929083|540188318|FG000|Intervention 2|Adverse Event|0|||
149742790|NCT01929083|540188319|FG001|Intervention 2|Adverse Event|1|||
149742791|NCT02945657|540188320|FG000|Overall Study|Adverse Event|1|||
149742792|NCT02945657|540188320|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
149742793|NCT00087438|540188327|FG000|Overall Study|Ineligible / No protocol treatment|4|||
149742794|NCT01486264|540188328|FG000|Overall Study|Death|1|||
149742795|NCT01486264|540188329|FG001|Overall Study|Death|1|||
149742796|NCT01486264|540188328|FG000|Overall Study|Adverse Event|3|||
149742797|NCT01486264|540188329|FG001|Overall Study|Adverse Event|3|||
149742798|NCT01486264|540188328|FG000|Overall Study|Lack of Efficacy|6|||
149742799|NCT01486264|540188329|FG001|Overall Study|Lack of Efficacy|10|||
149742800|NCT01486264|540188328|FG000|Overall Study|Withdrawal by Subject|7|||
149742801|NCT01486264|540188329|FG001|Overall Study|Withdrawal by Subject|18|||
149742802|NCT01486264|540188328|FG000|Overall Study|Physician Decision|1|||
149742803|NCT01486264|540188329|FG001|Overall Study|Physician Decision|1|||
149742804|NCT01486264|540188328|FG000|Overall Study|Protocol Violation|3|||
149742805|NCT01486264|540188329|FG001|Overall Study|Protocol Violation|0|||
149742806|NCT01486264|540188328|FG000|Overall Study|Lost to Follow-up|3|||
149742807|NCT01486264|540188329|FG001|Overall Study|Lost to Follow-up|2|||
149742808|NCT01486264|540188328|FG000|Overall Study|Other|5|||
149742809|NCT01486264|540188329|FG001|Overall Study|Other|11|||
149742810|NCT01486264|540188328|FG000|Overall Study|Not treated|0|||
149742811|NCT01486264|540188329|FG001|Overall Study|Not treated|1|||
149742812|NCT00283387|540188330|FG000|First Intervention|Subject non-compliant|1|||
149742813|NCT00283387|540188331|FG001|First Intervention|Subject non-compliant|1|||
149742814|NCT00283387|540188330|FG000|First Intervention|Withdrawal by Subject|0|||
149742815|NCT00283387|540188331|FG001|First Intervention|Withdrawal by Subject|1|||
149742816|NCT03182738|540188332|FG000|Overall Study|Lost to Follow-up|9|||
149742817|NCT03182738|540188333|FG001|Overall Study|Lost to Follow-up|3|||
149742818|NCT03182738|540188332|FG000|Overall Study|Pregnancy|0|||
149742819|NCT03182738|540188333|FG001|Overall Study|Pregnancy|1|||
149742820|NCT03182738|540188332|FG000|Overall Study|Withdrawal by Subject|0|||
149742821|NCT03182738|540188333|FG001|Overall Study|Withdrawal by Subject|1|||
149742822|NCT03584009|540188334|FG000|Overall Study|Death|25|||
149742823|NCT03584009|540188335|FG001|Overall Study|Death|18|||
149742824|NCT03584009|540188334|FG000|Overall Study|Lost to Follow-up|0|||
149742825|NCT03584009|540188335|FG001|Overall Study|Lost to Follow-up|1|||
149742826|NCT03584009|540188334|FG000|Overall Study|Physician Decision|1|||
149742827|NCT03584009|540188335|FG001|Overall Study|Physician Decision|1|||
149742828|NCT03584009|540188334|FG000|Overall Study|Study Terminated by Sponsor|22|||
149742829|NCT03584009|540188335|FG001|Overall Study|Study Terminated by Sponsor|30|||
149742830|NCT03584009|540188334|FG000|Overall Study|Withdrawal by Subject|3|||
149742831|NCT03584009|540188335|FG001|Overall Study|Withdrawal by Subject|2|||
149742832|NCT00509106|540188338|FG000|Overall Study|Adverse Event|3|||
149742833|NCT00509106|540188339|FG001|Overall Study|Adverse Event|2|||
149742834|NCT00509106|540188338|FG000|Overall Study|Noncompliance|0|||
149742835|NCT00509106|540188339|FG001|Overall Study|Noncompliance|1|||
149742836|NCT00509106|540188338|FG000|Overall Study|At the request of sponsor/investigator|1|||
149742837|NCT00509106|540188339|FG001|Overall Study|At the request of sponsor/investigator|2|||
149742838|NCT00509106|540188338|FG000|Overall Study|Withdrew consent|4|||
149742839|NCT00509106|540188339|FG001|Overall Study|Withdrew consent|8|||
149742840|NCT00509106|540188338|FG000|Overall Study|Lost to Follow-up|16|||
149742841|NCT00509106|540188339|FG001|Overall Study|Lost to Follow-up|10|||
149742842|NCT00509106|540188338|FG000|Overall Study|Other|1|||
149742843|NCT00509106|540188339|FG001|Overall Study|Other|0|||
149742844|NCT00509106|540188338|FG000|Overall Study|Death|6|||
149742845|NCT00509106|540188339|FG001|Overall Study|Death|6|||
149742846|NCT03527043|540188340|FG000|Overall Study|Withdrawal by Subject|1|||
149742847|NCT03527043|540188341|FG001|Overall Study|Withdrawal by Subject|0|||
149742848|NCT01772134|540188347|FG000|Overall Study|Adverse Event|6|||
150256122|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
150256123|NCT02663518|542072655|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256124|NCT02663518|542072656|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256125|NCT02663518|542072657|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149742849|NCT01772134|540188348|FG001|Overall Study|Adverse Event|5|||
149742850|NCT01772134|540188349|FG002|Overall Study|Adverse Event|10|||
149742851|NCT01772134|540188347|FG000|Overall Study|Withdrew Consent|3|||
149742852|NCT01772134|540188348|FG001|Overall Study|Withdrew Consent|1|||
149742853|NCT01772134|540188349|FG002|Overall Study|Withdrew Consent|5|||
149742854|NCT01772134|540188347|FG000|Overall Study|Lost to Follow-up|2|||
149742855|NCT01772134|540188348|FG001|Overall Study|Lost to Follow-up|0|||
149742856|NCT01772134|540188349|FG002|Overall Study|Lost to Follow-up|0|||
149742857|NCT01772134|540188347|FG000|Overall Study|Protocol Deviation|4|||
149742858|NCT01772134|540188348|FG001|Overall Study|Protocol Deviation|3|||
149742859|NCT01772134|540188349|FG002|Overall Study|Protocol Deviation|3|||
149742860|NCT01772134|540188347|FG000|Overall Study|Lack of Efficacy|11|||
149742861|NCT01772134|540188348|FG001|Overall Study|Lack of Efficacy|5|||
149742862|NCT01772134|540188349|FG002|Overall Study|Lack of Efficacy|3|||
149742863|NCT01772134|540188347|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
149742864|NCT01772134|540188348|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
149742865|NCT01772134|540188349|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
149742866|NCT01772134|540188347|FG000|Overall Study|Randomized Study Medication Not Received|2|||
149742867|NCT01772134|540188348|FG001|Overall Study|Randomized Study Medication Not Received|0|||
149742868|NCT01772134|540188349|FG002|Overall Study|Randomized Study Medication Not Received|1|||
149742869|NCT02500550|540188350|FG000|Overall Study|Death|7|||
149742870|NCT01309737|540188352|FG000|Week 0 to 16|Death|1|||
149742871|NCT01309737|540188353|FG001|Week 0 to 16|Death|0|||
149742872|NCT01309737|540188354|FG002|Week 0 to 16|Death|1|||
149742873|NCT01309737|540188355|FG003|Week 0 to 16|Death|0|||
149742874|NCT01309737|540188356|FG004|Week 0 to 16|Death|0|||
149742875|NCT01309737|540188352|FG000|Week 0 to 16|Adverse Event|11|||
149742876|NCT01309737|540188353|FG001|Week 0 to 16|Adverse Event|10|||
149742877|NCT01309737|540188354|FG002|Week 0 to 16|Adverse Event|5|||
149742878|NCT01309737|540188355|FG003|Week 0 to 16|Adverse Event|0|||
149742879|NCT01309737|540188356|FG004|Week 0 to 16|Adverse Event|0|||
149742880|NCT01309737|540188352|FG000|Week 0 to 16|Lack of Efficacy|15|||
149742881|NCT01309737|540188353|FG001|Week 0 to 16|Lack of Efficacy|2|||
149742882|NCT01309737|540188354|FG002|Week 0 to 16|Lack of Efficacy|24|||
149742883|NCT01309737|540188355|FG003|Week 0 to 16|Lack of Efficacy|0|||
149742884|NCT01309737|540188356|FG004|Week 0 to 16|Lack of Efficacy|0|||
149742885|NCT01309737|540188352|FG000|Week 0 to 16|Lost to Follow-up|7|||
149742886|NCT01309737|540188353|FG001|Week 0 to 16|Lost to Follow-up|8|||
149742887|NCT01309737|540188354|FG002|Week 0 to 16|Lost to Follow-up|3|||
149742888|NCT01309737|540188355|FG003|Week 0 to 16|Lost to Follow-up|0|||
149742889|NCT01309737|540188356|FG004|Week 0 to 16|Lost to Follow-up|0|||
149742890|NCT01309737|540188352|FG000|Week 0 to 16|Withdrawal by Subject|7|||
149742891|NCT01309737|540188353|FG001|Week 0 to 16|Withdrawal by Subject|6|||
149742892|NCT01309737|540188354|FG002|Week 0 to 16|Withdrawal by Subject|7|||
149742893|NCT01309737|540188355|FG003|Week 0 to 16|Withdrawal by Subject|0|||
149742894|NCT01309737|540188356|FG004|Week 0 to 16|Withdrawal by Subject|0|||
149742895|NCT01309737|540188352|FG000|Week 0 to 16|Other|10|||
149742896|NCT01309737|540188353|FG001|Week 0 to 16|Other|14|||
149742897|NCT01309737|540188354|FG002|Week 0 to 16|Other|4|||
149742898|NCT01309737|540188355|FG003|Week 0 to 16|Other|0|||
149742899|NCT01309737|540188356|FG004|Week 0 to 16|Other|0|||
149742900|NCT01309737|540188352|FG000|Week 0 to 16|Randomized, but not treated|1|||
149742901|NCT01309737|540188353|FG001|Week 0 to 16|Randomized, but not treated|0|||
149742902|NCT01309737|540188354|FG002|Week 0 to 16|Randomized, but not treated|0|||
149742903|NCT01309737|540188355|FG003|Week 0 to 16|Randomized, but not treated|0|||
149742904|NCT01309737|540188356|FG004|Week 0 to 16|Randomized, but not treated|0|||
149742905|NCT01309737|540188352|FG000|Week 16 to 52|Death|0|||
149742906|NCT01309737|540188353|FG001|Week 16 to 52|Death|0|||
149742907|NCT01309737|540188354|FG002|Week 16 to 52|Death|0|||
149742908|NCT01309737|540188355|FG003|Week 16 to 52|Death|0|||
149742909|NCT01309737|540188356|FG004|Week 16 to 52|Death|1|||
149742910|NCT01309737|540188352|FG000|Week 16 to 52|Adverse Event|7|||
149742911|NCT01309737|540188353|FG001|Week 16 to 52|Adverse Event|7|||
149742912|NCT01309737|540188354|FG002|Week 16 to 52|Adverse Event|0|||
149742913|NCT01309737|540188355|FG003|Week 16 to 52|Adverse Event|6|||
149742914|NCT01309737|540188356|FG004|Week 16 to 52|Adverse Event|5|||
149742915|NCT01309737|540188352|FG000|Week 16 to 52|Lack of Efficacy|107|||
149742916|NCT01309737|540188353|FG001|Week 16 to 52|Lack of Efficacy|76|||
149742917|NCT01309737|540188354|FG002|Week 16 to 52|Lack of Efficacy|0|||
149742918|NCT01309737|540188355|FG003|Week 16 to 52|Lack of Efficacy|25|||
149742919|NCT01309737|540188356|FG004|Week 16 to 52|Lack of Efficacy|21|||
149742920|NCT01309737|540188352|FG000|Week 16 to 52|Lost to Follow-up|4|||
149742921|NCT01309737|540188353|FG001|Week 16 to 52|Lost to Follow-up|2|||
149742922|NCT01309737|540188354|FG002|Week 16 to 52|Lost to Follow-up|0|||
149742923|NCT01309737|540188355|FG003|Week 16 to 52|Lost to Follow-up|1|||
149742924|NCT01309737|540188356|FG004|Week 16 to 52|Lost to Follow-up|4|||
149742925|NCT01309737|540188352|FG000|Week 16 to 52|Withdrawal by Subject|5|||
149742926|NCT01309737|540188353|FG001|Week 16 to 52|Withdrawal by Subject|6|||
149742927|NCT01309737|540188354|FG002|Week 16 to 52|Withdrawal by Subject|0|||
149742928|NCT01309737|540188355|FG003|Week 16 to 52|Withdrawal by Subject|0|||
149742929|NCT01309737|540188356|FG004|Week 16 to 52|Withdrawal by Subject|2|||
149742930|NCT01309737|540188352|FG000|Week 16 to 52|Other|10|||
149742931|NCT01309737|540188353|FG001|Week 16 to 52|Other|12|||
149742932|NCT01309737|540188354|FG002|Week 16 to 52|Other|0|||
149742933|NCT01309737|540188355|FG003|Week 16 to 52|Other|2|||
149742934|NCT01309737|540188356|FG004|Week 16 to 52|Other|0|||
149742935|NCT01073943|540188366|FG000|Overall Study|Withdrawal by Subject|8|||
149742936|NCT01073943|540188367|FG001|Overall Study|Withdrawal by Subject|2|||
149742937|NCT01073943|540188366|FG000|Overall Study|Protocol Violation|2|||
149742938|NCT01073943|540188367|FG001|Overall Study|Protocol Violation|1|||
149742939|NCT01073943|540188366|FG000|Overall Study|Adverse Event|1|||
149742940|NCT01073943|540188367|FG001|Overall Study|Adverse Event|1|||
149742941|NCT01073943|540188366|FG000|Overall Study|Lost to Follow-up|0|||
149742942|NCT01073943|540188367|FG001|Overall Study|Lost to Follow-up|2|||
149742943|NCT01073943|540188366|FG000|Overall Study|Power outage; colonoscopy not done|1|||
149742944|NCT01073943|540188367|FG001|Overall Study|Power outage; colonoscopy not done|0|||
149742945|NCT01073943|540188366|FG000|Overall Study|Subject forgot|0|||
149742946|NCT01073943|540188367|FG001|Overall Study|Subject forgot|1|||
149742947|NCT01073943|540188366|FG000|Overall Study|Unable to return for follow-up|0|||
149742948|NCT01073943|540188367|FG001|Overall Study|Unable to return for follow-up|1|||
149742949|NCT01073943|540188366|FG000|Overall Study|Could not tolerate prep|1|||
149742950|NCT01073943|540188367|FG001|Overall Study|Could not tolerate prep|0|||
149742951|NCT05300087|540188368|FG000|Overall Study|Withdrawal by Subject|0|||
149742952|NCT05300087|540188369|FG001|Overall Study|Withdrawal by Subject|1|||
149742953|NCT00761215|540188370|FG000|Overall Study|Randomized but didn't receive drug|1|||
149742954|NCT00761215|540188371|FG001|Overall Study|Randomized but didn't receive drug|1|||
149742955|NCT00761215|540188372|FG002|Overall Study|Randomized but didn't receive drug|2|||
149742956|NCT00761215|540188370|FG000|Overall Study|Lost to Follow-up|6|||
149742957|NCT00761215|540188371|FG001|Overall Study|Lost to Follow-up|3|||
149742958|NCT00761215|540188372|FG002|Overall Study|Lost to Follow-up|6|||
149742959|NCT00761215|540188370|FG000|Overall Study|Withdrawal by Subject|1|||
149742960|NCT00761215|540188371|FG001|Overall Study|Withdrawal by Subject|0|||
149742961|NCT00761215|540188372|FG002|Overall Study|Withdrawal by Subject|0|||
149742962|NCT00761215|540188370|FG000|Overall Study|Bacteremia|1|||
149742963|NCT00761215|540188371|FG001|Overall Study|Bacteremia|0|||
149742964|NCT00761215|540188372|FG002|Overall Study|Bacteremia|0|||
149742965|NCT05662332|540188373|FG000|Overall Study|Death|3|||
149742966|NCT05662332|540188374|FG001|Overall Study|Death|3|||
149742967|NCT05662332|540188373|FG000|Overall Study|Lost to Follow-up|3|||
149742968|NCT05662332|540188374|FG001|Overall Study|Lost to Follow-up|8|||
149742969|NCT05662332|540188373|FG000|Overall Study|Physician Decision|1|||
149742970|NCT05662332|540188374|FG001|Overall Study|Physician Decision|2|||
149742971|NCT05662332|540188373|FG000|Overall Study|Protocol Deviation|2|||
149742972|NCT05662332|540188374|FG001|Overall Study|Protocol Deviation|1|||
149742973|NCT05662332|540188373|FG000|Overall Study|Withdrawal by Subject|14|||
149742974|NCT05662332|540188374|FG001|Overall Study|Withdrawal by Subject|14|||
149742975|NCT05662332|540188373|FG000|Overall Study|Assigned Treatment by Mistake|5|||
149742976|NCT05662332|540188374|FG001|Overall Study|Assigned Treatment by Mistake|7|||
149742977|NCT05662332|540188373|FG000|Overall Study|Non-compliance with study drug|4|||
149742978|NCT05662332|540188374|FG001|Overall Study|Non-compliance with study drug|1|||
149742979|NCT05662332|540188373|FG000|Overall Study|Due to Bariatric surgery|1|||
149742980|NCT05662332|540188374|FG001|Overall Study|Due to Bariatric surgery|0|||
149742981|NCT05662332|540188373|FG000|Overall Study|Subject Moving out of State|0|||
150256126|NCT02663518|542072658|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256127|NCT02663518|542072659|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256128|NCT02663518|542072660|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256129|NCT02663518|542072661|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256130|NCT02663518|542072662|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256131|NCT02663518|542072663|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256132|NCT02663518|542072664|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256133|NCT02663518|542072665|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256134|NCT02663518|542072666|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256135|NCT02663518|542072667|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
150256136|NCT02663518|542072668|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
150256137|NCT01983254|542072669|FG000|Overall Study|Death|6|||
150256138|NCT01983254|542072670|FG001|Overall Study|Death|6|||
150256139|NCT01983254|542072669|FG000|Overall Study|Lost to Follow-up|17|||
150256140|NCT01983254|542072670|FG001|Overall Study|Lost to Follow-up|16|||
150256141|NCT01983254|542072669|FG000|Overall Study|too ill|11|||
150256142|NCT01983254|542072670|FG001|Overall Study|too ill|8|||
150256143|NCT00434213|542072673|FG000|Overall Study|Adverse Event|12|||
150256144|NCT00434213|542072673|FG000|Overall Study|Lack of Efficacy|9|||
150256145|NCT00434213|542072673|FG000|Overall Study|Lost to Follow-up|14|||
150256146|NCT00434213|542072673|FG000|Overall Study|Withdrawal by Subject|7|||
150256147|NCT00434213|542072673|FG000|Overall Study|Protocol Violation|3|||
150256148|NCT00434213|542072673|FG000|Overall Study|Unable to comply with study visit window|2|||
149742982|NCT05662332|540188374|FG001|Overall Study|Subject Moving out of State|1|||
149742983|NCT05662332|540188373|FG000|Overall Study|Subject Missed the Schedule|1|||
149742984|NCT05662332|540188374|FG001|Overall Study|Subject Missed the Schedule|0|||
149742985|NCT05662332|540188373|FG000|Overall Study|The Patient Moved to Another City|1|||
149742986|NCT05662332|540188374|FG001|Overall Study|The Patient Moved to Another City|0|||
149742987|NCT00667277|540188375|FG000|Overall Study|Withdrawal by Subject|2|||
149742988|NCT03248128|540188376|FG000|Overall Study|Lost to Follow-up|1|||
149742989|NCT03248128|540188377|FG001|Overall Study|Lost to Follow-up|0|||
149742990|NCT03248128|540188376|FG000|Overall Study|Withdrawal by Subject|16|||
149742991|NCT03248128|540188377|FG001|Overall Study|Withdrawal by Subject|14|||
149742992|NCT03248128|540188376|FG000|Overall Study|Site Closed|4|||
149742993|NCT03248128|540188377|FG001|Overall Study|Site Closed|3|||
149742994|NCT03248128|540188376|FG000|Overall Study|Randomized, but did not receive treatment|1|||
149742995|NCT03248128|540188377|FG001|Overall Study|Randomized, but did not receive treatment|3|||
149742996|NCT01914679|540188378|FG000|Overall Study|Lack of Efficacy|1|||
149742997|NCT01914679|540188378|FG000|Overall Study|Sponsor terminated study|4|||
149742998|NCT01126580|540188382|FG000|Overall Study|Adverse Event|14|||
149742999|NCT01126580|540188383|FG001|Overall Study|Adverse Event|8|||
149743000|NCT01126580|540188384|FG002|Overall Study|Adverse Event|12|||
149743001|NCT01126580|540188382|FG000|Overall Study|Withdrawal by Subject|11|||
149743002|NCT01126580|540188383|FG001|Overall Study|Withdrawal by Subject|19|||
149743003|NCT01126580|540188384|FG002|Overall Study|Withdrawal by Subject|14|||
149743004|NCT01126580|540188382|FG000|Overall Study|Sponsor Decision|5|||
149743005|NCT01126580|540188383|FG001|Overall Study|Sponsor Decision|4|||
149743006|NCT01126580|540188384|FG002|Overall Study|Sponsor Decision|7|||
149743007|NCT01126580|540188382|FG000|Overall Study|Physician Decision|1|||
149743008|NCT01126580|540188383|FG001|Overall Study|Physician Decision|1|||
149743009|NCT01126580|540188384|FG002|Overall Study|Physician Decision|2|||
149743010|NCT01126580|540188382|FG000|Overall Study|Entry Criteria Not Met|1|||
149743011|NCT01126580|540188383|FG001|Overall Study|Entry Criteria Not Met|1|||
149743012|NCT01126580|540188384|FG002|Overall Study|Entry Criteria Not Met|2|||
149743013|NCT01126580|540188382|FG000|Overall Study|Lack of Efficacy|2|||
149743014|NCT01126580|540188383|FG001|Overall Study|Lack of Efficacy|3|||
149743015|NCT01126580|540188384|FG002|Overall Study|Lack of Efficacy|4|||
149743016|NCT01126580|540188382|FG000|Overall Study|Protocol Violation|0|||
149743017|NCT01126580|540188383|FG001|Overall Study|Protocol Violation|1|||
149743018|NCT01126580|540188384|FG002|Overall Study|Protocol Violation|2|||
149743019|NCT01126580|540188382|FG000|Overall Study|Lost to Follow-up|15|||
149743020|NCT01126580|540188383|FG001|Overall Study|Lost to Follow-up|13|||
149743021|NCT01126580|540188384|FG002|Overall Study|Lost to Follow-up|9|||
149743022|NCT01126580|540188382|FG000|Overall Study|Treatment Non-compliance|0|||
149743023|NCT01126580|540188383|FG001|Overall Study|Treatment Non-compliance|2|||
149743024|NCT01126580|540188384|FG002|Overall Study|Treatment Non-compliance|3|||
149743025|NCT01731002|540188394|FG000|Overall Study|Adverse Event|0|||
149743026|NCT01731002|540188395|FG001|Overall Study|Adverse Event|2|||
149743027|NCT01731002|540188396|FG002|Overall Study|Adverse Event|2|||
149743028|NCT01731002|540188394|FG000|Overall Study|Non-Compliant|0|||
149743029|NCT01731002|540188395|FG001|Overall Study|Non-Compliant|1|||
149743030|NCT01731002|540188396|FG002|Overall Study|Non-Compliant|0|||
149743031|NCT01731002|540188394|FG000|Overall Study|Lost to Follow-up|1|||
149743032|NCT01731002|540188395|FG001|Overall Study|Lost to Follow-up|0|||
149743033|NCT01731002|540188396|FG002|Overall Study|Lost to Follow-up|0|||
149743034|NCT01731002|540188394|FG000|Overall Study|Test Agent Discontinuation|0|||
149743035|NCT01731002|540188395|FG001|Overall Study|Test Agent Discontinuation|1|||
149743036|NCT01731002|540188396|FG002|Overall Study|Test Agent Discontinuation|0|||
149743037|NCT01731002|540188394|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
149743038|NCT01731002|540188395|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
149743039|NCT01731002|540188396|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
149743040|NCT01731002|540188394|FG000|Overall Study|Elevated IOP|1|||
149743041|NCT01731002|540188395|FG001|Overall Study|Elevated IOP|0|||
149743042|NCT01731002|540188396|FG002|Overall Study|Elevated IOP|0|||
149743043|NCT01731002|540188394|FG000|Overall Study|Inappropriate use of study medications|0|||
149743044|NCT01731002|540188395|FG001|Overall Study|Inappropriate use of study medications|0|||
149743045|NCT01731002|540188396|FG002|Overall Study|Inappropriate use of study medications|1|||
149743046|NCT00538681|540188399|FG000|Overall Study|Progressive Disease|7|||
149743047|NCT00538681|540188400|FG001|Overall Study|Progressive Disease|0|||
149743048|NCT00538681|540188401|FG002|Overall Study|Progressive Disease|1|||
149743049|NCT00538681|540188402|FG003|Overall Study|Progressive Disease|0|||
150256149|NCT00434213|542072673|FG000|Overall Study|Application site reaction|1|||
150256150|NCT00434213|542072673|FG000|Overall Study|Non-compliant to study schedule|1|||
150256151|NCT01253304|542072674|FG000|Overall Study|Adverse Event|0|||
150256152|NCT01253304|542072675|FG001|Overall Study|Adverse Event|0|||
150256153|NCT01253304|542072676|FG002|Overall Study|Adverse Event|0|||
150256154|NCT01253304|542072677|FG003|Overall Study|Adverse Event|1|||
149743050|NCT00538681|540188399|FG000|Overall Study|Sponsor Decision|1|||
149743051|NCT00538681|540188400|FG001|Overall Study|Sponsor Decision|3|||
149743052|NCT00538681|540188401|FG002|Overall Study|Sponsor Decision|8|||
149743053|NCT00538681|540188402|FG003|Overall Study|Sponsor Decision|9|||
149743054|NCT00538681|540188399|FG000|Overall Study|Adverse Event|1|||
149743055|NCT00538681|540188400|FG001|Overall Study|Adverse Event|1|||
149743056|NCT00538681|540188401|FG002|Overall Study|Adverse Event|1|||
149743057|NCT00538681|540188402|FG003|Overall Study|Adverse Event|0|||
149743058|NCT00538681|540188399|FG000|Overall Study|Death|0|||
149743059|NCT00538681|540188400|FG001|Overall Study|Death|0|||
149743060|NCT00538681|540188401|FG002|Overall Study|Death|1|||
149743061|NCT00538681|540188402|FG003|Overall Study|Death|1|||
149801752|NCT01049360|540402430|FG016|Period 4|Withdrawal by Subject|0|||
149743062|NCT00538681|540188399|FG000|Overall Study|Investigator Decision|0|||
149743063|NCT00538681|540188400|FG001|Overall Study|Investigator Decision|0|||
149743064|NCT00538681|540188401|FG002|Overall Study|Investigator Decision|0|||
149743065|NCT00538681|540188402|FG003|Overall Study|Investigator Decision|1|||
149743066|NCT02581995|540188405|FG000|Overall Study|Unspecified other|3|||
149743067|NCT02581995|540188405|FG000|Overall Study|Adverse Event|6|||
149743068|NCT02581995|540188405|FG000|Overall Study|Lost to Follow-up|5|||
149743069|NCT02581995|540188405|FG000|Overall Study|Withdrawal by participant|12|||
149743070|NCT02581995|540188405|FG000|Overall Study|Physician Decision|1|||
149743071|NCT02581995|540188405|FG000|Overall Study|Death|4|||
149743072|NCT03528681|540190191|FG000|Open-Label Phase|Physician Decision|2|||
149743073|NCT03528681|540190192|FG001|Open-Label Phase|Physician Decision|0|||
149743074|NCT03528681|540190193|FG002|Open-Label Phase|Physician Decision|0|||
149743075|NCT03528681|540190194|FG003|Open-Label Phase|Physician Decision|0|||
149743076|NCT03528681|540190191|FG000|Open-Label Phase|Withdrawal by Subject|8|||
149743077|NCT03528681|540190192|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149743078|NCT03528681|540190193|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149743079|NCT03528681|540190194|FG003|Open-Label Phase|Withdrawal by Subject|0|||
149743080|NCT03528681|540190191|FG000|Open-Label Phase|(Not collected)|4|||
149743081|NCT03528681|540190192|FG001|Open-Label Phase|(Not collected)|0|||
149743082|NCT03528681|540190193|FG002|Open-Label Phase|(Not collected)|0|||
149743083|NCT03528681|540190194|FG003|Open-Label Phase|(Not collected)|0|||
149743084|NCT03528681|540190191|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
149743085|NCT03528681|540190192|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
149743086|NCT03528681|540190193|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
149743087|NCT03528681|540190194|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
149743088|NCT03528681|540190191|FG000|Randomized Treatment Phase|Physician Decision|0|||
149743089|NCT03528681|540190192|FG001|Randomized Treatment Phase|Physician Decision|5|||
149743090|NCT03528681|540190193|FG002|Randomized Treatment Phase|Physician Decision|1|||
149743091|NCT03528681|540190194|FG003|Randomized Treatment Phase|Physician Decision|2|||
149743092|NCT03528681|540190191|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
149743093|NCT03528681|540190192|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
149743094|NCT03528681|540190193|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
149743095|NCT03528681|540190194|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
149743096|NCT03528681|540190191|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
149743097|NCT03528681|540190192|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
149743098|NCT03528681|540190193|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
149743099|NCT03528681|540190194|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
149743100|NCT03528681|540190191|FG000|Randomized Treatment Phase|(Not collected)|0|||
149743101|NCT03528681|540190192|FG001|Randomized Treatment Phase|(Not collected)|4|||
149743102|NCT03528681|540190193|FG002|Randomized Treatment Phase|(Not collected)|6|||
149743103|NCT03528681|540190194|FG003|Randomized Treatment Phase|(Not collected)|5|||
149743104|NCT01614457|540190200|FG000|Overall Study|Non-Compliance|1|||
149743105|NCT01614457|540190201|FG001|Overall Study|Non-Compliance|0|||
149743106|NCT01614457|540190200|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
149743107|NCT01614457|540190201|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
149743108|NCT03518840|540190202|FG000|Overall Study|Lost to Follow-up|6|||
149743109|NCT01531725|540190208|FG000|Overall Study|Protocol Violation|5|||
149743110|NCT00500071|540190212|FG000|Screening and Washout Phase|Protocol Violation|1|||
149743111|NCT00500071|540190212|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
149743112|NCT00500071|540190212|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
149743113|NCT00500071|540190212|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
149743114|NCT00500071|540190212|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
149743115|NCT00500071|540190212|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
149743116|NCT00500071|540190212|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
149743117|NCT01122927|540190213|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
149743118|NCT01122927|540190214|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
149743119|NCT01122927|540190213|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
149743120|NCT01122927|540190214|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
149743121|NCT01122927|540190213|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
149743122|NCT01122927|540190214|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
149743123|NCT01122927|540190213|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
149743124|NCT01122927|540190214|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
149743125|NCT01122927|540190213|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
149743126|NCT01122927|540190214|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
149743127|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
149743128|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
149743129|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
149743130|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
150256155|NCT01699503|542072678|FG000|Overall Study|Death|31|||
149743131|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
149801753|NCT01049360|540402431|FG017|Period 4|Withdrawal by Subject|0|||
149743132|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
149743133|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
149743134|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
149743135|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
149743136|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
149743137|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
149743138|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
149743139|NCT01122927|540190213|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
149743140|NCT01122927|540190214|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
149743141|NCT00728416|540190223|FG000|Overall Study|Adverse Event|1|||
149743142|NCT00728416|540190224|FG001|Overall Study|Adverse Event|1|||
149743143|NCT00728416|540190223|FG000|Overall Study|Treatment Failure|0|||
149743144|NCT00728416|540190224|FG001|Overall Study|Treatment Failure|1|||
149743145|NCT00728416|540190223|FG000|Overall Study|Withdrawal by Subject|1|||
149743146|NCT00728416|540190224|FG001|Overall Study|Withdrawal by Subject|0|||
149743147|NCT00389207|540190225|FG000|Overall Study|Adverse Event|26|||
149743148|NCT00389207|540190226|FG001|Overall Study|Adverse Event|32|||
149743149|NCT00389207|540190227|FG002|Overall Study|Adverse Event|10|||
149743150|NCT00389207|540190225|FG000|Overall Study|Protocol Violation|3|||
149743151|NCT00389207|540190226|FG001|Overall Study|Protocol Violation|1|||
149743152|NCT00389207|540190227|FG002|Overall Study|Protocol Violation|4|||
149743153|NCT00389207|540190225|FG000|Overall Study|Lost to Follow-up|12|||
149743154|NCT00389207|540190226|FG001|Overall Study|Lost to Follow-up|9|||
149743155|NCT00389207|540190227|FG002|Overall Study|Lost to Follow-up|7|||
149743156|NCT00389207|540190225|FG000|Overall Study|Withdrawal by Subject|5|||
149743157|NCT00389207|540190226|FG001|Overall Study|Withdrawal by Subject|7|||
149743158|NCT00389207|540190227|FG002|Overall Study|Withdrawal by Subject|11|||
149743159|NCT00389207|540190225|FG000|Overall Study|Other|17|||
149743160|NCT00389207|540190226|FG001|Overall Study|Other|23|||
149743161|NCT00389207|540190227|FG002|Overall Study|Other|9|||
149743162|NCT02371629|540190236|FG000|Overall Study|Patient decision|14|||
149743163|NCT02371629|540190237|FG001|Overall Study|Patient decision|10|||
149743164|NCT02371629|540190236|FG000|Overall Study|Adverse Event|8|||
149743165|NCT02371629|540190237|FG001|Overall Study|Adverse Event|8|||
149743166|NCT02371629|540190236|FG000|Overall Study|Physician Decision|2|||
149743167|NCT02371629|540190237|FG001|Overall Study|Physician Decision|3|||
149743168|NCT02371629|540190236|FG000|Overall Study|Death|1|||
149743169|NCT02371629|540190237|FG001|Overall Study|Death|1|||
149743170|NCT02371629|540190236|FG000|Overall Study|Noncompliance with study treatment|1|||
149743171|NCT02371629|540190237|FG001|Overall Study|Noncompliance with study treatment|0|||
149743172|NCT02371629|540190236|FG000|Overall Study|Lack of Efficacy|0|||
149743173|NCT02371629|540190237|FG001|Overall Study|Lack of Efficacy|2|||
149743174|NCT02371629|540190236|FG000|Overall Study|Protocol deviation|0|||
149743175|NCT02371629|540190237|FG001|Overall Study|Protocol deviation|1|||
149743176|NCT05421754|540190241|FG000|Overall Study|Technical issue with sensor|1|||
149743177|NCT01051739|540190242|FG000|Overall Study|Death|3|||
149743178|NCT01051739|540190243|FG001|Overall Study|Death|3|||
149743179|NCT01051739|540190242|FG000|Overall Study|Withdrawal by Subject|25|||
149743180|NCT01051739|540190243|FG001|Overall Study|Withdrawal by Subject|10|||
149743181|NCT03192904|540190244|FG000|Overall Study|Physician Decision|3|||
149743182|NCT03192904|540190245|FG001|Overall Study|Physician Decision|1|||
149743183|NCT03192904|540190244|FG000|Overall Study|Lost to Follow-up|0|||
149743184|NCT03192904|540190245|FG001|Overall Study|Lost to Follow-up|1|||
149743185|NCT01023789|540190248|FG000|3 - Year Visit|Death|29|||
149743186|NCT01023789|540190248|FG000|3 - Year Visit|Withdrawal of consent|1|||
149743187|NCT01023789|540190248|FG000|3 - Year Visit|Lost to Follow-up|13|||
149743188|NCT02034123|540190258|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743189|NCT02034123|540190259|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743190|NCT02034123|540190260|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743191|NCT02034123|540190261|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743192|NCT02034123|540190262|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149743193|NCT02034123|540190263|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743194|NCT02034123|540190264|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743195|NCT02034123|540190265|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149743196|NCT02034123|540190266|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149743197|NCT02034123|540190267|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743198|NCT02034123|540190268|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743199|NCT02034123|540190269|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743200|NCT02034123|540190270|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743201|NCT02034123|540190271|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743202|NCT02034123|540190272|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743203|NCT02034123|540190273|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743204|NCT02034123|540190274|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743205|NCT02034123|540190275|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149743206|NCT02034123|540190258|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743207|NCT02034123|540190259|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743208|NCT02034123|540190260|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743209|NCT02034123|540190261|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
149743210|NCT02034123|540190262|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743211|NCT02034123|540190263|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743212|NCT02034123|540190264|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743213|NCT02034123|540190265|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743214|NCT02034123|540190266|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743215|NCT02034123|540190267|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743216|NCT02034123|540190268|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743217|NCT02034123|540190269|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743218|NCT02034123|540190270|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743219|NCT02034123|540190271|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743220|NCT02034123|540190272|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743221|NCT02034123|540190273|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743222|NCT02034123|540190274|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743223|NCT02034123|540190275|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149743224|NCT02034123|540190258|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743225|NCT02034123|540190259|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743226|NCT02034123|540190260|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743227|NCT02034123|540190261|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743228|NCT02034123|540190262|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743229|NCT02034123|540190263|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743230|NCT02034123|540190264|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743231|NCT02034123|540190265|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743232|NCT02034123|540190266|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
149743233|NCT02034123|540190267|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743234|NCT02034123|540190268|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743235|NCT02034123|540190269|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743236|NCT02034123|540190270|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743237|NCT02034123|540190271|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743238|NCT02034123|540190272|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743239|NCT02034123|540190273|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743240|NCT02034123|540190274|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743241|NCT02034123|540190275|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149743242|NCT02034123|540190258|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743243|NCT02034123|540190259|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743244|NCT02034123|540190260|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743245|NCT02034123|540190261|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
149743246|NCT02034123|540190262|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
149743247|NCT02034123|540190263|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743248|NCT02034123|540190264|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743249|NCT02034123|540190265|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743250|NCT02034123|540190266|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743251|NCT02034123|540190267|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743252|NCT02034123|540190268|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743253|NCT02034123|540190269|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743254|NCT02034123|540190270|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743255|NCT02034123|540190271|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149801754|NCT01049360|540402432|FG018|Period 4|Withdrawal by Subject|0|||
149743256|NCT02034123|540190272|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743257|NCT02034123|540190273|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743258|NCT02034123|540190274|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743259|NCT02034123|540190275|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149743260|NCT00246259|540190276|FG000|Overall Study|Other|3|||
149743261|NCT00246259|540190277|FG001|Overall Study|Other|3|||
149743262|NCT00246259|540190276|FG000|Overall Study|Not stable by Week 18|2|||
149743263|NCT00246259|540190277|FG001|Overall Study|Not stable by Week 18|1|||
149743264|NCT00246259|540190276|FG000|Overall Study|Participant non-compliant|4|||
149743265|NCT00246259|540190277|FG001|Overall Study|Participant non-compliant|9|||
149743266|NCT00246259|540190276|FG000|Overall Study|Lack of Efficacy|2|||
149743267|NCT00246259|540190277|FG001|Overall Study|Lack of Efficacy|2|||
149743268|NCT00246259|540190276|FG000|Overall Study|Investigator withdrew participant|2|||
149743269|NCT00246259|540190277|FG001|Overall Study|Investigator withdrew participant|0|||
149743270|NCT00246259|540190276|FG000|Overall Study|Adverse Event|5|||
149743271|NCT00246259|540190277|FG001|Overall Study|Adverse Event|0|||
149743272|NCT00246259|540190276|FG000|Overall Study|Lost to Follow-up|3|||
149743273|NCT00246259|540190277|FG001|Overall Study|Lost to Follow-up|4|||
149743274|NCT00246259|540190276|FG000|Overall Study|Withdrawal by Subject|5|||
149743275|NCT00246259|540190277|FG001|Overall Study|Withdrawal by Subject|1|||
149743276|NCT00246259|540190276|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
149743277|NCT00246259|540190277|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
149743278|NCT02240706|540190278|FG000|Overall Study|Lack of Efficacy|2|||
149743279|NCT02240706|540190279|FG001|Overall Study|Lack of Efficacy|2|||
149743280|NCT02240706|540190280|FG002|Overall Study|Lack of Efficacy|2|||
149743281|NCT02240706|540190281|FG003|Overall Study|Lack of Efficacy|2|||
149743282|NCT02240706|540190282|FG004|Overall Study|Lack of Efficacy|5|||
149743283|NCT02240706|540190283|FG005|Overall Study|Lack of Efficacy|0|||
149743284|NCT02240706|540190284|FG006|Overall Study|Lack of Efficacy|0|||
149743285|NCT02240706|540190278|FG000|Overall Study|Adverse Event|1|||
149743286|NCT02240706|540190279|FG001|Overall Study|Adverse Event|0|||
149743287|NCT02240706|540190280|FG002|Overall Study|Adverse Event|1|||
149743288|NCT02240706|540190281|FG003|Overall Study|Adverse Event|0|||
149743289|NCT02240706|540190282|FG004|Overall Study|Adverse Event|2|||
149743290|NCT02240706|540190283|FG005|Overall Study|Adverse Event|0|||
149743291|NCT02240706|540190284|FG006|Overall Study|Adverse Event|0|||
149743292|NCT02240706|540190278|FG000|Overall Study|Progressive disease|0|||
149743293|NCT02240706|540190279|FG001|Overall Study|Progressive disease|0|||
149743294|NCT02240706|540190280|FG002|Overall Study|Progressive disease|0|||
149743295|NCT02240706|540190281|FG003|Overall Study|Progressive disease|0|||
149743296|NCT02240706|540190282|FG004|Overall Study|Progressive disease|1|||
149743297|NCT02240706|540190283|FG005|Overall Study|Progressive disease|0|||
149743298|NCT02240706|540190284|FG006|Overall Study|Progressive disease|0|||
149743299|NCT02240706|540190278|FG000|Overall Study|Dose limiting toxicity|0|||
149743300|NCT02240706|540190279|FG001|Overall Study|Dose limiting toxicity|0|||
149743301|NCT02240706|540190280|FG002|Overall Study|Dose limiting toxicity|0|||
149743302|NCT02240706|540190281|FG003|Overall Study|Dose limiting toxicity|0|||
149743303|NCT02240706|540190282|FG004|Overall Study|Dose limiting toxicity|1|||
149743304|NCT02240706|540190283|FG005|Overall Study|Dose limiting toxicity|0|||
149743305|NCT02240706|540190284|FG006|Overall Study|Dose limiting toxicity|0|||
149743306|NCT02240706|540190278|FG000|Overall Study|Refused to continue taking medication|0|||
149743307|NCT02240706|540190279|FG001|Overall Study|Refused to continue taking medication|1|||
149743308|NCT02240706|540190280|FG002|Overall Study|Refused to continue taking medication|3|||
149743309|NCT02240706|540190281|FG003|Overall Study|Refused to continue taking medication|1|||
149743310|NCT02240706|540190282|FG004|Overall Study|Refused to continue taking medication|2|||
149743311|NCT02240706|540190283|FG005|Overall Study|Refused to continue taking medication|0|||
149743312|NCT02240706|540190284|FG006|Overall Study|Refused to continue taking medication|0|||
149743313|NCT02240706|540190278|FG000|Overall Study|Insurance billing concerns|0|||
149743314|NCT02240706|540190279|FG001|Overall Study|Insurance billing concerns|0|||
149743315|NCT02240706|540190280|FG002|Overall Study|Insurance billing concerns|0|||
149743316|NCT02240706|540190281|FG003|Overall Study|Insurance billing concerns|1|||
149743317|NCT02240706|540190282|FG004|Overall Study|Insurance billing concerns|0|||
149743318|NCT02240706|540190283|FG005|Overall Study|Insurance billing concerns|0|||
149743319|NCT02240706|540190284|FG006|Overall Study|Insurance billing concerns|0|||
149743320|NCT03022461|540190285|FG000|Overall Study|Death|3|||
149743321|NCT01076179|540190286|FG000|Overall Study|Withdrawal by Subject|1|||
149743322|NCT03459040|540190287|FG000|Overall Study|Death|8|||
149743323|NCT03459040|540190287|FG000|Overall Study|Withdrawal by Subject|1|||
149743324|NCT00986349|540190288|FG000|Overall Study|Unsuccessful implant procedure|3|||
149743325|NCT00986349|540190288|FG000|Overall Study|Adverse Event|2|||
149743326|NCT00986349|540190288|FG000|Overall Study|Physician Decision|1|||
149743327|NCT00986349|540190288|FG000|Overall Study|device migration|1|||
149743328|NCT02299934|540190289|FG000|Overall Study|Termination of study|13|||
149743329|NCT03815175|540190290|FG000|Overall Study|Subject Lost to Follow-up|6|||
149743330|NCT03815175|540190290|FG000|Overall Study|Subject Withdrew Consent|48|||
149801755|NCT01049360|540402433|FG019|Period 4|Withdrawal by Subject|0|||
149743331|NCT03815175|540190290|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
149743332|NCT03815175|540190290|FG000|Overall Study|Death|86|||
149743333|NCT03815175|540190290|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
149743334|NCT03815175|540190290|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
149743335|NCT03815175|540190290|FG000|Overall Study|Other Status Change Reason|1|||
149743336|NCT03815175|540190290|FG000|Overall Study|Missed Visit|12|||
149743337|NCT03577990|540190291|FG000|Overall Study|Lost to Follow-up|4|||
149743338|NCT03577990|540190292|FG001|Overall Study|Lost to Follow-up|6|||
149743339|NCT03577990|540190291|FG000|Overall Study|Withdrawal by Subject|4|||
149743340|NCT03577990|540190292|FG001|Overall Study|Withdrawal by Subject|7|||
149743341|NCT00488631|540190298|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
149743342|NCT00488631|540190299|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
149743343|NCT00488631|540190300|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
149743344|NCT00488631|540190301|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
149743345|NCT00488631|540190302|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
149743346|NCT00488631|540190303|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
149743347|NCT00488631|540190304|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
149743348|NCT00488631|540190305|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
149743349|NCT00488631|540190306|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
149743350|NCT00488631|540190307|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
149743351|NCT00488631|540190298|FG000|Double Blind Period (Week 0-54)|Death|0|||
149743352|NCT00488631|540190299|FG001|Double Blind Period (Week 0-54)|Death|0|||
149743353|NCT00488631|540190300|FG002|Double Blind Period (Week 0-54)|Death|0|||
149743354|NCT00488631|540190301|FG003|Double Blind Period (Week 0-54)|Death|0|||
149743355|NCT00488631|540190302|FG004|Double Blind Period (Week 0-54)|Death|0|||
149743356|NCT00488631|540190303|FG005|Double Blind Period (Week 0-54)|Death|1|||
149743357|NCT00488631|540190304|FG006|Double Blind Period (Week 0-54)|Death|0|||
149743358|NCT00488631|540190305|FG007|Double Blind Period (Week 0-54)|Death|0|||
149743359|NCT00488631|540190306|FG008|Double Blind Period (Week 0-54)|Death|0|||
149743360|NCT00488631|540190307|FG009|Double Blind Period (Week 0-54)|Death|0|||
149743361|NCT00488631|540190298|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
149743362|NCT00488631|540190299|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
149743363|NCT00488631|540190300|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
149743364|NCT00488631|540190301|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
149743365|NCT00488631|540190302|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
149743366|NCT00488631|540190303|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
149743367|NCT00488631|540190304|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149743368|NCT00488631|540190305|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149743369|NCT00488631|540190306|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149743370|NCT00488631|540190307|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149743371|NCT00488631|540190298|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
149743372|NCT00488631|540190299|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
149743373|NCT00488631|540190300|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
149743374|NCT00488631|540190301|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149743375|NCT00488631|540190302|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
149743376|NCT00488631|540190303|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
149743377|NCT00488631|540190304|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149743378|NCT00488631|540190305|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149743379|NCT00488631|540190306|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149743380|NCT00488631|540190307|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149743381|NCT00488631|540190298|FG000|Double Blind Period (Week 0-54)|Other|6|||
149743382|NCT00488631|540190299|FG001|Double Blind Period (Week 0-54)|Other|12|||
149743383|NCT00488631|540190300|FG002|Double Blind Period (Week 0-54)|Other|10|||
149743384|NCT00488631|540190301|FG003|Double Blind Period (Week 0-54)|Other|11|||
149743385|NCT00488631|540190302|FG004|Double Blind Period (Week 0-54)|Other|14|||
149743386|NCT00488631|540190303|FG005|Double Blind Period (Week 0-54)|Other|34|||
149743387|NCT00488631|540190304|FG006|Double Blind Period (Week 0-54)|Other|0|||
149743388|NCT00488631|540190305|FG007|Double Blind Period (Week 0-54)|Other|0|||
149743389|NCT00488631|540190306|FG008|Double Blind Period (Week 0-54)|Other|0|||
149743390|NCT00488631|540190307|FG009|Double Blind Period (Week 0-54)|Other|0|||
149743391|NCT00488631|540190298|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743392|NCT00488631|540190299|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743393|NCT00488631|540190300|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
150256156|NCT01699503|542072679|FG001|Overall Study|Death|40|||
150256157|NCT01699503|542072678|FG000|Overall Study|Withdrawal by Subject|65|||
149743394|NCT00488631|540190301|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743395|NCT00488631|540190302|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743396|NCT00488631|540190303|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743397|NCT00488631|540190304|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
150256158|NCT01699503|542072679|FG001|Overall Study|Withdrawal by Subject|57|||
150256159|NCT01699503|542072678|FG000|Overall Study|Lost to Follow-up|121|||
149743398|NCT00488631|540190305|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
149743399|NCT00488631|540190306|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
149743400|NCT00488631|540190307|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149743401|NCT00488631|540190298|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
149743402|NCT00488631|540190299|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
149743403|NCT00488631|540190300|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
149743404|NCT00488631|540190301|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
149743405|NCT00488631|540190302|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
149743406|NCT00488631|540190303|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
149743407|NCT00488631|540190304|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
149743408|NCT00488631|540190305|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
149743409|NCT00488631|540190306|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
149743410|NCT00488631|540190307|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
149743411|NCT00488631|540190298|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
150256160|NCT01699503|542072679|FG001|Overall Study|Lost to Follow-up|117|||
150256161|NCT01699503|542072678|FG000|Overall Study|Excluded due to quality|783|||
150256162|NCT01699503|542072679|FG001|Overall Study|Excluded due to quality|791|||
150256163|NCT00006011|542072681|FG000|Overall Study|Disease progression|13|||
150256164|NCT00006011|542072682|FG001|Overall Study|Disease progression|6|||
150256165|NCT00006011|542072683|FG002|Overall Study|Disease progression|26|||
150256166|NCT00006011|542072681|FG000|Overall Study|Refused further treatment|15|||
150256167|NCT00006011|542072682|FG001|Overall Study|Refused further treatment|13|||
150256168|NCT00006011|542072683|FG002|Overall Study|Refused further treatment|26|||
150256169|NCT00006011|542072681|FG000|Overall Study|Adverse Event|15|||
150256170|NCT00006011|542072682|FG001|Overall Study|Adverse Event|39|||
150256171|NCT00006011|542072683|FG002|Overall Study|Adverse Event|5|||
150256172|NCT00006011|542072681|FG000|Overall Study|Death|0|||
150256173|NCT00006011|542072682|FG001|Overall Study|Death|1|||
150256174|NCT00006011|542072683|FG002|Overall Study|Death|2|||
150256175|NCT00006011|542072681|FG000|Overall Study|Other|4|||
150256176|NCT00006011|542072682|FG001|Overall Study|Other|2|||
150256177|NCT00006011|542072683|FG002|Overall Study|Other|5|||
150256178|NCT00006011|542072681|FG000|Overall Study|Ineligible|18|||
150256179|NCT00006011|542072682|FG001|Overall Study|Ineligible|16|||
150256180|NCT00006011|542072683|FG002|Overall Study|Ineligible|9|||
150256181|NCT00911937|542072693|FG000|Overall Study|Death|1|||
150256182|NCT00911937|542072694|FG001|Overall Study|Death|0|||
150256183|NCT00911937|542072693|FG000|Overall Study|Lost to Follow-up|8|||
150256184|NCT00911937|542072694|FG001|Overall Study|Lost to Follow-up|5|||
150256185|NCT00911937|542072693|FG000|Overall Study|Withdrawal by Subject|10|||
150256186|NCT00911937|542072694|FG001|Overall Study|Withdrawal by Subject|7|||
150256187|NCT00911937|542072693|FG000|Overall Study|Withdrawn due to pregnancy|1|||
150256188|NCT00911937|542072694|FG001|Overall Study|Withdrawn due to pregnancy|0|||
150256189|NCT00911937|542072693|FG000|Overall Study|Adverse Event|11|||
150256190|NCT00911937|542072694|FG001|Overall Study|Adverse Event|25|||
150256191|NCT00911937|542072693|FG000|Overall Study|Lack of Efficacy|11|||
150256192|NCT00911937|542072694|FG001|Overall Study|Lack of Efficacy|6|||
150256193|NCT00911937|542072693|FG000|Overall Study|Did not meet inclusion criteria|9|||
150256194|NCT00911937|542072694|FG001|Overall Study|Did not meet inclusion criteria|11|||
150256195|NCT00911937|542072693|FG000|Overall Study|Protocol Violation|14|||
150256196|NCT00911937|542072694|FG001|Overall Study|Protocol Violation|23|||
150256197|NCT00911937|542072693|FG000|Overall Study|Randomized but not treated|13|||
150256198|NCT00911937|542072694|FG001|Overall Study|Randomized but not treated|13|||
150256199|NCT00911937|542072693|FG000|Overall Study|Other|9|||
150256200|NCT00911937|542072694|FG001|Overall Study|Other|5|||
150256201|NCT01871805|542072697|FG000|Phase I|Death|7|||
150256202|NCT01871805|542072698|FG001|Phase I|Death|4|||
150256203|NCT01871805|542072699|FG002|Phase I|Death|6|||
150256204|NCT01871805|542072700|FG003|Phase I|Death|2|||
150256205|NCT01871805|542072701|FG004|Phase I|Death|9|||
150256206|NCT01871805|542072702|FG005|Phase I|Death|0|||
150256207|NCT01871805|542072697|FG000|Phase I|Alive in Survival Follow-up|0|||
150256208|NCT01871805|542072698|FG001|Phase I|Alive in Survival Follow-up|2|||
150256209|NCT01871805|542072699|FG002|Phase I|Alive in Survival Follow-up|4|||
150256210|NCT01871805|542072700|FG003|Phase I|Alive in Survival Follow-up|5|||
150256211|NCT01871805|542072701|FG004|Phase I|Alive in Survival Follow-up|4|||
150256212|NCT01871805|542072702|FG005|Phase I|Alive in Survival Follow-up|0|||
150256213|NCT01871805|542072697|FG000|Phase I|Lost to Follow-up|0|||
150256214|NCT01871805|542072698|FG001|Phase I|Lost to Follow-up|1|||
150256215|NCT01871805|542072699|FG002|Phase I|Lost to Follow-up|3|||
150256216|NCT01871805|542072700|FG003|Phase I|Lost to Follow-up|0|||
150256217|NCT01871805|542072701|FG004|Phase I|Lost to Follow-up|0|||
150256218|NCT01871805|542072702|FG005|Phase I|Lost to Follow-up|0|||
150256219|NCT01871805|542072697|FG000|Phase II|Death|0|||
150256220|NCT01871805|542072698|FG001|Phase II|Death|0|||
150256221|NCT01871805|542072699|FG002|Phase II|Death|0|||
150256222|NCT01871805|542072700|FG003|Phase II|Death|0|||
150256223|NCT01871805|542072701|FG004|Phase II|Death|0|||
150256224|NCT01871805|542072702|FG005|Phase II|Death|45|||
150256225|NCT01871805|542072697|FG000|Phase II|Alive in Survival Follow-up|0|||
150256226|NCT01871805|542072698|FG001|Phase II|Alive in Survival Follow-up|0|||
150256227|NCT01871805|542072699|FG002|Phase II|Alive in Survival Follow-up|0|||
150256228|NCT01871805|542072700|FG003|Phase II|Alive in Survival Follow-up|0|||
150256229|NCT01871805|542072701|FG004|Phase II|Alive in Survival Follow-up|0|||
150256230|NCT01871805|542072702|FG005|Phase II|Alive in Survival Follow-up|29|||
150256231|NCT01871805|542072697|FG000|Phase II|Lost to Follow-up|0|||
150256232|NCT01871805|542072698|FG001|Phase II|Lost to Follow-up|0|||
150256233|NCT01871805|542072699|FG002|Phase II|Lost to Follow-up|0|||
150256234|NCT01871805|542072700|FG003|Phase II|Lost to Follow-up|0|||
150256235|NCT01871805|542072701|FG004|Phase II|Lost to Follow-up|0|||
150256236|NCT01871805|542072702|FG005|Phase II|Lost to Follow-up|13|||
150256237|NCT01435616|542072708|FG000|Overall Study|Adverse Event|39|||
150256238|NCT01435616|542072709|FG001|Overall Study|Adverse Event|21|||
150256239|NCT01435616|542072708|FG000|Overall Study|Death|7|||
150256240|NCT01435616|542072709|FG001|Overall Study|Death|2|||
150256241|NCT01435616|542072708|FG000|Overall Study|Lost to Follow-up|22|||
150256242|NCT01435616|542072709|FG001|Overall Study|Lost to Follow-up|13|||
150256243|NCT01435616|542072708|FG000|Overall Study|Protocol Violation|16|||
149743412|NCT00488631|540190299|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149743413|NCT00488631|540190300|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149743414|NCT00488631|540190301|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149743415|NCT00488631|540190302|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149743416|NCT00488631|540190303|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149743417|NCT00488631|540190304|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
149743418|NCT00488631|540190305|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
149743419|NCT00488631|540190306|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
149743420|NCT00488631|540190307|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
149743421|NCT00488631|540190298|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743422|NCT00488631|540190299|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743423|NCT00488631|540190300|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743424|NCT00488631|540190301|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743425|NCT00488631|540190302|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743426|NCT00488631|540190303|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743427|NCT00488631|540190304|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
149743428|NCT00488631|540190305|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743429|NCT00488631|540190306|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
149743430|NCT00488631|540190307|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149743431|NCT00488631|540190298|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743432|NCT00488631|540190299|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743433|NCT00488631|540190300|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743434|NCT00488631|540190301|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743435|NCT00488631|540190302|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743436|NCT00488631|540190303|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743437|NCT00488631|540190304|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
149743438|NCT00488631|540190305|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
149743439|NCT00488631|540190306|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
149743440|NCT00488631|540190307|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149743441|NCT05369806|540190311|FG000|Overall Study|Lost to Follow-up|1|||
149743442|NCT00628355|540190312|FG000|Overall Study|Withdrawal by Subject|1|||
149743443|NCT00628355|540190313|FG001|Overall Study|Withdrawal by Subject|1|||
149743444|NCT00140855|540190314|FG000|Overall Study|Progressive disease|2|||
149743445|NCT03542682|540190320|FG000|Overall Study|COVID-19 Protocol|0|||
149743446|NCT03542682|540190321|FG001|Overall Study|COVID-19 Protocol|1|||
149743447|NCT04321343|540190322|FG000|Overall Study|Adverse Event|0|||
149743448|NCT04321343|540190323|FG001|Overall Study|Adverse Event|0|||
149743449|NCT04321343|540190324|FG002|Overall Study|Adverse Event|1|||
149743450|NCT04321343|540190325|FG003|Overall Study|Adverse Event|0|||
149743451|NCT04321343|540190322|FG000|Overall Study|Death|0|||
149743452|NCT04321343|540190323|FG001|Overall Study|Death|0|||
149743453|NCT04321343|540190324|FG002|Overall Study|Death|0|||
149743454|NCT04321343|540190325|FG003|Overall Study|Death|1|||
149743455|NCT04321343|540190322|FG000|Overall Study|Pregnancy|1|||
149743456|NCT04321343|540190323|FG001|Overall Study|Pregnancy|0|||
149743457|NCT04321343|540190324|FG002|Overall Study|Pregnancy|0|||
149743458|NCT04321343|540190325|FG003|Overall Study|Pregnancy|0|||
149743459|NCT04321343|540190322|FG000|Overall Study|Protocol Violation|1|||
149743460|NCT04321343|540190323|FG001|Overall Study|Protocol Violation|1|||
149743461|NCT04321343|540190324|FG002|Overall Study|Protocol Violation|1|||
149743462|NCT04321343|540190325|FG003|Overall Study|Protocol Violation|1|||
149743463|NCT04321343|540190322|FG000|Overall Study|Withdrawal by Subject|0|||
149743464|NCT04321343|540190323|FG001|Overall Study|Withdrawal by Subject|6|||
149743465|NCT04321343|540190324|FG002|Overall Study|Withdrawal by Subject|0|||
149743466|NCT04321343|540190325|FG003|Overall Study|Withdrawal by Subject|2|||
149743467|NCT04321343|540190322|FG000|Overall Study|Lost to Follow-up|2|||
149743468|NCT04321343|540190323|FG001|Overall Study|Lost to Follow-up|2|||
149743469|NCT04321343|540190324|FG002|Overall Study|Lost to Follow-up|1|||
149743470|NCT04321343|540190325|FG003|Overall Study|Lost to Follow-up|3|||
149743471|NCT04865731|540190334|FG000|Overall Study|Physician Decision|2|||
149743472|NCT04865731|540190335|FG001|Overall Study|Physician Decision|1|||
149743473|NCT04865731|540190334|FG000|Overall Study|Adverse Event|1|||
149743474|NCT04865731|540190335|FG001|Overall Study|Adverse Event|0|||
149743475|NCT04865731|540190334|FG000|Overall Study|Withdrawal by Subject|0|||
149743476|NCT04865731|540190335|FG001|Overall Study|Withdrawal by Subject|1|||
149743477|NCT04909463|540192128|FG000|Overall Study|Withdrawal by Subject|0|||
149743478|NCT04909463|540192129|FG001|Overall Study|Withdrawal by Subject|1|||
149743479|NCT04909463|540192130|FG002|Overall Study|Withdrawal by Subject|0|||
149743480|NCT04909463|540192131|FG003|Overall Study|Withdrawal by Subject|0|||
149743481|NCT04909463|540192128|FG000|Overall Study|Lost to Follow-up|2|||
149743482|NCT04909463|540192129|FG001|Overall Study|Lost to Follow-up|1|||
149743483|NCT04909463|540192130|FG002|Overall Study|Lost to Follow-up|1|||
149743484|NCT04909463|540192131|FG003|Overall Study|Lost to Follow-up|0|||
149743485|NCT01672892|540192132|FG000|Overall Study|Protocol Violation|7|||
149743486|NCT01672892|540192133|FG001|Overall Study|Protocol Violation|3|||
149743487|NCT00875420|540192137|FG000|Overall Study|Adverse Event|0|||
149743488|NCT00875420|540192138|FG001|Overall Study|Adverse Event|1|||
149743489|NCT00875420|540192139|FG002|Overall Study|Adverse Event|1|||
149743490|NCT00875420|540192140|FG003|Overall Study|Adverse Event|0|||
149743491|NCT00875420|540192141|FG004|Overall Study|Adverse Event|0|||
149743492|NCT00875420|540192137|FG000|Overall Study|Inability to complete study procedures|1|||
149743493|NCT00875420|540192138|FG001|Overall Study|Inability to complete study procedures|0|||
149743494|NCT00875420|540192139|FG002|Overall Study|Inability to complete study procedures|1|||
149743495|NCT00875420|540192140|FG003|Overall Study|Inability to complete study procedures|1|||
149743496|NCT00875420|540192141|FG004|Overall Study|Inability to complete study procedures|1|||
149743497|NCT00875420|540192137|FG000|Overall Study|Lost to Follow-up|1|||
149743498|NCT00875420|540192138|FG001|Overall Study|Lost to Follow-up|0|||
149743499|NCT00875420|540192139|FG002|Overall Study|Lost to Follow-up|0|||
149743500|NCT00875420|540192140|FG003|Overall Study|Lost to Follow-up|0|||
149743501|NCT00875420|540192141|FG004|Overall Study|Lost to Follow-up|0|||
149743502|NCT00875420|540192137|FG000|Overall Study|Personal reason|0|||
149743503|NCT00875420|540192138|FG001|Overall Study|Personal reason|0|||
149743504|NCT00875420|540192139|FG002|Overall Study|Personal reason|0|||
149743505|NCT00875420|540192140|FG003|Overall Study|Personal reason|0|||
149743506|NCT00875420|540192141|FG004|Overall Study|Personal reason|1|||
149743507|NCT00875420|540192137|FG000|Overall Study|Prohibited medication|0|||
149743508|NCT00875420|540192138|FG001|Overall Study|Prohibited medication|0|||
149743509|NCT00875420|540192139|FG002|Overall Study|Prohibited medication|0|||
149743510|NCT00875420|540192140|FG003|Overall Study|Prohibited medication|1|||
149743511|NCT00875420|540192141|FG004|Overall Study|Prohibited medication|0|||
149743512|NCT00875420|540192137|FG000|Overall Study|Sponsor decision|0|||
149743513|NCT00875420|540192138|FG001|Overall Study|Sponsor decision|1|||
149743514|NCT00875420|540192139|FG002|Overall Study|Sponsor decision|0|||
149743515|NCT00875420|540192140|FG003|Overall Study|Sponsor decision|0|||
149743516|NCT00875420|540192141|FG004|Overall Study|Sponsor decision|0|||
149743517|NCT00875420|540192137|FG000|Overall Study|Withdrawal by Subject|0|||
149743518|NCT00875420|540192138|FG001|Overall Study|Withdrawal by Subject|0|||
149743519|NCT00875420|540192139|FG002|Overall Study|Withdrawal by Subject|1|||
149743520|NCT00875420|540192140|FG003|Overall Study|Withdrawal by Subject|0|||
149743521|NCT00875420|540192141|FG004|Overall Study|Withdrawal by Subject|0|||
149743522|NCT00886821|540192142|FG000|Stage 2|Adverse Event|0|||
149743523|NCT00886821|540192143|FG001|Stage 2|Adverse Event|0|||
149743524|NCT00886821|540192144|FG002|Stage 2|Adverse Event|0|||
149743525|NCT00886821|540192145|FG003|Stage 2|Adverse Event|0|||
149743526|NCT00886821|540192146|FG004|Stage 2|Adverse Event|0|||
149743527|NCT00886821|540192147|FG005|Stage 2|Adverse Event|0|||
149743528|NCT00886821|540192148|FG006|Stage 2|Adverse Event|0|||
149743529|NCT00886821|540192149|FG007|Stage 2|Adverse Event|0|||
149743530|NCT00886821|540192150|FG008|Stage 2|Adverse Event|0|||
149743531|NCT00886821|540192151|FG009|Stage 2|Adverse Event|0|||
149743532|NCT00886821|540192152|FG010|Stage 2|Adverse Event|0|||
149743533|NCT00886821|540192153|FG011|Stage 2|Adverse Event|1|||
149743534|NCT00886821|540192154|FG012|Stage 2|Adverse Event|3|||
149743535|NCT00886821|540192155|FG013|Stage 2|Adverse Event|0|||
149743536|NCT00886821|540192142|FG000|Stage 2|Lost to Follow-up|0|||
149743537|NCT00886821|540192143|FG001|Stage 2|Lost to Follow-up|0|||
149743538|NCT00886821|540192144|FG002|Stage 2|Lost to Follow-up|0|||
149743539|NCT00886821|540192145|FG003|Stage 2|Lost to Follow-up|0|||
149743540|NCT00886821|540192146|FG004|Stage 2|Lost to Follow-up|0|||
149743541|NCT00886821|540192147|FG005|Stage 2|Lost to Follow-up|0|||
149743542|NCT00886821|540192148|FG006|Stage 2|Lost to Follow-up|0|||
150256244|NCT01435616|542072709|FG001|Overall Study|Protocol Violation|13|||
150256245|NCT01435616|542072708|FG000|Overall Study|Withdrawal by Subject|66|||
149743543|NCT00886821|540192149|FG007|Stage 2|Lost to Follow-up|0|||
149743544|NCT00886821|540192150|FG008|Stage 2|Lost to Follow-up|0|||
149743545|NCT00886821|540192151|FG009|Stage 2|Lost to Follow-up|0|||
149743546|NCT00886821|540192152|FG010|Stage 2|Lost to Follow-up|0|||
149743547|NCT00886821|540192153|FG011|Stage 2|Lost to Follow-up|0|||
149743548|NCT00886821|540192154|FG012|Stage 2|Lost to Follow-up|2|||
149743549|NCT00886821|540192155|FG013|Stage 2|Lost to Follow-up|1|||
149743550|NCT00914628|540192156|FG000|Overall Study|Death|35|||
149743551|NCT00914628|540192157|FG001|Overall Study|Death|17|||
149743552|NCT00914628|540192156|FG000|Overall Study|Medical decision|4|||
149743553|NCT00914628|540192157|FG001|Overall Study|Medical decision|0|||
149743554|NCT00914628|540192156|FG000|Overall Study|Protocol Violation|1|||
149743555|NCT00914628|540192157|FG001|Overall Study|Protocol Violation|0|||
149743556|NCT00914628|540192156|FG000|Overall Study|Lack of Efficacy|1|||
149743557|NCT00914628|540192157|FG001|Overall Study|Lack of Efficacy|0|||
149743558|NCT00914628|540192156|FG000|Overall Study|non-randomized|1|||
149743559|NCT00914628|540192157|FG001|Overall Study|non-randomized|0|||
149743560|NCT00914628|540192156|FG000|Overall Study|Relapse|1|||
150256246|NCT01435616|542072709|FG001|Overall Study|Withdrawal by Subject|24|||
149743561|NCT00914628|540192157|FG001|Overall Study|Relapse|2|||
149743562|NCT00914628|540192156|FG000|Overall Study|Study terminated by Sponsor|14|||
149743563|NCT00914628|540192157|FG001|Overall Study|Study terminated by Sponsor|8|||
149743564|NCT00914628|540192156|FG000|Overall Study|Patients who did not receive a single dose|7|||
149743565|NCT00914628|540192157|FG001|Overall Study|Patients who did not receive a single dose|1|||
149743566|NCT03311126|540192158|FG000|Induction|Death|1|||
149743567|NCT03311126|540192158|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
149743568|NCT00942162|540192159|FG000|Overall Study|Death|45|||
149743569|NCT00942162|540192160|FG001|Overall Study|Death|35|||
149743570|NCT00942162|540192161|FG002|Overall Study|Death|0|||
149743571|NCT00942162|540192159|FG000|Overall Study|Withdrawal by Subject|7|||
149743572|NCT00942162|540192160|FG001|Overall Study|Withdrawal by Subject|2|||
149743573|NCT00942162|540192161|FG002|Overall Study|Withdrawal by Subject|0|||
149743574|NCT00942162|540192159|FG000|Overall Study|Lost to Follow-up|4|||
149743575|NCT00942162|540192160|FG001|Overall Study|Lost to Follow-up|0|||
149743576|NCT00942162|540192161|FG002|Overall Study|Lost to Follow-up|0|||
149743577|NCT00942162|540192159|FG000|Overall Study|Other|14|||
149743578|NCT00942162|540192160|FG001|Overall Study|Other|13|||
149743579|NCT00942162|540192161|FG002|Overall Study|Other|2|||
149743580|NCT01006356|540192165|FG000|Overall Study|Adverse Event|6|||
149743581|NCT01006356|540192165|FG000|Overall Study|Physician Decision|1|||
149743582|NCT01006356|540192165|FG000|Overall Study|Paticipants did not cooperate|6|||
149743583|NCT01006356|540192165|FG000|Overall Study|Withdrawal by Subject|1|||
149743584|NCT01006356|540192165|FG000|Overall Study|Choice by participants|2|||
149743585|NCT01006356|540192165|FG000|Overall Study|Protocol Violation|3|||
149743586|NCT01006356|540192165|FG000|Overall Study|Other|23|||
149743587|NCT01756157|540192167|FG000|First Intervention Period|Withdrawal by Subject|1|||
149743588|NCT01756157|540192168|FG001|First Intervention Period|Withdrawal by Subject|0|||
149743589|NCT01756157|540192167|FG000|First Intervention Period|Lost to Follow-up|0|||
149743590|NCT01756157|540192168|FG001|First Intervention Period|Lost to Follow-up|2|||
149743591|NCT02799381|540192171|FG000|Overall Study|Withdrew consent|3|||
149743592|NCT02799381|540192172|FG001|Overall Study|Withdrew consent|2|||
149743593|NCT02799381|540192171|FG000|Overall Study|Adverse Event|0|||
149743594|NCT02799381|540192172|FG001|Overall Study|Adverse Event|1|||
149743595|NCT02799381|540192171|FG000|Overall Study|Participant did not take any study drug|1|||
149743596|NCT02799381|540192172|FG001|Overall Study|Participant did not take any study drug|0|||
149743597|NCT03368859|540192173|FG000|Overall Study|Withdrew Consent|5|||
149743598|NCT03368859|540192174|FG001|Overall Study|Withdrew Consent|4|||
149743599|NCT03368859|540192173|FG000|Overall Study|Death|12|||
149743600|NCT03368859|540192174|FG001|Overall Study|Death|6|||
149743601|NCT03368859|540192173|FG000|Overall Study|Study terminated by Sponsor|18|||
149743602|NCT03368859|540192174|FG001|Overall Study|Study terminated by Sponsor|23|||
149743603|NCT03368859|540192173|FG000|Overall Study|Other|1|||
149743604|NCT03368859|540192174|FG001|Overall Study|Other|1|||
149743605|NCT02698410|540192175|FG000|Overall Study|Adverse Event|2|||
149743606|NCT02698410|540192175|FG000|Overall Study|Withdrawal by Subject|1|||
149743607|NCT02698410|540192175|FG000|Overall Study|Other|1|||
149743608|NCT01713348|540192176|FG000|Overall Study|Withdrawal by Subject|3|||
149743609|NCT01713348|540192177|FG001|Overall Study|Withdrawal by Subject|2|||
149743610|NCT01713348|540192178|FG002|Overall Study|Withdrawal by Subject|2|||
149743611|NCT01713348|540192179|FG003|Overall Study|Withdrawal by Subject|0|||
149743612|NCT01713348|540192176|FG000|Overall Study|Lost to Follow-up|1|||
149743613|NCT01713348|540192177|FG001|Overall Study|Lost to Follow-up|0|||
149743614|NCT01713348|540192178|FG002|Overall Study|Lost to Follow-up|0|||
149743615|NCT01713348|540192179|FG003|Overall Study|Lost to Follow-up|0|||
149743616|NCT02638012|540192180|FG000|Overall Study|Lost to Follow-up|1|||
149743617|NCT00817414|540192182|FG000|Overall Study|Adverse Event|1|||
149743618|NCT00817414|540192183|FG001|Overall Study|Adverse Event|1|||
149743619|NCT00817414|540192184|FG002|Overall Study|Adverse Event|1|||
149743620|NCT00817414|540192185|FG003|Overall Study|Adverse Event|0|||
149743621|NCT00817414|540192186|FG004|Overall Study|Adverse Event|0|||
149743622|NCT00817414|540192182|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
149743623|NCT00817414|540192183|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
149743624|NCT00817414|540192184|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
149743625|NCT00817414|540192185|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
149743626|NCT00817414|540192186|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
149743627|NCT00817414|540192182|FG000|Overall Study|Withdrawal by Subject|1|||
149743628|NCT00817414|540192183|FG001|Overall Study|Withdrawal by Subject|1|||
149743629|NCT00817414|540192184|FG002|Overall Study|Withdrawal by Subject|0|||
149743630|NCT00817414|540192185|FG003|Overall Study|Withdrawal by Subject|0|||
149743631|NCT00817414|540192186|FG004|Overall Study|Withdrawal by Subject|0|||
149743632|NCT00817414|540192182|FG000|Overall Study|Lost to Follow-up|0|||
149743633|NCT00817414|540192183|FG001|Overall Study|Lost to Follow-up|0|||
149743634|NCT00817414|540192184|FG002|Overall Study|Lost to Follow-up|1|||
149743635|NCT00817414|540192185|FG003|Overall Study|Lost to Follow-up|1|||
149743636|NCT00817414|540192186|FG004|Overall Study|Lost to Follow-up|1|||
149743637|NCT00817414|540192182|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149743638|NCT00817414|540192183|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149743639|NCT00817414|540192184|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149743640|NCT00817414|540192185|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
149743641|NCT00817414|540192186|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149743642|NCT00817414|540192182|FG000|Overall Study|Protocol Violation|0|||
149743643|NCT00817414|540192183|FG001|Overall Study|Protocol Violation|0|||
149743644|NCT00817414|540192184|FG002|Overall Study|Protocol Violation|0|||
149743645|NCT00817414|540192185|FG003|Overall Study|Protocol Violation|0|||
149743646|NCT00817414|540192186|FG004|Overall Study|Protocol Violation|1|||
149743647|NCT00886938|540192187|FG000|Overall Study|Adverse Event|1|||
149743648|NCT00886938|540192187|FG000|Overall Study|Withdrawal by Subject|1|||
149743649|NCT03872180|540192193|FG000|Overall Study|Adverse Event|4|||
149743650|NCT03872180|540192193|FG000|Overall Study|Lack of Efficacy|2|||
149743651|NCT01157117|540192196|FG000|Overall Study|Dosing Symptoms|0|||
149743652|NCT01157117|540192197|FG001|Overall Study|Dosing Symptoms|4|||
149743653|NCT01157117|540192198|FG002|Overall Study|Dosing Symptoms|0|||
149743654|NCT01157117|540192196|FG000|Overall Study|Withdrawal by Subject|4|||
149743655|NCT01157117|540192197|FG001|Overall Study|Withdrawal by Subject|1|||
149743656|NCT01157117|540192198|FG002|Overall Study|Withdrawal by Subject|1|||
149743657|NCT01157117|540192196|FG000|Overall Study|Lack of Efficacy|1|||
149743658|NCT01157117|540192197|FG001|Overall Study|Lack of Efficacy|1|||
149743659|NCT01157117|540192198|FG002|Overall Study|Lack of Efficacy|0|||
149743660|NCT01157117|540192196|FG000|Overall Study|Lost to Follow-up|0|||
149743661|NCT01157117|540192197|FG001|Overall Study|Lost to Follow-up|0|||
149743662|NCT01157117|540192198|FG002|Overall Study|Lost to Follow-up|1|||
149743663|NCT01157117|540192196|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
149743664|NCT01157117|540192197|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
149743665|NCT01157117|540192198|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
149743666|NCT01931865|540192199|FG000|Overall Study|Lost to Follow-up|2|||
149743667|NCT01931865|540192199|FG000|Overall Study|Withdrawal by Subject|2|||
149743668|NCT03215277|540192201|FG000|Overall Study|Adverse Event|2|||
149743669|NCT03215277|540192202|FG001|Overall Study|Adverse Event|3|||
149743670|NCT03215277|540192201|FG000|Overall Study|Death|1|||
149743671|NCT03215277|540192202|FG001|Overall Study|Death|0|||
149743672|NCT03215277|540192201|FG000|Overall Study|Lost to Follow-up|0|||
149743673|NCT03215277|540192202|FG001|Overall Study|Lost to Follow-up|1|||
149743674|NCT03215277|540192201|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
149743675|NCT03215277|540192202|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
149743676|NCT03596164|540192203|FG000|Overall Study|Adverse Event|0|||
149743677|NCT03596164|540192204|FG001|Overall Study|Adverse Event|1|||
149743678|NCT03596164|540192203|FG000|Overall Study|Death|1|||
149743679|NCT03596164|540192204|FG001|Overall Study|Death|0|||
149743680|NCT04112914|540192205|FG000|Overall Study|Lost to Follow-up|13|||
149743681|NCT04112914|540192206|FG001|Overall Study|Lost to Follow-up|9|||
149743682|NCT04112914|540192205|FG000|Overall Study|Withdrawal by Subject|1|||
149743683|NCT04112914|540192206|FG001|Overall Study|Withdrawal by Subject|0|||
149743684|NCT01120626|540192207|FG000|Overall Study|Withdrawal by Subject|1|||
149743685|NCT01120626|540192208|FG001|Overall Study|Withdrawal by Subject|0|||
149743686|NCT01244737|540192209|FG000|Overall Study|Physician Decision|2|||
149743687|NCT01244737|540192210|FG001|Overall Study|Physician Decision|18|||
149743688|NCT01244737|540192211|FG002|Overall Study|Physician Decision|5|||
149743689|NCT01244737|540192209|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
149743690|NCT01244737|540192210|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
149743691|NCT01244737|540192211|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
149743692|NCT01244737|540192209|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
149743693|NCT01244737|540192210|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
149743694|NCT01244737|540192211|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
149743695|NCT01244737|540192209|FG000|Overall Study|MIB immunopathology results not available|3|||
149743696|NCT01244737|540192210|FG001|Overall Study|MIB immunopathology results not available|2|||
149743697|NCT01244737|540192211|FG002|Overall Study|MIB immunopathology results not available|0|||
149743698|NCT01244737|540192209|FG000|Overall Study|PET data failure|0|||
149743699|NCT01244737|540192210|FG001|Overall Study|PET data failure|1|||
149743700|NCT01244737|540192211|FG002|Overall Study|PET data failure|0|||
149743701|NCT01244737|540192209|FG000|Overall Study|Withdrawal by Subject|0|||
149743702|NCT01244737|540192210|FG001|Overall Study|Withdrawal by Subject|0|||
149743703|NCT01244737|540192211|FG002|Overall Study|Withdrawal by Subject|1|||
149743704|NCT02835495|540192215|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
149743705|NCT02835495|540192216|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
149743706|NCT02835495|540192215|FG000|Overall Study|Declined in-person follow-up visit|4|||
149743707|NCT02835495|540192216|FG001|Overall Study|Declined in-person follow-up visit|2|||
149743708|NCT00356915|540192218|FG000|Overall Study|Non compliance|1|||
149743709|NCT00356915|540192219|FG001|Overall Study|Non compliance|2|||
149743710|NCT00356915|540192220|FG002|Overall Study|Non compliance|1|||
149743711|NCT00356915|540192218|FG000|Overall Study|Protocol Violation|2|||
149743712|NCT00356915|540192219|FG001|Overall Study|Protocol Violation|3|||
149743713|NCT00356915|540192220|FG002|Overall Study|Protocol Violation|2|||
149743714|NCT00356915|540192218|FG000|Overall Study|Withdrawal by Subject|14|||
149743715|NCT00356915|540192219|FG001|Overall Study|Withdrawal by Subject|14|||
149743716|NCT00356915|540192220|FG002|Overall Study|Withdrawal by Subject|10|||
149743717|NCT00356915|540192218|FG000|Overall Study|Lack of Efficacy|0|||
149743718|NCT00356915|540192219|FG001|Overall Study|Lack of Efficacy|0|||
149743719|NCT00356915|540192220|FG002|Overall Study|Lack of Efficacy|3|||
149743720|NCT00356915|540192218|FG000|Overall Study|Lost to Follow-up|27|||
149743721|NCT00356915|540192219|FG001|Overall Study|Lost to Follow-up|34|||
149743722|NCT00356915|540192220|FG002|Overall Study|Lost to Follow-up|14|||
149743723|NCT00356915|540192218|FG000|Overall Study|Administrative Decision|0|||
149743724|NCT00356915|540192219|FG001|Overall Study|Administrative Decision|0|||
149743725|NCT00356915|540192220|FG002|Overall Study|Administrative Decision|1|||
149743726|NCT00356915|540192218|FG000|Overall Study|Physician Decision|0|||
149743727|NCT00356915|540192219|FG001|Overall Study|Physician Decision|2|||
149743728|NCT00356915|540192220|FG002|Overall Study|Physician Decision|0|||
149743729|NCT00356915|540192218|FG000|Overall Study|Adverse Event|21|||
149743730|NCT00356915|540192219|FG001|Overall Study|Adverse Event|31|||
149743731|NCT00356915|540192220|FG002|Overall Study|Adverse Event|8|||
149743732|NCT00356915|540192218|FG000|Overall Study|Miscellaneous reasons|11|||
149743733|NCT00356915|540192219|FG001|Overall Study|Miscellaneous reasons|8|||
149743734|NCT00356915|540192220|FG002|Overall Study|Miscellaneous reasons|3|||
149743735|NCT02604264|540192227|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
150256247|NCT01435616|542072708|FG000|Overall Study|Physician Decision|20|||
150256248|NCT01435616|542072709|FG001|Overall Study|Physician Decision|7|||
150256249|NCT01435616|542072708|FG000|Overall Study|Sponsor Decision|1|||
150256250|NCT01435616|542072709|FG001|Overall Study|Sponsor Decision|0|||
150256251|NCT04860297|542072710|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
150256252|NCT04860297|542072711|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
150256253|NCT04860297|542072712|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
150256254|NCT04860297|542072713|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
150256255|NCT04860297|542072714|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
150256256|NCT04860297|542072715|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
150256257|NCT04860297|542072716|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
150256258|NCT04860297|542072717|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
150256259|NCT04860297|542072710|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
150256260|NCT04860297|542072711|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
149743736|NCT02604264|540192228|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
149743737|NCT00424398|540192229|FG000|Overall Study|Withdrawal by Subject|2|||
149743738|NCT00424398|540192230|FG001|Overall Study|Withdrawal by Subject|1|||
149743739|NCT00424398|540192231|FG002|Overall Study|Withdrawal by Subject|0|||
150256261|NCT04860297|542072712|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
150256262|NCT04860297|542072713|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
150256263|NCT04860297|542072714|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
149743740|NCT00424398|540192229|FG000|Overall Study|Subject met exclusion criteria|1|||
149743741|NCT00424398|540192230|FG001|Overall Study|Subject met exclusion criteria|0|||
149743742|NCT00424398|540192231|FG002|Overall Study|Subject met exclusion criteria|0|||
149743743|NCT01442181|540192236|FG000|Overall Study|patient refused surgery|1|||
149743744|NCT01442181|540192237|FG001|Overall Study|patient refused surgery|0|||
149743745|NCT01442181|540192236|FG000|Overall Study|no insurance for surgery|1|||
150256264|NCT04860297|542072715|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
150256265|NCT04860297|542072716|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
150256266|NCT04860297|542072717|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
150256267|NCT04860297|542072710|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
150256268|NCT04860297|542072711|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
149743746|NCT01442181|540192237|FG001|Overall Study|no insurance for surgery|0|||
149743747|NCT01442181|540192236|FG000|Overall Study|low ejection factor|0|||
149743748|NCT01442181|540192237|FG001|Overall Study|low ejection factor|1|||
149743749|NCT01442181|540192236|FG000|Overall Study|Lost to Follow-up|1|||
149743750|NCT01442181|540192237|FG001|Overall Study|Lost to Follow-up|1|||
149743751|NCT01442181|540192236|FG000|Overall Study|patient in an additional study|1|||
149743752|NCT01442181|540192237|FG001|Overall Study|patient in an additional study|0|||
149743753|NCT01442181|540192236|FG000|Overall Study|atrial fibrillation not noted|0|||
149743754|NCT01442181|540192237|FG001|Overall Study|atrial fibrillation not noted|1|||
149743755|NCT00709202|540192238|FG000|Overall Study|Withdrawal by Subject|6|||
149743756|NCT00709202|540192239|FG001|Overall Study|Withdrawal by Subject|6|||
149743757|NCT03133767|540192240|FG000|Overall Study|Lost to Follow-up|38|||
149743758|NCT03133767|540192241|FG001|Overall Study|Lost to Follow-up|24|||
149743759|NCT03133767|540192240|FG000|Overall Study|Protocol Violation|0|||
149743760|NCT03133767|540192241|FG001|Overall Study|Protocol Violation|1|||
149743761|NCT03301857|540192242|FG000|Overall Study|Death|0|||
149743762|NCT03301857|540192243|FG001|Overall Study|Death|2|||
149743763|NCT03301857|540192242|FG000|Overall Study|Lost to Follow-up|4|||
149743764|NCT03301857|540192243|FG001|Overall Study|Lost to Follow-up|2|||
149743765|NCT03301857|540192242|FG000|Overall Study|Decision by Sponsor|6|||
149743766|NCT03301857|540192243|FG001|Overall Study|Decision by Sponsor|0|||
149743767|NCT03301857|540192242|FG000|Overall Study|Withdrawal by Subject|12|||
149743768|NCT03301857|540192243|FG001|Overall Study|Withdrawal by Subject|4|||
149743769|NCT00855439|540192248|FG000|Overall Study|Withdrawal by Subject|2|||
149743770|NCT00855439|540192249|FG001|Overall Study|Withdrawal by Subject|0|||
149743771|NCT00855439|540192248|FG000|Overall Study|Pregnancy|1|||
149743772|NCT00855439|540192249|FG001|Overall Study|Pregnancy|0|||
149743773|NCT05502289|540192250|FG000|Period 1|Out Of Window|1|||
149743774|NCT05502289|540192251|FG001|Period 1|Out Of Window|0|||
149743775|NCT02333227|540192257|FG000|Overall Study|Lost to Follow-up|137|||
149743776|NCT02333227|540192258|FG001|Overall Study|Lost to Follow-up|106|||
149743777|NCT02333227|540192257|FG000|Overall Study|Pregnancy Interrupted|42|||
149743778|NCT02333227|540192258|FG001|Overall Study|Pregnancy Interrupted|89|||
149743779|NCT02333227|540192257|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
149743780|NCT02333227|540192258|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
149743781|NCT04375878|540192261|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
149743782|NCT04375878|540192262|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
149743783|NCT04375878|540192263|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149743784|NCT04375878|540192264|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149743785|NCT04375878|540192265|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149743786|NCT04375878|540192266|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149743787|NCT04375878|540192261|FG000|Crossover First and Second Interventions|Adverse Event|0|||
149743788|NCT04375878|540192262|FG001|Crossover First and Second Interventions|Adverse Event|0|||
149743789|NCT04375878|540192263|FG002|Crossover First and Second Interventions|Adverse Event|1|||
149743790|NCT04375878|540192264|FG003|Crossover First and Second Interventions|Adverse Event|0|||
149743791|NCT04375878|540192265|FG004|Crossover First and Second Interventions|Adverse Event|0|||
149743792|NCT04375878|540192266|FG005|Crossover First and Second Interventions|Adverse Event|0|||
149743793|NCT04375878|540192261|FG000|Extension Phase|Withdrawal by Subject|0|||
149743794|NCT04375878|540192262|FG001|Extension Phase|Withdrawal by Subject|0|||
149743795|NCT04375878|540192263|FG002|Extension Phase|Withdrawal by Subject|0|||
149743796|NCT04375878|540192264|FG003|Extension Phase|Withdrawal by Subject|0|||
149743797|NCT04375878|540192265|FG004|Extension Phase|Withdrawal by Subject|1|||
149743798|NCT04375878|540192266|FG005|Extension Phase|Withdrawal by Subject|0|||
149743799|NCT01982630|540192267|FG000|Overall Study|Adverse Event|2|||
150256269|NCT04860297|542072712|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
149743800|NCT01982630|540192268|FG001|Overall Study|Adverse Event|0|||
149743801|NCT01982630|540192269|FG002|Overall Study|Adverse Event|1|||
149743802|NCT01982630|540192270|FG003|Overall Study|Adverse Event|0|||
149743803|NCT01982630|540192271|FG004|Overall Study|Adverse Event|1|||
149743804|NCT01982630|540192272|FG005|Overall Study|Adverse Event|2|||
149743805|NCT01982630|540192273|FG006|Overall Study|Adverse Event|1|||
149743806|NCT01982630|540192274|FG007|Overall Study|Adverse Event|0|||
150256270|NCT04860297|542072713|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
149743807|NCT01982630|540192267|FG000|Overall Study|Physician Decision|1|||
149743808|NCT01982630|540192268|FG001|Overall Study|Physician Decision|0|||
149743809|NCT01982630|540192269|FG002|Overall Study|Physician Decision|2|||
149743810|NCT01982630|540192270|FG003|Overall Study|Physician Decision|1|||
149743811|NCT01982630|540192271|FG004|Overall Study|Physician Decision|2|||
149743812|NCT01982630|540192272|FG005|Overall Study|Physician Decision|0|||
149743813|NCT01982630|540192273|FG006|Overall Study|Physician Decision|0|||
149743814|NCT01982630|540192274|FG007|Overall Study|Physician Decision|0|||
149743815|NCT01982630|540192267|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743816|NCT01982630|540192268|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743817|NCT01982630|540192269|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
149743818|NCT01982630|540192270|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743819|NCT01982630|540192271|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743820|NCT01982630|540192272|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743821|NCT01982630|540192273|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743822|NCT01982630|540192274|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149743823|NCT01982630|540192267|FG000|Overall Study|Withdrawal by Subject|0|||
149743824|NCT01982630|540192268|FG001|Overall Study|Withdrawal by Subject|0|||
149743825|NCT01982630|540192269|FG002|Overall Study|Withdrawal by Subject|0|||
149743826|NCT01982630|540192270|FG003|Overall Study|Withdrawal by Subject|0|||
149743827|NCT01982630|540192271|FG004|Overall Study|Withdrawal by Subject|0|||
149743828|NCT01982630|540192272|FG005|Overall Study|Withdrawal by Subject|1|||
149743829|NCT01982630|540192273|FG006|Overall Study|Withdrawal by Subject|0|||
149743830|NCT01982630|540192274|FG007|Overall Study|Withdrawal by Subject|0|||
149743831|NCT00561353|540192275|FG000|Overall Study|Subject reached a virologic endpoint|2|||
149743832|NCT00561353|540192276|FG001|Overall Study|Subject reached a virologic endpoint|1|||
149743833|NCT00561353|540192277|FG002|Overall Study|Subject reached a virologic endpoint|1|||
149743834|NCT00561353|540192278|FG003|Overall Study|Subject reached a virologic endpoint|4|||
149743835|NCT00561353|540192279|FG004|Overall Study|Subject reached a virologic endpoint|1|||
149743836|NCT00561353|540192280|FG005|Overall Study|Subject reached a virologic endpoint|3|||
149743837|NCT00561353|540192281|FG006|Overall Study|Subject reached a virologic endpoint|4|||
149743838|NCT00561353|540192282|FG007|Overall Study|Subject reached a virologic endpoint|4|||
149743839|NCT00561353|540192283|FG008|Overall Study|Subject reached a virologic endpoint|5|||
149743840|NCT00561353|540192284|FG009|Overall Study|Subject reached a virologic endpoint|0|||
149743841|NCT00561353|540192275|FG000|Overall Study|Subject ineligible to continue the trial|0|||
149743842|NCT00561353|540192276|FG001|Overall Study|Subject ineligible to continue the trial|0|||
149743843|NCT00561353|540192277|FG002|Overall Study|Subject ineligible to continue the trial|0|||
149743844|NCT00561353|540192278|FG003|Overall Study|Subject ineligible to continue the trial|0|||
149743845|NCT00561353|540192279|FG004|Overall Study|Subject ineligible to continue the trial|0|||
149743846|NCT00561353|540192280|FG005|Overall Study|Subject ineligible to continue the trial|1|||
149743847|NCT00561353|540192281|FG006|Overall Study|Subject ineligible to continue the trial|1|||
149743848|NCT00561353|540192282|FG007|Overall Study|Subject ineligible to continue the trial|0|||
149743849|NCT00561353|540192283|FG008|Overall Study|Subject ineligible to continue the trial|2|||
149743850|NCT00561353|540192284|FG009|Overall Study|Subject ineligible to continue the trial|1|||
149743851|NCT00561353|540192275|FG000|Overall Study|Other|1|||
149743852|NCT00561353|540192276|FG001|Overall Study|Other|0|||
149743853|NCT00561353|540192277|FG002|Overall Study|Other|1|||
149743854|NCT00561353|540192278|FG003|Overall Study|Other|0|||
149743855|NCT00561353|540192279|FG004|Overall Study|Other|0|||
149743856|NCT00561353|540192280|FG005|Overall Study|Other|2|||
149743857|NCT00561353|540192281|FG006|Overall Study|Other|0|||
149743858|NCT00561353|540192282|FG007|Overall Study|Other|0|||
149743859|NCT00561353|540192283|FG008|Overall Study|Other|0|||
149743860|NCT00561353|540192284|FG009|Overall Study|Other|0|||
149743861|NCT00561353|540192275|FG000|Overall Study|Adverse Event|0|||
149743862|NCT00561353|540192276|FG001|Overall Study|Adverse Event|0|||
149743863|NCT00561353|540192277|FG002|Overall Study|Adverse Event|0|||
149743864|NCT00561353|540192278|FG003|Overall Study|Adverse Event|2|||
149743865|NCT00561353|540192279|FG004|Overall Study|Adverse Event|0|||
149743866|NCT00561353|540192280|FG005|Overall Study|Adverse Event|0|||
149743867|NCT00561353|540192281|FG006|Overall Study|Adverse Event|1|||
149743868|NCT00561353|540192282|FG007|Overall Study|Adverse Event|0|||
149743869|NCT00561353|540192283|FG008|Overall Study|Adverse Event|0|||
149743870|NCT00561353|540192284|FG009|Overall Study|Adverse Event|1|||
149743871|NCT00561353|540192275|FG000|Overall Study|Lost to Follow-up|2|||
149743872|NCT00561353|540192276|FG001|Overall Study|Lost to Follow-up|0|||
149743873|NCT00561353|540192277|FG002|Overall Study|Lost to Follow-up|1|||
149743874|NCT00561353|540192278|FG003|Overall Study|Lost to Follow-up|0|||
149743875|NCT00561353|540192279|FG004|Overall Study|Lost to Follow-up|0|||
149743876|NCT00561353|540192280|FG005|Overall Study|Lost to Follow-up|0|||
149743877|NCT00561353|540192281|FG006|Overall Study|Lost to Follow-up|0|||
149743878|NCT00561353|540192282|FG007|Overall Study|Lost to Follow-up|0|||
149743879|NCT00561353|540192283|FG008|Overall Study|Lost to Follow-up|0|||
149743880|NCT00561353|540192284|FG009|Overall Study|Lost to Follow-up|0|||
149743881|NCT00561353|540192275|FG000|Overall Study|Withdrawal by Subject|0|||
149743882|NCT00561353|540192276|FG001|Overall Study|Withdrawal by Subject|2|||
149743883|NCT00561353|540192277|FG002|Overall Study|Withdrawal by Subject|0|||
149743884|NCT00561353|540192278|FG003|Overall Study|Withdrawal by Subject|0|||
149743885|NCT00561353|540192279|FG004|Overall Study|Withdrawal by Subject|0|||
149743886|NCT00561353|540192280|FG005|Overall Study|Withdrawal by Subject|0|||
149743887|NCT00561353|540192281|FG006|Overall Study|Withdrawal by Subject|0|||
149743888|NCT00561353|540192282|FG007|Overall Study|Withdrawal by Subject|0|||
149743889|NCT00561353|540192283|FG008|Overall Study|Withdrawal by Subject|0|||
149743890|NCT00561353|540192284|FG009|Overall Study|Withdrawal by Subject|0|||
149743891|NCT01273818|540192285|FG000|Overall Study|Physician Decision|13|||
149743892|NCT01273818|540192286|FG001|Overall Study|Physician Decision|2|||
149743893|NCT01273818|540192287|FG002|Overall Study|Physician Decision|9|||
149743894|NCT03934684|540192288|FG000|Overall Study|Participants continuing in study|11|||
149743895|NCT03934684|540192289|FG001|Overall Study|Participants continuing in study|4|||
149743896|NCT03934684|540192288|FG000|Overall Study|Discontinuation of carfilzomib|20|||
149743897|NCT03934684|540192289|FG001|Overall Study|Discontinuation of carfilzomib|30|||
149743898|NCT03934684|540192288|FG000|Overall Study|Death|2|||
149743899|NCT03934684|540192289|FG001|Overall Study|Death|2|||
149743900|NCT03934684|540192288|FG000|Overall Study|Lost to Follow-up|2|||
149743901|NCT03934684|540192289|FG001|Overall Study|Lost to Follow-up|5|||
149743902|NCT03934684|540192288|FG000|Overall Study|Withdrawal by Subject|7|||
149743903|NCT03934684|540192289|FG001|Overall Study|Withdrawal by Subject|8|||
149743904|NCT00256295|540192290|FG000|Overall Study|Withdrawal by Subject|3|||
149743905|NCT00256295|540192290|FG000|Overall Study|Death|1|||
149743906|NCT01097044|540192292|FG000|Overall Study|Withdrawal by Subject|4|||
149743907|NCT01097044|540192293|FG001|Overall Study|Withdrawal by Subject|4|||
149743908|NCT01097044|540192292|FG000|Overall Study|Lost to Follow-up|1|||
149743909|NCT01097044|540192293|FG001|Overall Study|Lost to Follow-up|0|||
149743910|NCT01097044|540192292|FG000|Overall Study|Withdrawal by Sponsor|0|||
149743911|NCT01097044|540192293|FG001|Overall Study|Withdrawal by Sponsor|1|||
149743912|NCT01682044|540192294|FG000|Overall Study|Death|1|||
149743913|NCT01682044|540192294|FG000|Overall Study|Progression|3|||
149743914|NCT05405166|540194411|FG000|Overall Study|Death|49|||
149743915|NCT05405166|540194412|FG001|Overall Study|Death|50|||
149743916|NCT05405166|540194411|FG000|Overall Study|Withdrawal by Subject|10|||
149743917|NCT05405166|540194412|FG001|Overall Study|Withdrawal by Subject|3|||
149743918|NCT05405166|540194411|FG000|Overall Study|Ongoing at the time of PCD|209|||
149743919|NCT05405166|540194412|FG001|Overall Study|Ongoing at the time of PCD|210|||
149743920|NCT01386385|540194413|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
149743921|NCT01386385|540194414|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743922|NCT01386385|540194415|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743923|NCT01386385|540194416|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743924|NCT01386385|540194417|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743925|NCT01386385|540194418|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743926|NCT01386385|540194419|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743927|NCT01386385|540194420|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149743928|NCT01386385|540194413|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
149743929|NCT01386385|540194414|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743930|NCT01386385|540194415|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743931|NCT01386385|540194416|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743932|NCT01386385|540194417|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743933|NCT01386385|540194418|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743934|NCT01386385|540194419|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743935|NCT01386385|540194420|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149743936|NCT01386385|540194413|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743937|NCT01386385|540194414|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743938|NCT01386385|540194415|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
149743939|NCT01386385|540194416|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743940|NCT01386385|540194417|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743941|NCT01386385|540194418|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743942|NCT01386385|540194419|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743943|NCT01386385|540194420|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149743944|NCT01386385|540194413|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743945|NCT01386385|540194414|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743946|NCT01386385|540194415|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743947|NCT01386385|540194416|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743948|NCT01386385|540194417|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
149743949|NCT01386385|540194418|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743950|NCT01386385|540194419|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743951|NCT01386385|540194420|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149743952|NCT01386385|540194413|FG000|Phase II Concurrent CRT|Adverse Event|0|||
149743953|NCT01386385|540194414|FG001|Phase II Concurrent CRT|Adverse Event|0|||
149743954|NCT01386385|540194415|FG002|Phase II Concurrent CRT|Adverse Event|0|||
149743955|NCT01386385|540194416|FG003|Phase II Concurrent CRT|Adverse Event|0|||
149743956|NCT01386385|540194417|FG004|Phase II Concurrent CRT|Adverse Event|0|||
149743957|NCT01386385|540194418|FG005|Phase II Concurrent CRT|Adverse Event|0|||
149743958|NCT01386385|540194419|FG006|Phase II Concurrent CRT|Adverse Event|3|||
149743959|NCT01386385|540194420|FG007|Phase II Concurrent CRT|Adverse Event|3|||
149743960|NCT01386385|540194413|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743961|NCT01386385|540194414|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743962|NCT01386385|540194415|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743963|NCT01386385|540194416|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743964|NCT01386385|540194417|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743965|NCT01386385|540194418|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743966|NCT01386385|540194419|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
149743967|NCT01386385|540194420|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149743968|NCT01386385|540194413|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
149743969|NCT01386385|540194414|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
149743970|NCT01386385|540194415|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
149743971|NCT01386385|540194416|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
149743972|NCT01386385|540194417|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
149743973|NCT01386385|540194418|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
149743974|NCT01386385|540194419|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
149743975|NCT01386385|540194420|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
149743976|NCT01386385|540194413|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743977|NCT01386385|540194414|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743978|NCT01386385|540194415|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743979|NCT01386385|540194416|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743980|NCT01386385|540194417|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743981|NCT01386385|540194418|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743982|NCT01386385|540194419|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
149743983|NCT01386385|540194420|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149743984|NCT01386385|540194413|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743985|NCT01386385|540194414|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743986|NCT01386385|540194415|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743987|NCT01386385|540194416|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743988|NCT01386385|540194417|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743989|NCT01386385|540194418|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
149743990|NCT01386385|540194419|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
149743991|NCT01386385|540194420|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
149743992|NCT01084252|540194423|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743993|NCT01084252|540194424|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
150256271|NCT04860297|542072714|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
150256272|NCT04860297|542072715|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
150256273|NCT04860297|542072716|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
150256274|NCT04860297|542072717|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
150256275|NCT04860297|542072710|FG000|Part B (Booster Dose)|Other Than Specified|0|||
150256276|NCT04860297|542072711|FG001|Part B (Booster Dose)|Other Than Specified|0|||
150256277|NCT04860297|542072712|FG002|Part B (Booster Dose)|Other Than Specified|0|||
150256278|NCT04860297|542072713|FG003|Part B (Booster Dose)|Other Than Specified|0|||
150256279|NCT04860297|542072714|FG004|Part B (Booster Dose)|Other Than Specified|0|||
150256280|NCT04860297|542072715|FG005|Part B (Booster Dose)|Other Than Specified|1|||
150256281|NCT04860297|542072716|FG006|Part B (Booster Dose)|Other Than Specified|1|||
150256282|NCT04860297|542072717|FG007|Part B (Booster Dose)|Other Than Specified|0|||
150256283|NCT04860297|542072710|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256284|NCT04860297|542072711|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256285|NCT04860297|542072712|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256286|NCT04860297|542072713|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256287|NCT04860297|542072714|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256288|NCT04860297|542072715|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
150256289|NCT04860297|542072716|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
150256290|NCT04860297|542072717|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
150256291|NCT04860297|542072710|FG000|Part B (Booster Dose)|Death|0|||
150256292|NCT04860297|542072711|FG001|Part B (Booster Dose)|Death|0|||
150256293|NCT04860297|542072712|FG002|Part B (Booster Dose)|Death|0|||
150256294|NCT04860297|542072713|FG003|Part B (Booster Dose)|Death|0|||
150256295|NCT04860297|542072714|FG004|Part B (Booster Dose)|Death|1|||
150256296|NCT04860297|542072715|FG005|Part B (Booster Dose)|Death|2|||
150256297|NCT04860297|542072716|FG006|Part B (Booster Dose)|Death|1|||
150256298|NCT04860297|542072717|FG007|Part B (Booster Dose)|Death|0|||
150256299|NCT04860297|542072710|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
150256300|NCT04860297|542072711|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
150256301|NCT04860297|542072712|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
149743994|NCT01084252|540194425|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743995|NCT01084252|540194426|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743996|NCT01084252|540194427|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743997|NCT01084252|540194428|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743998|NCT01084252|540194429|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149743999|NCT01084252|540194430|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744000|NCT01084252|540194431|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744001|NCT01084252|540194432|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744002|NCT01084252|540194433|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744003|NCT01084252|540194434|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744004|NCT01084252|540194435|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
149744005|NCT01084252|540194436|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149744006|NCT00853632|540194437|FG000|Overall Study|Death|88|||
149744007|NCT00853632|540194437|FG000|Overall Study|Withdrawal by Subject|45|||
149744008|NCT00853632|540194437|FG000|Overall Study|Lost to Follow-up|30|||
149744009|NCT00853632|540194437|FG000|Overall Study|Reoperation/Explant|17|||
149744010|NCT00853632|540194437|FG000|Overall Study|Exit with other reason|22|||
149744011|NCT04364854|540194438|FG000|Overall Study|Withdrawal by Subject|1|||
149744012|NCT04364854|540194439|FG001|Overall Study|Withdrawal by Subject|0|||
149744013|NCT04364854|540194440|FG002|Overall Study|Withdrawal by Subject|1|||
149744014|NCT04364854|540194441|FG003|Overall Study|Withdrawal by Subject|3|||
149744015|NCT04364854|540194438|FG000|Overall Study|Death|1|||
149744016|NCT04364854|540194439|FG001|Overall Study|Death|0|||
149744017|NCT04364854|540194440|FG002|Overall Study|Death|0|||
149744018|NCT04364854|540194441|FG003|Overall Study|Death|0|||
149744019|NCT04364854|540194438|FG000|Overall Study|Lost to Follow-up|0|||
149744020|NCT04364854|540194439|FG001|Overall Study|Lost to Follow-up|0|||
149744021|NCT04364854|540194440|FG002|Overall Study|Lost to Follow-up|0|||
149744022|NCT04364854|540194441|FG003|Overall Study|Lost to Follow-up|1|||
149744023|NCT04493619|540194443|FG000|Overall Study|Death|4|||
149744024|NCT04493619|540194444|FG001|Overall Study|Death|3|||
149744025|NCT04493619|540194445|FG002|Overall Study|Death|3|||
149744026|NCT04493619|540194446|FG003|Overall Study|Death|4|||
149744027|NCT04493619|540194443|FG000|Overall Study|Study discontinued early|10|||
149744028|NCT04493619|540194444|FG001|Overall Study|Study discontinued early|0|||
149744029|NCT04493619|540194445|FG002|Overall Study|Study discontinued early|4|||
149744030|NCT04493619|540194446|FG003|Overall Study|Study discontinued early|8|||
149744031|NCT04493619|540194443|FG000|Overall Study|Lost to Follow-up|0|||
149744032|NCT04493619|540194444|FG001|Overall Study|Lost to Follow-up|0|||
149744033|NCT04493619|540194445|FG002|Overall Study|Lost to Follow-up|0|||
149744034|NCT04493619|540194446|FG003|Overall Study|Lost to Follow-up|1|||
149744035|NCT02017444|540194451|FG000|Overall Study|Physician Decision|1|||
149744036|NCT02017444|540194452|FG001|Overall Study|Physician Decision|0|||
149744037|NCT02017444|540194451|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
149744038|NCT02017444|540194452|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
149744039|NCT02342171|540194456|FG000|Overall Study|Death|4|||
149744040|NCT02342171|540194457|FG001|Overall Study|Death|87|||
149744041|NCT02342171|540194456|FG000|Overall Study|Received favipiravir|10|||
149744042|NCT02342171|540194457|FG001|Overall Study|Received favipiravir|0|||
149744043|NCT02342171|540194456|FG000|Overall Study|Missing cycle treshold value|1|||
149744044|NCT02342171|540194457|FG001|Overall Study|Missing cycle treshold value|0|||
149744045|NCT02342171|540194456|FG000|Overall Study|Unknown outcome|0|||
149744046|NCT02342171|540194457|FG001|Overall Study|Unknown outcome|1|||
149744047|NCT02342171|540194456|FG000|Overall Study|Missing age data|0|||
149744048|NCT02342171|540194457|FG001|Overall Study|Missing age data|1|||
149744049|NCT03716726|540194460|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
149744050|NCT03716726|540194461|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
149744051|NCT03716726|540194460|FG000|12 Months Followup|Lost to Follow-up|10|||
149744052|NCT03716726|540194461|FG001|12 Months Followup|Lost to Follow-up|17|||
149744053|NCT00469079|540194462|FG000|Overall Study|Lack of Efficacy|3|||
149744054|NCT00469079|540194463|FG001|Overall Study|Lack of Efficacy|8|||
149744055|NCT00469079|540194464|FG002|Overall Study|Lack of Efficacy|5|||
149744056|NCT00469079|540194462|FG000|Overall Study|Adverse Event|1|||
149744057|NCT00469079|540194463|FG001|Overall Study|Adverse Event|3|||
149744058|NCT00469079|540194464|FG002|Overall Study|Adverse Event|2|||
149744059|NCT00469079|540194462|FG000|Overall Study|Lost to Follow-up|4|||
149744060|NCT00469079|540194463|FG001|Overall Study|Lost to Follow-up|8|||
149744061|NCT00469079|540194464|FG002|Overall Study|Lost to Follow-up|10|||
149744062|NCT00469079|540194462|FG000|Overall Study|Withdrawal by Subject|1|||
149744063|NCT00469079|540194463|FG001|Overall Study|Withdrawal by Subject|2|||
149744064|NCT00469079|540194464|FG002|Overall Study|Withdrawal by Subject|2|||
149744065|NCT00469079|540194462|FG000|Overall Study|Ineligible|0|||
149744066|NCT00469079|540194463|FG001|Overall Study|Ineligible|1|||
149744067|NCT00469079|540194464|FG002|Overall Study|Ineligible|0|||
149744068|NCT02981472|540194465|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
149744069|NCT02981472|540194466|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
149744070|NCT02981472|540194465|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149744071|NCT02981472|540194466|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149744072|NCT02981472|540194465|FG000|Treatment Period|Adverse Event|6|||
149744073|NCT02981472|540194466|FG001|Treatment Period|Adverse Event|1|||
149744074|NCT02981472|540194465|FG000|Treatment Period|Participant withdrew consent|1|||
149744075|NCT02981472|540194466|FG001|Treatment Period|Participant withdrew consent|0|||
149744076|NCT02981472|540194465|FG000|Treatment Period|Lost to Follow-up|0|||
150256302|NCT04860297|542072713|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
150256303|NCT04860297|542072714|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
150256304|NCT04860297|542072715|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
150256305|NCT04860297|542072716|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
150256306|NCT04860297|542072717|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
150256307|NCT04811131|542072729|FG000|Overall Study|Adverse Event|0|||
150256308|NCT04811131|542072730|FG001|Overall Study|Adverse Event|0|||
150256309|NCT04811131|542072731|FG002|Overall Study|Adverse Event|1|||
150256310|NCT04811131|542072732|FG003|Overall Study|Adverse Event|0|||
150256311|NCT04811131|542072729|FG000|Overall Study|Lack of Efficacy|0|||
150256312|NCT04811131|542072730|FG001|Overall Study|Lack of Efficacy|0|||
150256313|NCT04811131|542072731|FG002|Overall Study|Lack of Efficacy|0|||
150256314|NCT04811131|542072732|FG003|Overall Study|Lack of Efficacy|1|||
150256315|NCT04811131|542072729|FG000|Overall Study|Lost to Follow-up|0|||
150256316|NCT04811131|542072730|FG001|Overall Study|Lost to Follow-up|1|||
150256317|NCT04811131|542072731|FG002|Overall Study|Lost to Follow-up|0|||
150256318|NCT04811131|542072732|FG003|Overall Study|Lost to Follow-up|0|||
150256319|NCT04811131|542072729|FG000|Overall Study|Sponsor request|31|||
150256320|NCT04811131|542072730|FG001|Overall Study|Sponsor request|35|||
150256321|NCT04811131|542072731|FG002|Overall Study|Sponsor request|27|||
150256322|NCT04811131|542072732|FG003|Overall Study|Sponsor request|10|||
150256323|NCT04811131|542072729|FG000|Overall Study|Withdrawal by Subject|3|||
150256324|NCT04811131|542072730|FG001|Overall Study|Withdrawal by Subject|1|||
150256325|NCT04811131|542072731|FG002|Overall Study|Withdrawal by Subject|3|||
150256326|NCT04811131|542072732|FG003|Overall Study|Withdrawal by Subject|1|||
150256327|NCT00620282|542072740|FG000|Overall Study|Adverse Event|0|||
150256328|NCT00620282|542072741|FG001|Overall Study|Adverse Event|1|||
150256329|NCT00620282|542072742|FG002|Overall Study|Adverse Event|0|||
150256330|NCT00620282|542072740|FG000|Overall Study|Arterial line unable to be placed|0|||
150256331|NCT00620282|542072741|FG001|Overall Study|Arterial line unable to be placed|0|||
150256332|NCT00620282|542072742|FG002|Overall Study|Arterial line unable to be placed|1|||
150256333|NCT00620282|542072740|FG000|Overall Study|Withdrawal by Subject|0|||
150256334|NCT00620282|542072741|FG001|Overall Study|Withdrawal by Subject|1|||
150256335|NCT00620282|542072742|FG002|Overall Study|Withdrawal by Subject|0|||
150256336|NCT02217475|542072743|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
150256337|NCT02217475|542072744|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
150256338|NCT02217475|542072745|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
150256339|NCT02217475|542072743|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
150256340|NCT02217475|542072744|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
150256341|NCT02217475|542072745|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
150256342|NCT02217475|542072743|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
150256343|NCT02217475|542072744|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
149744077|NCT02981472|540194466|FG001|Treatment Period|Lost to Follow-up|1|||
149744078|NCT03952130|540194469|FG000|Overall Study|Adverse Event|0|||
149744079|NCT03952130|540194470|FG001|Overall Study|Adverse Event|1|||
149744080|NCT03952130|540194469|FG000|Overall Study|Lost to Follow-up|1|||
149744081|NCT03952130|540194470|FG001|Overall Study|Lost to Follow-up|0|||
149744082|NCT03952130|540194469|FG000|Overall Study|Withdrawal by Subject|1|||
149744083|NCT03952130|540194470|FG001|Overall Study|Withdrawal by Subject|5|||
149744084|NCT00621023|540194471|FG000|Overall Study|Death|5|||
149744085|NCT00621023|540194471|FG000|Overall Study|Follow up discontinued|1|||
149744086|NCT02559505|540194480|FG000|Overall Study|Lost to Follow-up|23|||
149744087|NCT02559505|540194481|FG001|Overall Study|Lost to Follow-up|20|||
149744088|NCT02559505|540194480|FG000|Overall Study|Withdrawal by Subject|4|||
149744089|NCT02559505|540194481|FG001|Overall Study|Withdrawal by Subject|2|||
149744090|NCT03523585|540194482|FG000|Overall Study|Progressive Disease|174|||
149744091|NCT03523585|540194483|FG001|Overall Study|Progressive Disease|64|||
150256344|NCT02217475|542072745|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
150256345|NCT02217475|542072743|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
150256346|NCT02217475|542072744|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
150256347|NCT02217475|542072745|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
150256348|NCT02217475|542072743|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
150256349|NCT02217475|542072744|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
150256350|NCT02217475|542072745|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
149744092|NCT03523585|540194484|FG002|Overall Study|Progressive Disease|77|||
149744093|NCT03523585|540194482|FG000|Overall Study|Adverse Event|74|||
149744094|NCT03523585|540194483|FG001|Overall Study|Adverse Event|5|||
149744095|NCT03523585|540194484|FG002|Overall Study|Adverse Event|9|||
149744096|NCT03523585|540194482|FG000|Overall Study|Withdrawal by Subject|30|||
149744097|NCT03523585|540194483|FG001|Overall Study|Withdrawal by Subject|11|||
149744098|NCT03523585|540194484|FG002|Overall Study|Withdrawal by Subject|6|||
149744099|NCT03523585|540194482|FG000|Overall Study|Clinical Progression|23|||
149744100|NCT03523585|540194483|FG001|Overall Study|Clinical Progression|5|||
149744101|NCT03523585|540194484|FG002|Overall Study|Clinical Progression|10|||
149744102|NCT03523585|540194482|FG000|Overall Study|Death|4|||
149744103|NCT03523585|540194483|FG001|Overall Study|Death|0|||
149744104|NCT03523585|540194484|FG002|Overall Study|Death|1|||
149744105|NCT03523585|540194482|FG000|Overall Study|Physician Decision|2|||
149744106|NCT03523585|540194483|FG001|Overall Study|Physician Decision|1|||
149744107|NCT03523585|540194484|FG002|Overall Study|Physician Decision|0|||
149744108|NCT03523585|540194482|FG000|Overall Study|Lost to Follow-up|1|||
149744109|NCT03523585|540194483|FG001|Overall Study|Lost to Follow-up|0|||
149744110|NCT03523585|540194484|FG002|Overall Study|Lost to Follow-up|0|||
149744111|NCT03523585|540194482|FG000|Overall Study|Miscellaneous|1|||
149744112|NCT03523585|540194483|FG001|Overall Study|Miscellaneous|0|||
149744113|NCT03523585|540194484|FG002|Overall Study|Miscellaneous|0|||
149744114|NCT03523585|540194482|FG000|Overall Study|Protocol Deviation|1|||
149744115|NCT03523585|540194483|FG001|Overall Study|Protocol Deviation|0|||
149744116|NCT03523585|540194484|FG002|Overall Study|Protocol Deviation|1|||
149744117|NCT03523585|540194482|FG000|Overall Study|Randomized But Not Treated|2|||
149744118|NCT03523585|540194483|FG001|Overall Study|Randomized But Not Treated|4|||
149744119|NCT03523585|540194484|FG002|Overall Study|Randomized But Not Treated|3|||
149744120|NCT00698516|540194485|FG000|Overall Study|Study Termination|2|||
149744121|NCT00698516|540194485|FG000|Overall Study|Withdrawal by Subject|3|||
149744122|NCT05882890|540194486|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
149744123|NCT04331899|540194492|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
149744124|NCT04331899|540194493|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
149744125|NCT01062399|540194496|FG000|Overall Study|Protocol Violation|0|||
149744126|NCT01062399|540194497|FG001|Overall Study|Protocol Violation|1|||
149744127|NCT01062399|540194498|FG002|Overall Study|Protocol Violation|0|||
149744128|NCT01062399|540194499|FG003|Overall Study|Protocol Violation|6|||
149744129|NCT01062399|540194500|FG004|Overall Study|Protocol Violation|4|||
149744130|NCT02424539|540194501|FG000|Overall Study|Adverse Event|0|||
149744131|NCT02424539|540194502|FG001|Overall Study|Adverse Event|0|||
149744132|NCT02424539|540194503|FG002|Overall Study|Adverse Event|1|||
149744133|NCT02424539|540194501|FG000|Overall Study|Physician Decision|0|||
149744134|NCT02424539|540194502|FG001|Overall Study|Physician Decision|0|||
149744135|NCT02424539|540194503|FG002|Overall Study|Physician Decision|1|||
149744136|NCT02424539|540194501|FG000|Overall Study|Withdrawal by Subject|3|||
149744137|NCT02424539|540194502|FG001|Overall Study|Withdrawal by Subject|1|||
149744138|NCT02424539|540194503|FG002|Overall Study|Withdrawal by Subject|0|||
149744139|NCT02424539|540194501|FG000|Overall Study|Other: Reached stopping criteria|11|||
149744140|NCT02424539|540194502|FG001|Overall Study|Other: Reached stopping criteria|7|||
149744141|NCT02424539|540194503|FG002|Overall Study|Other: Reached stopping criteria|6|||
149744142|NCT00719810|540194504|FG000|Overall Study|Adverse Event|0|||
149744143|NCT00719810|540194505|FG001|Overall Study|Adverse Event|2|||
149744144|NCT00719810|540194506|FG002|Overall Study|Adverse Event|3|||
149744145|NCT00719810|540194504|FG000|Overall Study|Lost to Follow-up|2|||
149744146|NCT00719810|540194505|FG001|Overall Study|Lost to Follow-up|0|||
149744147|NCT00719810|540194506|FG002|Overall Study|Lost to Follow-up|3|||
149744148|NCT00719810|540194504|FG000|Overall Study|Physician Decision|0|||
149744149|NCT00719810|540194505|FG001|Overall Study|Physician Decision|1|||
149744150|NCT00719810|540194506|FG002|Overall Study|Physician Decision|0|||
149744151|NCT00719810|540194504|FG000|Overall Study|Withdrawal by Subject|1|||
149744152|NCT00719810|540194505|FG001|Overall Study|Withdrawal by Subject|1|||
149744153|NCT00719810|540194506|FG002|Overall Study|Withdrawal by Subject|2|||
149744154|NCT04893265|540194529|FG000|Overall Study|Withdrawal by Subject|2|||
149744155|NCT04893265|540194530|FG001|Overall Study|Withdrawal by Subject|5|||
149744156|NCT04893265|540194529|FG000|Overall Study|Lost to Follow-up|0|||
149744157|NCT04893265|540194530|FG001|Overall Study|Lost to Follow-up|4|||
149744158|NCT00573131|540194532|FG000|Overall Study|Withdrawal by Subject|10|||
149744159|NCT00573131|540194533|FG001|Overall Study|Withdrawal by Subject|8|||
149744160|NCT03090191|540194534|FG000|Overall Study|Adverse Event|90|||
149744161|NCT03090191|540194535|FG001|Overall Study|Adverse Event|72|||
149744162|NCT03090191|540194534|FG000|Overall Study|Death|365|||
149744163|NCT03090191|540194535|FG001|Overall Study|Death|358|||
149744164|NCT03090191|540194534|FG000|Overall Study|Lost to Follow-up|382|||
149744165|NCT03090191|540194535|FG001|Overall Study|Lost to Follow-up|394|||
150256351|NCT02217475|542072743|FG000|Discontinued After Period 1|Adverse Event|1|||
149744166|NCT03090191|540194534|FG000|Overall Study|Physician Decision|77|||
149744167|NCT03090191|540194535|FG001|Overall Study|Physician Decision|66|||
149744168|NCT03090191|540194534|FG000|Overall Study|Protocol Violation|43|||
149744169|NCT03090191|540194535|FG001|Overall Study|Protocol Violation|52|||
149744170|NCT03090191|540194534|FG000|Overall Study|Withdrawal by Subject|2160|||
149744171|NCT03090191|540194535|FG001|Overall Study|Withdrawal by Subject|2133|||
149744172|NCT03090191|540194534|FG000|Overall Study|Site terminated|7|||
149744173|NCT03090191|540194535|FG001|Overall Study|Site terminated|8|||
149744174|NCT03090191|540194534|FG000|Overall Study|Other|66|||
149744175|NCT03090191|540194535|FG001|Overall Study|Other|60|||
149744176|NCT03090191|540194534|FG000|Overall Study|Withdrawn before any study vaccination|43|||
149744177|NCT03090191|540194535|FG001|Overall Study|Withdrawn before any study vaccination|52|||
149744178|NCT01845025|540194537|FG000|Overall Study|Adverse Event|6|||
149744179|NCT01845025|540194538|FG001|Overall Study|Adverse Event|3|||
149744180|NCT01845025|540194537|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149744181|NCT01845025|540194538|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149744182|NCT01845025|540194537|FG000|Overall Study|Withdrawal by Subject|48|||
149744183|NCT01845025|540194538|FG001|Overall Study|Withdrawal by Subject|44|||
149744184|NCT01845025|540194537|FG000|Overall Study|Lost to Follow-up|13|||
149744185|NCT01845025|540194538|FG001|Overall Study|Lost to Follow-up|13|||
149744186|NCT01845025|540194537|FG000|Overall Study|Administrative problems|8|||
149744187|NCT01845025|540194538|FG001|Overall Study|Administrative problems|8|||
149744188|NCT01845025|540194537|FG000|Overall Study|Death|2|||
149744189|NCT01845025|540194538|FG001|Overall Study|Death|0|||
149744190|NCT01845025|540194537|FG000|Overall Study|Protocol deviation|3|||
149744191|NCT01845025|540194538|FG001|Overall Study|Protocol deviation|6|||
149744192|NCT01845025|540194537|FG000|Overall Study|Missing|1|||
149744193|NCT01845025|540194538|FG001|Overall Study|Missing|1|||
149744194|NCT01973283|540194541|FG000|Overall Study|Lost to Follow-up|4|||
149744195|NCT01126619|540194542|FG000|Overall Study|Not eligible for the study|2|||
149744196|NCT01126619|540194542|FG000|Overall Study|Investigator decision|4|||
149744197|NCT01126619|540194542|FG000|Overall Study|Serious adverse event|1|||
149744198|NCT01126619|540194542|FG000|Overall Study|Withdrawal by Subject|9|||
149744199|NCT01126619|540194542|FG000|Overall Study|Non-compliance|1|||
149744200|NCT00947154|540194543|FG000|Overall Study|Lost to Follow-up|1|||
149744201|NCT00900796|540194546|FG000|Phase 1|Lacked sufficient information|4|||
149744202|NCT00900796|540194546|FG000|Phase 1|Missing information at Week 16|7|||
149744203|NCT00900796|540194546|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
149744204|NCT00900796|540194546|FG000|Phase 2|Lost to Follow-up|5|||
149744205|NCT01829048|540194554|FG000|Overall Study|Withdrawal by Subject|0|||
149744206|NCT01829048|540194555|FG001|Overall Study|Withdrawal by Subject|0|||
149744207|NCT01829048|540194556|FG002|Overall Study|Withdrawal by Subject|0|||
149744208|NCT01829048|540194557|FG003|Overall Study|Withdrawal by Subject|2|||
149744209|NCT01829048|540194558|FG004|Overall Study|Withdrawal by Subject|0|||
149744210|NCT01121406|540194559|FG000|Overall Study|Progressive disease RECIST|44|||
149744211|NCT01121406|540194560|FG001|Overall Study|Progressive disease RECIST|28|||
149744212|NCT01121406|540194559|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
149744213|NCT01121406|540194560|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
149744214|NCT01121406|540194559|FG000|Overall Study|Other AE|3|||
149744215|NCT01121406|540194560|FG001|Overall Study|Other AE|10|||
149744216|NCT01121406|540194559|FG000|Overall Study|Non-compliant with protocol|0|||
149744217|NCT01121406|540194560|FG001|Overall Study|Non-compliant with protocol|2|||
149744218|NCT01121406|540194559|FG000|Overall Study|Lost to Follow-up|0|||
149744219|NCT01121406|540194560|FG001|Overall Study|Lost to Follow-up|1|||
149744220|NCT01121406|540194559|FG000|Overall Study|Refused continuation of study med.|1|||
149744221|NCT01121406|540194560|FG001|Overall Study|Refused continuation of study med.|2|||
149744222|NCT01121406|540194559|FG000|Overall Study|Reason other than specified above|2|||
149744223|NCT01121406|540194560|FG001|Overall Study|Reason other than specified above|6|||
149744224|NCT01121406|540194559|FG000|Overall Study|Not treated|1|||
149744225|NCT01121406|540194560|FG001|Overall Study|Not treated|0|||
149744226|NCT00504257|540194561|FG000|Overall Study|Withdrawal by Subject|2|||
149744227|NCT00504257|540194561|FG000|Overall Study|ineligible histology|2|||
149744228|NCT02750410|540194564|FG000|Double-Blind Treatment Period|Adverse Event|2|||
149744229|NCT02750410|540194565|FG001|Double-Blind Treatment Period|Adverse Event|2|||
149744230|NCT02750410|540194564|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149744231|NCT02750410|540194565|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149744232|NCT02750410|540194564|FG000|Open-Label Extension Period|Adverse Event|5|||
149744233|NCT02750410|540194565|FG001|Open-Label Extension Period|Adverse Event|3|||
149744234|NCT02750410|540194564|FG000|Open-Label Extension Period|Protocol Violation|0|||
149744235|NCT02750410|540194565|FG001|Open-Label Extension Period|Protocol Violation|1|||
149744236|NCT02750410|540194564|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
149744237|NCT02750410|540194565|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
149744238|NCT02504541|540194566|FG000|Overall Study|Adverse Event|4|||
149744239|NCT02504541|540194566|FG000|Overall Study|Withdrawal by Subject|4|||
149744240|NCT02504541|540194566|FG000|Overall Study|Lost to Follow-up|1|||
149744241|NCT02504541|540194566|FG000|Overall Study|Met Stopping Criteria|1|||
149744242|NCT02504541|540194566|FG000|Overall Study|Protocol Violation|2|||
149744243|NCT02504541|540194566|FG000|Overall Study|Termination by Sponsor|1|||
149744244|NCT02504541|540194566|FG000|Overall Study|Other|2|||
149744245|NCT02504541|540194566|FG000|Overall Study|Multiple|5|||
149744246|NCT00472303|540194576|FG000|Titration Phase|Adverse Event|22|||
149744247|NCT00472303|540194577|FG001|Titration Phase|Adverse Event|12|||
149744248|NCT00472303|540194578|FG002|Titration Phase|Adverse Event|0|||
149744249|NCT00472303|540194576|FG000|Titration Phase|Death|4|||
149744250|NCT00472303|540194577|FG001|Titration Phase|Death|2|||
149744251|NCT00472303|540194578|FG002|Titration Phase|Death|0|||
149744252|NCT00472303|540194576|FG000|Titration Phase|Lack of Efficacy|10|||
149744253|NCT00472303|540194577|FG001|Titration Phase|Lack of Efficacy|0|||
149744254|NCT00472303|540194578|FG002|Titration Phase|Lack of Efficacy|0|||
149744255|NCT00472303|540194576|FG000|Titration Phase|Withdrawal by Subject|16|||
149744256|NCT00472303|540194577|FG001|Titration Phase|Withdrawal by Subject|13|||
149744257|NCT00472303|540194578|FG002|Titration Phase|Withdrawal by Subject|0|||
149744258|NCT00472303|540194576|FG000|Titration Phase|Trial Medication non-compliant|4|||
149744259|NCT00472303|540194577|FG001|Titration Phase|Trial Medication non-compliant|1|||
149744260|NCT00472303|540194578|FG002|Titration Phase|Trial Medication non-compliant|0|||
149744261|NCT00472303|540194576|FG000|Titration Phase|Other|3|||
149744262|NCT00472303|540194577|FG001|Titration Phase|Other|1|||
149744263|NCT00472303|540194578|FG002|Titration Phase|Other|0|||
149744264|NCT00472303|540194576|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
149744265|NCT00472303|540194577|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
149744266|NCT00472303|540194578|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
149744267|NCT00472303|540194576|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
149744268|NCT00472303|540194577|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
149744269|NCT00472303|540194578|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
149744270|NCT00472303|540194576|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
149744271|NCT00472303|540194577|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
149744272|NCT00472303|540194578|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
149744273|NCT00472303|540194576|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
149744274|NCT00472303|540194577|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
149744275|NCT00472303|540194578|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
149744276|NCT00472303|540194576|FG000|Discontinuations After Titration Phase|Other|5|||
149744277|NCT00472303|540194577|FG001|Discontinuations After Titration Phase|Other|0|||
149744278|NCT00472303|540194578|FG002|Discontinuations After Titration Phase|Other|0|||
149744279|NCT00472303|540194576|FG000|Maintenance Phase|Adverse Event|5|||
149744280|NCT00472303|540194577|FG001|Maintenance Phase|Adverse Event|6|||
149744281|NCT00472303|540194578|FG002|Maintenance Phase|Adverse Event|6|||
149744282|NCT00472303|540194576|FG000|Maintenance Phase|Death|3|||
149744283|NCT00472303|540194577|FG001|Maintenance Phase|Death|0|||
149744284|NCT00472303|540194578|FG002|Maintenance Phase|Death|2|||
149744285|NCT00472303|540194576|FG000|Maintenance Phase|Lack of Efficacy|2|||
149744286|NCT00472303|540194577|FG001|Maintenance Phase|Lack of Efficacy|2|||
149744287|NCT00472303|540194578|FG002|Maintenance Phase|Lack of Efficacy|4|||
149744288|NCT00472303|540194576|FG000|Maintenance Phase|Withdrawal by Subject|6|||
149744289|NCT00472303|540194577|FG001|Maintenance Phase|Withdrawal by Subject|7|||
149744290|NCT00472303|540194578|FG002|Maintenance Phase|Withdrawal by Subject|3|||
149744291|NCT00472303|540194576|FG000|Maintenance Phase|Trial medication non-compliant|0|||
149744292|NCT00472303|540194577|FG001|Maintenance Phase|Trial medication non-compliant|0|||
149744293|NCT00472303|540194578|FG002|Maintenance Phase|Trial medication non-compliant|1|||
149744294|NCT00472303|540194576|FG000|Maintenance Phase|Resolution of pain|0|||
149744295|NCT00472303|540194577|FG001|Maintenance Phase|Resolution of pain|0|||
149744296|NCT00472303|540194578|FG002|Maintenance Phase|Resolution of pain|1|||
149744297|NCT00472303|540194576|FG000|Maintenance Phase|Other|1|||
149744298|NCT00472303|540194577|FG001|Maintenance Phase|Other|1|||
149744299|NCT00472303|540194578|FG002|Maintenance Phase|Other|0|||
149744300|NCT02580058|540194588|FG000|Overall Study|Adverse Event|16|||
149744301|NCT02580058|540194589|FG001|Overall Study|Adverse Event|30|||
149744302|NCT02580058|540194590|FG002|Overall Study|Adverse Event|20|||
149744303|NCT02580058|540194588|FG000|Overall Study|Death|4|||
149744304|NCT02580058|540194589|FG001|Overall Study|Death|4|||
149744305|NCT02580058|540194590|FG002|Overall Study|Death|5|||
149744306|NCT02580058|540194588|FG000|Overall Study|Physician Decision|1|||
149744307|NCT02580058|540194589|FG001|Overall Study|Physician Decision|3|||
149744308|NCT02580058|540194590|FG002|Overall Study|Physician Decision|11|||
149744309|NCT02580058|540194588|FG000|Overall Study|Other|5|||
149744310|NCT02580058|540194589|FG001|Overall Study|Other|1|||
149744311|NCT02580058|540194590|FG002|Overall Study|Other|3|||
149744312|NCT02580058|540194588|FG000|Overall Study|Withdrawal by Subject|4|||
149744313|NCT02580058|540194589|FG001|Overall Study|Withdrawal by Subject|7|||
149744314|NCT02580058|540194590|FG002|Overall Study|Withdrawal by Subject|31|||
149744315|NCT02580058|540194588|FG000|Overall Study|Global Deterioration of Health Status|19|||
149744316|NCT02580058|540194589|FG001|Overall Study|Global Deterioration of Health Status|18|||
149744317|NCT02580058|540194590|FG002|Overall Study|Global Deterioration of Health Status|24|||
149744318|NCT02580058|540194588|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
149744319|NCT02580058|540194589|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
149744320|NCT02580058|540194590|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
149744321|NCT02580058|540194588|FG000|Overall Study|Progressive Disease|137|||
149744322|NCT02580058|540194589|FG001|Overall Study|Progressive Disease|125|||
149744323|NCT02580058|540194590|FG002|Overall Study|Progressive Disease|94|||
149744324|NCT02580058|540194588|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149744325|NCT02580058|540194589|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149744326|NCT02580058|540194590|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149744327|NCT00730236|540194591|FG000|Overall Study|Adverse Event|4|||
149744328|NCT00730236|540194591|FG000|Overall Study|Withdrawal by Subject|1|||
149744329|NCT00730236|540194591|FG000|Overall Study|Non-compliance|1|||
149744330|NCT03486314|540194592|FG000|Part A|Adverse Event|1|||
149744331|NCT03486314|540194593|FG001|Part A|Adverse Event|0|||
149744332|NCT03486314|540194594|FG002|Part A|Adverse Event|0|||
149744333|NCT03486314|540194592|FG000|Part A|Symptomatic Deterioration|2|||
149744334|NCT03486314|540194593|FG001|Part A|Symptomatic Deterioration|0|||
149744335|NCT03486314|540194594|FG002|Part A|Symptomatic Deterioration|0|||
149744336|NCT00613626|540194595|FG000|Overall Study|Ineligible|0|||
149744337|NCT00613626|540194596|FG001|Overall Study|Ineligible|1|||
149744338|NCT00613626|540194597|FG002|Overall Study|Ineligible|0|||
149744339|NCT05480514|540194598|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
149744340|NCT05480514|540194599|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
149744341|NCT05480514|540194598|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
149744342|NCT05480514|540194599|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
149744343|NCT05480514|540194598|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
149744344|NCT05480514|540194599|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
149744345|NCT05480514|540194598|FG000|Period 1|Covid-19 Related|1|||
149744346|NCT05480514|540194599|FG001|Period 1|Covid-19 Related|0|||
149744347|NCT05480514|540194598|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
149744348|NCT05480514|540194599|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
149744349|NCT00519532|540194600|FG000|Overall Study|Adverse Event|11|||
149744350|NCT00519532|540194600|FG000|Overall Study|Withdrawal by Subject|5|||
149744351|NCT00519532|540194600|FG000|Overall Study|Lost to Follow-up|2|||
149744352|NCT03232073|540194601|FG000|Overall Study|Death|1|||
149744353|NCT03232073|540194602|FG001|Overall Study|Death|0|||
149744354|NCT03232073|540194601|FG000|Overall Study|Adverse Event|7|||
149744355|NCT03232073|540194602|FG001|Overall Study|Adverse Event|12|||
149744356|NCT03232073|540194601|FG000|Overall Study|Lost to Follow-up|6|||
149744357|NCT03232073|540194602|FG001|Overall Study|Lost to Follow-up|6|||
149744358|NCT03232073|540194601|FG000|Overall Study|Lack of Efficacy|10|||
149744359|NCT03232073|540194602|FG001|Overall Study|Lack of Efficacy|8|||
149744360|NCT03232073|540194601|FG000|Overall Study|Physician Decision|9|||
149744361|NCT03232073|540194602|FG001|Overall Study|Physician Decision|2|||
149744362|NCT03232073|540194601|FG000|Overall Study|Withdrawal by Subject|54|||
149744363|NCT03232073|540194602|FG001|Overall Study|Withdrawal by Subject|39|||
149744364|NCT03395210|540196275|FG000|Overall Study|Other|0|||
149744365|NCT03395210|540196276|FG001|Overall Study|Other|0|||
149744366|NCT03395210|540196277|FG002|Overall Study|Other|0|||
149744367|NCT03395210|540196278|FG003|Overall Study|Other|0|||
149744368|NCT03395210|540196279|FG004|Overall Study|Other|1|||
149744369|NCT03395210|540196275|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
149744370|NCT03395210|540196276|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
149744371|NCT03395210|540196277|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
149744372|NCT03395210|540196278|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
149744373|NCT03395210|540196279|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
149744374|NCT03395210|540196275|FG000|Overall Study|Adverse Event|1|||
149744375|NCT03395210|540196276|FG001|Overall Study|Adverse Event|0|||
149744376|NCT03395210|540196277|FG002|Overall Study|Adverse Event|2|||
149744377|NCT03395210|540196278|FG003|Overall Study|Adverse Event|4|||
149744378|NCT03395210|540196279|FG004|Overall Study|Adverse Event|3|||
149744379|NCT03395210|540196275|FG000|Overall Study|Need of Rescue Medication|1|||
149744380|NCT03395210|540196276|FG001|Overall Study|Need of Rescue Medication|0|||
149744381|NCT03395210|540196277|FG002|Overall Study|Need of Rescue Medication|1|||
149744382|NCT03395210|540196278|FG003|Overall Study|Need of Rescue Medication|4|||
149744383|NCT03395210|540196279|FG004|Overall Study|Need of Rescue Medication|0|||
149744384|NCT03395210|540196275|FG000|Overall Study|Lack of Response|0|||
149744385|NCT03395210|540196276|FG001|Overall Study|Lack of Response|0|||
149744386|NCT03395210|540196277|FG002|Overall Study|Lack of Response|0|||
149744387|NCT03395210|540196278|FG003|Overall Study|Lack of Response|5|||
149744388|NCT03395210|540196279|FG004|Overall Study|Lack of Response|5|||
149744389|NCT03395210|540196275|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
149744390|NCT03395210|540196276|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149744391|NCT03395210|540196277|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149744392|NCT03395210|540196278|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149744393|NCT03395210|540196279|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
149744394|NCT03395210|540196275|FG000|Overall Study|Participant Decision|1|||
149744395|NCT03395210|540196276|FG001|Overall Study|Participant Decision|1|||
149744396|NCT03395210|540196277|FG002|Overall Study|Participant Decision|0|||
149744397|NCT03395210|540196278|FG003|Overall Study|Participant Decision|4|||
149744398|NCT03395210|540196279|FG004|Overall Study|Participant Decision|0|||
149744399|NCT03395210|540196275|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
149744400|NCT03395210|540196276|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
149744401|NCT03395210|540196277|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
149744402|NCT03395210|540196278|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
149744403|NCT03395210|540196279|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
149744404|NCT02579603|540196288|FG000|Overall Study|Not treated|1|||
149744405|NCT02579603|540196289|FG001|Overall Study|Not treated|0|||
149744406|NCT02579603|540196288|FG000|Overall Study|Adverse Event|2|||
149744407|NCT02579603|540196289|FG001|Overall Study|Adverse Event|2|||
149744408|NCT02579603|540196288|FG000|Overall Study|Other than stated|1|||
149744409|NCT02579603|540196289|FG001|Overall Study|Other than stated|0|||
149744410|NCT03199911|540196291|FG000|Overall Study|Lost to Follow-up|5|||
149744411|NCT03199911|540196292|FG001|Overall Study|Lost to Follow-up|5|||
149744412|NCT03199911|540196291|FG000|Overall Study|Did not proceed with surgery|2|||
149744413|NCT03199911|540196292|FG001|Overall Study|Did not proceed with surgery|1|||
149744414|NCT01473004|540196293|FG000|Overall Study|Incomplete Lobar Treatment|1|||
149744415|NCT01473004|540196294|FG001|Overall Study|Incomplete Lobar Treatment|0|||
149744416|NCT05309668|540196296|FG000|Overall Study|Ongoing at data cut-off|14|||
149744417|NCT05309668|540196297|FG001|Overall Study|Ongoing at data cut-off|17|||
149744418|NCT05309668|540196298|FG002|Overall Study|Ongoing at data cut-off|4|||
149744419|NCT01584024|540196301|FG000|Overall Study|Lost to Follow-up|10|||
149744420|NCT01584024|540196301|FG000|Overall Study|Withdrawal by Subject|3|||
149744421|NCT00613314|540196302|FG000|Overall Study|Adverse Event|5|||
149744422|NCT00613314|540196302|FG000|Overall Study|Protocol Violation|14|||
149744423|NCT00613314|540196302|FG000|Overall Study|Lost to Follow-up|46|||
149744424|NCT00613314|540196302|FG000|Overall Study|Other reason not defined above|90|||
149744425|NCT02465034|540196312|FG000|Overall Study|Withdrawal by Subject|1|||
149744426|NCT02465034|540196313|FG001|Overall Study|Withdrawal by Subject|1|||
149744427|NCT02465034|540196312|FG000|Overall Study|Screen fail|2|||
149744428|NCT02465034|540196313|FG001|Overall Study|Screen fail|0|||
149744429|NCT02465034|540196312|FG000|Overall Study|Could not be scheduled for study visit|0|||
149744430|NCT02465034|540196313|FG001|Overall Study|Could not be scheduled for study visit|5|||
149744431|NCT02401256|540196318|FG000|Overall Study|Adverse Event|5|||
149744432|NCT02401256|540196318|FG000|Overall Study|Withdrawal by Subject|12|||
149744433|NCT00893789|540196319|FG000|Overall Study|Withdrawal by Subject|3|||
149744434|NCT00893789|540196320|FG001|Overall Study|Withdrawal by Subject|1|||
149744435|NCT00893789|540196321|FG002|Overall Study|Withdrawal by Subject|3|||
149744436|NCT00893789|540196322|FG003|Overall Study|Withdrawal by Subject|1|||
149744437|NCT00893789|540196319|FG000|Overall Study|Noncompliance With Study Drug|1|||
149744438|NCT00893789|540196320|FG001|Overall Study|Noncompliance With Study Drug|0|||
149744439|NCT00893789|540196321|FG002|Overall Study|Noncompliance With Study Drug|1|||
149744440|NCT00893789|540196322|FG003|Overall Study|Noncompliance With Study Drug|2|||
149744441|NCT00893789|540196319|FG000|Overall Study|Noncompliance With Study Procedures|1|||
149744442|NCT00893789|540196320|FG001|Overall Study|Noncompliance With Study Procedures|0|||
149744443|NCT00893789|540196321|FG002|Overall Study|Noncompliance With Study Procedures|0|||
149744444|NCT00893789|540196322|FG003|Overall Study|Noncompliance With Study Procedures|0|||
149744445|NCT00893789|540196319|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
149744446|NCT00893789|540196320|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
149744447|NCT00893789|540196321|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
149744448|NCT00893789|540196322|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
149744449|NCT00893789|540196319|FG000|Overall Study|Adverse Event|0|||
149744450|NCT00893789|540196320|FG001|Overall Study|Adverse Event|2|||
149744451|NCT00893789|540196321|FG002|Overall Study|Adverse Event|1|||
149744452|NCT00893789|540196322|FG003|Overall Study|Adverse Event|5|||
149744453|NCT00893789|540196319|FG000|Overall Study|Protocol Violation|0|||
149744454|NCT00893789|540196320|FG001|Overall Study|Protocol Violation|1|||
149744455|NCT00893789|540196321|FG002|Overall Study|Protocol Violation|1|||
149744456|NCT00893789|540196322|FG003|Overall Study|Protocol Violation|4|||
149744457|NCT00893789|540196319|FG000|Overall Study|Lost to Follow-up|0|||
149744458|NCT00893789|540196320|FG001|Overall Study|Lost to Follow-up|0|||
149744459|NCT00893789|540196321|FG002|Overall Study|Lost to Follow-up|0|||
149744460|NCT00893789|540196322|FG003|Overall Study|Lost to Follow-up|1|||
149744461|NCT02024464|540196323|FG000|Overall Study|Discontinued|5|||
149744462|NCT02024464|540196324|FG001|Overall Study|Discontinued|4|||
149744463|NCT02024464|540196323|FG000|Overall Study|Missed Visits|1|||
149744464|NCT02024464|540196324|FG001|Overall Study|Missed Visits|0|||
149744465|NCT02024464|540196323|FG000|Overall Study|Lost to Follow-up|4|||
149744466|NCT02024464|540196324|FG001|Overall Study|Lost to Follow-up|7|||
149744467|NCT04419506|540196329|FG000|Overall Study|Adverse Event|0|||
149744468|NCT04419506|540196330|FG001|Overall Study|Adverse Event|10|||
149744469|NCT04419506|540196331|FG002|Overall Study|Adverse Event|0|||
149744470|NCT04419506|540196332|FG003|Overall Study|Adverse Event|3|||
149744471|NCT04419506|540196329|FG000|Overall Study|Withdrawal by Subject|0|||
149744472|NCT04419506|540196330|FG001|Overall Study|Withdrawal by Subject|0|||
149744473|NCT04419506|540196331|FG002|Overall Study|Withdrawal by Subject|0|||
149744474|NCT04419506|540196332|FG003|Overall Study|Withdrawal by Subject|1|||
149744475|NCT04419506|540196329|FG000|Overall Study|poor-compliance|0|||
149744476|NCT04419506|540196330|FG001|Overall Study|poor-compliance|0|||
149744477|NCT04419506|540196331|FG002|Overall Study|poor-compliance|0|||
149744478|NCT04419506|540196332|FG003|Overall Study|poor-compliance|1|||
149744479|NCT03293030|540196341|FG000|Overall Study|Withdrawal by Subject|3|||
149744480|NCT02586805|540196343|FG000|Overall Study|Withdrawal by Subject|3|||
149744481|NCT02586805|540196344|FG001|Overall Study|Withdrawal by Subject|1|||
149744482|NCT02586805|540196345|FG002|Overall Study|Withdrawal by Subject|1|||
149744483|NCT02586805|540196346|FG003|Overall Study|Withdrawal by Subject|2|||
149744484|NCT02586805|540196343|FG000|Overall Study|Adverse Event|2|||
149744485|NCT02586805|540196344|FG001|Overall Study|Adverse Event|0|||
149744486|NCT02586805|540196345|FG002|Overall Study|Adverse Event|1|||
149744487|NCT02586805|540196346|FG003|Overall Study|Adverse Event|0|||
149744488|NCT02586805|540196343|FG000|Overall Study|Lost to Follow-up|0|||
149744489|NCT02586805|540196344|FG001|Overall Study|Lost to Follow-up|0|||
149744490|NCT02586805|540196345|FG002|Overall Study|Lost to Follow-up|1|||
149744491|NCT02586805|540196346|FG003|Overall Study|Lost to Follow-up|0|||
149744492|NCT02586805|540196343|FG000|Overall Study|Physician Decision|1|||
149744493|NCT02586805|540196344|FG001|Overall Study|Physician Decision|0|||
149744494|NCT02586805|540196345|FG002|Overall Study|Physician Decision|0|||
149744495|NCT02586805|540196346|FG003|Overall Study|Physician Decision|0|||
149744496|NCT01859403|540196347|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
149744497|NCT01859403|540196348|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
149744498|NCT01859403|540196347|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
149744499|NCT01859403|540196348|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
149744500|NCT01859403|540196347|FG000|Primary Endpoint Measure|Physician Decision|0|||
149744501|NCT01859403|540196348|FG001|Primary Endpoint Measure|Physician Decision|1|||
149744502|NCT01859403|540196347|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
149744503|NCT01859403|540196348|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
149744504|NCT00811252|540196349|FG000|Overall Study|Adverse Event|6|||
149744505|NCT00811252|540196350|FG001|Overall Study|Adverse Event|10|||
149744506|NCT00811252|540196351|FG002|Overall Study|Adverse Event|15|||
149744507|NCT00811252|540196349|FG000|Overall Study|Lack of Efficacy|7|||
149744508|NCT00811252|540196350|FG001|Overall Study|Lack of Efficacy|2|||
149744509|NCT00811252|540196351|FG002|Overall Study|Lack of Efficacy|0|||
149744510|NCT00811252|540196349|FG000|Overall Study|Protocol Violation|3|||
149744511|NCT00811252|540196350|FG001|Overall Study|Protocol Violation|3|||
149744512|NCT00811252|540196351|FG002|Overall Study|Protocol Violation|2|||
149744513|NCT00811252|540196349|FG000|Overall Study|Withdrawal of Consent|1|||
149744514|NCT00811252|540196350|FG001|Overall Study|Withdrawal of Consent|2|||
149744515|NCT00811252|540196351|FG002|Overall Study|Withdrawal of Consent|2|||
149744516|NCT00811252|540196349|FG000|Overall Study|Lost to Follow-up|0|||
149744517|NCT00811252|540196350|FG001|Overall Study|Lost to Follow-up|0|||
149744518|NCT00811252|540196351|FG002|Overall Study|Lost to Follow-up|2|||
149744519|NCT00811252|540196349|FG000|Overall Study|Administrative or Other Reasons|0|||
149744520|NCT00811252|540196350|FG001|Overall Study|Administrative or Other Reasons|3|||
149744521|NCT00811252|540196351|FG002|Overall Study|Administrative or Other Reasons|2|||
149744522|NCT03185130|540196352|FG000|Overall Study|Withdrawal by Subject|0|||
149744523|NCT03185130|540196353|FG001|Overall Study|Withdrawal by Subject|2|||
149744524|NCT02317510|540196357|FG000|Overall Study|Adverse Event|0|||
149744525|NCT02317510|540196358|FG001|Overall Study|Adverse Event|1|||
149744526|NCT02318602|540196359|FG000|Overall Study|Adverse Event|0|||
149744527|NCT02318602|540196360|FG001|Overall Study|Adverse Event|1|||
149744528|NCT02318602|540196361|FG002|Overall Study|Adverse Event|1|||
149744529|NCT02318602|540196359|FG000|Overall Study|Withdrawal by Subject|0|||
149744530|NCT02318602|540196360|FG001|Overall Study|Withdrawal by Subject|3|||
149744531|NCT02318602|540196361|FG002|Overall Study|Withdrawal by Subject|0|||
149744532|NCT02318602|540196359|FG000|Overall Study|Death|1|||
149744533|NCT02318602|540196360|FG001|Overall Study|Death|0|||
149744534|NCT02318602|540196361|FG002|Overall Study|Death|0|||
149744535|NCT02318602|540196359|FG000|Overall Study|Guardian decision to withdraw|0|||
149744536|NCT02318602|540196360|FG001|Overall Study|Guardian decision to withdraw|0|||
149744537|NCT02318602|540196361|FG002|Overall Study|Guardian decision to withdraw|1|||
149744538|NCT00465569|540196367|FG000|Overall Study|persistent eczema during dose escalation|1|||
149744539|NCT00465569|540196368|FG001|Overall Study|persistent eczema during dose escalation|0|||
149744540|NCT01985321|540196370|FG000|Overall Study|Protocol Violation|4|||
149744541|NCT01985321|540196371|FG001|Overall Study|Protocol Violation|3|||
149744542|NCT01985321|540196370|FG000|Overall Study|Withdrawal by Subject|1|||
149744543|NCT01985321|540196371|FG001|Overall Study|Withdrawal by Subject|0|||
149744544|NCT01985321|540196370|FG000|Overall Study|Lost to Follow-up|5|||
149744545|NCT01985321|540196371|FG001|Overall Study|Lost to Follow-up|2|||
149744546|NCT01985321|540196370|FG000|Overall Study|Subject treated wrong type of sore|1|||
149744547|NCT01985321|540196371|FG001|Overall Study|Subject treated wrong type of sore|0|||
149744548|NCT00482001|540196372|FG000|Overall Study|Protocol Violation|1|||
149744549|NCT00482001|540196373|FG001|Overall Study|Protocol Violation|1|||
149744550|NCT00542828|540196378|FG000|Overall Study|Physician Decision|1|||
149744551|NCT00542828|540196378|FG000|Overall Study|Need for Prohibited Treatment|3|||
149744552|NCT00542828|540196378|FG000|Overall Study|Study Prematurely Discontinued|7|||
149744553|NCT00542828|540196378|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
149744554|NCT00095303|540196379|FG000|Main Study|Lost to Follow-up|91|||
149744555|NCT00095303|540196380|FG001|Main Study|Lost to Follow-up|87|||
149744556|NCT00095303|540196379|FG000|Follow Up Study|Lost to Follow-up|59|||
149744557|NCT00095303|540196380|FG001|Follow Up Study|Lost to Follow-up|58|||
149744558|NCT01364467|540196383|FG000|Overall Study|Lost to Follow-up|1|||
149744559|NCT01364467|540196384|FG001|Overall Study|Lost to Follow-up|2|||
149744560|NCT03228186|540196385|FG000|Overall Study|Patient never started treatment|1|||
149744561|NCT01634243|540196388|FG000|Overall Study|Adverse Event|5|||
149744562|NCT01634243|540196389|FG001|Overall Study|Adverse Event|5|||
149744563|NCT01634243|540196388|FG000|Overall Study|Lack of Efficacy|1|||
149744564|NCT01634243|540196389|FG001|Overall Study|Lack of Efficacy|0|||
149744565|NCT03953118|540196390|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
149744566|NCT03953118|540196391|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
149744567|NCT04283461|540196392|FG000|Overall Study|Enrolled in separate trial|0|||
149744568|NCT04283461|540196393|FG001|Overall Study|Enrolled in separate trial|0|||
149744569|NCT04283461|540196394|FG002|Overall Study|Enrolled in separate trial|8|||
149744570|NCT04283461|540196395|FG003|Overall Study|Enrolled in separate trial|13|||
149744571|NCT04283461|540196396|FG004|Overall Study|Enrolled in separate trial|12|||
149744572|NCT04283461|540196397|FG005|Overall Study|Enrolled in separate trial|0|||
149744573|NCT04283461|540196398|FG006|Overall Study|Enrolled in separate trial|0|||
149744574|NCT04283461|540196399|FG007|Overall Study|Enrolled in separate trial|8|||
149744575|NCT04283461|540196400|FG008|Overall Study|Enrolled in separate trial|0|||
149744576|NCT04283461|540196401|FG009|Overall Study|Enrolled in separate trial|0|||
149744577|NCT04283461|540196402|FG010|Overall Study|Enrolled in separate trial|0|||
149744578|NCT04283461|540196403|FG011|Overall Study|Enrolled in separate trial|7|||
149744579|NCT04283461|540196404|FG012|Overall Study|Enrolled in separate trial|0|||
149744580|NCT05490771|540196405|FG000|Overall Study|Disease progression|18|||
149744581|NCT05490771|540196405|FG000|Overall Study|Adverse Event|3|||
149744582|NCT05490771|540196405|FG000|Overall Study|Other complicating disease|1|||
149744583|NCT05490771|540196405|FG000|Overall Study|Withdrawal by Subject|3|||
149744584|NCT05490771|540196405|FG000|Overall Study|Physician Decision|1|||
149744585|NCT05490771|540196405|FG000|Overall Study|Still on treatment|2|||
149744586|NCT05490771|540196405|FG000|Overall Study|Never start protocol therapy|5|||
149744587|NCT05490771|540196405|FG000|Overall Study|Ineligible|2|||
149744588|NCT05139030|540196408|FG000|Overall Study|Withdrawal by Subject|1|||
149744589|NCT05139030|540196409|FG001|Overall Study|Withdrawal by Subject|3|||
149744590|NCT05139030|540196408|FG000|Overall Study|Adverse Event|0|||
149744591|NCT05139030|540196409|FG001|Overall Study|Adverse Event|1|||
149744592|NCT05139030|540196408|FG000|Overall Study|Failure to meet continuation criteria|0|||
149744593|NCT05139030|540196409|FG001|Overall Study|Failure to meet continuation criteria|1|||
149744594|NCT00816036|540196414|FG000|Overall Study|Death|47|||
149744595|NCT00816036|540196415|FG001|Overall Study|Death|28|||
149744596|NCT00816036|540196414|FG000|Overall Study|Lost to Follow-up|75|||
149744597|NCT00816036|540196415|FG001|Overall Study|Lost to Follow-up|57|||
149744598|NCT00816036|540196414|FG000|Overall Study|Withdrawal by Subject|54|||
149744599|NCT00816036|540196415|FG001|Overall Study|Withdrawal by Subject|23|||
149744600|NCT01299025|540196416|FG000|Overall Study|Withdrawal by Subject|2|||
149744601|NCT01299025|540196417|FG001|Overall Study|Withdrawal by Subject|1|||
149744602|NCT01299025|540196416|FG000|Overall Study|Lost to Follow-up|1|||
149744603|NCT01299025|540196417|FG001|Overall Study|Lost to Follow-up|0|||
149744604|NCT00004980|540196418|FG000|Overall Study|Withdrawal by Subject|1|||
149744605|NCT00004980|540196419|FG001|Overall Study|Withdrawal by Subject|0|||
149744606|NCT00004980|540196418|FG000|Overall Study|memory difficulties|1|||
149744607|NCT00004980|540196419|FG001|Overall Study|memory difficulties|1|||
149744608|NCT00004980|540196418|FG000|Overall Study|Physician Decision|0|||
149744609|NCT00004980|540196419|FG001|Overall Study|Physician Decision|1|||
149744610|NCT01624194|540196420|FG000|Overall Study|Lost to Follow-up|1|||
149744611|NCT01624194|540196421|FG001|Overall Study|Lost to Follow-up|0|||
149744612|NCT01624194|540196420|FG000|Overall Study|Withdrawal by Subject|1|||
149744613|NCT01624194|540196421|FG001|Overall Study|Withdrawal by Subject|0|||
149744614|NCT03212261|540196422|FG000|Overall Study|Became ineligible d/t tech|2|||
149744615|NCT03212261|540196422|FG000|Overall Study|Tech Trouble- No first study visit|1|||
149744616|NCT03212261|540196422|FG000|Overall Study|Lost to Follow-up|7|||
149744617|NCT03212261|540196422|FG000|Overall Study|Family Emergency|1|||
149744618|NCT03212261|540196422|FG000|Overall Study|Too busy/ No time|5|||
149744619|NCT00820040|540196423|FG000|Overall Study|Death|1|||
149744620|NCT00820040|540196423|FG000|Overall Study|Sponsor terminated study|1|||
149744621|NCT00820040|540196423|FG000|Overall Study|Screen failure|1|||
149744622|NCT01259466|540196428|FG000|Overall Study|Withdrawal by Subject|1|||
149744623|NCT01259466|540196429|FG001|Overall Study|Withdrawal by Subject|9|||
149744624|NCT02296840|540196430|FG000|Overall Study|Adverse Event|1|||
149744625|NCT02296840|540196431|FG001|Overall Study|Adverse Event|1|||
149744626|NCT02296840|540196430|FG000|Overall Study|Protocol Violation|2|||
149744627|NCT02296840|540196431|FG001|Overall Study|Protocol Violation|1|||
149744628|NCT02296840|540196430|FG000|Overall Study|Lost to Follow-up|6|||
149744629|NCT02296840|540196431|FG001|Overall Study|Lost to Follow-up|17|||
149744630|NCT00814710|540196436|FG000|Overall Study|Adverse Event|1|||
149744631|NCT00814710|540196437|FG001|Overall Study|Adverse Event|0|||
149744632|NCT00814710|540196436|FG000|Overall Study|Lost to Follow-up|7|||
149744633|NCT00814710|540196437|FG001|Overall Study|Lost to Follow-up|3|||
149744634|NCT03885284|540196438|FG000|Overall Study|Disease Progression|1|||
149744635|NCT03885284|540196439|FG001|Overall Study|Disease Progression|3|||
149744636|NCT03885284|540196438|FG000|Overall Study|Physician Decision|0|||
149744637|NCT03885284|540196439|FG001|Overall Study|Physician Decision|1|||
149744638|NCT02932267|540196442|FG000|Overall Study|Withdrawal by Subject|3|||
149744639|NCT02932267|540196442|FG000|Overall Study|Lost to Follow-up|4|||
149744640|NCT02932267|540196442|FG000|Overall Study|Pregnancy|1|||
149744641|NCT03476239|540196443|FG000|Overall Study|Withdrawal by Subject|10|||
149744642|NCT03476239|540196443|FG000|Overall Study|Death|80|||
149744643|NCT03476239|540196443|FG000|Overall Study|Lost to Follow-up|8|||
149744644|NCT00630032|540196444|FG000|Overall Study|Death|55|||
149744645|NCT00630032|540196445|FG001|Overall Study|Death|49|||
149744646|NCT00630032|540196444|FG000|Overall Study|Withdrawal by Subject|3|||
149744647|NCT00630032|540196445|FG001|Overall Study|Withdrawal by Subject|2|||
149744648|NCT00630032|540196444|FG000|Overall Study|Lost to Follow-up|18|||
149744649|NCT00630032|540196445|FG001|Overall Study|Lost to Follow-up|31|||
149744650|NCT00630032|540196444|FG000|Overall Study|Protocol Violation|1|||
149744651|NCT00630032|540196445|FG001|Overall Study|Protocol Violation|0|||
149744652|NCT00630032|540196444|FG000|Overall Study|Patient has moved|1|||
149744653|NCT00630032|540196445|FG001|Overall Study|Patient has moved|1|||
149744654|NCT00630032|540196444|FG000|Overall Study|Disease progression|1|||
149744655|NCT00630032|540196445|FG001|Overall Study|Disease progression|1|||
149744656|NCT00630032|540196444|FG000|Overall Study|End of monitoring in US centers|11|||
149744657|NCT00630032|540196445|FG001|Overall Study|End of monitoring in US centers|11|||
149744658|NCT03746080|540197860|FG000|Overall Study|In follow up|2|||
149744659|NCT03746080|540197860|FG000|Overall Study|Death|15|||
149744660|NCT05738486|540197861|FG000|Overall Study|Continuing Study|194|||
149744661|NCT05738486|540197862|FG001|Overall Study|Continuing Study|196|||
149744662|NCT05738486|540197863|FG002|Overall Study|Continuing Study|193|||
149744663|NCT05738486|540197864|FG003|Overall Study|Continuing Study|191|||
149744664|NCT05738486|540197861|FG000|Overall Study|Withdrawal by Subject|8|||
149744665|NCT05738486|540197862|FG001|Overall Study|Withdrawal by Subject|5|||
149744666|NCT05738486|540197863|FG002|Overall Study|Withdrawal by Subject|7|||
149744667|NCT05738486|540197864|FG003|Overall Study|Withdrawal by Subject|13|||
149744668|NCT05738486|540197861|FG000|Overall Study|Adverse Event|4|||
149744669|NCT05738486|540197862|FG001|Overall Study|Adverse Event|6|||
149744670|NCT05738486|540197863|FG002|Overall Study|Adverse Event|4|||
149744671|NCT05738486|540197864|FG003|Overall Study|Adverse Event|5|||
149744672|NCT05738486|540197861|FG000|Overall Study|Physician Decision|0|||
149744673|NCT05738486|540197862|FG001|Overall Study|Physician Decision|2|||
149744674|NCT05738486|540197863|FG002|Overall Study|Physician Decision|4|||
149744675|NCT05738486|540197864|FG003|Overall Study|Physician Decision|1|||
149744676|NCT05738486|540197861|FG000|Overall Study|Lost to Follow-up|1|||
149744677|NCT05738486|540197862|FG001|Overall Study|Lost to Follow-up|1|||
149744678|NCT05738486|540197863|FG002|Overall Study|Lost to Follow-up|2|||
149744679|NCT05738486|540197864|FG003|Overall Study|Lost to Follow-up|1|||
149744680|NCT05738486|540197861|FG000|Overall Study|Participant was Non-ambulatory|0|||
149744681|NCT05738486|540197862|FG001|Overall Study|Participant was Non-ambulatory|0|||
149744682|NCT05738486|540197863|FG002|Overall Study|Participant was Non-ambulatory|1|||
149744683|NCT05738486|540197864|FG003|Overall Study|Participant was Non-ambulatory|0|||
149744684|NCT05738486|540197861|FG000|Overall Study|Participant had Poor Venous Access|0|||
149744685|NCT05738486|540197862|FG001|Overall Study|Participant had Poor Venous Access|0|||
149744686|NCT05738486|540197863|FG002|Overall Study|Participant had Poor Venous Access|0|||
149744687|NCT05738486|540197864|FG003|Overall Study|Participant had Poor Venous Access|1|||
149744688|NCT05738486|540197861|FG000|Overall Study|Assigned Treatment by Mistake|0|||
149744689|NCT05738486|540197862|FG001|Overall Study|Assigned Treatment by Mistake|0|||
149744690|NCT05738486|540197863|FG002|Overall Study|Assigned Treatment by Mistake|0|||
149744691|NCT05738486|540197864|FG003|Overall Study|Assigned Treatment by Mistake|1|||
149744692|NCT05738486|540197861|FG000|Overall Study|Death|0|||
149744693|NCT05738486|540197862|FG001|Overall Study|Death|0|||
149744694|NCT05738486|540197863|FG002|Overall Study|Death|1|||
149744695|NCT05738486|540197864|FG003|Overall Study|Death|0|||
149744696|NCT05738486|540197861|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
149744697|NCT05738486|540197862|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149744698|NCT05738486|540197863|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149744699|NCT05738486|540197864|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149744700|NCT00955110|540197865|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
149744701|NCT00955110|540197865|FG000|Treatment Phase|Adverse Event|2|||
149744702|NCT00955110|540197865|FG000|Treatment Phase|Administrative reasons|2|||
149744703|NCT00955110|540197865|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
149744704|NCT00955110|540197865|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
149744705|NCT02128490|540197866|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149744706|NCT02128490|540197867|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149744707|NCT02128490|540197868|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
149744708|NCT02128490|540197869|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
149744709|NCT02128490|540197870|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
149744710|NCT02128490|540197866|FG000|Overall Study|Major Protocol Deviation|1|||
149744711|NCT02128490|540197867|FG001|Overall Study|Major Protocol Deviation|2|||
149744712|NCT02128490|540197868|FG002|Overall Study|Major Protocol Deviation|0|||
149744713|NCT02128490|540197869|FG003|Overall Study|Major Protocol Deviation|2|||
149744714|NCT02128490|540197870|FG004|Overall Study|Major Protocol Deviation|2|||
149744715|NCT02128490|540197866|FG000|Overall Study|Lost to Follow-up|0|||
149744716|NCT02128490|540197867|FG001|Overall Study|Lost to Follow-up|0|||
149744717|NCT02128490|540197868|FG002|Overall Study|Lost to Follow-up|1|||
149744718|NCT02128490|540197869|FG003|Overall Study|Lost to Follow-up|1|||
149744719|NCT02128490|540197870|FG004|Overall Study|Lost to Follow-up|1|||
149744720|NCT02128490|540197866|FG000|Overall Study|Voluntary Withdrawal|3|||
149744721|NCT02128490|540197867|FG001|Overall Study|Voluntary Withdrawal|3|||
149744722|NCT02128490|540197868|FG002|Overall Study|Voluntary Withdrawal|1|||
149744723|NCT02128490|540197869|FG003|Overall Study|Voluntary Withdrawal|1|||
149744724|NCT02128490|540197870|FG004|Overall Study|Voluntary Withdrawal|2|||
149744725|NCT02128490|540197866|FG000|Overall Study|Lack of Efficacy|0|||
149744726|NCT02128490|540197867|FG001|Overall Study|Lack of Efficacy|1|||
149744727|NCT02128490|540197868|FG002|Overall Study|Lack of Efficacy|0|||
149744728|NCT02128490|540197869|FG003|Overall Study|Lack of Efficacy|0|||
149744729|NCT02128490|540197870|FG004|Overall Study|Lack of Efficacy|0|||
149744730|NCT02128490|540197866|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149744731|NCT02128490|540197867|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149744732|NCT02128490|540197868|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149744733|NCT02128490|540197869|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149744734|NCT02128490|540197870|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
149744735|NCT02128490|540197866|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149744736|NCT02128490|540197867|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149744737|NCT02128490|540197868|FG002|Overall Study|Other Miscellaneous Reasons|2|||
149744738|NCT02128490|540197869|FG003|Overall Study|Other Miscellaneous Reasons|1|||
149744739|NCT02128490|540197870|FG004|Overall Study|Other Miscellaneous Reasons|1|||
149744740|NCT02243176|540197871|FG000|Overall Study|Other reason|1|||
149744741|NCT02243176|540197872|FG001|Overall Study|Other reason|2|||
149744742|NCT02243176|540197871|FG000|Overall Study|protocol specified withdrawal critera|1|||
149744743|NCT02243176|540197872|FG001|Overall Study|protocol specified withdrawal critera|3|||
149744744|NCT02243176|540197871|FG000|Overall Study|Protocol Violation|2|||
149744745|NCT02243176|540197872|FG001|Overall Study|Protocol Violation|1|||
149744746|NCT02243176|540197871|FG000|Overall Study|Withdrawal by Subject|8|||
149744747|NCT02243176|540197872|FG001|Overall Study|Withdrawal by Subject|7|||
149744748|NCT02243176|540197871|FG000|Overall Study|Adverse Event|2|||
149744749|NCT02243176|540197872|FG001|Overall Study|Adverse Event|2|||
149744750|NCT03113500|540197873|FG000|Overall Study|Withdrawal by Subject|1|||
149744751|NCT02517515|540197876|FG000|Overall Study|Adverse Event|0|||
149744752|NCT02517515|540197877|FG001|Overall Study|Adverse Event|1|||
149744753|NCT02517515|540197876|FG000|Overall Study|Withdrew Consent|0|||
149744754|NCT02517515|540197877|FG001|Overall Study|Withdrew Consent|1|||
149744755|NCT02517515|540197876|FG000|Overall Study|Lost to Follow-up|1|||
149744756|NCT02517515|540197877|FG001|Overall Study|Lost to Follow-up|0|||
149744757|NCT02517515|540197876|FG000|Overall Study|Other|1|||
149744758|NCT02517515|540197877|FG001|Overall Study|Other|0|||
149744759|NCT01009463|540197885|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
149744760|NCT01009463|540197886|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149744761|NCT01009463|540197887|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149744762|NCT01009463|540197888|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149744763|NCT01009463|540197889|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149744764|NCT01009463|540197885|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
149744765|NCT01009463|540197886|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
149744766|NCT01009463|540197887|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
149744767|NCT01009463|540197888|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
149744768|NCT01009463|540197889|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
150256352|NCT02217475|542072744|FG001|Discontinued After Period 1|Adverse Event|2|||
149744769|NCT01009463|540197885|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
149744770|NCT01009463|540197886|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149744771|NCT01009463|540197887|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149744772|NCT01009463|540197888|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149744773|NCT01009463|540197889|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149744774|NCT01009463|540197885|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
150256353|NCT02217475|542072745|FG002|Discontinued After Period 1|Adverse Event|0|||
149744775|NCT01009463|540197886|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
149744776|NCT01009463|540197887|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
149744777|NCT01009463|540197888|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
149744778|NCT01009463|540197889|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
149744779|NCT01009463|540197885|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
149744780|NCT01009463|540197886|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149744781|NCT01009463|540197887|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149744782|NCT01009463|540197888|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149744783|NCT01009463|540197889|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149744784|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
149744785|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
149744786|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
149744787|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
149744788|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
149744789|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149744790|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
149744791|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
149744792|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
149744793|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
149744794|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149744795|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
149744796|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
149744797|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
149744798|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
149744799|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
149744800|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
150256354|NCT02217475|542072743|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
150256355|NCT02217475|542072744|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
149744801|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149744802|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
149744803|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149744804|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149744805|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
149744806|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
149744807|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
149744808|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
149744809|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149744810|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
149744811|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149744812|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149744813|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149744814|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149744815|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
149744816|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
149744817|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
150256356|NCT02217475|542072745|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
150256357|NCT02217475|542072743|FG000|Discontinued After Period 1|Physician Decision|0|||
150256358|NCT02217475|542072744|FG001|Discontinued After Period 1|Physician Decision|0|||
150256359|NCT02217475|542072745|FG002|Discontinued After Period 1|Physician Decision|1|||
150256360|NCT02217475|542072743|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
150256361|NCT02217475|542072744|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
150256362|NCT02217475|542072745|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
150256363|NCT02217475|542072743|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
150256364|NCT02217475|542072744|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
150256365|NCT02217475|542072745|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
150256366|NCT02217475|542072743|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
150256367|NCT02217475|542072744|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
150256368|NCT02217475|542072745|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
150256369|NCT02217475|542072743|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
150256370|NCT02217475|542072744|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
150256371|NCT02217475|542072745|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
150256372|NCT02217475|542072743|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
150256373|NCT02217475|542072744|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
150256374|NCT02217475|542072745|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
149744818|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
149744819|NCT01009463|540197885|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
149744820|NCT01009463|540197886|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
149744821|NCT01009463|540197887|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
149744822|NCT01009463|540197888|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
149744823|NCT01009463|540197889|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
149744824|NCT04430348|540197892|FG000|Overall Study|Death|3|||
149744825|NCT04430348|540197893|FG001|Overall Study|Death|2|||
149744826|NCT04430348|540197894|FG002|Overall Study|Death|2|||
149744827|NCT04430348|540197895|FG003|Overall Study|Death|2|||
149744828|NCT04430348|540197896|FG004|Overall Study|Death|2|||
149744829|NCT04430348|540197897|FG005|Overall Study|Death|3|||
149744830|NCT04430348|540197892|FG000|Overall Study|Lost to Follow-up|0|||
149744831|NCT04430348|540197893|FG001|Overall Study|Lost to Follow-up|0|||
149744832|NCT04430348|540197894|FG002|Overall Study|Lost to Follow-up|0|||
149744833|NCT04430348|540197895|FG003|Overall Study|Lost to Follow-up|1|||
149744834|NCT04430348|540197896|FG004|Overall Study|Lost to Follow-up|0|||
149744835|NCT04430348|540197897|FG005|Overall Study|Lost to Follow-up|0|||
149744836|NCT04430348|540197892|FG000|Overall Study|Adverse Event|0|||
149744837|NCT04430348|540197893|FG001|Overall Study|Adverse Event|0|||
149744838|NCT04430348|540197894|FG002|Overall Study|Adverse Event|0|||
149744839|NCT04430348|540197895|FG003|Overall Study|Adverse Event|0|||
149744840|NCT04430348|540197896|FG004|Overall Study|Adverse Event|0|||
149744841|NCT04430348|540197897|FG005|Overall Study|Adverse Event|1|||
149744842|NCT04430348|540197892|FG000|Overall Study|Withdrawal by Subject|0|||
149744843|NCT04430348|540197893|FG001|Overall Study|Withdrawal by Subject|1|||
149744844|NCT04430348|540197894|FG002|Overall Study|Withdrawal by Subject|0|||
149744845|NCT04430348|540197895|FG003|Overall Study|Withdrawal by Subject|0|||
149744846|NCT04430348|540197896|FG004|Overall Study|Withdrawal by Subject|0|||
149744847|NCT04430348|540197897|FG005|Overall Study|Withdrawal by Subject|1|||
149744848|NCT04430348|540197892|FG000|Overall Study|Study Terminated by Sponsor|0|||
149744849|NCT04430348|540197893|FG001|Overall Study|Study Terminated by Sponsor|0|||
149744850|NCT04430348|540197894|FG002|Overall Study|Study Terminated by Sponsor|2|||
149744851|NCT04430348|540197895|FG003|Overall Study|Study Terminated by Sponsor|0|||
149744852|NCT04430348|540197896|FG004|Overall Study|Study Terminated by Sponsor|1|||
149744853|NCT04430348|540197897|FG005|Overall Study|Study Terminated by Sponsor|1|||
149744854|NCT02874794|540197900|FG000|Overall Study|Physician Decision|3|||
149744855|NCT02874794|540197901|FG001|Overall Study|Physician Decision|2|||
149744856|NCT02874794|540197900|FG000|Overall Study|Withdrawal by Subject|2|||
149744857|NCT02874794|540197901|FG001|Overall Study|Withdrawal by Subject|8|||
149744858|NCT02874794|540197900|FG000|Overall Study|Death|2|||
149744859|NCT02874794|540197901|FG001|Overall Study|Death|1|||
149744860|NCT01021007|540197903|FG000|Overall Study|Lost to Follow-up|1|||
149744861|NCT01021007|540197904|FG001|Overall Study|Lost to Follow-up|1|||
149744862|NCT01021007|540197903|FG000|Overall Study|Adverse Event|1|||
149744863|NCT01021007|540197904|FG001|Overall Study|Adverse Event|3|||
149744864|NCT04876391|540197905|FG000|Overall Study|Withdrawal by Subject|1|||
149744865|NCT04876391|540197906|FG001|Overall Study|Withdrawal by Subject|10|||
149744866|NCT04876391|540197905|FG000|Overall Study|Lost to Follow-up|2|||
149744867|NCT04876391|540197906|FG001|Overall Study|Lost to Follow-up|4|||
149744868|NCT04876391|540197905|FG000|Overall Study|Lack of Efficacy|0|||
149744869|NCT04876391|540197906|FG001|Overall Study|Lack of Efficacy|2|||
149744870|NCT04876391|540197905|FG000|Overall Study|Adverse Event|3|||
149744871|NCT04876391|540197906|FG001|Overall Study|Adverse Event|1|||
149744872|NCT04876391|540197905|FG000|Overall Study|Patient non-compliance|0|||
149744873|NCT04876391|540197906|FG001|Overall Study|Patient non-compliance|1|||
149744874|NCT04876391|540197905|FG000|Overall Study|Personal reasons|0|||
149744875|NCT04876391|540197906|FG001|Overall Study|Personal reasons|1|||
149744876|NCT04876391|540197905|FG000|Overall Study|Withdrawn as per protocol|2|||
149744877|NCT04876391|540197906|FG001|Overall Study|Withdrawn as per protocol|2|||
149744878|NCT04899271|540197907|FG000|Overall Study|Lost to Follow-up|1|||
149744879|NCT04899271|540197908|FG001|Overall Study|Lost to Follow-up|0|||
149744880|NCT04899271|540197907|FG000|Overall Study|Subject request/consent withdrawal|2|||
149744881|NCT04899271|540197908|FG001|Overall Study|Subject request/consent withdrawal|0|||
149744882|NCT00813748|540197909|FG000|Skin Test Substudy|Physician Decision|0|||
149744883|NCT00813748|540197910|FG001|Skin Test Substudy|Physician Decision|1|||
149744884|NCT00892437|540197911|FG000|Randomized Phase|Randomized but not treated|6|||
149744885|NCT00892437|540197912|FG001|Randomized Phase|Randomized but not treated|0|||
149744886|NCT00892437|540197911|FG000|Randomized Phase|Adverse Event|2|||
149744887|NCT00892437|540197912|FG001|Randomized Phase|Adverse Event|2|||
149744888|NCT00892437|540197911|FG000|Randomized Phase|Lost to Follow-up|1|||
149744889|NCT00892437|540197912|FG001|Randomized Phase|Lost to Follow-up|3|||
149744890|NCT00892437|540197911|FG000|Randomized Phase|Investigator's Discretion|1|||
149744891|NCT00892437|540197912|FG001|Randomized Phase|Investigator's Discretion|0|||
149744892|NCT00892437|540197911|FG000|Randomized Phase|Withdrew Consent|1|||
149744893|NCT00892437|540197912|FG001|Randomized Phase|Withdrew Consent|0|||
149744894|NCT00892437|540197911|FG000|Open-Label Extension Phase|Adverse Event|4|||
149744895|NCT00892437|540197912|FG001|Open-Label Extension Phase|Adverse Event|2|||
149744896|NCT00892437|540197911|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
149744897|NCT00892437|540197912|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
149744898|NCT00892437|540197911|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
149744899|NCT00892437|540197912|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
149744900|NCT00892437|540197911|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
149744901|NCT00892437|540197912|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
149744902|NCT00892437|540197911|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
149744903|NCT00892437|540197912|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
149744904|NCT02286960|540197913|FG000|Overall Study|Lost to Follow-up|3|||
149744905|NCT02286960|540197914|FG001|Overall Study|Lost to Follow-up|3|||
149744906|NCT03427073|540197916|FG000|Overall Study|Disease Progression|1|||
149744907|NCT03427073|540197917|FG001|Overall Study|Disease Progression|1|||
149744908|NCT03427073|540197918|FG002|Overall Study|Disease Progression|1|||
149744909|NCT03427073|540197919|FG003|Overall Study|Disease Progression|3|||
149744910|NCT03427073|540197920|FG004|Overall Study|Disease Progression|3|||
149744911|NCT03427073|540197921|FG005|Overall Study|Disease Progression|4|||
149744912|NCT03427073|540197922|FG006|Overall Study|Disease Progression|2|||
149744913|NCT03427073|540197923|FG007|Overall Study|Disease Progression|3|||
149744914|NCT03427073|540197916|FG000|Overall Study|Physician Decision|0|||
149744915|NCT03427073|540197917|FG001|Overall Study|Physician Decision|0|||
149744916|NCT03427073|540197918|FG002|Overall Study|Physician Decision|0|||
149744917|NCT03427073|540197919|FG003|Overall Study|Physician Decision|0|||
149744918|NCT03427073|540197920|FG004|Overall Study|Physician Decision|0|||
149744919|NCT03427073|540197921|FG005|Overall Study|Physician Decision|0|||
149744920|NCT03427073|540197922|FG006|Overall Study|Physician Decision|1|||
149744921|NCT03427073|540197923|FG007|Overall Study|Physician Decision|1|||
149744922|NCT01193335|540197924|FG000|After Infant Series|Lost to Follow-up|1|||
149744923|NCT01193335|540197925|FG001|After Infant Series|Lost to Follow-up|2|||
149744924|NCT01193335|540197924|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
149744925|NCT01193335|540197925|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
149744926|NCT01193335|540197924|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
149744927|NCT01193335|540197925|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
149744928|NCT01193335|540197924|FG000|1-Year Follow-up|Lost to Follow-up|4|||
149744929|NCT01193335|540197925|FG001|1-Year Follow-up|Lost to Follow-up|0|||
149744930|NCT01193335|540197924|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
149744931|NCT01193335|540197925|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
149744932|NCT01193335|540197924|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
149744933|NCT01193335|540197925|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
149744934|NCT01733329|540197926|FG000|Overall Study|Protocol Violation|1|||
149744935|NCT01733329|540197927|FG001|Overall Study|Protocol Violation|1|||
149744936|NCT01733329|540197926|FG000|Overall Study|Uterine artery injury|1|||
149744937|NCT01733329|540197927|FG001|Overall Study|Uterine artery injury|0|||
149744938|NCT02388776|540197928|FG000|Overall Study|Death|1|||
149744939|NCT02388776|540197928|FG000|Overall Study|Lost to Follow-up|1|||
149744940|NCT03826914|540197929|FG000|Overall Study|Withdrawal by Subject|1|||
149744941|NCT03826914|540197930|FG001|Overall Study|Withdrawal by Subject|1|||
149744942|NCT04246047|540197933|FG000|Overall Study|Death|50|||
149744943|NCT04246047|540197934|FG001|Overall Study|Death|77|||
149744944|NCT04246047|540197933|FG000|Overall Study|Lost to Follow-up|1|||
149744945|NCT04246047|540197934|FG001|Overall Study|Lost to Follow-up|3|||
149744946|NCT04246047|540197933|FG000|Overall Study|Physician Decision|4|||
149744947|NCT04246047|540197934|FG001|Overall Study|Physician Decision|10|||
149744948|NCT04246047|540197933|FG000|Overall Study|Withdrawal by Subject|19|||
149744949|NCT04246047|540197934|FG001|Overall Study|Withdrawal by Subject|26|||
149744950|NCT04246047|540197933|FG000|Overall Study|Ongoing|169|||
149744951|NCT04246047|540197934|FG001|Overall Study|Ongoing|135|||
149744952|NCT02502864|540197937|FG000|Overall Study|Withdrawal by Subject|1|||
149744953|NCT01824602|540197947|FG000|Overall Study|Withdrawal by Subject|0|||
149744954|NCT01824602|540197948|FG001|Overall Study|Withdrawal by Subject|0|||
149744955|NCT01824602|540197949|FG002|Overall Study|Withdrawal by Subject|1|||
149744956|NCT01824602|540197950|FG003|Overall Study|Withdrawal by Subject|2|||
149744957|NCT01824602|540197947|FG000|Overall Study|Patient non-compliance|0|||
149744958|NCT01824602|540197948|FG001|Overall Study|Patient non-compliance|0|||
149744959|NCT01824602|540197949|FG002|Overall Study|Patient non-compliance|1|||
150256375|NCT04738292|542072750|FG000|Overall Study|Death|1|||
149744960|NCT01824602|540197950|FG003|Overall Study|Patient non-compliance|0|||
149744961|NCT01824602|540197947|FG000|Overall Study|Adverse Event|1|||
149744962|NCT01824602|540197948|FG001|Overall Study|Adverse Event|0|||
149744963|NCT01824602|540197949|FG002|Overall Study|Adverse Event|2|||
149744964|NCT01824602|540197950|FG003|Overall Study|Adverse Event|2|||
149744965|NCT01824602|540197947|FG000|Overall Study|Treatment failure|0|||
149744966|NCT01824602|540197948|FG001|Overall Study|Treatment failure|0|||
149744967|NCT01824602|540197949|FG002|Overall Study|Treatment failure|0|||
149744968|NCT01824602|540197950|FG003|Overall Study|Treatment failure|1|||
149744969|NCT00184054|540197951|FG000|Overall Study|Adverse Event|1|||
149744970|NCT02485717|540197954|FG000|Overall Study|Lost to Follow-up|6|||
149744971|NCT02485717|540197955|FG001|Overall Study|Lost to Follow-up|0|||
149744972|NCT02485717|540197956|FG002|Overall Study|Lost to Follow-up|0|||
149744973|NCT02485717|540197954|FG000|Overall Study|Withdrawal by Subject|0|||
149744974|NCT02485717|540197955|FG001|Overall Study|Withdrawal by Subject|0|||
149744975|NCT02485717|540197956|FG002|Overall Study|Withdrawal by Subject|1|||
149744976|NCT02485717|540197954|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
149744977|NCT02485717|540197955|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
149744978|NCT02485717|540197956|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
149744979|NCT02485717|540197954|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
149744980|NCT02485717|540197955|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
149744981|NCT02485717|540197956|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
149744982|NCT00104871|540197957|FG000|Overall Study|Not evaluable|1|||
149744983|NCT02192359|540197958|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149744984|NCT02192359|540197959|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149744985|NCT02192359|540197960|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
149744986|NCT02192359|540197961|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149744987|NCT02192359|540197958|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
149744988|NCT02192359|540197959|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149744989|NCT02192359|540197960|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149744990|NCT02192359|540197961|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149744991|NCT02192359|540197958|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149744992|NCT02192359|540197959|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149744993|NCT02192359|540197960|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149744994|NCT02192359|540197961|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
149744995|NCT00457639|540197965|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
149744996|NCT00457639|540197966|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
149744997|NCT00457639|540197965|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
149744998|NCT00457639|540197966|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
149744999|NCT00457639|540197965|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
149745000|NCT00457639|540197966|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
149745001|NCT02117687|540197969|FG000|Overall Study|Lost to Follow-up|0|||
149745002|NCT02117687|540197970|FG001|Overall Study|Lost to Follow-up|1|||
149745003|NCT02117687|540197969|FG000|Overall Study|Adverse Event|0|||
149745004|NCT02117687|540197970|FG001|Overall Study|Adverse Event|2|||
149745005|NCT02117687|540197969|FG000|Overall Study|Other Reasons|1|||
149745006|NCT02117687|540197970|FG001|Overall Study|Other Reasons|1|||
149745007|NCT00002850|540197971|FG000|Overall Study|Death|4|||
149745008|NCT00002850|540197972|FG001|Overall Study|Death|1|||
149745009|NCT00002850|540197973|FG002|Overall Study|Death|3|||
149745010|NCT00002850|540197971|FG000|Overall Study|Protocol Violation|1|||
149745011|NCT00002850|540197972|FG001|Overall Study|Protocol Violation|0|||
149745012|NCT00002850|540197973|FG002|Overall Study|Protocol Violation|1|||
149745013|NCT00002850|540197971|FG000|Overall Study|Withdrawal by Subject|0|||
149745014|NCT00002850|540197972|FG001|Overall Study|Withdrawal by Subject|1|||
149745015|NCT00002850|540197973|FG002|Overall Study|Withdrawal by Subject|0|||
149745016|NCT01450540|540197974|FG000|Overall Study|Withdrawal by Subject|19|||
149745017|NCT01450540|540197975|FG001|Overall Study|Withdrawal by Subject|13|||
149745018|NCT01450540|540197974|FG000|Overall Study|protocol deviation|3|||
149745019|NCT01450540|540197975|FG001|Overall Study|protocol deviation|23|||
149745020|NCT01687673|540197987|FG000|Overall Study|Physician Decision|1|||
149745021|NCT02234622|540197988|FG000|Overall Study|Withdrawal by Subject|16|||
149745022|NCT02234622|540197989|FG001|Overall Study|Withdrawal by Subject|22|||
149745023|NCT02234622|540197988|FG000|Overall Study|Lost to Follow-up|27|||
149745024|NCT02234622|540197989|FG001|Overall Study|Lost to Follow-up|14|||
149745025|NCT00618956|540197990|FG000|Overall Study|Adverse Event|10|||
149745026|NCT00618956|540197991|FG001|Overall Study|Adverse Event|34|||
149745027|NCT00618956|540197990|FG000|Overall Study|Lack of Efficacy|2|||
149745028|NCT00618956|540197991|FG001|Overall Study|Lack of Efficacy|1|||
149745029|NCT00618956|540197990|FG000|Overall Study|Withdrawal by Subject|5|||
149745030|NCT00618956|540197991|FG001|Overall Study|Withdrawal by Subject|7|||
149745031|NCT00618956|540197990|FG000|Overall Study|Lost to Follow-up|4|||
149745032|NCT00618956|540197991|FG001|Overall Study|Lost to Follow-up|5|||
149745033|NCT00618956|540197990|FG000|Overall Study|Protocol Violation|2|||
149745034|NCT00618956|540197991|FG001|Overall Study|Protocol Violation|2|||
149745035|NCT00618956|540197990|FG000|Overall Study|did not meet criteria, non-compliance|2|||
149745036|NCT00618956|540197991|FG001|Overall Study|did not meet criteria, non-compliance|1|||
149745037|NCT03598777|540197992|FG000|Overall Study|Study Terminated by Sponsor|3|||
149745038|NCT03598777|540197993|FG001|Overall Study|Study Terminated by Sponsor|0|||
149745039|NCT03598777|540197994|FG002|Overall Study|Study Terminated by Sponsor|0|||
149745040|NCT03598777|540197995|FG003|Overall Study|Study Terminated by Sponsor|0|||
149745041|NCT03598777|540197996|FG004|Overall Study|Study Terminated by Sponsor|15|||
149745042|NCT03598777|540197992|FG000|Overall Study|Withdrawal by Subject|1|||
149745043|NCT03598777|540197993|FG001|Overall Study|Withdrawal by Subject|1|||
149745044|NCT03598777|540197994|FG002|Overall Study|Withdrawal by Subject|0|||
149745045|NCT03598777|540197995|FG003|Overall Study|Withdrawal by Subject|0|||
149745046|NCT03598777|540197996|FG004|Overall Study|Withdrawal by Subject|0|||
149745047|NCT03598777|540197992|FG000|Overall Study|Adverse Event|1|||
149745048|NCT03598777|540197993|FG001|Overall Study|Adverse Event|0|||
149745049|NCT03598777|540197994|FG002|Overall Study|Adverse Event|0|||
149745050|NCT03598777|540197995|FG003|Overall Study|Adverse Event|0|||
149745051|NCT03598777|540197996|FG004|Overall Study|Adverse Event|0|||
149745052|NCT03598777|540197992|FG000|Overall Study|Lost to Follow-up|1|||
149745053|NCT03598777|540197993|FG001|Overall Study|Lost to Follow-up|0|||
149745054|NCT03598777|540197994|FG002|Overall Study|Lost to Follow-up|0|||
149745055|NCT03598777|540197995|FG003|Overall Study|Lost to Follow-up|0|||
149745056|NCT03598777|540197996|FG004|Overall Study|Lost to Follow-up|0|||
149745057|NCT02006576|540197997|FG000|Overall Study|Withdrawal by Subject|4|||
149745058|NCT02006576|540197998|FG001|Overall Study|Withdrawal by Subject|6|||
149745059|NCT02006576|540197999|FG002|Overall Study|Withdrawal by Subject|2|||
149745060|NCT02006576|540197997|FG000|Overall Study|Death|0|||
149745061|NCT02006576|540197998|FG001|Overall Study|Death|0|||
149745062|NCT02006576|540197999|FG002|Overall Study|Death|1|||
149745063|NCT02006576|540197997|FG000|Overall Study|Lost to Follow-up|1|||
149745064|NCT02006576|540197998|FG001|Overall Study|Lost to Follow-up|0|||
149745065|NCT02006576|540197999|FG002|Overall Study|Lost to Follow-up|1|||
149745066|NCT02006576|540197997|FG000|Overall Study|Screen Failure, too sick, other|13|||
149745067|NCT02006576|540197998|FG001|Overall Study|Screen Failure, too sick, other|1|||
149745068|NCT02006576|540197999|FG002|Overall Study|Screen Failure, too sick, other|13|||
149745069|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
149745070|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
149745071|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
149745072|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
149745073|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
149745074|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149745075|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149745076|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149745077|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149745078|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
149745079|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149745080|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149745081|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149745082|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
149745083|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149745084|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
149745085|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
149745086|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
149745087|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
149745088|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
149745089|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
149745090|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
149745091|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
149745092|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
149745093|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
149745094|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
149745095|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149745096|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149745097|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
149745098|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149745099|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149745100|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
149745101|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149745102|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149745103|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
149745104|NCT00785577|540198000|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
149745105|NCT00785577|540198001|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
149745106|NCT00785577|540198002|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
150256376|NCT02971761|542072751|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
149745107|NCT00785577|540198003|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
149745108|NCT00785577|540198004|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
149745109|NCT00785577|540198000|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149745110|NCT00785577|540198001|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
150256377|NCT02442336|542072752|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
149745111|NCT00785577|540198002|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149745112|NCT00785577|540198003|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
149745113|NCT00785577|540198004|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149745114|NCT00785577|540198000|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
149745115|NCT00785577|540198001|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
149745116|NCT00785577|540198002|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
149745117|NCT00785577|540198003|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
149745118|NCT00785577|540198004|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
149745119|NCT02452359|540198007|FG000|Overall Study|Adverse Event|1|||
149745120|NCT02452359|540198007|FG000|Overall Study|Lost to Follow-up|15|||
149745121|NCT02452359|540198007|FG000|Overall Study|Pregnancy|1|||
149745122|NCT02452359|540198007|FG000|Overall Study|Withdrawal by Subject|4|||
149745123|NCT01887210|540198008|FG000|Overall Study|Withdrawal by Subject|1|||
149745124|NCT01887210|540198009|FG001|Overall Study|Withdrawal by Subject|3|||
149745125|NCT01887210|540198008|FG000|Overall Study|Lost to Follow-up|0|||
149745126|NCT01887210|540198009|FG001|Overall Study|Lost to Follow-up|1|||
149745127|NCT02515669|540198014|FG000|228 Week Open-Label Phase|Other|0|||
149745128|NCT02515669|540198015|FG001|228 Week Open-Label Phase|Other|0|||
149745129|NCT02515669|540198016|FG002|228 Week Open-Label Phase|Other|1|||
149745130|NCT02515669|540198017|FG003|228 Week Open-Label Phase|Other|4|||
149745131|NCT02515669|540198014|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
149745132|NCT02515669|540198015|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
149745133|NCT02515669|540198016|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
149745134|NCT02515669|540198017|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
149745135|NCT02515669|540198014|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
149745136|NCT02515669|540198015|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
149745137|NCT02515669|540198016|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
149745138|NCT02515669|540198017|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
149745139|NCT02515669|540198014|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
149745140|NCT02515669|540198015|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
149745141|NCT02515669|540198016|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
149745142|NCT02515669|540198017|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
149745143|NCT02515669|540198014|FG000|228 Week Open-Label Phase|Missing|0|||
149745144|NCT02515669|540198015|FG001|228 Week Open-Label Phase|Missing|2|||
149745145|NCT02515669|540198016|FG002|228 Week Open-Label Phase|Missing|2|||
149745146|NCT02515669|540198017|FG003|228 Week Open-Label Phase|Missing|2|||
149745147|NCT01901328|540198023|FG000|Overall Study|Lost to Follow-up|1|||
149745148|NCT01901328|540198024|FG001|Overall Study|Lost to Follow-up|0|||
149745149|NCT01901328|540198023|FG000|Overall Study|Physician Decision|0|||
149745150|NCT01901328|540198024|FG001|Overall Study|Physician Decision|1|||
149745151|NCT01901328|540198023|FG000|Overall Study|Protocol Violation|1|||
149745152|NCT01901328|540198024|FG001|Overall Study|Protocol Violation|1|||
149745153|NCT01901328|540198023|FG000|Overall Study|Study Terminated by Sponsor|19|||
149745154|NCT01901328|540198024|FG001|Overall Study|Study Terminated by Sponsor|16|||
149745155|NCT01901328|540198023|FG000|Overall Study|Withdrawal by Subject|1|||
149745156|NCT01901328|540198024|FG001|Overall Study|Withdrawal by Subject|2|||
149745157|NCT01901328|540198023|FG000|Overall Study|Lack of Efficacy|0|||
149745158|NCT01901328|540198024|FG001|Overall Study|Lack of Efficacy|1|||
149745159|NCT03439345|540199999|FG000|Overall Study|Lost to Follow-up|0|||
149745160|NCT03439345|540200000|FG001|Overall Study|Lost to Follow-up|1|||
149745161|NCT03439345|540199999|FG000|Overall Study|Consent withdrawn|0|||
149745162|NCT03439345|540200000|FG001|Overall Study|Consent withdrawn|1|||
149745163|NCT01826214|540200006|FG000|Overall Study|Adverse Event|7|||
149745164|NCT01826214|540200007|FG001|Overall Study|Adverse Event|6|||
149745165|NCT01826214|540200006|FG000|Overall Study|Death|3|||
149745166|NCT01826214|540200007|FG001|Overall Study|Death|1|||
149745167|NCT01826214|540200006|FG000|Overall Study|Lost to Follow-up|1|||
149745168|NCT01826214|540200007|FG001|Overall Study|Lost to Follow-up|0|||
149745169|NCT01826214|540200006|FG000|Overall Study|Physician Decision|0|||
149745170|NCT01826214|540200007|FG001|Overall Study|Physician Decision|2|||
149745171|NCT01826214|540200006|FG000|Overall Study|Progressive disease|22|||
149745172|NCT01826214|540200007|FG001|Overall Study|Progressive disease|21|||
149745173|NCT01826214|540200006|FG000|Overall Study|Study terminated by Sponsor|0|||
149745174|NCT01826214|540200007|FG001|Overall Study|Study terminated by Sponsor|1|||
149745175|NCT01826214|540200006|FG000|Overall Study|Subject/guardian decision|2|||
149745176|NCT01826214|540200007|FG001|Overall Study|Subject/guardian decision|3|||
149745177|NCT06400238|540200008|FG000|Overall Study|Started Protocol Therapy|2|||
149745178|NCT06400238|540200008|FG000|Overall Study|Adverse Event|1|||
149745179|NCT06400238|540200008|FG000|Overall Study|Death|1|||
149745180|NCT06400238|540200008|FG000|Overall Study|Disease Progression|27|||
149745181|NCT06400238|540200008|FG000|Overall Study|Withdrawal by Subject|2|||
149745182|NCT06400238|540200008|FG000|Overall Study|Physician Decision|2|||
149745183|NCT01981187|540200011|FG000|Overall Study|Participant/guardian decision|2|||
149745184|NCT01981187|540200011|FG000|Overall Study|Physician Decision|1|||
149745185|NCT01981187|540200011|FG000|Overall Study|Disease progression|2|||
149745186|NCT01981187|540200011|FG000|Overall Study|Adverse Event|7|||
149745187|NCT03839524|540200014|FG000|Overall Study|Adverse Event|1|||
149745188|NCT04329949|540200016|FG000|Overall Study|Death|36|||
149745189|NCT04329949|540200016|FG000|Overall Study|Withdrawal by Subject|4|||
149745190|NCT04329949|540200016|FG000|Overall Study|Termination of study by sponsor|3|||
150256378|NCT02442336|542072752|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
150256379|NCT02442336|542072752|FG000|Overall Study|Lost to Follow-up|11|||
150256380|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
150256381|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
150256382|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
150256383|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
150256384|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
150256385|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
150256386|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
150256387|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
150256388|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
150256389|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
150256390|NCT01237587|542072753|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
150256391|NCT01237587|542072754|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
150256392|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
150256393|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
150256394|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
150256395|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
150256396|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
150256397|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
150256398|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
150256399|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
150256400|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
150256401|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
150256402|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
150256403|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
150256404|NCT01237587|542072753|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
150256405|NCT01237587|542072754|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
150256406|NCT01237587|542072753|FG000|Taper Phase|Adverse Event|0|||
150256407|NCT01237587|542072754|FG001|Taper Phase|Adverse Event|2|||
150256408|NCT01237587|542072753|FG000|Taper Phase|Protocol Violation|2|||
150256409|NCT01237587|542072754|FG001|Taper Phase|Protocol Violation|0|||
150256410|NCT01237587|542072753|FG000|Taper Phase|Lack of Efficacy|2|||
150256411|NCT01237587|542072754|FG001|Taper Phase|Lack of Efficacy|5|||
150256412|NCT01237587|542072753|FG000|Taper Phase|Parent/Guardian Decision|0|||
150256413|NCT01237587|542072754|FG001|Taper Phase|Parent/Guardian Decision|2|||
150256414|NCT01237587|542072753|FG000|Taper Phase|Sponsor Decision|1|||
150256415|NCT01237587|542072754|FG001|Taper Phase|Sponsor Decision|0|||
150256416|NCT01237587|542072753|FG000|Taper Phase|Withdrawal by Subject|0|||
150256417|NCT01237587|542072754|FG001|Taper Phase|Withdrawal by Subject|1|||
150256418|NCT01142115|542072755|FG000|First Intervention|Lack of Efficacy|1|||
150256419|NCT01142115|542072756|FG001|First Intervention|Lack of Efficacy|1|||
150256420|NCT01142115|542072755|FG000|First Intervention|Adverse Event|1|||
150256421|NCT01142115|542072756|FG001|First Intervention|Adverse Event|0|||
150256422|NCT03208036|542072757|FG000|Baseline Assessment|Withdrawal by Subject|1|||
150256423|NCT03208036|542072758|FG001|Baseline Assessment|Withdrawal by Subject|1|||
150256424|NCT03208036|542072757|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
150256425|NCT03208036|542072758|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
150256426|NCT03208036|542072757|FG000|Intervention|Withdrawal by Subject|3|||
150256427|NCT03208036|542072758|FG001|Intervention|Withdrawal by Subject|2|||
150256428|NCT03208036|542072757|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
150256429|NCT03208036|542072758|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
150256430|NCT01879553|542072760|FG000|Overall Study|Withdrawal by Subject|1|||
150256431|NCT01879553|542072761|FG001|Overall Study|Withdrawal by Subject|0|||
150256432|NCT00320528|542072762|FG000|Study Period II|Adverse Event|3|||
150256433|NCT00320528|542072763|FG001|Study Period II|Adverse Event|4|||
150256434|NCT00320528|542072764|FG002|Study Period II|Adverse Event|8|||
150256435|NCT00320528|542072762|FG000|Study Period II|Parent/Caregiver Decision|8|||
150256436|NCT00320528|542072763|FG001|Study Period II|Parent/Caregiver Decision|3|||
150256437|NCT00320528|542072764|FG002|Study Period II|Parent/Caregiver Decision|11|||
150256438|NCT00320528|542072762|FG000|Study Period II|Withdrawal by Subject|0|||
150256439|NCT00320528|542072763|FG001|Study Period II|Withdrawal by Subject|1|||
150256440|NCT00320528|542072764|FG002|Study Period II|Withdrawal by Subject|1|||
149745191|NCT02037919|540200017|FG000|Overall Study|Lost to Follow-up|30|||
149745192|NCT02037919|540200018|FG001|Overall Study|Lost to Follow-up|45|||
149745193|NCT00345605|540200023|FG000|Arm 1|Adverse Event|0|||
149745194|NCT00345605|540200024|FG001|Arm 1|Adverse Event|1|||
149745195|NCT00345605|540200023|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
149745196|NCT00345605|540200024|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
149745197|NCT00917384|540200030|FG000|Overall Study|Lost to Follow-up|4|||
149745198|NCT00917384|540200031|FG001|Overall Study|Lost to Follow-up|2|||
149745199|NCT00917384|540200030|FG000|Overall Study|Withdrawal by Subject|10|||
149745200|NCT00917384|540200031|FG001|Overall Study|Withdrawal by Subject|2|||
149745201|NCT01451515|540200034|FG000|Overall Study|Death|0|||
149745202|NCT01451515|540200035|FG001|Overall Study|Death|1|||
149745203|NCT01451515|540200036|FG002|Overall Study|Death|0|||
149745204|NCT01451515|540200034|FG000|Overall Study|Withdrawal by Subject|0|||
149745205|NCT01451515|540200035|FG001|Overall Study|Withdrawal by Subject|1|||
149745206|NCT01451515|540200036|FG002|Overall Study|Withdrawal by Subject|0|||
149745207|NCT01451515|540200034|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
149745208|NCT01451515|540200035|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
149745209|NCT01451515|540200036|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
149745210|NCT01451515|540200034|FG000|Overall Study|Relapse (except CNS)|1|||
149745211|NCT01451515|540200035|FG001|Overall Study|Relapse (except CNS)|1|||
149745212|NCT01451515|540200036|FG002|Overall Study|Relapse (except CNS)|0|||
149745213|NCT03717922|540200037|FG000|Overall Study|Lost to Follow-up|2|||
149745214|NCT03717922|540200038|FG001|Overall Study|Lost to Follow-up|2|||
149745215|NCT01458340|540200039|FG000|Overall Study|Adverse Event|5|||
149745216|NCT01458340|540200040|FG001|Overall Study|Adverse Event|4|||
149745217|NCT01458340|540200041|FG002|Overall Study|Adverse Event|2|||
149745218|NCT01458340|540200039|FG000|Overall Study|Lost to Follow-up|3|||
149745219|NCT01458340|540200040|FG001|Overall Study|Lost to Follow-up|3|||
149745220|NCT01458340|540200041|FG002|Overall Study|Lost to Follow-up|10|||
149745221|NCT01458340|540200039|FG000|Overall Study|Miscellaneous|0|||
149745222|NCT01458340|540200040|FG001|Overall Study|Miscellaneous|1|||
149745223|NCT01458340|540200041|FG002|Overall Study|Miscellaneous|0|||
149745224|NCT01458340|540200039|FG000|Overall Study|Physician Decision|1|||
149745225|NCT01458340|540200040|FG001|Overall Study|Physician Decision|1|||
149745226|NCT01458340|540200041|FG002|Overall Study|Physician Decision|2|||
149745227|NCT01458340|540200039|FG000|Overall Study|Protocol Violation|6|||
149745228|NCT01458340|540200040|FG001|Overall Study|Protocol Violation|6|||
149745229|NCT01458340|540200041|FG002|Overall Study|Protocol Violation|5|||
149745230|NCT01458340|540200039|FG000|Overall Study|Withdrawal by Subject|12|||
149745231|NCT01458340|540200040|FG001|Overall Study|Withdrawal by Subject|6|||
149745232|NCT01458340|540200041|FG002|Overall Study|Withdrawal by Subject|4|||
149745233|NCT01702805|540200043|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
149745234|NCT01702805|540200044|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
149745235|NCT01702805|540200043|FG000|Overall Study|Incomplete Follow-up|18|||
149745236|NCT01702805|540200044|FG001|Overall Study|Incomplete Follow-up|15|||
149745237|NCT01702805|540200043|FG000|Overall Study|Vital Status Assessment Only|40|||
149745238|NCT01702805|540200044|FG001|Overall Study|Vital Status Assessment Only|39|||
149745239|NCT01702805|540200043|FG000|Overall Study|Lost to Follow-up|5|||
149745240|NCT01702805|540200044|FG001|Overall Study|Lost to Follow-up|5|||
149745241|NCT01238120|540200045|FG000|Overall Study|Withdrawal by Subject|4|||
149745242|NCT01238120|540200046|FG001|Overall Study|Withdrawal by Subject|1|||
149745243|NCT01238120|540200047|FG002|Overall Study|Withdrawal by Subject|2|||
149745244|NCT01238120|540200048|FG003|Overall Study|Withdrawal by Subject|5|||
149745245|NCT01238120|540200045|FG000|Overall Study|Lost to Follow-up|2|||
149745246|NCT01238120|540200046|FG001|Overall Study|Lost to Follow-up|0|||
149745247|NCT01238120|540200047|FG002|Overall Study|Lost to Follow-up|1|||
149745248|NCT01238120|540200048|FG003|Overall Study|Lost to Follow-up|1|||
149745249|NCT01238120|540200045|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
149745250|NCT01238120|540200046|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
149745251|NCT01238120|540200047|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
149745252|NCT01238120|540200048|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
149745253|NCT00693706|540200053|FG000|Overall Study|Protocol Violation|0|||
149745254|NCT00693706|540200054|FG001|Overall Study|Protocol Violation|1|||
149745255|NCT04786210|540200057|FG000|Overall Study|Lost to Follow-up|2|||
149745256|NCT04786210|540200057|FG000|Overall Study|Withdrawal by Subject|4|||
149745257|NCT04334148|540200058|FG000|Overall Study|positive nasal swab at baseline|0|||
150256441|NCT00320528|542072762|FG000|Study Period II|Entry Criteria Exclusion|0|||
150256442|NCT00320528|542072763|FG001|Study Period II|Entry Criteria Exclusion|2|||
150256443|NCT00320528|542072764|FG002|Study Period II|Entry Criteria Exclusion|2|||
150256444|NCT00320528|542072762|FG000|Study Period III|Adverse Event|1|||
149745258|NCT04334148|540200059|FG001|Overall Study|positive nasal swab at baseline|1|||
149745259|NCT00498173|540200060|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
149745260|NCT00498173|540200061|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
149745261|NCT00498173|540200062|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
149745262|NCT00258154|540200063|FG000|Overall Study|Adverse Event|1|||
149745263|NCT00258154|540200064|FG001|Overall Study|Adverse Event|0|||
150256445|NCT00320528|542072763|FG001|Study Period III|Adverse Event|0|||
149745264|NCT00258154|540200063|FG000|Overall Study|Lost to Follow-up|0|||
149745265|NCT00258154|540200064|FG001|Overall Study|Lost to Follow-up|1|||
149745266|NCT00258154|540200063|FG000|Overall Study|Protocol Violation|2|||
149745267|NCT00258154|540200064|FG001|Overall Study|Protocol Violation|1|||
149745268|NCT00258154|540200063|FG000|Overall Study|Withdrawal by Subject|3|||
149745269|NCT00258154|540200064|FG001|Overall Study|Withdrawal by Subject|4|||
149745270|NCT00258154|540200063|FG000|Overall Study|Patient Moved|3|||
149745271|NCT00258154|540200064|FG001|Overall Study|Patient Moved|1|||
149745272|NCT03772327|540200068|FG000|Overall Study|Lost to Follow-up|3|||
149745273|NCT03772327|540200069|FG001|Overall Study|Lost to Follow-up|4|||
149745274|NCT03772327|540200068|FG000|Overall Study|Withdrawal by Subject|2|||
149745275|NCT03772327|540200069|FG001|Overall Study|Withdrawal by Subject|3|||
149745276|NCT04689828|540200070|FG000|Overall Study|Subject decision|5|||
149745277|NCT04689828|540200071|FG001|Overall Study|Subject decision|5|||
149745278|NCT04689828|540200070|FG000|Overall Study|Adverse Event|12|||
149745279|NCT04689828|540200071|FG001|Overall Study|Adverse Event|12|||
149745280|NCT04689828|540200070|FG000|Overall Study|Physician Decision|24|||
149745281|NCT04689828|540200071|FG001|Overall Study|Physician Decision|32|||
149745282|NCT04689828|540200070|FG000|Overall Study|Progressive disease|54|||
149745283|NCT04689828|540200071|FG001|Overall Study|Progressive disease|173|||
149745284|NCT04689828|540200070|FG000|Overall Study|Death|0|||
149745285|NCT04689828|540200071|FG001|Overall Study|Death|1|||
149745286|NCT04689828|540200070|FG000|Overall Study|Lost to Follow-up|1|||
149745287|NCT04689828|540200071|FG001|Overall Study|Lost to Follow-up|0|||
149745288|NCT04689828|540200070|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
149745289|NCT04689828|540200071|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
149745290|NCT04689828|540200070|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
149745291|NCT04689828|540200071|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
149745292|NCT04689828|540200070|FG000|Overall Study|Participants not treated|7|||
149745293|NCT04689828|540200071|FG001|Overall Study|Participants not treated|2|||
149745294|NCT00195351|540200085|FG000|Overall Study|Lost to Follow-up|9|||
149745295|NCT00195351|540200086|FG001|Overall Study|Lost to Follow-up|9|||
149745296|NCT00195351|540200085|FG000|Overall Study|Withdrawal by Subject|6|||
149745297|NCT00195351|540200086|FG001|Overall Study|Withdrawal by Subject|3|||
149745298|NCT00195351|540200085|FG000|Overall Study|Protocol Deviation|3|||
149745299|NCT00195351|540200086|FG001|Overall Study|Protocol Deviation|2|||
149745300|NCT00195351|540200085|FG000|Overall Study|Death|3|||
149745301|NCT00195351|540200086|FG001|Overall Study|Death|1|||
149745302|NCT00195351|540200085|FG000|Overall Study|Lack of Efficacy|0|||
149745303|NCT00195351|540200086|FG001|Overall Study|Lack of Efficacy|1|||
149745304|NCT02111369|540200087|FG000|Overall Study|Lost to Follow-up|2|||
149745305|NCT02111369|540200087|FG000|Overall Study|Withdrawal by Subject|1|||
149745306|NCT02493751|540200093|FG000|Overall Study|Withdrawal by Subject|2|||
149745307|NCT02493751|540200094|FG001|Overall Study|Withdrawal by Subject|8|||
149745308|NCT02493751|540200093|FG000|Overall Study|Death|6|||
149745309|NCT02493751|540200094|FG001|Overall Study|Death|13|||
149745310|NCT02493751|540200093|FG000|Overall Study|Lost to Follow-up|2|||
149745311|NCT02493751|540200094|FG001|Overall Study|Lost to Follow-up|3|||
149745312|NCT02493751|540200093|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
149745313|NCT02493751|540200094|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
149745314|NCT01480180|540200095|FG000|Main Phase|Withdrawal criteria|12|||
149745315|NCT01480180|540200096|FG001|Main Phase|Withdrawal criteria|1|||
149745316|NCT01480180|540200097|FG002|Main Phase|Withdrawal criteria|0|||
149745317|NCT01480180|540200098|FG003|Main Phase|Withdrawal criteria|0|||
149745318|NCT01480180|540200099|FG004|Main Phase|Withdrawal criteria|0|||
149745319|NCT01480180|540200100|FG005|Main Phase|Withdrawal criteria|0|||
149745320|NCT01480180|540200095|FG000|Main Phase|Lack of Efficacy|1|||
149745321|NCT01480180|540200096|FG001|Main Phase|Lack of Efficacy|0|||
149745322|NCT01480180|540200097|FG002|Main Phase|Lack of Efficacy|0|||
149745323|NCT01480180|540200098|FG003|Main Phase|Lack of Efficacy|0|||
149745324|NCT01480180|540200099|FG004|Main Phase|Lack of Efficacy|0|||
149745325|NCT01480180|540200100|FG005|Main Phase|Lack of Efficacy|0|||
150256446|NCT00320528|542072764|FG002|Study Period III|Adverse Event|0|||
149745326|NCT01480180|540200095|FG000|Main Phase|Non-compliance|3|||
150256447|NCT00320528|542072762|FG000|Study Period III|Lost to Follow-up|1|||
149745327|NCT01480180|540200096|FG001|Main Phase|Non-compliance|0|||
149745328|NCT01480180|540200097|FG002|Main Phase|Non-compliance|0|||
149745329|NCT01480180|540200098|FG003|Main Phase|Non-compliance|0|||
149745330|NCT01480180|540200099|FG004|Main Phase|Non-compliance|0|||
149745331|NCT01480180|540200100|FG005|Main Phase|Non-compliance|0|||
149745332|NCT01480180|540200095|FG000|Main Phase|Unclassified|3|||
149745333|NCT01480180|540200096|FG001|Main Phase|Unclassified|0|||
149745334|NCT01480180|540200097|FG002|Main Phase|Unclassified|0|||
149745335|NCT01480180|540200098|FG003|Main Phase|Unclassified|0|||
149745336|NCT01480180|540200099|FG004|Main Phase|Unclassified|0|||
149745337|NCT01480180|540200100|FG005|Main Phase|Unclassified|0|||
149745338|NCT01480180|540200095|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
149745339|NCT01480180|540200096|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
149745340|NCT01480180|540200097|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
149745341|NCT01480180|540200098|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
149745342|NCT01480180|540200099|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
149745343|NCT01480180|540200100|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
149745344|NCT01480180|540200095|FG000|Extension Phase, Part 1|Unclassified|0|||
149745345|NCT01480180|540200096|FG001|Extension Phase, Part 1|Unclassified|0|||
149745346|NCT01480180|540200097|FG002|Extension Phase, Part 1|Unclassified|1|||
149745347|NCT01480180|540200098|FG003|Extension Phase, Part 1|Unclassified|0|||
149745348|NCT01480180|540200099|FG004|Extension Phase, Part 1|Unclassified|0|||
149745349|NCT01480180|540200100|FG005|Extension Phase, Part 1|Unclassified|0|||
149745350|NCT01480180|540200095|FG000|Extension Phase, Part 1|Adverse Event|0|||
149745351|NCT01480180|540200096|FG001|Extension Phase, Part 1|Adverse Event|0|||
149745352|NCT01480180|540200097|FG002|Extension Phase, Part 1|Adverse Event|4|||
149745353|NCT01480180|540200098|FG003|Extension Phase, Part 1|Adverse Event|1|||
149745354|NCT01480180|540200099|FG004|Extension Phase, Part 1|Adverse Event|0|||
149745355|NCT01480180|540200100|FG005|Extension Phase, Part 1|Adverse Event|0|||
149745356|NCT01480180|540200095|FG000|Extension Phase, Part 1|Change of treatment|0|||
149745357|NCT01480180|540200096|FG001|Extension Phase, Part 1|Change of treatment|0|||
149745358|NCT01480180|540200097|FG002|Extension Phase, Part 1|Change of treatment|0|||
149745359|NCT01480180|540200098|FG003|Extension Phase, Part 1|Change of treatment|9|||
149745360|NCT01480180|540200099|FG004|Extension Phase, Part 1|Change of treatment|0|||
149745361|NCT01480180|540200100|FG005|Extension Phase, Part 1|Change of treatment|0|||
149745362|NCT01480180|540200095|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
149745363|NCT01480180|540200096|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
149745364|NCT01480180|540200097|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
149745365|NCT01480180|540200098|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
149745366|NCT01480180|540200099|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
149745367|NCT01480180|540200100|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
149745368|NCT01480180|540200095|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
149745369|NCT01480180|540200096|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
149745370|NCT01480180|540200097|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
149745371|NCT01480180|540200098|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
149745372|NCT01480180|540200099|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
149745373|NCT01480180|540200100|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
149745374|NCT01480180|540200095|FG000|Extension Phase, Part 2|Unclassified|0|||
149745375|NCT01480180|540200096|FG001|Extension Phase, Part 2|Unclassified|0|||
149745376|NCT01480180|540200097|FG002|Extension Phase, Part 2|Unclassified|3|||
149745377|NCT01480180|540200098|FG003|Extension Phase, Part 2|Unclassified|1|||
149745378|NCT01480180|540200099|FG004|Extension Phase, Part 2|Unclassified|1|||
149745379|NCT01480180|540200100|FG005|Extension Phase, Part 2|Unclassified|0|||
149745380|NCT00828451|540200107|FG000|Overall Study|Death|2|||
149745381|NCT00828451|540200107|FG000|Overall Study|Lack of intravenous line|7|||
149745382|NCT00828451|540200107|FG000|Overall Study|Withdrawal by Subject|1|||
149745383|NCT00828451|540200107|FG000|Overall Study|Deterioration in clinical status|1|||
149745384|NCT02827877|540200108|FG000|Overall Study|Withdrawal by Subject|1|||
149745385|NCT01650805|540200111|FG000|Overall Study|Withdrawal by Subject|1|||
149745386|NCT01650805|540200112|FG001|Overall Study|Withdrawal by Subject|0|||
149745387|NCT00840463|540200118|FG000|Overall Study|Adverse Event|1|||
149745388|NCT00840463|540200119|FG001|Overall Study|Adverse Event|0|||
149745389|NCT03414359|540200120|FG000|Overall Study|Lack of Efficacy|1|||
149745390|NCT03414359|540200121|FG001|Overall Study|Lack of Efficacy|1|||
149745391|NCT03414359|540200120|FG000|Overall Study|Protocol Violation|0|||
149745392|NCT03414359|540200121|FG001|Overall Study|Protocol Violation|1|||
149745393|NCT03750838|540200126|FG000|Overall Study|Lost to Follow-up|10|||
149745394|NCT03750838|540200127|FG001|Overall Study|Lost to Follow-up|6|||
149745395|NCT02332915|540200128|FG000|Overall Study|Moved out of region|3|||
149745396|NCT02332915|540200129|FG001|Overall Study|Moved out of region|0|||
149745397|NCT02332915|540200128|FG000|Overall Study|Unrelated illness|1|||
149745398|NCT02332915|540200129|FG001|Overall Study|Unrelated illness|1|||
149745399|NCT02332915|540200128|FG000|Overall Study|Travel distance prohibitive|0|||
149745400|NCT02332915|540200129|FG001|Overall Study|Travel distance prohibitive|1|||
149745401|NCT02332915|540200128|FG000|Overall Study|did not meet inclusion criteria|2|||
149745402|NCT02332915|540200129|FG001|Overall Study|did not meet inclusion criteria|4|||
149745403|NCT02462889|540200130|FG000|Overall Study|Withdrawal by Subject|2|||
149745404|NCT02462889|540200131|FG001|Overall Study|Withdrawal by Subject|6|||
150256448|NCT00320528|542072763|FG001|Study Period III|Lost to Follow-up|0|||
150256449|NCT00320528|542072764|FG002|Study Period III|Lost to Follow-up|0|||
149745405|NCT02462889|540200130|FG000|Overall Study|Death|1|||
149745406|NCT02462889|540200131|FG001|Overall Study|Death|5|||
149745407|NCT03497689|540200135|FG000|Overall Study|Adverse Event|2|||
149745408|NCT03497689|540200135|FG000|Overall Study|Death|1|||
149745409|NCT03497689|540200135|FG000|Overall Study|Physician Decision|1|||
149745410|NCT03497689|540200135|FG000|Overall Study|Withdrawal by Subject|1|||
149745411|NCT03497689|540200135|FG000|Overall Study|Protocol Violation|2|||
149745412|NCT02032875|540200136|FG000|Treatment Period|Adverse Event|1|||
149745413|NCT02032875|540200137|FG001|Treatment Period|Adverse Event|0|||
149745414|NCT02032875|540200136|FG000|Treatment Period|Liver transplant, No extension needed|0|||
149745415|NCT02032875|540200137|FG001|Treatment Period|Liver transplant, No extension needed|1|||
149745416|NCT02032875|540200136|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
149745417|NCT02032875|540200137|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
149745418|NCT02032875|540200136|FG000|Follow-up Period|Death|0|||
149745419|NCT02032875|540200137|FG001|Follow-up Period|Death|1|||
149745420|NCT02032875|540200136|FG000|Follow-up Period|Virologic Relapse|3|||
149745421|NCT02032875|540200137|FG001|Follow-up Period|Virologic Relapse|10|||
149745422|NCT04636177|540200142|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
149745423|NCT04636177|540200143|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
149745424|NCT04636177|540200142|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
149745425|NCT04636177|540200143|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
149745426|NCT04636177|540200142|FG000|Single-arm portion|Withdrawal by Subject|1|||
149745427|NCT04636177|540200143|FG001|Single-arm portion|Withdrawal by Subject|0|||
149745428|NCT04636177|540200142|FG000|Single-arm portion|Adverse Event|1|||
149745429|NCT04636177|540200143|FG001|Single-arm portion|Adverse Event|0|||
149745430|NCT03191786|540200144|FG000|Overall Study|Death|236|||
149745431|NCT03191786|540200145|FG001|Overall Study|Death|127|||
149745432|NCT03191786|540200144|FG000|Overall Study|Lost to Follow-up|9|||
149745433|NCT03191786|540200145|FG001|Overall Study|Lost to Follow-up|3|||
149745434|NCT03191786|540200144|FG000|Overall Study|Physician Decision|1|||
149745435|NCT03191786|540200145|FG001|Overall Study|Physician Decision|0|||
149745436|NCT03191786|540200144|FG000|Overall Study|Moved to Post Trial Access Program|30|||
149745437|NCT03191786|540200145|FG001|Overall Study|Moved to Post Trial Access Program|5|||
149745438|NCT03191786|540200144|FG000|Overall Study|Withdrawal by Subject|26|||
149745439|NCT03191786|540200145|FG001|Overall Study|Withdrawal by Subject|16|||
149745440|NCT05847881|540200146|FG000|Overall Study|Principal Investigator Decision|8|||
149745441|NCT05847881|540200146|FG000|Overall Study|Withdrawal by Subject|2|||
149745442|NCT01348919|540201570|FG000|Overall Study|Adverse Event|3|||
149745443|NCT01348919|540201571|FG001|Overall Study|Adverse Event|1|||
149745444|NCT01348919|540201572|FG002|Overall Study|Adverse Event|0|||
149745445|NCT01348919|540201570|FG000|Overall Study|Withdrawal by Subject|0|||
149745446|NCT01348919|540201571|FG001|Overall Study|Withdrawal by Subject|1|||
149745447|NCT01348919|540201572|FG002|Overall Study|Withdrawal by Subject|0|||
149745448|NCT01348919|540201570|FG000|Overall Study|Disease progression|0|||
149745449|NCT01348919|540201571|FG001|Overall Study|Disease progression|1|||
149745450|NCT01348919|540201572|FG002|Overall Study|Disease progression|1|||
149745451|NCT01943539|540201573|FG000|Overall Study|Non-compliance with at-home intervention|4|||
149745452|NCT01943539|540201574|FG001|Overall Study|Non-compliance with at-home intervention|0|||
149745453|NCT01362322|540201575|FG000|Overall Study|Withdrawal by Subject|3|||
149745454|NCT01362322|540201576|FG001|Overall Study|Withdrawal by Subject|1|||
149745455|NCT01362322|540201575|FG000|Overall Study|Lost to Follow-up|2|||
149745456|NCT01362322|540201576|FG001|Overall Study|Lost to Follow-up|6|||
149745457|NCT03715465|540201581|FG000|Overall Study|Withdrawal by Subject|1|||
149745458|NCT03715465|540201582|FG001|Overall Study|Withdrawal by Subject|2|||
149745459|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
149745460|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
149745461|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
149745462|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
149745463|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
149745464|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
149745465|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
149745466|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
149745467|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
149745468|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
149745469|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
149745470|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
149745471|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
149745472|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
149745473|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
149745474|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
149745475|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
149745476|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
149745477|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Death|0|||
149745478|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Death|1|||
149745479|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Death|0|||
149745480|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
149745481|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
149745482|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
149745483|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
149745484|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
149745485|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
149745486|NCT00430781|540201583|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
149745487|NCT00430781|540201584|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
149745488|NCT00430781|540201585|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
149745489|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
149745490|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
149745491|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
149745492|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
149745493|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
149745494|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
149745495|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
149745496|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
149745497|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
149745498|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
149745499|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
149745500|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
149745501|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Other|0|||
149745502|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Other|1|||
149745503|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Other|0|||
149745504|NCT00430781|540201583|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
149745505|NCT00430781|540201584|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
149745506|NCT00430781|540201585|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
149745507|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
149745508|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
149745509|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
149745510|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
149745511|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
149745512|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
149745513|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
149745514|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
149745515|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
149745516|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
149745517|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
149745518|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
149745519|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
149745520|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
149745521|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
149745522|NCT00430781|540201583|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
149745523|NCT00430781|540201584|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
149745524|NCT00430781|540201585|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
149745525|NCT05408858|540201588|FG000|Overall Study|no longer met eligibility criteria|1|||
149745526|NCT02158533|540201590|FG000|Stage 1|Adverse Event|6|||
149745527|NCT02158533|540201591|FG001|Stage 1|Adverse Event|4|||
149745528|NCT02158533|540201592|FG002|Stage 1|Adverse Event|7|||
149745529|NCT02158533|540201593|FG003|Stage 1|Adverse Event|0|||
149745530|NCT02158533|540201594|FG004|Stage 1|Adverse Event|0|||
149745531|NCT02158533|540201595|FG005|Stage 1|Adverse Event|0|||
149745532|NCT02158533|540201590|FG000|Stage 1|Withdrawal by Subject|3|||
149745533|NCT02158533|540201591|FG001|Stage 1|Withdrawal by Subject|2|||
149745534|NCT02158533|540201592|FG002|Stage 1|Withdrawal by Subject|1|||
149745535|NCT02158533|540201593|FG003|Stage 1|Withdrawal by Subject|0|||
149745536|NCT02158533|540201594|FG004|Stage 1|Withdrawal by Subject|0|||
149745537|NCT02158533|540201595|FG005|Stage 1|Withdrawal by Subject|0|||
149745538|NCT02158533|540201590|FG000|Stage 1|Lack of Efficacy|1|||
149745539|NCT02158533|540201591|FG001|Stage 1|Lack of Efficacy|0|||
149745540|NCT02158533|540201592|FG002|Stage 1|Lack of Efficacy|0|||
149745541|NCT02158533|540201593|FG003|Stage 1|Lack of Efficacy|0|||
149745542|NCT02158533|540201594|FG004|Stage 1|Lack of Efficacy|0|||
149745543|NCT02158533|540201595|FG005|Stage 1|Lack of Efficacy|0|||
149745544|NCT02158533|540201590|FG000|Stage 1|Lost to Follow-up|3|||
149745545|NCT02158533|540201591|FG001|Stage 1|Lost to Follow-up|1|||
149745546|NCT02158533|540201592|FG002|Stage 1|Lost to Follow-up|0|||
149745547|NCT02158533|540201593|FG003|Stage 1|Lost to Follow-up|0|||
149745548|NCT02158533|540201594|FG004|Stage 1|Lost to Follow-up|0|||
149745549|NCT02158533|540201595|FG005|Stage 1|Lost to Follow-up|0|||
149745550|NCT02158533|540201590|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
149745551|NCT02158533|540201591|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
149745552|NCT02158533|540201592|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
149745553|NCT02158533|540201593|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
149745554|NCT02158533|540201594|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
149745555|NCT02158533|540201595|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
149745556|NCT02158533|540201590|FG000|Stage 1|Non-compliance with study visits|1|||
149745557|NCT02158533|540201591|FG001|Stage 1|Non-compliance with study visits|0|||
149745558|NCT02158533|540201592|FG002|Stage 1|Non-compliance with study visits|0|||
149745559|NCT02158533|540201593|FG003|Stage 1|Non-compliance with study visits|0|||
149745560|NCT02158533|540201594|FG004|Stage 1|Non-compliance with study visits|0|||
149745561|NCT02158533|540201595|FG005|Stage 1|Non-compliance with study visits|0|||
149745562|NCT02158533|540201590|FG000|Stage 2|Adverse Event|0|||
149745563|NCT02158533|540201591|FG001|Stage 2|Adverse Event|0|||
149745564|NCT02158533|540201592|FG002|Stage 2|Adverse Event|0|||
149745565|NCT02158533|540201593|FG003|Stage 2|Adverse Event|0|||
149745566|NCT02158533|540201594|FG004|Stage 2|Adverse Event|0|||
149745567|NCT02158533|540201595|FG005|Stage 2|Adverse Event|1|||
149745568|NCT02158533|540201590|FG000|Stage 2|Lack of Efficacy|0|||
149745569|NCT02158533|540201591|FG001|Stage 2|Lack of Efficacy|0|||
149745570|NCT02158533|540201592|FG002|Stage 2|Lack of Efficacy|0|||
149745571|NCT02158533|540201593|FG003|Stage 2|Lack of Efficacy|0|||
149745572|NCT02158533|540201594|FG004|Stage 2|Lack of Efficacy|1|||
150256450|NCT00320528|542072762|FG000|Study Period III|Withdrawal by Subject|1|||
150256451|NCT00320528|542072763|FG001|Study Period III|Withdrawal by Subject|1|||
150256452|NCT00320528|542072764|FG002|Study Period III|Withdrawal by Subject|2|||
150256453|NCT00320528|542072762|FG000|Study Period III|Lack of Efficacy|2|||
149745573|NCT02158533|540201595|FG005|Stage 2|Lack of Efficacy|0|||
149745574|NCT02158533|540201590|FG000|Stage 2|Lost to Follow-up|0|||
149745575|NCT02158533|540201591|FG001|Stage 2|Lost to Follow-up|0|||
149745576|NCT02158533|540201592|FG002|Stage 2|Lost to Follow-up|0|||
149745577|NCT02158533|540201593|FG003|Stage 2|Lost to Follow-up|1|||
149745578|NCT02158533|540201594|FG004|Stage 2|Lost to Follow-up|1|||
149745579|NCT02158533|540201595|FG005|Stage 2|Lost to Follow-up|2|||
149745580|NCT02158533|540201590|FG000|Stage 2|Withdrawal by Subject|0|||
149745581|NCT02158533|540201591|FG001|Stage 2|Withdrawal by Subject|0|||
149745582|NCT02158533|540201592|FG002|Stage 2|Withdrawal by Subject|0|||
149745583|NCT02158533|540201593|FG003|Stage 2|Withdrawal by Subject|0|||
149745584|NCT02158533|540201594|FG004|Stage 2|Withdrawal by Subject|1|||
149745585|NCT02158533|540201595|FG005|Stage 2|Withdrawal by Subject|2|||
149745586|NCT02158533|540201590|FG000|Stage 2|Physician Decision|0|||
149745587|NCT02158533|540201591|FG001|Stage 2|Physician Decision|0|||
149745588|NCT02158533|540201592|FG002|Stage 2|Physician Decision|0|||
149745589|NCT02158533|540201593|FG003|Stage 2|Physician Decision|0|||
149745590|NCT02158533|540201594|FG004|Stage 2|Physician Decision|1|||
149745591|NCT02158533|540201595|FG005|Stage 2|Physician Decision|0|||
149745592|NCT02158533|540201590|FG000|Stage 2|Pregnancy|0|||
149745593|NCT02158533|540201591|FG001|Stage 2|Pregnancy|0|||
149745594|NCT02158533|540201592|FG002|Stage 2|Pregnancy|0|||
149745595|NCT02158533|540201593|FG003|Stage 2|Pregnancy|1|||
149745596|NCT02158533|540201594|FG004|Stage 2|Pregnancy|0|||
149745597|NCT02158533|540201595|FG005|Stage 2|Pregnancy|0|||
149745598|NCT02158533|540201590|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
149745599|NCT02158533|540201591|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
149745600|NCT02158533|540201592|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
149745601|NCT02158533|540201593|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
149745602|NCT02158533|540201594|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
149745603|NCT02158533|540201595|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
149745604|NCT02158533|540201590|FG000|Stage 2|Non-adherence with study visits|0|||
149745605|NCT02158533|540201591|FG001|Stage 2|Non-adherence with study visits|0|||
149745606|NCT02158533|540201592|FG002|Stage 2|Non-adherence with study visits|0|||
149745607|NCT02158533|540201593|FG003|Stage 2|Non-adherence with study visits|0|||
149745608|NCT02158533|540201594|FG004|Stage 2|Non-adherence with study visits|0|||
149745609|NCT02158533|540201595|FG005|Stage 2|Non-adherence with study visits|1|||
149745610|NCT00384956|540201598|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
149745611|NCT03126227|540201601|FG000|Overall Study|Adverse Event|43|||
149745612|NCT03126227|540201602|FG001|Overall Study|Adverse Event|4|||
149745613|NCT03126227|540201601|FG000|Overall Study|Death|0|||
150256454|NCT00320528|542072763|FG001|Study Period III|Lack of Efficacy|0|||
150256455|NCT00320528|542072764|FG002|Study Period III|Lack of Efficacy|0|||
149745614|NCT03126227|540201602|FG001|Overall Study|Death|1|||
149745615|NCT03126227|540201601|FG000|Overall Study|Lost to Follow-up|0|||
149745616|NCT03126227|540201602|FG001|Overall Study|Lost to Follow-up|1|||
149745617|NCT03126227|540201601|FG000|Overall Study|Physician Decision|2|||
149745618|NCT03126227|540201602|FG001|Overall Study|Physician Decision|0|||
149745619|NCT03126227|540201601|FG000|Overall Study|Protocol Violation|1|||
149745620|NCT03126227|540201602|FG001|Overall Study|Protocol Violation|0|||
149745621|NCT03126227|540201601|FG000|Overall Study|Withdrawal by Subject|19|||
149745622|NCT03126227|540201602|FG001|Overall Study|Withdrawal by Subject|3|||
150256456|NCT00320528|542072762|FG000|Study Period III|Parent/Caregiver Decision|14|||
150256457|NCT00320528|542072763|FG001|Study Period III|Parent/Caregiver Decision|3|||
149745623|NCT03126227|540201601|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
149745624|NCT03126227|540201602|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
149745625|NCT03126227|540201601|FG000|Overall Study|Lack of dosing compliance|2|||
149745626|NCT03126227|540201602|FG001|Overall Study|Lack of dosing compliance|0|||
149745627|NCT03126227|540201601|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
149745628|NCT03126227|540201602|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
149745629|NCT03126227|540201601|FG000|Overall Study|Scheduling conflict|1|||
149745630|NCT03126227|540201602|FG001|Overall Study|Scheduling conflict|0|||
149745631|NCT01575548|540201607|FG000|Overall Study|Adverse Event|15|||
149745632|NCT01575548|540201608|FG001|Overall Study|Adverse Event|2|||
149745633|NCT01575548|540201607|FG000|Overall Study|Disease progression|12|||
149745634|NCT01575548|540201608|FG001|Overall Study|Disease progression|25|||
149745635|NCT01575548|540201607|FG000|Overall Study|Death|1|||
149745636|NCT01575548|540201608|FG001|Overall Study|Death|0|||
149745637|NCT01575548|540201607|FG000|Overall Study|Other complicating disease|1|||
149745638|NCT01575548|540201608|FG001|Overall Study|Other complicating disease|0|||
149745639|NCT01575548|540201607|FG000|Overall Study|Withdrawal by Subject|7|||
149745640|NCT01575548|540201608|FG001|Overall Study|Withdrawal by Subject|3|||
149745641|NCT01575548|540201607|FG000|Overall Study|Noncompliance|1|||
149745642|NCT01575548|540201608|FG001|Overall Study|Noncompliance|0|||
149745643|NCT01575548|540201607|FG000|Overall Study|Anticipated surgery|0|||
149745644|NCT01575548|540201608|FG001|Overall Study|Anticipated surgery|1|||
149745645|NCT01575548|540201607|FG000|Overall Study|Never started protocol therapy|3|||
149745646|NCT01575548|540201608|FG001|Overall Study|Never started protocol therapy|2|||
149745647|NCT03230097|540201611|FG000|Overall Study|Adverse Event|2|||
149745648|NCT03230097|540201612|FG001|Overall Study|Adverse Event|1|||
149745649|NCT03230097|540201611|FG000|Overall Study|non-compliance|0|||
149745650|NCT03230097|540201612|FG001|Overall Study|non-compliance|1|||
149745651|NCT03230097|540201611|FG000|Overall Study|Lost to Follow-up|2|||
149745652|NCT03230097|540201612|FG001|Overall Study|Lost to Follow-up|4|||
149745653|NCT03230097|540201611|FG000|Overall Study|Withdrawal by Subject|7|||
149745654|NCT03230097|540201612|FG001|Overall Study|Withdrawal by Subject|3|||
149745655|NCT03230097|540201611|FG000|Overall Study|Trial termination|4|||
149745656|NCT03230097|540201612|FG001|Overall Study|Trial termination|5|||
149745657|NCT03230097|540201611|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
149745658|NCT03230097|540201612|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
149745659|NCT03230097|540201611|FG000|Overall Study|outcome event|0|||
149745660|NCT03230097|540201612|FG001|Overall Study|outcome event|1|||
149745661|NCT00635102|540201621|FG000|Overall Study|Withdrawal by Subject|7|||
149745662|NCT00635102|540201622|FG001|Overall Study|Withdrawal by Subject|8|||
149745663|NCT00440401|540201624|FG000|Overall Study|Adverse Event|2|||
149745664|NCT00440401|540201625|FG001|Overall Study|Adverse Event|1|||
149745665|NCT00440401|540201624|FG000|Overall Study|Other|2|||
149745666|NCT00440401|540201625|FG001|Overall Study|Other|5|||
149745667|NCT01925703|540201626|FG000|Overall Study|Physician Decision|1|||
149745668|NCT01925703|540201626|FG000|Overall Study|Lost to Follow-up|2|||
149745669|NCT01925703|540201626|FG000|Overall Study|Discharge prior to full iron repletion|1|||
149745670|NCT01937312|540201627|FG000|Overall Study|Adverse Event|10|||
149745671|NCT01937312|540201628|FG001|Overall Study|Adverse Event|1|||
149745672|NCT01937312|540201627|FG000|Overall Study|Lack of Efficacy|0|||
149745673|NCT01937312|540201628|FG001|Overall Study|Lack of Efficacy|1|||
149745674|NCT01937312|540201627|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
149745675|NCT01937312|540201628|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
149745676|NCT00881205|540201630|FG000|Overall Study|Adverse Event|8|||
149745677|NCT00881205|540201631|FG001|Overall Study|Adverse Event|3|||
149745678|NCT00881205|540201630|FG000|Overall Study|Withdrawal by Subject|1|||
149745679|NCT00881205|540201631|FG001|Overall Study|Withdrawal by Subject|2|||
149745680|NCT00881205|540201630|FG000|Overall Study|Lost to Follow-up|0|||
149745681|NCT00881205|540201631|FG001|Overall Study|Lost to Follow-up|1|||
149745682|NCT00881205|540201630|FG000|Overall Study|Administrative problems|1|||
149745683|NCT00881205|540201631|FG001|Overall Study|Administrative problems|1|||
149745684|NCT00881205|540201630|FG000|Overall Study|Condition no longer requires drug|1|||
149745685|NCT00881205|540201631|FG001|Overall Study|Condition no longer requires drug|0|||
149745686|NCT02498652|540201632|FG000|Overall Study|Protocol Violation|0|||
149745687|NCT02498652|540201633|FG001|Overall Study|Protocol Violation|1|||
149745688|NCT06129487|540201635|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
149745689|NCT06129487|540201636|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
149745690|NCT00847613|540201639|FG000|Overall Study|Ongoing at cut-off date|250|||
149745691|NCT00847613|540201640|FG001|Overall Study|Ongoing at cut-off date|265|||
150256458|NCT00320528|542072764|FG002|Study Period III|Parent/Caregiver Decision|11|||
149745692|NCT00847613|540201641|FG002|Overall Study|Ongoing at cut-off date|64|||
149745693|NCT00847613|540201642|FG003|Overall Study|Ongoing at cut-off date|64|||
149745694|NCT00847613|540201639|FG000|Overall Study|Death|1|||
149745695|NCT00847613|540201640|FG001|Overall Study|Death|1|||
149745696|NCT00847613|540201641|FG002|Overall Study|Death|0|||
149745697|NCT00847613|540201642|FG003|Overall Study|Death|0|||
149745698|NCT00847613|540201639|FG000|Overall Study|Adverse Event|36|||
149745699|NCT00847613|540201640|FG001|Overall Study|Adverse Event|26|||
149745700|NCT00847613|540201641|FG002|Overall Study|Adverse Event|5|||
149745701|NCT00847613|540201642|FG003|Overall Study|Adverse Event|6|||
150256459|NCT00320528|542072762|FG000|Study Period III|Protocol Violation|0|||
150256460|NCT00320528|542072763|FG001|Study Period III|Protocol Violation|1|||
149745702|NCT00847613|540201639|FG000|Overall Study|Lack of Efficacy|7|||
149745703|NCT00847613|540201640|FG001|Overall Study|Lack of Efficacy|3|||
149745704|NCT00847613|540201641|FG002|Overall Study|Lack of Efficacy|3|||
149745705|NCT00847613|540201642|FG003|Overall Study|Lack of Efficacy|1|||
149745706|NCT00847613|540201639|FG000|Overall Study|Study terminated by Sponsor|1|||
149745707|NCT00847613|540201640|FG001|Overall Study|Study terminated by Sponsor|0|||
149745708|NCT00847613|540201641|FG002|Overall Study|Study terminated by Sponsor|2|||
149745709|NCT00847613|540201642|FG003|Overall Study|Study terminated by Sponsor|1|||
149745710|NCT00847613|540201639|FG000|Overall Study|Lost to Follow-up|5|||
149745711|NCT00847613|540201640|FG001|Overall Study|Lost to Follow-up|0|||
149745712|NCT00847613|540201641|FG002|Overall Study|Lost to Follow-up|0|||
149745713|NCT00847613|540201642|FG003|Overall Study|Lost to Follow-up|3|||
149745714|NCT00847613|540201639|FG000|Overall Study|Protocol Violation|6|||
149745715|NCT00847613|540201640|FG001|Overall Study|Protocol Violation|6|||
149745716|NCT00847613|540201641|FG002|Overall Study|Protocol Violation|3|||
149745717|NCT00847613|540201642|FG003|Overall Study|Protocol Violation|1|||
149745718|NCT00847613|540201639|FG000|Overall Study|Pregnancy|1|||
149745719|NCT00847613|540201640|FG001|Overall Study|Pregnancy|1|||
149745720|NCT00847613|540201641|FG002|Overall Study|Pregnancy|0|||
149745721|NCT00847613|540201642|FG003|Overall Study|Pregnancy|0|||
149745722|NCT00847613|540201639|FG000|Overall Study|Site closure|1|||
149745723|NCT00847613|540201640|FG001|Overall Study|Site closure|0|||
149745724|NCT00847613|540201641|FG002|Overall Study|Site closure|0|||
149745725|NCT00847613|540201642|FG003|Overall Study|Site closure|1|||
149745726|NCT00847613|540201639|FG000|Overall Study|Withdrawal by Subject|8|||
149745727|NCT00847613|540201640|FG001|Overall Study|Withdrawal by Subject|11|||
149745728|NCT00847613|540201641|FG002|Overall Study|Withdrawal by Subject|2|||
149745729|NCT00847613|540201642|FG003|Overall Study|Withdrawal by Subject|2|||
149745730|NCT00847613|540201639|FG000|Overall Study|Participant moved|4|||
149745731|NCT00847613|540201640|FG001|Overall Study|Participant moved|1|||
149745732|NCT00847613|540201641|FG002|Overall Study|Participant moved|0|||
149745733|NCT00847613|540201642|FG003|Overall Study|Participant moved|0|||
149745734|NCT00847613|540201639|FG000|Overall Study|Sponsor request|0|||
149745735|NCT00847613|540201640|FG001|Overall Study|Sponsor request|1|||
149745736|NCT00847613|540201641|FG002|Overall Study|Sponsor request|0|||
149745737|NCT00847613|540201642|FG003|Overall Study|Sponsor request|0|||
149745738|NCT00847613|540201639|FG000|Overall Study|Randomized, but not treated|0|||
149745739|NCT00847613|540201640|FG001|Overall Study|Randomized, but not treated|3|||
149745740|NCT00847613|540201641|FG002|Overall Study|Randomized, but not treated|0|||
149745741|NCT00847613|540201642|FG003|Overall Study|Randomized, but not treated|0|||
149745742|NCT00847613|540201639|FG000|Overall Study|Other|1|||
149745743|NCT00847613|540201640|FG001|Overall Study|Other|1|||
149745744|NCT00847613|540201641|FG002|Overall Study|Other|2|||
149745745|NCT00847613|540201642|FG003|Overall Study|Other|0|||
149745746|NCT00587223|540201646|FG000|Overall Study|Adverse Event|1|||
149745747|NCT04332419|540201647|FG000|Overall Study|Withdrawal by Subject|1|||
149745748|NCT00519623|540201648|FG000|Overall Study|Adverse Event|1|||
149745749|NCT03819140|540201649|FG000|Overall Study|Lost to Follow-up|1|||
149745750|NCT03819140|540201650|FG001|Overall Study|Lost to Follow-up|2|||
149745751|NCT03819140|540201649|FG000|Overall Study|Withdrawal by Subject|3|||
149745752|NCT03819140|540201650|FG001|Overall Study|Withdrawal by Subject|2|||
149745753|NCT03819140|540201649|FG000|Overall Study|Adverse Event|0|||
149745754|NCT03819140|540201650|FG001|Overall Study|Adverse Event|1|||
149745755|NCT03819140|540201649|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
149745756|NCT03819140|540201650|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
149745757|NCT03819140|540201649|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
149745758|NCT03819140|540201650|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
149745759|NCT00658333|540201651|FG000|Overall Study|Adverse Event|2|||
149745760|NCT00658333|540201652|FG001|Overall Study|Adverse Event|1|||
149745761|NCT05755438|540201653|FG000|12-week DBVC Period|Adverse Event|4|||
149745762|NCT05755438|540201654|FG001|12-week DBVC Period|Adverse Event|1|||
149745763|NCT05755438|540201653|FG000|12-week DBVC Period|Physician Decision|1|||
149745764|NCT05755438|540201654|FG001|12-week DBVC Period|Physician Decision|1|||
149745765|NCT05755438|540201653|FG000|12-week DBVC Period|Protocol Violation|4|||
149745766|NCT05755438|540201654|FG001|12-week DBVC Period|Protocol Violation|2|||
149745767|NCT05755438|540201653|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
149745768|NCT05755438|540201654|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
149745769|NCT05755438|540201653|FG000|12-week DBVC Period|Sponsor Decision|1|||
149745770|NCT05755438|540201654|FG001|12-week DBVC Period|Sponsor Decision|0|||
149745771|NCT05755438|540201653|FG000|40-week OLE Period|Adverse Event|0|||
149745772|NCT05755438|540201654|FG001|40-week OLE Period|Adverse Event|2|||
149745773|NCT05755438|540201653|FG000|40-week OLE Period|Lack of Efficacy|1|||
149745774|NCT05755438|540201654|FG001|40-week OLE Period|Lack of Efficacy|1|||
149745775|NCT05755438|540201653|FG000|40-week OLE Period|Lost to Follow-up|1|||
149745776|NCT05755438|540201654|FG001|40-week OLE Period|Lost to Follow-up|0|||
149745777|NCT05755438|540201653|FG000|40-week OLE Period|Physician Decision|1|||
149745778|NCT05755438|540201654|FG001|40-week OLE Period|Physician Decision|1|||
149745779|NCT05755438|540201653|FG000|40-week OLE Period|Protocol Violation|1|||
149745780|NCT05755438|540201654|FG001|40-week OLE Period|Protocol Violation|1|||
149745781|NCT05755438|540201653|FG000|40-week OLE Period|Withdrawal by Subject|6|||
149745782|NCT05755438|540201654|FG001|40-week OLE Period|Withdrawal by Subject|6|||
149745783|NCT05755438|540201653|FG000|40-week OLE Period|Sponsor Decision|3|||
149745784|NCT05755438|540201654|FG001|40-week OLE Period|Sponsor Decision|0|||
149745785|NCT05755438|540201653|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
149745786|NCT05755438|540201654|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
149745787|NCT05755438|540201653|FG000|40-week OLE Period|Ongoing|46|||
149745788|NCT05755438|540201654|FG001|40-week OLE Period|Ongoing|58|||
149745789|NCT03914300|540201656|FG000|Overall Study|Adverse Event|1|||
149745790|NCT01548638|540201664|FG000|Overall Study|Protocol Violation|3|||
149745791|NCT01548638|540201664|FG000|Overall Study|Withdrawal by Subject|1|||
149745792|NCT04090164|540201677|FG000|Overall Study|incomplete data on file|245|||
149745793|NCT04090164|540201678|FG001|Overall Study|incomplete data on file|0|||
149745794|NCT05781542|540203272|FG000|Overall Study|Lost to Follow-up|1|||
149745795|NCT05781542|540203273|FG001|Overall Study|Lost to Follow-up|0|||
149745796|NCT05781542|540203274|FG002|Overall Study|Lost to Follow-up|1|||
149745797|NCT03704051|540203281|FG000|Overall Study|Withdrawal by Subject|4|||
149745798|NCT03704051|540203282|FG001|Overall Study|Withdrawal by Subject|0|||
149745799|NCT02495077|540203283|FG000|Overall Study|Adverse Event|0|||
149745800|NCT02495077|540203284|FG001|Overall Study|Adverse Event|1|||
149745801|NCT02495077|540203285|FG002|Overall Study|Adverse Event|1|||
149745802|NCT02495077|540203286|FG003|Overall Study|Adverse Event|0|||
149745803|NCT02495077|540203283|FG000|Overall Study|Death|3|||
149745804|NCT02495077|540203284|FG001|Overall Study|Death|5|||
149745805|NCT02495077|540203285|FG002|Overall Study|Death|0|||
149745806|NCT02495077|540203286|FG003|Overall Study|Death|0|||
149745807|NCT02495077|540203283|FG000|Overall Study|Lost to Follow-up|6|||
149745808|NCT02495077|540203284|FG001|Overall Study|Lost to Follow-up|4|||
149745809|NCT02495077|540203285|FG002|Overall Study|Lost to Follow-up|0|||
149745810|NCT02495077|540203286|FG003|Overall Study|Lost to Follow-up|0|||
149745811|NCT02495077|540203283|FG000|Overall Study|Physician Decision|2|||
149745812|NCT02495077|540203284|FG001|Overall Study|Physician Decision|1|||
149745813|NCT02495077|540203285|FG002|Overall Study|Physician Decision|4|||
149745814|NCT02495077|540203286|FG003|Overall Study|Physician Decision|0|||
149745815|NCT02495077|540203283|FG000|Overall Study|Protocol Violation|0|||
149745816|NCT02495077|540203284|FG001|Overall Study|Protocol Violation|1|||
149745817|NCT02495077|540203285|FG002|Overall Study|Protocol Violation|0|||
149745818|NCT02495077|540203286|FG003|Overall Study|Protocol Violation|0|||
149745819|NCT02495077|540203283|FG000|Overall Study|Screen Failure|0|||
149745820|NCT02495077|540203284|FG001|Overall Study|Screen Failure|0|||
149745821|NCT02495077|540203285|FG002|Overall Study|Screen Failure|0|||
149745822|NCT02495077|540203286|FG003|Overall Study|Screen Failure|48|||
149745823|NCT02495077|540203283|FG000|Overall Study|Withdrawal by Subject|7|||
149745824|NCT02495077|540203284|FG001|Overall Study|Withdrawal by Subject|7|||
149745825|NCT02495077|540203285|FG002|Overall Study|Withdrawal by Subject|7|||
149745826|NCT02495077|540203286|FG003|Overall Study|Withdrawal by Subject|0|||
149745827|NCT02495077|540203283|FG000|Overall Study|Covid-19 research restrictions|1|||
149745828|NCT02495077|540203284|FG001|Overall Study|Covid-19 research restrictions|0|||
149745829|NCT02495077|540203285|FG002|Overall Study|Covid-19 research restrictions|0|||
149745830|NCT02495077|540203286|FG003|Overall Study|Covid-19 research restrictions|0|||
149745831|NCT02495077|540203283|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
149745832|NCT02495077|540203284|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
149745833|NCT02495077|540203285|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
149745834|NCT02495077|540203286|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
149745835|NCT02495077|540203283|FG000|Overall Study|Incarcerated|0|||
149745836|NCT02495077|540203284|FG001|Overall Study|Incarcerated|1|||
149745837|NCT02495077|540203285|FG002|Overall Study|Incarcerated|0|||
149745838|NCT02495077|540203286|FG003|Overall Study|Incarcerated|0|||
149745839|NCT02495077|540203283|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
149745840|NCT02495077|540203284|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
149745841|NCT02495077|540203285|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
149745842|NCT02495077|540203286|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
150256461|NCT00320528|542072764|FG002|Study Period III|Protocol Violation|0|||
150256462|NCT00320528|542072762|FG000|Study Period III|Physician Decision|0|||
150256463|NCT00320528|542072763|FG001|Study Period III|Physician Decision|1|||
149745843|NCT02495077|540203283|FG000|Overall Study|Timing of transplant and randomization|0|||
149745844|NCT02495077|540203284|FG001|Overall Study|Timing of transplant and randomization|0|||
149745845|NCT02495077|540203285|FG002|Overall Study|Timing of transplant and randomization|5|||
150256464|NCT00320528|542072764|FG002|Study Period III|Physician Decision|2|||
149745846|NCT02495077|540203286|FG003|Overall Study|Timing of transplant and randomization|0|||
149745847|NCT02742649|540203287|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
149745848|NCT02742649|540203288|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149745849|NCT02742649|540203289|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149745850|NCT02742649|540203290|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149745851|NCT02742649|540203291|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149745852|NCT02742649|540203287|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149745853|NCT02742649|540203288|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149745854|NCT02742649|540203289|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149745855|NCT02742649|540203290|FG003|Double-Blind Treatment Period|Adverse Event|0|||
149745856|NCT02742649|540203291|FG004|Double-Blind Treatment Period|Adverse Event|0|||
149745857|NCT02742649|540203287|FG000|Open-Label Period|Lost to Follow-up|0|||
149745858|NCT02742649|540203288|FG001|Open-Label Period|Lost to Follow-up|0|||
149745859|NCT02742649|540203289|FG002|Open-Label Period|Lost to Follow-up|0|||
149745860|NCT02742649|540203290|FG003|Open-Label Period|Lost to Follow-up|0|||
149745861|NCT02742649|540203291|FG004|Open-Label Period|Lost to Follow-up|1|||
149745862|NCT03167619|540203294|FG000|Overall Study|Death|11|||
149745863|NCT03167619|540203295|FG001|Overall Study|Death|8|||
149745864|NCT03167619|540203294|FG000|Overall Study|Withdrawal by Subject|1|||
149745865|NCT03167619|540203295|FG001|Overall Study|Withdrawal by Subject|2|||
149745866|NCT03167619|540203294|FG000|Overall Study|Physician Decision|0|||
149745867|NCT03167619|540203295|FG001|Overall Study|Physician Decision|1|||
149745868|NCT01335971|540203298|FG000|Overall Study|Withdrawal by Subject|1|||
149745869|NCT01335971|540203299|FG001|Overall Study|Withdrawal by Subject|0|||
149745870|NCT01335971|540203300|FG002|Overall Study|Withdrawal by Subject|0|||
149745871|NCT01335971|540203298|FG000|Overall Study|Did not complete bronchoscopy|1|||
149745872|NCT01335971|540203299|FG001|Overall Study|Did not complete bronchoscopy|1|||
149745873|NCT01335971|540203300|FG002|Overall Study|Did not complete bronchoscopy|1|||
149745874|NCT03056287|540203301|FG000|Overall Study|Withdrawal by Subject|0|||
149745875|NCT03056287|540203302|FG001|Overall Study|Withdrawal by Subject|1|||
149745876|NCT03056287|540203303|FG002|Overall Study|Withdrawal by Subject|0|||
149745877|NCT03056287|540203304|FG003|Overall Study|Withdrawal by Subject|0|||
149745878|NCT03056287|540203301|FG000|Overall Study|move out of area|0|||
149745879|NCT03056287|540203302|FG001|Overall Study|move out of area|0|||
149745880|NCT03056287|540203303|FG002|Overall Study|move out of area|1|||
149745881|NCT03056287|540203304|FG003|Overall Study|move out of area|1|||
149745882|NCT01938625|540203312|FG000|Overall Study|Withdrawal by Subject|0|||
149745883|NCT01938625|540203313|FG001|Overall Study|Withdrawal by Subject|1|||
149745884|NCT01938625|540203312|FG000|Overall Study|Adverse Event|0|||
149745885|NCT01938625|540203313|FG001|Overall Study|Adverse Event|1|||
149745886|NCT01486238|540203316|FG000|Overall Study|Death|0|||
149745887|NCT01486238|540203317|FG001|Overall Study|Death|2|||
149745888|NCT01486238|540203316|FG000|Overall Study|Withdrawal by Subject|2|||
149745889|NCT01486238|540203317|FG001|Overall Study|Withdrawal by Subject|1|||
149745890|NCT01486238|540203316|FG000|Overall Study|Lost to Follow-up|0|||
149745891|NCT01486238|540203317|FG001|Overall Study|Lost to Follow-up|3|||
149745892|NCT01184989|540203320|FG000|Overall Study|Adverse Event|11|||
149745893|NCT01184989|540203320|FG000|Overall Study|Withdrawal by Subject|1|||
149745894|NCT01570491|540203321|FG000|Overall Study|Lost to Follow-up|3|||
149745895|NCT01570491|540203322|FG001|Overall Study|Lost to Follow-up|1|||
149745896|NCT01570491|540203321|FG000|Overall Study|treatment: not given or discontinued|2|||
149745897|NCT01570491|540203322|FG001|Overall Study|treatment: not given or discontinued|0|||
149745898|NCT05370157|540203323|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
149745899|NCT05370157|540203324|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
149745900|NCT05370157|540203323|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
149745901|NCT05370157|540203324|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
149745902|NCT01508676|540203325|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
149745903|NCT01508676|540203326|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
149745904|NCT01508676|540203325|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
149745905|NCT01508676|540203326|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
149745906|NCT01508676|540203325|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
149745907|NCT01508676|540203326|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
149745908|NCT01508676|540203325|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
149745909|NCT01508676|540203326|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
149745910|NCT01508676|540203325|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
149745911|NCT01508676|540203326|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
149745912|NCT00754390|540203330|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
149745913|NCT00754390|540203330|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
149745914|NCT00754390|540203330|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
149745915|NCT00754390|540203330|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
149745916|NCT00845429|540203331|FG000|Overall Study|Protocol Violation|5|||
149745917|NCT00845429|540203332|FG001|Overall Study|Protocol Violation|4|||
149745918|NCT00845429|540203333|FG002|Overall Study|Protocol Violation|7|||
149745919|NCT00845429|540203331|FG000|Overall Study|Lost to Follow-up|7|||
149745920|NCT00845429|540203332|FG001|Overall Study|Lost to Follow-up|9|||
149745921|NCT00845429|540203333|FG002|Overall Study|Lost to Follow-up|10|||
149745922|NCT00845429|540203331|FG000|Overall Study|Withdrawal by Subject|2|||
149745923|NCT00845429|540203332|FG001|Overall Study|Withdrawal by Subject|2|||
149745924|NCT00845429|540203333|FG002|Overall Study|Withdrawal by Subject|2|||
149745925|NCT00845429|540203331|FG000|Overall Study|Serious adverse event|0|||
149745926|NCT00845429|540203332|FG001|Overall Study|Serious adverse event|0|||
149745927|NCT00845429|540203333|FG002|Overall Study|Serious adverse event|1|||
149745928|NCT00971321|540203334|FG000|Up to Month 7|Withdrawal by Subject|1|||
149745929|NCT00971321|540203335|FG001|Up to Month 7|Withdrawal by Subject|0|||
149745930|NCT00971321|540203334|FG000|Up to Month 7|Migrated/moved from study area|3|||
149745931|NCT00971321|540203335|FG001|Up to Month 7|Migrated/moved from study area|2|||
149745932|NCT00971321|540203334|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
149745933|NCT00971321|540203335|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
149745934|NCT00971321|540203334|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
149745935|NCT00971321|540203335|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
149745936|NCT00971321|540203334|FG000|Up to Month 11-12|Lost to Follow-up|1|||
149745937|NCT00971321|540203335|FG001|Up to Month 11-12|Lost to Follow-up|0|||
149745938|NCT04222725|540203336|FG000|Overall Study|Adverse Event|0|||
149745939|NCT04222725|540203337|FG001|Overall Study|Adverse Event|1|||
149745940|NCT04222725|540203338|FG002|Overall Study|Adverse Event|0|||
149745941|NCT04222725|540203339|FG003|Overall Study|Adverse Event|0|||
149745942|NCT03519178|540203340|FG000|PF-06873600 Treatment|Adverse Event|0|||
149745943|NCT03519178|540203341|FG001|PF-06873600 Treatment|Adverse Event|0|||
149745944|NCT03519178|540203342|FG002|PF-06873600 Treatment|Adverse Event|0|||
149745945|NCT03519178|540203343|FG003|PF-06873600 Treatment|Adverse Event|0|||
149745946|NCT03519178|540203344|FG004|PF-06873600 Treatment|Adverse Event|0|||
149745947|NCT03519178|540203345|FG005|PF-06873600 Treatment|Adverse Event|0|||
149745948|NCT03519178|540203346|FG006|PF-06873600 Treatment|Adverse Event|0|||
149745949|NCT03519178|540203347|FG007|PF-06873600 Treatment|Adverse Event|2|||
149745950|NCT03519178|540203348|FG008|PF-06873600 Treatment|Adverse Event|1|||
149745951|NCT03519178|540203349|FG009|PF-06873600 Treatment|Adverse Event|0|||
149745952|NCT03519178|540203350|FG010|PF-06873600 Treatment|Adverse Event|0|||
149745953|NCT03519178|540203351|FG011|PF-06873600 Treatment|Adverse Event|0|||
149745954|NCT03519178|540203352|FG012|PF-06873600 Treatment|Adverse Event|1|||
149745955|NCT03519178|540203353|FG013|PF-06873600 Treatment|Adverse Event|3|||
149745956|NCT03519178|540203354|FG014|PF-06873600 Treatment|Adverse Event|2|||
149745957|NCT03519178|540203340|FG000|PF-06873600 Treatment|Death|0|||
149745958|NCT03519178|540203341|FG001|PF-06873600 Treatment|Death|0|||
149745959|NCT03519178|540203342|FG002|PF-06873600 Treatment|Death|0|||
149745960|NCT03519178|540203343|FG003|PF-06873600 Treatment|Death|0|||
149745961|NCT03519178|540203344|FG004|PF-06873600 Treatment|Death|0|||
149745962|NCT03519178|540203345|FG005|PF-06873600 Treatment|Death|0|||
149745963|NCT03519178|540203346|FG006|PF-06873600 Treatment|Death|0|||
149745964|NCT03519178|540203347|FG007|PF-06873600 Treatment|Death|0|||
149745965|NCT03519178|540203348|FG008|PF-06873600 Treatment|Death|1|||
149745966|NCT03519178|540203349|FG009|PF-06873600 Treatment|Death|1|||
149745967|NCT03519178|540203350|FG010|PF-06873600 Treatment|Death|0|||
149745968|NCT03519178|540203351|FG011|PF-06873600 Treatment|Death|0|||
149745969|NCT03519178|540203352|FG012|PF-06873600 Treatment|Death|0|||
149745970|NCT03519178|540203353|FG013|PF-06873600 Treatment|Death|0|||
149745971|NCT03519178|540203354|FG014|PF-06873600 Treatment|Death|1|||
149745972|NCT03519178|540203340|FG000|PF-06873600 Treatment|Physician Decision|0|||
149745973|NCT03519178|540203341|FG001|PF-06873600 Treatment|Physician Decision|0|||
149745974|NCT03519178|540203342|FG002|PF-06873600 Treatment|Physician Decision|0|||
149745975|NCT03519178|540203343|FG003|PF-06873600 Treatment|Physician Decision|0|||
149745976|NCT03519178|540203344|FG004|PF-06873600 Treatment|Physician Decision|0|||
149745977|NCT03519178|540203345|FG005|PF-06873600 Treatment|Physician Decision|0|||
149745978|NCT03519178|540203346|FG006|PF-06873600 Treatment|Physician Decision|0|||
149745979|NCT03519178|540203347|FG007|PF-06873600 Treatment|Physician Decision|1|||
149745980|NCT03519178|540203348|FG008|PF-06873600 Treatment|Physician Decision|0|||
149745981|NCT03519178|540203349|FG009|PF-06873600 Treatment|Physician Decision|0|||
149745982|NCT03519178|540203350|FG010|PF-06873600 Treatment|Physician Decision|1|||
149745983|NCT03519178|540203351|FG011|PF-06873600 Treatment|Physician Decision|0|||
149745984|NCT03519178|540203352|FG012|PF-06873600 Treatment|Physician Decision|0|||
149745985|NCT03519178|540203353|FG013|PF-06873600 Treatment|Physician Decision|4|||
149745986|NCT03519178|540203354|FG014|PF-06873600 Treatment|Physician Decision|1|||
149745987|NCT03519178|540203340|FG000|PF-06873600 Treatment|Progressive disease|1|||
149745988|NCT03519178|540203341|FG001|PF-06873600 Treatment|Progressive disease|1|||
149745989|NCT03519178|540203342|FG002|PF-06873600 Treatment|Progressive disease|1|||
149745990|NCT03519178|540203343|FG003|PF-06873600 Treatment|Progressive disease|1|||
149745991|NCT03519178|540203344|FG004|PF-06873600 Treatment|Progressive disease|6|||
149745992|NCT03519178|540203345|FG005|PF-06873600 Treatment|Progressive disease|7|||
149745993|NCT03519178|540203346|FG006|PF-06873600 Treatment|Progressive disease|3|||
149745994|NCT03519178|540203347|FG007|PF-06873600 Treatment|Progressive disease|7|||
149745995|NCT03519178|540203348|FG008|PF-06873600 Treatment|Progressive disease|3|||
149745996|NCT03519178|540203349|FG009|PF-06873600 Treatment|Progressive disease|5|||
149745997|NCT03519178|540203350|FG010|PF-06873600 Treatment|Progressive disease|4|||
149745998|NCT03519178|540203351|FG011|PF-06873600 Treatment|Progressive disease|3|||
149745999|NCT03519178|540203352|FG012|PF-06873600 Treatment|Progressive disease|4|||
149746000|NCT03519178|540203353|FG013|PF-06873600 Treatment|Progressive disease|28|||
149746001|NCT03519178|540203354|FG014|PF-06873600 Treatment|Progressive disease|8|||
149746002|NCT03519178|540203340|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746003|NCT03519178|540203341|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746004|NCT03519178|540203342|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
149746005|NCT03519178|540203343|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746006|NCT03519178|540203344|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
149746007|NCT03519178|540203345|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746008|NCT03519178|540203346|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746009|NCT03519178|540203347|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
149746010|NCT03519178|540203348|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
149746011|NCT03519178|540203349|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
149746012|NCT03519178|540203350|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
149746013|NCT03519178|540203351|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
149746014|NCT03519178|540203352|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
149746015|NCT03519178|540203353|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
149746016|NCT03519178|540203354|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
149746017|NCT03519178|540203340|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
149746018|NCT03519178|540203341|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
149746019|NCT03519178|540203342|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
149746020|NCT03519178|540203343|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
149746021|NCT03519178|540203344|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
149746022|NCT03519178|540203345|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
149746023|NCT03519178|540203346|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
149746024|NCT03519178|540203347|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
149746025|NCT03519178|540203348|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
149746026|NCT03519178|540203349|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
149746027|NCT03519178|540203350|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
149746028|NCT03519178|540203351|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
149746029|NCT03519178|540203352|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
149746030|NCT03519178|540203353|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
149746031|NCT03519178|540203354|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
149746032|NCT03519178|540203340|FG000|PF-06873600 Treatment|Refused further treatment|0|||
149746033|NCT03519178|540203341|FG001|PF-06873600 Treatment|Refused further treatment|1|||
149746034|NCT03519178|540203342|FG002|PF-06873600 Treatment|Refused further treatment|0|||
149746035|NCT03519178|540203343|FG003|PF-06873600 Treatment|Refused further treatment|0|||
149746036|NCT03519178|540203344|FG004|PF-06873600 Treatment|Refused further treatment|1|||
149746037|NCT03519178|540203345|FG005|PF-06873600 Treatment|Refused further treatment|0|||
149746038|NCT03519178|540203346|FG006|PF-06873600 Treatment|Refused further treatment|0|||
149746039|NCT03519178|540203347|FG007|PF-06873600 Treatment|Refused further treatment|0|||
149746040|NCT03519178|540203348|FG008|PF-06873600 Treatment|Refused further treatment|0|||
149746041|NCT03519178|540203349|FG009|PF-06873600 Treatment|Refused further treatment|0|||
149746042|NCT03519178|540203350|FG010|PF-06873600 Treatment|Refused further treatment|0|||
150256465|NCT00320528|542072762|FG000|Study Period III|Sponsor Decision|0|||
150256466|NCT00320528|542072763|FG001|Study Period III|Sponsor Decision|0|||
150256467|NCT00320528|542072764|FG002|Study Period III|Sponsor Decision|1|||
150256468|NCT00320528|542072762|FG000|Study Period III|Atomoxetine Commercially Available|68|||
150256469|NCT00320528|542072763|FG001|Study Period III|Atomoxetine Commercially Available|25|||
150256470|NCT00320528|542072764|FG002|Study Period III|Atomoxetine Commercially Available|90|||
150256471|NCT00760474|542072770|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
150256472|NCT00760474|542072771|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
150256473|NCT00760474|542072770|FG000|Placebo Washout Period|Other|0|||
150256474|NCT00760474|542072771|FG001|Placebo Washout Period|Other|1|||
150256475|NCT00760474|542072770|FG000|Period 2 (P2)|Lost to Follow-up|1|||
150256476|NCT00760474|542072771|FG001|Period 2 (P2)|Lost to Follow-up|0|||
150256477|NCT00760474|542072770|FG000|Period 2 (P2)|Adverse Event|0|||
150256478|NCT00760474|542072771|FG001|Period 2 (P2)|Adverse Event|1|||
150256479|NCT00513305|542072772|FG000|Overall Study|Adverse Event|6|||
150256480|NCT00513305|542072773|FG001|Overall Study|Adverse Event|2|||
150256481|NCT00513305|542072772|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
150256482|NCT00513305|542072773|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
150256483|NCT00513305|542072772|FG000|Overall Study|Lack of Efficacy|8|||
150256484|NCT00513305|542072773|FG001|Overall Study|Lack of Efficacy|13|||
150256485|NCT00513305|542072772|FG000|Overall Study|Withdrawal by Subject|1|||
150256486|NCT00513305|542072773|FG001|Overall Study|Withdrawal by Subject|2|||
150256487|NCT00513305|542072772|FG000|Overall Study|Disease progression|8|||
150256488|NCT00513305|542072773|FG001|Overall Study|Disease progression|5|||
150256489|NCT00513305|542072772|FG000|Overall Study|Eligible for stem cell transplant|1|||
150256490|NCT00513305|542072773|FG001|Overall Study|Eligible for stem cell transplant|0|||
150256491|NCT00513305|542072772|FG000|Overall Study|Hematologic counts did not recover|1|||
150256492|NCT00513305|542072773|FG001|Overall Study|Hematologic counts did not recover|0|||
150256493|NCT00513305|542072772|FG000|Overall Study|Physician Decision|1|||
150256494|NCT00513305|542072773|FG001|Overall Study|Physician Decision|0|||
149746043|NCT03519178|540203351|FG011|PF-06873600 Treatment|Refused further treatment|0|||
149746044|NCT03519178|540203352|FG012|PF-06873600 Treatment|Refused further treatment|0|||
149746045|NCT03519178|540203353|FG013|PF-06873600 Treatment|Refused further treatment|0|||
149746046|NCT03519178|540203354|FG014|PF-06873600 Treatment|Refused further treatment|1|||
149746047|NCT03519178|540203340|FG000|PF-06873600 Treatment|Other|0|||
149746048|NCT03519178|540203341|FG001|PF-06873600 Treatment|Other|0|||
149746049|NCT03519178|540203342|FG002|PF-06873600 Treatment|Other|0|||
149746050|NCT03519178|540203343|FG003|PF-06873600 Treatment|Other|0|||
149746051|NCT03519178|540203344|FG004|PF-06873600 Treatment|Other|0|||
149746052|NCT03519178|540203345|FG005|PF-06873600 Treatment|Other|0|||
149746053|NCT03519178|540203346|FG006|PF-06873600 Treatment|Other|0|||
149746054|NCT03519178|540203347|FG007|PF-06873600 Treatment|Other|0|||
149746055|NCT03519178|540203348|FG008|PF-06873600 Treatment|Other|1|||
149746056|NCT03519178|540203349|FG009|PF-06873600 Treatment|Other|0|||
149746057|NCT03519178|540203350|FG010|PF-06873600 Treatment|Other|0|||
149746058|NCT03519178|540203351|FG011|PF-06873600 Treatment|Other|0|||
149746059|NCT03519178|540203352|FG012|PF-06873600 Treatment|Other|0|||
149746060|NCT03519178|540203353|FG013|PF-06873600 Treatment|Other|1|||
149746061|NCT03519178|540203354|FG014|PF-06873600 Treatment|Other|3|||
149746062|NCT03519178|540203340|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
149746063|NCT03519178|540203341|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
149746064|NCT03519178|540203342|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
149746065|NCT03519178|540203343|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
149746066|NCT03519178|540203344|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
149746067|NCT03519178|540203345|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
149746068|NCT03519178|540203346|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
149746069|NCT03519178|540203347|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
149746070|NCT03519178|540203348|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
149746071|NCT03519178|540203349|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
149746072|NCT03519178|540203350|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
149746073|NCT03519178|540203351|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
149746074|NCT03519178|540203352|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
149746075|NCT03519178|540203353|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
149746076|NCT03519178|540203354|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
149746077|NCT03519178|540203340|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746078|NCT03519178|540203341|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746079|NCT03519178|540203342|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746080|NCT03519178|540203343|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746081|NCT03519178|540203344|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746082|NCT03519178|540203345|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746083|NCT03519178|540203346|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746084|NCT03519178|540203347|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746085|NCT03519178|540203348|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746086|NCT03519178|540203349|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746087|NCT03519178|540203350|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746088|NCT03519178|540203351|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746089|NCT03519178|540203352|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
149746090|NCT03519178|540203353|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
149746091|NCT03519178|540203354|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
149746092|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Adverse Event|0|||
149746093|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Adverse Event|0|||
149746094|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Adverse Event|0|||
149746095|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Adverse Event|0|||
149746096|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Adverse Event|0|||
149746097|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Adverse Event|0|||
149746098|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Adverse Event|0|||
149746099|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Adverse Event|0|||
149746100|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Adverse Event|0|||
149746101|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Adverse Event|0|||
149746102|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Adverse Event|0|||
149746103|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Adverse Event|0|||
149746104|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Adverse Event|0|||
149746105|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Adverse Event|1|||
149746106|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Adverse Event|0|||
149746107|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Death|0|||
149746108|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Death|0|||
149746109|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Death|0|||
149746110|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Death|0|||
149746111|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Death|0|||
149746112|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Death|0|||
149746113|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Death|0|||
149746114|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Death|0|||
149746115|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Death|0|||
149746116|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Death|1|||
149746117|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Death|0|||
149746118|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Death|0|||
149746119|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Death|0|||
149746120|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Death|0|||
149746121|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Death|1|||
149746122|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746123|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746124|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746125|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746126|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746127|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746128|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746129|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746130|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746131|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746132|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746133|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746134|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746135|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
149746136|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
149746137|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Physician Decision|0|||
149746138|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Physician Decision|0|||
149746139|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Physician Decision|0|||
149746140|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Physician Decision|0|||
149746141|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Physician Decision|0|||
149746142|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Physician Decision|0|||
149746143|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Physician Decision|0|||
149746144|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Physician Decision|0|||
149746145|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Physician Decision|0|||
149746146|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Physician Decision|0|||
149746147|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Physician Decision|0|||
149746148|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Physician Decision|0|||
149746149|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Physician Decision|0|||
149746150|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Physician Decision|4|||
149746151|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Physician Decision|2|||
149746152|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Progressive disease|0|||
149746153|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Progressive disease|0|||
149746154|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Progressive disease|0|||
149746155|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Progressive disease|0|||
149746156|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Progressive disease|0|||
149746157|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Progressive disease|0|||
149746158|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Progressive disease|0|||
149746159|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Progressive disease|0|||
149746160|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Progressive disease|0|||
149746161|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Progressive disease|5|||
149746162|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Progressive disease|0|||
149746163|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Progressive disease|0|||
149746164|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Progressive disease|0|||
149746165|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Progressive disease|30|||
149746166|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Progressive disease|8|||
149746167|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746168|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746169|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746170|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746171|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746172|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746173|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746174|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746175|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746176|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746177|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746178|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746179|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149746180|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
149746181|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
149746182|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746183|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746184|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746185|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746186|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746187|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746188|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746189|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746190|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746191|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
149746192|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746193|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746194|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149746195|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
149746196|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
149746197|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746198|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746199|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746200|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746201|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746202|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746203|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746204|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746205|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746206|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
149746207|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746208|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746209|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746210|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
149746211|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
149746212|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
149746213|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
149746214|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
149746215|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
149746216|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
149746217|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
149746218|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
149746219|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
149746220|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
149746221|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
149746222|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
149746223|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
149746224|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
149746225|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
149746226|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
149746227|NCT03519178|540203340|FG000|Fulvestrant. Treatment|Other|0|||
149746228|NCT03519178|540203341|FG001|Fulvestrant. Treatment|Other|0|||
149746229|NCT03519178|540203342|FG002|Fulvestrant. Treatment|Other|0|||
149746230|NCT03519178|540203343|FG003|Fulvestrant. Treatment|Other|0|||
149746231|NCT03519178|540203344|FG004|Fulvestrant. Treatment|Other|0|||
149746232|NCT03519178|540203345|FG005|Fulvestrant. Treatment|Other|0|||
149746233|NCT03519178|540203346|FG006|Fulvestrant. Treatment|Other|0|||
149746234|NCT03519178|540203347|FG007|Fulvestrant. Treatment|Other|0|||
149746235|NCT03519178|540203348|FG008|Fulvestrant. Treatment|Other|0|||
149746236|NCT03519178|540203349|FG009|Fulvestrant. Treatment|Other|0|||
149746237|NCT03519178|540203350|FG010|Fulvestrant. Treatment|Other|0|||
149746238|NCT03519178|540203351|FG011|Fulvestrant. Treatment|Other|0|||
149746239|NCT03519178|540203352|FG012|Fulvestrant. Treatment|Other|0|||
149746240|NCT03519178|540203353|FG013|Fulvestrant. Treatment|Other|1|||
149746241|NCT03519178|540203354|FG014|Fulvestrant. Treatment|Other|3|||
149746242|NCT03519178|540203340|FG000|Letrozole Treatment|Physician Decision|0|||
149746243|NCT03519178|540203341|FG001|Letrozole Treatment|Physician Decision|0|||
149746244|NCT03519178|540203342|FG002|Letrozole Treatment|Physician Decision|0|||
149746245|NCT03519178|540203343|FG003|Letrozole Treatment|Physician Decision|0|||
149746246|NCT03519178|540203344|FG004|Letrozole Treatment|Physician Decision|0|||
149746247|NCT03519178|540203345|FG005|Letrozole Treatment|Physician Decision|0|||
149746248|NCT03519178|540203346|FG006|Letrozole Treatment|Physician Decision|0|||
149746249|NCT03519178|540203347|FG007|Letrozole Treatment|Physician Decision|0|||
149746250|NCT03519178|540203348|FG008|Letrozole Treatment|Physician Decision|0|||
149746251|NCT03519178|540203349|FG009|Letrozole Treatment|Physician Decision|0|||
149746252|NCT03519178|540203350|FG010|Letrozole Treatment|Physician Decision|1|||
149746253|NCT03519178|540203351|FG011|Letrozole Treatment|Physician Decision|0|||
149746254|NCT03519178|540203352|FG012|Letrozole Treatment|Physician Decision|0|||
149746255|NCT03519178|540203353|FG013|Letrozole Treatment|Physician Decision|0|||
149746256|NCT03519178|540203354|FG014|Letrozole Treatment|Physician Decision|0|||
149746257|NCT03519178|540203340|FG000|Letrozole Treatment|Progressive disease|0|||
149746258|NCT03519178|540203341|FG001|Letrozole Treatment|Progressive disease|0|||
149746259|NCT03519178|540203342|FG002|Letrozole Treatment|Progressive disease|0|||
149746260|NCT03519178|540203343|FG003|Letrozole Treatment|Progressive disease|0|||
149746261|NCT03519178|540203344|FG004|Letrozole Treatment|Progressive disease|0|||
149746262|NCT03519178|540203345|FG005|Letrozole Treatment|Progressive disease|0|||
149746263|NCT03519178|540203346|FG006|Letrozole Treatment|Progressive disease|0|||
149746264|NCT03519178|540203347|FG007|Letrozole Treatment|Progressive disease|0|||
149746265|NCT03519178|540203348|FG008|Letrozole Treatment|Progressive disease|0|||
149746266|NCT03519178|540203349|FG009|Letrozole Treatment|Progressive disease|0|||
149746267|NCT03519178|540203350|FG010|Letrozole Treatment|Progressive disease|4|||
149746268|NCT03519178|540203351|FG011|Letrozole Treatment|Progressive disease|0|||
149746269|NCT03519178|540203352|FG012|Letrozole Treatment|Progressive disease|0|||
149746270|NCT03519178|540203353|FG013|Letrozole Treatment|Progressive disease|0|||
149746271|NCT03519178|540203354|FG014|Letrozole Treatment|Progressive disease|0|||
149746272|NCT03519178|540203340|FG000|Letrozole Treatment|Global deterioration of health status|0|||
149746273|NCT03519178|540203341|FG001|Letrozole Treatment|Global deterioration of health status|0|||
149746274|NCT03519178|540203342|FG002|Letrozole Treatment|Global deterioration of health status|0|||
149746275|NCT03519178|540203343|FG003|Letrozole Treatment|Global deterioration of health status|0|||
149746276|NCT03519178|540203344|FG004|Letrozole Treatment|Global deterioration of health status|0|||
149746277|NCT03519178|540203345|FG005|Letrozole Treatment|Global deterioration of health status|0|||
149746278|NCT03519178|540203346|FG006|Letrozole Treatment|Global deterioration of health status|0|||
149746279|NCT03519178|540203347|FG007|Letrozole Treatment|Global deterioration of health status|0|||
149746280|NCT03519178|540203348|FG008|Letrozole Treatment|Global deterioration of health status|0|||
149746281|NCT03519178|540203349|FG009|Letrozole Treatment|Global deterioration of health status|0|||
149746282|NCT03519178|540203350|FG010|Letrozole Treatment|Global deterioration of health status|2|||
149746283|NCT03519178|540203351|FG011|Letrozole Treatment|Global deterioration of health status|0|||
149746284|NCT03519178|540203352|FG012|Letrozole Treatment|Global deterioration of health status|0|||
149746285|NCT03519178|540203353|FG013|Letrozole Treatment|Global deterioration of health status|0|||
149746286|NCT03519178|540203354|FG014|Letrozole Treatment|Global deterioration of health status|0|||
149746287|NCT03519178|540203340|FG000|Follow-Up|Death|0|||
149746288|NCT03519178|540203341|FG001|Follow-Up|Death|0|||
149746289|NCT03519178|540203342|FG002|Follow-Up|Death|0|||
149746290|NCT03519178|540203343|FG003|Follow-Up|Death|0|||
149746291|NCT03519178|540203344|FG004|Follow-Up|Death|0|||
149746292|NCT03519178|540203345|FG005|Follow-Up|Death|0|||
149746293|NCT03519178|540203346|FG006|Follow-Up|Death|0|||
149746294|NCT03519178|540203347|FG007|Follow-Up|Death|0|||
149746295|NCT03519178|540203348|FG008|Follow-Up|Death|3|||
149746296|NCT03519178|540203349|FG009|Follow-Up|Death|1|||
149746297|NCT03519178|540203350|FG010|Follow-Up|Death|0|||
149746298|NCT03519178|540203351|FG011|Follow-Up|Death|0|||
149746299|NCT03519178|540203352|FG012|Follow-Up|Death|2|||
149746300|NCT03519178|540203353|FG013|Follow-Up|Death|0|||
149746301|NCT03519178|540203354|FG014|Follow-Up|Death|0|||
149746302|NCT03519178|540203340|FG000|Follow-Up|Lost to Follow-up|0|||
149746303|NCT03519178|540203341|FG001|Follow-Up|Lost to Follow-up|0|||
149746304|NCT03519178|540203342|FG002|Follow-Up|Lost to Follow-up|0|||
149746305|NCT03519178|540203343|FG003|Follow-Up|Lost to Follow-up|0|||
149746306|NCT03519178|540203344|FG004|Follow-Up|Lost to Follow-up|0|||
149746307|NCT03519178|540203345|FG005|Follow-Up|Lost to Follow-up|3|||
149746308|NCT03519178|540203346|FG006|Follow-Up|Lost to Follow-up|1|||
149746309|NCT03519178|540203347|FG007|Follow-Up|Lost to Follow-up|4|||
149746310|NCT03519178|540203348|FG008|Follow-Up|Lost to Follow-up|1|||
149746311|NCT03519178|540203349|FG009|Follow-Up|Lost to Follow-up|0|||
149746312|NCT03519178|540203350|FG010|Follow-Up|Lost to Follow-up|0|||
149746313|NCT03519178|540203351|FG011|Follow-Up|Lost to Follow-up|0|||
149746314|NCT03519178|540203352|FG012|Follow-Up|Lost to Follow-up|0|||
149746315|NCT03519178|540203353|FG013|Follow-Up|Lost to Follow-up|0|||
149746316|NCT03519178|540203354|FG014|Follow-Up|Lost to Follow-up|0|||
149746317|NCT03519178|540203340|FG000|Follow-Up|Withdrawal by Subject|1|||
149746318|NCT03519178|540203341|FG001|Follow-Up|Withdrawal by Subject|2|||
149746319|NCT03519178|540203342|FG002|Follow-Up|Withdrawal by Subject|2|||
149746320|NCT03519178|540203343|FG003|Follow-Up|Withdrawal by Subject|3|||
149746321|NCT03519178|540203344|FG004|Follow-Up|Withdrawal by Subject|5|||
149746322|NCT03519178|540203345|FG005|Follow-Up|Withdrawal by Subject|1|||
149746323|NCT03519178|540203346|FG006|Follow-Up|Withdrawal by Subject|2|||
149746324|NCT03519178|540203347|FG007|Follow-Up|Withdrawal by Subject|6|||
149746325|NCT03519178|540203348|FG008|Follow-Up|Withdrawal by Subject|5|||
149746326|NCT03519178|540203349|FG009|Follow-Up|Withdrawal by Subject|2|||
149746327|NCT03519178|540203350|FG010|Follow-Up|Withdrawal by Subject|3|||
149746328|NCT03519178|540203351|FG011|Follow-Up|Withdrawal by Subject|5|||
149746329|NCT03519178|540203352|FG012|Follow-Up|Withdrawal by Subject|2|||
149746330|NCT03519178|540203353|FG013|Follow-Up|Withdrawal by Subject|0|||
149746331|NCT03519178|540203354|FG014|Follow-Up|Withdrawal by Subject|0|||
149746332|NCT03519178|540203340|FG000|Follow-Up|Other|0|||
149746333|NCT03519178|540203341|FG001|Follow-Up|Other|0|||
149746334|NCT03519178|540203342|FG002|Follow-Up|Other|0|||
149746335|NCT03519178|540203343|FG003|Follow-Up|Other|0|||
149746336|NCT03519178|540203344|FG004|Follow-Up|Other|0|||
149746337|NCT03519178|540203345|FG005|Follow-Up|Other|0|||
149746338|NCT03519178|540203346|FG006|Follow-Up|Other|0|||
149746339|NCT03519178|540203347|FG007|Follow-Up|Other|1|||
149746340|NCT03519178|540203348|FG008|Follow-Up|Other|0|||
149746341|NCT03519178|540203349|FG009|Follow-Up|Other|0|||
149746342|NCT03519178|540203350|FG010|Follow-Up|Other|0|||
149746343|NCT03519178|540203351|FG011|Follow-Up|Other|0|||
149746344|NCT03519178|540203352|FG012|Follow-Up|Other|0|||
149746345|NCT03519178|540203353|FG013|Follow-Up|Other|0|||
149746346|NCT03519178|540203354|FG014|Follow-Up|Other|0|||
149746347|NCT03519178|540203340|FG000|Long-term Follow-up|Death|0|||
149746348|NCT03519178|540203341|FG001|Long-term Follow-up|Death|0|||
149746349|NCT03519178|540203342|FG002|Long-term Follow-up|Death|0|||
149746350|NCT03519178|540203343|FG003|Long-term Follow-up|Death|0|||
149746351|NCT03519178|540203344|FG004|Long-term Follow-up|Death|0|||
149746352|NCT03519178|540203345|FG005|Long-term Follow-up|Death|0|||
149746353|NCT03519178|540203346|FG006|Long-term Follow-up|Death|0|||
149746354|NCT03519178|540203347|FG007|Long-term Follow-up|Death|0|||
149746355|NCT03519178|540203348|FG008|Long-term Follow-up|Death|0|||
149746356|NCT03519178|540203349|FG009|Long-term Follow-up|Death|0|||
149746357|NCT03519178|540203350|FG010|Long-term Follow-up|Death|0|||
149746358|NCT03519178|540203351|FG011|Long-term Follow-up|Death|0|||
149746359|NCT03519178|540203352|FG012|Long-term Follow-up|Death|0|||
149746360|NCT03519178|540203353|FG013|Long-term Follow-up|Death|4|||
149746361|NCT03519178|540203354|FG014|Long-term Follow-up|Death|4|||
149746362|NCT03519178|540203340|FG000|Long-term Follow-up|Lost to Follow-up|0|||
149746363|NCT03519178|540203341|FG001|Long-term Follow-up|Lost to Follow-up|0|||
149746364|NCT03519178|540203342|FG002|Long-term Follow-up|Lost to Follow-up|0|||
150256495|NCT00513305|542072772|FG000|Overall Study|Persistent hypocellularity|0|||
150256496|NCT00513305|542072773|FG001|Overall Study|Persistent hypocellularity|1|||
150256497|NCT00513305|542072772|FG000|Overall Study|Sponsor Decision|0|||
150256498|NCT00513305|542072773|FG001|Overall Study|Sponsor Decision|2|||
150256499|NCT01262027|542072774|FG000|Overall Study|Adverse Event|1|||
150256500|NCT01262027|542072774|FG000|Overall Study|Withdrawal by Subject|3|||
150256501|NCT01262027|542072774|FG000|Overall Study|Protocol Violation|1|||
150256502|NCT03014479|542072775|FG000|Overall Study|Adverse Event|0|||
150256503|NCT03014479|542072776|FG001|Overall Study|Adverse Event|1|||
150256504|NCT03014479|542072775|FG000|Overall Study|Voluntary Withdrawal|0|||
150256505|NCT03014479|542072776|FG001|Overall Study|Voluntary Withdrawal|2|||
150256506|NCT03014479|542072775|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
150256507|NCT03014479|542072776|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
150256508|NCT01394978|542072782|FG000|Overall Study|Withdrawal by Subject|2|||
150256509|NCT01394978|542072783|FG001|Overall Study|Withdrawal by Subject|4|||
150256510|NCT01394978|542072782|FG000|Overall Study|Lost to Follow-up|13|||
149746365|NCT03519178|540203343|FG003|Long-term Follow-up|Lost to Follow-up|0|||
149746366|NCT03519178|540203344|FG004|Long-term Follow-up|Lost to Follow-up|0|||
149746367|NCT03519178|540203345|FG005|Long-term Follow-up|Lost to Follow-up|0|||
149746368|NCT03519178|540203346|FG006|Long-term Follow-up|Lost to Follow-up|0|||
149746369|NCT03519178|540203347|FG007|Long-term Follow-up|Lost to Follow-up|0|||
149746370|NCT03519178|540203348|FG008|Long-term Follow-up|Lost to Follow-up|0|||
149746371|NCT03519178|540203349|FG009|Long-term Follow-up|Lost to Follow-up|0|||
149746372|NCT03519178|540203350|FG010|Long-term Follow-up|Lost to Follow-up|0|||
149746373|NCT03519178|540203351|FG011|Long-term Follow-up|Lost to Follow-up|0|||
149746374|NCT03519178|540203352|FG012|Long-term Follow-up|Lost to Follow-up|0|||
149746375|NCT03519178|540203353|FG013|Long-term Follow-up|Lost to Follow-up|1|||
149746376|NCT03519178|540203354|FG014|Long-term Follow-up|Lost to Follow-up|1|||
149746377|NCT03519178|540203340|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
149746378|NCT03519178|540203341|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
149746379|NCT03519178|540203342|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
149746380|NCT03519178|540203343|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
149746381|NCT03519178|540203344|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
149746382|NCT03519178|540203345|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
149746383|NCT03519178|540203346|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
149746384|NCT03519178|540203347|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
149746385|NCT03519178|540203348|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
149746386|NCT03519178|540203349|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
149746387|NCT03519178|540203350|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
149746388|NCT03519178|540203351|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
149746389|NCT03519178|540203352|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
149746390|NCT03519178|540203353|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
149746391|NCT03519178|540203354|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
149746392|NCT03519178|540203340|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
149746393|NCT03519178|540203341|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
149746394|NCT03519178|540203342|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
149746395|NCT03519178|540203343|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
149746396|NCT03519178|540203344|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
149746397|NCT03519178|540203345|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
149746398|NCT03519178|540203346|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
149746399|NCT03519178|540203347|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
149746400|NCT03519178|540203348|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
149746401|NCT03519178|540203349|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
149746402|NCT03519178|540203350|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
149746403|NCT03519178|540203351|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
149746404|NCT03519178|540203352|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
149746405|NCT03519178|540203353|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
149746406|NCT03519178|540203354|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
149746407|NCT03519178|540203340|FG000|Long-term Follow-up|Other|0|||
149746408|NCT03519178|540203341|FG001|Long-term Follow-up|Other|0|||
149746409|NCT03519178|540203342|FG002|Long-term Follow-up|Other|0|||
149746410|NCT03519178|540203343|FG003|Long-term Follow-up|Other|0|||
149746411|NCT03519178|540203344|FG004|Long-term Follow-up|Other|0|||
149746412|NCT03519178|540203345|FG005|Long-term Follow-up|Other|0|||
149746413|NCT03519178|540203346|FG006|Long-term Follow-up|Other|0|||
149746414|NCT03519178|540203347|FG007|Long-term Follow-up|Other|0|||
149746415|NCT03519178|540203348|FG008|Long-term Follow-up|Other|0|||
149746416|NCT03519178|540203349|FG009|Long-term Follow-up|Other|0|||
149746417|NCT03519178|540203350|FG010|Long-term Follow-up|Other|0|||
149746418|NCT03519178|540203351|FG011|Long-term Follow-up|Other|0|||
149746419|NCT03519178|540203352|FG012|Long-term Follow-up|Other|0|||
149746420|NCT03519178|540203353|FG013|Long-term Follow-up|Other|0|||
149746421|NCT03519178|540203354|FG014|Long-term Follow-up|Other|1|||
149746422|NCT03519178|540203340|FG000|Long-term Follow-up|Global deterioration of health status|0|||
149746423|NCT03519178|540203341|FG001|Long-term Follow-up|Global deterioration of health status|0|||
149746424|NCT03519178|540203342|FG002|Long-term Follow-up|Global deterioration of health status|0|||
149746425|NCT03519178|540203343|FG003|Long-term Follow-up|Global deterioration of health status|0|||
149746426|NCT03519178|540203344|FG004|Long-term Follow-up|Global deterioration of health status|0|||
149746427|NCT03519178|540203345|FG005|Long-term Follow-up|Global deterioration of health status|0|||
149746428|NCT03519178|540203346|FG006|Long-term Follow-up|Global deterioration of health status|0|||
149746429|NCT03519178|540203347|FG007|Long-term Follow-up|Global deterioration of health status|0|||
149746430|NCT03519178|540203348|FG008|Long-term Follow-up|Global deterioration of health status|0|||
149746431|NCT03519178|540203349|FG009|Long-term Follow-up|Global deterioration of health status|0|||
149746432|NCT03519178|540203350|FG010|Long-term Follow-up|Global deterioration of health status|0|||
149746433|NCT03519178|540203351|FG011|Long-term Follow-up|Global deterioration of health status|0|||
149746434|NCT03519178|540203352|FG012|Long-term Follow-up|Global deterioration of health status|0|||
149746435|NCT03519178|540203353|FG013|Long-term Follow-up|Global deterioration of health status|1|||
149746436|NCT03519178|540203354|FG014|Long-term Follow-up|Global deterioration of health status|0|||
149746437|NCT03256539|540203355|FG000|Overall Study|Withdrawal by Subject|0|||
149746438|NCT03256539|540203356|FG001|Overall Study|Withdrawal by Subject|3|||
149746439|NCT03256539|540203355|FG000|Overall Study|Unexpected closure of study components|8|||
149746440|NCT03256539|540203356|FG001|Overall Study|Unexpected closure of study components|4|||
149746441|NCT01591330|540203361|FG000|Period 1|Adverse Event|1|||
149746442|NCT01591330|540203362|FG001|Period 1|Adverse Event|0|||
149746443|NCT01591330|540203363|FG002|Period 1|Adverse Event|0|||
149746444|NCT01591330|540203364|FG003|Period 1|Adverse Event|0|||
149746445|NCT01591330|540203361|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
149746446|NCT01591330|540203362|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149746447|NCT01591330|540203363|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149746448|NCT01591330|540203364|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149746449|NCT01591330|540203361|FG000|Period 2|Adverse Event|1|||
149746450|NCT01591330|540203362|FG001|Period 2|Adverse Event|0|||
149746451|NCT01591330|540203363|FG002|Period 2|Adverse Event|0|||
149746452|NCT01591330|540203364|FG003|Period 2|Adverse Event|0|||
149746453|NCT02782715|540203365|FG000|Overall Study|Withdrawal by Subject|1|||
149746454|NCT01919411|540203375|FG000|Overall Study|Lost to Follow-up|2|||
149746455|NCT01919411|540203376|FG001|Overall Study|Lost to Follow-up|4|||
149746456|NCT01919411|540203375|FG000|Overall Study|Physician Decision|1|||
149746457|NCT01919411|540203376|FG001|Overall Study|Physician Decision|0|||
149746458|NCT01919411|540203375|FG000|Overall Study|Protocol Violation|2|||
149746459|NCT01919411|540203376|FG001|Overall Study|Protocol Violation|1|||
149746460|NCT00144300|540203377|FG000|Overall Study|Adverse Event|18|||
149746461|NCT00144300|540203378|FG001|Overall Study|Adverse Event|16|||
149746462|NCT00144300|540203377|FG000|Overall Study|Protocol Violation|1|||
149746463|NCT00144300|540203378|FG001|Overall Study|Protocol Violation|3|||
149746464|NCT00144300|540203377|FG000|Overall Study|Lost to Follow-up|3|||
149746465|NCT00144300|540203378|FG001|Overall Study|Lost to Follow-up|0|||
149746466|NCT00144300|540203377|FG000|Overall Study|Withdrawal by Subject|6|||
149746467|NCT00144300|540203378|FG001|Overall Study|Withdrawal by Subject|6|||
149746468|NCT00144300|540203377|FG000|Overall Study|Other reason (not specified)|1|||
149746469|NCT00144300|540203378|FG001|Overall Study|Other reason (not specified)|3|||
149746470|NCT00957372|540203386|FG000|PART I|Lost to Follow-up|0|||
149746471|NCT00957372|540203387|FG001|PART I|Lost to Follow-up|0|||
149746472|NCT00957372|540203388|FG002|PART I|Lost to Follow-up|1|||
149746473|NCT00957372|540203389|FG003|PART I|Lost to Follow-up|0|||
149746474|NCT00957372|540203386|FG000|PART II|Withdrawal by Subject|0|||
149746475|NCT00957372|540203387|FG001|PART II|Withdrawal by Subject|0|||
149746476|NCT00957372|540203388|FG002|PART II|Withdrawal by Subject|0|||
149746477|NCT00957372|540203389|FG003|PART II|Withdrawal by Subject|8|||
149746478|NCT00957372|540203386|FG000|PART II|Physician Decision|0|||
149746479|NCT00957372|540203387|FG001|PART II|Physician Decision|0|||
149746480|NCT00957372|540203388|FG002|PART II|Physician Decision|0|||
149746481|NCT00957372|540203389|FG003|PART II|Physician Decision|1|||
149746482|NCT00957372|540203386|FG000|PART II|Pregnancy|0|||
149746483|NCT00957372|540203387|FG001|PART II|Pregnancy|0|||
149746484|NCT00957372|540203388|FG002|PART II|Pregnancy|0|||
149746485|NCT00957372|540203389|FG003|PART II|Pregnancy|1|||
149746486|NCT00957372|540203386|FG000|PART II|Not Know|0|||
149746487|NCT00957372|540203387|FG001|PART II|Not Know|0|||
149746488|NCT00957372|540203388|FG002|PART II|Not Know|0|||
149746489|NCT00957372|540203389|FG003|PART II|Not Know|20|||
149746490|NCT00957372|540203386|FG000|PART II|Adverse Event|0|||
149746491|NCT00957372|540203387|FG001|PART II|Adverse Event|0|||
149746492|NCT00957372|540203388|FG002|PART II|Adverse Event|0|||
149746493|NCT00957372|540203389|FG003|PART II|Adverse Event|10|||
149746494|NCT00957372|540203386|FG000|PART II|Patient non-compliance|0|||
149746495|NCT00957372|540203387|FG001|PART II|Patient non-compliance|0|||
149746496|NCT00957372|540203388|FG002|PART II|Patient non-compliance|0|||
149746497|NCT00957372|540203389|FG003|PART II|Patient non-compliance|4|||
149746498|NCT01444391|540203392|FG000|Overall Study|Death|1|||
149746499|NCT01877655|540203393|FG000|Overall Study|Death|57|||
149746500|NCT01877655|540203394|FG001|Overall Study|Death|52|||
149746501|NCT01877655|540203393|FG000|Overall Study|Withdrawal by Subject|18|||
149746502|NCT01877655|540203394|FG001|Overall Study|Withdrawal by Subject|26|||
149746503|NCT01877655|540203393|FG000|Overall Study|Physician Decision|11|||
149746504|NCT01877655|540203394|FG001|Overall Study|Physician Decision|10|||
149746505|NCT01877655|540203393|FG000|Overall Study|Miscellaneous|4|||
149746506|NCT01877655|540203394|FG001|Overall Study|Miscellaneous|4|||
149746507|NCT01877655|540203393|FG000|Overall Study|Randomized but Never Received Drug|8|||
149746508|NCT01877655|540203394|FG001|Overall Study|Randomized but Never Received Drug|5|||
149746509|NCT00538733|540203397|FG000|Overall Study|Adverse Event|8|||
149746510|NCT00538733|540203397|FG000|Overall Study|Death|1|||
149746511|NCT00538733|540203397|FG000|Overall Study|declined to participate|2|||
149746512|NCT00538733|540203397|FG000|Overall Study|still on therapy|1|||
149746513|NCT00095121|540203398|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
149746514|NCT00095121|540203399|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
149746515|NCT00095121|540203398|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
149746516|NCT00095121|540203399|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
149746517|NCT04070378|540203402|FG000|Overall Study|Withdrawal by Subject|2|||
149746518|NCT04070378|540203402|FG000|Overall Study|Screen Failure|6|||
149746519|NCT04070378|540203402|FG000|Overall Study|Physician Decision|1|||
149746520|NCT04070378|540203402|FG000|Overall Study|Adverse Event|1|||
149746521|NCT03567187|540203403|FG000|Overall Study|Lost to Follow-up|18|||
149746522|NCT03596645|540203406|FG000|Overall Study|Adverse Event|17|||
149746523|NCT03596645|540203407|FG001|Overall Study|Adverse Event|0|||
149746524|NCT03596645|540203406|FG000|Overall Study|Lack of Efficacy|8|||
149746525|NCT03596645|540203407|FG001|Overall Study|Lack of Efficacy|0|||
149746526|NCT03596645|540203406|FG000|Overall Study|Lost to Follow-up|1|||
149746527|NCT03596645|540203407|FG001|Overall Study|Lost to Follow-up|1|||
149746528|NCT03596645|540203406|FG000|Overall Study|Physician Decision|1|||
149746529|NCT03596645|540203407|FG001|Overall Study|Physician Decision|1|||
149746530|NCT03596645|540203406|FG000|Overall Study|Protocol Violation|1|||
149746531|NCT03596645|540203407|FG001|Overall Study|Protocol Violation|0|||
149746532|NCT03596645|540203406|FG000|Overall Study|Initiated Prohibited Medication|1|||
149746533|NCT03596645|540203407|FG001|Overall Study|Initiated Prohibited Medication|0|||
149746534|NCT03596645|540203406|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149746535|NCT03596645|540203407|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149746536|NCT03596645|540203406|FG000|Overall Study|No mucosal healing achieved|1|||
149746537|NCT03596645|540203407|FG001|Overall Study|No mucosal healing achieved|0|||
149746538|NCT03596645|540203406|FG000|Overall Study|Disease progression|1|||
149746539|NCT03596645|540203407|FG001|Overall Study|Disease progression|0|||
149746540|NCT03596645|540203406|FG000|Overall Study|Ongoing|37|||
149746541|NCT03596645|540203407|FG001|Overall Study|Ongoing|12|||
149746542|NCT03596645|540203406|FG000|Overall Study|Randomized but not treated|0|||
149746543|NCT03596645|540203407|FG001|Overall Study|Randomized but not treated|1|||
149746544|NCT04358458|540203408|FG000|Overall Study|Death|1|||
149746545|NCT04358458|540203409|FG001|Overall Study|Death|1|||
149746546|NCT04358458|540203410|FG002|Overall Study|Death|3|||
149746547|NCT04358458|540203411|FG003|Overall Study|Death|8|||
149746548|NCT04358458|540203412|FG004|Overall Study|Death|1|||
149746549|NCT04358458|540203413|FG005|Overall Study|Death|6|||
149746550|NCT04358458|540203414|FG006|Overall Study|Death|2|||
149746551|NCT04358458|540203415|FG007|Overall Study|Death|3|||
149746552|NCT04358458|540203408|FG000|Overall Study|Lost to Follow-up|0|||
149746553|NCT04358458|540203409|FG001|Overall Study|Lost to Follow-up|0|||
149746554|NCT04358458|540203410|FG002|Overall Study|Lost to Follow-up|0|||
149746555|NCT04358458|540203411|FG003|Overall Study|Lost to Follow-up|0|||
149746556|NCT04358458|540203412|FG004|Overall Study|Lost to Follow-up|0|||
149746557|NCT04358458|540203413|FG005|Overall Study|Lost to Follow-up|0|||
149746558|NCT04358458|540203414|FG006|Overall Study|Lost to Follow-up|0|||
149746559|NCT04358458|540203415|FG007|Overall Study|Lost to Follow-up|1|||
149746560|NCT04358458|540203408|FG000|Overall Study|Site is closing study participation|0|||
149746561|NCT04358458|540203409|FG001|Overall Study|Site is closing study participation|0|||
149746562|NCT04358458|540203410|FG002|Overall Study|Site is closing study participation|0|||
149746563|NCT04358458|540203411|FG003|Overall Study|Site is closing study participation|1|||
149746564|NCT04358458|540203412|FG004|Overall Study|Site is closing study participation|0|||
149746565|NCT04358458|540203413|FG005|Overall Study|Site is closing study participation|0|||
149746566|NCT04358458|540203414|FG006|Overall Study|Site is closing study participation|0|||
149746567|NCT04358458|540203415|FG007|Overall Study|Site is closing study participation|0|||
149746568|NCT04358458|540203408|FG000|Overall Study|Sponsor request|2|||
149746569|NCT04358458|540203409|FG001|Overall Study|Sponsor request|3|||
149746570|NCT04358458|540203410|FG002|Overall Study|Sponsor request|3|||
149746571|NCT04358458|540203411|FG003|Overall Study|Sponsor request|0|||
149746572|NCT04358458|540203412|FG004|Overall Study|Sponsor request|2|||
149746573|NCT04358458|540203413|FG005|Overall Study|Sponsor request|3|||
149746574|NCT04358458|540203414|FG006|Overall Study|Sponsor request|1|||
149746575|NCT04358458|540203415|FG007|Overall Study|Sponsor request|1|||
149746576|NCT04358458|540203408|FG000|Overall Study|Withdrawal by Subject|0|||
149746577|NCT04358458|540203409|FG001|Overall Study|Withdrawal by Subject|0|||
149746578|NCT04358458|540203410|FG002|Overall Study|Withdrawal by Subject|1|||
149746579|NCT04358458|540203411|FG003|Overall Study|Withdrawal by Subject|1|||
149746580|NCT04358458|540203412|FG004|Overall Study|Withdrawal by Subject|0|||
149746581|NCT04358458|540203413|FG005|Overall Study|Withdrawal by Subject|1|||
149746582|NCT04358458|540203414|FG006|Overall Study|Withdrawal by Subject|0|||
149746583|NCT04358458|540203415|FG007|Overall Study|Withdrawal by Subject|1|||
149746584|NCT02277444|540203418|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
149746585|NCT02277444|540203418|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
149746586|NCT02277444|540203418|FG000|Treatment Period (Week 0-52)|Other|1|||
149746587|NCT02277444|540203418|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
149746588|NCT02277444|540203418|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
149746589|NCT02277444|540203418|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
149746590|NCT02277444|540203418|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
149746591|NCT02277444|540203418|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
149746592|NCT02277444|540203418|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
149746593|NCT05278104|540203419|FG000|Overall Study|Not treated|1|||
149746594|NCT05278104|540203420|FG001|Overall Study|Not treated|0|||
150256511|NCT01394978|542072783|FG001|Overall Study|Lost to Follow-up|20|||
149746595|NCT05278104|540203419|FG000|Overall Study|Adverse Event|2|||
149746596|NCT05278104|540203420|FG001|Overall Study|Adverse Event|1|||
149746597|NCT05278104|540203419|FG000|Overall Study|Exclusion criteria not met|1|||
149746598|NCT05278104|540203420|FG001|Overall Study|Exclusion criteria not met|0|||
149746599|NCT01843374|540205275|FG000|Overall Study|Death|155|||
149746600|NCT01843374|540205276|FG001|Overall Study|Death|313|||
149746601|NCT01843374|540205275|FG000|Overall Study|Withdrawal by Subject|14|||
149746602|NCT01843374|540205276|FG001|Overall Study|Withdrawal by Subject|20|||
149746603|NCT01843374|540205275|FG000|Overall Study|Withdrawing due to Other reason|20|||
149746604|NCT01843374|540205276|FG001|Overall Study|Withdrawing due to Other reason|46|||
149746605|NCT01123889|540205280|FG000|Overall Study|Lost to Follow-up|3|||
149746606|NCT01123889|540205281|FG001|Overall Study|Lost to Follow-up|1|||
149746607|NCT00443560|540205283|FG000|Overall Study|No intrathecal dose|58|||
149746608|NCT00443560|540205284|FG001|Overall Study|No intrathecal dose|26|||
149746609|NCT00443560|540205283|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
149746610|NCT00443560|540205284|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
149746611|NCT02082184|540205285|FG000|Overall Study|Adverse Event|1|||
149746612|NCT02082184|540205286|FG001|Overall Study|Adverse Event|0|||
149746613|NCT02082184|540205285|FG000|Overall Study|Medical diagnosis|1|||
149746614|NCT02082184|540205286|FG001|Overall Study|Medical diagnosis|2|||
149746615|NCT02082184|540205285|FG000|Overall Study|Device associated symptoms|5|||
149746616|NCT02082184|540205286|FG001|Overall Study|Device associated symptoms|0|||
149746617|NCT02082184|540205285|FG000|Overall Study|Withdrawal by Subject|3|||
149746618|NCT02082184|540205286|FG001|Overall Study|Withdrawal by Subject|2|||
149746619|NCT02082184|540205285|FG000|Overall Study|Protocol Violation|0|||
149746620|NCT02082184|540205286|FG001|Overall Study|Protocol Violation|6|||
149746621|NCT02082184|540205285|FG000|Overall Study|Lost to Follow-up|0|||
149746622|NCT02082184|540205286|FG001|Overall Study|Lost to Follow-up|2|||
149746623|NCT02082184|540205285|FG000|Overall Study|Subject non-compliance|0|||
149746624|NCT02082184|540205286|FG001|Overall Study|Subject non-compliance|1|||
149746625|NCT02413255|540205295|FG000|Overall Study|Voluntary Withdrawal|0|||
149746626|NCT02413255|540205296|FG001|Overall Study|Voluntary Withdrawal|0|||
149746627|NCT02413255|540205297|FG002|Overall Study|Voluntary Withdrawal|0|||
149746628|NCT02413255|540205298|FG003|Overall Study|Voluntary Withdrawal|0|||
149746629|NCT02413255|540205299|FG004|Overall Study|Voluntary Withdrawal|0|||
149746630|NCT02413255|540205300|FG005|Overall Study|Voluntary Withdrawal|0|||
149746631|NCT02413255|540205301|FG006|Overall Study|Voluntary Withdrawal|0|||
149746632|NCT02413255|540205302|FG007|Overall Study|Voluntary Withdrawal|0|||
149746633|NCT02413255|540205303|FG008|Overall Study|Voluntary Withdrawal|0|||
149746634|NCT02413255|540205304|FG009|Overall Study|Voluntary Withdrawal|0|||
149746635|NCT02413255|540205305|FG010|Overall Study|Voluntary Withdrawal|0|||
149746636|NCT02413255|540205306|FG011|Overall Study|Voluntary Withdrawal|0|||
149746637|NCT02413255|540205307|FG012|Overall Study|Voluntary Withdrawal|0|||
149746638|NCT02413255|540205308|FG013|Overall Study|Voluntary Withdrawal|0|||
149746639|NCT02413255|540205309|FG014|Overall Study|Voluntary Withdrawal|1|||
149746640|NCT02413255|540205310|FG015|Overall Study|Voluntary Withdrawal|0|||
149746641|NCT02413255|540205311|FG016|Overall Study|Voluntary Withdrawal|0|||
149746642|NCT02333331|540205312|FG000|Overall Study|Adverse Event|1|||
149746643|NCT02333331|540205313|FG001|Overall Study|Adverse Event|0|||
149746644|NCT02333331|540205314|FG002|Overall Study|Adverse Event|4|||
149746645|NCT02333331|540205315|FG003|Overall Study|Adverse Event|1|||
149746646|NCT02333331|540205312|FG000|Overall Study|Death|0|||
149746647|NCT02333331|540205313|FG001|Overall Study|Death|0|||
149746648|NCT02333331|540205314|FG002|Overall Study|Death|2|||
149746649|NCT02333331|540205315|FG003|Overall Study|Death|0|||
149746650|NCT02333331|540205312|FG000|Overall Study|Lost to Follow-up|0|||
149746651|NCT02333331|540205313|FG001|Overall Study|Lost to Follow-up|0|||
149746652|NCT02333331|540205314|FG002|Overall Study|Lost to Follow-up|1|||
149746653|NCT02333331|540205315|FG003|Overall Study|Lost to Follow-up|0|||
149746654|NCT02333331|540205312|FG000|Overall Study|Physician Decision|0|||
149746655|NCT02333331|540205313|FG001|Overall Study|Physician Decision|1|||
149746656|NCT02333331|540205314|FG002|Overall Study|Physician Decision|0|||
149746657|NCT02333331|540205315|FG003|Overall Study|Physician Decision|0|||
149746658|NCT02333331|540205312|FG000|Overall Study|Protocol Deviation|0|||
149746659|NCT02333331|540205313|FG001|Overall Study|Protocol Deviation|3|||
149746660|NCT02333331|540205314|FG002|Overall Study|Protocol Deviation|2|||
149746661|NCT02333331|540205315|FG003|Overall Study|Protocol Deviation|1|||
150256512|NCT01394978|542072782|FG000|Overall Study|Death|6|||
149746662|NCT02333331|540205312|FG000|Overall Study|Patient/Guardian Decision|1|||
149746663|NCT02333331|540205313|FG001|Overall Study|Patient/Guardian Decision|2|||
149746664|NCT02333331|540205314|FG002|Overall Study|Patient/Guardian Decision|9|||
149746665|NCT02333331|540205315|FG003|Overall Study|Patient/Guardian Decision|1|||
149746666|NCT02413398|540205316|FG000|Overall Study|Lost to Follow-up|2|||
149746667|NCT02413398|540205317|FG001|Overall Study|Lost to Follow-up|4|||
149746668|NCT02413398|540205316|FG000|Overall Study|Withdrawal by Subject|1|||
149746669|NCT02413398|540205317|FG001|Overall Study|Withdrawal by Subject|1|||
149746670|NCT02413398|540205316|FG000|Overall Study|Other Eligibility criteria|1|||
149746671|NCT02413398|540205317|FG001|Overall Study|Other Eligibility criteria|2|||
149746672|NCT01494038|540205318|FG000|Overall Study|Protocol Violation|1|||
149746673|NCT01494038|540205319|FG001|Overall Study|Protocol Violation|1|||
149746674|NCT01494038|540205318|FG000|Overall Study|Lost to Follow-up|18|||
149746675|NCT01494038|540205319|FG001|Overall Study|Lost to Follow-up|20|||
149746676|NCT01494038|540205318|FG000|Overall Study|Withdrawal by Subject|44|||
149746677|NCT01494038|540205319|FG001|Overall Study|Withdrawal by Subject|34|||
149746678|NCT01494038|540205318|FG000|Overall Study|Not able to get to clinic|21|||
149746679|NCT01494038|540205319|FG001|Overall Study|Not able to get to clinic|15|||
149746680|NCT01494038|540205318|FG000|Overall Study|Not willing to adhere to reqs|2|||
149746681|NCT01494038|540205319|FG001|Overall Study|Not willing to adhere to reqs|9|||
149746682|NCT01494038|540205318|FG000|Overall Study|Death|2|||
149746683|NCT01494038|540205319|FG001|Overall Study|Death|4|||
149746684|NCT00537940|540205322|FG000|Overall Study|Adverse Event|20|||
149746685|NCT00537940|540205323|FG001|Overall Study|Adverse Event|19|||
149746686|NCT00537940|540205322|FG000|Overall Study|Lack of Efficacy|8|||
149746687|NCT00537940|540205323|FG001|Overall Study|Lack of Efficacy|16|||
149746688|NCT00537940|540205322|FG000|Overall Study|Lost to Follow-up|23|||
149746689|NCT00537940|540205323|FG001|Overall Study|Lost to Follow-up|29|||
149746690|NCT00537940|540205322|FG000|Overall Study|Withdrawal by Subject|113|||
149746691|NCT00537940|540205323|FG001|Overall Study|Withdrawal by Subject|95|||
149746692|NCT00537940|540205322|FG000|Overall Study|Protocol Violation|6|||
149746693|NCT00537940|540205323|FG001|Overall Study|Protocol Violation|4|||
149746694|NCT00537940|540205322|FG000|Overall Study|Pregnancy|1|||
149746695|NCT00537940|540205323|FG001|Overall Study|Pregnancy|1|||
149746696|NCT00537940|540205322|FG000|Overall Study|Study terminated by sponsor|2|||
149746697|NCT00537940|540205323|FG001|Overall Study|Study terminated by sponsor|3|||
149746698|NCT00537940|540205322|FG000|Overall Study|Other|10|||
149746699|NCT00537940|540205323|FG001|Overall Study|Other|12|||
149746700|NCT00685178|540205328|FG000|Overall Study|Adverse Event|1|||
149746701|NCT00685178|540205329|FG001|Overall Study|Adverse Event|5|||
149746702|NCT00685178|540205330|FG002|Overall Study|Adverse Event|2|||
149746703|NCT00685178|540205331|FG003|Overall Study|Adverse Event|4|||
149746704|NCT00685178|540205328|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
149746705|NCT00685178|540205329|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
149746706|NCT00685178|540205330|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
149746707|NCT00685178|540205331|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
149746708|NCT00685178|540205328|FG000|Overall Study|voluntary study discharge|4|||
149746709|NCT00685178|540205329|FG001|Overall Study|voluntary study discharge|5|||
149746710|NCT00685178|540205330|FG002|Overall Study|voluntary study discharge|1|||
149746711|NCT00685178|540205331|FG003|Overall Study|voluntary study discharge|1|||
149746712|NCT00685178|540205328|FG000|Overall Study|incarcerated|1|||
149746713|NCT00685178|540205329|FG001|Overall Study|incarcerated|3|||
149746714|NCT00685178|540205330|FG002|Overall Study|incarcerated|7|||
149746715|NCT00685178|540205331|FG003|Overall Study|incarcerated|0|||
149746716|NCT00685178|540205328|FG000|Overall Study|administrative (disciplinary) discharge|0|||
149746717|NCT00685178|540205329|FG001|Overall Study|administrative (disciplinary) discharge|1|||
149746718|NCT00685178|540205330|FG002|Overall Study|administrative (disciplinary) discharge|0|||
149746719|NCT00685178|540205331|FG003|Overall Study|administrative (disciplinary) discharge|2|||
149746720|NCT00685178|540205328|FG000|Overall Study|Pregnancy|0|||
149746721|NCT00685178|540205329|FG001|Overall Study|Pregnancy|0|||
149746722|NCT00685178|540205330|FG002|Overall Study|Pregnancy|0|||
149746723|NCT00685178|540205331|FG003|Overall Study|Pregnancy|1|||
149746724|NCT00077623|540205339|FG000|Overall Study|Adverse Event|1|||
149746725|NCT00077623|540205340|FG001|Overall Study|Adverse Event|0|||
149746726|NCT00077623|540205341|FG002|Overall Study|Adverse Event|1|||
149746727|NCT00077623|540205339|FG000|Overall Study|Withdrawal by Subject|2|||
149746728|NCT00077623|540205340|FG001|Overall Study|Withdrawal by Subject|10|||
149746729|NCT00077623|540205341|FG002|Overall Study|Withdrawal by Subject|1|||
149746730|NCT00077623|540205339|FG000|Overall Study|Other-Non safety reason|18|||
149746731|NCT00077623|540205340|FG001|Overall Study|Other-Non safety reason|15|||
149746732|NCT00077623|540205341|FG002|Overall Study|Other-Non safety reason|19|||
149746733|NCT00077623|540205339|FG000|Overall Study|Insufficient therapeutic response|2|||
149746734|NCT00077623|540205340|FG001|Overall Study|Insufficient therapeutic response|0|||
149746735|NCT00077623|540205341|FG002|Overall Study|Insufficient therapeutic response|0|||
149746736|NCT00077623|540205339|FG000|Overall Study|Death|12|||
149746737|NCT00077623|540205340|FG001|Overall Study|Death|18|||
149746738|NCT00077623|540205341|FG002|Overall Study|Death|11|||
149746739|NCT00077623|540205339|FG000|Overall Study|Failure to return|1|||
149746740|NCT00077623|540205340|FG001|Overall Study|Failure to return|0|||
149746741|NCT00077623|540205341|FG002|Overall Study|Failure to return|0|||
149746742|NCT01334125|540205342|FG000|Overall Study|Lost to Follow-up|3|||
149746743|NCT01334125|540205343|FG001|Overall Study|Lost to Follow-up|3|||
149746744|NCT02138110|540205347|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
149746745|NCT02138110|540205347|FG000|Overall Scaffold Implantation|Death|3|||
149746746|NCT00882713|540205349|FG000|Overall Study|Adverse Event|2|||
149746747|NCT00882713|540205349|FG000|Overall Study|Death|3|||
149746748|NCT00882713|540205349|FG000|Overall Study|Administrative reasons|4|||
149746749|NCT00882713|540205349|FG000|Overall Study|refused treatment/withdrew consent|4|||
149746750|NCT00882713|540205349|FG000|Overall Study|Blood transfusion|2|||
150256513|NCT01394978|542072783|FG001|Overall Study|Death|7|||
149746751|NCT00882713|540205349|FG000|Overall Study|Insufficient therapeutic response|3|||
149746752|NCT00882713|540205349|FG000|Overall Study|Failure to return|2|||
149746753|NCT00882713|540205349|FG000|Overall Study|Other - Reasons|2|||
149746754|NCT03180736|540205352|FG000|Overall Study|Adverse Event|3|||
149746755|NCT03180736|540205353|FG001|Overall Study|Adverse Event|4|||
149746756|NCT03180736|540205352|FG000|Overall Study|Death|10|||
149746757|NCT03180736|540205353|FG001|Overall Study|Death|7|||
149746758|NCT03180736|540205352|FG000|Overall Study|Withdrawal by Subject|5|||
149746759|NCT03180736|540205353|FG001|Overall Study|Withdrawal by Subject|12|||
149746760|NCT03180736|540205352|FG000|Overall Study|Lost to Follow-up|1|||
149746761|NCT03180736|540205353|FG001|Overall Study|Lost to Follow-up|0|||
149746762|NCT03180736|540205352|FG000|Overall Study|Lack of Efficacy|66|||
149746763|NCT03180736|540205353|FG001|Overall Study|Lack of Efficacy|87|||
149746764|NCT03180736|540205352|FG000|Overall Study|Physician Decision|4|||
149746765|NCT03180736|540205353|FG001|Overall Study|Physician Decision|7|||
149746766|NCT03180736|540205352|FG000|Overall Study|randomized but not treated|2|||
149746767|NCT03180736|540205353|FG001|Overall Study|randomized but not treated|3|||
149746768|NCT05299892|540205354|FG000|Overall Study|Withdrawal by Subject|2|||
149746769|NCT01389128|540205355|FG000|Overall Study|Fetal distress|1|||
149746770|NCT01389128|540205356|FG001|Overall Study|Fetal distress|0|||
149746771|NCT01389128|540205355|FG000|Overall Study|Cervix dilation stop|1|||
149746772|NCT01389128|540205356|FG001|Overall Study|Cervix dilation stop|2|||
149746773|NCT01389128|540205355|FG000|Overall Study|Rapid labor evolution|3|||
149746774|NCT01389128|540205356|FG001|Overall Study|Rapid labor evolution|2|||
149746775|NCT01389128|540205355|FG000|Overall Study|Intolerance to procedure|0|||
149746776|NCT01389128|540205356|FG001|Overall Study|Intolerance to procedure|2|||
149746777|NCT01059812|540205357|FG000|Overall Study|Adverse Event|9|||
149746778|NCT01059812|540205358|FG001|Overall Study|Adverse Event|5|||
149746779|NCT01059812|540205357|FG000|Overall Study|Lack of Efficacy|2|||
149746780|NCT01059812|540205358|FG001|Overall Study|Lack of Efficacy|2|||
149746781|NCT01059812|540205357|FG000|Overall Study|Protocol Violation|3|||
149746782|NCT01059812|540205358|FG001|Overall Study|Protocol Violation|1|||
149746783|NCT01059812|540205357|FG000|Overall Study|Withdrawal Criteria|9|||
149746784|NCT01059812|540205358|FG001|Overall Study|Withdrawal Criteria|4|||
149746785|NCT01059812|540205357|FG000|Overall Study|Unclassified|14|||
149746786|NCT01059812|540205358|FG001|Overall Study|Unclassified|4|||
149746787|NCT00149214|540205363|FG000|Overall Study|Adverse Event|12|||
149746788|NCT00149214|540205364|FG001|Overall Study|Adverse Event|9|||
149746789|NCT00149214|540205363|FG000|Overall Study|Withdrawal by Subject|4|||
149746790|NCT00149214|540205364|FG001|Overall Study|Withdrawal by Subject|1|||
149746791|NCT00149214|540205363|FG000|Overall Study|Physician Decision|3|||
149746792|NCT00149214|540205364|FG001|Overall Study|Physician Decision|3|||
149746793|NCT00149214|540205363|FG000|Overall Study|Sponsor Decision|0|||
149746794|NCT00149214|540205364|FG001|Overall Study|Sponsor Decision|1|||
149746795|NCT00149214|540205363|FG000|Overall Study|Progressive Disease|7|||
149746796|NCT00149214|540205364|FG001|Overall Study|Progressive Disease|3|||
149746797|NCT00756002|540205365|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
149746798|NCT00756002|540205366|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
149746799|NCT00756002|540205365|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149746800|NCT00756002|540205366|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149746801|NCT00756002|540205365|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
149746802|NCT00756002|540205366|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
149746803|NCT00756002|540205365|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
149746804|NCT00756002|540205366|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
149746805|NCT00756002|540205365|FG000|Double-Blind Treatment Period|Other|2|||
149746806|NCT00756002|540205366|FG001|Double-Blind Treatment Period|Other|2|||
149746807|NCT00174941|540205372|FG000|Overall Study|Adverse Event|1|||
149746808|NCT00174941|540205373|FG001|Overall Study|Adverse Event|10|||
149746809|NCT00174941|540205374|FG002|Overall Study|Adverse Event|2|||
149746810|NCT00174941|540205375|FG003|Overall Study|Adverse Event|13|||
149746811|NCT00174941|540205372|FG000|Overall Study|Protocol Violation|0|||
149746812|NCT00174941|540205373|FG001|Overall Study|Protocol Violation|1|||
149746813|NCT00174941|540205374|FG002|Overall Study|Protocol Violation|0|||
149746814|NCT00174941|540205375|FG003|Overall Study|Protocol Violation|1|||
149746815|NCT00174941|540205372|FG000|Overall Study|Lost to Follow-up|0|||
149746816|NCT00174941|540205373|FG001|Overall Study|Lost to Follow-up|3|||
149746817|NCT00174941|540205374|FG002|Overall Study|Lost to Follow-up|2|||
149746818|NCT00174941|540205375|FG003|Overall Study|Lost to Follow-up|5|||
149746819|NCT00174941|540205372|FG000|Overall Study|Personal Reason(s)|0|||
149746820|NCT00174941|540205373|FG001|Overall Study|Personal Reason(s)|14|||
150256514|NCT02217501|542072784|FG000|Overall Study|Death|3|||
149746821|NCT00174941|540205374|FG002|Overall Study|Personal Reason(s)|8|||
149746822|NCT00174941|540205375|FG003|Overall Study|Personal Reason(s)|22|||
149746823|NCT00174941|540205372|FG000|Overall Study|Gout Flare|0|||
149746824|NCT00174941|540205373|FG001|Overall Study|Gout Flare|4|||
149746825|NCT00174941|540205374|FG002|Overall Study|Gout Flare|4|||
149746826|NCT00174941|540205375|FG003|Overall Study|Gout Flare|8|||
149746827|NCT00174941|540205372|FG000|Overall Study|Reason Not Specified|1|||
149746828|NCT00174941|540205373|FG001|Overall Study|Reason Not Specified|6|||
149746829|NCT00174941|540205374|FG002|Overall Study|Reason Not Specified|2|||
149746830|NCT00174941|540205375|FG003|Overall Study|Reason Not Specified|9|||
149746831|NCT01844076|540205387|FG000|Overall Study|Adverse Event|1|||
149746832|NCT01844076|540205388|FG001|Overall Study|Adverse Event|0|||
149746833|NCT01844076|540205389|FG002|Overall Study|Adverse Event|0|||
149746834|NCT01844076|540205390|FG003|Overall Study|Adverse Event|0|||
149746835|NCT01844076|540205387|FG000|Overall Study|Withdrawal by Subject|1|||
149746836|NCT01844076|540205388|FG001|Overall Study|Withdrawal by Subject|0|||
149746837|NCT01844076|540205389|FG002|Overall Study|Withdrawal by Subject|0|||
149746838|NCT01844076|540205390|FG003|Overall Study|Withdrawal by Subject|0|||
149746839|NCT03794986|540205397|FG000|Overall Study|0 Sessions Attended|34|||
149746840|NCT03794986|540205398|FG001|Overall Study|0 Sessions Attended|37|||
149746841|NCT03794986|540205397|FG000|Overall Study|Withdrawal by Subject|4|||
149746842|NCT03794986|540205398|FG001|Overall Study|Withdrawal by Subject|6|||
149746843|NCT03794986|540205397|FG000|Overall Study|Protocol Violation|1|||
149746844|NCT03794986|540205398|FG001|Overall Study|Protocol Violation|0|||
149746845|NCT05309083|540205399|FG000|Overall Study|Withdrawal by Subject|2|||
149746846|NCT01165229|540205400|FG000|Overall Study|Serious Adverse Event|456|||
149746847|NCT01165229|540205401|FG001|Overall Study|Serious Adverse Event|487|||
149746848|NCT01165229|540205400|FG000|Overall Study|Non-Serious Adverse Event|47|||
149746849|NCT01165229|540205401|FG001|Overall Study|Non-Serious Adverse Event|15|||
149746850|NCT01165229|540205400|FG000|Overall Study|Protocol Violation|6|||
149746851|NCT01165229|540205401|FG001|Overall Study|Protocol Violation|8|||
149746852|NCT01165229|540205400|FG000|Overall Study|Withdrawal by Subject|387|||
149746853|NCT01165229|540205401|FG001|Overall Study|Withdrawal by Subject|396|||
149746854|NCT01165229|540205400|FG000|Overall Study|Migrated/moved from study area|51|||
149746855|NCT01165229|540205401|FG001|Overall Study|Migrated/moved from study area|46|||
149746856|NCT01165229|540205400|FG000|Overall Study|Lost to Follow-up|123|||
149746857|NCT01165229|540205401|FG001|Overall Study|Lost to Follow-up|133|||
149746858|NCT01165229|540205400|FG000|Overall Study|Suspected HZ Episode|2|||
149746859|NCT01165229|540205401|FG001|Overall Study|Suspected HZ Episode|2|||
149746860|NCT01165229|540205400|FG000|Overall Study|No reason from the subject|108|||
149746861|NCT01165229|540205401|FG001|Overall Study|No reason from the subject|102|||
149746862|NCT01165229|540205400|FG000|Overall Study|Unknown completion status|0|||
149746863|NCT01165229|540205401|FG001|Overall Study|Unknown completion status|1|||
149746864|NCT00474253|540205402|FG000|Overall Study|Withdrew consent|2|||
149746865|NCT00474253|540205403|FG001|Overall Study|Withdrew consent|0|||
149746866|NCT00474253|540205402|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
149746867|NCT00474253|540205403|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
149746868|NCT00474253|540205402|FG000|Overall Study|Lost to Follow-up|1|||
149746869|NCT00474253|540205403|FG001|Overall Study|Lost to Follow-up|0|||
149746870|NCT00474253|540205402|FG000|Overall Study|Discharged prior to study completion|0|||
149746871|NCT00474253|540205403|FG001|Overall Study|Discharged prior to study completion|1|||
149746872|NCT00550238|540205407|FG000|Overall Study|Adverse Event|88|||
149746873|NCT00550238|540205407|FG000|Overall Study|Death|34|||
149746874|NCT00550238|540205407|FG000|Overall Study|Disease progression|46|||
149746875|NCT00550238|540205407|FG000|Overall Study|Withdrawal by Subject|167|||
149746876|NCT00550238|540205407|FG000|Overall Study|Physician Decision|31|||
149746877|NCT00550238|540205407|FG000|Overall Study|Patient noncompliance|25|||
149746878|NCT00550238|540205407|FG000|Overall Study|Lost to Follow-up|13|||
149746879|NCT00550238|540205407|FG000|Overall Study|Sponsor decision|55|||
149746880|NCT03133481|540205408|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
149746881|NCT03133481|540205409|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
149746882|NCT03000452|540205414|FG000|Treatment Period|Death|1|||
149746883|NCT03000452|540205414|FG000|Treatment Period|Progressive Disease (PD)|14|||
149746884|NCT03000452|540205414|FG000|Treatment Period|Physician Decision|1|||
149746885|NCT03000452|540205414|FG000|Treatment Period|Miscellaneous|2|||
149746886|NCT03000452|540205414|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
149746887|NCT03000452|540205414|FG000|Follow-Up Period|Death|3|||
149746888|NCT03000452|540205414|FG000|Follow-Up Period|Withdrawal by Subject|3|||
149746889|NCT05372315|540205417|FG000|Overall Study|Withdrawal by Subject|1|||
149746890|NCT05372315|540205418|FG001|Overall Study|Withdrawal by Subject|0|||
149746891|NCT00537745|540205419|FG000|Overall Study|Did not meet eligibility criteria|2|||
149746892|NCT00537745|540205419|FG000|Overall Study|Withdrawal by Subject|2|||
149746893|NCT00537745|540205419|FG000|Overall Study|Subject unable to provide Interlock info|1|||
149746894|NCT01512368|540205420|FG000|Overall Study|Protocol Violation|3|||
149746895|NCT03700892|540205425|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
149746896|NCT03700892|540205426|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
150256515|NCT02217501|542072785|FG001|Overall Study|Death|4|||
149746897|NCT03700892|540205427|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
149746898|NCT00849212|540205428|FG000|Overall Study|Lack of Efficacy|1|||
149746899|NCT00849212|540205428|FG000|Overall Study|Withdrawal by Subject|3|||
149746900|NCT00849212|540205428|FG000|Overall Study|Adverse Event|2|||
149746901|NCT00849212|540205428|FG000|Overall Study|Miscellaneous|1|||
149746902|NCT04407507|540205429|FG000|Overall Study|Withdrawal by Subject|0|||
149746903|NCT04407507|540205430|FG001|Overall Study|Withdrawal by Subject|1|||
149746904|NCT01499576|540205431|FG000|Overall Study|Physician Decision|12|||
149746905|NCT01499576|540205431|FG000|Overall Study|Withdrawal by Subject|9|||
149746906|NCT01662999|540205435|FG000|Period 3|Withdrawal by Subject|0|||
149746907|NCT01662999|540205436|FG001|Period 3|Withdrawal by Subject|1|||
149746908|NCT01662999|540205437|FG002|Period 3|Withdrawal by Subject|0|||
149746909|NCT01662999|540205438|FG003|Period 3|Withdrawal by Subject|0|||
149746910|NCT01662999|540205439|FG004|Period 3|Withdrawal by Subject|0|||
149746911|NCT01662999|540205440|FG005|Period 3|Withdrawal by Subject|0|||
149746912|NCT02426086|540205441|FG000|Overall Study|Death|33|||
149746913|NCT02426086|540205442|FG001|Overall Study|Death|36|||
149746914|NCT02426086|540205441|FG000|Overall Study|Lost to Follow-up|2|||
149746915|NCT02426086|540205442|FG001|Overall Study|Lost to Follow-up|0|||
149746916|NCT02426086|540205441|FG000|Overall Study|Study Terminated by Sponsor|5|||
149746917|NCT02426086|540205442|FG001|Overall Study|Study Terminated by Sponsor|14|||
149746918|NCT02426086|540205441|FG000|Overall Study|Withdrawal by Subject|8|||
149746919|NCT02426086|540205442|FG001|Overall Study|Withdrawal by Subject|9|||
149746920|NCT00524303|540205443|FG000|Overall Study|Lost to Follow-up|6|||
149746921|NCT00524303|540205444|FG001|Overall Study|Lost to Follow-up|0|||
149746922|NCT00524303|540205445|FG002|Overall Study|Lost to Follow-up|3|||
149746923|NCT00524303|540205443|FG000|Overall Study|Protocol Violation|0|||
149746924|NCT00524303|540205444|FG001|Overall Study|Protocol Violation|1|||
149746925|NCT00524303|540205445|FG002|Overall Study|Protocol Violation|1|||
149746926|NCT00524303|540205443|FG000|Overall Study|Withdrawal by Subject|3|||
149746927|NCT00524303|540205444|FG001|Overall Study|Withdrawal by Subject|0|||
149746928|NCT00524303|540205445|FG002|Overall Study|Withdrawal by Subject|4|||
149746929|NCT00524303|540205443|FG000|Overall Study|Death|0|||
149746930|NCT00524303|540205444|FG001|Overall Study|Death|2|||
149746931|NCT00524303|540205445|FG002|Overall Study|Death|3|||
149746932|NCT00524303|540205443|FG000|Overall Study|Adverse Event|1|||
149746933|NCT00524303|540205444|FG001|Overall Study|Adverse Event|2|||
149746934|NCT00524303|540205445|FG002|Overall Study|Adverse Event|3|||
149746935|NCT00524303|540205443|FG000|Overall Study|Did not Complete Study Dosing|1|||
149746936|NCT00524303|540205444|FG001|Overall Study|Did not Complete Study Dosing|0|||
149746937|NCT00524303|540205445|FG002|Overall Study|Did not Complete Study Dosing|0|||
149746938|NCT00524303|540205443|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
149746939|NCT00524303|540205444|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
149746940|NCT00524303|540205445|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
149746941|NCT00524303|540205443|FG000|Overall Study|Disease Progression|0|||
149746942|NCT00524303|540205444|FG001|Overall Study|Disease Progression|4|||
149746943|NCT00524303|540205445|FG002|Overall Study|Disease Progression|1|||
149746944|NCT00524303|540205443|FG000|Overall Study|Disease Recurrence|0|||
149746945|NCT00524303|540205444|FG001|Overall Study|Disease Recurrence|1|||
149746946|NCT00524303|540205445|FG002|Overall Study|Disease Recurrence|0|||
149746947|NCT00524303|540205443|FG000|Overall Study|Sponsor Request|0|||
149746948|NCT00524303|540205444|FG001|Overall Study|Sponsor Request|0|||
149746949|NCT00524303|540205445|FG002|Overall Study|Sponsor Request|1|||
149746950|NCT00524303|540205443|FG000|Overall Study|Physician Decision|0|||
149746951|NCT00524303|540205444|FG001|Overall Study|Physician Decision|0|||
149746952|NCT00524303|540205445|FG002|Overall Study|Physician Decision|1|||
149746953|NCT00524303|540205443|FG000|Overall Study|Completed 5 years|0|||
149746954|NCT00524303|540205444|FG001|Overall Study|Completed 5 years|0|||
149746955|NCT00524303|540205445|FG002|Overall Study|Completed 5 years|1|||
149746956|NCT03478683|540205446|FG000|Overall Study|Adverse Event|5|||
149746957|NCT03478683|540205447|FG001|Overall Study|Adverse Event|3|||
149746958|NCT03478683|540205446|FG000|Overall Study|Lost to Follow-up|0|||
149746959|NCT03478683|540205447|FG001|Overall Study|Lost to Follow-up|5|||
149746960|NCT03478683|540205446|FG000|Overall Study|Physician Decision|1|||
149746961|NCT03478683|540205447|FG001|Overall Study|Physician Decision|3|||
149746962|NCT03478683|540205446|FG000|Overall Study|Withdrawal by Subject|7|||
149746963|NCT03478683|540205447|FG001|Overall Study|Withdrawal by Subject|7|||
149746964|NCT01769404|540205448|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
149746965|NCT01769404|540205449|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
149746966|NCT01769404|540205448|FG000|Treatment Period 1|Withdrawal by Subject|3|||
149746967|NCT01769404|540205449|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149746968|NCT01769404|540205448|FG000|Treatment Period 1|Sponsor decision|1|||
150256516|NCT02019667|542072786|FG000|First Intervention (6 Months)|Adverse Event|0|||
149746969|NCT01769404|540205449|FG001|Treatment Period 1|Sponsor decision|0|||
149746970|NCT01769404|540205448|FG000|Treatment Period 2|Sponsor decision|7|||
150256517|NCT02019667|542072787|FG001|First Intervention (6 Months)|Adverse Event|1|||
150256518|NCT02019667|542072786|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
149746971|NCT01769404|540205449|FG001|Treatment Period 2|Sponsor decision|0|||
149801756|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
149801757|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
150256519|NCT02019667|542072787|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
149801758|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
149801759|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
149801760|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
149746972|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
149746973|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
149746974|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
149746975|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
149746976|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
149746977|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
149746978|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
149746979|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
149746980|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
149746981|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
149746982|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
149746983|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
149746984|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
149746985|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
149746986|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
149746987|NCT01330381|540207089|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
149746988|NCT01330381|540207090|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
149746989|NCT01330381|540207091|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
149746990|NCT01330381|540207089|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
149746991|NCT01330381|540207090|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
149746992|NCT01330381|540207091|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
149746993|NCT01330381|540207089|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
149746994|NCT01330381|540207090|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
149746995|NCT01330381|540207091|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
149746996|NCT01330381|540207089|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
149746997|NCT01330381|540207090|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
149746998|NCT01330381|540207091|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
149746999|NCT01330381|540207089|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
149747000|NCT01330381|540207090|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
149747001|NCT01330381|540207091|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
149747002|NCT01978912|540207093|FG000|Overall Study|Adverse Event|0|||
149747003|NCT01978912|540207094|FG001|Overall Study|Adverse Event|1|||
149747004|NCT01978912|540207095|FG002|Overall Study|Adverse Event|0|||
149747005|NCT01978912|540207096|FG003|Overall Study|Adverse Event|0|||
149747006|NCT01978912|540207093|FG000|Overall Study|Lost to Follow-up|1|||
149747007|NCT01978912|540207094|FG001|Overall Study|Lost to Follow-up|1|||
149747008|NCT01978912|540207095|FG002|Overall Study|Lost to Follow-up|0|||
149747009|NCT01978912|540207096|FG003|Overall Study|Lost to Follow-up|1|||
149747010|NCT01978912|540207093|FG000|Overall Study|Withdrawal by Subject|1|||
149747011|NCT01978912|540207094|FG001|Overall Study|Withdrawal by Subject|0|||
149747012|NCT01978912|540207095|FG002|Overall Study|Withdrawal by Subject|2|||
149747013|NCT01978912|540207096|FG003|Overall Study|Withdrawal by Subject|2|||
149747014|NCT01978912|540207093|FG000|Overall Study|Lumbar Surgery|1|||
149747015|NCT01978912|540207094|FG001|Overall Study|Lumbar Surgery|0|||
149747016|NCT01978912|540207095|FG002|Overall Study|Lumbar Surgery|1|||
149747017|NCT01978912|540207096|FG003|Overall Study|Lumbar Surgery|0|||
149747018|NCT01978912|540207093|FG000|Overall Study|Intradiscal Steroid Injection|0|||
149747019|NCT01978912|540207094|FG001|Overall Study|Intradiscal Steroid Injection|1|||
149747020|NCT01978912|540207095|FG002|Overall Study|Intradiscal Steroid Injection|0|||
149747021|NCT01978912|540207096|FG003|Overall Study|Intradiscal Steroid Injection|0|||
149747022|NCT00401973|540207097|FG000|Overall Study|Adverse Event|2|||
149747023|NCT00401973|540207098|FG001|Overall Study|Adverse Event|8|||
149747024|NCT00401973|540207099|FG002|Overall Study|Adverse Event|4|||
149747025|NCT00401973|540207097|FG000|Overall Study|Clinical Relapse|0|||
149747026|NCT00401973|540207098|FG001|Overall Study|Clinical Relapse|1|||
149747027|NCT00401973|540207099|FG002|Overall Study|Clinical Relapse|1|||
149747028|NCT00401973|540207097|FG000|Overall Study|Lack of Efficacy|0|||
149747029|NCT00401973|540207098|FG001|Overall Study|Lack of Efficacy|0|||
149747030|NCT00401973|540207099|FG002|Overall Study|Lack of Efficacy|3|||
149747031|NCT00401973|540207097|FG000|Overall Study|Lost to Follow-up|2|||
149747032|NCT00401973|540207098|FG001|Overall Study|Lost to Follow-up|2|||
149747033|NCT00401973|540207099|FG002|Overall Study|Lost to Follow-up|2|||
149747034|NCT00401973|540207097|FG000|Overall Study|Physician Decision|2|||
149747035|NCT00401973|540207098|FG001|Overall Study|Physician Decision|0|||
149747036|NCT00401973|540207099|FG002|Overall Study|Physician Decision|1|||
149747037|NCT00401973|540207097|FG000|Overall Study|Protocol Violation|1|||
149747038|NCT00401973|540207098|FG001|Overall Study|Protocol Violation|2|||
149747039|NCT00401973|540207099|FG002|Overall Study|Protocol Violation|3|||
149747040|NCT00401973|540207097|FG000|Overall Study|Sponsor Decision|0|||
149747041|NCT00401973|540207098|FG001|Overall Study|Sponsor Decision|1|||
149747042|NCT00401973|540207099|FG002|Overall Study|Sponsor Decision|0|||
149747043|NCT00401973|540207097|FG000|Overall Study|Withdrawal by Subject|4|||
149747044|NCT00401973|540207098|FG001|Overall Study|Withdrawal by Subject|12|||
149747045|NCT00401973|540207099|FG002|Overall Study|Withdrawal by Subject|9|||
149747046|NCT01408537|540207100|FG000|Overall Study|Withdrawal by Subject|2|||
149747047|NCT01408537|540207100|FG000|Overall Study|Protocol Violation|3|||
149747048|NCT01408537|540207100|FG000|Overall Study|Lost to Follow-up|3|||
149747049|NCT04075604|540207109|FG000|Overall Study|Adverse Event|0|||
149747050|NCT04075604|540207110|FG001|Overall Study|Adverse Event|0|||
149747051|NCT04075604|540207111|FG002|Overall Study|Adverse Event|3|||
149747052|NCT04075604|540207109|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149747053|NCT04075604|540207110|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149747054|NCT04075604|540207111|FG002|Overall Study|Participant request to discontinue study treatment|1|||
149747055|NCT04075604|540207109|FG000|Overall Study|Participant withdrew consent|0|||
149747056|NCT04075604|540207110|FG001|Overall Study|Participant withdrew consent|0|||
149747057|NCT04075604|540207111|FG002|Overall Study|Participant withdrew consent|1|||
149747058|NCT04075604|540207109|FG000|Overall Study|Other reasons|1|||
149747059|NCT04075604|540207110|FG001|Overall Study|Other reasons|0|||
149747060|NCT04075604|540207111|FG002|Overall Study|Other reasons|0|||
149747061|NCT04075604|540207109|FG000|Overall Study|Disease progression|0|||
149747062|NCT04075604|540207110|FG001|Overall Study|Disease progression|1|||
149747063|NCT04075604|540207111|FG002|Overall Study|Disease progression|0|||
149747064|NCT04075604|540207109|FG000|Overall Study|Study drug toxicity|0|||
149747065|NCT04075604|540207110|FG001|Overall Study|Study drug toxicity|5|||
149747066|NCT04075604|540207111|FG002|Overall Study|Study drug toxicity|1|||
149747067|NCT02760602|540207112|FG000|Overall Study|Withdrawal by Subject|1|||
149747068|NCT02760602|540207113|FG001|Overall Study|Withdrawal by Subject|0|||
149747069|NCT02760602|540207112|FG000|Overall Study|Terminated by sponsor|12|||
149747070|NCT02760602|540207113|FG001|Overall Study|Terminated by sponsor|13|||
149747071|NCT04329923|540207118|FG000|Overall Study|Withdrawal by Subject|1|||
149747072|NCT04329923|540207119|FG001|Overall Study|Withdrawal by Subject|4|||
149747073|NCT04329923|540207120|FG002|Overall Study|Withdrawal by Subject|1|||
149747074|NCT04329923|540207121|FG003|Overall Study|Withdrawal by Subject|1|||
149747075|NCT04329923|540207122|FG004|Overall Study|Withdrawal by Subject|1|||
149747076|NCT04329923|540207123|FG005|Overall Study|Withdrawal by Subject|1|||
149747077|NCT04329923|540207118|FG000|Overall Study|early termination of study|0|||
149747078|NCT04329923|540207119|FG001|Overall Study|early termination of study|0|||
149747079|NCT04329923|540207120|FG002|Overall Study|early termination of study|0|||
149747080|NCT04329923|540207121|FG003|Overall Study|early termination of study|0|||
149747081|NCT04329923|540207122|FG004|Overall Study|early termination of study|1|||
149747082|NCT04329923|540207123|FG005|Overall Study|early termination of study|2|||
149747083|NCT04329923|540207118|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149747084|NCT04329923|540207119|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149747085|NCT04329923|540207120|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149747086|NCT04329923|540207121|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149747087|NCT04329923|540207122|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149747088|NCT04329923|540207123|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
149747089|NCT01272180|540207124|FG000|Overall Study|Adverse Event|0|||
149747090|NCT01272180|540207125|FG001|Overall Study|Adverse Event|0|||
149747091|NCT01272180|540207126|FG002|Overall Study|Adverse Event|1|||
149747092|NCT01272180|540207127|FG003|Overall Study|Adverse Event|0|||
149747093|NCT01272180|540207124|FG000|Overall Study|Withdrawal by Subject|2|||
149747094|NCT01272180|540207125|FG001|Overall Study|Withdrawal by Subject|6|||
149747095|NCT01272180|540207126|FG002|Overall Study|Withdrawal by Subject|3|||
149747096|NCT01272180|540207127|FG003|Overall Study|Withdrawal by Subject|2|||
149747097|NCT01272180|540207124|FG000|Overall Study|Lost to Follow-up|15|||
149747098|NCT01272180|540207125|FG001|Overall Study|Lost to Follow-up|14|||
149747099|NCT01272180|540207126|FG002|Overall Study|Lost to Follow-up|8|||
149747100|NCT01272180|540207127|FG003|Overall Study|Lost to Follow-up|10|||
149747101|NCT01272180|540207124|FG000|Overall Study|Inappropriate enrollment|0|||
149747102|NCT01272180|540207125|FG001|Overall Study|Inappropriate enrollment|0|||
149747103|NCT01272180|540207126|FG002|Overall Study|Inappropriate enrollment|1|||
149747104|NCT01272180|540207127|FG003|Overall Study|Inappropriate enrollment|1|||
149747105|NCT01272180|540207124|FG000|Overall Study|Protocol Violation|0|||
149747106|NCT01272180|540207125|FG001|Overall Study|Protocol Violation|1|||
149747107|NCT01272180|540207126|FG002|Overall Study|Protocol Violation|0|||
149747108|NCT01272180|540207127|FG003|Overall Study|Protocol Violation|1|||
149747109|NCT03334214|540207128|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
149747110|NCT03334214|540207129|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
149747111|NCT03334214|540207128|FG000|Overall Study|Withdrawal by Subject|0|||
149747112|NCT03334214|540207129|FG001|Overall Study|Withdrawal by Subject|1|||
149747113|NCT03334214|540207128|FG000|Overall Study|Other|1|||
149747114|NCT03334214|540207129|FG001|Overall Study|Other|0|||
149747115|NCT01260181|540207130|FG000|Overall Study|Decision of Investigator|1|||
149747116|NCT01588197|540207133|FG000|Overall Study|Lack of Efficacy|0|||
149747117|NCT01588197|540207134|FG001|Overall Study|Lack of Efficacy|1|||
149747118|NCT01588197|540207133|FG000|Overall Study|No MRI|1|||
149747119|NCT01588197|540207134|FG001|Overall Study|No MRI|0|||
149747120|NCT03351244|540207135|FG000|Overall Study|Adverse Event|7|||
149747121|NCT03351244|540207136|FG001|Overall Study|Adverse Event|11|||
149747122|NCT03351244|540207137|FG002|Overall Study|Adverse Event|12|||
149747123|NCT03351244|540207135|FG000|Overall Study|Investigator's decision|0|||
149747124|NCT03351244|540207136|FG001|Overall Study|Investigator's decision|0|||
149747125|NCT03351244|540207137|FG002|Overall Study|Investigator's decision|2|||
149747126|NCT03351244|540207135|FG000|Overall Study|System error|0|||
149747127|NCT03351244|540207136|FG001|Overall Study|System error|0|||
149747128|NCT03351244|540207137|FG002|Overall Study|System error|2|||
149747129|NCT03351244|540207135|FG000|Overall Study|COVID-19 restrictions|3|||
149747130|NCT03351244|540207136|FG001|Overall Study|COVID-19 restrictions|0|||
149747131|NCT03351244|540207137|FG002|Overall Study|COVID-19 restrictions|1|||
149747132|NCT03351244|540207135|FG000|Overall Study|Non-compliance|2|||
149747133|NCT03351244|540207136|FG001|Overall Study|Non-compliance|5|||
149747134|NCT03351244|540207137|FG002|Overall Study|Non-compliance|0|||
149747135|NCT03351244|540207135|FG000|Overall Study|Withdrawal by Subject|11|||
149747136|NCT03351244|540207136|FG001|Overall Study|Withdrawal by Subject|16|||
149747137|NCT03351244|540207137|FG002|Overall Study|Withdrawal by Subject|13|||
149747138|NCT03351244|540207135|FG000|Overall Study|Lost to Follow-up|2|||
149747139|NCT03351244|540207136|FG001|Overall Study|Lost to Follow-up|6|||
149747140|NCT03351244|540207137|FG002|Overall Study|Lost to Follow-up|4|||
149747141|NCT03351244|540207135|FG000|Overall Study|Protocol Violation|2|||
149747142|NCT03351244|540207136|FG001|Overall Study|Protocol Violation|2|||
149747143|NCT03351244|540207137|FG002|Overall Study|Protocol Violation|0|||
149747144|NCT02088034|540207143|FG000|Overall Study|Lost to Follow-up|1|||
149747145|NCT02088034|540207144|FG001|Overall Study|Lost to Follow-up|1|||
149747146|NCT02088034|540207145|FG002|Overall Study|Lost to Follow-up|0|||
149747147|NCT02088034|540207143|FG000|Overall Study|Pregnancy|2|||
149747148|NCT02088034|540207144|FG001|Overall Study|Pregnancy|1|||
149747149|NCT02088034|540207145|FG002|Overall Study|Pregnancy|2|||
149747150|NCT00308620|540207148|FG000|Overall Study|Death|1|||
149747151|NCT00308620|540207149|FG001|Overall Study|Death|1|||
149747152|NCT00308620|540207150|FG002|Overall Study|Death|0|||
149747153|NCT00308620|540207148|FG000|Overall Study|Lost to Follow-up|0|||
149747154|NCT00308620|540207149|FG001|Overall Study|Lost to Follow-up|0|||
149747155|NCT00308620|540207150|FG002|Overall Study|Lost to Follow-up|1|||
149747156|NCT00091793|540207151|FG000|Overall Study|Adverse Event|1|||
149747157|NCT00091793|540207152|FG001|Overall Study|Adverse Event|2|||
149747158|NCT00091793|540207151|FG000|Overall Study|Withdrawal by Subject|10|||
149747159|NCT00091793|540207152|FG001|Overall Study|Withdrawal by Subject|15|||
149747160|NCT00091793|540207151|FG000|Overall Study|Ineligibility determined|2|||
149747161|NCT00091793|540207152|FG001|Overall Study|Ineligibility determined|0|||
149747162|NCT00091793|540207151|FG000|Overall Study|Lost to Follow-up|7|||
149747163|NCT00091793|540207152|FG001|Overall Study|Lost to Follow-up|5|||
149747164|NCT00091793|540207151|FG000|Overall Study|Noncompliance|2|||
149747165|NCT00091793|540207152|FG001|Overall Study|Noncompliance|0|||
149747166|NCT00091793|540207151|FG000|Overall Study|Other|2|||
149747167|NCT00091793|540207152|FG001|Overall Study|Other|0|||
149747168|NCT01025336|540207154|FG000|Overall Study|Protocol Violation|0|||
149747169|NCT01025336|540207155|FG001|Overall Study|Protocol Violation|0|||
149747170|NCT01025336|540207156|FG002|Overall Study|Protocol Violation|0|||
149747171|NCT01025336|540207157|FG003|Overall Study|Protocol Violation|2|||
149747172|NCT01025336|540207158|FG004|Overall Study|Protocol Violation|0|||
149747173|NCT00637728|540207162|FG000|Double-blind Phase|Adverse Event|1|||
149747174|NCT00637728|540207163|FG001|Double-blind Phase|Adverse Event|0|||
149747175|NCT00637728|540207164|FG002|Double-blind Phase|Adverse Event|0|||
149747176|NCT00637728|540207162|FG000|Double-blind Phase|Non-compliance|2|||
149747177|NCT00637728|540207163|FG001|Double-blind Phase|Non-compliance|0|||
149747178|NCT00637728|540207164|FG002|Double-blind Phase|Non-compliance|0|||
149747179|NCT00637728|540207162|FG000|Double-blind Phase|Study Discontinued|1|||
149747180|NCT00637728|540207163|FG001|Double-blind Phase|Study Discontinued|1|||
149747181|NCT00637728|540207164|FG002|Double-blind Phase|Study Discontinued|0|||
149747182|NCT01050062|540207165|FG000|Overall Study|Adverse Event|75|||
149747183|NCT01050062|540207166|FG001|Overall Study|Adverse Event|22|||
149747184|NCT01050062|540207165|FG000|Overall Study|Lost to Follow-up|83|||
149747185|NCT01050062|540207166|FG001|Overall Study|Lost to Follow-up|35|||
149747186|NCT01050062|540207165|FG000|Overall Study|Lack of Efficacy|22|||
149747187|NCT01050062|540207166|FG001|Overall Study|Lack of Efficacy|35|||
149747188|NCT01050062|540207165|FG000|Overall Study|Physician Decision|74|||
149747189|NCT01050062|540207166|FG001|Overall Study|Physician Decision|9|||
149747190|NCT01050062|540207165|FG000|Overall Study|Others|17|||
149747191|NCT01050062|540207166|FG001|Overall Study|Others|11|||
149747192|NCT01873950|540207169|FG000|Period 5|Withdrawal by Subject|0|||
149747193|NCT01873950|540207170|FG001|Period 5|Withdrawal by Subject|0|||
149747194|NCT01873950|540207171|FG002|Period 5|Withdrawal by Subject|0|||
149747195|NCT01873950|540207172|FG003|Period 5|Withdrawal by Subject|1|||
149747196|NCT01873950|540207173|FG004|Period 5|Withdrawal by Subject|0|||
149747197|NCT03894540|540207174|FG000|Overall Study|Adverse Event|0|||
149747198|NCT03894540|540207175|FG001|Overall Study|Adverse Event|0|||
149747199|NCT03894540|540207176|FG002|Overall Study|Adverse Event|0|||
149747200|NCT03894540|540207177|FG003|Overall Study|Adverse Event|0|||
149747201|NCT03894540|540207178|FG004|Overall Study|Adverse Event|1|||
149747202|NCT03894540|540207179|FG005|Overall Study|Adverse Event|0|||
149747203|NCT03894540|540207174|FG000|Overall Study|Withdrawal by Subject|0|||
149747204|NCT03894540|540207175|FG001|Overall Study|Withdrawal by Subject|0|||
149747205|NCT03894540|540207176|FG002|Overall Study|Withdrawal by Subject|0|||
149747206|NCT03894540|540207177|FG003|Overall Study|Withdrawal by Subject|0|||
149747207|NCT03894540|540207178|FG004|Overall Study|Withdrawal by Subject|1|||
149747208|NCT03894540|540207179|FG005|Overall Study|Withdrawal by Subject|0|||
149747209|NCT03894540|540207174|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
149747210|NCT03894540|540207175|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
149747211|NCT03894540|540207176|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
149747212|NCT03894540|540207177|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
149747213|NCT03894540|540207178|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
149747214|NCT03894540|540207179|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
149747215|NCT03894540|540207174|FG000|Overall Study|Progressive Disease Clinical|1|||
149747216|NCT03894540|540207175|FG001|Overall Study|Progressive Disease Clinical|1|||
149747217|NCT03894540|540207176|FG002|Overall Study|Progressive Disease Clinical|0|||
149747218|NCT03894540|540207177|FG003|Overall Study|Progressive Disease Clinical|1|||
149747219|NCT03894540|540207178|FG004|Overall Study|Progressive Disease Clinical|5|||
150256520|NCT02019667|542072786|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
150256521|NCT02019667|542072787|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
150256522|NCT02432196|542072789|FG000|Overall Study|Exit - did not receive study device|1|||
150256523|NCT02432196|542072789|FG000|Overall Study|Death|2|||
150256524|NCT02432196|542072789|FG000|Overall Study|Reoperation|3|||
150256525|NCT01905150|542072790|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
150256526|NCT01905150|542072791|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
150256527|NCT02592876|542072792|FG000|Overall Study|Withdrawal by Subject|3|||
150256528|NCT02592876|542072793|FG001|Overall Study|Withdrawal by Subject|3|||
150256529|NCT02592876|542072792|FG000|Overall Study|Study Termination by Sponsor|32|||
150256530|NCT02592876|542072793|FG001|Overall Study|Study Termination by Sponsor|27|||
150256531|NCT02592876|542072792|FG000|Overall Study|Lost to Follow-up|0|||
150256532|NCT02592876|542072793|FG001|Overall Study|Lost to Follow-up|1|||
150256533|NCT02592876|542072792|FG000|Overall Study|Death|6|||
150256534|NCT02592876|542072793|FG001|Overall Study|Death|9|||
150256535|NCT00611975|542072796|FG000|Overall Study|Withdrawal by Subject|3|||
150256536|NCT00611975|542072797|FG001|Overall Study|Withdrawal by Subject|7|||
150256537|NCT00611975|542072796|FG000|Overall Study|Pregnancy|2|||
150256538|NCT00611975|542072797|FG001|Overall Study|Pregnancy|1|||
149747220|NCT03894540|540207179|FG005|Overall Study|Progressive Disease Clinical|1|||
149747221|NCT03894540|540207174|FG000|Overall Study|Study termination by sponsor|0|||
149747222|NCT03894540|540207175|FG001|Overall Study|Study termination by sponsor|0|||
149747223|NCT03894540|540207176|FG002|Overall Study|Study termination by sponsor|0|||
149747224|NCT03894540|540207177|FG003|Overall Study|Study termination by sponsor|0|||
149747225|NCT03894540|540207178|FG004|Overall Study|Study termination by sponsor|2|||
149747226|NCT03894540|540207179|FG005|Overall Study|Study termination by sponsor|0|||
149747227|NCT03043365|540207180|FG000|Weeks 0 to Week 8|Adverse Event|1|||
149747228|NCT03043365|540207181|FG001|Weeks 0 to Week 8|Adverse Event|3|||
149747229|NCT03043365|540207180|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
149747230|NCT03043365|540207181|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
149747231|NCT03043365|540207180|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
149747232|NCT03043365|540207181|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
149747233|NCT00593112|540207182|FG000|Overall Study|Scan Anxiety|3|||
149747234|NCT00593112|540207183|FG001|Overall Study|Scan Anxiety|0|||
149747235|NCT00593112|540207182|FG000|Overall Study|Abnormal Scan|1|||
149747236|NCT00593112|540207183|FG001|Overall Study|Abnormal Scan|0|||
149747237|NCT00593112|540207182|FG000|Overall Study|Unreadable Scan|1|||
149747238|NCT00593112|540207183|FG001|Overall Study|Unreadable Scan|0|||
149747239|NCT00593112|540207182|FG000|Overall Study|Withdrawal by Subject|5|||
149747240|NCT00593112|540207183|FG001|Overall Study|Withdrawal by Subject|0|||
149747241|NCT02723630|540207184|FG000|Intervention Period 1|Adverse Event|1|||
149747242|NCT02723630|540207185|FG001|Intervention Period 1|Adverse Event|0|||
149747243|NCT02723630|540207186|FG002|Intervention Period 1|Adverse Event|0|||
149747244|NCT02723630|540207187|FG003|Intervention Period 1|Adverse Event|0|||
149747245|NCT02723630|540207188|FG004|Intervention Period 1|Adverse Event|0|||
149747246|NCT02723630|540207189|FG005|Intervention Period 1|Adverse Event|0|||
149747247|NCT02723630|540207184|FG000|Intervention Period 3|consumption of restricted item|0|||
149747248|NCT02723630|540207185|FG001|Intervention Period 3|consumption of restricted item|1|||
149747249|NCT02723630|540207186|FG002|Intervention Period 3|consumption of restricted item|0|||
149747250|NCT02723630|540207187|FG003|Intervention Period 3|consumption of restricted item|0|||
149747251|NCT02723630|540207188|FG004|Intervention Period 3|consumption of restricted item|0|||
149747252|NCT02723630|540207189|FG005|Intervention Period 3|consumption of restricted item|0|||
149747253|NCT02532543|540207190|FG000|Overall Study|Lost to Follow-up|0|||
149747254|NCT02532543|540207191|FG001|Overall Study|Lost to Follow-up|0|||
149747255|NCT02532543|540207192|FG002|Overall Study|Lost to Follow-up|1|||
149747256|NCT02532543|540207193|FG003|Overall Study|Lost to Follow-up|0|||
149747257|NCT00650585|540207194|FG000|Overall Study|Lost to Follow-up|505|||
149747258|NCT00650585|540207195|FG001|Overall Study|Lost to Follow-up|482|||
149747259|NCT00650585|540207194|FG000|Overall Study|No parental consent|935|||
149747260|NCT00650585|540207195|FG001|Overall Study|No parental consent|866|||
149747261|NCT00650585|540207194|FG000|Overall Study|Excluded/ruled ineligible|357|||
149747262|NCT00650585|540207195|FG001|Overall Study|Excluded/ruled ineligible|129|||
149747263|NCT02640612|540207196|FG000|Overall Study|Adverse Event|6|||
149747264|NCT02640612|540207197|FG001|Overall Study|Adverse Event|7|||
149747265|NCT02640612|540207198|FG002|Overall Study|Adverse Event|2|||
149747266|NCT02640612|540207196|FG000|Overall Study|Death|1|||
149747267|NCT02640612|540207197|FG001|Overall Study|Death|0|||
149747268|NCT02640612|540207198|FG002|Overall Study|Death|0|||
149747269|NCT02640612|540207196|FG000|Overall Study|Withdrawal by Subject|10|||
149747270|NCT02640612|540207197|FG001|Overall Study|Withdrawal by Subject|3|||
149747271|NCT02640612|540207198|FG002|Overall Study|Withdrawal by Subject|3|||
149747272|NCT02640612|540207196|FG000|Overall Study|Lost to Follow-up|4|||
149747273|NCT02640612|540207197|FG001|Overall Study|Lost to Follow-up|1|||
149747274|NCT02640612|540207198|FG002|Overall Study|Lost to Follow-up|1|||
149747275|NCT02640612|540207196|FG000|Overall Study|Protocol Violation|0|||
149747276|NCT02640612|540207197|FG001|Overall Study|Protocol Violation|2|||
149747277|NCT02640612|540207198|FG002|Overall Study|Protocol Violation|0|||
149747278|NCT02640612|540207196|FG000|Overall Study|Lack of Efficacy|1|||
149747279|NCT02640612|540207197|FG001|Overall Study|Lack of Efficacy|1|||
149747280|NCT02640612|540207198|FG002|Overall Study|Lack of Efficacy|0|||
149747281|NCT00923091|540207209|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
149747282|NCT00923091|540207210|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
149747283|NCT00923091|540207211|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
149747284|NCT00923091|540207212|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
149747285|NCT00923091|540207213|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
149747286|NCT00923091|540207214|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
149747287|NCT00923091|540207215|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
149747288|NCT00923091|540207216|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
149747289|NCT00923091|540207217|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149747290|NCT00923091|540207218|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149747291|NCT00923091|540207219|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149747292|NCT00923091|540207220|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149747293|NCT00923091|540207221|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149747294|NCT00923091|540207209|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
149747295|NCT00923091|540207210|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
149747296|NCT00923091|540207211|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149747297|NCT00923091|540207212|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
149747298|NCT00923091|540207213|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
149747299|NCT00923091|540207214|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
149747300|NCT00923091|540207215|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149747301|NCT00923091|540207216|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149747302|NCT00923091|540207217|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149747303|NCT00923091|540207218|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149747304|NCT00923091|540207219|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149747305|NCT00923091|540207220|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149747306|NCT00923091|540207221|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149747307|NCT00923091|540207209|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149747308|NCT00923091|540207210|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149747309|NCT00923091|540207211|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149747310|NCT00923091|540207212|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
149747311|NCT00923091|540207213|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
149747312|NCT00923091|540207214|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
149747313|NCT00923091|540207215|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
149747314|NCT00923091|540207216|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
149747315|NCT00923091|540207217|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149747316|NCT00923091|540207218|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149747317|NCT00923091|540207219|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149747318|NCT00923091|540207220|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149747319|NCT00923091|540207221|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149747320|NCT00923091|540207209|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747321|NCT00923091|540207210|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747322|NCT00923091|540207211|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747323|NCT00923091|540207212|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747324|NCT00923091|540207213|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747325|NCT00923091|540207214|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
149747326|NCT00923091|540207215|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747327|NCT00923091|540207216|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747328|NCT00923091|540207217|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747329|NCT00923091|540207218|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747330|NCT00923091|540207219|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747331|NCT00923091|540207220|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747332|NCT00923091|540207221|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149747333|NCT00923091|540207209|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747334|NCT00923091|540207210|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149747335|NCT00923091|540207211|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747336|NCT00923091|540207212|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149747337|NCT00923091|540207213|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747338|NCT00923091|540207214|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149747339|NCT00923091|540207215|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747340|NCT00923091|540207216|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747341|NCT00923091|540207217|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747342|NCT00923091|540207218|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747343|NCT00923091|540207219|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747344|NCT00923091|540207220|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747345|NCT00923091|540207221|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149747346|NCT00923091|540207209|FG000|Period III (Single-Blind)|Adverse Event|5|||
149747347|NCT00923091|540207210|FG001|Period III (Single-Blind)|Adverse Event|0|||
149747348|NCT00923091|540207211|FG002|Period III (Single-Blind)|Adverse Event|0|||
149747349|NCT00923091|540207212|FG003|Period III (Single-Blind)|Adverse Event|0|||
149747350|NCT00923091|540207213|FG004|Period III (Single-Blind)|Adverse Event|0|||
149747351|NCT00923091|540207214|FG005|Period III (Single-Blind)|Adverse Event|0|||
149747352|NCT00923091|540207215|FG006|Period III (Single-Blind)|Adverse Event|0|||
149747353|NCT00923091|540207216|FG007|Period III (Single-Blind)|Adverse Event|0|||
149747354|NCT00923091|540207217|FG008|Period III (Single-Blind)|Adverse Event|0|||
149747355|NCT00923091|540207218|FG009|Period III (Single-Blind)|Adverse Event|0|||
149747356|NCT00923091|540207219|FG010|Period III (Single-Blind)|Adverse Event|0|||
149747357|NCT00923091|540207220|FG011|Period III (Single-Blind)|Adverse Event|0|||
149747358|NCT00923091|540207221|FG012|Period III (Single-Blind)|Adverse Event|0|||
149747359|NCT00923091|540207209|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
149747360|NCT00923091|540207210|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747361|NCT00923091|540207211|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747362|NCT00923091|540207212|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747363|NCT00923091|540207213|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747364|NCT00923091|540207214|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747365|NCT00923091|540207215|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747366|NCT00923091|540207216|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747367|NCT00923091|540207217|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747368|NCT00923091|540207218|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747369|NCT00923091|540207219|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747370|NCT00923091|540207220|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747371|NCT00923091|540207221|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
149747372|NCT00923091|540207209|FG000|Period III (Single-Blind)|Protocol Violation|3|||
149747373|NCT00923091|540207210|FG001|Period III (Single-Blind)|Protocol Violation|0|||
149747374|NCT00923091|540207211|FG002|Period III (Single-Blind)|Protocol Violation|0|||
149747375|NCT00923091|540207212|FG003|Period III (Single-Blind)|Protocol Violation|0|||
149747376|NCT00923091|540207213|FG004|Period III (Single-Blind)|Protocol Violation|0|||
149747377|NCT00923091|540207214|FG005|Period III (Single-Blind)|Protocol Violation|0|||
149747378|NCT00923091|540207215|FG006|Period III (Single-Blind)|Protocol Violation|0|||
149747379|NCT00923091|540207216|FG007|Period III (Single-Blind)|Protocol Violation|0|||
149747380|NCT00923091|540207217|FG008|Period III (Single-Blind)|Protocol Violation|0|||
149747381|NCT00923091|540207218|FG009|Period III (Single-Blind)|Protocol Violation|0|||
149747382|NCT00923091|540207219|FG010|Period III (Single-Blind)|Protocol Violation|0|||
149747383|NCT00923091|540207220|FG011|Period III (Single-Blind)|Protocol Violation|0|||
149747384|NCT00923091|540207221|FG012|Period III (Single-Blind)|Protocol Violation|0|||
149747385|NCT00923091|540207209|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
149747386|NCT00923091|540207210|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
149747387|NCT00923091|540207211|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
149747388|NCT00923091|540207212|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
149747389|NCT00923091|540207213|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
149747390|NCT00923091|540207214|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
149747391|NCT00923091|540207215|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
149747392|NCT00923091|540207216|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
149747393|NCT00923091|540207217|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
149747394|NCT00923091|540207218|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
149747395|NCT00923091|540207219|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
149747396|NCT00923091|540207220|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
149747397|NCT00923091|540207221|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
149747398|NCT00923091|540207209|FG000|Period IV (Double-Blind)|Adverse Event|2|||
149747399|NCT00923091|540207210|FG001|Period IV (Double-Blind)|Adverse Event|0|||
149747400|NCT00923091|540207211|FG002|Period IV (Double-Blind)|Adverse Event|0|||
149747401|NCT00923091|540207212|FG003|Period IV (Double-Blind)|Adverse Event|0|||
149747402|NCT00923091|540207213|FG004|Period IV (Double-Blind)|Adverse Event|0|||
149747403|NCT00923091|540207214|FG005|Period IV (Double-Blind)|Adverse Event|0|||
149747404|NCT00923091|540207215|FG006|Period IV (Double-Blind)|Adverse Event|0|||
149747405|NCT00923091|540207216|FG007|Period IV (Double-Blind)|Adverse Event|0|||
149747406|NCT00923091|540207217|FG008|Period IV (Double-Blind)|Adverse Event|0|||
149747407|NCT00923091|540207218|FG009|Period IV (Double-Blind)|Adverse Event|0|||
149747408|NCT00923091|540207219|FG010|Period IV (Double-Blind)|Adverse Event|0|||
149747409|NCT00923091|540207220|FG011|Period IV (Double-Blind)|Adverse Event|0|||
149747410|NCT00923091|540207221|FG012|Period IV (Double-Blind)|Adverse Event|0|||
149747411|NCT00923091|540207209|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747412|NCT00923091|540207210|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
149747413|NCT00923091|540207211|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747414|NCT00923091|540207212|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747415|NCT00923091|540207213|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747416|NCT00923091|540207214|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747417|NCT00923091|540207215|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747418|NCT00923091|540207216|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747419|NCT00923091|540207217|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747420|NCT00923091|540207218|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747421|NCT00923091|540207219|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747422|NCT00923091|540207220|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747423|NCT00923091|540207221|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149747424|NCT00923091|540207209|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
149747425|NCT00923091|540207210|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
149747426|NCT00923091|540207211|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
149747427|NCT00923091|540207212|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
149747428|NCT00923091|540207213|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
149747429|NCT00923091|540207214|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
149747430|NCT00923091|540207215|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
149747431|NCT00923091|540207216|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
149747432|NCT00923091|540207217|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
149747433|NCT00923091|540207218|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
149747434|NCT00923091|540207219|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
149747435|NCT00923091|540207220|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
149747436|NCT00923091|540207221|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
149747437|NCT00923091|540207209|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747438|NCT00923091|540207210|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747439|NCT00923091|540207211|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747440|NCT00923091|540207212|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747441|NCT00923091|540207213|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747442|NCT00923091|540207214|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747443|NCT00923091|540207215|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747444|NCT00923091|540207216|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747445|NCT00923091|540207217|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
149747446|NCT00923091|540207218|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747447|NCT00923091|540207219|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747448|NCT00923091|540207220|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
149747449|NCT00923091|540207221|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
149747450|NCT00923091|540207209|FG000|Period V (Double -Blind)|Protocol Violation|0|||
149747451|NCT00923091|540207210|FG001|Period V (Double -Blind)|Protocol Violation|0|||
149747452|NCT00923091|540207211|FG002|Period V (Double -Blind)|Protocol Violation|0|||
149747453|NCT00923091|540207212|FG003|Period V (Double -Blind)|Protocol Violation|0|||
149747454|NCT00923091|540207213|FG004|Period V (Double -Blind)|Protocol Violation|0|||
149747455|NCT00923091|540207214|FG005|Period V (Double -Blind)|Protocol Violation|0|||
149747456|NCT00923091|540207215|FG006|Period V (Double -Blind)|Protocol Violation|0|||
149747457|NCT00923091|540207216|FG007|Period V (Double -Blind)|Protocol Violation|0|||
149747458|NCT00923091|540207217|FG008|Period V (Double -Blind)|Protocol Violation|0|||
149747459|NCT00923091|540207218|FG009|Period V (Double -Blind)|Protocol Violation|0|||
149747460|NCT00923091|540207219|FG010|Period V (Double -Blind)|Protocol Violation|0|||
149747461|NCT00923091|540207220|FG011|Period V (Double -Blind)|Protocol Violation|0|||
149747462|NCT00923091|540207221|FG012|Period V (Double -Blind)|Protocol Violation|1|||
149747463|NCT00923091|540207209|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
149747464|NCT00923091|540207210|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
149747465|NCT00923091|540207211|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
149747466|NCT00923091|540207212|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
149747467|NCT00923091|540207213|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
149747468|NCT00923091|540207214|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
149747469|NCT00923091|540207215|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
149747470|NCT00923091|540207216|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
149747471|NCT00923091|540207217|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
149747472|NCT00923091|540207218|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
149747473|NCT00923091|540207219|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
149747474|NCT00923091|540207220|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
149747475|NCT00923091|540207221|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
149747476|NCT00923091|540207209|FG000|Period VI (Open-Label)|Adverse Event|17|||
149747477|NCT00923091|540207210|FG001|Period VI (Open-Label)|Adverse Event|0|||
149747478|NCT00923091|540207211|FG002|Period VI (Open-Label)|Adverse Event|4|||
149747479|NCT00923091|540207212|FG003|Period VI (Open-Label)|Adverse Event|1|||
149747480|NCT00923091|540207213|FG004|Period VI (Open-Label)|Adverse Event|1|||
149747481|NCT00923091|540207214|FG005|Period VI (Open-Label)|Adverse Event|0|||
149747482|NCT00923091|540207215|FG006|Period VI (Open-Label)|Adverse Event|0|||
149747483|NCT00923091|540207216|FG007|Period VI (Open-Label)|Adverse Event|0|||
149747484|NCT00923091|540207217|FG008|Period VI (Open-Label)|Adverse Event|0|||
149747485|NCT00923091|540207218|FG009|Period VI (Open-Label)|Adverse Event|0|||
149747486|NCT00923091|540207219|FG010|Period VI (Open-Label)|Adverse Event|0|||
149747487|NCT00923091|540207220|FG011|Period VI (Open-Label)|Adverse Event|0|||
149747488|NCT00923091|540207221|FG012|Period VI (Open-Label)|Adverse Event|0|||
149747489|NCT00923091|540207209|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
149747490|NCT00923091|540207210|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
149747491|NCT00923091|540207211|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
149747492|NCT00923091|540207212|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747493|NCT00923091|540207213|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
149747494|NCT00923091|540207214|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747495|NCT00923091|540207215|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747496|NCT00923091|540207216|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747497|NCT00923091|540207217|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747498|NCT00923091|540207218|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747499|NCT00923091|540207219|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747500|NCT00923091|540207220|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747501|NCT00923091|540207221|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
149747502|NCT00923091|540207209|FG000|Period VI (Open-Label)|Protocol Violation|6|||
149747503|NCT00923091|540207210|FG001|Period VI (Open-Label)|Protocol Violation|1|||
149747504|NCT00923091|540207211|FG002|Period VI (Open-Label)|Protocol Violation|3|||
149747505|NCT00923091|540207212|FG003|Period VI (Open-Label)|Protocol Violation|1|||
149747506|NCT00923091|540207213|FG004|Period VI (Open-Label)|Protocol Violation|4|||
149747507|NCT00923091|540207214|FG005|Period VI (Open-Label)|Protocol Violation|0|||
149747508|NCT00923091|540207215|FG006|Period VI (Open-Label)|Protocol Violation|0|||
149747509|NCT00923091|540207216|FG007|Period VI (Open-Label)|Protocol Violation|0|||
149747510|NCT00923091|540207217|FG008|Period VI (Open-Label)|Protocol Violation|0|||
149747511|NCT00923091|540207218|FG009|Period VI (Open-Label)|Protocol Violation|0|||
149747512|NCT00923091|540207219|FG010|Period VI (Open-Label)|Protocol Violation|0|||
149747513|NCT00923091|540207220|FG011|Period VI (Open-Label)|Protocol Violation|0|||
149747514|NCT00923091|540207221|FG012|Period VI (Open-Label)|Protocol Violation|0|||
149747515|NCT00923091|540207209|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
149747516|NCT00923091|540207210|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
149747517|NCT00923091|540207211|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
149747518|NCT00923091|540207212|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
149747519|NCT00923091|540207213|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
149747520|NCT00923091|540207214|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
149747521|NCT00923091|540207215|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
149747522|NCT00923091|540207216|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
149747523|NCT00923091|540207217|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
149747524|NCT00923091|540207218|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
149747525|NCT00923091|540207219|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
149747526|NCT00923091|540207220|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
149747527|NCT00923091|540207221|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
149747528|NCT00923091|540207209|FG000|Period VI (Open-Label)|Other Reason|0|||
149747529|NCT00923091|540207210|FG001|Period VI (Open-Label)|Other Reason|0|||
149747530|NCT00923091|540207211|FG002|Period VI (Open-Label)|Other Reason|0|||
149747531|NCT00923091|540207212|FG003|Period VI (Open-Label)|Other Reason|1|||
149747532|NCT00923091|540207213|FG004|Period VI (Open-Label)|Other Reason|1|||
149747533|NCT00923091|540207214|FG005|Period VI (Open-Label)|Other Reason|0|||
149747534|NCT00923091|540207215|FG006|Period VI (Open-Label)|Other Reason|0|||
149747535|NCT00923091|540207216|FG007|Period VI (Open-Label)|Other Reason|0|||
149747536|NCT00923091|540207217|FG008|Period VI (Open-Label)|Other Reason|0|||
149747537|NCT00923091|540207218|FG009|Period VI (Open-Label)|Other Reason|0|||
149747538|NCT00923091|540207219|FG010|Period VI (Open-Label)|Other Reason|0|||
149747539|NCT00923091|540207220|FG011|Period VI (Open-Label)|Other Reason|0|||
149747540|NCT00923091|540207221|FG012|Period VI (Open-Label)|Other Reason|0|||
149747541|NCT01645280|540207224|FG000|Overall Study|Death|0|||
149747542|NCT01645280|540207225|FG001|Overall Study|Death|1|||
149747543|NCT01645280|540207226|FG002|Overall Study|Death|0|||
149747544|NCT01645280|540207227|FG003|Overall Study|Death|0|||
149747545|NCT01645280|540207228|FG004|Overall Study|Death|0|||
149747546|NCT01645280|540207224|FG000|Overall Study|Withdrawal by Subject|4|||
149747547|NCT01645280|540207225|FG001|Overall Study|Withdrawal by Subject|0|||
149747548|NCT01645280|540207226|FG002|Overall Study|Withdrawal by Subject|2|||
149747549|NCT01645280|540207227|FG003|Overall Study|Withdrawal by Subject|4|||
149747550|NCT01645280|540207228|FG004|Overall Study|Withdrawal by Subject|5|||
149747551|NCT01645280|540207224|FG000|Overall Study|Lost to Follow-up|0|||
149747552|NCT01645280|540207225|FG001|Overall Study|Lost to Follow-up|0|||
149747553|NCT01645280|540207226|FG002|Overall Study|Lost to Follow-up|0|||
149747554|NCT01645280|540207227|FG003|Overall Study|Lost to Follow-up|2|||
149747555|NCT01645280|540207228|FG004|Overall Study|Lost to Follow-up|1|||
149747556|NCT01645280|540207224|FG000|Overall Study|Other|1|||
149747557|NCT01645280|540207225|FG001|Overall Study|Other|1|||
149747558|NCT01645280|540207226|FG002|Overall Study|Other|2|||
149747559|NCT01645280|540207227|FG003|Overall Study|Other|0|||
149747560|NCT01645280|540207228|FG004|Overall Study|Other|0|||
149747561|NCT01645280|540207224|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
149747562|NCT01645280|540207225|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
149747563|NCT01645280|540207226|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
149747564|NCT01645280|540207227|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
149747565|NCT01645280|540207228|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
149747566|NCT02460822|540207231|FG000|Overall Study|Withdrawal by Subject|1|||
149747567|NCT01254344|540207236|FG000|Overall Study|Adverse Event|2|||
149747568|NCT01254344|540207237|FG001|Overall Study|Adverse Event|5|||
149747569|NCT01254344|540207236|FG000|Overall Study|Physician Decision|7|||
149747570|NCT01254344|540207237|FG001|Overall Study|Physician Decision|4|||
149747571|NCT01254344|540207236|FG000|Overall Study|Protocol Violation|1|||
149747572|NCT01254344|540207237|FG001|Overall Study|Protocol Violation|4|||
149747573|NCT01254344|540207236|FG000|Overall Study|Withdrawal by Subject|3|||
149747574|NCT01254344|540207237|FG001|Overall Study|Withdrawal by Subject|6|||
149747575|NCT03249350|540207242|FG000|Overall Study|Participant did not initiate treatment|5|||
149747576|NCT03249350|540207243|FG001|Overall Study|Participant did not initiate treatment|8|||
149747577|NCT00624338|540207244|FG000|Overall Study|Adverse Event|14|||
149747578|NCT00624338|540207245|FG001|Overall Study|Adverse Event|14|||
149747579|NCT00624338|540207246|FG002|Overall Study|Adverse Event|18|||
149747580|NCT00624338|540207244|FG000|Overall Study|Lost to Follow-up|1|||
149747581|NCT00624338|540207245|FG001|Overall Study|Lost to Follow-up|0|||
149747582|NCT00624338|540207246|FG002|Overall Study|Lost to Follow-up|0|||
149747583|NCT00624338|540207244|FG000|Overall Study|Lack of Efficacy|11|||
149747584|NCT00624338|540207245|FG001|Overall Study|Lack of Efficacy|3|||
149747585|NCT00624338|540207246|FG002|Overall Study|Lack of Efficacy|14|||
149747586|NCT00624338|540207244|FG000|Overall Study|Protocol Violation|3|||
149747587|NCT00624338|540207245|FG001|Overall Study|Protocol Violation|3|||
149747588|NCT00624338|540207246|FG002|Overall Study|Protocol Violation|2|||
149747589|NCT00624338|540207244|FG000|Overall Study|Death|0|||
149747590|NCT00624338|540207245|FG001|Overall Study|Death|2|||
149747591|NCT00624338|540207246|FG002|Overall Study|Death|0|||
149747592|NCT00624338|540207244|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
149747593|NCT00624338|540207245|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
149747594|NCT00624338|540207246|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
149747595|NCT00624338|540207244|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
149747596|NCT00624338|540207245|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
149747597|NCT00624338|540207246|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
149747598|NCT00624338|540207244|FG000|Overall Study|Other|15|||
149747599|NCT00624338|540207245|FG001|Overall Study|Other|5|||
149747600|NCT00624338|540207246|FG002|Overall Study|Other|9|||
149747601|NCT00624338|540207244|FG000|Overall Study|Randomized but not treated|2|||
149747602|NCT00624338|540207245|FG001|Overall Study|Randomized but not treated|1|||
149747603|NCT00624338|540207246|FG002|Overall Study|Randomized but not treated|3|||
149747604|NCT01476787|540207247|FG000|Treatment|Progression|64|||
149747605|NCT01476787|540207248|FG001|Treatment|Progression|71|||
149747606|NCT01476787|540207247|FG000|Treatment|Toxicity|44|||
149747607|NCT01476787|540207248|FG001|Treatment|Toxicity|16|||
149747608|NCT01476787|540207247|FG000|Treatment|Death|0|||
149747609|NCT01476787|540207248|FG001|Treatment|Death|1|||
149747610|NCT01476787|540207247|FG000|Treatment|Withdrawal by Subject|3|||
149747611|NCT01476787|540207248|FG001|Treatment|Withdrawal by Subject|14|||
149747612|NCT01476787|540207247|FG000|Treatment|Major protocol violation|1|||
149747613|NCT01476787|540207248|FG001|Treatment|Major protocol violation|6|||
149747614|NCT01476787|540207247|FG000|Treatment|Other reasons|10|||
149747615|NCT01476787|540207248|FG001|Treatment|Other reasons|22|||
149747616|NCT01476787|540207247|FG000|Treatment|Concurrent illness|12|||
149747617|NCT01476787|540207248|FG001|Treatment|Concurrent illness|9|||
149747618|NCT01476787|540207247|FG000|Treatment|Insufficient response|15|||
149747619|NCT01476787|540207248|FG001|Treatment|Insufficient response|3|||
149747620|NCT01476787|540207247|FG000|Treatment|Voluntary treatment discontinuation|8|||
149747621|NCT01476787|540207248|FG001|Treatment|Voluntary treatment discontinuation|4|||
149747622|NCT02986373|540207250|FG000|Overall Study|Adverse Event|4|||
149747623|NCT02986373|540207250|FG000|Overall Study|Lost to Follow-up|1|||
149747624|NCT02986373|540207250|FG000|Overall Study|Withdrawal by Subject|10|||
149747625|NCT02986373|540207250|FG000|Overall Study|Other|24|||
149747626|NCT01151137|540207255|FG000|Overall Study|Death|15|||
149747627|NCT01151137|540207256|FG001|Overall Study|Death|27|||
149747628|NCT01151137|540207255|FG000|Overall Study|Lost to Follow-up|1|||
149747629|NCT01151137|540207256|FG001|Overall Study|Lost to Follow-up|1|||
149747630|NCT01933672|540207257|FG000|Metformin Run-in Period|Adverse Event|1|||
149747631|NCT01933672|540207258|FG001|Metformin Run-in Period|Adverse Event|0|||
149747632|NCT01933672|540207259|FG002|Metformin Run-in Period|Adverse Event|0|||
149747633|NCT01933672|540207260|FG003|Metformin Run-in Period|Adverse Event|0|||
149747634|NCT01933672|540207261|FG004|Metformin Run-in Period|Adverse Event|0|||
149747635|NCT01933672|540207262|FG005|Metformin Run-in Period|Adverse Event|0|||
149747636|NCT01933672|540207263|FG006|Metformin Run-in Period|Adverse Event|0|||
149747637|NCT01933672|540207257|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
149747638|NCT01933672|540207258|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747639|NCT01933672|540207259|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747640|NCT01933672|540207260|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747641|NCT01933672|540207261|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747642|NCT01933672|540207262|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747643|NCT01933672|540207263|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149747644|NCT01933672|540207257|FG000|Metformin Run-in Period|Other|5|||
149747645|NCT01933672|540207258|FG001|Metformin Run-in Period|Other|0|||
149747646|NCT01933672|540207259|FG002|Metformin Run-in Period|Other|0|||
149747647|NCT01933672|540207260|FG003|Metformin Run-in Period|Other|0|||
149747648|NCT01933672|540207261|FG004|Metformin Run-in Period|Other|0|||
149747649|NCT01933672|540207262|FG005|Metformin Run-in Period|Other|0|||
149747650|NCT01933672|540207263|FG006|Metformin Run-in Period|Other|0|||
149747651|NCT01933672|540207257|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747652|NCT01933672|540207258|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747653|NCT01933672|540207259|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747654|NCT01933672|540207260|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747655|NCT01933672|540207261|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
149747656|NCT01933672|540207262|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747657|NCT01933672|540207263|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747658|NCT01933672|540207257|FG000|First Intervention Period (12-16 Days)|Other|0|||
149747659|NCT01933672|540207258|FG001|First Intervention Period (12-16 Days)|Other|0|||
149747660|NCT01933672|540207259|FG002|First Intervention Period (12-16 Days)|Other|1|||
149747661|NCT01933672|540207260|FG003|First Intervention Period (12-16 Days)|Other|0|||
149747662|NCT01933672|540207261|FG004|First Intervention Period (12-16 Days)|Other|0|||
149747663|NCT01933672|540207262|FG005|First Intervention Period (12-16 Days)|Other|1|||
149747664|NCT01933672|540207263|FG006|First Intervention Period (12-16 Days)|Other|0|||
149747665|NCT01933672|540207257|FG000|Second Intervention Period (12-16 Days)|Other|0|||
149747666|NCT01933672|540207258|FG001|Second Intervention Period (12-16 Days)|Other|1|||
149747667|NCT01933672|540207259|FG002|Second Intervention Period (12-16 Days)|Other|1|||
149747668|NCT01933672|540207260|FG003|Second Intervention Period (12-16 Days)|Other|0|||
149747669|NCT01933672|540207261|FG004|Second Intervention Period (12-16 Days)|Other|0|||
149747670|NCT01933672|540207262|FG005|Second Intervention Period (12-16 Days)|Other|0|||
149747671|NCT01933672|540207263|FG006|Second Intervention Period (12-16 Days)|Other|0|||
149747672|NCT01933672|540207257|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747673|NCT01933672|540207258|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747674|NCT01933672|540207259|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747675|NCT01933672|540207260|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
149747676|NCT01933672|540207261|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747677|NCT01933672|540207262|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747678|NCT01933672|540207263|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149747679|NCT01933672|540207257|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747680|NCT01933672|540207258|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
149747681|NCT01933672|540207259|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747682|NCT01933672|540207260|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747683|NCT01933672|540207261|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747684|NCT01933672|540207262|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747685|NCT01933672|540207263|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149747686|NCT05635838|540209001|FG000|16-Week DBVC Period|Adverse Event|2|||
149747687|NCT05635838|540209002|FG001|16-Week DBVC Period|Adverse Event|0|||
149747688|NCT05635838|540209003|FG002|16-Week DBVC Period|Adverse Event|0|||
149747689|NCT05635838|540209004|FG003|16-Week DBVC Period|Adverse Event|0|||
149747690|NCT05635838|540209001|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
149747691|NCT05635838|540209002|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
149747692|NCT05635838|540209003|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
149747693|NCT05635838|540209004|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
149747694|NCT05635838|540209001|FG000|16-Week DBVC Period|Physician Decision|0|||
149747695|NCT05635838|540209002|FG001|16-Week DBVC Period|Physician Decision|1|||
149747696|NCT05635838|540209003|FG002|16-Week DBVC Period|Physician Decision|0|||
149747697|NCT05635838|540209004|FG003|16-Week DBVC Period|Physician Decision|0|||
149747698|NCT05635838|540209001|FG000|16-Week DBVC Period|Protocol Violation|1|||
149747699|NCT05635838|540209002|FG001|16-Week DBVC Period|Protocol Violation|0|||
149747700|NCT05635838|540209003|FG002|16-Week DBVC Period|Protocol Violation|0|||
149747701|NCT05635838|540209004|FG003|16-Week DBVC Period|Protocol Violation|0|||
149747702|NCT05635838|540209001|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
149747703|NCT05635838|540209002|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
149747704|NCT05635838|540209003|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
149747705|NCT05635838|540209004|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
149747706|NCT05635838|540209001|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
149747707|NCT05635838|540209002|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
149747708|NCT05635838|540209003|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
149747709|NCT05635838|540209004|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
149747710|NCT05635838|540209001|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
149747711|NCT05635838|540209002|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
149747712|NCT05635838|540209003|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
149747713|NCT05635838|540209004|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
149747714|NCT05635838|540209001|FG000|16-Week OLE Period|Adverse Event|0|||
149747715|NCT05635838|540209002|FG001|16-Week OLE Period|Adverse Event|0|||
149747716|NCT05635838|540209003|FG002|16-Week OLE Period|Adverse Event|0|||
149747717|NCT05635838|540209004|FG003|16-Week OLE Period|Adverse Event|2|||
149747718|NCT05635838|540209001|FG000|16-Week OLE Period|Lost to Follow-up|0|||
149747719|NCT05635838|540209002|FG001|16-Week OLE Period|Lost to Follow-up|0|||
149747720|NCT05635838|540209003|FG002|16-Week OLE Period|Lost to Follow-up|1|||
149747721|NCT05635838|540209004|FG003|16-Week OLE Period|Lost to Follow-up|3|||
149747722|NCT05635838|540209001|FG000|16-Week OLE Period|Physician Decision|0|||
149747723|NCT05635838|540209002|FG001|16-Week OLE Period|Physician Decision|0|||
149747724|NCT05635838|540209003|FG002|16-Week OLE Period|Physician Decision|0|||
149747725|NCT05635838|540209004|FG003|16-Week OLE Period|Physician Decision|1|||
149747726|NCT05635838|540209001|FG000|16-Week OLE Period|Protocol Violation|0|||
149747727|NCT05635838|540209002|FG001|16-Week OLE Period|Protocol Violation|0|||
149747728|NCT05635838|540209003|FG002|16-Week OLE Period|Protocol Violation|1|||
149747729|NCT05635838|540209004|FG003|16-Week OLE Period|Protocol Violation|1|||
149747730|NCT05635838|540209001|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
149747731|NCT05635838|540209002|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
149747732|NCT05635838|540209003|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
149747733|NCT05635838|540209004|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
149747734|NCT05635838|540209001|FG000|16-Week OLE Period|Pregnancy|0|||
149747735|NCT05635838|540209002|FG001|16-Week OLE Period|Pregnancy|0|||
149747736|NCT05635838|540209003|FG002|16-Week OLE Period|Pregnancy|1|||
149747737|NCT05635838|540209004|FG003|16-Week OLE Period|Pregnancy|0|||
149747738|NCT02031146|540209007|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149747739|NCT02031146|540209008|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149747740|NCT02031146|540209009|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149747741|NCT02031146|540209010|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
149747742|NCT02031146|540209011|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
149747743|NCT02031146|540209012|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
149747744|NCT02031146|540209013|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
149747745|NCT05165394|540209014|FG000|Overall Study|Withdrawal by Subject|5|||
149747746|NCT05165394|540209015|FG001|Overall Study|Withdrawal by Subject|1|||
149747747|NCT05165394|540209014|FG000|Overall Study|Lost to Follow-up|1|||
149747748|NCT05165394|540209015|FG001|Overall Study|Lost to Follow-up|2|||
149747749|NCT05165394|540209014|FG000|Overall Study|Other Than Specified|0|||
149747750|NCT05165394|540209015|FG001|Overall Study|Other Than Specified|1|||
149747751|NCT00001259|540209018|FG000|Study 2|Adverse Event|0|||
149747752|NCT00001259|540209019|FG001|Study 2|Adverse Event|0|||
149747753|NCT00001259|540209020|FG002|Study 2|Adverse Event|0|||
149747754|NCT00001259|540209021|FG003|Study 2|Adverse Event|0|||
149747755|NCT00001259|540209022|FG004|Study 2|Adverse Event|2|||
149747756|NCT00001259|540209023|FG005|Study 2|Adverse Event|0|||
149747757|NCT00001259|540209024|FG006|Study 2|Adverse Event|0|||
149747758|NCT01582282|540209025|FG000|Overall Study|Adverse Event|1|||
149747759|NCT01582282|540209026|FG001|Overall Study|Adverse Event|1|||
149747760|NCT01582282|540209027|FG002|Overall Study|Adverse Event|0|||
149747761|NCT01582282|540209025|FG000|Overall Study|Lost to Follow-up|1|||
149747762|NCT01582282|540209026|FG001|Overall Study|Lost to Follow-up|0|||
149747763|NCT01582282|540209027|FG002|Overall Study|Lost to Follow-up|0|||
149747764|NCT01582282|540209025|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
149747765|NCT01582282|540209026|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
149747766|NCT01582282|540209027|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
149747767|NCT02629393|540209029|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
149747768|NCT02629393|540209029|FG000|Overall Study|Physician Decision|1|||
149747769|NCT03937986|540209030|FG000|Overall Study|COVID-19 Pandemic|1|||
149747770|NCT01853228|540209033|FG000|Phase 1|Lack of Efficacy|8|||
149747771|NCT01853228|540209034|FG001|Phase 1|Lack of Efficacy|0|||
149747772|NCT01853228|540209033|FG000|Phase 1|Other|1|||
149747773|NCT01853228|540209034|FG001|Phase 1|Other|0|||
149747774|NCT01853228|540209033|FG000|Phase 2|Physician Decision|0|||
149747775|NCT01853228|540209034|FG001|Phase 2|Physician Decision|1|||
149747776|NCT01853228|540209033|FG000|Phase 2|Proceed To Transplant|0|||
149747777|NCT01853228|540209034|FG001|Phase 2|Proceed To Transplant|3|||
149747778|NCT01853228|540209033|FG000|Phase 2|Lack of Efficacy|0|||
149747779|NCT01853228|540209034|FG001|Phase 2|Lack of Efficacy|4|||
149747780|NCT02839746|540209041|FG000|Overall Study|Not met selection criteria|12|||
149747781|NCT02089737|540209042|FG000|Overall Study|Survey form not completed|5|||
149747782|NCT02089737|540209042|FG000|Overall Study|Not treated|1|||
149747783|NCT00744055|540209043|FG000|Overall Study|Withdrawal by Subject|6|||
149747784|NCT00744055|540209044|FG001|Overall Study|Withdrawal by Subject|9|||
149747785|NCT00744055|540209043|FG000|Overall Study|Lack of Efficacy|0|||
149747786|NCT00744055|540209044|FG001|Overall Study|Lack of Efficacy|1|||
149747787|NCT00744055|540209043|FG000|Overall Study|Physician Decision|0|||
149747788|NCT00744055|540209044|FG001|Overall Study|Physician Decision|2|||
149747789|NCT00744055|540209043|FG000|Overall Study|Protocol Violation|1|||
149747790|NCT00744055|540209044|FG001|Overall Study|Protocol Violation|1|||
149747791|NCT00744055|540209043|FG000|Overall Study|Lost to Follow-up|0|||
149747792|NCT00744055|540209044|FG001|Overall Study|Lost to Follow-up|1|||
149747793|NCT02767570|540209045|FG000|Overall Study|Lost to Follow-up|3|||
149747794|NCT02767570|540209046|FG001|Overall Study|Lost to Follow-up|0|||
149747795|NCT02767570|540209045|FG000|Overall Study|COVID shutdown|2|||
149747796|NCT02767570|540209046|FG001|Overall Study|COVID shutdown|5|||
149747797|NCT02767570|540209045|FG000|Overall Study|Increased pain|2|||
149747798|NCT02767570|540209046|FG001|Overall Study|Increased pain|0|||
149747799|NCT02767570|540209045|FG000|Overall Study|Withdrawal by Subject|1|||
149747800|NCT02767570|540209046|FG001|Overall Study|Withdrawal by Subject|3|||
149747801|NCT02767570|540209045|FG000|Overall Study|Unrelated medical issue|1|||
149747802|NCT02767570|540209046|FG001|Overall Study|Unrelated medical issue|1|||
149747803|NCT02767570|540209045|FG000|Overall Study|Received intra-articular injection|0|||
149747804|NCT02767570|540209046|FG001|Overall Study|Received intra-articular injection|1|||
149747805|NCT04426630|540209047|FG000|Overall Study|Death|4|||
149747806|NCT04426630|540209047|FG000|Overall Study|Lost to Follow-up|2|||
149747807|NCT05523362|540209048|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
149747808|NCT05523362|540209048|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
149747809|NCT05523362|540209048|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
149747810|NCT05523362|540209048|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
149747811|NCT00467649|540209049|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
149747812|NCT00467649|540209050|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
149747813|NCT00467649|540209051|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
149747814|NCT00467649|540209052|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
149747815|NCT00467649|540209053|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
149747816|NCT00467649|540209054|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
149747817|NCT00467649|540209049|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
149747818|NCT00467649|540209050|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
149747819|NCT00467649|540209051|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
149747820|NCT00467649|540209052|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
149747821|NCT00467649|540209053|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
149747822|NCT00467649|540209054|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
149747823|NCT00467649|540209049|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
149747824|NCT00467649|540209050|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
149747825|NCT00467649|540209051|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149747826|NCT00467649|540209052|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149747827|NCT00467649|540209053|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149747828|NCT00467649|540209054|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149747829|NCT00467649|540209049|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
149747830|NCT00467649|540209050|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
149747831|NCT00467649|540209051|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149747832|NCT00467649|540209052|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149747833|NCT00467649|540209053|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149747834|NCT00467649|540209054|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149747835|NCT00467649|540209049|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149747836|NCT00467649|540209050|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149747837|NCT00467649|540209051|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149747838|NCT00467649|540209052|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
149747839|NCT00467649|540209053|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149747840|NCT00467649|540209054|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149747841|NCT00467649|540209049|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149747842|NCT00467649|540209050|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149747843|NCT00467649|540209051|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149747844|NCT00467649|540209052|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
149747845|NCT00467649|540209053|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149747846|NCT00467649|540209054|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149747847|NCT00467649|540209049|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149747848|NCT00467649|540209050|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149747849|NCT00467649|540209051|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149747850|NCT00467649|540209052|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149747851|NCT00467649|540209053|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149747852|NCT00467649|540209054|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
149747853|NCT03240081|540209055|FG000|Overall Study|Withdrawal by Subject|0|||
149747854|NCT03240081|540209056|FG001|Overall Study|Withdrawal by Subject|2|||
149747855|NCT03240081|540209055|FG000|Overall Study|Lost to Follow-up|0|||
149747856|NCT03240081|540209056|FG001|Overall Study|Lost to Follow-up|1|||
149747857|NCT04925570|540209057|FG000|Overall Study|Protocol Violation|24|||
149747858|NCT04925570|540209058|FG001|Overall Study|Protocol Violation|30|||
149747859|NCT04925570|540209057|FG000|Overall Study|Withdrawal by Subject|0|||
149747860|NCT04925570|540209058|FG001|Overall Study|Withdrawal by Subject|2|||
149747861|NCT02111811|540209059|FG000|Treatment Phase|Lost to Follow-up|22|||
149747862|NCT02111811|540209060|FG001|Treatment Phase|Lost to Follow-up|18|||
149747863|NCT02111811|540209059|FG000|Treatment Phase|Death|2|||
149747864|NCT02111811|540209060|FG001|Treatment Phase|Death|0|||
149747865|NCT02111811|540209059|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
149747866|NCT02111811|540209060|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
149747867|NCT02111811|540209059|FG000|Follow up Period (Aim 2)|Death|2|||
149747868|NCT02111811|540209060|FG001|Follow up Period (Aim 2)|Death|0|||
149747869|NCT00149825|540209061|FG000|Overall Study|Intolerance to medication side effects|1|||
149747870|NCT00149825|540209062|FG001|Overall Study|Intolerance to medication side effects|2|||
149747871|NCT00149825|540209061|FG000|Overall Study|Time commitments|2|||
149747872|NCT00149825|540209062|FG001|Overall Study|Time commitments|1|||
149747873|NCT00149825|540209061|FG000|Overall Study|Not liking insomnia therapy|1|||
149747874|NCT00149825|540209062|FG001|Overall Study|Not liking insomnia therapy|0|||
149747875|NCT00149825|540209061|FG000|Overall Study|Other|1|||
149747876|NCT00149825|540209062|FG001|Overall Study|Other|0|||
149747877|NCT05593432|540209063|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
149747878|NCT05593432|540209064|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
149747879|NCT05593432|540209065|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
149747880|NCT05593432|540209066|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
149747881|NCT05593432|540209063|FG000|16-Week OLE Period|Lack of Efficacy|0|||
149747882|NCT05593432|540209064|FG001|16-Week OLE Period|Lack of Efficacy|0|||
149747883|NCT05593432|540209065|FG002|16-Week OLE Period|Lack of Efficacy|0|||
149747884|NCT05593432|540209066|FG003|16-Week OLE Period|Lack of Efficacy|1|||
149747885|NCT05593432|540209063|FG000|16-Week OLE Period|Lost to Follow-up|0|||
149747886|NCT05593432|540209064|FG001|16-Week OLE Period|Lost to Follow-up|0|||
149747887|NCT05593432|540209065|FG002|16-Week OLE Period|Lost to Follow-up|1|||
149747888|NCT05593432|540209066|FG003|16-Week OLE Period|Lost to Follow-up|2|||
149747889|NCT05593432|540209063|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
149747890|NCT05593432|540209064|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
149747891|NCT05593432|540209065|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
149747892|NCT05593432|540209066|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
149747893|NCT05897853|540209068|FG000|Overall Study|Lost to Follow-up|2|||
149747894|NCT05897853|540209069|FG001|Overall Study|Lost to Follow-up|0|||
149747895|NCT05897853|540209068|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
149747896|NCT05897853|540209069|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
149747897|NCT01450137|540209077|FG000|Up to Week 12|Adverse Event|2|||
149747898|NCT01450137|540209078|FG001|Up to Week 12|Adverse Event|1|||
149747899|NCT01450137|540209077|FG000|Up to Week 12|Withdrawal by Subject|0|||
149747900|NCT01450137|540209078|FG001|Up to Week 12|Withdrawal by Subject|2|||
149747901|NCT01450137|540209077|FG000|Week 12 to Study End|Death|0|||
149747902|NCT01450137|540209078|FG001|Week 12 to Study End|Death|1|||
149747903|NCT01450137|540209077|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
149747904|NCT01450137|540209078|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
149747905|NCT01926886|540209079|FG000|Overall Study|Administrative/other|1|||
149747906|NCT01926886|540209080|FG001|Overall Study|Administrative/other|0|||
149747907|NCT01926886|540209079|FG000|Overall Study|Adverse event/intercurrent illness|4|||
149747908|NCT01926886|540209080|FG001|Overall Study|Adverse event/intercurrent illness|0|||
149747909|NCT01926886|540209079|FG000|Overall Study|Disease progression/recurrence|4|||
149747910|NCT01926886|540209080|FG001|Overall Study|Disease progression/recurrence|0|||
149747911|NCT01926886|540209079|FG000|Overall Study|Withdrawal by Subject|15|||
149747912|NCT01926886|540209080|FG001|Overall Study|Withdrawal by Subject|0|||
149747913|NCT01926886|540209079|FG000|Overall Study|Failure to return|3|||
149747914|NCT01926886|540209080|FG001|Overall Study|Failure to return|0|||
149747915|NCT01926886|540209079|FG000|Overall Study|Recurrence of disease|1|||
149747916|NCT01926886|540209080|FG001|Overall Study|Recurrence of disease|0|||
149747917|NCT01926886|540209079|FG000|Overall Study|Progression of disease|2|||
149747918|NCT01926886|540209080|FG001|Overall Study|Progression of disease|0|||
149747919|NCT01926886|540209079|FG000|Overall Study|Death|1|||
149747920|NCT01926886|540209080|FG001|Overall Study|Death|0|||
149747921|NCT01926886|540209079|FG000|Overall Study|Did not cooperate|1|||
149747922|NCT01926886|540209080|FG001|Overall Study|Did not cooperate|0|||
149747923|NCT04458857|540209084|FG000|Overall Study|Adverse Event|0|||
149747924|NCT04458857|540209085|FG001|Overall Study|Adverse Event|1|||
149747925|NCT04458857|540209086|FG002|Overall Study|Adverse Event|0|||
149747926|NCT04458857|540209084|FG000|Overall Study|Withdrawal by Subject|2|||
149747927|NCT04458857|540209085|FG001|Overall Study|Withdrawal by Subject|0|||
149747928|NCT04458857|540209086|FG002|Overall Study|Withdrawal by Subject|0|||
149747929|NCT04458857|540209084|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149747930|NCT04458857|540209085|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149747931|NCT04458857|540209086|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149747932|NCT04458857|540209084|FG000|Overall Study|Non-compliance with study drug|0|||
149747933|NCT04458857|540209085|FG001|Overall Study|Non-compliance with study drug|1|||
149747934|NCT04458857|540209086|FG002|Overall Study|Non-compliance with study drug|0|||
149747935|NCT04458857|540209084|FG000|Overall Study|Lost to Follow-up|4|||
149747936|NCT04458857|540209085|FG001|Overall Study|Lost to Follow-up|1|||
149747937|NCT04458857|540209086|FG002|Overall Study|Lost to Follow-up|0|||
149747938|NCT04800315|540209087|FG000|Randomization|Did not receive study treatment|1|||
149747939|NCT04800315|540209088|FG001|Randomization|Did not receive study treatment|0|||
149747940|NCT04800315|540209089|FG002|Randomization|Did not receive study treatment|0|||
149747941|NCT04800315|540209090|FG003|Randomization|Did not receive study treatment|0|||
149747942|NCT04800315|540209087|FG000|Treatment Period|Adverse Event|4|||
149747943|NCT04800315|540209088|FG001|Treatment Period|Adverse Event|2|||
149747944|NCT04800315|540209089|FG002|Treatment Period|Adverse Event|1|||
149747945|NCT04800315|540209090|FG003|Treatment Period|Adverse Event|2|||
149747946|NCT04800315|540209087|FG000|Treatment Period|Lack of Efficacy|1|||
149747947|NCT04800315|540209088|FG001|Treatment Period|Lack of Efficacy|0|||
149747948|NCT04800315|540209089|FG002|Treatment Period|Lack of Efficacy|0|||
149747949|NCT04800315|540209090|FG003|Treatment Period|Lack of Efficacy|3|||
149747950|NCT04800315|540209087|FG000|Treatment Period|Lost to Follow-up|0|||
149747951|NCT04800315|540209088|FG001|Treatment Period|Lost to Follow-up|1|||
149747952|NCT04800315|540209089|FG002|Treatment Period|Lost to Follow-up|2|||
149747953|NCT04800315|540209090|FG003|Treatment Period|Lost to Follow-up|2|||
149747954|NCT04800315|540209087|FG000|Treatment Period|Withdrawal by participant|0|||
149747955|NCT04800315|540209088|FG001|Treatment Period|Withdrawal by participant|0|||
149747956|NCT04800315|540209089|FG002|Treatment Period|Withdrawal by participant|0|||
149747957|NCT04800315|540209090|FG003|Treatment Period|Withdrawal by participant|4|||
149747958|NCT04800315|540209087|FG000|Treatment Period|Other Reasons|0|||
149747959|NCT04800315|540209088|FG001|Treatment Period|Other Reasons|2|||
149747960|NCT04800315|540209089|FG002|Treatment Period|Other Reasons|0|||
149747961|NCT04800315|540209090|FG003|Treatment Period|Other Reasons|1|||
149747962|NCT00753922|540209093|FG000|Overall Study|Lost to Follow-up|155|||
149747963|NCT00753922|540209094|FG001|Overall Study|Lost to Follow-up|24|||
149747964|NCT00753922|540209095|FG002|Overall Study|Lost to Follow-up|28|||
149747965|NCT00753922|540209096|FG003|Overall Study|Lost to Follow-up|5|||
149747966|NCT00753922|540209093|FG000|Overall Study|Withdrawal by Subject|9|||
149747967|NCT00753922|540209094|FG001|Overall Study|Withdrawal by Subject|11|||
149747968|NCT00753922|540209095|FG002|Overall Study|Withdrawal by Subject|4|||
149747969|NCT00753922|540209096|FG003|Overall Study|Withdrawal by Subject|2|||
149747970|NCT00753922|540209093|FG000|Overall Study|Patient Non-compliance|55|||
149747971|NCT00753922|540209094|FG001|Overall Study|Patient Non-compliance|22|||
149747972|NCT00753922|540209095|FG002|Overall Study|Patient Non-compliance|14|||
149747973|NCT00753922|540209096|FG003|Overall Study|Patient Non-compliance|11|||
149747974|NCT00753922|540209093|FG000|Overall Study|Patients Not Completing Visit|11|||
149747975|NCT00753922|540209094|FG001|Overall Study|Patients Not Completing Visit|0|||
149747976|NCT00753922|540209095|FG002|Overall Study|Patients Not Completing Visit|1|||
149747977|NCT00753922|540209096|FG003|Overall Study|Patients Not Completing Visit|0|||
149747978|NCT00753922|540209093|FG000|Overall Study|Death|2|||
149747979|NCT00753922|540209094|FG001|Overall Study|Death|23|||
149747980|NCT00753922|540209095|FG002|Overall Study|Death|2|||
149747981|NCT00753922|540209096|FG003|Overall Study|Death|1|||
149747982|NCT00753922|540209093|FG000|Overall Study|Discontinuation Due to Explantation|14|||
149747983|NCT00753922|540209094|FG001|Overall Study|Discontinuation Due to Explantation|14|||
149747984|NCT00753922|540209095|FG002|Overall Study|Discontinuation Due to Explantation|14|||
149747985|NCT00753922|540209096|FG003|Overall Study|Discontinuation Due to Explantation|4|||
149747986|NCT00196937|540209097|FG000|Overall Study|Serious Adverse Event|1|||
149747987|NCT00196937|540209098|FG001|Overall Study|Serious Adverse Event|0|||
149747988|NCT00196937|540209099|FG002|Overall Study|Serious Adverse Event|0|||
149747989|NCT00196937|540209097|FG000|Overall Study|Non-serious adverse event|1|||
149747990|NCT00196937|540209098|FG001|Overall Study|Non-serious adverse event|1|||
149747991|NCT00196937|540209099|FG002|Overall Study|Non-serious adverse event|1|||
149747992|NCT00196937|540209097|FG000|Overall Study|Withdrawal by Subject|0|||
149747993|NCT00196937|540209098|FG001|Overall Study|Withdrawal by Subject|0|||
149747994|NCT00196937|540209099|FG002|Overall Study|Withdrawal by Subject|2|||
149747995|NCT00196937|540209097|FG000|Overall Study|Lost to Follow-up|4|||
149747996|NCT00196937|540209098|FG001|Overall Study|Lost to Follow-up|3|||
149747997|NCT00196937|540209099|FG002|Overall Study|Lost to Follow-up|3|||
149747998|NCT00196937|540209097|FG000|Overall Study|Other|3|||
149747999|NCT00196937|540209098|FG001|Overall Study|Other|1|||
149748000|NCT00196937|540209099|FG002|Overall Study|Other|1|||
149748001|NCT03368404|540209109|FG000|Overall Study|Adverse Event|2|||
149748002|NCT03368404|540209110|FG001|Overall Study|Adverse Event|1|||
149748003|NCT03368404|540209109|FG000|Overall Study|Withdrawal by Subject|1|||
149748004|NCT03368404|540209110|FG001|Overall Study|Withdrawal by Subject|1|||
149748005|NCT02983292|540209111|FG000|Overall Study|Participant unwell & cannot travel|2|||
149748006|NCT02983292|540209111|FG000|Overall Study|Lost to Follow-up|3|||
149748007|NCT02983292|540209111|FG000|Overall Study|Participant withdrew consent|2|||
149748008|NCT02983292|540209111|FG000|Overall Study|Revision|7|||
149748009|NCT02983292|540209111|FG000|Overall Study|Death|1|||
149748010|NCT02983292|540209111|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
149748011|NCT02983292|540209111|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
149748012|NCT02983292|540209111|FG000|Overall Study|Participant relocation|1|||
149748013|NCT04725682|540209112|FG000|Overall Study|Withdrawal by Subject|7|||
149748014|NCT04725682|540209113|FG001|Overall Study|Withdrawal by Subject|5|||
149748015|NCT04725682|540209112|FG000|Overall Study|Failed to comply with the requirements|2|||
149748016|NCT04725682|540209113|FG001|Overall Study|Failed to comply with the requirements|1|||
149748017|NCT04725682|540209112|FG000|Overall Study|Adverse Event|1|||
149748018|NCT04725682|540209113|FG001|Overall Study|Adverse Event|1|||
149748019|NCT04725682|540209112|FG000|Overall Study|Death|0|||
149748020|NCT04725682|540209113|FG001|Overall Study|Death|1|||
149748021|NCT00964795|540209114|FG000|Overall Study|Withdrawal by Subject|79|||
149748022|NCT00964795|540209114|FG000|Overall Study|Adverse Event|12|||
149748023|NCT00964795|540209114|FG000|Overall Study|Death|14|||
149748024|NCT00964795|540209114|FG000|Overall Study|Lost to Follow-up|7|||
149748025|NCT00964795|540209114|FG000|Overall Study|Termination of Study by Sponsor|169|||
149748026|NCT00964795|540209114|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
149748027|NCT00964795|540209114|FG000|Overall Study|Other|23|||
149748028|NCT00586690|540209122|FG000|Overall Study|Death|2|||
149748029|NCT00586690|540209123|FG001|Overall Study|Death|0|||
149748030|NCT00586690|540209122|FG000|Overall Study|Disease Progression|10|||
149748031|NCT00586690|540209123|FG001|Overall Study|Disease Progression|0|||
149748032|NCT00586690|540209122|FG000|Overall Study|Adverse Event|1|||
149748033|NCT00586690|540209123|FG001|Overall Study|Adverse Event|0|||
149748034|NCT00586690|540209122|FG000|Overall Study|Lack of Efficacy|2|||
149748035|NCT00586690|540209123|FG001|Overall Study|Lack of Efficacy|0|||
149748036|NCT00586690|540209122|FG000|Overall Study|Lab can't accommodate|1|||
149748037|NCT00586690|540209123|FG001|Overall Study|Lab can't accommodate|0|||
149748038|NCT01751646|540209124|FG000|Overall Study|Lost to Follow-up|5|||
149748039|NCT01751646|540209125|FG001|Overall Study|Lost to Follow-up|1|||
149748040|NCT01751646|540209124|FG000|Overall Study|Withdrawal by Subject|0|||
149748041|NCT01751646|540209125|FG001|Overall Study|Withdrawal by Subject|4|||
149748042|NCT01751646|540209124|FG000|Overall Study|Starting hormone therapy|1|||
149748043|NCT01751646|540209125|FG001|Overall Study|Starting hormone therapy|0|||
149748044|NCT01751646|540209124|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
149748045|NCT01751646|540209125|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
149748046|NCT01751646|540209124|FG000|Overall Study|Inadvertent enrollment|1|||
149748047|NCT01751646|540209125|FG001|Overall Study|Inadvertent enrollment|1|||
149748048|NCT01751646|540209124|FG000|Overall Study|Moved out of the area|1|||
149748049|NCT01751646|540209125|FG001|Overall Study|Moved out of the area|5|||
149748050|NCT01751646|540209124|FG000|Overall Study|Inability to attend required visits|0|||
149748051|NCT01751646|540209125|FG001|Overall Study|Inability to attend required visits|1|||
149748052|NCT01751646|540209124|FG000|Overall Study|Off study due to multiple obligations|0|||
149748053|NCT01751646|540209125|FG001|Overall Study|Off study due to multiple obligations|1|||
149748054|NCT01751646|540209124|FG000|Overall Study|Fails to comply with study requirements|0|||
149748055|NCT01751646|540209125|FG001|Overall Study|Fails to comply with study requirements|1|||
149748056|NCT01751646|540209124|FG000|Overall Study|Childcare issues|1|||
149748057|NCT01751646|540209125|FG001|Overall Study|Childcare issues|1|||
149748058|NCT02190591|540209126|FG000|Overall Study|Withdrawal by Subject|1|||
149748059|NCT02190591|540209127|FG001|Overall Study|Withdrawal by Subject|8|||
149748060|NCT02190591|540209126|FG000|Overall Study|Protocol Violation|1|||
149748061|NCT02190591|540209127|FG001|Overall Study|Protocol Violation|0|||
149748062|NCT02190591|540209126|FG000|Overall Study|did not use peanut ball as instructed|0|||
149748063|NCT02190591|540209127|FG001|Overall Study|did not use peanut ball as instructed|2|||
149748064|NCT02190591|540209126|FG000|Overall Study|face presentation so she was ineligible|0|||
149748065|NCT02190591|540209127|FG001|Overall Study|face presentation so she was ineligible|1|||
149748066|NCT00857246|540209128|FG000|Induction Regimen|Adverse Event|1|||
149748067|NCT00857246|540209128|FG000|Induction Regimen|disease-related complications|1|||
149748068|NCT00857246|540209128|FG000|Induction Regimen|Withdrawal by Subject|1|||
149748069|NCT00857246|540209128|FG000|Surgery (Curative)|disease progression|6|||
149748070|NCT00857246|540209128|FG000|ChemoRT|Withdrawal by Subject|1|||
149748071|NCT00857246|540209128|FG000|ChemoRT|Adverse Event|2|||
149748072|NCT00072189|540209129|FG000|Overall Study|Withdrawal by Subject|1|||
149748073|NCT02973815|540209130|FG000|Post Intervention|Death|1|||
149748074|NCT02973815|540209131|FG001|Post Intervention|Death|0|||
149748075|NCT02973815|540209130|FG000|Post Intervention|Lost to Follow-up|7|||
149748076|NCT02973815|540209131|FG001|Post Intervention|Lost to Follow-up|24|||
149748077|NCT02973815|540209130|FG000|Follow-up|Lost to Follow-up|2|||
149748078|NCT02973815|540209131|FG001|Follow-up|Lost to Follow-up|0|||
149748079|NCT04542291|540209132|FG000|Overall Study|Adverse Event|1|||
149748080|NCT04542291|540209132|FG000|Overall Study|Physician Decision|2|||
149748081|NCT01607892|540209142|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
149748082|NCT01607892|540209143|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
149748083|NCT01607892|540209144|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
149748084|NCT01607892|540209145|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
149748085|NCT01607892|540209146|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
149748086|NCT01607892|540209142|FG000|Overall Study|Death|4|||
149748087|NCT01607892|540209143|FG001|Overall Study|Death|2|||
149748088|NCT01607892|540209144|FG002|Overall Study|Death|8|||
149748089|NCT01607892|540209145|FG003|Overall Study|Death|10|||
149748090|NCT01607892|540209146|FG004|Overall Study|Death|3|||
149748091|NCT01607892|540209142|FG000|Overall Study|Investigator discretion|2|||
149748092|NCT01607892|540209143|FG001|Overall Study|Investigator discretion|4|||
149748093|NCT01607892|540209144|FG002|Overall Study|Investigator discretion|4|||
149748094|NCT01607892|540209145|FG003|Overall Study|Investigator discretion|8|||
149748095|NCT01607892|540209146|FG004|Overall Study|Investigator discretion|0|||
149748096|NCT01607892|540209142|FG000|Overall Study|Other treatments became available|1|||
149748097|NCT01607892|540209143|FG001|Overall Study|Other treatments became available|1|||
149748098|NCT01607892|540209144|FG002|Overall Study|Other treatments became available|0|||
149748099|NCT01607892|540209145|FG003|Overall Study|Other treatments became available|0|||
149748100|NCT01607892|540209146|FG004|Overall Study|Other treatments became available|2|||
149748101|NCT01607892|540209142|FG000|Overall Study|Intercurrent illness|1|||
149748102|NCT01607892|540209143|FG001|Overall Study|Intercurrent illness|0|||
149748103|NCT01607892|540209144|FG002|Overall Study|Intercurrent illness|0|||
149748104|NCT01607892|540209145|FG003|Overall Study|Intercurrent illness|3|||
149748105|NCT01607892|540209146|FG004|Overall Study|Intercurrent illness|0|||
149748106|NCT01607892|540209142|FG000|Overall Study|Non-Compliance with study procedures|0|||
149748107|NCT01607892|540209143|FG001|Overall Study|Non-Compliance with study procedures|0|||
149748108|NCT01607892|540209144|FG002|Overall Study|Non-Compliance with study procedures|1|||
149748109|NCT01607892|540209145|FG003|Overall Study|Non-Compliance with study procedures|0|||
149748110|NCT01607892|540209146|FG004|Overall Study|Non-Compliance with study procedures|0|||
149748111|NCT01607892|540209142|FG000|Overall Study|Consent withdrawn by participant|9|||
149748112|NCT01607892|540209143|FG001|Overall Study|Consent withdrawn by participant|4|||
149748113|NCT01607892|540209144|FG002|Overall Study|Consent withdrawn by participant|24|||
149748114|NCT01607892|540209145|FG003|Overall Study|Consent withdrawn by participant|14|||
149748115|NCT01607892|540209146|FG004|Overall Study|Consent withdrawn by participant|4|||
149748116|NCT01607892|540209142|FG000|Overall Study|Disease progression|38|||
149748117|NCT01607892|540209143|FG001|Overall Study|Disease progression|13|||
149748118|NCT01607892|540209144|FG002|Overall Study|Disease progression|37|||
149748119|NCT01607892|540209145|FG003|Overall Study|Disease progression|57|||
149748120|NCT01607892|540209146|FG004|Overall Study|Disease progression|9|||
149748121|NCT01607892|540209142|FG000|Overall Study|Incidence or severity of Adverse events|3|||
149748122|NCT01607892|540209143|FG001|Overall Study|Incidence or severity of Adverse events|3|||
149748123|NCT01607892|540209144|FG002|Overall Study|Incidence or severity of Adverse events|7|||
149748124|NCT01607892|540209145|FG003|Overall Study|Incidence or severity of Adverse events|2|||
149748125|NCT01607892|540209146|FG004|Overall Study|Incidence or severity of Adverse events|6|||
149748126|NCT02273973|540209149|FG000|Overall Study|Adverse Event|4|||
149748127|NCT02273973|540209150|FG001|Overall Study|Adverse Event|0|||
149748128|NCT02273973|540209149|FG000|Overall Study|Withdrawal by Subject|2|||
149748129|NCT02273973|540209150|FG001|Overall Study|Withdrawal by Subject|3|||
149748130|NCT02273973|540209149|FG000|Overall Study|Death|1|||
149748131|NCT02273973|540209150|FG001|Overall Study|Death|0|||
149748132|NCT02273973|540209149|FG000|Overall Study|Non-compliance|1|||
149748133|NCT02273973|540209150|FG001|Overall Study|Non-compliance|0|||
149748134|NCT02273973|540209149|FG000|Overall Study|Protocol Violation|1|||
149748135|NCT02273973|540209150|FG001|Overall Study|Protocol Violation|0|||
149748136|NCT02273973|540209149|FG000|Overall Study|Progression of disease|0|||
149748137|NCT02273973|540209150|FG001|Overall Study|Progression of disease|2|||
149748138|NCT02273973|540209149|FG000|Overall Study|Lost to Follow-up|0|||
149748139|NCT02273973|540209150|FG001|Overall Study|Lost to Follow-up|1|||
149748140|NCT02273973|540209149|FG000|Overall Study|Physician Decision|0|||
149748141|NCT02273973|540209150|FG001|Overall Study|Physician Decision|1|||
149748142|NCT02273973|540209149|FG000|Overall Study|Reason not specified|0|||
149748143|NCT02273973|540209150|FG001|Overall Study|Reason not specified|1|||
149748144|NCT03022422|540209151|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
149748145|NCT03022422|540209152|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
149748146|NCT03022422|540209153|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
149748147|NCT03022422|540209154|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
149748148|NCT03022422|540209155|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
149748149|NCT03022422|540209156|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
149748150|NCT02403206|540209157|FG000|Overall Study|Lost to Follow-up|4|||
149748151|NCT02403206|540209158|FG001|Overall Study|Lost to Follow-up|3|||
149748152|NCT02403206|540209157|FG000|Overall Study|Physician Decision|2|||
149748153|NCT02403206|540209158|FG001|Overall Study|Physician Decision|0|||
149748154|NCT02403206|540209157|FG000|Overall Study|Withdrawal by Subject|3|||
149748155|NCT02403206|540209158|FG001|Overall Study|Withdrawal by Subject|3|||
149748156|NCT02403206|540209157|FG000|Overall Study|Reason not given|2|||
149748157|NCT02403206|540209158|FG001|Overall Study|Reason not given|4|||
149748158|NCT01676116|540209159|FG000|Overall Study|Withdrawal criteria|2|||
149748159|NCT01676116|540209160|FG001|Overall Study|Withdrawal criteria|14|||
149748160|NCT01676116|540209159|FG000|Overall Study|Adverse Event|1|||
149748161|NCT01676116|540209160|FG001|Overall Study|Adverse Event|2|||
149748162|NCT01676116|540209159|FG000|Overall Study|Unclassified|4|||
149748163|NCT01676116|540209160|FG001|Overall Study|Unclassified|10|||
149748164|NCT01676116|540209159|FG000|Overall Study|Protocol Violation|9|||
149748165|NCT01676116|540209160|FG001|Overall Study|Protocol Violation|3|||
149748166|NCT01287117|540209161|FG000|Overall Study|Adverse Event|2|||
149748167|NCT01287117|540209162|FG001|Overall Study|Adverse Event|1|||
149748168|NCT01287117|540209163|FG002|Overall Study|Adverse Event|1|||
149748169|NCT01287117|540209164|FG003|Overall Study|Adverse Event|1|||
149748170|NCT01287117|540209161|FG000|Overall Study|Lost to Follow-up|1|||
149748171|NCT01287117|540209162|FG001|Overall Study|Lost to Follow-up|1|||
149748172|NCT01287117|540209163|FG002|Overall Study|Lost to Follow-up|0|||
149748173|NCT01287117|540209164|FG003|Overall Study|Lost to Follow-up|0|||
149748174|NCT01287117|540209161|FG000|Overall Study|Physician Decision|0|||
149748175|NCT01287117|540209162|FG001|Overall Study|Physician Decision|1|||
149748176|NCT01287117|540209163|FG002|Overall Study|Physician Decision|1|||
149748177|NCT01287117|540209164|FG003|Overall Study|Physician Decision|1|||
149748178|NCT01287117|540209161|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
149748179|NCT01287117|540209162|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
149748180|NCT01287117|540209163|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
149748181|NCT01287117|540209164|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
149748182|NCT01287117|540209161|FG000|Overall Study|Disease Progression|10|||
149748183|NCT01287117|540209162|FG001|Overall Study|Disease Progression|5|||
149748184|NCT01287117|540209163|FG002|Overall Study|Disease Progression|6|||
149748185|NCT01287117|540209164|FG003|Overall Study|Disease Progression|5|||
149748186|NCT01821677|540209170|FG000|Overall Study|Adverse Event|4|||
149748187|NCT01821677|540209171|FG001|Overall Study|Adverse Event|6|||
149748188|NCT01821677|540209172|FG002|Overall Study|Adverse Event|5|||
149748189|NCT01821677|540209170|FG000|Overall Study|Physician Decision|1|||
149748190|NCT01821677|540209171|FG001|Overall Study|Physician Decision|4|||
149748191|NCT01821677|540209172|FG002|Overall Study|Physician Decision|1|||
149748192|NCT01821677|540209170|FG000|Overall Study|Non-compliance|0|||
149748193|NCT01821677|540209171|FG001|Overall Study|Non-compliance|1|||
149748194|NCT01821677|540209172|FG002|Overall Study|Non-compliance|2|||
149748195|NCT01821677|540209170|FG000|Overall Study|Lost to Follow-up|2|||
149748196|NCT01821677|540209171|FG001|Overall Study|Lost to Follow-up|1|||
149748197|NCT01821677|540209172|FG002|Overall Study|Lost to Follow-up|3|||
149748198|NCT01821677|540209170|FG000|Overall Study|Protocol Violation|0|||
149748199|NCT01821677|540209171|FG001|Overall Study|Protocol Violation|0|||
149748200|NCT01821677|540209172|FG002|Overall Study|Protocol Violation|2|||
149748201|NCT01821677|540209170|FG000|Overall Study|Withdrawal by Subject|7|||
149748202|NCT01821677|540209171|FG001|Overall Study|Withdrawal by Subject|3|||
149748203|NCT01821677|540209172|FG002|Overall Study|Withdrawal by Subject|2|||
149748204|NCT01821677|540209170|FG000|Overall Study|Other|9|||
149748205|NCT01821677|540209171|FG001|Overall Study|Other|0|||
149748206|NCT01821677|540209172|FG002|Overall Study|Other|0|||
149748207|NCT02606877|540209181|FG000|Overall Study|Adverse Event|3|||
149748208|NCT02606877|540209182|FG001|Overall Study|Adverse Event|0|||
149748209|NCT02606877|540209181|FG000|Overall Study|Non-compliance with protocol|0|||
149748210|NCT02606877|540209182|FG001|Overall Study|Non-compliance with protocol|1|||
149748211|NCT02606877|540209181|FG000|Overall Study|Other than listed above|1|||
149748212|NCT02606877|540209182|FG001|Overall Study|Other than listed above|0|||
149748213|NCT00778999|540209183|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
149748214|NCT00778999|540209184|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
149748215|NCT00778999|540209183|FG000|Overall Study|Did not receive recFSH|14|||
149748216|NCT00778999|540209184|FG001|Overall Study|Did not receive recFSH|20|||
149748217|NCT02032524|540209185|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
149748218|NCT02032524|540209186|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
149748219|NCT02032524|540209187|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
149748220|NCT02032524|540209188|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
149748221|NCT02032524|540209189|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
149748222|NCT02032524|540209190|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
149748223|NCT02032524|540209185|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149748224|NCT02032524|540209186|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149748225|NCT02032524|540209187|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149748226|NCT02032524|540209188|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
149748227|NCT02032524|540209189|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149748228|NCT02032524|540209190|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
149748229|NCT02032524|540209185|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
149748230|NCT02032524|540209186|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
149748231|NCT02032524|540209187|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
149748232|NCT02032524|540209188|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
149748233|NCT02032524|540209189|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
149748234|NCT02032524|540209190|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
149748235|NCT02032524|540209185|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149748236|NCT02032524|540209186|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
149748237|NCT02032524|540209187|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149748238|NCT02032524|540209188|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149748239|NCT02032524|540209189|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
149748240|NCT02032524|540209190|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149748241|NCT02032524|540209185|FG000|Period 2: LTS13769 Study|Other|0|||
149748242|NCT02032524|540209186|FG001|Period 2: LTS13769 Study|Other|0|||
149748243|NCT02032524|540209187|FG002|Period 2: LTS13769 Study|Other|0|||
149748244|NCT02032524|540209188|FG003|Period 2: LTS13769 Study|Other|0|||
149748245|NCT02032524|540209189|FG004|Period 2: LTS13769 Study|Other|0|||
149748246|NCT02032524|540209190|FG005|Period 2: LTS13769 Study|Other|1|||
149748247|NCT04513158|540209191|FG000|Overall Study|Screen Failure|1|||
149748248|NCT03705494|540210911|FG000|Overall Study|Lost to Follow-up|2|||
149748249|NCT03705494|540210912|FG001|Overall Study|Lost to Follow-up|1|||
149748250|NCT03705494|540210911|FG000|Overall Study|Withdrawal by Subject|5|||
149748251|NCT03705494|540210912|FG001|Overall Study|Withdrawal by Subject|2|||
149748252|NCT02786537|540210913|FG000|As Randomized|Adverse Event|0|||
149748253|NCT02786537|540210914|FG001|As Randomized|Adverse Event|11|||
149748254|NCT02786537|540210915|FG002|As Randomized|Adverse Event|0|||
149748255|NCT02786537|540210916|FG003|As Randomized|Adverse Event|4|||
149748256|NCT02786537|540210917|FG004|As Randomized|Adverse Event|6|||
149748257|NCT02786537|540210918|FG005|As Randomized|Adverse Event|2|||
149748258|NCT02786537|540210913|FG000|As Randomized|Lack of Efficacy|0|||
149748259|NCT02786537|540210914|FG001|As Randomized|Lack of Efficacy|0|||
149748260|NCT02786537|540210915|FG002|As Randomized|Lack of Efficacy|0|||
149748261|NCT02786537|540210916|FG003|As Randomized|Lack of Efficacy|1|||
149748262|NCT02786537|540210917|FG004|As Randomized|Lack of Efficacy|0|||
149748263|NCT02786537|540210918|FG005|As Randomized|Lack of Efficacy|0|||
149748264|NCT02786537|540210913|FG000|As Randomized|Withdrawal by Subject|1|||
149748265|NCT02786537|540210914|FG001|As Randomized|Withdrawal by Subject|2|||
149748266|NCT02786537|540210915|FG002|As Randomized|Withdrawal by Subject|0|||
149748267|NCT02786537|540210916|FG003|As Randomized|Withdrawal by Subject|1|||
149748268|NCT02786537|540210917|FG004|As Randomized|Withdrawal by Subject|1|||
149748269|NCT02786537|540210918|FG005|As Randomized|Withdrawal by Subject|0|||
149748270|NCT02786537|540210913|FG000|As Randomized|Death|0|||
149748271|NCT02786537|540210914|FG001|As Randomized|Death|2|||
149748272|NCT02786537|540210915|FG002|As Randomized|Death|0|||
149748273|NCT02786537|540210916|FG003|As Randomized|Death|3|||
149748274|NCT02786537|540210917|FG004|As Randomized|Death|1|||
149748275|NCT02786537|540210918|FG005|As Randomized|Death|0|||
149748276|NCT02786537|540210913|FG000|As Randomized|Non-compliance with study drug|1|||
149748277|NCT02786537|540210914|FG001|As Randomized|Non-compliance with study drug|11|||
149748278|NCT02786537|540210915|FG002|As Randomized|Non-compliance with study drug|0|||
149748279|NCT02786537|540210916|FG003|As Randomized|Non-compliance with study drug|1|||
149748280|NCT02786537|540210917|FG004|As Randomized|Non-compliance with study drug|0|||
149748281|NCT02786537|540210918|FG005|As Randomized|Non-compliance with study drug|1|||
149748282|NCT02786537|540210913|FG000|As Randomized|Lost to treatment follow-up|4|||
149748283|NCT02786537|540210914|FG001|As Randomized|Lost to treatment follow-up|32|||
149748284|NCT02786537|540210915|FG002|As Randomized|Lost to treatment follow-up|0|||
149748285|NCT02786537|540210916|FG003|As Randomized|Lost to treatment follow-up|24|||
149748286|NCT02786537|540210917|FG004|As Randomized|Lost to treatment follow-up|4|||
149748287|NCT02786537|540210918|FG005|As Randomized|Lost to treatment follow-up|4|||
149748288|NCT02786537|540210913|FG000|As Randomized|Incarceration|0|||
149748289|NCT02786537|540210914|FG001|As Randomized|Incarceration|1|||
149748290|NCT02786537|540210915|FG002|As Randomized|Incarceration|0|||
149748291|NCT02786537|540210916|FG003|As Randomized|Incarceration|0|||
149748292|NCT02786537|540210917|FG004|As Randomized|Incarceration|0|||
149748293|NCT02786537|540210918|FG005|As Randomized|Incarceration|0|||
149748294|NCT02786537|540210913|FG000|As Randomized|Opiate Dependency Relapse|0|||
149748295|NCT02786537|540210914|FG001|As Randomized|Opiate Dependency Relapse|1|||
149748296|NCT02786537|540210915|FG002|As Randomized|Opiate Dependency Relapse|0|||
149748297|NCT02786537|540210916|FG003|As Randomized|Opiate Dependency Relapse|0|||
149748298|NCT02786537|540210917|FG004|As Randomized|Opiate Dependency Relapse|0|||
149748299|NCT02786537|540210918|FG005|As Randomized|Opiate Dependency Relapse|0|||
149748300|NCT02786537|540210913|FG000|As Randomized|HCV drugs stolen from pt|0|||
149748301|NCT02786537|540210914|FG001|As Randomized|HCV drugs stolen from pt|1|||
149748302|NCT02786537|540210915|FG002|As Randomized|HCV drugs stolen from pt|0|||
149748303|NCT02786537|540210916|FG003|As Randomized|HCV drugs stolen from pt|0|||
149748304|NCT02786537|540210917|FG004|As Randomized|HCV drugs stolen from pt|0|||
149748305|NCT02786537|540210918|FG005|As Randomized|HCV drugs stolen from pt|0|||
149748306|NCT02786537|540210913|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
149748307|NCT02786537|540210914|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
149748308|NCT02786537|540210915|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
149748309|NCT02786537|540210916|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
149748310|NCT02786537|540210917|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
149748311|NCT02786537|540210918|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
149748312|NCT02786537|540210913|FG000|As Randomized|Subject lost insurance|0|||
149748313|NCT02786537|540210914|FG001|As Randomized|Subject lost insurance|0|||
149748314|NCT02786537|540210915|FG002|As Randomized|Subject lost insurance|0|||
149748315|NCT02786537|540210916|FG003|As Randomized|Subject lost insurance|1|||
149748316|NCT02786537|540210917|FG004|As Randomized|Subject lost insurance|0|||
149748317|NCT02786537|540210918|FG005|As Randomized|Subject lost insurance|0|||
149748318|NCT02786537|540210913|FG000|As Treated|Adverse Event|0|||
149748319|NCT02786537|540210914|FG001|As Treated|Adverse Event|11|||
149748320|NCT02786537|540210915|FG002|As Treated|Adverse Event|0|||
149748321|NCT02786537|540210916|FG003|As Treated|Adverse Event|4|||
149748322|NCT02786537|540210917|FG004|As Treated|Adverse Event|6|||
149748323|NCT02786537|540210918|FG005|As Treated|Adverse Event|2|||
149748324|NCT02786537|540210913|FG000|As Treated|Death|0|||
149748325|NCT02786537|540210914|FG001|As Treated|Death|2|||
149748326|NCT02786537|540210915|FG002|As Treated|Death|0|||
149748327|NCT02786537|540210916|FG003|As Treated|Death|3|||
149748328|NCT02786537|540210917|FG004|As Treated|Death|1|||
149748329|NCT02786537|540210918|FG005|As Treated|Death|0|||
149748330|NCT02786537|540210913|FG000|As Treated|Lack of Efficacy|0|||
149748331|NCT02786537|540210914|FG001|As Treated|Lack of Efficacy|0|||
149748332|NCT02786537|540210915|FG002|As Treated|Lack of Efficacy|0|||
149748333|NCT02786537|540210916|FG003|As Treated|Lack of Efficacy|1|||
149748334|NCT02786537|540210917|FG004|As Treated|Lack of Efficacy|0|||
149748335|NCT02786537|540210918|FG005|As Treated|Lack of Efficacy|0|||
149748336|NCT02786537|540210913|FG000|As Treated|Lost to Follow-up|4|||
149748337|NCT02786537|540210914|FG001|As Treated|Lost to Follow-up|32|||
149748338|NCT02786537|540210915|FG002|As Treated|Lost to Follow-up|0|||
149748339|NCT02786537|540210916|FG003|As Treated|Lost to Follow-up|25|||
149748340|NCT02786537|540210917|FG004|As Treated|Lost to Follow-up|4|||
149748341|NCT02786537|540210918|FG005|As Treated|Lost to Follow-up|4|||
149748342|NCT02786537|540210913|FG000|As Treated|Non-compliance with study drug|1|||
149748343|NCT02786537|540210914|FG001|As Treated|Non-compliance with study drug|11|||
149748344|NCT02786537|540210915|FG002|As Treated|Non-compliance with study drug|0|||
149748345|NCT02786537|540210916|FG003|As Treated|Non-compliance with study drug|1|||
149748346|NCT02786537|540210917|FG004|As Treated|Non-compliance with study drug|0|||
149748347|NCT02786537|540210918|FG005|As Treated|Non-compliance with study drug|1|||
149748348|NCT02786537|540210913|FG000|As Treated|Lost insurance|0|||
149748349|NCT02786537|540210914|FG001|As Treated|Lost insurance|0|||
149748350|NCT02786537|540210915|FG002|As Treated|Lost insurance|0|||
149748351|NCT02786537|540210916|FG003|As Treated|Lost insurance|1|||
149748352|NCT02786537|540210917|FG004|As Treated|Lost insurance|0|||
149748353|NCT02786537|540210918|FG005|As Treated|Lost insurance|0|||
149748354|NCT02786537|540210913|FG000|As Treated|Withdrawal by Subject|1|||
149748355|NCT02786537|540210914|FG001|As Treated|Withdrawal by Subject|2|||
149748356|NCT02786537|540210915|FG002|As Treated|Withdrawal by Subject|0|||
149748357|NCT02786537|540210916|FG003|As Treated|Withdrawal by Subject|0|||
149748358|NCT02786537|540210917|FG004|As Treated|Withdrawal by Subject|1|||
149748359|NCT02786537|540210918|FG005|As Treated|Withdrawal by Subject|0|||
149748360|NCT02786537|540210913|FG000|As Treated|Incarceration|0|||
149748361|NCT02786537|540210914|FG001|As Treated|Incarceration|1|||
149748362|NCT02786537|540210915|FG002|As Treated|Incarceration|0|||
149748363|NCT02786537|540210916|FG003|As Treated|Incarceration|0|||
149748364|NCT02786537|540210917|FG004|As Treated|Incarceration|0|||
149748365|NCT02786537|540210918|FG005|As Treated|Incarceration|0|||
149748366|NCT02786537|540210913|FG000|As Treated|Opiate dependency relapse|0|||
149748367|NCT02786537|540210914|FG001|As Treated|Opiate dependency relapse|1|||
149748368|NCT02786537|540210915|FG002|As Treated|Opiate dependency relapse|0|||
149748369|NCT02786537|540210916|FG003|As Treated|Opiate dependency relapse|0|||
149748370|NCT02786537|540210917|FG004|As Treated|Opiate dependency relapse|0|||
149748371|NCT02786537|540210918|FG005|As Treated|Opiate dependency relapse|0|||
149748372|NCT02786537|540210913|FG000|As Treated|Drugs stolen from patient|0|||
149748373|NCT02786537|540210914|FG001|As Treated|Drugs stolen from patient|1|||
149748374|NCT02786537|540210915|FG002|As Treated|Drugs stolen from patient|0|||
149748375|NCT02786537|540210916|FG003|As Treated|Drugs stolen from patient|0|||
149748376|NCT02786537|540210917|FG004|As Treated|Drugs stolen from patient|0|||
149748377|NCT02786537|540210918|FG005|As Treated|Drugs stolen from patient|0|||
149748378|NCT02786537|540210913|FG000|As Treated|Advised to stop tx after loss of meds|0|||
149748379|NCT02786537|540210914|FG001|As Treated|Advised to stop tx after loss of meds|1|||
149748380|NCT02786537|540210915|FG002|As Treated|Advised to stop tx after loss of meds|0|||
149748381|NCT02786537|540210916|FG003|As Treated|Advised to stop tx after loss of meds|0|||
149748382|NCT02786537|540210917|FG004|As Treated|Advised to stop tx after loss of meds|0|||
149748383|NCT02786537|540210918|FG005|As Treated|Advised to stop tx after loss of meds|0|||
149748384|NCT01357239|540210923|FG000|Stratum: All Patients|Adverse Event|0|||
149748385|NCT01357239|540210924|FG001|Stratum: All Patients|Adverse Event|0|||
149748386|NCT01357239|540210925|FG002|Stratum: All Patients|Adverse Event|1|||
149748387|NCT01357239|540210926|FG003|Stratum: All Patients|Adverse Event|1|||
149748388|NCT01357239|540210923|FG000|Stratum: All Patients|Subject withdrew consent|0|||
149748389|NCT01357239|540210924|FG001|Stratum: All Patients|Subject withdrew consent|0|||
149748390|NCT01357239|540210925|FG002|Stratum: All Patients|Subject withdrew consent|1|||
149748391|NCT01357239|540210926|FG003|Stratum: All Patients|Subject withdrew consent|1|||
149748392|NCT01357239|540210923|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
149748393|NCT01357239|540210924|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
149748394|NCT01357239|540210925|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
149748395|NCT01357239|540210926|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
149748396|NCT01357239|540210923|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
149748397|NCT01357239|540210924|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
149748398|NCT01357239|540210925|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
149748399|NCT01357239|540210926|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
149748400|NCT01357239|540210923|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
149748401|NCT01357239|540210924|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
149748402|NCT01357239|540210925|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
149748403|NCT01357239|540210926|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
149748404|NCT03455543|540210931|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
149748405|NCT03455543|540210932|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
149748406|NCT03455543|540210933|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
149748407|NCT03455543|540210931|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
149748408|NCT03455543|540210932|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
149748409|NCT03455543|540210933|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
149748410|NCT03455543|540210931|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
149748411|NCT03455543|540210932|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
149748412|NCT03455543|540210933|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
149748413|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
149748414|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
149748415|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
149748416|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
149748417|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
149748418|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
149748419|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
149748420|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
149748421|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
149748422|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
149748423|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
149748424|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
149748425|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
149748426|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
149748427|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
149748428|NCT03455543|540210931|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
149748429|NCT03455543|540210932|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
149748430|NCT03455543|540210933|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
149748431|NCT00852930|540210934|FG000|Overall Study|Withdrawal by Subject|1|||
149748432|NCT00852930|540210935|FG001|Overall Study|Withdrawal by Subject|1|||
149748433|NCT00852930|540210936|FG002|Overall Study|Withdrawal by Subject|1|||
149748434|NCT00852930|540210934|FG000|Overall Study|Physician Decision|0|||
149748435|NCT00852930|540210935|FG001|Overall Study|Physician Decision|0|||
149748436|NCT00852930|540210936|FG002|Overall Study|Physician Decision|1|||
149748437|NCT00779038|540210937|FG000|Overall Study|Study Prematurely Terminated|13|||
149748438|NCT02614794|540210939|FG000|Overall Study|Death|258|||
149748439|NCT02614794|540210940|FG001|Overall Study|Death|151|||
149748440|NCT02614794|540210939|FG000|Overall Study|Study closure by Sponsor|119|||
149748441|NCT02614794|540210940|FG001|Overall Study|Study closure by Sponsor|45|||
149748442|NCT02614794|540210939|FG000|Overall Study|Withdrawal by Subject|24|||
149748443|NCT02614794|540210940|FG001|Overall Study|Withdrawal by Subject|5|||
149748444|NCT02614794|540210939|FG000|Overall Study|Lost to Follow-up|7|||
149748445|NCT02614794|540210940|FG001|Overall Study|Lost to Follow-up|0|||
149748446|NCT02614794|540210939|FG000|Overall Study|Physician Decision|1|||
149748447|NCT02614794|540210940|FG001|Overall Study|Physician Decision|1|||
149748448|NCT02614794|540210939|FG000|Overall Study|Hospital closure|1|||
149748449|NCT02614794|540210940|FG001|Overall Study|Hospital closure|0|||
149748450|NCT03396471|540210943|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
149748451|NCT03396471|540210943|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
149748452|NCT03396471|540210943|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
149748453|NCT03396471|540210943|FG000|Study Treatment - Up to 22 Months|Death|2|||
149748454|NCT03396471|540210943|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
149748455|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|Death|9|||
149748456|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
149748457|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
149748458|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|study terminated|1|||
149748459|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
149748460|NCT03396471|540210943|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
149748461|NCT01319929|540210947|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
149748462|NCT01319929|540210948|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
149748463|NCT01319929|540210947|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
149748464|NCT01319929|540210948|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
149748465|NCT01319929|540210947|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
149748466|NCT01319929|540210948|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
149748467|NCT01319929|540210947|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
149748468|NCT01319929|540210948|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
149748469|NCT01319929|540210947|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
149748470|NCT01319929|540210948|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
149748471|NCT03237845|540210949|FG000|Overall Study|Adverse Event|0|||
149748472|NCT03237845|540210950|FG001|Overall Study|Adverse Event|1|||
149748473|NCT03237845|540210949|FG000|Overall Study|Lost to Follow-up|13|||
149748474|NCT03237845|540210950|FG001|Overall Study|Lost to Follow-up|10|||
149748475|NCT03237845|540210949|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
149748476|NCT03237845|540210950|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
149748477|NCT03237845|540210949|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
149748478|NCT03237845|540210950|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
149748479|NCT03237845|540210949|FG000|Overall Study|Physician Decision|1|||
149748480|NCT03237845|540210950|FG001|Overall Study|Physician Decision|2|||
149748481|NCT03237845|540210949|FG000|Overall Study|Pregnancy|1|||
149748482|NCT03237845|540210950|FG001|Overall Study|Pregnancy|0|||
149748483|NCT03237845|540210949|FG000|Overall Study|Protocol Deviation|0|||
149748484|NCT03237845|540210950|FG001|Overall Study|Protocol Deviation|1|||
149748485|NCT03237845|540210949|FG000|Overall Study|Technical Problems|8|||
149748486|NCT03237845|540210950|FG001|Overall Study|Technical Problems|1|||
149748487|NCT03237845|540210949|FG000|Overall Study|Withdrawal by Subject|3|||
149748488|NCT03237845|540210950|FG001|Overall Study|Withdrawal by Subject|3|||
149748489|NCT03237845|540210949|FG000|Overall Study|Other Reasons|4|||
149748490|NCT03237845|540210950|FG001|Overall Study|Other Reasons|0|||
149748491|NCT01221233|540210951|FG000|Overall Study|Withdrawal by Subject|3|||
149748492|NCT01221233|540210952|FG001|Overall Study|Withdrawal by Subject|1|||
149748493|NCT00234104|540210955|FG000|Overall Study|Adverse Event|4|||
149748494|NCT00234104|540210956|FG001|Overall Study|Adverse Event|0|||
149748495|NCT00234104|540210957|FG002|Overall Study|Adverse Event|3|||
149748496|NCT00234104|540210958|FG003|Overall Study|Adverse Event|5|||
149748497|NCT00234104|540210955|FG000|Overall Study|Protocol Violation|0|||
149748498|NCT00234104|540210956|FG001|Overall Study|Protocol Violation|0|||
149748499|NCT00234104|540210957|FG002|Overall Study|Protocol Violation|0|||
149748500|NCT00234104|540210958|FG003|Overall Study|Protocol Violation|1|||
149748501|NCT00234104|540210955|FG000|Overall Study|Physician Decision|0|||
149748502|NCT00234104|540210956|FG001|Overall Study|Physician Decision|1|||
149748503|NCT00234104|540210957|FG002|Overall Study|Physician Decision|2|||
149748504|NCT00234104|540210958|FG003|Overall Study|Physician Decision|2|||
149748505|NCT04045613|540210959|FG000|Overall Study|Adverse Event|2|||
149748506|NCT04045613|540210960|FG001|Overall Study|Adverse Event|2|||
149748507|NCT04045613|540210961|FG002|Overall Study|Adverse Event|1|||
149748508|NCT04045613|540210962|FG003|Overall Study|Adverse Event|1|||
149748509|NCT04045613|540210963|FG004|Overall Study|Adverse Event|0|||
149748510|NCT04045613|540210964|FG005|Overall Study|Adverse Event|0|||
149748511|NCT04045613|540210965|FG006|Overall Study|Adverse Event|1|||
149748512|NCT04045613|540210959|FG000|Overall Study|Withdrawal by Subject|0|||
149748513|NCT04045613|540210960|FG001|Overall Study|Withdrawal by Subject|5|||
149748514|NCT04045613|540210961|FG002|Overall Study|Withdrawal by Subject|0|||
149748515|NCT04045613|540210962|FG003|Overall Study|Withdrawal by Subject|0|||
149748516|NCT04045613|540210963|FG004|Overall Study|Withdrawal by Subject|0|||
149748517|NCT04045613|540210964|FG005|Overall Study|Withdrawal by Subject|1|||
149748518|NCT04045613|540210965|FG006|Overall Study|Withdrawal by Subject|0|||
149748519|NCT04045613|540210959|FG000|Overall Study|Physician Decision|2|||
149748520|NCT04045613|540210960|FG001|Overall Study|Physician Decision|0|||
149748521|NCT04045613|540210961|FG002|Overall Study|Physician Decision|0|||
149748522|NCT04045613|540210962|FG003|Overall Study|Physician Decision|0|||
149748523|NCT04045613|540210963|FG004|Overall Study|Physician Decision|1|||
149748524|NCT04045613|540210964|FG005|Overall Study|Physician Decision|0|||
149748525|NCT04045613|540210965|FG006|Overall Study|Physician Decision|0|||
149748526|NCT04045613|540210959|FG000|Overall Study|Death|3|||
149748527|NCT04045613|540210960|FG001|Overall Study|Death|0|||
149748528|NCT04045613|540210961|FG002|Overall Study|Death|0|||
149748529|NCT04045613|540210962|FG003|Overall Study|Death|0|||
149748530|NCT04045613|540210963|FG004|Overall Study|Death|0|||
149748531|NCT04045613|540210964|FG005|Overall Study|Death|0|||
149748532|NCT04045613|540210965|FG006|Overall Study|Death|1|||
149748533|NCT04045613|540210959|FG000|Overall Study|Other reasons|0|||
149748534|NCT04045613|540210960|FG001|Overall Study|Other reasons|1|||
149748535|NCT04045613|540210961|FG002|Overall Study|Other reasons|0|||
149748536|NCT04045613|540210962|FG003|Overall Study|Other reasons|0|||
149748537|NCT04045613|540210963|FG004|Overall Study|Other reasons|0|||
149748538|NCT04045613|540210964|FG005|Overall Study|Other reasons|0|||
149748539|NCT04045613|540210965|FG006|Overall Study|Other reasons|1|||
149748540|NCT04045613|540210959|FG000|Overall Study|Progressive disease: Clinical progression|1|||
149748541|NCT04045613|540210960|FG001|Overall Study|Progressive disease: Clinical progression|0|||
149748542|NCT04045613|540210961|FG002|Overall Study|Progressive disease: Clinical progression|3|||
149748543|NCT04045613|540210962|FG003|Overall Study|Progressive disease: Clinical progression|1|||
149748544|NCT04045613|540210963|FG004|Overall Study|Progressive disease: Clinical progression|1|||
149748545|NCT04045613|540210964|FG005|Overall Study|Progressive disease: Clinical progression|3|||
149748546|NCT04045613|540210965|FG006|Overall Study|Progressive disease: Clinical progression|3|||
149748547|NCT04045613|540210959|FG000|Overall Study|Progressive disease: Radiological progression|24|||
149748548|NCT04045613|540210960|FG001|Overall Study|Progressive disease: Radiological progression|6|||
149748549|NCT04045613|540210961|FG002|Overall Study|Progressive disease: Radiological progression|8|||
149748550|NCT04045613|540210962|FG003|Overall Study|Progressive disease: Radiological progression|0|||
149748551|NCT04045613|540210963|FG004|Overall Study|Progressive disease: Radiological progression|6|||
149748552|NCT04045613|540210964|FG005|Overall Study|Progressive disease: Radiological progression|6|||
149748553|NCT04045613|540210965|FG006|Overall Study|Progressive disease: Radiological progression|11|||
149748554|NCT01633060|540210968|FG000|Randomization Phase|Protocol deviation|1|||
149748555|NCT01633060|540210969|FG001|Randomization Phase|Protocol deviation|2|||
149748556|NCT01633060|540210968|FG000|Randomization Phase|Technical problem|0|||
149748557|NCT01633060|540210969|FG001|Randomization Phase|Technical problem|1|||
149748558|NCT01633060|540210968|FG000|Treatment Phase|Adverse Event|24|||
149748559|NCT01633060|540210969|FG001|Treatment Phase|Adverse Event|3|||
149748560|NCT01633060|540210968|FG000|Treatment Phase|Lost to Follow-up|1|||
149748561|NCT01633060|540210969|FG001|Treatment Phase|Lost to Follow-up|0|||
149748562|NCT01633060|540210968|FG000|Treatment Phase|Physician Decision|16|||
149748563|NCT01633060|540210969|FG001|Treatment Phase|Physician Decision|7|||
149748564|NCT01633060|540210968|FG000|Treatment Phase|Progressive Disease|210|||
149748565|NCT01633060|540210969|FG001|Treatment Phase|Progressive Disease|120|||
149748566|NCT01633060|540210968|FG000|Treatment Phase|Protocol Deviation|1|||
149748567|NCT01633060|540210969|FG001|Treatment Phase|Protocol Deviation|0|||
149748568|NCT01633060|540210968|FG000|Treatment Phase|Study Terminated by sponsor|7|||
149748569|NCT01633060|540210969|FG001|Treatment Phase|Study Terminated by sponsor|3|||
149748570|NCT01633060|540210968|FG000|Treatment Phase|Subject/guardian decision|25|||
149748571|NCT01633060|540210969|FG001|Treatment Phase|Subject/guardian decision|4|||
149748572|NCT01633060|540210968|FG000|Treatment Phase|Death|4|||
149748573|NCT01633060|540210969|FG001|Treatment Phase|Death|3|||
149748574|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
149748575|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149748576|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
149748577|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
149748578|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
149748579|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
149748580|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
149748581|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
149748582|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
149748583|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
149748584|NCT01633060|540210968|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
149748585|NCT01633060|540210969|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
149748586|NCT01009294|540210977|FG000|Overall Study|Study discontinued by Sponsor|6|||
149748587|NCT01856673|540210978|FG000|Overall Study|Withdrawal by Subject|44|||
149748588|NCT01856673|540210979|FG001|Overall Study|Withdrawal by Subject|50|||
149748589|NCT01856673|540210980|FG002|Overall Study|Withdrawal by Subject|33|||
149748590|NCT01856673|540210978|FG000|Overall Study|Lost to Follow-up|31|||
149748591|NCT01856673|540210979|FG001|Overall Study|Lost to Follow-up|34|||
149748592|NCT01856673|540210980|FG002|Overall Study|Lost to Follow-up|0|||
149748593|NCT01856673|540210978|FG000|Overall Study|Unknown reasons|9|||
149748594|NCT01856673|540210979|FG001|Overall Study|Unknown reasons|0|||
149748595|NCT01856673|540210980|FG002|Overall Study|Unknown reasons|0|||
149748596|NCT01856673|540210978|FG000|Overall Study|Psychologist decision|1|||
149748597|NCT01856673|540210979|FG001|Overall Study|Psychologist decision|0|||
149748598|NCT01856673|540210980|FG002|Overall Study|Psychologist decision|0|||
149748599|NCT01856673|540210978|FG000|Overall Study|Paperwork errors|8|||
149748600|NCT01856673|540210979|FG001|Overall Study|Paperwork errors|0|||
149748601|NCT01856673|540210980|FG002|Overall Study|Paperwork errors|0|||
149748602|NCT01856673|540210978|FG000|Overall Study|Death|1|||
149748603|NCT01856673|540210979|FG001|Overall Study|Death|1|||
149748604|NCT01856673|540210980|FG002|Overall Study|Death|0|||
149748605|NCT01856673|540210978|FG000|Overall Study|Protocol Violation|1|||
149748606|NCT01856673|540210979|FG001|Overall Study|Protocol Violation|0|||
149748607|NCT01856673|540210980|FG002|Overall Study|Protocol Violation|1|||
149748608|NCT03114969|540210981|FG000|Overall Study|Lost to Follow-up|0|||
149748609|NCT03114969|540210982|FG001|Overall Study|Lost to Follow-up|0|||
149748610|NCT03114969|540210983|FG002|Overall Study|Lost to Follow-up|3|||
149748611|NCT03114969|540210984|FG003|Overall Study|Lost to Follow-up|2|||
149748612|NCT03114969|540210985|FG004|Overall Study|Lost to Follow-up|0|||
149748613|NCT03114969|540210986|FG005|Overall Study|Lost to Follow-up|0|||
149748614|NCT03114969|540210987|FG006|Overall Study|Lost to Follow-up|0|||
149748615|NCT03114969|540210988|FG007|Overall Study|Lost to Follow-up|0|||
149748616|NCT03114969|540210989|FG008|Overall Study|Lost to Follow-up|0|||
149748617|NCT03114969|540210981|FG000|Overall Study|Adverse Event|0|||
149748618|NCT03114969|540210982|FG001|Overall Study|Adverse Event|0|||
149748619|NCT03114969|540210983|FG002|Overall Study|Adverse Event|1|||
149748620|NCT03114969|540210984|FG003|Overall Study|Adverse Event|0|||
149748621|NCT03114969|540210985|FG004|Overall Study|Adverse Event|0|||
149748622|NCT03114969|540210986|FG005|Overall Study|Adverse Event|1|||
149748623|NCT03114969|540210987|FG006|Overall Study|Adverse Event|1|||
149748624|NCT03114969|540210988|FG007|Overall Study|Adverse Event|0|||
149748625|NCT03114969|540210989|FG008|Overall Study|Adverse Event|2|||
149748626|NCT02168946|540210990|FG000|Overall Study|Adverse Event|8|||
149748627|NCT02168946|540210991|FG001|Overall Study|Adverse Event|5|||
149748628|NCT02168946|540210990|FG000|Overall Study|Lost to Follow-up|3|||
149748629|NCT02168946|540210991|FG001|Overall Study|Lost to Follow-up|0|||
149748630|NCT02168946|540210990|FG000|Overall Study|Subject unable to come back for visits|1|||
149748631|NCT02168946|540210991|FG001|Overall Study|Subject unable to come back for visits|0|||
149748632|NCT01743027|540211001|FG000|Overall Study|Adverse Event|2|||
149748633|NCT01743027|540211002|FG001|Overall Study|Adverse Event|0|||
149748634|NCT01743027|540211003|FG002|Overall Study|Adverse Event|0|||
149748635|NCT01743027|540211004|FG003|Overall Study|Adverse Event|0|||
149748636|NCT01743027|540211001|FG000|Overall Study|Lost to Follow-up|0|||
149748637|NCT01743027|540211002|FG001|Overall Study|Lost to Follow-up|0|||
149748638|NCT01743027|540211003|FG002|Overall Study|Lost to Follow-up|2|||
149748639|NCT01743027|540211004|FG003|Overall Study|Lost to Follow-up|0|||
149748640|NCT01743027|540211001|FG000|Overall Study|Progressive Disease|1|||
149748641|NCT01743027|540211002|FG001|Overall Study|Progressive Disease|4|||
149748642|NCT01743027|540211003|FG002|Overall Study|Progressive Disease|3|||
149748643|NCT01743027|540211004|FG003|Overall Study|Progressive Disease|0|||
149748644|NCT01743027|540211001|FG000|Overall Study|Protocol Violation|1|||
149748645|NCT01743027|540211002|FG001|Overall Study|Protocol Violation|1|||
149748646|NCT01743027|540211003|FG002|Overall Study|Protocol Violation|1|||
149748647|NCT01743027|540211004|FG003|Overall Study|Protocol Violation|0|||
149748648|NCT01743027|540211001|FG000|Overall Study|Withdrawal by Subject|1|||
149748649|NCT01743027|540211002|FG001|Overall Study|Withdrawal by Subject|0|||
149748650|NCT01743027|540211003|FG002|Overall Study|Withdrawal by Subject|3|||
149748651|NCT01743027|540211004|FG003|Overall Study|Withdrawal by Subject|1|||
149748652|NCT00450866|540211005|FG000|Overall Study|Adverse Event|0|||
149748653|NCT00450866|540211006|FG001|Overall Study|Adverse Event|1|||
149748654|NCT00450866|540211005|FG000|Overall Study|Withdrawal by Subject|5|||
149748655|NCT00450866|540211006|FG001|Overall Study|Withdrawal by Subject|2|||
149748656|NCT00450866|540211005|FG000|Overall Study|Death|1|||
149748657|NCT00450866|540211006|FG001|Overall Study|Death|0|||
149748658|NCT00450866|540211005|FG000|Overall Study|Physician Decision|1|||
149748659|NCT00450866|540211006|FG001|Overall Study|Physician Decision|0|||
149748660|NCT00138151|540211007|FG000|Overall Study|Withdrawal by Subject|3|||
149748661|NCT00138151|540211007|FG000|Overall Study|Physician Decision|1|||
149748662|NCT02675517|540211010|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
149748663|NCT02675517|540211010|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
149748664|NCT05121103|540211013|FG000|Overall Study|Progressive disease|2|||
149748665|NCT05121103|540211014|FG001|Overall Study|Progressive disease|1|||
149748666|NCT05121103|540211015|FG002|Overall Study|Progressive disease|6|||
149748667|NCT05121103|540211013|FG000|Overall Study|Physician Decision|2|||
149748668|NCT05121103|540211014|FG001|Overall Study|Physician Decision|1|||
149748669|NCT05121103|540211015|FG002|Overall Study|Physician Decision|0|||
149748670|NCT05121103|540211013|FG000|Overall Study|Withdrawal by Subject|0|||
149748671|NCT05121103|540211014|FG001|Overall Study|Withdrawal by Subject|1|||
149748672|NCT05121103|540211015|FG002|Overall Study|Withdrawal by Subject|0|||
149748673|NCT03443024|540211020|FG000|Overall Study|Adverse Event|2|||
149748674|NCT03443024|540211021|FG001|Overall Study|Adverse Event|4|||
149748675|NCT03443024|540211022|FG002|Overall Study|Adverse Event|3|||
149748676|NCT03443024|540211023|FG003|Overall Study|Adverse Event|1|||
149748677|NCT03443024|540211020|FG000|Overall Study|Lost to Follow-up|9|||
149748678|NCT03443024|540211021|FG001|Overall Study|Lost to Follow-up|9|||
149748679|NCT03443024|540211022|FG002|Overall Study|Lost to Follow-up|7|||
149748680|NCT03443024|540211023|FG003|Overall Study|Lost to Follow-up|5|||
149748681|NCT03443024|540211020|FG000|Overall Study|Withdrawal by Subject|8|||
149748682|NCT03443024|540211021|FG001|Overall Study|Withdrawal by Subject|15|||
149748683|NCT03443024|540211022|FG002|Overall Study|Withdrawal by Subject|9|||
149748684|NCT03443024|540211023|FG003|Overall Study|Withdrawal by Subject|23|||
149748685|NCT03443024|540211020|FG000|Overall Study|Physician Decision|1|||
149748686|NCT03443024|540211021|FG001|Overall Study|Physician Decision|2|||
149748687|NCT03443024|540211022|FG002|Overall Study|Physician Decision|0|||
149748688|NCT03443024|540211023|FG003|Overall Study|Physician Decision|1|||
149748689|NCT03443024|540211020|FG000|Overall Study|Sponsor Decision|1|||
149748690|NCT03443024|540211021|FG001|Overall Study|Sponsor Decision|1|||
149748691|NCT03443024|540211022|FG002|Overall Study|Sponsor Decision|0|||
149748692|NCT03443024|540211023|FG003|Overall Study|Sponsor Decision|0|||
149748693|NCT03443024|540211020|FG000|Overall Study|Protocol Deviation|0|||
149748694|NCT03443024|540211021|FG001|Overall Study|Protocol Deviation|0|||
149748695|NCT03443024|540211022|FG002|Overall Study|Protocol Deviation|0|||
149748696|NCT03443024|540211023|FG003|Overall Study|Protocol Deviation|2|||
149748697|NCT00301067|540211024|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
149748698|NCT00301067|540211025|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
149748699|NCT00301067|540211026|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
149748700|NCT00301067|540211027|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
149748701|NCT00301067|540211024|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
149748702|NCT00301067|540211025|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
149748703|NCT00301067|540211026|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
149748704|NCT00301067|540211027|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
149748705|NCT00301067|540211024|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
149748706|NCT00301067|540211025|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
149748707|NCT00301067|540211026|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
149748708|NCT00301067|540211027|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
149748709|NCT00301067|540211024|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
149748710|NCT00301067|540211025|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
149748711|NCT00301067|540211026|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
149748712|NCT00301067|540211027|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
149748713|NCT00301067|540211024|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
149748714|NCT00301067|540211025|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
149748715|NCT00301067|540211026|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
149748716|NCT00301067|540211027|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
149748717|NCT00301067|540211024|FG000|Follow up Until Death|Alive at last data cut point|1|||
149748718|NCT00301067|540211025|FG001|Follow up Until Death|Alive at last data cut point|0|||
149748719|NCT00301067|540211026|FG002|Follow up Until Death|Alive at last data cut point|0|||
149748720|NCT00301067|540211027|FG003|Follow up Until Death|Alive at last data cut point|1|||
149748721|NCT01359982|540211028|FG000|Overall Study|Adverse Event|2|||
149748722|NCT01359982|540211029|FG001|Overall Study|Adverse Event|0|||
149748723|NCT01359982|540211030|FG002|Overall Study|Adverse Event|0|||
149748724|NCT01359982|540211031|FG003|Overall Study|Adverse Event|1|||
149748725|NCT01359982|540211032|FG004|Overall Study|Adverse Event|0|||
149748726|NCT01359982|540211033|FG005|Overall Study|Adverse Event|0|||
149748727|NCT01359982|540211028|FG000|Overall Study|Death|1|||
149748728|NCT01359982|540211029|FG001|Overall Study|Death|0|||
149748729|NCT01359982|540211030|FG002|Overall Study|Death|0|||
149748730|NCT01359982|540211031|FG003|Overall Study|Death|0|||
149748731|NCT01359982|540211032|FG004|Overall Study|Death|0|||
149748732|NCT01359982|540211033|FG005|Overall Study|Death|0|||
149748733|NCT02609399|540211034|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
149748734|NCT02609399|540211035|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
149748735|NCT02609399|540211034|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
149748736|NCT02609399|540211035|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
149748737|NCT02609399|540211034|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
149748738|NCT02609399|540211035|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
149748739|NCT02453841|540211036|FG000|Overall Study|Protocol Violation|1|||
149748740|NCT02453841|540211036|FG000|Overall Study|Unable to obtain blood samples|2|||
149748741|NCT00970294|540211039|FG000|Overall Study|Physician Decision|4|||
149748742|NCT00970294|540211039|FG000|Overall Study|Withdrawal by Subject|1|||
149748743|NCT04579393|540211040|FG000|Overall Study|Withdrawal by Subject|2|||
149748744|NCT04579393|540211041|FG001|Overall Study|Withdrawal by Subject|2|||
149748745|NCT04579393|540211040|FG000|Overall Study|Death|1|||
149748746|NCT04579393|540211041|FG001|Overall Study|Death|3|||
149748747|NCT01333189|540211042|FG000|Overall Study|Time constraints|1|||
149748748|NCT01333189|540211043|FG001|Overall Study|Time constraints|0|||
149748749|NCT01333189|540211042|FG000|Overall Study|Adverse Event|1|||
149748750|NCT01333189|540211043|FG001|Overall Study|Adverse Event|0|||
149748751|NCT01333189|540211042|FG000|Overall Study|Transportation difficulties|0|||
149748752|NCT01333189|540211043|FG001|Overall Study|Transportation difficulties|1|||
149748753|NCT01333189|540211042|FG000|Overall Study|Moved from region|0|||
149748754|NCT01333189|540211043|FG001|Overall Study|Moved from region|1|||
149748755|NCT01739595|540211045|FG000|Overall Study|Adverse Event|3|||
149748756|NCT01739595|540211046|FG001|Overall Study|Adverse Event|0|||
149748757|NCT01739595|540211047|FG002|Overall Study|Adverse Event|0|||
149748758|NCT01739595|540211045|FG000|Overall Study|Lost to Follow-up|2|||
149748759|NCT01739595|540211046|FG001|Overall Study|Lost to Follow-up|0|||
149748760|NCT01739595|540211047|FG002|Overall Study|Lost to Follow-up|0|||
149748761|NCT01739595|540211045|FG000|Overall Study|Withdrawal by Subject|2|||
149748762|NCT01739595|540211046|FG001|Overall Study|Withdrawal by Subject|1|||
149748763|NCT01739595|540211047|FG002|Overall Study|Withdrawal by Subject|2|||
149748764|NCT01739595|540211045|FG000|Overall Study|Eligibility issue|3|||
149748765|NCT01739595|540211046|FG001|Overall Study|Eligibility issue|0|||
149748766|NCT01739595|540211047|FG002|Overall Study|Eligibility issue|0|||
149748767|NCT01739595|540211045|FG000|Overall Study|Protocol Violation|1|||
149748768|NCT01739595|540211046|FG001|Overall Study|Protocol Violation|0|||
149748769|NCT01739595|540211047|FG002|Overall Study|Protocol Violation|0|||
149748770|NCT01739595|540211045|FG000|Overall Study|Lab assessment|1|||
149748771|NCT01739595|540211046|FG001|Overall Study|Lab assessment|0|||
149748772|NCT01739595|540211047|FG002|Overall Study|Lab assessment|0|||
149748773|NCT01739595|540211045|FG000|Overall Study|Drug discrepancy|1|||
149748774|NCT01739595|540211046|FG001|Overall Study|Drug discrepancy|0|||
149748775|NCT01739595|540211047|FG002|Overall Study|Drug discrepancy|0|||
149748776|NCT00393458|540211048|FG000|Overall Study|Adverse Event|35|||
149748777|NCT00393458|540211049|FG001|Overall Study|Adverse Event|24|||
149748778|NCT00393458|540211050|FG002|Overall Study|Adverse Event|40|||
149748779|NCT00393458|540211051|FG003|Overall Study|Adverse Event|35|||
149748780|NCT00393458|540211048|FG000|Overall Study|Subject withdrew consent|27|||
149748781|NCT00393458|540211049|FG001|Overall Study|Subject withdrew consent|40|||
149748782|NCT00393458|540211050|FG002|Overall Study|Subject withdrew consent|33|||
149748783|NCT00393458|540211051|FG003|Overall Study|Subject withdrew consent|50|||
149748784|NCT00393458|540211048|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
149748785|NCT00393458|540211049|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
149748786|NCT00393458|540211050|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
149748787|NCT00393458|540211051|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
149748788|NCT00393458|540211048|FG000|Overall Study|Protocol deviation|11|||
149748789|NCT00393458|540211049|FG001|Overall Study|Protocol deviation|11|||
149748790|NCT00393458|540211050|FG002|Overall Study|Protocol deviation|11|||
149748791|NCT00393458|540211051|FG003|Overall Study|Protocol deviation|10|||
149748792|NCT00393458|540211048|FG000|Overall Study|Administrative problems|7|||
149748793|NCT00393458|540211049|FG001|Overall Study|Administrative problems|8|||
149748794|NCT00393458|540211050|FG002|Overall Study|Administrative problems|5|||
149748795|NCT00393458|540211051|FG003|Overall Study|Administrative problems|2|||
149748796|NCT00393458|540211048|FG000|Overall Study|Lost to Follow-up|5|||
149748797|NCT00393458|540211049|FG001|Overall Study|Lost to Follow-up|6|||
149748798|NCT00393458|540211050|FG002|Overall Study|Lost to Follow-up|5|||
149748799|NCT00393458|540211051|FG003|Overall Study|Lost to Follow-up|3|||
149748800|NCT00393458|540211048|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149748801|NCT00393458|540211049|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149748802|NCT00393458|540211050|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149748803|NCT00393458|540211051|FG003|Overall Study|Abnormal laboratory value(s)|0|||
149748804|NCT00393458|540211048|FG000|Overall Study|Death|1|||
149748805|NCT00393458|540211049|FG001|Overall Study|Death|1|||
149748806|NCT00393458|540211050|FG002|Overall Study|Death|5|||
149748807|NCT00393458|540211051|FG003|Overall Study|Death|5|||
149748808|NCT00393458|540211048|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149748809|NCT00393458|540211049|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149748810|NCT00393458|540211050|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149748811|NCT00393458|540211051|FG003|Overall Study|Abnormal test procedure result(s)|2|||
149748812|NCT00393458|540211048|FG000|Overall Study|Subject no longer requires study drug|0|||
149748813|NCT00393458|540211049|FG001|Overall Study|Subject no longer requires study drug|1|||
149748814|NCT00393458|540211050|FG002|Overall Study|Subject no longer requires study drug|0|||
149748815|NCT00393458|540211051|FG003|Overall Study|Subject no longer requires study drug|0|||
149748816|NCT01282814|540211058|FG000|First Intervention|Emesis During Dosing Interval|0|||
149748817|NCT01282814|540211059|FG001|First Intervention|Emesis During Dosing Interval|3|||
149748818|NCT01282814|540211058|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
149748819|NCT01282814|540211059|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149748820|NCT01524289|540211060|FG000|Overall Study|Lost to Follow-up|0|||
149748821|NCT01524289|540211061|FG001|Overall Study|Lost to Follow-up|1|||
149748822|NCT01524289|540211060|FG000|Overall Study|Physician Decision|1|||
149748823|NCT01524289|540211061|FG001|Overall Study|Physician Decision|0|||
149748824|NCT01524289|540211060|FG000|Overall Study|Protocol Violation|5|||
149748825|NCT01524289|540211061|FG001|Overall Study|Protocol Violation|1|||
149748826|NCT01524289|540211060|FG000|Overall Study|Withdrawal by Subject|11|||
149748827|NCT01524289|540211061|FG001|Overall Study|Withdrawal by Subject|7|||
149748828|NCT01524289|540211060|FG000|Overall Study|Adverse Event|12|||
149748829|NCT01524289|540211061|FG001|Overall Study|Adverse Event|5|||
149748830|NCT01524289|540211060|FG000|Overall Study|Did not take study medication|1|||
149748831|NCT01524289|540211061|FG001|Overall Study|Did not take study medication|0|||
149748832|NCT02104180|540211062|FG000|Overall Study|Protocol Violation|1|||
149748833|NCT02104180|540211063|FG001|Overall Study|Protocol Violation|0|||
149748834|NCT01326962|540211066|FG000|Overall Study|Adverse Event|1|||
149748835|NCT01326962|540211066|FG000|Overall Study|Withdrawal by Subject|1|||
149748836|NCT01326962|540211066|FG000|Overall Study|Lost to Follow-up|3|||
149748837|NCT01326962|540211066|FG000|Overall Study|Other|2|||
149748838|NCT00793585|540211067|FG000|Overall Study|Adverse Event|1|||
149748839|NCT00793585|540211068|FG001|Overall Study|Adverse Event|1|||
149748840|NCT00793585|540211067|FG000|Overall Study|Protocol Violation|1|||
149748841|NCT00793585|540211068|FG001|Overall Study|Protocol Violation|2|||
149748842|NCT00035815|540211071|FG000|Overall Study|Withdrawal by Subject|17|||
149748843|NCT00035815|540211072|FG001|Overall Study|Withdrawal by Subject|11|||
149748844|NCT02209597|540211073|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
149748845|NCT02209597|540211073|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
149748846|NCT02209597|540211073|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
149748847|NCT02209597|540211073|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
149748848|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Adverse Event|37|||
149748849|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Adverse Event|0|||
149748850|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Adverse Event|0|||
149748851|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Adverse Event|0|||
149748852|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Death|2|||
149748853|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Death|0|||
149748854|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Death|0|||
149748855|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Death|0|||
149748856|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
149748857|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
149748858|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
149748859|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
149748860|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
149748861|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
149748862|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
149748863|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
149748864|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
149748865|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
149748866|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
149748867|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
149748868|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
149748869|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149748870|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149748871|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149748872|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Physician Decision|4|||
149748873|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Physician Decision|0|||
149748874|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Physician Decision|0|||
149748875|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Physician Decision|0|||
149748876|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Pregnancy|1|||
149748877|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Pregnancy|0|||
149748878|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Pregnancy|0|||
149748879|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Pregnancy|0|||
149748880|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
149748881|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
149748882|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
149748883|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
149748884|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
149748885|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
149748886|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
149748887|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
149748888|NCT01855789|540211075|FG000|1) Baseline up to Week 24|Other|4|||
149748889|NCT01855789|540211076|FG001|1) Baseline up to Week 24|Other|0|||
149748890|NCT01855789|540211077|FG002|1) Baseline up to Week 24|Other|0|||
149748891|NCT01855789|540211078|FG003|1) Baseline up to Week 24|Other|0|||
149748892|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
149748893|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
149748894|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
149748895|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
149748896|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149748897|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149748898|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149748899|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
149748900|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
149748901|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
149748902|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
149748903|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
149748904|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
149748905|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
149748906|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
149748907|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
149748908|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
149748909|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
149748910|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
149748911|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
149748912|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
149748913|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
149748914|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
149748915|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
149748916|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
149748917|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
149748918|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
149748919|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
149748920|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
149748921|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
149748922|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
149748923|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
149748924|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
149748925|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
149748926|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
149748927|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
149748928|NCT01855789|540211075|FG000|2) Week 24 up to End of Study|Other|0|||
149748929|NCT01855789|540211076|FG001|2) Week 24 up to End of Study|Other|0|||
149748930|NCT01855789|540211077|FG002|2) Week 24 up to End of Study|Other|0|||
149748931|NCT01855789|540211078|FG003|2) Week 24 up to End of Study|Other|1|||
149748932|NCT01863758|540211079|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
149748933|NCT01863758|540211079|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
149748934|NCT04952389|540211080|FG000|Overall Study|Withdrawal by Subject|8|||
149748935|NCT04952389|540211081|FG001|Overall Study|Withdrawal by Subject|4|||
149748936|NCT01089725|540211082|FG000|Overall Study|Adverse Event|1|||
149748937|NCT01089725|540211083|FG001|Overall Study|Adverse Event|1|||
149748938|NCT01089725|540211084|FG002|Overall Study|Adverse Event|0|||
149748939|NCT01089725|540211085|FG003|Overall Study|Adverse Event|0|||
149748940|NCT01089725|540211086|FG004|Overall Study|Adverse Event|2|||
149748941|NCT01089725|540211082|FG000|Overall Study|Lack of Efficacy|4|||
149748942|NCT01089725|540211083|FG001|Overall Study|Lack of Efficacy|3|||
149748943|NCT01089725|540211084|FG002|Overall Study|Lack of Efficacy|1|||
149748944|NCT01089725|540211085|FG003|Overall Study|Lack of Efficacy|0|||
149748945|NCT01089725|540211086|FG004|Overall Study|Lack of Efficacy|4|||
149748946|NCT01089725|540211082|FG000|Overall Study|Lost to Follow-up|2|||
149748947|NCT01089725|540211083|FG001|Overall Study|Lost to Follow-up|2|||
149748948|NCT01089725|540211084|FG002|Overall Study|Lost to Follow-up|0|||
149748949|NCT01089725|540211085|FG003|Overall Study|Lost to Follow-up|3|||
149748950|NCT01089725|540211086|FG004|Overall Study|Lost to Follow-up|0|||
149748951|NCT01089725|540211082|FG000|Overall Study|Protocol Violation|0|||
149748952|NCT01089725|540211083|FG001|Overall Study|Protocol Violation|0|||
149748953|NCT01089725|540211084|FG002|Overall Study|Protocol Violation|1|||
149748954|NCT01089725|540211085|FG003|Overall Study|Protocol Violation|1|||
149748955|NCT01089725|540211086|FG004|Overall Study|Protocol Violation|0|||
149748956|NCT01089725|540211082|FG000|Overall Study|Withdrawal by Subject|5|||
149748957|NCT01089725|540211083|FG001|Overall Study|Withdrawal by Subject|5|||
149748958|NCT01089725|540211084|FG002|Overall Study|Withdrawal by Subject|4|||
149748959|NCT01089725|540211085|FG003|Overall Study|Withdrawal by Subject|5|||
149748960|NCT01089725|540211086|FG004|Overall Study|Withdrawal by Subject|4|||
149748961|NCT01089725|540211082|FG000|Overall Study|Study Terminated by Sponsor|51|||
149748962|NCT01089725|540211083|FG001|Overall Study|Study Terminated by Sponsor|56|||
149748963|NCT01089725|540211084|FG002|Overall Study|Study Terminated by Sponsor|53|||
149748964|NCT01089725|540211085|FG003|Overall Study|Study Terminated by Sponsor|68|||
149748965|NCT01089725|540211086|FG004|Overall Study|Study Terminated by Sponsor|68|||
149748966|NCT01089725|540211082|FG000|Overall Study|Randomized, but not treated|0|||
149748967|NCT01089725|540211083|FG001|Overall Study|Randomized, but not treated|1|||
149748968|NCT01089725|540211084|FG002|Overall Study|Randomized, but not treated|2|||
149748969|NCT01089725|540211085|FG003|Overall Study|Randomized, but not treated|1|||
149748970|NCT01089725|540211086|FG004|Overall Study|Randomized, but not treated|2|||
149748971|NCT01089725|540211082|FG000|Overall Study|Other|3|||
149748972|NCT01089725|540211083|FG001|Overall Study|Other|0|||
149748973|NCT01089725|540211084|FG002|Overall Study|Other|0|||
149748974|NCT01089725|540211085|FG003|Overall Study|Other|1|||
149748975|NCT01089725|540211086|FG004|Overall Study|Other|0|||
149748976|NCT01266148|540212350|FG000|Overall Study|Adverse Event|2|||
149748977|NCT01266148|540212351|FG001|Overall Study|Adverse Event|0|||
149748978|NCT01266148|540212350|FG000|Overall Study|Ongoing rejection|1|||
149748979|NCT01266148|540212351|FG001|Overall Study|Ongoing rejection|0|||
149748980|NCT01266148|540212350|FG000|Overall Study|2 2R rejections|1|||
149748981|NCT01266148|540212351|FG001|Overall Study|2 2R rejections|0|||
149748982|NCT01266148|540212350|FG000|Overall Study|Death|2|||
149748983|NCT01266148|540212351|FG001|Overall Study|Death|3|||
149748984|NCT01266148|540212350|FG000|Overall Study|missing mGFR value + AE|1|||
149748985|NCT01266148|540212351|FG001|Overall Study|missing mGFR value + AE|0|||
149748986|NCT01269125|540212352|FG000|Overall Study|Adverse Event|3|||
149748987|NCT01269125|540212353|FG001|Overall Study|Adverse Event|5|||
149748988|NCT01269125|540212354|FG002|Overall Study|Adverse Event|0|||
149748989|NCT01269125|540212352|FG000|Overall Study|Lost to Follow-up|4|||
149748990|NCT01269125|540212353|FG001|Overall Study|Lost to Follow-up|0|||
149748991|NCT01269125|540212354|FG002|Overall Study|Lost to Follow-up|0|||
149748992|NCT01300286|540212355|FG000|Overall Study|did not get dosed|1|||
149748993|NCT03635190|540212356|FG000|Overall Study|Lost to Follow-up|4|||
149748994|NCT03635190|540212356|FG000|Overall Study|Death|3|||
149748995|NCT03635190|540212356|FG000|Overall Study|Withdrawal by Subject|1|||
149748996|NCT03635190|540212356|FG000|Overall Study|Patient moved and did not return for follow up|1|||
149748997|NCT00417612|540212359|FG000|Overall Study|Errant diagnosis|0|||
149748998|NCT00417612|540212360|FG001|Overall Study|Errant diagnosis|1|||
149748999|NCT00417612|540212359|FG000|Overall Study|Adverse Event|2|||
149749000|NCT00417612|540212360|FG001|Overall Study|Adverse Event|0|||
149749001|NCT00417612|540212359|FG000|Overall Study|Protocol Violation|0|||
149749002|NCT00417612|540212360|FG001|Overall Study|Protocol Violation|2|||
149749003|NCT00417612|540212359|FG000|Overall Study|Lost to Follow-up|1|||
149749004|NCT00417612|540212360|FG001|Overall Study|Lost to Follow-up|0|||
149749005|NCT01712438|540212363|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
149749006|NCT01712438|540212363|FG000|Overall Study|Ongoing ITI treatment|6|||
149749007|NCT01712438|540212363|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
149749008|NCT01712438|540212363|FG000|Overall Study|Prematurely Discontinued|25|||
149749009|NCT03216265|540212364|FG000|Overall Study|Adverse Event|2|||
149749010|NCT03216265|540212365|FG001|Overall Study|Adverse Event|0|||
149749011|NCT03216265|540212366|FG002|Overall Study|Adverse Event|2|||
149749012|NCT03216265|540212364|FG000|Overall Study|Lost to Follow-up|0|||
149749013|NCT03216265|540212365|FG001|Overall Study|Lost to Follow-up|1|||
149749014|NCT03216265|540212366|FG002|Overall Study|Lost to Follow-up|0|||
149749015|NCT03216265|540212364|FG000|Overall Study|Withdrawal by Subject|0|||
149749016|NCT03216265|540212365|FG001|Overall Study|Withdrawal by Subject|0|||
149749017|NCT03216265|540212366|FG002|Overall Study|Withdrawal by Subject|1|||
149749018|NCT01306058|540212367|FG000|Overall Study|Death|1|||
149749019|NCT01306058|540212367|FG000|Overall Study|Enrolled but did not get treatment|1|||
149749020|NCT00849693|540212368|FG000|Acute Treatment Phase|Adverse Event|12|||
149749021|NCT00849693|540212369|FG001|Acute Treatment Phase|Adverse Event|7|||
149749022|NCT00849693|540212370|FG002|Acute Treatment Phase|Adverse Event|6|||
149749023|NCT00849693|540212371|FG003|Acute Treatment Phase|Adverse Event|4|||
149749024|NCT00849693|540212368|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
149749025|NCT00849693|540212369|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
149749026|NCT00849693|540212370|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
149749027|NCT00849693|540212371|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
149749028|NCT00849693|540212368|FG000|Acute Treatment Phase|Protocol Violation|1|||
149749029|NCT00849693|540212369|FG001|Acute Treatment Phase|Protocol Violation|5|||
149749030|NCT00849693|540212370|FG002|Acute Treatment Phase|Protocol Violation|2|||
149749031|NCT00849693|540212371|FG003|Acute Treatment Phase|Protocol Violation|6|||
149749032|NCT00849693|540212368|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
149749033|NCT00849693|540212369|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
149749034|NCT00849693|540212370|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
149749035|NCT00849693|540212371|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
149749036|NCT00849693|540212368|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
149749037|NCT00849693|540212369|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
149749038|NCT00849693|540212370|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
149749039|NCT00849693|540212371|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
149749040|NCT00849693|540212368|FG000|Acute Treatment Phase|Physician Decision|2|||
149749041|NCT00849693|540212369|FG001|Acute Treatment Phase|Physician Decision|1|||
149749042|NCT00849693|540212370|FG002|Acute Treatment Phase|Physician Decision|2|||
149749043|NCT00849693|540212371|FG003|Acute Treatment Phase|Physician Decision|1|||
149749044|NCT00849693|540212368|FG000|Acute Treatment Phase|Sponsor decision|0|||
149749045|NCT00849693|540212369|FG001|Acute Treatment Phase|Sponsor decision|0|||
149749046|NCT00849693|540212370|FG002|Acute Treatment Phase|Sponsor decision|1|||
149749047|NCT00849693|540212371|FG003|Acute Treatment Phase|Sponsor decision|0|||
149749048|NCT00849693|540212368|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
149749049|NCT00849693|540212369|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
149749050|NCT00849693|540212370|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
149749051|NCT00849693|540212371|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
149749052|NCT00849693|540212368|FG000|Extension Phase|Adverse Event|4|||
149749053|NCT00849693|540212369|FG001|Extension Phase|Adverse Event|6|||
149749054|NCT00849693|540212370|FG002|Extension Phase|Adverse Event|3|||
149749055|NCT00849693|540212371|FG003|Extension Phase|Adverse Event|7|||
149749056|NCT00849693|540212368|FG000|Extension Phase|Lost to Follow-up|7|||
149749057|NCT00849693|540212369|FG001|Extension Phase|Lost to Follow-up|5|||
149749058|NCT00849693|540212370|FG002|Extension Phase|Lost to Follow-up|6|||
149749059|NCT00849693|540212371|FG003|Extension Phase|Lost to Follow-up|6|||
149749060|NCT00849693|540212368|FG000|Extension Phase|Protocol Violation|0|||
149749061|NCT00849693|540212369|FG001|Extension Phase|Protocol Violation|3|||
149749062|NCT00849693|540212370|FG002|Extension Phase|Protocol Violation|2|||
149749063|NCT00849693|540212371|FG003|Extension Phase|Protocol Violation|3|||
149749064|NCT00849693|540212368|FG000|Extension Phase|Withdrawal by Subject|6|||
149749065|NCT00849693|540212369|FG001|Extension Phase|Withdrawal by Subject|9|||
149749066|NCT00849693|540212370|FG002|Extension Phase|Withdrawal by Subject|10|||
149749067|NCT00849693|540212371|FG003|Extension Phase|Withdrawal by Subject|15|||
149749068|NCT00849693|540212368|FG000|Extension Phase|Parent or caregiver decision|9|||
149749069|NCT00849693|540212369|FG001|Extension Phase|Parent or caregiver decision|4|||
149749070|NCT00849693|540212370|FG002|Extension Phase|Parent or caregiver decision|10|||
149749071|NCT00849693|540212371|FG003|Extension Phase|Parent or caregiver decision|5|||
149749072|NCT00849693|540212368|FG000|Extension Phase|Physician Decision|1|||
149749073|NCT00849693|540212369|FG001|Extension Phase|Physician Decision|1|||
149749074|NCT00849693|540212370|FG002|Extension Phase|Physician Decision|2|||
149749075|NCT00849693|540212371|FG003|Extension Phase|Physician Decision|0|||
149749076|NCT00849693|540212368|FG000|Extension Phase|Sponsor decision|1|||
149749077|NCT00849693|540212369|FG001|Extension Phase|Sponsor decision|0|||
149749078|NCT00849693|540212370|FG002|Extension Phase|Sponsor decision|0|||
149749079|NCT00849693|540212371|FG003|Extension Phase|Sponsor decision|1|||
149749080|NCT00849693|540212368|FG000|Extension Phase|Lack of Efficacy|2|||
149749081|NCT00849693|540212369|FG001|Extension Phase|Lack of Efficacy|2|||
149749082|NCT00849693|540212370|FG002|Extension Phase|Lack of Efficacy|2|||
149749083|NCT00849693|540212371|FG003|Extension Phase|Lack of Efficacy|1|||
149749084|NCT00224107|540212372|FG000|Overall Study|Adverse Event|20|||
149749085|NCT00224107|540212373|FG001|Overall Study|Adverse Event|6|||
149749086|NCT00224107|540212372|FG000|Overall Study|Protocol Violation|2|||
149749087|NCT00224107|540212373|FG001|Overall Study|Protocol Violation|3|||
149749088|NCT00224107|540212372|FG000|Overall Study|Withdrawal by Subject|1|||
149749089|NCT00224107|540212373|FG001|Overall Study|Withdrawal by Subject|4|||
149749090|NCT00224107|540212372|FG000|Overall Study|Lack of Efficacy|2|||
149749091|NCT00224107|540212373|FG001|Overall Study|Lack of Efficacy|0|||
149749092|NCT00224107|540212372|FG000|Overall Study|Lost to Follow-up|4|||
149749093|NCT00224107|540212373|FG001|Overall Study|Lost to Follow-up|0|||
149749094|NCT00224107|540212372|FG000|Overall Study|Physician Decision|1|||
149749095|NCT00224107|540212373|FG001|Overall Study|Physician Decision|0|||
149749096|NCT00224107|540212372|FG000|Overall Study|Other|1|||
149749097|NCT00224107|540212373|FG001|Overall Study|Other|1|||
149749098|NCT01183858|540212374|FG000|Overall Study|Death not related to Progressive Disease|5|||
149749099|NCT01183858|540212375|FG001|Overall Study|Death not related to Progressive Disease|6|||
149749100|NCT01183858|540212374|FG000|Overall Study|Adverse Event|14|||
149749101|NCT01183858|540212375|FG001|Overall Study|Adverse Event|11|||
149749102|NCT01183858|540212374|FG000|Overall Study|Investigator's Decision|0|||
149749103|NCT01183858|540212375|FG001|Overall Study|Investigator's Decision|3|||
149749104|NCT01183858|540212374|FG000|Overall Study|Insufficient Therapeutic Response|2|||
149749105|NCT01183858|540212375|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149749106|NCT01183858|540212374|FG000|Overall Study|Refused Treatment|1|||
149749107|NCT01183858|540212375|FG001|Overall Study|Refused Treatment|4|||
149749108|NCT01183858|540212374|FG000|Overall Study|Withdrew Consent|4|||
149749109|NCT01183858|540212375|FG001|Overall Study|Withdrew Consent|4|||
149749110|NCT01183858|540212374|FG000|Overall Study|Discontinued Smoking|3|||
149749111|NCT01183858|540212375|FG001|Overall Study|Discontinued Smoking|1|||
149749112|NCT01183858|540212374|FG000|Overall Study|Protocol Violation|1|||
149749113|NCT01183858|540212375|FG001|Overall Study|Protocol Violation|0|||
149749114|NCT01183858|540212374|FG000|Overall Study|Administrative/Other|6|||
149749115|NCT01183858|540212375|FG001|Overall Study|Administrative/Other|6|||
149749116|NCT01183858|540212374|FG000|Overall Study|Progressive Disease|112|||
149749117|NCT01183858|540212375|FG001|Overall Study|Progressive Disease|115|||
149749118|NCT01183858|540212374|FG000|Overall Study|Death related to Progressive Disease|4|||
149749119|NCT01183858|540212375|FG001|Overall Study|Death related to Progressive Disease|5|||
149749120|NCT01183858|540212374|FG000|Overall Study|Lost to Follow-up|1|||
149749121|NCT01183858|540212375|FG001|Overall Study|Lost to Follow-up|1|||
149749122|NCT00098345|540212376|FG000|Overall Study|Adverse Event|7|||
149749123|NCT00098345|540212376|FG000|Overall Study|Withdrawal by Subject|2|||
149749124|NCT00098345|540212376|FG000|Overall Study|progression|4|||
149749125|NCT02046564|540212379|FG000|Overall Study|Adverse Event|6|||
149749126|NCT02046564|540212380|FG001|Overall Study|Adverse Event|3|||
149749127|NCT02046564|540212379|FG000|Overall Study|Physician Decision|0|||
149749128|NCT02046564|540212380|FG001|Overall Study|Physician Decision|1|||
149749129|NCT02046564|540212379|FG000|Overall Study|Protocol Violation|3|||
149749130|NCT02046564|540212380|FG001|Overall Study|Protocol Violation|1|||
149749131|NCT02046564|540212379|FG000|Overall Study|Withdrawal by Subject|4|||
149749132|NCT02046564|540212380|FG001|Overall Study|Withdrawal by Subject|10|||
149749133|NCT02046564|540212379|FG000|Overall Study|Subject met withdrawal criteria|2|||
149749134|NCT02046564|540212380|FG001|Overall Study|Subject met withdrawal criteria|5|||
149749135|NCT01295905|540212383|FG000|Overall Study|Did not meet inclusion criteria|1|||
149749136|NCT01295905|540212384|FG001|Overall Study|Did not meet inclusion criteria|0|||
149749137|NCT01295905|540212383|FG000|Overall Study|Met exclusion criteria|1|||
149749138|NCT01295905|540212384|FG001|Overall Study|Met exclusion criteria|0|||
149749139|NCT03707977|540212385|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
149749140|NCT03707977|540212386|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
149749141|NCT03707977|540212387|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
149749142|NCT03707977|540212385|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
149749143|NCT03707977|540212386|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
149749144|NCT03707977|540212387|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
149749145|NCT03842709|540212388|FG000|Overall Study|Withdrawal by Subject|3|||
149749146|NCT03842709|540212389|FG001|Overall Study|Withdrawal by Subject|3|||
149749147|NCT03842709|540212388|FG000|Overall Study|Lost to Follow-up|1|||
149749148|NCT03842709|540212389|FG001|Overall Study|Lost to Follow-up|0|||
149749149|NCT00641147|540212390|FG000|Completed 4 Months.|Physician Decision|1|||
149749150|NCT00641147|540212391|FG001|Completed 4 Months.|Physician Decision|0|||
149749151|NCT00641147|540212390|FG000|Completed 4 Months.|Adverse Event|1|||
149749152|NCT00641147|540212391|FG001|Completed 4 Months.|Adverse Event|0|||
149749153|NCT00641147|540212390|FG000|Completed 8 Months.|Physician Decision|2|||
149749154|NCT00641147|540212391|FG001|Completed 8 Months.|Physician Decision|1|||
149749155|NCT00641147|540212390|FG000|Completed 8 Months.|non compliance|1|||
149749156|NCT00641147|540212391|FG001|Completed 8 Months.|non compliance|0|||
149749157|NCT00641147|540212390|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
149749158|NCT00641147|540212391|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
149749159|NCT00641147|540212390|FG000|Completed 12 Months.|Physician Decision|1|||
149749160|NCT00641147|540212391|FG001|Completed 12 Months.|Physician Decision|1|||
149749161|NCT00641147|540212390|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
149749162|NCT00641147|540212391|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
149749163|NCT00641147|540212390|FG000|Completed 16 Months.|Physician Decision|1|||
149749164|NCT00641147|540212391|FG001|Completed 16 Months.|Physician Decision|0|||
149749165|NCT00641147|540212390|FG000|Completed 16 Months.|Lost to Follow-up|1|||
149749166|NCT00641147|540212391|FG001|Completed 16 Months.|Lost to Follow-up|0|||
149749167|NCT00791128|540212392|FG000|Overall Study|Adverse Event|4|||
149749168|NCT00791128|540212392|FG000|Overall Study|Device migration|2|||
149749169|NCT00791128|540212392|FG000|Overall Study|non-compliance by subject|2|||
149749170|NCT00791128|540212392|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
149749171|NCT00984659|540212393|FG000|2-week Run-in Period|Adverse Event|8|||
149749172|NCT00984659|540212394|FG001|2-week Run-in Period|Adverse Event|0|||
149749173|NCT00984659|540212395|FG002|2-week Run-in Period|Adverse Event|0|||
149749174|NCT00984659|540212396|FG003|2-week Run-in Period|Adverse Event|0|||
149749175|NCT00984659|540212393|FG000|2-week Run-in Period|Protocol Violation|5|||
149749176|NCT00984659|540212394|FG001|2-week Run-in Period|Protocol Violation|0|||
149749177|NCT00984659|540212395|FG002|2-week Run-in Period|Protocol Violation|0|||
149749178|NCT00984659|540212396|FG003|2-week Run-in Period|Protocol Violation|0|||
149749179|NCT00984659|540212393|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
149749180|NCT00984659|540212394|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
149749181|NCT00984659|540212395|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
149749182|NCT00984659|540212396|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
149749183|NCT00984659|540212393|FG000|2-week Run-in Period|Lost to Follow-up|3|||
149749184|NCT00984659|540212394|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149749185|NCT00984659|540212395|FG002|2-week Run-in Period|Lost to Follow-up|0|||
149749186|NCT00984659|540212396|FG003|2-week Run-in Period|Lost to Follow-up|0|||
149749187|NCT00984659|540212393|FG000|2-week Run-in Period|Physician Decision|10|||
149749188|NCT00984659|540212394|FG001|2-week Run-in Period|Physician Decision|0|||
149749189|NCT00984659|540212395|FG002|2-week Run-in Period|Physician Decision|0|||
149749190|NCT00984659|540212396|FG003|2-week Run-in Period|Physician Decision|0|||
149749191|NCT00984659|540212393|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
149749192|NCT00984659|540212394|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149749193|NCT00984659|540212395|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149749194|NCT00984659|540212396|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
149749195|NCT00984659|540212393|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
149749196|NCT00984659|540212394|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149749197|NCT00984659|540212395|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149749198|NCT00984659|540212396|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149749199|NCT00984659|540212393|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
149749200|NCT00984659|540212394|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
149749201|NCT00984659|540212395|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
149749202|NCT00984659|540212396|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
149749203|NCT00984659|540212393|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
149749204|NCT00984659|540212394|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
149749205|NCT00984659|540212395|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
149749206|NCT00984659|540212396|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
149749207|NCT00984659|540212393|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
149749208|NCT00984659|540212394|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
149749209|NCT00984659|540212395|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
149749210|NCT00984659|540212396|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
149749211|NCT00984659|540212393|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149749212|NCT00984659|540212394|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149749213|NCT00984659|540212395|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
149749214|NCT00984659|540212396|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149749215|NCT00984659|540212393|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149749216|NCT00984659|540212394|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
149749217|NCT00984659|540212395|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
149749218|NCT00984659|540212396|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
149749219|NCT02424149|540212398|FG000|Overall Study|surgery cancelled|2|||
149749220|NCT02424149|540212399|FG001|Overall Study|surgery cancelled|0|||
149749221|NCT02424149|540212398|FG000|Overall Study|Withdrawal by Subject|0|||
149749222|NCT02424149|540212399|FG001|Overall Study|Withdrawal by Subject|1|||
149749223|NCT00328198|540212406|FG000|Treatment|Adverse Event|21|||
149749224|NCT00328198|540212406|FG000|Treatment|Death|1|||
149749225|NCT00328198|540212406|FG000|Treatment|Physician Decision|5|||
149749226|NCT00328198|540212406|FG000|Treatment|Withdrawal by Subject|5|||
149749227|NCT00328198|540212406|FG000|Treatment|Evidence of disease progression|2|||
149749228|NCT00328198|540212406|FG000|Treatment|Non-compliance|1|||
149749229|NCT00328198|540212406|FG000|Treatment|Confirmed complete response, MRD -|3|||
149749230|NCT00328198|540212406|FG000|Follow-up|Lost to Follow-up|4|||
149749231|NCT00328198|540212406|FG000|Follow-up|Death|31|||
149749232|NCT01720667|540212411|FG000|Overall Study|Adverse Event|1|||
149749233|NCT01720667|540212412|FG001|Overall Study|Adverse Event|1|||
149749234|NCT01720667|540212411|FG000|Overall Study|Withdrawal by Subject|3|||
149749235|NCT01720667|540212412|FG001|Overall Study|Withdrawal by Subject|0|||
149749236|NCT03472534|540212413|FG000|Overall Study|Withdrawal by Subject|9|||
149749237|NCT03472534|540212413|FG000|Overall Study|Adverse Event|2|||
149749238|NCT03865407|540212420|FG000|Overall Study|Adverse Event|1|||
149749239|NCT03865407|540212421|FG001|Overall Study|Adverse Event|0|||
149749240|NCT03865407|540212420|FG000|Overall Study|Withdrawal by Subject|1|||
149749241|NCT03865407|540212421|FG001|Overall Study|Withdrawal by Subject|0|||
149749242|NCT03865407|540212420|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
149749243|NCT03865407|540212421|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
149749244|NCT02117050|540212422|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
149749245|NCT00546819|540212427|FG000|Overall Study|Adverse Event|2|||
149749246|NCT00546819|540212428|FG001|Overall Study|Adverse Event|3|||
149749247|NCT00546819|540212427|FG000|Overall Study|Lost to Follow-up|2|||
149749248|NCT00546819|540212428|FG001|Overall Study|Lost to Follow-up|1|||
149749249|NCT00546819|540212427|FG000|Overall Study|Withdrawal by Subject|4|||
149749250|NCT00546819|540212428|FG001|Overall Study|Withdrawal by Subject|2|||
149749251|NCT02052960|540212430|FG000|Overall Study|Adverse Event|19|||
149749252|NCT02052960|540212431|FG001|Overall Study|Adverse Event|17|||
149749253|NCT02052960|540212430|FG000|Overall Study|Protocol Violation|4|||
149749254|NCT02052960|540212431|FG001|Overall Study|Protocol Violation|3|||
149749255|NCT02052960|540212430|FG000|Overall Study|Withdrawal by Subject|6|||
149749256|NCT02052960|540212431|FG001|Overall Study|Withdrawal by Subject|11|||
149749257|NCT02052960|540212430|FG000|Overall Study|Other|25|||
149749258|NCT02052960|540212431|FG001|Overall Study|Other|15|||
149749259|NCT03633331|540212434|FG000|Overall Study|Withdrawal by Subject|1|||
149749260|NCT03233048|540212435|FG000|Overall Study|Withdrawal by Subject|1|||
149749261|NCT00491530|540212436|FG000|Overall Study|Adverse Event|6|||
149749262|NCT00491530|540212437|FG001|Overall Study|Adverse Event|1|||
149749263|NCT00491530|540212438|FG002|Overall Study|Adverse Event|2|||
149749264|NCT00491530|540212436|FG000|Overall Study|Withdrawal by Subject|3|||
149749265|NCT00491530|540212437|FG001|Overall Study|Withdrawal by Subject|0|||
149749266|NCT00491530|540212438|FG002|Overall Study|Withdrawal by Subject|0|||
149749267|NCT00491530|540212436|FG000|Overall Study|Lost to Follow-up|3|||
149749268|NCT00491530|540212437|FG001|Overall Study|Lost to Follow-up|2|||
149749269|NCT00491530|540212438|FG002|Overall Study|Lost to Follow-up|2|||
149749270|NCT00491530|540212436|FG000|Overall Study|Lack of Efficacy|0|||
149749271|NCT00491530|540212437|FG001|Overall Study|Lack of Efficacy|1|||
149749272|NCT00491530|540212438|FG002|Overall Study|Lack of Efficacy|0|||
149749273|NCT00491530|540212436|FG000|Overall Study|Investigator Discretion|0|||
149749274|NCT00491530|540212437|FG001|Overall Study|Investigator Discretion|1|||
149749275|NCT00491530|540212438|FG002|Overall Study|Investigator Discretion|0|||
149749276|NCT00491530|540212436|FG000|Overall Study|Patient Request|0|||
149749277|NCT00491530|540212437|FG001|Overall Study|Patient Request|1|||
149749278|NCT00491530|540212438|FG002|Overall Study|Patient Request|0|||
149749279|NCT00491530|540212436|FG000|Overall Study|Use of Prohibited Medication|0|||
149749280|NCT00491530|540212437|FG001|Overall Study|Use of Prohibited Medication|0|||
149749281|NCT00491530|540212438|FG002|Overall Study|Use of Prohibited Medication|1|||
149749282|NCT00883753|540212439|FG000|Overall Study|Adverse Event|37|||
149749283|NCT00883753|540212439|FG000|Overall Study|Death|2|||
149749284|NCT00883753|540212439|FG000|Overall Study|Insufficient therapeutic response|16|||
149749285|NCT00883753|540212439|FG000|Overall Study|Lost to Follow-up|4|||
149749286|NCT00883753|540212439|FG000|Overall Study|Violation of selection criteria at entry|7|||
149749287|NCT00883753|540212439|FG000|Overall Study|Protocol Violation|2|||
149749288|NCT00883753|540212439|FG000|Overall Study|Refused treatment|4|||
149749289|NCT00883753|540212439|FG000|Overall Study|Withdrew consent|10|||
149749290|NCT00883753|540212439|FG000|Overall Study|Investigator's decision|17|||
149749291|NCT00883753|540212439|FG000|Overall Study|Administrative/Other|8|||
149749292|NCT02859415|540212440|FG000|Overall Study|Physician Decision|1|||
149749293|NCT02859415|540212441|FG001|Overall Study|Physician Decision|0|||
149749294|NCT02859415|540212440|FG000|Overall Study|Off treatment due to cardiac event|0|||
149749295|NCT02859415|540212441|FG001|Overall Study|Off treatment due to cardiac event|1|||
149749296|NCT01396525|540212444|FG000|Overall Study|Withdrawal by Subject|8|||
149749297|NCT01396525|540212444|FG000|Overall Study|Death|14|||
149749298|NCT01396525|540212444|FG000|Overall Study|Lost to Follow-up|4|||
149749299|NCT00949650|540212445|FG000|Overall Study|Progressive disease|188|||
149749300|NCT00949650|540212446|FG001|Overall Study|Progressive disease|19|||
149749301|NCT00949650|540212445|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
149749302|NCT00949650|540212446|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
149749303|NCT00949650|540212445|FG000|Overall Study|Other Adverse Event (AE)|28|||
149749304|NCT00949650|540212446|FG001|Overall Study|Other Adverse Event (AE)|17|||
149749305|NCT00949650|540212445|FG000|Overall Study|Protocol Violation|1|||
149749306|NCT00949650|540212446|FG001|Overall Study|Protocol Violation|4|||
149749307|NCT00949650|540212445|FG000|Overall Study|Refusal to continue medication|7|||
149749308|NCT00949650|540212446|FG001|Overall Study|Refusal to continue medication|11|||
149749309|NCT00949650|540212445|FG000|Overall Study|Not treated|1|||
149749310|NCT00949650|540212446|FG001|Overall Study|Not treated|4|||
149749311|NCT00949650|540212445|FG000|Overall Study|Other not specified above|5|||
149749312|NCT00949650|540212446|FG001|Overall Study|Other not specified above|0|||
149749313|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Adverse Event|12|||
149749314|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Adverse Event|3|||
149749315|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Adverse Event|4|||
149749316|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Adverse Event|2|||
149749317|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
149749318|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
149749319|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
149749320|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
149749321|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
149749322|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
149749323|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
149749324|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
149749325|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
149749326|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
149749327|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
149749328|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
149749329|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
149749330|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
149749331|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
149749332|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
149749333|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
149749334|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
149749335|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
149749336|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
149749337|NCT02436239|540212450|FG000|Open-Lable Treatment Period|Other Reason|1|||
149749338|NCT02436239|540212451|FG001|Open-Lable Treatment Period|Other Reason|1|||
149749339|NCT02436239|540212452|FG002|Open-Lable Treatment Period|Other Reason|0|||
149749340|NCT02436239|540212453|FG003|Open-Lable Treatment Period|Other Reason|0|||
149749341|NCT02436239|540212450|FG000|Down-Taper Period|Withdrawal by Subject|4|||
149749342|NCT02436239|540212451|FG001|Down-Taper Period|Withdrawal by Subject|4|||
149749343|NCT02436239|540212452|FG002|Down-Taper Period|Withdrawal by Subject|1|||
149749344|NCT02436239|540212453|FG003|Down-Taper Period|Withdrawal by Subject|2|||
149749345|NCT03671369|540212454|FG000|Overall Study|Other|1|||
149749346|NCT03671369|540212454|FG000|Overall Study|Withdrawal by Subject|289|||
149749347|NCT03671369|540212454|FG000|Overall Study|Not willing to be vaccinated|1|||
149749348|NCT00069121|540212456|FG000|Overall Study|Death|286|||
149749349|NCT00069121|540212457|FG001|Overall Study|Death|242|||
149749350|NCT00069121|540212456|FG000|Overall Study|Withdrawal by Subject|18|||
149749351|NCT00069121|540212457|FG001|Overall Study|Withdrawal by Subject|20|||
149749352|NCT00069121|540212456|FG000|Overall Study|Lost to Follow-up|63|||
149749353|NCT00069121|540212457|FG001|Overall Study|Lost to Follow-up|63|||
149749354|NCT00942708|540212458|FG000|Overall Study|Withdrawal by Subject|1|||
149749355|NCT03851510|540212459|FG000|Overall Study|Screen Fail|1|||
149749356|NCT03851510|540212459|FG000|Overall Study|Adverse Event|1|||
149749357|NCT03851510|540212459|FG000|Overall Study|Withdrawal by Subject|1|||
149749358|NCT02704429|540212463|FG000|Part A: 24 Weeks|Adverse Event|3|||
149749359|NCT02704429|540212464|FG001|Part A: 24 Weeks|Adverse Event|0|||
149749360|NCT02704429|540212463|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
149749361|NCT02704429|540212464|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
149749362|NCT00104104|540212466|FG000|Overall Study|Adverse Event|8|||
149749363|NCT00104104|540212467|FG001|Overall Study|Adverse Event|8|||
149749364|NCT00104104|540212466|FG000|Overall Study|Abnormal laboratory value(s)|20|||
149749365|NCT00104104|540212467|FG001|Overall Study|Abnormal laboratory value(s)|14|||
149749366|NCT00104104|540212466|FG000|Overall Study|Lack of Efficacy|0|||
149749367|NCT00104104|540212467|FG001|Overall Study|Lack of Efficacy|3|||
149749368|NCT00104104|540212466|FG000|Overall Study|Condition no longer requires study drug|7|||
149749369|NCT00104104|540212467|FG001|Overall Study|Condition no longer requires study drug|4|||
149749370|NCT00104104|540212466|FG000|Overall Study|Protocol Violation|5|||
149749371|NCT00104104|540212467|FG001|Overall Study|Protocol Violation|2|||
149749372|NCT00104104|540212466|FG000|Overall Study|Withdrawal by Subject|11|||
149749373|NCT00104104|540212467|FG001|Overall Study|Withdrawal by Subject|15|||
149749374|NCT00104104|540212466|FG000|Overall Study|Lost to Follow-up|3|||
149749375|NCT00104104|540212467|FG001|Overall Study|Lost to Follow-up|7|||
149749376|NCT00104104|540212466|FG000|Overall Study|Administrative problems|12|||
149749377|NCT00104104|540212467|FG001|Overall Study|Administrative problems|13|||
149749378|NCT00104104|540212466|FG000|Overall Study|Death|9|||
149749379|NCT00104104|540212467|FG001|Overall Study|Death|6|||
149749380|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
149749381|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
149749382|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
149749383|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
149749384|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
149749385|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149749386|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149749387|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149749388|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
149749389|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
149749390|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
149749391|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
149749392|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149749393|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149749394|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
149749395|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149749396|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
149749397|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149749398|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149749399|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
149749400|NCT01894516|540213606|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149749401|NCT01894516|540213607|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
149749402|NCT01894516|540213608|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
149749403|NCT01894516|540213609|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149749404|NCT01894516|540213606|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
149749405|NCT01894516|540213607|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
149749406|NCT01894516|540213608|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
149749407|NCT01894516|540213609|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
149749408|NCT01894516|540213606|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149749409|NCT01894516|540213607|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149749410|NCT01894516|540213608|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
149749411|NCT01894516|540213609|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149749412|NCT02452970|540213611|FG000|Overall Study|Adverse Event|1|||
149749413|NCT01040832|540213613|FG000|Overall Study|Adverse Event|4|||
149749414|NCT01040832|540213614|FG001|Overall Study|Adverse Event|5|||
149749415|NCT01040832|540213613|FG000|Overall Study|Death|4|||
149749416|NCT01040832|540213614|FG001|Overall Study|Death|6|||
149749417|NCT01040832|540213613|FG000|Overall Study|Withdrawal by Subject|2|||
149749418|NCT01040832|540213614|FG001|Overall Study|Withdrawal by Subject|3|||
149749419|NCT01040832|540213613|FG000|Overall Study|Progressive disease|32|||
149749420|NCT01040832|540213614|FG001|Overall Study|Progressive disease|17|||
149749421|NCT01040832|540213613|FG000|Overall Study|Symptomatic deterioration|2|||
149749422|NCT01040832|540213614|FG001|Overall Study|Symptomatic deterioration|5|||
149749423|NCT01040832|540213613|FG000|Overall Study|Other|2|||
149749424|NCT01040832|540213614|FG001|Overall Study|Other|1|||
149749425|NCT01539837|540213615|FG000|Overall Study|reduce neutrophil level|0|||
149749426|NCT01539837|540213616|FG001|Overall Study|reduce neutrophil level|1|||
149749427|NCT01539837|540213617|FG002|Overall Study|reduce neutrophil level|1|||
149749428|NCT01539837|540213615|FG000|Overall Study|bad compliance|0|||
149749429|NCT01539837|540213616|FG001|Overall Study|bad compliance|0|||
149749430|NCT01539837|540213617|FG002|Overall Study|bad compliance|1|||
149749431|NCT01629667|540213620|FG000|Overall Study|Lost to Follow-up|0|||
149749432|NCT01629667|540213621|FG001|Overall Study|Lost to Follow-up|1|||
149749433|NCT01629667|540213622|FG002|Overall Study|Lost to Follow-up|1|||
149749434|NCT01629667|540213620|FG000|Overall Study|Withdrawal by Subject|31|||
149749435|NCT01629667|540213621|FG001|Overall Study|Withdrawal by Subject|20|||
149749436|NCT01629667|540213622|FG002|Overall Study|Withdrawal by Subject|28|||
149749437|NCT01629667|540213620|FG000|Overall Study|Death|1|||
149749438|NCT01629667|540213621|FG001|Overall Study|Death|5|||
149749439|NCT01629667|540213622|FG002|Overall Study|Death|3|||
149749440|NCT01629667|540213620|FG000|Overall Study|Randomized, not treated|2|||
149749441|NCT01629667|540213621|FG001|Overall Study|Randomized, not treated|1|||
149749442|NCT01629667|540213622|FG002|Overall Study|Randomized, not treated|0|||
149749443|NCT01629667|540213620|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
149749444|NCT01629667|540213621|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
149749445|NCT01629667|540213622|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
149749446|NCT01629667|540213620|FG000|Overall Study|Requiring lung transplant|2|||
149749447|NCT01629667|540213621|FG001|Overall Study|Requiring lung transplant|1|||
149749448|NCT01629667|540213622|FG002|Overall Study|Requiring lung transplant|3|||
149749449|NCT01629667|540213620|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
149749450|NCT01629667|540213621|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
149749451|NCT01629667|540213622|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
149749452|NCT01629667|540213620|FG000|Overall Study|Started other medicine|1|||
149749453|NCT01629667|540213621|FG001|Overall Study|Started other medicine|0|||
149749454|NCT01629667|540213622|FG002|Overall Study|Started other medicine|1|||
149749455|NCT01629667|540213620|FG000|Overall Study|Site error in safety follow-up|0|||
149749456|NCT01629667|540213621|FG001|Overall Study|Site error in safety follow-up|0|||
149749457|NCT01629667|540213622|FG002|Overall Study|Site error in safety follow-up|1|||
149749458|NCT01629667|540213620|FG000|Overall Study|Enrolled in another clinical study|0|||
149749459|NCT01629667|540213621|FG001|Overall Study|Enrolled in another clinical study|1|||
149749460|NCT01629667|540213622|FG002|Overall Study|Enrolled in another clinical study|0|||
149749461|NCT01629667|540213620|FG000|Overall Study|Code break|1|||
149749462|NCT01629667|540213621|FG001|Overall Study|Code break|0|||
149749463|NCT01629667|540213622|FG002|Overall Study|Code break|0|||
149749464|NCT02717546|540213624|FG000|Overall Study|Lost to Follow-up|12|||
149749465|NCT03849560|540213625|FG000|Overall Study|Withdrawal by Subject|1|||
149749466|NCT03849560|540213626|FG001|Overall Study|Withdrawal by Subject|0|||
149749467|NCT03849560|540213627|FG002|Overall Study|Withdrawal by Subject|0|||
149749468|NCT04382651|540213628|FG000|Overall Study|Death|26|||
149749469|NCT04382651|540213629|FG001|Overall Study|Death|23|||
149749470|NCT04382651|540213628|FG000|Overall Study|Lost to Follow-up|3|||
149749471|NCT04382651|540213629|FG001|Overall Study|Lost to Follow-up|4|||
149749472|NCT04382651|540213628|FG000|Overall Study|Withdrawal by Subject|2|||
149749473|NCT04382651|540213629|FG001|Overall Study|Withdrawal by Subject|0|||
149749474|NCT04382651|540213628|FG000|Overall Study|Physician Decision|0|||
149749475|NCT04382651|540213629|FG001|Overall Study|Physician Decision|1|||
149749476|NCT01507545|540213630|FG000|Overall Study|Withdrawal by Subject|6|||
149749477|NCT01507545|540213631|FG001|Overall Study|Withdrawal by Subject|2|||
149749478|NCT01507545|540213630|FG000|Overall Study|Lost to Follow-up|1|||
149749479|NCT01507545|540213631|FG001|Overall Study|Lost to Follow-up|0|||
149749480|NCT01507545|540213630|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
149749481|NCT01507545|540213631|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
149749482|NCT01507545|540213630|FG000|Overall Study|Progressive disease|60|||
149749483|NCT01507545|540213631|FG001|Overall Study|Progressive disease|27|||
149749484|NCT01507545|540213630|FG000|Overall Study|Other|6|||
149749485|NCT01507545|540213631|FG001|Overall Study|Other|4|||
149749486|NCT00790296|540213633|FG000|Overall Study|Did not meet study eligibility criteria|1|||
149749487|NCT00790296|540213634|FG001|Overall Study|Did not meet study eligibility criteria|1|||
149749488|NCT00790296|540213633|FG000|Overall Study|Adverse Event|0|||
149749489|NCT00790296|540213634|FG001|Overall Study|Adverse Event|1|||
149749490|NCT02612077|540213635|FG000|Overall Study|Adverse Event|3|||
149749491|NCT02612077|540213635|FG000|Overall Study|Withdrawal by Subject|9|||
149749492|NCT02612077|540213635|FG000|Overall Study|Protocol Violation|28|||
149749493|NCT02612077|540213635|FG000|Overall Study|Lost to Follow-up|20|||
149749494|NCT02612077|540213635|FG000|Overall Study|Death|377|||
149749495|NCT02612077|540213635|FG000|Overall Study|Moved or Changed Medical Team|23|||
149749496|NCT02612077|540213635|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
149749497|NCT02612077|540213635|FG000|Overall Study|Disease Progression|3|||
149749498|NCT02612077|540213635|FG000|Overall Study|Unknown reason|2|||
149749499|NCT01753518|540213636|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
149749500|NCT01753518|540213637|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
149749501|NCT01753518|540213636|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
149749502|NCT01753518|540213637|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
149749503|NCT01753518|540213636|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
149749504|NCT01753518|540213637|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
149749505|NCT01753518|540213636|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
149749506|NCT01753518|540213637|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
149749507|NCT01971476|540213638|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
149749508|NCT01971476|540213639|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
149749509|NCT01971476|540213640|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
149749510|NCT01971476|540213638|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
149749511|NCT01971476|540213639|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
149749512|NCT01971476|540213640|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
149749513|NCT01971476|540213638|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
149749514|NCT01971476|540213639|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
149749515|NCT01971476|540213640|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
149749516|NCT00940342|540213641|FG000|Overall Study|Adverse Event|0|||
149749517|NCT00940342|540213642|FG001|Overall Study|Adverse Event|2|||
149749518|NCT00940342|540213643|FG002|Overall Study|Adverse Event|1|||
149749519|NCT02498821|540213644|FG000|Overall Study|Screen failure|3|||
149749520|NCT02498821|540213645|FG001|Overall Study|Screen failure|5|||
149749521|NCT01716169|540213647|FG000|Overall Study|Adverse Event|1|||
149749522|NCT01716169|540213647|FG000|Overall Study|Lost to Follow-up|1|||
149749523|NCT01716169|540213647|FG000|Overall Study|Withdrawal by Subject|1|||
149749524|NCT01716169|540213647|FG000|Overall Study|inconsistent dressing application|1|||
149749525|NCT00553787|540213648|FG000|Overall Study|Adverse Event|34|||
149749526|NCT00553787|540213649|FG001|Overall Study|Adverse Event|21|||
149749527|NCT00553787|540213650|FG002|Overall Study|Adverse Event|67|||
149749528|NCT00553787|540213648|FG000|Overall Study|Lost to Follow-up|132|||
149749529|NCT00553787|540213649|FG001|Overall Study|Lost to Follow-up|44|||
149749530|NCT00553787|540213650|FG002|Overall Study|Lost to Follow-up|78|||
149749531|NCT00553787|540213648|FG000|Overall Study|Withdrawal by Subject|151|||
149749532|NCT00553787|540213649|FG001|Overall Study|Withdrawal by Subject|40|||
149749533|NCT00553787|540213650|FG002|Overall Study|Withdrawal by Subject|83|||
149749534|NCT00553787|540213648|FG000|Overall Study|Lack of Efficacy|31|||
149749535|NCT00553787|540213649|FG001|Overall Study|Lack of Efficacy|1|||
149749536|NCT00553787|540213650|FG002|Overall Study|Lack of Efficacy|3|||
149749537|NCT00553787|540213648|FG000|Overall Study|Pregnancy|0|||
149749538|NCT00553787|540213649|FG001|Overall Study|Pregnancy|1|||
149749539|NCT00553787|540213650|FG002|Overall Study|Pregnancy|2|||
149749540|NCT00553787|540213648|FG000|Overall Study|non compliance|4|||
149749541|NCT00553787|540213649|FG001|Overall Study|non compliance|0|||
149749542|NCT00553787|540213650|FG002|Overall Study|non compliance|11|||
149749543|NCT00553787|540213648|FG000|Overall Study|Requirement for restricted medication|8|||
149749544|NCT00553787|540213649|FG001|Overall Study|Requirement for restricted medication|7|||
149749545|NCT00553787|540213650|FG002|Overall Study|Requirement for restricted medication|5|||
149749546|NCT00553787|540213648|FG000|Overall Study|Other|18|||
149749547|NCT00553787|540213649|FG001|Overall Study|Other|10|||
149749548|NCT00553787|540213650|FG002|Overall Study|Other|13|||
149749549|NCT01088412|540213651|FG000|Overall Study|Adverse Event|38|||
149749550|NCT01088412|540213652|FG001|Overall Study|Adverse Event|0|||
149749551|NCT01088412|540213653|FG002|Overall Study|Adverse Event|0|||
149749552|NCT01088412|540213651|FG000|Overall Study|Death|42|||
149749553|NCT01088412|540213652|FG001|Overall Study|Death|6|||
149749554|NCT01088412|540213653|FG002|Overall Study|Death|0|||
149749555|NCT01088412|540213651|FG000|Overall Study|Other Reason per Case Report Form|2089|||
149749556|NCT01088412|540213652|FG001|Overall Study|Other Reason per Case Report Form|103|||
149749557|NCT01088412|540213653|FG002|Overall Study|Other Reason per Case Report Form|9|||
149749558|NCT01088412|540213651|FG000|Overall Study|Withdrawal by Subject|1761|||
149749559|NCT01088412|540213652|FG001|Overall Study|Withdrawal by Subject|25|||
149749560|NCT01088412|540213653|FG002|Overall Study|Withdrawal by Subject|1|||
149749561|NCT01088412|540213651|FG000|Overall Study|Received Another GH Product|79|||
149749562|NCT01088412|540213652|FG001|Overall Study|Received Another GH Product|0|||
149749563|NCT01088412|540213653|FG002|Overall Study|Received Another GH Product|0|||
149749564|NCT01088412|540213651|FG000|Overall Study|Participant Moved|601|||
149749565|NCT01088412|540213652|FG001|Overall Study|Participant Moved|21|||
149749566|NCT01088412|540213653|FG002|Overall Study|Participant Moved|2|||
149749567|NCT01088412|540213651|FG000|Overall Study|Physician Decision|1041|||
149749568|NCT01088412|540213652|FG001|Overall Study|Physician Decision|8|||
149749569|NCT01088412|540213653|FG002|Overall Study|Physician Decision|4|||
149749570|NCT01088412|540213651|FG000|Overall Study|Sponsor Decision|4467|||
149749571|NCT01088412|540213652|FG001|Overall Study|Sponsor Decision|79|||
149749572|NCT01088412|540213653|FG002|Overall Study|Sponsor Decision|23|||
149749573|NCT01088412|540213651|FG000|Overall Study|Third Party Required to Change Brand|487|||
149749574|NCT01088412|540213652|FG001|Overall Study|Third Party Required to Change Brand|0|||
149749575|NCT01088412|540213653|FG002|Overall Study|Third Party Required to Change Brand|0|||
149749576|NCT01088412|540213651|FG000|Overall Study|Lost to Follow-up|3052|||
149749577|NCT01088412|540213652|FG001|Overall Study|Lost to Follow-up|130|||
149749578|NCT01088412|540213653|FG002|Overall Study|Lost to Follow-up|11|||
149749579|NCT01088412|540213651|FG000|Overall Study|Study Summary Not Completed|4360|||
149749580|NCT01088412|540213652|FG001|Overall Study|Study Summary Not Completed|64|||
149749581|NCT01088412|540213653|FG002|Overall Study|Study Summary Not Completed|22|||
149749582|NCT00793104|540213654|FG000|Overall Study|Lost to Follow-up|1|||
149749583|NCT03494725|540213659|FG000|Overall Study|Withdrawal by Subject|0|||
149749584|NCT03494725|540213660|FG001|Overall Study|Withdrawal by Subject|2|||
149749585|NCT03494725|540213659|FG000|Overall Study|Antibiotic use|1|||
149749586|NCT03494725|540213660|FG001|Overall Study|Antibiotic use|0|||
149749587|NCT02619253|540213661|FG000|Overall Study|Adverse Event|0|||
149749588|NCT02619253|540213662|FG001|Overall Study|Adverse Event|0|||
149749589|NCT02619253|540213663|FG002|Overall Study|Adverse Event|1|||
149749590|NCT02619253|540213664|FG003|Overall Study|Adverse Event|1|||
149749591|NCT02619253|540213665|FG004|Overall Study|Adverse Event|3|||
149749592|NCT02619253|540213661|FG000|Overall Study|Alternative Therapy|0|||
149749593|NCT02619253|540213662|FG001|Overall Study|Alternative Therapy|0|||
149749594|NCT02619253|540213663|FG002|Overall Study|Alternative Therapy|1|||
149749595|NCT02619253|540213664|FG003|Overall Study|Alternative Therapy|0|||
149749596|NCT02619253|540213665|FG004|Overall Study|Alternative Therapy|0|||
149749597|NCT02619253|540213661|FG000|Overall Study|Death|0|||
149749598|NCT02619253|540213662|FG001|Overall Study|Death|0|||
149749599|NCT02619253|540213663|FG002|Overall Study|Death|0|||
149749600|NCT02619253|540213664|FG003|Overall Study|Death|1|||
149749601|NCT02619253|540213665|FG004|Overall Study|Death|0|||
149749602|NCT02619253|540213661|FG000|Overall Study|Disease Progression|4|||
149749603|NCT02619253|540213662|FG001|Overall Study|Disease Progression|2|||
149749604|NCT02619253|540213663|FG002|Overall Study|Disease Progression|8|||
149749605|NCT02619253|540213664|FG003|Overall Study|Disease Progression|9|||
149749606|NCT02619253|540213665|FG004|Overall Study|Disease Progression|10|||
149749607|NCT02619253|540213661|FG000|Overall Study|Needed a disqualifying therapy|0|||
149749608|NCT02619253|540213662|FG001|Overall Study|Needed a disqualifying therapy|0|||
149749609|NCT02619253|540213663|FG002|Overall Study|Needed a disqualifying therapy|1|||
149749610|NCT02619253|540213664|FG003|Overall Study|Needed a disqualifying therapy|0|||
149749611|NCT02619253|540213665|FG004|Overall Study|Needed a disqualifying therapy|0|||
149749612|NCT02619253|540213661|FG000|Overall Study|Transferred to hospice|0|||
149749613|NCT02619253|540213662|FG001|Overall Study|Transferred to hospice|0|||
149749614|NCT02619253|540213663|FG002|Overall Study|Transferred to hospice|1|||
149749615|NCT02619253|540213664|FG003|Overall Study|Transferred to hospice|0|||
149749616|NCT02619253|540213665|FG004|Overall Study|Transferred to hospice|0|||
149749617|NCT02619253|540213661|FG000|Overall Study|Physician Decision|0|||
149749618|NCT02619253|540213662|FG001|Overall Study|Physician Decision|1|||
149749619|NCT02619253|540213663|FG002|Overall Study|Physician Decision|2|||
149749620|NCT02619253|540213664|FG003|Overall Study|Physician Decision|3|||
149749621|NCT02619253|540213665|FG004|Overall Study|Physician Decision|0|||
149749622|NCT02619253|540213661|FG000|Overall Study|Withdrawal by Subject|0|||
149749623|NCT02619253|540213662|FG001|Overall Study|Withdrawal by Subject|1|||
149749624|NCT02619253|540213663|FG002|Overall Study|Withdrawal by Subject|0|||
149749625|NCT02619253|540213664|FG003|Overall Study|Withdrawal by Subject|0|||
149749626|NCT02619253|540213665|FG004|Overall Study|Withdrawal by Subject|2|||
149749627|NCT00514449|540213666|FG000|Overall Study|Withdrawal by Subject|1|||
149749628|NCT00514449|540213667|FG001|Overall Study|Withdrawal by Subject|2|||
149749629|NCT00514449|540213666|FG000|Overall Study|Protocol Violation|1|||
149749630|NCT00514449|540213667|FG001|Overall Study|Protocol Violation|2|||
149749631|NCT00514449|540213666|FG000|Overall Study|Lost to Follow-up|1|||
149749632|NCT00514449|540213667|FG001|Overall Study|Lost to Follow-up|0|||
149749633|NCT00995371|540213674|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
149749634|NCT00995371|540213675|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
149749635|NCT00306891|540213676|FG000|Part A|Withdrawal by Subject|1|||
149749636|NCT00306891|540213677|FG001|Part A|Withdrawal by Subject|1|||
149749637|NCT00306891|540213678|FG002|Part A|Withdrawal by Subject|0|||
149749638|NCT00306891|540213679|FG003|Part A|Withdrawal by Subject|0|||
149749639|NCT00306891|540213676|FG000|Part A|Condition under investigation worsened|2|||
149749640|NCT00306891|540213677|FG001|Part A|Condition under investigation worsened|2|||
149749641|NCT00306891|540213678|FG002|Part A|Condition under investigation worsened|0|||
149749642|NCT00306891|540213679|FG003|Part A|Condition under investigation worsened|0|||
149749643|NCT00306891|540213676|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149749644|NCT00306891|540213677|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
149749645|NCT00306891|540213678|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149749646|NCT00306891|540213679|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149749647|NCT00306891|540213676|FG000|Part A|Partial bowel obstruction|1|||
149749648|NCT00306891|540213677|FG001|Part A|Partial bowel obstruction|0|||
149749649|NCT00306891|540213678|FG002|Part A|Partial bowel obstruction|0|||
149749650|NCT00306891|540213679|FG003|Part A|Partial bowel obstruction|0|||
149749651|NCT00306891|540213676|FG000|Part A|Reaccumul. of ascites following drainage|0|||
149749652|NCT00306891|540213677|FG001|Part A|Reaccumul. of ascites following drainage|1|||
149749653|NCT00306891|540213678|FG002|Part A|Reaccumul. of ascites following drainage|0|||
149749654|NCT00306891|540213679|FG003|Part A|Reaccumul. of ascites following drainage|0|||
149749655|NCT00306891|540213676|FG000|Part A|Suspicion of second malignancy|0|||
149749656|NCT00306891|540213677|FG001|Part A|Suspicion of second malignancy|1|||
149749657|NCT00306891|540213678|FG002|Part A|Suspicion of second malignancy|0|||
149749658|NCT00306891|540213679|FG003|Part A|Suspicion of second malignancy|0|||
149749659|NCT00306891|540213676|FG000|Part A|QTC interval outwith elig. criteria|1|||
149749660|NCT00306891|540213677|FG001|Part A|QTC interval outwith elig. criteria|0|||
149749661|NCT00306891|540213678|FG002|Part A|QTC interval outwith elig. criteria|0|||
149749662|NCT00306891|540213679|FG003|Part A|QTC interval outwith elig. criteria|0|||
149749663|NCT00306891|540213676|FG000|Part B|Death|0|||
149749664|NCT00306891|540213677|FG001|Part B|Death|0|||
149749665|NCT00306891|540213678|FG002|Part B|Death|1|||
149749666|NCT00306891|540213679|FG003|Part B|Death|2|||
149749667|NCT00306891|540213676|FG000|Part B|Adverse Event|0|||
149749668|NCT00306891|540213677|FG001|Part B|Adverse Event|0|||
149749669|NCT00306891|540213678|FG002|Part B|Adverse Event|5|||
149749670|NCT00306891|540213679|FG003|Part B|Adverse Event|5|||
149749671|NCT00306891|540213676|FG000|Part B|Withdrawal by Subject|0|||
149749672|NCT00306891|540213677|FG001|Part B|Withdrawal by Subject|0|||
149749673|NCT00306891|540213678|FG002|Part B|Withdrawal by Subject|3|||
149749674|NCT00306891|540213679|FG003|Part B|Withdrawal by Subject|1|||
149749675|NCT00306891|540213676|FG000|Part B|Condition under investigation worsened|0|||
149749676|NCT00306891|540213677|FG001|Part B|Condition under investigation worsened|0|||
149749677|NCT00306891|540213678|FG002|Part B|Condition under investigation worsened|2|||
149749678|NCT00306891|540213679|FG003|Part B|Condition under investigation worsened|8|||
149749679|NCT00306891|540213676|FG000|Part B|Development of study specific disc crit.|0|||
149749680|NCT00306891|540213677|FG001|Part B|Development of study specific disc crit.|0|||
149749681|NCT00306891|540213678|FG002|Part B|Development of study specific disc crit.|0|||
149749682|NCT00306891|540213679|FG003|Part B|Development of study specific disc crit.|1|||
149749683|NCT00673673|540213680|FG000|Overall Study|Progressive disease|27|||
149749684|NCT00673673|540213680|FG000|Overall Study|Adverse Event|4|||
149749685|NCT00673673|540213680|FG000|Overall Study|Withdrawal by Subject|3|||
149749686|NCT00673673|540213680|FG000|Overall Study|Investigators' discretion|2|||
149749687|NCT00206518|540213687|FG000|Overall Study|Lack of Efficacy|6|||
149749688|NCT00206518|540213688|FG001|Overall Study|Lack of Efficacy|4|||
149749689|NCT00206518|540213687|FG000|Overall Study|Adverse Event|2|||
149749690|NCT00206518|540213688|FG001|Overall Study|Adverse Event|1|||
149749691|NCT00206518|540213687|FG000|Overall Study|Physician Decision|1|||
149749692|NCT00206518|540213688|FG001|Overall Study|Physician Decision|0|||
149749693|NCT00206518|540213687|FG000|Overall Study|Protocol Violation|1|||
149749694|NCT00206518|540213688|FG001|Overall Study|Protocol Violation|1|||
149749695|NCT02335450|540213689|FG000|Overall Study|Pregnancy|1|||
149749696|NCT02613572|540213690|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
149749697|NCT02613572|540213691|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
149749698|NCT02613572|540213692|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
149749699|NCT02613572|540213690|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
149749700|NCT02613572|540213691|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
149749701|NCT02613572|540213692|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
149749702|NCT04538950|540213694|FG000|Overall Study|Pulmonary Issues|2|||
149749703|NCT04538950|540213694|FG000|Overall Study|illness|2|||
149749704|NCT00231478|540213695|FG000|Overall Study|Protocol Violation|3|||
149749705|NCT00231478|540213696|FG001|Overall Study|Protocol Violation|2|||
149749706|NCT00231478|540213695|FG000|Overall Study|Refused Treatment|1|||
149749707|NCT00231478|540213696|FG001|Overall Study|Refused Treatment|1|||
149749708|NCT00231478|540213695|FG000|Overall Study|Withdrawal by Subject|1|||
149749709|NCT00231478|540213696|FG001|Overall Study|Withdrawal by Subject|0|||
149749710|NCT00231478|540213695|FG000|Overall Study|Adverse Event|0|||
149749711|NCT00231478|540213696|FG001|Overall Study|Adverse Event|1|||
149749712|NCT00231478|540213695|FG000|Overall Study|Administrative|3|||
149749713|NCT00231478|540213696|FG001|Overall Study|Administrative|2|||
149749714|NCT00853905|540213697|FG000|Overall Study|Lost to Follow-up|1|||
149749715|NCT00853905|540213698|FG001|Overall Study|Lost to Follow-up|3|||
149749716|NCT00853905|540213697|FG000|Overall Study|Withdrawal by Subject|0|||
149749717|NCT00853905|540213698|FG001|Overall Study|Withdrawal by Subject|1|||
149749718|NCT00853905|540213697|FG000|Overall Study|never had surgery|1|||
149749719|NCT00853905|540213698|FG001|Overall Study|never had surgery|0|||
149749720|NCT00847561|540213703|FG000|Overall Study|Withdrawal by Subject|4|||
149749721|NCT00847561|540213704|FG001|Overall Study|Withdrawal by Subject|3|||
149749722|NCT00847561|540213703|FG000|Overall Study|Unable to schedule|9|||
149749723|NCT00847561|540213704|FG001|Overall Study|Unable to schedule|1|||
149749724|NCT02053246|540213706|FG000|Overall Study|Withdrawal by Subject|3|||
149749725|NCT02053246|540213706|FG000|Overall Study|Physician Decision|1|||
149749726|NCT02369510|540213709|FG000|Overall Study|Spilled Medication|1|||
149749727|NCT02369510|540213710|FG001|Overall Study|Spilled Medication|2|||
149749728|NCT02369510|540213711|FG002|Overall Study|Spilled Medication|1|||
149749729|NCT02369510|540213709|FG000|Overall Study|Epidural Activation|1|||
149749730|NCT02369510|540213710|FG001|Overall Study|Epidural Activation|1|||
149749731|NCT02369510|540213711|FG002|Overall Study|Epidural Activation|5|||
149749732|NCT04285723|540213718|FG000|Overall Study|Subject decision|1|||
149749733|NCT04285723|540213719|FG001|Overall Study|Subject decision|2|||
149749734|NCT04285723|540213718|FG000|Overall Study|Physician Decision|1|||
149749735|NCT04285723|540213719|FG001|Overall Study|Physician Decision|0|||
149749736|NCT04285723|540213718|FG000|Overall Study|No efficiency|1|||
149749737|NCT04285723|540213719|FG001|Overall Study|No efficiency|0|||
149749738|NCT03067311|540213720|FG000|Overall Study|Lost to Follow-up|1|||
149749739|NCT03067311|540213721|FG001|Overall Study|Lost to Follow-up|1|||
149749740|NCT03067311|540213720|FG000|Overall Study|Moved away|1|||
149749741|NCT03067311|540213721|FG001|Overall Study|Moved away|1|||
149749742|NCT02903511|540213722|FG000|Overall Study|Withdrawal by Subject|1|||
149749743|NCT02903511|540213723|FG001|Overall Study|Withdrawal by Subject|0|||
149749744|NCT02903511|540213722|FG000|Overall Study|Lost to Follow-up|3|||
149749745|NCT02903511|540213723|FG001|Overall Study|Lost to Follow-up|2|||
149749746|NCT00907738|540213724|FG000|Overall Study|Adverse Event|2|||
149749747|NCT00907738|540213725|FG001|Overall Study|Adverse Event|0|||
149749748|NCT00907738|540213726|FG002|Overall Study|Adverse Event|1|||
149749749|NCT00907738|540213727|FG003|Overall Study|Adverse Event|0|||
149749750|NCT00907738|540213728|FG004|Overall Study|Adverse Event|0|||
149749751|NCT00907738|540213724|FG000|Overall Study|not specified or withdrew consent|3|||
149749752|NCT00907738|540213725|FG001|Overall Study|not specified or withdrew consent|0|||
149749753|NCT00907738|540213726|FG002|Overall Study|not specified or withdrew consent|0|||
149749754|NCT00907738|540213727|FG003|Overall Study|not specified or withdrew consent|0|||
149749755|NCT00907738|540213728|FG004|Overall Study|not specified or withdrew consent|0|||
149749756|NCT00907738|540213724|FG000|Overall Study|Disease progression|8|||
149749757|NCT00907738|540213725|FG001|Overall Study|Disease progression|1|||
149749758|NCT00907738|540213726|FG002|Overall Study|Disease progression|6|||
149749759|NCT00907738|540213727|FG003|Overall Study|Disease progression|4|||
149749760|NCT00907738|540213728|FG004|Overall Study|Disease progression|2|||
149749761|NCT05363293|540213729|FG000|Overall Study|Withdrawal by Subject|1|||
149749762|NCT05363293|540213730|FG001|Overall Study|Withdrawal by Subject|0|||
149749763|NCT05363293|540213731|FG002|Overall Study|Withdrawal by Subject|0|||
149749764|NCT05363293|540213732|FG003|Overall Study|Withdrawal by Subject|0|||
149749765|NCT05363293|540213733|FG004|Overall Study|Withdrawal by Subject|0|||
149749766|NCT05363293|540213734|FG005|Overall Study|Withdrawal by Subject|0|||
149749767|NCT05363293|540213735|FG006|Overall Study|Withdrawal by Subject|0|||
149749768|NCT05363293|540213736|FG007|Overall Study|Withdrawal by Subject|0|||
149749769|NCT05363293|540213737|FG008|Overall Study|Withdrawal by Subject|0|||
149749770|NCT05363293|540213738|FG009|Overall Study|Withdrawal by Subject|0|||
149749771|NCT00375934|540215230|FG000|Overall Study|Adverse Event|1|||
149749772|NCT00375934|540215231|FG001|Overall Study|Adverse Event|1|||
149749773|NCT00375934|540215230|FG000|Overall Study|Withdrawal by Subject|2|||
149749774|NCT00375934|540215231|FG001|Overall Study|Withdrawal by Subject|2|||
149749775|NCT00375934|540215230|FG000|Overall Study|Lack of Efficacy|0|||
149749776|NCT00375934|540215231|FG001|Overall Study|Lack of Efficacy|2|||
149749777|NCT00375934|540215230|FG000|Overall Study|Physician Decision|0|||
149749778|NCT00375934|540215231|FG001|Overall Study|Physician Decision|1|||
149749779|NCT03191396|540215233|FG000|Overall Study|Lost to Follow-up|0|||
149749780|NCT03191396|540215234|FG001|Overall Study|Lost to Follow-up|3|||
149749781|NCT03191396|540215233|FG000|Overall Study|Withdrawal by Subject|3|||
149749782|NCT03191396|540215234|FG001|Overall Study|Withdrawal by Subject|2|||
149749783|NCT05094154|540215237|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
149749784|NCT05094154|540215238|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
149749785|NCT05094154|540215237|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
149749786|NCT05094154|540215238|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
149749787|NCT00893113|540215245|FG000|Overall Study|Lost to Follow-up|4|||
149749788|NCT00893113|540215246|FG001|Overall Study|Lost to Follow-up|8|||
149749789|NCT00893113|540215245|FG000|Overall Study|Early Termination|1|||
149749790|NCT00893113|540215246|FG001|Overall Study|Early Termination|1|||
149749791|NCT00893113|540215245|FG000|Overall Study|Withdrew Consent|8|||
149749792|NCT00893113|540215246|FG001|Overall Study|Withdrew Consent|7|||
149749793|NCT02100657|540215247|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
149749794|NCT02100657|540215248|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
149749795|NCT02100657|540215249|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
149749796|NCT02100657|540215247|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
149749797|NCT02100657|540215248|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
149749798|NCT02100657|540215249|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
149749799|NCT02100657|540215247|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
149749800|NCT02100657|540215248|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
149749801|NCT02100657|540215249|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
149749802|NCT02100657|540215247|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
149749803|NCT02100657|540215248|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
149749804|NCT02100657|540215249|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
149749805|NCT02100657|540215247|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
149749806|NCT02100657|540215248|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
149749807|NCT02100657|540215249|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
149749808|NCT02100657|540215247|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
149749809|NCT02100657|540215248|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
149749810|NCT02100657|540215249|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
149749811|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
149749812|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
149749813|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
149749814|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Death|0|||
149749815|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Death|0|||
149749816|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Death|1|||
149749817|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
149749818|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
149749819|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
149749820|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
149749821|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
149749822|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
149749823|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
149749824|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
149749825|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
149749826|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
149749827|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
149749828|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
149749829|NCT02100657|540215247|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
149749830|NCT02100657|540215248|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
149749831|NCT02100657|540215249|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
149749832|NCT02531035|540215252|FG000|Overall Study|Death|0|||
149749833|NCT02531035|540215253|FG001|Overall Study|Death|1|||
149749834|NCT02531035|540215252|FG000|Overall Study|Protocol Violation|1|||
149749835|NCT02531035|540215253|FG001|Overall Study|Protocol Violation|1|||
149749836|NCT02531035|540215252|FG000|Overall Study|Noncompliance with study drug|8|||
149749837|NCT02531035|540215253|FG001|Overall Study|Noncompliance with study drug|3|||
149749838|NCT02531035|540215252|FG000|Overall Study|Physician Decision|1|||
149749839|NCT02531035|540215253|FG001|Overall Study|Physician Decision|0|||
149749840|NCT02531035|540215252|FG000|Overall Study|Adverse Event|16|||
149749841|NCT02531035|540215253|FG001|Overall Study|Adverse Event|45|||
149749842|NCT02531035|540215252|FG000|Overall Study|Other|3|||
149749843|NCT02531035|540215253|FG001|Overall Study|Other|2|||
149749844|NCT02531035|540215252|FG000|Overall Study|Withdrawal by Subject|42|||
149749845|NCT02531035|540215253|FG001|Overall Study|Withdrawal by Subject|32|||
149749846|NCT02531035|540215252|FG000|Overall Study|Lost to Follow-up|8|||
149749847|NCT02531035|540215253|FG001|Overall Study|Lost to Follow-up|10|||
149749848|NCT02531035|540215252|FG000|Overall Study|Randomized, not treated|2|||
149749849|NCT02531035|540215253|FG001|Overall Study|Randomized, not treated|1|||
149749850|NCT03270085|540215262|FG000|Overall Study|Withdrawal by Subject|1|||
149749851|NCT03270085|540215263|FG001|Overall Study|Withdrawal by Subject|0|||
149749852|NCT03692910|540215265|FG000|Overall Study|Lost to Follow-up|4|||
149749853|NCT03692910|540215266|FG001|Overall Study|Lost to Follow-up|0|||
149749854|NCT03692910|540215267|FG002|Overall Study|Lost to Follow-up|0|||
149749855|NCT03692910|540215265|FG000|Overall Study|Withdrawal by Subject|2|||
149749856|NCT03692910|540215266|FG001|Overall Study|Withdrawal by Subject|0|||
149749857|NCT03692910|540215267|FG002|Overall Study|Withdrawal by Subject|0|||
149749858|NCT00151411|540215270|FG000|Overall Study|Lost to Follow-up|15|||
149749859|NCT00151411|540215271|FG001|Overall Study|Lost to Follow-up|19|||
149749860|NCT00151411|540215270|FG000|Overall Study|Withdrawal by Subject|12|||
149749861|NCT00151411|540215271|FG001|Overall Study|Withdrawal by Subject|20|||
149749862|NCT00151411|540215270|FG000|Overall Study|Adverse Event|6|||
149749863|NCT00151411|540215271|FG001|Overall Study|Adverse Event|0|||
149749864|NCT00151411|540215270|FG000|Overall Study|Pregnancy|0|||
149749865|NCT00151411|540215271|FG001|Overall Study|Pregnancy|4|||
149749866|NCT01283581|540215272|FG000|Overall Study|Lost to Follow-up|8|||
149749867|NCT01283581|540215273|FG001|Overall Study|Lost to Follow-up|6|||
149749868|NCT01283581|540215274|FG002|Overall Study|Lost to Follow-up|8|||
149749869|NCT01283581|540215272|FG000|Overall Study|Withdrawal by Subject|2|||
149749870|NCT01283581|540215273|FG001|Overall Study|Withdrawal by Subject|5|||
149749871|NCT01283581|540215274|FG002|Overall Study|Withdrawal by Subject|2|||
149749872|NCT01283581|540215272|FG000|Overall Study|Adverse Event|1|||
149749873|NCT01283581|540215273|FG001|Overall Study|Adverse Event|1|||
149749874|NCT01283581|540215274|FG002|Overall Study|Adverse Event|4|||
149749875|NCT01283581|540215272|FG000|Overall Study|Physician Decision|0|||
149749876|NCT01283581|540215273|FG001|Overall Study|Physician Decision|1|||
149749877|NCT01283581|540215274|FG002|Overall Study|Physician Decision|2|||
149749878|NCT01283581|540215272|FG000|Overall Study|Protocol Violation|0|||
149749879|NCT01283581|540215273|FG001|Overall Study|Protocol Violation|1|||
149749880|NCT01283581|540215274|FG002|Overall Study|Protocol Violation|2|||
149749881|NCT01283581|540215272|FG000|Overall Study|Noncompliance|1|||
149749882|NCT01283581|540215273|FG001|Overall Study|Noncompliance|0|||
149749883|NCT01283581|540215274|FG002|Overall Study|Noncompliance|0|||
149749884|NCT01283581|540215272|FG000|Overall Study|Investigator unblinded|0|||
149749885|NCT01283581|540215273|FG001|Overall Study|Investigator unblinded|0|||
149749886|NCT01283581|540215274|FG002|Overall Study|Investigator unblinded|1|||
149749887|NCT01283581|540215272|FG000|Overall Study|"Early termination"|0|||
149749888|NCT01283581|540215273|FG001|Overall Study|"Early termination"|0|||
149749889|NCT01283581|540215274|FG002|Overall Study|"Early termination"|1|||
149749890|NCT00486226|540215275|FG000|Overall Study|Death|3|||
149749891|NCT00486226|540215275|FG000|Overall Study|Adverse Event|1|||
149749892|NCT00486226|540215275|FG000|Overall Study|Withdrawal by Subject|1|||
149749893|NCT00486226|540215275|FG000|Overall Study|Lost to Follow-up|8|||
149749894|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
149749895|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
149749896|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
149749897|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
149749898|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
149749899|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
149749900|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
149749901|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
149749902|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
149749903|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
149749904|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
149749905|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
149749906|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
149749907|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
149749908|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
149749909|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
149749910|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
149749911|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
149749912|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
149749913|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
149749914|NCT01259492|540215276|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
149749915|NCT01259492|540215277|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
149749916|NCT01259492|540215278|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
149749917|NCT01259492|540215279|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
149749918|NCT01259492|540215276|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
149749919|NCT01259492|540215277|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
149749920|NCT01259492|540215278|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
149749921|NCT01259492|540215279|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
149749922|NCT01259492|540215276|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
149749923|NCT01259492|540215277|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
149749924|NCT01259492|540215278|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
149749925|NCT01259492|540215279|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
149749926|NCT01259492|540215276|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
149749927|NCT01259492|540215277|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
149749928|NCT01259492|540215278|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
149749929|NCT01259492|540215279|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
149749930|NCT01259492|540215276|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
149749931|NCT01259492|540215277|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
149749932|NCT01259492|540215278|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
149749933|NCT01259492|540215279|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
149749934|NCT01259492|540215276|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
149749935|NCT01259492|540215277|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
149749936|NCT01259492|540215278|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
149749937|NCT01259492|540215279|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
149749938|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
149749939|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
149749940|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
149749941|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
149749942|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149749943|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149749944|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149749945|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
149749946|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149749947|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149749948|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
149749949|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149749950|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
149749951|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
149749952|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
149749953|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
149749954|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
149749955|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149749956|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149749957|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149749958|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
149749959|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
149749960|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
149749961|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
149749962|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
149749963|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
149749964|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
149749965|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
149749966|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149749967|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149749968|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
149749969|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149749970|NCT01259492|540215276|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
149749971|NCT01259492|540215277|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
149749972|NCT01259492|540215278|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
149749973|NCT01259492|540215279|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
149749974|NCT03846947|540215282|FG000|Overall Study|technical issues with imaging sequence|2|||
149749975|NCT00634543|540215288|FG000|Overall Study|Other|1|||
149749976|NCT00634543|540215289|FG001|Overall Study|Other|2|||
149749977|NCT00634543|540215288|FG000|Overall Study|Protocol Violation|3|||
149749978|NCT00634543|540215289|FG001|Overall Study|Protocol Violation|3|||
149749979|NCT00634543|540215288|FG000|Overall Study|Adverse Event|11|||
149749980|NCT00634543|540215289|FG001|Overall Study|Adverse Event|11|||
149749981|NCT00634543|540215288|FG000|Overall Study|Withdrawal by Subject|4|||
149749982|NCT00634543|540215289|FG001|Overall Study|Withdrawal by Subject|4|||
149749983|NCT00634543|540215288|FG000|Overall Study|Lost to Follow-up|0|||
149749984|NCT00634543|540215289|FG001|Overall Study|Lost to Follow-up|1|||
149749985|NCT00474630|540215290|FG000|Overall Study|Adverse Event|98|||
149749986|NCT00474630|540215291|FG001|Overall Study|Adverse Event|26|||
149749987|NCT00474630|540215290|FG000|Overall Study|Lost to Follow-up|22|||
149749988|NCT00474630|540215291|FG001|Overall Study|Lost to Follow-up|15|||
149749989|NCT00474630|540215290|FG000|Overall Study|Withdrawal by Subject|21|||
149749990|NCT00474630|540215291|FG001|Overall Study|Withdrawal by Subject|15|||
149749991|NCT00474630|540215290|FG000|Overall Study|Protocol Violation|3|||
149749992|NCT00474630|540215291|FG001|Overall Study|Protocol Violation|4|||
149749993|NCT00474630|540215290|FG000|Overall Study|Lack of Efficacy|5|||
149749994|NCT00474630|540215291|FG001|Overall Study|Lack of Efficacy|6|||
149749995|NCT00474630|540215290|FG000|Overall Study|Drug noncompliance, other|11|||
149749996|NCT00474630|540215291|FG001|Overall Study|Drug noncompliance, other|4|||
149749997|NCT03515538|540215292|FG000|Overall Study|Lack of Efficacy|2|||
149749998|NCT03515538|540215293|FG001|Overall Study|Lack of Efficacy|0|||
149749999|NCT03515538|540215294|FG002|Overall Study|Lack of Efficacy|2|||
149750000|NCT03515538|540215295|FG003|Overall Study|Lack of Efficacy|0|||
149750001|NCT03515538|540215292|FG000|Overall Study|Death|0|||
149750002|NCT03515538|540215293|FG001|Overall Study|Death|0|||
149750003|NCT03515538|540215294|FG002|Overall Study|Death|1|||
149750004|NCT03515538|540215295|FG003|Overall Study|Death|0|||
149750005|NCT03515538|540215292|FG000|Overall Study|Protocol Violation|0|||
149750006|NCT03515538|540215293|FG001|Overall Study|Protocol Violation|0|||
149750007|NCT03515538|540215294|FG002|Overall Study|Protocol Violation|0|||
149750008|NCT03515538|540215295|FG003|Overall Study|Protocol Violation|1|||
149750009|NCT03515538|540215292|FG000|Overall Study|Screen failure (baseline dropout)|0|||
149750010|NCT03515538|540215293|FG001|Overall Study|Screen failure (baseline dropout)|1|||
149750011|NCT03515538|540215294|FG002|Overall Study|Screen failure (baseline dropout)|0|||
149750012|NCT03515538|540215295|FG003|Overall Study|Screen failure (baseline dropout)|0|||
149750013|NCT03515538|540215292|FG000|Overall Study|Withdrawal by Subject|2|||
149750014|NCT03515538|540215293|FG001|Overall Study|Withdrawal by Subject|2|||
149750015|NCT03515538|540215294|FG002|Overall Study|Withdrawal by Subject|1|||
149750016|NCT03515538|540215295|FG003|Overall Study|Withdrawal by Subject|3|||
149750017|NCT03515538|540215292|FG000|Overall Study|Physician Decision|1|||
149750018|NCT03515538|540215293|FG001|Overall Study|Physician Decision|0|||
149750019|NCT03515538|540215294|FG002|Overall Study|Physician Decision|0|||
149750020|NCT03515538|540215295|FG003|Overall Study|Physician Decision|1|||
149750021|NCT01736683|540215303|FG000|Overall Study|Disease Relapse|0|||
149750022|NCT01736683|540215304|FG001|Overall Study|Disease Relapse|0|||
149750023|NCT01736683|540215305|FG002|Overall Study|Disease Relapse|2|||
149750024|NCT01736683|540215306|FG003|Overall Study|Disease Relapse|1|||
149750025|NCT01736683|540215307|FG004|Overall Study|Disease Relapse|0|||
149750026|NCT01736683|540215303|FG000|Overall Study|Adverse Event|0|||
149750027|NCT01736683|540215304|FG001|Overall Study|Adverse Event|2|||
149750028|NCT01736683|540215305|FG002|Overall Study|Adverse Event|2|||
149750029|NCT01736683|540215306|FG003|Overall Study|Adverse Event|3|||
149750030|NCT01736683|540215307|FG004|Overall Study|Adverse Event|2|||
149750031|NCT01736683|540215303|FG000|Overall Study|Withdrawal by Subject|0|||
149750032|NCT01736683|540215304|FG001|Overall Study|Withdrawal by Subject|0|||
149750033|NCT01736683|540215305|FG002|Overall Study|Withdrawal by Subject|3|||
149750034|NCT01736683|540215306|FG003|Overall Study|Withdrawal by Subject|1|||
149750035|NCT01736683|540215307|FG004|Overall Study|Withdrawal by Subject|1|||
149750036|NCT01736683|540215303|FG000|Overall Study|Lack of Therapeutic Effect|7|||
149750037|NCT01736683|540215304|FG001|Overall Study|Lack of Therapeutic Effect|4|||
149750038|NCT01736683|540215305|FG002|Overall Study|Lack of Therapeutic Effect|13|||
149750039|NCT01736683|540215306|FG003|Overall Study|Lack of Therapeutic Effect|20|||
149750040|NCT01736683|540215307|FG004|Overall Study|Lack of Therapeutic Effect|1|||
149750041|NCT01736683|540215303|FG000|Overall Study|Progressive Disease|0|||
149750042|NCT01736683|540215304|FG001|Overall Study|Progressive Disease|0|||
149750043|NCT01736683|540215305|FG002|Overall Study|Progressive Disease|0|||
149750044|NCT01736683|540215306|FG003|Overall Study|Progressive Disease|1|||
149750045|NCT01736683|540215307|FG004|Overall Study|Progressive Disease|0|||
149750046|NCT01736683|540215303|FG000|Overall Study|Other|0|||
149750047|NCT01736683|540215304|FG001|Overall Study|Other|0|||
149750048|NCT01736683|540215305|FG002|Overall Study|Other|1|||
149750049|NCT01736683|540215306|FG003|Overall Study|Other|9|||
149750050|NCT01736683|540215307|FG004|Overall Study|Other|1|||
149750051|NCT03069690|540215309|FG000|Pregnancy Intervention|Pregnancy loss|9|||
149750052|NCT03069690|540215310|FG001|Pregnancy Intervention|Pregnancy loss|4|||
149750053|NCT03069690|540215311|FG002|Pregnancy Intervention|Pregnancy loss|0|||
149750054|NCT03069690|540215312|FG003|Pregnancy Intervention|Pregnancy loss|0|||
149750055|NCT03069690|540215313|FG004|Pregnancy Intervention|Pregnancy loss|0|||
149750056|NCT03069690|540215314|FG005|Pregnancy Intervention|Pregnancy loss|0|||
149750057|NCT03069690|540215309|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
149750058|NCT03069690|540215310|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
149750059|NCT03069690|540215311|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
149750060|NCT03069690|540215312|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
149750061|NCT03069690|540215313|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
149750062|NCT03069690|540215314|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
149750063|NCT03069690|540215309|FG000|Postpartum Intervention|Lost to Follow-up|0|||
149750064|NCT03069690|540215310|FG001|Postpartum Intervention|Lost to Follow-up|0|||
149750065|NCT03069690|540215311|FG002|Postpartum Intervention|Lost to Follow-up|5|||
149750066|NCT03069690|540215312|FG003|Postpartum Intervention|Lost to Follow-up|5|||
149750067|NCT03069690|540215313|FG004|Postpartum Intervention|Lost to Follow-up|2|||
149750068|NCT03069690|540215314|FG005|Postpartum Intervention|Lost to Follow-up|4|||
149750069|NCT02564120|540215315|FG000|Overall Study|Did not return release forms|160|||
149750070|NCT02564120|540215315|FG000|Overall Study|Death|58|||
149750071|NCT02564120|540215315|FG000|Overall Study|Withdrawal by Subject|204|||
149750072|NCT02564120|540215315|FG000|Overall Study|Other medical condition|24|||
149750073|NCT00891657|540215318|FG000|Overall Study|Withdrawal by Subject|1|||
149750074|NCT00891657|540215319|FG001|Overall Study|Withdrawal by Subject|1|||
149750075|NCT00670111|540215323|FG000|Enrollment to One Month|Testing Failure|0|||
149750076|NCT00670111|540215324|FG001|Enrollment to One Month|Testing Failure|0|||
149750077|NCT00670111|540215325|FG002|Enrollment to One Month|Testing Failure|13|||
149750078|NCT00670111|540215323|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
149750079|NCT00670111|540215324|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
149750080|NCT00670111|540215325|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
149750081|NCT00670111|540215323|FG000|Enrollment to One Month|Physician Decision|1|||
149750082|NCT00670111|540215324|FG001|Enrollment to One Month|Physician Decision|0|||
149750083|NCT00670111|540215325|FG002|Enrollment to One Month|Physician Decision|0|||
149750084|NCT00844883|540215326|FG000|Overall Study|Bridged to liver transplant|3|||
149750085|NCT00844883|540215326|FG000|Overall Study|Bridged to resection|1|||
149750086|NCT02623361|540215327|FG000|Overall Study|Protocol Violation|0|||
149750087|NCT02623361|540215328|FG001|Overall Study|Protocol Violation|1|||
149750088|NCT02623361|540215327|FG000|Overall Study|Withdrawal by Subject|0|||
149750089|NCT02623361|540215328|FG001|Overall Study|Withdrawal by Subject|1|||
149750090|NCT00537823|540215333|FG000|Overall Study|Adverse Event|2|||
149750091|NCT00537823|540215334|FG001|Overall Study|Adverse Event|0|||
149750092|NCT02873221|540215335|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
149750093|NCT02873221|540215336|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
149750094|NCT02873221|540215337|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
149750095|NCT02873221|540215335|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
149750096|NCT02873221|540215336|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
149750097|NCT02873221|540215337|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
149750098|NCT02873221|540215335|FG000|Treatment Period|Protocol Violation|2|||
149750099|NCT02873221|540215336|FG001|Treatment Period|Protocol Violation|5|||
149750100|NCT02873221|540215337|FG002|Treatment Period|Protocol Violation|8|||
149750101|NCT02873221|540215335|FG000|Treatment Period|Pregnancy|4|||
149750102|NCT02873221|540215336|FG001|Treatment Period|Pregnancy|6|||
149750103|NCT02873221|540215337|FG002|Treatment Period|Pregnancy|3|||
149750104|NCT02873221|540215335|FG000|Treatment Period|Lack of Qualifying Event|0|||
149750105|NCT02873221|540215336|FG001|Treatment Period|Lack of Qualifying Event|3|||
149750106|NCT02873221|540215337|FG002|Treatment Period|Lack of Qualifying Event|1|||
149750107|NCT02873221|540215335|FG000|Treatment Period|Withdrawal of Consent|52|||
149750108|NCT02873221|540215336|FG001|Treatment Period|Withdrawal of Consent|51|||
149750109|NCT02873221|540215337|FG002|Treatment Period|Withdrawal of Consent|41|||
149750110|NCT02873221|540215335|FG000|Treatment Period|Lack of Efficacy|0|||
149750111|NCT02873221|540215336|FG001|Treatment Period|Lack of Efficacy|17|||
149750112|NCT02873221|540215337|FG002|Treatment Period|Lack of Efficacy|12|||
149750113|NCT02873221|540215335|FG000|Treatment Period|Adverse Event|4|||
149750114|NCT02873221|540215336|FG001|Treatment Period|Adverse Event|9|||
149750115|NCT02873221|540215337|FG002|Treatment Period|Adverse Event|11|||
149750116|NCT02873221|540215335|FG000|Treatment Period|Lost to Follow-up|26|||
149750117|NCT02873221|540215336|FG001|Treatment Period|Lost to Follow-up|30|||
149750118|NCT02873221|540215337|FG002|Treatment Period|Lost to Follow-up|26|||
149750119|NCT02873221|540215335|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
149750120|NCT02873221|540215336|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
149750121|NCT02873221|540215337|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
149750122|NCT02873221|540215335|FG000|Safety Follow-up Period|Protocol Violation|0|||
149750123|NCT02873221|540215336|FG001|Safety Follow-up Period|Protocol Violation|0|||
149750124|NCT02873221|540215337|FG002|Safety Follow-up Period|Protocol Violation|1|||
149750125|NCT02873221|540215335|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
149750126|NCT02873221|540215336|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
149750127|NCT02873221|540215337|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
149750128|NCT02873221|540215335|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
149750129|NCT02873221|540215336|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
149750130|NCT02873221|540215337|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
149750131|NCT00909090|540215340|FG000|Overall Study|Lost to Follow-up|17|||
149750132|NCT00909090|540215341|FG001|Overall Study|Lost to Follow-up|17|||
149750133|NCT01749735|540215343|FG000|Overall Study|Withdrawal by Subject|1|||
149750134|NCT01749735|540215344|FG001|Overall Study|Withdrawal by Subject|0|||
149750135|NCT02926573|540215345|FG000|Overall Study|Nausea|1|||
149750136|NCT02926573|540215346|FG001|Overall Study|Nausea|0|||
149750137|NCT02926573|540215345|FG000|Overall Study|Remain intubated|2|||
149750138|NCT02926573|540215346|FG001|Overall Study|Remain intubated|2|||
149750139|NCT02926573|540215345|FG000|Overall Study|Change in surgery plan|3|||
149750140|NCT02926573|540215346|FG001|Overall Study|Change in surgery plan|1|||
149750141|NCT02926573|540215345|FG000|Overall Study|Change to outpatient status|5|||
149750142|NCT02926573|540215346|FG001|Overall Study|Change to outpatient status|1|||
149750143|NCT02926573|540215345|FG000|Overall Study|Withdrawal by Subject|0|||
149750144|NCT02926573|540215346|FG001|Overall Study|Withdrawal by Subject|2|||
149750145|NCT02926573|540215345|FG000|Overall Study|Return to operating room|0|||
149750146|NCT02926573|540215346|FG001|Overall Study|Return to operating room|2|||
149750147|NCT02926573|540215345|FG000|Overall Study|Delirium|0|||
149750148|NCT02926573|540215346|FG001|Overall Study|Delirium|1|||
149750149|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
149750150|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
149750151|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149750152|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
149750153|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149750154|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149750155|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
149750156|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
149750157|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149750158|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149750159|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149750160|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149750161|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
149750162|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
149750163|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
149750164|NCT00611455|540215349|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
149750165|NCT00611455|540215350|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
149750166|NCT00611455|540215351|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
149750167|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149750168|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
149750169|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149750170|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149750171|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
149750172|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149750173|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149750174|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
149750175|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149750176|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149750177|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
149750178|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149750179|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149750180|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
149750181|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149750182|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
149750183|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
149750184|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
149750185|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149750186|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
149750187|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149750188|NCT00611455|540215349|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149750189|NCT00611455|540215350|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
149750190|NCT00611455|540215351|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149750191|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
149750192|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
149750193|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
149750194|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
149750195|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
149750196|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
149750197|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
149750198|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
149750199|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
149750200|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
149750201|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
149750202|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
149750203|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
149750204|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
149750205|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
149750206|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
149750207|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
149750208|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
149750209|NCT00611455|540215349|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
149750210|NCT00611455|540215350|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
149750211|NCT00611455|540215351|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
149750212|NCT04601272|540215352|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
149750213|NCT04601272|540215353|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
149750214|NCT04601272|540215354|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
149750215|NCT00414440|540215357|FG000|Core Period|Withdrawal by Subject|70|||
149750216|NCT00414440|540215358|FG001|Core Period|Withdrawal by Subject|32|||
149750217|NCT00414440|540215357|FG000|Extension Period|Lost to Follow-up|44|||
149750218|NCT00414440|540215358|FG001|Extension Period|Lost to Follow-up|52|||
149750219|NCT00414440|540215357|FG000|Extension Period|Did not consent to continue follow up|61|||
149750220|NCT00414440|540215358|FG001|Extension Period|Did not consent to continue follow up|54|||
149750221|NCT00414440|540215357|FG000|Extension Period|Other|1|||
149750222|NCT00414440|540215358|FG001|Extension Period|Other|1|||
149750223|NCT00414440|540215357|FG000|Extension Period|Administrative|16|||
149750224|NCT00414440|540215358|FG001|Extension Period|Administrative|16|||
149750225|NCT00414440|540215357|FG000|Extension Period|Death|1|||
149750226|NCT00414440|540215358|FG001|Extension Period|Death|2|||
149750227|NCT00414440|540215357|FG000|Extension Period|Withdrawal by Subject|9|||
149750228|NCT00414440|540215358|FG001|Extension Period|Withdrawal by Subject|7|||
149750229|NCT00414440|540215357|FG000|Extension Period|Not included in follow up period|18|||
149750230|NCT00414440|540215358|FG001|Extension Period|Not included in follow up period|8|||
149750231|NCT02732912|540215359|FG000|Overall Study|Discharged before night|2|||
149750232|NCT02732912|540215360|FG001|Overall Study|Discharged before night|6|||
149750233|NCT02732912|540215359|FG000|Overall Study|Incomplete completion of questionnaire|2|||
149750234|NCT02732912|540215360|FG001|Overall Study|Incomplete completion of questionnaire|3|||
149750235|NCT02732912|540215359|FG000|Overall Study|No outcome; discharged or refused|6|||
149750236|NCT02732912|540215360|FG001|Overall Study|No outcome; discharged or refused|9|||
149750237|NCT01873742|540215361|FG000|Overall Study|Lost to Follow-up|68|||
149750238|NCT01873742|540215362|FG001|Overall Study|Lost to Follow-up|76|||
149750239|NCT01707147|540215365|FG000|Overall Study|Administered Trajenta prior to contract|5|||
149750240|NCT01707147|540215365|FG000|Overall Study|Patients who have not taken Trajenta|1|||
149750241|NCT01707147|540215365|FG000|Overall Study|Follow-up failure|17|||
149750242|NCT01707147|540215365|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
149750243|NCT02489630|540215368|FG000|Overall Study|Oversedation|1|||
149750244|NCT02489630|540215369|FG001|Overall Study|Oversedation|1|||
149750245|NCT02489630|540215368|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
149750246|NCT02489630|540215369|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
149750247|NCT01056523|540215370|FG000|Overall Study|Death|1|||
149750248|NCT01056523|540215371|FG001|Overall Study|Death|0|||
149750249|NCT01056523|540215372|FG002|Overall Study|Death|2|||
149750250|NCT01056523|540215373|FG003|Overall Study|Death|3|||
149750251|NCT01056523|540215374|FG004|Overall Study|Death|0|||
149750252|NCT01056523|540215375|FG005|Overall Study|Death|0|||
149750253|NCT01056523|540215376|FG006|Overall Study|Death|1|||
149750254|NCT03429556|540215377|FG000|Overall Study|Lost to Follow-up|0|||
149750255|NCT03429556|540215378|FG001|Overall Study|Lost to Follow-up|1|||
149750256|NCT03429556|540215379|FG002|Overall Study|Lost to Follow-up|0|||
149750257|NCT03429556|540215380|FG003|Overall Study|Lost to Follow-up|0|||
149750258|NCT02050048|540215387|FG000|Overall Study|Lost to Follow-up|0|||
149750259|NCT02050048|540215388|FG001|Overall Study|Lost to Follow-up|1|||
149750260|NCT02050048|540215387|FG000|Overall Study|Death|1|||
149750261|NCT02050048|540215388|FG001|Overall Study|Death|0|||
149750262|NCT02050048|540215387|FG000|Overall Study|Ineligible after ERCP|4|||
149750263|NCT02050048|540215388|FG001|Overall Study|Ineligible after ERCP|1|||
149750264|NCT01589094|540215392|FG000|Overall Study|Did not receive treatment|2|||
149750265|NCT05243550|540217081|FG000|Overall Study|Ongoing in the Study|171|||
149750266|NCT05243550|540217081|FG000|Overall Study|Withdrawal by Subject|10|||
149750267|NCT05243550|540217081|FG000|Overall Study|Lost to Follow-up|7|||
149750268|NCT05243550|540217081|FG000|Overall Study|Adverse Event|3|||
149750269|NCT05243550|540217081|FG000|Overall Study|Noncompliance|1|||
149750270|NCT05243550|540217081|FG000|Overall Study|Physician Decision|1|||
149750271|NCT05243550|540217081|FG000|Overall Study|Other Reason|4|||
149750272|NCT01486316|540217082|FG000|Overall Study|Device explanted with/without re-implant|3|||
149750273|NCT01486316|540217083|FG001|Overall Study|Device explanted with/without re-implant|2|||
149750274|NCT01486316|540217084|FG002|Overall Study|Device explanted with/without re-implant|0|||
149750275|NCT01486316|540217085|FG003|Overall Study|Device explanted with/without re-implant|2|||
149750276|NCT01486316|540217082|FG000|Overall Study|Not meeting eligibility criteria|0|||
149750277|NCT01486316|540217083|FG001|Overall Study|Not meeting eligibility criteria|0|||
149750278|NCT01486316|540217084|FG002|Overall Study|Not meeting eligibility criteria|1|||
149750279|NCT01486316|540217085|FG003|Overall Study|Not meeting eligibility criteria|0|||
149750280|NCT01486316|540217082|FG000|Overall Study|Withdrawal by Subject|1|||
149750281|NCT01486316|540217083|FG001|Overall Study|Withdrawal by Subject|0|||
149750282|NCT01486316|540217084|FG002|Overall Study|Withdrawal by Subject|3|||
149750283|NCT01486316|540217085|FG003|Overall Study|Withdrawal by Subject|0|||
149750284|NCT01486316|540217082|FG000|Overall Study|Physician Decision|0|||
149750285|NCT01486316|540217083|FG001|Overall Study|Physician Decision|0|||
149750286|NCT01486316|540217084|FG002|Overall Study|Physician Decision|1|||
149750287|NCT01486316|540217085|FG003|Overall Study|Physician Decision|0|||
149750288|NCT01486316|540217082|FG000|Overall Study|Death|0|||
149750289|NCT01486316|540217083|FG001|Overall Study|Death|1|||
149750290|NCT01486316|540217084|FG002|Overall Study|Death|0|||
149750291|NCT01486316|540217085|FG003|Overall Study|Death|0|||
149750292|NCT01543490|540217089|FG000|Overall Study|Adverse Event|4|||
149750293|NCT01543490|540217090|FG001|Overall Study|Adverse Event|0|||
149750294|NCT01543490|540217089|FG000|Overall Study|Physician Decision|1|||
149750295|NCT01543490|540217090|FG001|Overall Study|Physician Decision|0|||
149750296|NCT01543490|540217089|FG000|Overall Study|Lack of Efficacy|3|||
149750297|NCT01543490|540217090|FG001|Overall Study|Lack of Efficacy|3|||
149750298|NCT01543490|540217089|FG000|Overall Study|Lost to Follow-up|5|||
149750299|NCT01543490|540217090|FG001|Overall Study|Lost to Follow-up|0|||
149750300|NCT01543490|540217089|FG000|Overall Study|Withdrawal by Subject|2|||
149750301|NCT01543490|540217090|FG001|Overall Study|Withdrawal by Subject|0|||
149750302|NCT01543490|540217089|FG000|Overall Study|Other-Various Administrative Reasons|1|||
149750303|NCT01543490|540217090|FG001|Overall Study|Other-Various Administrative Reasons|2|||
149750304|NCT04168645|540217095|FG000|Overall Study|Lost to Follow-up|23|||
149750305|NCT04168645|540217096|FG001|Overall Study|Lost to Follow-up|28|||
149750306|NCT04168645|540217097|FG002|Overall Study|Lost to Follow-up|15|||
149750307|NCT04168645|540217098|FG003|Overall Study|Lost to Follow-up|12|||
149750308|NCT04168645|540217095|FG000|Overall Study|Death|1|||
149750309|NCT04168645|540217096|FG001|Overall Study|Death|1|||
149750310|NCT04168645|540217097|FG002|Overall Study|Death|0|||
149750311|NCT04168645|540217098|FG003|Overall Study|Death|0|||
149750312|NCT04168645|540217095|FG000|Overall Study|Withdrawal by Subject|5|||
149750313|NCT04168645|540217096|FG001|Overall Study|Withdrawal by Subject|2|||
149750314|NCT04168645|540217097|FG002|Overall Study|Withdrawal by Subject|2|||
149750315|NCT04168645|540217098|FG003|Overall Study|Withdrawal by Subject|2|||
149750316|NCT04168645|540217095|FG000|Overall Study|Administrative Withdrawal|3|||
149750317|NCT04168645|540217096|FG001|Overall Study|Administrative Withdrawal|1|||
149750318|NCT04168645|540217097|FG002|Overall Study|Administrative Withdrawal|1|||
149750319|NCT04168645|540217098|FG003|Overall Study|Administrative Withdrawal|3|||
149750320|NCT02400346|540217099|FG000|Overall Study|Adverse Event|24|||
149750321|NCT02400346|540217099|FG000|Overall Study|Lack of Efficacy|9|||
149750322|NCT02400346|540217099|FG000|Overall Study|Non-compliance with IMP|1|||
149750323|NCT02400346|540217099|FG000|Overall Study|Withdrawal by Subject|7|||
149750324|NCT02400346|540217099|FG000|Overall Study|Administrative or other reason(s)|2|||
149750325|NCT02400346|540217099|FG000|Overall Study|Lost to Follow-up|1|||
149750326|NCT02114203|540217100|FG000|Overall Study|Adverse Event|0|||
149750327|NCT02114203|540217101|FG001|Overall Study|Adverse Event|1|||
149750328|NCT02114203|540217102|FG002|Overall Study|Adverse Event|0|||
149750329|NCT02114203|540217100|FG000|Overall Study|Withdrawal by Subject|0|||
149750330|NCT02114203|540217101|FG001|Overall Study|Withdrawal by Subject|1|||
149750331|NCT02114203|540217102|FG002|Overall Study|Withdrawal by Subject|0|||
149750332|NCT01518699|540217103|FG000|Period 2|Protocol Violation|1|||
149750333|NCT01518699|540217104|FG001|Period 2|Protocol Violation|1|||
149750334|NCT01518699|540217105|FG002|Period 2|Protocol Violation|0|||
149750335|NCT01518699|540217106|FG003|Period 2|Protocol Violation|0|||
149750336|NCT01518699|540217107|FG004|Period 2|Protocol Violation|0|||
149750337|NCT01518699|540217108|FG005|Period 2|Protocol Violation|0|||
149750338|NCT01518699|540217103|FG000|Period 2|Lost to Follow-up|0|||
149750339|NCT01518699|540217104|FG001|Period 2|Lost to Follow-up|1|||
149750340|NCT01518699|540217105|FG002|Period 2|Lost to Follow-up|0|||
149750341|NCT01518699|540217106|FG003|Period 2|Lost to Follow-up|0|||
149750342|NCT01518699|540217107|FG004|Period 2|Lost to Follow-up|0|||
149750343|NCT01518699|540217108|FG005|Period 2|Lost to Follow-up|0|||
149750344|NCT01518699|540217103|FG000|Period 2|Adverse Event|1|||
149750345|NCT01518699|540217104|FG001|Period 2|Adverse Event|0|||
149750346|NCT01518699|540217105|FG002|Period 2|Adverse Event|0|||
149750347|NCT01518699|540217106|FG003|Period 2|Adverse Event|0|||
149750348|NCT01518699|540217107|FG004|Period 2|Adverse Event|0|||
149750349|NCT01518699|540217108|FG005|Period 2|Adverse Event|0|||
149750350|NCT01981122|540217110|FG000|Overall Study|Withdrawal by Subject|0|||
149750351|NCT01981122|540217111|FG001|Overall Study|Withdrawal by Subject|2|||
149750352|NCT01981122|540217110|FG000|Overall Study|Protocol Violation|0|||
149750353|NCT01981122|540217111|FG001|Overall Study|Protocol Violation|1|||
149750354|NCT01981122|540217110|FG000|Overall Study|Lost to Follow-up|0|||
149750355|NCT01981122|540217111|FG001|Overall Study|Lost to Follow-up|1|||
149750356|NCT01981122|540217110|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
149750357|NCT01981122|540217111|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
149750358|NCT01981122|540217110|FG000|Overall Study|Death|14|||
149750359|NCT01981122|540217111|FG001|Overall Study|Death|15|||
149750360|NCT00500149|540217117|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
149750361|NCT00500149|540217118|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
149750362|NCT00500149|540217117|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
149750363|NCT00500149|540217118|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
149750364|NCT00500149|540217117|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
149750365|NCT00500149|540217118|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
149750366|NCT00500149|540217117|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
149750367|NCT00500149|540217118|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
149750368|NCT00500149|540217117|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
149750369|NCT00500149|540217118|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
149750370|NCT00500149|540217117|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
149750371|NCT00500149|540217118|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
149750372|NCT00500149|540217117|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
149750373|NCT00500149|540217118|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
149750374|NCT00521339|540217121|FG000|Treatment Phase|Adverse Event|2|||
149750375|NCT00521339|540217122|FG001|Treatment Phase|Adverse Event|0|||
149750376|NCT00521339|540217123|FG002|Treatment Phase|Adverse Event|0|||
149750377|NCT00521339|540217121|FG000|Treatment Phase|Intolerability to study drug|2|||
149750378|NCT00521339|540217122|FG001|Treatment Phase|Intolerability to study drug|0|||
149750379|NCT00521339|540217123|FG002|Treatment Phase|Intolerability to study drug|0|||
149750380|NCT00521339|540217121|FG000|Treatment Phase|Lack of Efficacy|3|||
149750381|NCT00521339|540217122|FG001|Treatment Phase|Lack of Efficacy|0|||
149750382|NCT00521339|540217123|FG002|Treatment Phase|Lack of Efficacy|0|||
149750383|NCT00521339|540217121|FG000|Treatment Phase|Withdrawal by Subject|3|||
149750384|NCT00521339|540217122|FG001|Treatment Phase|Withdrawal by Subject|0|||
149750385|NCT00521339|540217123|FG002|Treatment Phase|Withdrawal by Subject|0|||
149750386|NCT00521339|540217121|FG000|Treatment Phase|Lost to Follow-up|1|||
149750387|NCT00521339|540217122|FG001|Treatment Phase|Lost to Follow-up|0|||
149750388|NCT00521339|540217123|FG002|Treatment Phase|Lost to Follow-up|0|||
149750389|NCT00521339|540217121|FG000|Treatment Phase|Protocol Violation|1|||
149750390|NCT00521339|540217122|FG001|Treatment Phase|Protocol Violation|0|||
149750391|NCT00521339|540217123|FG002|Treatment Phase|Protocol Violation|0|||
149750392|NCT00521339|540217121|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
149750393|NCT00521339|540217122|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
149750394|NCT00521339|540217123|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
149750395|NCT00521339|540217121|FG000|Treatment Extension Phase|Death|0|||
149750396|NCT00521339|540217122|FG001|Treatment Extension Phase|Death|0|||
149750397|NCT00521339|540217123|FG002|Treatment Extension Phase|Death|1|||
149750398|NCT00089843|540217124|FG000|Overall Study|Withdrawal by Subject|1|||
149750399|NCT00089843|540217125|FG001|Overall Study|Withdrawal by Subject|4|||
149750400|NCT00089843|540217126|FG002|Overall Study|Withdrawal by Subject|5|||
149750401|NCT00089843|540217127|FG003|Overall Study|Withdrawal by Subject|6|||
149750402|NCT00089843|540217124|FG000|Overall Study|Physician Decision|1|||
149750403|NCT00089843|540217125|FG001|Overall Study|Physician Decision|0|||
149750404|NCT00089843|540217126|FG002|Overall Study|Physician Decision|0|||
149750405|NCT00089843|540217127|FG003|Overall Study|Physician Decision|1|||
149750406|NCT01157169|540217130|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
149750407|NCT01157169|540217131|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
149750408|NCT01157169|540217130|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
149750409|NCT01157169|540217131|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
149750410|NCT00663858|540217132|FG000|Overall Study|Adverse Event|9|||
149750411|NCT00663858|540217133|FG001|Overall Study|Adverse Event|1|||
149750412|NCT00663858|540217134|FG002|Overall Study|Adverse Event|6|||
149750413|NCT00663858|540217132|FG000|Overall Study|Lack of Efficacy|5|||
149750414|NCT00663858|540217133|FG001|Overall Study|Lack of Efficacy|1|||
149750415|NCT00663858|540217134|FG002|Overall Study|Lack of Efficacy|3|||
149750416|NCT00663858|540217132|FG000|Overall Study|Withdrawal by Subject|7|||
149750417|NCT00663858|540217133|FG001|Overall Study|Withdrawal by Subject|3|||
149750418|NCT00663858|540217134|FG002|Overall Study|Withdrawal by Subject|3|||
149750419|NCT00663858|540217132|FG000|Overall Study|Protocol Violation|5|||
149750420|NCT00663858|540217133|FG001|Overall Study|Protocol Violation|3|||
149750421|NCT00663858|540217134|FG002|Overall Study|Protocol Violation|4|||
149750422|NCT00663858|540217132|FG000|Overall Study|Other|8|||
149750423|NCT00663858|540217133|FG001|Overall Study|Other|2|||
149750424|NCT00663858|540217134|FG002|Overall Study|Other|4|||
149750425|NCT03060577|540217135|FG000|Overall Study|Withdrawal by Subject|25|||
149750426|NCT03060577|540217136|FG001|Overall Study|Withdrawal by Subject|5|||
149750427|NCT03060577|540217135|FG000|Overall Study|Physician Decision|4|||
149750428|NCT03060577|540217136|FG001|Overall Study|Physician Decision|3|||
149750429|NCT03060577|540217135|FG000|Overall Study|Lost to Follow-up|3|||
149750430|NCT03060577|540217136|FG001|Overall Study|Lost to Follow-up|0|||
149750431|NCT03060577|540217135|FG000|Overall Study|Death|7|||
149750432|NCT03060577|540217136|FG001|Overall Study|Death|1|||
149750433|NCT03060577|540217135|FG000|Overall Study|Adverse Event|9|||
149750434|NCT03060577|540217136|FG001|Overall Study|Adverse Event|1|||
149750435|NCT03060577|540217135|FG000|Overall Study|Inclusion/Exclusion|1|||
149750436|NCT03060577|540217136|FG001|Overall Study|Inclusion/Exclusion|0|||
149750437|NCT03060577|540217135|FG000|Overall Study|Other|8|||
149750438|NCT03060577|540217136|FG001|Overall Study|Other|2|||
149750439|NCT02940886|540217140|FG000|Overall Study|Adverse Event|7|||
149750440|NCT02940886|540217141|FG001|Overall Study|Adverse Event|3|||
149750441|NCT02940886|540217140|FG000|Overall Study|Protocol Violation|0|||
149750442|NCT02940886|540217141|FG001|Overall Study|Protocol Violation|2|||
149750443|NCT02940886|540217140|FG000|Overall Study|Withdrawal by Subject|28|||
149750444|NCT02940886|540217141|FG001|Overall Study|Withdrawal by Subject|20|||
149750445|NCT02940886|540217140|FG000|Overall Study|Death|1|||
149750446|NCT02940886|540217141|FG001|Overall Study|Death|0|||
149750447|NCT02940886|540217140|FG000|Overall Study|Lack of Efficacy|1|||
149750448|NCT02940886|540217141|FG001|Overall Study|Lack of Efficacy|0|||
149750449|NCT02940886|540217140|FG000|Overall Study|Lost to Follow-up|49|||
149750450|NCT02940886|540217141|FG001|Overall Study|Lost to Follow-up|21|||
149750451|NCT02940886|540217140|FG000|Overall Study|Physician Decision|9|||
149750452|NCT02940886|540217141|FG001|Overall Study|Physician Decision|4|||
149750453|NCT02940886|540217140|FG000|Overall Study|Sponsor decision|0|||
149750454|NCT02940886|540217141|FG001|Overall Study|Sponsor decision|1|||
149750455|NCT02940886|540217140|FG000|Overall Study|No treatment|7|||
149750456|NCT02940886|540217141|FG001|Overall Study|No treatment|2|||
149750457|NCT02940886|540217140|FG000|Overall Study|Enrolment error|0|||
149750458|NCT02940886|540217141|FG001|Overall Study|Enrolment error|1|||
149750459|NCT02584634|540217149|FG000|Overall Study|Adverse Event|3|||
149750460|NCT02584634|540217150|FG001|Overall Study|Adverse Event|5|||
149750461|NCT02584634|540217149|FG000|Overall Study|Death|0|||
149750462|NCT02584634|540217150|FG001|Overall Study|Death|1|||
149750463|NCT02584634|540217149|FG000|Overall Study|Lost to Follow-up|0|||
149750464|NCT02584634|540217150|FG001|Overall Study|Lost to Follow-up|1|||
149750465|NCT02584634|540217149|FG000|Overall Study|Physician Decision|1|||
149750466|NCT02584634|540217150|FG001|Overall Study|Physician Decision|2|||
149750467|NCT02584634|540217149|FG000|Overall Study|Progressive disease|7|||
149750468|NCT02584634|540217150|FG001|Overall Study|Progressive disease|15|||
149750469|NCT02584634|540217149|FG000|Overall Study|Withdrawal by Subject|1|||
149750470|NCT02584634|540217150|FG001|Overall Study|Withdrawal by Subject|1|||
149750471|NCT02584634|540217149|FG000|Overall Study|Other|0|||
149750472|NCT02584634|540217150|FG001|Overall Study|Other|6|||
149750473|NCT02225223|540217151|FG000|Overall Study|Death|10|||
149750474|NCT02225223|540217152|FG001|Overall Study|Death|1|||
149750475|NCT02225223|540217151|FG000|Overall Study|Lost to Follow-up|5|||
149750476|NCT02225223|540217152|FG001|Overall Study|Lost to Follow-up|0|||
149750477|NCT02225223|540217151|FG000|Overall Study|Other|1|||
149750478|NCT02225223|540217152|FG001|Overall Study|Other|2|||
149750479|NCT02225223|540217151|FG000|Overall Study|Physician Decision|1|||
149750480|NCT02225223|540217152|FG001|Overall Study|Physician Decision|0|||
149750481|NCT02225223|540217151|FG000|Overall Study|Withdrawal by Subject|2|||
149750482|NCT02225223|540217152|FG001|Overall Study|Withdrawal by Subject|2|||
149750483|NCT01650779|540217154|FG000|Overall Study|Withdrawal by Subject|1|||
149750484|NCT03567291|540217155|FG000|Period I|Adverse Event|14|||
149750485|NCT03567291|540217156|FG001|Period I|Adverse Event|0|||
149750486|NCT03567291|540217157|FG002|Period I|Adverse Event|0|||
149750487|NCT03567291|540217158|FG003|Period I|Adverse Event|0|||
149750488|NCT03567291|540217155|FG000|Period I|Protocol Violation|1|||
149750489|NCT03567291|540217156|FG001|Period I|Protocol Violation|0|||
149750490|NCT03567291|540217157|FG002|Period I|Protocol Violation|0|||
149750491|NCT03567291|540217158|FG003|Period I|Protocol Violation|0|||
149750492|NCT03567291|540217155|FG000|Period I|Withdrawal by Subject|23|||
149750493|NCT03567291|540217156|FG001|Period I|Withdrawal by Subject|0|||
149750494|NCT03567291|540217157|FG002|Period I|Withdrawal by Subject|0|||
149750495|NCT03567291|540217158|FG003|Period I|Withdrawal by Subject|0|||
149750496|NCT03567291|540217155|FG000|Period I|Lost to Follow-up|2|||
149750497|NCT03567291|540217156|FG001|Period I|Lost to Follow-up|0|||
149750498|NCT03567291|540217157|FG002|Period I|Lost to Follow-up|0|||
149750499|NCT03567291|540217158|FG003|Period I|Lost to Follow-up|0|||
149750500|NCT03567291|540217155|FG000|Period I|Terminated by sponsor|44|||
149750501|NCT03567291|540217156|FG001|Period I|Terminated by sponsor|0|||
149750502|NCT03567291|540217157|FG002|Period I|Terminated by sponsor|0|||
149750503|NCT03567291|540217158|FG003|Period I|Terminated by sponsor|0|||
149750504|NCT03567291|540217155|FG000|Period I|Missing or unknown|7|||
149750505|NCT03567291|540217156|FG001|Period I|Missing or unknown|0|||
149750506|NCT03567291|540217157|FG002|Period I|Missing or unknown|0|||
149750507|NCT03567291|540217158|FG003|Period I|Missing or unknown|0|||
149750508|NCT03567291|540217155|FG000|Period II|Adverse Event|0|||
149750509|NCT03567291|540217156|FG001|Period II|Adverse Event|1|||
149750510|NCT03567291|540217157|FG002|Period II|Adverse Event|0|||
149750511|NCT03567291|540217158|FG003|Period II|Adverse Event|0|||
149750512|NCT03567291|540217155|FG000|Period II|Missing or unknown|0|||
149750513|NCT03567291|540217156|FG001|Period II|Missing or unknown|2|||
149750514|NCT03567291|540217157|FG002|Period II|Missing or unknown|1|||
149750515|NCT03567291|540217158|FG003|Period II|Missing or unknown|0|||
149750516|NCT03567291|540217155|FG000|Period III|Adverse Event|0|||
149750517|NCT03567291|540217156|FG001|Period III|Adverse Event|0|||
149750518|NCT03567291|540217157|FG002|Period III|Adverse Event|0|||
149750519|NCT03567291|540217158|FG003|Period III|Adverse Event|4|||
149750520|NCT03567291|540217155|FG000|Period III|Withdrawal by Subject|0|||
149750521|NCT03567291|540217156|FG001|Period III|Withdrawal by Subject|0|||
149750522|NCT03567291|540217157|FG002|Period III|Withdrawal by Subject|0|||
149750523|NCT03567291|540217158|FG003|Period III|Withdrawal by Subject|4|||
149750524|NCT03567291|540217155|FG000|Period III|Lost to Follow-up|0|||
149750525|NCT03567291|540217156|FG001|Period III|Lost to Follow-up|0|||
149750526|NCT03567291|540217157|FG002|Period III|Lost to Follow-up|0|||
149750527|NCT03567291|540217158|FG003|Period III|Lost to Follow-up|1|||
149750528|NCT03567291|540217155|FG000|Period III|Terminated by sponsor|0|||
149750529|NCT03567291|540217156|FG001|Period III|Terminated by sponsor|0|||
149750530|NCT03567291|540217157|FG002|Period III|Terminated by sponsor|0|||
149750531|NCT03567291|540217158|FG003|Period III|Terminated by sponsor|68|||
149750532|NCT03567291|540217155|FG000|Period III|Missing or unknown|0|||
149750533|NCT03567291|540217156|FG001|Period III|Missing or unknown|0|||
149750534|NCT03567291|540217157|FG002|Period III|Missing or unknown|0|||
149750535|NCT03567291|540217158|FG003|Period III|Missing or unknown|8|||
149750536|NCT03666143|540217159|FG000|Overall Study|Death|158|||
149750537|NCT03666143|540217159|FG000|Overall Study|Sponsor Decision|31|||
149750538|NCT03666143|540217159|FG000|Overall Study|Withdrawal by Subject|11|||
149750539|NCT03666143|540217159|FG000|Overall Study|Lost to Follow-up|5|||
149750540|NCT03666143|540217159|FG000|Overall Study|Physician Decision|1|||
149750541|NCT03666143|540217159|FG000|Overall Study|Rolled into extension study|9|||
149750542|NCT03666143|540217159|FG000|Overall Study|Progressive Disease|1|||
149750543|NCT01103349|540217160|FG000|Overall Study|Adverse Event|8|||
149750544|NCT01103349|540217161|FG001|Overall Study|Adverse Event|5|||
149750545|NCT01103349|540217162|FG002|Overall Study|Adverse Event|3|||
149750546|NCT01103349|540217160|FG000|Overall Study|Consent withdrawn|1|||
149750547|NCT01103349|540217161|FG001|Overall Study|Consent withdrawn|0|||
149750548|NCT01103349|540217162|FG002|Overall Study|Consent withdrawn|0|||
149750549|NCT01103349|540217160|FG000|Overall Study|Incorrectly included in the trial|1|||
149750550|NCT01103349|540217161|FG001|Overall Study|Incorrectly included in the trial|0|||
149750551|NCT01103349|540217162|FG002|Overall Study|Incorrectly included in the trial|0|||
149750552|NCT01103349|540217160|FG000|Overall Study|Withdrawal by Subject|1|||
149750553|NCT01103349|540217161|FG001|Overall Study|Withdrawal by Subject|1|||
149750554|NCT01103349|540217162|FG002|Overall Study|Withdrawal by Subject|0|||
149750555|NCT01103349|540217160|FG000|Overall Study|did not want to take trial medication|0|||
149750556|NCT01103349|540217161|FG001|Overall Study|did not want to take trial medication|1|||
149750557|NCT01103349|540217162|FG002|Overall Study|did not want to take trial medication|0|||
149750558|NCT01103349|540217160|FG000|Overall Study|forgot to take medication|0|||
149750559|NCT01103349|540217161|FG001|Overall Study|forgot to take medication|0|||
149750560|NCT01103349|540217162|FG002|Overall Study|forgot to take medication|1|||
149750561|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
149750562|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149750563|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149750564|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149750565|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
149750566|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149750567|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149750568|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149750569|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
149750570|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149750571|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149750572|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149750573|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
149750574|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149750575|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149750576|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149750577|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
149750578|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149750579|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149750580|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149750581|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
149750582|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149750583|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149750584|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149750585|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
149750586|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149750587|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149750588|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149750589|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
149750590|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
149750591|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
149750592|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
149750593|NCT00958568|540217167|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
149750594|NCT00958568|540217168|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149750595|NCT00958568|540217169|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149750596|NCT00958568|540217170|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149750597|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149750598|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
149750599|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149750600|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149750601|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
149750602|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
149750603|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
149750604|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
149750605|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149750606|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
149750607|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149750608|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149750609|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149750610|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
149750611|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149750612|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149750613|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149750614|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
149750615|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149750616|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149750617|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149750618|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
149750619|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149750620|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149750621|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149750622|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
149750623|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149750624|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149750625|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
149750626|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
149750627|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
149750628|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
149750629|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
149750630|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
149750631|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
149750632|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
149750633|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
149750634|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
149750635|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
149750636|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
149750637|NCT00958568|540217167|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149750638|NCT00958568|540217168|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
149750639|NCT00958568|540217169|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149750640|NCT00958568|540217170|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149750641|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
149750642|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
149750643|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
149750644|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
149750645|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
149750646|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
149750647|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
149750648|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
149750649|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
149750650|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
149750651|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
149750652|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
149750653|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
149750654|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
149750655|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
149750656|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
149750657|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
149750658|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
149750659|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
149750660|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
149750661|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
149750662|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
149750663|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
149750664|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
149750665|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
149750666|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
149750667|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
149750668|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
149750669|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149750670|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149750671|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
149750672|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149750673|NCT00958568|540217167|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149750674|NCT00958568|540217168|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149750675|NCT00958568|540217169|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
149750676|NCT00958568|540217170|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149750677|NCT00915005|540217171|FG000|Overall Study|Withdrawal by Subject|4|||
149750678|NCT00915005|540217172|FG001|Overall Study|Withdrawal by Subject|4|||
149750679|NCT00915005|540217171|FG000|Overall Study|Patient preferred protons therapy|6|||
149750680|NCT00915005|540217172|FG001|Overall Study|Patient preferred protons therapy|0|||
149750681|NCT00915005|540217171|FG000|Overall Study|Insurance denial|3|||
149750682|NCT00915005|540217172|FG001|Overall Study|Insurance denial|15|||
149750683|NCT00283712|540217179|FG000|Overall Study|Death|0|||
149750684|NCT00283712|540217180|FG001|Overall Study|Death|1|||
149750685|NCT03952650|540217182|FG000|Overall Study|TRAVEL|0|||
149750686|NCT03952650|540217183|FG001|Overall Study|TRAVEL|4|||
149750687|NCT03952650|540217184|FG002|Overall Study|TRAVEL|0|||
149750688|NCT03952650|540217185|FG003|Overall Study|TRAVEL|4|||
149750689|NCT03952650|540217186|FG004|Overall Study|TRAVEL|0|||
149750690|NCT03952650|540217187|FG005|Overall Study|TRAVEL|3|||
149750691|NCT03952650|540217188|FG006|Overall Study|TRAVEL|2|||
149750692|NCT03952650|540217182|FG000|Overall Study|Withdrawal by Subject|0|||
149750693|NCT03952650|540217183|FG001|Overall Study|Withdrawal by Subject|2|||
149750694|NCT03952650|540217184|FG002|Overall Study|Withdrawal by Subject|0|||
149750695|NCT03952650|540217185|FG003|Overall Study|Withdrawal by Subject|3|||
149750696|NCT03952650|540217186|FG004|Overall Study|Withdrawal by Subject|0|||
149750697|NCT03952650|540217187|FG005|Overall Study|Withdrawal by Subject|1|||
149750698|NCT03952650|540217188|FG006|Overall Study|Withdrawal by Subject|1|||
149750699|NCT03952650|540217182|FG000|Overall Study|Lost to Follow-up|0|||
149750700|NCT03952650|540217183|FG001|Overall Study|Lost to Follow-up|1|||
149750701|NCT03952650|540217184|FG002|Overall Study|Lost to Follow-up|0|||
149750702|NCT03952650|540217185|FG003|Overall Study|Lost to Follow-up|0|||
149750703|NCT03952650|540217186|FG004|Overall Study|Lost to Follow-up|0|||
149750704|NCT03952650|540217187|FG005|Overall Study|Lost to Follow-up|1|||
149750705|NCT03952650|540217188|FG006|Overall Study|Lost to Follow-up|1|||
149750706|NCT03952650|540217182|FG000|Overall Study|Received wrong vaccine and travelled|0|||
149750707|NCT03952650|540217183|FG001|Overall Study|Received wrong vaccine and travelled|0|||
149750708|NCT03952650|540217184|FG002|Overall Study|Received wrong vaccine and travelled|0|||
149750709|NCT03952650|540217185|FG003|Overall Study|Received wrong vaccine and travelled|0|||
149750710|NCT03952650|540217186|FG004|Overall Study|Received wrong vaccine and travelled|0|||
149750711|NCT03952650|540217187|FG005|Overall Study|Received wrong vaccine and travelled|1|||
149750712|NCT03952650|540217188|FG006|Overall Study|Received wrong vaccine and travelled|0|||
149750713|NCT03952650|540217182|FG000|Overall Study|Unable to make study visit|0|||
149750714|NCT03952650|540217183|FG001|Overall Study|Unable to make study visit|0|||
149750715|NCT03952650|540217184|FG002|Overall Study|Unable to make study visit|0|||
149750716|NCT03952650|540217185|FG003|Overall Study|Unable to make study visit|0|||
149750717|NCT03952650|540217186|FG004|Overall Study|Unable to make study visit|0|||
149750718|NCT03952650|540217187|FG005|Overall Study|Unable to make study visit|1|||
149750719|NCT03952650|540217188|FG006|Overall Study|Unable to make study visit|0|||
149750720|NCT03988751|540217191|FG000|Overall Study|Withdrawal by Subject|1|||
149750721|NCT03988751|540217192|FG001|Overall Study|Withdrawal by Subject|0|||
149750722|NCT03988751|540217191|FG000|Overall Study|Protocol Violation|0|||
149750723|NCT03988751|540217192|FG001|Overall Study|Protocol Violation|1|||
149750724|NCT02441803|540217195|FG000|Overall Study|Physician Decision|0|||
149750725|NCT02441803|540217196|FG001|Overall Study|Physician Decision|2|||
149750726|NCT02441803|540217197|FG002|Overall Study|Physician Decision|2|||
149750727|NCT03065530|540217198|FG000|Overall Study|Lack of Efficacy|1|||
149750728|NCT03065530|540217199|FG001|Overall Study|Lack of Efficacy|1|||
149750729|NCT03065530|540217200|FG002|Overall Study|Lack of Efficacy|0|||
149750730|NCT03065530|540217201|FG003|Overall Study|Lack of Efficacy|1|||
149750731|NCT03065530|540217198|FG000|Overall Study|Protocol Violation|1|||
149750732|NCT03065530|540217199|FG001|Overall Study|Protocol Violation|0|||
149750733|NCT03065530|540217200|FG002|Overall Study|Protocol Violation|1|||
149750734|NCT03065530|540217201|FG003|Overall Study|Protocol Violation|1|||
149750735|NCT01325493|540217202|FG000|Overall Study|Protocol Violation|0|||
149750736|NCT01325493|540217203|FG001|Overall Study|Protocol Violation|1|||
149750737|NCT01325493|540217202|FG000|Overall Study|loss of neuromonitoring signals|0|||
149750738|NCT01325493|540217203|FG001|Overall Study|loss of neuromonitoring signals|2|||
149750739|NCT01325493|540217202|FG000|Overall Study|Allergy|1|||
149750740|NCT01325493|540217203|FG001|Overall Study|Allergy|0|||
149750741|NCT02240628|540217204|FG000|Overall Study|Physician Decision|6|||
149750742|NCT02240628|540217205|FG001|Overall Study|Physician Decision|5|||
149750743|NCT02285010|540217206|FG000|Overall Study|not abdominal hysterectomy|2|||
149750744|NCT02285010|540217207|FG001|Overall Study|not abdominal hysterectomy|0|||
149750745|NCT02285010|540217206|FG000|Overall Study|Not spinal anesthesia|3|||
149750746|NCT02285010|540217207|FG001|Overall Study|Not spinal anesthesia|1|||
149750747|NCT01457339|540217213|FG000|Period 3 (100 mg)|Adverse Event|0|||
149750748|NCT01457339|540217214|FG001|Period 3 (100 mg)|Adverse Event|1|||
149750749|NCT01457339|540217213|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
149750750|NCT01457339|540217214|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
149750751|NCT01457339|540217213|FG000|Period 6 (250 mg)|Family Emergency|1|||
149750752|NCT01457339|540217214|FG001|Period 6 (250 mg)|Family Emergency|0|||
149750753|NCT01457339|540217213|FG000|Period 6 (250 mg)|Personal appointment|0|||
149750754|NCT01457339|540217214|FG001|Period 6 (250 mg)|Personal appointment|1|||
149750755|NCT00394914|540217216|FG000|Treatment Period|Adverse Event|0|||
149750756|NCT00394914|540217217|FG001|Treatment Period|Adverse Event|3|||
149750757|NCT00394914|540217218|FG002|Treatment Period|Adverse Event|1|||
149750758|NCT00394914|540217216|FG000|Treatment Period|Lost to Follow-up|0|||
149750759|NCT00394914|540217217|FG001|Treatment Period|Lost to Follow-up|1|||
149750760|NCT00394914|540217218|FG002|Treatment Period|Lost to Follow-up|0|||
149750761|NCT00394914|540217216|FG000|Treatment Period|Withdrawal by Subject|0|||
149750762|NCT00394914|540217217|FG001|Treatment Period|Withdrawal by Subject|2|||
149750763|NCT00394914|540217218|FG002|Treatment Period|Withdrawal by Subject|2|||
149750764|NCT00394914|540217216|FG000|Treatment Period|Noncompliance with protocol|0|||
149750765|NCT00394914|540217217|FG001|Treatment Period|Noncompliance with protocol|3|||
149750766|NCT00394914|540217218|FG002|Treatment Period|Noncompliance with protocol|2|||
149750767|NCT00394914|540217216|FG000|Treatment Period|Did not meet protocol eligibility|0|||
149750768|NCT00394914|540217217|FG001|Treatment Period|Did not meet protocol eligibility|1|||
149750769|NCT00394914|540217218|FG002|Treatment Period|Did not meet protocol eligibility|1|||
149750770|NCT00312377|540217220|FG000|Overall Study|Death|403|||
149750771|NCT00312377|540217221|FG001|Overall Study|Death|418|||
149750772|NCT00312377|540217220|FG000|Overall Study|Withdrawal by Subject|23|||
149750773|NCT00312377|540217221|FG001|Overall Study|Withdrawal by Subject|30|||
149750774|NCT00312377|540217220|FG000|Overall Study|Lost to Follow-up|9|||
149750775|NCT00312377|540217221|FG001|Overall Study|Lost to Follow-up|12|||
149750776|NCT00312377|540217220|FG000|Overall Study|Non-compliance|0|||
149750777|NCT00312377|540217221|FG001|Overall Study|Non-compliance|2|||
149750778|NCT00312377|540217220|FG000|Overall Study|Randomised but never received treatment|6|||
149750779|NCT00312377|540217221|FG001|Overall Study|Randomised but never received treatment|6|||
149750780|NCT00312377|540217220|FG000|Overall Study|Discontinue treatment survival follow up|202|||
149750781|NCT00312377|540217221|FG001|Overall Study|Discontinue treatment survival follow up|200|||
149750782|NCT00312377|540217220|FG000|Overall Study|Site ended participation in study|1|||
149750783|NCT00312377|540217221|FG001|Overall Study|Site ended participation in study|0|||
149750784|NCT05258058|540217229|FG000|Overall Study|Withdrawal by Subject|2|||
149750785|NCT02179398|540217232|FG000|Overall Study|Lack of obligatory data|3|||
149750786|NCT02179398|540217233|FG001|Overall Study|Lack of obligatory data|3|||
149750787|NCT02179398|540217232|FG000|Overall Study|Lost to Follow-up|0|||
149750788|NCT02179398|540217233|FG001|Overall Study|Lost to Follow-up|1|||
149750789|NCT00408681|540217239|FG000|Overall Study|Lack of Efficacy|2|||
149750790|NCT00408681|540217239|FG000|Overall Study|Adverse Event|7|||
149750791|NCT02519231|540217246|FG000|Overall Study|Lost to Follow-up|2|||
149750792|NCT02519231|540217247|FG001|Overall Study|Lost to Follow-up|5|||
149750793|NCT02519231|540217246|FG000|Overall Study|Withdrawal by Subject|0|||
149750794|NCT02519231|540217247|FG001|Overall Study|Withdrawal by Subject|1|||
149750795|NCT00447421|540217248|FG000|Overall Study|Lack of Efficacy|1|||
149750796|NCT00447421|540217248|FG000|Overall Study|Adverse Event|3|||
149750797|NCT00447421|540217248|FG000|Overall Study|Sponsor Decision|2|||
149750798|NCT01787591|540217249|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149750799|NCT01787591|540217250|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149750800|NCT01787591|540217251|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149750801|NCT01787591|540217252|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
149750802|NCT02725177|540217253|FG000|Overall Study|Physician Decision|4|||
149750803|NCT02725177|540217253|FG000|Overall Study|Adverse Event|1|||
149750804|NCT02707757|540217254|FG000|Overall Study|Protocol Violation|3|||
149750805|NCT02707757|540217255|FG001|Overall Study|Protocol Violation|2|||
149750806|NCT02707757|540217254|FG000|Overall Study|Withdrawal by Subject|2|||
149750807|NCT02707757|540217255|FG001|Overall Study|Withdrawal by Subject|0|||
149750808|NCT02707757|540217254|FG000|Overall Study|Death|0|||
149750809|NCT02707757|540217255|FG001|Overall Study|Death|1|||
149750810|NCT02707757|540217254|FG000|Overall Study|Adverse Event|6|||
149750811|NCT02707757|540217255|FG001|Overall Study|Adverse Event|4|||
149750812|NCT02707757|540217254|FG000|Overall Study|Renal transplant/elective operation|1|||
149750813|NCT02707757|540217255|FG001|Overall Study|Renal transplant/elective operation|5|||
149750814|NCT00815308|540217256|FG000|Overall Study|Adverse Event|4|||
149750815|NCT00815308|540217256|FG000|Overall Study|Withdrawal by Subject|0|||
149750816|NCT00815308|540217256|FG000|Overall Study|Protocol Violation|6|||
149750817|NCT00377299|540217257|FG000|Overall Study|Lost to Follow-up|14|||
149750818|NCT00377299|540217258|FG001|Overall Study|Lost to Follow-up|19|||
149750819|NCT00377299|540217257|FG000|Overall Study|Adverse Event|0|||
149750820|NCT00377299|540217258|FG001|Overall Study|Adverse Event|1|||
149750821|NCT00377299|540217257|FG000|Overall Study|Withdrawal by Subject|5|||
149750822|NCT00377299|540217258|FG001|Overall Study|Withdrawal by Subject|4|||
149750823|NCT04799782|540217259|FG000|Washout|Physician Decision|2|||
149750824|NCT04799782|540217260|FG001|Washout|Physician Decision|0|||
149750825|NCT04799782|540217259|FG000|Washout|Withdrawal by Subject|0|||
149750826|NCT04799782|540217260|FG001|Washout|Withdrawal by Subject|2|||
149750827|NCT04799782|540217259|FG000|Washout|Lost to Follow-up|0|||
149750828|NCT04799782|540217260|FG001|Washout|Lost to Follow-up|1|||
149750829|NCT00969618|540217261|FG000|Overall Study|Adverse Event|29|||
149750830|NCT00969618|540217261|FG000|Overall Study|Entry Criteria Not Met|3|||
149750831|NCT00969618|540217261|FG000|Overall Study|Lack of Efficacy|2|||
149750832|NCT00969618|540217261|FG000|Overall Study|Lost to Follow-up|7|||
149750833|NCT00969618|540217261|FG000|Overall Study|Physician Decision|1|||
149750834|NCT00969618|540217261|FG000|Overall Study|Protocol Violation|9|||
149750835|NCT00969618|540217261|FG000|Overall Study|Withdrawal by Subject|27|||
149750836|NCT01277289|540219338|FG000|Overall Study|fragile vein|1|||
149750837|NCT01277289|540219339|FG001|Overall Study|fragile vein|0|||
149750838|NCT01277289|540219338|FG000|Overall Study|Physician Decision|1|||
149750839|NCT01277289|540219339|FG001|Overall Study|Physician Decision|0|||
149750840|NCT01277289|540219338|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
149750841|NCT01277289|540219339|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
149750842|NCT01277289|540219338|FG000|Overall Study|Protocol Violation|1|||
149750843|NCT01277289|540219339|FG001|Overall Study|Protocol Violation|1|||
149750844|NCT01277289|540219338|FG000|Overall Study|Adverse Event|2|||
149750845|NCT01277289|540219339|FG001|Overall Study|Adverse Event|1|||
149750846|NCT01277289|540219338|FG000|Overall Study|consent withdrawn|1|||
149750847|NCT01277289|540219339|FG001|Overall Study|consent withdrawn|1|||
149750848|NCT01277289|540219338|FG000|Overall Study|premature closure of the study|4|||
149750849|NCT01277289|540219339|FG001|Overall Study|premature closure of the study|2|||
149750850|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
149750851|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
149750852|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
149750853|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
149750854|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
149750855|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
149750856|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
149750857|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
149750858|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
149750859|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
149750860|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
149750861|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
149750862|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
149750863|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
149750864|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
149750865|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
149750866|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
149750867|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
149750868|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
149750869|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
149750870|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
149750871|NCT00092547|540219340|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
149750872|NCT00092547|540219341|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
149750873|NCT00092547|540219342|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
149750874|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
149750875|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
149750876|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
149750877|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
149750878|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
149750879|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
149750880|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
149750881|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
149750882|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
149750883|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
149750884|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
149750885|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
149750886|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
149750887|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
149750888|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
149750889|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
149750890|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
149750891|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
149750892|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
149750893|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
149750894|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
149750895|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
149750896|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
149750897|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
149750898|NCT00092547|540219340|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
149750899|NCT00092547|540219341|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
149750900|NCT00092547|540219342|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
149750901|NCT00092547|540219340|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
149750902|NCT00092547|540219341|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
149750903|NCT00092547|540219342|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
149750904|NCT00092547|540219340|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
149750905|NCT00092547|540219341|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
149750906|NCT00092547|540219342|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
149750907|NCT00092547|540219340|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
149750908|NCT00092547|540219341|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
149750909|NCT00092547|540219342|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
149750910|NCT00092547|540219340|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
149750911|NCT00092547|540219341|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
149750912|NCT00092547|540219342|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
149750913|NCT00084682|540219343|FG000|Overall Study|Withdrawal by Subject|1|||
149750914|NCT01166659|540219344|FG000|Overall Study|Subject Decision|8|||
149750915|NCT01166659|540219344|FG000|Overall Study|Investigator Decision|2|||
149750916|NCT01166659|540219344|FG000|Overall Study|Death|1|||
149750917|NCT01166659|540219344|FG000|Overall Study|Lost to Follow-up|1|||
149750918|NCT01166659|540219344|FG000|Overall Study|Study Closed at Site|1|||
149750919|NCT03088605|540219347|FG000|Overall Study|Withdrawal by Subject|1|||
149750920|NCT03088605|540219348|FG001|Overall Study|Withdrawal by Subject|0|||
149750921|NCT02397655|540219349|FG000|Overall Study|data not completed|1301|||
149750922|NCT02747043|540219356|FG000|Overall Study|Other|1|||
149750923|NCT02747043|540219357|FG001|Overall Study|Other|1|||
149750924|NCT02747043|540219356|FG000|Overall Study|Adverse Event|3|||
149750925|NCT02747043|540219357|FG001|Overall Study|Adverse Event|1|||
149750926|NCT02747043|540219356|FG000|Overall Study|Withdrawal by Subject|1|||
149750927|NCT02747043|540219357|FG001|Overall Study|Withdrawal by Subject|1|||
149750928|NCT02747043|540219356|FG000|Overall Study|Physician Decision|1|||
149750929|NCT02747043|540219357|FG001|Overall Study|Physician Decision|1|||
149750930|NCT02747043|540219356|FG000|Overall Study|Protocol Violation|0|||
149750931|NCT02747043|540219357|FG001|Overall Study|Protocol Violation|1|||
149750932|NCT02747043|540219356|FG000|Overall Study|Disease progression|4|||
149750933|NCT02747043|540219357|FG001|Overall Study|Disease progression|0|||
149750934|NCT04655586|540219366|FG000|Overall Study|Physician Decision|1|||
149750935|NCT04655586|540219367|FG001|Overall Study|Physician Decision|3|||
149750936|NCT04655586|540219368|FG002|Overall Study|Physician Decision|4|||
149750937|NCT04655586|540219366|FG000|Overall Study|Withdrawal by Subject|1|||
149750938|NCT04655586|540219367|FG001|Overall Study|Withdrawal by Subject|3|||
149750939|NCT04655586|540219368|FG002|Overall Study|Withdrawal by Subject|1|||
149750940|NCT00553059|540219373|FG000|Overall Study|Deemed ineligible|1|||
149750941|NCT00553059|540219374|FG001|Overall Study|Deemed ineligible|1|||
149750942|NCT00553059|540219373|FG000|Overall Study|Drug supply not available|0|||
149750943|NCT00553059|540219374|FG001|Overall Study|Drug supply not available|1|||
149750944|NCT01966731|540219375|FG000|Overall Study|Death|2|||
149750945|NCT01966731|540219375|FG000|Overall Study|Lost to Follow-up|1|||
149750946|NCT01966731|540219375|FG000|Overall Study|Physician Decision|2|||
149750947|NCT01966731|540219375|FG000|Overall Study|Follow up is not complete|600|||
149750948|NCT01966731|540219375|FG000|Overall Study|Screening Failure|29|||
149750949|NCT01966731|540219375|FG000|Overall Study|Found to be ineligible|1|||
149750950|NCT01380093|540219376|FG000|Naloxone Challenge Phase|Screen failures|21|||
149750951|NCT01380093|540219377|FG001|Naloxone Challenge Phase|Screen failures|0|||
149750952|NCT01380093|540219378|FG002|Naloxone Challenge Phase|Screen failures|0|||
149750953|NCT01380093|540219379|FG003|Naloxone Challenge Phase|Screen failures|0|||
149750954|NCT01380093|540219380|FG004|Naloxone Challenge Phase|Screen failures|0|||
149750955|NCT01380093|540219381|FG005|Naloxone Challenge Phase|Screen failures|0|||
149750956|NCT01380093|540219382|FG006|Naloxone Challenge Phase|Screen failures|0|||
149750957|NCT01380093|540219383|FG007|Naloxone Challenge Phase|Screen failures|0|||
149750958|NCT01380093|540219384|FG008|Naloxone Challenge Phase|Screen failures|0|||
149750959|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750960|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
149750961|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750962|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750963|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750964|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750965|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750966|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750967|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149750968|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750969|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
149750970|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
149750971|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750972|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750973|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750974|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750975|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750976|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149750977|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750978|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
149750979|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750980|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750981|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750982|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750983|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750984|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750985|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149750986|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750987|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
149750988|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
149750989|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750990|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750991|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750992|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750993|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750994|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149750995|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149750996|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
149750997|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
149750998|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149750999|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149751000|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149751001|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149751002|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149751003|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149751004|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751005|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751006|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
149751007|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751008|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751009|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751010|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751011|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751012|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
149751013|NCT01380093|540219376|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751014|NCT01380093|540219377|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751015|NCT01380093|540219378|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
149751016|NCT01380093|540219379|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751017|NCT01380093|540219380|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751018|NCT01380093|540219381|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751019|NCT01380093|540219382|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751020|NCT01380093|540219383|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751021|NCT01380093|540219384|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149751022|NCT01380093|540219376|FG000|Treatment Phase: Second Intervention|Other|0|||
149751023|NCT01380093|540219377|FG001|Treatment Phase: Second Intervention|Other|0|||
149751024|NCT01380093|540219378|FG002|Treatment Phase: Second Intervention|Other|0|||
149751025|NCT01380093|540219379|FG003|Treatment Phase: Second Intervention|Other|1|||
149751026|NCT01380093|540219380|FG004|Treatment Phase: Second Intervention|Other|0|||
149751027|NCT01380093|540219381|FG005|Treatment Phase: Second Intervention|Other|0|||
149751028|NCT01380093|540219382|FG006|Treatment Phase: Second Intervention|Other|0|||
149751029|NCT01380093|540219383|FG007|Treatment Phase: Second Intervention|Other|0|||
149751030|NCT01380093|540219384|FG008|Treatment Phase: Second Intervention|Other|0|||
149751031|NCT01380093|540219376|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
149751032|NCT01380093|540219377|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
149751033|NCT01380093|540219378|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
149751034|NCT01380093|540219379|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
149751035|NCT01380093|540219380|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
149751036|NCT01380093|540219381|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
149751037|NCT01380093|540219382|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
149751038|NCT01380093|540219383|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
149751039|NCT01380093|540219384|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
149751040|NCT01380093|540219376|FG000|Treatment Phase: Third Intervention|Other|0|||
149751041|NCT01380093|540219377|FG001|Treatment Phase: Third Intervention|Other|0|||
149751042|NCT01380093|540219378|FG002|Treatment Phase: Third Intervention|Other|0|||
149751043|NCT01380093|540219379|FG003|Treatment Phase: Third Intervention|Other|0|||
149751044|NCT01380093|540219380|FG004|Treatment Phase: Third Intervention|Other|0|||
149751045|NCT01380093|540219381|FG005|Treatment Phase: Third Intervention|Other|0|||
149751046|NCT01380093|540219382|FG006|Treatment Phase: Third Intervention|Other|0|||
149751047|NCT01380093|540219383|FG007|Treatment Phase: Third Intervention|Other|0|||
149751048|NCT01380093|540219384|FG008|Treatment Phase: Third Intervention|Other|1|||
149751049|NCT04734873|540219385|FG000|Overall Study|Lost to Follow-up|1|||
149751050|NCT04734873|540219386|FG001|Overall Study|Lost to Follow-up|3|||
149751051|NCT04734873|540219387|FG002|Overall Study|Lost to Follow-up|2|||
149751052|NCT04734873|540219385|FG000|Overall Study|Randomized but not dosed|1|||
149751053|NCT04734873|540219386|FG001|Overall Study|Randomized but not dosed|0|||
149751054|NCT04734873|540219387|FG002|Overall Study|Randomized but not dosed|1|||
149751055|NCT00592683|540219388|FG000|Overall Study|Found ineligible|0|||
149751056|NCT00592683|540219389|FG001|Overall Study|Found ineligible|1|||
149751057|NCT00592683|540219388|FG000|Overall Study|Withdrawal by Subject|1|||
149751058|NCT00592683|540219389|FG001|Overall Study|Withdrawal by Subject|0|||
149751059|NCT00592683|540219388|FG000|Overall Study|Adverse Event|0|||
149751060|NCT00592683|540219389|FG001|Overall Study|Adverse Event|2|||
149751061|NCT00592683|540219388|FG000|Overall Study|Protocol Violation|1|||
149751062|NCT00592683|540219389|FG001|Overall Study|Protocol Violation|0|||
149751063|NCT00592683|540219388|FG000|Overall Study|Study drug expired|1|||
149751064|NCT00592683|540219389|FG001|Overall Study|Study drug expired|0|||
149751065|NCT00592683|540219388|FG000|Overall Study|Other|1|||
149751066|NCT00592683|540219389|FG001|Overall Study|Other|0|||
149751067|NCT00592683|540219388|FG000|Overall Study|Lost to Follow-up|0|||
149751068|NCT00592683|540219389|FG001|Overall Study|Lost to Follow-up|1|||
149751069|NCT00201201|540219390|FG000|Overall Study|Death|0|||
149751070|NCT00201201|540219391|FG001|Overall Study|Death|2|||
149751071|NCT00201201|540219390|FG000|Overall Study|Withdrawal by Subject|5|||
149751072|NCT00201201|540219391|FG001|Overall Study|Withdrawal by Subject|5|||
149751073|NCT00545818|540219396|FG000|Overall Study|Protocol Violation|1|||
149751074|NCT00545818|540219397|FG001|Overall Study|Protocol Violation|0|||
149751075|NCT00545818|540219396|FG000|Overall Study|Adverse Event|1|||
149751076|NCT00545818|540219397|FG001|Overall Study|Adverse Event|1|||
149751077|NCT00545818|540219396|FG000|Overall Study|Lost to Follow-up|1|||
149751078|NCT00545818|540219397|FG001|Overall Study|Lost to Follow-up|6|||
149751079|NCT00609609|540219398|FG000|Overall Study|Withdrawal by Subject|2|||
149751080|NCT00609609|540219399|FG001|Overall Study|Withdrawal by Subject|0|||
149751081|NCT00609609|540219398|FG000|Overall Study|Progression|4|||
149751082|NCT00609609|540219399|FG001|Overall Study|Progression|2|||
149751083|NCT04530825|540219402|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
149751084|NCT04530825|540219403|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
149751085|NCT04530825|540219404|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
149751086|NCT04530825|540219405|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
149751087|NCT04530825|540219402|FG000|Overall Study|Did not complete follow-up|3|||
149751088|NCT04530825|540219403|FG001|Overall Study|Did not complete follow-up|0|||
149751089|NCT04530825|540219404|FG002|Overall Study|Did not complete follow-up|0|||
149751090|NCT04530825|540219405|FG003|Overall Study|Did not complete follow-up|0|||
149751091|NCT04101422|540219407|FG000|Overall Study|Ineligible|1|||
149751092|NCT04101422|540219408|FG001|Overall Study|Ineligible|0|||
149751093|NCT04101422|540219409|FG002|Overall Study|Ineligible|9|||
149751094|NCT04101422|540219410|FG003|Overall Study|Ineligible|0|||
149751095|NCT04101422|540219407|FG000|Overall Study|Withdrawal by Subject|0|||
149751096|NCT04101422|540219408|FG001|Overall Study|Withdrawal by Subject|0|||
149751097|NCT04101422|540219409|FG002|Overall Study|Withdrawal by Subject|1|||
149751098|NCT04101422|540219410|FG003|Overall Study|Withdrawal by Subject|0|||
149751099|NCT04101422|540219407|FG000|Overall Study|Not attending to the stimuli|0|||
149751100|NCT04101422|540219408|FG001|Overall Study|Not attending to the stimuli|0|||
149751101|NCT04101422|540219409|FG002|Overall Study|Not attending to the stimuli|4|||
149751102|NCT04101422|540219410|FG003|Overall Study|Not attending to the stimuli|0|||
149751103|NCT04101422|540219407|FG000|Overall Study|Did not download app|0|||
149751104|NCT04101422|540219408|FG001|Overall Study|Did not download app|0|||
149751105|NCT04101422|540219409|FG002|Overall Study|Did not download app|0|||
149751106|NCT04101422|540219410|FG003|Overall Study|Did not download app|17|||
149751107|NCT04101422|540219407|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149751108|NCT04101422|540219408|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149751109|NCT04101422|540219409|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149751110|NCT04101422|540219410|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
149751111|NCT00552305|540219411|FG000|Overall Study|Adverse Event|43|||
149751112|NCT00552305|540219411|FG000|Overall Study|Lack of Efficacy|120|||
149751113|NCT00552305|540219411|FG000|Overall Study|Lost to Follow-up|4|||
149751114|NCT00552305|540219411|FG000|Overall Study|Protocol Violation|3|||
149751115|NCT00552305|540219411|FG000|Overall Study|Withdrawal by Subject|44|||
149751116|NCT00552305|540219411|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
149751117|NCT00552305|540219411|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
149751118|NCT00552305|540219411|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
149751119|NCT00552305|540219411|FG000|Overall Study|Unsatisfactory compliance|11|||
149751120|NCT00552305|540219411|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
149751121|NCT00552305|540219411|FG000|Overall Study|AE/Other: prohibited drug required|1|||
149751122|NCT00552305|540219411|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
149751123|NCT00552305|540219411|FG000|Overall Study|Other: Site closed|4|||
149751124|NCT00552305|540219411|FG000|Overall Study|Other: Personal problems|1|||
149751125|NCT00552305|540219411|FG000|Overall Study|Other: Unable to attend visits|1|||
149751126|NCT00552305|540219411|FG000|Overall Study|Other: Subject underwent surgery|4|||
149751127|NCT00552305|540219411|FG000|Overall Study|Other: Subject became pregnant|1|||
149751128|NCT00552305|540219411|FG000|Overall Study|Other: Health problems, not drug related|1|||
149751129|NCT00552305|540219411|FG000|Overall Study|Other: Subject moved from area|2|||
149751130|NCT00552305|540219411|FG000|Overall Study|Other: Subject incarcerated|1|||
149751131|NCT00552305|540219411|FG000|Overall Study|Other: Subject went to rehab|1|||
149751132|NCT01174784|540219414|FG000|Overall Study|Screen fails|4|||
149751133|NCT01671488|540219415|FG000|Overall Study|Withdrawal by Subject|1|||
149751134|NCT03503773|540219416|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
149751135|NCT03503773|540219417|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
149751136|NCT03503773|540219416|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
149751137|NCT03503773|540219417|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
149751138|NCT03503773|540219416|FG000|Overall Study|Not completing the primary ABPM|3|||
149751139|NCT03503773|540219417|FG001|Overall Study|Not completing the primary ABPM|1|||
149751140|NCT03503773|540219416|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149751141|NCT03503773|540219417|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149751142|NCT00425438|540219421|FG000|Overall Study|Termination by Sponsor|25|||
149751143|NCT00425438|540219422|FG001|Overall Study|Termination by Sponsor|27|||
149751144|NCT02902809|540219425|FG000|Overall Study|Discontinuation of asthma program|28|||
149751145|NCT00532259|540219426|FG000|Overall Study|Withdrawal by Subject|2|||
149751146|NCT00532259|540219426|FG000|Overall Study|Adverse Event|1|||
149751147|NCT00532259|540219426|FG000|Overall Study|Death|1|||
149751148|NCT00532259|540219426|FG000|Overall Study|Lack of Efficacy|21|||
149751149|NCT00532259|540219426|FG000|Overall Study|Lost to Follow-up|3|||
149751150|NCT00532259|540219426|FG000|Overall Study|Physician Decision|3|||
149751151|NCT00532259|540219426|FG000|Overall Study|Protocol Violation|1|||
149751152|NCT01208181|540219429|FG000|Part 1|Withdrawal by Subject|11|||
149751153|NCT01208181|540219430|FG001|Part 1|Withdrawal by Subject|10|||
149751154|NCT01208181|540219431|FG002|Part 1|Withdrawal by Subject|0|||
149751155|NCT01208181|540219432|FG003|Part 1|Withdrawal by Subject|0|||
149751156|NCT01208181|540219433|FG004|Part 1|Withdrawal by Subject|0|||
149751157|NCT01208181|540219429|FG000|Part 1|Technical problem|5|||
149751158|NCT01208181|540219430|FG001|Part 1|Technical problem|0|||
149751159|NCT01208181|540219431|FG002|Part 1|Technical problem|0|||
149751160|NCT01208181|540219432|FG003|Part 1|Technical problem|0|||
149751161|NCT01208181|540219433|FG004|Part 1|Technical problem|0|||
149751162|NCT01208181|540219429|FG000|Part 1|Protocol Violation|10|||
149751163|NCT01208181|540219430|FG001|Part 1|Protocol Violation|5|||
149751164|NCT01208181|540219431|FG002|Part 1|Protocol Violation|0|||
149751165|NCT01208181|540219432|FG003|Part 1|Protocol Violation|0|||
149751166|NCT01208181|540219433|FG004|Part 1|Protocol Violation|0|||
149751167|NCT01208181|540219429|FG000|Part 1|Physician Decision|4|||
149751168|NCT01208181|540219430|FG001|Part 1|Physician Decision|0|||
149751169|NCT01208181|540219431|FG002|Part 1|Physician Decision|0|||
149751170|NCT01208181|540219432|FG003|Part 1|Physician Decision|0|||
149751171|NCT01208181|540219433|FG004|Part 1|Physician Decision|0|||
149751172|NCT01208181|540219429|FG000|Part 1|Non-compliance with study drug|1|||
149751173|NCT01208181|540219430|FG001|Part 1|Non-compliance with study drug|1|||
149751174|NCT01208181|540219431|FG002|Part 1|Non-compliance with study drug|0|||
149751175|NCT01208181|540219432|FG003|Part 1|Non-compliance with study drug|0|||
149751176|NCT01208181|540219433|FG004|Part 1|Non-compliance with study drug|0|||
149751177|NCT01208181|540219429|FG000|Part 1|Lost to Follow-up|5|||
149751178|NCT01208181|540219430|FG001|Part 1|Lost to Follow-up|3|||
149751179|NCT01208181|540219431|FG002|Part 1|Lost to Follow-up|0|||
149751180|NCT01208181|540219432|FG003|Part 1|Lost to Follow-up|0|||
149751181|NCT01208181|540219433|FG004|Part 1|Lost to Follow-up|1|||
149751182|NCT01208181|540219429|FG000|Part 1|Lack of Efficacy|37|||
149751183|NCT01208181|540219430|FG001|Part 1|Lack of Efficacy|12|||
149751184|NCT01208181|540219431|FG002|Part 1|Lack of Efficacy|0|||
149751185|NCT01208181|540219432|FG003|Part 1|Lack of Efficacy|0|||
149751186|NCT01208181|540219433|FG004|Part 1|Lack of Efficacy|17|||
149751187|NCT01208181|540219429|FG000|Part 1|Adverse Event|26|||
149751188|NCT01208181|540219430|FG001|Part 1|Adverse Event|24|||
149751189|NCT01208181|540219431|FG002|Part 1|Adverse Event|0|||
149751190|NCT01208181|540219432|FG003|Part 1|Adverse Event|0|||
149751191|NCT01208181|540219433|FG004|Part 1|Adverse Event|4|||
149751192|NCT01208181|540219429|FG000|Part 2|Adverse Event|0|||
149751193|NCT01208181|540219430|FG001|Part 2|Adverse Event|0|||
149751194|NCT01208181|540219431|FG002|Part 2|Adverse Event|6|||
149751195|NCT01208181|540219432|FG003|Part 2|Adverse Event|7|||
149751196|NCT01208181|540219433|FG004|Part 2|Adverse Event|0|||
149751197|NCT01208181|540219429|FG000|Part 2|Withdrawal by Subject|0|||
149751198|NCT01208181|540219430|FG001|Part 2|Withdrawal by Subject|0|||
149751199|NCT01208181|540219431|FG002|Part 2|Withdrawal by Subject|1|||
149751200|NCT01208181|540219432|FG003|Part 2|Withdrawal by Subject|1|||
149751201|NCT01208181|540219433|FG004|Part 2|Withdrawal by Subject|0|||
149751202|NCT01208181|540219429|FG000|Part 2|Protocol Violation|0|||
149751203|NCT01208181|540219430|FG001|Part 2|Protocol Violation|0|||
149751204|NCT01208181|540219431|FG002|Part 2|Protocol Violation|1|||
149751205|NCT01208181|540219432|FG003|Part 2|Protocol Violation|0|||
149751206|NCT01208181|540219433|FG004|Part 2|Protocol Violation|0|||
149751207|NCT01208181|540219429|FG000|Part 2|Physician Decision|0|||
149751208|NCT01208181|540219430|FG001|Part 2|Physician Decision|0|||
149751209|NCT01208181|540219431|FG002|Part 2|Physician Decision|1|||
149751210|NCT01208181|540219432|FG003|Part 2|Physician Decision|2|||
149751211|NCT01208181|540219433|FG004|Part 2|Physician Decision|0|||
149751212|NCT01208181|540219429|FG000|Part 2|Non-compliance with study drug|0|||
149751213|NCT01208181|540219430|FG001|Part 2|Non-compliance with study drug|0|||
149751214|NCT01208181|540219431|FG002|Part 2|Non-compliance with study drug|1|||
149751215|NCT01208181|540219432|FG003|Part 2|Non-compliance with study drug|1|||
149751216|NCT01208181|540219433|FG004|Part 2|Non-compliance with study drug|0|||
149751217|NCT01208181|540219429|FG000|Part 2|Lost to Follow-up|0|||
149751218|NCT01208181|540219430|FG001|Part 2|Lost to Follow-up|0|||
149751219|NCT01208181|540219431|FG002|Part 2|Lost to Follow-up|1|||
149751220|NCT01208181|540219432|FG003|Part 2|Lost to Follow-up|2|||
149751221|NCT01208181|540219433|FG004|Part 2|Lost to Follow-up|0|||
149751222|NCT01208181|540219429|FG000|Part 2|Lack of Efficacy|0|||
149751223|NCT01208181|540219430|FG001|Part 2|Lack of Efficacy|0|||
149751224|NCT01208181|540219431|FG002|Part 2|Lack of Efficacy|5|||
149751225|NCT01208181|540219432|FG003|Part 2|Lack of Efficacy|7|||
149751226|NCT01208181|540219433|FG004|Part 2|Lack of Efficacy|0|||
149751227|NCT01478347|540219438|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
149751228|NCT01478347|540219438|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
149751229|NCT01478347|540219438|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
149751230|NCT01645930|540219439|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
149751231|NCT01645930|540219439|FG000|Overall Study|Progressive Disease|12|||
149751232|NCT01645930|540219439|FG000|Overall Study|Adverse Event|4|||
149751233|NCT01645930|540219439|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
149751234|NCT01645930|540219439|FG000|Overall Study|Withdrawal by Participant|2|||
149751235|NCT01645930|540219439|FG000|Overall Study|Reason not Defined|1|||
149751236|NCT01164501|540219440|FG000|Overall Study|Not treated|2|||
149751237|NCT01164501|540219441|FG001|Overall Study|Not treated|0|||
149751238|NCT01164501|540219442|FG002|Overall Study|Not treated|1|||
149751239|NCT01164501|540219440|FG000|Overall Study|Adverse Event|18|||
149751240|NCT01164501|540219441|FG001|Overall Study|Adverse Event|4|||
149751241|NCT01164501|540219442|FG002|Overall Study|Adverse Event|21|||
149751242|NCT01164501|540219440|FG000|Overall Study|Lack of Efficacy|0|||
149751243|NCT01164501|540219441|FG001|Overall Study|Lack of Efficacy|0|||
149751244|NCT01164501|540219442|FG002|Overall Study|Lack of Efficacy|1|||
149751245|NCT01164501|540219440|FG000|Overall Study|Non compliant with protocol|1|||
149751246|NCT01164501|540219441|FG001|Overall Study|Non compliant with protocol|1|||
149751247|NCT01164501|540219442|FG002|Overall Study|Non compliant with protocol|4|||
149751248|NCT01164501|540219440|FG000|Overall Study|Lost to Follow-up|3|||
149751249|NCT01164501|540219441|FG001|Overall Study|Lost to Follow-up|0|||
149751250|NCT01164501|540219442|FG002|Overall Study|Lost to Follow-up|3|||
149751251|NCT01164501|540219440|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
149751252|NCT01164501|540219441|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
149751253|NCT01164501|540219442|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
149751254|NCT01164501|540219440|FG000|Overall Study|Other reason not defined above|9|||
149751255|NCT01164501|540219441|FG001|Overall Study|Other reason not defined above|1|||
149751256|NCT01164501|540219442|FG002|Overall Study|Other reason not defined above|4|||
149751257|NCT01096667|540219444|FG000|Overall Study|Lost to Follow-up|1|||
149751258|NCT01096667|540219445|FG001|Overall Study|Lost to Follow-up|1|||
149751259|NCT01096667|540219446|FG002|Overall Study|Lost to Follow-up|1|||
149751260|NCT01096667|540219447|FG003|Overall Study|Lost to Follow-up|0|||
149751261|NCT01096667|540219448|FG004|Overall Study|Lost to Follow-up|0|||
149751262|NCT01096667|540219444|FG000|Overall Study|Withdrawal by Subject|1|||
149751263|NCT01096667|540219445|FG001|Overall Study|Withdrawal by Subject|0|||
149751264|NCT01096667|540219446|FG002|Overall Study|Withdrawal by Subject|0|||
149751265|NCT01096667|540219447|FG003|Overall Study|Withdrawal by Subject|1|||
149751266|NCT01096667|540219448|FG004|Overall Study|Withdrawal by Subject|0|||
149751267|NCT01096667|540219444|FG000|Overall Study|Reason not available|0|||
149751268|NCT01096667|540219445|FG001|Overall Study|Reason not available|1|||
149751269|NCT01096667|540219446|FG002|Overall Study|Reason not available|1|||
149751270|NCT01096667|540219447|FG003|Overall Study|Reason not available|1|||
149751271|NCT01096667|540219448|FG004|Overall Study|Reason not available|0|||
149751272|NCT01096667|540219444|FG000|Overall Study|Protocol Violation|0|||
149751273|NCT01096667|540219445|FG001|Overall Study|Protocol Violation|0|||
149751274|NCT01096667|540219446|FG002|Overall Study|Protocol Violation|0|||
149751275|NCT01096667|540219447|FG003|Overall Study|Protocol Violation|1|||
149751276|NCT01096667|540219448|FG004|Overall Study|Protocol Violation|0|||
149751277|NCT01096667|540219444|FG000|Overall Study|Not treated|1|||
149751278|NCT01096667|540219445|FG001|Overall Study|Not treated|0|||
149751279|NCT01096667|540219446|FG002|Overall Study|Not treated|0|||
149751280|NCT01096667|540219447|FG003|Overall Study|Not treated|0|||
149751281|NCT01096667|540219448|FG004|Overall Study|Not treated|0|||
149751282|NCT01845077|540219451|FG000|Washout Period|Lost to Follow-up|0|||
149751283|NCT01845077|540219452|FG001|Washout Period|Lost to Follow-up|1|||
149751284|NCT01845077|540219453|FG002|Washout Period|Lost to Follow-up|0|||
149751285|NCT01845077|540219454|FG003|Washout Period|Lost to Follow-up|1|||
149751286|NCT01845077|540219455|FG004|Washout Period|Lost to Follow-up|0|||
149751287|NCT01845077|540219456|FG005|Washout Period|Lost to Follow-up|1|||
149751288|NCT01845077|540219451|FG000|Washout Period|Adverse Event|1|||
149751289|NCT01845077|540219452|FG001|Washout Period|Adverse Event|0|||
149751290|NCT01845077|540219453|FG002|Washout Period|Adverse Event|0|||
149751291|NCT01845077|540219454|FG003|Washout Period|Adverse Event|0|||
149751292|NCT01845077|540219455|FG004|Washout Period|Adverse Event|0|||
149751293|NCT01845077|540219456|FG005|Washout Period|Adverse Event|0|||
149751294|NCT01845077|540219451|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
149751295|NCT01845077|540219452|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
149751296|NCT01845077|540219453|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
149751297|NCT01845077|540219454|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
149751298|NCT01845077|540219455|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
149751299|NCT01845077|540219456|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
149751300|NCT01845077|540219451|FG000|Washout Period|Protocol Violation|0|||
149751301|NCT01845077|540219452|FG001|Washout Period|Protocol Violation|0|||
149751302|NCT01845077|540219453|FG002|Washout Period|Protocol Violation|0|||
149751303|NCT01845077|540219454|FG003|Washout Period|Protocol Violation|1|||
149751304|NCT01845077|540219455|FG004|Washout Period|Protocol Violation|1|||
149751305|NCT01845077|540219456|FG005|Washout Period|Protocol Violation|0|||
149751306|NCT00465738|540219459|FG000|Overall Study|Lost to Follow-up|2|||
149751307|NCT00465738|540219460|FG001|Overall Study|Lost to Follow-up|0|||
149751308|NCT00465738|540219459|FG000|Overall Study|Adverse Event|0|||
149751309|NCT00465738|540219460|FG001|Overall Study|Adverse Event|1|||
149751310|NCT00465738|540219459|FG000|Overall Study|Withdrawal by Subject|2|||
149751311|NCT00465738|540219460|FG001|Overall Study|Withdrawal by Subject|0|||
149751312|NCT00465738|540219459|FG000|Overall Study|Other|2|||
149751313|NCT00465738|540219460|FG001|Overall Study|Other|5|||
149751314|NCT01507246|540219467|FG000|Overall Study|Required different surgical procedures|2|||
149751315|NCT01507246|540219468|FG001|Overall Study|Required different surgical procedures|1|||
149751316|NCT02975349|540219471|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149751317|NCT02975349|540219472|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149751318|NCT02975349|540219473|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149751319|NCT02975349|540219474|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149751320|NCT02975349|540219475|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149751321|NCT02975349|540219476|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149751322|NCT02975349|540219477|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149751323|NCT02975349|540219471|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149751324|NCT02975349|540219472|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751325|NCT02975349|540219473|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751326|NCT02975349|540219474|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751327|NCT02975349|540219475|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751328|NCT02975349|540219476|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751329|NCT02975349|540219477|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149751330|NCT02975349|540219471|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
149751331|NCT02975349|540219472|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
149751332|NCT02975349|540219473|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
149751333|NCT02975349|540219474|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149751334|NCT02975349|540219475|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149751335|NCT02975349|540219476|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
149751336|NCT02975349|540219477|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149751337|NCT02975349|540219471|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149751338|NCT02975349|540219472|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149751339|NCT02975349|540219473|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149751340|NCT02975349|540219474|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149751341|NCT02975349|540219475|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
149751342|NCT02975349|540219476|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149751343|NCT02975349|540219477|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149751344|NCT02975349|540219471|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149751345|NCT02975349|540219472|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
149751346|NCT02975349|540219473|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149751347|NCT02975349|540219474|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
149751348|NCT02975349|540219475|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
149751349|NCT02975349|540219476|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
149751350|NCT02975349|540219477|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149751351|NCT02975349|540219471|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751352|NCT02975349|540219472|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751353|NCT02975349|540219473|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751354|NCT02975349|540219474|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
149751355|NCT02975349|540219475|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751356|NCT02975349|540219476|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751357|NCT02975349|540219477|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149751358|NCT02975349|540219471|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751359|NCT02975349|540219472|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
149751360|NCT02975349|540219473|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751361|NCT02975349|540219474|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751362|NCT02975349|540219475|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751363|NCT02975349|540219476|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751364|NCT02975349|540219477|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149751365|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
149751366|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
149751367|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
149751368|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149751369|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149751370|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
149751371|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149751372|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751373|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751374|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751375|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751376|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
149751377|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751378|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149751379|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149751380|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149751381|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149751382|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149751383|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
149751384|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149751385|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
149751386|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
149751387|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
149751388|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
149751389|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
149751390|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
149751391|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
149751392|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
149751393|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149751394|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149751395|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149751396|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
149751397|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
149751398|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
149751399|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
149751400|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149751401|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149751402|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
149751403|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149751404|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149751405|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
149751406|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149751407|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
149751408|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
149751409|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
149751410|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
149751411|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
149751412|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
149751413|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
149751414|NCT02975349|540219471|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
149751415|NCT02975349|540219472|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
149751416|NCT02975349|540219473|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
149751417|NCT02975349|540219474|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
149751418|NCT02975349|540219475|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
149751419|NCT02975349|540219476|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
149751420|NCT02975349|540219477|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
149751421|NCT01318902|540219487|FG000|Overall Study|Symptomatic Deterioration|0|||
149751422|NCT01318902|540219488|FG001|Overall Study|Symptomatic Deterioration|1|||
149751423|NCT01318902|540219489|FG002|Overall Study|Symptomatic Deterioration|1|||
149751424|NCT01318902|540219490|FG003|Overall Study|Symptomatic Deterioration|2|||
149751425|NCT01318902|540219487|FG000|Overall Study|Withdrawal by Patient|0|||
149751426|NCT01318902|540219488|FG001|Overall Study|Withdrawal by Patient|1|||
149751427|NCT01318902|540219489|FG002|Overall Study|Withdrawal by Patient|0|||
149751428|NCT01318902|540219490|FG003|Overall Study|Withdrawal by Patient|3|||
149751429|NCT01318902|540219487|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
149751430|NCT01318902|540219488|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
149751431|NCT01318902|540219489|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
149751432|NCT01318902|540219490|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
149751433|NCT01318902|540219487|FG000|Overall Study|Adverse Event|0|||
149751434|NCT01318902|540219488|FG001|Overall Study|Adverse Event|1|||
149751435|NCT01318902|540219489|FG002|Overall Study|Adverse Event|0|||
149751436|NCT01318902|540219490|FG003|Overall Study|Adverse Event|0|||
149751437|NCT01318902|540219487|FG000|Overall Study|Terminated by Sponsor|0|||
149751438|NCT01318902|540219488|FG001|Overall Study|Terminated by Sponsor|0|||
149751439|NCT01318902|540219489|FG002|Overall Study|Terminated by Sponsor|1|||
149751440|NCT01318902|540219490|FG003|Overall Study|Terminated by Sponsor|0|||
149751441|NCT02699515|540221253|FG000|Overall Study|Death|3|||
149751442|NCT02699515|540221254|FG001|Overall Study|Death|3|||
149751443|NCT02699515|540221255|FG002|Overall Study|Death|3|||
149751444|NCT02699515|540221256|FG003|Overall Study|Death|23|||
149751445|NCT02699515|540221257|FG004|Overall Study|Death|22|||
149751446|NCT02699515|540221258|FG005|Overall Study|Death|23|||
149751447|NCT02699515|540221259|FG006|Overall Study|Death|3|||
149751448|NCT02699515|540221260|FG007|Overall Study|Death|5|||
149751449|NCT02699515|540221253|FG000|Overall Study|Withdrawal by Subject|0|||
149751450|NCT02699515|540221254|FG001|Overall Study|Withdrawal by Subject|0|||
149751451|NCT02699515|540221255|FG002|Overall Study|Withdrawal by Subject|3|||
149751452|NCT02699515|540221256|FG003|Overall Study|Withdrawal by Subject|1|||
149751453|NCT02699515|540221257|FG004|Overall Study|Withdrawal by Subject|5|||
149751454|NCT02699515|540221258|FG005|Overall Study|Withdrawal by Subject|3|||
149751455|NCT02699515|540221259|FG006|Overall Study|Withdrawal by Subject|0|||
149751456|NCT02699515|540221260|FG007|Overall Study|Withdrawal by Subject|1|||
149751457|NCT02699515|540221253|FG000|Overall Study|Other|1|||
149751458|NCT02699515|540221254|FG001|Overall Study|Other|0|||
149751459|NCT02699515|540221255|FG002|Overall Study|Other|1|||
149751460|NCT02699515|540221256|FG003|Overall Study|Other|6|||
149751461|NCT02699515|540221257|FG004|Overall Study|Other|4|||
149751462|NCT02699515|540221258|FG005|Overall Study|Other|3|||
149751463|NCT02699515|540221259|FG006|Overall Study|Other|0|||
149751464|NCT02699515|540221260|FG007|Overall Study|Other|0|||
149751465|NCT01240811|540221261|FG000|Overall Study|Physician Decision|0|||
149751466|NCT01240811|540221262|FG001|Overall Study|Physician Decision|1|||
149751467|NCT01240811|540221263|FG002|Overall Study|Physician Decision|0|||
149751468|NCT01240811|540221261|FG000|Overall Study|Withdrawal by Subject|0|||
149751469|NCT01240811|540221262|FG001|Overall Study|Withdrawal by Subject|0|||
149751470|NCT01240811|540221263|FG002|Overall Study|Withdrawal by Subject|1|||
149751471|NCT03825042|540221272|FG000|Overall Study|Adverse Event|1|||
149751472|NCT03825042|540221273|FG001|Overall Study|Adverse Event|0|||
149751473|NCT03825042|540221272|FG000|Overall Study|Withdrawal by Subject|1|||
149751474|NCT03825042|540221273|FG001|Overall Study|Withdrawal by Subject|0|||
149751475|NCT01158534|540221286|FG000|Overall Study|Withdrawal by Subject|1|||
149751476|NCT01158534|540221286|FG000|Overall Study|Death|1|||
149751477|NCT01158534|540221286|FG000|Overall Study|Other|1|||
149751478|NCT01988012|540221287|FG000|Overall Study|Adverse Event|5|||
149751479|NCT01988012|540221287|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149751480|NCT01988012|540221287|FG000|Overall Study|Patient Withdrawal of Consent|4|||
149751481|NCT01988012|540221287|FG000|Overall Study|Lost to Follow-up|1|||
149751482|NCT01988012|540221287|FG000|Overall Study|Physician Decision|1|||
149751483|NCT01988012|540221287|FG000|Overall Study|Protocol Violation|1|||
149751484|NCT01058369|540221288|FG000|Overall Study|Adverse Event|1|||
149751485|NCT01058369|540221288|FG000|Overall Study|Early termination study|1|||
149751486|NCT04003155|540221289|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
149751487|NCT04003155|540221290|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
149751488|NCT04003155|540221291|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
149751489|NCT04003155|540221292|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
149751490|NCT04003155|540221293|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
149751491|NCT04003155|540221289|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
149751492|NCT04003155|540221290|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
149751493|NCT04003155|540221291|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149751494|NCT04003155|540221292|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149751495|NCT04003155|540221293|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149751496|NCT04003155|540221289|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
149751497|NCT04003155|540221290|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
149751498|NCT04003155|540221291|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
149751499|NCT04003155|540221292|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
149751500|NCT04003155|540221293|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
149751501|NCT04003155|540221289|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
149751502|NCT04003155|540221290|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
149751503|NCT04003155|540221291|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
149751504|NCT04003155|540221292|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
149751505|NCT04003155|540221293|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
149751506|NCT04003155|540221289|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
149751507|NCT04003155|540221290|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
149751508|NCT04003155|540221291|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
149751509|NCT04003155|540221292|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
149751510|NCT04003155|540221293|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
149751511|NCT04003155|540221289|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
149751512|NCT04003155|540221290|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
149751513|NCT04003155|540221291|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
149751514|NCT04003155|540221292|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
149751515|NCT04003155|540221293|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
149751516|NCT04003155|540221289|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
149751517|NCT04003155|540221290|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149751518|NCT04003155|540221291|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
149751519|NCT04003155|540221292|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149751520|NCT04003155|540221293|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149751521|NCT04003155|540221289|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
149751522|NCT04003155|540221290|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
149751523|NCT04003155|540221291|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
149751524|NCT04003155|540221292|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
149751525|NCT04003155|540221293|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
149751526|NCT04003155|540221289|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
149751527|NCT04003155|540221290|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
149751528|NCT04003155|540221291|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
149751529|NCT04003155|540221292|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
149751530|NCT04003155|540221293|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
149751531|NCT01666444|540221297|FG000|Overall Study|Did not initiate treatment|2|||
149751532|NCT01666444|540221298|FG001|Overall Study|Did not initiate treatment|1|||
149751533|NCT00950690|540221301|FG000|Overall Study|Death|4|||
149751534|NCT00950690|540221301|FG000|Overall Study|Adverse Event|15|||
149751535|NCT00950690|540221301|FG000|Overall Study|Lack of Efficacy|22|||
149751536|NCT00950690|540221301|FG000|Overall Study|Lost to Follow-up|40|||
149751537|NCT00950690|540221301|FG000|Overall Study|Other|163|||
149751538|NCT01713036|540221302|FG000|Overall Study|Death|1|||
149751539|NCT00592358|540221303|FG000|Overall Study|Withdrawal by Subject|2|||
149751540|NCT00592358|540221303|FG000|Overall Study|Adverse Event|1|||
149751541|NCT00592358|540221303|FG000|Overall Study|Lack of Efficacy|2|||
149751542|NCT00592358|540221303|FG000|Overall Study|Inability to swallow pills|1|||
149751543|NCT04760314|540221306|FG000|Induction Period|Withdrawal by Subject|0|||
149751544|NCT04760314|540221307|FG001|Induction Period|Withdrawal by Subject|1|||
149751545|NCT04760314|540221308|FG002|Induction Period|Withdrawal by Subject|1|||
149751546|NCT04760314|540221309|FG003|Induction Period|Withdrawal by Subject|0|||
149751547|NCT04760314|540221310|FG004|Induction Period|Withdrawal by Subject|0|||
149751548|NCT04760314|540221311|FG005|Induction Period|Withdrawal by Subject|0|||
149751549|NCT04760314|540221312|FG006|Induction Period|Withdrawal by Subject|0|||
149751550|NCT04760314|540221313|FG007|Induction Period|Withdrawal by Subject|0|||
149751551|NCT04760314|540221314|FG008|Induction Period|Withdrawal by Subject|0|||
149751552|NCT04760314|540221315|FG009|Induction Period|Withdrawal by Subject|0|||
149751553|NCT04760314|540221316|FG010|Induction Period|Withdrawal by Subject|0|||
149751554|NCT04760314|540221306|FG000|Induction Period|Adverse Event|0|||
149751555|NCT04760314|540221307|FG001|Induction Period|Adverse Event|0|||
149751556|NCT04760314|540221308|FG002|Induction Period|Adverse Event|2|||
149751557|NCT04760314|540221309|FG003|Induction Period|Adverse Event|0|||
149751558|NCT04760314|540221310|FG004|Induction Period|Adverse Event|0|||
149751559|NCT04760314|540221311|FG005|Induction Period|Adverse Event|0|||
149751560|NCT04760314|540221312|FG006|Induction Period|Adverse Event|0|||
149751561|NCT04760314|540221313|FG007|Induction Period|Adverse Event|0|||
149751562|NCT04760314|540221314|FG008|Induction Period|Adverse Event|0|||
149751563|NCT04760314|540221315|FG009|Induction Period|Adverse Event|0|||
149751564|NCT04760314|540221316|FG010|Induction Period|Adverse Event|0|||
149751565|NCT04760314|540221306|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751566|NCT04760314|540221307|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751567|NCT04760314|540221308|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751568|NCT04760314|540221309|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
149751569|NCT04760314|540221310|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
149751570|NCT04760314|540221311|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
149751571|NCT04760314|540221312|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
149751572|NCT04760314|540221313|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751573|NCT04760314|540221314|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751574|NCT04760314|540221315|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751575|NCT04760314|540221316|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
149751576|NCT04760314|540221306|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751577|NCT04760314|540221307|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751578|NCT04760314|540221308|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751579|NCT04760314|540221309|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
149751580|NCT04760314|540221310|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751581|NCT04760314|540221311|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
149751582|NCT04760314|540221312|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
149751583|NCT04760314|540221313|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751584|NCT04760314|540221314|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751585|NCT04760314|540221315|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751586|NCT04760314|540221316|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149751587|NCT04760314|540221306|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751588|NCT04760314|540221307|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751589|NCT04760314|540221308|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751590|NCT04760314|540221309|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751591|NCT04760314|540221310|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
149751592|NCT04760314|540221311|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751593|NCT04760314|540221312|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751594|NCT04760314|540221313|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751595|NCT04760314|540221314|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751596|NCT04760314|540221315|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751597|NCT04760314|540221316|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149751598|NCT04760314|540221306|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
149751599|NCT04760314|540221307|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
149751600|NCT04760314|540221308|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
149751601|NCT04760314|540221309|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
149751602|NCT04760314|540221310|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
149751603|NCT04760314|540221311|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
149751604|NCT04760314|540221312|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
149751605|NCT04760314|540221313|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
149751606|NCT04760314|540221314|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
149751607|NCT04760314|540221315|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
149751608|NCT04760314|540221316|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
149751609|NCT04760314|540221306|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751610|NCT04760314|540221307|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751611|NCT04760314|540221308|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751612|NCT04760314|540221309|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751613|NCT04760314|540221310|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751614|NCT04760314|540221311|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751615|NCT04760314|540221312|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751616|NCT04760314|540221313|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149751617|NCT04760314|540221314|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149751618|NCT04760314|540221315|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149751619|NCT04760314|540221316|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149751620|NCT04760314|540221306|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751621|NCT04760314|540221307|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751622|NCT04760314|540221308|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751623|NCT04760314|540221309|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751624|NCT04760314|540221310|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751625|NCT04760314|540221311|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751626|NCT04760314|540221312|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751627|NCT04760314|540221313|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
149751628|NCT04760314|540221314|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
149751629|NCT04760314|540221315|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
149751630|NCT04760314|540221316|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149751631|NCT04760314|540221306|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751632|NCT04760314|540221307|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751633|NCT04760314|540221308|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751634|NCT04760314|540221309|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751635|NCT04760314|540221310|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751636|NCT04760314|540221311|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751637|NCT04760314|540221312|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751638|NCT04760314|540221313|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
149751639|NCT04760314|540221314|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751640|NCT04760314|540221315|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751641|NCT04760314|540221316|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149751642|NCT04760314|540221306|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751643|NCT04760314|540221307|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751644|NCT04760314|540221308|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751645|NCT04760314|540221309|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751646|NCT04760314|540221310|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751647|NCT04760314|540221311|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751648|NCT04760314|540221312|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751649|NCT04760314|540221313|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751650|NCT04760314|540221314|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
149751651|NCT04760314|540221315|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
149751652|NCT04760314|540221316|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
149751653|NCT01013883|540221317|FG000|Overall Study|Lost to Follow-up|2|||
149751654|NCT01013883|540221318|FG001|Overall Study|Lost to Follow-up|2|||
149751655|NCT01371838|540221319|FG000|Overall Study|Withdrawal by Subject|27|||
149751656|NCT01371838|540221320|FG001|Overall Study|Withdrawal by Subject|33|||
149751657|NCT01371838|540221319|FG000|Overall Study|Lost to Follow-up|10|||
149751658|NCT01371838|540221320|FG001|Overall Study|Lost to Follow-up|20|||
149751659|NCT01371838|540221319|FG000|Overall Study|Death|3|||
149751660|NCT01371838|540221320|FG001|Overall Study|Death|4|||
149751661|NCT01371838|540221319|FG000|Overall Study|Protocol Violation|3|||
149751662|NCT01371838|540221320|FG001|Overall Study|Protocol Violation|0|||
149751663|NCT01371838|540221319|FG000|Overall Study|Investigator Decision|3|||
149751664|NCT01371838|540221320|FG001|Overall Study|Investigator Decision|8|||
149751665|NCT01371838|540221319|FG000|Overall Study|Last follow-up visit not conducted|2|||
149751666|NCT01371838|540221320|FG001|Overall Study|Last follow-up visit not conducted|0|||
149751667|NCT01371838|540221319|FG000|Overall Study|Lack of therapeutic response|0|||
149751668|NCT01371838|540221320|FG001|Overall Study|Lack of therapeutic response|1|||
149751669|NCT01371838|540221319|FG000|Overall Study|Surgery|1|||
149751670|NCT01371838|540221320|FG001|Overall Study|Surgery|0|||
149751671|NCT00641043|540221327|FG000|Overall Study|Adverse Event|6|||
149751672|NCT00641043|540221328|FG001|Overall Study|Adverse Event|4|||
149751673|NCT00641043|540221327|FG000|Overall Study|Protocol Violation|2|||
149751674|NCT00641043|540221328|FG001|Overall Study|Protocol Violation|3|||
149751675|NCT00641043|540221327|FG000|Overall Study|Lost to Follow-up|3|||
149751676|NCT00641043|540221328|FG001|Overall Study|Lost to Follow-up|2|||
149751677|NCT00641043|540221327|FG000|Overall Study|Withdrawal by Subject|4|||
149751678|NCT00641043|540221328|FG001|Overall Study|Withdrawal by Subject|4|||
149751679|NCT00641043|540221327|FG000|Overall Study|Other incl. lack of efficacy|4|||
149751680|NCT00641043|540221328|FG001|Overall Study|Other incl. lack of efficacy|2|||
149751681|NCT00907478|540221331|FG000|Overall Study|Ineligibility determined|0|||
149751682|NCT00907478|540221332|FG001|Overall Study|Ineligibility determined|0|||
149751683|NCT00907478|540221333|FG002|Overall Study|Ineligibility determined|1|||
149751684|NCT00907478|540221331|FG000|Overall Study|Noncompliance|0|||
149751685|NCT00907478|540221332|FG001|Overall Study|Noncompliance|0|||
149751686|NCT00907478|540221333|FG002|Overall Study|Noncompliance|1|||
149751687|NCT00907478|540221331|FG000|Overall Study|Adverse Event|3|||
149751688|NCT00907478|540221332|FG001|Overall Study|Adverse Event|1|||
149751689|NCT00907478|540221333|FG002|Overall Study|Adverse Event|2|||
149751690|NCT00907478|540221331|FG000|Overall Study|Withdrawal by Subject|8|||
149751691|NCT00907478|540221332|FG001|Overall Study|Withdrawal by Subject|9|||
149751692|NCT00907478|540221333|FG002|Overall Study|Withdrawal by Subject|6|||
149751693|NCT00907478|540221331|FG000|Overall Study|Requirement for alternative therapy|1|||
149751694|NCT00907478|540221332|FG001|Overall Study|Requirement for alternative therapy|2|||
149751695|NCT00907478|540221333|FG002|Overall Study|Requirement for alternative therapy|3|||
149751696|NCT00907478|540221331|FG000|Overall Study|Physician Decision|2|||
149751697|NCT00907478|540221332|FG001|Overall Study|Physician Decision|0|||
149751698|NCT00907478|540221333|FG002|Overall Study|Physician Decision|3|||
149751699|NCT00907478|540221331|FG000|Overall Study|Death|4|||
149751700|NCT00907478|540221332|FG001|Overall Study|Death|2|||
149751701|NCT00907478|540221333|FG002|Overall Study|Death|1|||
149751702|NCT00907478|540221331|FG000|Overall Study|Protocol-specified criteria|5|||
149751703|NCT00907478|540221332|FG001|Overall Study|Protocol-specified criteria|2|||
149751704|NCT00907478|540221333|FG002|Overall Study|Protocol-specified criteria|3|||
149751705|NCT00907478|540221331|FG000|Overall Study|Pregnancy|0|||
149751706|NCT00907478|540221332|FG001|Overall Study|Pregnancy|1|||
149751707|NCT00907478|540221333|FG002|Overall Study|Pregnancy|1|||
149751708|NCT00907478|540221331|FG000|Overall Study|Lost to Follow-up|1|||
149751709|NCT00907478|540221332|FG001|Overall Study|Lost to Follow-up|0|||
149751710|NCT00907478|540221333|FG002|Overall Study|Lost to Follow-up|0|||
149751711|NCT00907478|540221331|FG000|Overall Study|Other|3|||
149751712|NCT00907478|540221332|FG001|Overall Study|Other|0|||
149751713|NCT00907478|540221333|FG002|Overall Study|Other|1|||
149751714|NCT01936649|540221334|FG000|Overall Study|Withdrawal by Subject|4|||
149751715|NCT01936649|540221334|FG000|Overall Study|Physician Decision|2|||
149751716|NCT01936649|540221334|FG000|Overall Study|Protocol Violation|2|||
149751717|NCT01936649|540221334|FG000|Overall Study|Other than specified above|5|||
149751718|NCT02546856|540221337|FG000|4 Months Evaluation|Death|2|||
149751719|NCT02546856|540221338|FG001|4 Months Evaluation|Death|3|||
149751720|NCT02546856|540221337|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
149751721|NCT02546856|540221338|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
149751722|NCT02546856|540221337|FG000|4 Months Evaluation|Lost to Follow-up|3|||
149751723|NCT02546856|540221338|FG001|4 Months Evaluation|Lost to Follow-up|3|||
149751724|NCT02546856|540221337|FG000|4 Months Evaluation|Physician Decision|3|||
149751725|NCT02546856|540221338|FG001|4 Months Evaluation|Physician Decision|0|||
149751726|NCT02546856|540221337|FG000|4 Months Evaluation|Working or living abroad|5|||
149751727|NCT02546856|540221338|FG001|4 Months Evaluation|Working or living abroad|1|||
149751728|NCT02546856|540221337|FG000|4 Months Evaluation|reasons not due to titration|4|||
149751729|NCT02546856|540221338|FG001|4 Months Evaluation|reasons not due to titration|1|||
149751730|NCT02546856|540221337|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
149751731|NCT02546856|540221338|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
149751732|NCT02546856|540221337|FG000|6 Months Evaluation|Death|1|||
149751733|NCT02546856|540221338|FG001|6 Months Evaluation|Death|1|||
149751734|NCT02546856|540221337|FG000|6 Months Evaluation|Lost to Follow-up|1|||
149751735|NCT02546856|540221338|FG001|6 Months Evaluation|Lost to Follow-up|1|||
149751736|NCT02546856|540221337|FG000|6 Months Evaluation|Working or living abroad|6|||
149751737|NCT02546856|540221338|FG001|6 Months Evaluation|Working or living abroad|4|||
149751738|NCT02546856|540221337|FG000|6 Months Evaluation|reasons not due to titration|0|||
149751739|NCT02546856|540221338|FG001|6 Months Evaluation|reasons not due to titration|1|||
149751740|NCT03268746|540221340|FG000|Overall Study|Withdrawal by Subject|1|||
149751741|NCT00589472|540221341|FG000|Overall Study|Adverse Event|1|||
149751742|NCT00117338|540221342|FG000|Overall Study|Adverse Event|0|||
149751743|NCT00117338|540221343|FG001|Overall Study|Adverse Event|1|||
149751744|NCT00117338|540221342|FG000|Overall Study|Protocol Violation|3|||
149751745|NCT00117338|540221343|FG001|Overall Study|Protocol Violation|2|||
149751746|NCT00117338|540221342|FG000|Overall Study|Withdrawal by Subject|1|||
149751747|NCT00117338|540221343|FG001|Overall Study|Withdrawal by Subject|0|||
149751748|NCT00117338|540221342|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
149751749|NCT00117338|540221343|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
149751750|NCT00117338|540221342|FG000|Overall Study|Lack of Efficacy|0|||
149751751|NCT00117338|540221343|FG001|Overall Study|Lack of Efficacy|1|||
149751752|NCT00546351|540221344|FG000|Overall Study|Adverse Event|76|||
149751753|NCT00546351|540221344|FG000|Overall Study|Lack of Efficacy|15|||
149751754|NCT00546351|540221344|FG000|Overall Study|Withdrawal by Subject|109|||
149751755|NCT00546351|540221344|FG000|Overall Study|Lost to Follow-up|9|||
149751756|NCT00546351|540221344|FG000|Overall Study|Protocol Deviation|1|||
149751757|NCT00546351|540221344|FG000|Overall Study|Unsatisfactory compliance|9|||
149751758|NCT00546351|540221344|FG000|Overall Study|Other reasons for premature termination|17|||
149751759|NCT01342640|540221345|FG000|Overall Study|Adverse Event|3|||
149751760|NCT01342640|540221345|FG000|Overall Study|Protocol Violation|16|||
149751761|NCT01342640|540221345|FG000|Overall Study|Lost to Follow-up|21|||
149751762|NCT01342640|540221345|FG000|Overall Study|Other|1|||
149751763|NCT02616029|540221346|FG000|Overall Study|Adverse Event|1|||
149751764|NCT02616029|540221347|FG001|Overall Study|Adverse Event|0|||
149751765|NCT02616029|540221346|FG000|Overall Study|Death|0|||
149751766|NCT02616029|540221347|FG001|Overall Study|Death|1|||
149751767|NCT02616029|540221346|FG000|Overall Study|Protocol Violation|1|||
149751768|NCT02616029|540221347|FG001|Overall Study|Protocol Violation|0|||
149751769|NCT02616029|540221346|FG000|Overall Study|Withdrew Consent|1|||
149751770|NCT02616029|540221347|FG001|Overall Study|Withdrew Consent|0|||
149751771|NCT02616029|540221346|FG000|Overall Study|Enrolled and Never Treated|1|||
149751772|NCT02616029|540221347|FG001|Overall Study|Enrolled and Never Treated|1|||
149751773|NCT00479466|540221350|FG000|Overall Study|Adverse Event|5|||
149751774|NCT00479466|540221351|FG001|Overall Study|Adverse Event|1|||
149751775|NCT00479466|540221352|FG002|Overall Study|Adverse Event|0|||
149751776|NCT00479466|540221353|FG003|Overall Study|Adverse Event|1|||
149751777|NCT00479466|540221354|FG004|Overall Study|Adverse Event|2|||
149751778|NCT00479466|540221355|FG005|Overall Study|Adverse Event|0|||
149751779|NCT00479466|540221350|FG000|Overall Study|Hyperglycemia|0|||
149751780|NCT00479466|540221351|FG001|Overall Study|Hyperglycemia|0|||
149751781|NCT00479466|540221352|FG002|Overall Study|Hyperglycemia|0|||
149751782|NCT00479466|540221353|FG003|Overall Study|Hyperglycemia|0|||
149751783|NCT00479466|540221354|FG004|Overall Study|Hyperglycemia|0|||
149751784|NCT00479466|540221355|FG005|Overall Study|Hyperglycemia|1|||
149751785|NCT00479466|540221350|FG000|Overall Study|Lack of Efficacy|2|||
149751786|NCT00479466|540221351|FG001|Overall Study|Lack of Efficacy|0|||
149751787|NCT00479466|540221352|FG002|Overall Study|Lack of Efficacy|1|||
149751788|NCT00479466|540221353|FG003|Overall Study|Lack of Efficacy|0|||
149751789|NCT00479466|540221354|FG004|Overall Study|Lack of Efficacy|0|||
149751790|NCT00479466|540221355|FG005|Overall Study|Lack of Efficacy|0|||
149751791|NCT00479466|540221350|FG000|Overall Study|Lost to Follow-up|0|||
149751792|NCT00479466|540221351|FG001|Overall Study|Lost to Follow-up|1|||
149751793|NCT00479466|540221352|FG002|Overall Study|Lost to Follow-up|1|||
149751794|NCT00479466|540221353|FG003|Overall Study|Lost to Follow-up|0|||
149751795|NCT00479466|540221354|FG004|Overall Study|Lost to Follow-up|2|||
149751796|NCT00479466|540221355|FG005|Overall Study|Lost to Follow-up|2|||
149751797|NCT00479466|540221350|FG000|Overall Study|Physician Decision|2|||
149751798|NCT00479466|540221351|FG001|Overall Study|Physician Decision|1|||
149751799|NCT00479466|540221352|FG002|Overall Study|Physician Decision|1|||
149751800|NCT00479466|540221353|FG003|Overall Study|Physician Decision|0|||
149751801|NCT00479466|540221354|FG004|Overall Study|Physician Decision|0|||
149751802|NCT00479466|540221355|FG005|Overall Study|Physician Decision|0|||
149751803|NCT00479466|540221350|FG000|Overall Study|Pregnancy|0|||
149751804|NCT00479466|540221351|FG001|Overall Study|Pregnancy|0|||
149751805|NCT00479466|540221352|FG002|Overall Study|Pregnancy|0|||
149751806|NCT00479466|540221353|FG003|Overall Study|Pregnancy|0|||
149751807|NCT00479466|540221354|FG004|Overall Study|Pregnancy|1|||
149751808|NCT00479466|540221355|FG005|Overall Study|Pregnancy|0|||
149751809|NCT00479466|540221350|FG000|Overall Study|Protocol Violation|1|||
149751810|NCT00479466|540221351|FG001|Overall Study|Protocol Violation|0|||
149751811|NCT00479466|540221352|FG002|Overall Study|Protocol Violation|0|||
149751812|NCT00479466|540221353|FG003|Overall Study|Protocol Violation|0|||
149751813|NCT00479466|540221354|FG004|Overall Study|Protocol Violation|0|||
149751814|NCT00479466|540221355|FG005|Overall Study|Protocol Violation|0|||
149751815|NCT00479466|540221350|FG000|Overall Study|Withdrawal by Subject|3|||
149751816|NCT00479466|540221351|FG001|Overall Study|Withdrawal by Subject|5|||
149751817|NCT00479466|540221352|FG002|Overall Study|Withdrawal by Subject|0|||
149751818|NCT00479466|540221353|FG003|Overall Study|Withdrawal by Subject|2|||
149751819|NCT00479466|540221354|FG004|Overall Study|Withdrawal by Subject|3|||
149751820|NCT00479466|540221355|FG005|Overall Study|Withdrawal by Subject|1|||
149751821|NCT02927171|540221357|FG000|Overall Study|Lost to Follow-up|0|||
149751822|NCT02927171|540221358|FG001|Overall Study|Lost to Follow-up|1|||
149751823|NCT00850499|540221361|FG000|Overall Study|Adverse Event|3|||
149751824|NCT00850499|540221362|FG001|Overall Study|Adverse Event|1|||
149751825|NCT00850499|540221361|FG000|Overall Study|Lack of Efficacy|0|||
149751826|NCT00850499|540221362|FG001|Overall Study|Lack of Efficacy|1|||
149751827|NCT00718861|540221363|FG000|Overall Study|Withdrawal by Subject|15|||
149751828|NCT00718861|540221364|FG001|Overall Study|Withdrawal by Subject|10|||
149751829|NCT00718861|540221363|FG000|Overall Study|Adverse Event|2|||
149751830|NCT00718861|540221364|FG001|Overall Study|Adverse Event|1|||
149751831|NCT00718861|540221363|FG000|Overall Study|Lost to Follow-up|2|||
149751832|NCT00718861|540221364|FG001|Overall Study|Lost to Follow-up|1|||
149751833|NCT00718861|540221363|FG000|Overall Study|Administrative Problems|1|||
149751834|NCT00718861|540221364|FG001|Overall Study|Administrative Problems|1|||
149751835|NCT00718861|540221363|FG000|Overall Study|Death|1|||
149751836|NCT00718861|540221364|FG001|Overall Study|Death|5|||
149751837|NCT01703819|540221365|FG000|Overall Study|Adverse Event|0|||
149751838|NCT01703819|540221366|FG001|Overall Study|Adverse Event|1|||
149751839|NCT01703819|540221365|FG000|Overall Study|Withdrawal by Subject|0|||
149751840|NCT01703819|540221366|FG001|Overall Study|Withdrawal by Subject|1|||
149751841|NCT01302041|540221367|FG000|Overall Study|Death|5|||
149751842|NCT01302041|540221367|FG000|Overall Study|Withdrawal by Subject|4|||
149751843|NCT01302041|540221367|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
149751844|NCT01302041|540221367|FG000|Overall Study|Other-Miscellaneous Reason|2|||
149751845|NCT00858702|540221368|FG000|Overall Study|Lack of Efficacy|1|||
149751846|NCT00858702|540221369|FG001|Overall Study|Lack of Efficacy|0|||
149751847|NCT00858702|540221368|FG000|Overall Study|Protocol Violation|1|||
149751848|NCT00858702|540221369|FG001|Overall Study|Protocol Violation|1|||
149751849|NCT00858702|540221368|FG000|Overall Study|Other|2|||
149751850|NCT00858702|540221369|FG001|Overall Study|Other|1|||
149751851|NCT00858702|540221368|FG000|Overall Study|Withdrawal by Subject|1|||
149751852|NCT00858702|540221369|FG001|Overall Study|Withdrawal by Subject|0|||
149751853|NCT01849250|540221372|FG000|Overall Study|Withdrawal by Subject|1|||
149751854|NCT01849250|540221373|FG001|Overall Study|Withdrawal by Subject|0|||
149751855|NCT01849250|540221372|FG000|Overall Study|Not Evaluable|5|||
149751856|NCT01849250|540221373|FG001|Overall Study|Not Evaluable|3|||
149751857|NCT01849250|540221372|FG000|Overall Study|Screen Failure|1|||
149751858|NCT01849250|540221373|FG001|Overall Study|Screen Failure|0|||
149751859|NCT00367640|540221374|FG000|Overall Study|Adverse Event|3|||
149751860|NCT00367640|540221375|FG001|Overall Study|Adverse Event|6|||
149751861|NCT00367640|540221376|FG002|Overall Study|Adverse Event|8|||
149751862|NCT00367640|540221377|FG003|Overall Study|Adverse Event|0|||
149751863|NCT00367640|540221374|FG000|Overall Study|Withdrawal by Subject|8|||
149751864|NCT00367640|540221375|FG001|Overall Study|Withdrawal by Subject|11|||
149751865|NCT00367640|540221376|FG002|Overall Study|Withdrawal by Subject|8|||
149751866|NCT00367640|540221377|FG003|Overall Study|Withdrawal by Subject|6|||
149751867|NCT00367640|540221374|FG000|Overall Study|Any other reason not above-mentioned|7|||
149751868|NCT00367640|540221375|FG001|Overall Study|Any other reason not above-mentioned|5|||
149751869|NCT00367640|540221376|FG002|Overall Study|Any other reason not above-mentioned|3|||
149751870|NCT00367640|540221377|FG003|Overall Study|Any other reason not above-mentioned|4|||
149751871|NCT04504032|540221380|FG000|Overall Study|Adverse Event|1|||
149751872|NCT04504032|540221381|FG001|Overall Study|Adverse Event|2|||
149751873|NCT04504032|540221380|FG000|Overall Study|Lost to Follow-up|6|||
149751874|NCT04504032|540221381|FG001|Overall Study|Lost to Follow-up|9|||
149751875|NCT04504032|540221380|FG000|Overall Study|Protocol Violation|2|||
149751876|NCT04504032|540221381|FG001|Overall Study|Protocol Violation|0|||
149751877|NCT04504032|540221380|FG000|Overall Study|Study terminated by sponsor|1|||
149751878|NCT04504032|540221381|FG001|Overall Study|Study terminated by sponsor|2|||
149751879|NCT04504032|540221380|FG000|Overall Study|Withdrawal by Subject|9|||
149751880|NCT04504032|540221381|FG001|Overall Study|Withdrawal by Subject|11|||
149751881|NCT04504032|540221380|FG000|Overall Study|Disease progression prior to dosing|15|||
149751882|NCT04504032|540221381|FG001|Overall Study|Disease progression prior to dosing|3|||
149751883|NCT04504032|540221380|FG000|Overall Study|Drug supply issues|1|||
149751884|NCT04504032|540221381|FG001|Overall Study|Drug supply issues|1|||
149751885|NCT04504032|540221380|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
149751886|NCT04504032|540221381|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
149751887|NCT00771030|540221382|FG000|Overall Study|Adverse Event|0|||
149751888|NCT00771030|540221383|FG001|Overall Study|Adverse Event|1|||
149751889|NCT00771030|540221384|FG002|Overall Study|Adverse Event|0|||
149751890|NCT00771030|540221385|FG003|Overall Study|Adverse Event|0|||
149751891|NCT00771030|540221386|FG004|Overall Study|Adverse Event|0|||
149751892|NCT00771030|540221387|FG005|Overall Study|Adverse Event|0|||
149751893|NCT00771030|540221388|FG006|Overall Study|Adverse Event|0|||
149751894|NCT01839188|540221389|FG000|Overall Study|Withdrawal by Subject|1|||
149751895|NCT04983901|540221390|FG000|Overall Study|Death|1|||
149751896|NCT04983901|540221391|FG001|Overall Study|Death|4|||
149751897|NCT04983901|540221390|FG000|Overall Study|Lost to Follow-up|3|||
149751898|NCT04983901|540221391|FG001|Overall Study|Lost to Follow-up|0|||
149751899|NCT04983901|540221390|FG000|Overall Study|Protocol Violation|1|||
149751900|NCT04983901|540221391|FG001|Overall Study|Protocol Violation|0|||
149751901|NCT04983901|540221390|FG000|Overall Study|Withdrawal by Subject|1|||
149751902|NCT04983901|540221391|FG001|Overall Study|Withdrawal by Subject|2|||
149751903|NCT02805907|540221392|FG000|Overall Study|Lost to Follow-up|3|||
149751904|NCT02805907|540221393|FG001|Overall Study|Lost to Follow-up|3|||
149751905|NCT02416908|540221400|FG000|Dose Escalation Phase|Adverse Event|0|||
149751906|NCT02416908|540221401|FG001|Dose Escalation Phase|Adverse Event|0|||
149751907|NCT02416908|540221402|FG002|Dose Escalation Phase|Adverse Event|3|||
149751908|NCT02416908|540221403|FG003|Dose Escalation Phase|Adverse Event|0|||
149751909|NCT02416908|540221400|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149751910|NCT02416908|540221401|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149751911|NCT02416908|540221402|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
149751912|NCT02416908|540221403|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149751913|NCT03792750|540221405|FG000|Overall Study|Death|3|||
149751914|NCT01651052|540221406|FG000|Overall Study|Death|21|||
149751915|NCT01651052|540221406|FG000|Overall Study|Explant|1|||
149751916|NCT01651052|540221406|FG000|Overall Study|Withdrawal by Subject|1|||
149751917|NCT01651052|540221406|FG000|Overall Study|Lost to Follow-up|3|||
149751918|NCT04983940|540221407|FG000|Overall Study|Lost to Follow-up|14|||
149751919|NCT04983940|540221407|FG000|Overall Study|Lack of Efficacy|2|||
149751920|NCT04156646|540221408|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
149751921|NCT04156646|540221409|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
149751922|NCT00638846|540221416|FG000|Overall Study|Adverse Event|0|||
149751923|NCT00638846|540221417|FG001|Overall Study|Adverse Event|1|||
149751924|NCT00638846|540221416|FG000|Overall Study|Lost to Follow-up|3|||
149751925|NCT00638846|540221417|FG001|Overall Study|Lost to Follow-up|2|||
149751926|NCT00638846|540221416|FG000|Overall Study|lens issue|1|||
149751927|NCT00638846|540221417|FG001|Overall Study|lens issue|3|||
149751928|NCT00734929|540221418|FG000|Overall Study|Lost to Follow-up|1|||
149751929|NCT00734929|540221419|FG001|Overall Study|Lost to Follow-up|2|||
149751930|NCT00734929|540221418|FG000|Overall Study|No intervention/ screen fail|5|||
149751931|NCT00734929|540221419|FG001|Overall Study|No intervention/ screen fail|3|||
149751932|NCT03176966|540221423|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
149751933|NCT03176966|540221424|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
149751934|NCT03176966|540221423|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
149751935|NCT03176966|540221424|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
149751936|NCT03176966|540221423|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
149751937|NCT03176966|540221424|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
149751938|NCT03176966|540221423|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
149751939|NCT03176966|540221424|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
149751940|NCT03176966|540221423|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
149751941|NCT03176966|540221424|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
149751942|NCT03176966|540221423|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
149751943|NCT03176966|540221424|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
149751944|NCT03176966|540221423|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
149751945|NCT03176966|540221424|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
149751946|NCT01520922|540221425|FG000|Treatment Phase|Physician Decision|2|||
149751947|NCT01520922|540221426|FG001|Treatment Phase|Physician Decision|1|||
149751948|NCT01520922|540221425|FG000|Treatment Phase|Progression|0|||
149751949|NCT01520922|540221426|FG001|Treatment Phase|Progression|2|||
149751950|NCT01520922|540221425|FG000|Treatment Phase|Adverse Event|3|||
149751951|NCT01520922|540221426|FG001|Treatment Phase|Adverse Event|5|||
149751952|NCT01520922|540221425|FG000|Follow up|Lost to Follow-up|0|||
149751953|NCT01520922|540221426|FG001|Follow up|Lost to Follow-up|1|||
149751954|NCT01520922|540221425|FG000|Survival Follow-up|Withdrawal by Subject|1|||
149751955|NCT01520922|540221426|FG001|Survival Follow-up|Withdrawal by Subject|0|||
149751956|NCT01903434|540221427|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
149751957|NCT01903434|540221428|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
149751958|NCT01903434|540221427|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
149751959|NCT01903434|540221428|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
149751960|NCT02269319|540221431|FG000|Overall Study|Lost to Follow-up|4|||
149751961|NCT02269319|540221432|FG001|Overall Study|Lost to Follow-up|3|||
149751962|NCT02269319|540221431|FG000|Overall Study|Adverse Event|0|||
149751963|NCT02269319|540221432|FG001|Overall Study|Adverse Event|1|||
149751964|NCT02269319|540221431|FG000|Overall Study|Instructions not followed|1|||
149751965|NCT02269319|540221432|FG001|Overall Study|Instructions not followed|0|||
149751966|NCT03314519|540222895|FG000|Overall Study|Protocol Violation|3|||
149751967|NCT03314519|540222896|FG001|Overall Study|Protocol Violation|2|||
149751968|NCT01912872|540222897|FG000|Overall Study|Lost to Follow-up|2|||
149751969|NCT01912872|540222898|FG001|Overall Study|Lost to Follow-up|3|||
149751970|NCT01912872|540222899|FG002|Overall Study|Lost to Follow-up|5|||
149751971|NCT01912872|540222900|FG003|Overall Study|Lost to Follow-up|5|||
149751972|NCT01912872|540222897|FG000|Overall Study|Other unspecified|3|||
149751973|NCT01912872|540222898|FG001|Overall Study|Other unspecified|1|||
149751974|NCT01912872|540222899|FG002|Overall Study|Other unspecified|3|||
149751975|NCT01912872|540222900|FG003|Overall Study|Other unspecified|0|||
149751976|NCT01912872|540222897|FG000|Overall Study|Informed consent withdrawn|0|||
149751977|NCT01912872|540222898|FG001|Overall Study|Informed consent withdrawn|0|||
149751978|NCT01912872|540222899|FG002|Overall Study|Informed consent withdrawn|1|||
149751979|NCT01912872|540222900|FG003|Overall Study|Informed consent withdrawn|1|||
149751980|NCT01912872|540222897|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
149751981|NCT01912872|540222898|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
149751982|NCT01912872|540222899|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
149751983|NCT01912872|540222900|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
149751984|NCT01912872|540222897|FG000|Overall Study|Protocol Violation|0|||
149751985|NCT01912872|540222898|FG001|Overall Study|Protocol Violation|0|||
149751986|NCT01912872|540222899|FG002|Overall Study|Protocol Violation|1|||
149751987|NCT01912872|540222900|FG003|Overall Study|Protocol Violation|0|||
149751988|NCT01912872|540222897|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149751989|NCT01912872|540222898|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149751990|NCT01912872|540222899|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149751991|NCT01912872|540222900|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
149751992|NCT01912872|540222897|FG000|Overall Study|Withdrawal of study medication|0|||
149751993|NCT01912872|540222898|FG001|Overall Study|Withdrawal of study medication|0|||
149751994|NCT01912872|540222899|FG002|Overall Study|Withdrawal of study medication|0|||
149751995|NCT01912872|540222900|FG003|Overall Study|Withdrawal of study medication|2|||
149751996|NCT01912872|540222897|FG000|Overall Study|Missing|0|||
149751997|NCT01912872|540222898|FG001|Overall Study|Missing|0|||
149751998|NCT01912872|540222899|FG002|Overall Study|Missing|0|||
149751999|NCT01912872|540222900|FG003|Overall Study|Missing|1|||
149752000|NCT03042611|540222901|FG000|Core Phase|Withdrawal by Subject|13|||
149752001|NCT03042611|540222902|FG001|Core Phase|Withdrawal by Subject|4|||
149752002|NCT03042611|540222903|FG002|Core Phase|Withdrawal by Subject|0|||
149752003|NCT03042611|540222904|FG003|Core Phase|Withdrawal by Subject|0|||
149752004|NCT03042611|540222901|FG000|Core Phase|Death|232|||
149752005|NCT03042611|540222902|FG001|Core Phase|Death|110|||
149752006|NCT03042611|540222903|FG002|Core Phase|Death|0|||
149752007|NCT03042611|540222904|FG003|Core Phase|Death|0|||
149752008|NCT03042611|540222901|FG000|Core Phase|Lost to Follow-up|4|||
149752009|NCT03042611|540222902|FG001|Core Phase|Lost to Follow-up|7|||
149752010|NCT03042611|540222903|FG002|Core Phase|Lost to Follow-up|0|||
149752011|NCT03042611|540222904|FG003|Core Phase|Lost to Follow-up|0|||
149752012|NCT03042611|540222901|FG000|Core Phase|Physician Decision|7|||
149752013|NCT03042611|540222902|FG001|Core Phase|Physician Decision|2|||
149752014|NCT03042611|540222903|FG002|Core Phase|Physician Decision|0|||
149752015|NCT03042611|540222904|FG003|Core Phase|Physician Decision|0|||
149752016|NCT03042611|540222901|FG000|Core Phase|Study Closed|0|||
149752017|NCT03042611|540222902|FG001|Core Phase|Study Closed|1|||
149752018|NCT03042611|540222903|FG002|Core Phase|Study Closed|0|||
149752019|NCT03042611|540222904|FG003|Core Phase|Study Closed|0|||
149752020|NCT03042611|540222901|FG000|Extension Phase|Death|0|||
149752021|NCT03042611|540222902|FG001|Extension Phase|Death|0|||
149752022|NCT03042611|540222903|FG002|Extension Phase|Death|34|||
149752023|NCT03042611|540222904|FG003|Extension Phase|Death|16|||
149752024|NCT03042611|540222901|FG000|Extension Phase|Lost to Follow-up|0|||
149752025|NCT03042611|540222902|FG001|Extension Phase|Lost to Follow-up|0|||
149752026|NCT03042611|540222903|FG002|Extension Phase|Lost to Follow-up|1|||
149752027|NCT03042611|540222904|FG003|Extension Phase|Lost to Follow-up|1|||
149752028|NCT03042611|540222901|FG000|Extension Phase|Study Closed|0|||
149752029|NCT03042611|540222902|FG001|Extension Phase|Study Closed|0|||
149752030|NCT03042611|540222903|FG002|Extension Phase|Study Closed|17|||
149752031|NCT03042611|540222904|FG003|Extension Phase|Study Closed|11|||
149752032|NCT02241512|540222910|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
149752033|NCT02241512|540222911|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
149752034|NCT04275310|540222912|FG000|Overall Study|Non-randomized due to running out of funding|4|||
149752035|NCT04275310|540222913|FG001|Overall Study|Non-randomized due to running out of funding|0|||
149752036|NCT02345161|540222916|FG000|Overall Study|Withdrawal by Subject|25|||
149752037|NCT02345161|540222917|FG001|Overall Study|Withdrawal by Subject|33|||
149752038|NCT02345161|540222916|FG000|Overall Study|Adverse Event|16|||
149752039|NCT02345161|540222917|FG001|Overall Study|Adverse Event|19|||
149752040|NCT02345161|540222916|FG000|Overall Study|Physician Decision|4|||
149752041|NCT02345161|540222917|FG001|Overall Study|Physician Decision|4|||
149752042|NCT02345161|540222916|FG000|Overall Study|Lost to Follow-up|0|||
149752043|NCT02345161|540222917|FG001|Overall Study|Lost to Follow-up|1|||
149752044|NCT03554005|540222927|FG000|Overall Study|Not in participant's best interest|0|||
149752045|NCT03554005|540222928|FG001|Overall Study|Not in participant's best interest|0|||
149752046|NCT03554005|540222929|FG002|Overall Study|Not in participant's best interest|0|||
149752047|NCT03554005|540222930|FG003|Overall Study|Not in participant's best interest|0|||
149752048|NCT03554005|540222931|FG004|Overall Study|Not in participant's best interest|0|||
149752049|NCT03554005|540222932|FG005|Overall Study|Not in participant's best interest|1|||
149752050|NCT03554005|540222927|FG000|Overall Study|Disease Progression|1|||
149752051|NCT03554005|540222928|FG001|Overall Study|Disease Progression|1|||
149752052|NCT03554005|540222929|FG002|Overall Study|Disease Progression|1|||
149752053|NCT03554005|540222930|FG003|Overall Study|Disease Progression|1|||
149752054|NCT03554005|540222931|FG004|Overall Study|Disease Progression|5|||
149752055|NCT03554005|540222932|FG005|Overall Study|Disease Progression|6|||
149752056|NCT03554005|540222927|FG000|Overall Study|Adverse Event|0|||
149752057|NCT03554005|540222928|FG001|Overall Study|Adverse Event|0|||
149752058|NCT03554005|540222929|FG002|Overall Study|Adverse Event|0|||
149752059|NCT03554005|540222930|FG003|Overall Study|Adverse Event|0|||
149752060|NCT03554005|540222931|FG004|Overall Study|Adverse Event|0|||
149752061|NCT03554005|540222932|FG005|Overall Study|Adverse Event|3|||
149752062|NCT03554005|540222927|FG000|Overall Study|Physician Decision|0|||
149752063|NCT03554005|540222928|FG001|Overall Study|Physician Decision|0|||
149752064|NCT03554005|540222929|FG002|Overall Study|Physician Decision|0|||
149752065|NCT03554005|540222930|FG003|Overall Study|Physician Decision|0|||
149752066|NCT03554005|540222931|FG004|Overall Study|Physician Decision|1|||
149752067|NCT03554005|540222932|FG005|Overall Study|Physician Decision|0|||
149752068|NCT03554005|540222927|FG000|Overall Study|Other|0|||
149752069|NCT03554005|540222928|FG001|Overall Study|Other|0|||
149752070|NCT03554005|540222929|FG002|Overall Study|Other|0|||
149752071|NCT03554005|540222930|FG003|Overall Study|Other|0|||
149752072|NCT03554005|540222931|FG004|Overall Study|Other|0|||
149752073|NCT03554005|540222932|FG005|Overall Study|Other|1|||
149752074|NCT00631488|540222936|FG000|Overall Study|Adverse Event|1|||
149752075|NCT00631488|540222937|FG001|Overall Study|Adverse Event|0|||
149752076|NCT00631488|540222938|FG002|Overall Study|Adverse Event|0|||
149752077|NCT00631488|540222936|FG000|Overall Study|Lost to Follow-up|2|||
149752078|NCT00631488|540222937|FG001|Overall Study|Lost to Follow-up|2|||
149752079|NCT00631488|540222938|FG002|Overall Study|Lost to Follow-up|0|||
149752080|NCT00631488|540222936|FG000|Overall Study|Physician Decision|1|||
149752081|NCT00631488|540222937|FG001|Overall Study|Physician Decision|0|||
149752082|NCT00631488|540222938|FG002|Overall Study|Physician Decision|1|||
149752083|NCT00631488|540222936|FG000|Overall Study|Protocol Violation|0|||
149752084|NCT00631488|540222937|FG001|Overall Study|Protocol Violation|0|||
149752085|NCT00631488|540222938|FG002|Overall Study|Protocol Violation|1|||
149752086|NCT03648476|540222940|FG000|Overall Study|Withdrawal by Subject|2|||
149752087|NCT03648476|540222941|FG001|Overall Study|Withdrawal by Subject|1|||
149752088|NCT02855411|540222942|FG000|Overall Study|Study terminated by sponsor|21|||
149752089|NCT02855411|540222942|FG000|Overall Study|Does not meet entrance criteria|14|||
149752090|NCT02639182|540222943|FG000|Overall Study|Disease Progression|50|||
149752091|NCT02639182|540222944|FG001|Overall Study|Disease Progression|49|||
149752092|NCT02639182|540222943|FG000|Overall Study|Adverse Event|7|||
149752093|NCT02639182|540222944|FG001|Overall Study|Adverse Event|5|||
149752094|NCT02639182|540222943|FG000|Overall Study|Physician Decision|3|||
149752095|NCT02639182|540222944|FG001|Overall Study|Physician Decision|3|||
149752096|NCT02639182|540222943|FG000|Overall Study|Withdrew Consent|5|||
149752097|NCT02639182|540222944|FG001|Overall Study|Withdrew Consent|4|||
149752098|NCT02639182|540222943|FG000|Overall Study|Lost to Follow-up|0|||
149752099|NCT02639182|540222944|FG001|Overall Study|Lost to Follow-up|1|||
149752100|NCT02639182|540222943|FG000|Overall Study|Study Closure|1|||
149752101|NCT02639182|540222944|FG001|Overall Study|Study Closure|2|||
149752102|NCT02639182|540222943|FG000|Overall Study|Sponsor Ended Study|0|||
149752103|NCT02639182|540222944|FG001|Overall Study|Sponsor Ended Study|1|||
149752104|NCT02639182|540222943|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
149752105|NCT02639182|540222944|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
149752106|NCT00907881|540222945|FG000|Overall Study|Lost to Follow-up|59|||
149752107|NCT00907881|540222945|FG000|Overall Study|Noncompliance|5|||
149752108|NCT00907881|540222945|FG000|Overall Study|Withdrawal by Subject|5|||
149752109|NCT00907881|540222945|FG000|Overall Study|Protocol Violation|1|||
149752110|NCT00907881|540222945|FG000|Overall Study|Missing discontinuation information|15|||
149752111|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
149752112|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
149752113|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
149752114|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149752115|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149752116|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149752117|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149752118|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149752119|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
149752120|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
149752121|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
149752122|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149752123|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149752124|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149752125|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149752126|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149752127|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
149752128|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
149752129|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
149752130|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149752131|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149752132|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149752133|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149752134|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149752135|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149752136|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149752137|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752138|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752139|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752140|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752141|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752142|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149752143|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
149752144|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
149752145|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
149752146|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149752147|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149752148|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149752149|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149752150|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149752151|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
149752152|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
149752153|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752154|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752155|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752156|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752157|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752158|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149752159|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
149752160|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
149752161|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752162|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752163|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752164|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752165|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752166|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149752167|NCT01097616|540222950|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752168|NCT01097616|540222951|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752169|NCT01097616|540222952|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
149752170|NCT01097616|540222953|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752171|NCT01097616|540222954|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752172|NCT01097616|540222955|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752173|NCT01097616|540222956|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752174|NCT01097616|540222957|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149752175|NCT01097616|540222950|FG000|Optional DB EXT Phase|Adverse Event|0|||
149752176|NCT01097616|540222951|FG001|Optional DB EXT Phase|Adverse Event|7|||
149752177|NCT01097616|540222952|FG002|Optional DB EXT Phase|Adverse Event|2|||
149752178|NCT01097616|540222953|FG003|Optional DB EXT Phase|Adverse Event|0|||
149752179|NCT01097616|540222954|FG004|Optional DB EXT Phase|Adverse Event|0|||
149752180|NCT01097616|540222955|FG005|Optional DB EXT Phase|Adverse Event|0|||
149752181|NCT01097616|540222956|FG006|Optional DB EXT Phase|Adverse Event|0|||
149752182|NCT01097616|540222957|FG007|Optional DB EXT Phase|Adverse Event|0|||
149752183|NCT01097616|540222950|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
149752184|NCT01097616|540222951|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
149752185|NCT01097616|540222952|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
149752186|NCT01097616|540222953|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
149752187|NCT01097616|540222954|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
149752188|NCT01097616|540222955|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
149752189|NCT01097616|540222956|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
149752190|NCT01097616|540222957|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
149752191|NCT01097616|540222950|FG000|Optional DB EXT Phase|Protocol Violation|0|||
149752192|NCT01097616|540222951|FG001|Optional DB EXT Phase|Protocol Violation|2|||
149752193|NCT01097616|540222952|FG002|Optional DB EXT Phase|Protocol Violation|3|||
149752194|NCT01097616|540222953|FG003|Optional DB EXT Phase|Protocol Violation|0|||
149752195|NCT01097616|540222954|FG004|Optional DB EXT Phase|Protocol Violation|0|||
149752196|NCT01097616|540222955|FG005|Optional DB EXT Phase|Protocol Violation|0|||
149752197|NCT01097616|540222956|FG006|Optional DB EXT Phase|Protocol Violation|0|||
149752198|NCT01097616|540222957|FG007|Optional DB EXT Phase|Protocol Violation|0|||
149752199|NCT01097616|540222950|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
149752200|NCT01097616|540222951|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
149752201|NCT01097616|540222952|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
149752202|NCT01097616|540222953|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
149752203|NCT01097616|540222954|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
149752204|NCT01097616|540222955|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
149752205|NCT01097616|540222956|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
149752206|NCT01097616|540222957|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
149752207|NCT01097616|540222950|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
149752208|NCT01097616|540222951|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
149752209|NCT01097616|540222952|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
149752210|NCT01097616|540222953|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
149752211|NCT01097616|540222954|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
149752212|NCT01097616|540222955|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
149752213|NCT01097616|540222956|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
149752214|NCT01097616|540222957|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
149752215|NCT01097616|540222950|FG000|Optional DB EXT Phase|Physician Decision|1|||
149752216|NCT01097616|540222951|FG001|Optional DB EXT Phase|Physician Decision|0|||
149752217|NCT01097616|540222952|FG002|Optional DB EXT Phase|Physician Decision|0|||
149752218|NCT01097616|540222953|FG003|Optional DB EXT Phase|Physician Decision|0|||
149752219|NCT01097616|540222954|FG004|Optional DB EXT Phase|Physician Decision|0|||
149752220|NCT01097616|540222955|FG005|Optional DB EXT Phase|Physician Decision|0|||
149752221|NCT01097616|540222956|FG006|Optional DB EXT Phase|Physician Decision|0|||
149752222|NCT01097616|540222957|FG007|Optional DB EXT Phase|Physician Decision|0|||
149752223|NCT01097616|540222950|FG000|DB RO Phase|Adverse Event|0|||
149752224|NCT01097616|540222951|FG001|DB RO Phase|Adverse Event|0|||
149752225|NCT01097616|540222952|FG002|DB RO Phase|Adverse Event|0|||
149752226|NCT01097616|540222953|FG003|DB RO Phase|Adverse Event|0|||
149752227|NCT01097616|540222954|FG004|DB RO Phase|Adverse Event|0|||
149752228|NCT01097616|540222955|FG005|DB RO Phase|Adverse Event|0|||
149752229|NCT01097616|540222956|FG006|DB RO Phase|Adverse Event|1|||
149752230|NCT01097616|540222957|FG007|DB RO Phase|Adverse Event|0|||
149752231|NCT01097616|540222950|FG000|DB RO Phase|Withdrawal by Subject|0|||
149752232|NCT01097616|540222951|FG001|DB RO Phase|Withdrawal by Subject|0|||
149752233|NCT01097616|540222952|FG002|DB RO Phase|Withdrawal by Subject|0|||
149752234|NCT01097616|540222953|FG003|DB RO Phase|Withdrawal by Subject|0|||
149752235|NCT01097616|540222954|FG004|DB RO Phase|Withdrawal by Subject|0|||
149752236|NCT01097616|540222955|FG005|DB RO Phase|Withdrawal by Subject|1|||
149752237|NCT01097616|540222956|FG006|DB RO Phase|Withdrawal by Subject|0|||
149752238|NCT01097616|540222957|FG007|DB RO Phase|Withdrawal by Subject|0|||
149752239|NCT01097616|540222950|FG000|DB RO Phase|Lost to Follow-up|0|||
149752240|NCT01097616|540222951|FG001|DB RO Phase|Lost to Follow-up|0|||
149752241|NCT01097616|540222952|FG002|DB RO Phase|Lost to Follow-up|0|||
149752242|NCT01097616|540222953|FG003|DB RO Phase|Lost to Follow-up|1|||
149752243|NCT01097616|540222954|FG004|DB RO Phase|Lost to Follow-up|1|||
149752244|NCT01097616|540222955|FG005|DB RO Phase|Lost to Follow-up|0|||
149752245|NCT01097616|540222956|FG006|DB RO Phase|Lost to Follow-up|0|||
149752246|NCT01097616|540222957|FG007|DB RO Phase|Lost to Follow-up|1|||
149752247|NCT01097616|540222950|FG000|DB RO Phase|Not Treated in RO|0|||
149752248|NCT01097616|540222951|FG001|DB RO Phase|Not Treated in RO|0|||
149752249|NCT01097616|540222952|FG002|DB RO Phase|Not Treated in RO|0|||
149752250|NCT01097616|540222953|FG003|DB RO Phase|Not Treated in RO|0|||
149752251|NCT01097616|540222954|FG004|DB RO Phase|Not Treated in RO|0|||
149752252|NCT01097616|540222955|FG005|DB RO Phase|Not Treated in RO|1|||
149752253|NCT01097616|540222956|FG006|DB RO Phase|Not Treated in RO|0|||
149752254|NCT01097616|540222957|FG007|DB RO Phase|Not Treated in RO|0|||
149752255|NCT00130208|540222960|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
149752256|NCT00130208|540222961|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
149752257|NCT00130208|540222960|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
149752258|NCT00130208|540222961|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
149752259|NCT00130208|540222960|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
149752260|NCT00130208|540222961|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
149752261|NCT00130208|540222960|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
149752262|NCT00130208|540222961|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
149752263|NCT00130208|540222960|FG000|Maintenance Period (26 Weeks)|Other|1|||
149752264|NCT00130208|540222961|FG001|Maintenance Period (26 Weeks)|Other|1|||
149752265|NCT00130208|540222960|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
149752266|NCT00130208|540222961|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
149752267|NCT00130208|540222960|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
149752268|NCT00130208|540222961|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
149752269|NCT00130208|540222960|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
149752270|NCT00130208|540222961|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
149752271|NCT00130208|540222960|FG000|Washout Period (8 Weeks)|Other|1|||
149752272|NCT00130208|540222961|FG001|Washout Period (8 Weeks)|Other|1|||
149752273|NCT01372878|540222966|FG000|Overall Study|Withdrawal by Subject|63|||
149752274|NCT01372878|540222966|FG000|Overall Study|Protocol Violation|17|||
149752275|NCT01372878|540222966|FG000|Overall Study|incomplete study procedure|104|||
149752276|NCT02064439|540222982|FG000|Overall Study|Adverse Event|51|||
149752277|NCT02064439|540222983|FG001|Overall Study|Adverse Event|47|||
149752278|NCT02064439|540222984|FG002|Overall Study|Adverse Event|46|||
149752279|NCT02064439|540222982|FG000|Overall Study|Death|0|||
149752280|NCT02064439|540222983|FG001|Overall Study|Death|2|||
149752281|NCT02064439|540222984|FG002|Overall Study|Death|3|||
149752282|NCT02064439|540222982|FG000|Overall Study|Withdrawal by Subject|29|||
149752283|NCT02064439|540222983|FG001|Overall Study|Withdrawal by Subject|18|||
149752284|NCT02064439|540222984|FG002|Overall Study|Withdrawal by Subject|26|||
149752285|NCT02064439|540222982|FG000|Overall Study|Protocol Violation|3|||
149752286|NCT02064439|540222983|FG001|Overall Study|Protocol Violation|5|||
149752287|NCT02064439|540222984|FG002|Overall Study|Protocol Violation|3|||
149752288|NCT02064439|540222982|FG000|Overall Study|Lost to Follow-up|1|||
149752289|NCT02064439|540222983|FG001|Overall Study|Lost to Follow-up|3|||
149752290|NCT02064439|540222984|FG002|Overall Study|Lost to Follow-up|4|||
149752291|NCT02064439|540222982|FG000|Overall Study|Non-compliance with study medication|21|||
149752292|NCT02064439|540222983|FG001|Overall Study|Non-compliance with study medication|19|||
149752293|NCT02064439|540222984|FG002|Overall Study|Non-compliance with study medication|23|||
149752294|NCT02064439|540222982|FG000|Overall Study|Physician Decision|0|||
149752295|NCT02064439|540222983|FG001|Overall Study|Physician Decision|1|||
149752296|NCT02064439|540222984|FG002|Overall Study|Physician Decision|1|||
149752297|NCT02064439|540222982|FG000|Overall Study|Logistical difficulties|6|||
149752298|NCT02064439|540222983|FG001|Overall Study|Logistical difficulties|5|||
149752299|NCT02064439|540222984|FG002|Overall Study|Logistical difficulties|2|||
149752300|NCT02064439|540222982|FG000|Overall Study|Efficacy outcome reached|18|||
149752301|NCT02064439|540222983|FG001|Overall Study|Efficacy outcome reached|16|||
149752302|NCT02064439|540222984|FG002|Overall Study|Efficacy outcome reached|57|||
149752303|NCT02064439|540222982|FG000|Overall Study|Safety outcome reached|12|||
149752304|NCT02064439|540222983|FG001|Overall Study|Safety outcome reached|20|||
149752305|NCT02064439|540222984|FG002|Overall Study|Safety outcome reached|10|||
149752306|NCT02064439|540222982|FG000|Overall Study|Other|2|||
149752307|NCT02064439|540222983|FG001|Overall Study|Other|2|||
149752308|NCT02064439|540222984|FG002|Overall Study|Other|7|||
149752309|NCT03350750|540222985|FG000|Overall Study|Death|1|||
149752310|NCT03350750|540222986|FG001|Overall Study|Death|1|||
149752311|NCT02433288|540222987|FG000|Overall Study|Severe non-compliance to protocol|13|||
149752312|NCT02433288|540222988|FG001|Overall Study|Severe non-compliance to protocol|7|||
149752313|NCT02433288|540222987|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
149752314|NCT02433288|540222988|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
149752315|NCT02433288|540222987|FG000|Overall Study|Withdrawal by Subject|101|||
149752316|NCT02433288|540222988|FG001|Overall Study|Withdrawal by Subject|99|||
149752317|NCT02433288|540222987|FG000|Overall Study|Lost to Follow-up|2|||
149752318|NCT02433288|540222988|FG001|Overall Study|Lost to Follow-up|14|||
149752319|NCT02433288|540222987|FG000|Overall Study|Death|0|||
149752320|NCT02433288|540222988|FG001|Overall Study|Death|3|||
149752321|NCT02234583|540222991|FG000|Overall Study|Adverse Event|172|||
149752322|NCT02234583|540222992|FG001|Overall Study|Adverse Event|156|||
149752323|NCT02234583|540222991|FG000|Overall Study|Withdrawal by Subject|109|||
149752324|NCT02234583|540222992|FG001|Overall Study|Withdrawal by Subject|157|||
149752325|NCT02234583|540222991|FG000|Overall Study|Lost to Follow-up|0|||
149752326|NCT02234583|540222992|FG001|Overall Study|Lost to Follow-up|1|||
149752327|NCT02234583|540222991|FG000|Overall Study|Lack of Efficacy|58|||
149752328|NCT02234583|540222992|FG001|Overall Study|Lack of Efficacy|103|||
149752329|NCT02234583|540222991|FG000|Overall Study|Protocol Violation|35|||
149752330|NCT02234583|540222992|FG001|Overall Study|Protocol Violation|42|||
149752331|NCT02234583|540222991|FG000|Overall Study|Other|39|||
149752332|NCT02234583|540222992|FG001|Overall Study|Other|97|||
149752333|NCT01214434|540223008|FG000|Overall Study|Withdrawal by Subject|1|||
149752334|NCT01214434|540223009|FG001|Overall Study|Withdrawal by Subject|0|||
149752335|NCT01214434|540223008|FG000|Overall Study|Lost to Follow-up|2|||
149752336|NCT01214434|540223009|FG001|Overall Study|Lost to Follow-up|2|||
149752337|NCT01214434|540223008|FG000|Overall Study|Site error|1|||
149752338|NCT01214434|540223009|FG001|Overall Study|Site error|0|||
149752339|NCT02075255|540223010|FG000|Overall Study|Study specific withdrawal criteria|0|||
149752340|NCT02075255|540223011|FG001|Overall Study|Study specific withdrawal criteria|1|||
149752341|NCT02075255|540223012|FG002|Overall Study|Study specific withdrawal criteria|1|||
149752342|NCT02075255|540223010|FG000|Overall Study|Withdrawal by Subject|4|||
149752343|NCT02075255|540223011|FG001|Overall Study|Withdrawal by Subject|1|||
149752344|NCT02075255|540223012|FG002|Overall Study|Withdrawal by Subject|0|||
149752345|NCT02075255|540223010|FG000|Overall Study|Lost to Follow-up|0|||
149752346|NCT02075255|540223011|FG001|Overall Study|Lost to Follow-up|0|||
149752347|NCT02075255|540223012|FG002|Overall Study|Lost to Follow-up|1|||
149752348|NCT02075255|540223010|FG000|Overall Study|Adverse Event|0|||
149752349|NCT02075255|540223011|FG001|Overall Study|Adverse Event|0|||
149752350|NCT02075255|540223012|FG002|Overall Study|Adverse Event|1|||
149752351|NCT02075255|540223010|FG000|Overall Study|Death|0|||
149752352|NCT02075255|540223011|FG001|Overall Study|Death|2|||
149752353|NCT02075255|540223012|FG002|Overall Study|Death|0|||
149752354|NCT01188798|540223013|FG000|Overall Study|Death|0|||
149752355|NCT01188798|540223014|FG001|Overall Study|Death|1|||
149752356|NCT01188798|540223013|FG000|Overall Study|Required additional transplant|1|||
149752357|NCT01188798|540223014|FG001|Overall Study|Required additional transplant|1|||
149752358|NCT01188798|540223013|FG000|Overall Study|Protocol closure|1|||
149752359|NCT01188798|540223014|FG001|Overall Study|Protocol closure|1|||
149752360|NCT01748760|540223015|FG000|Overall Study|Withdrawal by Subject|1|||
149752361|NCT01748760|540223016|FG001|Overall Study|Withdrawal by Subject|1|||
149752362|NCT01748760|540223015|FG000|Overall Study|Lost to Follow-up|5|||
149752363|NCT01748760|540223016|FG001|Overall Study|Lost to Follow-up|1|||
149752364|NCT00872898|540223017|FG000|Part Two - Double Blind|Adverse Event|4|||
149752365|NCT00872898|540223018|FG001|Part Two - Double Blind|Adverse Event|3|||
149752366|NCT00872898|540223017|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
149752367|NCT00872898|540223018|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
149752368|NCT00872898|540223017|FG000|Part Two - Double Blind|Protocol Violation|1|||
149752369|NCT00872898|540223018|FG001|Part Two - Double Blind|Protocol Violation|0|||
149752370|NCT00872898|540223017|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
149752371|NCT00872898|540223018|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
149752372|NCT00872898|540223017|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
149752373|NCT00872898|540223018|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
149752374|NCT00872898|540223017|FG000|Part Two - Double Blind|Other reasons|2|||
149752375|NCT00872898|540223018|FG001|Part Two - Double Blind|Other reasons|0|||
149752376|NCT00863928|540223019|FG000|Overall Study|Protocol Violation|26|||
149752377|NCT00863928|540223020|FG001|Overall Study|Protocol Violation|0|||
149752378|NCT00863928|540223019|FG000|Overall Study|Withdrawal by Subject|3|||
149752379|NCT00863928|540223020|FG001|Overall Study|Withdrawal by Subject|0|||
149752380|NCT00863928|540223019|FG000|Overall Study|surgery cancellation|4|||
149752381|NCT00863928|540223020|FG001|Overall Study|surgery cancellation|0|||
149752382|NCT00863928|540223019|FG000|Overall Study|medication allergy|3|||
149752383|NCT00863928|540223020|FG001|Overall Study|medication allergy|0|||
149752384|NCT01001494|540223025|FG000|Overall Study|Adverse Event|8|||
149752385|NCT01001494|540223026|FG001|Overall Study|Adverse Event|4|||
149752386|NCT01001494|540223027|FG002|Overall Study|Adverse Event|6|||
149752387|NCT01001494|540223025|FG000|Overall Study|Protocol Violation|0|||
149752388|NCT01001494|540223026|FG001|Overall Study|Protocol Violation|1|||
149752389|NCT01001494|540223027|FG002|Overall Study|Protocol Violation|1|||
149752390|NCT01001494|540223025|FG000|Overall Study|Lost to Follow-up|2|||
149752391|NCT01001494|540223026|FG001|Overall Study|Lost to Follow-up|0|||
149752392|NCT01001494|540223027|FG002|Overall Study|Lost to Follow-up|1|||
149752393|NCT01001494|540223025|FG000|Overall Study|Withdrawal by Subject|9|||
149752394|NCT01001494|540223026|FG001|Overall Study|Withdrawal by Subject|7|||
149752395|NCT01001494|540223027|FG002|Overall Study|Withdrawal by Subject|17|||
149752396|NCT01001494|540223025|FG000|Overall Study|COPD exacerbation|3|||
149752397|NCT01001494|540223026|FG001|Overall Study|COPD exacerbation|4|||
149752398|NCT01001494|540223027|FG002|Overall Study|COPD exacerbation|5|||
149752399|NCT01001494|540223025|FG000|Overall Study|Lack of Efficacy|2|||
149752400|NCT01001494|540223026|FG001|Overall Study|Lack of Efficacy|0|||
149752401|NCT01001494|540223027|FG002|Overall Study|Lack of Efficacy|8|||
149752402|NCT01001494|540223025|FG000|Overall Study|Other|0|||
149752403|NCT01001494|540223026|FG001|Overall Study|Other|1|||
149752404|NCT01001494|540223027|FG002|Overall Study|Other|3|||
149752405|NCT02795156|540223028|FG000|Overall Study|Progressive Disease|22|||
149752406|NCT02795156|540223029|FG001|Overall Study|Progressive Disease|7|||
149752407|NCT02795156|540223030|FG002|Overall Study|Progressive Disease|34|||
149752408|NCT02795156|540223031|FG003|Overall Study|Progressive Disease|7|||
149752409|NCT02795156|540223028|FG000|Overall Study|Adverse Event|13|||
149752410|NCT02795156|540223029|FG001|Overall Study|Adverse Event|2|||
149752411|NCT02795156|540223030|FG002|Overall Study|Adverse Event|3|||
149752412|NCT02795156|540223031|FG003|Overall Study|Adverse Event|2|||
149752413|NCT02795156|540223028|FG000|Overall Study|Death|1|||
149752414|NCT02795156|540223029|FG001|Overall Study|Death|1|||
149752415|NCT02795156|540223030|FG002|Overall Study|Death|1|||
149752416|NCT02795156|540223031|FG003|Overall Study|Death|0|||
149752417|NCT02795156|540223028|FG000|Overall Study|Physician Decision|1|||
149752418|NCT02795156|540223029|FG001|Overall Study|Physician Decision|0|||
149752419|NCT02795156|540223030|FG002|Overall Study|Physician Decision|1|||
149752420|NCT02795156|540223031|FG003|Overall Study|Physician Decision|0|||
149752421|NCT02795156|540223028|FG000|Overall Study|Withdrawal by Subject|2|||
149752422|NCT02795156|540223029|FG001|Overall Study|Withdrawal by Subject|0|||
149752423|NCT02795156|540223030|FG002|Overall Study|Withdrawal by Subject|3|||
149752424|NCT02795156|540223031|FG003|Overall Study|Withdrawal by Subject|0|||
149752425|NCT02961764|540223038|FG000|Overall Study|Protocol Violation|0|||
149752426|NCT02961764|540223039|FG001|Overall Study|Protocol Violation|1|||
149752427|NCT02961764|540223038|FG000|Overall Study|Death|2|||
149752428|NCT02961764|540223039|FG001|Overall Study|Death|0|||
149752429|NCT02961764|540223038|FG000|Overall Study|Lost to Follow-up|35|||
149752430|NCT02961764|540223039|FG001|Overall Study|Lost to Follow-up|24|||
149752431|NCT02961764|540223038|FG000|Overall Study|Withdrawal by Subject|2|||
149752432|NCT02961764|540223039|FG001|Overall Study|Withdrawal by Subject|0|||
149752433|NCT01469052|540223043|FG000|Overall Study|Adverse Event|2|||
149752434|NCT01469052|540223044|FG001|Overall Study|Adverse Event|3|||
149752435|NCT01469052|540223045|FG002|Overall Study|Adverse Event|0|||
149752436|NCT01469052|540223046|FG003|Overall Study|Adverse Event|2|||
149752437|NCT01469052|540223047|FG004|Overall Study|Adverse Event|0|||
149752438|NCT01469052|540223048|FG005|Overall Study|Adverse Event|1|||
149752439|NCT01469052|540223043|FG000|Overall Study|Progressive disease|3|||
149752440|NCT01469052|540223044|FG001|Overall Study|Progressive disease|0|||
149752441|NCT01469052|540223045|FG002|Overall Study|Progressive disease|5|||
149752442|NCT01469052|540223046|FG003|Overall Study|Progressive disease|3|||
149752443|NCT01469052|540223047|FG004|Overall Study|Progressive disease|7|||
149752444|NCT01469052|540223048|FG005|Overall Study|Progressive disease|2|||
149752445|NCT01469052|540223043|FG000|Overall Study|Lack of Efficacy|0|||
149752446|NCT01469052|540223044|FG001|Overall Study|Lack of Efficacy|0|||
149752447|NCT01469052|540223045|FG002|Overall Study|Lack of Efficacy|0|||
149752448|NCT01469052|540223046|FG003|Overall Study|Lack of Efficacy|0|||
149752449|NCT01469052|540223047|FG004|Overall Study|Lack of Efficacy|0|||
149752450|NCT01469052|540223048|FG005|Overall Study|Lack of Efficacy|2|||
149752451|NCT01469052|540223043|FG000|Overall Study|Moved to rollover protocol|1|||
149752452|NCT01469052|540223044|FG001|Overall Study|Moved to rollover protocol|0|||
149752453|NCT01469052|540223045|FG002|Overall Study|Moved to rollover protocol|1|||
149752454|NCT01469052|540223046|FG003|Overall Study|Moved to rollover protocol|0|||
149752455|NCT01469052|540223047|FG004|Overall Study|Moved to rollover protocol|0|||
149752456|NCT01469052|540223048|FG005|Overall Study|Moved to rollover protocol|1|||
149752457|NCT01469052|540223043|FG000|Overall Study|Other|0|||
149752458|NCT01469052|540223044|FG001|Overall Study|Other|1|||
149752459|NCT01469052|540223045|FG002|Overall Study|Other|0|||
149752460|NCT01469052|540223046|FG003|Overall Study|Other|0|||
149752461|NCT01469052|540223047|FG004|Overall Study|Other|1|||
149752462|NCT01469052|540223048|FG005|Overall Study|Other|0|||
149752463|NCT00633139|540223049|FG000|Overall Study|Non compliance|0|||
149752464|NCT00633139|540223050|FG001|Overall Study|Non compliance|0|||
149752465|NCT00633139|540223051|FG002|Overall Study|Non compliance|1|||
149752466|NCT00633139|540223049|FG000|Overall Study|Withdrawal by Subject|0|||
149752467|NCT00633139|540223050|FG001|Overall Study|Withdrawal by Subject|1|||
149752468|NCT00633139|540223051|FG002|Overall Study|Withdrawal by Subject|0|||
149752469|NCT02160977|540223052|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
149752470|NCT02160977|540223053|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
149752471|NCT02160977|540223052|FG000|Three Months After Surgery|Lost to Follow-up|0|||
149752472|NCT02160977|540223053|FG001|Three Months After Surgery|Lost to Follow-up|2|||
149752473|NCT02160977|540223052|FG000|Six Months After Surgery|Lost to Follow-up|2|||
149752474|NCT02160977|540223053|FG001|Six Months After Surgery|Lost to Follow-up|1|||
149752475|NCT04773041|540223056|FG000|Overall Study|Unable to data match|1|||
149752476|NCT04773041|540223057|FG001|Overall Study|Unable to data match|0|||
149752477|NCT04773041|540223058|FG002|Overall Study|Unable to data match|0|||
149752478|NCT05270694|540224599|FG000|Overall Study|Death|1|||
149752479|NCT05270694|540224599|FG000|Overall Study|Medical issues impacted ability to participate|2|||
149752480|NCT05270694|540224599|FG000|Overall Study|Lost to Follow-up|3|||
149752481|NCT05270694|540224599|FG000|Overall Study|Withdrawal by Subject|3|||
149752482|NCT00128206|540224602|FG000|Overall Study|Lost to Follow-up|137|||
149752483|NCT00128206|540224603|FG001|Overall Study|Lost to Follow-up|118|||
149752484|NCT00128206|540224602|FG000|Overall Study|Adverse Event|0|||
149752485|NCT00128206|540224603|FG001|Overall Study|Adverse Event|2|||
149752486|NCT03032068|540224606|FG000|Overall Study|Adverse Event|1|||
149752487|NCT03132805|540224609|FG000|Overall Study|Lost to Follow-up|142|||
149752488|NCT03132805|540224610|FG001|Overall Study|Lost to Follow-up|141|||
149752489|NCT03132805|540224611|FG002|Overall Study|Lost to Follow-up|113|||
149752490|NCT03009539|540224612|FG000|Overall Study|Lost to Follow-up|132|||
149752491|NCT03009539|540224613|FG001|Overall Study|Lost to Follow-up|113|||
149752492|NCT03009539|540224614|FG002|Overall Study|Lost to Follow-up|132|||
149752493|NCT03009539|540224615|FG003|Overall Study|Lost to Follow-up|113|||
149752494|NCT03151148|540224616|FG000|Overall Study|Lost to Follow-up|1|||
149752495|NCT03151148|540224617|FG001|Overall Study|Lost to Follow-up|0|||
149752496|NCT03151148|540224616|FG000|Overall Study|Withdrawal by Subject|1|||
149752497|NCT03151148|540224617|FG001|Overall Study|Withdrawal by Subject|0|||
149752498|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
149752499|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
149752500|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
149752501|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
149752502|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
149752503|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
149752504|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
149752505|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
149752506|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
149752507|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
149752508|NCT00710034|540224618|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
149752509|NCT00710034|540224619|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
149752510|NCT00710034|540224618|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
149752511|NCT00710034|540224619|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
149752512|NCT00710034|540224618|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
149752513|NCT00710034|540224619|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
149752514|NCT00710034|540224618|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
149752515|NCT00710034|540224619|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
149752516|NCT00710034|540224618|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
149752517|NCT00710034|540224619|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
149752518|NCT00710034|540224618|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
149752519|NCT00710034|540224619|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
149752520|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
149752521|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
149752522|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
149752523|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
149752524|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Death|8|||
149752525|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Death|3|||
149752526|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
149752527|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
149752528|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
149752529|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
149752530|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
149752531|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
149752532|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
149752533|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
149752534|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
149752535|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
149752536|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
149752537|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
149752538|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
149752539|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
149752540|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
149752541|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
149752542|NCT00494871|540224620|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
149752543|NCT00494871|540224621|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
149752544|NCT00494871|540224620|FG000|Follow-up (FU) Period|Adverse Event|1|||
149752545|NCT00494871|540224621|FG001|Follow-up (FU) Period|Adverse Event|1|||
149752546|NCT00494871|540224620|FG000|Follow-up (FU) Period|Death|13|||
149752547|NCT00494871|540224621|FG001|Follow-up (FU) Period|Death|12|||
149752548|NCT00494871|540224620|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
149752549|NCT00494871|540224621|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
149752550|NCT00494871|540224620|FG000|Follow-up (FU) Period|Physician Decision|0|||
149752551|NCT00494871|540224621|FG001|Follow-up (FU) Period|Physician Decision|1|||
149752552|NCT00494871|540224620|FG000|Follow-up (FU) Period|Protocol Violation|1|||
149752553|NCT00494871|540224621|FG001|Follow-up (FU) Period|Protocol Violation|0|||
149752554|NCT00494871|540224620|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
149752555|NCT00494871|540224621|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
149752556|NCT00494871|540224620|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
149752557|NCT00494871|540224621|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
149752558|NCT03918642|540224622|FG000|Overall Study|Lost to Follow-up|12|||
149752559|NCT03918642|540224623|FG001|Overall Study|Lost to Follow-up|10|||
149752560|NCT03238248|540224624|FG000|Overall Study|Death|5|||
149752561|NCT03238248|540224624|FG000|Overall Study|Withdrawal by Subject|7|||
149752562|NCT03238248|540224624|FG000|Overall Study|Participant proceeding to transplant|10|||
149752563|NCT03238248|540224624|FG000|Overall Study|Lack of Efficacy|4|||
149752564|NCT03238248|540224624|FG000|Overall Study|Physician Decision|3|||
149752565|NCT03238248|540224624|FG000|Overall Study|Transitioning to another study|1|||
149752566|NCT03238248|540224624|FG000|Overall Study|No longer benefiting|1|||
149752567|NCT03238248|540224624|FG000|Overall Study|Other complicating disease|1|||
149752568|NCT03238248|540224624|FG000|Overall Study|Adverse Event|5|||
149752569|NCT03238248|540224624|FG000|Overall Study|Disease progression|26|||
149752570|NCT03238248|540224624|FG000|Overall Study|N/A participant is still on treatment|1|||
149752571|NCT03238248|540224624|FG000|Overall Study|Decline in condition|1|||
149752572|NCT03238248|540224624|FG000|Overall Study|Alternative therapy|2|||
149752573|NCT00972244|540224625|FG000|Overall Study|Incorrect Enrolment|1|||
149752574|NCT00972244|540224626|FG001|Overall Study|Incorrect Enrolment|0|||
149752575|NCT00972244|540224627|FG002|Overall Study|Incorrect Enrolment|0|||
149752576|NCT00972244|540224628|FG003|Overall Study|Incorrect Enrolment|0|||
149752577|NCT00972244|540224629|FG004|Overall Study|Incorrect Enrolment|0|||
149752578|NCT00972244|540224625|FG000|Overall Study|Adverse Event|0|||
149752579|NCT00972244|540224626|FG001|Overall Study|Adverse Event|1|||
149752580|NCT00972244|540224627|FG002|Overall Study|Adverse Event|1|||
149752581|NCT00972244|540224628|FG003|Overall Study|Adverse Event|0|||
149752582|NCT00972244|540224629|FG004|Overall Study|Adverse Event|0|||
149752583|NCT00972244|540224625|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
149752584|NCT00972244|540224626|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
149752585|NCT00972244|540224627|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
149752586|NCT00972244|540224628|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
149752587|NCT00972244|540224629|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
149752588|NCT00972244|540224625|FG000|Overall Study|Withdrawal by Subject|1|||
149752589|NCT00972244|540224626|FG001|Overall Study|Withdrawal by Subject|2|||
149752590|NCT00972244|540224627|FG002|Overall Study|Withdrawal by Subject|1|||
149752591|NCT00972244|540224628|FG003|Overall Study|Withdrawal by Subject|0|||
149752592|NCT00972244|540224629|FG004|Overall Study|Withdrawal by Subject|1|||
149752593|NCT00972244|540224625|FG000|Overall Study|Safety|0|||
149752594|NCT00972244|540224626|FG001|Overall Study|Safety|0|||
149752595|NCT00972244|540224627|FG002|Overall Study|Safety|0|||
149752596|NCT00972244|540224628|FG003|Overall Study|Safety|0|||
149752597|NCT00972244|540224629|FG004|Overall Study|Safety|1|||
149752598|NCT00972244|540224625|FG000|Overall Study|Death|1|||
149752599|NCT00972244|540224626|FG001|Overall Study|Death|0|||
149752600|NCT00972244|540224627|FG002|Overall Study|Death|0|||
149752601|NCT00972244|540224628|FG003|Overall Study|Death|0|||
149752602|NCT00972244|540224629|FG004|Overall Study|Death|0|||
149752603|NCT00972244|540224625|FG000|Overall Study|Various|0|||
149752604|NCT00972244|540224626|FG001|Overall Study|Various|0|||
149752605|NCT00972244|540224627|FG002|Overall Study|Various|0|||
149752606|NCT00972244|540224628|FG003|Overall Study|Various|0|||
149752607|NCT00972244|540224629|FG004|Overall Study|Various|2|||
149752608|NCT00090285|540224630|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
149752609|NCT00090285|540224631|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
149752610|NCT00090285|540224632|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149752611|NCT00090285|540224633|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149752612|NCT00090285|540224634|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149752613|NCT00090285|540224635|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149752614|NCT00090285|540224630|FG000|Base Study Vaccination Period|Adverse Event|2|||
149752615|NCT00090285|540224631|FG001|Base Study Vaccination Period|Adverse Event|4|||
149752616|NCT00090285|540224632|FG002|Base Study Vaccination Period|Adverse Event|0|||
149752617|NCT00090285|540224633|FG003|Base Study Vaccination Period|Adverse Event|0|||
149752618|NCT00090285|540224634|FG004|Base Study Vaccination Period|Adverse Event|0|||
149752619|NCT00090285|540224635|FG005|Base Study Vaccination Period|Adverse Event|0|||
149752620|NCT00090285|540224630|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
149752621|NCT00090285|540224631|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
149752622|NCT00090285|540224632|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
149752623|NCT00090285|540224633|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
149752624|NCT00090285|540224634|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
149752625|NCT00090285|540224635|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
149752626|NCT00090285|540224630|FG000|Base Study Vaccination Period|Protocol Violation|2|||
149752627|NCT00090285|540224631|FG001|Base Study Vaccination Period|Protocol Violation|3|||
149752628|NCT00090285|540224632|FG002|Base Study Vaccination Period|Protocol Violation|0|||
149752629|NCT00090285|540224633|FG003|Base Study Vaccination Period|Protocol Violation|0|||
149752630|NCT00090285|540224634|FG004|Base Study Vaccination Period|Protocol Violation|0|||
149752631|NCT00090285|540224635|FG005|Base Study Vaccination Period|Protocol Violation|0|||
149752632|NCT00090285|540224630|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
149752633|NCT00090285|540224631|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
149752634|NCT00090285|540224632|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
149752635|NCT00090285|540224633|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
149752636|NCT00090285|540224634|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
149752637|NCT00090285|540224635|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
149752638|NCT00090285|540224630|FG000|Base Study Vaccination Period|Uncooperative|2|||
149752639|NCT00090285|540224631|FG001|Base Study Vaccination Period|Uncooperative|2|||
149752640|NCT00090285|540224632|FG002|Base Study Vaccination Period|Uncooperative|0|||
149752641|NCT00090285|540224633|FG003|Base Study Vaccination Period|Uncooperative|0|||
149752642|NCT00090285|540224634|FG004|Base Study Vaccination Period|Uncooperative|0|||
149752643|NCT00090285|540224635|FG005|Base Study Vaccination Period|Uncooperative|0|||
149752644|NCT00090285|540224630|FG000|Base Study Vaccination Period|Moved|20|||
149752645|NCT00090285|540224631|FG001|Base Study Vaccination Period|Moved|21|||
149752646|NCT00090285|540224632|FG002|Base Study Vaccination Period|Moved|0|||
149752647|NCT00090285|540224633|FG003|Base Study Vaccination Period|Moved|0|||
149752648|NCT00090285|540224634|FG004|Base Study Vaccination Period|Moved|0|||
149752649|NCT00090285|540224635|FG005|Base Study Vaccination Period|Moved|0|||
149752650|NCT00090285|540224630|FG000|Base Study Vaccination Period|Site Terminated|1|||
149752651|NCT00090285|540224631|FG001|Base Study Vaccination Period|Site Terminated|0|||
149752652|NCT00090285|540224632|FG002|Base Study Vaccination Period|Site Terminated|0|||
149752653|NCT00090285|540224633|FG003|Base Study Vaccination Period|Site Terminated|0|||
149752654|NCT00090285|540224634|FG004|Base Study Vaccination Period|Site Terminated|0|||
149752655|NCT00090285|540224635|FG005|Base Study Vaccination Period|Site Terminated|0|||
149752656|NCT00090285|540224630|FG000|Base Study Vaccination Period|Other|2|||
149752657|NCT00090285|540224631|FG001|Base Study Vaccination Period|Other|2|||
149752658|NCT00090285|540224632|FG002|Base Study Vaccination Period|Other|0|||
149752659|NCT00090285|540224633|FG003|Base Study Vaccination Period|Other|0|||
149752660|NCT00090285|540224634|FG004|Base Study Vaccination Period|Other|0|||
149752661|NCT00090285|540224635|FG005|Base Study Vaccination Period|Other|0|||
149752662|NCT00090285|540224630|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
149752663|NCT00090285|540224631|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
149752664|NCT00090285|540224632|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
149752665|NCT00090285|540224633|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
149752666|NCT00090285|540224634|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
149752667|NCT00090285|540224635|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
149752668|NCT00090285|540224630|FG000|Base Study Vaccination Period|HIV positive|1|||
149752669|NCT00090285|540224631|FG001|Base Study Vaccination Period|HIV positive|1|||
149752670|NCT00090285|540224632|FG002|Base Study Vaccination Period|HIV positive|0|||
149752671|NCT00090285|540224633|FG003|Base Study Vaccination Period|HIV positive|0|||
149752672|NCT00090285|540224634|FG004|Base Study Vaccination Period|HIV positive|0|||
149752673|NCT00090285|540224635|FG005|Base Study Vaccination Period|HIV positive|0|||
149752674|NCT00090285|540224630|FG000|Base Study Follow-up Period|Adverse Event|3|||
149752675|NCT00090285|540224631|FG001|Base Study Follow-up Period|Adverse Event|10|||
149752676|NCT00090285|540224632|FG002|Base Study Follow-up Period|Adverse Event|0|||
149752677|NCT00090285|540224633|FG003|Base Study Follow-up Period|Adverse Event|0|||
149752678|NCT00090285|540224634|FG004|Base Study Follow-up Period|Adverse Event|0|||
149752679|NCT00090285|540224635|FG005|Base Study Follow-up Period|Adverse Event|0|||
149752680|NCT00090285|540224630|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
149752681|NCT00090285|540224631|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
149752682|NCT00090285|540224632|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
149752683|NCT00090285|540224633|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
149752684|NCT00090285|540224634|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
149752685|NCT00090285|540224635|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
149752686|NCT00090285|540224630|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
149752687|NCT00090285|540224631|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
149752688|NCT00090285|540224632|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
149752689|NCT00090285|540224633|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
149752690|NCT00090285|540224634|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
149752691|NCT00090285|540224635|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
149752692|NCT00090285|540224630|FG000|Base Study Follow-up Period|Moved|41|||
149752693|NCT00090285|540224631|FG001|Base Study Follow-up Period|Moved|36|||
149752694|NCT00090285|540224632|FG002|Base Study Follow-up Period|Moved|0|||
149752695|NCT00090285|540224633|FG003|Base Study Follow-up Period|Moved|0|||
149752696|NCT00090285|540224634|FG004|Base Study Follow-up Period|Moved|0|||
149752697|NCT00090285|540224635|FG005|Base Study Follow-up Period|Moved|0|||
149752698|NCT00090285|540224630|FG000|Base Study Follow-up Period|Other|2|||
149752699|NCT00090285|540224631|FG001|Base Study Follow-up Period|Other|0|||
149752700|NCT00090285|540224632|FG002|Base Study Follow-up Period|Other|0|||
149752701|NCT00090285|540224633|FG003|Base Study Follow-up Period|Other|0|||
149752702|NCT00090285|540224634|FG004|Base Study Follow-up Period|Other|0|||
149752703|NCT00090285|540224635|FG005|Base Study Follow-up Period|Other|0|||
149752704|NCT00090285|540224630|FG000|Base Study Follow-up Period|Protocol Violation|1|||
149752705|NCT00090285|540224631|FG001|Base Study Follow-up Period|Protocol Violation|0|||
149752706|NCT00090285|540224632|FG002|Base Study Follow-up Period|Protocol Violation|0|||
149752707|NCT00090285|540224633|FG003|Base Study Follow-up Period|Protocol Violation|0|||
149752708|NCT00090285|540224634|FG004|Base Study Follow-up Period|Protocol Violation|0|||
149752709|NCT00090285|540224635|FG005|Base Study Follow-up Period|Protocol Violation|0|||
149752710|NCT00090285|540224630|FG000|Base Study Follow-up Period|Uncooperative|3|||
149752711|NCT00090285|540224631|FG001|Base Study Follow-up Period|Uncooperative|4|||
149752712|NCT00090285|540224632|FG002|Base Study Follow-up Period|Uncooperative|0|||
149752713|NCT00090285|540224633|FG003|Base Study Follow-up Period|Uncooperative|0|||
149752714|NCT00090285|540224634|FG004|Base Study Follow-up Period|Uncooperative|0|||
149752715|NCT00090285|540224635|FG005|Base Study Follow-up Period|Uncooperative|0|||
149752716|NCT00090285|540224630|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
149752717|NCT00090285|540224631|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
149752718|NCT00090285|540224632|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
149752719|NCT00090285|540224633|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
149752720|NCT00090285|540224634|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
149752721|NCT00090285|540224635|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
149752722|NCT00090285|540224630|FG000|Extension 1|Adverse Event|0|||
149752723|NCT00090285|540224631|FG001|Extension 1|Adverse Event|0|||
149752724|NCT00090285|540224632|FG002|Extension 1|Adverse Event|2|||
149752725|NCT00090285|540224633|FG003|Extension 1|Adverse Event|0|||
149752726|NCT00090285|540224634|FG004|Extension 1|Adverse Event|0|||
149752727|NCT00090285|540224635|FG005|Extension 1|Adverse Event|0|||
149752728|NCT00090285|540224630|FG000|Extension 1|Lost to Follow-up|0|||
149752729|NCT00090285|540224631|FG001|Extension 1|Lost to Follow-up|0|||
149752730|NCT00090285|540224632|FG002|Extension 1|Lost to Follow-up|35|||
149752731|NCT00090285|540224633|FG003|Extension 1|Lost to Follow-up|0|||
149752732|NCT00090285|540224634|FG004|Extension 1|Lost to Follow-up|0|||
149752733|NCT00090285|540224635|FG005|Extension 1|Lost to Follow-up|0|||
149752734|NCT00090285|540224630|FG000|Extension 1|Withdrawal by Subject|0|||
149752735|NCT00090285|540224631|FG001|Extension 1|Withdrawal by Subject|0|||
149752736|NCT00090285|540224632|FG002|Extension 1|Withdrawal by Subject|13|||
149752737|NCT00090285|540224633|FG003|Extension 1|Withdrawal by Subject|1|||
149752738|NCT00090285|540224634|FG004|Extension 1|Withdrawal by Subject|0|||
149752739|NCT00090285|540224635|FG005|Extension 1|Withdrawal by Subject|0|||
149752740|NCT00090285|540224630|FG000|Extension 1|Other|0|||
149752741|NCT00090285|540224631|FG001|Extension 1|Other|0|||
149752742|NCT00090285|540224632|FG002|Extension 1|Other|4|||
149752743|NCT00090285|540224633|FG003|Extension 1|Other|0|||
149752744|NCT00090285|540224634|FG004|Extension 1|Other|0|||
149752745|NCT00090285|540224635|FG005|Extension 1|Other|0|||
149752746|NCT00090285|540224630|FG000|Extension 1|Moved|0|||
149752747|NCT00090285|540224631|FG001|Extension 1|Moved|0|||
149752748|NCT00090285|540224632|FG002|Extension 1|Moved|3|||
149752749|NCT00090285|540224633|FG003|Extension 1|Moved|0|||
149752750|NCT00090285|540224634|FG004|Extension 1|Moved|0|||
149752751|NCT00090285|540224635|FG005|Extension 1|Moved|0|||
149752752|NCT00090285|540224630|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
149752753|NCT00090285|540224631|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
149752754|NCT00090285|540224632|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
149752755|NCT00090285|540224633|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
149752756|NCT00090285|540224634|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
149752757|NCT00090285|540224635|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
149752758|NCT00090285|540224630|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149752759|NCT00090285|540224631|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149752760|NCT00090285|540224632|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149752761|NCT00090285|540224633|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149752762|NCT00090285|540224634|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
149752763|NCT00090285|540224635|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
149752764|NCT00090285|540224630|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149752765|NCT00090285|540224631|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149752766|NCT00090285|540224632|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149752767|NCT00090285|540224633|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149752768|NCT00090285|540224634|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
149752769|NCT00090285|540224635|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
149752770|NCT00090285|540224630|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
149752771|NCT00090285|540224631|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
149752772|NCT00090285|540224632|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
149752773|NCT00090285|540224633|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
149752774|NCT00090285|540224634|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
149752775|NCT00090285|540224635|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
149752776|NCT04498910|540224640|FG000|Overall Study|Lost to Follow-up|0|||
149752777|NCT04498910|540224641|FG001|Overall Study|Lost to Follow-up|1|||
149752778|NCT04498910|540224640|FG000|Overall Study|Withdrawal by Subject|2|||
149752779|NCT04498910|540224641|FG001|Overall Study|Withdrawal by Subject|1|||
149752780|NCT04498910|540224640|FG000|Overall Study|Adverse Event|1|||
149752781|NCT04498910|540224641|FG001|Overall Study|Adverse Event|0|||
149752782|NCT02345434|540224643|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
149752783|NCT02345434|540224644|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
149752784|NCT01022853|540224645|FG000|Overall Study|Progressive disease|2|||
149752785|NCT01022853|540224646|FG001|Overall Study|Progressive disease|3|||
149752786|NCT01022853|540224647|FG002|Overall Study|Progressive disease|11|||
149752787|NCT01022853|540224648|FG003|Overall Study|Progressive disease|7|||
149752788|NCT01022853|540224649|FG004|Overall Study|Progressive disease|1|||
149752789|NCT01022853|540224645|FG000|Overall Study|Dose-limiting toxicity|0|||
149752790|NCT01022853|540224646|FG001|Overall Study|Dose-limiting toxicity|0|||
149752791|NCT01022853|540224647|FG002|Overall Study|Dose-limiting toxicity|0|||
149752792|NCT01022853|540224648|FG003|Overall Study|Dose-limiting toxicity|0|||
149752793|NCT01022853|540224649|FG004|Overall Study|Dose-limiting toxicity|1|||
149752794|NCT01022853|540224645|FG000|Overall Study|Withdrawal by Subject|0|||
149752795|NCT01022853|540224646|FG001|Overall Study|Withdrawal by Subject|1|||
149752796|NCT01022853|540224647|FG002|Overall Study|Withdrawal by Subject|1|||
149752797|NCT01022853|540224648|FG003|Overall Study|Withdrawal by Subject|1|||
149752798|NCT01022853|540224649|FG004|Overall Study|Withdrawal by Subject|0|||
149752799|NCT01022853|540224645|FG000|Overall Study|Other not stated above|1|||
149752800|NCT01022853|540224646|FG001|Overall Study|Other not stated above|0|||
149752801|NCT01022853|540224647|FG002|Overall Study|Other not stated above|1|||
149752802|NCT01022853|540224648|FG003|Overall Study|Other not stated above|0|||
149752803|NCT01022853|540224649|FG004|Overall Study|Other not stated above|0|||
149752804|NCT00532883|540224650|FG000|Overall Study|Adverse Event|1|||
149752805|NCT00532883|540224651|FG001|Overall Study|Adverse Event|0|||
149752806|NCT00532883|540224652|FG002|Overall Study|Adverse Event|0|||
149752807|NCT00532883|540224653|FG003|Overall Study|Adverse Event|1|||
149752808|NCT00532883|540224650|FG000|Overall Study|Lost to Follow-up|1|||
149752809|NCT00532883|540224651|FG001|Overall Study|Lost to Follow-up|1|||
149752810|NCT00532883|540224652|FG002|Overall Study|Lost to Follow-up|1|||
149752811|NCT00532883|540224653|FG003|Overall Study|Lost to Follow-up|0|||
149752812|NCT00532883|540224650|FG000|Overall Study|Withdrawal by Subject|0|||
149752813|NCT00532883|540224651|FG001|Overall Study|Withdrawal by Subject|1|||
149752814|NCT00532883|540224652|FG002|Overall Study|Withdrawal by Subject|1|||
149752815|NCT00532883|540224653|FG003|Overall Study|Withdrawal by Subject|0|||
149752816|NCT00532883|540224650|FG000|Overall Study|Subject was Nonadherent|0|||
149752817|NCT00532883|540224651|FG001|Overall Study|Subject was Nonadherent|1|||
149752818|NCT00532883|540224652|FG002|Overall Study|Subject was Nonadherent|1|||
149752819|NCT00532883|540224653|FG003|Overall Study|Subject was Nonadherent|0|||
149752820|NCT00532883|540224650|FG000|Overall Study|Early Study Termination|4|||
149752821|NCT00532883|540224651|FG001|Overall Study|Early Study Termination|4|||
149752822|NCT00532883|540224652|FG002|Overall Study|Early Study Termination|1|||
149752823|NCT00532883|540224653|FG003|Overall Study|Early Study Termination|4|||
149752824|NCT01327339|540224654|FG000|Overall Study|Protocol Violation|8|||
149752825|NCT01172288|540224655|FG000|Overall Study|Adverse Event|1|||
149752826|NCT01172288|540224656|FG001|Overall Study|Adverse Event|0|||
149752827|NCT01172288|540224655|FG000|Overall Study|Protocol Violation|0|||
149752828|NCT01172288|540224656|FG001|Overall Study|Protocol Violation|1|||
149752829|NCT02795767|540224657|FG000|Overall Study|Received Commercial Emicizumab|1|||
149752830|NCT02795767|540224658|FG001|Overall Study|Received Commercial Emicizumab|0|||
149752831|NCT02795767|540224659|FG002|Overall Study|Received Commercial Emicizumab|0|||
149752832|NCT03964415|540224660|FG000|Overall Study|Sponsor's decision|1563|||
149752833|NCT03964415|540224661|FG001|Overall Study|Sponsor's decision|1528|||
149752834|NCT03964415|540224660|FG000|Overall Study|Lost to Follow-up|139|||
149752835|NCT03964415|540224661|FG001|Overall Study|Lost to Follow-up|146|||
149752836|NCT03964415|540224660|FG000|Overall Study|Withdrawal by Subject|68|||
149752837|NCT03964415|540224661|FG001|Overall Study|Withdrawal by Subject|72|||
149752838|NCT03964415|540224660|FG000|Overall Study|Physician Decision|34|||
149752839|NCT03964415|540224661|FG001|Overall Study|Physician Decision|48|||
149752840|NCT03964415|540224660|FG000|Overall Study|Adverse Event|3|||
149752841|NCT03964415|540224661|FG001|Overall Study|Adverse Event|0|||
149752842|NCT03964415|540224660|FG000|Overall Study|Death|4|||
149752843|NCT03964415|540224661|FG001|Overall Study|Death|6|||
149752844|NCT03964415|540224660|FG000|Overall Study|Protocol Violation|1|||
149752845|NCT03964415|540224661|FG001|Overall Study|Protocol Violation|4|||
149752846|NCT03964415|540224660|FG000|Overall Study|Other|35|||
149752847|NCT03964415|540224661|FG001|Overall Study|Other|38|||
149752848|NCT03964415|540224660|FG000|Overall Study|Randomized but not treated|6|||
149752849|NCT03964415|540224661|FG001|Overall Study|Randomized but not treated|7|||
149752850|NCT01302769|540224662|FG000|Overall Study|Lost to Follow-up|1|||
149752851|NCT01302769|540224663|FG001|Overall Study|Lost to Follow-up|1|||
149752852|NCT01097330|540224668|FG000|Overall Study|Study terminated early|7|||
149752853|NCT01097330|540224669|FG001|Overall Study|Study terminated early|5|||
149752854|NCT03245814|540224680|FG000|Overall Study|Lost to Follow-up|5|||
149752855|NCT03245814|540224681|FG001|Overall Study|Lost to Follow-up|8|||
149752856|NCT03245814|540224680|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
149752857|NCT03245814|540224681|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
149752858|NCT02263365|540224685|FG000|Overall Study|Physician Decision|22|||
149752859|NCT02263365|540224686|FG001|Overall Study|Physician Decision|18|||
149752860|NCT00510692|540224687|FG000|Overall Study|Adverse Event|1|||
149752861|NCT00510692|540224688|FG001|Overall Study|Adverse Event|3|||
149752862|NCT00510692|540224687|FG000|Overall Study|Withdrawal by Subject|1|||
149752863|NCT00510692|540224688|FG001|Overall Study|Withdrawal by Subject|0|||
149752864|NCT00945191|540224689|FG000|Overall Study|Did not achieve a complete response|18|||
149752865|NCT00945191|540224689|FG000|Overall Study|Participant relocated to another state|1|||
149752866|NCT00945191|540224689|FG000|Overall Study|Disease progression|3|||
149752867|NCT00945191|540224689|FG000|Overall Study|Serious adverse event or adverse event|1|||
149752868|NCT00945191|540224689|FG000|Overall Study|Investigator's discretion|1|||
149752869|NCT00784784|540224690|FG000|Overall Study|Withdrawal by Subject|2|||
149752870|NCT00784784|540224691|FG001|Overall Study|Withdrawal by Subject|2|||
149752871|NCT01004146|540224692|FG000|Overall Study|Withdrawal by Subject|4|||
149752872|NCT01004146|540224693|FG001|Overall Study|Withdrawal by Subject|5|||
149752873|NCT03290300|540224696|FG000|Overall Study|Lost to Follow-up|3|||
149752874|NCT02124798|540224697|FG000|Overall Study|Adverse Event|3|||
149752875|NCT02124798|540224697|FG000|Overall Study|Lost to Follow-up|1|||
149752876|NCT01797432|540224698|FG000|Overall Study|Lost to Follow-up|1|||
149752877|NCT01797432|540224698|FG000|Overall Study|Adverse Event|1|||
149752878|NCT01797432|540224698|FG000|Overall Study|Withdrawal by Subject|1|||
149752879|NCT01797432|540224698|FG000|Overall Study|lived too far from study site|1|||
149752880|NCT02792777|540224699|FG000|Overall Study|Withdrawal by Subject|2|||
149752881|NCT02792777|540224700|FG001|Overall Study|Withdrawal by Subject|0|||
149752882|NCT02792777|540224699|FG000|Overall Study|Recording malfunction|2|||
149752883|NCT02792777|540224700|FG001|Overall Study|Recording malfunction|0|||
149752884|NCT02792777|540224699|FG000|Overall Study|Later determined to be ineligible|2|||
149752885|NCT02792777|540224700|FG001|Overall Study|Later determined to be ineligible|0|||
149752886|NCT02792777|540224699|FG000|Overall Study|Participant interviewed twice|1|||
149752887|NCT02792777|540224700|FG001|Overall Study|Participant interviewed twice|0|||
149752888|NCT00487279|540224702|FG000|Overall Study|Death|1|||
149752889|NCT00487279|540224703|FG001|Overall Study|Death|0|||
149752890|NCT00487279|540224702|FG000|Overall Study|Withdrawal by Subject|0|||
149752891|NCT00487279|540224703|FG001|Overall Study|Withdrawal by Subject|2|||
149752892|NCT02746679|540224704|FG000|Overall Study|Lost to Follow-up|4|||
149752893|NCT02746679|540224705|FG001|Overall Study|Lost to Follow-up|6|||
149752894|NCT00469014|540224711|FG000|Initial Phase Randomization|Disease Progression|0|||
149752895|NCT00469014|540224712|FG001|Initial Phase Randomization|Disease Progression|1|||
149752896|NCT00469014|540224713|FG002|Initial Phase Randomization|Disease Progression|1|||
149752897|NCT00469014|540224714|FG003|Initial Phase Randomization|Disease Progression|0|||
149752898|NCT00469014|540224711|FG000|Initial Phase Randomization|No Response|1|||
149752899|NCT00469014|540224712|FG001|Initial Phase Randomization|No Response|0|||
149752900|NCT00469014|540224713|FG002|Initial Phase Randomization|No Response|0|||
149752901|NCT00469014|540224714|FG003|Initial Phase Randomization|No Response|1|||
149752902|NCT00469014|540224711|FG000|Adaptive Randomization|Not Evaluable|1|||
149752903|NCT00469014|540224712|FG001|Adaptive Randomization|Not Evaluable|0|||
149752904|NCT00469014|540224713|FG002|Adaptive Randomization|Not Evaluable|0|||
149752905|NCT00469014|540224714|FG003|Adaptive Randomization|Not Evaluable|1|||
149752906|NCT00469014|540224711|FG000|Adaptive Randomization|No Response|0|||
149752907|NCT00469014|540224712|FG001|Adaptive Randomization|No Response|1|||
149752908|NCT00469014|540224713|FG002|Adaptive Randomization|No Response|0|||
149752909|NCT00469014|540224714|FG003|Adaptive Randomization|No Response|0|||
149752910|NCT00469014|540224711|FG000|Adaptive Randomization|Death|0|||
149752911|NCT00469014|540224712|FG001|Adaptive Randomization|Death|0|||
149752912|NCT00469014|540224713|FG002|Adaptive Randomization|Death|1|||
149752913|NCT00469014|540224714|FG003|Adaptive Randomization|Death|0|||
149752914|NCT00515463|540224715|FG000|Overall Study|Physician Decision|4|||
149752915|NCT00515463|540224716|FG001|Overall Study|Physician Decision|2|||
149752916|NCT00515463|540224715|FG000|Overall Study|Adverse Event|1|||
149752917|NCT00515463|540224716|FG001|Overall Study|Adverse Event|2|||
149752918|NCT00515463|540224715|FG000|Overall Study|Withdrawal by Subject|3|||
149752919|NCT00515463|540224716|FG001|Overall Study|Withdrawal by Subject|4|||
149752920|NCT00515463|540224715|FG000|Overall Study|Lost to Follow-up|6|||
149752921|NCT00515463|540224716|FG001|Overall Study|Lost to Follow-up|5|||
149752922|NCT00515463|540224715|FG000|Overall Study|Other|0|||
149752923|NCT00515463|540224716|FG001|Overall Study|Other|1|||
149752924|NCT00916721|540224717|FG000|Overall Study|Lost to Follow-up|0|||
149752925|NCT00916721|540224718|FG001|Overall Study|Lost to Follow-up|1|||
149752926|NCT00916721|540224717|FG000|Overall Study|Adverse Event|6|||
149752927|NCT00916721|540224718|FG001|Overall Study|Adverse Event|3|||
149752928|NCT00916721|540224717|FG000|Overall Study|Withdrawal by Subject|2|||
149752929|NCT00916721|540224718|FG001|Overall Study|Withdrawal by Subject|2|||
149752930|NCT00916721|540224717|FG000|Overall Study|Protocol Violation|2|||
149752931|NCT00916721|540224718|FG001|Overall Study|Protocol Violation|4|||
149752932|NCT02399475|540224730|FG000|Overall Study|Physician Decision|1|||
149752933|NCT02399475|540224731|FG001|Overall Study|Physician Decision|0|||
149752934|NCT00404768|540224735|FG000|Part A and B|Withdrawn due to labor progression|1|||
149752935|NCT00404768|540224736|FG001|Part A and B|Withdrawn due to labor progression|0|||
149752936|NCT00404768|540224737|FG002|Part A and B|Withdrawn due to labor progression|0|||
149752937|NCT00404768|540224738|FG003|Part A and B|Withdrawn due to labor progression|0|||
149752938|NCT00404768|540224735|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
149752939|NCT00404768|540224736|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
149752940|NCT00404768|540224737|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
149752941|NCT00404768|540224738|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
149752942|NCT00404768|540224735|FG000|Part C|Adverse Event|0|||
149752943|NCT00404768|540224736|FG001|Part C|Adverse Event|0|||
149752944|NCT00404768|540224737|FG002|Part C|Adverse Event|0|||
149752945|NCT00404768|540224738|FG003|Part C|Adverse Event|3|||
149752946|NCT00404768|540224735|FG000|Part C|Lost to Follow-up|0|||
149752947|NCT00404768|540224736|FG001|Part C|Lost to Follow-up|0|||
149752948|NCT00404768|540224737|FG002|Part C|Lost to Follow-up|3|||
149752949|NCT00404768|540224738|FG003|Part C|Lost to Follow-up|1|||
149752950|NCT00404768|540224735|FG000|Part C|Withdrawal by Subject|0|||
149752951|NCT00404768|540224736|FG001|Part C|Withdrawal by Subject|0|||
149752952|NCT00404768|540224737|FG002|Part C|Withdrawal by Subject|2|||
149752953|NCT00404768|540224738|FG003|Part C|Withdrawal by Subject|1|||
149752954|NCT00404768|540224735|FG000|Part C|Early withdrawal from study medication|0|||
149752955|NCT00404768|540224736|FG001|Part C|Early withdrawal from study medication|0|||
149752956|NCT00404768|540224737|FG002|Part C|Early withdrawal from study medication|1|||
149752957|NCT00404768|540224738|FG003|Part C|Early withdrawal from study medication|0|||
149752958|NCT00404768|540224735|FG000|Part C|Participant did not respond to therapy|0|||
149752959|NCT00404768|540224736|FG001|Part C|Participant did not respond to therapy|0|||
149752960|NCT00404768|540224737|FG002|Part C|Participant did not respond to therapy|1|||
149752961|NCT00404768|540224738|FG003|Part C|Participant did not respond to therapy|1|||
149752962|NCT00404768|540224735|FG000|Part C|Physician withdrew the study medication|0|||
149752963|NCT00404768|540224736|FG001|Part C|Physician withdrew the study medication|0|||
149752964|NCT00404768|540224737|FG002|Part C|Physician withdrew the study medication|1|||
149752965|NCT00404768|540224738|FG003|Part C|Physician withdrew the study medication|0|||
149752966|NCT00404768|540224735|FG000|Part C|Participant delivered baby|0|||
149752967|NCT00404768|540224736|FG001|Part C|Participant delivered baby|0|||
149752968|NCT00404768|540224737|FG002|Part C|Participant delivered baby|0|||
149752969|NCT00404768|540224738|FG003|Part C|Participant delivered baby|1|||
149752970|NCT00404768|540224735|FG000|Part C|Unsatisfactory uterine response to IP|0|||
149752971|NCT00404768|540224736|FG001|Part C|Unsatisfactory uterine response to IP|0|||
149752972|NCT00404768|540224737|FG002|Part C|Unsatisfactory uterine response to IP|0|||
149752973|NCT00404768|540224738|FG003|Part C|Unsatisfactory uterine response to IP|1|||
149752974|NCT00404768|540224735|FG000|Part C|Active labor|0|||
149752975|NCT00404768|540224736|FG001|Part C|Active labor|0|||
149752976|NCT00404768|540224737|FG002|Part C|Active labor|0|||
149752977|NCT00404768|540224738|FG003|Part C|Active labor|1|||
149752978|NCT00404768|540224735|FG000|Part C|Lack of Efficacy|0|||
149752979|NCT00404768|540224736|FG001|Part C|Lack of Efficacy|0|||
149752980|NCT00404768|540224737|FG002|Part C|Lack of Efficacy|0|||
149752981|NCT00404768|540224738|FG003|Part C|Lack of Efficacy|2|||
149752982|NCT00404768|540224735|FG000|Part C|Treatment failure|0|||
149752983|NCT00404768|540224736|FG001|Part C|Treatment failure|0|||
149752984|NCT00404768|540224737|FG002|Part C|Treatment failure|0|||
149752985|NCT00404768|540224738|FG003|Part C|Treatment failure|1|||
149752986|NCT00404768|540224735|FG000|Part C|Investigator discretion|0|||
149752987|NCT00404768|540224736|FG001|Part C|Investigator discretion|0|||
149752988|NCT00404768|540224737|FG002|Part C|Investigator discretion|0|||
149752989|NCT00404768|540224738|FG003|Part C|Investigator discretion|1|||
149752990|NCT00404768|540224735|FG000|Part C|Researcher suspended study medication|0|||
149752991|NCT00404768|540224736|FG001|Part C|Researcher suspended study medication|0|||
149752992|NCT00404768|540224737|FG002|Part C|Researcher suspended study medication|0|||
149752993|NCT00404768|540224738|FG003|Part C|Researcher suspended study medication|1|||
149752994|NCT03575468|540224739|FG000|Overall Study|Withdrawal by Subject|3|||
149752995|NCT03575468|540224740|FG001|Overall Study|Withdrawal by Subject|0|||
149752996|NCT03575468|540224739|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
149752997|NCT03575468|540224740|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
149752998|NCT03575468|540224739|FG000|Overall Study|Lost to Follow-up|13|||
149752999|NCT03575468|540224740|FG001|Overall Study|Lost to Follow-up|17|||
149753000|NCT01118143|540224741|FG000|Overall Study|Withdrawal by Subject|2|||
149753001|NCT01118143|540224742|FG001|Overall Study|Withdrawal by Subject|5|||
149753002|NCT02112448|540224743|FG000|Overall Study|lab values precluding use of ketorolac|2|||
149753003|NCT02112448|540224744|FG001|Overall Study|lab values precluding use of ketorolac|2|||
149753004|NCT02112448|540224743|FG000|Overall Study|Protocol Violation|1|||
149753005|NCT02112448|540224744|FG001|Overall Study|Protocol Violation|2|||
149753006|NCT02112448|540224743|FG000|Overall Study|Physician Decision|4|||
149753007|NCT02112448|540224744|FG001|Overall Study|Physician Decision|6|||
149753008|NCT02112448|540224743|FG000|Overall Study|required heparin so could not use ketoro|1|||
149753009|NCT02112448|540224744|FG001|Overall Study|required heparin so could not use ketoro|0|||
149753010|NCT01597622|540226521|FG000|Overall Study|Adverse Event|7|||
149753011|NCT01597622|540226521|FG000|Overall Study|Lack of Efficacy|3|||
149753012|NCT01597622|540226521|FG000|Overall Study|Protocol Violation|1|||
149753013|NCT01597622|540226521|FG000|Overall Study|Lost to Follow-up|1|||
149753014|NCT01597622|540226521|FG000|Overall Study|Investigator Discretion|5|||
149753015|NCT01597622|540226521|FG000|Overall Study|Withdrawal by Subject|20|||
149753016|NCT01597622|540226521|FG000|Overall Study|Death|1|||
149753017|NCT04543955|540226522|FG000|Overall Study|Company cancelled study|1|||
149753018|NCT04543955|540226523|FG001|Overall Study|Company cancelled study|0|||
149753019|NCT01228071|540226526|FG000|Overall Study|Protocol Violation|1|||
149753020|NCT01228071|540226526|FG000|Overall Study|Withdrawal by Subject|1|||
149753021|NCT02385123|540226534|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
149753022|NCT04230486|540226536|FG000|Overall Study|Screen Failure|1|||
149753023|NCT03215264|540226537|FG000|Dose Level 2|Adverse Event|0|||
149753024|NCT03215264|540226538|FG001|Dose Level 2|Adverse Event|1|||
149753025|NCT03215264|540226539|FG002|Dose Level 2|Adverse Event|0|||
149753026|NCT03215264|540226537|FG000|Dose Level 3|Withdrawal by Subject|0|||
149753027|NCT03215264|540226538|FG001|Dose Level 3|Withdrawal by Subject|0|||
149753028|NCT03215264|540226539|FG002|Dose Level 3|Withdrawal by Subject|1|||
149753029|NCT02145156|540226541|FG000|Overall Study|No match to vaccination records|60|||
149753030|NCT02145156|540226542|FG001|Overall Study|No match to vaccination records|52|||
149753031|NCT02145156|540226543|FG002|Overall Study|No match to vaccination records|41|||
149753032|NCT01740440|540226546|FG000|Overall Study|Lost to Follow-up|3|||
149753033|NCT02417233|540226547|FG000|Overall Study|Death|4|||
149753034|NCT02417233|540226548|FG001|Overall Study|Death|10|||
149753035|NCT02417233|540226549|FG002|Overall Study|Death|14|||
149753036|NCT02417233|540226547|FG000|Overall Study|Lost to Follow-up|27|||
149753037|NCT02417233|540226548|FG001|Overall Study|Lost to Follow-up|39|||
149753038|NCT02417233|540226549|FG002|Overall Study|Lost to Follow-up|34|||
149753039|NCT02417233|540226547|FG000|Overall Study|Protocol Violation|2|||
149753040|NCT02417233|540226548|FG001|Overall Study|Protocol Violation|0|||
149753041|NCT02417233|540226549|FG002|Overall Study|Protocol Violation|2|||
149753042|NCT02417233|540226547|FG000|Overall Study|Withdrawal by Subject|2|||
149753043|NCT02417233|540226548|FG001|Overall Study|Withdrawal by Subject|1|||
149753044|NCT02417233|540226549|FG002|Overall Study|Withdrawal by Subject|8|||
149753045|NCT02417233|540226547|FG000|Overall Study|Relocation out of study area|1|||
149753046|NCT02417233|540226548|FG001|Overall Study|Relocation out of study area|0|||
149753047|NCT02417233|540226549|FG002|Overall Study|Relocation out of study area|1|||
149753048|NCT02417233|540226547|FG000|Overall Study|Mentally unstable|0|||
149753049|NCT02417233|540226548|FG001|Overall Study|Mentally unstable|1|||
149753050|NCT02417233|540226549|FG002|Overall Study|Mentally unstable|0|||
149753051|NCT01063751|540226551|FG000|Overall Study|Censored from analyses|42|||
149753052|NCT01063751|540226551|FG000|Overall Study|Withdrawal by Subject|34|||
149753053|NCT01063751|540226551|FG000|Overall Study|Lost to Follow-up|30|||
149753054|NCT01063751|540226551|FG000|Overall Study|Death|13|||
149753055|NCT01063751|540226551|FG000|Overall Study|Sponsored Terminated Study|60|||
149753056|NCT01063751|540226551|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
149753057|NCT01063751|540226551|FG000|Overall Study|Investigator site closed|10|||
149753058|NCT01063751|540226551|FG000|Overall Study|Revision|6|||
149753059|NCT01063751|540226551|FG000|Overall Study|Physician Decision|4|||
149753060|NCT01264965|540226559|FG000|Overall Study|Withdrawal by Subject|10|||
149753061|NCT00406315|540226564|FG000|Overall Study|Death|1|||
149753062|NCT00406315|540226564|FG000|Overall Study|Adverse Event|39|||
149753063|NCT00406315|540226564|FG000|Overall Study|Laboratory Abnormality|4|||
149753064|NCT00406315|540226564|FG000|Overall Study|Lack of Efficacy|13|||
149753065|NCT00406315|540226564|FG000|Overall Study|Other|33|||
149753066|NCT00406315|540226564|FG000|Overall Study|Lost to Follow-up|21|||
149753067|NCT00406315|540226564|FG000|Overall Study|Withdrawal by Subject|30|||
149753068|NCT03799718|540226566|FG000|Overall Study|Adverse Event|2|||
149753069|NCT00321984|540226567|FG000|Overall Study|Adverse Event|9|||
149753070|NCT00321984|540226568|FG001|Overall Study|Adverse Event|6|||
149753071|NCT00321984|540226569|FG002|Overall Study|Adverse Event|8|||
149753072|NCT00321984|540226567|FG000|Overall Study|Protocol Violation|0|||
149753073|NCT00321984|540226568|FG001|Overall Study|Protocol Violation|1|||
149753074|NCT00321984|540226569|FG002|Overall Study|Protocol Violation|1|||
149753075|NCT00321984|540226567|FG000|Overall Study|Lost to Follow-up|2|||
149753076|NCT00321984|540226568|FG001|Overall Study|Lost to Follow-up|4|||
149753077|NCT00321984|540226569|FG002|Overall Study|Lost to Follow-up|2|||
149753078|NCT00321984|540226567|FG000|Overall Study|Withdrawal by Subject|8|||
149753079|NCT00321984|540226568|FG001|Overall Study|Withdrawal by Subject|6|||
149753080|NCT00321984|540226569|FG002|Overall Study|Withdrawal by Subject|5|||
149753081|NCT00321984|540226567|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
149753082|NCT00321984|540226568|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
149753083|NCT00321984|540226569|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
149753084|NCT00321984|540226567|FG000|Overall Study|Lack of Efficacy|3|||
149753085|NCT00321984|540226568|FG001|Overall Study|Lack of Efficacy|1|||
149753086|NCT00321984|540226569|FG002|Overall Study|Lack of Efficacy|3|||
149753087|NCT00321984|540226567|FG000|Overall Study|Noncompliant|0|||
149753088|NCT00321984|540226568|FG001|Overall Study|Noncompliant|0|||
149753089|NCT00321984|540226569|FG002|Overall Study|Noncompliant|2|||
149753090|NCT00321984|540226567|FG000|Overall Study|Pregnancy|0|||
149753091|NCT00321984|540226568|FG001|Overall Study|Pregnancy|1|||
149753092|NCT00321984|540226569|FG002|Overall Study|Pregnancy|0|||
149753093|NCT00321984|540226567|FG000|Overall Study|Per Subject Request|1|||
149753094|NCT00321984|540226568|FG001|Overall Study|Per Subject Request|0|||
149753095|NCT00321984|540226569|FG002|Overall Study|Per Subject Request|0|||
149753096|NCT00321984|540226567|FG000|Overall Study|Per Investigator Request|1|||
149753097|NCT00321984|540226568|FG001|Overall Study|Per Investigator Request|0|||
149753098|NCT00321984|540226569|FG002|Overall Study|Per Investigator Request|0|||
149753099|NCT00321984|540226567|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
149753100|NCT00321984|540226568|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
149753101|NCT00321984|540226569|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
149753102|NCT01469013|540226570|FG000|Part A (Treatment Period)|Adverse Event|1|||
149753103|NCT01469013|540226571|FG001|Part A (Treatment Period)|Adverse Event|0|||
149753104|NCT01469013|540226572|FG002|Part A (Treatment Period)|Adverse Event|0|||
149753105|NCT01469013|540226573|FG003|Part A (Treatment Period)|Adverse Event|0|||
149753106|NCT01469013|540226574|FG004|Part A (Treatment Period)|Adverse Event|1|||
149753107|NCT01469013|540226575|FG005|Part A (Treatment Period)|Adverse Event|0|||
149753108|NCT01469013|540226576|FG006|Part A (Treatment Period)|Adverse Event|0|||
149753109|NCT01469013|540226577|FG007|Part A (Treatment Period)|Adverse Event|0|||
149753110|NCT01469013|540226578|FG008|Part A (Treatment Period)|Adverse Event|0|||
149753111|NCT01469013|540226579|FG009|Part A (Treatment Period)|Adverse Event|0|||
149753112|NCT01469013|540226580|FG010|Part A (Treatment Period)|Adverse Event|0|||
149753113|NCT01469013|540226581|FG011|Part A (Treatment Period)|Adverse Event|0|||
149753114|NCT01469013|540226582|FG012|Part A (Treatment Period)|Adverse Event|0|||
149753115|NCT01469013|540226570|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753116|NCT01469013|540226571|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753117|NCT01469013|540226572|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
149753118|NCT01469013|540226573|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753119|NCT01469013|540226574|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753120|NCT01469013|540226575|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753121|NCT01469013|540226576|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753122|NCT01469013|540226577|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753123|NCT01469013|540226578|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753124|NCT01469013|540226579|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753125|NCT01469013|540226580|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753126|NCT01469013|540226581|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753127|NCT01469013|540226582|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
149753128|NCT01469013|540226570|FG000|Part B (Extension Period)|Adverse Event|0|||
149753129|NCT01469013|540226571|FG001|Part B (Extension Period)|Adverse Event|0|||
149753130|NCT01469013|540226572|FG002|Part B (Extension Period)|Adverse Event|0|||
149753131|NCT01469013|540226573|FG003|Part B (Extension Period)|Adverse Event|0|||
149753132|NCT01469013|540226574|FG004|Part B (Extension Period)|Adverse Event|0|||
149753133|NCT01469013|540226575|FG005|Part B (Extension Period)|Adverse Event|2|||
149753134|NCT01469013|540226576|FG006|Part B (Extension Period)|Adverse Event|5|||
149753135|NCT01469013|540226577|FG007|Part B (Extension Period)|Adverse Event|5|||
149753136|NCT01469013|540226578|FG008|Part B (Extension Period)|Adverse Event|3|||
149753137|NCT01469013|540226579|FG009|Part B (Extension Period)|Adverse Event|3|||
149753138|NCT01469013|540226580|FG010|Part B (Extension Period)|Adverse Event|1|||
149753139|NCT01469013|540226581|FG011|Part B (Extension Period)|Adverse Event|6|||
149753140|NCT01469013|540226582|FG012|Part B (Extension Period)|Adverse Event|3|||
149753141|NCT01469013|540226570|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
149753142|NCT01469013|540226571|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
149753143|NCT01469013|540226572|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
149753144|NCT01469013|540226573|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
149753145|NCT01469013|540226574|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
149753146|NCT01469013|540226575|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
149753147|NCT01469013|540226576|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
149753148|NCT01469013|540226577|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
149753149|NCT01469013|540226578|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
149753150|NCT01469013|540226579|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
149753151|NCT01469013|540226580|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
149753152|NCT01469013|540226581|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
149753153|NCT01469013|540226582|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
149753154|NCT05232097|540226585|FG000|Overall Study|Physician Decision|1|||
149753155|NCT00871858|540226586|FG000|Overall Study|Protocol Violation|3|||
149753156|NCT00871858|540226587|FG001|Overall Study|Protocol Violation|4|||
149753157|NCT00871858|540226586|FG000|Overall Study|Adverse Event|1|||
149753158|NCT00871858|540226587|FG001|Overall Study|Adverse Event|1|||
149753159|NCT00871858|540226586|FG000|Overall Study|Withdrawal by Subject|1|||
149753160|NCT00871858|540226587|FG001|Overall Study|Withdrawal by Subject|1|||
149753161|NCT00871858|540226586|FG000|Overall Study|Lost to Follow-up|0|||
149753162|NCT00871858|540226587|FG001|Overall Study|Lost to Follow-up|1|||
149753163|NCT00700752|540226592|FG000|First Intervention|Withdrawal by Subject|0|||
149753164|NCT00700752|540226593|FG001|First Intervention|Withdrawal by Subject|2|||
149753165|NCT03303339|540226594|FG000|Overall Study|Death|2|||
149753166|NCT03303339|540226595|FG001|Overall Study|Death|2|||
149753167|NCT03303339|540226596|FG002|Overall Study|Death|2|||
149753168|NCT03303339|540226597|FG003|Overall Study|Death|1|||
149753169|NCT03303339|540226598|FG004|Overall Study|Death|4|||
149753170|NCT03303339|540226599|FG005|Overall Study|Death|2|||
149753171|NCT03303339|540226600|FG006|Overall Study|Death|2|||
149753172|NCT03303339|540226601|FG007|Overall Study|Death|2|||
149753173|NCT03303339|540226602|FG008|Overall Study|Death|3|||
149753174|NCT03303339|540226603|FG009|Overall Study|Death|3|||
149753175|NCT03303339|540226604|FG010|Overall Study|Death|4|||
149753176|NCT03303339|540226605|FG011|Overall Study|Death|24|||
149753177|NCT03303339|540226594|FG000|Overall Study|Study Terminated by Sponsor|0|||
149753178|NCT03303339|540226595|FG001|Overall Study|Study Terminated by Sponsor|0|||
149753179|NCT03303339|540226596|FG002|Overall Study|Study Terminated by Sponsor|0|||
149753180|NCT03303339|540226597|FG003|Overall Study|Study Terminated by Sponsor|0|||
149753181|NCT03303339|540226598|FG004|Overall Study|Study Terminated by Sponsor|0|||
149753182|NCT03303339|540226599|FG005|Overall Study|Study Terminated by Sponsor|0|||
149753183|NCT03303339|540226600|FG006|Overall Study|Study Terminated by Sponsor|0|||
149753184|NCT03303339|540226601|FG007|Overall Study|Study Terminated by Sponsor|0|||
149753185|NCT03303339|540226602|FG008|Overall Study|Study Terminated by Sponsor|1|||
149753186|NCT03303339|540226603|FG009|Overall Study|Study Terminated by Sponsor|0|||
149753187|NCT03303339|540226604|FG010|Overall Study|Study Terminated by Sponsor|1|||
149753188|NCT03303339|540226605|FG011|Overall Study|Study Terminated by Sponsor|1|||
149753189|NCT03303339|540226594|FG000|Overall Study|Withdrawal by Subject|1|||
149753190|NCT03303339|540226595|FG001|Overall Study|Withdrawal by Subject|0|||
149753191|NCT03303339|540226596|FG002|Overall Study|Withdrawal by Subject|0|||
149753192|NCT03303339|540226597|FG003|Overall Study|Withdrawal by Subject|0|||
149753193|NCT03303339|540226598|FG004|Overall Study|Withdrawal by Subject|0|||
149753194|NCT03303339|540226599|FG005|Overall Study|Withdrawal by Subject|1|||
149753195|NCT03303339|540226600|FG006|Overall Study|Withdrawal by Subject|1|||
149753196|NCT03303339|540226601|FG007|Overall Study|Withdrawal by Subject|0|||
149753197|NCT03303339|540226602|FG008|Overall Study|Withdrawal by Subject|0|||
149753198|NCT03303339|540226603|FG009|Overall Study|Withdrawal by Subject|0|||
149753199|NCT03303339|540226604|FG010|Overall Study|Withdrawal by Subject|0|||
149753200|NCT03303339|540226605|FG011|Overall Study|Withdrawal by Subject|2|||
149753201|NCT03303339|540226594|FG000|Overall Study|Physician Decision|0|||
149753202|NCT03303339|540226595|FG001|Overall Study|Physician Decision|0|||
149753203|NCT03303339|540226596|FG002|Overall Study|Physician Decision|0|||
149753204|NCT03303339|540226597|FG003|Overall Study|Physician Decision|0|||
149753205|NCT03303339|540226598|FG004|Overall Study|Physician Decision|1|||
149753206|NCT03303339|540226599|FG005|Overall Study|Physician Decision|0|||
149753207|NCT03303339|540226600|FG006|Overall Study|Physician Decision|0|||
149753208|NCT03303339|540226601|FG007|Overall Study|Physician Decision|0|||
149753209|NCT03303339|540226602|FG008|Overall Study|Physician Decision|0|||
149753210|NCT03303339|540226603|FG009|Overall Study|Physician Decision|0|||
149753211|NCT03303339|540226604|FG010|Overall Study|Physician Decision|0|||
149753212|NCT03303339|540226605|FG011|Overall Study|Physician Decision|0|||
149753213|NCT03303339|540226594|FG000|Overall Study|Safety/Non-compliance|0|||
149753214|NCT03303339|540226595|FG001|Overall Study|Safety/Non-compliance|0|||
149753215|NCT03303339|540226596|FG002|Overall Study|Safety/Non-compliance|0|||
149753216|NCT03303339|540226597|FG003|Overall Study|Safety/Non-compliance|0|||
149753217|NCT03303339|540226598|FG004|Overall Study|Safety/Non-compliance|0|||
149753218|NCT03303339|540226599|FG005|Overall Study|Safety/Non-compliance|0|||
149753219|NCT03303339|540226600|FG006|Overall Study|Safety/Non-compliance|0|||
149753220|NCT03303339|540226601|FG007|Overall Study|Safety/Non-compliance|0|||
149753221|NCT03303339|540226602|FG008|Overall Study|Safety/Non-compliance|0|||
149753222|NCT03303339|540226603|FG009|Overall Study|Safety/Non-compliance|0|||
149753223|NCT03303339|540226604|FG010|Overall Study|Safety/Non-compliance|0|||
149753224|NCT03303339|540226605|FG011|Overall Study|Safety/Non-compliance|1|||
149753225|NCT01426386|540226606|FG000|Overall Study|Adverse Event|0|||
149753226|NCT01426386|540226607|FG001|Overall Study|Adverse Event|1|||
149753227|NCT01426386|540226608|FG002|Overall Study|Adverse Event|0|||
149753228|NCT01426386|540226609|FG003|Overall Study|Adverse Event|0|||
149753229|NCT01426386|540226610|FG004|Overall Study|Adverse Event|0|||
149753230|NCT01426386|540226611|FG005|Overall Study|Adverse Event|0|||
149753231|NCT01426386|540226606|FG000|Overall Study|Did not attend scheduled visit|1|||
149753232|NCT01426386|540226607|FG001|Overall Study|Did not attend scheduled visit|4|||
149753233|NCT01426386|540226608|FG002|Overall Study|Did not attend scheduled visit|0|||
149753234|NCT01426386|540226609|FG003|Overall Study|Did not attend scheduled visit|0|||
149753235|NCT01426386|540226610|FG004|Overall Study|Did not attend scheduled visit|2|||
149753236|NCT01426386|540226611|FG005|Overall Study|Did not attend scheduled visit|1|||
149753237|NCT01426386|540226606|FG000|Overall Study|Poor response|2|||
149753238|NCT01426386|540226607|FG001|Overall Study|Poor response|1|||
149753239|NCT01426386|540226608|FG002|Overall Study|Poor response|2|||
149753240|NCT01426386|540226609|FG003|Overall Study|Poor response|0|||
149753241|NCT01426386|540226610|FG004|Overall Study|Poor response|1|||
149753242|NCT01426386|540226611|FG005|Overall Study|Poor response|0|||
149753243|NCT01426386|540226606|FG000|Overall Study|Personal reasons|0|||
149753244|NCT01426386|540226607|FG001|Overall Study|Personal reasons|0|||
149753245|NCT01426386|540226608|FG002|Overall Study|Personal reasons|0|||
149753246|NCT01426386|540226609|FG003|Overall Study|Personal reasons|0|||
149753247|NCT01426386|540226610|FG004|Overall Study|Personal reasons|1|||
149753248|NCT01426386|540226611|FG005|Overall Study|Personal reasons|0|||
149753249|NCT02116972|540226616|FG000|Overall Study|Adverse Event|4|||
149753250|NCT02116972|540226617|FG001|Overall Study|Adverse Event|4|||
149753251|NCT02116972|540226618|FG002|Overall Study|Adverse Event|1|||
149753252|NCT02116972|540226616|FG000|Overall Study|Withdrawal by Subject|1|||
149753253|NCT02116972|540226617|FG001|Overall Study|Withdrawal by Subject|1|||
149753254|NCT02116972|540226618|FG002|Overall Study|Withdrawal by Subject|5|||
149753255|NCT02116972|540226616|FG000|Overall Study|Protocol Violation|1|||
149753256|NCT02116972|540226617|FG001|Overall Study|Protocol Violation|0|||
149753257|NCT02116972|540226618|FG002|Overall Study|Protocol Violation|1|||
149753258|NCT02116972|540226616|FG000|Overall Study|Lost to Follow-up|4|||
149753259|NCT02116972|540226617|FG001|Overall Study|Lost to Follow-up|3|||
149753260|NCT02116972|540226618|FG002|Overall Study|Lost to Follow-up|1|||
149753261|NCT02116972|540226616|FG000|Overall Study|Lack of Efficacy|6|||
149753262|NCT02116972|540226617|FG001|Overall Study|Lack of Efficacy|6|||
149753263|NCT02116972|540226618|FG002|Overall Study|Lack of Efficacy|5|||
149753264|NCT02116972|540226616|FG000|Overall Study|scheduling conflicts and relocation|3|||
149753265|NCT02116972|540226617|FG001|Overall Study|scheduling conflicts and relocation|3|||
149753266|NCT02116972|540226618|FG002|Overall Study|scheduling conflicts and relocation|6|||
149753267|NCT01879618|540226619|FG000|Overall Study|Does not meet entrance criteria|1|||
149753268|NCT01879618|540226619|FG000|Overall Study|Withdrawal by Subject|1|||
149753269|NCT01879618|540226619|FG000|Overall Study|Surgery;changed schedule; not available|8|||
149753270|NCT01879618|540226619|FG000|Overall Study|Protocol Violation|6|||
149753271|NCT01879618|540226619|FG000|Overall Study|Adverse Event|5|||
149753272|NCT01137435|540226620|FG000|Overall Study|Lost to Follow-up|24|||
149753273|NCT01137435|540226620|FG000|Overall Study|Off label usage|4|||
149753274|NCT01416610|540226627|FG000|Overall Study|Adverse Event|4|||
149753275|NCT01416610|540226627|FG000|Overall Study|Adverse Event -Patient decision|3|||
149753276|NCT01416610|540226627|FG000|Overall Study|Lack of Efficacy|4|||
149753277|NCT01416610|540226627|FG000|Overall Study|No reason given|5|||
149753278|NCT01416610|540226627|FG000|Overall Study|Withdrawal by Subject|13|||
149753279|NCT01416610|540226627|FG000|Overall Study|Lost to Follow-up|7|||
149753280|NCT01416610|540226627|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
149753281|NCT00492921|540226628|FG000|Overall Study|Death|1|||
149753282|NCT00492921|540226629|FG001|Overall Study|Death|0|||
149753283|NCT00492921|540226630|FG002|Overall Study|Death|1|||
149753284|NCT01696877|540226631|FG000|Overall Study|Adverse Event|0|||
149753285|NCT01696877|540226632|FG001|Overall Study|Adverse Event|1|||
149753286|NCT00864227|540226635|FG000|Overall Study|Withdrawal by Subject|1|||
149753287|NCT00864227|540226635|FG000|Overall Study|Disease Relapse/Progression|3|||
149753288|NCT03461289|540226636|FG000|Overall Study|Death|1|||
149753289|NCT03241173|540226637|FG000|Overall Study|Death|3|||
149753290|NCT03241173|540226638|FG001|Overall Study|Death|2|||
149753291|NCT03241173|540226639|FG002|Overall Study|Death|4|||
149753292|NCT03241173|540226640|FG003|Overall Study|Death|4|||
149753293|NCT03241173|540226641|FG004|Overall Study|Death|2|||
149753294|NCT03241173|540226642|FG005|Overall Study|Death|2|||
149753295|NCT03241173|540226643|FG006|Overall Study|Death|3|||
149753296|NCT03241173|540226644|FG007|Overall Study|Death|1|||
149753297|NCT03241173|540226645|FG008|Overall Study|Death|0|||
149753298|NCT03241173|540226646|FG009|Overall Study|Death|5|||
149753299|NCT03241173|540226647|FG010|Overall Study|Death|4|||
149753300|NCT03241173|540226648|FG011|Overall Study|Death|3|||
149753301|NCT03241173|540226649|FG012|Overall Study|Death|0|||
149753302|NCT03241173|540226650|FG013|Overall Study|Death|0|||
149753303|NCT03241173|540226651|FG014|Overall Study|Death|0|||
149753304|NCT03241173|540226637|FG000|Overall Study|Withdrawal by Subject|0|||
149753305|NCT03241173|540226638|FG001|Overall Study|Withdrawal by Subject|0|||
149753306|NCT03241173|540226639|FG002|Overall Study|Withdrawal by Subject|1|||
149753307|NCT03241173|540226640|FG003|Overall Study|Withdrawal by Subject|0|||
149753308|NCT03241173|540226641|FG004|Overall Study|Withdrawal by Subject|0|||
149753309|NCT03241173|540226642|FG005|Overall Study|Withdrawal by Subject|1|||
149753310|NCT03241173|540226643|FG006|Overall Study|Withdrawal by Subject|0|||
149753311|NCT03241173|540226644|FG007|Overall Study|Withdrawal by Subject|0|||
149753312|NCT03241173|540226645|FG008|Overall Study|Withdrawal by Subject|0|||
149753313|NCT03241173|540226646|FG009|Overall Study|Withdrawal by Subject|0|||
149753314|NCT03241173|540226647|FG010|Overall Study|Withdrawal by Subject|0|||
149753315|NCT03241173|540226648|FG011|Overall Study|Withdrawal by Subject|0|||
149753316|NCT03241173|540226649|FG012|Overall Study|Withdrawal by Subject|0|||
149753317|NCT03241173|540226650|FG013|Overall Study|Withdrawal by Subject|0|||
149753318|NCT03241173|540226651|FG014|Overall Study|Withdrawal by Subject|0|||
149753319|NCT03241173|540226637|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149753320|NCT03241173|540226638|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149753321|NCT03241173|540226639|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753322|NCT03241173|540226640|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149753323|NCT03241173|540226641|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149753324|NCT03241173|540226642|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149753325|NCT03241173|540226643|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149753326|NCT03241173|540226644|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149753327|NCT03241173|540226645|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753328|NCT03241173|540226646|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753329|NCT03241173|540226647|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149753330|NCT03241173|540226648|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
149753331|NCT03241173|540226649|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753332|NCT03241173|540226650|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753333|NCT03241173|540226651|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149753334|NCT03241173|540226637|FG000|Overall Study|Lost to Follow-up|0|||
149753335|NCT03241173|540226638|FG001|Overall Study|Lost to Follow-up|0|||
149753336|NCT03241173|540226639|FG002|Overall Study|Lost to Follow-up|0|||
149753337|NCT03241173|540226640|FG003|Overall Study|Lost to Follow-up|0|||
149753338|NCT03241173|540226641|FG004|Overall Study|Lost to Follow-up|1|||
149753339|NCT03241173|540226642|FG005|Overall Study|Lost to Follow-up|0|||
149753340|NCT03241173|540226643|FG006|Overall Study|Lost to Follow-up|0|||
149753341|NCT03241173|540226644|FG007|Overall Study|Lost to Follow-up|0|||
149753342|NCT03241173|540226645|FG008|Overall Study|Lost to Follow-up|0|||
149753343|NCT03241173|540226646|FG009|Overall Study|Lost to Follow-up|1|||
149753344|NCT03241173|540226647|FG010|Overall Study|Lost to Follow-up|0|||
149753345|NCT03241173|540226648|FG011|Overall Study|Lost to Follow-up|0|||
149753346|NCT03241173|540226649|FG012|Overall Study|Lost to Follow-up|0|||
149753347|NCT03241173|540226650|FG013|Overall Study|Lost to Follow-up|0|||
149753348|NCT03241173|540226651|FG014|Overall Study|Lost to Follow-up|0|||
149753349|NCT02698423|540226653|FG000|Overall Study|Lost to Follow-up|19|||
149753350|NCT02698423|540226654|FG001|Overall Study|Lost to Follow-up|24|||
149753351|NCT00081289|540226657|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
149753352|NCT00081289|540226658|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
149753353|NCT00081289|540226657|FG000|Overall Study|Ineligible / no protocol treatment|3|||
149753354|NCT00081289|540226658|FG001|Overall Study|Ineligible / no protocol treatment|4|||
149753355|NCT00530712|540226660|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
149753356|NCT00530712|540226660|FG000|30 Day Follow-up Visit|Missed Visit|5|||
149753357|NCT00530712|540226660|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
149753358|NCT00530712|540226660|FG000|6 Month Follow-up Visit|Missed Visit|3|||
149753359|NCT00530712|540226660|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
149753360|NCT00530712|540226660|FG000|6 Month Follow-up Visit|Death|2|||
149753361|NCT00530712|540226660|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
149753362|NCT00530712|540226660|FG000|12 Month Follow-up Visit|Missed Visit|3|||
149753363|NCT00530712|540226660|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
149753364|NCT00530712|540226660|FG000|12 Month Follow-up Visit|Death|9|||
149753365|NCT02749370|540226661|FG000|Overall Study|Withdrawal by Subject|11|||
149753366|NCT02749370|540226661|FG000|Overall Study|Lost to Follow-up|3|||
149753367|NCT01519427|540226662|FG000|Overall Study|disease progression|2|||
149753368|NCT03894904|540226663|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
149753369|NCT03894904|540226664|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
149753370|NCT03894904|540226663|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
149753371|NCT03894904|540226664|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
149753372|NCT00651118|540226670|FG000|Overall Study|Adverse Event|4|||
149753373|NCT00651118|540226671|FG001|Overall Study|Adverse Event|0|||
149753374|NCT00651118|540226672|FG002|Overall Study|Adverse Event|1|||
149753375|NCT00651118|540226673|FG003|Overall Study|Adverse Event|1|||
149753376|NCT00651118|540226670|FG000|Overall Study|Protocol Violation|2|||
149753377|NCT00651118|540226671|FG001|Overall Study|Protocol Violation|2|||
149753378|NCT00651118|540226672|FG002|Overall Study|Protocol Violation|6|||
149753379|NCT00651118|540226673|FG003|Overall Study|Protocol Violation|2|||
149753380|NCT00651118|540226670|FG000|Overall Study|Lost to Follow-up|2|||
149753381|NCT00651118|540226671|FG001|Overall Study|Lost to Follow-up|0|||
149753382|NCT00651118|540226672|FG002|Overall Study|Lost to Follow-up|1|||
149753383|NCT00651118|540226673|FG003|Overall Study|Lost to Follow-up|2|||
149753384|NCT00651118|540226670|FG000|Overall Study|administrative|1|||
149753385|NCT00651118|540226671|FG001|Overall Study|administrative|4|||
149753386|NCT00651118|540226672|FG002|Overall Study|administrative|2|||
149753387|NCT00651118|540226673|FG003|Overall Study|administrative|1|||
149753388|NCT00651118|540226670|FG000|Overall Study|Withdrawal by Subject|0|||
149753389|NCT00651118|540226671|FG001|Overall Study|Withdrawal by Subject|1|||
149753390|NCT00651118|540226672|FG002|Overall Study|Withdrawal by Subject|1|||
149753391|NCT00651118|540226673|FG003|Overall Study|Withdrawal by Subject|1|||
149753392|NCT02190435|540226676|FG000|Overall Study|First 12 patients were lead-ins|12|||
149753393|NCT02190435|540226677|FG001|Overall Study|First 12 patients were lead-ins|0|||
149753394|NCT02190435|540226676|FG000|Overall Study|3 consented screen fails|3|||
149753395|NCT02190435|540226677|FG001|Overall Study|3 consented screen fails|0|||
149753396|NCT02260193|540226678|FG000|Overall Study|Lack of Efficacy|0|||
149753397|NCT02260193|540226679|FG001|Overall Study|Lack of Efficacy|1|||
149753398|NCT02260193|540226680|FG002|Overall Study|Lack of Efficacy|6|||
149753399|NCT02260193|540226678|FG000|Overall Study|Adverse Event|3|||
149753400|NCT02260193|540226679|FG001|Overall Study|Adverse Event|4|||
149753401|NCT02260193|540226680|FG002|Overall Study|Adverse Event|1|||
149753402|NCT02260193|540226678|FG000|Overall Study|Protocol Violation|0|||
149753403|NCT02260193|540226679|FG001|Overall Study|Protocol Violation|4|||
149753404|NCT02260193|540226680|FG002|Overall Study|Protocol Violation|0|||
149753405|NCT02260193|540226678|FG000|Overall Study|Withdrawal by Subject|3|||
149753406|NCT02260193|540226679|FG001|Overall Study|Withdrawal by Subject|0|||
149753407|NCT02260193|540226680|FG002|Overall Study|Withdrawal by Subject|2|||
149753408|NCT02260193|540226678|FG000|Overall Study|Kidney Transplantation|0|||
149753409|NCT02260193|540226679|FG001|Overall Study|Kidney Transplantation|0|||
149753410|NCT02260193|540226680|FG002|Overall Study|Kidney Transplantation|1|||
149753411|NCT00935220|540226681|FG000|Overall Study|Adverse Event|1|||
149753412|NCT00935220|540226681|FG000|Overall Study|Other reason (not specified)|1|||
149753413|NCT01415440|540226684|FG000|Overall Study|Lost to Follow-up|0|||
149753414|NCT01415440|540226685|FG001|Overall Study|Lost to Follow-up|1|||
149753415|NCT01415440|540226686|FG002|Overall Study|Lost to Follow-up|2|||
149753416|NCT01415440|540226684|FG000|Overall Study|Physician Decision|3|||
149753417|NCT01415440|540226685|FG001|Overall Study|Physician Decision|0|||
149753418|NCT01415440|540226686|FG002|Overall Study|Physician Decision|0|||
149753419|NCT01415440|540226684|FG000|Overall Study|Withdrawal by Subject|1|||
149753420|NCT01415440|540226685|FG001|Overall Study|Withdrawal by Subject|0|||
149753421|NCT01415440|540226686|FG002|Overall Study|Withdrawal by Subject|0|||
149753422|NCT00336492|540226687|FG000|Overall Study|Adverse Event|4|||
149753423|NCT00336492|540226688|FG001|Overall Study|Adverse Event|3|||
149753424|NCT00336492|540226689|FG002|Overall Study|Adverse Event|6|||
149753425|NCT00336492|540226687|FG000|Overall Study|Lack of Efficacy|6|||
149753426|NCT00336492|540226688|FG001|Overall Study|Lack of Efficacy|1|||
149753427|NCT00336492|540226689|FG002|Overall Study|Lack of Efficacy|4|||
149753428|NCT00336492|540226687|FG000|Overall Study|Other|5|||
149753429|NCT00336492|540226688|FG001|Overall Study|Other|0|||
149753430|NCT00336492|540226689|FG002|Overall Study|Other|1|||
149753431|NCT01781026|540226690|FG000|Overall Study|Lack of Efficacy|2|||
149753432|NCT03103750|540226692|FG000|Overall Study|Adverse Event|1|||
149753433|NCT03103750|540226693|FG001|Overall Study|Adverse Event|0|||
149753434|NCT03103750|540226692|FG000|Overall Study|Lost to Follow-up|1|||
149753435|NCT03103750|540226693|FG001|Overall Study|Lost to Follow-up|0|||
149753436|NCT03103750|540226692|FG000|Overall Study|PET Equipment Related|2|||
149753437|NCT03103750|540226693|FG001|Overall Study|PET Equipment Related|2|||
149753438|NCT01663740|540226694|FG000|Overall Study|Lost to Follow-up|1|||
149753439|NCT01663740|540226695|FG001|Overall Study|Lost to Follow-up|4|||
149753440|NCT01663740|540226694|FG000|Overall Study|Other|9|||
149753441|NCT01663740|540226695|FG001|Overall Study|Other|2|||
149753442|NCT01663740|540226694|FG000|Overall Study|Inclusion/Exclusion not met|1|||
149753443|NCT01663740|540226695|FG001|Overall Study|Inclusion/Exclusion not met|0|||
149753444|NCT01663740|540226694|FG000|Overall Study|Death|0|||
149753445|NCT01663740|540226695|FG001|Overall Study|Death|1|||
149753446|NCT01663740|540226694|FG000|Overall Study|Withdrawal by Subject|2|||
149753447|NCT01663740|540226695|FG001|Overall Study|Withdrawal by Subject|1|||
149753448|NCT01663740|540226694|FG000|Overall Study|No end of study status|3|||
149753449|NCT01663740|540226695|FG001|Overall Study|No end of study status|0|||
149753450|NCT01522651|540226696|FG000|Overall Study|Adverse Event|3|||
149753451|NCT01522651|540226697|FG001|Overall Study|Adverse Event|4|||
149753452|NCT01522651|540226698|FG002|Overall Study|Adverse Event|4|||
149753453|NCT01522651|540226699|FG003|Overall Study|Adverse Event|5|||
149753454|NCT01522651|540226700|FG004|Overall Study|Adverse Event|4|||
149753455|NCT01522651|540226696|FG000|Overall Study|Cardioversion|1|||
149753456|NCT01522651|540226697|FG001|Overall Study|Cardioversion|0|||
149753457|NCT01522651|540226698|FG002|Overall Study|Cardioversion|0|||
149753458|NCT01522651|540226699|FG003|Overall Study|Cardioversion|0|||
149753459|NCT01522651|540226700|FG004|Overall Study|Cardioversion|0|||
149753460|NCT01522651|540226696|FG000|Overall Study|Device Malfunction|0|||
149753461|NCT01522651|540226697|FG001|Overall Study|Device Malfunction|1|||
149753462|NCT01522651|540226698|FG002|Overall Study|Device Malfunction|0|||
149753463|NCT01522651|540226699|FG003|Overall Study|Device Malfunction|0|||
149753464|NCT01522651|540226700|FG004|Overall Study|Device Malfunction|0|||
149753465|NCT01522651|540226696|FG000|Overall Study|Investigator's Discretion|0|||
149753466|NCT01522651|540226697|FG001|Overall Study|Investigator's Discretion|1|||
149753467|NCT01522651|540226698|FG002|Overall Study|Investigator's Discretion|0|||
149753468|NCT01522651|540226699|FG003|Overall Study|Investigator's Discretion|0|||
149753469|NCT01522651|540226700|FG004|Overall Study|Investigator's Discretion|0|||
149753470|NCT01522651|540226696|FG000|Overall Study|Protocol Violation|3|||
149753471|NCT01522651|540226697|FG001|Overall Study|Protocol Violation|0|||
149753472|NCT01522651|540226698|FG002|Overall Study|Protocol Violation|0|||
149753473|NCT01522651|540226699|FG003|Overall Study|Protocol Violation|0|||
149753474|NCT01522651|540226700|FG004|Overall Study|Protocol Violation|0|||
149753475|NCT01522651|540226696|FG000|Overall Study|Reason Not Specified|0|||
149753476|NCT01522651|540226697|FG001|Overall Study|Reason Not Specified|0|||
149753477|NCT01522651|540226698|FG002|Overall Study|Reason Not Specified|0|||
149753478|NCT01522651|540226699|FG003|Overall Study|Reason Not Specified|1|||
149753479|NCT01522651|540226700|FG004|Overall Study|Reason Not Specified|0|||
149753480|NCT01522651|540226696|FG000|Overall Study|Participant Non-Compliance|1|||
149753481|NCT01522651|540226697|FG001|Overall Study|Participant Non-Compliance|0|||
149753482|NCT01522651|540226698|FG002|Overall Study|Participant Non-Compliance|0|||
149753483|NCT01522651|540226699|FG003|Overall Study|Participant Non-Compliance|0|||
149753484|NCT01522651|540226700|FG004|Overall Study|Participant Non-Compliance|0|||
149753485|NCT01522651|540226696|FG000|Overall Study|Withdrew Consent|1|||
149753486|NCT01522651|540226697|FG001|Overall Study|Withdrew Consent|1|||
149753487|NCT01522651|540226698|FG002|Overall Study|Withdrew Consent|0|||
149753488|NCT01522651|540226699|FG003|Overall Study|Withdrew Consent|1|||
149753489|NCT01522651|540226700|FG004|Overall Study|Withdrew Consent|1|||
149753490|NCT01522651|540226696|FG000|Overall Study|Randomized but Never Treated|0|||
149753491|NCT01522651|540226697|FG001|Overall Study|Randomized but Never Treated|1|||
149753492|NCT01522651|540226698|FG002|Overall Study|Randomized but Never Treated|0|||
149753493|NCT01522651|540226699|FG003|Overall Study|Randomized but Never Treated|1|||
149753494|NCT01522651|540226700|FG004|Overall Study|Randomized but Never Treated|1|||
149753495|NCT02658656|540226701|FG000|Screening|Failed eligibility criteria|0|||
149753496|NCT02658656|540226702|FG001|Screening|Failed eligibility criteria|0|||
149753497|NCT02658656|540226703|FG002|Screening|Failed eligibility criteria|263|||
149753498|NCT02658656|540226701|FG000|Randomization|Withdrawal by Subject|8|||
149753499|NCT02658656|540226702|FG001|Randomization|Withdrawal by Subject|7|||
149753500|NCT02658656|540226703|FG002|Randomization|Withdrawal by Subject|0|||
149753501|NCT02658656|540226701|FG000|Randomization|Lost to Follow-up|1|||
149753502|NCT02658656|540226702|FG001|Randomization|Lost to Follow-up|3|||
149753503|NCT02658656|540226703|FG002|Randomization|Lost to Follow-up|0|||
149753504|NCT02658656|540226701|FG000|Randomization|Adverse Event|4|||
149753505|NCT02658656|540226702|FG001|Randomization|Adverse Event|0|||
149753506|NCT02658656|540226703|FG002|Randomization|Adverse Event|0|||
149753507|NCT02658656|540226701|FG000|Randomization|Administrative Termination|3|||
149753508|NCT02658656|540226702|FG001|Randomization|Administrative Termination|1|||
149753509|NCT02658656|540226703|FG002|Randomization|Administrative Termination|0|||
149753510|NCT02658656|540226701|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
149753511|NCT02658656|540226702|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
149753512|NCT02658656|540226703|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
149753513|NCT02658656|540226701|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
149753514|NCT02658656|540226702|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
149753515|NCT02658656|540226703|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
149753516|NCT02658656|540226701|FG000|Randomization|Not eligible for Randomization|1|||
149753517|NCT02658656|540226702|FG001|Randomization|Not eligible for Randomization|0|||
149753518|NCT02658656|540226703|FG002|Randomization|Not eligible for Randomization|0|||
149753519|NCT02658656|540226701|FG000|Randomization|Protocol Violation|1|||
149753520|NCT02658656|540226702|FG001|Randomization|Protocol Violation|0|||
149753521|NCT02658656|540226703|FG002|Randomization|Protocol Violation|0|||
149753522|NCT04267562|540228403|FG000|Assessed for Eligibility|Screen Failure|64|||
149753523|NCT04267562|540228403|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
149753524|NCT04267562|540228403|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
149753525|NCT04267562|540228403|FG000|Assessed for Eligibility|Site closure|6|||
149753526|NCT04267562|540228403|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
149753527|NCT04267562|540228403|FG000|Assessed for Eligibility|Physician Decision|1|||
149753528|NCT04267562|540228403|FG000|Month 24|Elective hysterectomy|1|||
149753529|NCT04267562|540228403|FG000|Month 24|Lost to Follow-up|1|||
149753530|NCT04267562|540228403|FG000|Month 36|Elective hysterectomy|2|||
149753531|NCT04267562|540228403|FG000|Month 36|Lost to Follow-up|3|||
149753532|NCT00408421|540228410|FG000|Treatment Initial Randomization|Adverse Event|5|||
149753533|NCT00408421|540228411|FG001|Treatment Initial Randomization|Adverse Event|9|||
149753534|NCT00408421|540228412|FG002|Treatment Initial Randomization|Adverse Event|0|||
149753535|NCT00408421|540228410|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
149753536|NCT00408421|540228411|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
149753537|NCT00408421|540228412|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
149753538|NCT00408421|540228410|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
149753539|NCT00408421|540228411|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
149753540|NCT00408421|540228412|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
149753541|NCT00408421|540228410|FG000|Treatment Initial Randomization|Physician Decision|1|||
149753542|NCT00408421|540228411|FG001|Treatment Initial Randomization|Physician Decision|0|||
149753543|NCT00408421|540228412|FG002|Treatment Initial Randomization|Physician Decision|0|||
149753544|NCT00408421|540228410|FG000|Treatment Initial Randomization|Protocol Violation|0|||
149753545|NCT00408421|540228411|FG001|Treatment Initial Randomization|Protocol Violation|1|||
149753546|NCT00408421|540228412|FG002|Treatment Initial Randomization|Protocol Violation|0|||
149753547|NCT00408421|540228410|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
149753548|NCT00408421|540228411|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
149753549|NCT00408421|540228412|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
149753550|NCT00408421|540228410|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
149753551|NCT00408421|540228411|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
149753552|NCT00408421|540228412|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
149753553|NCT00408421|540228410|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
149753554|NCT00408421|540228411|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
149753555|NCT00408421|540228412|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
149753556|NCT00408421|540228410|FG000|Treatment Re-Randomization|Adverse Event|2|||
149753557|NCT00408421|540228411|FG001|Treatment Re-Randomization|Adverse Event|2|||
149753558|NCT00408421|540228412|FG002|Treatment Re-Randomization|Adverse Event|4|||
149753559|NCT00408421|540228410|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
149753560|NCT00408421|540228411|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
149753561|NCT00408421|540228412|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
149753562|NCT00408421|540228410|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
149753563|NCT00408421|540228411|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
149753564|NCT00408421|540228412|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
149753565|NCT00408421|540228410|FG000|Treatment Re-Randomization|Physician Decision|1|||
149753566|NCT00408421|540228411|FG001|Treatment Re-Randomization|Physician Decision|3|||
149753567|NCT00408421|540228412|FG002|Treatment Re-Randomization|Physician Decision|0|||
149753568|NCT00408421|540228410|FG000|Treatment Re-Randomization|Protocol Violation|1|||
149753569|NCT00408421|540228411|FG001|Treatment Re-Randomization|Protocol Violation|1|||
149753570|NCT00408421|540228412|FG002|Treatment Re-Randomization|Protocol Violation|0|||
149753571|NCT00408421|540228410|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
149753572|NCT00408421|540228411|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
149753573|NCT00408421|540228412|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
149753574|NCT01614769|540228419|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
149753575|NCT01614769|540228420|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
149753576|NCT01614769|540228421|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
149753577|NCT01614769|540228422|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
149753578|NCT01614769|540228423|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
149753579|NCT01614769|540228424|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
149753580|NCT01614769|540228419|FG000|Period 1|Protocol Violation|0|||
149753581|NCT01614769|540228420|FG001|Period 1|Protocol Violation|0|||
149753582|NCT01614769|540228421|FG002|Period 1|Protocol Violation|0|||
149753583|NCT01614769|540228422|FG003|Period 1|Protocol Violation|1|||
149753584|NCT01614769|540228423|FG004|Period 1|Protocol Violation|0|||
149753585|NCT01614769|540228424|FG005|Period 1|Protocol Violation|0|||
149753586|NCT01614769|540228419|FG000|Period 1|Withdrawal by Subject|1|||
149753587|NCT01614769|540228420|FG001|Period 1|Withdrawal by Subject|0|||
149753588|NCT01614769|540228421|FG002|Period 1|Withdrawal by Subject|0|||
149753589|NCT01614769|540228422|FG003|Period 1|Withdrawal by Subject|0|||
149753590|NCT01614769|540228423|FG004|Period 1|Withdrawal by Subject|0|||
149753591|NCT01614769|540228424|FG005|Period 1|Withdrawal by Subject|0|||
149753592|NCT01614769|540228419|FG000|Period 3|Withdrawal by Subject|0|||
149753593|NCT01614769|540228420|FG001|Period 3|Withdrawal by Subject|0|||
149753594|NCT01614769|540228421|FG002|Period 3|Withdrawal by Subject|1|||
149753595|NCT01614769|540228422|FG003|Period 3|Withdrawal by Subject|0|||
149753596|NCT01614769|540228423|FG004|Period 3|Withdrawal by Subject|0|||
149753597|NCT01614769|540228424|FG005|Period 3|Withdrawal by Subject|0|||
149753598|NCT02115815|540228425|FG000|Overall Study|Withdrawal by Subject|2|||
149753599|NCT02115815|540228426|FG001|Overall Study|Withdrawal by Subject|0|||
149753600|NCT02115815|540228427|FG002|Overall Study|Withdrawal by Subject|0|||
149753601|NCT02115815|540228428|FG003|Overall Study|Withdrawal by Subject|0|||
149753602|NCT02115815|540228429|FG004|Overall Study|Withdrawal by Subject|0|||
149753603|NCT02115815|540228430|FG005|Overall Study|Withdrawal by Subject|0|||
149753604|NCT02115815|540228431|FG006|Overall Study|Withdrawal by Subject|0|||
149753605|NCT02115815|540228425|FG000|Overall Study|Not enough drug to dose participant|0|||
149753606|NCT02115815|540228426|FG001|Overall Study|Not enough drug to dose participant|0|||
149753607|NCT02115815|540228427|FG002|Overall Study|Not enough drug to dose participant|0|||
149753608|NCT02115815|540228428|FG003|Overall Study|Not enough drug to dose participant|0|||
149753609|NCT02115815|540228429|FG004|Overall Study|Not enough drug to dose participant|0|||
149753610|NCT02115815|540228430|FG005|Overall Study|Not enough drug to dose participant|1|||
149753611|NCT02115815|540228431|FG006|Overall Study|Not enough drug to dose participant|0|||
149753612|NCT02115815|540228425|FG000|Overall Study|Missed appointment, randomized in error|0|||
149753613|NCT02115815|540228426|FG001|Overall Study|Missed appointment, randomized in error|0|||
149753614|NCT02115815|540228427|FG002|Overall Study|Missed appointment, randomized in error|0|||
149753615|NCT02115815|540228428|FG003|Overall Study|Missed appointment, randomized in error|0|||
149753616|NCT02115815|540228429|FG004|Overall Study|Missed appointment, randomized in error|0|||
149753617|NCT02115815|540228430|FG005|Overall Study|Missed appointment, randomized in error|1|||
149753618|NCT02115815|540228431|FG006|Overall Study|Missed appointment, randomized in error|0|||
149753619|NCT01989546|540228432|FG000|Overall Study|Clinical Progression|1|||
149753620|NCT01989546|540228432|FG000|Overall Study|Disease progression on study|8|||
149753621|NCT04439838|540228437|FG000|Overall Study|Withdrawal by Subject|0|||
149753622|NCT04439838|540228438|FG001|Overall Study|Withdrawal by Subject|0|||
149753623|NCT04439838|540228439|FG002|Overall Study|Withdrawal by Subject|0|||
149753624|NCT04439838|540228440|FG003|Overall Study|Withdrawal by Subject|0|||
149753625|NCT04439838|540228441|FG004|Overall Study|Withdrawal by Subject|0|||
149753626|NCT04439838|540228442|FG005|Overall Study|Withdrawal by Subject|0|||
149753627|NCT04439838|540228443|FG006|Overall Study|Withdrawal by Subject|0|||
149753628|NCT04439838|540228444|FG007|Overall Study|Withdrawal by Subject|0|||
149753629|NCT04439838|540228445|FG008|Overall Study|Withdrawal by Subject|1|||
149753630|NCT01958671|540228448|FG000|Overall Study|Adverse Event|1|||
149753631|NCT01958671|540228449|FG001|Overall Study|Adverse Event|1|||
149753632|NCT01958671|540228450|FG002|Overall Study|Adverse Event|5|||
149753633|NCT01958671|540228448|FG000|Overall Study|Death|1|||
149753634|NCT01958671|540228449|FG001|Overall Study|Death|0|||
149753635|NCT01958671|540228450|FG002|Overall Study|Death|0|||
149753636|NCT01958671|540228448|FG000|Overall Study|Excluded medication|0|||
149753637|NCT01958671|540228449|FG001|Overall Study|Excluded medication|0|||
149753638|NCT01958671|540228450|FG002|Overall Study|Excluded medication|1|||
149753639|NCT01958671|540228448|FG000|Overall Study|Hyperglycemia|0|||
149753640|NCT01958671|540228449|FG001|Overall Study|Hyperglycemia|0|||
149753641|NCT01958671|540228450|FG002|Overall Study|Hyperglycemia|2|||
149753642|NCT01958671|540228448|FG000|Overall Study|Lost to Follow-up|7|||
149753643|NCT01958671|540228449|FG001|Overall Study|Lost to Follow-up|11|||
149753644|NCT01958671|540228450|FG002|Overall Study|Lost to Follow-up|7|||
149753645|NCT01958671|540228448|FG000|Overall Study|Non-compliance with study drug|1|||
149753646|NCT01958671|540228449|FG001|Overall Study|Non-compliance with study drug|1|||
149753647|NCT01958671|540228450|FG002|Overall Study|Non-compliance with study drug|1|||
149753648|NCT01958671|540228448|FG000|Overall Study|Pregnancy|0|||
149753649|NCT01958671|540228449|FG001|Overall Study|Pregnancy|0|||
149753650|NCT01958671|540228450|FG002|Overall Study|Pregnancy|1|||
149753651|NCT01958671|540228448|FG000|Overall Study|Protocol Violation|0|||
149753652|NCT01958671|540228449|FG001|Overall Study|Protocol Violation|1|||
149753653|NCT01958671|540228450|FG002|Overall Study|Protocol Violation|0|||
149753654|NCT01958671|540228448|FG000|Overall Study|Study site terminated by sponsor|1|||
149753655|NCT01958671|540228449|FG001|Overall Study|Study site terminated by sponsor|0|||
149753656|NCT01958671|540228450|FG002|Overall Study|Study site terminated by sponsor|1|||
149753657|NCT01958671|540228448|FG000|Overall Study|Participant moved|0|||
149753658|NCT01958671|540228449|FG001|Overall Study|Participant moved|0|||
149753659|NCT01958671|540228450|FG002|Overall Study|Participant moved|1|||
149753660|NCT01958671|540228448|FG000|Overall Study|Withdrawal by Subject|8|||
149753661|NCT01958671|540228449|FG001|Overall Study|Withdrawal by Subject|10|||
149753662|NCT01958671|540228450|FG002|Overall Study|Withdrawal by Subject|13|||
149753663|NCT02778867|540228451|FG000|Phase 1|Withdrawal by Subject|2|||
149753664|NCT02778867|540228452|FG001|Phase 1|Withdrawal by Subject|3|||
149753665|NCT02778867|540228453|FG002|Phase 1|Withdrawal by Subject|0|||
149753666|NCT02778867|540228454|FG003|Phase 1|Withdrawal by Subject|0|||
149753667|NCT02778867|540228451|FG000|Phase 2|Withdrawal by Subject|0|||
149753668|NCT02778867|540228452|FG001|Phase 2|Withdrawal by Subject|0|||
149753669|NCT02778867|540228453|FG002|Phase 2|Withdrawal by Subject|1|||
149753670|NCT02778867|540228454|FG003|Phase 2|Withdrawal by Subject|0|||
149753671|NCT02778867|540228451|FG000|Phase 2|Physician Decision|0|||
149753672|NCT02778867|540228452|FG001|Phase 2|Physician Decision|0|||
149753673|NCT02778867|540228453|FG002|Phase 2|Physician Decision|0|||
149753674|NCT02778867|540228454|FG003|Phase 2|Physician Decision|1|||
149753675|NCT02778867|540228451|FG000|Phase 2|Adverse Event|0|||
149753676|NCT02778867|540228452|FG001|Phase 2|Adverse Event|0|||
149753677|NCT02778867|540228453|FG002|Phase 2|Adverse Event|0|||
149753678|NCT02778867|540228454|FG003|Phase 2|Adverse Event|1|||
149753679|NCT00960440|540228456|FG000|Overall Study|Death|0|||
149753680|NCT00960440|540228457|FG001|Overall Study|Death|0|||
149753681|NCT00960440|540228458|FG002|Overall Study|Death|0|||
149753682|NCT00960440|540228459|FG003|Overall Study|Death|1|||
149753683|NCT00960440|540228456|FG000|Overall Study|Adverse Event|12|||
149753684|NCT00960440|540228457|FG001|Overall Study|Adverse Event|12|||
149753685|NCT00960440|540228458|FG002|Overall Study|Adverse Event|4|||
149753686|NCT00960440|540228459|FG003|Overall Study|Adverse Event|4|||
149753687|NCT00960440|540228456|FG000|Overall Study|Lack of Efficacy|2|||
149753688|NCT00960440|540228457|FG001|Overall Study|Lack of Efficacy|5|||
149753689|NCT00960440|540228458|FG002|Overall Study|Lack of Efficacy|3|||
149753690|NCT00960440|540228459|FG003|Overall Study|Lack of Efficacy|8|||
149753691|NCT00960440|540228456|FG000|Overall Study|Protocol Violation|2|||
149753692|NCT00960440|540228457|FG001|Overall Study|Protocol Violation|8|||
149753693|NCT00960440|540228458|FG002|Overall Study|Protocol Violation|3|||
149753694|NCT00960440|540228459|FG003|Overall Study|Protocol Violation|4|||
149753695|NCT00960440|540228456|FG000|Overall Study|Withdrawal by Subject|9|||
149753696|NCT00960440|540228457|FG001|Overall Study|Withdrawal by Subject|5|||
149753697|NCT00960440|540228458|FG002|Overall Study|Withdrawal by Subject|2|||
149753698|NCT00960440|540228459|FG003|Overall Study|Withdrawal by Subject|1|||
149753699|NCT00960440|540228456|FG000|Overall Study|Other|1|||
149753700|NCT00960440|540228457|FG001|Overall Study|Other|1|||
149753701|NCT00960440|540228458|FG002|Overall Study|Other|1|||
149753702|NCT00960440|540228459|FG003|Overall Study|Other|0|||
149753703|NCT01070303|540228460|FG000|Overall Study|Adverse Event|39|||
149753704|NCT01070303|540228460|FG000|Overall Study|Withdrawal by Subject|20|||
149753705|NCT01070303|540228460|FG000|Overall Study|Lost to Follow-up|9|||
149753706|NCT01070303|540228460|FG000|Overall Study|Protocol Violation|0|||
149753707|NCT01070303|540228460|FG000|Overall Study|Lack of Efficacy|2|||
149753708|NCT01070303|540228460|FG000|Overall Study|Administrative Reason|1|||
149753709|NCT01070303|540228460|FG000|Overall Study|Other|18|||
149753710|NCT01505491|540228462|FG000|Overall Study|Other reason not listed|1|||
149753711|NCT01505491|540228463|FG001|Overall Study|Other reason not listed|0|||
149753712|NCT01505491|540228464|FG002|Overall Study|Other reason not listed|0|||
149753713|NCT01505491|540228462|FG000|Overall Study|Withdrawal by Subject|1|||
149753714|NCT01505491|540228463|FG001|Overall Study|Withdrawal by Subject|1|||
149753715|NCT01505491|540228464|FG002|Overall Study|Withdrawal by Subject|4|||
149753716|NCT01505491|540228462|FG000|Overall Study|Lost to Follow-up|0|||
149753717|NCT01505491|540228463|FG001|Overall Study|Lost to Follow-up|0|||
149753718|NCT01505491|540228464|FG002|Overall Study|Lost to Follow-up|1|||
149753719|NCT00859898|540228466|FG000|Overall Study|Lack of Efficacy|0|||
149753720|NCT00859898|540228467|FG001|Overall Study|Lack of Efficacy|1|||
149753721|NCT00859898|540228468|FG002|Overall Study|Lack of Efficacy|1|||
149753722|NCT00859898|540228466|FG000|Overall Study|Adverse Event|4|||
149753723|NCT00859898|540228467|FG001|Overall Study|Adverse Event|9|||
149753724|NCT00859898|540228468|FG002|Overall Study|Adverse Event|8|||
149753725|NCT00859898|540228466|FG000|Overall Study|Withdrawal by Subject|11|||
149753726|NCT00859898|540228467|FG001|Overall Study|Withdrawal by Subject|8|||
149753727|NCT00859898|540228468|FG002|Overall Study|Withdrawal by Subject|11|||
149753728|NCT00859898|540228466|FG000|Overall Study|Death|0|||
149753729|NCT00859898|540228467|FG001|Overall Study|Death|0|||
149753730|NCT00859898|540228468|FG002|Overall Study|Death|1|||
149753731|NCT00859898|540228466|FG000|Overall Study|Lost to Follow-up|10|||
149753732|NCT00859898|540228467|FG001|Overall Study|Lost to Follow-up|11|||
149753733|NCT00859898|540228468|FG002|Overall Study|Lost to Follow-up|5|||
149753734|NCT00859898|540228466|FG000|Overall Study|poor/non-compliance|2|||
149753735|NCT00859898|540228467|FG001|Overall Study|poor/non-compliance|0|||
149753736|NCT00859898|540228468|FG002|Overall Study|poor/non-compliance|0|||
149753737|NCT00859898|540228466|FG000|Overall Study|No longer meets criteria|0|||
149753738|NCT00859898|540228467|FG001|Overall Study|No longer meets criteria|1|||
149753739|NCT00859898|540228468|FG002|Overall Study|No longer meets criteria|0|||
149753740|NCT00859898|540228466|FG000|Overall Study|non-specified|1|||
149753741|NCT00859898|540228467|FG001|Overall Study|non-specified|1|||
149753742|NCT00859898|540228468|FG002|Overall Study|non-specified|1|||
149753743|NCT03408873|540228469|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
149753744|NCT03408873|540228469|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
149753745|NCT03408873|540228469|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
149753746|NCT03408873|540228469|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
149753747|NCT03408873|540228469|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
149753748|NCT03408873|540228469|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
149753749|NCT01312428|540228470|FG000|Overall Study|Study Termination|3|||
149753750|NCT01312428|540228471|FG001|Overall Study|Study Termination|4|||
149753751|NCT01797783|540228474|FG000|Overall Study|Adverse Event|1|||
149753752|NCT01797783|540228475|FG001|Overall Study|Adverse Event|1|||
149753753|NCT01797783|540228474|FG000|Overall Study|Withdrawal by Subject|1|||
149753754|NCT01797783|540228475|FG001|Overall Study|Withdrawal by Subject|0|||
149753755|NCT02214186|540228480|FG000|Overall Study|Lost to Follow-up|1|||
149753756|NCT02214186|540228481|FG001|Overall Study|Lost to Follow-up|1|||
149753757|NCT02214186|540228480|FG000|Overall Study|Protocol Violation|1|||
149753758|NCT02214186|540228481|FG001|Overall Study|Protocol Violation|1|||
149753759|NCT01525849|540228482|FG000|Overall Study|Lost to Follow-up|3|||
149753760|NCT01525849|540228483|FG001|Overall Study|Lost to Follow-up|2|||
149753761|NCT01525849|540228482|FG000|Overall Study|Withdrawal by Subject|1|||
149753762|NCT01525849|540228483|FG001|Overall Study|Withdrawal by Subject|9|||
149753763|NCT01525849|540228482|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
149753764|NCT01525849|540228483|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
149753765|NCT01525849|540228482|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
149753766|NCT01525849|540228483|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
149753767|NCT00793819|540228484|FG000|Overall Study|Adverse Event|8|||
149753768|NCT00793819|540228485|FG001|Overall Study|Adverse Event|4|||
149753769|NCT00793819|540228484|FG000|Overall Study|Lack of Efficacy|1|||
149753770|NCT00793819|540228485|FG001|Overall Study|Lack of Efficacy|1|||
149753771|NCT00793819|540228484|FG000|Overall Study|Withdrawal by Subject|4|||
149753772|NCT00793819|540228485|FG001|Overall Study|Withdrawal by Subject|3|||
149753773|NCT00793819|540228484|FG000|Overall Study|Lost to Follow-up|1|||
149753774|NCT00793819|540228485|FG001|Overall Study|Lost to Follow-up|1|||
149753775|NCT00611130|540228496|FG000|Overall Study|Lost to Follow-up|25|||
149753776|NCT00611130|540228497|FG001|Overall Study|Lost to Follow-up|29|||
149753777|NCT00611130|540228496|FG000|Overall Study|Protocol noncompliance|7|||
149753778|NCT00611130|540228497|FG001|Overall Study|Protocol noncompliance|6|||
149753779|NCT00611130|540228496|FG000|Overall Study|Withdrawal by Subject|6|||
149753780|NCT00611130|540228497|FG001|Overall Study|Withdrawal by Subject|5|||
149753781|NCT00611130|540228496|FG000|Overall Study|Other|5|||
149753782|NCT00611130|540228497|FG001|Overall Study|Other|4|||
149753783|NCT00611130|540228496|FG000|Overall Study|Incarceration|3|||
149753784|NCT00611130|540228497|FG001|Overall Study|Incarceration|2|||
149753785|NCT00611130|540228496|FG000|Overall Study|Administrative|1|||
149753786|NCT00611130|540228497|FG001|Overall Study|Administrative|1|||
149753787|NCT00611130|540228496|FG000|Overall Study|Adverse Event|1|||
149753788|NCT00611130|540228497|FG001|Overall Study|Adverse Event|0|||
149753789|NCT00611130|540228496|FG000|Overall Study|Death|1|||
149753790|NCT00611130|540228497|FG001|Overall Study|Death|0|||
149753791|NCT03662334|540228499|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
149753792|NCT03662334|540228500|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
149753793|NCT01734993|540228504|FG000|Overall Study|Adverse Event|1|||
149753794|NCT01734993|540228504|FG000|Overall Study|Lack of Efficacy|1|||
149753795|NCT03694522|540228505|FG000|Overall Study|Withdrawal by Subject|8|||
149753796|NCT03694522|540228506|FG001|Overall Study|Withdrawal by Subject|10|||
149753797|NCT03694522|540228505|FG000|Overall Study|Physician Decision|53|||
149753798|NCT03694522|540228506|FG001|Overall Study|Physician Decision|54|||
149753799|NCT03694522|540228505|FG000|Overall Study|Other|1|||
149753800|NCT03694522|540228506|FG001|Overall Study|Other|1|||
149753801|NCT03694522|540228505|FG000|Overall Study|Lost to Follow-up|0|||
149753802|NCT03694522|540228506|FG001|Overall Study|Lost to Follow-up|1|||
149753803|NCT02760407|540228507|FG000|Overall Study|Death|2|||
149753804|NCT02760407|540228508|FG001|Overall Study|Death|3|||
149753805|NCT02760407|540228509|FG002|Overall Study|Death|1|||
149753806|NCT02760407|540228510|FG003|Overall Study|Death|1|||
149753807|NCT02760407|540228507|FG000|Overall Study|Lost to Follow-up|1|||
149753808|NCT02760407|540228508|FG001|Overall Study|Lost to Follow-up|7|||
149753809|NCT02760407|540228509|FG002|Overall Study|Lost to Follow-up|4|||
149753810|NCT02760407|540228510|FG003|Overall Study|Lost to Follow-up|6|||
149753811|NCT02760407|540228507|FG000|Overall Study|Withdrawal by Subject|25|||
149753812|NCT02760407|540228508|FG001|Overall Study|Withdrawal by Subject|31|||
149753813|NCT02760407|540228509|FG002|Overall Study|Withdrawal by Subject|37|||
149753814|NCT02760407|540228510|FG003|Overall Study|Withdrawal by Subject|25|||
149753815|NCT02760407|540228507|FG000|Overall Study|Violation of Eligibility criteria|0|||
149753816|NCT02760407|540228508|FG001|Overall Study|Violation of Eligibility criteria|0|||
149753817|NCT02760407|540228509|FG002|Overall Study|Violation of Eligibility criteria|1|||
149753818|NCT02760407|540228510|FG003|Overall Study|Violation of Eligibility criteria|1|||
149753819|NCT02760407|540228507|FG000|Overall Study|Personal reasons|0|||
149753820|NCT02760407|540228508|FG001|Overall Study|Personal reasons|0|||
149753821|NCT02760407|540228509|FG002|Overall Study|Personal reasons|0|||
149753822|NCT02760407|540228510|FG003|Overall Study|Personal reasons|1|||
149753823|NCT02760407|540228507|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
149753824|NCT02760407|540228508|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149753825|NCT02760407|540228509|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149753826|NCT02760407|540228510|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149753827|NCT02760407|540228507|FG000|Overall Study|Use of prohibited Medication|0|||
149753828|NCT02760407|540228508|FG001|Overall Study|Use of prohibited Medication|0|||
149753829|NCT02760407|540228509|FG002|Overall Study|Use of prohibited Medication|1|||
149753830|NCT02760407|540228510|FG003|Overall Study|Use of prohibited Medication|0|||
149753831|NCT02760407|540228507|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149753832|NCT02760407|540228508|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149753833|NCT02760407|540228509|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
149753834|NCT02760407|540228510|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149753835|NCT02760407|540228507|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
149753836|NCT02760407|540228508|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149753837|NCT02760407|540228509|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149753838|NCT02760407|540228510|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149753839|NCT02760407|540228507|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
149753840|NCT02760407|540228508|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
149753841|NCT02760407|540228509|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
149753842|NCT02760407|540228510|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
149753843|NCT02760407|540228507|FG000|Overall Study|Inadequately Enrolled|0|||
149753844|NCT02760407|540228508|FG001|Overall Study|Inadequately Enrolled|0|||
149753845|NCT02760407|540228509|FG002|Overall Study|Inadequately Enrolled|0|||
149753846|NCT02760407|540228510|FG003|Overall Study|Inadequately Enrolled|1|||
149753847|NCT02760407|540228507|FG000|Overall Study|Withdrawal By PI's Decision|0|||
149753848|NCT02760407|540228508|FG001|Overall Study|Withdrawal By PI's Decision|1|||
149753849|NCT02760407|540228509|FG002|Overall Study|Withdrawal By PI's Decision|0|||
149753850|NCT02760407|540228510|FG003|Overall Study|Withdrawal By PI's Decision|0|||
149753851|NCT02760407|540228507|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
149753852|NCT02760407|540228508|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
149753853|NCT02760407|540228509|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
149753854|NCT02760407|540228510|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
149753855|NCT02760407|540228507|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149753856|NCT02760407|540228508|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149753857|NCT02760407|540228509|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
149753858|NCT02760407|540228510|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149753859|NCT02760407|540228507|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
149753860|NCT02760407|540228508|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149753861|NCT02760407|540228509|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149753862|NCT02760407|540228510|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149753863|NCT02760407|540228507|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
149753864|NCT02760407|540228508|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
149753865|NCT02760407|540228509|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
149753866|NCT02760407|540228510|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
149753867|NCT02760407|540228507|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
149753868|NCT02760407|540228508|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149753869|NCT02760407|540228509|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149753870|NCT02760407|540228510|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149753871|NCT02760407|540228507|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
149753872|NCT02760407|540228508|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149753873|NCT02760407|540228509|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149753874|NCT02760407|540228510|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149753875|NCT02760407|540228507|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
149753876|NCT02760407|540228508|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
149753877|NCT02760407|540228509|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
149753878|NCT02760407|540228510|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
149753879|NCT02760407|540228507|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
149753880|NCT02760407|540228508|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149753881|NCT02760407|540228509|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149753882|NCT02760407|540228510|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149753883|NCT02760407|540228507|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
149753884|NCT02760407|540228508|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
149753885|NCT02760407|540228509|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
149753886|NCT02760407|540228510|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
149753887|NCT02522377|540228511|FG000|Overall Study|Withdrawal by Subject|1|||
149753888|NCT02522377|540228512|FG001|Overall Study|Withdrawal by Subject|0|||
149753889|NCT02522377|540228511|FG000|Overall Study|Remission Achieved|3|||
149753890|NCT02522377|540228512|FG001|Overall Study|Remission Achieved|0|||
149753891|NCT01158950|540228513|FG000|1st Intervention (1 Day)|Physician Decision|1|||
149753892|NCT01158950|540228514|FG001|1st Intervention (1 Day)|Physician Decision|2|||
149753893|NCT02137772|540228515|FG000|Overall Study|Adverse Event|6|||
149753894|NCT02137772|540228516|FG001|Overall Study|Adverse Event|3|||
149753895|NCT02137772|540228515|FG000|Overall Study|Death|71|||
149753896|NCT02137772|540228516|FG001|Overall Study|Death|44|||
149753897|NCT02137772|540228515|FG000|Overall Study|Lost to Follow-up|8|||
149753898|NCT02137772|540228516|FG001|Overall Study|Lost to Follow-up|4|||
149753899|NCT02137772|540228515|FG000|Overall Study|Physician Decision|15|||
149753900|NCT02137772|540228516|FG001|Overall Study|Physician Decision|5|||
149753901|NCT02137772|540228515|FG000|Overall Study|Withdrawal by Subject|28|||
149753902|NCT02137772|540228516|FG001|Overall Study|Withdrawal by Subject|17|||
149753903|NCT02137772|540228515|FG000|Overall Study|Non-compliance with study drug|1|||
149753904|NCT02137772|540228516|FG001|Overall Study|Non-compliance with study drug|0|||
149753905|NCT02137772|540228515|FG000|Overall Study|Not treated|3|||
149753906|NCT02137772|540228516|FG001|Overall Study|Not treated|2|||
149753907|NCT01844700|540228517|FG000|Overall Study|Lack of Efficacy|1|||
149753908|NCT01844700|540228518|FG001|Overall Study|Lack of Efficacy|0|||
149753909|NCT01844700|540228517|FG000|Overall Study|refused medication switch|1|||
149753910|NCT01844700|540228518|FG001|Overall Study|refused medication switch|0|||
149753911|NCT01844700|540228517|FG000|Overall Study|Withdrawal by Subject|1|||
149753912|NCT01844700|540228518|FG001|Overall Study|Withdrawal by Subject|0|||
149753913|NCT01844700|540228517|FG000|Overall Study|stopped taking meds|0|||
149753914|NCT01844700|540228518|FG001|Overall Study|stopped taking meds|1|||
149753915|NCT00501852|540228522|FG000|Overall Study|Adverse Event|3|||
149753916|NCT00501852|540228522|FG000|Overall Study|Withdrawal by Subject|2|||
149753917|NCT01171521|540228523|FG000|Overall Study|Lost to Follow-up|5|||
149753918|NCT01171521|540228523|FG000|Overall Study|screen failure|1|||
149753919|NCT01927562|540228524|FG000|Overall Study|Lost to Follow-up|30|||
149753920|NCT01927562|540228524|FG000|Overall Study|Withdrawal by Subject|3|||
149753921|NCT01927562|540228524|FG000|Overall Study|Physician Decision|5|||
149753922|NCT00652093|540228525|FG000|Overall Study|Withdrawal by Subject|0|||
149753923|NCT00652093|540228526|FG001|Overall Study|Withdrawal by Subject|0|||
149753924|NCT00652093|540228527|FG002|Overall Study|Withdrawal by Subject|1|||
149753925|NCT00652093|540228528|FG003|Overall Study|Withdrawal by Subject|0|||
149753926|NCT00652093|540228529|FG004|Overall Study|Withdrawal by Subject|1|||
149753927|NCT00652093|540228530|FG005|Overall Study|Withdrawal by Subject|0|||
149753928|NCT00652093|540228525|FG000|Overall Study|Physician Decision|0|||
149753929|NCT00652093|540228526|FG001|Overall Study|Physician Decision|0|||
149753930|NCT00652093|540228527|FG002|Overall Study|Physician Decision|0|||
149753931|NCT00652093|540228528|FG003|Overall Study|Physician Decision|0|||
149753932|NCT00652093|540228529|FG004|Overall Study|Physician Decision|1|||
149753933|NCT00652093|540228530|FG005|Overall Study|Physician Decision|0|||
149753934|NCT01422304|540228533|FG000|Overall Study|Adverse Event|0|||
149753935|NCT01422304|540228534|FG001|Overall Study|Adverse Event|1|||
149753936|NCT01422304|540228533|FG000|Overall Study|Lost to Follow-up|14|||
149753937|NCT01422304|540228534|FG001|Overall Study|Lost to Follow-up|20|||
149753938|NCT01422304|540228533|FG000|Overall Study|Never Entered Follow-up|2|||
149753939|NCT01422304|540228534|FG001|Overall Study|Never Entered Follow-up|1|||
149753940|NCT01422304|540228533|FG000|Overall Study|Protocol Violation|1|||
149753941|NCT01422304|540228534|FG001|Overall Study|Protocol Violation|0|||
149753942|NCT01422304|540228533|FG000|Overall Study|Withdrawal by Subject|4|||
149753943|NCT01422304|540228534|FG001|Overall Study|Withdrawal by Subject|2|||
149753944|NCT01422304|540228533|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
149753945|NCT01422304|540228534|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
149753946|NCT01422304|540228533|FG000|Overall Study|Not Treated|3|||
149753947|NCT01422304|540228534|FG001|Overall Study|Not Treated|11|||
149753948|NCT00866294|540228538|FG000|Overall Study|Adverse Event|12|||
149753949|NCT00866294|540228539|FG001|Overall Study|Adverse Event|13|||
149753950|NCT00866294|540228540|FG002|Overall Study|Adverse Event|9|||
149753951|NCT00866294|540228538|FG000|Overall Study|Lack of Efficacy|7|||
149753952|NCT00866294|540228539|FG001|Overall Study|Lack of Efficacy|1|||
149753953|NCT00866294|540228540|FG002|Overall Study|Lack of Efficacy|0|||
149753954|NCT00866294|540228538|FG000|Overall Study|Protocol Violation|2|||
149753955|NCT00866294|540228539|FG001|Overall Study|Protocol Violation|0|||
149753956|NCT00866294|540228540|FG002|Overall Study|Protocol Violation|0|||
149753957|NCT00866294|540228538|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
149753958|NCT00866294|540228539|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149753959|NCT00866294|540228540|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149753960|NCT00866294|540228538|FG000|Overall Study|Lost to Follow-up|1|||
149753961|NCT00866294|540228539|FG001|Overall Study|Lost to Follow-up|3|||
149753962|NCT00866294|540228540|FG002|Overall Study|Lost to Follow-up|0|||
149753963|NCT00866294|540228538|FG000|Overall Study|Physician Decision|6|||
149753964|NCT00866294|540228539|FG001|Overall Study|Physician Decision|2|||
149753965|NCT00866294|540228540|FG002|Overall Study|Physician Decision|1|||
149753966|NCT02508701|540228541|FG000|Overall Study|Lost to Follow-up|9|||
149753967|NCT02508701|540228542|FG001|Overall Study|Lost to Follow-up|5|||
149753968|NCT02508701|540228543|FG002|Overall Study|Lost to Follow-up|5|||
149753969|NCT02508701|540228544|FG003|Overall Study|Lost to Follow-up|3|||
149753970|NCT03117049|540228553|FG000|Overall Study|Continued the follow-up period|109|||
149753971|NCT03117049|540228554|FG001|Overall Study|Continued the follow-up period|129|||
149753972|NCT03117049|540228553|FG000|Overall Study|Died|82|||
149753973|NCT03117049|540228554|FG001|Overall Study|Died|93|||
149753974|NCT03117049|540228553|FG000|Overall Study|Consent withdrawal|7|||
149753975|NCT03117049|540228554|FG001|Overall Study|Consent withdrawal|6|||
149753976|NCT03117049|540228553|FG000|Overall Study|Missing contact|3|||
149753977|NCT03117049|540228554|FG001|Overall Study|Missing contact|3|||
149753978|NCT00839098|540228555|FG000|Overall Study|Withdrawal by Subject|2|||
149753979|NCT00839098|540228556|FG001|Overall Study|Withdrawal by Subject|1|||
149753980|NCT00839098|540228557|FG002|Overall Study|Withdrawal by Subject|7|||
149753981|NCT00798967|540228558|FG000|Overall Study|Adverse Event|2|||
149753982|NCT00798967|540228559|FG001|Overall Study|Adverse Event|3|||
149753983|NCT00798967|540228558|FG000|Overall Study|Withdrawal by Subject|0|||
149753984|NCT00798967|540228559|FG001|Overall Study|Withdrawal by Subject|1|||
149753985|NCT00798967|540228558|FG000|Overall Study|Physician Decision|1|||
149753986|NCT00798967|540228559|FG001|Overall Study|Physician Decision|0|||
149753987|NCT00798967|540228558|FG000|Overall Study|Randomized in error by site|1|||
149753988|NCT00798967|540228559|FG001|Overall Study|Randomized in error by site|0|||
149753989|NCT03090737|540228562|FG000|Overall Study|Other reasons|1|||
149753990|NCT03090737|540228562|FG000|Overall Study|Completed treatment as per protocol|17|||
149753991|NCT03090737|540228562|FG000|Overall Study|Maximum clinical benefit|2|||
149753992|NCT03090737|540228562|FG000|Overall Study|Adverse event unrelated to study drug|7|||
149753993|NCT03090737|540228562|FG000|Overall Study|Study drug toxicity|4|||
149753994|NCT03090737|540228562|FG000|Overall Study|Disease progression|98|||
149753995|NCT03141307|540228563|FG000|In-Hospital|Withdrawal by Subject|0|||
149753996|NCT03141307|540228564|FG001|In-Hospital|Withdrawal by Subject|2|||
149753997|NCT03141307|540228563|FG000|In-Hospital|Protocol Violation|4|||
149753998|NCT03141307|540228564|FG001|In-Hospital|Protocol Violation|0|||
149753999|NCT03141307|540228563|FG000|Follow-Up|Lost to Follow-up|97|||
149754000|NCT03141307|540228564|FG001|Follow-Up|Lost to Follow-up|54|||
149754001|NCT00227877|540228565|FG000|Pre-visit Assessment|Technical difficulties|7|||
149754002|NCT00227877|540228566|FG001|Pre-visit Assessment|Technical difficulties|3|||
149754003|NCT00227877|540228567|FG002|Pre-visit Assessment|Technical difficulties|0|||
149754004|NCT00227877|540228568|FG003|Pre-visit Assessment|Technical difficulties|0|||
149754005|NCT00227877|540228565|FG000|Post-visit Checklist|Lost to Follow-up|24|||
149754006|NCT00227877|540228566|FG001|Post-visit Checklist|Lost to Follow-up|13|||
149754007|NCT00227877|540228567|FG002|Post-visit Checklist|Lost to Follow-up|1|||
149754008|NCT00227877|540228568|FG003|Post-visit Checklist|Lost to Follow-up|0|||
149754009|NCT00227877|540228565|FG000|3-months Follow-up|Completed late|135|||
149754010|NCT00227877|540228566|FG001|3-months Follow-up|Completed late|128|||
149754011|NCT00227877|540228567|FG002|3-months Follow-up|Completed late|34|||
149754012|NCT00227877|540228568|FG003|3-months Follow-up|Completed late|8|||
149754013|NCT00227877|540228565|FG000|3-months Follow-up|Lost to Follow-up|178|||
149754014|NCT00227877|540228566|FG001|3-months Follow-up|Lost to Follow-up|139|||
149754015|NCT00227877|540228567|FG002|3-months Follow-up|Lost to Follow-up|18|||
149754016|NCT00227877|540228568|FG003|3-months Follow-up|Lost to Follow-up|13|||
149754017|NCT00227877|540228565|FG000|12-months Follow-up|Completed late|78|||
149754018|NCT00227877|540228566|FG001|12-months Follow-up|Completed late|74|||
149754019|NCT00227877|540228567|FG002|12-months Follow-up|Completed late|1|||
149754020|NCT00227877|540228568|FG003|12-months Follow-up|Completed late|0|||
149754021|NCT00227877|540228565|FG000|12-months Follow-up|Lost to Follow-up|232|||
149754022|NCT00227877|540228566|FG001|12-months Follow-up|Lost to Follow-up|189|||
149754023|NCT00227877|540228567|FG002|12-months Follow-up|Lost to Follow-up|30|||
149754024|NCT00227877|540228568|FG003|12-months Follow-up|Lost to Follow-up|26|||
149754025|NCT02522481|540228574|FG000|Overall Study|discontinued|1|||
149754026|NCT02522481|540228574|FG000|Overall Study|Not dosed|2|||
149754027|NCT03123939|540228575|FG000|Overall Study|Lack of Efficacy|6|||
149754028|NCT03123939|540228575|FG000|Overall Study|Death|5|||
149754029|NCT03123939|540228575|FG000|Overall Study|Physician Decision|2|||
149754030|NCT03123939|540228575|FG000|Overall Study|Subject/guardian decision|2|||
149754031|NCT03123939|540228575|FG000|Overall Study|Lost to Follow-up|1|||
149754032|NCT03123939|540228575|FG000|Overall Study|New therapy for study indication|1|||
149754033|NCT03123939|540228575|FG000|Overall Study|Protocol deviation|1|||
149754034|NCT03123939|540228575|FG000|Overall Study|Progressive disease|18|||
149754035|NCT03123939|540228575|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
149754036|NCT03123939|540228575|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
149754037|NCT01115569|540229865|FG000|Conversion/Titration Phase|Adverse Event|59|||
149754038|NCT01115569|540229866|FG001|Conversion/Titration Phase|Adverse Event|0|||
149754039|NCT01115569|540229865|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
149754040|NCT01115569|540229866|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
149754041|NCT01115569|540229865|FG000|Conversion/Titration Phase|Physician Decision|5|||
149754042|NCT01115569|540229866|FG001|Conversion/Titration Phase|Physician Decision|0|||
149754043|NCT01115569|540229865|FG000|Conversion/Titration Phase|Protocol Violation|68|||
149754044|NCT01115569|540229866|FG001|Conversion/Titration Phase|Protocol Violation|0|||
149754045|NCT01115569|540229865|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
149754046|NCT01115569|540229866|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
149754047|NCT01115569|540229865|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
149754048|NCT01115569|540229866|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
149754049|NCT01115569|540229865|FG000|Maintenance Phase|Adverse Event|0|||
149754050|NCT01115569|540229866|FG001|Maintenance Phase|Adverse Event|43|||
149754051|NCT01115569|540229865|FG000|Maintenance Phase|Lost to Follow-up|0|||
149754052|NCT01115569|540229866|FG001|Maintenance Phase|Lost to Follow-up|8|||
149754053|NCT01115569|540229865|FG000|Maintenance Phase|Physician Decision|0|||
149754054|NCT01115569|540229866|FG001|Maintenance Phase|Physician Decision|3|||
149754055|NCT01115569|540229865|FG000|Maintenance Phase|Protocol Violation|0|||
149754056|NCT01115569|540229866|FG001|Maintenance Phase|Protocol Violation|9|||
149754057|NCT01115569|540229865|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149754058|NCT01115569|540229866|FG001|Maintenance Phase|Withdrawal by Subject|27|||
149754059|NCT01115569|540229865|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
149754060|NCT01115569|540229866|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
149754061|NCT01115569|540229865|FG000|Maintenance Phase|Administrative|0|||
149754062|NCT01115569|540229866|FG001|Maintenance Phase|Administrative|1|||
149754063|NCT01254604|540229867|FG000|Overall Study|Lost to Follow-up|1|||
149754064|NCT01254604|540229868|FG001|Overall Study|Lost to Follow-up|1|||
149754065|NCT01254604|540229867|FG000|Overall Study|Protocol Violation|2|||
149754066|NCT01254604|540229868|FG001|Overall Study|Protocol Violation|2|||
149754067|NCT01254604|540229867|FG000|Overall Study|Withdrawal by Subject|2|||
149754068|NCT01254604|540229868|FG001|Overall Study|Withdrawal by Subject|4|||
149754069|NCT01254604|540229867|FG000|Overall Study|Adverse Event|3|||
149754070|NCT01254604|540229868|FG001|Overall Study|Adverse Event|2|||
149754071|NCT03504774|540229869|FG000|Overall Study|Adverse Event|2|||
149754072|NCT03504774|540229870|FG001|Overall Study|Adverse Event|0|||
149754073|NCT03504774|540229869|FG000|Overall Study|Lost to Follow-up|0|||
149754074|NCT03504774|540229870|FG001|Overall Study|Lost to Follow-up|1|||
149754075|NCT03504774|540229869|FG000|Overall Study|Protocol Violation|11|||
149754076|NCT03504774|540229870|FG001|Overall Study|Protocol Violation|3|||
149754077|NCT03504774|540229869|FG000|Overall Study|failed wk 52 DBPCFC|1|||
149754078|NCT03504774|540229870|FG001|Overall Study|failed wk 52 DBPCFC|0|||
149754079|NCT01781429|540229871|FG000|Overall Study|Death|0|||
149754080|NCT01781429|540229872|FG001|Overall Study|Death|0|||
149754081|NCT01781429|540229873|FG002|Overall Study|Death|0|||
149754082|NCT01781429|540229874|FG003|Overall Study|Death|0|||
149754083|NCT01781429|540229875|FG004|Overall Study|Death|0|||
149754084|NCT01781429|540229876|FG005|Overall Study|Death|0|||
149754085|NCT01781429|540229877|FG006|Overall Study|Death|0|||
149754086|NCT01781429|540229878|FG007|Overall Study|Death|0|||
149754087|NCT01781429|540229879|FG008|Overall Study|Death|0|||
149754088|NCT01781429|540229880|FG009|Overall Study|Death|1|||
149754089|NCT01781429|540229881|FG010|Overall Study|Death|0|||
149754090|NCT01781429|540229882|FG011|Overall Study|Death|0|||
149754091|NCT01781429|540229883|FG012|Overall Study|Death|1|||
149754092|NCT01781429|540229884|FG013|Overall Study|Death|0|||
149754093|NCT01781429|540229885|FG014|Overall Study|Death|1|||
149754094|NCT01781429|540229886|FG015|Overall Study|Death|0|||
149754095|NCT01781429|540229871|FG000|Overall Study|Withdrawal by Subject|0|||
149754096|NCT01781429|540229872|FG001|Overall Study|Withdrawal by Subject|0|||
149754097|NCT01781429|540229873|FG002|Overall Study|Withdrawal by Subject|0|||
149754098|NCT01781429|540229874|FG003|Overall Study|Withdrawal by Subject|0|||
149754099|NCT01781429|540229875|FG004|Overall Study|Withdrawal by Subject|0|||
149754100|NCT01781429|540229876|FG005|Overall Study|Withdrawal by Subject|0|||
149754101|NCT01781429|540229877|FG006|Overall Study|Withdrawal by Subject|0|||
149754102|NCT01781429|540229878|FG007|Overall Study|Withdrawal by Subject|0|||
149754103|NCT01781429|540229879|FG008|Overall Study|Withdrawal by Subject|1|||
149754104|NCT01781429|540229880|FG009|Overall Study|Withdrawal by Subject|3|||
149754105|NCT01781429|540229881|FG010|Overall Study|Withdrawal by Subject|1|||
149754106|NCT01781429|540229882|FG011|Overall Study|Withdrawal by Subject|1|||
149754107|NCT01781429|540229883|FG012|Overall Study|Withdrawal by Subject|5|||
149754108|NCT01781429|540229884|FG013|Overall Study|Withdrawal by Subject|2|||
149754109|NCT01781429|540229885|FG014|Overall Study|Withdrawal by Subject|3|||
149754110|NCT01781429|540229886|FG015|Overall Study|Withdrawal by Subject|0|||
149754111|NCT01781429|540229871|FG000|Overall Study|Disease Progression|1|||
149754112|NCT01781429|540229872|FG001|Overall Study|Disease Progression|0|||
149754113|NCT01781429|540229873|FG002|Overall Study|Disease Progression|1|||
149754114|NCT01781429|540229874|FG003|Overall Study|Disease Progression|1|||
149754115|NCT01781429|540229875|FG004|Overall Study|Disease Progression|1|||
149754116|NCT01781429|540229876|FG005|Overall Study|Disease Progression|4|||
149754117|NCT01781429|540229877|FG006|Overall Study|Disease Progression|7|||
149754118|NCT01781429|540229878|FG007|Overall Study|Disease Progression|4|||
149754119|NCT01781429|540229879|FG008|Overall Study|Disease Progression|6|||
149754120|NCT01781429|540229880|FG009|Overall Study|Disease Progression|15|||
149754121|NCT01781429|540229881|FG010|Overall Study|Disease Progression|15|||
149754122|NCT01781429|540229882|FG011|Overall Study|Disease Progression|15|||
149754123|NCT01781429|540229883|FG012|Overall Study|Disease Progression|15|||
149754124|NCT01781429|540229884|FG013|Overall Study|Disease Progression|4|||
149754125|NCT01781429|540229885|FG014|Overall Study|Disease Progression|11|||
149754126|NCT01781429|540229886|FG015|Overall Study|Disease Progression|0|||
149754127|NCT01781429|540229871|FG000|Overall Study|Unacceptable Toxicity|0|||
149754128|NCT01781429|540229872|FG001|Overall Study|Unacceptable Toxicity|0|||
149754129|NCT01781429|540229873|FG002|Overall Study|Unacceptable Toxicity|0|||
149754130|NCT01781429|540229874|FG003|Overall Study|Unacceptable Toxicity|0|||
149754131|NCT01781429|540229875|FG004|Overall Study|Unacceptable Toxicity|0|||
149754132|NCT01781429|540229876|FG005|Overall Study|Unacceptable Toxicity|0|||
149754133|NCT01781429|540229877|FG006|Overall Study|Unacceptable Toxicity|0|||
149754134|NCT01781429|540229878|FG007|Overall Study|Unacceptable Toxicity|0|||
149754135|NCT01781429|540229879|FG008|Overall Study|Unacceptable Toxicity|0|||
149754136|NCT01781429|540229880|FG009|Overall Study|Unacceptable Toxicity|0|||
149754137|NCT01781429|540229881|FG010|Overall Study|Unacceptable Toxicity|0|||
149754138|NCT01781429|540229882|FG011|Overall Study|Unacceptable Toxicity|2|||
149754139|NCT01781429|540229883|FG012|Overall Study|Unacceptable Toxicity|0|||
149754140|NCT01781429|540229884|FG013|Overall Study|Unacceptable Toxicity|0|||
149754141|NCT01781429|540229885|FG014|Overall Study|Unacceptable Toxicity|0|||
149754142|NCT01781429|540229886|FG015|Overall Study|Unacceptable Toxicity|0|||
149754143|NCT01781429|540229871|FG000|Overall Study|Patient Condition Changed|0|||
149754144|NCT01781429|540229872|FG001|Overall Study|Patient Condition Changed|0|||
149754145|NCT01781429|540229873|FG002|Overall Study|Patient Condition Changed|0|||
149754146|NCT01781429|540229874|FG003|Overall Study|Patient Condition Changed|0|||
149754147|NCT01781429|540229875|FG004|Overall Study|Patient Condition Changed|0|||
149754148|NCT01781429|540229876|FG005|Overall Study|Patient Condition Changed|0|||
149754149|NCT01781429|540229877|FG006|Overall Study|Patient Condition Changed|0|||
149754150|NCT01781429|540229878|FG007|Overall Study|Patient Condition Changed|0|||
149754151|NCT01781429|540229879|FG008|Overall Study|Patient Condition Changed|0|||
149754152|NCT01781429|540229880|FG009|Overall Study|Patient Condition Changed|4|||
149754153|NCT01781429|540229881|FG010|Overall Study|Patient Condition Changed|0|||
149754154|NCT01781429|540229882|FG011|Overall Study|Patient Condition Changed|1|||
149754155|NCT01781429|540229883|FG012|Overall Study|Patient Condition Changed|0|||
149754156|NCT01781429|540229884|FG013|Overall Study|Patient Condition Changed|1|||
149754157|NCT01781429|540229885|FG014|Overall Study|Patient Condition Changed|0|||
149754158|NCT01781429|540229886|FG015|Overall Study|Patient Condition Changed|0|||
149754159|NCT01781429|540229871|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
149754160|NCT01781429|540229872|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
149754161|NCT01781429|540229873|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
149754162|NCT01781429|540229874|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
149754163|NCT01781429|540229875|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
149754164|NCT01781429|540229876|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
149754165|NCT01781429|540229877|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
149754166|NCT01781429|540229878|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
149754167|NCT01781429|540229879|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
149754168|NCT01781429|540229880|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
149754169|NCT01781429|540229881|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
149754170|NCT01781429|540229882|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
149754171|NCT01781429|540229883|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
149754172|NCT01781429|540229884|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
149754173|NCT01781429|540229885|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
149754174|NCT01781429|540229886|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
149754175|NCT01781429|540229871|FG000|Overall Study|Enrolled, but not treated|0|||
149754176|NCT01781429|540229872|FG001|Overall Study|Enrolled, but not treated|0|||
149754177|NCT01781429|540229873|FG002|Overall Study|Enrolled, but not treated|0|||
149754178|NCT01781429|540229874|FG003|Overall Study|Enrolled, but not treated|0|||
149754179|NCT01781429|540229875|FG004|Overall Study|Enrolled, but not treated|0|||
149754180|NCT01781429|540229876|FG005|Overall Study|Enrolled, but not treated|0|||
149754181|NCT01781429|540229877|FG006|Overall Study|Enrolled, but not treated|0|||
149754182|NCT01781429|540229878|FG007|Overall Study|Enrolled, but not treated|0|||
149754183|NCT01781429|540229879|FG008|Overall Study|Enrolled, but not treated|0|||
149754184|NCT01781429|540229880|FG009|Overall Study|Enrolled, but not treated|0|||
149754185|NCT01781429|540229881|FG010|Overall Study|Enrolled, but not treated|1|||
149754186|NCT01781429|540229882|FG011|Overall Study|Enrolled, but not treated|0|||
149754187|NCT01781429|540229883|FG012|Overall Study|Enrolled, but not treated|0|||
149754188|NCT01781429|540229884|FG013|Overall Study|Enrolled, but not treated|0|||
149754189|NCT01781429|540229885|FG014|Overall Study|Enrolled, but not treated|0|||
149754190|NCT01781429|540229886|FG015|Overall Study|Enrolled, but not treated|0|||
149754191|NCT06094296|540229889|FG000|Overall Study|Progressive Disease|1|||
149754192|NCT06094296|540229890|FG001|Overall Study|Progressive Disease|0|||
149754193|NCT06094296|540229891|FG002|Overall Study|Progressive Disease|0|||
149754194|NCT06094296|540229892|FG003|Overall Study|Progressive Disease|0|||
149754195|NCT03332667|540229893|FG000|Overall Study|Adverse Event|0|||
149754196|NCT03332667|540229894|FG001|Overall Study|Adverse Event|0|||
149754197|NCT03332667|540229895|FG002|Overall Study|Adverse Event|2|||
149754198|NCT03332667|540229896|FG003|Overall Study|Adverse Event|1|||
149754199|NCT03332667|540229893|FG000|Overall Study|Withdrawal by Subject|2|||
149754200|NCT03332667|540229894|FG001|Overall Study|Withdrawal by Subject|1|||
149754201|NCT03332667|540229895|FG002|Overall Study|Withdrawal by Subject|5|||
149754202|NCT03332667|540229896|FG003|Overall Study|Withdrawal by Subject|1|||
149754203|NCT03332667|540229893|FG000|Overall Study|Disease Progression or Relapse|2|||
149754204|NCT03332667|540229894|FG001|Overall Study|Disease Progression or Relapse|1|||
149754205|NCT03332667|540229895|FG002|Overall Study|Disease Progression or Relapse|3|||
149754206|NCT03332667|540229896|FG003|Overall Study|Disease Progression or Relapse|0|||
149754207|NCT03332667|540229893|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
149754208|NCT03332667|540229894|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
149754209|NCT03332667|540229895|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
149754210|NCT03332667|540229896|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
149754211|NCT03332667|540229893|FG000|Overall Study|No Treatment Received|0|||
149754212|NCT03332667|540229894|FG001|Overall Study|No Treatment Received|0|||
149754213|NCT03332667|540229895|FG002|Overall Study|No Treatment Received|1|||
149754214|NCT03332667|540229896|FG003|Overall Study|No Treatment Received|0|||
149754215|NCT01035606|540229897|FG000|Overall Study|change in health, job demands,family|3|||
149754216|NCT01035606|540229898|FG001|Overall Study|change in health, job demands,family|3|||
149754217|NCT01035606|540229899|FG002|Overall Study|change in health, job demands,family|4|||
149754218|NCT01849848|540229900|FG000|Overall Study|Physician Decision|1|||
149754219|NCT01849848|540229900|FG000|Overall Study|Progression of the primary disease|3|||
149754220|NCT01809262|540229901|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754221|NCT01809262|540229902|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754222|NCT01809262|540229903|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754223|NCT01809262|540229904|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754224|NCT01809262|540229905|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
149754225|NCT01809262|540229906|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754226|NCT01809262|540229907|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754227|NCT01809262|540229908|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754228|NCT01809262|540229909|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754229|NCT01809262|540229910|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
149754230|NCT01809262|540229901|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754231|NCT01809262|540229902|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
149754232|NCT01809262|540229903|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754233|NCT01809262|540229904|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754234|NCT01809262|540229905|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754235|NCT01809262|540229906|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754236|NCT01809262|540229907|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754237|NCT01809262|540229908|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754238|NCT01809262|540229909|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754239|NCT01809262|540229910|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149754240|NCT02202031|540229912|FG000|Overall Study|Lost to Follow-up|1|||
149754241|NCT02202031|540229913|FG001|Overall Study|Lost to Follow-up|0|||
149754242|NCT02202031|540229912|FG000|Overall Study|Too Busy|1|||
149754243|NCT02202031|540229913|FG001|Overall Study|Too Busy|3|||
149754244|NCT02202031|540229912|FG000|Overall Study|Illness/Medical Reason|0|||
149754245|NCT02202031|540229913|FG001|Overall Study|Illness/Medical Reason|2|||
149754246|NCT02202031|540229912|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
149754247|NCT02202031|540229913|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
149754248|NCT02184143|540229914|FG000|Overall Study|Withdrawal by Subject|4|||
149754249|NCT02184143|540229915|FG001|Overall Study|Withdrawal by Subject|4|||
149754250|NCT02184143|540229914|FG000|Overall Study|Lost to Follow-up|5|||
149754251|NCT02184143|540229915|FG001|Overall Study|Lost to Follow-up|3|||
149754252|NCT02184143|540229914|FG000|Overall Study|Death|1|||
149754253|NCT02184143|540229915|FG001|Overall Study|Death|0|||
149754254|NCT00431847|540229918|FG000|Overall Study|completion of less than two study visits|6|||
149754255|NCT00431847|540229919|FG001|Overall Study|completion of less than two study visits|3|||
149754256|NCT00431847|540229920|FG002|Overall Study|completion of less than two study visits|4|||
149754257|NCT00431847|540229921|FG003|Overall Study|completion of less than two study visits|14|||
149754258|NCT00431847|540229922|FG004|Overall Study|completion of less than two study visits|0|||
149754259|NCT00431847|540229918|FG000|Overall Study|Protocol Violation|0|||
149754260|NCT00431847|540229919|FG001|Overall Study|Protocol Violation|0|||
149754261|NCT00431847|540229920|FG002|Overall Study|Protocol Violation|0|||
149754262|NCT00431847|540229921|FG003|Overall Study|Protocol Violation|0|||
149754263|NCT00431847|540229922|FG004|Overall Study|Protocol Violation|1|||
149754264|NCT00339183|540229923|FG000|Overall Study|Adverse Event|5|||
149754265|NCT00339183|540229924|FG001|Overall Study|Adverse Event|3|||
149754266|NCT00339183|540229923|FG000|Overall Study|Withdrawal by Subject|16|||
149754267|NCT00339183|540229924|FG001|Overall Study|Withdrawal by Subject|19|||
149754268|NCT00339183|540229923|FG000|Overall Study|Physician Decision|2|||
149754269|NCT00339183|540229924|FG001|Overall Study|Physician Decision|4|||
149754270|NCT00339183|540229923|FG000|Overall Study|Lost to Follow-up|17|||
149754271|NCT00339183|540229924|FG001|Overall Study|Lost to Follow-up|17|||
149754272|NCT00339183|540229923|FG000|Overall Study|Protocol-specified criteria|12|||
149754273|NCT00339183|540229924|FG001|Overall Study|Protocol-specified criteria|8|||
149754274|NCT00339183|540229923|FG000|Overall Study|Missing reason|3|||
149754275|NCT00339183|540229924|FG001|Overall Study|Missing reason|1|||
149754276|NCT00339183|540229923|FG000|Overall Study|Other|46|||
149754277|NCT00339183|540229924|FG001|Overall Study|Other|40|||
149754278|NCT00339183|540229923|FG000|Overall Study|Ongoing|20|||
149754279|NCT00339183|540229924|FG001|Overall Study|Ongoing|13|||
149754280|NCT00446446|540229925|FG000|Overall Study|Death|10|||
149754281|NCT00446446|540229925|FG000|Overall Study|Withdrawal by Subject|6|||
149754282|NCT00446446|540229925|FG000|Overall Study|Other|4|||
149754283|NCT00446446|540229925|FG000|Overall Study|Disease Progession|2|||
149754284|NCT00446446|540229925|FG000|Overall Study|Adverse Event|1|||
149754285|NCT00446446|540229925|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
149754286|NCT02142894|540229926|FG000|Overall Study|Protocol Violation|8|||
149754287|NCT01024465|540229932|FG000|Overall Study|Adverse Event|2|||
149754288|NCT01024465|540229932|FG000|Overall Study|Physician Decision|1|||
149754289|NCT03078608|540229936|FG000|Overall Study|Death|1|||
149754290|NCT03078608|540229937|FG001|Overall Study|Death|2|||
149754291|NCT03078608|540229938|FG002|Overall Study|Death|0|||
149754292|NCT03078608|540229939|FG003|Overall Study|Death|0|||
149754293|NCT03078608|540229936|FG000|Overall Study|Withdrawal by Subject|8|||
149754294|NCT03078608|540229937|FG001|Overall Study|Withdrawal by Subject|1|||
149754295|NCT03078608|540229938|FG002|Overall Study|Withdrawal by Subject|0|||
149754296|NCT03078608|540229939|FG003|Overall Study|Withdrawal by Subject|0|||
149754297|NCT03078608|540229936|FG000|Overall Study|Lost to Follow-up|5|||
149754298|NCT03078608|540229937|FG001|Overall Study|Lost to Follow-up|8|||
149754299|NCT03078608|540229938|FG002|Overall Study|Lost to Follow-up|4|||
149754300|NCT03078608|540229939|FG003|Overall Study|Lost to Follow-up|1|||
149754301|NCT01455428|540229940|FG000|Overall Study|Protocol Violation|2|||
149754302|NCT01455428|540229941|FG001|Overall Study|Protocol Violation|1|||
149754303|NCT01455428|540229940|FG000|Overall Study|Adverse Event|6|||
149754304|NCT01455428|540229941|FG001|Overall Study|Adverse Event|2|||
149754305|NCT01455428|540229940|FG000|Overall Study|Lost to Follow-up|1|||
149754306|NCT01455428|540229941|FG001|Overall Study|Lost to Follow-up|1|||
149754307|NCT01455428|540229940|FG000|Overall Study|Withdrawal by Subject|2|||
149754308|NCT01455428|540229941|FG001|Overall Study|Withdrawal by Subject|5|||
149754309|NCT01455428|540229940|FG000|Overall Study|Did not meet entrance criteria|0|||
149754310|NCT01455428|540229941|FG001|Overall Study|Did not meet entrance criteria|2|||
149754311|NCT01455428|540229940|FG000|Overall Study|Insufficient clinical response|0|||
149754312|NCT01455428|540229941|FG001|Overall Study|Insufficient clinical response|2|||
149754313|NCT01455428|540229940|FG000|Overall Study|Did not receive treatment|1|||
149754314|NCT01455428|540229941|FG001|Overall Study|Did not receive treatment|1|||
149754315|NCT01455428|540229940|FG000|Overall Study|Other|2|||
149754316|NCT01455428|540229941|FG001|Overall Study|Other|4|||
149754317|NCT00789477|540229946|FG000|Overall Study|Withdrawal by Subject|2|||
149754318|NCT00789477|540229947|FG001|Overall Study|Withdrawal by Subject|1|||
149754319|NCT00789477|540229948|FG002|Overall Study|Withdrawal by Subject|3|||
149754320|NCT00789477|540229949|FG003|Overall Study|Withdrawal by Subject|2|||
149754321|NCT00789477|540229950|FG004|Overall Study|Withdrawal by Subject|3|||
149754322|NCT00789477|540229946|FG000|Overall Study|Protocol Violation|1|||
149754323|NCT00789477|540229947|FG001|Overall Study|Protocol Violation|0|||
149754324|NCT00789477|540229948|FG002|Overall Study|Protocol Violation|0|||
149754325|NCT00789477|540229949|FG003|Overall Study|Protocol Violation|1|||
149754326|NCT00789477|540229950|FG004|Overall Study|Protocol Violation|0|||
149754327|NCT00789477|540229946|FG000|Overall Study|Adverse Event|3|||
149754328|NCT00789477|540229947|FG001|Overall Study|Adverse Event|3|||
149754329|NCT00789477|540229948|FG002|Overall Study|Adverse Event|1|||
149754330|NCT00789477|540229949|FG003|Overall Study|Adverse Event|0|||
149754331|NCT00789477|540229950|FG004|Overall Study|Adverse Event|0|||
149754332|NCT00789477|540229946|FG000|Overall Study|Death|1|||
149754333|NCT00789477|540229947|FG001|Overall Study|Death|1|||
149754334|NCT00789477|540229948|FG002|Overall Study|Death|2|||
149754335|NCT00789477|540229949|FG003|Overall Study|Death|2|||
149754336|NCT00789477|540229950|FG004|Overall Study|Death|0|||
149754337|NCT00789477|540229946|FG000|Overall Study|Lost to Follow-up|0|||
149754338|NCT00789477|540229947|FG001|Overall Study|Lost to Follow-up|1|||
149754339|NCT00789477|540229948|FG002|Overall Study|Lost to Follow-up|4|||
149754340|NCT00789477|540229949|FG003|Overall Study|Lost to Follow-up|2|||
149754341|NCT00789477|540229950|FG004|Overall Study|Lost to Follow-up|4|||
149754342|NCT00789477|540229946|FG000|Overall Study|Lack of Efficacy|2|||
149754343|NCT00789477|540229947|FG001|Overall Study|Lack of Efficacy|0|||
149754344|NCT00789477|540229948|FG002|Overall Study|Lack of Efficacy|0|||
149754345|NCT00789477|540229949|FG003|Overall Study|Lack of Efficacy|0|||
149754346|NCT00789477|540229950|FG004|Overall Study|Lack of Efficacy|0|||
149754347|NCT00789477|540229946|FG000|Overall Study|Other|2|||
149754348|NCT00789477|540229947|FG001|Overall Study|Other|0|||
149754349|NCT00789477|540229948|FG002|Overall Study|Other|1|||
149754350|NCT00789477|540229949|FG003|Overall Study|Other|3|||
149754351|NCT00789477|540229950|FG004|Overall Study|Other|0|||
149754352|NCT00455858|540229951|FG000|Overall Study|Lost to Follow-up|2|||
149754353|NCT00455858|540229951|FG000|Overall Study|Protocol Violation|1|||
149754354|NCT00455858|540229951|FG000|Overall Study|Lack of Efficacy|1|||
149754355|NCT00455858|540229951|FG000|Overall Study|Well controlled FPG without insulin|1|||
149754356|NCT00455858|540229951|FG000|Overall Study|Withdrawal|1|||
149754357|NCT02092389|540229952|FG000|Overall Study|Adverse Event|1|||
149754358|NCT02092389|540229952|FG000|Overall Study|Other|5|||
149754359|NCT00751881|540229958|FG000|Core Treatment Period|Not treated|1|||
149754360|NCT00751881|540229959|FG001|Core Treatment Period|Not treated|1|||
149754361|NCT00751881|540229960|FG002|Core Treatment Period|Not treated|2|||
149754362|NCT00751881|540229958|FG000|Core Treatment Period|Adverse Event|26|||
149754363|NCT00751881|540229959|FG001|Core Treatment Period|Adverse Event|54|||
149754364|NCT00751881|540229960|FG002|Core Treatment Period|Adverse Event|58|||
149754365|NCT00751881|540229958|FG000|Core Treatment Period|Lack of Efficacy|37|||
149754366|NCT00751881|540229959|FG001|Core Treatment Period|Lack of Efficacy|30|||
149754367|NCT00751881|540229960|FG002|Core Treatment Period|Lack of Efficacy|20|||
149754368|NCT00751881|540229958|FG000|Core Treatment Period|Poor compliance to protocol|15|||
149754369|NCT00751881|540229959|FG001|Core Treatment Period|Poor compliance to protocol|3|||
149754370|NCT00751881|540229960|FG002|Core Treatment Period|Poor compliance to protocol|4|||
149754371|NCT00751881|540229958|FG000|Core Treatment Period|Lost to Follow-up|6|||
149754372|NCT00751881|540229959|FG001|Core Treatment Period|Lost to Follow-up|4|||
149754373|NCT00751881|540229960|FG002|Core Treatment Period|Lost to Follow-up|3|||
149754374|NCT00751881|540229958|FG000|Core Treatment Period|Other: protocol deviation|3|||
149754375|NCT00751881|540229959|FG001|Core Treatment Period|Other: protocol deviation|3|||
149754376|NCT00751881|540229960|FG002|Core Treatment Period|Other: protocol deviation|7|||
149754377|NCT00751881|540229958|FG000|Core Treatment Period|Other: wish to parent|5|||
149754378|NCT00751881|540229959|FG001|Core Treatment Period|Other: wish to parent|7|||
149754379|NCT00751881|540229960|FG002|Core Treatment Period|Other: wish to parent|4|||
149754380|NCT00751881|540229958|FG000|Core Treatment Period|Other: personal/family constraints|6|||
149754381|NCT00751881|540229959|FG001|Core Treatment Period|Other: personal/family constraints|7|||
149754382|NCT00751881|540229960|FG002|Core Treatment Period|Other: personal/family constraints|10|||
149754383|NCT00751881|540229958|FG000|Core Treatment Period|Other: MS treatment change|6|||
149754384|NCT00751881|540229959|FG001|Core Treatment Period|Other: MS treatment change|4|||
149754385|NCT00751881|540229960|FG002|Core Treatment Period|Other: MS treatment change|4|||
149754386|NCT00751881|540229958|FG000|Core Treatment Period|Other: tolerability complaints|2|||
149754387|NCT00751881|540229959|FG001|Core Treatment Period|Other: tolerability complaints|0|||
149754388|NCT00751881|540229960|FG002|Core Treatment Period|Other: tolerability complaints|0|||
149754389|NCT00751881|540229958|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
149754390|NCT00751881|540229959|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
149754391|NCT00751881|540229960|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
149754392|NCT00751881|540229958|FG000|Extension Study Period|Adverse Event|18|||
149754393|NCT00751881|540229959|FG001|Extension Study Period|Adverse Event|20|||
149754394|NCT00751881|540229960|FG002|Extension Study Period|Adverse Event|21|||
149754395|NCT00751881|540229958|FG000|Extension Study Period|Lack of Efficacy|14|||
149754396|NCT00751881|540229959|FG001|Extension Study Period|Lack of Efficacy|10|||
149754397|NCT00751881|540229960|FG002|Extension Study Period|Lack of Efficacy|20|||
149754398|NCT00751881|540229958|FG000|Extension Study Period|Lost to Follow-up|4|||
149754399|NCT00751881|540229959|FG001|Extension Study Period|Lost to Follow-up|9|||
149754400|NCT00751881|540229960|FG002|Extension Study Period|Lost to Follow-up|6|||
149754401|NCT00751881|540229958|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
149754402|NCT00751881|540229959|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
149754403|NCT00751881|540229960|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
149754404|NCT00751881|540229958|FG000|Extension Study Period|Other than specified above|26|||
149754405|NCT00751881|540229959|FG001|Extension Study Period|Other than specified above|30|||
149754406|NCT00751881|540229960|FG002|Extension Study Period|Other than specified above|18|||
149754407|NCT00564629|540229961|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
149754408|NCT00564629|540229962|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
149754409|NCT02119104|540229963|FG000|Overall Study|Protocol Violation|16|||
149754410|NCT01632878|540229964|FG000|Screening|Physician Decision|268|||
149754411|NCT01632878|540229964|FG000|Treatment|Lost to Follow-up|41|||
149754412|NCT01632878|540229964|FG000|Treatment|Withdrawal by Subject|36|||
149754413|NCT01632878|540229964|FG000|Treatment|Physician Decision|34|||
149754414|NCT01632878|540229964|FG000|Treatment|missing information|4|||
149754415|NCT01632878|540229964|FG000|Treatment|no information on study completion|43|||
149754416|NCT01651260|540229968|FG000|Overall Study|unable to apply product|3|||
149754417|NCT01558089|540229969|FG000|Overall Study|Adverse Event|1|||
149754418|NCT01558089|540229969|FG000|Overall Study|Lack of Efficacy|1|||
149754419|NCT01558089|540229969|FG000|Overall Study|Lost to Follow-up|5|||
149754420|NCT01558089|540229969|FG000|Overall Study|Withdrawal by Subject|6|||
149754421|NCT02144220|540229970|FG000|Overall Study|technology incompatibility|9|||
149754422|NCT02144220|540229970|FG000|Overall Study|Lack of Efficacy|4|||
149754423|NCT02144220|540229970|FG000|Overall Study|Physician Decision|3|||
149754424|NCT02144220|540229970|FG000|Overall Study|Withdrawal by Subject|2|||
149754425|NCT02144220|540229970|FG000|Overall Study|Protocol Violation|1|||
149754426|NCT01952015|540229973|FG000|Induction|Protocol Violation|1|||
149754427|NCT01952015|540229973|FG000|Maintenance|Adverse Event|2|||
149754428|NCT01952015|540229973|FG000|Treatment Period 3|Physician Decision|9|||
149754429|NCT02239094|540229974|FG000|Overall Study|Withdrawal by Subject|1|||
149754430|NCT02239094|540229974|FG000|Overall Study|Remitted before started|1|||
149754431|NCT03648996|540229975|FG000|Overall Study|Withdrawal by Subject|0|||
149754432|NCT03648996|540229976|FG001|Overall Study|Withdrawal by Subject|2|||
149754433|NCT03648996|540229977|FG002|Overall Study|Withdrawal by Subject|2|||
149754434|NCT03648996|540229975|FG000|Overall Study|Physician Decision|2|||
149754435|NCT03648996|540229976|FG001|Overall Study|Physician Decision|0|||
149754436|NCT03648996|540229977|FG002|Overall Study|Physician Decision|0|||
149754437|NCT03242759|540229981|FG000|Overall Study|Adverse Event|5|||
149754438|NCT03242759|540229982|FG001|Overall Study|Adverse Event|1|||
149754439|NCT03242759|540229981|FG000|Overall Study|Withdrawal by Subject|4|||
149754440|NCT03242759|540229982|FG001|Overall Study|Withdrawal by Subject|3|||
149754441|NCT03242759|540229981|FG000|Overall Study|Lost to Follow-up|3|||
149754442|NCT03242759|540229982|FG001|Overall Study|Lost to Follow-up|1|||
149754443|NCT03242759|540229981|FG000|Overall Study|Administrative problems|1|||
149754444|NCT03242759|540229982|FG001|Overall Study|Administrative problems|1|||
149754445|NCT03242759|540229981|FG000|Overall Study|Death|22|||
149754446|NCT03242759|540229982|FG001|Overall Study|Death|0|||
149754447|NCT03242759|540229981|FG000|Overall Study|Change visit schedule|0|||
149754448|NCT03242759|540229982|FG001|Overall Study|Change visit schedule|1|||
149754449|NCT00064662|540229983|FG000|Overall Study|Death|1|||
149754450|NCT00064662|540229984|FG001|Overall Study|Death|1|||
149754451|NCT00064662|540229983|FG000|Overall Study|Lost to Follow-up|57|||
149754452|NCT00064662|540229984|FG001|Overall Study|Lost to Follow-up|44|||
149754453|NCT00064662|540229983|FG000|Overall Study|Withdrawal by Subject|14|||
149754454|NCT00064662|540229984|FG001|Overall Study|Withdrawal by Subject|14|||
149754455|NCT00064662|540229983|FG000|Overall Study|Administratively withdrawn|2|||
149754456|NCT00064662|540229984|FG001|Overall Study|Administratively withdrawn|2|||
149754457|NCT00365976|540229991|FG000|Overall Study|Withdrawal by Subject|1|||
149754458|NCT00365976|540229992|FG001|Overall Study|Withdrawal by Subject|5|||
149754459|NCT01963117|540229995|FG000|Overall Study|Death|1|||
149754460|NCT01780389|540229996|FG000|Overall Study|Adverse Event|1|||
149754461|NCT01095250|540229997|FG000|Overall Study|administrative reasons|8|||
149754462|NCT01095250|540229998|FG001|Overall Study|administrative reasons|10|||
149754463|NCT01095250|540229999|FG002|Overall Study|administrative reasons|7|||
149754464|NCT01095250|540230000|FG003|Overall Study|administrative reasons|5|||
149754465|NCT01095250|540229997|FG000|Overall Study|Withdrawal by Subject|0|||
149754466|NCT01095250|540229998|FG001|Overall Study|Withdrawal by Subject|0|||
149754467|NCT01095250|540229999|FG002|Overall Study|Withdrawal by Subject|1|||
149754468|NCT01095250|540230000|FG003|Overall Study|Withdrawal by Subject|0|||
149754469|NCT01000064|540230001|FG000|Overall Study|Withdrawal by Subject|1|||
149754470|NCT01000064|540230002|FG001|Overall Study|Withdrawal by Subject|1|||
149754471|NCT02518620|540230003|FG000|Overall Study|Adverse Event|23|||
149754472|NCT02518620|540230004|FG001|Overall Study|Adverse Event|11|||
149754473|NCT02518620|540230003|FG000|Overall Study|Lack of Efficacy|2|||
149754474|NCT02518620|540230004|FG001|Overall Study|Lack of Efficacy|0|||
149754475|NCT02518620|540230003|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149754476|NCT02518620|540230004|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149754477|NCT02518620|540230003|FG000|Overall Study|Physician Decision|1|||
149754478|NCT02518620|540230004|FG001|Overall Study|Physician Decision|1|||
149754479|NCT02518620|540230003|FG000|Overall Study|Sponsor's Decision|0|||
149754480|NCT02518620|540230004|FG001|Overall Study|Sponsor's Decision|3|||
149754481|NCT02518620|540230003|FG000|Overall Study|Lost to Follow-up|1|||
149754482|NCT02518620|540230004|FG001|Overall Study|Lost to Follow-up|1|||
149754483|NCT02518620|540230003|FG000|Overall Study|Withdrawal by Subject|17|||
149754484|NCT02518620|540230004|FG001|Overall Study|Withdrawal by Subject|9|||
149754485|NCT02518620|540230003|FG000|Overall Study|Death|1|||
149754486|NCT02518620|540230004|FG001|Overall Study|Death|0|||
149754487|NCT02518620|540230003|FG000|Overall Study|Pregnancy Wish|3|||
149754488|NCT02518620|540230004|FG001|Overall Study|Pregnancy Wish|0|||
149754489|NCT02518620|540230003|FG000|Overall Study|Pregnancy|1|||
149754490|NCT02518620|540230004|FG001|Overall Study|Pregnancy|0|||
149754491|NCT02518620|540230003|FG000|Overall Study|Relocation|2|||
149754492|NCT02518620|540230004|FG001|Overall Study|Relocation|1|||
149754493|NCT03625986|540231687|FG000|Randomization Period|Lost to Follow-up|7|||
149754494|NCT03625986|540231688|FG001|Randomization Period|Lost to Follow-up|12|||
149754495|NCT03625986|540231687|FG000|Randomization Period|Withdrawal by Subject|10|||
149754496|NCT03625986|540231688|FG001|Randomization Period|Withdrawal by Subject|6|||
149754497|NCT01850563|540231689|FG000|Overall Study|Not eligible|3|||
149754498|NCT01850563|540231690|FG001|Overall Study|Not eligible|0|||
149754499|NCT04359823|540231691|FG000|Overall Study|Lost to Follow-up|0|||
149754500|NCT04359823|540231692|FG001|Overall Study|Lost to Follow-up|1|||
149754501|NCT04359823|540231691|FG000|Overall Study|Withdrawal by Subject|0|||
149754502|NCT04359823|540231692|FG001|Overall Study|Withdrawal by Subject|1|||
149754503|NCT02078713|540231693|FG000|Overall Study|Lost to Follow-up|49|||
149754504|NCT02078713|540231694|FG001|Overall Study|Lost to Follow-up|55|||
149754505|NCT02078713|540231695|FG002|Overall Study|Lost to Follow-up|0|||
149754506|NCT02078713|540231696|FG003|Overall Study|Lost to Follow-up|0|||
149754507|NCT02078713|540231693|FG000|Overall Study|Pregnant at baseline|3|||
149754508|NCT02078713|540231694|FG001|Overall Study|Pregnant at baseline|5|||
149754509|NCT02078713|540231695|FG002|Overall Study|Pregnant at baseline|0|||
149754510|NCT02078713|540231696|FG003|Overall Study|Pregnant at baseline|0|||
149754511|NCT02078713|540231693|FG000|Overall Study|Enrolled twice|0|||
149754512|NCT02078713|540231694|FG001|Overall Study|Enrolled twice|1|||
149754513|NCT02078713|540231695|FG002|Overall Study|Enrolled twice|0|||
149754514|NCT02078713|540231696|FG003|Overall Study|Enrolled twice|0|||
149754515|NCT03123354|540231701|FG000|Overall Study|Physician Decision|6|||
149754516|NCT03074162|540231702|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149754517|NCT03074162|540231703|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149754518|NCT03074162|540231704|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
149754519|NCT03074162|540231705|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149754520|NCT03074162|540231706|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149754521|NCT03074162|540231707|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149754522|NCT03074162|540231702|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149754523|NCT03074162|540231703|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149754524|NCT03074162|540231704|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
149754525|NCT03074162|540231705|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149754526|NCT03074162|540231706|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149754527|NCT03074162|540231707|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
149754528|NCT03074162|540231702|FG000|Period 3|Withdrawal by Subject|1|||
149754529|NCT03074162|540231703|FG001|Period 3|Withdrawal by Subject|0|||
149754530|NCT03074162|540231704|FG002|Period 3|Withdrawal by Subject|0|||
149754531|NCT03074162|540231705|FG003|Period 3|Withdrawal by Subject|0|||
149754532|NCT03074162|540231706|FG004|Period 3|Withdrawal by Subject|1|||
149754533|NCT03074162|540231707|FG005|Period 3|Withdrawal by Subject|0|||
149754534|NCT02948777|540231713|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
149754535|NCT03242928|540231714|FG000|Overall Study|Adverse Event|2|||
149754536|NCT03242928|540231715|FG001|Overall Study|Adverse Event|1|||
149754537|NCT03242928|540231714|FG000|Overall Study|Lost to Follow-up|2|||
149754538|NCT03242928|540231715|FG001|Overall Study|Lost to Follow-up|0|||
149754539|NCT03242928|540231714|FG000|Overall Study|Physician Decision|0|||
149754540|NCT03242928|540231715|FG001|Overall Study|Physician Decision|1|||
149754541|NCT03242928|540231714|FG000|Overall Study|Withdrawal by Subject|5|||
149754542|NCT03242928|540231715|FG001|Overall Study|Withdrawal by Subject|3|||
149754543|NCT00625365|540231719|FG000|Overall Study|Withdrawal by Subject|1|||
149754544|NCT00625365|540231719|FG000|Overall Study|No IV access|5|||
149754545|NCT00625365|540231719|FG000|Overall Study|VSD|1|||
149754546|NCT03650452|540231720|FG000|Overall Study|Physician Decision|1|||
149754547|NCT03650452|540231721|FG001|Overall Study|Physician Decision|0|||
149754548|NCT03650452|540231720|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
149754549|NCT03650452|540231721|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149754550|NCT03650452|540231720|FG000|Overall Study|Adverse Event|3|||
149754551|NCT03650452|540231721|FG001|Overall Study|Adverse Event|4|||
149754552|NCT03650452|540231720|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
149754553|NCT03650452|540231721|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
149754554|NCT01703286|540231730|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
149754555|NCT01703286|540231731|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
149754556|NCT01703286|540231732|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
149754557|NCT01703286|540231733|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
149754558|NCT01703286|540231734|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
149754559|NCT01703286|540231735|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
149754560|NCT01703286|540231730|FG000|Period 2 Including Washout|Adverse Event|0|||
149754561|NCT01703286|540231731|FG001|Period 2 Including Washout|Adverse Event|0|||
149754562|NCT01703286|540231732|FG002|Period 2 Including Washout|Adverse Event|0|||
149754563|NCT01703286|540231733|FG003|Period 2 Including Washout|Adverse Event|1|||
149754564|NCT01703286|540231734|FG004|Period 2 Including Washout|Adverse Event|0|||
149754565|NCT01703286|540231735|FG005|Period 2 Including Washout|Adverse Event|0|||
149754566|NCT02421120|540231736|FG000|Overall Study|Adverse Event|1|||
149754567|NCT00931892|540231737|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
149754568|NCT00931892|540231738|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
149754569|NCT01876732|540231739|FG000|Overall Study|MMA was not over 800mg/dL|75|||
149754570|NCT02207530|540231742|FG000|Overall Study|Worsening condition under investigation|78|||
149754571|NCT02207530|540231742|FG000|Overall Study|Patient decision to stop study treatment|5|||
149754572|NCT02207530|540231742|FG000|Overall Study|Adverse Event|8|||
149754573|NCT00305006|540231743|FG000|Overall Study|Withdrawal by Subject|1|||
149754574|NCT00305006|540231744|FG001|Overall Study|Withdrawal by Subject|0|||
149754575|NCT00305006|540231743|FG000|Overall Study|Failure to complete pretest|0|||
149754576|NCT00305006|540231744|FG001|Overall Study|Failure to complete pretest|1|||
149754577|NCT00986258|540231745|FG000|Observation Period|Not eligible to be dosed|11|||
149754578|NCT00986258|540231745|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
149754579|NCT00986258|540231745|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
149754580|NCT00986258|540231745|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
149754581|NCT00986258|540231745|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
149754582|NCT00986258|540231745|FG000|Titration and Optimal Dose Period|Other|1|||
149754583|NCT00986258|540231745|FG000|Maintenance Period|Adverse Event|5|||
149754584|NCT00986258|540231745|FG000|Maintenance Period|Lack of Efficacy|2|||
149754585|NCT00986258|540231745|FG000|Maintenance Period|Withdrawal by Subject|2|||
149754586|NCT04964063|540231746|FG000|Overall Study|Adverse Event|4|||
149754587|NCT04964063|540231746|FG000|Overall Study|Lost to Follow-up|47|||
149754588|NCT04964063|540231746|FG000|Overall Study|Withdrawal by Subject|5|||
149754589|NCT04964063|540231746|FG000|Overall Study|Baseline Tasks Expired|41|||
149754590|NCT04964063|540231746|FG000|Overall Study|Participant withdrawn in error|1|||
149754591|NCT01120093|540231749|FG000|Treatment Period 1|Adverse Event|0|||
149754592|NCT01120093|540231750|FG001|Treatment Period 1|Adverse Event|0|||
149754593|NCT01120093|540231751|FG002|Treatment Period 1|Adverse Event|1|||
149754594|NCT01120093|540231752|FG003|Treatment Period 1|Adverse Event|0|||
149754595|NCT01120093|540231753|FG004|Treatment Period 1|Adverse Event|1|||
149754596|NCT01120093|540231749|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149754597|NCT01120093|540231750|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149754598|NCT01120093|540231751|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149754599|NCT01120093|540231752|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149754600|NCT01120093|540231753|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149754601|NCT01120093|540231749|FG000|Treatment Period 2|Adverse Event|0|||
149754602|NCT01120093|540231750|FG001|Treatment Period 2|Adverse Event|0|||
149754603|NCT01120093|540231751|FG002|Treatment Period 2|Adverse Event|0|||
149754604|NCT01120093|540231752|FG003|Treatment Period 2|Adverse Event|1|||
149754605|NCT01120093|540231753|FG004|Treatment Period 2|Adverse Event|0|||
149754606|NCT01120093|540231749|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149754607|NCT01120093|540231750|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149754608|NCT01120093|540231751|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149754609|NCT01120093|540231752|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149754610|NCT01120093|540231753|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149754611|NCT01120093|540231749|FG000|Treatment Period 3|Lack of Efficacy|0|||
149754612|NCT01120093|540231750|FG001|Treatment Period 3|Lack of Efficacy|0|||
149754613|NCT01120093|540231751|FG002|Treatment Period 3|Lack of Efficacy|0|||
149754614|NCT01120093|540231752|FG003|Treatment Period 3|Lack of Efficacy|1|||
149754615|NCT01120093|540231753|FG004|Treatment Period 3|Lack of Efficacy|0|||
149754616|NCT01120093|540231749|FG000|Treatment Period 3|Adverse Event|0|||
149754617|NCT01120093|540231750|FG001|Treatment Period 3|Adverse Event|0|||
149754618|NCT01120093|540231751|FG002|Treatment Period 3|Adverse Event|0|||
149754619|NCT01120093|540231752|FG003|Treatment Period 3|Adverse Event|0|||
149754620|NCT01120093|540231753|FG004|Treatment Period 3|Adverse Event|1|||
149754621|NCT01120093|540231749|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149754622|NCT01120093|540231750|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149754623|NCT01120093|540231751|FG002|Treatment Period 3|Withdrawal by Subject|1|||
149754624|NCT01120093|540231752|FG003|Treatment Period 3|Withdrawal by Subject|0|||
149754625|NCT01120093|540231753|FG004|Treatment Period 3|Withdrawal by Subject|0|||
149754626|NCT01120093|540231749|FG000|Treatment Period 4|Adverse Event|1|||
149754627|NCT01120093|540231750|FG001|Treatment Period 4|Adverse Event|0|||
149754628|NCT01120093|540231751|FG002|Treatment Period 4|Adverse Event|0|||
149754629|NCT01120093|540231752|FG003|Treatment Period 4|Adverse Event|0|||
149754630|NCT01120093|540231753|FG004|Treatment Period 4|Adverse Event|0|||
149754631|NCT01120093|540231749|FG000|Treatment Period 5|Adverse Event|0|||
149754632|NCT01120093|540231750|FG001|Treatment Period 5|Adverse Event|1|||
149754633|NCT01120093|540231751|FG002|Treatment Period 5|Adverse Event|0|||
149754634|NCT01120093|540231752|FG003|Treatment Period 5|Adverse Event|1|||
149754635|NCT01120093|540231753|FG004|Treatment Period 5|Adverse Event|0|||
149754636|NCT03649321|540231754|FG000|Overall Study|Withdrawal by Subject|1|||
149754637|NCT03649321|540231755|FG001|Overall Study|Withdrawal by Subject|0|||
149754638|NCT03649321|540231754|FG000|Overall Study|Death|1|||
149754639|NCT03649321|540231755|FG001|Overall Study|Death|0|||
149754640|NCT00723840|540231762|FG000|Overall Study|Lost to Follow-up|2|||
149754641|NCT00723840|540231762|FG000|Overall Study|Failure to return|18|||
149754642|NCT00723840|540231762|FG000|Overall Study|Withdrawal by Subject|55|||
149754643|NCT00723840|540231762|FG000|Overall Study|Serious Adverse Events|3|||
149754644|NCT00723840|540231762|FG000|Overall Study|Other Medical Event|2|||
149754645|NCT00723840|540231762|FG000|Overall Study|Unspecified reason|2|||
149754646|NCT05100199|540231769|FG000|Overall Study|Lost to Follow-up|5|||
149754647|NCT05100199|540231770|FG001|Overall Study|Lost to Follow-up|8|||
149754648|NCT05100199|540231771|FG002|Overall Study|Lost to Follow-up|3|||
149754649|NCT05100199|540231772|FG003|Overall Study|Lost to Follow-up|6|||
149754650|NCT05100199|540231769|FG000|Overall Study|Withdrawal by Subject|3|||
149754651|NCT05100199|540231770|FG001|Overall Study|Withdrawal by Subject|3|||
149754652|NCT05100199|540231771|FG002|Overall Study|Withdrawal by Subject|9|||
149754653|NCT05100199|540231772|FG003|Overall Study|Withdrawal by Subject|7|||
149754654|NCT05100199|540231769|FG000|Overall Study|Other|0|||
149754655|NCT05100199|540231770|FG001|Overall Study|Other|0|||
149754656|NCT05100199|540231771|FG002|Overall Study|Other|1|||
149754657|NCT05100199|540231772|FG003|Overall Study|Other|1|||
149754658|NCT02853331|540231773|FG000|Overall Study|Death|59|||
149754659|NCT02853331|540231774|FG001|Overall Study|Death|95|||
149754660|NCT02853331|540231773|FG000|Overall Study|Withdrawal by Subject|5|||
149754661|NCT02853331|540231774|FG001|Overall Study|Withdrawal by Subject|9|||
149754662|NCT02853331|540231773|FG000|Overall Study|Ongoing in study|368|||
149754663|NCT02853331|540231774|FG001|Overall Study|Ongoing in study|325|||
149754664|NCT02062151|540231777|FG000|Overall Study|screen failure|1|||
149754665|NCT00257192|540231780|FG000|Overall Study|Adverse Event|21|||
149754666|NCT00257192|540231781|FG001|Overall Study|Adverse Event|10|||
149754667|NCT00257192|540231780|FG000|Overall Study|Laboratory abnormality|1|||
149754668|NCT00257192|540231781|FG001|Overall Study|Laboratory abnormality|1|||
149754669|NCT00257192|540231780|FG000|Overall Study|Lost to Follow-up|3|||
149754670|NCT00257192|540231781|FG001|Overall Study|Lost to Follow-up|3|||
149754671|NCT00257192|540231780|FG000|Overall Study|Insufficient clinical response|18|||
149754672|NCT00257192|540231781|FG001|Overall Study|Insufficient clinical response|18|||
149754673|NCT00257192|540231780|FG000|Overall Study|Withdrawal by Subject|14|||
149754674|NCT00257192|540231781|FG001|Overall Study|Withdrawal by Subject|2|||
149754675|NCT00257192|540231780|FG000|Overall Study|Randomized but not treated|0|||
149754676|NCT00257192|540231781|FG001|Overall Study|Randomized but not treated|1|||
149754677|NCT00257192|540231780|FG000|Overall Study|Study terminated by sponsor|1|||
149754678|NCT00257192|540231781|FG001|Overall Study|Study terminated by sponsor|0|||
149754679|NCT00257192|540231780|FG000|Overall Study|Miscellaneous|0|||
149754680|NCT00257192|540231781|FG001|Overall Study|Miscellaneous|4|||
149754681|NCT00751101|540231783|FG000|Overall Study|Withdrawal by Subject|1|||
149754682|NCT00751101|540231784|FG001|Overall Study|Withdrawal by Subject|0|||
149754683|NCT00751101|540231783|FG000|Overall Study|No HFS / Never Started Patch/|0|||
149754684|NCT00751101|540231784|FG001|Overall Study|No HFS / Never Started Patch/|4|||
149754685|NCT00751101|540231783|FG000|Overall Study|Never began capecitabine|1|||
149754686|NCT00751101|540231784|FG001|Overall Study|Never began capecitabine|0|||
149754687|NCT00751101|540231783|FG000|Overall Study|Physician Decision|0|||
149754688|NCT00751101|540231784|FG001|Overall Study|Physician Decision|1|||
149754689|NCT02086565|540231785|FG000|Overall Study|Lost to Follow-up|9|||
149754690|NCT02086565|540231786|FG001|Overall Study|Lost to Follow-up|7|||
149754691|NCT02086565|540231785|FG000|Overall Study|Withdrawal by Subject|2|||
149754692|NCT02086565|540231786|FG001|Overall Study|Withdrawal by Subject|1|||
149754693|NCT02086565|540231785|FG000|Overall Study|Death|3|||
149754694|NCT02086565|540231786|FG001|Overall Study|Death|2|||
149754695|NCT02086565|540231785|FG000|Overall Study|withdrawn by research team|2|||
149754696|NCT02086565|540231786|FG001|Overall Study|withdrawn by research team|2|||
149754697|NCT00739297|540231787|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
149754698|NCT00739297|540231788|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
149754699|NCT00739297|540231789|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
149754700|NCT00739297|540231790|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
149754701|NCT00739297|540231791|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
149754702|NCT00739297|540231792|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
149754703|NCT00739297|540231793|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
149754704|NCT00739297|540231787|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149754705|NCT00739297|540231788|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149754706|NCT00739297|540231789|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149754707|NCT00739297|540231790|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149754708|NCT00739297|540231791|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149754709|NCT00739297|540231792|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
149754710|NCT00739297|540231793|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
149754711|NCT01400971|540231794|FG000|Overall Study|Death|82|||
149754712|NCT01400971|540231794|FG000|Overall Study|Lost to Follow-up|196|||
149754713|NCT01400971|540231794|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
149754714|NCT01400971|540231794|FG000|Overall Study|Physician Decision|57|||
149754715|NCT01400971|540231794|FG000|Overall Study|Withdrawal by Subject|158|||
149754716|NCT01400971|540231794|FG000|Overall Study|Other|422|||
149754717|NCT01242020|540231795|FG000|Overall Study|Withdrawal by Subject|2|||
149754718|NCT01242020|540231796|FG001|Overall Study|Withdrawal by Subject|0|||
149754719|NCT01242020|540231795|FG000|Overall Study|Failed screening|1|||
149754720|NCT01242020|540231796|FG001|Overall Study|Failed screening|0|||
149754721|NCT01595646|540231797|FG000|Overall Study|Withdrawal by Subject|1|||
149754722|NCT01595646|540231798|FG001|Overall Study|Withdrawal by Subject|0|||
149754723|NCT01595646|540231799|FG002|Overall Study|Withdrawal by Subject|0|||
149754724|NCT00642616|540231802|FG000|Overall Study|Adverse Event|2|||
149754725|NCT00642616|540231803|FG001|Overall Study|Adverse Event|0|||
149754726|NCT00642616|540231804|FG002|Overall Study|Adverse Event|1|||
149754727|NCT00642616|540231805|FG003|Overall Study|Adverse Event|0|||
149754728|NCT00642616|540231802|FG000|Overall Study|Study Terminated by Sponsor|7|||
149754729|NCT00642616|540231803|FG001|Overall Study|Study Terminated by Sponsor|6|||
149754730|NCT00642616|540231804|FG002|Overall Study|Study Terminated by Sponsor|4|||
149754731|NCT00642616|540231805|FG003|Overall Study|Study Terminated by Sponsor|5|||
149754732|NCT00642616|540231802|FG000|Overall Study|Withdrawal by Subject|0|||
149754733|NCT00642616|540231803|FG001|Overall Study|Withdrawal by Subject|1|||
149754734|NCT00642616|540231804|FG002|Overall Study|Withdrawal by Subject|1|||
149754735|NCT00642616|540231805|FG003|Overall Study|Withdrawal by Subject|1|||
149754736|NCT00642616|540231802|FG000|Overall Study|Protocol Violation|0|||
149754737|NCT00642616|540231803|FG001|Overall Study|Protocol Violation|0|||
149754738|NCT00642616|540231804|FG002|Overall Study|Protocol Violation|2|||
149754739|NCT00642616|540231805|FG003|Overall Study|Protocol Violation|0|||
149754740|NCT00642616|540231802|FG000|Overall Study|Physician Decision|0|||
149754741|NCT00642616|540231803|FG001|Overall Study|Physician Decision|0|||
149754742|NCT00642616|540231804|FG002|Overall Study|Physician Decision|1|||
149754743|NCT00642616|540231805|FG003|Overall Study|Physician Decision|1|||
149754744|NCT01161524|540231806|FG000|Core Study (23 Weeks)|Adverse Event|3|||
149754745|NCT01161524|540231807|FG001|Core Study (23 Weeks)|Adverse Event|0|||
149754746|NCT01161524|540231808|FG002|Core Study (23 Weeks)|Adverse Event|0|||
149754747|NCT01161524|540231806|FG000|Core Study (23 Weeks)|Other|1|||
149754748|NCT01161524|540231807|FG001|Core Study (23 Weeks)|Other|0|||
149754749|NCT01161524|540231808|FG002|Core Study (23 Weeks)|Other|0|||
149754750|NCT01161524|540231806|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
149754751|NCT01161524|540231807|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
149754752|NCT01161524|540231808|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
149754753|NCT01161524|540231806|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
149754754|NCT01161524|540231807|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
149754755|NCT01161524|540231808|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
149754756|NCT01161524|540231806|FG000|Core Study (23 Weeks)|Subject Choice|3|||
149754757|NCT01161524|540231807|FG001|Core Study (23 Weeks)|Subject Choice|2|||
149754758|NCT01161524|540231808|FG002|Core Study (23 Weeks)|Subject Choice|0|||
149754759|NCT01161524|540231806|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
149754760|NCT01161524|540231807|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
149754761|NCT01161524|540231808|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
149754762|NCT01161524|540231806|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
149754763|NCT01161524|540231807|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
149754764|NCT01161524|540231808|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
149754765|NCT01161524|540231806|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
149754766|NCT01161524|540231807|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
149754767|NCT01161524|540231808|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
149754768|NCT01161524|540231806|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
149754769|NCT01161524|540231807|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
149754770|NCT01161524|540231808|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
149754771|NCT01161524|540231806|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
149754772|NCT01161524|540231807|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
149754773|NCT01161524|540231808|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
149754774|NCT00399802|540231813|FG000|Overall Study|Adverse Event|0|||
149754775|NCT00399802|540231814|FG001|Overall Study|Adverse Event|2|||
149754776|NCT00399802|540231813|FG000|Overall Study|Participant discontinued by mistake|0|||
149754777|NCT00399802|540231814|FG001|Overall Study|Participant discontinued by mistake|1|||
149754778|NCT00542815|540231815|FG000|Overall Study|Adverse Event|19|||
149754779|NCT00542815|540231816|FG001|Overall Study|Adverse Event|6|||
149754780|NCT00542815|540231817|FG002|Overall Study|Adverse Event|9|||
149754781|NCT00542815|540231815|FG000|Overall Study|Death|10|||
149754782|NCT00542815|540231816|FG001|Overall Study|Death|7|||
149754783|NCT00542815|540231817|FG002|Overall Study|Death|3|||
149754784|NCT00542815|540231815|FG000|Overall Study|Lack of Efficacy|9|||
149754785|NCT00542815|540231816|FG001|Overall Study|Lack of Efficacy|2|||
149754786|NCT00542815|540231817|FG002|Overall Study|Lack of Efficacy|0|||
149754787|NCT00542815|540231815|FG000|Overall Study|Physician Decision|2|||
149754788|NCT00542815|540231816|FG001|Overall Study|Physician Decision|1|||
149754789|NCT00542815|540231817|FG002|Overall Study|Physician Decision|0|||
149754790|NCT00542815|540231815|FG000|Overall Study|Protocol Violation|1|||
149754791|NCT00542815|540231816|FG001|Overall Study|Protocol Violation|1|||
149754792|NCT00542815|540231817|FG002|Overall Study|Protocol Violation|2|||
149754793|NCT00542815|540231815|FG000|Overall Study|Withdrawal by Subject|41|||
149754794|NCT00542815|540231816|FG001|Overall Study|Withdrawal by Subject|5|||
149754795|NCT00542815|540231817|FG002|Overall Study|Withdrawal by Subject|8|||
149754796|NCT00542815|540231815|FG000|Overall Study|Other reasons|24|||
149754797|NCT00542815|540231816|FG001|Overall Study|Other reasons|10|||
149754798|NCT00542815|540231817|FG002|Overall Study|Other reasons|10|||
149754799|NCT01041573|540231820|FG000|Overall Study|Withdrawal by Subject|2|||
149754800|NCT01041573|540231821|FG001|Overall Study|Withdrawal by Subject|5|||
149754801|NCT01041573|540231822|FG002|Overall Study|Withdrawal by Subject|2|||
149754802|NCT01041573|540231823|FG003|Overall Study|Withdrawal by Subject|0|||
149754803|NCT01041573|540231820|FG000|Overall Study|Death|1|||
149754804|NCT01041573|540231821|FG001|Overall Study|Death|0|||
149754805|NCT01041573|540231822|FG002|Overall Study|Death|0|||
149754806|NCT01041573|540231823|FG003|Overall Study|Death|0|||
149754807|NCT01041573|540231820|FG000|Overall Study|Lost to Follow-up|0|||
149754808|NCT01041573|540231821|FG001|Overall Study|Lost to Follow-up|1|||
149754809|NCT01041573|540231822|FG002|Overall Study|Lost to Follow-up|2|||
149754810|NCT01041573|540231823|FG003|Overall Study|Lost to Follow-up|1|||
149754811|NCT01041573|540231820|FG000|Overall Study|Adverse Event|0|||
149754812|NCT01041573|540231821|FG001|Overall Study|Adverse Event|2|||
149754813|NCT01041573|540231822|FG002|Overall Study|Adverse Event|0|||
149754814|NCT01041573|540231823|FG003|Overall Study|Adverse Event|0|||
149754815|NCT01041573|540231820|FG000|Overall Study|relocation|1|||
149754816|NCT01041573|540231821|FG001|Overall Study|relocation|4|||
149754817|NCT01041573|540231822|FG002|Overall Study|relocation|3|||
149754818|NCT01041573|540231823|FG003|Overall Study|relocation|1|||
149754819|NCT01041573|540231820|FG000|Overall Study|further blood extraction|0|||
149754820|NCT01041573|540231821|FG001|Overall Study|further blood extraction|1|||
149754821|NCT01041573|540231822|FG002|Overall Study|further blood extraction|0|||
149754822|NCT01041573|540231823|FG003|Overall Study|further blood extraction|0|||
149754823|NCT01041573|540231820|FG000|Overall Study|positive to anti-HCV|1|||
149754824|NCT01041573|540231821|FG001|Overall Study|positive to anti-HCV|0|||
149754825|NCT01041573|540231822|FG002|Overall Study|positive to anti-HCV|0|||
149754826|NCT01041573|540231823|FG003|Overall Study|positive to anti-HCV|0|||
149754827|NCT04172831|540231824|FG000|Overall Study|Adverse Event|21|||
149754828|NCT04172831|540231825|FG001|Overall Study|Adverse Event|9|||
149754829|NCT04172831|540231824|FG000|Overall Study|Lack of Efficacy|2|||
149754830|NCT04172831|540231825|FG001|Overall Study|Lack of Efficacy|8|||
149754831|NCT04172831|540231824|FG000|Overall Study|Physician Decision|0|||
149754832|NCT04172831|540231825|FG001|Overall Study|Physician Decision|1|||
149754833|NCT04172831|540231824|FG000|Overall Study|Withdrawal by Subject|12|||
149754834|NCT04172831|540231825|FG001|Overall Study|Withdrawal by Subject|11|||
149754835|NCT04172831|540231824|FG000|Overall Study|Lost to Follow-up|4|||
149754836|NCT04172831|540231825|FG001|Overall Study|Lost to Follow-up|9|||
149754837|NCT04172831|540231824|FG000|Overall Study|COVID-19 related crisis|3|||
149754838|NCT04172831|540231825|FG001|Overall Study|COVID-19 related crisis|3|||
149754839|NCT04172831|540231824|FG000|Overall Study|Subject non-compliance|1|||
149754840|NCT04172831|540231825|FG001|Overall Study|Subject non-compliance|1|||
149754841|NCT04172831|540231824|FG000|Overall Study|Family emergency|1|||
149754842|NCT04172831|540231825|FG001|Overall Study|Family emergency|0|||
149754843|NCT02955186|540231826|FG000|Overall Study|Withdrawal by Subject|6|||
149754844|NCT02955186|540231827|FG001|Overall Study|Withdrawal by Subject|2|||
149754845|NCT02955186|540231826|FG000|Overall Study|Protocol Violation|1|||
149754846|NCT02955186|540231827|FG001|Overall Study|Protocol Violation|0|||
149754847|NCT01618656|540231830|FG000|Overall Study|Withdrawal by Subject|7|||
149754848|NCT01618656|540231831|FG001|Overall Study|Withdrawal by Subject|3|||
149754849|NCT01618656|540231830|FG000|Overall Study|Physician Decision|1|||
149754850|NCT01618656|540231831|FG001|Overall Study|Physician Decision|1|||
149754851|NCT01276847|540231832|FG000|Overall Study|Withdrawal by Subject|1|||
149754852|NCT01276847|540231833|FG001|Overall Study|Withdrawal by Subject|0|||
149754853|NCT01276847|540231834|FG002|Overall Study|Withdrawal by Subject|0|||
149754854|NCT01899144|540231835|FG000|Treatment Period 2|Other|1|||
149754855|NCT01899144|540231835|FG000|Treatment Period 3|Other|2|||
149754856|NCT01899144|540231835|FG000|Treatment Period 5|Other|1|||
149754857|NCT04770155|540231836|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754858|NCT04770155|540231837|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754859|NCT04770155|540231838|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754860|NCT04770155|540231839|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754861|NCT04770155|540231840|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754862|NCT04770155|540231841|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754863|NCT04770155|540231842|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754864|NCT04770155|540231843|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149754865|NCT02021812|540231844|FG000|Overall Study|Death|8|||
149754866|NCT02021812|540231844|FG000|Overall Study|Withdrawal by Subject|3|||
149754867|NCT02021812|540231844|FG000|Overall Study|Lost to Follow-up|2|||
149754868|NCT02021812|540231844|FG000|Overall Study|Refuse to return, COVD 19|2|||
149754869|NCT03634072|540231845|FG000|Overall Study|Early termination of overall study|1|||
149754870|NCT03634072|540231846|FG001|Overall Study|Early termination of overall study|0|||
149754871|NCT01765764|540231847|FG000|Treatment Period|Adverse Event|1|||
149754872|NCT01765764|540231848|FG001|Treatment Period|Adverse Event|2|||
149754873|NCT01765764|540231849|FG002|Treatment Period|Adverse Event|1|||
149754874|NCT01765764|540231847|FG000|Treatment Period|Lost to Follow-up|0|||
149754875|NCT01765764|540231848|FG001|Treatment Period|Lost to Follow-up|3|||
149754876|NCT01765764|540231849|FG002|Treatment Period|Lost to Follow-up|2|||
149754877|NCT01765764|540231847|FG000|Treatment Period|Personal Reasons|1|||
149754878|NCT01765764|540231848|FG001|Treatment Period|Personal Reasons|2|||
149754879|NCT01765764|540231849|FG002|Treatment Period|Personal Reasons|1|||
149754880|NCT01765764|540231847|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
149754881|NCT01765764|540231848|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
149754882|NCT01765764|540231849|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
149754883|NCT01597193|540231851|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
149754884|NCT01597193|540231852|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
149754885|NCT01597193|540231853|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149754886|NCT01597193|540231854|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149754887|NCT01597193|540231855|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149754888|NCT01597193|540231856|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149754889|NCT01597193|540231857|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149754890|NCT01597193|540231851|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149754891|NCT01597193|540231852|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149754892|NCT01597193|540231853|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149754893|NCT01597193|540231854|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
149754894|NCT01597193|540231855|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
149754895|NCT01597193|540231856|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
149754896|NCT01597193|540231857|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149754897|NCT01597193|540231851|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
149754898|NCT01597193|540231852|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
149754899|NCT01597193|540231853|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
149754900|NCT01597193|540231854|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
149754901|NCT01597193|540231855|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
149754902|NCT01597193|540231856|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
149754903|NCT01597193|540231857|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
149754904|NCT01597193|540231851|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754905|NCT01597193|540231852|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754906|NCT01597193|540231853|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754907|NCT01597193|540231854|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754908|NCT01597193|540231855|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754909|NCT01597193|540231856|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
149754910|NCT01597193|540231857|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149754911|NCT01597193|540231851|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149754912|NCT01597193|540231852|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149754913|NCT01597193|540231853|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149754914|NCT01597193|540231854|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
149754915|NCT01597193|540231855|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149754916|NCT01597193|540231856|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
149754917|NCT01597193|540231857|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149754918|NCT03184701|540231859|FG000|Overall Study|Death|3|||
149754919|NCT03184701|540231859|FG000|Overall Study|Physician Decision|3|||
149754920|NCT03184701|540231859|FG000|Overall Study|Withdrawal by Subject|6|||
149754921|NCT03184701|540231859|FG000|Overall Study|Lost to Follow-up|5|||
149754922|NCT03844633|540231862|FG000|1 Week FU|Lost to Follow-up|0|||
149754923|NCT03844633|540231863|FG001|1 Week FU|Lost to Follow-up|1|||
149754924|NCT03844633|540231864|FG002|1 Week FU|Lost to Follow-up|4|||
149754925|NCT03844633|540231862|FG000|12-month Follow-up|Lost to Follow-up|7|||
149754926|NCT03844633|540231863|FG001|12-month Follow-up|Lost to Follow-up|5|||
149754927|NCT03844633|540231864|FG002|12-month Follow-up|Lost to Follow-up|8|||
149754928|NCT03596177|540231868|FG000|Single Blind Period|Withdrawal by Subject|1|||
149754929|NCT03596177|540231869|FG001|Single Blind Period|Withdrawal by Subject|1|||
149754930|NCT03596177|540231868|FG000|Single Blind Period|Other|1|||
149754931|NCT03596177|540231869|FG001|Single Blind Period|Other|0|||
149754932|NCT03596177|540231868|FG000|Double Blind Period|Withdrawal by Subject|0|||
149754933|NCT03596177|540231869|FG001|Double Blind Period|Withdrawal by Subject|1|||
149754934|NCT03596177|540231868|FG000|Double Blind Period|Other|0|||
149754935|NCT03596177|540231869|FG001|Double Blind Period|Other|4|||
149754936|NCT03596177|540231868|FG000|Double Blind Period|Death during safety follow-up|0|||
149754937|NCT03596177|540231869|FG001|Double Blind Period|Death during safety follow-up|1|||
149754938|NCT04083222|540231872|FG000|Overall Study|Voluntary Withdrawal|0|||
149754939|NCT04083222|540231873|FG001|Overall Study|Voluntary Withdrawal|1|||
149754940|NCT04083222|540231872|FG000|Overall Study|Reason not Specified|0|||
149754941|NCT04083222|540231873|FG001|Overall Study|Reason not Specified|1|||
149754942|NCT01937130|540233784|FG000|Overall Study|Withdrawal by Subject|0|||
149754943|NCT01937130|540233785|FG001|Overall Study|Withdrawal by Subject|0|||
149754944|NCT01937130|540233786|FG002|Overall Study|Withdrawal by Subject|0|||
149754945|NCT01937130|540233787|FG003|Overall Study|Withdrawal by Subject|1|||
149754946|NCT01937130|540233784|FG000|Overall Study|Adverse Event|0|||
149754947|NCT01937130|540233785|FG001|Overall Study|Adverse Event|1|||
149754948|NCT01937130|540233786|FG002|Overall Study|Adverse Event|0|||
149754949|NCT01937130|540233787|FG003|Overall Study|Adverse Event|1|||
149754950|NCT01937130|540233784|FG000|Overall Study|Death|1|||
149754951|NCT01937130|540233785|FG001|Overall Study|Death|1|||
149754952|NCT01937130|540233786|FG002|Overall Study|Death|1|||
149754953|NCT01937130|540233787|FG003|Overall Study|Death|0|||
149754954|NCT01937130|540233784|FG000|Overall Study|Lost to Follow-up|2|||
149754955|NCT01937130|540233785|FG001|Overall Study|Lost to Follow-up|0|||
149754956|NCT01937130|540233786|FG002|Overall Study|Lost to Follow-up|2|||
149754957|NCT01937130|540233787|FG003|Overall Study|Lost to Follow-up|0|||
149754958|NCT01937130|540233784|FG000|Overall Study|Physician Decision|0|||
149754959|NCT01937130|540233785|FG001|Overall Study|Physician Decision|1|||
149754960|NCT01937130|540233786|FG002|Overall Study|Physician Decision|0|||
149754961|NCT01937130|540233787|FG003|Overall Study|Physician Decision|0|||
149754962|NCT01937130|540233784|FG000|Overall Study|Patients unable to swallow|0|||
149754963|NCT01937130|540233785|FG001|Overall Study|Patients unable to swallow|1|||
149754964|NCT01937130|540233786|FG002|Overall Study|Patients unable to swallow|0|||
149754965|NCT01937130|540233787|FG003|Overall Study|Patients unable to swallow|0|||
149754966|NCT01937130|540233784|FG000|Overall Study|Patient lost to FU due to death|2|||
149754967|NCT01937130|540233785|FG001|Overall Study|Patient lost to FU due to death|0|||
149754968|NCT01937130|540233786|FG002|Overall Study|Patient lost to FU due to death|0|||
149754969|NCT01937130|540233787|FG003|Overall Study|Patient lost to FU due to death|0|||
149754970|NCT04191967|540233788|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
149754971|NCT04191967|540233788|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
149754972|NCT01431144|540233789|FG000|Overall Study|Implant mobility and removal|2|||
149754973|NCT01431144|540233790|FG001|Overall Study|Implant mobility and removal|0|||
149754974|NCT02322892|540233791|FG000|Overall Study|Surgery cancelled|1|||
149754975|NCT02322892|540233792|FG001|Overall Study|Surgery cancelled|2|||
149754976|NCT02322892|540233791|FG000|Overall Study|Met exclusion criteria|0|||
149754977|NCT02322892|540233792|FG001|Overall Study|Met exclusion criteria|1|||
149754978|NCT02322892|540233791|FG000|Overall Study|Protocol Violation|1|||
149754979|NCT02322892|540233792|FG001|Overall Study|Protocol Violation|0|||
149754980|NCT02125331|540233793|FG000|Overall Study|Protocol Violation|1|||
149754981|NCT02125331|540233794|FG001|Overall Study|Protocol Violation|0|||
149754982|NCT02125331|540233793|FG000|Overall Study|technical problem|2|||
149754983|NCT02125331|540233794|FG001|Overall Study|technical problem|0|||
149754984|NCT02125331|540233793|FG000|Overall Study|screen failure|2|||
149754985|NCT02125331|540233794|FG001|Overall Study|screen failure|0|||
149754986|NCT01432262|540233795|FG000|Overall Study|Withdrawal by Subject|2|||
149754987|NCT01432262|540233796|FG001|Overall Study|Withdrawal by Subject|1|||
149754988|NCT00165646|540233797|FG000|Overall Study|Adverse Event|1|||
149754989|NCT00165646|540233798|FG001|Overall Study|Adverse Event|1|||
149754990|NCT00165646|540233799|FG002|Overall Study|Adverse Event|1|||
149754991|NCT00165646|540233797|FG000|Overall Study|Lack of Efficacy|1|||
149754992|NCT00165646|540233798|FG001|Overall Study|Lack of Efficacy|2|||
149754993|NCT00165646|540233799|FG002|Overall Study|Lack of Efficacy|0|||
149754994|NCT00165646|540233797|FG000|Overall Study|Withdrawal by Subject|0|||
149754995|NCT00165646|540233798|FG001|Overall Study|Withdrawal by Subject|2|||
149754996|NCT00165646|540233799|FG002|Overall Study|Withdrawal by Subject|1|||
149754997|NCT00165646|540233797|FG000|Overall Study|Physician Decision|2|||
149754998|NCT00165646|540233798|FG001|Overall Study|Physician Decision|0|||
149754999|NCT00165646|540233799|FG002|Overall Study|Physician Decision|2|||
149755000|NCT00165646|540233797|FG000|Overall Study|Protocol Violation|1|||
149755001|NCT00165646|540233798|FG001|Overall Study|Protocol Violation|0|||
149755002|NCT00165646|540233799|FG002|Overall Study|Protocol Violation|0|||
149755003|NCT01104558|540233800|FG000|Overall Study|Protocol Violation|6|||
149755004|NCT01104558|540233800|FG000|Overall Study|Missing of primary efficacy assessment|10|||
149755005|NCT01104558|540233800|FG000|Overall Study|Missing of genetic analysis results|1|||
149755006|NCT00696657|540233801|FG000|Overall Study|Protocol Violation|0|||
149755007|NCT00696657|540233802|FG001|Overall Study|Protocol Violation|0|||
149755008|NCT00696657|540233803|FG002|Overall Study|Protocol Violation|0|||
149755009|NCT00696657|540233804|FG003|Overall Study|Protocol Violation|0|||
149755010|NCT00696657|540233805|FG004|Overall Study|Protocol Violation|0|||
149755011|NCT00696657|540233806|FG005|Overall Study|Protocol Violation|1|||
149755012|NCT00696657|540233807|FG006|Overall Study|Protocol Violation|0|||
149755013|NCT00696657|540233808|FG007|Overall Study|Protocol Violation|0|||
149755014|NCT00696657|540233809|FG008|Overall Study|Protocol Violation|1|||
149755015|NCT00696657|540233801|FG000|Overall Study|Lack of Efficacy|0|||
149755016|NCT00696657|540233802|FG001|Overall Study|Lack of Efficacy|1|||
149755017|NCT00696657|540233803|FG002|Overall Study|Lack of Efficacy|0|||
149755018|NCT00696657|540233804|FG003|Overall Study|Lack of Efficacy|0|||
149755019|NCT00696657|540233805|FG004|Overall Study|Lack of Efficacy|0|||
149755020|NCT00696657|540233806|FG005|Overall Study|Lack of Efficacy|0|||
149755021|NCT00696657|540233807|FG006|Overall Study|Lack of Efficacy|0|||
149755022|NCT00696657|540233808|FG007|Overall Study|Lack of Efficacy|0|||
149755023|NCT00696657|540233809|FG008|Overall Study|Lack of Efficacy|0|||
149755024|NCT00696657|540233801|FG000|Overall Study|Withdrawal criteria|1|||
149755025|NCT00696657|540233802|FG001|Overall Study|Withdrawal criteria|3|||
149755026|NCT00696657|540233803|FG002|Overall Study|Withdrawal criteria|2|||
149755027|NCT00696657|540233804|FG003|Overall Study|Withdrawal criteria|2|||
149755028|NCT00696657|540233805|FG004|Overall Study|Withdrawal criteria|0|||
149755029|NCT00696657|540233806|FG005|Overall Study|Withdrawal criteria|0|||
149755030|NCT00696657|540233807|FG006|Overall Study|Withdrawal criteria|1|||
149755031|NCT00696657|540233808|FG007|Overall Study|Withdrawal criteria|1|||
149755032|NCT00696657|540233809|FG008|Overall Study|Withdrawal criteria|2|||
149755033|NCT00696657|540233801|FG000|Overall Study|Unclassified|0|||
149755034|NCT00696657|540233802|FG001|Overall Study|Unclassified|1|||
149755035|NCT00696657|540233803|FG002|Overall Study|Unclassified|3|||
149755036|NCT00696657|540233804|FG003|Overall Study|Unclassified|2|||
149755037|NCT00696657|540233805|FG004|Overall Study|Unclassified|4|||
149755038|NCT00696657|540233806|FG005|Overall Study|Unclassified|2|||
149755039|NCT00696657|540233807|FG006|Overall Study|Unclassified|0|||
149755040|NCT00696657|540233808|FG007|Overall Study|Unclassified|0|||
149755041|NCT00696657|540233809|FG008|Overall Study|Unclassified|1|||
149755042|NCT00696657|540233801|FG000|Overall Study|Adverse Event|0|||
149755043|NCT00696657|540233802|FG001|Overall Study|Adverse Event|0|||
149755044|NCT00696657|540233803|FG002|Overall Study|Adverse Event|3|||
149755045|NCT00696657|540233804|FG003|Overall Study|Adverse Event|7|||
149755046|NCT00696657|540233805|FG004|Overall Study|Adverse Event|6|||
149755047|NCT00696657|540233806|FG005|Overall Study|Adverse Event|9|||
149755048|NCT00696657|540233807|FG006|Overall Study|Adverse Event|14|||
149755049|NCT00696657|540233808|FG007|Overall Study|Adverse Event|2|||
149755050|NCT00696657|540233809|FG008|Overall Study|Adverse Event|5|||
149755051|NCT02601001|540233812|FG000|Dosing Period 2|Adverse Event|0|||
149755052|NCT02601001|540233813|FG001|Dosing Period 2|Adverse Event|0|||
149755053|NCT02601001|540233814|FG002|Dosing Period 2|Adverse Event|0|||
149755054|NCT02601001|540233815|FG003|Dosing Period 2|Adverse Event|0|||
149755055|NCT02601001|540233816|FG004|Dosing Period 2|Adverse Event|0|||
149755056|NCT02601001|540233817|FG005|Dosing Period 2|Adverse Event|0|||
149755057|NCT02601001|540233818|FG006|Dosing Period 2|Adverse Event|1|||
149755058|NCT01790438|540233819|FG000|Overall Study|Adverse Event|3|||
149755059|NCT01790438|540233820|FG001|Overall Study|Adverse Event|2|||
149755060|NCT01790438|540233819|FG000|Overall Study|Death|4|||
149755061|NCT01790438|540233820|FG001|Overall Study|Death|0|||
149755062|NCT01790438|540233819|FG000|Overall Study|Lost to Follow-up|5|||
149755063|NCT01790438|540233820|FG001|Overall Study|Lost to Follow-up|2|||
149755064|NCT01790438|540233819|FG000|Overall Study|Withdrawal by Subject|13|||
149755065|NCT01790438|540233820|FG001|Overall Study|Withdrawal by Subject|2|||
149755066|NCT01790438|540233819|FG000|Overall Study|Physician Decision|3|||
149755067|NCT01790438|540233820|FG001|Overall Study|Physician Decision|1|||
149755068|NCT01790438|540233819|FG000|Overall Study|Sponsor Decision|0|||
149755069|NCT01790438|540233820|FG001|Overall Study|Sponsor Decision|3|||
149755070|NCT01790438|540233819|FG000|Overall Study|Protocol Required Discontinuation|7|||
149755071|NCT01790438|540233820|FG001|Overall Study|Protocol Required Discontinuation|1|||
149755072|NCT02433210|540233828|FG000|Overall Study|Physician Decision|1|||
149755073|NCT02433210|540233829|FG001|Overall Study|Physician Decision|0|||
149755074|NCT02433210|540233830|FG002|Overall Study|Physician Decision|0|||
149755075|NCT02819310|540233831|FG000|Overall Study|Withdrawal by Subject|37|||
149755076|NCT02819310|540233831|FG000|Overall Study|Lost to Follow-up|16|||
149755077|NCT02819310|540233831|FG000|Overall Study|Adverse Event|13|||
149755078|NCT02819310|540233831|FG000|Overall Study|Lack of Efficacy|5|||
149755079|NCT02819310|540233831|FG000|Overall Study|Physician Decision|8|||
149755080|NCT02819310|540233831|FG000|Overall Study|Protocol Violation|30|||
149755081|NCT01793051|540233836|FG000|Overall Study|Withdrawal by Subject|6|||
149755082|NCT01793051|540233837|FG001|Overall Study|Withdrawal by Subject|4|||
149755083|NCT01793051|540233836|FG000|Overall Study|Adverse Event|0|||
149755084|NCT01793051|540233837|FG001|Overall Study|Adverse Event|2|||
149755085|NCT01793051|540233836|FG000|Overall Study|Too ill to continue|1|||
149755086|NCT01793051|540233837|FG001|Overall Study|Too ill to continue|0|||
149755087|NCT01793051|540233836|FG000|Overall Study|Switched chemo|1|||
149755088|NCT01793051|540233837|FG001|Overall Study|Switched chemo|1|||
149755089|NCT01793051|540233836|FG000|Overall Study|Lack of compliance|1|||
149755090|NCT01793051|540233837|FG001|Overall Study|Lack of compliance|0|||
149755091|NCT01793051|540233836|FG000|Overall Study|Requested to be removed from the study|1|||
149755092|NCT01793051|540233837|FG001|Overall Study|Requested to be removed from the study|1|||
149755093|NCT00059215|540233838|FG000|Overall Study|Adverse Event|5|||
149755094|NCT00059215|540233839|FG001|Overall Study|Adverse Event|5|||
149755095|NCT00059215|540233840|FG002|Overall Study|Adverse Event|9|||
149755096|NCT00059215|540233841|FG003|Overall Study|Adverse Event|9|||
149755097|NCT00059215|540233838|FG000|Overall Study|Death|0|||
149755098|NCT00059215|540233839|FG001|Overall Study|Death|0|||
149755099|NCT00059215|540233840|FG002|Overall Study|Death|3|||
149755100|NCT00059215|540233841|FG003|Overall Study|Death|0|||
149755101|NCT00059215|540233838|FG000|Overall Study|Lost to Follow-up|1|||
149755102|NCT00059215|540233839|FG001|Overall Study|Lost to Follow-up|2|||
149755103|NCT00059215|540233840|FG002|Overall Study|Lost to Follow-up|0|||
149755104|NCT00059215|540233841|FG003|Overall Study|Lost to Follow-up|0|||
149755105|NCT00059215|540233838|FG000|Overall Study|Withdrawal by Subject|4|||
149755106|NCT00059215|540233839|FG001|Overall Study|Withdrawal by Subject|4|||
149755107|NCT00059215|540233840|FG002|Overall Study|Withdrawal by Subject|1|||
149755108|NCT00059215|540233841|FG003|Overall Study|Withdrawal by Subject|3|||
149755109|NCT00059215|540233838|FG000|Overall Study|Protocol Violation|1|||
149755110|NCT00059215|540233839|FG001|Overall Study|Protocol Violation|0|||
149755111|NCT00059215|540233840|FG002|Overall Study|Protocol Violation|1|||
149755112|NCT00059215|540233841|FG003|Overall Study|Protocol Violation|0|||
149755113|NCT00059215|540233838|FG000|Overall Study|Protocol entry criteria not met|1|||
149755114|NCT00059215|540233839|FG001|Overall Study|Protocol entry criteria not met|1|||
149755115|NCT00059215|540233840|FG002|Overall Study|Protocol entry criteria not met|0|||
149755116|NCT00059215|540233841|FG003|Overall Study|Protocol entry criteria not met|2|||
149755117|NCT00059215|540233838|FG000|Overall Study|Physician Decision|1|||
149755118|NCT00059215|540233839|FG001|Overall Study|Physician Decision|2|||
149755119|NCT00059215|540233840|FG002|Overall Study|Physician Decision|1|||
149755120|NCT00059215|540233841|FG003|Overall Study|Physician Decision|1|||
149755121|NCT04494633|540233847|FG000|Overall Study|Lost to Follow-up|5|||
149755122|NCT04494633|540233848|FG001|Overall Study|Lost to Follow-up|3|||
149755123|NCT04494633|540233847|FG000|Overall Study|Protocol Violation|1|||
149755124|NCT04494633|540233848|FG001|Overall Study|Protocol Violation|1|||
149755125|NCT04907539|540233849|FG000|Overall Study|Consent withdrawn|1|||
149755126|NCT04907539|540233850|FG001|Overall Study|Consent withdrawn|0|||
149755127|NCT04907539|540233849|FG000|Overall Study|Death|14|||
149755128|NCT04907539|540233850|FG001|Overall Study|Death|3|||
149755129|NCT02311478|540233853|FG000|Overall Study|Withdrawal by Subject|1|||
149755130|NCT02311478|540233853|FG000|Overall Study|Lost to Follow-up|5|||
149755131|NCT02311478|540233853|FG000|Overall Study|Failed IUD Insertion|1|||
149755132|NCT03276936|540233854|FG000|Overall Study|Adverse Event|4|||
149755133|NCT03276936|540233855|FG001|Overall Study|Adverse Event|2|||
149755134|NCT03276936|540233854|FG000|Overall Study|Lost to Follow-up|16|||
149755135|NCT03276936|540233855|FG001|Overall Study|Lost to Follow-up|13|||
149755136|NCT03276936|540233854|FG000|Overall Study|Withdrawal by Subject|30|||
149755137|NCT03276936|540233855|FG001|Overall Study|Withdrawal by Subject|20|||
149755138|NCT03276936|540233854|FG000|Overall Study|Not mentioned|6|||
149755139|NCT03276936|540233855|FG001|Overall Study|Not mentioned|3|||
149755140|NCT03041116|540233856|FG000|Double-blind|Death|0|||
149755141|NCT03041116|540233857|FG001|Double-blind|Death|2|||
149755142|NCT03041116|540233856|FG000|Double-blind|Withdrawal by Subject|0|||
149755143|NCT03041116|540233857|FG001|Double-blind|Withdrawal by Subject|4|||
149755144|NCT03041116|540233856|FG000|Open-label|Death|1|||
149755145|NCT03041116|540233857|FG001|Open-label|Death|0|||
149755146|NCT03041116|540233856|FG000|Open-label|Termination of the study by Sponsor|39|||
149755147|NCT03041116|540233857|FG001|Open-label|Termination of the study by Sponsor|37|||
149755148|NCT03041116|540233856|FG000|Open-label|Withdrawal by Subject|1|||
149755149|NCT03041116|540233857|FG001|Open-label|Withdrawal by Subject|0|||
149755150|NCT00943319|540233858|FG000|Overall Study|Death|1|||
149755151|NCT02043301|540233859|FG000|Overall Study|Discontinued|0|||
149755152|NCT02043301|540233860|FG001|Overall Study|Discontinued|1|||
149755153|NCT02043301|540233861|FG002|Overall Study|Discontinued|0|||
149755154|NCT02653976|540233862|FG000|Overall Study|Withdrawal by Subject|5|||
149755155|NCT02653976|540233862|FG000|Overall Study|Death|4|||
149755156|NCT02023164|540233863|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
149755157|NCT02023164|540233864|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
149755158|NCT02436577|540233865|FG000|Overall Study|Protocol Deviation|0|||
149755159|NCT02436577|540233866|FG001|Overall Study|Protocol Deviation|1|||
149755160|NCT02436577|540233867|FG002|Overall Study|Protocol Deviation|0|||
149755161|NCT02436577|540233868|FG003|Overall Study|Protocol Deviation|0|||
149755162|NCT02436577|540233869|FG004|Overall Study|Protocol Deviation|0|||
149755163|NCT02436577|540233870|FG005|Overall Study|Protocol Deviation|0|||
149755164|NCT03703375|540233871|FG000|Randomization Period|Withdrawal by Subject|0|||
149755165|NCT03703375|540233872|FG001|Randomization Period|Withdrawal by Subject|0|||
149755166|NCT03703375|540233873|FG002|Randomization Period|Withdrawal by Subject|0|||
149755167|NCT03703375|540233874|FG003|Randomization Period|Withdrawal by Subject|1|||
149755168|NCT03703375|540233871|FG000|Randomization Period|Completed safety run-in treatment|7|||
149755169|NCT03703375|540233872|FG001|Randomization Period|Completed safety run-in treatment|0|||
149755170|NCT03703375|540233873|FG002|Randomization Period|Completed safety run-in treatment|0|||
149755171|NCT03703375|540233874|FG003|Randomization Period|Completed safety run-in treatment|0|||
149755172|NCT03703375|540233871|FG000|Treatment Period|Other Reasons|0|||
149755173|NCT03703375|540233872|FG001|Treatment Period|Other Reasons|1|||
149755174|NCT03703375|540233873|FG002|Treatment Period|Other Reasons|0|||
149755175|NCT03703375|540233874|FG003|Treatment Period|Other Reasons|3|||
149755176|NCT03703375|540233871|FG000|Treatment Period|Consent Withdrawal|0|||
149755177|NCT03703375|540233872|FG001|Treatment Period|Consent Withdrawal|0|||
149755178|NCT03703375|540233873|FG002|Treatment Period|Consent Withdrawal|0|||
149755179|NCT03703375|540233874|FG003|Treatment Period|Consent Withdrawal|1|||
149755180|NCT03703375|540233871|FG000|Treatment Period|Death|1|||
149755181|NCT03703375|540233872|FG001|Treatment Period|Death|0|||
149755182|NCT03703375|540233873|FG002|Treatment Period|Death|1|||
149755183|NCT03703375|540233874|FG003|Treatment Period|Death|2|||
149755184|NCT03703375|540233871|FG000|Treatment Period|Toxicity of Study Treatment|2|||
149755185|NCT03703375|540233872|FG001|Treatment Period|Toxicity of Study Treatment|0|||
149755186|NCT03703375|540233873|FG002|Treatment Period|Toxicity of Study Treatment|4|||
149755187|NCT03703375|540233874|FG003|Treatment Period|Toxicity of Study Treatment|1|||
149755188|NCT03703375|540233871|FG000|Treatment Period|Progression|32|||
149755189|NCT03703375|540233872|FG001|Treatment Period|Progression|1|||
149755190|NCT03703375|540233873|FG002|Treatment Period|Progression|7|||
149755191|NCT03703375|540233874|FG003|Treatment Period|Progression|11|||
149755192|NCT03703375|540233871|FG000|Treatment Period|Completed treatment|7|||
149755193|NCT03703375|540233872|FG001|Treatment Period|Completed treatment|2|||
149755194|NCT03703375|540233873|FG002|Treatment Period|Completed treatment|0|||
149755195|NCT03703375|540233874|FG003|Treatment Period|Completed treatment|0|||
149755196|NCT01675011|540233875|FG000|Overall Study|Trial terminated by Sponsor|3|||
149755197|NCT01675011|540233876|FG001|Overall Study|Trial terminated by Sponsor|1|||
149755198|NCT00615290|540233877|FG000|Overall Study|Adverse Event|2|||
149755199|NCT00615290|540233877|FG000|Overall Study|Lost to Follow-up|3|||
149755200|NCT00615290|540233877|FG000|Overall Study|Withdrawal by Subject|1|||
149755201|NCT00615290|540233877|FG000|Overall Study|Other|2|||
149755202|NCT02849990|540233878|FG000|Overall Study|Adverse Event|1|||
149755203|NCT02849990|540233878|FG000|Overall Study|Withdrawal by Subject|1|||
149755204|NCT02531373|540233879|FG000|Overall Study|Lack of Efficacy|0|||
149755205|NCT02531373|540233880|FG001|Overall Study|Lack of Efficacy|0|||
149755206|NCT02531373|540233881|FG002|Overall Study|Lack of Efficacy|0|||
149755207|NCT02531373|540233882|FG003|Overall Study|Lack of Efficacy|0|||
149755208|NCT02531373|540233883|FG004|Overall Study|Lack of Efficacy|3|||
149755209|NCT02531373|540233884|FG005|Overall Study|Lack of Efficacy|2|||
149755210|NCT02531373|540233885|FG006|Overall Study|Lack of Efficacy|4|||
149755211|NCT02531373|540233886|FG007|Overall Study|Lack of Efficacy|8|||
149755212|NCT02531373|540233887|FG008|Overall Study|Lack of Efficacy|5|||
149755213|NCT02531373|540233879|FG000|Overall Study|Lost to Follow-up|0|||
149755214|NCT02531373|540233880|FG001|Overall Study|Lost to Follow-up|0|||
149755215|NCT02531373|540233881|FG002|Overall Study|Lost to Follow-up|0|||
149755216|NCT02531373|540233882|FG003|Overall Study|Lost to Follow-up|0|||
149755217|NCT02531373|540233883|FG004|Overall Study|Lost to Follow-up|0|||
149755218|NCT02531373|540233884|FG005|Overall Study|Lost to Follow-up|2|||
149755219|NCT02531373|540233885|FG006|Overall Study|Lost to Follow-up|2|||
149755220|NCT02531373|540233886|FG007|Overall Study|Lost to Follow-up|0|||
149755221|NCT02531373|540233887|FG008|Overall Study|Lost to Follow-up|0|||
149755222|NCT02531373|540233879|FG000|Overall Study|Physician Decision|0|||
149755223|NCT02531373|540233880|FG001|Overall Study|Physician Decision|0|||
149755224|NCT02531373|540233881|FG002|Overall Study|Physician Decision|0|||
149755225|NCT02531373|540233882|FG003|Overall Study|Physician Decision|0|||
149755226|NCT02531373|540233883|FG004|Overall Study|Physician Decision|2|||
149755227|NCT02531373|540233884|FG005|Overall Study|Physician Decision|1|||
149755228|NCT02531373|540233885|FG006|Overall Study|Physician Decision|0|||
149755229|NCT02531373|540233886|FG007|Overall Study|Physician Decision|0|||
149755230|NCT02531373|540233887|FG008|Overall Study|Physician Decision|0|||
149755231|NCT02531373|540233879|FG000|Overall Study|Protocol Violation|0|||
149755232|NCT02531373|540233880|FG001|Overall Study|Protocol Violation|0|||
149755233|NCT02531373|540233881|FG002|Overall Study|Protocol Violation|0|||
149755234|NCT02531373|540233882|FG003|Overall Study|Protocol Violation|0|||
149755235|NCT02531373|540233883|FG004|Overall Study|Protocol Violation|0|||
149755236|NCT02531373|540233884|FG005|Overall Study|Protocol Violation|1|||
149755237|NCT02531373|540233885|FG006|Overall Study|Protocol Violation|1|||
149755238|NCT02531373|540233886|FG007|Overall Study|Protocol Violation|0|||
149755239|NCT02531373|540233887|FG008|Overall Study|Protocol Violation|1|||
149755240|NCT02531373|540233879|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149755241|NCT02531373|540233880|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149755242|NCT02531373|540233881|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149755243|NCT02531373|540233882|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149755244|NCT02531373|540233883|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149755245|NCT02531373|540233884|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
149755246|NCT02531373|540233885|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
149755247|NCT02531373|540233886|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
149755248|NCT02531373|540233887|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
149755249|NCT02531373|540233879|FG000|Overall Study|Withdrawal by Subject|0|||
149755250|NCT02531373|540233880|FG001|Overall Study|Withdrawal by Subject|0|||
149755251|NCT02531373|540233881|FG002|Overall Study|Withdrawal by Subject|0|||
149755252|NCT02531373|540233882|FG003|Overall Study|Withdrawal by Subject|0|||
149755253|NCT02531373|540233883|FG004|Overall Study|Withdrawal by Subject|3|||
149755254|NCT02531373|540233884|FG005|Overall Study|Withdrawal by Subject|0|||
149755255|NCT02531373|540233885|FG006|Overall Study|Withdrawal by Subject|0|||
149755256|NCT02531373|540233886|FG007|Overall Study|Withdrawal by Subject|0|||
149755257|NCT02531373|540233887|FG008|Overall Study|Withdrawal by Subject|0|||
149755258|NCT01996319|540233889|FG000|Overall Study|Protocol Violation|1|||
149755259|NCT01996319|540233890|FG001|Overall Study|Protocol Violation|0|||
149755260|NCT01996319|540233889|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
149755261|NCT01996319|540233890|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
149755262|NCT01996319|540233889|FG000|Overall Study|Adverse Event|2|||
149755263|NCT01996319|540233890|FG001|Overall Study|Adverse Event|2|||
149755264|NCT00637273|540233891|FG000|Overall Study|Adverse Event|11|||
149755265|NCT00637273|540233892|FG001|Overall Study|Adverse Event|5|||
149755266|NCT00637273|540233893|FG002|Overall Study|Adverse Event|7|||
149755267|NCT00637273|540233891|FG000|Overall Study|Lost to Follow-up|8|||
149755268|NCT00637273|540233892|FG001|Overall Study|Lost to Follow-up|9|||
149755269|NCT00637273|540233893|FG002|Overall Study|Lost to Follow-up|13|||
149755270|NCT00637273|540233891|FG000|Overall Study|Protocol Violation|2|||
149755271|NCT00637273|540233892|FG001|Overall Study|Protocol Violation|4|||
149755272|NCT00637273|540233893|FG002|Overall Study|Protocol Violation|1|||
149755273|NCT00637273|540233891|FG000|Overall Study|Withdrawal of Consent|18|||
149755274|NCT00637273|540233892|FG001|Overall Study|Withdrawal of Consent|6|||
149755275|NCT00637273|540233893|FG002|Overall Study|Withdrawal of Consent|18|||
149755276|NCT00637273|540233891|FG000|Overall Study|Investigator Decision|1|||
149755277|NCT00637273|540233892|FG001|Overall Study|Investigator Decision|3|||
149755278|NCT00637273|540233893|FG002|Overall Study|Investigator Decision|1|||
149755279|NCT00637273|540233891|FG000|Overall Study|Administrative|2|||
149755280|NCT00637273|540233892|FG001|Overall Study|Administrative|0|||
149755281|NCT00637273|540233893|FG002|Overall Study|Administrative|0|||
149755282|NCT00637273|540233891|FG000|Overall Study|Loss of Glucose Control|1|||
149755283|NCT00637273|540233892|FG001|Overall Study|Loss of Glucose Control|1|||
149755284|NCT00637273|540233893|FG002|Overall Study|Loss of Glucose Control|1|||
149755285|NCT01702363|540233895|FG000|Overall Study|Adverse Event|14|||
149755286|NCT01702363|540233895|FG000|Overall Study|Lack of Efficacy|4|||
149755287|NCT01702363|540233895|FG000|Overall Study|Withdrawal by Subject|2|||
149755288|NCT00002663|540233896|FG000|Overall Study|Death|4|||
149755289|NCT00002663|540233897|FG001|Overall Study|Death|1|||
149755290|NCT00002663|540233898|FG002|Overall Study|Death|1|||
149755291|NCT00002663|540233899|FG003|Overall Study|Death|0|||
149755292|NCT00002663|540233900|FG004|Overall Study|Death|0|||
149755293|NCT00002663|540233901|FG005|Overall Study|Death|13|||
149755294|NCT00002663|540233902|FG006|Overall Study|Death|0|||
149755295|NCT00002663|540233903|FG007|Overall Study|Death|1|||
149755296|NCT00002663|540233904|FG008|Overall Study|Death|1|||
149755297|NCT00002663|540233905|FG009|Overall Study|Death|1|||
149755298|NCT00002663|540233896|FG000|Overall Study|Lost to Follow-up|3|||
149755299|NCT00002663|540233897|FG001|Overall Study|Lost to Follow-up|0|||
149755300|NCT00002663|540233898|FG002|Overall Study|Lost to Follow-up|0|||
149755301|NCT00002663|540233899|FG003|Overall Study|Lost to Follow-up|1|||
149755302|NCT00002663|540233900|FG004|Overall Study|Lost to Follow-up|0|||
149755303|NCT00002663|540233901|FG005|Overall Study|Lost to Follow-up|1|||
149755304|NCT00002663|540233902|FG006|Overall Study|Lost to Follow-up|0|||
149755305|NCT00002663|540233903|FG007|Overall Study|Lost to Follow-up|0|||
149755306|NCT00002663|540233904|FG008|Overall Study|Lost to Follow-up|0|||
149755307|NCT00002663|540233905|FG009|Overall Study|Lost to Follow-up|0|||
149755308|NCT00002663|540233896|FG000|Overall Study|Other|0|||
149755309|NCT00002663|540233897|FG001|Overall Study|Other|1|||
149755310|NCT00002663|540233898|FG002|Overall Study|Other|0|||
149755311|NCT00002663|540233899|FG003|Overall Study|Other|0|||
149755312|NCT00002663|540233900|FG004|Overall Study|Other|0|||
149755313|NCT00002663|540233901|FG005|Overall Study|Other|1|||
149755314|NCT00002663|540233902|FG006|Overall Study|Other|1|||
149755315|NCT00002663|540233903|FG007|Overall Study|Other|0|||
149755316|NCT00002663|540233904|FG008|Overall Study|Other|0|||
149755317|NCT00002663|540233905|FG009|Overall Study|Other|0|||
149755318|NCT00002663|540233896|FG000|Overall Study|Physician Decision|0|||
149755319|NCT00002663|540233897|FG001|Overall Study|Physician Decision|0|||
149755320|NCT00002663|540233898|FG002|Overall Study|Physician Decision|0|||
149755321|NCT00002663|540233899|FG003|Overall Study|Physician Decision|0|||
149755322|NCT00002663|540233900|FG004|Overall Study|Physician Decision|1|||
149755323|NCT00002663|540233901|FG005|Overall Study|Physician Decision|0|||
149755324|NCT00002663|540233902|FG006|Overall Study|Physician Decision|0|||
149755325|NCT00002663|540233903|FG007|Overall Study|Physician Decision|0|||
149755326|NCT00002663|540233904|FG008|Overall Study|Physician Decision|1|||
149755327|NCT00002663|540233905|FG009|Overall Study|Physician Decision|1|||
149755328|NCT00002663|540233896|FG000|Overall Study|Adverse Event|0|||
149755329|NCT00002663|540233897|FG001|Overall Study|Adverse Event|0|||
149755330|NCT00002663|540233898|FG002|Overall Study|Adverse Event|0|||
149755331|NCT00002663|540233899|FG003|Overall Study|Adverse Event|1|||
149755332|NCT00002663|540233900|FG004|Overall Study|Adverse Event|0|||
149755333|NCT00002663|540233901|FG005|Overall Study|Adverse Event|0|||
149755334|NCT00002663|540233902|FG006|Overall Study|Adverse Event|0|||
149755335|NCT00002663|540233903|FG007|Overall Study|Adverse Event|1|||
149755336|NCT00002663|540233904|FG008|Overall Study|Adverse Event|0|||
149755337|NCT00002663|540233905|FG009|Overall Study|Adverse Event|0|||
149755338|NCT00525148|540233909|FG000|Overall Study|Other Adverse Event|3|||
149755339|NCT00525148|540233910|FG001|Overall Study|Other Adverse Event|5|||
149755340|NCT00525148|540233911|FG002|Overall Study|Other Adverse Event|1|||
149755341|NCT00525148|540233912|FG003|Overall Study|Other Adverse Event|8|||
149755342|NCT00525148|540233909|FG000|Overall Study|Progressive disease|18|||
149755343|NCT00525148|540233910|FG001|Overall Study|Progressive disease|30|||
149755344|NCT00525148|540233911|FG002|Overall Study|Progressive disease|6|||
149755345|NCT00525148|540233912|FG003|Overall Study|Progressive disease|49|||
149755346|NCT00525148|540233909|FG000|Overall Study|Refused continuation of study medication|0|||
149755347|NCT00525148|540233910|FG001|Overall Study|Refused continuation of study medication|2|||
149755348|NCT00525148|540233911|FG002|Overall Study|Refused continuation of study medication|0|||
149755349|NCT00525148|540233912|FG003|Overall Study|Refused continuation of study medication|1|||
149755350|NCT00525148|540233909|FG000|Overall Study|Other than stated|2|||
149755351|NCT00525148|540233910|FG001|Overall Study|Other than stated|1|||
149755352|NCT00525148|540233911|FG002|Overall Study|Other than stated|0|||
149755353|NCT00525148|540233912|FG003|Overall Study|Other than stated|3|||
149755354|NCT03015610|540233913|FG000|Overall Study|Lost to Follow-up|1|||
149755355|NCT03015610|540233914|FG001|Overall Study|Lost to Follow-up|5|||
149755356|NCT01603641|540233915|FG000|Overall Study|Did not Receive Treatment|3|||
149755357|NCT01603641|540233915|FG000|Overall Study|Adverse Event|1|||
149755358|NCT01603641|540233915|FG000|Overall Study|Lack of Efficacy|1|||
149755359|NCT01603641|540233915|FG000|Overall Study|Lost to Follow-up|6|||
149755360|NCT01603641|540233915|FG000|Overall Study|Personal Reasons|18|||
149755361|NCT01603641|540233915|FG000|Overall Study|Other Miscellaneous Reasons|6|||
149755362|NCT00570739|540233916|FG000|Overall Study|Adverse Event|8|||
149755363|NCT00570739|540233917|FG001|Overall Study|Adverse Event|6|||
149755364|NCT00570739|540233918|FG002|Overall Study|Adverse Event|2|||
149755365|NCT00570739|540233919|FG003|Overall Study|Adverse Event|2|||
149755366|NCT00570739|540233916|FG000|Overall Study|Lost to Follow-up|4|||
149755367|NCT00570739|540233917|FG001|Overall Study|Lost to Follow-up|5|||
149755368|NCT00570739|540233918|FG002|Overall Study|Lost to Follow-up|4|||
149755369|NCT00570739|540233919|FG003|Overall Study|Lost to Follow-up|1|||
149755370|NCT00570739|540233916|FG000|Overall Study|Physician Decision|1|||
149755371|NCT00570739|540233917|FG001|Overall Study|Physician Decision|1|||
149755372|NCT00570739|540233918|FG002|Overall Study|Physician Decision|0|||
149755373|NCT00570739|540233919|FG003|Overall Study|Physician Decision|0|||
149755374|NCT00570739|540233916|FG000|Overall Study|Withdrawal by Subject|7|||
149755375|NCT00570739|540233917|FG001|Overall Study|Withdrawal by Subject|7|||
149755376|NCT00570739|540233918|FG002|Overall Study|Withdrawal by Subject|3|||
149755377|NCT00570739|540233919|FG003|Overall Study|Withdrawal by Subject|5|||
149755378|NCT00570739|540233916|FG000|Overall Study|Required restricted medication|0|||
149755379|NCT00570739|540233917|FG001|Overall Study|Required restricted medication|0|||
149755380|NCT00570739|540233918|FG002|Overall Study|Required restricted medication|1|||
149755381|NCT00570739|540233919|FG003|Overall Study|Required restricted medication|0|||
149755382|NCT00570739|540233916|FG000|Overall Study|Met discontinuation criteria|1|||
149755383|NCT00570739|540233917|FG001|Overall Study|Met discontinuation criteria|0|||
149755384|NCT00570739|540233918|FG002|Overall Study|Met discontinuation criteria|1|||
149755385|NCT00570739|540233919|FG003|Overall Study|Met discontinuation criteria|1|||
149755386|NCT00570739|540233916|FG000|Overall Study|Other|0|||
149755387|NCT00570739|540233917|FG001|Overall Study|Other|2|||
149755388|NCT00570739|540233918|FG002|Overall Study|Other|5|||
149755389|NCT00570739|540233919|FG003|Overall Study|Other|3|||
149755390|NCT01905397|540233924|FG000|Overall Study|Death|0|||
149755391|NCT01905397|540233925|FG001|Overall Study|Death|1|||
149755392|NCT01905397|540233924|FG000|Overall Study|Withdrawal by Subject|2|||
149755393|NCT01905397|540233925|FG001|Overall Study|Withdrawal by Subject|0|||
149755394|NCT01905397|540233924|FG000|Overall Study|Surgery canceled/aborted|9|||
149755395|NCT01905397|540233925|FG001|Overall Study|Surgery canceled/aborted|5|||
149755396|NCT01905397|540233924|FG000|Overall Study|Incision < 7 cm|2|||
149755397|NCT01905397|540233925|FG001|Overall Study|Incision < 7 cm|0|||
149755398|NCT01905397|540233924|FG000|Overall Study|Wrong treatment|1|||
149755399|NCT01905397|540233925|FG001|Overall Study|Wrong treatment|1|||
149755400|NCT01905397|540233924|FG000|Overall Study|Device not applied|3|||
149755401|NCT01905397|540233925|FG001|Overall Study|Device not applied|0|||
149755402|NCT01905397|540233924|FG000|Overall Study|Dressing not applied in operating room|1|||
149755403|NCT01905397|540233925|FG001|Overall Study|Dressing not applied in operating room|0|||
149755404|NCT01905397|540233924|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
149755405|NCT01905397|540233925|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
149755406|NCT01921270|540233926|FG000|Overall Study|Withdrawal by Subject|1|||
149755407|NCT00844428|540233927|FG000|Screening Period|Screen Failure|3|||
149755408|NCT00844428|540233927|FG000|Extension Treatment Period|Death|1|||
149755409|NCT00844428|540233927|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
149755410|NCT02680847|540233928|FG000|Overall Study|Other|2|||
149755411|NCT02680847|540233929|FG001|Overall Study|Other|0|||
149755412|NCT02680847|540233930|FG002|Overall Study|Other|0|||
149755413|NCT02680847|540233928|FG000|Overall Study|No longer met eligibility criteria|2|||
149755414|NCT02680847|540233929|FG001|Overall Study|No longer met eligibility criteria|2|||
149755415|NCT02680847|540233930|FG002|Overall Study|No longer met eligibility criteria|0|||
149755416|NCT02680847|540233928|FG000|Overall Study|Unwilling to participate in study|1|||
149755417|NCT02680847|540233929|FG001|Overall Study|Unwilling to participate in study|1|||
149755418|NCT02680847|540233930|FG002|Overall Study|Unwilling to participate in study|0|||
149755419|NCT02680847|540233928|FG000|Overall Study|Lack of Efficacy|0|||
149755420|NCT02680847|540233929|FG001|Overall Study|Lack of Efficacy|0|||
149755421|NCT02680847|540233930|FG002|Overall Study|Lack of Efficacy|2|||
149755422|NCT02680847|540233928|FG000|Overall Study|Adverse Event|0|||
149755423|NCT02680847|540233929|FG001|Overall Study|Adverse Event|0|||
149755424|NCT02680847|540233930|FG002|Overall Study|Adverse Event|1|||
149755425|NCT01096550|540233934|FG000|Overall Study|discontinued site|10|||
149755426|NCT01096550|540233935|FG001|Overall Study|discontinued site|11|||
149755427|NCT01096550|540233934|FG000|Overall Study|non-regular treatment track at clinic|1|||
149755428|NCT01096550|540233935|FG001|Overall Study|non-regular treatment track at clinic|1|||
149755429|NCT01096550|540233934|FG000|Overall Study|clinic readmission|1|||
149755430|NCT01096550|540233935|FG001|Overall Study|clinic readmission|1|||
149755431|NCT01096550|540233934|FG000|Overall Study|Withdrawal by Subject|0|||
149755432|NCT01096550|540233935|FG001|Overall Study|Withdrawal by Subject|1|||
149755433|NCT01096550|540233934|FG000|Overall Study|non-African American participant|13|||
149755434|NCT01096550|540233935|FG001|Overall Study|non-African American participant|6|||
149755435|NCT01096550|540233934|FG000|Overall Study|Lost to Follow-up|12|||
149755436|NCT01096550|540233935|FG001|Overall Study|Lost to Follow-up|9|||
149755437|NCT01345786|540233938|FG000|Overall Study|Adverse Event|0|||
149755438|NCT01345786|540233939|FG001|Overall Study|Adverse Event|1|||
149755439|NCT01345786|540233940|FG002|Overall Study|Adverse Event|3|||
149755440|NCT01345786|540233941|FG003|Overall Study|Adverse Event|1|||
149755441|NCT01345786|540233938|FG000|Overall Study|Subject withdrew consent|2|||
149755442|NCT01345786|540233939|FG001|Overall Study|Subject withdrew consent|2|||
149755443|NCT01345786|540233940|FG002|Overall Study|Subject withdrew consent|1|||
149755444|NCT01345786|540233941|FG003|Overall Study|Subject withdrew consent|0|||
149755445|NCT01345786|540233938|FG000|Overall Study|Noncompliance with protocol|1|||
149755446|NCT01345786|540233939|FG001|Overall Study|Noncompliance with protocol|0|||
149755447|NCT01345786|540233940|FG002|Overall Study|Noncompliance with protocol|1|||
149755448|NCT01345786|540233941|FG003|Overall Study|Noncompliance with protocol|0|||
149755449|NCT01345786|540233938|FG000|Overall Study|Administrative|3|||
149755450|NCT01345786|540233939|FG001|Overall Study|Administrative|5|||
149755451|NCT01345786|540233940|FG002|Overall Study|Administrative|0|||
149755452|NCT01345786|540233941|FG003|Overall Study|Administrative|0|||
149755453|NCT01345786|540233938|FG000|Overall Study|Lost to Follow-up|0|||
149755454|NCT01345786|540233939|FG001|Overall Study|Lost to Follow-up|0|||
149755455|NCT01345786|540233940|FG002|Overall Study|Lost to Follow-up|0|||
149755456|NCT01345786|540233941|FG003|Overall Study|Lost to Follow-up|2|||
149755457|NCT01605396|540233948|FG000|Overall Study|Adverse Event|5|||
149755458|NCT01605396|540233949|FG001|Overall Study|Adverse Event|3|||
149755459|NCT01605396|540233948|FG000|Overall Study|Lost to Follow-up|1|||
149755460|NCT01605396|540233949|FG001|Overall Study|Lost to Follow-up|0|||
149755461|NCT01605396|540233948|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149755462|NCT01605396|540233949|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149755463|NCT01605396|540233948|FG000|Overall Study|Physician Decision|2|||
149755464|NCT01605396|540233949|FG001|Overall Study|Physician Decision|2|||
149755465|NCT01605396|540233948|FG000|Overall Study|Progressive Disease|23|||
149755466|NCT01605396|540233949|FG001|Overall Study|Progressive Disease|27|||
149755467|NCT01605396|540233948|FG000|Overall Study|Withdrawal by Subject|4|||
149755468|NCT01605396|540233949|FG001|Overall Study|Withdrawal by Subject|2|||
149755469|NCT01605396|540233948|FG000|Overall Study|Transfer Off Study|4|||
149755470|NCT01605396|540233949|FG001|Overall Study|Transfer Off Study|5|||
149755471|NCT04598165|540233950|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
149755472|NCT04598165|540233951|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
149755473|NCT04598165|540233950|FG000|Completed 6-week Follow-up|Death|2|||
149755474|NCT04598165|540233951|FG001|Completed 6-week Follow-up|Death|1|||
149755475|NCT04598165|540233950|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
149755476|NCT04598165|540233951|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
149755477|NCT04598165|540233950|FG000|Completed 6-week Follow-up|Ineligible|4|||
149755478|NCT04598165|540233951|FG001|Completed 6-week Follow-up|Ineligible|3|||
149755479|NCT04598165|540233950|FG000|Completed 6-week Follow-up|Partner refusal|0|||
149755480|NCT04598165|540233951|FG001|Completed 6-week Follow-up|Partner refusal|1|||
149755481|NCT04598165|540233950|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
149755482|NCT04598165|540233951|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
149755483|NCT01323673|540233953|FG000|Overall Study|Adverse Event|0|||
149755484|NCT01323673|540233954|FG001|Overall Study|Adverse Event|1|||
149755485|NCT01323673|540233953|FG000|Overall Study|Lost to Follow-up|0|||
149755486|NCT01323673|540233954|FG001|Overall Study|Lost to Follow-up|1|||
149755487|NCT01323673|540233953|FG000|Overall Study|Protocol Violation|1|||
149755488|NCT01323673|540233954|FG001|Overall Study|Protocol Violation|0|||
149755489|NCT01323673|540233953|FG000|Overall Study|Withdrawal by Subject|2|||
149755490|NCT01323673|540233954|FG001|Overall Study|Withdrawal by Subject|3|||
149755491|NCT04400318|540236115|FG000|Overall Study|Adverse Event|1|||
149755492|NCT04400318|540236116|FG001|Overall Study|Adverse Event|0|||
149755493|NCT04400318|540236115|FG000|Overall Study|Withdrawal by Subject|1|||
149755494|NCT04400318|540236116|FG001|Overall Study|Withdrawal by Subject|1|||
149755495|NCT04400318|540236115|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
149755496|NCT04400318|540236116|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
149755497|NCT00953043|540236122|FG000|Overall Study|Withdrawal by Subject|4|||
149755498|NCT00953043|540236123|FG001|Overall Study|Withdrawal by Subject|0|||
149755499|NCT00953043|540236122|FG000|Overall Study|Physician Decision|0|||
149755500|NCT00953043|540236123|FG001|Overall Study|Physician Decision|2|||
149755501|NCT00747617|540236125|FG000|Overall Study|Lost to Follow-up|3|||
149755502|NCT00747617|540236126|FG001|Overall Study|Lost to Follow-up|1|||
149755503|NCT03509207|540236127|FG000|Overall Study|Death|2|||
149755504|NCT04657016|540236128|FG000|Overall Study|Adverse Event|2|||
149755505|NCT04657016|540236129|FG001|Overall Study|Adverse Event|4|||
149755506|NCT04657016|540236128|FG000|Overall Study|Death|1|||
149755507|NCT04657016|540236129|FG001|Overall Study|Death|1|||
149755508|NCT04657016|540236128|FG000|Overall Study|Lost to Follow-up|24|||
149755509|NCT04657016|540236129|FG001|Overall Study|Lost to Follow-up|12|||
149755510|NCT04657016|540236128|FG000|Overall Study|Physician Decision|1|||
149755511|NCT04657016|540236129|FG001|Overall Study|Physician Decision|2|||
149755512|NCT04657016|540236128|FG000|Overall Study|Pregnancy|2|||
149755513|NCT04657016|540236129|FG001|Overall Study|Pregnancy|2|||
149755514|NCT04657016|540236128|FG000|Overall Study|Protocol Deviation|1|||
149755515|NCT04657016|540236129|FG001|Overall Study|Protocol Deviation|0|||
149755516|NCT04657016|540236128|FG000|Overall Study|Withdrawal by Subject|28|||
149755517|NCT04657016|540236129|FG001|Overall Study|Withdrawal by Subject|14|||
149755518|NCT04657016|540236128|FG000|Overall Study|Other - as reported by the investigator|6|||
149755519|NCT04657016|540236129|FG001|Overall Study|Other - as reported by the investigator|0|||
149755520|NCT00523341|540236135|FG000|Overall Study|Withdrawal by Subject|399|||
149755521|NCT00523341|540236136|FG001|Overall Study|Withdrawal by Subject|427|||
149755522|NCT00523341|540236135|FG000|Overall Study|Other|181|||
149755523|NCT00523341|540236136|FG001|Overall Study|Other|198|||
149755524|NCT00523341|540236135|FG000|Overall Study|Adverse Event|122|||
149755525|NCT00523341|540236136|FG001|Overall Study|Adverse Event|155|||
149755526|NCT00523341|540236135|FG000|Overall Study|Death|101|||
149755527|NCT00523341|540236136|FG001|Overall Study|Death|110|||
149755528|NCT00523341|540236135|FG000|Overall Study|Lost to Follow-up|73|||
149755529|NCT00523341|540236136|FG001|Overall Study|Lost to Follow-up|61|||
149755530|NCT00523341|540236135|FG000|Overall Study|Non-compliance|20|||
149755531|NCT00523341|540236136|FG001|Overall Study|Non-compliance|13|||
149755532|NCT00523341|540236135|FG000|Overall Study|Physician Decision|14|||
149755533|NCT00523341|540236136|FG001|Overall Study|Physician Decision|13|||
149755534|NCT00523341|540236135|FG000|Overall Study|Requirement for Alternative Therapy|4|||
149755535|NCT00523341|540236136|FG001|Overall Study|Requirement for Alternative Therapy|14|||
149755536|NCT00523341|540236135|FG000|Overall Study|Protocol Deviation|6|||
149755537|NCT00523341|540236136|FG001|Overall Study|Protocol Deviation|5|||
149755538|NCT00523341|540236135|FG000|Overall Study|Ineligibility Determined|3|||
149755539|NCT00523341|540236136|FG001|Overall Study|Ineligibility Determined|4|||
149755540|NCT00523341|540236135|FG000|Overall Study|Disease Progression|1|||
149755541|NCT00523341|540236136|FG001|Overall Study|Disease Progression|0|||
149755542|NCT01356602|540236137|FG000|Overall Study|Protocol Deviation|0|||
149755543|NCT01356602|540236138|FG001|Overall Study|Protocol Deviation|1|||
149755544|NCT01356602|540236139|FG002|Overall Study|Protocol Deviation|1|||
149755545|NCT01356602|540236137|FG000|Overall Study|Administrative Problems|1|||
149755546|NCT01356602|540236138|FG001|Overall Study|Administrative Problems|4|||
149755547|NCT01356602|540236139|FG002|Overall Study|Administrative Problems|5|||
149755548|NCT01356602|540236137|FG000|Overall Study|Lost to Follow-up|4|||
149755549|NCT01356602|540236138|FG001|Overall Study|Lost to Follow-up|5|||
149755550|NCT01356602|540236139|FG002|Overall Study|Lost to Follow-up|6|||
149755551|NCT01356602|540236137|FG000|Overall Study|Withdrawal by Subject|4|||
149755552|NCT01356602|540236138|FG001|Overall Study|Withdrawal by Subject|3|||
149755553|NCT01356602|540236139|FG002|Overall Study|Withdrawal by Subject|7|||
149755554|NCT01356602|540236137|FG000|Overall Study|Lack of Efficacy|0|||
149755555|NCT01356602|540236138|FG001|Overall Study|Lack of Efficacy|1|||
149755556|NCT01356602|540236139|FG002|Overall Study|Lack of Efficacy|4|||
149755557|NCT01356602|540236137|FG000|Overall Study|Adverse Event|0|||
149755558|NCT01356602|540236138|FG001|Overall Study|Adverse Event|1|||
149755559|NCT01356602|540236139|FG002|Overall Study|Adverse Event|1|||
149755560|NCT01605071|540236140|FG000|Overall Study|Withdrawal by Subject|3|||
149755561|NCT01605071|540236141|FG001|Overall Study|Withdrawal by Subject|2|||
149755562|NCT01931462|540236142|FG000|Overall Study|Withdrawal by Subject|1|||
149755563|NCT00051558|540236143|FG000|Overall Study|Adverse Event|30|||
149755564|NCT00051558|540236144|FG001|Overall Study|Adverse Event|18|||
149755565|NCT00051558|540236143|FG000|Overall Study|Withdrawal by Subject|29|||
149755566|NCT00051558|540236144|FG001|Overall Study|Withdrawal by Subject|42|||
149755567|NCT00051558|540236143|FG000|Overall Study|Death|9|||
149755568|NCT00051558|540236144|FG001|Overall Study|Death|15|||
149755569|NCT00051558|540236143|FG000|Overall Study|Lost to Follow-up|4|||
149755570|NCT00051558|540236144|FG001|Overall Study|Lost to Follow-up|13|||
149755571|NCT00051558|540236143|FG000|Overall Study|Protocol Violation|3|||
149755572|NCT00051558|540236144|FG001|Overall Study|Protocol Violation|4|||
149755573|NCT00051558|540236143|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
149755574|NCT00051558|540236144|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
149755575|NCT00051558|540236143|FG000|Overall Study|Sponsor Decision|6|||
149755576|NCT00051558|540236144|FG001|Overall Study|Sponsor Decision|1|||
149755577|NCT00051558|540236143|FG000|Overall Study|Other|2|||
149755578|NCT00051558|540236144|FG001|Overall Study|Other|1|||
149755579|NCT00051558|540236143|FG000|Overall Study|Significant Lab Value|2|||
149755580|NCT00051558|540236144|FG001|Overall Study|Significant Lab Value|0|||
149755581|NCT00051558|540236143|FG000|Overall Study|Physician Decision|5|||
149755582|NCT00051558|540236144|FG001|Overall Study|Physician Decision|0|||
149755583|NCT01881620|540236147|FG000|Overall Study|Protocol Violation|4|||
149755584|NCT01808118|540236150|FG000|Period 1|Adverse Event|15|||
149755585|NCT01808118|540236151|FG001|Period 1|Adverse Event|0|||
149755586|NCT01808118|540236152|FG002|Period 1|Adverse Event|0|||
149755587|NCT01808118|540236150|FG000|Period 1|Withdrew consent|24|||
149755588|NCT01808118|540236151|FG001|Period 1|Withdrew consent|0|||
149755589|NCT01808118|540236152|FG002|Period 1|Withdrew consent|0|||
149755590|NCT01808118|540236150|FG000|Period 1|Lost to Follow-up|9|||
149755591|NCT01808118|540236151|FG001|Period 1|Lost to Follow-up|0|||
149755592|NCT01808118|540236152|FG002|Period 1|Lost to Follow-up|0|||
149755593|NCT01808118|540236150|FG000|Period 1|Did not meet criteria for remission|303|||
149755594|NCT01808118|540236151|FG001|Period 1|Did not meet criteria for remission|0|||
149755595|NCT01808118|540236152|FG002|Period 1|Did not meet criteria for remission|0|||
149755596|NCT01808118|540236150|FG000|Period 1|Enrolled in error|7|||
149755597|NCT01808118|540236151|FG001|Period 1|Enrolled in error|0|||
149755598|NCT01808118|540236152|FG002|Period 1|Enrolled in error|0|||
149755599|NCT01808118|540236150|FG000|Period 1|Did not meet inclusion criteria|3|||
149755600|NCT01808118|540236151|FG001|Period 1|Did not meet inclusion criteria|0|||
149755601|NCT01808118|540236152|FG002|Period 1|Did not meet inclusion criteria|0|||
149755602|NCT01808118|540236150|FG000|Period 1|Non-conformance with inclusion criteria|3|||
149755603|NCT01808118|540236151|FG001|Period 1|Non-conformance with inclusion criteria|0|||
149755604|NCT01808118|540236152|FG002|Period 1|Non-conformance with inclusion criteria|0|||
149755605|NCT01808118|540236150|FG000|Period 1|Investigator decision: site closure|2|||
149755606|NCT01808118|540236151|FG001|Period 1|Investigator decision: site closure|0|||
149755607|NCT01808118|540236152|FG002|Period 1|Investigator decision: site closure|0|||
149755608|NCT01808118|540236150|FG000|Period 1|Non-compliance per sponsor|1|||
149755609|NCT01808118|540236151|FG001|Period 1|Non-compliance per sponsor|0|||
149755610|NCT01808118|540236152|FG002|Period 1|Non-compliance per sponsor|0|||
149755611|NCT01808118|540236150|FG000|Period 1|Lack of Efficacy|1|||
149755612|NCT01808118|540236151|FG001|Period 1|Lack of Efficacy|0|||
149755613|NCT01808118|540236152|FG002|Period 1|Lack of Efficacy|0|||
149755614|NCT01808118|540236150|FG000|Period 2|Adverse Event|0|||
149755615|NCT01808118|540236151|FG001|Period 2|Adverse Event|4|||
149755616|NCT01808118|540236152|FG002|Period 2|Adverse Event|0|||
149755617|NCT01808118|540236150|FG000|Period 2|Withdrew consent|0|||
149755618|NCT01808118|540236151|FG001|Period 2|Withdrew consent|7|||
149755619|NCT01808118|540236152|FG002|Period 2|Withdrew consent|6|||
149755620|NCT01808118|540236150|FG000|Period 2|Lost to Follow-up|0|||
149755621|NCT01808118|540236151|FG001|Period 2|Lost to Follow-up|0|||
149755622|NCT01808118|540236152|FG002|Period 2|Lost to Follow-up|2|||
149755623|NCT01808118|540236150|FG000|Period 2|Investigator no longer conducting trials|0|||
149755624|NCT01808118|540236151|FG001|Period 2|Investigator no longer conducting trials|1|||
149755625|NCT01808118|540236152|FG002|Period 2|Investigator no longer conducting trials|0|||
149755626|NCT01808118|540236150|FG000|Period 2|Switched to other therapy|0|||
149755627|NCT01808118|540236151|FG001|Period 2|Switched to other therapy|1|||
149755628|NCT01808118|540236152|FG002|Period 2|Switched to other therapy|0|||
149755629|NCT00414310|540236153|FG000|Overall Study|Not treated|1|||
149755630|NCT00414310|540236154|FG001|Overall Study|Not treated|0|||
149755631|NCT01701583|540236161|FG000|Overall Study|Withdrawal by Subject|2|||
149755632|NCT01701583|540236162|FG001|Overall Study|Withdrawal by Subject|0|||
149755633|NCT01441440|540236163|FG000|Overall Study|Death|1|||
149755634|NCT01441440|540236164|FG001|Overall Study|Death|0|||
149755635|NCT01441440|540236165|FG002|Overall Study|Death|1|||
149755636|NCT01441440|540236163|FG000|Overall Study|Adverse Event|2|||
149755637|NCT01441440|540236164|FG001|Overall Study|Adverse Event|9|||
149755638|NCT01441440|540236165|FG002|Overall Study|Adverse Event|9|||
149755639|NCT01441440|540236163|FG000|Overall Study|Lost to Follow-up|0|||
149755640|NCT01441440|540236164|FG001|Overall Study|Lost to Follow-up|2|||
149755641|NCT01441440|540236165|FG002|Overall Study|Lost to Follow-up|1|||
149755642|NCT01441440|540236163|FG000|Overall Study|Withdrawal by Subject|11|||
149755643|NCT01441440|540236164|FG001|Overall Study|Withdrawal by Subject|9|||
149755644|NCT01441440|540236165|FG002|Overall Study|Withdrawal by Subject|9|||
149755645|NCT01441440|540236163|FG000|Overall Study|Pregnancy|1|||
149755646|NCT01441440|540236164|FG001|Overall Study|Pregnancy|0|||
149755647|NCT01441440|540236165|FG002|Overall Study|Pregnancy|0|||
149755648|NCT01441440|540236163|FG000|Overall Study|Lack of Efficacy|1|||
149755649|NCT01441440|540236164|FG001|Overall Study|Lack of Efficacy|0|||
149755650|NCT01441440|540236165|FG002|Overall Study|Lack of Efficacy|1|||
149755651|NCT01441440|540236163|FG000|Overall Study|Moving|0|||
149755652|NCT01441440|540236164|FG001|Overall Study|Moving|1|||
149755653|NCT01441440|540236165|FG002|Overall Study|Moving|1|||
149755654|NCT01441440|540236163|FG000|Overall Study|Work-related matter|0|||
149755655|NCT01441440|540236164|FG001|Overall Study|Work-related matter|1|||
149755656|NCT01441440|540236165|FG002|Overall Study|Work-related matter|0|||
149755657|NCT01441440|540236163|FG000|Overall Study|Difficllty in keeping the schedule|1|||
149755658|NCT01441440|540236164|FG001|Overall Study|Difficllty in keeping the schedule|1|||
149755659|NCT01441440|540236165|FG002|Overall Study|Difficllty in keeping the schedule|0|||
149755660|NCT01993329|540236166|FG000|Period 2|Adverse Event|0|||
149755661|NCT01993329|540236167|FG001|Period 2|Adverse Event|0|||
149755662|NCT01993329|540236168|FG002|Period 2|Adverse Event|0|||
149755663|NCT01993329|540236169|FG003|Period 2|Adverse Event|0|||
149755664|NCT01993329|540236170|FG004|Period 2|Adverse Event|0|||
149755665|NCT01993329|540236171|FG005|Period 2|Adverse Event|1|||
149755666|NCT01993329|540236166|FG000|Wash-out|Personal reasons|0|||
149755667|NCT01993329|540236167|FG001|Wash-out|Personal reasons|1|||
149755668|NCT01993329|540236168|FG002|Wash-out|Personal reasons|0|||
149755669|NCT01993329|540236169|FG003|Wash-out|Personal reasons|0|||
149755670|NCT01993329|540236170|FG004|Wash-out|Personal reasons|0|||
149755671|NCT01993329|540236171|FG005|Wash-out|Personal reasons|0|||
149755672|NCT05070429|540236172|FG000|Overall Study|Death|0|||
149755673|NCT05070429|540236173|FG001|Overall Study|Death|4|||
149755674|NCT05070429|540236172|FG000|Overall Study|Withdrawal by Subject|2|||
149755675|NCT05070429|540236173|FG001|Overall Study|Withdrawal by Subject|1|||
149755676|NCT05070429|540236172|FG000|Overall Study|Other|15|||
149755677|NCT05070429|540236173|FG001|Overall Study|Other|5|||
149755678|NCT03097328|540236174|FG000|Overall Study|Still on Therapy|2|||
149755679|NCT03097328|540236174|FG000|Overall Study|Progressive Disease|29|||
149755680|NCT03097328|540236174|FG000|Overall Study|Adverse Event|4|||
149755681|NCT03097328|540236174|FG000|Overall Study|Withdrawal by Subject|1|||
149755682|NCT03097328|540236174|FG000|Overall Study|Physician Decision|1|||
149755683|NCT03097328|540236174|FG000|Overall Study|Patient Decision|1|||
149755684|NCT03097328|540236174|FG000|Overall Study|Ineligible for Study Drug|1|||
149755685|NCT01798134|540236175|FG000|Overall Study|Lost to Follow-up|1|||
149755686|NCT01798134|540236175|FG000|Overall Study|Withdrawal by Subject|3|||
149755687|NCT01798134|540236175|FG000|Overall Study|Death|2|||
149755688|NCT01798134|540236175|FG000|Overall Study|Adverse Event|3|||
149755689|NCT01798134|540236175|FG000|Overall Study|Physician Decision|3|||
149755690|NCT01798134|540236175|FG000|Overall Study|Liver transplant/surgery|4|||
149755691|NCT00366548|540236176|FG000|Infant Series|Adverse Event|1|||
149755692|NCT00366548|540236177|FG001|Infant Series|Adverse Event|3|||
149755693|NCT00366548|540236176|FG000|Infant Series|Protocol Violation|0|||
149755694|NCT00366548|540236177|FG001|Infant Series|Protocol Violation|1|||
149755695|NCT00366548|540236176|FG000|Infant Series|Withdrawal by Subject|3|||
149755696|NCT00366548|540236177|FG001|Infant Series|Withdrawal by Subject|1|||
149755697|NCT00366548|540236176|FG000|After Infant Series|Withdrawal by Subject|3|||
149755698|NCT00366548|540236177|FG001|After Infant Series|Withdrawal by Subject|1|||
149755699|NCT00366548|540236176|FG000|After Infant Series|Adverse Event|2|||
149755700|NCT00366548|540236177|FG001|After Infant Series|Adverse Event|0|||
149755701|NCT00366548|540236176|FG000|After Infant Series|Lost to Follow-up|1|||
149755702|NCT00366548|540236177|FG001|After Infant Series|Lost to Follow-up|0|||
149755703|NCT01252134|540236178|FG000|Period 1, 8 Hours|Personal Reasons|0|||
149755704|NCT01252134|540236179|FG001|Period 1, 8 Hours|Personal Reasons|1|||
149755705|NCT01252134|540236180|FG002|Period 1, 8 Hours|Personal Reasons|1|||
149755706|NCT01252134|540236181|FG003|Period 1, 8 Hours|Personal Reasons|0|||
149755707|NCT01252134|540236182|FG004|Period 1, 8 Hours|Personal Reasons|0|||
149755708|NCT01252134|540236183|FG005|Period 1, 8 Hours|Personal Reasons|0|||
149755709|NCT02678741|540236184|FG000|Overall Study|Death|4|||
149755710|NCT02678741|540236184|FG000|Overall Study|Withdrawal by Subject|1|||
149755711|NCT02678741|540236184|FG000|Overall Study|ineligible|3|||
149755712|NCT02678741|540236184|FG000|Overall Study|Not RECIST Measurable|2|||
149755713|NCT02678741|540236184|FG000|Overall Study|Lack of Efficacy|10|||
149755714|NCT01795898|540236185|FG000|Overall Study|Adverse Event|27|||
149755715|NCT01795898|540236185|FG000|Overall Study|Lost to Follow-up|20|||
149755716|NCT01795898|540236185|FG000|Overall Study|Withdrawal of consent|6|||
149755717|NCT01795898|540236185|FG000|Overall Study|Diagnosed with metastasis|1|||
149755718|NCT01795898|540236185|FG000|Overall Study|No pain|1|||
149755719|NCT01795898|540236185|FG000|Overall Study|Death|1|||
149755720|NCT01795898|540236185|FG000|Overall Study|Withdrew consent & had adverse events|3|||
149755721|NCT01795898|540236185|FG000|Overall Study|Physician Decision|1|||
149755722|NCT01984346|540236193|FG000|Overall Study|Physician Decision|4|||
149755723|NCT01984346|540236194|FG001|Overall Study|Physician Decision|2|||
149755724|NCT01984346|540236193|FG000|Overall Study|Withdrawal by Subject|2|||
149755725|NCT01984346|540236194|FG001|Overall Study|Withdrawal by Subject|2|||
149755726|NCT01984346|540236193|FG000|Overall Study|Enrollment Closed|8|||
149755727|NCT01984346|540236194|FG001|Overall Study|Enrollment Closed|1|||
149755728|NCT01984346|540236193|FG000|Overall Study|Insurance Coverage|1|||
149755729|NCT01984346|540236194|FG001|Overall Study|Insurance Coverage|0|||
149755730|NCT01984346|540236193|FG000|Overall Study|Intra-operative Exclusion|2|||
149755731|NCT01984346|540236194|FG001|Overall Study|Intra-operative Exclusion|0|||
149755732|NCT00372190|540236199|FG000|Overall Study|Lost to Follow-up|3|||
149755733|NCT00372190|540236200|FG001|Overall Study|Lost to Follow-up|1|||
149755734|NCT01623531|540236201|FG000|Overall Study|Death|1|||
149755735|NCT01623531|540236202|FG001|Overall Study|Death|0|||
149755736|NCT01623531|540236201|FG000|Overall Study|Protocol Violation|2|||
149755737|NCT01623531|540236202|FG001|Overall Study|Protocol Violation|1|||
149755738|NCT01623531|540236201|FG000|Overall Study|Missing data at primary outcome time poi|1|||
149755739|NCT01623531|540236202|FG001|Overall Study|Missing data at primary outcome time poi|1|||
149755740|NCT00623467|540236203|FG000|Overall Study|Lost to Follow-up|1|||
149755741|NCT00623467|540236203|FG000|Overall Study|Protocol Violation|4|||
149755742|NCT00623467|540236203|FG000|Overall Study|Withdrawal by Subject|2|||
149755743|NCT02834403|540236212|FG000|Overall Study|Physician Decision|2|||
149755744|NCT02834403|540236213|FG001|Overall Study|Physician Decision|1|||
149755745|NCT02834403|540236214|FG002|Overall Study|Physician Decision|2|||
149755746|NCT02834403|540236215|FG003|Overall Study|Physician Decision|1|||
149755747|NCT02834403|540236216|FG004|Overall Study|Physician Decision|1|||
149755748|NCT02834403|540236217|FG005|Overall Study|Physician Decision|2|||
149755749|NCT02834403|540236218|FG006|Overall Study|Physician Decision|12|||
149755750|NCT02834403|540236212|FG000|Overall Study|Adverse Event|0|||
149755751|NCT02834403|540236213|FG001|Overall Study|Adverse Event|0|||
149755752|NCT02834403|540236214|FG002|Overall Study|Adverse Event|0|||
149755753|NCT02834403|540236215|FG003|Overall Study|Adverse Event|0|||
149755754|NCT02834403|540236216|FG004|Overall Study|Adverse Event|1|||
149755755|NCT02834403|540236217|FG005|Overall Study|Adverse Event|1|||
149755756|NCT02834403|540236218|FG006|Overall Study|Adverse Event|3|||
149755757|NCT02834403|540236212|FG000|Overall Study|Withdrawal by Subject|0|||
149755758|NCT02834403|540236213|FG001|Overall Study|Withdrawal by Subject|1|||
149755759|NCT02834403|540236214|FG002|Overall Study|Withdrawal by Subject|0|||
149755760|NCT02834403|540236215|FG003|Overall Study|Withdrawal by Subject|0|||
149755761|NCT02834403|540236216|FG004|Overall Study|Withdrawal by Subject|1|||
149755762|NCT02834403|540236217|FG005|Overall Study|Withdrawal by Subject|0|||
149755763|NCT02834403|540236218|FG006|Overall Study|Withdrawal by Subject|0|||
149755764|NCT02834403|540236212|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
149755765|NCT02834403|540236213|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
149755766|NCT02834403|540236214|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
149755767|NCT02834403|540236215|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
149755768|NCT02834403|540236216|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
149755769|NCT02834403|540236217|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
149755770|NCT02834403|540236218|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
149755771|NCT02341014|540236219|FG000|Overall Study|Adverse Event|0|||
149755772|NCT02341014|540236220|FG001|Overall Study|Adverse Event|1|||
149755773|NCT02341014|540236221|FG002|Overall Study|Adverse Event|0|||
149755774|NCT02341014|540236222|FG003|Overall Study|Adverse Event|0|||
149755775|NCT02341014|540236223|FG004|Overall Study|Adverse Event|2|||
149755776|NCT04705597|540236224|FG000|Overall Study|Death|16|||
149755777|NCT04705597|540236225|FG001|Overall Study|Death|9|||
149755778|NCT04705597|540236224|FG000|Overall Study|Lost to Follow-up|1|||
149755779|NCT04705597|540236225|FG001|Overall Study|Lost to Follow-up|0|||
149755780|NCT04705597|540236224|FG000|Overall Study|Withdrawal by Subject|1|||
149755781|NCT04705597|540236225|FG001|Overall Study|Withdrawal by Subject|2|||
149755782|NCT00390780|540236235|FG000|Overall Study|Not completed|10|||
149755783|NCT00390780|540236236|FG001|Overall Study|Not completed|4|||
149755784|NCT00390780|540236235|FG000|Overall Study|Protocol Violation|6|||
149755785|NCT00390780|540236236|FG001|Overall Study|Protocol Violation|4|||
149755786|NCT00390780|540236235|FG000|Overall Study|Lost to Follow-up|3|||
149755787|NCT00390780|540236236|FG001|Overall Study|Lost to Follow-up|6|||
149755788|NCT00390780|540236235|FG000|Overall Study|Adverse Event|2|||
149755789|NCT00390780|540236236|FG001|Overall Study|Adverse Event|3|||
149755790|NCT00390780|540236235|FG000|Overall Study|Death|1|||
149755791|NCT00390780|540236236|FG001|Overall Study|Death|3|||
149755792|NCT00390780|540236235|FG000|Overall Study|Withdrawal by Subject|1|||
149755793|NCT00390780|540236236|FG001|Overall Study|Withdrawal by Subject|2|||
149755794|NCT00390780|540236235|FG000|Overall Study|Inclusion criteria not satisfied|0|||
149755795|NCT00390780|540236236|FG001|Overall Study|Inclusion criteria not satisfied|2|||
149755796|NCT00390780|540236235|FG000|Overall Study|Lost to follow up and other reasons|0|||
149755797|NCT00390780|540236236|FG001|Overall Study|Lost to follow up and other reasons|1|||
149755798|NCT00390780|540236235|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
149755799|NCT00390780|540236236|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
149755800|NCT00390780|540236235|FG000|Overall Study|SAE, death|0|||
149755801|NCT00390780|540236236|FG001|Overall Study|SAE, death|1|||
149755802|NCT00273858|540236237|FG000|Overall Study|Not completed 24 month observation time|334|||
149755803|NCT00273858|540236237|FG000|Overall Study|Lost to Follow-up|101|||
149755804|NCT00273858|540236237|FG000|Overall Study|Withdrawal by Subject|21|||
149755805|NCT00273858|540236237|FG000|Overall Study|Adverse Event|81|||
149755806|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
149755807|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
149755808|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
149755809|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
149755810|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
149755811|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
149755812|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
149755813|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
149755814|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
149755815|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
149755816|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
149755817|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
149755818|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
149755819|NCT02232516|540236242|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
149755820|NCT02232516|540236242|FG000|Survival Follow-up|Death|15|||
149755821|NCT02232516|540236242|FG000|Survival Follow-up|Withdrawal by Subject|3|||
149755822|NCT02232516|540236242|FG000|Survival Follow-up|Lost to Follow-up|1|||
149755823|NCT02232516|540236242|FG000|Survival Follow-up|Still in follow-up|5|||
149755824|NCT01070550|540236244|FG000|Overall Study|Adverse Event|43|||
149755825|NCT01070550|540236245|FG001|Overall Study|Adverse Event|1|||
149755826|NCT01070550|540236246|FG002|Overall Study|Adverse Event|3|||
149755827|NCT01070550|540236247|FG003|Overall Study|Adverse Event|0|||
149755828|NCT01070550|540236248|FG004|Overall Study|Adverse Event|0|||
149755829|NCT01070550|540236249|FG005|Overall Study|Adverse Event|0|||
149755830|NCT01070550|540236244|FG000|Overall Study|Death|20|||
149755831|NCT01070550|540236245|FG001|Overall Study|Death|4|||
149755832|NCT01070550|540236246|FG002|Overall Study|Death|3|||
149755833|NCT01070550|540236247|FG003|Overall Study|Death|0|||
149755834|NCT01070550|540236248|FG004|Overall Study|Death|0|||
149755835|NCT01070550|540236249|FG005|Overall Study|Death|0|||
149755836|NCT01070550|540236244|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
149755837|NCT01070550|540236245|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149755838|NCT01070550|540236246|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149755839|NCT01070550|540236247|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149755840|NCT01070550|540236248|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149755841|NCT01070550|540236249|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149755842|NCT01070550|540236244|FG000|Overall Study|Early termination|3|||
149755843|NCT01070550|540236245|FG001|Overall Study|Early termination|0|||
149755844|NCT01070550|540236246|FG002|Overall Study|Early termination|0|||
149755845|NCT01070550|540236247|FG003|Overall Study|Early termination|0|||
149755846|NCT01070550|540236248|FG004|Overall Study|Early termination|0|||
149755847|NCT01070550|540236249|FG005|Overall Study|Early termination|0|||
149755848|NCT01070550|540236244|FG000|Overall Study|Failed to return|450|||
149755849|NCT01070550|540236245|FG001|Overall Study|Failed to return|33|||
149755850|NCT01070550|540236246|FG002|Overall Study|Failed to return|144|||
149755851|NCT01070550|540236247|FG003|Overall Study|Failed to return|40|||
149755852|NCT01070550|540236248|FG004|Overall Study|Failed to return|1|||
149755853|NCT01070550|540236249|FG005|Overall Study|Failed to return|2|||
149755854|NCT01070550|540236244|FG000|Overall Study|Incomplete treatment|2|||
149755855|NCT01070550|540236245|FG001|Overall Study|Incomplete treatment|0|||
149755856|NCT01070550|540236246|FG002|Overall Study|Incomplete treatment|0|||
149755857|NCT01070550|540236247|FG003|Overall Study|Incomplete treatment|0|||
149755858|NCT01070550|540236248|FG004|Overall Study|Incomplete treatment|0|||
149755859|NCT01070550|540236249|FG005|Overall Study|Incomplete treatment|0|||
149755860|NCT01070550|540236244|FG000|Overall Study|Lab test not done|22|||
149755861|NCT01070550|540236245|FG001|Overall Study|Lab test not done|3|||
149755862|NCT01070550|540236246|FG002|Overall Study|Lab test not done|4|||
149755863|NCT01070550|540236247|FG003|Overall Study|Lab test not done|1|||
149755864|NCT01070550|540236248|FG004|Overall Study|Lab test not done|0|||
149755865|NCT01070550|540236249|FG005|Overall Study|Lab test not done|1|||
149755866|NCT01070550|540236244|FG000|Overall Study|Lack of Efficacy|65|||
149755867|NCT01070550|540236245|FG001|Overall Study|Lack of Efficacy|1|||
149755868|NCT01070550|540236246|FG002|Overall Study|Lack of Efficacy|5|||
149755869|NCT01070550|540236247|FG003|Overall Study|Lack of Efficacy|5|||
149755870|NCT01070550|540236248|FG004|Overall Study|Lack of Efficacy|0|||
149755871|NCT01070550|540236249|FG005|Overall Study|Lack of Efficacy|1|||
149755872|NCT01070550|540236244|FG000|Overall Study|Miscellaneous|12|||
149755873|NCT01070550|540236245|FG001|Overall Study|Miscellaneous|2|||
149755874|NCT01070550|540236246|FG002|Overall Study|Miscellaneous|3|||
149755875|NCT01070550|540236247|FG003|Overall Study|Miscellaneous|1|||
149755876|NCT01070550|540236248|FG004|Overall Study|Miscellaneous|0|||
149755877|NCT01070550|540236249|FG005|Overall Study|Miscellaneous|0|||
149755878|NCT01070550|540236244|FG000|Overall Study|New treatment started|3|||
149755879|NCT01070550|540236245|FG001|Overall Study|New treatment started|1|||
149755880|NCT01070550|540236246|FG002|Overall Study|New treatment started|0|||
149755881|NCT01070550|540236247|FG003|Overall Study|New treatment started|2|||
149755882|NCT01070550|540236248|FG004|Overall Study|New treatment started|0|||
149755883|NCT01070550|540236249|FG005|Overall Study|New treatment started|0|||
149755884|NCT01070550|540236244|FG000|Overall Study|Non-responders|493|||
149755885|NCT01070550|540236245|FG001|Overall Study|Non-responders|4|||
149755886|NCT01070550|540236246|FG002|Overall Study|Non-responders|21|||
149755887|NCT01070550|540236247|FG003|Overall Study|Non-responders|20|||
149755888|NCT01070550|540236248|FG004|Overall Study|Non-responders|0|||
149755889|NCT01070550|540236249|FG005|Overall Study|Non-responders|2|||
149755890|NCT01070550|540236244|FG000|Overall Study|Not categorized|33|||
149755891|NCT01070550|540236245|FG001|Overall Study|Not categorized|2|||
149755892|NCT01070550|540236246|FG002|Overall Study|Not categorized|6|||
149755893|NCT01070550|540236247|FG003|Overall Study|Not categorized|1|||
149755894|NCT01070550|540236248|FG004|Overall Study|Not categorized|0|||
149755895|NCT01070550|540236249|FG005|Overall Study|Not categorized|1|||
149755896|NCT01070550|540236244|FG000|Overall Study|Protocol Violation|15|||
149755897|NCT01070550|540236245|FG001|Overall Study|Protocol Violation|1|||
149755898|NCT01070550|540236246|FG002|Overall Study|Protocol Violation|1|||
149755899|NCT01070550|540236247|FG003|Overall Study|Protocol Violation|1|||
149755900|NCT01070550|540236248|FG004|Overall Study|Protocol Violation|0|||
149755901|NCT01070550|540236249|FG005|Overall Study|Protocol Violation|0|||
149755902|NCT01070550|540236244|FG000|Overall Study|Relapse|44|||
149755903|NCT01070550|540236245|FG001|Overall Study|Relapse|5|||
149755904|NCT01070550|540236246|FG002|Overall Study|Relapse|14|||
149755905|NCT01070550|540236247|FG003|Overall Study|Relapse|4|||
149755906|NCT01070550|540236248|FG004|Overall Study|Relapse|0|||
149755907|NCT01070550|540236249|FG005|Overall Study|Relapse|0|||
149755908|NCT01070550|540236244|FG000|Overall Study|Result not available|3|||
149755909|NCT01070550|540236245|FG001|Overall Study|Result not available|1|||
149755910|NCT01070550|540236246|FG002|Overall Study|Result not available|3|||
149755911|NCT01070550|540236247|FG003|Overall Study|Result not available|0|||
149755912|NCT01070550|540236248|FG004|Overall Study|Result not available|0|||
149755913|NCT01070550|540236249|FG005|Overall Study|Result not available|0|||
149755914|NCT01070550|540236244|FG000|Overall Study|Screen failure|1|||
149755915|NCT01070550|540236245|FG001|Overall Study|Screen failure|0|||
149755916|NCT01070550|540236246|FG002|Overall Study|Screen failure|0|||
149755917|NCT01070550|540236247|FG003|Overall Study|Screen failure|0|||
149755918|NCT01070550|540236248|FG004|Overall Study|Screen failure|0|||
149755919|NCT01070550|540236249|FG005|Overall Study|Screen failure|0|||
149755920|NCT01070550|540236244|FG000|Overall Study|Sponsor decision|1|||
149755921|NCT01070550|540236245|FG001|Overall Study|Sponsor decision|0|||
149755922|NCT01070550|540236246|FG002|Overall Study|Sponsor decision|0|||
149755923|NCT01070550|540236247|FG003|Overall Study|Sponsor decision|0|||
149755924|NCT01070550|540236248|FG004|Overall Study|Sponsor decision|0|||
149755925|NCT01070550|540236249|FG005|Overall Study|Sponsor decision|0|||
149755926|NCT01070550|540236244|FG000|Overall Study|Treatment duration shortened|1|||
149755927|NCT01070550|540236245|FG001|Overall Study|Treatment duration shortened|0|||
149755928|NCT01070550|540236246|FG002|Overall Study|Treatment duration shortened|0|||
149755929|NCT01070550|540236247|FG003|Overall Study|Treatment duration shortened|0|||
149755930|NCT01070550|540236248|FG004|Overall Study|Treatment duration shortened|0|||
149755931|NCT01070550|540236249|FG005|Overall Study|Treatment duration shortened|0|||
149755932|NCT01070550|540236244|FG000|Overall Study|Treatment interrupted|7|||
149755933|NCT01070550|540236245|FG001|Overall Study|Treatment interrupted|0|||
149755934|NCT01070550|540236246|FG002|Overall Study|Treatment interrupted|1|||
149755935|NCT01070550|540236247|FG003|Overall Study|Treatment interrupted|1|||
149755936|NCT01070550|540236248|FG004|Overall Study|Treatment interrupted|0|||
149755937|NCT01070550|540236249|FG005|Overall Study|Treatment interrupted|0|||
149755938|NCT01070550|540236244|FG000|Overall Study|Treatment not started|14|||
149755939|NCT01070550|540236245|FG001|Overall Study|Treatment not started|2|||
149755940|NCT01070550|540236246|FG002|Overall Study|Treatment not started|4|||
149755941|NCT01070550|540236247|FG003|Overall Study|Treatment not started|0|||
149755942|NCT01070550|540236248|FG004|Overall Study|Treatment not started|0|||
149755943|NCT01070550|540236249|FG005|Overall Study|Treatment not started|0|||
149755944|NCT01070550|540236244|FG000|Overall Study|Treatment restarted|0|||
149755945|NCT01070550|540236245|FG001|Overall Study|Treatment restarted|1|||
149755946|NCT01070550|540236246|FG002|Overall Study|Treatment restarted|0|||
149755947|NCT01070550|540236247|FG003|Overall Study|Treatment restarted|0|||
149755948|NCT01070550|540236248|FG004|Overall Study|Treatment restarted|0|||
149755949|NCT01070550|540236249|FG005|Overall Study|Treatment restarted|0|||
149755950|NCT01070550|540236244|FG000|Overall Study|Treatment stopped|3|||
149755951|NCT01070550|540236245|FG001|Overall Study|Treatment stopped|0|||
149755952|NCT01070550|540236246|FG002|Overall Study|Treatment stopped|0|||
149755953|NCT01070550|540236247|FG003|Overall Study|Treatment stopped|0|||
149755954|NCT01070550|540236248|FG004|Overall Study|Treatment stopped|0|||
149755955|NCT01070550|540236249|FG005|Overall Study|Treatment stopped|0|||
149755956|NCT01070550|540236244|FG000|Overall Study|Treatment unavailable|1|||
149755957|NCT01070550|540236245|FG001|Overall Study|Treatment unavailable|0|||
149755958|NCT01070550|540236246|FG002|Overall Study|Treatment unavailable|0|||
149755959|NCT01070550|540236247|FG003|Overall Study|Treatment unavailable|0|||
149755960|NCT01070550|540236248|FG004|Overall Study|Treatment unavailable|0|||
149755961|NCT01070550|540236249|FG005|Overall Study|Treatment unavailable|0|||
149755962|NCT01070550|540236244|FG000|Overall Study|Treatment was stopped early|7|||
149755963|NCT01070550|540236245|FG001|Overall Study|Treatment was stopped early|0|||
149755964|NCT01070550|540236246|FG002|Overall Study|Treatment was stopped early|0|||
149755965|NCT01070550|540236247|FG003|Overall Study|Treatment was stopped early|0|||
149755966|NCT01070550|540236248|FG004|Overall Study|Treatment was stopped early|0|||
149755967|NCT01070550|540236249|FG005|Overall Study|Treatment was stopped early|0|||
149755968|NCT01070550|540236244|FG000|Overall Study|Other|5|||
149755969|NCT01070550|540236245|FG001|Overall Study|Other|0|||
149755970|NCT01070550|540236246|FG002|Overall Study|Other|0|||
149755971|NCT01070550|540236247|FG003|Overall Study|Other|1|||
149755972|NCT01070550|540236248|FG004|Overall Study|Other|0|||
149755973|NCT01070550|540236249|FG005|Overall Study|Other|0|||
149755974|NCT01070550|540236244|FG000|Overall Study|Withdrawal by Subject|35|||
149755975|NCT01070550|540236245|FG001|Overall Study|Withdrawal by Subject|0|||
149755976|NCT01070550|540236246|FG002|Overall Study|Withdrawal by Subject|3|||
149755977|NCT01070550|540236247|FG003|Overall Study|Withdrawal by Subject|0|||
149755978|NCT01070550|540236248|FG004|Overall Study|Withdrawal by Subject|0|||
149755979|NCT01070550|540236249|FG005|Overall Study|Withdrawal by Subject|0|||
149755980|NCT01585961|540236251|FG000|Overall Study|Death|6|||
149755981|NCT01585961|540236251|FG000|Overall Study|Physician Decision|1|||
149755982|NCT01585961|540236251|FG000|Overall Study|Decision to use non-study catheter|1|||
149755983|NCT01585961|540236251|FG000|Overall Study|Withdrawal by Subject|1|||
149755984|NCT01585961|540236251|FG000|Overall Study|Lost to Follow-up|23|||
149755985|NCT01585961|540236251|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
149755986|NCT05058664|540236252|FG000|Overall Study|No follow-up data provided|4|||
149755987|NCT05058664|540236253|FG001|Overall Study|No follow-up data provided|0|||
149755988|NCT05058664|540236254|FG002|Overall Study|No follow-up data provided|2|||
149755989|NCT05058664|540236252|FG000|Overall Study|Withdrawal by Subject|0|||
149755990|NCT05058664|540236253|FG001|Overall Study|Withdrawal by Subject|0|||
149755991|NCT05058664|540236254|FG002|Overall Study|Withdrawal by Subject|1|||
149755992|NCT01258348|540236255|FG000|Overall Study|Adverse Event|1|||
149755993|NCT01258348|540236256|FG001|Overall Study|Adverse Event|1|||
149755994|NCT01258348|540236257|FG002|Overall Study|Adverse Event|3|||
149755995|NCT01258348|540236258|FG003|Overall Study|Adverse Event|2|||
149755996|NCT01258348|540236259|FG004|Overall Study|Adverse Event|4|||
149755997|NCT01258348|540236255|FG000|Overall Study|Progressive Disease|0|||
149755998|NCT01258348|540236256|FG001|Overall Study|Progressive Disease|3|||
149755999|NCT01258348|540236257|FG002|Overall Study|Progressive Disease|0|||
149756000|NCT01258348|540236258|FG003|Overall Study|Progressive Disease|2|||
149756001|NCT01258348|540236259|FG004|Overall Study|Progressive Disease|2|||
149756002|NCT01258348|540236255|FG000|Overall Study|Physician Decision|0|||
149756003|NCT01258348|540236256|FG001|Overall Study|Physician Decision|0|||
149756004|NCT01258348|540236257|FG002|Overall Study|Physician Decision|0|||
149756005|NCT01258348|540236258|FG003|Overall Study|Physician Decision|2|||
149756006|NCT01258348|540236259|FG004|Overall Study|Physician Decision|0|||
149756007|NCT01258348|540236255|FG000|Overall Study|Withdrawal by Subject|0|||
149756008|NCT01258348|540236256|FG001|Overall Study|Withdrawal by Subject|1|||
149756009|NCT01258348|540236257|FG002|Overall Study|Withdrawal by Subject|0|||
149756010|NCT01258348|540236258|FG003|Overall Study|Withdrawal by Subject|0|||
149756011|NCT01258348|540236259|FG004|Overall Study|Withdrawal by Subject|0|||
149756012|NCT00109733|540236263|FG000|Overall Study|Protocol Violation|0|||
149756013|NCT00109733|540236264|FG001|Overall Study|Protocol Violation|1|||
149756014|NCT00109733|540236263|FG000|Overall Study|Stopped taking study drug|1|||
149756015|NCT00109733|540236264|FG001|Overall Study|Stopped taking study drug|1|||
149756016|NCT00109733|540236263|FG000|Overall Study|Non-compliant|0|||
149756017|NCT00109733|540236264|FG001|Overall Study|Non-compliant|1|||
149756018|NCT00109733|540236263|FG000|Overall Study|Could not commit time for study|1|||
149756019|NCT00109733|540236264|FG001|Overall Study|Could not commit time for study|1|||
149756020|NCT02606045|540236267|FG000|Overall Study|Study closed before treament could begin|1|||
149756021|NCT02606045|540236268|FG001|Overall Study|Study closed before treament could begin|2|||
149756022|NCT03952468|540236269|FG000|Overall Study|Death|0|||
149756023|NCT03952468|540236270|FG001|Overall Study|Death|1|||
149756024|NCT03952468|540236269|FG000|Overall Study|Adverse Event|0|||
149756025|NCT03952468|540236270|FG001|Overall Study|Adverse Event|1|||
149756026|NCT03952468|540236269|FG000|Overall Study|Physician Decision|1|||
149756027|NCT03952468|540236270|FG001|Overall Study|Physician Decision|0|||
149756028|NCT03952468|540236269|FG000|Overall Study|Lost to Follow-up|3|||
149756029|NCT03952468|540236270|FG001|Overall Study|Lost to Follow-up|4|||
149756030|NCT03952468|540236269|FG000|Overall Study|Withdrawal by Subject|2|||
149756031|NCT03952468|540236270|FG001|Overall Study|Withdrawal by Subject|1|||
149756032|NCT01671085|540236272|FG000|Overall Study|Withdrawal by Subject|1|||
149756033|NCT01671085|540236273|FG001|Overall Study|Withdrawal by Subject|0|||
149756034|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
149756035|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
149756036|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149756037|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149756038|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149756039|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149756040|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149756041|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149756042|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
149756043|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149756044|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149756045|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
149756046|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149756047|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149756048|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
149756049|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
149756050|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
149756051|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
149756052|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149756053|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149756054|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149756055|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Other|0|||
149756056|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Other|1|||
149756057|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Other|0|||
149756058|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Other|0|||
149756059|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Other|0|||
149756060|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Other|0|||
149756061|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Other|0|||
149756062|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
149756063|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
149756064|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
149756065|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
149756066|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
149756067|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
149756068|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
149756069|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
149756070|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
149756071|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149756072|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
149756073|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
149756074|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149756075|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149756076|NCT00365716|540236274|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
149756077|NCT00365716|540236275|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
149756078|NCT00365716|540236276|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
149756079|NCT00365716|540236277|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
149756080|NCT00365716|540236278|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
149756081|NCT00365716|540236279|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
149756082|NCT00365716|540236280|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
149756083|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
149756084|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149756085|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149756086|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
149756087|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
149756088|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149756089|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149756090|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
149756091|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
149756092|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
149756093|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
149756094|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
149756095|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
149756096|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
149756097|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
149756098|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
149756099|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
149756100|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
149756101|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149756102|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149756103|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149756104|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
149756105|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149756106|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149756107|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149756108|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
149756109|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149756110|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149756111|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149756112|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
149756113|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
149756114|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149756115|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149756116|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149756117|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149756118|NCT00365716|540236274|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
149756119|NCT00365716|540236275|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
149756120|NCT00365716|540236276|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
149756121|NCT00365716|540236277|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
149756122|NCT00365716|540236278|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
149756123|NCT00365716|540236279|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
149756124|NCT00365716|540236280|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
149756125|NCT00365716|540236274|FG000|Extension 1|Lost to Follow-up|0|||
149756126|NCT00365716|540236275|FG001|Extension 1|Lost to Follow-up|0|||
149756127|NCT00365716|540236276|FG002|Extension 1|Lost to Follow-up|0|||
149756128|NCT00365716|540236277|FG003|Extension 1|Lost to Follow-up|0|||
149756129|NCT00365716|540236278|FG004|Extension 1|Lost to Follow-up|0|||
149756130|NCT00365716|540236279|FG005|Extension 1|Lost to Follow-up|1|||
149756131|NCT00365716|540236280|FG006|Extension 1|Lost to Follow-up|0|||
149756132|NCT00365716|540236274|FG000|Extension 1|Other|0|||
149756133|NCT00365716|540236275|FG001|Extension 1|Other|0|||
149756134|NCT00365716|540236276|FG002|Extension 1|Other|0|||
149756135|NCT00365716|540236277|FG003|Extension 1|Other|0|||
149756136|NCT00365716|540236278|FG004|Extension 1|Other|0|||
149756137|NCT00365716|540236279|FG005|Extension 1|Other|9|||
149756138|NCT00365716|540236280|FG006|Extension 1|Other|0|||
149756139|NCT00365716|540236274|FG000|Extension 1|Moved|0|||
149756140|NCT00365716|540236275|FG001|Extension 1|Moved|0|||
149756141|NCT00365716|540236276|FG002|Extension 1|Moved|0|||
149756142|NCT00365716|540236277|FG003|Extension 1|Moved|0|||
149756143|NCT00365716|540236278|FG004|Extension 1|Moved|0|||
149756144|NCT00365716|540236279|FG005|Extension 1|Moved|4|||
149756145|NCT00365716|540236280|FG006|Extension 1|Moved|0|||
149756146|NCT00365716|540236274|FG000|Extension 1|Withdrawal by Subject|0|||
149756147|NCT00365716|540236275|FG001|Extension 1|Withdrawal by Subject|0|||
149756148|NCT00365716|540236276|FG002|Extension 1|Withdrawal by Subject|0|||
149756149|NCT00365716|540236277|FG003|Extension 1|Withdrawal by Subject|0|||
149756150|NCT00365716|540236278|FG004|Extension 1|Withdrawal by Subject|0|||
149756151|NCT00365716|540236279|FG005|Extension 1|Withdrawal by Subject|3|||
149756152|NCT00365716|540236280|FG006|Extension 1|Withdrawal by Subject|0|||
149756153|NCT00365716|540236274|FG000|Extension 1|Pregnancy|0|||
149756154|NCT00365716|540236275|FG001|Extension 1|Pregnancy|0|||
149756155|NCT00365716|540236276|FG002|Extension 1|Pregnancy|0|||
149756156|NCT00365716|540236277|FG003|Extension 1|Pregnancy|0|||
149756157|NCT00365716|540236278|FG004|Extension 1|Pregnancy|0|||
149756158|NCT00365716|540236279|FG005|Extension 1|Pregnancy|4|||
149756159|NCT00365716|540236280|FG006|Extension 1|Pregnancy|0|||
149756160|NCT00365716|540236274|FG000|Extension 1|Protocol Violation|0|||
149756161|NCT00365716|540236275|FG001|Extension 1|Protocol Violation|0|||
149756162|NCT00365716|540236276|FG002|Extension 1|Protocol Violation|0|||
149756163|NCT00365716|540236277|FG003|Extension 1|Protocol Violation|0|||
149756164|NCT00365716|540236278|FG004|Extension 1|Protocol Violation|0|||
149756165|NCT00365716|540236279|FG005|Extension 1|Protocol Violation|1|||
149756166|NCT00365716|540236280|FG006|Extension 1|Protocol Violation|0|||
149756167|NCT00365716|540236274|FG000|Extension 2|Lost to Follow-up|0|||
149756168|NCT00365716|540236275|FG001|Extension 2|Lost to Follow-up|0|||
149756169|NCT00365716|540236276|FG002|Extension 2|Lost to Follow-up|0|||
149756170|NCT00365716|540236277|FG003|Extension 2|Lost to Follow-up|0|||
149756171|NCT00365716|540236278|FG004|Extension 2|Lost to Follow-up|0|||
149756172|NCT00365716|540236279|FG005|Extension 2|Lost to Follow-up|0|||
149756173|NCT00365716|540236280|FG006|Extension 2|Lost to Follow-up|2|||
149756174|NCT00365716|540236274|FG000|Extension 2|Other|0|||
149756175|NCT00365716|540236275|FG001|Extension 2|Other|0|||
149756176|NCT00365716|540236276|FG002|Extension 2|Other|0|||
149756177|NCT00365716|540236277|FG003|Extension 2|Other|0|||
149756178|NCT00365716|540236278|FG004|Extension 2|Other|0|||
149756179|NCT00365716|540236279|FG005|Extension 2|Other|0|||
149756180|NCT00365716|540236280|FG006|Extension 2|Other|3|||
149756181|NCT00365716|540236274|FG000|Extension 2|Withdrawal by Subject|0|||
149756182|NCT00365716|540236275|FG001|Extension 2|Withdrawal by Subject|0|||
149756183|NCT00365716|540236276|FG002|Extension 2|Withdrawal by Subject|0|||
149756184|NCT00365716|540236277|FG003|Extension 2|Withdrawal by Subject|0|||
149756185|NCT00365716|540236278|FG004|Extension 2|Withdrawal by Subject|0|||
149756186|NCT00365716|540236279|FG005|Extension 2|Withdrawal by Subject|0|||
149756187|NCT00365716|540236280|FG006|Extension 2|Withdrawal by Subject|5|||
149756188|NCT00506077|540236288|FG000|Treatment Period 1|Adverse Event|2|||
149756189|NCT00506077|540236289|FG001|Treatment Period 1|Adverse Event|1|||
149756190|NCT00506077|540236288|FG000|Treatment Period 1|Lost to Follow-up|0|||
149756191|NCT00506077|540236289|FG001|Treatment Period 1|Lost to Follow-up|2|||
149756192|NCT00506077|540236288|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149756193|NCT00506077|540236289|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149756194|NCT00506077|540236288|FG000|Treatment Period 2|Adverse Event|0|||
149756195|NCT00506077|540236289|FG001|Treatment Period 2|Adverse Event|1|||
149756196|NCT00506077|540236288|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149756197|NCT00506077|540236289|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149756198|NCT00316303|540236291|FG000|Overall Study|Lost to Follow-up|11|||
149756199|NCT00316303|540236292|FG001|Overall Study|Lost to Follow-up|16|||
149756200|NCT02375698|540236295|FG000|Overall Study|Withdrawal by Subject|0|||
149756201|NCT02375698|540236296|FG001|Overall Study|Withdrawal by Subject|2|||
149756202|NCT02375698|540236295|FG000|Overall Study|Physician Decision|2|||
149756203|NCT02375698|540236296|FG001|Overall Study|Physician Decision|0|||
149756204|NCT00772967|540236297|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
149756205|NCT00772967|540236298|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
149756206|NCT00772967|540236299|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
149756207|NCT00772967|540236300|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
149756208|NCT00772967|540236301|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
149756209|NCT00772967|540236302|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
149756210|NCT00772967|540236297|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149756211|NCT00772967|540236298|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
149756212|NCT00772967|540236299|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149756213|NCT00772967|540236300|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149756214|NCT00772967|540236301|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149756215|NCT00772967|540236302|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149756216|NCT00772967|540236297|FG000|Crossover Treatment 3|Adverse Event|0|||
149756217|NCT00772967|540236298|FG001|Crossover Treatment 3|Adverse Event|0|||
149756218|NCT00772967|540236299|FG002|Crossover Treatment 3|Adverse Event|0|||
149756219|NCT00772967|540236300|FG003|Crossover Treatment 3|Adverse Event|0|||
149756220|NCT00772967|540236301|FG004|Crossover Treatment 3|Adverse Event|1|||
149756221|NCT00772967|540236302|FG005|Crossover Treatment 3|Adverse Event|0|||
149756222|NCT02229864|540236303|FG000|Overall Study|Death|2|||
149756223|NCT02229864|540236303|FG000|Overall Study|Lost to Follow-up|1|||
149756224|NCT02588248|540236310|FG000|Overall Study|Physician Decision|4|||
149756225|NCT02588248|540236311|FG001|Overall Study|Physician Decision|3|||
149756226|NCT04229446|540236312|FG000|Overall Study|Death|12|||
149756227|NCT04229446|540236313|FG001|Overall Study|Death|10|||
149756228|NCT04229446|540236312|FG000|Overall Study|Lost to Follow-up|5|||
149756229|NCT04229446|540236313|FG001|Overall Study|Lost to Follow-up|8|||
149756230|NCT00705224|540236314|FG000|Overall Study|Adverse Event|1|||
149756231|NCT00705224|540236314|FG000|Overall Study|Lack of Efficacy|2|||
149756232|NCT00705224|540236314|FG000|Overall Study|Withdrawal by Subject|3|||
149756233|NCT00705224|540236314|FG000|Overall Study|Lost to Follow-up|5|||
149756234|NCT02566525|540236315|FG000|Overall Study|Protocol Violation|3|||
149756235|NCT02566525|540236316|FG001|Overall Study|Protocol Violation|5|||
149756236|NCT00337467|540236317|FG000|Overall Study|Adverse Event|3|||
149756237|NCT00337467|540236317|FG000|Overall Study|Subject Withdrew Consent|2|||
149756238|NCT00337467|540236317|FG000|Overall Study|Pregnancy|1|||
149756239|NCT00337467|540236317|FG000|Overall Study|Lost to Follow-up|2|||
149756240|NCT00337467|540236317|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
149756241|NCT03141086|540236318|FG000|Overall Study|Study Terminated By Sponsor|1|||
149756242|NCT03141086|540236319|FG001|Overall Study|Study Terminated By Sponsor|1|||
149756243|NCT03141086|540236318|FG000|Overall Study|Withdrawal by Subject|0|||
149756244|NCT03141086|540236319|FG001|Overall Study|Withdrawal by Subject|1|||
149756245|NCT03141086|540236318|FG000|Overall Study|Protocol Violation|0|||
149756246|NCT03141086|540236319|FG001|Overall Study|Protocol Violation|1|||
149756247|NCT03141086|540236318|FG000|Overall Study|Adverse Event|0|||
149756248|NCT03141086|540236319|FG001|Overall Study|Adverse Event|2|||
149756249|NCT04430582|540236321|FG000|Overall Study|Found to meet exclusionary criteria|1|||
149756250|NCT04430582|540236322|FG001|Overall Study|Found to meet exclusionary criteria|0|||
149756251|NCT04430582|540236321|FG000|Overall Study|Withdrawal by Subject|0|||
149756252|NCT04430582|540236322|FG001|Overall Study|Withdrawal by Subject|1|||
149756253|NCT03607682|540236323|FG000|Overall Study|Withdrawal by Subject|1|||
149756254|NCT03607682|540236323|FG000|Overall Study|Disease progression|1|||
149756255|NCT02410902|540237935|FG000|Overall Study|Adverse Event|2|||
149756256|NCT02410902|540237936|FG001|Overall Study|Adverse Event|3|||
149756257|NCT02410902|540237935|FG000|Overall Study|Lost to Follow-up|4|||
149756258|NCT02410902|540237936|FG001|Overall Study|Lost to Follow-up|1|||
149756259|NCT02410902|540237935|FG000|Overall Study|Protocol Violation|1|||
149756260|NCT02410902|540237936|FG001|Overall Study|Protocol Violation|4|||
149756261|NCT02410902|540237935|FG000|Overall Study|Withdrawal by Subject|6|||
149756262|NCT02410902|540237936|FG001|Overall Study|Withdrawal by Subject|8|||
149756263|NCT02410902|540237935|FG000|Overall Study|Non-Compliance|8|||
149756264|NCT02410902|540237936|FG001|Overall Study|Non-Compliance|2|||
149756265|NCT01043185|540237937|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
149756266|NCT01043185|540237938|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
149756267|NCT01043185|540237939|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
149756268|NCT01043185|540237940|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
149756269|NCT01043185|540237941|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
149756270|NCT01043185|540237942|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
149756271|NCT01043185|540237943|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
149756272|NCT01043185|540237944|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
149756273|NCT01043185|540237945|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
149756274|NCT01043185|540237946|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
149756275|NCT00137436|540237947|FG000|Overall Study|Adverse Event|13|||
149756276|NCT00137436|540237947|FG000|Overall Study|Death|2|||
149756277|NCT00137436|540237947|FG000|Overall Study|Lack of Efficacy|17|||
149756278|NCT00137436|540237947|FG000|Overall Study|Withdrawal by Subject|6|||
149756279|NCT00137436|540237947|FG000|Overall Study|Other|5|||
149756280|NCT00701727|540237948|FG000|First Treatment Period|Adverse Event|0|||
149756281|NCT00701727|540237949|FG001|First Treatment Period|Adverse Event|0|||
149756282|NCT00701727|540237948|FG000|First Treatment Period|Withdrawal by Subject|1|||
149756283|NCT00701727|540237949|FG001|First Treatment Period|Withdrawal by Subject|0|||
149756284|NCT00701727|540237948|FG000|First Treatment Period|sponsor decision|0|||
149756285|NCT00701727|540237949|FG001|First Treatment Period|sponsor decision|1|||
149756286|NCT00701727|540237948|FG000|First Treatment Period|Lost to Follow-up|0|||
149756287|NCT00701727|540237949|FG001|First Treatment Period|Lost to Follow-up|1|||
149756288|NCT00701727|540237948|FG000|Second Treatment Period|Withdrawal by Subject|2|||
149756289|NCT00701727|540237949|FG001|Second Treatment Period|Withdrawal by Subject|0|||
149756290|NCT00912015|540237950|FG000|Overall Study|Lack of Efficacy|1|||
149756291|NCT00912015|540237951|FG001|Overall Study|Lack of Efficacy|0|||
149756292|NCT00912015|540237952|FG002|Overall Study|Lack of Efficacy|0|||
149756293|NCT00912015|540237953|FG003|Overall Study|Lack of Efficacy|0|||
149756294|NCT00912015|540237950|FG000|Overall Study|Withdrawal by Subject|8|||
149756295|NCT00912015|540237951|FG001|Overall Study|Withdrawal by Subject|8|||
149756296|NCT00912015|540237952|FG002|Overall Study|Withdrawal by Subject|3|||
149756297|NCT00912015|540237953|FG003|Overall Study|Withdrawal by Subject|0|||
149756298|NCT00912015|540237950|FG000|Overall Study|Protocol Violation|1|||
149756299|NCT00912015|540237951|FG001|Overall Study|Protocol Violation|0|||
149756300|NCT00912015|540237952|FG002|Overall Study|Protocol Violation|0|||
149756301|NCT00912015|540237953|FG003|Overall Study|Protocol Violation|1|||
149756302|NCT00912015|540237950|FG000|Overall Study|Adverse Event|6|||
149756303|NCT00912015|540237951|FG001|Overall Study|Adverse Event|0|||
149756304|NCT00912015|540237952|FG002|Overall Study|Adverse Event|0|||
149756305|NCT00912015|540237953|FG003|Overall Study|Adverse Event|1|||
149756306|NCT05137041|540237954|FG000|Overall Study|Lost to Follow-up|1|||
149756307|NCT05137041|540237955|FG001|Overall Study|Lost to Follow-up|1|||
149756308|NCT05137041|540237954|FG000|Overall Study|Withdrawal by Subject|0|||
149756309|NCT05137041|540237955|FG001|Overall Study|Withdrawal by Subject|2|||
149756310|NCT05137041|540237954|FG000|Overall Study|Reason not Specified|0|||
149756311|NCT05137041|540237955|FG001|Overall Study|Reason not Specified|1|||
149756312|NCT02090114|540237956|FG000|Overall Study|Withdrawal by Subject|3|||
149756313|NCT02090114|540237957|FG001|Overall Study|Withdrawal by Subject|6|||
149756314|NCT02090114|540237958|FG002|Overall Study|Withdrawal by Subject|2|||
149756315|NCT02090114|540237959|FG003|Overall Study|Withdrawal by Subject|1|||
149756316|NCT02090114|540237956|FG000|Overall Study|Physician Decision|5|||
149756317|NCT02090114|540237957|FG001|Overall Study|Physician Decision|0|||
149756318|NCT02090114|540237958|FG002|Overall Study|Physician Decision|1|||
149756319|NCT02090114|540237959|FG003|Overall Study|Physician Decision|1|||
149756320|NCT02090114|540237956|FG000|Overall Study|Adverse Event|1|||
149756321|NCT02090114|540237957|FG001|Overall Study|Adverse Event|2|||
149756322|NCT02090114|540237958|FG002|Overall Study|Adverse Event|2|||
149756323|NCT02090114|540237959|FG003|Overall Study|Adverse Event|0|||
149756324|NCT02090114|540237956|FG000|Overall Study|Progressive Disease|20|||
149756325|NCT02090114|540237957|FG001|Overall Study|Progressive Disease|21|||
149756326|NCT02090114|540237958|FG002|Overall Study|Progressive Disease|23|||
149756327|NCT02090114|540237959|FG003|Overall Study|Progressive Disease|6|||
149756328|NCT02090114|540237956|FG000|Overall Study|Death|1|||
149756329|NCT02090114|540237957|FG001|Overall Study|Death|0|||
149756330|NCT02090114|540237958|FG002|Overall Study|Death|1|||
149756331|NCT02090114|540237959|FG003|Overall Study|Death|0|||
149756332|NCT00392171|540237960|FG000|Overall Study|Did not meet inclusion criteria|4|||
149756333|NCT00392171|540237960|FG000|Overall Study|Disease progression|101|||
149756334|NCT03470922|540237962|FG000|Overall Study|Death|107|||
149756335|NCT03470922|540237963|FG001|Overall Study|Death|118|||
149756336|NCT03470922|540237962|FG000|Overall Study|Lost to Follow-up|5|||
149756337|NCT03470922|540237963|FG001|Overall Study|Lost to Follow-up|5|||
149756338|NCT03470922|540237962|FG000|Overall Study|Participant Withdrew Consent|4|||
149756339|NCT03470922|540237963|FG001|Overall Study|Participant Withdrew Consent|9|||
149756340|NCT03470922|540237962|FG000|Overall Study|Other reasons|1|||
149756341|NCT03470922|540237963|FG001|Overall Study|Other reasons|0|||
149756342|NCT03470922|540237962|FG000|Overall Study|Not reported|1|||
149756343|NCT03470922|540237963|FG001|Overall Study|Not reported|0|||
149756344|NCT02163993|540237966|FG000|Treatment Period|Adverse Event|0|||
149756345|NCT02163993|540237967|FG001|Treatment Period|Adverse Event|1|||
149756346|NCT02163993|540237968|FG002|Treatment Period|Adverse Event|0|||
149756347|NCT02163993|540237969|FG003|Treatment Period|Adverse Event|0|||
149756348|NCT02163993|540237970|FG004|Treatment Period|Adverse Event|1|||
149756349|NCT02163993|540237966|FG000|Treatment Period|Lost to Follow-up|2|||
149756350|NCT02163993|540237967|FG001|Treatment Period|Lost to Follow-up|3|||
149756351|NCT02163993|540237968|FG002|Treatment Period|Lost to Follow-up|1|||
149756352|NCT02163993|540237969|FG003|Treatment Period|Lost to Follow-up|3|||
149756353|NCT02163993|540237970|FG004|Treatment Period|Lost to Follow-up|1|||
149756354|NCT02163993|540237966|FG000|Treatment Period|Physician Decision|1|||
149756355|NCT02163993|540237967|FG001|Treatment Period|Physician Decision|0|||
149756356|NCT02163993|540237968|FG002|Treatment Period|Physician Decision|0|||
149756357|NCT02163993|540237969|FG003|Treatment Period|Physician Decision|0|||
149756358|NCT02163993|540237970|FG004|Treatment Period|Physician Decision|0|||
149756359|NCT02163993|540237966|FG000|Treatment Period|Protocol Violation|2|||
149756360|NCT02163993|540237967|FG001|Treatment Period|Protocol Violation|1|||
149756361|NCT02163993|540237968|FG002|Treatment Period|Protocol Violation|0|||
149756362|NCT02163993|540237969|FG003|Treatment Period|Protocol Violation|1|||
149756363|NCT02163993|540237970|FG004|Treatment Period|Protocol Violation|2|||
149756364|NCT02163993|540237966|FG000|Treatment Period|Withdrawal by Subject|6|||
149756365|NCT02163993|540237967|FG001|Treatment Period|Withdrawal by Subject|4|||
149756366|NCT02163993|540237968|FG002|Treatment Period|Withdrawal by Subject|1|||
149756367|NCT02163993|540237969|FG003|Treatment Period|Withdrawal by Subject|4|||
149756368|NCT02163993|540237970|FG004|Treatment Period|Withdrawal by Subject|1|||
149756369|NCT02163993|540237966|FG000|Treatment Period|Not treated|1|||
149756370|NCT02163993|540237967|FG001|Treatment Period|Not treated|0|||
149756371|NCT02163993|540237968|FG002|Treatment Period|Not treated|0|||
149756372|NCT02163993|540237969|FG003|Treatment Period|Not treated|1|||
149756373|NCT02163993|540237970|FG004|Treatment Period|Not treated|2|||
149756374|NCT02163993|540237966|FG000|Post-treatment Period|Adverse Event|0|||
149756375|NCT02163993|540237967|FG001|Post-treatment Period|Adverse Event|0|||
149756376|NCT02163993|540237968|FG002|Post-treatment Period|Adverse Event|1|||
149756377|NCT02163993|540237969|FG003|Post-treatment Period|Adverse Event|0|||
149756378|NCT02163993|540237970|FG004|Post-treatment Period|Adverse Event|0|||
149756379|NCT02163993|540237966|FG000|Post-treatment Period|Lost to Follow-up|2|||
149756380|NCT02163993|540237967|FG001|Post-treatment Period|Lost to Follow-up|2|||
149756381|NCT02163993|540237968|FG002|Post-treatment Period|Lost to Follow-up|3|||
149756382|NCT02163993|540237969|FG003|Post-treatment Period|Lost to Follow-up|1|||
149756383|NCT02163993|540237970|FG004|Post-treatment Period|Lost to Follow-up|0|||
149756384|NCT02163993|540237966|FG000|Post-treatment Period|Protocol Violation|0|||
149756385|NCT02163993|540237967|FG001|Post-treatment Period|Protocol Violation|0|||
149756386|NCT02163993|540237968|FG002|Post-treatment Period|Protocol Violation|0|||
149756387|NCT02163993|540237969|FG003|Post-treatment Period|Protocol Violation|0|||
149756388|NCT02163993|540237970|FG004|Post-treatment Period|Protocol Violation|1|||
149756389|NCT02163993|540237966|FG000|Post-treatment Period|Withdrawal by Subject|2|||
149756390|NCT02163993|540237967|FG001|Post-treatment Period|Withdrawal by Subject|4|||
149756391|NCT02163993|540237968|FG002|Post-treatment Period|Withdrawal by Subject|0|||
149756392|NCT02163993|540237969|FG003|Post-treatment Period|Withdrawal by Subject|1|||
149756393|NCT02163993|540237970|FG004|Post-treatment Period|Withdrawal by Subject|2|||
149756394|NCT01345123|540237971|FG000|Overall Study|participants no longer with health plan|79|||
149756395|NCT01345123|540237972|FG001|Overall Study|participants no longer with health plan|85|||
149756396|NCT01345123|540237973|FG002|Overall Study|participants no longer with health plan|88|||
149756397|NCT00883558|540237974|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
149756398|NCT00883558|540237975|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
149756399|NCT00883558|540237976|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
149756400|NCT00883558|540237974|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
149756401|NCT00883558|540237975|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
149756402|NCT00883558|540237976|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
149756403|NCT00883558|540237974|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
149756404|NCT00883558|540237975|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
149756405|NCT00883558|540237976|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
149756406|NCT00883558|540237974|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
149756407|NCT00883558|540237975|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
149756408|NCT00883558|540237976|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
149756409|NCT00883558|540237974|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
149756410|NCT00883558|540237975|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
149756411|NCT00883558|540237976|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
149756412|NCT00536731|540237978|FG000|Overall Study|Adverse Event|3|||
149756413|NCT00536731|540237979|FG001|Overall Study|Adverse Event|2|||
149756414|NCT00536731|540237980|FG002|Overall Study|Adverse Event|3|||
149756415|NCT00536731|540237978|FG000|Overall Study|Withdrawal by Subject|0|||
149756416|NCT00536731|540237979|FG001|Overall Study|Withdrawal by Subject|2|||
149756417|NCT00536731|540237980|FG002|Overall Study|Withdrawal by Subject|0|||
149756418|NCT00536731|540237978|FG000|Overall Study|Intake of prohibited conc. medication|0|||
149756419|NCT00536731|540237979|FG001|Overall Study|Intake of prohibited conc. medication|0|||
149756420|NCT00536731|540237980|FG002|Overall Study|Intake of prohibited conc. medication|1|||
149756421|NCT00536731|540237978|FG000|Overall Study|Safety reasons|0|||
149756422|NCT00536731|540237979|FG001|Overall Study|Safety reasons|0|||
149756423|NCT00536731|540237980|FG002|Overall Study|Safety reasons|1|||
149756424|NCT00536731|540237978|FG000|Overall Study|Other|1|||
149756425|NCT00536731|540237979|FG001|Overall Study|Other|1|||
149756426|NCT00536731|540237980|FG002|Overall Study|Other|0|||
149756427|NCT04184622|540237983|FG000|Primary Treatment Period|Adverse Event|6|||
149756428|NCT04184622|540237984|FG001|Primary Treatment Period|Adverse Event|4|||
149756429|NCT04184622|540237985|FG002|Primary Treatment Period|Adverse Event|8|||
149756430|NCT04184622|540237986|FG003|Primary Treatment Period|Adverse Event|6|||
149756431|NCT04184622|540237983|FG000|Primary Treatment Period|Death|4|||
149756432|NCT04184622|540237984|FG001|Primary Treatment Period|Death|4|||
149756433|NCT04184622|540237985|FG002|Primary Treatment Period|Death|2|||
149756434|NCT04184622|540237986|FG003|Primary Treatment Period|Death|1|||
149756435|NCT04184622|540237983|FG000|Primary Treatment Period|Lost to Follow-up|41|||
149756436|NCT04184622|540237984|FG001|Primary Treatment Period|Lost to Follow-up|17|||
149756437|NCT04184622|540237985|FG002|Primary Treatment Period|Lost to Follow-up|15|||
149756438|NCT04184622|540237986|FG003|Primary Treatment Period|Lost to Follow-up|13|||
149756439|NCT04184622|540237983|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
149756440|NCT04184622|540237984|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
149756441|NCT04184622|540237985|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
149756442|NCT04184622|540237986|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
149756443|NCT04184622|540237983|FG000|Primary Treatment Period|Physician Decision|0|||
149756444|NCT04184622|540237984|FG001|Primary Treatment Period|Physician Decision|0|||
149756445|NCT04184622|540237985|FG002|Primary Treatment Period|Physician Decision|3|||
149756446|NCT04184622|540237986|FG003|Primary Treatment Period|Physician Decision|1|||
149756447|NCT04184622|540237983|FG000|Primary Treatment Period|Pregnancy|4|||
149756448|NCT04184622|540237984|FG001|Primary Treatment Period|Pregnancy|3|||
149756449|NCT04184622|540237985|FG002|Primary Treatment Period|Pregnancy|4|||
149756450|NCT04184622|540237986|FG003|Primary Treatment Period|Pregnancy|1|||
149756451|NCT04184622|540237983|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
149756452|NCT04184622|540237984|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
149756453|NCT04184622|540237985|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
149756454|NCT04184622|540237986|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
149756455|NCT04184622|540237983|FG000|Additional Treatment Period|Adverse Event|1|||
149756456|NCT04184622|540237984|FG001|Additional Treatment Period|Adverse Event|2|||
149756457|NCT04184622|540237985|FG002|Additional Treatment Period|Adverse Event|1|||
149756458|NCT04184622|540237986|FG003|Additional Treatment Period|Adverse Event|0|||
149756459|NCT04184622|540237983|FG000|Additional Treatment Period|Death|0|||
149756460|NCT04184622|540237984|FG001|Additional Treatment Period|Death|0|||
149756461|NCT04184622|540237985|FG002|Additional Treatment Period|Death|1|||
149756462|NCT04184622|540237986|FG003|Additional Treatment Period|Death|1|||
149756463|NCT04184622|540237983|FG000|Additional Treatment Period|Lost to Follow-up|6|||
149756464|NCT04184622|540237984|FG001|Additional Treatment Period|Lost to Follow-up|4|||
149756465|NCT04184622|540237985|FG002|Additional Treatment Period|Lost to Follow-up|8|||
149756466|NCT04184622|540237986|FG003|Additional Treatment Period|Lost to Follow-up|6|||
149756467|NCT04184622|540237983|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
149756468|NCT04184622|540237984|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
149756469|NCT04184622|540237985|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
149756470|NCT04184622|540237986|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
149756471|NCT04184622|540237983|FG000|Additional Treatment Period|Physician Decision|0|||
149756472|NCT04184622|540237984|FG001|Additional Treatment Period|Physician Decision|0|||
149756473|NCT04184622|540237985|FG002|Additional Treatment Period|Physician Decision|1|||
149756474|NCT04184622|540237986|FG003|Additional Treatment Period|Physician Decision|0|||
149756475|NCT04184622|540237983|FG000|Additional Treatment Period|Pregnancy|0|||
149756476|NCT04184622|540237984|FG001|Additional Treatment Period|Pregnancy|0|||
149756477|NCT04184622|540237985|FG002|Additional Treatment Period|Pregnancy|0|||
149756478|NCT04184622|540237986|FG003|Additional Treatment Period|Pregnancy|1|||
149756479|NCT04184622|540237983|FG000|Additional Treatment Period|Protocol deviation|0|||
149756480|NCT04184622|540237984|FG001|Additional Treatment Period|Protocol deviation|0|||
149756481|NCT04184622|540237985|FG002|Additional Treatment Period|Protocol deviation|1|||
149756482|NCT04184622|540237986|FG003|Additional Treatment Period|Protocol deviation|0|||
149756483|NCT04184622|540237983|FG000|Additional Treatment Period|Site closed|1|||
149756484|NCT04184622|540237984|FG001|Additional Treatment Period|Site closed|0|||
149756485|NCT04184622|540237985|FG002|Additional Treatment Period|Site closed|1|||
149756486|NCT04184622|540237986|FG003|Additional Treatment Period|Site closed|0|||
149756487|NCT04184622|540237983|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
149756488|NCT04184622|540237984|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
149756489|NCT04184622|540237985|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
149756490|NCT04184622|540237986|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
149756491|NCT04184622|540237983|FG000|Safety Follow-up Period|Adverse Event|6|||
149756492|NCT04184622|540237984|FG001|Safety Follow-up Period|Adverse Event|8|||
149756493|NCT04184622|540237985|FG002|Safety Follow-up Period|Adverse Event|9|||
149756494|NCT04184622|540237986|FG003|Safety Follow-up Period|Adverse Event|16|||
149756495|NCT04184622|540237983|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
149756496|NCT04184622|540237984|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
149756497|NCT04184622|540237985|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
149756498|NCT04184622|540237986|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
149756499|NCT04184622|540237983|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
149756500|NCT04184622|540237984|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
149756501|NCT04184622|540237985|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
149756502|NCT04184622|540237986|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
149756503|NCT04184622|540237983|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
149756504|NCT04184622|540237984|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
149756505|NCT04184622|540237985|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
149756506|NCT04184622|540237986|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
149756507|NCT04184622|540237983|FG000|Safety Follow-up Period|Physician Decision|1|||
149756508|NCT04184622|540237984|FG001|Safety Follow-up Period|Physician Decision|0|||
149756509|NCT04184622|540237985|FG002|Safety Follow-up Period|Physician Decision|0|||
149756510|NCT04184622|540237986|FG003|Safety Follow-up Period|Physician Decision|1|||
149756511|NCT04184622|540237983|FG000|Safety Follow-up Period|Pregnancy|1|||
149756512|NCT04184622|540237984|FG001|Safety Follow-up Period|Pregnancy|3|||
149756513|NCT04184622|540237985|FG002|Safety Follow-up Period|Pregnancy|0|||
149756514|NCT04184622|540237986|FG003|Safety Follow-up Period|Pregnancy|6|||
149756515|NCT04184622|540237983|FG000|Safety Follow-up Period|Protocol deviation|1|||
149756516|NCT04184622|540237984|FG001|Safety Follow-up Period|Protocol deviation|0|||
149756517|NCT04184622|540237985|FG002|Safety Follow-up Period|Protocol deviation|0|||
149756518|NCT04184622|540237986|FG003|Safety Follow-up Period|Protocol deviation|0|||
149756519|NCT04184622|540237983|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
149756520|NCT04184622|540237984|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
149756521|NCT04184622|540237985|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
149756522|NCT04184622|540237986|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
149756523|NCT02795988|540237987|FG000|Phase 1b|Withdrawal by Subject|0|||
149756524|NCT02795988|540237988|FG001|Phase 1b|Withdrawal by Subject|1|||
149756525|NCT02795988|540237989|FG002|Phase 1b|Withdrawal by Subject|0|||
149756526|NCT02795988|540237990|FG003|Phase 1b|Withdrawal by Subject|0|||
149756527|NCT02795988|540237991|FG004|Phase 1b|Withdrawal by Subject|0|||
149756528|NCT02795988|540237992|FG005|Phase 1b|Withdrawal by Subject|0|||
149756529|NCT02795988|540237993|FG006|Phase 1b|Withdrawal by Subject|0|||
149756530|NCT02795988|540237987|FG000|Phase 1b|Death|1|||
149756531|NCT02795988|540237988|FG001|Phase 1b|Death|2|||
149756532|NCT02795988|540237989|FG002|Phase 1b|Death|1|||
149756533|NCT02795988|540237990|FG003|Phase 1b|Death|0|||
149756534|NCT02795988|540237991|FG004|Phase 1b|Death|0|||
149756535|NCT02795988|540237992|FG005|Phase 1b|Death|0|||
149756536|NCT02795988|540237993|FG006|Phase 1b|Death|0|||
149756537|NCT02795988|540237987|FG000|Phase 1b|Physician Decision|0|||
149756538|NCT02795988|540237988|FG001|Phase 1b|Physician Decision|0|||
149756539|NCT02795988|540237989|FG002|Phase 1b|Physician Decision|1|||
149756540|NCT02795988|540237990|FG003|Phase 1b|Physician Decision|0|||
149756541|NCT02795988|540237991|FG004|Phase 1b|Physician Decision|0|||
149756542|NCT02795988|540237992|FG005|Phase 1b|Physician Decision|0|||
149756543|NCT02795988|540237993|FG006|Phase 1b|Physician Decision|0|||
149756544|NCT02795988|540237987|FG000|Phase 1b|Progressive Disease|2|||
149756545|NCT02795988|540237988|FG001|Phase 1b|Progressive Disease|2|||
149756546|NCT02795988|540237989|FG002|Phase 1b|Progressive Disease|0|||
149756547|NCT02795988|540237990|FG003|Phase 1b|Progressive Disease|0|||
149756548|NCT02795988|540237991|FG004|Phase 1b|Progressive Disease|0|||
149756549|NCT02795988|540237992|FG005|Phase 1b|Progressive Disease|0|||
149756550|NCT02795988|540237993|FG006|Phase 1b|Progressive Disease|0|||
149756551|NCT02795988|540237987|FG000|Phase 2|Withdrawal by Subject|0|||
149756552|NCT02795988|540237988|FG001|Phase 2|Withdrawal by Subject|0|||
149756553|NCT02795988|540237989|FG002|Phase 2|Withdrawal by Subject|0|||
149756554|NCT02795988|540237990|FG003|Phase 2|Withdrawal by Subject|1|||
149756555|NCT02795988|540237991|FG004|Phase 2|Withdrawal by Subject|0|||
149756556|NCT02795988|540237992|FG005|Phase 2|Withdrawal by Subject|0|||
149756557|NCT02795988|540237993|FG006|Phase 2|Withdrawal by Subject|0|||
149756558|NCT02795988|540237987|FG000|Phase 2|Death|0|||
149756559|NCT02795988|540237988|FG001|Phase 2|Death|0|||
149756560|NCT02795988|540237989|FG002|Phase 2|Death|0|||
149756561|NCT02795988|540237990|FG003|Phase 2|Death|17|||
149756562|NCT02795988|540237991|FG004|Phase 2|Death|17|||
149756563|NCT02795988|540237992|FG005|Phase 2|Death|0|||
149756564|NCT02795988|540237993|FG006|Phase 2|Death|0|||
149756565|NCT02795988|540237987|FG000|Phase 2|Other|0|||
149756566|NCT02795988|540237988|FG001|Phase 2|Other|0|||
149756567|NCT02795988|540237989|FG002|Phase 2|Other|0|||
149756568|NCT02795988|540237990|FG003|Phase 2|Other|1|||
149756569|NCT02795988|540237991|FG004|Phase 2|Other|0|||
149756570|NCT02795988|540237992|FG005|Phase 2|Other|0|||
149756571|NCT02795988|540237993|FG006|Phase 2|Other|0|||
149756572|NCT02795988|540237987|FG000|Phase 2 Extension|Death|0|||
149756573|NCT02795988|540237988|FG001|Phase 2 Extension|Death|0|||
149756574|NCT02795988|540237989|FG002|Phase 2 Extension|Death|0|||
149756575|NCT02795988|540237990|FG003|Phase 2 Extension|Death|0|||
149756576|NCT02795988|540237991|FG004|Phase 2 Extension|Death|0|||
149756577|NCT02795988|540237992|FG005|Phase 2 Extension|Death|5|||
149756578|NCT02795988|540237993|FG006|Phase 2 Extension|Death|6|||
149756579|NCT02795988|540237987|FG000|Phase 2 Extension|Other reasons|0|||
149756580|NCT02795988|540237988|FG001|Phase 2 Extension|Other reasons|0|||
149756581|NCT02795988|540237989|FG002|Phase 2 Extension|Other reasons|0|||
149756582|NCT02795988|540237990|FG003|Phase 2 Extension|Other reasons|0|||
149756583|NCT02795988|540237991|FG004|Phase 2 Extension|Other reasons|0|||
149756584|NCT02795988|540237992|FG005|Phase 2 Extension|Other reasons|2|||
149756585|NCT02795988|540237993|FG006|Phase 2 Extension|Other reasons|1|||
149756586|NCT02985450|540237994|FG000|Overall Study|Lost to Follow-up|7|||
149756587|NCT00069576|540237995|FG000|Original Trial|Lost to Follow-up|25|||
149756588|NCT00069576|540237996|FG001|Original Trial|Lost to Follow-up|33|||
149756589|NCT00069576|540237995|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
149756590|NCT00069576|540237996|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
149756591|NCT04060667|540237997|FG000|Overall Study|Lost to Follow-up|75|||
149756592|NCT04060667|540237998|FG001|Overall Study|Lost to Follow-up|10|||
149756593|NCT00114972|540238001|FG000|Overall Study|Withdrawal by Subject|40|||
149756594|NCT00114972|540238002|FG001|Overall Study|Withdrawal by Subject|7|||
149756595|NCT00114972|540238001|FG000|Overall Study|Lost to Follow-up|8|||
149756596|NCT00114972|540238002|FG001|Overall Study|Lost to Follow-up|5|||
149756597|NCT00358917|540238003|FG000|Overall Study|Adverse Event|14|||
149756598|NCT00358917|540238004|FG001|Overall Study|Adverse Event|21|||
149756599|NCT00358917|540238003|FG000|Overall Study|Withdrawal by Subject|5|||
149756600|NCT00358917|540238004|FG001|Overall Study|Withdrawal by Subject|7|||
149756601|NCT00358917|540238003|FG000|Overall Study|Lost to Follow-up|20|||
149756602|NCT00358917|540238004|FG001|Overall Study|Lost to Follow-up|17|||
149756603|NCT00358917|540238003|FG000|Overall Study|Noncompliance|12|||
149756604|NCT00358917|540238004|FG001|Overall Study|Noncompliance|11|||
149756605|NCT00358917|540238003|FG000|Overall Study|Death|2|||
149756606|NCT00358917|540238004|FG001|Overall Study|Death|3|||
149756607|NCT00358917|540238003|FG000|Overall Study|Virologic failure|11|||
149756608|NCT00358917|540238004|FG001|Overall Study|Virologic failure|8|||
149756609|NCT00358917|540238003|FG000|Overall Study|Unable to Continue Participation|2|||
149756610|NCT00358917|540238004|FG001|Overall Study|Unable to Continue Participation|2|||
149756611|NCT02890329|540238012|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149756612|NCT02890329|540238013|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
149756613|NCT02890329|540238014|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149756614|NCT02890329|540238015|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149756615|NCT02890329|540238016|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149756616|NCT02890329|540238017|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149756617|NCT02890329|540238012|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
149756618|NCT02890329|540238013|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
149756619|NCT02890329|540238014|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149756620|NCT02890329|540238015|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149756621|NCT02890329|540238016|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149756622|NCT02890329|540238017|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149756623|NCT02890329|540238012|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149756624|NCT02890329|540238013|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149756625|NCT02890329|540238014|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149756626|NCT02890329|540238015|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
149756627|NCT02890329|540238016|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149756628|NCT02890329|540238017|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149756629|NCT02890329|540238012|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149756630|NCT02890329|540238013|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149756631|NCT02890329|540238014|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
149756632|NCT02890329|540238015|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149756633|NCT02890329|540238016|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149756634|NCT02890329|540238017|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149756635|NCT00231062|540238023|FG000|Overall Study|Physician Decision|6|||
149756636|NCT00590681|540238027|FG000|Overall Study|Withdrawal by Subject|7|||
149756637|NCT00590681|540238027|FG000|Overall Study|Adverse Event|8|||
149756638|NCT00590681|540238027|FG000|Overall Study|Death|3|||
149756639|NCT00590681|540238027|FG000|Overall Study|Lost to Follow-up|1|||
149756640|NCT00590681|540238027|FG000|Overall Study|disease progression|1|||
149756641|NCT01259297|540238028|FG000|Double Blind Randomized Period|Death|1|||
149756642|NCT01259297|540238029|FG001|Double Blind Randomized Period|Death|1|||
149756643|NCT01259297|540238030|FG002|Double Blind Randomized Period|Death|1|||
149756644|NCT01259297|540238031|FG003|Double Blind Randomized Period|Death|2|||
149756645|NCT01259297|540238032|FG004|Double Blind Randomized Period|Death|1|||
149756646|NCT01259297|540238033|FG005|Double Blind Randomized Period|Death|5|||
149756647|NCT01259297|540238034|FG006|Double Blind Randomized Period|Death|2|||
149756648|NCT01259297|540238035|FG007|Double Blind Randomized Period|Death|1|||
149756649|NCT01259297|540238028|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149756650|NCT01259297|540238029|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149756651|NCT01259297|540238030|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
149756652|NCT01259297|540238031|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
149756653|NCT01259297|540238032|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
149756654|NCT01259297|540238033|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149756655|NCT01259297|540238034|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149756656|NCT01259297|540238035|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149756657|NCT01259297|540238028|FG000|Double Blind Randomized Period|Other reasons|0|||
149756658|NCT01259297|540238029|FG001|Double Blind Randomized Period|Other reasons|1|||
149756659|NCT01259297|540238030|FG002|Double Blind Randomized Period|Other reasons|0|||
149756660|NCT01259297|540238031|FG003|Double Blind Randomized Period|Other reasons|0|||
149756661|NCT01259297|540238032|FG004|Double Blind Randomized Period|Other reasons|1|||
149756662|NCT01259297|540238033|FG005|Double Blind Randomized Period|Other reasons|2|||
149756663|NCT01259297|540238034|FG006|Double Blind Randomized Period|Other reasons|3|||
149756664|NCT01259297|540238035|FG007|Double Blind Randomized Period|Other reasons|1|||
149756665|NCT00443430|540238038|FG000|Overall Study|Lack of Efficacy|3|||
149756666|NCT00443430|540238039|FG001|Overall Study|Lack of Efficacy|3|||
149756667|NCT00443430|540238038|FG000|Overall Study|Adverse Event|1|||
149756668|NCT00443430|540238039|FG001|Overall Study|Adverse Event|1|||
149756669|NCT00592501|540238040|FG000|Overall Study|Withdrawal by Subject|1|||
149756670|NCT00592501|540238040|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
149756671|NCT00053846|540238041|FG000|Overall Study|Changed mind|8|||
149756672|NCT00053846|540238042|FG001|Overall Study|Changed mind|13|||
149756673|NCT00053846|540238041|FG000|Overall Study|Became too ill|8|||
149756674|NCT00053846|540238042|FG001|Overall Study|Became too ill|7|||
149756675|NCT00053846|540238041|FG000|Overall Study|Expired|5|||
149756676|NCT00053846|540238042|FG001|Overall Study|Expired|0|||
149756677|NCT00053846|540238041|FG000|Overall Study|Became ineligible|3|||
149756678|NCT00053846|540238042|FG001|Overall Study|Became ineligible|1|||
149756679|NCT00053846|540238041|FG000|Overall Study|Did not return data|1|||
149756680|NCT00053846|540238042|FG001|Overall Study|Did not return data|2|||
149756681|NCT00053846|540238041|FG000|Overall Study|Quit due to side effects|1|||
149756682|NCT00053846|540238042|FG001|Overall Study|Quit due to side effects|3|||
149756683|NCT00053846|540238041|FG000|Overall Study|Pills too large|0|||
149756684|NCT00053846|540238042|FG001|Overall Study|Pills too large|1|||
149756685|NCT03880227|540238044|FG000|First Visit|Withdrawal by Subject|1|||
149756686|NCT03880227|540238045|FG001|First Visit|Withdrawal by Subject|0|||
149756687|NCT03880227|540238046|FG002|First Visit|Withdrawal by Subject|0|||
149756688|NCT03880227|540238047|FG003|First Visit|Withdrawal by Subject|0|||
149756689|NCT03880227|540238044|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
149756690|NCT03880227|540238045|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
149756691|NCT03880227|540238046|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
149756692|NCT03880227|540238047|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
149756693|NCT03880227|540238044|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149756694|NCT03880227|540238045|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149756695|NCT03880227|540238046|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
149756696|NCT03880227|540238047|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149756697|NCT03880227|540238044|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149756698|NCT03880227|540238045|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149756699|NCT03880227|540238046|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
149756700|NCT03880227|540238047|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149756701|NCT00504166|540238048|FG000|Overall Study|Adverse Event|1|||
149756702|NCT00504166|540238049|FG001|Overall Study|Adverse Event|4|||
149756703|NCT00504166|540238048|FG000|Overall Study|Withdrawal by Subject|3|||
149756704|NCT00504166|540238049|FG001|Overall Study|Withdrawal by Subject|6|||
149756705|NCT00504166|540238048|FG000|Overall Study|Physician Decision|1|||
149756706|NCT00504166|540238049|FG001|Overall Study|Physician Decision|1|||
149756707|NCT00504166|540238048|FG000|Overall Study|Lost to Follow-up|1|||
149756708|NCT00504166|540238049|FG001|Overall Study|Lost to Follow-up|3|||
149756709|NCT02650284|540238052|FG000|Overall Study|Lost to Follow-up|3|||
149756710|NCT02650284|540238053|FG001|Overall Study|Lost to Follow-up|3|||
149756711|NCT02650284|540238052|FG000|Overall Study|Consent incorrectly taken|0|||
149756712|NCT02650284|540238053|FG001|Overall Study|Consent incorrectly taken|1|||
149756713|NCT01929044|540238059|FG000|Overall Study|Adverse Event|1|||
149756714|NCT01929044|540238060|FG001|Overall Study|Adverse Event|0|||
149756715|NCT01929044|540238059|FG000|Overall Study|Protocol Violation|9|||
149756716|NCT01929044|540238060|FG001|Overall Study|Protocol Violation|14|||
149756717|NCT01929044|540238059|FG000|Overall Study|Not Treated|1|||
149756718|NCT01929044|540238060|FG001|Overall Study|Not Treated|3|||
149756719|NCT01555463|540238065|FG000|Treatment|Adverse Event|6|||
149756720|NCT01555463|540238066|FG001|Treatment|Adverse Event|12|||
149756721|NCT01555463|540238065|FG000|Treatment|Withdrawal by Subject|24|||
149756722|NCT01555463|540238066|FG001|Treatment|Withdrawal by Subject|36|||
149756723|NCT01555463|540238065|FG000|Treatment|Lost to Follow-up|28|||
149756724|NCT01555463|540238066|FG001|Treatment|Lost to Follow-up|23|||
149756725|NCT01555463|540238065|FG000|Treatment|Protocol Violation|4|||
149756726|NCT01555463|540238066|FG001|Treatment|Protocol Violation|5|||
149756727|NCT01555463|540238065|FG000|Treatment|Other reason|2|||
149756728|NCT01555463|540238066|FG001|Treatment|Other reason|3|||
149756729|NCT01555463|540238065|FG000|Follow up|Adverse Event|2|||
149756730|NCT01555463|540238066|FG001|Follow up|Adverse Event|5|||
149756731|NCT01555463|540238065|FG000|Follow up|Death|0|||
149756732|NCT01555463|540238066|FG001|Follow up|Death|1|||
149756733|NCT01555463|540238065|FG000|Follow up|Withdrawal by Subject|22|||
149756734|NCT01555463|540238066|FG001|Follow up|Withdrawal by Subject|22|||
149756735|NCT01555463|540238065|FG000|Follow up|Lost to Follow-up|9|||
149756736|NCT01555463|540238066|FG001|Follow up|Lost to Follow-up|10|||
149756737|NCT01555463|540238065|FG000|Follow up|Protocol Violation|2|||
149756738|NCT01555463|540238066|FG001|Follow up|Protocol Violation|4|||
149756739|NCT01555463|540238065|FG000|Follow up|Other reason|3|||
149756740|NCT01555463|540238066|FG001|Follow up|Other reason|3|||
149756741|NCT02084134|540238067|FG000|Overall Study|Protocol Violation|4|||
149756742|NCT02084134|540238068|FG001|Overall Study|Protocol Violation|2|||
149756743|NCT02084134|540238067|FG000|Overall Study|Death|0|||
149756744|NCT02084134|540238068|FG001|Overall Study|Death|1|||
149756745|NCT04333433|540238069|FG000|Overall Study|Withdrawal by Subject|6|||
149756746|NCT04333433|540238070|FG001|Overall Study|Withdrawal by Subject|3|||
149756747|NCT04333433|540238069|FG000|Overall Study|Death|3|||
149756748|NCT04333433|540238070|FG001|Overall Study|Death|0|||
149756749|NCT04333433|540238069|FG000|Overall Study|Lost to Follow-up|6|||
149756750|NCT04333433|540238070|FG001|Overall Study|Lost to Follow-up|1|||
149756751|NCT04333433|540238069|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
149756752|NCT04333433|540238070|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
149756753|NCT02807454|540238071|FG000|Overall Study|Adverse Event|1|||
149756754|NCT02807454|540238072|FG001|Overall Study|Adverse Event|0|||
149756755|NCT02807454|540238071|FG000|Overall Study|Withdrawal by Subject|0|||
149756756|NCT02807454|540238072|FG001|Overall Study|Withdrawal by Subject|1|||
149756757|NCT02807454|540238071|FG000|Overall Study|Progressive Disease|30|||
149756758|NCT02807454|540238072|FG001|Overall Study|Progressive Disease|3|||
149756759|NCT02807454|540238071|FG000|Overall Study|Other Reasons|1|||
149756760|NCT02807454|540238072|FG001|Overall Study|Other Reasons|1|||
149756761|NCT05468086|540238073|FG000|Overall Study|Withdrawal by Subject|3|||
149756762|NCT05468086|540238073|FG000|Overall Study|Subject was found ineligible after consent|1|||
149756763|NCT01165203|540238074|FG000|Active Phase|Serious Adverse Event|1|||
149756764|NCT01165203|540238075|FG001|Active Phase|Serious Adverse Event|0|||
149756765|NCT01165203|540238074|FG000|Active Phase|Withdrawal by Subject|2|||
149756766|NCT01165203|540238075|FG001|Active Phase|Withdrawal by Subject|1|||
149756767|NCT01165203|540238074|FG000|Active Phase|Migrated/moved from study area|0|||
149756768|NCT01165203|540238075|FG001|Active Phase|Migrated/moved from study area|1|||
149756769|NCT01165203|540238074|FG000|Active Phase|Lost to Follow-up|2|||
149756770|NCT01165203|540238075|FG001|Active Phase|Lost to Follow-up|0|||
149756771|NCT01165203|540238074|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
149756772|NCT01165203|540238075|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
149756773|NCT01165203|540238074|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
149756774|NCT01165203|540238075|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
149756775|NCT01165203|540238074|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
149756776|NCT01165203|540238075|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
149756777|NCT01165203|540238074|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
149756778|NCT01165203|540238075|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
149756779|NCT01165203|540238074|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
149756780|NCT01165203|540238075|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
149756781|NCT01070784|540238076|FG000|Overall Study|Withdrawal by Subject|6|||
149756782|NCT01070784|540238077|FG001|Overall Study|Withdrawal by Subject|9|||
149756783|NCT01070784|540238076|FG000|Overall Study|Adverse Event|14|||
149756784|NCT01070784|540238077|FG001|Overall Study|Adverse Event|9|||
149756785|NCT02815397|540238079|FG000|Overall Study|Physician Decision|2|||
149756786|NCT00085540|540238080|FG000|Overall Study|Withdrawal by Subject|0|||
149756787|NCT00085540|540238081|FG001|Overall Study|Withdrawal by Subject|1|||
149756788|NCT00085540|540238080|FG000|Overall Study|Protocol Violation|0|||
149756789|NCT00085540|540238081|FG001|Overall Study|Protocol Violation|1|||
149756790|NCT01518192|540238082|FG000|Overall Study|Lost to Follow-up|29|||
149756791|NCT01518192|540238083|FG001|Overall Study|Lost to Follow-up|26|||
149756792|NCT01518192|540238084|FG002|Overall Study|Lost to Follow-up|35|||
149756793|NCT00783705|540238085|FG000|Overall Study|Adverse Event|2|||
149756794|NCT00783705|540238086|FG001|Overall Study|Adverse Event|0|||
149756795|NCT00783705|540238085|FG000|Overall Study|Withdrawal by Subject|3|||
149756796|NCT00783705|540238086|FG001|Overall Study|Withdrawal by Subject|2|||
149756797|NCT00783705|540238085|FG000|Overall Study|Lost to Follow-up|1|||
149756798|NCT00783705|540238086|FG001|Overall Study|Lost to Follow-up|3|||
149756799|NCT00426751|540238087|FG000|Overall Study|Adverse Event|8|||
149756800|NCT00426751|540238088|FG001|Overall Study|Adverse Event|1|||
149756801|NCT00426751|540238087|FG000|Overall Study|Lost to Follow-up|7|||
149756802|NCT00426751|540238088|FG001|Overall Study|Lost to Follow-up|6|||
149756803|NCT00426751|540238087|FG000|Overall Study|Consent Withdrawn|0|||
149756804|NCT00426751|540238088|FG001|Overall Study|Consent Withdrawn|1|||
149756805|NCT00426751|540238087|FG000|Overall Study|Other Reasons|7|||
149756806|NCT00426751|540238088|FG001|Overall Study|Other Reasons|12|||
149756807|NCT01200511|540238093|FG000|Overall Study|Lost to Follow-up|3|||
149756808|NCT01200511|540238093|FG000|Overall Study|Withdrawal by Subject|1|||
149756809|NCT01200511|540238093|FG000|Overall Study|Adverse Event|1|||
149756810|NCT03288779|540238094|FG000|Overall Study|Withdrawal by Subject|3|||
149756811|NCT01355068|540238097|FG000|First Intervention Period|Adverse Event|0|||
149756812|NCT01355068|540238098|FG001|First Intervention Period|Adverse Event|1|||
149756813|NCT01355068|540238097|FG000|First Intervention Period|Withdrawal by Subject|0|||
149756814|NCT01355068|540238098|FG001|First Intervention Period|Withdrawal by Subject|1|||
149756815|NCT01770353|540238100|FG000|Overall Study|Progressive disease|2|||
149756816|NCT01770353|540238101|FG001|Overall Study|Progressive disease|1|||
149756817|NCT01770353|540238100|FG000|Overall Study|Adverse Event|0|||
149756818|NCT01770353|540238101|FG001|Overall Study|Adverse Event|1|||
149756819|NCT01770353|540238100|FG000|Overall Study|Protocol Violation|1|||
149756820|NCT01770353|540238101|FG001|Overall Study|Protocol Violation|0|||
149756821|NCT01770353|540238100|FG000|Overall Study|Physician Decision|0|||
149756822|NCT01770353|540238101|FG001|Overall Study|Physician Decision|3|||
149756823|NCT01770353|540238100|FG000|Overall Study|Clinical deterioration|3|||
149756824|NCT01770353|540238101|FG001|Overall Study|Clinical deterioration|6|||
149756825|NCT01770353|540238100|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
149756826|NCT01770353|540238101|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
149756827|NCT00376688|540238102|FG000|Overall Study|Adverse Event|3|||
149756828|NCT00376688|540238102|FG000|Overall Study|Death|1|||
149756829|NCT00620321|540239419|FG000|Overall Study|Adverse Event|1|||
149756830|NCT00620321|540239420|FG001|Overall Study|Adverse Event|1|||
149756831|NCT00620321|540239419|FG000|Overall Study|Death|1|||
149756832|NCT00620321|540239420|FG001|Overall Study|Death|1|||
149756833|NCT00620321|540239419|FG000|Overall Study|Physician Decision|0|||
149756834|NCT00620321|540239420|FG001|Overall Study|Physician Decision|7|||
149756835|NCT00620321|540239419|FG000|Overall Study|Progressive Disease|5|||
149756836|NCT00620321|540239420|FG001|Overall Study|Progressive Disease|5|||
149756837|NCT00620321|540239419|FG000|Overall Study|Sponsor Decision|0|||
149756838|NCT00620321|540239420|FG001|Overall Study|Sponsor Decision|1|||
149756839|NCT00620321|540239419|FG000|Overall Study|Withdrawal by Subject|1|||
149756840|NCT00620321|540239420|FG001|Overall Study|Withdrawal by Subject|1|||
149756841|NCT02279524|540239422|FG000|Overall Study|Withdrawal by Subject|3|||
149756842|NCT02279524|540239423|FG001|Overall Study|Withdrawal by Subject|6|||
149756843|NCT02279524|540239424|FG002|Overall Study|Withdrawal by Subject|3|||
149756844|NCT02279524|540239422|FG000|Overall Study|Adverse Event|4|||
149756845|NCT02279524|540239423|FG001|Overall Study|Adverse Event|3|||
149756846|NCT02279524|540239424|FG002|Overall Study|Adverse Event|2|||
149756847|NCT02279524|540239422|FG000|Overall Study|Lost to Follow-up|1|||
149756848|NCT02279524|540239423|FG001|Overall Study|Lost to Follow-up|1|||
149756849|NCT02279524|540239424|FG002|Overall Study|Lost to Follow-up|0|||
149756850|NCT02279524|540239422|FG000|Overall Study|Disallowed medication|1|||
149756851|NCT02279524|540239423|FG001|Overall Study|Disallowed medication|1|||
149756852|NCT02279524|540239424|FG002|Overall Study|Disallowed medication|2|||
149756853|NCT02279524|540239422|FG000|Overall Study|Bariatric surgery|1|||
149756854|NCT02279524|540239423|FG001|Overall Study|Bariatric surgery|0|||
149756855|NCT02279524|540239424|FG002|Overall Study|Bariatric surgery|0|||
149756856|NCT01746732|540239425|FG000|Lead-In Period|Withdrawal by Subject|1|||
149756857|NCT01746732|540239426|FG001|Lead-In Period|Withdrawal by Subject|0|||
149756858|NCT01746732|540239427|FG002|Lead-In Period|Withdrawal by Subject|0|||
149756859|NCT01746732|540239425|FG000|Period 1|Physician Decision|0|||
149756860|NCT01746732|540239426|FG001|Period 1|Physician Decision|1|||
149756861|NCT01746732|540239427|FG002|Period 1|Physician Decision|0|||
149756862|NCT01746732|540239425|FG000|Period 2|Withdrawal by Subject|0|||
149756863|NCT01746732|540239426|FG001|Period 2|Withdrawal by Subject|0|||
149756864|NCT01746732|540239427|FG002|Period 2|Withdrawal by Subject|2|||
149756865|NCT01746732|540239425|FG000|Period 2|Adverse Event|0|||
149756866|NCT01746732|540239426|FG001|Period 2|Adverse Event|0|||
149756867|NCT01746732|540239427|FG002|Period 2|Adverse Event|1|||
149756868|NCT01746732|540239425|FG000|Period 2|Lost to Follow-up|0|||
149756869|NCT01746732|540239426|FG001|Period 2|Lost to Follow-up|0|||
149756870|NCT01746732|540239427|FG002|Period 2|Lost to Follow-up|1|||
149756871|NCT02817555|540239428|FG000|Overall Study|Death|1|||
149756872|NCT02817555|540239429|FG001|Overall Study|Death|3|||
149756873|NCT02817555|540239428|FG000|Overall Study|moved away|1|||
149756874|NCT02817555|540239429|FG001|Overall Study|moved away|0|||
149756875|NCT02817555|540239428|FG000|Overall Study|transplant|1|||
149756876|NCT02817555|540239429|FG001|Overall Study|transplant|1|||
149756877|NCT02817555|540239428|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
149756878|NCT02817555|540239429|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
149756879|NCT01755195|540239430|FG000|Overall Study|Participant noncompliance|2|||
149756880|NCT01755195|540239430|FG000|Overall Study|Switched to alternative treatment|4|||
149756881|NCT01755195|540239430|FG000|Overall Study|Withdrawal by Subject|1|||
149756882|NCT01755195|540239430|FG000|Overall Study|Participant refused to start treatment|1|||
149756883|NCT01755195|540239430|FG000|Overall Study|Participant has been consented for another trial|1|||
149756884|NCT01755195|540239430|FG000|Overall Study|Refused further treatment|3|||
149756885|NCT01755195|540239430|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
149756886|NCT02340819|540239431|FG000|Overall Study|Adverse Event|1|||
149756887|NCT02340819|540239431|FG000|Overall Study|Withdrawal by Subject|2|||
149756888|NCT02340819|540239431|FG000|Overall Study|Discontinued with other reason|1|||
149756889|NCT02273050|540239433|FG000|Overall Study|Adverse Event|4|||
149756890|NCT02273050|540239434|FG001|Overall Study|Adverse Event|3|||
149756891|NCT02273050|540239435|FG002|Overall Study|Adverse Event|3|||
149756892|NCT02273050|540239433|FG000|Overall Study|Death|0|||
149756893|NCT02273050|540239434|FG001|Overall Study|Death|0|||
149756894|NCT02273050|540239435|FG002|Overall Study|Death|1|||
149756895|NCT02273050|540239433|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
149756896|NCT02273050|540239434|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
149756897|NCT02273050|540239435|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
149756898|NCT02273050|540239433|FG000|Overall Study|Lack of Efficacy|0|||
149756899|NCT02273050|540239434|FG001|Overall Study|Lack of Efficacy|1|||
149756900|NCT02273050|540239435|FG002|Overall Study|Lack of Efficacy|1|||
149756901|NCT02273050|540239433|FG000|Overall Study|Withdrawal by Subject|17|||
149756902|NCT02273050|540239434|FG001|Overall Study|Withdrawal by Subject|14|||
149756903|NCT02273050|540239435|FG002|Overall Study|Withdrawal by Subject|16|||
149756904|NCT02273050|540239433|FG000|Overall Study|Lost to Follow-up|0|||
149756905|NCT02273050|540239434|FG001|Overall Study|Lost to Follow-up|2|||
149756906|NCT02273050|540239435|FG002|Overall Study|Lost to Follow-up|3|||
149756907|NCT02273050|540239433|FG000|Overall Study|Protocol Violation|3|||
149756908|NCT02273050|540239434|FG001|Overall Study|Protocol Violation|1|||
149756909|NCT02273050|540239435|FG002|Overall Study|Protocol Violation|4|||
149756910|NCT03539458|540239437|FG000|Overall Study|Death|1|||
149756911|NCT02042404|540239440|FG000|Overall Study|Death|1|||
149756912|NCT02042404|540239441|FG001|Overall Study|Death|0|||
149756913|NCT02042404|540239440|FG000|Overall Study|Unrelated Adverse Event|3|||
149756914|NCT02042404|540239441|FG001|Overall Study|Unrelated Adverse Event|0|||
149756915|NCT02042404|540239440|FG000|Overall Study|Inability to meet time requirements|1|||
149756916|NCT02042404|540239441|FG001|Overall Study|Inability to meet time requirements|0|||
149756917|NCT03100942|540239442|FG000|Randomized Treatment Period|Withdrew Consent|4|||
149756918|NCT03100942|540239443|FG001|Randomized Treatment Period|Withdrew Consent|5|||
149756919|NCT03100942|540239444|FG002|Randomized Treatment Period|Withdrew Consent|3|||
149756920|NCT03100942|540239445|FG003|Randomized Treatment Period|Withdrew Consent|3|||
149756921|NCT03100942|540239446|FG004|Randomized Treatment Period|Withdrew Consent|0|||
149756922|NCT03100942|540239447|FG005|Randomized Treatment Period|Withdrew Consent|0|||
149756923|NCT03100942|540239448|FG006|Randomized Treatment Period|Withdrew Consent|0|||
149756924|NCT03100942|540239442|FG000|Randomized Treatment Period|Adverse Event|5|||
149756925|NCT03100942|540239443|FG001|Randomized Treatment Period|Adverse Event|2|||
149756926|NCT03100942|540239444|FG002|Randomized Treatment Period|Adverse Event|1|||
149756927|NCT03100942|540239445|FG003|Randomized Treatment Period|Adverse Event|0|||
149756928|NCT03100942|540239446|FG004|Randomized Treatment Period|Adverse Event|0|||
149756929|NCT03100942|540239447|FG005|Randomized Treatment Period|Adverse Event|0|||
149756930|NCT03100942|540239448|FG006|Randomized Treatment Period|Adverse Event|0|||
149756931|NCT03100942|540239442|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
149756932|NCT03100942|540239443|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
149756933|NCT03100942|540239444|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
149756934|NCT03100942|540239445|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
149756935|NCT03100942|540239446|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
149756936|NCT03100942|540239447|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
149756937|NCT03100942|540239448|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
149756938|NCT03100942|540239442|FG000|Randomized Treatment Period|Protocol Violation|0|||
149756939|NCT03100942|540239443|FG001|Randomized Treatment Period|Protocol Violation|1|||
149756940|NCT03100942|540239444|FG002|Randomized Treatment Period|Protocol Violation|1|||
149756941|NCT03100942|540239445|FG003|Randomized Treatment Period|Protocol Violation|1|||
149756942|NCT03100942|540239446|FG004|Randomized Treatment Period|Protocol Violation|0|||
149756943|NCT03100942|540239447|FG005|Randomized Treatment Period|Protocol Violation|0|||
149756944|NCT03100942|540239448|FG006|Randomized Treatment Period|Protocol Violation|0|||
149756945|NCT03100942|540239442|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
149756946|NCT03100942|540239443|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
149756947|NCT03100942|540239444|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
149756948|NCT03100942|540239445|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
149756949|NCT03100942|540239446|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
149756950|NCT03100942|540239447|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
149756951|NCT03100942|540239448|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
149756952|NCT03100942|540239442|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
149756953|NCT03100942|540239443|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149756954|NCT03100942|540239444|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149756955|NCT03100942|540239445|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
149756956|NCT03100942|540239446|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149756957|NCT03100942|540239447|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149756958|NCT03100942|540239448|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149756959|NCT03100942|540239442|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756960|NCT03100942|540239443|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756961|NCT03100942|540239444|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756962|NCT03100942|540239445|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756963|NCT03100942|540239446|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756964|NCT03100942|540239447|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149756965|NCT03100942|540239448|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
149756966|NCT00718419|540239449|FG000|Overall Study|Adverse Event|2|||
149756967|NCT00718419|540239450|FG001|Overall Study|Adverse Event|1|||
149756968|NCT00718419|540239449|FG000|Overall Study|Physician Decision|1|||
149756969|NCT00718419|540239450|FG001|Overall Study|Physician Decision|6|||
149756970|NCT00718419|540239449|FG000|Overall Study|Sponsor decision|0|||
149756971|NCT00718419|540239450|FG001|Overall Study|Sponsor decision|1|||
149756972|NCT00718419|540239449|FG000|Overall Study|Withdrawal by Subject|0|||
149756973|NCT00718419|540239450|FG001|Overall Study|Withdrawal by Subject|5|||
149756974|NCT00718419|540239449|FG000|Overall Study|Progressive Disease|7|||
149756975|NCT00718419|540239450|FG001|Overall Study|Progressive Disease|25|||
149756976|NCT00718419|540239449|FG000|Overall Study|Death Due to Progressive Disease|2|||
149756977|NCT00718419|540239450|FG001|Overall Study|Death Due to Progressive Disease|0|||
149756978|NCT00718419|540239449|FG000|Overall Study|Death Due to Study Drug Related|0|||
149756979|NCT00718419|540239450|FG001|Overall Study|Death Due to Study Drug Related|1|||
149756980|NCT00718419|540239449|FG000|Overall Study|Death Due to Adverse Events|1|||
149756981|NCT00718419|540239450|FG001|Overall Study|Death Due to Adverse Events|0|||
149756982|NCT01675531|540239451|FG000|Overall Study|Adverse Event|9|||
149756983|NCT01675531|540239451|FG000|Overall Study|Withdrawal by Subject|7|||
149756984|NCT01675531|540239451|FG000|Overall Study|Lack of Efficacy|1|||
149756985|NCT01675531|540239451|FG000|Overall Study|Protocol Violation|8|||
149756986|NCT01617681|540239452|FG000|Period 1 Double Blind|Adverse Event|2|||
149756987|NCT01617681|540239453|FG001|Period 1 Double Blind|Adverse Event|0|||
149756988|NCT01617681|540239454|FG002|Period 1 Double Blind|Adverse Event|0|||
149756989|NCT01617681|540239455|FG003|Period 1 Double Blind|Adverse Event|2|||
149756990|NCT01617681|540239456|FG004|Period 1 Double Blind|Adverse Event|0|||
149756991|NCT01617681|540239452|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
149756992|NCT01617681|540239453|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
149756993|NCT01617681|540239454|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
149756994|NCT01617681|540239455|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
149756995|NCT01617681|540239456|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
149756996|NCT01617681|540239452|FG000|Period 2 Open Label|Adverse Event|0|||
149756997|NCT01617681|540239453|FG001|Period 2 Open Label|Adverse Event|0|||
149756998|NCT01617681|540239454|FG002|Period 2 Open Label|Adverse Event|0|||
149756999|NCT01617681|540239455|FG003|Period 2 Open Label|Adverse Event|0|||
149757000|NCT01617681|540239456|FG004|Period 2 Open Label|Adverse Event|3|||
149757001|NCT01617681|540239452|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
149757002|NCT01617681|540239453|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
149757003|NCT01617681|540239454|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
149757004|NCT01617681|540239455|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
149757005|NCT01617681|540239456|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
149757006|NCT02280291|540239461|FG000|Overall Study|Lost to Follow-up|2|||
149757007|NCT02280291|540239462|FG001|Overall Study|Lost to Follow-up|1|||
149757008|NCT02280291|540239463|FG002|Overall Study|Lost to Follow-up|3|||
149757009|NCT02280291|540239464|FG003|Overall Study|Lost to Follow-up|8|||
149757010|NCT02280291|540239461|FG000|Overall Study|Protocol Violation|1|||
149757011|NCT02280291|540239462|FG001|Overall Study|Protocol Violation|0|||
149757012|NCT02280291|540239463|FG002|Overall Study|Protocol Violation|0|||
149757013|NCT02280291|540239464|FG003|Overall Study|Protocol Violation|0|||
149757014|NCT02280291|540239461|FG000|Overall Study|Other|1|||
149757015|NCT02280291|540239462|FG001|Overall Study|Other|1|||
149757016|NCT02280291|540239463|FG002|Overall Study|Other|0|||
149757017|NCT02280291|540239464|FG003|Overall Study|Other|0|||
149757018|NCT02918266|540239466|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
149757019|NCT02918266|540239467|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757020|NCT02918266|540239468|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757021|NCT02918266|540239469|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757022|NCT02918266|540239470|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757023|NCT02918266|540239471|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757024|NCT02918266|540239472|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
149757025|NCT02918266|540239473|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757026|NCT02918266|540239474|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
149757027|NCT02918266|540239475|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757028|NCT02918266|540239476|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149757029|NCT01293032|540239477|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149757030|NCT01293032|540239478|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149757031|NCT01293032|540239479|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
149757032|NCT01293032|540239480|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149757033|NCT01293032|540239477|FG000|Treatment|Adverse Event|0|||
149757034|NCT01293032|540239478|FG001|Treatment|Adverse Event|0|||
149757035|NCT01293032|540239479|FG002|Treatment|Adverse Event|1|||
149757036|NCT01293032|540239480|FG003|Treatment|Adverse Event|1|||
149757037|NCT01293032|540239477|FG000|Treatment|Withdrawal by Subject|2|||
149757038|NCT01293032|540239478|FG001|Treatment|Withdrawal by Subject|4|||
149757039|NCT01293032|540239479|FG002|Treatment|Withdrawal by Subject|0|||
149757040|NCT01293032|540239480|FG003|Treatment|Withdrawal by Subject|0|||
149757041|NCT01293032|540239477|FG000|Treatment|Disease Progression, relapse|0|||
149757042|NCT01293032|540239478|FG001|Treatment|Disease Progression, relapse|1|||
149757043|NCT01293032|540239479|FG002|Treatment|Disease Progression, relapse|0|||
149757044|NCT01293032|540239480|FG003|Treatment|Disease Progression, relapse|0|||
149757045|NCT01106534|540239483|FG000|Overall Study|Withdrawal by Subject|18|||
149757046|NCT01106534|540239483|FG000|Overall Study|Lost to Follow-up|2|||
149757047|NCT01106534|540239483|FG000|Overall Study|Death|16|||
149757048|NCT01106534|540239483|FG000|Overall Study|Physician Decision|1|||
149757049|NCT00905307|540239493|FG000|Overall Study|Switched to Open Label Rescue|7|||
149757050|NCT00905307|540239494|FG001|Overall Study|Switched to Open Label Rescue|17|||
149757051|NCT00905307|540239495|FG002|Overall Study|Switched to Open Label Rescue|11|||
149757052|NCT00905307|540239496|FG003|Overall Study|Switched to Open Label Rescue|11|||
149757053|NCT00905307|540239497|FG004|Overall Study|Switched to Open Label Rescue|4|||
149757054|NCT00905307|540239498|FG005|Overall Study|Switched to Open Label Rescue|15|||
149757055|NCT00905307|540239493|FG000|Overall Study|Lost to Follow-up|0|||
149757056|NCT00905307|540239494|FG001|Overall Study|Lost to Follow-up|0|||
149757057|NCT00905307|540239495|FG002|Overall Study|Lost to Follow-up|0|||
149757058|NCT00905307|540239496|FG003|Overall Study|Lost to Follow-up|0|||
149757059|NCT00905307|540239497|FG004|Overall Study|Lost to Follow-up|1|||
149757060|NCT00905307|540239498|FG005|Overall Study|Lost to Follow-up|1|||
149757061|NCT00905307|540239493|FG000|Overall Study|Adverse Event|3|||
149757062|NCT00905307|540239494|FG001|Overall Study|Adverse Event|4|||
149757063|NCT00905307|540239495|FG002|Overall Study|Adverse Event|5|||
149757064|NCT00905307|540239496|FG003|Overall Study|Adverse Event|11|||
149757065|NCT00905307|540239497|FG004|Overall Study|Adverse Event|3|||
149757066|NCT00905307|540239498|FG005|Overall Study|Adverse Event|5|||
149757067|NCT00905307|540239493|FG000|Overall Study|Withdrawal by Subject|5|||
149757068|NCT00905307|540239494|FG001|Overall Study|Withdrawal by Subject|13|||
149757069|NCT00905307|540239495|FG002|Overall Study|Withdrawal by Subject|15|||
149757070|NCT00905307|540239496|FG003|Overall Study|Withdrawal by Subject|11|||
149757071|NCT00905307|540239497|FG004|Overall Study|Withdrawal by Subject|4|||
149757072|NCT00905307|540239498|FG005|Overall Study|Withdrawal by Subject|13|||
149757073|NCT00905307|540239493|FG000|Overall Study|Protocol Violation|1|||
149757074|NCT00905307|540239494|FG001|Overall Study|Protocol Violation|0|||
149757075|NCT00905307|540239495|FG002|Overall Study|Protocol Violation|1|||
149757076|NCT00905307|540239496|FG003|Overall Study|Protocol Violation|0|||
149757077|NCT00905307|540239497|FG004|Overall Study|Protocol Violation|0|||
149757078|NCT00905307|540239498|FG005|Overall Study|Protocol Violation|0|||
149757079|NCT00905307|540239493|FG000|Overall Study|Lack of Efficacy|6|||
149757080|NCT00905307|540239494|FG001|Overall Study|Lack of Efficacy|3|||
149757081|NCT00905307|540239495|FG002|Overall Study|Lack of Efficacy|5|||
149757082|NCT00905307|540239496|FG003|Overall Study|Lack of Efficacy|4|||
149757083|NCT00905307|540239497|FG004|Overall Study|Lack of Efficacy|4|||
149757084|NCT00905307|540239498|FG005|Overall Study|Lack of Efficacy|8|||
149757085|NCT05590793|540239499|FG000|Overall Study|Withdrawal by Subject|6|||
149757086|NCT05590793|540239499|FG000|Overall Study|Physician Decision|1|||
149757087|NCT04488822|540239500|FG000|Overall Study|Adverse Event|8|||
149757088|NCT04488822|540239500|FG000|Overall Study|Withdrawal by Subject|1|||
149757089|NCT03838367|540239501|FG000|Overall Study|Early termination of study|3|||
149757090|NCT03838367|540239502|FG001|Overall Study|Early termination of study|4|||
149757091|NCT03838367|540239503|FG002|Overall Study|Early termination of study|3|||
149757092|NCT03838367|540239504|FG003|Overall Study|Early termination of study|0|||
149757093|NCT03406104|540239505|FG000|Overall Study|Lost to Follow-up|2|||
149757094|NCT03406104|540239505|FG000|Overall Study|Withdrawal by Subject|2|||
149757095|NCT03406104|540239505|FG000|Overall Study|due to Covid patient did not want to travel|1|||
149757096|NCT03406104|540239505|FG000|Overall Study|Death|2|||
149757097|NCT01035255|540239512|FG000|Overall Study|Death|724|||
149757098|NCT01035255|540239513|FG001|Overall Study|Death|844|||
149757099|NCT01035255|540239512|FG000|Overall Study|Lost to Follow-up|2|||
149757100|NCT01035255|540239513|FG001|Overall Study|Lost to Follow-up|5|||
149757101|NCT01035255|540239512|FG000|Overall Study|patient's request|15|||
149757102|NCT01035255|540239513|FG001|Overall Study|patient's request|13|||
149757103|NCT00803244|540239514|FG000|Overall Study|Adverse Event|1|||
149757104|NCT00803244|540239515|FG001|Overall Study|Adverse Event|2|||
149757105|NCT00803244|540239514|FG000|Overall Study|Withdrawal by Subject|2|||
149757106|NCT00803244|540239515|FG001|Overall Study|Withdrawal by Subject|3|||
149757107|NCT00803244|540239514|FG000|Overall Study|Any other reason not above-mentioned|4|||
149757108|NCT00803244|540239515|FG001|Overall Study|Any other reason not above-mentioned|10|||
149757109|NCT00616239|540239516|FG000|Overall Study|Withdrawal by Subject|2|||
149757110|NCT02873715|540239517|FG000|Overall Study|Lost to Follow-up|84|||
149757111|NCT02873715|540239518|FG001|Overall Study|Lost to Follow-up|94|||
149757112|NCT02873715|540239517|FG000|Overall Study|Withdrawal by Subject|7|||
149757113|NCT02873715|540239518|FG001|Overall Study|Withdrawal by Subject|26|||
149757114|NCT00933335|540239521|FG000|Overall Study|Lost to Follow-up|1|||
149757115|NCT00933335|540239522|FG001|Overall Study|Lost to Follow-up|3|||
149757116|NCT00933335|540239521|FG000|Overall Study|Withdrawal by Subject|0|||
149757117|NCT00933335|540239522|FG001|Overall Study|Withdrawal by Subject|1|||
149757118|NCT00933335|540239521|FG000|Overall Study|Progressive Disease|0|||
149757119|NCT00933335|540239522|FG001|Overall Study|Progressive Disease|11|||
149757120|NCT00933335|540239521|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
149757121|NCT00933335|540239522|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
149757122|NCT00933335|540239521|FG000|Overall Study|Co-morbid Illness|1|||
149757123|NCT00933335|540239522|FG001|Overall Study|Co-morbid Illness|0|||
149757124|NCT04590937|540239523|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
149757125|NCT02026271|540239524|FG000|Overall Study|Adverse Event|2|||
149757126|NCT02026271|540239525|FG001|Overall Study|Adverse Event|3|||
149757127|NCT02026271|540239526|FG002|Overall Study|Adverse Event|2|||
149757128|NCT02026271|540239527|FG003|Overall Study|Adverse Event|3|||
149757129|NCT02026271|540239528|FG004|Overall Study|Adverse Event|0|||
149757130|NCT02026271|540239524|FG000|Overall Study|Withdrawal by Subject|0|||
149757131|NCT02026271|540239525|FG001|Overall Study|Withdrawal by Subject|0|||
149757132|NCT02026271|540239526|FG002|Overall Study|Withdrawal by Subject|0|||
149757133|NCT02026271|540239527|FG003|Overall Study|Withdrawal by Subject|0|||
149757134|NCT02026271|540239528|FG004|Overall Study|Withdrawal by Subject|1|||
149757135|NCT02275026|540239529|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
149757136|NCT02275026|540239529|FG000|Overall Study|Withdrawal by Subject|4|||
149757137|NCT02275026|540239529|FG000|Overall Study|Ineligible due to medical history|13|||
149757138|NCT02275026|540239529|FG000|Overall Study|MRI malfunction precluded testing|1|||
149757139|NCT02275026|540239529|FG000|Overall Study|Ineligible after MRI findings|1|||
149757140|NCT02275026|540239529|FG000|Overall Study|Lost to Follow-up|2|||
149757141|NCT02275026|540239529|FG000|Overall Study|Scanner failure|1|||
149757142|NCT00374907|540239532|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
149757143|NCT00374907|540239533|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
149757144|NCT00374907|540239532|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
149757145|NCT00374907|540239533|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
149757146|NCT00374907|540239532|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
149757147|NCT00374907|540239533|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
149757148|NCT00374907|540239532|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
149757149|NCT00374907|540239533|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
149757150|NCT00374907|540239532|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
149757151|NCT00374907|540239533|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
149757152|NCT01108809|540239534|FG000|Overall Study|Adverse Event|3|||
149757153|NCT01108809|540239534|FG000|Overall Study|Lost to Follow-up|1|||
149757154|NCT02213198|540239539|FG000|Baseline|No show for intake|7|||
149757155|NCT02213198|540239540|FG001|Baseline|No show for intake|9|||
149757156|NCT02213198|540239539|FG000|Baseline|Withdrawal by Subject|34|||
149757157|NCT02213198|540239540|FG001|Baseline|Withdrawal by Subject|11|||
149757158|NCT02213198|540239539|FG000|Baseline|transferred out of clinic|7|||
149757159|NCT02213198|540239540|FG001|Baseline|transferred out of clinic|9|||
149757160|NCT02213198|540239539|FG000|Baseline|Lost to Follow-up|40|||
149757161|NCT02213198|540239540|FG001|Baseline|Lost to Follow-up|21|||
149757162|NCT02213198|540239539|FG000|Baseline|incarcerated,violent|0|||
149757163|NCT02213198|540239540|FG001|Baseline|incarcerated,violent|1|||
149757164|NCT02213198|540239539|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
149757165|NCT02213198|540239540|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
149757166|NCT02213198|540239539|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
149757167|NCT02213198|540239540|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
149757168|NCT02213198|540239539|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
149757169|NCT02213198|540239540|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
149757170|NCT02213198|540239539|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
149757171|NCT02213198|540239540|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
149757172|NCT02213198|540239539|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
149757173|NCT02213198|540239540|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
149757174|NCT02213198|540239539|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
149757175|NCT02213198|540239540|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
149757176|NCT00001262|540239541|FG000|Overall Study|Death|10|||
149757177|NCT00001262|540239542|FG001|Overall Study|Death|11|||
149757178|NCT00001262|540239543|FG002|Overall Study|Death|0|||
149757179|NCT00001262|540239541|FG000|Overall Study|Withdrawal by Subject|0|||
149757180|NCT00001262|540239542|FG001|Overall Study|Withdrawal by Subject|3|||
149757181|NCT00001262|540239543|FG002|Overall Study|Withdrawal by Subject|0|||
149757182|NCT00878072|540239544|FG000|Overall Study|Withdrew consent|2|||
149757183|NCT02504892|540239553|FG000|Overall Study|Adverse event-pneumonitis|2|||
149757184|NCT00524745|540239554|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
149757185|NCT00524745|540239555|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
149757186|NCT00524745|540239556|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
149757187|NCT00524745|540239557|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
149757188|NCT00576693|540239558|FG000|Overall Study|Lost to Follow-up|7|||
149757189|NCT00576693|540239559|FG001|Overall Study|Lost to Follow-up|11|||
149757190|NCT00576693|540239558|FG000|Overall Study|Withdrawal by Subject|3|||
149757191|NCT00576693|540239559|FG001|Overall Study|Withdrawal by Subject|13|||
149757192|NCT00540449|540239560|FG000|Overall Study|Adverse Event|12|||
149757193|NCT00540449|540239561|FG001|Overall Study|Adverse Event|32|||
149757194|NCT00540449|540239560|FG000|Overall Study|Sponsor's Decision|1|||
149757195|NCT00540449|540239561|FG001|Overall Study|Sponsor's Decision|1|||
149757196|NCT00540449|540239560|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
149757197|NCT00540449|540239561|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
149757198|NCT00540449|540239560|FG000|Overall Study|Lost to Follow-up|19|||
149757199|NCT00540449|540239561|FG001|Overall Study|Lost to Follow-up|17|||
149757200|NCT00540449|540239560|FG000|Overall Study|Subject Non-Compliant|7|||
149757201|NCT00540449|540239561|FG001|Overall Study|Subject Non-Compliant|5|||
149757202|NCT00540449|540239560|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
149757203|NCT00540449|540239561|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
149757204|NCT00540449|540239560|FG000|Overall Study|Withdrawal by Subject|10|||
149757205|NCT00540449|540239561|FG001|Overall Study|Withdrawal by Subject|10|||
149757206|NCT00540449|540239560|FG000|Overall Study|Other|1|||
149757207|NCT00540449|540239561|FG001|Overall Study|Other|4|||
149757208|NCT03643432|540239562|FG000|Overall Study|Lost to Follow-up|1|||
149757209|NCT03643432|540239563|FG001|Overall Study|Lost to Follow-up|0|||
149757210|NCT03283163|540239564|FG000|Overall Study|Lost to Follow-up|1|||
149757211|NCT03283163|540239564|FG000|Overall Study|other life commitments|6|||
149757212|NCT03283163|540239564|FG000|Overall Study|COVID-19 institution wide halting|1|||
149757213|NCT03283163|540239564|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
149757214|NCT03283163|540239564|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
149757215|NCT04238663|540239565|FG000|Overall Study|Lost to Follow-up|0|||
149757216|NCT04238663|540239566|FG001|Overall Study|Lost to Follow-up|1|||
149757217|NCT04238663|540239567|FG002|Overall Study|Lost to Follow-up|0|||
149757218|NCT05128162|540239570|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
149757219|NCT05128162|540239570|FG000|Overall Study|Physician Decision|1|||
149757220|NCT00370149|540239571|FG000|Overall Study|Physician Decision|16|||
149757221|NCT00370149|540239572|FG001|Overall Study|Physician Decision|16|||
149757222|NCT00370149|540239571|FG000|Overall Study|Protocol Violation|1|||
149757223|NCT00370149|540239572|FG001|Overall Study|Protocol Violation|0|||
149757224|NCT00370149|540239571|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
149757225|NCT00370149|540239572|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
149757226|NCT00370149|540239571|FG000|Overall Study|Pre-existing infection|0|||
149757227|NCT00370149|540239572|FG001|Overall Study|Pre-existing infection|1|||
149757228|NCT00370149|540239571|FG000|Overall Study|Antibiotic coated dressing placed|0|||
149757229|NCT00370149|540239572|FG001|Overall Study|Antibiotic coated dressing placed|1|||
149757230|NCT01429792|540240738|FG000|Overall Study|Other Reasons|67|||
149757231|NCT01429792|540240738|FG000|Overall Study|Unknown Disposition|94|||
149757232|NCT01429792|540240738|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
149757233|NCT01429792|540240738|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
149757234|NCT01429792|540240738|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
149757235|NCT01429792|540240738|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
149757236|NCT01429792|540240738|FG000|Overall Study|Withdrawal by Subject|70|||
149757237|NCT01429792|540240738|FG000|Overall Study|Lost to Follow-up|88|||
149757238|NCT00726323|540240739|FG000|Overall Study|Withdrawal by Subject|3|||
149757239|NCT00726323|540240740|FG001|Overall Study|Withdrawal by Subject|1|||
149757240|NCT00726323|540240739|FG000|Overall Study|Physician Decision|1|||
149757241|NCT00726323|540240740|FG001|Overall Study|Physician Decision|0|||
149757242|NCT00726323|540240739|FG000|Overall Study|Progressive disease|23|||
149757243|NCT00726323|540240740|FG001|Overall Study|Progressive disease|16|||
149757244|NCT00726323|540240739|FG000|Overall Study|Clinical progression|0|||
149757245|NCT00726323|540240740|FG001|Overall Study|Clinical progression|3|||
149757246|NCT00726323|540240739|FG000|Overall Study|Adverse Event|9|||
149757247|NCT00726323|540240740|FG001|Overall Study|Adverse Event|9|||
149757248|NCT00726323|540240739|FG000|Overall Study|Death|1|||
149757249|NCT00726323|540240740|FG001|Overall Study|Death|0|||
149757250|NCT00726323|540240739|FG000|Overall Study|Participant wished to discontinue|0|||
149757251|NCT00726323|540240740|FG001|Overall Study|Participant wished to discontinue|1|||
149757252|NCT00726323|540240739|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
149757253|NCT00726323|540240740|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
149757254|NCT00879814|540240751|FG000|Overall Study|Adverse Event|0|||
149757255|NCT00879814|540240752|FG001|Overall Study|Adverse Event|1|||
149757256|NCT00879814|540240753|FG002|Overall Study|Adverse Event|0|||
149757257|NCT00879814|540240754|FG003|Overall Study|Adverse Event|0|||
149757258|NCT00879814|540240751|FG000|Overall Study|Lost to Follow-up|1|||
149757259|NCT00879814|540240752|FG001|Overall Study|Lost to Follow-up|0|||
149757260|NCT00879814|540240753|FG002|Overall Study|Lost to Follow-up|0|||
149757261|NCT00879814|540240754|FG003|Overall Study|Lost to Follow-up|2|||
149757262|NCT00879814|540240751|FG000|Overall Study|Participant Failed to Return|0|||
149757263|NCT00879814|540240752|FG001|Overall Study|Participant Failed to Return|0|||
149757264|NCT00879814|540240753|FG002|Overall Study|Participant Failed to Return|0|||
149757265|NCT00879814|540240754|FG003|Overall Study|Participant Failed to Return|1|||
149757266|NCT00879814|540240751|FG000|Overall Study|Withdrawal by Subject|3|||
149757267|NCT00879814|540240752|FG001|Overall Study|Withdrawal by Subject|1|||
149757268|NCT00879814|540240753|FG002|Overall Study|Withdrawal by Subject|1|||
149757269|NCT00879814|540240754|FG003|Overall Study|Withdrawal by Subject|2|||
149757270|NCT00879814|540240751|FG000|Overall Study|Physician Decision|0|||
149757271|NCT00879814|540240752|FG001|Overall Study|Physician Decision|0|||
149757272|NCT00879814|540240753|FG002|Overall Study|Physician Decision|1|||
149757273|NCT00879814|540240754|FG003|Overall Study|Physician Decision|0|||
149757274|NCT00879814|540240751|FG000|Overall Study|Other|0|||
149757275|NCT00879814|540240752|FG001|Overall Study|Other|0|||
149757276|NCT00879814|540240753|FG002|Overall Study|Other|1|||
149757277|NCT00879814|540240754|FG003|Overall Study|Other|0|||
149757278|NCT00630812|540240755|FG000|Randomisation to First Dose|Adverse Event|1|||
149757279|NCT00630812|540240756|FG001|Randomisation to First Dose|Adverse Event|1|||
149757280|NCT00630812|540240755|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
149757281|NCT00630812|540240756|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
149757282|NCT00630812|540240755|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
149757283|NCT00630812|540240756|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
149757284|NCT00630812|540240755|FG000|Randomisation to First Dose|Protocol Violation|4|||
149757285|NCT00630812|540240756|FG001|Randomisation to First Dose|Protocol Violation|1|||
149757286|NCT00630812|540240755|FG000|Double Blind Treatment Period|Adverse Event|13|||
149757287|NCT00630812|540240756|FG001|Double Blind Treatment Period|Adverse Event|5|||
149757288|NCT00630812|540240755|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
149757289|NCT00630812|540240756|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149757290|NCT00630812|540240755|FG000|Double Blind Treatment Period|Physician Decision|2|||
149757291|NCT00630812|540240756|FG001|Double Blind Treatment Period|Physician Decision|1|||
149757292|NCT00630812|540240755|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149757293|NCT00630812|540240756|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149757294|NCT00630812|540240755|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
149757295|NCT00630812|540240756|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
149757296|NCT00630812|540240755|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
149757297|NCT00630812|540240756|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
149757298|NCT00630812|540240755|FG000|Double Blind Treatment Period|Non-compliance|0|||
149757299|NCT00630812|540240756|FG001|Double Blind Treatment Period|Non-compliance|1|||
149757300|NCT00972478|540240757|FG000|Overall Study|Adverse Event|3|||
149757301|NCT00972478|540240758|FG001|Overall Study|Adverse Event|16|||
149757302|NCT00972478|540240757|FG000|Overall Study|Withdrawal by Subject|1|||
149757303|NCT00972478|540240758|FG001|Overall Study|Withdrawal by Subject|8|||
149757304|NCT00972478|540240757|FG000|Overall Study|Progression/Relapse|0|||
149757305|NCT00972478|540240758|FG001|Overall Study|Progression/Relapse|2|||
149757306|NCT00972478|540240757|FG000|Overall Study|Death|0|||
149757307|NCT00972478|540240758|FG001|Overall Study|Death|2|||
149757308|NCT00972478|540240757|FG000|Overall Study|Not protocol specified|1|||
149757309|NCT00972478|540240758|FG001|Overall Study|Not protocol specified|1|||
149757310|NCT00972478|540240757|FG000|Overall Study|Ineligible|1|||
149757311|NCT00972478|540240758|FG001|Overall Study|Ineligible|7|||
149757312|NCT00972478|540240757|FG000|Overall Study|Not start protocol treatment|1|||
149757313|NCT00972478|540240758|FG001|Overall Study|Not start protocol treatment|2|||
149757314|NCT02561000|540240759|FG000|Overall Study|Withdrawal by Subject|2|||
149757315|NCT02561000|540240760|FG001|Overall Study|Withdrawal by Subject|3|||
149757316|NCT02561000|540240761|FG002|Overall Study|Withdrawal by Subject|0|||
149757317|NCT02561000|540240759|FG000|Overall Study|Adverse Event|0|||
149757318|NCT02561000|540240760|FG001|Overall Study|Adverse Event|1|||
149757319|NCT02561000|540240761|FG002|Overall Study|Adverse Event|0|||
149757320|NCT01234402|540240762|FG000|Overall Study|Lost to Follow-up|0|||
149757321|NCT01234402|540240763|FG001|Overall Study|Lost to Follow-up|1|||
149757322|NCT01234402|540240764|FG002|Overall Study|Lost to Follow-up|3|||
149757323|NCT01234402|540240762|FG000|Overall Study|Withdrawal by Subject|1|||
149757324|NCT01234402|540240763|FG001|Overall Study|Withdrawal by Subject|3|||
149757325|NCT01234402|540240764|FG002|Overall Study|Withdrawal by Subject|4|||
149757326|NCT01234402|540240762|FG000|Overall Study|Never treated: Death|0|||
149757327|NCT01234402|540240763|FG001|Overall Study|Never treated: Death|0|||
149757328|NCT01234402|540240764|FG002|Overall Study|Never treated: Death|1|||
149757329|NCT01234402|540240762|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
149757330|NCT01234402|540240763|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
149757331|NCT01234402|540240764|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
149757332|NCT01234402|540240762|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
149757333|NCT01234402|540240763|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
149757334|NCT01234402|540240764|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
149757335|NCT05761444|540240766|FG000|Overall Study|Protocol Violation|2|||
149757336|NCT05761444|540240767|FG001|Overall Study|Protocol Violation|1|||
149757337|NCT05761444|540240766|FG000|Overall Study|Adverse Event|2|||
149757338|NCT05761444|540240767|FG001|Overall Study|Adverse Event|2|||
149757339|NCT05761444|540240766|FG000|Overall Study|Withdrawal by Subject|3|||
149757340|NCT05761444|540240767|FG001|Overall Study|Withdrawal by Subject|2|||
149757341|NCT05761444|540240766|FG000|Overall Study|Other|1|||
149757342|NCT05761444|540240767|FG001|Overall Study|Other|0|||
149757343|NCT00752609|540240768|FG000|Overall Study|Adverse Event|2|||
149757344|NCT00752609|540240769|FG001|Overall Study|Adverse Event|2|||
149757345|NCT00752609|540240768|FG000|Overall Study|Withdrawal by Subject|3|||
149757346|NCT00752609|540240769|FG001|Overall Study|Withdrawal by Subject|0|||
149757347|NCT00752609|540240768|FG000|Overall Study|Physician Decision|1|||
149757348|NCT00752609|540240769|FG001|Overall Study|Physician Decision|0|||
149757349|NCT00752609|540240768|FG000|Overall Study|Death|1|||
149757350|NCT00752609|540240769|FG001|Overall Study|Death|0|||
149757351|NCT00752609|540240768|FG000|Overall Study|Met exclusion criteria|1|||
149757352|NCT00752609|540240769|FG001|Overall Study|Met exclusion criteria|0|||
149757353|NCT00752609|540240768|FG000|Overall Study|Received Aranesp in error|1|||
149757354|NCT00752609|540240769|FG001|Overall Study|Received Aranesp in error|0|||
149757355|NCT05114590|540240770|FG000|Overall Study|Adverse Event|1|||
149757356|NCT05114590|540240770|FG000|Overall Study|Investigator decision|1|||
149757357|NCT05114590|540240770|FG000|Overall Study|Lost to Follow-up|5|||
149757358|NCT05114590|540240770|FG000|Overall Study|Withdrawal by Subject|5|||
149757359|NCT05114590|540240770|FG000|Overall Study|Other|2|||
149757360|NCT01757704|540240771|FG000|Overall Study|Protocol Violation|1|||
149757361|NCT01757704|540240772|FG001|Overall Study|Protocol Violation|3|||
149757362|NCT00938327|540240773|FG000|Overall Study|Adverse Event|2|||
149757363|NCT00938327|540240773|FG000|Overall Study|Protocol Violation|1|||
149757364|NCT00938327|540240773|FG000|Overall Study|Withdrawal by Subject|4|||
149757365|NCT00938327|540240773|FG000|Overall Study|Lost to Follow-up|37|||
149757366|NCT00938327|540240773|FG000|Overall Study|2nd dose received outside of the study|7|||
149757367|NCT00938327|540240773|FG000|Overall Study|Vaccine not received as out of stock|9|||
149757368|NCT01425190|540240774|FG000|Overall Study|Full dose not consumed.|1|||
149757369|NCT01425190|540240775|FG001|Overall Study|Full dose not consumed.|0|||
149757370|NCT01425190|540240776|FG002|Overall Study|Full dose not consumed.|0|||
149757371|NCT00195260|540240779|FG000|Part 1: Dose Escalation|Adverse Event|0|||
149757372|NCT00195260|540240780|FG001|Part 1: Dose Escalation|Adverse Event|1|||
149757373|NCT00195260|540240781|FG002|Part 1: Dose Escalation|Adverse Event|0|||
149757374|NCT00195260|540240782|FG003|Part 1: Dose Escalation|Adverse Event|1|||
149757375|NCT00195260|540240783|FG004|Part 1: Dose Escalation|Adverse Event|1|||
149757376|NCT00195260|540240784|FG005|Part 1: Dose Escalation|Adverse Event|0|||
149757377|NCT00195260|540240785|FG006|Part 1: Dose Escalation|Adverse Event|3|||
149757378|NCT00195260|540240786|FG007|Part 1: Dose Escalation|Adverse Event|0|||
149757379|NCT00195260|540240787|FG008|Part 1: Dose Escalation|Adverse Event|0|||
149757380|NCT00195260|540240788|FG009|Part 1: Dose Escalation|Adverse Event|0|||
149757381|NCT00195260|540240789|FG010|Part 1: Dose Escalation|Adverse Event|0|||
149757382|NCT00195260|540240779|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757383|NCT00195260|540240780|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757384|NCT00195260|540240781|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757385|NCT00195260|540240782|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757386|NCT00195260|540240783|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149757387|NCT00195260|540240784|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757388|NCT00195260|540240785|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757389|NCT00195260|540240786|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
149757390|NCT00195260|540240787|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757391|NCT00195260|540240788|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757392|NCT00195260|540240789|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149757393|NCT00195260|540240779|FG000|Part 1: Dose Escalation|Death|0|||
149757394|NCT00195260|540240780|FG001|Part 1: Dose Escalation|Death|0|||
149757395|NCT00195260|540240781|FG002|Part 1: Dose Escalation|Death|0|||
149757396|NCT00195260|540240782|FG003|Part 1: Dose Escalation|Death|0|||
149757397|NCT00195260|540240783|FG004|Part 1: Dose Escalation|Death|0|||
149757398|NCT00195260|540240784|FG005|Part 1: Dose Escalation|Death|0|||
149757399|NCT00195260|540240785|FG006|Part 1: Dose Escalation|Death|0|||
149757400|NCT00195260|540240786|FG007|Part 1: Dose Escalation|Death|1|||
149757401|NCT00195260|540240787|FG008|Part 1: Dose Escalation|Death|0|||
149757402|NCT00195260|540240788|FG009|Part 1: Dose Escalation|Death|0|||
149757403|NCT00195260|540240789|FG010|Part 1: Dose Escalation|Death|0|||
149757404|NCT00195260|540240779|FG000|Part 1: Dose Escalation|Disease Progression|3|||
149757405|NCT00195260|540240780|FG001|Part 1: Dose Escalation|Disease Progression|2|||
149757406|NCT00195260|540240781|FG002|Part 1: Dose Escalation|Disease Progression|5|||
149757407|NCT00195260|540240782|FG003|Part 1: Dose Escalation|Disease Progression|6|||
149757408|NCT00195260|540240783|FG004|Part 1: Dose Escalation|Disease Progression|4|||
149757409|NCT00195260|540240784|FG005|Part 1: Dose Escalation|Disease Progression|6|||
149757410|NCT00195260|540240785|FG006|Part 1: Dose Escalation|Disease Progression|7|||
149757411|NCT00195260|540240786|FG007|Part 1: Dose Escalation|Disease Progression|4|||
149757412|NCT00195260|540240787|FG008|Part 1: Dose Escalation|Disease Progression|0|||
149757413|NCT00195260|540240788|FG009|Part 1: Dose Escalation|Disease Progression|0|||
149757414|NCT00195260|540240789|FG010|Part 1: Dose Escalation|Disease Progression|0|||
149757415|NCT00195260|540240779|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149757416|NCT00195260|540240780|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149757417|NCT00195260|540240781|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149757418|NCT00195260|540240782|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757419|NCT00195260|540240783|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757420|NCT00195260|540240784|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149757421|NCT00195260|540240785|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757422|NCT00195260|540240786|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757423|NCT00195260|540240787|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757424|NCT00195260|540240788|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757425|NCT00195260|540240789|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149757426|NCT00195260|540240779|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757427|NCT00195260|540240780|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757428|NCT00195260|540240781|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757429|NCT00195260|540240782|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757430|NCT00195260|540240783|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757431|NCT00195260|540240784|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757432|NCT00195260|540240785|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757433|NCT00195260|540240786|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149757434|NCT00195260|540240787|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
149757435|NCT00195260|540240788|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
149757436|NCT00195260|540240789|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
149757437|NCT00195260|540240779|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757438|NCT00195260|540240780|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757439|NCT00195260|540240781|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757440|NCT00195260|540240782|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757441|NCT00195260|540240783|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757442|NCT00195260|540240784|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757443|NCT00195260|540240785|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757444|NCT00195260|540240786|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149757445|NCT00195260|540240787|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
149757446|NCT00195260|540240788|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
149757447|NCT00195260|540240789|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
149757448|NCT00195260|540240779|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757449|NCT00195260|540240780|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757450|NCT00195260|540240781|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757451|NCT00195260|540240782|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757452|NCT00195260|540240783|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757453|NCT00195260|540240784|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757454|NCT00195260|540240785|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757455|NCT00195260|540240786|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149757456|NCT00195260|540240787|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
149757457|NCT00195260|540240788|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
149757458|NCT00195260|540240789|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
149757459|NCT00195260|540240779|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757460|NCT00195260|540240780|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757461|NCT00195260|540240781|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757462|NCT00195260|540240782|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757463|NCT00195260|540240783|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757464|NCT00195260|540240784|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757465|NCT00195260|540240785|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757466|NCT00195260|540240786|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149757467|NCT00195260|540240787|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
149757468|NCT00195260|540240788|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
149757469|NCT00195260|540240789|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
149757470|NCT02749721|540240790|FG000|Screening|Withdrawal by Subject|1|||
149757471|NCT02749721|540240790|FG000|Screening|Lost to Follow-up|2|||
149757472|NCT02749721|540240790|FG000|Screening|Protocol Violation|3|||
149757473|NCT02749721|540240790|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
149757474|NCT02749721|540240790|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
149757475|NCT01379534|540240791|FG000|Treatment Phase|Withdrawal by Subject|2|||
149757476|NCT01379534|540240792|FG001|Treatment Phase|Withdrawal by Subject|2|||
149757477|NCT01379534|540240791|FG000|Treatment Phase|Progressive disease|13|||
149757478|NCT01379534|540240792|FG001|Treatment Phase|Progressive disease|22|||
149757479|NCT01379534|540240791|FG000|Treatment Phase|Adverse Event|7|||
149757480|NCT01379534|540240792|FG001|Treatment Phase|Adverse Event|7|||
149757481|NCT01379534|540240791|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
149757482|NCT01379534|540240792|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
149757483|NCT01379534|540240791|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
149757484|NCT01379534|540240792|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
149757485|NCT01379534|540240791|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
149757486|NCT01379534|540240792|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
149757487|NCT01379534|540240791|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
149757488|NCT01379534|540240792|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
149757489|NCT02691247|540240793|FG000|Overall Study|Withdrawal by Subject|1|||
149757490|NCT02691247|540240794|FG001|Overall Study|Withdrawal by Subject|2|||
149757491|NCT02691247|540240795|FG002|Overall Study|Withdrawal by Subject|2|||
149757492|NCT02691247|540240793|FG000|Overall Study|Lost to Follow-up|2|||
149757493|NCT02691247|540240794|FG001|Overall Study|Lost to Follow-up|0|||
149757494|NCT02691247|540240795|FG002|Overall Study|Lost to Follow-up|1|||
149757495|NCT02552355|540240796|FG000|Overall Study|Adverse Event|0|||
149757496|NCT02552355|540240797|FG001|Overall Study|Adverse Event|2|||
149757497|NCT02552355|540240798|FG002|Overall Study|Adverse Event|2|||
149757498|NCT02552355|540240799|FG003|Overall Study|Adverse Event|0|||
149757499|NCT02552355|540240796|FG000|Overall Study|Withdrawal by Subject|0|||
149757500|NCT02552355|540240797|FG001|Overall Study|Withdrawal by Subject|0|||
149757501|NCT02552355|540240798|FG002|Overall Study|Withdrawal by Subject|0|||
149757502|NCT02552355|540240799|FG003|Overall Study|Withdrawal by Subject|1|||
149757503|NCT01519245|540240800|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
149757504|NCT01519245|540240801|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
149757505|NCT03321929|540240804|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
149757506|NCT01052012|540240806|FG000|Overall Study|Not treated|2|||
149757507|NCT01052012|540240807|FG001|Overall Study|Not treated|5|||
149757508|NCT01052012|540240808|FG002|Overall Study|Not treated|0|||
149757509|NCT01052012|540240809|FG003|Overall Study|Not treated|0|||
149757510|NCT01052012|540240810|FG004|Overall Study|Not treated|11|||
149757511|NCT01052012|540240811|FG005|Overall Study|Not treated|8|||
149757512|NCT01052012|540240806|FG000|Overall Study|Adverse Event|1|||
149757513|NCT01052012|540240807|FG001|Overall Study|Adverse Event|0|||
149757514|NCT01052012|540240808|FG002|Overall Study|Adverse Event|0|||
149757515|NCT01052012|540240809|FG003|Overall Study|Adverse Event|1|||
149757516|NCT01052012|540240810|FG004|Overall Study|Adverse Event|0|||
149757517|NCT01052012|540240811|FG005|Overall Study|Adverse Event|0|||
149757518|NCT01052012|540240806|FG000|Overall Study|Lost to Follow-up|0|||
149757519|NCT01052012|540240807|FG001|Overall Study|Lost to Follow-up|0|||
149757520|NCT01052012|540240808|FG002|Overall Study|Lost to Follow-up|0|||
149757521|NCT01052012|540240809|FG003|Overall Study|Lost to Follow-up|0|||
149757522|NCT01052012|540240810|FG004|Overall Study|Lost to Follow-up|1|||
149757523|NCT01052012|540240811|FG005|Overall Study|Lost to Follow-up|0|||
149757524|NCT01052012|540240806|FG000|Overall Study|Withdrawal by Subject|1|||
149757525|NCT01052012|540240807|FG001|Overall Study|Withdrawal by Subject|1|||
149757526|NCT01052012|540240808|FG002|Overall Study|Withdrawal by Subject|0|||
149757527|NCT01052012|540240809|FG003|Overall Study|Withdrawal by Subject|0|||
149757528|NCT01052012|540240810|FG004|Overall Study|Withdrawal by Subject|3|||
149757529|NCT01052012|540240811|FG005|Overall Study|Withdrawal by Subject|1|||
149757530|NCT01052012|540240806|FG000|Overall Study|Physician Decision|0|||
149757531|NCT01052012|540240807|FG001|Overall Study|Physician Decision|0|||
149757532|NCT01052012|540240808|FG002|Overall Study|Physician Decision|0|||
149757533|NCT01052012|540240809|FG003|Overall Study|Physician Decision|0|||
149757534|NCT01052012|540240810|FG004|Overall Study|Physician Decision|0|||
149757535|NCT01052012|540240811|FG005|Overall Study|Physician Decision|1|||
149757536|NCT01052012|540240806|FG000|Overall Study|Other|0|||
149757537|NCT01052012|540240807|FG001|Overall Study|Other|0|||
149757538|NCT01052012|540240808|FG002|Overall Study|Other|0|||
149757539|NCT01052012|540240809|FG003|Overall Study|Other|0|||
149757540|NCT01052012|540240810|FG004|Overall Study|Other|1|||
149757541|NCT01052012|540240811|FG005|Overall Study|Other|0|||
149757542|NCT02582749|540240814|FG000|Overall Study|Study terminated by funder|5|||
149757543|NCT02582749|540240815|FG001|Overall Study|Study terminated by funder|10|||
149757544|NCT02582749|540240814|FG000|Overall Study|Withdrawal by Subject|0|||
149757545|NCT02582749|540240815|FG001|Overall Study|Withdrawal by Subject|1|||
149757546|NCT01413178|540240816|FG000|Overall Study|Toxicity|1|||
149757547|NCT01413178|540240817|FG001|Overall Study|Toxicity|0|||
149757548|NCT01413178|540240816|FG000|Overall Study|Ineligible|0|||
149757549|NCT01413178|540240817|FG001|Overall Study|Ineligible|2|||
149757550|NCT00872170|540240818|FG000|Overall Study|Adverse Event|1|||
149757551|NCT00872170|540240819|FG001|Overall Study|Adverse Event|0|||
149757552|NCT00804193|540240820|FG000|Overall Study|Lack of baseline fungus|32|||
149757553|NCT00804193|540240821|FG001|Overall Study|Lack of baseline fungus|31|||
149757554|NCT00804193|540240822|FG002|Overall Study|Lack of baseline fungus|19|||
149757555|NCT00804193|540240820|FG000|Overall Study|Adverse Event|0|||
149757556|NCT00804193|540240821|FG001|Overall Study|Adverse Event|0|||
149757557|NCT00804193|540240822|FG002|Overall Study|Adverse Event|2|||
149757558|NCT00804193|540240820|FG000|Overall Study|Lack of Efficacy|1|||
149757559|NCT00804193|540240821|FG001|Overall Study|Lack of Efficacy|1|||
149757560|NCT00804193|540240822|FG002|Overall Study|Lack of Efficacy|3|||
149757561|NCT00804193|540240820|FG000|Overall Study|Protocol Violation|0|||
149757562|NCT00804193|540240821|FG001|Overall Study|Protocol Violation|8|||
149757563|NCT00804193|540240822|FG002|Overall Study|Protocol Violation|2|||
149757564|NCT00804193|540240820|FG000|Overall Study|Lost to Follow-up|3|||
149757565|NCT00804193|540240821|FG001|Overall Study|Lost to Follow-up|3|||
149757566|NCT00804193|540240822|FG002|Overall Study|Lost to Follow-up|4|||
149757567|NCT00804193|540240820|FG000|Overall Study|Withdrawal by Subject|3|||
149757568|NCT00804193|540240821|FG001|Overall Study|Withdrawal by Subject|1|||
149757569|NCT00804193|540240822|FG002|Overall Study|Withdrawal by Subject|2|||
149757570|NCT00237796|540240825|FG000|Overall Study|Baseline and one other ILSS required|10|||
149757571|NCT00237796|540240826|FG001|Overall Study|Baseline and one other ILSS required|5|||
149757572|NCT01193348|540240827|FG000|Screening Period|Screen Failure|5|||
149757573|NCT01193348|540240827|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
149757574|NCT01193348|540240827|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
149757575|NCT01193348|540240827|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
149757576|NCT01193348|540240827|FG000|Extension Treatment Period|Physician Decision|1|||
149757577|NCT01193348|540240827|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
149757578|NCT00968253|540240828|FG000|Overall Study|Death|0|||
149757579|NCT00968253|540240829|FG001|Overall Study|Death|0|||
149757580|NCT00968253|540240830|FG002|Overall Study|Death|2|||
149757581|NCT00968253|540240828|FG000|Overall Study|Withdrawal by Subject|0|||
149757582|NCT00968253|540240829|FG001|Overall Study|Withdrawal by Subject|0|||
149757583|NCT00968253|540240830|FG002|Overall Study|Withdrawal by Subject|1|||
149757584|NCT00968253|540240828|FG000|Overall Study|Disease Progression|0|||
149757585|NCT00968253|540240829|FG001|Overall Study|Disease Progression|3|||
149757586|NCT00968253|540240830|FG002|Overall Study|Disease Progression|3|||
149757587|NCT00968253|540240828|FG000|Overall Study|Adverse Event|0|||
149757588|NCT00968253|540240829|FG001|Overall Study|Adverse Event|0|||
149757589|NCT00968253|540240830|FG002|Overall Study|Adverse Event|1|||
149757590|NCT01721408|540240831|FG000|Overall Study|Adverse Event|6|||
149757591|NCT01721408|540240832|FG001|Overall Study|Adverse Event|1|||
149757592|NCT01721408|540240831|FG000|Overall Study|Death|1|||
149757593|NCT01721408|540240832|FG001|Overall Study|Death|0|||
149757594|NCT01721408|540240831|FG000|Overall Study|Insufficient clinical response|15|||
149757595|NCT01721408|540240832|FG001|Overall Study|Insufficient clinical response|6|||
149757596|NCT01721408|540240831|FG000|Overall Study|No longer willing to participate study|9|||
149757597|NCT01721408|540240832|FG001|Overall Study|No longer willing to participate study|10|||
149757598|NCT01721408|540240831|FG000|Overall Study|Protocol Violation|0|||
149757599|NCT01721408|540240832|FG001|Overall Study|Protocol Violation|2|||
149757600|NCT01721408|540240831|FG000|Overall Study|Other|3|||
149757601|NCT01721408|540240832|FG001|Overall Study|Other|3|||
149757602|NCT01721408|540240831|FG000|Overall Study|Lost to Follow-up|1|||
149757603|NCT01721408|540240832|FG001|Overall Study|Lost to Follow-up|2|||
149757604|NCT01721408|540240831|FG000|Overall Study|Does not meet entrance criteria|1|||
149757605|NCT01721408|540240832|FG001|Overall Study|Does not meet entrance criteria|0|||
149757606|NCT04160468|540240833|FG000|Overall Study|Lost to Follow-up|19|||
149757607|NCT04160468|540240834|FG001|Overall Study|Lost to Follow-up|4|||
149757608|NCT04160468|540240833|FG000|Overall Study|Randomized but not dosed|6|||
149757609|NCT04160468|540240834|FG001|Overall Study|Randomized but not dosed|0|||
149757610|NCT04160468|540240833|FG000|Overall Study|Withdrawal by Subject|4|||
149757611|NCT04160468|540240834|FG001|Overall Study|Withdrawal by Subject|1|||
149757612|NCT04160468|540240833|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
149757613|NCT04160468|540240834|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
149757614|NCT04160468|540240833|FG000|Overall Study|Participant incarcerated|1|||
149757615|NCT04160468|540240834|FG001|Overall Study|Participant incarcerated|0|||
149757616|NCT01187901|540240835|FG000|Overall Study|Protocol Violation|1|||
149757617|NCT01187901|540240836|FG001|Overall Study|Protocol Violation|0|||
149757618|NCT01187901|540240835|FG000|Overall Study|Lost to Follow-up|1|||
149757619|NCT01187901|540240836|FG001|Overall Study|Lost to Follow-up|2|||
149757620|NCT01187901|540240835|FG000|Overall Study|Unrelated Health Reasons|1|||
149757621|NCT01187901|540240836|FG001|Overall Study|Unrelated Health Reasons|2|||
149757622|NCT01187901|540240835|FG000|Overall Study|Suspected Allergic Reaction|1|||
149757623|NCT01187901|540240836|FG001|Overall Study|Suspected Allergic Reaction|1|||
149757624|NCT01187901|540240835|FG000|Overall Study|Adverse Event|3|||
149757625|NCT01187901|540240836|FG001|Overall Study|Adverse Event|0|||
149757626|NCT01187901|540240835|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
149757627|NCT01187901|540240836|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
149757628|NCT01187901|540240835|FG000|Overall Study|Pregnancy|0|||
149757629|NCT01187901|540240836|FG001|Overall Study|Pregnancy|2|||
149757630|NCT03987620|540240837|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
149757631|NCT03987620|540240838|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
149757632|NCT03987620|540240837|FG000|Overall Study|Adverse Event|3|||
149757633|NCT03987620|540240838|FG001|Overall Study|Adverse Event|0|||
149757634|NCT03987620|540240837|FG000|Overall Study|Lost to Follow-up|1|||
149757635|NCT03987620|540240838|FG001|Overall Study|Lost to Follow-up|2|||
149757636|NCT03987620|540240837|FG000|Overall Study|Physician Decision|0|||
149757637|NCT03987620|540240838|FG001|Overall Study|Physician Decision|1|||
149757638|NCT03987620|540240837|FG000|Overall Study|Pregnancy|1|||
149757639|NCT03987620|540240838|FG001|Overall Study|Pregnancy|0|||
149757640|NCT03987620|540240837|FG000|Overall Study|Withdrawal by Subject|7|||
149757641|NCT03987620|540240838|FG001|Overall Study|Withdrawal by Subject|1|||
149757642|NCT03987620|540240837|FG000|Overall Study|Other|2|||
149757643|NCT03987620|540240838|FG001|Overall Study|Other|5|||
149757644|NCT02149836|540240839|FG000|Overall Study|Withdrawal by Subject|1|||
149757645|NCT03860844|540240840|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
149757646|NCT03860844|540240841|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
149757647|NCT03860844|540240842|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
149757648|NCT03860844|540240840|FG000|Overall Study|Progressive disease|5|||
149757649|NCT03860844|540240841|FG001|Overall Study|Progressive disease|3|||
149757650|NCT03860844|540240842|FG002|Overall Study|Progressive disease|4|||
149757651|NCT03860844|540240840|FG000|Overall Study|Other, Not related to COVID-19|0|||
149757652|NCT03860844|540240841|FG001|Overall Study|Other, Not related to COVID-19|1|||
149757653|NCT03860844|540240842|FG002|Overall Study|Other, Not related to COVID-19|0|||
149757654|NCT01678807|540240850|FG000|Overall Study|Adverse Event|4|||
149757655|NCT01678807|540240851|FG001|Overall Study|Adverse Event|4|||
149757656|NCT01678807|540240852|FG002|Overall Study|Adverse Event|0|||
149757657|NCT01678807|540240850|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
149757658|NCT01678807|540240851|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
149757659|NCT01678807|540240852|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
149757660|NCT02574312|540240853|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
149757661|NCT02574312|540240854|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
149757662|NCT05306873|540242341|FG000|Stage 2|Study stopped|1|||
149757663|NCT05306873|540242342|FG001|Stage 2|Study stopped|1|||
149757664|NCT05306873|540242343|FG002|Stage 2|Study stopped|0|||
149757665|NCT05306873|540242344|FG003|Stage 2|Study stopped|0|||
149757666|NCT05306873|540242341|FG000|Stage 2|Stage 2 Treatment Failure|2|||
149757667|NCT05306873|540242342|FG001|Stage 2|Stage 2 Treatment Failure|3|||
149757668|NCT05306873|540242343|FG002|Stage 2|Stage 2 Treatment Failure|0|||
149757669|NCT05306873|540242344|FG003|Stage 2|Stage 2 Treatment Failure|0|||
149757670|NCT05306873|540242341|FG000|Stage 2|Logistical issues due to participant moving|1|||
149757671|NCT05306873|540242342|FG001|Stage 2|Logistical issues due to participant moving|0|||
149757672|NCT05306873|540242343|FG002|Stage 2|Logistical issues due to participant moving|0|||
149757673|NCT05306873|540242344|FG003|Stage 2|Logistical issues due to participant moving|0|||
149757674|NCT05306873|540242341|FG000|Stage 3|Stage 3 Treatment Failure|0|||
149757675|NCT05306873|540242342|FG001|Stage 3|Stage 3 Treatment Failure|0|||
149757676|NCT05306873|540242343|FG002|Stage 3|Stage 3 Treatment Failure|0|||
149757677|NCT05306873|540242344|FG003|Stage 3|Stage 3 Treatment Failure|1|||
149757678|NCT05306873|540242341|FG000|Stage 3|Study Stopped|0|||
149757679|NCT05306873|540242342|FG001|Stage 3|Study Stopped|0|||
149757680|NCT05306873|540242343|FG002|Stage 3|Study Stopped|1|||
149757681|NCT05306873|540242344|FG003|Stage 3|Study Stopped|0|||
149757682|NCT04920084|540242346|FG000|Overall Study|Adverse Event|1|||
149757683|NCT04920084|540242346|FG000|Overall Study|Lost to Follow-up|2|||
149757684|NCT04920084|540242346|FG000|Overall Study|Withdrawal by Subject|2|||
149757685|NCT00074412|540242347|FG000|Overall Study|Death|30|||
149757686|NCT00074412|540242348|FG001|Overall Study|Death|26|||
149757687|NCT00074412|540242347|FG000|Overall Study|Lost to Follow-up|52|||
149757688|NCT00074412|540242348|FG001|Overall Study|Lost to Follow-up|58|||
149757689|NCT05113953|540242351|FG000|Overall Study|Adverse Event|5|||
149757690|NCT05113953|540242352|FG001|Overall Study|Adverse Event|0|||
149757691|NCT05113953|540242353|FG002|Overall Study|Adverse Event|3|||
149757692|NCT05113953|540242351|FG000|Overall Study|Lost to Follow-up|3|||
149757693|NCT05113953|540242352|FG001|Overall Study|Lost to Follow-up|4|||
149757694|NCT05113953|540242353|FG002|Overall Study|Lost to Follow-up|2|||
149757695|NCT05113953|540242351|FG000|Overall Study|Non-compliance with Study Drug|1|||
149757696|NCT05113953|540242352|FG001|Overall Study|Non-compliance with Study Drug|0|||
149757697|NCT05113953|540242353|FG002|Overall Study|Non-compliance with Study Drug|0|||
149757698|NCT05113953|540242351|FG000|Overall Study|Withdrawal by Subject|2|||
149757699|NCT05113953|540242352|FG001|Overall Study|Withdrawal by Subject|6|||
149757700|NCT05113953|540242353|FG002|Overall Study|Withdrawal by Subject|4|||
149757701|NCT05113953|540242351|FG000|Overall Study|Reason not Specified|2|||
149757702|NCT05113953|540242352|FG001|Overall Study|Reason not Specified|0|||
149757703|NCT05113953|540242353|FG002|Overall Study|Reason not Specified|0|||
149757704|NCT02626819|540242354|FG000|Overall Study|Lost to Follow-up|3|||
149757705|NCT02626819|540242355|FG001|Overall Study|Lost to Follow-up|2|||
149757706|NCT02626819|540242354|FG000|Overall Study|Withdrawal by Subject|1|||
149757707|NCT02626819|540242355|FG001|Overall Study|Withdrawal by Subject|0|||
149757708|NCT02626819|540242354|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
149757709|NCT02626819|540242355|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
149757710|NCT02361762|540242356|FG000|Overall Study|Withdrawal by Subject|0|||
149757711|NCT02361762|540242357|FG001|Overall Study|Withdrawal by Subject|1|||
149757712|NCT02361762|540242356|FG000|Overall Study|Lost to Follow-up|0|||
149757713|NCT02361762|540242357|FG001|Overall Study|Lost to Follow-up|1|||
149757714|NCT03488472|540242358|FG000|Overall Study|disease progression additional mets|1|||
149757715|NCT00028002|540242359|FG000|Overall Study|Withdrawal by Subject|3|||
149757716|NCT00028002|540242359|FG000|Overall Study|Ineligible|8|||
149757717|NCT00502307|540242362|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
149757718|NCT00502307|540242363|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
149757719|NCT00502307|540242364|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
149757720|NCT00502307|540242362|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
149757721|NCT00502307|540242363|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
149757722|NCT00502307|540242364|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
149757723|NCT00502307|540242362|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
149757724|NCT00502307|540242363|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
149757725|NCT00502307|540242364|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
149757726|NCT00502307|540242362|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
149757727|NCT00502307|540242363|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
149757728|NCT00502307|540242364|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
149757729|NCT00502307|540242362|FG000|Maintenance Period|Progressive disease|80|||
149757730|NCT00502307|540242363|FG001|Maintenance Period|Progressive disease|0|||
149757731|NCT00502307|540242364|FG002|Maintenance Period|Progressive disease|0|||
149757732|NCT00502307|540242362|FG000|Maintenance Period|Discontinued due to other reasons|68|||
149757733|NCT00502307|540242363|FG001|Maintenance Period|Discontinued due to other reasons|0|||
149757734|NCT00502307|540242364|FG002|Maintenance Period|Discontinued due to other reasons|0|||
149757735|NCT04467164|540242367|FG000|Washout (1 Week)|Lost to Follow-up|2|||
149757736|NCT04467164|540242368|FG001|Washout (1 Week)|Lost to Follow-up|0|||
149757737|NCT02750813|540242369|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
149757738|NCT02750813|540242370|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
149757739|NCT02750813|540242369|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
149757740|NCT02750813|540242370|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
149757741|NCT01998581|540242371|FG000|Overall Study|Refused repeat treatment|20|||
149757742|NCT01998581|540242372|FG001|Overall Study|Refused repeat treatment|4|||
149757743|NCT01998581|540242371|FG000|Overall Study|Protocol Violation|1|||
149757744|NCT01998581|540242372|FG001|Overall Study|Protocol Violation|0|||
149757745|NCT01998581|540242371|FG000|Overall Study|Withdrawal by Subject|8|||
149757746|NCT01998581|540242372|FG001|Overall Study|Withdrawal by Subject|1|||
149757747|NCT01998581|540242371|FG000|Overall Study|Lost to Follow-up|12|||
149757748|NCT01998581|540242372|FG001|Overall Study|Lost to Follow-up|4|||
149757749|NCT01998581|540242371|FG000|Overall Study|Adverse Event|1|||
149757750|NCT01998581|540242372|FG001|Overall Study|Adverse Event|1|||
149757751|NCT01998581|540242371|FG000|Overall Study|Other reasons|3|||
149757752|NCT01998581|540242372|FG001|Overall Study|Other reasons|2|||
149757753|NCT01998581|540242371|FG000|Overall Study|Randomized but withdrew before treatment|1|||
149757754|NCT01998581|540242372|FG001|Overall Study|Randomized but withdrew before treatment|0|||
149757755|NCT02273752|540242374|FG000|Overall Study|Trial was terminated early|2|||
149757756|NCT00903032|540242375|FG000|Overall Study|Withdrawal by Subject|5|||
149757757|NCT00903032|540242376|FG001|Overall Study|Withdrawal by Subject|3|||
149757758|NCT00903032|540242375|FG000|Overall Study|Lost to Follow-up|2|||
149757759|NCT00903032|540242376|FG001|Overall Study|Lost to Follow-up|2|||
149757760|NCT01763905|540242379|FG000|Overall Study|Withdrawal by Subject|1|||
149757761|NCT01763905|540242380|FG001|Overall Study|Withdrawal by Subject|1|||
149757762|NCT01763905|540242381|FG002|Overall Study|Withdrawal by Subject|0|||
149757763|NCT01763905|540242382|FG003|Overall Study|Withdrawal by Subject|1|||
149757764|NCT01763905|540242379|FG000|Overall Study|Decision by sponsor|5|||
149757765|NCT01763905|540242380|FG001|Overall Study|Decision by sponsor|0|||
149757766|NCT01763905|540242381|FG002|Overall Study|Decision by sponsor|8|||
149757767|NCT01763905|540242382|FG003|Overall Study|Decision by sponsor|0|||
149757768|NCT01763905|540242379|FG000|Overall Study|Lost to Follow-up|0|||
149757769|NCT01763905|540242380|FG001|Overall Study|Lost to Follow-up|0|||
149757770|NCT01763905|540242381|FG002|Overall Study|Lost to Follow-up|1|||
149757771|NCT01763905|540242382|FG003|Overall Study|Lost to Follow-up|0|||
149757772|NCT04346628|540242383|FG000|Overall Study|Lost to Follow-up|4|||
149757773|NCT04346628|540242384|FG001|Overall Study|Lost to Follow-up|4|||
149757774|NCT04346628|540242383|FG000|Overall Study|Withdrew (had personal reasons)|2|||
149757775|NCT04346628|540242384|FG001|Overall Study|Withdrew (had personal reasons)|5|||
149757776|NCT04346628|540242383|FG000|Overall Study|Withdrew (medication intolerant)|0|||
149757777|NCT04346628|540242384|FG001|Overall Study|Withdrew (medication intolerant)|3|||
149757778|NCT04346628|540242383|FG000|Overall Study|Withdrew (declined intervention)|0|||
149757779|NCT04346628|540242384|FG001|Overall Study|Withdrew (declined intervention)|1|||
149757780|NCT03430245|540242399|FG000|Overall Study|Withdrawal by Subject|6|||
149757781|NCT03430245|540242399|FG000|Overall Study|Lost to Follow-up|1|||
149757782|NCT05628181|540242400|FG000|Overall Study|Death|2|||
149757783|NCT05628181|540242401|FG001|Overall Study|Death|4|||
149757784|NCT05628181|540242402|FG002|Overall Study|Death|0|||
149757785|NCT04742907|540242409|FG000|Overall Study|Adverse Event|1|||
149757786|NCT04742907|540242410|FG001|Overall Study|Adverse Event|0|||
149757787|NCT04742907|540242411|FG002|Overall Study|Adverse Event|1|||
149757788|NCT04742907|540242409|FG000|Overall Study|Lost to Follow-up|3|||
149757789|NCT04742907|540242410|FG001|Overall Study|Lost to Follow-up|3|||
149757790|NCT04742907|540242411|FG002|Overall Study|Lost to Follow-up|2|||
149757791|NCT04742907|540242409|FG000|Overall Study|Physician Decision|0|||
149757792|NCT04742907|540242410|FG001|Overall Study|Physician Decision|1|||
149757793|NCT04742907|540242411|FG002|Overall Study|Physician Decision|0|||
149757794|NCT04742907|540242409|FG000|Overall Study|Protocol Violation|1|||
149757795|NCT04742907|540242410|FG001|Overall Study|Protocol Violation|1|||
149757796|NCT04742907|540242411|FG002|Overall Study|Protocol Violation|1|||
149757797|NCT04742907|540242409|FG000|Overall Study|Withdrawal by Subject|5|||
149757798|NCT04742907|540242410|FG001|Overall Study|Withdrawal by Subject|6|||
149757799|NCT04742907|540242411|FG002|Overall Study|Withdrawal by Subject|4|||
149757800|NCT04742907|540242409|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
149757801|NCT04742907|540242410|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
149757802|NCT04742907|540242411|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
149757803|NCT04742907|540242409|FG000|Overall Study|Did Not Receive the Study Drug|2|||
149757804|NCT04742907|540242410|FG001|Overall Study|Did Not Receive the Study Drug|4|||
149757805|NCT04742907|540242411|FG002|Overall Study|Did Not Receive the Study Drug|4|||
149757806|NCT01428063|540242412|FG000|Overall Study|Lack of Efficacy|8|||
149757807|NCT01428063|540242413|FG001|Overall Study|Lack of Efficacy|4|||
149757808|NCT01428063|540242414|FG002|Overall Study|Lack of Efficacy|1|||
149757809|NCT01428063|540242412|FG000|Overall Study|Adverse Event|2|||
149757810|NCT01428063|540242413|FG001|Overall Study|Adverse Event|3|||
149757811|NCT01428063|540242414|FG002|Overall Study|Adverse Event|0|||
149757812|NCT01428063|540242412|FG000|Overall Study|Lost to Follow-up|0|||
149757813|NCT01428063|540242413|FG001|Overall Study|Lost to Follow-up|2|||
149757814|NCT01428063|540242414|FG002|Overall Study|Lost to Follow-up|0|||
149757815|NCT01428063|540242412|FG000|Overall Study|No longer meets study criteria|0|||
149757816|NCT01428063|540242413|FG001|Overall Study|No longer meets study criteria|1|||
149757817|NCT01428063|540242414|FG002|Overall Study|No longer meets study criteria|0|||
149757818|NCT03508622|540242415|FG000|Overall Study|Protocol Violation|1|||
149757819|NCT03508622|540242416|FG001|Overall Study|Protocol Violation|0|||
149757820|NCT03508622|540242415|FG000|Overall Study|Withdrawal by Subject|1|||
149757821|NCT03508622|540242416|FG001|Overall Study|Withdrawal by Subject|0|||
149757822|NCT03508622|540242415|FG000|Overall Study|Lost to Follow-up|16|||
149757823|NCT03508622|540242416|FG001|Overall Study|Lost to Follow-up|0|||
149757824|NCT03508622|540242415|FG000|Overall Study|Incomplete data|0|||
149757825|NCT03508622|540242416|FG001|Overall Study|Incomplete data|24|||
149757826|NCT01005719|540242417|FG000|Period 1|Adverse Event|0|||
149757827|NCT01005719|540242418|FG001|Period 1|Adverse Event|0|||
149757828|NCT01005719|540242419|FG002|Period 1|Adverse Event|0|||
149757829|NCT01005719|540242420|FG003|Period 1|Adverse Event|1|||
149757830|NCT01005719|540242421|FG004|Period 1|Adverse Event|0|||
149757831|NCT01005719|540242422|FG005|Period 1|Adverse Event|0|||
149757832|NCT01005719|540242417|FG000|Period 1|Delay in completing study procedures|0|||
149757833|NCT01005719|540242418|FG001|Period 1|Delay in completing study procedures|0|||
149757834|NCT01005719|540242419|FG002|Period 1|Delay in completing study procedures|0|||
149757835|NCT01005719|540242420|FG003|Period 1|Delay in completing study procedures|0|||
149757836|NCT01005719|540242421|FG004|Period 1|Delay in completing study procedures|0|||
149757837|NCT01005719|540242422|FG005|Period 1|Delay in completing study procedures|1|||
149757838|NCT01005719|540242417|FG000|Period 2|Adverse Event|0|||
149757839|NCT01005719|540242418|FG001|Period 2|Adverse Event|0|||
149757840|NCT01005719|540242419|FG002|Period 2|Adverse Event|0|||
149757841|NCT01005719|540242420|FG003|Period 2|Adverse Event|0|||
149757842|NCT01005719|540242421|FG004|Period 2|Adverse Event|1|||
149757843|NCT01005719|540242422|FG005|Period 2|Adverse Event|1|||
149757844|NCT02499146|540242423|FG000|Overall Study|Lost to Follow-up|1|||
149757845|NCT02499146|540242423|FG000|Overall Study|Withdrawal by Subject|1|||
149757846|NCT02499146|540242423|FG000|Overall Study|Other|2|||
149757847|NCT02499146|540242423|FG000|Overall Study|Ongoing at date of cut-off|9|||
149757848|NCT02499146|540242423|FG000|Overall Study|Began other treatment/therapy|13|||
149757849|NCT03161678|540242424|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149757850|NCT03161678|540242425|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149757851|NCT03161678|540242426|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149757852|NCT03161678|540242427|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
149757853|NCT03161678|540242428|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149757854|NCT03161678|540242429|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149757855|NCT03161678|540242424|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
149757856|NCT03161678|540242425|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
149757857|NCT03161678|540242426|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
149757858|NCT03161678|540242427|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
149757859|NCT03161678|540242428|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
149757860|NCT03161678|540242429|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
149757861|NCT03161678|540242424|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
149757862|NCT03161678|540242425|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
149757863|NCT03161678|540242426|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
149757864|NCT03161678|540242427|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
149757865|NCT03161678|540242428|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
149757866|NCT03161678|540242429|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
149757867|NCT03161678|540242424|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149757868|NCT03161678|540242425|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149757869|NCT03161678|540242426|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149757870|NCT03161678|540242427|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
149757871|NCT03161678|540242428|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149757872|NCT03161678|540242429|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149757873|NCT03007953|540242433|FG000|Overall Study|Withdrawal by Subject|5|||
149757874|NCT03007953|540242434|FG001|Overall Study|Withdrawal by Subject|2|||
149757875|NCT03007953|540242433|FG000|Overall Study|Death|5|||
149757876|NCT03007953|540242434|FG001|Overall Study|Death|7|||
149757877|NCT03007953|540242433|FG000|Overall Study|Lost to Follow-up|3|||
149757878|NCT03007953|540242434|FG001|Overall Study|Lost to Follow-up|2|||
149757879|NCT03007953|540242433|FG000|Overall Study|Enrolled in Hospice|3|||
149757880|NCT03007953|540242434|FG001|Overall Study|Enrolled in Hospice|2|||
149757881|NCT00829166|540242437|FG000|Overall Study|Death|305|||
149757882|NCT00829166|540242438|FG001|Overall Study|Death|333|||
149757883|NCT00829166|540242437|FG000|Overall Study|Lost to Follow-up|5|||
149757884|NCT00829166|540242438|FG001|Overall Study|Lost to Follow-up|4|||
149757885|NCT00829166|540242437|FG000|Overall Study|Physician's Decision|4|||
149757886|NCT00829166|540242438|FG001|Overall Study|Physician's Decision|3|||
149757887|NCT00829166|540242437|FG000|Overall Study|Subject's Decision|41|||
149757888|NCT00829166|540242438|FG001|Overall Study|Subject's Decision|55|||
149757889|NCT00829166|540242437|FG000|Overall Study|Sponsor's Decision|137|||
149757890|NCT00829166|540242438|FG001|Overall Study|Sponsor's Decision|98|||
149757891|NCT00829166|540242437|FG000|Overall Study|Reason Not Specified|3|||
149757892|NCT00829166|540242438|FG001|Overall Study|Reason Not Specified|3|||
149757893|NCT01635933|540242439|FG000|Overall Study|Adverse Event|1|||
149757894|NCT01635933|540242440|FG001|Overall Study|Adverse Event|0|||
149757895|NCT01635933|540242439|FG000|Overall Study|Lost to Follow-up|0|||
149757896|NCT01635933|540242440|FG001|Overall Study|Lost to Follow-up|5|||
149757897|NCT01635933|540242439|FG000|Overall Study|Subject decision|1|||
149757898|NCT01635933|540242440|FG001|Overall Study|Subject decision|1|||
149757899|NCT01635933|540242439|FG000|Overall Study|Noncompliance|0|||
149757900|NCT01635933|540242440|FG001|Overall Study|Noncompliance|1|||
149757901|NCT01635933|540242439|FG000|Overall Study|No longer had transportation|0|||
149757902|NCT01635933|540242440|FG001|Overall Study|No longer had transportation|1|||
149757903|NCT01544595|540242443|FG000|Status at Week 68|Adverse Event|3|||
149757904|NCT01544595|540242444|FG001|Status at Week 68|Adverse Event|2|||
149757905|NCT01544595|540242445|FG002|Status at Week 68|Adverse Event|1|||
149757906|NCT01544595|540242446|FG003|Status at Week 68|Adverse Event|0|||
149757907|NCT01544595|540242447|FG004|Status at Week 68|Adverse Event|0|||
149757908|NCT01544595|540242448|FG005|Status at Week 68|Adverse Event|0|||
149757909|NCT01544595|540242443|FG000|Status at Week 68|Lack of Efficacy|1|||
149757910|NCT01544595|540242444|FG001|Status at Week 68|Lack of Efficacy|0|||
149757911|NCT01544595|540242445|FG002|Status at Week 68|Lack of Efficacy|0|||
149757912|NCT01544595|540242446|FG003|Status at Week 68|Lack of Efficacy|0|||
149757913|NCT01544595|540242447|FG004|Status at Week 68|Lack of Efficacy|0|||
149757914|NCT01544595|540242448|FG005|Status at Week 68|Lack of Efficacy|0|||
149757915|NCT01544595|540242443|FG000|Status at Week 68|Lost to Follow-up|1|||
149757916|NCT01544595|540242444|FG001|Status at Week 68|Lost to Follow-up|1|||
149757917|NCT01544595|540242445|FG002|Status at Week 68|Lost to Follow-up|0|||
149757918|NCT01544595|540242446|FG003|Status at Week 68|Lost to Follow-up|0|||
149757919|NCT01544595|540242447|FG004|Status at Week 68|Lost to Follow-up|0|||
149757920|NCT01544595|540242448|FG005|Status at Week 68|Lost to Follow-up|0|||
149757921|NCT01544595|540242443|FG000|Status at Week 68|Non-compliance with study treatment|1|||
149757922|NCT01544595|540242444|FG001|Status at Week 68|Non-compliance with study treatment|0|||
149757923|NCT01544595|540242445|FG002|Status at Week 68|Non-compliance with study treatment|0|||
149757924|NCT01544595|540242446|FG003|Status at Week 68|Non-compliance with study treatment|1|||
149757925|NCT01544595|540242447|FG004|Status at Week 68|Non-compliance with study treatment|0|||
149757926|NCT01544595|540242448|FG005|Status at Week 68|Non-compliance with study treatment|0|||
149757927|NCT01544595|540242443|FG000|Status at Week 68|Protocol Violation|2|||
149757928|NCT01544595|540242444|FG001|Status at Week 68|Protocol Violation|0|||
149757929|NCT01544595|540242445|FG002|Status at Week 68|Protocol Violation|1|||
149757930|NCT01544595|540242446|FG003|Status at Week 68|Protocol Violation|1|||
149757931|NCT01544595|540242447|FG004|Status at Week 68|Protocol Violation|0|||
149757932|NCT01544595|540242448|FG005|Status at Week 68|Protocol Violation|0|||
149757933|NCT01544595|540242443|FG000|Status at Week 68|Technical problems|1|||
149757934|NCT01544595|540242444|FG001|Status at Week 68|Technical problems|0|||
149757935|NCT01544595|540242445|FG002|Status at Week 68|Technical problems|0|||
149757936|NCT01544595|540242446|FG003|Status at Week 68|Technical problems|1|||
149757937|NCT01544595|540242447|FG004|Status at Week 68|Technical problems|0|||
149757938|NCT01544595|540242448|FG005|Status at Week 68|Technical problems|0|||
149757939|NCT01544595|540242443|FG000|Status at Week 68|Withdrawal by Subject|0|||
149757940|NCT01544595|540242444|FG001|Status at Week 68|Withdrawal by Subject|1|||
149757941|NCT01544595|540242445|FG002|Status at Week 68|Withdrawal by Subject|1|||
149757942|NCT01544595|540242446|FG003|Status at Week 68|Withdrawal by Subject|2|||
149757943|NCT01544595|540242447|FG004|Status at Week 68|Withdrawal by Subject|0|||
149757944|NCT01544595|540242448|FG005|Status at Week 68|Withdrawal by Subject|0|||
149757945|NCT01544595|540242443|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
149757946|NCT01544595|540242444|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
149757947|NCT01544595|540242445|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
149757948|NCT01544595|540242446|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
149757949|NCT01544595|540242447|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
149757950|NCT01544595|540242448|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
149757951|NCT01544595|540242443|FG000|Status at Week 156|Withdrawal by Subject|9|||
149757952|NCT01544595|540242444|FG001|Status at Week 156|Withdrawal by Subject|10|||
149757953|NCT01544595|540242445|FG002|Status at Week 156|Withdrawal by Subject|4|||
149757954|NCT01544595|540242446|FG003|Status at Week 156|Withdrawal by Subject|9|||
149757955|NCT01544595|540242447|FG004|Status at Week 156|Withdrawal by Subject|20|||
149757956|NCT01544595|540242448|FG005|Status at Week 156|Withdrawal by Subject|6|||
149757957|NCT01544595|540242443|FG000|Status at Week 156|Adverse Event|9|||
149757958|NCT01544595|540242444|FG001|Status at Week 156|Adverse Event|11|||
149757959|NCT01544595|540242445|FG002|Status at Week 156|Adverse Event|1|||
149757960|NCT01544595|540242446|FG003|Status at Week 156|Adverse Event|3|||
149757961|NCT01544595|540242447|FG004|Status at Week 156|Adverse Event|4|||
149757962|NCT01544595|540242448|FG005|Status at Week 156|Adverse Event|2|||
149757963|NCT01544595|540242443|FG000|Status at Week 156|Lost to Follow-up|4|||
149757964|NCT01544595|540242444|FG001|Status at Week 156|Lost to Follow-up|4|||
149757965|NCT01544595|540242445|FG002|Status at Week 156|Lost to Follow-up|0|||
149757966|NCT01544595|540242446|FG003|Status at Week 156|Lost to Follow-up|1|||
149757967|NCT01544595|540242447|FG004|Status at Week 156|Lost to Follow-up|4|||
149757968|NCT01544595|540242448|FG005|Status at Week 156|Lost to Follow-up|1|||
149757969|NCT01544595|540242443|FG000|Status at Week 156|Non-compliance with study treatement|0|||
149757970|NCT01544595|540242444|FG001|Status at Week 156|Non-compliance with study treatement|1|||
149757971|NCT01544595|540242445|FG002|Status at Week 156|Non-compliance with study treatement|0|||
149757972|NCT01544595|540242446|FG003|Status at Week 156|Non-compliance with study treatement|1|||
149757973|NCT01544595|540242447|FG004|Status at Week 156|Non-compliance with study treatement|0|||
149757974|NCT01544595|540242448|FG005|Status at Week 156|Non-compliance with study treatement|1|||
149757975|NCT01544595|540242443|FG000|Status at Week 156|Physician Decision|0|||
149757976|NCT01544595|540242444|FG001|Status at Week 156|Physician Decision|3|||
149757977|NCT01544595|540242445|FG002|Status at Week 156|Physician Decision|1|||
149757978|NCT01544595|540242446|FG003|Status at Week 156|Physician Decision|0|||
149757979|NCT01544595|540242447|FG004|Status at Week 156|Physician Decision|0|||
149757980|NCT01544595|540242448|FG005|Status at Week 156|Physician Decision|0|||
149757981|NCT01544595|540242443|FG000|Status at Week 156|Pregnancy|2|||
149757982|NCT01544595|540242444|FG001|Status at Week 156|Pregnancy|3|||
149757983|NCT01544595|540242445|FG002|Status at Week 156|Pregnancy|0|||
149757984|NCT01544595|540242446|FG003|Status at Week 156|Pregnancy|0|||
149757985|NCT01544595|540242447|FG004|Status at Week 156|Pregnancy|0|||
149757986|NCT01544595|540242448|FG005|Status at Week 156|Pregnancy|0|||
149757987|NCT01544595|540242443|FG000|Status at Week 156|Protocol Violation|3|||
149757988|NCT01544595|540242444|FG001|Status at Week 156|Protocol Violation|1|||
149757989|NCT01544595|540242445|FG002|Status at Week 156|Protocol Violation|2|||
149757990|NCT01544595|540242446|FG003|Status at Week 156|Protocol Violation|2|||
149757991|NCT01544595|540242447|FG004|Status at Week 156|Protocol Violation|0|||
149757992|NCT01544595|540242448|FG005|Status at Week 156|Protocol Violation|0|||
149757993|NCT01544595|540242443|FG000|Status at Week 156|Technical problems|3|||
149757994|NCT01544595|540242444|FG001|Status at Week 156|Technical problems|1|||
149757995|NCT01544595|540242445|FG002|Status at Week 156|Technical problems|0|||
149757996|NCT01544595|540242446|FG003|Status at Week 156|Technical problems|1|||
149757997|NCT01544595|540242447|FG004|Status at Week 156|Technical problems|0|||
149757998|NCT01544595|540242448|FG005|Status at Week 156|Technical problems|0|||
149757999|NCT01544595|540242443|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
149758000|NCT01544595|540242444|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
149758001|NCT01544595|540242445|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
149758002|NCT01544595|540242446|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
149758003|NCT01544595|540242447|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
149758004|NCT01544595|540242448|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
149758005|NCT01544595|540242443|FG000|Status at Week 156|Lack of Efficacy|1|||
149758006|NCT01544595|540242444|FG001|Status at Week 156|Lack of Efficacy|0|||
149758007|NCT01544595|540242445|FG002|Status at Week 156|Lack of Efficacy|1|||
149758008|NCT01544595|540242446|FG003|Status at Week 156|Lack of Efficacy|4|||
149758009|NCT01544595|540242447|FG004|Status at Week 156|Lack of Efficacy|10|||
149758010|NCT01544595|540242448|FG005|Status at Week 156|Lack of Efficacy|5|||
149758011|NCT02379923|540242451|FG000|Overall Study|Death|5|||
149758012|NCT03382899|540242452|FG000|Overall Study|Ineligibility Determined|0|||
149758013|NCT03382899|540242453|FG001|Overall Study|Ineligibility Determined|1|||
149758014|NCT03382899|540242452|FG000|Overall Study|Lost to Follow-up|0|||
149758015|NCT03382899|540242453|FG001|Overall Study|Lost to Follow-up|1|||
149758016|NCT03382899|540242452|FG000|Overall Study|Sponsor's decision|31|||
149758017|NCT03382899|540242453|FG001|Overall Study|Sponsor's decision|28|||
149758018|NCT03382899|540242452|FG000|Overall Study|Withdrawal by Subject|0|||
149758019|NCT03382899|540242453|FG001|Overall Study|Withdrawal by Subject|5|||
149758020|NCT01402284|540242456|FG000|Overall Study|Withdrawal consent|2|||
149758021|NCT01402284|540242456|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
149758022|NCT01402284|540242456|FG000|Overall Study|Physician Decision|1|||
149758023|NCT01402284|540242456|FG000|Overall Study|Disease progression on study|10|||
149758024|NCT02928406|540242457|FG000|Overall Study|Death|780|||
149758025|NCT02928406|540242457|FG000|Overall Study|Progressive disease|3|||
149758026|NCT02928406|540242457|FG000|Overall Study|Lost to Follow-up|49|||
149758027|NCT02928406|540242457|FG000|Overall Study|Non-compliance|2|||
149758028|NCT02928406|540242457|FG000|Overall Study|Withdrawal by Subject|40|||
149758029|NCT02928406|540242457|FG000|Overall Study|Study terminated by sponsor|57|||
149758030|NCT02928406|540242457|FG000|Overall Study|Physician Decision|1|||
149758031|NCT02928406|540242457|FG000|Overall Study|Various reasons|72|||
149758032|NCT01745393|540242459|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
149758033|NCT01745393|540242460|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
149758034|NCT01745393|540242459|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
149758035|NCT01745393|540242460|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
149758036|NCT01745393|540242459|FG000|12-month Follow-up|Lost to Follow-up|6|||
149758037|NCT01745393|540242460|FG001|12-month Follow-up|Lost to Follow-up|5|||
149758038|NCT01064648|540242465|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
149758039|NCT01064648|540242466|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
149758040|NCT01064648|540242467|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
149758041|NCT01064648|540242468|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
149758042|NCT01064648|540242465|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
149758043|NCT01064648|540242466|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149758044|NCT01064648|540242467|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149758045|NCT01064648|540242468|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149758046|NCT01064648|540242465|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149758047|NCT01064648|540242466|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
149758048|NCT01064648|540242467|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149758049|NCT01064648|540242468|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149758050|NCT01064648|540242465|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
149758051|NCT01064648|540242466|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
149758052|NCT01064648|540242467|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
149758053|NCT01064648|540242468|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
149758054|NCT01064648|540242465|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
149758055|NCT01064648|540242466|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
149758056|NCT01064648|540242467|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
149758057|NCT01064648|540242468|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
149758058|NCT01064648|540242465|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149758059|NCT01064648|540242466|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
149758060|NCT01064648|540242467|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149758061|NCT01064648|540242468|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149758062|NCT01064648|540242465|FG000|Phase II|Adverse Event|0|||
149758063|NCT01064648|540242466|FG001|Phase II|Adverse Event|0|||
149758064|NCT01064648|540242467|FG002|Phase II|Adverse Event|15|||
149758065|NCT01064648|540242468|FG003|Phase II|Adverse Event|8|||
149758066|NCT01064648|540242465|FG000|Phase II|Death|0|||
149758067|NCT01064648|540242466|FG001|Phase II|Death|0|||
149758068|NCT01064648|540242467|FG002|Phase II|Death|4|||
149758069|NCT01064648|540242468|FG003|Phase II|Death|5|||
149758070|NCT01064648|540242465|FG000|Phase II|Withdrawal by Subject|0|||
149758071|NCT01064648|540242466|FG001|Phase II|Withdrawal by Subject|0|||
149758072|NCT01064648|540242467|FG002|Phase II|Withdrawal by Subject|2|||
149758073|NCT01064648|540242468|FG003|Phase II|Withdrawal by Subject|5|||
149758074|NCT01064648|540242465|FG000|Phase II|Progression|0|||
149758075|NCT01064648|540242466|FG001|Phase II|Progression|0|||
149758076|NCT01064648|540242467|FG002|Phase II|Progression|21|||
149758077|NCT01064648|540242468|FG003|Phase II|Progression|27|||
149758078|NCT01064648|540242465|FG000|Phase II|Non-protocol specified|0|||
149758079|NCT01064648|540242466|FG001|Phase II|Non-protocol specified|0|||
149758080|NCT01064648|540242467|FG002|Phase II|Non-protocol specified|5|||
149758081|NCT01064648|540242468|FG003|Phase II|Non-protocol specified|3|||
149758082|NCT01064648|540242465|FG000|Phase II|Under Review|0|||
149758083|NCT01064648|540242466|FG001|Phase II|Under Review|0|||
149758084|NCT01064648|540242467|FG002|Phase II|Under Review|2|||
149758085|NCT01064648|540242468|FG003|Phase II|Under Review|0|||
149758086|NCT05513391|540242469|FG000|Overall Study|Adverse Event|1|||
149758087|NCT05513391|540242470|FG001|Overall Study|Adverse Event|0|||
149758088|NCT05513391|540242469|FG000|Overall Study|Protocol Deviation|0|||
149758089|NCT05513391|540242470|FG001|Overall Study|Protocol Deviation|1|||
149758090|NCT05513391|540242469|FG000|Overall Study|Withdrawal by Subject|3|||
149758091|NCT05513391|540242470|FG001|Overall Study|Withdrawal by Subject|1|||
149758092|NCT05513391|540242469|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149758093|NCT05513391|540242470|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
149758094|NCT05513391|540242469|FG000|Overall Study|Lost to Follow-up|0|||
149758095|NCT05513391|540242470|FG001|Overall Study|Lost to Follow-up|2|||
149758096|NCT02429427|540242471|FG000|Overall Study|Adverse Event|220|||
149758097|NCT02429427|540242472|FG001|Overall Study|Adverse Event|92|||
149758098|NCT02429427|540242471|FG000|Overall Study|Protocol Violation|10|||
149758099|NCT02429427|540242472|FG001|Overall Study|Protocol Violation|6|||
149758100|NCT02429427|540242471|FG000|Overall Study|Lost to Follow-up|15|||
149758101|NCT02429427|540242472|FG001|Overall Study|Lost to Follow-up|6|||
149758102|NCT02429427|540242471|FG000|Overall Study|Withdrawal by Subject|64|||
149758103|NCT02429427|540242472|FG001|Overall Study|Withdrawal by Subject|34|||
149758104|NCT02429427|540242471|FG000|Overall Study|Other|62|||
149758105|NCT02429427|540242472|FG001|Overall Study|Other|41|||
149758106|NCT00719732|540242473|FG000|Overall Study|Lost to Follow-up|20|||
149758107|NCT00719732|540242473|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
149758108|NCT00719732|540242473|FG000|Overall Study|Illness not associated with device|1|||
149758109|NCT04038255|540244069|FG000|Overall Study|Lost to Follow-up|0|||
149758110|NCT04038255|540244070|FG001|Overall Study|Lost to Follow-up|9|||
149758111|NCT04038255|540244071|FG002|Overall Study|Lost to Follow-up|5|||
149758112|NCT04038255|540244069|FG000|Overall Study|Withdrawal by Subject|0|||
149758113|NCT04038255|540244070|FG001|Overall Study|Withdrawal by Subject|0|||
149758114|NCT04038255|540244071|FG002|Overall Study|Withdrawal by Subject|1|||
149758115|NCT05183867|540244072|FG000|Overall Study|Withdrawal by Subject|3|||
149758116|NCT05183867|540244073|FG001|Overall Study|Withdrawal by Subject|2|||
149758117|NCT05183867|540244074|FG002|Overall Study|Withdrawal by Subject|0|||
149758118|NCT04491877|540244075|FG000|Overall Study|Protocol Deviation|1|||
149758119|NCT04491877|540244076|FG001|Overall Study|Protocol Deviation|0|||
149758120|NCT04491877|540244077|FG002|Overall Study|Protocol Deviation|2|||
149758121|NCT04491877|540244078|FG003|Overall Study|Protocol Deviation|0|||
149758122|NCT04491877|540244079|FG004|Overall Study|Protocol Deviation|0|||
149758123|NCT04491877|540244080|FG005|Overall Study|Protocol Deviation|0|||
149758124|NCT04491877|540244081|FG006|Overall Study|Protocol Deviation|1|||
149758125|NCT04491877|540244082|FG007|Overall Study|Protocol Deviation|1|||
149758126|NCT04491877|540244083|FG008|Overall Study|Protocol Deviation|0|||
149758127|NCT04491877|540244075|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149758128|NCT04491877|540244076|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149758129|NCT04491877|540244077|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149758130|NCT04491877|540244078|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
149758131|NCT04491877|540244079|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149758132|NCT04491877|540244080|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
149758133|NCT04491877|540244081|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
149758134|NCT04491877|540244082|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
149758135|NCT04491877|540244083|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
149758136|NCT04491877|540244075|FG000|Overall Study|Lost to Follow-up|0|||
149758137|NCT04491877|540244076|FG001|Overall Study|Lost to Follow-up|2|||
149758138|NCT04491877|540244077|FG002|Overall Study|Lost to Follow-up|0|||
149758139|NCT04491877|540244078|FG003|Overall Study|Lost to Follow-up|0|||
149758140|NCT04491877|540244079|FG004|Overall Study|Lost to Follow-up|0|||
149758141|NCT04491877|540244080|FG005|Overall Study|Lost to Follow-up|0|||
149758142|NCT04491877|540244081|FG006|Overall Study|Lost to Follow-up|2|||
149758143|NCT04491877|540244082|FG007|Overall Study|Lost to Follow-up|1|||
149758144|NCT04491877|540244083|FG008|Overall Study|Lost to Follow-up|1|||
149758145|NCT01597557|540244095|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
149758146|NCT01597557|540244096|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
149758147|NCT03165721|540244106|FG000|Overall Study|Refused further treatment|3|||
149758148|NCT03165721|540244107|FG001|Overall Study|Refused further treatment|0|||
149758149|NCT03165721|540244108|FG002|Overall Study|Refused further treatment|0|||
149758150|NCT03165721|540244106|FG000|Overall Study|Physician Decision|1|||
149758151|NCT03165721|540244107|FG001|Overall Study|Physician Decision|0|||
149758152|NCT03165721|540244108|FG002|Overall Study|Physician Decision|0|||
149758153|NCT01863849|540244109|FG000|Overall Study|Lost to Follow-up|1|||
149758154|NCT01863849|540244110|FG001|Overall Study|Lost to Follow-up|0|||
149758155|NCT01457118|540244111|FG000|Overall Study|Adverse Event|1|||
149758156|NCT01457118|540244112|FG001|Overall Study|Adverse Event|0|||
149758157|NCT01457118|540244113|FG002|Overall Study|Adverse Event|0|||
149758158|NCT01457118|540244114|FG003|Overall Study|Adverse Event|1|||
149758159|NCT01457118|540244111|FG000|Overall Study|Clinical Progression|0|||
149758160|NCT01457118|540244112|FG001|Overall Study|Clinical Progression|1|||
149758161|NCT01457118|540244113|FG002|Overall Study|Clinical Progression|0|||
149758162|NCT01457118|540244114|FG003|Overall Study|Clinical Progression|1|||
149758163|NCT01457118|540244111|FG000|Overall Study|Physician Decision|2|||
149758164|NCT01457118|540244112|FG001|Overall Study|Physician Decision|0|||
149758165|NCT01457118|540244113|FG002|Overall Study|Physician Decision|0|||
149758166|NCT01457118|540244114|FG003|Overall Study|Physician Decision|0|||
149758167|NCT01457118|540244111|FG000|Overall Study|Progressive Disease by RECIST|12|||
149758168|NCT01457118|540244112|FG001|Overall Study|Progressive Disease by RECIST|3|||
149758169|NCT01457118|540244113|FG002|Overall Study|Progressive Disease by RECIST|1|||
149758170|NCT01457118|540244114|FG003|Overall Study|Progressive Disease by RECIST|0|||
149758171|NCT01457118|540244111|FG000|Overall Study|Withdrawal by Subject|5|||
149758172|NCT01457118|540244112|FG001|Overall Study|Withdrawal by Subject|0|||
149758173|NCT01457118|540244113|FG002|Overall Study|Withdrawal by Subject|0|||
149758174|NCT01457118|540244114|FG003|Overall Study|Withdrawal by Subject|0|||
149758175|NCT02324842|540244115|FG000|Overall Study|Lost to Follow-up|1|||
149758176|NCT02324842|540244116|FG001|Overall Study|Lost to Follow-up|1|||
149758177|NCT02324842|540244117|FG002|Overall Study|Lost to Follow-up|2|||
149758178|NCT02750800|540244121|FG000|Overall Study|Adverse Event|18|||
149758179|NCT02750800|540244121|FG000|Overall Study|Lost to Follow-up|12|||
149758180|NCT02750800|540244121|FG000|Overall Study|Investigator decision|53|||
149758181|NCT02750800|540244121|FG000|Overall Study|Patient request|12|||
149758182|NCT02750800|540244121|FG000|Overall Study|Other, not specified|3|||
149758183|NCT03456713|540244124|FG000|Overall Study|Lost to Follow-up|1|||
149758184|NCT03456713|540244125|FG001|Overall Study|Lost to Follow-up|0|||
149758185|NCT03456713|540244126|FG002|Overall Study|Lost to Follow-up|0|||
149758186|NCT03456713|540244127|FG003|Overall Study|Lost to Follow-up|0|||
149758187|NCT01263691|540244131|FG000|Overall Study|Lost to Follow-up|1|||
149758188|NCT01263691|540244132|FG001|Overall Study|Lost to Follow-up|0|||
149758189|NCT01263691|540244133|FG002|Overall Study|Lost to Follow-up|1|||
149758190|NCT01263691|540244134|FG003|Overall Study|Lost to Follow-up|1|||
149758191|NCT01263691|540244135|FG004|Overall Study|Lost to Follow-up|0|||
149758192|NCT01263691|540244136|FG005|Overall Study|Lost to Follow-up|0|||
149758193|NCT01263691|540244131|FG000|Overall Study|Withdrawal by Subject|1|||
149758194|NCT01263691|540244132|FG001|Overall Study|Withdrawal by Subject|0|||
149758195|NCT01263691|540244133|FG002|Overall Study|Withdrawal by Subject|0|||
149758196|NCT01263691|540244134|FG003|Overall Study|Withdrawal by Subject|0|||
149758197|NCT01263691|540244135|FG004|Overall Study|Withdrawal by Subject|0|||
149758198|NCT01263691|540244136|FG005|Overall Study|Withdrawal by Subject|0|||
149758199|NCT01263691|540244131|FG000|Overall Study|Adverse Event|1|||
149758200|NCT01263691|540244132|FG001|Overall Study|Adverse Event|0|||
149758201|NCT01263691|540244133|FG002|Overall Study|Adverse Event|0|||
149758202|NCT01263691|540244134|FG003|Overall Study|Adverse Event|0|||
149758203|NCT01263691|540244135|FG004|Overall Study|Adverse Event|0|||
149758204|NCT01263691|540244136|FG005|Overall Study|Adverse Event|0|||
149758205|NCT01202227|540244139|FG000|Overall Study|Adverse Event|16|||
149758206|NCT01202227|540244139|FG000|Overall Study|Withdrawal by Subject|2|||
149758207|NCT01202227|540244139|FG000|Overall Study|Lack of Efficacy|1|||
149758208|NCT00643487|540244140|FG000|Overall Study|Technical difficulty|3|||
149758209|NCT01894477|540244141|FG000|Overall Study|Protocol Violation|0|||
149758210|NCT01894477|540244142|FG001|Overall Study|Protocol Violation|1|||
149758211|NCT01894477|540244141|FG000|Overall Study|protocol changed due SC changed to cord|0|||
149758212|NCT01894477|540244142|FG001|Overall Study|protocol changed due SC changed to cord|1|||
149758213|NCT00850759|540244147|FG000|Overall Study|Lost to Follow-up|7|||
149758214|NCT00850759|540244148|FG001|Overall Study|Lost to Follow-up|5|||
149758215|NCT00850759|540244149|FG002|Overall Study|Lost to Follow-up|5|||
149758216|NCT00850759|540244150|FG003|Overall Study|Lost to Follow-up|3|||
149758217|NCT03196505|540244151|FG000|Overall Study|Physician Decision|26|||
149758218|NCT03196505|540244152|FG001|Overall Study|Physician Decision|26|||
149758219|NCT01753076|540244153|FG000|Overall Study|Adverse Event|17|||
149758220|NCT01753076|540244154|FG001|Overall Study|Adverse Event|18|||
149758221|NCT01753076|540244153|FG000|Overall Study|Lack of Efficacy|3|||
149758222|NCT01753076|540244154|FG001|Overall Study|Lack of Efficacy|1|||
149758223|NCT01753076|540244153|FG000|Overall Study|Lost to Follow-up|2|||
149758224|NCT01753076|540244154|FG001|Overall Study|Lost to Follow-up|1|||
149758225|NCT01753076|540244153|FG000|Overall Study|Physician Decision|4|||
149758226|NCT01753076|540244154|FG001|Overall Study|Physician Decision|2|||
149758227|NCT01753076|540244153|FG000|Overall Study|Withdrawal by Subject|14|||
149758228|NCT01753076|540244154|FG001|Overall Study|Withdrawal by Subject|24|||
149758229|NCT01753076|540244153|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
149758230|NCT01753076|540244154|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
149758231|NCT02575079|540244155|FG000|Overall Study|Death|3|||
149758232|NCT02575079|540244156|FG001|Overall Study|Death|0|||
149758233|NCT02575079|540244155|FG000|Overall Study|Withdrawal by Subject|3|||
149758234|NCT02575079|540244156|FG001|Overall Study|Withdrawal by Subject|0|||
149758235|NCT02389816|540244157|FG000|Overall Study|Randomized but Not Treated|1|||
149758236|NCT02389816|540244158|FG001|Overall Study|Randomized but Not Treated|0|||
149758237|NCT02389816|540244159|FG002|Overall Study|Randomized but Not Treated|0|||
149758238|NCT02389816|540244157|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
149758239|NCT02389816|540244158|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
149758240|NCT02389816|540244159|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
149758241|NCT02389816|540244157|FG000|Overall Study|Major Protocol Deviation|1|||
149758242|NCT02389816|540244158|FG001|Overall Study|Major Protocol Deviation|0|||
149758243|NCT02389816|540244159|FG002|Overall Study|Major Protocol Deviation|0|||
149758244|NCT02389816|540244157|FG000|Overall Study|Lost to Follow-up|1|||
149758245|NCT02389816|540244158|FG001|Overall Study|Lost to Follow-up|0|||
149758246|NCT02389816|540244159|FG002|Overall Study|Lost to Follow-up|0|||
149758247|NCT02389816|540244157|FG000|Overall Study|Withdrawal of Consent|6|||
149758248|NCT02389816|540244158|FG001|Overall Study|Withdrawal of Consent|4|||
149758249|NCT02389816|540244159|FG002|Overall Study|Withdrawal of Consent|4|||
149758250|NCT02389816|540244157|FG000|Overall Study|Lack of Efficacy|1|||
149758251|NCT02389816|540244158|FG001|Overall Study|Lack of Efficacy|0|||
149758252|NCT02389816|540244159|FG002|Overall Study|Lack of Efficacy|0|||
149758253|NCT02389816|540244157|FG000|Overall Study|Non Compliance with Study Drug|1|||
149758254|NCT02389816|540244158|FG001|Overall Study|Non Compliance with Study Drug|1|||
149758255|NCT02389816|540244159|FG002|Overall Study|Non Compliance with Study Drug|1|||
149758256|NCT02389816|540244157|FG000|Overall Study|Reason not Specified|0|||
149758257|NCT02389816|540244158|FG001|Overall Study|Reason not Specified|2|||
149758258|NCT02389816|540244159|FG002|Overall Study|Reason not Specified|0|||
149758259|NCT01259856|540244166|FG000|Overall Study|Adverse Event|12|||
149758260|NCT01259856|540244167|FG001|Overall Study|Adverse Event|9|||
149758261|NCT01259856|540244166|FG000|Overall Study|Death|0|||
149758262|NCT01259856|540244167|FG001|Overall Study|Death|1|||
149758263|NCT01259856|540244166|FG000|Overall Study|Lack of Efficacy|3|||
149758264|NCT01259856|540244167|FG001|Overall Study|Lack of Efficacy|1|||
149758265|NCT01259856|540244166|FG000|Overall Study|Lost to Follow-up|1|||
149758266|NCT01259856|540244167|FG001|Overall Study|Lost to Follow-up|1|||
149758267|NCT01259856|540244166|FG000|Overall Study|Physician Decision|2|||
149758268|NCT01259856|540244167|FG001|Overall Study|Physician Decision|1|||
149758269|NCT01259856|540244166|FG000|Overall Study|Withdrawal by Subject|9|||
149758270|NCT01259856|540244167|FG001|Overall Study|Withdrawal by Subject|10|||
149758271|NCT01259856|540244166|FG000|Overall Study|Treatment never started|0|||
149758272|NCT01259856|540244167|FG001|Overall Study|Treatment never started|6|||
149758273|NCT01259856|540244166|FG000|Overall Study|Study closure by sponsor|40|||
149758274|NCT01259856|540244167|FG001|Overall Study|Study closure by sponsor|41|||
149758275|NCT01259856|540244166|FG000|Overall Study|Patient developed other disease|0|||
149758276|NCT01259856|540244167|FG001|Overall Study|Patient developed other disease|1|||
149758277|NCT01259856|540244166|FG000|Overall Study|Transfer to another study|0|||
149758278|NCT01259856|540244167|FG001|Overall Study|Transfer to another study|1|||
149758279|NCT01259856|540244166|FG000|Overall Study|Unknown/missing|2|||
149758280|NCT01259856|540244167|FG001|Overall Study|Unknown/missing|2|||
149758281|NCT00788775|540244168|FG000|Overall Study|Progressive Disease|8|||
149758282|NCT00788775|540244169|FG001|Overall Study|Progressive Disease|6|||
149758283|NCT00788775|540244168|FG000|Overall Study|Withdrawal by Subject|0|||
149758284|NCT00788775|540244169|FG001|Overall Study|Withdrawal by Subject|2|||
149758285|NCT00788775|540244168|FG000|Overall Study|Patient Non-Compliance|1|||
149758286|NCT00788775|540244169|FG001|Overall Study|Patient Non-Compliance|0|||
149758287|NCT00788775|540244168|FG000|Overall Study|Patient's measurable disease resected.|1|||
149758288|NCT00788775|540244169|FG001|Overall Study|Patient's measurable disease resected.|0|||
149758289|NCT00578864|540244170|FG000|Overall Study|Death|1|||
149758290|NCT00578864|540244171|FG001|Overall Study|Death|0|||
149758291|NCT01217190|540244175|FG000|Second Dosing|Withdrawal by Subject|0|||
149758292|NCT01217190|540244176|FG001|Second Dosing|Withdrawal by Subject|2|||
149758293|NCT01594476|540244177|FG000|Overall Study|Protocol Violation|1|||
149758294|NCT01594476|540244178|FG001|Overall Study|Protocol Violation|3|||
149758295|NCT01087528|540244179|FG000|Overall Study|Withdrawal by Subject|1|||
149758296|NCT01087528|540244179|FG000|Overall Study|Incomplete CE procedure|6|||
149758297|NCT03116399|540244182|FG000|Overall Study|Death|8|||
149758298|NCT03116399|540244183|FG001|Overall Study|Death|3|||
149758299|NCT03116399|540244182|FG000|Overall Study|Lost to Follow-up|7|||
149758300|NCT03116399|540244183|FG001|Overall Study|Lost to Follow-up|11|||
149758301|NCT03116399|540244182|FG000|Overall Study|Investigator Decision|1|||
149758302|NCT03116399|540244183|FG001|Overall Study|Investigator Decision|1|||
149758303|NCT03116399|540244182|FG000|Overall Study|Withdrawal by Subject|24|||
149758304|NCT03116399|540244183|FG001|Overall Study|Withdrawal by Subject|9|||
149758305|NCT00601523|540244186|FG000|Overall Study|Adverse Event|42|||
149758306|NCT00601523|540244187|FG001|Overall Study|Adverse Event|14|||
149758307|NCT00601523|540244186|FG000|Overall Study|Lack of Efficacy|3|||
149758308|NCT00601523|540244187|FG001|Overall Study|Lack of Efficacy|0|||
149758309|NCT00601523|540244186|FG000|Overall Study|Protocol Violation|5|||
149758310|NCT00601523|540244187|FG001|Overall Study|Protocol Violation|1|||
149758311|NCT00601523|540244186|FG000|Overall Study|Lost to Follow-up|0|||
149758312|NCT00601523|540244187|FG001|Overall Study|Lost to Follow-up|1|||
149758313|NCT00601523|540244186|FG000|Overall Study|Withdrawal by Subject|18|||
149758314|NCT00601523|540244187|FG001|Overall Study|Withdrawal by Subject|9|||
149758315|NCT00601523|540244186|FG000|Overall Study|Other|9|||
149758316|NCT00601523|540244187|FG001|Overall Study|Other|1|||
149758317|NCT04072146|540244188|FG000|Overall Study|Adverse Event|0|||
149758318|NCT04072146|540244189|FG001|Overall Study|Adverse Event|1|||
149758319|NCT01617434|540244190|FG000|Overall Study|Adverse Event|12|||
149758320|NCT01617434|540244191|FG001|Overall Study|Adverse Event|3|||
149758321|NCT01617434|540244190|FG000|Overall Study|Protocol Violation|8|||
149758322|NCT01617434|540244191|FG001|Overall Study|Protocol Violation|7|||
149758323|NCT01617434|540244190|FG000|Overall Study|Withdrawal Criteria|12|||
149758324|NCT01617434|540244191|FG001|Overall Study|Withdrawal Criteria|37|||
149758325|NCT01617434|540244190|FG000|Overall Study|Unclassified|3|||
149758326|NCT01617434|540244191|FG001|Overall Study|Unclassified|4|||
149758327|NCT01987986|540244192|FG000|Overall Study|Lost to Follow-up|1|||
149758328|NCT01987986|540244193|FG001|Overall Study|Lost to Follow-up|0|||
149758329|NCT01987986|540244194|FG002|Overall Study|Lost to Follow-up|0|||
149758330|NCT01987986|540244195|FG003|Overall Study|Lost to Follow-up|0|||
149758331|NCT01987986|540244192|FG000|Overall Study|Adverse Event|1|||
149758332|NCT01987986|540244193|FG001|Overall Study|Adverse Event|0|||
149758333|NCT01987986|540244194|FG002|Overall Study|Adverse Event|2|||
149758334|NCT01987986|540244195|FG003|Overall Study|Adverse Event|0|||
149758335|NCT00540436|540244196|FG000|First 12-Week Treatment Period|Adverse Event|1|||
149758336|NCT00540436|540244196|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
149758337|NCT00540436|540244196|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
149758338|NCT00540436|540244196|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
149758339|NCT00905021|540244197|FG000|Overall Study|Adverse Event|2|||
149758340|NCT00786838|540244198|FG000|Overall Study|Physician Decision|4|||
149758341|NCT00786838|540244198|FG000|Overall Study|Death|4|||
149758342|NCT00786838|540244198|FG000|Overall Study|Adverse Event|6|||
149758343|NCT00786838|540244198|FG000|Overall Study|Progressive disease|31|||
149758344|NCT00786838|540244198|FG000|Overall Study|Withdrawal by Subject|4|||
149758345|NCT04937816|540244199|FG000|Overall Study|Study drug stopped, reason missing|5|||
149758346|NCT04937816|540244200|FG001|Overall Study|Study drug stopped, reason missing|3|||
149758347|NCT04937816|540244201|FG002|Overall Study|Study drug stopped, reason missing|4|||
149758348|NCT04937816|540244202|FG003|Overall Study|Study drug stopped, reason missing|6|||
149758349|NCT04937816|540244203|FG004|Overall Study|Study drug stopped, reason missing|1|||
149758350|NCT04937816|540244204|FG005|Overall Study|Study drug stopped, reason missing|0|||
149758351|NCT04937816|540244205|FG006|Overall Study|Study drug stopped, reason missing|0|||
149758352|NCT04937816|540244199|FG000|Overall Study|Other than stated below|173|||
149758353|NCT04937816|540244200|FG001|Overall Study|Other than stated below|143|||
149758354|NCT04937816|540244201|FG002|Overall Study|Other than stated below|125|||
149758355|NCT04937816|540244202|FG003|Overall Study|Other than stated below|44|||
149758356|NCT04937816|540244203|FG004|Overall Study|Other than stated below|45|||
149758357|NCT04937816|540244204|FG005|Overall Study|Other than stated below|28|||
149758358|NCT04937816|540244205|FG006|Overall Study|Other than stated below|31|||
149758359|NCT04937816|540244199|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
149758360|NCT04937816|540244200|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
149758361|NCT04937816|540244201|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
149758362|NCT04937816|540244202|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
149758363|NCT04937816|540244203|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
149758364|NCT04937816|540244204|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
149758365|NCT04937816|540244205|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
149758366|NCT04937816|540244199|FG000|Overall Study|Lost to Follow-up|15|||
149758367|NCT04937816|540244200|FG001|Overall Study|Lost to Follow-up|9|||
149758368|NCT04937816|540244201|FG002|Overall Study|Lost to Follow-up|6|||
149758369|NCT04937816|540244202|FG003|Overall Study|Lost to Follow-up|6|||
149758370|NCT04937816|540244203|FG004|Overall Study|Lost to Follow-up|16|||
149758371|NCT04937816|540244204|FG005|Overall Study|Lost to Follow-up|11|||
149758372|NCT04937816|540244205|FG006|Overall Study|Lost to Follow-up|17|||
149758373|NCT04937816|540244199|FG000|Overall Study|Protocol Violation|15|||
149758374|NCT04937816|540244200|FG001|Overall Study|Protocol Violation|15|||
149758375|NCT04937816|540244201|FG002|Overall Study|Protocol Violation|12|||
149758376|NCT04937816|540244202|FG003|Overall Study|Protocol Violation|30|||
149758377|NCT04937816|540244203|FG004|Overall Study|Protocol Violation|24|||
149758378|NCT04937816|540244204|FG005|Overall Study|Protocol Violation|5|||
149758379|NCT04937816|540244205|FG006|Overall Study|Protocol Violation|5|||
149758380|NCT04937816|540244199|FG000|Overall Study|Adverse Event|303|||
149758381|NCT04937816|540244200|FG001|Overall Study|Adverse Event|267|||
149758382|NCT04937816|540244201|FG002|Overall Study|Adverse Event|273|||
149758383|NCT04937816|540244202|FG003|Overall Study|Adverse Event|553|||
149758384|NCT04937816|540244203|FG004|Overall Study|Adverse Event|575|||
149758385|NCT04937816|540244204|FG005|Overall Study|Adverse Event|343|||
149758386|NCT04937816|540244205|FG006|Overall Study|Adverse Event|337|||
149758387|NCT04937816|540244199|FG000|Overall Study|Not treated|4|||
149758388|NCT04937816|540244200|FG001|Overall Study|Not treated|2|||
149758389|NCT04937816|540244201|FG002|Overall Study|Not treated|2|||
149758390|NCT04937816|540244202|FG003|Overall Study|Not treated|2|||
149758391|NCT04937816|540244203|FG004|Overall Study|Not treated|1|||
149758392|NCT04937816|540244204|FG005|Overall Study|Not treated|4|||
149758393|NCT04937816|540244205|FG006|Overall Study|Not treated|0|||
149758394|NCT02488759|540244207|FG000|Overall Study|Disease progression|73|||
149758395|NCT02488759|540244208|FG001|Overall Study|Disease progression|111|||
149758396|NCT02488759|540244209|FG002|Overall Study|Disease progression|62|||
149758397|NCT02488759|540244210|FG003|Overall Study|Disease progression|7|||
149758398|NCT02488759|540244211|FG004|Overall Study|Disease progression|4|||
149758399|NCT02488759|540244212|FG005|Overall Study|Disease progression|2|||
149758400|NCT02488759|540244207|FG000|Overall Study|Study drug toxicity|11|||
149758401|NCT02488759|540244208|FG001|Overall Study|Study drug toxicity|33|||
149758402|NCT02488759|540244209|FG002|Overall Study|Study drug toxicity|31|||
149758403|NCT02488759|540244210|FG003|Overall Study|Study drug toxicity|0|||
149758404|NCT02488759|540244211|FG004|Overall Study|Study drug toxicity|0|||
149758405|NCT02488759|540244212|FG005|Overall Study|Study drug toxicity|2|||
149758406|NCT02488759|540244207|FG000|Overall Study|Adverse event unrelated to study drug|9|||
149758407|NCT02488759|540244208|FG001|Overall Study|Adverse event unrelated to study drug|11|||
149758408|NCT02488759|540244209|FG002|Overall Study|Adverse event unrelated to study drug|7|||
149758409|NCT02488759|540244210|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149758410|NCT02488759|540244211|FG004|Overall Study|Adverse event unrelated to study drug|1|||
149758411|NCT02488759|540244212|FG005|Overall Study|Adverse event unrelated to study drug|0|||
149758412|NCT02488759|540244207|FG000|Overall Study|Participant request to discontinue study treatment|6|||
149758413|NCT02488759|540244208|FG001|Overall Study|Participant request to discontinue study treatment|8|||
149758414|NCT02488759|540244209|FG002|Overall Study|Participant request to discontinue study treatment|4|||
149758415|NCT02488759|540244210|FG003|Overall Study|Participant request to discontinue study treatment|0|||
149758416|NCT02488759|540244211|FG004|Overall Study|Participant request to discontinue study treatment|0|||
149758417|NCT02488759|540244212|FG005|Overall Study|Participant request to discontinue study treatment|0|||
149758418|NCT02488759|540244207|FG000|Overall Study|Withdrawal by Subject|4|||
149758419|NCT02488759|540244208|FG001|Overall Study|Withdrawal by Subject|0|||
149758420|NCT02488759|540244209|FG002|Overall Study|Withdrawal by Subject|3|||
149758421|NCT02488759|540244210|FG003|Overall Study|Withdrawal by Subject|0|||
149758422|NCT02488759|540244211|FG004|Overall Study|Withdrawal by Subject|0|||
149758423|NCT02488759|540244212|FG005|Overall Study|Withdrawal by Subject|2|||
149758424|NCT02488759|540244207|FG000|Overall Study|Lost to Follow-up|0|||
149758425|NCT02488759|540244208|FG001|Overall Study|Lost to Follow-up|0|||
149758426|NCT02488759|540244209|FG002|Overall Study|Lost to Follow-up|2|||
149758427|NCT02488759|540244210|FG003|Overall Study|Lost to Follow-up|0|||
149758428|NCT02488759|540244211|FG004|Overall Study|Lost to Follow-up|0|||
149758429|NCT02488759|540244212|FG005|Overall Study|Lost to Follow-up|0|||
149758430|NCT02488759|540244207|FG000|Overall Study|Maximum clinical benefit|3|||
149758431|NCT02488759|540244208|FG001|Overall Study|Maximum clinical benefit|0|||
149758432|NCT02488759|540244209|FG002|Overall Study|Maximum clinical benefit|1|||
149758433|NCT02488759|540244210|FG003|Overall Study|Maximum clinical benefit|0|||
149758434|NCT02488759|540244211|FG004|Overall Study|Maximum clinical benefit|0|||
149758435|NCT02488759|540244212|FG005|Overall Study|Maximum clinical benefit|0|||
149758436|NCT02488759|540244207|FG000|Overall Study|Other reasons|7|||
149758437|NCT02488759|540244208|FG001|Overall Study|Other reasons|32|||
149758438|NCT02488759|540244209|FG002|Overall Study|Other reasons|23|||
149758439|NCT02488759|540244210|FG003|Overall Study|Other reasons|1|||
149758440|NCT02488759|540244211|FG004|Overall Study|Other reasons|1|||
149758441|NCT02488759|540244212|FG005|Overall Study|Other reasons|1|||
149758442|NCT05281523|540244213|FG000|Overall Study|Adverse Event|1|||
149758443|NCT05281523|540244214|FG001|Overall Study|Adverse Event|1|||
149758444|NCT05281523|540244213|FG000|Overall Study|Physician Decision|1|||
149758445|NCT05281523|540244214|FG001|Overall Study|Physician Decision|1|||
149758446|NCT05281523|540244213|FG000|Overall Study|Withdrawal by Subject|5|||
149758447|NCT05281523|540244214|FG001|Overall Study|Withdrawal by Subject|15|||
149758448|NCT05281523|540244213|FG000|Overall Study|GCP violations|3|||
149758449|NCT05281523|540244214|FG001|Overall Study|GCP violations|4|||
149758450|NCT05513053|540244215|FG000|Overall Study|Lost to Follow-up|9|||
149758451|NCT05513053|540244216|FG001|Overall Study|Lost to Follow-up|11|||
149758452|NCT05513053|540244215|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149758453|NCT05513053|540244216|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149758454|NCT05513053|540244215|FG000|Overall Study|Withdrawal by Subject|2|||
149758455|NCT05513053|540244216|FG001|Overall Study|Withdrawal by Subject|9|||
149758456|NCT05513053|540244215|FG000|Overall Study|Protocol Violation|6|||
149758457|NCT05513053|540244216|FG001|Overall Study|Protocol Violation|3|||
149758458|NCT05513053|540244215|FG000|Overall Study|Adverse Event|0|||
149758459|NCT05513053|540244216|FG001|Overall Study|Adverse Event|2|||
149758460|NCT00418834|540245740|FG000|Overall Study|Adverse Event|16|||
149758461|NCT00418834|540245741|FG001|Overall Study|Adverse Event|9|||
149758462|NCT00418834|540245740|FG000|Overall Study|Lost to Follow-up|0|||
149758463|NCT00418834|540245741|FG001|Overall Study|Lost to Follow-up|1|||
149758464|NCT00418834|540245740|FG000|Overall Study|Protocol Violation|4|||
149758465|NCT00418834|540245741|FG001|Overall Study|Protocol Violation|3|||
149758466|NCT00418834|540245740|FG000|Overall Study|Withdrawal by Subject|3|||
149758467|NCT00418834|540245741|FG001|Overall Study|Withdrawal by Subject|7|||
149758468|NCT01953328|540245742|FG000|Overall Study|Withdrawal by Subject|0|||
149758469|NCT01953328|540245743|FG001|Overall Study|Withdrawal by Subject|0|||
149758470|NCT01953328|540245744|FG002|Overall Study|Withdrawal by Subject|0|||
149758471|NCT01953328|540245745|FG003|Overall Study|Withdrawal by Subject|0|||
149758472|NCT01953328|540245746|FG004|Overall Study|Withdrawal by Subject|1|||
149758473|NCT01953328|540245747|FG005|Overall Study|Withdrawal by Subject|0|||
149758474|NCT01953328|540245748|FG006|Overall Study|Withdrawal by Subject|0|||
149758475|NCT01953328|540245749|FG007|Overall Study|Withdrawal by Subject|0|||
149758476|NCT01953328|540245742|FG000|Overall Study|Lost to Follow-up|0|||
149758477|NCT01953328|540245743|FG001|Overall Study|Lost to Follow-up|0|||
149758478|NCT01953328|540245744|FG002|Overall Study|Lost to Follow-up|0|||
149758479|NCT01953328|540245745|FG003|Overall Study|Lost to Follow-up|0|||
149758480|NCT01953328|540245746|FG004|Overall Study|Lost to Follow-up|1|||
149758481|NCT01953328|540245747|FG005|Overall Study|Lost to Follow-up|0|||
149758482|NCT01953328|540245748|FG006|Overall Study|Lost to Follow-up|0|||
149758483|NCT01953328|540245749|FG007|Overall Study|Lost to Follow-up|0|||
149758484|NCT00492856|540245753|FG000|Induction|Adverse Event|2|||
149758485|NCT00492856|540245754|FG001|Induction|Adverse Event|0|||
149758486|NCT00492856|540245755|FG002|Induction|Adverse Event|0|||
149758487|NCT00492856|540245756|FG003|Induction|Adverse Event|0|||
149758488|NCT00492856|540245753|FG000|Induction|Withdrawal by Subject|1|||
149758489|NCT00492856|540245754|FG001|Induction|Withdrawal by Subject|0|||
149758490|NCT00492856|540245755|FG002|Induction|Withdrawal by Subject|0|||
149758491|NCT00492856|540245756|FG003|Induction|Withdrawal by Subject|0|||
149758492|NCT00492856|540245753|FG000|Induction|Death|3|||
149758493|NCT00492856|540245754|FG001|Induction|Death|0|||
149758494|NCT00492856|540245755|FG002|Induction|Death|0|||
149758495|NCT00492856|540245756|FG003|Induction|Death|0|||
149758496|NCT00492856|540245753|FG000|Consolidation|Adverse Event|6|||
149758497|NCT00492856|540245754|FG001|Consolidation|Adverse Event|0|||
149758498|NCT00492856|540245755|FG002|Consolidation|Adverse Event|0|||
149758499|NCT00492856|540245756|FG003|Consolidation|Adverse Event|0|||
149758500|NCT00492856|540245753|FG000|Consolidation|Not protocol specified|2|||
149758501|NCT00492856|540245754|FG001|Consolidation|Not protocol specified|0|||
149758502|NCT00492856|540245755|FG002|Consolidation|Not protocol specified|0|||
149758503|NCT00492856|540245756|FG003|Consolidation|Not protocol specified|0|||
149758504|NCT00492856|540245753|FG000|Consolidation|Lost to Follow-up|1|||
149758505|NCT00492856|540245754|FG001|Consolidation|Lost to Follow-up|0|||
149758506|NCT00492856|540245755|FG002|Consolidation|Lost to Follow-up|0|||
149758507|NCT00492856|540245756|FG003|Consolidation|Lost to Follow-up|0|||
149758508|NCT00492856|540245753|FG000|Post-consolidation|Adverse Event|0|||
149758509|NCT00492856|540245754|FG001|Post-consolidation|Adverse Event|4|||
149758510|NCT00492856|540245755|FG002|Post-consolidation|Adverse Event|0|||
149758511|NCT00492856|540245756|FG003|Post-consolidation|Adverse Event|1|||
149758512|NCT00492856|540245753|FG000|Post-consolidation|Withdrawal by Subject|0|||
149758513|NCT00492856|540245754|FG001|Post-consolidation|Withdrawal by Subject|4|||
149758514|NCT00492856|540245755|FG002|Post-consolidation|Withdrawal by Subject|0|||
149758515|NCT00492856|540245756|FG003|Post-consolidation|Withdrawal by Subject|0|||
149758516|NCT00492856|540245753|FG000|Post-consolidation|Death|0|||
149758517|NCT00492856|540245754|FG001|Post-consolidation|Death|1|||
149758518|NCT00492856|540245755|FG002|Post-consolidation|Death|0|||
149758519|NCT00492856|540245756|FG003|Post-consolidation|Death|0|||
149758520|NCT00492856|540245753|FG000|Post-consolidation|Not protocol specified|0|||
149758521|NCT00492856|540245754|FG001|Post-consolidation|Not protocol specified|1|||
149758522|NCT00492856|540245755|FG002|Post-consolidation|Not protocol specified|0|||
149758523|NCT00492856|540245756|FG003|Post-consolidation|Not protocol specified|0|||
149758524|NCT00492856|540245753|FG000|Post-consolidation|Lost to Follow-up|0|||
149758525|NCT00492856|540245754|FG001|Post-consolidation|Lost to Follow-up|2|||
149758526|NCT00492856|540245755|FG002|Post-consolidation|Lost to Follow-up|0|||
149758527|NCT00492856|540245756|FG003|Post-consolidation|Lost to Follow-up|0|||
149758528|NCT00492856|540245753|FG000|Post-consolidation|Observation Arm|0|||
149758529|NCT00492856|540245754|FG001|Post-consolidation|Observation Arm|0|||
149758530|NCT00492856|540245755|FG002|Post-consolidation|Observation Arm|27|||
149758531|NCT00492856|540245756|FG003|Post-consolidation|Observation Arm|0|||
149758532|NCT02245568|540245759|FG000|Overall Study|Study terminated by Sponsor|346|||
149758533|NCT02245568|540245759|FG000|Overall Study|Adverse Event|144|||
149758534|NCT02245568|540245759|FG000|Overall Study|Lack of Efficacy|98|||
149758535|NCT02245568|540245759|FG000|Overall Study|Withdrawal by Caregiver|85|||
149758536|NCT02245568|540245759|FG000|Overall Study|Withdrawal by Subject|77|||
149758537|NCT02245568|540245759|FG000|Overall Study|Withdrawal by Legal Representative|31|||
149758538|NCT02245568|540245759|FG000|Overall Study|Missing (Site closure)|16|||
149758539|NCT02245568|540245759|FG000|Overall Study|Physician Decision|14|||
149758540|NCT02245568|540245759|FG000|Overall Study|Non-compliance with study drug|11|||
149758541|NCT02245568|540245759|FG000|Overall Study|Death|9|||
149758542|NCT02245568|540245759|FG000|Overall Study|Blue staining|6|||
149758543|NCT02245568|540245759|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
149758544|NCT02245568|540245759|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
149758545|NCT02245568|540245759|FG000|Overall Study|Lost to Follow-up|5|||
149758546|NCT02044159|540245760|FG000|Overall Study|Consent declined (deferred consent)|2|||
149758547|NCT02044159|540245761|FG001|Overall Study|Consent declined (deferred consent)|4|||
149758548|NCT02044159|540245760|FG000|Overall Study|No longer eligible, drug not given|1|||
149758549|NCT02044159|540245761|FG001|Overall Study|No longer eligible, drug not given|0|||
149758550|NCT02044159|540245760|FG000|Overall Study|Nurse declined to give study drug|1|||
149758551|NCT02044159|540245761|FG001|Overall Study|Nurse declined to give study drug|0|||
149758552|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
149758553|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149758554|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149758555|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149758556|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149758557|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
149758558|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149758559|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149758560|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149758561|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149758562|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
149758563|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149758564|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149758565|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149758566|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149758567|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
149758568|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149758569|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149758570|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149758571|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149758572|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
149758573|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149758574|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149758575|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149758576|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149758577|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
149758578|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149758579|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149758580|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149758581|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149758582|NCT01111539|540245762|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
149758583|NCT01111539|540245763|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149758584|NCT01111539|540245764|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149758585|NCT01111539|540245765|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149758586|NCT01111539|540245766|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149758587|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149758588|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149758589|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
149758590|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149758591|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
149758592|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149758593|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149758594|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
149758595|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149758596|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
149758597|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
149758598|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
149758599|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
149758600|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149758601|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149758602|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149758603|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149758604|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149758605|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149758606|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
149758607|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149758608|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149758609|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149758610|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
149758611|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149758612|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149758613|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149758614|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149758615|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
149758616|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149758617|NCT01111539|540245762|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149758618|NCT01111539|540245763|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149758619|NCT01111539|540245764|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149758620|NCT01111539|540245765|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149758621|NCT01111539|540245766|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
149758622|NCT03628417|540245767|FG000|Overall Study|Death|1|||
149758623|NCT03628417|540245768|FG001|Overall Study|Death|1|||
149758624|NCT05619172|540245772|FG000|Safety Cohort 1|Death|7|||
149758625|NCT05619172|540245773|FG001|Safety Cohort 1|Death|0|||
149758626|NCT05619172|540245772|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
149758627|NCT05619172|540245773|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
149758628|NCT05619172|540245772|FG000|Safety Cohort 2|Death|0|||
149758629|NCT05619172|540245773|FG001|Safety Cohort 2|Death|1|||
149758630|NCT05619172|540245772|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
149758631|NCT05619172|540245773|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
149758632|NCT00769704|540245775|FG000|Overall Study|Lost to Follow-up|3|||
149758633|NCT00769704|540245776|FG001|Overall Study|Lost to Follow-up|2|||
149758634|NCT00769704|540245775|FG000|Overall Study|Death|95|||
149758635|NCT00769704|540245776|FG001|Overall Study|Death|190|||
149758636|NCT00769704|540245775|FG000|Overall Study|Withdrawal by Subject|12|||
149758637|NCT00769704|540245776|FG001|Overall Study|Withdrawal by Subject|5|||
149758638|NCT00769704|540245775|FG000|Overall Study|Other|1|||
149758639|NCT00769704|540245776|FG001|Overall Study|Other|2|||
149758640|NCT00450372|540245777|FG000|Overall Study|Physician Decision|1|||
149758641|NCT05131451|540245778|FG000|Overall Study|Protocol Violation|1|||
149758642|NCT05131451|540245779|FG001|Overall Study|Protocol Violation|0|||
149758643|NCT01856595|540245786|FG000|Overall Study|Withdrawal by Subject|0|||
149758644|NCT01856595|540245787|FG001|Overall Study|Withdrawal by Subject|1|||
149758645|NCT01856595|540245788|FG002|Overall Study|Withdrawal by Subject|0|||
149758646|NCT01856595|540245789|FG003|Overall Study|Withdrawal by Subject|0|||
149758647|NCT01856595|540245790|FG004|Overall Study|Withdrawal by Subject|0|||
149758648|NCT01856595|540245791|FG005|Overall Study|Withdrawal by Subject|0|||
149758649|NCT01856595|540245792|FG006|Overall Study|Withdrawal by Subject|1|||
149758650|NCT01856595|540245793|FG007|Overall Study|Withdrawal by Subject|0|||
149758651|NCT01856595|540245794|FG008|Overall Study|Withdrawal by Subject|0|||
149758652|NCT04426825|540245796|FG000|Overall Study|Death|17|||
149758653|NCT04426825|540245796|FG000|Overall Study|Lost to Follow-up|1|||
149758654|NCT04426825|540245796|FG000|Overall Study|Study terminated by sponsor|5|||
149758655|NCT06150573|540245800|FG000|Overall Study|Did not meet study criteria|1|||
149758656|NCT06150573|540245801|FG001|Overall Study|Did not meet study criteria|0|||
149758657|NCT06150573|540245800|FG000|Overall Study|Adverse Event|1|||
149758658|NCT06150573|540245801|FG001|Overall Study|Adverse Event|0|||
149758659|NCT06150573|540245800|FG000|Overall Study|Lost to Follow-up|0|||
149758660|NCT06150573|540245801|FG001|Overall Study|Lost to Follow-up|1|||
149758661|NCT06150573|540245800|FG000|Overall Study|Protocol Violation|0|||
149758662|NCT06150573|540245801|FG001|Overall Study|Protocol Violation|1|||
149758663|NCT06150573|540245800|FG000|Overall Study|Withdrawal by Subject|2|||
149758664|NCT06150573|540245801|FG001|Overall Study|Withdrawal by Subject|0|||
149758665|NCT02284906|540245804|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149758666|NCT02284906|540245805|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
149758667|NCT02284906|540245806|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149758668|NCT02284906|540245804|FG000|Overall Study|Major Protocol Deviation|0|||
149758669|NCT02284906|540245805|FG001|Overall Study|Major Protocol Deviation|1|||
149758670|NCT02284906|540245806|FG002|Overall Study|Major Protocol Deviation|0|||
149758671|NCT02284906|540245804|FG000|Overall Study|Voluntary Withdrawal|2|||
149758672|NCT02284906|540245805|FG001|Overall Study|Voluntary Withdrawal|4|||
149758673|NCT02284906|540245806|FG002|Overall Study|Voluntary Withdrawal|5|||
149758674|NCT02284906|540245804|FG000|Overall Study|Study Termination|0|||
149758675|NCT02284906|540245805|FG001|Overall Study|Study Termination|11|||
149758676|NCT02284906|540245806|FG002|Overall Study|Study Termination|14|||
149758677|NCT02284906|540245804|FG000|Overall Study|Reason not Specified|1|||
149758678|NCT02284906|540245805|FG001|Overall Study|Reason not Specified|1|||
149758679|NCT02284906|540245806|FG002|Overall Study|Reason not Specified|0|||
149758680|NCT01727713|540245809|FG000|Overall Study|Lost to Follow-up|5|||
149758681|NCT01727713|540245809|FG000|Overall Study|Adverse Event|10|||
149758682|NCT01727713|540245809|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
149758683|NCT01727713|540245809|FG000|Overall Study|Withdrawal by Subject|13|||
149758684|NCT01727713|540245809|FG000|Overall Study|Protocol Deviation|2|||
149758685|NCT01253044|540245812|FG000|Overall Study|Lost to Follow-up|38|||
149758686|NCT01253044|540245813|FG001|Overall Study|Lost to Follow-up|29|||
149758687|NCT03885726|540245814|FG000|Overall Study|Staffing issues/lost interest|1|||
149758688|NCT03885726|540245814|FG000|Overall Study|Early discharge from hospital|3|||
149758689|NCT02868216|540245817|FG000|Overall Study|Death|0|||
149758690|NCT02868216|540245818|FG001|Overall Study|Death|1|||
149758691|NCT02868216|540245817|FG000|Overall Study|coronary artery bypass|1|||
149758692|NCT02868216|540245818|FG001|Overall Study|coronary artery bypass|0|||
149758693|NCT02868216|540245817|FG000|Overall Study|Withdrawal by Subject|7|||
149758694|NCT02868216|540245818|FG001|Overall Study|Withdrawal by Subject|5|||
149758695|NCT00987623|540245819|FG000|Overall Study|Lost to Follow-up|2|||
149758696|NCT00987623|540245820|FG001|Overall Study|Lost to Follow-up|1|||
149758697|NCT00987623|540245819|FG000|Overall Study|Time/job conflict|2|||
149758698|NCT00987623|540245820|FG001|Overall Study|Time/job conflict|0|||
149758699|NCT00987623|540245819|FG000|Overall Study|Discomfort|1|||
149758700|NCT00987623|540245820|FG001|Overall Study|Discomfort|0|||
149758701|NCT00987623|540245819|FG000|Overall Study|Biomicroscopy|0|||
149758702|NCT00987623|540245820|FG001|Overall Study|Biomicroscopy|1|||
149758703|NCT00987623|540245819|FG000|Overall Study|Influenza|0|||
149758704|NCT00987623|540245820|FG001|Overall Study|Influenza|1|||
149758705|NCT00850460|540245824|FG000|Overall Study|Lost to Follow-up|4|||
149758706|NCT00850460|540245825|FG001|Overall Study|Lost to Follow-up|4|||
149758707|NCT00988559|540245828|FG000|Overall Study|Withdrawal by Subject|1|||
149758708|NCT00988559|540245829|FG001|Overall Study|Withdrawal by Subject|1|||
149758709|NCT00988559|540245830|FG002|Overall Study|Withdrawal by Subject|0|||
149758710|NCT00988559|540245831|FG003|Overall Study|Withdrawal by Subject|1|||
149758711|NCT00988559|540245828|FG000|Overall Study|Pregnancy|0|||
149758712|NCT00988559|540245829|FG001|Overall Study|Pregnancy|1|||
149758713|NCT00988559|540245830|FG002|Overall Study|Pregnancy|1|||
149758714|NCT00988559|540245831|FG003|Overall Study|Pregnancy|0|||
149758715|NCT00988559|540245828|FG000|Overall Study|Lost to Follow-up|0|||
149758716|NCT00988559|540245829|FG001|Overall Study|Lost to Follow-up|0|||
149758717|NCT00988559|540245830|FG002|Overall Study|Lost to Follow-up|1|||
149758718|NCT00988559|540245831|FG003|Overall Study|Lost to Follow-up|0|||
149758719|NCT02224846|540245832|FG000|Period 1 (Month 3)|Adverse Event|2|||
149758720|NCT02224846|540245833|FG001|Period 1 (Month 3)|Adverse Event|1|||
149758721|NCT02224846|540245832|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
149758722|NCT02224846|540245833|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
149758723|NCT02224846|540245832|FG000|Period 1 (Month 3)|Protocol Violation|4|||
149758724|NCT02224846|540245833|FG001|Period 1 (Month 3)|Protocol Violation|8|||
149758725|NCT02224846|540245832|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
149758726|NCT02224846|540245833|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
149758727|NCT02224846|540245832|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
149758728|NCT02224846|540245833|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
149758729|NCT02224846|540245832|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
149758730|NCT02224846|540245833|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
149758731|NCT02224846|540245832|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
149758732|NCT02224846|540245833|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
149758733|NCT02224846|540245832|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
149758734|NCT02224846|540245833|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
149758735|NCT02224846|540245832|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
149758736|NCT02224846|540245833|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
149758737|NCT02224846|540245832|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
149758738|NCT02224846|540245833|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
149758739|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
149758740|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
149758741|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
149758742|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
149758743|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
149758744|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
149758745|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
149758746|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
149758747|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
149758748|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
149758749|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
149758750|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
149758751|NCT02224846|540245832|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
149758752|NCT02224846|540245833|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
149758753|NCT05372575|540245834|FG000|Overall Study|Protocol Violation|7|||
149758754|NCT05372575|540245835|FG001|Overall Study|Protocol Violation|16|||
149758755|NCT03196297|540245836|FG000|Main Period|Withdrawal by Subject|4|||
149758756|NCT03196297|540245836|FG000|Extension Period|Withdrawal by Subject|1|||
149758757|NCT03196297|540245836|FG000|Extension Period|Lack of Efficacy|2|||
149758758|NCT02538666|540245837|FG000|Pre-Treatment|Disease progression|1|||
149758759|NCT02538666|540245838|FG001|Pre-Treatment|Disease progression|0|||
149758760|NCT02538666|540245839|FG002|Pre-Treatment|Disease progression|0|||
149758761|NCT02538666|540245837|FG000|Pre-Treatment|no longer meets study criteria|1|||
149758762|NCT02538666|540245838|FG001|Pre-Treatment|no longer meets study criteria|0|||
149758763|NCT02538666|540245839|FG002|Pre-Treatment|no longer meets study criteria|0|||
149758764|NCT02538666|540245837|FG000|Pre-Treatment|Withdrew Consent|0|||
149758765|NCT02538666|540245838|FG001|Pre-Treatment|Withdrew Consent|1|||
149758766|NCT02538666|540245839|FG002|Pre-Treatment|Withdrew Consent|1|||
149758767|NCT02538666|540245837|FG000|Treatment|Disease progression|270|||
149758768|NCT02538666|540245838|FG001|Treatment|Disease progression|227|||
149758769|NCT02538666|540245839|FG002|Treatment|Disease progression|165|||
149758770|NCT02538666|540245837|FG000|Treatment|Study drug toxicity|1|||
149758771|NCT02538666|540245838|FG001|Treatment|Study drug toxicity|29|||
149758772|NCT02538666|540245839|FG002|Treatment|Study drug toxicity|92|||
149758773|NCT02538666|540245837|FG000|Treatment|Death|0|||
149758774|NCT02538666|540245838|FG001|Treatment|Death|2|||
149758775|NCT02538666|540245839|FG002|Treatment|Death|3|||
149758776|NCT02538666|540245837|FG000|Treatment|Adverse event unrelated to study drug|8|||
149758777|NCT02538666|540245838|FG001|Treatment|Adverse event unrelated to study drug|10|||
149758778|NCT02538666|540245839|FG002|Treatment|Adverse event unrelated to study drug|15|||
149758779|NCT02538666|540245837|FG000|Treatment|Participant request to discontinue study treatment|3|||
149758780|NCT02538666|540245838|FG001|Treatment|Participant request to discontinue study treatment|6|||
149758781|NCT02538666|540245839|FG002|Treatment|Participant request to discontinue study treatment|11|||
149758782|NCT02538666|540245837|FG000|Treatment|Participant withdrew consent|2|||
149758783|NCT02538666|540245838|FG001|Treatment|Participant withdrew consent|5|||
149758784|NCT02538666|540245839|FG002|Treatment|Participant withdrew consent|3|||
149758785|NCT02538666|540245837|FG000|Treatment|Lost to Follow-up|0|||
149758786|NCT02538666|540245838|FG001|Treatment|Lost to Follow-up|1|||
149758787|NCT02538666|540245839|FG002|Treatment|Lost to Follow-up|1|||
149758788|NCT02538666|540245837|FG000|Treatment|Maximum clinical benefit|4|||
149758789|NCT02538666|540245838|FG001|Treatment|Maximum clinical benefit|3|||
149758790|NCT02538666|540245839|FG002|Treatment|Maximum clinical benefit|4|||
149758791|NCT02538666|540245837|FG000|Treatment|Poor/non-compliance|0|||
149758792|NCT02538666|540245838|FG001|Treatment|Poor/non-compliance|1|||
149758793|NCT02538666|540245839|FG002|Treatment|Poor/non-compliance|0|||
149758794|NCT02538666|540245837|FG000|Treatment|Participant no longer meets study criteria|0|||
149758795|NCT02538666|540245838|FG001|Treatment|Participant no longer meets study criteria|2|||
149758796|NCT02538666|540245839|FG002|Treatment|Participant no longer meets study criteria|0|||
149758797|NCT02538666|540245837|FG000|Treatment|Administrative reason by sponsor|0|||
149758798|NCT02538666|540245838|FG001|Treatment|Administrative reason by sponsor|0|||
149758799|NCT02538666|540245839|FG002|Treatment|Administrative reason by sponsor|1|||
149758800|NCT02538666|540245837|FG000|Treatment|Other reasons|8|||
149758801|NCT02538666|540245838|FG001|Treatment|Other reasons|15|||
149758802|NCT02538666|540245839|FG002|Treatment|Other reasons|5|||
149758803|NCT02538666|540245837|FG000|Treatment|Not reported|2|||
149758804|NCT02538666|540245838|FG001|Treatment|Not reported|2|||
149758805|NCT02538666|540245839|FG002|Treatment|Not reported|2|||
149758806|NCT03510663|540245840|FG000|Overall Study|Withdrawal by Subject|0|||
149758807|NCT03510663|540245841|FG001|Overall Study|Withdrawal by Subject|1|||
149758808|NCT03510663|540245842|FG002|Overall Study|Withdrawal by Subject|0|||
149758809|NCT03510663|540245843|FG003|Overall Study|Withdrawal by Subject|0|||
149758810|NCT03510663|540245844|FG004|Overall Study|Withdrawal by Subject|0|||
149758811|NCT03510663|540245845|FG005|Overall Study|Withdrawal by Subject|0|||
149758812|NCT03510663|540245846|FG006|Overall Study|Withdrawal by Subject|0|||
149758813|NCT03510663|540245847|FG007|Overall Study|Withdrawal by Subject|0|||
149758814|NCT00320385|540245856|FG000|Overall Study|Lost to Follow-up|7|||
149758815|NCT00320385|540245857|FG001|Overall Study|Lost to Follow-up|10|||
149758816|NCT00320385|540245856|FG000|Overall Study|Withdrawal by Subject|6|||
149758817|NCT00320385|540245857|FG001|Overall Study|Withdrawal by Subject|7|||
149758818|NCT00320385|540245856|FG000|Overall Study|Sponsor Terminated Study|2|||
149758819|NCT00320385|540245857|FG001|Overall Study|Sponsor Terminated Study|1|||
149758820|NCT00320385|540245856|FG000|Overall Study|Investigator Decision|0|||
149758821|NCT00320385|540245857|FG001|Overall Study|Investigator Decision|1|||
149758822|NCT00320385|540245856|FG000|Overall Study|Death|1|||
149758823|NCT00320385|540245857|FG001|Overall Study|Death|2|||
149758824|NCT00320385|540245856|FG000|Overall Study|Serious Adverse Event|1|||
149758825|NCT00320385|540245857|FG001|Overall Study|Serious Adverse Event|0|||
149758826|NCT00320385|540245856|FG000|Overall Study|Withdrew Consent|1|||
149758827|NCT00320385|540245857|FG001|Overall Study|Withdrew Consent|0|||
149758828|NCT00320385|540245856|FG000|Overall Study|Adverse Event|0|||
149758829|NCT00320385|540245857|FG001|Overall Study|Adverse Event|1|||
149758830|NCT04370028|540245858|FG000|Overall Study|Withdrawal by Subject|695|||
149758831|NCT04370028|540245858|FG000|Overall Study|Protocol Violation|9|||
149758832|NCT04370028|540245858|FG000|Overall Study|Adverse Event|3|||
149758833|NCT00748540|540245866|FG000|Overall Study|Physician Decision|1|||
149758834|NCT04743635|540245867|FG000|Overall Study|Lost to Follow-up|2|||
149758835|NCT04743635|540245868|FG001|Overall Study|Lost to Follow-up|0|||
149758836|NCT01954121|540245869|FG000|Overall Study|Lack of Efficacy|94|||
149758837|NCT01954121|540245870|FG001|Overall Study|Lack of Efficacy|41|||
149758838|NCT01954121|540245869|FG000|Overall Study|Protocol Violation|0|||
149758839|NCT01954121|540245870|FG001|Overall Study|Protocol Violation|2|||
149758840|NCT01954121|540245869|FG000|Overall Study|Lost to Follow-up|5|||
149758841|NCT01954121|540245870|FG001|Overall Study|Lost to Follow-up|6|||
149758842|NCT01954121|540245869|FG000|Overall Study|Withdrawal by Subject|18|||
149758843|NCT01954121|540245870|FG001|Overall Study|Withdrawal by Subject|12|||
149758844|NCT01954121|540245869|FG000|Overall Study|Pregnancy|1|||
149758845|NCT01954121|540245870|FG001|Overall Study|Pregnancy|1|||
149758846|NCT01954121|540245869|FG000|Overall Study|AE, serious fatal|1|||
149758847|NCT01954121|540245870|FG001|Overall Study|AE, serious fatal|0|||
149758848|NCT01954121|540245869|FG000|Overall Study|AE, non-serious non-fatal|5|||
149758849|NCT01954121|540245870|FG001|Overall Study|AE, non-serious non-fatal|22|||
149758850|NCT01954121|540245869|FG000|Overall Study|SAE, non-fatal|1|||
149758851|NCT01954121|540245870|FG001|Overall Study|SAE, non-fatal|4|||
149758852|NCT01954121|540245869|FG000|Overall Study|Non-compliant with study procedures|1|||
149758853|NCT01954121|540245870|FG001|Overall Study|Non-compliant with study procedures|0|||
149758854|NCT01954121|540245869|FG000|Overall Study|Non-compliant patient|1|||
149758855|NCT01954121|540245870|FG001|Overall Study|Non-compliant patient|1|||
149758856|NCT01954121|540245869|FG000|Overall Study|Subject did not follow instructions|0|||
149758857|NCT01954121|540245870|FG001|Overall Study|Subject did not follow instructions|2|||
149758858|NCT01465178|540245873|FG000|Overall Study|Withdrawal by Subject|1|||
149758859|NCT01465178|540245874|FG001|Overall Study|Withdrawal by Subject|0|||
149758860|NCT01096446|540247518|FG000|Overall Study|Death|1|||
149758861|NCT01096446|540247519|FG001|Overall Study|Death|0|||
149758862|NCT01096446|540247518|FG000|Overall Study|Protocol Violation|2|||
149758863|NCT01096446|540247519|FG001|Overall Study|Protocol Violation|0|||
149758864|NCT01520324|540247523|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
149758865|NCT01328249|540247524|FG000|Overall Study|Adverse Event|3|||
149758866|NCT01328249|540247525|FG001|Overall Study|Adverse Event|0|||
149758867|NCT01328249|540247524|FG000|Overall Study|Disease progression|1|||
149758868|NCT01328249|540247525|FG001|Overall Study|Disease progression|0|||
149758869|NCT01328249|540247524|FG000|Overall Study|Withdrawal by Subject|1|||
149758870|NCT01328249|540247525|FG001|Overall Study|Withdrawal by Subject|1|||
149758871|NCT01328249|540247524|FG000|Overall Study|Moved before end of treatment visit|1|||
149758872|NCT01328249|540247525|FG001|Overall Study|Moved before end of treatment visit|0|||
149758873|NCT01328249|540247524|FG000|Overall Study|Subject choice|1|||
149758874|NCT01328249|540247525|FG001|Overall Study|Subject choice|1|||
149758875|NCT01328249|540247524|FG000|Overall Study|Protocol Violation|0|||
149758876|NCT01328249|540247525|FG001|Overall Study|Protocol Violation|1|||
149758877|NCT00748553|540247526|FG000|Overall Study|Adverse Event|0|||
149758878|NCT00748553|540247527|FG001|Overall Study|Adverse Event|1|||
149758879|NCT00748553|540247526|FG000|Overall Study|disease progression|2|||
149758880|NCT00748553|540247527|FG001|Overall Study|disease progression|0|||
149758881|NCT00748553|540247526|FG000|Overall Study|noncompliance|1|||
149758882|NCT00748553|540247527|FG001|Overall Study|noncompliance|0|||
149758883|NCT00948818|540247528|FG000|Overall Study|Adverse Event|10|||
149758884|NCT00948818|540247529|FG001|Overall Study|Adverse Event|32|||
149758885|NCT00948818|540247528|FG000|Overall Study|Protocol Violation|9|||
149758886|NCT00948818|540247529|FG001|Overall Study|Protocol Violation|10|||
149758887|NCT00948818|540247528|FG000|Overall Study|Withdrawal by Subject|25|||
149758888|NCT00948818|540247529|FG001|Overall Study|Withdrawal by Subject|25|||
149758889|NCT00948818|540247528|FG000|Overall Study|Lost to Follow-up|10|||
149758890|NCT00948818|540247529|FG001|Overall Study|Lost to Follow-up|17|||
149758891|NCT00948818|540247528|FG000|Overall Study|Lack of Efficacy|4|||
149758892|NCT00948818|540247529|FG001|Overall Study|Lack of Efficacy|5|||
149758893|NCT00948818|540247528|FG000|Overall Study|Other Reason|4|||
149758894|NCT00948818|540247529|FG001|Overall Study|Other Reason|5|||
149758895|NCT00745368|540247530|FG000|Overall Study|Unable to provide sample|3|||
149758896|NCT02364947|540247531|FG000|Overall Study|Withdrawal by Subject|10|||
149758897|NCT02364947|540247532|FG001|Overall Study|Withdrawal by Subject|8|||
149758898|NCT02364947|540247533|FG002|Overall Study|Withdrawal by Subject|9|||
149758899|NCT02364947|540247531|FG000|Overall Study|Adverse Event|45|||
149758900|NCT02364947|540247532|FG001|Overall Study|Adverse Event|33|||
149758901|NCT02364947|540247533|FG002|Overall Study|Adverse Event|11|||
149758902|NCT02364947|540247531|FG000|Overall Study|Protocol Violation|1|||
149758903|NCT02364947|540247532|FG001|Overall Study|Protocol Violation|1|||
149758904|NCT02364947|540247533|FG002|Overall Study|Protocol Violation|1|||
149758905|NCT02364947|540247531|FG000|Overall Study|Physician Decision|3|||
149758906|NCT02364947|540247532|FG001|Overall Study|Physician Decision|2|||
149758907|NCT02364947|540247533|FG002|Overall Study|Physician Decision|5|||
149758908|NCT02364947|540247531|FG000|Overall Study|Death|0|||
149758909|NCT02364947|540247532|FG001|Overall Study|Death|1|||
149758910|NCT02364947|540247533|FG002|Overall Study|Death|0|||
149758911|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
149758912|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
149758913|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
149758914|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
149758915|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
149758916|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
149758917|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
149758918|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149758919|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
149758920|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
149758921|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
149758922|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149758923|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
149758924|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
149758925|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
149758926|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
149758927|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
149758928|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
149758929|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
149758930|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
149758931|NCT00423085|540247534|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
149758932|NCT00423085|540247535|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149758933|NCT00423085|540247536|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149758934|NCT00423085|540247537|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149758935|NCT00423085|540247534|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
149758936|NCT00423085|540247535|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
149758937|NCT00423085|540247536|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
149758938|NCT00423085|540247537|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
149758939|NCT00423085|540247534|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
149758940|NCT00423085|540247535|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
149758941|NCT00423085|540247536|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
149758942|NCT00423085|540247537|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
149758943|NCT00423085|540247534|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
149758944|NCT00423085|540247535|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
149758945|NCT00423085|540247536|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
149758946|NCT00423085|540247537|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
149758947|NCT00423085|540247534|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149758948|NCT00423085|540247535|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149758949|NCT00423085|540247536|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149758950|NCT00423085|540247537|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
149758951|NCT00423085|540247534|FG000|52-Week Open-Label Extension Phase|Death|0|||
149758952|NCT00423085|540247535|FG001|52-Week Open-Label Extension Phase|Death|0|||
149758953|NCT00423085|540247536|FG002|52-Week Open-Label Extension Phase|Death|0|||
149758954|NCT00423085|540247537|FG003|52-Week Open-Label Extension Phase|Death|2|||
149758955|NCT00441441|540247539|FG000|Overall Study|Adverse Event|2|||
149758956|NCT00441441|540247540|FG001|Overall Study|Adverse Event|1|||
149758957|NCT00441441|540247539|FG000|Overall Study|Protocol Violation|4|||
149758958|NCT00441441|540247540|FG001|Overall Study|Protocol Violation|6|||
149758959|NCT00441441|540247539|FG000|Overall Study|Exacerbation of asthma|1|||
149758960|NCT00441441|540247540|FG001|Overall Study|Exacerbation of asthma|2|||
149758961|NCT00441441|540247539|FG000|Overall Study|Withdrawal by Subject|1|||
149758962|NCT00441441|540247540|FG001|Overall Study|Withdrawal by Subject|2|||
149758963|NCT00441441|540247539|FG000|Overall Study|Other|3|||
149758964|NCT00441441|540247540|FG001|Overall Study|Other|3|||
149758965|NCT01725152|540247541|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
149758966|NCT01725152|540247542|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
149758967|NCT01725152|540247541|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
149758968|NCT01725152|540247542|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
149758969|NCT01725152|540247541|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
149758970|NCT01725152|540247542|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
149758971|NCT01725152|540247541|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
149758972|NCT01725152|540247542|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
149758973|NCT02808312|540247545|FG000|Overall Study|Enrolled but Never Treated|0|||
149758974|NCT02808312|540247546|FG001|Overall Study|Enrolled but Never Treated|0|||
149758975|NCT02808312|540247547|FG002|Overall Study|Enrolled but Never Treated|1|||
149758976|NCT02808312|540247548|FG003|Overall Study|Enrolled but Never Treated|0|||
149758977|NCT02808312|540247549|FG004|Overall Study|Enrolled but Never Treated|0|||
149758978|NCT01826422|540247550|FG000|Overall Study|Withdrawal by Subject|1|||
149758979|NCT01826422|540247551|FG001|Overall Study|Withdrawal by Subject|3|||
149758980|NCT05151471|540247552|FG000|Overall Study|Adverse Event|21|||
149758981|NCT05151471|540247553|FG001|Overall Study|Adverse Event|16|||
149758982|NCT05151471|540247552|FG000|Overall Study|Death|1|||
149758983|NCT05151471|540247553|FG001|Overall Study|Death|0|||
149758984|NCT05151471|540247552|FG000|Overall Study|Lost to Follow-up|0|||
149758985|NCT05151471|540247553|FG001|Overall Study|Lost to Follow-up|1|||
149758986|NCT05151471|540247552|FG000|Overall Study|Withdrawal by Subject|7|||
149758987|NCT05151471|540247553|FG001|Overall Study|Withdrawal by Subject|9|||
149758988|NCT05151471|540247552|FG000|Overall Study|Study terminated by sponsor|49|||
149758989|NCT05151471|540247553|FG001|Overall Study|Study terminated by sponsor|47|||
149758990|NCT05151471|540247552|FG000|Overall Study|Other|2|||
149758991|NCT05151471|540247553|FG001|Overall Study|Other|1|||
149758992|NCT04263142|540247554|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149758993|NCT04263142|540247555|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149758994|NCT04263142|540247556|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149758995|NCT04263142|540247557|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149758996|NCT04263142|540247558|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
149758997|NCT04263142|540247554|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149758998|NCT04263142|540247555|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149758999|NCT04263142|540247556|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149759000|NCT04263142|540247557|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149759001|NCT04263142|540247558|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
149759002|NCT03010423|540247559|FG000|Overall Study|Study termination|8|||
149759003|NCT00115349|540247563|FG000|Overall Study|Study closed due to low enrollment.|11|||
149759004|NCT00115349|540247564|FG001|Overall Study|Study closed due to low enrollment.|9|||
149759005|NCT04402008|540247565|FG000|Overall Study|Adverse Event|0|||
149759006|NCT04402008|540247566|FG001|Overall Study|Adverse Event|0|||
149759007|NCT04402008|540247567|FG002|Overall Study|Adverse Event|0|||
149759008|NCT04402008|540247568|FG003|Overall Study|Adverse Event|1|||
149759009|NCT04402008|540247569|FG004|Overall Study|Adverse Event|0|||
149759010|NCT04402008|540247570|FG005|Overall Study|Adverse Event|0|||
149759011|NCT04402008|540247571|FG006|Overall Study|Adverse Event|0|||
149759012|NCT04402008|540247565|FG000|Overall Study|Disease Progression|3|||
149759013|NCT04402008|540247566|FG001|Overall Study|Disease Progression|2|||
149759014|NCT04402008|540247567|FG002|Overall Study|Disease Progression|3|||
149759015|NCT04402008|540247568|FG003|Overall Study|Disease Progression|3|||
149759016|NCT04402008|540247569|FG004|Overall Study|Disease Progression|4|||
149759017|NCT04402008|540247570|FG005|Overall Study|Disease Progression|3|||
149759018|NCT04402008|540247571|FG006|Overall Study|Disease Progression|10|||
149759019|NCT04402008|540247565|FG000|Overall Study|Withdrawal by Subject|0|||
149759020|NCT04402008|540247566|FG001|Overall Study|Withdrawal by Subject|1|||
149759021|NCT04402008|540247567|FG002|Overall Study|Withdrawal by Subject|0|||
149759022|NCT04402008|540247568|FG003|Overall Study|Withdrawal by Subject|0|||
149759023|NCT04402008|540247569|FG004|Overall Study|Withdrawal by Subject|1|||
149759024|NCT04402008|540247570|FG005|Overall Study|Withdrawal by Subject|0|||
149759025|NCT04402008|540247571|FG006|Overall Study|Withdrawal by Subject|0|||
149759026|NCT04402008|540247565|FG000|Overall Study|Sponsor Decision|0|||
149759027|NCT04402008|540247566|FG001|Overall Study|Sponsor Decision|0|||
149759028|NCT04402008|540247567|FG002|Overall Study|Sponsor Decision|0|||
149759029|NCT04402008|540247568|FG003|Overall Study|Sponsor Decision|0|||
149759030|NCT04402008|540247569|FG004|Overall Study|Sponsor Decision|0|||
149759031|NCT04402008|540247570|FG005|Overall Study|Sponsor Decision|0|||
149759032|NCT04402008|540247571|FG006|Overall Study|Sponsor Decision|3|||
149759033|NCT04402008|540247565|FG000|Overall Study|Death|0|||
149759034|NCT04402008|540247566|FG001|Overall Study|Death|0|||
149759035|NCT04402008|540247567|FG002|Overall Study|Death|0|||
149759036|NCT04402008|540247568|FG003|Overall Study|Death|0|||
149759037|NCT04402008|540247569|FG004|Overall Study|Death|1|||
149759038|NCT04402008|540247570|FG005|Overall Study|Death|0|||
149759039|NCT04402008|540247571|FG006|Overall Study|Death|2|||
149759040|NCT04402008|540247565|FG000|Overall Study|Other|0|||
149759041|NCT04402008|540247566|FG001|Overall Study|Other|0|||
149759042|NCT04402008|540247567|FG002|Overall Study|Other|0|||
149759043|NCT04402008|540247568|FG003|Overall Study|Other|0|||
149759044|NCT04402008|540247569|FG004|Overall Study|Other|0|||
149759045|NCT04402008|540247570|FG005|Overall Study|Other|0|||
149759046|NCT04402008|540247571|FG006|Overall Study|Other|5|||
149759047|NCT05132569|540247572|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
149759048|NCT05132569|540247573|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
149759049|NCT05132569|540247572|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
149759050|NCT05132569|540247573|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
149759051|NCT05132569|540247572|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
149759052|NCT05132569|540247573|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
149759053|NCT03656926|540247574|FG000|Overall Study|Adverse Event|5|||
149759054|NCT03656926|540247575|FG001|Overall Study|Adverse Event|4|||
149759055|NCT03656926|540247574|FG000|Overall Study|Withdrawal by Subject|7|||
149759056|NCT03656926|540247575|FG001|Overall Study|Withdrawal by Subject|2|||
149759057|NCT03656926|540247574|FG000|Overall Study|Screen fail after randomization|1|||
149759058|NCT03656926|540247575|FG001|Overall Study|Screen fail after randomization|0|||
149759059|NCT03656926|540247574|FG000|Overall Study|PI decision due to patient condition|1|||
149759060|NCT03656926|540247575|FG001|Overall Study|PI decision due to patient condition|0|||
149759061|NCT03656926|540247574|FG000|Overall Study|Patient unresponsiveness|1|||
149759062|NCT03656926|540247575|FG001|Overall Study|Patient unresponsiveness|0|||
149759063|NCT00069095|540247576|FG000|Primary Treatment Phase|Ongoing|0|||
149759064|NCT00069095|540247577|FG001|Primary Treatment Phase|Ongoing|0|||
149759065|NCT00069095|540247578|FG002|Primary Treatment Phase|Ongoing|5|||
149759066|NCT00069095|540247579|FG003|Primary Treatment Phase|Ongoing|7|||
149759067|NCT00069095|540247580|FG004|Primary Treatment Phase|Ongoing|7|||
149759068|NCT00069095|540247581|FG005|Primary Treatment Phase|Ongoing|4|||
149759069|NCT00069095|540247576|FG000|Primary Treatment Phase|Admin/Other|29|||
149759070|NCT00069095|540247577|FG001|Primary Treatment Phase|Admin/Other|38|||
149759071|NCT00069095|540247578|FG002|Primary Treatment Phase|Admin/Other|31|||
149759072|NCT00069095|540247579|FG003|Primary Treatment Phase|Admin/Other|45|||
149759073|NCT00069095|540247580|FG004|Primary Treatment Phase|Admin/Other|48|||
149759074|NCT00069095|540247581|FG005|Primary Treatment Phase|Admin/Other|42|||
149759075|NCT00069095|540247576|FG000|Primary Treatment Phase|Adverse Event|99|||
149759076|NCT00069095|540247577|FG001|Primary Treatment Phase|Adverse Event|92|||
149759077|NCT00069095|540247578|FG002|Primary Treatment Phase|Adverse Event|71|||
149759078|NCT00069095|540247579|FG003|Primary Treatment Phase|Adverse Event|72|||
149759079|NCT00069095|540247580|FG004|Primary Treatment Phase|Adverse Event|109|||
149759080|NCT00069095|540247581|FG005|Primary Treatment Phase|Adverse Event|101|||
149759081|NCT00069095|540247576|FG000|Primary Treatment Phase|Death|14|||
149759082|NCT00069095|540247577|FG001|Primary Treatment Phase|Death|8|||
149759083|NCT00069095|540247578|FG002|Primary Treatment Phase|Death|2|||
149759084|NCT00069095|540247579|FG003|Primary Treatment Phase|Death|5|||
149759085|NCT00069095|540247580|FG004|Primary Treatment Phase|Death|8|||
149759086|NCT00069095|540247581|FG005|Primary Treatment Phase|Death|8|||
149759087|NCT00069095|540247576|FG000|Primary Treatment Phase|Failure to return|5|||
149759088|NCT00069095|540247577|FG001|Primary Treatment Phase|Failure to return|5|||
149759089|NCT00069095|540247578|FG002|Primary Treatment Phase|Failure to return|0|||
149759090|NCT00069095|540247579|FG003|Primary Treatment Phase|Failure to return|0|||
149759091|NCT00069095|540247580|FG004|Primary Treatment Phase|Failure to return|0|||
149759092|NCT00069095|540247581|FG005|Primary Treatment Phase|Failure to return|2|||
149759093|NCT00069095|540247576|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
149759094|NCT00069095|540247577|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
149759095|NCT00069095|540247578|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
149759096|NCT00069095|540247579|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
149759097|NCT00069095|540247580|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
149759098|NCT00069095|540247581|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
149759099|NCT00069095|540247576|FG000|Primary Treatment Phase|Refused treatment|15|||
149759100|NCT00069095|540247577|FG001|Primary Treatment Phase|Refused treatment|26|||
149759101|NCT00069095|540247578|FG002|Primary Treatment Phase|Refused treatment|17|||
149759102|NCT00069095|540247579|FG003|Primary Treatment Phase|Refused treatment|31|||
149759103|NCT00069095|540247580|FG004|Primary Treatment Phase|Refused treatment|24|||
149759104|NCT00069095|540247581|FG005|Primary Treatment Phase|Refused treatment|27|||
149759105|NCT00069095|540247576|FG000|Primary Treatment Phase|Withdrew|2|||
149759106|NCT00069095|540247577|FG001|Primary Treatment Phase|Withdrew|3|||
149759107|NCT00069095|540247578|FG002|Primary Treatment Phase|Withdrew|8|||
149759108|NCT00069095|540247579|FG003|Primary Treatment Phase|Withdrew|2|||
149759109|NCT00069095|540247580|FG004|Primary Treatment Phase|Withdrew|4|||
149759110|NCT00069095|540247581|FG005|Primary Treatment Phase|Withdrew|9|||
149759111|NCT00069095|540247576|FG000|Primary Treatment Phase|Other Violation|0|||
149759112|NCT00069095|540247577|FG001|Primary Treatment Phase|Other Violation|1|||
149759113|NCT00069095|540247578|FG002|Primary Treatment Phase|Other Violation|1|||
149759114|NCT00069095|540247579|FG003|Primary Treatment Phase|Other Violation|1|||
149759115|NCT00069095|540247580|FG004|Primary Treatment Phase|Other Violation|0|||
149759116|NCT00069095|540247581|FG005|Primary Treatment Phase|Other Violation|1|||
149759117|NCT00069095|540247576|FG000|Primary Treatment Phase|Violation criteria|0|||
149759118|NCT00069095|540247577|FG001|Primary Treatment Phase|Violation criteria|2|||
149759119|NCT00069095|540247578|FG002|Primary Treatment Phase|Violation criteria|4|||
149759120|NCT00069095|540247579|FG003|Primary Treatment Phase|Violation criteria|3|||
149759121|NCT00069095|540247580|FG004|Primary Treatment Phase|Violation criteria|1|||
149759122|NCT00069095|540247581|FG005|Primary Treatment Phase|Violation criteria|5|||
149759123|NCT00069095|540247576|FG000|Post-study Treatment Phase|Missing reason|1|||
149759124|NCT00069095|540247577|FG001|Post-study Treatment Phase|Missing reason|3|||
149759125|NCT00069095|540247578|FG002|Post-study Treatment Phase|Missing reason|12|||
149759126|NCT00069095|540247579|FG003|Post-study Treatment Phase|Missing reason|8|||
149759127|NCT00069095|540247580|FG004|Post-study Treatment Phase|Missing reason|18|||
149759128|NCT00069095|540247581|FG005|Post-study Treatment Phase|Missing reason|17|||
149759129|NCT00069095|540247576|FG000|Post-study Treatment Phase|Adverse Event|2|||
149759130|NCT00069095|540247577|FG001|Post-study Treatment Phase|Adverse Event|3|||
149759131|NCT00069095|540247578|FG002|Post-study Treatment Phase|Adverse Event|1|||
149759132|NCT00069095|540247579|FG003|Post-study Treatment Phase|Adverse Event|0|||
149759133|NCT00069095|540247580|FG004|Post-study Treatment Phase|Adverse Event|5|||
149759134|NCT00069095|540247581|FG005|Post-study Treatment Phase|Adverse Event|1|||
149759135|NCT00069095|540247576|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
149759136|NCT00069095|540247577|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
149759137|NCT00069095|540247578|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
149759138|NCT00069095|540247579|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
149759139|NCT00069095|540247580|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
149759140|NCT00069095|540247581|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
149759141|NCT00069095|540247576|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
149759142|NCT00069095|540247577|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
149759143|NCT00069095|540247578|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
149759144|NCT00069095|540247579|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
149759145|NCT00069095|540247580|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
149759146|NCT00069095|540247581|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
149759147|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
149759148|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149759149|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149759150|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149759151|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149759152|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
149759153|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant had complete response|1|||
149759154|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant had complete response|1|||
149759155|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant had complete response|0|||
149759156|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant had complete response|0|||
149759157|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant had complete response|0|||
149759158|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant had complete response|0|||
149759159|NCT00069095|540247576|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149759160|NCT00069095|540247577|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
149759161|NCT00069095|540247578|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149759162|NCT00069095|540247579|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149759163|NCT00069095|540247580|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149759164|NCT00069095|540247581|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149759165|NCT00069095|540247576|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
149759166|NCT00069095|540247577|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149759167|NCT00069095|540247578|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149759168|NCT00069095|540247579|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
149759169|NCT00069095|540247580|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149759170|NCT00069095|540247581|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
149759171|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
149759172|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
149759173|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
149759174|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
149759175|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
149759176|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
149759177|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
149759178|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
149759179|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
149759180|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
149759181|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
149759182|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
149759183|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149759184|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149759185|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149759186|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
149759187|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149759188|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149759189|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
149759190|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
149759191|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
149759192|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
149759193|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
149759194|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
149759195|NCT00069095|540247576|FG000|Post-study Treatment Phase|Surgery|0|||
149759196|NCT00069095|540247577|FG001|Post-study Treatment Phase|Surgery|0|||
149759197|NCT00069095|540247578|FG002|Post-study Treatment Phase|Surgery|0|||
149759198|NCT00069095|540247579|FG003|Post-study Treatment Phase|Surgery|1|||
149759199|NCT00069095|540247580|FG004|Post-study Treatment Phase|Surgery|1|||
149759200|NCT00069095|540247581|FG005|Post-study Treatment Phase|Surgery|0|||
149759201|NCT00069095|540247576|FG000|Post-study Treatment Phase|Death|0|||
149759202|NCT00069095|540247577|FG001|Post-study Treatment Phase|Death|0|||
149759203|NCT00069095|540247578|FG002|Post-study Treatment Phase|Death|0|||
149759204|NCT00069095|540247579|FG003|Post-study Treatment Phase|Death|0|||
149759205|NCT00069095|540247580|FG004|Post-study Treatment Phase|Death|1|||
149759206|NCT00069095|540247581|FG005|Post-study Treatment Phase|Death|0|||
149759207|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
149759208|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
149759209|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
149759210|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
149759211|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
149759212|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
149759213|NCT00069095|540247576|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149759214|NCT00069095|540247577|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149759215|NCT00069095|540247578|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149759216|NCT00069095|540247579|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149759217|NCT00069095|540247580|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
149759218|NCT00069095|540247581|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149759219|NCT00069095|540247576|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149759220|NCT00069095|540247577|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149759221|NCT00069095|540247578|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149759222|NCT00069095|540247579|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149759223|NCT00069095|540247580|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
149759224|NCT00069095|540247581|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149759225|NCT00069095|540247576|FG000|Post-study Treatment Phase|Investigator decision|0|||
149759226|NCT00069095|540247577|FG001|Post-study Treatment Phase|Investigator decision|0|||
149759227|NCT00069095|540247578|FG002|Post-study Treatment Phase|Investigator decision|0|||
149759228|NCT00069095|540247579|FG003|Post-study Treatment Phase|Investigator decision|0|||
149759229|NCT00069095|540247580|FG004|Post-study Treatment Phase|Investigator decision|0|||
149759230|NCT00069095|540247581|FG005|Post-study Treatment Phase|Investigator decision|1|||
149759231|NCT00069095|540247576|FG000|Follow-up Phase|Death|174|||
149759232|NCT00069095|540247577|FG001|Follow-up Phase|Death|206|||
149759233|NCT00069095|540247578|FG002|Follow-up Phase|Death|120|||
149759234|NCT00069095|540247579|FG003|Follow-up Phase|Death|112|||
149759235|NCT00069095|540247580|FG004|Follow-up Phase|Death|92|||
149759236|NCT00069095|540247581|FG005|Follow-up Phase|Death|101|||
149759237|NCT05610176|540247585|FG000|Overall Study|Death|6|||
149759238|NCT03249792|540247586|FG000|Arms 1, 2, and 4|Death|1|||
149759239|NCT03249792|540247587|FG001|Arms 1, 2, and 4|Death|1|||
149759240|NCT03249792|540247588|FG002|Arms 1, 2, and 4|Death|0|||
149759241|NCT03249792|540247589|FG003|Arms 1, 2, and 4|Death|2|||
149759242|NCT03249792|540247590|FG004|Arms 1, 2, and 4|Death|3|||
149759243|NCT03249792|540247591|FG005|Arms 1, 2, and 4|Death|2|||
149759244|NCT03249792|540247592|FG006|Arms 1, 2, and 4|Death|2|||
149759245|NCT03249792|540247593|FG007|Arms 1, 2, and 4|Death|4|||
149759246|NCT03249792|540247594|FG008|Arms 1, 2, and 4|Death|2|||
149759247|NCT03249792|540247595|FG009|Arms 1, 2, and 4|Death|1|||
149759248|NCT03249792|540247596|FG010|Arms 1, 2, and 4|Death|7|||
149759249|NCT03249792|540247597|FG011|Arms 1, 2, and 4|Death|7|||
149759250|NCT03249792|540247598|FG012|Arms 1, 2, and 4|Death|12|||
149759251|NCT03249792|540247599|FG013|Arms 1, 2, and 4|Death|7|||
149759252|NCT03249792|540247600|FG014|Arms 1, 2, and 4|Death|0|||
149759253|NCT03249792|540247601|FG015|Arms 1, 2, and 4|Death|4|||
149759254|NCT03249792|540247602|FG016|Arms 1, 2, and 4|Death|4|||
149759255|NCT03249792|540247603|FG017|Arms 1, 2, and 4|Death|12|||
149759256|NCT03249792|540247604|FG018|Arms 1, 2, and 4|Death|6|||
149759257|NCT03249792|540247605|FG019|Arms 1, 2, and 4|Death|4|||
149759258|NCT03249792|540247606|FG020|Arms 1, 2, and 4|Death|2|||
149759259|NCT03249792|540247607|FG021|Arms 1, 2, and 4|Death|3|||
149759260|NCT03249792|540247608|FG022|Arms 1, 2, and 4|Death|1|||
149759261|NCT03249792|540247609|FG023|Arms 1, 2, and 4|Death|1|||
149759262|NCT03249792|540247610|FG024|Arms 1, 2, and 4|Death|4|||
149759263|NCT03249792|540247611|FG025|Arms 1, 2, and 4|Death|0|||
149759264|NCT03249792|540247612|FG026|Arms 1, 2, and 4|Death|0|||
149759265|NCT03249792|540247613|FG027|Arms 1, 2, and 4|Death|0|||
149759266|NCT03249792|540247614|FG028|Arms 1, 2, and 4|Death|0|||
149759267|NCT03249792|540247615|FG029|Arms 1, 2, and 4|Death|0|||
149759268|NCT03249792|540247616|FG030|Arms 1, 2, and 4|Death|0|||
149759269|NCT03249792|540247617|FG031|Arms 1, 2, and 4|Death|0|||
149759270|NCT03249792|540247618|FG032|Arms 1, 2, and 4|Death|0|||
149759271|NCT03249792|540247586|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759272|NCT03249792|540247587|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759273|NCT03249792|540247588|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759274|NCT03249792|540247589|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759275|NCT03249792|540247590|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759276|NCT03249792|540247591|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759277|NCT03249792|540247592|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
149759278|NCT03249792|540247593|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759279|NCT03249792|540247594|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
149759280|NCT03249792|540247595|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759281|NCT03249792|540247596|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
149759282|NCT03249792|540247597|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149759283|NCT03249792|540247598|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
149759284|NCT03249792|540247599|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149759285|NCT03249792|540247600|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759286|NCT03249792|540247601|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759287|NCT03249792|540247602|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149759288|NCT03249792|540247603|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759289|NCT03249792|540247604|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759290|NCT03249792|540247605|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759291|NCT03249792|540247606|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759292|NCT03249792|540247607|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759293|NCT03249792|540247608|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759294|NCT03249792|540247609|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149759295|NCT03249792|540247610|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759296|NCT03249792|540247611|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759297|NCT03249792|540247612|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759298|NCT03249792|540247613|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759299|NCT03249792|540247614|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759300|NCT03249792|540247615|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759301|NCT03249792|540247616|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759302|NCT03249792|540247617|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759303|NCT03249792|540247618|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149759304|NCT03249792|540247586|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
149759305|NCT03249792|540247587|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
149759306|NCT03249792|540247588|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
149759307|NCT03249792|540247589|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
149759308|NCT03249792|540247590|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
149759309|NCT03249792|540247591|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
149759310|NCT03249792|540247592|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
149759311|NCT03249792|540247593|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
149759312|NCT03249792|540247594|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
149759313|NCT03249792|540247595|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
149759314|NCT03249792|540247596|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
149759315|NCT03249792|540247597|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
149759316|NCT03249792|540247598|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
149759317|NCT03249792|540247599|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
149759318|NCT03249792|540247600|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
149759319|NCT03249792|540247601|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
149759320|NCT03249792|540247602|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
149759321|NCT03249792|540247603|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
149759322|NCT03249792|540247604|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
149759323|NCT03249792|540247605|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
149759324|NCT03249792|540247606|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
149759325|NCT03249792|540247607|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
149759326|NCT03249792|540247608|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
149759327|NCT03249792|540247609|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
149759328|NCT03249792|540247610|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
149759329|NCT03249792|540247611|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
149759330|NCT03249792|540247612|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
149759331|NCT03249792|540247613|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
149759332|NCT03249792|540247614|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
149759333|NCT03249792|540247615|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
149759334|NCT03249792|540247616|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
149759335|NCT03249792|540247617|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
149759336|NCT03249792|540247618|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
149759337|NCT03249792|540247586|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759338|NCT03249792|540247587|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759339|NCT03249792|540247588|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759340|NCT03249792|540247589|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759341|NCT03249792|540247590|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759342|NCT03249792|540247591|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759343|NCT03249792|540247592|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759344|NCT03249792|540247593|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759345|NCT03249792|540247594|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
149759346|NCT03249792|540247595|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759347|NCT03249792|540247596|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759348|NCT03249792|540247597|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759349|NCT03249792|540247598|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759350|NCT03249792|540247599|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759351|NCT03249792|540247600|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759352|NCT03249792|540247601|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759353|NCT03249792|540247602|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
149759354|NCT03249792|540247603|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
149759355|NCT03249792|540247604|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759356|NCT03249792|540247605|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
149759357|NCT03249792|540247606|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759358|NCT03249792|540247607|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759359|NCT03249792|540247608|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759360|NCT03249792|540247609|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759361|NCT03249792|540247610|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759362|NCT03249792|540247611|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759363|NCT03249792|540247612|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759364|NCT03249792|540247613|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759365|NCT03249792|540247614|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759366|NCT03249792|540247615|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759367|NCT03249792|540247616|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759368|NCT03249792|540247617|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759369|NCT03249792|540247618|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
149759370|NCT03249792|540247586|FG000|Switch Over Period|Withdrawal by Subject|0|||
149759371|NCT03249792|540247587|FG001|Switch Over Period|Withdrawal by Subject|0|||
149759372|NCT03249792|540247588|FG002|Switch Over Period|Withdrawal by Subject|0|||
149759373|NCT03249792|540247589|FG003|Switch Over Period|Withdrawal by Subject|0|||
149759374|NCT03249792|540247590|FG004|Switch Over Period|Withdrawal by Subject|0|||
149759375|NCT03249792|540247591|FG005|Switch Over Period|Withdrawal by Subject|0|||
149759376|NCT03249792|540247592|FG006|Switch Over Period|Withdrawal by Subject|0|||
149759377|NCT03249792|540247593|FG007|Switch Over Period|Withdrawal by Subject|0|||
149759378|NCT03249792|540247594|FG008|Switch Over Period|Withdrawal by Subject|0|||
149759379|NCT03249792|540247595|FG009|Switch Over Period|Withdrawal by Subject|0|||
149759380|NCT03249792|540247596|FG010|Switch Over Period|Withdrawal by Subject|0|||
149759381|NCT03249792|540247597|FG011|Switch Over Period|Withdrawal by Subject|0|||
149759382|NCT03249792|540247598|FG012|Switch Over Period|Withdrawal by Subject|0|||
149759383|NCT03249792|540247599|FG013|Switch Over Period|Withdrawal by Subject|0|||
149759384|NCT03249792|540247600|FG014|Switch Over Period|Withdrawal by Subject|0|||
149759385|NCT03249792|540247601|FG015|Switch Over Period|Withdrawal by Subject|0|||
149759386|NCT03249792|540247602|FG016|Switch Over Period|Withdrawal by Subject|0|||
149759387|NCT03249792|540247603|FG017|Switch Over Period|Withdrawal by Subject|0|||
149759388|NCT03249792|540247604|FG018|Switch Over Period|Withdrawal by Subject|0|||
149759389|NCT03249792|540247605|FG019|Switch Over Period|Withdrawal by Subject|0|||
149759390|NCT03249792|540247606|FG020|Switch Over Period|Withdrawal by Subject|0|||
149759391|NCT03249792|540247607|FG021|Switch Over Period|Withdrawal by Subject|0|||
149759392|NCT03249792|540247608|FG022|Switch Over Period|Withdrawal by Subject|0|||
149759393|NCT03249792|540247609|FG023|Switch Over Period|Withdrawal by Subject|0|||
149759394|NCT03249792|540247610|FG024|Switch Over Period|Withdrawal by Subject|0|||
149759395|NCT03249792|540247611|FG025|Switch Over Period|Withdrawal by Subject|0|||
149759396|NCT03249792|540247612|FG026|Switch Over Period|Withdrawal by Subject|0|||
149759397|NCT03249792|540247613|FG027|Switch Over Period|Withdrawal by Subject|0|||
149759398|NCT03249792|540247614|FG028|Switch Over Period|Withdrawal by Subject|0|||
149759399|NCT03249792|540247615|FG029|Switch Over Period|Withdrawal by Subject|0|||
149759400|NCT03249792|540247616|FG030|Switch Over Period|Withdrawal by Subject|0|||
149759401|NCT03249792|540247617|FG031|Switch Over Period|Withdrawal by Subject|1|||
149759402|NCT03249792|540247618|FG032|Switch Over Period|Withdrawal by Subject|0|||
149759403|NCT03249792|540247586|FG000|Switch Over Period|Progressive Disease|0|||
149759404|NCT03249792|540247587|FG001|Switch Over Period|Progressive Disease|0|||
149759405|NCT03249792|540247588|FG002|Switch Over Period|Progressive Disease|0|||
149759406|NCT03249792|540247589|FG003|Switch Over Period|Progressive Disease|0|||
149759407|NCT03249792|540247590|FG004|Switch Over Period|Progressive Disease|0|||
149759408|NCT03249792|540247591|FG005|Switch Over Period|Progressive Disease|0|||
149759409|NCT03249792|540247592|FG006|Switch Over Period|Progressive Disease|0|||
149759410|NCT03249792|540247593|FG007|Switch Over Period|Progressive Disease|0|||
149759411|NCT03249792|540247594|FG008|Switch Over Period|Progressive Disease|0|||
149759412|NCT03249792|540247595|FG009|Switch Over Period|Progressive Disease|0|||
149759413|NCT03249792|540247596|FG010|Switch Over Period|Progressive Disease|0|||
149759414|NCT03249792|540247597|FG011|Switch Over Period|Progressive Disease|0|||
149759415|NCT03249792|540247598|FG012|Switch Over Period|Progressive Disease|0|||
149759416|NCT03249792|540247599|FG013|Switch Over Period|Progressive Disease|0|||
149759417|NCT03249792|540247600|FG014|Switch Over Period|Progressive Disease|0|||
149759418|NCT03249792|540247601|FG015|Switch Over Period|Progressive Disease|0|||
149759419|NCT03249792|540247602|FG016|Switch Over Period|Progressive Disease|0|||
149759420|NCT03249792|540247603|FG017|Switch Over Period|Progressive Disease|0|||
149759421|NCT03249792|540247604|FG018|Switch Over Period|Progressive Disease|0|||
149759422|NCT03249792|540247605|FG019|Switch Over Period|Progressive Disease|0|||
149759423|NCT03249792|540247606|FG020|Switch Over Period|Progressive Disease|0|||
149759424|NCT03249792|540247607|FG021|Switch Over Period|Progressive Disease|0|||
149759425|NCT03249792|540247608|FG022|Switch Over Period|Progressive Disease|0|||
149759426|NCT03249792|540247609|FG023|Switch Over Period|Progressive Disease|0|||
149759427|NCT03249792|540247610|FG024|Switch Over Period|Progressive Disease|0|||
149759428|NCT03249792|540247611|FG025|Switch Over Period|Progressive Disease|0|||
149759429|NCT03249792|540247612|FG026|Switch Over Period|Progressive Disease|1|||
149759430|NCT03249792|540247613|FG027|Switch Over Period|Progressive Disease|0|||
149759431|NCT03249792|540247614|FG028|Switch Over Period|Progressive Disease|1|||
149759432|NCT03249792|540247615|FG029|Switch Over Period|Progressive Disease|2|||
149759433|NCT03249792|540247616|FG030|Switch Over Period|Progressive Disease|1|||
149759434|NCT03249792|540247617|FG031|Switch Over Period|Progressive Disease|0|||
149759435|NCT03249792|540247618|FG032|Switch Over Period|Progressive Disease|1|||
149759436|NCT03249792|540247586|FG000|Switch Over Period|Adverse Event|0|||
149759437|NCT03249792|540247587|FG001|Switch Over Period|Adverse Event|0|||
149759438|NCT03249792|540247588|FG002|Switch Over Period|Adverse Event|0|||
149759439|NCT03249792|540247589|FG003|Switch Over Period|Adverse Event|0|||
149759440|NCT03249792|540247590|FG004|Switch Over Period|Adverse Event|0|||
149759441|NCT03249792|540247591|FG005|Switch Over Period|Adverse Event|0|||
149759442|NCT03249792|540247592|FG006|Switch Over Period|Adverse Event|0|||
149759443|NCT03249792|540247593|FG007|Switch Over Period|Adverse Event|0|||
149759444|NCT03249792|540247594|FG008|Switch Over Period|Adverse Event|0|||
149759445|NCT03249792|540247595|FG009|Switch Over Period|Adverse Event|0|||
149759446|NCT03249792|540247596|FG010|Switch Over Period|Adverse Event|0|||
149759447|NCT03249792|540247597|FG011|Switch Over Period|Adverse Event|0|||
149759448|NCT03249792|540247598|FG012|Switch Over Period|Adverse Event|0|||
149759449|NCT03249792|540247599|FG013|Switch Over Period|Adverse Event|0|||
149759450|NCT03249792|540247600|FG014|Switch Over Period|Adverse Event|0|||
149759451|NCT03249792|540247601|FG015|Switch Over Period|Adverse Event|0|||
149759452|NCT03249792|540247602|FG016|Switch Over Period|Adverse Event|0|||
149759453|NCT03249792|540247603|FG017|Switch Over Period|Adverse Event|0|||
149759454|NCT03249792|540247604|FG018|Switch Over Period|Adverse Event|0|||
149759455|NCT03249792|540247605|FG019|Switch Over Period|Adverse Event|0|||
149759456|NCT03249792|540247606|FG020|Switch Over Period|Adverse Event|0|||
149759457|NCT03249792|540247607|FG021|Switch Over Period|Adverse Event|0|||
149759458|NCT03249792|540247608|FG022|Switch Over Period|Adverse Event|0|||
149759459|NCT03249792|540247609|FG023|Switch Over Period|Adverse Event|0|||
149759460|NCT03249792|540247610|FG024|Switch Over Period|Adverse Event|0|||
149759461|NCT03249792|540247611|FG025|Switch Over Period|Adverse Event|1|||
149759462|NCT03249792|540247612|FG026|Switch Over Period|Adverse Event|0|||
149759463|NCT03249792|540247613|FG027|Switch Over Period|Adverse Event|1|||
149759464|NCT03249792|540247614|FG028|Switch Over Period|Adverse Event|0|||
149759465|NCT03249792|540247615|FG029|Switch Over Period|Adverse Event|0|||
149759466|NCT03249792|540247616|FG030|Switch Over Period|Adverse Event|0|||
149759467|NCT03249792|540247617|FG031|Switch Over Period|Adverse Event|0|||
149759468|NCT03249792|540247618|FG032|Switch Over Period|Adverse Event|0|||
149759469|NCT00532948|540247625|FG000|Overall Study|Protocol Violation|1|||
149759470|NCT00532948|540247626|FG001|Overall Study|Protocol Violation|0|||
149759471|NCT00532948|540247627|FG002|Overall Study|Protocol Violation|0|||
149759472|NCT00532948|540247625|FG000|Overall Study|Death|3|||
149759473|NCT00532948|540247626|FG001|Overall Study|Death|3|||
149759474|NCT00532948|540247627|FG002|Overall Study|Death|4|||
149759475|NCT00532948|540247625|FG000|Overall Study|Violation of selection criteria at entry|0|||
149759476|NCT00532948|540247626|FG001|Overall Study|Violation of selection criteria at entry|1|||
149759477|NCT00532948|540247627|FG002|Overall Study|Violation of selection criteria at entry|0|||
149759478|NCT00532948|540247625|FG000|Overall Study|Failure to return|0|||
149759479|NCT00532948|540247626|FG001|Overall Study|Failure to return|1|||
149759480|NCT00532948|540247627|FG002|Overall Study|Failure to return|0|||
149759481|NCT02702193|540247629|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
149759482|NCT02702193|540247630|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
149759483|NCT02702193|540247629|FG000|4 Month Follow up|Withdrawal by Subject|1|||
149759484|NCT02702193|540247630|FG001|4 Month Follow up|Withdrawal by Subject|0|||
149759485|NCT02702193|540247629|FG000|4 Month Follow up|Lost to Follow-up|17|||
149759486|NCT02702193|540247630|FG001|4 Month Follow up|Lost to Follow-up|18|||
149759487|NCT02702193|540247629|FG000|8 Month Follow up|Withdrawal by Subject|1|||
149759488|NCT02702193|540247630|FG001|8 Month Follow up|Withdrawal by Subject|0|||
149759489|NCT02702193|540247629|FG000|8 Month Follow up|Lost to Follow-up|14|||
149759490|NCT02702193|540247630|FG001|8 Month Follow up|Lost to Follow-up|18|||
149759491|NCT02702193|540247629|FG000|12 Month Follow up|Withdrawal by Subject|1|||
149759492|NCT02702193|540247630|FG001|12 Month Follow up|Withdrawal by Subject|0|||
149759493|NCT02702193|540247629|FG000|12 Month Follow up|Lost to Follow-up|16|||
149759494|NCT02702193|540247630|FG001|12 Month Follow up|Lost to Follow-up|18|||
149759495|NCT01201798|540247635|FG000|Overall Study|Adverse Event|2|||
149759496|NCT01201798|540247636|FG001|Overall Study|Adverse Event|0|||
149759497|NCT01201798|540247635|FG000|Overall Study|Lost to Follow-up|3|||
149759498|NCT01201798|540247636|FG001|Overall Study|Lost to Follow-up|5|||
149759499|NCT01201798|540247635|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
149759500|NCT01201798|540247636|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
149759501|NCT01201798|540247635|FG000|Overall Study|Noncompliance|1|||
149759502|NCT01201798|540247636|FG001|Overall Study|Noncompliance|0|||
149759503|NCT01201798|540247635|FG000|Overall Study|Protocol Violation|1|||
149759504|NCT01201798|540247636|FG001|Overall Study|Protocol Violation|1|||
149759505|NCT01201798|540247635|FG000|Overall Study|Treatment Failure|1|||
149759506|NCT01201798|540247636|FG001|Overall Study|Treatment Failure|8|||
149759507|NCT05692154|540247639|FG000|Overall Study|Adverse Event|0|||
149759508|NCT05692154|540247640|FG001|Overall Study|Adverse Event|1|||
149759509|NCT01912729|540247643|FG000|Overall Study|Withdrawal by Subject|0|||
149759510|NCT01912729|540247644|FG001|Overall Study|Withdrawal by Subject|1|||
149759511|NCT04285346|540247652|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
149759512|NCT04285346|540247653|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
149759513|NCT04285346|540247652|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
149759514|NCT04285346|540247653|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149759515|NCT04285346|540247652|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
149759516|NCT04285346|540247653|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149759517|NCT01975272|540247656|FG000|Overall Study|Excluded after protocol amendment|1|||
149759518|NCT01975272|540247657|FG001|Overall Study|Excluded after protocol amendment|1|||
149759519|NCT01975272|540247658|FG002|Overall Study|Excluded after protocol amendment|2|||
149759520|NCT03259334|540247662|FG000|Overall Study|Adverse Event|3|||
149759521|NCT03259334|540247663|FG001|Overall Study|Adverse Event|8|||
149759522|NCT03259334|540247664|FG002|Overall Study|Adverse Event|5|||
149759523|NCT03259334|540247662|FG000|Overall Study|Withdrawal by Subject|4|||
149759524|NCT03259334|540247663|FG001|Overall Study|Withdrawal by Subject|2|||
149759525|NCT03259334|540247664|FG002|Overall Study|Withdrawal by Subject|4|||
149759526|NCT03259334|540247662|FG000|Overall Study|Physician Decision|1|||
149759527|NCT03259334|540247663|FG001|Overall Study|Physician Decision|0|||
149759528|NCT03259334|540247664|FG002|Overall Study|Physician Decision|0|||
149759529|NCT03259334|540247662|FG000|Overall Study|Lost to Follow-up|0|||
149759530|NCT03259334|540247663|FG001|Overall Study|Lost to Follow-up|2|||
149759531|NCT03259334|540247664|FG002|Overall Study|Lost to Follow-up|1|||
149759532|NCT03259334|540247662|FG000|Overall Study|Protocol Deviation|0|||
149759533|NCT03259334|540247663|FG001|Overall Study|Protocol Deviation|3|||
149759534|NCT03259334|540247664|FG002|Overall Study|Protocol Deviation|2|||
149759535|NCT03259334|540247662|FG000|Overall Study|Lack of Efficacy|2|||
149759536|NCT03259334|540247663|FG001|Overall Study|Lack of Efficacy|0|||
149759537|NCT03259334|540247664|FG002|Overall Study|Lack of Efficacy|1|||
149759538|NCT03259334|540247662|FG000|Overall Study|Randomized but never treated|0|||
149759539|NCT03259334|540247663|FG001|Overall Study|Randomized but never treated|2|||
149759540|NCT03259334|540247664|FG002|Overall Study|Randomized but never treated|0|||
149759541|NCT00436215|540247665|FG000|Overall Study|Refused further treatment|3|||
149759542|NCT00436215|540247665|FG000|Overall Study|Small bowel obstruction|1|||
149759543|NCT00309777|540247666|FG000|Overall Study|Adverse Event|13|||
149759544|NCT00309777|540247667|FG001|Overall Study|Adverse Event|2|||
149759545|NCT00309777|540247668|FG002|Overall Study|Adverse Event|8|||
149759546|NCT00309777|540247669|FG003|Overall Study|Adverse Event|1|||
149759547|NCT00309777|540247666|FG000|Overall Study|Protocol Violation|4|||
149759548|NCT00309777|540247667|FG001|Overall Study|Protocol Violation|1|||
149759549|NCT00309777|540247668|FG002|Overall Study|Protocol Violation|3|||
149759550|NCT00309777|540247669|FG003|Overall Study|Protocol Violation|1|||
149759551|NCT00309777|540247666|FG000|Overall Study|Withdrawal by Subject|6|||
149759552|NCT00309777|540247667|FG001|Overall Study|Withdrawal by Subject|5|||
149759553|NCT00309777|540247668|FG002|Overall Study|Withdrawal by Subject|7|||
149759554|NCT00309777|540247669|FG003|Overall Study|Withdrawal by Subject|2|||
149759555|NCT00309777|540247666|FG000|Overall Study|Lost to Follow-up|0|||
149759556|NCT00309777|540247667|FG001|Overall Study|Lost to Follow-up|0|||
149759557|NCT00309777|540247668|FG002|Overall Study|Lost to Follow-up|1|||
149759558|NCT00309777|540247669|FG003|Overall Study|Lost to Follow-up|0|||
149759559|NCT00309777|540247666|FG000|Overall Study|Death|0|||
149759560|NCT00309777|540247667|FG001|Overall Study|Death|1|||
149759561|NCT00309777|540247668|FG002|Overall Study|Death|0|||
149759562|NCT00309777|540247669|FG003|Overall Study|Death|0|||
149759563|NCT00683475|540249263|FG000|Overall Study|Withdrawal by Subject|1|||
149759564|NCT00683475|540249264|FG001|Overall Study|Withdrawal by Subject|0|||
149759565|NCT00683475|540249263|FG000|Overall Study|Never Treated: Adverse Event|2|||
149759566|NCT00683475|540249264|FG001|Overall Study|Never Treated: Adverse Event|3|||
149759567|NCT00683475|540249263|FG000|Overall Study|Never Treated: Progressive Disease|1|||
149759568|NCT00683475|540249264|FG001|Overall Study|Never Treated: Progressive Disease|0|||
149759569|NCT02429258|540249267|FG000|Overall Study|Withdrawal by Subject|2|||
149759570|NCT02429258|540249268|FG001|Overall Study|Withdrawal by Subject|0|||
149759571|NCT02429258|540249267|FG000|Overall Study|Protocol Violation|0|||
149759572|NCT02429258|540249268|FG001|Overall Study|Protocol Violation|1|||
149759573|NCT03364335|540249270|FG000|Overall Study|Adverse Event|3|||
149759574|NCT03364335|540249271|FG001|Overall Study|Adverse Event|4|||
149759575|NCT03364335|540249272|FG002|Overall Study|Adverse Event|1|||
149759576|NCT03364335|540249273|FG003|Overall Study|Adverse Event|2|||
149759577|NCT03364335|540249274|FG004|Overall Study|Adverse Event|0|||
149759578|NCT03364335|540249270|FG000|Overall Study|Lost to Follow-up|7|||
149759579|NCT03364335|540249271|FG001|Overall Study|Lost to Follow-up|7|||
149759580|NCT03364335|540249272|FG002|Overall Study|Lost to Follow-up|10|||
149759581|NCT03364335|540249273|FG003|Overall Study|Lost to Follow-up|11|||
149759582|NCT03364335|540249274|FG004|Overall Study|Lost to Follow-up|11|||
149759583|NCT03987919|540249275|FG000|Overall Study|Adverse Event|1|||
149759584|NCT03987919|540249276|FG001|Overall Study|Adverse Event|4|||
149759585|NCT03987919|540249277|FG002|Overall Study|Adverse Event|1|||
149759586|NCT03987919|540249278|FG003|Overall Study|Adverse Event|3|||
149759587|NCT03987919|540249275|FG000|Overall Study|Death|4|||
149759588|NCT03987919|540249276|FG001|Overall Study|Death|4|||
149759589|NCT03987919|540249277|FG002|Overall Study|Death|4|||
149759590|NCT03987919|540249278|FG003|Overall Study|Death|1|||
149759591|NCT03987919|540249275|FG000|Overall Study|Lost to Follow-up|5|||
149759592|NCT03987919|540249276|FG001|Overall Study|Lost to Follow-up|6|||
149759593|NCT03987919|540249277|FG002|Overall Study|Lost to Follow-up|8|||
149759594|NCT03987919|540249278|FG003|Overall Study|Lost to Follow-up|12|||
149759595|NCT03987919|540249275|FG000|Overall Study|Physician Decision|0|||
149759596|NCT03987919|540249276|FG001|Overall Study|Physician Decision|2|||
149759597|NCT03987919|540249277|FG002|Overall Study|Physician Decision|0|||
149759598|NCT03987919|540249278|FG003|Overall Study|Physician Decision|4|||
149759599|NCT03987919|540249275|FG000|Overall Study|Pregnancy|1|||
149759600|NCT03987919|540249276|FG001|Overall Study|Pregnancy|0|||
149759601|NCT03987919|540249277|FG002|Overall Study|Pregnancy|1|||
149759602|NCT03987919|540249278|FG003|Overall Study|Pregnancy|1|||
149759603|NCT03987919|540249275|FG000|Overall Study|Protocol Violation|0|||
149759604|NCT03987919|540249276|FG001|Overall Study|Protocol Violation|1|||
149759605|NCT03987919|540249277|FG002|Overall Study|Protocol Violation|0|||
149759606|NCT03987919|540249278|FG003|Overall Study|Protocol Violation|0|||
149759607|NCT03987919|540249275|FG000|Overall Study|Site terminated by Sponsor|0|||
149759608|NCT03987919|540249276|FG001|Overall Study|Site terminated by Sponsor|0|||
149759609|NCT03987919|540249277|FG002|Overall Study|Site terminated by Sponsor|0|||
149759610|NCT03987919|540249278|FG003|Overall Study|Site terminated by Sponsor|1|||
149759611|NCT03987919|540249275|FG000|Overall Study|Withdrawal by Subject|7|||
149759612|NCT03987919|540249276|FG001|Overall Study|Withdrawal by Subject|7|||
149759613|NCT03987919|540249277|FG002|Overall Study|Withdrawal by Subject|8|||
149759614|NCT03987919|540249278|FG003|Overall Study|Withdrawal by Subject|4|||
149759615|NCT03987919|540249275|FG000|Overall Study|Other - as reported by the investigator|1|||
149759616|NCT03987919|540249276|FG001|Overall Study|Other - as reported by the investigator|3|||
149759617|NCT03987919|540249277|FG002|Overall Study|Other - as reported by the investigator|2|||
149759618|NCT03987919|540249278|FG003|Overall Study|Other - as reported by the investigator|0|||
149759619|NCT02330549|540249282|FG000|Overall Study|Adverse Event|1|||
149759620|NCT02330549|540249283|FG001|Overall Study|Adverse Event|0|||
149759621|NCT02330549|540249282|FG000|Overall Study|Subject withdrew consent|2|||
149759622|NCT02330549|540249283|FG001|Overall Study|Subject withdrew consent|1|||
149759623|NCT02330549|540249282|FG000|Overall Study|Failure to meet randomization criteria|1|||
149759624|NCT02330549|540249283|FG001|Overall Study|Failure to meet randomization criteria|0|||
149759625|NCT00853489|540249289|FG000|Overall Study|Lost to Follow-up|5|||
149759626|NCT00853489|540249290|FG001|Overall Study|Lost to Follow-up|2|||
149759627|NCT05525975|540249291|FG000|Overall Study|Surgery cancellation|4|||
149759628|NCT05525975|540249292|FG001|Overall Study|Surgery cancellation|5|||
149759629|NCT05525975|540249291|FG000|Overall Study|didn't fill prescription|1|||
149759630|NCT05525975|540249292|FG001|Overall Study|didn't fill prescription|0|||
149759631|NCT05525975|540249291|FG000|Overall Study|Withdrawal by Subject|0|||
149759632|NCT05525975|540249292|FG001|Overall Study|Withdrawal by Subject|3|||
149759633|NCT02326467|540249293|FG000|Overall Study|Withdrawal by Subject|1|||
149759634|NCT01251276|540249297|FG000|Overall Study|Protocol Violation|1|||
149759635|NCT01251276|540249298|FG001|Overall Study|Protocol Violation|0|||
149759636|NCT01251276|540249297|FG000|Overall Study|Lost to Follow-up|0|||
149759637|NCT01251276|540249298|FG001|Overall Study|Lost to Follow-up|1|||
149759638|NCT01051986|540249302|FG000|Overall Study|Death|1|||
149759639|NCT01051986|540249303|FG001|Overall Study|Death|0|||
149759640|NCT01051986|540249302|FG000|Overall Study|Withdrawal by Subject|2|||
149759641|NCT01051986|540249303|FG001|Overall Study|Withdrawal by Subject|1|||
149759642|NCT01051986|540249302|FG000|Overall Study|Protocol Violation|2|||
149759643|NCT01051986|540249303|FG001|Overall Study|Protocol Violation|3|||
149759644|NCT00262080|540249304|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
149759645|NCT00262080|540249305|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149759646|NCT00262080|540249306|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
149759647|NCT00262080|540249304|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
149759648|NCT00262080|540249305|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
149759649|NCT00262080|540249306|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
149759650|NCT00262080|540249304|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
149759651|NCT00262080|540249305|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
149759652|NCT00262080|540249306|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
149759653|NCT00262080|540249304|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
149759654|NCT00262080|540249305|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
149759655|NCT00262080|540249306|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
149759656|NCT00262080|540249304|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
149759657|NCT00262080|540249305|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
149759658|NCT00262080|540249306|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
149759659|NCT00262080|540249304|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
149759660|NCT00262080|540249305|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
149759661|NCT00262080|540249306|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
149759662|NCT03580382|540249312|FG000|Overall Study|Early Termination of Study|0|||
149759663|NCT03580382|540249313|FG001|Overall Study|Early Termination of Study|3|||
149759664|NCT02420223|540249314|FG000|Overall Study|Adverse Event|1|||
149759665|NCT02420223|540249315|FG001|Overall Study|Adverse Event|0|||
149759666|NCT02420223|540249314|FG000|Overall Study|Physician Decision|0|||
149759667|NCT02420223|540249315|FG001|Overall Study|Physician Decision|2|||
149759668|NCT01361009|540249316|FG000|Overall Study|Protocol Violation|116|||
149759669|NCT04009096|540249320|FG000|Overall Study|Withdrawal by Subject|0|||
149759670|NCT04009096|540249321|FG001|Overall Study|Withdrawal by Subject|7|||
149759671|NCT04009096|540249322|FG002|Overall Study|Withdrawal by Subject|0|||
149759672|NCT04009096|540249320|FG000|Overall Study|Physician Decision|0|||
149759673|NCT04009096|540249321|FG001|Overall Study|Physician Decision|1|||
149759674|NCT04009096|540249322|FG002|Overall Study|Physician Decision|0|||
149759675|NCT00520676|540249325|FG000|Overall Study|Death|84|||
149759676|NCT00520676|540249326|FG001|Overall Study|Death|81|||
149759677|NCT00520676|540249325|FG000|Overall Study|Lost to Follow-up|6|||
149759678|NCT00520676|540249326|FG001|Overall Study|Lost to Follow-up|10|||
149759679|NCT00520676|540249325|FG000|Overall Study|Physician Decision|4|||
149759680|NCT00520676|540249326|FG001|Overall Study|Physician Decision|1|||
149759681|NCT00520676|540249325|FG000|Overall Study|Withdrawal by Subject|7|||
149759682|NCT00520676|540249326|FG001|Overall Study|Withdrawal by Subject|11|||
149759683|NCT03484923|540249329|FG000|Overall Study|Adverse Event|3|||
149759684|NCT03484923|540249330|FG001|Overall Study|Adverse Event|3|||
149759685|NCT03484923|540249331|FG002|Overall Study|Adverse Event|5|||
149759686|NCT03484923|540249332|FG003|Overall Study|Adverse Event|11|||
149759687|NCT03484923|540249333|FG004|Overall Study|Adverse Event|1|||
149759688|NCT03484923|540249329|FG000|Overall Study|Death|2|||
149759689|NCT03484923|540249330|FG001|Overall Study|Death|2|||
149759690|NCT03484923|540249331|FG002|Overall Study|Death|3|||
149759691|NCT03484923|540249332|FG003|Overall Study|Death|0|||
149759692|NCT03484923|540249333|FG004|Overall Study|Death|1|||
149759693|NCT03484923|540249329|FG000|Overall Study|Physician Decision|6|||
149759694|NCT03484923|540249330|FG001|Overall Study|Physician Decision|7|||
149759695|NCT03484923|540249331|FG002|Overall Study|Physician Decision|6|||
149759696|NCT03484923|540249332|FG003|Overall Study|Physician Decision|3|||
149759697|NCT03484923|540249333|FG004|Overall Study|Physician Decision|2|||
149759698|NCT03484923|540249329|FG000|Overall Study|Progressive disease|33|||
149759699|NCT03484923|540249330|FG001|Overall Study|Progressive disease|28|||
149759700|NCT03484923|540249331|FG002|Overall Study|Progressive disease|26|||
149759701|NCT03484923|540249332|FG003|Overall Study|Progressive disease|30|||
149759702|NCT03484923|540249333|FG004|Overall Study|Progressive disease|16|||
149759703|NCT03484923|540249329|FG000|Overall Study|Subject Decision|1|||
149759704|NCT03484923|540249330|FG001|Overall Study|Subject Decision|3|||
149759705|NCT03484923|540249331|FG002|Overall Study|Subject Decision|3|||
149759706|NCT03484923|540249332|FG003|Overall Study|Subject Decision|0|||
149759707|NCT03484923|540249333|FG004|Overall Study|Subject Decision|1|||
149759708|NCT03439748|540249334|FG000|Overall Study|Withdrawal by Subject|11|||
149759709|NCT03439748|540249335|FG001|Overall Study|Withdrawal by Subject|17|||
149759710|NCT03298412|540249338|FG000|Run-in Period|Other, Not Specified|1|||
149759711|NCT03298412|540249338|FG000|Run-in Period|Disease Progression|1|||
149759712|NCT03298412|540249338|FG000|Run-in Period|Ineligibility Determined|1|||
149759713|NCT03298412|540249338|FG000|Run-in Period|Decision by Sponsor|6|||
149759714|NCT01028651|540249343|FG000|Overall Study|Death|2|||
149759715|NCT01028651|540249343|FG000|Overall Study|Adverse Event|1|||
149759716|NCT01533935|540249344|FG000|Overall Study|Adverse Event|5|||
149759717|NCT01533935|540249345|FG001|Overall Study|Adverse Event|7|||
149759718|NCT01533935|540249346|FG002|Overall Study|Adverse Event|1|||
149759719|NCT01533935|540249347|FG003|Overall Study|Adverse Event|5|||
149759720|NCT01533935|540249348|FG004|Overall Study|Adverse Event|3|||
149759721|NCT01533935|540249344|FG000|Overall Study|Protocol Violation|0|||
149759722|NCT01533935|540249345|FG001|Overall Study|Protocol Violation|2|||
149759723|NCT01533935|540249346|FG002|Overall Study|Protocol Violation|0|||
149759724|NCT01533935|540249347|FG003|Overall Study|Protocol Violation|0|||
149759725|NCT01533935|540249348|FG004|Overall Study|Protocol Violation|0|||
149759726|NCT01533935|540249344|FG000|Overall Study|Lost to Follow-up|0|||
149759727|NCT01533935|540249345|FG001|Overall Study|Lost to Follow-up|0|||
149759728|NCT01533935|540249346|FG002|Overall Study|Lost to Follow-up|1|||
149759729|NCT01533935|540249347|FG003|Overall Study|Lost to Follow-up|0|||
149759730|NCT01533935|540249348|FG004|Overall Study|Lost to Follow-up|0|||
149759731|NCT01533935|540249344|FG000|Overall Study|Withdrawal by Subject|0|||
149759732|NCT01533935|540249345|FG001|Overall Study|Withdrawal by Subject|4|||
149759733|NCT01533935|540249346|FG002|Overall Study|Withdrawal by Subject|5|||
149759734|NCT01533935|540249347|FG003|Overall Study|Withdrawal by Subject|2|||
149759735|NCT01533935|540249348|FG004|Overall Study|Withdrawal by Subject|4|||
149759736|NCT01533935|540249344|FG000|Overall Study|Other reason not defined above|1|||
149759737|NCT01533935|540249345|FG001|Overall Study|Other reason not defined above|0|||
149759738|NCT01533935|540249346|FG002|Overall Study|Other reason not defined above|1|||
149759739|NCT01533935|540249347|FG003|Overall Study|Other reason not defined above|0|||
149759740|NCT01533935|540249348|FG004|Overall Study|Other reason not defined above|1|||
149759741|NCT05631548|540249349|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
149759742|NCT05631548|540249350|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
149759743|NCT02935634|540249351|FG000|Randomization|Participant withdrew consent|0|||
149759744|NCT02935634|540249352|FG001|Randomization|Participant withdrew consent|1|||
149759745|NCT02935634|540249353|FG002|Randomization|Participant withdrew consent|0|||
149759746|NCT02935634|540249354|FG003|Randomization|Participant withdrew consent|0|||
149759747|NCT02935634|540249355|FG004|Randomization|Participant withdrew consent|0|||
149759748|NCT02935634|540249356|FG005|Randomization|Participant withdrew consent|0|||
149759749|NCT02935634|540249351|FG000|Randomization|Death|2|||
149759750|NCT02935634|540249352|FG001|Randomization|Death|1|||
149759751|NCT02935634|540249353|FG002|Randomization|Death|1|||
149759752|NCT02935634|540249354|FG003|Randomization|Death|0|||
149759753|NCT02935634|540249355|FG004|Randomization|Death|0|||
149759754|NCT02935634|540249356|FG005|Randomization|Death|0|||
149759755|NCT02935634|540249351|FG000|Randomization|Other reasons|0|||
149759756|NCT02935634|540249352|FG001|Randomization|Other reasons|2|||
149759757|NCT02935634|540249353|FG002|Randomization|Other reasons|2|||
149759758|NCT02935634|540249354|FG003|Randomization|Other reasons|0|||
149759759|NCT02935634|540249355|FG004|Randomization|Other reasons|0|||
149759760|NCT02935634|540249356|FG005|Randomization|Other reasons|0|||
149759761|NCT02935634|540249351|FG000|Treatment: Track 1|Disease progression|15|||
149759762|NCT02935634|540249352|FG001|Treatment: Track 1|Disease progression|17|||
149759763|NCT02935634|540249353|FG002|Treatment: Track 1|Disease progression|28|||
149759764|NCT02935634|540249354|FG003|Treatment: Track 1|Disease progression|4|||
149759765|NCT02935634|540249355|FG004|Treatment: Track 1|Disease progression|6|||
149759766|NCT02935634|540249356|FG005|Treatment: Track 1|Disease progression|2|||
149759767|NCT02935634|540249351|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
149759768|NCT02935634|540249352|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
149759769|NCT02935634|540249353|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
149759770|NCT02935634|540249354|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
149759771|NCT02935634|540249355|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
149759772|NCT02935634|540249356|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
149759773|NCT02935634|540249351|FG000|Treatment: Track 1|Lost to Follow-up|1|||
149759774|NCT02935634|540249352|FG001|Treatment: Track 1|Lost to Follow-up|0|||
149759775|NCT02935634|540249353|FG002|Treatment: Track 1|Lost to Follow-up|0|||
149759776|NCT02935634|540249354|FG003|Treatment: Track 1|Lost to Follow-up|0|||
149759777|NCT02935634|540249355|FG004|Treatment: Track 1|Lost to Follow-up|0|||
149759778|NCT02935634|540249356|FG005|Treatment: Track 1|Lost to Follow-up|0|||
149759779|NCT02935634|540249351|FG000|Treatment: Track 1|Study drug toxicity|2|||
149759780|NCT02935634|540249352|FG001|Treatment: Track 1|Study drug toxicity|1|||
149759781|NCT02935634|540249353|FG002|Treatment: Track 1|Study drug toxicity|3|||
149759782|NCT02935634|540249354|FG003|Treatment: Track 1|Study drug toxicity|0|||
149759783|NCT02935634|540249355|FG004|Treatment: Track 1|Study drug toxicity|0|||
149759784|NCT02935634|540249356|FG005|Treatment: Track 1|Study drug toxicity|1|||
149759785|NCT02935634|540249351|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
149759786|NCT02935634|540249352|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
149759787|NCT02935634|540249353|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
149759788|NCT02935634|540249354|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
149759789|NCT02935634|540249355|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
149759790|NCT02935634|540249356|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
149759791|NCT02935634|540249351|FG000|Treatment: Track 1|Participant withdrew consent|2|||
149759792|NCT02935634|540249352|FG001|Treatment: Track 1|Participant withdrew consent|0|||
149759793|NCT02935634|540249353|FG002|Treatment: Track 1|Participant withdrew consent|1|||
149759794|NCT02935634|540249354|FG003|Treatment: Track 1|Participant withdrew consent|0|||
149759795|NCT02935634|540249355|FG004|Treatment: Track 1|Participant withdrew consent|1|||
149759796|NCT02935634|540249356|FG005|Treatment: Track 1|Participant withdrew consent|0|||
149759797|NCT02935634|540249351|FG000|Treatment: Track 1|Other reasons|0|||
149759798|NCT02935634|540249352|FG001|Treatment: Track 1|Other reasons|0|||
149759799|NCT02935634|540249353|FG002|Treatment: Track 1|Other reasons|2|||
149759800|NCT02935634|540249354|FG003|Treatment: Track 1|Other reasons|0|||
149759801|NCT02935634|540249355|FG004|Treatment: Track 1|Other reasons|0|||
149759802|NCT02935634|540249356|FG005|Treatment: Track 1|Other reasons|0|||
149759803|NCT02935634|540249351|FG000|Treatment: Track 2|Disease progression|13|||
149759804|NCT02935634|540249352|FG001|Treatment: Track 2|Disease progression|26|||
149759805|NCT02935634|540249353|FG002|Treatment: Track 2|Disease progression|20|||
149759806|NCT02935634|540249354|FG003|Treatment: Track 2|Disease progression|5|||
149759807|NCT02935634|540249355|FG004|Treatment: Track 2|Disease progression|1|||
149759808|NCT02935634|540249356|FG005|Treatment: Track 2|Disease progression|4|||
149759809|NCT02935634|540249351|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
149759810|NCT02935634|540249352|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
149759811|NCT02935634|540249353|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149759812|NCT02935634|540249354|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149759813|NCT02935634|540249355|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149759814|NCT02935634|540249356|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149759815|NCT02935634|540249351|FG000|Treatment: Track 2|Study drug toxicity|7|||
149759816|NCT02935634|540249352|FG001|Treatment: Track 2|Study drug toxicity|3|||
149759817|NCT02935634|540249353|FG002|Treatment: Track 2|Study drug toxicity|0|||
149759818|NCT02935634|540249354|FG003|Treatment: Track 2|Study drug toxicity|0|||
149759819|NCT02935634|540249355|FG004|Treatment: Track 2|Study drug toxicity|0|||
149759820|NCT02935634|540249356|FG005|Treatment: Track 2|Study drug toxicity|0|||
149759821|NCT02935634|540249351|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
149759822|NCT02935634|540249352|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
149759823|NCT02935634|540249353|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
149759824|NCT02935634|540249354|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
149759825|NCT02935634|540249355|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
149759826|NCT02935634|540249356|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
149759827|NCT02935634|540249351|FG000|Treatment: Track 2|Participant withdrew consent|0|||
149759828|NCT02935634|540249352|FG001|Treatment: Track 2|Participant withdrew consent|1|||
149759829|NCT02935634|540249353|FG002|Treatment: Track 2|Participant withdrew consent|1|||
149759830|NCT02935634|540249354|FG003|Treatment: Track 2|Participant withdrew consent|0|||
149759831|NCT02935634|540249355|FG004|Treatment: Track 2|Participant withdrew consent|1|||
149759832|NCT02935634|540249356|FG005|Treatment: Track 2|Participant withdrew consent|0|||
149759833|NCT04075266|540249357|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
149759834|NCT04075266|540249358|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
149759835|NCT04075266|540249357|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
149759836|NCT04075266|540249358|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
149759837|NCT01554956|540249359|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
149759838|NCT01554956|540249360|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
149759839|NCT01554956|540249361|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
149759840|NCT01554956|540249359|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
149759841|NCT01554956|540249360|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
149759842|NCT01554956|540249361|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
149759843|NCT01554956|540249359|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
149759844|NCT01554956|540249360|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
149759845|NCT01554956|540249361|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
149759846|NCT00913978|540249362|FG000|Overall Study|Surgeon choice|1|||
149759847|NCT00913978|540249363|FG001|Overall Study|Surgeon choice|3|||
149759848|NCT00210158|540249364|FG000|Overall Study|Protocol Violation|0|||
149759849|NCT00210158|540249365|FG001|Overall Study|Protocol Violation|2|||
149759850|NCT04716933|540249366|FG000|Overall Study|Sponsor Decision|36|||
149759851|NCT04716933|540249367|FG001|Overall Study|Sponsor Decision|33|||
149759852|NCT04716933|540249366|FG000|Overall Study|Death|65|||
149759853|NCT04716933|540249367|FG001|Overall Study|Death|67|||
149759854|NCT01327651|540249368|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
149759855|NCT01327651|540249369|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
149759856|NCT01327651|540249370|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
149759857|NCT01327651|540249371|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
149759858|NCT01327651|540249372|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
149759859|NCT01327651|540249373|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
149759860|NCT01327651|540249374|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
149759861|NCT01327651|540249375|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
149759862|NCT01327651|540249376|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
149759863|NCT01327651|540249368|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
149759864|NCT01327651|540249369|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759865|NCT01327651|540249370|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759866|NCT01327651|540249371|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759867|NCT01327651|540249372|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759868|NCT01327651|540249373|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759869|NCT01327651|540249374|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759870|NCT01327651|540249375|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759871|NCT01327651|540249376|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149759872|NCT01327651|540249368|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
149759873|NCT01327651|540249369|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
149759874|NCT01327651|540249370|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
149759875|NCT01327651|540249371|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
149759876|NCT01327651|540249372|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
149759877|NCT01327651|540249373|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
149759878|NCT01327651|540249374|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
149759879|NCT01327651|540249375|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
149759880|NCT01327651|540249376|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
149759881|NCT01327651|540249368|FG000|Post Study Follow-up|Lost to Follow-up|0|||
149759882|NCT01327651|540249369|FG001|Post Study Follow-up|Lost to Follow-up|1|||
149759883|NCT01327651|540249370|FG002|Post Study Follow-up|Lost to Follow-up|1|||
149759884|NCT01327651|540249371|FG003|Post Study Follow-up|Lost to Follow-up|0|||
149759885|NCT01327651|540249372|FG004|Post Study Follow-up|Lost to Follow-up|0|||
149759886|NCT01327651|540249373|FG005|Post Study Follow-up|Lost to Follow-up|0|||
149759887|NCT01327651|540249374|FG006|Post Study Follow-up|Lost to Follow-up|4|||
149759888|NCT01327651|540249375|FG007|Post Study Follow-up|Lost to Follow-up|1|||
149759889|NCT01327651|540249376|FG008|Post Study Follow-up|Lost to Follow-up|2|||
149759890|NCT01842308|540249381|FG000|Overall Study|Withdrawal by Subject|0|||
149759891|NCT01842308|540249382|FG001|Overall Study|Withdrawal by Subject|0|||
149759892|NCT01842308|540249383|FG002|Overall Study|Withdrawal by Subject|0|||
149759893|NCT01842308|540249384|FG003|Overall Study|Withdrawal by Subject|0|||
149759894|NCT01842308|540249385|FG004|Overall Study|Withdrawal by Subject|1|||
149759895|NCT03521687|540249392|FG000|Overall Study|Adverse Event|4|||
149759896|NCT03521687|540249392|FG000|Overall Study|Physician Decision|1|||
149759897|NCT03609359|540249398|FG000|Overall Study|Progression of primary disease (PD)|25|||
149759898|NCT03609359|540249398|FG000|Overall Study|Patient's refusal|1|||
149759899|NCT03609359|540249398|FG000|Overall Study|Physician Decision|1|||
149759900|NCT03609359|540249398|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
149759901|NCT00610935|540249400|FG000|Overall Study|Lost to Follow-up|0|||
149759902|NCT00610935|540249401|FG001|Overall Study|Lost to Follow-up|1|||
149759903|NCT00610935|540249400|FG000|Overall Study|Withdrawal by Subject|0|||
149759904|NCT00610935|540249401|FG001|Overall Study|Withdrawal by Subject|2|||
149759905|NCT00610935|540249400|FG000|Overall Study|Sponsor Discontinuation|1|||
149759906|NCT00610935|540249401|FG001|Overall Study|Sponsor Discontinuation|0|||
149759907|NCT00740779|540249402|FG000|Overall Study|Adverse Event|4|||
149759908|NCT00740779|540249403|FG001|Overall Study|Adverse Event|6|||
149759909|NCT00740779|540249404|FG002|Overall Study|Adverse Event|3|||
149759910|NCT00740779|540249402|FG000|Overall Study|Protocol Violation|1|||
149759911|NCT00740779|540249403|FG001|Overall Study|Protocol Violation|1|||
149759912|NCT00740779|540249404|FG002|Overall Study|Protocol Violation|1|||
149759913|NCT00740779|540249402|FG000|Overall Study|Lack of Efficacy|0|||
149759914|NCT00740779|540249403|FG001|Overall Study|Lack of Efficacy|0|||
149759915|NCT00740779|540249404|FG002|Overall Study|Lack of Efficacy|2|||
149759916|NCT00740779|540249402|FG000|Overall Study|Withdrawal by Subject|2|||
149759917|NCT00740779|540249403|FG001|Overall Study|Withdrawal by Subject|4|||
149759918|NCT00740779|540249404|FG002|Overall Study|Withdrawal by Subject|2|||
149759919|NCT00740779|540249402|FG000|Overall Study|Lost to Follow-up|2|||
149759920|NCT00740779|540249403|FG001|Overall Study|Lost to Follow-up|3|||
149759921|NCT00740779|540249404|FG002|Overall Study|Lost to Follow-up|5|||
149759922|NCT02399813|540249408|FG000|Overall Study|Progressive Disease-Radiographic|2|||
149759923|NCT02399813|540249408|FG000|Overall Study|Death|20|||
149759924|NCT02399813|540249408|FG000|Overall Study|Withdrawal by Subject|3|||
149759925|NCT02399813|540249408|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
149759926|NCT02399813|540249408|FG000|Overall Study|Lost to Follow-up|2|||
149759927|NCT02399813|540249408|FG000|Overall Study|Other than specified|5|||
149759928|NCT03345836|540249409|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
149759929|NCT03345836|540249410|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
149759930|NCT03345836|540249411|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
149759931|NCT03345836|540249412|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
149759932|NCT03345836|540249413|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
149759933|NCT03345836|540249414|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
149759934|NCT03345836|540249409|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
149759935|NCT03345836|540249410|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
149759936|NCT03345836|540249411|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
149759937|NCT03345836|540249412|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149759938|NCT03345836|540249413|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149759939|NCT03345836|540249414|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149759940|NCT03345836|540249409|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149759941|NCT03345836|540249410|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
149759942|NCT03345836|540249411|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149759943|NCT03345836|540249412|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149759944|NCT03345836|540249413|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149759945|NCT03345836|540249414|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149759946|NCT03345836|540249409|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
149759947|NCT03345836|540249410|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
149759948|NCT03345836|540249411|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149759949|NCT03345836|540249412|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149759950|NCT03345836|540249413|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149759951|NCT03345836|540249414|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149759952|NCT03345836|540249409|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
149759953|NCT03345836|540249410|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
149759954|NCT03345836|540249411|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
149759955|NCT03345836|540249412|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149759956|NCT03345836|540249413|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149759957|NCT03345836|540249414|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149759958|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149759959|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149759960|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149759961|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
149759962|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
149759963|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149759964|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149759965|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149759966|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149759967|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149759968|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
149759969|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
149759970|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149759971|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149759972|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149759973|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149759974|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149759975|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
149759976|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149759977|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149759978|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149759979|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
149759980|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
149759981|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
149759982|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149759983|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149759984|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149759985|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149759986|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
149759987|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149759988|NCT03345836|540249409|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149759989|NCT03345836|540249410|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149759990|NCT03345836|540249411|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149759991|NCT03345836|540249412|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149759992|NCT03345836|540249413|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149759993|NCT03345836|540249414|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149759994|NCT01915849|540249417|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
149759995|NCT01915849|540249418|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149759996|NCT01915849|540249419|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149759997|NCT01915849|540249420|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149759998|NCT01915849|540249417|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
149759999|NCT01915849|540249418|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149760000|NCT01915849|540249419|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149760001|NCT01915849|540249420|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149760002|NCT02761993|540249424|FG000|Overall Study|Adverse Event|0|||
149760003|NCT02761993|540249425|FG001|Overall Study|Adverse Event|2|||
149760004|NCT02761993|540249426|FG002|Overall Study|Adverse Event|0|||
149760005|NCT02761993|540249424|FG000|Overall Study|Lost to Follow-up|1|||
149760006|NCT02761993|540249425|FG001|Overall Study|Lost to Follow-up|3|||
149760007|NCT02761993|540249426|FG002|Overall Study|Lost to Follow-up|2|||
149760008|NCT02761993|540249424|FG000|Overall Study|Withdrawal by Subject|1|||
149760009|NCT02761993|540249425|FG001|Overall Study|Withdrawal by Subject|1|||
149760010|NCT02761993|540249426|FG002|Overall Study|Withdrawal by Subject|2|||
149760011|NCT01842620|540249427|FG000|Period 1|Withdrawal by Subject|1|||
149760012|NCT01842620|540249428|FG001|Period 1|Withdrawal by Subject|0|||
149760013|NCT00488033|540249429|FG000|Overall Study|Withdrawal by Subject|1|||
149760014|NCT00488033|540249430|FG001|Overall Study|Withdrawal by Subject|0|||
149760015|NCT01515306|540249431|FG000|Overall Study|Adverse Event|3|||
149760016|NCT01515306|540249432|FG001|Overall Study|Adverse Event|2|||
149760017|NCT01515306|540249431|FG000|Overall Study|Progressive Disease|19|||
149760018|NCT01515306|540249432|FG001|Overall Study|Progressive Disease|9|||
149760019|NCT01515306|540249431|FG000|Overall Study|Withdrawal by Subject|1|||
149760020|NCT01515306|540249432|FG001|Overall Study|Withdrawal by Subject|2|||
149760021|NCT01515306|540249431|FG000|Overall Study|Physician Decision|1|||
149760022|NCT01515306|540249432|FG001|Overall Study|Physician Decision|1|||
149760023|NCT04973228|540249433|FG000|Overall Study|Adverse Event|2|||
149760024|NCT04973228|540249434|FG001|Overall Study|Adverse Event|3|||
149760025|NCT04973228|540249433|FG000|Overall Study|Lack of Efficacy|1|||
149760026|NCT04973228|540249434|FG001|Overall Study|Lack of Efficacy|3|||
149760027|NCT04973228|540249433|FG000|Overall Study|Lost to Follow-up|12|||
149760028|NCT04973228|540249434|FG001|Overall Study|Lost to Follow-up|4|||
149760029|NCT04973228|540249433|FG000|Overall Study|Withdrawal by Subject|11|||
149760030|NCT04973228|540249434|FG001|Overall Study|Withdrawal by Subject|4|||
149760031|NCT04973228|540249433|FG000|Overall Study|Did not tolerate application|1|||
149760032|NCT04973228|540249434|FG001|Overall Study|Did not tolerate application|0|||
149760033|NCT04973228|540249433|FG000|Overall Study|Wanted to early terminate and use own product|0|||
149760034|NCT04973228|540249434|FG001|Overall Study|Wanted to early terminate and use own product|1|||
149760035|NCT04973228|540249433|FG000|Overall Study|Missed visits due to new work schedule|1|||
149760036|NCT04973228|540249434|FG001|Overall Study|Missed visits due to new work schedule|0|||
149760037|NCT02614287|540250998|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
149760038|NCT02614287|540250999|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
149760039|NCT02614287|540250998|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
149760040|NCT02614287|540250999|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
149760041|NCT02614287|540250998|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
149760042|NCT02614287|540250999|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
149760043|NCT02614287|540250998|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
149760044|NCT02614287|540250999|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
149760045|NCT02614287|540250998|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
149760046|NCT02614287|540250999|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
149760047|NCT02614287|540250998|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
149760048|NCT02614287|540250999|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
149760049|NCT02614287|540250998|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
149760050|NCT02614287|540250999|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
149760051|NCT02614287|540250998|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
149760052|NCT02614287|540250999|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
149760053|NCT02294318|540251002|FG000|Overall Study|Worsening of drinking|3|||
149760054|NCT02294318|540251003|FG001|Overall Study|Worsening of drinking|0|||
149760055|NCT02294318|540251002|FG000|Overall Study|Not exposed to intervention|0|||
149760056|NCT02294318|540251003|FG001|Overall Study|Not exposed to intervention|2|||
149760057|NCT01694420|540251004|FG000|Overall Study|Lost to Follow-up|3|||
149760058|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
149760059|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
149760060|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
149760061|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149760062|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149760063|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149760064|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149760065|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149760066|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
149760067|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
149760068|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
149760069|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149760070|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149760071|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149760072|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149760073|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149760074|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
149760075|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760076|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760077|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760078|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760079|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760080|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760081|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149760082|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
149760083|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760084|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760085|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760086|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760087|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760088|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760089|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149760090|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149760091|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149760092|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149760093|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149760094|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149760095|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149760096|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149760097|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149760098|NCT03725202|540251005|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760099|NCT03725202|540251006|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760100|NCT03725202|540251007|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
149760101|NCT03725202|540251008|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760102|NCT03725202|540251009|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760103|NCT03725202|540251010|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760104|NCT03725202|540251011|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760105|NCT03725202|540251012|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149760106|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149760107|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149760108|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149760109|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
149760110|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
149760111|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
149760112|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
149760113|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
149760114|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149760115|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149760116|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149760117|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
149760118|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
149760119|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
149760120|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
149760121|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
149760122|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149760123|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149760124|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149760125|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
149760126|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149760127|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149760128|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
149760129|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
149760130|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760131|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760132|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760133|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760134|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760135|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760136|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
149760137|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149760138|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760139|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760140|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760141|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760142|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760143|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
149760144|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760145|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149760146|NCT03725202|540251005|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149760147|NCT03725202|540251006|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149760148|NCT03725202|540251007|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149760149|NCT03725202|540251008|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
149760150|NCT03725202|540251009|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149760151|NCT03725202|540251010|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149760152|NCT03725202|540251011|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
149760153|NCT03725202|540251012|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
149760154|NCT00495495|540251013|FG000|Overall Study|Protocol Violation|99|||
149760155|NCT02702518|540251014|FG000|Overall Study|Lost to Follow-up|3|||
149760156|NCT02702518|540251015|FG001|Overall Study|Lost to Follow-up|4|||
149760157|NCT03331666|540251016|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
149760158|NCT03331666|540251017|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
149760159|NCT00434512|540251018|FG000|Overall Study|Migrated/moved from study area|0|||
149760160|NCT00434512|540251019|FG001|Overall Study|Migrated/moved from study area|0|||
149760161|NCT00434512|540251020|FG002|Overall Study|Migrated/moved from study area|0|||
149760162|NCT00434512|540251021|FG003|Overall Study|Migrated/moved from study area|1|||
149760163|NCT00434512|540251022|FG004|Overall Study|Migrated/moved from study area|1|||
149760164|NCT00434512|540251023|FG005|Overall Study|Migrated/moved from study area|1|||
149760165|NCT00434512|540251018|FG000|Overall Study|Other|0|||
149760166|NCT00434512|540251019|FG001|Overall Study|Other|1|||
149760167|NCT00434512|540251020|FG002|Overall Study|Other|0|||
149760168|NCT00434512|540251021|FG003|Overall Study|Other|0|||
149760169|NCT00434512|540251022|FG004|Overall Study|Other|0|||
149760170|NCT00434512|540251023|FG005|Overall Study|Other|0|||
149760171|NCT01575197|540251024|FG000|Overall Study|Migration out of study area|1|||
149760172|NCT01575197|540251025|FG001|Overall Study|Migration out of study area|5|||
149760173|NCT01575197|540251026|FG002|Overall Study|Migration out of study area|4|||
149760174|NCT01575197|540251024|FG000|Overall Study|SAE|0|||
149760175|NCT01575197|540251025|FG001|Overall Study|SAE|1|||
149760176|NCT01575197|540251026|FG002|Overall Study|SAE|0|||
149760177|NCT01575197|540251024|FG000|Overall Study|Lost to Follow-up|0|||
149760178|NCT01575197|540251025|FG001|Overall Study|Lost to Follow-up|1|||
149760179|NCT01575197|540251026|FG002|Overall Study|Lost to Follow-up|0|||
149760180|NCT01575197|540251024|FG000|Overall Study|Withdrawal by Subject|0|||
149760181|NCT01575197|540251025|FG001|Overall Study|Withdrawal by Subject|1|||
149760182|NCT01575197|540251026|FG002|Overall Study|Withdrawal by Subject|1|||
149760183|NCT01575197|540251024|FG000|Overall Study|Protocol Violation|2|||
149760184|NCT01575197|540251025|FG001|Overall Study|Protocol Violation|1|||
149760185|NCT01575197|540251026|FG002|Overall Study|Protocol Violation|1|||
149760186|NCT03303092|540251027|FG000|Overall Study|Adverse Event|1|||
149760187|NCT03303092|540251028|FG001|Overall Study|Adverse Event|0|||
149760188|NCT03303092|540251029|FG002|Overall Study|Adverse Event|1|||
149760189|NCT03303092|540251027|FG000|Overall Study|Protocol Violation|1|||
149760190|NCT03303092|540251028|FG001|Overall Study|Protocol Violation|5|||
149760191|NCT03303092|540251029|FG002|Overall Study|Protocol Violation|1|||
149760192|NCT03303092|540251027|FG000|Overall Study|Withdrawal by Subject|1|||
149760193|NCT03303092|540251028|FG001|Overall Study|Withdrawal by Subject|1|||
149760194|NCT03303092|540251029|FG002|Overall Study|Withdrawal by Subject|3|||
149760195|NCT00833248|540251034|FG000|Overall Study|Adverse Event|3|||
149760196|NCT00833248|540251035|FG001|Overall Study|Adverse Event|0|||
149760197|NCT00833248|540251034|FG000|Overall Study|Protocol Violation|1|||
149760198|NCT00833248|540251035|FG001|Overall Study|Protocol Violation|2|||
149760199|NCT00833248|540251034|FG000|Overall Study|Withdrawal by Subject|0|||
149760200|NCT00833248|540251035|FG001|Overall Study|Withdrawal by Subject|1|||
149760201|NCT01030458|540251036|FG000|Overall Study|Lost to Follow-up|9|||
149760202|NCT01030458|540251037|FG001|Overall Study|Lost to Follow-up|10|||
149760203|NCT01030458|540251036|FG000|Overall Study|Withdrawal by Subject|2|||
149760204|NCT01030458|540251037|FG001|Overall Study|Withdrawal by Subject|3|||
149760205|NCT01030458|540251036|FG000|Overall Study|Logistical reasons|9|||
149760206|NCT01030458|540251037|FG001|Overall Study|Logistical reasons|5|||
149760207|NCT01030458|540251036|FG000|Overall Study|Moved or changed job|6|||
149760208|NCT01030458|540251037|FG001|Overall Study|Moved or changed job|13|||
149760209|NCT01030458|540251036|FG000|Overall Study|Side effect of medication|1|||
149760210|NCT01030458|540251037|FG001|Overall Study|Side effect of medication|1|||
149760211|NCT00411788|540251040|FG000|Overall Study|Protocol Violation|1|||
149760212|NCT00411788|540251040|FG000|Overall Study|Adverse Event|1|||
149760213|NCT00995345|540251042|FG000|Overall Study|Withdrawal by Subject|4|||
149760214|NCT00995345|540251043|FG001|Overall Study|Withdrawal by Subject|2|||
149760215|NCT00995345|540251044|FG002|Overall Study|Withdrawal by Subject|1|||
149760216|NCT00995345|540251045|FG003|Overall Study|Withdrawal by Subject|3|||
149760217|NCT00995345|540251046|FG004|Overall Study|Withdrawal by Subject|1|||
149760218|NCT00995345|540251042|FG000|Overall Study|Adverse Event|3|||
149760219|NCT00995345|540251043|FG001|Overall Study|Adverse Event|1|||
149760220|NCT00995345|540251044|FG002|Overall Study|Adverse Event|2|||
149760221|NCT00995345|540251045|FG003|Overall Study|Adverse Event|0|||
149760222|NCT00995345|540251046|FG004|Overall Study|Adverse Event|1|||
149760223|NCT00995345|540251042|FG000|Overall Study|Lost to Follow-up|2|||
149760224|NCT00995345|540251043|FG001|Overall Study|Lost to Follow-up|2|||
149760225|NCT00995345|540251044|FG002|Overall Study|Lost to Follow-up|2|||
149760226|NCT00995345|540251045|FG003|Overall Study|Lost to Follow-up|1|||
149760227|NCT00995345|540251046|FG004|Overall Study|Lost to Follow-up|0|||
149760228|NCT00995345|540251042|FG000|Overall Study|all other reasons combined|2|||
149760229|NCT00995345|540251043|FG001|Overall Study|all other reasons combined|2|||
149760230|NCT00995345|540251044|FG002|Overall Study|all other reasons combined|2|||
149760231|NCT00995345|540251045|FG003|Overall Study|all other reasons combined|1|||
149760232|NCT00995345|540251046|FG004|Overall Study|all other reasons combined|3|||
149760233|NCT05122650|540251047|FG000|Overall Study|Adverse Event|4|||
149760234|NCT05122650|540251048|FG001|Overall Study|Adverse Event|16|||
149760235|NCT05122650|540251049|FG002|Overall Study|Adverse Event|11|||
149760236|NCT05122650|540251050|FG003|Overall Study|Adverse Event|12|||
149760237|NCT05122650|540251047|FG000|Overall Study|Lack of Efficacy|0|||
149760238|NCT05122650|540251048|FG001|Overall Study|Lack of Efficacy|1|||
149760239|NCT05122650|540251049|FG002|Overall Study|Lack of Efficacy|1|||
149760240|NCT05122650|540251050|FG003|Overall Study|Lack of Efficacy|2|||
149760241|NCT05122650|540251047|FG000|Overall Study|Lost to Follow-up|1|||
149760242|NCT05122650|540251048|FG001|Overall Study|Lost to Follow-up|1|||
149760243|NCT05122650|540251049|FG002|Overall Study|Lost to Follow-up|3|||
149760244|NCT05122650|540251050|FG003|Overall Study|Lost to Follow-up|0|||
149760245|NCT05122650|540251047|FG000|Overall Study|Non-compliance with study intervention|0|||
149760246|NCT05122650|540251048|FG001|Overall Study|Non-compliance with study intervention|0|||
149760247|NCT05122650|540251049|FG002|Overall Study|Non-compliance with study intervention|0|||
149760248|NCT05122650|540251050|FG003|Overall Study|Non-compliance with study intervention|2|||
149760249|NCT05122650|540251047|FG000|Overall Study|Protocol Violation|0|||
149760250|NCT05122650|540251048|FG001|Overall Study|Protocol Violation|1|||
149760251|NCT05122650|540251049|FG002|Overall Study|Protocol Violation|0|||
149760252|NCT05122650|540251050|FG003|Overall Study|Protocol Violation|1|||
149760253|NCT05122650|540251047|FG000|Overall Study|Randomized by mistake|0|||
149760254|NCT05122650|540251048|FG001|Overall Study|Randomized by mistake|0|||
149760255|NCT05122650|540251049|FG002|Overall Study|Randomized by mistake|3|||
149760256|NCT05122650|540251050|FG003|Overall Study|Randomized by mistake|2|||
149760257|NCT05122650|540251047|FG000|Overall Study|Sponsor request|0|||
149760258|NCT05122650|540251048|FG001|Overall Study|Sponsor request|1|||
149760259|NCT05122650|540251049|FG002|Overall Study|Sponsor request|1|||
149760260|NCT05122650|540251050|FG003|Overall Study|Sponsor request|2|||
149760261|NCT05122650|540251047|FG000|Overall Study|Withdrawal by Subject|3|||
149760262|NCT05122650|540251048|FG001|Overall Study|Withdrawal by Subject|7|||
149760263|NCT05122650|540251049|FG002|Overall Study|Withdrawal by Subject|4|||
149760264|NCT05122650|540251050|FG003|Overall Study|Withdrawal by Subject|8|||
149760265|NCT05122650|540251047|FG000|Overall Study|Other|5|||
149760266|NCT05122650|540251048|FG001|Overall Study|Other|0|||
149760267|NCT05122650|540251049|FG002|Overall Study|Other|0|||
149760268|NCT05122650|540251050|FG003|Overall Study|Other|0|||
149760269|NCT00830037|540251054|FG000|Overall Study|Withdrawal by Subject|2|||
149760270|NCT00830037|540251055|FG001|Overall Study|Withdrawal by Subject|3|||
149760271|NCT00830037|540251054|FG000|Overall Study|Lost to Follow-up|1|||
149760272|NCT00830037|540251055|FG001|Overall Study|Lost to Follow-up|2|||
149760273|NCT00830037|540251054|FG000|Overall Study|Active when terminated by DSMB|15|||
149760274|NCT00830037|540251055|FG001|Overall Study|Active when terminated by DSMB|14|||
149760275|NCT03280550|540251062|FG000|Overall Study|Withdrawal by Subject|2|||
149760276|NCT03280550|540251063|FG001|Overall Study|Withdrawal by Subject|2|||
149760277|NCT03280550|540251062|FG000|Overall Study|Physician Decision|0|||
149760278|NCT03280550|540251063|FG001|Overall Study|Physician Decision|1|||
149760279|NCT00222729|540251068|FG000|Overall Study|Adverse Event|3|||
149760280|NCT02775864|540251069|FG000|Overall Study|Data ended end of 2010|1764|||
149760281|NCT02775864|540251070|FG001|Overall Study|Data ended end of 2010|2880|||
149760282|NCT02775864|540251071|FG002|Overall Study|Data ended end of 2010|1140|||
149760283|NCT02775864|540251072|FG003|Overall Study|Data ended end of 2010|1194|||
149760284|NCT02775864|540251069|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
149760285|NCT02775864|540251070|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
149760286|NCT02775864|540251071|FG002|Overall Study|Medicaid eligibility discontinued|720|||
149760287|NCT02775864|540251072|FG003|Overall Study|Medicaid eligibility discontinued|890|||
149760288|NCT02028338|540251073|FG000|Overall Study|Withdrawal by Subject|3|||
149760289|NCT02028338|540251074|FG001|Overall Study|Withdrawal by Subject|1|||
149760290|NCT02028338|540251073|FG000|Overall Study|Unable to contact participant|1|||
149760291|NCT02028338|540251074|FG001|Overall Study|Unable to contact participant|0|||
149760292|NCT00256867|540251079|FG000|Overall Study|Adverse Event|0|||
149760293|NCT00256867|540251080|FG001|Overall Study|Adverse Event|1|||
149760294|NCT00256867|540251081|FG002|Overall Study|Adverse Event|1|||
149760295|NCT00256867|540251082|FG003|Overall Study|Adverse Event|1|||
149760296|NCT00256867|540251083|FG004|Overall Study|Adverse Event|2|||
149760297|NCT00256867|540251084|FG005|Overall Study|Adverse Event|2|||
149760298|NCT00256867|540251085|FG006|Overall Study|Adverse Event|1|||
149760299|NCT00256867|540251086|FG007|Overall Study|Adverse Event|4|||
149760300|NCT00256867|540251079|FG000|Overall Study|Lost to Follow-up|2|||
149760301|NCT00256867|540251080|FG001|Overall Study|Lost to Follow-up|2|||
149760302|NCT00256867|540251081|FG002|Overall Study|Lost to Follow-up|2|||
149760303|NCT00256867|540251082|FG003|Overall Study|Lost to Follow-up|3|||
149760304|NCT00256867|540251083|FG004|Overall Study|Lost to Follow-up|2|||
149760305|NCT00256867|540251084|FG005|Overall Study|Lost to Follow-up|0|||
149760306|NCT00256867|540251085|FG006|Overall Study|Lost to Follow-up|1|||
149760307|NCT00256867|540251086|FG007|Overall Study|Lost to Follow-up|2|||
149760308|NCT00256867|540251079|FG000|Overall Study|Protocol Violation|0|||
149760309|NCT00256867|540251080|FG001|Overall Study|Protocol Violation|0|||
149760310|NCT00256867|540251081|FG002|Overall Study|Protocol Violation|0|||
149760311|NCT00256867|540251082|FG003|Overall Study|Protocol Violation|1|||
149760312|NCT00256867|540251083|FG004|Overall Study|Protocol Violation|0|||
149760313|NCT00256867|540251084|FG005|Overall Study|Protocol Violation|1|||
149760314|NCT00256867|540251085|FG006|Overall Study|Protocol Violation|0|||
149760315|NCT00256867|540251086|FG007|Overall Study|Protocol Violation|1|||
149760316|NCT00256867|540251079|FG000|Overall Study|Withdrawal by Subject|0|||
149760317|NCT00256867|540251080|FG001|Overall Study|Withdrawal by Subject|0|||
149760318|NCT00256867|540251081|FG002|Overall Study|Withdrawal by Subject|1|||
149760319|NCT00256867|540251082|FG003|Overall Study|Withdrawal by Subject|1|||
149760320|NCT00256867|540251083|FG004|Overall Study|Withdrawal by Subject|2|||
149760321|NCT00256867|540251084|FG005|Overall Study|Withdrawal by Subject|2|||
149760322|NCT00256867|540251085|FG006|Overall Study|Withdrawal by Subject|3|||
149760323|NCT00256867|540251086|FG007|Overall Study|Withdrawal by Subject|2|||
149760324|NCT00256867|540251079|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760325|NCT00256867|540251080|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
149760326|NCT00256867|540251081|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760327|NCT00256867|540251082|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760328|NCT00256867|540251083|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760329|NCT00256867|540251084|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760330|NCT00256867|540251085|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760331|NCT00256867|540251086|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149760332|NCT00256867|540251079|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760333|NCT00256867|540251080|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760334|NCT00256867|540251081|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760335|NCT00256867|540251082|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760336|NCT00256867|540251083|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760337|NCT00256867|540251084|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760338|NCT00256867|540251085|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149760339|NCT00256867|540251086|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
149760340|NCT00256867|540251079|FG000|Overall Study|Investigator's Decision|0|||
149760341|NCT00256867|540251080|FG001|Overall Study|Investigator's Decision|0|||
149760342|NCT00256867|540251081|FG002|Overall Study|Investigator's Decision|0|||
149760343|NCT00256867|540251082|FG003|Overall Study|Investigator's Decision|0|||
149760344|NCT00256867|540251083|FG004|Overall Study|Investigator's Decision|1|||
149760345|NCT00256867|540251084|FG005|Overall Study|Investigator's Decision|0|||
149760346|NCT00256867|540251085|FG006|Overall Study|Investigator's Decision|0|||
149760347|NCT00256867|540251086|FG007|Overall Study|Investigator's Decision|0|||
149760348|NCT00256867|540251079|FG000|Overall Study|Non-compliance with study medication|0|||
149760349|NCT00256867|540251080|FG001|Overall Study|Non-compliance with study medication|0|||
149760350|NCT00256867|540251081|FG002|Overall Study|Non-compliance with study medication|0|||
149760351|NCT00256867|540251082|FG003|Overall Study|Non-compliance with study medication|0|||
149760352|NCT00256867|540251083|FG004|Overall Study|Non-compliance with study medication|0|||
149760353|NCT00256867|540251084|FG005|Overall Study|Non-compliance with study medication|0|||
149760354|NCT00256867|540251085|FG006|Overall Study|Non-compliance with study medication|0|||
149760355|NCT00256867|540251086|FG007|Overall Study|Non-compliance with study medication|1|||
149760356|NCT00256867|540251079|FG000|Overall Study|Participant travelled Overseas|0|||
149760357|NCT00256867|540251080|FG001|Overall Study|Participant travelled Overseas|1|||
149760358|NCT00256867|540251081|FG002|Overall Study|Participant travelled Overseas|0|||
149760359|NCT00256867|540251082|FG003|Overall Study|Participant travelled Overseas|0|||
149760360|NCT00256867|540251083|FG004|Overall Study|Participant travelled Overseas|0|||
149760361|NCT00256867|540251084|FG005|Overall Study|Participant travelled Overseas|0|||
149760362|NCT00256867|540251085|FG006|Overall Study|Participant travelled Overseas|0|||
149760363|NCT00256867|540251086|FG007|Overall Study|Participant travelled Overseas|0|||
149760364|NCT00256867|540251079|FG000|Overall Study|Participant out of assessment window|0|||
149760365|NCT00256867|540251080|FG001|Overall Study|Participant out of assessment window|0|||
149760366|NCT00256867|540251081|FG002|Overall Study|Participant out of assessment window|1|||
149760367|NCT00256867|540251082|FG003|Overall Study|Participant out of assessment window|0|||
149760368|NCT00256867|540251083|FG004|Overall Study|Participant out of assessment window|0|||
149760369|NCT00256867|540251084|FG005|Overall Study|Participant out of assessment window|0|||
149760370|NCT00256867|540251085|FG006|Overall Study|Participant out of assessment window|0|||
149760371|NCT00256867|540251086|FG007|Overall Study|Participant out of assessment window|0|||
149760372|NCT00256867|540251079|FG000|Overall Study|Withdrawal by participant|0|||
149760373|NCT00256867|540251080|FG001|Overall Study|Withdrawal by participant|0|||
149760374|NCT00256867|540251081|FG002|Overall Study|Withdrawal by participant|0|||
149760375|NCT00256867|540251082|FG003|Overall Study|Withdrawal by participant|0|||
149760376|NCT00256867|540251083|FG004|Overall Study|Withdrawal by participant|0|||
149760377|NCT00256867|540251084|FG005|Overall Study|Withdrawal by participant|1|||
149760378|NCT00256867|540251085|FG006|Overall Study|Withdrawal by participant|0|||
149760379|NCT00256867|540251086|FG007|Overall Study|Withdrawal by participant|0|||
149760380|NCT00527111|540251091|FG000|Overall Study|Adverse Event|14|||
149760381|NCT00527111|540251092|FG001|Overall Study|Adverse Event|13|||
149760382|NCT00527111|540251091|FG000|Overall Study|Death|0|||
149760383|NCT00527111|540251092|FG001|Overall Study|Death|1|||
149760384|NCT00527111|540251091|FG000|Overall Study|Investigator Request|2|||
149760385|NCT00527111|540251092|FG001|Overall Study|Investigator Request|1|||
149760386|NCT00527111|540251091|FG000|Overall Study|Patient Request|2|||
149760387|NCT00527111|540251092|FG001|Overall Study|Patient Request|5|||
149760388|NCT00527111|540251091|FG000|Overall Study|Other|2|||
149760389|NCT00527111|540251092|FG001|Overall Study|Other|2|||
149760390|NCT02993224|540251093|FG000|Core Phase - Period 1|Adverse Event|4|||
149760391|NCT02993224|540251093|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
149760392|NCT02993224|540251093|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
149760393|NCT02993224|540251093|FG000|Core Phase- Period 2|Adverse Event|1|||
149760394|NCT02993224|540251093|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
149760395|NCT02993224|540251093|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
149760396|NCT02993224|540251093|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
149760397|NCT02993224|540251093|FG000|Extension Phase|Adverse Event|3|||
149760398|NCT02993224|540251093|FG000|Extension Phase|Withdrawal by Subject|3|||
149760399|NCT02993224|540251093|FG000|Extension Phase|Lost to Follow-up|2|||
149760400|NCT02993224|540251093|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
149760401|NCT01930799|540251094|FG000|Overall Study|Withdrawal by Subject|3|||
149760402|NCT01930799|540251094|FG000|Overall Study|Lost to Follow-up|5|||
149760403|NCT00875017|540251097|FG000|First Intervention|Withdrawal by Subject|1|||
149760404|NCT00875017|540251098|FG001|First Intervention|Withdrawal by Subject|0|||
149760405|NCT00875017|540251099|FG002|First Intervention|Withdrawal by Subject|1|||
149760406|NCT00875017|540251100|FG003|First Intervention|Withdrawal by Subject|0|||
149760407|NCT00875017|540251101|FG004|First Intervention|Withdrawal by Subject|0|||
149760408|NCT00875017|540251102|FG005|First Intervention|Withdrawal by Subject|0|||
149760409|NCT00875017|540251097|FG000|First Intervention|Adverse Event|0|||
149760410|NCT00875017|540251098|FG001|First Intervention|Adverse Event|0|||
149760411|NCT00875017|540251099|FG002|First Intervention|Adverse Event|0|||
149760412|NCT00875017|540251100|FG003|First Intervention|Adverse Event|1|||
149760413|NCT00875017|540251101|FG004|First Intervention|Adverse Event|0|||
149760414|NCT00875017|540251102|FG005|First Intervention|Adverse Event|0|||
149760415|NCT00875017|540251097|FG000|First Intervention|Problems collecting rectal effluent|1|||
149760416|NCT00875017|540251098|FG001|First Intervention|Problems collecting rectal effluent|0|||
149760417|NCT00875017|540251099|FG002|First Intervention|Problems collecting rectal effluent|0|||
149760418|NCT00875017|540251100|FG003|First Intervention|Problems collecting rectal effluent|0|||
149760419|NCT00875017|540251101|FG004|First Intervention|Problems collecting rectal effluent|0|||
149760420|NCT00875017|540251102|FG005|First Intervention|Problems collecting rectal effluent|0|||
149760421|NCT00875017|540251097|FG000|First Intervention|Intolerance to nasogastric tube|0|||
149760422|NCT00875017|540251098|FG001|First Intervention|Intolerance to nasogastric tube|0|||
149760423|NCT00875017|540251099|FG002|First Intervention|Intolerance to nasogastric tube|0|||
149760424|NCT00875017|540251100|FG003|First Intervention|Intolerance to nasogastric tube|0|||
149760425|NCT00875017|540251101|FG004|First Intervention|Intolerance to nasogastric tube|1|||
149760426|NCT00875017|540251102|FG005|First Intervention|Intolerance to nasogastric tube|0|||
149760427|NCT00875017|540251097|FG000|Washout|Problem collecting rectal effluent|0|||
149760428|NCT00875017|540251098|FG001|Washout|Problem collecting rectal effluent|0|||
149760429|NCT00875017|540251099|FG002|Washout|Problem collecting rectal effluent|1|||
149760430|NCT00875017|540251100|FG003|Washout|Problem collecting rectal effluent|0|||
149760431|NCT00875017|540251101|FG004|Washout|Problem collecting rectal effluent|0|||
149760432|NCT00875017|540251102|FG005|Washout|Problem collecting rectal effluent|0|||
149760433|NCT00875017|540251097|FG000|Second Intervention|Adverse Event|0|||
149760434|NCT00875017|540251098|FG001|Second Intervention|Adverse Event|0|||
149760435|NCT00875017|540251099|FG002|Second Intervention|Adverse Event|0|||
149760436|NCT00875017|540251100|FG003|Second Intervention|Adverse Event|1|||
149760437|NCT00875017|540251101|FG004|Second Intervention|Adverse Event|0|||
149760438|NCT00875017|540251102|FG005|Second Intervention|Adverse Event|0|||
149760439|NCT00875017|540251097|FG000|Washout|Problems collecting rectal effluent|0|||
149760440|NCT00875017|540251098|FG001|Washout|Problems collecting rectal effluent|1|||
149760441|NCT00875017|540251099|FG002|Washout|Problems collecting rectal effluent|0|||
149760442|NCT00875017|540251100|FG003|Washout|Problems collecting rectal effluent|0|||
149760443|NCT00875017|540251101|FG004|Washout|Problems collecting rectal effluent|0|||
149760444|NCT00875017|540251102|FG005|Washout|Problems collecting rectal effluent|0|||
149760445|NCT00875017|540251097|FG000|Third Intervention|Adverse Event|0|||
149760446|NCT00875017|540251098|FG001|Third Intervention|Adverse Event|1|||
149760447|NCT00875017|540251099|FG002|Third Intervention|Adverse Event|1|||
149760448|NCT00875017|540251100|FG003|Third Intervention|Adverse Event|0|||
149760449|NCT00875017|540251101|FG004|Third Intervention|Adverse Event|0|||
149760450|NCT00875017|540251102|FG005|Third Intervention|Adverse Event|0|||
149760451|NCT00875017|540251097|FG000|Washout|Withdrawal by Subject|0|||
149760452|NCT00875017|540251098|FG001|Washout|Withdrawal by Subject|0|||
149760453|NCT00875017|540251099|FG002|Washout|Withdrawal by Subject|0|||
149760454|NCT00875017|540251100|FG003|Washout|Withdrawal by Subject|0|||
149760455|NCT00875017|540251101|FG004|Washout|Withdrawal by Subject|1|||
149760456|NCT00875017|540251102|FG005|Washout|Withdrawal by Subject|0|||
149760457|NCT00875017|540251097|FG000|Fourth Intervention|Inability to comply with fasting|0|||
149760458|NCT00875017|540251098|FG001|Fourth Intervention|Inability to comply with fasting|0|||
149760459|NCT00875017|540251099|FG002|Fourth Intervention|Inability to comply with fasting|0|||
149760460|NCT00875017|540251100|FG003|Fourth Intervention|Inability to comply with fasting|0|||
149760461|NCT00875017|540251101|FG004|Fourth Intervention|Inability to comply with fasting|0|||
149760462|NCT00875017|540251102|FG005|Fourth Intervention|Inability to comply with fasting|1|||
149760463|NCT02689219|540251103|FG000|Overall Study|Death|1|||
149760464|NCT02689219|540251104|FG001|Overall Study|Death|1|||
149760465|NCT02689219|540251103|FG000|Overall Study|Disease Progression|10|||
149760466|NCT02689219|540251104|FG001|Overall Study|Disease Progression|6|||
149760467|NCT03342469|540251105|FG000|Overall Study|Withdrawal by Subject|0|||
149760468|NCT03342469|540251106|FG001|Overall Study|Withdrawal by Subject|1|||
149760469|NCT03342469|540251107|FG002|Overall Study|Withdrawal by Subject|0|||
149760470|NCT03342469|540251108|FG003|Overall Study|Withdrawal by Subject|0|||
149760471|NCT01477892|540251109|FG000|Overall Study|Withdrawal by Subject|0|||
149760472|NCT01477892|540251110|FG001|Overall Study|Withdrawal by Subject|2|||
149760473|NCT01921257|540251112|FG000|Overall Study|Adverse Event|1|||
149760474|NCT01921257|540251112|FG000|Overall Study|Protocol Violation|1|||
149760475|NCT01921257|540251112|FG000|Overall Study|Withdrawal by Subject|1|||
149760476|NCT05515601|540251117|FG000|Overall Study|Withdrawal by Subject|1|||
149760477|NCT05515601|540251118|FG001|Overall Study|Withdrawal by Subject|3|||
149760478|NCT05515601|540251119|FG002|Overall Study|Withdrawal by Subject|2|||
149760479|NCT05515601|540251120|FG003|Overall Study|Withdrawal by Subject|1|||
149760480|NCT05515601|540251121|FG004|Overall Study|Withdrawal by Subject|1|||
149760481|NCT05515601|540251122|FG005|Overall Study|Withdrawal by Subject|1|||
149760482|NCT05515601|540251117|FG000|Overall Study|Lost to Follow-up|0|||
149760483|NCT05515601|540251118|FG001|Overall Study|Lost to Follow-up|0|||
149760484|NCT05515601|540251119|FG002|Overall Study|Lost to Follow-up|0|||
149760485|NCT05515601|540251120|FG003|Overall Study|Lost to Follow-up|0|||
149760486|NCT05515601|540251121|FG004|Overall Study|Lost to Follow-up|1|||
149760487|NCT05515601|540251122|FG005|Overall Study|Lost to Follow-up|0|||
149760488|NCT01689207|540251123|FG000|Overall Study|Adverse Event|0|||
149760489|NCT01689207|540251124|FG001|Overall Study|Adverse Event|1|||
149760490|NCT01689207|540251125|FG002|Overall Study|Adverse Event|0|||
149760491|NCT01689207|540251126|FG003|Overall Study|Adverse Event|0|||
149760492|NCT01689207|540251127|FG004|Overall Study|Adverse Event|2|||
149760493|NCT01689207|540251128|FG005|Overall Study|Adverse Event|1|||
149760494|NCT01689207|540251129|FG006|Overall Study|Adverse Event|0|||
149760495|NCT01689207|540251130|FG007|Overall Study|Adverse Event|0|||
149760496|NCT01689207|540251131|FG008|Overall Study|Adverse Event|1|||
149760497|NCT01689207|540251132|FG009|Overall Study|Adverse Event|0|||
149760498|NCT01689207|540251133|FG010|Overall Study|Adverse Event|0|||
149760499|NCT01912768|540251134|FG000|Overall Study|Adverse Event|2|||
149760500|NCT01912768|540251135|FG001|Overall Study|Adverse Event|0|||
149760501|NCT01912768|540251134|FG000|Overall Study|Lost to Follow-up|2|||
149760502|NCT01912768|540251135|FG001|Overall Study|Lost to Follow-up|1|||
149760503|NCT01912768|540251134|FG000|Overall Study|Withdrawal by Subject|5|||
149760504|NCT01912768|540251135|FG001|Overall Study|Withdrawal by Subject|3|||
149760505|NCT01912768|540251134|FG000|Overall Study|Randomized in error|1|||
149760506|NCT01912768|540251135|FG001|Overall Study|Randomized in error|0|||
149760507|NCT02426658|540251138|FG000|Overall Study|Withdrawal by Subject|1|||
149760508|NCT02426658|540251138|FG000|Overall Study|Patient expired before treatment|2|||
149760509|NCT00524316|540251139|FG000|Overall Study|Withdrawal by Subject|2|||
149760510|NCT00524316|540251139|FG000|Overall Study|Adverse Event|7|||
149760511|NCT00524316|540251139|FG000|Overall Study|Disease Progression|7|||
149760512|NCT01199263|540251140|FG000|Overall Study|Ineligible|0|||
149760513|NCT01199263|540251141|FG001|Overall Study|Ineligible|2|||
149760514|NCT01199263|540251140|FG000|Overall Study|Never Treated|6|||
149760515|NCT01199263|540251141|FG001|Overall Study|Never Treated|0|||
149760516|NCT00634244|540251142|FG000|Overall Study|Never started treatment|0|||
149760517|NCT00634244|540251143|FG001|Overall Study|Never started treatment|1|||
149760518|NCT00634244|540251144|FG002|Overall Study|Never started treatment|0|||
149760519|NCT00634244|540251142|FG000|Overall Study|Death|1|||
149760520|NCT00634244|540251143|FG001|Overall Study|Death|6|||
149760521|NCT00634244|540251144|FG002|Overall Study|Death|0|||
149760522|NCT00634244|540251142|FG000|Overall Study|Adverse Event|0|||
149760523|NCT00634244|540251143|FG001|Overall Study|Adverse Event|2|||
149760524|NCT00634244|540251144|FG002|Overall Study|Adverse Event|0|||
149760525|NCT00634244|540251142|FG000|Overall Study|Withdrawal by Subject|0|||
149760526|NCT00634244|540251143|FG001|Overall Study|Withdrawal by Subject|1|||
149760527|NCT00634244|540251144|FG002|Overall Study|Withdrawal by Subject|0|||
149760528|NCT00634244|540251142|FG000|Overall Study|Physician Decision|0|||
149760529|NCT00634244|540251143|FG001|Overall Study|Physician Decision|1|||
149760530|NCT00634244|540251144|FG002|Overall Study|Physician Decision|0|||
149760531|NCT00634244|540251142|FG000|Overall Study|Disease progression/relapse|0|||
149760532|NCT00634244|540251143|FG001|Overall Study|Disease progression/relapse|1|||
149760533|NCT00634244|540251144|FG002|Overall Study|Disease progression/relapse|0|||
149760534|NCT00634244|540251142|FG000|Overall Study|Other complicating disease|0|||
149760535|NCT00634244|540251143|FG001|Overall Study|Other complicating disease|1|||
149760536|NCT00634244|540251144|FG002|Overall Study|Other complicating disease|0|||
149760537|NCT03453151|540251149|FG000|Overall Study|Withdrawal by Subject|1|||
149760538|NCT03453151|540251149|FG000|Overall Study|Physician Decision|3|||
149760539|NCT01204658|540251155|FG000|Primary Phase|Adverse Event|0|||
149760540|NCT01204658|540251156|FG001|Primary Phase|Adverse Event|0|||
149760541|NCT01204658|540251157|FG002|Primary Phase|Adverse Event|1|||
149760542|NCT01204658|540251158|FG003|Primary Phase|Adverse Event|0|||
149760543|NCT04594239|540251159|FG000|Overall Study|Withdrawal by Subject|3|||
149760544|NCT04594239|540251160|FG001|Overall Study|Withdrawal by Subject|4|||
149760545|NCT04594239|540251161|FG002|Overall Study|Withdrawal by Subject|2|||
149760546|NCT04594239|540251162|FG003|Overall Study|Withdrawal by Subject|4|||
149760547|NCT04594239|540251159|FG000|Overall Study|Lost to Follow-up|8|||
149760548|NCT04594239|540251160|FG001|Overall Study|Lost to Follow-up|5|||
149760549|NCT04594239|540251161|FG002|Overall Study|Lost to Follow-up|4|||
149760550|NCT04594239|540251162|FG003|Overall Study|Lost to Follow-up|6|||
149760551|NCT04594239|540251159|FG000|Overall Study|Subject relocated|0|||
149760552|NCT04594239|540251160|FG001|Overall Study|Subject relocated|0|||
149760553|NCT04594239|540251161|FG002|Overall Study|Subject relocated|0|||
149760554|NCT04594239|540251162|FG003|Overall Study|Subject relocated|1|||
149760555|NCT02678780|540251165|FG000|Overall Study|Adverse Event|11|||
149760556|NCT02678780|540251166|FG001|Overall Study|Adverse Event|14|||
149760557|NCT02678780|540251165|FG000|Overall Study|Withdrawal by Subject|2|||
149760558|NCT02678780|540251166|FG001|Overall Study|Withdrawal by Subject|1|||
149760559|NCT02678780|540251165|FG000|Overall Study|Sponsor discontinuation|7|||
149760560|NCT02678780|540251166|FG001|Overall Study|Sponsor discontinuation|4|||
149760561|NCT02678780|540251165|FG000|Overall Study|Death|1|||
149760562|NCT02678780|540251166|FG001|Overall Study|Death|1|||
149760563|NCT02678780|540251165|FG000|Overall Study|Other|6|||
149760564|NCT02678780|540251166|FG001|Overall Study|Other|8|||
149760565|NCT00091390|540251180|FG000|Overall Study|Protocol Violation|1|||
149760566|NCT00091390|540251180|FG000|Overall Study|No protocol treatment|3|||
149760567|NCT00406640|540251185|FG000|Acute Phase|Adverse Event|18|||
149760568|NCT00406640|540251186|FG001|Acute Phase|Adverse Event|13|||
149760569|NCT00406640|540251185|FG000|Acute Phase|Failed to Return|5|||
149760570|NCT00406640|540251186|FG001|Acute Phase|Failed to Return|1|||
149760571|NCT00406640|540251185|FG000|Acute Phase|Physician Decision|0|||
149760572|NCT00406640|540251186|FG001|Acute Phase|Physician Decision|1|||
149760573|NCT00406640|540251185|FG000|Acute Phase|Lost to Follow-up|7|||
149760574|NCT00406640|540251186|FG001|Acute Phase|Lost to Follow-up|4|||
149760575|NCT00406640|540251185|FG000|Acute Phase|Protocol deviation|4|||
149760576|NCT00406640|540251186|FG001|Acute Phase|Protocol deviation|10|||
149760577|NCT00406640|540251185|FG000|Acute Phase|Protocol Violation|3|||
149760578|NCT00406640|540251186|FG001|Acute Phase|Protocol Violation|2|||
149760579|NCT00406640|540251185|FG000|Acute Phase|Withdrawal by Subject|11|||
149760580|NCT00406640|540251186|FG001|Acute Phase|Withdrawal by Subject|9|||
149760581|NCT00406640|540251185|FG000|Acute Phase|Lack of Efficacy|3|||
149760582|NCT00406640|540251186|FG001|Acute Phase|Lack of Efficacy|3|||
149760583|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
149760584|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
149760585|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Death|1|||
149760586|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Death|0|||
149760587|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
149760588|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
149760589|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
149760590|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
149760591|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
149760592|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
149760593|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|non-compliance|7|||
149760594|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|non-compliance|5|||
149760595|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
149760596|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
149760597|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
149760598|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
149760599|NCT00406640|540251185|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
149760600|NCT00406640|540251186|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
149760601|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
149760602|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
149760603|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
149760604|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
149760605|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
149760606|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
149760607|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
149760608|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
149760609|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
149760610|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
149760611|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
149760612|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
149760613|NCT00406640|540251185|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
149760614|NCT00406640|540251186|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
149760615|NCT03050359|540252595|FG000|Overall Study|Randomized But Not Treated|2|||
149760616|NCT03050359|540252596|FG001|Overall Study|Randomized But Not Treated|0|||
149760617|NCT03050359|540252595|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
149760618|NCT03050359|540252596|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
149760619|NCT03050359|540252595|FG000|Overall Study|Significant Protocol Deviation|2|||
149760620|NCT03050359|540252596|FG001|Overall Study|Significant Protocol Deviation|3|||
149760621|NCT03050359|540252595|FG000|Overall Study|Lost to Follow-up|2|||
149760622|NCT03050359|540252596|FG001|Overall Study|Lost to Follow-up|1|||
149760623|NCT03050359|540252595|FG000|Overall Study|Voluntary Withdrawal|4|||
149760624|NCT03050359|540252596|FG001|Overall Study|Voluntary Withdrawal|6|||
149760625|NCT03050359|540252595|FG000|Overall Study|Pregnancy|1|||
149760626|NCT03050359|540252596|FG001|Overall Study|Pregnancy|0|||
149760627|NCT03050359|540252595|FG000|Overall Study|Reason Not Specified|1|||
149760628|NCT03050359|540252596|FG001|Overall Study|Reason Not Specified|0|||
149760629|NCT02020031|540252597|FG000|Overall Study|Physician Decision|1|||
149760630|NCT02020031|540252598|FG001|Overall Study|Physician Decision|1|||
149760631|NCT01592409|540252603|FG000|Overall Study|Withdrawal by Subject|0|||
149760632|NCT01592409|540252604|FG001|Overall Study|Withdrawal by Subject|1|||
149760633|NCT01728584|540252605|FG000|Overall Study|Adverse Event|1|||
149760634|NCT01728584|540252606|FG001|Overall Study|Adverse Event|0|||
149760635|NCT01728584|540252607|FG002|Overall Study|Adverse Event|0|||
149760636|NCT01728584|540252608|FG003|Overall Study|Adverse Event|0|||
149760637|NCT01728584|540252605|FG000|Overall Study|Physician Decision|4|||
149760638|NCT01728584|540252606|FG001|Overall Study|Physician Decision|0|||
149760639|NCT01728584|540252607|FG002|Overall Study|Physician Decision|1|||
149760640|NCT01728584|540252608|FG003|Overall Study|Physician Decision|0|||
149760641|NCT01728584|540252605|FG000|Overall Study|Withdrawal by Subject|1|||
149760642|NCT01728584|540252606|FG001|Overall Study|Withdrawal by Subject|0|||
149760643|NCT01728584|540252607|FG002|Overall Study|Withdrawal by Subject|0|||
149760644|NCT01728584|540252608|FG003|Overall Study|Withdrawal by Subject|0|||
149760645|NCT01728584|540252605|FG000|Overall Study|Screen failure|1|||
149760646|NCT01728584|540252606|FG001|Overall Study|Screen failure|0|||
149760647|NCT01728584|540252607|FG002|Overall Study|Screen failure|0|||
149760648|NCT01728584|540252608|FG003|Overall Study|Screen failure|0|||
149760649|NCT01728584|540252605|FG000|Overall Study|Other reason (not specified)|1|||
149760650|NCT01728584|540252606|FG001|Overall Study|Other reason (not specified)|0|||
149760651|NCT01728584|540252607|FG002|Overall Study|Other reason (not specified)|0|||
149760652|NCT01728584|540252608|FG003|Overall Study|Other reason (not specified)|1|||
149760653|NCT00471536|540252615|FG000|Overall Study|Withdrawal by Subject|1|||
149760654|NCT02651194|540252616|FG000|Overall Study|Lost to Follow-up|3|||
149760655|NCT02651194|540252616|FG000|Overall Study|Other|2|||
149760656|NCT01980706|540252619|FG000|Overall Study|Withdrawal by Subject|9|||
149760657|NCT01980706|540252620|FG001|Overall Study|Withdrawal by Subject|6|||
149760658|NCT01980706|540252621|FG002|Overall Study|Withdrawal by Subject|2|||
149760659|NCT01980706|540252619|FG000|Overall Study|Adverse Event|1|||
149760660|NCT01980706|540252620|FG001|Overall Study|Adverse Event|2|||
149760661|NCT01980706|540252621|FG002|Overall Study|Adverse Event|5|||
149760662|NCT01980706|540252619|FG000|Overall Study|Lost to Follow-up|3|||
149760663|NCT01980706|540252620|FG001|Overall Study|Lost to Follow-up|4|||
149760664|NCT01980706|540252621|FG002|Overall Study|Lost to Follow-up|3|||
149760665|NCT01980706|540252619|FG000|Overall Study|miscellaneous|4|||
149760666|NCT01980706|540252620|FG001|Overall Study|miscellaneous|5|||
149760667|NCT01980706|540252621|FG002|Overall Study|miscellaneous|3|||
149760668|NCT02546674|540252622|FG000|Overall Study|Adverse Event|19|||
149760669|NCT02546674|540252622|FG000|Overall Study|Death|1|||
149760670|NCT02546674|540252622|FG000|Overall Study|Lost to Follow-up|1|||
149760671|NCT02546674|540252622|FG000|Overall Study|Physician Decision|13|||
149760672|NCT02546674|540252622|FG000|Overall Study|Pregnancy|1|||
149760673|NCT02546674|540252622|FG000|Overall Study|Progressive Disease|2|||
149760674|NCT02546674|540252622|FG000|Overall Study|Protocol Deviation|2|||
149760675|NCT02546674|540252622|FG000|Overall Study|Subject/Guardian Decision|6|||
149760676|NCT02546674|540252622|FG000|Overall Study|Withdrawal of Informed Consent|3|||
149760677|NCT01864018|540252626|FG000|Overall Study|Ineligible|3|||
149760678|NCT01864018|540252627|FG001|Overall Study|Ineligible|1|||
149760679|NCT02509598|540252628|FG000|Overall Study|Withdrawal by Subject|1|||
149760680|NCT04056455|540252630|FG000|Overall Study|Adverse Event|1|||
149760681|NCT04056455|540252631|FG001|Overall Study|Adverse Event|0|||
149760682|NCT02512068|540252632|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
149760683|NCT02512068|540252633|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
149760684|NCT02512068|540252632|FG000|Overall Study|Major Protocol Deviation|1|||
149760685|NCT02512068|540252633|FG001|Overall Study|Major Protocol Deviation|0|||
149760686|NCT02512068|540252632|FG000|Overall Study|Voluntary Withdrawal|0|||
149760687|NCT02512068|540252633|FG001|Overall Study|Voluntary Withdrawal|1|||
149760688|NCT02512068|540252632|FG000|Overall Study|Lack of Efficacy|0|||
149760689|NCT02512068|540252633|FG001|Overall Study|Lack of Efficacy|1|||
149760690|NCT02512068|540252632|FG000|Overall Study|Reason Not Specified|3|||
149760691|NCT02512068|540252633|FG001|Overall Study|Reason Not Specified|5|||
149760692|NCT04891770|540252637|FG000|Overall Study|Withdrew consent|1|||
149760693|NCT04891770|540252638|FG001|Overall Study|Withdrew consent|3|||
149760694|NCT04891770|540252639|FG002|Overall Study|Withdrew consent|0|||
149760695|NCT04891770|540252637|FG000|Overall Study|Enrolled but never treated|0|||
149760696|NCT04891770|540252638|FG001|Overall Study|Enrolled but never treated|0|||
149760697|NCT04891770|540252639|FG002|Overall Study|Enrolled but never treated|1|||
149760698|NCT04891770|540252637|FG000|Overall Study|Investigator's discretion|0|||
149760699|NCT04891770|540252638|FG001|Overall Study|Investigator's discretion|1|||
149760700|NCT04891770|540252639|FG002|Overall Study|Investigator's discretion|0|||
149760701|NCT01401010|540252640|FG000|Overall Study|Could not interpret assay results|1|||
149760702|NCT01401010|540252641|FG001|Overall Study|Could not interpret assay results|0|||
149760703|NCT01952834|540252642|FG000|Overall Study|Adverse Event|1|||
149760704|NCT04360187|540252645|FG000|Double-Blind Treatment|Adverse Event|9|||
149760705|NCT04360187|540252646|FG001|Double-Blind Treatment|Adverse Event|11|||
149760706|NCT04360187|540252645|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
149760707|NCT04360187|540252646|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
149760708|NCT04360187|540252645|FG000|Double-Blind Treatment|Physician Decision|1|||
149760709|NCT04360187|540252646|FG001|Double-Blind Treatment|Physician Decision|0|||
149760710|NCT04360187|540252645|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
149760711|NCT04360187|540252646|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
149760712|NCT04360187|540252645|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
149760713|NCT04360187|540252646|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
149760714|NCT04360187|540252645|FG000|Follow-Up|Lost to Follow-up|1|||
149760715|NCT04360187|540252646|FG001|Follow-Up|Lost to Follow-up|0|||
149760716|NCT02203838|540252652|FG000|Overall Study|Lack of Efficacy|7|||
149760717|NCT02203838|540252653|FG001|Overall Study|Lack of Efficacy|0|||
149760718|NCT02203838|540252654|FG002|Overall Study|Lack of Efficacy|1|||
149760719|NCT02203838|540252655|FG003|Overall Study|Lack of Efficacy|1|||
149760720|NCT02203838|540252652|FG000|Overall Study|Adverse Event|46|||
149760721|NCT02203838|540252653|FG001|Overall Study|Adverse Event|6|||
149760722|NCT02203838|540252654|FG002|Overall Study|Adverse Event|3|||
149760723|NCT02203838|540252655|FG003|Overall Study|Adverse Event|2|||
149760724|NCT02203838|540252652|FG000|Overall Study|Lost to Follow-up|39|||
149760725|NCT02203838|540252653|FG001|Overall Study|Lost to Follow-up|3|||
149760726|NCT02203838|540252654|FG002|Overall Study|Lost to Follow-up|2|||
149760727|NCT02203838|540252655|FG003|Overall Study|Lost to Follow-up|1|||
149760728|NCT02203838|540252652|FG000|Overall Study|Protocol Violation|7|||
149760729|NCT02203838|540252653|FG001|Overall Study|Protocol Violation|3|||
149760730|NCT02203838|540252654|FG002|Overall Study|Protocol Violation|0|||
149760731|NCT02203838|540252655|FG003|Overall Study|Protocol Violation|0|||
149760732|NCT02203838|540252652|FG000|Overall Study|Withdrawal by Subject|83|||
149760733|NCT02203838|540252653|FG001|Overall Study|Withdrawal by Subject|10|||
149760734|NCT02203838|540252654|FG002|Overall Study|Withdrawal by Subject|8|||
149760735|NCT02203838|540252655|FG003|Overall Study|Withdrawal by Subject|11|||
149760736|NCT02203838|540252652|FG000|Overall Study|Physician Decision|27|||
149760737|NCT02203838|540252653|FG001|Overall Study|Physician Decision|0|||
149760738|NCT02203838|540252654|FG002|Overall Study|Physician Decision|2|||
149760739|NCT02203838|540252655|FG003|Overall Study|Physician Decision|3|||
149760740|NCT02203838|540252652|FG000|Overall Study|Other|1|||
149760741|NCT02203838|540252653|FG001|Overall Study|Other|0|||
149760742|NCT02203838|540252654|FG002|Overall Study|Other|0|||
149760743|NCT02203838|540252655|FG003|Overall Study|Other|0|||
149760744|NCT05091060|540252656|FG000|Overall Study|Lost to Follow-up|1|||
149760745|NCT01798706|540252657|FG000|Overall Study|Adverse Event|15|||
149760746|NCT01798706|540252658|FG001|Overall Study|Adverse Event|10|||
149760747|NCT01798706|540252657|FG000|Overall Study|Lack of Efficacy|0|||
149760748|NCT01798706|540252658|FG001|Overall Study|Lack of Efficacy|2|||
149760749|NCT01798706|540252657|FG000|Overall Study|Poor compliance to protocol|1|||
149760750|NCT01798706|540252658|FG001|Overall Study|Poor compliance to protocol|0|||
149760751|NCT01798706|540252657|FG000|Overall Study|Other than specified above|5|||
149760752|NCT01798706|540252658|FG001|Overall Study|Other than specified above|9|||
149760753|NCT00496873|540252659|FG000|Overall Study|Ineligible|2|||
149760754|NCT00496873|540252659|FG000|Overall Study|Death|2|||
149760755|NCT00496873|540252659|FG000|Overall Study|Withdrawal by Subject|3|||
149760756|NCT05896761|540252660|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
149760757|NCT05896761|540252661|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
149760758|NCT05896761|540252660|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
149760759|NCT05896761|540252661|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
149760760|NCT01318083|540252662|FG000|Overall Study|Adverse Event|4|||
149760761|NCT01318083|540252663|FG001|Overall Study|Adverse Event|1|||
149760762|NCT01318083|540252664|FG002|Overall Study|Adverse Event|2|||
149760763|NCT01318083|540252662|FG000|Overall Study|Withdrawal by Subject|1|||
149760764|NCT01318083|540252663|FG001|Overall Study|Withdrawal by Subject|0|||
149760765|NCT01318083|540252664|FG002|Overall Study|Withdrawal by Subject|2|||
149760766|NCT01318083|540252662|FG000|Overall Study|Lack of Efficacy|0|||
149760767|NCT01318083|540252663|FG001|Overall Study|Lack of Efficacy|0|||
149760768|NCT01318083|540252664|FG002|Overall Study|Lack of Efficacy|1|||
149760769|NCT01318083|540252662|FG000|Overall Study|Treatment Complications|1|||
149760770|NCT01318083|540252663|FG001|Overall Study|Treatment Complications|0|||
149760771|NCT01318083|540252664|FG002|Overall Study|Treatment Complications|0|||
149760772|NCT01318083|540252662|FG000|Overall Study|Lack of Study Medication Compliance|0|||
149760773|NCT01318083|540252663|FG001|Overall Study|Lack of Study Medication Compliance|1|||
149760774|NCT01318083|540252664|FG002|Overall Study|Lack of Study Medication Compliance|0|||
149760775|NCT03552549|540252667|FG000|Overall Study|Disease progression|25|||
149760776|NCT03552549|540252668|FG001|Overall Study|Disease progression|17|||
149760777|NCT03552549|540252667|FG000|Overall Study|Adverse event in first 12 months|12|||
149760778|NCT03552549|540252668|FG001|Overall Study|Adverse event in first 12 months|8|||
149760779|NCT03552549|540252667|FG000|Overall Study|Withdrawal by Subject|7|||
149760780|NCT03552549|540252668|FG001|Overall Study|Withdrawal by Subject|7|||
149760781|NCT03552549|540252667|FG000|Overall Study|Unknown (no reason provided)|4|||
149760782|NCT03552549|540252668|FG001|Overall Study|Unknown (no reason provided)|2|||
149760783|NCT03552549|540252667|FG000|Overall Study|Not in participant's best interest|2|||
149760784|NCT03552549|540252668|FG001|Overall Study|Not in participant's best interest|1|||
149760785|NCT03552549|540252667|FG000|Overall Study|Did not complete study treatment|2|||
149760786|NCT03552549|540252668|FG001|Overall Study|Did not complete study treatment|3|||
149760787|NCT03552549|540252667|FG000|Overall Study|Did not meet eligibility criteria|1|||
149760788|NCT03552549|540252668|FG001|Overall Study|Did not meet eligibility criteria|0|||
149760789|NCT03552549|540252667|FG000|Overall Study|Administrative|0|||
149760790|NCT03552549|540252668|FG001|Overall Study|Administrative|14|||
149760791|NCT02739594|540252671|FG000|Overall Study|Undesired Event|3|||
149760792|NCT02739594|540252672|FG001|Overall Study|Undesired Event|4|||
149760793|NCT02739594|540252671|FG000|Overall Study|Violation of Eligibility Criteria|1|||
149760794|NCT02739594|540252672|FG001|Overall Study|Violation of Eligibility Criteria|2|||
149760795|NCT02739594|540252671|FG000|Overall Study|Protocol Violation|5|||
149760796|NCT02739594|540252672|FG001|Overall Study|Protocol Violation|6|||
149760797|NCT02739594|540252671|FG000|Overall Study|Death|4|||
149760798|NCT02739594|540252672|FG001|Overall Study|Death|2|||
149760799|NCT02739594|540252671|FG000|Overall Study|Renal Insufficiency|4|||
149760800|NCT02739594|540252672|FG001|Overall Study|Renal Insufficiency|6|||
149760801|NCT02739594|540252671|FG000|Overall Study|Administrative Reasons|1|||
149760802|NCT02739594|540252672|FG001|Overall Study|Administrative Reasons|3|||
149760803|NCT02739594|540252671|FG000|Overall Study|Withdrawal by Subject|1|||
149760804|NCT02739594|540252672|FG001|Overall Study|Withdrawal by Subject|1|||
149760805|NCT02739594|540252671|FG000|Overall Study|Lost to Follow-up|0|||
149760806|NCT02739594|540252672|FG001|Overall Study|Lost to Follow-up|1|||
149760807|NCT02739594|540252671|FG000|Overall Study|Elevated Serum Creatinine|0|||
149760808|NCT02739594|540252672|FG001|Overall Study|Elevated Serum Creatinine|1|||
149760809|NCT02739594|540252671|FG000|Overall Study|Other|6|||
149760810|NCT02739594|540252672|FG001|Overall Study|Other|2|||
149760811|NCT00952289|540252680|FG000|All Participants|Death|9|||
149760812|NCT00952289|540252681|FG001|All Participants|Death|9|||
149760813|NCT00952289|540252680|FG000|All Participants|Adverse Event|8|||
149760814|NCT00952289|540252681|FG001|All Participants|Adverse Event|8|||
149760815|NCT00952289|540252680|FG000|All Participants|Disease progression|3|||
149760816|NCT00952289|540252681|FG001|All Participants|Disease progression|12|||
149760817|NCT00952289|540252680|FG000|All Participants|Withdrawal by Subject|1|||
149760818|NCT00952289|540252681|FG001|All Participants|Withdrawal by Subject|10|||
149760819|NCT00952289|540252680|FG000|All Participants|Data lost during site relocation|0|||
149760820|NCT00952289|540252681|FG001|All Participants|Data lost during site relocation|1|||
149760821|NCT00952289|540252680|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
149760822|NCT00952289|540252681|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
149760823|NCT00952289|540252680|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
149760824|NCT00952289|540252681|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
149760825|NCT00952289|540252680|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
149760826|NCT00952289|540252681|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
149760827|NCT00952289|540252680|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
149760828|NCT00952289|540252681|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
149760829|NCT00952289|540252680|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
149760830|NCT00952289|540252681|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
149760831|NCT00777491|540252686|FG000|Overall Study|Protocol Violation|0|||
149760832|NCT00777491|540252687|FG001|Overall Study|Protocol Violation|2|||
149760833|NCT00777491|540252686|FG000|Overall Study|Did not receive any protocol treatment|2|||
149760834|NCT00777491|540252687|FG001|Overall Study|Did not receive any protocol treatment|0|||
149760835|NCT00364845|540252688|FG000|Overall Study|Adverse Event|1|||
149760836|NCT00364845|540252689|FG001|Overall Study|Adverse Event|0|||
149760837|NCT00364845|540252688|FG000|Overall Study|Withdrawal by Subject|2|||
149760838|NCT00364845|540252689|FG001|Overall Study|Withdrawal by Subject|1|||
149760839|NCT00364845|540252688|FG000|Overall Study|Physician Decision|8|||
149760840|NCT00364845|540252689|FG001|Overall Study|Physician Decision|8|||
149760841|NCT00364845|540252688|FG000|Overall Study|Lost to Follow-up|0|||
149760842|NCT00364845|540252689|FG001|Overall Study|Lost to Follow-up|1|||
149760843|NCT00364845|540252688|FG000|Overall Study|Death|0|||
149760844|NCT00364845|540252689|FG001|Overall Study|Death|1|||
149760845|NCT01423617|540252690|FG000|Overall Study|Lost to Follow-up|0|||
149760846|NCT01423617|540252691|FG001|Overall Study|Lost to Follow-up|1|||
149760847|NCT03255291|540252692|FG000|Overall Study|Determined to be ineligible|10|||
149760848|NCT03255291|540252693|FG001|Overall Study|Determined to be ineligible|12|||
149760849|NCT03255291|540252694|FG002|Overall Study|Determined to be ineligible|6|||
149760850|NCT03255291|540252695|FG003|Overall Study|Determined to be ineligible|6|||
149760851|NCT03255291|540252696|FG004|Overall Study|Determined to be ineligible|5|||
149760852|NCT03255291|540252697|FG005|Overall Study|Determined to be ineligible|10|||
149760853|NCT03255291|540252692|FG000|Overall Study|Baseline data collection issues|3|||
149760854|NCT03255291|540252693|FG001|Overall Study|Baseline data collection issues|0|||
149760855|NCT03255291|540252694|FG002|Overall Study|Baseline data collection issues|0|||
149760856|NCT03255291|540252695|FG003|Overall Study|Baseline data collection issues|0|||
149760857|NCT03255291|540252696|FG004|Overall Study|Baseline data collection issues|2|||
149760858|NCT03255291|540252697|FG005|Overall Study|Baseline data collection issues|0|||
149760859|NCT04369430|540252704|FG000|Overall Study|Adverse Event|2|||
149760860|NCT04369430|540252705|FG001|Overall Study|Adverse Event|3|||
149760861|NCT04369430|540252704|FG000|Overall Study|Death|1|||
149760862|NCT04369430|540252705|FG001|Overall Study|Death|0|||
149760863|NCT04369430|540252704|FG000|Overall Study|Withdrawal by Subject|4|||
149760864|NCT04369430|540252705|FG001|Overall Study|Withdrawal by Subject|3|||
149760865|NCT04369430|540252704|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
149760866|NCT04369430|540252705|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
149760867|NCT04369430|540252704|FG000|Overall Study|Lost to Follow-up|0|||
149760868|NCT04369430|540252705|FG001|Overall Study|Lost to Follow-up|1|||
149760869|NCT00444626|540252706|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
149760870|NCT00444626|540252706|FG000|Initial Treatment Period|Adverse Event|1|||
149760871|NCT00444626|540252706|FG000|Initial Treatment Period|Lost to Follow-up|9|||
149760872|NCT00008138|540252707|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
149760873|NCT00008138|540252707|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
149760874|NCT00008138|540252707|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
149760875|NCT00008138|540252707|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
149760876|NCT00008138|540252707|FG000|Interval Debulking|Withdrawal by Subject|2|||
149760877|NCT00008138|540252707|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
149760878|NCT00008138|540252707|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
149760879|NCT00008138|540252707|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
149760880|NCT00142519|540252708|FG000|Overall Study|Not Treated|7|||
149760881|NCT00142519|540252709|FG001|Overall Study|Not Treated|9|||
149760882|NCT00142519|540252708|FG000|Overall Study|Protocol Violation|1|||
149760883|NCT00142519|540252709|FG001|Overall Study|Protocol Violation|0|||
149760884|NCT00142519|540252708|FG000|Overall Study|Withdrawal by Subject|10|||
149760885|NCT00142519|540252709|FG001|Overall Study|Withdrawal by Subject|7|||
149760886|NCT01687413|540252716|FG000|Overall Study|Withdrawal by Subject|0|||
149760887|NCT01687413|540252717|FG001|Overall Study|Withdrawal by Subject|2|||
149760888|NCT01687413|540252716|FG000|Overall Study|Not eligible|0|||
149760889|NCT01687413|540252717|FG001|Overall Study|Not eligible|2|||
149760890|NCT01687413|540252716|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
149760891|NCT01687413|540252717|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
149760892|NCT03229759|540252720|FG000|Overall Study|Screen Failure|30|||
149760893|NCT02669862|540254829|FG000|Overall Study|Lost to Follow-up|0|||
149760894|NCT02669862|540254830|FG001|Overall Study|Lost to Follow-up|2|||
149760895|NCT02669862|540254831|FG002|Overall Study|Lost to Follow-up|1|||
149760896|NCT02669862|540254829|FG000|Overall Study|Withdrawal by Subject|2|||
149760897|NCT02669862|540254830|FG001|Overall Study|Withdrawal by Subject|2|||
149760898|NCT02669862|540254831|FG002|Overall Study|Withdrawal by Subject|3|||
149760899|NCT02669862|540254829|FG000|Overall Study|moved|0|||
149760900|NCT02669862|540254830|FG001|Overall Study|moved|1|||
149760901|NCT02669862|540254831|FG002|Overall Study|moved|0|||
149760902|NCT02669862|540254829|FG000|Overall Study|Protocol Violation|0|||
149760903|NCT02669862|540254830|FG001|Overall Study|Protocol Violation|0|||
149760904|NCT02669862|540254831|FG002|Overall Study|Protocol Violation|1|||
149760905|NCT00762372|540254834|FG000|Overall Study|Adverse Event|1|||
149760906|NCT00762372|540254835|FG001|Overall Study|Adverse Event|0|||
149760907|NCT00762372|540254836|FG002|Overall Study|Adverse Event|0|||
149760908|NCT02670915|540254837|FG000|Overall Study|Withdrawal by Subject|0|||
149760909|NCT02670915|540254838|FG001|Overall Study|Withdrawal by Subject|1|||
149760910|NCT02670915|540254839|FG002|Overall Study|Withdrawal by Subject|4|||
149760911|NCT02670915|540254837|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149760912|NCT02670915|540254838|FG001|Overall Study|Withdrawal by parent/guardian|4|||
149760913|NCT02670915|540254839|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149760914|NCT02670915|540254837|FG000|Overall Study|Unclassified|0|||
149760915|NCT02670915|540254838|FG001|Overall Study|Unclassified|3|||
149760916|NCT02670915|540254839|FG002|Overall Study|Unclassified|0|||
149760917|NCT00818207|540254840|FG000|Overall Study|Adverse Event|6|||
149760918|NCT00818207|540254841|FG001|Overall Study|Adverse Event|0|||
149760919|NCT00818207|540254840|FG000|Overall Study|Lost to Follow-up|160|||
149760920|NCT00818207|540254841|FG001|Overall Study|Lost to Follow-up|146|||
149760921|NCT00818207|540254840|FG000|Overall Study|Multiple reasons|11|||
149760922|NCT00818207|540254841|FG001|Overall Study|Multiple reasons|12|||
149760923|NCT00818207|540254840|FG000|Overall Study|Withdrawal by Subject|42|||
149760924|NCT00818207|540254841|FG001|Overall Study|Withdrawal by Subject|104|||
149760925|NCT00818207|540254840|FG000|Overall Study|Death|3|||
149760926|NCT00818207|540254841|FG001|Overall Study|Death|5|||
149760927|NCT02616185|540254842|FG000|Overall Study|Death|0|||
149760928|NCT02616185|540254843|FG001|Overall Study|Death|0|||
149760929|NCT02616185|540254844|FG002|Overall Study|Death|0|||
149760930|NCT02616185|540254845|FG003|Overall Study|Death|1|||
149760931|NCT02616185|540254846|FG004|Overall Study|Death|2|||
149760932|NCT02616185|540254847|FG005|Overall Study|Death|0|||
149760933|NCT02616185|540254848|FG006|Overall Study|Death|0|||
149760934|NCT02616185|540254849|FG007|Overall Study|Death|2|||
149760935|NCT02616185|540254850|FG008|Overall Study|Death|1|||
149760936|NCT02616185|540254842|FG000|Overall Study|Study terminated by sponsor|0|||
149760937|NCT02616185|540254843|FG001|Overall Study|Study terminated by sponsor|0|||
149760938|NCT02616185|540254844|FG002|Overall Study|Study terminated by sponsor|1|||
149760939|NCT02616185|540254845|FG003|Overall Study|Study terminated by sponsor|0|||
149760940|NCT02616185|540254846|FG004|Overall Study|Study terminated by sponsor|0|||
149760941|NCT02616185|540254847|FG005|Overall Study|Study terminated by sponsor|0|||
149760942|NCT02616185|540254848|FG006|Overall Study|Study terminated by sponsor|5|||
149760943|NCT02616185|540254849|FG007|Overall Study|Study terminated by sponsor|2|||
149760944|NCT02616185|540254850|FG008|Overall Study|Study terminated by sponsor|0|||
149760945|NCT02616185|540254842|FG000|Overall Study|Participant refused further follow-up|1|||
149760946|NCT02616185|540254843|FG001|Overall Study|Participant refused further follow-up|1|||
149760947|NCT02616185|540254844|FG002|Overall Study|Participant refused further follow-up|2|||
149760948|NCT02616185|540254845|FG003|Overall Study|Participant refused further follow-up|3|||
149760949|NCT02616185|540254846|FG004|Overall Study|Participant refused further follow-up|4|||
149760950|NCT02616185|540254847|FG005|Overall Study|Participant refused further follow-up|0|||
149760951|NCT02616185|540254848|FG006|Overall Study|Participant refused further follow-up|3|||
149760952|NCT02616185|540254849|FG007|Overall Study|Participant refused further follow-up|4|||
149760953|NCT02616185|540254850|FG008|Overall Study|Participant refused further follow-up|3|||
149760954|NCT02616185|540254842|FG000|Overall Study|Not reported|0|||
149760955|NCT02616185|540254843|FG001|Overall Study|Not reported|0|||
149760956|NCT02616185|540254844|FG002|Overall Study|Not reported|0|||
149760957|NCT02616185|540254845|FG003|Overall Study|Not reported|1|||
149760958|NCT02616185|540254846|FG004|Overall Study|Not reported|3|||
149760959|NCT02616185|540254847|FG005|Overall Study|Not reported|1|||
149760960|NCT02616185|540254848|FG006|Overall Study|Not reported|0|||
149760961|NCT02616185|540254849|FG007|Overall Study|Not reported|5|||
149760962|NCT02616185|540254850|FG008|Overall Study|Not reported|2|||
149760963|NCT01346371|540254851|FG000|Overall Study|Lost to Follow-up|2|||
149760964|NCT01346371|540254852|FG001|Overall Study|Lost to Follow-up|0|||
149760965|NCT01670656|540254856|FG000|Overall Study|Non-compliance with study drug|0|||
149760966|NCT01670656|540254857|FG001|Overall Study|Non-compliance with study drug|0|||
149760967|NCT01670656|540254858|FG002|Overall Study|Non-compliance with study drug|3|||
149760968|NCT01670656|540254859|FG003|Overall Study|Non-compliance with study drug|0|||
149760969|NCT01670656|540254860|FG004|Overall Study|Non-compliance with study drug|1|||
149760970|NCT01670656|540254856|FG000|Overall Study|Pregnancy|0|||
149760971|NCT01670656|540254857|FG001|Overall Study|Pregnancy|0|||
149760972|NCT01670656|540254858|FG002|Overall Study|Pregnancy|0|||
149760973|NCT01670656|540254859|FG003|Overall Study|Pregnancy|0|||
149760974|NCT01670656|540254860|FG004|Overall Study|Pregnancy|1|||
149760975|NCT01670656|540254856|FG000|Overall Study|Withdrawal by Subject|1|||
149760976|NCT01670656|540254857|FG001|Overall Study|Withdrawal by Subject|1|||
149760977|NCT01670656|540254858|FG002|Overall Study|Withdrawal by Subject|0|||
149760978|NCT01670656|540254859|FG003|Overall Study|Withdrawal by Subject|0|||
149760979|NCT01670656|540254860|FG004|Overall Study|Withdrawal by Subject|0|||
149760980|NCT01670656|540254856|FG000|Overall Study|Non-compliance with protocol|0|||
149760981|NCT01670656|540254857|FG001|Overall Study|Non-compliance with protocol|3|||
149760982|NCT01670656|540254858|FG002|Overall Study|Non-compliance with protocol|1|||
149760983|NCT01670656|540254859|FG003|Overall Study|Non-compliance with protocol|1|||
149760984|NCT01670656|540254860|FG004|Overall Study|Non-compliance with protocol|2|||
149760985|NCT01670656|540254856|FG000|Overall Study|Adverse Event|2|||
149760986|NCT01670656|540254857|FG001|Overall Study|Adverse Event|2|||
149760987|NCT01670656|540254858|FG002|Overall Study|Adverse Event|2|||
149760988|NCT01670656|540254859|FG003|Overall Study|Adverse Event|3|||
149760989|NCT01670656|540254860|FG004|Overall Study|Adverse Event|3|||
149760990|NCT01670656|540254856|FG000|Overall Study|Subject withdrew consent|0|||
149760991|NCT01670656|540254857|FG001|Overall Study|Subject withdrew consent|1|||
149760992|NCT01670656|540254858|FG002|Overall Study|Subject withdrew consent|2|||
149760993|NCT01670656|540254859|FG003|Overall Study|Subject withdrew consent|1|||
149760994|NCT01670656|540254860|FG004|Overall Study|Subject withdrew consent|1|||
149760995|NCT01670656|540254856|FG000|Overall Study|Lost to Follow-up|0|||
149760996|NCT01670656|540254857|FG001|Overall Study|Lost to Follow-up|0|||
149760997|NCT01670656|540254858|FG002|Overall Study|Lost to Follow-up|0|||
149760998|NCT01670656|540254859|FG003|Overall Study|Lost to Follow-up|0|||
149760999|NCT01670656|540254860|FG004|Overall Study|Lost to Follow-up|3|||
149761000|NCT01670656|540254856|FG000|Overall Study|Subject moved|0|||
149761001|NCT01670656|540254857|FG001|Overall Study|Subject moved|0|||
149761002|NCT01670656|540254858|FG002|Overall Study|Subject moved|0|||
149761003|NCT01670656|540254859|FG003|Overall Study|Subject moved|1|||
149761004|NCT01670656|540254860|FG004|Overall Study|Subject moved|0|||
149761005|NCT02622724|540254863|FG000|Overall Study|Death|51|||
149761006|NCT02622724|540254864|FG001|Overall Study|Death|53|||
149761007|NCT02622724|540254863|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
149761008|NCT02622724|540254864|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
149761009|NCT02622724|540254863|FG000|Overall Study|Early termination of study|38|||
149761010|NCT02622724|540254864|FG001|Overall Study|Early termination of study|43|||
149761011|NCT00111475|540254865|FG000|Overall Study|Lost to Follow-up|0|||
149761012|NCT00111475|540254866|FG001|Overall Study|Lost to Follow-up|0|||
149761013|NCT00111475|540254867|FG002|Overall Study|Lost to Follow-up|0|||
149761014|NCT00111475|540254868|FG003|Overall Study|Lost to Follow-up|0|||
149761015|NCT00111475|540254869|FG004|Overall Study|Lost to Follow-up|0|||
149761016|NCT00111475|540254870|FG005|Overall Study|Lost to Follow-up|1|||
149761017|NCT00111475|540254871|FG006|Overall Study|Lost to Follow-up|0|||
149761018|NCT00111475|540254872|FG007|Overall Study|Lost to Follow-up|0|||
149761019|NCT00111475|540254873|FG008|Overall Study|Lost to Follow-up|0|||
149761020|NCT00111475|540254874|FG009|Overall Study|Lost to Follow-up|0|||
149761021|NCT01026389|540254879|FG000|Overall Study|Withdrawal by Subject|1|||
149761022|NCT01026389|540254880|FG001|Overall Study|Withdrawal by Subject|3|||
149761023|NCT01026389|540254879|FG000|Overall Study|change of treatment, patient moved|4|||
149761024|NCT01026389|540254880|FG001|Overall Study|change of treatment, patient moved|2|||
149761025|NCT01995136|540254881|FG000|Overall Study|Change in residence|1|||
149761026|NCT03544268|540254882|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
149761027|NCT03544268|540254883|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
149761028|NCT01830543|540254887|FG000|Overall Study|Subject Decision|19|||
149761029|NCT01830543|540254888|FG001|Overall Study|Subject Decision|21|||
149761030|NCT01830543|540254889|FG002|Overall Study|Subject Decision|57|||
149761031|NCT01830543|540254887|FG000|Overall Study|Adverse Event|91|||
149761032|NCT01830543|540254888|FG001|Overall Study|Adverse Event|77|||
149761033|NCT01830543|540254889|FG002|Overall Study|Adverse Event|76|||
149761034|NCT01830543|540254887|FG000|Overall Study|Death|20|||
149761035|NCT01830543|540254888|FG001|Overall Study|Death|22|||
149761036|NCT01830543|540254889|FG002|Overall Study|Death|22|||
149761037|NCT01830543|540254887|FG000|Overall Study|Protocol Violation|3|||
149761038|NCT01830543|540254888|FG001|Overall Study|Protocol Violation|7|||
149761039|NCT01830543|540254889|FG002|Overall Study|Protocol Violation|7|||
149761040|NCT01830543|540254887|FG000|Overall Study|Physician Decision|11|||
149761041|NCT01830543|540254888|FG001|Overall Study|Physician Decision|5|||
149761042|NCT01830543|540254889|FG002|Overall Study|Physician Decision|12|||
149761043|NCT01830543|540254887|FG000|Overall Study|Withdrawal by consent|3|||
149761044|NCT01830543|540254888|FG001|Overall Study|Withdrawal by consent|3|||
149761045|NCT01830543|540254889|FG002|Overall Study|Withdrawal by consent|3|||
149761046|NCT01830543|540254887|FG000|Overall Study|Other|12|||
149761047|NCT01830543|540254888|FG001|Overall Study|Other|17|||
149761048|NCT01830543|540254889|FG002|Overall Study|Other|37|||
149761049|NCT02695524|540254894|FG000|Overall Study|Lost to Follow-up|3|||
149761050|NCT02695524|540254895|FG001|Overall Study|Lost to Follow-up|2|||
149761051|NCT02695524|540254894|FG000|Overall Study|Death|0|||
149761052|NCT02695524|540254895|FG001|Overall Study|Death|1|||
149761053|NCT00798655|540254904|FG000|Overall Study|Did not receive at least one dose of pan|2|||
149761054|NCT03446651|540254905|FG000|Overall Study|Lost to Follow-up|4|||
149761055|NCT03446651|540254906|FG001|Overall Study|Lost to Follow-up|0|||
149761056|NCT03446651|540254905|FG000|Overall Study|Open Label Participants|5|||
149761057|NCT03446651|540254906|FG001|Overall Study|Open Label Participants|0|||
149761058|NCT00343291|540254907|FG000|Overall Study|Adverse Event|13|||
149761059|NCT00343291|540254908|FG001|Overall Study|Adverse Event|13|||
149761060|NCT00343291|540254907|FG000|Overall Study|Death|3|||
149761061|NCT00343291|540254908|FG001|Overall Study|Death|2|||
149761062|NCT00343291|540254907|FG000|Overall Study|Progressive disease|33|||
149761063|NCT00343291|540254908|FG001|Overall Study|Progressive disease|34|||
149761064|NCT00343291|540254907|FG000|Overall Study|Withdrawal by Subject|0|||
149761065|NCT00343291|540254908|FG001|Overall Study|Withdrawal by Subject|2|||
149761066|NCT00343291|540254907|FG000|Overall Study|Other|8|||
149761067|NCT00343291|540254908|FG001|Overall Study|Other|5|||
149761068|NCT00960934|540254911|FG000|Overall Study|Adverse Event|2|||
149761069|NCT00960934|540254912|FG001|Overall Study|Adverse Event|3|||
149761070|NCT00960934|540254913|FG002|Overall Study|Adverse Event|3|||
149761071|NCT00960934|540254914|FG003|Overall Study|Adverse Event|2|||
149761072|NCT00960934|540254915|FG004|Overall Study|Adverse Event|4|||
149761073|NCT00960934|540254916|FG005|Overall Study|Adverse Event|3|||
149761074|NCT00960934|540254911|FG000|Overall Study|Lack of Efficacy|1|||
149761075|NCT00960934|540254912|FG001|Overall Study|Lack of Efficacy|0|||
149761076|NCT00960934|540254913|FG002|Overall Study|Lack of Efficacy|0|||
149761077|NCT00960934|540254914|FG003|Overall Study|Lack of Efficacy|0|||
149761078|NCT00960934|540254915|FG004|Overall Study|Lack of Efficacy|0|||
149761079|NCT00960934|540254916|FG005|Overall Study|Lack of Efficacy|0|||
149761080|NCT00960934|540254911|FG000|Overall Study|Lost to Follow-up|0|||
149761081|NCT00960934|540254912|FG001|Overall Study|Lost to Follow-up|1|||
149761082|NCT00960934|540254913|FG002|Overall Study|Lost to Follow-up|0|||
149761083|NCT00960934|540254914|FG003|Overall Study|Lost to Follow-up|0|||
149761084|NCT00960934|540254915|FG004|Overall Study|Lost to Follow-up|0|||
149761085|NCT00960934|540254916|FG005|Overall Study|Lost to Follow-up|0|||
149761086|NCT00960934|540254911|FG000|Overall Study|Other|2|||
149761087|NCT00960934|540254912|FG001|Overall Study|Other|1|||
149761088|NCT00960934|540254913|FG002|Overall Study|Other|5|||
149761089|NCT00960934|540254914|FG003|Overall Study|Other|4|||
149761090|NCT00960934|540254915|FG004|Overall Study|Other|2|||
149761091|NCT00960934|540254916|FG005|Overall Study|Other|2|||
149761092|NCT00960934|540254911|FG000|Overall Study|Physician Decision|0|||
149761093|NCT00960934|540254912|FG001|Overall Study|Physician Decision|1|||
149761094|NCT00960934|540254913|FG002|Overall Study|Physician Decision|0|||
149761095|NCT00960934|540254914|FG003|Overall Study|Physician Decision|0|||
149761096|NCT00960934|540254915|FG004|Overall Study|Physician Decision|0|||
149761097|NCT00960934|540254916|FG005|Overall Study|Physician Decision|0|||
149761098|NCT00960934|540254911|FG000|Overall Study|Progressive Disease|1|||
149761099|NCT00960934|540254912|FG001|Overall Study|Progressive Disease|1|||
149761100|NCT00960934|540254913|FG002|Overall Study|Progressive Disease|0|||
149761101|NCT00960934|540254914|FG003|Overall Study|Progressive Disease|0|||
149761102|NCT00960934|540254915|FG004|Overall Study|Progressive Disease|1|||
149761103|NCT00960934|540254916|FG005|Overall Study|Progressive Disease|1|||
149761104|NCT00960934|540254911|FG000|Overall Study|Protocol Violation|3|||
149761105|NCT00960934|540254912|FG001|Overall Study|Protocol Violation|4|||
149761106|NCT00960934|540254913|FG002|Overall Study|Protocol Violation|0|||
149761107|NCT00960934|540254914|FG003|Overall Study|Protocol Violation|3|||
149761108|NCT00960934|540254915|FG004|Overall Study|Protocol Violation|3|||
149761109|NCT00960934|540254916|FG005|Overall Study|Protocol Violation|2|||
149761110|NCT00960934|540254911|FG000|Overall Study|Withdrawal by Subject|5|||
149761111|NCT00960934|540254912|FG001|Overall Study|Withdrawal by Subject|6|||
149761112|NCT00960934|540254913|FG002|Overall Study|Withdrawal by Subject|4|||
149761113|NCT00960934|540254914|FG003|Overall Study|Withdrawal by Subject|5|||
149761114|NCT00960934|540254915|FG004|Overall Study|Withdrawal by Subject|5|||
149761115|NCT00960934|540254916|FG005|Overall Study|Withdrawal by Subject|7|||
149761116|NCT00960934|540254911|FG000|Overall Study|Study Terminated by Sponsor|50|||
149761117|NCT00960934|540254912|FG001|Overall Study|Study Terminated by Sponsor|46|||
149761118|NCT00960934|540254913|FG002|Overall Study|Study Terminated by Sponsor|52|||
149761119|NCT00960934|540254914|FG003|Overall Study|Study Terminated by Sponsor|50|||
149761120|NCT00960934|540254915|FG004|Overall Study|Study Terminated by Sponsor|49|||
149761121|NCT00960934|540254916|FG005|Overall Study|Study Terminated by Sponsor|49|||
149761122|NCT04281030|540254921|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
149761123|NCT04281030|540254922|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
149761124|NCT04281030|540254921|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
149761125|NCT04281030|540254922|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
149761126|NCT01395368|540254923|FG000|Overall Study|Physician Decision|14|||
149761127|NCT01395368|540254923|FG000|Overall Study|Withdrawal by Subject|2|||
149761128|NCT00288860|540254928|FG000|Overall Study|Did not complete intake|4|||
149761129|NCT00288860|540254929|FG001|Overall Study|Did not complete intake|8|||
149761130|NCT00288860|540254928|FG000|Overall Study|Death|4|||
149761131|NCT00288860|540254929|FG001|Overall Study|Death|3|||
149761132|NCT00288860|540254928|FG000|Overall Study|Withdrawal by Subject|20|||
149761133|NCT00288860|540254929|FG001|Overall Study|Withdrawal by Subject|15|||
149761134|NCT00288860|540254928|FG000|Overall Study|Lost to Follow-up|74|||
149761135|NCT00288860|540254929|FG001|Overall Study|Lost to Follow-up|71|||
149761136|NCT05142332|540254930|FG000|Overall Study|Withdrawal by Subject|0|||
149761137|NCT05142332|540254931|FG001|Overall Study|Withdrawal by Subject|1|||
149761138|NCT05142332|540254932|FG002|Overall Study|Withdrawal by Subject|2|||
149761139|NCT05142332|540254933|FG003|Overall Study|Withdrawal by Subject|0|||
149761140|NCT05142332|540254934|FG004|Overall Study|Withdrawal by Subject|0|||
149761141|NCT05142332|540254935|FG005|Overall Study|Withdrawal by Subject|2|||
149761142|NCT05142332|540254936|FG006|Overall Study|Withdrawal by Subject|6|||
149761143|NCT05142332|540254930|FG000|Overall Study|Left ED|3|||
149761144|NCT05142332|540254931|FG001|Overall Study|Left ED|0|||
149761145|NCT05142332|540254932|FG002|Overall Study|Left ED|4|||
149761146|NCT05142332|540254933|FG003|Overall Study|Left ED|6|||
149761147|NCT05142332|540254934|FG004|Overall Study|Left ED|1|||
149761148|NCT05142332|540254935|FG005|Overall Study|Left ED|2|||
149761149|NCT05142332|540254936|FG006|Overall Study|Left ED|6|||
149761150|NCT05142332|540254930|FG000|Overall Study|Physician Decision|0|||
149761151|NCT05142332|540254931|FG001|Overall Study|Physician Decision|0|||
149761152|NCT05142332|540254932|FG002|Overall Study|Physician Decision|2|||
149761153|NCT05142332|540254933|FG003|Overall Study|Physician Decision|1|||
149761154|NCT05142332|540254934|FG004|Overall Study|Physician Decision|0|||
149761155|NCT05142332|540254935|FG005|Overall Study|Physician Decision|0|||
149761156|NCT05142332|540254936|FG006|Overall Study|Physician Decision|3|||
149761157|NCT05142332|540254930|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
149761158|NCT05142332|540254931|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149761159|NCT05142332|540254932|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
149761160|NCT05142332|540254933|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
149761161|NCT05142332|540254934|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149761162|NCT05142332|540254935|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
149761163|NCT05142332|540254936|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149761164|NCT00390416|540254937|FG000|Overall Study|Withdrawal by Subject|1|||
149761165|NCT00390416|540254937|FG000|Overall Study|Not treated|3|||
149761166|NCT01219959|540254938|FG000|Overall Study|Adverse Event|6|||
149761167|NCT01219959|540254939|FG001|Overall Study|Adverse Event|14|||
149761168|NCT01219959|540254938|FG000|Overall Study|Physician Decision|0|||
149761169|NCT01219959|540254939|FG001|Overall Study|Physician Decision|4|||
149761170|NCT01219959|540254938|FG000|Overall Study|Withdrawal by Subject|0|||
149761171|NCT01219959|540254939|FG001|Overall Study|Withdrawal by Subject|2|||
149761172|NCT01219959|540254938|FG000|Overall Study|Renal Transplantation|0|||
149761173|NCT01219959|540254939|FG001|Overall Study|Renal Transplantation|3|||
149761174|NCT01219959|540254938|FG000|Overall Study|Other|1|||
149761175|NCT01219959|540254939|FG001|Overall Study|Other|0|||
149761176|NCT01409031|540254941|FG000|Overall Study|transferred to other hosp|1|||
149761177|NCT01409031|540254942|FG001|Overall Study|transferred to other hosp|0|||
149761178|NCT02345252|540254943|FG000|Double-Blind Phase|Adverse Event|2|||
149761179|NCT02345252|540254944|FG001|Double-Blind Phase|Adverse Event|3|||
149761180|NCT02345252|540254943|FG000|Double-Blind Phase|Death|1|||
149761181|NCT02345252|540254944|FG001|Double-Blind Phase|Death|2|||
149761182|NCT02345252|540254943|FG000|Double-Blind Phase|Lack of Efficacy|1|||
149761183|NCT02345252|540254944|FG001|Double-Blind Phase|Lack of Efficacy|0|||
149761184|NCT02345252|540254943|FG000|Double-Blind Phase|Investigator's Discretion|4|||
149761185|NCT02345252|540254944|FG001|Double-Blind Phase|Investigator's Discretion|6|||
149761186|NCT02345252|540254943|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
149761187|NCT02345252|540254944|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
149761188|NCT02345252|540254943|FG000|Double-Blind Phase|Protocol Violation|2|||
149761189|NCT02345252|540254944|FG001|Double-Blind Phase|Protocol Violation|1|||
149761190|NCT02345252|540254943|FG000|Double-Blind Phase|Withdrew Consent|21|||
149761191|NCT02345252|540254944|FG001|Double-Blind Phase|Withdrew Consent|23|||
149761192|NCT02345252|540254943|FG000|Double-Blind Phase|Lost to Follow-up|8|||
149761193|NCT02345252|540254944|FG001|Double-Blind Phase|Lost to Follow-up|10|||
149761194|NCT02345252|540254943|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
149761195|NCT02345252|540254944|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
149761196|NCT01094730|540254947|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
149761197|NCT01094730|540254948|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
149761198|NCT01094730|540254947|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
149761199|NCT01094730|540254948|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
149761200|NCT01094730|540254947|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
149761201|NCT01094730|540254948|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
149761202|NCT01094730|540254947|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
149761203|NCT01094730|540254948|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
149761204|NCT01094730|540254947|FG000|Period 2 (14 Days)|Protocol Violation|2|||
149761205|NCT01094730|540254948|FG001|Period 2 (14 Days)|Protocol Violation|0|||
149761206|NCT01094730|540254947|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
149761207|NCT01094730|540254948|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
149761208|NCT01094730|540254947|FG000|Period 2 (14 Days)|Adverse Event|0|||
149761209|NCT01094730|540254948|FG001|Period 2 (14 Days)|Adverse Event|1|||
149761210|NCT01094730|540254947|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
149761211|NCT01094730|540254948|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
149761212|NCT02232087|540254949|FG000|Overall Study|Withdrawal by Subject|2|||
149761213|NCT02232087|540254950|FG001|Overall Study|Withdrawal by Subject|0|||
149761214|NCT02232087|540254951|FG002|Overall Study|Withdrawal by Subject|0|||
149761215|NCT02232087|540254952|FG003|Overall Study|Withdrawal by Subject|0|||
149761216|NCT02232087|540254953|FG004|Overall Study|Withdrawal by Subject|0|||
149761217|NCT02232087|540254954|FG005|Overall Study|Withdrawal by Subject|1|||
149761218|NCT02232087|540254949|FG000|Overall Study|poor inhalation technique|0|||
149761219|NCT02232087|540254950|FG001|Overall Study|poor inhalation technique|1|||
149761220|NCT02232087|540254951|FG002|Overall Study|poor inhalation technique|0|||
149761221|NCT02232087|540254952|FG003|Overall Study|poor inhalation technique|0|||
149761222|NCT02232087|540254953|FG004|Overall Study|poor inhalation technique|0|||
149761223|NCT02232087|540254954|FG005|Overall Study|poor inhalation technique|2|||
149761224|NCT02232087|540254949|FG000|Overall Study|protocol stop criteria|0|||
149761225|NCT02232087|540254950|FG001|Overall Study|protocol stop criteria|1|||
149761226|NCT02232087|540254951|FG002|Overall Study|protocol stop criteria|0|||
149761227|NCT02232087|540254952|FG003|Overall Study|protocol stop criteria|1|||
149761228|NCT02232087|540254953|FG004|Overall Study|protocol stop criteria|0|||
149761229|NCT02232087|540254954|FG005|Overall Study|protocol stop criteria|0|||
149761230|NCT02232087|540254949|FG000|Overall Study|Adverse Event|0|||
149761231|NCT02232087|540254950|FG001|Overall Study|Adverse Event|0|||
149761232|NCT02232087|540254951|FG002|Overall Study|Adverse Event|0|||
149761233|NCT02232087|540254952|FG003|Overall Study|Adverse Event|0|||
149761234|NCT02232087|540254953|FG004|Overall Study|Adverse Event|1|||
149761235|NCT02232087|540254954|FG005|Overall Study|Adverse Event|0|||
149761236|NCT01958125|540254955|FG000|Overall Study|Missing diary data|2|||
149761237|NCT01958125|540254956|FG001|Overall Study|Missing diary data|6|||
149761238|NCT01958125|540254955|FG000|Overall Study|No headache attacks|0|||
149761239|NCT01958125|540254956|FG001|Overall Study|No headache attacks|2|||
149761240|NCT04096326|540254957|FG000|Overall Study|Withdrawal by Subject|0|||
149761241|NCT04096326|540254958|FG001|Overall Study|Withdrawal by Subject|0|||
149761242|NCT04096326|540254959|FG002|Overall Study|Withdrawal by Subject|0|||
149761243|NCT04096326|540254960|FG003|Overall Study|Withdrawal by Subject|0|||
149761244|NCT04096326|540254961|FG004|Overall Study|Withdrawal by Subject|0|||
149761245|NCT04096326|540254962|FG005|Overall Study|Withdrawal by Subject|0|||
149761246|NCT04096326|540254963|FG006|Overall Study|Withdrawal by Subject|1|||
149761247|NCT04096326|540254964|FG007|Overall Study|Withdrawal by Subject|0|||
149761248|NCT04096326|540254965|FG008|Overall Study|Withdrawal by Subject|0|||
149761249|NCT04096326|540254966|FG009|Overall Study|Withdrawal by Subject|0|||
149761250|NCT04096326|540254957|FG000|Overall Study|Lost to Follow-up|0|||
149761251|NCT04096326|540254958|FG001|Overall Study|Lost to Follow-up|1|||
149761252|NCT04096326|540254959|FG002|Overall Study|Lost to Follow-up|0|||
149761253|NCT04096326|540254960|FG003|Overall Study|Lost to Follow-up|0|||
149761254|NCT04096326|540254961|FG004|Overall Study|Lost to Follow-up|0|||
149761255|NCT04096326|540254962|FG005|Overall Study|Lost to Follow-up|0|||
149761256|NCT04096326|540254963|FG006|Overall Study|Lost to Follow-up|0|||
149761257|NCT04096326|540254964|FG007|Overall Study|Lost to Follow-up|0|||
149761258|NCT04096326|540254965|FG008|Overall Study|Lost to Follow-up|0|||
149761259|NCT04096326|540254966|FG009|Overall Study|Lost to Follow-up|0|||
149761260|NCT04096326|540254957|FG000|Overall Study|COVID-19-related reasons|0|||
149761261|NCT04096326|540254958|FG001|Overall Study|COVID-19-related reasons|0|||
149761262|NCT04096326|540254959|FG002|Overall Study|COVID-19-related reasons|0|||
149761263|NCT04096326|540254960|FG003|Overall Study|COVID-19-related reasons|0|||
149761264|NCT04096326|540254961|FG004|Overall Study|COVID-19-related reasons|1|||
149761265|NCT04096326|540254962|FG005|Overall Study|COVID-19-related reasons|5|||
149761266|NCT04096326|540254963|FG006|Overall Study|COVID-19-related reasons|0|||
149761267|NCT04096326|540254964|FG007|Overall Study|COVID-19-related reasons|0|||
149761268|NCT04096326|540254965|FG008|Overall Study|COVID-19-related reasons|0|||
149761269|NCT04096326|540254966|FG009|Overall Study|COVID-19-related reasons|0|||
149761270|NCT04804033|540254967|FG000|Period 1: DBT Phase|Adverse Event|1|||
149761271|NCT04804033|540254968|FG001|Period 1: DBT Phase|Adverse Event|5|||
149761272|NCT04804033|540254969|FG002|Period 1: DBT Phase|Adverse Event|3|||
149761273|NCT04804033|540254970|FG003|Period 1: DBT Phase|Adverse Event|4|||
149761274|NCT04804033|540254967|FG000|Period 1: DBT Phase|Death|1|||
149761275|NCT04804033|540254968|FG001|Period 1: DBT Phase|Death|0|||
149761276|NCT04804033|540254969|FG002|Period 1: DBT Phase|Death|0|||
149761277|NCT04804033|540254970|FG003|Period 1: DBT Phase|Death|0|||
149761278|NCT04804033|540254967|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
149761279|NCT04804033|540254968|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
149761280|NCT04804033|540254969|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
149761281|NCT04804033|540254970|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
149761282|NCT04804033|540254967|FG000|Period 1: DBT Phase|Non-compliance|1|||
149761283|NCT04804033|540254968|FG001|Period 1: DBT Phase|Non-compliance|0|||
149761284|NCT04804033|540254969|FG002|Period 1: DBT Phase|Non-compliance|1|||
149761285|NCT04804033|540254970|FG003|Period 1: DBT Phase|Non-compliance|2|||
149761286|NCT04804033|540254967|FG000|Period 1: DBT Phase|Other|0|||
149761287|NCT04804033|540254968|FG001|Period 1: DBT Phase|Other|1|||
149761288|NCT04804033|540254969|FG002|Period 1: DBT Phase|Other|0|||
149761289|NCT04804033|540254970|FG003|Period 1: DBT Phase|Other|0|||
149761290|NCT04804033|540254967|FG000|Period 1: DBT Phase|Pregnancy|2|||
149761291|NCT04804033|540254968|FG001|Period 1: DBT Phase|Pregnancy|0|||
149761292|NCT04804033|540254969|FG002|Period 1: DBT Phase|Pregnancy|0|||
149761293|NCT04804033|540254970|FG003|Period 1: DBT Phase|Pregnancy|0|||
149761294|NCT04804033|540254967|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
149761295|NCT04804033|540254968|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
149761296|NCT04804033|540254969|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
149761297|NCT04804033|540254970|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
149761298|NCT04804033|540254967|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
149761299|NCT04804033|540254968|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
149761300|NCT04804033|540254969|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
149761301|NCT04804033|540254970|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
149761302|NCT04804033|540254967|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
149761303|NCT04804033|540254968|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
149761304|NCT04804033|540254969|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
149761305|NCT04804033|540254970|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
149761306|NCT04804033|540254967|FG000|Period 2: OLE Phase|Adverse Event|3|||
149761307|NCT04804033|540254968|FG001|Period 2: OLE Phase|Adverse Event|4|||
149761308|NCT04804033|540254969|FG002|Period 2: OLE Phase|Adverse Event|2|||
149761309|NCT04804033|540254970|FG003|Period 2: OLE Phase|Adverse Event|0|||
149761310|NCT04804033|540254967|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
149761311|NCT04804033|540254968|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
149761312|NCT04804033|540254969|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
149761313|NCT04804033|540254970|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
149761314|NCT04804033|540254967|FG000|Period 2: OLE Phase|Non-compliance|2|||
149761315|NCT04804033|540254968|FG001|Period 2: OLE Phase|Non-compliance|2|||
149761316|NCT04804033|540254969|FG002|Period 2: OLE Phase|Non-compliance|0|||
149761317|NCT04804033|540254970|FG003|Period 2: OLE Phase|Non-compliance|1|||
149761318|NCT04804033|540254967|FG000|Period 2: OLE Phase|Other|0|||
149761319|NCT04804033|540254968|FG001|Period 2: OLE Phase|Other|2|||
149761320|NCT04804033|540254969|FG002|Period 2: OLE Phase|Other|0|||
149761321|NCT04804033|540254970|FG003|Period 2: OLE Phase|Other|0|||
149761322|NCT04804033|540254967|FG000|Period 2: OLE Phase|Physician Decision|1|||
149761323|NCT04804033|540254968|FG001|Period 2: OLE Phase|Physician Decision|1|||
149761324|NCT04804033|540254969|FG002|Period 2: OLE Phase|Physician Decision|0|||
149761325|NCT04804033|540254970|FG003|Period 2: OLE Phase|Physician Decision|0|||
149761326|NCT04804033|540254967|FG000|Period 2: OLE Phase|Pregnancy|0|||
149761327|NCT04804033|540254968|FG001|Period 2: OLE Phase|Pregnancy|0|||
149761328|NCT04804033|540254969|FG002|Period 2: OLE Phase|Pregnancy|2|||
149761329|NCT04804033|540254970|FG003|Period 2: OLE Phase|Pregnancy|0|||
149761330|NCT04804033|540254967|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
149761331|NCT04804033|540254968|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
149761332|NCT04804033|540254969|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
149761333|NCT04804033|540254970|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
149761334|NCT04804033|540254967|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
149761335|NCT04804033|540254968|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
149761336|NCT04804033|540254969|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
149761337|NCT04804033|540254970|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
149761338|NCT04804033|540254967|FG000|Period 2: OLE Phase|Not reported|0|||
149761339|NCT04804033|540254968|FG001|Period 2: OLE Phase|Not reported|2|||
149761340|NCT04804033|540254969|FG002|Period 2: OLE Phase|Not reported|0|||
149761341|NCT04804033|540254970|FG003|Period 2: OLE Phase|Not reported|0|||
149761342|NCT04804033|540254967|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
149761343|NCT04804033|540254968|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
149761344|NCT04804033|540254969|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
149761345|NCT04804033|540254970|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
149761346|NCT04804033|540254967|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
149761347|NCT04804033|540254968|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
149761348|NCT04804033|540254969|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
149761349|NCT04804033|540254970|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
149761350|NCT04804033|540254967|FG000|Period 3: Follow-up Phase|Other|0|||
149761351|NCT04804033|540254968|FG001|Period 3: Follow-up Phase|Other|1|||
149761352|NCT04804033|540254969|FG002|Period 3: Follow-up Phase|Other|2|||
149761353|NCT04804033|540254970|FG003|Period 3: Follow-up Phase|Other|1|||
149761354|NCT04804033|540254967|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
149761355|NCT04804033|540254968|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
149761356|NCT04804033|540254969|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
149761357|NCT04804033|540254970|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
149761358|NCT04804033|540254967|FG000|Period 3: Follow-up Phase|Not reported|18|||
149761359|NCT04804033|540254968|FG001|Period 3: Follow-up Phase|Not reported|15|||
149761360|NCT04804033|540254969|FG002|Period 3: Follow-up Phase|Not reported|1|||
149761361|NCT04804033|540254970|FG003|Period 3: Follow-up Phase|Not reported|4|||
149761362|NCT03591146|540254978|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149761363|NCT03591146|540254979|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149761364|NCT03591146|540254980|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149761365|NCT03591146|540254981|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149761366|NCT03591146|540254982|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
149761367|NCT03591146|540254978|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149761368|NCT03591146|540254979|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
149761369|NCT03591146|540254980|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149761370|NCT03591146|540254981|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149761371|NCT03591146|540254982|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149761372|NCT03591146|540254978|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149761373|NCT03591146|540254979|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149761374|NCT03591146|540254980|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149761375|NCT03591146|540254981|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149761376|NCT03591146|540254982|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
149761377|NCT03591146|540254978|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149761378|NCT03591146|540254979|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149761379|NCT03591146|540254980|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
149761380|NCT03591146|540254981|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149761381|NCT03591146|540254982|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
149761382|NCT04737031|540254983|FG000|Overall Study|Patients who did not have a treatment visit|0|||
149761383|NCT04737031|540254984|FG001|Overall Study|Patients who did not have a treatment visit|31|||
149761384|NCT04737031|540254985|FG002|Overall Study|Patients who did not have a treatment visit|93|||
149761385|NCT04737031|540254986|FG003|Overall Study|Patients who did not have a treatment visit|227|||
149761386|NCT02435277|540254987|FG000|Overall Study|Adverse Event|1|||
149761387|NCT02435277|540254988|FG001|Overall Study|Adverse Event|1|||
149761388|NCT02435277|540254989|FG002|Overall Study|Adverse Event|0|||
149761389|NCT02435277|540254990|FG003|Overall Study|Adverse Event|0|||
149761390|NCT02435277|540254987|FG000|Overall Study|Withdrawal by Subject|1|||
149761391|NCT02435277|540254988|FG001|Overall Study|Withdrawal by Subject|0|||
149761392|NCT02435277|540254989|FG002|Overall Study|Withdrawal by Subject|0|||
149761393|NCT02435277|540254990|FG003|Overall Study|Withdrawal by Subject|0|||
149761394|NCT01067508|540254991|FG000|Overall Study|Physician Decision|0|||
149761395|NCT01067508|540254992|FG001|Overall Study|Physician Decision|1|||
149761396|NCT01067508|540254991|FG000|Overall Study|Withdrawal by Subject|0|||
149761397|NCT01067508|540254992|FG001|Overall Study|Withdrawal by Subject|1|||
149761398|NCT01468909|540255000|FG000|Overall Study|Never Treated|2|||
149761399|NCT01468909|540255001|FG001|Overall Study|Never Treated|2|||
149761400|NCT02635737|540255002|FG000|Overall Study|Protocol Violation|1|||
149761401|NCT01552928|540255003|FG000|Period 3|Adverse Event|0|||
149761402|NCT01552928|540255004|FG001|Period 3|Adverse Event|0|||
149761403|NCT01552928|540255005|FG002|Period 3|Adverse Event|1|||
149761404|NCT01552928|540255006|FG003|Period 3|Adverse Event|0|||
149761405|NCT01511419|540255007|FG000|Dose 2|Physician Decision|1|||
149761406|NCT01511419|540255008|FG001|Dose 2|Physician Decision|0|||
149761407|NCT00937768|540255009|FG000|Overall Study|Refused Further Treatment|3|||
149761408|NCT00937768|540255010|FG001|Overall Study|Refused Further Treatment|2|||
149761409|NCT00937768|540255009|FG000|Overall Study|Disease Progression|1|||
149761410|NCT00937768|540255010|FG001|Overall Study|Disease Progression|1|||
149761411|NCT00937768|540255009|FG000|Overall Study|Alternate Treatment|0|||
149761412|NCT00937768|540255010|FG001|Overall Study|Alternate Treatment|1|||
149761413|NCT00937768|540255009|FG000|Overall Study|No Further Funding|4|||
149761414|NCT00937768|540255010|FG001|Overall Study|No Further Funding|4|||
149761415|NCT00992446|540255016|FG000|Overall Study|Disease Progression|1|||
149761416|NCT00992446|540255016|FG000|Overall Study|Withdrawal by Subject|2|||
149761417|NCT00992446|540255016|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
149761418|NCT00755846|540257228|FG000|Overall Study|Adverse Event|0|||
149761419|NCT00755846|540257229|FG001|Overall Study|Adverse Event|0|||
149761420|NCT00755846|540257230|FG002|Overall Study|Adverse Event|0|||
149761421|NCT00755846|540257231|FG003|Overall Study|Adverse Event|1|||
149761422|NCT00755846|540257232|FG004|Overall Study|Adverse Event|3|||
149761423|NCT00755846|540257233|FG005|Overall Study|Adverse Event|2|||
149761424|NCT00755846|540257228|FG000|Overall Study|Protocol Violation|1|||
149761425|NCT00755846|540257229|FG001|Overall Study|Protocol Violation|1|||
149761426|NCT00755846|540257230|FG002|Overall Study|Protocol Violation|1|||
149761427|NCT00755846|540257231|FG003|Overall Study|Protocol Violation|1|||
149761428|NCT00755846|540257232|FG004|Overall Study|Protocol Violation|1|||
149761429|NCT00755846|540257233|FG005|Overall Study|Protocol Violation|1|||
149761430|NCT00755846|540257228|FG000|Overall Study|Lost to Follow-up|0|||
149761431|NCT00755846|540257229|FG001|Overall Study|Lost to Follow-up|2|||
149761432|NCT00755846|540257230|FG002|Overall Study|Lost to Follow-up|1|||
149761433|NCT00755846|540257231|FG003|Overall Study|Lost to Follow-up|0|||
149761434|NCT00755846|540257232|FG004|Overall Study|Lost to Follow-up|4|||
149761435|NCT00755846|540257233|FG005|Overall Study|Lost to Follow-up|2|||
149761436|NCT00755846|540257228|FG000|Overall Study|Withdrawal by Subject|2|||
149761437|NCT00755846|540257229|FG001|Overall Study|Withdrawal by Subject|3|||
149761438|NCT00755846|540257230|FG002|Overall Study|Withdrawal by Subject|5|||
149761439|NCT00755846|540257231|FG003|Overall Study|Withdrawal by Subject|2|||
149761440|NCT00755846|540257232|FG004|Overall Study|Withdrawal by Subject|0|||
149761441|NCT00755846|540257233|FG005|Overall Study|Withdrawal by Subject|1|||
149761442|NCT00755846|540257228|FG000|Overall Study|Hyperglycemic Rescue|21|||
149761443|NCT00755846|540257229|FG001|Overall Study|Hyperglycemic Rescue|7|||
149761444|NCT00755846|540257230|FG002|Overall Study|Hyperglycemic Rescue|5|||
149761445|NCT00755846|540257231|FG003|Overall Study|Hyperglycemic Rescue|8|||
149761446|NCT00755846|540257232|FG004|Overall Study|Hyperglycemic Rescue|8|||
149761447|NCT00755846|540257233|FG005|Overall Study|Hyperglycemic Rescue|7|||
149761448|NCT00755846|540257228|FG000|Overall Study|Physician Decision|1|||
149761449|NCT00755846|540257229|FG001|Overall Study|Physician Decision|3|||
149761450|NCT00755846|540257230|FG002|Overall Study|Physician Decision|0|||
149761451|NCT00755846|540257231|FG003|Overall Study|Physician Decision|1|||
149761452|NCT00755846|540257232|FG004|Overall Study|Physician Decision|0|||
149761453|NCT00755846|540257233|FG005|Overall Study|Physician Decision|1|||
149761454|NCT00755846|540257228|FG000|Overall Study|Administrative Error|0|||
149761455|NCT00755846|540257229|FG001|Overall Study|Administrative Error|1|||
149761456|NCT00755846|540257230|FG002|Overall Study|Administrative Error|0|||
149761457|NCT00755846|540257231|FG003|Overall Study|Administrative Error|0|||
149761458|NCT00755846|540257232|FG004|Overall Study|Administrative Error|0|||
149761459|NCT00755846|540257233|FG005|Overall Study|Administrative Error|0|||
149761460|NCT00755846|540257228|FG000|Overall Study|Participant Non-compliance|0|||
149761461|NCT00755846|540257229|FG001|Overall Study|Participant Non-compliance|0|||
149761462|NCT00755846|540257230|FG002|Overall Study|Participant Non-compliance|0|||
149761463|NCT00755846|540257231|FG003|Overall Study|Participant Non-compliance|0|||
149761464|NCT00755846|540257232|FG004|Overall Study|Participant Non-compliance|1|||
149761465|NCT00755846|540257233|FG005|Overall Study|Participant Non-compliance|0|||
149761466|NCT02922634|540257244|FG000|Overall Study|Withdrawal by Subject|5|||
149761467|NCT02922634|540257244|FG000|Overall Study|Did not have their surgery|5|||
149761468|NCT02723604|540257245|FG000|Overall Study|ineligible|1|||
149761469|NCT02723604|540257245|FG000|Overall Study|never received treatment|1|||
149761470|NCT00311181|540257246|FG000|Overall Study|Final DFTs were not obtained|96|||
149761471|NCT00506948|540257252|FG000|Overall Study|Death|4|||
149761472|NCT00506948|540257252|FG000|Overall Study|Adverse Event|5|||
149761473|NCT00506948|540257252|FG000|Overall Study|Physician Decision|1|||
149761474|NCT02395653|540257253|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
149761475|NCT02395653|540257253|FG000|Overall Study|Consent Withdrawn at Screening|1|||
149761476|NCT02395653|540257253|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
149761477|NCT02395653|540257253|FG000|Overall Study|Investigator Decision at Screening|1|||
149761478|NCT02395653|540257253|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
149761479|NCT02395653|540257253|FG000|Overall Study|Withdrawal by Subject|1|||
149761480|NCT02395653|540257253|FG000|Overall Study|Lost to Follow-up|1|||
149761481|NCT01194804|540257254|FG000|Overall Study|Withdrawal by Subject|1|||
149761482|NCT02494778|540257255|FG000|Overall Study|Death|3|||
149761483|NCT02494778|540257255|FG000|Overall Study|Other|173|||
149761484|NCT02494778|540257255|FG000|Overall Study|Lack of Efficacy|4|||
149761485|NCT02494778|540257255|FG000|Overall Study|Adverse Event|18|||
149761486|NCT02494778|540257255|FG000|Overall Study|Withdrawal by Subject|20|||
149761487|NCT02494778|540257255|FG000|Overall Study|Lost to Follow-up|2|||
149761488|NCT02494778|540257255|FG000|Overall Study|Noncompliant with study drug admin.|1|||
149761489|NCT01303380|540257256|FG000|Overall Study|Lack of compliance to study procedures|1|||
149761490|NCT03621943|540257257|FG000|First Randomized Intervention|Lost to Follow-up|51|||
149761491|NCT03621943|540257258|FG001|First Randomized Intervention|Lost to Follow-up|54|||
149761492|NCT03621943|540257257|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
149761493|NCT03621943|540257258|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
149761494|NCT03621943|540257257|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
149761495|NCT03621943|540257258|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
149761496|NCT03621943|540257257|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
149761497|NCT03621943|540257258|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
149761498|NCT02174861|540257259|FG000|Overall Study|Decision by sponsor|8|||
149761499|NCT02174861|540257259|FG000|Overall Study|Withdrawal by Subject|124|||
149761500|NCT02174861|540257259|FG000|Overall Study|Lost to Follow-up|26|||
149761501|NCT01215734|540257260|FG000|Overall Study|Death|0|||
149761502|NCT01215734|540257261|FG001|Overall Study|Death|1|||
149761503|NCT00315705|540257262|FG000|Phase 1|Refused further treatment|1|||
149761504|NCT00315705|540257262|FG000|Phase 1|Failure to achieve response|8|||
149761505|NCT00315705|540257262|FG000|Phase 1|Disease relapse|4|||
149761506|NCT00315705|540257262|FG000|Phase 1|Scheduled for transplant|9|||
149761507|NCT00315705|540257262|FG000|Phase 1|Death|3|||
149761508|NCT00315705|540257262|FG000|Phase 2|Physician Decision|4|||
149761509|NCT00315705|540257262|FG000|Phase 2|Adverse Event|1|||
149761510|NCT00315705|540257262|FG000|Phase 2|Failure to achieve response|3|||
149761511|NCT00315705|540257262|FG000|Phase 2|Disease relapse|1|||
149761512|NCT00315705|540257262|FG000|Phase 2|Scheduled for transplant|8|||
149761513|NCT00315705|540257262|FG000|Phase 2|Other|1|||
149761514|NCT00315705|540257262|FG000|Phase 2|Death|7|||
149761515|NCT01716533|540257263|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
149761516|NCT01716533|540257264|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
149761517|NCT01716533|540257265|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
149761518|NCT01716533|540257266|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
149761519|NCT01716533|540257263|FG000|Overall Study|Withdrawal by Subject|0|||
149761520|NCT01716533|540257264|FG001|Overall Study|Withdrawal by Subject|0|||
149761521|NCT01716533|540257265|FG002|Overall Study|Withdrawal by Subject|0|||
149761522|NCT01716533|540257266|FG003|Overall Study|Withdrawal by Subject|5|||
149761523|NCT01716533|540257263|FG000|Overall Study|Death|0|||
149761524|NCT01716533|540257264|FG001|Overall Study|Death|0|||
149761525|NCT01716533|540257265|FG002|Overall Study|Death|0|||
149761526|NCT01716533|540257266|FG003|Overall Study|Death|2|||
149761527|NCT01716533|540257263|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
149761528|NCT01716533|540257264|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
149761529|NCT01716533|540257265|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
149761530|NCT01716533|540257266|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
149761531|NCT00165841|540257274|FG000|Overall Study|Adverse Event|2|||
149761532|NCT00165841|540257275|FG001|Overall Study|Adverse Event|3|||
149761533|NCT00165841|540257274|FG000|Overall Study|Lack of Efficacy|6|||
149761534|NCT00165841|540257275|FG001|Overall Study|Lack of Efficacy|33|||
149761535|NCT00165841|540257274|FG000|Overall Study|Lost to Follow-up|4|||
149761536|NCT00165841|540257275|FG001|Overall Study|Lost to Follow-up|4|||
149761537|NCT00165841|540257274|FG000|Overall Study|Withdrawal by Subject|7|||
149761538|NCT00165841|540257275|FG001|Overall Study|Withdrawal by Subject|8|||
149761539|NCT00165841|540257274|FG000|Overall Study|Physician Decision|1|||
149761540|NCT00165841|540257275|FG001|Overall Study|Physician Decision|0|||
149761541|NCT00165841|540257274|FG000|Overall Study|Protocol Violation|6|||
149761542|NCT00165841|540257275|FG001|Overall Study|Protocol Violation|8|||
149761543|NCT00165841|540257274|FG000|Overall Study|Other|3|||
149761544|NCT00165841|540257275|FG001|Overall Study|Other|5|||
149761545|NCT00165841|540257274|FG000|Overall Study|Medication Noncompliance|1|||
149761546|NCT00165841|540257275|FG001|Overall Study|Medication Noncompliance|1|||
149761547|NCT00789958|540257276|FG000|Overall Study|Adverse Event|3|||
149761548|NCT00789958|540257276|FG000|Overall Study|Withdrawal by Subject|4|||
149761549|NCT00789958|540257276|FG000|Overall Study|Progression|3|||
149761550|NCT00789958|540257276|FG000|Overall Study|not protocol specified|1|||
149761551|NCT00789958|540257276|FG000|Overall Study|Not eligible/not analyzable|26|||
149761552|NCT00296725|540257277|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
149761553|NCT00296725|540257277|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
149761554|NCT00296725|540257277|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
149761555|NCT00487084|540257278|FG000|Overall Study|Did not receive intervention|4|||
149761556|NCT00487084|540257279|FG001|Overall Study|Did not receive intervention|3|||
149761557|NCT00487084|540257280|FG002|Overall Study|Did not receive intervention|5|||
149761558|NCT00254293|540257281|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149761559|NCT00254293|540257282|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
149761560|NCT00254293|540257283|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149761561|NCT00254293|540257284|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
149761562|NCT00254293|540257285|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149761563|NCT00254293|540257286|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149761564|NCT00254293|540257287|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149761565|NCT00254293|540257281|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761566|NCT00254293|540257282|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761567|NCT00254293|540257283|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
149761568|NCT00254293|540257284|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761569|NCT00254293|540257285|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761570|NCT00254293|540257286|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761571|NCT00254293|540257287|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149761572|NCT00254293|540257281|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761573|NCT00254293|540257282|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761574|NCT00254293|540257283|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
149761575|NCT00254293|540257284|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761576|NCT00254293|540257285|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761577|NCT00254293|540257286|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761578|NCT00254293|540257287|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149761579|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Death|0|||
149761580|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Death|0|||
149761581|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Death|1|||
149761582|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Death|0|||
149761583|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Death|0|||
149761584|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Death|0|||
149761585|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Death|0|||
149761586|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
149761587|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149761588|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
149761589|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149761590|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
149761591|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149761592|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149761593|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
149761594|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149761595|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
149761596|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149761597|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
149761598|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149761599|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149761600|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761601|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761602|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
149761603|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761604|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761605|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761606|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149761607|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761608|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761609|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
149761610|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761611|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761612|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761613|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149761614|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761615|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761616|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
149761617|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761618|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761619|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761620|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149761621|NCT00254293|540257281|FG000|LTE Open Label Variable SC Dosing|Other|0|||
149761622|NCT00254293|540257282|FG001|LTE Open Label Variable SC Dosing|Other|0|||
149761623|NCT00254293|540257283|FG002|LTE Open Label Variable SC Dosing|Other|2|||
149761624|NCT00254293|540257284|FG003|LTE Open Label Variable SC Dosing|Other|0|||
149761625|NCT00254293|540257285|FG004|LTE Open Label Variable SC Dosing|Other|0|||
149761626|NCT00254293|540257286|FG005|LTE Open Label Variable SC Dosing|Other|0|||
149761627|NCT00254293|540257287|FG006|LTE Open Label Variable SC Dosing|Other|0|||
149761628|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Death|0|||
149761629|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Death|0|||
149761630|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Death|0|||
149761631|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Death|0|||
149761632|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Death|0|||
149761633|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Death|0|||
149761634|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Death|3|||
149761635|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761636|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761637|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761638|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761639|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761640|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
149761641|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
149761642|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761643|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761644|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761645|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761646|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761647|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149761648|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
149761649|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761650|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761651|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761652|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761653|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761654|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149761655|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
149761656|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761657|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761658|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761659|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761660|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761661|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149761662|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
149761663|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761664|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761665|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761666|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761667|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761668|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149761669|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
149761670|NCT00254293|540257281|FG000|LTE Open Label Fixed Dosing|Other|0|||
149761671|NCT00254293|540257282|FG001|LTE Open Label Fixed Dosing|Other|0|||
149761672|NCT00254293|540257283|FG002|LTE Open Label Fixed Dosing|Other|0|||
149761673|NCT00254293|540257284|FG003|LTE Open Label Fixed Dosing|Other|0|||
149761674|NCT00254293|540257285|FG004|LTE Open Label Fixed Dosing|Other|0|||
149761675|NCT00254293|540257286|FG005|LTE Open Label Fixed Dosing|Other|0|||
149761676|NCT00254293|540257287|FG006|LTE Open Label Fixed Dosing|Other|1|||
149761677|NCT03712345|540257297|FG000|Overall Study|Failure to meet randomization criteria|0|||
149761678|NCT03712345|540257298|FG001|Overall Study|Failure to meet randomization criteria|0|||
149761679|NCT03712345|540257299|FG002|Overall Study|Failure to meet randomization criteria|1|||
149761680|NCT00839423|540257304|FG000|Overall Study|Adverse Event|4|||
149761681|NCT00839423|540257305|FG001|Overall Study|Adverse Event|3|||
149761682|NCT00839423|540257306|FG002|Overall Study|Adverse Event|7|||
149761683|NCT00839423|540257307|FG003|Overall Study|Adverse Event|16|||
149761684|NCT00839423|540257304|FG000|Overall Study|Lack of Efficacy|6|||
149761685|NCT00839423|540257305|FG001|Overall Study|Lack of Efficacy|6|||
149761686|NCT00839423|540257306|FG002|Overall Study|Lack of Efficacy|3|||
149761687|NCT00839423|540257307|FG003|Overall Study|Lack of Efficacy|2|||
149761688|NCT00839423|540257304|FG000|Overall Study|Non-compliance|0|||
149761689|NCT00839423|540257305|FG001|Overall Study|Non-compliance|0|||
149761690|NCT00839423|540257306|FG002|Overall Study|Non-compliance|0|||
149761691|NCT00839423|540257307|FG003|Overall Study|Non-compliance|1|||
149761692|NCT00839423|540257304|FG000|Overall Study|Protocol Violation|0|||
149761693|NCT00839423|540257305|FG001|Overall Study|Protocol Violation|1|||
149761694|NCT00839423|540257306|FG002|Overall Study|Protocol Violation|2|||
149761695|NCT00839423|540257307|FG003|Overall Study|Protocol Violation|0|||
149761696|NCT00839423|540257304|FG000|Overall Study|Withdrawal of consent|4|||
149761697|NCT00839423|540257305|FG001|Overall Study|Withdrawal of consent|0|||
149761698|NCT00839423|540257306|FG002|Overall Study|Withdrawal of consent|4|||
149761699|NCT00839423|540257307|FG003|Overall Study|Withdrawal of consent|1|||
149761700|NCT00839423|540257304|FG000|Overall Study|Lost to Follow-up|1|||
149761701|NCT00839423|540257305|FG001|Overall Study|Lost to Follow-up|0|||
149761702|NCT00839423|540257306|FG002|Overall Study|Lost to Follow-up|1|||
149761703|NCT00839423|540257307|FG003|Overall Study|Lost to Follow-up|0|||
149761704|NCT00839423|540257304|FG000|Overall Study|Administrative or other reasons|3|||
149761705|NCT00839423|540257305|FG001|Overall Study|Administrative or other reasons|0|||
149761706|NCT00839423|540257306|FG002|Overall Study|Administrative or other reasons|1|||
149761707|NCT00839423|540257307|FG003|Overall Study|Administrative or other reasons|0|||
149761708|NCT01071096|540257308|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
149761709|NCT01071096|540257309|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
149761710|NCT02585999|540257310|FG000|Overall Study|Lost to Follow-up|1|||
149761711|NCT02585999|540257310|FG000|Overall Study|Protocol Violation|1|||
149761712|NCT01332019|540257311|FG000|Overall Study|Was Not Dosed|1|||
149761713|NCT01332019|540257312|FG001|Overall Study|Was Not Dosed|0|||
149761714|NCT01332019|540257311|FG000|Overall Study|Other|16|||
149761715|NCT01332019|540257312|FG001|Overall Study|Other|18|||
149761716|NCT01332019|540257311|FG000|Overall Study|Death|2|||
149761717|NCT01332019|540257312|FG001|Overall Study|Death|1|||
149761718|NCT01332019|540257311|FG000|Overall Study|Physician Decision|4|||
149761719|NCT01332019|540257312|FG001|Overall Study|Physician Decision|3|||
149761720|NCT01332019|540257311|FG000|Overall Study|Withdrawal by Subject|73|||
149761721|NCT01332019|540257312|FG001|Overall Study|Withdrawal by Subject|71|||
149761722|NCT01332019|540257311|FG000|Overall Study|Lost to Follow-up|4|||
149761723|NCT01332019|540257312|FG001|Overall Study|Lost to Follow-up|7|||
149761724|NCT01332019|540257311|FG000|Overall Study|Adverse Event|13|||
149761725|NCT01332019|540257312|FG001|Overall Study|Adverse Event|22|||
149761726|NCT01369849|540257313|FG000|Overall Study|Ineligible prior to treatment|0|||
149761727|NCT01369849|540257314|FG001|Overall Study|Ineligible prior to treatment|0|||
149761728|NCT01369849|540257315|FG002|Overall Study|Ineligible prior to treatment|1|||
149761729|NCT01369849|540257313|FG000|Overall Study|Ineligible after receiving treatment|0|||
149761730|NCT01369849|540257314|FG001|Overall Study|Ineligible after receiving treatment|1|||
149761731|NCT01369849|540257315|FG002|Overall Study|Ineligible after receiving treatment|0|||
149761732|NCT00871377|540257316|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149761733|NCT00871377|540257317|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149761734|NCT00871377|540257318|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
149761735|NCT00871377|540257319|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149761736|NCT00871377|540257320|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149761737|NCT00871377|540257321|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149761738|NCT00871377|540257316|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149761739|NCT00871377|540257317|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149761740|NCT00871377|540257318|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149761741|NCT00871377|540257319|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149761742|NCT00871377|540257320|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149761743|NCT00871377|540257321|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
149761744|NCT00871377|540257316|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
149761745|NCT00871377|540257317|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761746|NCT00871377|540257318|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761747|NCT00871377|540257319|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761748|NCT00871377|540257320|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761749|NCT00871377|540257321|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761750|NCT00871377|540257316|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761751|NCT00871377|540257317|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761752|NCT00871377|540257318|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761753|NCT00871377|540257319|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761754|NCT00871377|540257320|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
149761755|NCT00871377|540257321|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
149761756|NCT00871377|540257316|FG000|Third Intervention (10 Weeks)|Death|0|||
149761757|NCT00871377|540257317|FG001|Third Intervention (10 Weeks)|Death|0|||
149761758|NCT00871377|540257318|FG002|Third Intervention (10 Weeks)|Death|0|||
149761759|NCT00871377|540257319|FG003|Third Intervention (10 Weeks)|Death|1|||
149761760|NCT00871377|540257320|FG004|Third Intervention (10 Weeks)|Death|0|||
149761761|NCT00871377|540257321|FG005|Third Intervention (10 Weeks)|Death|0|||
149761762|NCT02179515|540257326|FG000|Overall Study|switched to alternative treatment|0|||
149761763|NCT02179515|540257327|FG001|Overall Study|switched to alternative treatment|1|||
149761764|NCT02179515|540257328|FG002|Overall Study|switched to alternative treatment|1|||
149761765|NCT02179515|540257326|FG000|Overall Study|Death|0|||
149761766|NCT02179515|540257327|FG001|Overall Study|Death|1|||
149761767|NCT02179515|540257328|FG002|Overall Study|Death|1|||
149761768|NCT02179515|540257326|FG000|Overall Study|refused further treatment|0|||
149761769|NCT02179515|540257327|FG001|Overall Study|refused further treatment|3|||
149761770|NCT02179515|540257328|FG002|Overall Study|refused further treatment|4|||
149761771|NCT02179515|540257326|FG000|Overall Study|Disease progression on study|2|||
149761772|NCT02179515|540257327|FG001|Overall Study|Disease progression on study|11|||
149761773|NCT02179515|540257328|FG002|Overall Study|Disease progression on study|8|||
149761774|NCT02116660|540257329|FG000|Overall Study|Deteriorating renal function|0|||
149761775|NCT02116660|540257330|FG001|Overall Study|Deteriorating renal function|1|||
149761776|NCT02116660|540257329|FG000|Overall Study|Adverse Event|1|||
149761777|NCT02116660|540257330|FG001|Overall Study|Adverse Event|1|||
149761778|NCT02116660|540257329|FG000|Overall Study|Withdrawal by Subject|0|||
149761779|NCT02116660|540257330|FG001|Overall Study|Withdrawal by Subject|2|||
149761780|NCT02116660|540257329|FG000|Overall Study|Organization reason|1|||
149761781|NCT02116660|540257330|FG001|Overall Study|Organization reason|0|||
149761782|NCT01718509|540257331|FG000|Overall Study|Lost to Follow-up|18|||
149761783|NCT01718509|540257332|FG001|Overall Study|Lost to Follow-up|15|||
149761784|NCT01718509|540257331|FG000|Overall Study|Withdrawal by Subject|7|||
149761785|NCT01718509|540257332|FG001|Overall Study|Withdrawal by Subject|13|||
149761786|NCT01718509|540257331|FG000|Overall Study|Adverse Event|5|||
149761787|NCT01718509|540257332|FG001|Overall Study|Adverse Event|7|||
149761788|NCT01718509|540257331|FG000|Overall Study|Other|13|||
149761789|NCT01718509|540257332|FG001|Overall Study|Other|11|||
149761790|NCT01718509|540257331|FG000|Overall Study|Protocol Violation|4|||
149761791|NCT01718509|540257332|FG001|Overall Study|Protocol Violation|2|||
149761792|NCT01718509|540257331|FG000|Overall Study|Lack of Efficacy|1|||
149761793|NCT01718509|540257332|FG001|Overall Study|Lack of Efficacy|0|||
149761794|NCT02561299|540257333|FG000|Overall Study|Death|2|||
149761795|NCT02561299|540257334|FG001|Overall Study|Death|4|||
149761796|NCT02561299|540257333|FG000|Overall Study|Lost to Follow-up|1|||
149761797|NCT02561299|540257334|FG001|Overall Study|Lost to Follow-up|0|||
149761798|NCT02561299|540257333|FG000|Overall Study|Withdrawal by Subject|2|||
149761799|NCT02561299|540257334|FG001|Overall Study|Withdrawal by Subject|2|||
149761800|NCT05906732|540257335|FG000|Overall Study|Withdrawal by Subject|1|||
149761801|NCT05906732|540257336|FG001|Overall Study|Withdrawal by Subject|0|||
149761802|NCT05906732|540257337|FG002|Overall Study|Withdrawal by Subject|0|||
149761803|NCT05906732|540257338|FG003|Overall Study|Withdrawal by Subject|0|||
149761804|NCT05906732|540257335|FG000|Overall Study|Physician Decision|2|||
149761805|NCT05906732|540257336|FG001|Overall Study|Physician Decision|4|||
149761806|NCT05906732|540257337|FG002|Overall Study|Physician Decision|0|||
149761807|NCT05906732|540257338|FG003|Overall Study|Physician Decision|0|||
149761808|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149761809|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149761810|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149761811|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
149761812|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149761813|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
149761814|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761815|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
149761816|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
149761817|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149761818|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
149761819|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
149761820|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149761821|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
149761822|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761823|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761824|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761825|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761826|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761827|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761828|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761829|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761830|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149761831|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149761832|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149761833|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149761834|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149761835|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149761836|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149761837|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
149761838|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149761839|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149761840|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761841|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761842|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149761843|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149761844|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
149761845|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761846|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761847|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761848|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761849|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761850|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761851|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761852|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761853|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149761854|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761855|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761856|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761857|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761858|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761859|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761860|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761861|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761862|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761863|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761864|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761865|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761866|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761867|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
149761868|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761869|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761870|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761871|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761872|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761873|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761874|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761875|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761876|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149761877|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
149761878|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
149761879|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
149761880|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
149761881|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
149761882|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
149761883|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
149761884|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
149761885|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
149761886|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
149761887|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
149761888|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
149761889|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
149761890|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
149761891|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
149761892|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
149761893|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
149761894|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
149761895|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
149761896|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
149761897|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
149761898|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
149761899|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
149761900|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761901|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761902|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761903|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761904|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761905|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761906|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761907|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761908|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
149761909|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761910|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761911|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761912|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761913|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
149761914|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761915|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761916|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761917|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761918|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761919|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761920|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761921|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761922|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149761923|NCT02052778|540257339|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761924|NCT02052778|540257340|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761925|NCT02052778|540257341|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761926|NCT02052778|540257342|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761927|NCT02052778|540257343|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761928|NCT02052778|540257344|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
149761929|NCT02052778|540257345|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761930|NCT02052778|540257346|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761931|NCT02052778|540257347|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761932|NCT02052778|540257348|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761933|NCT02052778|540257349|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761934|NCT02052778|540257350|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761935|NCT02052778|540257351|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
149761936|NCT02052778|540257352|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761937|NCT02052778|540257353|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761938|NCT02052778|540257354|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761939|NCT02052778|540257355|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761940|NCT02052778|540257356|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761941|NCT02052778|540257357|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761942|NCT02052778|540257358|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761943|NCT02052778|540257359|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761944|NCT02052778|540257360|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761945|NCT02052778|540257361|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149761946|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761947|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761948|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761949|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761950|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761951|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761952|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761953|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761954|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761955|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761956|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761957|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761958|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761959|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761960|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
149761961|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
149761962|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
149761963|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
149761964|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
149761965|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
149761966|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
149761967|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
149761968|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149761969|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761970|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761971|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761972|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761973|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761974|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761975|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761976|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761977|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761978|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761979|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761980|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761981|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761982|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761983|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
149761984|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
149761985|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761986|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
149761987|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
149761988|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
149761989|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
149761990|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
149761991|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149761992|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761993|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761994|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761995|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761996|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761997|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761998|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149761999|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762000|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762001|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762002|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762003|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762004|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762005|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762006|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
149762007|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
149762008|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
149762009|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762010|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
149762011|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
149762012|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762013|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762014|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149762015|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762016|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762017|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762018|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762019|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762020|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762021|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762022|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762023|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762024|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762025|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762026|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762027|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762028|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762029|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
149762030|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
149762031|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762032|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762033|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762034|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762035|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762036|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762037|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149762038|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762039|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762040|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762041|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762042|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762043|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762044|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762045|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762046|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762047|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762048|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762049|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762050|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762051|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762052|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
149762053|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
149762054|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762055|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762056|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762057|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
149762058|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762059|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762060|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149762061|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
149762062|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
149762063|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
149762064|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
149762065|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
149762066|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
149762067|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
149762068|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
149762069|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
149762070|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
149762071|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
149762072|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
149762073|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
149762074|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
149762075|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
149762076|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
149762077|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
149762078|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
149762079|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
149762080|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
149762081|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
149762082|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
149762083|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
149762084|NCT02052778|540257339|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762085|NCT02052778|540257340|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762086|NCT02052778|540257341|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762087|NCT02052778|540257342|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762088|NCT02052778|540257343|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762089|NCT02052778|540257344|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762090|NCT02052778|540257345|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762091|NCT02052778|540257346|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762092|NCT02052778|540257347|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762093|NCT02052778|540257348|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762094|NCT02052778|540257349|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762095|NCT02052778|540257350|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762096|NCT02052778|540257351|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762097|NCT02052778|540257352|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762098|NCT02052778|540257353|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149762099|NCT02052778|540257354|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149762100|NCT02052778|540257355|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149762101|NCT02052778|540257356|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762102|NCT02052778|540257357|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149762103|NCT02052778|540257358|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762104|NCT02052778|540257359|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762105|NCT02052778|540257360|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762106|NCT02052778|540257361|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149762107|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762108|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762109|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762110|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762111|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762112|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762113|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762114|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762115|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762116|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762117|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762118|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762119|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762120|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762121|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762122|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762123|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762124|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762125|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762126|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762127|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762128|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149762129|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
149762130|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762131|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762132|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762133|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762134|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762135|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762136|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762137|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762138|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762139|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762140|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762141|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762142|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762143|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762144|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762145|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762146|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762147|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762148|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762149|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762150|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762151|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149762152|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
149762153|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762154|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762155|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762156|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762157|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762158|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762159|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762160|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762161|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762162|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762163|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762164|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762165|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762166|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762167|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762168|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762169|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762170|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762171|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762172|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762173|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762174|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149762175|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
149762176|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762177|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762178|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762179|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762180|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762181|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762182|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762183|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762184|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762185|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762186|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762187|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762188|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762189|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762190|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762191|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762192|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762193|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762194|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762195|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762196|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762197|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149762198|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
149762199|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762200|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762201|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762202|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762203|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762204|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762205|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762206|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762207|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762208|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762209|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762210|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762211|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762212|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762213|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762214|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762215|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762216|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762217|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762218|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762219|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762220|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149762221|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
149762222|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
149762223|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
149762224|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
149762225|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
149762226|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
149762227|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
149762228|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
149762229|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
149762230|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
149762231|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
149762232|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
149762233|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
149762234|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
149762235|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
149762236|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
149762237|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
149762238|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
149762239|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
149762240|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
149762241|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
149762242|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
149762243|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
149762244|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
149762245|NCT02052778|540257339|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762246|NCT02052778|540257340|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762247|NCT02052778|540257341|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762248|NCT02052778|540257342|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762249|NCT02052778|540257343|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762250|NCT02052778|540257344|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762251|NCT02052778|540257345|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762252|NCT02052778|540257346|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762253|NCT02052778|540257347|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762254|NCT02052778|540257348|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762255|NCT02052778|540257349|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762256|NCT02052778|540257350|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762257|NCT02052778|540257351|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762258|NCT02052778|540257352|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762259|NCT02052778|540257353|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762260|NCT02052778|540257354|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762261|NCT02052778|540257355|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762262|NCT02052778|540257356|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762263|NCT02052778|540257357|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762264|NCT02052778|540257358|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762265|NCT02052778|540257359|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762266|NCT02052778|540257360|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
149762267|NCT02052778|540257361|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
149762268|NCT02864940|540257368|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
149762269|NCT02864940|540257369|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
149762270|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
149762271|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762272|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762273|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762274|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762275|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762276|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762277|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762278|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149762279|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
149762280|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762281|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762282|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762283|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762284|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762285|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762286|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762287|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149762288|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
149762289|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762290|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762291|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762292|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762293|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762294|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762295|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762296|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149762297|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
149762298|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762299|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762300|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762301|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762302|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762303|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762304|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762305|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
149762306|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
149762307|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762308|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762309|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762310|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762311|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762312|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762313|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762314|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149762315|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
149762316|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762317|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762318|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762319|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762320|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762321|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762322|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762323|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149762324|NCT02175771|540257370|FG000|Run-In Period (Pre-assignment)|Other|8|||
149762325|NCT02175771|540257371|FG001|Run-In Period (Pre-assignment)|Other|0|||
149762326|NCT02175771|540257372|FG002|Run-In Period (Pre-assignment)|Other|0|||
149762327|NCT02175771|540257373|FG003|Run-In Period (Pre-assignment)|Other|0|||
149762328|NCT02175771|540257374|FG004|Run-In Period (Pre-assignment)|Other|0|||
149762329|NCT02175771|540257375|FG005|Run-In Period (Pre-assignment)|Other|0|||
149762330|NCT02175771|540257376|FG006|Run-In Period (Pre-assignment)|Other|0|||
149762331|NCT02175771|540257377|FG007|Run-In Period (Pre-assignment)|Other|0|||
149762332|NCT02175771|540257378|FG008|Run-In Period (Pre-assignment)|Other|0|||
149762333|NCT02175771|540257370|FG000|Treatment Period|Adverse Event|0|||
149762334|NCT02175771|540257371|FG001|Treatment Period|Adverse Event|2|||
149762335|NCT02175771|540257372|FG002|Treatment Period|Adverse Event|1|||
149762336|NCT02175771|540257373|FG003|Treatment Period|Adverse Event|1|||
149762337|NCT02175771|540257374|FG004|Treatment Period|Adverse Event|1|||
149762338|NCT02175771|540257375|FG005|Treatment Period|Adverse Event|3|||
149762339|NCT02175771|540257376|FG006|Treatment Period|Adverse Event|2|||
149762340|NCT02175771|540257377|FG007|Treatment Period|Adverse Event|0|||
149762341|NCT02175771|540257378|FG008|Treatment Period|Adverse Event|1|||
149762342|NCT02175771|540257370|FG000|Treatment Period|Withdrawal by Subject|0|||
149762343|NCT02175771|540257371|FG001|Treatment Period|Withdrawal by Subject|9|||
149762344|NCT02175771|540257372|FG002|Treatment Period|Withdrawal by Subject|3|||
149762345|NCT02175771|540257373|FG003|Treatment Period|Withdrawal by Subject|6|||
149762346|NCT02175771|540257374|FG004|Treatment Period|Withdrawal by Subject|2|||
149762347|NCT02175771|540257375|FG005|Treatment Period|Withdrawal by Subject|4|||
149762348|NCT02175771|540257376|FG006|Treatment Period|Withdrawal by Subject|2|||
149762349|NCT02175771|540257377|FG007|Treatment Period|Withdrawal by Subject|9|||
149762350|NCT02175771|540257378|FG008|Treatment Period|Withdrawal by Subject|2|||
149762351|NCT02175771|540257370|FG000|Treatment Period|Noncompliance|0|||
149762352|NCT02175771|540257371|FG001|Treatment Period|Noncompliance|1|||
149762353|NCT02175771|540257372|FG002|Treatment Period|Noncompliance|2|||
149762354|NCT02175771|540257373|FG003|Treatment Period|Noncompliance|0|||
149762355|NCT02175771|540257374|FG004|Treatment Period|Noncompliance|0|||
149762356|NCT02175771|540257375|FG005|Treatment Period|Noncompliance|0|||
149762357|NCT02175771|540257376|FG006|Treatment Period|Noncompliance|0|||
149762358|NCT02175771|540257377|FG007|Treatment Period|Noncompliance|0|||
149762359|NCT02175771|540257378|FG008|Treatment Period|Noncompliance|1|||
149762360|NCT02175771|540257370|FG000|Treatment Period|Protocol Violation|0|||
149762361|NCT02175771|540257371|FG001|Treatment Period|Protocol Violation|0|||
149762362|NCT02175771|540257372|FG002|Treatment Period|Protocol Violation|0|||
149762363|NCT02175771|540257373|FG003|Treatment Period|Protocol Violation|0|||
149762364|NCT02175771|540257374|FG004|Treatment Period|Protocol Violation|0|||
149762365|NCT02175771|540257375|FG005|Treatment Period|Protocol Violation|0|||
149762366|NCT02175771|540257376|FG006|Treatment Period|Protocol Violation|0|||
149762367|NCT02175771|540257377|FG007|Treatment Period|Protocol Violation|1|||
149762368|NCT02175771|540257378|FG008|Treatment Period|Protocol Violation|0|||
149762369|NCT02175771|540257370|FG000|Treatment Period|Disease progression|0|||
149762370|NCT02175771|540257371|FG001|Treatment Period|Disease progression|0|||
149762371|NCT02175771|540257372|FG002|Treatment Period|Disease progression|0|||
149762372|NCT02175771|540257373|FG003|Treatment Period|Disease progression|0|||
149762373|NCT02175771|540257374|FG004|Treatment Period|Disease progression|0|||
149762374|NCT02175771|540257375|FG005|Treatment Period|Disease progression|0|||
149762375|NCT02175771|540257376|FG006|Treatment Period|Disease progression|0|||
149762376|NCT02175771|540257377|FG007|Treatment Period|Disease progression|2|||
149762377|NCT02175771|540257378|FG008|Treatment Period|Disease progression|0|||
149762378|NCT02175771|540257370|FG000|Treatment Period|Lost to Follow-up|0|||
149762379|NCT02175771|540257371|FG001|Treatment Period|Lost to Follow-up|3|||
149762380|NCT02175771|540257372|FG002|Treatment Period|Lost to Follow-up|1|||
149762381|NCT02175771|540257373|FG003|Treatment Period|Lost to Follow-up|3|||
149762382|NCT02175771|540257374|FG004|Treatment Period|Lost to Follow-up|1|||
149762383|NCT02175771|540257375|FG005|Treatment Period|Lost to Follow-up|2|||
149762384|NCT02175771|540257376|FG006|Treatment Period|Lost to Follow-up|1|||
149762385|NCT02175771|540257377|FG007|Treatment Period|Lost to Follow-up|2|||
149762386|NCT02175771|540257378|FG008|Treatment Period|Lost to Follow-up|2|||
149762387|NCT02175771|540257370|FG000|Treatment Period|Lack of Efficacy|0|||
149762388|NCT02175771|540257371|FG001|Treatment Period|Lack of Efficacy|0|||
149762389|NCT02175771|540257372|FG002|Treatment Period|Lack of Efficacy|0|||
149762390|NCT02175771|540257373|FG003|Treatment Period|Lack of Efficacy|0|||
149762391|NCT02175771|540257374|FG004|Treatment Period|Lack of Efficacy|0|||
149762392|NCT02175771|540257375|FG005|Treatment Period|Lack of Efficacy|1|||
149762393|NCT02175771|540257376|FG006|Treatment Period|Lack of Efficacy|0|||
149762394|NCT02175771|540257377|FG007|Treatment Period|Lack of Efficacy|1|||
149762395|NCT02175771|540257378|FG008|Treatment Period|Lack of Efficacy|0|||
149762396|NCT02175771|540257370|FG000|Treatment Period|Other|0|||
149762397|NCT02175771|540257371|FG001|Treatment Period|Other|1|||
149762398|NCT02175771|540257372|FG002|Treatment Period|Other|0|||
149762399|NCT02175771|540257373|FG003|Treatment Period|Other|3|||
149762400|NCT02175771|540257374|FG004|Treatment Period|Other|1|||
149762401|NCT02175771|540257375|FG005|Treatment Period|Other|0|||
149762402|NCT02175771|540257376|FG006|Treatment Period|Other|0|||
149762403|NCT02175771|540257377|FG007|Treatment Period|Other|2|||
149762404|NCT02175771|540257378|FG008|Treatment Period|Other|0|||
149762405|NCT03558555|540257379|FG000|Overall Study|Lost to Follow-up|2|||
149762406|NCT03558555|540257380|FG001|Overall Study|Lost to Follow-up|1|||
149762407|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
149762408|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
149762409|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
149762410|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
149762411|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
149762412|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
149762413|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
149762414|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
149762415|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
149762416|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
149762417|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
149762418|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
149762419|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
149762420|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
149762421|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
149762422|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
149762423|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
149762424|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149762425|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
149762426|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
149762427|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
149762428|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149762429|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149762430|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149762431|NCT01106625|540257390|FG000|Core Period: Baseline to Week 26|Other|8|||
149762432|NCT01106625|540257391|FG001|Core Period: Baseline to Week 26|Other|7|||
149762433|NCT01106625|540257392|FG002|Core Period: Baseline to Week 26|Other|4|||
149762434|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149762435|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149762436|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
149762437|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
149762438|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
149762439|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
149762440|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
149762441|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149762442|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
149762443|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149762444|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149762445|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149762446|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
149762447|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149762448|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149762449|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
149762450|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
149762451|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
149762452|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
149762453|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
149762454|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
149762455|NCT01106625|540257390|FG000|Extension Period: Week 26 to Week 52|Other|5|||
149762456|NCT01106625|540257391|FG001|Extension Period: Week 26 to Week 52|Other|5|||
149762457|NCT01106625|540257392|FG002|Extension Period: Week 26 to Week 52|Other|4|||
149762458|NCT02496585|540257393|FG000|Overall Study|Death|3|||
149762459|NCT02496585|540257394|FG001|Overall Study|Death|0|||
149762460|NCT02496585|540257393|FG000|Overall Study|Lost to Follow-up|2|||
149762461|NCT02496585|540257394|FG001|Overall Study|Lost to Follow-up|0|||
149762462|NCT02496585|540257393|FG000|Overall Study|Withdrawal by Subject|1|||
149762463|NCT02496585|540257394|FG001|Overall Study|Withdrawal by Subject|2|||
149762464|NCT02496585|540257393|FG000|Overall Study|Progression of Malignancy|4|||
149762465|NCT02496585|540257394|FG001|Overall Study|Progression of Malignancy|1|||
149762466|NCT01100307|540257395|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
149762467|NCT01100307|540257396|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
149762468|NCT01100307|540257395|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
149762469|NCT01100307|540257396|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
149762470|NCT01100307|540257395|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
149762471|NCT01100307|540257396|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
149762472|NCT01100307|540257395|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
149762473|NCT01100307|540257396|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
149762474|NCT01100307|540257395|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
149762475|NCT01100307|540257396|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
149762476|NCT01100307|540257395|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
149762477|NCT01100307|540257396|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
149762478|NCT00997321|540257397|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
149762479|NCT00997321|540257398|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
149762480|NCT01276457|540257401|FG000|Core Study|Adverse Event|6|||
149762481|NCT01276457|540257402|FG001|Core Study|Adverse Event|3|||
149762482|NCT01276457|540257401|FG000|Core Study|Lost to Follow-up|1|||
149762483|NCT01276457|540257402|FG001|Core Study|Lost to Follow-up|2|||
149762484|NCT01276457|540257401|FG000|Core Study|Administrative problems|1|||
149762485|NCT01276457|540257402|FG001|Core Study|Administrative problems|1|||
149762486|NCT01276457|540257401|FG000|Core Study|Death|2|||
149762487|NCT01276457|540257402|FG001|Core Study|Death|2|||
149762488|NCT01276457|540257401|FG000|Core Study|Lack of Efficacy|3|||
149762489|NCT01276457|540257402|FG001|Core Study|Lack of Efficacy|12|||
149762490|NCT01276457|540257401|FG000|Extension Study|Lost to Follow-up|3|||
149762491|NCT01276457|540257402|FG001|Extension Study|Lost to Follow-up|0|||
149762492|NCT01276457|540257401|FG000|Extension Study|Death|0|||
149762493|NCT01276457|540257402|FG001|Extension Study|Death|1|||
149762494|NCT01276457|540257401|FG000|Extension Study|Lack of Efficacy|3|||
149762495|NCT01276457|540257402|FG001|Extension Study|Lack of Efficacy|1|||
149762496|NCT02065869|540257403|FG000|Overall Study|Death|7|||
149762497|NCT02065869|540257403|FG000|Overall Study|Disease relapse|16|||
149762498|NCT02065869|540257403|FG000|Overall Study|Lost to Follow-up|4|||
149762499|NCT02065869|540257403|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
149762500|NCT02065869|540257403|FG000|Overall Study|Withdrawal by Subject|1|||
149762501|NCT03827473|540257404|FG000|Overall Study|Withdrawal by Subject|1|||
149762502|NCT03827473|540257405|FG001|Overall Study|Withdrawal by Subject|0|||
149762503|NCT00303108|540257408|FG000|Overall Study|Adverse Event|5|||
149762504|NCT00303108|540257409|FG001|Overall Study|Adverse Event|6|||
149762505|NCT00303108|540257410|FG002|Overall Study|Adverse Event|7|||
149762506|NCT00303108|540257408|FG000|Overall Study|Patient Request|4|||
149762507|NCT00303108|540257409|FG001|Overall Study|Patient Request|2|||
149762508|NCT00303108|540257410|FG002|Overall Study|Patient Request|8|||
149762509|NCT00303108|540257408|FG000|Overall Study|Failed Entry|1|||
149762510|NCT00303108|540257409|FG001|Overall Study|Failed Entry|0|||
149762511|NCT00303108|540257410|FG002|Overall Study|Failed Entry|1|||
149762512|NCT00303108|540257408|FG000|Overall Study|ineligible|2|||
149762513|NCT00303108|540257409|FG001|Overall Study|ineligible|1|||
149762514|NCT00303108|540257410|FG002|Overall Study|ineligible|0|||
149762515|NCT00894413|540257413|FG000|Overall Study|Physician Decision|0|||
149762516|NCT00894413|540257414|FG001|Overall Study|Physician Decision|2|||
149762517|NCT00894413|540257413|FG000|Overall Study|Adverse Event|0|||
149762518|NCT00894413|540257414|FG001|Overall Study|Adverse Event|2|||
149762519|NCT00894413|540257413|FG000|Overall Study|Withdrawal by Subject|0|||
149762520|NCT00894413|540257414|FG001|Overall Study|Withdrawal by Subject|4|||
149762521|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
149762522|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
149762523|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
149762524|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
149762525|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
149762526|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
149762527|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
149762528|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
149762529|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
149762530|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
149762531|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
149762532|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
149762533|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
149762534|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
149762535|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
149762536|NCT03855137|540257415|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
149762537|NCT03855137|540257416|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
149762538|NCT03855137|540257417|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
149762539|NCT03855137|540257415|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
149762540|NCT03855137|540257416|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
149762541|NCT03855137|540257417|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
149762542|NCT03855137|540257415|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
149762543|NCT03855137|540257416|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
149762544|NCT03855137|540257417|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
149762545|NCT03855137|540257415|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
149762546|NCT03855137|540257416|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
149762547|NCT03855137|540257417|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
149762548|NCT03855137|540257415|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
149762549|NCT03855137|540257416|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
149762550|NCT03855137|540257417|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
149762551|NCT02427477|540257420|FG000|Period 1|Adverse Event|1|||
149762552|NCT02427477|540257421|FG001|Period 1|Adverse Event|0|||
149762553|NCT00471445|540257422|FG000|Overall Study|Withdrawal by Subject|1|||
149762554|NCT00471445|540257423|FG001|Overall Study|Withdrawal by Subject|1|||
149762555|NCT00471445|540257422|FG000|Overall Study|Ineligible|1|||
149762556|NCT00471445|540257423|FG001|Overall Study|Ineligible|0|||
149762557|NCT00471445|540257422|FG000|Overall Study|Protocol Violation|0|||
149762558|NCT00471445|540257423|FG001|Overall Study|Protocol Violation|1|||
149762559|NCT02065622|540257424|FG000|Induction Study|Adverse Event|13|||
149762560|NCT02065622|540257425|FG001|Induction Study|Adverse Event|19|||
149762561|NCT02065622|540257426|FG002|Induction Study|Adverse Event|0|||
149762562|NCT02065622|540257427|FG003|Induction Study|Adverse Event|0|||
149762563|NCT02065622|540257428|FG004|Induction Study|Adverse Event|0|||
149762564|NCT02065622|540257424|FG000|Induction Study|Withdrawal by Subject|3|||
149762565|NCT02065622|540257425|FG001|Induction Study|Withdrawal by Subject|5|||
149762566|NCT02065622|540257426|FG002|Induction Study|Withdrawal by Subject|0|||
149762567|NCT02065622|540257427|FG003|Induction Study|Withdrawal by Subject|0|||
149762568|NCT02065622|540257428|FG004|Induction Study|Withdrawal by Subject|0|||
149762569|NCT02065622|540257424|FG000|Induction Study|Lost to Follow-up|1|||
149762570|NCT02065622|540257425|FG001|Induction Study|Lost to Follow-up|0|||
149762571|NCT02065622|540257426|FG002|Induction Study|Lost to Follow-up|0|||
149762572|NCT02065622|540257427|FG003|Induction Study|Lost to Follow-up|0|||
149762573|NCT02065622|540257428|FG004|Induction Study|Lost to Follow-up|0|||
149762574|NCT02065622|540257424|FG000|Induction Study|Lack of Efficacy|22|||
149762575|NCT02065622|540257425|FG001|Induction Study|Lack of Efficacy|27|||
149762576|NCT02065622|540257426|FG002|Induction Study|Lack of Efficacy|0|||
149762577|NCT02065622|540257427|FG003|Induction Study|Lack of Efficacy|0|||
149762578|NCT02065622|540257428|FG004|Induction Study|Lack of Efficacy|0|||
149762579|NCT02065622|540257424|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
149762580|NCT02065622|540257425|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
149762581|NCT02065622|540257426|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
149762582|NCT02065622|540257427|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
149762583|NCT02065622|540257428|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
149762584|NCT02065622|540257424|FG000|Induction Study|Subject Noncompliance|1|||
149762585|NCT02065622|540257425|FG001|Induction Study|Subject Noncompliance|1|||
149762586|NCT02065622|540257426|FG002|Induction Study|Subject Noncompliance|0|||
149762587|NCT02065622|540257427|FG003|Induction Study|Subject Noncompliance|0|||
149762588|NCT02065622|540257428|FG004|Induction Study|Subject Noncompliance|0|||
149762589|NCT02065622|540257424|FG000|Induction Study|Other, Not Specified|3|||
149762590|NCT02065622|540257425|FG001|Induction Study|Other, Not Specified|2|||
149762591|NCT02065622|540257426|FG002|Induction Study|Other, Not Specified|0|||
149762592|NCT02065622|540257427|FG003|Induction Study|Other, Not Specified|0|||
149762593|NCT02065622|540257428|FG004|Induction Study|Other, Not Specified|0|||
149762594|NCT02065622|540257424|FG000|Maintenance Study|Adverse Event|0|||
149762595|NCT02065622|540257425|FG001|Maintenance Study|Adverse Event|0|||
149762596|NCT02065622|540257426|FG002|Maintenance Study|Adverse Event|25|||
149762597|NCT02065622|540257427|FG003|Maintenance Study|Adverse Event|22|||
149762598|NCT02065622|540257428|FG004|Maintenance Study|Adverse Event|11|||
149762599|NCT02065622|540257424|FG000|Maintenance Study|Withdrawal by Subject|0|||
149762600|NCT02065622|540257425|FG001|Maintenance Study|Withdrawal by Subject|0|||
149762601|NCT02065622|540257426|FG002|Maintenance Study|Withdrawal by Subject|11|||
149762602|NCT02065622|540257427|FG003|Maintenance Study|Withdrawal by Subject|5|||
149762603|NCT02065622|540257428|FG004|Maintenance Study|Withdrawal by Subject|7|||
149762604|NCT02065622|540257424|FG000|Maintenance Study|Lost to Follow-up|0|||
149762605|NCT02065622|540257425|FG001|Maintenance Study|Lost to Follow-up|0|||
149762606|NCT02065622|540257426|FG002|Maintenance Study|Lost to Follow-up|4|||
149762607|NCT02065622|540257427|FG003|Maintenance Study|Lost to Follow-up|1|||
149762608|NCT02065622|540257428|FG004|Maintenance Study|Lost to Follow-up|1|||
149762609|NCT02065622|540257424|FG000|Maintenance Study|Lack of Efficacy|0|||
149762610|NCT02065622|540257425|FG001|Maintenance Study|Lack of Efficacy|0|||
149762611|NCT02065622|540257426|FG002|Maintenance Study|Lack of Efficacy|70|||
149762612|NCT02065622|540257427|FG003|Maintenance Study|Lack of Efficacy|55|||
149762613|NCT02065622|540257428|FG004|Maintenance Study|Lack of Efficacy|19|||
149762614|NCT02065622|540257424|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
149762615|NCT02065622|540257425|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
149762616|NCT02065622|540257426|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
149762617|NCT02065622|540257427|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
149762618|NCT02065622|540257428|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
149762619|NCT02065622|540257424|FG000|Maintenance Study|Subject Non-Compliance|0|||
149762620|NCT02065622|540257425|FG001|Maintenance Study|Subject Non-Compliance|0|||
149762621|NCT02065622|540257426|FG002|Maintenance Study|Subject Non-Compliance|1|||
149762622|NCT02065622|540257427|FG003|Maintenance Study|Subject Non-Compliance|3|||
149762623|NCT02065622|540257428|FG004|Maintenance Study|Subject Non-Compliance|2|||
149762624|NCT02065622|540257424|FG000|Maintenance Study|Other, Not Specified|0|||
149762625|NCT02065622|540257425|FG001|Maintenance Study|Other, Not Specified|0|||
149762626|NCT02065622|540257426|FG002|Maintenance Study|Other, Not Specified|6|||
149762627|NCT02065622|540257427|FG003|Maintenance Study|Other, Not Specified|14|||
149762628|NCT02065622|540257428|FG004|Maintenance Study|Other, Not Specified|2|||
149762629|NCT02065622|540257424|FG000|Maintenance Study|Unknown Reason|0|||
149762630|NCT02065622|540257425|FG001|Maintenance Study|Unknown Reason|0|||
149762631|NCT02065622|540257426|FG002|Maintenance Study|Unknown Reason|0|||
149762632|NCT02065622|540257427|FG003|Maintenance Study|Unknown Reason|1|||
149762633|NCT02065622|540257428|FG004|Maintenance Study|Unknown Reason|0|||
149762634|NCT00488618|540257435|FG000|Overall Study|Adverse Event|13|||
149762635|NCT00488618|540257436|FG001|Overall Study|Adverse Event|17|||
149762636|NCT00488618|540257435|FG000|Overall Study|Insufficient Therapeutic Response|18|||
149762637|NCT00488618|540257436|FG001|Overall Study|Insufficient Therapeutic Response|11|||
149762638|NCT00488618|540257435|FG000|Overall Study|Protocol Violation|0|||
149762639|NCT00488618|540257436|FG001|Overall Study|Protocol Violation|2|||
149762640|NCT00488618|540257435|FG000|Overall Study|Withdrawal of Consent|15|||
149762641|NCT00488618|540257436|FG001|Overall Study|Withdrawal of Consent|13|||
149762642|NCT00488618|540257435|FG000|Overall Study|Lost to Follow-up|1|||
149762643|NCT00488618|540257436|FG001|Overall Study|Lost to Follow-up|0|||
149762644|NCT00786032|540258747|FG000|Overall Study|Death|4|||
149762645|NCT00786032|540258747|FG000|Overall Study|Withdrawal by Subject|14|||
149762646|NCT00786032|540258747|FG000|Overall Study|Did not complete in the timeframe|6|||
149762647|NCT02625324|540258748|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
149762648|NCT02625324|540258748|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
149762649|NCT02625324|540258748|FG000|6-Month Follow-up Subject Accountability|Death|5|||
149762650|NCT02625324|540258748|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
149762651|NCT02625324|540258748|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
149762652|NCT02625324|540258748|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
149762653|NCT02625324|540258748|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
149762654|NCT02625324|540258748|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
149762655|NCT02625324|540258748|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
149762656|NCT02625324|540258748|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
149762657|NCT02625324|540258748|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
149762658|NCT02625324|540258748|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
149762659|NCT02625324|540258748|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
149762660|NCT02625324|540258748|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
149762661|NCT02625324|540258748|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
149762662|NCT02625324|540258748|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
149762663|NCT02625324|540258748|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
149762664|NCT00967226|540258751|FG000|Overall Study|Adverse Event|0|||
149762665|NCT00967226|540258752|FG001|Overall Study|Adverse Event|5|||
149762666|NCT00967226|540258751|FG000|Overall Study|Protocol Violation|2|||
149762667|NCT00967226|540258752|FG001|Overall Study|Protocol Violation|0|||
149762668|NCT00967226|540258751|FG000|Overall Study|Physician Decision|0|||
149762669|NCT00967226|540258752|FG001|Overall Study|Physician Decision|1|||
149762670|NCT01000727|540258757|FG000|Overall Study|Lost to Follow-up|41|||
149762671|NCT01000727|540258758|FG001|Overall Study|Lost to Follow-up|43|||
149762672|NCT01000727|540258757|FG000|Overall Study|Withdrawal by Subject|111|||
149762673|NCT01000727|540258758|FG001|Overall Study|Withdrawal by Subject|109|||
149762674|NCT01000727|540258757|FG000|Overall Study|Study closed/terminated|23|||
149762675|NCT01000727|540258758|FG001|Overall Study|Study closed/terminated|24|||
149762676|NCT03137121|540258759|FG000|Overall Study|Withdrawal by Subject|0|||
149762677|NCT03137121|540258760|FG001|Overall Study|Withdrawal by Subject|1|||
149762678|NCT03196193|540258761|FG000|Overall Study|Adverse Event|1|||
149762679|NCT03196193|540258762|FG001|Overall Study|Adverse Event|0|||
149762680|NCT03196193|540258761|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
149762681|NCT03196193|540258762|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
149762682|NCT02709083|540258768|FG000|Overall Study|Original PI left institution|7|||
149762683|NCT01697267|540258770|FG000|Overall Study|Death|3|||
149762684|NCT01697267|540258771|FG001|Overall Study|Death|1|||
149762685|NCT01697267|540258770|FG000|Overall Study|Withdrawal by Subject|5|||
149762686|NCT01697267|540258771|FG001|Overall Study|Withdrawal by Subject|5|||
149762687|NCT01697267|540258770|FG000|Overall Study|Adverse Event|2|||
149762688|NCT01697267|540258771|FG001|Overall Study|Adverse Event|1|||
149762689|NCT01697267|540258770|FG000|Overall Study|Lost to Follow-up|2|||
149762690|NCT01697267|540258771|FG001|Overall Study|Lost to Follow-up|4|||
149762691|NCT01697267|540258770|FG000|Overall Study|Physician Decision|2|||
149762692|NCT01697267|540258771|FG001|Overall Study|Physician Decision|4|||
149762693|NCT02006667|540258772|FG000|Overall Study|Adverse Event|3|||
149762694|NCT02006667|540258772|FG000|Overall Study|Death|2|||
149762695|NCT02006667|540258772|FG000|Overall Study|Withdrawal by Subject|1|||
149762696|NCT01626352|540258773|FG000|Overall Study|Disease Progression|3|||
149762697|NCT01626352|540258773|FG000|Overall Study|Intercurrent Illness|2|||
149762698|NCT01626352|540258773|FG000|Overall Study|Death|2|||
149762699|NCT01626352|540258773|FG000|Overall Study|Withdrawal by Subject|1|||
149762700|NCT01626352|540258773|FG000|Overall Study|Non-Compliance|1|||
149762701|NCT01626352|540258773|FG000|Overall Study|Never Treated|1|||
149762702|NCT02681055|540258775|FG000|Weeks 5-12|Adverse Event|1|||
149762703|NCT00310388|540258776|FG000|Primary Reporting Phase|Adverse Event|101|||
149762704|NCT00310388|540258777|FG001|Primary Reporting Phase|Adverse Event|0|||
149762705|NCT00310388|540258776|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
149762706|NCT00310388|540258777|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
149762707|NCT00310388|540258776|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
149762708|NCT00310388|540258777|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
149762709|NCT00310388|540258776|FG000|Primary Reporting Phase|Protocol Violation|10|||
149762710|NCT00310388|540258777|FG001|Primary Reporting Phase|Protocol Violation|0|||
149762711|NCT00310388|540258776|FG000|Primary Reporting Phase|Pregnancy|3|||
149762712|NCT00310388|540258777|FG001|Primary Reporting Phase|Pregnancy|0|||
149762713|NCT00310388|540258776|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
149762714|NCT00310388|540258777|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
149762715|NCT00310388|540258776|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
149762716|NCT00310388|540258777|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
149762717|NCT00310388|540258776|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
149762718|NCT00310388|540258777|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
149762719|NCT00310388|540258776|FG000|Primary Reporting Phase|Physician Decision|2|||
149762720|NCT00310388|540258777|FG001|Primary Reporting Phase|Physician Decision|0|||
149762721|NCT00310388|540258776|FG000|Primary Reporting Phase|Request of the sponsor|19|||
149762722|NCT00310388|540258777|FG001|Primary Reporting Phase|Request of the sponsor|0|||
149762723|NCT00310388|540258776|FG000|Primary Reporting Phase|Failed to return|8|||
149762724|NCT00310388|540258777|FG001|Primary Reporting Phase|Failed to return|0|||
149762725|NCT00310388|540258776|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
149762726|NCT00310388|540258777|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
149762727|NCT00310388|540258776|FG000|Primary Reporting Phase|Participant request|2|||
149762728|NCT00310388|540258777|FG001|Primary Reporting Phase|Participant request|0|||
149762729|NCT00310388|540258776|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
149762730|NCT00310388|540258777|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
149762731|NCT00310388|540258776|FG000|Primary Reporting Phase|Discontinuation of study|1|||
149762732|NCT00310388|540258777|FG001|Primary Reporting Phase|Discontinuation of study|0|||
149762733|NCT00310388|540258776|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
149762734|NCT00310388|540258777|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
149762735|NCT00310388|540258776|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
149762736|NCT00310388|540258777|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
149762737|NCT00310388|540258776|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
149762738|NCT00310388|540258777|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
149762739|NCT00310388|540258776|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
149762740|NCT00310388|540258777|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
149762741|NCT00310388|540258776|FG000|Primary Reporting Phase|Participant passed away|1|||
149762742|NCT00310388|540258777|FG001|Primary Reporting Phase|Participant passed away|0|||
149762743|NCT00310388|540258776|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
149762744|NCT00310388|540258777|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
149762745|NCT00310388|540258776|FG000|Primary Reporting Phase|Missing|1|||
149762746|NCT00310388|540258777|FG001|Primary Reporting Phase|Missing|0|||
149762747|NCT00310388|540258776|FG000|Primary Reporting Phase|Other|1|||
149762748|NCT00310388|540258777|FG001|Primary Reporting Phase|Other|0|||
149762749|NCT00310388|540258776|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
149762750|NCT00310388|540258777|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
149762751|NCT00310388|540258776|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
149762752|NCT00310388|540258777|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
149762753|NCT00310388|540258776|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
149762754|NCT00310388|540258777|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
149762755|NCT00310388|540258776|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
149762756|NCT00310388|540258777|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
149762757|NCT00782418|540258782|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
149762758|NCT00782418|540258783|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762759|NCT00782418|540258784|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762760|NCT00782418|540258785|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762761|NCT00782418|540258786|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762762|NCT00782418|540258787|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762763|NCT00782418|540258788|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149762764|NCT00782418|540258782|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149762765|NCT00782418|540258783|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149762766|NCT00782418|540258784|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149762767|NCT00782418|540258785|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149762768|NCT00782418|540258786|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149762769|NCT00782418|540258787|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149762770|NCT00782418|540258788|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149762771|NCT00882999|540258789|FG000|Overall Study|Adverse Event|0|||
149762772|NCT00882999|540258790|FG001|Overall Study|Adverse Event|0|||
149762773|NCT00882999|540258791|FG002|Overall Study|Adverse Event|0|||
149762774|NCT00882999|540258792|FG003|Overall Study|Adverse Event|0|||
149762775|NCT00882999|540258793|FG004|Overall Study|Adverse Event|1|||
149762776|NCT00882999|540258794|FG005|Overall Study|Adverse Event|0|||
149762777|NCT00882999|540258795|FG006|Overall Study|Adverse Event|0|||
149762778|NCT00882999|540258789|FG000|Overall Study|Death|0|||
149762779|NCT00882999|540258790|FG001|Overall Study|Death|1|||
149762780|NCT00882999|540258791|FG002|Overall Study|Death|0|||
149762781|NCT00882999|540258792|FG003|Overall Study|Death|0|||
149762782|NCT00882999|540258793|FG004|Overall Study|Death|0|||
149762783|NCT00882999|540258794|FG005|Overall Study|Death|0|||
149762784|NCT00882999|540258795|FG006|Overall Study|Death|0|||
149762785|NCT00882999|540258789|FG000|Overall Study|Withdrawal by Subject|7|||
149762786|NCT00882999|540258790|FG001|Overall Study|Withdrawal by Subject|6|||
149762787|NCT00882999|540258791|FG002|Overall Study|Withdrawal by Subject|3|||
149762788|NCT00882999|540258792|FG003|Overall Study|Withdrawal by Subject|3|||
149762789|NCT00882999|540258793|FG004|Overall Study|Withdrawal by Subject|6|||
149762790|NCT00882999|540258794|FG005|Overall Study|Withdrawal by Subject|5|||
149762791|NCT00882999|540258795|FG006|Overall Study|Withdrawal by Subject|5|||
149762792|NCT00882999|540258789|FG000|Overall Study|Lost to Follow-up|0|||
149762793|NCT00882999|540258790|FG001|Overall Study|Lost to Follow-up|1|||
149762794|NCT00882999|540258791|FG002|Overall Study|Lost to Follow-up|1|||
149762795|NCT00882999|540258792|FG003|Overall Study|Lost to Follow-up|2|||
149762796|NCT00882999|540258793|FG004|Overall Study|Lost to Follow-up|1|||
149762797|NCT00882999|540258794|FG005|Overall Study|Lost to Follow-up|1|||
149762798|NCT00882999|540258795|FG006|Overall Study|Lost to Follow-up|2|||
149762799|NCT00882999|540258789|FG000|Overall Study|Physician Decision|1|||
149762800|NCT00882999|540258790|FG001|Overall Study|Physician Decision|0|||
149762801|NCT00882999|540258791|FG002|Overall Study|Physician Decision|0|||
149762802|NCT00882999|540258792|FG003|Overall Study|Physician Decision|0|||
149762803|NCT00882999|540258793|FG004|Overall Study|Physician Decision|0|||
149762804|NCT00882999|540258794|FG005|Overall Study|Physician Decision|1|||
149762805|NCT00882999|540258795|FG006|Overall Study|Physician Decision|1|||
149762806|NCT01757405|540258798|FG000|Overall Study|Lost to Follow-up|1|||
149762807|NCT01757405|540258799|FG001|Overall Study|Lost to Follow-up|1|||
149762808|NCT01757405|540258798|FG000|Overall Study|Withdrawal by Subject|0|||
149762809|NCT01757405|540258799|FG001|Overall Study|Withdrawal by Subject|1|||
149762810|NCT00082758|540258801|FG000|Overall Study|Adverse Event|0|||
149762811|NCT00082758|540258802|FG001|Overall Study|Adverse Event|2|||
149762812|NCT00082758|540258803|FG002|Overall Study|Adverse Event|0|||
149762813|NCT00082758|540258801|FG000|Overall Study|Lack of Efficacy|12|||
149762814|NCT00082758|540258802|FG001|Overall Study|Lack of Efficacy|13|||
149762815|NCT00082758|540258803|FG002|Overall Study|Lack of Efficacy|0|||
149762816|NCT00082758|540258801|FG000|Overall Study|Physician Decision|0|||
149762817|NCT00082758|540258802|FG001|Overall Study|Physician Decision|1|||
149762818|NCT00082758|540258803|FG002|Overall Study|Physician Decision|0|||
149762819|NCT00082758|540258801|FG000|Overall Study|Withdrawal by Subject|3|||
149762820|NCT00082758|540258802|FG001|Overall Study|Withdrawal by Subject|0|||
149762821|NCT00082758|540258803|FG002|Overall Study|Withdrawal by Subject|0|||
149762822|NCT00082758|540258801|FG000|Overall Study|Protocol Violation|0|||
149762823|NCT00082758|540258802|FG001|Overall Study|Protocol Violation|1|||
149762824|NCT00082758|540258803|FG002|Overall Study|Protocol Violation|0|||
149762825|NCT00238303|540258804|FG000|Overall Study|Withdrawal by Subject|11|||
149762826|NCT00238303|540258805|FG001|Overall Study|Withdrawal by Subject|1|||
149762827|NCT00238303|540258806|FG002|Overall Study|Withdrawal by Subject|2|||
149762828|NCT00238303|540258804|FG000|Overall Study|Death|1|||
149762829|NCT00238303|540258805|FG001|Overall Study|Death|0|||
149762830|NCT00238303|540258806|FG002|Overall Study|Death|1|||
149762831|NCT00238303|540258804|FG000|Overall Study|Other Medical Problems|2|||
149762832|NCT00238303|540258805|FG001|Overall Study|Other Medical Problems|0|||
149762833|NCT00238303|540258806|FG002|Overall Study|Other Medical Problems|2|||
149762834|NCT00238303|540258804|FG000|Overall Study|Poor tolerance of study treatment|1|||
149762835|NCT00238303|540258805|FG001|Overall Study|Poor tolerance of study treatment|0|||
149762836|NCT00238303|540258806|FG002|Overall Study|Poor tolerance of study treatment|1|||
149762837|NCT00238303|540258804|FG000|Overall Study|Adverse Event|0|||
149762838|NCT00238303|540258805|FG001|Overall Study|Adverse Event|1|||
149762839|NCT00238303|540258806|FG002|Overall Study|Adverse Event|3|||
149762840|NCT00937560|540258808|FG000|Initial Treatment|Death|6|||
149762841|NCT00937560|540258808|FG000|Initial Treatment|Withdraw consent|3|||
149762842|NCT00937560|540258808|FG000|Initial Treatment|Adverse Event|1|||
149762843|NCT00937560|540258808|FG000|Initial Treatment|Lost to Follow-up|1|||
149762844|NCT00937560|540258808|FG000|Initial Treatment|No end of study page|10|||
149762845|NCT00937560|540258808|FG000|Maintenance Treatment|Death|12|||
149762846|NCT00937560|540258808|FG000|Maintenance Treatment|Withdraw consent|5|||
149762847|NCT00937560|540258808|FG000|Maintenance Treatment|According to protocol|1|||
149762848|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
149762849|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
149762850|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
149762851|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
149762852|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
149762853|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
149762854|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
149762855|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
149762856|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
149762857|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
149762858|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
149762859|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
149762860|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
149762861|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
149762862|NCT00848549|540258809|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
149762863|NCT00848549|540258810|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
149762864|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
149762865|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
149762866|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
149762867|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
149762868|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
149762869|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
149762870|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
149762871|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
149762872|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
149762873|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
149762874|NCT00848549|540258809|FG000|E2090-E044-314 (Extension Study)|Other|5|||
149762875|NCT00848549|540258810|FG001|E2090-E044-314 (Extension Study)|Other|6|||
149762876|NCT01248130|540258813|FG000|Overall Study|Protocol Violation|1|||
149762877|NCT01248130|540258814|FG001|Overall Study|Protocol Violation|0|||
149762878|NCT01248130|540258813|FG000|Overall Study|Ineligible|1|||
149762879|NCT01248130|540258814|FG001|Overall Study|Ineligible|0|||
149762880|NCT01994226|540258817|FG000|Overall Study|Protocol Violation|13|||
149762881|NCT01994226|540258818|FG001|Overall Study|Protocol Violation|10|||
149762882|NCT01994226|540258817|FG000|Overall Study|Early Cessation of treatment|6|||
149762883|NCT01994226|540258818|FG001|Overall Study|Early Cessation of treatment|11|||
149762884|NCT02488551|540258824|FG000|Overall Study|Lost to Follow-up|4|||
149762885|NCT02488551|540258825|FG001|Overall Study|Lost to Follow-up|7|||
149762886|NCT02488551|540258826|FG002|Overall Study|Lost to Follow-up|0|||
149762887|NCT02488551|540258827|FG003|Overall Study|Lost to Follow-up|0|||
149762888|NCT02488551|540258824|FG000|Overall Study|Military Deployment|1|||
149762889|NCT02488551|540258825|FG001|Overall Study|Military Deployment|1|||
149762890|NCT02488551|540258826|FG002|Overall Study|Military Deployment|0|||
149762891|NCT02488551|540258827|FG003|Overall Study|Military Deployment|0|||
149762892|NCT04507867|540258837|FG000|Overall Study|Death|7|||
149762893|NCT04507867|540258838|FG001|Overall Study|Death|1|||
149762894|NCT01860534|540258841|FG000|ROP #1|Needed treatment for ROP|0|||
149762895|NCT01860534|540258842|FG001|ROP #1|Needed treatment for ROP|1|||
149762896|NCT01860534|540258841|FG000|ROP #2|discharged prior to ROP #2|1|||
149762897|NCT01860534|540258842|FG001|ROP #2|discharged prior to ROP #2|0|||
149762898|NCT01188564|540258843|FG000|Double-blind Phase|randomized not treated|1|||
149762899|NCT01188564|540258844|FG001|Double-blind Phase|randomized not treated|0|||
149762900|NCT04171037|540258845|FG000|Overall Study|Lost to Follow-up|1|||
149762901|NCT04171037|540258846|FG001|Overall Study|Lost to Follow-up|0|||
149762902|NCT04171037|540258845|FG000|Overall Study|Physician Decision|3|||
149762903|NCT04171037|540258846|FG001|Overall Study|Physician Decision|3|||
149762904|NCT01934894|540258847|FG000|Overall Study|Adverse Event|1|||
149762905|NCT01934894|540258848|FG001|Overall Study|Adverse Event|2|||
149762906|NCT01934894|540258847|FG000|Overall Study|Death|2|||
149762907|NCT01934894|540258848|FG001|Overall Study|Death|0|||
149762908|NCT01934894|540258847|FG000|Overall Study|Withdrawal by Subject|0|||
149762909|NCT01934894|540258848|FG001|Overall Study|Withdrawal by Subject|1|||
149762910|NCT01934894|540258847|FG000|Overall Study|Progressive Disease|3|||
149762911|NCT01934894|540258848|FG001|Overall Study|Progressive Disease|2|||
149762912|NCT03364673|540258854|FG000|Overall Study|Withdrawal by Subject|2|||
149762913|NCT03364673|540258854|FG000|Overall Study|Injury unrelated to study|3|||
149762914|NCT02208024|540258855|FG000|Overall Study|Withdrawal by Subject|1|||
149762915|NCT00779324|540258856|FG000|Overall Study|Lost to Follow-up|2|||
149762916|NCT00779324|540258857|FG001|Overall Study|Lost to Follow-up|1|||
149762917|NCT00779324|540258856|FG000|Overall Study|Withdrawal by Subject|4|||
149762918|NCT00779324|540258857|FG001|Overall Study|Withdrawal by Subject|2|||
149762919|NCT00779324|540258856|FG000|Overall Study|Missed visit|1|||
149762920|NCT00779324|540258857|FG001|Overall Study|Missed visit|1|||
149762921|NCT02207556|540258858|FG000|Overall Study|Physician Decision|1|||
149762922|NCT02207556|540258859|FG001|Overall Study|Physician Decision|0|||
149762923|NCT02207556|540258858|FG000|Overall Study|Withdrawal by Subject|1|||
149762924|NCT02207556|540258859|FG001|Overall Study|Withdrawal by Subject|0|||
149762925|NCT02207556|540258858|FG000|Overall Study|Death|0|||
149762926|NCT02207556|540258859|FG001|Overall Study|Death|5|||
149762927|NCT00194025|540258860|FG000|Overall Study|Adverse Event|1|||
149762928|NCT00194025|540258860|FG000|Overall Study|non-adherence with study medication|4|||
149762929|NCT00511342|540258863|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
149762930|NCT00511342|540258864|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
149762931|NCT00511342|540258863|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
149762932|NCT00511342|540258864|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
149762933|NCT00511342|540258863|FG000|Overall Study|Pregnancy|0|||
149762934|NCT00511342|540258864|FG001|Overall Study|Pregnancy|1|||
149762935|NCT00511342|540258863|FG000|Overall Study|Pregnancy wish|0|||
149762936|NCT00511342|540258864|FG001|Overall Study|Pregnancy wish|1|||
149762937|NCT00511342|540258863|FG000|Overall Study|Lost to Follow-up|1|||
149762938|NCT00511342|540258864|FG001|Overall Study|Lost to Follow-up|5|||
149762939|NCT00511342|540258863|FG000|Overall Study|Other Reason|2|||
149762940|NCT00511342|540258864|FG001|Overall Study|Other Reason|2|||
149762941|NCT02432040|540258865|FG000|Overall Study|Lack of Efficacy|3|||
149762942|NCT02432040|540258866|FG001|Overall Study|Lack of Efficacy|0|||
149762943|NCT02432040|540258865|FG000|Overall Study|Lost to Follow-up|4|||
149762944|NCT02432040|540258866|FG001|Overall Study|Lost to Follow-up|5|||
149762945|NCT02432040|540258865|FG000|Overall Study|Physician Decision|1|||
149762946|NCT02432040|540258866|FG001|Overall Study|Physician Decision|1|||
149762947|NCT01153763|540258867|FG000|Overall Study|Study Closed|16|||
149762948|NCT01153763|540258867|FG000|Overall Study|Lost to Follow-up|1|||
149762949|NCT01153763|540258867|FG000|Overall Study|Physician Decision|2|||
149762950|NCT01153763|540258867|FG000|Overall Study|Withdrawal by Subject|2|||
149762951|NCT04544709|540258868|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
149762952|NCT03238235|540258869|FG000|Overall Study|Adverse Event|2|||
149762953|NCT03238235|540258870|FG001|Overall Study|Adverse Event|0|||
149762954|NCT03238235|540258869|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
149762955|NCT03238235|540258870|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
149762956|NCT04436822|540258871|FG000|Overall Study|Physician Decision|2|||
149762957|NCT04436822|540258872|FG001|Overall Study|Physician Decision|0|||
149762958|NCT04436822|540258871|FG000|Overall Study|Sponsor request|1|||
149762959|NCT04436822|540258872|FG001|Overall Study|Sponsor request|0|||
149762960|NCT04436822|540258871|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149762961|NCT04436822|540258872|FG001|Overall Study|Withdrawal by parent/guardian|3|||
149762962|NCT04436822|540258871|FG000|Overall Study|Unsuccessful procedure|0|||
149762963|NCT04436822|540258872|FG001|Overall Study|Unsuccessful procedure|1|||
149762964|NCT04436822|540258871|FG000|Overall Study|Withdrawal due to Covid-19|8|||
149762965|NCT04436822|540258872|FG001|Overall Study|Withdrawal due to Covid-19|1|||
149762966|NCT04436822|540258871|FG000|Overall Study|Withdrawal by Subject|1|||
149762967|NCT04436822|540258872|FG001|Overall Study|Withdrawal by Subject|0|||
149762968|NCT04436822|540258871|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
149762969|NCT04436822|540258872|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
149762970|NCT04715230|540258873|FG000|Overall Study|Withdrawal by Subject|1|||
149762971|NCT04715230|540258874|FG001|Overall Study|Withdrawal by Subject|0|||
149762972|NCT04715230|540258875|FG002|Overall Study|Withdrawal by Subject|0|||
149762973|NCT04715230|540258873|FG000|Overall Study|Lost to Follow-up|0|||
149762974|NCT04715230|540258874|FG001|Overall Study|Lost to Follow-up|5|||
149762975|NCT04715230|540258875|FG002|Overall Study|Lost to Follow-up|1|||
149762976|NCT02457182|540260549|FG000|Overall Study|Lost to Follow-up|1|||
149762977|NCT02457182|540260550|FG001|Overall Study|Lost to Follow-up|0|||
149762978|NCT01009983|540260551|FG000|Overall Study|necessary scans not completed|1|||
149762979|NCT04410198|540260552|FG000|Overall Study|Death|10|||
149762980|NCT04410198|540260552|FG000|Overall Study|Withdrawal by Subject|7|||
149762981|NCT04410198|540260552|FG000|Overall Study|Transferred/Relocation|4|||
149762982|NCT04410198|540260552|FG000|Overall Study|Kidney Transplant|9|||
149762983|NCT04410198|540260552|FG000|Overall Study|Adverse Event|4|||
149762984|NCT04410198|540260552|FG000|Overall Study|Physician Decision|2|||
149762985|NCT04410198|540260552|FG000|Overall Study|Other than specified|1|||
149762986|NCT02338492|540260557|FG000|Overall Study|Death|32|||
149762987|NCT02338492|540260557|FG000|Overall Study|Adverse Event|3|||
149762988|NCT02338492|540260557|FG000|Overall Study|Lost to Follow-up|4|||
149762989|NCT02338492|540260557|FG000|Overall Study|Reason not captured above|6|||
149762990|NCT00756886|540260558|FG000|Overall Study|Lost to Follow-up|1|||
149762991|NCT00756886|540260559|FG001|Overall Study|Lost to Follow-up|0|||
149762992|NCT00756886|540260558|FG000|Overall Study|Adverse Event|0|||
149762993|NCT00756886|540260559|FG001|Overall Study|Adverse Event|3|||
149762994|NCT00756886|540260558|FG000|Overall Study|Lack of Efficacy|1|||
149762995|NCT00756886|540260559|FG001|Overall Study|Lack of Efficacy|0|||
149762996|NCT00756886|540260558|FG000|Overall Study|Ineligible|9|||
149762997|NCT00756886|540260559|FG001|Overall Study|Ineligible|4|||
149762998|NCT00120289|540260561|FG000|Overall Study|Death|96|||
149762999|NCT00120289|540260562|FG001|Overall Study|Death|82|||
149763000|NCT00120289|540260561|FG000|Overall Study|Lost to Follow-up|11|||
149763001|NCT00120289|540260562|FG001|Overall Study|Lost to Follow-up|14|||
149763002|NCT00120289|540260561|FG000|Overall Study|Withdrawal by Subject|14|||
149763003|NCT00120289|540260562|FG001|Overall Study|Withdrawal by Subject|13|||
149763004|NCT04348656|540260564|FG000|Overall Study|Withdrawal by Subject|2|||
149763005|NCT04348656|540260565|FG001|Overall Study|Withdrawal by Subject|0|||
149763006|NCT04348656|540260564|FG000|Overall Study|Lost to Follow-up|11|||
149763007|NCT04348656|540260565|FG001|Overall Study|Lost to Follow-up|6|||
149763008|NCT01911845|540260568|FG000|Overall Study|Adverse Event|2|||
149763009|NCT01911845|540260568|FG000|Overall Study|Lost to Follow-up|1|||
149763010|NCT01911845|540260568|FG000|Overall Study|Other (not specified)|3|||
149763011|NCT00501046|540260569|FG000|Overall Study|Adverse Event|21|||
149763012|NCT00501046|540260570|FG001|Overall Study|Adverse Event|25|||
149763013|NCT00501046|540260569|FG000|Overall Study|Death|23|||
149763014|NCT00501046|540260570|FG001|Overall Study|Death|30|||
149763015|NCT00501046|540260569|FG000|Overall Study|Lost to Follow-up|14|||
149763016|NCT00501046|540260570|FG001|Overall Study|Lost to Follow-up|13|||
149763017|NCT00501046|540260569|FG000|Overall Study|Physician Decision|7|||
149763018|NCT00501046|540260570|FG001|Overall Study|Physician Decision|2|||
149763019|NCT00501046|540260569|FG000|Overall Study|Pregnancy|0|||
149763020|NCT00501046|540260570|FG001|Overall Study|Pregnancy|3|||
149763021|NCT00501046|540260569|FG000|Overall Study|Protocol Violation|2|||
149763022|NCT00501046|540260570|FG001|Overall Study|Protocol Violation|1|||
149763023|NCT00501046|540260569|FG000|Overall Study|Withdrawal by Subject|84|||
149763024|NCT00501046|540260570|FG001|Overall Study|Withdrawal by Subject|83|||
149763025|NCT00501046|540260569|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
149763026|NCT00501046|540260570|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
149763027|NCT01576016|540260571|FG000|Lead Safety|Death|132|||
149763028|NCT01576016|540260572|FG001|Lead Safety|Death|0|||
149763029|NCT01576016|540260571|FG000|Lead Safety|Withdrawal by Subject|81|||
149763030|NCT01576016|540260572|FG001|Lead Safety|Withdrawal by Subject|0|||
149763031|NCT01576016|540260571|FG000|Lead Safety|System Explanted without Replacement|24|||
149763032|NCT01576016|540260572|FG001|Lead Safety|System Explanted without Replacement|0|||
149763033|NCT01576016|540260571|FG000|Lead Safety|Physician Decision|14|||
149763034|NCT01576016|540260572|FG001|Lead Safety|Physician Decision|0|||
149763035|NCT01576016|540260571|FG000|Lead Safety|Lost to Follow-up|13|||
149763036|NCT01576016|540260572|FG001|Lead Safety|Lost to Follow-up|0|||
149763037|NCT01576016|540260571|FG000|Lead Safety|Unsuccessful implant|2|||
149763038|NCT01576016|540260572|FG001|Lead Safety|Unsuccessful implant|0|||
149763039|NCT01576016|540260571|FG000|Lead Safety|Sponsor request|1|||
149763040|NCT01576016|540260572|FG001|Lead Safety|Sponsor request|0|||
149763041|NCT01576016|540260571|FG000|Lead Safety|Device replaced with CRT-D|1|||
149763042|NCT01576016|540260572|FG001|Lead Safety|Device replaced with CRT-D|0|||
149763043|NCT01576016|540260571|FG000|Lead Safety|Patient on Palliative Care|1|||
149763044|NCT01576016|540260572|FG001|Lead Safety|Patient on Palliative Care|0|||
149763045|NCT01576016|540260571|FG000|Lead Safety|Patient noncompliance|1|||
149763046|NCT01576016|540260572|FG001|Lead Safety|Patient noncompliance|0|||
149763047|NCT01576016|540260571|FG000|Lead Safety|Too far from study site|1|||
149763048|NCT01576016|540260572|FG001|Lead Safety|Too far from study site|0|||
149763049|NCT01576016|540260571|FG000|Lead Safety|System deactivated|1|||
149763050|NCT01576016|540260572|FG001|Lead Safety|System deactivated|0|||
149763051|NCT01576016|540260571|FG000|Lead Safety|Patient no longer followed by study PI|1|||
149763052|NCT01576016|540260572|FG001|Lead Safety|Patient no longer followed by study PI|0|||
149763053|NCT01576016|540260571|FG000|MRI Safety|Withdrawal by Subject|0|||
149763054|NCT01576016|540260572|FG001|MRI Safety|Withdrawal by Subject|10|||
149763055|NCT01576016|540260571|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
149763056|NCT01576016|540260572|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
149763057|NCT01576016|540260571|FG000|MRI Safety|Has not yet completed MRI scan|0|||
149763058|NCT01576016|540260572|FG001|MRI Safety|Has not yet completed MRI scan|56|||
149763059|NCT01576016|540260571|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
149763060|NCT01576016|540260572|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
149763061|NCT00543569|540260575|FG000|Overall Study|Death|2|||
149763062|NCT00543569|540260576|FG001|Overall Study|Death|2|||
149763063|NCT00543569|540260577|FG002|Overall Study|Death|3|||
149763064|NCT00543569|540260578|FG003|Overall Study|Death|1|||
149763065|NCT00543569|540260575|FG000|Overall Study|Lost to Follow-up|0|||
149763066|NCT00543569|540260576|FG001|Overall Study|Lost to Follow-up|0|||
149763067|NCT00543569|540260577|FG002|Overall Study|Lost to Follow-up|1|||
149763068|NCT00543569|540260578|FG003|Overall Study|Lost to Follow-up|1|||
149763069|NCT00543569|540260575|FG000|Overall Study|Miscellaneous Reasons|7|||
149763070|NCT00543569|540260576|FG001|Overall Study|Miscellaneous Reasons|3|||
149763071|NCT00543569|540260577|FG002|Overall Study|Miscellaneous Reasons|11|||
149763072|NCT00543569|540260578|FG003|Overall Study|Miscellaneous Reasons|4|||
149763073|NCT00543569|540260575|FG000|Overall Study|Randomized but never received study drug|3|||
149763074|NCT00543569|540260576|FG001|Overall Study|Randomized but never received study drug|3|||
149763075|NCT00543569|540260577|FG002|Overall Study|Randomized but never received study drug|5|||
149763076|NCT00543569|540260578|FG003|Overall Study|Randomized but never received study drug|3|||
149763077|NCT00862849|540260579|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149763078|NCT00862849|540260580|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
149763079|NCT00862849|540260581|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149763080|NCT00862849|540260582|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149763081|NCT00862849|540260583|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149763082|NCT00862849|540260584|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149763083|NCT00862849|540260579|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149763084|NCT00862849|540260580|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
149763085|NCT00862849|540260581|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149763086|NCT00862849|540260582|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149763087|NCT00862849|540260583|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149763088|NCT00862849|540260584|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149763089|NCT03198754|540260598|FG000|Overall Study|Withdrawal by Subject|5|||
149763090|NCT03198754|540260599|FG001|Overall Study|Withdrawal by Subject|4|||
149763091|NCT03198754|540260598|FG000|Overall Study|Lost to Follow-up|4|||
149763092|NCT03198754|540260599|FG001|Overall Study|Lost to Follow-up|3|||
149763093|NCT03198754|540260598|FG000|Overall Study|Ineligible|2|||
149763094|NCT03198754|540260599|FG001|Overall Study|Ineligible|1|||
149763095|NCT00668200|540260600|FG000|Overall Study|Withdrawal by Subject|2|||
149763096|NCT00668200|540260600|FG000|Overall Study|Lost to Follow-up|1|||
149763097|NCT01474746|540260605|FG000|Overall Study|Lost to Follow-up|1|||
149763098|NCT01474746|540260606|FG001|Overall Study|Lost to Follow-up|1|||
149763099|NCT01474746|540260605|FG000|Overall Study|Withdrawal by Subject|2|||
149763100|NCT01474746|540260606|FG001|Overall Study|Withdrawal by Subject|1|||
149763101|NCT01606761|540260611|FG000|Prior to Week 24|Lost to Follow-up|0|||
149763102|NCT01606761|540260612|FG001|Prior to Week 24|Lost to Follow-up|3|||
149763103|NCT01606761|540260613|FG002|Prior to Week 24|Lost to Follow-up|2|||
149763104|NCT01606761|540260614|FG003|Prior to Week 24|Lost to Follow-up|0|||
149763105|NCT01606761|540260615|FG004|Prior to Week 24|Lost to Follow-up|0|||
149763106|NCT01606761|540260611|FG000|Prior to Week 24|Withdrawal by Subject|12|||
149763107|NCT01606761|540260612|FG001|Prior to Week 24|Withdrawal by Subject|10|||
149763108|NCT01606761|540260613|FG002|Prior to Week 24|Withdrawal by Subject|9|||
149763109|NCT01606761|540260614|FG003|Prior to Week 24|Withdrawal by Subject|0|||
149763110|NCT01606761|540260615|FG004|Prior to Week 24|Withdrawal by Subject|0|||
149763111|NCT01606761|540260611|FG000|Prior to Week 24|Adverse Event|11|||
149763112|NCT01606761|540260612|FG001|Prior to Week 24|Adverse Event|18|||
149763113|NCT01606761|540260613|FG002|Prior to Week 24|Adverse Event|22|||
149763114|NCT01606761|540260614|FG003|Prior to Week 24|Adverse Event|0|||
149763115|NCT01606761|540260615|FG004|Prior to Week 24|Adverse Event|0|||
149763116|NCT01606761|540260611|FG000|Prior to Week 24|Lack of Efficacy|15|||
149763117|NCT01606761|540260612|FG001|Prior to Week 24|Lack of Efficacy|14|||
149763118|NCT01606761|540260613|FG002|Prior to Week 24|Lack of Efficacy|8|||
149763119|NCT01606761|540260614|FG003|Prior to Week 24|Lack of Efficacy|0|||
149763120|NCT01606761|540260615|FG004|Prior to Week 24|Lack of Efficacy|0|||
149763121|NCT01606761|540260611|FG000|Prior to Week 24|Physician Decision|0|||
149763122|NCT01606761|540260612|FG001|Prior to Week 24|Physician Decision|3|||
149763123|NCT01606761|540260613|FG002|Prior to Week 24|Physician Decision|1|||
149763124|NCT01606761|540260614|FG003|Prior to Week 24|Physician Decision|0|||
149763125|NCT01606761|540260615|FG004|Prior to Week 24|Physician Decision|0|||
149763126|NCT01606761|540260611|FG000|Prior to Week 24|Other|4|||
149763127|NCT01606761|540260612|FG001|Prior to Week 24|Other|7|||
149763128|NCT01606761|540260613|FG002|Prior to Week 24|Other|5|||
149763129|NCT01606761|540260614|FG003|Prior to Week 24|Other|0|||
149763130|NCT01606761|540260615|FG004|Prior to Week 24|Other|0|||
149763131|NCT01606761|540260611|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
149763132|NCT01606761|540260612|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
149763133|NCT01606761|540260613|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
149763134|NCT01606761|540260614|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
149763135|NCT01606761|540260615|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
149763136|NCT01606761|540260611|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
149763137|NCT01606761|540260612|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
149763138|NCT01606761|540260613|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
149763139|NCT01606761|540260614|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
149763140|NCT01606761|540260615|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
149763141|NCT01606761|540260611|FG000|Week 24 to Week 52|Adverse Event|0|||
149763142|NCT01606761|540260612|FG001|Week 24 to Week 52|Adverse Event|11|||
149763143|NCT01606761|540260613|FG002|Week 24 to Week 52|Adverse Event|14|||
149763144|NCT01606761|540260614|FG003|Week 24 to Week 52|Adverse Event|3|||
149763145|NCT01606761|540260615|FG004|Week 24 to Week 52|Adverse Event|15|||
149763146|NCT01606761|540260611|FG000|Week 24 to Week 52|Death|0|||
149763147|NCT01606761|540260612|FG001|Week 24 to Week 52|Death|0|||
149763148|NCT01606761|540260613|FG002|Week 24 to Week 52|Death|2|||
149763149|NCT01606761|540260614|FG003|Week 24 to Week 52|Death|1|||
149763150|NCT01606761|540260615|FG004|Week 24 to Week 52|Death|0|||
149763151|NCT01606761|540260611|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
149763152|NCT01606761|540260612|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
149763153|NCT01606761|540260613|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
149763154|NCT01606761|540260614|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
149763155|NCT01606761|540260615|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
149763156|NCT01606761|540260611|FG000|Week 24 to Week 52|Physician Decision|0|||
149763157|NCT01606761|540260612|FG001|Week 24 to Week 52|Physician Decision|1|||
149763158|NCT01606761|540260613|FG002|Week 24 to Week 52|Physician Decision|1|||
149763159|NCT01606761|540260614|FG003|Week 24 to Week 52|Physician Decision|0|||
149763160|NCT01606761|540260615|FG004|Week 24 to Week 52|Physician Decision|0|||
149763161|NCT01606761|540260611|FG000|Week 24 to Week 52|Other|0|||
149763162|NCT01606761|540260612|FG001|Week 24 to Week 52|Other|1|||
149763163|NCT01606761|540260613|FG002|Week 24 to Week 52|Other|5|||
149763164|NCT01606761|540260614|FG003|Week 24 to Week 52|Other|2|||
149763165|NCT01606761|540260615|FG004|Week 24 to Week 52|Other|2|||
149763166|NCT01606761|540260611|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
149763167|NCT01606761|540260612|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
149763168|NCT01606761|540260613|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
149763169|NCT01606761|540260614|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
149763170|NCT01606761|540260615|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
149763171|NCT01606761|540260611|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
149763172|NCT01606761|540260612|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
149763173|NCT01606761|540260613|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
149763174|NCT01606761|540260614|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
149763175|NCT01606761|540260615|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
149763176|NCT01606761|540260611|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
149763177|NCT01606761|540260612|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
149763178|NCT01606761|540260613|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
149763179|NCT01606761|540260614|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
149763180|NCT01606761|540260615|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
149763181|NCT01606761|540260611|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
149763182|NCT01606761|540260612|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
149763183|NCT01606761|540260613|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
149763184|NCT01606761|540260614|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
149763185|NCT01606761|540260615|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
149763186|NCT05086289|540260616|FG000|Overall Study|Adverse Event|4|||
149763187|NCT05086289|540260617|FG001|Overall Study|Adverse Event|2|||
149763188|NCT05086289|540260616|FG000|Overall Study|Lost to Follow-up|2|||
149763189|NCT05086289|540260617|FG001|Overall Study|Lost to Follow-up|0|||
149763190|NCT05086289|540260616|FG000|Overall Study|Non-compliance with study drug|2|||
149763191|NCT05086289|540260617|FG001|Overall Study|Non-compliance with study drug|1|||
149763192|NCT05086289|540260616|FG000|Overall Study|Physician Decision|2|||
149763193|NCT05086289|540260617|FG001|Overall Study|Physician Decision|0|||
149763194|NCT05086289|540260616|FG000|Overall Study|Withdrawal by Subject|5|||
149763195|NCT05086289|540260617|FG001|Overall Study|Withdrawal by Subject|2|||
149763196|NCT00515008|540260620|FG000|Overall Study|Lost to Follow-up|1|||
149763197|NCT00515008|540260621|FG001|Overall Study|Lost to Follow-up|0|||
149763198|NCT00515008|540260620|FG000|Overall Study|Declined|0|||
149763199|NCT00515008|540260621|FG001|Overall Study|Declined|3|||
149763200|NCT00515008|540260620|FG000|Overall Study|Left the Boston Area|1|||
149763201|NCT00515008|540260621|FG001|Overall Study|Left the Boston Area|1|||
149763202|NCT00515008|540260620|FG000|Overall Study|Scheduling conflict|1|||
149763203|NCT00515008|540260621|FG001|Overall Study|Scheduling conflict|0|||
149763204|NCT03135028|540260622|FG000|Overall Study|Death|6|||
149763205|NCT03135028|540260622|FG000|Overall Study|Study Terminated by Sponsor|2|||
149763206|NCT03135028|540260622|FG000|Overall Study|Withdrew Consent|1|||
149763207|NCT01814800|540260623|FG000|Overall Study|Adverse Event|2|||
149763208|NCT01814800|540260623|FG000|Overall Study|Pregnancy|1|||
149763209|NCT01814800|540260623|FG000|Overall Study|Sponsor decision|1|||
149763210|NCT01814800|540260623|FG000|Overall Study|Subject relocation|1|||
149763211|NCT02402218|540260624|FG000|Overall Study|Did not pickup study medication|12|||
149763212|NCT02402218|540260625|FG001|Overall Study|Did not pickup study medication|9|||
149763213|NCT02402218|540260626|FG002|Overall Study|Did not pickup study medication|13|||
149763214|NCT02402218|540260624|FG000|Overall Study|Lack of Efficacy|0|||
149763215|NCT02402218|540260625|FG001|Overall Study|Lack of Efficacy|1|||
149763216|NCT02402218|540260626|FG002|Overall Study|Lack of Efficacy|1|||
149763217|NCT02402218|540260624|FG000|Overall Study|Death|1|||
149763218|NCT02402218|540260625|FG001|Overall Study|Death|0|||
149763219|NCT02402218|540260626|FG002|Overall Study|Death|0|||
149763220|NCT02402218|540260624|FG000|Overall Study|Reinfection|0|||
149763221|NCT02402218|540260625|FG001|Overall Study|Reinfection|0|||
149763222|NCT02402218|540260626|FG002|Overall Study|Reinfection|1|||
149763223|NCT02402218|540260624|FG000|Overall Study|Adverse Event|0|||
149763224|NCT02402218|540260625|FG001|Overall Study|Adverse Event|2|||
149763225|NCT02402218|540260626|FG002|Overall Study|Adverse Event|1|||
149763226|NCT02402218|540260624|FG000|Overall Study|Withdrawal by Subject|1|||
149763227|NCT02402218|540260625|FG001|Overall Study|Withdrawal by Subject|1|||
149763228|NCT02402218|540260626|FG002|Overall Study|Withdrawal by Subject|1|||
149763229|NCT03807739|540260627|FG000|Overall Study|Adverse Event|1|||
149763230|NCT03807739|540260628|FG001|Overall Study|Adverse Event|0|||
149763231|NCT03807739|540260629|FG002|Overall Study|Adverse Event|0|||
149763232|NCT03807739|540260630|FG003|Overall Study|Adverse Event|0|||
149763233|NCT03807739|540260627|FG000|Overall Study|Withdrawal by Subject|1|||
149763234|NCT03807739|540260628|FG001|Overall Study|Withdrawal by Subject|0|||
149763235|NCT03807739|540260629|FG002|Overall Study|Withdrawal by Subject|0|||
149763236|NCT03807739|540260630|FG003|Overall Study|Withdrawal by Subject|0|||
149763237|NCT02371759|540260631|FG000|Overall Study|Protocol Violation|3|||
149763238|NCT02371759|540260632|FG001|Overall Study|Protocol Violation|1|||
149763239|NCT02371759|540260633|FG002|Overall Study|Protocol Violation|1|||
149763240|NCT02371759|540260634|FG003|Overall Study|Protocol Violation|0|||
149763241|NCT02371759|540260635|FG004|Overall Study|Protocol Violation|3|||
149763242|NCT02371759|540260636|FG005|Overall Study|Protocol Violation|1|||
149763243|NCT02371759|540260637|FG006|Overall Study|Protocol Violation|0|||
149763244|NCT02371759|540260638|FG007|Overall Study|Protocol Violation|3|||
149763245|NCT02371759|540260631|FG000|Overall Study|Withdrawal by Subject|0|||
149763246|NCT02371759|540260632|FG001|Overall Study|Withdrawal by Subject|0|||
149763247|NCT02371759|540260633|FG002|Overall Study|Withdrawal by Subject|0|||
149763248|NCT02371759|540260634|FG003|Overall Study|Withdrawal by Subject|0|||
149763249|NCT02371759|540260635|FG004|Overall Study|Withdrawal by Subject|0|||
149763250|NCT02371759|540260636|FG005|Overall Study|Withdrawal by Subject|0|||
149763251|NCT02371759|540260637|FG006|Overall Study|Withdrawal by Subject|0|||
149763252|NCT02371759|540260638|FG007|Overall Study|Withdrawal by Subject|1|||
149763253|NCT03375112|540260644|FG000|Overall Study|Withdrawal by Subject|3|||
149763254|NCT03375112|540260645|FG001|Overall Study|Withdrawal by Subject|0|||
149763255|NCT03599141|540260648|FG000|Overall Study|Lost to Follow-up|3|||
149763256|NCT03599141|540260649|FG001|Overall Study|Lost to Follow-up|1|||
149763257|NCT03136185|540260650|FG000|Overall Study|Adverse Event|0|||
149763258|NCT03136185|540260651|FG001|Overall Study|Adverse Event|1|||
149763259|NCT03136185|540260652|FG002|Overall Study|Adverse Event|3|||
149763260|NCT03136185|540260653|FG003|Overall Study|Adverse Event|1|||
149763261|NCT03136185|540260654|FG004|Overall Study|Adverse Event|2|||
149763262|NCT03136185|540260655|FG005|Overall Study|Adverse Event|2|||
149763263|NCT03136185|540260656|FG006|Overall Study|Adverse Event|5|||
149763264|NCT03136185|540260657|FG007|Overall Study|Adverse Event|1|||
149763265|NCT03136185|540260658|FG008|Overall Study|Adverse Event|1|||
149763266|NCT03136185|540260650|FG000|Overall Study|Death|0|||
149763267|NCT03136185|540260651|FG001|Overall Study|Death|0|||
149763268|NCT03136185|540260652|FG002|Overall Study|Death|0|||
149763269|NCT03136185|540260653|FG003|Overall Study|Death|1|||
149763270|NCT03136185|540260654|FG004|Overall Study|Death|1|||
149763271|NCT03136185|540260655|FG005|Overall Study|Death|0|||
149763272|NCT03136185|540260656|FG006|Overall Study|Death|1|||
149763273|NCT03136185|540260657|FG007|Overall Study|Death|0|||
149763274|NCT03136185|540260658|FG008|Overall Study|Death|0|||
149763275|NCT03136185|540260650|FG000|Overall Study|Physician Decision|3|||
149763276|NCT03136185|540260651|FG001|Overall Study|Physician Decision|1|||
149763277|NCT03136185|540260652|FG002|Overall Study|Physician Decision|1|||
149763278|NCT03136185|540260653|FG003|Overall Study|Physician Decision|2|||
149763279|NCT03136185|540260654|FG004|Overall Study|Physician Decision|1|||
149763280|NCT03136185|540260655|FG005|Overall Study|Physician Decision|2|||
149763281|NCT03136185|540260656|FG006|Overall Study|Physician Decision|1|||
149763282|NCT03136185|540260657|FG007|Overall Study|Physician Decision|0|||
149763283|NCT03136185|540260658|FG008|Overall Study|Physician Decision|1|||
149763284|NCT03136185|540260650|FG000|Overall Study|Protocol Defined Disease Progression|0|||
149763285|NCT03136185|540260651|FG001|Overall Study|Protocol Defined Disease Progression|0|||
149763286|NCT03136185|540260652|FG002|Overall Study|Protocol Defined Disease Progression|1|||
149763287|NCT03136185|540260653|FG003|Overall Study|Protocol Defined Disease Progression|0|||
149763288|NCT03136185|540260654|FG004|Overall Study|Protocol Defined Disease Progression|0|||
149763289|NCT03136185|540260655|FG005|Overall Study|Protocol Defined Disease Progression|1|||
149763290|NCT03136185|540260656|FG006|Overall Study|Protocol Defined Disease Progression|0|||
149763291|NCT03136185|540260657|FG007|Overall Study|Protocol Defined Disease Progression|1|||
149763292|NCT03136185|540260658|FG008|Overall Study|Protocol Defined Disease Progression|1|||
149763293|NCT03136185|540260650|FG000|Overall Study|Withdrawal by Subject|1|||
149763294|NCT03136185|540260651|FG001|Overall Study|Withdrawal by Subject|0|||
149763295|NCT03136185|540260652|FG002|Overall Study|Withdrawal by Subject|1|||
149763296|NCT03136185|540260653|FG003|Overall Study|Withdrawal by Subject|1|||
149763297|NCT03136185|540260654|FG004|Overall Study|Withdrawal by Subject|1|||
149763298|NCT03136185|540260655|FG005|Overall Study|Withdrawal by Subject|1|||
149763299|NCT03136185|540260656|FG006|Overall Study|Withdrawal by Subject|2|||
149763300|NCT03136185|540260657|FG007|Overall Study|Withdrawal by Subject|3|||
149763301|NCT03136185|540260658|FG008|Overall Study|Withdrawal by Subject|3|||
149763302|NCT03136185|540260650|FG000|Overall Study|Not Reported|4|||
149763303|NCT03136185|540260651|FG001|Overall Study|Not Reported|1|||
149763304|NCT03136185|540260652|FG002|Overall Study|Not Reported|0|||
149763305|NCT03136185|540260653|FG003|Overall Study|Not Reported|1|||
149763306|NCT03136185|540260654|FG004|Overall Study|Not Reported|0|||
149763307|NCT03136185|540260655|FG005|Overall Study|Not Reported|2|||
149763308|NCT03136185|540260656|FG006|Overall Study|Not Reported|1|||
149763309|NCT03136185|540260657|FG007|Overall Study|Not Reported|1|||
149763310|NCT03136185|540260658|FG008|Overall Study|Not Reported|0|||
149763311|NCT05118386|540260665|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149763312|NCT05118386|540260666|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149763313|NCT05118386|540260667|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149763314|NCT05118386|540260668|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
149763315|NCT05118386|540260669|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149763316|NCT05118386|540260670|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149763317|NCT05118386|540260665|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149763318|NCT05118386|540260666|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149763319|NCT05118386|540260667|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149763320|NCT05118386|540260668|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149763321|NCT05118386|540260669|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
149763322|NCT05118386|540260670|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149763323|NCT00369668|540260674|FG000|Overall Study|Lack of Efficacy|4|||
149763324|NCT00369668|540260675|FG001|Overall Study|Lack of Efficacy|5|||
149763325|NCT00369668|540260676|FG002|Overall Study|Lack of Efficacy|7|||
149763326|NCT03201198|540260679|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
149763327|NCT03201198|540260680|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
149763328|NCT03201198|540260679|FG000|Overall Study|Withdrawal by Subject|2|||
149763329|NCT03201198|540260680|FG001|Overall Study|Withdrawal by Subject|3|||
149763330|NCT03126539|540260686|FG000|Overall Study|Lost to Follow-up|1|||
149763331|NCT03126539|540260687|FG001|Overall Study|Lost to Follow-up|1|||
149763332|NCT03126539|540260688|FG002|Overall Study|Lost to Follow-up|1|||
149763333|NCT03126539|540260689|FG003|Overall Study|Lost to Follow-up|0|||
149763334|NCT03126539|540260690|FG004|Overall Study|Lost to Follow-up|0|||
149763335|NCT03213626|540260693|FG000|Overall Study|Adverse Event|1|||
149763336|NCT03213626|540260693|FG000|Overall Study|Progressive Disease|6|||
149763337|NCT02596711|540260694|FG000|Overall Study|Lost to Follow-up|1|||
149763338|NCT02596711|540260695|FG001|Overall Study|Lost to Follow-up|2|||
149763339|NCT02596711|540260696|FG002|Overall Study|Lost to Follow-up|3|||
149763340|NCT01005732|540260697|FG000|Overall Study|Lost to Follow-up|10|||
149763341|NCT01005732|540260697|FG000|Overall Study|Death|1|||
149763342|NCT00632463|540260699|FG000|Overall Study|Adverse Event|0|||
149763343|NCT00632463|540260700|FG001|Overall Study|Adverse Event|1|||
149763344|NCT00632463|540260701|FG002|Overall Study|Adverse Event|0|||
149763345|NCT01767194|540260704|FG000|Overall Study|Adverse Event|1|||
149763346|NCT01767194|540260705|FG001|Overall Study|Adverse Event|1|||
149763347|NCT01767194|540260704|FG000|Overall Study|Death|0|||
149763348|NCT01767194|540260705|FG001|Overall Study|Death|1|||
149763349|NCT01767194|540260704|FG000|Overall Study|Lack of Efficacy|12|||
149763350|NCT01767194|540260705|FG001|Overall Study|Lack of Efficacy|11|||
149763351|NCT01767194|540260704|FG000|Overall Study|Physician Decision|2|||
149763352|NCT01767194|540260705|FG001|Overall Study|Physician Decision|23|||
149763353|NCT01767194|540260704|FG000|Overall Study|Withdrawal by Subject|0|||
149763354|NCT01767194|540260705|FG001|Overall Study|Withdrawal by Subject|1|||
149763355|NCT01767194|540260704|FG000|Overall Study|Ineligible|1|||
149763356|NCT01767194|540260705|FG001|Overall Study|Ineligible|1|||
149763357|NCT01767194|540260704|FG000|Overall Study|Refusal by patient/parent|2|||
149763358|NCT01767194|540260705|FG001|Overall Study|Refusal by patient/parent|4|||
149763359|NCT01767194|540260704|FG000|Overall Study|Criteria not met on time for next cycle|0|||
149763360|NCT01767194|540260705|FG001|Overall Study|Criteria not met on time for next cycle|1|||
149763361|NCT02112994|540260706|FG000|Overall Study|Progressive Disease|0|||
149763362|NCT02112994|540260707|FG001|Overall Study|Progressive Disease|0|||
149763363|NCT02112994|540260708|FG002|Overall Study|Progressive Disease|1|||
149763364|NCT02112994|540260706|FG000|Overall Study|Pregnancy|0|||
149763365|NCT02112994|540260707|FG001|Overall Study|Pregnancy|1|||
149763366|NCT02112994|540260708|FG002|Overall Study|Pregnancy|1|||
149763367|NCT02112994|540260706|FG000|Overall Study|Liver Transplant|0|||
149763368|NCT02112994|540260707|FG001|Overall Study|Liver Transplant|1|||
149763369|NCT02112994|540260708|FG002|Overall Study|Liver Transplant|0|||
149763370|NCT02112994|540260706|FG000|Overall Study|Withdrawal by Subject|0|||
149763371|NCT02112994|540260707|FG001|Overall Study|Withdrawal by Subject|0|||
149763372|NCT02112994|540260708|FG002|Overall Study|Withdrawal by Subject|1|||
149763373|NCT01683071|540260712|FG000|Part 1|Lack of Efficacy|1|||
149763374|NCT01683071|540260713|FG001|Part 1|Lack of Efficacy|0|||
149763375|NCT01683071|540260714|FG002|Part 1|Lack of Efficacy|0|||
149763376|NCT01683071|540260715|FG003|Part 1|Lack of Efficacy|3|||
149763377|NCT01683071|540260716|FG004|Part 1|Lack of Efficacy|0|||
149763378|NCT01683071|540260717|FG005|Part 1|Lack of Efficacy|0|||
149763379|NCT01683071|540260712|FG000|Part 1|Withdrawal by Subject|1|||
149763380|NCT01683071|540260713|FG001|Part 1|Withdrawal by Subject|2|||
149763381|NCT01683071|540260714|FG002|Part 1|Withdrawal by Subject|2|||
149763382|NCT01683071|540260715|FG003|Part 1|Withdrawal by Subject|1|||
149763383|NCT01683071|540260716|FG004|Part 1|Withdrawal by Subject|0|||
149763384|NCT01683071|540260717|FG005|Part 1|Withdrawal by Subject|0|||
149763385|NCT01683071|540260712|FG000|Part 1|Surgery Cancelled|1|||
149763386|NCT01683071|540260713|FG001|Part 1|Surgery Cancelled|0|||
149763387|NCT01683071|540260714|FG002|Part 1|Surgery Cancelled|0|||
149763388|NCT01683071|540260715|FG003|Part 1|Surgery Cancelled|0|||
149763389|NCT01683071|540260716|FG004|Part 1|Surgery Cancelled|0|||
149763390|NCT01683071|540260717|FG005|Part 1|Surgery Cancelled|0|||
149763391|NCT01683071|540260712|FG000|Part 1|Did not receive study drug|1|||
149763392|NCT01683071|540260713|FG001|Part 1|Did not receive study drug|0|||
149763393|NCT01683071|540260714|FG002|Part 1|Did not receive study drug|0|||
149763394|NCT01683071|540260715|FG003|Part 1|Did not receive study drug|1|||
149763395|NCT01683071|540260716|FG004|Part 1|Did not receive study drug|0|||
149763396|NCT01683071|540260717|FG005|Part 1|Did not receive study drug|0|||
149763397|NCT01683071|540260712|FG000|Part 1|Early termination; met exclusion criteria|0|||
149763398|NCT01683071|540260713|FG001|Part 1|Early termination; met exclusion criteria|2|||
149763399|NCT01683071|540260714|FG002|Part 1|Early termination; met exclusion criteria|1|||
149763400|NCT01683071|540260715|FG003|Part 1|Early termination; met exclusion criteria|0|||
149763401|NCT01683071|540260716|FG004|Part 1|Early termination; met exclusion criteria|0|||
149763402|NCT01683071|540260717|FG005|Part 1|Early termination; met exclusion criteria|0|||
149763403|NCT01683071|540260712|FG000|Part 2|Lack of Efficacy|0|||
149763404|NCT01683071|540260713|FG001|Part 2|Lack of Efficacy|0|||
149763405|NCT01683071|540260714|FG002|Part 2|Lack of Efficacy|0|||
149763406|NCT01683071|540260715|FG003|Part 2|Lack of Efficacy|0|||
149763407|NCT01683071|540260716|FG004|Part 2|Lack of Efficacy|3|||
149763408|NCT01683071|540260717|FG005|Part 2|Lack of Efficacy|4|||
149763409|NCT01683071|540260712|FG000|Part 2|Lost to Follow-up|0|||
149763410|NCT01683071|540260713|FG001|Part 2|Lost to Follow-up|0|||
149763411|NCT01683071|540260714|FG002|Part 2|Lost to Follow-up|0|||
149763412|NCT01683071|540260715|FG003|Part 2|Lost to Follow-up|0|||
149763413|NCT01683071|540260716|FG004|Part 2|Lost to Follow-up|2|||
149763414|NCT01683071|540260717|FG005|Part 2|Lost to Follow-up|0|||
149763415|NCT01683071|540260712|FG000|Part 2|Withdrawal by Subject|0|||
149763416|NCT01683071|540260713|FG001|Part 2|Withdrawal by Subject|0|||
149763417|NCT01683071|540260714|FG002|Part 2|Withdrawal by Subject|0|||
149763418|NCT01683071|540260715|FG003|Part 2|Withdrawal by Subject|0|||
149763419|NCT01683071|540260716|FG004|Part 2|Withdrawal by Subject|3|||
149763420|NCT01683071|540260717|FG005|Part 2|Withdrawal by Subject|3|||
149763421|NCT01683071|540260712|FG000|Part 2|Surgery cancelled|0|||
149763422|NCT01683071|540260713|FG001|Part 2|Surgery cancelled|0|||
149763423|NCT01683071|540260714|FG002|Part 2|Surgery cancelled|0|||
149763424|NCT01683071|540260715|FG003|Part 2|Surgery cancelled|0|||
149763425|NCT01683071|540260716|FG004|Part 2|Surgery cancelled|4|||
149763426|NCT01683071|540260717|FG005|Part 2|Surgery cancelled|2|||
149763427|NCT01683071|540260712|FG000|Part 2|Did not receive study drug|0|||
149763428|NCT01683071|540260713|FG001|Part 2|Did not receive study drug|0|||
149763429|NCT01683071|540260714|FG002|Part 2|Did not receive study drug|0|||
149763430|NCT01683071|540260715|FG003|Part 2|Did not receive study drug|0|||
149763431|NCT01683071|540260716|FG004|Part 2|Did not receive study drug|2|||
149763432|NCT01683071|540260717|FG005|Part 2|Did not receive study drug|1|||
149763433|NCT01683071|540260712|FG000|Part 2|Met exclusion criterion|0|||
149763434|NCT01683071|540260713|FG001|Part 2|Met exclusion criterion|0|||
149763435|NCT01683071|540260714|FG002|Part 2|Met exclusion criterion|0|||
149763436|NCT01683071|540260715|FG003|Part 2|Met exclusion criterion|0|||
149763437|NCT01683071|540260716|FG004|Part 2|Met exclusion criterion|1|||
149763438|NCT01683071|540260717|FG005|Part 2|Met exclusion criterion|1|||
149763439|NCT01683071|540260712|FG000|Part 2|Protocol deviation|0|||
149763440|NCT01683071|540260713|FG001|Part 2|Protocol deviation|0|||
149763441|NCT01683071|540260714|FG002|Part 2|Protocol deviation|0|||
149763442|NCT01683071|540260715|FG003|Part 2|Protocol deviation|0|||
149763443|NCT01683071|540260716|FG004|Part 2|Protocol deviation|1|||
149763444|NCT01683071|540260717|FG005|Part 2|Protocol deviation|2|||
149763445|NCT01683071|540260712|FG000|Part 2|Withdrawal by investigator decision|0|||
149763446|NCT01683071|540260713|FG001|Part 2|Withdrawal by investigator decision|0|||
149763447|NCT01683071|540260714|FG002|Part 2|Withdrawal by investigator decision|0|||
149763448|NCT01683071|540260715|FG003|Part 2|Withdrawal by investigator decision|0|||
149763449|NCT01683071|540260716|FG004|Part 2|Withdrawal by investigator decision|1|||
149763450|NCT01683071|540260717|FG005|Part 2|Withdrawal by investigator decision|2|||
149763451|NCT00352755|540262893|FG000|Overall Study|Physician Decision|1|||
149763452|NCT00352755|540262893|FG000|Overall Study|Adverse Event|1|||
149763453|NCT02397694|540262894|FG000|Double-Blinded Phase|Adverse Event|1|||
149763454|NCT02397694|540262895|FG001|Double-Blinded Phase|Adverse Event|0|||
149763455|NCT02397694|540262894|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
149763456|NCT02397694|540262895|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
149763457|NCT02397694|540262894|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
149763458|NCT02397694|540262895|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
149763459|NCT02397694|540262894|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
149763460|NCT02397694|540262895|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
149763461|NCT02397694|540262894|FG000|Open Label Extension Phase|Protocol Violation|1|||
149763462|NCT02397694|540262895|FG001|Open Label Extension Phase|Protocol Violation|0|||
149763463|NCT02397694|540262894|FG000|Open Label Extension Phase|Withdrew Consent|3|||
149763464|NCT02397694|540262895|FG001|Open Label Extension Phase|Withdrew Consent|1|||
149763465|NCT02397694|540262894|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
149763466|NCT02397694|540262895|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
149763467|NCT01116687|540262896|FG000|Overall Study|Withdrawal by Subject|4|||
149763468|NCT00424528|540262897|FG000|Overall Study|Adverse Event|2|||
149763469|NCT00424528|540262898|FG001|Overall Study|Adverse Event|1|||
149763470|NCT00424528|540262899|FG002|Overall Study|Adverse Event|2|||
149763471|NCT00424528|540262897|FG000|Overall Study|Protocol Violation|1|||
149763472|NCT00424528|540262898|FG001|Overall Study|Protocol Violation|1|||
149763473|NCT00424528|540262899|FG002|Overall Study|Protocol Violation|0|||
149763474|NCT00424528|540262897|FG000|Overall Study|Lost to Follow-up|0|||
149763475|NCT00424528|540262898|FG001|Overall Study|Lost to Follow-up|1|||
149763476|NCT00424528|540262899|FG002|Overall Study|Lost to Follow-up|0|||
149763477|NCT00424528|540262897|FG000|Overall Study|noncompliance with study requirements|2|||
149763478|NCT00424528|540262898|FG001|Overall Study|noncompliance with study requirements|1|||
149763479|NCT00424528|540262899|FG002|Overall Study|noncompliance with study requirements|2|||
149763480|NCT02115113|540262900|FG000|Participants in Run-in Period|Death|0|||
149763481|NCT02115113|540262901|FG001|Participants in Run-in Period|Death|0|||
149763482|NCT02115113|540262902|FG002|Participants in Run-in Period|Death|1|||
149763483|NCT02115113|540262900|FG000|Participants in Run-in Period|Administrative problems|0|||
149763484|NCT02115113|540262901|FG001|Participants in Run-in Period|Administrative problems|0|||
149763485|NCT02115113|540262902|FG002|Participants in Run-in Period|Administrative problems|1|||
149763486|NCT02115113|540262900|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
149763487|NCT02115113|540262901|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
149763488|NCT02115113|540262902|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
149763489|NCT02115113|540262900|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
149763490|NCT02115113|540262901|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
149763491|NCT02115113|540262902|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
149763492|NCT02115113|540262900|FG000|Participants Randomized|Lost to Follow-up|1|||
149763493|NCT02115113|540262901|FG001|Participants Randomized|Lost to Follow-up|0|||
149763494|NCT02115113|540262902|FG002|Participants Randomized|Lost to Follow-up|0|||
149763495|NCT02115113|540262900|FG000|Participants Randomized|Death|1|||
149763496|NCT02115113|540262901|FG001|Participants Randomized|Death|0|||
149763497|NCT02115113|540262902|FG002|Participants Randomized|Death|0|||
149763498|NCT00789191|540262904|FG000|Overall Study|Adverse Event|2|||
149763499|NCT00789191|540262905|FG001|Overall Study|Adverse Event|4|||
149763500|NCT00789191|540262904|FG000|Overall Study|Lack of Efficacy|0|||
149763501|NCT00789191|540262905|FG001|Overall Study|Lack of Efficacy|5|||
149763502|NCT00789191|540262904|FG000|Overall Study|Protocol Violation|5|||
149763503|NCT00789191|540262905|FG001|Overall Study|Protocol Violation|3|||
149763504|NCT00789191|540262904|FG000|Overall Study|Withdrawal Criteria|2|||
149763505|NCT00789191|540262905|FG001|Overall Study|Withdrawal Criteria|4|||
149763506|NCT00789191|540262904|FG000|Overall Study|Unclassified|5|||
149763507|NCT00789191|540262905|FG001|Overall Study|Unclassified|3|||
149763508|NCT03497429|540262907|FG000|Overall Study|Progressive disease|3|||
149763509|NCT03497429|540262908|FG001|Overall Study|Progressive disease|4|||
149763510|NCT03497429|540262907|FG000|Overall Study|Adverse Event|0|||
149763511|NCT03497429|540262908|FG001|Overall Study|Adverse Event|2|||
149763512|NCT00280150|540262912|FG000|Overall Study|Adverse Event|0|||
149763513|NCT00280150|540262913|FG001|Overall Study|Adverse Event|1|||
149763514|NCT00280150|540262914|FG002|Overall Study|Adverse Event|2|||
149763515|NCT00280150|540262915|FG003|Overall Study|Adverse Event|3|||
149763516|NCT00280150|540262912|FG000|Overall Study|Lack of Efficacy|0|||
149763517|NCT00280150|540262913|FG001|Overall Study|Lack of Efficacy|0|||
149763518|NCT00280150|540262914|FG002|Overall Study|Lack of Efficacy|0|||
149763519|NCT00280150|540262915|FG003|Overall Study|Lack of Efficacy|3|||
149763520|NCT00280150|540262912|FG000|Overall Study|Physician Decision|0|||
149763521|NCT00280150|540262913|FG001|Overall Study|Physician Decision|0|||
149763522|NCT00280150|540262914|FG002|Overall Study|Physician Decision|0|||
149763523|NCT00280150|540262915|FG003|Overall Study|Physician Decision|1|||
149763524|NCT00280150|540262912|FG000|Overall Study|Protocol Violation|0|||
149763525|NCT00280150|540262913|FG001|Overall Study|Protocol Violation|0|||
149763526|NCT00280150|540262914|FG002|Overall Study|Protocol Violation|0|||
149763527|NCT00280150|540262915|FG003|Overall Study|Protocol Violation|1|||
149763528|NCT00280150|540262912|FG000|Overall Study|Withdrawal by Subject|0|||
149763529|NCT00280150|540262913|FG001|Overall Study|Withdrawal by Subject|0|||
149763530|NCT00280150|540262914|FG002|Overall Study|Withdrawal by Subject|0|||
149763531|NCT00280150|540262915|FG003|Overall Study|Withdrawal by Subject|1|||
149763532|NCT00280150|540262912|FG000|Overall Study|Did not get consolidation therapy|3|||
149763533|NCT00280150|540262913|FG001|Overall Study|Did not get consolidation therapy|0|||
149763534|NCT00280150|540262914|FG002|Overall Study|Did not get consolidation therapy|3|||
149763535|NCT00280150|540262915|FG003|Overall Study|Did not get consolidation therapy|0|||
149763536|NCT00280150|540262912|FG000|Overall Study|Declining Performance Status|0|||
149763537|NCT00280150|540262913|FG001|Overall Study|Declining Performance Status|0|||
149763538|NCT00280150|540262914|FG002|Overall Study|Declining Performance Status|0|||
149763539|NCT00280150|540262915|FG003|Overall Study|Declining Performance Status|1|||
149763540|NCT02939937|540262916|FG000|Overall Study|Adverse Event|5|||
149763541|NCT02939937|540262917|FG001|Overall Study|Adverse Event|0|||
149763542|NCT02939937|540262916|FG000|Overall Study|Lost to Follow-up|1|||
149763543|NCT02939937|540262917|FG001|Overall Study|Lost to Follow-up|3|||
149763544|NCT00568958|540262918|FG000|Allocation|Withdrawal by Subject|7|||
149763545|NCT00568958|540262919|FG001|Allocation|Withdrawal by Subject|3|||
149763546|NCT00568958|540262918|FG000|Allocation|Physician Decision|2|||
149763547|NCT00568958|540262919|FG001|Allocation|Physician Decision|0|||
149763548|NCT00568958|540262918|FG000|Follow-Up|Withdrawal by Subject|6|||
149763549|NCT00568958|540262919|FG001|Follow-Up|Withdrawal by Subject|6|||
149763550|NCT00568958|540262918|FG000|Follow-Up|Physician Decision|1|||
149763551|NCT00568958|540262919|FG001|Follow-Up|Physician Decision|1|||
149763552|NCT00568958|540262918|FG000|Follow-Up|Family Emergency|1|||
149763553|NCT00568958|540262919|FG001|Follow-Up|Family Emergency|0|||
149763554|NCT00568958|540262918|FG000|Follow-Up|Adverse Event|1|||
149763555|NCT00568958|540262919|FG001|Follow-Up|Adverse Event|0|||
149763556|NCT03583372|540262923|FG000|Overall Study|Withdrawal by Subject|6|||
149763557|NCT03583372|540262924|FG001|Overall Study|Withdrawal by Subject|11|||
149763558|NCT03583372|540262925|FG002|Overall Study|Withdrawal by Subject|7|||
149763559|NCT03583372|540262926|FG003|Overall Study|Withdrawal by Subject|8|||
149763560|NCT03583372|540262923|FG000|Overall Study|Lost to Follow-up|4|||
149763561|NCT03583372|540262924|FG001|Overall Study|Lost to Follow-up|6|||
149763562|NCT03583372|540262925|FG002|Overall Study|Lost to Follow-up|3|||
149763563|NCT03583372|540262926|FG003|Overall Study|Lost to Follow-up|2|||
149763564|NCT03583372|540262923|FG000|Overall Study|Adverse Event|1|||
149763565|NCT03583372|540262924|FG001|Overall Study|Adverse Event|3|||
149763566|NCT03583372|540262925|FG002|Overall Study|Adverse Event|4|||
149763567|NCT03583372|540262926|FG003|Overall Study|Adverse Event|4|||
149763568|NCT03583372|540262923|FG000|Overall Study|Physician Decision|0|||
149763569|NCT03583372|540262924|FG001|Overall Study|Physician Decision|1|||
149763570|NCT03583372|540262925|FG002|Overall Study|Physician Decision|1|||
149763571|NCT03583372|540262926|FG003|Overall Study|Physician Decision|1|||
149763572|NCT03583372|540262923|FG000|Overall Study|Lack of Efficacy|0|||
149763573|NCT03583372|540262924|FG001|Overall Study|Lack of Efficacy|1|||
149763574|NCT03583372|540262925|FG002|Overall Study|Lack of Efficacy|0|||
149763575|NCT03583372|540262926|FG003|Overall Study|Lack of Efficacy|1|||
149763576|NCT03583372|540262923|FG000|Overall Study|Death|1|||
149763577|NCT03583372|540262924|FG001|Overall Study|Death|0|||
149763578|NCT03583372|540262925|FG002|Overall Study|Death|0|||
149763579|NCT03583372|540262926|FG003|Overall Study|Death|0|||
149763580|NCT03583372|540262923|FG000|Overall Study|Protocol Violation|0|||
149763581|NCT03583372|540262924|FG001|Overall Study|Protocol Violation|1|||
149763582|NCT03583372|540262925|FG002|Overall Study|Protocol Violation|0|||
149763583|NCT03583372|540262926|FG003|Overall Study|Protocol Violation|0|||
149763584|NCT03583372|540262923|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
149763585|NCT03583372|540262924|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
149763586|NCT03583372|540262925|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
149763587|NCT03583372|540262926|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
149763588|NCT03583372|540262923|FG000|Overall Study|Did Not Receive Study Drug|0|||
149763589|NCT03583372|540262924|FG001|Overall Study|Did Not Receive Study Drug|1|||
149763590|NCT03583372|540262925|FG002|Overall Study|Did Not Receive Study Drug|0|||
149763591|NCT03583372|540262926|FG003|Overall Study|Did Not Receive Study Drug|0|||
149763592|NCT03583372|540262923|FG000|Overall Study|Captured as Other in the Database|1|||
149763593|NCT03583372|540262924|FG001|Overall Study|Captured as Other in the Database|2|||
149763594|NCT03583372|540262925|FG002|Overall Study|Captured as Other in the Database|4|||
149763595|NCT03583372|540262926|FG003|Overall Study|Captured as Other in the Database|1|||
149763596|NCT02796391|540262927|FG000|Overall Study|Lost to Follow-up|2|||
149763597|NCT02796391|540262928|FG001|Overall Study|Lost to Follow-up|2|||
149763598|NCT02796391|540262929|FG002|Overall Study|Lost to Follow-up|13|||
149763599|NCT02796391|540262930|FG003|Overall Study|Lost to Follow-up|8|||
149763600|NCT02796391|540262931|FG004|Overall Study|Lost to Follow-up|14|||
149763601|NCT02796391|540262932|FG005|Overall Study|Lost to Follow-up|13|||
149763602|NCT02796391|540262927|FG000|Overall Study|COVID|0|||
149763603|NCT02796391|540262928|FG001|Overall Study|COVID|0|||
149763604|NCT02796391|540262929|FG002|Overall Study|COVID|5|||
149763605|NCT02796391|540262930|FG003|Overall Study|COVID|5|||
149763606|NCT02796391|540262931|FG004|Overall Study|COVID|2|||
149763607|NCT02796391|540262932|FG005|Overall Study|COVID|4|||
149763608|NCT02796391|540262927|FG000|Overall Study|Participant did not like study cigarettes|0|||
149763609|NCT02796391|540262928|FG001|Overall Study|Participant did not like study cigarettes|0|||
149763610|NCT02796391|540262929|FG002|Overall Study|Participant did not like study cigarettes|3|||
149763611|NCT02796391|540262930|FG003|Overall Study|Participant did not like study cigarettes|0|||
149763612|NCT02796391|540262931|FG004|Overall Study|Participant did not like study cigarettes|0|||
149763613|NCT02796391|540262932|FG005|Overall Study|Participant did not like study cigarettes|0|||
149763614|NCT02796391|540262927|FG000|Overall Study|Withdrawal by Subject|1|||
149763615|NCT02796391|540262928|FG001|Overall Study|Withdrawal by Subject|1|||
149763616|NCT02796391|540262929|FG002|Overall Study|Withdrawal by Subject|4|||
149763617|NCT02796391|540262930|FG003|Overall Study|Withdrawal by Subject|3|||
149763618|NCT02796391|540262931|FG004|Overall Study|Withdrawal by Subject|4|||
149763619|NCT02796391|540262932|FG005|Overall Study|Withdrawal by Subject|3|||
149763620|NCT02796391|540262927|FG000|Overall Study|Adverse Event|0|||
149763621|NCT02796391|540262928|FG001|Overall Study|Adverse Event|0|||
149763622|NCT02796391|540262929|FG002|Overall Study|Adverse Event|0|||
149763623|NCT02796391|540262930|FG003|Overall Study|Adverse Event|1|||
149763624|NCT02796391|540262931|FG004|Overall Study|Adverse Event|0|||
149763625|NCT02796391|540262932|FG005|Overall Study|Adverse Event|0|||
149763626|NCT02796391|540262927|FG000|Overall Study|Protocol Violation|0|||
149763627|NCT02796391|540262928|FG001|Overall Study|Protocol Violation|0|||
149763628|NCT02796391|540262929|FG002|Overall Study|Protocol Violation|0|||
149763629|NCT02796391|540262930|FG003|Overall Study|Protocol Violation|1|||
149763630|NCT02796391|540262931|FG004|Overall Study|Protocol Violation|0|||
149763631|NCT02796391|540262932|FG005|Overall Study|Protocol Violation|0|||
149763632|NCT00377611|540262933|FG000|Overall Study|Adverse Event|2|||
149763633|NCT00377611|540262934|FG001|Overall Study|Adverse Event|9|||
149763634|NCT00377611|540262933|FG000|Overall Study|Protocol Violation|2|||
149763635|NCT00377611|540262934|FG001|Overall Study|Protocol Violation|0|||
149763636|NCT00377611|540262933|FG000|Overall Study|Withdrawal by Subject|0|||
149763637|NCT00377611|540262934|FG001|Overall Study|Withdrawal by Subject|5|||
149763638|NCT00377611|540262933|FG000|Overall Study|Lost to Follow-up|18|||
149763639|NCT00377611|540262934|FG001|Overall Study|Lost to Follow-up|16|||
149763640|NCT00377611|540262933|FG000|Overall Study|Other|0|||
149763641|NCT00377611|540262934|FG001|Overall Study|Other|3|||
149763642|NCT04831515|540262935|FG000|First Intervention|Adverse Event|0|||
149763643|NCT04831515|540262936|FG001|First Intervention|Adverse Event|1|||
149763644|NCT05254613|540262940|FG000|Overall Study|Lost to Follow-up|0|||
149763645|NCT05254613|540262941|FG001|Overall Study|Lost to Follow-up|0|||
149763646|NCT05254613|540262942|FG002|Overall Study|Lost to Follow-up|1|||
149763647|NCT00174785|540262946|FG000|Overall Study|Adverse Event|293|||
149763648|NCT00174785|540262947|FG001|Overall Study|Adverse Event|191|||
149763649|NCT00174785|540262946|FG000|Overall Study|Protocol Violation|14|||
149763650|NCT00174785|540262947|FG001|Overall Study|Protocol Violation|14|||
149763651|NCT00174785|540262946|FG000|Overall Study|Withdrawal by Subject|173|||
149763652|NCT00174785|540262947|FG001|Overall Study|Withdrawal by Subject|175|||
149763653|NCT00174785|540262946|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
149763654|NCT00174785|540262947|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
149763655|NCT00174785|540262946|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
149763656|NCT00174785|540262947|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
149763657|NCT00174785|540262946|FG000|Overall Study|Other prohibited medication|5|||
149763658|NCT00174785|540262947|FG001|Overall Study|Other prohibited medication|3|||
149763659|NCT00174785|540262946|FG000|Overall Study|Family request|6|||
149763660|NCT00174785|540262947|FG001|Overall Study|Family request|8|||
149763661|NCT00174785|540262946|FG000|Overall Study|Not pre-specified/Not coded|56|||
149763662|NCT00174785|540262947|FG001|Overall Study|Not pre-specified/Not coded|70|||
149763663|NCT02387372|540262948|FG000|Overall Study|Not Treated|1|||
149763664|NCT02387372|540262949|FG001|Overall Study|Not Treated|0|||
149763665|NCT00436566|540262953|FG000|Overall Study|Withdrawal by Subject|2|||
149763666|NCT00436566|540262953|FG000|Overall Study|Protocol Violation|1|||
149763667|NCT01954251|540262954|FG000|Overall Study|Adverse Event|5|||
149763668|NCT01954251|540262955|FG001|Overall Study|Adverse Event|7|||
149763669|NCT01954251|540262954|FG000|Overall Study|Lost to Follow-up|6|||
149763670|NCT01954251|540262955|FG001|Overall Study|Lost to Follow-up|6|||
149763671|NCT01954251|540262954|FG000|Overall Study|Withdrawal by Subject|2|||
149763672|NCT01954251|540262955|FG001|Overall Study|Withdrawal by Subject|6|||
149763673|NCT02504268|540262958|FG000|Overall Study|Adverse Event|18|||
149763674|NCT02504268|540262959|FG001|Overall Study|Adverse Event|8|||
149763675|NCT02504268|540262960|FG002|Overall Study|Adverse Event|14|||
149763676|NCT02504268|540262961|FG003|Overall Study|Adverse Event|0|||
149763677|NCT02504268|540262962|FG004|Overall Study|Adverse Event|0|||
149763678|NCT02504268|540262963|FG005|Overall Study|Adverse Event|0|||
149763679|NCT02504268|540262964|FG006|Overall Study|Adverse Event|0|||
149763680|NCT02504268|540262965|FG007|Overall Study|Adverse Event|0|||
149763681|NCT02504268|540262966|FG008|Overall Study|Adverse Event|0|||
149763682|NCT02504268|540262958|FG000|Overall Study|Withdrawal of Consent|11|||
149763683|NCT02504268|540262959|FG001|Overall Study|Withdrawal of Consent|10|||
149763684|NCT02504268|540262960|FG002|Overall Study|Withdrawal of Consent|3|||
149763685|NCT02504268|540262961|FG003|Overall Study|Withdrawal of Consent|0|||
149763686|NCT02504268|540262962|FG004|Overall Study|Withdrawal of Consent|0|||
149763687|NCT02504268|540262963|FG005|Overall Study|Withdrawal of Consent|0|||
149763688|NCT02504268|540262964|FG006|Overall Study|Withdrawal of Consent|0|||
149763689|NCT02504268|540262965|FG007|Overall Study|Withdrawal of Consent|0|||
149763690|NCT02504268|540262966|FG008|Overall Study|Withdrawal of Consent|0|||
149763691|NCT02504268|540262958|FG000|Overall Study|Pregnancy|2|||
149763692|NCT02504268|540262959|FG001|Overall Study|Pregnancy|0|||
149763693|NCT02504268|540262960|FG002|Overall Study|Pregnancy|0|||
149763694|NCT02504268|540262961|FG003|Overall Study|Pregnancy|0|||
149763695|NCT02504268|540262962|FG004|Overall Study|Pregnancy|0|||
149763696|NCT02504268|540262963|FG005|Overall Study|Pregnancy|0|||
149763697|NCT02504268|540262964|FG006|Overall Study|Pregnancy|0|||
149763698|NCT02504268|540262965|FG007|Overall Study|Pregnancy|0|||
149763699|NCT02504268|540262966|FG008|Overall Study|Pregnancy|0|||
149763700|NCT02504268|540262958|FG000|Overall Study|Lost to Follow-up|3|||
149763701|NCT02504268|540262959|FG001|Overall Study|Lost to Follow-up|6|||
149763702|NCT02504268|540262960|FG002|Overall Study|Lost to Follow-up|4|||
149763703|NCT02504268|540262961|FG003|Overall Study|Lost to Follow-up|0|||
149763704|NCT02504268|540262962|FG004|Overall Study|Lost to Follow-up|0|||
149763705|NCT02504268|540262963|FG005|Overall Study|Lost to Follow-up|0|||
149763706|NCT02504268|540262964|FG006|Overall Study|Lost to Follow-up|0|||
149763707|NCT02504268|540262965|FG007|Overall Study|Lost to Follow-up|0|||
149763708|NCT02504268|540262966|FG008|Overall Study|Lost to Follow-up|0|||
149763709|NCT02504268|540262958|FG000|Overall Study|Death|1|||
149763710|NCT02504268|540262959|FG001|Overall Study|Death|1|||
149763711|NCT02504268|540262960|FG002|Overall Study|Death|0|||
149763712|NCT02504268|540262961|FG003|Overall Study|Death|0|||
149763713|NCT02504268|540262962|FG004|Overall Study|Death|0|||
149763714|NCT02504268|540262963|FG005|Overall Study|Death|0|||
149763715|NCT02504268|540262964|FG006|Overall Study|Death|0|||
149763716|NCT02504268|540262965|FG007|Overall Study|Death|0|||
149763717|NCT02504268|540262966|FG008|Overall Study|Death|0|||
149763718|NCT02504268|540262958|FG000|Overall Study|Subject Request to Discontinue|11|||
149763719|NCT02504268|540262959|FG001|Overall Study|Subject Request to Discontinue|3|||
149763720|NCT02504268|540262960|FG002|Overall Study|Subject Request to Discontinue|6|||
149763721|NCT02504268|540262961|FG003|Overall Study|Subject Request to Discontinue|0|||
149763722|NCT02504268|540262962|FG004|Overall Study|Subject Request to Discontinue|0|||
149763723|NCT02504268|540262963|FG005|Overall Study|Subject Request to Discontinue|0|||
149763724|NCT02504268|540262964|FG006|Overall Study|Subject Request to Discontinue|0|||
149763725|NCT02504268|540262965|FG007|Overall Study|Subject Request to Discontinue|0|||
149763726|NCT02504268|540262966|FG008|Overall Study|Subject Request to Discontinue|0|||
149763727|NCT02504268|540262958|FG000|Overall Study|No Longer Meets Study Criteria|2|||
149763728|NCT02504268|540262959|FG001|Overall Study|No Longer Meets Study Criteria|3|||
149763729|NCT02504268|540262960|FG002|Overall Study|No Longer Meets Study Criteria|0|||
149763730|NCT02504268|540262961|FG003|Overall Study|No Longer Meets Study Criteria|0|||
149763731|NCT02504268|540262962|FG004|Overall Study|No Longer Meets Study Criteria|0|||
149763732|NCT02504268|540262963|FG005|Overall Study|No Longer Meets Study Criteria|0|||
149763733|NCT02504268|540262964|FG006|Overall Study|No Longer Meets Study Criteria|0|||
149763734|NCT02504268|540262965|FG007|Overall Study|No Longer Meets Study Criteria|0|||
149763735|NCT02504268|540262966|FG008|Overall Study|No Longer Meets Study Criteria|0|||
149763736|NCT02504268|540262958|FG000|Overall Study|Lack of Efficacy|11|||
149763737|NCT02504268|540262959|FG001|Overall Study|Lack of Efficacy|35|||
149763738|NCT02504268|540262960|FG002|Overall Study|Lack of Efficacy|9|||
149763739|NCT02504268|540262961|FG003|Overall Study|Lack of Efficacy|0|||
149763740|NCT02504268|540262962|FG004|Overall Study|Lack of Efficacy|0|||
149763741|NCT02504268|540262963|FG005|Overall Study|Lack of Efficacy|0|||
149763742|NCT02504268|540262964|FG006|Overall Study|Lack of Efficacy|0|||
149763743|NCT02504268|540262965|FG007|Overall Study|Lack of Efficacy|0|||
149763744|NCT02504268|540262966|FG008|Overall Study|Lack of Efficacy|0|||
149763745|NCT02504268|540262958|FG000|Overall Study|Poor/Non-Compliance|3|||
149763746|NCT02504268|540262959|FG001|Overall Study|Poor/Non-Compliance|2|||
149763747|NCT02504268|540262960|FG002|Overall Study|Poor/Non-Compliance|3|||
149763748|NCT02504268|540262961|FG003|Overall Study|Poor/Non-Compliance|0|||
149763749|NCT02504268|540262962|FG004|Overall Study|Poor/Non-Compliance|0|||
149763750|NCT02504268|540262963|FG005|Overall Study|Poor/Non-Compliance|0|||
149763751|NCT02504268|540262964|FG006|Overall Study|Poor/Non-Compliance|0|||
149763752|NCT02504268|540262965|FG007|Overall Study|Poor/Non-Compliance|0|||
149763753|NCT02504268|540262966|FG008|Overall Study|Poor/Non-Compliance|0|||
149763754|NCT02504268|540262958|FG000|Overall Study|Not Disclosed|1|||
149763755|NCT02504268|540262959|FG001|Overall Study|Not Disclosed|0|||
149763756|NCT02504268|540262960|FG002|Overall Study|Not Disclosed|2|||
149763757|NCT02504268|540262961|FG003|Overall Study|Not Disclosed|0|||
149763758|NCT02504268|540262962|FG004|Overall Study|Not Disclosed|0|||
149763759|NCT02504268|540262963|FG005|Overall Study|Not Disclosed|0|||
149763760|NCT02504268|540262964|FG006|Overall Study|Not Disclosed|0|||
149763761|NCT02504268|540262965|FG007|Overall Study|Not Disclosed|0|||
149763762|NCT02504268|540262966|FG008|Overall Study|Not Disclosed|0|||
149763763|NCT03025217|540262967|FG000|Overall Study|Pregnancy|1|||
149763764|NCT03025217|540262967|FG000|Overall Study|Lost to Follow-up|1|||
149763765|NCT03025217|540262967|FG000|Overall Study|Not eligible, poor English|2|||
149763766|NCT00617409|540262969|FG000|Overall Study|Withdrawal by Subject|4|||
149763767|NCT00617409|540262970|FG001|Overall Study|Withdrawal by Subject|1|||
149763768|NCT00617409|540262971|FG002|Overall Study|Withdrawal by Subject|2|||
149763769|NCT00617409|540262969|FG000|Overall Study|Adverse Event|0|||
149763770|NCT00617409|540262970|FG001|Overall Study|Adverse Event|2|||
149763771|NCT00617409|540262971|FG002|Overall Study|Adverse Event|3|||
149763772|NCT00617409|540262969|FG000|Overall Study|Disease Progression|8|||
149763773|NCT00617409|540262970|FG001|Overall Study|Disease Progression|8|||
149763774|NCT00617409|540262971|FG002|Overall Study|Disease Progression|18|||
149763775|NCT00617409|540262969|FG000|Overall Study|Death|3|||
149763776|NCT00617409|540262970|FG001|Overall Study|Death|5|||
149763777|NCT00617409|540262971|FG002|Overall Study|Death|4|||
149763778|NCT00617409|540262969|FG000|Overall Study|Alternative Therapy|1|||
149763779|NCT00617409|540262970|FG001|Overall Study|Alternative Therapy|2|||
149763780|NCT00617409|540262971|FG002|Overall Study|Alternative Therapy|0|||
149763781|NCT01496430|540262978|FG000|Overall Study|Adverse Event|0|||
149763782|NCT01496430|540262979|FG001|Overall Study|Adverse Event|0|||
149763783|NCT01496430|540262980|FG002|Overall Study|Adverse Event|1|||
149763784|NCT01496430|540262978|FG000|Overall Study|Major Protocol Deviation|0|||
149763785|NCT01496430|540262979|FG001|Overall Study|Major Protocol Deviation|0|||
149763786|NCT01496430|540262980|FG002|Overall Study|Major Protocol Deviation|1|||
149763787|NCT01496430|540262978|FG000|Overall Study|Lost to Follow-up|2|||
149763788|NCT01496430|540262979|FG001|Overall Study|Lost to Follow-up|3|||
149763789|NCT01496430|540262980|FG002|Overall Study|Lost to Follow-up|1|||
149763790|NCT01496430|540262978|FG000|Overall Study|Voluntary Withdrawal|2|||
149763791|NCT01496430|540262979|FG001|Overall Study|Voluntary Withdrawal|1|||
149763792|NCT01496430|540262980|FG002|Overall Study|Voluntary Withdrawal|6|||
149763793|NCT01496430|540262978|FG000|Overall Study|Principal Investigator Discretion|0|||
149763794|NCT01496430|540262979|FG001|Overall Study|Principal Investigator Discretion|1|||
149763795|NCT01496430|540262980|FG002|Overall Study|Principal Investigator Discretion|1|||
149763796|NCT01496430|540262978|FG000|Overall Study|Other|2|||
149763797|NCT01496430|540262979|FG001|Overall Study|Other|0|||
149763798|NCT01496430|540262980|FG002|Overall Study|Other|0|||
149763799|NCT02108951|540262981|FG000|Overall Study|Lost to Follow-up|1|||
149763800|NCT02108951|540262981|FG000|Overall Study|Patient's/guardian's decision|1|||
149763801|NCT02108951|540262981|FG000|Overall Study|Study Terminated by Sponsor|14|||
149763802|NCT00421343|540262985|FG000|Overall Study|Death|1|||
149763803|NCT00421343|540262985|FG000|Overall Study|Withdrawal by Subject|2|||
149763804|NCT00421343|540262985|FG000|Overall Study|Lost to Follow-up|3|||
149763805|NCT01151579|540262988|FG000|Overall Study|Physician Decision|3|||
149763806|NCT01151579|540262989|FG001|Overall Study|Physician Decision|1|||
149763807|NCT01151579|540262988|FG000|Overall Study|Withdrawal by Subject|3|||
149763808|NCT01151579|540262989|FG001|Overall Study|Withdrawal by Subject|2|||
149763809|NCT01151579|540262988|FG000|Overall Study|Not meet inclusion criteria|6|||
149763810|NCT01151579|540262989|FG001|Overall Study|Not meet inclusion criteria|4|||
149763811|NCT00608530|540262990|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
149763812|NCT00608530|540262991|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
149763813|NCT00608530|540262992|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
149763814|NCT00608530|540262993|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
149763815|NCT00608530|540262990|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
149763816|NCT00608530|540262991|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
149763817|NCT00608530|540262992|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
149763818|NCT00608530|540262993|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
149763819|NCT00608530|540262990|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
149763820|NCT00608530|540262991|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
149763821|NCT00608530|540262992|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
149763822|NCT00608530|540262993|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
149763823|NCT00608530|540262990|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149763824|NCT00608530|540262991|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149763825|NCT00608530|540262992|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
149763826|NCT00608530|540262993|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149763827|NCT00608530|540262990|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
149763828|NCT00608530|540262991|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
149763829|NCT00608530|540262992|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
149763830|NCT00608530|540262993|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
149763831|NCT00608530|540262990|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149763832|NCT00608530|540262991|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149763833|NCT00608530|540262992|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
149763834|NCT00608530|540262993|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149763835|NCT00077610|540262994|FG000|Overall Study|Adverse Event|9|||
149763836|NCT00077610|540262995|FG001|Overall Study|Adverse Event|7|||
149763837|NCT00077610|540262996|FG002|Overall Study|Adverse Event|1|||
149763838|NCT00077610|540262994|FG000|Overall Study|Lost to Follow-up|0|||
149763839|NCT00077610|540262995|FG001|Overall Study|Lost to Follow-up|1|||
149763840|NCT00077610|540262996|FG002|Overall Study|Lost to Follow-up|2|||
149763841|NCT00077610|540262994|FG000|Overall Study|Withdrawal by Subject|4|||
149763842|NCT00077610|540262995|FG001|Overall Study|Withdrawal by Subject|10|||
149763843|NCT00077610|540262996|FG002|Overall Study|Withdrawal by Subject|6|||
149763844|NCT00077610|540262994|FG000|Overall Study|Death|17|||
149763845|NCT00077610|540262995|FG001|Overall Study|Death|13|||
149763846|NCT00077610|540262996|FG002|Overall Study|Death|13|||
149763847|NCT00077610|540262994|FG000|Overall Study|Renal transplant|12|||
149763848|NCT00077610|540262995|FG001|Overall Study|Renal transplant|15|||
149763849|NCT00077610|540262996|FG002|Overall Study|Renal transplant|11|||
149763850|NCT00077610|540262994|FG000|Overall Study|Withdrew from dialysis care|5|||
149763851|NCT00077610|540262995|FG001|Overall Study|Withdrew from dialysis care|0|||
149763852|NCT00077610|540262996|FG002|Overall Study|Withdrew from dialysis care|3|||
149763853|NCT00077610|540262994|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149763854|NCT00077610|540262995|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149763855|NCT00077610|540262996|FG002|Overall Study|Insufficient Therapeutic Response|0|||
149763856|NCT00077610|540262994|FG000|Overall Study|Multiple blood transfusions|0|||
149763857|NCT00077610|540262995|FG001|Overall Study|Multiple blood transfusions|0|||
149763858|NCT00077610|540262996|FG002|Overall Study|Multiple blood transfusions|1|||
149763859|NCT00077610|540262994|FG000|Overall Study|Principal Investigator's decision|1|||
149763860|NCT00077610|540262995|FG001|Overall Study|Principal Investigator's decision|0|||
149763861|NCT00077610|540262996|FG002|Overall Study|Principal Investigator's decision|1|||
149763862|NCT00077610|540262994|FG000|Overall Study|Worsening of health condition|1|||
149763863|NCT00077610|540262995|FG001|Overall Study|Worsening of health condition|1|||
149763864|NCT00077610|540262996|FG002|Overall Study|Worsening of health condition|0|||
149763865|NCT00077610|540262994|FG000|Overall Study|Given Epogen in hospital|1|||
149763866|NCT00077610|540262995|FG001|Overall Study|Given Epogen in hospital|0|||
149763867|NCT00077610|540262996|FG002|Overall Study|Given Epogen in hospital|0|||
149763868|NCT00077610|540262994|FG000|Overall Study|Transferred to other unit|0|||
149763869|NCT00077610|540262995|FG001|Overall Study|Transferred to other unit|0|||
149763870|NCT00077610|540262996|FG002|Overall Study|Transferred to other unit|1|||
149763871|NCT00077610|540262994|FG000|Overall Study|Transferred to nursing home|0|||
149763872|NCT00077610|540262995|FG001|Overall Study|Transferred to nursing home|0|||
149763873|NCT00077610|540262996|FG002|Overall Study|Transferred to nursing home|1|||
149763874|NCT00077610|540262994|FG000|Overall Study|Transfer to satellite unit|1|||
149763875|NCT00077610|540262995|FG001|Overall Study|Transfer to satellite unit|0|||
149763876|NCT00077610|540262996|FG002|Overall Study|Transfer to satellite unit|0|||
149763877|NCT00077610|540262994|FG000|Overall Study|Transfer to other center for surgery|1|||
149763878|NCT00077610|540262995|FG001|Overall Study|Transfer to other center for surgery|0|||
149763879|NCT00077610|540262996|FG002|Overall Study|Transfer to other center for surgery|0|||
149763880|NCT00077610|540262994|FG000|Overall Study|Change in dialysis modality|1|||
149763881|NCT00077610|540262995|FG001|Overall Study|Change in dialysis modality|0|||
149763882|NCT00077610|540262996|FG002|Overall Study|Change in dialysis modality|0|||
149763883|NCT00077610|540262994|FG000|Overall Study|Relocation|0|||
149763884|NCT00077610|540262995|FG001|Overall Study|Relocation|8|||
149763885|NCT00077610|540262996|FG002|Overall Study|Relocation|5|||
149763886|NCT00077610|540262994|FG000|Overall Study|Financial issues|0|||
149763887|NCT00077610|540262995|FG001|Overall Study|Financial issues|1|||
149763888|NCT00077610|540262996|FG002|Overall Study|Financial issues|0|||
149763889|NCT00077610|540262994|FG000|Overall Study|Sponsors decision to withdraw|0|||
149763890|NCT00077610|540262995|FG001|Overall Study|Sponsors decision to withdraw|0|||
149763891|NCT00077610|540262996|FG002|Overall Study|Sponsors decision to withdraw|1|||
149763892|NCT00305253|540263000|FG000|Overall Study|Withdrawal by Subject|0|||
149763893|NCT00305253|540263001|FG001|Overall Study|Withdrawal by Subject|1|||
149763894|NCT01357915|540263002|FG000|Overall Study|Lost to Follow-up|3|||
149763895|NCT01357915|540263003|FG001|Overall Study|Lost to Follow-up|0|||
149763896|NCT01098461|540263004|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
149763897|NCT01098461|540263005|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
149763898|NCT01098461|540263006|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
149763899|NCT01098461|540263007|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
149763900|NCT01098461|540263004|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
149763901|NCT01098461|540263005|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
149763902|NCT01098461|540263006|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
149763903|NCT01098461|540263007|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
149763904|NCT01098461|540263004|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
149763905|NCT01098461|540263005|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
149763906|NCT01098461|540263006|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
149763907|NCT01098461|540263007|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
149763908|NCT01098461|540263004|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149763909|NCT01098461|540263005|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
149763910|NCT01098461|540263006|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149763911|NCT01098461|540263007|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149763912|NCT01098461|540263004|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149763913|NCT01098461|540263005|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
149763914|NCT01098461|540263006|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149763915|NCT01098461|540263007|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149763916|NCT01098461|540263004|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149763917|NCT01098461|540263005|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
149763918|NCT01098461|540263006|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149763919|NCT01098461|540263007|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149801761|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
149763920|NCT01098461|540263004|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
149763921|NCT01098461|540263005|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
149763922|NCT01098461|540263006|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
149763923|NCT01098461|540263007|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
149763924|NCT02841787|540263008|FG000|Overall Study|Lost to Follow-up|1|||
149763925|NCT02841787|540263009|FG001|Overall Study|Lost to Follow-up|0|||
149763926|NCT02841787|540263010|FG002|Overall Study|Lost to Follow-up|0|||
149763927|NCT02841787|540263008|FG000|Overall Study|Symptoms dropped below threshold|1|||
149763928|NCT02841787|540263009|FG001|Overall Study|Symptoms dropped below threshold|0|||
149763929|NCT02841787|540263010|FG002|Overall Study|Symptoms dropped below threshold|0|||
149763930|NCT02841787|540263008|FG000|Overall Study|Withdrawal by Subject|1|||
149763931|NCT02841787|540263009|FG001|Overall Study|Withdrawal by Subject|4|||
149763932|NCT02841787|540263010|FG002|Overall Study|Withdrawal by Subject|0|||
149763933|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
149763934|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
149763935|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Death|2|||
149763936|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Death|1|||
149763937|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
149763938|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
149763939|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
149763940|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
149763941|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
149763942|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
149763943|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
149763944|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
149763945|NCT03633227|540263011|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
149763946|NCT03633227|540263012|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
149763947|NCT03633227|540263011|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
149763948|NCT03633227|540263012|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
149763949|NCT03633227|540263011|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
149763950|NCT03633227|540263012|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
149763951|NCT03633227|540263011|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
149763952|NCT03633227|540263012|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
149763953|NCT03633227|540263011|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
149763954|NCT03633227|540263012|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
149763955|NCT03633227|540263011|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
149763956|NCT03633227|540263012|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
149763957|NCT03491553|540263013|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
149763958|NCT03491553|540263014|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
149763959|NCT03491553|540263015|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
149763960|NCT03491553|540263016|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
149763961|NCT03491553|540263017|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
149763962|NCT03491553|540263018|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
149763963|NCT03491553|540263013|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
149763964|NCT03491553|540263014|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
149763965|NCT03491553|540263015|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
149763966|NCT03491553|540263016|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
149763967|NCT03491553|540263017|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
149763968|NCT03491553|540263018|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
149763969|NCT01766336|540263024|FG000|Overall Study|Adverse Event|11|||
149763970|NCT01766336|540263025|FG001|Overall Study|Adverse Event|8|||
149763971|NCT01766336|540263024|FG000|Overall Study|Death|4|||
149763972|NCT01766336|540263025|FG001|Overall Study|Death|3|||
149763973|NCT01766336|540263024|FG000|Overall Study|Lost to Follow-up|1|||
149763974|NCT01766336|540263025|FG001|Overall Study|Lost to Follow-up|3|||
149763975|NCT01766336|540263024|FG000|Overall Study|Physician Decision|4|||
149763976|NCT01766336|540263025|FG001|Overall Study|Physician Decision|2|||
149763977|NCT01766336|540263024|FG000|Overall Study|Protocol Violation|0|||
149763978|NCT01766336|540263025|FG001|Overall Study|Protocol Violation|1|||
149763979|NCT01766336|540263024|FG000|Overall Study|Sponsor Decision|52|||
149763980|NCT01766336|540263025|FG001|Overall Study|Sponsor Decision|43|||
149763981|NCT01766336|540263024|FG000|Overall Study|Withdrawal by Subject|18|||
149763982|NCT01766336|540263025|FG001|Overall Study|Withdrawal by Subject|15|||
149763983|NCT02605447|540263027|FG000|Overall Study|Death|66|||
149763984|NCT02605447|540263027|FG000|Overall Study|Physician Decision|1|||
149763985|NCT02605447|540263027|FG000|Overall Study|Lost to Follow-up|24|||
149763986|NCT02605447|540263027|FG000|Overall Study|Withdrawal by Subject|10|||
149763987|NCT02605447|540263027|FG000|Overall Study|Not disclosed|1|||
149763988|NCT01479374|540263028|FG000|Overall Study|Adverse Event|2|||
149763989|NCT01479374|540263029|FG001|Overall Study|Adverse Event|1|||
149763990|NCT01479374|540263030|FG002|Overall Study|Adverse Event|0|||
149763991|NCT01479374|540263028|FG000|Overall Study|Lost to Follow-up|1|||
149763992|NCT01479374|540263029|FG001|Overall Study|Lost to Follow-up|2|||
149763993|NCT01479374|540263030|FG002|Overall Study|Lost to Follow-up|0|||
149763994|NCT01479374|540263028|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
149763995|NCT01479374|540263029|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
149763996|NCT01479374|540263030|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
149763997|NCT01479374|540263028|FG000|Overall Study|Other|0|||
149763998|NCT01479374|540263029|FG001|Overall Study|Other|4|||
149763999|NCT01479374|540263030|FG002|Overall Study|Other|5|||
149764000|NCT02045212|540263032|FG000|Overall Study|Adverse Event|0|||
149764001|NCT02045212|540263033|FG001|Overall Study|Adverse Event|1|||
149764002|NCT02045212|540263032|FG000|Overall Study|Withdrawal by Subject|1|||
149764003|NCT02045212|540263033|FG001|Overall Study|Withdrawal by Subject|0|||
149764004|NCT02045212|540263032|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
149764005|NCT02045212|540263033|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
149764006|NCT00243230|540263041|FG000|Double-Blind Period|Adverse Event|0|||
149764007|NCT00243230|540263042|FG001|Double-Blind Period|Adverse Event|2|||
149764008|NCT00243230|540263043|FG002|Double-Blind Period|Adverse Event|2|||
149764009|NCT00243230|540263044|FG003|Double-Blind Period|Adverse Event|0|||
149764010|NCT00243230|540263041|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149764011|NCT00243230|540263042|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149764012|NCT00243230|540263043|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149764013|NCT00243230|540263044|FG003|Double-Blind Period|Withdrawal by Subject|0|||
149764014|NCT00243230|540263041|FG000|Double-Blind Period|Protocol Violation|0|||
149764015|NCT00243230|540263042|FG001|Double-Blind Period|Protocol Violation|0|||
149764016|NCT00243230|540263043|FG002|Double-Blind Period|Protocol Violation|1|||
149764017|NCT00243230|540263044|FG003|Double-Blind Period|Protocol Violation|0|||
149764018|NCT00243230|540263041|FG000|Double-Blind Period|Randomized but Not Treated|0|||
149764019|NCT00243230|540263042|FG001|Double-Blind Period|Randomized but Not Treated|0|||
149764020|NCT00243230|540263043|FG002|Double-Blind Period|Randomized but Not Treated|2|||
149764021|NCT00243230|540263044|FG003|Double-Blind Period|Randomized but Not Treated|0|||
149764022|NCT00243230|540263041|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
149764023|NCT00243230|540263042|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
149764024|NCT00243230|540263043|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
149764025|NCT00243230|540263044|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
149764026|NCT00243230|540263041|FG000|Open Label Period|Adverse Event|0|||
149764027|NCT00243230|540263042|FG001|Open Label Period|Adverse Event|0|||
149764028|NCT00243230|540263043|FG002|Open Label Period|Adverse Event|0|||
149764029|NCT00243230|540263044|FG003|Open Label Period|Adverse Event|2|||
149764030|NCT00243230|540263041|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
149764031|NCT00243230|540263042|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
149764032|NCT00243230|540263043|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
149764033|NCT00243230|540263044|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
149764034|NCT00243230|540263041|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149764035|NCT00243230|540263042|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149764036|NCT00243230|540263043|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149764037|NCT00243230|540263044|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
149764038|NCT00243230|540263041|FG000|Open Label Period|Lost to Follow-up|0|||
149764039|NCT00243230|540263042|FG001|Open Label Period|Lost to Follow-up|0|||
149764040|NCT00243230|540263043|FG002|Open Label Period|Lost to Follow-up|0|||
149764041|NCT00243230|540263044|FG003|Open Label Period|Lost to Follow-up|2|||
149764042|NCT00243230|540263041|FG000|Open Label Period|Withdrawal by Subject|0|||
149764043|NCT00243230|540263042|FG001|Open Label Period|Withdrawal by Subject|0|||
149764044|NCT00243230|540263043|FG002|Open Label Period|Withdrawal by Subject|0|||
149764045|NCT00243230|540263044|FG003|Open Label Period|Withdrawal by Subject|2|||
149764046|NCT00243230|540263041|FG000|Open Label Period|Protocol Violation|0|||
149764047|NCT00243230|540263042|FG001|Open Label Period|Protocol Violation|0|||
149764048|NCT00243230|540263043|FG002|Open Label Period|Protocol Violation|0|||
149764049|NCT00243230|540263044|FG003|Open Label Period|Protocol Violation|2|||
149764050|NCT00243230|540263041|FG000|Open Label Period|Administrative Reason|0|||
149764051|NCT00243230|540263042|FG001|Open Label Period|Administrative Reason|0|||
149764052|NCT00243230|540263043|FG002|Open Label Period|Administrative Reason|0|||
149764053|NCT00243230|540263044|FG003|Open Label Period|Administrative Reason|63|||
149764054|NCT00586924|540263047|FG000|Overall Study|Adverse event/serious adverse event|0|||
149764055|NCT00586924|540263048|FG001|Overall Study|Adverse event/serious adverse event|0|||
149764056|NCT00586924|540263049|FG002|Overall Study|Adverse event/serious adverse event|0|||
149764057|NCT00586924|540263050|FG003|Overall Study|Adverse event/serious adverse event|1|||
149764058|NCT00586924|540263051|FG004|Overall Study|Adverse event/serious adverse event|0|||
149764059|NCT00586924|540263052|FG005|Overall Study|Adverse event/serious adverse event|2|||
149764060|NCT00586924|540263047|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
149764061|NCT00586924|540263048|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
149764062|NCT00586924|540263049|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
149764063|NCT00586924|540263050|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
149764064|NCT00586924|540263051|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
149764065|NCT00586924|540263052|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
149764066|NCT00586924|540263047|FG000|Overall Study|Disease progression|0|||
149764067|NCT00586924|540263048|FG001|Overall Study|Disease progression|0|||
149764068|NCT00586924|540263049|FG002|Overall Study|Disease progression|0|||
149764069|NCT00586924|540263050|FG003|Overall Study|Disease progression|1|||
149764070|NCT00586924|540263051|FG004|Overall Study|Disease progression|1|||
149764071|NCT00586924|540263052|FG005|Overall Study|Disease progression|0|||
149764072|NCT00586924|540263047|FG000|Overall Study|Development of neutralizing antibodies|2|||
149764073|NCT00586924|540263048|FG001|Overall Study|Development of neutralizing antibodies|2|||
149764074|NCT00586924|540263049|FG002|Overall Study|Development of neutralizing antibodies|2|||
149764075|NCT00586924|540263050|FG003|Overall Study|Development of neutralizing antibodies|0|||
149764076|NCT00586924|540263051|FG004|Overall Study|Development of neutralizing antibodies|0|||
149764077|NCT00586924|540263052|FG005|Overall Study|Development of neutralizing antibodies|22|||
149764078|NCT00586924|540263047|FG000|Overall Study|Complete response|0|||
149764079|NCT00586924|540263048|FG001|Overall Study|Complete response|1|||
149764080|NCT00586924|540263049|FG002|Overall Study|Complete response|0|||
149764081|NCT00586924|540263050|FG003|Overall Study|Complete response|0|||
149764082|NCT00586924|540263051|FG004|Overall Study|Complete response|2|||
149764083|NCT00586924|540263052|FG005|Overall Study|Complete response|2|||
149764084|NCT00586924|540263047|FG000|Overall Study|Other|1|||
149764085|NCT00586924|540263048|FG001|Overall Study|Other|0|||
149764086|NCT00586924|540263049|FG002|Overall Study|Other|1|||
149764087|NCT00586924|540263050|FG003|Overall Study|Other|1|||
149764088|NCT00586924|540263051|FG004|Overall Study|Other|1|||
149764089|NCT00586924|540263052|FG005|Overall Study|Other|6|||
149764090|NCT04570657|540263058|FG000|Overall Study|Adverse Event|0|||
149764091|NCT04570657|540263059|FG001|Overall Study|Adverse Event|0|||
149764092|NCT04570657|540263060|FG002|Overall Study|Adverse Event|1|||
149764093|NCT04570657|540263058|FG000|Overall Study|Lost to Follow-up|0|||
149764094|NCT04570657|540263059|FG001|Overall Study|Lost to Follow-up|0|||
149764095|NCT04570657|540263060|FG002|Overall Study|Lost to Follow-up|1|||
149764096|NCT04570657|540263058|FG000|Overall Study|Physician Decision|0|||
149764097|NCT04570657|540263059|FG001|Overall Study|Physician Decision|1|||
149764098|NCT04570657|540263060|FG002|Overall Study|Physician Decision|0|||
149764099|NCT04570657|540263058|FG000|Overall Study|Withdrawal by Subject|1|||
149764100|NCT04570657|540263059|FG001|Overall Study|Withdrawal by Subject|2|||
149764101|NCT04570657|540263060|FG002|Overall Study|Withdrawal by Subject|2|||
149764102|NCT02998554|540263061|FG000|Overall Study|Adverse Event|8|||
149764103|NCT02998554|540263062|FG001|Overall Study|Adverse Event|3|||
149764104|NCT02998554|540263061|FG000|Overall Study|Protocol deviation|1|||
149764105|NCT02998554|540263062|FG001|Overall Study|Protocol deviation|0|||
149764106|NCT02998554|540263061|FG000|Overall Study|Withdrawal by Subject|2|||
149764107|NCT02998554|540263062|FG001|Overall Study|Withdrawal by Subject|6|||
149764108|NCT02998554|540263061|FG000|Overall Study|Lost to Follow-up|0|||
149764109|NCT02998554|540263062|FG001|Overall Study|Lost to Follow-up|1|||
149764110|NCT02998554|540263061|FG000|Overall Study|Lack of Efficacy|0|||
149764111|NCT02998554|540263062|FG001|Overall Study|Lack of Efficacy|1|||
149764112|NCT02349789|540264511|FG000|Overall Study|Withdrawal by Subject|2|||
149764113|NCT00836277|540264516|FG000|Overall Study|Not evaluable for response|6|||
149764114|NCT00831441|540264526|FG000|Randomized|Death|82|||
149764115|NCT00831441|540264527|FG001|Randomized|Death|81|||
149764116|NCT00831441|540264526|FG000|Randomized|Adverse Event|248|||
149764117|NCT00831441|540264527|FG001|Randomized|Adverse Event|321|||
149764118|NCT00831441|540264526|FG000|Randomized|Emergency procedure|2|||
149764119|NCT00831441|540264527|FG001|Randomized|Emergency procedure|2|||
149764120|NCT00831441|540264526|FG000|Randomized|Elective procedure|26|||
149764121|NCT00831441|540264527|FG001|Randomized|Elective procedure|25|||
149764122|NCT00831441|540264526|FG000|Randomized|Physician Decision|26|||
149764123|NCT00831441|540264527|FG001|Randomized|Physician Decision|35|||
149764124|NCT00831441|540264526|FG000|Randomized|No longer met criteria|13|||
149764125|NCT00831441|540264527|FG001|Randomized|No longer met criteria|19|||
149764126|NCT00831441|540264526|FG000|Randomized|Withdrawal by Subject|178|||
149764127|NCT00831441|540264527|FG001|Randomized|Withdrawal by Subject|212|||
149764128|NCT00831441|540264526|FG000|Randomized|Lost to Follow-up|26|||
149764129|NCT00831441|540264527|FG001|Randomized|Lost to Follow-up|35|||
149764130|NCT00831441|540264526|FG000|Randomized|Administrative reason by sponsor|2780|||
149764131|NCT00831441|540264527|FG001|Randomized|Administrative reason by sponsor|2671|||
149764132|NCT00831441|540264526|FG000|Randomized|poor/non-compliance|30|||
149764133|NCT00831441|540264527|FG001|Randomized|poor/non-compliance|38|||
149764134|NCT00831441|540264526|FG000|Randomized|non-specified|276|||
149764135|NCT00831441|540264527|FG001|Randomized|non-specified|266|||
149764136|NCT00831441|540264526|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
149764137|NCT00831441|540264527|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
149764138|NCT00831441|540264526|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
149764139|NCT00831441|540264527|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
149764140|NCT00831441|540264526|FG000|Follow Up (30 Days)|Death|63|||
149764141|NCT00831441|540264527|FG001|Follow Up (30 Days)|Death|86|||
149764142|NCT00831441|540264526|FG000|Follow Up (30 Days)|non-specified|16|||
149764143|NCT00831441|540264527|FG001|Follow Up (30 Days)|non-specified|26|||
149764144|NCT00831441|540264526|FG000|Follow Up (30 Days)|missing end of study status|0|||
149764145|NCT00831441|540264527|FG001|Follow Up (30 Days)|missing end of study status|1|||
149764146|NCT05674344|540264528|FG000|Overall Study|Screen Fail|21|||
149764147|NCT05674344|540264528|FG000|Overall Study|Incomplete study procedures|3|||
149764148|NCT00111917|540264529|FG000|Overall Study|Withdrawal by Subject|1|||
149764149|NCT00111917|540264530|FG001|Overall Study|Withdrawal by Subject|1|||
149764150|NCT01640925|540264531|FG000|Overall Study|Withdrawal by Subject|1|||
149764151|NCT01640925|540264532|FG001|Overall Study|Withdrawal by Subject|0|||
149764152|NCT01640925|540264531|FG000|Overall Study|Previously enrolled in this trial|13|||
149764153|NCT01640925|540264532|FG001|Overall Study|Previously enrolled in this trial|11|||
149764154|NCT02156492|540264533|FG000|Period 1|No Reason Given|0|||
149764155|NCT02156492|540264534|FG001|Period 1|No Reason Given|1|||
149764156|NCT02156492|540264535|FG002|Period 1|No Reason Given|0|||
149764157|NCT02156492|540264533|FG000|Period 3|Adverse Event|0|||
149764158|NCT02156492|540264534|FG001|Period 3|Adverse Event|1|||
149764159|NCT02156492|540264535|FG002|Period 3|Adverse Event|0|||
149764160|NCT00485589|540264552|FG000|Overall Study|Death|2|||
149764161|NCT00485589|540264553|FG001|Overall Study|Death|2|||
149764162|NCT00485589|540264554|FG002|Overall Study|Death|0|||
149764163|NCT00485589|540264552|FG000|Overall Study|Failure to return|6|||
149764164|NCT00485589|540264553|FG001|Overall Study|Failure to return|5|||
149764165|NCT00485589|540264554|FG002|Overall Study|Failure to return|1|||
149764166|NCT00485589|540264552|FG000|Overall Study|Protocol Violation|1|||
149764167|NCT00485589|540264553|FG001|Overall Study|Protocol Violation|0|||
149764168|NCT00485589|540264554|FG002|Overall Study|Protocol Violation|0|||
149764169|NCT00485589|540264552|FG000|Overall Study|Violation of selection criteria at entry|0|||
149764170|NCT00485589|540264553|FG001|Overall Study|Violation of selection criteria at entry|3|||
149764171|NCT00485589|540264554|FG002|Overall Study|Violation of selection criteria at entry|1|||
149764172|NCT00485589|540264552|FG000|Overall Study|Administrative/Other|1|||
149764173|NCT00485589|540264553|FG001|Overall Study|Administrative/Other|2|||
149764174|NCT00485589|540264554|FG002|Overall Study|Administrative/Other|1|||
149764175|NCT00485589|540264552|FG000|Overall Study|Insufficient therapeutic response|10|||
149764176|NCT00485589|540264553|FG001|Overall Study|Insufficient therapeutic response|3|||
149764177|NCT00485589|540264554|FG002|Overall Study|Insufficient therapeutic response|1|||
149764178|NCT00485589|540264552|FG000|Overall Study|Refused treatment/did not cooperate|1|||
149764179|NCT00485589|540264553|FG001|Overall Study|Refused treatment/did not cooperate|0|||
149764180|NCT00485589|540264554|FG002|Overall Study|Refused treatment/did not cooperate|2|||
149764181|NCT00485589|540264552|FG000|Overall Study|Withdrawal by Subject|3|||
149764182|NCT00485589|540264553|FG001|Overall Study|Withdrawal by Subject|2|||
149764183|NCT00485589|540264554|FG002|Overall Study|Withdrawal by Subject|2|||
149764184|NCT00485589|540264552|FG000|Overall Study|Adverse Event|3|||
149764185|NCT00485589|540264553|FG001|Overall Study|Adverse Event|3|||
149764186|NCT00485589|540264554|FG002|Overall Study|Adverse Event|10|||
149764187|NCT01944969|540264555|FG000|Overall Study|Adverse Event|1|||
149764188|NCT01944969|540264555|FG000|Overall Study|Lack of Efficacy|1|||
149764189|NCT01944969|540264555|FG000|Overall Study|Non-compliance with IMP|1|||
149764190|NCT01944969|540264555|FG000|Overall Study|Administrative or other reasons|23|||
149764191|NCT03072719|540264556|FG000|Overall Study|Adverse Event|1|||
149764192|NCT03072719|540264557|FG001|Overall Study|Adverse Event|1|||
149764193|NCT03421964|540264561|FG000|Overall Study|Lost to Follow-up|11|||
149764194|NCT03421964|540264562|FG001|Overall Study|Lost to Follow-up|21|||
149764195|NCT03421964|540264561|FG000|Overall Study|Withdrawal by Subject|9|||
149764196|NCT03421964|540264562|FG001|Overall Study|Withdrawal by Subject|3|||
149764197|NCT03421964|540264561|FG000|Overall Study|Incarcerated|1|||
149764198|NCT03421964|540264562|FG001|Overall Study|Incarcerated|0|||
149764199|NCT03421964|540264561|FG000|Overall Study|Inpt Treatment Facility|1|||
149764200|NCT03421964|540264562|FG001|Overall Study|Inpt Treatment Facility|1|||
149764201|NCT03421964|540264561|FG000|Overall Study|Virtual Platform Issues|1|||
149764202|NCT03421964|540264562|FG001|Overall Study|Virtual Platform Issues|1|||
149764203|NCT02938585|540264563|FG000|Overall Study|Withdrawal by parent or guardian|0|||
149764204|NCT02938585|540264564|FG001|Overall Study|Withdrawal by parent or guardian|1|||
149764205|NCT02938585|540264565|FG002|Overall Study|Withdrawal by parent or guardian|0|||
149764206|NCT02938585|540264566|FG003|Overall Study|Withdrawal by parent or guardian|0|||
149764207|NCT02938585|540264563|FG000|Overall Study|Withdrawal by Subject|0|||
149764208|NCT02938585|540264564|FG001|Overall Study|Withdrawal by Subject|0|||
149764209|NCT02938585|540264565|FG002|Overall Study|Withdrawal by Subject|0|||
149764210|NCT02938585|540264566|FG003|Overall Study|Withdrawal by Subject|5|||
149764211|NCT03888391|540264571|FG000|Overall Study|Lost to Follow-up|15|||
149764212|NCT00502320|540264572|FG000|Overall Study|Lost to Follow-up|1|||
149764213|NCT00502320|540264573|FG001|Overall Study|Lost to Follow-up|1|||
149764214|NCT00502320|540264572|FG000|Overall Study|Withdrew Consent|1|||
149764215|NCT00502320|540264573|FG001|Overall Study|Withdrew Consent|0|||
149764216|NCT00502320|540264572|FG000|Overall Study|No longer met criteria|1|||
149764217|NCT00502320|540264573|FG001|Overall Study|No longer met criteria|0|||
149764218|NCT00502320|540264572|FG000|Overall Study|Screen Failure|0|||
149764219|NCT00502320|540264573|FG001|Overall Study|Screen Failure|1|||
149764220|NCT00502320|540264572|FG000|Overall Study|Adverse Event|3|||
149764221|NCT00502320|540264573|FG001|Overall Study|Adverse Event|5|||
149764222|NCT03654755|540264574|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
149764223|NCT03654755|540264575|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
149764224|NCT03654755|540264576|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
149764225|NCT03654755|540264574|FG000|Overall Study|Withdrawal by Subject|2|||
149764226|NCT03654755|540264575|FG001|Overall Study|Withdrawal by Subject|4|||
149764227|NCT03654755|540264576|FG002|Overall Study|Withdrawal by Subject|8|||
149764228|NCT03654755|540264574|FG000|Overall Study|Lost to Follow-up|1|||
149764229|NCT03654755|540264575|FG001|Overall Study|Lost to Follow-up|3|||
149764230|NCT03654755|540264576|FG002|Overall Study|Lost to Follow-up|7|||
149764231|NCT03654755|540264574|FG000|Overall Study|Physician Decision|0|||
149764232|NCT03654755|540264575|FG001|Overall Study|Physician Decision|1|||
149764233|NCT03654755|540264576|FG002|Overall Study|Physician Decision|0|||
149764234|NCT03654755|540264574|FG000|Overall Study|Adverse Event|0|||
149764235|NCT03654755|540264575|FG001|Overall Study|Adverse Event|0|||
149764236|NCT03654755|540264576|FG002|Overall Study|Adverse Event|4|||
149764237|NCT03654755|540264574|FG000|Overall Study|Lack of Efficacy|0|||
149764238|NCT03654755|540264575|FG001|Overall Study|Lack of Efficacy|0|||
149764239|NCT03654755|540264576|FG002|Overall Study|Lack of Efficacy|1|||
149764240|NCT00781599|540264578|FG000|Overall Study|Lost to Follow-up|7|||
149764241|NCT00781599|540264579|FG001|Overall Study|Lost to Follow-up|4|||
149764242|NCT01088438|540264588|FG000|Overall Study|Withdrawal by Subject|11|||
149764243|NCT01088438|540264589|FG001|Overall Study|Withdrawal by Subject|6|||
149764244|NCT01088438|540264588|FG000|Overall Study|Lost to Follow-up|18|||
149764245|NCT01088438|540264589|FG001|Overall Study|Lost to Follow-up|30|||
149764246|NCT01199055|540264590|FG000|Overall Study|Death|0|||
149764247|NCT01199055|540264591|FG001|Overall Study|Death|1|||
149764248|NCT01199055|540264592|FG002|Overall Study|Death|0|||
149764249|NCT01199055|540264590|FG000|Overall Study|Physician Decision|0|||
149764250|NCT01199055|540264591|FG001|Overall Study|Physician Decision|1|||
149764251|NCT01199055|540264592|FG002|Overall Study|Physician Decision|1|||
149764252|NCT01199055|540264590|FG000|Overall Study|Progressive disease|2|||
149764253|NCT01199055|540264591|FG001|Overall Study|Progressive disease|1|||
149764254|NCT01199055|540264592|FG002|Overall Study|Progressive disease|2|||
149764255|NCT01199055|540264590|FG000|Overall Study|Withdrawal by Subject|0|||
149764256|NCT01199055|540264591|FG001|Overall Study|Withdrawal by Subject|0|||
149764257|NCT01199055|540264592|FG002|Overall Study|Withdrawal by Subject|1|||
149764258|NCT00718666|540264593|FG000|Booster Phase Year 5|No active participation request|0|||
149764259|NCT00718666|540264594|FG001|Booster Phase Year 5|No active participation request|0|||
149764260|NCT00718666|540264595|FG002|Booster Phase Year 5|No active participation request|1|||
149764261|NCT00718666|540264593|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
149764262|NCT00718666|540264594|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
149764263|NCT00718666|540264595|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
149764264|NCT00718666|540264593|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
149764265|NCT00718666|540264594|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
149764266|NCT00718666|540264595|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
149764267|NCT00718666|540264593|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
149764268|NCT00718666|540264594|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
149764269|NCT00718666|540264595|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
149764270|NCT02196038|540264598|FG000|Overall Study|Death|16|||
149764271|NCT02196038|540264599|FG001|Overall Study|Death|21|||
149764272|NCT02196038|540264598|FG000|Overall Study|Withdrawal by Subject|0|||
149764273|NCT02196038|540264599|FG001|Overall Study|Withdrawal by Subject|1|||
149764274|NCT02196038|540264598|FG000|Overall Study|Lost to Follow-up|1|||
149764275|NCT02196038|540264599|FG001|Overall Study|Lost to Follow-up|0|||
149764276|NCT03471767|540264608|FG000|Overall Study|Withdrawal by Subject|3|||
149764277|NCT03471767|540264609|FG001|Overall Study|Withdrawal by Subject|1|||
149764278|NCT03471767|540264608|FG000|Overall Study|Adverse Event|1|||
149764279|NCT03471767|540264609|FG001|Overall Study|Adverse Event|0|||
149764280|NCT03471767|540264608|FG000|Overall Study|Lost to Follow-up|1|||
149764281|NCT03471767|540264609|FG001|Overall Study|Lost to Follow-up|0|||
149764282|NCT03471767|540264608|FG000|Overall Study|PI Withdrawal|1|||
149764283|NCT03471767|540264609|FG001|Overall Study|PI Withdrawal|3|||
149764284|NCT00678587|540264610|FG000|Overall Study|Adverse Event|3|||
149764285|NCT00678587|540264611|FG001|Overall Study|Adverse Event|3|||
149764286|NCT00678587|540264610|FG000|Overall Study|Lack of Efficacy|1|||
149764287|NCT00678587|540264611|FG001|Overall Study|Lack of Efficacy|0|||
149764288|NCT00678587|540264610|FG000|Overall Study|Protocol Violation|2|||
149764289|NCT00678587|540264611|FG001|Overall Study|Protocol Violation|1|||
149764290|NCT00678587|540264610|FG000|Overall Study|Study Closed/Terminated|1|||
149764291|NCT00678587|540264611|FG001|Overall Study|Study Closed/Terminated|0|||
149764292|NCT00678587|540264610|FG000|Overall Study|Lost to Follow-up|3|||
149764293|NCT00678587|540264611|FG001|Overall Study|Lost to Follow-up|5|||
149764294|NCT00678587|540264610|FG000|Overall Study|Investigator Discretion|2|||
149764295|NCT00678587|540264611|FG001|Overall Study|Investigator Discretion|6|||
149764296|NCT00678587|540264610|FG000|Overall Study|Withdrew Consent|8|||
149764297|NCT00678587|540264611|FG001|Overall Study|Withdrew Consent|3|||
149764298|NCT03806179|540264612|FG000|Overall Study|Progressive disease|0|||
149764299|NCT03806179|540264613|FG001|Overall Study|Progressive disease|2|||
149764300|NCT01952730|540264616|FG000|Overall Study|FDA shut down core lab used by study|1|||
149764301|NCT01514188|540264622|FG000|Overall Study|Adverse Event|3|||
149764302|NCT01514188|540264623|FG001|Overall Study|Adverse Event|5|||
149764303|NCT01514188|540264622|FG000|Overall Study|Withdrawal by Subject|2|||
149764304|NCT01514188|540264623|FG001|Overall Study|Withdrawal by Subject|4|||
149764305|NCT01514188|540264622|FG000|Overall Study|Protocol Violation|2|||
149764306|NCT01514188|540264623|FG001|Overall Study|Protocol Violation|4|||
149764307|NCT01514188|540264622|FG000|Overall Study|Physician Decision|0|||
149764308|NCT01514188|540264623|FG001|Overall Study|Physician Decision|2|||
149764309|NCT01514188|540264622|FG000|Overall Study|Disease Progression|13|||
149764310|NCT01514188|540264623|FG001|Overall Study|Disease Progression|14|||
149764311|NCT01514188|540264622|FG000|Overall Study|Death|1|||
149764312|NCT01514188|540264623|FG001|Overall Study|Death|3|||
149764313|NCT01514188|540264622|FG000|Overall Study|Other|2|||
149764314|NCT01514188|540264623|FG001|Overall Study|Other|1|||
149764315|NCT02662985|540264624|FG000|Treatment Period 1|Adverse Event|0|||
149764316|NCT02662985|540264625|FG001|Treatment Period 1|Adverse Event|2|||
149764317|NCT02662985|540264624|FG000|Treatment Period 1|Protocol Violation|0|||
149764318|NCT02662985|540264625|FG001|Treatment Period 1|Protocol Violation|1|||
149764319|NCT02662985|540264624|FG000|Treatment Period 1|Physician Decision|1|||
149764320|NCT02662985|540264625|FG001|Treatment Period 1|Physician Decision|0|||
149764321|NCT02662985|540264624|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149764322|NCT02662985|540264625|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149764323|NCT02662985|540264624|FG000|Treatment Period 2|Lack of Efficacy|0|||
149764324|NCT02662985|540264625|FG001|Treatment Period 2|Lack of Efficacy|1|||
149764325|NCT02662985|540264624|FG000|Treatment Period 2|Lost to Follow-up|1|||
149764326|NCT02662985|540264625|FG001|Treatment Period 2|Lost to Follow-up|0|||
149764327|NCT02662985|540264624|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
149764328|NCT02662985|540264625|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
149764329|NCT02662985|540264624|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
149764330|NCT02662985|540264625|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
149764331|NCT02662985|540264624|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
149764332|NCT02662985|540264625|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
149764333|NCT02662985|540264624|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
149764334|NCT02662985|540264625|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
149764335|NCT02662985|540264624|FG000|Treatment Period 3 (Extension Period)|Death|0|||
149764336|NCT02662985|540264625|FG001|Treatment Period 3 (Extension Period)|Death|1|||
149764337|NCT01019486|540264626|FG000|Overall Study|Withdrawal by Subject|1|||
149764338|NCT01019486|540264627|FG001|Overall Study|Withdrawal by Subject|1|||
149764339|NCT01019486|540264628|FG002|Overall Study|Withdrawal by Subject|1|||
149764340|NCT05373706|540264634|FG000|Overall Study|Lost to Follow-up|2|||
149764341|NCT05373706|540264635|FG001|Overall Study|Lost to Follow-up|2|||
149764342|NCT03442829|540264636|FG000|Overall Study|Scheduling clash|3|||
149764343|NCT03442829|540264637|FG001|Overall Study|Scheduling clash|1|||
149764344|NCT03442829|540264636|FG000|Overall Study|Illness unrelated to study|1|||
149764345|NCT03442829|540264637|FG001|Overall Study|Illness unrelated to study|1|||
149764346|NCT01486784|540264638|FG000|Overall Study|Withdrawal by Subject|0|||
149764347|NCT01486784|540264639|FG001|Overall Study|Withdrawal by Subject|0|||
149764348|NCT01486784|540264640|FG002|Overall Study|Withdrawal by Subject|1|||
149764349|NCT01486784|540264641|FG003|Overall Study|Withdrawal by Subject|0|||
149764350|NCT01486784|540264642|FG004|Overall Study|Withdrawal by Subject|1|||
149764351|NCT01486784|540264643|FG005|Overall Study|Withdrawal by Subject|2|||
149764352|NCT01486784|540264638|FG000|Overall Study|Subject did not meet entry criteria|0|||
149764353|NCT01486784|540264639|FG001|Overall Study|Subject did not meet entry criteria|0|||
149764354|NCT01486784|540264640|FG002|Overall Study|Subject did not meet entry criteria|0|||
149764355|NCT01486784|540264641|FG003|Overall Study|Subject did not meet entry criteria|0|||
149764356|NCT01486784|540264642|FG004|Overall Study|Subject did not meet entry criteria|1|||
149764357|NCT01486784|540264643|FG005|Overall Study|Subject did not meet entry criteria|0|||
149764358|NCT01486784|540264638|FG000|Overall Study|Death|0|||
149764359|NCT01486784|540264639|FG001|Overall Study|Death|0|||
149764360|NCT01486784|540264640|FG002|Overall Study|Death|0|||
149764361|NCT01486784|540264641|FG003|Overall Study|Death|0|||
149764362|NCT01486784|540264642|FG004|Overall Study|Death|0|||
149764363|NCT01486784|540264643|FG005|Overall Study|Death|1|||
149764364|NCT03029650|540264646|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
149764365|NCT03029650|540264647|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
149764366|NCT03029650|540264646|FG000|Washout (1 Week)|Physician Decision|0|||
149764367|NCT03029650|540264647|FG001|Washout (1 Week)|Physician Decision|1|||
149764368|NCT02237157|540264648|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
149764369|NCT02237157|540264649|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
149764370|NCT02237157|540264650|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
149764371|NCT02237157|540264651|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
149764372|NCT02237157|540264648|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
149764373|NCT02237157|540264649|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149764374|NCT02237157|540264650|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149764375|NCT02237157|540264651|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149764376|NCT03628508|540264652|FG000|Overall Study|Lost to Follow-up|1|||
149764377|NCT01996748|540264653|FG000|Overall Study|Personal reason|1|||
149764378|NCT01996748|540264654|FG001|Overall Study|Personal reason|0|||
149764379|NCT01996748|540264653|FG000|Overall Study|Physician Decision|2|||
149764380|NCT01996748|540264654|FG001|Overall Study|Physician Decision|0|||
149764381|NCT01996748|540264653|FG000|Overall Study|Adverse Event|1|||
149764382|NCT01996748|540264654|FG001|Overall Study|Adverse Event|4|||
149764383|NCT01996748|540264653|FG000|Overall Study|Withdrawal by Subject|0|||
149764384|NCT01996748|540264654|FG001|Overall Study|Withdrawal by Subject|1|||
149764385|NCT01996748|540264653|FG000|Overall Study|Lost to Follow-up|4|||
149764386|NCT01996748|540264654|FG001|Overall Study|Lost to Follow-up|1|||
149764387|NCT03011840|540264655|FG000|Overall Study|Not received PIL in post PIL phase|0|||
149764388|NCT03011840|540264656|FG001|Overall Study|Not received PIL in post PIL phase|21|||
149764389|NCT03738566|540264657|FG000|Initial Study Phase|Withdrawal by Subject|1|||
149764390|NCT03738566|540264658|FG001|Initial Study Phase|Withdrawal by Subject|1|||
149764391|NCT03738566|540264659|FG002|Initial Study Phase|Withdrawal by Subject|2|||
149764392|NCT03738566|540264660|FG003|Initial Study Phase|Withdrawal by Subject|0|||
149764393|NCT03738566|540264657|FG000|Initial Study Phase|Death|0|||
149764394|NCT03738566|540264658|FG001|Initial Study Phase|Death|1|||
149764395|NCT03738566|540264659|FG002|Initial Study Phase|Death|0|||
149764396|NCT03738566|540264660|FG003|Initial Study Phase|Death|0|||
149764397|NCT03738566|540264657|FG000|Initial Study Phase|Treatment failure|5|||
149764398|NCT03738566|540264658|FG001|Initial Study Phase|Treatment failure|0|||
149764399|NCT03738566|540264659|FG002|Initial Study Phase|Treatment failure|0|||
149764400|NCT03738566|540264660|FG003|Initial Study Phase|Treatment failure|0|||
149764401|NCT03738566|540264657|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149764402|NCT03738566|540264658|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149764403|NCT03738566|540264659|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149764404|NCT03738566|540264660|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
149764405|NCT00516269|540264664|FG000|Overall Study|Adverse Event|2|||
149764406|NCT00516269|540264665|FG001|Overall Study|Adverse Event|1|||
149764407|NCT00516269|540264664|FG000|Overall Study|Lost to Follow-up|0|||
149764408|NCT00516269|540264665|FG001|Overall Study|Lost to Follow-up|1|||
149764409|NCT00516269|540264664|FG000|Overall Study|Protocol Violation|0|||
149764410|NCT00516269|540264665|FG001|Overall Study|Protocol Violation|1|||
149764411|NCT00926796|540264666|FG000|Overall Study|Did not receive randomized treatment|4|||
149764412|NCT00926796|540264667|FG001|Overall Study|Did not receive randomized treatment|7|||
149764413|NCT00926796|540264666|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
149764414|NCT00926796|540264667|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
149764415|NCT00926796|540264666|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
149764416|NCT00926796|540264667|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
149764417|NCT00926796|540264666|FG000|Overall Study|Adverse Event|7|||
149764418|NCT00926796|540264667|FG001|Overall Study|Adverse Event|14|||
149764419|NCT00926796|540264666|FG000|Overall Study|Lost to Follow-up|22|||
149764420|NCT00926796|540264667|FG001|Overall Study|Lost to Follow-up|13|||
149764421|NCT00926796|540264666|FG000|Overall Study|Protocol Violation|15|||
149764422|NCT00926796|540264667|FG001|Overall Study|Protocol Violation|11|||
149764423|NCT00926796|540264666|FG000|Overall Study|Withdrawal by Subject|1|||
149764424|NCT00926796|540264667|FG001|Overall Study|Withdrawal by Subject|0|||
149764425|NCT01341652|540264671|FG000|Overall Study|Incorrect Random Assignment|0|||
149764426|NCT01341652|540264672|FG001|Overall Study|Incorrect Random Assignment|1|||
149764427|NCT01341652|540264671|FG000|Overall Study|ineligible; presence metastatic disease|0|||
149764428|NCT01341652|540264672|FG001|Overall Study|ineligible; presence metastatic disease|1|||
149764429|NCT01079962|540264674|FG000|Overall Study|Adverse Event|2|||
149764430|NCT01079962|540264675|FG001|Overall Study|Adverse Event|2|||
149764431|NCT01079962|540264674|FG000|Overall Study|Withdrawal by Subject|5|||
149764432|NCT01079962|540264675|FG001|Overall Study|Withdrawal by Subject|7|||
149764433|NCT01079962|540264674|FG000|Overall Study|Protocol Violation|2|||
149764434|NCT01079962|540264675|FG001|Overall Study|Protocol Violation|2|||
149764435|NCT01079962|540264674|FG000|Overall Study|No blood pressure (BP) control|3|||
149764436|NCT01079962|540264675|FG001|Overall Study|No blood pressure (BP) control|0|||
149764437|NCT01079962|540264674|FG000|Overall Study|Inclusion/exclusion criteria|1|||
149764438|NCT01079962|540264675|FG001|Overall Study|Inclusion/exclusion criteria|3|||
149764439|NCT01079962|540264674|FG000|Overall Study|Participant not returning for next visit|1|||
149764440|NCT01079962|540264675|FG001|Overall Study|Participant not returning for next visit|0|||
149764441|NCT01079962|540264674|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
149764442|NCT01079962|540264675|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
149764443|NCT01072539|540264676|FG000|Overall Study|Treated prior to the Site Initiation|1|||
149764444|NCT01072539|540264676|FG000|Overall Study|Protocol Violation|2|||
149764445|NCT01331239|540264677|FG000|Part II: Core Study|Adverse Event|0|||
149764446|NCT01331239|540264678|FG001|Part II: Core Study|Adverse Event|3|||
149764447|NCT01331239|540264679|FG002|Part II: Core Study|Adverse Event|0|||
149764448|NCT01331239|540264677|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
149764449|NCT01331239|540264678|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
149764450|NCT01331239|540264679|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
149764451|NCT01331239|540264677|FG000|Part II: Core Study|Withdrawal by Subject|0|||
149764452|NCT01331239|540264678|FG001|Part II: Core Study|Withdrawal by Subject|2|||
149764453|NCT01331239|540264679|FG002|Part II: Core Study|Withdrawal by Subject|0|||
149764454|NCT01331239|540264677|FG000|Part II: Core Study|Administrative problems|0|||
149764455|NCT01331239|540264678|FG001|Part II: Core Study|Administrative problems|1|||
149764456|NCT01331239|540264679|FG002|Part II: Core Study|Administrative problems|0|||
149764457|NCT00946530|540264681|FG000|Overall Study|Withdrawal by Subject|0|||
149764458|NCT00946530|540264682|FG001|Overall Study|Withdrawal by Subject|3|||
149764459|NCT00946530|540264683|FG002|Overall Study|Withdrawal by Subject|0|||
149764460|NCT00946530|540264684|FG003|Overall Study|Withdrawal by Subject|3|||
149764461|NCT00946530|540264681|FG000|Overall Study|Physician Decision|1|||
149764462|NCT00946530|540264682|FG001|Overall Study|Physician Decision|1|||
149764463|NCT00946530|540264683|FG002|Overall Study|Physician Decision|1|||
149764464|NCT00946530|540264684|FG003|Overall Study|Physician Decision|1|||
149764465|NCT01008995|540264685|FG000|Controlled Period|Adverse Event|1|||
149764466|NCT01008995|540264686|FG001|Controlled Period|Adverse Event|2|||
149764467|NCT01008995|540264687|FG002|Controlled Period|Adverse Event|0|||
149764468|NCT01008995|540264688|FG003|Controlled Period|Adverse Event|0|||
149764469|NCT01008995|540264685|FG000|Controlled Period|Other|2|||
149764470|NCT01008995|540264686|FG001|Controlled Period|Other|1|||
149764471|NCT01008995|540264687|FG002|Controlled Period|Other|0|||
149764472|NCT01008995|540264688|FG003|Controlled Period|Other|0|||
149764473|NCT01008995|540264685|FG000|After Controlled Period|Adverse Event|0|||
149764474|NCT01008995|540264686|FG001|After Controlled Period|Adverse Event|0|||
149764475|NCT01008995|540264687|FG002|After Controlled Period|Adverse Event|1|||
149764476|NCT01008995|540264688|FG003|After Controlled Period|Adverse Event|1|||
149764477|NCT01008995|540264685|FG000|After Controlled Period|Other|0|||
149764478|NCT01008995|540264686|FG001|After Controlled Period|Other|0|||
149764479|NCT01008995|540264687|FG002|After Controlled Period|Other|1|||
149764480|NCT01008995|540264688|FG003|After Controlled Period|Other|0|||
149764481|NCT00115804|540264691|FG000|Overall Study|Adverse Event|2|||
149764482|NCT00621855|540264692|FG000|Overall Study|Adverse Event|32|||
149764483|NCT00621855|540264693|FG001|Overall Study|Adverse Event|31|||
149764484|NCT00621855|540264694|FG002|Overall Study|Adverse Event|48|||
149764485|NCT00621855|540264695|FG003|Overall Study|Adverse Event|34|||
149764486|NCT00621855|540264696|FG004|Overall Study|Adverse Event|31|||
149764487|NCT00621855|540264692|FG000|Overall Study|Lost to Follow-up|0|||
149764488|NCT00621855|540264693|FG001|Overall Study|Lost to Follow-up|1|||
149764489|NCT00621855|540264694|FG002|Overall Study|Lost to Follow-up|3|||
149764490|NCT00621855|540264695|FG003|Overall Study|Lost to Follow-up|4|||
149764491|NCT00621855|540264696|FG004|Overall Study|Lost to Follow-up|1|||
149764492|NCT00621855|540264692|FG000|Overall Study|Protocol Violation|16|||
149764493|NCT00621855|540264693|FG001|Overall Study|Protocol Violation|8|||
149764494|NCT00621855|540264694|FG002|Overall Study|Protocol Violation|6|||
149764495|NCT00621855|540264695|FG003|Overall Study|Protocol Violation|7|||
149764496|NCT00621855|540264696|FG004|Overall Study|Protocol Violation|8|||
149764497|NCT00621855|540264692|FG000|Overall Study|Withdrawal by Subject|16|||
149764498|NCT00621855|540264693|FG001|Overall Study|Withdrawal by Subject|11|||
149764499|NCT00621855|540264694|FG002|Overall Study|Withdrawal by Subject|13|||
149764500|NCT00621855|540264695|FG003|Overall Study|Withdrawal by Subject|13|||
149764501|NCT00621855|540264696|FG004|Overall Study|Withdrawal by Subject|9|||
149764502|NCT00621855|540264692|FG000|Overall Study|Other|9|||
149764503|NCT00621855|540264693|FG001|Overall Study|Other|7|||
149764504|NCT00621855|540264694|FG002|Overall Study|Other|6|||
149764505|NCT00621855|540264695|FG003|Overall Study|Other|5|||
149764506|NCT00621855|540264696|FG004|Overall Study|Other|4|||
149764507|NCT00621855|540264692|FG000|Overall Study|Patients did not receive study drug|3|||
149764508|NCT00621855|540264693|FG001|Overall Study|Patients did not receive study drug|3|||
149764509|NCT00621855|540264694|FG002|Overall Study|Patients did not receive study drug|5|||
149764510|NCT00621855|540264695|FG003|Overall Study|Patients did not receive study drug|4|||
149764511|NCT00621855|540264696|FG004|Overall Study|Patients did not receive study drug|2|||
149764512|NCT03675737|540264697|FG000|Overall Study|Death|593|||
149764513|NCT03675737|540264698|FG001|Overall Study|Death|660|||
149764514|NCT03675737|540264697|FG000|Overall Study|Lost to Follow-up|1|||
149764515|NCT03675737|540264698|FG001|Overall Study|Lost to Follow-up|5|||
149764516|NCT03675737|540264697|FG000|Overall Study|Physician Decision|1|||
149764517|NCT03675737|540264698|FG001|Overall Study|Physician Decision|0|||
149764518|NCT03675737|540264697|FG000|Overall Study|Withdrawal by Subject|14|||
149764519|NCT03675737|540264698|FG001|Overall Study|Withdrawal by Subject|12|||
149764520|NCT03675737|540264697|FG000|Overall Study|Ongoing in Study|181|||
149764521|NCT03675737|540264698|FG001|Overall Study|Ongoing in Study|112|||
149764522|NCT00605722|540266695|FG000|Overall Study|Adverse Event|6|||
149764523|NCT00605722|540266695|FG000|Overall Study|Insufficient therapeutic response|44|||
149764524|NCT00605722|540266695|FG000|Overall Study|Failure to return|1|||
149764525|NCT00356863|540266698|FG000|Overall Study|Death|16|||
149764526|NCT00356863|540266699|FG001|Overall Study|Death|32|||
149764527|NCT00356863|540266698|FG000|Overall Study|Lost to Follow-up|76|||
149764528|NCT00356863|540266699|FG001|Overall Study|Lost to Follow-up|43|||
149764529|NCT02871401|540266701|FG000|Overall Study|Adverse Event|1|||
149764530|NCT02871401|540266702|FG001|Overall Study|Adverse Event|0|||
149764531|NCT01993615|540266706|FG000|Overall Study|Death|1|||
149764532|NCT01993615|540266707|FG001|Overall Study|Death|0|||
149764533|NCT01354353|540266710|FG000|Overall Study|Adverse Event|1|||
149764534|NCT01354353|540266711|FG001|Overall Study|Adverse Event|0|||
149764535|NCT01354353|540266712|FG002|Overall Study|Adverse Event|0|||
149764536|NCT01354353|540266713|FG003|Overall Study|Adverse Event|4|||
149764537|NCT01354353|540266714|FG004|Overall Study|Adverse Event|0|||
149764538|NCT01354353|540266715|FG005|Overall Study|Adverse Event|5|||
149764539|NCT01354353|540266710|FG000|Overall Study|Entry Criteria Not Met|0|||
149764540|NCT01354353|540266711|FG001|Overall Study|Entry Criteria Not Met|0|||
149764541|NCT01354353|540266712|FG002|Overall Study|Entry Criteria Not Met|0|||
149764542|NCT01354353|540266713|FG003|Overall Study|Entry Criteria Not Met|1|||
149764543|NCT01354353|540266714|FG004|Overall Study|Entry Criteria Not Met|1|||
149764544|NCT01354353|540266715|FG005|Overall Study|Entry Criteria Not Met|0|||
149764545|NCT01354353|540266710|FG000|Overall Study|Physician Decision|0|||
149764546|NCT01354353|540266711|FG001|Overall Study|Physician Decision|1|||
149764547|NCT01354353|540266712|FG002|Overall Study|Physician Decision|1|||
149764548|NCT01354353|540266713|FG003|Overall Study|Physician Decision|0|||
149764549|NCT01354353|540266714|FG004|Overall Study|Physician Decision|0|||
149764550|NCT01354353|540266715|FG005|Overall Study|Physician Decision|0|||
149764551|NCT01354353|540266710|FG000|Overall Study|Withdrawal by Subject|2|||
149764552|NCT01354353|540266711|FG001|Overall Study|Withdrawal by Subject|0|||
149764553|NCT01354353|540266712|FG002|Overall Study|Withdrawal by Subject|1|||
149764554|NCT01354353|540266713|FG003|Overall Study|Withdrawal by Subject|0|||
149764555|NCT01354353|540266714|FG004|Overall Study|Withdrawal by Subject|0|||
149764556|NCT01354353|540266715|FG005|Overall Study|Withdrawal by Subject|1|||
149764557|NCT02924688|540266718|FG000|Overall Study|Adverse Event|9|||
149764558|NCT02924688|540266719|FG001|Overall Study|Adverse Event|3|||
149764559|NCT02924688|540266720|FG002|Overall Study|Adverse Event|2|||
149764560|NCT02924688|540266721|FG003|Overall Study|Adverse Event|2|||
149764561|NCT02924688|540266722|FG004|Overall Study|Adverse Event|3|||
149764562|NCT02924688|540266723|FG005|Overall Study|Adverse Event|2|||
149764563|NCT02924688|540266718|FG000|Overall Study|Lack of Efficacy|2|||
149764564|NCT02924688|540266719|FG001|Overall Study|Lack of Efficacy|3|||
149764565|NCT02924688|540266720|FG002|Overall Study|Lack of Efficacy|4|||
149764566|NCT02924688|540266721|FG003|Overall Study|Lack of Efficacy|2|||
149764567|NCT02924688|540266722|FG004|Overall Study|Lack of Efficacy|1|||
149764568|NCT02924688|540266723|FG005|Overall Study|Lack of Efficacy|1|||
149764569|NCT02924688|540266718|FG000|Overall Study|Protocol Violation|3|||
149764570|NCT02924688|540266719|FG001|Overall Study|Protocol Violation|7|||
149764571|NCT02924688|540266720|FG002|Overall Study|Protocol Violation|5|||
149764572|NCT02924688|540266721|FG003|Overall Study|Protocol Violation|6|||
149764573|NCT02924688|540266722|FG004|Overall Study|Protocol Violation|2|||
149764574|NCT02924688|540266723|FG005|Overall Study|Protocol Violation|2|||
149764575|NCT02924688|540266718|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
149764576|NCT02924688|540266719|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
149764577|NCT02924688|540266720|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
149764578|NCT02924688|540266721|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
149764579|NCT02924688|540266722|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
149764580|NCT02924688|540266723|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
149764581|NCT02924688|540266718|FG000|Overall Study|Lost to Follow-up|2|||
149764582|NCT02924688|540266719|FG001|Overall Study|Lost to Follow-up|4|||
149764583|NCT02924688|540266720|FG002|Overall Study|Lost to Follow-up|2|||
149764584|NCT02924688|540266721|FG003|Overall Study|Lost to Follow-up|4|||
149764585|NCT02924688|540266722|FG004|Overall Study|Lost to Follow-up|2|||
149764586|NCT02924688|540266723|FG005|Overall Study|Lost to Follow-up|4|||
149764587|NCT02924688|540266718|FG000|Overall Study|Physician Decision|2|||
149764588|NCT02924688|540266719|FG001|Overall Study|Physician Decision|1|||
149764589|NCT02924688|540266720|FG002|Overall Study|Physician Decision|0|||
149764590|NCT02924688|540266721|FG003|Overall Study|Physician Decision|1|||
149764591|NCT02924688|540266722|FG004|Overall Study|Physician Decision|1|||
149764592|NCT02924688|540266723|FG005|Overall Study|Physician Decision|1|||
149764593|NCT02924688|540266718|FG000|Overall Study|Withdrawal by Subject|14|||
149764594|NCT02924688|540266719|FG001|Overall Study|Withdrawal by Subject|13|||
149764595|NCT02924688|540266720|FG002|Overall Study|Withdrawal by Subject|9|||
149764596|NCT02924688|540266721|FG003|Overall Study|Withdrawal by Subject|12|||
149764597|NCT02924688|540266722|FG004|Overall Study|Withdrawal by Subject|13|||
149764598|NCT02924688|540266723|FG005|Overall Study|Withdrawal by Subject|14|||
149764599|NCT01104584|540266728|FG000|Overall Study|Study drug never administered|21|||
149764600|NCT01104584|540266728|FG000|Overall Study|Study prematurely discontinued|2|||
149764601|NCT02370498|540266729|FG000|Overall Study|Adverse Event|10|||
149764602|NCT02370498|540266730|FG001|Overall Study|Adverse Event|8|||
149764603|NCT02370498|540266729|FG000|Overall Study|Death|263|||
149764604|NCT02370498|540266730|FG001|Overall Study|Death|265|||
149764605|NCT02370498|540266729|FG000|Overall Study|Protocol Violation|1|||
149764606|NCT02370498|540266730|FG001|Overall Study|Protocol Violation|2|||
149764607|NCT02370498|540266729|FG000|Overall Study|Withdrawal by Subject|7|||
149764608|NCT02370498|540266730|FG001|Overall Study|Withdrawal by Subject|12|||
149764609|NCT02370498|540266729|FG000|Overall Study|Sponsor's decision|15|||
149764610|NCT02370498|540266730|FG001|Overall Study|Sponsor's decision|9|||
149764611|NCT04017442|540266731|FG000|Overall Study|Withdrawal by Subject|0|||
149764612|NCT04017442|540266732|FG001|Overall Study|Withdrawal by Subject|3|||
149764613|NCT04017442|540266731|FG000|Overall Study|Lost to Follow-up|21|||
149764614|NCT04017442|540266732|FG001|Overall Study|Lost to Follow-up|19|||
149764615|NCT02586233|540266736|FG000|Overall Study|Randomized but did not receive treatment|0|||
149764616|NCT02586233|540266737|FG001|Overall Study|Randomized but did not receive treatment|1|||
149764617|NCT02586233|540266738|FG002|Overall Study|Randomized but did not receive treatment|0|||
149764618|NCT02586233|540266739|FG003|Overall Study|Randomized but did not receive treatment|0|||
149764619|NCT02586233|540266740|FG004|Overall Study|Randomized but did not receive treatment|0|||
149764620|NCT02586233|540266741|FG005|Overall Study|Randomized but did not receive treatment|2|||
149764621|NCT02586233|540266742|FG006|Overall Study|Randomized but did not receive treatment|2|||
149764622|NCT02586233|540266736|FG000|Overall Study|Death|0|||
149764623|NCT02586233|540266737|FG001|Overall Study|Death|1|||
149764624|NCT02586233|540266738|FG002|Overall Study|Death|0|||
149764625|NCT02586233|540266739|FG003|Overall Study|Death|0|||
149764626|NCT02586233|540266740|FG004|Overall Study|Death|2|||
149764627|NCT02586233|540266741|FG005|Overall Study|Death|0|||
149764628|NCT02586233|540266742|FG006|Overall Study|Death|0|||
149764629|NCT03225716|540266743|FG000|Overall Study|Withdrawal by Subject|2|||
149764630|NCT03225716|540266744|FG001|Overall Study|Withdrawal by Subject|2|||
149764631|NCT03225716|540266745|FG002|Overall Study|Withdrawal by Subject|0|||
149764632|NCT03225716|540266743|FG000|Overall Study|Lack of Efficacy|1|||
149764633|NCT03225716|540266744|FG001|Overall Study|Lack of Efficacy|0|||
149764634|NCT03225716|540266745|FG002|Overall Study|Lack of Efficacy|0|||
149764635|NCT03225716|540266743|FG000|Overall Study|Adverse Event|2|||
149764636|NCT03225716|540266744|FG001|Overall Study|Adverse Event|0|||
149764637|NCT03225716|540266745|FG002|Overall Study|Adverse Event|1|||
149764638|NCT03225716|540266743|FG000|Overall Study|Study early termination by Sponsor|0|||
149764639|NCT03225716|540266744|FG001|Overall Study|Study early termination by Sponsor|0|||
149764640|NCT03225716|540266745|FG002|Overall Study|Study early termination by Sponsor|2|||
149764641|NCT00848250|540266746|FG000|Overall Study|surgery was completed without cardiopulm|0|||
149764642|NCT00848250|540266747|FG001|Overall Study|surgery was completed without cardiopulm|1|||
149764643|NCT01205451|540266755|FG000|Overall Study|Lost to Follow-up|1|||
149764644|NCT01205451|540266756|FG001|Overall Study|Lost to Follow-up|1|||
149764645|NCT01205451|540266755|FG000|Overall Study|Withdrawal by Subject|5|||
149764646|NCT01205451|540266756|FG001|Overall Study|Withdrawal by Subject|9|||
149764647|NCT02106455|540266768|FG000|Overall Study|Case Report Form Uncollected|6|||
149764648|NCT02106455|540266768|FG000|Overall Study|Protocol Deviation|2|||
149764649|NCT00213980|540266769|FG000|Overall Study|Withdrawal by Subject|3|||
149764650|NCT00213980|540266770|FG001|Overall Study|Withdrawal by Subject|1|||
149764651|NCT00213980|540266769|FG000|Overall Study|Adverse Event|1|||
149764652|NCT00213980|540266770|FG001|Overall Study|Adverse Event|1|||
149764653|NCT00213980|540266769|FG000|Overall Study|Disease progression|0|||
149764654|NCT00213980|540266770|FG001|Overall Study|Disease progression|2|||
149764655|NCT00213980|540266769|FG000|Overall Study|Developed ovarian cancer|1|||
149764656|NCT00213980|540266770|FG001|Overall Study|Developed ovarian cancer|0|||
149764657|NCT00213980|540266769|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
149764658|NCT00213980|540266770|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
149764659|NCT03607838|540266771|FG000|Overall Study|Lack of Efficacy|14|||
149764660|NCT03607838|540266772|FG001|Overall Study|Lack of Efficacy|20|||
149764661|NCT03607838|540266771|FG000|Overall Study|Withdrawal by Subject|13|||
149764662|NCT03607838|540266772|FG001|Overall Study|Withdrawal by Subject|8|||
149764663|NCT03607838|540266771|FG000|Overall Study|Lost to Follow-up|6|||
149764664|NCT03607838|540266772|FG001|Overall Study|Lost to Follow-up|11|||
149764665|NCT03607838|540266771|FG000|Overall Study|Adverse Event|2|||
149764666|NCT03607838|540266772|FG001|Overall Study|Adverse Event|2|||
149764667|NCT03607838|540266771|FG000|Overall Study|Physician Decision|2|||
149764668|NCT03607838|540266772|FG001|Overall Study|Physician Decision|0|||
149764669|NCT03607838|540266771|FG000|Overall Study|Failure to meet randomization criteria|1|||
149764670|NCT03607838|540266772|FG001|Overall Study|Failure to meet randomization criteria|2|||
149764671|NCT03607838|540266771|FG000|Overall Study|Pregnancy|1|||
149764672|NCT03607838|540266772|FG001|Overall Study|Pregnancy|0|||
149764673|NCT03607838|540266771|FG000|Overall Study|Protocol Violation|1|||
149764674|NCT03607838|540266772|FG001|Overall Study|Protocol Violation|0|||
149764675|NCT03607838|540266771|FG000|Overall Study|Due to work|1|||
149764676|NCT03607838|540266772|FG001|Overall Study|Due to work|0|||
149764677|NCT03607838|540266771|FG000|Overall Study|Litigation|0|||
149764678|NCT03607838|540266772|FG001|Overall Study|Litigation|1|||
149764679|NCT03607838|540266771|FG000|Overall Study|Temperature excursion for study drug|0|||
149764680|NCT03607838|540266772|FG001|Overall Study|Temperature excursion for study drug|1|||
149764681|NCT03607838|540266771|FG000|Overall Study|Change of mind|0|||
149764682|NCT03607838|540266772|FG001|Overall Study|Change of mind|1|||
149764683|NCT02411201|540266773|FG000|Overall Study|Adverse Event|2|||
149764684|NCT02411201|540266773|FG000|Overall Study|Withdrawal by Subject|2|||
149764685|NCT02411201|540266773|FG000|Overall Study|Age group completed|2|||
149764686|NCT01260467|540266774|FG000|Overall Study|Withdrawal by Subject|2|||
149764687|NCT00798694|540266775|FG000|Overall Study|Lost to Follow-up|1|||
149764688|NCT00798694|540266776|FG001|Overall Study|Lost to Follow-up|1|||
149764689|NCT00798694|540266775|FG000|Overall Study|Physician Decision|1|||
149764690|NCT00798694|540266776|FG001|Overall Study|Physician Decision|0|||
149764691|NCT01774344|540266778|FG000|Overall Study|Withdrawal by Subject|3|||
149764692|NCT01774344|540266779|FG001|Overall Study|Withdrawal by Subject|10|||
149764693|NCT01774344|540266778|FG000|Overall Study|Protocol Violation|0|||
149764694|NCT01774344|540266779|FG001|Overall Study|Protocol Violation|1|||
149764695|NCT01774344|540266778|FG000|Overall Study|Lost to Follow-up|4|||
149764696|NCT01774344|540266779|FG001|Overall Study|Lost to Follow-up|10|||
149764697|NCT01774344|540266778|FG000|Overall Study|End of survival follow-up not available|2|||
149764698|NCT01774344|540266779|FG001|Overall Study|End of survival follow-up not available|2|||
149764699|NCT01774344|540266778|FG000|Overall Study|Data collection finished|4|||
149764700|NCT01774344|540266779|FG001|Overall Study|Data collection finished|14|||
149764701|NCT01774344|540266778|FG000|Overall Study|Other|0|||
149764702|NCT01774344|540266779|FG001|Overall Study|Other|1|||
149764703|NCT01774344|540266778|FG000|Overall Study|Did not enter Survival Follow up|49|||
149764704|NCT01774344|540266779|FG001|Overall Study|Did not enter Survival Follow up|83|||
149764705|NCT03364608|540266788|FG000|Overall Study|Withdrawal by Subject|4|||
149764706|NCT03364608|540266788|FG000|Overall Study|Protocol Violation|2|||
149764707|NCT03364608|540266788|FG000|Overall Study|Lost to Follow-up|2|||
149764708|NCT02124707|540266794|FG000|Overall Study|Adverse Event|5|||
149764709|NCT02124707|540266794|FG000|Overall Study|Physician Decision|1|||
149764710|NCT02124707|540266794|FG000|Overall Study|Death|1|||
149764711|NCT01363713|540266795|FG000|Overall Study|Adverse Event|1|||
149764712|NCT01363713|540266795|FG000|Overall Study|Protocol Violation|3|||
149764713|NCT01363713|540266795|FG000|Overall Study|Withdrawal by Subject|2|||
149764714|NCT02932332|540266797|FG000|Overall Study|Withdrawal by Subject|1|||
149764715|NCT02932332|540266798|FG001|Overall Study|Withdrawal by Subject|1|||
149764716|NCT02932332|540266799|FG002|Overall Study|Withdrawal by Subject|0|||
149764717|NCT02932332|540266800|FG003|Overall Study|Withdrawal by Subject|1|||
149764718|NCT02932332|540266797|FG000|Overall Study|Chest pain|0|||
149764719|NCT02932332|540266798|FG001|Overall Study|Chest pain|0|||
149764720|NCT02932332|540266799|FG002|Overall Study|Chest pain|0|||
149764721|NCT02932332|540266800|FG003|Overall Study|Chest pain|1|||
149764722|NCT02932332|540266797|FG000|Overall Study|Not Dyspneic cough|1|||
149764723|NCT02932332|540266798|FG001|Overall Study|Not Dyspneic cough|2|||
149764724|NCT02932332|540266799|FG002|Overall Study|Not Dyspneic cough|1|||
149764725|NCT02932332|540266800|FG003|Overall Study|Not Dyspneic cough|0|||
149764726|NCT01875367|540266801|FG000|Overall Study|Not complete at least 2 questionaries|4|||
149764727|NCT01875367|540266802|FG001|Overall Study|Not complete at least 2 questionaries|2|||
149764728|NCT01875367|540266801|FG000|Overall Study|Not receive study treatment|1|||
149764729|NCT01875367|540266802|FG001|Overall Study|Not receive study treatment|0|||
149764730|NCT01419665|540266803|FG000|Combination Treatment|Adverse Event|7|||
149764731|NCT01419665|540266804|FG001|Combination Treatment|Adverse Event|10|||
149764732|NCT01419665|540266803|FG000|Combination Treatment|Physician Decision|5|||
149764733|NCT01419665|540266804|FG001|Combination Treatment|Physician Decision|8|||
149764734|NCT01419665|540266803|FG000|Combination Treatment|Protocol Violation|6|||
149764735|NCT01419665|540266804|FG001|Combination Treatment|Protocol Violation|2|||
149764736|NCT01419665|540266803|FG000|Combination Treatment|disease progression|10|||
149764737|NCT01419665|540266804|FG001|Combination Treatment|disease progression|9|||
149764738|NCT01419665|540266803|FG000|Combination Treatment|Death|5|||
149764739|NCT01419665|540266804|FG001|Combination Treatment|Death|7|||
149764740|NCT01419665|540266803|FG000|Combination Treatment|administrative problems|0|||
149764741|NCT01419665|540266804|FG001|Combination Treatment|administrative problems|1|||
149764742|NCT01419665|540266803|FG000|Combination Treatment|Withdrawal by Subject|5|||
149764743|NCT01419665|540266804|FG001|Combination Treatment|Withdrawal by Subject|4|||
149764744|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
149764745|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
149764746|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
149764747|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
149764748|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
149764749|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
149764750|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
149764751|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
149764752|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
149764753|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
149764754|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
149764755|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
149764756|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Death|1|||
149764757|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Death|2|||
149764758|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
149764759|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
149764760|NCT01419665|540266803|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
149764761|NCT01419665|540266804|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
149764762|NCT01419665|540266803|FG000|Open Label Phase|Death|1|||
149764763|NCT01419665|540266804|FG001|Open Label Phase|Death|0|||
149764764|NCT01419665|540266803|FG000|Open Label Phase|disease progression|0|||
149764765|NCT01419665|540266804|FG001|Open Label Phase|disease progression|1|||
149764766|NCT03977727|540266805|FG000|Second Treatment|Lost to Follow-up|0|||
149764767|NCT03977727|540266806|FG001|Second Treatment|Lost to Follow-up|3|||
149764768|NCT03731364|540266807|FG000|Overall Study|Adverse Event|0|||
149764769|NCT03731364|540266808|FG001|Overall Study|Adverse Event|0|||
149764770|NCT03731364|540266809|FG002|Overall Study|Adverse Event|1|||
149764771|NCT03731364|540266810|FG003|Overall Study|Adverse Event|2|||
149764772|NCT03731364|540266811|FG004|Overall Study|Adverse Event|1|||
149764773|NCT02953782|540266812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
149764774|NCT02953782|540266813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
149764775|NCT02953782|540266814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
149764776|NCT02953782|540266815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
149764777|NCT02953782|540266816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
149764778|NCT02953782|540266817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149764779|NCT02953782|540266818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149764780|NCT02953782|540266819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149764781|NCT02953782|540266812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
149764782|NCT02953782|540266813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149764783|NCT02953782|540266814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
149764784|NCT02953782|540266815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149764785|NCT02953782|540266816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
149764786|NCT02953782|540266817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149764787|NCT02953782|540266818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149764788|NCT02953782|540266819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149764789|NCT02953782|540266812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149764790|NCT02953782|540266813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149764791|NCT02953782|540266814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149764792|NCT02953782|540266815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149764793|NCT02953782|540266816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149764794|NCT02953782|540266817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149764795|NCT02953782|540266818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149764796|NCT02953782|540266819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149764797|NCT02953782|540266812|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764798|NCT02953782|540266813|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764799|NCT02953782|540266814|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
149764800|NCT02953782|540266815|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
149764801|NCT02953782|540266816|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764802|NCT02953782|540266817|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764803|NCT02953782|540266818|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764804|NCT02953782|540266819|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149764805|NCT02953782|540266812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149764806|NCT02953782|540266813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149764807|NCT02953782|540266814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149764808|NCT02953782|540266815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149764809|NCT02953782|540266816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149764810|NCT02953782|540266817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
149764811|NCT02953782|540266818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
149764812|NCT02953782|540266819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
149764813|NCT02953782|540266812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149764814|NCT02953782|540266813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149764815|NCT02953782|540266814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149764816|NCT02953782|540266815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149764817|NCT02953782|540266816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149764818|NCT02953782|540266817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
149764819|NCT02953782|540266818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
149764820|NCT02953782|540266819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
149764821|NCT02953782|540266812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149764822|NCT02953782|540266813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149764823|NCT02953782|540266814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149764824|NCT02953782|540266815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149764825|NCT02953782|540266816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149764826|NCT02953782|540266817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
149764827|NCT02953782|540266818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
149764828|NCT02953782|540266819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
149764829|NCT02953782|540266812|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764830|NCT02953782|540266813|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764831|NCT02953782|540266814|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764832|NCT02953782|540266815|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764833|NCT02953782|540266816|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764834|NCT02953782|540266817|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764835|NCT02953782|540266818|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
149764836|NCT02953782|540266819|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149764837|NCT01934192|540266822|FG000|Overall Study|Protocol Violation|0|||
149764838|NCT01934192|540266823|FG001|Overall Study|Protocol Violation|0|||
149764839|NCT01934192|540266824|FG002|Overall Study|Protocol Violation|0|||
149764840|NCT01934192|540266825|FG003|Overall Study|Protocol Violation|1|||
149764841|NCT01934192|540266822|FG000|Overall Study|Other: reached stopping criteria|6|||
149764842|NCT01934192|540266823|FG001|Overall Study|Other: reached stopping criteria|5|||
149764843|NCT01934192|540266824|FG002|Overall Study|Other: reached stopping criteria|1|||
149764844|NCT01934192|540266825|FG003|Overall Study|Other: reached stopping criteria|0|||
149764845|NCT01934192|540266822|FG000|Overall Study|Physician Decision|3|||
149764846|NCT01934192|540266823|FG001|Overall Study|Physician Decision|2|||
149764847|NCT01934192|540266824|FG002|Overall Study|Physician Decision|0|||
149764848|NCT01934192|540266825|FG003|Overall Study|Physician Decision|0|||
149764849|NCT01737840|540266826|FG000|Overall Study|Diagnosed with an other pathology|2|||
149764850|NCT01737840|540266827|FG001|Overall Study|Diagnosed with an other pathology|2|||
149764851|NCT03105700|540266830|FG000|Overall Study|screen fail|3|||
149764852|NCT03105700|540266830|FG000|Overall Study|Lost to Follow-up|4|||
149764853|NCT02768194|540266831|FG000|Period 1|Adverse Event|0|||
149764854|NCT02768194|540266832|FG001|Period 1|Adverse Event|0|||
149764855|NCT02768194|540266833|FG002|Period 1|Adverse Event|0|||
149764856|NCT02768194|540266834|FG003|Period 1|Adverse Event|1|||
149764857|NCT02768194|540266835|FG004|Period 1|Adverse Event|0|||
149764858|NCT02768194|540266836|FG005|Period 1|Adverse Event|0|||
149764859|NCT02768194|540266831|FG000|Period 2|Other (Reason not specified)|1|||
149764860|NCT02768194|540266832|FG001|Period 2|Other (Reason not specified)|0|||
149764861|NCT02768194|540266833|FG002|Period 2|Other (Reason not specified)|0|||
149764862|NCT02768194|540266834|FG003|Period 2|Other (Reason not specified)|0|||
149764863|NCT02768194|540266835|FG004|Period 2|Other (Reason not specified)|0|||
149764864|NCT02768194|540266836|FG005|Period 2|Other (Reason not specified)|0|||
149764865|NCT02768194|540266831|FG000|Period 3|Other (Reason not specified)|0|||
149764866|NCT02768194|540266832|FG001|Period 3|Other (Reason not specified)|1|||
149764867|NCT02768194|540266833|FG002|Period 3|Other (Reason not specified)|0|||
149764868|NCT02768194|540266834|FG003|Period 3|Other (Reason not specified)|0|||
149764869|NCT02768194|540266835|FG004|Period 3|Other (Reason not specified)|0|||
149764870|NCT02768194|540266836|FG005|Period 3|Other (Reason not specified)|0|||
149764871|NCT03089216|540266839|FG000|Overall Study|Adverse Event|0|||
149764872|NCT03089216|540266840|FG001|Overall Study|Adverse Event|0|||
149764873|NCT03089216|540266841|FG002|Overall Study|Adverse Event|0|||
149764874|NCT03089216|540266842|FG003|Overall Study|Adverse Event|1|||
149764875|NCT03095521|540266843|FG000|Overall Study|Withdrawal by Subject|0|||
149764876|NCT03095521|540266844|FG001|Overall Study|Withdrawal by Subject|1|||
149764877|NCT03095521|540266843|FG000|Overall Study|Lost to Follow-up|0|||
149764878|NCT03095521|540266844|FG001|Overall Study|Lost to Follow-up|1|||
149764879|NCT01536119|540266845|FG000|Overall Study|Lost to Follow-up|17|||
149764880|NCT01536119|540266846|FG001|Overall Study|Lost to Follow-up|14|||
149764881|NCT03521193|540266847|FG000|Overall Study|Withdrawal by Subject|8|||
149764882|NCT03521193|540266848|FG001|Overall Study|Withdrawal by Subject|0|||
149764883|NCT03521193|540266847|FG000|Overall Study|non compliant to ASA treatment|8|||
149764884|NCT03521193|540266848|FG001|Overall Study|non compliant to ASA treatment|0|||
149764885|NCT01810042|540266849|FG000|Overall Study|Lost to Follow-up|10|||
149764886|NCT01208038|540266850|FG000|Overall Study|Withdrawal by Subject|1|||
149764887|NCT01454401|540266851|FG000|Overall Study|Death|1|||
149764888|NCT01454401|540266851|FG000|Overall Study|hospitalised|1|||
149764889|NCT01454401|540266851|FG000|Overall Study|osteomyelitis|2|||
149764890|NCT01454401|540266851|FG000|Overall Study|non-adherence|1|||
149764891|NCT00430521|540266856|FG000|Overall Study|Adverse Event|0|||
149764892|NCT00430521|540266857|FG001|Overall Study|Adverse Event|0|||
149764893|NCT00430521|540266858|FG002|Overall Study|Adverse Event|0|||
149764894|NCT00430521|540266859|FG003|Overall Study|Adverse Event|0|||
149764895|NCT00430521|540266860|FG004|Overall Study|Adverse Event|0|||
149764896|NCT00430521|540266861|FG005|Overall Study|Adverse Event|2|||
149764897|NCT00430521|540266862|FG006|Overall Study|Adverse Event|1|||
149764898|NCT00430521|540266863|FG007|Overall Study|Adverse Event|0|||
149764899|NCT00430521|540266856|FG000|Overall Study|Lost to Follow-up|7|||
149764900|NCT00430521|540266857|FG001|Overall Study|Lost to Follow-up|8|||
149764901|NCT00430521|540266858|FG002|Overall Study|Lost to Follow-up|3|||
149764902|NCT00430521|540266859|FG003|Overall Study|Lost to Follow-up|5|||
149764903|NCT00430521|540266860|FG004|Overall Study|Lost to Follow-up|5|||
149764904|NCT00430521|540266861|FG005|Overall Study|Lost to Follow-up|2|||
149764905|NCT00430521|540266862|FG006|Overall Study|Lost to Follow-up|8|||
149764906|NCT00430521|540266863|FG007|Overall Study|Lost to Follow-up|10|||
149764907|NCT00430521|540266856|FG000|Overall Study|Pregnancy|0|||
149764908|NCT00430521|540266857|FG001|Overall Study|Pregnancy|0|||
149764909|NCT00430521|540266858|FG002|Overall Study|Pregnancy|0|||
149764910|NCT00430521|540266859|FG003|Overall Study|Pregnancy|0|||
149764911|NCT00430521|540266860|FG004|Overall Study|Pregnancy|0|||
149764912|NCT00430521|540266861|FG005|Overall Study|Pregnancy|0|||
149764913|NCT00430521|540266862|FG006|Overall Study|Pregnancy|1|||
149764914|NCT00430521|540266863|FG007|Overall Study|Pregnancy|0|||
149764915|NCT00430521|540266856|FG000|Overall Study|Vaccine Expired|0|||
149764916|NCT00430521|540266857|FG001|Overall Study|Vaccine Expired|0|||
149764917|NCT00430521|540266858|FG002|Overall Study|Vaccine Expired|0|||
149764918|NCT00430521|540266859|FG003|Overall Study|Vaccine Expired|0|||
149764919|NCT00430521|540266860|FG004|Overall Study|Vaccine Expired|0|||
149764920|NCT00430521|540266861|FG005|Overall Study|Vaccine Expired|1|||
149764921|NCT00430521|540266862|FG006|Overall Study|Vaccine Expired|0|||
149764922|NCT00430521|540266863|FG007|Overall Study|Vaccine Expired|0|||
149764923|NCT00430521|540266856|FG000|Overall Study|Protocol Violation|1|||
149764924|NCT00430521|540266857|FG001|Overall Study|Protocol Violation|0|||
149764925|NCT00430521|540266858|FG002|Overall Study|Protocol Violation|0|||
149764926|NCT00430521|540266859|FG003|Overall Study|Protocol Violation|0|||
149764927|NCT00430521|540266860|FG004|Overall Study|Protocol Violation|0|||
149764928|NCT00430521|540266861|FG005|Overall Study|Protocol Violation|0|||
149764929|NCT00430521|540266862|FG006|Overall Study|Protocol Violation|0|||
149764930|NCT00430521|540266863|FG007|Overall Study|Protocol Violation|0|||
149764931|NCT00430521|540266856|FG000|Overall Study|Withdrawal by Subject|3|||
149764932|NCT00430521|540266857|FG001|Overall Study|Withdrawal by Subject|1|||
149764933|NCT00430521|540266858|FG002|Overall Study|Withdrawal by Subject|0|||
149764934|NCT00430521|540266859|FG003|Overall Study|Withdrawal by Subject|3|||
149764935|NCT00430521|540266860|FG004|Overall Study|Withdrawal by Subject|0|||
149764936|NCT00430521|540266861|FG005|Overall Study|Withdrawal by Subject|0|||
149764937|NCT00430521|540266862|FG006|Overall Study|Withdrawal by Subject|0|||
149764938|NCT00430521|540266863|FG007|Overall Study|Withdrawal by Subject|2|||
149764939|NCT05108805|540266864|FG000|Overall Study|T-cell expansion was not successful.|5|||
149764940|NCT02198651|540268892|FG000|Lead-in Period|Withdrew consent|13|||
149764941|NCT02198651|540268893|FG001|Lead-in Period|Withdrew consent|0|||
149764942|NCT02198651|540268894|FG002|Lead-in Period|Withdrew consent|0|||
149764943|NCT02198651|540268895|FG003|Lead-in Period|Withdrew consent|0|||
149764944|NCT02198651|540268896|FG004|Lead-in Period|Withdrew consent|0|||
149764945|NCT02198651|540268892|FG000|Lead-in Period|Adverse Event|2|||
149764946|NCT02198651|540268893|FG001|Lead-in Period|Adverse Event|0|||
149764947|NCT02198651|540268894|FG002|Lead-in Period|Adverse Event|0|||
149764948|NCT02198651|540268895|FG003|Lead-in Period|Adverse Event|0|||
149764949|NCT02198651|540268896|FG004|Lead-in Period|Adverse Event|0|||
149764950|NCT02198651|540268892|FG000|Lead-in Period|Other, not specified|22|||
149764951|NCT02198651|540268893|FG001|Lead-in Period|Other, not specified|0|||
149764952|NCT02198651|540268894|FG002|Lead-in Period|Other, not specified|0|||
149764953|NCT02198651|540268895|FG003|Lead-in Period|Other, not specified|0|||
149764954|NCT02198651|540268896|FG004|Lead-in Period|Other, not specified|0|||
149764955|NCT02198651|540268892|FG000|Double-blind Period|Withdrew consent|0|||
149764956|NCT02198651|540268893|FG001|Double-blind Period|Withdrew consent|4|||
149764957|NCT02198651|540268894|FG002|Double-blind Period|Withdrew consent|0|||
149764958|NCT02198651|540268895|FG003|Double-blind Period|Withdrew consent|0|||
149764959|NCT02198651|540268896|FG004|Double-blind Period|Withdrew consent|0|||
149764960|NCT02198651|540268892|FG000|Double-blind Period|Adverse Event|0|||
149764961|NCT02198651|540268893|FG001|Double-blind Period|Adverse Event|1|||
149764962|NCT02198651|540268894|FG002|Double-blind Period|Adverse Event|0|||
149764963|NCT02198651|540268895|FG003|Double-blind Period|Adverse Event|0|||
149764964|NCT02198651|540268896|FG004|Double-blind Period|Adverse Event|0|||
149764965|NCT02198651|540268892|FG000|Double-blind Period|Other, not specified|0|||
149764966|NCT02198651|540268893|FG001|Double-blind Period|Other, not specified|4|||
149764967|NCT02198651|540268894|FG002|Double-blind Period|Other, not specified|1|||
149764968|NCT02198651|540268895|FG003|Double-blind Period|Other, not specified|0|||
149764969|NCT02198651|540268896|FG004|Double-blind Period|Other, not specified|0|||
149764970|NCT02198651|540268892|FG000|Open-label Rescue Period|Withdrew consent|0|||
149764971|NCT02198651|540268893|FG001|Open-label Rescue Period|Withdrew consent|0|||
149764972|NCT02198651|540268894|FG002|Open-label Rescue Period|Withdrew consent|0|||
149764973|NCT02198651|540268895|FG003|Open-label Rescue Period|Withdrew consent|2|||
149764974|NCT02198651|540268896|FG004|Open-label Rescue Period|Withdrew consent|0|||
149764975|NCT02198651|540268892|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149764976|NCT02198651|540268893|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149764977|NCT02198651|540268894|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149764978|NCT02198651|540268895|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
149764979|NCT02198651|540268896|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149764980|NCT00333619|540268904|FG000|Overall Study|Death|12|||
149764981|NCT00333619|540268905|FG001|Overall Study|Death|6|||
149764982|NCT00333619|540268904|FG000|Overall Study|Withdrawal by Subject|6|||
149764983|NCT00333619|540268905|FG001|Overall Study|Withdrawal by Subject|1|||
149764984|NCT00333619|540268904|FG000|Overall Study|Lost to Follow-up|3|||
149764985|NCT00333619|540268905|FG001|Overall Study|Lost to Follow-up|3|||
149764986|NCT01120379|540268914|FG000|One Year Timepoint|Withdrawal by Subject|41|||
149764987|NCT01120379|540268914|FG000|One Year Timepoint|Lost to Follow-up|115|||
149764988|NCT01120379|540268914|FG000|One Year Timepoint|Death|108|||
149764989|NCT01120379|540268914|FG000|One Year Timepoint|Physician Decision|9|||
149764990|NCT01120379|540268914|FG000|One Year Timepoint|Any other reason for early termination|5|||
149764991|NCT01120379|540268914|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
149764992|NCT01120379|540268914|FG000|Two Year Timepoint|Lost to Follow-up|87|||
149764993|NCT01120379|540268914|FG000|Two Year Timepoint|Death|123|||
149764994|NCT01120379|540268914|FG000|Two Year Timepoint|Physician Decision|12|||
149764995|NCT01120379|540268914|FG000|Two Year Timepoint|Any other reason for early termination|4|||
149764996|NCT01120379|540268914|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
149764997|NCT01120379|540268914|FG000|Three Year Timepoint|Lost to Follow-up|43|||
149764998|NCT01120379|540268914|FG000|Three Year Timepoint|Death|120|||
149764999|NCT01120379|540268914|FG000|Three Year Timepoint|Physician Decision|9|||
149765000|NCT01120379|540268914|FG000|Three Year Timepoint|Any other reason for early termination|17|||
149765001|NCT01120379|540268914|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
149765002|NCT01120379|540268914|FG000|Four Year Timepoint|Lost to Follow-up|10|||
149765003|NCT01120379|540268914|FG000|Four Year Timepoint|Death|131|||
149765004|NCT01120379|540268914|FG000|Four Year Timepoint|Physician Decision|5|||
149765005|NCT01120379|540268914|FG000|Four Year Timepoint|Any other reason for early termination|217|||
149765006|NCT03162055|540268915|FG000|Overall Study|Adverse Event|6|||
149765007|NCT03162055|540268916|FG001|Overall Study|Adverse Event|5|||
149765008|NCT03162055|540268915|FG000|Overall Study|Death|3|||
149765009|NCT03162055|540268916|FG001|Overall Study|Death|3|||
149765010|NCT03162055|540268915|FG000|Overall Study|Lost to Follow-up|0|||
149765011|NCT03162055|540268916|FG001|Overall Study|Lost to Follow-up|1|||
149765012|NCT03162055|540268915|FG000|Overall Study|Study-specific withdrawal criteria|22|||
149765013|NCT03162055|540268916|FG001|Overall Study|Study-specific withdrawal criteria|14|||
149765014|NCT03162055|540268915|FG000|Overall Study|Withdrawal by Subject|17|||
149765015|NCT03162055|540268916|FG001|Overall Study|Withdrawal by Subject|2|||
149765016|NCT03162055|540268915|FG000|Overall Study|Did not receive treatment|2|||
149765017|NCT03162055|540268916|FG001|Overall Study|Did not receive treatment|0|||
149765018|NCT03162055|540268915|FG000|Overall Study|Incorrect randomization|4|||
149765019|NCT03162055|540268916|FG001|Overall Study|Incorrect randomization|3|||
149765020|NCT03162055|540268915|FG000|Overall Study|Other|8|||
149765021|NCT03162055|540268916|FG001|Overall Study|Other|15|||
149765022|NCT04031404|540268917|FG000|Baseline|Lost to Follow-up|0|||
149765023|NCT04031404|540268918|FG001|Baseline|Lost to Follow-up|1|||
149765024|NCT04031404|540268917|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
149765025|NCT04031404|540268918|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
149765026|NCT04031404|540268917|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
149765027|NCT04031404|540268918|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
149765028|NCT04031404|540268917|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
149765029|NCT04031404|540268918|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
149765030|NCT04031404|540268917|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
149765031|NCT04031404|540268918|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
149765032|NCT02282982|540268922|FG000|Overall Study|Lost to Follow-up|15|||
149765033|NCT02282982|540268922|FG000|Overall Study|Withdrew consent|2|||
149765034|NCT02282982|540268922|FG000|Overall Study|Death|4|||
149765035|NCT02282982|540268922|FG000|Overall Study|Lack of product|156|||
149765036|NCT02282982|540268922|FG000|Overall Study|Palivizumab is ended|11|||
149765037|NCT02282982|540268922|FG000|Overall Study|Other, not specified|18|||
149765038|NCT01295580|540268924|FG000|Overall Study|Protocol Violation|4|||
149765039|NCT01295580|540268925|FG001|Overall Study|Protocol Violation|2|||
149765040|NCT01295580|540268924|FG000|Overall Study|Withdrawal by Subject|1|||
149765041|NCT01295580|540268925|FG001|Overall Study|Withdrawal by Subject|4|||
149765042|NCT01295580|540268924|FG000|Overall Study|Adverse Event|2|||
149765043|NCT01295580|540268925|FG001|Overall Study|Adverse Event|1|||
149765044|NCT01295580|540268924|FG000|Overall Study|Lost to Follow-up|1|||
149765045|NCT01295580|540268925|FG001|Overall Study|Lost to Follow-up|0|||
149765046|NCT01295580|540268924|FG000|Overall Study|Lack of Efficacy|1|||
149765047|NCT01295580|540268925|FG001|Overall Study|Lack of Efficacy|0|||
149765048|NCT01295580|540268924|FG000|Overall Study|Other: inconvenience|1|||
149765049|NCT01295580|540268925|FG001|Overall Study|Other: inconvenience|0|||
149765050|NCT01295580|540268924|FG000|Overall Study|Other: family objection|0|||
149765051|NCT01295580|540268925|FG001|Overall Study|Other: family objection|1|||
149765052|NCT04032171|540268926|FG000|Overall Study|Study Termination|1|||
149765053|NCT04032171|540268927|FG001|Overall Study|Study Termination|0|||
149765054|NCT01742078|540268928|FG000|Overall Study|Withdrawal by Subject|0|||
149765055|NCT01742078|540268929|FG001|Overall Study|Withdrawal by Subject|0|||
149765056|NCT01742078|540268930|FG002|Overall Study|Withdrawal by Subject|0|||
149765057|NCT01742078|540268931|FG003|Overall Study|Withdrawal by Subject|1|||
149765058|NCT01742078|540268932|FG004|Overall Study|Withdrawal by Subject|0|||
149765059|NCT01742078|540268933|FG005|Overall Study|Withdrawal by Subject|0|||
149765060|NCT01742078|540268934|FG006|Overall Study|Withdrawal by Subject|0|||
149765061|NCT01742078|540268935|FG007|Overall Study|Withdrawal by Subject|0|||
149765062|NCT01742078|540268936|FG008|Overall Study|Withdrawal by Subject|0|||
149765063|NCT03247413|540268942|FG000|Overall Study|Lost to Follow-up|28|||
149765064|NCT00642746|540268943|FG000|Overall Study|Patient unevaluable|1|||
149765065|NCT00642746|540268944|FG001|Overall Study|Patient unevaluable|0|||
149765066|NCT00424294|540268945|FG000|Overall Study|Adverse Event|4|||
149765067|NCT00424294|540268946|FG001|Overall Study|Adverse Event|10|||
149765068|NCT00424294|540268945|FG000|Overall Study|Lack of Efficacy|2|||
149765069|NCT00424294|540268946|FG001|Overall Study|Lack of Efficacy|1|||
149765070|NCT00424294|540268945|FG000|Overall Study|Withdrawal by Subject|1|||
149765071|NCT00424294|540268946|FG001|Overall Study|Withdrawal by Subject|2|||
149765072|NCT00424294|540268945|FG000|Overall Study|Other|0|||
149765073|NCT00424294|540268946|FG001|Overall Study|Other|2|||
149765074|NCT00424294|540268945|FG000|Overall Study|Randomized but not Treated|1|||
149765075|NCT00424294|540268946|FG001|Overall Study|Randomized but not Treated|0|||
149765076|NCT03337152|540268949|FG000|Overall Study|Physician Decision|1|||
149765077|NCT03337152|540268950|FG001|Overall Study|Physician Decision|0|||
149765078|NCT03337152|540268949|FG000|Overall Study|Lost to Follow-up|1|||
149765079|NCT03337152|540268950|FG001|Overall Study|Lost to Follow-up|3|||
149765080|NCT03337152|540268949|FG000|Overall Study|Adverse Event|3|||
149765081|NCT03337152|540268950|FG001|Overall Study|Adverse Event|1|||
149765082|NCT03337152|540268949|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
149765083|NCT03337152|540268950|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
149765084|NCT00976950|540268951|FG000|Overall Study|Adverse Event|3|||
149765085|NCT00976950|540268951|FG000|Overall Study|Events with no relationship to Aptivus|3|||
149765086|NCT02493426|540268961|FG000|Overall Study|Withdrawal by Subject|0|||
149765087|NCT02493426|540268962|FG001|Overall Study|Withdrawal by Subject|1|||
149765088|NCT01069523|540268963|FG000|Overall Study|Withdrawal by Subject|4|||
149765089|NCT01069523|540268964|FG001|Overall Study|Withdrawal by Subject|7|||
149765090|NCT01025817|540268967|FG000|Completed Study Medication|Adverse Event|66|||
149765091|NCT01025817|540268968|FG001|Completed Study Medication|Adverse Event|39|||
149765092|NCT01025817|540268967|FG000|Completed Study Medication|Protocol Deviation|9|||
149765093|NCT01025817|540268968|FG001|Completed Study Medication|Protocol Deviation|8|||
149765094|NCT01025817|540268967|FG000|Completed Study Medication|Withdrawal by Subject|8|||
149765095|NCT01025817|540268968|FG001|Completed Study Medication|Withdrawal by Subject|9|||
149765096|NCT01025817|540268967|FG000|Completed Study Medication|Administrative problems|7|||
149765097|NCT01025817|540268968|FG001|Completed Study Medication|Administrative problems|5|||
149765098|NCT01025817|540268967|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
149765099|NCT01025817|540268968|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
149765100|NCT01025817|540268967|FG000|Completed Study Medication|Abnormal test procedure|4|||
149765101|NCT01025817|540268968|FG001|Completed Study Medication|Abnormal test procedure|0|||
149765102|NCT01025817|540268967|FG000|Completed Study Medication|Graft loss|2|||
149765103|NCT01025817|540268968|FG001|Completed Study Medication|Graft loss|5|||
149765104|NCT01025817|540268967|FG000|Completed Study Medication|Death|2|||
149765105|NCT01025817|540268968|FG001|Completed Study Medication|Death|2|||
149765106|NCT01025817|540268967|FG000|Completed Study Medication|Abnormal lab values|0|||
149765107|NCT01025817|540268968|FG001|Completed Study Medication|Abnormal lab values|2|||
149765108|NCT01025817|540268967|FG000|Completed Study Medication|Subject no longer required study drug|0|||
149765109|NCT01025817|540268968|FG001|Completed Study Medication|Subject no longer required study drug|1|||
149765110|NCT01025817|540268967|FG000|Completed Study Medication|Lost to Follow-up|0|||
149765111|NCT01025817|540268968|FG001|Completed Study Medication|Lost to Follow-up|1|||
149765112|NCT01025817|540268967|FG000|Completed Study|Withdrawal by Subject|8|||
149765113|NCT01025817|540268968|FG001|Completed Study|Withdrawal by Subject|16|||
149765114|NCT01025817|540268967|FG000|Completed Study|Death|6|||
149765115|NCT01025817|540268968|FG001|Completed Study|Death|5|||
149765116|NCT01025817|540268967|FG000|Completed Study|Missing|2|||
149765117|NCT01025817|540268968|FG001|Completed Study|Missing|0|||
149765118|NCT01025817|540268967|FG000|Completed Study|Lost to Follow-up|0|||
149765119|NCT01025817|540268968|FG001|Completed Study|Lost to Follow-up|1|||
149765120|NCT04533815|540268972|FG000|Overall Study|Adverse Event|2|||
149765121|NCT04533815|540268972|FG000|Overall Study|Site withdrew|5|||
149765122|NCT00488592|540268975|FG000|Overall Study|Withdrawal by Subject|1|||
149765123|NCT00488592|540268975|FG000|Overall Study|Disease progression|1|||
149765124|NCT00488592|540268975|FG000|Overall Study|Enrolled but not treated|1|||
149765125|NCT00441103|540268976|FG000|Overall Study|Adverse Event|2|||
149765126|NCT00441103|540268977|FG001|Overall Study|Adverse Event|1|||
149765127|NCT00441103|540268976|FG000|Overall Study|Death|1|||
149765128|NCT00441103|540268977|FG001|Overall Study|Death|0|||
149765129|NCT00441103|540268976|FG000|Overall Study|Disease Progression|2|||
149765130|NCT00441103|540268977|FG001|Overall Study|Disease Progression|0|||
149765131|NCT00441103|540268976|FG000|Overall Study|Lost to Follow-up|1|||
149765132|NCT00441103|540268977|FG001|Overall Study|Lost to Follow-up|0|||
149765133|NCT00441103|540268976|FG000|Overall Study|Protocol Violation|1|||
149765134|NCT00441103|540268977|FG001|Overall Study|Protocol Violation|0|||
149765135|NCT00441103|540268976|FG000|Overall Study|Participant unable to use Rebiject II|1|||
149765136|NCT00441103|540268977|FG001|Overall Study|Participant unable to use Rebiject II|0|||
149765137|NCT00441103|540268976|FG000|Overall Study|Participant refused MRI|1|||
149765138|NCT00441103|540268977|FG001|Overall Study|Participant refused MRI|0|||
149765139|NCT00441103|540268976|FG000|Overall Study|Inclusion criteria absent|1|||
149765140|NCT00441103|540268977|FG001|Overall Study|Inclusion criteria absent|0|||
149765141|NCT00441103|540268976|FG000|Overall Study|Non-compliant|0|||
149765142|NCT00441103|540268977|FG001|Overall Study|Non-compliant|1|||
149765143|NCT00441103|540268976|FG000|Overall Study|Participant decided to withdraw|1|||
149765144|NCT00441103|540268977|FG001|Overall Study|Participant decided to withdraw|0|||
149765145|NCT00441103|540268976|FG000|Overall Study|Participant's reason|0|||
149765146|NCT00441103|540268977|FG001|Overall Study|Participant's reason|1|||
149765147|NCT00441103|540268976|FG000|Overall Study|Participant decided to stop|0|||
149765148|NCT00441103|540268977|FG001|Overall Study|Participant decided to stop|1|||
149765149|NCT02951988|540268978|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
149765150|NCT02951988|540268979|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
149765151|NCT02951988|540268980|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
149765152|NCT02951988|540268981|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
149765153|NCT02951988|540268978|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
149765154|NCT02951988|540268979|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
149765155|NCT02951988|540268980|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
149765156|NCT02951988|540268981|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
149765157|NCT02951988|540268978|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
149765158|NCT02951988|540268979|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149765159|NCT02951988|540268980|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149765160|NCT02951988|540268981|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149765161|NCT02951988|540268978|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
149765162|NCT02951988|540268979|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
149765163|NCT02951988|540268980|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
149765164|NCT02951988|540268981|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
149765165|NCT02951988|540268978|FG000|Open-Label Treatment Period|Protocol Violation|22|||
149765166|NCT02951988|540268979|FG001|Open-Label Treatment Period|Protocol Violation|0|||
149765167|NCT02951988|540268980|FG002|Open-Label Treatment Period|Protocol Violation|0|||
149765168|NCT02951988|540268981|FG003|Open-Label Treatment Period|Protocol Violation|0|||
149765169|NCT02951988|540268978|FG000|Open-Label Treatment Period|Pregnancy|2|||
149765170|NCT02951988|540268979|FG001|Open-Label Treatment Period|Pregnancy|0|||
149765171|NCT02951988|540268980|FG002|Open-Label Treatment Period|Pregnancy|0|||
149765172|NCT02951988|540268981|FG003|Open-Label Treatment Period|Pregnancy|0|||
149765173|NCT02951988|540268978|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
149765174|NCT02951988|540268979|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
149765175|NCT02951988|540268980|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
149765176|NCT02951988|540268981|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
149765177|NCT02951988|540268978|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
149765178|NCT02951988|540268979|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
149765179|NCT02951988|540268980|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
149765180|NCT02951988|540268981|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
149765181|NCT02951988|540268978|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
149765182|NCT02951988|540268979|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
149765183|NCT02951988|540268980|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
149765184|NCT02951988|540268981|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
149765185|NCT02951988|540268978|FG000|Open-Label Treatment Period|Adverse Event|45|||
149765186|NCT02951988|540268979|FG001|Open-Label Treatment Period|Adverse Event|0|||
149765187|NCT02951988|540268980|FG002|Open-Label Treatment Period|Adverse Event|0|||
149765188|NCT02951988|540268981|FG003|Open-Label Treatment Period|Adverse Event|0|||
149765189|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
149765190|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
149765191|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
149765192|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
149765193|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
149765194|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
149765195|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
149765196|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
149765197|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
149765198|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
149765199|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
149765200|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
149765201|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
149765202|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
149765203|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
149765204|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
149765205|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Pregnancy|0|||
149765206|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Pregnancy|1|||
149765207|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Pregnancy|1|||
149765208|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Pregnancy|0|||
149765209|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149765210|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
149765211|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
149765212|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
149765213|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149765214|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
149765215|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
149765216|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
149765217|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149765218|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Adverse Event|8|||
149765219|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Adverse Event|3|||
149765220|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Adverse Event|6|||
149765221|NCT02951988|540268978|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
149765222|NCT02951988|540268979|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
149765223|NCT02951988|540268980|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
149765224|NCT02951988|540268981|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
149765225|NCT05836818|540268982|FG000|Overall Study|Physician Decision|1|||
149765226|NCT05836818|540268983|FG001|Overall Study|Physician Decision|1|||
149765227|NCT05836818|540268984|FG002|Overall Study|Physician Decision|0|||
149765228|NCT05836818|540268982|FG000|Overall Study|Withdrawal by Subject|0|||
149765229|NCT05836818|540268983|FG001|Overall Study|Withdrawal by Subject|0|||
149765230|NCT05836818|540268984|FG002|Overall Study|Withdrawal by Subject|1|||
149765231|NCT05836818|540268982|FG000|Overall Study|Later found to be previously vaccinated|0|||
149765232|NCT05836818|540268983|FG001|Overall Study|Later found to be previously vaccinated|1|||
149765233|NCT05836818|540268984|FG002|Overall Study|Later found to be previously vaccinated|3|||
149765234|NCT05836818|540268982|FG000|Overall Study|Pregnancy|0|||
149765235|NCT05836818|540268983|FG001|Overall Study|Pregnancy|1|||
149765236|NCT05836818|540268984|FG002|Overall Study|Pregnancy|0|||
149765237|NCT05836818|540268982|FG000|Overall Study|Allergic to vaccines|0|||
149765238|NCT05836818|540268983|FG001|Overall Study|Allergic to vaccines|1|||
149765239|NCT05836818|540268984|FG002|Overall Study|Allergic to vaccines|0|||
149765240|NCT00807846|540268985|FG000|Overall Study|Adverse Event|5|||
149765241|NCT00807846|540268986|FG001|Overall Study|Adverse Event|0|||
149765242|NCT00807846|540268985|FG000|Overall Study|Lack of Efficacy|2|||
149765243|NCT00807846|540268986|FG001|Overall Study|Lack of Efficacy|0|||
149765244|NCT00807846|540268985|FG000|Overall Study|Protocol Violation|2|||
149765245|NCT00807846|540268986|FG001|Overall Study|Protocol Violation|1|||
149765246|NCT00807846|540268985|FG000|Overall Study|Withdrawal by Subject|2|||
149765247|NCT00807846|540268986|FG001|Overall Study|Withdrawal by Subject|1|||
149765248|NCT00807846|540268985|FG000|Overall Study|Other|1|||
149765249|NCT00807846|540268986|FG001|Overall Study|Other|2|||
149765250|NCT01081873|540268987|FG000|Overall Study|Death|86|||
149765251|NCT01081873|540268987|FG000|Overall Study|Withdrawal by Subject|10|||
149765252|NCT01081873|540268987|FG000|Overall Study|Lost to Follow-up|142|||
149765253|NCT01081873|540268987|FG000|Overall Study|Progression of prostate cancer|13|||
149765254|NCT01081873|540268987|FG000|Overall Study|Other|47|||
149765255|NCT01165021|540268988|FG000|Overall Study|Death|1|||
149765256|NCT02491073|540268989|FG000|Overall Study|screen failure|1|||
149765257|NCT02491073|540268990|FG001|Overall Study|screen failure|0|||
149765258|NCT01655823|540268991|FG000|Overall Study|Lost to Follow-up|0|||
149765259|NCT01655823|540268992|FG001|Overall Study|Lost to Follow-up|1|||
149765260|NCT01655823|540268993|FG002|Overall Study|Lost to Follow-up|0|||
149765261|NCT01655823|540268994|FG003|Overall Study|Lost to Follow-up|0|||
149765262|NCT01655823|540268995|FG004|Overall Study|Lost to Follow-up|1|||
149765263|NCT01655823|540268991|FG000|Overall Study|Withdrawal by Subject|0|||
149765264|NCT01655823|540268992|FG001|Overall Study|Withdrawal by Subject|1|||
149765265|NCT01655823|540268993|FG002|Overall Study|Withdrawal by Subject|0|||
149765266|NCT01655823|540268994|FG003|Overall Study|Withdrawal by Subject|1|||
149765267|NCT01655823|540268995|FG004|Overall Study|Withdrawal by Subject|0|||
149765268|NCT02683525|540268996|FG000|Overall Study|Lost to Follow-up|1|||
149765269|NCT02683525|540268996|FG000|Overall Study|Physician Decision|1|||
149765270|NCT02683525|540268996|FG000|Overall Study|Disease Progression|6|||
149765271|NCT01627067|540268997|FG000|Overall Study|Screen Failure|1|||
149765272|NCT03352414|540269001|FG000|Overall Study|Ineligible by operative criteria|12|||
149765273|NCT03352414|540269002|FG001|Overall Study|Ineligible by operative criteria|10|||
149765274|NCT04167306|540269007|FG000|Overall Study|Lost to Follow-up|2|||
149765275|NCT04167306|540269008|FG001|Overall Study|Lost to Follow-up|2|||
149765276|NCT04167306|540269009|FG002|Overall Study|Lost to Follow-up|5|||
149765277|NCT04167306|540269010|FG003|Overall Study|Lost to Follow-up|5|||
149765278|NCT04167306|540269007|FG000|Overall Study|Adverse Event|13|||
149765279|NCT04167306|540269008|FG001|Overall Study|Adverse Event|14|||
149765280|NCT04167306|540269009|FG002|Overall Study|Adverse Event|5|||
149765281|NCT04167306|540269010|FG003|Overall Study|Adverse Event|4|||
149765282|NCT04167306|540269007|FG000|Overall Study|Withdrawal by Subject|4|||
149765283|NCT04167306|540269008|FG001|Overall Study|Withdrawal by Subject|6|||
149765284|NCT04167306|540269009|FG002|Overall Study|Withdrawal by Subject|8|||
149765285|NCT04167306|540269010|FG003|Overall Study|Withdrawal by Subject|3|||
149765286|NCT04167306|540269007|FG000|Overall Study|covid|1|||
149765287|NCT04167306|540269008|FG001|Overall Study|covid|1|||
149765288|NCT04167306|540269009|FG002|Overall Study|covid|2|||
149765289|NCT04167306|540269010|FG003|Overall Study|covid|1|||
149765290|NCT04167306|540269007|FG000|Overall Study|concomitant medication|0|||
149765291|NCT04167306|540269008|FG001|Overall Study|concomitant medication|0|||
149765292|NCT04167306|540269009|FG002|Overall Study|concomitant medication|0|||
149765293|NCT04167306|540269010|FG003|Overall Study|concomitant medication|1|||
149765294|NCT04167306|540269007|FG000|Overall Study|Alcohol treatment|0|||
149765295|NCT04167306|540269008|FG001|Overall Study|Alcohol treatment|4|||
149765296|NCT04167306|540269009|FG002|Overall Study|Alcohol treatment|3|||
149765297|NCT04167306|540269010|FG003|Overall Study|Alcohol treatment|2|||
149765298|NCT04167306|540269007|FG000|Overall Study|non-compliance|0|||
149765299|NCT04167306|540269008|FG001|Overall Study|non-compliance|0|||
149765300|NCT04167306|540269009|FG002|Overall Study|non-compliance|1|||
149765301|NCT04167306|540269010|FG003|Overall Study|non-compliance|0|||
149765302|NCT04167306|540269007|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
149765303|NCT04167306|540269008|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
149765304|NCT04167306|540269009|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
149765305|NCT04167306|540269010|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
149765306|NCT02357849|540269011|FG000|Overall Study|Withdrawal by Subject|2|||
149765307|NCT02357849|540269012|FG001|Overall Study|Withdrawal by Subject|3|||
149765308|NCT00403559|540269013|FG000|Overall Study|Adverse Event|0|||
149765309|NCT00403559|540269014|FG001|Overall Study|Adverse Event|1|||
149765310|NCT00403559|540269013|FG000|Overall Study|Lost to Follow-up|3|||
149765311|NCT00403559|540269014|FG001|Overall Study|Lost to Follow-up|3|||
149765312|NCT00403559|540269013|FG000|Overall Study|Withdrawal by Subject|1|||
149765313|NCT00403559|540269014|FG001|Overall Study|Withdrawal by Subject|0|||
149765314|NCT04105244|540269017|FG000|Overall Study|Withdrawal by Subject|10|||
149765315|NCT04105244|540269018|FG001|Overall Study|Withdrawal by Subject|12|||
149765316|NCT04105244|540269017|FG000|Overall Study|Lost to Follow-up|20|||
149765317|NCT04105244|540269018|FG001|Overall Study|Lost to Follow-up|15|||
149765318|NCT04105244|540269017|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
149765319|NCT04105244|540269018|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
149765320|NCT04105244|540269017|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
149765321|NCT04105244|540269018|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
149765322|NCT04387136|540269019|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
149765323|NCT04387136|540269020|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
149765324|NCT01029886|540269023|FG000|Overall Study|Adverse Event|12|||
149765325|NCT01029886|540269024|FG001|Overall Study|Adverse Event|25|||
149765326|NCT01029886|540269023|FG000|Overall Study|Lost to Follow-up|1|||
149765327|NCT01029886|540269024|FG001|Overall Study|Lost to Follow-up|0|||
149765328|NCT01029886|540269023|FG000|Overall Study|Physician Decision|2|||
149765329|NCT01029886|540269024|FG001|Overall Study|Physician Decision|6|||
149765330|NCT01029886|540269023|FG000|Overall Study|Protocol Violation|17|||
149765331|NCT01029886|540269024|FG001|Overall Study|Protocol Violation|5|||
149765332|NCT01029886|540269023|FG000|Overall Study|Withdrawal by Subject|8|||
149765333|NCT01029886|540269024|FG001|Overall Study|Withdrawal by Subject|18|||
149765334|NCT01029886|540269023|FG000|Overall Study|Entry Criteria Not Met|13|||
149765335|NCT01029886|540269024|FG001|Overall Study|Entry Criteria Not Met|5|||
149765336|NCT01029886|540269023|FG000|Overall Study|Sponsor Decision|1|||
149765337|NCT01029886|540269024|FG001|Overall Study|Sponsor Decision|0|||
149765338|NCT01029886|540269023|FG000|Overall Study|Loss Glucose Control|7|||
149765339|NCT01029886|540269024|FG001|Overall Study|Loss Glucose Control|1|||
149765340|NCT03294681|540269025|FG000|Overall Study|Withdrawal by Subject|1|||
149765341|NCT00417976|540269026|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
149765342|NCT00417976|540269026|FG000|Overall Study|Treatment -related toxicity|2|||
149765343|NCT02720016|540269027|FG000|Overall Study|Separation of couple|6|||
149765344|NCT02720016|540269028|FG001|Overall Study|Separation of couple|8|||
149765345|NCT02720016|540269029|FG002|Overall Study|Separation of couple|2|||
149765346|NCT02720016|540269027|FG000|Overall Study|Withdrawal by Subject|6|||
149765347|NCT02720016|540269028|FG001|Overall Study|Withdrawal by Subject|6|||
149765348|NCT02720016|540269029|FG002|Overall Study|Withdrawal by Subject|4|||
149765349|NCT02720016|540269027|FG000|Overall Study|Scheduling issues|2|||
149765350|NCT02720016|540269028|FG001|Overall Study|Scheduling issues|4|||
149765351|NCT02720016|540269029|FG002|Overall Study|Scheduling issues|7|||
149765352|NCT02720016|540269027|FG000|Overall Study|Childcare|2|||
149765353|NCT02720016|540269028|FG001|Overall Study|Childcare|0|||
149765354|NCT02720016|540269029|FG002|Overall Study|Childcare|2|||
149765355|NCT02720016|540269027|FG000|Overall Study|Withdrawal by PI|2|||
149765356|NCT02720016|540269028|FG001|Overall Study|Withdrawal by PI|2|||
149765357|NCT02720016|540269029|FG002|Overall Study|Withdrawal by PI|0|||
149765358|NCT02720016|540269027|FG000|Overall Study|Moved away|2|||
149765359|NCT02720016|540269028|FG001|Overall Study|Moved away|0|||
149765360|NCT02720016|540269029|FG002|Overall Study|Moved away|0|||
149765361|NCT02720016|540269027|FG000|Overall Study|Not Primary Health Concern|0|||
149765362|NCT02720016|540269028|FG001|Overall Study|Not Primary Health Concern|0|||
149765363|NCT02720016|540269029|FG002|Overall Study|Not Primary Health Concern|2|||
149765364|NCT02720016|540269027|FG000|Overall Study|Transportation issues|0|||
149765365|NCT02720016|540269028|FG001|Overall Study|Transportation issues|0|||
149765366|NCT02720016|540269029|FG002|Overall Study|Transportation issues|1|||
149765367|NCT02720016|540269027|FG000|Overall Study|Other|0|||
149765368|NCT02720016|540269028|FG001|Overall Study|Other|0|||
149765369|NCT02720016|540269029|FG002|Overall Study|Other|2|||
149765370|NCT01968954|540269032|FG000|Overall Study|Adverse Event|6|||
149765371|NCT01968954|540269033|FG001|Overall Study|Adverse Event|3|||
149765372|NCT01968954|540269032|FG000|Overall Study|Death|1|||
149765373|NCT01968954|540269033|FG001|Overall Study|Death|2|||
149765374|NCT01968954|540269032|FG000|Overall Study|Lost to Follow-up|6|||
149765375|NCT01968954|540269033|FG001|Overall Study|Lost to Follow-up|4|||
149765376|NCT01968954|540269032|FG000|Overall Study|Withdrawal by Subject|20|||
149765377|NCT01968954|540269033|FG001|Overall Study|Withdrawal by Subject|23|||
149765378|NCT01968954|540269032|FG000|Overall Study|Other|7|||
149765379|NCT01968954|540269033|FG001|Overall Study|Other|8|||
149765380|NCT01968954|540269032|FG000|Overall Study|Protocol Violation|0|||
149765381|NCT01968954|540269033|FG001|Overall Study|Protocol Violation|1|||
149765382|NCT01968954|540269032|FG000|Overall Study|Did not met inclusion criteria|0|||
149765383|NCT01968954|540269033|FG001|Overall Study|Did not met inclusion criteria|2|||
149765384|NCT05319080|540269034|FG000|Overall Study|Withdrawal by Subject|2|||
149765385|NCT05319080|540269034|FG000|Overall Study|Physician Decision|4|||
149765386|NCT00751114|540269035|FG000|Overall Study|Adverse Event|2|||
149765387|NCT00751114|540269036|FG001|Overall Study|Adverse Event|4|||
149765388|NCT00751114|540269035|FG000|Overall Study|Protocol Violation|8|||
149765389|NCT00751114|540269036|FG001|Overall Study|Protocol Violation|9|||
149765390|NCT00751114|540269035|FG000|Overall Study|Withdrawal by Subject|9|||
149765391|NCT00751114|540269036|FG001|Overall Study|Withdrawal by Subject|4|||
149765392|NCT00751114|540269035|FG000|Overall Study|Lost to Follow-up|4|||
149765393|NCT00751114|540269036|FG001|Overall Study|Lost to Follow-up|7|||
149765394|NCT00751114|540269035|FG000|Overall Study|Lack of Efficacy|0|||
149765395|NCT00751114|540269036|FG001|Overall Study|Lack of Efficacy|7|||
149765396|NCT00751114|540269035|FG000|Overall Study|Not Treated|13|||
149765397|NCT00751114|540269036|FG001|Overall Study|Not Treated|1|||
149765398|NCT00751114|540269035|FG000|Overall Study|Out of country for 2 months|1|||
149765399|NCT00751114|540269036|FG001|Overall Study|Out of country for 2 months|0|||
149765400|NCT00751114|540269035|FG000|Overall Study|Move to another city|1|||
149765401|NCT00751114|540269036|FG001|Overall Study|Move to another city|0|||
149765402|NCT02358369|540269037|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
149765403|NCT02358369|540269038|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149765404|NCT02358369|540269039|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149765405|NCT02358369|540269040|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149765406|NCT02358369|540269041|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149765407|NCT02358369|540269037|FG000|Treatment Period A/B|Adverse Event|0|||
149765408|NCT02358369|540269038|FG001|Treatment Period A/B|Adverse Event|0|||
149765409|NCT02358369|540269039|FG002|Treatment Period A/B|Adverse Event|1|||
149765410|NCT02358369|540269040|FG003|Treatment Period A/B|Adverse Event|2|||
149765411|NCT02358369|540269041|FG004|Treatment Period A/B|Adverse Event|0|||
149765412|NCT02358369|540269037|FG000|Treatment Period A/B|Death|0|||
149765413|NCT02358369|540269038|FG001|Treatment Period A/B|Death|0|||
149765414|NCT02358369|540269039|FG002|Treatment Period A/B|Death|1|||
149765415|NCT02358369|540269040|FG003|Treatment Period A/B|Death|0|||
149765416|NCT02358369|540269041|FG004|Treatment Period A/B|Death|0|||
149765417|NCT02358369|540269037|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
149765418|NCT02358369|540269038|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
149765419|NCT02358369|540269039|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
149765420|NCT02358369|540269040|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
149765421|NCT02358369|540269041|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
149765422|NCT02358369|540269037|FG000|Treatment Period C|Adverse Event|0|||
149765423|NCT02358369|540269038|FG001|Treatment Period C|Adverse Event|0|||
149765424|NCT02358369|540269039|FG002|Treatment Period C|Adverse Event|0|||
149765425|NCT02358369|540269040|FG003|Treatment Period C|Adverse Event|0|||
149765426|NCT02358369|540269041|FG004|Treatment Period C|Adverse Event|7|||
149765427|NCT00448916|540269044|FG000|Overall Study|Adverse Event|2|||
149765428|NCT00448916|540269045|FG001|Overall Study|Adverse Event|2|||
149765429|NCT00448916|540269046|FG002|Overall Study|Adverse Event|3|||
149765430|NCT00448916|540269047|FG003|Overall Study|Adverse Event|2|||
149765431|NCT00448916|540269044|FG000|Overall Study|Lack of Efficacy|1|||
149765432|NCT00448916|540269045|FG001|Overall Study|Lack of Efficacy|0|||
149765433|NCT00448916|540269046|FG002|Overall Study|Lack of Efficacy|2|||
149765434|NCT00448916|540269047|FG003|Overall Study|Lack of Efficacy|1|||
149765435|NCT00448916|540269044|FG000|Overall Study|Withdrawal by Subject|3|||
149765436|NCT00448916|540269045|FG001|Overall Study|Withdrawal by Subject|3|||
149765437|NCT00448916|540269046|FG002|Overall Study|Withdrawal by Subject|1|||
149765438|NCT00448916|540269047|FG003|Overall Study|Withdrawal by Subject|1|||
149765439|NCT00448916|540269044|FG000|Overall Study|Other|1|||
149765440|NCT00448916|540269045|FG001|Overall Study|Other|0|||
149765441|NCT00448916|540269046|FG002|Overall Study|Other|0|||
149765442|NCT00448916|540269047|FG003|Overall Study|Other|0|||
149765443|NCT00448916|540269044|FG000|Overall Study|Lost to Follow-up|0|||
149765444|NCT00448916|540269045|FG001|Overall Study|Lost to Follow-up|1|||
149765445|NCT00448916|540269046|FG002|Overall Study|Lost to Follow-up|0|||
149765446|NCT00448916|540269047|FG003|Overall Study|Lost to Follow-up|1|||
149765447|NCT00448916|540269044|FG000|Overall Study|Protocol Violation|0|||
149765448|NCT00448916|540269045|FG001|Overall Study|Protocol Violation|0|||
149765449|NCT00448916|540269046|FG002|Overall Study|Protocol Violation|0|||
149765450|NCT00448916|540269047|FG003|Overall Study|Protocol Violation|1|||
149765451|NCT03655717|540269048|FG000|Overall Study|Withdrawal by Subject|4|||
149765452|NCT03655717|540269049|FG001|Overall Study|Withdrawal by Subject|8|||
149765453|NCT03655717|540269050|FG002|Overall Study|Withdrawal by Subject|1|||
149765454|NCT03655717|540269051|FG003|Overall Study|Withdrawal by Subject|0|||
149765455|NCT03655717|540269052|FG004|Overall Study|Withdrawal by Subject|0|||
149765456|NCT03655717|540269053|FG005|Overall Study|Withdrawal by Subject|1|||
149765457|NCT03655717|540269054|FG006|Overall Study|Withdrawal by Subject|3|||
149765458|NCT03655717|540269055|FG007|Overall Study|Withdrawal by Subject|1|||
149765459|NCT03655717|540269056|FG008|Overall Study|Withdrawal by Subject|2|||
149765460|NCT03655717|540269057|FG009|Overall Study|Withdrawal by Subject|0|||
149765461|NCT03655717|540269058|FG010|Overall Study|Withdrawal by Subject|0|||
149765462|NCT03655717|540269059|FG011|Overall Study|Withdrawal by Subject|1|||
149765463|NCT03655717|540269060|FG012|Overall Study|Withdrawal by Subject|0|||
149765464|NCT03655717|540269061|FG013|Overall Study|Withdrawal by Subject|3|||
149765465|NCT03655717|540269062|FG014|Overall Study|Withdrawal by Subject|0|||
149765466|NCT03655717|540269063|FG015|Overall Study|Withdrawal by Subject|1|||
149765467|NCT03655717|540269064|FG016|Overall Study|Withdrawal by Subject|0|||
149765468|NCT03655717|540269065|FG017|Overall Study|Withdrawal by Subject|0|||
149765469|NCT03655717|540269066|FG018|Overall Study|Withdrawal by Subject|1|||
149765470|NCT03655717|540269067|FG019|Overall Study|Withdrawal by Subject|0|||
149765471|NCT03655717|540269068|FG020|Overall Study|Withdrawal by Subject|0|||
149765472|NCT03655717|540269069|FG021|Overall Study|Withdrawal by Subject|1|||
149765473|NCT03655717|540269070|FG022|Overall Study|Withdrawal by Subject|2|||
149765474|NCT03655717|540269071|FG023|Overall Study|Withdrawal by Subject|1|||
149765475|NCT03655717|540269072|FG024|Overall Study|Withdrawal by Subject|1|||
149765476|NCT03655717|540269073|FG025|Overall Study|Withdrawal by Subject|0|||
149765477|NCT03655717|540269048|FG000|Overall Study|Physician Decision|3|||
149765478|NCT03655717|540269049|FG001|Overall Study|Physician Decision|3|||
149765479|NCT03655717|540269050|FG002|Overall Study|Physician Decision|0|||
149765480|NCT03655717|540269051|FG003|Overall Study|Physician Decision|0|||
149765481|NCT03655717|540269052|FG004|Overall Study|Physician Decision|0|||
149765482|NCT03655717|540269053|FG005|Overall Study|Physician Decision|0|||
149765483|NCT03655717|540269054|FG006|Overall Study|Physician Decision|0|||
149765484|NCT03655717|540269055|FG007|Overall Study|Physician Decision|0|||
149765485|NCT03655717|540269056|FG008|Overall Study|Physician Decision|0|||
149765486|NCT03655717|540269057|FG009|Overall Study|Physician Decision|1|||
149765487|NCT03655717|540269058|FG010|Overall Study|Physician Decision|0|||
149765488|NCT03655717|540269059|FG011|Overall Study|Physician Decision|0|||
149765489|NCT03655717|540269060|FG012|Overall Study|Physician Decision|0|||
149765490|NCT03655717|540269061|FG013|Overall Study|Physician Decision|0|||
149765491|NCT03655717|540269062|FG014|Overall Study|Physician Decision|0|||
149765492|NCT03655717|540269063|FG015|Overall Study|Physician Decision|0|||
149765493|NCT03655717|540269064|FG016|Overall Study|Physician Decision|0|||
149765494|NCT03655717|540269065|FG017|Overall Study|Physician Decision|0|||
149765495|NCT03655717|540269066|FG018|Overall Study|Physician Decision|0|||
149765496|NCT03655717|540269067|FG019|Overall Study|Physician Decision|1|||
149765497|NCT03655717|540269068|FG020|Overall Study|Physician Decision|0|||
149765498|NCT03655717|540269069|FG021|Overall Study|Physician Decision|0|||
149765499|NCT03655717|540269070|FG022|Overall Study|Physician Decision|0|||
149765500|NCT03655717|540269071|FG023|Overall Study|Physician Decision|1|||
149765501|NCT03655717|540269072|FG024|Overall Study|Physician Decision|0|||
149765502|NCT03655717|540269073|FG025|Overall Study|Physician Decision|0|||
149765503|NCT03655717|540269048|FG000|Overall Study|Lost to Follow-up|3|||
149765504|NCT03655717|540269049|FG001|Overall Study|Lost to Follow-up|1|||
149765505|NCT03655717|540269050|FG002|Overall Study|Lost to Follow-up|0|||
149765506|NCT03655717|540269051|FG003|Overall Study|Lost to Follow-up|1|||
149765507|NCT03655717|540269052|FG004|Overall Study|Lost to Follow-up|0|||
149765508|NCT03655717|540269053|FG005|Overall Study|Lost to Follow-up|1|||
149765509|NCT03655717|540269054|FG006|Overall Study|Lost to Follow-up|0|||
149765510|NCT03655717|540269055|FG007|Overall Study|Lost to Follow-up|0|||
149765511|NCT03655717|540269056|FG008|Overall Study|Lost to Follow-up|0|||
149765512|NCT03655717|540269057|FG009|Overall Study|Lost to Follow-up|0|||
149765513|NCT03655717|540269058|FG010|Overall Study|Lost to Follow-up|0|||
149765514|NCT03655717|540269059|FG011|Overall Study|Lost to Follow-up|1|||
149765515|NCT03655717|540269060|FG012|Overall Study|Lost to Follow-up|0|||
149765516|NCT03655717|540269061|FG013|Overall Study|Lost to Follow-up|0|||
149765517|NCT03655717|540269062|FG014|Overall Study|Lost to Follow-up|0|||
149765518|NCT03655717|540269063|FG015|Overall Study|Lost to Follow-up|0|||
149765519|NCT03655717|540269064|FG016|Overall Study|Lost to Follow-up|0|||
149765520|NCT03655717|540269065|FG017|Overall Study|Lost to Follow-up|0|||
149765521|NCT03655717|540269066|FG018|Overall Study|Lost to Follow-up|0|||
149765522|NCT03655717|540269067|FG019|Overall Study|Lost to Follow-up|0|||
149765523|NCT03655717|540269068|FG020|Overall Study|Lost to Follow-up|0|||
149765524|NCT03655717|540269069|FG021|Overall Study|Lost to Follow-up|0|||
149765525|NCT03655717|540269070|FG022|Overall Study|Lost to Follow-up|0|||
149765526|NCT03655717|540269071|FG023|Overall Study|Lost to Follow-up|0|||
149765527|NCT03655717|540269072|FG024|Overall Study|Lost to Follow-up|0|||
149765528|NCT03655717|540269073|FG025|Overall Study|Lost to Follow-up|0|||
149765529|NCT00592553|540269074|FG000|Overall Study|Protocol Noncompliance|1|||
149765530|NCT00592553|540269075|FG001|Overall Study|Protocol Noncompliance|0|||
149765531|NCT00592553|540269076|FG002|Overall Study|Protocol Noncompliance|0|||
149765532|NCT01968187|540269080|FG000|Overall Study|Adverse Event|0|||
149765533|NCT01968187|540269081|FG001|Overall Study|Adverse Event|1|||
149765534|NCT01968187|540269080|FG000|Overall Study|Randomized but not treated|1|||
149765535|NCT01968187|540269081|FG001|Overall Study|Randomized but not treated|0|||
149765536|NCT01877382|540269082|FG000|Dose Escalation|Progressive disease|2|||
149765537|NCT01877382|540269083|FG001|Dose Escalation|Progressive disease|0|||
149765538|NCT01877382|540269084|FG002|Dose Escalation|Progressive disease|1|||
149765539|NCT01877382|540269085|FG003|Dose Escalation|Progressive disease|6|||
149765540|NCT01877382|540269086|FG004|Dose Escalation|Progressive disease|1|||
149765541|NCT01877382|540269087|FG005|Dose Escalation|Progressive disease|0|||
149765542|NCT01877382|540269088|FG006|Dose Escalation|Progressive disease|3|||
149765543|NCT01877382|540269089|FG007|Dose Escalation|Progressive disease|10|||
149765544|NCT01877382|540269090|FG008|Dose Escalation|Progressive disease|4|||
149765545|NCT01877382|540269091|FG009|Dose Escalation|Progressive disease|2|||
149765546|NCT01877382|540269092|FG010|Dose Escalation|Progressive disease|3|||
149765547|NCT01877382|540269093|FG011|Dose Escalation|Progressive disease|3|||
149765548|NCT01877382|540269094|FG012|Dose Escalation|Progressive disease|13|||
149765549|NCT01877382|540269095|FG013|Dose Escalation|Progressive disease|1|||
149765550|NCT01877382|540269096|FG014|Dose Escalation|Progressive disease|0|||
149765551|NCT01877382|540269082|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149765552|NCT01877382|540269083|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765553|NCT01877382|540269084|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765554|NCT01877382|540269085|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149765555|NCT01877382|540269086|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765556|NCT01877382|540269087|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765557|NCT01877382|540269088|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149765558|NCT01877382|540269089|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765559|NCT01877382|540269090|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765560|NCT01877382|540269091|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765561|NCT01877382|540269092|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765562|NCT01877382|540269093|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765563|NCT01877382|540269094|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765564|NCT01877382|540269095|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765565|NCT01877382|540269096|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765566|NCT01877382|540269082|FG000|Dose Escalation|Clinical progression|0|||
149765567|NCT01877382|540269083|FG001|Dose Escalation|Clinical progression|1|||
149765568|NCT01877382|540269084|FG002|Dose Escalation|Clinical progression|0|||
149765569|NCT01877382|540269085|FG003|Dose Escalation|Clinical progression|2|||
149765570|NCT01877382|540269086|FG004|Dose Escalation|Clinical progression|0|||
149765571|NCT01877382|540269087|FG005|Dose Escalation|Clinical progression|0|||
149765572|NCT01877382|540269088|FG006|Dose Escalation|Clinical progression|1|||
149765573|NCT01877382|540269089|FG007|Dose Escalation|Clinical progression|0|||
149765574|NCT01877382|540269090|FG008|Dose Escalation|Clinical progression|0|||
149765575|NCT01877382|540269091|FG009|Dose Escalation|Clinical progression|1|||
149765576|NCT01877382|540269092|FG010|Dose Escalation|Clinical progression|0|||
149765577|NCT01877382|540269093|FG011|Dose Escalation|Clinical progression|0|||
149765578|NCT01877382|540269094|FG012|Dose Escalation|Clinical progression|2|||
149765579|NCT01877382|540269095|FG013|Dose Escalation|Clinical progression|1|||
149765580|NCT01877382|540269096|FG014|Dose Escalation|Clinical progression|0|||
149765581|NCT01877382|540269082|FG000|Dose Escalation|Adverse Event|0|||
149765582|NCT01877382|540269083|FG001|Dose Escalation|Adverse Event|0|||
149765583|NCT01877382|540269084|FG002|Dose Escalation|Adverse Event|0|||
149765584|NCT01877382|540269085|FG003|Dose Escalation|Adverse Event|4|||
149765585|NCT01877382|540269086|FG004|Dose Escalation|Adverse Event|1|||
149765586|NCT01877382|540269087|FG005|Dose Escalation|Adverse Event|2|||
149765587|NCT01877382|540269088|FG006|Dose Escalation|Adverse Event|1|||
149765588|NCT01877382|540269089|FG007|Dose Escalation|Adverse Event|2|||
149765589|NCT01877382|540269090|FG008|Dose Escalation|Adverse Event|0|||
149765590|NCT01877382|540269091|FG009|Dose Escalation|Adverse Event|0|||
149765591|NCT01877382|540269092|FG010|Dose Escalation|Adverse Event|0|||
149765592|NCT01877382|540269093|FG011|Dose Escalation|Adverse Event|0|||
149765593|NCT01877382|540269094|FG012|Dose Escalation|Adverse Event|1|||
149765594|NCT01877382|540269095|FG013|Dose Escalation|Adverse Event|0|||
149765595|NCT01877382|540269096|FG014|Dose Escalation|Adverse Event|0|||
149765596|NCT01877382|540269082|FG000|Dose Escalation|Withdrawal by Subject|0|||
149765597|NCT01877382|540269083|FG001|Dose Escalation|Withdrawal by Subject|0|||
149765598|NCT01877382|540269084|FG002|Dose Escalation|Withdrawal by Subject|0|||
149765599|NCT01877382|540269085|FG003|Dose Escalation|Withdrawal by Subject|0|||
149765600|NCT01877382|540269086|FG004|Dose Escalation|Withdrawal by Subject|0|||
149765601|NCT01877382|540269087|FG005|Dose Escalation|Withdrawal by Subject|3|||
149765602|NCT01877382|540269088|FG006|Dose Escalation|Withdrawal by Subject|2|||
149765603|NCT01877382|540269089|FG007|Dose Escalation|Withdrawal by Subject|1|||
149765604|NCT01877382|540269090|FG008|Dose Escalation|Withdrawal by Subject|1|||
149765605|NCT01877382|540269091|FG009|Dose Escalation|Withdrawal by Subject|0|||
149765606|NCT01877382|540269092|FG010|Dose Escalation|Withdrawal by Subject|0|||
149765607|NCT01877382|540269093|FG011|Dose Escalation|Withdrawal by Subject|0|||
149765608|NCT01877382|540269094|FG012|Dose Escalation|Withdrawal by Subject|0|||
149765609|NCT01877382|540269095|FG013|Dose Escalation|Withdrawal by Subject|0|||
149765610|NCT01877382|540269096|FG014|Dose Escalation|Withdrawal by Subject|0|||
149765611|NCT01877382|540269082|FG000|Dose Escalation|Protocol Violation|0|||
149765612|NCT01877382|540269083|FG001|Dose Escalation|Protocol Violation|0|||
149765613|NCT01877382|540269084|FG002|Dose Escalation|Protocol Violation|0|||
149765614|NCT01877382|540269085|FG003|Dose Escalation|Protocol Violation|0|||
149765615|NCT01877382|540269086|FG004|Dose Escalation|Protocol Violation|0|||
149765616|NCT01877382|540269087|FG005|Dose Escalation|Protocol Violation|0|||
149765617|NCT01877382|540269088|FG006|Dose Escalation|Protocol Violation|1|||
149765618|NCT01877382|540269089|FG007|Dose Escalation|Protocol Violation|0|||
149765619|NCT01877382|540269090|FG008|Dose Escalation|Protocol Violation|0|||
149765620|NCT01877382|540269091|FG009|Dose Escalation|Protocol Violation|0|||
149765621|NCT01877382|540269092|FG010|Dose Escalation|Protocol Violation|0|||
149765622|NCT01877382|540269093|FG011|Dose Escalation|Protocol Violation|0|||
149765623|NCT01877382|540269094|FG012|Dose Escalation|Protocol Violation|0|||
149765624|NCT01877382|540269095|FG013|Dose Escalation|Protocol Violation|0|||
149765625|NCT01877382|540269096|FG014|Dose Escalation|Protocol Violation|0|||
149765626|NCT01877382|540269082|FG000|Dose Escalation|Study terminated by sponsor|0|||
149765627|NCT01877382|540269083|FG001|Dose Escalation|Study terminated by sponsor|0|||
149765628|NCT01877382|540269084|FG002|Dose Escalation|Study terminated by sponsor|0|||
149765629|NCT01877382|540269085|FG003|Dose Escalation|Study terminated by sponsor|0|||
149765630|NCT01877382|540269086|FG004|Dose Escalation|Study terminated by sponsor|0|||
149765631|NCT01877382|540269087|FG005|Dose Escalation|Study terminated by sponsor|0|||
149765632|NCT01877382|540269088|FG006|Dose Escalation|Study terminated by sponsor|0|||
149765633|NCT01877382|540269089|FG007|Dose Escalation|Study terminated by sponsor|1|||
149765634|NCT01877382|540269090|FG008|Dose Escalation|Study terminated by sponsor|1|||
149765635|NCT01877382|540269091|FG009|Dose Escalation|Study terminated by sponsor|0|||
149765636|NCT01877382|540269092|FG010|Dose Escalation|Study terminated by sponsor|0|||
149765637|NCT01877382|540269093|FG011|Dose Escalation|Study terminated by sponsor|0|||
149765638|NCT01877382|540269094|FG012|Dose Escalation|Study terminated by sponsor|3|||
149765639|NCT01877382|540269095|FG013|Dose Escalation|Study terminated by sponsor|0|||
149765640|NCT01877382|540269096|FG014|Dose Escalation|Study terminated by sponsor|0|||
149765641|NCT01877382|540269082|FG000|Dose Escalation|Death|0|||
149765642|NCT01877382|540269083|FG001|Dose Escalation|Death|0|||
149765643|NCT01877382|540269084|FG002|Dose Escalation|Death|0|||
149765644|NCT01877382|540269085|FG003|Dose Escalation|Death|0|||
149765645|NCT01877382|540269086|FG004|Dose Escalation|Death|0|||
149765646|NCT01877382|540269087|FG005|Dose Escalation|Death|0|||
149765647|NCT01877382|540269088|FG006|Dose Escalation|Death|0|||
149765648|NCT01877382|540269089|FG007|Dose Escalation|Death|1|||
149765649|NCT01877382|540269090|FG008|Dose Escalation|Death|0|||
149765650|NCT01877382|540269091|FG009|Dose Escalation|Death|0|||
149765651|NCT01877382|540269092|FG010|Dose Escalation|Death|0|||
149765652|NCT01877382|540269093|FG011|Dose Escalation|Death|0|||
149765653|NCT01877382|540269094|FG012|Dose Escalation|Death|1|||
149765654|NCT01877382|540269095|FG013|Dose Escalation|Death|1|||
149765655|NCT01877382|540269096|FG014|Dose Escalation|Death|0|||
149765656|NCT01877382|540269082|FG000|Dose Expansion|Progressive disease|0|||
149765657|NCT01877382|540269083|FG001|Dose Expansion|Progressive disease|0|||
149765658|NCT01877382|540269084|FG002|Dose Expansion|Progressive disease|0|||
149765659|NCT01877382|540269085|FG003|Dose Expansion|Progressive disease|0|||
149765660|NCT01877382|540269086|FG004|Dose Expansion|Progressive disease|0|||
149765661|NCT01877382|540269087|FG005|Dose Expansion|Progressive disease|0|||
149765662|NCT01877382|540269088|FG006|Dose Expansion|Progressive disease|0|||
149765663|NCT01877382|540269089|FG007|Dose Expansion|Progressive disease|0|||
149765664|NCT01877382|540269090|FG008|Dose Expansion|Progressive disease|0|||
149765665|NCT01877382|540269091|FG009|Dose Expansion|Progressive disease|0|||
149765666|NCT01877382|540269092|FG010|Dose Expansion|Progressive disease|0|||
149765667|NCT01877382|540269093|FG011|Dose Expansion|Progressive disease|0|||
149765668|NCT01877382|540269094|FG012|Dose Expansion|Progressive disease|0|||
149765669|NCT01877382|540269095|FG013|Dose Expansion|Progressive disease|0|||
149765670|NCT01877382|540269096|FG014|Dose Expansion|Progressive disease|11|||
149765671|NCT01877382|540269082|FG000|Dose Expansion|Clinical progression|0|||
149765672|NCT01877382|540269083|FG001|Dose Expansion|Clinical progression|0|||
149765673|NCT01877382|540269084|FG002|Dose Expansion|Clinical progression|0|||
149765674|NCT01877382|540269085|FG003|Dose Expansion|Clinical progression|0|||
149765675|NCT01877382|540269086|FG004|Dose Expansion|Clinical progression|0|||
149765676|NCT01877382|540269087|FG005|Dose Expansion|Clinical progression|0|||
149765677|NCT01877382|540269088|FG006|Dose Expansion|Clinical progression|0|||
149765678|NCT01877382|540269089|FG007|Dose Expansion|Clinical progression|0|||
149765679|NCT01877382|540269090|FG008|Dose Expansion|Clinical progression|0|||
149765680|NCT01877382|540269091|FG009|Dose Expansion|Clinical progression|0|||
149765681|NCT01877382|540269092|FG010|Dose Expansion|Clinical progression|0|||
149765682|NCT01877382|540269093|FG011|Dose Expansion|Clinical progression|0|||
149765683|NCT01877382|540269094|FG012|Dose Expansion|Clinical progression|0|||
149765684|NCT01877382|540269095|FG013|Dose Expansion|Clinical progression|0|||
149765685|NCT01877382|540269096|FG014|Dose Expansion|Clinical progression|6|||
149765686|NCT01877382|540269082|FG000|Dose Expansion|Adverse Event|0|||
149765687|NCT01877382|540269083|FG001|Dose Expansion|Adverse Event|0|||
149765688|NCT01877382|540269084|FG002|Dose Expansion|Adverse Event|0|||
149765689|NCT01877382|540269085|FG003|Dose Expansion|Adverse Event|0|||
149765690|NCT01877382|540269086|FG004|Dose Expansion|Adverse Event|0|||
149765691|NCT01877382|540269087|FG005|Dose Expansion|Adverse Event|0|||
149765692|NCT01877382|540269088|FG006|Dose Expansion|Adverse Event|0|||
149765693|NCT01877382|540269089|FG007|Dose Expansion|Adverse Event|0|||
149765694|NCT01877382|540269090|FG008|Dose Expansion|Adverse Event|0|||
149765695|NCT01877382|540269091|FG009|Dose Expansion|Adverse Event|0|||
149765696|NCT01877382|540269092|FG010|Dose Expansion|Adverse Event|0|||
149765697|NCT01877382|540269093|FG011|Dose Expansion|Adverse Event|0|||
149765698|NCT01877382|540269094|FG012|Dose Expansion|Adverse Event|0|||
149765699|NCT01877382|540269095|FG013|Dose Expansion|Adverse Event|0|||
149765700|NCT01877382|540269096|FG014|Dose Expansion|Adverse Event|1|||
149765701|NCT01877382|540269082|FG000|Dose Expansion|Death|0|||
149765702|NCT01877382|540269083|FG001|Dose Expansion|Death|0|||
149765703|NCT01877382|540269084|FG002|Dose Expansion|Death|0|||
149765704|NCT01877382|540269085|FG003|Dose Expansion|Death|0|||
149765705|NCT01877382|540269086|FG004|Dose Expansion|Death|0|||
149765706|NCT01877382|540269087|FG005|Dose Expansion|Death|0|||
149765707|NCT01877382|540269088|FG006|Dose Expansion|Death|0|||
149765708|NCT01877382|540269089|FG007|Dose Expansion|Death|0|||
149765709|NCT01877382|540269090|FG008|Dose Expansion|Death|0|||
149765710|NCT01877382|540269091|FG009|Dose Expansion|Death|0|||
149765711|NCT01877382|540269092|FG010|Dose Expansion|Death|0|||
149765712|NCT01877382|540269093|FG011|Dose Expansion|Death|0|||
149765713|NCT01877382|540269094|FG012|Dose Expansion|Death|0|||
149765714|NCT01877382|540269095|FG013|Dose Expansion|Death|0|||
149765715|NCT01877382|540269096|FG014|Dose Expansion|Death|1|||
149765716|NCT01877382|540269082|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765717|NCT01877382|540269083|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765718|NCT01877382|540269084|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765719|NCT01877382|540269085|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765720|NCT01877382|540269086|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765721|NCT01877382|540269087|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765722|NCT01877382|540269088|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765723|NCT01877382|540269089|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765724|NCT01877382|540269090|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765725|NCT01877382|540269091|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765726|NCT01877382|540269092|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765727|NCT01877382|540269093|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765728|NCT01877382|540269094|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765729|NCT01877382|540269095|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149765730|NCT01877382|540269096|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149765731|NCT01274338|540270614|FG000|Overall Study|Lack of Efficacy|72|||
149765732|NCT01274338|540270615|FG001|Overall Study|Lack of Efficacy|108|||
149765733|NCT01274338|540270616|FG002|Overall Study|Lack of Efficacy|116|||
149765734|NCT01274338|540270617|FG003|Overall Study|Lack of Efficacy|0|||
149765735|NCT01274338|540270618|FG004|Overall Study|Lack of Efficacy|0|||
149765736|NCT01274338|540270619|FG005|Overall Study|Lack of Efficacy|0|||
149765737|NCT01274338|540270614|FG000|Overall Study|Adverse Event|272|||
149765738|NCT01274338|540270615|FG001|Overall Study|Adverse Event|105|||
149765739|NCT01274338|540270616|FG002|Overall Study|Adverse Event|180|||
149765740|NCT01274338|540270617|FG003|Overall Study|Adverse Event|1|||
149765741|NCT01274338|540270618|FG004|Overall Study|Adverse Event|0|||
149765742|NCT01274338|540270619|FG005|Overall Study|Adverse Event|0|||
149765743|NCT01274338|540270614|FG000|Overall Study|Death|8|||
149765744|NCT01274338|540270615|FG001|Overall Study|Death|1|||
149765745|NCT01274338|540270616|FG002|Overall Study|Death|0|||
149765746|NCT01274338|540270617|FG003|Overall Study|Death|0|||
149765747|NCT01274338|540270618|FG004|Overall Study|Death|0|||
149765748|NCT01274338|540270619|FG005|Overall Study|Death|0|||
149765749|NCT01274338|540270614|FG000|Overall Study|Withdrawal by Subject|27|||
149765750|NCT01274338|540270615|FG001|Overall Study|Withdrawal by Subject|99|||
149765751|NCT01274338|540270616|FG002|Overall Study|Withdrawal by Subject|17|||
149765752|NCT01274338|540270617|FG003|Overall Study|Withdrawal by Subject|0|||
149765753|NCT01274338|540270618|FG004|Overall Study|Withdrawal by Subject|0|||
149765754|NCT01274338|540270619|FG005|Overall Study|Withdrawal by Subject|0|||
149765755|NCT01274338|540270614|FG000|Overall Study|Did not start treatment|8|||
149765756|NCT01274338|540270615|FG001|Overall Study|Did not start treatment|116|||
149765757|NCT01274338|540270616|FG002|Overall Study|Did not start treatment|7|||
149765758|NCT01274338|540270617|FG003|Overall Study|Did not start treatment|0|||
149765759|NCT01274338|540270618|FG004|Overall Study|Did not start treatment|0|||
149765760|NCT01274338|540270619|FG005|Overall Study|Did not start treatment|0|||
149765761|NCT01274338|540270614|FG000|Overall Study|Alternative therapy|0|||
149765762|NCT01274338|540270615|FG001|Overall Study|Alternative therapy|1|||
149765763|NCT01274338|540270616|FG002|Overall Study|Alternative therapy|0|||
149765764|NCT01274338|540270617|FG003|Overall Study|Alternative therapy|0|||
149765765|NCT01274338|540270618|FG004|Overall Study|Alternative therapy|0|||
149765766|NCT01274338|540270619|FG005|Overall Study|Alternative therapy|0|||
149765767|NCT01274338|540270614|FG000|Overall Study|Other complicating diseases|0|||
149765768|NCT01274338|540270615|FG001|Overall Study|Other complicating diseases|3|||
149765769|NCT01274338|540270616|FG002|Overall Study|Other complicating diseases|1|||
149765770|NCT01274338|540270617|FG003|Overall Study|Other complicating diseases|0|||
149765771|NCT01274338|540270618|FG004|Overall Study|Other complicating diseases|0|||
149765772|NCT01274338|540270619|FG005|Overall Study|Other complicating diseases|0|||
149765773|NCT01274338|540270614|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
149765774|NCT01274338|540270615|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
149765775|NCT01274338|540270616|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
149765776|NCT01274338|540270617|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
149765777|NCT01274338|540270618|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
149765778|NCT01274338|540270619|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
149765779|NCT01274338|540270614|FG000|Overall Study|Pregnancy|0|||
149765780|NCT01274338|540270615|FG001|Overall Study|Pregnancy|0|||
149765781|NCT01274338|540270616|FG002|Overall Study|Pregnancy|1|||
149765782|NCT01274338|540270617|FG003|Overall Study|Pregnancy|0|||
149765783|NCT01274338|540270618|FG004|Overall Study|Pregnancy|0|||
149765784|NCT01274338|540270619|FG005|Overall Study|Pregnancy|0|||
149765785|NCT01274338|540270614|FG000|Overall Study|Reason not reported|12|||
149765786|NCT01274338|540270615|FG001|Overall Study|Reason not reported|21|||
149765787|NCT01274338|540270616|FG002|Overall Study|Reason not reported|3|||
149765788|NCT01274338|540270617|FG003|Overall Study|Reason not reported|0|||
149765789|NCT01274338|540270618|FG004|Overall Study|Reason not reported|1|||
149765790|NCT01274338|540270619|FG005|Overall Study|Reason not reported|0|||
149765791|NCT01927744|540270620|FG000|Overall Study|Death|2|||
149765792|NCT01927744|540270621|FG001|Overall Study|Death|9|||
149765793|NCT00369967|540270626|FG000|Overall Study|Lost to Follow-up|23|||
149765794|NCT00369967|540270627|FG001|Overall Study|Lost to Follow-up|12|||
149765795|NCT01617655|540270630|FG000|Overall Study|Adverse Event|2|||
149765796|NCT01617655|540270631|FG001|Overall Study|Adverse Event|3|||
149765797|NCT01617655|540270630|FG000|Overall Study|Poor compliance to protocol|1|||
149765798|NCT01617655|540270631|FG001|Overall Study|Poor compliance to protocol|4|||
149765799|NCT01617655|540270630|FG000|Overall Study|Participants moved|0|||
149765800|NCT01617655|540270631|FG001|Overall Study|Participants moved|4|||
149765801|NCT01617655|540270630|FG000|Overall Study|Consent withdrawn by participant|1|||
149765802|NCT01617655|540270631|FG001|Overall Study|Consent withdrawn by participant|1|||
149765803|NCT01617655|540270630|FG000|Overall Study|Last visit outside protocol visit window|1|||
149765804|NCT01617655|540270631|FG001|Overall Study|Last visit outside protocol visit window|10|||
149765805|NCT01617655|540270630|FG000|Overall Study|Site closure|3|||
149765806|NCT01617655|540270631|FG001|Overall Study|Site closure|5|||
149765807|NCT01617655|540270630|FG000|Overall Study|Other than specified above|1|||
149765808|NCT01617655|540270631|FG001|Overall Study|Other than specified above|2|||
149765809|NCT00423735|540270638|FG000|Overall Study|Ineligible / No protocol treatment|8|||
149765810|NCT00423735|540270639|FG001|Overall Study|Ineligible / No protocol treatment|6|||
149765811|NCT00423735|540270640|FG002|Overall Study|Ineligible / No protocol treatment|0|||
149765812|NCT01089582|540270641|FG000|Overall Study|Death|2|||
149765813|NCT01089582|540270641|FG000|Overall Study|Adverse Event|15|||
149765814|NCT01089582|540270641|FG000|Overall Study|Lost to Follow-up|8|||
149765815|NCT01089582|540270641|FG000|Overall Study|Other|4|||
149765816|NCT01089582|540270641|FG000|Overall Study|Withdrawal by Subject|1|||
149765817|NCT02394808|540270642|FG000|Period 1|Unsatisfactory lens fitting|0|||
149765818|NCT02394808|540270643|FG001|Period 1|Unsatisfactory lens fitting|1|||
149765819|NCT02394808|540270642|FG000|Period 2|Lost to Follow-up|1|||
149765820|NCT02394808|540270643|FG001|Period 2|Lost to Follow-up|0|||
149765821|NCT00209170|540270644|FG000|Overall Study|Adverse Event|0|||
149765822|NCT00209170|540270645|FG001|Overall Study|Adverse Event|1|||
149765823|NCT00209170|540270644|FG000|Overall Study|Withdrawal by Subject|2|||
149765824|NCT00209170|540270645|FG001|Overall Study|Withdrawal by Subject|1|||
149765825|NCT00209170|540270644|FG000|Overall Study|Lack of Efficacy|0|||
149765826|NCT00209170|540270645|FG001|Overall Study|Lack of Efficacy|1|||
149765827|NCT02130427|540270646|FG000|Overall Study|Imaging results not interpretable|30|||
149765828|NCT02108600|540270651|FG000|Overall Study|Withdrawal by Subject|2|||
149765829|NCT02108600|540270652|FG001|Overall Study|Withdrawal by Subject|0|||
149765830|NCT02108600|540270651|FG000|Overall Study|Lost to Follow-up|1|||
149765831|NCT02108600|540270652|FG001|Overall Study|Lost to Follow-up|1|||
149765832|NCT00992784|540270653|FG000|Overall Study|Adverse Event|2|||
149765833|NCT00992784|540270654|FG001|Overall Study|Adverse Event|1|||
149765834|NCT00992784|540270655|FG002|Overall Study|Adverse Event|0|||
149765835|NCT00992784|540270653|FG000|Overall Study|Withdrawal by Subject|1|||
149765836|NCT00992784|540270654|FG001|Overall Study|Withdrawal by Subject|1|||
149765837|NCT00992784|540270655|FG002|Overall Study|Withdrawal by Subject|1|||
149765838|NCT01124448|540270656|FG000|Overall Study|Lost to Follow-up|0|||
149765839|NCT01124448|540270657|FG001|Overall Study|Lost to Follow-up|3|||
149765840|NCT01124448|540270656|FG000|Overall Study|Protocol Violation|2|||
149765841|NCT01124448|540270657|FG001|Overall Study|Protocol Violation|0|||
149765842|NCT01029002|540270658|FG000|Overall Study|Lost to Follow-up|2|||
149765843|NCT01029002|540270659|FG001|Overall Study|Lost to Follow-up|4|||
149765844|NCT02632110|540270664|FG000|Overall Study|Withdrawal by Subject|1|||
149765845|NCT02632110|540270665|FG001|Overall Study|Withdrawal by Subject|1|||
149765846|NCT02632110|540270666|FG002|Overall Study|Withdrawal by Subject|0|||
149765847|NCT02632110|540270667|FG003|Overall Study|Withdrawal by Subject|0|||
149765848|NCT02632110|540270668|FG004|Overall Study|Withdrawal by Subject|1|||
149765849|NCT02632110|540270669|FG005|Overall Study|Withdrawal by Subject|1|||
149765850|NCT02632110|540270670|FG006|Overall Study|Withdrawal by Subject|3|||
149765851|NCT02632110|540270671|FG007|Overall Study|Withdrawal by Subject|3|||
149765852|NCT02632110|540270672|FG008|Overall Study|Withdrawal by Subject|1|||
149765853|NCT02632110|540270673|FG009|Overall Study|Withdrawal by Subject|1|||
149765854|NCT04146467|540270674|FG000|Overall Study|Adverse Event|0|||
149765855|NCT04146467|540270675|FG001|Overall Study|Adverse Event|1|||
149765856|NCT04146467|540270674|FG000|Overall Study|Lost to Follow-up|0|||
149765857|NCT04146467|540270675|FG001|Overall Study|Lost to Follow-up|2|||
149765858|NCT01189435|540270676|FG000|Overall Study|Withdrawal by Subject|1|||
149765859|NCT01189435|540270676|FG000|Overall Study|Physician Decision|1|||
149765860|NCT00547378|540270677|FG000|Randomized Cohort|Withdrawal by Subject|7|||
149765861|NCT00547378|540270678|FG001|Randomized Cohort|Withdrawal by Subject|5|||
149765862|NCT00547378|540270679|FG002|Randomized Cohort|Withdrawal by Subject|0|||
149765863|NCT00547378|540270677|FG000|Randomized Cohort|Death|0|||
149765864|NCT00547378|540270678|FG001|Randomized Cohort|Death|1|||
149765865|NCT00547378|540270679|FG002|Randomized Cohort|Death|0|||
149765866|NCT00547378|540270677|FG000|Randomized Cohort|Lost to Follow-up|1|||
149765867|NCT00547378|540270678|FG001|Randomized Cohort|Lost to Follow-up|0|||
149765868|NCT00547378|540270679|FG002|Randomized Cohort|Lost to Follow-up|0|||
149765869|NCT00547378|540270677|FG000|Randomized Cohort|Adverse Event|1|||
149765870|NCT00547378|540270678|FG001|Randomized Cohort|Adverse Event|0|||
149765871|NCT00547378|540270679|FG002|Randomized Cohort|Adverse Event|0|||
149765872|NCT00547378|540270677|FG000|Randomized Cohort|Other reasons|2|||
149765873|NCT00547378|540270678|FG001|Randomized Cohort|Other reasons|0|||
149765874|NCT00547378|540270679|FG002|Randomized Cohort|Other reasons|0|||
149765875|NCT00547378|540270677|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
149765876|NCT00547378|540270678|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
149765877|NCT00547378|540270679|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
149765878|NCT00547378|540270677|FG000|All Implanted Cohort|Adverse Event|4|||
149765879|NCT00547378|540270678|FG001|All Implanted Cohort|Adverse Event|10|||
149765880|NCT00547378|540270679|FG002|All Implanted Cohort|Adverse Event|17|||
149765881|NCT00547378|540270677|FG000|All Implanted Cohort|Lost to Follow-up|0|||
149765882|NCT00547378|540270678|FG001|All Implanted Cohort|Lost to Follow-up|1|||
149765883|NCT00547378|540270679|FG002|All Implanted Cohort|Lost to Follow-up|14|||
149765884|NCT00547378|540270677|FG000|All Implanted Cohort|Death|3|||
149765885|NCT00547378|540270678|FG001|All Implanted Cohort|Death|1|||
149765886|NCT00547378|540270679|FG002|All Implanted Cohort|Death|4|||
149765887|NCT00547378|540270677|FG000|All Implanted Cohort|Physician Decision|0|||
149765888|NCT00547378|540270678|FG001|All Implanted Cohort|Physician Decision|2|||
149765889|NCT00547378|540270679|FG002|All Implanted Cohort|Physician Decision|6|||
149765890|NCT00547378|540270677|FG000|All Implanted Cohort|Site closure|2|||
149765891|NCT00547378|540270678|FG001|All Implanted Cohort|Site closure|0|||
149765892|NCT00547378|540270679|FG002|All Implanted Cohort|Site closure|1|||
149765893|NCT00547378|540270677|FG000|All Implanted Cohort|Other reasons|1|||
149765894|NCT00547378|540270678|FG001|All Implanted Cohort|Other reasons|0|||
149765895|NCT00547378|540270679|FG002|All Implanted Cohort|Other reasons|1|||
149765896|NCT01449682|540270680|FG000|Overall Study|Death|0|||
149765897|NCT01449682|540270681|FG001|Overall Study|Death|1|||
149765898|NCT01449682|540270680|FG000|Overall Study|Adverse Event|1|||
149765899|NCT01449682|540270681|FG001|Overall Study|Adverse Event|0|||
149765900|NCT04863014|540270682|FG000|Overall Study|Lost to Follow-up|3|||
149765901|NCT04863014|540270683|FG001|Overall Study|Lost to Follow-up|2|||
149765902|NCT04863014|540270682|FG000|Overall Study|Subject Decision|0|||
149765903|NCT04863014|540270683|FG001|Overall Study|Subject Decision|4|||
149765904|NCT04633473|540270684|FG000|Overall Study|Withdrawal by Subject|6|||
149765905|NCT01982773|540270689|FG000|Overall Study|Withdrawal by Subject|1|||
149765906|NCT01982773|540270690|FG001|Overall Study|Withdrawal by Subject|3|||
149765907|NCT01982773|540270689|FG000|Overall Study|Lost to Follow-up|7|||
149765908|NCT01982773|540270690|FG001|Overall Study|Lost to Follow-up|1|||
149765909|NCT01778127|540270695|FG000|Overall Study|Lost to Follow-up|5|||
149765910|NCT01778127|540270696|FG001|Overall Study|Lost to Follow-up|1|||
149765911|NCT01778127|540270697|FG002|Overall Study|Lost to Follow-up|2|||
149765912|NCT01778127|540270695|FG000|Overall Study|Withdrawal by Subject|3|||
149765913|NCT01778127|540270696|FG001|Overall Study|Withdrawal by Subject|1|||
149765914|NCT01778127|540270697|FG002|Overall Study|Withdrawal by Subject|4|||
149765915|NCT01348425|540270698|FG000|Overall Study|Imaging was not taken.|1|||
149765916|NCT01348425|540270699|FG001|Overall Study|Imaging was not taken.|1|||
149765917|NCT04191577|540270708|FG000|Overall Study|Withdrawal by Subject|2|||
149765918|NCT04191577|540270709|FG001|Overall Study|Withdrawal by Subject|2|||
149765919|NCT04191577|540270710|FG002|Overall Study|Withdrawal by Subject|1|||
149765920|NCT04191577|540270708|FG000|Overall Study|Physician Decision|1|||
149765921|NCT04191577|540270709|FG001|Overall Study|Physician Decision|1|||
149765922|NCT04191577|540270710|FG002|Overall Study|Physician Decision|0|||
149765923|NCT04191577|540270708|FG000|Overall Study|Adverse Event|0|||
149765924|NCT04191577|540270709|FG001|Overall Study|Adverse Event|0|||
149765925|NCT04191577|540270710|FG002|Overall Study|Adverse Event|1|||
149765926|NCT04191577|540270708|FG000|Overall Study|Death|0|||
149765927|NCT04191577|540270709|FG001|Overall Study|Death|0|||
149765928|NCT04191577|540270710|FG002|Overall Study|Death|1|||
149765929|NCT02365584|540270711|FG000|Overall Study|Adverse Event|2|||
149765930|NCT02365584|540270712|FG001|Overall Study|Adverse Event|2|||
149765931|NCT02365584|540270711|FG000|Overall Study|Withdrawal by Subject|1|||
149765932|NCT02365584|540270712|FG001|Overall Study|Withdrawal by Subject|0|||
149765933|NCT02365584|540270711|FG000|Overall Study|Disease Progression|9|||
149765934|NCT02365584|540270712|FG001|Overall Study|Disease Progression|12|||
149765935|NCT01185249|540270713|FG000|Overall Study|Patients discharged or change in status|42|||
149765936|NCT01973452|540270714|FG000|Overall Study|Lack of Efficacy|0|||
149765937|NCT01973452|540270715|FG001|Overall Study|Lack of Efficacy|1|||
149765938|NCT01973452|540270714|FG000|Overall Study|Lost to Follow-up|1|||
149765939|NCT01973452|540270715|FG001|Overall Study|Lost to Follow-up|0|||
149765940|NCT01973452|540270714|FG000|Overall Study|Withdrawal by Subject|10|||
149765941|NCT01973452|540270715|FG001|Overall Study|Withdrawal by Subject|9|||
149765942|NCT01973452|540270714|FG000|Overall Study|Ineligible|1|||
149765943|NCT01973452|540270715|FG001|Overall Study|Ineligible|1|||
149765944|NCT01973452|540270714|FG000|Overall Study|Surgery canceled by participant|5|||
149765945|NCT01973452|540270715|FG001|Overall Study|Surgery canceled by participant|3|||
149765946|NCT00406783|540270719|FG000|Overall Study|Adverse Event|4|||
149765947|NCT00406783|540270720|FG001|Overall Study|Adverse Event|4|||
149765948|NCT00406783|540270719|FG000|Overall Study|Treatment Failure|2|||
149765949|NCT00406783|540270720|FG001|Overall Study|Treatment Failure|3|||
149765950|NCT00406783|540270719|FG000|Overall Study|Lost to Follow-up|3|||
149765951|NCT00406783|540270720|FG001|Overall Study|Lost to Follow-up|0|||
149765952|NCT00406783|540270719|FG000|Overall Study|Withdrawal by Subject|1|||
149765953|NCT00406783|540270720|FG001|Overall Study|Withdrawal by Subject|4|||
149765954|NCT00406783|540270719|FG000|Overall Study|Protocol Violation|4|||
149765955|NCT00406783|540270720|FG001|Overall Study|Protocol Violation|4|||
149765956|NCT05294211|540270721|FG000|Overall Study|Withdrawal by Subject|3|||
149765957|NCT05294211|540270721|FG000|Overall Study|Physician Decision|2|||
149765958|NCT05294211|540270721|FG000|Overall Study|Progressed to active labor|1|||
149765959|NCT05294211|540270721|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
149765960|NCT05294211|540270721|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
149765961|NCT00064350|540270722|FG000|Induction Treatment|Disease Progression|5|||
149765962|NCT00064350|540270723|FG001|Induction Treatment|Disease Progression|1|||
149765963|NCT00064350|540270724|FG002|Induction Treatment|Disease Progression|110|||
149765964|NCT00064350|540270722|FG000|Induction Treatment|Adverse Event|0|||
149765965|NCT00064350|540270723|FG001|Induction Treatment|Adverse Event|2|||
149765966|NCT00064350|540270724|FG002|Induction Treatment|Adverse Event|49|||
149765967|NCT00064350|540270722|FG000|Induction Treatment|Death|0|||
149765968|NCT00064350|540270723|FG001|Induction Treatment|Death|0|||
149765969|NCT00064350|540270724|FG002|Induction Treatment|Death|9|||
149765970|NCT00064350|540270722|FG000|Induction Treatment|Withdrawal by Subject|0|||
149765971|NCT00064350|540270723|FG001|Induction Treatment|Withdrawal by Subject|0|||
149765972|NCT00064350|540270724|FG002|Induction Treatment|Withdrawal by Subject|21|||
149765973|NCT00064350|540270722|FG000|Induction Treatment|Ineligible or never started treatment|3|||
149765974|NCT00064350|540270723|FG001|Induction Treatment|Ineligible or never started treatment|6|||
149765975|NCT00064350|540270724|FG002|Induction Treatment|Ineligible or never started treatment|34|||
149765976|NCT00064350|540270722|FG000|Induction Treatment|Other|0|||
149765977|NCT00064350|540270723|FG001|Induction Treatment|Other|0|||
149765978|NCT00064350|540270724|FG002|Induction Treatment|Other|13|||
149765979|NCT00064350|540270722|FG000|Randomization|Adverse Event|8|||
149765980|NCT00064350|540270723|FG001|Randomization|Adverse Event|3|||
149765981|NCT00064350|540270724|FG002|Randomization|Adverse Event|0|||
149765982|NCT00064350|540270722|FG000|Randomization|Death|3|||
149765983|NCT00064350|540270723|FG001|Randomization|Death|0|||
149765984|NCT00064350|540270724|FG002|Randomization|Death|0|||
149765985|NCT00064350|540270722|FG000|Randomization|Withdrawal by Subject|1|||
149765986|NCT00064350|540270723|FG001|Randomization|Withdrawal by Subject|0|||
149765987|NCT00064350|540270724|FG002|Randomization|Withdrawal by Subject|0|||
149765988|NCT00064350|540270722|FG000|Randomization|Ineligible or never started treatment|9|||
149765989|NCT00064350|540270723|FG001|Randomization|Ineligible or never started treatment|15|||
149765990|NCT00064350|540270724|FG002|Randomization|Ineligible or never started treatment|0|||
149765991|NCT00064350|540270722|FG000|Randomization|Other|5|||
149765992|NCT00064350|540270723|FG001|Randomization|Other|0|||
149765993|NCT00064350|540270724|FG002|Randomization|Other|0|||
149765994|NCT00064350|540270722|FG000|Cross-Over|Adverse Event|0|||
149765995|NCT00064350|540270723|FG001|Cross-Over|Adverse Event|1|||
149765996|NCT00064350|540270724|FG002|Cross-Over|Adverse Event|0|||
149765997|NCT00064350|540270722|FG000|Cross-Over|Death|1|||
149765998|NCT00064350|540270723|FG001|Cross-Over|Death|3|||
149765999|NCT00064350|540270724|FG002|Cross-Over|Death|0|||
149766000|NCT00064350|540270722|FG000|Cross-Over|Withdrawal by Subject|2|||
149766001|NCT00064350|540270723|FG001|Cross-Over|Withdrawal by Subject|2|||
149766002|NCT00064350|540270724|FG002|Cross-Over|Withdrawal by Subject|0|||
149766003|NCT00064350|540270722|FG000|Cross-Over|Ineligible or never started treatment|3|||
149766004|NCT00064350|540270723|FG001|Cross-Over|Ineligible or never started treatment|6|||
149766005|NCT00064350|540270724|FG002|Cross-Over|Ineligible or never started treatment|0|||
149766006|NCT00064350|540270722|FG000|Cross-Over|Other|0|||
149766007|NCT00064350|540270723|FG001|Cross-Over|Other|2|||
149766008|NCT00064350|540270724|FG002|Cross-Over|Other|0|||
149766009|NCT03600714|540270725|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
149766010|NCT01935336|540270728|FG000|Overall Study|Adverse Event|1|||
149766011|NCT01935336|540270729|FG001|Overall Study|Adverse Event|0|||
149766012|NCT01935336|540270730|FG002|Overall Study|Adverse Event|0|||
149766013|NCT01935336|540270731|FG003|Overall Study|Adverse Event|0|||
149766014|NCT01935336|540270728|FG000|Overall Study|Progressive disease|5|||
149766015|NCT01935336|540270729|FG001|Overall Study|Progressive disease|3|||
149766016|NCT01935336|540270730|FG002|Overall Study|Progressive disease|47|||
149766017|NCT01935336|540270731|FG003|Overall Study|Progressive disease|66|||
149766018|NCT03707158|540270732|FG000|Midtreatment|Lost to Follow-up|16|||
149766019|NCT03707158|540270733|FG001|Midtreatment|Lost to Follow-up|7|||
149766020|NCT03707158|540270732|FG000|Midtreatment|Withdrawal by Subject|28|||
149766021|NCT03707158|540270733|FG001|Midtreatment|Withdrawal by Subject|19|||
149766022|NCT03707158|540270732|FG000|Posttreatment|Lost to Follow-up|0|||
149766023|NCT03707158|540270733|FG001|Posttreatment|Lost to Follow-up|5|||
149766024|NCT03707158|540270732|FG000|Follow-up|Lost to Follow-up|19|||
149766025|NCT03707158|540270733|FG001|Follow-up|Lost to Follow-up|18|||
149766026|NCT03707158|540270732|FG000|Follow-up|Withdrawal by Subject|13|||
149766027|NCT03707158|540270733|FG001|Follow-up|Withdrawal by Subject|6|||
149766028|NCT04092816|540272618|FG000|Overall Study|Lost to Follow-up|1|||
149766029|NCT04092816|540272619|FG001|Overall Study|Lost to Follow-up|2|||
149766030|NCT01747811|540272620|FG000|Overall Study|Lack of Efficacy|2|||
149766031|NCT01747811|540272621|FG001|Overall Study|Lack of Efficacy|4|||
149766032|NCT03073213|540272622|FG000|Multiple Dose Period|Protocol Violation|0|||
149766033|NCT03073213|540272623|FG001|Multiple Dose Period|Protocol Violation|0|||
149766034|NCT03073213|540272624|FG002|Multiple Dose Period|Protocol Violation|1|||
149766035|NCT03057951|540272625|FG000|Overall Study|Adverse Event|553|||
149766036|NCT03057951|540272626|FG001|Overall Study|Adverse Event|575|||
149766037|NCT03057951|540272625|FG000|Overall Study|Protocol Violation|30|||
149766038|NCT03057951|540272626|FG001|Overall Study|Protocol Violation|24|||
149766039|NCT03057951|540272625|FG000|Overall Study|Lost to Follow-up|6|||
149766040|NCT03057951|540272626|FG001|Overall Study|Lost to Follow-up|16|||
149766041|NCT03057951|540272625|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
149766042|NCT03057951|540272626|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
149766043|NCT03057951|540272625|FG000|Overall Study|Study drug stopped, reason missing|6|||
149766044|NCT03057951|540272626|FG001|Overall Study|Study drug stopped, reason missing|1|||
149766045|NCT03057951|540272625|FG000|Overall Study|Medical advice|6|||
149766046|NCT03057951|540272626|FG001|Overall Study|Medical advice|2|||
149766047|NCT03057951|540272625|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
149766048|NCT03057951|540272626|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
149766049|NCT03057951|540272625|FG000|Overall Study|Investigator decision|2|||
149766050|NCT03057951|540272626|FG001|Overall Study|Investigator decision|0|||
149766051|NCT03057951|540272625|FG000|Overall Study|Patient decision|5|||
149766052|NCT03057951|540272626|FG001|Overall Study|Patient decision|2|||
149766053|NCT03057951|540272625|FG000|Overall Study|Not attending study visits|3|||
149766054|NCT03057951|540272626|FG001|Overall Study|Not attending study visits|0|||
149766055|NCT03057951|540272625|FG000|Overall Study|Patient moved away|3|||
149766056|NCT03057951|540272626|FG001|Overall Study|Patient moved away|4|||
149766057|NCT03057951|540272625|FG000|Overall Study|Other reason than stated above|23|||
149766058|NCT03057951|540272626|FG001|Overall Study|Other reason than stated above|29|||
149766059|NCT03057951|540272625|FG000|Overall Study|Not treated|2|||
149766060|NCT03057951|540272626|FG001|Overall Study|Not treated|1|||
149766061|NCT02064205|540272627|FG000|Overall Study|Withdrawal by Subject|1|||
149766062|NCT02700919|540272628|FG000|Overall Study|Physician Decision|1|||
149766063|NCT02700919|540272629|FG001|Overall Study|Physician Decision|0|||
149766064|NCT02700919|540272630|FG002|Overall Study|Physician Decision|0|||
149766065|NCT02700919|540272628|FG000|Overall Study|Protocol Violation|1|||
149766066|NCT02700919|540272629|FG001|Overall Study|Protocol Violation|0|||
149766067|NCT02700919|540272630|FG002|Overall Study|Protocol Violation|0|||
149766068|NCT02700919|540272628|FG000|Overall Study|Adverse Event|1|||
149766069|NCT02700919|540272629|FG001|Overall Study|Adverse Event|3|||
149766070|NCT02700919|540272630|FG002|Overall Study|Adverse Event|1|||
149766071|NCT02700919|540272628|FG000|Overall Study|Withdrawal by Subject|5|||
149766072|NCT02700919|540272629|FG001|Overall Study|Withdrawal by Subject|8|||
149766073|NCT02700919|540272630|FG002|Overall Study|Withdrawal by Subject|2|||
149766074|NCT02700919|540272628|FG000|Overall Study|Lost to Follow-up|2|||
149766075|NCT02700919|540272629|FG001|Overall Study|Lost to Follow-up|0|||
149766076|NCT02700919|540272630|FG002|Overall Study|Lost to Follow-up|0|||
149766077|NCT02700919|540272628|FG000|Overall Study|Other|2|||
149766078|NCT02700919|540272629|FG001|Overall Study|Other|1|||
149766079|NCT02700919|540272630|FG002|Overall Study|Other|1|||
149766080|NCT02680587|540272631|FG000|Overall Study|Withdrawal by Subject|1|||
149766081|NCT02680587|540272632|FG001|Overall Study|Withdrawal by Subject|0|||
149766082|NCT01194869|540272634|FG000|Overall Study|Disease Progression|2|||
149766083|NCT01194869|540272634|FG000|Overall Study|Toxicity|2|||
149766084|NCT01708941|540272635|FG000|Overall Study|Adverse Event|4|||
149766085|NCT01708941|540272636|FG001|Overall Study|Adverse Event|6|||
149766086|NCT01708941|540272637|FG002|Overall Study|Adverse Event|1|||
149766087|NCT01708941|540272638|FG003|Overall Study|Adverse Event|0|||
149766088|NCT01708941|540272635|FG000|Overall Study|Death|1|||
149766089|NCT01708941|540272636|FG001|Overall Study|Death|1|||
149766090|NCT01708941|540272637|FG002|Overall Study|Death|2|||
149766091|NCT01708941|540272638|FG003|Overall Study|Death|14|||
149766092|NCT01708941|540272635|FG000|Overall Study|Withdrawal by Subject|1|||
149766093|NCT01708941|540272636|FG001|Overall Study|Withdrawal by Subject|0|||
149766094|NCT01708941|540272637|FG002|Overall Study|Withdrawal by Subject|3|||
149766095|NCT01708941|540272638|FG003|Overall Study|Withdrawal by Subject|4|||
149766096|NCT01708941|540272635|FG000|Overall Study|Disease progression|9|||
149766097|NCT01708941|540272636|FG001|Overall Study|Disease progression|10|||
149766098|NCT01708941|540272637|FG002|Overall Study|Disease progression|8|||
149766099|NCT01708941|540272638|FG003|Overall Study|Disease progression|0|||
149766100|NCT01708941|540272635|FG000|Overall Study|Alternative therapy|0|||
149766101|NCT01708941|540272636|FG001|Overall Study|Alternative therapy|0|||
149766102|NCT01708941|540272637|FG002|Overall Study|Alternative therapy|2|||
149766103|NCT01708941|540272638|FG003|Overall Study|Alternative therapy|0|||
149766104|NCT01708941|540272635|FG000|Overall Study|Ineligible and never started treatment|1|||
149766105|NCT01708941|540272636|FG001|Overall Study|Ineligible and never started treatment|0|||
149766106|NCT01708941|540272637|FG002|Overall Study|Ineligible and never started treatment|1|||
149766107|NCT01708941|540272638|FG003|Overall Study|Ineligible and never started treatment|0|||
149766108|NCT01708941|540272635|FG000|Overall Study|Never started treatment|2|||
149766109|NCT01708941|540272636|FG001|Overall Study|Never started treatment|1|||
149766110|NCT01708941|540272637|FG002|Overall Study|Never started treatment|0|||
149766111|NCT01708941|540272638|FG003|Overall Study|Never started treatment|0|||
149766112|NCT01708941|540272635|FG000|Overall Study|Ineligible|0|||
149766113|NCT01708941|540272636|FG001|Overall Study|Ineligible|0|||
149766114|NCT01708941|540272637|FG002|Overall Study|Ineligible|2|||
149766115|NCT01708941|540272638|FG003|Overall Study|Ineligible|0|||
149766116|NCT02226146|540272639|FG000|Overall Study|Received rescue therapy|1|||
149766117|NCT02226146|540272639|FG000|Overall Study|Withdrawal by Subject|2|||
149766118|NCT05464836|540272640|FG000|Overall Study|Progression of Disease|1|||
149766119|NCT05464836|540272640|FG000|Overall Study|Physician Decision|1|||
149766120|NCT01522976|540272641|FG000|Overall Study|Ineligible|4|||
149766121|NCT01522976|540272642|FG001|Overall Study|Ineligible|0|||
149766122|NCT01522976|540272643|FG002|Overall Study|Ineligible|1|||
149766123|NCT01522976|540272641|FG000|Overall Study|Death|7|||
149766124|NCT01522976|540272642|FG001|Overall Study|Death|6|||
149766125|NCT01522976|540272643|FG002|Overall Study|Death|2|||
149766126|NCT01522976|540272641|FG000|Overall Study|Still on treatment|9|||
149766127|NCT01522976|540272642|FG001|Overall Study|Still on treatment|9|||
149766128|NCT01522976|540272643|FG002|Overall Study|Still on treatment|6|||
149766129|NCT01522976|540272641|FG000|Overall Study|Disease progression|28|||
149766130|NCT01522976|540272642|FG001|Overall Study|Disease progression|30|||
149766131|NCT01522976|540272643|FG002|Overall Study|Disease progression|25|||
149766132|NCT01522976|540272641|FG000|Overall Study|Adverse Event|17|||
149766133|NCT01522976|540272642|FG001|Overall Study|Adverse Event|7|||
149766134|NCT01522976|540272643|FG002|Overall Study|Adverse Event|18|||
149766135|NCT01522976|540272641|FG000|Overall Study|Refusal unrelated to adverse event|10|||
149766136|NCT01522976|540272642|FG001|Overall Study|Refusal unrelated to adverse event|13|||
149766137|NCT01522976|540272643|FG002|Overall Study|Refusal unrelated to adverse event|14|||
149766138|NCT01522976|540272641|FG000|Overall Study|Not protocol specified|22|||
149766139|NCT01522976|540272642|FG001|Overall Study|Not protocol specified|27|||
149766140|NCT01522976|540272643|FG002|Overall Study|Not protocol specified|27|||
149766141|NCT02883049|540272644|FG000|Induction|Adverse Event|52|||
149766142|NCT02883049|540272645|FG001|Induction|Adverse Event|2|||
149766143|NCT02883049|540272646|FG002|Induction|Adverse Event|0|||
149766144|NCT02883049|540272647|FG003|Induction|Adverse Event|0|||
149766145|NCT02883049|540272648|FG004|Induction|Adverse Event|0|||
149766146|NCT02883049|540272649|FG005|Induction|Adverse Event|0|||
149766147|NCT02883049|540272650|FG006|Induction|Adverse Event|0|||
149766148|NCT02883049|540272651|FG007|Induction|Adverse Event|0|||
149766149|NCT02883049|540272652|FG008|Induction|Adverse Event|0|||
149766150|NCT02883049|540272653|FG009|Induction|Adverse Event|0|||
149766151|NCT02883049|540272654|FG010|Induction|Adverse Event|0|||
149766152|NCT02883049|540272655|FG011|Induction|Adverse Event|0|||
149766153|NCT02883049|540272656|FG012|Induction|Adverse Event|0|||
149766154|NCT02883049|540272657|FG013|Induction|Adverse Event|0|||
149766155|NCT02883049|540272658|FG014|Induction|Adverse Event|0|||
149766156|NCT02883049|540272659|FG015|Induction|Adverse Event|0|||
149766157|NCT02883049|540272644|FG000|Induction|Death|76|||
149766158|NCT02883049|540272645|FG001|Induction|Death|8|||
149766159|NCT02883049|540272646|FG002|Induction|Death|0|||
149766160|NCT02883049|540272647|FG003|Induction|Death|0|||
149766161|NCT02883049|540272648|FG004|Induction|Death|0|||
149766162|NCT02883049|540272649|FG005|Induction|Death|0|||
149766163|NCT02883049|540272650|FG006|Induction|Death|0|||
149766164|NCT02883049|540272651|FG007|Induction|Death|0|||
149766165|NCT02883049|540272652|FG008|Induction|Death|0|||
149766166|NCT02883049|540272653|FG009|Induction|Death|0|||
149766167|NCT02883049|540272654|FG010|Induction|Death|0|||
149766168|NCT02883049|540272655|FG011|Induction|Death|0|||
149766169|NCT02883049|540272656|FG012|Induction|Death|0|||
149766170|NCT02883049|540272657|FG013|Induction|Death|0|||
149766171|NCT02883049|540272658|FG014|Induction|Death|0|||
149766172|NCT02883049|540272659|FG015|Induction|Death|0|||
149766173|NCT02883049|540272644|FG000|Induction|Lost to Follow-up|2|||
149766174|NCT02883049|540272645|FG001|Induction|Lost to Follow-up|0|||
149766175|NCT02883049|540272646|FG002|Induction|Lost to Follow-up|0|||
149766176|NCT02883049|540272647|FG003|Induction|Lost to Follow-up|0|||
149766177|NCT02883049|540272648|FG004|Induction|Lost to Follow-up|0|||
149766178|NCT02883049|540272649|FG005|Induction|Lost to Follow-up|0|||
149766179|NCT02883049|540272650|FG006|Induction|Lost to Follow-up|0|||
149766180|NCT02883049|540272651|FG007|Induction|Lost to Follow-up|0|||
149766181|NCT02883049|540272652|FG008|Induction|Lost to Follow-up|0|||
149766182|NCT02883049|540272653|FG009|Induction|Lost to Follow-up|0|||
149766183|NCT02883049|540272654|FG010|Induction|Lost to Follow-up|0|||
149766184|NCT02883049|540272655|FG011|Induction|Lost to Follow-up|0|||
149766185|NCT02883049|540272656|FG012|Induction|Lost to Follow-up|0|||
149766186|NCT02883049|540272657|FG013|Induction|Lost to Follow-up|0|||
149766187|NCT02883049|540272658|FG014|Induction|Lost to Follow-up|0|||
149766188|NCT02883049|540272659|FG015|Induction|Lost to Follow-up|0|||
149766189|NCT02883049|540272644|FG000|Induction|Physician Decision|1407|||
149766190|NCT02883049|540272645|FG001|Induction|Physician Decision|8|||
149766191|NCT02883049|540272646|FG002|Induction|Physician Decision|0|||
149766192|NCT02883049|540272647|FG003|Induction|Physician Decision|0|||
149766193|NCT02883049|540272648|FG004|Induction|Physician Decision|0|||
149766194|NCT02883049|540272649|FG005|Induction|Physician Decision|0|||
149766195|NCT02883049|540272650|FG006|Induction|Physician Decision|0|||
149766196|NCT02883049|540272651|FG007|Induction|Physician Decision|0|||
149766197|NCT02883049|540272652|FG008|Induction|Physician Decision|0|||
149766198|NCT02883049|540272653|FG009|Induction|Physician Decision|0|||
149766199|NCT02883049|540272654|FG010|Induction|Physician Decision|0|||
149766200|NCT02883049|540272655|FG011|Induction|Physician Decision|0|||
149766201|NCT02883049|540272656|FG012|Induction|Physician Decision|0|||
149766202|NCT02883049|540272657|FG013|Induction|Physician Decision|0|||
149766203|NCT02883049|540272658|FG014|Induction|Physician Decision|0|||
149766204|NCT02883049|540272659|FG015|Induction|Physician Decision|0|||
149766205|NCT02883049|540272644|FG000|Induction|Protocol Violation|6|||
149766206|NCT02883049|540272645|FG001|Induction|Protocol Violation|0|||
149766207|NCT02883049|540272646|FG002|Induction|Protocol Violation|0|||
149766208|NCT02883049|540272647|FG003|Induction|Protocol Violation|0|||
149766209|NCT02883049|540272648|FG004|Induction|Protocol Violation|0|||
149766210|NCT02883049|540272649|FG005|Induction|Protocol Violation|0|||
149766211|NCT02883049|540272650|FG006|Induction|Protocol Violation|0|||
149766212|NCT02883049|540272651|FG007|Induction|Protocol Violation|0|||
149766213|NCT02883049|540272652|FG008|Induction|Protocol Violation|0|||
149766214|NCT02883049|540272653|FG009|Induction|Protocol Violation|0|||
149766215|NCT02883049|540272654|FG010|Induction|Protocol Violation|0|||
149766216|NCT02883049|540272655|FG011|Induction|Protocol Violation|0|||
149766217|NCT02883049|540272656|FG012|Induction|Protocol Violation|0|||
149766218|NCT02883049|540272657|FG013|Induction|Protocol Violation|0|||
149766219|NCT02883049|540272658|FG014|Induction|Protocol Violation|0|||
149766220|NCT02883049|540272659|FG015|Induction|Protocol Violation|0|||
149766221|NCT02883049|540272644|FG000|Induction|Withdrawal by Subject|6|||
149766222|NCT02883049|540272645|FG001|Induction|Withdrawal by Subject|0|||
149766223|NCT02883049|540272646|FG002|Induction|Withdrawal by Subject|0|||
149766224|NCT02883049|540272647|FG003|Induction|Withdrawal by Subject|0|||
149766225|NCT02883049|540272648|FG004|Induction|Withdrawal by Subject|0|||
149766226|NCT02883049|540272649|FG005|Induction|Withdrawal by Subject|0|||
149766227|NCT02883049|540272650|FG006|Induction|Withdrawal by Subject|0|||
149766228|NCT02883049|540272651|FG007|Induction|Withdrawal by Subject|0|||
149766229|NCT02883049|540272652|FG008|Induction|Withdrawal by Subject|0|||
149766230|NCT02883049|540272653|FG009|Induction|Withdrawal by Subject|0|||
149766231|NCT02883049|540272654|FG010|Induction|Withdrawal by Subject|0|||
149766232|NCT02883049|540272655|FG011|Induction|Withdrawal by Subject|0|||
149766233|NCT02883049|540272656|FG012|Induction|Withdrawal by Subject|0|||
149766234|NCT02883049|540272657|FG013|Induction|Withdrawal by Subject|0|||
149766235|NCT02883049|540272658|FG014|Induction|Withdrawal by Subject|0|||
149766236|NCT02883049|540272659|FG015|Induction|Withdrawal by Subject|0|||
149766237|NCT02883049|540272644|FG000|Induction|Ineligible|35|||
149766238|NCT02883049|540272645|FG001|Induction|Ineligible|1|||
149766239|NCT02883049|540272646|FG002|Induction|Ineligible|0|||
149766240|NCT02883049|540272647|FG003|Induction|Ineligible|0|||
149766241|NCT02883049|540272648|FG004|Induction|Ineligible|0|||
149766242|NCT02883049|540272649|FG005|Induction|Ineligible|0|||
149766243|NCT02883049|540272650|FG006|Induction|Ineligible|0|||
149766244|NCT02883049|540272651|FG007|Induction|Ineligible|0|||
149766245|NCT02883049|540272652|FG008|Induction|Ineligible|0|||
149766246|NCT02883049|540272653|FG009|Induction|Ineligible|0|||
149766247|NCT02883049|540272654|FG010|Induction|Ineligible|0|||
149766248|NCT02883049|540272655|FG011|Induction|Ineligible|0|||
149766249|NCT02883049|540272656|FG012|Induction|Ineligible|0|||
149766250|NCT02883049|540272657|FG013|Induction|Ineligible|0|||
149766251|NCT02883049|540272658|FG014|Induction|Ineligible|0|||
149766252|NCT02883049|540272659|FG015|Induction|Ineligible|0|||
149766253|NCT02883049|540272644|FG000|Induction|Refusal of further protocol therapy|466|||
149766254|NCT02883049|540272645|FG001|Induction|Refusal of further protocol therapy|2|||
149766255|NCT02883049|540272646|FG002|Induction|Refusal of further protocol therapy|0|||
149766256|NCT02883049|540272647|FG003|Induction|Refusal of further protocol therapy|0|||
149766257|NCT02883049|540272648|FG004|Induction|Refusal of further protocol therapy|0|||
149766258|NCT02883049|540272649|FG005|Induction|Refusal of further protocol therapy|0|||
149766259|NCT02883049|540272650|FG006|Induction|Refusal of further protocol therapy|0|||
149766260|NCT02883049|540272651|FG007|Induction|Refusal of further protocol therapy|0|||
149766261|NCT02883049|540272652|FG008|Induction|Refusal of further protocol therapy|0|||
149766262|NCT02883049|540272653|FG009|Induction|Refusal of further protocol therapy|0|||
149766263|NCT02883049|540272654|FG010|Induction|Refusal of further protocol therapy|0|||
149766264|NCT02883049|540272655|FG011|Induction|Refusal of further protocol therapy|0|||
149766265|NCT02883049|540272656|FG012|Induction|Refusal of further protocol therapy|0|||
149766266|NCT02883049|540272657|FG013|Induction|Refusal of further protocol therapy|0|||
149766267|NCT02883049|540272658|FG014|Induction|Refusal of further protocol therapy|0|||
149766268|NCT02883049|540272659|FG015|Induction|Refusal of further protocol therapy|0|||
149766269|NCT02883049|540272644|FG000|Induction|Identified as Ph+ patients|279|||
149766270|NCT02883049|540272645|FG001|Induction|Identified as Ph+ patients|1|||
149766271|NCT02883049|540272646|FG002|Induction|Identified as Ph+ patients|0|||
149766272|NCT02883049|540272647|FG003|Induction|Identified as Ph+ patients|0|||
149766273|NCT02883049|540272648|FG004|Induction|Identified as Ph+ patients|0|||
149766274|NCT02883049|540272649|FG005|Induction|Identified as Ph+ patients|0|||
149766275|NCT02883049|540272650|FG006|Induction|Identified as Ph+ patients|0|||
149766276|NCT02883049|540272651|FG007|Induction|Identified as Ph+ patients|0|||
149766277|NCT02883049|540272652|FG008|Induction|Identified as Ph+ patients|0|||
149766278|NCT02883049|540272653|FG009|Induction|Identified as Ph+ patients|0|||
149766279|NCT02883049|540272654|FG010|Induction|Identified as Ph+ patients|0|||
149766280|NCT02883049|540272655|FG011|Induction|Identified as Ph+ patients|0|||
149766281|NCT02883049|540272656|FG012|Induction|Identified as Ph+ patients|0|||
149766282|NCT02883049|540272657|FG013|Induction|Identified as Ph+ patients|0|||
149766283|NCT02883049|540272658|FG014|Induction|Identified as Ph+ patients|0|||
149766284|NCT02883049|540272659|FG015|Induction|Identified as Ph+ patients|0|||
149766285|NCT02883049|540272644|FG000|Induction|M3 Marrow at Day29|8|||
149766286|NCT02883049|540272645|FG001|Induction|M3 Marrow at Day29|1|||
149766287|NCT02883049|540272646|FG002|Induction|M3 Marrow at Day29|0|||
149766288|NCT02883049|540272647|FG003|Induction|M3 Marrow at Day29|0|||
149766289|NCT02883049|540272648|FG004|Induction|M3 Marrow at Day29|0|||
149766290|NCT02883049|540272649|FG005|Induction|M3 Marrow at Day29|0|||
149766291|NCT02883049|540272650|FG006|Induction|M3 Marrow at Day29|0|||
149766292|NCT02883049|540272651|FG007|Induction|M3 Marrow at Day29|0|||
149766293|NCT02883049|540272652|FG008|Induction|M3 Marrow at Day29|0|||
149766294|NCT02883049|540272653|FG009|Induction|M3 Marrow at Day29|0|||
149766295|NCT02883049|540272654|FG010|Induction|M3 Marrow at Day29|0|||
149766296|NCT02883049|540272655|FG011|Induction|M3 Marrow at Day29|0|||
149766297|NCT02883049|540272656|FG012|Induction|M3 Marrow at Day29|0|||
149766298|NCT02883049|540272657|FG013|Induction|M3 Marrow at Day29|0|||
149766299|NCT02883049|540272658|FG014|Induction|M3 Marrow at Day29|0|||
149766300|NCT02883049|540272659|FG015|Induction|M3 Marrow at Day29|0|||
149766301|NCT02883049|540272644|FG000|Induction|Inevaluable|33|||
149766302|NCT02883049|540272645|FG001|Induction|Inevaluable|1|||
149766303|NCT02883049|540272646|FG002|Induction|Inevaluable|0|||
149766304|NCT02883049|540272647|FG003|Induction|Inevaluable|0|||
149766305|NCT02883049|540272648|FG004|Induction|Inevaluable|0|||
149766306|NCT02883049|540272649|FG005|Induction|Inevaluable|0|||
149766307|NCT02883049|540272650|FG006|Induction|Inevaluable|0|||
149766308|NCT02883049|540272651|FG007|Induction|Inevaluable|0|||
149766309|NCT02883049|540272652|FG008|Induction|Inevaluable|0|||
149766310|NCT02883049|540272653|FG009|Induction|Inevaluable|0|||
149766311|NCT02883049|540272654|FG010|Induction|Inevaluable|0|||
149766312|NCT02883049|540272655|FG011|Induction|Inevaluable|0|||
149766313|NCT02883049|540272656|FG012|Induction|Inevaluable|0|||
149766314|NCT02883049|540272657|FG013|Induction|Inevaluable|0|||
149766315|NCT02883049|540272658|FG014|Induction|Inevaluable|0|||
149766316|NCT02883049|540272659|FG015|Induction|Inevaluable|0|||
149766317|NCT02883049|540272644|FG000|Induction|Identified as VHR at end of Induction|244|||
149766318|NCT02883049|540272645|FG001|Induction|Identified as VHR at end of Induction|0|||
149766319|NCT02883049|540272646|FG002|Induction|Identified as VHR at end of Induction|0|||
149766320|NCT02883049|540272647|FG003|Induction|Identified as VHR at end of Induction|0|||
149766321|NCT02883049|540272648|FG004|Induction|Identified as VHR at end of Induction|0|||
149766322|NCT02883049|540272649|FG005|Induction|Identified as VHR at end of Induction|0|||
149766323|NCT02883049|540272650|FG006|Induction|Identified as VHR at end of Induction|0|||
149766324|NCT02883049|540272651|FG007|Induction|Identified as VHR at end of Induction|0|||
149766325|NCT02883049|540272652|FG008|Induction|Identified as VHR at end of Induction|0|||
149766326|NCT02883049|540272653|FG009|Induction|Identified as VHR at end of Induction|0|||
149766327|NCT02883049|540272654|FG010|Induction|Identified as VHR at end of Induction|0|||
149766328|NCT02883049|540272655|FG011|Induction|Identified as VHR at end of Induction|0|||
149766329|NCT02883049|540272656|FG012|Induction|Identified as VHR at end of Induction|0|||
149766330|NCT02883049|540272657|FG013|Induction|Identified as VHR at end of Induction|0|||
149766331|NCT02883049|540272658|FG014|Induction|Identified as VHR at end of Induction|0|||
149766332|NCT02883049|540272659|FG015|Induction|Identified as VHR at end of Induction|0|||
149766333|NCT02883049|540272644|FG000|Induction|Moved to another non-COG institution|3|||
149766334|NCT02883049|540272645|FG001|Induction|Moved to another non-COG institution|0|||
149766335|NCT02883049|540272646|FG002|Induction|Moved to another non-COG institution|0|||
149766336|NCT02883049|540272647|FG003|Induction|Moved to another non-COG institution|0|||
149766337|NCT02883049|540272648|FG004|Induction|Moved to another non-COG institution|0|||
149766338|NCT02883049|540272649|FG005|Induction|Moved to another non-COG institution|0|||
149766339|NCT02883049|540272650|FG006|Induction|Moved to another non-COG institution|0|||
149766340|NCT02883049|540272651|FG007|Induction|Moved to another non-COG institution|0|||
149766341|NCT02883049|540272652|FG008|Induction|Moved to another non-COG institution|0|||
149766342|NCT02883049|540272653|FG009|Induction|Moved to another non-COG institution|0|||
149766343|NCT02883049|540272654|FG010|Induction|Moved to another non-COG institution|0|||
149766344|NCT02883049|540272655|FG011|Induction|Moved to another non-COG institution|0|||
149766345|NCT02883049|540272656|FG012|Induction|Moved to another non-COG institution|0|||
149766346|NCT02883049|540272657|FG013|Induction|Moved to another non-COG institution|0|||
149766347|NCT02883049|540272658|FG014|Induction|Moved to another non-COG institution|0|||
149766348|NCT02883049|540272659|FG015|Induction|Moved to another non-COG institution|0|||
149766349|NCT02883049|540272644|FG000|Induction|Randomization closed|41|||
149766350|NCT02883049|540272645|FG001|Induction|Randomization closed|0|||
149766351|NCT02883049|540272646|FG002|Induction|Randomization closed|0|||
149766352|NCT02883049|540272647|FG003|Induction|Randomization closed|0|||
149766353|NCT02883049|540272648|FG004|Induction|Randomization closed|0|||
149766354|NCT02883049|540272649|FG005|Induction|Randomization closed|0|||
149766355|NCT02883049|540272650|FG006|Induction|Randomization closed|0|||
149766356|NCT02883049|540272651|FG007|Induction|Randomization closed|0|||
149766357|NCT02883049|540272652|FG008|Induction|Randomization closed|0|||
149766358|NCT02883049|540272653|FG009|Induction|Randomization closed|0|||
149766359|NCT02883049|540272654|FG010|Induction|Randomization closed|0|||
149766360|NCT02883049|540272655|FG011|Induction|Randomization closed|0|||
149766361|NCT02883049|540272656|FG012|Induction|Randomization closed|0|||
149766362|NCT02883049|540272657|FG013|Induction|Randomization closed|0|||
149766363|NCT02883049|540272658|FG014|Induction|Randomization closed|0|||
149766364|NCT02883049|540272659|FG015|Induction|Randomization closed|0|||
149766365|NCT02883049|540272644|FG000|Induction|MRD negative|36|||
149766366|NCT02883049|540272645|FG001|Induction|MRD negative|0|||
149766367|NCT02883049|540272646|FG002|Induction|MRD negative|0|||
149766368|NCT02883049|540272647|FG003|Induction|MRD negative|0|||
149766369|NCT02883049|540272648|FG004|Induction|MRD negative|0|||
149766370|NCT02883049|540272649|FG005|Induction|MRD negative|0|||
149766371|NCT02883049|540272650|FG006|Induction|MRD negative|0|||
149766372|NCT02883049|540272651|FG007|Induction|MRD negative|0|||
149766373|NCT02883049|540272652|FG008|Induction|MRD negative|0|||
149766374|NCT02883049|540272653|FG009|Induction|MRD negative|0|||
149766375|NCT02883049|540272654|FG010|Induction|MRD negative|0|||
149766376|NCT02883049|540272655|FG011|Induction|MRD negative|0|||
149766377|NCT02883049|540272656|FG012|Induction|MRD negative|0|||
149766378|NCT02883049|540272657|FG013|Induction|MRD negative|0|||
149766379|NCT02883049|540272658|FG014|Induction|MRD negative|0|||
149766380|NCT02883049|540272659|FG015|Induction|MRD negative|0|||
149766381|NCT02883049|540272644|FG000|Induction|Identified as HR patients|165|||
149766382|NCT02883049|540272645|FG001|Induction|Identified as HR patients|0|||
149766383|NCT02883049|540272646|FG002|Induction|Identified as HR patients|0|||
149766384|NCT02883049|540272647|FG003|Induction|Identified as HR patients|0|||
149766385|NCT02883049|540272648|FG004|Induction|Identified as HR patients|0|||
149766386|NCT02883049|540272649|FG005|Induction|Identified as HR patients|0|||
149766387|NCT02883049|540272650|FG006|Induction|Identified as HR patients|0|||
149766388|NCT02883049|540272651|FG007|Induction|Identified as HR patients|0|||
149766389|NCT02883049|540272652|FG008|Induction|Identified as HR patients|0|||
149766390|NCT02883049|540272653|FG009|Induction|Identified as HR patients|0|||
149766391|NCT02883049|540272654|FG010|Induction|Identified as HR patients|0|||
149766392|NCT02883049|540272655|FG011|Induction|Identified as HR patients|0|||
149766393|NCT02883049|540272656|FG012|Induction|Identified as HR patients|0|||
149766394|NCT02883049|540272657|FG013|Induction|Identified as HR patients|0|||
149766395|NCT02883049|540272658|FG014|Induction|Identified as HR patients|0|||
149766396|NCT02883049|540272659|FG015|Induction|Identified as HR patients|0|||
149766397|NCT02883049|540272644|FG000|Induction|Developed SMN|0|||
149766398|NCT02883049|540272645|FG001|Induction|Developed SMN|1|||
149766399|NCT02883049|540272646|FG002|Induction|Developed SMN|0|||
149766400|NCT02883049|540272647|FG003|Induction|Developed SMN|0|||
149766401|NCT02883049|540272648|FG004|Induction|Developed SMN|0|||
149766402|NCT02883049|540272649|FG005|Induction|Developed SMN|0|||
149766403|NCT02883049|540272650|FG006|Induction|Developed SMN|0|||
149766404|NCT02883049|540272651|FG007|Induction|Developed SMN|0|||
149766405|NCT02883049|540272652|FG008|Induction|Developed SMN|0|||
149766406|NCT02883049|540272653|FG009|Induction|Developed SMN|0|||
149766407|NCT02883049|540272654|FG010|Induction|Developed SMN|0|||
149766408|NCT02883049|540272655|FG011|Induction|Developed SMN|0|||
149766409|NCT02883049|540272656|FG012|Induction|Developed SMN|0|||
149766410|NCT02883049|540272657|FG013|Induction|Developed SMN|0|||
149766411|NCT02883049|540272658|FG014|Induction|Developed SMN|0|||
149766412|NCT02883049|540272659|FG015|Induction|Developed SMN|0|||
149766413|NCT02883049|540272644|FG000|Induction|Enrolled onto another COG study|72|||
149766414|NCT02883049|540272645|FG001|Induction|Enrolled onto another COG study|0|||
149766415|NCT02883049|540272646|FG002|Induction|Enrolled onto another COG study|0|||
149766416|NCT02883049|540272647|FG003|Induction|Enrolled onto another COG study|0|||
149766417|NCT02883049|540272648|FG004|Induction|Enrolled onto another COG study|0|||
149766418|NCT02883049|540272649|FG005|Induction|Enrolled onto another COG study|0|||
149766419|NCT02883049|540272650|FG006|Induction|Enrolled onto another COG study|0|||
149766420|NCT02883049|540272651|FG007|Induction|Enrolled onto another COG study|0|||
149766421|NCT02883049|540272652|FG008|Induction|Enrolled onto another COG study|0|||
149766422|NCT02883049|540272653|FG009|Induction|Enrolled onto another COG study|0|||
149766423|NCT02883049|540272654|FG010|Induction|Enrolled onto another COG study|0|||
149766424|NCT02883049|540272655|FG011|Induction|Enrolled onto another COG study|0|||
149766425|NCT02883049|540272656|FG012|Induction|Enrolled onto another COG study|0|||
149766426|NCT02883049|540272657|FG013|Induction|Enrolled onto another COG study|0|||
149766427|NCT02883049|540272658|FG014|Induction|Enrolled onto another COG study|0|||
149766428|NCT02883049|540272659|FG015|Induction|Enrolled onto another COG study|0|||
149766429|NCT02883049|540272644|FG000|Induction|Incomplete induction data|17|||
149766430|NCT02883049|540272645|FG001|Induction|Incomplete induction data|0|||
149766431|NCT02883049|540272646|FG002|Induction|Incomplete induction data|0|||
149766432|NCT02883049|540272647|FG003|Induction|Incomplete induction data|0|||
149766433|NCT02883049|540272648|FG004|Induction|Incomplete induction data|0|||
149766434|NCT02883049|540272649|FG005|Induction|Incomplete induction data|0|||
149766435|NCT02883049|540272650|FG006|Induction|Incomplete induction data|0|||
149766436|NCT02883049|540272651|FG007|Induction|Incomplete induction data|0|||
149766437|NCT02883049|540272652|FG008|Induction|Incomplete induction data|0|||
149766438|NCT02883049|540272653|FG009|Induction|Incomplete induction data|0|||
149766439|NCT02883049|540272654|FG010|Induction|Incomplete induction data|0|||
149766440|NCT02883049|540272655|FG011|Induction|Incomplete induction data|0|||
149766441|NCT02883049|540272656|FG012|Induction|Incomplete induction data|0|||
149766442|NCT02883049|540272657|FG013|Induction|Incomplete induction data|0|||
149766443|NCT02883049|540272658|FG014|Induction|Incomplete induction data|0|||
149766444|NCT02883049|540272659|FG015|Induction|Incomplete induction data|0|||
149766445|NCT02883049|540272644|FG000|Post Induction|Adverse Event|0|||
149766446|NCT02883049|540272645|FG001|Post Induction|Adverse Event|0|||
149766447|NCT02883049|540272646|FG002|Post Induction|Adverse Event|0|||
149766448|NCT02883049|540272647|FG003|Post Induction|Adverse Event|7|||
149766449|NCT02883049|540272648|FG004|Post Induction|Adverse Event|8|||
149766450|NCT02883049|540272649|FG005|Post Induction|Adverse Event|3|||
149766451|NCT02883049|540272650|FG006|Post Induction|Adverse Event|4|||
149766452|NCT02883049|540272651|FG007|Post Induction|Adverse Event|5|||
149766453|NCT02883049|540272652|FG008|Post Induction|Adverse Event|6|||
149766454|NCT02883049|540272653|FG009|Post Induction|Adverse Event|7|||
149766455|NCT02883049|540272654|FG010|Post Induction|Adverse Event|2|||
149766456|NCT02883049|540272655|FG011|Post Induction|Adverse Event|2|||
149766457|NCT02883049|540272656|FG012|Post Induction|Adverse Event|0|||
149766458|NCT02883049|540272657|FG013|Post Induction|Adverse Event|0|||
149766459|NCT02883049|540272658|FG014|Post Induction|Adverse Event|5|||
149766460|NCT02883049|540272659|FG015|Post Induction|Adverse Event|2|||
149766461|NCT02883049|540272644|FG000|Post Induction|Death|0|||
149766462|NCT02883049|540272645|FG001|Post Induction|Death|0|||
149766463|NCT02883049|540272646|FG002|Post Induction|Death|0|||
149766464|NCT02883049|540272647|FG003|Post Induction|Death|9|||
149766465|NCT02883049|540272648|FG004|Post Induction|Death|9|||
149766466|NCT02883049|540272649|FG005|Post Induction|Death|0|||
149766467|NCT02883049|540272650|FG006|Post Induction|Death|1|||
149766468|NCT02883049|540272651|FG007|Post Induction|Death|6|||
149766469|NCT02883049|540272652|FG008|Post Induction|Death|5|||
149766470|NCT02883049|540272653|FG009|Post Induction|Death|3|||
149766471|NCT02883049|540272654|FG010|Post Induction|Death|1|||
149766472|NCT02883049|540272655|FG011|Post Induction|Death|0|||
149766473|NCT02883049|540272656|FG012|Post Induction|Death|1|||
149766474|NCT02883049|540272657|FG013|Post Induction|Death|1|||
149766475|NCT02883049|540272658|FG014|Post Induction|Death|10|||
149766476|NCT02883049|540272659|FG015|Post Induction|Death|2|||
149766477|NCT02883049|540272644|FG000|Post Induction|Lost to Follow-up|0|||
149766478|NCT02883049|540272645|FG001|Post Induction|Lost to Follow-up|0|||
149766479|NCT02883049|540272646|FG002|Post Induction|Lost to Follow-up|0|||
149766480|NCT02883049|540272647|FG003|Post Induction|Lost to Follow-up|0|||
149766481|NCT02883049|540272648|FG004|Post Induction|Lost to Follow-up|1|||
149766482|NCT02883049|540272649|FG005|Post Induction|Lost to Follow-up|1|||
149766483|NCT02883049|540272650|FG006|Post Induction|Lost to Follow-up|0|||
149766484|NCT02883049|540272651|FG007|Post Induction|Lost to Follow-up|0|||
149766485|NCT02883049|540272652|FG008|Post Induction|Lost to Follow-up|3|||
149766486|NCT02883049|540272653|FG009|Post Induction|Lost to Follow-up|0|||
149766487|NCT02883049|540272654|FG010|Post Induction|Lost to Follow-up|1|||
149766488|NCT02883049|540272655|FG011|Post Induction|Lost to Follow-up|0|||
149766489|NCT02883049|540272656|FG012|Post Induction|Lost to Follow-up|0|||
149766490|NCT02883049|540272657|FG013|Post Induction|Lost to Follow-up|0|||
149766491|NCT02883049|540272658|FG014|Post Induction|Lost to Follow-up|0|||
149766492|NCT02883049|540272659|FG015|Post Induction|Lost to Follow-up|0|||
149766493|NCT02883049|540272644|FG000|Post Induction|Physician Decision|0|||
149766494|NCT02883049|540272645|FG001|Post Induction|Physician Decision|0|||
149766495|NCT02883049|540272646|FG002|Post Induction|Physician Decision|0|||
149766496|NCT02883049|540272647|FG003|Post Induction|Physician Decision|27|||
149766497|NCT02883049|540272648|FG004|Post Induction|Physician Decision|27|||
149766498|NCT02883049|540272649|FG005|Post Induction|Physician Decision|23|||
149766499|NCT02883049|540272650|FG006|Post Induction|Physician Decision|30|||
149766500|NCT02883049|540272651|FG007|Post Induction|Physician Decision|56|||
149766501|NCT02883049|540272652|FG008|Post Induction|Physician Decision|85|||
149766502|NCT02883049|540272653|FG009|Post Induction|Physician Decision|12|||
149766503|NCT02883049|540272654|FG010|Post Induction|Physician Decision|5|||
149766504|NCT02883049|540272655|FG011|Post Induction|Physician Decision|14|||
149766505|NCT02883049|540272656|FG012|Post Induction|Physician Decision|1|||
149766506|NCT02883049|540272657|FG013|Post Induction|Physician Decision|11|||
149766507|NCT02883049|540272658|FG014|Post Induction|Physician Decision|19|||
149766508|NCT02883049|540272659|FG015|Post Induction|Physician Decision|5|||
149766509|NCT02883049|540272644|FG000|Post Induction|Protocol Violation|0|||
149766510|NCT02883049|540272645|FG001|Post Induction|Protocol Violation|0|||
149766511|NCT02883049|540272646|FG002|Post Induction|Protocol Violation|0|||
149766512|NCT02883049|540272647|FG003|Post Induction|Protocol Violation|0|||
149766513|NCT02883049|540272648|FG004|Post Induction|Protocol Violation|0|||
149766514|NCT02883049|540272649|FG005|Post Induction|Protocol Violation|0|||
149766515|NCT02883049|540272650|FG006|Post Induction|Protocol Violation|0|||
149766516|NCT02883049|540272651|FG007|Post Induction|Protocol Violation|1|||
149766517|NCT02883049|540272652|FG008|Post Induction|Protocol Violation|0|||
149766518|NCT02883049|540272653|FG009|Post Induction|Protocol Violation|0|||
149766519|NCT02883049|540272654|FG010|Post Induction|Protocol Violation|0|||
149766520|NCT02883049|540272655|FG011|Post Induction|Protocol Violation|0|||
149766521|NCT02883049|540272656|FG012|Post Induction|Protocol Violation|0|||
149766522|NCT02883049|540272657|FG013|Post Induction|Protocol Violation|0|||
149766523|NCT02883049|540272658|FG014|Post Induction|Protocol Violation|0|||
149766524|NCT02883049|540272659|FG015|Post Induction|Protocol Violation|0|||
149766525|NCT02883049|540272644|FG000|Post Induction|Withdrawal by Subject|0|||
149766526|NCT02883049|540272645|FG001|Post Induction|Withdrawal by Subject|0|||
149766527|NCT02883049|540272646|FG002|Post Induction|Withdrawal by Subject|0|||
149766528|NCT02883049|540272647|FG003|Post Induction|Withdrawal by Subject|5|||
149766529|NCT02883049|540272648|FG004|Post Induction|Withdrawal by Subject|2|||
149766530|NCT02883049|540272649|FG005|Post Induction|Withdrawal by Subject|1|||
149766531|NCT02883049|540272650|FG006|Post Induction|Withdrawal by Subject|0|||
149766532|NCT02883049|540272651|FG007|Post Induction|Withdrawal by Subject|0|||
149766533|NCT02883049|540272652|FG008|Post Induction|Withdrawal by Subject|2|||
149766534|NCT02883049|540272653|FG009|Post Induction|Withdrawal by Subject|0|||
149766535|NCT02883049|540272654|FG010|Post Induction|Withdrawal by Subject|1|||
149766536|NCT02883049|540272655|FG011|Post Induction|Withdrawal by Subject|1|||
149766537|NCT02883049|540272656|FG012|Post Induction|Withdrawal by Subject|0|||
149766538|NCT02883049|540272657|FG013|Post Induction|Withdrawal by Subject|0|||
149766539|NCT02883049|540272658|FG014|Post Induction|Withdrawal by Subject|1|||
149766540|NCT02883049|540272659|FG015|Post Induction|Withdrawal by Subject|0|||
149766541|NCT02883049|540272644|FG000|Post Induction|Ineligible|0|||
149766542|NCT02883049|540272645|FG001|Post Induction|Ineligible|0|||
149766543|NCT02883049|540272646|FG002|Post Induction|Ineligible|2|||
149766544|NCT02883049|540272647|FG003|Post Induction|Ineligible|0|||
149766545|NCT02883049|540272648|FG004|Post Induction|Ineligible|0|||
149766546|NCT02883049|540272649|FG005|Post Induction|Ineligible|0|||
149766547|NCT02883049|540272650|FG006|Post Induction|Ineligible|1|||
149766548|NCT02883049|540272651|FG007|Post Induction|Ineligible|0|||
149766549|NCT02883049|540272652|FG008|Post Induction|Ineligible|0|||
149766550|NCT02883049|540272653|FG009|Post Induction|Ineligible|0|||
149766551|NCT02883049|540272654|FG010|Post Induction|Ineligible|1|||
149766552|NCT02883049|540272655|FG011|Post Induction|Ineligible|0|||
149766553|NCT02883049|540272656|FG012|Post Induction|Ineligible|0|||
149766554|NCT02883049|540272657|FG013|Post Induction|Ineligible|0|||
149766555|NCT02883049|540272658|FG014|Post Induction|Ineligible|0|||
149766556|NCT02883049|540272659|FG015|Post Induction|Ineligible|1|||
149766557|NCT02883049|540272644|FG000|Post Induction|Refusal of further protocol therapy|0|||
149766558|NCT02883049|540272645|FG001|Post Induction|Refusal of further protocol therapy|0|||
149766559|NCT02883049|540272646|FG002|Post Induction|Refusal of further protocol therapy|0|||
149766560|NCT02883049|540272647|FG003|Post Induction|Refusal of further protocol therapy|11|||
149766561|NCT02883049|540272648|FG004|Post Induction|Refusal of further protocol therapy|15|||
149766562|NCT02883049|540272649|FG005|Post Induction|Refusal of further protocol therapy|9|||
149766563|NCT02883049|540272650|FG006|Post Induction|Refusal of further protocol therapy|13|||
149766564|NCT02883049|540272651|FG007|Post Induction|Refusal of further protocol therapy|5|||
149766565|NCT02883049|540272652|FG008|Post Induction|Refusal of further protocol therapy|21|||
149766566|NCT02883049|540272653|FG009|Post Induction|Refusal of further protocol therapy|7|||
149766567|NCT02883049|540272654|FG010|Post Induction|Refusal of further protocol therapy|0|||
149766568|NCT02883049|540272655|FG011|Post Induction|Refusal of further protocol therapy|7|||
149766569|NCT02883049|540272656|FG012|Post Induction|Refusal of further protocol therapy|3|||
149766570|NCT02883049|540272657|FG013|Post Induction|Refusal of further protocol therapy|0|||
149766571|NCT02883049|540272658|FG014|Post Induction|Refusal of further protocol therapy|4|||
149766572|NCT02883049|540272659|FG015|Post Induction|Refusal of further protocol therapy|1|||
149766573|NCT02883049|540272644|FG000|Post Induction|Inevaluable|0|||
149766574|NCT02883049|540272645|FG001|Post Induction|Inevaluable|0|||
149766575|NCT02883049|540272646|FG002|Post Induction|Inevaluable|0|||
149766576|NCT02883049|540272647|FG003|Post Induction|Inevaluable|1|||
149766577|NCT02883049|540272648|FG004|Post Induction|Inevaluable|1|||
149766578|NCT02883049|540272649|FG005|Post Induction|Inevaluable|2|||
149766579|NCT02883049|540272650|FG006|Post Induction|Inevaluable|7|||
149766580|NCT02883049|540272651|FG007|Post Induction|Inevaluable|6|||
149766581|NCT02883049|540272652|FG008|Post Induction|Inevaluable|4|||
149766582|NCT02883049|540272653|FG009|Post Induction|Inevaluable|4|||
149766583|NCT02883049|540272654|FG010|Post Induction|Inevaluable|1|||
149766584|NCT02883049|540272655|FG011|Post Induction|Inevaluable|1|||
149766585|NCT02883049|540272656|FG012|Post Induction|Inevaluable|2|||
149766586|NCT02883049|540272657|FG013|Post Induction|Inevaluable|0|||
149766587|NCT02883049|540272658|FG014|Post Induction|Inevaluable|0|||
149766588|NCT02883049|540272659|FG015|Post Induction|Inevaluable|1|||
149766589|NCT02883049|540272644|FG000|Post Induction|Moved to another non-COG institution|0|||
149766590|NCT02883049|540272645|FG001|Post Induction|Moved to another non-COG institution|0|||
149766591|NCT02883049|540272646|FG002|Post Induction|Moved to another non-COG institution|0|||
149766592|NCT02883049|540272647|FG003|Post Induction|Moved to another non-COG institution|0|||
149766593|NCT02883049|540272648|FG004|Post Induction|Moved to another non-COG institution|0|||
149766594|NCT02883049|540272649|FG005|Post Induction|Moved to another non-COG institution|0|||
149766595|NCT02883049|540272650|FG006|Post Induction|Moved to another non-COG institution|0|||
149766596|NCT02883049|540272651|FG007|Post Induction|Moved to another non-COG institution|2|||
149766597|NCT02883049|540272652|FG008|Post Induction|Moved to another non-COG institution|2|||
149766598|NCT02883049|540272653|FG009|Post Induction|Moved to another non-COG institution|0|||
149766599|NCT02883049|540272654|FG010|Post Induction|Moved to another non-COG institution|0|||
149766600|NCT02883049|540272655|FG011|Post Induction|Moved to another non-COG institution|1|||
149766601|NCT02883049|540272656|FG012|Post Induction|Moved to another non-COG institution|0|||
149766602|NCT02883049|540272657|FG013|Post Induction|Moved to another non-COG institution|0|||
149766603|NCT02883049|540272658|FG014|Post Induction|Moved to another non-COG institution|0|||
149766604|NCT02883049|540272659|FG015|Post Induction|Moved to another non-COG institution|0|||
149766605|NCT02883049|540272644|FG000|Post Induction|Randomization closed|0|||
149766606|NCT02883049|540272645|FG001|Post Induction|Randomization closed|0|||
149766607|NCT02883049|540272646|FG002|Post Induction|Randomization closed|0|||
149766608|NCT02883049|540272647|FG003|Post Induction|Randomization closed|0|||
149766609|NCT02883049|540272648|FG004|Post Induction|Randomization closed|0|||
149766610|NCT02883049|540272649|FG005|Post Induction|Randomization closed|0|||
149766611|NCT02883049|540272650|FG006|Post Induction|Randomization closed|0|||
149766612|NCT02883049|540272651|FG007|Post Induction|Randomization closed|20|||
149766613|NCT02883049|540272652|FG008|Post Induction|Randomization closed|0|||
149766614|NCT02883049|540272653|FG009|Post Induction|Randomization closed|0|||
149766615|NCT02883049|540272654|FG010|Post Induction|Randomization closed|0|||
149766616|NCT02883049|540272655|FG011|Post Induction|Randomization closed|0|||
149766617|NCT02883049|540272656|FG012|Post Induction|Randomization closed|0|||
149766618|NCT02883049|540272657|FG013|Post Induction|Randomization closed|0|||
149766619|NCT02883049|540272658|FG014|Post Induction|Randomization closed|0|||
149766620|NCT02883049|540272659|FG015|Post Induction|Randomization closed|0|||
149766621|NCT02883049|540272644|FG000|Post Induction|MRD negative|0|||
149766622|NCT02883049|540272645|FG001|Post Induction|MRD negative|0|||
149766623|NCT02883049|540272646|FG002|Post Induction|MRD negative|0|||
149766624|NCT02883049|540272647|FG003|Post Induction|MRD negative|0|||
149766625|NCT02883049|540272648|FG004|Post Induction|MRD negative|0|||
149766626|NCT02883049|540272649|FG005|Post Induction|MRD negative|0|||
149766627|NCT02883049|540272650|FG006|Post Induction|MRD negative|0|||
149766628|NCT02883049|540272651|FG007|Post Induction|MRD negative|11|||
149766629|NCT02883049|540272652|FG008|Post Induction|MRD negative|0|||
149766630|NCT02883049|540272653|FG009|Post Induction|MRD negative|0|||
149766631|NCT02883049|540272654|FG010|Post Induction|MRD negative|0|||
149766632|NCT02883049|540272655|FG011|Post Induction|MRD negative|0|||
149766633|NCT02883049|540272656|FG012|Post Induction|MRD negative|0|||
149766634|NCT02883049|540272657|FG013|Post Induction|MRD negative|0|||
149766635|NCT02883049|540272658|FG014|Post Induction|MRD negative|0|||
149766636|NCT02883049|540272659|FG015|Post Induction|MRD negative|0|||
149766637|NCT02883049|540272644|FG000|Post Induction|Developed SMN|0|||
149766638|NCT02883049|540272645|FG001|Post Induction|Developed SMN|0|||
149766639|NCT02883049|540272646|FG002|Post Induction|Developed SMN|0|||
149766640|NCT02883049|540272647|FG003|Post Induction|Developed SMN|0|||
149766641|NCT02883049|540272648|FG004|Post Induction|Developed SMN|1|||
149766642|NCT02883049|540272649|FG005|Post Induction|Developed SMN|0|||
149766643|NCT02883049|540272650|FG006|Post Induction|Developed SMN|1|||
149766644|NCT02883049|540272651|FG007|Post Induction|Developed SMN|0|||
149766645|NCT02883049|540272652|FG008|Post Induction|Developed SMN|0|||
149766646|NCT02883049|540272653|FG009|Post Induction|Developed SMN|0|||
149766647|NCT02883049|540272654|FG010|Post Induction|Developed SMN|1|||
149766648|NCT02883049|540272655|FG011|Post Induction|Developed SMN|1|||
149766649|NCT02883049|540272656|FG012|Post Induction|Developed SMN|0|||
149766650|NCT02883049|540272657|FG013|Post Induction|Developed SMN|0|||
149766651|NCT02883049|540272658|FG014|Post Induction|Developed SMN|1|||
149766652|NCT02883049|540272659|FG015|Post Induction|Developed SMN|0|||
149766653|NCT02883049|540272644|FG000|Post Induction|Enrolled onto another COG study|0|||
149766654|NCT02883049|540272645|FG001|Post Induction|Enrolled onto another COG study|0|||
149766655|NCT02883049|540272646|FG002|Post Induction|Enrolled onto another COG study|0|||
149766656|NCT02883049|540272647|FG003|Post Induction|Enrolled onto another COG study|1|||
149766657|NCT02883049|540272648|FG004|Post Induction|Enrolled onto another COG study|1|||
149766658|NCT02883049|540272649|FG005|Post Induction|Enrolled onto another COG study|0|||
149766659|NCT02883049|540272650|FG006|Post Induction|Enrolled onto another COG study|0|||
149766660|NCT02883049|540272651|FG007|Post Induction|Enrolled onto another COG study|4|||
149766661|NCT02883049|540272652|FG008|Post Induction|Enrolled onto another COG study|0|||
149766662|NCT02883049|540272653|FG009|Post Induction|Enrolled onto another COG study|0|||
149766663|NCT02883049|540272654|FG010|Post Induction|Enrolled onto another COG study|0|||
149766664|NCT02883049|540272655|FG011|Post Induction|Enrolled onto another COG study|2|||
149766665|NCT02883049|540272656|FG012|Post Induction|Enrolled onto another COG study|0|||
149766666|NCT02883049|540272657|FG013|Post Induction|Enrolled onto another COG study|1|||
149766667|NCT02883049|540272658|FG014|Post Induction|Enrolled onto another COG study|0|||
149766668|NCT02883049|540272659|FG015|Post Induction|Enrolled onto another COG study|0|||
149766669|NCT02883049|540272644|FG000|Post Induction|Recurrent leukemia|0|||
149766670|NCT02883049|540272645|FG001|Post Induction|Recurrent leukemia|0|||
149766671|NCT02883049|540272646|FG002|Post Induction|Recurrent leukemia|0|||
149766672|NCT02883049|540272647|FG003|Post Induction|Recurrent leukemia|17|||
149766673|NCT02883049|540272648|FG004|Post Induction|Recurrent leukemia|12|||
149766674|NCT02883049|540272649|FG005|Post Induction|Recurrent leukemia|4|||
149766675|NCT02883049|540272650|FG006|Post Induction|Recurrent leukemia|1|||
149766676|NCT02883049|540272651|FG007|Post Induction|Recurrent leukemia|13|||
149766677|NCT02883049|540272652|FG008|Post Induction|Recurrent leukemia|27|||
149766678|NCT02883049|540272653|FG009|Post Induction|Recurrent leukemia|5|||
149766679|NCT02883049|540272654|FG010|Post Induction|Recurrent leukemia|3|||
149766680|NCT02883049|540272655|FG011|Post Induction|Recurrent leukemia|12|||
149766681|NCT02883049|540272656|FG012|Post Induction|Recurrent leukemia|1|||
149766682|NCT02883049|540272657|FG013|Post Induction|Recurrent leukemia|1|||
149766683|NCT02883049|540272658|FG014|Post Induction|Recurrent leukemia|9|||
149766684|NCT02883049|540272659|FG015|Post Induction|Recurrent leukemia|3|||
149766685|NCT02883049|540272644|FG000|Post Induction|Induction Failure|0|||
149766686|NCT02883049|540272645|FG001|Post Induction|Induction Failure|0|||
149766687|NCT02883049|540272646|FG002|Post Induction|Induction Failure|0|||
149766688|NCT02883049|540272647|FG003|Post Induction|Induction Failure|0|||
149766689|NCT02883049|540272648|FG004|Post Induction|Induction Failure|0|||
149766690|NCT02883049|540272649|FG005|Post Induction|Induction Failure|0|||
149766691|NCT02883049|540272650|FG006|Post Induction|Induction Failure|0|||
149766692|NCT02883049|540272651|FG007|Post Induction|Induction Failure|2|||
149766693|NCT02883049|540272652|FG008|Post Induction|Induction Failure|2|||
149766694|NCT02883049|540272653|FG009|Post Induction|Induction Failure|0|||
149766695|NCT02883049|540272654|FG010|Post Induction|Induction Failure|0|||
149766696|NCT02883049|540272655|FG011|Post Induction|Induction Failure|0|||
149766697|NCT02883049|540272656|FG012|Post Induction|Induction Failure|0|||
149766698|NCT02883049|540272657|FG013|Post Induction|Induction Failure|2|||
149766699|NCT02883049|540272658|FG014|Post Induction|Induction Failure|0|||
149766700|NCT02883049|540272659|FG015|Post Induction|Induction Failure|0|||
149766701|NCT00229203|540272660|FG000|Overall Study|Progressive disease|18|||
149766702|NCT00229203|540272661|FG001|Overall Study|Progressive disease|9|||
149766703|NCT00229203|540272660|FG000|Overall Study|Toxicity|6|||
149766704|NCT00229203|540272661|FG001|Overall Study|Toxicity|1|||
149766705|NCT00229203|540272660|FG000|Overall Study|Death|4|||
149766706|NCT00229203|540272661|FG001|Overall Study|Death|2|||
149766707|NCT00229203|540272660|FG000|Overall Study|Other|3|||
149766708|NCT00229203|540272661|FG001|Overall Study|Other|3|||
149766709|NCT00229203|540272660|FG000|Overall Study|Withdrawal by Subject|1|||
149766710|NCT00229203|540272661|FG001|Overall Study|Withdrawal by Subject|4|||
149766711|NCT03457103|540272662|FG000|Overall Study|illness/hospitalization|4|||
149766712|NCT03457103|540272663|FG001|Overall Study|illness/hospitalization|2|||
149766713|NCT03457103|540272662|FG000|Overall Study|Lost to Follow-up|2|||
149766714|NCT03457103|540272663|FG001|Overall Study|Lost to Follow-up|1|||
149766715|NCT03457103|540272662|FG000|Overall Study|Withdrawal by Subject|1|||
149766716|NCT03457103|540272663|FG001|Overall Study|Withdrawal by Subject|2|||
149766717|NCT03457103|540272662|FG000|Overall Study|financial/ insurance issues|1|||
149766718|NCT03457103|540272663|FG001|Overall Study|financial/ insurance issues|1|||
149766719|NCT03004469|540272664|FG000|Overall Study|Adverse Event|6|||
149766720|NCT03004469|540272665|FG001|Overall Study|Adverse Event|4|||
149766721|NCT03004469|540272666|FG002|Overall Study|Adverse Event|6|||
149766722|NCT03004469|540272664|FG000|Overall Study|Lack of Efficacy|1|||
149766723|NCT03004469|540272665|FG001|Overall Study|Lack of Efficacy|0|||
149766724|NCT03004469|540272666|FG002|Overall Study|Lack of Efficacy|1|||
149766725|NCT03004469|540272664|FG000|Overall Study|Lost to Follow-up|23|||
149766726|NCT03004469|540272665|FG001|Overall Study|Lost to Follow-up|14|||
149766727|NCT03004469|540272666|FG002|Overall Study|Lost to Follow-up|6|||
149766728|NCT03004469|540272664|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149766729|NCT03004469|540272665|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149766730|NCT03004469|540272666|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149766731|NCT03004469|540272664|FG000|Overall Study|Protocol Violation|0|||
149766732|NCT03004469|540272665|FG001|Overall Study|Protocol Violation|0|||
149766733|NCT03004469|540272666|FG002|Overall Study|Protocol Violation|1|||
149766734|NCT03004469|540272664|FG000|Overall Study|Withdrawal by Subject|29|||
149766735|NCT03004469|540272665|FG001|Overall Study|Withdrawal by Subject|27|||
149766736|NCT03004469|540272666|FG002|Overall Study|Withdrawal by Subject|10|||
149766737|NCT03004469|540272664|FG000|Overall Study|Other unspecified reason|0|||
149766738|NCT03004469|540272665|FG001|Overall Study|Other unspecified reason|4|||
149766739|NCT03004469|540272666|FG002|Overall Study|Other unspecified reason|1|||
149766740|NCT01163253|540272667|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
149766741|NCT01163253|540272668|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
149766742|NCT01163253|540272667|FG000|Overall Study|Study Terminated by Sponsor|978|||
149766743|NCT01163253|540272668|FG001|Overall Study|Study Terminated by Sponsor|349|||
149766744|NCT01163253|540272667|FG000|Overall Study|Protocol Violation|43|||
149766745|NCT01163253|540272668|FG001|Overall Study|Protocol Violation|12|||
149766746|NCT01163253|540272667|FG000|Overall Study|Withdrawal by Subject|199|||
149766747|NCT01163253|540272668|FG001|Overall Study|Withdrawal by Subject|50|||
149766748|NCT01163253|540272667|FG000|Overall Study|Medication Error|1|||
149766749|NCT01163253|540272668|FG001|Overall Study|Medication Error|0|||
149766750|NCT01163253|540272667|FG000|Overall Study|Lost to Follow-up|125|||
149766751|NCT01163253|540272668|FG001|Overall Study|Lost to Follow-up|23|||
149766752|NCT01163253|540272667|FG000|Overall Study|Insufficient Clinical Response|423|||
149766753|NCT01163253|540272668|FG001|Overall Study|Insufficient Clinical Response|29|||
149766754|NCT01163253|540272667|FG000|Overall Study|Adverse Event|300|||
149766755|NCT01163253|540272668|FG001|Overall Study|Adverse Event|78|||
149766756|NCT01163253|540272667|FG000|Overall Study|Death|17|||
149766757|NCT01163253|540272668|FG001|Overall Study|Death|5|||
149766758|NCT01163253|540272667|FG000|Overall Study|Ongoing|13|||
149766759|NCT01163253|540272668|FG001|Overall Study|Ongoing|4|||
149766760|NCT01163253|540272667|FG000|Overall Study|Other Unspecified|170|||
149766761|NCT01163253|540272668|FG001|Overall Study|Other Unspecified|34|||
149766762|NCT02492997|540272669|FG000|Overall Study|Withdrawal by Subject|1|||
149766763|NCT02492997|540272670|FG001|Overall Study|Withdrawal by Subject|0|||
149766764|NCT02492997|540272669|FG000|Overall Study|Gained Weight|1|||
149766765|NCT02492997|540272670|FG001|Overall Study|Gained Weight|0|||
149766766|NCT02492997|540272669|FG000|Overall Study|Lost to Follow-up|0|||
149766767|NCT02492997|540272670|FG001|Overall Study|Lost to Follow-up|1|||
149766768|NCT01397552|540272671|FG000|Overall Study|Adverse Event|1|||
149766769|NCT01397552|540272672|FG001|Overall Study|Adverse Event|0|||
149766770|NCT01397552|540272671|FG000|Overall Study|Withdrawal by Subject|2|||
149766771|NCT01397552|540272672|FG001|Overall Study|Withdrawal by Subject|1|||
149766772|NCT00579501|540272678|FG000|Overall Study|Death|1|||
149766773|NCT00579501|540272678|FG000|Overall Study|End of neoadjuvant therapy|25|||
149766774|NCT00579501|540272678|FG000|Overall Study|toxicity|1|||
149766775|NCT00579501|540272678|FG000|Overall Study|Secondary lesion|1|||
149766776|NCT00579501|540272678|FG000|Overall Study|Radiation therapy before surgery|1|||
149766777|NCT00190983|540272679|FG000|Overall Study|Inevaluable (never treated)|2|||
149766778|NCT02287402|540272680|FG000|Treatment Period|Adverse Event|17|||
149766779|NCT02287402|540272680|FG000|Treatment Period|Voluntary Withdrawal|10|||
149766780|NCT02287402|540272680|FG000|Follow-up|Lost to Follow-up|1|||
149766781|NCT02287402|540272680|FG000|Follow-up|Voluntary Withdrawal|2|||
149766782|NCT04069156|540272681|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
149766783|NCT04069156|540272682|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
149766784|NCT04069156|540272681|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
149766785|NCT04069156|540272682|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
149766786|NCT04069156|540272681|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
149766787|NCT04069156|540272682|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
149766788|NCT04069156|540272681|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
149766789|NCT04069156|540272682|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
149766790|NCT04247815|540272683|FG000|Overall Study|Adverse Event|1|||
149766791|NCT04247815|540272684|FG001|Overall Study|Adverse Event|0|||
149766792|NCT04247815|540272683|FG000|Overall Study|Withdrawal by Subject|1|||
149766793|NCT04247815|540272684|FG001|Overall Study|Withdrawal by Subject|0|||
149766794|NCT04247815|540272683|FG000|Overall Study|Protocol Violation|0|||
149766795|NCT04247815|540272684|FG001|Overall Study|Protocol Violation|1|||
149766796|NCT00089479|540272693|FG000|Overall Study|Death|108|||
149766797|NCT00089479|540272694|FG001|Overall Study|Death|75|||
149766798|NCT00089479|540272693|FG000|Overall Study|Withdrawal by Subject|86|||
149766799|NCT00089479|540272694|FG001|Overall Study|Withdrawal by Subject|107|||
149766800|NCT00089479|540272693|FG000|Overall Study|Lost to Follow-up|137|||
149766801|NCT00089479|540272694|FG001|Overall Study|Lost to Follow-up|107|||
149766802|NCT03943953|540272695|FG000|Trial of ITG 1|Lost to Follow-up|19|||
149766803|NCT03943953|540272696|FG001|Trial of ITG 1|Lost to Follow-up|1|||
149766804|NCT03943953|540272695|FG000|Trial of ITG 2|Lost to Follow-up|8|||
149766805|NCT03943953|540272696|FG001|Trial of ITG 2|Lost to Follow-up|0|||
149766806|NCT03943953|540272695|FG000|Trial of ITG 3|Lost to Follow-up|2|||
149766807|NCT03943953|540272696|FG001|Trial of ITG 3|Lost to Follow-up|0|||
149766808|NCT03943953|540272695|FG000|Trial of ITG 4|Lost to Follow-up|2|||
149766809|NCT03943953|540272696|FG001|Trial of ITG 4|Lost to Follow-up|0|||
149766810|NCT00289185|540272699|FG000|Overall Study|Withdrawal by Subject|4|||
149766811|NCT00289185|540272700|FG001|Overall Study|Withdrawal by Subject|8|||
149766812|NCT00289185|540272699|FG000|Overall Study|Lost to Follow-up|23|||
149766813|NCT00289185|540272700|FG001|Overall Study|Lost to Follow-up|17|||
149766814|NCT00289185|540272699|FG000|Overall Study|Death|1|||
149766815|NCT00289185|540272700|FG001|Overall Study|Death|1|||
149766816|NCT01021852|540272703|FG000|Treatment Period 1|Adverse Event|3|||
149766817|NCT01021852|540272704|FG001|Treatment Period 1|Adverse Event|1|||
149766818|NCT01021852|540272705|FG002|Treatment Period 1|Adverse Event|1|||
149766819|NCT01021852|540272706|FG003|Treatment Period 1|Adverse Event|0|||
149766820|NCT01021852|540272707|FG004|Treatment Period 1|Adverse Event|2|||
149766821|NCT01021852|540272708|FG005|Treatment Period 1|Adverse Event|2|||
149766822|NCT01021852|540272709|FG006|Treatment Period 1|Adverse Event|0|||
149766823|NCT01021852|540272710|FG007|Treatment Period 1|Adverse Event|0|||
149766824|NCT01021852|540272703|FG000|Treatment Period 1|Pregnancy|0|||
149766825|NCT01021852|540272704|FG001|Treatment Period 1|Pregnancy|0|||
149766826|NCT01021852|540272705|FG002|Treatment Period 1|Pregnancy|1|||
149766827|NCT01021852|540272706|FG003|Treatment Period 1|Pregnancy|0|||
149766828|NCT01021852|540272707|FG004|Treatment Period 1|Pregnancy|0|||
149766829|NCT01021852|540272708|FG005|Treatment Period 1|Pregnancy|0|||
149766830|NCT01021852|540272709|FG006|Treatment Period 1|Pregnancy|0|||
149766831|NCT01021852|540272710|FG007|Treatment Period 1|Pregnancy|0|||
149766832|NCT01021852|540272703|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149766833|NCT01021852|540272704|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149766834|NCT01021852|540272705|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149766835|NCT01021852|540272706|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149766836|NCT01021852|540272707|FG004|Treatment Period 1|Withdrawal by Subject|1|||
149766837|NCT01021852|540272708|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149766838|NCT01021852|540272709|FG006|Treatment Period 1|Withdrawal by Subject|0|||
149766839|NCT01021852|540272710|FG007|Treatment Period 1|Withdrawal by Subject|1|||
149766840|NCT01021852|540272703|FG000|Treatment Period 1|Not Treated|0|||
149766841|NCT01021852|540272704|FG001|Treatment Period 1|Not Treated|0|||
149766842|NCT01021852|540272705|FG002|Treatment Period 1|Not Treated|0|||
149766843|NCT01021852|540272706|FG003|Treatment Period 1|Not Treated|2|||
149766844|NCT01021852|540272707|FG004|Treatment Period 1|Not Treated|0|||
149766845|NCT01021852|540272708|FG005|Treatment Period 1|Not Treated|0|||
149766846|NCT01021852|540272709|FG006|Treatment Period 1|Not Treated|0|||
149766847|NCT01021852|540272710|FG007|Treatment Period 1|Not Treated|0|||
149766848|NCT01021852|540272703|FG000|Washout Period-Placebo|Adverse Event|0|||
149766849|NCT01021852|540272704|FG001|Washout Period-Placebo|Adverse Event|0|||
149766850|NCT01021852|540272705|FG002|Washout Period-Placebo|Adverse Event|0|||
149766851|NCT01021852|540272706|FG003|Washout Period-Placebo|Adverse Event|1|||
149766852|NCT01021852|540272707|FG004|Washout Period-Placebo|Adverse Event|0|||
149766853|NCT01021852|540272708|FG005|Washout Period-Placebo|Adverse Event|1|||
149766854|NCT01021852|540272709|FG006|Washout Period-Placebo|Adverse Event|0|||
149766855|NCT01021852|540272710|FG007|Washout Period-Placebo|Adverse Event|0|||
149766856|NCT01021852|540272703|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
149766857|NCT01021852|540272704|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
149766858|NCT01021852|540272705|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
149766859|NCT01021852|540272706|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
149766860|NCT01021852|540272707|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
149766861|NCT01021852|540272708|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
149766862|NCT01021852|540272709|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
149766863|NCT01021852|540272710|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
149766864|NCT01021852|540272703|FG000|Washout Period-Placebo|Protocol Violation|0|||
149766865|NCT01021852|540272704|FG001|Washout Period-Placebo|Protocol Violation|0|||
149766866|NCT01021852|540272705|FG002|Washout Period-Placebo|Protocol Violation|0|||
149766867|NCT01021852|540272706|FG003|Washout Period-Placebo|Protocol Violation|0|||
149766868|NCT01021852|540272707|FG004|Washout Period-Placebo|Protocol Violation|0|||
149766869|NCT01021852|540272708|FG005|Washout Period-Placebo|Protocol Violation|0|||
149766870|NCT01021852|540272709|FG006|Washout Period-Placebo|Protocol Violation|1|||
149766871|NCT01021852|540272710|FG007|Washout Period-Placebo|Protocol Violation|0|||
149766872|NCT01021852|540272703|FG000|Washout Period-No Drug|Adverse Event|1|||
149766873|NCT01021852|540272704|FG001|Washout Period-No Drug|Adverse Event|0|||
149766874|NCT01021852|540272705|FG002|Washout Period-No Drug|Adverse Event|0|||
149766875|NCT01021852|540272706|FG003|Washout Period-No Drug|Adverse Event|0|||
149766876|NCT01021852|540272707|FG004|Washout Period-No Drug|Adverse Event|0|||
149766877|NCT01021852|540272708|FG005|Washout Period-No Drug|Adverse Event|1|||
149766878|NCT01021852|540272709|FG006|Washout Period-No Drug|Adverse Event|0|||
149766879|NCT01021852|540272710|FG007|Washout Period-No Drug|Adverse Event|0|||
149766880|NCT01021852|540272703|FG000|Treatment Period 2|Adverse Event|0|||
149766881|NCT01021852|540272704|FG001|Treatment Period 2|Adverse Event|1|||
149766882|NCT01021852|540272705|FG002|Treatment Period 2|Adverse Event|0|||
149766883|NCT01021852|540272706|FG003|Treatment Period 2|Adverse Event|0|||
149766884|NCT01021852|540272707|FG004|Treatment Period 2|Adverse Event|1|||
149766885|NCT01021852|540272708|FG005|Treatment Period 2|Adverse Event|0|||
149766886|NCT01021852|540272709|FG006|Treatment Period 2|Adverse Event|1|||
149766887|NCT01021852|540272710|FG007|Treatment Period 2|Adverse Event|0|||
149766888|NCT01021852|540272703|FG000|Treatment Period 2|Lack of Efficacy|0|||
149766889|NCT01021852|540272704|FG001|Treatment Period 2|Lack of Efficacy|0|||
149766890|NCT01021852|540272705|FG002|Treatment Period 2|Lack of Efficacy|0|||
149766891|NCT01021852|540272706|FG003|Treatment Period 2|Lack of Efficacy|0|||
149766892|NCT01021852|540272707|FG004|Treatment Period 2|Lack of Efficacy|0|||
149766893|NCT01021852|540272708|FG005|Treatment Period 2|Lack of Efficacy|1|||
149766894|NCT01021852|540272709|FG006|Treatment Period 2|Lack of Efficacy|0|||
149766895|NCT01021852|540272710|FG007|Treatment Period 2|Lack of Efficacy|0|||
149766896|NCT01021852|540272703|FG000|Treatment Period 2|Physician Decision|0|||
149766897|NCT01021852|540272704|FG001|Treatment Period 2|Physician Decision|0|||
149766898|NCT01021852|540272705|FG002|Treatment Period 2|Physician Decision|1|||
149766899|NCT01021852|540272706|FG003|Treatment Period 2|Physician Decision|0|||
149766900|NCT01021852|540272707|FG004|Treatment Period 2|Physician Decision|0|||
149766901|NCT01021852|540272708|FG005|Treatment Period 2|Physician Decision|0|||
149766902|NCT01021852|540272709|FG006|Treatment Period 2|Physician Decision|0|||
149766903|NCT01021852|540272710|FG007|Treatment Period 2|Physician Decision|0|||
149766904|NCT01021852|540272703|FG000|Treatment Period 2|Protocol Violation|0|||
149766905|NCT01021852|540272704|FG001|Treatment Period 2|Protocol Violation|0|||
149766906|NCT01021852|540272705|FG002|Treatment Period 2|Protocol Violation|0|||
149766907|NCT01021852|540272706|FG003|Treatment Period 2|Protocol Violation|0|||
149766908|NCT01021852|540272707|FG004|Treatment Period 2|Protocol Violation|1|||
149766909|NCT01021852|540272708|FG005|Treatment Period 2|Protocol Violation|0|||
149766910|NCT01021852|540272709|FG006|Treatment Period 2|Protocol Violation|1|||
149766911|NCT01021852|540272710|FG007|Treatment Period 2|Protocol Violation|0|||
149766912|NCT01021852|540272703|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149766913|NCT01021852|540272704|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149766914|NCT01021852|540272705|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149766915|NCT01021852|540272706|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149766916|NCT01021852|540272707|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149766917|NCT01021852|540272708|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149766918|NCT01021852|540272709|FG006|Treatment Period 2|Withdrawal by Subject|1|||
149766919|NCT01021852|540272710|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149766920|NCT04799405|540272713|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
149766921|NCT00603980|540272714|FG000|Study Qualification|Protocol Violation|3|||
149766922|NCT00603980|540272714|FG000|Study Qualification|Inconsistent data reporting|13|||
149766923|NCT00603980|540272714|FG000|Main Study|14th subject completed trial|1|||
149766924|NCT02618928|540272717|FG000|Overall Study|Failure to Return|28|||
149766925|NCT02618928|540272717|FG000|Overall Study|Insufficient Virological Response|1|||
149766926|NCT02618928|540272717|FG000|Overall Study|Withdrawal by Subject|2|||
149766927|NCT02618928|540272717|FG000|Overall Study|Death|3|||
149766928|NCT02618928|540272717|FG000|Overall Study|Other|11|||
149766929|NCT02618928|540272717|FG000|Overall Study|Missing|6|||
149766930|NCT02618928|540272717|FG000|Overall Study|Treatment Never Started|7|||
149766931|NCT01096849|540272718|FG000|Overall Study|Consent Withdrawn|1|||
149766932|NCT01096849|540272719|FG001|Overall Study|Consent Withdrawn|4|||
149766933|NCT01096849|540272720|FG002|Overall Study|Consent Withdrawn|2|||
149766934|NCT01096849|540272718|FG000|Overall Study|Lack of Efficacy|0|||
149766935|NCT01096849|540272719|FG001|Overall Study|Lack of Efficacy|2|||
149766936|NCT01096849|540272720|FG002|Overall Study|Lack of Efficacy|0|||
149766937|NCT01096849|540272718|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
149766938|NCT01096849|540272719|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
149766939|NCT01096849|540272720|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
149766940|NCT01096849|540272718|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
149766941|NCT01096849|540272719|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
149766942|NCT01096849|540272720|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
149766943|NCT01096849|540272718|FG000|Overall Study|Administrative Reasons|0|||
149766944|NCT01096849|540272719|FG001|Overall Study|Administrative Reasons|1|||
149766945|NCT01096849|540272720|FG002|Overall Study|Administrative Reasons|2|||
149766946|NCT01096849|540272718|FG000|Overall Study|Lost to Follow-up|1|||
149766947|NCT01096849|540272719|FG001|Overall Study|Lost to Follow-up|3|||
149766948|NCT01096849|540272720|FG002|Overall Study|Lost to Follow-up|1|||
149766949|NCT01253421|540272728|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
149766950|NCT01253421|540272729|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
149766951|NCT01253421|540272730|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
149766952|NCT01253421|540272731|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
149766953|NCT01253421|540272732|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
149766954|NCT01253421|540272728|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
149766955|NCT01253421|540272729|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
149766956|NCT01253421|540272730|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
149766957|NCT01253421|540272731|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
149766958|NCT01253421|540272732|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
149766959|NCT01253421|540272728|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
149766960|NCT01253421|540272729|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
149766961|NCT01253421|540272730|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
149766962|NCT01253421|540272731|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
149766963|NCT01253421|540272732|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
149766964|NCT01253421|540272728|FG000|Assessment and Scheduling|Physician Decision|1|||
149766965|NCT01253421|540272729|FG001|Assessment and Scheduling|Physician Decision|0|||
149766966|NCT01253421|540272730|FG002|Assessment and Scheduling|Physician Decision|0|||
149766967|NCT01253421|540272731|FG003|Assessment and Scheduling|Physician Decision|0|||
149766968|NCT01253421|540272732|FG004|Assessment and Scheduling|Physician Decision|0|||
149766969|NCT01253421|540272728|FG000|Drug+Scanning Visit|Physician Decision|0|||
149766970|NCT01253421|540272729|FG001|Drug+Scanning Visit|Physician Decision|0|||
149766971|NCT01253421|540272730|FG002|Drug+Scanning Visit|Physician Decision|0|||
149766972|NCT01253421|540272731|FG003|Drug+Scanning Visit|Physician Decision|0|||
149766973|NCT01253421|540272732|FG004|Drug+Scanning Visit|Physician Decision|1|||
149766974|NCT00264849|540272733|FG000|Overall Study|Adverse Event|7|||
149766975|NCT00264849|540272734|FG001|Overall Study|Adverse Event|2|||
149766976|NCT00264849|540272733|FG000|Overall Study|Withdrawal by Subject|7|||
149766977|NCT00264849|540272734|FG001|Overall Study|Withdrawal by Subject|11|||
149766978|NCT00264849|540272733|FG000|Overall Study|Protocol Violation|5|||
149766979|NCT00264849|540272734|FG001|Overall Study|Protocol Violation|3|||
149766980|NCT00264849|540272733|FG000|Overall Study|Lack of Efficacy|1|||
149766981|NCT00264849|540272734|FG001|Overall Study|Lack of Efficacy|6|||
149766982|NCT00264849|540272733|FG000|Overall Study|Lost to Follow-up|0|||
149766983|NCT00264849|540272734|FG001|Overall Study|Lost to Follow-up|2|||
149766984|NCT00264849|540272733|FG000|Overall Study|Death|0|||
149766985|NCT00264849|540272734|FG001|Overall Study|Death|1|||
149766986|NCT00264849|540272733|FG000|Overall Study|Administrative Problems|2|||
149766987|NCT00264849|540272734|FG001|Overall Study|Administrative Problems|0|||
149766988|NCT00099359|540272735|FG000|Overall Study|Death|11|||
149766989|NCT00099359|540272736|FG001|Overall Study|Death|15|||
149766990|NCT00099359|540272737|FG002|Overall Study|Death|17|||
149766991|NCT00099359|540272735|FG000|Overall Study|Withdrawal by Subject|19|||
149766992|NCT00099359|540272736|FG001|Overall Study|Withdrawal by Subject|19|||
149766993|NCT00099359|540272737|FG002|Overall Study|Withdrawal by Subject|23|||
149766994|NCT00099359|540272735|FG000|Overall Study|Lost to Follow-up|15|||
149766995|NCT00099359|540272736|FG001|Overall Study|Lost to Follow-up|24|||
149766996|NCT00099359|540272737|FG002|Overall Study|Lost to Follow-up|24|||
149766997|NCT00099359|540272735|FG000|Overall Study|moved out of area|9|||
149766998|NCT00099359|540272736|FG001|Overall Study|moved out of area|7|||
149766999|NCT00099359|540272737|FG002|Overall Study|moved out of area|4|||
149767000|NCT02104804|540272738|FG000|Overall Study|Did not take study medication|0|||
149767001|NCT02104804|540272739|FG001|Overall Study|Did not take study medication|1|||
149767002|NCT02104804|540272738|FG000|Overall Study|Study specific discontinuation criteria|6|||
149767003|NCT02104804|540272739|FG001|Overall Study|Study specific discontinuation criteria|1|||
149767004|NCT02104804|540272738|FG000|Overall Study|Other listed|2|||
149767005|NCT02104804|540272739|FG001|Overall Study|Other listed|1|||
149767006|NCT02104804|540272738|FG000|Overall Study|Protocol Violation|0|||
149767007|NCT02104804|540272739|FG001|Overall Study|Protocol Violation|1|||
149767008|NCT02104804|540272738|FG000|Overall Study|Adverse Event|4|||
149767009|NCT02104804|540272739|FG001|Overall Study|Adverse Event|3|||
149767010|NCT02104804|540272738|FG000|Overall Study|Withdrawal by Subject|4|||
149767011|NCT02104804|540272739|FG001|Overall Study|Withdrawal by Subject|12|||
149767012|NCT04501679|540272740|FG000|Overall Study|Pregnancy|0|||
149767013|NCT04501679|540272741|FG001|Overall Study|Pregnancy|1|||
149767014|NCT04501679|540272740|FG000|Overall Study|Adverse Event|4|||
149767015|NCT04501679|540272741|FG001|Overall Study|Adverse Event|2|||
149767016|NCT04501679|540272740|FG000|Overall Study|Withdrawal by Subject|2|||
149767017|NCT04501679|540272741|FG001|Overall Study|Withdrawal by Subject|0|||
149767018|NCT04501679|540272740|FG000|Overall Study|Physician Decision|1|||
149767019|NCT04501679|540272741|FG001|Overall Study|Physician Decision|0|||
149767020|NCT04501679|540272740|FG000|Overall Study|Lost to Follow-up|2|||
149767021|NCT04501679|540272741|FG001|Overall Study|Lost to Follow-up|0|||
149767022|NCT02121756|540272743|FG000|Overall Study|Adverse Event|3|||
149767023|NCT02121756|540272744|FG001|Overall Study|Adverse Event|0|||
149767024|NCT02121756|540272743|FG000|Overall Study|Protocol Violation|1|||
149767025|NCT02121756|540272744|FG001|Overall Study|Protocol Violation|1|||
149767026|NCT02121756|540272743|FG000|Overall Study|Physician Decision|2|||
149767027|NCT02121756|540272744|FG001|Overall Study|Physician Decision|1|||
149767028|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
149767029|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
149767030|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
149767031|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
149767032|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
149767033|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
149767034|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
149767035|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
149767036|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
149767037|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
149767038|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
149767039|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
149767040|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
149767041|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
149767042|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
149767043|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
149767044|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Missing|3|||
149767045|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Missing|1|||
149767046|NCT00838916|540272745|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
149767047|NCT00838916|540272746|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
149767048|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
149767049|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
149767050|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
149767051|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
149767052|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
149767053|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
149767054|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
149767055|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
149767056|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
149767057|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
149767058|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
149767059|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
149767060|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
149767061|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
149767062|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
149767063|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
149767064|NCT00838916|540272745|FG000|Follow-up Period (8 Weeks)|Missing|3|||
149767065|NCT00838916|540272746|FG001|Follow-up Period (8 Weeks)|Missing|0|||
149767066|NCT01927419|540272747|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149767067|NCT01927419|540272748|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
149767068|NCT01927419|540272747|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
149767069|NCT01927419|540272748|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
149767070|NCT01927419|540272747|FG000|Treatment Period|Disease progression|17|||
149767071|NCT01927419|540272748|FG001|Treatment Period|Disease progression|20|||
149767072|NCT01927419|540272747|FG000|Treatment Period|Study drug toxicity|48|||
149767073|NCT01927419|540272748|FG001|Treatment Period|Study drug toxicity|10|||
149767074|NCT01927419|540272747|FG000|Treatment Period|Death|0|||
149767075|NCT01927419|540272748|FG001|Treatment Period|Death|1|||
149767076|NCT01927419|540272747|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
149767077|NCT01927419|540272748|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
149767078|NCT01927419|540272747|FG000|Treatment Period|Participant request to discontinue|12|||
149767079|NCT01927419|540272748|FG001|Treatment Period|Participant request to discontinue|4|||
149767080|NCT01927419|540272747|FG000|Treatment Period|Withdrawal by Subject|1|||
149767081|NCT01927419|540272748|FG001|Treatment Period|Withdrawal by Subject|1|||
149767082|NCT01927419|540272747|FG000|Treatment Period|Maximum Clinical Benefit|6|||
149767083|NCT01927419|540272748|FG001|Treatment Period|Maximum Clinical Benefit|2|||
149767084|NCT01927419|540272747|FG000|Treatment Period|Other reasons|3|||
149767085|NCT01927419|540272748|FG001|Treatment Period|Other reasons|4|||
149767086|NCT01927419|540272747|FG000|Treatment Period|Not Reported|1|||
149767087|NCT01927419|540272748|FG001|Treatment Period|Not Reported|1|||
149767088|NCT03488251|540272749|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
149767089|NCT03488251|540272750|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149767090|NCT03488251|540272751|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149767091|NCT03488251|540272752|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149767092|NCT03488251|540272749|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
149767093|NCT03488251|540272750|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149767094|NCT03488251|540272751|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149767095|NCT03488251|540272752|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149767096|NCT03488251|540272749|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
149767097|NCT03488251|540272750|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149767098|NCT03488251|540272751|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149767099|NCT03488251|540272752|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149767100|NCT03488251|540272749|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
149767101|NCT03488251|540272750|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149767102|NCT03488251|540272751|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149767103|NCT03488251|540272752|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149767104|NCT03488251|540272749|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
149767105|NCT03488251|540272750|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149767106|NCT03488251|540272751|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149767107|NCT03488251|540272752|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149767108|NCT00115765|540272755|FG000|Overall Study|Withdrawal by Subject|22|||
149767109|NCT00115765|540272756|FG001|Overall Study|Withdrawal by Subject|53|||
149767110|NCT00115765|540272757|FG002|Overall Study|Withdrawal by Subject|76|||
149767111|NCT00115765|540272758|FG003|Overall Study|Withdrawal by Subject|15|||
149767112|NCT00115765|540272755|FG000|Overall Study|Physician Decision|4|||
149767113|NCT00115765|540272756|FG001|Overall Study|Physician Decision|15|||
149767114|NCT00115765|540272757|FG002|Overall Study|Physician Decision|18|||
149767115|NCT00115765|540272758|FG003|Overall Study|Physician Decision|13|||
149767116|NCT00115765|540272755|FG000|Overall Study|Lost to Follow-up|3|||
149767117|NCT00115765|540272756|FG001|Overall Study|Lost to Follow-up|20|||
149767118|NCT00115765|540272757|FG002|Overall Study|Lost to Follow-up|18|||
149767119|NCT00115765|540272758|FG003|Overall Study|Lost to Follow-up|1|||
149767120|NCT00115765|540272755|FG000|Overall Study|Other|6|||
149767121|NCT00115765|540272756|FG001|Overall Study|Other|12|||
149767122|NCT00115765|540272757|FG002|Overall Study|Other|9|||
149767123|NCT00115765|540272758|FG003|Overall Study|Other|2|||
149767124|NCT00995670|540272759|FG000|Overall Study|Failed arterial cannulation|1|||
149767125|NCT00995670|540272760|FG001|Overall Study|Failed arterial cannulation|0|||
149767126|NCT00995670|540272761|FG002|Overall Study|Failed arterial cannulation|3|||
149767127|NCT00675103|540272762|FG000|Overall Study|Lack of Efficacy|2|||
149767128|NCT00675103|540272762|FG000|Overall Study|Adverse Event|1|||
149767129|NCT01244191|540272766|FG000|Overall Study|Progressive disease|295|||
149767130|NCT01244191|540272767|FG001|Overall Study|Progressive disease|350|||
149767131|NCT01244191|540272766|FG000|Overall Study|Clinical disease progression|54|||
149767132|NCT01244191|540272767|FG001|Overall Study|Clinical disease progression|36|||
149767133|NCT01244191|540272766|FG000|Overall Study|Adverse Event|65|||
149767134|NCT01244191|540272767|FG001|Overall Study|Adverse Event|48|||
149767135|NCT01244191|540272766|FG000|Overall Study|Death|22|||
149767136|NCT01244191|540272767|FG001|Overall Study|Death|29|||
149767137|NCT01244191|540272766|FG000|Overall Study|Lost to Follow-up|0|||
149767138|NCT01244191|540272767|FG001|Overall Study|Lost to Follow-up|2|||
149767139|NCT01244191|540272766|FG000|Overall Study|Protocol Violation|1|||
149767140|NCT01244191|540272767|FG001|Overall Study|Protocol Violation|2|||
149767141|NCT01244191|540272766|FG000|Overall Study|Withdrawal by Subject|31|||
149767142|NCT01244191|540272767|FG001|Overall Study|Withdrawal by Subject|23|||
149767143|NCT01244191|540272766|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
149767144|NCT01244191|540272767|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
149767145|NCT01752842|540272768|FG000|Overall Study|Adverse Event|3|||
149767146|NCT01752842|540272769|FG001|Overall Study|Adverse Event|0|||
149767147|NCT01752842|540272768|FG000|Overall Study|Withdrawal by Subject|0|||
149767148|NCT01752842|540272769|FG001|Overall Study|Withdrawal by Subject|2|||
149767149|NCT05584202|540272770|FG000|Overall Study|Withdrawal of Consent|3|||
149767150|NCT05584202|540272771|FG001|Overall Study|Withdrawal of Consent|2|||
149767151|NCT05584202|540272770|FG000|Overall Study|Lost to Follow-up|2|||
149767152|NCT05584202|540272771|FG001|Overall Study|Lost to Follow-up|1|||
149767153|NCT05584202|540272770|FG000|Overall Study|Death|0|||
149767154|NCT05584202|540272771|FG001|Overall Study|Death|1|||
149767155|NCT02773238|540272772|FG000|Overall Study|Lack of Efficacy|4|||
149767156|NCT03260205|540272773|FG000|Overall Study|Adverse Event|2|||
149767157|NCT03260205|540272774|FG001|Overall Study|Adverse Event|0|||
149767158|NCT03260205|540272775|FG002|Overall Study|Adverse Event|2|||
149767159|NCT03260205|540272776|FG003|Overall Study|Adverse Event|2|||
149767160|NCT03260205|540272777|FG004|Overall Study|Adverse Event|4|||
149767161|NCT03260205|540272773|FG000|Overall Study|Lost to Follow-up|2|||
149767162|NCT03260205|540272774|FG001|Overall Study|Lost to Follow-up|2|||
149767163|NCT03260205|540272775|FG002|Overall Study|Lost to Follow-up|1|||
149767164|NCT03260205|540272776|FG003|Overall Study|Lost to Follow-up|1|||
149767165|NCT03260205|540272777|FG004|Overall Study|Lost to Follow-up|5|||
149767166|NCT03260205|540272773|FG000|Overall Study|Protocol Violation|0|||
149767167|NCT03260205|540272774|FG001|Overall Study|Protocol Violation|0|||
149767168|NCT03260205|540272775|FG002|Overall Study|Protocol Violation|2|||
149767169|NCT03260205|540272776|FG003|Overall Study|Protocol Violation|0|||
149767170|NCT03260205|540272777|FG004|Overall Study|Protocol Violation|1|||
149767171|NCT03260205|540272773|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
149767172|NCT03260205|540272774|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
149767173|NCT03260205|540272775|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
149767174|NCT03260205|540272776|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
149767175|NCT03260205|540272777|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
149767176|NCT03260205|540272773|FG000|Overall Study|Other: Unspecified|0|||
149767177|NCT03260205|540272774|FG001|Overall Study|Other: Unspecified|0|||
149767178|NCT03260205|540272775|FG002|Overall Study|Other: Unspecified|3|||
149767179|NCT03260205|540272776|FG003|Overall Study|Other: Unspecified|1|||
149767180|NCT03260205|540272777|FG004|Overall Study|Other: Unspecified|1|||
149767181|NCT03260205|540272773|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
149767182|NCT03260205|540272774|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
149767183|NCT03260205|540272775|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
149767184|NCT03260205|540272776|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
149767185|NCT03260205|540272777|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
149767186|NCT04095286|540272778|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767187|NCT04095286|540272779|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
149767188|NCT04095286|540272780|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767189|NCT04095286|540272781|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767190|NCT04095286|540272782|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767191|NCT04095286|540272783|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767192|NCT04095286|540272778|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
149767193|NCT04095286|540272779|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149767194|NCT04095286|540272780|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149767195|NCT04095286|540272781|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149767196|NCT04095286|540272782|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149767197|NCT04095286|540272783|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149767198|NCT04095286|540272778|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149767199|NCT04095286|540272779|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149767200|NCT04095286|540272780|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
149767201|NCT04095286|540272781|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149767202|NCT04095286|540272782|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149767203|NCT04095286|540272783|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149767204|NCT04095286|540272778|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767205|NCT04095286|540272779|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767206|NCT04095286|540272780|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
149767207|NCT04095286|540272781|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767208|NCT04095286|540272782|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767209|NCT04095286|540272783|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149767210|NCT04095286|540272778|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149767211|NCT04095286|540272779|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149767212|NCT04095286|540272780|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149767213|NCT04095286|540272781|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149767214|NCT04095286|540272782|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
149767215|NCT04095286|540272783|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149767216|NCT00479557|540272784|FG000|Overall Study|Death|0|||
149767217|NCT00479557|540272785|FG001|Overall Study|Death|0|||
149767218|NCT00479557|540272786|FG002|Overall Study|Death|0|||
149767219|NCT00479557|540272787|FG003|Overall Study|Death|0|||
149767220|NCT00479557|540272788|FG004|Overall Study|Death|0|||
149767221|NCT00479557|540272789|FG005|Overall Study|Death|1|||
149767222|NCT00479557|540272790|FG006|Overall Study|Death|0|||
149767223|NCT00479557|540272784|FG000|Overall Study|Lack of Efficacy|1|||
149767224|NCT00479557|540272785|FG001|Overall Study|Lack of Efficacy|0|||
149767225|NCT00479557|540272786|FG002|Overall Study|Lack of Efficacy|0|||
149767226|NCT00479557|540272787|FG003|Overall Study|Lack of Efficacy|0|||
149767227|NCT00479557|540272788|FG004|Overall Study|Lack of Efficacy|0|||
149767228|NCT00479557|540272789|FG005|Overall Study|Lack of Efficacy|0|||
149767229|NCT00479557|540272790|FG006|Overall Study|Lack of Efficacy|0|||
149767230|NCT00479557|540272784|FG000|Overall Study|Lost to Follow-up|0|||
149767231|NCT00479557|540272785|FG001|Overall Study|Lost to Follow-up|2|||
149767232|NCT00479557|540272786|FG002|Overall Study|Lost to Follow-up|0|||
149767233|NCT00479557|540272787|FG003|Overall Study|Lost to Follow-up|2|||
149767234|NCT00479557|540272788|FG004|Overall Study|Lost to Follow-up|0|||
149767235|NCT00479557|540272789|FG005|Overall Study|Lost to Follow-up|0|||
149767236|NCT00479557|540272790|FG006|Overall Study|Lost to Follow-up|0|||
149767237|NCT00479557|540272784|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
149767238|NCT00479557|540272785|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149767239|NCT00479557|540272786|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
149767240|NCT00479557|540272787|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
149767241|NCT00479557|540272788|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149767242|NCT00479557|540272789|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
149767243|NCT00479557|540272790|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149767244|NCT00479557|540272784|FG000|Overall Study|AE not related to Study Drug|1|||
149767245|NCT00479557|540272785|FG001|Overall Study|AE not related to Study Drug|3|||
149767246|NCT00479557|540272786|FG002|Overall Study|AE not related to Study Drug|0|||
149767247|NCT00479557|540272787|FG003|Overall Study|AE not related to Study Drug|0|||
149767248|NCT00479557|540272788|FG004|Overall Study|AE not related to Study Drug|2|||
149767249|NCT00479557|540272789|FG005|Overall Study|AE not related to Study Drug|2|||
149767250|NCT00479557|540272790|FG006|Overall Study|AE not related to Study Drug|1|||
149767251|NCT00479557|540272784|FG000|Overall Study|Caregiver Request|2|||
149767252|NCT00479557|540272785|FG001|Overall Study|Caregiver Request|2|||
149767253|NCT00479557|540272786|FG002|Overall Study|Caregiver Request|2|||
149767254|NCT00479557|540272787|FG003|Overall Study|Caregiver Request|0|||
149767255|NCT00479557|540272788|FG004|Overall Study|Caregiver Request|1|||
149767256|NCT00479557|540272789|FG005|Overall Study|Caregiver Request|2|||
149767257|NCT00479557|540272790|FG006|Overall Study|Caregiver Request|0|||
149767258|NCT00479557|540272784|FG000|Overall Study|Investigator Request|0|||
149767259|NCT00479557|540272785|FG001|Overall Study|Investigator Request|0|||
149767260|NCT00479557|540272786|FG002|Overall Study|Investigator Request|1|||
149767261|NCT00479557|540272787|FG003|Overall Study|Investigator Request|0|||
149767262|NCT00479557|540272788|FG004|Overall Study|Investigator Request|0|||
149767263|NCT00479557|540272789|FG005|Overall Study|Investigator Request|0|||
149767264|NCT00479557|540272790|FG006|Overall Study|Investigator Request|0|||
149767265|NCT00479557|540272784|FG000|Overall Study|Subject Request|3|||
149767266|NCT00479557|540272785|FG001|Overall Study|Subject Request|0|||
149767267|NCT00479557|540272786|FG002|Overall Study|Subject Request|1|||
149767268|NCT00479557|540272787|FG003|Overall Study|Subject Request|1|||
149767269|NCT00479557|540272788|FG004|Overall Study|Subject Request|1|||
149767270|NCT00479557|540272789|FG005|Overall Study|Subject Request|4|||
149767271|NCT00479557|540272790|FG006|Overall Study|Subject Request|1|||
149767272|NCT00479557|540272784|FG000|Overall Study|Other|2|||
149767273|NCT00479557|540272785|FG001|Overall Study|Other|3|||
149767274|NCT00479557|540272786|FG002|Overall Study|Other|1|||
149767275|NCT00479557|540272787|FG003|Overall Study|Other|0|||
149767276|NCT00479557|540272788|FG004|Overall Study|Other|0|||
149767277|NCT00479557|540272789|FG005|Overall Study|Other|3|||
149767278|NCT00479557|540272790|FG006|Overall Study|Other|0|||
149767279|NCT02509494|540272791|FG000|Overall Study|Lost to Follow-up|8|||
149767280|NCT02509494|540272792|FG001|Overall Study|Lost to Follow-up|47|||
149767281|NCT02509494|540272793|FG002|Overall Study|Lost to Follow-up|19|||
149767282|NCT02509494|540272794|FG003|Overall Study|Lost to Follow-up|6|||
149767283|NCT02509494|540272795|FG004|Overall Study|Lost to Follow-up|3|||
149767284|NCT02509494|540272796|FG005|Overall Study|Lost to Follow-up|3|||
149767285|NCT02509494|540272797|FG006|Overall Study|Lost to Follow-up|1|||
149767286|NCT02509494|540272798|FG007|Overall Study|Lost to Follow-up|3|||
149767287|NCT02509494|540272799|FG008|Overall Study|Lost to Follow-up|1|||
149767288|NCT02509494|540272791|FG000|Overall Study|Physician Decision|2|||
149767289|NCT02509494|540272792|FG001|Overall Study|Physician Decision|1|||
149767290|NCT02509494|540272793|FG002|Overall Study|Physician Decision|0|||
149767291|NCT02509494|540272794|FG003|Overall Study|Physician Decision|0|||
149767292|NCT02509494|540272795|FG004|Overall Study|Physician Decision|0|||
149767293|NCT02509494|540272796|FG005|Overall Study|Physician Decision|0|||
149767294|NCT02509494|540272797|FG006|Overall Study|Physician Decision|0|||
149767295|NCT02509494|540272798|FG007|Overall Study|Physician Decision|0|||
149767296|NCT02509494|540272799|FG008|Overall Study|Physician Decision|0|||
149767297|NCT02509494|540272791|FG000|Overall Study|Withdrawal by Subject|4|||
149767298|NCT02509494|540272792|FG001|Overall Study|Withdrawal by Subject|17|||
149767299|NCT02509494|540272793|FG002|Overall Study|Withdrawal by Subject|7|||
149767300|NCT02509494|540272794|FG003|Overall Study|Withdrawal by Subject|5|||
149767301|NCT02509494|540272795|FG004|Overall Study|Withdrawal by Subject|0|||
149767302|NCT02509494|540272796|FG005|Overall Study|Withdrawal by Subject|6|||
149767303|NCT02509494|540272797|FG006|Overall Study|Withdrawal by Subject|1|||
149767304|NCT02509494|540272798|FG007|Overall Study|Withdrawal by Subject|2|||
149767305|NCT02509494|540272799|FG008|Overall Study|Withdrawal by Subject|1|||
149767306|NCT02509494|540272791|FG000|Overall Study|Death|0|||
149767307|NCT02509494|540272792|FG001|Overall Study|Death|1|||
149767308|NCT02509494|540272793|FG002|Overall Study|Death|0|||
149767309|NCT02509494|540272794|FG003|Overall Study|Death|0|||
149767310|NCT02509494|540272795|FG004|Overall Study|Death|1|||
149767311|NCT02509494|540272796|FG005|Overall Study|Death|0|||
149767312|NCT02509494|540272797|FG006|Overall Study|Death|0|||
149767313|NCT02509494|540272798|FG007|Overall Study|Death|1|||
149767314|NCT02509494|540272799|FG008|Overall Study|Death|0|||
149767315|NCT02509494|540272791|FG000|Overall Study|Other|0|||
149767316|NCT02509494|540272792|FG001|Overall Study|Other|4|||
149767317|NCT02509494|540272793|FG002|Overall Study|Other|5|||
149767318|NCT02509494|540272794|FG003|Overall Study|Other|0|||
149767319|NCT02509494|540272795|FG004|Overall Study|Other|0|||
149767320|NCT02509494|540272796|FG005|Overall Study|Other|0|||
149767321|NCT02509494|540272797|FG006|Overall Study|Other|0|||
149767322|NCT02509494|540272798|FG007|Overall Study|Other|0|||
149767323|NCT02509494|540272799|FG008|Overall Study|Other|0|||
149767324|NCT02509494|540272791|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149767325|NCT02509494|540272792|FG001|Overall Study|Non-Compliance With Study Drug|11|||
149767326|NCT02509494|540272793|FG002|Overall Study|Non-Compliance With Study Drug|7|||
149767327|NCT02509494|540272794|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149767328|NCT02509494|540272795|FG004|Overall Study|Non-Compliance With Study Drug|1|||
149767329|NCT02509494|540272796|FG005|Overall Study|Non-Compliance With Study Drug|2|||
149767330|NCT02509494|540272797|FG006|Overall Study|Non-Compliance With Study Drug|1|||
149767331|NCT02509494|540272798|FG007|Overall Study|Non-Compliance With Study Drug|1|||
149767332|NCT02509494|540272799|FG008|Overall Study|Non-Compliance With Study Drug|0|||
149767333|NCT01511107|540272800|FG000|Overall Study|Ineligible|3|||
149767334|NCT01511107|540272801|FG001|Overall Study|Ineligible|2|||
149767335|NCT01511107|540272800|FG000|Overall Study|Lost to Follow-up|10|||
149767336|NCT01511107|540272801|FG001|Overall Study|Lost to Follow-up|19|||
149767337|NCT01511107|540272800|FG000|Overall Study|Withdrawal by Subject|9|||
149767338|NCT01511107|540272801|FG001|Overall Study|Withdrawal by Subject|20|||
149767339|NCT04752189|540272802|FG000|Overall Study|Withdrawal by Subject|0|||
149767340|NCT04752189|540272803|FG001|Overall Study|Withdrawal by Subject|150|||
149767341|NCT04752189|540272802|FG000|Overall Study|Lost to Follow-up|261|||
149767342|NCT04752189|540272803|FG001|Overall Study|Lost to Follow-up|126|||
149767343|NCT00975195|540272804|FG000|Overall Study|Adverse Event|108|||
149767344|NCT00975195|540272805|FG001|Overall Study|Adverse Event|101|||
149767345|NCT00975195|540272804|FG000|Overall Study|Lack of Efficacy|6|||
149767346|NCT00975195|540272805|FG001|Overall Study|Lack of Efficacy|6|||
149767347|NCT00975195|540272804|FG000|Overall Study|Protocol Violation|27|||
149767348|NCT00975195|540272805|FG001|Overall Study|Protocol Violation|23|||
149767349|NCT00975195|540272804|FG000|Overall Study|Lost to Follow-up|9|||
149767350|NCT00975195|540272805|FG001|Overall Study|Lost to Follow-up|7|||
149767351|NCT00975195|540272804|FG000|Overall Study|Withdrawal by Subject|48|||
149767352|NCT00975195|540272805|FG001|Overall Study|Withdrawal by Subject|61|||
149767353|NCT00975195|540272804|FG000|Overall Study|Other reason not defined above|29|||
149767354|NCT00975195|540272805|FG001|Overall Study|Other reason not defined above|33|||
149767355|NCT00975195|540272804|FG000|Overall Study|Not treated|1|||
149767356|NCT00975195|540272805|FG001|Overall Study|Not treated|2|||
149767357|NCT05084053|540274003|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
149767358|NCT05084053|540274004|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149767359|NCT05084053|540274005|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149767360|NCT05084053|540274006|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149767361|NCT05084053|540274003|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
149767362|NCT05084053|540274004|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
149767363|NCT05084053|540274005|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
149767364|NCT05084053|540274006|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
149767365|NCT05084053|540274003|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
149767366|NCT05084053|540274004|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
149767367|NCT05084053|540274005|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
149767368|NCT05084053|540274006|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
149767369|NCT02180724|540274007|FG000|Overall Study|Death|26|||
149767370|NCT02180724|540274008|FG001|Overall Study|Death|1|||
149767371|NCT02180724|540274007|FG000|Overall Study|Lost to Follow-up|3|||
149767372|NCT02180724|540274008|FG001|Overall Study|Lost to Follow-up|1|||
149767373|NCT02180724|540274007|FG000|Overall Study|Withdrawal by Subject|4|||
149767374|NCT02180724|540274008|FG001|Overall Study|Withdrawal by Subject|2|||
149767375|NCT02180724|540274007|FG000|Overall Study|PI Decision|5|||
149767376|NCT02180724|540274008|FG001|Overall Study|PI Decision|2|||
149767377|NCT02180724|540274007|FG000|Overall Study|Study terminated by sponsor|54|||
149767378|NCT02180724|540274008|FG001|Overall Study|Study terminated by sponsor|8|||
149767379|NCT05195359|540274009|FG000|Overall Study|Lost to Follow-up|124|||
149767380|NCT05195359|540274010|FG001|Overall Study|Lost to Follow-up|34|||
149767381|NCT01146951|540274015|FG000|Overall Study|Adverse Event|4|||
149767382|NCT01146951|540274016|FG001|Overall Study|Adverse Event|1|||
149767383|NCT02690207|540274020|FG000|Overall Study|Lost to Follow-up|48|||
149767384|NCT02690207|540274020|FG000|Overall Study|Withdrawal by Subject|46|||
149767385|NCT02690207|540274020|FG000|Overall Study|Protocol Violation|2|||
149767386|NCT02690207|540274020|FG000|Overall Study|Serious adverse event|110|||
149767387|NCT02690207|540274020|FG000|Overall Study|Non-serious Adverse Event|18|||
149767388|NCT02690207|540274020|FG000|Overall Study|Migrated/moved from study area|5|||
149767389|NCT02690207|540274020|FG000|Overall Study|Suspected HZ Episode|1|||
149767390|NCT02690207|540274020|FG000|Overall Study|Other reasons for withdrawal|23|||
149767391|NCT01175213|540274025|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
149767392|NCT01175213|540274026|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
149767393|NCT01175213|540274025|FG000|IGSC, 10%/rHuPH20|Death|1|||
149767394|NCT01175213|540274026|FG001|IGSC, 10%/rHuPH20|Death|0|||
149767395|NCT01175213|540274025|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
149767396|NCT01175213|540274026|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
149767397|NCT01175213|540274025|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
149767398|NCT01175213|540274026|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
149767399|NCT01175213|540274025|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
149767400|NCT01175213|540274026|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
149767401|NCT01175213|540274025|FG000|Safety Follow-up|Adverse Event|1|||
149767402|NCT01175213|540274026|FG001|Safety Follow-up|Adverse Event|0|||
149767403|NCT05136170|540274028|FG000|Overall Study|Withdrawal by Subject|2|||
149767404|NCT05136170|540274029|FG001|Overall Study|Withdrawal by Subject|2|||
149767405|NCT05136170|540274028|FG000|Overall Study|Can no longer make office visits|1|||
149767406|NCT05136170|540274029|FG001|Overall Study|Can no longer make office visits|0|||
149767407|NCT00571688|540274036|FG000|Overall Study|Lost to Follow-up|3|||
149767408|NCT00571688|540274037|FG001|Overall Study|Lost to Follow-up|6|||
149767409|NCT00571688|540274036|FG000|Overall Study|subject did not tolerate Consta|1|||
149767410|NCT00571688|540274037|FG001|Overall Study|subject did not tolerate Consta|0|||
149767411|NCT00571688|540274036|FG000|Overall Study|subject moved out of the area|1|||
149767412|NCT00571688|540274037|FG001|Overall Study|subject moved out of the area|0|||
149767413|NCT01048853|540274038|FG000|Overall Study|Death|1|||
149767414|NCT01048853|540274039|FG001|Overall Study|Death|0|||
149767415|NCT01048853|540274040|FG002|Overall Study|Death|0|||
149767416|NCT01048853|540274038|FG000|Overall Study|Lost to Follow-up|1|||
149767417|NCT01048853|540274039|FG001|Overall Study|Lost to Follow-up|4|||
149767418|NCT01048853|540274040|FG002|Overall Study|Lost to Follow-up|0|||
149767419|NCT04999969|540274041|FG000|Overall Study|Death|76|||
149767420|NCT04999969|540274041|FG000|Overall Study|Progressive Disease|1|||
149767421|NCT04999969|540274041|FG000|Overall Study|Withdrawal by Subject|8|||
149767422|NCT04735393|540274051|FG000|Overall Study|Lost to Follow-up|46|||
149767423|NCT04735393|540274052|FG001|Overall Study|Lost to Follow-up|24|||
149767424|NCT04735393|540274051|FG000|Overall Study|Physician Decision|2|||
149767425|NCT04735393|540274052|FG001|Overall Study|Physician Decision|1|||
149767426|NCT04735393|540274051|FG000|Overall Study|Not Detailed|1|||
149767427|NCT04735393|540274052|FG001|Overall Study|Not Detailed|2|||
149767428|NCT04735393|540274051|FG000|Overall Study|Withdrawal by Subject|71|||
149767429|NCT04735393|540274052|FG001|Overall Study|Withdrawal by Subject|28|||
149767430|NCT04735393|540274051|FG000|Overall Study|Adverse Event|56|||
149767431|NCT04735393|540274052|FG001|Overall Study|Adverse Event|7|||
149767432|NCT04735393|540274051|FG000|Overall Study|Protocol Violation|6|||
149767433|NCT04735393|540274052|FG001|Overall Study|Protocol Violation|1|||
149767434|NCT04735393|540274051|FG000|Overall Study|Trial terminated by Sponsor|49|||
149767435|NCT04735393|540274052|FG001|Overall Study|Trial terminated by Sponsor|29|||
149767436|NCT03150095|540274055|FG000|Overall Study|Death|0|||
149767437|NCT03150095|540274056|FG001|Overall Study|Death|1|||
149767438|NCT03150095|540274055|FG000|Overall Study|Lost to Follow-up|1|||
149767439|NCT03150095|540274056|FG001|Overall Study|Lost to Follow-up|1|||
149767440|NCT03150095|540274055|FG000|Overall Study|Withdrawal by Subject|4|||
149767441|NCT03150095|540274056|FG001|Overall Study|Withdrawal by Subject|0|||
149767442|NCT03150095|540274055|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
149767443|NCT03150095|540274056|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
149767444|NCT03224104|540274060|FG000|Overall Study|Lack of Efficacy|2|||
149767445|NCT03224104|540274061|FG001|Overall Study|Lack of Efficacy|6|||
149767446|NCT03224104|540274062|FG002|Overall Study|Lack of Efficacy|3|||
149767447|NCT03224104|540274063|FG003|Overall Study|Lack of Efficacy|4|||
149767448|NCT03224104|540274064|FG004|Overall Study|Lack of Efficacy|42|||
149767449|NCT03224104|540274060|FG000|Overall Study|Withdrawal by Subject|0|||
149767450|NCT03224104|540274061|FG001|Overall Study|Withdrawal by Subject|2|||
149767451|NCT03224104|540274062|FG002|Overall Study|Withdrawal by Subject|0|||
149767452|NCT03224104|540274063|FG003|Overall Study|Withdrawal by Subject|1|||
149767453|NCT03224104|540274064|FG004|Overall Study|Withdrawal by Subject|3|||
149767454|NCT03224104|540274060|FG000|Overall Study|Death|0|||
149767455|NCT03224104|540274061|FG001|Overall Study|Death|1|||
149767456|NCT03224104|540274062|FG002|Overall Study|Death|0|||
149767457|NCT03224104|540274063|FG003|Overall Study|Death|0|||
149767458|NCT03224104|540274064|FG004|Overall Study|Death|0|||
149767459|NCT03224104|540274060|FG000|Overall Study|Adverse Event|1|||
149767460|NCT03224104|540274061|FG001|Overall Study|Adverse Event|0|||
149767461|NCT03224104|540274062|FG002|Overall Study|Adverse Event|0|||
149767462|NCT03224104|540274063|FG003|Overall Study|Adverse Event|1|||
149767463|NCT03224104|540274064|FG004|Overall Study|Adverse Event|3|||
149767464|NCT03224104|540274060|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
149767465|NCT03224104|540274061|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
149767466|NCT03224104|540274062|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
149767467|NCT03224104|540274063|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
149767468|NCT03224104|540274064|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
149767469|NCT03224104|540274060|FG000|Overall Study|Treatment ongoing|0|||
149767470|NCT03224104|540274061|FG001|Overall Study|Treatment ongoing|0|||
149767471|NCT03224104|540274062|FG002|Overall Study|Treatment ongoing|0|||
149767472|NCT03224104|540274063|FG003|Overall Study|Treatment ongoing|0|||
149767473|NCT03224104|540274064|FG004|Overall Study|Treatment ongoing|1|||
149767474|NCT05025787|540274065|FG000|Overall Study|Lack of Efficacy|0|||
149767475|NCT05025787|540274066|FG001|Overall Study|Lack of Efficacy|1|||
149767476|NCT05025787|540274065|FG000|Overall Study|Adverse Event|2|||
149767477|NCT05025787|540274066|FG001|Overall Study|Adverse Event|4|||
149767478|NCT05025787|540274065|FG000|Overall Study|Non compliance|0|||
149767479|NCT05025787|540274066|FG001|Overall Study|Non compliance|1|||
149767480|NCT05025787|540274065|FG000|Overall Study|Protocol Violation|3|||
149767481|NCT05025787|540274066|FG001|Overall Study|Protocol Violation|1|||
149767482|NCT05025787|540274065|FG000|Overall Study|Stopping criteria met|1|||
149767483|NCT05025787|540274066|FG001|Overall Study|Stopping criteria met|1|||
149767484|NCT05025787|540274065|FG000|Overall Study|Withdrawal by Subject|3|||
149767485|NCT05025787|540274066|FG001|Overall Study|Withdrawal by Subject|1|||
149767486|NCT05600309|540274067|FG000|Overall Study|Death|41|||
149767487|NCT05600309|540274068|FG001|Overall Study|Death|38|||
149767488|NCT05600309|540274067|FG000|Overall Study|Sponsor Decision|9|||
149767489|NCT05600309|540274068|FG001|Overall Study|Sponsor Decision|6|||
149767490|NCT06087328|540274069|FG000|28-Day Treatment|Lost to Follow-up|7|||
149767491|NCT06087328|540274070|FG001|28-Day Treatment|Lost to Follow-up|3|||
149767492|NCT06087328|540274071|FG002|28-Day Treatment|Lost to Follow-up|4|||
149767493|NCT06087328|540274069|FG000|1-month Follow-up|Lost to Follow-up|0|||
149767494|NCT06087328|540274070|FG001|1-month Follow-up|Lost to Follow-up|1|||
149767495|NCT06087328|540274071|FG002|1-month Follow-up|Lost to Follow-up|1|||
149767496|NCT05822830|540274072|FG000|Overall Study|Adverse Event|6|||
149767497|NCT05822830|540274073|FG001|Overall Study|Adverse Event|6|||
149767498|NCT05822830|540274072|FG000|Overall Study|Assigned Treatment by Mistake|5|||
149767499|NCT05822830|540274073|FG001|Overall Study|Assigned Treatment by Mistake|3|||
149767500|NCT05822830|540274072|FG000|Overall Study|Lost to Follow-up|16|||
149767501|NCT05822830|540274073|FG001|Overall Study|Lost to Follow-up|18|||
149767502|NCT05822830|540274072|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149767503|NCT05822830|540274073|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149767504|NCT05822830|540274072|FG000|Overall Study|Participant was Out of the Country|0|||
149767505|NCT05822830|540274073|FG001|Overall Study|Participant was Out of the Country|1|||
149767506|NCT05822830|540274072|FG000|Overall Study|Pregnancy|1|||
149767507|NCT05822830|540274073|FG001|Overall Study|Pregnancy|2|||
149767508|NCT05822830|540274072|FG000|Overall Study|Withdrawal by Subject|27|||
149767509|NCT05822830|540274073|FG001|Overall Study|Withdrawal by Subject|26|||
149767510|NCT03368664|540274075|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
149767511|NCT03368664|540274075|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
149767512|NCT03368664|540274075|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
149767513|NCT03368664|540274075|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
149767514|NCT03589326|540274083|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
149767515|NCT03589326|540274084|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
149767516|NCT03589326|540274083|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
149767517|NCT03589326|540274084|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
149767518|NCT03589326|540274083|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
149767519|NCT03589326|540274084|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
149767520|NCT03589326|540274083|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
149767521|NCT03589326|540274084|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
149767522|NCT03589326|540274083|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
149767523|NCT03589326|540274084|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
149767524|NCT05441592|540274085|FG000|Overall Study|Lost to Follow-up|1|||
149767525|NCT05441592|540274086|FG001|Overall Study|Lost to Follow-up|5|||
149767526|NCT01371981|540274087|FG000|Overall Study|Adverse Event|12|||
149767527|NCT01371981|540274088|FG001|Overall Study|Adverse Event|17|||
149767528|NCT01371981|540274089|FG002|Overall Study|Adverse Event|0|||
149767529|NCT01371981|540274090|FG003|Overall Study|Adverse Event|4|||
149767530|NCT01371981|540274091|FG004|Overall Study|Adverse Event|1|||
149767531|NCT01371981|540274092|FG005|Overall Study|Adverse Event|0|||
149767532|NCT01371981|540274087|FG000|Overall Study|Death|22|||
149767533|NCT01371981|540274088|FG001|Overall Study|Death|16|||
149767534|NCT01371981|540274089|FG002|Overall Study|Death|0|||
149767535|NCT01371981|540274090|FG003|Overall Study|Death|0|||
149767536|NCT01371981|540274091|FG004|Overall Study|Death|2|||
149767537|NCT01371981|540274092|FG005|Overall Study|Death|2|||
149767538|NCT01371981|540274087|FG000|Overall Study|Lack of Efficacy|69|||
149767539|NCT01371981|540274088|FG001|Overall Study|Lack of Efficacy|61|||
149767540|NCT01371981|540274089|FG002|Overall Study|Lack of Efficacy|4|||
149767541|NCT01371981|540274090|FG003|Overall Study|Lack of Efficacy|8|||
149767542|NCT01371981|540274091|FG004|Overall Study|Lack of Efficacy|5|||
149767543|NCT01371981|540274092|FG005|Overall Study|Lack of Efficacy|0|||
149767544|NCT01371981|540274087|FG000|Overall Study|Physician Decision|48|||
149767545|NCT01371981|540274088|FG001|Overall Study|Physician Decision|63|||
149767546|NCT01371981|540274089|FG002|Overall Study|Physician Decision|1|||
149767547|NCT01371981|540274090|FG003|Overall Study|Physician Decision|7|||
149767548|NCT01371981|540274091|FG004|Overall Study|Physician Decision|14|||
149767549|NCT01371981|540274092|FG005|Overall Study|Physician Decision|3|||
149767550|NCT01371981|540274087|FG000|Overall Study|Withdrawal by Subject|12|||
149767551|NCT01371981|540274088|FG001|Overall Study|Withdrawal by Subject|19|||
149767552|NCT01371981|540274089|FG002|Overall Study|Withdrawal by Subject|1|||
149767553|NCT01371981|540274090|FG003|Overall Study|Withdrawal by Subject|2|||
149767554|NCT01371981|540274091|FG004|Overall Study|Withdrawal by Subject|10|||
149767555|NCT01371981|540274092|FG005|Overall Study|Withdrawal by Subject|3|||
149767556|NCT01371981|540274087|FG000|Overall Study|Ineligible|19|||
149767557|NCT01371981|540274088|FG001|Overall Study|Ineligible|13|||
149767558|NCT01371981|540274089|FG002|Overall Study|Ineligible|0|||
149767559|NCT01371981|540274090|FG003|Overall Study|Ineligible|0|||
149767560|NCT01371981|540274091|FG004|Overall Study|Ineligible|0|||
149767561|NCT01371981|540274092|FG005|Overall Study|Ineligible|4|||
149767562|NCT01371981|540274087|FG000|Overall Study|Did not start treatment|2|||
149767563|NCT01371981|540274088|FG001|Overall Study|Did not start treatment|3|||
149767564|NCT01371981|540274089|FG002|Overall Study|Did not start treatment|0|||
149767565|NCT01371981|540274090|FG003|Overall Study|Did not start treatment|0|||
149767566|NCT01371981|540274091|FG004|Overall Study|Did not start treatment|0|||
149767567|NCT01371981|540274092|FG005|Overall Study|Did not start treatment|2|||
149767568|NCT01586156|540274093|FG000|Overall Study|Pregnancy|0|||
149767569|NCT01586156|540274094|FG001|Overall Study|Pregnancy|1|||
149767570|NCT01586156|540274095|FG002|Overall Study|Pregnancy|0|||
149767571|NCT00414960|540274096|FG000|Overall Study|Adverse Event|4|||
149767572|NCT00414960|540274097|FG001|Overall Study|Adverse Event|0|||
149767573|NCT00414960|540274096|FG000|Overall Study|Withdrawal by Subject|3|||
149767574|NCT00414960|540274097|FG001|Overall Study|Withdrawal by Subject|0|||
149767575|NCT00414960|540274096|FG000|Overall Study|Physician Decision|0|||
149767576|NCT00414960|540274097|FG001|Overall Study|Physician Decision|1|||
149767577|NCT00717366|540274100|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
149767578|NCT00717366|540274101|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
149767579|NCT00717366|540274100|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
149767580|NCT00717366|540274101|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
149767581|NCT00717366|540274100|FG000|Core Study Period (20 Weeks)|Death|0|||
149767582|NCT00717366|540274101|FG001|Core Study Period (20 Weeks)|Death|1|||
149767583|NCT00717366|540274100|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
149767584|NCT00717366|540274101|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
149767585|NCT00717366|540274100|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
149767586|NCT00717366|540274101|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
149767587|NCT00717366|540274100|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
149767588|NCT00717366|540274101|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
149767589|NCT00717366|540274100|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
149767590|NCT00717366|540274101|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
149767591|NCT00434122|540274105|FG000|Overall Study|Non-compliance with protocol|0|||
149767592|NCT00434122|540274106|FG001|Overall Study|Non-compliance with protocol|1|||
149767593|NCT00434122|540274105|FG000|Overall Study|loss of subject contact|1|||
149767594|NCT00434122|540274106|FG001|Overall Study|loss of subject contact|1|||
149767595|NCT00434122|540274105|FG000|Overall Study|Personal reasons|1|||
149767596|NCT00434122|540274106|FG001|Overall Study|Personal reasons|1|||
149767597|NCT00434122|540274105|FG000|Overall Study|Large follicle size|2|||
149767598|NCT00434122|540274106|FG001|Overall Study|Large follicle size|2|||
149767599|NCT00434122|540274105|FG000|Overall Study|Low follicular response.|1|||
149767600|NCT00434122|540274106|FG001|Overall Study|Low follicular response.|2|||
149767601|NCT00434122|540274105|FG000|Overall Study|Travelling of subject.|1|||
149767602|NCT00434122|540274106|FG001|Overall Study|Travelling of subject.|0|||
149767603|NCT01842607|540274107|FG000|Overall Study|Adverse Event|11|||
149767604|NCT01842607|540274107|FG000|Overall Study|Lack of Efficacy|19|||
149767605|NCT01842607|540274107|FG000|Overall Study|Protocol Violation|8|||
149767606|NCT01842607|540274107|FG000|Overall Study|Protocol defined stopping criteria|2|||
149767607|NCT01842607|540274107|FG000|Overall Study|Lost to Follow-up|3|||
149767608|NCT01842607|540274107|FG000|Overall Study|Physician Decision|9|||
149767609|NCT01842607|540274107|FG000|Overall Study|Withdrawal by Subject|14|||
149767610|NCT00012012|540274108|FG000|Overall Study|Protocol Violation|1|||
149767611|NCT00012012|540274109|FG001|Overall Study|Protocol Violation|1|||
149767612|NCT00012012|540274108|FG000|Overall Study|Withdrawal by Subject|0|||
149767613|NCT00012012|540274109|FG001|Overall Study|Withdrawal by Subject|2|||
149767614|NCT02034474|540274110|FG000|Overall Study|Adverse Event|3|||
149767615|NCT02034474|540274111|FG001|Overall Study|Adverse Event|2|||
149767616|NCT02034474|540274110|FG000|Overall Study|Withdrawal by Subject|1|||
149767617|NCT02034474|540274111|FG001|Overall Study|Withdrawal by Subject|2|||
149767618|NCT01391819|540274112|FG000|Overall Study|Withdrawal by Subject|56|||
149767619|NCT01391819|540274112|FG000|Overall Study|Migrated/moved from study area|82|||
149767620|NCT01391819|540274112|FG000|Overall Study|Lost to Follow-up|252|||
149767621|NCT01391819|540274112|FG000|Overall Study|Death|3|||
149767622|NCT01391819|540274112|FG000|Overall Study|Other|9|||
149767623|NCT02164513|540274118|FG000|Overall Study|Adverse Event|162|||
149767624|NCT02164513|540274119|FG001|Overall Study|Adverse Event|180|||
149767625|NCT02164513|540274120|FG002|Overall Study|Adverse Event|111|||
149767626|NCT02164513|540274118|FG000|Overall Study|Other: Study Closed or terminated|5|||
149767627|NCT02164513|540274119|FG001|Overall Study|Other: Study Closed or terminated|2|||
149767628|NCT02164513|540274120|FG002|Overall Study|Other: Study Closed or terminated|4|||
149767629|NCT02164513|540274118|FG000|Overall Study|Lost to Follow-up|30|||
149767630|NCT02164513|540274119|FG001|Overall Study|Lost to Follow-up|36|||
149767631|NCT02164513|540274120|FG002|Overall Study|Lost to Follow-up|22|||
149767632|NCT02164513|540274118|FG000|Overall Study|Physician Decision|47|||
149767633|NCT02164513|540274119|FG001|Overall Study|Physician Decision|57|||
149767634|NCT02164513|540274120|FG002|Overall Study|Physician Decision|28|||
149767635|NCT02164513|540274118|FG000|Overall Study|Withdrawal by Subject|192|||
149767636|NCT02164513|540274119|FG001|Overall Study|Withdrawal by Subject|261|||
149767637|NCT02164513|540274120|FG002|Overall Study|Withdrawal by Subject|130|||
149767638|NCT02164513|540274118|FG000|Overall Study|Other: Reason not provided by site|1|||
149767639|NCT02164513|540274119|FG001|Overall Study|Other: Reason not provided by site|0|||
149767640|NCT02164513|540274120|FG002|Overall Study|Other: Reason not provided by site|0|||
149767641|NCT03423979|540274124|FG000|Overall Study|Death|5|||
149767642|NCT03423979|540274124|FG000|Overall Study|Adverse Event|4|||
149767643|NCT03423979|540274124|FG000|Overall Study|Withdrawal by Subject|3|||
149767644|NCT03423979|540274124|FG000|Overall Study|Lost to Follow-up|16|||
149767645|NCT02598661|540274125|FG000|Overall Study|Death|27|||
149767646|NCT02598661|540274126|FG001|Overall Study|Death|34|||
149767647|NCT02598661|540274127|FG002|Overall Study|Death|14|||
149767648|NCT02598661|540274128|FG003|Overall Study|Death|1|||
149767649|NCT02598661|540274129|FG004|Overall Study|Death|0|||
149767650|NCT02598661|540274125|FG000|Overall Study|Lost to Follow-up|2|||
149767651|NCT02598661|540274126|FG001|Overall Study|Lost to Follow-up|3|||
149767652|NCT02598661|540274127|FG002|Overall Study|Lost to Follow-up|2|||
149767653|NCT02598661|540274128|FG003|Overall Study|Lost to Follow-up|0|||
149767654|NCT02598661|540274129|FG004|Overall Study|Lost to Follow-up|0|||
149767655|NCT02598661|540274125|FG000|Overall Study|Withdrawal by Subject|13|||
149767656|NCT02598661|540274126|FG001|Overall Study|Withdrawal by Subject|24|||
149767657|NCT02598661|540274127|FG002|Overall Study|Withdrawal by Subject|14|||
149767658|NCT02598661|540274128|FG003|Overall Study|Withdrawal by Subject|1|||
149767659|NCT02598661|540274129|FG004|Overall Study|Withdrawal by Subject|1|||
149767660|NCT02598661|540274125|FG000|Overall Study|Adverse Event|0|||
149767661|NCT02598661|540274126|FG001|Overall Study|Adverse Event|0|||
149767662|NCT02598661|540274127|FG002|Overall Study|Adverse Event|1|||
149767663|NCT02598661|540274128|FG003|Overall Study|Adverse Event|0|||
149767664|NCT02598661|540274129|FG004|Overall Study|Adverse Event|0|||
149767665|NCT02598661|540274125|FG000|Overall Study|Randomized, Never Treated|0|||
149767666|NCT02598661|540274126|FG001|Overall Study|Randomized, Never Treated|0|||
149767667|NCT02598661|540274127|FG002|Overall Study|Randomized, Never Treated|0|||
149767668|NCT02598661|540274128|FG003|Overall Study|Randomized, Never Treated|0|||
149767669|NCT02598661|540274129|FG004|Overall Study|Randomized, Never Treated|1|||
149767670|NCT03422133|540274130|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
149767671|NCT03422133|540274131|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
149767672|NCT03003403|540274132|FG000|Overall Study|Ineligible|8|||
149767673|NCT03003403|540274133|FG001|Overall Study|Ineligible|7|||
149767674|NCT03003403|540274132|FG000|Overall Study|Withdrawal by Subject|3|||
149767675|NCT03003403|540274133|FG001|Overall Study|Withdrawal by Subject|1|||
149767676|NCT05458011|540275401|FG000|DB Period (12 Weeks)|Adverse Event|2|||
149767677|NCT05458011|540275402|FG001|DB Period (12 Weeks)|Adverse Event|1|||
149767678|NCT05458011|540275403|FG002|DB Period (12 Weeks)|Adverse Event|1|||
149767679|NCT05458011|540275401|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
149767680|NCT05458011|540275402|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
149767681|NCT05458011|540275403|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
149767682|NCT05458011|540275401|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
149767683|NCT05458011|540275402|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
149767684|NCT05458011|540275403|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
149767685|NCT05458011|540275401|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
149767686|NCT05458011|540275402|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
149767687|NCT05458011|540275403|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
149767688|NCT05458011|540275401|FG000|OL Period (12 Weeks)|Adverse Event|1|||
149767689|NCT05458011|540275402|FG001|OL Period (12 Weeks)|Adverse Event|2|||
149767690|NCT05458011|540275403|FG002|OL Period (12 Weeks)|Adverse Event|1|||
149767691|NCT05458011|540275401|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
149767692|NCT05458011|540275402|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
149767693|NCT05458011|540275403|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
149767694|NCT03569449|540275406|FG000|Overall Study|Lost to Follow-up|0|||
149767695|NCT03569449|540275407|FG001|Overall Study|Lost to Follow-up|1|||
149767696|NCT03569449|540275408|FG002|Overall Study|Lost to Follow-up|0|||
149767697|NCT03569449|540275409|FG003|Overall Study|Lost to Follow-up|2|||
149767698|NCT03569449|540275410|FG004|Overall Study|Lost to Follow-up|0|||
149767699|NCT03569449|540275411|FG005|Overall Study|Lost to Follow-up|0|||
149767700|NCT03569449|540275412|FG006|Overall Study|Lost to Follow-up|0|||
149767701|NCT03569449|540275413|FG007|Overall Study|Lost to Follow-up|0|||
149767702|NCT03569449|540275414|FG008|Overall Study|Lost to Follow-up|0|||
149767703|NCT03569449|540275415|FG009|Overall Study|Lost to Follow-up|0|||
149767704|NCT03569449|540275416|FG010|Overall Study|Lost to Follow-up|0|||
149767705|NCT03569449|540275417|FG011|Overall Study|Lost to Follow-up|0|||
149767706|NCT03569449|540275418|FG012|Overall Study|Lost to Follow-up|0|||
149767707|NCT03569449|540275419|FG013|Overall Study|Lost to Follow-up|0|||
149767708|NCT03569449|540275420|FG014|Overall Study|Lost to Follow-up|1|||
149767709|NCT03569449|540275421|FG015|Overall Study|Lost to Follow-up|0|||
149767710|NCT03569449|540275406|FG000|Overall Study|Withdrawal by Subject|0|||
149767711|NCT03569449|540275407|FG001|Overall Study|Withdrawal by Subject|1|||
149767712|NCT03569449|540275408|FG002|Overall Study|Withdrawal by Subject|0|||
149767713|NCT03569449|540275409|FG003|Overall Study|Withdrawal by Subject|0|||
149767714|NCT03569449|540275410|FG004|Overall Study|Withdrawal by Subject|1|||
149767715|NCT03569449|540275411|FG005|Overall Study|Withdrawal by Subject|0|||
149767716|NCT03569449|540275412|FG006|Overall Study|Withdrawal by Subject|0|||
149767717|NCT03569449|540275413|FG007|Overall Study|Withdrawal by Subject|0|||
149767718|NCT03569449|540275414|FG008|Overall Study|Withdrawal by Subject|0|||
149767719|NCT03569449|540275415|FG009|Overall Study|Withdrawal by Subject|0|||
149767720|NCT03569449|540275416|FG010|Overall Study|Withdrawal by Subject|0|||
149767721|NCT03569449|540275417|FG011|Overall Study|Withdrawal by Subject|0|||
149767722|NCT03569449|540275418|FG012|Overall Study|Withdrawal by Subject|0|||
149767723|NCT03569449|540275419|FG013|Overall Study|Withdrawal by Subject|0|||
149767724|NCT03569449|540275420|FG014|Overall Study|Withdrawal by Subject|0|||
149767725|NCT03569449|540275421|FG015|Overall Study|Withdrawal by Subject|0|||
149767726|NCT04124692|540275422|FG000|Overall Study|Medical reason|0|||
149767727|NCT04124692|540275423|FG001|Overall Study|Medical reason|1|||
149767728|NCT04124692|540275422|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
149767729|NCT04124692|540275423|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
149767730|NCT04124692|540275422|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
149767731|NCT04124692|540275423|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
149767732|NCT04124692|540275422|FG000|Overall Study|Lost to Follow-up|2|||
149767733|NCT04124692|540275423|FG001|Overall Study|Lost to Follow-up|4|||
149767734|NCT04124692|540275422|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
149767735|NCT04124692|540275423|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
149767736|NCT00205699|540275427|FG000|Overall Study|Lost to Follow-up|1|||
149767737|NCT00205699|540275428|FG001|Overall Study|Lost to Follow-up|3|||
149767738|NCT00205699|540275429|FG002|Overall Study|Lost to Follow-up|5|||
149767739|NCT00205699|540275427|FG000|Overall Study|Adverse Event|1|||
149767740|NCT00205699|540275428|FG001|Overall Study|Adverse Event|0|||
149767741|NCT00205699|540275429|FG002|Overall Study|Adverse Event|0|||
149767742|NCT00205699|540275427|FG000|Overall Study|Withdrawal by Subject|1|||
149767743|NCT00205699|540275428|FG001|Overall Study|Withdrawal by Subject|2|||
149767744|NCT00205699|540275429|FG002|Overall Study|Withdrawal by Subject|1|||
149767745|NCT00205699|540275427|FG000|Overall Study|Lack of Efficacy|0|||
149767746|NCT00205699|540275428|FG001|Overall Study|Lack of Efficacy|1|||
149767747|NCT00205699|540275429|FG002|Overall Study|Lack of Efficacy|0|||
149767748|NCT05279898|540275432|FG000|Overall Study|Withdrawal by Subject|1|||
149767749|NCT05279898|540275433|FG001|Overall Study|Withdrawal by Subject|0|||
149767750|NCT05279898|540275432|FG000|Overall Study|Physician Decision|1|||
149767751|NCT05279898|540275433|FG001|Overall Study|Physician Decision|1|||
149767752|NCT04393038|540275434|FG000|Overall Study|Adverse Event|11|||
149767753|NCT04393038|540275435|FG001|Overall Study|Adverse Event|2|||
149767754|NCT04393038|540275434|FG000|Overall Study|Protocol Violation|1|||
149767755|NCT04393038|540275435|FG001|Overall Study|Protocol Violation|0|||
149767756|NCT04393038|540275434|FG000|Overall Study|Death|6|||
149767757|NCT04393038|540275435|FG001|Overall Study|Death|4|||
149767758|NCT04393038|540275434|FG000|Overall Study|Withdrawal by Subject|24|||
149767759|NCT04393038|540275435|FG001|Overall Study|Withdrawal by Subject|8|||
149767760|NCT04393038|540275434|FG000|Overall Study|Lost to Follow-up|5|||
149767761|NCT04393038|540275435|FG001|Overall Study|Lost to Follow-up|4|||
149767762|NCT04393038|540275434|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
149767763|NCT04393038|540275435|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
149767764|NCT04393038|540275434|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
149767765|NCT04393038|540275435|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
149767766|NCT05168813|540275436|FG000|Part A (Open-label)|Lost to Follow-up|21|||
149767767|NCT05168813|540275437|FG001|Part A (Open-label)|Lost to Follow-up|39|||
149767768|NCT05168813|540275438|FG002|Part A (Open-label)|Lost to Follow-up|8|||
149767769|NCT05168813|540275439|FG003|Part A (Open-label)|Lost to Follow-up|26|||
149767770|NCT05168813|540275440|FG004|Part A (Open-label)|Lost to Follow-up|0|||
149767771|NCT05168813|540275441|FG005|Part A (Open-label)|Lost to Follow-up|0|||
149767772|NCT05168813|540275436|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
149767773|NCT05168813|540275437|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
149767774|NCT05168813|540275438|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
149767775|NCT05168813|540275439|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
149767776|NCT05168813|540275440|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
149767777|NCT05168813|540275441|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
149767778|NCT05168813|540275436|FG000|Part A (Open-label)|Death|23|||
149767779|NCT05168813|540275437|FG001|Part A (Open-label)|Death|28|||
149767780|NCT05168813|540275438|FG002|Part A (Open-label)|Death|1|||
149767781|NCT05168813|540275439|FG003|Part A (Open-label)|Death|9|||
149767782|NCT05168813|540275440|FG004|Part A (Open-label)|Death|0|||
149767783|NCT05168813|540275441|FG005|Part A (Open-label)|Death|0|||
149767784|NCT05168813|540275436|FG000|Part A (Open-label)|Physician Decision|0|||
149767785|NCT05168813|540275437|FG001|Part A (Open-label)|Physician Decision|1|||
149767786|NCT05168813|540275438|FG002|Part A (Open-label)|Physician Decision|0|||
149767787|NCT05168813|540275439|FG003|Part A (Open-label)|Physician Decision|2|||
149767788|NCT05168813|540275440|FG004|Part A (Open-label)|Physician Decision|0|||
149767789|NCT05168813|540275441|FG005|Part A (Open-label)|Physician Decision|0|||
149767790|NCT05168813|540275436|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
149767791|NCT05168813|540275437|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
149767792|NCT05168813|540275438|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149767793|NCT05168813|540275439|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
149767794|NCT05168813|540275440|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149767795|NCT05168813|540275441|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149767796|NCT05168813|540275436|FG000|Part A (Open-label)|Protocol Violation|0|||
149767797|NCT05168813|540275437|FG001|Part A (Open-label)|Protocol Violation|1|||
149767798|NCT05168813|540275438|FG002|Part A (Open-label)|Protocol Violation|0|||
149767799|NCT05168813|540275439|FG003|Part A (Open-label)|Protocol Violation|0|||
149767800|NCT05168813|540275440|FG004|Part A (Open-label)|Protocol Violation|0|||
149767801|NCT05168813|540275441|FG005|Part A (Open-label)|Protocol Violation|0|||
149767802|NCT05168813|540275436|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
149767803|NCT05168813|540275437|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
149767804|NCT05168813|540275438|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
149767805|NCT05168813|540275439|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
149767806|NCT05168813|540275440|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
149767807|NCT05168813|540275441|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
149767808|NCT05168813|540275436|FG000|Part A (Open-label)|Other|0|||
149767809|NCT05168813|540275437|FG001|Part A (Open-label)|Other|1|||
149767810|NCT05168813|540275438|FG002|Part A (Open-label)|Other|0|||
149767811|NCT05168813|540275439|FG003|Part A (Open-label)|Other|0|||
149767812|NCT05168813|540275440|FG004|Part A (Open-label)|Other|0|||
149767813|NCT05168813|540275441|FG005|Part A (Open-label)|Other|0|||
149767814|NCT05168813|540275436|FG000|Part B (Blinded)|Lost to Follow-up|0|||
149767815|NCT05168813|540275437|FG001|Part B (Blinded)|Lost to Follow-up|0|||
149767816|NCT05168813|540275438|FG002|Part B (Blinded)|Lost to Follow-up|0|||
149767817|NCT05168813|540275439|FG003|Part B (Blinded)|Lost to Follow-up|0|||
149767818|NCT05168813|540275440|FG004|Part B (Blinded)|Lost to Follow-up|219|||
149767819|NCT05168813|540275441|FG005|Part B (Blinded)|Lost to Follow-up|88|||
149767820|NCT05168813|540275436|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
149767821|NCT05168813|540275437|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
149767822|NCT05168813|540275438|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
149767823|NCT05168813|540275439|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
149767824|NCT05168813|540275440|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
149767825|NCT05168813|540275441|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
149767826|NCT05168813|540275436|FG000|Part B (Blinded)|Death|0|||
149767827|NCT05168813|540275437|FG001|Part B (Blinded)|Death|0|||
149767828|NCT05168813|540275438|FG002|Part B (Blinded)|Death|0|||
149767829|NCT05168813|540275439|FG003|Part B (Blinded)|Death|0|||
149767830|NCT05168813|540275440|FG004|Part B (Blinded)|Death|63|||
149767831|NCT05168813|540275441|FG005|Part B (Blinded)|Death|19|||
149767832|NCT05168813|540275436|FG000|Part B (Blinded)|Physician Decision|0|||
149767833|NCT05168813|540275437|FG001|Part B (Blinded)|Physician Decision|0|||
149767834|NCT05168813|540275438|FG002|Part B (Blinded)|Physician Decision|0|||
149767835|NCT05168813|540275439|FG003|Part B (Blinded)|Physician Decision|0|||
149767836|NCT05168813|540275440|FG004|Part B (Blinded)|Physician Decision|6|||
149767837|NCT05168813|540275441|FG005|Part B (Blinded)|Physician Decision|1|||
149767838|NCT05168813|540275436|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149767839|NCT05168813|540275437|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149767840|NCT05168813|540275438|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149767841|NCT05168813|540275439|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149767842|NCT05168813|540275440|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
149767843|NCT05168813|540275441|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
149767844|NCT05168813|540275436|FG000|Part B (Blinded)|Pregnancy|0|||
149767845|NCT05168813|540275437|FG001|Part B (Blinded)|Pregnancy|0|||
149767846|NCT05168813|540275438|FG002|Part B (Blinded)|Pregnancy|0|||
149767847|NCT05168813|540275439|FG003|Part B (Blinded)|Pregnancy|0|||
149767848|NCT05168813|540275440|FG004|Part B (Blinded)|Pregnancy|1|||
149767849|NCT05168813|540275441|FG005|Part B (Blinded)|Pregnancy|0|||
149767850|NCT05168813|540275436|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
149767851|NCT05168813|540275437|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
149767852|NCT05168813|540275438|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
149767853|NCT05168813|540275439|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
149767854|NCT05168813|540275440|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
149767855|NCT05168813|540275441|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
149767856|NCT05168813|540275436|FG000|Part B (Blinded)|Other|0|||
149767857|NCT05168813|540275437|FG001|Part B (Blinded)|Other|0|||
149767858|NCT05168813|540275438|FG002|Part B (Blinded)|Other|0|||
149767859|NCT05168813|540275439|FG003|Part B (Blinded)|Other|0|||
149767860|NCT05168813|540275440|FG004|Part B (Blinded)|Other|41|||
149767861|NCT05168813|540275441|FG005|Part B (Blinded)|Other|27|||
149767862|NCT06964165|540275442|FG000|Overall Study|Death|4|||
149767863|NCT06964165|540275443|FG001|Overall Study|Death|4|||
149767864|NCT06964165|540275442|FG000|Overall Study|Physician Decision|1|||
149767865|NCT06964165|540275443|FG001|Overall Study|Physician Decision|1|||
149767866|NCT06964165|540275442|FG000|Overall Study|Withdrawal by Subject|0|||
149767867|NCT06964165|540275443|FG001|Overall Study|Withdrawal by Subject|2|||
149767868|NCT06964165|540275442|FG000|Overall Study|Study terminated by sponsor|12|||
149767869|NCT06964165|540275443|FG001|Overall Study|Study terminated by sponsor|10|||
149767870|NCT06964165|540275442|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
149767871|NCT06964165|540275443|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
149767872|NCT06964165|540275442|FG000|Overall Study|Participant removed due to non-compliance|0|||
149767873|NCT06964165|540275443|FG001|Overall Study|Participant removed due to non-compliance|1|||
149767874|NCT04321252|540275444|FG000|Overall Study|Withdrawal by Subject|0|||
149767875|NCT04321252|540275445|FG001|Overall Study|Withdrawal by Subject|0|||
149767876|NCT04321252|540275446|FG002|Overall Study|Withdrawal by Subject|0|||
149767877|NCT04321252|540275447|FG003|Overall Study|Withdrawal by Subject|0|||
149767878|NCT04321252|540275448|FG004|Overall Study|Withdrawal by Subject|0|||
149767879|NCT04321252|540275449|FG005|Overall Study|Withdrawal by Subject|1|||
149767880|NCT04321252|540275450|FG006|Overall Study|Withdrawal by Subject|0|||
149767881|NCT04321252|540275451|FG007|Overall Study|Withdrawal by Subject|0|||
149767882|NCT04321252|540275452|FG008|Overall Study|Withdrawal by Subject|0|||
149767883|NCT06245044|540275453|FG000|No MI help|Technical issues|18|||
149767884|NCT00259740|540275456|FG000|Overall Study|Physician Decision|1|||
149767885|NCT00259740|540275457|FG001|Overall Study|Physician Decision|1|||
149767886|NCT00259740|540275456|FG000|Overall Study|Adverse Event|0|||
149767887|NCT00259740|540275457|FG001|Overall Study|Adverse Event|2|||
149767888|NCT00259740|540275456|FG000|Overall Study|Withdrawal by Subject|2|||
149767889|NCT00259740|540275457|FG001|Overall Study|Withdrawal by Subject|6|||
149767890|NCT00259740|540275456|FG000|Overall Study|Death|1|||
149767891|NCT00259740|540275457|FG001|Overall Study|Death|1|||
149767892|NCT00259740|540275456|FG000|Overall Study|Disease progression|19|||
149767893|NCT00259740|540275457|FG001|Overall Study|Disease progression|36|||
149767894|NCT00259740|540275456|FG000|Overall Study|Ongoing|17|||
149767895|NCT00259740|540275457|FG001|Overall Study|Ongoing|3|||
149767896|NCT00259740|540275456|FG000|Overall Study|Other|3|||
149767897|NCT00259740|540275457|FG001|Overall Study|Other|0|||
149767898|NCT00259740|540275456|FG000|Overall Study|Requirement for alternative therapy|0|||
149767899|NCT00259740|540275457|FG001|Overall Study|Requirement for alternative therapy|4|||
149767900|NCT01844830|540275462|FG000|Overall Study|Withdrawal by Subject|1|||
149767901|NCT01844830|540275463|FG001|Overall Study|Withdrawal by Subject|0|||
149767902|NCT01658579|540275464|FG000|Treatment Period A|Other|0|||
149767903|NCT01658579|540275465|FG001|Treatment Period A|Other|0|||
149767904|NCT01658579|540275466|FG002|Treatment Period A|Other|1|||
149767905|NCT01658579|540275467|FG003|Treatment Period A|Other|1|||
149767906|NCT01658579|540275464|FG000|Treatment Period A|Adverse Event|1|||
149767907|NCT01658579|540275465|FG001|Treatment Period A|Adverse Event|0|||
149767908|NCT01658579|540275466|FG002|Treatment Period A|Adverse Event|0|||
149767909|NCT01658579|540275467|FG003|Treatment Period A|Adverse Event|0|||
149767910|NCT01658579|540275464|FG000|Treatment Period B|Other|0|||
149767911|NCT01658579|540275465|FG001|Treatment Period B|Other|0|||
149767912|NCT01658579|540275466|FG002|Treatment Period B|Other|0|||
149767913|NCT01658579|540275467|FG003|Treatment Period B|Other|1|||
149767914|NCT04580394|540275468|FG000|First Intervention|Incorrectly Randomized|1|||
149767915|NCT04580394|540275468|FG000|First Intervention|Physician Decision|1|||
149767916|NCT04580394|540275468|FG000|First Intervention|Lost to Follow-up|1|||
149767917|NCT04580394|540275468|FG000|Washout (One Week)|Withdrawal by Subject|1|||
149767918|NCT04580394|540275468|FG000|Washout (One Week)|Adverse Event|1|||
149767919|NCT04580394|540275468|FG000|Washout (One Week)|Withdrawal by Subject|2|||
149767920|NCT04580394|540275468|FG000|Third Intervention|Adverse Event|1|||
149767921|NCT04580394|540275468|FG000|Third Intervention|Withdrawal by Subject|1|||
149767922|NCT04580394|540275468|FG000|Washout (One Week)|Withdrawal by Subject|2|||
149767923|NCT01464788|540275469|FG000|Overall Study|Lost to Follow-up|0|||
149767924|NCT01464788|540275470|FG001|Overall Study|Lost to Follow-up|1|||
149767925|NCT01464788|540275471|FG002|Overall Study|Lost to Follow-up|0|||
149767926|NCT01464788|540275469|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
149767927|NCT01464788|540275470|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
149767928|NCT01464788|540275471|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
149767929|NCT04397718|540275474|FG000|Overall Study|Death|7|||
149767930|NCT04397718|540275475|FG001|Overall Study|Death|11|||
149767931|NCT04397718|540275474|FG000|Overall Study|Lost to Follow-up|0|||
149767932|NCT04397718|540275475|FG001|Overall Study|Lost to Follow-up|4|||
149767933|NCT03201965|540275478|FG000|Overall Study|Death|5|||
149767934|NCT03201965|540275479|FG001|Overall Study|Death|65|||
149767935|NCT03201965|540275480|FG002|Overall Study|Death|47|||
149767936|NCT03201965|540275478|FG000|Overall Study|Lost to Follow-up|0|||
149767937|NCT03201965|540275479|FG001|Overall Study|Lost to Follow-up|6|||
149767938|NCT03201965|540275480|FG002|Overall Study|Lost to Follow-up|0|||
149767939|NCT03201965|540275478|FG000|Overall Study|Withdrawal by Subject|3|||
149767940|NCT03201965|540275479|FG001|Overall Study|Withdrawal by Subject|23|||
149767941|NCT03201965|540275480|FG002|Overall Study|Withdrawal by Subject|8|||
149767942|NCT03201965|540275478|FG000|Overall Study|Sponsor's Decision|20|||
149767943|NCT03201965|540275479|FG001|Overall Study|Sponsor's Decision|99|||
149767944|NCT03201965|540275480|FG002|Overall Study|Sponsor's Decision|140|||
149767945|NCT01153893|540275483|FG000|Overall Study|Adverse Event|1|||
149767946|NCT01153893|540275484|FG001|Overall Study|Adverse Event|0|||
149767947|NCT00118482|540275485|FG000|Overall Study|Lost to Follow-up|7|||
149767948|NCT00118482|540275486|FG001|Overall Study|Lost to Follow-up|7|||
149767949|NCT00118482|540275485|FG000|Overall Study|Withdrawal by Subject|23|||
149767950|NCT00118482|540275486|FG001|Overall Study|Withdrawal by Subject|22|||
149767951|NCT00125190|540275487|FG000|Overall Study|Subject/Parent Decision|7|||
149767952|NCT00125190|540275487|FG000|Overall Study|Non-compliance|2|||
149767953|NCT00125190|540275487|FG000|Overall Study|Adverse Event|1|||
149767954|NCT00125190|540275487|FG000|Overall Study|Other|1|||
149767955|NCT00125190|540275487|FG000|Overall Study|Lost to Follow-up|4|||
149767956|NCT02128763|540275488|FG000|Overall Study|Death|1|||
149767957|NCT02128763|540275489|FG001|Overall Study|Death|0|||
149767958|NCT02128763|540275488|FG000|Overall Study|Lost to Follow-up|19|||
149767959|NCT02128763|540275489|FG001|Overall Study|Lost to Follow-up|16|||
149767960|NCT03259490|540275490|FG000|Period 1|Withdrawal by Subject|0|||
149767961|NCT03259490|540275491|FG001|Period 1|Withdrawal by Subject|1|||
149767962|NCT03259490|540275490|FG000|Period 2|Protocol Violation|1|||
149767963|NCT03259490|540275491|FG001|Period 2|Protocol Violation|0|||
149767964|NCT00255086|540275493|FG000|Overall Study|Adverse Event|1|||
149767965|NCT00255086|540275494|FG001|Overall Study|Adverse Event|1|||
149767966|NCT00255086|540275493|FG000|Overall Study|Protocol Violation|1|||
149767967|NCT00255086|540275494|FG001|Overall Study|Protocol Violation|1|||
149767968|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
149767969|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149767970|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
149767971|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
149767972|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149767973|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149767974|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149767975|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
149767976|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
149767977|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
149767978|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149767979|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149767980|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149767981|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149767982|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
149767983|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149767984|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149767985|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149767986|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149767987|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149767988|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
149767989|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
149767990|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149767991|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149767992|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
149767993|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
149767994|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
149767995|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
149767996|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
149767997|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
149767998|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149767999|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149768000|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149768001|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
149768002|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149768003|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149768004|NCT01963208|540275495|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149768005|NCT01963208|540275496|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149768006|NCT01963208|540275497|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149768007|NCT01963208|540275498|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
149768008|NCT01963208|540275499|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149768009|NCT01963208|540275500|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149768010|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149768011|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149768012|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149768013|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149768014|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
149768015|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
149768016|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149768017|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149768018|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149768019|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149768020|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
149768021|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
149768022|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149768023|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149768024|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149768025|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149768026|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149768027|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
149768028|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149768029|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149768030|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149768031|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149768032|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149768033|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
149768034|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
149768035|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
149768036|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
149768037|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
149768038|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
149768039|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
149768040|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149768041|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149768042|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149768043|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149768044|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
149768045|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
149768046|NCT01963208|540275495|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
149768047|NCT01963208|540275496|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
149768048|NCT01963208|540275497|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
149768049|NCT01963208|540275498|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
149768050|NCT01963208|540275499|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
149768051|NCT01963208|540275500|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
149768052|NCT02159469|540275502|FG000|Overall Study|Missing Completion status|1|||
149768053|NCT02159469|540275502|FG000|Overall Study|Adverse Event|5|||
149768054|NCT02159469|540275502|FG000|Overall Study|Non-compliance|2|||
149768055|NCT02159469|540275502|FG000|Overall Study|Withdrawal by Subject|9|||
149768056|NCT02159469|540275502|FG000|Overall Study|Lost to Follow-up|1|||
149768057|NCT02159469|540275502|FG000|Overall Study|Sponsor's request|2|||
149768058|NCT02159469|540275502|FG000|Overall Study|Met Stopping Criteria|3|||
149768059|NCT02159469|540275502|FG000|Overall Study|Other|1|||
149768060|NCT02159469|540275502|FG000|Overall Study|Multiple|29|||
149768061|NCT03629041|540275503|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149768062|NCT03629041|540275504|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
149768063|NCT03629041|540275505|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149768064|NCT03629041|540275506|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149768065|NCT05301322|540275510|FG000|Overall Study|Adverse Event|7|||
149768066|NCT05301322|540275511|FG001|Overall Study|Adverse Event|3|||
149768067|NCT05301322|540275510|FG000|Overall Study|Death|0|||
149768068|NCT05301322|540275511|FG001|Overall Study|Death|1|||
149768069|NCT05301322|540275510|FG000|Overall Study|Lost to Follow-up|2|||
149768070|NCT05301322|540275511|FG001|Overall Study|Lost to Follow-up|1|||
149768071|NCT05301322|540275510|FG000|Overall Study|Protocol Violation|3|||
149768072|NCT05301322|540275511|FG001|Overall Study|Protocol Violation|1|||
149768073|NCT05301322|540275510|FG000|Overall Study|Withdrawal by Subject|3|||
149768074|NCT05301322|540275511|FG001|Overall Study|Withdrawal by Subject|0|||
149768075|NCT05301322|540275510|FG000|Overall Study|Other|4|||
149768076|NCT05301322|540275511|FG001|Overall Study|Other|0|||
149768077|NCT04971785|540275512|FG000|Overall Study|Withdrew Consent|5|||
149768078|NCT04971785|540275513|FG001|Overall Study|Withdrew Consent|5|||
149768079|NCT04971785|540275514|FG002|Overall Study|Withdrew Consent|17|||
149768080|NCT04971785|540275515|FG003|Overall Study|Withdrew Consent|7|||
149768081|NCT04971785|540275512|FG000|Overall Study|Adverse Event|7|||
149768082|NCT04971785|540275513|FG001|Overall Study|Adverse Event|8|||
149768083|NCT04971785|540275514|FG002|Overall Study|Adverse Event|6|||
149768084|NCT04971785|540275515|FG003|Overall Study|Adverse Event|3|||
149768085|NCT04971785|540275512|FG000|Overall Study|Lost to Follow-up|2|||
149768086|NCT04971785|540275513|FG001|Overall Study|Lost to Follow-up|1|||
149768087|NCT04971785|540275514|FG002|Overall Study|Lost to Follow-up|6|||
149768088|NCT04971785|540275515|FG003|Overall Study|Lost to Follow-up|7|||
149768089|NCT04971785|540275512|FG000|Overall Study|Protocol Violation|3|||
149768090|NCT04971785|540275513|FG001|Overall Study|Protocol Violation|1|||
149768091|NCT04971785|540275514|FG002|Overall Study|Protocol Violation|1|||
149768092|NCT04971785|540275515|FG003|Overall Study|Protocol Violation|2|||
149768093|NCT04971785|540275512|FG000|Overall Study|Investigator's Discretion|3|||
149768094|NCT04971785|540275513|FG001|Overall Study|Investigator's Discretion|1|||
149768095|NCT04971785|540275514|FG002|Overall Study|Investigator's Discretion|1|||
149768096|NCT04971785|540275515|FG003|Overall Study|Investigator's Discretion|0|||
149768097|NCT04971785|540275512|FG000|Overall Study|Randomized but Never Treated|1|||
149768098|NCT04971785|540275513|FG001|Overall Study|Randomized but Never Treated|2|||
149768099|NCT04971785|540275514|FG002|Overall Study|Randomized but Never Treated|0|||
149768100|NCT04971785|540275515|FG003|Overall Study|Randomized but Never Treated|1|||
149768101|NCT04971785|540275512|FG000|Overall Study|Death|0|||
149768102|NCT04971785|540275513|FG001|Overall Study|Death|1|||
149768103|NCT04971785|540275514|FG002|Overall Study|Death|1|||
149768104|NCT04971785|540275515|FG003|Overall Study|Death|0|||
149768105|NCT04971785|540275512|FG000|Overall Study|Site Terminated by Sponsor|1|||
149768106|NCT04971785|540275513|FG001|Overall Study|Site Terminated by Sponsor|1|||
149768107|NCT04971785|540275514|FG002|Overall Study|Site Terminated by Sponsor|0|||
149768108|NCT04971785|540275515|FG003|Overall Study|Site Terminated by Sponsor|0|||
149768109|NCT00808249|540275516|FG000|Overall Study|Adverse Event|4|||
149768110|NCT00808249|540275517|FG001|Overall Study|Adverse Event|7|||
149768111|NCT00808249|540275518|FG002|Overall Study|Adverse Event|10|||
149768112|NCT00808249|540275519|FG003|Overall Study|Adverse Event|6|||
149768113|NCT00808249|540275516|FG000|Overall Study|Lost to Follow-up|2|||
149768114|NCT00808249|540275517|FG001|Overall Study|Lost to Follow-up|3|||
149768115|NCT00808249|540275518|FG002|Overall Study|Lost to Follow-up|3|||
149768116|NCT00808249|540275519|FG003|Overall Study|Lost to Follow-up|5|||
149768117|NCT00808249|540275516|FG000|Overall Study|Withdrawal by Subject|4|||
149768118|NCT00808249|540275517|FG001|Overall Study|Withdrawal by Subject|0|||
149768119|NCT00808249|540275518|FG002|Overall Study|Withdrawal by Subject|2|||
149768120|NCT00808249|540275519|FG003|Overall Study|Withdrawal by Subject|4|||
149768121|NCT00808249|540275516|FG000|Overall Study|Protocol Violation|3|||
149768122|NCT00808249|540275517|FG001|Overall Study|Protocol Violation|3|||
149768123|NCT00808249|540275518|FG002|Overall Study|Protocol Violation|3|||
149768124|NCT00808249|540275519|FG003|Overall Study|Protocol Violation|0|||
149768125|NCT00808249|540275516|FG000|Overall Study|Lack of Efficacy|1|||
149768126|NCT00808249|540275517|FG001|Overall Study|Lack of Efficacy|1|||
149768127|NCT00808249|540275518|FG002|Overall Study|Lack of Efficacy|0|||
149768128|NCT00808249|540275519|FG003|Overall Study|Lack of Efficacy|0|||
149768129|NCT00808249|540275516|FG000|Overall Study|study specific discontinuation criteria|1|||
149768130|NCT00808249|540275517|FG001|Overall Study|study specific discontinuation criteria|0|||
149768131|NCT00808249|540275518|FG002|Overall Study|study specific discontinuation criteria|1|||
149768132|NCT00808249|540275519|FG003|Overall Study|study specific discontinuation criteria|0|||
149768133|NCT00808249|540275516|FG000|Overall Study|All other reasons|2|||
149768134|NCT00808249|540275517|FG001|Overall Study|All other reasons|1|||
149768135|NCT00808249|540275518|FG002|Overall Study|All other reasons|3|||
149768136|NCT00808249|540275519|FG003|Overall Study|All other reasons|1|||
149768137|NCT03829332|540275520|FG000|Overall Study|Death|225|||
149768138|NCT03829332|540275521|FG001|Overall Study|Death|230|||
149768139|NCT03829332|540275520|FG000|Overall Study|Lost to Follow-up|1|||
149768140|NCT03829332|540275521|FG001|Overall Study|Lost to Follow-up|3|||
149768141|NCT03829332|540275520|FG000|Overall Study|Physician Decision|1|||
149768142|NCT03829332|540275521|FG001|Overall Study|Physician Decision|0|||
149768143|NCT03829332|540275520|FG000|Overall Study|Sponsor Decision|71|||
149768144|NCT03829332|540275521|FG001|Overall Study|Sponsor Decision|72|||
149768145|NCT03829332|540275520|FG000|Overall Study|Withdrawal by Subject|11|||
149768146|NCT03829332|540275521|FG001|Overall Study|Withdrawal by Subject|9|||
149768147|NCT05371912|540275522|FG000|Overall Study|Lost to Follow-up|3|||
149768148|NCT05371912|540275523|FG001|Overall Study|Lost to Follow-up|2|||
149768149|NCT01646398|540278036|FG000|Overall Study|Withdrawal by Subject|1|||
149768150|NCT01646398|540278037|FG001|Overall Study|Withdrawal by Subject|0|||
149768151|NCT00571519|540278038|FG000|Overall Study|Subject withdrew consent|0|||
149768152|NCT00571519|540278039|FG001|Overall Study|Subject withdrew consent|1|||
149768153|NCT00571519|540278040|FG002|Overall Study|Subject withdrew consent|0|||
149768154|NCT00571519|540278041|FG003|Overall Study|Subject withdrew consent|2|||
149768155|NCT00571519|540278042|FG004|Overall Study|Subject withdrew consent|1|||
149768156|NCT00571519|540278043|FG005|Overall Study|Subject withdrew consent|1|||
149768157|NCT00571519|540278044|FG006|Overall Study|Subject withdrew consent|2|||
149768158|NCT00571519|540278038|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149768159|NCT00571519|540278039|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149768160|NCT00571519|540278040|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149768161|NCT00571519|540278041|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149768162|NCT00571519|540278042|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149768163|NCT00571519|540278043|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149768164|NCT00571519|540278044|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149768165|NCT00571519|540278038|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768166|NCT00571519|540278039|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
149768167|NCT00571519|540278040|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768168|NCT00571519|540278041|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768169|NCT00571519|540278042|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768170|NCT00571519|540278043|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768171|NCT00571519|540278044|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
149768172|NCT00571519|540278038|FG000|Overall Study|Termination of study by Sponsor|2|||
149768173|NCT00571519|540278039|FG001|Overall Study|Termination of study by Sponsor|7|||
149768174|NCT00571519|540278040|FG002|Overall Study|Termination of study by Sponsor|10|||
149768175|NCT00571519|540278041|FG003|Overall Study|Termination of study by Sponsor|24|||
149768176|NCT00571519|540278042|FG004|Overall Study|Termination of study by Sponsor|8|||
149768177|NCT00571519|540278043|FG005|Overall Study|Termination of study by Sponsor|9|||
149768178|NCT00571519|540278044|FG006|Overall Study|Termination of study by Sponsor|22|||
149768179|NCT00571519|540278038|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768180|NCT00571519|540278039|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768181|NCT00571519|540278040|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
149768182|NCT00571519|540278041|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768183|NCT00571519|540278042|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768184|NCT00571519|540278043|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768185|NCT00571519|540278044|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149768186|NCT04656418|540278048|FG000|Overall Study|Withdrawal by Subject|1|||
149768187|NCT04656418|540278049|FG001|Overall Study|Withdrawal by Subject|3|||
149768188|NCT02475850|540278050|FG000|Overall Study|Death|155|||
149768189|NCT02475850|540278051|FG001|Overall Study|Death|141|||
149768190|NCT02475850|540278050|FG000|Overall Study|Lost to Follow-up|217|||
149768191|NCT02475850|540278051|FG001|Overall Study|Lost to Follow-up|188|||
149768192|NCT02475850|540278050|FG000|Overall Study|Withdrawal by Subject|221|||
149768193|NCT02475850|540278051|FG001|Overall Study|Withdrawal by Subject|155|||
149768194|NCT03297216|540278056|FG000|Overall Study|Death|0|||
149768195|NCT03297216|540278057|FG001|Overall Study|Death|1|||
149768196|NCT03297216|540278056|FG000|Overall Study|Miscarriage|0|||
149768197|NCT03297216|540278057|FG001|Overall Study|Miscarriage|2|||
149768198|NCT03297216|540278056|FG000|Overall Study|Lost to Follow-up|3|||
149768199|NCT03297216|540278057|FG001|Overall Study|Lost to Follow-up|2|||
149768200|NCT00781963|540278058|FG000|Overall Study|Death|3|||
149768201|NCT00781963|540278059|FG001|Overall Study|Death|0|||
149768202|NCT00781963|540278058|FG000|Overall Study|Lost to Follow-up|2|||
149768203|NCT00781963|540278059|FG001|Overall Study|Lost to Follow-up|1|||
149768204|NCT00781963|540278058|FG000|Overall Study|Withdrawal by Subject|3|||
149768205|NCT00781963|540278059|FG001|Overall Study|Withdrawal by Subject|1|||
149768206|NCT00781963|540278058|FG000|Overall Study|Refused follow-up|9|||
149768207|NCT00781963|540278059|FG001|Overall Study|Refused follow-up|0|||
149768208|NCT03434418|540278060|FG000|Overall Study|Disease Progression|11|||
149768209|NCT03434418|540278060|FG000|Overall Study|Adverse Event|2|||
149768210|NCT03434418|540278060|FG000|Overall Study|Physician Decision|1|||
149768211|NCT03434418|540278060|FG000|Overall Study|Decline in Performance Status (PS)|1|||
149768212|NCT00696436|540278061|FG000|Overall Study|Adverse Event|7|||
149768213|NCT00696436|540278062|FG001|Overall Study|Adverse Event|9|||
149768214|NCT00696436|540278063|FG002|Overall Study|Adverse Event|8|||
149768215|NCT00696436|540278064|FG003|Overall Study|Adverse Event|6|||
149768216|NCT00696436|540278065|FG004|Overall Study|Adverse Event|4|||
149768217|NCT00696436|540278061|FG000|Overall Study|Protocol Violation|3|||
149768218|NCT00696436|540278062|FG001|Overall Study|Protocol Violation|2|||
149768219|NCT00696436|540278063|FG002|Overall Study|Protocol Violation|2|||
149768220|NCT00696436|540278064|FG003|Overall Study|Protocol Violation|0|||
149768221|NCT00696436|540278065|FG004|Overall Study|Protocol Violation|1|||
149768222|NCT00696436|540278061|FG000|Overall Study|Lost to Follow-up|1|||
149768223|NCT00696436|540278062|FG001|Overall Study|Lost to Follow-up|6|||
149768224|NCT00696436|540278063|FG002|Overall Study|Lost to Follow-up|2|||
149768225|NCT00696436|540278064|FG003|Overall Study|Lost to Follow-up|4|||
149768226|NCT00696436|540278065|FG004|Overall Study|Lost to Follow-up|3|||
149768227|NCT00696436|540278061|FG000|Overall Study|Withdrawal by Subject|4|||
149768228|NCT00696436|540278062|FG001|Overall Study|Withdrawal by Subject|11|||
149768229|NCT00696436|540278063|FG002|Overall Study|Withdrawal by Subject|5|||
149768230|NCT00696436|540278064|FG003|Overall Study|Withdrawal by Subject|7|||
149768231|NCT00696436|540278065|FG004|Overall Study|Withdrawal by Subject|1|||
149768232|NCT00696436|540278061|FG000|Overall Study|Lack of Efficacy|3|||
149768233|NCT00696436|540278062|FG001|Overall Study|Lack of Efficacy|1|||
149768234|NCT00696436|540278063|FG002|Overall Study|Lack of Efficacy|5|||
149768235|NCT00696436|540278064|FG003|Overall Study|Lack of Efficacy|2|||
149768236|NCT00696436|540278065|FG004|Overall Study|Lack of Efficacy|4|||
149768237|NCT00696436|540278061|FG000|Overall Study|Participant Unavailability|2|||
149768238|NCT00696436|540278062|FG001|Overall Study|Participant Unavailability|0|||
149768239|NCT00696436|540278063|FG002|Overall Study|Participant Unavailability|2|||
149768240|NCT00696436|540278064|FG003|Overall Study|Participant Unavailability|1|||
149768241|NCT00696436|540278065|FG004|Overall Study|Participant Unavailability|0|||
149768242|NCT00696436|540278061|FG000|Overall Study|Administrative Error|2|||
149768243|NCT00696436|540278062|FG001|Overall Study|Administrative Error|0|||
149768244|NCT00696436|540278063|FG002|Overall Study|Administrative Error|2|||
149768245|NCT00696436|540278064|FG003|Overall Study|Administrative Error|0|||
149768246|NCT00696436|540278065|FG004|Overall Study|Administrative Error|0|||
149768247|NCT00696436|540278061|FG000|Overall Study|Participant Non-compliance|0|||
149768248|NCT00696436|540278062|FG001|Overall Study|Participant Non-compliance|0|||
149768249|NCT00696436|540278063|FG002|Overall Study|Participant Non-compliance|1|||
149768250|NCT00696436|540278064|FG003|Overall Study|Participant Non-compliance|2|||
149768251|NCT00696436|540278065|FG004|Overall Study|Participant Non-compliance|0|||
149768252|NCT00696436|540278061|FG000|Overall Study|Administrative Decision|1|||
149768253|NCT00696436|540278062|FG001|Overall Study|Administrative Decision|0|||
149768254|NCT00696436|540278063|FG002|Overall Study|Administrative Decision|0|||
149768255|NCT00696436|540278064|FG003|Overall Study|Administrative Decision|0|||
149768256|NCT00696436|540278065|FG004|Overall Study|Administrative Decision|0|||
149768257|NCT00696436|540278061|FG000|Overall Study|Missing|0|||
149768258|NCT00696436|540278062|FG001|Overall Study|Missing|1|||
149768259|NCT00696436|540278063|FG002|Overall Study|Missing|1|||
149768260|NCT00696436|540278064|FG003|Overall Study|Missing|0|||
149768261|NCT00696436|540278065|FG004|Overall Study|Missing|0|||
149768262|NCT01517412|540278068|FG000|Overall Study|Adverse Event|10|||
149768263|NCT01517412|540278069|FG001|Overall Study|Adverse Event|11|||
149768264|NCT01517412|540278068|FG000|Overall Study|Lack of Efficacy|10|||
149768265|NCT01517412|540278069|FG001|Overall Study|Lack of Efficacy|5|||
149768266|NCT01517412|540278068|FG000|Overall Study|Poor compliance to protocol|8|||
149768267|NCT01517412|540278069|FG001|Overall Study|Poor compliance to protocol|3|||
149768268|NCT01517412|540278068|FG000|Overall Study|Other than specified above|8|||
149768269|NCT01517412|540278069|FG001|Overall Study|Other than specified above|5|||
149768270|NCT01830816|540278075|FG000|Overall Study|Progressive Disease|12|||
149768271|NCT01830816|540278076|FG001|Overall Study|Progressive Disease|7|||
149768272|NCT01830816|540278077|FG002|Overall Study|Progressive Disease|7|||
149768273|NCT01830816|540278075|FG000|Overall Study|Adverse Event|3|||
149768274|NCT01830816|540278076|FG001|Overall Study|Adverse Event|4|||
149768275|NCT01830816|540278077|FG002|Overall Study|Adverse Event|0|||
149768276|NCT01830816|540278075|FG000|Overall Study|Study Terminated by Sponsor|1|||
149768277|NCT01830816|540278076|FG001|Overall Study|Study Terminated by Sponsor|1|||
149768278|NCT01830816|540278077|FG002|Overall Study|Study Terminated by Sponsor|0|||
149768279|NCT01830816|540278075|FG000|Overall Study|Withdrawal by Subject|1|||
149768280|NCT01830816|540278076|FG001|Overall Study|Withdrawal by Subject|1|||
149768281|NCT01830816|540278077|FG002|Overall Study|Withdrawal by Subject|0|||
149768282|NCT01830816|540278075|FG000|Overall Study|Lost to Follow-up|0|||
149768283|NCT01830816|540278076|FG001|Overall Study|Lost to Follow-up|1|||
149768284|NCT01830816|540278077|FG002|Overall Study|Lost to Follow-up|0|||
149768285|NCT01830816|540278075|FG000|Overall Study|Symptomatic Deterioration|1|||
149768286|NCT01830816|540278076|FG001|Overall Study|Symptomatic Deterioration|0|||
149768287|NCT01830816|540278077|FG002|Overall Study|Symptomatic Deterioration|0|||
149768288|NCT01830816|540278075|FG000|Overall Study|Reason not Specified|2|||
149768289|NCT01830816|540278076|FG001|Overall Study|Reason not Specified|0|||
149768290|NCT01830816|540278077|FG002|Overall Study|Reason not Specified|0|||
149768291|NCT02716194|540278078|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
149768292|NCT02716194|540278079|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
149768293|NCT02716194|540278080|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
149768294|NCT01754922|540278089|FG000|Overall Study|Adverse Event|0|||
149768295|NCT01754922|540278090|FG001|Overall Study|Adverse Event|1|||
149768296|NCT01207388|540278091|FG000|Overall Study|Death|67|||
149768297|NCT01207388|540278091|FG000|Overall Study|Withdrawal by Subject|1|||
149768298|NCT01885078|540278092|FG000|Treatment Period|Adverse Event|52|||
149768299|NCT01885078|540278093|FG001|Treatment Period|Adverse Event|136|||
149768300|NCT01885078|540278094|FG002|Treatment Period|Adverse Event|30|||
149768301|NCT01885078|540278095|FG003|Treatment Period|Adverse Event|73|||
149768302|NCT01885078|540278096|FG004|Treatment Period|Adverse Event|17|||
149768303|NCT01885078|540278097|FG005|Treatment Period|Adverse Event|72|||
149768304|NCT01885078|540278098|FG006|Treatment Period|Adverse Event|24|||
149768305|NCT01885078|540278099|FG007|Treatment Period|Adverse Event|5|||
149768306|NCT01885078|540278100|FG008|Treatment Period|Adverse Event|0|||
149768307|NCT01885078|540278101|FG009|Treatment Period|Adverse Event|0|||
149768308|NCT01885078|540278092|FG000|Treatment Period|Death|13|||
149768309|NCT01885078|540278093|FG001|Treatment Period|Death|33|||
149768310|NCT01885078|540278094|FG002|Treatment Period|Death|5|||
149768311|NCT01885078|540278095|FG003|Treatment Period|Death|9|||
149768312|NCT01885078|540278096|FG004|Treatment Period|Death|2|||
149768313|NCT01885078|540278097|FG005|Treatment Period|Death|10|||
149768314|NCT01885078|540278098|FG006|Treatment Period|Death|3|||
149768315|NCT01885078|540278099|FG007|Treatment Period|Death|2|||
149768316|NCT01885078|540278100|FG008|Treatment Period|Death|0|||
149768317|NCT01885078|540278101|FG009|Treatment Period|Death|0|||
149768318|NCT01885078|540278092|FG000|Treatment Period|Lack of Efficacy|12|||
149768319|NCT01885078|540278093|FG001|Treatment Period|Lack of Efficacy|33|||
149768320|NCT01885078|540278094|FG002|Treatment Period|Lack of Efficacy|10|||
149768321|NCT01885078|540278095|FG003|Treatment Period|Lack of Efficacy|23|||
149768322|NCT01885078|540278096|FG004|Treatment Period|Lack of Efficacy|24|||
149768323|NCT01885078|540278097|FG005|Treatment Period|Lack of Efficacy|58|||
149768324|NCT01885078|540278098|FG006|Treatment Period|Lack of Efficacy|9|||
149768325|NCT01885078|540278099|FG007|Treatment Period|Lack of Efficacy|5|||
149768326|NCT01885078|540278100|FG008|Treatment Period|Lack of Efficacy|0|||
149768327|NCT01885078|540278101|FG009|Treatment Period|Lack of Efficacy|0|||
149768328|NCT01885078|540278092|FG000|Treatment Period|Lost to Follow-up|16|||
149768329|NCT01885078|540278093|FG001|Treatment Period|Lost to Follow-up|19|||
149768330|NCT01885078|540278094|FG002|Treatment Period|Lost to Follow-up|7|||
149768331|NCT01885078|540278095|FG003|Treatment Period|Lost to Follow-up|9|||
149768332|NCT01885078|540278096|FG004|Treatment Period|Lost to Follow-up|2|||
149768333|NCT01885078|540278097|FG005|Treatment Period|Lost to Follow-up|8|||
149768334|NCT01885078|540278098|FG006|Treatment Period|Lost to Follow-up|2|||
149768335|NCT01885078|540278099|FG007|Treatment Period|Lost to Follow-up|0|||
149768336|NCT01885078|540278100|FG008|Treatment Period|Lost to Follow-up|0|||
149768337|NCT01885078|540278101|FG009|Treatment Period|Lost to Follow-up|0|||
149768338|NCT01885078|540278092|FG000|Treatment Period|Physician Decision|19|||
149768339|NCT01885078|540278093|FG001|Treatment Period|Physician Decision|21|||
149768340|NCT01885078|540278094|FG002|Treatment Period|Physician Decision|5|||
149768341|NCT01885078|540278095|FG003|Treatment Period|Physician Decision|12|||
149768342|NCT01885078|540278096|FG004|Treatment Period|Physician Decision|9|||
149768343|NCT01885078|540278097|FG005|Treatment Period|Physician Decision|24|||
149768344|NCT01885078|540278098|FG006|Treatment Period|Physician Decision|4|||
149768345|NCT01885078|540278099|FG007|Treatment Period|Physician Decision|3|||
149768346|NCT01885078|540278100|FG008|Treatment Period|Physician Decision|0|||
149768347|NCT01885078|540278101|FG009|Treatment Period|Physician Decision|0|||
149768348|NCT01885078|540278092|FG000|Treatment Period|Protocol Violation|3|||
149768349|NCT01885078|540278093|FG001|Treatment Period|Protocol Violation|5|||
149768350|NCT01885078|540278094|FG002|Treatment Period|Protocol Violation|0|||
149768351|NCT01885078|540278095|FG003|Treatment Period|Protocol Violation|3|||
149768352|NCT01885078|540278096|FG004|Treatment Period|Protocol Violation|1|||
149768353|NCT01885078|540278097|FG005|Treatment Period|Protocol Violation|6|||
149768354|NCT01885078|540278098|FG006|Treatment Period|Protocol Violation|0|||
149768355|NCT01885078|540278099|FG007|Treatment Period|Protocol Violation|0|||
149768356|NCT01885078|540278100|FG008|Treatment Period|Protocol Violation|0|||
149768357|NCT01885078|540278101|FG009|Treatment Period|Protocol Violation|0|||
149768358|NCT01885078|540278092|FG000|Treatment Period|Sponsor Decision|245|||
149768359|NCT01885078|540278093|FG001|Treatment Period|Sponsor Decision|648|||
149768360|NCT01885078|540278094|FG002|Treatment Period|Sponsor Decision|49|||
149768361|NCT01885078|540278095|FG003|Treatment Period|Sponsor Decision|90|||
149768362|NCT01885078|540278096|FG004|Treatment Period|Sponsor Decision|20|||
149768363|NCT01885078|540278097|FG005|Treatment Period|Sponsor Decision|38|||
149768364|NCT01885078|540278098|FG006|Treatment Period|Sponsor Decision|162|||
149768365|NCT01885078|540278099|FG007|Treatment Period|Sponsor Decision|3|||
149768366|NCT01885078|540278100|FG008|Treatment Period|Sponsor Decision|0|||
149768367|NCT01885078|540278101|FG009|Treatment Period|Sponsor Decision|0|||
149768368|NCT01885078|540278092|FG000|Treatment Period|Withdrawal by Subject|72|||
149768369|NCT01885078|540278093|FG001|Treatment Period|Withdrawal by Subject|132|||
149768370|NCT01885078|540278094|FG002|Treatment Period|Withdrawal by Subject|25|||
149768371|NCT01885078|540278095|FG003|Treatment Period|Withdrawal by Subject|63|||
149768372|NCT01885078|540278096|FG004|Treatment Period|Withdrawal by Subject|15|||
149768373|NCT01885078|540278097|FG005|Treatment Period|Withdrawal by Subject|34|||
149768374|NCT01885078|540278098|FG006|Treatment Period|Withdrawal by Subject|17|||
149768375|NCT01885078|540278099|FG007|Treatment Period|Withdrawal by Subject|10|||
149768376|NCT01885078|540278100|FG008|Treatment Period|Withdrawal by Subject|0|||
149768377|NCT01885078|540278101|FG009|Treatment Period|Withdrawal by Subject|0|||
149768378|NCT01885078|540278092|FG000|Treatment Period|Other|0|||
149768379|NCT01885078|540278093|FG001|Treatment Period|Other|0|||
149768380|NCT01885078|540278094|FG002|Treatment Period|Other|0|||
149768381|NCT01885078|540278095|FG003|Treatment Period|Other|1|||
149768382|NCT01885078|540278096|FG004|Treatment Period|Other|0|||
149768383|NCT01885078|540278097|FG005|Treatment Period|Other|0|||
149768384|NCT01885078|540278098|FG006|Treatment Period|Other|0|||
149768385|NCT01885078|540278099|FG007|Treatment Period|Other|0|||
149768386|NCT01885078|540278100|FG008|Treatment Period|Other|0|||
149768387|NCT01885078|540278101|FG009|Treatment Period|Other|0|||
149768388|NCT01885078|540278092|FG000|Step-down Period|Sponsor Decision|0|||
149768389|NCT01885078|540278093|FG001|Step-down Period|Sponsor Decision|0|||
149768390|NCT01885078|540278094|FG002|Step-down Period|Sponsor Decision|0|||
149768391|NCT01885078|540278095|FG003|Step-down Period|Sponsor Decision|0|||
149768392|NCT01885078|540278096|FG004|Step-down Period|Sponsor Decision|0|||
149768393|NCT01885078|540278097|FG005|Step-down Period|Sponsor Decision|0|||
149768394|NCT01885078|540278098|FG006|Step-down Period|Sponsor Decision|0|||
149768395|NCT01885078|540278099|FG007|Step-down Period|Sponsor Decision|0|||
149768396|NCT01885078|540278100|FG008|Step-down Period|Sponsor Decision|1|||
149768397|NCT01885078|540278101|FG009|Step-down Period|Sponsor Decision|1|||
149768398|NCT01885078|540278092|FG000|Step-down Period|Adverse Event|0|||
149768399|NCT01885078|540278093|FG001|Step-down Period|Adverse Event|0|||
149768400|NCT01885078|540278094|FG002|Step-down Period|Adverse Event|0|||
149768401|NCT01885078|540278095|FG003|Step-down Period|Adverse Event|0|||
149768402|NCT01885078|540278096|FG004|Step-down Period|Adverse Event|0|||
149768403|NCT01885078|540278097|FG005|Step-down Period|Adverse Event|0|||
149768404|NCT01885078|540278098|FG006|Step-down Period|Adverse Event|0|||
149768405|NCT01885078|540278099|FG007|Step-down Period|Adverse Event|0|||
149768406|NCT01885078|540278100|FG008|Step-down Period|Adverse Event|29|||
149768407|NCT01885078|540278101|FG009|Step-down Period|Adverse Event|38|||
149768408|NCT01885078|540278092|FG000|Step-down Period|Withdrawal by Subject|0|||
149768409|NCT01885078|540278093|FG001|Step-down Period|Withdrawal by Subject|0|||
149768410|NCT01885078|540278094|FG002|Step-down Period|Withdrawal by Subject|0|||
149768411|NCT01885078|540278095|FG003|Step-down Period|Withdrawal by Subject|0|||
149768412|NCT01885078|540278096|FG004|Step-down Period|Withdrawal by Subject|0|||
149768413|NCT01885078|540278097|FG005|Step-down Period|Withdrawal by Subject|0|||
149768414|NCT01885078|540278098|FG006|Step-down Period|Withdrawal by Subject|0|||
149768415|NCT01885078|540278099|FG007|Step-down Period|Withdrawal by Subject|0|||
149768416|NCT01885078|540278100|FG008|Step-down Period|Withdrawal by Subject|25|||
149768417|NCT01885078|540278101|FG009|Step-down Period|Withdrawal by Subject|15|||
149768418|NCT01885078|540278092|FG000|Step-down Period|Physician Decision|0|||
149768419|NCT01885078|540278093|FG001|Step-down Period|Physician Decision|0|||
149768420|NCT01885078|540278094|FG002|Step-down Period|Physician Decision|0|||
149768421|NCT01885078|540278095|FG003|Step-down Period|Physician Decision|0|||
149768422|NCT01885078|540278096|FG004|Step-down Period|Physician Decision|0|||
149768423|NCT01885078|540278097|FG005|Step-down Period|Physician Decision|0|||
149768424|NCT01885078|540278098|FG006|Step-down Period|Physician Decision|0|||
149768425|NCT01885078|540278099|FG007|Step-down Period|Physician Decision|0|||
149768426|NCT01885078|540278100|FG008|Step-down Period|Physician Decision|7|||
149768427|NCT01885078|540278101|FG009|Step-down Period|Physician Decision|2|||
149768428|NCT01885078|540278092|FG000|Step-down Period|Death|0|||
149768429|NCT01885078|540278093|FG001|Step-down Period|Death|0|||
149768430|NCT01885078|540278094|FG002|Step-down Period|Death|0|||
149768431|NCT01885078|540278095|FG003|Step-down Period|Death|0|||
149768432|NCT01885078|540278096|FG004|Step-down Period|Death|0|||
149768433|NCT01885078|540278097|FG005|Step-down Period|Death|0|||
149768434|NCT01885078|540278098|FG006|Step-down Period|Death|0|||
149768435|NCT01885078|540278099|FG007|Step-down Period|Death|0|||
149768436|NCT01885078|540278100|FG008|Step-down Period|Death|4|||
149768437|NCT01885078|540278101|FG009|Step-down Period|Death|3|||
149768438|NCT01885078|540278092|FG000|Step-down Period|Lost to Follow-up|0|||
149768439|NCT01885078|540278093|FG001|Step-down Period|Lost to Follow-up|0|||
149768440|NCT01885078|540278094|FG002|Step-down Period|Lost to Follow-up|0|||
149768441|NCT01885078|540278095|FG003|Step-down Period|Lost to Follow-up|0|||
149768442|NCT01885078|540278096|FG004|Step-down Period|Lost to Follow-up|0|||
149768443|NCT01885078|540278097|FG005|Step-down Period|Lost to Follow-up|0|||
149768444|NCT01885078|540278098|FG006|Step-down Period|Lost to Follow-up|0|||
149768445|NCT01885078|540278099|FG007|Step-down Period|Lost to Follow-up|0|||
149768446|NCT01885078|540278100|FG008|Step-down Period|Lost to Follow-up|1|||
149768447|NCT01885078|540278101|FG009|Step-down Period|Lost to Follow-up|1|||
149768448|NCT01885078|540278092|FG000|Step-down Period|Lack of Efficacy|0|||
149768449|NCT01885078|540278093|FG001|Step-down Period|Lack of Efficacy|0|||
149768450|NCT01885078|540278094|FG002|Step-down Period|Lack of Efficacy|0|||
149768451|NCT01885078|540278095|FG003|Step-down Period|Lack of Efficacy|0|||
149768452|NCT01885078|540278096|FG004|Step-down Period|Lack of Efficacy|0|||
149768453|NCT01885078|540278097|FG005|Step-down Period|Lack of Efficacy|0|||
149768454|NCT01885078|540278098|FG006|Step-down Period|Lack of Efficacy|0|||
149768455|NCT01885078|540278099|FG007|Step-down Period|Lack of Efficacy|0|||
149768456|NCT01885078|540278100|FG008|Step-down Period|Lack of Efficacy|1|||
149768457|NCT01885078|540278101|FG009|Step-down Period|Lack of Efficacy|0|||
149768458|NCT01885078|540278092|FG000|Step-down Period|Protocol Violation|0|||
149768459|NCT01885078|540278093|FG001|Step-down Period|Protocol Violation|0|||
149768460|NCT01885078|540278094|FG002|Step-down Period|Protocol Violation|0|||
149768461|NCT01885078|540278095|FG003|Step-down Period|Protocol Violation|0|||
149768462|NCT01885078|540278096|FG004|Step-down Period|Protocol Violation|0|||
149768463|NCT01885078|540278097|FG005|Step-down Period|Protocol Violation|0|||
149768464|NCT01885078|540278098|FG006|Step-down Period|Protocol Violation|0|||
149768465|NCT01885078|540278099|FG007|Step-down Period|Protocol Violation|0|||
149768466|NCT01885078|540278100|FG008|Step-down Period|Protocol Violation|1|||
149768467|NCT01885078|540278101|FG009|Step-down Period|Protocol Violation|1|||
149768468|NCT01895452|540278105|FG000|Overall Study|Adverse Event|1|||
149768469|NCT01895452|540278106|FG001|Overall Study|Adverse Event|4|||
149768470|NCT01895452|540278105|FG000|Overall Study|Lost to Follow-up|1|||
149768471|NCT01895452|540278106|FG001|Overall Study|Lost to Follow-up|5|||
149768472|NCT01895452|540278105|FG000|Overall Study|Pregnancy|0|||
149768473|NCT01895452|540278106|FG001|Overall Study|Pregnancy|1|||
149768474|NCT01895452|540278105|FG000|Overall Study|Withdrawal by Subject|2|||
149768475|NCT01895452|540278106|FG001|Overall Study|Withdrawal by Subject|14|||
149768476|NCT01895452|540278105|FG000|Overall Study|Underlying disease|0|||
149768477|NCT01895452|540278106|FG001|Overall Study|Underlying disease|3|||
149768478|NCT01895452|540278105|FG000|Overall Study|Noncompliance with study drug|0|||
149768479|NCT01895452|540278106|FG001|Overall Study|Noncompliance with study drug|1|||
149768480|NCT00980343|540278107|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
149768481|NCT00980343|540278108|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
149768482|NCT02899377|540278115|FG000|Overall Study|Adverse Event|1|||
149768483|NCT02899377|540278116|FG001|Overall Study|Adverse Event|0|||
149768484|NCT01231607|540278117|FG000|Overall Study|Adverse Event|0|||
149768485|NCT01231607|540278118|FG001|Overall Study|Adverse Event|8|||
149768486|NCT01231607|540278119|FG002|Overall Study|Adverse Event|4|||
149768487|NCT01231607|540278120|FG003|Overall Study|Adverse Event|4|||
149768488|NCT01231607|540278121|FG004|Overall Study|Adverse Event|5|||
149768489|NCT01231607|540278117|FG000|Overall Study|Lost to Follow-up|13|||
149768490|NCT01231607|540278118|FG001|Overall Study|Lost to Follow-up|11|||
149768491|NCT01231607|540278119|FG002|Overall Study|Lost to Follow-up|10|||
149768492|NCT01231607|540278120|FG003|Overall Study|Lost to Follow-up|10|||
149768493|NCT01231607|540278121|FG004|Overall Study|Lost to Follow-up|4|||
149768494|NCT01231607|540278117|FG000|Overall Study|Physician Decision|4|||
149768495|NCT01231607|540278118|FG001|Overall Study|Physician Decision|4|||
149768496|NCT01231607|540278119|FG002|Overall Study|Physician Decision|3|||
149768497|NCT01231607|540278120|FG003|Overall Study|Physician Decision|5|||
149768498|NCT01231607|540278121|FG004|Overall Study|Physician Decision|4|||
149768499|NCT01231607|540278117|FG000|Overall Study|Protocol Violation|3|||
149768500|NCT01231607|540278118|FG001|Overall Study|Protocol Violation|2|||
149768501|NCT01231607|540278119|FG002|Overall Study|Protocol Violation|0|||
149768502|NCT01231607|540278120|FG003|Overall Study|Protocol Violation|2|||
149768503|NCT01231607|540278121|FG004|Overall Study|Protocol Violation|2|||
149768504|NCT01231607|540278117|FG000|Overall Study|Withdrawal by Subject|9|||
149768505|NCT01231607|540278118|FG001|Overall Study|Withdrawal by Subject|9|||
149768506|NCT01231607|540278119|FG002|Overall Study|Withdrawal by Subject|14|||
149768507|NCT01231607|540278120|FG003|Overall Study|Withdrawal by Subject|17|||
149768508|NCT01231607|540278121|FG004|Overall Study|Withdrawal by Subject|9|||
149768509|NCT01677507|540278124|FG000|Initial Assignment|Adverse Event|0|||
149768510|NCT01677507|540278125|FG001|Initial Assignment|Adverse Event|1|||
149768511|NCT01677507|540278124|FG000|Initial Assignment|Protocol Violation|0|||
149768512|NCT01677507|540278125|FG001|Initial Assignment|Protocol Violation|1|||
149768513|NCT01677507|540278124|FG000|Second Assigment|Withdrawal by Subject|2|||
149768514|NCT01677507|540278125|FG001|Second Assigment|Withdrawal by Subject|2|||
149768515|NCT01677507|540278124|FG000|Second Assigment|Adverse Event|1|||
149768516|NCT01677507|540278125|FG001|Second Assigment|Adverse Event|3|||
149768517|NCT03779334|540278126|FG000|Overall Study|Withdrawal by Subject|3|||
149768518|NCT03779334|540278127|FG001|Overall Study|Withdrawal by Subject|0|||
149768519|NCT03779334|540278128|FG002|Overall Study|Withdrawal by Subject|0|||
149768520|NCT03779334|540278126|FG000|Overall Study|Ongoing in Study|5|||
149768521|NCT03779334|540278127|FG001|Overall Study|Ongoing in Study|13|||
149768522|NCT03779334|540278128|FG002|Overall Study|Ongoing in Study|5|||
149768523|NCT01608724|540278141|FG000|Overall Study|Withdrawal by Subject|131|||
149768524|NCT01608724|540278141|FG000|Overall Study|Lost to Follow-up|41|||
149768525|NCT01608724|540278141|FG000|Overall Study|Study-specific discontinuation criteria|32|||
149768526|NCT01608724|540278141|FG000|Overall Study|Adverse Event|29|||
149768527|NCT01608724|540278141|FG000|Overall Study|Protocol Violation|6|||
149768528|NCT01608724|540278141|FG000|Overall Study|bood sugar too high, etc.|3|||
149768529|NCT01608724|540278141|FG000|Overall Study|Safety reasons|1|||
149768530|NCT00363246|540278142|FG000|Overall Study|Death|40|||
149768531|NCT00363246|540278142|FG000|Overall Study|Withdrawal by Subject|19|||
149768532|NCT00363246|540278142|FG000|Overall Study|Lost to Follow-up|14|||
149768533|NCT00363246|540278142|FG000|Overall Study|Bad health|6|||
149768534|NCT00363246|540278142|FG000|Overall Study|Stopped using wheelchair|11|||
149768535|NCT00363246|540278142|FG000|Overall Study|Subject expressed security concerns|2|||
149768536|NCT00363246|540278142|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
149768537|NCT01822691|540278145|FG000|Overall Study|Withdrawal by Subject|2|||
149768538|NCT01553916|540278146|FG000|Overall Study|Withdrawal by Subject|2|||
149768539|NCT01553916|540278146|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
149768540|NCT00645567|540278149|FG000|Overall Study|Adverse Event|1|||
149768541|NCT00438399|540278152|FG000|Overall Study|Lost to Follow-up|2|||
149768542|NCT00438399|540278153|FG001|Overall Study|Lost to Follow-up|2|||
149768543|NCT00438399|540278154|FG002|Overall Study|Lost to Follow-up|1|||
149768544|NCT00438399|540278155|FG003|Overall Study|Lost to Follow-up|1|||
149768545|NCT00438399|540278156|FG004|Overall Study|Lost to Follow-up|1|||
149768546|NCT00438399|540278157|FG005|Overall Study|Lost to Follow-up|1|||
149768547|NCT00438399|540278152|FG000|Overall Study|Adverse Event|0|||
149768548|NCT00438399|540278153|FG001|Overall Study|Adverse Event|0|||
149768549|NCT00438399|540278154|FG002|Overall Study|Adverse Event|1|||
149768550|NCT00438399|540278155|FG003|Overall Study|Adverse Event|1|||
149768551|NCT00438399|540278156|FG004|Overall Study|Adverse Event|0|||
149768552|NCT00438399|540278157|FG005|Overall Study|Adverse Event|1|||
149768553|NCT00438399|540278152|FG000|Overall Study|Withdrawal by Subject|5|||
149768554|NCT00438399|540278153|FG001|Overall Study|Withdrawal by Subject|6|||
149768555|NCT00438399|540278154|FG002|Overall Study|Withdrawal by Subject|3|||
149768556|NCT00438399|540278155|FG003|Overall Study|Withdrawal by Subject|2|||
149768557|NCT00438399|540278156|FG004|Overall Study|Withdrawal by Subject|2|||
149768558|NCT00438399|540278157|FG005|Overall Study|Withdrawal by Subject|2|||
149768559|NCT00438399|540278152|FG000|Overall Study|Protocol Violation|0|||
149768560|NCT00438399|540278153|FG001|Overall Study|Protocol Violation|0|||
149768561|NCT00438399|540278154|FG002|Overall Study|Protocol Violation|1|||
149768562|NCT00438399|540278155|FG003|Overall Study|Protocol Violation|0|||
149768563|NCT00438399|540278156|FG004|Overall Study|Protocol Violation|0|||
149768564|NCT00438399|540278157|FG005|Overall Study|Protocol Violation|1|||
149768565|NCT00438399|540278152|FG000|Overall Study|Subje stopped study|0|||
149768566|NCT00438399|540278153|FG001|Overall Study|Subje stopped study|0|||
149768567|NCT00438399|540278154|FG002|Overall Study|Subje stopped study|1|||
149768568|NCT00438399|540278155|FG003|Overall Study|Subje stopped study|0|||
149768569|NCT00438399|540278156|FG004|Overall Study|Subje stopped study|0|||
149768570|NCT00438399|540278157|FG005|Overall Study|Subje stopped study|0|||
149768571|NCT00438399|540278152|FG000|Overall Study|Pregnancy|0|||
149768572|NCT00438399|540278153|FG001|Overall Study|Pregnancy|0|||
149768573|NCT00438399|540278154|FG002|Overall Study|Pregnancy|0|||
149768574|NCT00438399|540278155|FG003|Overall Study|Pregnancy|0|||
149768575|NCT00438399|540278156|FG004|Overall Study|Pregnancy|0|||
149768576|NCT00438399|540278157|FG005|Overall Study|Pregnancy|1|||
149768577|NCT00438399|540278152|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
149768578|NCT00438399|540278153|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
149768579|NCT00438399|540278154|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
149768580|NCT00438399|540278155|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
149768581|NCT00438399|540278156|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
149768582|NCT00438399|540278157|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
149768583|NCT00349752|540278161|FG000|Overall Study|Adverse Event|8|||
149768584|NCT00349752|540278162|FG001|Overall Study|Adverse Event|12|||
149768585|NCT00349752|540278161|FG000|Overall Study|Lack of Efficacy|37|||
149768586|NCT00349752|540278162|FG001|Overall Study|Lack of Efficacy|42|||
149768587|NCT00349752|540278161|FG000|Overall Study|Lost to Follow-up|4|||
149768588|NCT00349752|540278162|FG001|Overall Study|Lost to Follow-up|2|||
149768589|NCT00349752|540278161|FG000|Overall Study|Personal reasons|6|||
149768590|NCT00349752|540278162|FG001|Overall Study|Personal reasons|5|||
149768591|NCT00349752|540278161|FG000|Overall Study|Other: Required exclusionary medication|0|||
149768592|NCT00349752|540278162|FG001|Overall Study|Other: Required exclusionary medication|1|||
149768593|NCT00349752|540278161|FG000|Overall Study|Other: Non compliance|0|||
149768594|NCT00349752|540278162|FG001|Overall Study|Other: Non compliance|1|||
149768595|NCT00349752|540278161|FG000|Overall Study|Other: Patient stopped steroids|0|||
149768596|NCT00349752|540278162|FG001|Overall Study|Other: Patient stopped steroids|1|||
149768597|NCT00349752|540278161|FG000|Overall Study|Other: Patient's steroid use|1|||
149768598|NCT00349752|540278162|FG001|Overall Study|Other: Patient's steroid use|0|||
149768599|NCT00349752|540278161|FG000|Overall Study|Other: Ineligible|1|||
149768600|NCT00349752|540278162|FG001|Overall Study|Other: Ineligible|0|||
149768601|NCT00349752|540278161|FG000|Overall Study|Other: Inadvertently unblinded|1|||
149768602|NCT00349752|540278162|FG001|Overall Study|Other: Inadvertently unblinded|0|||
149768603|NCT00349752|540278161|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
149768604|NCT00349752|540278162|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
149768605|NCT00819585|540278163|FG000|Core Study|Adverse Event|2|||
149768606|NCT00819585|540278164|FG001|Core Study|Adverse Event|1|||
149768607|NCT00819585|540278165|FG002|Core Study|Adverse Event|1|||
149768608|NCT00819585|540278166|FG003|Core Study|Adverse Event|4|||
149768609|NCT00819585|540278167|FG004|Core Study|Adverse Event|1|||
149768610|NCT00819585|540278168|FG005|Core Study|Adverse Event|0|||
149768611|NCT00819585|540278169|FG006|Core Study|Adverse Event|2|||
149768612|NCT00819585|540278170|FG007|Core Study|Adverse Event|0|||
149768613|NCT00819585|540278171|FG008|Core Study|Adverse Event|0|||
149768614|NCT00819585|540278172|FG009|Core Study|Adverse Event|0|||
149768615|NCT00819585|540278173|FG010|Core Study|Adverse Event|0|||
149768616|NCT00819585|540278163|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
149768617|NCT00819585|540278164|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
149768618|NCT00819585|540278165|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
149768619|NCT00819585|540278166|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
149768620|NCT00819585|540278167|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
149768621|NCT00819585|540278168|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
149768622|NCT00819585|540278169|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
149768623|NCT00819585|540278170|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
149768624|NCT00819585|540278171|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
149768625|NCT00819585|540278172|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
149768626|NCT00819585|540278173|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
149768627|NCT00819585|540278163|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768628|NCT00819585|540278164|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
149768629|NCT00819585|540278165|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768630|NCT00819585|540278166|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768631|NCT00819585|540278167|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768632|NCT00819585|540278168|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768633|NCT00819585|540278169|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
149768634|NCT00819585|540278170|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768635|NCT00819585|540278171|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768636|NCT00819585|540278172|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768637|NCT00819585|540278173|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
149768638|NCT00819585|540278163|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
149768639|NCT00819585|540278164|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
149768640|NCT00819585|540278165|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
149768641|NCT00819585|540278166|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
149768642|NCT00819585|540278167|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
149768643|NCT00819585|540278168|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
149768644|NCT00819585|540278169|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
149768645|NCT00819585|540278170|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
149768646|NCT00819585|540278171|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
149768647|NCT00819585|540278172|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
149768648|NCT00819585|540278173|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
149768649|NCT00819585|540278163|FG000|Core Study|Subject Withdrew Consent|0|||
149768650|NCT00819585|540278164|FG001|Core Study|Subject Withdrew Consent|3|||
149768651|NCT00819585|540278165|FG002|Core Study|Subject Withdrew Consent|2|||
149768652|NCT00819585|540278166|FG003|Core Study|Subject Withdrew Consent|1|||
149768653|NCT00819585|540278167|FG004|Core Study|Subject Withdrew Consent|0|||
149768654|NCT00819585|540278168|FG005|Core Study|Subject Withdrew Consent|0|||
149768655|NCT00819585|540278169|FG006|Core Study|Subject Withdrew Consent|3|||
149768656|NCT00819585|540278170|FG007|Core Study|Subject Withdrew Consent|0|||
149768657|NCT00819585|540278171|FG008|Core Study|Subject Withdrew Consent|0|||
149768658|NCT00819585|540278172|FG009|Core Study|Subject Withdrew Consent|0|||
149768659|NCT00819585|540278173|FG010|Core Study|Subject Withdrew Consent|0|||
149768660|NCT00819585|540278163|FG000|Core Study|Lost to Follow-up|2|||
149768661|NCT00819585|540278164|FG001|Core Study|Lost to Follow-up|1|||
149768662|NCT00819585|540278165|FG002|Core Study|Lost to Follow-up|2|||
149768663|NCT00819585|540278166|FG003|Core Study|Lost to Follow-up|0|||
149768664|NCT00819585|540278167|FG004|Core Study|Lost to Follow-up|1|||
149768665|NCT00819585|540278168|FG005|Core Study|Lost to Follow-up|1|||
149768666|NCT00819585|540278169|FG006|Core Study|Lost to Follow-up|1|||
149768667|NCT00819585|540278170|FG007|Core Study|Lost to Follow-up|0|||
149768668|NCT00819585|540278171|FG008|Core Study|Lost to Follow-up|0|||
149768669|NCT00819585|540278172|FG009|Core Study|Lost to Follow-up|0|||
149768670|NCT00819585|540278173|FG010|Core Study|Lost to Follow-up|0|||
149768671|NCT00819585|540278163|FG000|Core Study|Administrative Problems|0|||
149768672|NCT00819585|540278164|FG001|Core Study|Administrative Problems|0|||
149768673|NCT00819585|540278165|FG002|Core Study|Administrative Problems|0|||
149768674|NCT00819585|540278166|FG003|Core Study|Administrative Problems|0|||
149768675|NCT00819585|540278167|FG004|Core Study|Administrative Problems|0|||
149768676|NCT00819585|540278168|FG005|Core Study|Administrative Problems|0|||
149768677|NCT00819585|540278169|FG006|Core Study|Administrative Problems|2|||
149768678|NCT00819585|540278170|FG007|Core Study|Administrative Problems|0|||
149768679|NCT00819585|540278171|FG008|Core Study|Administrative Problems|0|||
149768680|NCT00819585|540278172|FG009|Core Study|Administrative Problems|0|||
149768681|NCT00819585|540278173|FG010|Core Study|Administrative Problems|0|||
149768682|NCT00819585|540278163|FG000|Core Study|Death|0|||
149768683|NCT00819585|540278164|FG001|Core Study|Death|0|||
149768684|NCT00819585|540278165|FG002|Core Study|Death|0|||
149768685|NCT00819585|540278166|FG003|Core Study|Death|0|||
149768686|NCT00819585|540278167|FG004|Core Study|Death|0|||
149768687|NCT00819585|540278168|FG005|Core Study|Death|0|||
149768688|NCT00819585|540278169|FG006|Core Study|Death|1|||
149768689|NCT00819585|540278170|FG007|Core Study|Death|0|||
149768690|NCT00819585|540278171|FG008|Core Study|Death|0|||
149768691|NCT00819585|540278172|FG009|Core Study|Death|0|||
149768692|NCT00819585|540278173|FG010|Core Study|Death|0|||
149768693|NCT00819585|540278163|FG000|Core Study|Protocol Violation|0|||
149768694|NCT00819585|540278164|FG001|Core Study|Protocol Violation|0|||
149768695|NCT00819585|540278165|FG002|Core Study|Protocol Violation|1|||
149768696|NCT00819585|540278166|FG003|Core Study|Protocol Violation|0|||
149768697|NCT00819585|540278167|FG004|Core Study|Protocol Violation|0|||
149768698|NCT00819585|540278168|FG005|Core Study|Protocol Violation|1|||
149768699|NCT00819585|540278169|FG006|Core Study|Protocol Violation|3|||
149768700|NCT00819585|540278170|FG007|Core Study|Protocol Violation|0|||
149768701|NCT00819585|540278171|FG008|Core Study|Protocol Violation|0|||
149768702|NCT00819585|540278172|FG009|Core Study|Protocol Violation|0|||
149768703|NCT00819585|540278173|FG010|Core Study|Protocol Violation|0|||
149768704|NCT00819585|540278163|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
149768705|NCT00819585|540278164|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
149768706|NCT00819585|540278165|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
149768707|NCT00819585|540278166|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
149768708|NCT00819585|540278167|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
149768709|NCT00819585|540278168|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
149768710|NCT00819585|540278169|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
149768711|NCT00819585|540278170|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
149768712|NCT00819585|540278171|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
149768713|NCT00819585|540278172|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
149768714|NCT00819585|540278173|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
149768715|NCT00819585|540278163|FG000|Extension Study|Subject Withdrew Consent|0|||
149768716|NCT00819585|540278164|FG001|Extension Study|Subject Withdrew Consent|0|||
149768717|NCT00819585|540278165|FG002|Extension Study|Subject Withdrew Consent|0|||
149768718|NCT00819585|540278166|FG003|Extension Study|Subject Withdrew Consent|0|||
149768719|NCT00819585|540278167|FG004|Extension Study|Subject Withdrew Consent|0|||
149768720|NCT00819585|540278168|FG005|Extension Study|Subject Withdrew Consent|0|||
149768721|NCT00819585|540278169|FG006|Extension Study|Subject Withdrew Consent|0|||
149768722|NCT00819585|540278170|FG007|Extension Study|Subject Withdrew Consent|0|||
149768723|NCT00819585|540278171|FG008|Extension Study|Subject Withdrew Consent|3|||
149768724|NCT00819585|540278172|FG009|Extension Study|Subject Withdrew Consent|0|||
149768725|NCT00819585|540278173|FG010|Extension Study|Subject Withdrew Consent|1|||
149768726|NCT00819585|540278163|FG000|Extension Study|Lost to Follow-up|0|||
149768727|NCT00819585|540278164|FG001|Extension Study|Lost to Follow-up|0|||
149768728|NCT00819585|540278165|FG002|Extension Study|Lost to Follow-up|0|||
149768729|NCT00819585|540278166|FG003|Extension Study|Lost to Follow-up|0|||
149768730|NCT00819585|540278167|FG004|Extension Study|Lost to Follow-up|0|||
149768731|NCT00819585|540278168|FG005|Extension Study|Lost to Follow-up|0|||
149768732|NCT00819585|540278169|FG006|Extension Study|Lost to Follow-up|0|||
149768733|NCT00819585|540278170|FG007|Extension Study|Lost to Follow-up|0|||
149768734|NCT00819585|540278171|FG008|Extension Study|Lost to Follow-up|2|||
149768735|NCT00819585|540278172|FG009|Extension Study|Lost to Follow-up|1|||
149768736|NCT00819585|540278173|FG010|Extension Study|Lost to Follow-up|1|||
149768737|NCT00819585|540278163|FG000|Extension Study|Death|0|||
149768738|NCT00819585|540278164|FG001|Extension Study|Death|0|||
149768739|NCT00819585|540278165|FG002|Extension Study|Death|0|||
149768740|NCT00819585|540278166|FG003|Extension Study|Death|0|||
149768741|NCT00819585|540278167|FG004|Extension Study|Death|0|||
149768742|NCT00819585|540278168|FG005|Extension Study|Death|0|||
149768743|NCT00819585|540278169|FG006|Extension Study|Death|0|||
149768744|NCT00819585|540278170|FG007|Extension Study|Death|0|||
149768745|NCT00819585|540278171|FG008|Extension Study|Death|2|||
149768746|NCT00819585|540278172|FG009|Extension Study|Death|0|||
149768747|NCT00819585|540278173|FG010|Extension Study|Death|0|||
149768748|NCT03334396|540278174|FG000|Overall Study|Adverse Event|1|||
149768749|NCT03334396|540278175|FG001|Overall Study|Adverse Event|0|||
149768750|NCT03334396|540278176|FG002|Overall Study|Adverse Event|1|||
149768751|NCT03334396|540278177|FG003|Overall Study|Adverse Event|0|||
149768752|NCT03334396|540278178|FG004|Overall Study|Adverse Event|0|||
149768753|NCT03334396|540278179|FG005|Overall Study|Adverse Event|0|||
149768754|NCT03334396|540278180|FG006|Overall Study|Adverse Event|0|||
149768755|NCT03334396|540278181|FG007|Overall Study|Adverse Event|0|||
149768756|NCT03334396|540278174|FG000|Overall Study|Lack of Efficacy|10|||
149768757|NCT03334396|540278175|FG001|Overall Study|Lack of Efficacy|4|||
149768758|NCT03334396|540278176|FG002|Overall Study|Lack of Efficacy|1|||
149768759|NCT03334396|540278177|FG003|Overall Study|Lack of Efficacy|3|||
149768760|NCT03334396|540278178|FG004|Overall Study|Lack of Efficacy|1|||
149768761|NCT03334396|540278179|FG005|Overall Study|Lack of Efficacy|0|||
149768762|NCT03334396|540278180|FG006|Overall Study|Lack of Efficacy|0|||
149768763|NCT03334396|540278181|FG007|Overall Study|Lack of Efficacy|1|||
149768764|NCT03334396|540278174|FG000|Overall Study|Lost to Follow-up|0|||
149768765|NCT03334396|540278175|FG001|Overall Study|Lost to Follow-up|0|||
149768766|NCT03334396|540278176|FG002|Overall Study|Lost to Follow-up|1|||
149768767|NCT03334396|540278177|FG003|Overall Study|Lost to Follow-up|0|||
149768768|NCT03334396|540278178|FG004|Overall Study|Lost to Follow-up|0|||
149768769|NCT03334396|540278179|FG005|Overall Study|Lost to Follow-up|0|||
149768770|NCT03334396|540278180|FG006|Overall Study|Lost to Follow-up|1|||
149768771|NCT03334396|540278181|FG007|Overall Study|Lost to Follow-up|0|||
149768772|NCT03334396|540278174|FG000|Overall Study|Physician Decision|1|||
149768773|NCT03334396|540278175|FG001|Overall Study|Physician Decision|0|||
149768774|NCT03334396|540278176|FG002|Overall Study|Physician Decision|0|||
149768775|NCT03334396|540278177|FG003|Overall Study|Physician Decision|0|||
149768776|NCT03334396|540278178|FG004|Overall Study|Physician Decision|0|||
149768777|NCT03334396|540278179|FG005|Overall Study|Physician Decision|0|||
149768778|NCT03334396|540278180|FG006|Overall Study|Physician Decision|0|||
149768779|NCT03334396|540278181|FG007|Overall Study|Physician Decision|0|||
149768780|NCT03334396|540278174|FG000|Overall Study|Withdrawal by Subject|10|||
149768781|NCT03334396|540278175|FG001|Overall Study|Withdrawal by Subject|5|||
149768782|NCT03334396|540278176|FG002|Overall Study|Withdrawal by Subject|7|||
149768783|NCT03334396|540278177|FG003|Overall Study|Withdrawal by Subject|2|||
149768784|NCT03334396|540278178|FG004|Overall Study|Withdrawal by Subject|2|||
149768785|NCT03334396|540278179|FG005|Overall Study|Withdrawal by Subject|1|||
149768786|NCT03334396|540278180|FG006|Overall Study|Withdrawal by Subject|2|||
149768787|NCT03334396|540278181|FG007|Overall Study|Withdrawal by Subject|0|||
149768788|NCT03334396|540278174|FG000|Overall Study|Pregnancy|0|||
149768789|NCT03334396|540278175|FG001|Overall Study|Pregnancy|1|||
149768790|NCT03334396|540278176|FG002|Overall Study|Pregnancy|0|||
149768791|NCT03334396|540278177|FG003|Overall Study|Pregnancy|0|||
149768792|NCT03334396|540278178|FG004|Overall Study|Pregnancy|0|||
149768793|NCT03334396|540278179|FG005|Overall Study|Pregnancy|0|||
149768794|NCT03334396|540278180|FG006|Overall Study|Pregnancy|0|||
149768795|NCT03334396|540278181|FG007|Overall Study|Pregnancy|0|||
149768796|NCT03334396|540278174|FG000|Overall Study|Ineligible|0|||
149768797|NCT03334396|540278175|FG001|Overall Study|Ineligible|1|||
149768798|NCT03334396|540278176|FG002|Overall Study|Ineligible|0|||
149768799|NCT03334396|540278177|FG003|Overall Study|Ineligible|0|||
149768800|NCT03334396|540278178|FG004|Overall Study|Ineligible|0|||
149768801|NCT03334396|540278179|FG005|Overall Study|Ineligible|0|||
149768802|NCT03334396|540278180|FG006|Overall Study|Ineligible|0|||
149768803|NCT03334396|540278181|FG007|Overall Study|Ineligible|0|||
149768804|NCT03334396|540278174|FG000|Overall Study|Started New Job|1|||
149768805|NCT03334396|540278175|FG001|Overall Study|Started New Job|0|||
149768806|NCT03334396|540278176|FG002|Overall Study|Started New Job|0|||
149768807|NCT03334396|540278177|FG003|Overall Study|Started New Job|0|||
149768808|NCT03334396|540278178|FG004|Overall Study|Started New Job|0|||
149768809|NCT03334396|540278179|FG005|Overall Study|Started New Job|0|||
149768810|NCT03334396|540278180|FG006|Overall Study|Started New Job|0|||
149768811|NCT03334396|540278181|FG007|Overall Study|Started New Job|0|||
149768812|NCT03730194|540278185|FG000|First Stage Treatment|Withdrawal by Subject|1|||
149768813|NCT03730194|540278186|FG001|First Stage Treatment|Withdrawal by Subject|1|||
149768814|NCT03730194|540278187|FG002|First Stage Treatment|Withdrawal by Subject|0|||
149768815|NCT03730194|540278188|FG003|First Stage Treatment|Withdrawal by Subject|0|||
149768816|NCT03730194|540278189|FG004|First Stage Treatment|Withdrawal by Subject|0|||
149768817|NCT03730194|540278190|FG005|First Stage Treatment|Withdrawal by Subject|0|||
149768818|NCT03730194|540278185|FG000|First Stage Treatment|Protocol Violation|3|||
149768819|NCT03730194|540278186|FG001|First Stage Treatment|Protocol Violation|3|||
149768820|NCT03730194|540278187|FG002|First Stage Treatment|Protocol Violation|0|||
149768821|NCT03730194|540278188|FG003|First Stage Treatment|Protocol Violation|0|||
149768822|NCT03730194|540278189|FG004|First Stage Treatment|Protocol Violation|0|||
149768823|NCT03730194|540278190|FG005|First Stage Treatment|Protocol Violation|0|||
149768824|NCT01766817|540278191|FG000|Overall Study|Drug-related adverse event|1|||
149768825|NCT01766817|540278192|FG001|Overall Study|Drug-related adverse event|2|||
149768826|NCT01766817|540278193|FG002|Overall Study|Drug-related adverse event|1|||
149768827|NCT01766817|540278191|FG000|Overall Study|Drug-unrelated adverse event|3|||
149768828|NCT01766817|540278192|FG001|Overall Study|Drug-unrelated adverse event|3|||
149768829|NCT01766817|540278193|FG002|Overall Study|Drug-unrelated adverse event|3|||
149768830|NCT01766817|540278191|FG000|Overall Study|Death|1|||
149768831|NCT01766817|540278192|FG001|Overall Study|Death|1|||
149768832|NCT01766817|540278193|FG002|Overall Study|Death|0|||
149768833|NCT01766817|540278191|FG000|Overall Study|Unable to take study drug|0|||
149768834|NCT01766817|540278192|FG001|Overall Study|Unable to take study drug|1|||
149768835|NCT01766817|540278193|FG002|Overall Study|Unable to take study drug|0|||
149768836|NCT01766817|540278191|FG000|Overall Study|Withdrawal by Subject|2|||
149768837|NCT01766817|540278192|FG001|Overall Study|Withdrawal by Subject|0|||
149768838|NCT01766817|540278193|FG002|Overall Study|Withdrawal by Subject|3|||
149768839|NCT01766817|540278191|FG000|Overall Study|Subject non-compliance|0|||
149768840|NCT01766817|540278192|FG001|Overall Study|Subject non-compliance|1|||
149768841|NCT01766817|540278193|FG002|Overall Study|Subject non-compliance|2|||
149768842|NCT01766817|540278191|FG000|Overall Study|Physician Decision|3|||
149768843|NCT01766817|540278192|FG001|Overall Study|Physician Decision|3|||
149768844|NCT01766817|540278193|FG002|Overall Study|Physician Decision|4|||
149768845|NCT01766817|540278191|FG000|Overall Study|Other|1|||
149768846|NCT01766817|540278192|FG001|Overall Study|Other|0|||
149768847|NCT01766817|540278193|FG002|Overall Study|Other|0|||
149768848|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
149768849|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
149768850|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
149768851|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
149768852|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
149768853|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
149768854|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
149768855|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
149768856|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
149768857|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
149768858|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
149768859|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
149768860|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
149768861|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
149768862|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
149768863|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
149768864|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
149768865|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
149768866|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
149768867|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
149768868|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
149768869|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
149768870|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
149768871|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
149768872|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
149768873|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
149768874|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
149768875|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
149768876|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
149768877|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
149768878|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
149768879|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
149768880|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
149768881|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
149768882|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
149768883|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
149768884|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
149768885|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
149768886|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
149768887|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
149768888|NCT00383721|540278200|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
149768889|NCT00383721|540278201|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
149768890|NCT00383721|540278202|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
149768891|NCT00383721|540278203|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
149768892|NCT00383721|540278204|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
149768893|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
149768894|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
149768895|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
149768896|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
149768897|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
149768898|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
149768899|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
149768900|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
149768901|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
149768902|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
149768903|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
149768904|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
149768905|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
149768906|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
149768907|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
149768908|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
149768909|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
149768910|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
149768911|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
149768912|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
149768913|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149768914|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149768915|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149768916|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149768917|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
149768918|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
149768919|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
149768920|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
149768921|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
149768922|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
149768923|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149768924|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
149768925|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149768926|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149768927|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
149768928|NCT00383721|540278200|FG000|26-Week Treatment Safety Extension|Administrative|1|||
149768929|NCT00383721|540278201|FG001|26-Week Treatment Safety Extension|Administrative|2|||
149768930|NCT00383721|540278202|FG002|26-Week Treatment Safety Extension|Administrative|3|||
149768931|NCT00383721|540278203|FG003|26-Week Treatment Safety Extension|Administrative|1|||
149768932|NCT00383721|540278204|FG004|26-Week Treatment Safety Extension|Administrative|0|||
149768933|NCT03814590|540278205|FG000|Overall Study|Adverse Event|0|||
149768934|NCT03814590|540278206|FG001|Overall Study|Adverse Event|0|||
149768935|NCT03814590|540278207|FG002|Overall Study|Adverse Event|0|||
149768936|NCT03814590|540278208|FG003|Overall Study|Adverse Event|0|||
149768937|NCT03814590|540278209|FG004|Overall Study|Adverse Event|0|||
149768938|NCT03814590|540278210|FG005|Overall Study|Adverse Event|1|||
149768939|NCT03814590|540278211|FG006|Overall Study|Adverse Event|1|||
149768940|NCT03814590|540278212|FG007|Overall Study|Adverse Event|1|||
149768941|NCT03814590|540278213|FG008|Overall Study|Adverse Event|0|||
149768942|NCT03814590|540278214|FG009|Overall Study|Adverse Event|0|||
149768943|NCT03814590|540278215|FG010|Overall Study|Adverse Event|1|||
149768944|NCT03814590|540278216|FG011|Overall Study|Adverse Event|0|||
149768945|NCT03814590|540278217|FG012|Overall Study|Adverse Event|3|||
149768946|NCT03814590|540278218|FG013|Overall Study|Adverse Event|0|||
149768947|NCT03814590|540278205|FG000|Overall Study|Lost to Follow-up|0|||
149768948|NCT03814590|540278206|FG001|Overall Study|Lost to Follow-up|2|||
149768949|NCT03814590|540278207|FG002|Overall Study|Lost to Follow-up|1|||
149768950|NCT03814590|540278208|FG003|Overall Study|Lost to Follow-up|0|||
149768951|NCT03814590|540278209|FG004|Overall Study|Lost to Follow-up|1|||
149768952|NCT03814590|540278210|FG005|Overall Study|Lost to Follow-up|1|||
149768953|NCT03814590|540278211|FG006|Overall Study|Lost to Follow-up|1|||
149768954|NCT03814590|540278212|FG007|Overall Study|Lost to Follow-up|1|||
149768955|NCT03814590|540278213|FG008|Overall Study|Lost to Follow-up|0|||
149768956|NCT03814590|540278214|FG009|Overall Study|Lost to Follow-up|0|||
149768957|NCT03814590|540278215|FG010|Overall Study|Lost to Follow-up|1|||
149768958|NCT03814590|540278216|FG011|Overall Study|Lost to Follow-up|0|||
149768959|NCT03814590|540278217|FG012|Overall Study|Lost to Follow-up|0|||
149768960|NCT03814590|540278218|FG013|Overall Study|Lost to Follow-up|1|||
149768961|NCT03814590|540278205|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768962|NCT03814590|540278206|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768963|NCT03814590|540278207|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768964|NCT03814590|540278208|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768965|NCT03814590|540278209|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768966|NCT03814590|540278210|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768967|NCT03814590|540278211|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768968|NCT03814590|540278212|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768969|NCT03814590|540278213|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768970|NCT03814590|540278214|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
149768971|NCT03814590|540278215|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768972|NCT03814590|540278216|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768973|NCT03814590|540278217|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768974|NCT03814590|540278218|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149768975|NCT03814590|540278205|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768976|NCT03814590|540278206|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768977|NCT03814590|540278207|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768978|NCT03814590|540278208|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768979|NCT03814590|540278209|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768980|NCT03814590|540278210|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
149768981|NCT03814590|540278211|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149768982|NCT03814590|540278212|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
149768983|NCT03814590|540278213|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768984|NCT03814590|540278214|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
149768985|NCT03814590|540278215|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149768986|NCT03814590|540278216|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149768987|NCT03814590|540278217|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149768988|NCT03814590|540278218|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
149768989|NCT03814590|540278205|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768990|NCT03814590|540278206|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768991|NCT03814590|540278207|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768992|NCT03814590|540278208|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768993|NCT03814590|540278209|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768994|NCT03814590|540278210|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768995|NCT03814590|540278211|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768996|NCT03814590|540278212|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149768997|NCT03814590|540278213|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149768998|NCT03814590|540278214|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149768999|NCT03814590|540278215|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769000|NCT03814590|540278216|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769001|NCT03814590|540278217|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769002|NCT03814590|540278218|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769003|NCT03814590|540278205|FG000|Overall Study|UNKNOWN REASON|0|||
149769004|NCT03814590|540278206|FG001|Overall Study|UNKNOWN REASON|0|||
149769005|NCT03814590|540278207|FG002|Overall Study|UNKNOWN REASON|0|||
149769006|NCT03814590|540278208|FG003|Overall Study|UNKNOWN REASON|0|||
149769007|NCT03814590|540278209|FG004|Overall Study|UNKNOWN REASON|0|||
149769008|NCT03814590|540278210|FG005|Overall Study|UNKNOWN REASON|0|||
149769009|NCT03814590|540278211|FG006|Overall Study|UNKNOWN REASON|0|||
149769010|NCT03814590|540278212|FG007|Overall Study|UNKNOWN REASON|1|||
149769011|NCT03814590|540278213|FG008|Overall Study|UNKNOWN REASON|0|||
149769012|NCT03814590|540278214|FG009|Overall Study|UNKNOWN REASON|0|||
149769013|NCT03814590|540278215|FG010|Overall Study|UNKNOWN REASON|0|||
149769014|NCT03814590|540278216|FG011|Overall Study|UNKNOWN REASON|0|||
149769015|NCT03814590|540278217|FG012|Overall Study|UNKNOWN REASON|0|||
149769016|NCT03814590|540278218|FG013|Overall Study|UNKNOWN REASON|0|||
149769017|NCT03519516|540278219|FG000|Overall Study|Adverse Event|0|||
149769018|NCT03519516|540278220|FG001|Overall Study|Adverse Event|1|||
149769019|NCT05757427|540278224|FG000|Overall Study|Adverse Event|1|||
149769020|NCT05757427|540278224|FG000|Overall Study|Device deficiency|1|||
149769021|NCT05757427|540278224|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
149769022|NCT05757427|540278224|FG000|Overall Study|MWBI scan of only 1 breast|3|||
149769023|NCT05757427|540278224|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
149769024|NCT01255306|540280310|FG000|Overall Study|Physician Decision|1|||
149769025|NCT01255306|540280311|FG001|Overall Study|Physician Decision|1|||
149769026|NCT01179347|540280312|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
149769027|NCT01179347|540280313|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
149769028|NCT01179347|540280312|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
149769029|NCT01179347|540280313|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
149769030|NCT01179347|540280312|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
149769031|NCT01179347|540280313|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
149769032|NCT01179347|540280312|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
149769033|NCT01179347|540280313|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
149769034|NCT01179347|540280312|FG000|Double-blind Period (12 Weeks)|Other|2|||
149769035|NCT01179347|540280313|FG001|Double-blind Period (12 Weeks)|Other|4|||
149769036|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
149769037|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
149769038|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
149769039|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
149769040|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
149769041|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
149769042|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
149769043|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
149769044|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
149769045|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
149769046|NCT01179347|540280312|FG000|Open-label Period (12 Weeks)|Other|7|||
149769047|NCT01179347|540280313|FG001|Open-label Period (12 Weeks)|Other|4|||
149769048|NCT03363919|540280321|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
149769049|NCT03363919|540280322|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
149769050|NCT03363919|540280321|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
149769051|NCT03363919|540280322|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
149769052|NCT01827319|540280323|FG000|Overall Study|Lost to Follow-up|3|||
149769053|NCT00574119|540280324|FG000|Overall Study|Adverse Event|1|||
149769054|NCT00574119|540280324|FG000|Overall Study|Protocol Violation|1|||
149769055|NCT00574119|540280324|FG000|Overall Study|Withdrawal by Subject|1|||
149769056|NCT00574119|540280324|FG000|Overall Study|Physician Decision|1|||
149769057|NCT02586077|540280325|FG000|Overall Study|Withdrawal by Subject|1|||
149769058|NCT02586077|540280325|FG000|Overall Study|Physician Decision|4|||
149769059|NCT02586077|540280325|FG000|Overall Study|Lost to Follow-up|3|||
149769060|NCT03287245|540280326|FG000|Overall Study|Study terminated by sponsor|3|||
149769061|NCT03287245|540280327|FG001|Overall Study|Study terminated by sponsor|0|||
149769062|NCT03287245|540280328|FG002|Overall Study|Study terminated by sponsor|3|||
149769063|NCT03287245|540280329|FG003|Overall Study|Study terminated by sponsor|1|||
149769064|NCT03287245|540280326|FG000|Overall Study|Adverse Event|1|||
149769065|NCT03287245|540280327|FG001|Overall Study|Adverse Event|0|||
149769066|NCT03287245|540280328|FG002|Overall Study|Adverse Event|0|||
149769067|NCT03287245|540280329|FG003|Overall Study|Adverse Event|0|||
149769068|NCT03287245|540280326|FG000|Overall Study|Withdrawal by Subject|8|||
149769069|NCT03287245|540280327|FG001|Overall Study|Withdrawal by Subject|3|||
149769070|NCT03287245|540280328|FG002|Overall Study|Withdrawal by Subject|3|||
149769071|NCT03287245|540280329|FG003|Overall Study|Withdrawal by Subject|0|||
149769072|NCT03287245|540280326|FG000|Overall Study|Physician Decision|3|||
149769073|NCT03287245|540280327|FG001|Overall Study|Physician Decision|2|||
149769074|NCT03287245|540280328|FG002|Overall Study|Physician Decision|0|||
149769075|NCT03287245|540280329|FG003|Overall Study|Physician Decision|0|||
149769076|NCT02701192|540280330|FG000|Overall Study|Protocol Violation|2|||
149769077|NCT02701192|540280330|FG000|Overall Study|Lost to Follow-up|4|||
149769078|NCT02862548|540280331|FG000|Randomized Phase (Up to Week 48)|Death|0|||
149769079|NCT02862548|540280332|FG001|Randomized Phase (Up to Week 48)|Death|1|||
149769080|NCT02862548|540280331|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
149769081|NCT02862548|540280332|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
149769082|NCT02862548|540280331|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
149769083|NCT02862548|540280332|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
149769084|NCT02862548|540280331|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
149769085|NCT02862548|540280332|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
149769086|NCT00880763|540280333|FG000|Extension Period (Part 2)|Adverse Event|0|||
149769087|NCT00880763|540280334|FG001|Extension Period (Part 2)|Adverse Event|0|||
149769088|NCT00880763|540280335|FG002|Extension Period (Part 2)|Adverse Event|1|||
149769089|NCT00880763|540280336|FG003|Extension Period (Part 2)|Adverse Event|1|||
149769090|NCT00880763|540280333|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
149769091|NCT00880763|540280334|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
149769092|NCT00880763|540280335|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
149769093|NCT00880763|540280336|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
149769094|NCT00880763|540280333|FG000|Extension Period (Part 2)|Physician Decision|0|||
149769095|NCT00880763|540280334|FG001|Extension Period (Part 2)|Physician Decision|1|||
149769096|NCT00880763|540280335|FG002|Extension Period (Part 2)|Physician Decision|1|||
149769097|NCT00880763|540280336|FG003|Extension Period (Part 2)|Physician Decision|0|||
149769098|NCT00880763|540280333|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
149769099|NCT00880763|540280334|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
149769100|NCT00880763|540280335|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
149769101|NCT00880763|540280336|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
149769102|NCT00003476|540280338|FG000|Overall Study|Not evaluable|1|||
149769103|NCT00363051|540280343|FG000|Overall Study|Adminstrative problems|1|||
149769104|NCT00363051|540280344|FG001|Overall Study|Adminstrative problems|1|||
149769105|NCT00363051|540280343|FG000|Overall Study|Adverse Event|21|||
149769106|NCT00363051|540280344|FG001|Overall Study|Adverse Event|12|||
149769107|NCT00363051|540280343|FG000|Overall Study|New Cancer Therapy|2|||
149769108|NCT00363051|540280344|FG001|Overall Study|New Cancer Therapy|1|||
149769109|NCT00363051|540280343|FG000|Overall Study|Withdrawal by Subject|11|||
149769110|NCT00363051|540280344|FG001|Overall Study|Withdrawal by Subject|3|||
149769111|NCT00363051|540280343|FG000|Overall Study|Lost to Follow-up|0|||
149769112|NCT00363051|540280344|FG001|Overall Study|Lost to Follow-up|1|||
149769113|NCT00363051|540280343|FG000|Overall Study|Protocol Violation|0|||
149769114|NCT00363051|540280344|FG001|Overall Study|Protocol Violation|2|||
149769115|NCT00363051|540280343|FG000|Overall Study|Death|3|||
149769116|NCT00363051|540280344|FG001|Overall Study|Death|2|||
149769117|NCT01610076|540280352|FG000|Overall Study|Technical issue with video|0|||
149769118|NCT01610076|540280353|FG001|Overall Study|Technical issue with video|1|||
149769119|NCT01610076|540280352|FG000|Overall Study|Lost to Follow-up|3|||
149769120|NCT01610076|540280353|FG001|Overall Study|Lost to Follow-up|4|||
149769121|NCT01653158|540280357|FG000|Overall Study|Death|0|||
149769122|NCT01653158|540280358|FG001|Overall Study|Death|0|||
149769123|NCT01653158|540280359|FG002|Overall Study|Death|0|||
149769124|NCT01653158|540280360|FG003|Overall Study|Death|1|||
149769125|NCT01653158|540280361|FG004|Overall Study|Death|0|||
149769126|NCT01653158|540280362|FG005|Overall Study|Death|0|||
149769127|NCT01653158|540280363|FG006|Overall Study|Death|0|||
149769128|NCT01653158|540280364|FG007|Overall Study|Death|2|||
149769129|NCT01653158|540280357|FG000|Overall Study|Adverse Event|0|||
149769130|NCT01653158|540280358|FG001|Overall Study|Adverse Event|0|||
149769131|NCT01653158|540280359|FG002|Overall Study|Adverse Event|0|||
149769132|NCT01653158|540280360|FG003|Overall Study|Adverse Event|1|||
149769133|NCT01653158|540280361|FG004|Overall Study|Adverse Event|0|||
149769134|NCT01653158|540280362|FG005|Overall Study|Adverse Event|0|||
149769135|NCT01653158|540280363|FG006|Overall Study|Adverse Event|0|||
149769136|NCT01653158|540280364|FG007|Overall Study|Adverse Event|3|||
149769137|NCT01653158|540280357|FG000|Overall Study|Other|0|||
149769138|NCT01653158|540280358|FG001|Overall Study|Other|0|||
149769139|NCT01653158|540280359|FG002|Overall Study|Other|0|||
149769140|NCT01653158|540280360|FG003|Overall Study|Other|0|||
149769141|NCT01653158|540280361|FG004|Overall Study|Other|0|||
149769142|NCT01653158|540280362|FG005|Overall Study|Other|0|||
149769143|NCT01653158|540280363|FG006|Overall Study|Other|0|||
149769144|NCT01653158|540280364|FG007|Overall Study|Other|1|||
149769145|NCT01653158|540280357|FG000|Overall Study|Progressive disease|0|||
149769146|NCT01653158|540280358|FG001|Overall Study|Progressive disease|0|||
149769147|NCT01653158|540280359|FG002|Overall Study|Progressive disease|0|||
149769148|NCT01653158|540280360|FG003|Overall Study|Progressive disease|0|||
149769149|NCT01653158|540280361|FG004|Overall Study|Progressive disease|1|||
149769150|NCT01653158|540280362|FG005|Overall Study|Progressive disease|1|||
149769151|NCT01653158|540280363|FG006|Overall Study|Progressive disease|2|||
149769152|NCT01653158|540280364|FG007|Overall Study|Progressive disease|9|||
149769153|NCT01653158|540280357|FG000|Overall Study|Withdrawal by Subject|1|||
149769154|NCT01653158|540280358|FG001|Overall Study|Withdrawal by Subject|0|||
149769155|NCT01653158|540280359|FG002|Overall Study|Withdrawal by Subject|0|||
149769156|NCT01653158|540280360|FG003|Overall Study|Withdrawal by Subject|0|||
149769157|NCT01653158|540280361|FG004|Overall Study|Withdrawal by Subject|0|||
149769158|NCT01653158|540280362|FG005|Overall Study|Withdrawal by Subject|0|||
149769159|NCT01653158|540280363|FG006|Overall Study|Withdrawal by Subject|0|||
149769160|NCT01653158|540280364|FG007|Overall Study|Withdrawal by Subject|0|||
149769161|NCT01840228|540280373|FG000|Overall Study|Lost to Follow-up|1|||
149769162|NCT01840228|540280374|FG001|Overall Study|Lost to Follow-up|1|||
149769163|NCT01103778|540280377|FG000|Overall Study|Lost to Follow-up|1|||
149769164|NCT01103778|540280377|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
149769165|NCT01103778|540280377|FG000|Overall Study|Screen failure|1|||
149769166|NCT05590767|540280378|FG000|Overall Study|Protocol Violation|1|||
149769167|NCT05590767|540280378|FG000|Overall Study|surgery canceled|1|||
149769168|NCT05590767|540280378|FG000|Overall Study|interscalene brachial block not performed|1|||
149769169|NCT00634114|540280379|FG000|Overall Study|Adverse Event|6|||
149769170|NCT00634114|540280380|FG001|Overall Study|Adverse Event|8|||
149769171|NCT00634114|540280381|FG002|Overall Study|Adverse Event|3|||
149769172|NCT00634114|540280379|FG000|Overall Study|Withdrawal by Subject|9|||
149769173|NCT00634114|540280380|FG001|Overall Study|Withdrawal by Subject|6|||
149769174|NCT00634114|540280381|FG002|Overall Study|Withdrawal by Subject|11|||
149769175|NCT00634114|540280379|FG000|Overall Study|Lost to Follow-up|0|||
149769176|NCT00634114|540280380|FG001|Overall Study|Lost to Follow-up|0|||
149769177|NCT00634114|540280381|FG002|Overall Study|Lost to Follow-up|1|||
149769178|NCT00634114|540280379|FG000|Overall Study|Protocol Violation|3|||
149769179|NCT00634114|540280380|FG001|Overall Study|Protocol Violation|3|||
149769180|NCT00634114|540280381|FG002|Overall Study|Protocol Violation|1|||
149769181|NCT00634114|540280379|FG000|Overall Study|Pregnancy|1|||
149769182|NCT00634114|540280380|FG001|Overall Study|Pregnancy|0|||
149769183|NCT00634114|540280381|FG002|Overall Study|Pregnancy|0|||
149769184|NCT00634114|540280379|FG000|Overall Study|Incorrect enrolment|0|||
149769185|NCT00634114|540280380|FG001|Overall Study|Incorrect enrolment|1|||
149769186|NCT00634114|540280381|FG002|Overall Study|Incorrect enrolment|0|||
149769187|NCT00634114|540280379|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
149769188|NCT00634114|540280380|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
149769189|NCT00634114|540280381|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
149769190|NCT00634114|540280379|FG000|Overall Study|Difficult to continue|3|||
149769191|NCT00634114|540280380|FG001|Overall Study|Difficult to continue|1|||
149769192|NCT00634114|540280381|FG002|Overall Study|Difficult to continue|1|||
149769193|NCT00634114|540280379|FG000|Overall Study|Other reason|1|||
149769194|NCT00634114|540280380|FG001|Overall Study|Other reason|1|||
149769195|NCT00634114|540280381|FG002|Overall Study|Other reason|1|||
149769196|NCT02802878|540280382|FG000|Overall Study|Withdrawal by Subject|3|||
149769197|NCT02802878|540280383|FG001|Overall Study|Withdrawal by Subject|3|||
149769198|NCT02802878|540280382|FG000|Overall Study|Protocol Violation|1|||
149769199|NCT02802878|540280383|FG001|Overall Study|Protocol Violation|0|||
149769200|NCT01599754|540280384|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
149769201|NCT01599754|540280385|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
149769202|NCT01599754|540280384|FG000|Overall Study|Participant noncompliance|4|||
149769203|NCT01599754|540280385|FG001|Overall Study|Participant noncompliance|4|||
149769204|NCT01599754|540280384|FG000|Overall Study|Lost to Follow-up|13|||
149769205|NCT01599754|540280385|FG001|Overall Study|Lost to Follow-up|6|||
149769206|NCT01599754|540280384|FG000|Overall Study|Death|31|||
149769207|NCT01599754|540280385|FG001|Overall Study|Death|33|||
149769208|NCT01599754|540280384|FG000|Overall Study|Adverse Event|3|||
149769209|NCT01599754|540280385|FG001|Overall Study|Adverse Event|2|||
149769210|NCT01599754|540280384|FG000|Overall Study|Investigator decision|1|||
149769211|NCT01599754|540280385|FG001|Overall Study|Investigator decision|3|||
149769212|NCT01599754|540280384|FG000|Overall Study|Withdrawal by Subject|24|||
149769213|NCT01599754|540280385|FG001|Overall Study|Withdrawal by Subject|25|||
149769214|NCT01599754|540280384|FG000|Overall Study|Study terminated by sponsor|282|||
149769215|NCT01599754|540280385|FG001|Overall Study|Study terminated by sponsor|285|||
149769216|NCT01577160|540280390|FG000|Overall Study|Adverse Event|9|||
149769217|NCT01577160|540280390|FG000|Overall Study|Lack of Efficacy|15|||
149769218|NCT01577160|540280390|FG000|Overall Study|Lost to Follow-up|40|||
149769219|NCT01577160|540280390|FG000|Overall Study|Withdrawal by Subject|18|||
149769220|NCT01577160|540280390|FG000|Overall Study|Subject Uncooperative|7|||
149769221|NCT01577160|540280390|FG000|Overall Study|Other|9|||
149769222|NCT01551758|540280391|FG000|Overall Study|Adverse Event|29|||
149769223|NCT01551758|540280392|FG001|Overall Study|Adverse Event|43|||
149769224|NCT01551758|540280391|FG000|Overall Study|Lack of Efficacy|0|||
149769225|NCT01551758|540280392|FG001|Overall Study|Lack of Efficacy|1|||
149769226|NCT01551758|540280391|FG000|Overall Study|Protocol Violation|5|||
149769227|NCT01551758|540280392|FG001|Overall Study|Protocol Violation|6|||
149769228|NCT01551758|540280391|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
149769229|NCT01551758|540280392|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
149769230|NCT01551758|540280391|FG000|Overall Study|Lost to Follow-up|29|||
149769231|NCT01551758|540280392|FG001|Overall Study|Lost to Follow-up|25|||
149769232|NCT01551758|540280391|FG000|Overall Study|Physician Decision|9|||
149769233|NCT01551758|540280392|FG001|Overall Study|Physician Decision|3|||
149769234|NCT01551758|540280391|FG000|Overall Study|Withdrawal by Subject|14|||
149769235|NCT01551758|540280392|FG001|Overall Study|Withdrawal by Subject|17|||
149769236|NCT00101192|540280393|FG000|Overall Study|Ineligible|6|||
149769237|NCT00101192|540280393|FG000|Overall Study|Inevaluable|1|||
149769238|NCT03670641|540280394|FG000|Overall Study|Lost to Follow-up|3|||
149769239|NCT03691610|540280395|FG000|Overall Study|Adverse Event|0|||
149769240|NCT03691610|540280396|FG001|Overall Study|Adverse Event|1|||
149769241|NCT03691610|540280397|FG002|Overall Study|Adverse Event|0|||
149769242|NCT03691610|540280398|FG003|Overall Study|Adverse Event|0|||
149769243|NCT03691610|540280395|FG000|Overall Study|Protocol Deviation|15|||
149769244|NCT03691610|540280396|FG001|Overall Study|Protocol Deviation|8|||
149769245|NCT03691610|540280397|FG002|Overall Study|Protocol Deviation|1|||
149769246|NCT03691610|540280398|FG003|Overall Study|Protocol Deviation|2|||
149769247|NCT03691610|540280395|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
149769248|NCT03691610|540280396|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
149769249|NCT03691610|540280397|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
149769250|NCT03691610|540280398|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
149769251|NCT03691610|540280395|FG000|Overall Study|Lost to Follow-up|20|||
149769252|NCT03691610|540280396|FG001|Overall Study|Lost to Follow-up|11|||
149769253|NCT03691610|540280397|FG002|Overall Study|Lost to Follow-up|5|||
149769254|NCT03691610|540280398|FG003|Overall Study|Lost to Follow-up|2|||
149769255|NCT00242580|540280402|FG000|Overall Study|Adverse Event|3|||
149769256|NCT00242580|540280403|FG001|Overall Study|Adverse Event|0|||
149769257|NCT00242580|540280404|FG002|Overall Study|Adverse Event|2|||
149769258|NCT00242580|540280402|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149769259|NCT00242580|540280403|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
149769260|NCT00242580|540280404|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
149769261|NCT00242580|540280402|FG000|Overall Study|Protocol Violation|0|||
149769262|NCT00242580|540280403|FG001|Overall Study|Protocol Violation|0|||
149769263|NCT00242580|540280404|FG002|Overall Study|Protocol Violation|1|||
149769264|NCT00242580|540280402|FG000|Overall Study|Subject withdrew consent|2|||
149769265|NCT00242580|540280403|FG001|Overall Study|Subject withdrew consent|2|||
149769266|NCT00242580|540280404|FG002|Overall Study|Subject withdrew consent|5|||
149769267|NCT00242580|540280402|FG000|Overall Study|Lost to Follow-up|0|||
149769268|NCT00242580|540280403|FG001|Overall Study|Lost to Follow-up|3|||
149769269|NCT00242580|540280404|FG002|Overall Study|Lost to Follow-up|0|||
149769270|NCT00242580|540280402|FG000|Overall Study|Death|1|||
149769271|NCT00242580|540280403|FG001|Overall Study|Death|2|||
149769272|NCT00242580|540280404|FG002|Overall Study|Death|1|||
149769273|NCT01232894|540280405|FG000|Overall Study|Lost to Follow-up|0|||
149769274|NCT01232894|540280406|FG001|Overall Study|Lost to Follow-up|1|||
149769275|NCT01232894|540280405|FG000|Overall Study|Death|1|||
149769276|NCT01232894|540280406|FG001|Overall Study|Death|0|||
149769277|NCT01232894|540280405|FG000|Overall Study|Protocol Violation|1|||
149769278|NCT01232894|540280406|FG001|Overall Study|Protocol Violation|1|||
149769279|NCT01232894|540280405|FG000|Overall Study|Withdrawal by Subject|8|||
149769280|NCT01232894|540280406|FG001|Overall Study|Withdrawal by Subject|5|||
149769281|NCT01232894|540280405|FG000|Overall Study|Physician Decision|2|||
149769282|NCT01232894|540280406|FG001|Overall Study|Physician Decision|1|||
149769283|NCT03970395|540280411|FG000|Overall Study|Withdrawal by Subject|3|||
149769284|NCT03970395|540280412|FG001|Overall Study|Withdrawal by Subject|4|||
149769285|NCT03970395|540280411|FG000|Overall Study|Lost to Follow-up|4|||
149769286|NCT03970395|540280412|FG001|Overall Study|Lost to Follow-up|8|||
149769287|NCT00916370|540280413|FG000|Overall Study|Death|3|||
149769288|NCT00916370|540280414|FG001|Overall Study|Death|1|||
149769289|NCT00916370|540280413|FG000|Overall Study|Withdrawal by Subject|2|||
149769290|NCT00916370|540280414|FG001|Overall Study|Withdrawal by Subject|0|||
149769291|NCT00916370|540280413|FG000|Overall Study|Physician Decision|0|||
149769292|NCT00916370|540280414|FG001|Overall Study|Physician Decision|1|||
149769293|NCT00929734|540280415|FG000|Overall Study|Lost to Follow-up|2|||
149769294|NCT00929734|540280416|FG001|Overall Study|Lost to Follow-up|1|||
149769295|NCT00929734|540280415|FG000|Overall Study|Withdrawal by Subject|0|||
149769296|NCT00929734|540280416|FG001|Overall Study|Withdrawal by Subject|2|||
149769297|NCT00121992|540280418|FG000|Overall Study|Treatment not received|2|||
149769298|NCT00121992|540280419|FG001|Overall Study|Treatment not received|11|||
149769299|NCT01318512|540280420|FG000|Maintenance Period (6 Months)|Death|2|||
149769300|NCT01318512|540280420|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
149769301|NCT02756650|540280421|FG000|Overall Study|Physician Decision|1|||
149769302|NCT02756650|540280421|FG000|Overall Study|Adverse Event|1|||
149769303|NCT04348591|540280425|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
149769304|NCT04348591|540280426|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
149769305|NCT04348591|540280425|FG000|Imaging Session (120 Min)|Physician Decision|0|||
149769306|NCT04348591|540280426|FG001|Imaging Session (120 Min)|Physician Decision|1|||
149769307|NCT04348591|540280425|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
149769308|NCT04348591|540280426|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
149769309|NCT03722784|540280429|FG000|Overall Study|Withdrawal by Subject|1|||
149769310|NCT03722784|540280430|FG001|Overall Study|Withdrawal by Subject|0|||
149769311|NCT03722784|540280429|FG000|Overall Study|Physician Decision|1|||
149769312|NCT03722784|540280430|FG001|Overall Study|Physician Decision|1|||
149769313|NCT03722784|540280429|FG000|Overall Study|Protocol Violation|0|||
149769314|NCT03722784|540280430|FG001|Overall Study|Protocol Violation|1|||
149769315|NCT00910429|540280433|FG000|Overall Study|Death|18|||
149769316|NCT00910429|540280434|FG001|Overall Study|Death|12|||
149769317|NCT00910429|540280433|FG000|Overall Study|Withdrawal by Subject|3|||
149769318|NCT00910429|540280434|FG001|Overall Study|Withdrawal by Subject|2|||
149769319|NCT00910429|540280433|FG000|Overall Study|Protocol Violation|1|||
149769320|NCT00910429|540280434|FG001|Overall Study|Protocol Violation|0|||
149769321|NCT00910429|540280433|FG000|Overall Study|Lost to Follow-up|2|||
149769322|NCT00910429|540280434|FG001|Overall Study|Lost to Follow-up|1|||
149769323|NCT00910429|540280433|FG000|Overall Study|Adverse Event|10|||
149769324|NCT00910429|540280434|FG001|Overall Study|Adverse Event|5|||
149769325|NCT00910429|540280433|FG000|Overall Study|Drug non-compliance|1|||
149769326|NCT00910429|540280434|FG001|Overall Study|Drug non-compliance|0|||
149769327|NCT00910429|540280433|FG000|Overall Study|Lack of Efficacy|4|||
149769328|NCT00910429|540280434|FG001|Overall Study|Lack of Efficacy|1|||
149769329|NCT01317615|540280435|FG000|Overall Study|Disease progression|25|||
149769330|NCT01317615|540280435|FG000|Overall Study|New cancer therapy|5|||
149769331|NCT01317615|540280435|FG000|Overall Study|Death|6|||
149769332|NCT01317615|540280435|FG000|Overall Study|Withdrawal by Subject|5|||
149769333|NCT01317615|540280435|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149769334|NCT01317615|540280435|FG000|Overall Study|Adverse Event|7|||
149769335|NCT04465396|540280438|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
149769336|NCT04465396|540280439|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
149769337|NCT04465396|540280440|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
149769338|NCT04465396|540280441|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
149769339|NCT02648724|540280442|FG000|Overall Study|Withdrawal by Subject|0|||
149769340|NCT02648724|540280443|FG001|Overall Study|Withdrawal by Subject|1|||
149769341|NCT02648724|540280444|FG002|Overall Study|Withdrawal by Subject|1|||
149769342|NCT02648724|540280445|FG003|Overall Study|Withdrawal by Subject|0|||
149769343|NCT02648724|540280446|FG004|Overall Study|Withdrawal by Subject|1|||
149769344|NCT02648724|540280447|FG005|Overall Study|Withdrawal by Subject|0|||
149769345|NCT02648724|540280448|FG006|Overall Study|Withdrawal by Subject|0|||
149769346|NCT02648724|540280442|FG000|Overall Study|Progressive disease|2|||
149769347|NCT02648724|540280443|FG001|Overall Study|Progressive disease|2|||
149769348|NCT02648724|540280444|FG002|Overall Study|Progressive disease|2|||
149769349|NCT02648724|540280445|FG003|Overall Study|Progressive disease|3|||
149769350|NCT02648724|540280446|FG004|Overall Study|Progressive disease|22|||
149769351|NCT02648724|540280447|FG005|Overall Study|Progressive disease|7|||
149769352|NCT02648724|540280448|FG006|Overall Study|Progressive disease|8|||
149769353|NCT02648724|540280442|FG000|Overall Study|Other reason (unknown)|1|||
149769354|NCT02648724|540280443|FG001|Overall Study|Other reason (unknown)|0|||
149769355|NCT02648724|540280444|FG002|Overall Study|Other reason (unknown)|0|||
149769356|NCT02648724|540280445|FG003|Overall Study|Other reason (unknown)|0|||
149769357|NCT02648724|540280446|FG004|Overall Study|Other reason (unknown)|0|||
149769358|NCT02648724|540280447|FG005|Overall Study|Other reason (unknown)|0|||
149769359|NCT02648724|540280448|FG006|Overall Study|Other reason (unknown)|0|||
149769360|NCT02648724|540280442|FG000|Overall Study|Protocol Violation|0|||
149769361|NCT02648724|540280443|FG001|Overall Study|Protocol Violation|0|||
149769362|NCT02648724|540280444|FG002|Overall Study|Protocol Violation|0|||
149769363|NCT02648724|540280445|FG003|Overall Study|Protocol Violation|0|||
149769364|NCT02648724|540280446|FG004|Overall Study|Protocol Violation|1|||
149769365|NCT02648724|540280447|FG005|Overall Study|Protocol Violation|0|||
149769366|NCT02648724|540280448|FG006|Overall Study|Protocol Violation|0|||
149769367|NCT02648724|540280442|FG000|Overall Study|Death|0|||
149769368|NCT02648724|540280443|FG001|Overall Study|Death|0|||
149769369|NCT02648724|540280444|FG002|Overall Study|Death|0|||
149769370|NCT02648724|540280445|FG003|Overall Study|Death|0|||
149769371|NCT02648724|540280446|FG004|Overall Study|Death|0|||
149769372|NCT02648724|540280447|FG005|Overall Study|Death|0|||
149769373|NCT02648724|540280448|FG006|Overall Study|Death|3|||
149769374|NCT02648724|540280442|FG000|Overall Study|Physician Decision|0|||
149769375|NCT02648724|540280443|FG001|Overall Study|Physician Decision|0|||
149769376|NCT02648724|540280444|FG002|Overall Study|Physician Decision|0|||
149769377|NCT02648724|540280445|FG003|Overall Study|Physician Decision|0|||
149769378|NCT02648724|540280446|FG004|Overall Study|Physician Decision|1|||
149769379|NCT02648724|540280447|FG005|Overall Study|Physician Decision|0|||
149769380|NCT02648724|540280448|FG006|Overall Study|Physician Decision|1|||
149769381|NCT02648724|540280442|FG000|Overall Study|Transferred to named patient program|0|||
149769382|NCT02648724|540280443|FG001|Overall Study|Transferred to named patient program|0|||
149769383|NCT02648724|540280444|FG002|Overall Study|Transferred to named patient program|0|||
149769384|NCT02648724|540280445|FG003|Overall Study|Transferred to named patient program|0|||
149769385|NCT02648724|540280446|FG004|Overall Study|Transferred to named patient program|0|||
149769386|NCT02648724|540280447|FG005|Overall Study|Transferred to named patient program|1|||
149769387|NCT02648724|540280448|FG006|Overall Study|Transferred to named patient program|0|||
149769388|NCT01364233|540280449|FG000|Overall Study|Lost to Follow-up|1|||
149769389|NCT00302718|540280450|FG000|Overall Study|Participant left the hospital|1|||
149769390|NCT00302718|540280451|FG001|Overall Study|Participant left the hospital|0|||
149769391|NCT00302718|540280452|FG002|Overall Study|Participant left the hospital|0|||
149769392|NCT00302718|540280453|FG003|Overall Study|Participant left the hospital|1|||
149769393|NCT00302718|540280450|FG000|Overall Study|Withdrawal by Subject|0|||
149769394|NCT00302718|540280451|FG001|Overall Study|Withdrawal by Subject|1|||
149769395|NCT00302718|540280452|FG002|Overall Study|Withdrawal by Subject|0|||
149769396|NCT00302718|540280453|FG003|Overall Study|Withdrawal by Subject|0|||
149769397|NCT00302718|540280450|FG000|Overall Study|Participant left primary care setting|0|||
149769398|NCT00302718|540280451|FG001|Overall Study|Participant left primary care setting|0|||
149769399|NCT00302718|540280452|FG002|Overall Study|Participant left primary care setting|2|||
149769400|NCT00302718|540280453|FG003|Overall Study|Participant left primary care setting|1|||
149769401|NCT00738374|540280454|FG000|Induction Treatment Phase|Adverse Event|14|||
149769402|NCT00738374|540280455|FG001|Induction Treatment Phase|Adverse Event|0|||
149769403|NCT00738374|540280456|FG002|Induction Treatment Phase|Adverse Event|0|||
149769404|NCT00738374|540280457|FG003|Induction Treatment Phase|Adverse Event|0|||
149769405|NCT00738374|540280454|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
149769406|NCT00738374|540280455|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149769407|NCT00738374|540280456|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149769408|NCT00738374|540280457|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149769409|NCT00738374|540280454|FG000|Induction Treatment Phase|Physician Decision|2|||
149769410|NCT00738374|540280455|FG001|Induction Treatment Phase|Physician Decision|0|||
149769411|NCT00738374|540280456|FG002|Induction Treatment Phase|Physician Decision|0|||
149769412|NCT00738374|540280457|FG003|Induction Treatment Phase|Physician Decision|0|||
149769413|NCT00738374|540280454|FG000|Induction Treatment Phase|Protocol Violation|2|||
149769414|NCT00738374|540280455|FG001|Induction Treatment Phase|Protocol Violation|0|||
149769415|NCT00738374|540280456|FG002|Induction Treatment Phase|Protocol Violation|0|||
149769416|NCT00738374|540280457|FG003|Induction Treatment Phase|Protocol Violation|0|||
149769417|NCT00738374|540280454|FG000|Induction Treatment Phase|Non-compliance|1|||
149769418|NCT00738374|540280455|FG001|Induction Treatment Phase|Non-compliance|0|||
149769419|NCT00738374|540280456|FG002|Induction Treatment Phase|Non-compliance|0|||
149769420|NCT00738374|540280457|FG003|Induction Treatment Phase|Non-compliance|0|||
149769421|NCT00738374|540280454|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
149769422|NCT00738374|540280455|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
149769423|NCT00738374|540280456|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
149769424|NCT00738374|540280457|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
149769425|NCT00738374|540280454|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
149769426|NCT00738374|540280455|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
149769427|NCT00738374|540280456|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
149769428|NCT00738374|540280457|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
149769429|NCT00738374|540280454|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
149769430|NCT00738374|540280455|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
149769431|NCT00738374|540280456|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
149769432|NCT00738374|540280457|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
149769433|NCT00738374|540280454|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149769434|NCT00738374|540280455|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149769435|NCT00738374|540280456|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149769436|NCT00738374|540280457|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
149769437|NCT00738374|540280454|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149769438|NCT00738374|540280455|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
149769439|NCT00738374|540280456|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149769440|NCT00738374|540280457|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149769441|NCT00738374|540280454|FG000|Maintenance Treatment/Observation Phase|Other|0|||
149769442|NCT00738374|540280455|FG001|Maintenance Treatment/Observation Phase|Other|1|||
149769443|NCT00738374|540280456|FG002|Maintenance Treatment/Observation Phase|Other|0|||
149769444|NCT00738374|540280457|FG003|Maintenance Treatment/Observation Phase|Other|0|||
149769445|NCT00632541|540280458|FG000|Overall Study|Adverse Event|7|||
149769446|NCT02927873|540280459|FG000|Overall Study|Lost to Follow-up|0|||
149769447|NCT02927873|540280460|FG001|Overall Study|Lost to Follow-up|1|||
149769448|NCT02927873|540280461|FG002|Overall Study|Lost to Follow-up|0|||
149769449|NCT02927873|540280462|FG003|Overall Study|Lost to Follow-up|0|||
149769450|NCT02927873|540280463|FG004|Overall Study|Lost to Follow-up|0|||
149769451|NCT02927873|540280464|FG005|Overall Study|Lost to Follow-up|0|||
149769452|NCT02927873|540280459|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149769453|NCT02927873|540280460|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
149769454|NCT02927873|540280461|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149769455|NCT02927873|540280462|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149769456|NCT02927873|540280463|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149769457|NCT02927873|540280464|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149769458|NCT02927873|540280459|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769459|NCT02927873|540280460|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769460|NCT02927873|540280461|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769461|NCT02927873|540280462|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769462|NCT02927873|540280463|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149769463|NCT02927873|540280464|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149769464|NCT02927873|540280459|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149769465|NCT02927873|540280460|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
149769466|NCT02927873|540280461|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149769467|NCT02927873|540280462|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149769468|NCT02927873|540280463|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149769469|NCT02927873|540280464|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149769470|NCT02927873|540280459|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
149769471|NCT02927873|540280460|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149769472|NCT02927873|540280461|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149769473|NCT02927873|540280462|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149769474|NCT02927873|540280463|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149769475|NCT02927873|540280464|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149769476|NCT02927873|540280459|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
149769477|NCT02927873|540280460|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149769478|NCT02927873|540280461|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149769479|NCT02927873|540280462|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149769480|NCT02927873|540280463|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149769481|NCT02927873|540280464|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149769482|NCT03833817|540281774|FG000|Overall Study|Withdrawal by Subject|3|||
149769483|NCT03833817|540281775|FG001|Overall Study|Withdrawal by Subject|3|||
149769484|NCT03833817|540281774|FG000|Overall Study|Lost to Follow-up|3|||
149769485|NCT03833817|540281775|FG001|Overall Study|Lost to Follow-up|3|||
149769486|NCT00884221|540281776|FG000|Overall Study|Withdrawal by Subject|0|||
149769487|NCT00884221|540281777|FG001|Overall Study|Withdrawal by Subject|3|||
149769488|NCT00884221|540281776|FG000|Overall Study|Adverse Event|6|||
149769489|NCT00884221|540281777|FG001|Overall Study|Adverse Event|3|||
149769490|NCT00884221|540281776|FG000|Overall Study|Protocol Violation|16|||
149769491|NCT00884221|540281777|FG001|Overall Study|Protocol Violation|13|||
149769492|NCT00884221|540281776|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
149769493|NCT00884221|540281777|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
149769494|NCT01975246|540281782|FG000|Overall Study|Adverse Event|2|||
149769495|NCT01975246|540281783|FG001|Overall Study|Adverse Event|1|||
149769496|NCT01975246|540281782|FG000|Overall Study|Lack of Efficacy|1|||
149769497|NCT01975246|540281783|FG001|Overall Study|Lack of Efficacy|0|||
149769498|NCT01975246|540281782|FG000|Overall Study|Protocol Violation|1|||
149769499|NCT01975246|540281783|FG001|Overall Study|Protocol Violation|0|||
149769500|NCT01975246|540281782|FG000|Overall Study|Other than stated|0|||
149769501|NCT01975246|540281783|FG001|Overall Study|Other than stated|1|||
149769502|NCT00255034|540281784|FG000|Overall Study|Withdrawal by Subject|15|||
149769503|NCT00255034|540281785|FG001|Overall Study|Withdrawal by Subject|38|||
149769504|NCT01263093|540281786|FG000|Washout|Physician Decision|1|||
149769505|NCT01263093|540281787|FG001|Washout|Physician Decision|0|||
149769506|NCT01263093|540281786|FG000|Period 2|Adverse Event|1|||
149769507|NCT01263093|540281787|FG001|Period 2|Adverse Event|0|||
149769508|NCT00424346|540281788|FG000|Core Study|Adverse Event|5|||
149769509|NCT00424346|540281789|FG001|Core Study|Adverse Event|3|||
149769510|NCT00424346|540281790|FG002|Core Study|Adverse Event|1|||
149769511|NCT00424346|540281791|FG003|Core Study|Adverse Event|1|||
149769512|NCT00424346|540281788|FG000|Core Study|Abnormal Laboratory Values|0|||
149769513|NCT00424346|540281789|FG001|Core Study|Abnormal Laboratory Values|1|||
149769514|NCT00424346|540281790|FG002|Core Study|Abnormal Laboratory Values|0|||
149769515|NCT00424346|540281791|FG003|Core Study|Abnormal Laboratory Values|0|||
149769516|NCT00424346|540281788|FG000|Core Study|Lack of Efficacy|1|||
149769517|NCT00424346|540281789|FG001|Core Study|Lack of Efficacy|3|||
149769518|NCT00424346|540281790|FG002|Core Study|Lack of Efficacy|0|||
149769519|NCT00424346|540281791|FG003|Core Study|Lack of Efficacy|4|||
149769520|NCT00424346|540281788|FG000|Core Study|Withdrawal by Subject|1|||
149769521|NCT00424346|540281789|FG001|Core Study|Withdrawal by Subject|0|||
149769522|NCT00424346|540281790|FG002|Core Study|Withdrawal by Subject|0|||
149769523|NCT00424346|540281791|FG003|Core Study|Withdrawal by Subject|2|||
149769524|NCT00424346|540281788|FG000|Core Study|Lost to Follow-up|1|||
149769525|NCT00424346|540281789|FG001|Core Study|Lost to Follow-up|1|||
149769526|NCT00424346|540281790|FG002|Core Study|Lost to Follow-up|0|||
149769527|NCT00424346|540281791|FG003|Core Study|Lost to Follow-up|0|||
149769528|NCT00424346|540281788|FG000|Core Study|Administrative Problems|1|||
149769529|NCT00424346|540281789|FG001|Core Study|Administrative Problems|0|||
149769530|NCT00424346|540281790|FG002|Core Study|Administrative Problems|1|||
149769531|NCT00424346|540281791|FG003|Core Study|Administrative Problems|0|||
149769532|NCT00424346|540281788|FG000|Core Study|Protocol Violation|0|||
149769533|NCT00424346|540281789|FG001|Core Study|Protocol Violation|0|||
149769534|NCT00424346|540281790|FG002|Core Study|Protocol Violation|2|||
149769535|NCT00424346|540281791|FG003|Core Study|Protocol Violation|0|||
149769536|NCT00424346|540281788|FG000|Extension Phase|Adverse Event|0|||
149769537|NCT00424346|540281789|FG001|Extension Phase|Adverse Event|9|||
149769538|NCT00424346|540281790|FG002|Extension Phase|Adverse Event|5|||
149769539|NCT00424346|540281791|FG003|Extension Phase|Adverse Event|4|||
149769540|NCT00424346|540281788|FG000|Extension Phase|Lack of Efficacy|0|||
149769541|NCT00424346|540281789|FG001|Extension Phase|Lack of Efficacy|16|||
149769542|NCT00424346|540281790|FG002|Extension Phase|Lack of Efficacy|14|||
149769543|NCT00424346|540281791|FG003|Extension Phase|Lack of Efficacy|11|||
149769544|NCT00424346|540281788|FG000|Extension Phase|Withdrawal by Subject|0|||
149769545|NCT00424346|540281789|FG001|Extension Phase|Withdrawal by Subject|5|||
149769546|NCT00424346|540281790|FG002|Extension Phase|Withdrawal by Subject|3|||
149769547|NCT00424346|540281791|FG003|Extension Phase|Withdrawal by Subject|4|||
149769548|NCT00424346|540281788|FG000|Extension Phase|Lost to Follow-up|0|||
149769549|NCT00424346|540281789|FG001|Extension Phase|Lost to Follow-up|2|||
149769550|NCT00424346|540281790|FG002|Extension Phase|Lost to Follow-up|0|||
149769551|NCT00424346|540281791|FG003|Extension Phase|Lost to Follow-up|0|||
149769552|NCT00424346|540281788|FG000|Extension Phase|Administrative Problems|0|||
149769553|NCT00424346|540281789|FG001|Extension Phase|Administrative Problems|69|||
149769554|NCT00424346|540281790|FG002|Extension Phase|Administrative Problems|32|||
149769555|NCT00424346|540281791|FG003|Extension Phase|Administrative Problems|35|||
149769556|NCT00424346|540281788|FG000|Extension Phase|Death|0|||
149769557|NCT00424346|540281789|FG001|Extension Phase|Death|0|||
149769558|NCT00424346|540281790|FG002|Extension Phase|Death|0|||
149769559|NCT00424346|540281791|FG003|Extension Phase|Death|1|||
149769560|NCT00424346|540281788|FG000|Extension Phase|Protocol Violation|0|||
149769561|NCT00424346|540281789|FG001|Extension Phase|Protocol Violation|1|||
149769562|NCT00424346|540281790|FG002|Extension Phase|Protocol Violation|1|||
149769563|NCT00424346|540281791|FG003|Extension Phase|Protocol Violation|0|||
149769564|NCT03947255|540281793|FG000|Overall Study|Study Closure by Sponsor|2|||
149769565|NCT03947255|540281794|FG001|Overall Study|Study Closure by Sponsor|2|||
149769566|NCT03947255|540281793|FG000|Overall Study|Withdrawal by Subject|2|||
149769567|NCT03947255|540281794|FG001|Overall Study|Withdrawal by Subject|2|||
149769568|NCT03947255|540281793|FG000|Overall Study|Lost to Follow-up|2|||
149769569|NCT03947255|540281794|FG001|Overall Study|Lost to Follow-up|0|||
149769570|NCT03947255|540281793|FG000|Overall Study|Death|0|||
149769571|NCT03947255|540281794|FG001|Overall Study|Death|2|||
149769572|NCT02499575|540281795|FG000|Overall Study|Protocol Violation|0|||
149769573|NCT02499575|540281796|FG001|Overall Study|Protocol Violation|1|||
149769574|NCT01245764|540281799|FG000|Study Phase A|Other|3|||
149769575|NCT01245764|540281800|FG001|Study Phase A|Other|2|||
149769576|NCT01245764|540281801|FG002|Study Phase A|Other|3|||
149769577|NCT01245764|540281802|FG003|Study Phase A|Other|1|||
149769578|NCT01245764|540281799|FG000|Study Phase A|Protocol Violation|6|||
149769579|NCT01245764|540281800|FG001|Study Phase A|Protocol Violation|3|||
149769580|NCT01245764|540281801|FG002|Study Phase A|Protocol Violation|2|||
149769581|NCT01245764|540281802|FG003|Study Phase A|Protocol Violation|2|||
149769582|NCT01245764|540281799|FG000|Study Phase A|Lost to Follow-up|0|||
149769583|NCT01245764|540281800|FG001|Study Phase A|Lost to Follow-up|0|||
149769584|NCT01245764|540281801|FG002|Study Phase A|Lost to Follow-up|5|||
149769585|NCT01245764|540281802|FG003|Study Phase A|Lost to Follow-up|0|||
149769586|NCT02667457|540281803|FG000|Overall Study|Withdrawal by Subject|1|||
149769587|NCT02667457|540281804|FG001|Overall Study|Withdrawal by Subject|0|||
149769588|NCT02667457|540281803|FG000|Overall Study|Other Reason|0|||
149769589|NCT02667457|540281804|FG001|Overall Study|Other Reason|2|||
149769590|NCT00603733|540281805|FG000|Active Phase ITT|Adverse Event|8|||
149769591|NCT00603733|540281806|FG001|Active Phase ITT|Adverse Event|7|||
149769592|NCT00603733|540281805|FG000|Active Phase ITT|Withdrawal by Subject|0|||
149769593|NCT00603733|540281806|FG001|Active Phase ITT|Withdrawal by Subject|3|||
149769594|NCT00603733|540281805|FG000|Active Phase ITT|Lost to Follow-up|0|||
149769595|NCT00603733|540281806|FG001|Active Phase ITT|Lost to Follow-up|1|||
149769596|NCT00603733|540281805|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
149769597|NCT00603733|540281806|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
149769598|NCT00603733|540281805|FG000|Active Phase ITT|Lack of Efficacy|1|||
149769599|NCT00603733|540281806|FG001|Active Phase ITT|Lack of Efficacy|2|||
149769600|NCT00603733|540281805|FG000|Active Phase ITT|Subject moved, site closed|1|||
149769601|NCT00603733|540281806|FG001|Active Phase ITT|Subject moved, site closed|1|||
149769602|NCT00603733|540281805|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
149769603|NCT00603733|540281806|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
149769604|NCT00603733|540281805|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
149769605|NCT00603733|540281806|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
149769606|NCT00603733|540281805|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
149769607|NCT00603733|540281806|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
149769608|NCT00603733|540281805|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
149769609|NCT00603733|540281806|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
149769610|NCT00603733|540281805|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
149769611|NCT00603733|540281806|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
149769612|NCT00603733|540281805|FG000|Maintenance Phase ITT|Adverse Event|3|||
149769613|NCT00603733|540281806|FG001|Maintenance Phase ITT|Adverse Event|6|||
149769614|NCT00603733|540281805|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
149769615|NCT00603733|540281806|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
149769616|NCT00603733|540281805|FG000|Maintenance Phase ITT|Protocol Violation|1|||
149769617|NCT00603733|540281806|FG001|Maintenance Phase ITT|Protocol Violation|1|||
149769618|NCT00603733|540281805|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
149769619|NCT00603733|540281806|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
149769620|NCT00603733|540281805|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
149769621|NCT00603733|540281806|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
149769622|NCT00603733|540281805|FG000|Maintenance Phase ITT|Physician Decision|0|||
149769623|NCT00603733|540281806|FG001|Maintenance Phase ITT|Physician Decision|1|||
149769624|NCT00603733|540281805|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
149769625|NCT00603733|540281806|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
149769626|NCT03039738|540281819|FG000|Overall Study|Incomplete data sets|54|||
149769627|NCT03039738|540281820|FG001|Overall Study|Incomplete data sets|0|||
149769628|NCT00912340|540281821|FG000|Overall Study|Adverse Event|2|||
149769629|NCT00912340|540281822|FG001|Overall Study|Adverse Event|4|||
149769630|NCT00912340|540281823|FG002|Overall Study|Adverse Event|0|||
149769631|NCT00912340|540281821|FG000|Overall Study|Protocol revised to remove arm|0|||
149769632|NCT00912340|540281822|FG001|Overall Study|Protocol revised to remove arm|0|||
149769633|NCT00912340|540281823|FG002|Overall Study|Protocol revised to remove arm|4|||
149769634|NCT01253187|540281826|FG000|Period 2|Withdrawal by Subject|0|||
149769635|NCT01253187|540281827|FG001|Period 2|Withdrawal by Subject|0|||
149769636|NCT01253187|540281828|FG002|Period 2|Withdrawal by Subject|0|||
149769637|NCT01253187|540281829|FG003|Period 2|Withdrawal by Subject|0|||
149769638|NCT01253187|540281830|FG004|Period 2|Withdrawal by Subject|1|||
149769639|NCT01253187|540281831|FG005|Period 2|Withdrawal by Subject|0|||
149769640|NCT01253187|540281826|FG000|Period 3|Pregnancy|1|||
149769641|NCT01253187|540281827|FG001|Period 3|Pregnancy|0|||
149769642|NCT01253187|540281828|FG002|Period 3|Pregnancy|0|||
149769643|NCT01253187|540281829|FG003|Period 3|Pregnancy|0|||
149769644|NCT01253187|540281830|FG004|Period 3|Pregnancy|0|||
149769645|NCT01253187|540281831|FG005|Period 3|Pregnancy|0|||
149769646|NCT01253187|540281826|FG000|Period 3|difficulty with blood sampling|0|||
149769647|NCT01253187|540281827|FG001|Period 3|difficulty with blood sampling|1|||
149769648|NCT01253187|540281828|FG002|Period 3|difficulty with blood sampling|0|||
149769649|NCT01253187|540281829|FG003|Period 3|difficulty with blood sampling|0|||
149769650|NCT01253187|540281830|FG004|Period 3|difficulty with blood sampling|0|||
149769651|NCT01253187|540281831|FG005|Period 3|difficulty with blood sampling|0|||
149769652|NCT01253187|540281826|FG000|Period 3|non-compliance|0|||
149769653|NCT01253187|540281827|FG001|Period 3|non-compliance|0|||
149769654|NCT01253187|540281828|FG002|Period 3|non-compliance|0|||
149769655|NCT01253187|540281829|FG003|Period 3|non-compliance|0|||
149769656|NCT01253187|540281830|FG004|Period 3|non-compliance|1|||
149769657|NCT01253187|540281831|FG005|Period 3|non-compliance|0|||
149769658|NCT01293006|540281835|FG000|Period 2|Lost to Follow-up|1|||
149769659|NCT01293006|540281836|FG001|Period 2|Lost to Follow-up|0|||
149769660|NCT01293006|540281837|FG002|Period 2|Lost to Follow-up|0|||
149769661|NCT01293006|540281838|FG003|Period 2|Lost to Follow-up|0|||
149769662|NCT01494987|540281839|FG000|Overall Study|Adverse Event|6|||
149769663|NCT01494987|540281840|FG001|Overall Study|Adverse Event|5|||
149769664|NCT01494987|540281839|FG000|Overall Study|Hyperglycemia|6|||
149769665|NCT01494987|540281840|FG001|Overall Study|Hyperglycemia|4|||
149769666|NCT01494987|540281839|FG000|Overall Study|Investigator's Discretion|1|||
149769667|NCT01494987|540281840|FG001|Overall Study|Investigator's Discretion|2|||
149769668|NCT01494987|540281839|FG000|Overall Study|Lost to Follow-up|1|||
149769669|NCT01494987|540281840|FG001|Overall Study|Lost to Follow-up|1|||
149769670|NCT01494987|540281839|FG000|Overall Study|Protocol Violation|3|||
149769671|NCT01494987|540281840|FG001|Overall Study|Protocol Violation|3|||
149769672|NCT01494987|540281839|FG000|Overall Study|Subject Non-Compliance|9|||
149769673|NCT01494987|540281840|FG001|Overall Study|Subject Non-Compliance|10|||
149769674|NCT01494987|540281839|FG000|Overall Study|Subject Withdrew Consent|2|||
149769675|NCT01494987|540281840|FG001|Overall Study|Subject Withdrew Consent|3|||
149769676|NCT02254551|540281843|FG000|Dose Escalation|Physician Decision|1|||
149769677|NCT02254551|540281843|FG000|Dose Escalation|Dose-limiting toxicity|2|||
149769678|NCT02062463|540281844|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
149769679|NCT02062463|540281845|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
149769680|NCT02062463|540281846|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
149769681|NCT02062463|540281847|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
149769682|NCT02062463|540281844|FG000|Stage 2|Adverse Event|0|||
149769683|NCT02062463|540281845|FG001|Stage 2|Adverse Event|0|||
149769684|NCT02062463|540281846|FG002|Stage 2|Adverse Event|12|||
149769685|NCT02062463|540281847|FG003|Stage 2|Adverse Event|20|||
149769686|NCT02062463|540281844|FG000|Stage 2|Lack of Efficacy|0|||
149769687|NCT02062463|540281845|FG001|Stage 2|Lack of Efficacy|0|||
149769688|NCT02062463|540281846|FG002|Stage 2|Lack of Efficacy|3|||
149769689|NCT02062463|540281847|FG003|Stage 2|Lack of Efficacy|4|||
149769690|NCT02062463|540281844|FG000|Stage 2|Lost to Follow-up|0|||
149769691|NCT02062463|540281845|FG001|Stage 2|Lost to Follow-up|0|||
149769692|NCT02062463|540281846|FG002|Stage 2|Lost to Follow-up|20|||
149769693|NCT02062463|540281847|FG003|Stage 2|Lost to Follow-up|20|||
149769694|NCT02062463|540281844|FG000|Stage 2|Non-Compliance|0|||
149769695|NCT02062463|540281845|FG001|Stage 2|Non-Compliance|0|||
149769696|NCT02062463|540281846|FG002|Stage 2|Non-Compliance|0|||
149769697|NCT02062463|540281847|FG003|Stage 2|Non-Compliance|1|||
149769698|NCT02062463|540281844|FG000|Stage 2|Other than specified|0|||
149769699|NCT02062463|540281845|FG001|Stage 2|Other than specified|0|||
149769700|NCT02062463|540281846|FG002|Stage 2|Other than specified|3|||
149769701|NCT02062463|540281847|FG003|Stage 2|Other than specified|1|||
149769702|NCT02062463|540281844|FG000|Stage 2|Withdrawal by Subject|0|||
149769703|NCT02062463|540281845|FG001|Stage 2|Withdrawal by Subject|0|||
149769704|NCT02062463|540281846|FG002|Stage 2|Withdrawal by Subject|15|||
149769705|NCT02062463|540281847|FG003|Stage 2|Withdrawal by Subject|10|||
149769706|NCT00600028|540281858|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149769707|NCT00600028|540281859|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
149769708|NCT00600028|540281858|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
149769709|NCT00600028|540281859|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
149769710|NCT00600028|540281858|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
149769711|NCT00600028|540281859|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
149769712|NCT03172481|540281860|FG000|Double-blind|Withdrawal by Subject|1|||
149769713|NCT03172481|540281861|FG001|Double-blind|Withdrawal by Subject|0|||
149769714|NCT00830115|540281862|FG000|Overall Study|Adverse Event|2|||
149769715|NCT00830115|540281862|FG000|Overall Study|Improvement/recovery|1|||
149769716|NCT01925612|540281863|FG000|Overall Study|Progressive Disease|1|||
149769717|NCT01925612|540281864|FG001|Overall Study|Progressive Disease|1|||
149769718|NCT01925612|540281865|FG002|Overall Study|Progressive Disease|1|||
149769719|NCT01925612|540281866|FG003|Overall Study|Progressive Disease|0|||
149769720|NCT01925612|540281867|FG004|Overall Study|Progressive Disease|0|||
149769721|NCT01925612|540281863|FG000|Overall Study|Adverse Event|3|||
149769722|NCT01925612|540281864|FG001|Overall Study|Adverse Event|3|||
149769723|NCT01925612|540281865|FG002|Overall Study|Adverse Event|0|||
149769724|NCT01925612|540281866|FG003|Overall Study|Adverse Event|1|||
149769725|NCT01925612|540281867|FG004|Overall Study|Adverse Event|2|||
149769726|NCT01107405|540281872|FG000|Overall Study|Adverse Event|1|||
149769727|NCT01107405|540281873|FG001|Overall Study|Adverse Event|1|||
149769728|NCT01107405|540281874|FG002|Overall Study|Adverse Event|0|||
149769729|NCT01107405|540281875|FG003|Overall Study|Adverse Event|0|||
149769730|NCT01107405|540281876|FG004|Overall Study|Adverse Event|2|||
149769731|NCT01107405|540281872|FG000|Overall Study|Withdrawal by Subject|1|||
149769732|NCT01107405|540281873|FG001|Overall Study|Withdrawal by Subject|0|||
149769733|NCT01107405|540281874|FG002|Overall Study|Withdrawal by Subject|1|||
149769734|NCT01107405|540281875|FG003|Overall Study|Withdrawal by Subject|2|||
149769735|NCT01107405|540281876|FG004|Overall Study|Withdrawal by Subject|1|||
149769736|NCT01107405|540281872|FG000|Overall Study|Protocol Violation|0|||
149769737|NCT01107405|540281873|FG001|Overall Study|Protocol Violation|0|||
149769738|NCT01107405|540281874|FG002|Overall Study|Protocol Violation|1|||
149769739|NCT01107405|540281875|FG003|Overall Study|Protocol Violation|1|||
149769740|NCT01107405|540281876|FG004|Overall Study|Protocol Violation|0|||
149769741|NCT01170702|540281878|FG000|Overall Study|Exclusion criteria met after consent|1|||
149769742|NCT01170702|540281879|FG001|Overall Study|Exclusion criteria met after consent|2|||
149769743|NCT01170702|540281880|FG002|Overall Study|Exclusion criteria met after consent|0|||
149769744|NCT01170702|540281881|FG003|Overall Study|Exclusion criteria met after consent|2|||
149769745|NCT00085917|540281882|FG000|Overall Study|Adverse Event|4|||
149769746|NCT00085917|540281883|FG001|Overall Study|Adverse Event|3|||
149769747|NCT01360762|540281886|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
149769748|NCT01360762|540281886|FG000|Main Study Period (12-month Treatment)|Death|5|||
149769749|NCT01360762|540281886|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
149769750|NCT01360762|540281886|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
149769751|NCT01360762|540281886|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
149769752|NCT01360762|540281886|FG000|Whole Study Period|Lost to Follow-up|10|||
149769753|NCT01360762|540281886|FG000|Whole Study Period|Death|7|||
149769754|NCT01360762|540281886|FG000|Whole Study Period|Patient relapsed|18|||
149769755|NCT01360762|540281886|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
149769756|NCT03084718|540281887|FG000|Overall Study|Withdrawal by Subject|4|||
149769757|NCT03084718|540281888|FG001|Overall Study|Withdrawal by Subject|3|||
149769758|NCT03084718|540281889|FG002|Overall Study|Withdrawal by Subject|4|||
149769759|NCT03084718|540281890|FG003|Overall Study|Withdrawal by Subject|0|||
149769760|NCT03084718|540281891|FG004|Overall Study|Withdrawal by Subject|0|||
149769761|NCT03084718|540281887|FG000|Overall Study|Physician Decision|1|||
149769762|NCT03084718|540281888|FG001|Overall Study|Physician Decision|0|||
149769763|NCT03084718|540281889|FG002|Overall Study|Physician Decision|0|||
149769764|NCT03084718|540281890|FG003|Overall Study|Physician Decision|0|||
149769765|NCT03084718|540281891|FG004|Overall Study|Physician Decision|0|||
149769766|NCT03084718|540281887|FG000|Overall Study|Adverse Event|3|||
149769767|NCT03084718|540281888|FG001|Overall Study|Adverse Event|5|||
149769768|NCT03084718|540281889|FG002|Overall Study|Adverse Event|5|||
149769769|NCT03084718|540281890|FG003|Overall Study|Adverse Event|8|||
149769770|NCT03084718|540281891|FG004|Overall Study|Adverse Event|2|||
149769771|NCT03084718|540281887|FG000|Overall Study|Lack of Efficacy|2|||
149769772|NCT03084718|540281888|FG001|Overall Study|Lack of Efficacy|0|||
149769773|NCT03084718|540281889|FG002|Overall Study|Lack of Efficacy|1|||
149769774|NCT03084718|540281890|FG003|Overall Study|Lack of Efficacy|4|||
149769775|NCT03084718|540281891|FG004|Overall Study|Lack of Efficacy|0|||
149769776|NCT03084718|540281887|FG000|Overall Study|Lost to Follow-up|0|||
149769777|NCT03084718|540281888|FG001|Overall Study|Lost to Follow-up|1|||
149769778|NCT03084718|540281889|FG002|Overall Study|Lost to Follow-up|0|||
149769779|NCT03084718|540281890|FG003|Overall Study|Lost to Follow-up|0|||
149769780|NCT03084718|540281891|FG004|Overall Study|Lost to Follow-up|2|||
149769781|NCT03084718|540281887|FG000|Overall Study|Protocol Violation|0|||
149769782|NCT03084718|540281888|FG001|Overall Study|Protocol Violation|0|||
149769783|NCT03084718|540281889|FG002|Overall Study|Protocol Violation|1|||
149769784|NCT03084718|540281890|FG003|Overall Study|Protocol Violation|0|||
149769785|NCT03084718|540281891|FG004|Overall Study|Protocol Violation|0|||
149769786|NCT03084718|540281887|FG000|Overall Study|Death|0|||
149769787|NCT03084718|540281888|FG001|Overall Study|Death|1|||
149769788|NCT03084718|540281889|FG002|Overall Study|Death|0|||
149769789|NCT03084718|540281890|FG003|Overall Study|Death|0|||
149769790|NCT03084718|540281891|FG004|Overall Study|Death|0|||
149769791|NCT03084718|540281887|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
149769792|NCT03084718|540281888|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
149769793|NCT03084718|540281889|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
149769794|NCT03084718|540281890|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
149769795|NCT03084718|540281891|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
149769796|NCT02806947|540281892|FG000|Overall Study|Withdrawal by Subject|5|||
149769797|NCT02806947|540281893|FG001|Overall Study|Withdrawal by Subject|1|||
149769798|NCT00865189|540281894|FG000|Overall Study|Other|1|||
149769799|NCT00865189|540281895|FG001|Overall Study|Other|2|||
149769800|NCT00865189|540281894|FG000|Overall Study|Death|4|||
149769801|NCT00865189|540281895|FG001|Overall Study|Death|11|||
149769802|NCT00865189|540281894|FG000|Overall Study|Lost to Follow-up|6|||
149769803|NCT00865189|540281895|FG001|Overall Study|Lost to Follow-up|6|||
149769804|NCT00865189|540281894|FG000|Overall Study|Withdrawal by Subject|1|||
149769805|NCT00865189|540281895|FG001|Overall Study|Withdrawal by Subject|0|||
149769806|NCT00084929|540281897|FG000|Overall Study|ineligible - medical contraindication|1|||
149769807|NCT00084929|540281897|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
149769808|NCT00084929|540281897|FG000|Overall Study|Ineligible - Medical history|6|||
149769809|NCT00084929|540281897|FG000|Overall Study|Withdrawal by Subject|10|||
149769810|NCT00084929|540281897|FG000|Overall Study|Missing/incomplete CTC exam|9|||
149769811|NCT00084929|540281897|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
149769812|NCT00091026|540281899|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
149769813|NCT00091026|540281900|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
149769814|NCT00091026|540281899|FG000|Overall Study|Patient withdrew and never received trea|0|||
149769815|NCT00091026|540281900|FG001|Overall Study|Patient withdrew and never received trea|2|||
149769816|NCT00091026|540281899|FG000|Overall Study|Unknown-never received treatment|0|||
149769817|NCT00091026|540281900|FG001|Overall Study|Unknown-never received treatment|1|||
149769818|NCT03666858|540281901|FG000|Cohort 1|Adverse Event|1|||
149769819|NCT03666858|540281902|FG001|Cohort 1|Adverse Event|0|||
149769820|NCT03666858|540281901|FG000|Cohort 2|Adverse Event|0|||
149769821|NCT03666858|540281902|FG001|Cohort 2|Adverse Event|1|||
149769822|NCT00980980|540281903|FG000|Overall Study|Withdrawal by Hospital|0|||
149769823|NCT00980980|540281904|FG001|Overall Study|Withdrawal by Hospital|1|||
149769824|NCT00980980|540281905|FG002|Overall Study|Withdrawal by Hospital|0|||
149769825|NCT02921919|540281906|FG000|Overall Study|Other|5|||
149769826|NCT02921919|540281907|FG001|Overall Study|Other|6|||
149769827|NCT02921919|540281906|FG000|Overall Study|Lost to Follow-up|0|||
149769828|NCT02921919|540281907|FG001|Overall Study|Lost to Follow-up|1|||
149769829|NCT02921919|540281906|FG000|Overall Study|Withdrawal by Subject|5|||
149769830|NCT02921919|540281907|FG001|Overall Study|Withdrawal by Subject|1|||
149769831|NCT02921919|540281906|FG000|Overall Study|Disease Progression|47|||
149769832|NCT02921919|540281907|FG001|Overall Study|Disease Progression|38|||
149769833|NCT02921919|540281906|FG000|Overall Study|Physician Decision|3|||
149769834|NCT02921919|540281907|FG001|Overall Study|Physician Decision|2|||
149769835|NCT02921919|540281906|FG000|Overall Study|Adverse Event|6|||
149769836|NCT02921919|540281907|FG001|Overall Study|Adverse Event|4|||
149769837|NCT03550131|540281908|FG000|Overall Study|Lost to Follow-up|16|||
149769838|NCT03550131|540281909|FG001|Overall Study|Lost to Follow-up|24|||
149769839|NCT03550131|540281908|FG000|Overall Study|Withdrawal by Subject|36|||
149769840|NCT03550131|540281909|FG001|Overall Study|Withdrawal by Subject|28|||
149769841|NCT03550131|540281908|FG000|Overall Study|Illness of dyad member|10|||
149769842|NCT03550131|540281909|FG001|Overall Study|Illness of dyad member|2|||
149769843|NCT03550131|540281908|FG000|Overall Study|Death of person with dementia|4|||
149769844|NCT03550131|540281909|FG001|Overall Study|Death of person with dementia|8|||
149769845|NCT00986427|540281910|FG000|Overall Study|Lost to Follow-up|2|||
149769846|NCT00986427|540281911|FG001|Overall Study|Lost to Follow-up|0|||
149769847|NCT00986427|540281910|FG000|Overall Study|Lack of Efficacy|1|||
149769848|NCT00986427|540281911|FG001|Overall Study|Lack of Efficacy|0|||
149769849|NCT00986427|540281910|FG000|Overall Study|Withdrawal by Subject|1|||
149769850|NCT00986427|540281911|FG001|Overall Study|Withdrawal by Subject|0|||
149769851|NCT03245723|540281917|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
149769852|NCT03245723|540281918|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
149769853|NCT03245723|540281917|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
149769854|NCT03245723|540281918|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
149769855|NCT03245723|540281917|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
149769856|NCT03245723|540281918|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
149769857|NCT03245723|540281917|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
149769858|NCT03245723|540281918|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
149769859|NCT00077376|540281919|FG000|Overall Study|Adverse Event|8|||
149769860|NCT00077376|540281919|FG000|Overall Study|Withdrawal by Subject|2|||
149769861|NCT00077376|540281919|FG000|Overall Study|Death|1|||
149769862|NCT00077376|540281919|FG000|Overall Study|Physician Decision|1|||
149769863|NCT00077376|540281919|FG000|Overall Study|Alternative therapy|5|||
149769864|NCT00077376|540281919|FG000|Overall Study|Complicating disease|1|||
149769865|NCT00077376|540281919|FG000|Overall Study|Still on treatment|1|||
149769866|NCT00077376|540281919|FG000|Overall Study|Symptomatic deterioration|1|||
149769867|NCT00077376|540281919|FG000|Overall Study|Surgery|1|||
149769868|NCT00077376|540281919|FG000|Overall Study|Insurance ran out|1|||
149769869|NCT01283997|540283510|FG000|Overall Study|Physician Decision|8|||
149769870|NCT01283997|540283511|FG001|Overall Study|Physician Decision|10|||
149769871|NCT01283997|540283510|FG000|Overall Study|Withdrawal by Subject|3|||
149769872|NCT01283997|540283511|FG001|Overall Study|Withdrawal by Subject|2|||
149769873|NCT01283997|540283510|FG000|Overall Study|Physically unable to continue|0|||
149769874|NCT01283997|540283511|FG001|Overall Study|Physically unable to continue|1|||
149769875|NCT01283997|540283510|FG000|Overall Study|Progressive disease|1|||
149769876|NCT01283997|540283511|FG001|Overall Study|Progressive disease|0|||
149769877|NCT01283997|540283510|FG000|Overall Study|Other|4|||
149769878|NCT01283997|540283511|FG001|Overall Study|Other|4|||
149769879|NCT02109744|540283512|FG000|Overall Study|Death|1|||
149769880|NCT02109744|540283513|FG001|Overall Study|Death|1|||
149769881|NCT02109744|540283512|FG000|Overall Study|no marrow exam|1|||
149769882|NCT02109744|540283513|FG001|Overall Study|no marrow exam|0|||
149769883|NCT04095442|540283517|FG000|Overall Study|Lost to Follow-up|0|||
149769884|NCT04095442|540283518|FG001|Overall Study|Lost to Follow-up|1|||
149769885|NCT04095442|540283517|FG000|Overall Study|Screen failure|1|||
149769886|NCT04095442|540283518|FG001|Overall Study|Screen failure|0|||
149769887|NCT01677624|540283519|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
149769888|NCT01337167|540283520|FG000|Infant Series|Adverse Event|1|||
149769889|NCT01337167|540283521|FG001|Infant Series|Adverse Event|1|||
149769890|NCT01337167|540283520|FG000|Infant Series|Death|1|||
149769891|NCT01337167|540283521|FG001|Infant Series|Death|1|||
149769892|NCT01337167|540283520|FG000|Infant Series|Lost to Follow-up|13|||
149769893|NCT01337167|540283521|FG001|Infant Series|Lost to Follow-up|7|||
149769894|NCT01337167|540283520|FG000|Infant Series|Non-compliance with study drug|2|||
149769895|NCT01337167|540283521|FG001|Infant Series|Non-compliance with study drug|1|||
149769896|NCT01337167|540283520|FG000|Infant Series|Physician Decision|3|||
149769897|NCT01337167|540283521|FG001|Infant Series|Physician Decision|1|||
149769898|NCT01337167|540283520|FG000|Infant Series|Protocol Violation|22|||
149769899|NCT01337167|540283521|FG001|Infant Series|Protocol Violation|9|||
149769900|NCT01337167|540283520|FG000|Infant Series|Withdrawal by Subject|15|||
149769901|NCT01337167|540283521|FG001|Infant Series|Withdrawal by Subject|4|||
149769902|NCT01337167|540283520|FG000|Infant Series|Randomized but not vaccinated|5|||
149769903|NCT01337167|540283521|FG001|Infant Series|Randomized but not vaccinated|3|||
149769904|NCT01337167|540283520|FG000|Interim Period|Lost to Follow-up|51|||
149769905|NCT01337167|540283521|FG001|Interim Period|Lost to Follow-up|23|||
149769906|NCT01337167|540283520|FG000|Interim Period|Non-compliance with study drug|1|||
149769907|NCT01337167|540283521|FG001|Interim Period|Non-compliance with study drug|0|||
149769908|NCT01337167|540283520|FG000|Interim Period|Physician Decision|6|||
149769909|NCT01337167|540283521|FG001|Interim Period|Physician Decision|3|||
149769910|NCT01337167|540283520|FG000|Interim Period|Protocol Violation|5|||
149769911|NCT01337167|540283521|FG001|Interim Period|Protocol Violation|3|||
149769912|NCT01337167|540283520|FG000|Interim Period|Withdrawal by Subject|18|||
149769913|NCT01337167|540283521|FG001|Interim Period|Withdrawal by Subject|10|||
149769914|NCT01337167|540283520|FG000|Interim Period|Other protocol criterion not met|0|||
149769915|NCT01337167|540283521|FG001|Interim Period|Other protocol criterion not met|1|||
149769916|NCT01337167|540283520|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
149769917|NCT01337167|540283521|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
149769918|NCT01337167|540283520|FG000|Toddler Vaccinations|Protocol Violation|0|||
149769919|NCT01337167|540283521|FG001|Toddler Vaccinations|Protocol Violation|1|||
149769920|NCT01337167|540283520|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
149769921|NCT01337167|540283521|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
149769922|NCT02126670|540283524|FG000|Overall Study|Withdrawal by Subject|1|||
149769923|NCT02126670|540283525|FG001|Overall Study|Withdrawal by Subject|0|||
149769924|NCT02126670|540283526|FG002|Overall Study|Withdrawal by Subject|0|||
149769925|NCT02126670|540283527|FG003|Overall Study|Withdrawal by Subject|1|||
149769926|NCT03097614|540283531|FG000|Overall Study|Adverse Event|3|||
149769927|NCT00436982|540283532|FG000|Overall Study|Withdrawal by Subject|3|||
149769928|NCT00436982|540283533|FG001|Overall Study|Withdrawal by Subject|1|||
149769929|NCT00436982|540283532|FG000|Overall Study|Did not receive allocated intervention|0|||
149769930|NCT00436982|540283533|FG001|Overall Study|Did not receive allocated intervention|1|||
149769931|NCT00436982|540283532|FG000|Overall Study|no RSA data|1|||
149769932|NCT00436982|540283533|FG001|Overall Study|no RSA data|2|||
149769933|NCT00953225|540283534|FG000|Overall Study|Withdrawal by Subject|2|||
149769934|NCT00953225|540283535|FG001|Overall Study|Withdrawal by Subject|0|||
149769935|NCT04058158|540283539|FG000|Period 1|Death|1|||
149769936|NCT04058158|540283540|FG001|Period 1|Death|0|||
149769937|NCT04058158|540283539|FG000|Period 1|Adverse Event|1|||
149769938|NCT04058158|540283540|FG001|Period 1|Adverse Event|1|||
149769939|NCT04058158|540283539|FG000|Period 1|Pregnancy|0|||
149769940|NCT04058158|540283540|FG001|Period 1|Pregnancy|1|||
149769941|NCT02215616|540283541|FG000|Overall Study|Sponsor requested to stop study drug|0|||
149769942|NCT02215616|540283542|FG001|Overall Study|Sponsor requested to stop study drug|0|||
149769943|NCT02215616|540283543|FG002|Overall Study|Sponsor requested to stop study drug|1|||
149769944|NCT02215616|540283544|FG003|Overall Study|Sponsor requested to stop study drug|4|||
149769945|NCT02215616|540283541|FG000|Overall Study|Death|1|||
149769946|NCT02215616|540283542|FG001|Overall Study|Death|0|||
149769947|NCT02215616|540283543|FG002|Overall Study|Death|0|||
149769948|NCT02215616|540283544|FG003|Overall Study|Death|0|||
149769949|NCT02215616|540283541|FG000|Overall Study|Adverse Event|7|||
149769950|NCT02215616|540283542|FG001|Overall Study|Adverse Event|4|||
149769951|NCT02215616|540283543|FG002|Overall Study|Adverse Event|9|||
149769952|NCT02215616|540283544|FG003|Overall Study|Adverse Event|2|||
149769953|NCT02215616|540283541|FG000|Overall Study|Withdrawal by Subject|1|||
149769954|NCT02215616|540283542|FG001|Overall Study|Withdrawal by Subject|8|||
149769955|NCT02215616|540283543|FG002|Overall Study|Withdrawal by Subject|2|||
149769956|NCT02215616|540283544|FG003|Overall Study|Withdrawal by Subject|5|||
149769957|NCT02215616|540283541|FG000|Overall Study|Non-compliance|0|||
149769958|NCT02215616|540283542|FG001|Overall Study|Non-compliance|2|||
149769959|NCT02215616|540283543|FG002|Overall Study|Non-compliance|1|||
149769960|NCT02215616|540283544|FG003|Overall Study|Non-compliance|0|||
149769961|NCT02215616|540283541|FG000|Overall Study|Protocol Violation|0|||
149769962|NCT02215616|540283542|FG001|Overall Study|Protocol Violation|2|||
149769963|NCT02215616|540283543|FG002|Overall Study|Protocol Violation|0|||
149769964|NCT02215616|540283544|FG003|Overall Study|Protocol Violation|0|||
149769965|NCT02215616|540283541|FG000|Overall Study|Lost to Follow-up|1|||
149769966|NCT02215616|540283542|FG001|Overall Study|Lost to Follow-up|1|||
149769967|NCT02215616|540283543|FG002|Overall Study|Lost to Follow-up|0|||
149769968|NCT02215616|540283544|FG003|Overall Study|Lost to Follow-up|1|||
149769969|NCT02215616|540283541|FG000|Overall Study|Other than specified|1|||
149769970|NCT02215616|540283542|FG001|Overall Study|Other than specified|0|||
149769971|NCT02215616|540283543|FG002|Overall Study|Other than specified|1|||
149769972|NCT02215616|540283544|FG003|Overall Study|Other than specified|1|||
149769973|NCT01634113|540283545|FG000|Overall Study|Not treated|0|||
149769974|NCT01634113|540283546|FG001|Overall Study|Not treated|0|||
149769975|NCT01634113|540283547|FG002|Overall Study|Not treated|1|||
149769976|NCT00520299|540283550|FG000|Overall Study|Withdrawal by Subject|0|||
149769977|NCT00520299|540283551|FG001|Overall Study|Withdrawal by Subject|0|||
149769978|NCT00520299|540283552|FG002|Overall Study|Withdrawal by Subject|2|||
149769979|NCT00520299|540283550|FG000|Overall Study|Progressive disease|0|||
149769980|NCT00520299|540283551|FG001|Overall Study|Progressive disease|3|||
149769981|NCT00520299|540283552|FG002|Overall Study|Progressive disease|4|||
149769982|NCT01352845|540283553|FG000|Overall Study|Lost to Follow-up|313|||
149769983|NCT01352845|540283554|FG001|Overall Study|Lost to Follow-up|92|||
149769984|NCT01352845|540283553|FG000|Overall Study|No Longer Willing to Participate|205|||
149769985|NCT01352845|540283554|FG001|Overall Study|No Longer Willing to Participate|58|||
149769986|NCT01352845|540283553|FG000|Overall Study|Withdrawal by Subject|48|||
149769987|NCT01352845|540283554|FG001|Overall Study|Withdrawal by Subject|16|||
149769988|NCT01352845|540283553|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
149769989|NCT01352845|540283554|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
149769990|NCT01352845|540283553|FG000|Overall Study|Pregnancy|27|||
149769991|NCT01352845|540283554|FG001|Overall Study|Pregnancy|7|||
149769992|NCT01352845|540283553|FG000|Overall Study|Adverse Event|22|||
149769993|NCT01352845|540283554|FG001|Overall Study|Adverse Event|6|||
149769994|NCT01352845|540283553|FG000|Overall Study|Other|17|||
149769995|NCT01352845|540283554|FG001|Overall Study|Other|7|||
149769996|NCT01352845|540283553|FG000|Overall Study|Protocol Violation|12|||
149769997|NCT01352845|540283554|FG001|Overall Study|Protocol Violation|6|||
149769998|NCT01352845|540283553|FG000|Overall Study|Death|3|||
149769999|NCT01352845|540283554|FG001|Overall Study|Death|0|||
149770000|NCT01956240|540283555|FG000|Overall Study|Lost to Follow-up|6|||
149770001|NCT01956240|540283556|FG001|Overall Study|Lost to Follow-up|20|||
149770002|NCT01956240|540283555|FG000|Overall Study|Adverse Event|17|||
149770003|NCT01956240|540283556|FG001|Overall Study|Adverse Event|4|||
149770004|NCT02759562|540283560|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
149770005|NCT02759562|540283561|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
149770006|NCT02759562|540283560|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
149770007|NCT02759562|540283561|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
149770008|NCT02293993|540283562|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
149770009|NCT02293993|540283563|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
149770010|NCT02293993|540283564|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
149770011|NCT02293993|540283565|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
149770012|NCT02293993|540283562|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
149770013|NCT02293993|540283563|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
149770014|NCT02293993|540283564|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
149770015|NCT02293993|540283565|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
149770016|NCT02293993|540283562|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149770017|NCT02293993|540283563|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149770018|NCT02293993|540283564|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
149770019|NCT02293993|540283565|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149770020|NCT02293993|540283562|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
149770021|NCT02293993|540283563|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
149770022|NCT02293993|540283564|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
149770023|NCT02293993|540283565|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
149770024|NCT02293993|540283562|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149770025|NCT02293993|540283563|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
149770026|NCT02293993|540283564|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149770027|NCT02293993|540283565|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149770028|NCT01957709|540283566|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
149770029|NCT03587584|540283567|FG000|Overall Study|SOC deviations|4|||
149770030|NCT03587584|540283568|FG001|Overall Study|SOC deviations|6|||
149770031|NCT03587584|540283567|FG000|Overall Study|Incomplete data|0|||
149770032|NCT03587584|540283568|FG001|Overall Study|Incomplete data|3|||
149770033|NCT01061736|540283571|FG000|Overall Study|Dose regimen not selected|0|||
149770034|NCT01061736|540283572|FG001|Overall Study|Dose regimen not selected|0|||
149770035|NCT01061736|540283573|FG002|Overall Study|Dose regimen not selected|0|||
149770036|NCT01061736|540283574|FG003|Overall Study|Dose regimen not selected|0|||
149770037|NCT01061736|540283575|FG004|Overall Study|Dose regimen not selected|0|||
149770038|NCT01061736|540283576|FG005|Overall Study|Dose regimen not selected|0|||
149770039|NCT01061736|540283577|FG006|Overall Study|Dose regimen not selected|79|||
149770040|NCT01061736|540283578|FG007|Overall Study|Dose regimen not selected|0|||
149770041|NCT01061736|540283579|FG008|Overall Study|Dose regimen not selected|0|||
149770042|NCT01061736|540283580|FG009|Overall Study|Dose regimen not selected|0|||
149770043|NCT01061736|540283571|FG000|Overall Study|Adverse Event|13|||
149770044|NCT01061736|540283572|FG001|Overall Study|Adverse Event|1|||
149770045|NCT01061736|540283573|FG002|Overall Study|Adverse Event|3|||
149770046|NCT01061736|540283574|FG003|Overall Study|Adverse Event|2|||
149770047|NCT01061736|540283575|FG004|Overall Study|Adverse Event|4|||
149770048|NCT01061736|540283576|FG005|Overall Study|Adverse Event|1|||
149770049|NCT01061736|540283577|FG006|Overall Study|Adverse Event|4|||
149770050|NCT01061736|540283578|FG007|Overall Study|Adverse Event|63|||
149770051|NCT01061736|540283579|FG008|Overall Study|Adverse Event|67|||
149770052|NCT01061736|540283580|FG009|Overall Study|Adverse Event|34|||
149770053|NCT01061736|540283571|FG000|Overall Study|Lack of Efficacy|0|||
149770054|NCT01061736|540283572|FG001|Overall Study|Lack of Efficacy|2|||
149770055|NCT01061736|540283573|FG002|Overall Study|Lack of Efficacy|1|||
149770056|NCT01061736|540283574|FG003|Overall Study|Lack of Efficacy|1|||
149770057|NCT01061736|540283575|FG004|Overall Study|Lack of Efficacy|1|||
149770058|NCT01061736|540283576|FG005|Overall Study|Lack of Efficacy|2|||
149770059|NCT01061736|540283577|FG006|Overall Study|Lack of Efficacy|1|||
149770060|NCT01061736|540283578|FG007|Overall Study|Lack of Efficacy|9|||
149770061|NCT01061736|540283579|FG008|Overall Study|Lack of Efficacy|9|||
149770062|NCT01061736|540283580|FG009|Overall Study|Lack of Efficacy|10|||
149770063|NCT01061736|540283571|FG000|Overall Study|Poor compliance to protocol|0|||
149770064|NCT01061736|540283572|FG001|Overall Study|Poor compliance to protocol|0|||
149770065|NCT01061736|540283573|FG002|Overall Study|Poor compliance to protocol|0|||
149770066|NCT01061736|540283574|FG003|Overall Study|Poor compliance to protocol|0|||
149770067|NCT01061736|540283575|FG004|Overall Study|Poor compliance to protocol|0|||
149770068|NCT01061736|540283576|FG005|Overall Study|Poor compliance to protocol|0|||
149770069|NCT01061736|540283577|FG006|Overall Study|Poor compliance to protocol|0|||
149770070|NCT01061736|540283578|FG007|Overall Study|Poor compliance to protocol|2|||
149770071|NCT01061736|540283579|FG008|Overall Study|Poor compliance to protocol|5|||
149770072|NCT01061736|540283580|FG009|Overall Study|Poor compliance to protocol|9|||
149770073|NCT01061736|540283571|FG000|Overall Study|Not treated|0|||
149770074|NCT01061736|540283572|FG001|Overall Study|Not treated|0|||
149770075|NCT01061736|540283573|FG002|Overall Study|Not treated|0|||
149770076|NCT01061736|540283574|FG003|Overall Study|Not treated|0|||
149770077|NCT01061736|540283575|FG004|Overall Study|Not treated|1|||
149770078|NCT01061736|540283576|FG005|Overall Study|Not treated|0|||
149770079|NCT01061736|540283577|FG006|Overall Study|Not treated|0|||
149770080|NCT01061736|540283578|FG007|Overall Study|Not treated|2|||
149770081|NCT01061736|540283579|FG008|Overall Study|Not treated|1|||
149770082|NCT01061736|540283580|FG009|Overall Study|Not treated|0|||
149770083|NCT01061736|540283571|FG000|Overall Study|Other than specified above|0|||
149770084|NCT01061736|540283572|FG001|Overall Study|Other than specified above|1|||
149770085|NCT01061736|540283573|FG002|Overall Study|Other than specified above|2|||
149770086|NCT01061736|540283574|FG003|Overall Study|Other than specified above|0|||
149770087|NCT01061736|540283575|FG004|Overall Study|Other than specified above|1|||
149770088|NCT01061736|540283576|FG005|Overall Study|Other than specified above|0|||
149770089|NCT01061736|540283577|FG006|Overall Study|Other than specified above|0|||
149770090|NCT01061736|540283578|FG007|Overall Study|Other than specified above|18|||
149770091|NCT01061736|540283579|FG008|Overall Study|Other than specified above|15|||
149770092|NCT01061736|540283580|FG009|Overall Study|Other than specified above|21|||
149770093|NCT01093755|540283582|FG000|Overall Study|Withdrawal by Subject|3|||
149770094|NCT01093755|540283583|FG001|Overall Study|Withdrawal by Subject|4|||
149770095|NCT03115112|540283584|FG000|Overall Study|Adverse Event|5|||
149770096|NCT03115112|540283585|FG001|Overall Study|Adverse Event|1|||
149770097|NCT03115112|540283584|FG000|Overall Study|Withdrawal by Subject|4|||
149770098|NCT03115112|540283585|FG001|Overall Study|Withdrawal by Subject|2|||
149770099|NCT03115112|540283584|FG000|Overall Study|Lost to Follow-up|0|||
149770100|NCT03115112|540283585|FG001|Overall Study|Lost to Follow-up|1|||
149770101|NCT03115112|540283584|FG000|Overall Study|Death|1|||
149770102|NCT03115112|540283585|FG001|Overall Study|Death|0|||
149770103|NCT03115112|540283584|FG000|Overall Study|Pregnancy|1|||
149770104|NCT03115112|540283585|FG001|Overall Study|Pregnancy|0|||
149770105|NCT03115112|540283584|FG000|Overall Study|Site closure|1|||
149770106|NCT03115112|540283585|FG001|Overall Study|Site closure|1|||
149770107|NCT04019795|540283587|FG000|Overall Study|Withdrawal by Subject|1|||
149770108|NCT04019795|540283588|FG001|Overall Study|Withdrawal by Subject|2|||
149770109|NCT04019795|540283589|FG002|Overall Study|Withdrawal by Subject|2|||
149770110|NCT04019795|540283590|FG003|Overall Study|Withdrawal by Subject|1|||
149770111|NCT04019795|540283587|FG000|Overall Study|Lost to Follow-up|0|||
149770112|NCT04019795|540283588|FG001|Overall Study|Lost to Follow-up|1|||
149770113|NCT04019795|540283589|FG002|Overall Study|Lost to Follow-up|1|||
149770114|NCT04019795|540283590|FG003|Overall Study|Lost to Follow-up|2|||
149770115|NCT04019795|540283587|FG000|Overall Study|Treatment non-compliance|3|||
149770116|NCT04019795|540283588|FG001|Overall Study|Treatment non-compliance|1|||
149770117|NCT04019795|540283589|FG002|Overall Study|Treatment non-compliance|2|||
149770118|NCT04019795|540283590|FG003|Overall Study|Treatment non-compliance|0|||
149770119|NCT04019795|540283587|FG000|Overall Study|Physician Decision|0|||
149770120|NCT04019795|540283588|FG001|Overall Study|Physician Decision|0|||
149770121|NCT04019795|540283589|FG002|Overall Study|Physician Decision|1|||
149770122|NCT04019795|540283590|FG003|Overall Study|Physician Decision|0|||
149770123|NCT04019795|540283587|FG000|Overall Study|Adverse Event|1|||
149770124|NCT04019795|540283588|FG001|Overall Study|Adverse Event|0|||
149770125|NCT04019795|540283589|FG002|Overall Study|Adverse Event|0|||
149770126|NCT04019795|540283590|FG003|Overall Study|Adverse Event|0|||
149770127|NCT02310906|540283591|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
149770128|NCT02310906|540283592|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
149770129|NCT02310906|540283593|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
149770130|NCT02310906|540283594|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
149770131|NCT02310906|540283591|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
149770132|NCT02310906|540283592|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
149770133|NCT02310906|540283593|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
149770134|NCT02310906|540283594|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
149770135|NCT02310906|540283591|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149770136|NCT02310906|540283592|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149770137|NCT02310906|540283593|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149770138|NCT02310906|540283594|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
149770139|NCT02310906|540283591|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149770140|NCT02310906|540283592|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149770141|NCT02310906|540283593|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149770142|NCT02310906|540283594|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
149770143|NCT00433446|540283595|FG000|Overall Study|Adverse Event|4|||
149770144|NCT00433446|540283595|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149770145|NCT00433446|540283595|FG000|Overall Study|Progression|44|||
149770146|NCT00433446|540283595|FG000|Overall Study|Other - Not Protocol specified|3|||
149770147|NCT00433446|540283595|FG000|Overall Study|Ineligible|9|||
149770148|NCT01188538|540283596|FG000|Overall Study|Lost to Follow-up|0|||
149770149|NCT01188538|540283597|FG001|Overall Study|Lost to Follow-up|1|||
149770150|NCT00098020|540283603|FG000|Overall Study|Adverse Event|2|||
149770151|NCT00098020|540283603|FG000|Overall Study|Lost to Follow-up|1|||
149770152|NCT00098020|540283603|FG000|Overall Study|elevated liver enzymes|1|||
149770153|NCT00098020|540283603|FG000|Overall Study|Low urine PCR|1|||
149770154|NCT00098020|540283603|FG000|Overall Study|Low epidermal growth factor receptor|1|||
149770155|NCT03495453|540283606|FG000|Overall Study|Withdrawal by Subject|0|||
149770156|NCT03495453|540283607|FG001|Overall Study|Withdrawal by Subject|1|||
149770157|NCT00712933|540283608|FG000|Overall Study|Adverse Event|69|||
149770158|NCT00712933|540283608|FG000|Overall Study|Lack of Efficacy|6|||
149770159|NCT00712933|540283608|FG000|Overall Study|Lost to Follow-up|22|||
149770160|NCT00712933|540283608|FG000|Overall Study|Non-compliance with study drug|13|||
149770161|NCT00712933|540283608|FG000|Overall Study|Other Pregnancy|37|||
149770162|NCT00712933|540283608|FG000|Overall Study|Sponsor decision|14|||
149770163|NCT00712933|540283608|FG000|Overall Study|Withdrew consent|4|||
149770164|NCT00712933|540283608|FG000|Overall Study|Hip replacement surgery|1|||
149770165|NCT00712933|540283608|FG000|Overall Study|Involved in Clinical research|3|||
149770166|NCT00712933|540283608|FG000|Overall Study|Participant hospitalized|1|||
149770167|NCT00712933|540283608|FG000|Overall Study|Participant travelled overseas|2|||
149770168|NCT00712933|540283608|FG000|Overall Study|Death of patient|1|||
149770169|NCT00712933|540283608|FG000|Overall Study|Other Physician decision|1|||
149770170|NCT00712933|540283608|FG000|Overall Study|Not committed to contraception|1|||
149770171|NCT00712933|540283608|FG000|Overall Study|Participant received medication|1|||
149770172|NCT00712933|540283608|FG000|Overall Study|Physician Decision|36|||
149770173|NCT00712933|540283608|FG000|Overall Study|Protocol Violation|4|||
149770174|NCT00712933|540283608|FG000|Overall Study|Withdrawal by Subject|151|||
149770175|NCT00065442|540283626|FG000|Overall Study|Lost to Follow-up|1|||
149770176|NCT00065442|540283627|FG001|Overall Study|Lost to Follow-up|1|||
149770177|NCT00065442|540283626|FG000|Overall Study|Death|121|||
149770178|NCT00065442|540283627|FG001|Overall Study|Death|210|||
149770179|NCT00065442|540283626|FG000|Overall Study|Withdrawal by Subject|3|||
149770180|NCT00065442|540283627|FG001|Overall Study|Withdrawal by Subject|9|||
149770181|NCT01797965|540283628|FG000|Overall Study|Adverse Event|104|||
149770182|NCT01797965|540283629|FG001|Overall Study|Adverse Event|129|||
149770183|NCT01797965|540283630|FG002|Overall Study|Adverse Event|4|||
149770184|NCT01797965|540283631|FG003|Overall Study|Adverse Event|21|||
149770185|NCT01797965|540283628|FG000|Overall Study|Lost to Follow-up|9|||
149770186|NCT01797965|540283629|FG001|Overall Study|Lost to Follow-up|8|||
149770187|NCT01797965|540283630|FG002|Overall Study|Lost to Follow-up|1|||
149770188|NCT01797965|540283631|FG003|Overall Study|Lost to Follow-up|2|||
149770189|NCT01797965|540283628|FG000|Overall Study|Consent withdrawn|130|||
149770190|NCT01797965|540283629|FG001|Overall Study|Consent withdrawn|117|||
149770191|NCT01797965|540283630|FG002|Overall Study|Consent withdrawn|3|||
149770192|NCT01797965|540283631|FG003|Overall Study|Consent withdrawn|35|||
149770193|NCT01797965|540283628|FG000|Overall Study|Investigator decision|21|||
149770194|NCT01797965|540283629|FG001|Overall Study|Investigator decision|15|||
149770195|NCT01797965|540283630|FG002|Overall Study|Investigator decision|0|||
149770196|NCT01797965|540283631|FG003|Overall Study|Investigator decision|0|||
149770197|NCT01797965|540283628|FG000|Overall Study|Death|2|||
149770198|NCT01797965|540283629|FG001|Overall Study|Death|4|||
149770199|NCT01797965|540283630|FG002|Overall Study|Death|0|||
149770200|NCT01797965|540283631|FG003|Overall Study|Death|0|||
149770201|NCT01797965|540283628|FG000|Overall Study|Disease progression, defined by protocol|3|||
149770202|NCT01797965|540283629|FG001|Overall Study|Disease progression, defined by protocol|1|||
149770203|NCT01797965|540283630|FG002|Overall Study|Disease progression, defined by protocol|0|||
149770204|NCT01797965|540283631|FG003|Overall Study|Disease progression, defined by protocol|0|||
149770205|NCT01797965|540283628|FG000|Overall Study|Reason Not Specified|280|||
149770206|NCT01797965|540283629|FG001|Overall Study|Reason Not Specified|295|||
149770207|NCT01797965|540283630|FG002|Overall Study|Reason Not Specified|0|||
149770208|NCT01797965|540283631|FG003|Overall Study|Reason Not Specified|15|||
149770209|NCT00712322|540283632|FG000|Overall Study|Protocol deviation|0|||
149770210|NCT00712322|540283633|FG001|Overall Study|Protocol deviation|1|||
149770211|NCT00712322|540283634|FG002|Overall Study|Protocol deviation|0|||
149770212|NCT00973921|540283637|FG000|Overall Study|IVUS results were not available|9|||
149770213|NCT02670330|540283648|FG000|Overall Study|Protocol Deviation|1|||
149770214|NCT02670330|540283649|FG001|Overall Study|Protocol Deviation|0|||
149770215|NCT02670330|540283648|FG000|Overall Study|Study Terminated By Sponsor|36|||
149770216|NCT02670330|540283649|FG001|Overall Study|Study Terminated By Sponsor|43|||
149770217|NCT02670330|540283648|FG000|Overall Study|Adverse Event|1|||
149770218|NCT02670330|540283649|FG001|Overall Study|Adverse Event|3|||
149770219|NCT02670330|540283648|FG000|Overall Study|Withdrawal by Subject|34|||
149770220|NCT02670330|540283649|FG001|Overall Study|Withdrawal by Subject|29|||
149770221|NCT02670330|540283648|FG000|Overall Study|Lost to Follow-up|3|||
149770222|NCT02670330|540283649|FG001|Overall Study|Lost to Follow-up|2|||
149770223|NCT04404010|540283650|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
149770224|NCT04404010|540283651|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
149770225|NCT02120157|540283652|FG000|Overall Study|Death|8|||
149770226|NCT01354431|540283658|FG000|Pre-Treatment Period|Not reported|1|||
149770227|NCT01354431|540283659|FG001|Pre-Treatment Period|Not reported|0|||
149770228|NCT01354431|540283660|FG002|Pre-Treatment Period|Not reported|0|||
149770229|NCT01354431|540283658|FG000|Treatment Period|Disease Progression|50|||
149770230|NCT01354431|540283659|FG001|Treatment Period|Disease Progression|40|||
149770231|NCT01354431|540283660|FG002|Treatment Period|Disease Progression|44|||
149770232|NCT01354431|540283658|FG000|Treatment Period|Study Drug Toxicity|5|||
149770233|NCT01354431|540283659|FG001|Treatment Period|Study Drug Toxicity|8|||
149770234|NCT01354431|540283660|FG002|Treatment Period|Study Drug Toxicity|4|||
149770235|NCT01354431|540283658|FG000|Treatment Period|Death|0|||
149770236|NCT01354431|540283659|FG001|Treatment Period|Death|1|||
149770237|NCT01354431|540283660|FG002|Treatment Period|Death|0|||
149770238|NCT01354431|540283658|FG000|Treatment Period|AE unrelated to study drug|1|||
149770239|NCT01354431|540283659|FG001|Treatment Period|AE unrelated to study drug|2|||
149770240|NCT01354431|540283660|FG002|Treatment Period|AE unrelated to study drug|5|||
149770241|NCT01354431|540283658|FG000|Treatment Period|Participant request to discontinue|2|||
149770242|NCT01354431|540283659|FG001|Treatment Period|Participant request to discontinue|2|||
149770243|NCT01354431|540283660|FG002|Treatment Period|Participant request to discontinue|1|||
149770244|NCT01354431|540283658|FG000|Treatment Period|Participant withdrew consent|0|||
149770245|NCT01354431|540283659|FG001|Treatment Period|Participant withdrew consent|1|||
149770246|NCT01354431|540283660|FG002|Treatment Period|Participant withdrew consent|0|||
149770247|NCT01354431|540283658|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
149770248|NCT01354431|540283659|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
149770249|NCT01354431|540283660|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
149770250|NCT04685499|540283661|FG000|Overall Study|Study Terminated Early|1|||
149770251|NCT03176277|540283662|FG000|Part A Dose Escalation Study|Adverse Event|1|||
149770252|NCT03176277|540283663|FG001|Part A Dose Escalation Study|Adverse Event|0|||
149770253|NCT03176277|540283664|FG002|Part A Dose Escalation Study|Adverse Event|1|||
149770254|NCT03176277|540283665|FG003|Part A Dose Escalation Study|Adverse Event|0|||
149770255|NCT03176277|540283662|FG000|Part A Dose Escalation Study|Physician Decision|1|||
149770256|NCT03176277|540283663|FG001|Part A Dose Escalation Study|Physician Decision|1|||
149770257|NCT03176277|540283664|FG002|Part A Dose Escalation Study|Physician Decision|2|||
149770258|NCT03176277|540283665|FG003|Part A Dose Escalation Study|Physician Decision|0|||
149770259|NCT03176277|540283662|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
149770260|NCT03176277|540283663|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
149770261|NCT03176277|540283664|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
149770262|NCT03176277|540283665|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
149770263|NCT03176277|540283662|FG000|Part A Dose Escalation Study|Progressive disease|3|||
149770264|NCT03176277|540283663|FG001|Part A Dose Escalation Study|Progressive disease|1|||
149770265|NCT03176277|540283664|FG002|Part A Dose Escalation Study|Progressive disease|3|||
149770266|NCT03176277|540283665|FG003|Part A Dose Escalation Study|Progressive disease|0|||
149770267|NCT00702052|540283666|FG000|Overall Study|Adverse Event|23|||
149770268|NCT00702052|540283666|FG000|Overall Study|Disease Progression|30|||
149770269|NCT00702052|540283666|FG000|Overall Study|Withdrawal by Subject|5|||
149770270|NCT03282357|540283667|FG000|Overall Study|Lost to Follow-up|3|||
149770271|NCT03282357|540283667|FG000|Overall Study|Withdrawal by Subject|4|||
149770272|NCT03282357|540283667|FG000|Overall Study|Adverse Event|1|||
149770273|NCT03282357|540283667|FG000|Overall Study|Other|9|||
149770274|NCT00393913|540283669|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
149770275|NCT00393913|540283669|FG000|Initial Assessment|Withdrawal by Subject|16|||
149770276|NCT00393913|540283669|FG000|CPAP|Withdrawal by Subject|3|||
149770277|NCT00393913|540283669|FG000|CPAP|Physician Decision|1|||
149770278|NCT00393913|540283669|FG000|CPAP|TEchnical problem with CPAP|3|||
149770279|NCT01518244|540283670|FG000|Overall Study|Adverse Event|3|||
149770280|NCT04900038|540283671|FG000|Overall Study|Adverse Event|1|||
149770281|NCT04900038|540283672|FG001|Overall Study|Adverse Event|0|||
149770282|NCT04900038|540283673|FG002|Overall Study|Adverse Event|1|||
149770283|NCT04900038|540283674|FG003|Overall Study|Adverse Event|1|||
149770284|NCT04900038|540283671|FG000|Overall Study|Withdrawal by Subject|0|||
149770285|NCT04900038|540283672|FG001|Overall Study|Withdrawal by Subject|1|||
149770286|NCT04900038|540283673|FG002|Overall Study|Withdrawal by Subject|0|||
149770287|NCT04900038|540283674|FG003|Overall Study|Withdrawal by Subject|0|||
149770288|NCT04900038|540283671|FG000|Overall Study|Study terminated by sponsor|18|||
149770289|NCT04900038|540283672|FG001|Overall Study|Study terminated by sponsor|15|||
149770290|NCT04900038|540283673|FG002|Overall Study|Study terminated by sponsor|17|||
149770291|NCT04900038|540283674|FG003|Overall Study|Study terminated by sponsor|14|||
149770292|NCT04900038|540283671|FG000|Overall Study|Protocol Deviation|1|||
149770293|NCT04900038|540283672|FG001|Overall Study|Protocol Deviation|1|||
149770294|NCT04900038|540283673|FG002|Overall Study|Protocol Deviation|0|||
149770295|NCT04900038|540283674|FG003|Overall Study|Protocol Deviation|0|||
149770296|NCT04900038|540283671|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
149770297|NCT04900038|540283672|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
149770298|NCT04900038|540283673|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
149770299|NCT04900038|540283674|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
149770300|NCT04900038|540283671|FG000|Overall Study|Lost to Follow-up|0|||
149770301|NCT04900038|540283672|FG001|Overall Study|Lost to Follow-up|0|||
149770302|NCT04900038|540283673|FG002|Overall Study|Lost to Follow-up|0|||
149770303|NCT04900038|540283674|FG003|Overall Study|Lost to Follow-up|1|||
149770304|NCT04093258|540283678|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
149770305|NCT04093258|540283679|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
149770306|NCT02379390|540283680|FG000|Overall Study|Adverse Event|1|||
149770307|NCT02379390|540283681|FG001|Overall Study|Adverse Event|1|||
149770308|NCT02379390|540283680|FG000|Overall Study|Investigator's decision|1|||
149770309|NCT02379390|540283681|FG001|Overall Study|Investigator's decision|0|||
149770310|NCT02379390|540283680|FG000|Overall Study|Study Termination|0|||
149770311|NCT02379390|540283681|FG001|Overall Study|Study Termination|1|||
149770312|NCT04268004|540285009|FG000|Overall Study|Excluded from analyses|0|||
149770313|NCT04268004|540285010|FG001|Overall Study|Excluded from analyses|1|||
149770314|NCT01082367|540285011|FG000|Double-blind Period|Administrative problems|0|||
149770315|NCT01082367|540285012|FG001|Double-blind Period|Administrative problems|1|||
149770316|NCT01082367|540285011|FG000|Double-blind Period|Lack of Efficacy|5|||
149770317|NCT01082367|540285012|FG001|Double-blind Period|Lack of Efficacy|11|||
149770318|NCT01082367|540285011|FG000|Double-blind Period|Adverse Event|0|||
149770319|NCT01082367|540285012|FG001|Double-blind Period|Adverse Event|1|||
149770320|NCT01082367|540285011|FG000|Follow-up (F-U) Period|Administrative problems|1|||
149770321|NCT01082367|540285012|FG001|Follow-up (F-U) Period|Administrative problems|0|||
149770322|NCT01082367|540285011|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
149770323|NCT01082367|540285012|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
149770324|NCT01082367|540285011|FG000|Follow-up (F-U) Period|Adverse Event|0|||
149770325|NCT01082367|540285012|FG001|Follow-up (F-U) Period|Adverse Event|1|||
149770326|NCT01453998|540285013|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
149770327|NCT01453998|540285014|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
149770328|NCT01453998|540285015|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
149770329|NCT02022033|540285022|FG000|Overall Study|Physician Decision|1|||
149770330|NCT01429077|540285023|FG000|Overall Study|Lost to Follow-up|0|||
149770331|NCT01429077|540285024|FG001|Overall Study|Lost to Follow-up|3|||
149770332|NCT01413542|540285026|FG000|Overall Study|Physician Decision|1|||
149770333|NCT01413542|540285027|FG001|Overall Study|Physician Decision|0|||
149770334|NCT01413542|540285028|FG002|Overall Study|Physician Decision|3|||
149770335|NCT01413542|540285029|FG003|Overall Study|Physician Decision|0|||
149770336|NCT01413542|540285026|FG000|Overall Study|Adverse Event|0|||
149770337|NCT01413542|540285027|FG001|Overall Study|Adverse Event|0|||
149770338|NCT01413542|540285028|FG002|Overall Study|Adverse Event|0|||
149770339|NCT01413542|540285029|FG003|Overall Study|Adverse Event|1|||
149770340|NCT01879319|540285032|FG000|Overall Study|Withdrawal by Subject|1|||
149770341|NCT01879319|540285033|FG001|Overall Study|Withdrawal by Subject|0|||
149770342|NCT01879319|540285032|FG000|Overall Study|Lost to Follow-up|1|||
149770343|NCT01879319|540285033|FG001|Overall Study|Lost to Follow-up|5|||
149770344|NCT04724733|540285036|FG000|Overall Study|Lost to Follow-up|1|||
149770345|NCT04724733|540285037|FG001|Overall Study|Lost to Follow-up|1|||
149770346|NCT04724733|540285038|FG002|Overall Study|Lost to Follow-up|1|||
149770347|NCT03067129|540285039|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149770348|NCT03067129|540285040|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149770349|NCT03067129|540285041|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149770350|NCT03067129|540285042|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
149770351|NCT03067129|540285039|FG000|Overall Study|Withdrawal by Subject|0|||
149770352|NCT03067129|540285040|FG001|Overall Study|Withdrawal by Subject|0|||
149770353|NCT03067129|540285041|FG002|Overall Study|Withdrawal by Subject|1|||
149770354|NCT03067129|540285042|FG003|Overall Study|Withdrawal by Subject|2|||
149770355|NCT03067129|540285039|FG000|Overall Study|Lost to Follow-up|5|||
149770356|NCT03067129|540285040|FG001|Overall Study|Lost to Follow-up|5|||
149770357|NCT03067129|540285041|FG002|Overall Study|Lost to Follow-up|4|||
149770358|NCT03067129|540285042|FG003|Overall Study|Lost to Follow-up|3|||
149770359|NCT03372603|540285043|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
149770360|NCT03372603|540285044|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
149770361|NCT03372603|540285043|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
149770362|NCT03372603|540285044|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
149770363|NCT03986190|540285045|FG000|Overall Study|Withdrawal by Subject|12|||
149770364|NCT03986190|540285046|FG001|Overall Study|Withdrawal by Subject|0|||
149770365|NCT04929613|540285047|FG000|Overall Study|Withdrawal by Subject|12|||
149770366|NCT00844649|540285053|FG000|Overall Study|Progressive Disease|196|||
149770367|NCT00844649|540285054|FG001|Overall Study|Progressive Disease|245|||
149770368|NCT00844649|540285053|FG000|Overall Study|Adverse Event|128|||
149770369|NCT00844649|540285054|FG001|Overall Study|Adverse Event|73|||
149770370|NCT00844649|540285053|FG000|Overall Study|Physician Decision|25|||
149770371|NCT00844649|540285054|FG001|Overall Study|Physician Decision|18|||
149770372|NCT00844649|540285053|FG000|Overall Study|Protocol Violation|10|||
149770373|NCT00844649|540285054|FG001|Overall Study|Protocol Violation|6|||
149770374|NCT00844649|540285053|FG000|Overall Study|Withdrawal by Subject|28|||
149770375|NCT00844649|540285054|FG001|Overall Study|Withdrawal by Subject|39|||
149770376|NCT00844649|540285053|FG000|Overall Study|Other|7|||
149770377|NCT00844649|540285054|FG001|Overall Study|Other|10|||
149770378|NCT00844649|540285053|FG000|Overall Study|Withdrew prior to starting treatment|11|||
149770379|NCT00844649|540285054|FG001|Overall Study|Withdrew prior to starting treatment|27|||
149770380|NCT00664209|540285055|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
149770381|NCT00664209|540285055|FG000|Study Treatment Period|Physician Decision|4|||
149770382|NCT00664209|540285055|FG000|Study Treatment Period|Withdrawal by Subject|2|||
149770383|NCT02767856|540285056|FG000|Overall Study|Lost to Follow-up|9|||
149770384|NCT02767856|540285057|FG001|Overall Study|Lost to Follow-up|1|||
149770385|NCT02767856|540285056|FG000|Overall Study|Withdrawal by Subject|2|||
149770386|NCT02767856|540285057|FG001|Overall Study|Withdrawal by Subject|1|||
149770387|NCT00843843|540285058|FG000|Overall Study|Physician Decision|1|||
149770388|NCT00843843|540285059|FG001|Overall Study|Physician Decision|1|||
149770389|NCT00843843|540285058|FG000|Overall Study|Protocol Violation|1|||
149770390|NCT00843843|540285059|FG001|Overall Study|Protocol Violation|1|||
149770391|NCT00418379|540285060|FG000|Year 1|Adverse Event|9|||
149770392|NCT00418379|540285061|FG001|Year 1|Adverse Event|15|||
149770393|NCT00418379|540285062|FG002|Year 1|Adverse Event|3|||
149770394|NCT00418379|540285060|FG000|Year 1|Withdrawal by Subject|7|||
149770395|NCT00418379|540285061|FG001|Year 1|Withdrawal by Subject|8|||
149770396|NCT00418379|540285062|FG002|Year 1|Withdrawal by Subject|5|||
149770397|NCT00418379|540285060|FG000|Year 1|Any other reason not above-mentioned|2|||
149770398|NCT00418379|540285061|FG001|Year 1|Any other reason not above-mentioned|5|||
149770399|NCT00418379|540285062|FG002|Year 1|Any other reason not above-mentioned|7|||
149770400|NCT00418379|540285060|FG000|Year 2|Adverse Event|5|||
149770401|NCT00418379|540285061|FG001|Year 2|Adverse Event|2|||
149770402|NCT00418379|540285062|FG002|Year 2|Adverse Event|1|||
149770403|NCT00418379|540285060|FG000|Year 2|Withdrawal by Subject|1|||
149770404|NCT00418379|540285061|FG001|Year 2|Withdrawal by Subject|1|||
149770405|NCT00418379|540285062|FG002|Year 2|Withdrawal by Subject|3|||
149770406|NCT00418379|540285060|FG000|Year 2|Any other reason not above-mentioned|2|||
149770407|NCT00418379|540285061|FG001|Year 2|Any other reason not above-mentioned|1|||
149770408|NCT00418379|540285062|FG002|Year 2|Any other reason not above-mentioned|6|||
149770409|NCT00418379|540285060|FG000|Year 3|Withdrawal by Subject|1|||
149770410|NCT00418379|540285061|FG001|Year 3|Withdrawal by Subject|1|||
149770411|NCT00418379|540285062|FG002|Year 3|Withdrawal by Subject|2|||
149770412|NCT00418379|540285060|FG000|Year 3|Any other reason not above-mentioned|2|||
149770413|NCT00418379|540285061|FG001|Year 3|Any other reason not above-mentioned|1|||
149770414|NCT00418379|540285062|FG002|Year 3|Any other reason not above-mentioned|1|||
149770415|NCT00418379|540285060|FG000|Year 4|Adverse Event|0|||
149770416|NCT00418379|540285061|FG001|Year 4|Adverse Event|1|||
149770417|NCT00418379|540285062|FG002|Year 4|Adverse Event|0|||
149770418|NCT00418379|540285060|FG000|Year 4|Withdrawal by Subject|2|||
149770419|NCT00418379|540285061|FG001|Year 4|Withdrawal by Subject|3|||
149770420|NCT00418379|540285062|FG002|Year 4|Withdrawal by Subject|2|||
149770421|NCT00418379|540285060|FG000|Year 4|Any other reason not above-mentioned|1|||
149770422|NCT00418379|540285061|FG001|Year 4|Any other reason not above-mentioned|1|||
149770423|NCT00418379|540285062|FG002|Year 4|Any other reason not above-mentioned|0|||
149770424|NCT00418379|540285060|FG000|Year 5|Adverse Event|0|||
149770425|NCT00418379|540285061|FG001|Year 5|Adverse Event|1|||
149770426|NCT00418379|540285062|FG002|Year 5|Adverse Event|0|||
149770427|NCT00418379|540285060|FG000|Year 5|Any other reason not above-mentioned|2|||
149770428|NCT00418379|540285061|FG001|Year 5|Any other reason not above-mentioned|4|||
149770429|NCT00418379|540285062|FG002|Year 5|Any other reason not above-mentioned|3|||
149770430|NCT01594333|540285063|FG000|Overall Study|Death|96|||
149770431|NCT01594333|540285064|FG001|Overall Study|Death|83|||
149770432|NCT01594333|540285063|FG000|Overall Study|Lost to Follow-up|5|||
149770433|NCT01594333|540285064|FG001|Overall Study|Lost to Follow-up|5|||
149770434|NCT01594333|540285063|FG000|Overall Study|Withdrawal by Subject|60|||
149770435|NCT01594333|540285064|FG001|Overall Study|Withdrawal by Subject|63|||
149770436|NCT01764256|540285065|FG000|Received All Vaccinations|Adverse Event|1|||
149770437|NCT01764256|540285066|FG001|Received All Vaccinations|Adverse Event|1|||
149770438|NCT01764256|540285067|FG002|Received All Vaccinations|Adverse Event|0|||
149770439|NCT01764256|540285068|FG003|Received All Vaccinations|Adverse Event|0|||
149770440|NCT01764256|540285065|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
149770441|NCT01764256|540285066|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
149770442|NCT01764256|540285067|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
149770443|NCT01764256|540285068|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
149770444|NCT01764256|540285065|FG000|Received All Vaccinations|Lost to Follow-up|1|||
149770445|NCT01764256|540285066|FG001|Received All Vaccinations|Lost to Follow-up|0|||
149770446|NCT01764256|540285067|FG002|Received All Vaccinations|Lost to Follow-up|0|||
149770447|NCT01764256|540285068|FG003|Received All Vaccinations|Lost to Follow-up|0|||
149770448|NCT01764256|540285065|FG000|Completed Study|Lost to Follow-up|0|||
149770449|NCT01764256|540285066|FG001|Completed Study|Lost to Follow-up|0|||
149770450|NCT01764256|540285067|FG002|Completed Study|Lost to Follow-up|0|||
149770451|NCT01764256|540285068|FG003|Completed Study|Lost to Follow-up|1|||
149770452|NCT00304915|540285069|FG000|Overall Study|Lost to Follow-up|11|||
149770453|NCT00304915|540285070|FG001|Overall Study|Lost to Follow-up|11|||
149770454|NCT00304915|540285069|FG000|Overall Study|Death|4|||
149770455|NCT00304915|540285070|FG001|Overall Study|Death|5|||
149770456|NCT00304915|540285069|FG000|Overall Study|Withdrawal by Subject|3|||
149770457|NCT00304915|540285070|FG001|Overall Study|Withdrawal by Subject|0|||
149770458|NCT00565058|540285071|FG000|Overall Study|Adverse Event|1|||
149770459|NCT00565058|540285072|FG001|Overall Study|Adverse Event|0|||
149770460|NCT02029638|540285073|FG000|Overall Study|Death|0|||
149770461|NCT02029638|540285074|FG001|Overall Study|Death|0|||
149770462|NCT02029638|540285075|FG002|Overall Study|Death|1|||
149770463|NCT02029638|540285073|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
149770464|NCT02029638|540285074|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
149770465|NCT02029638|540285075|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
149770466|NCT03428997|540285083|FG000|Overall Study|Sponsor decision.|1|||
149770467|NCT03428997|540285083|FG000|Overall Study|Withdrawal by Subject|3|||
149770468|NCT03428997|540285083|FG000|Overall Study|Lost to Follow-up|4|||
149770469|NCT01397448|540285087|FG000|Overall Study|Adverse Event|4|||
149770470|NCT01397448|540285088|FG001|Overall Study|Adverse Event|4|||
149770471|NCT01397448|540285089|FG002|Overall Study|Adverse Event|6|||
149770472|NCT01397448|540285087|FG000|Overall Study|Withdrawal by Subject|4|||
149770473|NCT01397448|540285088|FG001|Overall Study|Withdrawal by Subject|4|||
149770474|NCT01397448|540285089|FG002|Overall Study|Withdrawal by Subject|3|||
149770475|NCT01397448|540285087|FG000|Overall Study|Lack of Efficacy|2|||
149770476|NCT01397448|540285088|FG001|Overall Study|Lack of Efficacy|0|||
149770477|NCT01397448|540285089|FG002|Overall Study|Lack of Efficacy|5|||
149770478|NCT01397448|540285087|FG000|Overall Study|Other|8|||
149770479|NCT01397448|540285088|FG001|Overall Study|Other|7|||
149770480|NCT01397448|540285089|FG002|Overall Study|Other|4|||
149770481|NCT02180217|540285094|FG000|Overall Study|Adverse Event|3|||
149770482|NCT02180217|540285095|FG001|Overall Study|Adverse Event|2|||
149770483|NCT02180217|540285096|FG002|Overall Study|Adverse Event|22|||
149770484|NCT02180217|540285094|FG000|Overall Study|Death|1|||
149770485|NCT02180217|540285095|FG001|Overall Study|Death|1|||
149770486|NCT02180217|540285096|FG002|Overall Study|Death|0|||
149770487|NCT02180217|540285094|FG000|Overall Study|Withdrawal by Subject|1|||
149770488|NCT02180217|540285095|FG001|Overall Study|Withdrawal by Subject|1|||
149770489|NCT02180217|540285096|FG002|Overall Study|Withdrawal by Subject|4|||
149770490|NCT02180217|540285094|FG000|Overall Study|Subject/Guardian decision|5|||
149770491|NCT02180217|540285095|FG001|Overall Study|Subject/Guardian decision|3|||
149770492|NCT02180217|540285096|FG002|Overall Study|Subject/Guardian decision|6|||
149770493|NCT02180217|540285094|FG000|Overall Study|Physician Decision|1|||
149770494|NCT02180217|540285095|FG001|Overall Study|Physician Decision|1|||
149770495|NCT02180217|540285096|FG002|Overall Study|Physician Decision|6|||
149770496|NCT02180217|540285094|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149770497|NCT02180217|540285095|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149770498|NCT02180217|540285096|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149770499|NCT00239837|540285097|FG000|Overall Study|Lost to Follow-up|3|||
149770500|NCT00239837|540285098|FG001|Overall Study|Lost to Follow-up|7|||
149770501|NCT00536978|540285099|FG000|Overall Study|Not eligible for Adback Infusion|22|||
149770502|NCT00622869|540285105|FG000|Overall Study|Subject Withdrew Consent|13|||
149770503|NCT00622869|540285106|FG001|Overall Study|Subject Withdrew Consent|17|||
149770504|NCT00622869|540285107|FG002|Overall Study|Subject Withdrew Consent|11|||
149770505|NCT00622869|540285105|FG000|Overall Study|Administrative Problems|11|||
149770506|NCT00622869|540285106|FG001|Overall Study|Administrative Problems|17|||
149770507|NCT00622869|540285107|FG002|Overall Study|Administrative Problems|13|||
149770508|NCT00622869|540285105|FG000|Overall Study|Death|12|||
149770509|NCT00622869|540285106|FG001|Overall Study|Death|15|||
149770510|NCT00622869|540285107|FG002|Overall Study|Death|10|||
149770511|NCT00622869|540285105|FG000|Overall Study|Lost to Follow-up|2|||
149770512|NCT00622869|540285106|FG001|Overall Study|Lost to Follow-up|4|||
149770513|NCT00622869|540285107|FG002|Overall Study|Lost to Follow-up|2|||
149770514|NCT00622869|540285105|FG000|Overall Study|Graft Loss|5|||
149770515|NCT00622869|540285106|FG001|Overall Study|Graft Loss|3|||
149770516|NCT00622869|540285107|FG002|Overall Study|Graft Loss|2|||
149770517|NCT00622869|540285105|FG000|Overall Study|Missing|0|||
149770518|NCT00622869|540285106|FG001|Overall Study|Missing|1|||
149770519|NCT00622869|540285107|FG002|Overall Study|Missing|1|||
149770520|NCT03076190|540285109|FG000|Overall Study|Lost to Follow-up|9|||
149770521|NCT03076190|540285110|FG001|Overall Study|Lost to Follow-up|34|||
149770522|NCT03076190|540285109|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
149770523|NCT03076190|540285110|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
149770524|NCT00870818|540285111|FG000|Overall Study|Lost to Follow-up|3|||
149770525|NCT00870818|540285112|FG001|Overall Study|Lost to Follow-up|2|||
149770526|NCT00870818|540285113|FG002|Overall Study|Lost to Follow-up|1|||
149770527|NCT00870818|540285114|FG003|Overall Study|Lost to Follow-up|0|||
149770528|NCT00870818|540285115|FG004|Overall Study|Lost to Follow-up|0|||
149770529|NCT00870818|540285111|FG000|Overall Study|Withdrawal by Subject|0|||
149770530|NCT00870818|540285112|FG001|Overall Study|Withdrawal by Subject|0|||
149770531|NCT00870818|540285113|FG002|Overall Study|Withdrawal by Subject|1|||
149770532|NCT00870818|540285114|FG003|Overall Study|Withdrawal by Subject|2|||
149770533|NCT00870818|540285115|FG004|Overall Study|Withdrawal by Subject|0|||
149770534|NCT00870818|540285111|FG000|Overall Study|Terminated by sponsor|29|||
149770535|NCT00870818|540285112|FG001|Overall Study|Terminated by sponsor|70|||
149770536|NCT00870818|540285113|FG002|Overall Study|Terminated by sponsor|36|||
149770537|NCT00870818|540285114|FG003|Overall Study|Terminated by sponsor|36|||
149770538|NCT00870818|540285115|FG004|Overall Study|Terminated by sponsor|38|||
149770539|NCT00870818|540285111|FG000|Overall Study|Other|0|||
149770540|NCT00870818|540285112|FG001|Overall Study|Other|1|||
149770541|NCT00870818|540285113|FG002|Overall Study|Other|0|||
149770542|NCT00870818|540285114|FG003|Overall Study|Other|0|||
149770543|NCT00870818|540285115|FG004|Overall Study|Other|0|||
149770544|NCT00772382|540285116|FG000|Overall Study|Adverse Event|19|||
149770545|NCT00772382|540285116|FG000|Overall Study|Death|6|||
149770546|NCT00772382|540285116|FG000|Overall Study|Lack of Efficacy|4|||
149770547|NCT00772382|540285116|FG000|Overall Study|Physician Decision|5|||
149770548|NCT00772382|540285116|FG000|Overall Study|Protocol Violation|1|||
149770549|NCT00772382|540285116|FG000|Overall Study|Withdrawal by Subject|10|||
149770550|NCT00772382|540285116|FG000|Overall Study|Other Reasons|10|||
149770551|NCT01582971|540285121|FG000|Overall Study|Death|2|||
149770552|NCT01582971|540285122|FG001|Overall Study|Death|1|||
149770553|NCT01582971|540285121|FG000|Overall Study|Lost to Follow-up|18|||
149770554|NCT01582971|540285122|FG001|Overall Study|Lost to Follow-up|21|||
149770555|NCT01582971|540285121|FG000|Overall Study|Withdrawal by Subject|4|||
149770556|NCT01582971|540285122|FG001|Overall Study|Withdrawal by Subject|2|||
149770557|NCT01582971|540285121|FG000|Overall Study|Other|15|||
149770558|NCT01582971|540285122|FG001|Overall Study|Other|13|||
149770559|NCT02007954|540285123|FG000|Overall Study|Received liver transplant|3|||
149770560|NCT02007954|540285123|FG000|Overall Study|Switch in treatment modality|2|||
149770561|NCT02007954|540285123|FG000|Overall Study|Disease progression and unrelated AE|1|||
149770562|NCT02007954|540285123|FG000|Overall Study|Death|1|||
149770563|NCT03784027|540285124|FG000|Period 1|Withdrawal by Subject|0|||
149770564|NCT03784027|540285125|FG001|Period 1|Withdrawal by Subject|1|||
149770565|NCT06025396|540286952|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
149770566|NCT06025396|540286953|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
149770567|NCT06025396|540286954|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
149770568|NCT06025396|540286955|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
149770569|NCT06025396|540286956|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
149770570|NCT06025396|540286952|FG000|Overall Study|Withdrawal by Subject|0|||
149770571|NCT06025396|540286953|FG001|Overall Study|Withdrawal by Subject|1|||
149770572|NCT06025396|540286954|FG002|Overall Study|Withdrawal by Subject|1|||
149770573|NCT06025396|540286955|FG003|Overall Study|Withdrawal by Subject|0|||
149770574|NCT06025396|540286956|FG004|Overall Study|Withdrawal by Subject|0|||
149770575|NCT01512108|540286957|FG000|Overall Study|Adverse Event|9|||
149770576|NCT01512108|540286958|FG001|Overall Study|Adverse Event|4|||
149770577|NCT01512108|540286957|FG000|Overall Study|Protocol Violation|1|||
149770578|NCT01512108|540286958|FG001|Overall Study|Protocol Violation|2|||
149770579|NCT01512108|540286957|FG000|Overall Study|Withdrawal Criteria|1|||
149770580|NCT01512108|540286958|FG001|Overall Study|Withdrawal Criteria|0|||
149770581|NCT01512108|540286957|FG000|Overall Study|Unclassified|11|||
149770582|NCT01512108|540286958|FG001|Overall Study|Unclassified|3|||
149770583|NCT06422377|540286961|FG000|Overall Study|Study Terminated by Sponsor|1|||
149770584|NCT02017899|540286962|FG000|Overall Study|Withdrawal by Subject|0|||
149770585|NCT02017899|540286963|FG001|Overall Study|Withdrawal by Subject|0|||
149770586|NCT02017899|540286964|FG002|Overall Study|Withdrawal by Subject|0|||
149770587|NCT02017899|540286965|FG003|Overall Study|Withdrawal by Subject|1|||
149770588|NCT02017899|540286966|FG004|Overall Study|Withdrawal by Subject|1|||
149770589|NCT02017899|540286967|FG005|Overall Study|Withdrawal by Subject|0|||
149770590|NCT02843178|540286971|FG000|Overall Study|Lost to Follow-up|8|||
149770591|NCT02843178|540286972|FG001|Overall Study|Lost to Follow-up|8|||
149770592|NCT02843178|540286973|FG002|Overall Study|Lost to Follow-up|6|||
149770593|NCT02843178|540286974|FG003|Overall Study|Lost to Follow-up|3|||
149770594|NCT02843178|540286971|FG000|Overall Study|Withdrawal by Subject|0|||
149770595|NCT02843178|540286972|FG001|Overall Study|Withdrawal by Subject|0|||
149770596|NCT02843178|540286973|FG002|Overall Study|Withdrawal by Subject|1|||
149770597|NCT02843178|540286974|FG003|Overall Study|Withdrawal by Subject|1|||
149770598|NCT00646113|540286975|FG000|Overall Study|Lost to Follow-up|5|||
149770599|NCT00646113|540286975|FG000|Overall Study|Adverse Event|3|||
149770600|NCT02420795|540286984|FG000|Overall Study|Withdrawal by Subject|1|||
149770601|NCT02420795|540286985|FG001|Overall Study|Withdrawal by Subject|0|||
149770602|NCT02420795|540286986|FG002|Overall Study|Withdrawal by Subject|0|||
149770603|NCT02420795|540286984|FG000|Overall Study|Adverse Event|1|||
149770604|NCT02420795|540286985|FG001|Overall Study|Adverse Event|0|||
149770605|NCT02420795|540286986|FG002|Overall Study|Adverse Event|0|||
149770606|NCT02420795|540286984|FG000|Overall Study|Progressive disease|2|||
149770607|NCT02420795|540286985|FG001|Overall Study|Progressive disease|2|||
149770608|NCT02420795|540286986|FG002|Overall Study|Progressive disease|4|||
149770609|NCT02420795|540286984|FG000|Overall Study|Death|0|||
149770610|NCT02420795|540286985|FG001|Overall Study|Death|0|||
149770611|NCT02420795|540286986|FG002|Overall Study|Death|1|||
149770612|NCT02658968|540286987|FG000|Received Rituximab|Adverse Event|0|||
149770613|NCT02658968|540286988|FG001|Received Rituximab|Adverse Event|0|||
149770614|NCT02658968|540286989|FG002|Received Rituximab|Adverse Event|0|||
149770615|NCT02658968|540286990|FG003|Received Rituximab|Adverse Event|0|||
149770616|NCT02658968|540286991|FG004|Received Rituximab|Adverse Event|1|||
149770617|NCT02658968|540286987|FG000|Received Rituximab|Progressive disease|0|||
149770618|NCT02658968|540286988|FG001|Received Rituximab|Progressive disease|0|||
149770619|NCT02658968|540286989|FG002|Received Rituximab|Progressive disease|0|||
149770620|NCT02658968|540286990|FG003|Received Rituximab|Progressive disease|0|||
149770621|NCT02658968|540286991|FG004|Received Rituximab|Progressive disease|1|||
149770622|NCT02658968|540286987|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
149770623|NCT02658968|540286988|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
149770624|NCT02658968|540286989|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
149770625|NCT02658968|540286990|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
149770626|NCT02658968|540286991|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
149770627|NCT02658968|540286987|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
149770628|NCT02658968|540286988|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
149770629|NCT02658968|540286989|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
149770630|NCT02658968|540286990|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
149770631|NCT02658968|540286991|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
149770632|NCT02658968|540286987|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149770633|NCT02658968|540286988|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
149770634|NCT02658968|540286989|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149770635|NCT02658968|540286990|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
149770636|NCT02658968|540286991|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149770637|NCT02658968|540286987|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149770638|NCT02658968|540286988|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
149770639|NCT02658968|540286989|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149770640|NCT02658968|540286990|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149770641|NCT02658968|540286991|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149770642|NCT02658968|540286987|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
149770643|NCT02658968|540286988|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
149770644|NCT02658968|540286989|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
149770645|NCT02658968|540286990|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
149770646|NCT02658968|540286991|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
149770647|NCT00949910|540286992|FG000|Overall Study|Progressive Disease|3750|||
149770648|NCT00949910|540286992|FG000|Overall Study|Symptomatic Deterioration|1088|||
149770649|NCT00949910|540286992|FG000|Overall Study|Lost to Follow-up|100|||
149770650|NCT00949910|540286992|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
149770651|NCT00949910|540286992|FG000|Overall Study|Participant Refusal|390|||
149770652|NCT00949910|540286992|FG000|Overall Study|Death Due to Malignant Disease|456|||
149770653|NCT00949910|540286992|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
149770654|NCT00949910|540286992|FG000|Overall Study|Death Due to Adverse Event|115|||
149770655|NCT00949910|540286992|FG000|Overall Study|Death Due to Toxicity|3|||
149770656|NCT00949910|540286992|FG000|Overall Study|Death from Unknown Cause|5|||
149770657|NCT00949910|540286992|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
149770658|NCT00949910|540286992|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
149770659|NCT00949910|540286992|FG000|Overall Study|Switched to Commercial Treatment|4|||
149770660|NCT00949910|540286992|FG000|Overall Study|Violation of Eligibility|23|||
149770661|NCT00949910|540286992|FG000|Overall Study|Logistical Reasons|13|||
149770662|NCT00949910|540286992|FG000|Overall Study|Non-Compliance|10|||
149770663|NCT00949910|540286992|FG000|Overall Study|Prolonged Dosing Interruption|4|||
149770664|NCT00949910|540286992|FG000|Overall Study|Adverse Event|83|||
149770665|NCT00949910|540286992|FG000|Overall Study|Serious Adverse Event|6|||
149770666|NCT00949910|540286992|FG000|Overall Study|Physician/Participant Decision|7|||
149770667|NCT00949910|540286992|FG000|Overall Study|Other|4|||
149770668|NCT00949910|540286992|FG000|Overall Study|No Data|9|||
149770669|NCT03287869|540286993|FG000|Overall Study|Adverse Event|14|||
149770670|NCT03287869|540286994|FG001|Overall Study|Adverse Event|12|||
149770671|NCT03287869|540286993|FG000|Overall Study|Lack of Efficacy|1|||
149770672|NCT03287869|540286994|FG001|Overall Study|Lack of Efficacy|0|||
149770673|NCT03287869|540286993|FG000|Overall Study|Lost to Follow-up|13|||
149770674|NCT03287869|540286994|FG001|Overall Study|Lost to Follow-up|19|||
149770675|NCT03287869|540286993|FG000|Overall Study|Non-Compliance With Study Drug|5|||
149770676|NCT03287869|540286994|FG001|Overall Study|Non-Compliance With Study Drug|9|||
149770677|NCT03287869|540286993|FG000|Overall Study|Progressive Disease|1|||
149770678|NCT03287869|540286994|FG001|Overall Study|Progressive Disease|0|||
149770679|NCT03287869|540286993|FG000|Overall Study|Protocol Deviation|2|||
149770680|NCT03287869|540286994|FG001|Overall Study|Protocol Deviation|1|||
149770681|NCT03287869|540286993|FG000|Overall Study|Withdrawal by Subject|36|||
149770682|NCT03287869|540286994|FG001|Overall Study|Withdrawal by Subject|43|||
149770683|NCT03287869|540286993|FG000|Overall Study|Early Closure of the Site|0|||
149770684|NCT03287869|540286994|FG001|Overall Study|Early Closure of the Site|1|||
149770685|NCT03287869|540286993|FG000|Overall Study|Physician Decision|5|||
149770686|NCT03287869|540286994|FG001|Overall Study|Physician Decision|5|||
149770687|NCT03287869|540286993|FG000|Overall Study|Reason not Specified|6|||
149770688|NCT03287869|540286994|FG001|Overall Study|Reason not Specified|3|||
149770689|NCT02455388|540286995|FG000|Overall Study|Protocol Violation|1|||
149770690|NCT02455388|540286996|FG001|Overall Study|Protocol Violation|0|||
149770691|NCT02455388|540286997|FG002|Overall Study|Protocol Violation|4|||
149770692|NCT02455388|540286995|FG000|Overall Study|Withdrawal by Subject|0|||
149770693|NCT02455388|540286996|FG001|Overall Study|Withdrawal by Subject|0|||
149770694|NCT02455388|540286997|FG002|Overall Study|Withdrawal by Subject|7|||
149770695|NCT04847141|540286998|FG000|Overall Study|Adverse Event|1|||
149770696|NCT04847141|540286999|FG001|Overall Study|Adverse Event|0|||
149770697|NCT04847141|540287000|FG002|Overall Study|Adverse Event|1|||
149770698|NCT04847141|540286998|FG000|Overall Study|Withdrawal by Subject|2|||
149770699|NCT04847141|540286999|FG001|Overall Study|Withdrawal by Subject|4|||
149770700|NCT04847141|540287000|FG002|Overall Study|Withdrawal by Subject|3|||
149770701|NCT04847141|540286998|FG000|Overall Study|Lost to Follow-up|7|||
149770702|NCT04847141|540286999|FG001|Overall Study|Lost to Follow-up|5|||
149770703|NCT04847141|540287000|FG002|Overall Study|Lost to Follow-up|7|||
149770704|NCT04847141|540286998|FG000|Overall Study|Reason not Specified|0|||
149770705|NCT04847141|540286999|FG001|Overall Study|Reason not Specified|1|||
149770706|NCT04847141|540287000|FG002|Overall Study|Reason not Specified|0|||
149770707|NCT00324740|540287001|FG000|Overall Study|Withdrawal by Subject|1|||
149770708|NCT00324740|540287002|FG001|Overall Study|Withdrawal by Subject|0|||
149770709|NCT00324740|540287003|FG002|Overall Study|Withdrawal by Subject|1|||
149770710|NCT00971425|540287004|FG000|Overall Study|Adverse Event|1|||
149770711|NCT00971425|540287005|FG001|Overall Study|Adverse Event|1|||
149770712|NCT00971425|540287004|FG000|Overall Study|Withdrawal by Subject|0|||
149770713|NCT00971425|540287005|FG001|Overall Study|Withdrawal by Subject|1|||
149770714|NCT02528253|540287006|FG000|Overall Study|Adverse Event|3|||
149770715|NCT02528253|540287007|FG001|Overall Study|Adverse Event|4|||
149770716|NCT02528253|540287008|FG002|Overall Study|Adverse Event|4|||
149770717|NCT02528253|540287009|FG003|Overall Study|Adverse Event|8|||
149770718|NCT02528253|540287010|FG004|Overall Study|Adverse Event|18|||
149770719|NCT02528253|540287006|FG000|Overall Study|Death|2|||
149770720|NCT02528253|540287007|FG001|Overall Study|Death|2|||
149770721|NCT02528253|540287008|FG002|Overall Study|Death|1|||
149770722|NCT02528253|540287009|FG003|Overall Study|Death|0|||
149770723|NCT02528253|540287010|FG004|Overall Study|Death|1|||
149770724|NCT02528253|540287006|FG000|Overall Study|Insufficient clinical response|7|||
149770725|NCT02528253|540287007|FG001|Overall Study|Insufficient clinical response|10|||
149770726|NCT02528253|540287008|FG002|Overall Study|Insufficient clinical response|13|||
149770727|NCT02528253|540287009|FG003|Overall Study|Insufficient clinical response|12|||
149770728|NCT02528253|540287010|FG004|Overall Study|Insufficient clinical response|16|||
149770729|NCT02528253|540287006|FG000|Overall Study|Lost to Follow-up|16|||
149770730|NCT02528253|540287007|FG001|Overall Study|Lost to Follow-up|9|||
149770731|NCT02528253|540287008|FG002|Overall Study|Lost to Follow-up|31|||
149770732|NCT02528253|540287009|FG003|Overall Study|Lost to Follow-up|16|||
149770733|NCT02528253|540287010|FG004|Overall Study|Lost to Follow-up|34|||
149770734|NCT02528253|540287006|FG000|Overall Study|Other|21|||
149770735|NCT02528253|540287007|FG001|Overall Study|Other|22|||
149770736|NCT02528253|540287008|FG002|Overall Study|Other|58|||
149770737|NCT02528253|540287009|FG003|Overall Study|Other|52|||
149770738|NCT02528253|540287010|FG004|Overall Study|Other|76|||
149770739|NCT02528253|540287006|FG000|Overall Study|Withdrawal by Subject|25|||
149770740|NCT02528253|540287007|FG001|Overall Study|Withdrawal by Subject|20|||
149770741|NCT02528253|540287008|FG002|Overall Study|Withdrawal by Subject|29|||
149770742|NCT02528253|540287009|FG003|Overall Study|Withdrawal by Subject|48|||
149770743|NCT02528253|540287010|FG004|Overall Study|Withdrawal by Subject|73|||
149770744|NCT02528253|540287006|FG000|Overall Study|Protocol Violation|1|||
149770745|NCT02528253|540287007|FG001|Overall Study|Protocol Violation|2|||
149770746|NCT02528253|540287008|FG002|Overall Study|Protocol Violation|4|||
149770747|NCT02528253|540287009|FG003|Overall Study|Protocol Violation|0|||
149770748|NCT02528253|540287010|FG004|Overall Study|Protocol Violation|4|||
149770749|NCT02528253|540287006|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
149770750|NCT02528253|540287007|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
149770751|NCT02528253|540287008|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
149770752|NCT02528253|540287009|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
149770753|NCT02528253|540287010|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
149770754|NCT01357980|540287011|FG000|Overall Study|Lack of Efficacy|0|||
149770755|NCT01357980|540287012|FG001|Overall Study|Lack of Efficacy|1|||
149770756|NCT01357980|540287013|FG002|Overall Study|Lack of Efficacy|0|||
149770757|NCT01357980|540287014|FG003|Overall Study|Lack of Efficacy|0|||
149770758|NCT01357980|540287011|FG000|Overall Study|Consent withdrawn|0|||
149770759|NCT01357980|540287012|FG001|Overall Study|Consent withdrawn|0|||
149770760|NCT01357980|540287013|FG002|Overall Study|Consent withdrawn|1|||
149770761|NCT01357980|540287014|FG003|Overall Study|Consent withdrawn|0|||
149770762|NCT00094835|540287017|FG000|Overall Study|Physician Decision|1|||
149770763|NCT00094835|540287018|FG001|Overall Study|Physician Decision|0|||
149770764|NCT00094835|540287019|FG002|Overall Study|Physician Decision|0|||
149770765|NCT00094835|540287020|FG003|Overall Study|Physician Decision|0|||
149770766|NCT00094835|540287021|FG004|Overall Study|Physician Decision|0|||
149770767|NCT00094835|540287022|FG005|Overall Study|Physician Decision|1|||
149770768|NCT00094835|540287023|FG006|Overall Study|Physician Decision|0|||
149770769|NCT00094835|540287017|FG000|Overall Study|Withdrawal by Subject|0|||
149770770|NCT00094835|540287018|FG001|Overall Study|Withdrawal by Subject|0|||
149770771|NCT00094835|540287019|FG002|Overall Study|Withdrawal by Subject|0|||
149770772|NCT00094835|540287020|FG003|Overall Study|Withdrawal by Subject|0|||
149770773|NCT00094835|540287021|FG004|Overall Study|Withdrawal by Subject|0|||
149770774|NCT00094835|540287022|FG005|Overall Study|Withdrawal by Subject|0|||
149770775|NCT00094835|540287023|FG006|Overall Study|Withdrawal by Subject|1|||
149770776|NCT00094835|540287017|FG000|Overall Study|Lost to Follow-up|0|||
149770777|NCT00094835|540287018|FG001|Overall Study|Lost to Follow-up|0|||
149770778|NCT00094835|540287019|FG002|Overall Study|Lost to Follow-up|0|||
149770779|NCT00094835|540287020|FG003|Overall Study|Lost to Follow-up|0|||
149770780|NCT00094835|540287021|FG004|Overall Study|Lost to Follow-up|1|||
149770781|NCT00094835|540287022|FG005|Overall Study|Lost to Follow-up|0|||
149770782|NCT00094835|540287023|FG006|Overall Study|Lost to Follow-up|0|||
149770783|NCT00094835|540287017|FG000|Overall Study|Death|1|||
149770784|NCT00094835|540287018|FG001|Overall Study|Death|0|||
149770785|NCT00094835|540287019|FG002|Overall Study|Death|0|||
149770786|NCT00094835|540287020|FG003|Overall Study|Death|0|||
149770787|NCT00094835|540287021|FG004|Overall Study|Death|1|||
149770788|NCT00094835|540287022|FG005|Overall Study|Death|0|||
149770789|NCT00094835|540287023|FG006|Overall Study|Death|0|||
149770790|NCT00094835|540287017|FG000|Overall Study|Non-compliance|1|||
149770791|NCT00094835|540287018|FG001|Overall Study|Non-compliance|2|||
149770792|NCT00094835|540287019|FG002|Overall Study|Non-compliance|2|||
149770793|NCT00094835|540287020|FG003|Overall Study|Non-compliance|0|||
149770794|NCT00094835|540287021|FG004|Overall Study|Non-compliance|2|||
149770795|NCT00094835|540287022|FG005|Overall Study|Non-compliance|2|||
149770796|NCT00094835|540287023|FG006|Overall Study|Non-compliance|1|||
149770797|NCT00094835|540287017|FG000|Overall Study|Other|1|||
149770798|NCT00094835|540287018|FG001|Overall Study|Other|1|||
149770799|NCT00094835|540287019|FG002|Overall Study|Other|1|||
149770800|NCT00094835|540287020|FG003|Overall Study|Other|1|||
149770801|NCT00094835|540287021|FG004|Overall Study|Other|0|||
149770802|NCT00094835|540287022|FG005|Overall Study|Other|0|||
149770803|NCT00094835|540287023|FG006|Overall Study|Other|0|||
149770804|NCT00505752|540287024|FG000|Overall Study|Adverse Event|1|||
149770805|NCT00505752|540287025|FG001|Overall Study|Adverse Event|0|||
149770806|NCT00505752|540287026|FG002|Overall Study|Adverse Event|1|||
149770807|NCT00505752|540287027|FG003|Overall Study|Adverse Event|0|||
149770808|NCT00505752|540287024|FG000|Overall Study|Lost to Follow-up|1|||
149770809|NCT00505752|540287025|FG001|Overall Study|Lost to Follow-up|0|||
149770810|NCT00505752|540287026|FG002|Overall Study|Lost to Follow-up|0|||
149770811|NCT00505752|540287027|FG003|Overall Study|Lost to Follow-up|0|||
149770812|NCT00505752|540287024|FG000|Overall Study|Lack of ovarian response|1|||
149770813|NCT00505752|540287025|FG001|Overall Study|Lack of ovarian response|3|||
149770814|NCT00505752|540287026|FG002|Overall Study|Lack of ovarian response|0|||
149770815|NCT00505752|540287027|FG003|Overall Study|Lack of ovarian response|0|||
149770816|NCT00505752|540287024|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149770817|NCT00505752|540287025|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149770818|NCT00505752|540287026|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
149770819|NCT00505752|540287027|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149770820|NCT00505752|540287024|FG000|Overall Study|No oocytes retrieved|0|||
149770821|NCT00505752|540287025|FG001|Overall Study|No oocytes retrieved|2|||
149770822|NCT00505752|540287026|FG002|Overall Study|No oocytes retrieved|0|||
149770823|NCT00505752|540287027|FG003|Overall Study|No oocytes retrieved|1|||
149770824|NCT00505752|540287024|FG000|Overall Study|No Fertilization|1|||
149770825|NCT00505752|540287025|FG001|Overall Study|No Fertilization|1|||
149770826|NCT00505752|540287026|FG002|Overall Study|No Fertilization|2|||
149770827|NCT00505752|540287027|FG003|Overall Study|No Fertilization|1|||
149770828|NCT00505752|540287024|FG000|Overall Study|All embryos/blastocysts discarded|0|||
149770829|NCT00505752|540287025|FG001|Overall Study|All embryos/blastocysts discarded|0|||
149770830|NCT00505752|540287026|FG002|Overall Study|All embryos/blastocysts discarded|1|||
149770831|NCT00505752|540287027|FG003|Overall Study|All embryos/blastocysts discarded|1|||
149770832|NCT00505752|540287024|FG000|Overall Study|Other|1|||
149770833|NCT00505752|540287025|FG001|Overall Study|Other|2|||
149770834|NCT00505752|540287026|FG002|Overall Study|Other|1|||
149770835|NCT00505752|540287027|FG003|Overall Study|Other|2|||
149770836|NCT03819218|540287031|FG000|Overall Study|Protocol Violation|1|||
149770837|NCT02267278|540287032|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
149770838|NCT02267278|540287032|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
149770839|NCT02267278|540287032|FG000|Overall Study|Developed new cancer diagnoses|2|||
149770840|NCT02267278|540287032|FG000|Overall Study|prescribed prohibited medication|1|||
149770841|NCT02513771|540287033|FG000|Overall Study|Lost to Follow-up|1|||
149770842|NCT02513771|540287034|FG001|Overall Study|Lost to Follow-up|1|||
149770843|NCT02513771|540287033|FG000|Overall Study|Not being able to get to clinic|1|||
149770844|NCT02513771|540287034|FG001|Overall Study|Not being able to get to clinic|0|||
149770845|NCT01595438|540287035|FG000|Overall Study|Lost to Follow-up|20|||
149770846|NCT01595438|540287036|FG001|Overall Study|Lost to Follow-up|20|||
149770847|NCT01595438|540287035|FG000|Overall Study|Withdrawal by Subject|12|||
149770848|NCT01595438|540287036|FG001|Overall Study|Withdrawal by Subject|12|||
149770849|NCT01595438|540287035|FG000|Overall Study|Other Eligibility criteria|11|||
149770850|NCT01595438|540287036|FG001|Overall Study|Other Eligibility criteria|9|||
149770851|NCT00650091|540287038|FG000|Amended Study Design|Withdrawal by Subject|12|||
149770852|NCT00650091|540287039|FG001|Amended Study Design|Withdrawal by Subject|11|||
149770853|NCT00650091|540287040|FG002|Amended Study Design|Withdrawal by Subject|0|||
149770854|NCT00650091|540287038|FG000|Amended Study Design|Physician Decision|5|||
149770855|NCT00650091|540287039|FG001|Amended Study Design|Physician Decision|0|||
149770856|NCT00650091|540287040|FG002|Amended Study Design|Physician Decision|0|||
149770857|NCT00650091|540287038|FG000|Amended Study Design|Adverse Event|1|||
149770858|NCT00650091|540287039|FG001|Amended Study Design|Adverse Event|4|||
149770859|NCT00650091|540287040|FG002|Amended Study Design|Adverse Event|0|||
149770860|NCT00650091|540287038|FG000|Amended Study Design|Lung transplantation|4|||
149770861|NCT00650091|540287039|FG001|Amended Study Design|Lung transplantation|2|||
149770862|NCT00650091|540287040|FG002|Amended Study Design|Lung transplantation|0|||
149770863|NCT00650091|540287038|FG000|Amended Study Design|Other|1|||
149770864|NCT00650091|540287039|FG001|Amended Study Design|Other|3|||
149770865|NCT00650091|540287040|FG002|Amended Study Design|Other|0|||
149770866|NCT01204697|540287041|FG000|Overall Study|Death|26|||
149770867|NCT01204697|540287042|FG001|Overall Study|Death|27|||
149770868|NCT01204697|540287041|FG000|Overall Study|Lost to Follow-up|3|||
149770869|NCT01204697|540287042|FG001|Overall Study|Lost to Follow-up|4|||
149770870|NCT01204697|540287041|FG000|Overall Study|Withdrawal by Subject|2|||
149770871|NCT01204697|540287042|FG001|Overall Study|Withdrawal by Subject|4|||
149770872|NCT01204697|540287041|FG000|Overall Study|Randomized, but not treated|0|||
149770873|NCT01204697|540287042|FG001|Overall Study|Randomized, but not treated|1|||
149770874|NCT01280266|540287043|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
149770875|NCT01280266|540287044|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
149770876|NCT01280266|540287043|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
149770877|NCT01280266|540287044|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
149770878|NCT04295356|540287045|FG000|Overall Study|Physician Decision|1|||
149770879|NCT04295356|540287046|FG001|Overall Study|Physician Decision|0|||
149770880|NCT04295356|540287045|FG000|Overall Study|Lost to Follow-up|0|||
149770881|NCT04295356|540287046|FG001|Overall Study|Lost to Follow-up|3|||
149770882|NCT04295356|540287045|FG000|Overall Study|Protocol Violation|0|||
149770883|NCT04295356|540287046|FG001|Overall Study|Protocol Violation|1|||
149770884|NCT00469209|540287055|FG000|Overall Study|Adverse Event|1|||
149770885|NCT00469209|540287056|FG001|Overall Study|Adverse Event|0|||
149770886|NCT00469209|540287057|FG002|Overall Study|Adverse Event|1|||
149770887|NCT04116073|540287063|FG000|Overall Study|Withdrawal by Subject|2|||
149770888|NCT04116073|540287063|FG000|Overall Study|failed to maintained eligibility|1|||
149770889|NCT03939637|540287066|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
149770890|NCT03939637|540287067|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
149770891|NCT03939637|540287066|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
149770892|NCT03939637|540287067|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
149770893|NCT03341923|540287070|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
149770894|NCT03341923|540287071|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
149770895|NCT04511819|540287072|FG000|Overall Study|Non-compliance with study drug|5|||
149770896|NCT04511819|540287073|FG001|Overall Study|Non-compliance with study drug|1|||
149770897|NCT04511819|540287072|FG000|Overall Study|Withdrawal by Subject|0|||
149770898|NCT04511819|540287073|FG001|Overall Study|Withdrawal by Subject|3|||
149770899|NCT04511819|540287072|FG000|Overall Study|Adverse Event|0|||
149770900|NCT04511819|540287073|FG001|Overall Study|Adverse Event|1|||
149770901|NCT04511819|540287072|FG000|Overall Study|Protocol deviation|1|||
149770902|NCT04511819|540287073|FG001|Overall Study|Protocol deviation|0|||
149770903|NCT00589979|540287075|FG000|Run-In Period|Adverse Event|5|||
149770904|NCT00589979|540287076|FG001|Run-In Period|Adverse Event|0|||
149770905|NCT00589979|540287077|FG002|Run-In Period|Adverse Event|0|||
149770906|NCT00589979|540287075|FG000|Run-In Period|Protocol Violation|3|||
149770907|NCT00589979|540287076|FG001|Run-In Period|Protocol Violation|0|||
149770908|NCT00589979|540287077|FG002|Run-In Period|Protocol Violation|0|||
149770909|NCT00589979|540287075|FG000|Run-In Period|Did not qualify for randomization|54|||
149770910|NCT00589979|540287076|FG001|Run-In Period|Did not qualify for randomization|0|||
149770911|NCT00589979|540287077|FG002|Run-In Period|Did not qualify for randomization|0|||
149770912|NCT00589979|540287075|FG000|Run-In Period|Withdrawal by Subject|10|||
149770913|NCT00589979|540287076|FG001|Run-In Period|Withdrawal by Subject|0|||
149770914|NCT00589979|540287077|FG002|Run-In Period|Withdrawal by Subject|0|||
149770915|NCT00589979|540287075|FG000|Run-In Period|Informed Consent Withdrawn|4|||
149770916|NCT00589979|540287076|FG001|Run-In Period|Informed Consent Withdrawn|0|||
149770917|NCT00589979|540287077|FG002|Run-In Period|Informed Consent Withdrawn|0|||
149770918|NCT00589979|540287075|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
149770919|NCT00589979|540287076|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
149770920|NCT00589979|540287077|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
149770921|NCT00589979|540287075|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
149770922|NCT00589979|540287076|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
149770923|NCT00589979|540287077|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
149770924|NCT00589979|540287075|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
149770925|NCT00589979|540287076|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
149770926|NCT00589979|540287077|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
149770927|NCT00589979|540287075|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
149770928|NCT00589979|540287076|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
149770929|NCT00589979|540287077|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
149770930|NCT00589979|540287075|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
149770931|NCT00589979|540287076|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
149770932|NCT00589979|540287077|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
149770933|NCT00589979|540287075|FG000|Double-Blind Treatment Period 2|Other|0|||
149770934|NCT00589979|540287076|FG001|Double-Blind Treatment Period 2|Other|0|||
149770935|NCT00589979|540287077|FG002|Double-Blind Treatment Period 2|Other|1|||
149770936|NCT00589979|540287075|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
149770937|NCT00589979|540287076|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
149770938|NCT00589979|540287077|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
149770939|NCT00589979|540287075|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
149770940|NCT00589979|540287076|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
149770941|NCT00589979|540287077|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
149770942|NCT01153841|540287078|FG000|Overall Study|Adverse Event|1|||
149770943|NCT01153841|540287079|FG001|Overall Study|Adverse Event|0|||
149770944|NCT01153841|540287078|FG000|Overall Study|Withdrawal by Subject|1|||
149770945|NCT01153841|540287079|FG001|Overall Study|Withdrawal by Subject|0|||
149770946|NCT01153841|540287078|FG000|Overall Study|Protocol Violation|2|||
149770947|NCT01153841|540287079|FG001|Overall Study|Protocol Violation|0|||
149770948|NCT01153841|540287078|FG000|Overall Study|Lost to Follow-up|2|||
149770949|NCT01153841|540287079|FG001|Overall Study|Lost to Follow-up|0|||
149770950|NCT00830804|540287085|FG000|Overall Study|Lost to Follow-up|4|||
149770951|NCT00830804|540287085|FG000|Overall Study|Death|1|||
149770952|NCT00830804|540287085|FG000|Overall Study|Unable to get to clinic|7|||
149770953|NCT00830804|540287085|FG000|Overall Study|Consent withdrawn|2|||
149770954|NCT00830804|540287085|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
149770955|NCT05489081|540287090|FG000|Overall Study|student left classroom|0|||
149770956|NCT05489081|540287091|FG001|Overall Study|student left classroom|1|||
149770957|NCT05489081|540287090|FG000|Overall Study|teacher left school|0|||
149770958|NCT05489081|540287091|FG001|Overall Study|teacher left school|2|||
149770959|NCT00510068|540287092|FG000|Double-blind Period|Disease progression|98|||
149770960|NCT00510068|540287093|FG001|Double-blind Period|Disease progression|169|||
149770961|NCT00510068|540287092|FG000|Double-blind Period|Final primary analysis|52|||
149770962|NCT00510068|540287093|FG001|Double-blind Period|Final primary analysis|18|||
149770963|NCT00510068|540287092|FG000|Double-blind Period|Adverse Event|37|||
149770964|NCT00510068|540287093|FG001|Double-blind Period|Adverse Event|7|||
149770965|NCT00510068|540287092|FG000|Double-blind Period|Withdrawal by Subject|8|||
149770966|NCT00510068|540287093|FG001|Double-blind Period|Withdrawal by Subject|6|||
149770967|NCT00510068|540287092|FG000|Double-blind Period|Death|4|||
149770968|NCT00510068|540287093|FG001|Double-blind Period|Death|3|||
149770969|NCT00510068|540287092|FG000|Double-blind Period|Abnormal test result (s)|1|||
149770970|NCT00510068|540287093|FG001|Double-blind Period|Abnormal test result (s)|0|||
149770971|NCT00510068|540287092|FG000|Double-blind Period|Lost to Follow-up|1|||
149770972|NCT00510068|540287093|FG001|Double-blind Period|Lost to Follow-up|0|||
149770973|NCT00510068|540287092|FG000|Double-blind Period|Protocol Violation|6|||
149770974|NCT00510068|540287093|FG001|Double-blind Period|Protocol Violation|0|||
149770975|NCT00510068|540287092|FG000|Open-label Period|Disease Progression|124|||
149770976|NCT00510068|540287093|FG001|Open-label Period|Disease Progression|0|||
149770977|NCT00510068|540287092|FG000|Open-label Period|Adverse Event|46|||
149770978|NCT00510068|540287093|FG001|Open-label Period|Adverse Event|0|||
149770979|NCT00510068|540287092|FG000|Open-label Period|Withdrawal by Subject|21|||
149770980|NCT00510068|540287093|FG001|Open-label Period|Withdrawal by Subject|0|||
149770981|NCT00510068|540287092|FG000|Open-label Period|Administrative problems|17|||
149770982|NCT00510068|540287093|FG001|Open-label Period|Administrative problems|0|||
149770983|NCT00510068|540287092|FG000|Open-label Period|Death|7|||
149770984|NCT00510068|540287093|FG001|Open-label Period|Death|0|||
149770985|NCT00510068|540287092|FG000|Open-label Period|New cancer therapy|7|||
149770986|NCT00510068|540287093|FG001|Open-label Period|New cancer therapy|0|||
149770987|NCT00510068|540287092|FG000|Open-label Period|Protocol Violation|2|||
149770988|NCT00510068|540287093|FG001|Open-label Period|Protocol Violation|0|||
149770989|NCT00510068|540287092|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
149770990|NCT00510068|540287093|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
149770991|NCT00400712|540287094|FG000|Overall Study|Death|1|||
149770992|NCT00400712|540287095|FG001|Overall Study|Death|0|||
149770993|NCT00400712|540287094|FG000|Overall Study|Withdrawal by Subject|11|||
149770994|NCT00400712|540287095|FG001|Overall Study|Withdrawal by Subject|12|||
149770995|NCT00400712|540287094|FG000|Overall Study|Physician Decision|5|||
149770996|NCT00400712|540287095|FG001|Overall Study|Physician Decision|4|||
149770997|NCT00776555|540287098|FG000|Overall Study|Study terminated|3|||
149770998|NCT00776555|540287099|FG001|Overall Study|Study terminated|0|||
149770999|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
149771000|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
149771001|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
149771002|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
149771003|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
149771004|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
149771005|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Death|1|||
149771006|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Death|3|||
149771007|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
149771008|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
149771009|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
149771010|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
149771011|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
149771012|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
149771013|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
149771014|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
149771015|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
149771016|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
149771017|NCT02553317|540287100|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
149771018|NCT02553317|540287101|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
149771019|NCT03483116|540287103|FG000|Overall Study|Adverse Event|0|||
149771020|NCT03483116|540287104|FG001|Overall Study|Adverse Event|1|||
149771021|NCT03483116|540287105|FG002|Overall Study|Adverse Event|0|||
149771022|NCT03483116|540287106|FG003|Overall Study|Adverse Event|1|||
149771023|NCT03483116|540287103|FG000|Overall Study|Protocol Violation|1|||
149771024|NCT03483116|540287104|FG001|Overall Study|Protocol Violation|0|||
149771025|NCT03483116|540287105|FG002|Overall Study|Protocol Violation|0|||
149771026|NCT03483116|540287106|FG003|Overall Study|Protocol Violation|7|||
149771027|NCT03483116|540287103|FG000|Overall Study|Lost to Follow-up|9|||
149771028|NCT03483116|540287104|FG001|Overall Study|Lost to Follow-up|4|||
149771029|NCT03483116|540287105|FG002|Overall Study|Lost to Follow-up|9|||
149771030|NCT03483116|540287106|FG003|Overall Study|Lost to Follow-up|5|||
149771031|NCT03483116|540287103|FG000|Overall Study|Death|1|||
149771032|NCT03483116|540287104|FG001|Overall Study|Death|0|||
149771033|NCT03483116|540287105|FG002|Overall Study|Death|2|||
149771034|NCT03483116|540287106|FG003|Overall Study|Death|1|||
149771035|NCT03483116|540287103|FG000|Overall Study|Withdrawal by Subject|14|||
149771036|NCT03483116|540287104|FG001|Overall Study|Withdrawal by Subject|16|||
149771037|NCT03483116|540287105|FG002|Overall Study|Withdrawal by Subject|14|||
149771038|NCT03483116|540287106|FG003|Overall Study|Withdrawal by Subject|16|||
149771039|NCT03483116|540287103|FG000|Overall Study|Unknown other reason|3|||
149771040|NCT03483116|540287104|FG001|Overall Study|Unknown other reason|2|||
149771041|NCT03483116|540287105|FG002|Overall Study|Unknown other reason|1|||
149771042|NCT03483116|540287106|FG003|Overall Study|Unknown other reason|1|||
149771043|NCT01181102|540287107|FG000|Overall Study|Adverse Event|28|||
149771044|NCT01181102|540287108|FG001|Overall Study|Adverse Event|26|||
149771045|NCT01181102|540287107|FG000|Overall Study|Lack of Efficacy|3|||
149771046|NCT01181102|540287108|FG001|Overall Study|Lack of Efficacy|1|||
149771047|NCT01181102|540287107|FG000|Overall Study|Lost to Follow-up|2|||
149771048|NCT01181102|540287108|FG001|Overall Study|Lost to Follow-up|0|||
149771049|NCT01181102|540287107|FG000|Overall Study|Physician Decision|3|||
149771050|NCT01181102|540287108|FG001|Overall Study|Physician Decision|1|||
149771051|NCT01181102|540287107|FG000|Overall Study|Protocol Violation|5|||
149771052|NCT01181102|540287108|FG001|Overall Study|Protocol Violation|6|||
149771053|NCT01181102|540287107|FG000|Overall Study|Withdrawal by Subject|10|||
149771054|NCT01181102|540287108|FG001|Overall Study|Withdrawal by Subject|12|||
149771055|NCT01838590|540287114|FG000|Overall Study|Lack of Efficacy|12|||
149771056|NCT01838590|540287115|FG001|Overall Study|Lack of Efficacy|4|||
149771057|NCT01838590|540287114|FG000|Overall Study|Lost to Follow-up|0|||
149771058|NCT01838590|540287115|FG001|Overall Study|Lost to Follow-up|1|||
149771059|NCT04664855|540287116|FG000|Overall Study|Withdrawal by Subject|0|||
149771060|NCT04664855|540287117|FG001|Overall Study|Withdrawal by Subject|2|||
149771061|NCT01529385|540287118|FG000|Overall Study|Lost to Follow-up|2|||
149771062|NCT01529385|540287119|FG001|Overall Study|Lost to Follow-up|1|||
149771063|NCT00862121|540287122|FG000|Overall Study|Adverse Event|1|||
149771064|NCT00862121|540287123|FG001|Overall Study|Adverse Event|2|||
149771065|NCT00862121|540287122|FG000|Overall Study|Lack of Efficacy|0|||
149771066|NCT00862121|540287123|FG001|Overall Study|Lack of Efficacy|3|||
149771067|NCT00862121|540287122|FG000|Overall Study|Protocol Violation|0|||
149771068|NCT00862121|540287123|FG001|Overall Study|Protocol Violation|1|||
149771069|NCT00862121|540287122|FG000|Overall Study|Exclusion criterion violation|0|||
149771070|NCT00862121|540287123|FG001|Overall Study|Exclusion criterion violation|1|||
149771071|NCT00862121|540287122|FG000|Overall Study|Incorrect randomisation|0|||
149771072|NCT00862121|540287123|FG001|Overall Study|Incorrect randomisation|1|||
149771073|NCT05691829|540289416|FG000|Overall Study|Physician Decision|2|||
149771074|NCT05691829|540289416|FG000|Overall Study|Eligibility criteria not met|3|||
149771075|NCT02591238|540289418|FG000|Overall Study|Pregnancy|1|||
149771076|NCT02591238|540289419|FG001|Overall Study|Pregnancy|0|||
149771077|NCT02591238|540289420|FG002|Overall Study|Pregnancy|0|||
149771078|NCT02591238|540289421|FG003|Overall Study|Pregnancy|0|||
149771079|NCT02591238|540289418|FG000|Overall Study|Withdrawal by Subject|0|||
149771080|NCT02591238|540289419|FG001|Overall Study|Withdrawal by Subject|0|||
149771081|NCT02591238|540289420|FG002|Overall Study|Withdrawal by Subject|0|||
149771082|NCT02591238|540289421|FG003|Overall Study|Withdrawal by Subject|1|||
149771083|NCT02591238|540289418|FG000|Overall Study|influenza|0|||
149771084|NCT02591238|540289419|FG001|Overall Study|influenza|0|||
149771085|NCT02591238|540289420|FG002|Overall Study|influenza|0|||
149771086|NCT02591238|540289421|FG003|Overall Study|influenza|1|||
149771087|NCT02591238|540289418|FG000|Overall Study|personal circumstances|0|||
149771088|NCT02591238|540289419|FG001|Overall Study|personal circumstances|0|||
149771089|NCT02591238|540289420|FG002|Overall Study|personal circumstances|0|||
149771090|NCT02591238|540289421|FG003|Overall Study|personal circumstances|1|||
149771091|NCT02591238|540289418|FG000|Overall Study|personal circumstances|0|||
149771092|NCT02591238|540289419|FG001|Overall Study|personal circumstances|1|||
149771093|NCT02591238|540289420|FG002|Overall Study|personal circumstances|0|||
149771094|NCT02591238|540289421|FG003|Overall Study|personal circumstances|0|||
149771095|NCT00640146|540289422|FG000|Overall Study|Adverse Event|2|||
149771096|NCT00640146|540289423|FG001|Overall Study|Adverse Event|0|||
149771097|NCT00640146|540289422|FG000|Overall Study|Lost to Follow-up|0|||
149771098|NCT00640146|540289423|FG001|Overall Study|Lost to Follow-up|1|||
149771099|NCT00640146|540289422|FG000|Overall Study|Lack of Efficacy|0|||
149771100|NCT00640146|540289423|FG001|Overall Study|Lack of Efficacy|1|||
149771101|NCT00640146|540289422|FG000|Overall Study|Withdrawal by Subject|1|||
149771102|NCT00640146|540289423|FG001|Overall Study|Withdrawal by Subject|1|||
149771103|NCT00640146|540289422|FG000|Overall Study|Randomized but not treated|1|||
149771104|NCT00640146|540289423|FG001|Overall Study|Randomized but not treated|3|||
149771105|NCT00387348|540289431|FG000|Overall Study|Death|1|||
149771106|NCT00387348|540289432|FG001|Overall Study|Death|1|||
149771107|NCT00387348|540289433|FG002|Overall Study|Death|0|||
149771108|NCT00387348|540289431|FG000|Overall Study|Physician Decision|1|||
149771109|NCT00387348|540289432|FG001|Overall Study|Physician Decision|0|||
149771110|NCT00387348|540289433|FG002|Overall Study|Physician Decision|1|||
149771111|NCT00387348|540289431|FG000|Overall Study|Withdrawal by Subject|0|||
149771112|NCT00387348|540289432|FG001|Overall Study|Withdrawal by Subject|2|||
149771113|NCT00387348|540289433|FG002|Overall Study|Withdrawal by Subject|2|||
149771114|NCT00387348|540289431|FG000|Overall Study|Adverse Event|1|||
149771115|NCT00387348|540289432|FG001|Overall Study|Adverse Event|0|||
149771116|NCT00387348|540289433|FG002|Overall Study|Adverse Event|1|||
149771117|NCT03628599|540289434|FG000|Overall Study|Adverse Event|0|||
149771118|NCT03628599|540289435|FG001|Overall Study|Adverse Event|1|||
149771119|NCT01624506|540289438|FG000|Overall Study|Lost to Follow-up|29|||
149771120|NCT01624506|540289439|FG001|Overall Study|Lost to Follow-up|15|||
149771121|NCT01624506|540289438|FG000|Overall Study|Withdrawal by Subject|9|||
149771122|NCT01624506|540289439|FG001|Overall Study|Withdrawal by Subject|2|||
149771123|NCT01624506|540289438|FG000|Overall Study|Death|1|||
149771124|NCT01624506|540289439|FG001|Overall Study|Death|0|||
149771125|NCT01624506|540289438|FG000|Overall Study|LINX explants|23|||
149771126|NCT01624506|540289439|FG001|Overall Study|LINX explants|0|||
149771127|NCT01624506|540289438|FG000|Overall Study|Adverse Event|3|||
149771128|NCT01624506|540289439|FG001|Overall Study|Adverse Event|0|||
149771129|NCT01149343|540289440|FG000|Overall Study|Withdrawal by Subject|1|||
149771130|NCT01149343|540289441|FG001|Overall Study|Withdrawal by Subject|1|||
149771131|NCT01149343|540289442|FG002|Overall Study|Withdrawal by Subject|1|||
149771132|NCT01149343|540289443|FG003|Overall Study|Withdrawal by Subject|5|||
149771133|NCT01149343|540289440|FG000|Overall Study|Death|10|||
149771134|NCT01149343|540289441|FG001|Overall Study|Death|13|||
149771135|NCT01149343|540289442|FG002|Overall Study|Death|18|||
149771136|NCT01149343|540289443|FG003|Overall Study|Death|18|||
149771137|NCT01149343|540289440|FG000|Overall Study|Lost to Follow-up|1|||
149771138|NCT01149343|540289441|FG001|Overall Study|Lost to Follow-up|0|||
149771139|NCT01149343|540289442|FG002|Overall Study|Lost to Follow-up|0|||
149771140|NCT01149343|540289443|FG003|Overall Study|Lost to Follow-up|1|||
149771141|NCT01149343|540289440|FG000|Overall Study|Other|8|||
149771142|NCT01149343|540289441|FG001|Overall Study|Other|10|||
149771143|NCT01149343|540289442|FG002|Overall Study|Other|2|||
149771144|NCT01149343|540289443|FG003|Overall Study|Other|14|||
149771145|NCT01149343|540289440|FG000|Overall Study|Sponsor study termination|0|||
149771146|NCT01149343|540289441|FG001|Overall Study|Sponsor study termination|0|||
149771147|NCT01149343|540289442|FG002|Overall Study|Sponsor study termination|0|||
149771148|NCT01149343|540289443|FG003|Overall Study|Sponsor study termination|2|||
149771149|NCT01149343|540289440|FG000|Overall Study|Recurrence / Progressive disease|0|||
149771150|NCT01149343|540289441|FG001|Overall Study|Recurrence / Progressive disease|0|||
149771151|NCT01149343|540289442|FG002|Overall Study|Recurrence / Progressive disease|1|||
149771152|NCT01149343|540289443|FG003|Overall Study|Recurrence / Progressive disease|0|||
149771153|NCT00132314|540289452|FG000|Overall Study|Lost to Follow-up|70|||
149771154|NCT00132314|540289453|FG001|Overall Study|Lost to Follow-up|62|||
149771155|NCT00132314|540289452|FG000|Overall Study|Lacked SSN|1|||
149771156|NCT00132314|540289453|FG001|Overall Study|Lacked SSN|3|||
149771157|NCT00132314|540289452|FG000|Overall Study|Refused intervention at baseline|2|||
149771158|NCT00132314|540289453|FG001|Overall Study|Refused intervention at baseline|7|||
149771159|NCT04624672|540289464|FG000|Overall Study|Early Study Closure|2|||
149771160|NCT04624672|540289465|FG001|Overall Study|Early Study Closure|1|||
149771161|NCT03472040|540289466|FG000|Overall Study|Physician Decision|0|||
149771162|NCT03472040|540289467|FG001|Overall Study|Physician Decision|3|||
149771163|NCT03472040|540289466|FG000|Overall Study|Withdrawal by Subject|10|||
149771164|NCT03472040|540289467|FG001|Overall Study|Withdrawal by Subject|23|||
149771165|NCT03472040|540289466|FG000|Overall Study|Perceived Lack of Efficacy|29|||
149771166|NCT03472040|540289467|FG001|Overall Study|Perceived Lack of Efficacy|30|||
149771167|NCT03472040|540289466|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
149771168|NCT03472040|540289467|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
149771169|NCT03472040|540289466|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
149771170|NCT03472040|540289467|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
149771171|NCT03472040|540289466|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
149771172|NCT03472040|540289467|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
149771173|NCT03472040|540289466|FG000|Overall Study|Subject Non-compliance|2|||
149771174|NCT03472040|540289467|FG001|Overall Study|Subject Non-compliance|5|||
149771175|NCT03472040|540289466|FG000|Overall Study|Discontinuation due to Rash|0|||
149771176|NCT03472040|540289467|FG001|Overall Study|Discontinuation due to Rash|1|||
149771177|NCT03472040|540289466|FG000|Overall Study|Subsequent Ineligibility|0|||
149771178|NCT03472040|540289467|FG001|Overall Study|Subsequent Ineligibility|2|||
149771179|NCT03472040|540289466|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
149771180|NCT03472040|540289467|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
149771181|NCT02769832|540289468|FG000|Overall Study|Death|30|||
149771182|NCT00225147|540289477|FG000|Open-label Phase|Lost to Follow-up|0|||
149771183|NCT00225147|540289478|FG001|Open-label Phase|Lost to Follow-up|0|||
149771184|NCT00225147|540289479|FG002|Open-label Phase|Lost to Follow-up|0|||
149771185|NCT00225147|540289480|FG003|Open-label Phase|Lost to Follow-up|4|||
149771186|NCT00225147|540289477|FG000|Open-label Phase|Withdrawal by Subject|0|||
149771187|NCT00225147|540289478|FG001|Open-label Phase|Withdrawal by Subject|0|||
149771188|NCT00225147|540289479|FG002|Open-label Phase|Withdrawal by Subject|0|||
149771189|NCT00225147|540289480|FG003|Open-label Phase|Withdrawal by Subject|6|||
149771190|NCT03024255|540289481|FG000|Overall Study|Adverse Event|1|||
149771191|NCT03024255|540289482|FG001|Overall Study|Adverse Event|4|||
149771192|NCT03024255|540289483|FG002|Overall Study|Adverse Event|8|||
149771193|NCT03024255|540289484|FG003|Overall Study|Adverse Event|0|||
149771194|NCT03024255|540289481|FG000|Overall Study|Withdrawal by Subject|3|||
149771195|NCT03024255|540289482|FG001|Overall Study|Withdrawal by Subject|1|||
149771196|NCT03024255|540289483|FG002|Overall Study|Withdrawal by Subject|0|||
149771197|NCT03024255|540289484|FG003|Overall Study|Withdrawal by Subject|3|||
149771198|NCT03024255|540289481|FG000|Overall Study|Protocol Violation|0|||
149771199|NCT03024255|540289482|FG001|Overall Study|Protocol Violation|0|||
149771200|NCT03024255|540289483|FG002|Overall Study|Protocol Violation|2|||
149771201|NCT03024255|540289484|FG003|Overall Study|Protocol Violation|0|||
149771202|NCT03024255|540289481|FG000|Overall Study|Lost to Follow-up|1|||
149771203|NCT03024255|540289482|FG001|Overall Study|Lost to Follow-up|2|||
149771204|NCT03024255|540289483|FG002|Overall Study|Lost to Follow-up|1|||
149771205|NCT03024255|540289484|FG003|Overall Study|Lost to Follow-up|1|||
149771206|NCT03024255|540289481|FG000|Overall Study|Lack of Efficacy|1|||
149771207|NCT03024255|540289482|FG001|Overall Study|Lack of Efficacy|0|||
149771208|NCT03024255|540289483|FG002|Overall Study|Lack of Efficacy|0|||
149771209|NCT03024255|540289484|FG003|Overall Study|Lack of Efficacy|0|||
149771210|NCT03024255|540289481|FG000|Overall Study|Protocol Noncompliance|1|||
149771211|NCT03024255|540289482|FG001|Overall Study|Protocol Noncompliance|1|||
149771212|NCT03024255|540289483|FG002|Overall Study|Protocol Noncompliance|0|||
149771213|NCT03024255|540289484|FG003|Overall Study|Protocol Noncompliance|1|||
149771214|NCT01415908|540289488|FG000|Overall Study|Withdrawal by Subject|1|||
149771215|NCT01415908|540289489|FG001|Overall Study|Withdrawal by Subject|0|||
149771216|NCT02685995|540289492|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
149771217|NCT02685995|540289493|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
149771218|NCT03625141|540289494|FG000|Overall Study|Adverse Event|0|||
149771219|NCT03625141|540289495|FG001|Overall Study|Adverse Event|2|||
149771220|NCT03625141|540289494|FG000|Overall Study|Study Terminated By Sponsor|1|||
149771221|NCT03625141|540289495|FG001|Overall Study|Study Terminated By Sponsor|13|||
149771222|NCT03625141|540289494|FG000|Overall Study|Withdrawal by Subject|3|||
149771223|NCT03625141|540289495|FG001|Overall Study|Withdrawal by Subject|0|||
149771224|NCT03625141|540289494|FG000|Overall Study|Withdrawal Of Consent|0|||
149771225|NCT03625141|540289495|FG001|Overall Study|Withdrawal Of Consent|1|||
149771226|NCT03625141|540289494|FG000|Overall Study|Death|11|||
149771227|NCT03625141|540289495|FG001|Overall Study|Death|47|||
149771228|NCT03625141|540289494|FG000|Overall Study|Progressive Disease|0|||
149771229|NCT03625141|540289495|FG001|Overall Study|Progressive Disease|2|||
149771230|NCT03250377|540289496|FG000|Overall Study|Adverse Event|2|||
149771231|NCT03250377|540289497|FG001|Overall Study|Adverse Event|4|||
149771232|NCT03250377|540289498|FG002|Overall Study|Adverse Event|0|||
149771233|NCT03250377|540289499|FG003|Overall Study|Adverse Event|4|||
149771234|NCT03250377|540289496|FG000|Overall Study|Lack of Efficacy|5|||
149771235|NCT03250377|540289497|FG001|Overall Study|Lack of Efficacy|14|||
149771236|NCT03250377|540289498|FG002|Overall Study|Lack of Efficacy|1|||
149771237|NCT03250377|540289499|FG003|Overall Study|Lack of Efficacy|3|||
149771238|NCT03250377|540289496|FG000|Overall Study|Protocol Violation|0|||
149771239|NCT03250377|540289497|FG001|Overall Study|Protocol Violation|2|||
149771240|NCT03250377|540289498|FG002|Overall Study|Protocol Violation|0|||
149771241|NCT03250377|540289499|FG003|Overall Study|Protocol Violation|1|||
149771242|NCT03250377|540289496|FG000|Overall Study|Lost to Follow-up|0|||
149771243|NCT03250377|540289497|FG001|Overall Study|Lost to Follow-up|1|||
149771244|NCT03250377|540289498|FG002|Overall Study|Lost to Follow-up|0|||
149771245|NCT03250377|540289499|FG003|Overall Study|Lost to Follow-up|0|||
149771246|NCT03250377|540289496|FG000|Overall Study|Withdrawal by Subject|7|||
149771247|NCT03250377|540289497|FG001|Overall Study|Withdrawal by Subject|7|||
149771248|NCT03250377|540289498|FG002|Overall Study|Withdrawal by Subject|0|||
149771249|NCT03250377|540289499|FG003|Overall Study|Withdrawal by Subject|4|||
149771250|NCT03250377|540289496|FG000|Overall Study|Investigator's Judgment|1|||
149771251|NCT03250377|540289497|FG001|Overall Study|Investigator's Judgment|0|||
149771252|NCT03250377|540289498|FG002|Overall Study|Investigator's Judgment|0|||
149771253|NCT03250377|540289499|FG003|Overall Study|Investigator's Judgment|0|||
149771254|NCT03250377|540289496|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
149771255|NCT03250377|540289497|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
149771256|NCT03250377|540289498|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
149771257|NCT03250377|540289499|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
149771258|NCT03250377|540289496|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
149771259|NCT03250377|540289497|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
149771260|NCT03250377|540289498|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
149771261|NCT03250377|540289499|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
149771262|NCT03250377|540289496|FG000|Overall Study|Epilepsy Surgery|0|||
149771263|NCT03250377|540289497|FG001|Overall Study|Epilepsy Surgery|1|||
149771264|NCT03250377|540289498|FG002|Overall Study|Epilepsy Surgery|2|||
149771265|NCT03250377|540289499|FG003|Overall Study|Epilepsy Surgery|0|||
149771266|NCT03250377|540289496|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149771267|NCT03250377|540289497|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
149771268|NCT03250377|540289498|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149771269|NCT03250377|540289499|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149771270|NCT03250377|540289496|FG000|Overall Study|Request From The Sponsor|0|||
149771271|NCT03250377|540289497|FG001|Overall Study|Request From The Sponsor|1|||
149771272|NCT03250377|540289498|FG002|Overall Study|Request From The Sponsor|0|||
149771273|NCT03250377|540289499|FG003|Overall Study|Request From The Sponsor|0|||
149771274|NCT03250377|540289496|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
149771275|NCT03250377|540289497|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
149771276|NCT03250377|540289498|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
149771277|NCT03250377|540289499|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
149771278|NCT03250377|540289496|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
149771279|NCT03250377|540289497|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
149771280|NCT03250377|540289498|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
149771281|NCT03250377|540289499|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
149771282|NCT03250377|540289496|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
149771283|NCT03250377|540289497|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
149771284|NCT03250377|540289498|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
149771285|NCT03250377|540289499|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
149771286|NCT03250377|540289496|FG000|Overall Study|Pregnancy Event|0|||
149771287|NCT03250377|540289497|FG001|Overall Study|Pregnancy Event|1|||
149771288|NCT03250377|540289498|FG002|Overall Study|Pregnancy Event|0|||
149771289|NCT03250377|540289499|FG003|Overall Study|Pregnancy Event|0|||
149771290|NCT03250377|540289496|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
149771291|NCT03250377|540289497|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
149771292|NCT03250377|540289498|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
149771293|NCT03250377|540289499|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
149771294|NCT03250377|540289496|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
149771295|NCT03250377|540289497|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
149771296|NCT03250377|540289498|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
149771297|NCT03250377|540289499|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
149771298|NCT03250377|540289496|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
149771299|NCT03250377|540289497|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
149771300|NCT03250377|540289498|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
149771301|NCT03250377|540289499|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
149771302|NCT03250377|540289496|FG000|Overall Study|Patient requested to change hospital|0|||
149771303|NCT03250377|540289497|FG001|Overall Study|Patient requested to change hospital|0|||
149771304|NCT03250377|540289498|FG002|Overall Study|Patient requested to change hospital|0|||
149771305|NCT03250377|540289499|FG003|Overall Study|Patient requested to change hospital|1|||
149771306|NCT03250377|540289496|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
149771307|NCT03250377|540289497|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
149771308|NCT03250377|540289498|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
149771309|NCT03250377|540289499|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
149771310|NCT02168803|540289501|FG000|Overall Study|Lost to Follow-up|1|||
149771311|NCT02168803|540289502|FG001|Overall Study|Lost to Follow-up|0|||
149771312|NCT02168803|540289503|FG002|Overall Study|Lost to Follow-up|1|||
149771313|NCT02168803|540289501|FG000|Overall Study|Withdrawal by Subject|1|||
149771314|NCT02168803|540289502|FG001|Overall Study|Withdrawal by Subject|1|||
149771315|NCT02168803|540289503|FG002|Overall Study|Withdrawal by Subject|2|||
149771316|NCT02168803|540289501|FG000|Overall Study|Physician Decision|0|||
149771317|NCT02168803|540289502|FG001|Overall Study|Physician Decision|1|||
149771318|NCT02168803|540289503|FG002|Overall Study|Physician Decision|0|||
149771319|NCT02168803|540289501|FG000|Overall Study|Adverse Event|0|||
149771320|NCT02168803|540289502|FG001|Overall Study|Adverse Event|1|||
149771321|NCT02168803|540289503|FG002|Overall Study|Adverse Event|1|||
149771322|NCT02168803|540289501|FG000|Overall Study|Death|0|||
149771323|NCT02168803|540289502|FG001|Overall Study|Death|0|||
149771324|NCT02168803|540289503|FG002|Overall Study|Death|1|||
149771325|NCT02168803|540289501|FG000|Overall Study|Sponsor Decision|0|||
149771326|NCT02168803|540289502|FG001|Overall Study|Sponsor Decision|0|||
149771327|NCT02168803|540289503|FG002|Overall Study|Sponsor Decision|1|||
149771328|NCT01114373|540289504|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
149771329|NCT01114373|540289505|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
149771330|NCT01114373|540289504|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
149771331|NCT01114373|540289505|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
149771332|NCT01114373|540289504|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
149771333|NCT01114373|540289505|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
149771334|NCT01114373|540289504|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
149771335|NCT01114373|540289505|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
149771336|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149771337|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149771338|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
149771339|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
149771340|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149771341|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149771342|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
149771343|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
149771344|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
149771345|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149771346|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149771347|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149771348|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
149771349|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
149771350|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
149771351|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149771352|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149771353|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149771354|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
149771355|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
149771356|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149771357|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149771358|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149771359|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149771360|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
149771361|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
149771362|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149771363|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149771364|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149771365|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149771366|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
149771367|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149771368|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149771369|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149771370|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149771371|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149771372|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
149771373|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
149771374|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
149771375|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
149771376|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
149771377|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
149771378|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
149771379|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
149771380|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149771381|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149771382|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149771383|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149771384|NCT03444870|540289506|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
149771385|NCT03444870|540289507|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149771386|NCT03444870|540289508|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149771387|NCT03444870|540289509|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149771388|NCT03444870|540289510|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149771389|NCT03444870|540289511|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149771390|NCT03444870|540289506|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149771391|NCT03444870|540289507|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149771392|NCT03444870|540289508|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149771393|NCT03444870|540289509|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149771394|NCT03444870|540289510|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
149771395|NCT03444870|540289511|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
149771396|NCT03444870|540289506|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
149771397|NCT03444870|540289507|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
149771398|NCT03444870|540289508|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
149771399|NCT03444870|540289509|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
149771400|NCT03444870|540289510|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
149771401|NCT03444870|540289511|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
149771402|NCT03444870|540289506|FG000|Open-Label Extension (OLE) Period|Death|0|||
149771403|NCT03444870|540289507|FG001|Open-Label Extension (OLE) Period|Death|0|||
149771404|NCT03444870|540289508|FG002|Open-Label Extension (OLE) Period|Death|0|||
149771405|NCT03444870|540289509|FG003|Open-Label Extension (OLE) Period|Death|0|||
149771406|NCT03444870|540289510|FG004|Open-Label Extension (OLE) Period|Death|1|||
149771407|NCT03444870|540289511|FG005|Open-Label Extension (OLE) Period|Death|0|||
149771408|NCT00868166|540289512|FG000|Overall Study|Death|58|||
149771409|NCT00868166|540289513|FG001|Overall Study|Death|65|||
149771410|NCT00868166|540289512|FG000|Overall Study|Withdrawal by Subject|33|||
149771411|NCT00868166|540289513|FG001|Overall Study|Withdrawal by Subject|25|||
149771412|NCT00868166|540289512|FG000|Overall Study|Protocol Violation|1|||
149771413|NCT00868166|540289513|FG001|Overall Study|Protocol Violation|0|||
149771414|NCT00868166|540289512|FG000|Overall Study|Lost to Follow-up|1|||
149771415|NCT00868166|540289513|FG001|Overall Study|Lost to Follow-up|3|||
149771416|NCT00868166|540289512|FG000|Overall Study|Adverse Event|9|||
149771417|NCT00868166|540289513|FG001|Overall Study|Adverse Event|10|||
149771418|NCT00868166|540289512|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
149771419|NCT00868166|540289513|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
149771420|NCT00868166|540289512|FG000|Overall Study|Non-compliance with IMP|1|||
149771421|NCT00868166|540289513|FG001|Overall Study|Non-compliance with IMP|1|||
149771422|NCT02034552|540289518|FG000|Overall Study|Never treated|3|||
149771423|NCT02034552|540289519|FG001|Overall Study|Never treated|2|||
149771424|NCT02034552|540289520|FG002|Overall Study|Never treated|0|||
149771425|NCT02034552|540289518|FG000|Overall Study|Radiological progression|3|||
149771426|NCT02034552|540289519|FG001|Overall Study|Radiological progression|5|||
149771427|NCT02034552|540289520|FG002|Overall Study|Radiological progression|4|||
149771428|NCT02034552|540289518|FG000|Overall Study|AE not assoc. with disease progression|1|||
149771429|NCT02034552|540289519|FG001|Overall Study|AE not assoc. with disease progression|4|||
149771430|NCT02034552|540289520|FG002|Overall Study|AE not assoc. with disease progression|2|||
149771431|NCT02034552|540289518|FG000|Overall Study|AE associated with disease progression|0|||
149771432|NCT02034552|540289519|FG001|Overall Study|AE associated with disease progression|1|||
149771433|NCT02034552|540289520|FG002|Overall Study|AE associated with disease progression|0|||
149771434|NCT02034552|540289518|FG000|Overall Study|Withdrawal by Subject|2|||
149771435|NCT02034552|540289519|FG001|Overall Study|Withdrawal by Subject|1|||
149771436|NCT02034552|540289520|FG002|Overall Study|Withdrawal by Subject|1|||
149771437|NCT02034552|540289518|FG000|Overall Study|Non-compliance with study drug|0|||
149771438|NCT02034552|540289519|FG001|Overall Study|Non-compliance with study drug|0|||
149771439|NCT02034552|540289520|FG002|Overall Study|Non-compliance with study drug|1|||
149771440|NCT02034552|540289518|FG000|Overall Study|Clinical progression|5|||
149771441|NCT02034552|540289519|FG001|Overall Study|Clinical progression|7|||
149771442|NCT02034552|540289520|FG002|Overall Study|Clinical progression|9|||
149771443|NCT02197897|540289528|FG000|Overall Study|not eligible|1|||
149771444|NCT02501902|540289529|FG000|Overall Study|Subject Refused Further Follow-up|0|||
149771445|NCT02501902|540289530|FG001|Overall Study|Subject Refused Further Follow-up|0|||
149771446|NCT02501902|540289531|FG002|Overall Study|Subject Refused Further Follow-up|0|||
149771447|NCT02501902|540289532|FG003|Overall Study|Subject Refused Further Follow-up|0|||
149771448|NCT02501902|540289533|FG004|Overall Study|Subject Refused Further Follow-up|0|||
149771449|NCT02501902|540289534|FG005|Overall Study|Subject Refused Further Follow-up|0|||
149771450|NCT02501902|540289535|FG006|Overall Study|Subject Refused Further Follow-up|0|||
149771451|NCT02501902|540289536|FG007|Overall Study|Subject Refused Further Follow-up|1|||
149771452|NCT02501902|540289529|FG000|Overall Study|Study Terminated by Sponsor|0|||
149771453|NCT02501902|540289530|FG001|Overall Study|Study Terminated by Sponsor|3|||
149771454|NCT02501902|540289531|FG002|Overall Study|Study Terminated by Sponsor|0|||
149771455|NCT02501902|540289532|FG003|Overall Study|Study Terminated by Sponsor|1|||
149771456|NCT02501902|540289533|FG004|Overall Study|Study Terminated by Sponsor|1|||
149771457|NCT02501902|540289534|FG005|Overall Study|Study Terminated by Sponsor|0|||
149771458|NCT02501902|540289535|FG006|Overall Study|Study Terminated by Sponsor|2|||
149771459|NCT02501902|540289536|FG007|Overall Study|Study Terminated by Sponsor|4|||
149771460|NCT02501902|540289529|FG000|Overall Study|Death|3|||
149771461|NCT02501902|540289530|FG001|Overall Study|Death|4|||
149771462|NCT02501902|540289531|FG002|Overall Study|Death|4|||
149771463|NCT02501902|540289532|FG003|Overall Study|Death|10|||
149771464|NCT02501902|540289533|FG004|Overall Study|Death|10|||
149771465|NCT02501902|540289534|FG005|Overall Study|Death|11|||
149771466|NCT02501902|540289535|FG006|Overall Study|Death|7|||
149771467|NCT02501902|540289536|FG007|Overall Study|Death|15|||
149771468|NCT01797445|540289539|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
149771469|NCT01797445|540289540|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
149771470|NCT01797445|540289539|FG000|Double-Blind Phase|Adverse Event|3|||
149771471|NCT01797445|540289540|FG001|Double-Blind Phase|Adverse Event|0|||
149771472|NCT01797445|540289539|FG000|Double-Blind Phase|Death|5|||
149771473|NCT01797445|540289540|FG001|Double-Blind Phase|Death|4|||
149771474|NCT01797445|540289539|FG000|Double-Blind Phase|Pregnancy|0|||
149771475|NCT01797445|540289540|FG001|Double-Blind Phase|Pregnancy|1|||
149771476|NCT01797445|540289539|FG000|Double-Blind Phase|Lack of Efficacy|1|||
149771477|NCT01797445|540289540|FG001|Double-Blind Phase|Lack of Efficacy|2|||
149771478|NCT01797445|540289539|FG000|Double-Blind Phase|Investigator's Discretion|15|||
149771479|NCT01797445|540289540|FG001|Double-Blind Phase|Investigator's Discretion|17|||
149771480|NCT01797445|540289539|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
149771481|NCT01797445|540289540|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
149771482|NCT01797445|540289539|FG000|Double-Blind Phase|Protocol Violation|0|||
149771483|NCT01797445|540289540|FG001|Double-Blind Phase|Protocol Violation|1|||
149771484|NCT01797445|540289539|FG000|Double-Blind Phase|Withdrew Consent|20|||
149771485|NCT01797445|540289540|FG001|Double-Blind Phase|Withdrew Consent|35|||
149771486|NCT01797445|540289539|FG000|Double-Blind Phase|Lost to Follow-up|34|||
149771487|NCT01797445|540289540|FG001|Double-Blind Phase|Lost to Follow-up|26|||
149771488|NCT01797445|540289539|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
149771489|NCT01797445|540289540|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
149771490|NCT00688545|540289541|FG000|Overall Study|Lost to Follow-up|1|||
149771491|NCT00688545|540289542|FG001|Overall Study|Lost to Follow-up|4|||
149771492|NCT00688545|540289541|FG000|Overall Study|Insurance/cost of drug|0|||
149771493|NCT00688545|540289542|FG001|Overall Study|Insurance/cost of drug|1|||
149771494|NCT00688545|540289541|FG000|Overall Study|Withdrawal by Subject|2|||
149771495|NCT00688545|540289542|FG001|Overall Study|Withdrawal by Subject|3|||
149771496|NCT00688545|540289541|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
149771497|NCT00688545|540289542|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
149771498|NCT01878097|540289545|FG000|Baseline|Surveys not fully completed|2497|||
149771499|NCT01878097|540289546|FG001|Baseline|Surveys not fully completed|1800|||
149771500|NCT01878097|540289545|FG000|Implementation Year 1|Surveys not fully completed|3202|||
149771501|NCT01878097|540289546|FG001|Implementation Year 1|Surveys not fully completed|2549|||
149771502|NCT01878097|540289545|FG000|Implementation Year 2|Surveys not fully completed|3281|||
149771503|NCT01878097|540289546|FG001|Implementation Year 2|Surveys not fully completed|2841|||
149771504|NCT01878097|540289545|FG000|Implementation Year 3|Surveys not fully completed|3494|||
149771505|NCT01878097|540289546|FG001|Implementation Year 3|Surveys not fully completed|2980|||
149771506|NCT01878097|540289545|FG000|Implementation Year 4|Surveys not fully completed|3604|||
149771507|NCT01878097|540289546|FG001|Implementation Year 4|Surveys not fully completed|3007|||
149771508|NCT03783442|540289554|FG000|Overall Study|Death|252|||
149771509|NCT03783442|540289555|FG001|Overall Study|Death|268|||
149771510|NCT03783442|540289554|FG000|Overall Study|Withdrawal by Subject|19|||
149771511|NCT03783442|540289555|FG001|Overall Study|Withdrawal by Subject|21|||
149771512|NCT03783442|540289554|FG000|Overall Study|Lost to Follow-up|7|||
149771513|NCT03783442|540289555|FG001|Overall Study|Lost to Follow-up|6|||
149771514|NCT03783442|540289554|FG000|Overall Study|Sponsor Ended Study|48|||
149771515|NCT03783442|540289555|FG001|Overall Study|Sponsor Ended Study|28|||
149771516|NCT00168064|540289556|FG000|Overall Study|Adverse Event|26|||
149771517|NCT00168064|540289557|FG001|Overall Study|Adverse Event|22|||
149771518|NCT00168064|540289556|FG000|Overall Study|Withdrawal by Subject|3|||
149771519|NCT00168064|540289557|FG001|Overall Study|Withdrawal by Subject|4|||
149771520|NCT00168064|540289556|FG000|Overall Study|Lack of Efficacy|4|||
149771521|NCT00168064|540289557|FG001|Overall Study|Lack of Efficacy|4|||
149771522|NCT00168064|540289556|FG000|Overall Study|Lost to Follow-up|4|||
149771523|NCT00168064|540289557|FG001|Overall Study|Lost to Follow-up|3|||
149771524|NCT00168064|540289556|FG000|Overall Study|Non-compliance|2|||
149771525|NCT00168064|540289557|FG001|Overall Study|Non-compliance|3|||
149771526|NCT00168064|540289556|FG000|Overall Study|Concurrent Illness|4|||
149771527|NCT00168064|540289557|FG001|Overall Study|Concurrent Illness|3|||
149771528|NCT00168064|540289556|FG000|Overall Study|Subject's Best interest|2|||
149771529|NCT00168064|540289557|FG001|Overall Study|Subject's Best interest|2|||
149771530|NCT00168064|540289556|FG000|Overall Study|Various|4|||
149771531|NCT00168064|540289557|FG001|Overall Study|Various|3|||
149771532|NCT01309841|540289559|FG000|Overall Study|Other|0|||
149771533|NCT01309841|540289560|FG001|Overall Study|Other|1|||
149771534|NCT01309841|540289561|FG002|Overall Study|Other|1|||
149771535|NCT01309841|540289559|FG000|Overall Study|Lost to Follow-up|7|||
149771536|NCT01309841|540289560|FG001|Overall Study|Lost to Follow-up|6|||
149771537|NCT01309841|540289561|FG002|Overall Study|Lost to Follow-up|4|||
149771538|NCT01309841|540289559|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
149771539|NCT01309841|540289560|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
149771540|NCT01309841|540289561|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
149771541|NCT01309841|540289559|FG000|Overall Study|Lack of Efficacy|0|||
149771542|NCT01309841|540289560|FG001|Overall Study|Lack of Efficacy|0|||
149771543|NCT01309841|540289561|FG002|Overall Study|Lack of Efficacy|2|||
149771544|NCT01309841|540289559|FG000|Overall Study|Adverse Event|9|||
149771545|NCT01309841|540289560|FG001|Overall Study|Adverse Event|22|||
149771546|NCT01309841|540289561|FG002|Overall Study|Adverse Event|11|||
149771547|NCT01309841|540289559|FG000|Overall Study|Death|1|||
149771548|NCT01309841|540289560|FG001|Overall Study|Death|0|||
149771549|NCT01309841|540289561|FG002|Overall Study|Death|0|||
149771550|NCT01309841|540289559|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149771551|NCT01309841|540289560|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149771552|NCT01309841|540289561|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
149771553|NCT01309841|540289559|FG000|Overall Study|Withdrawal by Subject|17|||
149771554|NCT01309841|540289560|FG001|Overall Study|Withdrawal by Subject|6|||
149771555|NCT01309841|540289561|FG002|Overall Study|Withdrawal by Subject|13|||
149771556|NCT01309841|540289559|FG000|Overall Study|Did Not Receive Treatment|2|||
149771557|NCT01309841|540289560|FG001|Overall Study|Did Not Receive Treatment|0|||
149771558|NCT01309841|540289561|FG002|Overall Study|Did Not Receive Treatment|1|||
149771559|NCT01309841|540289559|FG000|Overall Study|Severe non-compliance with protocol|0|||
149771560|NCT01309841|540289560|FG001|Overall Study|Severe non-compliance with protocol|5|||
149771561|NCT01309841|540289561|FG002|Overall Study|Severe non-compliance with protocol|2|||
149771562|NCT01441115|540289562|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
149771563|NCT02475395|540289569|FG000|Overall Study|Protocol Violation|30|||
149771564|NCT02475395|540289570|FG001|Overall Study|Protocol Violation|3|||
149771565|NCT01086150|540289571|FG000|Overall Study|Withdrawal by Subject|0|||
149771566|NCT01086150|540289572|FG001|Overall Study|Withdrawal by Subject|4|||
149771567|NCT01086150|540289573|FG002|Overall Study|Withdrawal by Subject|1|||
149771568|NCT01086150|540289571|FG000|Overall Study|Lost to Follow-up|0|||
149771569|NCT01086150|540289572|FG001|Overall Study|Lost to Follow-up|1|||
149771570|NCT01086150|540289573|FG002|Overall Study|Lost to Follow-up|0|||
149771571|NCT01086150|540289571|FG000|Overall Study|Screen Failure|0|||
149771572|NCT01086150|540289572|FG001|Overall Study|Screen Failure|1|||
149771573|NCT01086150|540289573|FG002|Overall Study|Screen Failure|0|||
149771574|NCT02227108|540289574|FG000|Overall Study|Did not receive treatment|2|||
149771575|NCT02227108|540289574|FG000|Overall Study|Other|3|||
149771576|NCT02227108|540289574|FG000|Overall Study|Progressive disease|17|||
149771577|NCT02227108|540289574|FG000|Overall Study|Initiation of alternative therapy|2|||
149771578|NCT02227108|540289574|FG000|Overall Study|Investigator discretion|1|||
149771579|NCT02227108|540289574|FG000|Overall Study|Adverse Event|6|||
149771580|NCT02486952|540289575|FG000|Overall Study|Not Started Induction Therapy|3|||
149771581|NCT02486952|540289575|FG000|Overall Study|Adverse Event|1|||
149771582|NCT02486952|540289575|FG000|Overall Study|Death|15|||
149771583|NCT02486952|540289575|FG000|Overall Study|Lack of Efficacy|3|||
149771584|NCT02486952|540289575|FG000|Overall Study|Lost to Follow-up|26|||
149771585|NCT02486952|540289575|FG000|Overall Study|Other|2|||
149771586|NCT00594204|540289576|FG000|Overall Study|Adverse Event|15|||
149771587|NCT00594204|540289577|FG001|Overall Study|Adverse Event|3|||
149771588|NCT00594204|540289576|FG000|Overall Study|Lost to Follow-up|9|||
149771589|NCT00594204|540289577|FG001|Overall Study|Lost to Follow-up|5|||
149771590|NCT00594204|540289576|FG000|Overall Study|Withdrawal by Subject|23|||
149771591|NCT00594204|540289577|FG001|Overall Study|Withdrawal by Subject|29|||
149771592|NCT00594204|540289576|FG000|Overall Study|Other|4|||
149771593|NCT00594204|540289577|FG001|Overall Study|Other|3|||
149771594|NCT00594204|540289576|FG000|Overall Study|Lack of Efficacy|3|||
149771595|NCT00594204|540289577|FG001|Overall Study|Lack of Efficacy|4|||
149771596|NCT00594204|540289576|FG000|Overall Study|Randomized but not treated|4|||
149771597|NCT00594204|540289577|FG001|Overall Study|Randomized but not treated|1|||
149771598|NCT00567541|540289578|FG000|Overall Study|Adverse Event|0|||
149771599|NCT00567541|540289579|FG001|Overall Study|Adverse Event|1|||
149771600|NCT01890512|540289582|FG000|Overall Study|Physician Decision|1|||
149771601|NCT01890512|540289582|FG000|Overall Study|Withdrawal by Subject|1|||
149771602|NCT01890512|540289582|FG000|Overall Study|Protocol Violation|1|||
149771603|NCT01401465|540289583|FG000|Treatment Period 1|Adverse Event|4|||
149771604|NCT01401465|540289584|FG001|Treatment Period 1|Adverse Event|1|||
149771605|NCT01401465|540289583|FG000|Treatment Period 1|Pregnancy|0|||
149771606|NCT01401465|540289584|FG001|Treatment Period 1|Pregnancy|1|||
149771607|NCT01401465|540289583|FG000|Treatment Period 1|Protocol Violation|5|||
149771608|NCT01401465|540289584|FG001|Treatment Period 1|Protocol Violation|0|||
149771609|NCT01401465|540289583|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149771610|NCT01401465|540289584|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149771611|NCT01401465|540289583|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
149771612|NCT01401465|540289584|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
149771613|NCT01401465|540289583|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
149771614|NCT01401465|540289584|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
149771615|NCT01401465|540289583|FG000|Treatment Period 1|Scheduling Difficulties|1|||
149771616|NCT01401465|540289584|FG001|Treatment Period 1|Scheduling Difficulties|1|||
149771617|NCT01401465|540289583|FG000|Treatment Period 2|Lost to Follow-up|0|||
149771618|NCT01401465|540289584|FG001|Treatment Period 2|Lost to Follow-up|1|||
149771619|NCT01401465|540289583|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149771620|NCT01401465|540289584|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149771621|NCT01115738|540289585|FG000|Overall Study|Death|1|||
149771622|NCT01115738|540289586|FG001|Overall Study|Death|0|||
149771623|NCT01115738|540289587|FG002|Overall Study|Death|0|||
149771624|NCT01115738|540289585|FG000|Overall Study|Lost to Follow-up|0|||
149771625|NCT01115738|540289586|FG001|Overall Study|Lost to Follow-up|0|||
149771626|NCT01115738|540289587|FG002|Overall Study|Lost to Follow-up|1|||
149771627|NCT01115738|540289585|FG000|Overall Study|Physician Decision|18|||
149771628|NCT01115738|540289586|FG001|Overall Study|Physician Decision|15|||
149771629|NCT01115738|540289587|FG002|Overall Study|Physician Decision|17|||
149771630|NCT01115738|540289585|FG000|Overall Study|Withdrawal by Subject|6|||
149771631|NCT01115738|540289586|FG001|Overall Study|Withdrawal by Subject|6|||
149771632|NCT01115738|540289587|FG002|Overall Study|Withdrawal by Subject|9|||
149771633|NCT00575094|540289588|FG000|Overall Study|Adverse Event|2|||
149771634|NCT00575094|540289588|FG000|Overall Study|Withdrawal by Subject|1|||
149771635|NCT02721251|540289589|FG000|Overall Study|Withdrawal by Subject|8|||
149771636|NCT02721251|540289590|FG001|Overall Study|Withdrawal by Subject|7|||
149771637|NCT02721251|540289591|FG002|Overall Study|Withdrawal by Subject|9|||
149771638|NCT02721251|540289589|FG000|Overall Study|poor adherence|2|||
149771639|NCT02721251|540289590|FG001|Overall Study|poor adherence|2|||
149771640|NCT02721251|540289591|FG002|Overall Study|poor adherence|2|||
149771641|NCT02921763|540289592|FG000|Overall Study|Adverse Event|4|||
149771642|NCT02921763|540289592|FG000|Overall Study|Lost to Follow-up|4|||
149771643|NCT02921763|540289592|FG000|Overall Study|Lack of Efficacy|3|||
149771644|NCT02921763|540289592|FG000|Overall Study|Protocol Violation|2|||
149771645|NCT02921763|540289592|FG000|Overall Study|Withdrawal by Subject|2|||
149771646|NCT02921763|540289592|FG000|Overall Study|Physician Decision|1|||
149771647|NCT02921763|540289592|FG000|Overall Study|No data obtained|2|||
149771648|NCT01195363|540289596|FG000|Overall Study|Lost to Follow-up|7|||
149771649|NCT01195363|540289597|FG001|Overall Study|Lost to Follow-up|4|||
149771650|NCT01195363|540289596|FG000|Overall Study|Adverse Event|3|||
149771651|NCT01195363|540289597|FG001|Overall Study|Adverse Event|1|||
149771652|NCT01195363|540289596|FG000|Overall Study|Lack of Efficacy|0|||
149771653|NCT01195363|540289597|FG001|Overall Study|Lack of Efficacy|4|||
149771654|NCT01195363|540289596|FG000|Overall Study|incarceration|1|||
149771655|NCT01195363|540289597|FG001|Overall Study|incarceration|0|||
149771656|NCT01763866|540289599|FG000|Overall Study|Withdrawal by Subject|2|||
149771657|NCT01763866|540289600|FG001|Overall Study|Withdrawal by Subject|1|||
149771658|NCT01763866|540289601|FG002|Overall Study|Withdrawal by Subject|4|||
149771659|NCT01763866|540289602|FG003|Overall Study|Withdrawal by Subject|0|||
149771660|NCT01763866|540289603|FG004|Overall Study|Withdrawal by Subject|0|||
149771661|NCT01763866|540289604|FG005|Overall Study|Withdrawal by Subject|3|||
149771662|NCT01763866|540289605|FG006|Overall Study|Withdrawal by Subject|4|||
149771663|NCT01763866|540289606|FG007|Overall Study|Withdrawal by Subject|0|||
149771664|NCT01763866|540289607|FG008|Overall Study|Withdrawal by Subject|1|||
149771665|NCT01763866|540289608|FG009|Overall Study|Withdrawal by Subject|1|||
149771666|NCT01763866|540289609|FG010|Overall Study|Withdrawal by Subject|2|||
149771667|NCT01763866|540289610|FG011|Overall Study|Withdrawal by Subject|2|||
149771668|NCT01763866|540289611|FG012|Overall Study|Withdrawal by Subject|2|||
149771669|NCT01763866|540289612|FG013|Overall Study|Withdrawal by Subject|0|||
149771670|NCT01763866|540289613|FG014|Overall Study|Withdrawal by Subject|6|||
149771671|NCT01763866|540289614|FG015|Overall Study|Withdrawal by Subject|3|||
149771672|NCT01763866|540289615|FG016|Overall Study|Withdrawal by Subject|0|||
149771673|NCT01763866|540289616|FG017|Overall Study|Withdrawal by Subject|1|||
149771674|NCT01763866|540289617|FG018|Overall Study|Withdrawal by Subject|1|||
149771675|NCT01763866|540289618|FG019|Overall Study|Withdrawal by Subject|1|||
149771676|NCT01763866|540289619|FG020|Overall Study|Withdrawal by Subject|2|||
149771677|NCT01763866|540289620|FG021|Overall Study|Withdrawal by Subject|1|||
149771678|NCT01763866|540289621|FG022|Overall Study|Withdrawal by Subject|2|||
149771679|NCT01763866|540289622|FG023|Overall Study|Withdrawal by Subject|1|||
149771680|NCT01763866|540289599|FG000|Overall Study|Decision by sponsor|0|||
149771681|NCT01763866|540289600|FG001|Overall Study|Decision by sponsor|0|||
149771682|NCT01763866|540289601|FG002|Overall Study|Decision by sponsor|1|||
149771683|NCT01763866|540289602|FG003|Overall Study|Decision by sponsor|0|||
149771684|NCT01763866|540289603|FG004|Overall Study|Decision by sponsor|2|||
149771685|NCT01763866|540289604|FG005|Overall Study|Decision by sponsor|0|||
149771686|NCT01763866|540289605|FG006|Overall Study|Decision by sponsor|2|||
149771687|NCT01763866|540289606|FG007|Overall Study|Decision by sponsor|0|||
149771688|NCT01763866|540289607|FG008|Overall Study|Decision by sponsor|2|||
149771689|NCT01763866|540289608|FG009|Overall Study|Decision by sponsor|0|||
149771690|NCT01763866|540289609|FG010|Overall Study|Decision by sponsor|6|||
149771691|NCT01763866|540289610|FG011|Overall Study|Decision by sponsor|0|||
149771692|NCT01763866|540289611|FG012|Overall Study|Decision by sponsor|1|||
149771693|NCT01763866|540289612|FG013|Overall Study|Decision by sponsor|0|||
149771694|NCT01763866|540289613|FG014|Overall Study|Decision by sponsor|5|||
149771695|NCT01763866|540289614|FG015|Overall Study|Decision by sponsor|0|||
149771696|NCT01763866|540289615|FG016|Overall Study|Decision by sponsor|0|||
149771697|NCT01763866|540289616|FG017|Overall Study|Decision by sponsor|0|||
149771698|NCT01763866|540289617|FG018|Overall Study|Decision by sponsor|4|||
149771699|NCT01763866|540289618|FG019|Overall Study|Decision by sponsor|0|||
149771700|NCT01763866|540289619|FG020|Overall Study|Decision by sponsor|2|||
149771701|NCT01763866|540289620|FG021|Overall Study|Decision by sponsor|0|||
149771702|NCT01763866|540289621|FG022|Overall Study|Decision by sponsor|1|||
149771703|NCT01763866|540289622|FG023|Overall Study|Decision by sponsor|0|||
149771704|NCT01763866|540289599|FG000|Overall Study|Lost to Follow-up|0|||
149771705|NCT01763866|540289600|FG001|Overall Study|Lost to Follow-up|0|||
149771706|NCT01763866|540289601|FG002|Overall Study|Lost to Follow-up|0|||
149771707|NCT01763866|540289602|FG003|Overall Study|Lost to Follow-up|0|||
149771708|NCT01763866|540289603|FG004|Overall Study|Lost to Follow-up|0|||
149771709|NCT01763866|540289604|FG005|Overall Study|Lost to Follow-up|0|||
149771710|NCT01763866|540289605|FG006|Overall Study|Lost to Follow-up|1|||
149771711|NCT01763866|540289606|FG007|Overall Study|Lost to Follow-up|0|||
149771712|NCT01763866|540289607|FG008|Overall Study|Lost to Follow-up|0|||
149771713|NCT01763866|540289608|FG009|Overall Study|Lost to Follow-up|0|||
149771714|NCT01763866|540289609|FG010|Overall Study|Lost to Follow-up|0|||
149771715|NCT01763866|540289610|FG011|Overall Study|Lost to Follow-up|0|||
149771716|NCT01763866|540289611|FG012|Overall Study|Lost to Follow-up|1|||
149771717|NCT01763866|540289612|FG013|Overall Study|Lost to Follow-up|0|||
149771718|NCT01763866|540289613|FG014|Overall Study|Lost to Follow-up|1|||
149771719|NCT01763866|540289614|FG015|Overall Study|Lost to Follow-up|0|||
149771720|NCT01763866|540289615|FG016|Overall Study|Lost to Follow-up|0|||
149771721|NCT01763866|540289616|FG017|Overall Study|Lost to Follow-up|0|||
149771722|NCT01763866|540289617|FG018|Overall Study|Lost to Follow-up|1|||
149771723|NCT01763866|540289618|FG019|Overall Study|Lost to Follow-up|1|||
149771724|NCT01763866|540289619|FG020|Overall Study|Lost to Follow-up|0|||
149771725|NCT01763866|540289620|FG021|Overall Study|Lost to Follow-up|0|||
149771726|NCT01763866|540289621|FG022|Overall Study|Lost to Follow-up|0|||
149771727|NCT01763866|540289622|FG023|Overall Study|Lost to Follow-up|1|||
149771728|NCT01763866|540289599|FG000|Overall Study|Death|0|||
149771729|NCT01763866|540289600|FG001|Overall Study|Death|0|||
149771730|NCT01763866|540289601|FG002|Overall Study|Death|0|||
149771731|NCT01763866|540289602|FG003|Overall Study|Death|0|||
149771732|NCT01763866|540289603|FG004|Overall Study|Death|0|||
149771733|NCT01763866|540289604|FG005|Overall Study|Death|0|||
149771734|NCT01763866|540289605|FG006|Overall Study|Death|0|||
149771735|NCT01763866|540289606|FG007|Overall Study|Death|0|||
149771736|NCT01763866|540289607|FG008|Overall Study|Death|0|||
149771737|NCT01763866|540289608|FG009|Overall Study|Death|0|||
149771738|NCT01763866|540289609|FG010|Overall Study|Death|0|||
149771739|NCT01763866|540289610|FG011|Overall Study|Death|0|||
149771740|NCT01763866|540289611|FG012|Overall Study|Death|0|||
149771741|NCT01763866|540289612|FG013|Overall Study|Death|0|||
149771742|NCT01763866|540289613|FG014|Overall Study|Death|0|||
149771743|NCT01763866|540289614|FG015|Overall Study|Death|0|||
149771744|NCT01763866|540289615|FG016|Overall Study|Death|1|||
149771745|NCT01763866|540289616|FG017|Overall Study|Death|0|||
149771746|NCT01763866|540289617|FG018|Overall Study|Death|0|||
149771747|NCT01763866|540289618|FG019|Overall Study|Death|0|||
149771748|NCT01763866|540289619|FG020|Overall Study|Death|0|||
149771749|NCT01763866|540289620|FG021|Overall Study|Death|0|||
149771750|NCT01763866|540289621|FG022|Overall Study|Death|0|||
149771751|NCT01763866|540289622|FG023|Overall Study|Death|0|||
149771752|NCT00804843|540290848|FG000|Overall Study|Protocol Violation|1|||
149771753|NCT00804843|540290849|FG001|Overall Study|Protocol Violation|0|||
149771754|NCT00804843|540290848|FG000|Overall Study|Adverse Event|8|||
149771755|NCT00804843|540290849|FG001|Overall Study|Adverse Event|5|||
149771756|NCT00804843|540290848|FG000|Overall Study|Withdrawal by Subject|1|||
149771757|NCT00804843|540290849|FG001|Overall Study|Withdrawal by Subject|2|||
149771758|NCT03927911|540290850|FG000|Overall Study|problems with eDiary|0|||
149771759|NCT03927911|540290851|FG001|Overall Study|problems with eDiary|1|||
149771760|NCT03927911|540290852|FG002|Overall Study|problems with eDiary|0|||
149771761|NCT03927911|540290853|FG003|Overall Study|problems with eDiary|1|||
149771762|NCT03927911|540290854|FG004|Overall Study|problems with eDiary|0|||
149771763|NCT03927911|540290855|FG005|Overall Study|problems with eDiary|4|||
149771764|NCT03927911|540290850|FG000|Overall Study|Adverse Event|0|||
149771765|NCT03927911|540290851|FG001|Overall Study|Adverse Event|0|||
149771766|NCT03927911|540290852|FG002|Overall Study|Adverse Event|0|||
149771767|NCT03927911|540290853|FG003|Overall Study|Adverse Event|0|||
149771768|NCT03927911|540290854|FG004|Overall Study|Adverse Event|0|||
149771769|NCT03927911|540290855|FG005|Overall Study|Adverse Event|1|||
149771770|NCT03927911|540290850|FG000|Overall Study|not treated -study terminated by sponsor|0|||
149771771|NCT03927911|540290851|FG001|Overall Study|not treated -study terminated by sponsor|1|||
149771772|NCT03927911|540290852|FG002|Overall Study|not treated -study terminated by sponsor|0|||
149771773|NCT03927911|540290853|FG003|Overall Study|not treated -study terminated by sponsor|0|||
149771774|NCT03927911|540290854|FG004|Overall Study|not treated -study terminated by sponsor|0|||
149771775|NCT03927911|540290855|FG005|Overall Study|not treated -study terminated by sponsor|0|||
149771776|NCT03927911|540290850|FG000|Overall Study|Surgery cancelled|0|||
149771777|NCT03927911|540290851|FG001|Overall Study|Surgery cancelled|0|||
149771778|NCT03927911|540290852|FG002|Overall Study|Surgery cancelled|0|||
149771779|NCT03927911|540290853|FG003|Overall Study|Surgery cancelled|1|||
149771780|NCT03927911|540290854|FG004|Overall Study|Surgery cancelled|0|||
149771781|NCT03927911|540290855|FG005|Overall Study|Surgery cancelled|1|||
149771782|NCT03927911|540290850|FG000|Overall Study|Protocol Violation|0|||
149771783|NCT03927911|540290851|FG001|Overall Study|Protocol Violation|0|||
149771784|NCT03927911|540290852|FG002|Overall Study|Protocol Violation|0|||
149771785|NCT03927911|540290853|FG003|Overall Study|Protocol Violation|0|||
149771786|NCT03927911|540290854|FG004|Overall Study|Protocol Violation|0|||
149771787|NCT03927911|540290855|FG005|Overall Study|Protocol Violation|1|||
149771788|NCT01297309|540290859|FG000|Overall Study|Eligibility failure|2|||
149771789|NCT01297309|540290859|FG000|Overall Study|Screen failure|2|||
149771790|NCT01297309|540290859|FG000|Overall Study|Withdrawal by Subject|5|||
149771791|NCT01297309|540290859|FG000|Overall Study|Adverse Event|1|||
149771792|NCT01297309|540290859|FG000|Overall Study|Investigator Decision|2|||
149771793|NCT01297309|540290859|FG000|Overall Study|Death|1|||
149771794|NCT01297309|540290859|FG000|Overall Study|Participant not entering extensionperiod|1|||
149771795|NCT02016898|540290863|FG000|Overall Study|Death|1|||
149771796|NCT02016898|540290864|FG001|Overall Study|Death|1|||
149771797|NCT02016898|540290863|FG000|Overall Study|Lost to Follow-up|4|||
149771798|NCT02016898|540290864|FG001|Overall Study|Lost to Follow-up|4|||
149771799|NCT01381718|540290865|FG000|Overall Study|Withdrawal by Subject|2|||
149771800|NCT01381718|540290866|FG001|Overall Study|Withdrawal by Subject|5|||
149771801|NCT01381718|540290865|FG000|Overall Study|Lost to Follow-up|3|||
149771802|NCT01381718|540290866|FG001|Overall Study|Lost to Follow-up|5|||
149771803|NCT01381718|540290865|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
149771804|NCT01381718|540290866|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
149771805|NCT02505542|540290871|FG000|Part A: Open-Label Period|Adverse Event|31|||
149771806|NCT02505542|540290872|FG001|Part A: Open-Label Period|Adverse Event|0|||
149771807|NCT02505542|540290873|FG002|Part A: Open-Label Period|Adverse Event|0|||
149771808|NCT02505542|540290874|FG003|Part A: Open-Label Period|Adverse Event|0|||
149771809|NCT02505542|540290871|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
149771810|NCT02505542|540290872|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
149771811|NCT02505542|540290873|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
149771812|NCT02505542|540290874|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
149771813|NCT02505542|540290871|FG000|Part A: Open-Label Period|Protocol Violation|1|||
149771814|NCT02505542|540290872|FG001|Part A: Open-Label Period|Protocol Violation|0|||
149771815|NCT02505542|540290873|FG002|Part A: Open-Label Period|Protocol Violation|0|||
149771816|NCT02505542|540290874|FG003|Part A: Open-Label Period|Protocol Violation|0|||
149771817|NCT02505542|540290871|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
149771818|NCT02505542|540290872|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
149771819|NCT02505542|540290873|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
149771820|NCT02505542|540290874|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
149771821|NCT02505542|540290871|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
149771822|NCT02505542|540290872|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
149771823|NCT02505542|540290873|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
149771824|NCT02505542|540290874|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
149771825|NCT02505542|540290871|FG000|Part A: Open-Label Period|New medical history available|1|||
149771826|NCT02505542|540290872|FG001|Part A: Open-Label Period|New medical history available|0|||
149771827|NCT02505542|540290873|FG002|Part A: Open-Label Period|New medical history available|0|||
149771828|NCT02505542|540290874|FG003|Part A: Open-Label Period|New medical history available|0|||
149771829|NCT02505542|540290871|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
149771830|NCT02505542|540290872|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149771831|NCT02505542|540290873|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149771832|NCT02505542|540290874|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149771833|NCT02505542|540290871|FG000|Part A: Open-Label Period|Pregnancy|2|||
149771834|NCT02505542|540290872|FG001|Part A: Open-Label Period|Pregnancy|0|||
149771835|NCT02505542|540290873|FG002|Part A: Open-Label Period|Pregnancy|0|||
149771836|NCT02505542|540290874|FG003|Part A: Open-Label Period|Pregnancy|0|||
149771837|NCT02505542|540290871|FG000|Part A: Open-Label Period|Sponsor directive|1|||
149771838|NCT02505542|540290872|FG001|Part A: Open-Label Period|Sponsor directive|0|||
149771839|NCT02505542|540290873|FG002|Part A: Open-Label Period|Sponsor directive|0|||
149771840|NCT02505542|540290874|FG003|Part A: Open-Label Period|Sponsor directive|0|||
149771841|NCT02505542|540290871|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
149771842|NCT02505542|540290872|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
149771843|NCT02505542|540290873|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
149771844|NCT02505542|540290874|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
149771845|NCT02505542|540290871|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
149771846|NCT02505542|540290872|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149771847|NCT02505542|540290873|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149771848|NCT02505542|540290874|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149771849|NCT02505542|540290871|FG000|Part A: Open-Label Period|Non-compliance|1|||
149771850|NCT02505542|540290872|FG001|Part A: Open-Label Period|Non-compliance|0|||
149771851|NCT02505542|540290873|FG002|Part A: Open-Label Period|Non-compliance|0|||
149771852|NCT02505542|540290874|FG003|Part A: Open-Label Period|Non-compliance|0|||
149771853|NCT02505542|540290871|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
149771854|NCT02505542|540290872|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149771855|NCT02505542|540290873|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149771856|NCT02505542|540290874|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149771857|NCT02505542|540290871|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
149771858|NCT02505542|540290872|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149771859|NCT02505542|540290873|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149771860|NCT02505542|540290874|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149771861|NCT02505542|540290871|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
149771862|NCT02505542|540290872|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149771863|NCT02505542|540290873|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149771864|NCT02505542|540290874|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149771865|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Adverse Event|0|||
149771866|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Adverse Event|0|||
149771867|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Adverse Event|1|||
149771868|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Adverse Event|3|||
149771869|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
149771870|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
149771871|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
149771872|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
149771873|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
149771874|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
149771875|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
149771876|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
149771877|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
149771878|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
149771879|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
149771880|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
149771881|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
149771882|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
149771883|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
149771884|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
149771885|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
149771886|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
149771887|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
149771888|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
149771889|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
149771890|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
149771891|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
149771892|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
149771893|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Miscalculation|0|||
149771894|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Miscalculation|1|||
149771895|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Miscalculation|0|||
149771896|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Miscalculation|0|||
149771897|NCT02505542|540290871|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149771898|NCT02505542|540290872|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
149771899|NCT02505542|540290873|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149771900|NCT02505542|540290874|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149771901|NCT00992186|540290875|FG000|Overall Study|Withdrawal by Subject|2|||
149771902|NCT00992186|540290875|FG000|Overall Study|Protocol Violation|1|||
149771903|NCT00992186|540290875|FG000|Overall Study|Physician Decision|1|||
149771904|NCT00992186|540290875|FG000|Overall Study|Adverse Event|9|||
149771905|NCT00992186|540290875|FG000|Overall Study|Progressive Disease|30|||
149771906|NCT00992186|540290875|FG000|Overall Study|Refusal To Receive Study Agent|3|||
149771907|NCT00973622|540290876|FG000|Overall Study|did not attend MRI|14|||
149771908|NCT00973622|540290877|FG001|Overall Study|did not attend MRI|3|||
149771909|NCT00973622|540290876|FG000|Overall Study|did not pass MRI screen|6|||
149771910|NCT00973622|540290877|FG001|Overall Study|did not pass MRI screen|0|||
149771911|NCT00973622|540290876|FG000|Overall Study|did not complete rTMS sessions|11|||
149771912|NCT00973622|540290877|FG001|Overall Study|did not complete rTMS sessions|2|||
149771913|NCT00830960|540290880|FG000|Overall Study|Death|5|||
149771914|NCT00830960|540290881|FG001|Overall Study|Death|4|||
149771915|NCT00830960|540290882|FG002|Overall Study|Death|3|||
149771916|NCT00830960|540290883|FG003|Overall Study|Death|2|||
149771917|NCT00830960|540290884|FG004|Overall Study|Death|6|||
149771918|NCT00830960|540290885|FG005|Overall Study|Death|1|||
149771919|NCT00830960|540290880|FG000|Overall Study|Lost to Follow-up|1|||
149771920|NCT00830960|540290881|FG001|Overall Study|Lost to Follow-up|1|||
149771921|NCT00830960|540290882|FG002|Overall Study|Lost to Follow-up|1|||
149771922|NCT00830960|540290883|FG003|Overall Study|Lost to Follow-up|0|||
149771923|NCT00830960|540290884|FG004|Overall Study|Lost to Follow-up|0|||
149771924|NCT00830960|540290885|FG005|Overall Study|Lost to Follow-up|1|||
149771925|NCT00830960|540290880|FG000|Overall Study|Withdrawal by Subject|19|||
149771926|NCT00830960|540290881|FG001|Overall Study|Withdrawal by Subject|19|||
149771927|NCT00830960|540290882|FG002|Overall Study|Withdrawal by Subject|18|||
149771928|NCT00830960|540290883|FG003|Overall Study|Withdrawal by Subject|23|||
149771929|NCT00830960|540290884|FG004|Overall Study|Withdrawal by Subject|16|||
149771930|NCT00830960|540290885|FG005|Overall Study|Withdrawal by Subject|21|||
149771931|NCT00830960|540290880|FG000|Overall Study|Sponsor Decision|1|||
149771932|NCT00830960|540290881|FG001|Overall Study|Sponsor Decision|2|||
149771933|NCT00830960|540290882|FG002|Overall Study|Sponsor Decision|3|||
149771934|NCT00830960|540290883|FG003|Overall Study|Sponsor Decision|4|||
149771935|NCT00830960|540290884|FG004|Overall Study|Sponsor Decision|5|||
149771936|NCT00830960|540290885|FG005|Overall Study|Sponsor Decision|7|||
149771937|NCT00830960|540290880|FG000|Overall Study|No study drug received|7|||
149771938|NCT00830960|540290881|FG001|Overall Study|No study drug received|2|||
149771939|NCT00830960|540290882|FG002|Overall Study|No study drug received|4|||
149771940|NCT00830960|540290883|FG003|Overall Study|No study drug received|3|||
149771941|NCT00830960|540290884|FG004|Overall Study|No study drug received|5|||
149771942|NCT00830960|540290885|FG005|Overall Study|No study drug received|7|||
149771943|NCT03074149|540290886|FG000|Overall Study|Reason unknown|22|||
149771944|NCT03074149|540290887|FG001|Overall Study|Reason unknown|35|||
149771945|NCT03074149|540290886|FG000|Overall Study|Death|10|||
149771946|NCT03074149|540290887|FG001|Overall Study|Death|45|||
149771947|NCT00050960|540290896|FG000|Overall Study|Progressive Disease|137|||
149771948|NCT00050960|540290897|FG001|Overall Study|Progressive Disease|93|||
149771949|NCT00050960|540290896|FG000|Overall Study|Stable Disease|19|||
149771950|NCT00050960|540290897|FG001|Overall Study|Stable Disease|48|||
149771951|NCT00050960|540290896|FG000|Overall Study|Partial Response|14|||
149771952|NCT00050960|540290897|FG001|Overall Study|Partial Response|19|||
149771953|NCT00050960|540290896|FG000|Overall Study|Complete Response|0|||
149771954|NCT00050960|540290897|FG001|Overall Study|Complete Response|2|||
149771955|NCT00050960|540290896|FG000|Overall Study|Adverse Event|62|||
149771956|NCT00050960|540290897|FG001|Overall Study|Adverse Event|61|||
149771957|NCT00050960|540290896|FG000|Overall Study|Lost to Follow-up|0|||
149771958|NCT00050960|540290897|FG001|Overall Study|Lost to Follow-up|1|||
149771959|NCT00050960|540290896|FG000|Overall Study|Withdrawal by Subject|23|||
149771960|NCT00050960|540290897|FG001|Overall Study|Withdrawal by Subject|18|||
149771961|NCT00050960|540290896|FG000|Overall Study|Administrative|31|||
149771962|NCT00050960|540290897|FG001|Overall Study|Administrative|46|||
149771963|NCT00050960|540290896|FG000|Overall Study|Non-compliance|3|||
149771964|NCT00050960|540290897|FG001|Overall Study|Non-compliance|1|||
149771965|NCT00050960|540290896|FG000|Overall Study|Death|13|||
149771966|NCT00050960|540290897|FG001|Overall Study|Death|15|||
149771967|NCT05127421|540290899|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
149771968|NCT05127421|540290900|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
149771969|NCT05127421|540290901|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
149771970|NCT05127421|540290902|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
149771971|NCT05127421|540290899|FG000|4-Week Double-Blind Period|Physician Decision|1|||
149771972|NCT05127421|540290900|FG001|4-Week Double-Blind Period|Physician Decision|0|||
149771973|NCT05127421|540290901|FG002|4-Week Double-Blind Period|Physician Decision|0|||
149771974|NCT05127421|540290902|FG003|4-Week Double-Blind Period|Physician Decision|0|||
149771975|NCT05127421|540290899|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
149771976|NCT05127421|540290900|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
149771977|NCT05127421|540290901|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
149771978|NCT05127421|540290902|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
149771979|NCT05127421|540290899|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149771980|NCT05127421|540290900|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
149771981|NCT05127421|540290901|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149771982|NCT05127421|540290902|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149771983|NCT05127421|540290899|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149771984|NCT05127421|540290900|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
149771985|NCT05127421|540290901|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149771986|NCT05127421|540290902|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149771987|NCT05127421|540290899|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
149771988|NCT05127421|540290900|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
149771989|NCT05127421|540290901|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
149771990|NCT05127421|540290902|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
149771991|NCT05127421|540290899|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
149771992|NCT05127421|540290900|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
149771993|NCT05127421|540290901|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
149771994|NCT05127421|540290902|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
149771995|NCT05127421|540290899|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149771996|NCT05127421|540290900|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149771997|NCT05127421|540290901|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149771998|NCT05127421|540290902|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
149771999|NCT00878215|540290904|FG000|Overall Study|Determined to be ineligible|0|||
149772000|NCT00878215|540290905|FG001|Overall Study|Determined to be ineligible|10|||
149772001|NCT00878215|540290906|FG002|Overall Study|Determined to be ineligible|0|||
149772002|NCT00878215|540290907|FG003|Overall Study|Determined to be ineligible|0|||
149772003|NCT00574496|540290912|FG000|Overall Study|Withdrawal by Subject|1|||
149772004|NCT01969799|540290913|FG000|Overall Study|Adverse Event|0|||
149772005|NCT01969799|540290914|FG001|Overall Study|Adverse Event|1|||
149772006|NCT01969799|540290913|FG000|Overall Study|Death|16|||
149772007|NCT01969799|540290914|FG001|Overall Study|Death|11|||
149772008|NCT01969799|540290913|FG000|Overall Study|Lost to Follow-up|0|||
149772009|NCT01969799|540290914|FG001|Overall Study|Lost to Follow-up|2|||
149772010|NCT01969799|540290913|FG000|Overall Study|Physician Decision|1|||
149772011|NCT01969799|540290914|FG001|Overall Study|Physician Decision|0|||
149772012|NCT02815293|540290915|FG000|Overall Study|Study termination by sponsor|10|||
149772013|NCT02815293|540290916|FG001|Overall Study|Study termination by sponsor|7|||
149772014|NCT02815293|540290917|FG002|Overall Study|Study termination by sponsor|0|||
149772015|NCT02815293|540290915|FG000|Overall Study|Participants not randomized|0|||
149772016|NCT02815293|540290916|FG001|Overall Study|Participants not randomized|0|||
149772017|NCT02815293|540290917|FG002|Overall Study|Participants not randomized|18|||
149772018|NCT02815293|540290915|FG000|Overall Study|Adverse Event|0|||
149772019|NCT02815293|540290916|FG001|Overall Study|Adverse Event|1|||
149772020|NCT02815293|540290917|FG002|Overall Study|Adverse Event|0|||
149772021|NCT01056341|540290918|FG000|Overall Study|Treatment Intolerance|0|||
149772022|NCT01056341|540290919|FG001|Overall Study|Treatment Intolerance|2|||
149772023|NCT01056341|540290920|FG002|Overall Study|Treatment Intolerance|0|||
149772024|NCT01056341|540290921|FG003|Overall Study|Treatment Intolerance|2|||
149772025|NCT01056341|540290922|FG004|Overall Study|Treatment Intolerance|0|||
149772026|NCT01056341|540290918|FG000|Overall Study|Lack of Efficacy|32|||
149772027|NCT01056341|540290919|FG001|Overall Study|Lack of Efficacy|30|||
149772028|NCT01056341|540290920|FG002|Overall Study|Lack of Efficacy|7|||
149772029|NCT01056341|540290921|FG003|Overall Study|Lack of Efficacy|25|||
149772030|NCT01056341|540290922|FG004|Overall Study|Lack of Efficacy|9|||
149772031|NCT01056341|540290918|FG000|Overall Study|Other reasons|4|||
149772032|NCT01056341|540290919|FG001|Overall Study|Other reasons|4|||
149772033|NCT01056341|540290920|FG002|Overall Study|Other reasons|8|||
149772034|NCT01056341|540290921|FG003|Overall Study|Other reasons|9|||
149772035|NCT01056341|540290922|FG004|Overall Study|Other reasons|5|||
149772036|NCT01361919|540290923|FG000|Overall Study|technical issues|10|||
149772037|NCT01361919|540290924|FG001|Overall Study|technical issues|12|||
149772038|NCT01361919|540290925|FG002|Overall Study|technical issues|10|||
149772039|NCT01681576|540290928|FG000|Period 1|Adverse Event|1|||
149772040|NCT01681576|540290929|FG001|Period 1|Adverse Event|0|||
149772041|NCT01681576|540290928|FG000|Period 1|Protocol Deviation|1|||
149772042|NCT01681576|540290929|FG001|Period 1|Protocol Deviation|0|||
149772043|NCT01681576|540290928|FG000|Period 2|subject/guardian decision|3|||
149772044|NCT01681576|540290929|FG001|Period 2|subject/guardian decision|1|||
149772045|NCT01681576|540290928|FG000|Period 2|Non-compliance with study treatment|1|||
149772046|NCT01681576|540290929|FG001|Period 2|Non-compliance with study treatment|0|||
149772047|NCT03543358|540290931|FG000|Overall Study|Death|1|||
149772048|NCT03543358|540290932|FG001|Overall Study|Death|0|||
149772049|NCT03543358|540290931|FG000|Overall Study|Disease Progression|1|||
149772050|NCT03543358|540290932|FG001|Overall Study|Disease Progression|0|||
149772051|NCT03543358|540290931|FG000|Overall Study|Parent Study Closure|1|||
149772052|NCT03543358|540290932|FG001|Overall Study|Parent Study Closure|0|||
149772053|NCT00178464|540290933|FG000|Overall Study|Withdrawal by Subject|1|||
149772054|NCT00178464|540290933|FG000|Overall Study|Physician Decision|1|||
149772055|NCT04111107|540290934|FG000|Overall Study|Withdrawal by Subject|6|||
149772056|NCT04111107|540290934|FG000|Overall Study|Declining Health|5|||
149772057|NCT03956225|540290935|FG000|Overall Study|Lack of Efficacy|1|||
149772058|NCT03956225|540290936|FG001|Overall Study|Lack of Efficacy|1|||
149772059|NCT03956225|540290935|FG000|Overall Study|Lost to Follow-up|0|||
149772060|NCT03956225|540290936|FG001|Overall Study|Lost to Follow-up|1|||
149772061|NCT03956225|540290935|FG000|Overall Study|Withdrawal by Subject|2|||
149772062|NCT03956225|540290936|FG001|Overall Study|Withdrawal by Subject|1|||
149772063|NCT03956225|540290935|FG000|Overall Study|Other Reasons|2|||
149772064|NCT03956225|540290936|FG001|Overall Study|Other Reasons|1|||
149772065|NCT02260648|540290937|FG000|Overall Study|Adverse Event|3|||
149772066|NCT02260648|540290938|FG001|Overall Study|Adverse Event|0|||
149772067|NCT02260648|540290939|FG002|Overall Study|Adverse Event|1|||
149772068|NCT02260648|540290937|FG000|Overall Study|Withdrawal by Subject|1|||
149772069|NCT02260648|540290938|FG001|Overall Study|Withdrawal by Subject|1|||
149772070|NCT02260648|540290939|FG002|Overall Study|Withdrawal by Subject|0|||
149772071|NCT02260648|540290937|FG000|Overall Study|Protocol Violation|1|||
149772072|NCT02260648|540290938|FG001|Overall Study|Protocol Violation|0|||
149772073|NCT02260648|540290939|FG002|Overall Study|Protocol Violation|0|||
149772074|NCT02260648|540290937|FG000|Overall Study|Discontinue Due to Study Termination|13|||
149772075|NCT02260648|540290938|FG001|Overall Study|Discontinue Due to Study Termination|12|||
149772076|NCT02260648|540290939|FG002|Overall Study|Discontinue Due to Study Termination|7|||
149772077|NCT00805545|540290942|FG000|Overall Study|Protocol Violation|3|||
149772078|NCT00805545|540290943|FG001|Overall Study|Protocol Violation|2|||
149772079|NCT00805545|540290942|FG000|Overall Study|Protocol Violation|3|||
149772080|NCT00805545|540290943|FG001|Overall Study|Protocol Violation|1|||
149772081|NCT01054976|540290955|FG000|Overall Study|Adverse Event|16|||
149772082|NCT01054976|540290955|FG000|Overall Study|Uncooperative participations to study|7|||
149772083|NCT01054976|540290955|FG000|Overall Study|Withdrawal by Subject|4|||
149772084|NCT01054976|540290955|FG000|Overall Study|Other|8|||
149772085|NCT01641991|540290956|FG000|Overall Study|Physician Decision|0|||
149772086|NCT01641991|540290957|FG001|Overall Study|Physician Decision|1|||
149772087|NCT01641991|540290958|FG002|Overall Study|Physician Decision|7|||
149772088|NCT01641991|540290959|FG003|Overall Study|Physician Decision|5|||
149772089|NCT01641991|540290956|FG000|Overall Study|Withdrawal by Subject|4|||
149772090|NCT01641991|540290957|FG001|Overall Study|Withdrawal by Subject|2|||
149772091|NCT01641991|540290958|FG002|Overall Study|Withdrawal by Subject|1|||
149772092|NCT01641991|540290959|FG003|Overall Study|Withdrawal by Subject|5|||
149772093|NCT01641991|540290956|FG000|Overall Study|Adverse Event|2|||
149772094|NCT01641991|540290957|FG001|Overall Study|Adverse Event|1|||
149772095|NCT01641991|540290958|FG002|Overall Study|Adverse Event|2|||
149772096|NCT01641991|540290959|FG003|Overall Study|Adverse Event|1|||
149772097|NCT01641991|540290956|FG000|Overall Study|Lost to Follow-up|0|||
149772098|NCT01641991|540290957|FG001|Overall Study|Lost to Follow-up|2|||
149772099|NCT01641991|540290958|FG002|Overall Study|Lost to Follow-up|3|||
149772100|NCT01641991|540290959|FG003|Overall Study|Lost to Follow-up|1|||
149772101|NCT01641991|540290956|FG000|Overall Study|Protocol Violation|1|||
149772102|NCT01641991|540290957|FG001|Overall Study|Protocol Violation|1|||
149772103|NCT01641991|540290958|FG002|Overall Study|Protocol Violation|3|||
149772104|NCT01641991|540290959|FG003|Overall Study|Protocol Violation|0|||
149772105|NCT01641991|540290956|FG000|Overall Study|Pregnancy|0|||
149772106|NCT01641991|540290957|FG001|Overall Study|Pregnancy|0|||
149772107|NCT01641991|540290958|FG002|Overall Study|Pregnancy|1|||
149772108|NCT01641991|540290959|FG003|Overall Study|Pregnancy|0|||
149772109|NCT01641991|540290956|FG000|Overall Study|no longer eligible|2|||
149772110|NCT01641991|540290957|FG001|Overall Study|no longer eligible|1|||
149772111|NCT01641991|540290958|FG002|Overall Study|no longer eligible|0|||
149772112|NCT01641991|540290959|FG003|Overall Study|no longer eligible|4|||
149772113|NCT01164865|540290964|FG000|Overall Study|Lost to Follow-up|2|||
149772114|NCT01164865|540290965|FG001|Overall Study|Lost to Follow-up|1|||
149772115|NCT00599027|540290967|FG000|Overall Study|Withdrawal by Subject|1|||
149772116|NCT00599027|540290968|FG001|Overall Study|Withdrawal by Subject|1|||
149772117|NCT00599027|540290967|FG000|Overall Study|Adverse Event|0|||
149772118|NCT00599027|540290968|FG001|Overall Study|Adverse Event|1|||
149772119|NCT00599027|540290967|FG000|Overall Study|Treatment Failure|0|||
149772120|NCT00599027|540290968|FG001|Overall Study|Treatment Failure|1|||
149772121|NCT00171314|540290969|FG000|Overall Study|Adverse Event|44|||
149772122|NCT00171314|540290970|FG001|Overall Study|Adverse Event|41|||
149772123|NCT00171314|540290969|FG000|Overall Study|Lack of Efficacy|19|||
149772124|NCT00171314|540290970|FG001|Overall Study|Lack of Efficacy|14|||
149772125|NCT00171314|540290969|FG000|Overall Study|Withdrawal by Subject|9|||
149772126|NCT00171314|540290970|FG001|Overall Study|Withdrawal by Subject|6|||
149772127|NCT00171314|540290969|FG000|Overall Study|Abnormal Test Procedure Results|9|||
149772128|NCT00171314|540290970|FG001|Overall Study|Abnormal Test Procedure Results|3|||
149772129|NCT00171314|540290969|FG000|Overall Study|Protocol Violation|3|||
149772130|NCT00171314|540290970|FG001|Overall Study|Protocol Violation|7|||
149772131|NCT00171314|540290969|FG000|Overall Study|Administrative Problems|4|||
149772132|NCT00171314|540290970|FG001|Overall Study|Administrative Problems|3|||
149772133|NCT00171314|540290969|FG000|Overall Study|Lost to Follow-up|1|||
149772134|NCT00171314|540290970|FG001|Overall Study|Lost to Follow-up|3|||
149772135|NCT00171314|540290969|FG000|Overall Study|Death|2|||
149772136|NCT00171314|540290970|FG001|Overall Study|Death|1|||
149772137|NCT00475540|540290971|FG000|36 Months|Lost to Follow-up|4|||
149772138|NCT00475540|540290972|FG001|36 Months|Lost to Follow-up|4|||
149772139|NCT00475540|540290971|FG000|36 Months|Death|1|||
149772140|NCT00475540|540290972|FG001|36 Months|Death|2|||
149772141|NCT00475540|540290971|FG000|36 Months|Censored due to reoperation|3|||
149772142|NCT00475540|540290972|FG001|36 Months|Censored due to reoperation|0|||
149772143|NCT00377429|540290973|FG000|Overall Study|Withdrawal by Subject|5|||
149772144|NCT00377429|540290973|FG000|Overall Study|Adverse Event|8|||
149772145|NCT00377429|540290973|FG000|Overall Study|Physician Decision|1|||
149772146|NCT00377429|540290973|FG000|Overall Study|Patient non-compliance|1|||
149772147|NCT02394795|540290976|FG000|Overall Study|Adverse Event|92|||
149772148|NCT02394795|540290977|FG001|Overall Study|Adverse Event|70|||
149772149|NCT02394795|540290976|FG000|Overall Study|Lost to Follow-up|0|||
149772150|NCT02394795|540290977|FG001|Overall Study|Lost to Follow-up|1|||
149772151|NCT02394795|540290976|FG000|Overall Study|Withdrawal by Subject|17|||
149772152|NCT02394795|540290977|FG001|Overall Study|Withdrawal by Subject|26|||
149772153|NCT02394795|540290976|FG000|Overall Study|Lack of Efficacy|181|||
149772154|NCT02394795|540290977|FG001|Overall Study|Lack of Efficacy|211|||
149772155|NCT02394795|540290976|FG000|Overall Study|Death|4|||
149772156|NCT02394795|540290977|FG001|Overall Study|Death|5|||
149772157|NCT02394795|540290976|FG000|Overall Study|Physician Decision|109|||
149772158|NCT02394795|540290977|FG001|Overall Study|Physician Decision|93|||
149772159|NCT02939599|540290979|FG000|Overall Study|Adverse Event|1|||
149772160|NCT02939599|540290980|FG001|Overall Study|Adverse Event|0|||
149772161|NCT02939599|540290979|FG000|Overall Study|Study Terminated By Sponsor|2|||
149772162|NCT02939599|540290980|FG001|Overall Study|Study Terminated By Sponsor|2|||
149772163|NCT01669811|540290981|FG000|Overall Study|Investigator decision|0|||
149772164|NCT01669811|540290982|FG001|Overall Study|Investigator decision|1|||
149772165|NCT01669811|540290981|FG000|Overall Study|Withdrawal by Subject|1|||
149772166|NCT01669811|540290982|FG001|Overall Study|Withdrawal by Subject|2|||
149772167|NCT01669811|540290981|FG000|Overall Study|Adverse Event|2|||
149772168|NCT01669811|540290982|FG001|Overall Study|Adverse Event|6|||
149772169|NCT01669811|540290981|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149772170|NCT01669811|540290982|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
149772171|NCT03337139|540290983|FG000|Phase I|Withdrawal by Subject|10|||
149772172|NCT03337139|540290984|FG001|Phase I|Withdrawal by Subject|0|||
149772173|NCT03288493|540290985|FG000|Overall Study|Withdrawal by Subject|4|||
149772174|NCT03288493|540290986|FG001|Overall Study|Withdrawal by Subject|0|||
149772175|NCT03288493|540290987|FG002|Overall Study|Withdrawal by Subject|0|||
149772176|NCT03288493|540290988|FG003|Overall Study|Withdrawal by Subject|0|||
149772177|NCT03288493|540290989|FG004|Overall Study|Withdrawal by Subject|0|||
149772178|NCT03288493|540290990|FG005|Overall Study|Withdrawal by Subject|2|||
149772179|NCT03288493|540290991|FG006|Overall Study|Withdrawal by Subject|0|||
149772180|NCT03288493|540290985|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
149772181|NCT03288493|540290986|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
149772182|NCT03288493|540290987|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
149772183|NCT03288493|540290988|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
149772184|NCT03288493|540290989|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
149772185|NCT03288493|540290990|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
149772186|NCT03288493|540290991|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
149772187|NCT03288493|540290985|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
149772188|NCT03288493|540290986|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149772189|NCT03288493|540290987|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149772190|NCT03288493|540290988|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
149772191|NCT03288493|540290989|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149772192|NCT03288493|540290990|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
149772193|NCT03288493|540290991|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149772194|NCT03288493|540290985|FG000|Overall Study|Death|2|||
149772195|NCT03288493|540290986|FG001|Overall Study|Death|0|||
149772196|NCT03288493|540290987|FG002|Overall Study|Death|0|||
149772197|NCT03288493|540290988|FG003|Overall Study|Death|0|||
149772198|NCT03288493|540290989|FG004|Overall Study|Death|0|||
149772199|NCT03288493|540290990|FG005|Overall Study|Death|0|||
149772200|NCT03288493|540290991|FG006|Overall Study|Death|0|||
149772201|NCT03288493|540290985|FG000|Overall Study|other reason not listed above|2|||
149772202|NCT03288493|540290986|FG001|Overall Study|other reason not listed above|0|||
149772203|NCT03288493|540290987|FG002|Overall Study|other reason not listed above|0|||
149772204|NCT03288493|540290988|FG003|Overall Study|other reason not listed above|0|||
149772205|NCT03288493|540290989|FG004|Overall Study|other reason not listed above|0|||
149772206|NCT03288493|540290990|FG005|Overall Study|other reason not listed above|0|||
149772207|NCT03288493|540290991|FG006|Overall Study|other reason not listed above|0|||
149772208|NCT01871896|540290992|FG000|Overall Study|Lost to Follow-up|1|||
149772209|NCT00453180|540292444|FG000|Overall Study|Lost to Follow-up|2|||
149772210|NCT00453180|540292445|FG001|Overall Study|Lost to Follow-up|1|||
149772211|NCT00453180|540292444|FG000|Overall Study|Adverse Event|1|||
149772212|NCT00453180|540292445|FG001|Overall Study|Adverse Event|2|||
149772213|NCT00562640|540292447|FG000|Overall Study|Death|0|||
149772214|NCT00562640|540292448|FG001|Overall Study|Death|1|||
149772215|NCT00562640|540292449|FG002|Overall Study|Death|1|||
149772216|NCT00562640|540292450|FG003|Overall Study|Death|0|||
149772217|NCT01412151|540292451|FG000|Week 0 - 306 - Treatment Period|Death|1|||
149772218|NCT01412151|540292451|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
149772219|NCT01412151|540292451|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
149772220|NCT01412151|540292451|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
149772221|NCT03127852|540292452|FG000|Overall Study|Withdrawal by Subject|4|||
149772222|NCT03127852|540292453|FG001|Overall Study|Withdrawal by Subject|1|||
149772223|NCT03127852|540292452|FG000|Overall Study|Death|1|||
149772224|NCT03127852|540292453|FG001|Overall Study|Death|1|||
149772225|NCT01824693|540292454|FG000|Overall Study|Death|0|||
149772226|NCT01824693|540292455|FG001|Overall Study|Death|1|||
149772227|NCT01824693|540292456|FG002|Overall Study|Death|0|||
149772228|NCT01824693|540292454|FG000|Overall Study|Physician Decision|1|||
149772229|NCT01824693|540292455|FG001|Overall Study|Physician Decision|1|||
149772230|NCT01824693|540292456|FG002|Overall Study|Physician Decision|1|||
149772231|NCT01824693|540292454|FG000|Overall Study|Withdrawal by Subject|0|||
149772232|NCT01824693|540292455|FG001|Overall Study|Withdrawal by Subject|0|||
149772233|NCT01824693|540292456|FG002|Overall Study|Withdrawal by Subject|1|||
149772234|NCT01824693|540292454|FG000|Overall Study|Progressive Disease|0|||
149772235|NCT01824693|540292455|FG001|Overall Study|Progressive Disease|5|||
149772236|NCT01824693|540292456|FG002|Overall Study|Progressive Disease|0|||
149772237|NCT01824693|540292454|FG000|Overall Study|Ineligible|0|||
149772238|NCT01824693|540292455|FG001|Overall Study|Ineligible|0|||
149772239|NCT01824693|540292456|FG002|Overall Study|Ineligible|3|||
149772240|NCT01824693|540292454|FG000|Overall Study|No Transplant Planned|0|||
149772241|NCT01824693|540292455|FG001|Overall Study|No Transplant Planned|0|||
149772242|NCT01824693|540292456|FG002|Overall Study|No Transplant Planned|10|||
149772243|NCT02150213|540292457|FG000|Overall Study|Lost to Follow-up|1|||
149772244|NCT02150213|540292457|FG000|Overall Study|Withdrawal by Subject|1|||
149772245|NCT00656084|540292458|FG000|Overall Study|Adverse Event|4|||
149772246|NCT00656084|540292458|FG000|Overall Study|Withdrawal by Subject|1|||
149772247|NCT00656084|540292458|FG000|Overall Study|Patient Request|1|||
149772248|NCT00656084|540292458|FG000|Overall Study|Investigator Request|1|||
149772249|NCT00525785|540292461|FG000|Overall Study|Withdrawal by Subject|1|||
149772250|NCT00525785|540292461|FG000|Overall Study|Lack of Efficacy|1|||
149772251|NCT00525785|540292461|FG000|Overall Study|Physician Decision|1|||
149772252|NCT01306032|540292464|FG000|First Intervention|Adverse Event|1|||
149772253|NCT01306032|540292465|FG001|First Intervention|Adverse Event|0|||
149772254|NCT01306032|540292466|FG002|First Intervention|Adverse Event|1|||
149772255|NCT01306032|540292467|FG003|First Intervention|Adverse Event|0|||
149772256|NCT01306032|540292468|FG004|First Intervention|Adverse Event|0|||
149772257|NCT01306032|540292469|FG005|First Intervention|Adverse Event|1|||
149772258|NCT01306032|540292464|FG000|First Intervention|Withdrawal by Subject|0|||
149772259|NCT01306032|540292465|FG001|First Intervention|Withdrawal by Subject|2|||
149772260|NCT01306032|540292466|FG002|First Intervention|Withdrawal by Subject|0|||
149772261|NCT01306032|540292467|FG003|First Intervention|Withdrawal by Subject|1|||
149772262|NCT01306032|540292468|FG004|First Intervention|Withdrawal by Subject|0|||
149772263|NCT01306032|540292469|FG005|First Intervention|Withdrawal by Subject|0|||
149772264|NCT01306032|540292464|FG000|First Intervention|Death|0|||
149772265|NCT01306032|540292465|FG001|First Intervention|Death|0|||
149772266|NCT01306032|540292466|FG002|First Intervention|Death|1|||
149772267|NCT01306032|540292467|FG003|First Intervention|Death|0|||
149772268|NCT01306032|540292468|FG004|First Intervention|Death|0|||
149772269|NCT01306032|540292469|FG005|First Intervention|Death|0|||
149772270|NCT01306032|540292464|FG000|First Intervention|Ineligible|0|||
149772271|NCT01306032|540292465|FG001|First Intervention|Ineligible|0|||
149772272|NCT01306032|540292466|FG002|First Intervention|Ineligible|0|||
149772273|NCT01306032|540292467|FG003|First Intervention|Ineligible|0|||
149772274|NCT01306032|540292468|FG004|First Intervention|Ineligible|0|||
149772275|NCT01306032|540292469|FG005|First Intervention|Ineligible|1|||
149772276|NCT01306032|540292464|FG000|First Intervention|Progressive disease|0|||
149772277|NCT01306032|540292465|FG001|First Intervention|Progressive disease|0|||
149772278|NCT01306032|540292466|FG002|First Intervention|Progressive disease|0|||
149772279|NCT01306032|540292467|FG003|First Intervention|Progressive disease|0|||
149772280|NCT01306032|540292468|FG004|First Intervention|Progressive disease|2|||
149772281|NCT01306032|540292469|FG005|First Intervention|Progressive disease|0|||
149772282|NCT01306032|540292464|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
149772283|NCT01306032|540292465|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
149772284|NCT01306032|540292466|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
149772285|NCT01306032|540292467|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
149772286|NCT01306032|540292468|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
149772287|NCT01306032|540292469|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
149772288|NCT01306032|540292464|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
149772289|NCT01306032|540292465|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
149772290|NCT01306032|540292466|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
149772291|NCT01306032|540292467|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
149772292|NCT01306032|540292468|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
149772293|NCT01306032|540292469|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
149772294|NCT02855450|540292474|FG000|Overall Study|Adverse Event|1|||
149772295|NCT02855450|540292475|FG001|Overall Study|Adverse Event|0|||
149772296|NCT02855450|540292474|FG000|Overall Study|Lost to Follow-up|4|||
149772297|NCT02855450|540292475|FG001|Overall Study|Lost to Follow-up|0|||
149772298|NCT05159362|540292476|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
149772299|NCT05159362|540292477|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
149772300|NCT05159362|540292478|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
149772301|NCT01376245|540292479|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
149772302|NCT01376245|540292480|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149772303|NCT01376245|540292481|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149772304|NCT01376245|540292482|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149772305|NCT01376245|540292483|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149772306|NCT01376245|540292479|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
149772307|NCT01376245|540292480|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149772308|NCT01376245|540292481|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149772309|NCT01376245|540292482|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149772310|NCT01376245|540292483|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149772311|NCT01376245|540292479|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
149772312|NCT01376245|540292480|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149772313|NCT01376245|540292481|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149772314|NCT01376245|540292482|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149772315|NCT01376245|540292483|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149772316|NCT01376245|540292479|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
149772317|NCT01376245|540292480|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149772318|NCT01376245|540292481|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149772319|NCT01376245|540292482|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149772320|NCT01376245|540292483|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149772321|NCT01376245|540292479|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
149772322|NCT01376245|540292480|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149772323|NCT01376245|540292481|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149772324|NCT01376245|540292482|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149772325|NCT01376245|540292483|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149772326|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
149772327|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
149772328|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
149772329|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
149772330|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
149772331|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149772332|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
149772333|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
149772334|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
149772335|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
149772336|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
149772337|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
149772338|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
149772339|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
149772340|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
149772341|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149772342|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
149772343|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
149772344|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
149772345|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149772346|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149772347|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
149772348|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149772349|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
149772350|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
149772351|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
149772352|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
149772353|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
149772354|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
149772355|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
149772356|NCT01376245|540292479|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149772357|NCT01376245|540292480|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
149772358|NCT01376245|540292481|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
149772359|NCT01376245|540292482|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
149772360|NCT01376245|540292483|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
149772361|NCT00764946|540292487|FG000|Overall Study|Lack of Efficacy|1|||
149772362|NCT00764946|540292488|FG001|Overall Study|Lack of Efficacy|0|||
149772363|NCT00764946|540292489|FG002|Overall Study|Lack of Efficacy|0|||
149772364|NCT00764946|540292487|FG000|Overall Study|Lost to Follow-up|3|||
149772365|NCT00764946|540292488|FG001|Overall Study|Lost to Follow-up|4|||
149772366|NCT00764946|540292489|FG002|Overall Study|Lost to Follow-up|0|||
149772367|NCT00764946|540292487|FG000|Overall Study|Physician Decision|2|||
149772368|NCT00764946|540292488|FG001|Overall Study|Physician Decision|4|||
149772369|NCT00764946|540292489|FG002|Overall Study|Physician Decision|0|||
149772370|NCT00764946|540292487|FG000|Overall Study|Adverse Event|3|||
149772371|NCT00764946|540292488|FG001|Overall Study|Adverse Event|2|||
149772372|NCT00764946|540292489|FG002|Overall Study|Adverse Event|1|||
149772373|NCT00764946|540292487|FG000|Overall Study|Withdrawal by Subject|3|||
149772374|NCT00764946|540292488|FG001|Overall Study|Withdrawal by Subject|6|||
149772375|NCT00764946|540292489|FG002|Overall Study|Withdrawal by Subject|2|||
149772376|NCT00764946|540292487|FG000|Overall Study|Never Treated|1|||
149772377|NCT00764946|540292488|FG001|Overall Study|Never Treated|1|||
149772378|NCT00764946|540292489|FG002|Overall Study|Never Treated|1|||
149772379|NCT01162304|540292490|FG000|Overall Study|Beck scale to high|11|||
149772380|NCT01996904|540292491|FG000|Overall Study|Lost to Follow-up|38|||
149772381|NCT01996904|540292492|FG001|Overall Study|Lost to Follow-up|27|||
149772382|NCT00585923|540292493|FG000|Overall Study|Physician decided not to continue|31|||
149772383|NCT00585923|540292494|FG001|Overall Study|Physician decided not to continue|33|||
149772384|NCT01324622|540292495|FG000|Overall Study|Lost to Follow-up|7|||
149772385|NCT01324622|540292496|FG001|Overall Study|Lost to Follow-up|7|||
149772386|NCT01324622|540292495|FG000|Overall Study|Death|1|||
149772387|NCT01324622|540292496|FG001|Overall Study|Death|0|||
149772388|NCT01324622|540292495|FG000|Overall Study|Lack of Efficacy|1|||
149772389|NCT01324622|540292496|FG001|Overall Study|Lack of Efficacy|0|||
149772390|NCT02219087|540292497|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
149772391|NCT02219087|540292498|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
149772392|NCT00618449|540292499|FG000|Overall Study|Lost to Follow-up|98|||
149772393|NCT00618449|540292500|FG001|Overall Study|Lost to Follow-up|110|||
149772394|NCT00138424|540292501|FG000|Overall Study|Physician Decision|0|||
149772395|NCT00138424|540292502|FG001|Overall Study|Physician Decision|1|||
149772396|NCT00138424|540292503|FG002|Overall Study|Physician Decision|0|||
149772397|NCT00138424|540292504|FG003|Overall Study|Physician Decision|0|||
149772398|NCT04311177|540292505|FG000|Overall Study|Adverse Event|3|||
149772399|NCT04311177|540292506|FG001|Overall Study|Adverse Event|1|||
149772400|NCT04311177|540292505|FG000|Overall Study|Physician Decision|4|||
149772401|NCT04311177|540292506|FG001|Overall Study|Physician Decision|3|||
149772402|NCT04311177|540292505|FG000|Overall Study|Withdrawal by Subject|1|||
149772403|NCT04311177|540292506|FG001|Overall Study|Withdrawal by Subject|0|||
149772404|NCT00413062|540292511|FG000|Overall Study|Adverse event/serious adverse event|289|||
149772405|NCT00413062|540292512|FG001|Overall Study|Adverse event/serious adverse event|56|||
149772406|NCT00413062|540292511|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
149772407|NCT00413062|540292512|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
149772408|NCT00413062|540292511|FG000|Overall Study|Withdrawal of informed consent|111|||
149772409|NCT00413062|540292512|FG001|Overall Study|Withdrawal of informed consent|36|||
149772410|NCT00413062|540292511|FG000|Overall Study|Pregnancy|15|||
149772411|NCT00413062|540292512|FG001|Overall Study|Pregnancy|5|||
149772412|NCT00413062|540292511|FG000|Overall Study|Pregnancy wish|17|||
149772413|NCT00413062|540292512|FG001|Overall Study|Pregnancy wish|6|||
149772414|NCT00413062|540292511|FG000|Overall Study|Lost to Follow-up|175|||
149772415|NCT00413062|540292512|FG001|Overall Study|Lost to Follow-up|73|||
149772416|NCT00413062|540292511|FG000|Overall Study|Other reason|70|||
149772417|NCT00413062|540292512|FG001|Overall Study|Other reason|34|||
149772418|NCT02176291|540292513|FG000|Overall Study|Death|1|||
149772419|NCT02176291|540292514|FG001|Overall Study|Death|0|||
149772420|NCT02176291|540292513|FG000|Overall Study|non compliance with protocol|2|||
149772421|NCT02176291|540292514|FG001|Overall Study|non compliance with protocol|0|||
149772422|NCT02176291|540292513|FG000|Overall Study|Withdrawal by Subject|2|||
149772423|NCT02176291|540292514|FG001|Overall Study|Withdrawal by Subject|0|||
149772424|NCT02431468|540292515|FG000|Overall Study|Adverse Event|2|||
149772425|NCT02431468|540292516|FG001|Overall Study|Adverse Event|4|||
149772426|NCT02431468|540292517|FG002|Overall Study|Adverse Event|5|||
149772427|NCT02431468|540292515|FG000|Overall Study|Withdrawal by Subject|4|||
149772428|NCT02431468|540292516|FG001|Overall Study|Withdrawal by Subject|12|||
149772429|NCT02431468|540292517|FG002|Overall Study|Withdrawal by Subject|2|||
149772430|NCT02431468|540292515|FG000|Overall Study|noncompliance, investigator termination,|2|||
149772431|NCT02431468|540292516|FG001|Overall Study|noncompliance, investigator termination,|2|||
149772432|NCT02431468|540292517|FG002|Overall Study|noncompliance, investigator termination,|2|||
149772433|NCT00006604|540292518|FG000|Overall Study|Met study objective - no further FU|1|||
149772434|NCT00006604|540292519|FG001|Overall Study|Met study objective - no further FU|0|||
149772435|NCT00006604|540292520|FG002|Overall Study|Met study objective - no further FU|0|||
149772436|NCT00006604|540292521|FG003|Overall Study|Met study objective - no further FU|0|||
149772437|NCT00006604|540292522|FG004|Overall Study|Met study objective - no further FU|0|||
149772438|NCT00006604|540292523|FG005|Overall Study|Met study objective - no further FU|0|||
149772439|NCT00006604|540292524|FG006|Overall Study|Met study objective - no further FU|0|||
149772440|NCT00006604|540292525|FG007|Overall Study|Met study objective - no further FU|0|||
149772441|NCT00006604|540292526|FG008|Overall Study|Met study objective - no further FU|0|||
149772442|NCT00006604|540292527|FG009|Overall Study|Met study objective - no further FU|0|||
149772443|NCT00006604|540292528|FG010|Overall Study|Met study objective - no further FU|0|||
149772444|NCT00006604|540292529|FG011|Overall Study|Met study objective - no further FU|0|||
149772445|NCT00006604|540292530|FG012|Overall Study|Met study objective - no further FU|0|||
149772446|NCT00006604|540292531|FG013|Overall Study|Met study objective - no further FU|0|||
149772447|NCT00006604|540292532|FG014|Overall Study|Met study objective - no further FU|1|||
149772448|NCT00006604|540292533|FG015|Overall Study|Met study objective - no further FU|1|||
149772449|NCT00006604|540292534|FG016|Overall Study|Met study objective - no further FU|0|||
149772450|NCT00006604|540292518|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
149772451|NCT00006604|540292519|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
149772452|NCT00006604|540292520|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
149772453|NCT00006604|540292521|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
149772454|NCT00006604|540292522|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
149772455|NCT00006604|540292523|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
149772456|NCT00006604|540292524|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
149772457|NCT00006604|540292525|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
149772458|NCT00006604|540292526|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
149772459|NCT00006604|540292527|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
149772460|NCT00006604|540292528|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
149772461|NCT00006604|540292529|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
149772462|NCT00006604|540292530|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
149772463|NCT00006604|540292531|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
149772464|NCT00006604|540292532|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
149772465|NCT00006604|540292533|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
149772466|NCT00006604|540292534|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
149772467|NCT00006604|540292518|FG000|Overall Study|Death|0|||
149772468|NCT00006604|540292519|FG001|Overall Study|Death|0|||
149772469|NCT00006604|540292520|FG002|Overall Study|Death|0|||
149772470|NCT00006604|540292521|FG003|Overall Study|Death|0|||
149772471|NCT00006604|540292522|FG004|Overall Study|Death|0|||
149772472|NCT00006604|540292523|FG005|Overall Study|Death|0|||
149772473|NCT00006604|540292524|FG006|Overall Study|Death|0|||
149772474|NCT00006604|540292525|FG007|Overall Study|Death|0|||
149772475|NCT00006604|540292526|FG008|Overall Study|Death|0|||
149772476|NCT00006604|540292527|FG009|Overall Study|Death|1|||
149772477|NCT00006604|540292528|FG010|Overall Study|Death|1|||
149772478|NCT00006604|540292529|FG011|Overall Study|Death|1|||
149772479|NCT00006604|540292530|FG012|Overall Study|Death|0|||
149772480|NCT00006604|540292531|FG013|Overall Study|Death|0|||
149772481|NCT00006604|540292532|FG014|Overall Study|Death|0|||
149772482|NCT00006604|540292533|FG015|Overall Study|Death|0|||
149772483|NCT00006604|540292534|FG016|Overall Study|Death|0|||
149772484|NCT00006604|540292518|FG000|Overall Study|Severe debilitation, unable to continue|0|||
149772485|NCT00006604|540292519|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149772486|NCT00006604|540292520|FG002|Overall Study|Severe debilitation, unable to continue|0|||
149772487|NCT00006604|540292521|FG003|Overall Study|Severe debilitation, unable to continue|0|||
149772488|NCT00006604|540292522|FG004|Overall Study|Severe debilitation, unable to continue|0|||
149772489|NCT00006604|540292523|FG005|Overall Study|Severe debilitation, unable to continue|0|||
149772490|NCT00006604|540292524|FG006|Overall Study|Severe debilitation, unable to continue|3|||
149772491|NCT00006604|540292525|FG007|Overall Study|Severe debilitation, unable to continue|0|||
149772492|NCT00006604|540292526|FG008|Overall Study|Severe debilitation, unable to continue|0|||
149772493|NCT00006604|540292527|FG009|Overall Study|Severe debilitation, unable to continue|5|||
149772494|NCT00006604|540292528|FG010|Overall Study|Severe debilitation, unable to continue|0|||
149772495|NCT00006604|540292529|FG011|Overall Study|Severe debilitation, unable to continue|2|||
149772496|NCT00006604|540292530|FG012|Overall Study|Severe debilitation, unable to continue|1|||
149772497|NCT00006604|540292531|FG013|Overall Study|Severe debilitation, unable to continue|0|||
149772498|NCT00006604|540292532|FG014|Overall Study|Severe debilitation, unable to continue|2|||
149772499|NCT00006604|540292533|FG015|Overall Study|Severe debilitation, unable to continue|0|||
149772500|NCT00006604|540292534|FG016|Overall Study|Severe debilitation, unable to continue|0|||
149772501|NCT00006604|540292518|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
149772502|NCT00006604|540292519|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
149772503|NCT00006604|540292520|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
149772504|NCT00006604|540292521|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
149772505|NCT00006604|540292522|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
149772506|NCT00006604|540292523|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
149772507|NCT00006604|540292524|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
149772508|NCT00006604|540292525|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
149772509|NCT00006604|540292526|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
149772510|NCT00006604|540292527|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
149772511|NCT00006604|540292528|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
149772512|NCT00006604|540292529|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
149772513|NCT00006604|540292530|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
149772514|NCT00006604|540292531|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
149772515|NCT00006604|540292532|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
149772516|NCT00006604|540292533|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
149772517|NCT00006604|540292534|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
149772518|NCT00006604|540292518|FG000|Overall Study|Site closing|0|||
149772519|NCT00006604|540292519|FG001|Overall Study|Site closing|0|||
149772520|NCT00006604|540292520|FG002|Overall Study|Site closing|1|||
149772521|NCT00006604|540292521|FG003|Overall Study|Site closing|1|||
149772522|NCT00006604|540292522|FG004|Overall Study|Site closing|0|||
149772523|NCT00006604|540292523|FG005|Overall Study|Site closing|0|||
149772524|NCT00006604|540292524|FG006|Overall Study|Site closing|0|||
149772525|NCT00006604|540292525|FG007|Overall Study|Site closing|1|||
149772526|NCT00006604|540292526|FG008|Overall Study|Site closing|0|||
149772527|NCT00006604|540292527|FG009|Overall Study|Site closing|0|||
149772528|NCT00006604|540292528|FG010|Overall Study|Site closing|0|||
149772529|NCT00006604|540292529|FG011|Overall Study|Site closing|1|||
149772530|NCT00006604|540292530|FG012|Overall Study|Site closing|1|||
149772531|NCT00006604|540292531|FG013|Overall Study|Site closing|1|||
149772532|NCT00006604|540292532|FG014|Overall Study|Site closing|0|||
149772533|NCT00006604|540292533|FG015|Overall Study|Site closing|0|||
149772534|NCT00006604|540292534|FG016|Overall Study|Site closing|1|||
149772535|NCT00006604|540292518|FG000|Overall Study|Withdrawal by Subject|1|||
149772536|NCT00006604|540292519|FG001|Overall Study|Withdrawal by Subject|0|||
149772537|NCT00006604|540292520|FG002|Overall Study|Withdrawal by Subject|2|||
149772538|NCT00006604|540292521|FG003|Overall Study|Withdrawal by Subject|0|||
149772539|NCT00006604|540292522|FG004|Overall Study|Withdrawal by Subject|1|||
149772540|NCT00006604|540292523|FG005|Overall Study|Withdrawal by Subject|2|||
149772541|NCT00006604|540292524|FG006|Overall Study|Withdrawal by Subject|2|||
149772542|NCT00006604|540292525|FG007|Overall Study|Withdrawal by Subject|0|||
149772543|NCT00006604|540292526|FG008|Overall Study|Withdrawal by Subject|1|||
149772544|NCT00006604|540292527|FG009|Overall Study|Withdrawal by Subject|3|||
149772545|NCT00006604|540292528|FG010|Overall Study|Withdrawal by Subject|2|||
149772546|NCT00006604|540292529|FG011|Overall Study|Withdrawal by Subject|0|||
149772547|NCT00006604|540292530|FG012|Overall Study|Withdrawal by Subject|1|||
149772548|NCT00006604|540292531|FG013|Overall Study|Withdrawal by Subject|2|||
149772549|NCT00006604|540292532|FG014|Overall Study|Withdrawal by Subject|1|||
149772550|NCT00006604|540292533|FG015|Overall Study|Withdrawal by Subject|0|||
149772551|NCT00006604|540292534|FG016|Overall Study|Withdrawal by Subject|1|||
149772552|NCT00006604|540292518|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
149772553|NCT00006604|540292519|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
149772554|NCT00006604|540292520|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
149772555|NCT00006604|540292521|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
149772556|NCT00006604|540292522|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
149772557|NCT00006604|540292523|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
149772558|NCT00006604|540292524|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
149772559|NCT00006604|540292525|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
149772560|NCT00006604|540292526|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
149772561|NCT00006604|540292527|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
149772562|NCT00006604|540292528|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
149772563|NCT00006604|540292529|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
149772564|NCT00006604|540292530|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
149772565|NCT00006604|540292531|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
149772566|NCT00006604|540292532|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
149772567|NCT00006604|540292533|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
149772568|NCT00006604|540292534|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
149772569|NCT00006604|540292518|FG000|Overall Study|Lost to Follow-up|0|||
149772570|NCT00006604|540292519|FG001|Overall Study|Lost to Follow-up|0|||
149772571|NCT00006604|540292520|FG002|Overall Study|Lost to Follow-up|0|||
149772572|NCT00006604|540292521|FG003|Overall Study|Lost to Follow-up|0|||
149772573|NCT00006604|540292522|FG004|Overall Study|Lost to Follow-up|0|||
149772574|NCT00006604|540292523|FG005|Overall Study|Lost to Follow-up|0|||
149772575|NCT00006604|540292524|FG006|Overall Study|Lost to Follow-up|0|||
149772576|NCT00006604|540292525|FG007|Overall Study|Lost to Follow-up|1|||
149772577|NCT00006604|540292526|FG008|Overall Study|Lost to Follow-up|0|||
149772578|NCT00006604|540292527|FG009|Overall Study|Lost to Follow-up|2|||
149772579|NCT00006604|540292528|FG010|Overall Study|Lost to Follow-up|0|||
149772580|NCT00006604|540292529|FG011|Overall Study|Lost to Follow-up|0|||
149772581|NCT00006604|540292530|FG012|Overall Study|Lost to Follow-up|0|||
149772582|NCT00006604|540292531|FG013|Overall Study|Lost to Follow-up|0|||
149772583|NCT00006604|540292532|FG014|Overall Study|Lost to Follow-up|0|||
149772584|NCT00006604|540292533|FG015|Overall Study|Lost to Follow-up|1|||
149772585|NCT00006604|540292534|FG016|Overall Study|Lost to Follow-up|3|||
149772586|NCT00006604|540292518|FG000|Overall Study|Other Reason|0|||
149772587|NCT00006604|540292519|FG001|Overall Study|Other Reason|0|||
149772588|NCT00006604|540292520|FG002|Overall Study|Other Reason|0|||
149772589|NCT00006604|540292521|FG003|Overall Study|Other Reason|0|||
149772590|NCT00006604|540292522|FG004|Overall Study|Other Reason|0|||
149772591|NCT00006604|540292523|FG005|Overall Study|Other Reason|1|||
149772592|NCT00006604|540292524|FG006|Overall Study|Other Reason|0|||
149772593|NCT00006604|540292525|FG007|Overall Study|Other Reason|0|||
149772594|NCT00006604|540292526|FG008|Overall Study|Other Reason|0|||
149772595|NCT00006604|540292527|FG009|Overall Study|Other Reason|1|||
149772596|NCT00006604|540292528|FG010|Overall Study|Other Reason|0|||
149772597|NCT00006604|540292529|FG011|Overall Study|Other Reason|0|||
149772598|NCT00006604|540292530|FG012|Overall Study|Other Reason|0|||
149772599|NCT00006604|540292531|FG013|Overall Study|Other Reason|0|||
149772600|NCT00006604|540292532|FG014|Overall Study|Other Reason|0|||
149772601|NCT00006604|540292533|FG015|Overall Study|Other Reason|0|||
149772602|NCT00006604|540292534|FG016|Overall Study|Other Reason|0|||
149772603|NCT03589885|540292537|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
149772604|NCT03589885|540292538|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
149772605|NCT03589885|540292539|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
149772606|NCT03589885|540292540|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
149772607|NCT03589885|540292541|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
149772608|NCT03589885|540292537|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149772609|NCT03589885|540292538|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149772610|NCT03589885|540292539|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
149772611|NCT03589885|540292540|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149772612|NCT03589885|540292541|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149772613|NCT03589885|540292537|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149772614|NCT03589885|540292538|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
149772615|NCT03589885|540292539|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149772616|NCT03589885|540292540|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149772617|NCT03589885|540292541|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149772618|NCT03589885|540292537|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149772619|NCT03589885|540292538|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149772620|NCT03589885|540292539|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
149772621|NCT03589885|540292540|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149772622|NCT03589885|540292541|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149772623|NCT03589885|540292537|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
149772624|NCT03589885|540292538|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
149772625|NCT03589885|540292539|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
149772626|NCT03589885|540292540|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
149772627|NCT03589885|540292541|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
149772628|NCT03589885|540292537|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
149772629|NCT03589885|540292538|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
149772630|NCT03589885|540292539|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
149772631|NCT03589885|540292540|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
149772632|NCT03589885|540292541|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
149772633|NCT03589885|540292537|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
149772634|NCT03589885|540292538|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
149772635|NCT03589885|540292539|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
149772636|NCT03589885|540292540|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
149772637|NCT03589885|540292541|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
149772638|NCT03589885|540292537|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149772639|NCT03589885|540292538|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
149772640|NCT03589885|540292539|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149772641|NCT03589885|540292540|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149772642|NCT03589885|540292541|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149772643|NCT02157506|540292544|FG000|Overall Study|Adverse Event|0|||
149772644|NCT02157506|540292545|FG001|Overall Study|Adverse Event|1|||
149772645|NCT02157506|540292546|FG002|Overall Study|Adverse Event|0|||
149772646|NCT02157506|540292547|FG003|Overall Study|Adverse Event|0|||
149772647|NCT02157506|540292548|FG004|Overall Study|Adverse Event|0|||
149772648|NCT02157506|540292544|FG000|Overall Study|Lost to Follow-up|0|||
149772649|NCT02157506|540292545|FG001|Overall Study|Lost to Follow-up|0|||
149772650|NCT02157506|540292546|FG002|Overall Study|Lost to Follow-up|1|||
149772651|NCT02157506|540292547|FG003|Overall Study|Lost to Follow-up|0|||
149772652|NCT02157506|540292548|FG004|Overall Study|Lost to Follow-up|0|||
149772653|NCT03448224|540292549|FG000|Overall Study|Provided same answer to every question|1|||
149772654|NCT03448224|540292550|FG001|Overall Study|Provided same answer to every question|0|||
149772655|NCT03103906|540292551|FG000|Overall Study|Adverse Event|2|||
149772656|NCT03103906|540292552|FG001|Overall Study|Adverse Event|3|||
149772657|NCT03103906|540292551|FG000|Overall Study|Other|2|||
149772658|NCT03103906|540292552|FG001|Overall Study|Other|0|||
149772659|NCT00764478|540292553|FG000|Overall Study|Adverse Event|1|||
149772660|NCT00764478|540292554|FG001|Overall Study|Adverse Event|1|||
149772661|NCT00764478|540292555|FG002|Overall Study|Adverse Event|1|||
149772662|NCT00764478|540292553|FG000|Overall Study|Withdrawal by Subject|7|||
149772663|NCT00764478|540292554|FG001|Overall Study|Withdrawal by Subject|12|||
149772664|NCT00764478|540292555|FG002|Overall Study|Withdrawal by Subject|1|||
149772665|NCT00764478|540292553|FG000|Overall Study|Lost to Follow-up|7|||
149772666|NCT00764478|540292554|FG001|Overall Study|Lost to Follow-up|8|||
149772667|NCT00764478|540292555|FG002|Overall Study|Lost to Follow-up|5|||
149772668|NCT00764478|540292553|FG000|Overall Study|Protocol Violation|0|||
149772669|NCT00764478|540292554|FG001|Overall Study|Protocol Violation|1|||
149772670|NCT00764478|540292555|FG002|Overall Study|Protocol Violation|1|||
149772671|NCT00643604|540292558|FG000|Overall Study|Death|1|||
149772672|NCT02702011|540292559|FG000|Overall Study|Withdrawal by Subject|0|||
149772673|NCT02702011|540292560|FG001|Overall Study|Withdrawal by Subject|1|||
149772674|NCT02702011|540292561|FG002|Overall Study|Withdrawal by Subject|0|||
149772675|NCT02702011|540292562|FG003|Overall Study|Withdrawal by Subject|0|||
149772676|NCT03498287|540292566|FG000|Overall Study|Withdrawal by Subject|3|||
149772677|NCT03498287|540292567|FG001|Overall Study|Withdrawal by Subject|0|||
149772678|NCT03498287|540292566|FG000|Overall Study|Protocol Violation|0|||
149772679|NCT03498287|540292567|FG001|Overall Study|Protocol Violation|4|||
149772680|NCT03498287|540292566|FG000|Overall Study|Adverse Event|0|||
149772681|NCT03498287|540292567|FG001|Overall Study|Adverse Event|1|||
149772682|NCT01740388|540292570|FG000|Overall Study|Withdrawal by Subject|1|||
149772683|NCT01740388|540292571|FG001|Overall Study|Withdrawal by Subject|2|||
149772684|NCT01740388|540292570|FG000|Overall Study|Lost to Follow-up|2|||
149772685|NCT01740388|540292571|FG001|Overall Study|Lost to Follow-up|0|||
149772686|NCT01740388|540292570|FG000|Overall Study|Physician Decision|2|||
149772687|NCT01740388|540292571|FG001|Overall Study|Physician Decision|6|||
149772688|NCT01740388|540292570|FG000|Overall Study|Subjects missing data, completed|41|||
149772689|NCT01740388|540292571|FG001|Overall Study|Subjects missing data, completed|36|||
149772690|NCT04142216|540292572|FG000|Overall Study|Hospitalization|0|||
149772691|NCT04142216|540292573|FG001|Overall Study|Hospitalization|2|||
149772692|NCT04142216|540292572|FG000|Overall Study|Death|3|||
149772693|NCT04142216|540292573|FG001|Overall Study|Death|1|||
149772694|NCT04142216|540292572|FG000|Overall Study|Referral to another hemodialysis unit|3|||
149772695|NCT04142216|540292573|FG001|Overall Study|Referral to another hemodialysis unit|2|||
149772696|NCT04142216|540292572|FG000|Overall Study|Use of clove|0|||
149772697|NCT04142216|540292573|FG001|Overall Study|Use of clove|1|||
149772698|NCT02555657|540292574|FG000|Overall Study|Death|274|||
149772699|NCT02555657|540292575|FG001|Overall Study|Death|262|||
149772700|NCT02555657|540292574|FG000|Overall Study|Physician Decision|0|||
149772701|NCT02555657|540292575|FG001|Overall Study|Physician Decision|1|||
149772702|NCT02555657|540292574|FG000|Overall Study|Sponsor Decision|27|||
149772703|NCT02555657|540292575|FG001|Overall Study|Sponsor Decision|15|||
149772704|NCT02555657|540292574|FG000|Overall Study|Withdrawal by Subject|11|||
149772705|NCT02555657|540292575|FG001|Overall Study|Withdrawal by Subject|32|||
149772706|NCT01578785|540292577|FG000|Overall Study|Withdrawal by Subject|0|||
149772707|NCT01578785|540292578|FG001|Overall Study|Withdrawal by Subject|1|||
149772708|NCT01578785|540292577|FG000|Overall Study|Study terminated by sponsor|59|||
149772709|NCT01578785|540292578|FG001|Overall Study|Study terminated by sponsor|118|||
149772710|NCT02133742|540292605|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
149772711|NCT02133742|540292605|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
149772712|NCT02133742|540292605|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
149772713|NCT02133742|540292605|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
149772714|NCT02133742|540292605|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
149772715|NCT03479216|540292606|FG000|Overall Study|Withdrawal by Subject|3|||
149772716|NCT03479216|540292607|FG001|Overall Study|Withdrawal by Subject|2|||
149772717|NCT03479216|540292606|FG000|Overall Study|Physician Decision|2|||
149772718|NCT03479216|540292607|FG001|Overall Study|Physician Decision|3|||
149772719|NCT01265420|540292608|FG000|Overall Study|Lost to Follow-up|1|||
149772720|NCT02554253|540292609|FG000|Overall Study|ineligible after enrollment|1|||
149772721|NCT02554253|540292610|FG001|Overall Study|ineligible after enrollment|0|||
149772722|NCT02554253|540292609|FG000|Overall Study|converted to transcatheter procedure|0|||
149772723|NCT02554253|540292610|FG001|Overall Study|converted to transcatheter procedure|1|||
149772724|NCT02554253|540292609|FG000|Overall Study|received both drugs|0|||
149772725|NCT02554253|540292610|FG001|Overall Study|received both drugs|1|||
149772726|NCT01736254|540292612|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
149772727|NCT01736254|540292612|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
149772728|NCT02559206|540292613|FG000|Overall Study|Adverse Event|0|||
149772729|NCT02559206|540292614|FG001|Overall Study|Adverse Event|4|||
149772730|NCT02559206|540292615|FG002|Overall Study|Adverse Event|1|||
149772731|NCT02559206|540292616|FG003|Overall Study|Adverse Event|5|||
149772732|NCT02559206|540292617|FG004|Overall Study|Adverse Event|3|||
149772733|NCT02559206|540292618|FG005|Overall Study|Adverse Event|0|||
149772734|NCT02559206|540292619|FG006|Overall Study|Adverse Event|1|||
149772735|NCT02559206|540292620|FG007|Overall Study|Adverse Event|0|||
149772736|NCT02559206|540292613|FG000|Overall Study|Protocol Violation|1|||
149772737|NCT02559206|540292614|FG001|Overall Study|Protocol Violation|0|||
149772738|NCT02559206|540292615|FG002|Overall Study|Protocol Violation|1|||
149772739|NCT02559206|540292616|FG003|Overall Study|Protocol Violation|0|||
149772740|NCT02559206|540292617|FG004|Overall Study|Protocol Violation|0|||
149772741|NCT02559206|540292618|FG005|Overall Study|Protocol Violation|2|||
149772742|NCT02559206|540292619|FG006|Overall Study|Protocol Violation|0|||
149772743|NCT02559206|540292620|FG007|Overall Study|Protocol Violation|0|||
149772744|NCT02559206|540292613|FG000|Overall Study|Withdrawal by Subject|3|||
149772745|NCT02559206|540292614|FG001|Overall Study|Withdrawal by Subject|3|||
149772746|NCT02559206|540292615|FG002|Overall Study|Withdrawal by Subject|1|||
149772747|NCT02559206|540292616|FG003|Overall Study|Withdrawal by Subject|3|||
149772748|NCT02559206|540292617|FG004|Overall Study|Withdrawal by Subject|5|||
149772749|NCT02559206|540292618|FG005|Overall Study|Withdrawal by Subject|4|||
149772750|NCT02559206|540292619|FG006|Overall Study|Withdrawal by Subject|1|||
149772751|NCT02559206|540292620|FG007|Overall Study|Withdrawal by Subject|2|||
149772752|NCT02559206|540292613|FG000|Overall Study|Lost to Follow-up|3|||
149772753|NCT02559206|540292614|FG001|Overall Study|Lost to Follow-up|5|||
149772754|NCT02559206|540292615|FG002|Overall Study|Lost to Follow-up|3|||
149772755|NCT02559206|540292616|FG003|Overall Study|Lost to Follow-up|3|||
149772756|NCT02559206|540292617|FG004|Overall Study|Lost to Follow-up|2|||
149772757|NCT02559206|540292618|FG005|Overall Study|Lost to Follow-up|5|||
149772758|NCT02559206|540292619|FG006|Overall Study|Lost to Follow-up|1|||
149772759|NCT02559206|540292620|FG007|Overall Study|Lost to Follow-up|4|||
149772760|NCT02559206|540292613|FG000|Overall Study|Lack of Efficacy|1|||
149772761|NCT02559206|540292614|FG001|Overall Study|Lack of Efficacy|0|||
149772762|NCT02559206|540292615|FG002|Overall Study|Lack of Efficacy|3|||
149772763|NCT02559206|540292616|FG003|Overall Study|Lack of Efficacy|2|||
149772764|NCT02559206|540292617|FG004|Overall Study|Lack of Efficacy|2|||
149772765|NCT02559206|540292618|FG005|Overall Study|Lack of Efficacy|3|||
149772766|NCT02559206|540292619|FG006|Overall Study|Lack of Efficacy|3|||
149772767|NCT02559206|540292620|FG007|Overall Study|Lack of Efficacy|3|||
149772768|NCT02559206|540292613|FG000|Overall Study|Other Not Specified|0|||
149772769|NCT02559206|540292614|FG001|Overall Study|Other Not Specified|0|||
149772770|NCT02559206|540292615|FG002|Overall Study|Other Not Specified|0|||
149772771|NCT02559206|540292616|FG003|Overall Study|Other Not Specified|1|||
149772772|NCT02559206|540292617|FG004|Overall Study|Other Not Specified|0|||
149772773|NCT02559206|540292618|FG005|Overall Study|Other Not Specified|0|||
149772774|NCT02559206|540292619|FG006|Overall Study|Other Not Specified|0|||
149772775|NCT02559206|540292620|FG007|Overall Study|Other Not Specified|0|||
149772776|NCT03862131|540292621|FG000|Overall Study|Lost to Follow-up|1|||
149772777|NCT03862131|540292622|FG001|Overall Study|Lost to Follow-up|0|||
149772778|NCT03862131|540292623|FG002|Overall Study|Lost to Follow-up|1|||
149772779|NCT03862131|540292621|FG000|Overall Study|Determined to be ineligible|0|||
149772780|NCT03862131|540292622|FG001|Overall Study|Determined to be ineligible|0|||
149772781|NCT03862131|540292623|FG002|Overall Study|Determined to be ineligible|5|||
149772782|NCT03862131|540292621|FG000|Overall Study|Death|4|||
149772783|NCT03862131|540292622|FG001|Overall Study|Death|4|||
149772784|NCT03862131|540292623|FG002|Overall Study|Death|0|||
149772785|NCT03862131|540292621|FG000|Overall Study|Withdrawal by Subject|5|||
149772786|NCT03862131|540292622|FG001|Overall Study|Withdrawal by Subject|3|||
149772787|NCT03862131|540292623|FG002|Overall Study|Withdrawal by Subject|0|||
149772788|NCT03862131|540292621|FG000|Overall Study|Physician Decision|0|||
149772789|NCT03862131|540292622|FG001|Overall Study|Physician Decision|1|||
149772790|NCT03862131|540292623|FG002|Overall Study|Physician Decision|0|||
149772791|NCT03326869|540294506|FG000|Overall Study|Study data has been lost to natural disa|1|||
149772792|NCT03326869|540294507|FG001|Overall Study|Study data has been lost to natural disa|1|||
149772793|NCT01002742|540294510|FG000|Overall Study|Determined to be ineligible|0|||
149772794|NCT01002742|540294511|FG001|Overall Study|Determined to be ineligible|1|||
149772795|NCT05263921|540294512|FG000|Overall Study|Other: family emergency.|0|||
149772796|NCT05263921|540294513|FG001|Overall Study|Other: family emergency.|0|||
149772797|NCT05263921|540294514|FG002|Overall Study|Other: family emergency.|1|||
149772798|NCT05263921|540294515|FG003|Overall Study|Other: family emergency.|0|||
149772799|NCT02670928|540294516|FG000|Overall Study|Adverse Event|3|||
149772800|NCT02670928|540294517|FG001|Overall Study|Adverse Event|1|||
149772801|NCT02670928|540294516|FG000|Overall Study|Withdrawal by Subject|4|||
149772802|NCT02670928|540294517|FG001|Overall Study|Withdrawal by Subject|0|||
149772803|NCT02670928|540294516|FG000|Overall Study|Lost to Follow-up|1|||
149772804|NCT02670928|540294517|FG001|Overall Study|Lost to Follow-up|0|||
149772805|NCT02670928|540294516|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
149772806|NCT02670928|540294517|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
149772807|NCT02678312|540294518|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
149772808|NCT02678312|540294519|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149772809|NCT02678312|540294520|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149772810|NCT02678312|540294521|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149772811|NCT02678312|540294522|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149772812|NCT02678312|540294518|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
149772813|NCT02678312|540294519|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149772814|NCT02678312|540294520|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149772815|NCT02678312|540294521|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149772816|NCT02678312|540294522|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149772817|NCT02678312|540294518|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
149772818|NCT02678312|540294519|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149772819|NCT02678312|540294520|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149772820|NCT02678312|540294521|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149772821|NCT02678312|540294522|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149772822|NCT02678312|540294518|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
149772823|NCT02678312|540294519|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
149772824|NCT02678312|540294520|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
149772825|NCT02678312|540294521|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
149772826|NCT02678312|540294522|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
149772827|NCT02678312|540294518|FG000|Part 2 Double Blind Epoch|Death|0|||
149772828|NCT02678312|540294519|FG001|Part 2 Double Blind Epoch|Death|0|||
149772829|NCT02678312|540294520|FG002|Part 2 Double Blind Epoch|Death|0|||
149772830|NCT02678312|540294521|FG003|Part 2 Double Blind Epoch|Death|8|||
149772831|NCT02678312|540294522|FG004|Part 2 Double Blind Epoch|Death|12|||
149772832|NCT02678312|540294518|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
149772833|NCT02678312|540294519|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
149772834|NCT02678312|540294520|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
149772835|NCT02678312|540294521|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
149772836|NCT02678312|540294522|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
149772837|NCT02678312|540294518|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149772838|NCT02678312|540294519|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149772839|NCT02678312|540294520|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149772840|NCT02678312|540294521|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149772841|NCT02678312|540294522|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
149772842|NCT02678312|540294518|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149772843|NCT02678312|540294519|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149772844|NCT02678312|540294520|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149772845|NCT02678312|540294521|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
149772846|NCT02678312|540294522|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
149772847|NCT04507776|540294523|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
149772848|NCT01136746|540294525|FG000|Overall Study|Lost to Follow-up|0|||
149772849|NCT01136746|540294526|FG001|Overall Study|Lost to Follow-up|2|||
149772850|NCT01136746|540294525|FG000|Overall Study|Protocol Violation|2|||
149772851|NCT01136746|540294526|FG001|Overall Study|Protocol Violation|1|||
149772852|NCT01136746|540294525|FG000|Overall Study|Death|1|||
149772853|NCT01136746|540294526|FG001|Overall Study|Death|0|||
149772854|NCT00092677|540294542|FG000|Overall Study|Lost to Follow-up|0|||
149772855|NCT00092677|540294543|FG001|Overall Study|Lost to Follow-up|2|||
149772856|NCT00092677|540294542|FG000|Overall Study|Adminstrative|5|||
149772857|NCT00092677|540294543|FG001|Overall Study|Adminstrative|9|||
149772858|NCT02966353|540294544|FG000|Overall Study|Withdrawal by Subject|7|||
149772859|NCT02966353|540294544|FG000|Overall Study|Adverse Event|4|||
149772860|NCT02966353|540294544|FG000|Overall Study|Death|4|||
149772861|NCT02966353|540294544|FG000|Overall Study|Physician Decision|3|||
149772862|NCT02966353|540294544|FG000|Overall Study|Progressive disease|2|||
149772863|NCT02966353|540294544|FG000|Overall Study|Protocol deviation|2|||
149772864|NCT00093470|540294557|FG000|Overall Study|Disease progression|39|||
149772865|NCT00093470|540294558|FG001|Overall Study|Disease progression|0|||
149772866|NCT00093470|540294557|FG000|Overall Study|Adverse Event|15|||
149772867|NCT00093470|540294558|FG001|Overall Study|Adverse Event|0|||
149772868|NCT00093470|540294557|FG000|Overall Study|Death|2|||
149772869|NCT00093470|540294558|FG001|Overall Study|Death|0|||
149772870|NCT00093470|540294557|FG000|Overall Study|Withdrawal by Subject|8|||
149772871|NCT00093470|540294558|FG001|Overall Study|Withdrawal by Subject|0|||
149772872|NCT00093470|540294557|FG000|Overall Study|Alternative therapy|2|||
149772873|NCT00093470|540294558|FG001|Overall Study|Alternative therapy|0|||
149772874|NCT00093470|540294557|FG000|Overall Study|Other complicating disease|3|||
149772875|NCT00093470|540294558|FG001|Overall Study|Other complicating disease|0|||
149772876|NCT00093470|540294557|FG000|Overall Study|Physician Decision|2|||
149772877|NCT00093470|540294558|FG001|Overall Study|Physician Decision|0|||
149772878|NCT00093470|540294557|FG000|Overall Study|Never started treatment|1|||
149772879|NCT00093470|540294558|FG001|Overall Study|Never started treatment|0|||
149772880|NCT00093470|540294557|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
149772881|NCT00093470|540294558|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
149772882|NCT00010803|540294559|FG000|Overall Study|Withdrawal by Subject|97|||
149772883|NCT00010803|540294560|FG001|Overall Study|Withdrawal by Subject|98|||
149772884|NCT05905601|540294561|FG000|Overall Study|Lost to Follow-up|1|||
149772885|NCT05905601|540294562|FG001|Overall Study|Lost to Follow-up|3|||
149772886|NCT02514772|540294563|FG000|Overall Study|Adverse Event|1|||
149772887|NCT02514772|540294564|FG001|Overall Study|Adverse Event|0|||
149772888|NCT02514772|540294563|FG000|Overall Study|Death|0|||
149772889|NCT02514772|540294564|FG001|Overall Study|Death|1|||
149772890|NCT02514772|540294563|FG000|Overall Study|Withdrawal by Subject|2|||
149772891|NCT02514772|540294564|FG001|Overall Study|Withdrawal by Subject|1|||
149772892|NCT00877006|540294565|FG000|Treatment Period|Death|2|||
149772893|NCT00877006|540294566|FG001|Treatment Period|Death|1|||
149772894|NCT00877006|540294565|FG000|Treatment Period|Adverse Event|10|||
149772895|NCT00877006|540294566|FG001|Treatment Period|Adverse Event|3|||
149772896|NCT00877006|540294565|FG000|Treatment Period|Withdrawal by Subject|2|||
149772897|NCT00877006|540294566|FG001|Treatment Period|Withdrawal by Subject|3|||
149772898|NCT00877006|540294565|FG000|Treatment Period|Protocol Violation|1|||
149772899|NCT00877006|540294566|FG001|Treatment Period|Protocol Violation|0|||
149772900|NCT00877006|540294565|FG000|Treatment Period|Lost to Follow-up|0|||
149772901|NCT00877006|540294566|FG001|Treatment Period|Lost to Follow-up|1|||
149772902|NCT00877006|540294565|FG000|Treatment Period|Disease Progression|1|||
149772903|NCT00877006|540294566|FG001|Treatment Period|Disease Progression|2|||
149772904|NCT00877006|540294565|FG000|Treatment Period|Started New Treatment Regimen|2|||
149772905|NCT00877006|540294566|FG001|Treatment Period|Started New Treatment Regimen|5|||
149772906|NCT00877006|540294565|FG000|Treatment Period|Other|4|||
149772907|NCT00877006|540294566|FG001|Treatment Period|Other|4|||
149772908|NCT00877006|540294565|FG000|Treatment Period|Randomized but Not Treated|3|||
149772909|NCT00877006|540294566|FG001|Treatment Period|Randomized but Not Treated|8|||
149772910|NCT00877006|540294565|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
149772911|NCT00877006|540294566|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
149772912|NCT00877006|540294565|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
149772913|NCT00877006|540294566|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
149772914|NCT00877006|540294565|FG000|Long-Term Follow-up Period|Death|26|||
149772915|NCT00877006|540294566|FG001|Long-Term Follow-up Period|Death|18|||
149772916|NCT00877006|540294565|FG000|Long-Term Follow-up Period|Other|7|||
149772917|NCT00877006|540294566|FG001|Long-Term Follow-up Period|Other|9|||
149772918|NCT04671342|540294567|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
149772919|NCT04671342|540294567|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
149772920|NCT04671342|540294567|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
149772921|NCT04671342|540294567|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
149772922|NCT04671342|540294567|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
149772923|NCT04671342|540294567|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
149772924|NCT03583606|540294568|FG000|Overall Study|Lost to Follow-up|0|||
149772925|NCT03583606|540294569|FG001|Overall Study|Lost to Follow-up|1|||
149772926|NCT03583606|540294570|FG002|Overall Study|Lost to Follow-up|0|||
149772927|NCT03583606|540294568|FG000|Overall Study|Ineligible at baseline|1|||
149772928|NCT03583606|540294569|FG001|Overall Study|Ineligible at baseline|0|||
149772929|NCT03583606|540294570|FG002|Overall Study|Ineligible at baseline|0|||
149772930|NCT00817206|540294575|FG000|Overall Study|Adverse Event|10|||
149772931|NCT00817206|540294576|FG001|Overall Study|Adverse Event|3|||
149772932|NCT00817206|540294575|FG000|Overall Study|Protocol Violation|0|||
149772933|NCT00817206|540294576|FG001|Overall Study|Protocol Violation|2|||
149772934|NCT00817206|540294575|FG000|Overall Study|Lost to Follow-up|0|||
149772935|NCT00817206|540294576|FG001|Overall Study|Lost to Follow-up|1|||
149772936|NCT00817206|540294575|FG000|Overall Study|Death|2|||
149772937|NCT00817206|540294576|FG001|Overall Study|Death|0|||
149772938|NCT00817206|540294575|FG000|Overall Study|Withdrawal by Subject|7|||
149772939|NCT00817206|540294576|FG001|Overall Study|Withdrawal by Subject|3|||
149772940|NCT00817206|540294575|FG000|Overall Study|Physician Decision|2|||
149772941|NCT00817206|540294576|FG001|Overall Study|Physician Decision|0|||
149772942|NCT00126581|540294577|FG000|Overall Study|Adverse Event|3|||
149772943|NCT00126581|540294578|FG001|Overall Study|Adverse Event|7|||
149772944|NCT00126581|540294577|FG000|Overall Study|Death|3|||
149772945|NCT00126581|540294578|FG001|Overall Study|Death|2|||
149772946|NCT00126581|540294577|FG000|Overall Study|Withdrawal by Subject|1|||
149772947|NCT00126581|540294578|FG001|Overall Study|Withdrawal by Subject|4|||
149772948|NCT00126581|540294577|FG000|Overall Study|Alternative therapy|3|||
149772949|NCT00126581|540294578|FG001|Overall Study|Alternative therapy|3|||
149772950|NCT00126581|540294577|FG000|Overall Study|Other illness/MD discretion|3|||
149772951|NCT00126581|540294578|FG001|Overall Study|Other illness/MD discretion|4|||
149772952|NCT00793182|540294579|FG000|Overall Study|Adverse Event|0|||
149772953|NCT00793182|540294580|FG001|Overall Study|Adverse Event|1|||
149772954|NCT03728140|540294582|FG000|Overall Study|Abnormal embryo transfer operation|10|||
149772955|NCT03728140|540294583|FG001|Overall Study|Abnormal embryo transfer operation|7|||
149772956|NCT01188096|540294584|FG000|Overall Study|progression of disease|4|||
149772957|NCT01188096|540294584|FG000|Overall Study|Withdrawal by Subject|2|||
149772958|NCT00851253|540294585|FG000|Overall Study|Disease Progression|1|||
149772959|NCT00851253|540294586|FG001|Overall Study|Disease Progression|0|||
149772960|NCT03004976|540294596|FG000|Overall Study|Lost to Follow-up|7|||
149772961|NCT03004976|540294597|FG001|Overall Study|Lost to Follow-up|5|||
149772962|NCT03004976|540294596|FG000|Overall Study|Physician Decision|1|||
149772963|NCT03004976|540294597|FG001|Overall Study|Physician Decision|0|||
149772964|NCT03004976|540294596|FG000|Overall Study|Withdrawal by Subject|1|||
149772965|NCT03004976|540294597|FG001|Overall Study|Withdrawal by Subject|0|||
149772966|NCT03004976|540294596|FG000|Overall Study|Death|4|||
149772967|NCT03004976|540294597|FG001|Overall Study|Death|1|||
149772968|NCT02786836|540294598|FG000|Overall Study|Death|1|||
149772969|NCT02786836|540294598|FG000|Overall Study|Lack of Efficacy|2|||
149772970|NCT02786836|540294598|FG000|Overall Study|Protocol Violation|3|||
149772971|NCT02786836|540294598|FG000|Overall Study|Withdrawal by Subject|3|||
149772972|NCT02786836|540294598|FG000|Overall Study|Liver Transplantation|2|||
149772973|NCT02786836|540294598|FG000|Overall Study|Device or Pharmacy Issues|3|||
149772974|NCT01143714|540294599|FG000|Overall Study|Adverse Event|4|||
149772975|NCT01143714|540294600|FG001|Overall Study|Adverse Event|2|||
149772976|NCT01143714|540294599|FG000|Overall Study|Withdrawal by Subject|1|||
149772977|NCT01143714|540294600|FG001|Overall Study|Withdrawal by Subject|0|||
149772978|NCT01143714|540294599|FG000|Overall Study|Subject non-compliance|0|||
149772979|NCT01143714|540294600|FG001|Overall Study|Subject non-compliance|1|||
149772980|NCT01143714|540294599|FG000|Overall Study|wound closed = deemed healed|1|||
149772981|NCT01143714|540294600|FG001|Overall Study|wound closed = deemed healed|0|||
149772982|NCT01143714|540294599|FG000|Overall Study|wound size increased|1|||
149772983|NCT01143714|540294600|FG001|Overall Study|wound size increased|0|||
149772984|NCT01106391|540294601|FG000|Overall Study|Death|12|||
149772985|NCT01106391|540294601|FG000|Overall Study|Withdrawal by Subject|7|||
149772986|NCT00150345|540294602|FG000|Overall Study|Death|5|||
149772987|NCT00150345|540294603|FG001|Overall Study|Death|2|||
149772988|NCT00150345|540294602|FG000|Overall Study|Adverse Event|8|||
149772989|NCT00150345|540294603|FG001|Overall Study|Adverse Event|6|||
149772990|NCT00150345|540294602|FG000|Overall Study|Lack of Efficacy|5|||
149772991|NCT00150345|540294603|FG001|Overall Study|Lack of Efficacy|4|||
149772992|NCT00150345|540294602|FG000|Overall Study|Withdrawal by Subject|3|||
149772993|NCT00150345|540294603|FG001|Overall Study|Withdrawal by Subject|4|||
149772994|NCT00150345|540294602|FG000|Overall Study|Laboratory abnormality|1|||
149772995|NCT00150345|540294603|FG001|Overall Study|Laboratory abnormality|2|||
149772996|NCT00150345|540294602|FG000|Overall Study|Other|12|||
149772997|NCT00150345|540294603|FG001|Overall Study|Other|14|||
149772998|NCT05224076|540294609|FG000|Overall Study|Lost to Follow-up|24|||
149772999|NCT01807949|540294610|FG000|Overall Study|Adverse Event|1|||
149773000|NCT01807949|540294611|FG001|Overall Study|Adverse Event|2|||
149773001|NCT01807949|540294612|FG002|Overall Study|Adverse Event|2|||
149773002|NCT01807949|540294610|FG000|Overall Study|Withdrawal by Subject|1|||
149773003|NCT01807949|540294611|FG001|Overall Study|Withdrawal by Subject|2|||
149773004|NCT01807949|540294612|FG002|Overall Study|Withdrawal by Subject|2|||
149773005|NCT01807949|540294610|FG000|Overall Study|Non-Compliance|0|||
149773006|NCT01807949|540294611|FG001|Overall Study|Non-Compliance|0|||
149773007|NCT01807949|540294612|FG002|Overall Study|Non-Compliance|1|||
149773008|NCT01807949|540294610|FG000|Overall Study|Undefined|0|||
149773009|NCT01807949|540294611|FG001|Overall Study|Undefined|1|||
149773010|NCT01807949|540294612|FG002|Overall Study|Undefined|2|||
149773011|NCT01807949|540294610|FG000|Overall Study|Randomized But Not Treated|0|||
149773012|NCT01807949|540294611|FG001|Overall Study|Randomized But Not Treated|2|||
149773013|NCT01807949|540294612|FG002|Overall Study|Randomized But Not Treated|2|||
149773014|NCT04325906|540294613|FG000|Overall Study|Withdrawal by Subject|2|||
149773015|NCT04325906|540294614|FG001|Overall Study|Withdrawal by Subject|0|||
149773016|NCT00555568|540294617|FG000|Overall Study|Lost to Follow-up|26|||
149773017|NCT00555568|540294618|FG001|Overall Study|Lost to Follow-up|16|||
149773018|NCT00555568|540294619|FG002|Overall Study|Lost to Follow-up|16|||
149773019|NCT01588353|540294620|FG000|Step2|Withdrawal by Subject|0|||
149773020|NCT01588353|540294621|FG001|Step2|Withdrawal by Subject|1|||
149773021|NCT01588353|540294622|FG002|Step2|Withdrawal by Subject|0|||
149773022|NCT01588353|540294620|FG000|Step3|Adverse Event|0|||
149773023|NCT01588353|540294621|FG001|Step3|Adverse Event|0|||
149773024|NCT01588353|540294622|FG002|Step3|Adverse Event|2|||
149773025|NCT01409993|540294623|FG000|Overall Study|Adverse Event|4|||
149773026|NCT01409993|540294624|FG001|Overall Study|Adverse Event|4|||
149773027|NCT01409993|540294625|FG002|Overall Study|Adverse Event|3|||
149773028|NCT01409993|540294626|FG003|Overall Study|Adverse Event|1|||
149773029|NCT01409993|540294623|FG000|Overall Study|Withdrawal by Subject|0|||
149773030|NCT01409993|540294624|FG001|Overall Study|Withdrawal by Subject|0|||
149773031|NCT01409993|540294625|FG002|Overall Study|Withdrawal by Subject|0|||
149773032|NCT01409993|540294626|FG003|Overall Study|Withdrawal by Subject|4|||
149773033|NCT01409993|540294623|FG000|Overall Study|Lost to Follow-up|0|||
149773034|NCT01409993|540294624|FG001|Overall Study|Lost to Follow-up|1|||
149773035|NCT01409993|540294625|FG002|Overall Study|Lost to Follow-up|0|||
149773036|NCT01409993|540294626|FG003|Overall Study|Lost to Follow-up|0|||
149773037|NCT02677220|540294627|FG000|Overall Study|Adverse Event|1|||
149773038|NCT00965146|540294628|FG000|Overall Study|Death|7|||
149773039|NCT00965146|540294628|FG000|Overall Study|Lost to Follow-up|22|||
149773040|NCT00965146|540294628|FG000|Overall Study|Withdrawal by Subject|17|||
149773041|NCT00965146|540294628|FG000|Overall Study|Unable to return|1|||
149773042|NCT00965146|540294628|FG000|Overall Study|Unwilling to return|11|||
149773043|NCT00965146|540294628|FG000|Overall Study|Intercurrent illness|1|||
149773044|NCT00965146|540294628|FG000|Overall Study|Revision / Removal of Study Implant|6|||
149773045|NCT00965146|540294628|FG000|Overall Study|Overall Study Termination|145|||
149773046|NCT01148693|540294629|FG000|Overall Study|Attempts for cannulation were failed|13|||
149773047|NCT01148693|540294630|FG001|Overall Study|Attempts for cannulation were failed|10|||
149773048|NCT01504971|540294631|FG000|Overall Study|Physician Decision|13|||
149773049|NCT04581863|540294632|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
149773050|NCT04581863|540294633|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
149773051|NCT00225212|540294634|FG000|Overall Study|Disease progression|2|||
149773052|NCT00225212|540294634|FG000|Overall Study|Death|1|||
149773053|NCT00225212|540294634|FG000|Overall Study|Adverse Event|2|||
149773054|NCT00225212|540294634|FG000|Overall Study|Intercurrent illness|1|||
149773055|NCT01335698|540294637|FG000|Treatment Stage 1|Lack of Efficacy|3|||
149773056|NCT01335698|540294638|FG001|Treatment Stage 1|Lack of Efficacy|1|||
149773057|NCT01335698|540294639|FG002|Treatment Stage 1|Lack of Efficacy|3|||
149773058|NCT01335698|540294640|FG003|Treatment Stage 1|Lack of Efficacy|3|||
149773059|NCT01335698|540294641|FG004|Treatment Stage 1|Lack of Efficacy|1|||
149773060|NCT01335698|540294637|FG000|Treatment Stage 1|Adverse Event|1|||
149773061|NCT01335698|540294638|FG001|Treatment Stage 1|Adverse Event|2|||
149773062|NCT01335698|540294639|FG002|Treatment Stage 1|Adverse Event|2|||
149773063|NCT01335698|540294640|FG003|Treatment Stage 1|Adverse Event|1|||
149773064|NCT01335698|540294641|FG004|Treatment Stage 1|Adverse Event|1|||
149773065|NCT01335698|540294637|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
149773066|NCT01335698|540294638|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
149773067|NCT01335698|540294639|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
149773068|NCT01335698|540294640|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
149773069|NCT01335698|540294641|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
149773070|NCT01335698|540294637|FG000|Treatment Stage 1|Lost to Follow-up|1|||
149773071|NCT01335698|540294638|FG001|Treatment Stage 1|Lost to Follow-up|1|||
149773072|NCT01335698|540294639|FG002|Treatment Stage 1|Lost to Follow-up|0|||
149773073|NCT01335698|540294640|FG003|Treatment Stage 1|Lost to Follow-up|0|||
149773074|NCT01335698|540294641|FG004|Treatment Stage 1|Lost to Follow-up|0|||
149773075|NCT01335698|540294637|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
149773076|NCT01335698|540294638|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
149773077|NCT01335698|540294639|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
149773078|NCT01335698|540294640|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
149773079|NCT01335698|540294641|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
149773080|NCT01335698|540294637|FG000|Treatment Stage 1|No longer meets study criteria|1|||
149773081|NCT01335698|540294638|FG001|Treatment Stage 1|No longer meets study criteria|1|||
149773082|NCT01335698|540294639|FG002|Treatment Stage 1|No longer meets study criteria|0|||
149773083|NCT01335698|540294640|FG003|Treatment Stage 1|No longer meets study criteria|1|||
149773084|NCT01335698|540294641|FG004|Treatment Stage 1|No longer meets study criteria|0|||
149773085|NCT01335698|540294637|FG000|Treatment Stage 1|Other|1|||
149773086|NCT01335698|540294638|FG001|Treatment Stage 1|Other|0|||
149773087|NCT01335698|540294639|FG002|Treatment Stage 1|Other|0|||
149773088|NCT01335698|540294640|FG003|Treatment Stage 1|Other|1|||
149773089|NCT01335698|540294641|FG004|Treatment Stage 1|Other|0|||
149773090|NCT01335698|540294637|FG000|Treatment Stage 2|Lack of Efficacy|2|||
149773091|NCT01335698|540294638|FG001|Treatment Stage 2|Lack of Efficacy|1|||
149773092|NCT01335698|540294639|FG002|Treatment Stage 2|Lack of Efficacy|3|||
149773093|NCT01335698|540294640|FG003|Treatment Stage 2|Lack of Efficacy|1|||
149773094|NCT01335698|540294641|FG004|Treatment Stage 2|Lack of Efficacy|0|||
149773095|NCT01335698|540294637|FG000|Treatment Stage 2|Adverse Event|2|||
149773096|NCT01335698|540294638|FG001|Treatment Stage 2|Adverse Event|0|||
149773097|NCT01335698|540294639|FG002|Treatment Stage 2|Adverse Event|0|||
149773098|NCT01335698|540294640|FG003|Treatment Stage 2|Adverse Event|3|||
149773099|NCT01335698|540294641|FG004|Treatment Stage 2|Adverse Event|0|||
149773100|NCT01335698|540294637|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
149773101|NCT01335698|540294638|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
149773102|NCT01335698|540294639|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
149773103|NCT01335698|540294640|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
149773104|NCT01335698|540294641|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
149773105|NCT01335698|540294637|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
149773106|NCT01335698|540294638|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
149773107|NCT01335698|540294639|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
149773108|NCT01335698|540294640|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
149773109|NCT01335698|540294641|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
149773110|NCT01335698|540294637|FG000|Treatment Stage 2|Lost to Follow-up|1|||
149773111|NCT01335698|540294638|FG001|Treatment Stage 2|Lost to Follow-up|0|||
149773112|NCT01335698|540294639|FG002|Treatment Stage 2|Lost to Follow-up|0|||
149773113|NCT01335698|540294640|FG003|Treatment Stage 2|Lost to Follow-up|0|||
149773114|NCT01335698|540294641|FG004|Treatment Stage 2|Lost to Follow-up|0|||
149773115|NCT01335698|540294637|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
149773116|NCT01335698|540294638|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
149773117|NCT01335698|540294639|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
149773118|NCT01335698|540294640|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
149773119|NCT01335698|540294641|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
149773120|NCT01335698|540294637|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
149773121|NCT01335698|540294638|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
149773122|NCT01335698|540294639|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
149773123|NCT01335698|540294640|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
149773124|NCT01335698|540294641|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
149773125|NCT01335698|540294637|FG000|Treatment Stage 2|Switched to another formulation|1|||
149773126|NCT01335698|540294638|FG001|Treatment Stage 2|Switched to another formulation|1|||
149773127|NCT01335698|540294639|FG002|Treatment Stage 2|Switched to another formulation|0|||
149773128|NCT01335698|540294640|FG003|Treatment Stage 2|Switched to another formulation|0|||
149773129|NCT01335698|540294641|FG004|Treatment Stage 2|Switched to another formulation|0|||
149773130|NCT01357889|540294642|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
149773131|NCT01357889|540294643|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
149773132|NCT01357889|540294642|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
149773133|NCT01357889|540294643|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
149773134|NCT01357889|540294642|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
149773135|NCT01357889|540294643|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
149773136|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
149773137|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
149773138|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
149773139|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
149773140|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
149773141|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
149773142|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
149773143|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
149773144|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
149773145|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
149773146|NCT01357889|540294642|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
149773147|NCT01357889|540294643|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
149773148|NCT01357889|540294642|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
149773149|NCT01357889|540294643|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
149773150|NCT01357889|540294642|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
149773151|NCT01357889|540294643|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
149773152|NCT01357889|540294642|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
149773153|NCT01357889|540294643|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
149773154|NCT01357889|540294642|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
149773155|NCT01357889|540294643|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
149773156|NCT01170221|540294644|FG000|Overall Study|Lost to Follow-up|22|||
149773157|NCT01170221|540294645|FG001|Overall Study|Lost to Follow-up|21|||
149773158|NCT01170221|540294644|FG000|Overall Study|Withdrawal by Subject|9|||
149773159|NCT01170221|540294645|FG001|Overall Study|Withdrawal by Subject|7|||
149773160|NCT01170221|540294644|FG000|Overall Study|Subject completed only screening and LFU|1|||
149773161|NCT01170221|540294645|FG001|Overall Study|Subject completed only screening and LFU|0|||
149773162|NCT01170221|540294644|FG000|Overall Study|Randomized but not treated|1|||
149773163|NCT01170221|540294645|FG001|Overall Study|Randomized but not treated|0|||
149773164|NCT01714817|540294647|FG000|Year 1 Period|Lack of Efficacy|11|||
149773165|NCT01714817|540294648|FG001|Year 1 Period|Lack of Efficacy|9|||
149773166|NCT01714817|540294647|FG000|Year 1 Period|Adverse Event|20|||
149773167|NCT01714817|540294648|FG001|Year 1 Period|Adverse Event|17|||
149773168|NCT01714817|540294647|FG000|Year 1 Period|Withdrawal by Subject|6|||
149773169|NCT01714817|540294648|FG001|Year 1 Period|Withdrawal by Subject|7|||
149773170|NCT01714817|540294647|FG000|Year 1 Period|Death|1|||
149773171|NCT01714817|540294648|FG001|Year 1 Period|Death|1|||
149773172|NCT01714817|540294647|FG000|Year 1 Period|Lost to Follow-up|0|||
149773173|NCT01714817|540294648|FG001|Year 1 Period|Lost to Follow-up|2|||
149773174|NCT01714817|540294647|FG000|Year 1 Period|Poor / non-compliance|0|||
149773175|NCT01714817|540294648|FG001|Year 1 Period|Poor / non-compliance|1|||
149773176|NCT01714817|540294647|FG000|Year 1 Period|Pregnancy|2|||
149773177|NCT01714817|540294648|FG001|Year 1 Period|Pregnancy|0|||
149773178|NCT01714817|540294647|FG000|Year 1 Period|Participant no longer meets criteria|6|||
149773179|NCT01714817|540294648|FG001|Year 1 Period|Participant no longer meets criteria|2|||
149773180|NCT01714817|540294647|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
149773181|NCT01714817|540294648|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
149773182|NCT01714817|540294647|FG000|Year 1 Period|Change in Concomitant Medication|0|||
149773183|NCT01714817|540294648|FG001|Year 1 Period|Change in Concomitant Medication|1|||
149773184|NCT01714817|540294647|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
149773185|NCT01714817|540294648|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
149773186|NCT01714817|540294647|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
149773187|NCT01714817|540294648|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
149773188|NCT01714817|540294647|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
149773189|NCT01714817|540294648|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
149773190|NCT01714817|540294647|FG000|Year 2 Period|Lack of Efficacy|4|||
149773191|NCT01714817|540294648|FG001|Year 2 Period|Lack of Efficacy|12|||
149773192|NCT01714817|540294647|FG000|Year 2 Period|Adverse Event|7|||
149773193|NCT01714817|540294648|FG001|Year 2 Period|Adverse Event|6|||
149773194|NCT01714817|540294647|FG000|Year 2 Period|Participant request to stop treatment|4|||
149773195|NCT01714817|540294648|FG001|Year 2 Period|Participant request to stop treatment|4|||
149773196|NCT01714817|540294647|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
149773197|NCT01714817|540294648|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
149773198|NCT01714817|540294647|FG000|Year 2 Period|Participant withdrew consent|1|||
149773199|NCT01714817|540294648|FG001|Year 2 Period|Participant withdrew consent|5|||
149773200|NCT01714817|540294647|FG000|Year 2 Period|Participant no longer meets criteria|1|||
149773201|NCT01714817|540294648|FG001|Year 2 Period|Participant no longer meets criteria|4|||
149773202|NCT01714817|540294647|FG000|Year 2 Period|Lost to Follow-up|2|||
149773203|NCT01714817|540294648|FG001|Year 2 Period|Lost to Follow-up|0|||
149773204|NCT01714817|540294647|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
149773205|NCT01714817|540294648|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
149773206|NCT01714817|540294647|FG000|Year 2 Period|Pregnancy|1|||
149773207|NCT01714817|540294648|FG001|Year 2 Period|Pregnancy|1|||
149773208|NCT01714817|540294647|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
149773209|NCT01714817|540294648|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
149773210|NCT01714817|540294647|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
149773211|NCT01714817|540294648|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
149773212|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
149773213|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
149773214|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
149773215|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
149773216|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
149773217|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
149773218|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
149773219|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
149773220|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
149773221|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
149773222|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
149773223|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
149773224|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149773225|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
149773226|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
149773227|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
149773228|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
149773229|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
149773230|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
149773231|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
149773232|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
149773233|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
149773234|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
149773235|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
149773236|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
149773237|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
149773238|NCT01714817|540294647|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
149773239|NCT01714817|540294648|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
149773240|NCT02031432|540294651|FG000|Overall Study|Protocol Violation|1|||
149773241|NCT02031432|540294651|FG000|Overall Study|Lack of Efficacy|5|||
149773242|NCT02031432|540294651|FG000|Overall Study|Cancer Progression|2|||
149773243|NCT02031432|540294651|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
149773244|NCT02031432|540294651|FG000|Overall Study|Adverse Event|8|||
149773245|NCT02031432|540294651|FG000|Overall Study|Withdrawal by Subject|5|||
149773246|NCT02031432|540294651|FG000|Overall Study|Lost to Follow-up|1|||
149773247|NCT02031432|540294651|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
149773248|NCT02031432|540294651|FG000|Overall Study|Death|10|||
149773249|NCT01617187|540294652|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149773250|NCT01617187|540294653|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149773251|NCT01617187|540294654|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149773252|NCT01617187|540294655|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
149773253|NCT01617187|540294652|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149773254|NCT01617187|540294653|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149773255|NCT01617187|540294654|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149773256|NCT01617187|540294655|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
149773257|NCT01617187|540294652|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
149773258|NCT01617187|540294653|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149773259|NCT01617187|540294654|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149773260|NCT01617187|540294655|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149773261|NCT01617187|540294652|FG000|Treatment Through Study Completion|Adverse Event|1|||
149773262|NCT01617187|540294653|FG001|Treatment Through Study Completion|Adverse Event|1|||
149773263|NCT01617187|540294654|FG002|Treatment Through Study Completion|Adverse Event|0|||
149773264|NCT01617187|540294655|FG003|Treatment Through Study Completion|Adverse Event|1|||
149773265|NCT01617187|540294652|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
149773266|NCT01617187|540294653|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
149773267|NCT01617187|540294654|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
149773268|NCT01617187|540294655|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
149773269|NCT01617187|540294652|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
149773270|NCT01617187|540294653|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
149773271|NCT01617187|540294654|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
149773272|NCT01617187|540294655|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
149773273|NCT01617187|540294652|FG000|Treatment Through Study Completion|Protocol Violation|1|||
149773274|NCT01617187|540294653|FG001|Treatment Through Study Completion|Protocol Violation|0|||
149773275|NCT01617187|540294654|FG002|Treatment Through Study Completion|Protocol Violation|0|||
149773276|NCT01617187|540294655|FG003|Treatment Through Study Completion|Protocol Violation|1|||
149773277|NCT01561560|540294665|FG000|First Two Weeks of Wear|Time/job conflict|0|||
149773278|NCT01561560|540294666|FG001|First Two Weeks of Wear|Time/job conflict|1|||
149773279|NCT01561560|540294665|FG000|First Two Weeks of Wear|Adverse Event|0|||
149773280|NCT01561560|540294666|FG001|First Two Weeks of Wear|Adverse Event|1|||
149773281|NCT01561560|540294665|FG000|Second Two Weeks of Wear|Adverse Event|0|||
149773282|NCT01561560|540294666|FG001|Second Two Weeks of Wear|Adverse Event|1|||
149773283|NCT05406440|540296949|FG000|Overall Study|Lost to Follow-up|0|||
149773284|NCT05406440|540296950|FG001|Overall Study|Lost to Follow-up|0|||
149773285|NCT05406440|540296951|FG002|Overall Study|Lost to Follow-up|0|||
149773286|NCT05406440|540296952|FG003|Overall Study|Lost to Follow-up|0|||
149773287|NCT05406440|540296953|FG004|Overall Study|Lost to Follow-up|2|||
149773288|NCT05406440|540296954|FG005|Overall Study|Lost to Follow-up|0|||
149773289|NCT05406440|540296955|FG006|Overall Study|Lost to Follow-up|0|||
149773290|NCT05406440|540296949|FG000|Overall Study|Physician Decision|0|||
149773291|NCT05406440|540296950|FG001|Overall Study|Physician Decision|0|||
149773292|NCT05406440|540296951|FG002|Overall Study|Physician Decision|0|||
149773293|NCT05406440|540296952|FG003|Overall Study|Physician Decision|0|||
149773294|NCT05406440|540296953|FG004|Overall Study|Physician Decision|1|||
149773295|NCT05406440|540296954|FG005|Overall Study|Physician Decision|0|||
149773296|NCT05406440|540296955|FG006|Overall Study|Physician Decision|0|||
149773297|NCT05406440|540296949|FG000|Overall Study|Withdrawal by Subject|0|||
149773298|NCT05406440|540296950|FG001|Overall Study|Withdrawal by Subject|0|||
149773299|NCT05406440|540296951|FG002|Overall Study|Withdrawal by Subject|0|||
149773300|NCT05406440|540296952|FG003|Overall Study|Withdrawal by Subject|0|||
149773301|NCT05406440|540296953|FG004|Overall Study|Withdrawal by Subject|0|||
149773302|NCT05406440|540296954|FG005|Overall Study|Withdrawal by Subject|2|||
149773303|NCT05406440|540296955|FG006|Overall Study|Withdrawal by Subject|0|||
149773304|NCT00859573|540296956|FG000|Overall Study|Withdrawal by Subject|4|||
149773305|NCT00859573|540296957|FG001|Overall Study|Withdrawal by Subject|1|||
149773306|NCT00859573|540296956|FG000|Overall Study|Physician Decision|1|||
149773307|NCT00859573|540296957|FG001|Overall Study|Physician Decision|1|||
149773308|NCT03488238|540296958|FG000|Overall Study|Equipment malfunction|1|||
149773309|NCT03488238|540296958|FG000|Overall Study|Adverse Event|1|||
149773310|NCT01316939|540296959|FG000|Overall Study|Study closed/terminated|26|||
149773311|NCT01316939|540296960|FG001|Overall Study|Study closed/terminated|25|||
149773312|NCT01316939|540296961|FG002|Overall Study|Study closed/terminated|23|||
149773313|NCT01316939|540296959|FG000|Overall Study|Lack of Efficacy|24|||
149773314|NCT01316939|540296960|FG001|Overall Study|Lack of Efficacy|25|||
149773315|NCT01316939|540296961|FG002|Overall Study|Lack of Efficacy|25|||
149773316|NCT01316939|540296959|FG000|Overall Study|Adverse Event|9|||
149773317|NCT01316939|540296960|FG001|Overall Study|Adverse Event|12|||
149773318|NCT01316939|540296961|FG002|Overall Study|Adverse Event|11|||
149773319|NCT01316939|540296959|FG000|Overall Study|Withdrawal by Subject|1|||
149773320|NCT01316939|540296960|FG001|Overall Study|Withdrawal by Subject|3|||
149773321|NCT01316939|540296961|FG002|Overall Study|Withdrawal by Subject|6|||
149773322|NCT01316939|540296959|FG000|Overall Study|Physician Decision|2|||
149773323|NCT01316939|540296960|FG001|Overall Study|Physician Decision|2|||
149773324|NCT01316939|540296961|FG002|Overall Study|Physician Decision|1|||
149773325|NCT01316939|540296959|FG000|Overall Study|Lost to Follow-up|0|||
149773326|NCT01316939|540296960|FG001|Overall Study|Lost to Follow-up|0|||
149773327|NCT01316939|540296961|FG002|Overall Study|Lost to Follow-up|2|||
149773328|NCT01316939|540296959|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
149773329|NCT01316939|540296960|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
149773330|NCT01316939|540296961|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
149773331|NCT01316939|540296959|FG000|Overall Study|Protocol Violation|0|||
149773332|NCT01316939|540296960|FG001|Overall Study|Protocol Violation|1|||
149773333|NCT01316939|540296961|FG002|Overall Study|Protocol Violation|0|||
149773334|NCT01432457|540296962|FG000|Overall Study|Adverse Event|7|||
149773335|NCT01432457|540296963|FG001|Overall Study|Adverse Event|10|||
149773336|NCT01432457|540296964|FG002|Overall Study|Adverse Event|16|||
149773337|NCT01432457|540296962|FG000|Overall Study|Lack of Efficacy|2|||
149773338|NCT01432457|540296963|FG001|Overall Study|Lack of Efficacy|1|||
149773339|NCT01432457|540296964|FG002|Overall Study|Lack of Efficacy|1|||
149773340|NCT01432457|540296962|FG000|Overall Study|Lost to Follow-up|11|||
149773341|NCT01432457|540296963|FG001|Overall Study|Lost to Follow-up|15|||
149773342|NCT01432457|540296964|FG002|Overall Study|Lost to Follow-up|20|||
149773343|NCT01432457|540296962|FG000|Overall Study|Protocol Violation|3|||
149773344|NCT01432457|540296963|FG001|Overall Study|Protocol Violation|2|||
149773345|NCT01432457|540296964|FG002|Overall Study|Protocol Violation|6|||
149773346|NCT01432457|540296962|FG000|Overall Study|Withdrawal by Subject|6|||
149773347|NCT01432457|540296963|FG001|Overall Study|Withdrawal by Subject|11|||
149773348|NCT01432457|540296964|FG002|Overall Study|Withdrawal by Subject|9|||
149773349|NCT01432457|540296962|FG000|Overall Study|Reasons not defined|2|||
149773350|NCT01432457|540296963|FG001|Overall Study|Reasons not defined|3|||
149773351|NCT01432457|540296964|FG002|Overall Study|Reasons not defined|4|||
149773352|NCT01432457|540296962|FG000|Overall Study|Did not take study drug|6|||
149773353|NCT01432457|540296963|FG001|Overall Study|Did not take study drug|6|||
149773354|NCT01432457|540296964|FG002|Overall Study|Did not take study drug|3|||
149773355|NCT04134728|540296965|FG000|Overall Study|Adverse Event|3|||
149773356|NCT04134728|540296966|FG001|Overall Study|Adverse Event|2|||
149773357|NCT04134728|540296967|FG002|Overall Study|Adverse Event|9|||
149773358|NCT04134728|540296968|FG003|Overall Study|Adverse Event|0|||
149773359|NCT04134728|540296969|FG004|Overall Study|Adverse Event|0|||
149773360|NCT04134728|540296970|FG005|Overall Study|Adverse Event|0|||
149773361|NCT04134728|540296965|FG000|Overall Study|Lack of Efficacy|3|||
149773362|NCT04134728|540296966|FG001|Overall Study|Lack of Efficacy|3|||
149773363|NCT04134728|540296967|FG002|Overall Study|Lack of Efficacy|1|||
149773364|NCT04134728|540296968|FG003|Overall Study|Lack of Efficacy|2|||
149773365|NCT04134728|540296969|FG004|Overall Study|Lack of Efficacy|0|||
149773366|NCT04134728|540296970|FG005|Overall Study|Lack of Efficacy|0|||
149773367|NCT04134728|540296965|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
149773368|NCT04134728|540296966|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149773369|NCT04134728|540296967|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
149773370|NCT04134728|540296968|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149773371|NCT04134728|540296969|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149773372|NCT04134728|540296970|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149773373|NCT04134728|540296965|FG000|Overall Study|Protocol Deviation|0|||
149773374|NCT04134728|540296966|FG001|Overall Study|Protocol Deviation|0|||
149773375|NCT04134728|540296967|FG002|Overall Study|Protocol Deviation|1|||
149773376|NCT04134728|540296968|FG003|Overall Study|Protocol Deviation|0|||
149773377|NCT04134728|540296969|FG004|Overall Study|Protocol Deviation|0|||
149773378|NCT04134728|540296970|FG005|Overall Study|Protocol Deviation|0|||
149773379|NCT04134728|540296965|FG000|Overall Study|Informed Consent Withdrawn|3|||
149773380|NCT04134728|540296966|FG001|Overall Study|Informed Consent Withdrawn|6|||
149773381|NCT04134728|540296967|FG002|Overall Study|Informed Consent Withdrawn|8|||
149773382|NCT04134728|540296968|FG003|Overall Study|Informed Consent Withdrawn|1|||
149773383|NCT04134728|540296969|FG004|Overall Study|Informed Consent Withdrawn|1|||
149773384|NCT04134728|540296970|FG005|Overall Study|Informed Consent Withdrawn|0|||
149773385|NCT04134728|540296965|FG000|Overall Study|Physician Decision|2|||
149773386|NCT04134728|540296966|FG001|Overall Study|Physician Decision|0|||
149773387|NCT04134728|540296967|FG002|Overall Study|Physician Decision|0|||
149773388|NCT04134728|540296968|FG003|Overall Study|Physician Decision|0|||
149773389|NCT04134728|540296969|FG004|Overall Study|Physician Decision|0|||
149773390|NCT04134728|540296970|FG005|Overall Study|Physician Decision|0|||
149773391|NCT04134728|540296965|FG000|Overall Study|Lost to Follow-up|1|||
149773392|NCT04134728|540296966|FG001|Overall Study|Lost to Follow-up|2|||
149773393|NCT04134728|540296967|FG002|Overall Study|Lost to Follow-up|1|||
149773394|NCT04134728|540296968|FG003|Overall Study|Lost to Follow-up|0|||
149773395|NCT04134728|540296969|FG004|Overall Study|Lost to Follow-up|0|||
149773396|NCT04134728|540296970|FG005|Overall Study|Lost to Follow-up|1|||
149773397|NCT04134728|540296965|FG000|Overall Study|Investigator Site Closed|0|||
149773398|NCT04134728|540296966|FG001|Overall Study|Investigator Site Closed|1|||
149773399|NCT04134728|540296967|FG002|Overall Study|Investigator Site Closed|1|||
149773400|NCT04134728|540296968|FG003|Overall Study|Investigator Site Closed|0|||
149773401|NCT04134728|540296969|FG004|Overall Study|Investigator Site Closed|0|||
149773402|NCT04134728|540296970|FG005|Overall Study|Investigator Site Closed|0|||
149773403|NCT01175590|540296976|FG000|Overall Study|Lost to Follow-up|1|||
149773404|NCT01175590|540296977|FG001|Overall Study|Lost to Follow-up|0|||
149773405|NCT01175590|540296976|FG000|Overall Study|Withdrawal by Subject|0|||
149773406|NCT01175590|540296977|FG001|Overall Study|Withdrawal by Subject|2|||
149773407|NCT01175590|540296976|FG000|Overall Study|Adverse Event|4|||
149773408|NCT01175590|540296977|FG001|Overall Study|Adverse Event|0|||
149773409|NCT01175590|540296976|FG000|Overall Study|Physician Decision|1|||
149773410|NCT01175590|540296977|FG001|Overall Study|Physician Decision|4|||
149773411|NCT01175590|540296976|FG000|Overall Study|Lack of Efficacy|1|||
149773412|NCT01175590|540296977|FG001|Overall Study|Lack of Efficacy|1|||
149773413|NCT01175590|540296976|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
149773414|NCT01175590|540296977|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
149773415|NCT01175590|540296976|FG000|Overall Study|Treated not as randomized|3|||
149773416|NCT01175590|540296977|FG001|Overall Study|Treated not as randomized|2|||
149773417|NCT01175590|540296976|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
149773418|NCT01175590|540296977|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
149773419|NCT01175590|540296976|FG000|Overall Study|Protocol Violation|0|||
149773420|NCT01175590|540296977|FG001|Overall Study|Protocol Violation|1|||
149773421|NCT01019252|540296978|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
149773422|NCT01019252|540296979|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
149773423|NCT01019252|540296978|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
149773424|NCT01019252|540296979|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
149773425|NCT01019252|540296978|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
149773426|NCT01019252|540296979|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
149773427|NCT01019252|540296978|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
149773428|NCT01019252|540296979|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
149773429|NCT01779648|540296980|FG000|Overall Study|Protocol Violation|1|||
149773430|NCT01779648|540296981|FG001|Overall Study|Protocol Violation|0|||
149773431|NCT02384395|540296982|FG000|Overall Study|Physician Decision|4|||
149773432|NCT02384395|540296982|FG000|Overall Study|Withdrawal by Subject|3|||
149773433|NCT02384395|540296982|FG000|Overall Study|Lost to Follow-up|3|||
149773434|NCT03351478|540296983|FG000|Overall Study|At the subject's own request|11|||
149773435|NCT03351478|540296984|FG001|Overall Study|At the subject's own request|12|||
149773436|NCT03351478|540296985|FG002|Overall Study|At the subject's own request|5|||
149773437|NCT03351478|540296983|FG000|Overall Study|Adverse Event|1|||
149773438|NCT03351478|540296984|FG001|Overall Study|Adverse Event|2|||
149773439|NCT03351478|540296985|FG002|Overall Study|Adverse Event|1|||
149773440|NCT03351478|540296983|FG000|Overall Study|Poor compliance to protocol|1|||
149773441|NCT03351478|540296984|FG001|Overall Study|Poor compliance to protocol|0|||
149773442|NCT03351478|540296985|FG002|Overall Study|Poor compliance to protocol|0|||
149773443|NCT03351478|540296983|FG000|Overall Study|Reason not Specified|1|||
149773444|NCT03351478|540296984|FG001|Overall Study|Reason not Specified|3|||
149773445|NCT03351478|540296985|FG002|Overall Study|Reason not Specified|0|||
149773446|NCT03351478|540296983|FG000|Overall Study|Lost to Follow-up|0|||
149773447|NCT03351478|540296984|FG001|Overall Study|Lost to Follow-up|0|||
149773448|NCT03351478|540296985|FG002|Overall Study|Lost to Follow-up|1|||
149773449|NCT03485222|540296992|FG000|Overall Study|Death|0|||
149773450|NCT03485222|540296993|FG001|Overall Study|Death|1|||
149773451|NCT03485222|540296992|FG000|Overall Study|Lost to Follow-up|2|||
149773452|NCT03485222|540296993|FG001|Overall Study|Lost to Follow-up|1|||
149773453|NCT03657810|540296994|FG000|Overall Study|Adverse Event|0|||
149773454|NCT03657810|540296995|FG001|Overall Study|Adverse Event|1|||
149773455|NCT03657810|540296996|FG002|Overall Study|Adverse Event|0|||
149773456|NCT03657810|540296994|FG000|Overall Study|Lack of Efficacy|4|||
149773457|NCT03657810|540296995|FG001|Overall Study|Lack of Efficacy|1|||
149773458|NCT03657810|540296996|FG002|Overall Study|Lack of Efficacy|3|||
149773459|NCT03657810|540296994|FG000|Overall Study|Protocol Violation|1|||
149773460|NCT03657810|540296995|FG001|Overall Study|Protocol Violation|0|||
149773461|NCT03657810|540296996|FG002|Overall Study|Protocol Violation|0|||
149773462|NCT03657810|540296994|FG000|Overall Study|Lost to Follow-up|0|||
149773463|NCT03657810|540296995|FG001|Overall Study|Lost to Follow-up|1|||
149773464|NCT03657810|540296996|FG002|Overall Study|Lost to Follow-up|0|||
149773465|NCT03657810|540296994|FG000|Overall Study|Not provided|0|||
149773466|NCT03657810|540296995|FG001|Overall Study|Not provided|1|||
149773467|NCT03657810|540296996|FG002|Overall Study|Not provided|0|||
149773468|NCT03911869|540296997|FG000|Safety Lead-in Phase|Death|7|||
149773469|NCT03911869|540296998|FG001|Safety Lead-in Phase|Death|0|||
149773470|NCT03911869|540296999|FG002|Safety Lead-in Phase|Death|0|||
149773471|NCT03911869|540296997|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
149773472|NCT03911869|540296998|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
149773473|NCT03911869|540296999|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
149773474|NCT03911869|540296997|FG000|Safety Lead-in Phase|Other|1|||
149773475|NCT03911869|540296998|FG001|Safety Lead-in Phase|Other|0|||
149773476|NCT03911869|540296999|FG002|Safety Lead-in Phase|Other|0|||
149773477|NCT03911869|540296997|FG000|Phase 2|Death|0|||
149773478|NCT03911869|540296998|FG001|Phase 2|Death|3|||
149773479|NCT03911869|540296999|FG002|Phase 2|Death|0|||
149773480|NCT00985738|540297002|FG000|Overall Study|Study closed prematurely|8|||
149773481|NCT00985738|540297003|FG001|Overall Study|Study closed prematurely|8|||
149773482|NCT00367341|540297004|FG000|Overall Study|Physician Decision|1|||
149773483|NCT00367341|540297005|FG001|Overall Study|Physician Decision|0|||
149773484|NCT00367341|540297004|FG000|Overall Study|Protocol Violation|1|||
149773485|NCT00367341|540297005|FG001|Overall Study|Protocol Violation|0|||
149773486|NCT03325556|540297006|FG000|Open-label Period|Lack of Response in OL period|70|||
149773487|NCT03325556|540297007|FG001|Open-label Period|Lack of Response in OL period|0|||
149773488|NCT03325556|540297008|FG002|Open-label Period|Lack of Response in OL period|0|||
149773489|NCT03325556|540297006|FG000|Open-label Period|Adverse Event|27|||
149773490|NCT03325556|540297007|FG001|Open-label Period|Adverse Event|0|||
149773491|NCT03325556|540297008|FG002|Open-label Period|Adverse Event|0|||
149773492|NCT03325556|540297006|FG000|Open-label Period|Death|1|||
149773493|NCT03325556|540297007|FG001|Open-label Period|Death|0|||
149773494|NCT03325556|540297008|FG002|Open-label Period|Death|0|||
149773495|NCT03325556|540297006|FG000|Open-label Period|Lost to Follow-up|1|||
149773496|NCT03325556|540297007|FG001|Open-label Period|Lost to Follow-up|0|||
149773497|NCT03325556|540297008|FG002|Open-label Period|Lost to Follow-up|0|||
149773498|NCT03325556|540297006|FG000|Open-label Period|Non-compliance with study drug|5|||
149773499|NCT03325556|540297007|FG001|Open-label Period|Non-compliance with study drug|0|||
149773500|NCT03325556|540297008|FG002|Open-label Period|Non-compliance with study drug|0|||
149773501|NCT03325556|540297006|FG000|Open-label Period|Use of prohibited medication|1|||
149773502|NCT03325556|540297007|FG001|Open-label Period|Use of prohibited medication|0|||
149773503|NCT03325556|540297008|FG002|Open-label Period|Use of prohibited medication|0|||
149773504|NCT03325556|540297006|FG000|Open-label Period|Protocol Violation|4|||
149773505|NCT03325556|540297007|FG001|Open-label Period|Protocol Violation|0|||
149773506|NCT03325556|540297008|FG002|Open-label Period|Protocol Violation|0|||
149773507|NCT03325556|540297006|FG000|Open-label Period|Withdrawal by Subject|17|||
149773508|NCT03325556|540297007|FG001|Open-label Period|Withdrawal by Subject|0|||
149773509|NCT03325556|540297008|FG002|Open-label Period|Withdrawal by Subject|0|||
149773510|NCT03325556|540297006|FG000|Open-label Period|Not otherwise specified|8|||
149773511|NCT03325556|540297007|FG001|Open-label Period|Not otherwise specified|0|||
149773512|NCT03325556|540297008|FG002|Open-label Period|Not otherwise specified|0|||
149773513|NCT03325556|540297006|FG000|Open-label Period|Administrative discont. at study termination|41|||
149773514|NCT03325556|540297007|FG001|Open-label Period|Administrative discont. at study termination|0|||
149773515|NCT03325556|540297008|FG002|Open-label Period|Administrative discont. at study termination|0|||
149773516|NCT03325556|540297006|FG000|Double-blind Period|Relapse|0|||
149773517|NCT03325556|540297007|FG001|Double-blind Period|Relapse|15|||
149773518|NCT03325556|540297008|FG002|Double-blind Period|Relapse|34|||
149773519|NCT03325556|540297006|FG000|Double-blind Period|Adverse Event|0|||
149773520|NCT03325556|540297007|FG001|Double-blind Period|Adverse Event|3|||
149773521|NCT03325556|540297008|FG002|Double-blind Period|Adverse Event|1|||
149773522|NCT03325556|540297006|FG000|Double-blind Period|Noncompliance with study drug|0|||
149773523|NCT03325556|540297007|FG001|Double-blind Period|Noncompliance with study drug|0|||
149773524|NCT03325556|540297008|FG002|Double-blind Period|Noncompliance with study drug|1|||
149773525|NCT03325556|540297006|FG000|Double-blind Period|Use of prohibited medication|0|||
149773526|NCT03325556|540297007|FG001|Double-blind Period|Use of prohibited medication|1|||
149773527|NCT03325556|540297008|FG002|Double-blind Period|Use of prohibited medication|0|||
149773528|NCT03325556|540297006|FG000|Double-blind Period|Physician Decision|0|||
149773529|NCT03325556|540297007|FG001|Double-blind Period|Physician Decision|0|||
149773530|NCT03325556|540297008|FG002|Double-blind Period|Physician Decision|1|||
149773531|NCT03325556|540297006|FG000|Double-blind Period|Withdrawal by Subject|0|||
149773532|NCT03325556|540297007|FG001|Double-blind Period|Withdrawal by Subject|6|||
149773533|NCT03325556|540297008|FG002|Double-blind Period|Withdrawal by Subject|4|||
149773534|NCT03325556|540297006|FG000|Double-blind Period|Not otherwise specified|0|||
149773535|NCT03325556|540297007|FG001|Double-blind Period|Not otherwise specified|1|||
149773536|NCT03325556|540297008|FG002|Double-blind Period|Not otherwise specified|5|||
149773537|NCT03325556|540297006|FG000|Double-blind Period|Administrative discont. at study termination|0|||
149773538|NCT03325556|540297007|FG001|Double-blind Period|Administrative discont. at study termination|35|||
149773539|NCT03325556|540297008|FG002|Double-blind Period|Administrative discont. at study termination|31|||
149773540|NCT01705587|540297009|FG000|Overall Study|Withdrawal by Subject|0|||
149773541|NCT01705587|540297010|FG001|Overall Study|Withdrawal by Subject|1|||
149773542|NCT02227849|540297011|FG000|Overall Study|Adverse Event|4|||
149773543|NCT02227849|540297011|FG000|Overall Study|Physician Decision|1|||
149773544|NCT02227849|540297011|FG000|Overall Study|Withdrawal by Subject|3|||
149773545|NCT02119026|540297012|FG000|1st-line Treatment|Adverse Event|9|||
149773546|NCT02119026|540297013|FG001|1st-line Treatment|Adverse Event|14|||
149773547|NCT02119026|540297012|FG000|1st-line Treatment|Physician Decision|3|||
149773548|NCT02119026|540297013|FG001|1st-line Treatment|Physician Decision|8|||
149773549|NCT02119026|540297012|FG000|1st-line Treatment|Withdrawal by Subject|4|||
149773550|NCT02119026|540297013|FG001|1st-line Treatment|Withdrawal by Subject|10|||
149773551|NCT02119026|540297012|FG000|1st-line Treatment|Patient condition or compliance|6|||
149773552|NCT02119026|540297013|FG001|1st-line Treatment|Patient condition or compliance|4|||
149773553|NCT02119026|540297012|FG000|1st-line Treatment|Surgery of metastases|2|||
149773554|NCT02119026|540297013|FG001|1st-line Treatment|Surgery of metastases|1|||
149773555|NCT02119026|540297012|FG000|1st-line Treatment|Death|2|||
149773556|NCT02119026|540297013|FG001|1st-line Treatment|Death|1|||
149773557|NCT02119026|540297012|FG000|2nd-line Treatment|Lost to Follow-up|2|||
149773558|NCT02119026|540297013|FG001|2nd-line Treatment|Lost to Follow-up|0|||
149773559|NCT02119026|540297012|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
149773560|NCT02119026|540297013|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
149773561|NCT02119026|540297012|FG000|2nd-line Treatment|Adverse Event|4|||
149773562|NCT02119026|540297013|FG001|2nd-line Treatment|Adverse Event|1|||
149773563|NCT01373918|540297016|FG000|Overall Study|Physician Decision|0|||
149773564|NCT01373918|540297017|FG001|Overall Study|Physician Decision|1|||
149773565|NCT00340834|540297018|FG000|Core Phase of Study|Adverse Event|26|||
149773566|NCT00340834|540297019|FG001|Core Phase of Study|Adverse Event|9|||
149773567|NCT00340834|540297020|FG002|Core Phase of Study|Adverse Event|9|||
149773568|NCT00340834|540297021|FG003|Core Phase of Study|Adverse Event|0|||
149773569|NCT00340834|540297022|FG004|Core Phase of Study|Adverse Event|0|||
149773570|NCT00340834|540297018|FG000|Core Phase of Study|Withdrawal by Subject|11|||
149773571|NCT00340834|540297019|FG001|Core Phase of Study|Withdrawal by Subject|9|||
149773572|NCT00340834|540297020|FG002|Core Phase of Study|Withdrawal by Subject|16|||
149773573|NCT00340834|540297021|FG003|Core Phase of Study|Withdrawal by Subject|0|||
149773574|NCT00340834|540297022|FG004|Core Phase of Study|Withdrawal by Subject|0|||
149773575|NCT00340834|540297018|FG000|Core Phase of Study|Administrative Problems|6|||
149773576|NCT00340834|540297019|FG001|Core Phase of Study|Administrative Problems|2|||
149773577|NCT00340834|540297020|FG002|Core Phase of Study|Administrative Problems|7|||
149773578|NCT00340834|540297021|FG003|Core Phase of Study|Administrative Problems|0|||
149773579|NCT00340834|540297022|FG004|Core Phase of Study|Administrative Problems|0|||
149773580|NCT00340834|540297018|FG000|Core Phase of Study|Lack of Efficacy|3|||
149773581|NCT00340834|540297019|FG001|Core Phase of Study|Lack of Efficacy|3|||
149773582|NCT00340834|540297020|FG002|Core Phase of Study|Lack of Efficacy|7|||
149773583|NCT00340834|540297021|FG003|Core Phase of Study|Lack of Efficacy|0|||
149773584|NCT00340834|540297022|FG004|Core Phase of Study|Lack of Efficacy|0|||
149773585|NCT00340834|540297018|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
149773586|NCT00340834|540297019|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
149773587|NCT00340834|540297020|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
149773588|NCT00340834|540297021|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
149773589|NCT00340834|540297022|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
149773590|NCT00340834|540297018|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
149773591|NCT00340834|540297019|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
149773592|NCT00340834|540297020|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
149773593|NCT00340834|540297021|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
149773594|NCT00340834|540297022|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
149773595|NCT00340834|540297018|FG000|Core Phase of Study|Lost to Follow-up|1|||
149773596|NCT00340834|540297019|FG001|Core Phase of Study|Lost to Follow-up|1|||
149773597|NCT00340834|540297020|FG002|Core Phase of Study|Lost to Follow-up|4|||
149773598|NCT00340834|540297021|FG003|Core Phase of Study|Lost to Follow-up|0|||
149773599|NCT00340834|540297022|FG004|Core Phase of Study|Lost to Follow-up|0|||
149773600|NCT00340834|540297018|FG000|Core Phase of Study|Death|2|||
149773601|NCT00340834|540297019|FG001|Core Phase of Study|Death|0|||
149773602|NCT00340834|540297020|FG002|Core Phase of Study|Death|0|||
149773603|NCT00340834|540297021|FG003|Core Phase of Study|Death|0|||
149773604|NCT00340834|540297022|FG004|Core Phase of Study|Death|0|||
149773605|NCT00340834|540297018|FG000|Core Phase of Study|Protocol Violation|0|||
149773606|NCT00340834|540297019|FG001|Core Phase of Study|Protocol Violation|0|||
149773607|NCT00340834|540297020|FG002|Core Phase of Study|Protocol Violation|2|||
149773608|NCT00340834|540297021|FG003|Core Phase of Study|Protocol Violation|0|||
149773609|NCT00340834|540297022|FG004|Core Phase of Study|Protocol Violation|0|||
149773610|NCT00340834|540297018|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
149773611|NCT00340834|540297019|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
149773612|NCT00340834|540297020|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
149773613|NCT00340834|540297021|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
149773614|NCT00340834|540297022|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
149773615|NCT00340834|540297018|FG000|Extension Phase of Study|Subject withdrew consent|26|||
149773616|NCT00340834|540297019|FG001|Extension Phase of Study|Subject withdrew consent|31|||
149773617|NCT00340834|540297020|FG002|Extension Phase of Study|Subject withdrew consent|0|||
149773618|NCT00340834|540297021|FG003|Extension Phase of Study|Subject withdrew consent|12|||
149773619|NCT00340834|540297022|FG004|Extension Phase of Study|Subject withdrew consent|15|||
149773620|NCT00340834|540297018|FG000|Extension Phase of Study|Adverse Event|21|||
149773621|NCT00340834|540297019|FG001|Extension Phase of Study|Adverse Event|22|||
149773622|NCT00340834|540297020|FG002|Extension Phase of Study|Adverse Event|0|||
149773623|NCT00340834|540297021|FG003|Extension Phase of Study|Adverse Event|19|||
149773624|NCT00340834|540297022|FG004|Extension Phase of Study|Adverse Event|7|||
149773625|NCT00340834|540297018|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
149773626|NCT00340834|540297019|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
149773627|NCT00340834|540297020|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
149773628|NCT00340834|540297021|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
149773629|NCT00340834|540297022|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
149773630|NCT00340834|540297018|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
149773631|NCT00340834|540297019|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
149773632|NCT00340834|540297020|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
149773633|NCT00340834|540297021|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
149773634|NCT00340834|540297022|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
149773635|NCT00340834|540297018|FG000|Extension Phase of Study|Lost to Follow-up|1|||
149773636|NCT00340834|540297019|FG001|Extension Phase of Study|Lost to Follow-up|1|||
149773637|NCT00340834|540297020|FG002|Extension Phase of Study|Lost to Follow-up|0|||
149773638|NCT00340834|540297021|FG003|Extension Phase of Study|Lost to Follow-up|2|||
149773639|NCT00340834|540297022|FG004|Extension Phase of Study|Lost to Follow-up|3|||
149773640|NCT00340834|540297018|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
149773641|NCT00340834|540297019|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
149773642|NCT00340834|540297020|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
149773643|NCT00340834|540297021|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
149773644|NCT00340834|540297022|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
149773645|NCT00340834|540297018|FG000|Extension Phase of Study|Administrative problems|3|||
149773646|NCT00340834|540297019|FG001|Extension Phase of Study|Administrative problems|0|||
149773647|NCT00340834|540297020|FG002|Extension Phase of Study|Administrative problems|0|||
149773648|NCT00340834|540297021|FG003|Extension Phase of Study|Administrative problems|1|||
149773649|NCT00340834|540297022|FG004|Extension Phase of Study|Administrative problems|1|||
149773650|NCT00340834|540297018|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
149773651|NCT00340834|540297019|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
149773652|NCT00340834|540297020|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
149773653|NCT00340834|540297021|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
149773654|NCT00340834|540297022|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
149773655|NCT00340834|540297018|FG000|Extension Phase of Study|Protocol Violation|3|||
149773656|NCT00340834|540297019|FG001|Extension Phase of Study|Protocol Violation|0|||
149773657|NCT00340834|540297020|FG002|Extension Phase of Study|Protocol Violation|0|||
149773658|NCT00340834|540297021|FG003|Extension Phase of Study|Protocol Violation|0|||
149773659|NCT00340834|540297022|FG004|Extension Phase of Study|Protocol Violation|0|||
149773660|NCT00340834|540297018|FG000|Extension Phase of Study|Death|0|||
149773661|NCT00340834|540297019|FG001|Extension Phase of Study|Death|0|||
149773662|NCT00340834|540297020|FG002|Extension Phase of Study|Death|0|||
149773663|NCT00340834|540297021|FG003|Extension Phase of Study|Death|0|||
149773664|NCT00340834|540297022|FG004|Extension Phase of Study|Death|1|||
149773665|NCT00762268|540297023|FG000|Overall Study|Withdrawal by Subject|3|||
149773666|NCT00762268|540297024|FG001|Overall Study|Withdrawal by Subject|3|||
149773667|NCT00291499|540297025|FG000|Overall Study|Adverse Event|3|||
149773668|NCT00291499|540297026|FG001|Overall Study|Adverse Event|8|||
149773669|NCT00291499|540297025|FG000|Overall Study|Change to other therapy|2|||
149773670|NCT00291499|540297026|FG001|Overall Study|Change to other therapy|1|||
149773671|NCT00291499|540297025|FG000|Overall Study|Intercurrent illness|1|||
149773672|NCT00291499|540297026|FG001|Overall Study|Intercurrent illness|0|||
149773673|NCT00291499|540297025|FG000|Overall Study|Protocol Violation|2|||
149773674|NCT00291499|540297026|FG001|Overall Study|Protocol Violation|2|||
149773675|NCT00291499|540297025|FG000|Overall Study|Other reasons|1|||
149773676|NCT00291499|540297026|FG001|Overall Study|Other reasons|4|||
149773677|NCT04897594|540297031|FG000|Overall Study|Lost to Follow-up|0|||
149773678|NCT04897594|540297032|FG001|Overall Study|Lost to Follow-up|1|||
149773679|NCT04897594|540297033|FG002|Overall Study|Lost to Follow-up|1|||
149773680|NCT04897594|540297031|FG000|Overall Study|Sponsor Decision|0|||
149773681|NCT04897594|540297032|FG001|Overall Study|Sponsor Decision|0|||
149773682|NCT04897594|540297033|FG002|Overall Study|Sponsor Decision|1|||
149773683|NCT04897594|540297031|FG000|Overall Study|Withdrawal by Subject|1|||
149773684|NCT04897594|540297032|FG001|Overall Study|Withdrawal by Subject|0|||
149773685|NCT04897594|540297033|FG002|Overall Study|Withdrawal by Subject|1|||
149773686|NCT01387074|540297034|FG000|Overall Study|Lost to Follow-up|7|||
149773687|NCT01387074|540297034|FG000|Overall Study|Lack of Efficacy|1|||
149773688|NCT01532570|540297048|FG000|Overall Study|Lack of Efficacy|1|||
149773689|NCT01532570|540297049|FG001|Overall Study|Lack of Efficacy|0|||
149773690|NCT01532570|540297050|FG002|Overall Study|Lack of Efficacy|0|||
149773691|NCT01532570|540297051|FG003|Overall Study|Lack of Efficacy|0|||
149773692|NCT01532570|540297048|FG000|Overall Study|Withdrawal by Subject|0|||
149773693|NCT01532570|540297049|FG001|Overall Study|Withdrawal by Subject|1|||
149773694|NCT01532570|540297050|FG002|Overall Study|Withdrawal by Subject|0|||
149773695|NCT01532570|540297051|FG003|Overall Study|Withdrawal by Subject|0|||
149773696|NCT03892707|540297052|FG000|Overall Study|Screen failure|6|||
149773697|NCT03892707|540297053|FG001|Overall Study|Screen failure|0|||
149773698|NCT03892707|540297052|FG000|Overall Study|Pain resolution|0|||
149773699|NCT03892707|540297053|FG001|Overall Study|Pain resolution|4|||
149773700|NCT03892707|540297052|FG000|Overall Study|Withdrawal by Subject|0|||
149773701|NCT03892707|540297053|FG001|Overall Study|Withdrawal by Subject|1|||
149773702|NCT03892707|540297052|FG000|Overall Study|Other (long business trip)|0|||
149773703|NCT03892707|540297053|FG001|Overall Study|Other (long business trip)|1|||
149773704|NCT04190186|540297055|FG000|Overall Study|ILR is no longer functioning|0|||
149773705|NCT04190186|540297056|FG001|Overall Study|ILR is no longer functioning|1|||
149773706|NCT04190186|540297055|FG000|Overall Study|Lost to Follow-up|0|||
149773707|NCT04190186|540297056|FG001|Overall Study|Lost to Follow-up|1|||
149773708|NCT04190186|540297055|FG000|Overall Study|Withdrawal by Subject|2|||
149773709|NCT04190186|540297056|FG001|Overall Study|Withdrawal by Subject|0|||
149773710|NCT04190186|540297055|FG000|Overall Study|Subject choice to explant|1|||
149773711|NCT04190186|540297056|FG001|Overall Study|Subject choice to explant|0|||
149773712|NCT04190186|540297055|FG000|Overall Study|Physician Decision|0|||
149773713|NCT04190186|540297056|FG001|Overall Study|Physician Decision|1|||
149773714|NCT04190186|540297055|FG000|Overall Study|Study was stopped|4|||
149773715|NCT04190186|540297056|FG001|Overall Study|Study was stopped|5|||
149773716|NCT02141217|540297057|FG000|Overall Study|Adverse Event|1|||
149773717|NCT02141217|540297058|FG001|Overall Study|Adverse Event|2|||
149773718|NCT02141217|540297057|FG000|Overall Study|Protocol Violation|1|||
149773719|NCT02141217|540297058|FG001|Overall Study|Protocol Violation|4|||
149773720|NCT02141217|540297057|FG000|Overall Study|Withdrawal by Subject|6|||
149773721|NCT02141217|540297058|FG001|Overall Study|Withdrawal by Subject|0|||
149773722|NCT02141217|540297057|FG000|Overall Study|Lost to Follow-up|1|||
149773723|NCT02141217|540297058|FG001|Overall Study|Lost to Follow-up|1|||
149773724|NCT02141217|540297057|FG000|Overall Study|Physician Decision|1|||
149773725|NCT02141217|540297058|FG001|Overall Study|Physician Decision|0|||
149773726|NCT02141217|540297057|FG000|Overall Study|Surgical Intervention|1|||
149773727|NCT02141217|540297058|FG001|Overall Study|Surgical Intervention|1|||
149773728|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
149773729|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
149773730|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
149773731|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
149773732|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
149773733|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149773734|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149773735|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149773736|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149773737|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
149773738|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
149773739|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149773740|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149773741|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149773742|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149773743|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
149773744|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149773745|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
149773746|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149773747|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149773748|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149773749|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149773750|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149773751|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
149773752|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
149773753|NCT01457924|540297061|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
149773754|NCT01457924|540297062|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
149773755|NCT01457924|540297063|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
149773756|NCT01457924|540297064|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
149773757|NCT01457924|540297065|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
149773758|NCT01457924|540297061|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
149773759|NCT01457924|540297062|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
149773760|NCT01457924|540297063|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
149773761|NCT01457924|540297064|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
149773762|NCT01457924|540297065|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
149773763|NCT01457924|540297061|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
149773764|NCT01457924|540297062|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
149773765|NCT01457924|540297063|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
149773766|NCT01457924|540297064|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
149773767|NCT01457924|540297065|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
149773768|NCT01457924|540297061|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149773769|NCT01457924|540297062|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149773770|NCT01457924|540297063|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149773771|NCT01457924|540297064|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
149773772|NCT01457924|540297065|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149773773|NCT01457924|540297061|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
149773774|NCT01457924|540297062|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
149773775|NCT01457924|540297063|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
149773776|NCT01457924|540297064|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
149773777|NCT01457924|540297065|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
149773778|NCT01457924|540297061|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
149773779|NCT01457924|540297062|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149773780|NCT01457924|540297063|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
149773781|NCT01457924|540297064|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149773782|NCT01457924|540297065|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149773783|NCT01457924|540297061|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
149773784|NCT01457924|540297062|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
149773785|NCT01457924|540297063|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
149773786|NCT01457924|540297064|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
149773787|NCT01457924|540297065|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
149773788|NCT01457924|540297061|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149773789|NCT01457924|540297062|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
149773790|NCT01457924|540297063|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149773791|NCT01457924|540297064|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
149773792|NCT01457924|540297065|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149773793|NCT01665768|540297066|FG000|Overall Study|Adverse Event|3|||
149773794|NCT01665768|540297066|FG000|Overall Study|Lack of Efficacy|19|||
149773795|NCT01665768|540297066|FG000|Overall Study|Withdrawal by Subject|1|||
149773796|NCT01329341|540297067|FG000|Overall Study|Withdrawal by Subject|44|||
149773797|NCT00448760|540297068|FG000|Overall Study|Death|3|||
149773798|NCT03017846|540297071|FG000|Overall Study|Lost to Follow-up|3|||
149773799|NCT03017846|540297071|FG000|Overall Study|Adverse Event|2|||
149773800|NCT04603391|540297072|FG000|First Intervention (4 Days)|Adverse Event|1|||
149773801|NCT04603391|540297073|FG001|First Intervention (4 Days)|Adverse Event|0|||
149773802|NCT04603391|540297072|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
149773803|NCT04603391|540297073|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
149773804|NCT05067452|540297077|FG000|Overall Study|Lost to Follow-up|0|||
149773805|NCT05067452|540297078|FG001|Overall Study|Lost to Follow-up|4|||
149773806|NCT00067470|540297079|FG000|Overall Study|Withdrawal by Subject|0|||
149773807|NCT00067470|540297080|FG001|Overall Study|Withdrawal by Subject|1|||
149773808|NCT01135017|540297081|FG000|Overall Study|Adverse Event|3|||
149773809|NCT01135017|540297082|FG001|Overall Study|Adverse Event|8|||
149773810|NCT01135017|540297081|FG000|Overall Study|Other than above|3|||
149773811|NCT01135017|540297082|FG001|Overall Study|Other than above|4|||
149773812|NCT00050622|540297084|FG000|Overall Study|Adverse Event|1|||
149773813|NCT00936117|540297087|FG000|Overall Study|Adverse Event|7|||
149773814|NCT00936117|540297087|FG000|Overall Study|Unable to continue oral medication|3|||
149773815|NCT01803711|540297088|FG000|Overall Study|Adverse Event|1|||
149773816|NCT01803711|540297089|FG001|Overall Study|Adverse Event|1|||
149773817|NCT02693691|540297090|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
149773818|NCT02693691|540297090|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
149773819|NCT02693691|540297090|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
149773820|NCT02693691|540297090|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
149773821|NCT02693691|540297090|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
149773822|NCT02693691|540297090|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
149773823|NCT02693691|540297090|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
149773824|NCT02727660|540297091|FG000|Overall Study|Lack of Efficacy|40|||
149773825|NCT02727660|540297092|FG001|Overall Study|Lack of Efficacy|40|||
149773826|NCT02727660|540297093|FG002|Overall Study|Lack of Efficacy|70|||
149773827|NCT02727660|540297091|FG000|Overall Study|Adverse Event|28|||
149773828|NCT02727660|540297092|FG001|Overall Study|Adverse Event|21|||
149773829|NCT02727660|540297093|FG002|Overall Study|Adverse Event|32|||
149773830|NCT02727660|540297091|FG000|Overall Study|Withdrawal by Subject|26|||
149773831|NCT02727660|540297092|FG001|Overall Study|Withdrawal by Subject|25|||
149773832|NCT02727660|540297093|FG002|Overall Study|Withdrawal by Subject|30|||
149773833|NCT02727660|540297091|FG000|Overall Study|Physician Decision|3|||
149773834|NCT02727660|540297092|FG001|Overall Study|Physician Decision|8|||
149773835|NCT02727660|540297093|FG002|Overall Study|Physician Decision|14|||
149773836|NCT02727660|540297091|FG000|Overall Study|Lost to Follow-up|5|||
149773837|NCT02727660|540297092|FG001|Overall Study|Lost to Follow-up|9|||
149773838|NCT02727660|540297093|FG002|Overall Study|Lost to Follow-up|8|||
149773839|NCT02727660|540297091|FG000|Overall Study|Protocol Violation|7|||
149773840|NCT02727660|540297092|FG001|Overall Study|Protocol Violation|5|||
149773841|NCT02727660|540297093|FG002|Overall Study|Protocol Violation|5|||
149773842|NCT02727660|540297091|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
149773843|NCT02727660|540297092|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
149773844|NCT02727660|540297093|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
149773845|NCT02727660|540297091|FG000|Overall Study|Administrative Reasons|2|||
149773846|NCT02727660|540297092|FG001|Overall Study|Administrative Reasons|3|||
149773847|NCT02727660|540297093|FG002|Overall Study|Administrative Reasons|4|||
149773848|NCT01192204|540297097|FG000|Overall Study|could not keep recall appointments|1|||
149773849|NCT01192204|540297098|FG001|Overall Study|could not keep recall appointments|0|||
149773850|NCT03454412|540297099|FG000|Baseline Assesment|Physician Decision|12|||
149773851|NCT01167582|540297100|FG000|Overall Study|Lost to Follow-up|0|||
149773852|NCT01167582|540297101|FG001|Overall Study|Lost to Follow-up|1|||
149773853|NCT01928485|540297102|FG000|Overall Study|Physician Decision|0|||
149773854|NCT01928485|540297103|FG001|Overall Study|Physician Decision|1|||
149773855|NCT00039741|540297104|FG000|Overall Study|Death|0|||
149773856|NCT00039741|540297105|FG001|Overall Study|Death|1|||
149773857|NCT00039741|540297106|FG002|Overall Study|Death|0|||
149773858|NCT00039741|540297107|FG003|Overall Study|Death|0|||
149773859|NCT00039741|540297104|FG000|Overall Study|Lost to Follow-up|3|||
149773860|NCT00039741|540297105|FG001|Overall Study|Lost to Follow-up|1|||
149773861|NCT00039741|540297106|FG002|Overall Study|Lost to Follow-up|5|||
149773862|NCT00039741|540297107|FG003|Overall Study|Lost to Follow-up|2|||
149773863|NCT00039741|540297104|FG000|Overall Study|Confounding medical condition|1|||
149773864|NCT00039741|540297105|FG001|Overall Study|Confounding medical condition|0|||
149773865|NCT00039741|540297106|FG002|Overall Study|Confounding medical condition|0|||
149773866|NCT00039741|540297107|FG003|Overall Study|Confounding medical condition|0|||
149773867|NCT00039741|540297104|FG000|Overall Study|Not able to get to clinic|5|||
149773868|NCT00039741|540297105|FG001|Overall Study|Not able to get to clinic|2|||
149773869|NCT00039741|540297106|FG002|Overall Study|Not able to get to clinic|0|||
149773870|NCT00039741|540297107|FG003|Overall Study|Not able to get to clinic|3|||
149773871|NCT00039741|540297104|FG000|Overall Study|Moved|3|||
149773872|NCT00039741|540297105|FG001|Overall Study|Moved|2|||
149773873|NCT00039741|540297106|FG002|Overall Study|Moved|3|||
149773874|NCT00039741|540297107|FG003|Overall Study|Moved|6|||
149773875|NCT00039741|540297104|FG000|Overall Study|Non-compliance with protocol|1|||
149773876|NCT00039741|540297105|FG001|Overall Study|Non-compliance with protocol|0|||
149773877|NCT00039741|540297106|FG002|Overall Study|Non-compliance with protocol|1|||
149773878|NCT00039741|540297107|FG003|Overall Study|Non-compliance with protocol|0|||
149773879|NCT00039741|540297104|FG000|Overall Study|Withdrew consent|0|||
149773880|NCT00039741|540297105|FG001|Overall Study|Withdrew consent|5|||
149773881|NCT00039741|540297106|FG002|Overall Study|Withdrew consent|0|||
149773882|NCT00039741|540297107|FG003|Overall Study|Withdrew consent|1|||
149773883|NCT00039741|540297104|FG000|Overall Study|Missed final visit|2|||
149773884|NCT00039741|540297105|FG001|Overall Study|Missed final visit|1|||
149773885|NCT00039741|540297106|FG002|Overall Study|Missed final visit|2|||
149773886|NCT00039741|540297107|FG003|Overall Study|Missed final visit|2|||
149773887|NCT00946881|540297108|FG000|First Treatment|Withdrawal by Subject|1|||
149773888|NCT00946881|540297108|FG000|First Treatment|Patient relocated to another state|1|||
149773889|NCT00946881|540297108|FG000|Retreatment|Withdrawal by Subject|1|||
149773890|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
149773891|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
149773892|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
149773893|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
149773894|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
149773895|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
149773896|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
149773897|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
149773898|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
149773899|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
149773900|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
149773901|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
149773902|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149773903|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
149773904|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149773905|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149773906|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
149773907|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
149773908|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
149773909|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
149773910|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
149773911|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
149773912|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
149773913|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
149773914|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
149773915|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
149773916|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
149773917|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
149773918|NCT00476996|540297114|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
149773919|NCT00476996|540297115|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
149773920|NCT00476996|540297116|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
149773921|NCT00476996|540297117|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
149773922|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149773923|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149773924|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149773925|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
149773926|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
149773927|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
149773928|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
149773929|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
149773930|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Death|0|||
149773931|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Death|0|||
149773932|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Death|0|||
149773933|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Death|7|||
149773934|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149773935|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149773936|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149773937|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
149773938|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149773939|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149773940|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149773941|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
149773942|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149773943|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149773944|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149773945|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
149773946|NCT00476996|540297114|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
149773947|NCT00476996|540297115|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
149773948|NCT00476996|540297116|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
149773949|NCT00476996|540297117|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
149773950|NCT01769469|540297122|FG000|Overall Study|Consent Withdrawn|5|||
149773951|NCT01769469|540297122|FG000|Overall Study|Moved Out Of Area|3|||
149773952|NCT01769469|540297122|FG000|Overall Study|Lost to Follow-up|17|||
149773953|NCT01769469|540297122|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
149773954|NCT01769469|540297122|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
149773955|NCT02726113|540297128|FG000|Total Enrollment|Physician Decision|0|||
149773956|NCT02726113|540297129|FG001|Total Enrollment|Physician Decision|1|||
149773957|NCT02726113|540297128|FG000|Total Enrollment|Protocol Violation|1|||
149773958|NCT02726113|540297129|FG001|Total Enrollment|Protocol Violation|0|||
149773959|NCT02726113|540297128|FG000|Total Enrollment|Withdrawal by Subject|2|||
149773960|NCT02726113|540297129|FG001|Total Enrollment|Withdrawal by Subject|1|||
149773961|NCT02726113|540297128|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
149773962|NCT02726113|540297129|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
149773963|NCT02726113|540297128|FG000|Genomic Analysis|Protocol Violation|1|||
149773964|NCT02726113|540297129|FG001|Genomic Analysis|Protocol Violation|0|||
149773965|NCT02726113|540297128|FG000|Genomic Analysis|Withdrawal by Subject|2|||
149773966|NCT02726113|540297129|FG001|Genomic Analysis|Withdrawal by Subject|1|||
149773967|NCT02726113|540297128|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
149773968|NCT02726113|540297129|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
149773969|NCT01770145|540298999|FG000|Baseline|Adverse Event|20|||
149773970|NCT01770145|540298999|FG000|Baseline|Withdrawal by Subject|1|||
149773971|NCT01770145|540298999|FG000|Baseline|Lost to Follow-up|1|||
149773972|NCT01770145|540298999|FG000|Baseline|Unable to define optimal dose|4|||
149773973|NCT01770145|540298999|FG000|Treatment|Adverse Event|3|||
149773974|NCT01770145|540298999|FG000|Treatment|Withdrawal by Subject|1|||
149773975|NCT02759861|540299001|FG000|Overall Study|Death|1|||
149773976|NCT02151682|540299002|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149773977|NCT02151682|540299003|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
149773978|NCT02151682|540299004|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149773979|NCT02151682|540299005|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149773980|NCT02151682|540299006|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149773981|NCT02151682|540299007|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149773982|NCT02151682|540299002|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149773983|NCT02151682|540299003|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
149773984|NCT02151682|540299004|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149773985|NCT02151682|540299005|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149773986|NCT02151682|540299006|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149773987|NCT02151682|540299007|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149773988|NCT02151682|540299002|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149773989|NCT02151682|540299003|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
149773990|NCT02151682|540299004|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149773991|NCT02151682|540299005|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149773992|NCT02151682|540299006|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149773993|NCT02151682|540299007|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149773994|NCT02151682|540299002|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
149773995|NCT02151682|540299003|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
149773996|NCT02151682|540299004|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149773997|NCT02151682|540299005|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149773998|NCT02151682|540299006|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149773999|NCT02151682|540299007|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149774000|NCT02151682|540299002|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
149774001|NCT02151682|540299003|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149774002|NCT02151682|540299004|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149774003|NCT02151682|540299005|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149774004|NCT02151682|540299006|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149774005|NCT02151682|540299007|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149774006|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149774007|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149774008|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
149774009|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149774010|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149774011|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149774012|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
149774013|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
149774014|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
149774015|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
149774016|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
149774017|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
149774018|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149774019|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149774020|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
149774021|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
149774022|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149774023|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149774024|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149774025|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149774026|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
149774027|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149774028|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149774029|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149774030|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149774031|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149774032|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
149774033|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149774034|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149774035|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149774036|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149774037|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149774038|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
149774039|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149774040|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149774041|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149774042|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
149774043|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
149774044|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
149774045|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
149774046|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
149774047|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
149774048|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
149774049|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
149774050|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
149774051|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
149774052|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
149774053|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
149774054|NCT02151682|540299002|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149774055|NCT02151682|540299003|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149774056|NCT02151682|540299004|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
149774057|NCT02151682|540299005|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149774058|NCT02151682|540299006|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149774059|NCT02151682|540299007|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149774060|NCT02151682|540299002|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149774061|NCT02151682|540299003|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149774062|NCT02151682|540299004|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149774063|NCT02151682|540299005|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149774064|NCT02151682|540299006|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149774065|NCT02151682|540299007|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
149774066|NCT02151682|540299002|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149774067|NCT02151682|540299003|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149774068|NCT02151682|540299004|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149774069|NCT02151682|540299005|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149774070|NCT02151682|540299006|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149774071|NCT02151682|540299007|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
149774072|NCT02151682|540299002|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149774073|NCT02151682|540299003|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149774074|NCT02151682|540299004|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149774075|NCT02151682|540299005|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149774076|NCT02151682|540299006|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149774077|NCT02151682|540299007|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
149774078|NCT02151682|540299002|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149774079|NCT02151682|540299003|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149774080|NCT02151682|540299004|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149774081|NCT02151682|540299005|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149774082|NCT02151682|540299006|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149774083|NCT02151682|540299007|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
149774084|NCT00618995|540299008|FG000|Period 1|Adverse Event|0|||
149774085|NCT00618995|540299009|FG001|Period 1|Adverse Event|0|||
149774086|NCT00618995|540299010|FG002|Period 1|Adverse Event|1|||
149774087|NCT00618995|540299011|FG003|Period 1|Adverse Event|0|||
149774088|NCT00618995|540299008|FG000|Period 1|Protocol Violation|0|||
149774089|NCT00618995|540299009|FG001|Period 1|Protocol Violation|1|||
149774090|NCT00618995|540299010|FG002|Period 1|Protocol Violation|1|||
149774091|NCT00618995|540299011|FG003|Period 1|Protocol Violation|0|||
149774092|NCT00618995|540299008|FG000|Period 2|Protocol Violation|0|||
149774093|NCT00618995|540299009|FG001|Period 2|Protocol Violation|0|||
149774094|NCT00618995|540299010|FG002|Period 2|Protocol Violation|1|||
149774095|NCT00618995|540299011|FG003|Period 2|Protocol Violation|0|||
149774096|NCT00618995|540299008|FG000|Period 4|Adverse Event|1|||
149774097|NCT00618995|540299009|FG001|Period 4|Adverse Event|0|||
149774098|NCT00618995|540299010|FG002|Period 4|Adverse Event|0|||
149774099|NCT00618995|540299011|FG003|Period 4|Adverse Event|0|||
149774100|NCT02988219|540299012|FG000|Overall Study|Lack of Efficacy|1|||
149774101|NCT02988219|540299013|FG001|Overall Study|Lack of Efficacy|1|||
149774102|NCT02988219|540299012|FG000|Overall Study|Withdrawal by Subject|0|||
149774103|NCT02988219|540299013|FG001|Overall Study|Withdrawal by Subject|2|||
149774104|NCT01213264|540299014|FG000|Overall Study|Adverse Event|1|||
149774105|NCT01213264|540299015|FG001|Overall Study|Adverse Event|0|||
149774106|NCT01213264|540299016|FG002|Overall Study|Adverse Event|0|||
149774107|NCT01213264|540299014|FG000|Overall Study|Lost to Follow-up|1|||
149774108|NCT01213264|540299015|FG001|Overall Study|Lost to Follow-up|2|||
149774109|NCT01213264|540299016|FG002|Overall Study|Lost to Follow-up|6|||
149774110|NCT01522443|540299018|FG000|Overall Study|No longer receiving clinical benefit|36|||
149774111|NCT01522443|540299019|FG001|Overall Study|No longer receiving clinical benefit|28|||
149774112|NCT01522443|540299018|FG000|Overall Study|Adverse Event|10|||
149774113|NCT01522443|540299019|FG001|Overall Study|Adverse Event|15|||
149774114|NCT01522443|540299018|FG000|Overall Study|Withdrawal by Subject|5|||
149774115|NCT01522443|540299019|FG001|Overall Study|Withdrawal by Subject|8|||
149774116|NCT01522443|540299018|FG000|Overall Study|No study treatment given|1|||
149774117|NCT01522443|540299019|FG001|Overall Study|No study treatment given|1|||
149774118|NCT01522443|540299018|FG000|Overall Study|Other|1|||
149774119|NCT01522443|540299019|FG001|Overall Study|Other|3|||
149774120|NCT03260894|540299020|FG000|Overall Study|Death|6|||
149774121|NCT03260894|540299021|FG001|Overall Study|Death|8|||
149774122|NCT03260894|540299020|FG000|Overall Study|Withdrawal by Subject|4|||
149774123|NCT03260894|540299021|FG001|Overall Study|Withdrawal by Subject|11|||
149774124|NCT03260894|540299020|FG000|Overall Study|On-going at clinical cut off date|36|||
149774125|NCT03260894|540299021|FG001|Overall Study|On-going at clinical cut off date|31|||
149774126|NCT00290589|540299023|FG000|Overall Study|Lost to Follow-up|2|||
149774127|NCT00290589|540299024|FG001|Overall Study|Lost to Follow-up|2|||
149774128|NCT05014542|540299025|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
149774129|NCT05014542|540299026|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
149774130|NCT05014542|540299025|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
149774131|NCT05014542|540299026|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
149774132|NCT05014542|540299025|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
149774133|NCT05014542|540299026|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
149774134|NCT05014542|540299025|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
149774135|NCT05014542|540299026|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
149774136|NCT01438307|540299027|FG000|Overall Study|Death|1|||
149774137|NCT01438307|540299028|FG001|Overall Study|Death|1|||
149774138|NCT02378883|540299029|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
149774139|NCT02378883|540299029|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
149774140|NCT02378883|540299029|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
149774141|NCT02378883|540299029|FG000|30 Day Follow-Up|Physician Decision|2|||
149774142|NCT02378883|540299029|FG000|30 Day Follow-Up|Missed Visit|2|||
149774143|NCT02378883|540299029|FG000|30 Day Follow-Up|Death|1|||
149774144|NCT02378883|540299029|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
149774145|NCT02378883|540299029|FG000|12 Months Follow-Up|Death|2|||
149774146|NCT00318565|540299030|FG000|Overall Study|Excluded per protocol|24|||
149774147|NCT00691093|540299031|FG000|Overall Study|Adverse Event|1|||
149774148|NCT00691093|540299031|FG000|Overall Study|Lost to Follow-up|1|||
149774149|NCT00691093|540299031|FG000|Overall Study|Lack of Efficacy|1|||
149774150|NCT00691093|540299031|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
149774151|NCT00493467|540299032|FG000|Overall Study|Death|1|||
149774152|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
149774153|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
149774154|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
149774155|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
149774156|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
149774157|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
149774158|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
149774159|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
149774160|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
149774161|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
149774162|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
149774163|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
149774164|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
149774165|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
149774166|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
149774167|NCT03814005|540299034|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
149774168|NCT03814005|540299035|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
149774169|NCT03814005|540299036|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
149774170|NCT00810810|540299037|FG000|Overall Study|Withdrawal by Subject|0|||
149774171|NCT00810810|540299038|FG001|Overall Study|Withdrawal by Subject|8|||
149774172|NCT00810810|540299039|FG002|Overall Study|Withdrawal by Subject|10|||
149774173|NCT00810810|540299040|FG003|Overall Study|Withdrawal by Subject|8|||
149774174|NCT00810810|540299037|FG000|Overall Study|Physician Decision|0|||
149774175|NCT00810810|540299038|FG001|Overall Study|Physician Decision|3|||
149774176|NCT00810810|540299039|FG002|Overall Study|Physician Decision|1|||
149774177|NCT00810810|540299040|FG003|Overall Study|Physician Decision|5|||
149774178|NCT01896856|540299041|FG000|Overall Study|Transportation issues / Non-compliance|0|||
149774179|NCT01896856|540299042|FG001|Overall Study|Transportation issues / Non-compliance|0|||
149774180|NCT01896856|540299043|FG002|Overall Study|Transportation issues / Non-compliance|1|||
149774181|NCT01896856|540299044|FG003|Overall Study|Transportation issues / Non-compliance|0|||
149774182|NCT01896856|540299045|FG004|Overall Study|Transportation issues / Non-compliance|0|||
149774183|NCT01896856|540299046|FG005|Overall Study|Transportation issues / Non-compliance|0|||
149774184|NCT02563925|540299049|FG000|Overall Study|Withdrawal by Subject|2|||
149774185|NCT01700985|540299050|FG000|Overall Study|Incarcerated|0|||
149774186|NCT01700985|540299051|FG001|Overall Study|Incarcerated|1|||
149774187|NCT01342952|540299053|FG000|Overall Study|Adverse Event|0|||
149774188|NCT01342952|540299054|FG001|Overall Study|Adverse Event|5|||
149774189|NCT01342952|540299055|FG002|Overall Study|Adverse Event|1|||
149774190|NCT01342952|540299056|FG003|Overall Study|Adverse Event|0|||
149774191|NCT01342952|540299053|FG000|Overall Study|Lost to Follow-up|0|||
149774192|NCT01342952|540299054|FG001|Overall Study|Lost to Follow-up|2|||
149774193|NCT01342952|540299055|FG002|Overall Study|Lost to Follow-up|0|||
149774194|NCT01342952|540299056|FG003|Overall Study|Lost to Follow-up|0|||
149774195|NCT01342952|540299053|FG000|Overall Study|Withdrawal by Subject|1|||
149774196|NCT01342952|540299054|FG001|Overall Study|Withdrawal by Subject|1|||
149774197|NCT01342952|540299055|FG002|Overall Study|Withdrawal by Subject|0|||
149774198|NCT01342952|540299056|FG003|Overall Study|Withdrawal by Subject|0|||
149774199|NCT01342952|540299053|FG000|Overall Study|Physician Decision|3|||
149774200|NCT01342952|540299054|FG001|Overall Study|Physician Decision|3|||
149774201|NCT01342952|540299055|FG002|Overall Study|Physician Decision|1|||
149774202|NCT01342952|540299056|FG003|Overall Study|Physician Decision|0|||
149774203|NCT00426556|540299059|FG000|Phase I - Core Phase|Disease Progression|0|||
149774204|NCT00426556|540299060|FG001|Phase I - Core Phase|Disease Progression|6|||
149774205|NCT00426556|540299061|FG002|Phase I - Core Phase|Disease Progression|2|||
149774206|NCT00426556|540299062|FG003|Phase I - Core Phase|Disease Progression|0|||
149774207|NCT00426556|540299059|FG000|Phase I - Core Phase|Adverse Event|1|||
149774208|NCT00426556|540299060|FG001|Phase I - Core Phase|Adverse Event|3|||
149774209|NCT00426556|540299061|FG002|Phase I - Core Phase|Adverse Event|1|||
149774210|NCT00426556|540299062|FG003|Phase I - Core Phase|Adverse Event|0|||
149774211|NCT00426556|540299059|FG000|Phase I - Core Phase|Death|0|||
149774212|NCT00426556|540299060|FG001|Phase I - Core Phase|Death|1|||
149774213|NCT00426556|540299061|FG002|Phase I - Core Phase|Death|0|||
149774214|NCT00426556|540299062|FG003|Phase I - Core Phase|Death|0|||
149774215|NCT00426556|540299059|FG000|Phase I - Extension Phase|Adverse Event|0|||
149774216|NCT00426556|540299060|FG001|Phase I - Extension Phase|Adverse Event|1|||
149774217|NCT00426556|540299061|FG002|Phase I - Extension Phase|Adverse Event|1|||
149774218|NCT00426556|540299062|FG003|Phase I - Extension Phase|Adverse Event|0|||
149774219|NCT00426556|540299059|FG000|Phase I - Extension Phase|Disease Progression|5|||
149774220|NCT00426556|540299060|FG001|Phase I - Extension Phase|Disease Progression|5|||
149774221|NCT00426556|540299061|FG002|Phase I - Extension Phase|Disease Progression|6|||
149774222|NCT00426556|540299062|FG003|Phase I - Extension Phase|Disease Progression|0|||
149774223|NCT00426556|540299059|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
149774224|NCT00426556|540299060|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
149774225|NCT00426556|540299061|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
149774226|NCT00426556|540299062|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
149774227|NCT00426556|540299059|FG000|Phase II - Core Phase|Disease Progression|0|||
149774228|NCT00426556|540299060|FG001|Phase II - Core Phase|Disease Progression|0|||
149774229|NCT00426556|540299061|FG002|Phase II - Core Phase|Disease Progression|0|||
149774230|NCT00426556|540299062|FG003|Phase II - Core Phase|Disease Progression|16|||
149774231|NCT00426556|540299059|FG000|Phase II - Core Phase|Adverse Event|0|||
149774232|NCT00426556|540299060|FG001|Phase II - Core Phase|Adverse Event|0|||
149774233|NCT00426556|540299061|FG002|Phase II - Core Phase|Adverse Event|0|||
149774234|NCT00426556|540299062|FG003|Phase II - Core Phase|Adverse Event|8|||
149774235|NCT00426556|540299059|FG000|Phase II - Extension Phase|Disease Progression|0|||
149774236|NCT00426556|540299060|FG001|Phase II - Extension Phase|Disease Progression|0|||
149774237|NCT00426556|540299061|FG002|Phase II - Extension Phase|Disease Progression|0|||
149774238|NCT00426556|540299062|FG003|Phase II - Extension Phase|Disease Progression|21|||
149774239|NCT00426556|540299059|FG000|Phase II - Extension Phase|Adverse Event|0|||
149774240|NCT00426556|540299060|FG001|Phase II - Extension Phase|Adverse Event|0|||
149774241|NCT00426556|540299061|FG002|Phase II - Extension Phase|Adverse Event|0|||
149774242|NCT00426556|540299062|FG003|Phase II - Extension Phase|Adverse Event|2|||
149774243|NCT03970824|540299066|FG000|Overall Study|Withdrawal by Subject|1|||
149774244|NCT03970824|540299067|FG001|Overall Study|Withdrawal by Subject|1|||
149774245|NCT03970824|540299068|FG002|Overall Study|Withdrawal by Subject|3|||
149774246|NCT03970824|540299066|FG000|Overall Study|Lost to Follow-up|0|||
149774247|NCT03970824|540299067|FG001|Overall Study|Lost to Follow-up|2|||
149774248|NCT03970824|540299068|FG002|Overall Study|Lost to Follow-up|1|||
149774249|NCT03970824|540299066|FG000|Overall Study|Adverse Event|1|||
149774250|NCT03970824|540299067|FG001|Overall Study|Adverse Event|0|||
149774251|NCT03970824|540299068|FG002|Overall Study|Adverse Event|0|||
149774252|NCT00416312|540299069|FG000|Overall Study|tumors not visible on imaging|2|||
149774253|NCT00105560|540299072|FG000|Overall Study|Lost to Follow-up|1|||
149774254|NCT00425100|540299073|FG000|Overall Study|Adverse Event|36|||
149774255|NCT00425100|540299073|FG000|Overall Study|Lack of Efficacy|4|||
149774256|NCT00425100|540299073|FG000|Overall Study|Lost to Follow-up|2|||
149774257|NCT00425100|540299073|FG000|Overall Study|Protocol Violation|4|||
149774258|NCT00425100|540299073|FG000|Overall Study|Withdrawal by Subject|7|||
149774259|NCT01315847|540299074|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
149774260|NCT01315847|540299075|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
149774261|NCT01315847|540299074|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
149774262|NCT01315847|540299075|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
149774263|NCT03699631|540299079|FG000|Overall Study|Adverse Event|3|||
149774264|NCT02940626|540299080|FG000|Overall Study|Death|40|||
149774265|NCT02940626|540299081|FG001|Overall Study|Death|32|||
149774266|NCT02940626|540299080|FG000|Overall Study|Lost to Follow-up|5|||
149774267|NCT02940626|540299081|FG001|Overall Study|Lost to Follow-up|2|||
149774268|NCT02940626|540299080|FG000|Overall Study|Withdrawal by Subject|1|||
149774269|NCT02940626|540299081|FG001|Overall Study|Withdrawal by Subject|0|||
149774270|NCT02940626|540299080|FG000|Overall Study|Transfer to Hospice Care|1|||
149774271|NCT02940626|540299081|FG001|Overall Study|Transfer to Hospice Care|0|||
149774272|NCT02940626|540299080|FG000|Overall Study|Prohibited Concomitant Medication|0|||
149774273|NCT02940626|540299081|FG001|Overall Study|Prohibited Concomitant Medication|1|||
149774274|NCT02559713|540299084|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
149774275|NCT01767519|540299085|FG000|Overall Study|Other Reasons|4|||
149774276|NCT01767519|540299086|FG001|Overall Study|Other Reasons|4|||
149774277|NCT01767519|540299087|FG002|Overall Study|Other Reasons|2|||
149774278|NCT01767519|540299085|FG000|Overall Study|Protocol Violation|0|||
149774279|NCT01767519|540299086|FG001|Overall Study|Protocol Violation|3|||
149774280|NCT01767519|540299087|FG002|Overall Study|Protocol Violation|0|||
149774281|NCT01767519|540299085|FG000|Overall Study|Personal Reasons|1|||
149774282|NCT01767519|540299086|FG001|Overall Study|Personal Reasons|0|||
149774283|NCT01767519|540299087|FG002|Overall Study|Personal Reasons|0|||
149774284|NCT01767519|540299085|FG000|Overall Study|Lost to Follow-up|3|||
149774285|NCT01767519|540299086|FG001|Overall Study|Lost to Follow-up|1|||
149774286|NCT01767519|540299087|FG002|Overall Study|Lost to Follow-up|2|||
149774287|NCT01767519|540299085|FG000|Overall Study|Lack of Efficacy|1|||
149774288|NCT01767519|540299086|FG001|Overall Study|Lack of Efficacy|0|||
149774289|NCT01767519|540299087|FG002|Overall Study|Lack of Efficacy|0|||
149774290|NCT01767519|540299085|FG000|Overall Study|Adverse Event|5|||
149774291|NCT01767519|540299086|FG001|Overall Study|Adverse Event|5|||
149774292|NCT01767519|540299087|FG002|Overall Study|Adverse Event|1|||
149774293|NCT00293423|540299088|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
149774294|NCT00293423|540299089|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
149774295|NCT00293423|540299088|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
149774296|NCT00293423|540299089|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
149774297|NCT00293423|540299088|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
149774298|NCT00293423|540299089|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
149774299|NCT00293423|540299088|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
149774300|NCT00293423|540299089|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
149774301|NCT00293423|540299088|FG000|Surgical Resection|processing error during surgical resection|1|||
149774302|NCT00293423|540299089|FG001|Surgical Resection|processing error during surgical resection|0|||
149774303|NCT00293423|540299088|FG000|Surgical Resection|Withdrawal by Subject|4|||
149774304|NCT00293423|540299089|FG001|Surgical Resection|Withdrawal by Subject|0|||
149774305|NCT00293423|540299088|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
149774306|NCT00293423|540299089|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
149774307|NCT00964158|540299090|FG000|Overall Study|Lost to Follow-up|0|||
149774308|NCT00964158|540299091|FG001|Overall Study|Lost to Follow-up|1|||
149774309|NCT00964158|540299092|FG002|Overall Study|Lost to Follow-up|2|||
149774310|NCT00964158|540299090|FG000|Overall Study|Withdrawal by Subject|0|||
149774311|NCT00964158|540299091|FG001|Overall Study|Withdrawal by Subject|0|||
149774312|NCT00964158|540299092|FG002|Overall Study|Withdrawal by Subject|6|||
149774313|NCT00507416|540299093|FG000|Overall Study|Adverse Event|58|||
149774314|NCT00507416|540299094|FG001|Overall Study|Adverse Event|67|||
149774315|NCT00507416|540299095|FG002|Overall Study|Adverse Event|65|||
149774316|NCT00507416|540299093|FG000|Overall Study|Protocol Violation|1|||
149774317|NCT00507416|540299094|FG001|Overall Study|Protocol Violation|2|||
149774318|NCT00507416|540299095|FG002|Overall Study|Protocol Violation|0|||
149774319|NCT00507416|540299093|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
149774320|NCT00507416|540299094|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
149774321|NCT00507416|540299095|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
149774322|NCT00507416|540299093|FG000|Overall Study|Progressive Disease|20|||
149774323|NCT00507416|540299094|FG001|Overall Study|Progressive Disease|10|||
149774324|NCT00507416|540299095|FG002|Overall Study|Progressive Disease|13|||
149774325|NCT00507416|540299093|FG000|Overall Study|Patient declined further treatment|18|||
149774326|NCT00507416|540299094|FG001|Overall Study|Patient declined further treatment|14|||
149774327|NCT00507416|540299095|FG002|Overall Study|Patient declined further treatment|11|||
149774328|NCT00507416|540299093|FG000|Overall Study|Other|11|||
149774329|NCT00507416|540299094|FG001|Overall Study|Other|16|||
149774330|NCT00507416|540299095|FG002|Overall Study|Other|13|||
149774331|NCT00507416|540299093|FG000|Overall Study|Did not Receive Study Treatment|3|||
149774332|NCT00507416|540299094|FG001|Overall Study|Did not Receive Study Treatment|9|||
149774333|NCT00507416|540299095|FG002|Overall Study|Did not Receive Study Treatment|4|||
149774334|NCT01182337|540299098|FG000|Overall Study|Withdrawal by Subject|3|||
149774335|NCT01182337|540299099|FG001|Overall Study|Withdrawal by Subject|1|||
149774336|NCT01182337|540299098|FG000|Overall Study|Lost to Follow-up|0|||
149774337|NCT01182337|540299099|FG001|Overall Study|Lost to Follow-up|1|||
149774338|NCT03101514|540299100|FG000|Overall Study|Withdrawal by Subject|4|||
149774339|NCT03101514|540299100|FG000|Overall Study|Protocol Violation|2|||
149774340|NCT03101514|540299100|FG000|Overall Study|patient's information was incomplete|1|||
149774341|NCT01021813|540299101|FG000|DB Treatment Phase|Adverse Event|60|||
149774342|NCT01021813|540299102|FG001|DB Treatment Phase|Adverse Event|22|||
149774343|NCT01021813|540299103|FG002|DB Treatment Phase|Adverse Event|0|||
149774344|NCT01021813|540299104|FG003|DB Treatment Phase|Adverse Event|0|||
149774345|NCT01021813|540299105|FG004|DB Treatment Phase|Adverse Event|0|||
149774346|NCT01021813|540299101|FG000|DB Treatment Phase|Lack of Efficacy|44|||
149774347|NCT01021813|540299102|FG001|DB Treatment Phase|Lack of Efficacy|28|||
149774348|NCT01021813|540299103|FG002|DB Treatment Phase|Lack of Efficacy|0|||
149774349|NCT01021813|540299104|FG003|DB Treatment Phase|Lack of Efficacy|0|||
149774350|NCT01021813|540299105|FG004|DB Treatment Phase|Lack of Efficacy|0|||
149774351|NCT01021813|540299101|FG000|DB Treatment Phase|Lost to Follow-up|14|||
149774352|NCT01021813|540299102|FG001|DB Treatment Phase|Lost to Follow-up|12|||
149774353|NCT01021813|540299103|FG002|DB Treatment Phase|Lost to Follow-up|0|||
149774354|NCT01021813|540299104|FG003|DB Treatment Phase|Lost to Follow-up|0|||
149774355|NCT01021813|540299105|FG004|DB Treatment Phase|Lost to Follow-up|0|||
149774356|NCT01021813|540299101|FG000|DB Treatment Phase|Physician Decision|17|||
149774357|NCT01021813|540299102|FG001|DB Treatment Phase|Physician Decision|8|||
149774358|NCT01021813|540299103|FG002|DB Treatment Phase|Physician Decision|0|||
149774359|NCT01021813|540299104|FG003|DB Treatment Phase|Physician Decision|0|||
149774360|NCT01021813|540299105|FG004|DB Treatment Phase|Physician Decision|0|||
149774361|NCT01021813|540299101|FG000|DB Treatment Phase|Pregnancy|1|||
149774362|NCT01021813|540299102|FG001|DB Treatment Phase|Pregnancy|0|||
149774363|NCT01021813|540299103|FG002|DB Treatment Phase|Pregnancy|0|||
149774364|NCT01021813|540299104|FG003|DB Treatment Phase|Pregnancy|0|||
149774365|NCT01021813|540299105|FG004|DB Treatment Phase|Pregnancy|0|||
149774366|NCT01021813|540299101|FG000|DB Treatment Phase|Protocol Violation|4|||
149774367|NCT01021813|540299102|FG001|DB Treatment Phase|Protocol Violation|3|||
149774368|NCT01021813|540299103|FG002|DB Treatment Phase|Protocol Violation|0|||
149774369|NCT01021813|540299104|FG003|DB Treatment Phase|Protocol Violation|0|||
149774370|NCT01021813|540299105|FG004|DB Treatment Phase|Protocol Violation|0|||
149774371|NCT01021813|540299101|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
149774372|NCT01021813|540299102|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
149774373|NCT01021813|540299103|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
149774374|NCT01021813|540299104|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
149774375|NCT01021813|540299105|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
149774376|NCT01021813|540299101|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
149774377|NCT01021813|540299102|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
149774378|NCT01021813|540299103|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
149774379|NCT01021813|540299104|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
149774380|NCT01021813|540299105|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
149774381|NCT01021813|540299101|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149774382|NCT01021813|540299102|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149774383|NCT01021813|540299103|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149774384|NCT01021813|540299104|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
149774385|NCT01021813|540299105|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149774386|NCT01021813|540299101|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149774387|NCT01021813|540299102|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149774388|NCT01021813|540299103|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149774389|NCT01021813|540299104|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149774390|NCT01021813|540299105|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
149774391|NCT01021813|540299101|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149774392|NCT01021813|540299102|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149774393|NCT01021813|540299103|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
149774394|NCT01021813|540299104|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149774395|NCT01021813|540299105|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149774396|NCT01021813|540299101|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
149774397|NCT01021813|540299102|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
149774398|NCT01021813|540299103|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
149774399|NCT01021813|540299104|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
149774400|NCT01021813|540299105|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
149774401|NCT03571256|540299106|FG000|Overall Study|Adverse Event|3|||
149774402|NCT03571256|540299107|FG001|Overall Study|Adverse Event|0|||
149774403|NCT03571256|540299108|FG002|Overall Study|Adverse Event|1|||
149774404|NCT03571256|540299106|FG000|Overall Study|Withdrawal by Subject|3|||
149774405|NCT03571256|540299107|FG001|Overall Study|Withdrawal by Subject|1|||
149774406|NCT03571256|540299108|FG002|Overall Study|Withdrawal by Subject|1|||
149774407|NCT03571256|540299106|FG000|Overall Study|Other than specified|0|||
149774408|NCT03571256|540299107|FG001|Overall Study|Other than specified|1|||
149774409|NCT03571256|540299108|FG002|Overall Study|Other than specified|1|||
149774410|NCT03571256|540299106|FG000|Overall Study|Protocol Violation|0|||
149774411|NCT03571256|540299107|FG001|Overall Study|Protocol Violation|1|||
149774412|NCT03571256|540299108|FG002|Overall Study|Protocol Violation|1|||
149774413|NCT02270684|540299109|FG000|Overall Study|Lost to Follow-up|0|||
149774414|NCT02270684|540299110|FG001|Overall Study|Lost to Follow-up|3|||
149774415|NCT02270684|540299109|FG000|Overall Study|Study terminated|1|||
149774416|NCT02270684|540299110|FG001|Overall Study|Study terminated|0|||
149774417|NCT02247401|540299117|FG000|Overall Study|Adverse Event|1|||
149774418|NCT02247401|540299118|FG001|Overall Study|Adverse Event|0|||
149774419|NCT02247401|540299119|FG002|Overall Study|Adverse Event|0|||
149774420|NCT02247401|540299117|FG000|Overall Study|Withdrawal by Subject|4|||
149774421|NCT02247401|540299118|FG001|Overall Study|Withdrawal by Subject|1|||
149774422|NCT02247401|540299119|FG002|Overall Study|Withdrawal by Subject|1|||
149774423|NCT02247401|540299117|FG000|Overall Study|Lost to Follow-up|1|||
149774424|NCT02247401|540299118|FG001|Overall Study|Lost to Follow-up|1|||
149774425|NCT02247401|540299119|FG002|Overall Study|Lost to Follow-up|1|||
149774426|NCT03695393|540299123|FG000|Overall Study|Death|3|||
149774427|NCT03695393|540299124|FG001|Overall Study|Death|1|||
149774428|NCT03695393|540299123|FG000|Overall Study|Lost to Follow-up|0|||
149774429|NCT03695393|540299124|FG001|Overall Study|Lost to Follow-up|1|||
149774430|NCT04169061|540299127|FG000|Overall Study|Adverse Event|2|||
149774431|NCT04169061|540299127|FG000|Overall Study|Death|1|||
149774432|NCT04169061|540299127|FG000|Overall Study|Withdrawal by Subject|1|||
149774433|NCT04169061|540299127|FG000|Overall Study|Protocol Violation|1|||
149774434|NCT04585451|540299128|FG000|Overall Study|Withdrawal by Subject|26|||
149774435|NCT04585451|540299129|FG001|Overall Study|Withdrawal by Subject|0|||
149774436|NCT00493974|540299130|FG000|Overall Study|Death|1|||
149774437|NCT00493974|540299131|FG001|Overall Study|Death|2|||
149774438|NCT00493974|540299130|FG000|Overall Study|Withdrawal by Subject|8|||
149774439|NCT00493974|540299131|FG001|Overall Study|Withdrawal by Subject|6|||
149774440|NCT00493974|540299130|FG000|Overall Study|Lost to Follow-up|4|||
149774441|NCT00493974|540299131|FG001|Overall Study|Lost to Follow-up|6|||
149774442|NCT02807363|540299132|FG000|Dosing Period|Adverse Event|0|||
149774443|NCT02807363|540299133|FG001|Dosing Period|Adverse Event|1|||
149774444|NCT02807363|540299134|FG002|Dosing Period|Adverse Event|0|||
149774445|NCT02807363|540299135|FG003|Dosing Period|Adverse Event|0|||
149774446|NCT02188719|540299136|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149774447|NCT02188719|540299137|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
149774448|NCT02188719|540299138|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149774449|NCT02188719|540299139|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149774450|NCT00966693|540299140|FG000|Overall Study|Adverse Event|0|||
149774451|NCT00966693|540299141|FG001|Overall Study|Adverse Event|0|||
149774452|NCT00966693|540299142|FG002|Overall Study|Adverse Event|1|||
149774453|NCT00966693|540299143|FG003|Overall Study|Adverse Event|2|||
149774454|NCT00966693|540299140|FG000|Overall Study|Death|0|||
149774455|NCT00966693|540299141|FG001|Overall Study|Death|0|||
149774456|NCT00966693|540299142|FG002|Overall Study|Death|1|||
149774457|NCT00966693|540299143|FG003|Overall Study|Death|0|||
149774458|NCT00966693|540299140|FG000|Overall Study|Withdrawal by Subject|1|||
149774459|NCT00966693|540299141|FG001|Overall Study|Withdrawal by Subject|0|||
149774460|NCT00966693|540299142|FG002|Overall Study|Withdrawal by Subject|0|||
149774461|NCT00966693|540299143|FG003|Overall Study|Withdrawal by Subject|5|||
149774462|NCT00966693|540299140|FG000|Overall Study|Disease Progression|0|||
149774463|NCT00966693|540299141|FG001|Overall Study|Disease Progression|0|||
149774464|NCT00966693|540299142|FG002|Overall Study|Disease Progression|1|||
149774465|NCT00966693|540299143|FG003|Overall Study|Disease Progression|16|||
149774466|NCT00192036|540299144|FG000|Overall Study|Protocol Violation|3|||
149774467|NCT00192036|540299144|FG000|Overall Study|Adverse Event|6|||
149774468|NCT00192036|540299144|FG000|Overall Study|Patient/Physician Perception|1|||
149774469|NCT00192036|540299144|FG000|Overall Study|Objective Tumor Progression|4|||
149774470|NCT00192036|540299144|FG000|Overall Study|Clinical Disease Progression|1|||
149774471|NCT00192036|540299144|FG000|Overall Study|Death|1|||
149774472|NCT00192036|540299144|FG000|Overall Study|Unknown or Not Specified|5|||
149774473|NCT03371732|540299145|FG000|Overall Study|Withdrawal by Subject|9|||
149774474|NCT03371732|540299146|FG001|Overall Study|Withdrawal by Subject|3|||
149774475|NCT03371732|540299145|FG000|Overall Study|Refusal to continue|3|||
149774476|NCT03371732|540299146|FG001|Overall Study|Refusal to continue|4|||
149774477|NCT02581982|540299149|FG000|Overall Study|Lack of Efficacy|12|||
149774478|NCT02581982|540299149|FG000|Overall Study|Adverse Event|3|||
149774479|NCT02581982|540299149|FG000|Overall Study|Physician Decision|1|||
149774480|NCT00405821|540299150|FG000|Overall Study|Death|5|||
149774481|NCT00405821|540299151|FG001|Overall Study|Death|7|||
149774482|NCT00405821|540299150|FG000|Overall Study|Lost to Follow-up|7|||
149774483|NCT00405821|540299151|FG001|Overall Study|Lost to Follow-up|7|||
149774484|NCT00405821|540299150|FG000|Overall Study|Protocol Violation|1|||
149774485|NCT00405821|540299151|FG001|Overall Study|Protocol Violation|0|||
149774486|NCT00405821|540299150|FG000|Overall Study|initiated ART|9|||
149774487|NCT00405821|540299151|FG001|Overall Study|initiated ART|8|||
149774488|NCT02148211|540299155|FG000|Overall Study|Lost to Follow-up|352|||
149774489|NCT03148756|540299157|FG000|Overall Study|Study Terminated|0|||
149774490|NCT03148756|540299158|FG001|Overall Study|Study Terminated|1|||
149774491|NCT03788967|540300904|FG000|Overall Study|Lost to Follow-up|14|||
149774492|NCT03788967|540300905|FG001|Overall Study|Lost to Follow-up|10|||
149774493|NCT03788967|540300904|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
149774494|NCT03788967|540300905|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
149774495|NCT03788967|540300904|FG000|Overall Study|Participant Withdrawal of Consent|13|||
149774496|NCT03788967|540300905|FG001|Overall Study|Participant Withdrawal of Consent|5|||
149774497|NCT03788967|540300904|FG000|Overall Study|Adverse Event|1|||
149774498|NCT03788967|540300905|FG001|Overall Study|Adverse Event|1|||
149774499|NCT03788967|540300904|FG000|Overall Study|COVID-19|1|||
149774500|NCT03788967|540300905|FG001|Overall Study|COVID-19|2|||
149774501|NCT04268303|540300906|FG000|Overall Study|Lost to Follow-up|1|||
149774502|NCT04268303|540300907|FG001|Overall Study|Lost to Follow-up|1|||
149774503|NCT04268303|540300908|FG002|Overall Study|Lost to Follow-up|2|||
149774504|NCT04268303|540300906|FG000|Overall Study|Withdrawal by Subject|0|||
149774505|NCT04268303|540300907|FG001|Overall Study|Withdrawal by Subject|1|||
149774506|NCT04268303|540300908|FG002|Overall Study|Withdrawal by Subject|1|||
149774507|NCT04268303|540300906|FG000|Overall Study|Adverse Event|2|||
149774508|NCT04268303|540300907|FG001|Overall Study|Adverse Event|0|||
149774509|NCT04268303|540300908|FG002|Overall Study|Adverse Event|0|||
149774510|NCT00355134|540300909|FG000|Core Phase|Withdrawal by Subject|35|||
149774511|NCT00355134|540300910|FG001|Core Phase|Withdrawal by Subject|24|||
149774512|NCT00355134|540300911|FG002|Core Phase|Withdrawal by Subject|35|||
149774513|NCT00355134|540300912|FG003|Core Phase|Withdrawal by Subject|0|||
149774514|NCT00355134|540300913|FG004|Core Phase|Withdrawal by Subject|0|||
149774515|NCT00355134|540300909|FG000|Core Phase|Adverse Event|28|||
149774516|NCT00355134|540300910|FG001|Core Phase|Adverse Event|22|||
149774517|NCT00355134|540300911|FG002|Core Phase|Adverse Event|16|||
149774518|NCT00355134|540300912|FG003|Core Phase|Adverse Event|0|||
149774519|NCT00355134|540300913|FG004|Core Phase|Adverse Event|0|||
149774520|NCT00355134|540300909|FG000|Core Phase|Lost to Follow-up|17|||
149774521|NCT00355134|540300910|FG001|Core Phase|Lost to Follow-up|13|||
149774522|NCT00355134|540300911|FG002|Core Phase|Lost to Follow-up|21|||
149774523|NCT00355134|540300912|FG003|Core Phase|Lost to Follow-up|0|||
149774524|NCT00355134|540300913|FG004|Core Phase|Lost to Follow-up|0|||
149774525|NCT00355134|540300909|FG000|Core Phase|Abnormal laboratory value(s)|19|||
149774526|NCT00355134|540300910|FG001|Core Phase|Abnormal laboratory value(s)|14|||
149774527|NCT00355134|540300911|FG002|Core Phase|Abnormal laboratory value(s)|2|||
149774528|NCT00355134|540300912|FG003|Core Phase|Abnormal laboratory value(s)|0|||
149774529|NCT00355134|540300913|FG004|Core Phase|Abnormal laboratory value(s)|0|||
149774530|NCT00355134|540300909|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
149774531|NCT00355134|540300910|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
149774532|NCT00355134|540300911|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
149774533|NCT00355134|540300912|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
149774534|NCT00355134|540300913|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
149774535|NCT00355134|540300909|FG000|Core Phase|Administrative problems|5|||
149774536|NCT00355134|540300910|FG001|Core Phase|Administrative problems|3|||
149774537|NCT00355134|540300911|FG002|Core Phase|Administrative problems|5|||
149774538|NCT00355134|540300912|FG003|Core Phase|Administrative problems|0|||
149774539|NCT00355134|540300913|FG004|Core Phase|Administrative problems|0|||
149774540|NCT00355134|540300909|FG000|Core Phase|Protocol Violation|3|||
149774541|NCT00355134|540300910|FG001|Core Phase|Protocol Violation|2|||
149774542|NCT00355134|540300911|FG002|Core Phase|Protocol Violation|2|||
149774543|NCT00355134|540300912|FG003|Core Phase|Protocol Violation|0|||
149774544|NCT00355134|540300913|FG004|Core Phase|Protocol Violation|0|||
149774545|NCT00355134|540300909|FG000|Core Phase|Abnormal test procedure result(s)|1|||
149774546|NCT00355134|540300910|FG001|Core Phase|Abnormal test procedure result(s)|2|||
149774547|NCT00355134|540300911|FG002|Core Phase|Abnormal test procedure result(s)|1|||
149774548|NCT00355134|540300912|FG003|Core Phase|Abnormal test procedure result(s)|0|||
149774549|NCT00355134|540300913|FG004|Core Phase|Abnormal test procedure result(s)|0|||
149774550|NCT00355134|540300909|FG000|Core Phase|Condition no longer requires study drug|1|||
149774551|NCT00355134|540300910|FG001|Core Phase|Condition no longer requires study drug|0|||
149774552|NCT00355134|540300911|FG002|Core Phase|Condition no longer requires study drug|1|||
149774553|NCT00355134|540300912|FG003|Core Phase|Condition no longer requires study drug|0|||
149774554|NCT00355134|540300913|FG004|Core Phase|Condition no longer requires study drug|0|||
149774555|NCT00355134|540300909|FG000|Extension Phase|Withdrawal by Subject|7|||
149774556|NCT00355134|540300910|FG001|Extension Phase|Withdrawal by Subject|11|||
149774557|NCT00355134|540300911|FG002|Extension Phase|Withdrawal by Subject|0|||
149774558|NCT00355134|540300912|FG003|Extension Phase|Withdrawal by Subject|7|||
149774559|NCT00355134|540300913|FG004|Extension Phase|Withdrawal by Subject|5|||
149774560|NCT00355134|540300909|FG000|Extension Phase|Adverse Event|13|||
149774561|NCT00355134|540300910|FG001|Extension Phase|Adverse Event|9|||
149774562|NCT00355134|540300911|FG002|Extension Phase|Adverse Event|0|||
149774563|NCT00355134|540300912|FG003|Extension Phase|Adverse Event|3|||
149774564|NCT00355134|540300913|FG004|Extension Phase|Adverse Event|5|||
149774565|NCT00355134|540300909|FG000|Extension Phase|Lost to Follow-up|2|||
149774566|NCT00355134|540300910|FG001|Extension Phase|Lost to Follow-up|6|||
149774567|NCT00355134|540300911|FG002|Extension Phase|Lost to Follow-up|0|||
149774568|NCT00355134|540300912|FG003|Extension Phase|Lost to Follow-up|2|||
149774569|NCT00355134|540300913|FG004|Extension Phase|Lost to Follow-up|4|||
149774570|NCT00355134|540300909|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
149774571|NCT00355134|540300910|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
149774572|NCT00355134|540300911|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
149774573|NCT00355134|540300912|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
149774574|NCT00355134|540300913|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
149774575|NCT00355134|540300909|FG000|Extension Phase|Administrative problems|2|||
149774576|NCT00355134|540300910|FG001|Extension Phase|Administrative problems|4|||
149774577|NCT00355134|540300911|FG002|Extension Phase|Administrative problems|0|||
149774578|NCT00355134|540300912|FG003|Extension Phase|Administrative problems|1|||
149774579|NCT00355134|540300913|FG004|Extension Phase|Administrative problems|1|||
149774580|NCT00355134|540300909|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
149774581|NCT00355134|540300910|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
149774582|NCT00355134|540300911|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
149774583|NCT00355134|540300912|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
149774584|NCT00355134|540300913|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
149774585|NCT00355134|540300909|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
149774586|NCT00355134|540300910|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
149774587|NCT00355134|540300911|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
149774588|NCT00355134|540300912|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
149774589|NCT00355134|540300913|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
149774590|NCT00355134|540300909|FG000|Extension Phase|Protocol Violation|0|||
149774591|NCT00355134|540300910|FG001|Extension Phase|Protocol Violation|0|||
149774592|NCT00355134|540300911|FG002|Extension Phase|Protocol Violation|0|||
149774593|NCT00355134|540300912|FG003|Extension Phase|Protocol Violation|1|||
149774594|NCT00355134|540300913|FG004|Extension Phase|Protocol Violation|0|||
149774595|NCT03621189|540300929|FG000|Overall Study|Withdrawal by Subject|0|||
149774596|NCT03621189|540300930|FG001|Overall Study|Withdrawal by Subject|3|||
149774597|NCT03621189|540300929|FG000|Overall Study|Physician Decision|0|||
149774598|NCT03621189|540300930|FG001|Overall Study|Physician Decision|2|||
149774599|NCT01135394|540300931|FG000|Screening|Lost to Follow-up|2|||
149774600|NCT01135394|540300931|FG000|Screening|Withdrawal by Subject|10|||
149774601|NCT01135394|540300931|FG000|Screening|Screening failure|16|||
149774602|NCT01135394|540300931|FG000|Screening|Physician Decision|5|||
149774603|NCT01135394|540300931|FG000|Baseline Assessment|Withdrawal by Subject|9|||
149774604|NCT01135394|540300931|FG000|Baseline Assessment|Physician Decision|3|||
149774605|NCT01135394|540300931|FG000|Baseline Assessment|Lost to Follow-up|2|||
149774606|NCT01135394|540300931|FG000|Baseline Assessment|Adverse Event|1|||
149774607|NCT01135394|540300931|FG000|Study Treatment|Withdrawal by Subject|1|||
149774608|NCT01135394|540300931|FG000|Study Treatment|Physician Decision|1|||
149774609|NCT01135394|540300931|FG000|Study Treatment|Adverse Event|2|||
149774610|NCT04432376|540300932|FG000|Double-blind Treatment Period|Adverse Event|2|||
149774611|NCT04432376|540300933|FG001|Double-blind Treatment Period|Adverse Event|6|||
149774612|NCT04432376|540300934|FG002|Double-blind Treatment Period|Adverse Event|0|||
149774613|NCT04432376|540300932|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
149774614|NCT04432376|540300933|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
149774615|NCT04432376|540300934|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
149774616|NCT04432376|540300932|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149774617|NCT04432376|540300933|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149774618|NCT04432376|540300934|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149774619|NCT04432376|540300932|FG000|Double-blind Treatment Period|Protocol Violation|0|||
149774620|NCT04432376|540300933|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149774621|NCT04432376|540300934|FG002|Double-blind Treatment Period|Protocol Violation|0|||
149774622|NCT04432376|540300932|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
149774623|NCT04432376|540300933|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
149774624|NCT04432376|540300934|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
149774625|NCT05742841|540300935|FG000|Overall Study|Withdrawal by Subject|1|||
149774626|NCT05742841|540300935|FG000|Overall Study|Lost to Follow-up|1|||
149774627|NCT02088541|540300936|FG000|Overall Study|Adverse Event|3|||
149774628|NCT02088541|540300937|FG001|Overall Study|Adverse Event|0|||
149774629|NCT02088541|540300938|FG002|Overall Study|Adverse Event|3|||
149774630|NCT02088541|540300939|FG003|Overall Study|Adverse Event|3|||
149774631|NCT02088541|540300940|FG004|Overall Study|Adverse Event|0|||
149774632|NCT02088541|540300936|FG000|Overall Study|Death|51|||
149774633|NCT02088541|540300937|FG001|Overall Study|Death|21|||
149774634|NCT02088541|540300938|FG002|Overall Study|Death|85|||
149774635|NCT02088541|540300939|FG003|Overall Study|Death|28|||
149774636|NCT02088541|540300940|FG004|Overall Study|Death|38|||
149774637|NCT02088541|540300936|FG000|Overall Study|Lost to Follow-up|2|||
149774638|NCT02088541|540300937|FG001|Overall Study|Lost to Follow-up|0|||
149774639|NCT02088541|540300938|FG002|Overall Study|Lost to Follow-up|1|||
149774640|NCT02088541|540300939|FG003|Overall Study|Lost to Follow-up|0|||
149774641|NCT02088541|540300940|FG004|Overall Study|Lost to Follow-up|0|||
149774642|NCT02088541|540300936|FG000|Overall Study|Physician Decision|2|||
149774643|NCT02088541|540300937|FG001|Overall Study|Physician Decision|1|||
149774644|NCT02088541|540300938|FG002|Overall Study|Physician Decision|2|||
149774645|NCT02088541|540300939|FG003|Overall Study|Physician Decision|0|||
149774646|NCT02088541|540300940|FG004|Overall Study|Physician Decision|2|||
149774647|NCT02088541|540300936|FG000|Overall Study|Disease progression|7|||
149774648|NCT02088541|540300937|FG001|Overall Study|Disease progression|1|||
149774649|NCT02088541|540300938|FG002|Overall Study|Disease progression|2|||
149774650|NCT02088541|540300939|FG003|Overall Study|Disease progression|3|||
149774651|NCT02088541|540300940|FG004|Overall Study|Disease progression|1|||
149774652|NCT02088541|540300936|FG000|Overall Study|Study terminated by sponsor|1|||
149774653|NCT02088541|540300937|FG001|Overall Study|Study terminated by sponsor|1|||
149774654|NCT02088541|540300938|FG002|Overall Study|Study terminated by sponsor|12|||
149774655|NCT02088541|540300939|FG003|Overall Study|Study terminated by sponsor|2|||
149774656|NCT02088541|540300940|FG004|Overall Study|Study terminated by sponsor|6|||
149774657|NCT02088541|540300936|FG000|Overall Study|Withdrawal by Subject|3|||
149774658|NCT02088541|540300937|FG001|Overall Study|Withdrawal by Subject|2|||
149774659|NCT02088541|540300938|FG002|Overall Study|Withdrawal by Subject|9|||
149774660|NCT02088541|540300939|FG003|Overall Study|Withdrawal by Subject|7|||
149774661|NCT02088541|540300940|FG004|Overall Study|Withdrawal by Subject|10|||
149774662|NCT02088541|540300936|FG000|Overall Study|Other|2|||
149774663|NCT02088541|540300937|FG001|Overall Study|Other|1|||
149774664|NCT02088541|540300938|FG002|Overall Study|Other|3|||
149774665|NCT02088541|540300939|FG003|Overall Study|Other|1|||
149774666|NCT02088541|540300940|FG004|Overall Study|Other|1|||
149774667|NCT00379236|540300941|FG000|Double-blind|Adverse Event|11|||
149774668|NCT00379236|540300942|FG001|Double-blind|Adverse Event|6|||
149774669|NCT00379236|540300943|FG002|Double-blind|Adverse Event|0|||
149774670|NCT00379236|540300941|FG000|Double-blind|Protocol Violation|3|||
149774671|NCT00379236|540300942|FG001|Double-blind|Protocol Violation|3|||
149774672|NCT00379236|540300943|FG002|Double-blind|Protocol Violation|0|||
149774673|NCT00379236|540300941|FG000|Double-blind|Withdrawal by Subject|12|||
149774674|NCT00379236|540300942|FG001|Double-blind|Withdrawal by Subject|13|||
149774675|NCT00379236|540300943|FG002|Double-blind|Withdrawal by Subject|0|||
149774676|NCT00379236|540300941|FG000|Double-blind|Lost to Follow-up|4|||
149774677|NCT00379236|540300942|FG001|Double-blind|Lost to Follow-up|3|||
149774678|NCT00379236|540300943|FG002|Double-blind|Lost to Follow-up|0|||
149774679|NCT00379236|540300941|FG000|Double-blind|Use of exclusionary medication|1|||
149774680|NCT00379236|540300942|FG001|Double-blind|Use of exclusionary medication|2|||
149774681|NCT00379236|540300943|FG002|Double-blind|Use of exclusionary medication|0|||
149774682|NCT00379236|540300941|FG000|Double-blind|Other|3|||
149774683|NCT00379236|540300942|FG001|Double-blind|Other|7|||
149774684|NCT00379236|540300943|FG002|Double-blind|Other|0|||
149774685|NCT00379236|540300941|FG000|Double-blind|Data could not be retrieved|2|||
149774686|NCT00379236|540300942|FG001|Double-blind|Data could not be retrieved|2|||
149774687|NCT00379236|540300943|FG002|Double-blind|Data could not be retrieved|0|||
149774688|NCT00379236|540300941|FG000|Open-label Extension|Adverse Event|0|||
149774689|NCT00379236|540300942|FG001|Open-label Extension|Adverse Event|0|||
149774690|NCT00379236|540300943|FG002|Open-label Extension|Adverse Event|13|||
149774691|NCT00379236|540300941|FG000|Open-label Extension|Protocol Violation|0|||
149774692|NCT00379236|540300942|FG001|Open-label Extension|Protocol Violation|0|||
149774693|NCT00379236|540300943|FG002|Open-label Extension|Protocol Violation|7|||
149774694|NCT00379236|540300941|FG000|Open-label Extension|Withdrawal by Subject|0|||
149774695|NCT00379236|540300942|FG001|Open-label Extension|Withdrawal by Subject|0|||
149774696|NCT00379236|540300943|FG002|Open-label Extension|Withdrawal by Subject|13|||
149774697|NCT00379236|540300941|FG000|Open-label Extension|Lost to Follow-up|0|||
149774698|NCT00379236|540300942|FG001|Open-label Extension|Lost to Follow-up|0|||
149774699|NCT00379236|540300943|FG002|Open-label Extension|Lost to Follow-up|12|||
149774700|NCT00379236|540300941|FG000|Open-label Extension|Use of exclusionary medication|0|||
149774701|NCT00379236|540300942|FG001|Open-label Extension|Use of exclusionary medication|0|||
149774702|NCT00379236|540300943|FG002|Open-label Extension|Use of exclusionary medication|3|||
149774703|NCT00379236|540300941|FG000|Open-label Extension|Other|0|||
149774704|NCT00379236|540300942|FG001|Open-label Extension|Other|0|||
149774705|NCT00379236|540300943|FG002|Open-label Extension|Other|7|||
149774706|NCT00801892|540300949|FG000|Main Study Period|Withdrawal by Subject|0|||
149774707|NCT00801892|540300950|FG001|Main Study Period|Withdrawal by Subject|1|||
149774708|NCT00801892|540300949|FG000|Sham Crossover Period|Lost to Follow-up|0|||
149774709|NCT00801892|540300950|FG001|Sham Crossover Period|Lost to Follow-up|2|||
149774710|NCT01711541|540300953|FG000|Overall Study|Cancel prior to treatment|0|||
149774711|NCT01711541|540300954|FG001|Overall Study|Cancel prior to treatment|0|||
149774712|NCT01711541|540300955|FG002|Overall Study|Cancel prior to treatment|0|||
149774713|NCT01711541|540300956|FG003|Overall Study|Cancel prior to treatment|1|||
149774714|NCT01711541|540300957|FG004|Overall Study|Cancel prior to treatment|0|||
149774715|NCT01711541|540300953|FG000|Overall Study|Ineligible|0|||
149774716|NCT01711541|540300954|FG001|Overall Study|Ineligible|1|||
149774717|NCT01711541|540300955|FG002|Overall Study|Ineligible|0|||
149774718|NCT01711541|540300956|FG003|Overall Study|Ineligible|0|||
149774719|NCT01711541|540300957|FG004|Overall Study|Ineligible|0|||
149774720|NCT00728936|540300958|FG000|Overall Study|Withdrawal by Subject|0|||
149774721|NCT00728936|540300959|FG001|Overall Study|Withdrawal by Subject|0|||
149774722|NCT00728936|540300960|FG002|Overall Study|Withdrawal by Subject|0|||
149774723|NCT00728936|540300961|FG003|Overall Study|Withdrawal by Subject|0|||
149774724|NCT00728936|540300962|FG004|Overall Study|Withdrawal by Subject|0|||
149774725|NCT00728936|540300963|FG005|Overall Study|Withdrawal by Subject|1|||
149774726|NCT00728936|540300964|FG006|Overall Study|Withdrawal by Subject|0|||
149774727|NCT00438464|540300965|FG000|Overall Study|Terminated Early|14|||
149774728|NCT00438464|540300966|FG001|Overall Study|Terminated Early|5|||
149774729|NCT00438464|540300965|FG000|Overall Study|Incomplete data submission|0|||
149774730|NCT00438464|540300966|FG001|Overall Study|Incomplete data submission|2|||
149774731|NCT03943446|540300967|FG000|Overall Study|Lost to Follow-up|0|||
149774732|NCT03943446|540300968|FG001|Overall Study|Lost to Follow-up|0|||
149774733|NCT03943446|540300969|FG002|Overall Study|Lost to Follow-up|1|||
149774734|NCT03943446|540300967|FG000|Overall Study|Withdrawal by Subject|1|||
149774735|NCT03943446|540300968|FG001|Overall Study|Withdrawal by Subject|1|||
149774736|NCT03943446|540300969|FG002|Overall Study|Withdrawal by Subject|2|||
149774737|NCT03943446|540300967|FG000|Overall Study|Study Terminated by Sponsor|1|||
149774738|NCT03943446|540300968|FG001|Overall Study|Study Terminated by Sponsor|2|||
149774739|NCT03943446|540300969|FG002|Overall Study|Study Terminated by Sponsor|1|||
149774740|NCT03943446|540300967|FG000|Overall Study|Reason not Specified|5|||
149774741|NCT03943446|540300968|FG001|Overall Study|Reason not Specified|1|||
149774742|NCT03943446|540300969|FG002|Overall Study|Reason not Specified|3|||
149774743|NCT01281189|540300974|FG000|Overall Study|Adverse Event|7|||
149774744|NCT01281189|540300975|FG001|Overall Study|Adverse Event|9|||
149774745|NCT01281189|540300974|FG000|Overall Study|Lost to Follow-up|6|||
149774746|NCT01281189|540300975|FG001|Overall Study|Lost to Follow-up|4|||
149774747|NCT01281189|540300974|FG000|Overall Study|Withdrawal by Subject|21|||
149774748|NCT01281189|540300975|FG001|Overall Study|Withdrawal by Subject|24|||
149774749|NCT01281189|540300974|FG000|Overall Study|Physician Decision|2|||
149774750|NCT01281189|540300975|FG001|Overall Study|Physician Decision|3|||
149774751|NCT01281189|540300974|FG000|Overall Study|Death|103|||
149774752|NCT01281189|540300975|FG001|Overall Study|Death|91|||
149774753|NCT01281189|540300974|FG000|Overall Study|Other|8|||
149774754|NCT01281189|540300975|FG001|Overall Study|Other|12|||
149774755|NCT05355818|540300976|FG000|Overall Study|Adverse Event|1|||
149774756|NCT05355818|540300977|FG001|Overall Study|Adverse Event|1|||
149774757|NCT05355818|540300976|FG000|Overall Study|Lack of Efficacy|2|||
149774758|NCT05355818|540300977|FG001|Overall Study|Lack of Efficacy|1|||
149774759|NCT05355818|540300976|FG000|Overall Study|Lost to Follow-up|0|||
149774760|NCT05355818|540300977|FG001|Overall Study|Lost to Follow-up|1|||
149774761|NCT01090102|540300978|FG000|First 12 Weeks|Withdrawal by Subject|1|||
149774762|NCT01090102|540300979|FG001|First 12 Weeks|Withdrawal by Subject|1|||
149774763|NCT01090102|540300978|FG000|First 12 Weeks|Adverse Event|2|||
149774764|NCT01090102|540300979|FG001|First 12 Weeks|Adverse Event|0|||
149774765|NCT01090102|540300978|FG000|First 12 Weeks|Death|1|||
149774766|NCT01090102|540300979|FG001|First 12 Weeks|Death|1|||
149774767|NCT01090102|540300978|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
149774768|NCT01090102|540300979|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
149774769|NCT01601704|540300980|FG000|Overall Study|Randomized but not dispensed study med|1|||
149774770|NCT01601704|540300981|FG001|Overall Study|Randomized but not dispensed study med|4|||
149774771|NCT03518034|540300982|FG000|Overall Study|Not Treated|5|||
149774772|NCT03518034|540300983|FG001|Overall Study|Not Treated|1|||
149774773|NCT03518034|540300982|FG000|Overall Study|Withdrawal by Subject|309|||
149774774|NCT03518034|540300983|FG001|Overall Study|Withdrawal by Subject|351|||
149774775|NCT03518034|540300982|FG000|Overall Study|Lost to Follow-up|446|||
149774776|NCT03518034|540300983|FG001|Overall Study|Lost to Follow-up|458|||
149774777|NCT03518034|540300982|FG000|Overall Study|Adverse Event|138|||
149774778|NCT03518034|540300983|FG001|Overall Study|Adverse Event|130|||
149774779|NCT03518034|540300982|FG000|Overall Study|Lack of Efficacy|11|||
149774780|NCT03518034|540300983|FG001|Overall Study|Lack of Efficacy|23|||
149774781|NCT03518034|540300982|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
149774782|NCT03518034|540300983|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
149774783|NCT03518034|540300982|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
149774784|NCT03518034|540300983|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
149774785|NCT03518034|540300982|FG000|Overall Study|Other, Not Specified|84|||
149774786|NCT03518034|540300983|FG001|Overall Study|Other, Not Specified|53|||
149774787|NCT03518034|540300982|FG000|Overall Study|Reason Missing|2|||
149774788|NCT03518034|540300983|FG001|Overall Study|Reason Missing|3|||
149774789|NCT02273037|540300985|FG000|Overall Study|Lost to Follow-up|1|||
149774790|NCT02273037|540300986|FG001|Overall Study|Lost to Follow-up|0|||
149774791|NCT02273037|540300985|FG000|Overall Study|Delivered before monitoring initiated|1|||
149774792|NCT02273037|540300986|FG001|Overall Study|Delivered before monitoring initiated|3|||
149774793|NCT02273037|540300985|FG000|Overall Study|Breech delivery|2|||
149774794|NCT02273037|540300986|FG001|Overall Study|Breech delivery|3|||
149774795|NCT02273037|540300985|FG000|Overall Study|Multiple delivery|2|||
149774796|NCT02273037|540300986|FG001|Overall Study|Multiple delivery|2|||
149774797|NCT02273037|540300985|FG000|Overall Study|Other complication|2|||
149774798|NCT02273037|540300986|FG001|Overall Study|Other complication|0|||
149774799|NCT02062398|540300987|FG000|Overall Study|Implant removal|1|||
149774800|NCT00415519|540300989|FG000|Overall Study|Adverse Event|1|||
149774801|NCT00415519|540300990|FG001|Overall Study|Adverse Event|0|||
149774802|NCT00415519|540300989|FG000|Overall Study|Withdrawal by Subject|2|||
149774803|NCT00415519|540300990|FG001|Overall Study|Withdrawal by Subject|0|||
149774804|NCT00415519|540300989|FG000|Overall Study|Patient's convenience|1|||
149774805|NCT00415519|540300990|FG001|Overall Study|Patient's convenience|0|||
149774806|NCT00510484|540300992|FG000|Wash-out Period|Adverse Event|0|||
149774807|NCT00510484|540300993|FG001|Wash-out Period|Adverse Event|1|||
149774808|NCT01590212|540300994|FG000|Overall Study|Withdrawal by Subject|2|||
149774809|NCT01590212|540300995|FG001|Overall Study|Withdrawal by Subject|2|||
149774810|NCT01590212|540300996|FG002|Overall Study|Withdrawal by Subject|2|||
149774811|NCT01590212|540300994|FG000|Overall Study|Lost to Follow-up|1|||
149774812|NCT01590212|540300995|FG001|Overall Study|Lost to Follow-up|2|||
149774813|NCT01590212|540300996|FG002|Overall Study|Lost to Follow-up|3|||
149774814|NCT02533401|540300997|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
149774815|NCT02533401|540300997|FG000|Overall Study|Death|5|||
149774816|NCT02533401|540300997|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
149774817|NCT02533401|540300997|FG000|Overall Study|Lost to Follow-up|1|||
149774818|NCT02533401|540300997|FG000|Overall Study|Violation of Selection Criteria|1|||
149774819|NCT00881361|540301004|FG000|Overall Study|Terminated prior to surgery|27|||
149774820|NCT00881361|540301005|FG001|Overall Study|Terminated prior to surgery|7|||
149774821|NCT00881361|540301006|FG002|Overall Study|Terminated prior to surgery|0|||
149774822|NCT00881361|540301004|FG000|Overall Study|Ineligible|17|||
149774823|NCT00881361|540301005|FG001|Overall Study|Ineligible|2|||
149774824|NCT00881361|540301006|FG002|Overall Study|Ineligible|2|||
149774825|NCT06000501|540301010|FG000|Overall Study|Screen failure|3|||
149774826|NCT06000501|540301010|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
149774827|NCT06000501|540301010|FG000|Overall Study|Physician Decision|4|||
149774828|NCT06000501|540301010|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
149774829|NCT06000501|540301010|FG000|Overall Study|Scheduling issues|2|||
149774830|NCT03496662|540301011|FG000|Overall Study|Adverse Event|0|||
149774831|NCT03496662|540301012|FG001|Overall Study|Adverse Event|0|||
149774832|NCT03496662|540301013|FG002|Overall Study|Adverse Event|4|||
149774833|NCT03496662|540301011|FG000|Overall Study|Withdrawal by Subject|1|||
149774834|NCT03496662|540301012|FG001|Overall Study|Withdrawal by Subject|0|||
149774835|NCT03496662|540301013|FG002|Overall Study|Withdrawal by Subject|2|||
149774836|NCT03496662|540301011|FG000|Overall Study|Death|0|||
149774837|NCT03496662|540301012|FG001|Overall Study|Death|0|||
149774838|NCT03496662|540301013|FG002|Overall Study|Death|2|||
149774839|NCT03496662|540301011|FG000|Overall Study|Noncompliance|0|||
149774840|NCT03496662|540301012|FG001|Overall Study|Noncompliance|0|||
149774841|NCT03496662|540301013|FG002|Overall Study|Noncompliance|1|||
149774842|NCT00282867|540301018|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
149774843|NCT00282867|540301019|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
149774844|NCT00282867|540301020|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
149774845|NCT01074658|540301021|FG000|Overall Study|No implant attempted|19|||
149774846|NCT00432562|540301025|FG000|Overall Study|Death|3|||
149774847|NCT00432562|540301026|FG001|Overall Study|Death|0|||
149774848|NCT02146248|540301027|FG000|Overall Study|Withdrawal by Subject|2|||
149774849|NCT01374217|540301031|FG000|Overall Study|Lack of Efficacy|13|||
149774850|NCT00555906|540301032|FG000|Phase 1|Objective Progression or Relapse|3|||
149774851|NCT00555906|540301033|FG001|Phase 1|Objective Progression or Relapse|5|||
149774852|NCT00555906|540301034|FG002|Phase 1|Objective Progression or Relapse|3|||
149774853|NCT00555906|540301035|FG003|Phase 1|Objective Progression or Relapse|1|||
149774854|NCT00555906|540301036|FG004|Phase 1|Objective Progression or Relapse|0|||
149774855|NCT00555906|540301032|FG000|Phase 1|Global Deterioration of Health Status|0|||
149774856|NCT00555906|540301033|FG001|Phase 1|Global Deterioration of Health Status|1|||
149774857|NCT00555906|540301034|FG002|Phase 1|Global Deterioration of Health Status|1|||
149774858|NCT00555906|540301035|FG003|Phase 1|Global Deterioration of Health Status|1|||
149774859|NCT00555906|540301036|FG004|Phase 1|Global Deterioration of Health Status|0|||
149774860|NCT00555906|540301032|FG000|Phase 1|Adverse Event|0|||
149774861|NCT00555906|540301033|FG001|Phase 1|Adverse Event|0|||
149774862|NCT00555906|540301034|FG002|Phase 1|Adverse Event|3|||
149774863|NCT00555906|540301035|FG003|Phase 1|Adverse Event|2|||
149774864|NCT00555906|540301036|FG004|Phase 1|Adverse Event|0|||
149774865|NCT00555906|540301032|FG000|Phase 1|Withdrawal by Subject|0|||
149774866|NCT00555906|540301033|FG001|Phase 1|Withdrawal by Subject|0|||
149774867|NCT00555906|540301034|FG002|Phase 1|Withdrawal by Subject|0|||
149774868|NCT00555906|540301035|FG003|Phase 1|Withdrawal by Subject|1|||
149774869|NCT00555906|540301036|FG004|Phase 1|Withdrawal by Subject|0|||
149774870|NCT00555906|540301032|FG000|Phase 2|Adverse Event|0|||
149774871|NCT00555906|540301033|FG001|Phase 2|Adverse Event|0|||
149774872|NCT00555906|540301034|FG002|Phase 2|Adverse Event|0|||
149774873|NCT00555906|540301035|FG003|Phase 2|Adverse Event|0|||
149774874|NCT00555906|540301036|FG004|Phase 2|Adverse Event|4|||
149774875|NCT00555906|540301032|FG000|Phase 2|Global Deterioration of Health Status|0|||
149774876|NCT00555906|540301033|FG001|Phase 2|Global Deterioration of Health Status|0|||
149774877|NCT00555906|540301034|FG002|Phase 2|Global Deterioration of Health Status|0|||
149774878|NCT00555906|540301035|FG003|Phase 2|Global Deterioration of Health Status|0|||
149774879|NCT00555906|540301036|FG004|Phase 2|Global Deterioration of Health Status|2|||
149774880|NCT00555906|540301032|FG000|Phase 2|Objective Progression or Relapse|0|||
149774881|NCT00555906|540301033|FG001|Phase 2|Objective Progression or Relapse|0|||
149774882|NCT00555906|540301034|FG002|Phase 2|Objective Progression or Relapse|0|||
149774883|NCT00555906|540301035|FG003|Phase 2|Objective Progression or Relapse|0|||
149774884|NCT00555906|540301036|FG004|Phase 2|Objective Progression or Relapse|16|||
149774885|NCT00555906|540301032|FG000|Phase 2|Withdrawal by Subject|0|||
149774886|NCT00555906|540301033|FG001|Phase 2|Withdrawal by Subject|0|||
149774887|NCT00555906|540301034|FG002|Phase 2|Withdrawal by Subject|0|||
149774888|NCT00555906|540301035|FG003|Phase 2|Withdrawal by Subject|0|||
149774889|NCT00555906|540301036|FG004|Phase 2|Withdrawal by Subject|2|||
149774890|NCT00555906|540301032|FG000|Phase 2|Other|0|||
149774891|NCT00555906|540301033|FG001|Phase 2|Other|0|||
149774892|NCT00555906|540301034|FG002|Phase 2|Other|0|||
149774893|NCT00555906|540301035|FG003|Phase 2|Other|0|||
149774894|NCT00555906|540301036|FG004|Phase 2|Other|6|||
149774895|NCT00555906|540301032|FG000|Phase 2|Randomized but not Treated|0|||
149774896|NCT00555906|540301033|FG001|Phase 2|Randomized but not Treated|0|||
149774897|NCT00555906|540301034|FG002|Phase 2|Randomized but not Treated|0|||
149774898|NCT00555906|540301035|FG003|Phase 2|Randomized but not Treated|0|||
149774899|NCT00555906|540301036|FG004|Phase 2|Randomized but not Treated|2|||
149774900|NCT01033487|540301037|FG000|Fourth Intervention Period|Adverse Event|0|||
149774901|NCT01033487|540301038|FG001|Fourth Intervention Period|Adverse Event|0|||
149774902|NCT01033487|540301039|FG002|Fourth Intervention Period|Adverse Event|0|||
149774903|NCT01033487|540301040|FG003|Fourth Intervention Period|Adverse Event|0|||
149774904|NCT01033487|540301041|FG004|Fourth Intervention Period|Adverse Event|0|||
149774905|NCT01033487|540301042|FG005|Fourth Intervention Period|Adverse Event|0|||
149774906|NCT01033487|540301043|FG006|Fourth Intervention Period|Adverse Event|0|||
149774907|NCT01033487|540301044|FG007|Fourth Intervention Period|Adverse Event|0|||
149774908|NCT01033487|540301045|FG008|Fourth Intervention Period|Adverse Event|1|||
149774909|NCT01033487|540301046|FG009|Fourth Intervention Period|Adverse Event|0|||
149774910|NCT00862654|540301047|FG000|Overall Study|Lack of Efficacy|1|||
149774911|NCT00862654|540301048|FG001|Overall Study|Lack of Efficacy|0|||
149774912|NCT00862654|540301049|FG002|Overall Study|Lack of Efficacy|1|||
149774913|NCT00862654|540301050|FG003|Overall Study|Lack of Efficacy|0|||
149774914|NCT00862654|540301047|FG000|Overall Study|Lost to Follow-up|1|||
149774915|NCT00862654|540301048|FG001|Overall Study|Lost to Follow-up|2|||
149774916|NCT00862654|540301049|FG002|Overall Study|Lost to Follow-up|1|||
149774917|NCT00862654|540301050|FG003|Overall Study|Lost to Follow-up|3|||
149774918|NCT00862654|540301047|FG000|Overall Study|Adverse Event|0|||
149774919|NCT00862654|540301048|FG001|Overall Study|Adverse Event|1|||
149774920|NCT00862654|540301049|FG002|Overall Study|Adverse Event|1|||
149774921|NCT00862654|540301050|FG003|Overall Study|Adverse Event|0|||
149774922|NCT00862654|540301047|FG000|Overall Study|Pregnancy|1|||
149774923|NCT00862654|540301048|FG001|Overall Study|Pregnancy|1|||
149774924|NCT00862654|540301049|FG002|Overall Study|Pregnancy|0|||
149774925|NCT00862654|540301050|FG003|Overall Study|Pregnancy|0|||
149774926|NCT00862654|540301047|FG000|Overall Study|Withdrawal by Subject|2|||
149774927|NCT00862654|540301048|FG001|Overall Study|Withdrawal by Subject|2|||
149774928|NCT00862654|540301049|FG002|Overall Study|Withdrawal by Subject|2|||
149774929|NCT00862654|540301050|FG003|Overall Study|Withdrawal by Subject|3|||
149774930|NCT00862654|540301047|FG000|Overall Study|Subject mistake|0|||
149774931|NCT00862654|540301048|FG001|Overall Study|Subject mistake|1|||
149774932|NCT00862654|540301049|FG002|Overall Study|Subject mistake|0|||
149774933|NCT00862654|540301050|FG003|Overall Study|Subject mistake|0|||
149774934|NCT00862654|540301047|FG000|Overall Study|Familly constraint|0|||
149774935|NCT00862654|540301048|FG001|Overall Study|Familly constraint|1|||
149774936|NCT00862654|540301049|FG002|Overall Study|Familly constraint|0|||
149774937|NCT00862654|540301050|FG003|Overall Study|Familly constraint|0|||
149774938|NCT00862654|540301047|FG000|Overall Study|Never used study drugs|1|||
149774939|NCT00862654|540301048|FG001|Overall Study|Never used study drugs|0|||
149774940|NCT00862654|540301049|FG002|Overall Study|Never used study drugs|0|||
149774941|NCT00862654|540301050|FG003|Overall Study|Never used study drugs|0|||
149774942|NCT00862654|540301047|FG000|Overall Study|Included after end of inclusions|0|||
149774943|NCT00862654|540301048|FG001|Overall Study|Included after end of inclusions|0|||
149774944|NCT00862654|540301049|FG002|Overall Study|Included after end of inclusions|1|||
149774945|NCT00862654|540301050|FG003|Overall Study|Included after end of inclusions|0|||
149774946|NCT03219567|540301051|FG000|Overall Study|Withdrawal by Subject|0|||
149774947|NCT03219567|540301052|FG001|Overall Study|Withdrawal by Subject|1|||
149774948|NCT00889681|540301053|FG000|Overall Study|Not meeting qualification Criteria|2|||
149774949|NCT00889681|540301053|FG000|Overall Study|Insurance disapproval|1|||
149774950|NCT04176445|540301054|FG000|Overall Study|Adverse Event|0|||
149774951|NCT04176445|540301055|FG001|Overall Study|Adverse Event|1|||
149774952|NCT04176445|540301054|FG000|Overall Study|change plans weaning after first intervention|0|||
149774953|NCT04176445|540301055|FG001|Overall Study|change plans weaning after first intervention|1|||
149774954|NCT04377672|540301057|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
149774955|NCT03954444|540301058|FG000|Overall Study|Withdrawal by Subject|5|||
149774956|NCT03954444|540301059|FG001|Overall Study|Withdrawal by Subject|5|||
149774957|NCT03954444|540301060|FG002|Overall Study|Withdrawal by Subject|5|||
149774958|NCT03954444|540301058|FG000|Overall Study|Adverse Event|1|||
149774959|NCT03954444|540301059|FG001|Overall Study|Adverse Event|3|||
149774960|NCT03954444|540301060|FG002|Overall Study|Adverse Event|2|||
149774961|NCT03954444|540301058|FG000|Overall Study|Protocol Violation|0|||
149774962|NCT03954444|540301059|FG001|Overall Study|Protocol Violation|3|||
149774963|NCT03954444|540301060|FG002|Overall Study|Protocol Violation|5|||
149774964|NCT03954444|540301058|FG000|Overall Study|Use of prohibited therapy|1|||
149774965|NCT03954444|540301059|FG001|Overall Study|Use of prohibited therapy|1|||
149774966|NCT03954444|540301060|FG002|Overall Study|Use of prohibited therapy|2|||
149774967|NCT03954444|540301058|FG000|Overall Study|Lost to Follow-up|1|||
149774968|NCT03954444|540301059|FG001|Overall Study|Lost to Follow-up|0|||
149774969|NCT03954444|540301060|FG002|Overall Study|Lost to Follow-up|1|||
149774970|NCT03954444|540301058|FG000|Overall Study|Non-compliant with study drug application|2|||
149774971|NCT03954444|540301059|FG001|Overall Study|Non-compliant with study drug application|2|||
149774972|NCT03954444|540301060|FG002|Overall Study|Non-compliant with study drug application|0|||
149774973|NCT03954444|540301058|FG000|Overall Study|Administrative reasons|0|||
149774974|NCT03954444|540301059|FG001|Overall Study|Administrative reasons|0|||
149774975|NCT03954444|540301060|FG002|Overall Study|Administrative reasons|1|||
149774976|NCT03954444|540301058|FG000|Overall Study|Miscellaneous|3|||
149774977|NCT03954444|540301059|FG001|Overall Study|Miscellaneous|2|||
149774978|NCT03954444|540301060|FG002|Overall Study|Miscellaneous|1|||
149774979|NCT02447458|540301061|FG000|Overall Study|Other|0|||
149774980|NCT02447458|540301062|FG001|Overall Study|Other|0|||
149774981|NCT02447458|540301063|FG002|Overall Study|Other|1|||
149774982|NCT02447458|540301064|FG003|Overall Study|Other|0|||
149774983|NCT02447458|540301065|FG004|Overall Study|Other|0|||
149774984|NCT02447458|540301066|FG005|Overall Study|Other|0|||
149774985|NCT03094832|540301069|FG000|Overall Study|Lost to Follow-up|0|||
149774986|NCT03094832|540301070|FG001|Overall Study|Lost to Follow-up|0|||
149774987|NCT03094832|540301071|FG002|Overall Study|Lost to Follow-up|0|||
149774988|NCT03094832|540301072|FG003|Overall Study|Lost to Follow-up|1|||
149774989|NCT03094832|540301073|FG004|Overall Study|Lost to Follow-up|1|||
149774990|NCT03094832|540301069|FG000|Overall Study|Death|1|||
149774991|NCT03094832|540301070|FG001|Overall Study|Death|0|||
149774992|NCT03094832|540301071|FG002|Overall Study|Death|0|||
149774993|NCT03094832|540301072|FG003|Overall Study|Death|0|||
149774994|NCT03094832|540301073|FG004|Overall Study|Death|0|||
149774995|NCT03094832|540301069|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149774996|NCT03094832|540301070|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149774997|NCT03094832|540301071|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149774998|NCT03094832|540301072|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149774999|NCT03094832|540301073|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149775000|NCT03094832|540301069|FG000|Overall Study|Other|13|||
149775001|NCT03094832|540301070|FG001|Overall Study|Other|20|||
149775002|NCT03094832|540301071|FG002|Overall Study|Other|1|||
149775003|NCT03094832|540301072|FG003|Overall Study|Other|7|||
149775004|NCT03094832|540301073|FG004|Overall Study|Other|1|||
149775005|NCT01181778|540301079|FG000|Overall Study|Physician Decision|48|||
149775006|NCT02674685|540301080|FG000|Overall Study|Withdrawal by Subject|4|||
149775007|NCT02713789|540301081|FG000|Overall Study|Lost to Follow-up|0|||
149775008|NCT02713789|540301082|FG001|Overall Study|Lost to Follow-up|1|||
149775009|NCT02713789|540301083|FG002|Overall Study|Lost to Follow-up|1|||
149775010|NCT01293084|540301089|FG000|Overall Study|Physician Decision|3|||
149775011|NCT01293084|540301089|FG000|Overall Study|Withdrawal by Subject|2|||
149801762|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
149801763|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
149801764|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
149801765|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
149801766|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
149801767|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
149801768|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
149801769|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
149801770|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
149801771|NCT01694849|540402434|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
149801772|NCT01694849|540402435|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
149801773|NCT01694849|540402436|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
149801774|NCT01694849|540402434|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
149801775|NCT01694849|540402435|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
149801776|NCT01694849|540402436|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
149801777|NCT01694849|540402434|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
149801778|NCT01694849|540402435|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
149801779|NCT01694849|540402436|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
149801780|NCT02304484|540402437|FG000|Overall Study|Death|9|||
149801781|NCT02304484|540402437|FG000|Overall Study|Withdrawal by Subject|14|||
149801782|NCT02304484|540402437|FG000|Overall Study|Lost to Follow-up|2|||
149801783|NCT04338685|540402438|FG000|Overall Study|Death|3|||
149801784|NCT04338685|540402439|FG001|Overall Study|Death|4|||
149801785|NCT04338685|540402440|FG002|Overall Study|Death|2|||
149775012|NCT00462488|540302852|FG000|Overall Study|Protocol Violation|1|||
149775013|NCT00462488|540302853|FG001|Overall Study|Protocol Violation|0|||
149775014|NCT00462488|540302852|FG000|Overall Study|Lack of Efficacy|19|||
149775015|NCT00462488|540302853|FG001|Overall Study|Lack of Efficacy|17|||
149775016|NCT02848313|540302856|FG000|Overall Study|Adverse Event|1|||
149775017|NCT02848313|540302857|FG001|Overall Study|Adverse Event|2|||
149775018|NCT02848313|540302856|FG000|Overall Study|Lack of Efficacy|0|||
149775019|NCT02848313|540302857|FG001|Overall Study|Lack of Efficacy|1|||
149775020|NCT02848313|540302856|FG000|Overall Study|Withdrawal by Subject|1|||
149775021|NCT02848313|540302857|FG001|Overall Study|Withdrawal by Subject|1|||
149775022|NCT02848313|540302856|FG000|Overall Study|Lost to follow up|1|||
149775023|NCT02848313|540302857|FG001|Overall Study|Lost to follow up|0|||
149775024|NCT03510910|540302858|FG000|Overall Study|Incomplete Survey|2|||
149775025|NCT03510910|540302859|FG001|Overall Study|Incomplete Survey|3|||
149775026|NCT01673490|540302860|FG000|Overall Study|Lost to Follow-up|1|||
149775027|NCT01673490|540302860|FG000|Overall Study|Adverse Event|3|||
149775028|NCT01673490|540302860|FG000|Overall Study|Withdrawal by Subject|3|||
149775029|NCT03382262|540302861|FG000|Overall Study|Physician Decision|0|||
149775030|NCT03382262|540302862|FG001|Overall Study|Physician Decision|0|||
149775031|NCT03382262|540302863|FG002|Overall Study|Physician Decision|1|||
149775032|NCT03382262|540302864|FG003|Overall Study|Physician Decision|0|||
149775033|NCT03382262|540302861|FG000|Overall Study|Withdrawal by Subject|0|||
149775034|NCT03382262|540302862|FG001|Overall Study|Withdrawal by Subject|0|||
149775035|NCT03382262|540302863|FG002|Overall Study|Withdrawal by Subject|0|||
149775036|NCT03382262|540302864|FG003|Overall Study|Withdrawal by Subject|1|||
149775037|NCT04914819|540302865|FG000|Overall Study|Pregnancy|3|||
149775038|NCT04914819|540302866|FG001|Overall Study|Pregnancy|1|||
149775039|NCT04914819|540302865|FG000|Overall Study|Discontinued study|4|||
149775040|NCT04914819|540302866|FG001|Overall Study|Discontinued study|1|||
149775041|NCT04914819|540302865|FG000|Overall Study|Lost to Follow-up|7|||
149775042|NCT04914819|540302866|FG001|Overall Study|Lost to Follow-up|0|||
149775043|NCT02715804|540302867|FG000|Overall Study|Death|222|||
149775044|NCT02715804|540302868|FG001|Overall Study|Death|106|||
149775045|NCT02715804|540302867|FG000|Overall Study|Withdrawal by Subject|5|||
149775046|NCT02715804|540302868|FG001|Overall Study|Withdrawal by Subject|4|||
149775047|NCT02715804|540302867|FG000|Overall Study|Other than specified|2|||
149775048|NCT02715804|540302868|FG001|Overall Study|Other than specified|3|||
149775049|NCT01625611|540302871|FG000|Overall Study|No adlib drinks Lab 1|3|||
149775050|NCT01625611|540302872|FG001|Overall Study|No adlib drinks Lab 1|0|||
149775051|NCT01625611|540302871|FG000|Overall Study|Technical issues with PET|1|||
149775052|NCT01625611|540302872|FG001|Overall Study|Technical issues with PET|0|||
149775053|NCT01625611|540302871|FG000|Overall Study|Unable to complete study procedures|1|||
149775054|NCT01625611|540302872|FG001|Overall Study|Unable to complete study procedures|0|||
149775055|NCT01625611|540302871|FG000|Overall Study|Withdrawal by Subject|3|||
149775056|NCT01625611|540302872|FG001|Overall Study|Withdrawal by Subject|0|||
149775057|NCT00948194|540302873|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
149775058|NCT00948194|540302874|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
149775059|NCT00233324|540302875|FG000|Main Study|Death|68|||
149775060|NCT00233324|540302876|FG001|Main Study|Death|60|||
149775061|NCT00233324|540302877|FG002|Main Study|Death|62|||
149775062|NCT00233324|540302878|FG003|Main Study|Death|47|||
149775063|NCT00233324|540302875|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
149775064|NCT00233324|540302876|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
149775065|NCT00233324|540302877|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
149775066|NCT00233324|540302878|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
149775067|NCT00233324|540302875|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
149775068|NCT00233324|540302876|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
149775069|NCT00233324|540302877|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
149775070|NCT00233324|540302878|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
149775071|NCT02905825|540302881|FG000|Overall Study|Protocol Violation|11|||
149775072|NCT02905825|540302881|FG000|Overall Study|Device Malfunction|1|||
149775073|NCT01709708|540302883|FG000|Overall Study|Protocol Violation|1|||
149775074|NCT01709708|540302884|FG001|Overall Study|Protocol Violation|2|||
149775075|NCT01527110|540302885|FG000|Overall Study|Adverse Event|1|||
149775076|NCT02007252|540302886|FG000|Overall Study|Administrative problems|3|||
149775077|NCT02007252|540302887|FG001|Overall Study|Administrative problems|7|||
149775078|NCT02007252|540302886|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149775079|NCT02007252|540302887|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149775080|NCT02007252|540302886|FG000|Overall Study|Adverse Event|7|||
149775081|NCT02007252|540302887|FG001|Overall Study|Adverse Event|4|||
149775082|NCT02657434|540302888|FG000|Overall Study|Study Terminated By Sponsor|64|||
149775083|NCT02657434|540302889|FG001|Overall Study|Study Terminated By Sponsor|82|||
149775084|NCT02657434|540302888|FG000|Overall Study|Death|189|||
149775085|NCT02657434|540302889|FG001|Overall Study|Death|190|||
149775086|NCT02657434|540302888|FG000|Overall Study|Lost to Follow-up|2|||
149775087|NCT02657434|540302889|FG001|Overall Study|Lost to Follow-up|2|||
149775088|NCT02657434|540302888|FG000|Overall Study|Randomization by Error|2|||
149775089|NCT02657434|540302889|FG001|Overall Study|Randomization by Error|0|||
149775090|NCT02657434|540302888|FG000|Overall Study|Withdrawal by Subject|28|||
149775091|NCT02657434|540302889|FG001|Overall Study|Withdrawal by Subject|17|||
149775092|NCT02657434|540302888|FG000|Overall Study|Protocol Violation|1|||
149775093|NCT02657434|540302889|FG001|Overall Study|Protocol Violation|0|||
149775094|NCT02657434|540302888|FG000|Overall Study|Physician Decision|0|||
149775095|NCT02657434|540302889|FG001|Overall Study|Physician Decision|1|||
149775096|NCT00511108|540302892|FG000|Overall Study|Adverse Event|2|||
149775097|NCT00511108|540302893|FG001|Overall Study|Adverse Event|0|||
149775098|NCT00511108|540302894|FG002|Overall Study|Adverse Event|1|||
149775099|NCT00511108|540302895|FG003|Overall Study|Adverse Event|2|||
149775100|NCT00511108|540302892|FG000|Overall Study|Lost to Follow-up|0|||
149775101|NCT00511108|540302893|FG001|Overall Study|Lost to Follow-up|2|||
149775102|NCT00511108|540302894|FG002|Overall Study|Lost to Follow-up|1|||
149775103|NCT00511108|540302895|FG003|Overall Study|Lost to Follow-up|0|||
149775104|NCT00511108|540302892|FG000|Overall Study|Physician Decision|0|||
149775105|NCT00511108|540302893|FG001|Overall Study|Physician Decision|0|||
149775106|NCT00511108|540302894|FG002|Overall Study|Physician Decision|0|||
149775107|NCT00511108|540302895|FG003|Overall Study|Physician Decision|1|||
149775108|NCT00511108|540302892|FG000|Overall Study|Withdrawal by Subject|4|||
149775109|NCT00511108|540302893|FG001|Overall Study|Withdrawal by Subject|0|||
149775110|NCT00511108|540302894|FG002|Overall Study|Withdrawal by Subject|3|||
149775111|NCT00511108|540302895|FG003|Overall Study|Withdrawal by Subject|2|||
149775112|NCT02147691|540302898|FG000|Overall Study|Withdrawal by Subject|2|||
149775113|NCT02147691|540302899|FG001|Overall Study|Withdrawal by Subject|0|||
149775114|NCT02147691|540302898|FG000|Overall Study|Adverse Event|2|||
149775115|NCT02147691|540302899|FG001|Overall Study|Adverse Event|0|||
149775116|NCT02147691|540302898|FG000|Overall Study|Lost to Follow-up|0|||
149775117|NCT02147691|540302899|FG001|Overall Study|Lost to Follow-up|1|||
149775118|NCT01392742|540302902|FG000|Overall Study|Premature study termination|42|||
149775119|NCT01392742|540302902|FG000|Overall Study|Failure to return|35|||
149775120|NCT01392742|540302902|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
149775121|NCT01392742|540302902|FG000|Overall Study|Lost to Follow-up|34|||
149775122|NCT01392742|540302902|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
149775123|NCT01392742|540302902|FG000|Overall Study|ITR and Protocol deviation|1|||
149775124|NCT01392742|540302902|FG000|Overall Study|Adverse event/intercurrent illness|17|||
149775125|NCT01392742|540302902|FG000|Overall Study|Protocol Violation|14|||
149775126|NCT01392742|540302902|FG000|Overall Study|Other|3|||
149775127|NCT01392742|540302902|FG000|Overall Study|Missing information|13|||
149775128|NCT01998958|540302903|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775129|NCT01998958|540302904|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
149775130|NCT01998958|540302905|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775131|NCT01998958|540302906|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775132|NCT01998958|540302907|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775133|NCT01998958|540302908|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775134|NCT01998958|540302909|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775135|NCT01998958|540302910|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775136|NCT01998958|540302911|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775137|NCT01998958|540302912|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775138|NCT01998958|540302913|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775139|NCT01998958|540302914|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775140|NCT01998958|540302915|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775141|NCT01998958|540302916|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775142|NCT01998958|540302917|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775143|NCT01998958|540302918|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775144|NCT01998958|540302919|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775145|NCT01998958|540302920|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775146|NCT01998958|540302921|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775147|NCT01998958|540302922|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775148|NCT01998958|540302923|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775149|NCT01998958|540302924|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775150|NCT01998958|540302925|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775151|NCT01998958|540302926|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775152|NCT01998958|540302927|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775153|NCT01998958|540302928|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775154|NCT01998958|540302929|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775155|NCT01998958|540302930|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775156|NCT01998958|540302931|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775157|NCT01998958|540302932|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775158|NCT01998958|540302933|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775159|NCT01998958|540302934|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149775160|NCT01998958|540302903|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775161|NCT01998958|540302904|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
149775162|NCT01998958|540302905|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775163|NCT01998958|540302906|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775164|NCT01998958|540302907|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775165|NCT01998958|540302908|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775166|NCT01998958|540302909|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775167|NCT01998958|540302910|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775168|NCT01998958|540302911|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775169|NCT01998958|540302912|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775170|NCT01998958|540302913|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775171|NCT01998958|540302914|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775172|NCT01998958|540302915|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775173|NCT01998958|540302916|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775174|NCT01998958|540302917|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775175|NCT01998958|540302918|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775176|NCT01998958|540302919|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775177|NCT01998958|540302920|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775178|NCT01998958|540302921|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775179|NCT01998958|540302922|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775180|NCT01998958|540302923|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775181|NCT01998958|540302924|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775182|NCT01998958|540302925|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775183|NCT01998958|540302926|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775184|NCT01998958|540302927|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775185|NCT01998958|540302928|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775186|NCT01998958|540302929|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775187|NCT01998958|540302930|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775188|NCT01998958|540302931|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775189|NCT01998958|540302932|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775190|NCT01998958|540302933|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775191|NCT01998958|540302934|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149775192|NCT01998958|540302903|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
149775193|NCT01998958|540302904|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
149775194|NCT01998958|540302905|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
149775195|NCT01998958|540302906|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
149775196|NCT01998958|540302907|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
149775197|NCT01998958|540302908|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
149775198|NCT01998958|540302909|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
149775199|NCT01998958|540302910|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
149775200|NCT01998958|540302911|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
149775201|NCT01998958|540302912|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
149775202|NCT01998958|540302913|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
149775203|NCT01998958|540302914|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
149775204|NCT01998958|540302915|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
149775205|NCT01998958|540302916|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
149775206|NCT01998958|540302917|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
149775207|NCT01998958|540302918|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
149775208|NCT01998958|540302919|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
149775209|NCT01998958|540302920|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
149775210|NCT01998958|540302921|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
149775211|NCT01998958|540302922|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
149775212|NCT01998958|540302923|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
149775213|NCT01998958|540302924|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
149775214|NCT01998958|540302925|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
149775215|NCT01998958|540302926|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
149775216|NCT01998958|540302927|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
149775217|NCT01998958|540302928|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
149775218|NCT01998958|540302929|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
149775219|NCT01998958|540302930|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
149775220|NCT01998958|540302931|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
149775221|NCT01998958|540302932|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
149775222|NCT01998958|540302933|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
149775223|NCT01998958|540302934|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
149775224|NCT01998958|540302903|FG000|Period 1 (Panel A and B)|Other|1|||
149775225|NCT01998958|540302904|FG001|Period 1 (Panel A and B)|Other|0|||
149775226|NCT01998958|540302905|FG002|Period 1 (Panel A and B)|Other|0|||
149775227|NCT01998958|540302906|FG003|Period 1 (Panel A and B)|Other|0|||
149775228|NCT01998958|540302907|FG004|Period 1 (Panel A and B)|Other|0|||
149775229|NCT01998958|540302908|FG005|Period 1 (Panel A and B)|Other|0|||
149775230|NCT01998958|540302909|FG006|Period 1 (Panel A and B)|Other|0|||
149775231|NCT01998958|540302910|FG007|Period 1 (Panel A and B)|Other|0|||
149775232|NCT01998958|540302911|FG008|Period 1 (Panel A and B)|Other|0|||
149775233|NCT01998958|540302912|FG009|Period 1 (Panel A and B)|Other|0|||
149775234|NCT01998958|540302913|FG010|Period 1 (Panel A and B)|Other|0|||
149775235|NCT01998958|540302914|FG011|Period 1 (Panel A and B)|Other|0|||
149775236|NCT01998958|540302915|FG012|Period 1 (Panel A and B)|Other|0|||
149775237|NCT01998958|540302916|FG013|Period 1 (Panel A and B)|Other|0|||
149775238|NCT01998958|540302917|FG014|Period 1 (Panel A and B)|Other|0|||
149775239|NCT01998958|540302918|FG015|Period 1 (Panel A and B)|Other|0|||
149775240|NCT01998958|540302919|FG016|Period 1 (Panel A and B)|Other|0|||
149775241|NCT01998958|540302920|FG017|Period 1 (Panel A and B)|Other|0|||
149775242|NCT01998958|540302921|FG018|Period 1 (Panel A and B)|Other|0|||
149775243|NCT01998958|540302922|FG019|Period 1 (Panel A and B)|Other|0|||
149775244|NCT01998958|540302923|FG020|Period 1 (Panel A and B)|Other|0|||
149775245|NCT01998958|540302924|FG021|Period 1 (Panel A and B)|Other|0|||
149775246|NCT01998958|540302925|FG022|Period 1 (Panel A and B)|Other|0|||
149775247|NCT01998958|540302926|FG023|Period 1 (Panel A and B)|Other|0|||
149775248|NCT01998958|540302927|FG024|Period 1 (Panel A and B)|Other|0|||
149775249|NCT01998958|540302928|FG025|Period 1 (Panel A and B)|Other|0|||
149775250|NCT01998958|540302929|FG026|Period 1 (Panel A and B)|Other|0|||
149775251|NCT01998958|540302930|FG027|Period 1 (Panel A and B)|Other|0|||
149775252|NCT01998958|540302931|FG028|Period 1 (Panel A and B)|Other|0|||
149775253|NCT01998958|540302932|FG029|Period 1 (Panel A and B)|Other|0|||
149775254|NCT01998958|540302933|FG030|Period 1 (Panel A and B)|Other|0|||
149775255|NCT01998958|540302934|FG031|Period 1 (Panel A and B)|Other|0|||
149775256|NCT01998958|540302903|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
149775257|NCT01998958|540302904|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
149775258|NCT01998958|540302905|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
149775259|NCT01998958|540302906|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
149775260|NCT01998958|540302907|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
149775261|NCT01998958|540302908|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
149775262|NCT01998958|540302909|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
149775263|NCT01998958|540302910|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
149775264|NCT01998958|540302911|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
149775265|NCT01998958|540302912|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
149775266|NCT01998958|540302913|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
149775267|NCT01998958|540302914|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
149775268|NCT01998958|540302915|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
149775269|NCT01998958|540302916|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
149775270|NCT01998958|540302917|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
149775271|NCT01998958|540302918|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
149775272|NCT01998958|540302919|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
149775273|NCT01998958|540302920|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
149775274|NCT01998958|540302921|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
149775275|NCT01998958|540302922|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
149775276|NCT01998958|540302923|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
149775277|NCT01998958|540302924|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
149775278|NCT01998958|540302925|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
149775279|NCT01998958|540302926|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
149775280|NCT01998958|540302927|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
149775281|NCT01998958|540302928|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
149775282|NCT01998958|540302929|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
149775283|NCT01998958|540302930|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
149775284|NCT01998958|540302931|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
149775285|NCT01998958|540302932|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
149775286|NCT01998958|540302933|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
149775287|NCT01998958|540302934|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
149775288|NCT01998958|540302903|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775289|NCT01998958|540302904|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775290|NCT01998958|540302905|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775291|NCT01998958|540302906|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775292|NCT01998958|540302907|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775293|NCT01998958|540302908|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775294|NCT01998958|540302909|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775295|NCT01998958|540302910|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775296|NCT01998958|540302911|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775297|NCT01998958|540302912|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775298|NCT01998958|540302913|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775299|NCT01998958|540302914|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775300|NCT01998958|540302915|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775301|NCT01998958|540302916|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775302|NCT01998958|540302917|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
149775303|NCT01998958|540302918|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775304|NCT01998958|540302919|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775305|NCT01998958|540302920|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775306|NCT01998958|540302921|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
149775307|NCT01998958|540302922|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775308|NCT01998958|540302923|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775309|NCT01998958|540302924|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775310|NCT01998958|540302925|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775311|NCT01998958|540302926|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775312|NCT01998958|540302927|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775313|NCT01998958|540302928|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775314|NCT01998958|540302929|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775315|NCT01998958|540302930|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775316|NCT01998958|540302931|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775317|NCT01998958|540302932|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775318|NCT01998958|540302933|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775319|NCT01998958|540302934|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149775320|NCT01998958|540302903|FG000|Open Label Phase (Optional)|Adverse Event|0|||
149775321|NCT01998958|540302904|FG001|Open Label Phase (Optional)|Adverse Event|0|||
149775322|NCT01998958|540302905|FG002|Open Label Phase (Optional)|Adverse Event|0|||
149775323|NCT01998958|540302906|FG003|Open Label Phase (Optional)|Adverse Event|0|||
149775324|NCT01998958|540302907|FG004|Open Label Phase (Optional)|Adverse Event|0|||
149775325|NCT01998958|540302908|FG005|Open Label Phase (Optional)|Adverse Event|0|||
149775326|NCT01998958|540302909|FG006|Open Label Phase (Optional)|Adverse Event|0|||
149775327|NCT01998958|540302910|FG007|Open Label Phase (Optional)|Adverse Event|0|||
149775328|NCT01998958|540302911|FG008|Open Label Phase (Optional)|Adverse Event|0|||
149775329|NCT01998958|540302912|FG009|Open Label Phase (Optional)|Adverse Event|0|||
149775330|NCT01998958|540302913|FG010|Open Label Phase (Optional)|Adverse Event|0|||
149775331|NCT01998958|540302914|FG011|Open Label Phase (Optional)|Adverse Event|0|||
149775332|NCT01998958|540302915|FG012|Open Label Phase (Optional)|Adverse Event|0|||
149775333|NCT01998958|540302916|FG013|Open Label Phase (Optional)|Adverse Event|0|||
149775334|NCT01998958|540302917|FG014|Open Label Phase (Optional)|Adverse Event|0|||
149775335|NCT01998958|540302918|FG015|Open Label Phase (Optional)|Adverse Event|0|||
149775336|NCT01998958|540302919|FG016|Open Label Phase (Optional)|Adverse Event|0|||
149775337|NCT01998958|540302920|FG017|Open Label Phase (Optional)|Adverse Event|0|||
149775338|NCT01998958|540302921|FG018|Open Label Phase (Optional)|Adverse Event|0|||
149775339|NCT01998958|540302922|FG019|Open Label Phase (Optional)|Adverse Event|0|||
149775340|NCT01998958|540302923|FG020|Open Label Phase (Optional)|Adverse Event|0|||
149775341|NCT01998958|540302924|FG021|Open Label Phase (Optional)|Adverse Event|0|||
149775342|NCT01998958|540302925|FG022|Open Label Phase (Optional)|Adverse Event|0|||
149775343|NCT01998958|540302926|FG023|Open Label Phase (Optional)|Adverse Event|1|||
149775344|NCT01998958|540302927|FG024|Open Label Phase (Optional)|Adverse Event|0|||
149775345|NCT01998958|540302928|FG025|Open Label Phase (Optional)|Adverse Event|0|||
149775346|NCT01998958|540302929|FG026|Open Label Phase (Optional)|Adverse Event|0|||
149775347|NCT01998958|540302930|FG027|Open Label Phase (Optional)|Adverse Event|0|||
149775348|NCT01998958|540302931|FG028|Open Label Phase (Optional)|Adverse Event|0|||
149775349|NCT01998958|540302932|FG029|Open Label Phase (Optional)|Adverse Event|0|||
149775350|NCT01998958|540302933|FG030|Open Label Phase (Optional)|Adverse Event|0|||
149775351|NCT01998958|540302934|FG031|Open Label Phase (Optional)|Adverse Event|0|||
149775352|NCT01998958|540302903|FG000|Open Label Phase (Optional)|Other|0|||
149775353|NCT01998958|540302904|FG001|Open Label Phase (Optional)|Other|0|||
149775354|NCT01998958|540302905|FG002|Open Label Phase (Optional)|Other|0|||
149775355|NCT01998958|540302906|FG003|Open Label Phase (Optional)|Other|0|||
149775356|NCT01998958|540302907|FG004|Open Label Phase (Optional)|Other|0|||
149775357|NCT01998958|540302908|FG005|Open Label Phase (Optional)|Other|0|||
149775358|NCT01998958|540302909|FG006|Open Label Phase (Optional)|Other|0|||
149775359|NCT01998958|540302910|FG007|Open Label Phase (Optional)|Other|0|||
149775360|NCT01998958|540302911|FG008|Open Label Phase (Optional)|Other|0|||
149775361|NCT01998958|540302912|FG009|Open Label Phase (Optional)|Other|0|||
149775362|NCT01998958|540302913|FG010|Open Label Phase (Optional)|Other|0|||
149775363|NCT01998958|540302914|FG011|Open Label Phase (Optional)|Other|0|||
149775364|NCT01998958|540302915|FG012|Open Label Phase (Optional)|Other|0|||
149775365|NCT01998958|540302916|FG013|Open Label Phase (Optional)|Other|0|||
149775366|NCT01998958|540302917|FG014|Open Label Phase (Optional)|Other|0|||
149775367|NCT01998958|540302918|FG015|Open Label Phase (Optional)|Other|0|||
149775368|NCT01998958|540302919|FG016|Open Label Phase (Optional)|Other|0|||
149775369|NCT01998958|540302920|FG017|Open Label Phase (Optional)|Other|0|||
149775370|NCT01998958|540302921|FG018|Open Label Phase (Optional)|Other|0|||
149775371|NCT01998958|540302922|FG019|Open Label Phase (Optional)|Other|0|||
149775372|NCT01998958|540302923|FG020|Open Label Phase (Optional)|Other|0|||
149775373|NCT01998958|540302924|FG021|Open Label Phase (Optional)|Other|0|||
149775374|NCT01998958|540302925|FG022|Open Label Phase (Optional)|Other|5|||
149775375|NCT01998958|540302926|FG023|Open Label Phase (Optional)|Other|1|||
149775376|NCT01998958|540302927|FG024|Open Label Phase (Optional)|Other|0|||
149775377|NCT01998958|540302928|FG025|Open Label Phase (Optional)|Other|0|||
149775378|NCT01998958|540302929|FG026|Open Label Phase (Optional)|Other|0|||
149775379|NCT01998958|540302930|FG027|Open Label Phase (Optional)|Other|0|||
149775380|NCT01998958|540302931|FG028|Open Label Phase (Optional)|Other|0|||
149775381|NCT01998958|540302932|FG029|Open Label Phase (Optional)|Other|0|||
149775382|NCT01998958|540302933|FG030|Open Label Phase (Optional)|Other|0|||
149775383|NCT01998958|540302934|FG031|Open Label Phase (Optional)|Other|0|||
149775384|NCT01998958|540302903|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775385|NCT01998958|540302904|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775386|NCT01998958|540302905|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775387|NCT01998958|540302906|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775388|NCT01998958|540302907|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775389|NCT01998958|540302908|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775390|NCT01998958|540302909|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775391|NCT01998958|540302910|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775392|NCT01998958|540302911|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775393|NCT01998958|540302912|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775394|NCT01998958|540302913|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775395|NCT01998958|540302914|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775396|NCT01998958|540302915|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775397|NCT01998958|540302916|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775398|NCT01998958|540302917|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775399|NCT01998958|540302918|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775400|NCT01998958|540302919|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775401|NCT01998958|540302920|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775402|NCT01998958|540302921|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775403|NCT01998958|540302922|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775404|NCT01998958|540302923|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775405|NCT01998958|540302924|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775406|NCT01998958|540302925|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
149775407|NCT01998958|540302926|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775408|NCT01998958|540302927|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775409|NCT01998958|540302928|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775410|NCT01998958|540302929|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775411|NCT01998958|540302930|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775412|NCT01998958|540302931|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775413|NCT01998958|540302932|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775414|NCT01998958|540302933|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775415|NCT01998958|540302934|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
149775416|NCT01998958|540302903|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775417|NCT01998958|540302904|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775418|NCT01998958|540302905|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775419|NCT01998958|540302906|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775420|NCT01998958|540302907|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775421|NCT01998958|540302908|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775422|NCT01998958|540302909|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775423|NCT01998958|540302910|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775424|NCT01998958|540302911|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775425|NCT01998958|540302912|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775426|NCT01998958|540302913|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775427|NCT01998958|540302914|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775428|NCT01998958|540302915|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775429|NCT01998958|540302916|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775430|NCT01998958|540302917|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775431|NCT01998958|540302918|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775432|NCT01998958|540302919|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775433|NCT01998958|540302920|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775434|NCT01998958|540302921|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775435|NCT01998958|540302922|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775436|NCT01998958|540302923|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775437|NCT01998958|540302924|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
149775438|NCT01998958|540302925|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
149775439|NCT01998958|540302926|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775440|NCT01998958|540302927|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775441|NCT01998958|540302928|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775442|NCT01998958|540302929|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775443|NCT01998958|540302930|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775444|NCT01998958|540302931|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775445|NCT01998958|540302932|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775446|NCT01998958|540302933|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775447|NCT01998958|540302934|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
149775448|NCT01998958|540302903|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775449|NCT01998958|540302904|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775450|NCT01998958|540302905|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775451|NCT01998958|540302906|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775452|NCT01998958|540302907|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775453|NCT01998958|540302908|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775454|NCT01998958|540302909|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775455|NCT01998958|540302910|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775456|NCT01998958|540302911|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775457|NCT01998958|540302912|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775458|NCT01998958|540302913|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775459|NCT01998958|540302914|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775460|NCT01998958|540302915|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775461|NCT01998958|540302916|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775462|NCT01998958|540302917|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775463|NCT01998958|540302918|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775464|NCT01998958|540302919|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775465|NCT01998958|540302920|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775466|NCT01998958|540302921|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775467|NCT01998958|540302922|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775468|NCT01998958|540302923|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775469|NCT01998958|540302924|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
149775470|NCT01998958|540302925|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
149775471|NCT01998958|540302926|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
149775472|NCT01998958|540302927|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775473|NCT01998958|540302928|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775474|NCT01998958|540302929|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775475|NCT01998958|540302930|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775476|NCT01998958|540302931|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775477|NCT01998958|540302932|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775478|NCT01998958|540302933|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775479|NCT01998958|540302934|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149775480|NCT02432703|540302935|FG000|Overall Study|Adverse Event|1|||
149775481|NCT02432703|540302936|FG001|Overall Study|Adverse Event|4|||
149775482|NCT02432703|540302935|FG000|Overall Study|Lack of Efficacy|1|||
149775483|NCT02432703|540302936|FG001|Overall Study|Lack of Efficacy|0|||
149775484|NCT02432703|540302935|FG000|Overall Study|Lost to Follow-up|5|||
149775485|NCT02432703|540302936|FG001|Overall Study|Lost to Follow-up|3|||
149775486|NCT02432703|540302935|FG000|Overall Study|Withdrawal by Subject|9|||
149775487|NCT02432703|540302936|FG001|Overall Study|Withdrawal by Subject|6|||
149775488|NCT02432703|540302935|FG000|Overall Study|Other|6|||
149775489|NCT02432703|540302936|FG001|Overall Study|Other|5|||
149775490|NCT02137837|540302937|FG000|Overall Study|Adverse Event|0|||
149775491|NCT02137837|540302938|FG001|Overall Study|Adverse Event|2|||
149775492|NCT02137837|540302939|FG002|Overall Study|Adverse Event|1|||
149775493|NCT02137837|540302937|FG000|Overall Study|Refusal unrelated to adverse event|2|||
149775494|NCT02137837|540302938|FG001|Overall Study|Refusal unrelated to adverse event|2|||
149775495|NCT02137837|540302939|FG002|Overall Study|Refusal unrelated to adverse event|1|||
149775496|NCT02137837|540302937|FG000|Overall Study|Progression/relapse|9|||
149775497|NCT02137837|540302938|FG001|Overall Study|Progression/relapse|7|||
149775498|NCT02137837|540302939|FG002|Overall Study|Progression/relapse|7|||
149775499|NCT02137837|540302937|FG000|Overall Study|Not protocol specified|2|||
149775500|NCT02137837|540302938|FG001|Overall Study|Not protocol specified|1|||
149775501|NCT02137837|540302939|FG002|Overall Study|Not protocol specified|3|||
149775502|NCT01181141|540302940|FG000|Overall Study|Adverse Event|2|||
149775503|NCT01181141|540302941|FG001|Overall Study|Adverse Event|1|||
149775504|NCT01181141|540302940|FG000|Overall Study|Lack of Efficacy|1|||
149775505|NCT01181141|540302941|FG001|Overall Study|Lack of Efficacy|0|||
149775506|NCT01181141|540302940|FG000|Overall Study|Lost to Follow-up|1|||
149775507|NCT01181141|540302941|FG001|Overall Study|Lost to Follow-up|1|||
149775508|NCT01181141|540302940|FG000|Overall Study|Physician Decision|2|||
149775509|NCT01181141|540302941|FG001|Overall Study|Physician Decision|0|||
149775510|NCT01181141|540302940|FG000|Overall Study|Protocol Violation|3|||
149775511|NCT01181141|540302941|FG001|Overall Study|Protocol Violation|1|||
149775512|NCT01181141|540302940|FG000|Overall Study|Withdrawal by Subject|3|||
149775513|NCT01181141|540302941|FG001|Overall Study|Withdrawal by Subject|1|||
149775514|NCT01628393|540302942|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
149775515|NCT01628393|540302943|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149775516|NCT01628393|540302944|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149775517|NCT01628393|540302945|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149775518|NCT01628393|540302946|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149775519|NCT01628393|540302942|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
149775520|NCT01628393|540302943|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
149775521|NCT01628393|540302944|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
149775522|NCT01628393|540302945|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
149775523|NCT01628393|540302946|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
149775524|NCT01628393|540302942|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
149775525|NCT01628393|540302943|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
149775526|NCT01628393|540302944|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
149775527|NCT01628393|540302945|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149775528|NCT01628393|540302946|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149775529|NCT01628393|540302942|FG000|Blinded Active Extension Period|Adverse Event|0|||
149775530|NCT01628393|540302943|FG001|Blinded Active Extension Period|Adverse Event|1|||
149775531|NCT01628393|540302944|FG002|Blinded Active Extension Period|Adverse Event|0|||
149775532|NCT01628393|540302945|FG003|Blinded Active Extension Period|Adverse Event|2|||
149775533|NCT01628393|540302946|FG004|Blinded Active Extension Period|Adverse Event|2|||
149775534|NCT01628393|540302942|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
149775535|NCT01628393|540302943|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
149775536|NCT01628393|540302944|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
149775537|NCT01628393|540302945|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
149775538|NCT01628393|540302946|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
149775539|NCT01628393|540302942|FG000|Blinded Active Extension Period|Physician Decision|0|||
149775540|NCT01628393|540302943|FG001|Blinded Active Extension Period|Physician Decision|3|||
149775541|NCT01628393|540302944|FG002|Blinded Active Extension Period|Physician Decision|0|||
149775542|NCT01628393|540302945|FG003|Blinded Active Extension Period|Physician Decision|1|||
149775543|NCT01628393|540302946|FG004|Blinded Active Extension Period|Physician Decision|0|||
149775544|NCT01628393|540302942|FG000|Blinded Active Extension Period|Protocol Violation|0|||
149775545|NCT01628393|540302943|FG001|Blinded Active Extension Period|Protocol Violation|0|||
149775546|NCT01628393|540302944|FG002|Blinded Active Extension Period|Protocol Violation|2|||
149775547|NCT01628393|540302945|FG003|Blinded Active Extension Period|Protocol Violation|1|||
149775548|NCT01628393|540302946|FG004|Blinded Active Extension Period|Protocol Violation|0|||
149775549|NCT01628393|540302942|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
149775550|NCT01628393|540302943|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
149775551|NCT01628393|540302944|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
149775552|NCT01628393|540302945|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
149775553|NCT01628393|540302946|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
149775554|NCT03395223|540302947|FG000|Overall Study|Lost to Follow-up|3|||
149775555|NCT03395223|540302947|FG000|Overall Study|Other|1|||
149775556|NCT01248364|540302951|FG000|Overall Study|Adverse Event|0|||
149775557|NCT01248364|540302952|FG001|Overall Study|Adverse Event|1|||
149775558|NCT01248364|540302953|FG002|Overall Study|Adverse Event|0|||
149775559|NCT01248364|540302954|FG003|Overall Study|Adverse Event|0|||
149775560|NCT00673894|540302957|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
149775561|NCT00673894|540302958|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
149775562|NCT00673894|540302957|FG000|First Intervention 4 Weeks|Adverse Event|1|||
149775563|NCT00673894|540302958|FG001|First Intervention 4 Weeks|Adverse Event|0|||
149775564|NCT02193828|540302959|FG000|Overall Study|Withdrawal by Subject|0|||
149775565|NCT02193828|540302960|FG001|Overall Study|Withdrawal by Subject|0|||
149775566|NCT02193828|540302961|FG002|Overall Study|Withdrawal by Subject|1|||
149775567|NCT02193828|540302962|FG003|Overall Study|Withdrawal by Subject|1|||
149775568|NCT04046341|540302963|FG000|Overall Study|Lost to Follow-up|2|||
149775569|NCT04046341|540302963|FG000|Overall Study|Withdrawal by Subject|1|||
149775570|NCT00405652|540302964|FG000|Overall Study|Adverse Event|4|||
149775571|NCT05109702|540302966|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
149775572|NCT05109702|540302967|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
149775573|NCT05109702|540302968|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
149775574|NCT05109702|540302966|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
149775575|NCT05109702|540302967|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
149775576|NCT05109702|540302968|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
149775577|NCT05109702|540302966|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
149775578|NCT05109702|540302967|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
149775579|NCT05109702|540302968|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
149775580|NCT05109702|540302966|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
149775581|NCT05109702|540302967|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
149775582|NCT05109702|540302968|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
149775583|NCT05109702|540302966|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
149775584|NCT05109702|540302967|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
149775585|NCT05109702|540302968|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
149775586|NCT01392378|540302969|FG000|Infant Series|Adverse Event|0|||
149775587|NCT01392378|540302970|FG001|Infant Series|Adverse Event|0|||
149775588|NCT01392378|540302971|FG002|Infant Series|Adverse Event|0|||
149775589|NCT01392378|540302972|FG003|Infant Series|Adverse Event|1|||
149775590|NCT01392378|540302973|FG004|Infant Series|Adverse Event|0|||
149775591|NCT01392378|540302969|FG000|Infant Series|Lost to Follow-up|0|||
149775592|NCT01392378|540302970|FG001|Infant Series|Lost to Follow-up|0|||
149775593|NCT01392378|540302971|FG002|Infant Series|Lost to Follow-up|0|||
149775594|NCT01392378|540302972|FG003|Infant Series|Lost to Follow-up|1|||
149775595|NCT01392378|540302973|FG004|Infant Series|Lost to Follow-up|0|||
149775596|NCT01392378|540302969|FG000|Infant Series|Protocol Violation|0|||
149775597|NCT01392378|540302970|FG001|Infant Series|Protocol Violation|1|||
149775598|NCT01392378|540302971|FG002|Infant Series|Protocol Violation|0|||
149775599|NCT01392378|540302972|FG003|Infant Series|Protocol Violation|0|||
149775600|NCT01392378|540302973|FG004|Infant Series|Protocol Violation|0|||
149775601|NCT01392378|540302969|FG000|Infant Series|Withdrawal by Parent|4|||
149775602|NCT01392378|540302970|FG001|Infant Series|Withdrawal by Parent|1|||
149775603|NCT01392378|540302971|FG002|Infant Series|Withdrawal by Parent|0|||
149775604|NCT01392378|540302972|FG003|Infant Series|Withdrawal by Parent|0|||
149775605|NCT01392378|540302973|FG004|Infant Series|Withdrawal by Parent|0|||
149775606|NCT01392378|540302969|FG000|After Infant Series|Lost to Follow-up|0|||
149775607|NCT01392378|540302970|FG001|After Infant Series|Lost to Follow-up|0|||
149775608|NCT01392378|540302971|FG002|After Infant Series|Lost to Follow-up|1|||
149775609|NCT01392378|540302972|FG003|After Infant Series|Lost to Follow-up|0|||
149775610|NCT01392378|540302973|FG004|After Infant Series|Lost to Follow-up|0|||
149775611|NCT01392378|540302969|FG000|After Infant Series|Withdrawal by Parent|0|||
149775612|NCT01392378|540302970|FG001|After Infant Series|Withdrawal by Parent|1|||
149775613|NCT01392378|540302971|FG002|After Infant Series|Withdrawal by Parent|1|||
149775614|NCT01392378|540302972|FG003|After Infant Series|Withdrawal by Parent|0|||
149775615|NCT01392378|540302973|FG004|After Infant Series|Withdrawal by Parent|1|||
149775616|NCT01392378|540302969|FG000|Toddler Dose|Lost to Follow-up|0|||
149775617|NCT01392378|540302970|FG001|Toddler Dose|Lost to Follow-up|0|||
149775618|NCT01392378|540302971|FG002|Toddler Dose|Lost to Follow-up|0|||
149775619|NCT01392378|540302972|FG003|Toddler Dose|Lost to Follow-up|1|||
149775620|NCT01392378|540302973|FG004|Toddler Dose|Lost to Follow-up|0|||
149775621|NCT01392378|540302969|FG000|Toddler Dose|Withdrawal by Parent|0|||
149775622|NCT01392378|540302970|FG001|Toddler Dose|Withdrawal by Parent|1|||
149775623|NCT01392378|540302971|FG002|Toddler Dose|Withdrawal by Parent|0|||
149775624|NCT01392378|540302972|FG003|Toddler Dose|Withdrawal by Parent|1|||
149775625|NCT01392378|540302973|FG004|Toddler Dose|Withdrawal by Parent|1|||
149775626|NCT02322411|540302974|FG000|Overall Study|Lost to Follow-up|4|||
149775627|NCT02322411|540302975|FG001|Overall Study|Lost to Follow-up|7|||
149775628|NCT02322411|540302974|FG000|Overall Study|Withdrawal by Subject|1|||
149775629|NCT02322411|540302975|FG001|Overall Study|Withdrawal by Subject|0|||
149775630|NCT02671461|540302982|FG000|Treatment|Adverse Event|0|||
149775631|NCT02671461|540302983|FG001|Treatment|Adverse Event|0|||
149775632|NCT02671461|540302984|FG002|Treatment|Adverse Event|1|||
149775633|NCT02671461|540302982|FG000|Treatment|Administrative Reason by Sponsor|1|||
149775634|NCT02671461|540302983|FG001|Treatment|Administrative Reason by Sponsor|3|||
149775635|NCT02671461|540302984|FG002|Treatment|Administrative Reason by Sponsor|4|||
149775636|NCT02671461|540302982|FG000|Treatment|Randomized, not treated|1|||
149775637|NCT02671461|540302983|FG001|Treatment|Randomized, not treated|0|||
149775638|NCT02671461|540302984|FG002|Treatment|Randomized, not treated|0|||
149775639|NCT02671461|540302982|FG000|Follow-up|Withdrawal by Subject|1|||
149775640|NCT02671461|540302983|FG001|Follow-up|Withdrawal by Subject|0|||
149775641|NCT02671461|540302984|FG002|Follow-up|Withdrawal by Subject|0|||
149775642|NCT02671461|540302982|FG000|Follow-up|Lost to Follow-up|0|||
149775643|NCT02671461|540302983|FG001|Follow-up|Lost to Follow-up|0|||
149775644|NCT02671461|540302984|FG002|Follow-up|Lost to Follow-up|1|||
149775645|NCT02671461|540302982|FG000|Follow-up|Administrative Reason by Sponsor|0|||
149775646|NCT02671461|540302983|FG001|Follow-up|Administrative Reason by Sponsor|1|||
149775647|NCT02671461|540302984|FG002|Follow-up|Administrative Reason by Sponsor|0|||
149775648|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
149775649|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
149775650|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
149775651|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
149775652|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
149775653|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
149775654|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
149775655|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
149775656|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
149775657|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
149775658|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
149775659|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
149775660|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
149775661|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
149775662|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
149775663|NCT01412060|540302985|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
149775664|NCT01412060|540302986|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
149775665|NCT01412060|540302987|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
149775666|NCT01412060|540302985|FG000|Period Between RIP and SP|Adverse Event|4|||
149775667|NCT01412060|540302986|FG001|Period Between RIP and SP|Adverse Event|0|||
149775668|NCT01412060|540302987|FG002|Period Between RIP and SP|Adverse Event|0|||
149775669|NCT01412060|540302985|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
149775670|NCT01412060|540302986|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
149775671|NCT01412060|540302987|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
149775672|NCT01412060|540302985|FG000|Period Between RIP and SP|Protocol Violation|2|||
149775673|NCT01412060|540302986|FG001|Period Between RIP and SP|Protocol Violation|0|||
149775674|NCT01412060|540302987|FG002|Period Between RIP and SP|Protocol Violation|0|||
149775675|NCT01412060|540302985|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
149775676|NCT01412060|540302986|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
149775677|NCT01412060|540302987|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
149775678|NCT01412060|540302985|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
149775679|NCT01412060|540302986|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
149775680|NCT01412060|540302987|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
149775681|NCT01412060|540302985|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
149775682|NCT01412060|540302986|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
149775683|NCT01412060|540302987|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
149775684|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
149775685|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
149775686|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
149775687|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
149775688|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
149775689|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
149775690|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
149775691|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
149775692|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
149775693|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
149775694|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
149775695|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
149775696|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
149775697|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
149775698|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
149775699|NCT01412060|540302985|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
149775700|NCT01412060|540302986|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
149775701|NCT01412060|540302987|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
149775702|NCT01412060|540302985|FG000|Period Between SP and DBP|Protocol Violation|2|||
149775703|NCT01412060|540302986|FG001|Period Between SP and DBP|Protocol Violation|0|||
149775704|NCT01412060|540302987|FG002|Period Between SP and DBP|Protocol Violation|0|||
149775705|NCT01412060|540302985|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
149775706|NCT01412060|540302986|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
149775707|NCT01412060|540302987|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
149775708|NCT01412060|540302985|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
149775709|NCT01412060|540302986|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
149775710|NCT01412060|540302987|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
149775711|NCT01412060|540302985|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
149775712|NCT01412060|540302986|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
149775713|NCT01412060|540302987|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
149775714|NCT01412060|540302985|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
149775715|NCT01412060|540302986|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
149775716|NCT01412060|540302987|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
149775717|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
149775718|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
149775719|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
149775720|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
149775721|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
149775722|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
149775723|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
149775724|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
149775725|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
149775726|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
149775727|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
149775728|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
149775729|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
149775730|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
149775731|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
149775732|NCT01412060|540302985|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
149775733|NCT01412060|540302986|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
149775734|NCT01412060|540302987|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
149775735|NCT00004732|540302989|FG000|Overall Study|Withdrawal by Subject|36|||
149775736|NCT00004732|540302990|FG001|Overall Study|Withdrawal by Subject|64|||
149775737|NCT00004732|540302989|FG000|Overall Study|Lost to Follow-up|33|||
149775738|NCT00004732|540302990|FG001|Overall Study|Lost to Follow-up|47|||
149775739|NCT01688635|540302993|FG000|Washout 1|Withdrawal by Subject|1|||
149775740|NCT01688635|540302994|FG001|Washout 1|Withdrawal by Subject|0|||
149775741|NCT01688635|540302993|FG000|Washout 1|Adverse Event|0|||
149775742|NCT01688635|540302994|FG001|Washout 1|Adverse Event|1|||
149775743|NCT01688635|540302993|FG000|Washout 1|Physician Decision|0|||
149775744|NCT01688635|540302994|FG001|Washout 1|Physician Decision|1|||
149775745|NCT01688635|540302993|FG000|Washout 2|Physician Decision|1|||
149775746|NCT01688635|540302994|FG001|Washout 2|Physician Decision|0|||
149775747|NCT01688635|540302993|FG000|Washout 2|Withdrawal by Subject|1|||
149775748|NCT01688635|540302994|FG001|Washout 2|Withdrawal by Subject|0|||
149775749|NCT01688635|540302993|FG000|Washout 2|Sponsor Decision|1|||
149775750|NCT01688635|540302994|FG001|Washout 2|Sponsor Decision|2|||
149775751|NCT01688635|540302993|FG000|Washout 3|Withdrawal by Subject|1|||
149775752|NCT01688635|540302994|FG001|Washout 3|Withdrawal by Subject|0|||
149775753|NCT02661464|540302995|FG000|Overall Study|Lost to Follow-up|28|||
149775754|NCT02661464|540302996|FG001|Overall Study|Lost to Follow-up|0|||
149775755|NCT02661464|540302997|FG002|Overall Study|Lost to Follow-up|0|||
149775756|NCT02661464|540302998|FG003|Overall Study|Lost to Follow-up|0|||
149775757|NCT02661464|540302995|FG000|Overall Study|Withdrawal by Subject|3|||
149775758|NCT02661464|540302996|FG001|Overall Study|Withdrawal by Subject|1|||
149775759|NCT02661464|540302997|FG002|Overall Study|Withdrawal by Subject|0|||
149775760|NCT02661464|540302998|FG003|Overall Study|Withdrawal by Subject|0|||
149775761|NCT02661464|540302995|FG000|Overall Study|Participants terminated prematurely|288|||
149775762|NCT02661464|540302996|FG001|Overall Study|Participants terminated prematurely|52|||
149775763|NCT02661464|540302997|FG002|Overall Study|Participants terminated prematurely|1|||
149775764|NCT02661464|540302998|FG003|Overall Study|Participants terminated prematurely|1|||
149775765|NCT02661464|540302995|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
149775766|NCT02661464|540302996|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
149775767|NCT02661464|540302997|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
149775768|NCT02661464|540302998|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
149775769|NCT00367432|540302999|FG000|First Period (16 Weeks)|Adverse Event|6|||
149775770|NCT00367432|540303000|FG001|First Period (16 Weeks)|Adverse Event|0|||
149775771|NCT00367432|540302999|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
149775772|NCT00367432|540303000|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
149775773|NCT00367432|540302999|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
149775774|NCT00367432|540303000|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
149775775|NCT00367432|540302999|FG000|First Period (16 Weeks)|Other Reason|2|||
149775776|NCT00367432|540303000|FG001|First Period (16 Weeks)|Other Reason|0|||
149775777|NCT00367432|540302999|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
149775778|NCT00367432|540303000|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
149775779|NCT00367432|540302999|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
149775780|NCT00367432|540303000|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
149775781|NCT00367432|540302999|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
149775782|NCT00367432|540303000|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
149775783|NCT00367432|540302999|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
149775784|NCT00367432|540303000|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
149775785|NCT00367432|540302999|FG000|Second Period (up to 54 Months)|Other Reason|6|||
149775786|NCT00367432|540303000|FG001|Second Period (up to 54 Months)|Other Reason|2|||
149775787|NCT00903370|540303001|FG000|Overall Study|Death|13|||
149775788|NCT00903370|540303002|FG001|Overall Study|Death|10|||
149775789|NCT00903370|540303001|FG000|Overall Study|Withdrawal by Subject|9|||
149775790|NCT00903370|540303002|FG001|Overall Study|Withdrawal by Subject|6|||
149775791|NCT00903370|540303001|FG000|Overall Study|Lost to Follow-up|6|||
149775792|NCT00903370|540303002|FG001|Overall Study|Lost to Follow-up|8|||
149775793|NCT05567393|540303006|FG000|Overall Study|Voluntary Withdrawal|0|||
149775794|NCT05567393|540303007|FG001|Overall Study|Voluntary Withdrawal|0|||
149775795|NCT05567393|540303008|FG002|Overall Study|Voluntary Withdrawal|0|||
149775796|NCT05567393|540303009|FG003|Overall Study|Voluntary Withdrawal|0|||
149775797|NCT05567393|540303010|FG004|Overall Study|Voluntary Withdrawal|0|||
149775798|NCT05567393|540303011|FG005|Overall Study|Voluntary Withdrawal|0|||
149775799|NCT05567393|540303012|FG006|Overall Study|Voluntary Withdrawal|0|||
149775800|NCT05567393|540303013|FG007|Overall Study|Voluntary Withdrawal|0|||
149775801|NCT05567393|540303014|FG008|Overall Study|Voluntary Withdrawal|0|||
149775802|NCT05567393|540303015|FG009|Overall Study|Voluntary Withdrawal|0|||
149775803|NCT05567393|540303016|FG010|Overall Study|Voluntary Withdrawal|0|||
149775804|NCT05567393|540303017|FG011|Overall Study|Voluntary Withdrawal|0|||
149775805|NCT05567393|540303018|FG012|Overall Study|Voluntary Withdrawal|0|||
149775806|NCT05567393|540303019|FG013|Overall Study|Voluntary Withdrawal|1|||
149775807|NCT05567393|540303020|FG014|Overall Study|Voluntary Withdrawal|0|||
149775808|NCT05567393|540303021|FG015|Overall Study|Voluntary Withdrawal|0|||
149775809|NCT05567393|540303022|FG016|Overall Study|Voluntary Withdrawal|0|||
149775810|NCT05567393|540303023|FG017|Overall Study|Voluntary Withdrawal|0|||
149775811|NCT02177175|540303028|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
149775812|NCT02177175|540303029|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
149775813|NCT01924299|540303030|FG000|Period 2|Withdrawal by Subject|1|||
149775814|NCT01924299|540303031|FG001|Period 2|Withdrawal by Subject|0|||
149775815|NCT01924299|540303030|FG000|Period 2|Adverse Event|0|||
149775816|NCT01924299|540303031|FG001|Period 2|Adverse Event|1|||
149775817|NCT00141037|540303036|FG000|Overall Study|Physician Decision|1|||
149775818|NCT00141037|540303037|FG001|Overall Study|Physician Decision|2|||
149775819|NCT00141037|540303036|FG000|Overall Study|Lost to Follow-up|3|||
149775820|NCT00141037|540303037|FG001|Overall Study|Lost to Follow-up|1|||
149775821|NCT00141037|540303036|FG000|Overall Study|Protocol Violation|0|||
149775822|NCT00141037|540303037|FG001|Overall Study|Protocol Violation|2|||
149775823|NCT00141037|540303036|FG000|Overall Study|Withdrawal by Subject|2|||
149775824|NCT00141037|540303037|FG001|Overall Study|Withdrawal by Subject|1|||
149775825|NCT00141037|540303036|FG000|Overall Study|Other|0|||
149775826|NCT00141037|540303037|FG001|Overall Study|Other|1|||
149775827|NCT00141037|540303036|FG000|Overall Study|Moved from area|1|||
149775828|NCT00141037|540303037|FG001|Overall Study|Moved from area|7|||
149775829|NCT00141037|540303036|FG000|Overall Study|Graft Failure|3|||
149775830|NCT00141037|540303037|FG001|Overall Study|Graft Failure|4|||
149775831|NCT00888615|540303038|FG000|Overall Study|No treatment|2|||
149775832|NCT00637377|540303039|FG000|Overall Study|Adverse Event|2|||
149775833|NCT00637377|540303040|FG001|Overall Study|Adverse Event|6|||
149775834|NCT00637377|540303041|FG002|Overall Study|Adverse Event|8|||
149775835|NCT00637377|540303042|FG003|Overall Study|Adverse Event|9|||
149775836|NCT00637377|540303039|FG000|Overall Study|Death|1|||
149775837|NCT00637377|540303040|FG001|Overall Study|Death|3|||
149775838|NCT00637377|540303041|FG002|Overall Study|Death|2|||
149775839|NCT00637377|540303042|FG003|Overall Study|Death|1|||
149775840|NCT00637377|540303039|FG000|Overall Study|Lack of Efficacy|0|||
149775841|NCT00637377|540303040|FG001|Overall Study|Lack of Efficacy|0|||
149775842|NCT00637377|540303041|FG002|Overall Study|Lack of Efficacy|1|||
149775843|NCT00637377|540303042|FG003|Overall Study|Lack of Efficacy|1|||
149775844|NCT00637377|540303039|FG000|Overall Study|Lost to Follow-up|4|||
149775845|NCT00637377|540303040|FG001|Overall Study|Lost to Follow-up|1|||
149775846|NCT00637377|540303041|FG002|Overall Study|Lost to Follow-up|2|||
149775847|NCT00637377|540303042|FG003|Overall Study|Lost to Follow-up|2|||
149775848|NCT00637377|540303039|FG000|Overall Study|Protocol Violation|2|||
149775849|NCT00637377|540303040|FG001|Overall Study|Protocol Violation|1|||
149775850|NCT00637377|540303041|FG002|Overall Study|Protocol Violation|1|||
149775851|NCT00637377|540303042|FG003|Overall Study|Protocol Violation|0|||
149775852|NCT00637377|540303039|FG000|Overall Study|Withdrawal by Subject|11|||
149775853|NCT00637377|540303040|FG001|Overall Study|Withdrawal by Subject|15|||
149775854|NCT00637377|540303041|FG002|Overall Study|Withdrawal by Subject|13|||
149775855|NCT00637377|540303042|FG003|Overall Study|Withdrawal by Subject|11|||
149775856|NCT00637377|540303039|FG000|Overall Study|Other (no further information available)|7|||
149775857|NCT00637377|540303040|FG001|Overall Study|Other (no further information available)|6|||
149775858|NCT00637377|540303041|FG002|Overall Study|Other (no further information available)|10|||
149775859|NCT00637377|540303042|FG003|Overall Study|Other (no further information available)|5|||
149775860|NCT04186663|540303043|FG000|Overall Study|Lost to Follow-up|1|||
149775861|NCT04186663|540303043|FG000|Overall Study|Unable to complete blood draw|3|||
149775862|NCT00719862|540303044|FG000|Overall Study|Adverse Event|1|||
149775863|NCT00719862|540303045|FG001|Overall Study|Adverse Event|2|||
149775864|NCT00719862|540303044|FG000|Overall Study|Lack of Efficacy|3|||
149775865|NCT00719862|540303045|FG001|Overall Study|Lack of Efficacy|0|||
149775866|NCT00719862|540303044|FG000|Overall Study|Non-Compliance|1|||
149775867|NCT00719862|540303045|FG001|Overall Study|Non-Compliance|0|||
149775868|NCT00719862|540303044|FG000|Overall Study|Withdrawal by Subject|1|||
149775869|NCT00719862|540303045|FG001|Overall Study|Withdrawal by Subject|0|||
149775870|NCT00719862|540303044|FG000|Overall Study|Lost to Follow-up|0|||
149775871|NCT00719862|540303045|FG001|Overall Study|Lost to Follow-up|1|||
149775872|NCT00719862|540303044|FG000|Overall Study|Other|2|||
149775873|NCT00719862|540303045|FG001|Overall Study|Other|3|||
149775874|NCT01184846|540303046|FG000|Overall Study|Adverse Event|2|||
149775875|NCT01184846|540303046|FG000|Overall Study|Insufficient response|1|||
149775876|NCT01999946|540303047|FG000|Overall Study|Participant not released from jail|2|||
149775877|NCT01999946|540303048|FG001|Overall Study|Participant not released from jail|2|||
149775878|NCT01999946|540303049|FG002|Overall Study|Participant not released from jail|0|||
149775879|NCT01999946|540303047|FG000|Overall Study|Not included in primary outcome analysis|0|||
149775880|NCT01999946|540303048|FG001|Overall Study|Not included in primary outcome analysis|0|||
149775881|NCT01999946|540303049|FG002|Overall Study|Not included in primary outcome analysis|79|||
149775882|NCT00719953|540303050|FG000|Overall Study|Adverse Event|4|||
149775883|NCT04021706|540304947|FG000|Overall Study|Adverse Event|2|||
149775884|NCT04021706|540304948|FG001|Overall Study|Adverse Event|0|||
149775885|NCT04021706|540304947|FG000|Overall Study|Withdrawal by Subject|1|||
149775886|NCT04021706|540304948|FG001|Overall Study|Withdrawal by Subject|2|||
149775887|NCT04021706|540304947|FG000|Overall Study|Physician Decision|1|||
149775888|NCT04021706|540304948|FG001|Overall Study|Physician Decision|0|||
149775889|NCT01375647|540304949|FG000|Overall Study|Lost to Follow-up|3|||
149775890|NCT01375647|540304950|FG001|Overall Study|Lost to Follow-up|3|||
149775891|NCT01375647|540304951|FG002|Overall Study|Lost to Follow-up|7|||
149775892|NCT01375647|540304952|FG003|Overall Study|Lost to Follow-up|10|||
149775893|NCT01375647|540304949|FG000|Overall Study|Death|1|||
149775894|NCT01375647|540304950|FG001|Overall Study|Death|2|||
149775895|NCT01375647|540304951|FG002|Overall Study|Death|1|||
149775896|NCT01375647|540304952|FG003|Overall Study|Death|0|||
149775897|NCT01375647|540304949|FG000|Overall Study|Withdrawal by Subject|17|||
149775898|NCT01375647|540304950|FG001|Overall Study|Withdrawal by Subject|20|||
149775899|NCT01375647|540304951|FG002|Overall Study|Withdrawal by Subject|26|||
149775900|NCT01375647|540304952|FG003|Overall Study|Withdrawal by Subject|14|||
149775901|NCT01375647|540304949|FG000|Overall Study|Physician Decision|1|||
149775902|NCT01375647|540304950|FG001|Overall Study|Physician Decision|0|||
149775903|NCT01375647|540304951|FG002|Overall Study|Physician Decision|0|||
149775904|NCT01375647|540304952|FG003|Overall Study|Physician Decision|0|||
149775905|NCT02332798|540304955|FG000|Overall Study|Unwilling to Participate in Study|0|||
149775906|NCT02332798|540304956|FG001|Overall Study|Unwilling to Participate in Study|1|||
149775907|NCT02332798|540304957|FG002|Overall Study|Unwilling to Participate in Study|1|||
149775908|NCT02332798|540304955|FG000|Overall Study|Positive Urine Drug Test|0|||
149775909|NCT02332798|540304956|FG001|Overall Study|Positive Urine Drug Test|1|||
149775910|NCT02332798|540304957|FG002|Overall Study|Positive Urine Drug Test|0|||
149775911|NCT02332798|540304955|FG000|Overall Study|Abnormal Laboratory Findings|1|||
149775912|NCT02332798|540304956|FG001|Overall Study|Abnormal Laboratory Findings|0|||
149775913|NCT02332798|540304957|FG002|Overall Study|Abnormal Laboratory Findings|0|||
149775914|NCT00595868|540304958|FG000|Overall Study|Lost to Follow-up|45|||
149775915|NCT00595868|540304959|FG001|Overall Study|Lost to Follow-up|50|||
149775916|NCT02688153|540304960|FG000|Overall Study|Death|7|||
149775917|NCT02688153|540304961|FG001|Overall Study|Death|5|||
149775918|NCT02688153|540304960|FG000|Overall Study|Withdrawal by Subject|4|||
149775919|NCT02688153|540304961|FG001|Overall Study|Withdrawal by Subject|2|||
149775920|NCT02688153|540304960|FG000|Overall Study|Valve Explant|1|||
149775921|NCT02688153|540304961|FG001|Overall Study|Valve Explant|0|||
149775922|NCT02688153|540304960|FG000|Overall Study|Conversion to Commercial Valve|3|||
149775923|NCT02688153|540304961|FG001|Overall Study|Conversion to Commercial Valve|0|||
149775924|NCT00107172|540304962|FG000|Overall Study|Withdrawal by Subject|1|||
149775925|NCT00107172|540304963|FG001|Overall Study|Withdrawal by Subject|0|||
149775926|NCT00107172|540304962|FG000|Overall Study|Death|0|||
149775927|NCT00107172|540304963|FG001|Overall Study|Death|2|||
149775928|NCT00107172|540304962|FG000|Overall Study|Other Reason|4|||
149775929|NCT00107172|540304963|FG001|Overall Study|Other Reason|3|||
149775930|NCT01102140|540304964|FG000|Overall Study|Lost to Follow-up|1|||
149775931|NCT01102140|540304965|FG001|Overall Study|Lost to Follow-up|0|||
149775932|NCT01102140|540304964|FG000|Overall Study|Investigator terminated study|2|||
149775933|NCT01102140|540304965|FG001|Overall Study|Investigator terminated study|2|||
149775934|NCT01742091|540304973|FG000|Overall Study|Adverse Event|0|||
149775935|NCT01742091|540304974|FG001|Overall Study|Adverse Event|0|||
149775936|NCT01742091|540304975|FG002|Overall Study|Adverse Event|0|||
149775937|NCT01742091|540304976|FG003|Overall Study|Adverse Event|0|||
149775938|NCT01742091|540304977|FG004|Overall Study|Adverse Event|1|||
149775939|NCT01742091|540304978|FG005|Overall Study|Adverse Event|0|||
149775940|NCT01742091|540304973|FG000|Overall Study|Physician Decision|0|||
149775941|NCT01742091|540304974|FG001|Overall Study|Physician Decision|0|||
149775942|NCT01742091|540304975|FG002|Overall Study|Physician Decision|0|||
149775943|NCT01742091|540304976|FG003|Overall Study|Physician Decision|0|||
149775944|NCT01742091|540304977|FG004|Overall Study|Physician Decision|0|||
149775945|NCT01742091|540304978|FG005|Overall Study|Physician Decision|1|||
149775946|NCT01742091|540304973|FG000|Overall Study|Withdrawal by Subject|0|||
149775947|NCT01742091|540304974|FG001|Overall Study|Withdrawal by Subject|0|||
149775948|NCT01742091|540304975|FG002|Overall Study|Withdrawal by Subject|0|||
149775949|NCT01742091|540304976|FG003|Overall Study|Withdrawal by Subject|1|||
149775950|NCT01742091|540304977|FG004|Overall Study|Withdrawal by Subject|0|||
149775951|NCT01742091|540304978|FG005|Overall Study|Withdrawal by Subject|0|||
149775952|NCT01742091|540304973|FG000|Overall Study|Lost to Follow-up|0|||
149775953|NCT01742091|540304974|FG001|Overall Study|Lost to Follow-up|0|||
149775954|NCT01742091|540304975|FG002|Overall Study|Lost to Follow-up|0|||
149775955|NCT01742091|540304976|FG003|Overall Study|Lost to Follow-up|0|||
149775956|NCT01742091|540304977|FG004|Overall Study|Lost to Follow-up|0|||
149775957|NCT01742091|540304978|FG005|Overall Study|Lost to Follow-up|1|||
149775958|NCT03750240|540304980|FG000|Overall Study|Technical Difficulties|2|||
149775959|NCT03706040|540304981|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
149775960|NCT03706040|540304982|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
149775961|NCT03706040|540304983|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
149775962|NCT03706040|540304984|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
149775963|NCT03706040|540304985|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
149775964|NCT03706040|540304986|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
149775965|NCT03706040|540304987|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
149775966|NCT03706040|540304981|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
149775967|NCT03706040|540304982|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
149775968|NCT03706040|540304983|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
149775969|NCT03706040|540304984|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149775970|NCT03706040|540304985|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149775971|NCT03706040|540304986|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149775972|NCT03706040|540304987|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149775973|NCT03706040|540304981|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
149775974|NCT03706040|540304982|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
149775975|NCT03706040|540304983|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
149775976|NCT03706040|540304984|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149775977|NCT03706040|540304985|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149775978|NCT03706040|540304986|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149775979|NCT03706040|540304987|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149775980|NCT03706040|540304981|FG000|Period A (Week 0 to Week 16)|Other|2|||
149775981|NCT03706040|540304982|FG001|Period A (Week 0 to Week 16)|Other|0|||
149775982|NCT03706040|540304983|FG002|Period A (Week 0 to Week 16)|Other|2|||
149775983|NCT03706040|540304984|FG003|Period A (Week 0 to Week 16)|Other|0|||
149775984|NCT03706040|540304985|FG004|Period A (Week 0 to Week 16)|Other|0|||
149775985|NCT03706040|540304986|FG005|Period A (Week 0 to Week 16)|Other|0|||
149775986|NCT03706040|540304987|FG006|Period A (Week 0 to Week 16)|Other|0|||
149775987|NCT03706040|540304981|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
149775988|NCT03706040|540304982|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
149775989|NCT03706040|540304983|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
149775990|NCT03706040|540304984|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
149775991|NCT03706040|540304985|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
149775992|NCT03706040|540304986|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
149775993|NCT03706040|540304987|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
149775994|NCT03706040|540304981|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
149775995|NCT03706040|540304982|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
149775996|NCT03706040|540304983|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
149775997|NCT03706040|540304984|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
149775998|NCT03706040|540304985|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
149775999|NCT03706040|540304986|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
149776000|NCT03706040|540304987|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
149776001|NCT03706040|540304981|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149776002|NCT03706040|540304982|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149776003|NCT03706040|540304983|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149776004|NCT03706040|540304984|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149776005|NCT03706040|540304985|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149776006|NCT03706040|540304986|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
149776007|NCT03706040|540304987|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
149776008|NCT03706040|540304981|FG000|Period B (Week 16 to Week 52)|Other|0|||
149776009|NCT03706040|540304982|FG001|Period B (Week 16 to Week 52)|Other|0|||
149776010|NCT03706040|540304983|FG002|Period B (Week 16 to Week 52)|Other|0|||
149776011|NCT03706040|540304984|FG003|Period B (Week 16 to Week 52)|Other|4|||
149776012|NCT03706040|540304985|FG004|Period B (Week 16 to Week 52)|Other|5|||
149776013|NCT03706040|540304986|FG005|Period B (Week 16 to Week 52)|Other|23|||
149776014|NCT03706040|540304987|FG006|Period B (Week 16 to Week 52)|Other|17|||
149776015|NCT00927758|540304988|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149776016|NCT00927758|540304989|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149776017|NCT00927758|540304990|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149776018|NCT00927758|540304991|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
149776019|NCT00927758|540304992|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149776020|NCT00927758|540304993|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
149776021|NCT00927758|540304988|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149776022|NCT00927758|540304989|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149776023|NCT00927758|540304990|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149776024|NCT00927758|540304991|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149776025|NCT00927758|540304992|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149776026|NCT00927758|540304993|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149776027|NCT00439725|540304994|FG000|Treatment Period|Withdrawal by Subject|22|||
149776028|NCT00439725|540304995|FG001|Treatment Period|Withdrawal by Subject|19|||
149776029|NCT00439725|540304994|FG000|Treatment Period|Study terminated by sponsor|156|||
149776030|NCT00439725|540304995|FG001|Treatment Period|Study terminated by sponsor|148|||
149776031|NCT00439725|540304994|FG000|Treatment Period|Site closed by investigator|1|||
149776032|NCT00439725|540304995|FG001|Treatment Period|Site closed by investigator|2|||
149776033|NCT00439725|540304994|FG000|Treatment Period|Adverse Event|39|||
149776034|NCT00439725|540304995|FG001|Treatment Period|Adverse Event|18|||
149776035|NCT00439725|540304994|FG000|Treatment Period|Physician Decision|1|||
149776036|NCT00439725|540304995|FG001|Treatment Period|Physician Decision|1|||
149776037|NCT00439725|540304994|FG000|Treatment Period|Protocol Violation|2|||
149776038|NCT00439725|540304995|FG001|Treatment Period|Protocol Violation|1|||
149776039|NCT00439725|540304994|FG000|Treatment Period|Clinical endpoint reached|6|||
149776040|NCT00439725|540304995|FG001|Treatment Period|Clinical endpoint reached|50|||
149776041|NCT00439725|540304994|FG000|Treatment Period|Technical problems|1|||
149776042|NCT00439725|540304995|FG001|Treatment Period|Technical problems|0|||
149776043|NCT00439725|540304994|FG000|Treatment Period|Lost to Follow-up|1|||
149776044|NCT00439725|540304995|FG001|Treatment Period|Lost to Follow-up|1|||
149776045|NCT00439725|540304994|FG000|Treatment Period|Participant convenience|1|||
149776046|NCT00439725|540304995|FG001|Treatment Period|Participant convenience|0|||
149776047|NCT00439725|540304994|FG000|Treatment Period|Protocol driven decision point|1|||
149776048|NCT00439725|540304995|FG001|Treatment Period|Protocol driven decision point|1|||
149776049|NCT00439725|540304994|FG000|Treatment Period|Death|1|||
149776050|NCT00439725|540304995|FG001|Treatment Period|Death|1|||
149776051|NCT00439725|540304994|FG000|Treatment Period|Participant did not receive treatment|4|||
149776052|NCT00439725|540304995|FG001|Treatment Period|Participant did not receive treatment|4|||
149776053|NCT00439725|540304994|FG000|Observational Period|Withdrawal by Subject|2|||
149776054|NCT00439725|540304995|FG001|Observational Period|Withdrawal by Subject|2|||
149776055|NCT00439725|540304994|FG000|Observational Period|Lost to Follow-up|0|||
149776056|NCT00439725|540304995|FG001|Observational Period|Lost to Follow-up|1|||
149776057|NCT00439725|540304994|FG000|Observational Period|Death|0|||
149776058|NCT00439725|540304995|FG001|Observational Period|Death|2|||
149776059|NCT00439725|540304994|FG000|Observational Period|Study termination by sponsor|1|||
149776060|NCT00439725|540304995|FG001|Observational Period|Study termination by sponsor|1|||
149776061|NCT00439725|540304994|FG000|Observational Period|Clinical endpoint reached|3|||
149776062|NCT00439725|540304995|FG001|Observational Period|Clinical endpoint reached|1|||
149776063|NCT00439725|540304994|FG000|Observational Period|Technical problems|1|||
149776064|NCT00439725|540304995|FG001|Observational Period|Technical problems|0|||
149776065|NCT00439725|540304994|FG000|Observational Period|Participant convenience|1|||
149776066|NCT00439725|540304995|FG001|Observational Period|Participant convenience|0|||
149776067|NCT01544478|540304996|FG000|Overall Study|Adverse Event|1|||
149776068|NCT01544478|540304996|FG000|Overall Study|Death|1|||
149776069|NCT01544478|540304996|FG000|Overall Study|Lost to Follow-up|48|||
149776070|NCT01544478|540304996|FG000|Overall Study|Physician Decision|15|||
149776071|NCT01544478|540304996|FG000|Overall Study|Pregnancy|1|||
149776072|NCT01544478|540304996|FG000|Overall Study|Withdrawal by Subject|52|||
149776073|NCT00212758|540304999|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
149776074|NCT00212758|540305000|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
149776075|NCT00212758|540304999|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
149776076|NCT00212758|540305000|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
149776077|NCT02574481|540305001|FG000|Overall Study|Withdrawal by Subject|29|||
149776078|NCT02574481|540305002|FG001|Overall Study|Withdrawal by Subject|15|||
149776079|NCT02574481|540305003|FG002|Overall Study|Withdrawal by Subject|4|||
149776080|NCT02574481|540305004|FG003|Overall Study|Withdrawal by Subject|1|||
149776081|NCT02574481|540305001|FG000|Overall Study|Adverse Event|5|||
149776082|NCT02574481|540305002|FG001|Overall Study|Adverse Event|1|||
149776083|NCT02574481|540305003|FG002|Overall Study|Adverse Event|1|||
149776084|NCT02574481|540305004|FG003|Overall Study|Adverse Event|0|||
149776085|NCT02574481|540305001|FG000|Overall Study|Visit Missed|15|||
149776086|NCT02574481|540305002|FG001|Overall Study|Visit Missed|7|||
149776087|NCT02574481|540305003|FG002|Overall Study|Visit Missed|5|||
149776088|NCT02574481|540305004|FG003|Overall Study|Visit Missed|0|||
149776089|NCT02574481|540305001|FG000|Overall Study|Other|7|||
149776090|NCT02574481|540305002|FG001|Overall Study|Other|2|||
149776091|NCT02574481|540305003|FG002|Overall Study|Other|0|||
149776092|NCT02574481|540305004|FG003|Overall Study|Other|0|||
149776093|NCT02574481|540305001|FG000|Overall Study|Death|48|||
149776094|NCT02574481|540305002|FG001|Overall Study|Death|26|||
149776095|NCT02574481|540305003|FG002|Overall Study|Death|12|||
149776096|NCT02574481|540305004|FG003|Overall Study|Death|4|||
149776097|NCT02574481|540305001|FG000|Overall Study|Physician Decision|5|||
149776098|NCT02574481|540305002|FG001|Overall Study|Physician Decision|2|||
149776099|NCT02574481|540305003|FG002|Overall Study|Physician Decision|0|||
149776100|NCT02574481|540305004|FG003|Overall Study|Physician Decision|0|||
149776101|NCT02574481|540305001|FG000|Overall Study|Lost to Follow-up|5|||
149776102|NCT02574481|540305002|FG001|Overall Study|Lost to Follow-up|1|||
149776103|NCT02574481|540305003|FG002|Overall Study|Lost to Follow-up|3|||
149776104|NCT02574481|540305004|FG003|Overall Study|Lost to Follow-up|0|||
149776105|NCT02940860|540305007|FG000|Overall Study|Non-serious AE|1|||
149776106|NCT02940860|540305008|FG001|Overall Study|Non-serious AE|2|||
149776107|NCT02940860|540305007|FG000|Overall Study|Serious AE|7|||
149776108|NCT02940860|540305008|FG001|Overall Study|Serious AE|3|||
149776109|NCT02940860|540305007|FG000|Overall Study|Withdrawal by Subject|19|||
149776110|NCT02940860|540305008|FG001|Overall Study|Withdrawal by Subject|9|||
149776111|NCT02940860|540305007|FG000|Overall Study|Lost to Follow-up|13|||
149776112|NCT02940860|540305008|FG001|Overall Study|Lost to Follow-up|7|||
149776113|NCT02940860|540305007|FG000|Overall Study|Physician Decision|5|||
149776114|NCT02940860|540305008|FG001|Overall Study|Physician Decision|3|||
149776115|NCT02940860|540305007|FG000|Overall Study|Sponsor Decision|0|||
149776116|NCT02940860|540305008|FG001|Overall Study|Sponsor Decision|1|||
149776117|NCT02940860|540305007|FG000|Overall Study|Protocol Violation|0|||
149776118|NCT02940860|540305008|FG001|Overall Study|Protocol Violation|2|||
149776119|NCT02940860|540305007|FG000|Overall Study|Death|3|||
149776120|NCT02940860|540305008|FG001|Overall Study|Death|2|||
149776121|NCT02940860|540305007|FG000|Overall Study|Moved, poor venous access, transport|6|||
149776122|NCT02940860|540305008|FG001|Overall Study|Moved, poor venous access, transport|4|||
149776123|NCT02940860|540305007|FG000|Overall Study|Not treated|2|||
149776124|NCT02940860|540305008|FG001|Overall Study|Not treated|2|||
149776125|NCT04209530|540305014|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
149776126|NCT04209530|540305015|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
149776127|NCT04209530|540305014|FG000|Overall Study|Withdrawal by Subject|0|||
149776128|NCT04209530|540305015|FG001|Overall Study|Withdrawal by Subject|1|||
149776129|NCT00527072|540305018|FG000|Overall Study|Adverse Event|13|||
149776130|NCT00527072|540305018|FG000|Overall Study|Lack of Efficacy|11|||
149776131|NCT00527072|540305018|FG000|Overall Study|Lost to Follow-up|3|||
149776132|NCT00527072|540305018|FG000|Overall Study|Protocol Violation|2|||
149776133|NCT00527072|540305018|FG000|Overall Study|Withdrawal by Subject|7|||
149776134|NCT00608881|540305019|FG000|Overall Study|Death|22|||
149776135|NCT00608881|540305020|FG001|Overall Study|Death|13|||
149776136|NCT00608881|540305019|FG000|Overall Study|Adverse Event|5|||
149776137|NCT00608881|540305020|FG001|Overall Study|Adverse Event|3|||
149776138|NCT00608881|540305019|FG000|Overall Study|Lost to Follow-up|28|||
149776139|NCT00608881|540305020|FG001|Overall Study|Lost to Follow-up|14|||
149776140|NCT00608881|540305019|FG000|Overall Study|Withdrawal by Subject|18|||
149776141|NCT00608881|540305020|FG001|Overall Study|Withdrawal by Subject|29|||
149776142|NCT00608881|540305019|FG000|Overall Study|Physician Decision|5|||
149776143|NCT00608881|540305020|FG001|Overall Study|Physician Decision|5|||
149776144|NCT00608881|540305019|FG000|Overall Study|Institutionalized|1|||
149776145|NCT00608881|540305020|FG001|Overall Study|Institutionalized|2|||
149776146|NCT02954952|540305021|FG000|Overall Study|Withdrawal by Subject|1|||
149776147|NCT02954952|540305022|FG001|Overall Study|Withdrawal by Subject|0|||
149776148|NCT02954952|540305023|FG002|Overall Study|Withdrawal by Subject|0|||
149776149|NCT02954952|540305021|FG000|Overall Study|No data collected|0|||
149776150|NCT02954952|540305022|FG001|Overall Study|No data collected|1|||
149776151|NCT02954952|540305023|FG002|Overall Study|No data collected|0|||
149776152|NCT00724815|540305024|FG000|Overall Study|Randomized, not treated|31|||
149776153|NCT00724815|540305025|FG001|Overall Study|Randomized, not treated|30|||
149776154|NCT00724815|540305024|FG000|Overall Study|Adverse Event|5|||
149776155|NCT00724815|540305025|FG001|Overall Study|Adverse Event|3|||
149776156|NCT00724815|540305024|FG000|Overall Study|Lost to Follow-up|4|||
149776157|NCT00724815|540305025|FG001|Overall Study|Lost to Follow-up|1|||
149776158|NCT00724815|540305024|FG000|Overall Study|Other Various|3|||
149776159|NCT00724815|540305025|FG001|Overall Study|Other Various|5|||
149776160|NCT00810043|540305026|FG000|Overall Study|Withdrawal by Subject|1|||
149776161|NCT00810043|540305027|FG001|Overall Study|Withdrawal by Subject|0|||
149776162|NCT00810043|540305028|FG002|Overall Study|Withdrawal by Subject|2|||
149776163|NCT00810043|540305026|FG000|Overall Study|Lost to Follow-up|1|||
149776164|NCT00810043|540305027|FG001|Overall Study|Lost to Follow-up|0|||
149776165|NCT00810043|540305028|FG002|Overall Study|Lost to Follow-up|0|||
149776166|NCT00810043|540305026|FG000|Overall Study|Physician Decision|0|||
149776167|NCT00810043|540305027|FG001|Overall Study|Physician Decision|0|||
149776168|NCT00810043|540305028|FG002|Overall Study|Physician Decision|2|||
149776169|NCT00810043|540305026|FG000|Overall Study|Death|2|||
149776170|NCT00810043|540305027|FG001|Overall Study|Death|0|||
149776171|NCT00810043|540305028|FG002|Overall Study|Death|0|||
149776172|NCT00810043|540305026|FG000|Overall Study|Unrelated medical problem|0|||
149776173|NCT00810043|540305027|FG001|Overall Study|Unrelated medical problem|1|||
149776174|NCT00810043|540305028|FG002|Overall Study|Unrelated medical problem|0|||
149776175|NCT00810043|540305026|FG000|Overall Study|Non-medical problem|0|||
149776176|NCT00810043|540305027|FG001|Overall Study|Non-medical problem|0|||
149776177|NCT00810043|540305028|FG002|Overall Study|Non-medical problem|1|||
149776178|NCT00810043|540305026|FG000|Overall Study|No longer met enrollment criteria|0|||
149776179|NCT00810043|540305027|FG001|Overall Study|No longer met enrollment criteria|0|||
149776180|NCT00810043|540305028|FG002|Overall Study|No longer met enrollment criteria|3|||
149776181|NCT02001688|540305029|FG000|Overall Study|Withdrawal by Subject|0|||
149776182|NCT02001688|540305030|FG001|Overall Study|Withdrawal by Subject|0|||
149776183|NCT02001688|540305031|FG002|Overall Study|Withdrawal by Subject|1|||
149776184|NCT02001688|540305029|FG000|Overall Study|Adverse Event|0|||
149776185|NCT02001688|540305030|FG001|Overall Study|Adverse Event|1|||
149776186|NCT02001688|540305031|FG002|Overall Study|Adverse Event|0|||
149776187|NCT00561340|540305032|FG000|Overall Study|refused to drink pediasure|6|||
149776188|NCT00561340|540305033|FG001|Overall Study|refused to drink pediasure|0|||
149776189|NCT01989754|540305034|FG000|Overall Study|Withdrawal by Subject|10|||
149776190|NCT01989754|540305035|FG001|Overall Study|Withdrawal by Subject|14|||
149776191|NCT01989754|540305034|FG000|Overall Study|Lost to Follow-up|28|||
149776192|NCT01989754|540305035|FG001|Overall Study|Lost to Follow-up|20|||
149776193|NCT01989754|540305034|FG000|Overall Study|Closed Site|1|||
149776194|NCT01989754|540305035|FG001|Overall Study|Closed Site|1|||
149776195|NCT01369225|540305038|FG000|Overall Study|Withdrawal by Subject|1|||
149776196|NCT01369225|540305039|FG001|Overall Study|Withdrawal by Subject|0|||
149776197|NCT01369225|540305040|FG002|Overall Study|Withdrawal by Subject|2|||
149776198|NCT01369225|540305041|FG003|Overall Study|Withdrawal by Subject|1|||
149776199|NCT01369225|540305042|FG004|Overall Study|Withdrawal by Subject|0|||
149776200|NCT01369225|540305043|FG005|Overall Study|Withdrawal by Subject|0|||
149776201|NCT01369225|540305038|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
149776202|NCT01369225|540305039|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
149776203|NCT01369225|540305040|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
149776204|NCT01369225|540305041|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
149776205|NCT01369225|540305042|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
149776206|NCT01369225|540305043|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
149776207|NCT01369225|540305038|FG000|Overall Study|Other|1|||
149776208|NCT01369225|540305039|FG001|Overall Study|Other|0|||
149776209|NCT01369225|540305040|FG002|Overall Study|Other|0|||
149776210|NCT01369225|540305041|FG003|Overall Study|Other|0|||
149776211|NCT01369225|540305042|FG004|Overall Study|Other|1|||
149776212|NCT01369225|540305043|FG005|Overall Study|Other|0|||
149776213|NCT01369225|540305038|FG000|Overall Study|Adverse Event|0|||
149776214|NCT01369225|540305039|FG001|Overall Study|Adverse Event|0|||
149776215|NCT01369225|540305040|FG002|Overall Study|Adverse Event|0|||
149776216|NCT01369225|540305041|FG003|Overall Study|Adverse Event|1|||
149776217|NCT01369225|540305042|FG004|Overall Study|Adverse Event|1|||
149776218|NCT01369225|540305043|FG005|Overall Study|Adverse Event|0|||
149776219|NCT00118911|540305044|FG000|Overall Study|Withdrawal by Subject|2|||
149776220|NCT00118911|540305045|FG001|Overall Study|Withdrawal by Subject|5|||
149776221|NCT05507580|540305046|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149776222|NCT05507580|540305047|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149776223|NCT05507580|540305048|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
149776224|NCT05507580|540305049|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
149776225|NCT05507580|540305050|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
149776226|NCT05507580|540305051|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
149776227|NCT05507580|540305046|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
149776228|NCT05507580|540305047|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149776229|NCT05507580|540305048|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149776230|NCT05507580|540305049|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149776231|NCT05507580|540305050|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149776232|NCT05507580|540305051|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149776233|NCT05507580|540305046|FG000|Double-Blind Treatment Period|Other, not specified|5|||
149776234|NCT05507580|540305047|FG001|Double-Blind Treatment Period|Other, not specified|4|||
149776235|NCT05507580|540305048|FG002|Double-Blind Treatment Period|Other, not specified|0|||
149776236|NCT05507580|540305049|FG003|Double-Blind Treatment Period|Other, not specified|0|||
149776237|NCT05507580|540305050|FG004|Double-Blind Treatment Period|Other, not specified|0|||
149776238|NCT05507580|540305051|FG005|Double-Blind Treatment Period|Other, not specified|0|||
149776239|NCT05507580|540305046|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
149776240|NCT05507580|540305047|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
149776241|NCT05507580|540305048|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
149776242|NCT05507580|540305049|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
149776243|NCT05507580|540305050|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
149776244|NCT05507580|540305051|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
149776245|NCT05507580|540305046|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
149776246|NCT05507580|540305047|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
149776247|NCT05507580|540305048|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
149776248|NCT05507580|540305049|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
149776249|NCT05507580|540305050|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
149776250|NCT05507580|540305051|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
149776251|NCT05507580|540305046|FG000|Single-Blind Treatment Period|Other, not specified|0|||
149776252|NCT05507580|540305047|FG001|Single-Blind Treatment Period|Other, not specified|0|||
149776253|NCT05507580|540305048|FG002|Single-Blind Treatment Period|Other, not specified|2|||
149776254|NCT05507580|540305049|FG003|Single-Blind Treatment Period|Other, not specified|7|||
149776255|NCT05507580|540305050|FG004|Single-Blind Treatment Period|Other, not specified|3|||
149776256|NCT05507580|540305051|FG005|Single-Blind Treatment Period|Other, not specified|5|||
149776257|NCT01117012|540305054|FG000|Overall Study|Adverse Event|0|||
149776258|NCT01117012|540305055|FG001|Overall Study|Adverse Event|1|||
149776259|NCT01117012|540305054|FG000|Overall Study|Death|1|||
149776260|NCT01117012|540305055|FG001|Overall Study|Death|1|||
149776261|NCT01117012|540305054|FG000|Overall Study|Withdrawal by Subject|3|||
149776262|NCT01117012|540305055|FG001|Overall Study|Withdrawal by Subject|0|||
149776263|NCT01117012|540305054|FG000|Overall Study|Undefined|4|||
149776264|NCT01117012|540305055|FG001|Overall Study|Undefined|3|||
149776265|NCT05425719|540305060|FG000|Overall Study|Lost to Follow-up|4|||
149776266|NCT05425719|540305061|FG001|Overall Study|Lost to Follow-up|0|||
149776267|NCT05425719|540305060|FG000|Overall Study|Withdrew consent|1|||
149776268|NCT05425719|540305061|FG001|Overall Study|Withdrew consent|1|||
149776269|NCT04682353|540305062|FG000|Overall Study|Lost to Follow-up|0|||
149776270|NCT04682353|540305063|FG001|Overall Study|Lost to Follow-up|1|||
149776271|NCT04682353|540305064|FG002|Overall Study|Lost to Follow-up|0|||
149776272|NCT04682353|540305065|FG003|Overall Study|Lost to Follow-up|1|||
149776273|NCT04682353|540305062|FG000|Overall Study|Personal reasons|0|||
149776274|NCT04682353|540305063|FG001|Overall Study|Personal reasons|1|||
149776275|NCT04682353|540305064|FG002|Overall Study|Personal reasons|0|||
149776276|NCT04682353|540305065|FG003|Overall Study|Personal reasons|0|||
149776277|NCT02849626|540305066|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
149776278|NCT02849626|540305067|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
149776279|NCT02849626|540305068|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
149776280|NCT02849626|540305069|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
149776281|NCT02849626|540305066|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
149776282|NCT02849626|540305067|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
149776283|NCT02849626|540305068|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
149776284|NCT02849626|540305069|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
149776285|NCT02849626|540305066|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
149776286|NCT02849626|540305067|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
149776287|NCT02849626|540305068|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
149776288|NCT02849626|540305069|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
149776289|NCT02849626|540305066|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
149776290|NCT02849626|540305067|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
149776291|NCT02849626|540305068|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
149776292|NCT02849626|540305069|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
149776293|NCT02849626|540305066|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
149776294|NCT02849626|540305067|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
149776295|NCT02849626|540305068|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
149776296|NCT02849626|540305069|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
149776297|NCT02849626|540305066|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
149776298|NCT02849626|540305067|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149776299|NCT02849626|540305068|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149776300|NCT02849626|540305069|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149776301|NCT02849626|540305066|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
149776302|NCT02849626|540305067|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
149776303|NCT02849626|540305068|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
149776304|NCT02849626|540305069|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
149776305|NCT02849626|540305066|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
149776306|NCT02849626|540305067|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149776307|NCT02849626|540305068|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149776308|NCT02849626|540305069|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149776309|NCT02849626|540305066|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
149776310|NCT02849626|540305067|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
149776311|NCT02849626|540305068|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
149776312|NCT02849626|540305069|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
149776313|NCT02849626|540305066|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
149776314|NCT02849626|540305067|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
149776315|NCT02849626|540305068|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
149776316|NCT02849626|540305069|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
149776317|NCT02849626|540305066|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
149776318|NCT02849626|540305067|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
149776319|NCT02849626|540305068|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
149776320|NCT02849626|540305069|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
149776321|NCT03505749|540305072|FG000|Overall Study|Lost to Follow-up|7|||
149776322|NCT03505749|540305073|FG001|Overall Study|Lost to Follow-up|11|||
149776323|NCT03505749|540305072|FG000|Overall Study|Withdrawal by Subject|6|||
149776324|NCT03505749|540305073|FG001|Overall Study|Withdrawal by Subject|0|||
149776325|NCT03505749|540305072|FG000|Overall Study|Discharged from treatment|3|||
149776326|NCT03505749|540305073|FG001|Overall Study|Discharged from treatment|6|||
149776327|NCT01151540|540305074|FG000|Overall Study|Other|2|||
149776328|NCT01151540|540305074|FG000|Overall Study|Adverse event, non-fatal|4|||
149776329|NCT01151540|540305074|FG000|Overall Study|Withdrawal by Subject|7|||
149776330|NCT03846219|540305075|FG000|Overall Study|Withdrawal by Subject|3|||
149776331|NCT03846219|540305076|FG001|Overall Study|Withdrawal by Subject|2|||
149776332|NCT03846219|540305077|FG002|Overall Study|Withdrawal by Subject|2|||
149776333|NCT03846219|540305075|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
149776334|NCT03846219|540305076|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
149776335|NCT03846219|540305077|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
149776336|NCT03846219|540305075|FG000|Overall Study|Physician Decision|0|||
149776337|NCT03846219|540305076|FG001|Overall Study|Physician Decision|0|||
149776338|NCT03846219|540305077|FG002|Overall Study|Physician Decision|2|||
149776339|NCT02261883|540305080|FG000|Overall Study|Death|3|||
149776340|NCT02261883|540305081|FG001|Overall Study|Death|2|||
149776341|NCT02261883|540305080|FG000|Overall Study|Physician Decision|1|||
149776342|NCT02261883|540305081|FG001|Overall Study|Physician Decision|0|||
149776343|NCT02261883|540305080|FG000|Overall Study|Protocol Violation|1|||
149776344|NCT02261883|540305081|FG001|Overall Study|Protocol Violation|0|||
149776345|NCT02261883|540305080|FG000|Overall Study|Withdrawal by Subject|0|||
149776346|NCT02261883|540305081|FG001|Overall Study|Withdrawal by Subject|1|||
149776347|NCT02261883|540305080|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
149776348|NCT02261883|540305081|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
149776349|NCT04199793|540305082|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
149776350|NCT04199793|540305083|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
149776351|NCT04199793|540305082|FG000|Overall Study|Withdrawal by Subject|1|||
149776352|NCT04199793|540305083|FG001|Overall Study|Withdrawal by Subject|1|||
149776353|NCT03820726|540305088|FG000|Overall Study|Other than listed|23|||
149776354|NCT03820726|540305088|FG000|Overall Study|Withdrawal by Subject|37|||
149776355|NCT03820726|540305088|FG000|Overall Study|Lost to Follow-up|3|||
149776356|NCT03820726|540305088|FG000|Overall Study|Protocol deviation|1|||
149776357|NCT03820726|540305088|FG000|Overall Study|Adverse Event|146|||
149776358|NCT03820726|540305088|FG000|Overall Study|Not treated|1|||
149776359|NCT00628758|540305089|FG000|Overall Study|Adverse Event|2|||
149776360|NCT00628758|540305090|FG001|Overall Study|Adverse Event|3|||
149776361|NCT00628758|540305089|FG000|Overall Study|Withdrawal by Subject|6|||
149776362|NCT00628758|540305090|FG001|Overall Study|Withdrawal by Subject|3|||
149776363|NCT00628758|540305089|FG000|Overall Study|Death|1|||
149776364|NCT00628758|540305090|FG001|Overall Study|Death|0|||
149776365|NCT00628758|540305089|FG000|Overall Study|Protocol Violation|5|||
149776366|NCT00628758|540305090|FG001|Overall Study|Protocol Violation|1|||
149776367|NCT00628758|540305089|FG000|Overall Study|Lost to Follow-up|25|||
149776368|NCT00628758|540305090|FG001|Overall Study|Lost to Follow-up|31|||
149776369|NCT00628758|540305089|FG000|Overall Study|Pregnancy|2|||
149776370|NCT00628758|540305090|FG001|Overall Study|Pregnancy|2|||
149776371|NCT00628758|540305089|FG000|Overall Study|Investigator Moved|3|||
149776372|NCT00628758|540305090|FG001|Overall Study|Investigator Moved|0|||
149776373|NCT00628758|540305089|FG000|Overall Study|Treatment Failure|0|||
149776374|NCT00628758|540305090|FG001|Overall Study|Treatment Failure|2|||
149776375|NCT01938001|540305091|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
149776376|NCT01938001|540305092|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
149776377|NCT01938001|540305091|FG000|Pre-Treatment|Death|1|||
149776378|NCT01938001|540305092|FG001|Pre-Treatment|Death|0|||
149776379|NCT01938001|540305091|FG000|Treatment|Death|2|||
149776380|NCT01938001|540305092|FG001|Treatment|Death|0|||
149776381|NCT01938001|540305091|FG000|Treatment|Adverse Event|14|||
149776382|NCT01938001|540305092|FG001|Treatment|Adverse Event|8|||
149776383|NCT01938001|540305091|FG000|Treatment|Progressive Disease|21|||
149776384|NCT01938001|540305092|FG001|Treatment|Progressive Disease|54|||
149776385|NCT01938001|540305091|FG000|Treatment|Withdrawal by Subject|13|||
149776386|NCT01938001|540305092|FG001|Treatment|Withdrawal by Subject|7|||
149776387|NCT01938001|540305091|FG000|Treatment|Other reasons|2|||
149776388|NCT01938001|540305092|FG001|Treatment|Other reasons|1|||
149776389|NCT01626989|540305103|FG000|Screening Period|Screen Failure|15|||
149776390|NCT01626989|540305104|FG001|Screening Period|Screen Failure|0|||
149776391|NCT01626989|540305105|FG002|Screening Period|Screen Failure|0|||
149776392|NCT01626989|540305103|FG000|Screening Period|Withdrawal by Subject|2|||
149776393|NCT01626989|540305104|FG001|Screening Period|Withdrawal by Subject|0|||
149776394|NCT01626989|540305105|FG002|Screening Period|Withdrawal by Subject|0|||
149776395|NCT02293902|540305108|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
149776396|NCT02293902|540305109|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
149776397|NCT02293902|540305110|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
149776398|NCT02293902|540305111|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
149776399|NCT02293902|540305112|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
149776400|NCT02293902|540305108|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
149776401|NCT02293902|540305109|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
149776402|NCT02293902|540305110|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
149776403|NCT02293902|540305111|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
149776404|NCT02293902|540305112|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
149776405|NCT02293902|540305108|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
149776406|NCT02293902|540305109|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149776407|NCT02293902|540305110|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149776408|NCT02293902|540305111|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149776409|NCT02293902|540305112|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149776410|NCT02293902|540305108|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
149776411|NCT02293902|540305109|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
149776412|NCT02293902|540305110|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
149776413|NCT02293902|540305111|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
149776414|NCT02293902|540305112|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
149776415|NCT02293902|540305108|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149801786|NCT04338685|540402441|FG003|Overall Study|Death|4|||
149776416|NCT02293902|540305109|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
149776417|NCT02293902|540305110|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
149776418|NCT02293902|540305111|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149776419|NCT02293902|540305112|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149776420|NCT02947022|540305114|FG000|Overall Study|Study Stopped|1|||
149776421|NCT00105183|540306632|FG000|Overall Study|Death|19|||
149776422|NCT00105183|540306633|FG001|Overall Study|Death|13|||
149776423|NCT00105183|540306634|FG002|Overall Study|Death|15|||
149776424|NCT00105183|540306632|FG000|Overall Study|Withdrawal by Subject|1|||
149776425|NCT00105183|540306633|FG001|Overall Study|Withdrawal by Subject|1|||
149776426|NCT00105183|540306634|FG002|Overall Study|Withdrawal by Subject|4|||
149776427|NCT00105183|540306632|FG000|Overall Study|Physician Decision|1|||
149776428|NCT00105183|540306633|FG001|Overall Study|Physician Decision|2|||
149776429|NCT00105183|540306634|FG002|Overall Study|Physician Decision|3|||
149776430|NCT00105183|540306632|FG000|Overall Study|Lost to Follow-up|0|||
149776431|NCT00105183|540306633|FG001|Overall Study|Lost to Follow-up|1|||
149776432|NCT00105183|540306634|FG002|Overall Study|Lost to Follow-up|1|||
149776433|NCT00105183|540306632|FG000|Overall Study|Other reason|1|||
149776434|NCT00105183|540306633|FG001|Overall Study|Other reason|2|||
149776435|NCT00105183|540306634|FG002|Overall Study|Other reason|0|||
149776436|NCT00792701|540306635|FG000|Overall Study|Adverse Event|0|||
149776437|NCT00792701|540306636|FG001|Overall Study|Adverse Event|22|||
149776438|NCT00792701|540306635|FG000|Overall Study|Ineligible|1|||
149776439|NCT00792701|540306636|FG001|Overall Study|Ineligible|3|||
149776440|NCT00792701|540306635|FG000|Overall Study|Withdrawal by Subject|1|||
149776441|NCT00792701|540306636|FG001|Overall Study|Withdrawal by Subject|19|||
149776442|NCT00792701|540306635|FG000|Overall Study|Not protocol specified|17|||
149776443|NCT00792701|540306636|FG001|Overall Study|Not protocol specified|0|||
149776444|NCT04702984|540306640|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
149776445|NCT00615914|540306643|FG000|Overall Study|Adverse Event|274|||
149776446|NCT00615914|540306643|FG000|Overall Study|Death|20|||
149776447|NCT00615914|540306643|FG000|Overall Study|Lack of Efficacy|59|||
149776448|NCT00615914|540306643|FG000|Overall Study|Lost to Follow-up|187|||
149776449|NCT00615914|540306643|FG000|Overall Study|Withdrawal by Subject|16|||
149776450|NCT00615914|540306643|FG000|Overall Study|Physician Decision|4|||
149776451|NCT00615914|540306643|FG000|Overall Study|No data was collected.|65|||
149776452|NCT00615914|540306643|FG000|Overall Study|No treatment|2|||
149776453|NCT00615914|540306643|FG000|Overall Study|Irregularly enrolled patients|10|||
149776454|NCT01467661|540306644|FG000|Overall Study|Adverse Event|16|||
149776455|NCT01467661|540306644|FG000|Overall Study|Withdrawal by Subject|1|||
149776456|NCT01467661|540306644|FG000|Overall Study|Lack of Efficacy|3|||
149776457|NCT01467661|540306644|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
149776458|NCT03673956|540306645|FG000|Overall Study|Lost to Follow-up|1|||
149776459|NCT03673956|540306646|FG001|Overall Study|Lost to Follow-up|0|||
149776460|NCT03673956|540306647|FG002|Overall Study|Lost to Follow-up|0|||
149776461|NCT03673956|540306648|FG003|Overall Study|Lost to Follow-up|0|||
149776462|NCT03673956|540306645|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
149776463|NCT03673956|540306646|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149776464|NCT03673956|540306647|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149776465|NCT03673956|540306648|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149776466|NCT03037307|540306651|FG000|Period 1|Did Not Meet Study Criteria|0|||
149776467|NCT03037307|540306652|FG001|Period 1|Did Not Meet Study Criteria|0|||
149776468|NCT03037307|540306653|FG002|Period 1|Did Not Meet Study Criteria|0|||
149776469|NCT03037307|540306654|FG003|Period 1|Did Not Meet Study Criteria|1|||
149776470|NCT03037307|540306655|FG004|Period 1|Did Not Meet Study Criteria|0|||
149776471|NCT03037307|540306656|FG005|Period 1|Did Not Meet Study Criteria|0|||
149776472|NCT00270998|540306657|FG000|3 Month Follow-up|Adverse Event|1|||
149776473|NCT00270998|540306658|FG001|3 Month Follow-up|Adverse Event|0|||
149776474|NCT00270998|540306659|FG002|3 Month Follow-up|Adverse Event|0|||
149776475|NCT00270998|540306657|FG000|3 Month Follow-up|Lack of Efficacy|1|||
149776476|NCT00270998|540306658|FG001|3 Month Follow-up|Lack of Efficacy|2|||
149776477|NCT00270998|540306659|FG002|3 Month Follow-up|Lack of Efficacy|1|||
149776478|NCT00270998|540306657|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
149776479|NCT00270998|540306658|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
149776480|NCT00270998|540306659|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
149776481|NCT00270998|540306657|FG000|3 Month Follow-up|Pessary did not fit|12|||
149776482|NCT00270998|540306658|FG001|3 Month Follow-up|Pessary did not fit|0|||
149776483|NCT00270998|540306659|FG002|3 Month Follow-up|Pessary did not fit|0|||
149776484|NCT00270998|540306657|FG000|3 Month Follow-up|Personal/family health|1|||
149776485|NCT00270998|540306658|FG001|3 Month Follow-up|Personal/family health|1|||
149776486|NCT00270998|540306659|FG002|3 Month Follow-up|Personal/family health|0|||
149776487|NCT00270998|540306657|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
149776488|NCT00270998|540306658|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
149776489|NCT00270998|540306659|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
149776490|NCT00270998|540306657|FG000|12 Month Follow-up|Lack of Efficacy|5|||
149776491|NCT00270998|540306658|FG001|12 Month Follow-up|Lack of Efficacy|4|||
149776492|NCT00270998|540306659|FG002|12 Month Follow-up|Lack of Efficacy|3|||
149776493|NCT00270998|540306657|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
149776494|NCT00270998|540306658|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
149776495|NCT00270998|540306659|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
149776496|NCT00270998|540306657|FG000|12 Month Follow-up|Pessary did not fit|1|||
149776497|NCT00270998|540306658|FG001|12 Month Follow-up|Pessary did not fit|0|||
149776498|NCT00270998|540306659|FG002|12 Month Follow-up|Pessary did not fit|0|||
149776499|NCT00270998|540306657|FG000|12 Month Follow-up|Personal/family health|0|||
149776500|NCT00270998|540306658|FG001|12 Month Follow-up|Personal/family health|5|||
149776501|NCT00270998|540306659|FG002|12 Month Follow-up|Personal/family health|1|||
149776502|NCT00270998|540306657|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
149776503|NCT00270998|540306658|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
149776504|NCT00270998|540306659|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
149776505|NCT04075396|540306664|FG000|Overall Study|Death|11|||
149776506|NCT04075396|540306665|FG001|Overall Study|Death|9|||
149776507|NCT04075396|540306664|FG000|Overall Study|Withdrawal by Subject|1|||
149776508|NCT04075396|540306665|FG001|Overall Study|Withdrawal by Subject|2|||
149776509|NCT04075396|540306664|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
149776510|NCT04075396|540306665|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
149776511|NCT04075396|540306664|FG000|Overall Study|Enrolled but not-treated|0|||
149776512|NCT04075396|540306665|FG001|Overall Study|Enrolled but not-treated|1|||
149776513|NCT01156532|540306666|FG000|Overall Study|Family Reasons|1|||
149776514|NCT01156532|540306666|FG000|Overall Study|Lost to Follow-up|1|||
149776515|NCT01855945|540306667|FG000|Overall Study|Adverse Event|0|||
149776516|NCT01855945|540306668|FG001|Overall Study|Adverse Event|0|||
149776517|NCT01855945|540306669|FG002|Overall Study|Adverse Event|0|||
149776518|NCT01855945|540306670|FG003|Overall Study|Adverse Event|0|||
149776519|NCT01855945|540306671|FG004|Overall Study|Adverse Event|0|||
149776520|NCT01855945|540306672|FG005|Overall Study|Adverse Event|0|||
149776521|NCT01855945|540306673|FG006|Overall Study|Adverse Event|1|||
149776522|NCT01855945|540306674|FG007|Overall Study|Adverse Event|0|||
149776523|NCT01855945|540306675|FG008|Overall Study|Adverse Event|0|||
149776524|NCT01855945|540306676|FG009|Overall Study|Adverse Event|0|||
149776525|NCT01855945|540306677|FG010|Overall Study|Adverse Event|0|||
149776526|NCT01855945|540306678|FG011|Overall Study|Adverse Event|0|||
149776527|NCT01855945|540306667|FG000|Overall Study|Death|0|||
149776528|NCT01855945|540306668|FG001|Overall Study|Death|0|||
149776529|NCT01855945|540306669|FG002|Overall Study|Death|0|||
149776530|NCT01855945|540306670|FG003|Overall Study|Death|0|||
149776531|NCT01855945|540306671|FG004|Overall Study|Death|0|||
149776532|NCT01855945|540306672|FG005|Overall Study|Death|0|||
149776533|NCT01855945|540306673|FG006|Overall Study|Death|2|||
149776534|NCT01855945|540306674|FG007|Overall Study|Death|0|||
149776535|NCT01855945|540306675|FG008|Overall Study|Death|0|||
149776536|NCT01855945|540306676|FG009|Overall Study|Death|0|||
149776537|NCT01855945|540306677|FG010|Overall Study|Death|0|||
149776538|NCT01855945|540306678|FG011|Overall Study|Death|0|||
149776539|NCT01855945|540306667|FG000|Overall Study|Lost to Follow-up|11|||
149776540|NCT01855945|540306668|FG001|Overall Study|Lost to Follow-up|10|||
149776541|NCT01855945|540306669|FG002|Overall Study|Lost to Follow-up|7|||
149776542|NCT01855945|540306670|FG003|Overall Study|Lost to Follow-up|3|||
149776543|NCT01855945|540306671|FG004|Overall Study|Lost to Follow-up|0|||
149776544|NCT01855945|540306672|FG005|Overall Study|Lost to Follow-up|3|||
149776545|NCT01855945|540306673|FG006|Overall Study|Lost to Follow-up|4|||
149776546|NCT01855945|540306674|FG007|Overall Study|Lost to Follow-up|7|||
149776547|NCT01855945|540306675|FG008|Overall Study|Lost to Follow-up|2|||
149776548|NCT01855945|540306676|FG009|Overall Study|Lost to Follow-up|0|||
149776549|NCT01855945|540306677|FG010|Overall Study|Lost to Follow-up|0|||
149776550|NCT01855945|540306678|FG011|Overall Study|Lost to Follow-up|2|||
149776551|NCT01855945|540306667|FG000|Overall Study|Other - Unclassified|1|||
149776552|NCT01855945|540306668|FG001|Overall Study|Other - Unclassified|1|||
149776553|NCT01855945|540306669|FG002|Overall Study|Other - Unclassified|1|||
149776554|NCT01855945|540306670|FG003|Overall Study|Other - Unclassified|0|||
149776555|NCT01855945|540306671|FG004|Overall Study|Other - Unclassified|0|||
149776556|NCT01855945|540306672|FG005|Overall Study|Other - Unclassified|0|||
149776557|NCT01855945|540306673|FG006|Overall Study|Other - Unclassified|2|||
149776558|NCT01855945|540306674|FG007|Overall Study|Other - Unclassified|1|||
149776559|NCT01855945|540306675|FG008|Overall Study|Other - Unclassified|0|||
149776560|NCT01855945|540306676|FG009|Overall Study|Other - Unclassified|0|||
149776561|NCT01855945|540306677|FG010|Overall Study|Other - Unclassified|1|||
149776562|NCT01855945|540306678|FG011|Overall Study|Other - Unclassified|0|||
149776563|NCT01855945|540306667|FG000|Overall Study|Withdrawal by Subject|4|||
149776564|NCT01855945|540306668|FG001|Overall Study|Withdrawal by Subject|0|||
149776565|NCT01855945|540306669|FG002|Overall Study|Withdrawal by Subject|4|||
149776566|NCT01855945|540306670|FG003|Overall Study|Withdrawal by Subject|1|||
149776567|NCT01855945|540306671|FG004|Overall Study|Withdrawal by Subject|1|||
149776568|NCT01855945|540306672|FG005|Overall Study|Withdrawal by Subject|0|||
149776569|NCT01855945|540306673|FG006|Overall Study|Withdrawal by Subject|1|||
149776570|NCT01855945|540306674|FG007|Overall Study|Withdrawal by Subject|0|||
149776571|NCT01855945|540306675|FG008|Overall Study|Withdrawal by Subject|0|||
149776572|NCT01855945|540306676|FG009|Overall Study|Withdrawal by Subject|2|||
149776573|NCT01855945|540306677|FG010|Overall Study|Withdrawal by Subject|4|||
149776574|NCT01855945|540306678|FG011|Overall Study|Withdrawal by Subject|1|||
149776575|NCT02156804|540306679|FG000|Overall Study|Withdrawal by Subject|1|||
149776576|NCT01112982|540306680|FG000|Overall Study|Withdrawal by Subject|1|||
149776577|NCT01112982|540306680|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
149776578|NCT00389441|540306681|FG000|Overall Study|Adverse Event|7|||
149776579|NCT00389441|540306681|FG000|Overall Study|Death|4|||
149776580|NCT00389441|540306681|FG000|Overall Study|Lost to Follow-up|2|||
149776581|NCT00389441|540306681|FG000|Overall Study|Withdrawal by Subject|4|||
149776582|NCT00389441|540306681|FG000|Overall Study|Physician Decision|1|||
149776583|NCT00389441|540306681|FG000|Overall Study|Protocol Violation|1|||
149776584|NCT00389441|540306681|FG000|Overall Study|Global deterioration of health status|4|||
149776585|NCT00389441|540306681|FG000|Overall Study|Objective progression or relapse|26|||
149776586|NCT00389441|540306681|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
149776587|NCT00389441|540306681|FG000|Overall Study|Clinical progression|1|||
149776588|NCT00305604|540306682|FG000|Overall Study|Adverse Event|6|||
149776589|NCT00305604|540306683|FG001|Overall Study|Adverse Event|3|||
149776590|NCT00305604|540306682|FG000|Overall Study|Lack of Efficacy|11|||
149776591|NCT00305604|540306683|FG001|Overall Study|Lack of Efficacy|18|||
149776592|NCT00305604|540306682|FG000|Overall Study|Lost to Follow-up|0|||
149776593|NCT00305604|540306683|FG001|Overall Study|Lost to Follow-up|4|||
149776594|NCT00305604|540306682|FG000|Overall Study|Protocol Violation|2|||
149776595|NCT00305604|540306683|FG001|Overall Study|Protocol Violation|1|||
149776596|NCT00305604|540306682|FG000|Overall Study|Withdrawal by Subject|12|||
149776597|NCT00305604|540306683|FG001|Overall Study|Withdrawal by Subject|21|||
149776598|NCT00305604|540306682|FG000|Overall Study|Patient moved|1|||
149776599|NCT00305604|540306683|FG001|Overall Study|Patient moved|0|||
149776600|NCT00636441|540306684|FG000|Overall Study|Adverse Event|0|||
149776601|NCT00636441|540306685|FG001|Overall Study|Adverse Event|1|||
149776602|NCT00636441|540306686|FG002|Overall Study|Adverse Event|1|||
149776603|NCT00636441|540306687|FG003|Overall Study|Adverse Event|0|||
149776604|NCT00636441|540306688|FG004|Overall Study|Adverse Event|0|||
149776605|NCT00636441|540306689|FG005|Overall Study|Adverse Event|1|||
149776606|NCT00636441|540306690|FG006|Overall Study|Adverse Event|0|||
149776607|NCT00636441|540306684|FG000|Overall Study|Late, ineligible|0|||
149776608|NCT00636441|540306685|FG001|Overall Study|Late, ineligible|0|||
149776609|NCT00636441|540306686|FG002|Overall Study|Late, ineligible|0|||
149776610|NCT00636441|540306687|FG003|Overall Study|Late, ineligible|0|||
149776611|NCT00636441|540306688|FG004|Overall Study|Late, ineligible|0|||
149776612|NCT00636441|540306689|FG005|Overall Study|Late, ineligible|0|||
149776613|NCT00636441|540306690|FG006|Overall Study|Late, ineligible|1|||
149776614|NCT00636441|540306684|FG000|Overall Study|Screen Failure|0|||
149776615|NCT00636441|540306685|FG001|Overall Study|Screen Failure|0|||
149776616|NCT00636441|540306686|FG002|Overall Study|Screen Failure|0|||
149776617|NCT00636441|540306687|FG003|Overall Study|Screen Failure|0|||
149776618|NCT00636441|540306688|FG004|Overall Study|Screen Failure|0|||
149776619|NCT00636441|540306689|FG005|Overall Study|Screen Failure|0|||
149776620|NCT00636441|540306690|FG006|Overall Study|Screen Failure|17|||
149776621|NCT03332303|540306693|FG000|Overall Study|Participant did not dose|1|||
149776622|NCT03332303|540306694|FG001|Overall Study|Participant did not dose|2|||
149776623|NCT03332303|540306695|FG002|Overall Study|Participant did not dose|0|||
149776624|NCT03332303|540306693|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
149776625|NCT03332303|540306694|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
149776626|NCT03332303|540306695|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
149776627|NCT03332303|540306693|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
149776628|NCT03332303|540306694|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
149776629|NCT03332303|540306695|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
149776630|NCT03332303|540306693|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
149776631|NCT03332303|540306694|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
149776632|NCT03332303|540306695|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
149776633|NCT03332303|540306693|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
149776634|NCT03332303|540306694|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
149776635|NCT03332303|540306695|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
149776636|NCT03332303|540306693|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
149776637|NCT03332303|540306694|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
149776638|NCT03332303|540306695|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
149776639|NCT03332303|540306693|FG000|Overall Study|Participant had a significant protocol deviation|0|||
149776640|NCT03332303|540306694|FG001|Overall Study|Participant had a significant protocol deviation|1|||
149776641|NCT03332303|540306695|FG002|Overall Study|Participant had a significant protocol deviation|0|||
149776642|NCT03495817|540306697|FG000|26 Week Open Label|Adverse Event|3|||
149776643|NCT03495817|540306697|FG000|26 Week Open Label|Withdrawal by Subject|4|||
149776644|NCT03495817|540306697|FG000|26 Week Open Label|Lost to Follow-up|1|||
149776645|NCT03495817|540306697|FG000|26 Week Extension|Lost to Follow-up|2|||
149776646|NCT00326417|540306701|FG000|Overall Study|Withdrawal by Subject|0|||
149776647|NCT00326417|540306702|FG001|Overall Study|Withdrawal by Subject|0|||
149776648|NCT00326417|540306703|FG002|Overall Study|Withdrawal by Subject|1|||
149776649|NCT00326417|540306704|FG003|Overall Study|Withdrawal by Subject|0|||
149776650|NCT00326417|540306701|FG000|Overall Study|Arm Closed|7|||
149776651|NCT00326417|540306702|FG001|Overall Study|Arm Closed|0|||
149776652|NCT00326417|540306703|FG002|Overall Study|Arm Closed|0|||
149776653|NCT00326417|540306704|FG003|Overall Study|Arm Closed|3|||
149776654|NCT00326417|540306701|FG000|Overall Study|Death|7|||
149776655|NCT00326417|540306702|FG001|Overall Study|Death|0|||
149776656|NCT00326417|540306703|FG002|Overall Study|Death|0|||
149776657|NCT00326417|540306704|FG003|Overall Study|Death|0|||
149776658|NCT00844285|540306705|FG000|Overall Study|Other|0|||
149776659|NCT00844285|540306706|FG001|Overall Study|Other|1|||
149776660|NCT00844285|540306707|FG002|Overall Study|Other|0|||
149776661|NCT00844285|540306705|FG000|Overall Study|Other than specified|95|||
149776662|NCT00844285|540306706|FG001|Overall Study|Other than specified|129|||
149776663|NCT00844285|540306707|FG002|Overall Study|Other than specified|12|||
149776664|NCT00844285|540306705|FG000|Overall Study|Site closure|256|||
149776665|NCT00844285|540306706|FG001|Overall Study|Site closure|450|||
149776666|NCT00844285|540306707|FG002|Overall Study|Site closure|50|||
149776667|NCT00844285|540306705|FG000|Overall Study|Follow-up < 8 years|16|||
149776668|NCT00844285|540306706|FG001|Overall Study|Follow-up < 8 years|23|||
149776669|NCT00844285|540306707|FG002|Overall Study|Follow-up < 8 years|4|||
149776670|NCT00844285|540306705|FG000|Overall Study|Protocol Violation|26|||
149776671|NCT00844285|540306706|FG001|Overall Study|Protocol Violation|28|||
149776672|NCT00844285|540306707|FG002|Overall Study|Protocol Violation|54|||
149776673|NCT00844285|540306705|FG000|Overall Study|Death|22|||
149776674|NCT00844285|540306706|FG001|Overall Study|Death|21|||
149776675|NCT00844285|540306707|FG002|Overall Study|Death|8|||
149776676|NCT00844285|540306705|FG000|Overall Study|Withdrew Consent|344|||
149776677|NCT00844285|540306706|FG001|Overall Study|Withdrew Consent|466|||
149776678|NCT00844285|540306707|FG002|Overall Study|Withdrew Consent|70|||
149776679|NCT00844285|540306705|FG000|Overall Study|Lost to Follow-up|330|||
149776680|NCT00844285|540306706|FG001|Overall Study|Lost to Follow-up|486|||
149776681|NCT00844285|540306707|FG002|Overall Study|Lost to Follow-up|74|||
149776682|NCT01586806|540306708|FG000|Overall Study|Protocol Violation|0|||
149776683|NCT01586806|540306709|FG001|Overall Study|Protocol Violation|1|||
149776684|NCT01586806|540306710|FG002|Overall Study|Protocol Violation|0|||
149776685|NCT01586806|540306708|FG000|Overall Study|Withdrawal by Subject|1|||
149776686|NCT01586806|540306709|FG001|Overall Study|Withdrawal by Subject|0|||
149776687|NCT01586806|540306710|FG002|Overall Study|Withdrawal by Subject|0|||
149776688|NCT01586806|540306708|FG000|Overall Study|Lost to Follow-up|2|||
149776689|NCT01586806|540306709|FG001|Overall Study|Lost to Follow-up|3|||
149776690|NCT01586806|540306710|FG002|Overall Study|Lost to Follow-up|2|||
149776691|NCT01185704|540306711|FG000|Overall Study|Randomized but not treated|3|||
149776692|NCT01185704|540306712|FG001|Overall Study|Randomized but not treated|3|||
149776693|NCT01185704|540306711|FG000|Overall Study|Lack of ovarian response|5|||
149776694|NCT01185704|540306712|FG001|Overall Study|Lack of ovarian response|1|||
149776695|NCT01185704|540306711|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
149776696|NCT01185704|540306712|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
149776697|NCT01185704|540306711|FG000|Overall Study|Ectopic pregnancy|0|||
149776698|NCT01185704|540306712|FG001|Overall Study|Ectopic pregnancy|1|||
149776699|NCT01313208|540306713|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
149776700|NCT01313208|540306714|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
149776701|NCT01313208|540306713|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
149776702|NCT01313208|540306714|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
149776703|NCT01313208|540306713|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
149776704|NCT01313208|540306714|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
149776705|NCT01313208|540306713|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
149776706|NCT01313208|540306714|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
149776707|NCT01313208|540306713|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
149776708|NCT01313208|540306714|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
149776709|NCT01313208|540306713|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
149776710|NCT01313208|540306714|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
149776711|NCT01313208|540306713|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
149776712|NCT01313208|540306714|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
149776713|NCT01313208|540306713|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
149776714|NCT01313208|540306714|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
149776715|NCT01313208|540306713|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
149776716|NCT01313208|540306714|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
149776717|NCT01957787|540306715|FG000|Overall Study|Death|18|||
149776718|NCT01957787|540306715|FG000|Overall Study|Lost to Follow-up|3|||
149776719|NCT01957787|540306715|FG000|Overall Study|Withdrawal by Subject|3|||
149776720|NCT01957787|540306715|FG000|Overall Study|Entered Hospice or Similar Program|2|||
149776721|NCT01957787|540306715|FG000|Overall Study|Index Tumor(s) Resected|2|||
149776722|NCT01957787|540306715|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
149776723|NCT01957787|540306715|FG000|Overall Study|Local therapy, not cryoablation|6|||
149776724|NCT00187889|540306716|FG000|Overall Study|Withdrawal by Subject|6|||
149776725|NCT00187889|540306717|FG001|Overall Study|Withdrawal by Subject|4|||
149776726|NCT00435994|540306718|FG000|Overall Study|Lost to Follow-up|7|||
149776727|NCT00435994|540306719|FG001|Overall Study|Lost to Follow-up|0|||
149776728|NCT00435994|540306720|FG002|Overall Study|Lost to Follow-up|0|||
149776729|NCT00788697|540306723|FG000|Overall Study|No study drug administered|12|||
149776730|NCT00788697|540306723|FG000|Overall Study|Training Patients|74|||
149776731|NCT00788697|540306723|FG000|Overall Study|no truth standard procedure available|5|||
149776732|NCT00788697|540306723|FG000|Overall Study|Technically inadequate truth standard|1|||
149776733|NCT00788697|540306723|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
149776734|NCT01998880|540306724|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
149776735|NCT01998880|540306725|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
149776736|NCT01998880|540306724|FG000|Overall Study|Disease Progression|1|||
149776737|NCT01998880|540306725|FG001|Overall Study|Disease Progression|8|||
149776738|NCT01998880|540306724|FG000|Overall Study|Withdrew Consent|2|||
149776739|NCT01998880|540306725|FG001|Overall Study|Withdrew Consent|1|||
149776740|NCT01998880|540306724|FG000|Overall Study|Death|3|||
149776741|NCT01998880|540306725|FG001|Overall Study|Death|6|||
149776742|NCT01998880|540306724|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149776743|NCT01998880|540306725|FG001|Overall Study|Insufficient Therapeutic Response|5|||
149776744|NCT01998880|540306724|FG000|Overall Study|Administrative/Other|1|||
149776745|NCT01998880|540306725|FG001|Overall Study|Administrative/Other|1|||
149776746|NCT01998880|540306724|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
149776747|NCT01998880|540306725|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
149776748|NCT01998880|540306724|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
149776749|NCT01998880|540306725|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
149776750|NCT01998880|540306724|FG000|Overall Study|Did Not Receive Treatment|3|||
149776751|NCT01998880|540306725|FG001|Overall Study|Did Not Receive Treatment|2|||
149776752|NCT02248857|540306726|FG000|3 Month|Withdrawal by Subject|9|||
149776753|NCT02248857|540306727|FG001|3 Month|Withdrawal by Subject|3|||
149776754|NCT02248857|540306728|FG002|3 Month|Withdrawal by Subject|4|||
149776755|NCT02248857|540306726|FG000|3 Month|Unable to reach for 3 month|35|||
149776756|NCT02248857|540306727|FG001|3 Month|Unable to reach for 3 month|29|||
149776757|NCT02248857|540306728|FG002|3 Month|Unable to reach for 3 month|26|||
149776758|NCT02248857|540306726|FG000|3 Month|Partially completed, unable to finish|2|||
149776759|NCT02248857|540306727|FG001|3 Month|Partially completed, unable to finish|2|||
149776760|NCT02248857|540306728|FG002|3 Month|Partially completed, unable to finish|1|||
149776761|NCT02248857|540306726|FG000|6 Month|Lost to Follow-up|27|||
149776762|NCT02248857|540306727|FG001|6 Month|Lost to Follow-up|26|||
149776763|NCT02248857|540306728|FG002|6 Month|Lost to Follow-up|15|||
149776764|NCT02248857|540306726|FG000|6 Month|Partially completed, unable to finish|0|||
149776765|NCT02248857|540306727|FG001|6 Month|Partially completed, unable to finish|1|||
149776766|NCT02248857|540306728|FG002|6 Month|Partially completed, unable to finish|0|||
149776767|NCT02248857|540306726|FG000|6 Month|Withdrawal by Subject|0|||
149776768|NCT02248857|540306727|FG001|6 Month|Withdrawal by Subject|2|||
149776769|NCT02248857|540306728|FG002|6 Month|Withdrawal by Subject|2|||
149776770|NCT02248857|540306726|FG000|6 Month|Death|1|||
149776771|NCT02248857|540306727|FG001|6 Month|Death|0|||
149776772|NCT02248857|540306728|FG002|6 Month|Death|0|||
149776773|NCT03549117|540306732|FG000|Overall Study|Withdrawal by Subject|1|||
149776774|NCT03549117|540306733|FG001|Overall Study|Withdrawal by Subject|0|||
149776775|NCT00014911|540306734|FG000|Overall Study|Adverse Event|1|||
149776776|NCT00014911|540306734|FG000|Overall Study|Lost to Follow-up|1|||
149776777|NCT00014911|540306734|FG000|Overall Study|Withdrawal by Subject|6|||
149776778|NCT00014911|540306734|FG000|Overall Study|Unknown Reasons|2|||
149776779|NCT00014911|540306734|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
149776780|NCT00345540|540306735|FG000|Overall Study|Withdrawal by Subject|1|||
149776781|NCT00861380|540306736|FG000|Overall Study|Withdrawal Information not recorded|8427|||
149776782|NCT00861380|540306737|FG001|Overall Study|Withdrawal Information not recorded|9112|||
149776783|NCT00861380|540306738|FG002|Overall Study|Withdrawal Information not recorded|8872|||
149776784|NCT00861380|540306739|FG003|Overall Study|Withdrawal Information not recorded|3689|||
149776785|NCT00861380|540306740|FG004|Overall Study|Withdrawal Information not recorded|1812|||
149776786|NCT00861380|540306741|FG005|Overall Study|Withdrawal Information not recorded|6249|||
149776787|NCT00861380|540306742|FG006|Overall Study|Withdrawal Information not recorded|3020|||
149776788|NCT04179786|540306743|FG000|Overall Study|Withdrawal by Subject|8|||
149776789|NCT03310580|540306744|FG000|Overall Study|Adverse Event|0|||
149776790|NCT03310580|540306745|FG001|Overall Study|Adverse Event|1|||
149776791|NCT03310580|540306746|FG002|Overall Study|Adverse Event|0|||
149776792|NCT03205982|540306753|FG000|Overall Study|Lost to Follow-up|20|||
149776793|NCT03205982|540306754|FG001|Overall Study|Lost to Follow-up|19|||
149776794|NCT03205982|540306753|FG000|Overall Study|Withdrawal by Subject|4|||
149776795|NCT03205982|540306754|FG001|Overall Study|Withdrawal by Subject|3|||
149776796|NCT03205982|540306753|FG000|Overall Study|Withdrawal by PI|0|||
149776797|NCT03205982|540306754|FG001|Overall Study|Withdrawal by PI|1|||
149776798|NCT00994162|540306755|FG000|Overall Study|Withdrawal by Subject|1|||
149776799|NCT00994162|540306755|FG000|Overall Study|Lost to Follow-up|2|||
149776800|NCT00994162|540306755|FG000|Overall Study|Product Complaint|1|||
149776801|NCT00994162|540306755|FG000|Overall Study|Poor Compliance|5|||
149776802|NCT00994162|540306755|FG000|Overall Study|Lack of Response|3|||
149776803|NCT00994162|540306755|FG000|Overall Study|Discharged from Hospital|4|||
149776804|NCT00994162|540306755|FG000|Overall Study|Death|2|||
149776805|NCT00994162|540306755|FG000|Overall Study|Care Transferred to Another Physician|2|||
149776806|NCT00994162|540306755|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
149776807|NCT00994162|540306755|FG000|Overall Study|Physician Decision|2|||
149776808|NCT00994162|540306755|FG000|Overall Study|Surrounding Wound Erythematous|1|||
149776809|NCT00994162|540306755|FG000|Overall Study|Machine Losing Vaccum|1|||
149776810|NCT00994162|540306755|FG000|Overall Study|Patient Lived Too Far Away|1|||
149776811|NCT00994162|540306755|FG000|Overall Study|Above Knee Amputation|1|||
149776812|NCT00994162|540306755|FG000|Overall Study|Reason Not Reported By Site|1|||
149776813|NCT02983799|540306756|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
149776814|NCT02983799|540306757|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
149776815|NCT02983799|540306758|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
149776816|NCT02983799|540306759|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
149776817|NCT02983799|540306760|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
149776818|NCT02983799|540306756|FG000|Overall Study|Death|20|||
149776819|NCT02983799|540306757|FG001|Overall Study|Death|5|||
149776820|NCT02983799|540306758|FG002|Overall Study|Death|23|||
149776821|NCT02983799|540306759|FG003|Overall Study|Death|47|||
149776822|NCT02983799|540306760|FG004|Overall Study|Death|7|||
149776823|NCT02983799|540306756|FG000|Overall Study|Withdrawal by Subject|1|||
149776824|NCT02983799|540306757|FG001|Overall Study|Withdrawal by Subject|0|||
149776825|NCT02983799|540306758|FG002|Overall Study|Withdrawal by Subject|3|||
149776826|NCT02983799|540306759|FG003|Overall Study|Withdrawal by Subject|4|||
149776827|NCT02983799|540306760|FG004|Overall Study|Withdrawal by Subject|1|||
149776828|NCT02983799|540306756|FG000|Overall Study|Protocol Violation|0|||
149776829|NCT02983799|540306757|FG001|Overall Study|Protocol Violation|1|||
149776830|NCT02983799|540306758|FG002|Overall Study|Protocol Violation|0|||
149776831|NCT02983799|540306759|FG003|Overall Study|Protocol Violation|0|||
149776832|NCT02983799|540306760|FG004|Overall Study|Protocol Violation|1|||
149776833|NCT02983799|540306756|FG000|Overall Study|Lost to Follow-up|1|||
149776834|NCT02983799|540306757|FG001|Overall Study|Lost to Follow-up|0|||
149776835|NCT02983799|540306758|FG002|Overall Study|Lost to Follow-up|1|||
149776836|NCT02983799|540306759|FG003|Overall Study|Lost to Follow-up|0|||
149776837|NCT02983799|540306760|FG004|Overall Study|Lost to Follow-up|0|||
149776838|NCT00795509|540306767|FG000|Overall Study|Protocol Violation|31|||
149776839|NCT00970268|540306768|FG000|Overall Study|Withdrawal by Subject|12|||
149776840|NCT00970268|540306769|FG001|Overall Study|Withdrawal by Subject|19|||
149776841|NCT00970268|540306768|FG000|Overall Study|Adverse Event|15|||
149776842|NCT00970268|540306769|FG001|Overall Study|Adverse Event|12|||
149776843|NCT00970268|540306768|FG000|Overall Study|Lack of Efficacy|3|||
149776844|NCT00970268|540306769|FG001|Overall Study|Lack of Efficacy|6|||
149776845|NCT00970268|540306768|FG000|Overall Study|Protocol Violation|4|||
149776846|NCT00970268|540306769|FG001|Overall Study|Protocol Violation|7|||
149776847|NCT00970268|540306768|FG000|Overall Study|Other Reason|3|||
149776848|NCT00970268|540306769|FG001|Overall Study|Other Reason|1|||
149776849|NCT00970268|540306768|FG000|Overall Study|COPD Exacerbation|4|||
149776850|NCT00970268|540306769|FG001|Overall Study|COPD Exacerbation|2|||
149776851|NCT00970268|540306768|FG000|Overall Study|Lost to Follow-up|1|||
149776852|NCT00970268|540306769|FG001|Overall Study|Lost to Follow-up|2|||
149776853|NCT00970268|540306768|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
149776854|NCT00970268|540306769|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
149776855|NCT03136367|540306770|FG000|T1 Consultation|discontinued mistakenly included|2|||
149776856|NCT03136367|540306771|FG001|T1 Consultation|discontinued mistakenly included|6|||
149776857|NCT03136367|540306772|FG002|T1 Consultation|discontinued mistakenly included|1|||
149776858|NCT03136367|540306770|FG000|T1 Consultation|Discontinued other|0|||
149776859|NCT03136367|540306771|FG001|T1 Consultation|Discontinued other|1|||
149776860|NCT03136367|540306772|FG002|T1 Consultation|Discontinued other|0|||
149776861|NCT03136367|540306770|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
149776862|NCT03136367|540306771|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
149776863|NCT03136367|540306772|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
149776864|NCT03136367|540306770|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
149776865|NCT03136367|540306771|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
149776866|NCT03136367|540306772|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
149776867|NCT03136367|540306770|FG000|T2 Post-consultation|Discontinued other|0|||
149776868|NCT03136367|540306771|FG001|T2 Post-consultation|Discontinued other|2|||
149776869|NCT03136367|540306772|FG002|T2 Post-consultation|Discontinued other|6|||
149776870|NCT03136367|540306770|FG000|T2 Post-consultation|Discontinued transferred care|0|||
149776871|NCT03136367|540306771|FG001|T2 Post-consultation|Discontinued transferred care|0|||
149776872|NCT03136367|540306772|FG002|T2 Post-consultation|Discontinued transferred care|3|||
149776873|NCT03136367|540306770|FG000|T2 Post-consultation|Discontinued lost contact|0|||
149776874|NCT03136367|540306771|FG001|T2 Post-consultation|Discontinued lost contact|1|||
149776875|NCT03136367|540306772|FG002|T2 Post-consultation|Discontinued lost contact|0|||
149776876|NCT03136367|540306770|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
149776877|NCT03136367|540306771|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
149776878|NCT03136367|540306772|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
149776879|NCT03136367|540306770|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
149776880|NCT03136367|540306771|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
149776881|NCT03136367|540306772|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
149776882|NCT03136367|540306770|FG000|T3 1 Week After Surgery|other discontinued|2|||
149776883|NCT03136367|540306771|FG001|T3 1 Week After Surgery|other discontinued|4|||
149776884|NCT03136367|540306772|FG002|T3 1 Week After Surgery|other discontinued|3|||
149776885|NCT03136367|540306770|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
149776886|NCT03136367|540306771|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
149776887|NCT03136367|540306772|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
149776888|NCT03136367|540306770|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
149776889|NCT03136367|540306771|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
149776890|NCT03136367|540306772|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
149776891|NCT03136367|540306770|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
149776892|NCT03136367|540306771|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
149776893|NCT03136367|540306772|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
149776894|NCT03136367|540306770|FG000|T4 12 Weeks After Surgery|Death|0|||
149776895|NCT03136367|540306771|FG001|T4 12 Weeks After Surgery|Death|1|||
149776896|NCT03136367|540306772|FG002|T4 12 Weeks After Surgery|Death|3|||
149776897|NCT03136367|540306770|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
149776898|NCT03136367|540306771|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
149776899|NCT03136367|540306772|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
149776900|NCT03136367|540306770|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
149776901|NCT03136367|540306771|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
149776902|NCT03136367|540306772|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
149776903|NCT03136367|540306770|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
149776904|NCT03136367|540306771|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
149776905|NCT03136367|540306772|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
149776906|NCT03136367|540306770|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
149776907|NCT03136367|540306771|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
149776908|NCT03136367|540306772|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
149776909|NCT03136367|540306770|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
149776910|NCT03136367|540306771|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
149776911|NCT03136367|540306772|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
149776912|NCT03136367|540306770|FG000|T5 1 Year After Surgery|Death|0|||
149776913|NCT03136367|540306771|FG001|T5 1 Year After Surgery|Death|0|||
149776914|NCT03136367|540306772|FG002|T5 1 Year After Surgery|Death|1|||
149776915|NCT03136367|540306770|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
149776916|NCT03136367|540306771|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
149776917|NCT03136367|540306772|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
149776918|NCT03136367|540306770|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
149776919|NCT03136367|540306771|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
149776920|NCT03136367|540306772|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
149776921|NCT03136367|540306770|FG000|T5 1 Year After Surgery|study ended before due|31|||
149776922|NCT03136367|540306771|FG001|T5 1 Year After Surgery|study ended before due|103|||
149776923|NCT03136367|540306772|FG002|T5 1 Year After Surgery|study ended before due|110|||
149776924|NCT03136367|540306770|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
149776925|NCT03136367|540306771|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
149776926|NCT03136367|540306772|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
149776927|NCT03175562|540306776|FG000|Overall Study|Adverse Event|1|||
149776928|NCT03175562|540306776|FG000|Overall Study|Lost to Follow-up|3|||
149776929|NCT03175562|540306776|FG000|Overall Study|Withdrawal by Subject|7|||
149776930|NCT03175562|540306776|FG000|Overall Study|Other (Not Specified)|5|||
149776931|NCT02146833|540306777|FG000|Overall Study|Death|10|||
149776932|NCT02146833|540306777|FG000|Overall Study|No longer consented to study treatment|1|||
149776933|NCT01105936|540308685|FG000|Period 1|Adverse Event|0|||
149776934|NCT01105936|540308686|FG001|Period 1|Adverse Event|0|||
149776935|NCT01105936|540308687|FG002|Period 1|Adverse Event|0|||
149776936|NCT01105936|540308688|FG003|Period 1|Adverse Event|1|||
149776937|NCT01105936|540308685|FG000|Period 2|Adverse Event|1|||
149776938|NCT01105936|540308686|FG001|Period 2|Adverse Event|0|||
149776939|NCT01105936|540308687|FG002|Period 2|Adverse Event|0|||
149776940|NCT01105936|540308688|FG003|Period 2|Adverse Event|0|||
149776941|NCT01105936|540308685|FG000|Period 3|Protocol Violation|0|||
149776942|NCT01105936|540308686|FG001|Period 3|Protocol Violation|2|||
149776943|NCT01105936|540308687|FG002|Period 3|Protocol Violation|0|||
149776944|NCT01105936|540308688|FG003|Period 3|Protocol Violation|0|||
149776945|NCT01563107|540308689|FG000|Overall Study|Physician Decision|0|||
149776946|NCT01563107|540308690|FG001|Overall Study|Physician Decision|1|||
149776947|NCT01563107|540308691|FG002|Overall Study|Physician Decision|1|||
149776948|NCT01563107|540308692|FG003|Overall Study|Physician Decision|3|||
149776949|NCT01563107|540308689|FG000|Overall Study|Withdrawal by Subject|1|||
149776950|NCT01563107|540308690|FG001|Overall Study|Withdrawal by Subject|2|||
149776951|NCT01563107|540308691|FG002|Overall Study|Withdrawal by Subject|1|||
149776952|NCT01563107|540308692|FG003|Overall Study|Withdrawal by Subject|2|||
149776953|NCT02707601|540308693|FG000|Overall Study|Death|0|||
149776954|NCT02707601|540308694|FG001|Overall Study|Death|1|||
149776955|NCT02707601|540308693|FG000|Overall Study|Lack of Efficacy|0|||
149776956|NCT02707601|540308694|FG001|Overall Study|Lack of Efficacy|1|||
149776957|NCT02707601|540308693|FG000|Overall Study|Investigator's Discretion|1|||
149776958|NCT02707601|540308694|FG001|Overall Study|Investigator's Discretion|0|||
149776959|NCT02707601|540308693|FG000|Overall Study|Withdrew Consent|0|||
149776960|NCT02707601|540308694|FG001|Overall Study|Withdrew Consent|1|||
149776961|NCT02707601|540308693|FG000|Overall Study|Lost to Follow-up|1|||
149776962|NCT02707601|540308694|FG001|Overall Study|Lost to Follow-up|1|||
149776963|NCT02707601|540308693|FG000|Overall Study|Participants Randomized but Not Treated|2|||
149776964|NCT02707601|540308694|FG001|Overall Study|Participants Randomized but Not Treated|0|||
149776965|NCT03907969|540308696|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
149776966|NCT03907969|540308697|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
149776967|NCT03907969|540308698|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
149776968|NCT03907969|540308699|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
149776969|NCT03907969|540308700|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
149776970|NCT03907969|540308701|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
149776971|NCT03907969|540308702|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
149776972|NCT03907969|540308703|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
149776973|NCT03907969|540308704|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
149776974|NCT03907969|540308705|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
149776975|NCT03907969|540308706|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
149776976|NCT03907969|540308696|FG000|Monotherapy Part A|Progressive Disease|0|||
149776977|NCT03907969|540308697|FG001|Monotherapy Part A|Progressive Disease|1|||
149776978|NCT03907969|540308698|FG002|Monotherapy Part A|Progressive Disease|0|||
149776979|NCT03907969|540308699|FG003|Monotherapy Part A|Progressive Disease|0|||
149776980|NCT03907969|540308700|FG004|Monotherapy Part A|Progressive Disease|0|||
149776981|NCT03907969|540308701|FG005|Monotherapy Part A|Progressive Disease|1|||
149776982|NCT03907969|540308702|FG006|Monotherapy Part A|Progressive Disease|2|||
149776983|NCT03907969|540308703|FG007|Monotherapy Part A|Progressive Disease|0|||
149776984|NCT03907969|540308704|FG008|Monotherapy Part A|Progressive Disease|0|||
149776985|NCT03907969|540308705|FG009|Monotherapy Part A|Progressive Disease|0|||
149776986|NCT03907969|540308706|FG010|Monotherapy Part A|Progressive Disease|0|||
149776987|NCT03907969|540308696|FG000|Monotherapy Part A|Death|0|||
149776988|NCT03907969|540308697|FG001|Monotherapy Part A|Death|0|||
149776989|NCT03907969|540308698|FG002|Monotherapy Part A|Death|1|||
149776990|NCT03907969|540308699|FG003|Monotherapy Part A|Death|1|||
149776991|NCT03907969|540308700|FG004|Monotherapy Part A|Death|0|||
149776992|NCT03907969|540308701|FG005|Monotherapy Part A|Death|1|||
149776993|NCT03907969|540308702|FG006|Monotherapy Part A|Death|0|||
149776994|NCT03907969|540308703|FG007|Monotherapy Part A|Death|0|||
149776995|NCT03907969|540308704|FG008|Monotherapy Part A|Death|0|||
149776996|NCT03907969|540308705|FG009|Monotherapy Part A|Death|0|||
149776997|NCT03907969|540308706|FG010|Monotherapy Part A|Death|0|||
149776998|NCT03907969|540308696|FG000|Combination Therapy Part A|Adverse Event|0|||
149776999|NCT03907969|540308697|FG001|Combination Therapy Part A|Adverse Event|0|||
149777000|NCT03907969|540308698|FG002|Combination Therapy Part A|Adverse Event|0|||
149777001|NCT03907969|540308699|FG003|Combination Therapy Part A|Adverse Event|0|||
149777002|NCT03907969|540308700|FG004|Combination Therapy Part A|Adverse Event|0|||
149777003|NCT03907969|540308701|FG005|Combination Therapy Part A|Adverse Event|0|||
149777004|NCT03907969|540308702|FG006|Combination Therapy Part A|Adverse Event|0|||
149777005|NCT03907969|540308703|FG007|Combination Therapy Part A|Adverse Event|0|||
149777006|NCT03907969|540308704|FG008|Combination Therapy Part A|Adverse Event|0|||
149777007|NCT03907969|540308705|FG009|Combination Therapy Part A|Adverse Event|1|||
149777008|NCT03907969|540308706|FG010|Combination Therapy Part A|Adverse Event|1|||
149777009|NCT03907969|540308696|FG000|Combination Therapy Part A|Progressive disease|0|||
149777010|NCT03907969|540308697|FG001|Combination Therapy Part A|Progressive disease|0|||
149777011|NCT03907969|540308698|FG002|Combination Therapy Part A|Progressive disease|0|||
149777012|NCT03907969|540308699|FG003|Combination Therapy Part A|Progressive disease|0|||
149777013|NCT03907969|540308700|FG004|Combination Therapy Part A|Progressive disease|0|||
149777014|NCT03907969|540308701|FG005|Combination Therapy Part A|Progressive disease|0|||
149777015|NCT03907969|540308702|FG006|Combination Therapy Part A|Progressive disease|0|||
149777016|NCT03907969|540308703|FG007|Combination Therapy Part A|Progressive disease|1|||
149777017|NCT03907969|540308704|FG008|Combination Therapy Part A|Progressive disease|0|||
149777018|NCT03907969|540308705|FG009|Combination Therapy Part A|Progressive disease|2|||
149777019|NCT03907969|540308706|FG010|Combination Therapy Part A|Progressive disease|3|||
149777020|NCT03907969|540308696|FG000|Combination Therapy Part A|Death|0|||
149777021|NCT03907969|540308697|FG001|Combination Therapy Part A|Death|0|||
149777022|NCT03907969|540308698|FG002|Combination Therapy Part A|Death|0|||
149777023|NCT03907969|540308699|FG003|Combination Therapy Part A|Death|0|||
149777024|NCT03907969|540308700|FG004|Combination Therapy Part A|Death|0|||
149777025|NCT03907969|540308701|FG005|Combination Therapy Part A|Death|0|||
149777026|NCT03907969|540308702|FG006|Combination Therapy Part A|Death|0|||
149777027|NCT03907969|540308703|FG007|Combination Therapy Part A|Death|0|||
149777028|NCT03907969|540308704|FG008|Combination Therapy Part A|Death|1|||
149777029|NCT03907969|540308705|FG009|Combination Therapy Part A|Death|0|||
149777030|NCT03907969|540308706|FG010|Combination Therapy Part A|Death|1|||
149777031|NCT03907969|540308696|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
149777032|NCT03907969|540308697|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
149777033|NCT03907969|540308698|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
149777034|NCT03907969|540308699|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
149777035|NCT03907969|540308700|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
149777036|NCT03907969|540308701|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
149777037|NCT03907969|540308702|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
149777038|NCT03907969|540308703|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
149777039|NCT03907969|540308704|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
149777040|NCT03907969|540308705|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
149777041|NCT03907969|540308706|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
149777042|NCT03907969|540308696|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
149777043|NCT03907969|540308697|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
149777044|NCT03907969|540308698|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
149777045|NCT03907969|540308699|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
149777046|NCT03907969|540308700|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
149777047|NCT03907969|540308701|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
149777048|NCT03907969|540308702|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
149777049|NCT03907969|540308703|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
149777050|NCT03907969|540308704|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
149777051|NCT03907969|540308705|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
149777052|NCT03907969|540308706|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
149777053|NCT03907969|540308696|FG000|Combination Therapy Part A|Physician Decision|0|||
149777054|NCT03907969|540308697|FG001|Combination Therapy Part A|Physician Decision|0|||
149777055|NCT03907969|540308698|FG002|Combination Therapy Part A|Physician Decision|0|||
149777056|NCT03907969|540308699|FG003|Combination Therapy Part A|Physician Decision|0|||
149777057|NCT03907969|540308700|FG004|Combination Therapy Part A|Physician Decision|0|||
149777058|NCT03907969|540308701|FG005|Combination Therapy Part A|Physician Decision|0|||
149777059|NCT03907969|540308702|FG006|Combination Therapy Part A|Physician Decision|0|||
149777060|NCT03907969|540308703|FG007|Combination Therapy Part A|Physician Decision|1|||
149777061|NCT03907969|540308704|FG008|Combination Therapy Part A|Physician Decision|0|||
149777062|NCT03907969|540308705|FG009|Combination Therapy Part A|Physician Decision|0|||
149777063|NCT03907969|540308706|FG010|Combination Therapy Part A|Physician Decision|1|||
149777064|NCT00247273|540308707|FG000|Overall Study|Adverse Event|85|||
149777065|NCT00247273|540308708|FG001|Overall Study|Adverse Event|80|||
149777066|NCT00247273|540308707|FG000|Overall Study|Physician Decision|6|||
149777067|NCT00247273|540308708|FG001|Overall Study|Physician Decision|3|||
149777068|NCT00247273|540308707|FG000|Overall Study|Lost to Follow-up|7|||
149777069|NCT00247273|540308708|FG001|Overall Study|Lost to Follow-up|7|||
149777070|NCT00247273|540308707|FG000|Overall Study|Withdrawal by Subject|46|||
149777071|NCT00247273|540308708|FG001|Overall Study|Withdrawal by Subject|47|||
149777072|NCT00247273|540308707|FG000|Overall Study|Did not take any study drug|2|||
149777073|NCT00247273|540308708|FG001|Overall Study|Did not take any study drug|0|||
149777074|NCT03276572|540308709|FG000|Overall Study|In follow-up|0|||
149777075|NCT03276572|540308710|FG001|Overall Study|In follow-up|0|||
149777076|NCT03276572|540308711|FG002|Overall Study|In follow-up|0|||
149777077|NCT03276572|540308712|FG003|Overall Study|In follow-up|0|||
149777078|NCT03276572|540308713|FG004|Overall Study|In follow-up|0|||
149777079|NCT03276572|540308714|FG005|Overall Study|In follow-up|1|||
149777080|NCT03276572|540308715|FG006|Overall Study|In follow-up|1|||
149777081|NCT03276572|540308709|FG000|Overall Study|Lost to Follow-up|0|||
149777082|NCT03276572|540308710|FG001|Overall Study|Lost to Follow-up|0|||
149777083|NCT03276572|540308711|FG002|Overall Study|Lost to Follow-up|0|||
149777084|NCT03276572|540308712|FG003|Overall Study|Lost to Follow-up|0|||
149777085|NCT03276572|540308713|FG004|Overall Study|Lost to Follow-up|0|||
149777086|NCT03276572|540308714|FG005|Overall Study|Lost to Follow-up|0|||
149777087|NCT03276572|540308715|FG006|Overall Study|Lost to Follow-up|1|||
149777088|NCT02580240|540308716|FG000|Overall Study|Physician Decision|2|||
149777089|NCT02580240|540308717|FG001|Overall Study|Physician Decision|0|||
149777090|NCT00607919|540308718|FG000|Acute Phase|Adverse Event|9|||
149777091|NCT00607919|540308719|FG001|Acute Phase|Adverse Event|2|||
149777092|NCT00607919|540308718|FG000|Acute Phase|Entry Criteria Not Met|1|||
149777093|NCT00607919|540308719|FG001|Acute Phase|Entry Criteria Not Met|1|||
149777094|NCT00607919|540308718|FG000|Acute Phase|Lack of Efficacy|1|||
149777095|NCT00607919|540308719|FG001|Acute Phase|Lack of Efficacy|2|||
149777096|NCT00607919|540308718|FG000|Acute Phase|Lost to Follow-up|9|||
149777097|NCT00607919|540308719|FG001|Acute Phase|Lost to Follow-up|3|||
149777098|NCT00607919|540308718|FG000|Acute Phase|Parent/Caregiver Decision|6|||
149777099|NCT00607919|540308719|FG001|Acute Phase|Parent/Caregiver Decision|4|||
149777100|NCT00607919|540308718|FG000|Acute Phase|Protocol Violation|5|||
149777101|NCT00607919|540308719|FG001|Acute Phase|Protocol Violation|1|||
149777102|NCT00607919|540308718|FG000|Acute Phase|Withdrawal by Subject|3|||
149777103|NCT00607919|540308719|FG001|Acute Phase|Withdrawal by Subject|3|||
149777104|NCT00607919|540308718|FG000|Open-Label Phase|Adverse Event|1|||
149777105|NCT00607919|540308719|FG001|Open-Label Phase|Adverse Event|5|||
149777106|NCT00607919|540308718|FG000|Open-Label Phase|Lost to Follow-up|4|||
149777107|NCT00607919|540308719|FG001|Open-Label Phase|Lost to Follow-up|1|||
149777108|NCT00607919|540308718|FG000|Open-Label Phase|Protocol Violation|2|||
149777109|NCT00607919|540308719|FG001|Open-Label Phase|Protocol Violation|2|||
149777110|NCT00607919|540308718|FG000|Open-Label Phase|Withdrawal by Subject|2|||
149777111|NCT00607919|540308719|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149777112|NCT00607919|540308718|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
149777113|NCT00607919|540308719|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
149777114|NCT00445341|540308744|FG000|Overall Study|refused further treatment|1|||
149777115|NCT00445341|540308744|FG000|Overall Study|taken off treatment too early|1|||
149777116|NCT03051217|540308745|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
149777117|NCT03051217|540308746|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149777118|NCT03051217|540308747|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
149777119|NCT03051217|540308748|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149777120|NCT03051217|540308749|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149777121|NCT03051217|540308750|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149777122|NCT03051217|540308751|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149777123|NCT03051217|540308745|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777124|NCT03051217|540308746|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
149777125|NCT03051217|540308747|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777126|NCT03051217|540308748|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777127|NCT03051217|540308749|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777128|NCT03051217|540308750|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777129|NCT03051217|540308751|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149777130|NCT03051217|540308745|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149777131|NCT03051217|540308746|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149777132|NCT03051217|540308747|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149777133|NCT03051217|540308748|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149777134|NCT03051217|540308749|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149777135|NCT03051217|540308750|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149777136|NCT03051217|540308751|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149777137|NCT03051217|540308745|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149777138|NCT03051217|540308746|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149777139|NCT03051217|540308747|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149777140|NCT03051217|540308748|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149777141|NCT03051217|540308749|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
149777142|NCT03051217|540308750|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149777143|NCT03051217|540308751|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149777144|NCT03051217|540308745|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777145|NCT03051217|540308746|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777146|NCT03051217|540308747|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777147|NCT03051217|540308748|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
149777148|NCT03051217|540308749|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777149|NCT03051217|540308750|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777150|NCT03051217|540308751|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149777151|NCT03051217|540308745|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149777152|NCT03051217|540308746|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149777153|NCT03051217|540308747|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149777154|NCT03051217|540308748|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
149777155|NCT03051217|540308749|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149777156|NCT03051217|540308750|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149777157|NCT03051217|540308751|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149801787|NCT04338685|540402442|FG004|Overall Study|Death|4|||
149777158|NCT03051217|540308745|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777159|NCT03051217|540308746|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777160|NCT03051217|540308747|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777161|NCT03051217|540308748|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777162|NCT03051217|540308749|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
149777163|NCT03051217|540308750|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777164|NCT03051217|540308751|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149777165|NCT03051217|540308745|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777166|NCT03051217|540308746|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777167|NCT03051217|540308747|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777168|NCT03051217|540308748|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777169|NCT03051217|540308749|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777170|NCT03051217|540308750|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
149777171|NCT03051217|540308751|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149777172|NCT00641706|540308754|FG000|Overall Study|Adverse Event|2|||
149777173|NCT00641706|540308755|FG001|Overall Study|Adverse Event|1|||
149777174|NCT00641706|540308754|FG000|Overall Study|Withdrawal by Subject|6|||
149777175|NCT00641706|540308755|FG001|Overall Study|Withdrawal by Subject|1|||
149777176|NCT00641706|540308754|FG000|Overall Study|Clinical Decline|1|||
149777177|NCT00641706|540308755|FG001|Overall Study|Clinical Decline|0|||
149777178|NCT00641706|540308754|FG000|Overall Study|Lead Investigator Decision|0|||
149777179|NCT00641706|540308755|FG001|Overall Study|Lead Investigator Decision|1|||
149777180|NCT01675141|540308756|FG000|Overall Study|Lenalidomide outside NIH|3|||
149777181|NCT01675141|540308756|FG000|Overall Study|Withdrawal by Subject|3|||
149777182|NCT01675141|540308756|FG000|Overall Study|Physician Decision|4|||
149777183|NCT01675141|540308756|FG000|Overall Study|No treatment, per protocol|1|||
149777184|NCT00109772|540308759|FG000|Double-blind Treatment|Adverse Event|14|||
149777185|NCT00109772|540308760|FG001|Double-blind Treatment|Adverse Event|5|||
149777186|NCT00109772|540308759|FG000|Double-blind Treatment|Lack of Efficacy|1|||
149777187|NCT00109772|540308760|FG001|Double-blind Treatment|Lack of Efficacy|0|||
149777188|NCT00109772|540308759|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
149777189|NCT00109772|540308760|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
149777190|NCT00109772|540308759|FG000|Double-blind Treatment|Lost to Follow-up|2|||
149777191|NCT00109772|540308760|FG001|Double-blind Treatment|Lost to Follow-up|3|||
149777192|NCT00109772|540308759|FG000|Double-blind Treatment|Protocol Violation|0|||
149777193|NCT00109772|540308760|FG001|Double-blind Treatment|Protocol Violation|1|||
149777194|NCT00109772|540308759|FG000|Double-blind Treatment|Other|0|||
149777195|NCT00109772|540308760|FG001|Double-blind Treatment|Other|4|||
149777196|NCT00109772|540308759|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
149777197|NCT00109772|540308760|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
149777198|NCT00109772|540308759|FG000|Open-label Extension|Adverse Event|10|||
149777199|NCT00109772|540308760|FG001|Open-label Extension|Adverse Event|19|||
149777200|NCT00109772|540308759|FG000|Open-label Extension|Lack of Efficacy|19|||
149777201|NCT00109772|540308760|FG001|Open-label Extension|Lack of Efficacy|11|||
149777202|NCT00109772|540308759|FG000|Open-label Extension|Withdrawal by Subject|9|||
149777203|NCT00109772|540308760|FG001|Open-label Extension|Withdrawal by Subject|6|||
149777204|NCT00109772|540308759|FG000|Open-label Extension|Lost to Follow-up|1|||
149777205|NCT00109772|540308760|FG001|Open-label Extension|Lost to Follow-up|0|||
149777206|NCT00109772|540308759|FG000|Open-label Extension|Death|0|||
149777207|NCT00109772|540308760|FG001|Open-label Extension|Death|1|||
149777208|NCT00109772|540308759|FG000|Open-label Extension|Protocol Violation|2|||
149777209|NCT00109772|540308760|FG001|Open-label Extension|Protocol Violation|2|||
149777210|NCT00109772|540308759|FG000|Open-label Extension|Other|4|||
149777211|NCT00109772|540308760|FG001|Open-label Extension|Other|10|||
149777212|NCT00813917|540308762|FG000|Overall Study|Adverse Event|0|||
149777213|NCT00813917|540308763|FG001|Overall Study|Adverse Event|1|||
149777214|NCT00813917|540308762|FG000|Overall Study|Withdrawal by Subject|3|||
149777215|NCT00813917|540308763|FG001|Overall Study|Withdrawal by Subject|4|||
149777216|NCT00813917|540308762|FG000|Overall Study|Lost to Follow-up|3|||
149777217|NCT00813917|540308763|FG001|Overall Study|Lost to Follow-up|1|||
149777218|NCT05441540|540308764|FG000|Overall Study|Withdrawal by Subject|2|||
149777219|NCT01359046|540308765|FG000|Overall Study|Did not receive allocated intervention|6|||
149777220|NCT01359046|540308766|FG001|Overall Study|Did not receive allocated intervention|6|||
149777221|NCT01359046|540308765|FG000|Overall Study|Physician Decision|1|||
149777222|NCT01359046|540308766|FG001|Overall Study|Physician Decision|11|||
149777223|NCT04539262|540308773|FG000|Overall Study|Adverse Event|0|||
149777224|NCT04539262|540308774|FG001|Overall Study|Adverse Event|0|||
149777225|NCT04539262|540308775|FG002|Overall Study|Adverse Event|1|||
149777226|NCT04539262|540308776|FG003|Overall Study|Adverse Event|0|||
149777227|NCT04539262|540308777|FG004|Overall Study|Adverse Event|0|||
149777228|NCT04539262|540308778|FG005|Overall Study|Adverse Event|0|||
149777229|NCT04539262|540308779|FG006|Overall Study|Adverse Event|0|||
149777230|NCT04539262|540308780|FG007|Overall Study|Adverse Event|0|||
149777231|NCT04539262|540308773|FG000|Overall Study|Withdrew Consent|0|||
149777232|NCT04539262|540308774|FG001|Overall Study|Withdrew Consent|0|||
149777233|NCT04539262|540308775|FG002|Overall Study|Withdrew Consent|0|||
149777234|NCT04539262|540308776|FG003|Overall Study|Withdrew Consent|1|||
149777235|NCT04539262|540308777|FG004|Overall Study|Withdrew Consent|0|||
149777236|NCT04539262|540308778|FG005|Overall Study|Withdrew Consent|0|||
149777237|NCT04539262|540308779|FG006|Overall Study|Withdrew Consent|0|||
149777238|NCT04539262|540308780|FG007|Overall Study|Withdrew Consent|0|||
149777239|NCT04539262|540308773|FG000|Overall Study|Randomized, Not treated|0|||
149777240|NCT04539262|540308774|FG001|Overall Study|Randomized, Not treated|1|||
149777241|NCT04539262|540308775|FG002|Overall Study|Randomized, Not treated|0|||
149777242|NCT04539262|540308776|FG003|Overall Study|Randomized, Not treated|0|||
149777243|NCT04539262|540308777|FG004|Overall Study|Randomized, Not treated|0|||
149777244|NCT04539262|540308778|FG005|Overall Study|Randomized, Not treated|0|||
149777245|NCT04539262|540308779|FG006|Overall Study|Randomized, Not treated|1|||
149777246|NCT04539262|540308780|FG007|Overall Study|Randomized, Not treated|0|||
149777247|NCT03228394|540308781|FG000|Overall Study|Lost to Follow-up|0|||
149777248|NCT03228394|540308782|FG001|Overall Study|Lost to Follow-up|0|||
149777249|NCT03228394|540308783|FG002|Overall Study|Lost to Follow-up|1|||
149777250|NCT03228394|540308784|FG003|Overall Study|Lost to Follow-up|1|||
149777251|NCT03228394|540308785|FG004|Overall Study|Lost to Follow-up|0|||
149777252|NCT03228394|540308786|FG005|Overall Study|Lost to Follow-up|0|||
149777253|NCT03228394|540308787|FG006|Overall Study|Lost to Follow-up|2|||
149777254|NCT03228394|540308788|FG007|Overall Study|Lost to Follow-up|0|||
149777255|NCT03228394|540308781|FG000|Overall Study|Withdrawal by Subject|0|||
149777256|NCT03228394|540308782|FG001|Overall Study|Withdrawal by Subject|0|||
149777257|NCT03228394|540308783|FG002|Overall Study|Withdrawal by Subject|1|||
149777258|NCT03228394|540308784|FG003|Overall Study|Withdrawal by Subject|0|||
149777259|NCT03228394|540308785|FG004|Overall Study|Withdrawal by Subject|0|||
149777260|NCT03228394|540308786|FG005|Overall Study|Withdrawal by Subject|0|||
149777261|NCT03228394|540308787|FG006|Overall Study|Withdrawal by Subject|1|||
149777262|NCT03228394|540308788|FG007|Overall Study|Withdrawal by Subject|3|||
149777263|NCT03228394|540308781|FG000|Overall Study|Protocol Violation|0|||
149777264|NCT03228394|540308782|FG001|Overall Study|Protocol Violation|0|||
149777265|NCT03228394|540308783|FG002|Overall Study|Protocol Violation|0|||
149777266|NCT03228394|540308784|FG003|Overall Study|Protocol Violation|1|||
149777267|NCT03228394|540308785|FG004|Overall Study|Protocol Violation|0|||
149777268|NCT03228394|540308786|FG005|Overall Study|Protocol Violation|0|||
149777269|NCT03228394|540308787|FG006|Overall Study|Protocol Violation|0|||
149777270|NCT03228394|540308788|FG007|Overall Study|Protocol Violation|0|||
149777271|NCT03228394|540308781|FG000|Overall Study|Physician Decision|0|||
149777272|NCT03228394|540308782|FG001|Overall Study|Physician Decision|0|||
149777273|NCT03228394|540308783|FG002|Overall Study|Physician Decision|0|||
149777274|NCT03228394|540308784|FG003|Overall Study|Physician Decision|0|||
149777275|NCT03228394|540308785|FG004|Overall Study|Physician Decision|0|||
149777276|NCT03228394|540308786|FG005|Overall Study|Physician Decision|0|||
149777277|NCT03228394|540308787|FG006|Overall Study|Physician Decision|1|||
149777278|NCT03228394|540308788|FG007|Overall Study|Physician Decision|0|||
149777279|NCT03228394|540308781|FG000|Overall Study|Noncompliance|0|||
149777280|NCT03228394|540308782|FG001|Overall Study|Noncompliance|0|||
149777281|NCT03228394|540308783|FG002|Overall Study|Noncompliance|0|||
149777282|NCT03228394|540308784|FG003|Overall Study|Noncompliance|0|||
149777283|NCT03228394|540308785|FG004|Overall Study|Noncompliance|0|||
149777284|NCT03228394|540308786|FG005|Overall Study|Noncompliance|0|||
149777285|NCT03228394|540308787|FG006|Overall Study|Noncompliance|1|||
149777286|NCT03228394|540308788|FG007|Overall Study|Noncompliance|0|||
149777287|NCT00770224|540308795|FG000|Step 1: Induction|Adverse Event|3|||
149777288|NCT00770224|540308796|FG001|Step 1: Induction|Adverse Event|0|||
149777289|NCT00770224|540308795|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
149777290|NCT00770224|540308796|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
149777291|NCT00770224|540308795|FG000|Step 1: Induction|Other reason not protocol specified|2|||
149777292|NCT00770224|540308796|FG001|Step 1: Induction|Other reason not protocol specified|0|||
149777293|NCT00770224|540308795|FG000|Step 1: Induction|Ineligible|2|||
149777294|NCT00770224|540308796|FG001|Step 1: Induction|Ineligible|0|||
149777295|NCT00770224|540308795|FG000|Step 1: Induction|No protocol treatment given|1|||
149777296|NCT00770224|540308796|FG001|Step 1: Induction|No protocol treatment given|0|||
149777297|NCT00770224|540308795|FG000|Step 2: Maintenance|Adverse Event|0|||
149777298|NCT00770224|540308796|FG001|Step 2: Maintenance|Adverse Event|10|||
149777299|NCT00770224|540308795|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
149777300|NCT00770224|540308796|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
149777301|NCT00770224|540308795|FG000|Step 2: Maintenance|Progression/relapse|0|||
149777302|NCT00770224|540308796|FG001|Step 2: Maintenance|Progression/relapse|1|||
149777303|NCT00770224|540308795|FG000|Step 2: Maintenance|Death|0|||
149777304|NCT00770224|540308796|FG001|Step 2: Maintenance|Death|2|||
149777305|NCT00770224|540308795|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
149777306|NCT00770224|540308796|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
149777307|NCT00770224|540308795|FG000|Step 2: Maintenance|Ineligible|0|||
149777308|NCT00770224|540308796|FG001|Step 2: Maintenance|Ineligible|2|||
149777309|NCT00294684|540308799|FG000|Overall Study|Lost to Follow-up|5|||
149777310|NCT00294684|540308800|FG001|Overall Study|Lost to Follow-up|8|||
149777311|NCT02443805|540308803|FG000|Overall Study|Adverse Event|100|||
149777312|NCT02443805|540308804|FG001|Overall Study|Adverse Event|18|||
149777313|NCT02443805|540308803|FG000|Overall Study|Withdrawal by Subject|73|||
149777314|NCT02443805|540308804|FG001|Overall Study|Withdrawal by Subject|74|||
149777315|NCT02443805|540308803|FG000|Overall Study|Lost to Follow-up|19|||
149777316|NCT02443805|540308804|FG001|Overall Study|Lost to Follow-up|14|||
149777317|NCT02443805|540308803|FG000|Overall Study|Pregnancy|6|||
149777318|NCT02443805|540308804|FG001|Overall Study|Pregnancy|5|||
149777319|NCT02443805|540308803|FG000|Overall Study|Protocol Violation|2|||
149777320|NCT02443805|540308804|FG001|Overall Study|Protocol Violation|4|||
149777321|NCT02443805|540308803|FG000|Overall Study|Lack of Efficacy|1|||
149777322|NCT02443805|540308804|FG001|Overall Study|Lack of Efficacy|1|||
149777323|NCT02443805|540308803|FG000|Overall Study|Non-compliance with study drug|6|||
149777324|NCT02443805|540308804|FG001|Overall Study|Non-compliance with study drug|4|||
149777325|NCT02443805|540308803|FG000|Overall Study|Withdrawal by parent/guardian|3|||
149777326|NCT02443805|540308804|FG001|Overall Study|Withdrawal by parent/guardian|5|||
149777327|NCT02443805|540308803|FG000|Overall Study|Any other reason not above-mentioned|3|||
149777328|NCT02443805|540308804|FG001|Overall Study|Any other reason not above-mentioned|2|||
149777329|NCT00961116|540308805|FG000|Washout Period of 7 Days|Adverse Event|1|||
149777330|NCT00961116|540308806|FG001|Washout Period of 7 Days|Adverse Event|1|||
149777331|NCT00961116|540308805|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149777332|NCT00961116|540308806|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149777333|NCT00961116|540308805|FG000|Washout Period of 7 Days|Protocol Violation|0|||
149777334|NCT00961116|540308806|FG001|Washout Period of 7 Days|Protocol Violation|1|||
149777335|NCT00968708|540308807|FG000|Overall Study|Adverse Event|169|||
149777336|NCT00968708|540308808|FG001|Overall Study|Adverse Event|150|||
149777337|NCT00968708|540308807|FG000|Overall Study|Major Protocol Deviation|0|||
149777338|NCT00968708|540308808|FG001|Overall Study|Major Protocol Deviation|1|||
149777339|NCT00968708|540308807|FG000|Overall Study|Lost to Follow-up|19|||
149777340|NCT00968708|540308808|FG001|Overall Study|Lost to Follow-up|11|||
149777341|NCT00968708|540308807|FG000|Overall Study|Voluntary Withdrawal|104|||
149777342|NCT00968708|540308808|FG001|Overall Study|Voluntary Withdrawal|101|||
149777343|NCT00968708|540308807|FG000|Overall Study|Investigator Discretion|0|||
149777344|NCT00968708|540308808|FG001|Overall Study|Investigator Discretion|1|||
149777345|NCT00968708|540308807|FG000|Overall Study|Other|26|||
149777346|NCT00968708|540308808|FG001|Overall Study|Other|34|||
149777347|NCT02708966|540308809|FG000|Overall Study|Lost to Follow-up|2|||
149777348|NCT02708966|540308810|FG001|Overall Study|Lost to Follow-up|2|||
149777349|NCT02260388|540308813|FG000|Overall Study|Lost to Follow-up|2|||
149777350|NCT02260388|540308814|FG001|Overall Study|Lost to Follow-up|8|||
149777351|NCT02260388|540308815|FG002|Overall Study|Lost to Follow-up|3|||
149777352|NCT02260388|540308816|FG003|Overall Study|Lost to Follow-up|4|||
149777353|NCT01981109|540308817|FG000|Overall Study|Death|36|||
149777354|NCT01981109|540308817|FG000|Overall Study|Withdrawal by Subject|40|||
149777355|NCT01981109|540308817|FG000|Overall Study|Lost to Follow-up|9|||
149777356|NCT01981109|540308817|FG000|Overall Study|No Discontinuation Documentation|37|||
149777357|NCT01981109|540308817|FG000|Overall Study|Study Termination|100|||
149777358|NCT01981109|540308817|FG000|Overall Study|No data available|2|||
149777359|NCT03407170|540308818|FG000|Overall Study|Adverse Event|1|||
149777360|NCT00126672|540308820|FG000|Overall Study|Adverse Event|4|||
149777361|NCT00126672|540308820|FG000|Overall Study|Lost to Follow-up|4|||
149777362|NCT01001234|540308821|FG000|Overall Study|Withdrawal by Subject|2|||
149777363|NCT01001234|540308822|FG001|Overall Study|Withdrawal by Subject|0|||
149777364|NCT01001234|540308823|FG002|Overall Study|Withdrawal by Subject|3|||
149777365|NCT01001234|540308824|FG003|Overall Study|Withdrawal by Subject|0|||
149777366|NCT01001234|540308825|FG004|Overall Study|Withdrawal by Subject|0|||
149777367|NCT01001234|540308821|FG000|Overall Study|Protocol Violation|34|||
149777368|NCT01001234|540308822|FG001|Overall Study|Protocol Violation|3|||
149777369|NCT01001234|540308823|FG002|Overall Study|Protocol Violation|19|||
149777370|NCT01001234|540308824|FG003|Overall Study|Protocol Violation|18|||
149777371|NCT01001234|540308825|FG004|Overall Study|Protocol Violation|0|||
149777372|NCT01001234|540308821|FG000|Overall Study|Lost to Follow-up|0|||
149777373|NCT01001234|540308822|FG001|Overall Study|Lost to Follow-up|0|||
149777374|NCT01001234|540308823|FG002|Overall Study|Lost to Follow-up|1|||
149777375|NCT01001234|540308824|FG003|Overall Study|Lost to Follow-up|2|||
149777376|NCT01001234|540308825|FG004|Overall Study|Lost to Follow-up|0|||
149777377|NCT01001234|540308821|FG000|Overall Study|Physician Decision|1|||
149777378|NCT01001234|540308822|FG001|Overall Study|Physician Decision|0|||
149777379|NCT01001234|540308823|FG002|Overall Study|Physician Decision|0|||
149777380|NCT01001234|540308824|FG003|Overall Study|Physician Decision|0|||
149777381|NCT01001234|540308825|FG004|Overall Study|Physician Decision|0|||
149777382|NCT01001234|540308821|FG000|Overall Study|Not Treated: Adverse Event|1|||
149777383|NCT01001234|540308822|FG001|Overall Study|Not Treated: Adverse Event|0|||
149777384|NCT01001234|540308823|FG002|Overall Study|Not Treated: Adverse Event|0|||
149777385|NCT01001234|540308824|FG003|Overall Study|Not Treated: Adverse Event|0|||
149777386|NCT01001234|540308825|FG004|Overall Study|Not Treated: Adverse Event|0|||
149777387|NCT01001234|540308821|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
149777388|NCT01001234|540308822|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
149777389|NCT01001234|540308823|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
149777390|NCT01001234|540308824|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
149777391|NCT01001234|540308825|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
149777392|NCT01001234|540308821|FG000|Overall Study|Not Treated: Protocol Violation|3|||
149777393|NCT01001234|540308822|FG001|Overall Study|Not Treated: Protocol Violation|0|||
149777394|NCT01001234|540308823|FG002|Overall Study|Not Treated: Protocol Violation|0|||
149777395|NCT01001234|540308824|FG003|Overall Study|Not Treated: Protocol Violation|0|||
149777396|NCT01001234|540308825|FG004|Overall Study|Not Treated: Protocol Violation|0|||
149777397|NCT01001234|540308821|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
149777398|NCT01001234|540308822|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
149777399|NCT01001234|540308823|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
149777400|NCT01001234|540308824|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
149777401|NCT01001234|540308825|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
149777402|NCT01001234|540308821|FG000|Overall Study|Not Treated: Pregnancy|3|||
149777403|NCT01001234|540308822|FG001|Overall Study|Not Treated: Pregnancy|0|||
149777404|NCT01001234|540308823|FG002|Overall Study|Not Treated: Pregnancy|0|||
149777405|NCT01001234|540308824|FG003|Overall Study|Not Treated: Pregnancy|0|||
149777406|NCT01001234|540308825|FG004|Overall Study|Not Treated: Pregnancy|0|||
149777407|NCT01001234|540308821|FG000|Overall Study|Not Treated: Physician Decision|37|||
149777408|NCT01001234|540308822|FG001|Overall Study|Not Treated: Physician Decision|4|||
149777409|NCT01001234|540308823|FG002|Overall Study|Not Treated: Physician Decision|0|||
149777410|NCT01001234|540308824|FG003|Overall Study|Not Treated: Physician Decision|0|||
149777411|NCT01001234|540308825|FG004|Overall Study|Not Treated: Physician Decision|0|||
149777412|NCT01001234|540308821|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
149777413|NCT01001234|540308822|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
149777414|NCT01001234|540308823|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149777415|NCT01001234|540308824|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149777416|NCT01001234|540308825|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149777417|NCT01851863|540308827|FG000|Overall Study|Did not receive study medication|2|||
149777418|NCT01851863|540308828|FG001|Overall Study|Did not receive study medication|5|||
149777419|NCT01851863|540308829|FG002|Overall Study|Did not receive study medication|3|||
149777420|NCT01851863|540308830|FG003|Overall Study|Did not receive study medication|0|||
149777421|NCT01851863|540308827|FG000|Overall Study|Lost to Follow-up|3|||
149777422|NCT01851863|540308828|FG001|Overall Study|Lost to Follow-up|4|||
149777423|NCT01851863|540308829|FG002|Overall Study|Lost to Follow-up|2|||
149777424|NCT01851863|540308830|FG003|Overall Study|Lost to Follow-up|3|||
149777425|NCT02076334|540308831|FG000|Overall Study|Protocol Violation|1|||
149777426|NCT02076334|540308832|FG001|Overall Study|Protocol Violation|0|||
149777427|NCT02076334|540308833|FG002|Overall Study|Protocol Violation|0|||
149777428|NCT02076334|540308834|FG003|Overall Study|Protocol Violation|0|||
149777429|NCT02076334|540308831|FG000|Overall Study|Lost to Follow-up|0|||
149777430|NCT02076334|540308832|FG001|Overall Study|Lost to Follow-up|1|||
149777431|NCT02076334|540308833|FG002|Overall Study|Lost to Follow-up|1|||
149777432|NCT02076334|540308834|FG003|Overall Study|Lost to Follow-up|0|||
149777433|NCT02076334|540308831|FG000|Overall Study|muscle soreness|0|||
149777434|NCT02076334|540308832|FG001|Overall Study|muscle soreness|0|||
149777435|NCT02076334|540308833|FG002|Overall Study|muscle soreness|0|||
149777436|NCT02076334|540308834|FG003|Overall Study|muscle soreness|1|||
149777437|NCT03379376|540308835|FG000|Overall Study|Lost to Follow-up|2|||
149777438|NCT03379376|540308835|FG000|Overall Study|Did not wish to complete follow up|1|||
149777439|NCT03379376|540308835|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
149777440|NCT03379376|540308835|FG000|Overall Study|Death|1|||
149777441|NCT01611298|540308836|FG000|Overall Study|Relapsed|2|||
149777442|NCT00753623|540308837|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
149777443|NCT00753623|540308838|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
149777444|NCT00753623|540308837|FG000|Phase I (14 Days)|Physician Decision|1|||
149777445|NCT00753623|540308838|FG001|Phase I (14 Days)|Physician Decision|2|||
149777446|NCT00753623|540308837|FG000|Phase I (14 Days)|Adverse Event|0|||
149777447|NCT00753623|540308838|FG001|Phase I (14 Days)|Adverse Event|1|||
149777448|NCT00753623|540308837|FG000|Washout (7 Days)|Physician Decision|1|||
149777449|NCT00753623|540308838|FG001|Washout (7 Days)|Physician Decision|0|||
149777450|NCT00753623|540308837|FG000|Phase II (14 Days)|Physician Decision|0|||
149777451|NCT00753623|540308838|FG001|Phase II (14 Days)|Physician Decision|1|||
149777452|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
149777453|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
149777454|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
149777455|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149777456|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
149777457|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
149777458|NCT00996593|540308839|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
149777459|NCT00996593|540308839|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
149777460|NCT00996593|540308839|FG000|Long-Term Follow-Up|Site Closed|1|||
149777461|NCT00871572|540308840|FG000|Overall Study|Adverse Event|0|||
149777462|NCT00871572|540308841|FG001|Overall Study|Adverse Event|2|||
149777463|NCT00871572|540308842|FG002|Overall Study|Adverse Event|0|||
149777464|NCT00871572|540308843|FG003|Overall Study|Adverse Event|3|||
149777465|NCT00871572|540308840|FG000|Overall Study|Investigator Decision|0|||
149777466|NCT00871572|540308841|FG001|Overall Study|Investigator Decision|1|||
149777467|NCT00871572|540308842|FG002|Overall Study|Investigator Decision|0|||
149777468|NCT00871572|540308843|FG003|Overall Study|Investigator Decision|1|||
149777469|NCT00871572|540308840|FG000|Overall Study|Lost to Follow-up|0|||
149777470|NCT00871572|540308841|FG001|Overall Study|Lost to Follow-up|1|||
149777471|NCT00871572|540308842|FG002|Overall Study|Lost to Follow-up|0|||
149777472|NCT00871572|540308843|FG003|Overall Study|Lost to Follow-up|1|||
149777473|NCT00871572|540308840|FG000|Overall Study|Protocol Violation|0|||
149777474|NCT00871572|540308841|FG001|Overall Study|Protocol Violation|0|||
149777475|NCT00871572|540308842|FG002|Overall Study|Protocol Violation|1|||
149777476|NCT00871572|540308843|FG003|Overall Study|Protocol Violation|1|||
149777477|NCT00871572|540308840|FG000|Overall Study|Sponsor Decision|1|||
149777478|NCT00871572|540308841|FG001|Overall Study|Sponsor Decision|0|||
149777479|NCT00871572|540308842|FG002|Overall Study|Sponsor Decision|0|||
149777480|NCT00871572|540308843|FG003|Overall Study|Sponsor Decision|0|||
149777481|NCT00871572|540308840|FG000|Overall Study|Withdrawal by Subject|1|||
149777482|NCT00871572|540308841|FG001|Overall Study|Withdrawal by Subject|2|||
149777483|NCT00871572|540308842|FG002|Overall Study|Withdrawal by Subject|3|||
149777484|NCT00871572|540308843|FG003|Overall Study|Withdrawal by Subject|1|||
149777485|NCT01686958|540308848|FG000|Overall Study|Withdrawal by Subject|1|||
149777486|NCT04294095|540308857|FG000|Overall Study|Adverse Event|1|||
149777487|NCT04294095|540308858|FG001|Overall Study|Adverse Event|0|||
149777488|NCT02224638|540308862|FG000|Overall Study|Adverse Event|1|||
149777489|NCT02224638|540308863|FG001|Overall Study|Adverse Event|1|||
149777490|NCT01406652|540308864|FG000|Overall Study|Lost-to-follow-up|3|||
149777491|NCT01406652|540308865|FG001|Overall Study|Lost-to-follow-up|4|||
149777492|NCT01406652|540308864|FG000|Overall Study|Withdrawal by Subject|2|||
149777493|NCT01406652|540308865|FG001|Overall Study|Withdrawal by Subject|2|||
149777494|NCT01406652|540308864|FG000|Overall Study|Insufficient follow-up|5|||
149777495|NCT01406652|540308865|FG001|Overall Study|Insufficient follow-up|4|||
149777496|NCT01406652|540308864|FG000|Overall Study|Infection not sure|10|||
149777497|NCT01406652|540308865|FG001|Overall Study|Infection not sure|10|||
149777498|NCT01230749|540308866|FG000|Overall Study|Adverse Event|0|||
149777499|NCT01230749|540308867|FG001|Overall Study|Adverse Event|0|||
149777500|NCT01230749|540308868|FG002|Overall Study|Adverse Event|0|||
149777501|NCT01230749|540308869|FG003|Overall Study|Adverse Event|1|||
149777502|NCT01230749|540308866|FG000|Overall Study|Physician Decision|0|||
149777503|NCT01230749|540308867|FG001|Overall Study|Physician Decision|0|||
149777504|NCT01230749|540308868|FG002|Overall Study|Physician Decision|1|||
149777505|NCT01230749|540308869|FG003|Overall Study|Physician Decision|0|||
149777506|NCT01230749|540308866|FG000|Overall Study|Withdrawal by Subject|0|||
149777507|NCT01230749|540308867|FG001|Overall Study|Withdrawal by Subject|1|||
149777508|NCT01230749|540308868|FG002|Overall Study|Withdrawal by Subject|0|||
149777509|NCT01230749|540308869|FG003|Overall Study|Withdrawal by Subject|0|||
149777510|NCT01230749|540308866|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
149777511|NCT01230749|540308867|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149777512|NCT01230749|540308868|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149777513|NCT01230749|540308869|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149777514|NCT03366844|540310608|FG000|Overall Study|Physician Decision|1|||
149777515|NCT03366844|540310608|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
149777516|NCT02687711|540310614|FG000|Overall Study|Adverse Event|89|||
149777517|NCT02687711|540310614|FG000|Overall Study|Lack of Efficacy|70|||
149777518|NCT02687711|540310614|FG000|Overall Study|Lost to Follow-up|20|||
149777519|NCT02687711|540310614|FG000|Overall Study|Consent withdrawn|15|||
149777520|NCT02687711|540310614|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
149777521|NCT02687711|540310614|FG000|Overall Study|Too expensive|4|||
149777522|NCT02687711|540310614|FG000|Overall Study|Participant moved abroad|1|||
149777523|NCT02687711|540310614|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
149777524|NCT02687711|540310614|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
149777525|NCT02687711|540310614|FG000|Overall Study|Disliked taste|1|||
149777526|NCT02687711|540310614|FG000|Overall Study|Low mood|1|||
149777527|NCT02687711|540310614|FG000|Overall Study|Side effects|1|||
149777528|NCT02687711|540310614|FG000|Overall Study|Change of Hospital|1|||
149777529|NCT02687711|540310614|FG000|Overall Study|Liver Encephalopathy|1|||
149777530|NCT02687711|540310614|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
149777531|NCT02687711|540310614|FG000|Overall Study|Withdrawn due to intake interruption|1|||
149777532|NCT02687711|540310614|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
149777533|NCT02687711|540310614|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
149777534|NCT02687711|540310614|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
149777535|NCT00191386|540310615|FG000|Overall Study|Adverse Event|16|||
149777536|NCT00191386|540310615|FG000|Overall Study|Lost to Follow-up|1|||
149777537|NCT00191386|540310615|FG000|Overall Study|Entry Criteria Exclusion|3|||
149777538|NCT00191386|540310615|FG000|Overall Study|Protocol Violation|18|||
149777539|NCT00191386|540310615|FG000|Overall Study|Withdrawal by Subject|96|||
149777540|NCT00191386|540310615|FG000|Overall Study|Physician Decision|11|||
149777541|NCT00191386|540310615|FG000|Overall Study|Lack of Efficacy|15|||
149777542|NCT03077243|540310616|FG000|Overall Study|Death|1|||
149777543|NCT03077243|540310617|FG001|Overall Study|Death|2|||
149777544|NCT03077243|540310618|FG002|Overall Study|Death|0|||
149777545|NCT03077243|540310619|FG003|Overall Study|Death|0|||
149777546|NCT03077243|540310616|FG000|Overall Study|Withdrawal by Subject|1|||
149777547|NCT03077243|540310617|FG001|Overall Study|Withdrawal by Subject|3|||
149777548|NCT03077243|540310618|FG002|Overall Study|Withdrawal by Subject|0|||
149777549|NCT03077243|540310619|FG003|Overall Study|Withdrawal by Subject|0|||
149777550|NCT03077243|540310616|FG000|Overall Study|Physician Decision|1|||
149777551|NCT03077243|540310617|FG001|Overall Study|Physician Decision|0|||
149777552|NCT03077243|540310618|FG002|Overall Study|Physician Decision|0|||
149777553|NCT03077243|540310619|FG003|Overall Study|Physician Decision|0|||
149777554|NCT03077243|540310616|FG000|Overall Study|Research at two study sites terminated early|0|||
149777555|NCT03077243|540310617|FG001|Overall Study|Research at two study sites terminated early|0|||
149777556|NCT03077243|540310618|FG002|Overall Study|Research at two study sites terminated early|0|||
149777557|NCT03077243|540310619|FG003|Overall Study|Research at two study sites terminated early|69|||
149777558|NCT03984812|540310620|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777559|NCT03984812|540310621|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777560|NCT03984812|540310622|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
149777561|NCT03984812|540310623|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777562|NCT03984812|540310624|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777563|NCT03984812|540310625|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777564|NCT03984812|540310626|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777565|NCT03984812|540310627|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777566|NCT03984812|540310628|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777567|NCT03984812|540310629|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777568|NCT03984812|540310630|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149777569|NCT01826448|540310631|FG000|Overall Study|Adverse Event|1|||
149777570|NCT01826448|540310632|FG001|Overall Study|Adverse Event|3|||
149777571|NCT01826448|540310631|FG000|Overall Study|Disease progression|2|||
149777572|NCT01826448|540310632|FG001|Overall Study|Disease progression|4|||
149777573|NCT01826448|540310631|FG000|Overall Study|Withdrawal by Subject|1|||
149777574|NCT01826448|540310632|FG001|Overall Study|Withdrawal by Subject|0|||
149777575|NCT01826448|540310631|FG000|Overall Study|Physician Decision|0|||
149777576|NCT01826448|540310632|FG001|Overall Study|Physician Decision|1|||
149777577|NCT01826448|540310631|FG000|Overall Study|2 active cancers|0|||
149777578|NCT01826448|540310632|FG001|Overall Study|2 active cancers|1|||
149777579|NCT04038385|540310633|FG000|Overall Study|Completed baseline assessment only|7|||
149777580|NCT04038385|540310634|FG001|Overall Study|Completed baseline assessment only|4|||
149777581|NCT04038385|540310633|FG000|Overall Study|Moved out of area|4|||
149777582|NCT04038385|540310634|FG001|Overall Study|Moved out of area|2|||
149777583|NCT04038385|540310633|FG000|Overall Study|Discontinued study involvement|6|||
149777584|NCT04038385|540310634|FG001|Overall Study|Discontinued study involvement|1|||
149777585|NCT02971007|540310637|FG000|Overall Study|Adverse Event|1|||
149777586|NCT02971007|540310638|FG001|Overall Study|Adverse Event|0|||
149777587|NCT02971007|540310639|FG002|Overall Study|Adverse Event|0|||
149777588|NCT02971007|540310637|FG000|Overall Study|Lost to Follow-up|0|||
149777589|NCT02971007|540310638|FG001|Overall Study|Lost to Follow-up|1|||
149777590|NCT02971007|540310639|FG002|Overall Study|Lost to Follow-up|1|||
149777591|NCT02971007|540310637|FG000|Overall Study|Withdrawal by Subject|0|||
149777592|NCT02971007|540310638|FG001|Overall Study|Withdrawal by Subject|1|||
149777593|NCT02971007|540310639|FG002|Overall Study|Withdrawal by Subject|0|||
149777594|NCT02971007|540310637|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
149777595|NCT02971007|540310638|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
149777596|NCT02971007|540310639|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
149777597|NCT02971007|540310637|FG000|Overall Study|Patient discontinued study drug|0|||
149777598|NCT02971007|540310638|FG001|Overall Study|Patient discontinued study drug|1|||
149777599|NCT02971007|540310639|FG002|Overall Study|Patient discontinued study drug|0|||
149777600|NCT02038790|540310641|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
149777601|NCT02038790|540310642|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
149777602|NCT02431793|540310643|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
149777603|NCT02431793|540310644|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
149777604|NCT02431793|540310645|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
149777605|NCT02431793|540310643|FG000|Overall Study|Withdrawal by Subject|7|||
149777606|NCT02431793|540310644|FG001|Overall Study|Withdrawal by Subject|5|||
149777607|NCT02431793|540310645|FG002|Overall Study|Withdrawal by Subject|5|||
149777608|NCT02431793|540310643|FG000|Overall Study|Lost to Follow-up|101|||
149777609|NCT02431793|540310644|FG001|Overall Study|Lost to Follow-up|122|||
149777610|NCT02431793|540310645|FG002|Overall Study|Lost to Follow-up|104|||
149777611|NCT03170258|540310653|FG000|Overall Study|Physician Decision|4|||
149777612|NCT03170258|540310654|FG001|Overall Study|Physician Decision|0|||
149777613|NCT03170258|540310653|FG000|Overall Study|Equipment issues|1|||
149777614|NCT03170258|540310654|FG001|Overall Study|Equipment issues|0|||
149777615|NCT03170258|540310653|FG000|Overall Study|Medication|1|||
149777616|NCT03170258|540310654|FG001|Overall Study|Medication|0|||
149777617|NCT03170258|540310653|FG000|Overall Study|Sleep issues|1|||
149777618|NCT03170258|540310654|FG001|Overall Study|Sleep issues|0|||
149777619|NCT00063986|540310658|FG000|Overall Study|Withdrawal by Subject|1|||
149777620|NCT00063986|540310658|FG000|Overall Study|Ineligible|1|||
149777621|NCT00063986|540310658|FG000|Overall Study|Intra-operatively ineligible|4|||
149777622|NCT01419015|540310666|FG000|Overall Study|Death|2|||
149777623|NCT02911519|540310667|FG000|Overall Study|Lost to Follow-up|2|||
149777624|NCT02911519|540310668|FG001|Overall Study|Lost to Follow-up|2|||
149777625|NCT02911519|540310667|FG000|Overall Study|Death|0|||
149777626|NCT02911519|540310668|FG001|Overall Study|Death|2|||
149777627|NCT01237223|540310669|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
149777628|NCT01237223|540310670|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149777629|NCT01237223|540310671|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149777630|NCT01237223|540310672|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149777631|NCT01237223|540310673|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149777632|NCT01237223|540310674|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149777633|NCT01237223|540310669|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
149777634|NCT01237223|540310670|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149777635|NCT01237223|540310671|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149777636|NCT01237223|540310672|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149777637|NCT01237223|540310673|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149777638|NCT01237223|540310674|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149777639|NCT01237223|540310669|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
149777640|NCT01237223|540310670|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149777641|NCT01237223|540310671|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149777642|NCT01237223|540310672|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149777643|NCT01237223|540310673|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149777644|NCT01237223|540310674|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149777645|NCT01237223|540310669|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
149777646|NCT01237223|540310670|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149777647|NCT01237223|540310671|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149777648|NCT01237223|540310672|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149777649|NCT01237223|540310673|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149777650|NCT01237223|540310674|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149777651|NCT01237223|540310669|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
149777652|NCT01237223|540310670|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149777653|NCT01237223|540310671|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149777654|NCT01237223|540310672|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149777655|NCT01237223|540310673|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149777656|NCT01237223|540310674|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149777657|NCT01237223|540310669|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
149777658|NCT01237223|540310670|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
149777659|NCT01237223|540310671|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
149777660|NCT01237223|540310672|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
149777661|NCT01237223|540310673|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
149777662|NCT01237223|540310674|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
149777663|NCT01237223|540310669|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
149777664|NCT01237223|540310670|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
149777665|NCT01237223|540310671|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
149777666|NCT01237223|540310672|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
149777667|NCT01237223|540310673|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
149777668|NCT01237223|540310674|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
149777669|NCT01237223|540310669|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149777670|NCT01237223|540310670|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
149777671|NCT01237223|540310671|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
149777672|NCT01237223|540310672|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
149777673|NCT01237223|540310673|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149777674|NCT01237223|540310674|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149777675|NCT01237223|540310669|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149777676|NCT01237223|540310670|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149777677|NCT01237223|540310671|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149777678|NCT01237223|540310672|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149777679|NCT01237223|540310673|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149777680|NCT01237223|540310674|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
149777681|NCT01237223|540310669|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
149777682|NCT01237223|540310670|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149777683|NCT01237223|540310671|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149777684|NCT01237223|540310672|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
149777685|NCT01237223|540310673|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149777686|NCT01237223|540310674|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149777687|NCT00443846|540310675|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
149777688|NCT00443846|540310676|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
149777689|NCT00443846|540310675|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
149777690|NCT00443846|540310676|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
149777691|NCT00443846|540310675|FG000|Overall Study|Adverse Event|0|||
149777692|NCT00443846|540310676|FG001|Overall Study|Adverse Event|1|||
149777693|NCT00443846|540310675|FG000|Overall Study|Personal reason|8|||
149777694|NCT00443846|540310676|FG001|Overall Study|Personal reason|3|||
149777695|NCT00443846|540310675|FG000|Overall Study|Lost to Follow-up|1|||
149777696|NCT00443846|540310676|FG001|Overall Study|Lost to Follow-up|2|||
149777697|NCT00802867|540310684|FG000|Overall Study|Lost to Follow-up|6|||
149777698|NCT00802867|540310684|FG000|Overall Study|Protocol Violation|6|||
149777699|NCT00802867|540310684|FG000|Overall Study|Withdrawal by Subject|1|||
149777700|NCT01809197|540310685|FG000|Overall Study|Lost to Follow-up|4|||
149777701|NCT01809197|540310686|FG001|Overall Study|Lost to Follow-up|2|||
149777702|NCT01809197|540310685|FG000|Overall Study|Adverse Event|2|||
149777703|NCT01809197|540310686|FG001|Overall Study|Adverse Event|3|||
149777704|NCT01809197|540310685|FG000|Overall Study|Failed slit lamp exam|1|||
149777705|NCT01809197|540310686|FG001|Overall Study|Failed slit lamp exam|0|||
149777706|NCT01809197|540310685|FG000|Overall Study|Non-Compliance|1|||
149777707|NCT01809197|540310686|FG001|Overall Study|Non-Compliance|1|||
149777708|NCT01809197|540310685|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
149777709|NCT01809197|540310686|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
149777710|NCT01809197|540310685|FG000|Overall Study|Withdrawal by Subject|1|||
149777711|NCT01809197|540310686|FG001|Overall Study|Withdrawal by Subject|1|||
149777712|NCT01809197|540310685|FG000|Overall Study|Product not available|0|||
149777713|NCT01809197|540310686|FG001|Overall Study|Product not available|1|||
149777714|NCT00268463|540310691|FG000|Overall Study|study terminated due to low accrual|10|||
149777715|NCT00268463|540310692|FG001|Overall Study|study terminated due to low accrual|12|||
149777716|NCT03000686|540310693|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149777717|NCT03000686|540310694|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
149777718|NCT03000686|540310695|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149777719|NCT03000686|540310696|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149777720|NCT02920450|540310697|FG000|Overall Study|Death|1|||
149777721|NCT02920450|540310698|FG001|Overall Study|Death|0|||
149777722|NCT02920450|540310699|FG002|Overall Study|Death|0|||
149777723|NCT02920450|540310700|FG003|Overall Study|Death|0|||
149777724|NCT02920450|540310697|FG000|Overall Study|Withdrawal by Subject|1|||
149777725|NCT02920450|540310698|FG001|Overall Study|Withdrawal by Subject|0|||
149777726|NCT02920450|540310699|FG002|Overall Study|Withdrawal by Subject|0|||
149777727|NCT02920450|540310700|FG003|Overall Study|Withdrawal by Subject|0|||
149777728|NCT04737759|540310703|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
149777729|NCT04737759|540310704|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
149777730|NCT04737759|540310703|FG000|Overall Study|Death|2|||
149777731|NCT04737759|540310704|FG001|Overall Study|Death|0|||
149777732|NCT04737759|540310703|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
149777733|NCT04737759|540310704|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
149777734|NCT04737759|540310703|FG000|Overall Study|Lost to Follow-up|4|||
149777735|NCT04737759|540310704|FG001|Overall Study|Lost to Follow-up|12|||
149777736|NCT01484561|540310705|FG000|Overall Study|Lack of Efficacy|3|||
149777737|NCT01484561|540310706|FG001|Overall Study|Lack of Efficacy|1|||
149777738|NCT01484561|540310705|FG000|Overall Study|Lost to Follow-up|1|||
149777739|NCT01484561|540310706|FG001|Overall Study|Lost to Follow-up|0|||
149777740|NCT01484561|540310705|FG000|Overall Study|Withdrawal by Subject|3|||
149777741|NCT01484561|540310706|FG001|Overall Study|Withdrawal by Subject|0|||
149777742|NCT01484561|540310705|FG000|Overall Study|Other|1|||
149777743|NCT01484561|540310706|FG001|Overall Study|Other|1|||
149777744|NCT01484561|540310705|FG000|Overall Study|Adverse Event|1|||
149777745|NCT01484561|540310706|FG001|Overall Study|Adverse Event|4|||
149777746|NCT03371251|540310707|FG000|Overall Study|Withdrawal by Subject|1|||
149777747|NCT03371251|540310708|FG001|Overall Study|Withdrawal by Subject|0|||
149777748|NCT03371251|540310709|FG002|Overall Study|Withdrawal by Subject|1|||
149777749|NCT03371251|540310710|FG003|Overall Study|Withdrawal by Subject|0|||
149777750|NCT03371251|540310711|FG004|Overall Study|Withdrawal by Subject|2|||
149777751|NCT03371251|540310712|FG005|Overall Study|Withdrawal by Subject|2|||
149777752|NCT03371251|540310707|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
149777753|NCT03371251|540310708|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149777754|NCT03371251|540310709|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149777755|NCT03371251|540310710|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149777756|NCT03371251|540310711|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
149777757|NCT03371251|540310712|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
149777758|NCT03371251|540310707|FG000|Overall Study|Adverse Event|0|||
149777759|NCT03371251|540310708|FG001|Overall Study|Adverse Event|0|||
149777760|NCT03371251|540310709|FG002|Overall Study|Adverse Event|0|||
149777761|NCT03371251|540310710|FG003|Overall Study|Adverse Event|0|||
149777762|NCT03371251|540310711|FG004|Overall Study|Adverse Event|1|||
149777763|NCT03371251|540310712|FG005|Overall Study|Adverse Event|0|||
149777764|NCT03371251|540310707|FG000|Overall Study|Decision by Sponsor|0|||
149777765|NCT03371251|540310708|FG001|Overall Study|Decision by Sponsor|0|||
149777766|NCT03371251|540310709|FG002|Overall Study|Decision by Sponsor|0|||
149777767|NCT03371251|540310710|FG003|Overall Study|Decision by Sponsor|0|||
149777768|NCT03371251|540310711|FG004|Overall Study|Decision by Sponsor|2|||
149777769|NCT03371251|540310712|FG005|Overall Study|Decision by Sponsor|0|||
149777770|NCT04362813|540310713|FG000|Overall Study|Death|12|||
149777771|NCT04362813|540310714|FG001|Overall Study|Death|16|||
149777772|NCT04362813|540310713|FG000|Overall Study|Withdrawal by Subject|3|||
149777773|NCT04362813|540310714|FG001|Overall Study|Withdrawal by Subject|1|||
149777774|NCT04362813|540310713|FG000|Overall Study|Protocol Violation|0|||
149777775|NCT04362813|540310714|FG001|Overall Study|Protocol Violation|3|||
149777776|NCT04362813|540310713|FG000|Overall Study|Lost to Follow-up|1|||
149777777|NCT04362813|540310714|FG001|Overall Study|Lost to Follow-up|1|||
149777778|NCT04362813|540310713|FG000|Overall Study|Enrolled but did not receive treatment|2|||
149777779|NCT04362813|540310714|FG001|Overall Study|Enrolled but did not receive treatment|4|||
149777780|NCT02023268|540310715|FG000|Overall Study|Lack of Efficacy|0|||
149777781|NCT02023268|540310716|FG001|Overall Study|Lack of Efficacy|1|||
149777782|NCT02023268|540310715|FG000|Overall Study|Adverse Event|0|||
149777783|NCT02023268|540310716|FG001|Overall Study|Adverse Event|2|||
149777784|NCT02023268|540310715|FG000|Overall Study|Withdrawal by Subject|0|||
149777785|NCT02023268|540310716|FG001|Overall Study|Withdrawal by Subject|1|||
149777786|NCT01202760|540310723|FG000|Overall Study|Entry Criteria Not Met|0|||
149777787|NCT01202760|540310724|FG001|Overall Study|Entry Criteria Not Met|3|||
149777788|NCT01202760|540310725|FG002|Overall Study|Entry Criteria Not Met|1|||
149777789|NCT01202760|540310723|FG000|Overall Study|Adverse Event|11|||
149777790|NCT01202760|540310724|FG001|Overall Study|Adverse Event|9|||
149777791|NCT01202760|540310725|FG002|Overall Study|Adverse Event|10|||
149777792|NCT01202760|540310723|FG000|Overall Study|Death|2|||
149777793|NCT01202760|540310724|FG001|Overall Study|Death|1|||
149777794|NCT01202760|540310725|FG002|Overall Study|Death|0|||
149777795|NCT01202760|540310723|FG000|Overall Study|Lack of Efficacy|6|||
149777796|NCT01202760|540310724|FG001|Overall Study|Lack of Efficacy|8|||
149777797|NCT01202760|540310725|FG002|Overall Study|Lack of Efficacy|7|||
149777798|NCT01202760|540310723|FG000|Overall Study|Lost to Follow-up|0|||
149777799|NCT01202760|540310724|FG001|Overall Study|Lost to Follow-up|2|||
149777800|NCT01202760|540310725|FG002|Overall Study|Lost to Follow-up|1|||
149777801|NCT01202760|540310723|FG000|Overall Study|Parent / Caregiver Decision|0|||
149777802|NCT01202760|540310724|FG001|Overall Study|Parent / Caregiver Decision|1|||
149777803|NCT01202760|540310725|FG002|Overall Study|Parent / Caregiver Decision|0|||
149777804|NCT01202760|540310723|FG000|Overall Study|Withdrawal by Subject|17|||
149777805|NCT01202760|540310724|FG001|Overall Study|Withdrawal by Subject|18|||
149777806|NCT01202760|540310725|FG002|Overall Study|Withdrawal by Subject|14|||
149777807|NCT01202760|540310723|FG000|Overall Study|Physician Decision|0|||
149777808|NCT01202760|540310724|FG001|Overall Study|Physician Decision|1|||
149777809|NCT01202760|540310725|FG002|Overall Study|Physician Decision|0|||
149777810|NCT01202760|540310723|FG000|Overall Study|Protocol Violation|7|||
149777811|NCT01202760|540310724|FG001|Overall Study|Protocol Violation|5|||
149777812|NCT01202760|540310725|FG002|Overall Study|Protocol Violation|2|||
149777813|NCT01202760|540310723|FG000|Overall Study|Sponsor Decision|4|||
149777814|NCT01202760|540310724|FG001|Overall Study|Sponsor Decision|4|||
149777815|NCT01202760|540310725|FG002|Overall Study|Sponsor Decision|0|||
149777816|NCT01654523|540310726|FG000|Overall Study|Withdrawal by Subject|1|||
149777817|NCT04354155|540310727|FG000|Overall Study|Withdrawal by Subject|1|||
149777818|NCT04354155|540310727|FG000|Overall Study|Did not meet criteria for study intervention|1|||
149777819|NCT01998399|540310737|FG000|Overall Study|Lost to Follow-up|1|||
149777820|NCT01998399|540310738|FG001|Overall Study|Lost to Follow-up|3|||
149777821|NCT01998399|540310737|FG000|Overall Study|Death|4|||
149777822|NCT01998399|540310738|FG001|Overall Study|Death|2|||
149777823|NCT01998399|540310737|FG000|Overall Study|Study stopped before dosing completed|3|||
149777824|NCT01998399|540310738|FG001|Overall Study|Study stopped before dosing completed|3|||
149777825|NCT01998399|540310737|FG000|Overall Study|Withdrawal by Subject|0|||
149777826|NCT01998399|540310738|FG001|Overall Study|Withdrawal by Subject|1|||
149777827|NCT00376246|540310739|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
149777828|NCT00376246|540310740|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
149777829|NCT00376246|540310739|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149777830|NCT00376246|540310740|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
149777831|NCT00376246|540310739|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
149777832|NCT00376246|540310740|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149777833|NCT02762708|540310742|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149777834|NCT02762708|540310743|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
149777835|NCT02762708|540310744|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149777836|NCT02762708|540310745|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149777837|NCT01468701|540310751|FG000|Overall Study|Not eligible|91|||
149777838|NCT01468701|540310752|FG001|Overall Study|Not eligible|140|||
149777839|NCT01468701|540310753|FG002|Overall Study|Not eligible|29|||
149777840|NCT01468701|540310754|FG003|Overall Study|Not eligible|12|||
149777841|NCT01468701|540310755|FG004|Overall Study|Not eligible|22|||
149777842|NCT01468701|540310756|FG005|Overall Study|Not eligible|2|||
149777843|NCT01468701|540310757|FG006|Overall Study|Not eligible|39|||
149777844|NCT01468701|540310758|FG007|Overall Study|Not eligible|1|||
149777845|NCT01468701|540310759|FG008|Overall Study|Not eligible|40|||
149777846|NCT01468701|540310760|FG009|Overall Study|Not eligible|126|||
149777847|NCT01468701|540310761|FG010|Overall Study|Not eligible|39|||
149777848|NCT01468701|540310762|FG011|Overall Study|Not eligible|33|||
149777849|NCT01468701|540310763|FG012|Overall Study|Not eligible|1|||
149777850|NCT01468701|540310764|FG013|Overall Study|Not eligible|19|||
149777851|NCT01468701|540310765|FG014|Overall Study|Not eligible|1|||
149777852|NCT01468701|540310766|FG015|Overall Study|Not eligible|32|||
149777853|NCT01468701|540310767|FG016|Overall Study|Not eligible|0|||
149777854|NCT01468701|540310751|FG000|Overall Study|Lost to Follow-up|306|||
149777855|NCT01468701|540310752|FG001|Overall Study|Lost to Follow-up|0|||
149777856|NCT01468701|540310753|FG002|Overall Study|Lost to Follow-up|0|||
149777857|NCT01468701|540310754|FG003|Overall Study|Lost to Follow-up|0|||
149777858|NCT01468701|540310755|FG004|Overall Study|Lost to Follow-up|0|||
149777859|NCT01468701|540310756|FG005|Overall Study|Lost to Follow-up|0|||
149777860|NCT01468701|540310757|FG006|Overall Study|Lost to Follow-up|0|||
149777861|NCT01468701|540310758|FG007|Overall Study|Lost to Follow-up|0|||
149777862|NCT01468701|540310759|FG008|Overall Study|Lost to Follow-up|215|||
149777863|NCT01468701|540310760|FG009|Overall Study|Lost to Follow-up|309|||
149777864|NCT01468701|540310761|FG010|Overall Study|Lost to Follow-up|224|||
149777865|NCT01468701|540310762|FG011|Overall Study|Lost to Follow-up|212|||
149777866|NCT01468701|540310763|FG012|Overall Study|Lost to Follow-up|11|||
149777867|NCT01468701|540310764|FG013|Overall Study|Lost to Follow-up|164|||
149777868|NCT01468701|540310765|FG014|Overall Study|Lost to Follow-up|17|||
149777869|NCT01468701|540310766|FG015|Overall Study|Lost to Follow-up|127|||
149777870|NCT01468701|540310767|FG016|Overall Study|Lost to Follow-up|1|||
149777871|NCT01468701|540310751|FG000|Overall Study|Withdrawal by Subject|165|||
149777872|NCT01468701|540310752|FG001|Overall Study|Withdrawal by Subject|0|||
149777873|NCT01468701|540310753|FG002|Overall Study|Withdrawal by Subject|0|||
149777874|NCT01468701|540310754|FG003|Overall Study|Withdrawal by Subject|0|||
149777875|NCT01468701|540310755|FG004|Overall Study|Withdrawal by Subject|0|||
149777876|NCT01468701|540310756|FG005|Overall Study|Withdrawal by Subject|0|||
149777877|NCT01468701|540310757|FG006|Overall Study|Withdrawal by Subject|0|||
149777878|NCT01468701|540310758|FG007|Overall Study|Withdrawal by Subject|0|||
149777879|NCT01468701|540310759|FG008|Overall Study|Withdrawal by Subject|83|||
149777880|NCT01468701|540310760|FG009|Overall Study|Withdrawal by Subject|88|||
149777881|NCT01468701|540310761|FG010|Overall Study|Withdrawal by Subject|100|||
149777882|NCT01468701|540310762|FG011|Overall Study|Withdrawal by Subject|114|||
149777883|NCT01468701|540310763|FG012|Overall Study|Withdrawal by Subject|9|||
149777884|NCT01468701|540310764|FG013|Overall Study|Withdrawal by Subject|47|||
149777885|NCT01468701|540310765|FG014|Overall Study|Withdrawal by Subject|6|||
149777886|NCT01468701|540310766|FG015|Overall Study|Withdrawal by Subject|31|||
149777887|NCT01468701|540310767|FG016|Overall Study|Withdrawal by Subject|0|||
149777888|NCT01468701|540310751|FG000|Overall Study|Other reasons than listed|437|||
149777889|NCT01468701|540310752|FG001|Overall Study|Other reasons than listed|0|||
149777890|NCT01468701|540310753|FG002|Overall Study|Other reasons than listed|0|||
149777891|NCT01468701|540310754|FG003|Overall Study|Other reasons than listed|0|||
149777892|NCT01468701|540310755|FG004|Overall Study|Other reasons than listed|0|||
149777893|NCT01468701|540310756|FG005|Overall Study|Other reasons than listed|0|||
149777894|NCT01468701|540310757|FG006|Overall Study|Other reasons than listed|0|||
149777895|NCT01468701|540310758|FG007|Overall Study|Other reasons than listed|0|||
149777896|NCT01468701|540310759|FG008|Overall Study|Other reasons than listed|318|||
149777897|NCT01468701|540310760|FG009|Overall Study|Other reasons than listed|658|||
149777898|NCT01468701|540310761|FG010|Overall Study|Other reasons than listed|433|||
149777899|NCT01468701|540310762|FG011|Overall Study|Other reasons than listed|504|||
149777900|NCT01468701|540310763|FG012|Overall Study|Other reasons than listed|28|||
149777901|NCT01468701|540310764|FG013|Overall Study|Other reasons than listed|239|||
149777902|NCT01468701|540310765|FG014|Overall Study|Other reasons than listed|39|||
149777903|NCT01468701|540310766|FG015|Overall Study|Other reasons than listed|172|||
149777904|NCT01468701|540310767|FG016|Overall Study|Other reasons than listed|0|||
149777905|NCT01468701|540310751|FG000|Overall Study|No end of study case report form|0|||
149777906|NCT01468701|540310752|FG001|Overall Study|No end of study case report form|0|||
149777907|NCT01468701|540310753|FG002|Overall Study|No end of study case report form|0|||
149777908|NCT01468701|540310754|FG003|Overall Study|No end of study case report form|0|||
149777909|NCT01468701|540310755|FG004|Overall Study|No end of study case report form|0|||
149777910|NCT01468701|540310756|FG005|Overall Study|No end of study case report form|0|||
149777911|NCT01468701|540310757|FG006|Overall Study|No end of study case report form|0|||
149777912|NCT01468701|540310758|FG007|Overall Study|No end of study case report form|0|||
149777913|NCT01468701|540310759|FG008|Overall Study|No end of study case report form|4|||
149777914|NCT01468701|540310760|FG009|Overall Study|No end of study case report form|1|||
149777915|NCT01468701|540310761|FG010|Overall Study|No end of study case report form|2|||
149777916|NCT01468701|540310762|FG011|Overall Study|No end of study case report form|3|||
149777917|NCT01468701|540310763|FG012|Overall Study|No end of study case report form|0|||
149777918|NCT01468701|540310764|FG013|Overall Study|No end of study case report form|1|||
149777919|NCT01468701|540310765|FG014|Overall Study|No end of study case report form|0|||
149777920|NCT01468701|540310766|FG015|Overall Study|No end of study case report form|0|||
149777921|NCT01468701|540310767|FG016|Overall Study|No end of study case report form|0|||
149777922|NCT01468701|540310751|FG000|Overall Study|Not being followed up|0|||
149777923|NCT01468701|540310752|FG001|Overall Study|Not being followed up|4963|||
149777924|NCT01468701|540310753|FG002|Overall Study|Not being followed up|1755|||
149777925|NCT01468701|540310754|FG003|Overall Study|Not being followed up|703|||
149777926|NCT01468701|540310755|FG004|Overall Study|Not being followed up|1714|||
149777927|NCT01468701|540310756|FG005|Overall Study|Not being followed up|126|||
149777928|NCT01468701|540310757|FG006|Overall Study|Not being followed up|1170|||
149777929|NCT01468701|540310758|FG007|Overall Study|Not being followed up|4|||
149777930|NCT01468701|540310759|FG008|Overall Study|Not being followed up|0|||
149777931|NCT01468701|540310760|FG009|Overall Study|Not being followed up|0|||
149777932|NCT01468701|540310761|FG010|Overall Study|Not being followed up|0|||
149777933|NCT01468701|540310762|FG011|Overall Study|Not being followed up|0|||
149777934|NCT01468701|540310763|FG012|Overall Study|Not being followed up|0|||
149777935|NCT01468701|540310764|FG013|Overall Study|Not being followed up|0|||
149777936|NCT01468701|540310765|FG014|Overall Study|Not being followed up|0|||
149777937|NCT01468701|540310766|FG015|Overall Study|Not being followed up|0|||
149777938|NCT01468701|540310767|FG016|Overall Study|Not being followed up|0|||
149777939|NCT00631540|540310772|FG000|Overall Study|Withdrawal by Subject|5|||
149777940|NCT00631540|540310772|FG000|Overall Study|Death|4|||
149777941|NCT00631540|540310772|FG000|Overall Study|Lost to Follow-up|2|||
149777942|NCT00631540|540310772|FG000|Overall Study|Core Lab Data Unavailable|3|||
149777943|NCT01079195|540310778|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
149777944|NCT01079195|540310778|FG000|Overall Study|No Documentation Available|437|||
149777945|NCT01079195|540310778|FG000|Overall Study|Adverse Event|157|||
149777946|NCT01079195|540310778|FG000|Overall Study|Reason Unknown|39|||
149777947|NCT01079195|540310778|FG000|Overall Study|Withdrawal by Subject|18|||
149777948|NCT01079195|540310778|FG000|Overall Study|Financial Reasons|15|||
149777949|NCT01079195|540310778|FG000|Overall Study|Lack of Effectiveness|12|||
149777950|NCT01079195|540310778|FG000|Overall Study|Physician Decision|4|||
149777951|NCT01079195|540310778|FG000|Overall Study|Improved Status of Participant|4|||
149777952|NCT01079195|540310778|FG000|Overall Study|No Follow-up Documentation Available|4|||
149777953|NCT01079195|540310778|FG000|Overall Study|Non-compliance|2|||
149777954|NCT03700736|540310783|FG000|Overall Study|Pregnancy|1|||
149777955|NCT03700736|540310784|FG001|Overall Study|Pregnancy|1|||
149777956|NCT03700736|540310783|FG000|Overall Study|Withdrawal by Subject|2|||
149777957|NCT03700736|540310784|FG001|Overall Study|Withdrawal by Subject|6|||
149777958|NCT03726333|540310785|FG000|Overall Study|Progressive Disease|0|||
149777959|NCT03726333|540310786|FG001|Overall Study|Progressive Disease|0|||
149777960|NCT03726333|540310787|FG002|Overall Study|Progressive Disease|1|||
149777961|NCT03726333|540310788|FG003|Overall Study|Progressive Disease|0|||
149777962|NCT03726333|540310789|FG004|Overall Study|Progressive Disease|0|||
149777963|NCT00402285|540312695|FG000|Overall Study|insufficient RNA quality|7|||
149777964|NCT00402285|540312696|FG001|Overall Study|insufficient RNA quality|6|||
149777965|NCT00402285|540312697|FG002|Overall Study|insufficient RNA quality|2|||
149777966|NCT00784459|540312698|FG000|Overall Study|Adverse Event|0|||
149777967|NCT00784459|540312699|FG001|Overall Study|Adverse Event|2|||
149777968|NCT02431702|540312700|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
149777969|NCT02431702|540312701|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777970|NCT02431702|540312702|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777971|NCT02431702|540312703|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777972|NCT02431702|540312704|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777973|NCT02431702|540312705|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777974|NCT02431702|540312706|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149777975|NCT02431702|540312700|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
149777976|NCT02431702|540312701|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149777977|NCT02431702|540312702|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149777978|NCT02431702|540312703|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149777979|NCT02431702|540312704|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149777980|NCT02431702|540312705|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149777981|NCT02431702|540312706|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
149777982|NCT02431702|540312700|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
149777983|NCT02431702|540312701|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149777984|NCT02431702|540312702|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149777985|NCT02431702|540312703|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149777986|NCT02431702|540312704|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149777987|NCT02431702|540312705|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149777988|NCT02431702|540312706|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
149777989|NCT02431702|540312700|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
149777990|NCT02431702|540312701|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149777991|NCT02431702|540312702|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149777992|NCT02431702|540312703|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149777993|NCT02431702|540312704|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149777994|NCT02431702|540312705|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149777995|NCT02431702|540312706|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
149777996|NCT02431702|540312700|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
149777997|NCT02431702|540312701|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149777998|NCT02431702|540312702|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149777999|NCT02431702|540312703|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149778000|NCT02431702|540312704|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149778001|NCT02431702|540312705|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149778002|NCT02431702|540312706|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149778003|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149778004|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
149778005|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
149778006|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149778007|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149778008|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149778009|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149778010|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149778011|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
149778012|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
149778013|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149778014|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149778015|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149778016|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149778017|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149778018|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
149778019|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
149778020|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149778021|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149778022|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149778023|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149778024|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778025|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
149778026|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778027|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778028|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778029|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778030|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149778031|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
149778032|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
149778033|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
149778034|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
149778035|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
149778036|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
149778037|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
149778038|NCT02431702|540312700|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778039|NCT02431702|540312701|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778040|NCT02431702|540312702|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
149778041|NCT02431702|540312703|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778042|NCT02431702|540312704|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778043|NCT02431702|540312705|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778044|NCT02431702|540312706|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149778045|NCT02431702|540312700|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149778046|NCT02431702|540312701|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149778047|NCT02431702|540312702|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149778048|NCT02431702|540312703|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
149778049|NCT02431702|540312704|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
149778050|NCT02431702|540312705|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149778051|NCT02431702|540312706|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149778052|NCT02431702|540312700|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149778053|NCT02431702|540312701|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149778054|NCT02431702|540312702|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149778055|NCT02431702|540312703|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
149778056|NCT02431702|540312704|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149778057|NCT02431702|540312705|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
149778058|NCT02431702|540312706|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149778059|NCT02431702|540312700|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149778060|NCT02431702|540312701|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149778061|NCT02431702|540312702|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149778062|NCT02431702|540312703|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
149778063|NCT02431702|540312704|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
149778064|NCT02431702|540312705|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
149778065|NCT02431702|540312706|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149778066|NCT02431702|540312700|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
149778067|NCT02431702|540312701|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
149778068|NCT02431702|540312702|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
149778069|NCT02431702|540312703|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
149778070|NCT02431702|540312704|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
149778071|NCT02431702|540312705|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
149778072|NCT02431702|540312706|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
149778073|NCT01510028|540312709|FG000|Overall Study|Lack of Efficacy|1|||
149778074|NCT01510028|540312710|FG001|Overall Study|Lack of Efficacy|0|||
149778075|NCT01510028|540312711|FG002|Overall Study|Lack of Efficacy|0|||
149778076|NCT01510028|540312712|FG003|Overall Study|Lack of Efficacy|0|||
149778077|NCT00633893|540312713|FG000|Overall Study|Death|1|||
149778078|NCT00633893|540312714|FG001|Overall Study|Death|3|||
149778079|NCT00633893|540312715|FG002|Overall Study|Death|9|||
149778080|NCT00633893|540312713|FG000|Overall Study|Adverse Event|65|||
149778081|NCT00633893|540312714|FG001|Overall Study|Adverse Event|58|||
149778082|NCT00633893|540312715|FG002|Overall Study|Adverse Event|126|||
149778083|NCT00633893|540312713|FG000|Overall Study|Withdrawal by Subject|7|||
149778084|NCT00633893|540312714|FG001|Overall Study|Withdrawal by Subject|12|||
149778085|NCT00633893|540312715|FG002|Overall Study|Withdrawal by Subject|6|||
149778086|NCT00633893|540312713|FG000|Overall Study|Lost to Follow-up|2|||
149778087|NCT00633893|540312714|FG001|Overall Study|Lost to Follow-up|4|||
149778088|NCT00633893|540312715|FG002|Overall Study|Lost to Follow-up|8|||
149778089|NCT00633893|540312713|FG000|Overall Study|Poor/non-compliance|5|||
149778090|NCT00633893|540312714|FG001|Overall Study|Poor/non-compliance|12|||
149778091|NCT00633893|540312715|FG002|Overall Study|Poor/non-compliance|3|||
149778092|NCT00633893|540312713|FG000|Overall Study|Pregnancy|2|||
149778093|NCT00633893|540312714|FG001|Overall Study|Pregnancy|1|||
149778094|NCT00633893|540312715|FG002|Overall Study|Pregnancy|1|||
149778095|NCT00633893|540312713|FG000|Overall Study|Not meet/no longer meets criteria|4|||
149778096|NCT00633893|540312714|FG001|Overall Study|Not meet/no longer meets criteria|6|||
149778097|NCT00633893|540312715|FG002|Overall Study|Not meet/no longer meets criteria|4|||
149778098|NCT00633893|540312713|FG000|Overall Study|Other|28|||
149778099|NCT00633893|540312714|FG001|Overall Study|Other|33|||
149778100|NCT00633893|540312715|FG002|Overall Study|Other|31|||
149778101|NCT02741310|540312716|FG000|Overall Study|Sponsor Decision|2|||
149778102|NCT02741310|540312717|FG001|Overall Study|Sponsor Decision|2|||
149778103|NCT05091918|540312718|FG000|Overall Study|Adverse Event|1|||
149778104|NCT05091918|540312718|FG000|Overall Study|Withdrawal by Subject|81|||
149778105|NCT01784211|540312722|FG000|Part A (Days 1-15)|Adverse Event|1|||
149778106|NCT01784211|540312723|FG001|Part A (Days 1-15)|Adverse Event|1|||
149778107|NCT01784211|540312724|FG002|Part A (Days 1-15)|Adverse Event|0|||
149778108|NCT01784211|540312725|FG003|Part A (Days 1-15)|Adverse Event|0|||
149778109|NCT01784211|540312726|FG004|Part A (Days 1-15)|Adverse Event|0|||
149778110|NCT01784211|540312727|FG005|Part A (Days 1-15)|Adverse Event|0|||
149778111|NCT01784211|540312722|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
149778112|NCT01784211|540312723|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
149778113|NCT01784211|540312724|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
149778114|NCT01784211|540312725|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
149778115|NCT01784211|540312726|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
149778116|NCT01784211|540312727|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
149778117|NCT00239356|540312728|FG000|Overall Study|Lack of Efficacy|1|||
149778118|NCT00239356|540312729|FG001|Overall Study|Lack of Efficacy|0|||
149778119|NCT00239356|540312728|FG000|Overall Study|Adverse Event|6|||
149778120|NCT00239356|540312729|FG001|Overall Study|Adverse Event|0|||
149778121|NCT00239356|540312728|FG000|Overall Study|Withdrawal by Subject|15|||
149778122|NCT00239356|540312729|FG001|Overall Study|Withdrawal by Subject|6|||
149778123|NCT00239356|540312728|FG000|Overall Study|Lost to Follow-up|3|||
149778124|NCT00239356|540312729|FG001|Overall Study|Lost to Follow-up|0|||
149778125|NCT00239356|540312728|FG000|Overall Study|poor/non-compliance|2|||
149778126|NCT00239356|540312729|FG001|Overall Study|poor/non-compliance|0|||
149778127|NCT00239356|540312728|FG000|Overall Study|Pregnancy|1|||
149778128|NCT00239356|540312729|FG001|Overall Study|Pregnancy|0|||
149778129|NCT00239356|540312728|FG000|Overall Study|Administrative reason|0|||
149778130|NCT00239356|540312729|FG001|Overall Study|Administrative reason|1|||
149778131|NCT00239356|540312728|FG000|Overall Study|Drug available on market|11|||
149778132|NCT00239356|540312729|FG001|Overall Study|Drug available on market|2|||
149778133|NCT03417505|540312730|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
149778134|NCT03417505|540312731|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
149778135|NCT03551626|540312732|FG000|Overall Study|Adverse Event|88|||
149778136|NCT03551626|540312732|FG000|Overall Study|Disease relapse|18|||
149778137|NCT03551626|540312732|FG000|Overall Study|Withdrawal of informed consent|6|||
149778138|NCT03551626|540312732|FG000|Overall Study|Patient decision|5|||
149778139|NCT03551626|540312732|FG000|Overall Study|Physician Decision|4|||
149778140|NCT03551626|540312732|FG000|Overall Study|Lost to Follow-up|3|||
149778141|NCT03551626|540312732|FG000|Overall Study|Pregnancy|1|||
149778142|NCT03551626|540312732|FG000|Overall Study|Protocol deviation|1|||
149778143|NCT03551626|540312732|FG000|Overall Study|Technical problems|1|||
149778144|NCT00653328|540312733|FG000|Overall Study|Withdrawal by Subject|1|||
149778145|NCT00653328|540312733|FG000|Overall Study|Adverse Event|2|||
149778146|NCT00653328|540312733|FG000|Overall Study|Disease progression|10|||
149778147|NCT00653328|540312733|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
149778148|NCT01017549|540312736|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
149778149|NCT01017549|540312736|FG000|One-year Follow-up|Lost to Follow-up|2|||
149778150|NCT01017549|540312736|FG000|One-year Follow-up|Withdrawal by Subject|5|||
149778151|NCT01017549|540312736|FG000|5 Year Follow-up|Lost to Follow-up|9|||
149778152|NCT01017549|540312736|FG000|5 Year Follow-up|Mastectomy|3|||
149778153|NCT00391807|540312745|FG000|Overall Study|Did not receive study medication|23|||
149778154|NCT00391807|540312745|FG000|Overall Study|Adverse Event|177|||
149778155|NCT00391807|540312745|FG000|Overall Study|Pregnancy|25|||
149778156|NCT00391807|540312745|FG000|Overall Study|Lost to Follow-up|227|||
149778157|NCT00391807|540312745|FG000|Overall Study|Withdrawal by Subject|147|||
149778158|NCT00391807|540312745|FG000|Overall Study|Protocol Violation|20|||
149778159|NCT00391807|540312745|FG000|Overall Study|Various|96|||
149778160|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
149778161|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
149778162|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
149778163|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
149778164|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
149778165|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149778166|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
149778167|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149778168|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149778169|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
149778170|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149778171|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149778172|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149778173|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
149778174|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149778175|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
149778176|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
149778177|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
149778178|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
149778179|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
149778180|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
149778181|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149778182|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
149778183|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149778184|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149778185|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Other|1|||
149778186|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Other|0|||
149778187|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Other|0|||
149778188|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Other|0|||
149778189|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Other|1|||
149778190|NCT02980692|540312748|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
149778191|NCT02980692|540312749|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
149778192|NCT02980692|540312750|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
149778193|NCT02980692|540312751|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
149778194|NCT02980692|540312752|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
149778195|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Adverse Event|0|||
149778196|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Adverse Event|0|||
149778197|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Adverse Event|0|||
149778198|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Adverse Event|1|||
149778199|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Adverse Event|1|||
149778200|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149778201|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
149778202|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
149778203|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149778204|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149778205|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
149778206|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
149778207|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
149778208|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
149778209|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
149778210|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Pregnancy|0|||
149778211|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Pregnancy|0|||
149778212|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Pregnancy|1|||
149778213|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Pregnancy|1|||
149778214|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Pregnancy|0|||
149778215|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
149778216|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149778217|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
149778218|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149778219|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149778220|NCT02980692|540312748|FG000|Double-blind Follow-up Period|Other|0|||
149778221|NCT02980692|540312749|FG001|Double-blind Follow-up Period|Other|0|||
149778222|NCT02980692|540312750|FG002|Double-blind Follow-up Period|Other|1|||
149778223|NCT02980692|540312751|FG003|Double-blind Follow-up Period|Other|1|||
149778224|NCT02980692|540312752|FG004|Double-blind Follow-up Period|Other|3|||
149778225|NCT03725293|540312760|FG000|Overall Study|Physician Decision|9|||
149778226|NCT03725293|540312761|FG001|Overall Study|Physician Decision|6|||
149778227|NCT03725293|540312760|FG000|Overall Study|alternative vascular access needs|1|||
149778228|NCT03725293|540312761|FG001|Overall Study|alternative vascular access needs|2|||
149778229|NCT03725293|540312760|FG000|Overall Study|venous anatomy screen failures|2|||
149778230|NCT03725293|540312761|FG001|Overall Study|venous anatomy screen failures|1|||
149778231|NCT02143141|540312762|FG000|Overall Study|pain scores at 24 hours not collected|1|||
149778232|NCT02143141|540312763|FG001|Overall Study|pain scores at 24 hours not collected|0|||
149778233|NCT03862495|540312764|FG000|Overall Study|Lost to Follow-up|37|||
149778234|NCT03862495|540312765|FG001|Overall Study|Lost to Follow-up|35|||
149778235|NCT00064077|540312766|FG000|Overall Study|Improper prior treatment|1|||
149778236|NCT00064077|540312767|FG001|Overall Study|Improper prior treatment|0|||
149778237|NCT00064077|540312768|FG002|Overall Study|Improper prior treatment|0|||
149778238|NCT00064077|540312769|FG003|Overall Study|Improper prior treatment|0|||
149778239|NCT00064077|540312766|FG000|Overall Study|Poor risk|2|||
149778240|NCT00064077|540312767|FG001|Overall Study|Poor risk|0|||
149778241|NCT00064077|540312768|FG002|Overall Study|Poor risk|1|||
149778242|NCT00064077|540312769|FG003|Overall Study|Poor risk|1|||
149778243|NCT00064077|540312766|FG000|Overall Study|Pathology|10|||
149778244|NCT00064077|540312767|FG001|Overall Study|Pathology|7|||
149778245|NCT00064077|540312768|FG002|Overall Study|Pathology|3|||
149778246|NCT00064077|540312769|FG003|Overall Study|Pathology|4|||
149778247|NCT00064077|540312766|FG000|Overall Study|No surgery|0|||
149778248|NCT00064077|540312767|FG001|Overall Study|No surgery|0|||
149778249|NCT00064077|540312768|FG002|Overall Study|No surgery|1|||
149778250|NCT00064077|540312769|FG003|Overall Study|No surgery|0|||
149778251|NCT00064077|540312766|FG000|Overall Study|No tumor|0|||
149778252|NCT00064077|540312767|FG001|Overall Study|No tumor|0|||
149778253|NCT00064077|540312768|FG002|Overall Study|No tumor|1|||
149778254|NCT00064077|540312769|FG003|Overall Study|No tumor|0|||
149778255|NCT00064077|540312766|FG000|Overall Study|Other reasons|2|||
149778256|NCT00064077|540312767|FG001|Overall Study|Other reasons|2|||
149778257|NCT00064077|540312768|FG002|Overall Study|Other reasons|1|||
149778258|NCT00064077|540312769|FG003|Overall Study|Other reasons|2|||
149778259|NCT04397796|540312770|FG000|Overall Study|Death|3|||
149778260|NCT04397796|540312771|FG001|Overall Study|Death|1|||
149778261|NCT01057862|540312772|FG000|Overall Study|Withdrawal by Subject|1|||
149778262|NCT01057862|540312773|FG001|Overall Study|Withdrawal by Subject|2|||
149778263|NCT03363165|540312776|FG000|3-month Follow-up|Death|0|||
149778264|NCT03363165|540312777|FG001|3-month Follow-up|Death|1|||
149778265|NCT03363165|540312776|FG000|6-month Follow-up|Death|0|||
149778266|NCT03363165|540312777|FG001|6-month Follow-up|Death|1|||
149778267|NCT03363165|540312776|FG000|6-month Follow-up|Withdrawal by Subject|1|||
149778268|NCT03363165|540312777|FG001|6-month Follow-up|Withdrawal by Subject|1|||
149778269|NCT03363165|540312776|FG000|12-month Follow-up|Death|1|||
149778270|NCT03363165|540312777|FG001|12-month Follow-up|Death|1|||
149778271|NCT03363165|540312776|FG000|12-month Follow-up|Withdrawal by Subject|1|||
149778272|NCT03363165|540312777|FG001|12-month Follow-up|Withdrawal by Subject|1|||
149778273|NCT02255760|540312778|FG000|Overall Study|Lost to Follow-up|0|||
149778274|NCT02255760|540312779|FG001|Overall Study|Lost to Follow-up|1|||
149778275|NCT02255760|540312780|FG002|Overall Study|Lost to Follow-up|0|||
149778276|NCT02255760|540312781|FG003|Overall Study|Lost to Follow-up|0|||
149778277|NCT02255760|540312782|FG004|Overall Study|Lost to Follow-up|0|||
149778278|NCT00003838|540312783|FG000|Overall Study|Death|0|||
149778279|NCT00003838|540312784|FG001|Overall Study|Death|12|||
149778280|NCT00003838|540312785|FG002|Overall Study|Death|7|||
149778281|NCT00003838|540312783|FG000|Overall Study|Lost to Follow-up|0|||
149778282|NCT00003838|540312784|FG001|Overall Study|Lost to Follow-up|1|||
149778283|NCT00003838|540312785|FG002|Overall Study|Lost to Follow-up|1|||
149778284|NCT00003838|540312783|FG000|Overall Study|Disease Progression|0|||
149778285|NCT00003838|540312784|FG001|Overall Study|Disease Progression|12|||
149778286|NCT00003838|540312785|FG002|Overall Study|Disease Progression|0|||
149778287|NCT00618813|540312786|FG000|Overall Study|Lack of Efficacy|1|||
149778288|NCT00618813|540312786|FG000|Overall Study|Physician Decision|2|||
149778289|NCT00618813|540312786|FG000|Overall Study|Withdrawal by Subject|1|||
149778290|NCT00425113|540312787|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
149778291|NCT00425113|540312788|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
149778292|NCT00425113|540312787|FG000|Overall Study|diagnosis of abdominal TB|0|||
149778293|NCT00425113|540312788|FG001|Overall Study|diagnosis of abdominal TB|1|||
149778294|NCT00425113|540312787|FG000|Overall Study|missing study drug more than 14 days|0|||
149778295|NCT00425113|540312788|FG001|Overall Study|missing study drug more than 14 days|1|||
149778296|NCT00425113|540312787|FG000|Overall Study|Withdrawal by Subject|1|||
149778297|NCT00425113|540312788|FG001|Overall Study|Withdrawal by Subject|0|||
149778298|NCT00879437|540312789|FG000|Overall Study|Protocol Violation|0|||
149778299|NCT00879437|540312790|FG001|Overall Study|Protocol Violation|1|||
149778300|NCT00879437|540312789|FG000|Overall Study|Death|1|||
149778301|NCT00879437|540312790|FG001|Overall Study|Death|0|||
149778302|NCT00291187|540312791|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
149778303|NCT00291187|540312792|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
149778304|NCT00291187|540312793|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
149778305|NCT00291187|540312794|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
149778306|NCT00615459|540312796|FG000|Period I|Adverse Event|2|||
149778307|NCT00615459|540312797|FG001|Period I|Adverse Event|0|||
149778308|NCT00615459|540312798|FG002|Period I|Adverse Event|1|||
149778309|NCT00615459|540312799|FG003|Period I|Adverse Event|0|||
149778310|NCT00615459|540312796|FG000|Period I|Subject withdrew consent|1|||
149778311|NCT00615459|540312797|FG001|Period I|Subject withdrew consent|0|||
149778312|NCT00615459|540312798|FG002|Period I|Subject withdrew consent|0|||
149778313|NCT00615459|540312799|FG003|Period I|Subject withdrew consent|1|||
149778314|NCT00615459|540312796|FG000|Period I|Abnormal test procedure results|1|||
149778315|NCT00615459|540312797|FG001|Period I|Abnormal test procedure results|1|||
149778316|NCT00615459|540312798|FG002|Period I|Abnormal test procedure results|1|||
149778317|NCT00615459|540312799|FG003|Period I|Abnormal test procedure results|0|||
149778318|NCT00615459|540312796|FG000|Period II|Adverse Event|1|||
149778319|NCT00615459|540312797|FG001|Period II|Adverse Event|0|||
149778320|NCT00615459|540312798|FG002|Period II|Adverse Event|0|||
149778321|NCT00615459|540312799|FG003|Period II|Adverse Event|0|||
149778322|NCT00615459|540312796|FG000|Period II|Lost to Follow-up|0|||
149778323|NCT00615459|540312797|FG001|Period II|Lost to Follow-up|0|||
149778324|NCT00615459|540312798|FG002|Period II|Lost to Follow-up|0|||
149778325|NCT00615459|540312799|FG003|Period II|Lost to Follow-up|1|||
149778326|NCT00615459|540312796|FG000|Period III|Adverse Event|0|||
149778327|NCT00615459|540312797|FG001|Period III|Adverse Event|1|||
149778328|NCT00615459|540312798|FG002|Period III|Adverse Event|0|||
149778329|NCT00615459|540312799|FG003|Period III|Adverse Event|0|||
149778330|NCT00615459|540312796|FG000|Period III|Administrative problems|0|||
149778331|NCT00615459|540312797|FG001|Period III|Administrative problems|1|||
149778332|NCT00615459|540312798|FG002|Period III|Administrative problems|1|||
149778333|NCT00615459|540312799|FG003|Period III|Administrative problems|0|||
149778334|NCT00615459|540312796|FG000|Period III|Unsatisfactory therapeutic effect|0|||
149778335|NCT00615459|540312797|FG001|Period III|Unsatisfactory therapeutic effect|1|||
149778336|NCT00615459|540312798|FG002|Period III|Unsatisfactory therapeutic effect|0|||
149778337|NCT00615459|540312799|FG003|Period III|Unsatisfactory therapeutic effect|0|||
149778338|NCT00918346|540312800|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
149778339|NCT00918346|540312801|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
149778340|NCT03238352|540312802|FG000|Overall Study|Lost to Follow-up|0|||
149778341|NCT03238352|540312803|FG001|Overall Study|Lost to Follow-up|2|||
149778342|NCT03238352|540312804|FG002|Overall Study|Lost to Follow-up|1|||
149778343|NCT03238352|540312802|FG000|Overall Study|Withdrawal by Subject|0|||
149778344|NCT03238352|540312803|FG001|Overall Study|Withdrawal by Subject|1|||
149778345|NCT03238352|540312804|FG002|Overall Study|Withdrawal by Subject|0|||
149778346|NCT04153929|540312805|FG000|Overall Study|Other than listed|2|||
149778347|NCT04153929|540312806|FG001|Overall Study|Other than listed|2|||
149778348|NCT04153929|540312807|FG002|Overall Study|Other than listed|0|||
149778349|NCT04153929|540312808|FG003|Overall Study|Other than listed|1|||
149778350|NCT04153929|540312809|FG004|Overall Study|Other than listed|0|||
149778351|NCT04153929|540312810|FG005|Overall Study|Other than listed|2|||
149778352|NCT04153929|540312811|FG006|Overall Study|Other than listed|2|||
149778353|NCT04153929|540312812|FG007|Overall Study|Other than listed|1|||
149778354|NCT04153929|540312805|FG000|Overall Study|Lost to Follow-up|2|||
149778355|NCT04153929|540312806|FG001|Overall Study|Lost to Follow-up|1|||
149778356|NCT04153929|540312807|FG002|Overall Study|Lost to Follow-up|0|||
149778357|NCT04153929|540312808|FG003|Overall Study|Lost to Follow-up|1|||
149778358|NCT04153929|540312809|FG004|Overall Study|Lost to Follow-up|1|||
149778359|NCT04153929|540312810|FG005|Overall Study|Lost to Follow-up|0|||
149778360|NCT04153929|540312811|FG006|Overall Study|Lost to Follow-up|0|||
149778361|NCT04153929|540312812|FG007|Overall Study|Lost to Follow-up|0|||
149778362|NCT04153929|540312805|FG000|Overall Study|Withdrawal by Subject|3|||
149778363|NCT04153929|540312806|FG001|Overall Study|Withdrawal by Subject|1|||
149778364|NCT04153929|540312807|FG002|Overall Study|Withdrawal by Subject|0|||
149778365|NCT04153929|540312808|FG003|Overall Study|Withdrawal by Subject|3|||
149778366|NCT04153929|540312809|FG004|Overall Study|Withdrawal by Subject|1|||
149778367|NCT04153929|540312810|FG005|Overall Study|Withdrawal by Subject|0|||
149778368|NCT04153929|540312811|FG006|Overall Study|Withdrawal by Subject|1|||
149778369|NCT04153929|540312812|FG007|Overall Study|Withdrawal by Subject|0|||
149778370|NCT04153929|540312805|FG000|Overall Study|Protocol Violation|0|||
149778371|NCT04153929|540312806|FG001|Overall Study|Protocol Violation|0|||
149778372|NCT04153929|540312807|FG002|Overall Study|Protocol Violation|0|||
149778373|NCT04153929|540312808|FG003|Overall Study|Protocol Violation|0|||
149778374|NCT04153929|540312809|FG004|Overall Study|Protocol Violation|0|||
149778375|NCT04153929|540312810|FG005|Overall Study|Protocol Violation|0|||
149778376|NCT04153929|540312811|FG006|Overall Study|Protocol Violation|1|||
149778377|NCT04153929|540312812|FG007|Overall Study|Protocol Violation|2|||
149778378|NCT04153929|540312805|FG000|Overall Study|Adverse Event|3|||
149778379|NCT04153929|540312806|FG001|Overall Study|Adverse Event|5|||
149778380|NCT04153929|540312807|FG002|Overall Study|Adverse Event|5|||
149778381|NCT04153929|540312808|FG003|Overall Study|Adverse Event|11|||
149778382|NCT04153929|540312809|FG004|Overall Study|Adverse Event|15|||
149778383|NCT04153929|540312810|FG005|Overall Study|Adverse Event|4|||
149778384|NCT04153929|540312811|FG006|Overall Study|Adverse Event|8|||
149778385|NCT04153929|540312812|FG007|Overall Study|Adverse Event|2|||
149778386|NCT04153929|540312805|FG000|Overall Study|Not treated|1|||
149778387|NCT04153929|540312806|FG001|Overall Study|Not treated|0|||
149778388|NCT04153929|540312807|FG002|Overall Study|Not treated|0|||
149778389|NCT04153929|540312808|FG003|Overall Study|Not treated|0|||
149778390|NCT04153929|540312809|FG004|Overall Study|Not treated|0|||
149778391|NCT04153929|540312810|FG005|Overall Study|Not treated|0|||
149778392|NCT04153929|540312811|FG006|Overall Study|Not treated|1|||
149778393|NCT04153929|540312812|FG007|Overall Study|Not treated|0|||
149778394|NCT04083794|540312813|FG000|Overall Study|Lost to Follow-up|9|||
149778395|NCT00224003|540312816|FG000|Overall Study|Adverse Event|1|||
149778396|NCT00224003|540312816|FG000|Overall Study|Protocol Violation|2|||
149778397|NCT00224003|540312816|FG000|Overall Study|Withdrawal by Subject|1|||
149778398|NCT00224003|540312816|FG000|Overall Study|unk|3|||
149778399|NCT02228564|540312821|FG000|Overall Study|Withdrawal by Subject|10|||
149778400|NCT02228564|540312821|FG000|Overall Study|Death|11|||
149778401|NCT02228564|540312821|FG000|Overall Study|Physician Decision|5|||
149778402|NCT02228564|540312821|FG000|Overall Study|Lost to Follow-up|17|||
149778403|NCT02228564|540312821|FG000|Overall Study|Other|6|||
149778404|NCT01455415|540312829|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
149778405|NCT01455415|540312830|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
149778406|NCT01455415|540312829|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
149778407|NCT01455415|540312830|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
149778408|NCT01455415|540312829|FG000|Period 1|Drug Error not Associated to AE|0|||
149778409|NCT01455415|540312830|FG001|Period 1|Drug Error not Associated to AE|1|||
149778410|NCT01455415|540312829|FG000|Period 1|AE Not Related to Study Drug|2|||
149778411|NCT01455415|540312830|FG001|Period 1|AE Not Related to Study Drug|6|||
149778412|NCT01455415|540312829|FG000|Period 1|Withdrawal by Subject|4|||
149778413|NCT01455415|540312830|FG001|Period 1|Withdrawal by Subject|5|||
149778414|NCT01455415|540312829|FG000|Period 1|Unspecified Reason|1|||
149778415|NCT01455415|540312830|FG001|Period 1|Unspecified Reason|1|||
149778416|NCT01455415|540312829|FG000|Period 1|Protocol Violation|0|||
149778417|NCT01455415|540312830|FG001|Period 1|Protocol Violation|2|||
149778418|NCT01455415|540312829|FG000|Washout|AE Related to Study Drug|2|||
149778419|NCT01455415|540312830|FG001|Washout|AE Related to Study Drug|0|||
149778420|NCT01455415|540312829|FG000|Washout|Lost to Follow-up|1|||
149778421|NCT01455415|540312830|FG001|Washout|Lost to Follow-up|0|||
149778422|NCT01455415|540312829|FG000|Washout|Drug Error not Associated to AE|2|||
149778423|NCT01455415|540312830|FG001|Washout|Drug Error not Associated to AE|1|||
149778424|NCT01455415|540312829|FG000|Washout|AE Not Related to Study Drug|2|||
149778425|NCT01455415|540312830|FG001|Washout|AE Not Related to Study Drug|3|||
149778426|NCT01455415|540312829|FG000|Washout|Unspecified Reason|1|||
149778427|NCT01455415|540312830|FG001|Washout|Unspecified Reason|2|||
149778428|NCT01455415|540312829|FG000|Washout|Protocol Violation|0|||
149778429|NCT01455415|540312830|FG001|Washout|Protocol Violation|1|||
149778430|NCT01455415|540312829|FG000|Period 2|AE Related to Study Drug|1|||
149778431|NCT01455415|540312830|FG001|Period 2|AE Related to Study Drug|2|||
149778432|NCT01455415|540312829|FG000|Period 2|Lost to Follow-up|2|||
149778433|NCT01455415|540312830|FG001|Period 2|Lost to Follow-up|1|||
149778434|NCT01455415|540312829|FG000|Period 2|AE Not Related to Study Drug|2|||
149778435|NCT01455415|540312830|FG001|Period 2|AE Not Related to Study Drug|1|||
149778436|NCT01455415|540312829|FG000|Period 2|Lack of Efficacy|2|||
149778437|NCT01455415|540312830|FG001|Period 2|Lack of Efficacy|0|||
149778438|NCT01455415|540312829|FG000|Period 2|Withdrawal by Subject|2|||
149778439|NCT01455415|540312830|FG001|Period 2|Withdrawal by Subject|3|||
149778440|NCT01455415|540312829|FG000|Period 2|Unspecified Reason|2|||
149778441|NCT01455415|540312830|FG001|Period 2|Unspecified Reason|3|||
149778442|NCT01455415|540312829|FG000|Period 2|Protocol Violation|2|||
149778443|NCT01455415|540312830|FG001|Period 2|Protocol Violation|0|||
149778444|NCT01455415|540312829|FG000|Follow-up|AE Related to Study Drug|0|||
149778445|NCT01455415|540312830|FG001|Follow-up|AE Related to Study Drug|1|||
149778446|NCT01455415|540312829|FG000|Follow-up|Lack of Efficacy|0|||
149778447|NCT01455415|540312830|FG001|Follow-up|Lack of Efficacy|1|||
149778448|NCT01455415|540312829|FG000|Follow-up|Withdrawal by Subject|2|||
149778449|NCT01455415|540312830|FG001|Follow-up|Withdrawal by Subject|0|||
149778450|NCT01455415|540312829|FG000|Follow-up|Unspecified Reason|1|||
149778451|NCT01455415|540312830|FG001|Follow-up|Unspecified Reason|0|||
149778452|NCT00587301|540312831|FG000|Overall Study|Screen Failure|9|||
149778453|NCT00587301|540312831|FG000|Overall Study|Lost to Follow-up|22|||
149778454|NCT00587301|540312831|FG000|Overall Study|Withdrawal by Subject|7|||
149778455|NCT00587301|540312831|FG000|Overall Study|Protocol Violation|7|||
149778456|NCT00351819|540312832|FG000|Overall Study|Lost to Follow-up|4|||
149778457|NCT00351819|540312833|FG001|Overall Study|Lost to Follow-up|4|||
149778458|NCT00351819|540312832|FG000|Overall Study|Withdrawal by Subject|0|||
149778459|NCT00351819|540312833|FG001|Overall Study|Withdrawal by Subject|4|||
149778460|NCT00351819|540312832|FG000|Overall Study|Elevated PSA|1|||
149778461|NCT00351819|540312833|FG001|Overall Study|Elevated PSA|1|||
149778462|NCT00351819|540312832|FG000|Overall Study|Traumatic ankle fracture|1|||
149778463|NCT00351819|540312833|FG001|Overall Study|Traumatic ankle fracture|0|||
149778464|NCT00351819|540312832|FG000|Overall Study|Unprofessional behavior|1|||
149778465|NCT00351819|540312833|FG001|Overall Study|Unprofessional behavior|0|||
149778466|NCT00351819|540312832|FG000|Overall Study|Non-compliance|0|||
149778467|NCT00351819|540312833|FG001|Overall Study|Non-compliance|1|||
149778468|NCT00351819|540312832|FG000|Overall Study|Incarcerated|0|||
149778469|NCT00351819|540312833|FG001|Overall Study|Incarcerated|1|||
149778470|NCT00351819|540312832|FG000|Overall Study|Enrolled in another trial|0|||
149778471|NCT00351819|540312833|FG001|Overall Study|Enrolled in another trial|1|||
149778472|NCT01400139|540312835|FG000|HYD Core Study|Adverse Event|210|||
149778473|NCT01400139|540312835|FG000|HYD Core Study|Lack of Efficacy|59|||
149778474|NCT01400139|540312835|FG000|HYD Core Study|Withdrawal by Subject|114|||
149778475|NCT01400139|540312835|FG000|HYD Core Study|Lost to Follow-up|39|||
149778476|NCT01400139|540312835|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
149778477|NCT01400139|540312835|FG000|HYD Core Study|Administrative|56|||
149778478|NCT01400139|540312835|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
149778479|NCT01400139|540312835|FG000|HYD Extension Period|Adverse Event|8|||
149778480|NCT01400139|540312835|FG000|HYD Extension Period|Withdrawal by Subject|5|||
149778481|NCT01400139|540312835|FG000|HYD Extension Period|Administrative|10|||
149778482|NCT00418717|540312836|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
149778483|NCT00418717|540312836|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
149778484|NCT00249795|540312837|FG000|Overall Study|Not treated|16|||
149778485|NCT00249795|540312838|FG001|Overall Study|Not treated|14|||
149778486|NCT00249795|540312837|FG000|Overall Study|Symptomatic hypotension|127|||
149778487|NCT00249795|540312838|FG001|Overall Study|Symptomatic hypotension|64|||
149778488|NCT00249795|540312837|FG000|Overall Study|Other Serious Adverse Event|84|||
149778489|NCT00249795|540312838|FG001|Overall Study|Other Serious Adverse Event|93|||
149778490|NCT00249795|540312837|FG000|Overall Study|Qualifying condition not present|26|||
149778491|NCT00249795|540312838|FG001|Overall Study|Qualifying condition not present|29|||
149778492|NCT00249795|540312837|FG000|Overall Study|Withdrawal by Subject|678|||
149778493|NCT00249795|540312838|FG001|Overall Study|Withdrawal by Subject|742|||
149778494|NCT00249795|540312837|FG000|Overall Study|Thromboembolic / outcome event|39|||
149778495|NCT00249795|540312838|FG001|Overall Study|Thromboembolic / outcome event|45|||
149778496|NCT00249795|540312837|FG000|Overall Study|Oral anticoagulant required|2|||
149778497|NCT00249795|540312838|FG001|Overall Study|Oral anticoagulant required|0|||
149778498|NCT00249795|540312837|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
149778499|NCT00249795|540312838|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
149778500|NCT00249795|540312837|FG000|Overall Study|Non-compliance|71|||
149778501|NCT00249795|540312838|FG001|Overall Study|Non-compliance|69|||
149778502|NCT00249795|540312837|FG000|Overall Study|Study drug intolerance|3|||
149778503|NCT00249795|540312838|FG001|Overall Study|Study drug intolerance|3|||
149778504|NCT00249795|540312837|FG000|Overall Study|Other adverse events (non-serious)|188|||
149778505|NCT00249795|540312838|FG001|Overall Study|Other adverse events (non-serious)|159|||
149778506|NCT00249795|540312837|FG000|Overall Study|Physician withdrew consent|71|||
149778507|NCT00249795|540312838|FG001|Overall Study|Physician withdrew consent|63|||
149778508|NCT00249795|540312837|FG000|Overall Study|Surgery / procedure|4|||
149778509|NCT00249795|540312838|FG001|Overall Study|Surgery / procedure|5|||
149778510|NCT00249795|540312837|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
149778511|NCT00249795|540312838|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
149778512|NCT00249795|540312837|FG000|Overall Study|Lightheadedness / dizziness|15|||
149778513|NCT00249795|540312838|FG001|Overall Study|Lightheadedness / dizziness|11|||
149778514|NCT00249795|540312837|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
149778515|NCT00249795|540312838|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
149778516|NCT00249795|540312837|FG000|Overall Study|Other contraindicated medication|1|||
149778517|NCT00249795|540312838|FG001|Overall Study|Other contraindicated medication|1|||
149778518|NCT00249795|540312837|FG000|Overall Study|Event related to cardiac condition|17|||
149778519|NCT00249795|540312838|FG001|Overall Study|Event related to cardiac condition|16|||
149778520|NCT00249795|540312837|FG000|Overall Study|Patient not wish to continue after May08|4|||
149778521|NCT00249795|540312838|FG001|Overall Study|Patient not wish to continue after May08|6|||
149778522|NCT00249795|540312837|FG000|Overall Study|Site not agree to continue after May08|1|||
149778523|NCT00249795|540312838|FG001|Overall Study|Site not agree to continue after May08|1|||
149778524|NCT00249795|540312837|FG000|Overall Study|Lost to Follow-up|0|||
149778525|NCT00249795|540312838|FG001|Overall Study|Lost to Follow-up|2|||
149778526|NCT00249795|540312837|FG000|Overall Study|Missing|0|||
149778527|NCT00249795|540312838|FG001|Overall Study|Missing|1|||
149778528|NCT00719537|540312841|FG000|Overall Study|Withdrawal by Subject|1|||
149778529|NCT00719537|540312842|FG001|Overall Study|Withdrawal by Subject|0|||
149778530|NCT00719537|540312841|FG000|Overall Study|Lost to Follow-up|0|||
149778531|NCT00719537|540312842|FG001|Overall Study|Lost to Follow-up|1|||
149778532|NCT01142193|540312843|FG000|Overall Study|Adverse Event|12|||
149778533|NCT01142193|540312844|FG001|Overall Study|Adverse Event|4|||
149778534|NCT01142193|540312843|FG000|Overall Study|Lack of Efficacy|2|||
149778535|NCT01142193|540312844|FG001|Overall Study|Lack of Efficacy|1|||
149778536|NCT01142193|540312843|FG000|Overall Study|Physician Decision|1|||
149778537|NCT01142193|540312844|FG001|Overall Study|Physician Decision|1|||
149778538|NCT01142193|540312843|FG000|Overall Study|Withdrawal by Subject|4|||
149778539|NCT01142193|540312844|FG001|Overall Study|Withdrawal by Subject|3|||
149778540|NCT01142193|540312843|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
149778541|NCT01142193|540312844|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
149778542|NCT01142193|540312843|FG000|Overall Study|Other|1|||
149778543|NCT01142193|540312844|FG001|Overall Study|Other|2|||
149778544|NCT03549429|540312847|FG000|Overall Study|Protocol Violation|5|||
149778545|NCT03549429|540312848|FG001|Overall Study|Protocol Violation|3|||
149778546|NCT02910219|540312849|FG000|Overall Study|Withdrawal by Subject|1|||
149778547|NCT02910219|540312850|FG001|Overall Study|Withdrawal by Subject|1|||
149778548|NCT01425749|540312851|FG000|Overall Study|progression of melanoma|0|||
149778549|NCT01425749|540312852|FG001|Overall Study|progression of melanoma|1|||
149778550|NCT02096042|540312853|FG000|Overall Study|Disease Progression|1|||
149778551|NCT02096042|540312854|FG001|Overall Study|Disease Progression|0|||
149778552|NCT02096042|540312855|FG002|Overall Study|Disease Progression|0|||
149778553|NCT05200455|540312859|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
149778554|NCT00807014|540312862|FG000|Overall Study|Participant Considered Disease Cured|13|||
149778555|NCT00807014|540312863|FG001|Overall Study|Participant Considered Disease Cured|2|||
149778556|NCT00807014|540312862|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
149778557|NCT00807014|540312863|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
149778558|NCT00807014|540312862|FG000|Overall Study|Protocol Violation|2|||
149778559|NCT00807014|540312863|FG001|Overall Study|Protocol Violation|8|||
149778560|NCT00807014|540312862|FG000|Overall Study|Adverse Event|0|||
149778561|NCT00807014|540312863|FG001|Overall Study|Adverse Event|2|||
149778562|NCT00807014|540312862|FG000|Overall Study|Lost to Follow-up|9|||
149778563|NCT00807014|540312863|FG001|Overall Study|Lost to Follow-up|7|||
149778564|NCT00807014|540312862|FG000|Overall Study|Recovery|1|||
149778565|NCT00807014|540312863|FG001|Overall Study|Recovery|0|||
149778566|NCT00807014|540312862|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
149778567|NCT00807014|540312863|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
149778568|NCT02091921|540312864|FG000|Overall Study|Adverse Event|3|||
149778569|NCT03307629|540312865|FG000|Overall Study|Withdrawal by Subject|0|||
149778570|NCT03307629|540312866|FG001|Overall Study|Withdrawal by Subject|0|||
149778571|NCT03307629|540312867|FG002|Overall Study|Withdrawal by Subject|0|||
149778572|NCT03307629|540312868|FG003|Overall Study|Withdrawal by Subject|2|||
149778573|NCT03307629|540312865|FG000|Overall Study|Disease Progression|0|||
149778574|NCT03307629|540312866|FG001|Overall Study|Disease Progression|0|||
149778575|NCT03307629|540312867|FG002|Overall Study|Disease Progression|0|||
149778576|NCT03307629|540312868|FG003|Overall Study|Disease Progression|3|||
149778577|NCT03307629|540312865|FG000|Overall Study|Death|0|||
149778578|NCT03307629|540312866|FG001|Overall Study|Death|3|||
149778579|NCT03307629|540312867|FG002|Overall Study|Death|0|||
149778580|NCT03307629|540312868|FG003|Overall Study|Death|1|||
149778581|NCT02483078|540312869|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
149778582|NCT02483078|540312870|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
149778583|NCT02483078|540312869|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
149778584|NCT02483078|540312870|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
149778585|NCT02483078|540312869|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
149778586|NCT02483078|540312870|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
149778587|NCT02483078|540312869|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
149778588|NCT02483078|540312870|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
149778589|NCT02483078|540312869|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
149778590|NCT02483078|540312870|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
149778591|NCT02483078|540312869|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
149778592|NCT02483078|540312870|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
149778593|NCT02853032|540312875|FG000|Overall Study|Adverse Event|4|||
149778594|NCT02853032|540312876|FG001|Overall Study|Adverse Event|0|||
149778595|NCT02853032|540312875|FG000|Overall Study|Withdrawal by Subject|3|||
149778596|NCT02853032|540312876|FG001|Overall Study|Withdrawal by Subject|1|||
149778597|NCT02853032|540312875|FG000|Overall Study|Requested to withdraw from all treatment|2|||
149778598|NCT02853032|540312876|FG001|Overall Study|Requested to withdraw from all treatment|2|||
149778599|NCT04876599|540312877|FG000|Overall Study|Missed|2|||
149778600|NCT04876599|540312878|FG001|Overall Study|Missed|0|||
149778601|NCT04876599|540312877|FG000|Overall Study|Declined|2|||
149778602|NCT04876599|540312878|FG001|Overall Study|Declined|3|||
149778603|NCT01280812|540314718|FG000|Overall Study|Withdrawal by Subject|2|||
149778604|NCT01280812|540314719|FG001|Overall Study|Withdrawal by Subject|1|||
149778605|NCT01280812|540314720|FG002|Overall Study|Withdrawal by Subject|0|||
149778606|NCT01280812|540314718|FG000|Overall Study|Lost to Follow-up|1|||
149778607|NCT01280812|540314719|FG001|Overall Study|Lost to Follow-up|1|||
149778608|NCT01280812|540314720|FG002|Overall Study|Lost to Follow-up|1|||
149778609|NCT03682055|540314721|FG000|Overall Study|Lack of Efficacy|1|||
149778610|NCT03682055|540314722|FG001|Overall Study|Lack of Efficacy|2|||
149778611|NCT03682055|540314723|FG002|Overall Study|Lack of Efficacy|1|||
149778612|NCT03682055|540314724|FG003|Overall Study|Lack of Efficacy|2|||
149778613|NCT03682055|540314725|FG004|Overall Study|Lack of Efficacy|1|||
149778614|NCT03682055|540314726|FG005|Overall Study|Lack of Efficacy|3|||
149778615|NCT03682055|540314721|FG000|Overall Study|Withdrawal by Subject|0|||
149778616|NCT03682055|540314722|FG001|Overall Study|Withdrawal by Subject|0|||
149778617|NCT03682055|540314723|FG002|Overall Study|Withdrawal by Subject|0|||
149778618|NCT03682055|540314724|FG003|Overall Study|Withdrawal by Subject|0|||
149778619|NCT03682055|540314725|FG004|Overall Study|Withdrawal by Subject|0|||
149778620|NCT03682055|540314726|FG005|Overall Study|Withdrawal by Subject|1|||
149778621|NCT03682055|540314721|FG000|Overall Study|Termination of Study by Sponsor|0|||
149778622|NCT03682055|540314722|FG001|Overall Study|Termination of Study by Sponsor|0|||
149778623|NCT03682055|540314723|FG002|Overall Study|Termination of Study by Sponsor|0|||
149778624|NCT03682055|540314724|FG003|Overall Study|Termination of Study by Sponsor|0|||
149778625|NCT03682055|540314725|FG004|Overall Study|Termination of Study by Sponsor|0|||
149778626|NCT03682055|540314726|FG005|Overall Study|Termination of Study by Sponsor|3|||
149778627|NCT00880100|540314727|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
149778628|NCT00880100|540314727|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
149778629|NCT00880100|540314727|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
149778630|NCT03424044|540314729|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778631|NCT03424044|540314730|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778632|NCT03424044|540314731|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
149778633|NCT03424044|540314732|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778634|NCT03424044|540314733|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778635|NCT03424044|540314734|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778636|NCT03424044|540314735|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778637|NCT03424044|540314736|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778638|NCT03424044|540314737|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149778639|NCT03424044|540314729|FG000|First Intervention (76 Hours)|Adverse Event|0|||
149778640|NCT03424044|540314730|FG001|First Intervention (76 Hours)|Adverse Event|0|||
149778641|NCT03424044|540314731|FG002|First Intervention (76 Hours)|Adverse Event|0|||
149778642|NCT03424044|540314732|FG003|First Intervention (76 Hours)|Adverse Event|0|||
149778643|NCT03424044|540314733|FG004|First Intervention (76 Hours)|Adverse Event|1|||
149778644|NCT03424044|540314734|FG005|First Intervention (76 Hours)|Adverse Event|0|||
149778645|NCT03424044|540314735|FG006|First Intervention (76 Hours)|Adverse Event|0|||
149778646|NCT03424044|540314736|FG007|First Intervention (76 Hours)|Adverse Event|0|||
149778647|NCT03424044|540314737|FG008|First Intervention (76 Hours)|Adverse Event|0|||
149778648|NCT03424044|540314729|FG000|First Intervention (76 Hours)|device issues|0|||
149778649|NCT03424044|540314730|FG001|First Intervention (76 Hours)|device issues|0|||
149778650|NCT03424044|540314731|FG002|First Intervention (76 Hours)|device issues|0|||
149778651|NCT03424044|540314732|FG003|First Intervention (76 Hours)|device issues|0|||
149778652|NCT03424044|540314733|FG004|First Intervention (76 Hours)|device issues|0|||
149778653|NCT03424044|540314734|FG005|First Intervention (76 Hours)|device issues|0|||
149778654|NCT03424044|540314735|FG006|First Intervention (76 Hours)|device issues|1|||
149778655|NCT03424044|540314736|FG007|First Intervention (76 Hours)|device issues|1|||
149778656|NCT03424044|540314737|FG008|First Intervention (76 Hours)|device issues|1|||
149778657|NCT03424044|540314729|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
149778658|NCT03424044|540314730|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
149778659|NCT03424044|540314731|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
149778660|NCT03424044|540314732|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
149778661|NCT03424044|540314733|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
149778662|NCT03424044|540314734|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
149778663|NCT03424044|540314735|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
149778664|NCT03424044|540314736|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
149778665|NCT03424044|540314737|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
149778666|NCT03424044|540314729|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778667|NCT03424044|540314730|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778668|NCT03424044|540314731|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778669|NCT03424044|540314732|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
149778670|NCT03424044|540314733|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778671|NCT03424044|540314734|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778672|NCT03424044|540314735|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778673|NCT03424044|540314736|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778674|NCT03424044|540314737|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149778675|NCT04839393|540314738|FG000|Overall Study|Adverse Event|0|||
149778676|NCT04839393|540314739|FG001|Overall Study|Adverse Event|0|||
149778677|NCT04839393|540314740|FG002|Overall Study|Adverse Event|2|||
149778678|NCT04839393|540314738|FG000|Overall Study|Withdrawal by participant|0|||
149778679|NCT04839393|540314739|FG001|Overall Study|Withdrawal by participant|0|||
149778680|NCT04839393|540314740|FG002|Overall Study|Withdrawal by participant|1|||
149778681|NCT01100658|540314742|FG000|Overall Study|Withdrawal by Subject|1|||
149778682|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
149778683|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
149778684|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
149778685|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
149778686|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
149778687|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
149778688|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
149778689|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
149778690|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
149778691|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
149778692|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
149778693|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
149778694|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
149778695|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
149778696|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
149778697|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
149778698|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
149778699|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
149778700|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
149778701|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
149778702|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
149778703|NCT01001572|540314745|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
149778704|NCT01001572|540314746|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
149778705|NCT01001572|540314747|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
149778706|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149778707|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
149778708|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
149778709|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149778710|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
149778711|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
149778712|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
149778713|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
149778714|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
149778715|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149778716|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149778717|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
149778718|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
149778719|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
149778720|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
149778721|NCT01001572|540314745|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149778722|NCT01001572|540314746|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149778723|NCT01001572|540314747|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149778724|NCT01094808|540314748|FG000|Overall Study|Withdrawal by Subject|1|||
149778725|NCT01094808|540314749|FG001|Overall Study|Withdrawal by Subject|1|||
149778726|NCT01094808|540314750|FG002|Overall Study|Withdrawal by Subject|0|||
149778727|NCT00369278|540314751|FG000|Overall Study|Adverse Event|14|||
149778728|NCT00369278|540314752|FG001|Overall Study|Adverse Event|11|||
149778729|NCT00369278|540314751|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149778730|NCT00369278|540314752|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
149778731|NCT00369278|540314751|FG000|Overall Study|Protocol Violation|2|||
149778732|NCT00369278|540314752|FG001|Overall Study|Protocol Violation|1|||
149778733|NCT00369278|540314751|FG000|Overall Study|Withdrawal by Subject|2|||
149778734|NCT00369278|540314752|FG001|Overall Study|Withdrawal by Subject|2|||
149778735|NCT00369278|540314751|FG000|Overall Study|Lost to Follow-up|1|||
149778736|NCT00369278|540314752|FG001|Overall Study|Lost to Follow-up|0|||
149778737|NCT00369278|540314751|FG000|Overall Study|Graft loss|1|||
149778738|NCT00369278|540314752|FG001|Overall Study|Graft loss|2|||
149778739|NCT02044822|540314753|FG000|Overall Study|Study Terminated by Sponsor|77|||
149778740|NCT02044822|540314753|FG000|Overall Study|Investigator's Discretion|10|||
149778741|NCT02044822|540314753|FG000|Overall Study|Withdrew Consent|3|||
149778742|NCT02044822|540314753|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
149778743|NCT02044822|540314753|FG000|Overall Study|Lost to Follow-up|1|||
149778744|NCT02025530|540314756|FG000|Overall Study|No longer met elligibility criteria|5|||
149778745|NCT02025530|540314757|FG001|Overall Study|No longer met elligibility criteria|1|||
149778746|NCT01040845|540314762|FG000|Overall Study|Withdrawal by Subject|1|||
149778747|NCT01040845|540314763|FG001|Overall Study|Withdrawal by Subject|1|||
149778748|NCT01040845|540314762|FG000|Overall Study|Physician Decision|1|||
149778749|NCT01040845|540314763|FG001|Overall Study|Physician Decision|0|||
149778750|NCT01732107|540314767|FG000|Overall Study|Adverse Event|2|||
149778751|NCT01732107|540314767|FG000|Overall Study|Disease Progression|8|||
149778752|NCT01732107|540314767|FG000|Overall Study|Physician Decision|1|||
149778753|NCT01732107|540314767|FG000|Overall Study|Withdrawal by Subject|2|||
149778754|NCT04445688|540314768|FG000|Washout (One Week)|Adverse Event|2|||
149778755|NCT04445688|540314768|FG000|Washout (One Week)|Withdrawal by Subject|1|||
149778756|NCT00928512|540314775|FG000|Overall Study|Adverse Event|4|||
149778757|NCT00928512|540314776|FG001|Overall Study|Adverse Event|3|||
149778758|NCT00928512|540314777|FG002|Overall Study|Adverse Event|2|||
149778759|NCT00928512|540314778|FG003|Overall Study|Adverse Event|8|||
149778760|NCT00928512|540314779|FG004|Overall Study|Adverse Event|6|||
149778761|NCT00928512|540314775|FG000|Overall Study|Lack of Efficacy|2|||
149778762|NCT00928512|540314776|FG001|Overall Study|Lack of Efficacy|0|||
149778763|NCT00928512|540314777|FG002|Overall Study|Lack of Efficacy|4|||
149778764|NCT00928512|540314778|FG003|Overall Study|Lack of Efficacy|7|||
149778765|NCT00928512|540314779|FG004|Overall Study|Lack of Efficacy|3|||
149778766|NCT00928512|540314775|FG000|Overall Study|Protocol Violation|0|||
149778767|NCT00928512|540314776|FG001|Overall Study|Protocol Violation|1|||
149778768|NCT00928512|540314777|FG002|Overall Study|Protocol Violation|0|||
149778769|NCT00928512|540314778|FG003|Overall Study|Protocol Violation|1|||
149778770|NCT00928512|540314779|FG004|Overall Study|Protocol Violation|3|||
149778771|NCT00928512|540314775|FG000|Overall Study|Withdrawal by Subject|3|||
149778772|NCT00928512|540314776|FG001|Overall Study|Withdrawal by Subject|0|||
149778773|NCT00928512|540314777|FG002|Overall Study|Withdrawal by Subject|3|||
149778774|NCT00928512|540314778|FG003|Overall Study|Withdrawal by Subject|4|||
149778775|NCT00928512|540314779|FG004|Overall Study|Withdrawal by Subject|0|||
149778776|NCT00928512|540314775|FG000|Overall Study|Lost to Follow-up|1|||
149778777|NCT00928512|540314776|FG001|Overall Study|Lost to Follow-up|1|||
149778778|NCT00928512|540314777|FG002|Overall Study|Lost to Follow-up|2|||
149778779|NCT00928512|540314778|FG003|Overall Study|Lost to Follow-up|1|||
149778780|NCT00928512|540314779|FG004|Overall Study|Lost to Follow-up|3|||
149778781|NCT00928512|540314775|FG000|Overall Study|Administrative Problems|0|||
149778782|NCT00928512|540314776|FG001|Overall Study|Administrative Problems|1|||
149778783|NCT00928512|540314777|FG002|Overall Study|Administrative Problems|0|||
149778784|NCT00928512|540314778|FG003|Overall Study|Administrative Problems|0|||
149778785|NCT00928512|540314779|FG004|Overall Study|Administrative Problems|0|||
149778786|NCT01963780|540314780|FG000|Overall Study|Death|7|||
149778787|NCT01749800|540314781|FG000|Overall Study|not meeting inclusion criteria|3|||
149778788|NCT01749800|540314782|FG001|Overall Study|not meeting inclusion criteria|0|||
149778789|NCT01749800|540314783|FG002|Overall Study|not meeting inclusion criteria|0|||
149778790|NCT01749800|540314781|FG000|Overall Study|Withdrawal by Subject|0|||
149778791|NCT01749800|540314782|FG001|Overall Study|Withdrawal by Subject|1|||
149778792|NCT01749800|540314783|FG002|Overall Study|Withdrawal by Subject|0|||
149778793|NCT01296698|540314784|FG000|Overall Study|Adverse Event|1|||
149778794|NCT01296698|540314785|FG001|Overall Study|Adverse Event|0|||
149778795|NCT01296698|540314784|FG000|Overall Study|Death|1|||
149778796|NCT01296698|540314785|FG001|Overall Study|Death|0|||
149778797|NCT01296698|540314784|FG000|Overall Study|Lost to Follow-up|19|||
149778798|NCT01296698|540314785|FG001|Overall Study|Lost to Follow-up|1|||
149778799|NCT01296698|540314784|FG000|Overall Study|Withdrawal by Subject|12|||
149778800|NCT01296698|540314785|FG001|Overall Study|Withdrawal by Subject|0|||
149778801|NCT01296698|540314784|FG000|Overall Study|Difficulty Contacting Subject|2|||
149778802|NCT01296698|540314785|FG001|Overall Study|Difficulty Contacting Subject|0|||
149778803|NCT01296698|540314784|FG000|Overall Study|Study Terminated by Sponsor|209|||
149778804|NCT01296698|540314785|FG001|Overall Study|Study Terminated by Sponsor|12|||
149778805|NCT01975675|540314786|FG000|Overall Study|Death|0|||
149778806|NCT01975675|540314787|FG001|Overall Study|Death|1|||
149778807|NCT01975675|540314788|FG002|Overall Study|Death|0|||
149778808|NCT01975675|540314789|FG003|Overall Study|Death|0|||
149778809|NCT03639987|540314790|FG000|Overall Study|Study terminated by sponsor|26|||
149778810|NCT03639987|540314791|FG001|Overall Study|Study terminated by sponsor|25|||
149778811|NCT03639987|540314790|FG000|Overall Study|Lost to Follow-up|0|||
149778812|NCT03639987|540314791|FG001|Overall Study|Lost to Follow-up|1|||
149778813|NCT00729326|540314798|FG000|Overall Study|Lost to Follow-up|2|||
149778814|NCT00729326|540314799|FG001|Overall Study|Lost to Follow-up|0|||
149778815|NCT00729326|540314798|FG000|Overall Study|Physician Decision|0|||
149778816|NCT00729326|540314799|FG001|Overall Study|Physician Decision|1|||
149778817|NCT00729326|540314798|FG000|Overall Study|Protocol Violation|3|||
149778818|NCT00729326|540314799|FG001|Overall Study|Protocol Violation|2|||
149778819|NCT00729326|540314798|FG000|Overall Study|Subject Decision|4|||
149778820|NCT00729326|540314799|FG001|Overall Study|Subject Decision|4|||
149778821|NCT00729326|540314798|FG000|Overall Study|Sponsor Decision|1|||
149778822|NCT00729326|540314799|FG001|Overall Study|Sponsor Decision|2|||
149778823|NCT01235728|540314800|FG000|Overall Study|Protocol Violation|0|||
149778824|NCT01235728|540314801|FG001|Overall Study|Protocol Violation|0|||
149778825|NCT01235728|540314802|FG002|Overall Study|Protocol Violation|0|||
149778826|NCT01235728|540314803|FG003|Overall Study|Protocol Violation|1|||
149778827|NCT01235728|540314804|FG004|Overall Study|Protocol Violation|0|||
149778828|NCT01235728|540314805|FG005|Overall Study|Protocol Violation|0|||
149778829|NCT01235728|540314806|FG006|Overall Study|Protocol Violation|0|||
149778830|NCT01235728|540314807|FG007|Overall Study|Protocol Violation|0|||
149778831|NCT02810951|540314808|FG000|Overall Study|Adverse Event|1|||
149778832|NCT03199638|540314809|FG000|Overall Study|inability to drink glutamine during regularly|0|||
149778833|NCT03199638|540314810|FG001|Overall Study|inability to drink glutamine during regularly|2|||
149778834|NCT01575899|540314811|FG000|Overall Study|Lost to Follow-up|3|||
149778835|NCT01575899|540314812|FG001|Overall Study|Lost to Follow-up|4|||
149778836|NCT01575899|540314813|FG002|Overall Study|Lost to Follow-up|2|||
149778837|NCT01575899|540314811|FG000|Overall Study|Protocol Violation|2|||
149778838|NCT01575899|540314812|FG001|Overall Study|Protocol Violation|1|||
149778839|NCT01575899|540314813|FG002|Overall Study|Protocol Violation|0|||
149778840|NCT02807844|540314814|FG000|Overall Study|Physician Decision|0|||
149778841|NCT02807844|540314815|FG001|Overall Study|Physician Decision|0|||
149778842|NCT02807844|540314816|FG002|Overall Study|Physician Decision|0|||
149778843|NCT02807844|540314817|FG003|Overall Study|Physician Decision|0|||
149778844|NCT02807844|540314818|FG004|Overall Study|Physician Decision|0|||
149778845|NCT02807844|540314819|FG005|Overall Study|Physician Decision|0|||
149778846|NCT02807844|540314820|FG006|Overall Study|Physician Decision|3|||
149778847|NCT02807844|540314821|FG007|Overall Study|Physician Decision|0|||
149778848|NCT02807844|540314822|FG008|Overall Study|Physician Decision|1|||
149778849|NCT02807844|540314823|FG009|Overall Study|Physician Decision|2|||
149778850|NCT02807844|540314814|FG000|Overall Study|Death|0|||
149778851|NCT02807844|540314815|FG001|Overall Study|Death|0|||
149778852|NCT02807844|540314816|FG002|Overall Study|Death|2|||
149778853|NCT02807844|540314817|FG003|Overall Study|Death|4|||
149778854|NCT02807844|540314818|FG004|Overall Study|Death|1|||
149778855|NCT02807844|540314819|FG005|Overall Study|Death|2|||
149778856|NCT02807844|540314820|FG006|Overall Study|Death|1|||
149778857|NCT02807844|540314821|FG007|Overall Study|Death|2|||
149778858|NCT02807844|540314822|FG008|Overall Study|Death|0|||
149778859|NCT02807844|540314823|FG009|Overall Study|Death|1|||
149778860|NCT02807844|540314814|FG000|Overall Study|Withdrawal by Subject|0|||
149778861|NCT02807844|540314815|FG001|Overall Study|Withdrawal by Subject|0|||
149778862|NCT02807844|540314816|FG002|Overall Study|Withdrawal by Subject|2|||
149778863|NCT02807844|540314817|FG003|Overall Study|Withdrawal by Subject|1|||
149778864|NCT02807844|540314818|FG004|Overall Study|Withdrawal by Subject|1|||
149778865|NCT02807844|540314819|FG005|Overall Study|Withdrawal by Subject|0|||
149778866|NCT02807844|540314820|FG006|Overall Study|Withdrawal by Subject|1|||
149778867|NCT02807844|540314821|FG007|Overall Study|Withdrawal by Subject|0|||
149778868|NCT02807844|540314822|FG008|Overall Study|Withdrawal by Subject|0|||
149778869|NCT02807844|540314823|FG009|Overall Study|Withdrawal by Subject|0|||
149778870|NCT02807844|540314814|FG000|Overall Study|Progressive disease|5|||
149778871|NCT02807844|540314815|FG001|Overall Study|Progressive disease|12|||
149778872|NCT02807844|540314816|FG002|Overall Study|Progressive disease|8|||
149778873|NCT02807844|540314817|FG003|Overall Study|Progressive disease|8|||
149778874|NCT02807844|540314818|FG004|Overall Study|Progressive disease|3|||
149778875|NCT02807844|540314819|FG005|Overall Study|Progressive disease|8|||
149778876|NCT02807844|540314820|FG006|Overall Study|Progressive disease|14|||
149778877|NCT02807844|540314821|FG007|Overall Study|Progressive disease|17|||
149778878|NCT02807844|540314822|FG008|Overall Study|Progressive disease|19|||
149778879|NCT02807844|540314823|FG009|Overall Study|Progressive disease|15|||
149778880|NCT02807844|540314814|FG000|Overall Study|Adverse Event|1|||
149778881|NCT02807844|540314815|FG001|Overall Study|Adverse Event|0|||
149778882|NCT02807844|540314816|FG002|Overall Study|Adverse Event|0|||
149778883|NCT02807844|540314817|FG003|Overall Study|Adverse Event|0|||
149778884|NCT02807844|540314818|FG004|Overall Study|Adverse Event|1|||
149778885|NCT02807844|540314819|FG005|Overall Study|Adverse Event|1|||
149778886|NCT02807844|540314820|FG006|Overall Study|Adverse Event|1|||
149778887|NCT02807844|540314821|FG007|Overall Study|Adverse Event|1|||
149778888|NCT02807844|540314822|FG008|Overall Study|Adverse Event|1|||
149778889|NCT02807844|540314823|FG009|Overall Study|Adverse Event|2|||
149778890|NCT03097029|540314824|FG000|Overall Study|Withdrawal by Subject|1|||
149778891|NCT00709124|540314825|FG000|Overall Study|Death|3|||
149778892|NCT00709124|540314826|FG001|Overall Study|Death|1|||
149778893|NCT00709124|540314825|FG000|Overall Study|encephalopathy; can't do assessment|1|||
149778894|NCT00709124|540314826|FG001|Overall Study|encephalopathy; can't do assessment|0|||
149778895|NCT00373490|540314827|FG000|Overall Study|Adverse Event|0|||
149778896|NCT00373490|540314828|FG001|Overall Study|Adverse Event|1|||
149778897|NCT00373490|540314827|FG000|Overall Study|Lack of Efficacy|9|||
149778898|NCT00373490|540314828|FG001|Overall Study|Lack of Efficacy|4|||
149778899|NCT00373490|540314827|FG000|Overall Study|Withdrawal by Subject|0|||
149778900|NCT00373490|540314828|FG001|Overall Study|Withdrawal by Subject|1|||
149778901|NCT00753688|540314835|FG000|Overall Study|Death|102|||
149778902|NCT00753688|540314836|FG001|Overall Study|Death|203|||
149778903|NCT00753688|540314835|FG000|Overall Study|Missing|4|||
149778904|NCT00753688|540314836|FG001|Overall Study|Missing|9|||
149778905|NCT00753688|540314835|FG000|Overall Study|Participant Withdrew Consent|2|||
149778906|NCT00753688|540314836|FG001|Overall Study|Participant Withdrew Consent|2|||
149778907|NCT00753688|540314835|FG000|Overall Study|Ongoing - in Follow-up|15|||
149778908|NCT00753688|540314836|FG001|Overall Study|Ongoing - in Follow-up|31|||
149778909|NCT00753688|540314835|FG000|Overall Study|Adverse Event|0|||
149778910|NCT00753688|540314836|FG001|Overall Study|Adverse Event|1|||
149778911|NCT00108953|540314837|FG000|Follow-up|Death|18|||
149778912|NCT00108953|540314838|FG001|Follow-up|Death|26|||
149778913|NCT00108953|540314837|FG000|Follow-up|Lost to Follow-up|1|||
149778914|NCT00108953|540314838|FG001|Follow-up|Lost to Follow-up|1|||
149778915|NCT00108953|540314837|FG000|Follow-up|Study terminated by sponsor|10|||
149778916|NCT00108953|540314838|FG001|Follow-up|Study terminated by sponsor|6|||
149778917|NCT01125293|540314841|FG000|Overall Study|Disease Progression|1|||
149778918|NCT01125293|540314842|FG001|Overall Study|Disease Progression|3|||
149778919|NCT01125293|540314843|FG002|Overall Study|Disease Progression|4|||
149778920|NCT01125293|540314844|FG003|Overall Study|Disease Progression|3|||
149778921|NCT01125293|540314845|FG004|Overall Study|Disease Progression|5|||
149778922|NCT01125293|540314846|FG005|Overall Study|Disease Progression|12|||
149778923|NCT01125293|540314841|FG000|Overall Study|Adverse Event|1|||
149778924|NCT01125293|540314842|FG001|Overall Study|Adverse Event|0|||
149778925|NCT01125293|540314843|FG002|Overall Study|Adverse Event|0|||
149778926|NCT01125293|540314844|FG003|Overall Study|Adverse Event|0|||
149778927|NCT01125293|540314845|FG004|Overall Study|Adverse Event|2|||
149778928|NCT01125293|540314846|FG005|Overall Study|Adverse Event|8|||
149778929|NCT01125293|540314841|FG000|Overall Study|Symptomatic Deterioration|1|||
149778930|NCT01125293|540314842|FG001|Overall Study|Symptomatic Deterioration|0|||
149778931|NCT01125293|540314843|FG002|Overall Study|Symptomatic Deterioration|0|||
149778932|NCT01125293|540314844|FG003|Overall Study|Symptomatic Deterioration|0|||
149778933|NCT01125293|540314845|FG004|Overall Study|Symptomatic Deterioration|0|||
149778934|NCT01125293|540314846|FG005|Overall Study|Symptomatic Deterioration|0|||
149778935|NCT01125293|540314841|FG000|Overall Study|Death|0|||
149778936|NCT01125293|540314842|FG001|Overall Study|Death|0|||
149778937|NCT01125293|540314843|FG002|Overall Study|Death|0|||
149778938|NCT01125293|540314844|FG003|Overall Study|Death|0|||
149778939|NCT01125293|540314845|FG004|Overall Study|Death|1|||
149778940|NCT01125293|540314846|FG005|Overall Study|Death|0|||
149778941|NCT01125293|540314841|FG000|Overall Study|Withdrawal by Subject|0|||
149778942|NCT01125293|540314842|FG001|Overall Study|Withdrawal by Subject|0|||
149778943|NCT01125293|540314843|FG002|Overall Study|Withdrawal by Subject|0|||
149778944|NCT01125293|540314844|FG003|Overall Study|Withdrawal by Subject|0|||
149778945|NCT01125293|540314845|FG004|Overall Study|Withdrawal by Subject|2|||
149778946|NCT01125293|540314846|FG005|Overall Study|Withdrawal by Subject|1|||
149778947|NCT01125293|540314841|FG000|Overall Study|Physician Decision|0|||
149778948|NCT01125293|540314842|FG001|Overall Study|Physician Decision|0|||
149778949|NCT01125293|540314843|FG002|Overall Study|Physician Decision|0|||
149778950|NCT01125293|540314844|FG003|Overall Study|Physician Decision|0|||
149778951|NCT01125293|540314845|FG004|Overall Study|Physician Decision|0|||
149778952|NCT01125293|540314846|FG005|Overall Study|Physician Decision|2|||
149778953|NCT00659126|540314849|FG000|Overall Study|Adverse Event|2|||
149778954|NCT00659126|540314850|FG001|Overall Study|Adverse Event|2|||
149778955|NCT00659126|540314849|FG000|Overall Study|Screen failure|1|||
149778956|NCT00659126|540314850|FG001|Overall Study|Screen failure|1|||
149778957|NCT00659126|540314849|FG000|Overall Study|Technical problems with MRI|0|||
149778958|NCT00659126|540314850|FG001|Overall Study|Technical problems with MRI|1|||
149778959|NCT00260429|540314851|FG000|Overall Study|failure to follow appointments|1|||
149778960|NCT00260429|540314852|FG001|Overall Study|failure to follow appointments|0|||
149778961|NCT00260429|540314851|FG000|Overall Study|scheduled hand surgery|1|||
149778962|NCT00260429|540314852|FG001|Overall Study|scheduled hand surgery|0|||
149778963|NCT02633046|540314856|FG000|Overall Study|Adverse Event|8|||
149778964|NCT02633046|540314856|FG000|Overall Study|Physician Decision|7|||
149778965|NCT02633046|540314856|FG000|Overall Study|Withdrawal by Subject|8|||
149778966|NCT02633046|540314856|FG000|Overall Study|Increased proteinuria|2|||
149778967|NCT02633046|540314856|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
149778968|NCT02633046|540314856|FG000|Overall Study|Mutual decision patient and physician|1|||
149778969|NCT02758613|540314859|FG000|Treatment|Physician and Sponsor Decision|1|||
149778970|NCT02758613|540314860|FG001|Treatment|Physician and Sponsor Decision|0|||
149778971|NCT02758613|540314861|FG002|Treatment|Physician and Sponsor Decision|0|||
149778972|NCT02758613|540314862|FG003|Treatment|Physician and Sponsor Decision|0|||
149778973|NCT02758613|540314859|FG000|Treatment|Withdrawal by Subject|1|||
149778974|NCT02758613|540314860|FG001|Treatment|Withdrawal by Subject|0|||
149778975|NCT02758613|540314861|FG002|Treatment|Withdrawal by Subject|1|||
149778976|NCT02758613|540314862|FG003|Treatment|Withdrawal by Subject|0|||
149778977|NCT01496274|540314864|FG000|Overall Study|Protocol Violation|0|||
149778978|NCT01496274|540314865|FG001|Overall Study|Protocol Violation|1|||
149778979|NCT01496274|540314864|FG000|Overall Study|Adverse Event|1|||
149778980|NCT01496274|540314865|FG001|Overall Study|Adverse Event|1|||
149778981|NCT01496274|540314864|FG000|Overall Study|Withdrawal by Subject|2|||
149778982|NCT01496274|540314865|FG001|Overall Study|Withdrawal by Subject|0|||
149778983|NCT01496274|540314864|FG000|Overall Study|Lost to Follow-up|0|||
149778984|NCT01496274|540314865|FG001|Overall Study|Lost to Follow-up|3|||
149778985|NCT01225172|540314867|FG000|Overall Study|Subject decision to stop|1|||
149778986|NCT01225172|540314868|FG001|Overall Study|Subject decision to stop|0|||
149778987|NCT01225172|540314867|FG000|Overall Study|Subject request to discontinue treatment|3|||
149778988|NCT01225172|540314868|FG001|Overall Study|Subject request to discontinue treatment|1|||
149778989|NCT01225172|540314867|FG000|Overall Study|Subject no longer meets study criteria|1|||
149778990|NCT01225172|540314868|FG001|Overall Study|Subject no longer meets study criteria|0|||
149778991|NCT01225172|540314867|FG000|Overall Study|Withdrawal by Subject|1|||
149778992|NCT01225172|540314868|FG001|Overall Study|Withdrawal by Subject|0|||
149778993|NCT01068717|540314869|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
149778994|NCT01068717|540314870|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149778995|NCT01068717|540314871|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149778996|NCT01068717|540314872|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149778997|NCT01822223|540314873|FG000|Overall Study|Death|0|||
149778998|NCT01822223|540314874|FG001|Overall Study|Death|1|||
149778999|NCT02679781|540314877|FG000|Overall Study|Lost to Follow-up|1|||
149779000|NCT02679781|540314878|FG001|Overall Study|Lost to Follow-up|2|||
149779001|NCT02679781|540314877|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
149779002|NCT02679781|540314878|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
149779003|NCT04209400|540314879|FG000|Overall Study|Withdrawal by Subject|0|||
149779004|NCT04209400|540314880|FG001|Overall Study|Withdrawal by Subject|1|||
149779005|NCT03404518|540314881|FG000|Overall Study|Lost to Follow-up|28|||
149779006|NCT03404518|540314882|FG001|Overall Study|Lost to Follow-up|30|||
149779007|NCT03404518|540314881|FG000|Overall Study|Protocol Violation|13|||
149779008|NCT03404518|540314882|FG001|Overall Study|Protocol Violation|6|||
149779009|NCT01602549|540314883|FG000|Overall Study|Protocol Violation|0|||
149779010|NCT01602549|540314884|FG001|Overall Study|Protocol Violation|1|||
149779011|NCT01602549|540314883|FG000|Overall Study|Withdrawal by Subject|1|||
149779012|NCT01602549|540314884|FG001|Overall Study|Withdrawal by Subject|0|||
149779013|NCT00676208|540314891|FG000|Overall Study|Lost to Follow-up|0|||
149779014|NCT00676208|540314892|FG001|Overall Study|Lost to Follow-up|2|||
149779015|NCT00676208|540314891|FG000|Overall Study|Incomplete data|2|||
149779016|NCT00676208|540314892|FG001|Overall Study|Incomplete data|4|||
149779017|NCT03906136|540317643|FG000|Overall Study|Adverse Event|1|||
149779018|NCT03906136|540317644|FG001|Overall Study|Adverse Event|0|||
149779019|NCT03906136|540317643|FG000|Overall Study|Lost to Follow-up|7|||
149779020|NCT03906136|540317644|FG001|Overall Study|Lost to Follow-up|4|||
149779021|NCT03906136|540317643|FG000|Overall Study|Physician Decision|1|||
149779022|NCT03906136|540317644|FG001|Overall Study|Physician Decision|0|||
149779023|NCT03906136|540317643|FG000|Overall Study|Withdrawal by Subject|3|||
149779024|NCT03906136|540317644|FG001|Overall Study|Withdrawal by Subject|7|||
149779025|NCT02371980|540317654|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
149779026|NCT02371980|540317655|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
149779027|NCT02371980|540317656|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
149779028|NCT02371980|540317657|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
149779029|NCT02371980|540317658|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
149779030|NCT02371980|540317654|FG000|Open-label Period|Significant Protocol Deviation|19|||
149779031|NCT02371980|540317655|FG001|Open-label Period|Significant Protocol Deviation|0|||
149779032|NCT02371980|540317656|FG002|Open-label Period|Significant Protocol Deviation|0|||
149779033|NCT02371980|540317657|FG003|Open-label Period|Significant Protocol Deviation|0|||
149779034|NCT02371980|540317658|FG004|Open-label Period|Significant Protocol Deviation|0|||
149779035|NCT02371980|540317654|FG000|Open-label Period|Noncompliance with Study Drug|10|||
149779036|NCT02371980|540317655|FG001|Open-label Period|Noncompliance with Study Drug|0|||
149779037|NCT02371980|540317656|FG002|Open-label Period|Noncompliance with Study Drug|0|||
149779038|NCT02371980|540317657|FG003|Open-label Period|Noncompliance with Study Drug|0|||
149779039|NCT02371980|540317658|FG004|Open-label Period|Noncompliance with Study Drug|0|||
149779040|NCT02371980|540317654|FG000|Open-label Period|Lost to Follow-up|55|||
149779041|NCT02371980|540317655|FG001|Open-label Period|Lost to Follow-up|0|||
149779042|NCT02371980|540317656|FG002|Open-label Period|Lost to Follow-up|0|||
149779043|NCT02371980|540317657|FG003|Open-label Period|Lost to Follow-up|0|||
149779044|NCT02371980|540317658|FG004|Open-label Period|Lost to Follow-up|0|||
149779045|NCT02371980|540317654|FG000|Open-label Period|Voluntary Withdrawal|91|||
149779046|NCT02371980|540317655|FG001|Open-label Period|Voluntary Withdrawal|0|||
149779047|NCT02371980|540317656|FG002|Open-label Period|Voluntary Withdrawal|0|||
149779048|NCT02371980|540317657|FG003|Open-label Period|Voluntary Withdrawal|0|||
149779049|NCT02371980|540317658|FG004|Open-label Period|Voluntary Withdrawal|0|||
149779050|NCT02371980|540317654|FG000|Open-label Period|Pregnancy|1|||
149779051|NCT02371980|540317655|FG001|Open-label Period|Pregnancy|0|||
149779052|NCT02371980|540317656|FG002|Open-label Period|Pregnancy|0|||
149779053|NCT02371980|540317657|FG003|Open-label Period|Pregnancy|0|||
149779054|NCT02371980|540317658|FG004|Open-label Period|Pregnancy|0|||
149779055|NCT02371980|540317654|FG000|Open-label Period|Lack of Efficacy|116|||
149779056|NCT02371980|540317655|FG001|Open-label Period|Lack of Efficacy|0|||
149779057|NCT02371980|540317656|FG002|Open-label Period|Lack of Efficacy|0|||
149779058|NCT02371980|540317657|FG003|Open-label Period|Lack of Efficacy|0|||
149779059|NCT02371980|540317658|FG004|Open-label Period|Lack of Efficacy|0|||
149779060|NCT02371980|540317654|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
149779061|NCT02371980|540317655|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
149779062|NCT02371980|540317656|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
149779063|NCT02371980|540317657|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
149779064|NCT02371980|540317658|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
149779065|NCT02371980|540317654|FG000|Open-label Period|Reason not Specified|9|||
149779066|NCT02371980|540317655|FG001|Open-label Period|Reason not Specified|0|||
149779067|NCT02371980|540317656|FG002|Open-label Period|Reason not Specified|0|||
149779068|NCT02371980|540317657|FG003|Open-label Period|Reason not Specified|0|||
149779069|NCT02371980|540317658|FG004|Open-label Period|Reason not Specified|0|||
149779070|NCT02371980|540317654|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
149779071|NCT02371980|540317655|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
149779072|NCT02371980|540317656|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
149779073|NCT02371980|540317657|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
149779074|NCT02371980|540317658|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
149779075|NCT02371980|540317654|FG000|Double-blind Period|Significant Protocol Deviation|0|||
149779076|NCT02371980|540317655|FG001|Double-blind Period|Significant Protocol Deviation|2|||
149779077|NCT02371980|540317656|FG002|Double-blind Period|Significant Protocol Deviation|7|||
149779078|NCT02371980|540317657|FG003|Double-blind Period|Significant Protocol Deviation|3|||
149779079|NCT02371980|540317658|FG004|Double-blind Period|Significant Protocol Deviation|3|||
149779080|NCT02371980|540317654|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
149779081|NCT02371980|540317655|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
149779082|NCT02371980|540317656|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
149779083|NCT02371980|540317657|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
149779084|NCT02371980|540317658|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
149779085|NCT02371980|540317654|FG000|Double-blind Period|Lost to Follow-up|0|||
149779086|NCT02371980|540317655|FG001|Double-blind Period|Lost to Follow-up|8|||
149779087|NCT02371980|540317656|FG002|Double-blind Period|Lost to Follow-up|8|||
149779088|NCT02371980|540317657|FG003|Double-blind Period|Lost to Follow-up|6|||
149779089|NCT02371980|540317658|FG004|Double-blind Period|Lost to Follow-up|5|||
149779090|NCT02371980|540317654|FG000|Double-blind Period|Voluntary Withdrawal|0|||
149779091|NCT02371980|540317655|FG001|Double-blind Period|Voluntary Withdrawal|12|||
149779092|NCT02371980|540317656|FG002|Double-blind Period|Voluntary Withdrawal|8|||
149779093|NCT02371980|540317657|FG003|Double-blind Period|Voluntary Withdrawal|9|||
149779094|NCT02371980|540317658|FG004|Double-blind Period|Voluntary Withdrawal|11|||
149779095|NCT02371980|540317654|FG000|Double-blind Period|Relapse|0|||
149779096|NCT02371980|540317655|FG001|Double-blind Period|Relapse|50|||
149779097|NCT02371980|540317656|FG002|Double-blind Period|Relapse|25|||
149779098|NCT02371980|540317657|FG003|Double-blind Period|Relapse|25|||
149779099|NCT02371980|540317658|FG004|Double-blind Period|Relapse|26|||
149779100|NCT02371980|540317654|FG000|Double-blind Period|Reason not Specified|0|||
149779101|NCT02371980|540317655|FG001|Double-blind Period|Reason not Specified|3|||
149779102|NCT02371980|540317656|FG002|Double-blind Period|Reason not Specified|3|||
149779103|NCT02371980|540317657|FG003|Double-blind Period|Reason not Specified|2|||
149779104|NCT02371980|540317658|FG004|Double-blind Period|Reason not Specified|1|||
149779105|NCT02371980|540317654|FG000|Double-blind Period|Missing|0|||
149779106|NCT02371980|540317655|FG001|Double-blind Period|Missing|1|||
149779107|NCT02371980|540317656|FG002|Double-blind Period|Missing|0|||
149779108|NCT02371980|540317657|FG003|Double-blind Period|Missing|0|||
149779109|NCT02371980|540317658|FG004|Double-blind Period|Missing|0|||
149779110|NCT00959894|540317662|FG000|Overall Study|Lost to Follow-up|10|||
149779111|NCT00959894|540317662|FG000|Overall Study|Adverse Event|3|||
149779112|NCT00959894|540317662|FG000|Overall Study|Withdrawal by Subject|1|||
149779113|NCT00959894|540317662|FG000|Overall Study|Need for contraindicated medication|1|||
149779114|NCT00959894|540317662|FG000|Overall Study|Subject moved out of town|1|||
149779115|NCT00922974|540317663|FG000|Phase II Component|Protocol Violation|2|||
149779116|NCT00922974|540317664|FG001|Phase II Component|Protocol Violation|0|||
149779117|NCT00922974|540317663|FG000|Phase II Component|Not evaluable for treatment review|5|||
149779118|NCT00922974|540317664|FG001|Phase II Component|Not evaluable for treatment review|0|||
149779119|NCT00922974|540317663|FG000|Phase III Component|Protocol Violation|8|||
149779120|NCT00922974|540317664|FG001|Phase III Component|Protocol Violation|6|||
149779121|NCT00323310|540317665|FG000|Overall Study|Withdrawal by Subject|1|||
149779122|NCT00323310|540317665|FG000|Overall Study|a parent refused blood draw|1|||
149779123|NCT00323310|540317665|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
149779124|NCT00446641|540317666|FG000|Overall Study|Withdrawal by Subject|8|||
149779125|NCT00446641|540317667|FG001|Overall Study|Withdrawal by Subject|3|||
149779126|NCT00446641|540317666|FG000|Overall Study|poor compliance|8|||
149779127|NCT00446641|540317667|FG001|Overall Study|poor compliance|6|||
149779128|NCT00446641|540317666|FG000|Overall Study|Lost to Follow-up|1|||
149779129|NCT00446641|540317667|FG001|Overall Study|Lost to Follow-up|1|||
149779130|NCT03565991|540317669|FG000|Overall Study|Other|11|||
149779131|NCT03565991|540317670|FG001|Overall Study|Other|0|||
149779132|NCT03565991|540317669|FG000|Overall Study|Global deterioration of health status|14|||
149779133|NCT03565991|540317670|FG001|Overall Study|Global deterioration of health status|4|||
149779134|NCT03565991|540317669|FG000|Overall Study|Withdrawal by Subject|2|||
149779135|NCT03565991|540317670|FG001|Overall Study|Withdrawal by Subject|6|||
149779136|NCT03565991|540317669|FG000|Overall Study|Progressive disease|121|||
149779137|NCT03565991|540317670|FG001|Overall Study|Progressive disease|29|||
149779138|NCT03565991|540317669|FG000|Overall Study|Death|3|||
149779139|NCT03565991|540317670|FG001|Overall Study|Death|0|||
149779140|NCT03565991|540317669|FG000|Overall Study|Adverse Event|7|||
149779141|NCT03565991|540317670|FG001|Overall Study|Adverse Event|2|||
149779142|NCT00086385|540317673|FG000|Overall Study|Death|2|||
149779143|NCT00086385|540317674|FG001|Overall Study|Death|2|||
149779144|NCT00086385|540317675|FG002|Overall Study|Death|1|||
149779145|NCT00086385|540317676|FG003|Overall Study|Death|1|||
149779146|NCT01376388|540317683|FG000|Overall Study|Adverse Event|13|||
149779147|NCT01376388|540317683|FG000|Overall Study|Lack of Efficacy|2|||
149779148|NCT01376388|540317683|FG000|Overall Study|Withdrawal by Subject|3|||
149779149|NCT02009930|540317691|FG000|Overall Study|withdrawn|5|||
149779150|NCT02471586|540317702|FG000|Overall Study|Lost to Follow-up|3|||
149779151|NCT02471586|540317703|FG001|Overall Study|Lost to Follow-up|8|||
149779152|NCT02471586|540317704|FG002|Overall Study|Lost to Follow-up|4|||
149779153|NCT02471586|540317702|FG000|Overall Study|Death|2|||
149779154|NCT02471586|540317703|FG001|Overall Study|Death|2|||
149779155|NCT02471586|540317704|FG002|Overall Study|Death|0|||
149779156|NCT03235726|540317710|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779157|NCT03235726|540317711|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779158|NCT03235726|540317712|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779159|NCT03235726|540317713|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779160|NCT03235726|540317714|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
149779161|NCT03235726|540317715|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779162|NCT03235726|540317716|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779163|NCT03235726|540317717|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779164|NCT03235726|540317718|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779165|NCT03235726|540317719|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149779166|NCT03235726|540317710|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779167|NCT03235726|540317711|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779168|NCT03235726|540317712|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779169|NCT03235726|540317713|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779170|NCT03235726|540317714|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
149779171|NCT03235726|540317715|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779172|NCT03235726|540317716|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779173|NCT03235726|540317717|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779174|NCT03235726|540317718|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779175|NCT03235726|540317719|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149779176|NCT00563368|540317720|FG000|Overall Study|Lost to Follow-up|14|||
149779177|NCT00563368|540317721|FG001|Overall Study|Lost to Follow-up|14|||
149779178|NCT00563368|540317722|FG002|Overall Study|Lost to Follow-up|12|||
149779179|NCT00563368|540317723|FG003|Overall Study|Lost to Follow-up|6|||
149779180|NCT00563368|540317724|FG004|Overall Study|Lost to Follow-up|9|||
149779181|NCT00563368|540317725|FG005|Overall Study|Lost to Follow-up|8|||
149779182|NCT00563368|540317726|FG006|Overall Study|Lost to Follow-up|9|||
149779183|NCT00563368|540317720|FG000|Overall Study|Adverse Event|3|||
149779184|NCT00563368|540317721|FG001|Overall Study|Adverse Event|4|||
149779185|NCT00563368|540317722|FG002|Overall Study|Adverse Event|5|||
149779186|NCT00563368|540317723|FG003|Overall Study|Adverse Event|9|||
149779187|NCT00563368|540317724|FG004|Overall Study|Adverse Event|6|||
149779188|NCT00563368|540317725|FG005|Overall Study|Adverse Event|10|||
149779189|NCT00563368|540317726|FG006|Overall Study|Adverse Event|17|||
149779190|NCT00563368|540317720|FG000|Overall Study|Withdrawal by Subject|11|||
149779191|NCT00563368|540317721|FG001|Overall Study|Withdrawal by Subject|6|||
149779192|NCT00563368|540317722|FG002|Overall Study|Withdrawal by Subject|5|||
149779193|NCT00563368|540317723|FG003|Overall Study|Withdrawal by Subject|7|||
149779194|NCT00563368|540317724|FG004|Overall Study|Withdrawal by Subject|8|||
149779195|NCT00563368|540317725|FG005|Overall Study|Withdrawal by Subject|5|||
149779196|NCT00563368|540317726|FG006|Overall Study|Withdrawal by Subject|4|||
149779197|NCT00563368|540317720|FG000|Overall Study|protocol non-compliance|1|||
149779198|NCT00563368|540317721|FG001|Overall Study|protocol non-compliance|1|||
149779199|NCT00563368|540317722|FG002|Overall Study|protocol non-compliance|2|||
149779200|NCT00563368|540317723|FG003|Overall Study|protocol non-compliance|1|||
149779201|NCT00563368|540317724|FG004|Overall Study|protocol non-compliance|0|||
149779202|NCT00563368|540317725|FG005|Overall Study|protocol non-compliance|1|||
149779203|NCT00563368|540317726|FG006|Overall Study|protocol non-compliance|3|||
149779204|NCT00563368|540317720|FG000|Overall Study|Pregnancy|1|||
149779205|NCT00563368|540317721|FG001|Overall Study|Pregnancy|0|||
149779206|NCT00563368|540317722|FG002|Overall Study|Pregnancy|1|||
149779207|NCT00563368|540317723|FG003|Overall Study|Pregnancy|2|||
149779208|NCT00563368|540317724|FG004|Overall Study|Pregnancy|1|||
149779209|NCT00563368|540317725|FG005|Overall Study|Pregnancy|2|||
149779210|NCT00563368|540317726|FG006|Overall Study|Pregnancy|0|||
149779211|NCT00563368|540317720|FG000|Overall Study|requirement for restricted medication|0|||
149779212|NCT00563368|540317721|FG001|Overall Study|requirement for restricted medication|0|||
149779213|NCT00563368|540317722|FG002|Overall Study|requirement for restricted medication|2|||
149779214|NCT00563368|540317723|FG003|Overall Study|requirement for restricted medication|0|||
149779215|NCT00563368|540317724|FG004|Overall Study|requirement for restricted medication|0|||
149779216|NCT00563368|540317725|FG005|Overall Study|requirement for restricted medication|0|||
149779217|NCT00563368|540317726|FG006|Overall Study|requirement for restricted medication|0|||
149779218|NCT00563368|540317720|FG000|Overall Study|Other|5|||
149779219|NCT00563368|540317721|FG001|Overall Study|Other|5|||
149779220|NCT00563368|540317722|FG002|Overall Study|Other|3|||
149779221|NCT00563368|540317723|FG003|Overall Study|Other|4|||
149779222|NCT00563368|540317724|FG004|Overall Study|Other|4|||
149779223|NCT00563368|540317725|FG005|Overall Study|Other|4|||
149779224|NCT00563368|540317726|FG006|Overall Study|Other|0|||
149779225|NCT00114218|540317735|FG000|Overall Study|Wrong Cell Type|2|||
149779226|NCT00114218|540317735|FG000|Overall Study|Wrong Primary|1|||
149779227|NCT00114218|540317735|FG000|Overall Study|Never Treated|1|||
149779228|NCT01505114|540317737|FG000|Overall Study|Withdrawal by Subject|5|||
149779229|NCT01505114|540317738|FG001|Overall Study|Withdrawal by Subject|4|||
149779230|NCT01505114|540317739|FG002|Overall Study|Withdrawal by Subject|4|||
149779231|NCT01505114|540317740|FG003|Overall Study|Withdrawal by Subject|7|||
149779232|NCT01505114|540317737|FG000|Overall Study|Death|1|||
149779233|NCT01505114|540317738|FG001|Overall Study|Death|0|||
149779234|NCT01505114|540317739|FG002|Overall Study|Death|0|||
149779235|NCT01505114|540317740|FG003|Overall Study|Death|1|||
149779236|NCT01505114|540317737|FG000|Overall Study|unable to adhere to visit schedule|3|||
149779237|NCT01505114|540317738|FG001|Overall Study|unable to adhere to visit schedule|2|||
149801788|NCT04338685|540402443|FG005|Overall Study|Death|8|||
149779238|NCT01505114|540317739|FG002|Overall Study|unable to adhere to visit schedule|3|||
149779239|NCT01505114|540317740|FG003|Overall Study|unable to adhere to visit schedule|3|||
149779240|NCT01505114|540317737|FG000|Overall Study|Lost to Follow-up|11|||
149779241|NCT01505114|540317738|FG001|Overall Study|Lost to Follow-up|5|||
149779242|NCT01505114|540317739|FG002|Overall Study|Lost to Follow-up|8|||
149779243|NCT01505114|540317740|FG003|Overall Study|Lost to Follow-up|7|||
149779244|NCT01505114|540317737|FG000|Overall Study|relocated|4|||
149779245|NCT01505114|540317738|FG001|Overall Study|relocated|2|||
149779246|NCT01505114|540317739|FG002|Overall Study|relocated|2|||
149779247|NCT01505114|540317740|FG003|Overall Study|relocated|3|||
149779248|NCT01505114|540317737|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
149779249|NCT01505114|540317738|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
149779250|NCT01505114|540317739|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
149779251|NCT01505114|540317740|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
149779252|NCT01505114|540317737|FG000|Overall Study|staff safety concerns|0|||
149779253|NCT01505114|540317738|FG001|Overall Study|staff safety concerns|0|||
149779254|NCT01505114|540317739|FG002|Overall Study|staff safety concerns|0|||
149779255|NCT01505114|540317740|FG003|Overall Study|staff safety concerns|1|||
149779256|NCT01505114|540317737|FG000|Overall Study|investigator decision|1|||
149779257|NCT01505114|540317738|FG001|Overall Study|investigator decision|0|||
149779258|NCT01505114|540317739|FG002|Overall Study|investigator decision|1|||
149779259|NCT01505114|540317740|FG003|Overall Study|investigator decision|0|||
149779260|NCT03168555|540317741|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
149779261|NCT03168555|540317741|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
149779262|NCT03168555|540317741|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
149779263|NCT03168555|540317741|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
149779264|NCT01000025|540317749|FG000|Overall Study|Adverse Event|43|||
149779265|NCT01000025|540317750|FG001|Overall Study|Adverse Event|2|||
149779266|NCT01000025|540317749|FG000|Overall Study|Withdrawal by Subject|13|||
149779267|NCT01000025|540317750|FG001|Overall Study|Withdrawal by Subject|8|||
149779268|NCT01000025|540317749|FG000|Overall Study|Death|23|||
149779269|NCT01000025|540317750|FG001|Overall Study|Death|13|||
149779270|NCT01000025|540317749|FG000|Overall Study|Lack of Efficacy|363|||
149779271|NCT01000025|540317750|FG001|Overall Study|Lack of Efficacy|208|||
149779272|NCT01000025|540317749|FG000|Overall Study|Intercurrent Illness|26|||
149779273|NCT01000025|540317750|FG001|Overall Study|Intercurrent Illness|7|||
149779274|NCT04423757|540317751|FG000|Overall Study|Adverse Event|2|||
149779275|NCT04423757|540317752|FG001|Overall Study|Adverse Event|0|||
149779276|NCT04423757|540317751|FG000|Overall Study|Not treated|1|||
149779277|NCT04423757|540317752|FG001|Overall Study|Not treated|1|||
149779278|NCT02738580|540317753|FG000|Overall Study|Adverse Event|1|||
149779279|NCT02738580|540317754|FG001|Overall Study|Adverse Event|0|||
149779280|NCT02738580|540317753|FG000|Overall Study|Lack of Efficacy|3|||
149779281|NCT02738580|540317754|FG001|Overall Study|Lack of Efficacy|2|||
149779282|NCT02738580|540317753|FG000|Overall Study|Withdrawal by Subject|0|||
149779283|NCT02738580|540317754|FG001|Overall Study|Withdrawal by Subject|1|||
149779284|NCT02738580|540317753|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
149779285|NCT02738580|540317754|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
149779286|NCT01250756|540317757|FG000|Infant Series|Withdrawal by Subject|4|||
149779287|NCT01250756|540317758|FG001|Infant Series|Withdrawal by Subject|5|||
149779288|NCT01250756|540317757|FG000|Infant Series|Randomized, Not Vaccinated|2|||
149779289|NCT01250756|540317758|FG001|Infant Series|Randomized, Not Vaccinated|2|||
149779290|NCT01250756|540317757|FG000|Infant Series|Other|22|||
149779291|NCT01250756|540317758|FG001|Infant Series|Other|0|||
149779292|NCT01250756|540317757|FG000|After Infant Series|Adverse Event|5|||
149779293|NCT01250756|540317758|FG001|After Infant Series|Adverse Event|2|||
149779294|NCT01250756|540317757|FG000|After Infant Series|Withdrawal by Subject|4|||
149779295|NCT01250756|540317758|FG001|After Infant Series|Withdrawal by Subject|1|||
149779296|NCT01250756|540317757|FG000|After Infant Series|Other|2|||
149779297|NCT01250756|540317758|FG001|After Infant Series|Other|1|||
149779298|NCT01250756|540317757|FG000|Toddler Dose|Adverse Event|0|||
149779299|NCT01250756|540317758|FG001|Toddler Dose|Adverse Event|1|||
149779300|NCT01250756|540317757|FG000|After Toddler Dose|Adverse Event|0|||
149779301|NCT01250756|540317758|FG001|After Toddler Dose|Adverse Event|1|||
149779302|NCT02999100|540317759|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
149779303|NCT02999100|540317760|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
149779304|NCT02999100|540317761|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
149779305|NCT02999100|540317762|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
149779306|NCT02999100|540317763|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
149779307|NCT02999100|540317764|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
149779308|NCT02999100|540317759|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149779309|NCT02999100|540317760|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149779310|NCT02999100|540317761|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149779311|NCT02999100|540317762|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149779312|NCT02999100|540317763|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149779313|NCT02999100|540317764|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
149779314|NCT02999100|540317759|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149779315|NCT02999100|540317760|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149779316|NCT02999100|540317761|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
149779317|NCT02999100|540317762|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149779318|NCT02999100|540317763|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149779319|NCT02999100|540317764|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149779320|NCT00293241|540317765|FG000|Overall Study|Lost to Follow-up|9|||
149779321|NCT00293241|540317766|FG001|Overall Study|Lost to Follow-up|16|||
149779322|NCT00293241|540317765|FG000|Overall Study|Physician Decision|23|||
149779323|NCT00293241|540317766|FG001|Overall Study|Physician Decision|17|||
149779324|NCT00293241|540317765|FG000|Overall Study|Withdrawal by Subject|4|||
149779325|NCT00293241|540317766|FG001|Overall Study|Withdrawal by Subject|8|||
149779326|NCT03803202|540317767|FG000|Overall Study|Other|0|||
149779327|NCT03803202|540317768|FG001|Overall Study|Other|1|||
149779328|NCT03803202|540317769|FG002|Overall Study|Other|0|||
149779329|NCT03803202|540317770|FG003|Overall Study|Other|0|||
149779330|NCT03803202|540317771|FG004|Overall Study|Other|0|||
149779331|NCT03803202|540317772|FG005|Overall Study|Other|0|||
149779332|NCT03803202|540317773|FG006|Overall Study|Other|0|||
149779333|NCT03803202|540317774|FG007|Overall Study|Other|0|||
149779334|NCT03803202|540317775|FG008|Overall Study|Other|0|||
149779335|NCT03803202|540317767|FG000|Overall Study|Death|0|||
149779336|NCT03803202|540317768|FG001|Overall Study|Death|0|||
149779337|NCT03803202|540317769|FG002|Overall Study|Death|0|||
149779338|NCT03803202|540317770|FG003|Overall Study|Death|0|||
149779339|NCT03803202|540317771|FG004|Overall Study|Death|0|||
149779340|NCT03803202|540317772|FG005|Overall Study|Death|1|||
149779341|NCT03803202|540317773|FG006|Overall Study|Death|0|||
149779342|NCT03803202|540317774|FG007|Overall Study|Death|0|||
149779343|NCT03803202|540317775|FG008|Overall Study|Death|0|||
149779344|NCT03803202|540317767|FG000|Overall Study|Withdrawal by Subject|0|||
149779345|NCT03803202|540317768|FG001|Overall Study|Withdrawal by Subject|0|||
149779346|NCT03803202|540317769|FG002|Overall Study|Withdrawal by Subject|1|||
149779347|NCT03803202|540317770|FG003|Overall Study|Withdrawal by Subject|0|||
149779348|NCT03803202|540317771|FG004|Overall Study|Withdrawal by Subject|0|||
149779349|NCT03803202|540317772|FG005|Overall Study|Withdrawal by Subject|0|||
149779350|NCT03803202|540317773|FG006|Overall Study|Withdrawal by Subject|0|||
149779351|NCT03803202|540317774|FG007|Overall Study|Withdrawal by Subject|1|||
149779352|NCT03803202|540317775|FG008|Overall Study|Withdrawal by Subject|0|||
149779353|NCT03803202|540317767|FG000|Overall Study|Lost to Follow-up|0|||
149779354|NCT03803202|540317768|FG001|Overall Study|Lost to Follow-up|0|||
149779355|NCT03803202|540317769|FG002|Overall Study|Lost to Follow-up|0|||
149779356|NCT03803202|540317770|FG003|Overall Study|Lost to Follow-up|1|||
149779357|NCT03803202|540317771|FG004|Overall Study|Lost to Follow-up|1|||
149779358|NCT03803202|540317772|FG005|Overall Study|Lost to Follow-up|0|||
149779359|NCT03803202|540317773|FG006|Overall Study|Lost to Follow-up|1|||
149779360|NCT03803202|540317774|FG007|Overall Study|Lost to Follow-up|0|||
149779361|NCT03803202|540317775|FG008|Overall Study|Lost to Follow-up|0|||
149779362|NCT03595384|540317776|FG000|Overall Study|Other time commitments|8|||
149779363|NCT03595384|540317776|FG000|Overall Study|Changes to session time|7|||
149779364|NCT03595384|540317776|FG000|Overall Study|Relocation out of country|1|||
149779365|NCT01270958|540317780|FG000|Overall Study|Lost to Follow-up|2|||
149779366|NCT01270958|540317780|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
149779367|NCT02142504|540317781|FG000|Overall Study|Protocol Violation|2|||
149779368|NCT02142504|540317782|FG001|Overall Study|Protocol Violation|1|||
149779369|NCT02142504|540317783|FG002|Overall Study|Protocol Violation|2|||
149779370|NCT02142504|540317781|FG000|Overall Study|Adverse Event|2|||
149779371|NCT02142504|540317782|FG001|Overall Study|Adverse Event|3|||
149779372|NCT02142504|540317783|FG002|Overall Study|Adverse Event|4|||
149779373|NCT02142504|540317781|FG000|Overall Study|Lost to Follow-up|12|||
149779374|NCT02142504|540317782|FG001|Overall Study|Lost to Follow-up|19|||
149779375|NCT02142504|540317783|FG002|Overall Study|Lost to Follow-up|17|||
149779376|NCT02142504|540317781|FG000|Overall Study|Withdrawal by Subject|7|||
149779377|NCT02142504|540317782|FG001|Overall Study|Withdrawal by Subject|9|||
149779378|NCT02142504|540317783|FG002|Overall Study|Withdrawal by Subject|11|||
149779379|NCT02142504|540317781|FG000|Overall Study|Pregnancy|4|||
149779380|NCT02142504|540317782|FG001|Overall Study|Pregnancy|4|||
149779381|NCT02142504|540317783|FG002|Overall Study|Pregnancy|2|||
149779382|NCT02142504|540317781|FG000|Overall Study|Physician Decision|0|||
149779383|NCT02142504|540317782|FG001|Overall Study|Physician Decision|1|||
149779384|NCT02142504|540317783|FG002|Overall Study|Physician Decision|3|||
149779385|NCT02142504|540317781|FG000|Overall Study|Reason Not Specified|4|||
149779386|NCT02142504|540317782|FG001|Overall Study|Reason Not Specified|5|||
149779387|NCT02142504|540317783|FG002|Overall Study|Reason Not Specified|4|||
149779388|NCT00617591|540317785|FG000|Overall Study|Withdrew consent during Induction|4|||
149779389|NCT00617591|540317785|FG000|Overall Study|Withdrew consent during Maintenance|6|||
149779390|NCT04114539|540317786|FG000|Overall Study|Adverse Event|14|||
149779391|NCT04114539|540317786|FG000|Overall Study|Lost to Follow-up|2|||
149779392|NCT04114539|540317786|FG000|Overall Study|Non-compliance with Protocol|2|||
149779393|NCT04114539|540317786|FG000|Overall Study|Non-compliance with Study Drug|1|||
149779394|NCT04114539|540317786|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
149779395|NCT04114539|540317786|FG000|Overall Study|Withdrew consent|10|||
149779396|NCT04114539|540317786|FG000|Overall Study|Others not specified|5|||
149779397|NCT04114539|540317786|FG000|Overall Study|Investigator Decision|2|||
149779398|NCT03094611|540317792|FG000|Overall Study|Lack of Efficacy|1|||
149779399|NCT03094611|540317792|FG000|Overall Study|Stem Cell Transplant|1|||
149779400|NCT02186561|540317793|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
149779401|NCT02186561|540317793|FG000|Enrollment|Enrollment Cap Reached|5|||
149779402|NCT02186561|540317793|FG000|Enrollment|Insurance Denial|2|||
149779403|NCT02186561|540317793|FG000|Enrollment|Withdrawal by Subject|2|||
149779404|NCT02186561|540317793|FG000|Enrollment|Investigator Withdrew Consent|1|||
149779405|NCT02186561|540317793|FG000|30-Day Post Index Procedure Visit|Death|1|||
149779406|NCT02186561|540317793|FG000|1- Year Post Index Procedure Visit|Death|1|||
149779407|NCT02186561|540317793|FG000|1- Year Post Index Procedure Visit|Missed|1|||
149779408|NCT04285853|540317794|FG000|Overall Study|Withdrawal by Subject|1|||
149779409|NCT04285853|540317795|FG001|Overall Study|Withdrawal by Subject|0|||
149779410|NCT04285853|540317794|FG000|Overall Study|Lost to Follow-up|9|||
149779411|NCT04285853|540317795|FG001|Overall Study|Lost to Follow-up|5|||
149779412|NCT02460978|540317798|FG000|Overall Study|Adverse Event|17|||
149779413|NCT02460978|540317799|FG001|Overall Study|Adverse Event|11|||
149779414|NCT02460978|540317800|FG002|Overall Study|Adverse Event|11|||
149779415|NCT02460978|540317798|FG000|Overall Study|Withdrawal by Subject|5|||
149779416|NCT02460978|540317799|FG001|Overall Study|Withdrawal by Subject|5|||
149779417|NCT02460978|540317800|FG002|Overall Study|Withdrawal by Subject|14|||
149779418|NCT02460978|540317798|FG000|Overall Study|Lost to Follow-up|2|||
149779419|NCT02460978|540317799|FG001|Overall Study|Lost to Follow-up|3|||
149779420|NCT02460978|540317800|FG002|Overall Study|Lost to Follow-up|1|||
149779421|NCT02460978|540317798|FG000|Overall Study|Protocol Violation|1|||
149779422|NCT02460978|540317799|FG001|Overall Study|Protocol Violation|1|||
149779423|NCT02460978|540317800|FG002|Overall Study|Protocol Violation|1|||
149779424|NCT02460978|540317798|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
149779425|NCT02460978|540317799|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
149779426|NCT02460978|540317800|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
149779427|NCT02460978|540317798|FG000|Overall Study|Pregnancy|0|||
149779428|NCT02460978|540317799|FG001|Overall Study|Pregnancy|0|||
149779429|NCT02460978|540317800|FG002|Overall Study|Pregnancy|2|||
149779430|NCT00588523|540317804|FG000|Overall Study|Not treated|3|||
149779431|NCT01459068|540317805|FG000|Overall Study|Withdrawal by Subject|8|||
149779432|NCT01459068|540317806|FG001|Overall Study|Withdrawal by Subject|18|||
149779433|NCT01459068|540317805|FG000|Overall Study|Lost to Follow-up|31|||
149779434|NCT01459068|540317806|FG001|Overall Study|Lost to Follow-up|15|||
149779435|NCT01459068|540317805|FG000|Overall Study|Death|0|||
149779436|NCT01459068|540317806|FG001|Overall Study|Death|1|||
149779437|NCT02023112|540317811|FG000|Overall Study|Withdrawal by Subject|2|||
149779438|NCT02023112|540317812|FG001|Overall Study|Withdrawal by Subject|1|||
149779439|NCT00701441|540317813|FG000|Overall Study|failure in cpap compliance|0|||
149779440|NCT00701441|540317814|FG001|Overall Study|failure in cpap compliance|4|||
149779441|NCT03693404|540317825|FG000|Overall Study|Withdrawal by Subject|1|||
149779442|NCT03693404|540317826|FG001|Overall Study|Withdrawal by Subject|0|||
149779443|NCT03693404|540317825|FG000|Overall Study|Lost to Follow-up|0|||
149779444|NCT03693404|540317826|FG001|Overall Study|Lost to Follow-up|5|||
149779445|NCT03693404|540317825|FG000|Overall Study|Excluded from Analysis|0|||
149779446|NCT03693404|540317826|FG001|Overall Study|Excluded from Analysis|1|||
149779447|NCT01576406|540317827|FG000|Overall Study|Lost to Follow-up|1|||
149779448|NCT01576406|540317828|FG001|Overall Study|Lost to Follow-up|2|||
149779449|NCT01576406|540317829|FG002|Overall Study|Lost to Follow-up|0|||
149779450|NCT01576406|540317830|FG003|Overall Study|Lost to Follow-up|0|||
149779451|NCT01576406|540317831|FG004|Overall Study|Lost to Follow-up|0|||
149779452|NCT01576406|540317832|FG005|Overall Study|Lost to Follow-up|0|||
149779453|NCT01576406|540317827|FG000|Overall Study|Death|3|||
149779454|NCT01576406|540317828|FG001|Overall Study|Death|4|||
149779455|NCT01576406|540317829|FG002|Overall Study|Death|8|||
149779456|NCT01576406|540317830|FG003|Overall Study|Death|5|||
149779457|NCT01576406|540317831|FG004|Overall Study|Death|7|||
149779458|NCT01576406|540317832|FG005|Overall Study|Death|9|||
149779459|NCT01576406|540317827|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149779460|NCT01576406|540317828|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149779461|NCT01576406|540317829|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
149779462|NCT01576406|540317830|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
149779463|NCT01576406|540317831|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149779464|NCT01576406|540317832|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149779465|NCT01576406|540317827|FG000|Overall Study|Withdrawal the consent|2|||
149779466|NCT01576406|540317828|FG001|Overall Study|Withdrawal the consent|2|||
149779467|NCT01576406|540317829|FG002|Overall Study|Withdrawal the consent|5|||
149779468|NCT01576406|540317830|FG003|Overall Study|Withdrawal the consent|1|||
149779469|NCT01576406|540317831|FG004|Overall Study|Withdrawal the consent|1|||
149779470|NCT01576406|540317832|FG005|Overall Study|Withdrawal the consent|3|||
149779471|NCT01576406|540317827|FG000|Overall Study|Other|0|||
149779472|NCT01576406|540317828|FG001|Overall Study|Other|0|||
149779473|NCT01576406|540317829|FG002|Overall Study|Other|2|||
149779474|NCT01576406|540317830|FG003|Overall Study|Other|2|||
149779475|NCT01576406|540317831|FG004|Overall Study|Other|0|||
149779476|NCT01576406|540317832|FG005|Overall Study|Other|0|||
149779477|NCT00651313|540317833|FG000|Overall Study|Adverse Event|0|||
149779478|NCT00651313|540317834|FG001|Overall Study|Adverse Event|1|||
149779479|NCT00651313|540317833|FG000|Overall Study|Withdrawal by Subject|3|||
149779480|NCT00651313|540317834|FG001|Overall Study|Withdrawal by Subject|1|||
149779481|NCT00651313|540317833|FG000|Overall Study|Lost to Follow-up|1|||
149779482|NCT00651313|540317834|FG001|Overall Study|Lost to Follow-up|1|||
149779483|NCT00651313|540317833|FG000|Overall Study|Adminstrative Discontinuation|2|||
149779484|NCT00651313|540317834|FG001|Overall Study|Adminstrative Discontinuation|3|||
149779485|NCT00892957|540317836|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
149779486|NCT00892957|540317837|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
149779487|NCT00892957|540317836|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
149779488|NCT00892957|540317837|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
149779489|NCT00669032|540317845|FG000|Overall Study|Lost to Follow-up|6|||
149779490|NCT00669032|540317846|FG001|Overall Study|Lost to Follow-up|5|||
149779491|NCT00669032|540317845|FG000|Overall Study|Lack of Efficacy|8|||
149779492|NCT00669032|540317846|FG001|Overall Study|Lack of Efficacy|19|||
149779493|NCT00669032|540317845|FG000|Overall Study|Withdrawal by Subject|12|||
149779494|NCT00669032|540317846|FG001|Overall Study|Withdrawal by Subject|13|||
149779495|NCT00669032|540317845|FG000|Overall Study|Adverse Event|12|||
149779496|NCT00669032|540317846|FG001|Overall Study|Adverse Event|16|||
149779497|NCT00669032|540317845|FG000|Overall Study|Physician Decision|1|||
149779498|NCT00669032|540317846|FG001|Overall Study|Physician Decision|1|||
149779499|NCT00669032|540317845|FG000|Overall Study|No fulfilment of the selection criteria|5|||
149779500|NCT00669032|540317846|FG001|Overall Study|No fulfilment of the selection criteria|5|||
149779501|NCT00642018|540317847|FG000|Overall Study|Adverse Event|11|||
149779502|NCT00642018|540317848|FG001|Overall Study|Adverse Event|36|||
149779503|NCT00642018|540317847|FG000|Overall Study|Withdrawal by Subject|4|||
149779504|NCT00642018|540317848|FG001|Overall Study|Withdrawal by Subject|10|||
149779505|NCT00642018|540317847|FG000|Overall Study|Progressive Disease|13|||
149779506|NCT00642018|540317848|FG001|Overall Study|Progressive Disease|18|||
149779507|NCT00642018|540317847|FG000|Overall Study|Physician Decision|0|||
149779508|NCT00642018|540317848|FG001|Overall Study|Physician Decision|10|||
149779509|NCT00642018|540317847|FG000|Overall Study|Protocol Violation|0|||
149779510|NCT00642018|540317848|FG001|Overall Study|Protocol Violation|1|||
149779511|NCT00642018|540317847|FG000|Overall Study|Death|0|||
149779512|NCT00642018|540317848|FG001|Overall Study|Death|3|||
149779513|NCT00642018|540317847|FG000|Overall Study|Entry Criteria Not Met|0|||
149779514|NCT00642018|540317848|FG001|Overall Study|Entry Criteria Not Met|1|||
149779515|NCT01607073|540317849|FG000|Overall Study|Adverse Event|1|||
149779516|NCT01410799|540317850|FG000|Overall Study|PI decision|13|||
149779517|NCT04126031|540317852|FG000|Part A|Withdrawal by Subject|0|||
149779518|NCT04126031|540317853|FG001|Part A|Withdrawal by Subject|0|||
149779519|NCT04126031|540317854|FG002|Part A|Withdrawal by Subject|1|||
149779520|NCT04126031|540317855|FG003|Part A|Withdrawal by Subject|0|||
149779521|NCT04126031|540317856|FG004|Part A|Withdrawal by Subject|0|||
149779522|NCT04126031|540317857|FG005|Part A|Withdrawal by Subject|0|||
149779523|NCT04126031|540317852|FG000|Part A|Other|1|||
149779524|NCT04126031|540317853|FG001|Part A|Other|0|||
149779525|NCT04126031|540317854|FG002|Part A|Other|0|||
149779526|NCT04126031|540317855|FG003|Part A|Other|0|||
149779527|NCT04126031|540317856|FG004|Part A|Other|0|||
149779528|NCT04126031|540317857|FG005|Part A|Other|0|||
149779529|NCT04126031|540317852|FG000|Part B|Adverse Event|0|||
149779530|NCT04126031|540317853|FG001|Part B|Adverse Event|0|||
149779531|NCT04126031|540317854|FG002|Part B|Adverse Event|0|||
149779532|NCT04126031|540317855|FG003|Part B|Adverse Event|0|||
149779533|NCT04126031|540317856|FG004|Part B|Adverse Event|0|||
149779534|NCT04126031|540317857|FG005|Part B|Adverse Event|2|||
149779535|NCT04126031|540317852|FG000|Part B|Pre-existing hypertransaminasemia|0|||
149779536|NCT04126031|540317853|FG001|Part B|Pre-existing hypertransaminasemia|0|||
149779537|NCT04126031|540317854|FG002|Part B|Pre-existing hypertransaminasemia|0|||
149779538|NCT04126031|540317855|FG003|Part B|Pre-existing hypertransaminasemia|0|||
149779539|NCT04126031|540317856|FG004|Part B|Pre-existing hypertransaminasemia|1|||
149779540|NCT04126031|540317857|FG005|Part B|Pre-existing hypertransaminasemia|0|||
149779541|NCT00617656|540317858|FG000|Overall Study|Inclusion error|4|||
149779542|NCT00617656|540317859|FG001|Overall Study|Inclusion error|4|||
149779543|NCT00617656|540317860|FG002|Overall Study|Inclusion error|0|||
149779544|NCT00617656|540317861|FG003|Overall Study|Inclusion error|0|||
149779545|NCT00617656|540317858|FG000|Overall Study|Missing data|44|||
149779546|NCT00617656|540317859|FG001|Overall Study|Missing data|30|||
149779547|NCT00617656|540317860|FG002|Overall Study|Missing data|13|||
149779548|NCT00617656|540317861|FG003|Overall Study|Missing data|6|||
149779549|NCT00617656|540317858|FG000|Overall Study|Withdrawal by Subject|0|||
149779550|NCT00617656|540317859|FG001|Overall Study|Withdrawal by Subject|2|||
149779551|NCT00617656|540317860|FG002|Overall Study|Withdrawal by Subject|0|||
149779552|NCT00617656|540317861|FG003|Overall Study|Withdrawal by Subject|0|||
149779553|NCT01946412|540317862|FG000|Overall Study|Adverse Event|1|||
149779554|NCT01946412|540317862|FG000|Overall Study|Non-Compliance|1|||
149779555|NCT01946412|540317862|FG000|Overall Study|Continued with commercial Kalydeco|2|||
149779556|NCT01946412|540317862|FG000|Overall Study|Difficulty in swallowing|1|||
149779557|NCT00131664|540317863|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
149779558|NCT00131664|540317864|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
149779559|NCT00131664|540317865|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
149779560|NCT00131664|540317866|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
149779561|NCT00131664|540317867|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
149779562|NCT00131664|540317868|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
149779563|NCT00131664|540317863|FG000|First Period (First 6 Months)|Death|0|||
149779564|NCT00131664|540317864|FG001|First Period (First 6 Months)|Death|1|||
149779565|NCT00131664|540317865|FG002|First Period (First 6 Months)|Death|0|||
149779566|NCT00131664|540317866|FG003|First Period (First 6 Months)|Death|0|||
149779567|NCT00131664|540317867|FG004|First Period (First 6 Months)|Death|0|||
149779568|NCT00131664|540317868|FG005|First Period (First 6 Months)|Death|0|||
149779569|NCT00131664|540317863|FG000|First Period (First 6 Months)|Protocol Violation|2|||
149779570|NCT00131664|540317864|FG001|First Period (First 6 Months)|Protocol Violation|2|||
149779571|NCT00131664|540317865|FG002|First Period (First 6 Months)|Protocol Violation|1|||
149779572|NCT00131664|540317866|FG003|First Period (First 6 Months)|Protocol Violation|0|||
149779573|NCT00131664|540317867|FG004|First Period (First 6 Months)|Protocol Violation|0|||
149779574|NCT00131664|540317868|FG005|First Period (First 6 Months)|Protocol Violation|0|||
149779575|NCT00131664|540317863|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
149779576|NCT00131664|540317864|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
149779577|NCT00131664|540317865|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
149779578|NCT00131664|540317866|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
149779579|NCT00131664|540317867|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
149779580|NCT00131664|540317868|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
149779581|NCT00131664|540317863|FG000|First Period (First 6 Months)|Adverse Event|9|||
149779582|NCT00131664|540317864|FG001|First Period (First 6 Months)|Adverse Event|4|||
149779583|NCT00131664|540317865|FG002|First Period (First 6 Months)|Adverse Event|5|||
149779584|NCT00131664|540317866|FG003|First Period (First 6 Months)|Adverse Event|0|||
149779585|NCT00131664|540317867|FG004|First Period (First 6 Months)|Adverse Event|0|||
149779586|NCT00131664|540317868|FG005|First Period (First 6 Months)|Adverse Event|0|||
149779587|NCT00131664|540317863|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
149779588|NCT00131664|540317864|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
149779589|NCT00131664|540317865|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149779590|NCT00131664|540317866|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149779591|NCT00131664|540317867|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149779592|NCT00131664|540317868|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149779593|NCT00131664|540317863|FG000|First Period (First 6 Months)|Administrative reasons|2|||
149779594|NCT00131664|540317864|FG001|First Period (First 6 Months)|Administrative reasons|0|||
149779595|NCT00131664|540317865|FG002|First Period (First 6 Months)|Administrative reasons|5|||
149779596|NCT00131664|540317866|FG003|First Period (First 6 Months)|Administrative reasons|0|||
149779597|NCT00131664|540317867|FG004|First Period (First 6 Months)|Administrative reasons|0|||
149779598|NCT00131664|540317868|FG005|First Period (First 6 Months)|Administrative reasons|0|||
149779599|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
149779600|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
149779601|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
149779602|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
149779603|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
149779604|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
149779605|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
149779606|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
149779607|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
149779608|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
149779609|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
149779610|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
149779611|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
149779612|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149779613|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149779614|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149779615|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149779616|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149779617|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
149779618|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
149779619|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
149779620|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
149779621|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
149779622|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
149779623|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149779624|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149779625|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149779626|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
149779627|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149779628|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149779629|NCT00131664|540317863|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
149779630|NCT00131664|540317864|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
149779631|NCT00131664|540317865|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
149779632|NCT00131664|540317866|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
149779633|NCT00131664|540317867|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
149779634|NCT00131664|540317868|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
149779635|NCT00937326|540320260|FG000|Overall Study|Adverse Event|0|||
149779636|NCT00937326|540320261|FG001|Overall Study|Adverse Event|3|||
149779637|NCT00937326|540320262|FG002|Overall Study|Adverse Event|1|||
149779638|NCT00937326|540320263|FG003|Overall Study|Adverse Event|1|||
149779639|NCT00937326|540320264|FG004|Overall Study|Adverse Event|2|||
149779640|NCT00937326|540320260|FG000|Overall Study|Death|0|||
149779641|NCT00937326|540320261|FG001|Overall Study|Death|0|||
149779642|NCT00937326|540320262|FG002|Overall Study|Death|1|||
149779643|NCT00937326|540320263|FG003|Overall Study|Death|0|||
149779644|NCT00937326|540320264|FG004|Overall Study|Death|0|||
149779645|NCT00937326|540320260|FG000|Overall Study|Withdrawal by Subject|3|||
149779646|NCT00937326|540320261|FG001|Overall Study|Withdrawal by Subject|4|||
149779647|NCT00937326|540320262|FG002|Overall Study|Withdrawal by Subject|1|||
149779648|NCT00937326|540320263|FG003|Overall Study|Withdrawal by Subject|4|||
149779649|NCT00937326|540320264|FG004|Overall Study|Withdrawal by Subject|3|||
149779650|NCT00937326|540320260|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149779651|NCT00937326|540320261|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149779652|NCT00937326|540320262|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
149779653|NCT00937326|540320263|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149779654|NCT00937326|540320264|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149779655|NCT00790218|540320265|FG000|Overall Study|Death|1|||
149779656|NCT00790218|540320266|FG001|Overall Study|Death|0|||
149779657|NCT00790218|540320267|FG002|Overall Study|Death|0|||
149779658|NCT00405275|540320268|FG000|Overall Study|Death|1|||
149779659|NCT00405275|540320269|FG001|Overall Study|Death|0|||
149779660|NCT00405275|540320268|FG000|Overall Study|Lost to Follow-up|5|||
149779661|NCT00405275|540320269|FG001|Overall Study|Lost to Follow-up|1|||
149779662|NCT00405275|540320268|FG000|Overall Study|Withdrawal by Subject|7|||
149779663|NCT00405275|540320269|FG001|Overall Study|Withdrawal by Subject|9|||
149779664|NCT00405275|540320268|FG000|Overall Study|Unwilling to continue|10|||
149779665|NCT00405275|540320269|FG001|Overall Study|Unwilling to continue|9|||
149779666|NCT00088595|540320270|FG000|Overall Study|Adverse Event|11|||
149779667|NCT00088595|540320270|FG000|Overall Study|Withdrawal by Subject|8|||
149779668|NCT00088595|540320270|FG000|Overall Study|Ongoing (After Core)|7|||
149779669|NCT00088595|540320270|FG000|Overall Study|New Cancer Therapy|2|||
149779670|NCT01308853|540320281|FG000|Overall Study|Adverse Event|1|||
149779671|NCT01308853|540320281|FG000|Overall Study|Lost to Follow-up|2|||
149779672|NCT01308853|540320281|FG000|Overall Study|Insertion of permanent implants|1|||
149779673|NCT02959970|540320286|FG000|Overall Study|Adverse Event|1|||
149779674|NCT02959970|540320287|FG001|Overall Study|Adverse Event|0|||
149779675|NCT02959970|540320286|FG000|Overall Study|Withdrawal by Subject|0|||
149779676|NCT02959970|540320287|FG001|Overall Study|Withdrawal by Subject|2|||
149779677|NCT02959970|540320286|FG000|Overall Study|Lost to Follow-up|1|||
149779678|NCT02959970|540320287|FG001|Overall Study|Lost to Follow-up|5|||
149779679|NCT00666536|540320288|FG000|Overall Study|Adverse Event|9|||
149779680|NCT00666536|540320289|FG001|Overall Study|Adverse Event|19|||
149779681|NCT00666536|540320288|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149779682|NCT00666536|540320289|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149779683|NCT00666536|540320288|FG000|Overall Study|Protocol deviation(s)|8|||
149779684|NCT00666536|540320289|FG001|Overall Study|Protocol deviation(s)|6|||
149779685|NCT00666536|540320288|FG000|Overall Study|Withdrawal by Subject|10|||
149779686|NCT00666536|540320289|FG001|Overall Study|Withdrawal by Subject|9|||
149779687|NCT00666536|540320288|FG000|Overall Study|Lost to Follow-up|4|||
149779688|NCT00666536|540320289|FG001|Overall Study|Lost to Follow-up|3|||
149779689|NCT00693420|540320292|FG000|Overall Study|Adverse Event|4|||
149779690|NCT00693420|540320293|FG001|Overall Study|Adverse Event|4|||
149779691|NCT00693420|540320292|FG000|Overall Study|Lost to Follow-up|0|||
149779692|NCT00693420|540320293|FG001|Overall Study|Lost to Follow-up|3|||
149779693|NCT00693420|540320292|FG000|Overall Study|Withdrawal by Subject|1|||
149779694|NCT00693420|540320293|FG001|Overall Study|Withdrawal by Subject|0|||
149779695|NCT00693420|540320292|FG000|Overall Study|Protocol Violation|0|||
149779696|NCT00693420|540320293|FG001|Overall Study|Protocol Violation|2|||
149779697|NCT00693420|540320292|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
149779698|NCT00693420|540320293|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
149779699|NCT00693420|540320292|FG000|Overall Study|Personal Reasons|1|||
149779700|NCT00693420|540320293|FG001|Overall Study|Personal Reasons|4|||
149779701|NCT02853123|540320294|FG000|Treatment Period 1|Adverse Event|0|||
149779702|NCT02853123|540320295|FG001|Treatment Period 1|Adverse Event|3|||
149779703|NCT02853123|540320294|FG000|Washout Period|Worsening of COPD|0|||
149779704|NCT02853123|540320295|FG001|Washout Period|Worsening of COPD|3|||
149779705|NCT02853123|540320294|FG000|Washout Period|Adverse Event|1|||
149779706|NCT02853123|540320295|FG001|Washout Period|Adverse Event|0|||
149779707|NCT03250624|540320296|FG000|Overall Study|Lack of Efficacy|1|||
149779708|NCT03250624|540320297|FG001|Overall Study|Lack of Efficacy|4|||
149779709|NCT03250624|540320296|FG000|Overall Study|Adverse Event|0|||
149779710|NCT03250624|540320297|FG001|Overall Study|Adverse Event|1|||
149779711|NCT03250624|540320296|FG000|Overall Study|Other|1|||
149779712|NCT03250624|540320297|FG001|Overall Study|Other|2|||
149779713|NCT03805971|540320308|FG000|Overall Study|Withdrawal by Subject|1|||
149779714|NCT03805971|540320308|FG000|Overall Study|Protocol Violation|2|||
149779715|NCT01843205|540320322|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
149779716|NCT01843205|540320323|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
149779717|NCT00517413|540320324|FG000|Overall Study|Adverse Event|7|||
149779718|NCT00517413|540320324|FG000|Overall Study|Death|13|||
149779719|NCT00517413|540320324|FG000|Overall Study|Protocol Violation|15|||
149779720|NCT00517413|540320324|FG000|Overall Study|Withdrawal by Subject|2|||
149779721|NCT00517413|540320324|FG000|Overall Study|Failure to return|1|||
149779722|NCT00517413|540320324|FG000|Overall Study|Other-Reasons|23|||
149779723|NCT00136357|540320325|FG000|Overall Study|Withdrawal by Subject|3|||
149779724|NCT00136357|540320326|FG001|Overall Study|Withdrawal by Subject|2|||
149779725|NCT01355497|540320327|FG000|Overall Study|Death|19|||
149779726|NCT01355497|540320328|FG001|Overall Study|Death|18|||
149779727|NCT01355497|540320327|FG000|Overall Study|Lost to Follow-up|3|||
149779728|NCT01355497|540320328|FG001|Overall Study|Lost to Follow-up|0|||
149779729|NCT01355497|540320327|FG000|Overall Study|Protocol Violation|0|||
149779730|NCT01355497|540320328|FG001|Overall Study|Protocol Violation|1|||
149779731|NCT01355497|540320327|FG000|Overall Study|other-not provided|9|||
149779732|NCT01355497|540320328|FG001|Overall Study|other-not provided|4|||
149779733|NCT01355497|540320327|FG000|Overall Study|Withdrawal by Subject|12|||
149779734|NCT01355497|540320328|FG001|Overall Study|Withdrawal by Subject|20|||
149779735|NCT01355497|540320327|FG000|Overall Study|noncompliance|1|||
149779736|NCT01355497|540320328|FG001|Overall Study|noncompliance|2|||
149779737|NCT01355497|540320327|FG000|Overall Study|progressive disease|11|||
149779738|NCT01355497|540320328|FG001|Overall Study|progressive disease|8|||
149779739|NCT01355497|540320327|FG000|Overall Study|Adverse Event|11|||
149779740|NCT01355497|540320328|FG001|Overall Study|Adverse Event|10|||
149779741|NCT00441727|540320334|FG000|Overall Study|Protocol Violation|19|||
149779742|NCT00441727|540320335|FG001|Overall Study|Protocol Violation|28|||
149779743|NCT00441727|540320336|FG002|Overall Study|Protocol Violation|32|||
149779744|NCT00441727|540320334|FG000|Overall Study|Adverse Event|26|||
149779745|NCT00441727|540320335|FG001|Overall Study|Adverse Event|33|||
149779746|NCT00441727|540320336|FG002|Overall Study|Adverse Event|28|||
149779747|NCT00441727|540320334|FG000|Overall Study|Lack of Efficacy|7|||
149779748|NCT00441727|540320335|FG001|Overall Study|Lack of Efficacy|8|||
149779749|NCT00441727|540320336|FG002|Overall Study|Lack of Efficacy|48|||
149779750|NCT00441727|540320334|FG000|Overall Study|Withdrawal by Subject|40|||
149779751|NCT00441727|540320335|FG001|Overall Study|Withdrawal by Subject|34|||
149779752|NCT00441727|540320336|FG002|Overall Study|Withdrawal by Subject|47|||
149779753|NCT00441727|540320334|FG000|Overall Study|Lost to Follow-up|5|||
149779754|NCT00441727|540320335|FG001|Overall Study|Lost to Follow-up|6|||
149779755|NCT00441727|540320336|FG002|Overall Study|Lost to Follow-up|5|||
149779756|NCT00441727|540320334|FG000|Overall Study|Safety Reasons|3|||
149779757|NCT00441727|540320335|FG001|Overall Study|Safety Reasons|1|||
149779758|NCT00441727|540320336|FG002|Overall Study|Safety Reasons|3|||
149779759|NCT00441727|540320334|FG000|Overall Study|Various reason specified|6|||
149779760|NCT00441727|540320335|FG001|Overall Study|Various reason specified|8|||
149779761|NCT00441727|540320336|FG002|Overall Study|Various reason specified|5|||
149779762|NCT02133001|540320337|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
149779763|NCT02133001|540320338|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
149779764|NCT02133001|540320337|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
149779765|NCT02133001|540320338|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
149779766|NCT02133001|540320337|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
149779767|NCT02133001|540320338|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
149779768|NCT02133001|540320337|FG000|Double Blind (Day 1-25)|Other|2|||
149779769|NCT02133001|540320338|FG001|Double Blind (Day 1-25)|Other|2|||
149779770|NCT02133001|540320337|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
149779771|NCT02133001|540320338|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
149779772|NCT02133001|540320337|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
149779773|NCT02133001|540320338|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
149779774|NCT02133001|540320337|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
149779775|NCT02133001|540320338|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
149779776|NCT02133001|540320337|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
149779777|NCT02133001|540320338|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
149779778|NCT04211961|540320339|FG000|Overall Study|Death|0|||
149779779|NCT04211961|540320340|FG001|Overall Study|Death|1|||
149779780|NCT04211961|540320339|FG000|Overall Study|Lost to Follow-up|0|||
149779781|NCT04211961|540320340|FG001|Overall Study|Lost to Follow-up|1|||
149779782|NCT04211961|540320339|FG000|Overall Study|Withdrawal by Subject|0|||
149779783|NCT04211961|540320340|FG001|Overall Study|Withdrawal by Subject|1|||
149779784|NCT03210220|540320341|FG000|Overall Study|Physician Decision|1|||
149779785|NCT03210220|540320342|FG001|Overall Study|Physician Decision|0|||
149779786|NCT01444898|540320345|FG000|Overall Study|Withdrawal by Subject|1|||
149779787|NCT04583969|540320346|FG000|Overall Study|Death|31|||
149779788|NCT04583969|540320347|FG001|Overall Study|Death|38|||
149779789|NCT04583969|540320346|FG000|Overall Study|Lost to Follow-up|16|||
149779790|NCT04583969|540320347|FG001|Overall Study|Lost to Follow-up|13|||
149779791|NCT04583969|540320346|FG000|Overall Study|Protocol Violation|1|||
149779792|NCT04583969|540320347|FG001|Overall Study|Protocol Violation|0|||
149779793|NCT04583969|540320346|FG000|Overall Study|Withdrawal by Subject|3|||
149779794|NCT04583969|540320347|FG001|Overall Study|Withdrawal by Subject|3|||
149779795|NCT04583969|540320346|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
149779796|NCT04583969|540320347|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
149779797|NCT04583969|540320346|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
149779798|NCT04583969|540320347|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
149779799|NCT04583969|540320346|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
149779800|NCT04583969|540320347|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
149779801|NCT04583969|540320346|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
149779802|NCT04583969|540320347|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
149779803|NCT04583969|540320346|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
149779804|NCT04583969|540320347|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
149779805|NCT01061567|540320348|FG000|Overall Study|Adverse Event|32|||
149779806|NCT01061567|540320348|FG000|Overall Study|Death|2|||
149779807|NCT01061567|540320348|FG000|Overall Study|Lack of Efficacy|3|||
149779808|NCT01061567|540320348|FG000|Overall Study|Lost to Follow-up|24|||
149779809|NCT01061567|540320348|FG000|Overall Study|Protocol Violation|1|||
149779810|NCT01061567|540320348|FG000|Overall Study|Withdrawal by Subject|11|||
149779811|NCT01061567|540320348|FG000|Overall Study|Other reason than stated above|3|||
149779812|NCT01831804|540320349|FG000|Overall Study|Adverse Event|0|||
149779813|NCT01831804|540320350|FG001|Overall Study|Adverse Event|0|||
149779814|NCT01831804|540320351|FG002|Overall Study|Adverse Event|0|||
149779815|NCT01831804|540320352|FG003|Overall Study|Adverse Event|0|||
149779816|NCT01831804|540320353|FG004|Overall Study|Adverse Event|0|||
149779817|NCT01831804|540320354|FG005|Overall Study|Adverse Event|0|||
149779818|NCT01831804|540320355|FG006|Overall Study|Adverse Event|1|||
149779819|NCT01831804|540320356|FG007|Overall Study|Adverse Event|0|||
149779820|NCT01831804|540320357|FG008|Overall Study|Adverse Event|1|||
149779821|NCT01831804|540320349|FG000|Overall Study|Protocol Violation|0|||
149779822|NCT01831804|540320350|FG001|Overall Study|Protocol Violation|0|||
149779823|NCT01831804|540320351|FG002|Overall Study|Protocol Violation|2|||
149779824|NCT01831804|540320352|FG003|Overall Study|Protocol Violation|0|||
149779825|NCT01831804|540320353|FG004|Overall Study|Protocol Violation|0|||
149779826|NCT01831804|540320354|FG005|Overall Study|Protocol Violation|0|||
149779827|NCT01831804|540320355|FG006|Overall Study|Protocol Violation|0|||
149779828|NCT01831804|540320356|FG007|Overall Study|Protocol Violation|0|||
149779829|NCT01831804|540320357|FG008|Overall Study|Protocol Violation|0|||
149779830|NCT01831804|540320349|FG000|Overall Study|Protocol defined stopping criteria|1|||
149779831|NCT01831804|540320350|FG001|Overall Study|Protocol defined stopping criteria|1|||
149779832|NCT01831804|540320351|FG002|Overall Study|Protocol defined stopping criteria|3|||
149779833|NCT01831804|540320352|FG003|Overall Study|Protocol defined stopping criteria|0|||
149779834|NCT01831804|540320353|FG004|Overall Study|Protocol defined stopping criteria|1|||
149779835|NCT01831804|540320354|FG005|Overall Study|Protocol defined stopping criteria|0|||
149779836|NCT01831804|540320355|FG006|Overall Study|Protocol defined stopping criteria|0|||
149779837|NCT01831804|540320356|FG007|Overall Study|Protocol defined stopping criteria|0|||
149779838|NCT01831804|540320357|FG008|Overall Study|Protocol defined stopping criteria|0|||
149779839|NCT01831804|540320349|FG000|Overall Study|Lost to Follow-up|0|||
149779840|NCT01831804|540320350|FG001|Overall Study|Lost to Follow-up|0|||
149779841|NCT01831804|540320351|FG002|Overall Study|Lost to Follow-up|1|||
149779842|NCT01831804|540320352|FG003|Overall Study|Lost to Follow-up|0|||
149779843|NCT01831804|540320353|FG004|Overall Study|Lost to Follow-up|0|||
149779844|NCT01831804|540320354|FG005|Overall Study|Lost to Follow-up|0|||
149779845|NCT01831804|540320355|FG006|Overall Study|Lost to Follow-up|0|||
149779846|NCT01831804|540320356|FG007|Overall Study|Lost to Follow-up|0|||
149779847|NCT01831804|540320357|FG008|Overall Study|Lost to Follow-up|1|||
149779848|NCT01831804|540320349|FG000|Overall Study|Investigator discretion|0|||
149779849|NCT01831804|540320350|FG001|Overall Study|Investigator discretion|0|||
149779850|NCT01831804|540320351|FG002|Overall Study|Investigator discretion|0|||
149779851|NCT01831804|540320352|FG003|Overall Study|Investigator discretion|0|||
149779852|NCT01831804|540320353|FG004|Overall Study|Investigator discretion|1|||
149779853|NCT01831804|540320354|FG005|Overall Study|Investigator discretion|0|||
149779854|NCT01831804|540320355|FG006|Overall Study|Investigator discretion|0|||
149779855|NCT01831804|540320356|FG007|Overall Study|Investigator discretion|1|||
149779856|NCT01831804|540320357|FG008|Overall Study|Investigator discretion|0|||
149779857|NCT01831804|540320349|FG000|Overall Study|Withdrew Consent|0|||
149779858|NCT01831804|540320350|FG001|Overall Study|Withdrew Consent|1|||
149779859|NCT01831804|540320351|FG002|Overall Study|Withdrew Consent|0|||
149779860|NCT01831804|540320352|FG003|Overall Study|Withdrew Consent|0|||
149779861|NCT01831804|540320353|FG004|Overall Study|Withdrew Consent|0|||
149779862|NCT01831804|540320354|FG005|Overall Study|Withdrew Consent|0|||
149779863|NCT01831804|540320355|FG006|Overall Study|Withdrew Consent|0|||
149779864|NCT01831804|540320356|FG007|Overall Study|Withdrew Consent|2|||
149779865|NCT01831804|540320357|FG008|Overall Study|Withdrew Consent|0|||
149779866|NCT01819506|540320358|FG000|Overall Study|Physician Decision|5|||
149779867|NCT01819506|540320359|FG001|Overall Study|Physician Decision|2|||
149779868|NCT01819506|540320358|FG000|Overall Study|Withdrawal by Subject|3|||
149779869|NCT01819506|540320359|FG001|Overall Study|Withdrawal by Subject|3|||
149779870|NCT03447821|540320364|FG000|Overall Study|Withdrawal by Subject|1|||
149779871|NCT03447821|540320365|FG001|Overall Study|Withdrawal by Subject|1|||
149779872|NCT03447821|540320366|FG002|Overall Study|Withdrawal by Subject|0|||
149779873|NCT03447821|540320364|FG000|Overall Study|Lost to Follow-up|0|||
149779874|NCT03447821|540320365|FG001|Overall Study|Lost to Follow-up|0|||
149779875|NCT03447821|540320366|FG002|Overall Study|Lost to Follow-up|1|||
149779876|NCT04685538|540320368|FG000|Overall Study|Adverse Event|0|||
149779877|NCT04685538|540320369|FG001|Overall Study|Adverse Event|1|||
149779878|NCT04685538|540320368|FG000|Overall Study|Lost to Follow-up|0|||
149779879|NCT04685538|540320369|FG001|Overall Study|Lost to Follow-up|2|||
149779880|NCT02475629|540320371|FG000|Overall Study|Adverse Event|1|||
149779881|NCT02475629|540320371|FG000|Overall Study|Death|4|||
149779882|NCT02475629|540320371|FG000|Overall Study|Physician Decision|1|||
149779883|NCT02475629|540320371|FG000|Overall Study|Withdrawal by Subject|1|||
149779884|NCT02475629|540320371|FG000|Overall Study|Lost to Follow-up|1|||
149779885|NCT02475629|540320371|FG000|Overall Study|Subject non-compliance|1|||
149779886|NCT01421069|540320372|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
149779887|NCT01421069|540320372|FG000|Parent Study|Failed to return|3|||
149779888|NCT01421069|540320372|FG000|Parent Study|Withdrawal by Subject|1|||
149779889|NCT01421069|540320372|FG000|Parent Study|Lost to Follow-up|2|||
149779890|NCT01421069|540320372|FG000|Parent Study|Lack of Efficacy|1|||
149779891|NCT01421069|540320372|FG000|Overall Period for Extension Study|Other|2|||
149779892|NCT01421069|540320372|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
149779893|NCT01421069|540320372|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
149779894|NCT01421069|540320372|FG000|Overall Period for Extension Study|Pregnancy|1|||
149779895|NCT01421069|540320372|FG000|Overall Period for Extension Study|Adverse Event|1|||
149779896|NCT01421069|540320372|FG000|Overall Period for Extension Study|Protocol Violation|1|||
149779897|NCT01421069|540320372|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
149779898|NCT01421069|540320372|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
149779899|NCT01421069|540320372|FG000|Active Treatment Period|Other|1|||
149779900|NCT01421069|540320372|FG000|Active Treatment Period|No longer willing to participate in study|8|||
149779901|NCT01421069|540320372|FG000|Active Treatment Period|Insufficient clinical response|1|||
149779902|NCT01421069|540320372|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
149779903|NCT01421069|540320372|FG000|Active Treatment Period|Pregnancy|1|||
149779904|NCT01421069|540320372|FG000|Active Treatment Period|Adverse Event|1|||
149779905|NCT01421069|540320372|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
149779906|NCT01421069|540320372|FG000|Active Treatment Period|Enrolled in observational period|29|||
149779907|NCT01421069|540320372|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
149779908|NCT01421069|540320372|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
149779909|NCT01421069|540320372|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
149779910|NCT01421069|540320372|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
149779911|NCT01421069|540320372|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
149779912|NCT01421069|540320372|FG000|2b. Retreatment Period|Protocol Violation|1|||
149779913|NCT01421069|540320372|FG000|Observational Period|Other|1|||
149779914|NCT01421069|540320372|FG000|Observational Period|No longer willing to participate in study|4|||
149779915|NCT01421069|540320372|FG000|Observational Period|Lost to Follow-up|3|||
149779916|NCT01641081|540320373|FG000|Period 1|Sponsor request (potential unblinding)|0|||
149779917|NCT01641081|540320374|FG001|Period 1|Sponsor request (potential unblinding)|0|||
149779918|NCT01641081|540320375|FG002|Period 1|Sponsor request (potential unblinding)|0|||
149779919|NCT01641081|540320376|FG003|Period 1|Sponsor request (potential unblinding)|0|||
149779920|NCT01641081|540320377|FG004|Period 1|Sponsor request (potential unblinding)|0|||
149779921|NCT01641081|540320378|FG005|Period 1|Sponsor request (potential unblinding)|0|||
149779922|NCT01641081|540320379|FG006|Period 1|Sponsor request (potential unblinding)|1|||
149779923|NCT01641081|540320380|FG007|Period 1|Sponsor request (potential unblinding)|0|||
149779924|NCT01641081|540320381|FG008|Period 1|Sponsor request (potential unblinding)|0|||
149779925|NCT01641081|540320382|FG009|Period 1|Sponsor request (potential unblinding)|0|||
149779926|NCT01641081|540320373|FG000|Period 1|Protocol Violation|0|||
149779927|NCT01641081|540320374|FG001|Period 1|Protocol Violation|0|||
149779928|NCT01641081|540320375|FG002|Period 1|Protocol Violation|0|||
149779929|NCT01641081|540320376|FG003|Period 1|Protocol Violation|0|||
149779930|NCT01641081|540320377|FG004|Period 1|Protocol Violation|1|||
149779931|NCT01641081|540320378|FG005|Period 1|Protocol Violation|0|||
149779932|NCT01641081|540320379|FG006|Period 1|Protocol Violation|0|||
149779933|NCT01641081|540320380|FG007|Period 1|Protocol Violation|1|||
149779934|NCT01641081|540320381|FG008|Period 1|Protocol Violation|0|||
149779935|NCT01641081|540320382|FG009|Period 1|Protocol Violation|0|||
149779936|NCT01641081|540320373|FG000|Period 1|Adverse Event|1|||
149779937|NCT01641081|540320374|FG001|Period 1|Adverse Event|0|||
149779938|NCT01641081|540320375|FG002|Period 1|Adverse Event|0|||
149779939|NCT01641081|540320376|FG003|Period 1|Adverse Event|0|||
149779940|NCT01641081|540320377|FG004|Period 1|Adverse Event|0|||
149779941|NCT01641081|540320378|FG005|Period 1|Adverse Event|0|||
149779942|NCT01641081|540320379|FG006|Period 1|Adverse Event|0|||
149779943|NCT01641081|540320380|FG007|Period 1|Adverse Event|2|||
149779944|NCT01641081|540320381|FG008|Period 1|Adverse Event|0|||
149779945|NCT01641081|540320382|FG009|Period 1|Adverse Event|0|||
149779946|NCT01641081|540320373|FG000|Period 2|Adverse Event|0|||
149779947|NCT01641081|540320374|FG001|Period 2|Adverse Event|0|||
149779948|NCT01641081|540320375|FG002|Period 2|Adverse Event|0|||
149779949|NCT01641081|540320376|FG003|Period 2|Adverse Event|0|||
149779950|NCT01641081|540320377|FG004|Period 2|Adverse Event|0|||
149779951|NCT01641081|540320378|FG005|Period 2|Adverse Event|1|||
149779952|NCT01641081|540320379|FG006|Period 2|Adverse Event|0|||
149779953|NCT01641081|540320380|FG007|Period 2|Adverse Event|0|||
149779954|NCT01641081|540320381|FG008|Period 2|Adverse Event|0|||
149779955|NCT01641081|540320382|FG009|Period 2|Adverse Event|0|||
149779956|NCT01641081|540320373|FG000|Period 2|Withdrawal by Subject|0|||
149779957|NCT01641081|540320374|FG001|Period 2|Withdrawal by Subject|0|||
149779958|NCT01641081|540320375|FG002|Period 2|Withdrawal by Subject|0|||
149779959|NCT01641081|540320376|FG003|Period 2|Withdrawal by Subject|1|||
149779960|NCT01641081|540320377|FG004|Period 2|Withdrawal by Subject|0|||
149779961|NCT01641081|540320378|FG005|Period 2|Withdrawal by Subject|0|||
149779962|NCT01641081|540320379|FG006|Period 2|Withdrawal by Subject|2|||
149779963|NCT01641081|540320380|FG007|Period 2|Withdrawal by Subject|0|||
149779964|NCT01641081|540320381|FG008|Period 2|Withdrawal by Subject|0|||
149779965|NCT01641081|540320382|FG009|Period 2|Withdrawal by Subject|0|||
149779966|NCT01641081|540320373|FG000|Period 2|Protocol Violation|1|||
149779967|NCT01641081|540320374|FG001|Period 2|Protocol Violation|0|||
149779968|NCT01641081|540320375|FG002|Period 2|Protocol Violation|0|||
149779969|NCT01641081|540320376|FG003|Period 2|Protocol Violation|0|||
149779970|NCT01641081|540320377|FG004|Period 2|Protocol Violation|0|||
149779971|NCT01641081|540320378|FG005|Period 2|Protocol Violation|0|||
149779972|NCT01641081|540320379|FG006|Period 2|Protocol Violation|0|||
149779973|NCT01641081|540320380|FG007|Period 2|Protocol Violation|0|||
149779974|NCT01641081|540320381|FG008|Period 2|Protocol Violation|0|||
149779975|NCT01641081|540320382|FG009|Period 2|Protocol Violation|0|||
149779976|NCT01641081|540320373|FG000|Period 3|Adverse Event|0|||
149779977|NCT01641081|540320374|FG001|Period 3|Adverse Event|0|||
149779978|NCT01641081|540320375|FG002|Period 3|Adverse Event|1|||
149779979|NCT01641081|540320376|FG003|Period 3|Adverse Event|0|||
149779980|NCT01641081|540320377|FG004|Period 3|Adverse Event|0|||
149779981|NCT01641081|540320378|FG005|Period 3|Adverse Event|0|||
149779982|NCT01641081|540320379|FG006|Period 3|Adverse Event|0|||
149779983|NCT01641081|540320380|FG007|Period 3|Adverse Event|0|||
149779984|NCT01641081|540320381|FG008|Period 3|Adverse Event|0|||
149779985|NCT01641081|540320382|FG009|Period 3|Adverse Event|0|||
149779986|NCT01641081|540320373|FG000|Period 3|Withdrawal by Subject|0|||
149779987|NCT01641081|540320374|FG001|Period 3|Withdrawal by Subject|0|||
149779988|NCT01641081|540320375|FG002|Period 3|Withdrawal by Subject|0|||
149779989|NCT01641081|540320376|FG003|Period 3|Withdrawal by Subject|0|||
149779990|NCT01641081|540320377|FG004|Period 3|Withdrawal by Subject|0|||
149779991|NCT01641081|540320378|FG005|Period 3|Withdrawal by Subject|0|||
149779992|NCT01641081|540320379|FG006|Period 3|Withdrawal by Subject|0|||
149779993|NCT01641081|540320380|FG007|Period 3|Withdrawal by Subject|0|||
149779994|NCT01641081|540320381|FG008|Period 3|Withdrawal by Subject|1|||
149779995|NCT01641081|540320382|FG009|Period 3|Withdrawal by Subject|0|||
149779996|NCT01641081|540320373|FG000|Period 4|Adverse Event|0|||
149779997|NCT01641081|540320374|FG001|Period 4|Adverse Event|1|||
149779998|NCT01641081|540320375|FG002|Period 4|Adverse Event|0|||
149779999|NCT01641081|540320376|FG003|Period 4|Adverse Event|1|||
149780000|NCT01641081|540320377|FG004|Period 4|Adverse Event|0|||
149780001|NCT01641081|540320378|FG005|Period 4|Adverse Event|0|||
149780002|NCT01641081|540320379|FG006|Period 4|Adverse Event|0|||
149780003|NCT01641081|540320380|FG007|Period 4|Adverse Event|0|||
149780004|NCT01641081|540320381|FG008|Period 4|Adverse Event|0|||
149780005|NCT01641081|540320382|FG009|Period 4|Adverse Event|0|||
149780006|NCT01641081|540320373|FG000|Period 5|Adverse Event|0|||
149780007|NCT01641081|540320374|FG001|Period 5|Adverse Event|0|||
149780008|NCT01641081|540320375|FG002|Period 5|Adverse Event|2|||
149780009|NCT01641081|540320376|FG003|Period 5|Adverse Event|0|||
149780010|NCT01641081|540320377|FG004|Period 5|Adverse Event|0|||
149780011|NCT01641081|540320378|FG005|Period 5|Adverse Event|0|||
149780012|NCT01641081|540320379|FG006|Period 5|Adverse Event|0|||
149780013|NCT01641081|540320380|FG007|Period 5|Adverse Event|0|||
149780014|NCT01641081|540320381|FG008|Period 5|Adverse Event|0|||
149780015|NCT01641081|540320382|FG009|Period 5|Adverse Event|0|||
149780016|NCT03383614|540320383|FG000|Overall Study|Withdrawal by Subject|0|||
149780017|NCT03383614|540320384|FG001|Overall Study|Withdrawal by Subject|1|||
149780018|NCT03383614|540320385|FG002|Overall Study|Withdrawal by Subject|0|||
149780019|NCT03383614|540320386|FG003|Overall Study|Withdrawal by Subject|0|||
149780020|NCT02925312|540320392|FG000|Overall Study|Lost to Follow-up|25|||
149780021|NCT02925312|540320393|FG001|Overall Study|Lost to Follow-up|0|||
149780022|NCT02925312|540320392|FG000|Overall Study|Adverse Event|2|||
149780023|NCT02925312|540320393|FG001|Overall Study|Adverse Event|0|||
149780024|NCT00166517|540320397|FG000|Overall Study|Lost to Follow-up|1|||
149780025|NCT00166517|540320398|FG001|Overall Study|Lost to Follow-up|0|||
149780026|NCT00166517|540320397|FG000|Overall Study|Protocol Violation|4|||
149780027|NCT00166517|540320398|FG001|Overall Study|Protocol Violation|1|||
149780028|NCT00166517|540320397|FG000|Overall Study|Withdrawal by Subject|0|||
149780029|NCT00166517|540320398|FG001|Overall Study|Withdrawal by Subject|1|||
149780030|NCT00842361|540320399|FG000|Overall Study|Protocol Violation|1|||
149780031|NCT00842361|540320400|FG001|Overall Study|Protocol Violation|0|||
149780032|NCT00842361|540320399|FG000|Overall Study|Unclassified|0|||
149780033|NCT00842361|540320400|FG001|Overall Study|Unclassified|2|||
149780034|NCT01072448|540320401|FG000|Overall Study|Adverse Event|9|||
149780035|NCT01072448|540320402|FG001|Overall Study|Adverse Event|10|||
149780036|NCT01072448|540320401|FG000|Overall Study|Subject withdrew consent|4|||
149780037|NCT01072448|540320402|FG001|Overall Study|Subject withdrew consent|9|||
149780038|NCT01072448|540320401|FG000|Overall Study|Protocol deviation|3|||
149780039|NCT01072448|540320402|FG001|Overall Study|Protocol deviation|4|||
149780040|NCT01072448|540320401|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149780041|NCT01072448|540320402|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149780042|NCT01072448|540320401|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149780043|NCT01072448|540320402|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149780044|NCT01072448|540320401|FG000|Overall Study|Lost to Follow-up|1|||
149780045|NCT01072448|540320402|FG001|Overall Study|Lost to Follow-up|1|||
149780046|NCT01072448|540320401|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149780047|NCT01072448|540320402|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149780048|NCT01072448|540320401|FG000|Overall Study|Death|0|||
149780049|NCT01072448|540320402|FG001|Overall Study|Death|2|||
149780050|NCT01015820|540320405|FG000|Overall Study|Suboptimal measurements|1|||
149780051|NCT01015820|540320406|FG001|Overall Study|Suboptimal measurements|0|||
149780052|NCT01313078|540320407|FG000|Overall Study|Death|1|||
149780053|NCT01313078|540320407|FG000|Overall Study|Discontinued study drug|1|||
149780054|NCT01313078|540320407|FG000|Overall Study|Withdrawal by Subject|1|||
149780055|NCT03136484|540320408|FG000|Overall Study|Withdrawal by Subject|19|||
149780056|NCT03136484|540320409|FG001|Overall Study|Withdrawal by Subject|14|||
149780057|NCT03136484|540320408|FG000|Overall Study|Lost to Follow-up|7|||
149780058|NCT03136484|540320409|FG001|Overall Study|Lost to Follow-up|8|||
149780059|NCT03136484|540320408|FG000|Overall Study|Death|1|||
149780060|NCT03136484|540320409|FG001|Overall Study|Death|0|||
149780061|NCT01449955|540320412|FG000|Overall Study|Withdrawal by Subject|1|||
149780062|NCT01449955|540320413|FG001|Overall Study|Withdrawal by Subject|2|||
149780063|NCT01601470|540320414|FG000|Period 2 - LCZ696|Physician Decision|1|||
149780064|NCT01203787|540320415|FG000|Overall Study|Death|12|||
149780065|NCT01203787|540320416|FG001|Overall Study|Death|10|||
149780066|NCT01203787|540320415|FG000|Overall Study|Withdrawal by Subject|6|||
149780067|NCT01203787|540320416|FG001|Overall Study|Withdrawal by Subject|2|||
149780068|NCT01203787|540320415|FG000|Overall Study|Lost to Follow-up|2|||
149780069|NCT01203787|540320416|FG001|Overall Study|Lost to Follow-up|0|||
149780070|NCT01203787|540320415|FG000|Overall Study|Adverse Event|11|||
149780071|NCT01203787|540320416|FG001|Overall Study|Adverse Event|15|||
149780072|NCT02079519|540320419|FG000|Overall Study|Disease Progression|9|||
149780073|NCT02079519|540320419|FG000|Overall Study|Adverse Event|1|||
149780074|NCT01176240|540320420|FG000|Study 306A|Lack of Efficacy|2|||
149780075|NCT01176240|540320421|FG001|Study 306A|Lack of Efficacy|1|||
149780076|NCT01176240|540320420|FG000|Study 306A|Protocol Violation|0|||
149780077|NCT01176240|540320421|FG001|Study 306A|Protocol Violation|1|||
149780078|NCT01176240|540320420|FG000|Study 306A|Withdrawal by Subject|0|||
149780079|NCT01176240|540320421|FG001|Study 306A|Withdrawal by Subject|1|||
149780080|NCT01176240|540320420|FG000|Study 306A|Stop due to diverse problems|1|||
149780081|NCT01176240|540320421|FG001|Study 306A|Stop due to diverse problems|0|||
149780082|NCT01176240|540320420|FG000|Study 306B|Lack of Efficacy|5|||
149780083|NCT01176240|540320421|FG001|Study 306B|Lack of Efficacy|3|||
149780084|NCT01176240|540320420|FG000|Study 306B|Adverse Event|10|||
149780085|NCT01176240|540320421|FG001|Study 306B|Adverse Event|5|||
149780086|NCT01176240|540320420|FG000|Study 306B|Protocol Violation|2|||
149780087|NCT01176240|540320421|FG001|Study 306B|Protocol Violation|3|||
149780088|NCT01176240|540320420|FG000|Study 306B|Withdrawal by Subject|4|||
149780089|NCT01176240|540320421|FG001|Study 306B|Withdrawal by Subject|1|||
149780090|NCT01176240|540320420|FG000|Study 306B|Physician Decision|2|||
149780091|NCT01176240|540320421|FG001|Study 306B|Physician Decision|1|||
149780092|NCT01176240|540320420|FG000|Study 306B|Supine Hypertension|1|||
149780093|NCT01176240|540320421|FG001|Study 306B|Supine Hypertension|2|||
149780094|NCT01176240|540320420|FG000|Study 306B|Lost to Follow-up|0|||
149780095|NCT01176240|540320421|FG001|Study 306B|Lost to Follow-up|1|||
149780096|NCT01176240|540320420|FG000|Study 306B|withdrew prior to dosing|2|||
149780097|NCT01176240|540320421|FG001|Study 306B|withdrew prior to dosing|1|||
149780098|NCT03627494|540320424|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
149780099|NCT03627494|540320425|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780100|NCT03627494|540320426|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
149780101|NCT03627494|540320427|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780102|NCT03627494|540320428|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780103|NCT03627494|540320429|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780104|NCT03627494|540320430|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780105|NCT03627494|540320431|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780106|NCT03627494|540320432|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780107|NCT03627494|540320433|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780108|NCT03627494|540320434|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780109|NCT03627494|540320435|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
149780110|NCT03627494|540320424|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780111|NCT03627494|540320425|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780112|NCT03627494|540320426|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780113|NCT03627494|540320427|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780114|NCT03627494|540320428|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780115|NCT03627494|540320429|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780116|NCT03627494|540320430|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780117|NCT03627494|540320431|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780118|NCT03627494|540320432|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
149780119|NCT03627494|540320433|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780120|NCT03627494|540320434|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780121|NCT03627494|540320435|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
149780122|NCT03627494|540320424|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780123|NCT03627494|540320425|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780124|NCT03627494|540320426|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780125|NCT03627494|540320427|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780126|NCT03627494|540320428|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780127|NCT03627494|540320429|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780128|NCT03627494|540320430|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780129|NCT03627494|540320431|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780130|NCT03627494|540320432|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780131|NCT03627494|540320433|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
149780132|NCT03627494|540320434|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
149780133|NCT03627494|540320435|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
149780134|NCT02578992|540322624|FG000|Overall Study|equipment not available or malfunction|3|||
149780135|NCT02578992|540322625|FG001|Overall Study|equipment not available or malfunction|3|||
149780136|NCT02443155|540322626|FG000|Overall Study|Adverse Event|3|||
149780137|NCT02443155|540322627|FG001|Overall Study|Adverse Event|4|||
149780138|NCT02443155|540322628|FG002|Overall Study|Adverse Event|1|||
149780139|NCT02443155|540322629|FG003|Overall Study|Adverse Event|2|||
149780140|NCT02443155|540322626|FG000|Overall Study|Unclassified|0|||
149780141|NCT02443155|540322627|FG001|Overall Study|Unclassified|0|||
149780142|NCT02443155|540322628|FG002|Overall Study|Unclassified|2|||
149780143|NCT02443155|540322629|FG003|Overall Study|Unclassified|1|||
149780144|NCT02443155|540322626|FG000|Overall Study|Withdrawal by Subject|4|||
149780145|NCT02443155|540322627|FG001|Overall Study|Withdrawal by Subject|7|||
149780146|NCT02443155|540322628|FG002|Overall Study|Withdrawal by Subject|3|||
149780147|NCT02443155|540322629|FG003|Overall Study|Withdrawal by Subject|9|||
149780148|NCT02443155|540322626|FG000|Overall Study|Pregnancy|3|||
149780149|NCT02443155|540322627|FG001|Overall Study|Pregnancy|1|||
149780150|NCT02443155|540322628|FG002|Overall Study|Pregnancy|1|||
149780151|NCT02443155|540322629|FG003|Overall Study|Pregnancy|2|||
149780152|NCT02443155|540322626|FG000|Overall Study|Lost to Follow-up|1|||
149780153|NCT02443155|540322627|FG001|Overall Study|Lost to Follow-up|2|||
149780154|NCT02443155|540322628|FG002|Overall Study|Lost to Follow-up|0|||
149780155|NCT02443155|540322629|FG003|Overall Study|Lost to Follow-up|1|||
149780156|NCT02443155|540322626|FG000|Overall Study|Protocol Violation|1|||
149780157|NCT02443155|540322627|FG001|Overall Study|Protocol Violation|0|||
149780158|NCT02443155|540322628|FG002|Overall Study|Protocol Violation|1|||
149780159|NCT02443155|540322629|FG003|Overall Study|Protocol Violation|1|||
149780160|NCT02443155|540322626|FG000|Overall Study|Death|0|||
149780161|NCT02443155|540322627|FG001|Overall Study|Death|0|||
149780162|NCT02443155|540322628|FG002|Overall Study|Death|1|||
149780163|NCT02443155|540322629|FG003|Overall Study|Death|0|||
149780164|NCT00731666|540322637|FG000|Overall Study|Adverse Event|2|||
149780165|NCT00731666|540322637|FG000|Overall Study|Lost to Follow-up|8|||
149780166|NCT00731666|540322637|FG000|Overall Study|Withdrawal by Subject|2|||
149780167|NCT01473355|540322639|FG000|Overall Study|Protocol Violation|2|||
149780168|NCT01473355|540322639|FG000|Overall Study|Adverse Event|2|||
149780169|NCT01473355|540322639|FG000|Overall Study|Lost to Follow-up|2|||
149780170|NCT00106249|540322640|FG000|Overall Study|Lost to Follow-up|3|||
149780171|NCT00106249|540322641|FG001|Overall Study|Lost to Follow-up|2|||
149780172|NCT00509028|540322644|FG000|Overall Study|Adverse Event|2|||
149780173|NCT00509028|540322645|FG001|Overall Study|Adverse Event|0|||
149780174|NCT00509028|540322644|FG000|Overall Study|Withdrawal by Subject|4|||
149780175|NCT00509028|540322645|FG001|Overall Study|Withdrawal by Subject|3|||
149780176|NCT00509028|540322644|FG000|Overall Study|Lost to Follow-up|0|||
149780177|NCT00509028|540322645|FG001|Overall Study|Lost to Follow-up|1|||
149780178|NCT00509028|540322644|FG000|Overall Study|Protocol Violation|4|||
149780179|NCT00509028|540322645|FG001|Overall Study|Protocol Violation|2|||
149780180|NCT00509028|540322644|FG000|Overall Study|Non-compliance|2|||
149780181|NCT00509028|540322645|FG001|Overall Study|Non-compliance|1|||
149780182|NCT00948428|540322646|FG000|Overall Study|Withdrawal by Subject|6|||
149780183|NCT00948428|540322647|FG001|Overall Study|Withdrawal by Subject|12|||
149780184|NCT00948428|540322648|FG002|Overall Study|Withdrawal by Subject|7|||
149780185|NCT00948428|540322646|FG000|Overall Study|Adverse Event|6|||
149780186|NCT00948428|540322647|FG001|Overall Study|Adverse Event|3|||
149780187|NCT00948428|540322648|FG002|Overall Study|Adverse Event|0|||
149780188|NCT00948428|540322646|FG000|Overall Study|Lost to Follow-up|2|||
149780189|NCT00948428|540322647|FG001|Overall Study|Lost to Follow-up|1|||
149780190|NCT00948428|540322648|FG002|Overall Study|Lost to Follow-up|1|||
149780191|NCT00948428|540322646|FG000|Overall Study|Death|2|||
149780192|NCT00948428|540322647|FG001|Overall Study|Death|0|||
149780193|NCT00948428|540322648|FG002|Overall Study|Death|0|||
149780194|NCT00948428|540322646|FG000|Overall Study|Intercurrent Illness|1|||
149780195|NCT00948428|540322647|FG001|Overall Study|Intercurrent Illness|0|||
149780196|NCT00948428|540322648|FG002|Overall Study|Intercurrent Illness|0|||
149780197|NCT00948428|540322646|FG000|Overall Study|Non-compliance|1|||
149780198|NCT00948428|540322647|FG001|Overall Study|Non-compliance|2|||
149780199|NCT00948428|540322648|FG002|Overall Study|Non-compliance|0|||
149780200|NCT01495689|540322651|FG000|Overall Study|Death|0|||
149780201|NCT01495689|540322652|FG001|Overall Study|Death|1|||
149780202|NCT01495689|540322651|FG000|Overall Study|Withdrawal by Subject|3|||
149780203|NCT01495689|540322652|FG001|Overall Study|Withdrawal by Subject|0|||
149780204|NCT01495689|540322651|FG000|Overall Study|Lost to Follow-up|7|||
149780205|NCT01495689|540322652|FG001|Overall Study|Lost to Follow-up|6|||
149780206|NCT05516134|540322653|FG000|Overall Study|Lost to Follow-up|1|||
149780207|NCT05516134|540322654|FG001|Overall Study|Lost to Follow-up|0|||
149780208|NCT05516134|540322655|FG002|Overall Study|Lost to Follow-up|0|||
149780209|NCT00254163|540322656|FG000|Overall Study|Adverse Event|29|||
149780210|NCT00254163|540322657|FG001|Overall Study|Adverse Event|26|||
149780211|NCT00254163|540322656|FG000|Overall Study|Patient request/withdrew consent|6|||
149780212|NCT00254163|540322657|FG001|Overall Study|Patient request/withdrew consent|4|||
149780213|NCT00254163|540322656|FG000|Overall Study|Investigator request|1|||
149780214|NCT00254163|540322657|FG001|Overall Study|Investigator request|3|||
149780215|NCT00254163|540322656|FG000|Overall Study|Failed entry|1|||
149780216|NCT00254163|540322657|FG001|Overall Study|Failed entry|3|||
149780217|NCT00254163|540322656|FG000|Overall Study|Progressive disease|0|||
149780218|NCT00254163|540322657|FG001|Overall Study|Progressive disease|1|||
149780219|NCT00254163|540322656|FG000|Overall Study|Death|0|||
149780220|NCT00254163|540322657|FG001|Overall Study|Death|1|||
149780221|NCT00254163|540322656|FG000|Overall Study|Other|8|||
149780222|NCT00254163|540322657|FG001|Overall Study|Other|8|||
149780223|NCT00606177|540322660|FG000|Overall Study|Adverse Event|9|||
149780224|NCT00606177|540322661|FG001|Overall Study|Adverse Event|5|||
149780225|NCT00606177|540322660|FG000|Overall Study|Lack of Efficacy|3|||
149780226|NCT00606177|540322661|FG001|Overall Study|Lack of Efficacy|7|||
149780227|NCT00606177|540322660|FG000|Overall Study|Physician Decision|1|||
149780228|NCT00606177|540322661|FG001|Overall Study|Physician Decision|0|||
149780229|NCT00606177|540322660|FG000|Overall Study|Protocol Violation|1|||
149780230|NCT00606177|540322661|FG001|Overall Study|Protocol Violation|4|||
149780231|NCT00606177|540322660|FG000|Overall Study|Withdrawal by Subject|5|||
149780232|NCT00606177|540322661|FG001|Overall Study|Withdrawal by Subject|6|||
149780233|NCT00606177|540322660|FG000|Overall Study|Progression to depressive phase|6|||
149780234|NCT00606177|540322661|FG001|Overall Study|Progression to depressive phase|1|||
149780235|NCT00606177|540322660|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
149780236|NCT00606177|540322661|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
149780237|NCT00606177|540322660|FG000|Overall Study|Change of residence or other commitments|1|||
149780238|NCT00606177|540322661|FG001|Overall Study|Change of residence or other commitments|1|||
149780239|NCT02603172|540322662|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780240|NCT02603172|540322663|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780241|NCT02603172|540322664|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
149780242|NCT02603172|540322665|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780243|NCT02603172|540322666|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780244|NCT02603172|540322667|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780245|NCT02603172|540322668|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780246|NCT02603172|540322669|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149780247|NCT00420342|540322674|FG000|Overall Study|Lost to Follow-up|1|||
149780248|NCT00420342|540322675|FG001|Overall Study|Lost to Follow-up|0|||
149780249|NCT00420342|540322676|FG002|Overall Study|Lost to Follow-up|1|||
149780250|NCT00420342|540322674|FG000|Overall Study|Withdrawal by Subject|0|||
149780251|NCT00420342|540322675|FG001|Overall Study|Withdrawal by Subject|2|||
149780252|NCT00420342|540322676|FG002|Overall Study|Withdrawal by Subject|0|||
149780253|NCT00839436|540322677|FG000|Overall Study|Developed exclusionary condition|1|||
149780254|NCT00839436|540322678|FG001|Overall Study|Developed exclusionary condition|0|||
149780255|NCT00839436|540322679|FG002|Overall Study|Developed exclusionary condition|0|||
149780256|NCT00839436|540322677|FG000|Overall Study|Withdrawal by Subject|0|||
149780257|NCT00839436|540322678|FG001|Overall Study|Withdrawal by Subject|1|||
149780258|NCT00839436|540322679|FG002|Overall Study|Withdrawal by Subject|0|||
149780259|NCT00839436|540322677|FG000|Overall Study|Study drug no longer available|0|||
149780260|NCT00839436|540322678|FG001|Overall Study|Study drug no longer available|0|||
149780261|NCT00839436|540322679|FG002|Overall Study|Study drug no longer available|1|||
149780262|NCT01440972|540322680|FG000|Overall Study|Withdrawal by Subject|3|||
149780263|NCT01440972|540322681|FG001|Overall Study|Withdrawal by Subject|2|||
149780264|NCT03933215|540322682|FG000|Overall Study|Other|6|||
149780265|NCT03933215|540322682|FG000|Overall Study|Sponsor decision|5|||
149780266|NCT03933215|540322682|FG000|Overall Study|Protocol Violation|5|||
149780267|NCT03933215|540322682|FG000|Overall Study|Withdrawal by Subject|6|||
149780268|NCT03933215|540322682|FG000|Overall Study|Lost to Follow-up|6|||
149780269|NCT03933215|540322682|FG000|Overall Study|Enrolled but not treated|38|||
149780270|NCT05784129|540322683|FG000|Overall Study|Study terminated by sponsor|2|||
149780271|NCT05784129|540322684|FG001|Overall Study|Study terminated by sponsor|2|||
149780272|NCT00407550|540322685|FG000|Overall Study|Adverse Event|0|||
149780273|NCT00407550|540322686|FG001|Overall Study|Adverse Event|1|||
149780274|NCT00407550|540322685|FG000|Overall Study|Withdrawal by Subject|0|||
149780275|NCT00407550|540322686|FG001|Overall Study|Withdrawal by Subject|2|||
149780276|NCT00407550|540322685|FG000|Overall Study|Death|1|||
149780277|NCT00407550|540322686|FG001|Overall Study|Death|0|||
149780278|NCT00407550|540322685|FG000|Overall Study|Insurance or Other medical condition|2|||
149780279|NCT00407550|540322686|FG001|Overall Study|Insurance or Other medical condition|1|||
149780280|NCT02580591|540322688|FG000|Overall Study|Adverse Event|0|||
149780281|NCT02580591|540322689|FG001|Overall Study|Adverse Event|1|||
149780282|NCT02580591|540322690|FG002|Overall Study|Adverse Event|2|||
149780283|NCT02580591|540322691|FG003|Overall Study|Adverse Event|5|||
149780284|NCT02580591|540322688|FG000|Overall Study|Protocol Violation|3|||
149780285|NCT02580591|540322689|FG001|Overall Study|Protocol Violation|2|||
149780286|NCT02580591|540322690|FG002|Overall Study|Protocol Violation|1|||
149780287|NCT02580591|540322691|FG003|Overall Study|Protocol Violation|1|||
149780288|NCT02580591|540322688|FG000|Overall Study|Lost to Follow-up|5|||
149780289|NCT02580591|540322689|FG001|Overall Study|Lost to Follow-up|3|||
149780290|NCT02580591|540322690|FG002|Overall Study|Lost to Follow-up|3|||
149780291|NCT02580591|540322691|FG003|Overall Study|Lost to Follow-up|1|||
149780292|NCT02580591|540322688|FG000|Overall Study|Withdrawal by Subject|6|||
149780293|NCT02580591|540322689|FG001|Overall Study|Withdrawal by Subject|1|||
149780294|NCT02580591|540322690|FG002|Overall Study|Withdrawal by Subject|2|||
149780295|NCT02580591|540322691|FG003|Overall Study|Withdrawal by Subject|3|||
149780296|NCT02580591|540322688|FG000|Overall Study|Not treated|1|||
149780297|NCT02580591|540322689|FG001|Overall Study|Not treated|1|||
149780298|NCT02580591|540322690|FG002|Overall Study|Not treated|0|||
149780299|NCT02580591|540322691|FG003|Overall Study|Not treated|0|||
149780300|NCT02580591|540322688|FG000|Overall Study|Other than specified|3|||
149780301|NCT02580591|540322689|FG001|Overall Study|Other than specified|2|||
149780302|NCT02580591|540322690|FG002|Overall Study|Other than specified|5|||
149780303|NCT02580591|540322691|FG003|Overall Study|Other than specified|2|||
149780304|NCT01599806|540322695|FG000|Overall Study|Lost to Follow-up|20|||
149780305|NCT01599806|540322696|FG001|Overall Study|Lost to Follow-up|20|||
149780306|NCT01599806|540322695|FG000|Overall Study|Withdrawal by Subject|12|||
149780307|NCT01599806|540322696|FG001|Overall Study|Withdrawal by Subject|12|||
149780308|NCT01599806|540322695|FG000|Overall Study|Other Eligibility criteria|11|||
149780309|NCT01599806|540322696|FG001|Overall Study|Other Eligibility criteria|9|||
149780310|NCT00282568|540322708|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
149780311|NCT00282568|540322708|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
149780312|NCT00282568|540322708|FG000|Extended Treatment Period|Adverse Event|17|||
149780313|NCT00282568|540322708|FG000|Extended Treatment Period|Non-compliance|4|||
149780314|NCT00282568|540322708|FG000|Extended Treatment Period|Physician Decision|1|||
149780315|NCT00282568|540322708|FG000|Extended Treatment Period|Lost to Follow-up|2|||
149780316|NCT03006926|540322709|FG000|Overall Study|Adverse Event|0|||
149780317|NCT03006926|540322710|FG001|Overall Study|Adverse Event|27|||
149780318|NCT03006926|540322709|FG000|Overall Study|Withdrawal by Subject|0|||
149780319|NCT03006926|540322710|FG001|Overall Study|Withdrawal by Subject|1|||
149780320|NCT03006926|540322709|FG000|Overall Study|Radiological Disease Progression|0|||
149780321|NCT03006926|540322710|FG001|Overall Study|Radiological Disease Progression|52|||
149780322|NCT03006926|540322709|FG000|Overall Study|Clinical Disease Progression|0|||
149780323|NCT03006926|540322710|FG001|Overall Study|Clinical Disease Progression|10|||
149780324|NCT03006926|540322709|FG000|Overall Study|Other|0|||
149780325|NCT03006926|540322710|FG001|Overall Study|Other|8|||
149780326|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
149780327|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
149780328|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149780329|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149780330|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149780331|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149780332|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
149780333|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149780334|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149780335|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149780336|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149780337|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
149780338|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149780339|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149780340|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149780341|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
149780342|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
149780343|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149780344|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149780345|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149780346|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
149780347|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
149780348|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149780349|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149780350|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149780351|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
149780352|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
149780353|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149780354|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149780355|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149780356|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
149780357|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
149780358|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149780359|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149780360|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149780361|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
149780362|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
149780363|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149780364|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149780365|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149780366|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
149780367|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
149780368|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149780369|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149780370|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149780371|NCT03689972|540322711|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
149780372|NCT03689972|540322712|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
149780373|NCT03689972|540322713|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149780374|NCT03689972|540322714|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149780375|NCT03689972|540322715|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149780376|NCT03689972|540322711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149780377|NCT03689972|540322712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149780378|NCT03689972|540322713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
149780379|NCT03689972|540322714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149780380|NCT03689972|540322715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149780381|NCT03689972|540322711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149780382|NCT03689972|540322712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149780383|NCT03689972|540322713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
149780384|NCT03689972|540322714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149780385|NCT03689972|540322715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149780386|NCT03689972|540322711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149780387|NCT03689972|540322712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149780388|NCT03689972|540322713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
149780389|NCT03689972|540322714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149780390|NCT03689972|540322715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149780391|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149780392|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149780393|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149780394|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
149780395|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
149780396|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149780397|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149780398|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149780399|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
149780400|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
149780401|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149780402|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149780403|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149780404|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
149780405|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
149780406|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149780407|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149780408|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149780409|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149780410|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
149780411|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149780412|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149780413|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149780414|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
149780415|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
149780416|NCT03689972|540322711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149780417|NCT03689972|540322712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149780418|NCT03689972|540322713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149780419|NCT03689972|540322714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149780420|NCT03689972|540322715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
149780421|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
149780422|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
149780423|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
149780424|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149780425|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149780426|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
149780427|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149780428|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
149780429|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149780430|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
149780431|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149780432|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149780433|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149780434|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
149780435|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149780436|NCT02417064|540322720|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
149780437|NCT02417064|540322721|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
149780438|NCT02417064|540322722|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
149780439|NCT02417064|540322720|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
149780440|NCT02417064|540322721|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
149780441|NCT02417064|540322722|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
149780442|NCT02417064|540322720|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
149780443|NCT02417064|540322721|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
149780444|NCT02417064|540322722|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
149780445|NCT02417064|540322720|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
149780446|NCT02417064|540322721|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
149780447|NCT02417064|540322722|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
149780448|NCT02417064|540322720|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
149780449|NCT02417064|540322721|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
149780450|NCT02417064|540322722|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
149780451|NCT02417064|540322720|FG000|Follow-up Phase (24 Weeks)|Other|2|||
149780452|NCT02417064|540322721|FG001|Follow-up Phase (24 Weeks)|Other|2|||
149780453|NCT02417064|540322722|FG002|Follow-up Phase (24 Weeks)|Other|3|||
149780454|NCT00990249|540322723|FG000|Overall Study|Disease Progression|8|||
149780455|NCT00990249|540322723|FG000|Overall Study|Non-Compliance|1|||
149780456|NCT00990249|540322723|FG000|Overall Study|Death|2|||
149780457|NCT00990249|540322723|FG000|Overall Study|Not treated|2|||
149780458|NCT01548417|540322724|FG000|Overall Study|Withdrawal by Subject|0|||
149780459|NCT01548417|540322725|FG001|Overall Study|Withdrawal by Subject|2|||
149780460|NCT00732641|540322728|FG000|Overall Study|Relapse or Progressive Disease|65|||
149780461|NCT00732641|540322729|FG001|Overall Study|Relapse or Progressive Disease|101|||
149780462|NCT00732641|540322728|FG000|Overall Study|Serious Adverse Events|12|||
149780463|NCT00732641|540322729|FG001|Overall Study|Serious Adverse Events|3|||
149780464|NCT00732641|540322728|FG000|Overall Study|Physician Decision|6|||
149780465|NCT00732641|540322729|FG001|Overall Study|Physician Decision|0|||
149780466|NCT00732641|540322728|FG000|Overall Study|Withdrawal by Subject|4|||
149780467|NCT00732641|540322729|FG001|Overall Study|Withdrawal by Subject|2|||
149780468|NCT00732641|540322728|FG000|Overall Study|Unable to Complete|1|||
149780469|NCT00732641|540322729|FG001|Overall Study|Unable to Complete|1|||
149780470|NCT00732641|540322728|FG000|Overall Study|Other|18|||
149780471|NCT00732641|540322729|FG001|Overall Study|Other|5|||
149780472|NCT02873208|540322730|FG000|Overall Study|Withdrawal by Subject|36|||
149780473|NCT02873208|540322730|FG000|Overall Study|Lost to Follow-up|22|||
149780474|NCT02873208|540322730|FG000|Overall Study|Adverse Event|15|||
149780475|NCT02873208|540322730|FG000|Overall Study|Non-compliance with study drug|12|||
149780476|NCT02873208|540322730|FG000|Overall Study|Protocol Violation|8|||
149780477|NCT02873208|540322730|FG000|Overall Study|Pregnancy|2|||
149780478|NCT02873208|540322730|FG000|Overall Study|Incarceration|1|||
149780479|NCT02873208|540322730|FG000|Overall Study|Lack of Efficacy|1|||
149780480|NCT02873208|540322730|FG000|Overall Study|Physician Decision|1|||
149780481|NCT00415584|540322731|FG000|Overall Study|Withdrawal by Subject|1|||
149780482|NCT02640755|540322732|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
149780483|NCT02640755|540322733|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
149780484|NCT02640755|540322732|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
149780485|NCT02640755|540322733|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
149780486|NCT02640755|540322732|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
149780487|NCT02640755|540322733|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
149780488|NCT01192100|540322740|FG000|Overall Study|Withdrawal by Subject|0|||
149780489|NCT01192100|540322741|FG001|Overall Study|Withdrawal by Subject|0|||
149780490|NCT01192100|540322742|FG002|Overall Study|Withdrawal by Subject|0|||
149780491|NCT01192100|540322743|FG003|Overall Study|Withdrawal by Subject|0|||
149780492|NCT01192100|540322744|FG004|Overall Study|Withdrawal by Subject|1|||
149780493|NCT01192100|540322745|FG005|Overall Study|Withdrawal by Subject|0|||
149780494|NCT01192100|540322740|FG000|Overall Study|Protocol Violation|0|||
149780495|NCT01192100|540322741|FG001|Overall Study|Protocol Violation|0|||
149780496|NCT01192100|540322742|FG002|Overall Study|Protocol Violation|0|||
149780497|NCT01192100|540322743|FG003|Overall Study|Protocol Violation|1|||
149780498|NCT01192100|540322744|FG004|Overall Study|Protocol Violation|0|||
149780499|NCT01192100|540322745|FG005|Overall Study|Protocol Violation|0|||
149780500|NCT02057068|540322746|FG000|Overall Study|Withdrawal by Subject|2|||
149780501|NCT02057068|540322747|FG001|Overall Study|Withdrawal by Subject|2|||
149780502|NCT02057068|540322746|FG000|Overall Study|Caregiver (CG) Health|0|||
149780503|NCT02057068|540322747|FG001|Overall Study|Caregiver (CG) Health|2|||
149780504|NCT02057068|540322746|FG000|Overall Study|Carepartner (CP) Health|4|||
149780505|NCT02057068|540322747|FG001|Overall Study|Carepartner (CP) Health|2|||
149780506|NCT02057068|540322746|FG000|Overall Study|Lost to Follow-up|2|||
149780507|NCT02057068|540322747|FG001|Overall Study|Lost to Follow-up|2|||
149780508|NCT00865046|540322748|FG000|Overall Study|Lost to Follow-up|1|||
149780509|NCT00865046|540322749|FG001|Overall Study|Lost to Follow-up|4|||
149780510|NCT00865046|540322750|FG002|Overall Study|Lost to Follow-up|0|||
149780511|NCT00865046|540322748|FG000|Overall Study|Death|0|||
149780512|NCT00865046|540322749|FG001|Overall Study|Death|1|||
149780513|NCT00865046|540322750|FG002|Overall Study|Death|1|||
149780514|NCT00865046|540322748|FG000|Overall Study|Withdrawal by Subject|5|||
149780515|NCT00865046|540322749|FG001|Overall Study|Withdrawal by Subject|0|||
149780516|NCT00865046|540322750|FG002|Overall Study|Withdrawal by Subject|0|||
149780517|NCT02959190|540322751|FG000|Open Label|Adverse Event|5|||
149780518|NCT02959190|540322752|FG001|Open Label|Adverse Event|7|||
149780519|NCT02959190|540322753|FG002|Open Label|Adverse Event|3|||
149780520|NCT02959190|540322754|FG003|Open Label|Adverse Event|4|||
149780521|NCT02959190|540322751|FG000|Open Label|Pregnancy|0|||
149780522|NCT02959190|540322752|FG001|Open Label|Pregnancy|1|||
149780523|NCT02959190|540322753|FG002|Open Label|Pregnancy|0|||
149780524|NCT02959190|540322754|FG003|Open Label|Pregnancy|0|||
149780525|NCT02959190|540322751|FG000|Open Label|Withdrawal by Subject|2|||
149780526|NCT02959190|540322752|FG001|Open Label|Withdrawal by Subject|8|||
149780527|NCT02959190|540322753|FG002|Open Label|Withdrawal by Subject|0|||
149780528|NCT02959190|540322754|FG003|Open Label|Withdrawal by Subject|0|||
149780529|NCT02959190|540322751|FG000|Open Label|Physician Decision|0|||
149780530|NCT02959190|540322752|FG001|Open Label|Physician Decision|0|||
149780531|NCT02959190|540322753|FG002|Open Label|Physician Decision|1|||
149780532|NCT02959190|540322754|FG003|Open Label|Physician Decision|0|||
149780533|NCT02959190|540322751|FG000|Open Label|Protocol Violation|0|||
149780534|NCT02959190|540322752|FG001|Open Label|Protocol Violation|0|||
149780535|NCT02959190|540322753|FG002|Open Label|Protocol Violation|0|||
149780536|NCT02959190|540322754|FG003|Open Label|Protocol Violation|2|||
149780537|NCT02959190|540322751|FG000|Post Treatment Follow Up|Adverse Event|1|||
149780538|NCT02959190|540322752|FG001|Post Treatment Follow Up|Adverse Event|1|||
149780539|NCT02959190|540322753|FG002|Post Treatment Follow Up|Adverse Event|0|||
149780540|NCT02959190|540322754|FG003|Post Treatment Follow Up|Adverse Event|0|||
149780541|NCT02959190|540322751|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
149780542|NCT02959190|540322752|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
149780543|NCT02959190|540322753|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
149780544|NCT02959190|540322754|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
149780545|NCT01235507|540322756|FG000|Overall Study|Adverse Event|1|||
149780546|NCT01235507|540322756|FG000|Overall Study|Withdrawal by Subject|1|||
149780547|NCT02017704|540322759|FG000|Overall Study|Withdrawal by Subject|2|||
149780548|NCT02017704|540322760|FG001|Overall Study|Withdrawal by Subject|0|||
149780549|NCT01587274|540322761|FG000|Overall Study|Lost to Follow-up|4|||
149780550|NCT01587274|540322762|FG001|Overall Study|Lost to Follow-up|5|||
149780551|NCT01587274|540322763|FG002|Overall Study|Lost to Follow-up|3|||
149780552|NCT01095666|540322767|FG000|Overall Study|Lack of Efficacy|0|||
149780553|NCT01095666|540322768|FG001|Overall Study|Lack of Efficacy|0|||
149780554|NCT01095666|540322769|FG002|Overall Study|Lack of Efficacy|1|||
149780555|NCT01095666|540322767|FG000|Overall Study|Adverse Event|2|||
149780556|NCT01095666|540322768|FG001|Overall Study|Adverse Event|1|||
149780557|NCT01095666|540322769|FG002|Overall Study|Adverse Event|3|||
149780558|NCT01095666|540322767|FG000|Overall Study|Lost to Follow-up|2|||
149780559|NCT01095666|540322768|FG001|Overall Study|Lost to Follow-up|2|||
149780560|NCT01095666|540322769|FG002|Overall Study|Lost to Follow-up|0|||
149780561|NCT01095666|540322767|FG000|Overall Study|Withdrawal by Subject|6|||
149780562|NCT01095666|540322768|FG001|Overall Study|Withdrawal by Subject|6|||
149780563|NCT01095666|540322769|FG002|Overall Study|Withdrawal by Subject|1|||
149780564|NCT01095666|540322767|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
149780565|NCT01095666|540322768|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
149780566|NCT01095666|540322769|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
149780567|NCT03034057|540322771|FG000|Overall Study|Withdrawal by Subject|10|||
149780568|NCT03034057|540322771|FG000|Overall Study|Protocol Violation|1|||
149780569|NCT03034057|540322771|FG000|Overall Study|Not defined|2|||
149780570|NCT03034057|540322771|FG000|Overall Study|Lost to Follow-up|19|||
149780571|NCT03034057|540322771|FG000|Overall Study|Adverse Event|22|||
149780572|NCT03034057|540322771|FG000|Overall Study|Medication error without associated AE|1|||
149780573|NCT02917629|540322772|FG000|Overall Study|Withdrawal by Subject|0|||
149780574|NCT02917629|540322773|FG001|Overall Study|Withdrawal by Subject|1|||
149780575|NCT00718523|540322774|FG000|Overall Study|Withdrawal by Subject|5|||
149780576|NCT00718523|540322775|FG001|Overall Study|Withdrawal by Subject|7|||
149780577|NCT00718523|540322774|FG000|Overall Study|Death|13|||
149780578|NCT00718523|540322775|FG001|Overall Study|Death|17|||
149780579|NCT03271307|540322776|FG000|Overall Study|Lost to Follow-up|0|||
149780580|NCT03271307|540322777|FG001|Overall Study|Lost to Follow-up|0|||
149780581|NCT03271307|540322778|FG002|Overall Study|Lost to Follow-up|0|||
149780582|NCT03271307|540322779|FG003|Overall Study|Lost to Follow-up|28|||
149780583|NCT03271307|540322780|FG004|Overall Study|Lost to Follow-up|91|||
149780584|NCT00910728|540322781|FG000|Overall Study|Lack of Efficacy|2|||
149780585|NCT00910728|540322782|FG001|Overall Study|Lack of Efficacy|3|||
149780586|NCT00910728|540322783|FG002|Overall Study|Lack of Efficacy|1|||
149780587|NCT00910728|540322784|FG003|Overall Study|Lack of Efficacy|2|||
149780588|NCT00910728|540322785|FG004|Overall Study|Lack of Efficacy|1|||
149780589|NCT00910728|540322786|FG005|Overall Study|Lack of Efficacy|0|||
149780590|NCT00910728|540322787|FG006|Overall Study|Lack of Efficacy|2|||
149780591|NCT00910728|540322788|FG007|Overall Study|Lack of Efficacy|2|||
149780592|NCT00910728|540322789|FG008|Overall Study|Lack of Efficacy|2|||
149780593|NCT00910728|540322781|FG000|Overall Study|Withdrawal by Subject|0|||
149780594|NCT00910728|540322782|FG001|Overall Study|Withdrawal by Subject|0|||
149780595|NCT00910728|540322783|FG002|Overall Study|Withdrawal by Subject|0|||
149780596|NCT00910728|540322784|FG003|Overall Study|Withdrawal by Subject|0|||
149780597|NCT00910728|540322785|FG004|Overall Study|Withdrawal by Subject|3|||
149780598|NCT00910728|540322786|FG005|Overall Study|Withdrawal by Subject|1|||
149780599|NCT00910728|540322787|FG006|Overall Study|Withdrawal by Subject|2|||
149780600|NCT00910728|540322788|FG007|Overall Study|Withdrawal by Subject|0|||
149780601|NCT00910728|540322789|FG008|Overall Study|Withdrawal by Subject|0|||
149780602|NCT00910728|540322781|FG000|Overall Study|(not specified)|2|||
149780603|NCT00910728|540322782|FG001|Overall Study|(not specified)|0|||
149780604|NCT00910728|540322783|FG002|Overall Study|(not specified)|1|||
149780605|NCT00910728|540322784|FG003|Overall Study|(not specified)|0|||
149780606|NCT00910728|540322785|FG004|Overall Study|(not specified)|1|||
149780607|NCT00910728|540322786|FG005|Overall Study|(not specified)|0|||
149780608|NCT00910728|540322787|FG006|Overall Study|(not specified)|0|||
149780609|NCT00910728|540322788|FG007|Overall Study|(not specified)|0|||
149780610|NCT00910728|540322789|FG008|Overall Study|(not specified)|0|||
149780611|NCT00910728|540322781|FG000|Overall Study|Adverse Event|2|||
149780612|NCT00910728|540322782|FG001|Overall Study|Adverse Event|0|||
149780613|NCT00910728|540322783|FG002|Overall Study|Adverse Event|1|||
149780614|NCT00910728|540322784|FG003|Overall Study|Adverse Event|1|||
149780615|NCT00910728|540322785|FG004|Overall Study|Adverse Event|0|||
149780616|NCT00910728|540322786|FG005|Overall Study|Adverse Event|0|||
149780617|NCT00910728|540322787|FG006|Overall Study|Adverse Event|2|||
149780618|NCT00910728|540322788|FG007|Overall Study|Adverse Event|1|||
149780619|NCT00910728|540322789|FG008|Overall Study|Adverse Event|1|||
149780620|NCT05041062|540322790|FG000|Overall Study|Adverse Event|2|||
149780621|NCT03619837|540322800|FG000|Screening|received organs from HCV-negative donors|47|||
149780622|NCT03619837|540322800|FG000|Screening|died on the wait-list|2|||
149780623|NCT03619837|540322800|FG000|Screening|remained on the wait list|40|||
149780624|NCT03619837|540322800|FG000|Screening|didn't meet eligibility criteria|3|||
149780625|NCT03619837|540322800|FG000|Screening|withdrew consent|2|||
149780626|NCT03619837|540322800|FG000|Screening|never listed for HCV-viremic donor|1|||
149780627|NCT03619837|540322800|FG000|Screening|developed exclusion criteria|2|||
149780628|NCT03619837|540322800|FG000|Screening|excluded by the investigator due to non-compliance|1|||
149780629|NCT01696396|540324206|FG000|Overall Study|Withdrawal by Subject|19|||
149780630|NCT01696396|540324207|FG001|Overall Study|Withdrawal by Subject|5|||
149780631|NCT01696396|540324208|FG002|Overall Study|Withdrawal by Subject|19|||
149780632|NCT01696396|540324209|FG003|Overall Study|Withdrawal by Subject|11|||
149780633|NCT01696396|540324206|FG000|Overall Study|Decision by Sponsor|3|||
149780634|NCT01696396|540324207|FG001|Overall Study|Decision by Sponsor|1|||
149780635|NCT01696396|540324208|FG002|Overall Study|Decision by Sponsor|2|||
149780636|NCT01696396|540324209|FG003|Overall Study|Decision by Sponsor|2|||
149780637|NCT01696396|540324206|FG000|Overall Study|Lost to Follow-up|9|||
149780638|NCT01696396|540324207|FG001|Overall Study|Lost to Follow-up|1|||
149780639|NCT01696396|540324208|FG002|Overall Study|Lost to Follow-up|4|||
149780640|NCT01696396|540324209|FG003|Overall Study|Lost to Follow-up|1|||
149780641|NCT01696396|540324206|FG000|Overall Study|Death|0|||
149780642|NCT01696396|540324207|FG001|Overall Study|Death|0|||
149780643|NCT01696396|540324208|FG002|Overall Study|Death|1|||
149780644|NCT01696396|540324209|FG003|Overall Study|Death|0|||
149780645|NCT01731990|540324211|FG000|Overall Study|Adverse Event|1|||
149780646|NCT01731990|540324212|FG001|Overall Study|Adverse Event|5|||
149780647|NCT01731990|540324211|FG000|Overall Study|Withdrawal by Subject|1|||
149780648|NCT01731990|540324212|FG001|Overall Study|Withdrawal by Subject|1|||
149780649|NCT01731990|540324211|FG000|Overall Study|Protocol deviation|1|||
149780650|NCT01731990|540324212|FG001|Overall Study|Protocol deviation|2|||
149780651|NCT01731990|540324211|FG000|Overall Study|Death|1|||
149780652|NCT01731990|540324212|FG001|Overall Study|Death|0|||
149780653|NCT01957215|540324221|FG000|Overall Study|Adverse Event|2|||
149780654|NCT01957215|540324222|FG001|Overall Study|Adverse Event|2|||
149780655|NCT01957215|540324221|FG000|Overall Study|Lost to Follow-up|3|||
149780656|NCT01957215|540324222|FG001|Overall Study|Lost to Follow-up|3|||
149780657|NCT01957215|540324221|FG000|Overall Study|Protocol Violation|1|||
149780658|NCT01957215|540324222|FG001|Overall Study|Protocol Violation|2|||
149780659|NCT01957215|540324221|FG000|Overall Study|Withdrawal by Subject|7|||
149780660|NCT01957215|540324222|FG001|Overall Study|Withdrawal by Subject|5|||
149780661|NCT03597503|540324226|FG000|Overall Study|Withdrawal by Subject|0|||
149780662|NCT03597503|540324227|FG001|Overall Study|Withdrawal by Subject|2|||
149780663|NCT03597503|540324226|FG000|Overall Study|Lost to Follow-up|1|||
149780664|NCT03597503|540324227|FG001|Overall Study|Lost to Follow-up|2|||
149780665|NCT03597503|540324226|FG000|Overall Study|Protocol Violation|1|||
149780666|NCT03597503|540324227|FG001|Overall Study|Protocol Violation|0|||
149780667|NCT02944513|540324228|FG000|Overall Study|Withdrawal by Subject|4|||
149780668|NCT02944513|540324229|FG001|Overall Study|Withdrawal by Subject|1|||
149780669|NCT00688623|540324234|FG000|Overall Study|Adverse Event|22|||
149780670|NCT00688623|540324234|FG000|Overall Study|abnormal lab value|1|||
149780671|NCT00688623|540324234|FG000|Overall Study|Withdrawal by Subject|4|||
149780672|NCT00688623|540324234|FG000|Overall Study|Death|3|||
149780673|NCT00688623|540324234|FG000|Overall Study|disease progression|23|||
149780674|NCT00688623|540324234|FG000|Overall Study|Protocol Violation|2|||
149780675|NCT02667236|540324235|FG000|Overall Study|Adverse Event|1|||
149780676|NCT02667236|540324236|FG001|Overall Study|Adverse Event|1|||
149780677|NCT02667236|540324235|FG000|Overall Study|Withdrawal by Subject|2|||
149780678|NCT02667236|540324236|FG001|Overall Study|Withdrawal by Subject|0|||
149780679|NCT04402385|540324238|FG000|Overall Study|Withdrawal by Subject|4|||
149780680|NCT04402385|540324239|FG001|Overall Study|Withdrawal by Subject|4|||
149780681|NCT04402385|540324238|FG000|Overall Study|Lost to Follow-up|1|||
149780682|NCT04402385|540324239|FG001|Overall Study|Lost to Follow-up|1|||
149780683|NCT04402385|540324238|FG000|Overall Study|Physician Decision|0|||
149780684|NCT04402385|540324239|FG001|Overall Study|Physician Decision|1|||
149780685|NCT01235338|540324241|FG000|Overall Study|Adverse Event|3|||
149780686|NCT01235338|540324242|FG001|Overall Study|Adverse Event|2|||
149780687|NCT01235338|540324241|FG000|Overall Study|Protocol Violation|1|||
149780688|NCT01235338|540324242|FG001|Overall Study|Protocol Violation|1|||
149780689|NCT01235338|540324241|FG000|Overall Study|Withdrawal by Subject|5|||
149780690|NCT01235338|540324242|FG001|Overall Study|Withdrawal by Subject|0|||
149780691|NCT01235338|540324241|FG000|Overall Study|Exclusion criteria violations|1|||
149780692|NCT01235338|540324242|FG001|Overall Study|Exclusion criteria violations|1|||
149780693|NCT01235338|540324241|FG000|Overall Study|Positive drug screen|0|||
149780694|NCT01235338|540324242|FG001|Overall Study|Positive drug screen|1|||
149780695|NCT01235338|540324241|FG000|Overall Study|Prohibited meds|1|||
149780696|NCT01235338|540324242|FG001|Overall Study|Prohibited meds|0|||
149780697|NCT02809118|540324243|FG000|Overall Study|Withdrawal by Subject|0|||
149780698|NCT02809118|540324244|FG001|Overall Study|Withdrawal by Subject|1|||
149780699|NCT02809118|540324245|FG002|Overall Study|Withdrawal by Subject|1|||
149780700|NCT05283499|540324249|FG000|Overall Study|Did not receive intervention|1|||
149780701|NCT05283499|540324250|FG001|Overall Study|Did not receive intervention|2|||
149780702|NCT02436915|540324251|FG000|Overall Study|Withdrawal by Subject|0|||
149780703|NCT02436915|540324252|FG001|Overall Study|Withdrawal by Subject|1|||
149780704|NCT01518309|540324254|FG000|Overall Study|Adverse Event|6|||
149780705|NCT01518309|540324254|FG000|Overall Study|Death|6|||
149780706|NCT01518309|540324254|FG000|Overall Study|Lack of Efficacy|7|||
149780707|NCT01518309|540324254|FG000|Overall Study|Withdrawal by Subject|6|||
149780708|NCT01518309|540324254|FG000|Overall Study|Physician Decision|3|||
149780709|NCT01518309|540324254|FG000|Overall Study|Sponsor Decision|2|||
149780710|NCT01518309|540324254|FG000|Overall Study|Not in Predefined Categories|9|||
149780711|NCT00863317|540324255|FG000|Overall Study|Lost to Follow-up|8|||
149780712|NCT00863317|540324256|FG001|Overall Study|Lost to Follow-up|9|||
149780713|NCT00038142|540324259|FG000|Overall Study|Ineligible|1|||
149780714|NCT00038142|540324260|FG001|Overall Study|Ineligible|0|||
149780715|NCT00038142|540324259|FG000|Overall Study|Progressive Disease|11|||
149780716|NCT00038142|540324260|FG001|Overall Study|Progressive Disease|7|||
149780717|NCT00038142|540324259|FG000|Overall Study|Death|1|||
149780718|NCT00038142|540324260|FG001|Overall Study|Death|0|||
149780719|NCT00038142|540324259|FG000|Overall Study|Adverse Event|1|||
149780720|NCT00038142|540324260|FG001|Overall Study|Adverse Event|0|||
149780721|NCT00038142|540324259|FG000|Overall Study|Unknown Reason|8|||
149780722|NCT00038142|540324260|FG001|Overall Study|Unknown Reason|0|||
149780723|NCT00809614|540324261|FG000|Overall Study|Lack of Efficacy|2|||
149780724|NCT00809614|540324262|FG001|Overall Study|Lack of Efficacy|3|||
149780725|NCT00809614|540324261|FG000|Overall Study|Withdrawal by Subject|1|||
149780726|NCT00809614|540324262|FG001|Overall Study|Withdrawal by Subject|1|||
149780727|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
149780728|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
149780729|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
149780730|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
149780731|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
149780732|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
149780733|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
149780734|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
149780735|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
149780736|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
149780737|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
149780738|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
149780739|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
149780740|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
149780741|NCT03434041|540324267|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
149780742|NCT03434041|540324268|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
149780743|NCT03434041|540324267|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
149780744|NCT03434041|540324268|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
149780745|NCT03434041|540324267|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
149780746|NCT03434041|540324268|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
149780747|NCT03434041|540324267|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
149801789|NCT04338685|540402444|FG006|Overall Study|Death|1|||
149780748|NCT03434041|540324268|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
149780749|NCT00654420|540324269|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
149780750|NCT00654420|540324270|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
149780751|NCT00654420|540324271|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
149780752|NCT00654420|540324272|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
149780753|NCT00654420|540324269|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
149780754|NCT00654420|540324270|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
149780755|NCT00654420|540324271|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
149780756|NCT00654420|540324272|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
149780757|NCT00654420|540324269|FG000|Phase II|Adverse Event|0|||
149780758|NCT00654420|540324270|FG001|Phase II|Adverse Event|0|||
149780759|NCT00654420|540324271|FG002|Phase II|Adverse Event|3|||
149780760|NCT00654420|540324272|FG003|Phase II|Adverse Event|3|||
149780761|NCT00654420|540324269|FG000|Phase II|Lost to Follow-up|0|||
149780762|NCT00654420|540324270|FG001|Phase II|Lost to Follow-up|0|||
149780763|NCT00654420|540324271|FG002|Phase II|Lost to Follow-up|0|||
149780764|NCT00654420|540324272|FG003|Phase II|Lost to Follow-up|1|||
149780765|NCT00654420|540324269|FG000|Phase II|Physician Decision|0|||
149780766|NCT00654420|540324270|FG001|Phase II|Physician Decision|0|||
149780767|NCT00654420|540324271|FG002|Phase II|Physician Decision|0|||
149780768|NCT00654420|540324272|FG003|Phase II|Physician Decision|4|||
149780769|NCT00654420|540324269|FG000|Phase II|Progressive Disease|0|||
149780770|NCT00654420|540324270|FG001|Phase II|Progressive Disease|0|||
149780771|NCT00654420|540324271|FG002|Phase II|Progressive Disease|29|||
149780772|NCT00654420|540324272|FG003|Phase II|Progressive Disease|29|||
149780773|NCT00654420|540324269|FG000|Phase II|Withdrawal by Subject|0|||
149780774|NCT00654420|540324270|FG001|Phase II|Withdrawal by Subject|0|||
149780775|NCT00654420|540324271|FG002|Phase II|Withdrawal by Subject|4|||
149780776|NCT00654420|540324272|FG003|Phase II|Withdrawal by Subject|1|||
149780777|NCT00654420|540324269|FG000|Phase II|Missing Disposition Record|0|||
149780778|NCT00654420|540324270|FG001|Phase II|Missing Disposition Record|0|||
149780779|NCT00654420|540324271|FG002|Phase II|Missing Disposition Record|1|||
149780780|NCT00654420|540324272|FG003|Phase II|Missing Disposition Record|0|||
149780781|NCT00841672|540324278|FG000|Overall Study|Adverse Event|7|||
149780782|NCT00841672|540324279|FG001|Overall Study|Adverse Event|16|||
149780783|NCT00841672|540324278|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149780784|NCT00841672|540324279|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149780785|NCT00841672|540324278|FG000|Overall Study|Subject withdrew consent|2|||
149780786|NCT00841672|540324279|FG001|Overall Study|Subject withdrew consent|4|||
149780787|NCT00841672|540324278|FG000|Overall Study|Lost to Follow-up|1|||
149780788|NCT00841672|540324279|FG001|Overall Study|Lost to Follow-up|1|||
149780789|NCT00841672|540324278|FG000|Overall Study|Administrative problems|9|||
149780790|NCT00841672|540324279|FG001|Overall Study|Administrative problems|9|||
149780791|NCT00841672|540324278|FG000|Overall Study|Misrandomized|1|||
149780792|NCT00841672|540324279|FG001|Overall Study|Misrandomized|0|||
149780793|NCT00841672|540324278|FG000|Overall Study|Protocol Deviation|0|||
149780794|NCT00841672|540324279|FG001|Overall Study|Protocol Deviation|1|||
149780795|NCT02709109|540324280|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
149780796|NCT02709109|540324281|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
149780797|NCT02709109|540324282|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
149780798|NCT02709109|540324283|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
149780799|NCT02709109|540324280|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149780800|NCT02709109|540324281|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
149780801|NCT02709109|540324282|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149780802|NCT02709109|540324283|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149780803|NCT02709109|540324280|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
149780804|NCT02709109|540324281|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149780805|NCT02709109|540324282|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149780806|NCT02709109|540324283|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149780807|NCT02709109|540324280|FG000|Washout Period (28 Days)|Other|2|||
149780808|NCT02709109|540324281|FG001|Washout Period (28 Days)|Other|2|||
149780809|NCT02709109|540324282|FG002|Washout Period (28 Days)|Other|3|||
149780810|NCT02709109|540324283|FG003|Washout Period (28 Days)|Other|0|||
149780811|NCT02709109|540324280|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
149780812|NCT02709109|540324281|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
149780813|NCT02709109|540324282|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
149780814|NCT02709109|540324283|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
149780815|NCT02709109|540324280|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
149780816|NCT02709109|540324281|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
149780817|NCT02709109|540324282|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
149780818|NCT02709109|540324283|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
149780819|NCT02709109|540324280|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149780820|NCT02709109|540324281|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149801790|NCT04338685|540402445|FG007|Overall Study|Death|0|||
149780821|NCT02709109|540324282|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
149780822|NCT02709109|540324283|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149780823|NCT02709109|540324280|FG000|Treatment Period 2 (28 Days)|Other|0|||
149780824|NCT02709109|540324281|FG001|Treatment Period 2 (28 Days)|Other|0|||
149780825|NCT02709109|540324282|FG002|Treatment Period 2 (28 Days)|Other|1|||
149780826|NCT02709109|540324283|FG003|Treatment Period 2 (28 Days)|Other|0|||
149780827|NCT01928082|540324285|FG000|Overall Study|Study terminated.|1|||
149780828|NCT01815580|540324289|FG000|Overall Study|Lost to Follow-up|4|||
149780829|NCT01815580|540324290|FG001|Overall Study|Lost to Follow-up|7|||
149780830|NCT01815580|540324289|FG000|Overall Study|Withdrawal by Subject|3|||
149780831|NCT01815580|540324290|FG001|Overall Study|Withdrawal by Subject|4|||
149780832|NCT01815580|540324289|FG000|Overall Study|Excluded from analysis|5|||
149780833|NCT01815580|540324290|FG001|Overall Study|Excluded from analysis|4|||
149780834|NCT00924729|540324298|FG000|Overall Study|insufficient volume for analysis|1|||
149780835|NCT00924729|540324299|FG001|Overall Study|insufficient volume for analysis|0|||
149780836|NCT00924729|540324298|FG000|Overall Study|Protocol Violation|1|||
149780837|NCT00924729|540324299|FG001|Overall Study|Protocol Violation|0|||
149780838|NCT00196196|540324300|FG000|Overall Study|Withdrawal by Subject|2|||
149780839|NCT00196196|540324300|FG000|Overall Study|Did not have required condition (hydroce|5|||
149780840|NCT01814826|540324305|FG000|Overall Study|Other|3|||
149780841|NCT01814826|540324306|FG001|Overall Study|Other|5|||
149780842|NCT01814826|540324307|FG002|Overall Study|Other|0|||
149780843|NCT01814826|540324305|FG000|Overall Study|Death|29|||
149780844|NCT01814826|540324306|FG001|Overall Study|Death|24|||
149780845|NCT01814826|540324307|FG002|Overall Study|Death|3|||
149780846|NCT03339401|540324308|FG000|Overall Study|Death|2|||
149780847|NCT03339401|540324309|FG001|Overall Study|Death|1|||
149780848|NCT03339401|540324308|FG000|Overall Study|Withdrawal by Subject|2|||
149780849|NCT03339401|540324309|FG001|Overall Study|Withdrawal by Subject|0|||
149780850|NCT03339401|540324308|FG000|Overall Study|Study terminated|4|||
149780851|NCT03339401|540324309|FG001|Overall Study|Study terminated|3|||
149780852|NCT03339401|540324308|FG000|Overall Study|Investigator Decision|1|||
149780853|NCT03339401|540324309|FG001|Overall Study|Investigator Decision|0|||
149780854|NCT01042938|540324310|FG000|Overall Study|Withdrawal by Subject|1|||
149780855|NCT01042938|540324311|FG001|Overall Study|Withdrawal by Subject|1|||
149780856|NCT01042938|540324310|FG000|Overall Study|Protocol Violation|1|||
149780857|NCT01042938|540324311|FG001|Overall Study|Protocol Violation|1|||
149780858|NCT01042938|540324310|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
149780859|NCT01042938|540324311|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
149780860|NCT03997760|540324312|FG000|Overall Study|Protocol Deviation|0|||
149780861|NCT03997760|540324313|FG001|Overall Study|Protocol Deviation|1|||
149780862|NCT03997760|540324314|FG002|Overall Study|Protocol Deviation|0|||
149780863|NCT03997760|540324315|FG003|Overall Study|Protocol Deviation|0|||
149780864|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
149780865|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
149780866|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
149780867|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
149780868|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
149780869|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149780870|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149780871|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149780872|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
149780873|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149780874|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149780875|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149780876|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149780877|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
149780878|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149780879|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149780880|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149780881|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149780882|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
149780883|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149780884|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149780885|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149780886|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149780887|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
149780888|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149780889|NCT00856986|540324316|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
149780890|NCT00856986|540324317|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
149780891|NCT00856986|540324318|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
149780892|NCT00856986|540324319|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
149780893|NCT00856986|540324320|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
149780894|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
149780895|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
149780896|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
149780897|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
149780898|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
149780899|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
149780900|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
149780901|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
149780902|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
149780903|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
149780904|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
149780905|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149780906|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
149780907|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149780908|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149780909|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
149780910|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
149780911|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
149780912|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
149780913|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
149780914|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
149780915|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
149780916|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149780917|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149780918|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149780919|NCT00856986|540324316|FG000|Main Period, Weeks 0-26|Unclassified|7|||
149780920|NCT00856986|540324317|FG001|Main Period, Weeks 0-26|Unclassified|6|||
149780921|NCT00856986|540324318|FG002|Main Period, Weeks 0-26|Unclassified|7|||
149780922|NCT00856986|540324319|FG003|Main Period, Weeks 0-26|Unclassified|0|||
149780923|NCT00856986|540324320|FG004|Main Period, Weeks 0-26|Unclassified|0|||
149780924|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
149780925|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
149780926|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
149780927|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
149780928|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
149780929|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
149780930|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
149780931|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
149780932|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
149780933|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
149780934|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
149780935|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149780936|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
149780937|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149780938|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149780939|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149780940|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
149780941|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
149780942|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149780943|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149780944|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
149780945|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
149780946|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
149780947|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
149780948|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
149780949|NCT00856986|540324316|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
149780950|NCT00856986|540324317|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
149780951|NCT00856986|540324318|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
149780952|NCT00856986|540324319|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
149780953|NCT00856986|540324320|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
149780954|NCT03032510|540324321|FG000|Overall Study|Adverse Event|5|||
149780955|NCT03032510|540324322|FG001|Overall Study|Adverse Event|2|||
149780956|NCT03032510|540324321|FG000|Overall Study|Lost to Follow-up|8|||
149780957|NCT03032510|540324322|FG001|Overall Study|Lost to Follow-up|7|||
149780958|NCT03032510|540324321|FG000|Overall Study|Withdrawal by Subject|8|||
149780959|NCT03032510|540324322|FG001|Overall Study|Withdrawal by Subject|7|||
149780960|NCT03032510|540324321|FG000|Overall Study|Subject noncompliance|4|||
149780961|NCT03032510|540324322|FG001|Overall Study|Subject noncompliance|2|||
149780962|NCT03032510|540324321|FG000|Overall Study|Physician Decision|2|||
149780963|NCT03032510|540324322|FG001|Overall Study|Physician Decision|0|||
149780964|NCT04018612|540324325|FG000|Overall Study|Withdrawal by Subject|1|||
149780965|NCT04018612|540324326|FG001|Overall Study|Withdrawal by Subject|0|||
149780966|NCT04018612|540324327|FG002|Overall Study|Withdrawal by Subject|1|||
149780967|NCT00361218|540324328|FG000|Overall Study|Lost to Follow-up|11|||
149780968|NCT00361218|540324328|FG000|Overall Study|Personal Reasons|7|||
149780969|NCT00361218|540324328|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
149780970|NCT02566109|540324332|FG000|Overall Study|Withdrawal by Subject|1|||
149780971|NCT01802515|540324333|FG000|Overall Study|Withdrawal by Subject|3|||
149780972|NCT01802515|540324334|FG001|Overall Study|Withdrawal by Subject|0|||
149780973|NCT01802515|540324335|FG002|Overall Study|Withdrawal by Subject|0|||
149780974|NCT01906476|540324336|FG000|Overall Study|Lost to Follow-up|17|||
149780975|NCT01906476|540324337|FG001|Overall Study|Lost to Follow-up|16|||
149780976|NCT01041404|540324339|FG000|Overall Study|Adverse Event|45|||
149780977|NCT01041404|540324340|FG001|Overall Study|Adverse Event|35|||
149780978|NCT01041404|540324339|FG000|Overall Study|Lack of Efficacy|200|||
149780979|NCT01041404|540324340|FG001|Overall Study|Lack of Efficacy|210|||
149780980|NCT01041404|540324339|FG000|Overall Study|Violation of Selection Criteria|0|||
149780981|NCT01041404|540324340|FG001|Overall Study|Violation of Selection Criteria|1|||
149780982|NCT01041404|540324339|FG000|Overall Study|Protocol Violation|4|||
149780983|NCT01041404|540324340|FG001|Overall Study|Protocol Violation|0|||
149780984|NCT01041404|540324339|FG000|Overall Study|Withdrawal by Subject|29|||
149780985|NCT01041404|540324340|FG001|Overall Study|Withdrawal by Subject|23|||
149780986|NCT01041404|540324339|FG000|Overall Study|Failure to Return|1|||
149780987|NCT01041404|540324340|FG001|Overall Study|Failure to Return|2|||
149780988|NCT01041404|540324339|FG000|Overall Study|Other|11|||
149780989|NCT01041404|540324340|FG001|Overall Study|Other|23|||
149780990|NCT01993667|540324341|FG000|Overall Study|Insufficient data to analyze|16|||
149780991|NCT01993667|540324342|FG001|Overall Study|Insufficient data to analyze|16|||
149780992|NCT01993667|540324341|FG000|Overall Study|Insufficient altitude reached|3|||
149780993|NCT01993667|540324342|FG001|Overall Study|Insufficient altitude reached|1|||
149780994|NCT01993667|540324341|FG000|Overall Study|Lost to Follow-up|2|||
149780995|NCT01993667|540324342|FG001|Overall Study|Lost to Follow-up|2|||
149780996|NCT01931150|540324343|FG000|Overall Study|Withdrawal by Subject|1|||
149780997|NCT01931150|540324344|FG001|Overall Study|Withdrawal by Subject|2|||
149780998|NCT01131078|540326083|FG000|Overall Study|Adverse Event|22|||
149780999|NCT01131078|540326084|FG001|Overall Study|Adverse Event|12|||
149781000|NCT01131078|540326085|FG002|Overall Study|Adverse Event|17|||
149781001|NCT01131078|540326083|FG000|Overall Study|Progressive Disease|58|||
149781002|NCT01131078|540326084|FG001|Overall Study|Progressive Disease|77|||
149781003|NCT01131078|540326085|FG002|Overall Study|Progressive Disease|71|||
149781004|NCT01131078|540326083|FG000|Overall Study|Protocol Violation|1|||
149781005|NCT01131078|540326084|FG001|Overall Study|Protocol Violation|0|||
149781006|NCT01131078|540326085|FG002|Overall Study|Protocol Violation|0|||
149781007|NCT01131078|540326083|FG000|Overall Study|Lost to Follow-up|1|||
149781008|NCT01131078|540326084|FG001|Overall Study|Lost to Follow-up|1|||
149781009|NCT01131078|540326085|FG002|Overall Study|Lost to Follow-up|1|||
149781010|NCT01131078|540326083|FG000|Overall Study|Withdrawal by Subject|2|||
149781011|NCT01131078|540326084|FG001|Overall Study|Withdrawal by Subject|4|||
149781012|NCT01131078|540326085|FG002|Overall Study|Withdrawal by Subject|3|||
149781013|NCT01131078|540326083|FG000|Overall Study|Non-compliance|3|||
149781014|NCT01131078|540326084|FG001|Overall Study|Non-compliance|0|||
149781015|NCT01131078|540326085|FG002|Overall Study|Non-compliance|0|||
149781016|NCT01131078|540326083|FG000|Overall Study|Physician Decision|10|||
149781017|NCT01131078|540326084|FG001|Overall Study|Physician Decision|6|||
149781018|NCT01131078|540326085|FG002|Overall Study|Physician Decision|8|||
149781019|NCT01131078|540326083|FG000|Overall Study|Death|4|||
149781020|NCT01131078|540326084|FG001|Overall Study|Death|0|||
149781021|NCT01131078|540326085|FG002|Overall Study|Death|2|||
149781022|NCT01131078|540326083|FG000|Overall Study|Other|0|||
149781023|NCT01131078|540326084|FG001|Overall Study|Other|1|||
149781024|NCT01131078|540326085|FG002|Overall Study|Other|0|||
149781025|NCT00608244|540326086|FG000|Overall Study|Adverse Event|1|||
149781026|NCT00608244|540326086|FG000|Overall Study|Low trough levels|1|||
149781027|NCT01977040|540326088|FG000|Overall Study|Vasa previa not confirmed|2|||
149781028|NCT01685060|540326089|FG000|Overall Study|Rollover patients|16|||
149781029|NCT01685060|540326089|FG000|Overall Study|Adverse Event|12|||
149781030|NCT01685060|540326089|FG000|Overall Study|Progressive disease|69|||
149781031|NCT01685060|540326089|FG000|Overall Study|Physician Decision|14|||
149781032|NCT01685060|540326089|FG000|Overall Study|Subject/guardian decision|20|||
149781033|NCT01685060|540326089|FG000|Overall Study|Lost to Follow-up|1|||
149781034|NCT01685060|540326089|FG000|Overall Study|Death|8|||
149781035|NCT02000219|540326090|FG000|14-Week Study Period|Physician Decision|1|||
149781036|NCT02000219|540326090|FG000|14-Week Study Period|Adverse Event|1|||
149781037|NCT02000219|540326090|FG000|14-Week Study Period|Underwent transplantation|1|||
149781038|NCT02000219|540326090|FG000|Continuation Period|Withdrawal by Subject|1|||
149781039|NCT02000219|540326090|FG000|Continuation Period|Had liver transplant|2|||
149781040|NCT02000219|540326090|FG000|Continuation Period|Non-compliance with study drug|2|||
149781041|NCT00608894|540326094|FG000|Overall Study|Withdrawal by Subject|0|||
149781042|NCT00608894|540326095|FG001|Overall Study|Withdrawal by Subject|2|||
149781043|NCT00209092|540326100|FG000|Overall Study|Progression of disease|7|||
149781044|NCT00209092|540326101|FG001|Overall Study|Progression of disease|1|||
149781045|NCT00209092|540326100|FG000|Overall Study|Adverse Event|0|||
149781046|NCT00209092|540326101|FG001|Overall Study|Adverse Event|1|||
149781047|NCT00209092|540326100|FG000|Overall Study|Withdrawal by Subject|1|||
149781048|NCT00209092|540326101|FG001|Overall Study|Withdrawal by Subject|0|||
149781049|NCT02408484|540326102|FG000|Overall Study|Withdrawal by Subject|3|||
149781050|NCT02408484|540326102|FG000|Overall Study|Not treated during study period|1|||
149781051|NCT01117181|540326104|FG000|Overall Study|Lost to Follow-up|1|||
149781052|NCT01117181|540326105|FG001|Overall Study|Lost to Follow-up|0|||
149781053|NCT01117181|540326104|FG000|Overall Study|Withdrawal by Subject|0|||
149781054|NCT01117181|540326105|FG001|Overall Study|Withdrawal by Subject|2|||
149781055|NCT00216086|540326106|FG000|Overall Study|Protocol Violation|1|||
149781056|NCT00216086|540326106|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
149781057|NCT00216086|540326106|FG000|Overall Study|Social Reasons|2|||
149781058|NCT01080625|540326107|FG000|Overall Study|Physician Decision|0|||
149781059|NCT01080625|540326108|FG001|Overall Study|Physician Decision|2|||
149781060|NCT01080625|540326109|FG002|Overall Study|Physician Decision|1|||
149781061|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Death|3|||
149781062|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Death|0|||
149781063|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Death|0|||
149781064|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Death|0|||
149781065|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Death|0|||
149781066|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
149781067|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
149781068|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
149781069|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
149781070|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
149781071|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149781072|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
149781073|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
149781074|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149781075|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
149781076|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Other|0|||
149781077|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Other|0|||
149781078|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Other|1|||
149781079|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Other|0|||
149781080|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Other|0|||
149781081|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
149781082|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
149781083|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
149781084|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
149781085|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
149781086|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
149781087|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
149781088|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
149781089|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
149781090|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
149781091|NCT01224106|540326110|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149781092|NCT01224106|540326111|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149781093|NCT01224106|540326112|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149781094|NCT01224106|540326113|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149781095|NCT01224106|540326114|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149781096|NCT01224106|540326110|FG000|Open-Label Extension (OLE) Phase|Death|0|||
149781097|NCT01224106|540326111|FG001|Open-Label Extension (OLE) Phase|Death|0|||
149781098|NCT01224106|540326112|FG002|Open-Label Extension (OLE) Phase|Death|0|||
149781099|NCT01224106|540326113|FG003|Open-Label Extension (OLE) Phase|Death|1|||
149781100|NCT01224106|540326114|FG004|Open-Label Extension (OLE) Phase|Death|3|||
149781101|NCT01224106|540326110|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149781102|NCT01224106|540326111|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149781103|NCT01224106|540326112|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149781104|NCT01224106|540326113|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
149781105|NCT01224106|540326114|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
149781106|NCT01224106|540326110|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149781107|NCT01224106|540326111|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149781108|NCT01224106|540326112|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149781109|NCT01224106|540326113|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
149781110|NCT01224106|540326114|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
149781111|NCT01224106|540326110|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
149781112|NCT01224106|540326111|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
149781113|NCT01224106|540326112|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
149781114|NCT01224106|540326113|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
149781115|NCT01224106|540326114|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
149781116|NCT01224106|540326110|FG000|Open-Label Extension (OLE) Phase|Other|0|||
149781117|NCT01224106|540326111|FG001|Open-Label Extension (OLE) Phase|Other|0|||
149781118|NCT01224106|540326112|FG002|Open-Label Extension (OLE) Phase|Other|0|||
149781119|NCT01224106|540326113|FG003|Open-Label Extension (OLE) Phase|Other|5|||
149781120|NCT01224106|540326114|FG004|Open-Label Extension (OLE) Phase|Other|3|||
149781121|NCT00446797|540326115|FG000|Overall Study|Lack of Efficacy|0|||
149781122|NCT00446797|540326116|FG001|Overall Study|Lack of Efficacy|2|||
149781123|NCT00446797|540326115|FG000|Overall Study|Lost to Follow-up|5|||
149781124|NCT00446797|540326116|FG001|Overall Study|Lost to Follow-up|3|||
149781125|NCT00446797|540326115|FG000|Overall Study|Withdrawal by Subject|2|||
149781126|NCT00446797|540326116|FG001|Overall Study|Withdrawal by Subject|2|||
149781127|NCT00446797|540326115|FG000|Overall Study|Protocol Violation|1|||
149781128|NCT00446797|540326116|FG001|Overall Study|Protocol Violation|3|||
149781129|NCT00446797|540326115|FG000|Overall Study|subject entered at another site|0|||
149781130|NCT00446797|540326116|FG001|Overall Study|subject entered at another site|1|||
149781131|NCT00446797|540326115|FG000|Overall Study|did not meet entrance criteria|0|||
149781132|NCT00446797|540326116|FG001|Overall Study|did not meet entrance criteria|1|||
149781133|NCT00364832|540326119|FG000|Core Period|Early Withdrawals|2|||
149781134|NCT00364832|540326120|FG001|Core Period|Early Withdrawals|2|||
149781135|NCT00364832|540326121|FG002|Core Period|Early Withdrawals|1|||
149781136|NCT00364832|540326122|FG003|Core Period|Early Withdrawals|1|||
149781137|NCT00364832|540326123|FG004|Core Period|Early Withdrawals|0|||
149781138|NCT00364832|540326124|FG005|Core Period|Early Withdrawals|0|||
149781139|NCT00364832|540326125|FG006|Core Period|Early Withdrawals|4|||
149781140|NCT00364832|540326126|FG007|Core Period|Early Withdrawals|1|||
149781141|NCT00364832|540326127|FG008|Core Period|Early Withdrawals|0|||
149781142|NCT00364832|540326128|FG009|Core Period|Early Withdrawals|0|||
149781143|NCT00364832|540326129|FG010|Core Period|Early Withdrawals|0|||
149781144|NCT00364832|540326130|FG011|Core Period|Early Withdrawals|0|||
149781145|NCT00364832|540326119|FG000|Extension Year 1|Early Withdrawals|0|||
149781146|NCT00364832|540326120|FG001|Extension Year 1|Early Withdrawals|0|||
149781147|NCT00364832|540326121|FG002|Extension Year 1|Early Withdrawals|0|||
149781148|NCT00364832|540326122|FG003|Extension Year 1|Early Withdrawals|0|||
149781149|NCT00364832|540326123|FG004|Extension Year 1|Early Withdrawals|0|||
149781150|NCT00364832|540326124|FG005|Extension Year 1|Early Withdrawals|0|||
149781151|NCT00364832|540326125|FG006|Extension Year 1|Early Withdrawals|0|||
149781152|NCT00364832|540326126|FG007|Extension Year 1|Early Withdrawals|0|||
149781153|NCT00364832|540326127|FG008|Extension Year 1|Early Withdrawals|0|||
149781154|NCT00364832|540326128|FG009|Extension Year 1|Early Withdrawals|4|||
149781155|NCT00364832|540326129|FG010|Extension Year 1|Early Withdrawals|2|||
149781156|NCT00364832|540326130|FG011|Extension Year 1|Early Withdrawals|10|||
149781157|NCT00364832|540326119|FG000|Extension Year 2|Early Withdrawals|0|||
149781158|NCT00364832|540326120|FG001|Extension Year 2|Early Withdrawals|0|||
149781159|NCT00364832|540326121|FG002|Extension Year 2|Early Withdrawals|0|||
149781160|NCT00364832|540326122|FG003|Extension Year 2|Early Withdrawals|0|||
149781161|NCT00364832|540326123|FG004|Extension Year 2|Early Withdrawals|0|||
149781162|NCT00364832|540326124|FG005|Extension Year 2|Early Withdrawals|0|||
149781163|NCT00364832|540326125|FG006|Extension Year 2|Early Withdrawals|0|||
149781164|NCT00364832|540326126|FG007|Extension Year 2|Early Withdrawals|0|||
149781165|NCT00364832|540326127|FG008|Extension Year 2|Early Withdrawals|0|||
149781166|NCT00364832|540326128|FG009|Extension Year 2|Early Withdrawals|5|||
149781167|NCT00364832|540326129|FG010|Extension Year 2|Early Withdrawals|5|||
149781168|NCT00364832|540326130|FG011|Extension Year 2|Early Withdrawals|3|||
149781169|NCT04072575|540326135|FG000|Overall Study|Physician Decision|1|||
149781170|NCT04072575|540326135|FG000|Overall Study|Adverse Event|7|||
149781171|NCT04072575|540326135|FG000|Overall Study|Withdrawal by Subject|14|||
149781172|NCT04072575|540326135|FG000|Overall Study|Other|2|||
149781173|NCT01266070|540326136|FG000|Overall Study|Adverse Event|3|||
149781174|NCT01266070|540326136|FG000|Overall Study|Protocol Violation|1|||
149781175|NCT01838213|540326137|FG000|Overall Study|Ineligible|166|||
149781176|NCT01838213|540326138|FG001|Overall Study|Ineligible|191|||
149781177|NCT04882072|540326139|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
149781178|NCT04882072|540326140|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
149781179|NCT04882072|540326139|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
149781180|NCT04882072|540326140|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
149781181|NCT04882072|540326139|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
149781182|NCT04882072|540326140|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
149781183|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
149781184|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
149781185|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
149781186|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
149781187|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
149781188|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149781189|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149781190|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149781191|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
149781192|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149781193|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149781194|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149781195|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149781196|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
149781197|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149781198|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
149781199|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
149781200|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149781201|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149781202|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149781203|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149781204|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149781205|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149781206|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
149781207|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149781208|NCT02918318|540326141|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
149781209|NCT02918318|540326142|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
149781210|NCT02918318|540326143|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
149781211|NCT02918318|540326144|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
149781212|NCT02918318|540326145|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
149781213|NCT02918318|540326141|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149781214|NCT02918318|540326142|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149781215|NCT02918318|540326143|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149781216|NCT02918318|540326144|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
149781217|NCT02918318|540326145|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149781218|NCT02918318|540326141|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149781219|NCT02918318|540326142|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781220|NCT02918318|540326143|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149781221|NCT02918318|540326144|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149781222|NCT02918318|540326145|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781223|NCT02918318|540326141|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
149781224|NCT02918318|540326142|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149781225|NCT02918318|540326143|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149781226|NCT02918318|540326144|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
149781227|NCT02918318|540326145|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149781228|NCT02918318|540326141|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
149781229|NCT02918318|540326142|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
149781230|NCT02918318|540326143|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
149781231|NCT02918318|540326144|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
149781232|NCT02918318|540326145|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
149781233|NCT02918318|540326141|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149781234|NCT02918318|540326142|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149781235|NCT02918318|540326143|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149781236|NCT02918318|540326144|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149781237|NCT02918318|540326145|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
149781238|NCT02918318|540326141|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781239|NCT02918318|540326142|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781240|NCT02918318|540326143|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781241|NCT02918318|540326144|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149781242|NCT02918318|540326145|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
149781243|NCT03185819|540326146|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149781244|NCT03185819|540326147|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149781245|NCT03185819|540326148|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149781246|NCT03185819|540326149|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
149781247|NCT03185819|540326146|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
149781248|NCT03185819|540326147|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
149781249|NCT03185819|540326148|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
149781250|NCT03185819|540326149|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
149781251|NCT03185819|540326146|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
149781252|NCT03185819|540326147|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149781253|NCT03185819|540326148|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149781254|NCT03185819|540326149|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149781255|NCT03185819|540326146|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
149781256|NCT03185819|540326147|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
149781257|NCT03185819|540326148|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
149781258|NCT03185819|540326149|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
149781259|NCT03185819|540326146|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149781260|NCT03185819|540326147|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149781261|NCT03185819|540326148|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149781262|NCT03185819|540326149|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
149781263|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
149781264|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
149781265|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
149781266|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
149781267|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
149781268|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
149781269|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
149781270|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
149781271|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
149781272|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
149781273|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
149781274|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
149781275|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
149781276|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149781277|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149781278|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149781279|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
149781280|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
149781281|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
149781282|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
149781283|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
149781284|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
149781285|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
149781286|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
149781287|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
149781288|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
149781289|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
149781290|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
149781291|NCT03185819|540326146|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
149781292|NCT03185819|540326147|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149781293|NCT03185819|540326148|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149781294|NCT03185819|540326149|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149781295|NCT03097133|540326150|FG000|Overall Study|Lost to Follow-up|3|||
149781296|NCT03097133|540326151|FG001|Overall Study|Lost to Follow-up|2|||
149781297|NCT03097133|540326150|FG000|Overall Study|Withdrawal by Subject|2|||
149781298|NCT03097133|540326151|FG001|Overall Study|Withdrawal by Subject|5|||
149781299|NCT03097133|540326150|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
149781300|NCT03097133|540326151|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
149781301|NCT03097133|540326150|FG000|Overall Study|Other|3|||
149781302|NCT03097133|540326151|FG001|Overall Study|Other|2|||
149781303|NCT03097133|540326150|FG000|Overall Study|Adverse Event|1|||
149781304|NCT03097133|540326151|FG001|Overall Study|Adverse Event|0|||
149781305|NCT02910089|540326154|FG000|Overall Study|Lost insurance eligibility|22|||
149781306|NCT02910089|540326155|FG001|Overall Study|Lost insurance eligibility|16|||
149781307|NCT02939976|540326156|FG000|Overall Study|Lost to Follow-up|7|||
149781308|NCT02939976|540326157|FG001|Overall Study|Lost to Follow-up|1|||
149781309|NCT02939976|540326158|FG002|Overall Study|Lost to Follow-up|1|||
149781310|NCT02939976|540326159|FG003|Overall Study|Lost to Follow-up|2|||
149781311|NCT02939976|540326156|FG000|Overall Study|Withdrawal by Subject|4|||
149781312|NCT02939976|540326157|FG001|Overall Study|Withdrawal by Subject|0|||
149781313|NCT02939976|540326158|FG002|Overall Study|Withdrawal by Subject|2|||
149781314|NCT02939976|540326159|FG003|Overall Study|Withdrawal by Subject|4|||
149781315|NCT02939976|540326156|FG000|Overall Study|Due to early study closure|4|||
149781316|NCT02939976|540326157|FG001|Overall Study|Due to early study closure|3|||
149781317|NCT02939976|540326158|FG002|Overall Study|Due to early study closure|2|||
149781318|NCT02939976|540326159|FG003|Overall Study|Due to early study closure|3|||
149781319|NCT04080752|540326160|FG000|Overall Study|Adverse Event|2|||
149781320|NCT04080752|540326161|FG001|Overall Study|Adverse Event|3|||
149781321|NCT04080752|540326160|FG000|Overall Study|Lack of Efficacy|1|||
149781322|NCT04080752|540326161|FG001|Overall Study|Lack of Efficacy|0|||
149781323|NCT04080752|540326160|FG000|Overall Study|Lost to Follow-up|1|||
149781324|NCT04080752|540326161|FG001|Overall Study|Lost to Follow-up|0|||
149781325|NCT04080752|540326160|FG000|Overall Study|Pregnancy|0|||
149781326|NCT04080752|540326161|FG001|Overall Study|Pregnancy|1|||
149781327|NCT04080752|540326160|FG000|Overall Study|Withdrawal by Subject|7|||
149781328|NCT04080752|540326161|FG001|Overall Study|Withdrawal by Subject|0|||
149781329|NCT04080752|540326160|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149781330|NCT04080752|540326161|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149781331|NCT04080752|540326160|FG000|Overall Study|Other|2|||
149781332|NCT04080752|540326161|FG001|Overall Study|Other|1|||
149781333|NCT01585168|540326162|FG000|Overall Study|Lost to Follow-up|3|||
149781334|NCT01585168|540326163|FG001|Overall Study|Lost to Follow-up|1|||
149781335|NCT01585168|540326164|FG002|Overall Study|Lost to Follow-up|1|||
149781336|NCT01585168|540326165|FG003|Overall Study|Lost to Follow-up|1|||
149781337|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
149781338|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
149781339|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
149781340|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
149781341|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
149781342|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
149781343|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
149781344|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
149781345|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
149781346|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
149781347|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
149781348|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
149781349|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149781350|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
149781351|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149781352|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149781353|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
149781354|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
149781355|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
149781356|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
149781357|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
149781358|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
149781359|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
149781360|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
149781361|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Other|0|||
149781362|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Other|1|||
149781363|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Other|0|||
149781364|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Other|0|||
149781365|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
149781366|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
149781367|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
149781368|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
149781369|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
149781370|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
149781371|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
149781372|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
149781373|NCT01194414|540326166|FG000|24 Weeks Double Blind Period|Death|0|||
149781374|NCT01194414|540326167|FG001|24 Weeks Double Blind Period|Death|1|||
149781375|NCT01194414|540326168|FG002|24 Weeks Double Blind Period|Death|0|||
149781376|NCT01194414|540326169|FG003|24 Weeks Double Blind Period|Death|0|||
149781377|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
149781378|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
149781379|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
149781380|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
149781381|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
149781382|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
149781383|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
149781384|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
149781385|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
149781386|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
149781387|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
149781388|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
149781389|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
149781390|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
149781391|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
149781392|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
149781393|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
149781394|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
149781395|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
149781396|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
149781397|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
149781398|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
149781399|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
149781400|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
149781401|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Other|2|||
149781402|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Other|1|||
149781403|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Other|0|||
149781404|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Other|0|||
149781405|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
149781406|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
149781407|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
149781408|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
149781409|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
149781410|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
149781411|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
149781412|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
149781413|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
149781414|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
149781415|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
149781416|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
149781417|NCT01194414|540326166|FG000|72 Weeks Open Label Extension|Death|1|||
149781418|NCT01194414|540326167|FG001|72 Weeks Open Label Extension|Death|2|||
149781419|NCT01194414|540326168|FG002|72 Weeks Open Label Extension|Death|0|||
149781420|NCT01194414|540326169|FG003|72 Weeks Open Label Extension|Death|2|||
149781421|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
149781422|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149781423|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149781424|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149781425|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
149781426|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149781427|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149781428|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149781429|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
149781430|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
149781431|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
149781432|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
149781433|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
149781434|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
149781435|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
149781436|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
149781437|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
149781438|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149781439|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149781440|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149781441|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
149781442|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149781443|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149781444|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149781445|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
149781446|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149781447|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149781448|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149781449|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
149781450|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149781451|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149781452|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149781453|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
149781454|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149781455|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149781456|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149781457|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
149781458|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149781459|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149781460|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149781461|NCT03605836|540326170|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
149781462|NCT03605836|540326171|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149781463|NCT03605836|540326172|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149781464|NCT03605836|540326173|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149781465|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
149781466|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
149781467|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
149781468|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
149781469|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
149781470|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
149781471|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
149781472|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
149781473|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
149781474|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
149781475|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
149781476|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
149781477|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
149781478|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
149781479|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
149781480|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
149781481|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
149781482|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
149781483|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
149781484|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
149781485|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149781486|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
149781487|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149781488|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149781489|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
149781490|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
149781491|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
149781492|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
149781493|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
149781494|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
149781495|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
149781496|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
149781497|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
149781498|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
149781499|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
149781500|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
149781501|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
149781502|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
149781503|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
149781504|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
149781505|NCT03605836|540326170|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
149781506|NCT03605836|540326171|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
149781507|NCT03605836|540326172|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
149781508|NCT03605836|540326173|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
149781509|NCT01782885|540326176|FG000|Overall Study|Lost to Follow-up|4|||
149781510|NCT01782885|540326177|FG001|Overall Study|Lost to Follow-up|6|||
149781511|NCT02977507|540326180|FG000|Overall Study|Protocol Deviation|1|||
149781512|NCT02977507|540326181|FG001|Overall Study|Protocol Deviation|0|||
149781513|NCT02977507|540326180|FG000|Overall Study|Lost to Follow-up|1|||
149781514|NCT02977507|540326181|FG001|Overall Study|Lost to Follow-up|0|||
149781515|NCT00422669|540326184|FG000|Overall Study|The study was terminated early.|98|||
149781516|NCT00422669|540326185|FG001|Overall Study|The study was terminated early.|100|||
149781517|NCT00422669|540326186|FG002|Overall Study|The study was terminated early.|7|||
149781518|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
149781519|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
149781520|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
149781521|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
149781522|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
149781523|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
149781524|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
149781525|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
149781526|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781527|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781528|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781529|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781530|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781531|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149781532|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
149781533|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
149781534|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
149781535|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
149781536|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
149781537|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
149781538|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
149781539|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
149781540|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781541|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781542|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781543|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781544|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781545|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149781546|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
149781547|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781548|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781549|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781550|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781551|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781552|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149781553|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
149781554|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781555|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781556|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781557|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781558|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781559|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149781560|NCT02120352|540326189|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
149781561|NCT02120352|540326190|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
149781562|NCT02120352|540326191|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
149781563|NCT02120352|540326192|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
149781564|NCT02120352|540326193|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
149781565|NCT02120352|540326194|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
149781566|NCT02120352|540326195|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
149781567|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149781568|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
149781569|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
149781570|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
149781571|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149781572|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149781573|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149781574|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149781575|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
149781576|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149781577|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
149781578|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149781579|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149781580|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149781581|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149781582|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
149781583|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
149781584|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149781585|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149781586|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149781587|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149781588|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149781589|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149781590|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
149781591|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
149781592|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149781593|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149781594|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149781595|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781596|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781597|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781598|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
149781599|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781600|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781601|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149781602|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149781603|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
149781604|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
149781605|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
149781606|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149781607|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149781608|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149781609|NCT02120352|540326189|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781610|NCT02120352|540326190|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
149781611|NCT02120352|540326191|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781612|NCT02120352|540326192|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781613|NCT02120352|540326193|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781614|NCT02120352|540326194|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781615|NCT02120352|540326195|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149781616|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149781617|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
149781618|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
149781619|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149781620|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
149781621|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
149781622|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149781623|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781624|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781625|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781626|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781627|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
149781628|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781629|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149781630|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149781631|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
149781632|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
149781633|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149781634|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
149781635|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149781636|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149781637|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149781638|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
149781639|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
149781640|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149781641|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
149781642|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149781643|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149781644|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149781645|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
149781646|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
149781647|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149781648|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
149781649|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149781650|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149781651|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149801791|NCT04338685|540402446|FG008|Overall Study|Death|0|||
149781652|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
149781653|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
149781654|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149781655|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149781656|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149781657|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149781658|NCT02120352|540326189|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
149781659|NCT02120352|540326190|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
149781660|NCT02120352|540326191|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
149781661|NCT02120352|540326192|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
149781662|NCT02120352|540326193|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
149781663|NCT02120352|540326194|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
149781664|NCT02120352|540326195|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
149781665|NCT02120352|540326189|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781666|NCT02120352|540326190|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781667|NCT02120352|540326191|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781668|NCT02120352|540326192|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781669|NCT02120352|540326193|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781670|NCT02120352|540326194|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149781671|NCT02120352|540326195|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
149781672|NCT02427100|540326196|FG000|Overall Study|Lost to Follow-up|0|||
149781673|NCT02427100|540326197|FG001|Overall Study|Lost to Follow-up|2|||
149781674|NCT01610206|540326198|FG000|Overall Study|Adverse Event|10|||
149781675|NCT01610206|540326199|FG001|Overall Study|Adverse Event|30|||
149781676|NCT01929707|540326201|FG000|Intervention Period 1|Lost to Follow-up|0|||
149781677|NCT01929707|540326202|FG001|Intervention Period 1|Lost to Follow-up|0|||
149781678|NCT01929707|540326203|FG002|Intervention Period 1|Lost to Follow-up|0|||
149781679|NCT01929707|540326204|FG003|Intervention Period 1|Lost to Follow-up|1|||
149781680|NCT01929707|540326205|FG004|Intervention Period 1|Lost to Follow-up|0|||
149781681|NCT01929707|540326206|FG005|Intervention Period 1|Lost to Follow-up|0|||
149781682|NCT01929707|540326207|FG006|Intervention Period 1|Lost to Follow-up|0|||
149781683|NCT01929707|540326208|FG007|Intervention Period 1|Lost to Follow-up|0|||
149781684|NCT01929707|540326201|FG000|Intervention Period 1|Withdrawal by Subject|0|||
149781685|NCT01929707|540326202|FG001|Intervention Period 1|Withdrawal by Subject|0|||
149781686|NCT01929707|540326203|FG002|Intervention Period 1|Withdrawal by Subject|0|||
149781687|NCT01929707|540326204|FG003|Intervention Period 1|Withdrawal by Subject|2|||
149781688|NCT01929707|540326205|FG004|Intervention Period 1|Withdrawal by Subject|0|||
149781689|NCT01929707|540326206|FG005|Intervention Period 1|Withdrawal by Subject|0|||
149781690|NCT01929707|540326207|FG006|Intervention Period 1|Withdrawal by Subject|0|||
149781691|NCT01929707|540326208|FG007|Intervention Period 1|Withdrawal by Subject|0|||
149781692|NCT01929707|540326201|FG000|Intervention Period 2|Withdrawal by Subject|0|||
149781693|NCT01929707|540326202|FG001|Intervention Period 2|Withdrawal by Subject|0|||
149781694|NCT01929707|540326203|FG002|Intervention Period 2|Withdrawal by Subject|0|||
149781695|NCT01929707|540326204|FG003|Intervention Period 2|Withdrawal by Subject|0|||
149781696|NCT01929707|540326205|FG004|Intervention Period 2|Withdrawal by Subject|0|||
149781697|NCT01929707|540326206|FG005|Intervention Period 2|Withdrawal by Subject|2|||
149781698|NCT01929707|540326207|FG006|Intervention Period 2|Withdrawal by Subject|0|||
149781699|NCT01929707|540326208|FG007|Intervention Period 2|Withdrawal by Subject|0|||
149781700|NCT00437203|540326209|FG000|Overall Study|Death|0|||
149781701|NCT00437203|540326210|FG001|Overall Study|Death|0|||
149781702|NCT00437203|540326211|FG002|Overall Study|Death|1|||
149781703|NCT00437203|540326212|FG003|Overall Study|Death|0|||
149781704|NCT00437203|540326213|FG004|Overall Study|Death|0|||
149781705|NCT00437203|540326214|FG005|Overall Study|Death|0|||
149781706|NCT00437203|540326215|FG006|Overall Study|Death|0|||
149781707|NCT00437203|540326216|FG007|Overall Study|Death|1|||
149781708|NCT00437203|540326217|FG008|Overall Study|Death|0|||
149781709|NCT00437203|540326218|FG009|Overall Study|Death|1|||
149781710|NCT00437203|540326209|FG000|Overall Study|Adverse Event|1|||
149781711|NCT00437203|540326210|FG001|Overall Study|Adverse Event|1|||
149781712|NCT00437203|540326211|FG002|Overall Study|Adverse Event|0|||
149781713|NCT00437203|540326212|FG003|Overall Study|Adverse Event|0|||
149781714|NCT00437203|540326213|FG004|Overall Study|Adverse Event|0|||
149781715|NCT00437203|540326214|FG005|Overall Study|Adverse Event|0|||
149781716|NCT00437203|540326215|FG006|Overall Study|Adverse Event|0|||
149781717|NCT00437203|540326216|FG007|Overall Study|Adverse Event|1|||
149781718|NCT00437203|540326217|FG008|Overall Study|Adverse Event|0|||
149781719|NCT00437203|540326218|FG009|Overall Study|Adverse Event|1|||
149781720|NCT00437203|540326209|FG000|Overall Study|Study terminated by sponsor|0|||
149781721|NCT00437203|540326210|FG001|Overall Study|Study terminated by sponsor|0|||
149781722|NCT00437203|540326211|FG002|Overall Study|Study terminated by sponsor|0|||
149781723|NCT00437203|540326212|FG003|Overall Study|Study terminated by sponsor|0|||
149781724|NCT00437203|540326213|FG004|Overall Study|Study terminated by sponsor|0|||
149781725|NCT00437203|540326214|FG005|Overall Study|Study terminated by sponsor|0|||
149781726|NCT00437203|540326215|FG006|Overall Study|Study terminated by sponsor|0|||
149781727|NCT00437203|540326216|FG007|Overall Study|Study terminated by sponsor|0|||
149781728|NCT00437203|540326217|FG008|Overall Study|Study terminated by sponsor|1|||
149781729|NCT00437203|540326218|FG009|Overall Study|Study terminated by sponsor|0|||
149781730|NCT00437203|540326209|FG000|Overall Study|Objective progression or relapse|5|||
149781731|NCT00437203|540326210|FG001|Overall Study|Objective progression or relapse|6|||
149781732|NCT00437203|540326211|FG002|Overall Study|Objective progression or relapse|2|||
149781733|NCT00437203|540326212|FG003|Overall Study|Objective progression or relapse|3|||
149781734|NCT00437203|540326213|FG004|Overall Study|Objective progression or relapse|3|||
149781735|NCT00437203|540326214|FG005|Overall Study|Objective progression or relapse|3|||
149781736|NCT00437203|540326215|FG006|Overall Study|Objective progression or relapse|6|||
149781737|NCT00437203|540326216|FG007|Overall Study|Objective progression or relapse|1|||
149781738|NCT00437203|540326217|FG008|Overall Study|Objective progression or relapse|2|||
149781739|NCT00437203|540326218|FG009|Overall Study|Objective progression or relapse|2|||
149781740|NCT00437203|540326209|FG000|Overall Study|Other|0|||
149781741|NCT00437203|540326210|FG001|Overall Study|Other|1|||
149781742|NCT00437203|540326211|FG002|Overall Study|Other|0|||
149781743|NCT00437203|540326212|FG003|Overall Study|Other|0|||
149781744|NCT00437203|540326213|FG004|Overall Study|Other|0|||
149781745|NCT00437203|540326214|FG005|Overall Study|Other|0|||
149781746|NCT00437203|540326215|FG006|Overall Study|Other|1|||
149781747|NCT00437203|540326216|FG007|Overall Study|Other|0|||
149781748|NCT00437203|540326217|FG008|Overall Study|Other|0|||
149781749|NCT00437203|540326218|FG009|Overall Study|Other|0|||
149781750|NCT00431496|540326225|FG000|Overall Study|Adverse Event|3|||
149781751|NCT00431496|540326225|FG000|Overall Study|Lost to Follow-up|1|||
149781752|NCT00431496|540326225|FG000|Overall Study|Withdrawal by Subject|2|||
149781753|NCT00431496|540326225|FG000|Overall Study|Protocol-specified criteria|5|||
149781754|NCT01915095|540326226|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
149781755|NCT01915095|540326227|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
149781756|NCT01915095|540326228|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
149781757|NCT01915095|540326229|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
149781758|NCT01915095|540326230|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
149781759|NCT02343952|540326231|FG000|Study Treatment|Disease Progression|23|||
149781760|NCT02343952|540326231|FG000|Study Treatment|Death|3|||
149781761|NCT02343952|540326231|FG000|Study Treatment|Adverse Event|19|||
149781762|NCT02343952|540326231|FG000|Study Treatment|Withdrawal by Subject|7|||
149781763|NCT02343952|540326231|FG000|Study Treatment|other complicating Diseases|1|||
149781764|NCT02343952|540326231|FG000|Follow up|Withdrawal by Subject|3|||
149781765|NCT02343952|540326231|FG000|Follow up|Death|33|||
149781766|NCT02343952|540326231|FG000|Follow up|Patient does not meet eligibility for study.|1|||
149781767|NCT02343952|540326231|FG000|Follow up|Research department closed by the practice.|5|||
149781768|NCT02343952|540326231|FG000|Follow up|Patient went home to Russia|1|||
149781769|NCT02343952|540326231|FG000|Follow up|Disease Progression|1|||
149781770|NCT02343952|540326231|FG000|Follow up|study terminated|1|||
149781771|NCT02067533|540326232|FG000|Overall Study|Lost to Follow-up|4|||
149781772|NCT02067533|540326233|FG001|Overall Study|Lost to Follow-up|2|||
149781773|NCT02671760|540326234|FG000|Overall Study|Lost to Follow-up|0|||
149781774|NCT02671760|540326235|FG001|Overall Study|Lost to Follow-up|1|||
149781775|NCT02671760|540326236|FG002|Overall Study|Lost to Follow-up|0|||
149781776|NCT02999191|540326237|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
149781777|NCT02999191|540326238|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
149781778|NCT02999191|540326239|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
149781779|NCT04968353|540326244|FG000|Overall Study|Non-compliance|1|||
149781780|NCT04968353|540326245|FG001|Overall Study|Non-compliance|0|||
149781781|NCT04968353|540326246|FG002|Overall Study|Non-compliance|2|||
149781782|NCT04968353|540326247|FG003|Overall Study|Non-compliance|0|||
149781783|NCT00845845|540326248|FG000|Overall Study|Lost to Follow-up|0|||
149781784|NCT00845845|540326249|FG001|Overall Study|Lost to Follow-up|4|||
149781785|NCT01685203|540326250|FG000|Overall Study|Lost to Follow-up|3|||
149781786|NCT01685203|540326251|FG001|Overall Study|Lost to Follow-up|3|||
149781787|NCT01685203|540326252|FG002|Overall Study|Lost to Follow-up|0|||
149781788|NCT01685203|540326253|FG003|Overall Study|Lost to Follow-up|1|||
149781789|NCT01685203|540326254|FG004|Overall Study|Lost to Follow-up|0|||
149781790|NCT01685203|540326255|FG005|Overall Study|Lost to Follow-up|0|||
149781791|NCT01685203|540326256|FG006|Overall Study|Lost to Follow-up|0|||
149781792|NCT01685203|540326250|FG000|Overall Study|Adverse Event|0|||
149781793|NCT01685203|540326251|FG001|Overall Study|Adverse Event|0|||
149781794|NCT01685203|540326252|FG002|Overall Study|Adverse Event|0|||
149781795|NCT01685203|540326253|FG003|Overall Study|Adverse Event|0|||
149781796|NCT01685203|540326254|FG004|Overall Study|Adverse Event|0|||
149781797|NCT01685203|540326255|FG005|Overall Study|Adverse Event|2|||
149781798|NCT01685203|540326256|FG006|Overall Study|Adverse Event|0|||
149781799|NCT01685203|540326250|FG000|Overall Study|Adverse event and withdrew consent|1|||
149781800|NCT01685203|540326251|FG001|Overall Study|Adverse event and withdrew consent|0|||
149781801|NCT01685203|540326252|FG002|Overall Study|Adverse event and withdrew consent|0|||
149781802|NCT01685203|540326253|FG003|Overall Study|Adverse event and withdrew consent|0|||
149781803|NCT01685203|540326254|FG004|Overall Study|Adverse event and withdrew consent|0|||
149781804|NCT01685203|540326255|FG005|Overall Study|Adverse event and withdrew consent|0|||
149781805|NCT01685203|540326256|FG006|Overall Study|Adverse event and withdrew consent|0|||
149781806|NCT01685203|540326250|FG000|Overall Study|Patient's decision|0|||
149781807|NCT01685203|540326251|FG001|Overall Study|Patient's decision|0|||
149781808|NCT01685203|540326252|FG002|Overall Study|Patient's decision|0|||
149781809|NCT01685203|540326253|FG003|Overall Study|Patient's decision|0|||
149781810|NCT01685203|540326254|FG004|Overall Study|Patient's decision|0|||
149781811|NCT01685203|540326255|FG005|Overall Study|Patient's decision|1|||
149781812|NCT01685203|540326256|FG006|Overall Study|Patient's decision|0|||
149781813|NCT02896192|540326257|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
149781814|NCT02896192|540326257|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
149781815|NCT02896192|540326257|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
149781816|NCT00383708|540326258|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
149781817|NCT00383708|540326258|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
149781818|NCT00383708|540326258|FG000|Run-in Period|Protocol Violation|4|||
149781819|NCT00383708|540326258|FG000|Run-in Period|Adverse Event|2|||
149781820|NCT00383708|540326258|FG000|Run-in Period|Claustrophobia|1|||
149781821|NCT00383708|540326258|FG000|Co-administration Period|Adverse Event|5|||
149781822|NCT00318370|540326259|FG000|Period 1|Lack of Efficacy|5|||
149781823|NCT00318370|540326260|FG001|Period 1|Lack of Efficacy|0|||
149781824|NCT00318370|540326261|FG002|Period 1|Lack of Efficacy|0|||
149781825|NCT00318370|540326259|FG000|Period 1|Physician Decision|1|||
149781826|NCT00318370|540326260|FG001|Period 1|Physician Decision|0|||
149781827|NCT00318370|540326261|FG002|Period 1|Physician Decision|0|||
149781828|NCT00318370|540326259|FG000|Period 1|Withdrawal by Subject|1|||
149781829|NCT00318370|540326260|FG001|Period 1|Withdrawal by Subject|0|||
149781830|NCT00318370|540326261|FG002|Period 1|Withdrawal by Subject|0|||
149781831|NCT00318370|540326259|FG000|Period 2|Adverse Event|0|||
149781832|NCT00318370|540326260|FG001|Period 2|Adverse Event|3|||
149781833|NCT00318370|540326261|FG002|Period 2|Adverse Event|0|||
149781834|NCT00318370|540326259|FG000|Period 2|Lack of Efficacy|0|||
149781835|NCT00318370|540326260|FG001|Period 2|Lack of Efficacy|5|||
149781836|NCT00318370|540326261|FG002|Period 2|Lack of Efficacy|0|||
149781837|NCT00318370|540326259|FG000|Period 2|Physician Decision|0|||
149781838|NCT00318370|540326260|FG001|Period 2|Physician Decision|1|||
149781839|NCT00318370|540326261|FG002|Period 2|Physician Decision|0|||
149781840|NCT00318370|540326259|FG000|Period 2|Withdrawal by Subject|0|||
149781841|NCT00318370|540326260|FG001|Period 2|Withdrawal by Subject|1|||
149781842|NCT00318370|540326261|FG002|Period 2|Withdrawal by Subject|0|||
149781843|NCT00318370|540326259|FG000|Period 2|Other|0|||
149781844|NCT00318370|540326260|FG001|Period 2|Other|1|||
149781845|NCT00318370|540326261|FG002|Period 2|Other|0|||
149781846|NCT00318370|540326259|FG000|Period 3|Adverse Event|0|||
149781847|NCT00318370|540326260|FG001|Period 3|Adverse Event|0|||
149781848|NCT00318370|540326261|FG002|Period 3|Adverse Event|1|||
149781849|NCT00318370|540326259|FG000|Period 3|Lack of Efficacy|0|||
149781850|NCT00318370|540326260|FG001|Period 3|Lack of Efficacy|0|||
149781851|NCT00318370|540326261|FG002|Period 3|Lack of Efficacy|24|||
149781852|NCT00318370|540326259|FG000|Period 3|Death|0|||
149781853|NCT00318370|540326260|FG001|Period 3|Death|0|||
149781854|NCT00318370|540326261|FG002|Period 3|Death|1|||
149781855|NCT00318370|540326259|FG000|Period 3|Physician Decision|0|||
149781856|NCT00318370|540326260|FG001|Period 3|Physician Decision|0|||
149781857|NCT00318370|540326261|FG002|Period 3|Physician Decision|1|||
149781858|NCT00318370|540326259|FG000|Period 3|Withdrawal by Subject|0|||
149781859|NCT00318370|540326260|FG001|Period 3|Withdrawal by Subject|0|||
149781860|NCT00318370|540326261|FG002|Period 3|Withdrawal by Subject|3|||
149781861|NCT00318370|540326259|FG000|Period 3|Other|0|||
149781862|NCT00318370|540326260|FG001|Period 3|Other|0|||
149781863|NCT00318370|540326261|FG002|Period 3|Other|3|||
149781864|NCT01750840|540326265|FG000|Overall Study|Lost to Follow-up|4|||
149781865|NCT02650895|540326266|FG000|Overall Study|Withdrawal by Subject|0|||
149781866|NCT02650895|540326267|FG001|Overall Study|Withdrawal by Subject|1|||
149781867|NCT02650895|540326268|FG002|Overall Study|Withdrawal by Subject|0|||
149781868|NCT02650895|540326269|FG003|Overall Study|Withdrawal by Subject|0|||
149781869|NCT02650895|540326270|FG004|Overall Study|Withdrawal by Subject|0|||
149781870|NCT02650895|540326271|FG005|Overall Study|Withdrawal by Subject|0|||
149781871|NCT00981682|540326275|FG000|Overall Study|Adverse Event|48|||
149781872|NCT00981682|540326275|FG000|Overall Study|Withdrawal by Subject|52|||
149781873|NCT00981682|540326275|FG000|Overall Study|Lost to Follow-up|14|||
149781874|NCT00981682|540326275|FG000|Overall Study|Lack of Efficacy|13|||
149781875|NCT00981682|540326275|FG000|Overall Study|Protocol Violation|6|||
149781876|NCT00981682|540326275|FG000|Overall Study|administrative|9|||
149781877|NCT04507360|540328284|FG000|Week 1|Lost to Follow-up|0|||
149781878|NCT04507360|540328285|FG001|Week 1|Lost to Follow-up|0|||
149781879|NCT04507360|540328286|FG002|Week 1|Lost to Follow-up|0|||
149781880|NCT04507360|540328287|FG003|Week 1|Lost to Follow-up|0|||
149781881|NCT04507360|540328288|FG004|Week 1|Lost to Follow-up|0|||
149781882|NCT04507360|540328289|FG005|Week 1|Lost to Follow-up|0|||
149781883|NCT04507360|540328290|FG006|Week 1|Lost to Follow-up|0|||
149781884|NCT04507360|540328291|FG007|Week 1|Lost to Follow-up|0|||
149781885|NCT04507360|540328292|FG008|Week 1|Lost to Follow-up|72|||
149781886|NCT04507360|540328293|FG009|Week 1|Lost to Follow-up|22|||
149781887|NCT04507360|540328294|FG010|Week 1|Lost to Follow-up|10|||
149781888|NCT04507360|540328284|FG000|Week 2|Lost to Follow-up|0|||
149781889|NCT04507360|540328285|FG001|Week 2|Lost to Follow-up|0|||
149781890|NCT04507360|540328286|FG002|Week 2|Lost to Follow-up|0|||
149781891|NCT04507360|540328287|FG003|Week 2|Lost to Follow-up|0|||
149781892|NCT04507360|540328288|FG004|Week 2|Lost to Follow-up|0|||
149781893|NCT04507360|540328289|FG005|Week 2|Lost to Follow-up|0|||
149781894|NCT04507360|540328290|FG006|Week 2|Lost to Follow-up|0|||
149781895|NCT04507360|540328291|FG007|Week 2|Lost to Follow-up|0|||
149781896|NCT04507360|540328292|FG008|Week 2|Lost to Follow-up|121|||
149781897|NCT04507360|540328293|FG009|Week 2|Lost to Follow-up|85|||
149781898|NCT04507360|540328294|FG010|Week 2|Lost to Follow-up|82|||
149781899|NCT04507360|540328284|FG000|Week 3|Lost to Follow-up|0|||
149781900|NCT04507360|540328285|FG001|Week 3|Lost to Follow-up|0|||
149781901|NCT04507360|540328286|FG002|Week 3|Lost to Follow-up|0|||
149781902|NCT04507360|540328287|FG003|Week 3|Lost to Follow-up|0|||
149781903|NCT04507360|540328288|FG004|Week 3|Lost to Follow-up|0|||
149781904|NCT04507360|540328289|FG005|Week 3|Lost to Follow-up|0|||
149781905|NCT04507360|540328290|FG006|Week 3|Lost to Follow-up|0|||
149781906|NCT04507360|540328291|FG007|Week 3|Lost to Follow-up|0|||
149781907|NCT04507360|540328292|FG008|Week 3|Lost to Follow-up|123|||
149781908|NCT04507360|540328293|FG009|Week 3|Lost to Follow-up|92|||
149781909|NCT04507360|540328294|FG010|Week 3|Lost to Follow-up|84|||
149781910|NCT04507360|540328284|FG000|Week 4|Lost to Follow-up|0|||
149781911|NCT04507360|540328285|FG001|Week 4|Lost to Follow-up|0|||
149781912|NCT04507360|540328286|FG002|Week 4|Lost to Follow-up|0|||
149781913|NCT04507360|540328287|FG003|Week 4|Lost to Follow-up|0|||
149781914|NCT04507360|540328288|FG004|Week 4|Lost to Follow-up|0|||
149781915|NCT04507360|540328289|FG005|Week 4|Lost to Follow-up|0|||
149781916|NCT04507360|540328290|FG006|Week 4|Lost to Follow-up|0|||
149781917|NCT04507360|540328291|FG007|Week 4|Lost to Follow-up|0|||
149781918|NCT04507360|540328292|FG008|Week 4|Lost to Follow-up|131|||
149781919|NCT04507360|540328293|FG009|Week 4|Lost to Follow-up|115|||
149781920|NCT04507360|540328294|FG010|Week 4|Lost to Follow-up|102|||
149781921|NCT04507360|540328284|FG000|Week 5|Lost to Follow-up|0|||
149781922|NCT04507360|540328285|FG001|Week 5|Lost to Follow-up|0|||
149781923|NCT04507360|540328286|FG002|Week 5|Lost to Follow-up|0|||
149781924|NCT04507360|540328287|FG003|Week 5|Lost to Follow-up|0|||
149781925|NCT04507360|540328288|FG004|Week 5|Lost to Follow-up|0|||
149781926|NCT04507360|540328289|FG005|Week 5|Lost to Follow-up|0|||
149781927|NCT04507360|540328290|FG006|Week 5|Lost to Follow-up|0|||
149781928|NCT04507360|540328291|FG007|Week 5|Lost to Follow-up|0|||
149781929|NCT04507360|540328292|FG008|Week 5|Lost to Follow-up|103|||
149781930|NCT04507360|540328293|FG009|Week 5|Lost to Follow-up|135|||
149781931|NCT04507360|540328294|FG010|Week 5|Lost to Follow-up|143|||
149781932|NCT04507360|540328284|FG000|Week 8|Lost to Follow-up|0|||
149781933|NCT04507360|540328285|FG001|Week 8|Lost to Follow-up|0|||
149781934|NCT04507360|540328286|FG002|Week 8|Lost to Follow-up|0|||
149781935|NCT04507360|540328287|FG003|Week 8|Lost to Follow-up|0|||
149781936|NCT04507360|540328288|FG004|Week 8|Lost to Follow-up|0|||
149781937|NCT04507360|540328289|FG005|Week 8|Lost to Follow-up|0|||
149781938|NCT04507360|540328290|FG006|Week 8|Lost to Follow-up|0|||
149781939|NCT04507360|540328291|FG007|Week 8|Lost to Follow-up|0|||
149781940|NCT04507360|540328292|FG008|Week 8|Lost to Follow-up|139|||
149781941|NCT04507360|540328293|FG009|Week 8|Lost to Follow-up|145|||
149781942|NCT04507360|540328294|FG010|Week 8|Lost to Follow-up|152|||
149781943|NCT01004159|540328295|FG000|Overall Study|Adverse Event|2|||
149781944|NCT01004159|540328295|FG000|Overall Study|Disease Progression|18|||
149781945|NCT02712008|540328296|FG000|Baseline (Day 1) up to Week 12|Death|3|||
149781946|NCT02712008|540328297|FG001|Baseline (Day 1) up to Week 12|Death|0|||
149781947|NCT02712008|540328298|FG002|Baseline (Day 1) up to Week 12|Death|0|||
149781948|NCT02712008|540328299|FG003|Baseline (Day 1) up to Week 12|Death|0|||
149781949|NCT02712008|540328300|FG004|Baseline (Day 1) up to Week 12|Death|0|||
149781950|NCT02712008|540328301|FG005|Baseline (Day 1) up to Week 12|Death|0|||
149781951|NCT02712008|540328302|FG006|Baseline (Day 1) up to Week 12|Death|0|||
149781952|NCT02712008|540328303|FG007|Baseline (Day 1) up to Week 12|Death|0|||
149781953|NCT02712008|540328296|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781954|NCT02712008|540328297|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
149781955|NCT02712008|540328298|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
149781956|NCT02712008|540328299|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781957|NCT02712008|540328300|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781958|NCT02712008|540328301|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781959|NCT02712008|540328302|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781960|NCT02712008|540328303|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149781961|NCT02712008|540328296|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
149781962|NCT02712008|540328297|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781963|NCT02712008|540328298|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
149781964|NCT02712008|540328299|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781965|NCT02712008|540328300|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781966|NCT02712008|540328301|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781967|NCT02712008|540328302|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781968|NCT02712008|540328303|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149781969|NCT02712008|540328296|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781970|NCT02712008|540328297|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781971|NCT02712008|540328298|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
149781972|NCT02712008|540328299|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781973|NCT02712008|540328300|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781974|NCT02712008|540328301|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781975|NCT02712008|540328302|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781976|NCT02712008|540328303|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149781977|NCT02712008|540328296|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781978|NCT02712008|540328297|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
149781979|NCT02712008|540328298|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781980|NCT02712008|540328299|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781981|NCT02712008|540328300|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781982|NCT02712008|540328301|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781983|NCT02712008|540328302|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781984|NCT02712008|540328303|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149781985|NCT02712008|540328296|FG000|From Week 12 up to Week 36|Adverse Event|0|||
149781986|NCT02712008|540328297|FG001|From Week 12 up to Week 36|Adverse Event|0|||
149781987|NCT02712008|540328298|FG002|From Week 12 up to Week 36|Adverse Event|0|||
149781988|NCT02712008|540328299|FG003|From Week 12 up to Week 36|Adverse Event|0|||
149781989|NCT02712008|540328300|FG004|From Week 12 up to Week 36|Adverse Event|1|||
149781990|NCT02712008|540328301|FG005|From Week 12 up to Week 36|Adverse Event|0|||
149781991|NCT02712008|540328302|FG006|From Week 12 up to Week 36|Adverse Event|0|||
149781992|NCT02712008|540328303|FG007|From Week 12 up to Week 36|Adverse Event|2|||
149781993|NCT02712008|540328296|FG000|From Week 12 up to Week 36|Death|1|||
149781994|NCT02712008|540328297|FG001|From Week 12 up to Week 36|Death|0|||
149781995|NCT02712008|540328298|FG002|From Week 12 up to Week 36|Death|0|||
149781996|NCT02712008|540328299|FG003|From Week 12 up to Week 36|Death|0|||
149781997|NCT02712008|540328300|FG004|From Week 12 up to Week 36|Death|0|||
149781998|NCT02712008|540328301|FG005|From Week 12 up to Week 36|Death|0|||
149781999|NCT02712008|540328302|FG006|From Week 12 up to Week 36|Death|1|||
149782000|NCT02712008|540328303|FG007|From Week 12 up to Week 36|Death|0|||
149782001|NCT02712008|540328296|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782002|NCT02712008|540328297|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782003|NCT02712008|540328298|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782004|NCT02712008|540328299|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
149782005|NCT02712008|540328300|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782006|NCT02712008|540328301|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782007|NCT02712008|540328302|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
149782008|NCT02712008|540328303|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
149782009|NCT02712008|540328296|FG000|From Week 12 up to Week 36|Physician Decision|0|||
149782010|NCT02712008|540328297|FG001|From Week 12 up to Week 36|Physician Decision|0|||
149782011|NCT02712008|540328298|FG002|From Week 12 up to Week 36|Physician Decision|0|||
149782012|NCT02712008|540328299|FG003|From Week 12 up to Week 36|Physician Decision|1|||
149782013|NCT02712008|540328300|FG004|From Week 12 up to Week 36|Physician Decision|1|||
149782014|NCT02712008|540328301|FG005|From Week 12 up to Week 36|Physician Decision|0|||
149782015|NCT02712008|540328302|FG006|From Week 12 up to Week 36|Physician Decision|0|||
149782016|NCT02712008|540328303|FG007|From Week 12 up to Week 36|Physician Decision|0|||
149782017|NCT02712008|540328296|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782018|NCT02712008|540328297|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782019|NCT02712008|540328298|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782020|NCT02712008|540328299|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782021|NCT02712008|540328300|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782022|NCT02712008|540328301|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149782023|NCT02712008|540328302|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
149782024|NCT02712008|540328303|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
149782025|NCT04483544|540328305|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
149782026|NCT04483544|540328305|FG000|Post-Treatment|Admitted to hospice|2|||
149782027|NCT04483544|540328305|FG000|Post-Treatment|Study terminated|3|||
149782028|NCT01199198|540328306|FG000|Overall Study|Adverse Event|3|||
149782029|NCT01199198|540328307|FG001|Overall Study|Adverse Event|0|||
149782030|NCT01199198|540328306|FG000|Overall Study|Lost to Follow-up|1|||
149782031|NCT01199198|540328307|FG001|Overall Study|Lost to Follow-up|5|||
149782032|NCT01199198|540328306|FG000|Overall Study|Withdrawal by Subject|1|||
149782033|NCT01199198|540328307|FG001|Overall Study|Withdrawal by Subject|2|||
149782034|NCT01199198|540328306|FG000|Overall Study|ICU Transfer|1|||
149782035|NCT01199198|540328307|FG001|Overall Study|ICU Transfer|2|||
149782036|NCT01199198|540328306|FG000|Overall Study|Hospice-care transfer|1|||
149782037|NCT01199198|540328307|FG001|Overall Study|Hospice-care transfer|2|||
149782038|NCT04315298|540328308|FG000|Overall Study|Withdrawal by Subject|0|||
149782039|NCT04315298|540328309|FG001|Overall Study|Withdrawal by Subject|0|||
149782040|NCT04315298|540328310|FG002|Overall Study|Withdrawal by Subject|0|||
149782041|NCT04315298|540328311|FG003|Overall Study|Withdrawal by Subject|2|||
149782042|NCT04315298|540328312|FG004|Overall Study|Withdrawal by Subject|2|||
149782043|NCT04315298|540328313|FG005|Overall Study|Withdrawal by Subject|2|||
149782044|NCT04315298|540328314|FG006|Overall Study|Withdrawal by Subject|0|||
149782045|NCT04315298|540328315|FG007|Overall Study|Withdrawal by Subject|1|||
149782046|NCT04315298|540328316|FG008|Overall Study|Withdrawal by Subject|1|||
149782047|NCT04315298|540328317|FG009|Overall Study|Withdrawal by Subject|1|||
149782048|NCT04315298|540328318|FG010|Overall Study|Withdrawal by Subject|0|||
149782049|NCT04315298|540328319|FG011|Overall Study|Withdrawal by Subject|0|||
149782050|NCT04315298|540328320|FG012|Overall Study|Withdrawal by Subject|0|||
149782051|NCT04315298|540328321|FG013|Overall Study|Withdrawal by Subject|0|||
149782052|NCT04315298|540328322|FG014|Overall Study|Withdrawal by Subject|0|||
149782053|NCT04315298|540328323|FG015|Overall Study|Withdrawal by Subject|0|||
149782054|NCT04315298|540328324|FG016|Overall Study|Withdrawal by Subject|0|||
149782055|NCT04315298|540328325|FG017|Overall Study|Withdrawal by Subject|0|||
149782056|NCT04315298|540328326|FG018|Overall Study|Withdrawal by Subject|0|||
149782057|NCT04315298|540328308|FG000|Overall Study|Physician Decision|0|||
149782058|NCT04315298|540328309|FG001|Overall Study|Physician Decision|0|||
149782059|NCT04315298|540328310|FG002|Overall Study|Physician Decision|0|||
149782060|NCT04315298|540328311|FG003|Overall Study|Physician Decision|0|||
149782061|NCT04315298|540328312|FG004|Overall Study|Physician Decision|1|||
149782062|NCT04315298|540328313|FG005|Overall Study|Physician Decision|0|||
149782063|NCT04315298|540328314|FG006|Overall Study|Physician Decision|0|||
149782064|NCT04315298|540328315|FG007|Overall Study|Physician Decision|0|||
149782065|NCT04315298|540328316|FG008|Overall Study|Physician Decision|0|||
149782066|NCT04315298|540328317|FG009|Overall Study|Physician Decision|0|||
149782067|NCT04315298|540328318|FG010|Overall Study|Physician Decision|0|||
149782068|NCT04315298|540328319|FG011|Overall Study|Physician Decision|0|||
149782069|NCT04315298|540328320|FG012|Overall Study|Physician Decision|0|||
149782070|NCT04315298|540328321|FG013|Overall Study|Physician Decision|0|||
149782071|NCT04315298|540328322|FG014|Overall Study|Physician Decision|0|||
149782072|NCT04315298|540328323|FG015|Overall Study|Physician Decision|0|||
149782073|NCT04315298|540328324|FG016|Overall Study|Physician Decision|0|||
149782074|NCT04315298|540328325|FG017|Overall Study|Physician Decision|0|||
149782075|NCT04315298|540328326|FG018|Overall Study|Physician Decision|0|||
149782076|NCT04315298|540328308|FG000|Overall Study|Lost to Follow-up|5|||
149782077|NCT04315298|540328309|FG001|Overall Study|Lost to Follow-up|10|||
149782078|NCT04315298|540328310|FG002|Overall Study|Lost to Follow-up|6|||
149782079|NCT04315298|540328311|FG003|Overall Study|Lost to Follow-up|8|||
149782080|NCT04315298|540328312|FG004|Overall Study|Lost to Follow-up|12|||
149782081|NCT04315298|540328313|FG005|Overall Study|Lost to Follow-up|13|||
149782082|NCT04315298|540328314|FG006|Overall Study|Lost to Follow-up|9|||
149782083|NCT04315298|540328315|FG007|Overall Study|Lost to Follow-up|16|||
149782084|NCT04315298|540328316|FG008|Overall Study|Lost to Follow-up|14|||
149782085|NCT04315298|540328317|FG009|Overall Study|Lost to Follow-up|0|||
149782086|NCT04315298|540328318|FG010|Overall Study|Lost to Follow-up|2|||
149782087|NCT04315298|540328319|FG011|Overall Study|Lost to Follow-up|1|||
149782088|NCT04315298|540328320|FG012|Overall Study|Lost to Follow-up|0|||
149782089|NCT04315298|540328321|FG013|Overall Study|Lost to Follow-up|0|||
149782090|NCT04315298|540328322|FG014|Overall Study|Lost to Follow-up|0|||
149782091|NCT04315298|540328323|FG015|Overall Study|Lost to Follow-up|2|||
149782092|NCT04315298|540328324|FG016|Overall Study|Lost to Follow-up|0|||
149782093|NCT04315298|540328325|FG017|Overall Study|Lost to Follow-up|0|||
149782094|NCT04315298|540328326|FG018|Overall Study|Lost to Follow-up|0|||
149782095|NCT04315298|540328308|FG000|Overall Study|Death|24|||
149782096|NCT04315298|540328309|FG001|Overall Study|Death|60|||
149782097|NCT04315298|540328310|FG002|Overall Study|Death|49|||
149782098|NCT04315298|540328311|FG003|Overall Study|Death|59|||
149782099|NCT04315298|540328312|FG004|Overall Study|Death|70|||
149782100|NCT04315298|540328313|FG005|Overall Study|Death|114|||
149782101|NCT04315298|540328314|FG006|Overall Study|Death|9|||
149782102|NCT04315298|540328315|FG007|Overall Study|Death|12|||
149782103|NCT04315298|540328316|FG008|Overall Study|Death|21|||
149782104|NCT04315298|540328317|FG009|Overall Study|Death|16|||
149782105|NCT04315298|540328318|FG010|Overall Study|Death|40|||
149782106|NCT04315298|540328319|FG011|Overall Study|Death|40|||
149782107|NCT04315298|540328320|FG012|Overall Study|Death|3|||
149782108|NCT04315298|540328321|FG013|Overall Study|Death|4|||
149782109|NCT04315298|540328322|FG014|Overall Study|Death|6|||
149782110|NCT04315298|540328323|FG015|Overall Study|Death|4|||
149782111|NCT04315298|540328324|FG016|Overall Study|Death|3|||
149782112|NCT04315298|540328325|FG017|Overall Study|Death|1|||
149782113|NCT04315298|540328326|FG018|Overall Study|Death|0|||
149782114|NCT00736385|540328327|FG000|Overall Study|Withdrawal by Subject|2|||
149782115|NCT00736385|540328328|FG001|Overall Study|Withdrawal by Subject|2|||
149782116|NCT00736385|540328327|FG000|Overall Study|Adverse Event|0|||
149782117|NCT00736385|540328328|FG001|Overall Study|Adverse Event|1|||
149782118|NCT01183104|540328329|FG000|Overall Study|Adverse Event|8|||
149782119|NCT01183104|540328330|FG001|Overall Study|Adverse Event|6|||
149782120|NCT01183104|540328329|FG000|Overall Study|Death|0|||
149782121|NCT01183104|540328330|FG001|Overall Study|Death|1|||
149782122|NCT01183104|540328329|FG000|Overall Study|Lost to Follow-up|14|||
149782123|NCT01183104|540328330|FG001|Overall Study|Lost to Follow-up|7|||
149782124|NCT01183104|540328329|FG000|Overall Study|Physician Decision|5|||
149782125|NCT01183104|540328330|FG001|Overall Study|Physician Decision|8|||
149782126|NCT01183104|540328329|FG000|Overall Study|Withdrawal by Subject|6|||
149782127|NCT01183104|540328330|FG001|Overall Study|Withdrawal by Subject|11|||
149782128|NCT01183104|540328329|FG000|Overall Study|Nonparticipation in Extension Study|39|||
149782129|NCT01183104|540328330|FG001|Overall Study|Nonparticipation in Extension Study|50|||
149782130|NCT01183104|540328329|FG000|Overall Study|Did not receive study drug|5|||
149782131|NCT01183104|540328330|FG001|Overall Study|Did not receive study drug|9|||
149782132|NCT03267511|540328331|FG000|Overall Study|Lost to Follow-up|0|||
149782133|NCT03267511|540328332|FG001|Overall Study|Lost to Follow-up|0|||
149782134|NCT03267511|540328333|FG002|Overall Study|Lost to Follow-up|0|||
149782135|NCT03267511|540328334|FG003|Overall Study|Lost to Follow-up|1|||
149782136|NCT01594749|540328335|FG000|Overall Study|Adverse Event|2|||
149782137|NCT01594749|540328336|FG001|Overall Study|Adverse Event|1|||
149782138|NCT01594749|540328335|FG000|Overall Study|Withdrawal by Subject|2|||
149782139|NCT01594749|540328336|FG001|Overall Study|Withdrawal by Subject|2|||
149782140|NCT01594749|540328335|FG000|Overall Study|Protocol Violation|2|||
149782141|NCT01594749|540328336|FG001|Overall Study|Protocol Violation|0|||
149782142|NCT01594749|540328335|FG000|Overall Study|Physician Decision|1|||
149782143|NCT01594749|540328336|FG001|Overall Study|Physician Decision|1|||
149782144|NCT01594749|540328335|FG000|Overall Study|Non-compliance with Protocol|0|||
149782145|NCT01594749|540328336|FG001|Overall Study|Non-compliance with Protocol|1|||
149782146|NCT01594749|540328335|FG000|Overall Study|Lost to Follow-up|1|||
149782147|NCT01594749|540328336|FG001|Overall Study|Lost to Follow-up|0|||
149782148|NCT01594749|540328335|FG000|Overall Study|Death|9|||
149782149|NCT01594749|540328336|FG001|Overall Study|Death|3|||
149782150|NCT01594749|540328335|FG000|Overall Study|Not Treated|4|||
149782151|NCT01594749|540328336|FG001|Overall Study|Not Treated|10|||
149782152|NCT01594749|540328335|FG000|Overall Study|Lost Source Documentation|1|||
149782153|NCT01594749|540328336|FG001|Overall Study|Lost Source Documentation|0|||
149782154|NCT00364351|540328337|FG000|Overall Study|Adverse Event|90|||
149782155|NCT00364351|540328338|FG001|Overall Study|Adverse Event|44|||
149782156|NCT00364351|540328337|FG000|Overall Study|Condition under investigation worsened|469|||
149782157|NCT00364351|540328338|FG001|Overall Study|Condition under investigation worsened|497|||
149782158|NCT00364351|540328337|FG000|Overall Study|Prohibited concomitant medication|0|||
149782159|NCT00364351|540328338|FG001|Overall Study|Prohibited concomitant medication|2|||
149782160|NCT00364351|540328337|FG000|Overall Study|Lost to Follow-up|1|||
149782161|NCT00364351|540328338|FG001|Overall Study|Lost to Follow-up|1|||
149782162|NCT00364351|540328337|FG000|Overall Study|Withdrawal by Subject|30|||
149782163|NCT00364351|540328338|FG001|Overall Study|Withdrawal by Subject|29|||
149782164|NCT00364351|540328337|FG000|Overall Study|Incorrect enrollment|1|||
149782165|NCT00364351|540328338|FG001|Overall Study|Incorrect enrollment|1|||
149782166|NCT00364351|540328337|FG000|Overall Study|Sponsor decision|1|||
149782167|NCT00364351|540328338|FG001|Overall Study|Sponsor decision|0|||
149782168|NCT00364351|540328337|FG000|Overall Study|Poor treatment compliance|0|||
149782169|NCT00364351|540328338|FG001|Overall Study|Poor treatment compliance|3|||
149782170|NCT00364351|540328337|FG000|Overall Study|Investigator error|0|||
149782171|NCT00364351|540328338|FG001|Overall Study|Investigator error|2|||
149782172|NCT00364351|540328337|FG000|Overall Study|Patient could not travel to site|0|||
149782173|NCT00364351|540328338|FG001|Overall Study|Patient could not travel to site|1|||
149782174|NCT00364351|540328337|FG000|Overall Study|Randomised treatment not started|0|||
149782175|NCT00364351|540328338|FG001|Overall Study|Randomised treatment not started|3|||
149782176|NCT00653068|540328340|FG000|Overall Study|Death|9|||
149782177|NCT00653068|540328340|FG000|Overall Study|Lack of Efficacy|34|||
149782178|NCT00653068|540328340|FG000|Overall Study|Physician Decision|4|||
149782179|NCT00653068|540328340|FG000|Overall Study|Withdrawal by Subject|1|||
149782180|NCT00653068|540328340|FG000|Overall Study|Ineligible|2|||
149782181|NCT02177786|540328341|FG000|Overall Study|Withdrew Consent|2|||
149782182|NCT02177786|540328342|FG001|Overall Study|Withdrew Consent|6|||
149782183|NCT02177786|540328343|FG002|Overall Study|Withdrew Consent|9|||
149782184|NCT02177786|540328344|FG003|Overall Study|Withdrew Consent|5|||
149782185|NCT02177786|540328341|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
149782186|NCT02177786|540328342|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
149782187|NCT02177786|540328343|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
149782188|NCT02177786|540328344|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
149782189|NCT02177786|540328341|FG000|Overall Study|Adverse Event|1|||
149782190|NCT02177786|540328342|FG001|Overall Study|Adverse Event|1|||
149782191|NCT02177786|540328343|FG002|Overall Study|Adverse Event|2|||
149782192|NCT02177786|540328344|FG003|Overall Study|Adverse Event|3|||
149782193|NCT02177786|540328341|FG000|Overall Study|Death|1|||
149782194|NCT02177786|540328342|FG001|Overall Study|Death|1|||
149782195|NCT02177786|540328343|FG002|Overall Study|Death|1|||
149782196|NCT02177786|540328344|FG003|Overall Study|Death|1|||
149782197|NCT02177786|540328341|FG000|Overall Study|Lost to Follow-up|0|||
149782198|NCT02177786|540328342|FG001|Overall Study|Lost to Follow-up|0|||
149782199|NCT02177786|540328343|FG002|Overall Study|Lost to Follow-up|2|||
149782200|NCT02177786|540328344|FG003|Overall Study|Lost to Follow-up|2|||
149782201|NCT02177786|540328341|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149782202|NCT02177786|540328342|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149782203|NCT02177786|540328343|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149782204|NCT02177786|540328344|FG003|Overall Study|Non-Compliance with Study Drug|1|||
149782205|NCT02177786|540328341|FG000|Overall Study|Protocol Violation|0|||
149782206|NCT02177786|540328342|FG001|Overall Study|Protocol Violation|0|||
149782207|NCT02177786|540328343|FG002|Overall Study|Protocol Violation|2|||
149782208|NCT02177786|540328344|FG003|Overall Study|Protocol Violation|0|||
149782209|NCT02177786|540328341|FG000|Overall Study|Progressive Disease|0|||
149782210|NCT02177786|540328342|FG001|Overall Study|Progressive Disease|1|||
149782211|NCT02177786|540328343|FG002|Overall Study|Progressive Disease|0|||
149782212|NCT02177786|540328344|FG003|Overall Study|Progressive Disease|0|||
149782213|NCT02177786|540328341|FG000|Overall Study|Missing study completion status|0|||
149782214|NCT02177786|540328342|FG001|Overall Study|Missing study completion status|1|||
149782215|NCT02177786|540328343|FG002|Overall Study|Missing study completion status|0|||
149782216|NCT02177786|540328344|FG003|Overall Study|Missing study completion status|0|||
149782217|NCT01305941|540328345|FG000|Overall Study|Adverse Event|6|||
149782218|NCT01305941|540328345|FG000|Overall Study|Clinical decline|2|||
149782219|NCT01305941|540328345|FG000|Overall Study|Withdrawal by Subject|1|||
149782220|NCT01305941|540328345|FG000|Overall Study|Death|1|||
149782221|NCT03950440|540328346|FG000|Overall Study|Death|8|||
149782222|NCT03950440|540328347|FG001|Overall Study|Death|2|||
149782223|NCT03950440|540328348|FG002|Overall Study|Death|1|||
149782224|NCT02892734|540328349|FG000|Treatment on Study|Progressive Disease|2|||
149782225|NCT02892734|540328349|FG000|Follow up for 2 Years|Death|2|||
149782226|NCT02892734|540328349|FG000|Follow up for 2 Years|Study closed early|1|||
149782227|NCT02043509|540328350|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
149782228|NCT02043509|540328351|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
149782229|NCT02043509|540328350|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
149782230|NCT02043509|540328351|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
149782231|NCT02043509|540328350|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
149782232|NCT02043509|540328351|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
149782233|NCT02043509|540328350|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
149782234|NCT02043509|540328351|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
149782235|NCT00634751|540328359|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
149782236|NCT00634751|540328360|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
149782237|NCT00634751|540328361|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
149782238|NCT00634751|540328362|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
149782239|NCT00634751|540328359|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149782240|NCT00634751|540328360|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
149782241|NCT00634751|540328361|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149782242|NCT00634751|540328362|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149782243|NCT00634751|540328359|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
149782244|NCT00634751|540328360|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
149782245|NCT00634751|540328361|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
149782246|NCT00634751|540328362|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
149782247|NCT03654560|540328363|FG000|Overall Study|Death|3|||
149782248|NCT03654560|540328364|FG001|Overall Study|Death|1|||
149782249|NCT03654560|540328363|FG000|Overall Study|Lost to Follow-up|1|||
149782250|NCT03654560|540328364|FG001|Overall Study|Lost to Follow-up|0|||
149782251|NCT03135262|540328365|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
149782252|NCT03135262|540328366|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149782253|NCT03135262|540328367|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149782254|NCT03135262|540328368|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149782255|NCT03135262|540328369|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149782256|NCT03135262|540328365|FG000|Overall Study|Progression of disease|0|||
149782257|NCT03135262|540328366|FG001|Overall Study|Progression of disease|0|||
149782258|NCT03135262|540328367|FG002|Overall Study|Progression of disease|0|||
149782259|NCT03135262|540328368|FG003|Overall Study|Progression of disease|1|||
149782260|NCT03135262|540328369|FG004|Overall Study|Progression of disease|0|||
149782261|NCT03135262|540328365|FG000|Overall Study|Death|6|||
149782262|NCT03135262|540328366|FG001|Overall Study|Death|2|||
149782263|NCT03135262|540328367|FG002|Overall Study|Death|2|||
149782264|NCT03135262|540328368|FG003|Overall Study|Death|2|||
149782265|NCT03135262|540328369|FG004|Overall Study|Death|0|||
149782266|NCT03135262|540328365|FG000|Overall Study|Withdrawal by Subject|0|||
149782267|NCT03135262|540328366|FG001|Overall Study|Withdrawal by Subject|0|||
149782268|NCT03135262|540328367|FG002|Overall Study|Withdrawal by Subject|1|||
149782269|NCT03135262|540328368|FG003|Overall Study|Withdrawal by Subject|0|||
149782270|NCT03135262|540328369|FG004|Overall Study|Withdrawal by Subject|1|||
149782271|NCT03135262|540328365|FG000|Overall Study|Study terminated by sponsor|2|||
149782272|NCT03135262|540328366|FG001|Overall Study|Study terminated by sponsor|4|||
149782273|NCT03135262|540328367|FG002|Overall Study|Study terminated by sponsor|4|||
149782274|NCT03135262|540328368|FG003|Overall Study|Study terminated by sponsor|3|||
149782275|NCT03135262|540328369|FG004|Overall Study|Study terminated by sponsor|0|||
149782276|NCT02728206|540328370|FG000|Overall Study|Death|1|||
149782277|NCT02773368|540328371|FG000|Overall Study|Lost to Follow-up|4|||
149782278|NCT02773368|540328372|FG001|Overall Study|Lost to Follow-up|1|||
149782279|NCT02773368|540328371|FG000|Overall Study|Withdrawal by Subject|5|||
149782280|NCT02773368|540328372|FG001|Overall Study|Withdrawal by Subject|1|||
149782281|NCT02773368|540328371|FG000|Overall Study|Unclassified|1|||
149782282|NCT02773368|540328372|FG001|Overall Study|Unclassified|1|||
149782283|NCT02773368|540328371|FG000|Overall Study|Missing|0|||
149782284|NCT02773368|540328372|FG001|Overall Study|Missing|1|||
149782285|NCT00732238|540328374|FG000|Overall Study|Bacteremia|4|||
149782286|NCT00732238|540328375|FG001|Overall Study|Bacteremia|1|||
149782287|NCT00732238|540328374|FG000|Overall Study|Asymptomatic bacteriuria|1|||
149782288|NCT00732238|540328375|FG001|Overall Study|Asymptomatic bacteriuria|0|||
149782289|NCT01098032|540328378|FG000|Overall Study|Withdrawal by Subject|1|||
149782290|NCT01098032|540328379|FG001|Overall Study|Withdrawal by Subject|1|||
149782291|NCT00481988|540328380|FG000|Overall Study|Withdrawal by Subject|1|||
149782292|NCT00481988|540328381|FG001|Overall Study|Withdrawal by Subject|1|||
149782293|NCT00610207|540328386|FG000|Overall Study|Lost to Follow-up|3|||
149782294|NCT01594411|540328405|FG000|Overall Study|Lost to Follow-up|2|||
149782295|NCT01451398|540328414|FG000|Overall Study|Adverse Event|7|||
149782296|NCT01451398|540328415|FG001|Overall Study|Adverse Event|9|||
149782297|NCT01451398|540328414|FG000|Overall Study|Protocol Violation|1|||
149782298|NCT01451398|540328415|FG001|Overall Study|Protocol Violation|2|||
149782299|NCT01451398|540328414|FG000|Overall Study|Physician Decision|1|||
149782300|NCT01451398|540328415|FG001|Overall Study|Physician Decision|1|||
149782301|NCT01451398|540328414|FG000|Overall Study|Withdrawal by Subject|10|||
149782302|NCT01451398|540328415|FG001|Overall Study|Withdrawal by Subject|14|||
149782303|NCT01451398|540328414|FG000|Overall Study|Lost to Follow-up|6|||
149782304|NCT01451398|540328415|FG001|Overall Study|Lost to Follow-up|4|||
149782305|NCT01451398|540328414|FG000|Overall Study|Non-compliance with study drug|1|||
149782306|NCT01451398|540328415|FG001|Overall Study|Non-compliance with study drug|3|||
149782307|NCT01451398|540328414|FG000|Overall Study|Non-compliance with protocol|1|||
149782308|NCT01451398|540328415|FG001|Overall Study|Non-compliance with protocol|1|||
149782309|NCT01451398|540328414|FG000|Overall Study|Moved out of country|0|||
149782310|NCT01451398|540328415|FG001|Overall Study|Moved out of country|1|||
149782311|NCT01451398|540328414|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
149782312|NCT01451398|540328415|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
149782313|NCT01451398|540328414|FG000|Overall Study|Lack of Efficacy|0|||
149782314|NCT01451398|540328415|FG001|Overall Study|Lack of Efficacy|1|||
149782315|NCT00741260|540328417|FG000|Overall Study|Disease Progression|3|||
149782316|NCT00741260|540328418|FG001|Overall Study|Disease Progression|5|||
149782317|NCT00741260|540328419|FG002|Overall Study|Disease Progression|3|||
149782318|NCT00741260|540328420|FG003|Overall Study|Disease Progression|3|||
149782319|NCT00741260|540328421|FG004|Overall Study|Disease Progression|5|||
149782320|NCT00741260|540328422|FG005|Overall Study|Disease Progression|37|||
149782321|NCT00741260|540328423|FG006|Overall Study|Disease Progression|4|||
149782322|NCT00741260|540328417|FG000|Overall Study|Death|0|||
149782323|NCT00741260|540328418|FG001|Overall Study|Death|1|||
149782324|NCT00741260|540328419|FG002|Overall Study|Death|0|||
149782325|NCT00741260|540328420|FG003|Overall Study|Death|1|||
149782326|NCT00741260|540328421|FG004|Overall Study|Death|2|||
149782327|NCT00741260|540328422|FG005|Overall Study|Death|2|||
149782328|NCT00741260|540328423|FG006|Overall Study|Death|1|||
149782329|NCT00741260|540328417|FG000|Overall Study|Withdrawal by Subject|0|||
149782330|NCT00741260|540328418|FG001|Overall Study|Withdrawal by Subject|0|||
149782331|NCT00741260|540328419|FG002|Overall Study|Withdrawal by Subject|0|||
149782332|NCT00741260|540328420|FG003|Overall Study|Withdrawal by Subject|0|||
149782333|NCT00741260|540328421|FG004|Overall Study|Withdrawal by Subject|1|||
149782334|NCT00741260|540328422|FG005|Overall Study|Withdrawal by Subject|3|||
149782335|NCT00741260|540328423|FG006|Overall Study|Withdrawal by Subject|1|||
149782336|NCT00741260|540328417|FG000|Overall Study|Physician Decision|1|||
149782337|NCT00741260|540328418|FG001|Overall Study|Physician Decision|1|||
149782338|NCT00741260|540328419|FG002|Overall Study|Physician Decision|0|||
149782339|NCT00741260|540328420|FG003|Overall Study|Physician Decision|0|||
149782340|NCT00741260|540328421|FG004|Overall Study|Physician Decision|0|||
149782341|NCT00741260|540328422|FG005|Overall Study|Physician Decision|0|||
149782342|NCT00741260|540328423|FG006|Overall Study|Physician Decision|0|||
149782343|NCT00741260|540328417|FG000|Overall Study|Other|2|||
149782344|NCT00741260|540328418|FG001|Overall Study|Other|1|||
149782345|NCT00741260|540328419|FG002|Overall Study|Other|1|||
149782346|NCT00741260|540328420|FG003|Overall Study|Other|2|||
149782347|NCT00741260|540328421|FG004|Overall Study|Other|1|||
149782348|NCT00741260|540328422|FG005|Overall Study|Other|3|||
149782349|NCT00741260|540328423|FG006|Overall Study|Other|1|||
149782350|NCT02565615|540328424|FG000|Overall Study|Death|0|||
149782351|NCT02565615|540328425|FG001|Overall Study|Death|1|||
149782352|NCT02565615|540328426|FG002|Overall Study|Death|0|||
149782353|NCT02565615|540328427|FG003|Overall Study|Death|0|||
149782354|NCT02565615|540328428|FG004|Overall Study|Death|4|||
149782355|NCT02565615|540328424|FG000|Overall Study|Not willing to participate in study|2|||
149782356|NCT02565615|540328425|FG001|Overall Study|Not willing to participate in study|21|||
149782357|NCT02565615|540328426|FG002|Overall Study|Not willing to participate in study|0|||
149782358|NCT02565615|540328427|FG003|Overall Study|Not willing to participate in study|1|||
149782359|NCT02565615|540328428|FG004|Overall Study|Not willing to participate in study|169|||
149782360|NCT02565615|540328424|FG000|Overall Study|Lost to Follow-up|0|||
149782361|NCT02565615|540328425|FG001|Overall Study|Lost to Follow-up|4|||
149782362|NCT02565615|540328426|FG002|Overall Study|Lost to Follow-up|0|||
149782363|NCT02565615|540328427|FG003|Overall Study|Lost to Follow-up|1|||
149782364|NCT02565615|540328428|FG004|Overall Study|Lost to Follow-up|765|||
149782365|NCT02565615|540328424|FG000|Overall Study|Not meeting eligibility criteria|0|||
149782366|NCT02565615|540328425|FG001|Overall Study|Not meeting eligibility criteria|7|||
149782367|NCT02565615|540328426|FG002|Overall Study|Not meeting eligibility criteria|0|||
149782368|NCT02565615|540328427|FG003|Overall Study|Not meeting eligibility criteria|0|||
149782369|NCT02565615|540328428|FG004|Overall Study|Not meeting eligibility criteria|25|||
149782370|NCT02565615|540328424|FG000|Overall Study|Reason not defined|0|||
149782371|NCT02565615|540328425|FG001|Overall Study|Reason not defined|2|||
149782372|NCT02565615|540328426|FG002|Overall Study|Reason not defined|0|||
149782373|NCT02565615|540328427|FG003|Overall Study|Reason not defined|1|||
149782374|NCT02565615|540328428|FG004|Overall Study|Reason not defined|62|||
149782375|NCT02565615|540328424|FG000|Overall Study|Adverse Event|1|||
149782376|NCT02565615|540328425|FG001|Overall Study|Adverse Event|1|||
149782377|NCT02565615|540328426|FG002|Overall Study|Adverse Event|0|||
149782378|NCT02565615|540328427|FG003|Overall Study|Adverse Event|0|||
149782379|NCT02565615|540328428|FG004|Overall Study|Adverse Event|9|||
149782380|NCT02565615|540328424|FG000|Overall Study|Untreated|0|||
149782381|NCT02565615|540328425|FG001|Overall Study|Untreated|0|||
149782382|NCT02565615|540328426|FG002|Overall Study|Untreated|0|||
149782383|NCT02565615|540328427|FG003|Overall Study|Untreated|0|||
149782384|NCT02565615|540328428|FG004|Overall Study|Untreated|567|||
149782385|NCT05563714|540328432|FG000|Overall Study|Death|2|||
149782386|NCT05563714|540328433|FG001|Overall Study|Death|2|||
149782387|NCT05563714|540328434|FG002|Overall Study|Death|0|||
149782388|NCT05563714|540328435|FG003|Overall Study|Death|0|||
149782389|NCT05563714|540328432|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
149782390|NCT05563714|540328433|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
149782391|NCT05563714|540328434|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
149782392|NCT05563714|540328435|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
149782393|NCT05563714|540328432|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
149782394|NCT05563714|540328433|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
149782395|NCT05563714|540328434|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
149782396|NCT05563714|540328435|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
149782397|NCT05563714|540328432|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149782398|NCT05563714|540328433|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
149782399|NCT05563714|540328434|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149782400|NCT05563714|540328435|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149782401|NCT05563714|540328432|FG000|Overall Study|Lost to Follow-up|22|||
149782402|NCT05563714|540328433|FG001|Overall Study|Lost to Follow-up|19|||
149782403|NCT05563714|540328434|FG002|Overall Study|Lost to Follow-up|0|||
149782404|NCT05563714|540328435|FG003|Overall Study|Lost to Follow-up|0|||
149782405|NCT00479167|540328439|FG000|Overall Study|Withdrawal by Subject|1|||
149782406|NCT01997281|540328442|FG000|Overall Study|Withdrawal by Subject|1|||
149782407|NCT01997281|540328443|FG001|Overall Study|Withdrawal by Subject|0|||
149782408|NCT00560794|540328446|FG000|Overall Study|Adverse Event|2|||
149782409|NCT00560794|540328446|FG000|Overall Study|Patient was not Compliant|1|||
149782410|NCT00560794|540328446|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
149782411|NCT00560794|540328446|FG000|Overall Study|Hematological Relapse|1|||
149782412|NCT00560794|540328446|FG000|Overall Study|Received Bone Marrow Transplant|6|||
149782413|NCT02384993|540328449|FG000|Overall Study|Adverse Event|0|||
149782414|NCT02384993|540328450|FG001|Overall Study|Adverse Event|1|||
149782415|NCT00880607|540328452|FG000|Overall Study|Physician Decision|2|||
149782416|NCT00880607|540328453|FG001|Overall Study|Physician Decision|2|||
149782417|NCT00880607|540328452|FG000|Overall Study|Protocol Violation|2|||
149782418|NCT00880607|540328453|FG001|Overall Study|Protocol Violation|1|||
149782419|NCT00880607|540328452|FG000|Overall Study|surgery did not extend past L1 level|3|||
149782420|NCT00880607|540328453|FG001|Overall Study|surgery did not extend past L1 level|0|||
149782421|NCT02828644|540329641|FG000|Overall Study|Lost to Follow-up|23|||
149782422|NCT02828644|540329642|FG001|Overall Study|Lost to Follow-up|22|||
149782423|NCT02996110|540329643|FG000|Pre-Treatment|Other Reasons|0|||
149782424|NCT02996110|540329644|FG001|Pre-Treatment|Other Reasons|1|||
149782425|NCT02996110|540329645|FG002|Pre-Treatment|Other Reasons|0|||
149782426|NCT02996110|540329646|FG003|Pre-Treatment|Other Reasons|0|||
149782427|NCT02996110|540329647|FG004|Pre-Treatment|Other Reasons|1|||
149782428|NCT02996110|540329643|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
149782429|NCT02996110|540329644|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
149782430|NCT02996110|540329645|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
149782431|NCT02996110|540329646|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
149782432|NCT02996110|540329647|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
149782433|NCT02996110|540329643|FG000|Track 1|Disease Progression|15|||
149782434|NCT02996110|540329644|FG001|Track 1|Disease Progression|17|||
149782435|NCT02996110|540329645|FG002|Track 1|Disease Progression|0|||
149782436|NCT02996110|540329646|FG003|Track 1|Disease Progression|0|||
149782437|NCT02996110|540329647|FG004|Track 1|Disease Progression|0|||
149782438|NCT02996110|540329643|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
149782439|NCT02996110|540329644|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
149782440|NCT02996110|540329645|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
149782441|NCT02996110|540329646|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
149782442|NCT02996110|540329647|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
149782443|NCT02996110|540329643|FG000|Track 1|Study Drug Toxicity|5|||
149782444|NCT02996110|540329644|FG001|Track 1|Study Drug Toxicity|3|||
149782445|NCT02996110|540329645|FG002|Track 1|Study Drug Toxicity|0|||
149782446|NCT02996110|540329646|FG003|Track 1|Study Drug Toxicity|0|||
149782447|NCT02996110|540329647|FG004|Track 1|Study Drug Toxicity|0|||
149782448|NCT02996110|540329643|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
149782449|NCT02996110|540329644|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149782450|NCT02996110|540329645|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149782451|NCT02996110|540329646|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149782452|NCT02996110|540329647|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149782453|NCT02996110|540329643|FG000|Track 1|Administrative Reason by Sponsor|0|||
149782454|NCT02996110|540329644|FG001|Track 1|Administrative Reason by Sponsor|1|||
149782455|NCT02996110|540329645|FG002|Track 1|Administrative Reason by Sponsor|0|||
149782456|NCT02996110|540329646|FG003|Track 1|Administrative Reason by Sponsor|0|||
149782457|NCT02996110|540329647|FG004|Track 1|Administrative Reason by Sponsor|0|||
149782458|NCT02996110|540329643|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
149782459|NCT02996110|540329644|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
149782460|NCT02996110|540329645|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
149782461|NCT02996110|540329646|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
149782462|NCT02996110|540329647|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
149782463|NCT02996110|540329643|FG000|Track 2|Disease Progression|33|||
149782464|NCT02996110|540329644|FG001|Track 2|Disease Progression|26|||
149782465|NCT02996110|540329645|FG002|Track 2|Disease Progression|19|||
149782466|NCT02996110|540329646|FG003|Track 2|Disease Progression|16|||
149782467|NCT02996110|540329647|FG004|Track 2|Disease Progression|15|||
149782468|NCT02996110|540329643|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
149782469|NCT02996110|540329644|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
149782470|NCT02996110|540329645|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
149782471|NCT02996110|540329646|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
149782472|NCT02996110|540329647|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
149782473|NCT02996110|540329643|FG000|Track 2|Death|0|||
149782474|NCT02996110|540329644|FG001|Track 2|Death|0|||
149782475|NCT02996110|540329645|FG002|Track 2|Death|1|||
149782476|NCT02996110|540329646|FG003|Track 2|Death|0|||
149782477|NCT02996110|540329647|FG004|Track 2|Death|1|||
149782478|NCT02996110|540329643|FG000|Track 2|Study Drug Toxicity|4|||
149782479|NCT02996110|540329644|FG001|Track 2|Study Drug Toxicity|1|||
149782480|NCT02996110|540329645|FG002|Track 2|Study Drug Toxicity|4|||
149782481|NCT02996110|540329646|FG003|Track 2|Study Drug Toxicity|1|||
149782482|NCT02996110|540329647|FG004|Track 2|Study Drug Toxicity|0|||
149782483|NCT02996110|540329643|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
149782484|NCT02996110|540329644|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
149782485|NCT02996110|540329645|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
149782486|NCT02996110|540329646|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
149782487|NCT02996110|540329647|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
149782488|NCT02996110|540329643|FG000|Track 2|Participant Withdrew Consent|1|||
149782489|NCT02996110|540329644|FG001|Track 2|Participant Withdrew Consent|2|||
149782490|NCT02996110|540329645|FG002|Track 2|Participant Withdrew Consent|3|||
149782491|NCT02996110|540329646|FG003|Track 2|Participant Withdrew Consent|1|||
149782492|NCT02996110|540329647|FG004|Track 2|Participant Withdrew Consent|1|||
149782493|NCT02996110|540329643|FG000|Track 2|Other Reasons|0|||
149782494|NCT02996110|540329644|FG001|Track 2|Other Reasons|0|||
149782495|NCT02996110|540329645|FG002|Track 2|Other Reasons|1|||
149782496|NCT02996110|540329646|FG003|Track 2|Other Reasons|0|||
149782497|NCT02996110|540329647|FG004|Track 2|Other Reasons|1|||
149782498|NCT01119963|540329651|FG000|Overall Study|Lost to Follow-up|1|||
149782499|NCT01119963|540329652|FG001|Overall Study|Lost to Follow-up|1|||
149782500|NCT00524043|540329653|FG000|Overall Study|Lack of Efficacy|15|||
149782501|NCT00524043|540329654|FG001|Overall Study|Lack of Efficacy|13|||
149782502|NCT00524043|540329655|FG002|Overall Study|Lack of Efficacy|14|||
149782503|NCT00524043|540329653|FG000|Overall Study|Withdrawal by Subject|5|||
149782504|NCT00524043|540329654|FG001|Overall Study|Withdrawal by Subject|7|||
149782505|NCT00524043|540329655|FG002|Overall Study|Withdrawal by Subject|7|||
149782506|NCT00524043|540329653|FG000|Overall Study|Adverse Event|5|||
149782507|NCT00524043|540329654|FG001|Overall Study|Adverse Event|2|||
149782508|NCT00524043|540329655|FG002|Overall Study|Adverse Event|7|||
149782509|NCT00524043|540329653|FG000|Overall Study|Lost to Follow-up|3|||
149782510|NCT00524043|540329654|FG001|Overall Study|Lost to Follow-up|5|||
149782511|NCT00524043|540329655|FG002|Overall Study|Lost to Follow-up|3|||
149782512|NCT00524043|540329653|FG000|Overall Study|Various (eg, incarceration)|2|||
149782513|NCT00524043|540329654|FG001|Overall Study|Various (eg, incarceration)|1|||
149782514|NCT00524043|540329655|FG002|Overall Study|Various (eg, incarceration)|0|||
149782515|NCT03938636|540329656|FG000|Overall Study|Protocol Violation|0|||
149782516|NCT03938636|540329657|FG001|Overall Study|Protocol Violation|1|||
149782517|NCT03938636|540329658|FG002|Overall Study|Protocol Violation|1|||
149782518|NCT03938636|540329656|FG000|Overall Study|Subject withdrew due to death in family|0|||
149782519|NCT03938636|540329657|FG001|Overall Study|Subject withdrew due to death in family|1|||
149782520|NCT03938636|540329658|FG002|Overall Study|Subject withdrew due to death in family|0|||
149782521|NCT03938636|540329656|FG000|Overall Study|Missed visit|0|||
149782522|NCT03938636|540329657|FG001|Overall Study|Missed visit|1|||
149782523|NCT03938636|540329658|FG002|Overall Study|Missed visit|0|||
149782524|NCT03938636|540329656|FG000|Overall Study|Adverse Event|0|||
149782525|NCT03938636|540329657|FG001|Overall Study|Adverse Event|0|||
149782526|NCT03938636|540329658|FG002|Overall Study|Adverse Event|1|||
149782527|NCT03938636|540329656|FG000|Overall Study|Lost to Follow-up|0|||
149782528|NCT03938636|540329657|FG001|Overall Study|Lost to Follow-up|0|||
149782529|NCT03938636|540329658|FG002|Overall Study|Lost to Follow-up|1|||
149782530|NCT02579863|540329659|FG000|Overall Study|Final Disposition Unknown|2|||
149782531|NCT02579863|540329660|FG001|Overall Study|Final Disposition Unknown|1|||
149782532|NCT02579863|540329659|FG000|Overall Study|Adverse Event|18|||
149782533|NCT02579863|540329660|FG001|Overall Study|Adverse Event|11|||
149782534|NCT02579863|540329659|FG000|Overall Study|Death|31|||
149782535|NCT02579863|540329660|FG001|Overall Study|Death|29|||
149782536|NCT02579863|540329659|FG000|Overall Study|Lost to Follow-up|2|||
149782537|NCT02579863|540329660|FG001|Overall Study|Lost to Follow-up|1|||
149782538|NCT02579863|540329659|FG000|Overall Study|Physician Decision|1|||
149782539|NCT02579863|540329660|FG001|Overall Study|Physician Decision|2|||
149782540|NCT02579863|540329659|FG000|Overall Study|Screen Failure|0|||
149782541|NCT02579863|540329660|FG001|Overall Study|Screen Failure|2|||
149782542|NCT02579863|540329659|FG000|Overall Study|Study Terminated at Selected Sites|82|||
149782543|NCT02579863|540329660|FG001|Overall Study|Study Terminated at Selected Sites|88|||
149782544|NCT02579863|540329659|FG000|Overall Study|Withdrawal by Subject|20|||
149782545|NCT02579863|540329660|FG001|Overall Study|Withdrawal by Subject|20|||
149782546|NCT04097028|540329686|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
149782547|NCT04097028|540329686|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
149782548|NCT04097028|540329686|FG000|Overall Study|Disease Progression prior to Surgery|2|||
149782549|NCT04097028|540329686|FG000|Overall Study|Adverse Event prior to Surgery|1|||
149782550|NCT02473289|540329687|FG000|Overall Study|Adverse Event|2|||
149782551|NCT02473289|540329688|FG001|Overall Study|Adverse Event|3|||
149782552|NCT02473289|540329687|FG000|Overall Study|Lost to Follow-up|1|||
149782553|NCT02473289|540329688|FG001|Overall Study|Lost to Follow-up|1|||
149782554|NCT02473289|540329687|FG000|Overall Study|Protocol Violation|0|||
149782555|NCT02473289|540329688|FG001|Overall Study|Protocol Violation|1|||
149782556|NCT02473289|540329687|FG000|Overall Study|Withdrawal of consent|6|||
149782557|NCT02473289|540329688|FG001|Overall Study|Withdrawal of consent|7|||
149782558|NCT02473289|540329687|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
149782559|NCT02473289|540329688|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
149782560|NCT02473289|540329687|FG000|Overall Study|Other|2|||
149782561|NCT02473289|540329688|FG001|Overall Study|Other|0|||
149782562|NCT01156363|540329689|FG000|Overall Study|Adverse Event|6|||
149782563|NCT01156363|540329689|FG000|Overall Study|Insufficient Therapeutic Response|5|||
149782564|NCT01156363|540329689|FG000|Overall Study|Failure to Return|1|||
149782565|NCT01156363|540329689|FG000|Overall Study|Refused Treatment|4|||
149782566|NCT01156363|540329689|FG000|Overall Study|Other|6|||
149782567|NCT03285490|540329691|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
149782568|NCT03285490|540329692|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
149782569|NCT03285490|540329691|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
149782570|NCT03285490|540329692|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
149782571|NCT03745989|540329693|FG000|Overall Study|Death|3|||
149782572|NCT03745989|540329694|FG001|Overall Study|Death|7|||
149782573|NCT03745989|540329695|FG002|Overall Study|Death|4|||
149782574|NCT03745989|540329693|FG000|Overall Study|Lost to Follow-up|0|||
149782575|NCT03745989|540329694|FG001|Overall Study|Lost to Follow-up|2|||
149782576|NCT03745989|540329695|FG002|Overall Study|Lost to Follow-up|0|||
149782577|NCT03745989|540329693|FG000|Overall Study|Sponsor Decision|0|||
149782578|NCT03745989|540329694|FG001|Overall Study|Sponsor Decision|2|||
149782579|NCT03745989|540329695|FG002|Overall Study|Sponsor Decision|8|||
149782580|NCT03745989|540329693|FG000|Overall Study|Withdrawal by Subject|0|||
149782581|NCT03745989|540329694|FG001|Overall Study|Withdrawal by Subject|1|||
149782582|NCT03745989|540329695|FG002|Overall Study|Withdrawal by Subject|3|||
149782583|NCT00735072|540329701|FG000|Overall Study|interrupted study med during ARV change|1|||
149782584|NCT00735072|540329702|FG001|Overall Study|interrupted study med during ARV change|0|||
149782585|NCT00735072|540329701|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
149782586|NCT00735072|540329702|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
149782587|NCT00911144|540329706|FG000|Overall Study|Withdrawal by Subject|16|||
149782588|NCT00911144|540329707|FG001|Overall Study|Withdrawal by Subject|5|||
149782589|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
149782590|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
149782591|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
149782592|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
149782593|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
149782594|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
149782595|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
149782596|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
149782597|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
149782598|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
149782599|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
149782600|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
149782601|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
149782602|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
149782603|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
149782604|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
149782605|NCT01291511|540329708|FG000|Cross-Titration and Stabilization Phase|Death|1|||
149782606|NCT01291511|540329709|FG001|Cross-Titration and Stabilization Phase|Death|0|||
149782607|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
149782608|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
149782609|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
149782610|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
149782611|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
149782612|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
149782613|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
149782614|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
149782615|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
149782616|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
149782617|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
149782618|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
149782619|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
149782620|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
149782621|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
149782622|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
149782623|NCT01291511|540329708|FG000|Double-blind Relapse Prevention Phase|Death|1|||
149782624|NCT01291511|540329709|FG001|Double-blind Relapse Prevention Phase|Death|0|||
149782625|NCT00047008|540329711|FG000|Overall Study|Withdrawn consent|2|||
149782626|NCT00047008|540329712|FG001|Overall Study|Withdrawn consent|3|||
149782627|NCT00047008|540329711|FG000|Overall Study|Ineligible|9|||
149782628|NCT00047008|540329712|FG001|Overall Study|Ineligible|8|||
149782629|NCT01929018|540329713|FG000|Overall Study|Lost to Follow-up|1|||
149782630|NCT01929018|540329714|FG001|Overall Study|Lost to Follow-up|0|||
149782631|NCT01929018|540329713|FG000|Overall Study|Hospitalization|0|||
149782632|NCT01929018|540329714|FG001|Overall Study|Hospitalization|1|||
149782633|NCT01366534|540329715|FG000|Overall Study|Lost to Follow-up|1|||
149782634|NCT01366534|540329716|FG001|Overall Study|Lost to Follow-up|0|||
149782635|NCT01366534|540329717|FG002|Overall Study|Lost to Follow-up|0|||
149782636|NCT01366534|540329715|FG000|Overall Study|Migrated|1|||
149782637|NCT01366534|540329716|FG001|Overall Study|Migrated|1|||
149782638|NCT01366534|540329717|FG002|Overall Study|Migrated|0|||
149782639|NCT01366534|540329715|FG000|Overall Study|Declined challenged|0|||
149782640|NCT01366534|540329716|FG001|Overall Study|Declined challenged|1|||
149782641|NCT01366534|540329717|FG002|Overall Study|Declined challenged|0|||
149782642|NCT01047436|540329721|FG000|Overall Study|Protocol Violation|1|||
149782643|NCT01047436|540329722|FG001|Overall Study|Protocol Violation|0|||
149782644|NCT02635867|540329725|FG000|Overall Study|Lost to Follow-up|4|||
149782645|NCT02635867|540329726|FG001|Overall Study|Lost to Follow-up|3|||
149782646|NCT02635867|540329727|FG002|Overall Study|Lost to Follow-up|3|||
149782647|NCT02635867|540329728|FG003|Overall Study|Lost to Follow-up|4|||
149782648|NCT02635867|540329729|FG004|Overall Study|Lost to Follow-up|1|||
149782649|NCT02565576|540329732|FG000|Overall Study|abnormal lab value|2|||
149782650|NCT02565576|540329733|FG001|Overall Study|abnormal lab value|0|||
149782651|NCT02565576|540329732|FG000|Overall Study|subject / guardian decision|1|||
149782652|NCT02565576|540329733|FG001|Overall Study|subject / guardian decision|3|||
149782653|NCT02565576|540329732|FG000|Overall Study|Lost to Follow-up|1|||
149782654|NCT02565576|540329733|FG001|Overall Study|Lost to Follow-up|0|||
149782655|NCT02565576|540329732|FG000|Overall Study|Death|0|||
149782656|NCT02565576|540329733|FG001|Overall Study|Death|2|||
149782657|NCT02565576|540329732|FG000|Overall Study|Adverse Event|1|||
149782658|NCT02565576|540329733|FG001|Overall Study|Adverse Event|0|||
149782659|NCT00939341|540329734|FG000|Overall Study|Adverse Event|15|||
149782660|NCT00939341|540329734|FG000|Overall Study|Pregnancy|1|||
149782661|NCT00939341|540329734|FG000|Overall Study|Lost to Follow-up|23|||
149782662|NCT00939341|540329734|FG000|Overall Study|Withdrawal by Subject|13|||
149782663|NCT00939341|540329734|FG000|Overall Study|Protocol Violation|6|||
149782664|NCT00939341|540329734|FG000|Overall Study|Incorrect enrolment|8|||
149782665|NCT01131130|540329737|FG000|Period 1 - Baseline|Pregnancy|1|||
149782666|NCT01131130|540329737|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
149782667|NCT01849562|540329746|FG000|Overall Study|Lost to Follow-up|1|||
149782668|NCT01849562|540329747|FG001|Overall Study|Lost to Follow-up|0|||
149782669|NCT01849562|540329748|FG002|Overall Study|Lost to Follow-up|0|||
149782670|NCT01849562|540329746|FG000|Overall Study|Non-compliance with Study Drug|1|||
149782671|NCT01849562|540329747|FG001|Overall Study|Non-compliance with Study Drug|0|||
149782672|NCT01849562|540329748|FG002|Overall Study|Non-compliance with Study Drug|0|||
149782673|NCT00633360|540329749|FG000|Overall Study|Lost to Follow-up|1|||
149782674|NCT00633360|540329750|FG001|Overall Study|Lost to Follow-up|1|||
149782675|NCT00633360|540329749|FG000|Overall Study|Adverse Event|3|||
149782676|NCT00633360|540329750|FG001|Overall Study|Adverse Event|1|||
149782677|NCT00633360|540329749|FG000|Overall Study|Protocol Violation|0|||
149782678|NCT00633360|540329750|FG001|Overall Study|Protocol Violation|1|||
149782679|NCT04095793|540329761|FG000|Overall Study|Adverse Event|3|||
149782680|NCT04095793|540329761|FG000|Overall Study|Study Terminated by Sponsor|103|||
149782681|NCT04095793|540329761|FG000|Overall Study|Withdrawal by Subject|4|||
149782682|NCT02224274|540329764|FG000|Overall Study|Death|1|||
149782683|NCT02224274|540329765|FG001|Overall Study|Death|0|||
149782684|NCT00499460|540329766|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
149782685|NCT00499460|540329767|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
149782686|NCT00499460|540329766|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
149782687|NCT00499460|540329767|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
149782688|NCT00499460|540329766|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
149782689|NCT00499460|540329767|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
149782690|NCT00887068|540329768|FG000|Overall Study|Withdrawal by Subject|2|||
149782691|NCT00887068|540329769|FG001|Overall Study|Withdrawal by Subject|0|||
149782692|NCT00887068|540329768|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
149782693|NCT00887068|540329769|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
149782694|NCT00901394|540329770|FG000|Overall Study|Physician Decision|1|||
149782695|NCT00901394|540329771|FG001|Overall Study|Physician Decision|1|||
149782696|NCT00901394|540329772|FG002|Overall Study|Physician Decision|2|||
149782697|NCT02290340|540329773|FG000|Overall Study|Lost to Follow-up|0|||
149782698|NCT02290340|540329774|FG001|Overall Study|Lost to Follow-up|0|||
149782699|NCT02290340|540329775|FG002|Overall Study|Lost to Follow-up|0|||
149782700|NCT02290340|540329776|FG003|Overall Study|Lost to Follow-up|1|||
149782701|NCT02290340|540329773|FG000|Overall Study|Withdrawal by Subject|1|||
149782702|NCT02290340|540329774|FG001|Overall Study|Withdrawal by Subject|0|||
149782703|NCT02290340|540329775|FG002|Overall Study|Withdrawal by Subject|0|||
149782704|NCT02290340|540329776|FG003|Overall Study|Withdrawal by Subject|0|||
149782705|NCT02290340|540329773|FG000|Overall Study|Other|1|||
149782706|NCT02290340|540329774|FG001|Overall Study|Other|0|||
149782707|NCT02290340|540329775|FG002|Overall Study|Other|0|||
149782708|NCT02290340|540329776|FG003|Overall Study|Other|1|||
149782709|NCT00089999|540329780|FG000|Overall Study|Adverse Event|4|||
149782710|NCT00089999|540329781|FG001|Overall Study|Adverse Event|7|||
149782711|NCT00089999|540329780|FG000|Overall Study|Withdrawal by Subject|0|||
149782712|NCT00089999|540329781|FG001|Overall Study|Withdrawal by Subject|4|||
149782713|NCT00089999|540329780|FG000|Overall Study|Lost to Follow-up|2|||
149782714|NCT00089999|540329781|FG001|Overall Study|Lost to Follow-up|1|||
149782715|NCT00089999|540329780|FG000|Overall Study|Radiological Progression of Cancer|52|||
149782716|NCT00089999|540329781|FG001|Overall Study|Radiological Progression of Cancer|44|||
149782717|NCT00089999|540329780|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
149782718|NCT00089999|540329781|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
149782719|NCT00089999|540329780|FG000|Overall Study|Death|3|||
149782720|NCT00089999|540329781|FG001|Overall Study|Death|3|||
149782721|NCT00089999|540329780|FG000|Overall Study|Poor General Condition|1|||
149782722|NCT00089999|540329781|FG001|Overall Study|Poor General Condition|0|||
149782723|NCT00089999|540329780|FG000|Overall Study|Clinical Progression|1|||
149782724|NCT00089999|540329781|FG001|Overall Study|Clinical Progression|2|||
149782725|NCT00089999|540329780|FG000|Overall Study|Physician Decision|2|||
149782726|NCT00089999|540329781|FG001|Overall Study|Physician Decision|2|||
149782727|NCT00089999|540329780|FG000|Overall Study|Patient Underwent Surgery|2|||
149782728|NCT00089999|540329781|FG001|Overall Study|Patient Underwent Surgery|0|||
149782729|NCT00089999|540329780|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
149782730|NCT00089999|540329781|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
149782731|NCT01167153|540329782|FG000|Overall Study|Non-effective therapy|1|||
149782732|NCT01167153|540329783|FG001|Overall Study|Non-effective therapy|4|||
149782733|NCT01167153|540329782|FG000|Overall Study|AE including clinical laboratory AE|2|||
149782734|NCT01167153|540329783|FG001|Overall Study|AE including clinical laboratory AE|8|||
149782735|NCT01167153|540329782|FG000|Overall Study|Hypotension|1|||
149782736|NCT01167153|540329783|FG001|Overall Study|Hypotension|0|||
149782737|NCT01167153|540329782|FG000|Overall Study|Lost to Follow-up|7|||
149782738|NCT01167153|540329783|FG001|Overall Study|Lost to Follow-up|9|||
149782739|NCT01167153|540329782|FG000|Overall Study|Non-compliance to concomitant medication|0|||
149782740|NCT01167153|540329783|FG001|Overall Study|Non-compliance to concomitant medication|2|||
149782741|NCT01167153|540329782|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
149782742|NCT01167153|540329783|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
149782743|NCT01167153|540329782|FG000|Overall Study|Withdrawal consent|1|||
149782744|NCT01167153|540329783|FG001|Overall Study|Withdrawal consent|1|||
149782745|NCT01167153|540329782|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
149782746|NCT01167153|540329783|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
149782747|NCT02859558|540332238|FG000|Step 1|Not Eligible|0|||
149782748|NCT02859558|540332239|FG001|Step 1|Not Eligible|0|||
149782749|NCT02859558|540332240|FG002|Step 1|Not Eligible|0|||
149782750|NCT02859558|540332241|FG003|Step 1|Not Eligible|0|||
149782751|NCT02859558|540332242|FG004|Step 1|Not Eligible|3|||
149782752|NCT02859558|540332238|FG000|Step 1|Lost to Follow-up|1|||
149782753|NCT02859558|540332239|FG001|Step 1|Lost to Follow-up|3|||
149782754|NCT02859558|540332240|FG002|Step 1|Lost to Follow-up|3|||
149782755|NCT02859558|540332241|FG003|Step 1|Lost to Follow-up|0|||
149782756|NCT02859558|540332242|FG004|Step 1|Lost to Follow-up|0|||
149782757|NCT02859558|540332238|FG000|Step 1|Did Not Return to Clinic|2|||
149782758|NCT02859558|540332239|FG001|Step 1|Did Not Return to Clinic|3|||
149782759|NCT02859558|540332240|FG002|Step 1|Did Not Return to Clinic|4|||
149782760|NCT02859558|540332241|FG003|Step 1|Did Not Return to Clinic|0|||
149782761|NCT02859558|540332242|FG004|Step 1|Did Not Return to Clinic|0|||
149782762|NCT02859558|540332238|FG000|Step 1|Moved|0|||
149782763|NCT02859558|540332239|FG001|Step 1|Moved|1|||
149782764|NCT02859558|540332240|FG002|Step 1|Moved|1|||
149782765|NCT02859558|540332241|FG003|Step 1|Moved|0|||
149782766|NCT02859558|540332242|FG004|Step 1|Moved|0|||
149782767|NCT02859558|540332238|FG000|Step 1|Withdrawal By Participant|1|||
149782768|NCT02859558|540332239|FG001|Step 1|Withdrawal By Participant|2|||
149782769|NCT02859558|540332240|FG002|Step 1|Withdrawal By Participant|1|||
149782770|NCT02859558|540332241|FG003|Step 1|Withdrawal By Participant|0|||
149782771|NCT02859558|540332242|FG004|Step 1|Withdrawal By Participant|0|||
149782772|NCT02859558|540332238|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
149782773|NCT02859558|540332239|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149782774|NCT02859558|540332240|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149782775|NCT02859558|540332241|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149782776|NCT02859558|540332242|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149782777|NCT02859558|540332238|FG000|Step 1|Incarceration|0|||
149782778|NCT02859558|540332239|FG001|Step 1|Incarceration|1|||
149782779|NCT02859558|540332240|FG002|Step 1|Incarceration|0|||
149782780|NCT02859558|540332241|FG003|Step 1|Incarceration|0|||
149782781|NCT02859558|540332242|FG004|Step 1|Incarceration|0|||
149782782|NCT02859558|540332238|FG000|Step 1|Non-Adherence to Study Drug|2|||
149782783|NCT02859558|540332239|FG001|Step 1|Non-Adherence to Study Drug|0|||
149782784|NCT02859558|540332240|FG002|Step 1|Non-Adherence to Study Drug|1|||
149782785|NCT02859558|540332241|FG003|Step 1|Non-Adherence to Study Drug|0|||
149782786|NCT02859558|540332242|FG004|Step 1|Non-Adherence to Study Drug|0|||
149782787|NCT02859558|540332238|FG000|Step 1|Non-Adherence to Study Requirements|3|||
149782788|NCT02859558|540332239|FG001|Step 1|Non-Adherence to Study Requirements|1|||
149782789|NCT02859558|540332240|FG002|Step 1|Non-Adherence to Study Requirements|0|||
149782790|NCT02859558|540332241|FG003|Step 1|Non-Adherence to Study Requirements|0|||
149782791|NCT02859558|540332242|FG004|Step 1|Non-Adherence to Study Requirements|0|||
149782792|NCT02859558|540332238|FG000|Step 1|Virologic Failure|2|||
149782793|NCT02859558|540332239|FG001|Step 1|Virologic Failure|1|||
149782794|NCT02859558|540332240|FG002|Step 1|Virologic Failure|1|||
149782795|NCT02859558|540332241|FG003|Step 1|Virologic Failure|0|||
149782796|NCT02859558|540332242|FG004|Step 1|Virologic Failure|0|||
149782797|NCT02859558|540332238|FG000|Step 2|Lost to Follow-up|3|||
149782798|NCT02859558|540332239|FG001|Step 2|Lost to Follow-up|3|||
149782799|NCT02859558|540332240|FG002|Step 2|Lost to Follow-up|1|||
149782800|NCT02859558|540332241|FG003|Step 2|Lost to Follow-up|0|||
149782801|NCT02859558|540332242|FG004|Step 2|Lost to Follow-up|0|||
149782802|NCT02859558|540332238|FG000|Step 2|Withdrawal by Subject|0|||
149782803|NCT02859558|540332239|FG001|Step 2|Withdrawal by Subject|1|||
149782804|NCT02859558|540332240|FG002|Step 2|Withdrawal by Subject|1|||
149782805|NCT02859558|540332241|FG003|Step 2|Withdrawal by Subject|0|||
149782806|NCT02859558|540332242|FG004|Step 2|Withdrawal by Subject|0|||
149782807|NCT02859558|540332238|FG000|Step 2|Unexpected Closure of Site|0|||
149782808|NCT02859558|540332239|FG001|Step 2|Unexpected Closure of Site|1|||
149782809|NCT02859558|540332240|FG002|Step 2|Unexpected Closure of Site|1|||
149782810|NCT02859558|540332241|FG003|Step 2|Unexpected Closure of Site|0|||
149782811|NCT02859558|540332242|FG004|Step 2|Unexpected Closure of Site|0|||
149782812|NCT02859558|540332238|FG000|Step 2|Death|1|||
149782813|NCT02859558|540332239|FG001|Step 2|Death|0|||
149782814|NCT02859558|540332240|FG002|Step 2|Death|0|||
149782815|NCT02859558|540332241|FG003|Step 2|Death|0|||
149782816|NCT02859558|540332242|FG004|Step 2|Death|0|||
149782817|NCT02859558|540332238|FG000|Step 2|Incarceration|0|||
149782818|NCT02859558|540332239|FG001|Step 2|Incarceration|0|||
149782819|NCT02859558|540332240|FG002|Step 2|Incarceration|1|||
149782820|NCT02859558|540332241|FG003|Step 2|Incarceration|0|||
149782821|NCT02859558|540332242|FG004|Step 2|Incarceration|0|||
149782822|NCT01432756|540332243|FG000|Overall Study|Lost to Follow-up|1|||
149782823|NCT01432756|540332244|FG001|Overall Study|Lost to Follow-up|0|||
149782824|NCT01432756|540332245|FG002|Overall Study|Lost to Follow-up|2|||
149782825|NCT01432756|540332246|FG003|Overall Study|Lost to Follow-up|1|||
149782826|NCT00098865|540332249|FG000|Overall Study|Progressive Disease|6|||
149782827|NCT00098865|540332249|FG000|Overall Study|Adverse Event|2|||
149782828|NCT00098865|540332249|FG000|Overall Study|Alternative Therapy|1|||
149782829|NCT03050307|540332250|FG000|Overall Study|Adverse Event|4|||
149782830|NCT03050307|540332251|FG001|Overall Study|Adverse Event|2|||
149782831|NCT03050307|540332250|FG000|Overall Study|Significant Protocol Deviation|0|||
149782832|NCT03050307|540332251|FG001|Overall Study|Significant Protocol Deviation|1|||
149782833|NCT03050307|540332250|FG000|Overall Study|Lost to Follow-up|0|||
149782834|NCT03050307|540332251|FG001|Overall Study|Lost to Follow-up|1|||
149782835|NCT03050307|540332250|FG000|Overall Study|Voluntary Withdrawal|3|||
149782836|NCT03050307|540332251|FG001|Overall Study|Voluntary Withdrawal|4|||
149782837|NCT03050307|540332250|FG000|Overall Study|Reason not Specified|1|||
149782838|NCT03050307|540332251|FG001|Overall Study|Reason not Specified|1|||
149782839|NCT00439309|540332252|FG000|Follow-Up|Death|1|||
149782840|NCT00439309|540332253|FG001|Follow-Up|Death|0|||
149782841|NCT00439309|540332252|FG000|Follow-Up|Lost to Follow-up|2|||
149782842|NCT00439309|540332253|FG001|Follow-Up|Lost to Follow-up|0|||
149782843|NCT00439309|540332252|FG000|Follow-Up|Withdrawal by Subject|0|||
149782844|NCT00439309|540332253|FG001|Follow-Up|Withdrawal by Subject|1|||
149782845|NCT00439309|540332252|FG000|Follow-Up|Late response by subject|0|||
149782846|NCT00439309|540332253|FG001|Follow-Up|Late response by subject|1|||
149782847|NCT00430027|540332255|FG000|Overall Study|Study terminated|8|||
149782848|NCT01998906|540332256|FG000|Overall Study|Participants ongoing in follow-up|77|||
149782849|NCT01998906|540332257|FG001|Overall Study|Participants ongoing in follow-up|60|||
149782850|NCT01998906|540332258|FG002|Overall Study|Participants ongoing in follow-up|58|||
149782851|NCT01998906|540332256|FG000|Overall Study|Death|21|||
149782852|NCT01998906|540332257|FG001|Overall Study|Death|30|||
149782853|NCT01998906|540332258|FG002|Overall Study|Death|17|||
149782854|NCT01998906|540332256|FG000|Overall Study|Lack of Efficacy|10|||
149782855|NCT01998906|540332257|FG001|Overall Study|Lack of Efficacy|9|||
149782856|NCT01998906|540332258|FG002|Overall Study|Lack of Efficacy|8|||
149782857|NCT01998906|540332256|FG000|Overall Study|Failure to return|0|||
149782858|NCT01998906|540332257|FG001|Overall Study|Failure to return|2|||
149782859|NCT01998906|540332258|FG002|Overall Study|Failure to return|4|||
149782860|NCT01998906|540332256|FG000|Overall Study|Violation of Selection Criteria|0|||
149782861|NCT01998906|540332257|FG001|Overall Study|Violation of Selection Criteria|0|||
149782862|NCT01998906|540332258|FG002|Overall Study|Violation of Selection Criteria|1|||
149782863|NCT01998906|540332256|FG000|Overall Study|Withdrawal by Subject|1|||
149782864|NCT01998906|540332257|FG001|Overall Study|Withdrawal by Subject|4|||
149782865|NCT01998906|540332258|FG002|Overall Study|Withdrawal by Subject|3|||
149782866|NCT01998906|540332256|FG000|Overall Study|Administrative/Other|2|||
149782867|NCT01998906|540332257|FG001|Overall Study|Administrative/Other|1|||
149782868|NCT01998906|540332258|FG002|Overall Study|Administrative/Other|3|||
149782869|NCT01998906|540332256|FG000|Overall Study|Other|3|||
149782870|NCT01998906|540332257|FG001|Overall Study|Other|8|||
149782871|NCT01998906|540332258|FG002|Overall Study|Other|4|||
149782872|NCT01572844|540332259|FG000|Overall Study|Physician Decision|1|||
149782873|NCT01572844|540332260|FG001|Overall Study|Physician Decision|1|||
149782874|NCT01536418|540332265|FG000|Overall Study|Protocol Violation|2|||
149782875|NCT01536418|540332266|FG001|Overall Study|Protocol Violation|3|||
149782876|NCT01536418|540332265|FG000|Overall Study|Physician Decision|1|||
149782877|NCT01536418|540332266|FG001|Overall Study|Physician Decision|3|||
149782878|NCT01536418|540332265|FG000|Overall Study|Study closed/terminated|41|||
149782879|NCT01536418|540332266|FG001|Overall Study|Study closed/terminated|37|||
149782880|NCT01536418|540332265|FG000|Overall Study|Lack of Efficacy|10|||
149782881|NCT01536418|540332266|FG001|Overall Study|Lack of Efficacy|16|||
149782882|NCT01536418|540332265|FG000|Overall Study|Adverse Event|9|||
149782883|NCT01536418|540332266|FG001|Overall Study|Adverse Event|4|||
149782884|NCT01536418|540332265|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
149782885|NCT01536418|540332266|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
149782886|NCT01536418|540332265|FG000|Overall Study|Withdrawal by Subject|5|||
149782887|NCT01536418|540332266|FG001|Overall Study|Withdrawal by Subject|3|||
149782888|NCT02658149|540332267|FG000|Overall Study|Physician Decision|1|||
149782889|NCT02658149|540332268|FG001|Overall Study|Physician Decision|0|||
149782890|NCT00711412|540332269|FG000|Induction Treatment|Death|2|||
149782891|NCT00711412|540332269|FG000|Induction Treatment|Adverse Event|1|||
149782892|NCT00711412|540332269|FG000|Induction Treatment|Other|1|||
149782893|NCT00711412|540332269|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
149782894|NCT00711412|540332269|FG000|Evaluated for Combination Treatment|Death|1|||
149782895|NCT00711412|540332269|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
149782896|NCT00711412|540332269|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
149782897|NCT00711412|540332269|FG000|Combination Treatment|Progressive Disease|1|||
149782898|NCT00711412|540332269|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
149782899|NCT00711412|540332269|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
149782900|NCT00711412|540332269|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
149782901|NCT00711412|540332269|FG000|Evaluation for Response and Surgery|Death|1|||
149782902|NCT00711412|540332269|FG000|Survival Follow up Until Death|Other|12|||
149782903|NCT01680991|540332272|FG000|Overall Study|Adverse Event|1|||
149782904|NCT01680991|540332273|FG001|Overall Study|Adverse Event|0|||
149782905|NCT01680991|540332274|FG002|Overall Study|Adverse Event|0|||
149782906|NCT01680991|540332272|FG000|Overall Study|Death|1|||
149782907|NCT01680991|540332273|FG001|Overall Study|Death|0|||
149782908|NCT01680991|540332274|FG002|Overall Study|Death|1|||
149782909|NCT01680991|540332272|FG000|Overall Study|Protocol Violation|0|||
149782910|NCT01680991|540332273|FG001|Overall Study|Protocol Violation|1|||
149782911|NCT01680991|540332274|FG002|Overall Study|Protocol Violation|0|||
149782912|NCT01680991|540332272|FG000|Overall Study|Withdrawal by Subject|5|||
149782913|NCT01680991|540332273|FG001|Overall Study|Withdrawal by Subject|1|||
149782914|NCT01680991|540332274|FG002|Overall Study|Withdrawal by Subject|0|||
149782915|NCT01680991|540332272|FG000|Overall Study|Progressive disease (PD)|0|||
149782916|NCT01680991|540332273|FG001|Overall Study|Progressive disease (PD)|10|||
149782917|NCT01680991|540332274|FG002|Overall Study|Progressive disease (PD)|0|||
149782918|NCT01680991|540332272|FG000|Overall Study|Physician Decision|0|||
149782919|NCT01680991|540332273|FG001|Overall Study|Physician Decision|7|||
149782920|NCT01680991|540332274|FG002|Overall Study|Physician Decision|2|||
149782921|NCT01680991|540332272|FG000|Overall Study|Bad physical condition|0|||
149782922|NCT01680991|540332273|FG001|Overall Study|Bad physical condition|0|||
149782923|NCT01680991|540332274|FG002|Overall Study|Bad physical condition|1|||
149782924|NCT01680991|540332272|FG000|Overall Study|PD confirmed in other hospital|1|||
149782925|NCT01680991|540332273|FG001|Overall Study|PD confirmed in other hospital|0|||
149782926|NCT01680991|540332274|FG002|Overall Study|PD confirmed in other hospital|0|||
149782927|NCT02498392|540332275|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
149782928|NCT02498392|540332276|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
149782929|NCT02498392|540332275|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
149782930|NCT02498392|540332276|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
149782931|NCT02498392|540332275|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
149782932|NCT02498392|540332276|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
149782933|NCT02498392|540332275|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
149782934|NCT02498392|540332276|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
149782935|NCT02498392|540332275|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
149782936|NCT02498392|540332276|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
149782937|NCT02498392|540332275|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
149782938|NCT02498392|540332276|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
149782939|NCT06073054|540332277|FG000|Overall Study|Withdrawal by Subject|2|||
149782940|NCT03687827|540332278|FG000|Treatment Period 1|Death|0|||
149782941|NCT03687827|540332279|FG001|Treatment Period 1|Death|1|||
149782942|NCT03687827|540332278|FG000|Treatment Period 1|Lost to Follow-up|2|||
149782943|NCT03687827|540332279|FG001|Treatment Period 1|Lost to Follow-up|2|||
149782944|NCT03687827|540332278|FG000|Treatment Period 1|Physician Decision|5|||
149782945|NCT03687827|540332279|FG001|Treatment Period 1|Physician Decision|2|||
149782946|NCT03687827|540332278|FG000|Treatment Period 1|Withdrawal by Subject|7|||
149782947|NCT03687827|540332279|FG001|Treatment Period 1|Withdrawal by Subject|3|||
149782948|NCT03687827|540332278|FG000|Treatment Period 2|Physician Decision|4|||
149782949|NCT03687827|540332279|FG001|Treatment Period 2|Physician Decision|1|||
149782950|NCT03687827|540332278|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149782951|NCT03687827|540332279|FG001|Treatment Period 2|Withdrawal by Subject|2|||
149782952|NCT02244619|540332280|FG000|Overall Study|Did not receive study intervention|8|||
149782953|NCT02244619|540332281|FG001|Overall Study|Did not receive study intervention|21|||
149782954|NCT00068822|540332282|FG000|First Randomized Intervention|Lost to Follow-up|1|||
149782955|NCT00068822|540332283|FG001|First Randomized Intervention|Lost to Follow-up|2|||
149782956|NCT00429572|540332285|FG000|Overall Study|Disease progression|1|||
149782957|NCT00424099|540332288|FG000|Overall Study|Adverse Event|0|||
149782958|NCT00424099|540332289|FG001|Overall Study|Adverse Event|1|||
149782959|NCT00424099|540332290|FG002|Overall Study|Adverse Event|1|||
149782960|NCT00424099|540332291|FG003|Overall Study|Adverse Event|0|||
149782961|NCT00424099|540332288|FG000|Overall Study|Death|0|||
149782962|NCT00424099|540332289|FG001|Overall Study|Death|1|||
149782963|NCT00424099|540332290|FG002|Overall Study|Death|0|||
149782964|NCT00424099|540332291|FG003|Overall Study|Death|0|||
149782965|NCT00424099|540332288|FG000|Overall Study|Illness|2|||
149782966|NCT00424099|540332289|FG001|Overall Study|Illness|0|||
149782967|NCT00424099|540332290|FG002|Overall Study|Illness|1|||
149782968|NCT00424099|540332291|FG003|Overall Study|Illness|4|||
149782969|NCT00424099|540332288|FG000|Overall Study|Lost to Follow-up|0|||
149782970|NCT00424099|540332289|FG001|Overall Study|Lost to Follow-up|0|||
149782971|NCT00424099|540332290|FG002|Overall Study|Lost to Follow-up|3|||
149782972|NCT00424099|540332291|FG003|Overall Study|Lost to Follow-up|0|||
149782973|NCT00424099|540332288|FG000|Overall Study|Hospitalized|1|||
149782974|NCT00424099|540332289|FG001|Overall Study|Hospitalized|2|||
149782975|NCT00424099|540332290|FG002|Overall Study|Hospitalized|1|||
149782976|NCT00424099|540332291|FG003|Overall Study|Hospitalized|3|||
149782977|NCT00424099|540332288|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
149782978|NCT00424099|540332289|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
149782979|NCT00424099|540332290|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
149782980|NCT00424099|540332291|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
149782981|NCT00424099|540332288|FG000|Overall Study|Withdrawal by Subject|1|||
149782982|NCT00424099|540332289|FG001|Overall Study|Withdrawal by Subject|9|||
149782983|NCT00424099|540332290|FG002|Overall Study|Withdrawal by Subject|4|||
149782984|NCT00424099|540332291|FG003|Overall Study|Withdrawal by Subject|6|||
149782985|NCT00424099|540332288|FG000|Overall Study|Physician Decision|0|||
149782986|NCT00424099|540332289|FG001|Overall Study|Physician Decision|0|||
149782987|NCT00424099|540332290|FG002|Overall Study|Physician Decision|1|||
149782988|NCT00424099|540332291|FG003|Overall Study|Physician Decision|0|||
149782989|NCT00424099|540332288|FG000|Overall Study|Missing|0|||
149782990|NCT00424099|540332289|FG001|Overall Study|Missing|0|||
149782991|NCT00424099|540332290|FG002|Overall Study|Missing|1|||
149782992|NCT00424099|540332291|FG003|Overall Study|Missing|0|||
149782993|NCT01408732|540332292|FG000|Overall Study|Withdrawal by Subject|2|||
149782994|NCT01408732|540332293|FG001|Overall Study|Withdrawal by Subject|2|||
149782995|NCT00764322|540332294|FG000|Overall Study|Withdrawal by Subject|11|||
149782996|NCT00764322|540332294|FG000|Overall Study|No CYP2D6 genotyping|9|||
149782997|NCT01989572|540332295|FG000|Overall Study|Lack of Efficacy|35|||
149782998|NCT01989572|540332296|FG001|Overall Study|Lack of Efficacy|48|||
149782999|NCT01989572|540332297|FG002|Overall Study|Lack of Efficacy|48|||
149783000|NCT01989572|540332298|FG003|Overall Study|Lack of Efficacy|43|||
149783001|NCT01989572|540332299|FG004|Overall Study|Lack of Efficacy|71|||
149783002|NCT01989572|540332300|FG005|Overall Study|Lack of Efficacy|79|||
149783003|NCT01989572|540332295|FG000|Overall Study|Adverse Event|2|||
149783004|NCT01989572|540332296|FG001|Overall Study|Adverse Event|1|||
149783005|NCT01989572|540332297|FG002|Overall Study|Adverse Event|3|||
149783006|NCT01989572|540332298|FG003|Overall Study|Adverse Event|0|||
149783007|NCT01989572|540332299|FG004|Overall Study|Adverse Event|3|||
149783008|NCT01989572|540332300|FG005|Overall Study|Adverse Event|0|||
149783009|NCT01989572|540332295|FG000|Overall Study|Death|0|||
149783010|NCT01989572|540332296|FG001|Overall Study|Death|0|||
149783011|NCT01989572|540332297|FG002|Overall Study|Death|0|||
149783012|NCT01989572|540332298|FG003|Overall Study|Death|0|||
149783013|NCT01989572|540332299|FG004|Overall Study|Death|1|||
149783014|NCT01989572|540332300|FG005|Overall Study|Death|0|||
149783015|NCT01989572|540332295|FG000|Overall Study|Withdrawal by Subject|4|||
149783016|NCT01989572|540332296|FG001|Overall Study|Withdrawal by Subject|1|||
149783017|NCT01989572|540332297|FG002|Overall Study|Withdrawal by Subject|5|||
149783018|NCT01989572|540332298|FG003|Overall Study|Withdrawal by Subject|1|||
149783019|NCT01989572|540332299|FG004|Overall Study|Withdrawal by Subject|12|||
149783020|NCT01989572|540332300|FG005|Overall Study|Withdrawal by Subject|4|||
149783021|NCT01989572|540332295|FG000|Overall Study|complicating disease|1|||
149783022|NCT01989572|540332296|FG001|Overall Study|complicating disease|1|||
149783023|NCT01989572|540332297|FG002|Overall Study|complicating disease|2|||
149783024|NCT01989572|540332298|FG003|Overall Study|complicating disease|0|||
149783025|NCT01989572|540332299|FG004|Overall Study|complicating disease|1|||
149783026|NCT01989572|540332300|FG005|Overall Study|complicating disease|0|||
149783027|NCT01989572|540332295|FG000|Overall Study|error|2|||
149783028|NCT01989572|540332296|FG001|Overall Study|error|1|||
149783029|NCT01989572|540332297|FG002|Overall Study|error|1|||
149783030|NCT01989572|540332298|FG003|Overall Study|error|1|||
149783031|NCT01989572|540332299|FG004|Overall Study|error|1|||
149783032|NCT01989572|540332300|FG005|Overall Study|error|1|||
149783033|NCT01989572|540332295|FG000|Overall Study|maximum dose reached|0|||
149783034|NCT01989572|540332296|FG001|Overall Study|maximum dose reached|1|||
149783035|NCT01989572|540332297|FG002|Overall Study|maximum dose reached|0|||
149783036|NCT01989572|540332298|FG003|Overall Study|maximum dose reached|0|||
149783037|NCT01989572|540332299|FG004|Overall Study|maximum dose reached|1|||
149783038|NCT01989572|540332300|FG005|Overall Study|maximum dose reached|0|||
149783039|NCT01989572|540332295|FG000|Overall Study|unknown/not specify|3|||
149783040|NCT01989572|540332296|FG001|Overall Study|unknown/not specify|4|||
149783041|NCT01989572|540332297|FG002|Overall Study|unknown/not specify|1|||
149783042|NCT01989572|540332298|FG003|Overall Study|unknown/not specify|3|||
149783043|NCT01989572|540332299|FG004|Overall Study|unknown/not specify|3|||
149783044|NCT01989572|540332300|FG005|Overall Study|unknown/not specify|5|||
149783045|NCT01989572|540332295|FG000|Overall Study|not start protocol therapy|5|||
149783046|NCT01989572|540332296|FG001|Overall Study|not start protocol therapy|1|||
149783047|NCT01989572|540332297|FG002|Overall Study|not start protocol therapy|2|||
149783048|NCT01989572|540332298|FG003|Overall Study|not start protocol therapy|3|||
149783049|NCT01989572|540332299|FG004|Overall Study|not start protocol therapy|4|||
149783050|NCT01989572|540332300|FG005|Overall Study|not start protocol therapy|18|||
149783051|NCT01989572|540332295|FG000|Overall Study|alternative therapy|3|||
149783052|NCT01989572|540332296|FG001|Overall Study|alternative therapy|0|||
149783053|NCT01989572|540332297|FG002|Overall Study|alternative therapy|0|||
149783054|NCT01989572|540332298|FG003|Overall Study|alternative therapy|0|||
149783055|NCT01989572|540332299|FG004|Overall Study|alternative therapy|1|||
149783056|NCT01989572|540332300|FG005|Overall Study|alternative therapy|3|||
149783057|NCT02280096|540332305|FG000|Overall Study|Pregnancy|1|||
149783058|NCT02280096|540332306|FG001|Overall Study|Pregnancy|0|||
149783059|NCT02280096|540332305|FG000|Overall Study|Functional neurological disorder|1|||
149783060|NCT02280096|540332306|FG001|Overall Study|Functional neurological disorder|0|||
149783061|NCT02280096|540332305|FG000|Overall Study|Lack of attachment|0|||
149783062|NCT02280096|540332306|FG001|Overall Study|Lack of attachment|1|||
149783063|NCT00246376|540332307|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
149783064|NCT00246376|540332308|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
149783065|NCT00246376|540332309|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
149783066|NCT00246376|540332310|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
149783067|NCT00246376|540332311|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
149783068|NCT00246376|540332307|FG000|Overall Study|Adverse Event|2|||
149783069|NCT00246376|540332308|FG001|Overall Study|Adverse Event|3|||
149783070|NCT00246376|540332309|FG002|Overall Study|Adverse Event|1|||
149783071|NCT00246376|540332310|FG003|Overall Study|Adverse Event|3|||
149783072|NCT00246376|540332311|FG004|Overall Study|Adverse Event|1|||
149783073|NCT00246376|540332307|FG000|Overall Study|Lost to Follow-up|2|||
149783074|NCT00246376|540332308|FG001|Overall Study|Lost to Follow-up|11|||
149783075|NCT00246376|540332309|FG002|Overall Study|Lost to Follow-up|11|||
149783076|NCT00246376|540332310|FG003|Overall Study|Lost to Follow-up|16|||
149783077|NCT00246376|540332311|FG004|Overall Study|Lost to Follow-up|13|||
149783078|NCT01872897|540332312|FG000|Overall Study|Withdrawal by Subject|1|||
149783079|NCT01872897|540332313|FG001|Overall Study|Withdrawal by Subject|0|||
149783080|NCT01024920|540332314|FG000|Overall Study|Progressive disease|47|||
149783081|NCT01024920|540332315|FG001|Overall Study|Progressive disease|25|||
149783082|NCT01024920|540332314|FG000|Overall Study|Adverse Event|8|||
149783083|NCT01024920|540332315|FG001|Overall Study|Adverse Event|4|||
149783084|NCT01024920|540332314|FG000|Overall Study|Lost to Follow-up|0|||
149783085|NCT01024920|540332315|FG001|Overall Study|Lost to Follow-up|1|||
149783086|NCT01024920|540332314|FG000|Overall Study|Patient refusal to continue|4|||
149783087|NCT01024920|540332315|FG001|Overall Study|Patient refusal to continue|0|||
149783088|NCT01024920|540332314|FG000|Overall Study|Other than listed|5|||
149783089|NCT01024920|540332315|FG001|Overall Study|Other than listed|1|||
149783090|NCT01024920|540332314|FG000|Overall Study|Not treated|3|||
149783091|NCT01024920|540332315|FG001|Overall Study|Not treated|0|||
149783092|NCT01024920|540332314|FG000|Overall Study|Protocol Violation|0|||
149783093|NCT01024920|540332315|FG001|Overall Study|Protocol Violation|1|||
149783094|NCT00329784|540332316|FG000|Overall Study|Lost to Follow-up|0|||
149783095|NCT00329784|540332317|FG001|Overall Study|Lost to Follow-up|1|||
149783096|NCT00329784|540332318|FG002|Overall Study|Lost to Follow-up|0|||
149783097|NCT00329784|540332319|FG003|Overall Study|Lost to Follow-up|0|||
149783098|NCT00329784|540332316|FG000|Overall Study|Withdrawal by Subject|4|||
149783099|NCT00329784|540332317|FG001|Overall Study|Withdrawal by Subject|2|||
149783100|NCT00329784|540332318|FG002|Overall Study|Withdrawal by Subject|0|||
149783101|NCT00329784|540332319|FG003|Overall Study|Withdrawal by Subject|0|||
149783102|NCT00329784|540332316|FG000|Overall Study|Other|1|||
149783103|NCT00329784|540332317|FG001|Overall Study|Other|2|||
149783104|NCT00329784|540332318|FG002|Overall Study|Other|0|||
149783105|NCT00329784|540332319|FG003|Overall Study|Other|0|||
149783106|NCT04599972|540332324|FG000|Overall Study|Withdrawal by Subject|6|||
149783107|NCT04599972|540332325|FG001|Overall Study|Withdrawal by Subject|1|||
149783108|NCT04599972|540332324|FG000|Overall Study|Adverse Event|1|||
149783109|NCT04599972|540332325|FG001|Overall Study|Adverse Event|1|||
149783110|NCT04599972|540332324|FG000|Overall Study|Lost to Follow-up|1|||
149783111|NCT04599972|540332325|FG001|Overall Study|Lost to Follow-up|6|||
149783112|NCT04599972|540332324|FG000|Overall Study|Protocol Violation|1|||
149783113|NCT04599972|540332325|FG001|Overall Study|Protocol Violation|0|||
149783114|NCT04599972|540332324|FG000|Overall Study|Other reason|1|||
149783115|NCT04599972|540332325|FG001|Overall Study|Other reason|0|||
149783116|NCT00638690|540332326|FG000|Overall Study|Death|655|||
149783117|NCT00638690|540332327|FG001|Overall Study|Death|335|||
149783118|NCT00638690|540332326|FG000|Overall Study|Withdrawal by Subject|22|||
149783119|NCT00638690|540332327|FG001|Overall Study|Withdrawal by Subject|5|||
149783120|NCT00638690|540332326|FG000|Overall Study|Lost to Follow-up|4|||
149783121|NCT00638690|540332327|FG001|Overall Study|Lost to Follow-up|2|||
149783122|NCT01347073|540332335|FG000|Overall Study|Adverse Event|1|||
149783123|NCT01347073|540332335|FG000|Overall Study|Liver Transplant|1|||
149783124|NCT03236506|540332337|FG000|Overall Study|Death|1|||
149783125|NCT03236506|540332338|FG001|Overall Study|Death|1|||
149783126|NCT03236506|540332339|FG002|Overall Study|Death|1|||
149783127|NCT03236506|540332337|FG000|Overall Study|Withdrawal by Subject|3|||
149783128|NCT03236506|540332338|FG001|Overall Study|Withdrawal by Subject|3|||
149783129|NCT03236506|540332339|FG002|Overall Study|Withdrawal by Subject|4|||
149783130|NCT03236506|540332337|FG000|Overall Study|Did not initiate treatment|2|||
149783131|NCT03236506|540332338|FG001|Overall Study|Did not initiate treatment|1|||
149783132|NCT03236506|540332339|FG002|Overall Study|Did not initiate treatment|2|||
149783133|NCT00621244|540332340|FG000|Overall Study|Withdrawal by Subject|7|||
149783134|NCT00621244|540332341|FG001|Overall Study|Withdrawal by Subject|3|||
149783135|NCT00621244|540332342|FG002|Overall Study|Withdrawal by Subject|3|||
149783136|NCT00621244|540332343|FG003|Overall Study|Withdrawal by Subject|3|||
149783137|NCT00621244|540332340|FG000|Overall Study|Disease progression|44|||
149783138|NCT00621244|540332341|FG001|Overall Study|Disease progression|20|||
149783139|NCT00621244|540332342|FG002|Overall Study|Disease progression|20|||
149783140|NCT00621244|540332343|FG003|Overall Study|Disease progression|15|||
149783141|NCT00621244|540332340|FG000|Overall Study|Death|3|||
149783142|NCT00621244|540332341|FG001|Overall Study|Death|3|||
149783143|NCT00621244|540332342|FG002|Overall Study|Death|1|||
149783144|NCT00621244|540332343|FG003|Overall Study|Death|1|||
149783145|NCT00621244|540332340|FG000|Overall Study|Adverse Event|27|||
149783146|NCT00621244|540332341|FG001|Overall Study|Adverse Event|7|||
149783147|NCT00621244|540332342|FG002|Overall Study|Adverse Event|9|||
149783148|NCT00621244|540332343|FG003|Overall Study|Adverse Event|2|||
149783149|NCT00621244|540332340|FG000|Overall Study|Administrative problems|5|||
149783150|NCT00621244|540332341|FG001|Overall Study|Administrative problems|1|||
149783151|NCT00621244|540332342|FG002|Overall Study|Administrative problems|0|||
149783152|NCT00621244|540332343|FG003|Overall Study|Administrative problems|2|||
149783153|NCT02865928|540332346|FG000|Overall Study|Withdrawal by Subject|1|||
149783154|NCT02865928|540332347|FG001|Overall Study|Withdrawal by Subject|0|||
149783155|NCT02865928|540332346|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
149783156|NCT02865928|540332347|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
149783157|NCT02865928|540332346|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
149783158|NCT02865928|540332347|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
149783159|NCT01925014|540332354|FG000|Overall Study|Inappropriate enrollment|4|||
149783160|NCT01925014|540332355|FG001|Overall Study|Inappropriate enrollment|6|||
149783161|NCT01925014|540332354|FG000|Overall Study|Withdrawal by Subject|5|||
149783162|NCT01925014|540332355|FG001|Overall Study|Withdrawal by Subject|13|||
149783163|NCT01690988|540332356|FG000|Overall Study|Withdrawal by Subject|2|||
149783164|NCT01690988|540332357|FG001|Overall Study|Withdrawal by Subject|2|||
149783165|NCT01690988|540332358|FG002|Overall Study|Withdrawal by Subject|3|||
149783166|NCT01690988|540332356|FG000|Overall Study|Physician Decision|0|||
149783167|NCT01690988|540332357|FG001|Overall Study|Physician Decision|0|||
149783168|NCT01690988|540332358|FG002|Overall Study|Physician Decision|1|||
149783169|NCT01690988|540332356|FG000|Overall Study|Operation Cancelled|1|||
149783170|NCT01690988|540332357|FG001|Overall Study|Operation Cancelled|1|||
149783171|NCT01690988|540332358|FG002|Overall Study|Operation Cancelled|0|||
149783172|NCT01690988|540332356|FG000|Overall Study|Determined ineligible|1|||
149783173|NCT01690988|540332357|FG001|Overall Study|Determined ineligible|0|||
149783174|NCT01690988|540332358|FG002|Overall Study|Determined ineligible|0|||
149783175|NCT01690988|540332356|FG000|Overall Study|Death|1|||
149783176|NCT01690988|540332357|FG001|Overall Study|Death|1|||
149783177|NCT01690988|540332358|FG002|Overall Study|Death|1|||
149783178|NCT01690988|540332356|FG000|Overall Study|Sedated|1|||
149783179|NCT01690988|540332357|FG001|Overall Study|Sedated|1|||
149783180|NCT01690988|540332358|FG002|Overall Study|Sedated|2|||
149783181|NCT03696576|540332361|FG000|Overall Study|Soreness of throat after therapy|1|||
149783182|NCT03696576|540332362|FG001|Overall Study|Soreness of throat after therapy|1|||
149783183|NCT03696576|540332361|FG000|Overall Study|Lost to Follow-up|2|||
149783184|NCT03696576|540332362|FG001|Overall Study|Lost to Follow-up|4|||
149783185|NCT00312728|540332370|FG000|Overall Study|Progressive disease|53|||
149783186|NCT00312728|540332370|FG000|Overall Study|Adverse Event|32|||
149783187|NCT00312728|540332370|FG000|Overall Study|Withdrawal by Subject|10|||
149783188|NCT00312728|540332370|FG000|Overall Study|Required non-protocol cancer treatment|2|||
149783189|NCT00312728|540332370|FG000|Overall Study|Protocol Violation|2|||
149783190|NCT00312728|540332370|FG000|Overall Study|Other|10|||
149783191|NCT00312728|540332370|FG000|Overall Study|Other|1|||
149783192|NCT00552344|540332371|FG000|Overall Study|Lack of Efficacy|55|||
149783193|NCT00552344|540332371|FG000|Overall Study|Loss of efficacy|75|||
149783194|NCT00552344|540332371|FG000|Overall Study|Lost to Follow-up|8|||
149783195|NCT00552344|540332371|FG000|Overall Study|Withdrawal by Subject|48|||
149783196|NCT00552344|540332371|FG000|Overall Study|SAE, non-fatal|6|||
149783197|NCT00552344|540332371|FG000|Overall Study|AE, non-serious non-fatal|38|||
149783198|NCT00552344|540332371|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
149783199|NCT00552344|540332371|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
149783200|NCT00552344|540332371|FG000|Overall Study|Other Reason|22|||
149783201|NCT01975376|540332372|FG000|Overall Study|Adverse Event|5|||
149783202|NCT01975376|540332373|FG001|Overall Study|Adverse Event|5|||
149783203|NCT01975376|540332372|FG000|Overall Study|Death|65|||
149783204|NCT01975376|540332373|FG001|Overall Study|Death|72|||
149783205|NCT01975376|540332372|FG000|Overall Study|Lost to Follow-up|70|||
149783206|NCT01975376|540332373|FG001|Overall Study|Lost to Follow-up|66|||
149783207|NCT01975376|540332372|FG000|Overall Study|Withdrew consent|68|||
149783208|NCT01975376|540332373|FG001|Overall Study|Withdrew consent|62|||
149783209|NCT01975376|540332372|FG000|Overall Study|Other|2|||
149783210|NCT01975376|540332373|FG001|Overall Study|Other|4|||
149783211|NCT01975376|540332372|FG000|Overall Study|Randomized, Not Treated|16|||
149783212|NCT01975376|540332373|FG001|Overall Study|Randomized, Not Treated|8|||
149783213|NCT00179517|540332374|FG000|Overall Study|Withdrawal by Subject|2|||
149783214|NCT00179517|540332375|FG001|Overall Study|Withdrawal by Subject|1|||
149783215|NCT00023712|540332376|FG000|Overall Study|Not platinum sensitive|1|||
149783216|NCT00023712|540332377|FG001|Overall Study|Not platinum sensitive|0|||
149783217|NCT00023712|540332376|FG000|Overall Study|Never treated|1|||
149783218|NCT00023712|540332377|FG001|Overall Study|Never treated|1|||
149783219|NCT00565812|540332378|FG000|Overall Study|Death|2|||
149783220|NCT00565812|540332379|FG001|Overall Study|Death|1|||
149783221|NCT00565812|540332380|FG002|Overall Study|Death|3|||
149783222|NCT00565812|540332378|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
149783223|NCT00565812|540332379|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
149783224|NCT00565812|540332380|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
149783225|NCT00565812|540332378|FG000|Overall Study|Lost to Follow-up|10|||
149783226|NCT00565812|540332379|FG001|Overall Study|Lost to Follow-up|8|||
149783227|NCT00565812|540332380|FG002|Overall Study|Lost to Follow-up|8|||
149783228|NCT00565812|540332378|FG000|Overall Study|Withdrawal by Subject|58|||
149783229|NCT00565812|540332379|FG001|Overall Study|Withdrawal by Subject|47|||
149783230|NCT00565812|540332380|FG002|Overall Study|Withdrawal by Subject|48|||
149783231|NCT00565812|540332378|FG000|Overall Study|Work Schedule|5|||
149783232|NCT00565812|540332379|FG001|Overall Study|Work Schedule|3|||
149783233|NCT00565812|540332380|FG002|Overall Study|Work Schedule|1|||
149783234|NCT00565812|540332378|FG000|Overall Study|Protocol Violation|2|||
149783235|NCT00565812|540332379|FG001|Overall Study|Protocol Violation|6|||
149783236|NCT00565812|540332380|FG002|Overall Study|Protocol Violation|4|||
149783237|NCT00565812|540332378|FG000|Overall Study|Adverse Event|41|||
149783238|NCT00565812|540332379|FG001|Overall Study|Adverse Event|54|||
149783239|NCT00565812|540332380|FG002|Overall Study|Adverse Event|40|||
149783240|NCT00565812|540332378|FG000|Overall Study|Jury Duty|1|||
149783241|NCT00565812|540332379|FG001|Overall Study|Jury Duty|0|||
149783242|NCT00565812|540332380|FG002|Overall Study|Jury Duty|0|||
149783243|NCT00565812|540332378|FG000|Overall Study|Relocated Out of Area|5|||
149783244|NCT00565812|540332379|FG001|Overall Study|Relocated Out of Area|8|||
149783245|NCT00565812|540332380|FG002|Overall Study|Relocated Out of Area|9|||
149783246|NCT00565812|540332378|FG000|Overall Study|Sponsor Decision|1|||
149783247|NCT00565812|540332379|FG001|Overall Study|Sponsor Decision|5|||
149783248|NCT00565812|540332380|FG002|Overall Study|Sponsor Decision|1|||
149783249|NCT00565812|540332378|FG000|Overall Study|Domestic Reasons|7|||
149783250|NCT00565812|540332379|FG001|Overall Study|Domestic Reasons|1|||
149783251|NCT00565812|540332380|FG002|Overall Study|Domestic Reasons|3|||
149783252|NCT00565812|540332378|FG000|Overall Study|Research Site Closure|6|||
149783253|NCT00565812|540332379|FG001|Overall Study|Research Site Closure|1|||
149783254|NCT00565812|540332380|FG002|Overall Study|Research Site Closure|8|||
149783255|NCT00565812|540332378|FG000|Overall Study|Surgical Intervention|0|||
149783256|NCT00565812|540332379|FG001|Overall Study|Surgical Intervention|1|||
149783257|NCT00565812|540332380|FG002|Overall Study|Surgical Intervention|2|||
149783258|NCT00565812|540332378|FG000|Overall Study|Low Compliance|1|||
149783259|NCT00565812|540332379|FG001|Overall Study|Low Compliance|0|||
149783260|NCT00565812|540332380|FG002|Overall Study|Low Compliance|1|||
149783261|NCT00565812|540332378|FG000|Overall Study|Follow-up Visit Not Completed|2|||
149783262|NCT00565812|540332379|FG001|Overall Study|Follow-up Visit Not Completed|0|||
149783263|NCT00565812|540332380|FG002|Overall Study|Follow-up Visit Not Completed|1|||
149783264|NCT00565812|540332378|FG000|Overall Study|Physician Decision|2|||
149783265|NCT00565812|540332379|FG001|Overall Study|Physician Decision|0|||
149783266|NCT00565812|540332380|FG002|Overall Study|Physician Decision|0|||
149783267|NCT01570309|540332382|FG000|Overall Study|Withdrawal by Subject|3|||
149783268|NCT01570309|540332383|FG001|Overall Study|Withdrawal by Subject|3|||
149783269|NCT00614991|540332384|FG000|Overall Study|Adverse Event|3|||
149783270|NCT00614991|540332385|FG001|Overall Study|Adverse Event|3|||
149783271|NCT00614991|540332386|FG002|Overall Study|Adverse Event|0|||
149783272|NCT00614991|540332387|FG003|Overall Study|Adverse Event|0|||
149783273|NCT00614991|540332388|FG004|Overall Study|Adverse Event|1|||
149783274|NCT00614991|540332389|FG005|Overall Study|Adverse Event|0|||
149783275|NCT04857892|540332390|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
149783276|NCT04857892|540332391|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149783277|NCT04857892|540332392|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149783278|NCT04857892|540332393|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149783279|NCT04857892|540332394|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149783280|NCT04857892|540332390|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
149783281|NCT04857892|540332391|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
149783282|NCT04857892|540332392|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
149783283|NCT04857892|540332393|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
149783284|NCT04857892|540332394|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
149783285|NCT04857892|540332390|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149783286|NCT04857892|540332391|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149783287|NCT04857892|540332392|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149783288|NCT04857892|540332393|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149783289|NCT04857892|540332394|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
149783290|NCT00368472|540332398|FG000|Overall Study|Adverse Event|22|||
149783291|NCT00368472|540332398|FG000|Overall Study|Medication non-compliance|4|||
149783292|NCT00368472|540332398|FG000|Overall Study|Protocol Violation|2|||
149783293|NCT00368472|540332398|FG000|Overall Study|Request of Investigator or Sponsor|3|||
149783294|NCT00368472|540332398|FG000|Overall Study|Withdrawal by Subject|40|||
149783295|NCT00368472|540332398|FG000|Overall Study|Diary non-compliance|1|||
149783296|NCT00368472|540332398|FG000|Overall Study|Other|32|||
149783297|NCT00368472|540332398|FG000|Overall Study|Missing Final Disposition Date|1|||
149783298|NCT03209362|540332403|FG000|Overall Study|Adverse Event|0|||
149783299|NCT03209362|540332404|FG001|Overall Study|Adverse Event|1|||
149783300|NCT03209362|540332403|FG000|Overall Study|Lost to Follow-up|0|||
149783301|NCT03209362|540332404|FG001|Overall Study|Lost to Follow-up|1|||
149783302|NCT03209362|540332403|FG000|Overall Study|Withdrawal by Subject|2|||
149783303|NCT03209362|540332404|FG001|Overall Study|Withdrawal by Subject|0|||
149783304|NCT03209362|540332403|FG000|Overall Study|Other|0|||
149783305|NCT03209362|540332404|FG001|Overall Study|Other|1|||
149783306|NCT00251589|540332405|FG000|Overall Study|Adverse Event|5|||
149783307|NCT00251589|540332406|FG001|Overall Study|Adverse Event|1|||
149783308|NCT00251589|540332407|FG002|Overall Study|Adverse Event|2|||
149783309|NCT00251589|540332408|FG003|Overall Study|Adverse Event|1|||
149783310|NCT00251589|540332405|FG000|Overall Study|Withdrawal by Subject|1|||
149783311|NCT00251589|540332406|FG001|Overall Study|Withdrawal by Subject|1|||
149783312|NCT00251589|540332407|FG002|Overall Study|Withdrawal by Subject|0|||
149783313|NCT00251589|540332408|FG003|Overall Study|Withdrawal by Subject|0|||
149783314|NCT00251589|540332405|FG000|Overall Study|Discontinued due to progressive disease|9|||
149783315|NCT00251589|540332406|FG001|Overall Study|Discontinued due to progressive disease|1|||
149783316|NCT00251589|540332407|FG002|Overall Study|Discontinued due to progressive disease|0|||
149783317|NCT00251589|540332408|FG003|Overall Study|Discontinued due to progressive disease|1|||
149783318|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Adverse Event|22|||
149783319|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Adverse Event|0|||
149783320|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
149783321|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
149783322|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
149783323|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
149783324|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
149783325|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
149783326|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
149783327|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
149783328|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
149783329|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
149783330|NCT02493868|540332411|FG000|Induction Phase: DE Participants|Other|8|||
149783331|NCT02493868|540332412|FG001|Induction Phase: DE Participants|Other|0|||
149783332|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
149783333|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
149783334|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
149783335|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
149783336|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
149783337|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
149783338|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
149783339|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
149783340|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
149783341|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
149783342|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
149783343|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
149783344|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
149783345|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
149783346|NCT02493868|540332411|FG000|Optimization Phase: DE+TE Participants|Other|10|||
149783347|NCT02493868|540332412|FG001|Optimization Phase: DE+TE Participants|Other|2|||
149783348|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
149783349|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
149783350|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
149783351|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
149783352|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
149783353|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
149783354|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
149783355|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
149783356|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
149783357|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
149783358|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
149783359|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
149783360|NCT02493868|540332411|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
149783361|NCT02493868|540332412|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
149783362|NCT02493868|540332411|FG000|Follow-up Phase|Lost to Follow-up|1|||
149783363|NCT02493868|540332412|FG001|Follow-up Phase|Lost to Follow-up|0|||
149783364|NCT02493868|540332411|FG000|Follow-up Phase|Withdrawal by Subject|3|||
149783365|NCT02493868|540332412|FG001|Follow-up Phase|Withdrawal by Subject|0|||
149783366|NCT02493868|540332411|FG000|Follow-up Phase|Investigator Decision|5|||
149783367|NCT02493868|540332412|FG001|Follow-up Phase|Investigator Decision|1|||
149783368|NCT02493868|540332411|FG000|Follow-up Phase|Other|2|||
149783369|NCT02493868|540332412|FG001|Follow-up Phase|Other|1|||
149783370|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
149783371|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
149783372|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
149783373|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
149783374|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
149783375|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
149783376|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
149783377|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
149783378|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
149783379|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
149783380|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
149783381|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
149783382|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
149783383|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Death|0|||
149783384|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Death|0|||
149783385|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Death|1|||
149783386|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Death|0|||
149783387|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Death|0|||
149783388|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Death|0|||
149783389|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Death|0|||
149783390|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Death|0|||
149783391|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Death|0|||
149783392|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Death|0|||
149783393|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Death|0|||
149783394|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Death|0|||
149783395|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Death|0|||
149783396|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
149783397|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
149783398|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
149783399|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783400|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783401|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783402|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783403|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783404|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783405|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783406|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783407|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783408|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149783409|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783410|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783411|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
149783412|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783413|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783414|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783415|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783416|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783417|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783418|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783419|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783420|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783421|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149783422|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
149783423|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
149783424|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
149783425|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
149783426|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
149783427|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
149783428|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
149783429|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
149783430|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
149783431|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
149783432|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
149783433|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
149783434|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
149783435|NCT02407236|540332413|FG000|Induction Study (8 Weeks)|Other|2|||
149783436|NCT02407236|540332414|FG001|Induction Study (8 Weeks)|Other|1|||
149783437|NCT02407236|540332415|FG002|Induction Study (8 Weeks)|Other|5|||
149783438|NCT02407236|540332416|FG003|Induction Study (8 Weeks)|Other|0|||
149783439|NCT02407236|540332417|FG004|Induction Study (8 Weeks)|Other|0|||
149783440|NCT02407236|540332418|FG005|Induction Study (8 Weeks)|Other|0|||
149783441|NCT02407236|540332419|FG006|Induction Study (8 Weeks)|Other|0|||
149783442|NCT02407236|540332420|FG007|Induction Study (8 Weeks)|Other|0|||
149783443|NCT02407236|540332421|FG008|Induction Study (8 Weeks)|Other|0|||
149783444|NCT02407236|540332422|FG009|Induction Study (8 Weeks)|Other|0|||
149783445|NCT02407236|540332423|FG010|Induction Study (8 Weeks)|Other|0|||
149783446|NCT02407236|540332424|FG011|Induction Study (8 Weeks)|Other|0|||
149783447|NCT02407236|540332425|FG012|Induction Study (8 Weeks)|Other|0|||
149783448|NCT02407236|540332413|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783449|NCT02407236|540332414|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783450|NCT02407236|540332415|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783451|NCT02407236|540332416|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
149783452|NCT02407236|540332417|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
149783453|NCT02407236|540332418|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
149783454|NCT02407236|540332419|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
149783455|NCT02407236|540332420|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
149783456|NCT02407236|540332421|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783457|NCT02407236|540332422|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783458|NCT02407236|540332423|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783459|NCT02407236|540332424|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783460|NCT02407236|540332425|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
149783461|NCT02407236|540332413|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783462|NCT02407236|540332414|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783463|NCT02407236|540332415|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783464|NCT02407236|540332416|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
149783465|NCT02407236|540332417|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
149783466|NCT02407236|540332418|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
149783467|NCT02407236|540332419|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
149783468|NCT02407236|540332420|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
149783469|NCT02407236|540332421|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783470|NCT02407236|540332422|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783471|NCT02407236|540332423|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783472|NCT02407236|540332424|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783473|NCT02407236|540332425|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149783474|NCT02407236|540332413|FG000|Maintenance Study (44 Weeks)|Other|0|||
149783475|NCT02407236|540332414|FG001|Maintenance Study (44 Weeks)|Other|0|||
149783476|NCT02407236|540332415|FG002|Maintenance Study (44 Weeks)|Other|0|||
149783477|NCT02407236|540332416|FG003|Maintenance Study (44 Weeks)|Other|5|||
149783478|NCT02407236|540332417|FG004|Maintenance Study (44 Weeks)|Other|7|||
149783479|NCT02407236|540332418|FG005|Maintenance Study (44 Weeks)|Other|8|||
149783480|NCT02407236|540332419|FG006|Maintenance Study (44 Weeks)|Other|4|||
149783481|NCT02407236|540332420|FG007|Maintenance Study (44 Weeks)|Other|6|||
149783482|NCT02407236|540332421|FG008|Maintenance Study (44 Weeks)|Other|0|||
149783483|NCT02407236|540332422|FG009|Maintenance Study (44 Weeks)|Other|0|||
149783484|NCT02407236|540332423|FG010|Maintenance Study (44 Weeks)|Other|0|||
149783485|NCT02407236|540332424|FG011|Maintenance Study (44 Weeks)|Other|0|||
149783486|NCT02407236|540332425|FG012|Maintenance Study (44 Weeks)|Other|0|||
149783487|NCT02407236|540332413|FG000|Maintenance Study (44 Weeks)|Death|0|||
149783488|NCT02407236|540332414|FG001|Maintenance Study (44 Weeks)|Death|0|||
149783489|NCT02407236|540332415|FG002|Maintenance Study (44 Weeks)|Death|0|||
149783490|NCT02407236|540332416|FG003|Maintenance Study (44 Weeks)|Death|0|||
149783491|NCT02407236|540332417|FG004|Maintenance Study (44 Weeks)|Death|0|||
149783492|NCT02407236|540332418|FG005|Maintenance Study (44 Weeks)|Death|0|||
149783493|NCT02407236|540332419|FG006|Maintenance Study (44 Weeks)|Death|0|||
149783494|NCT02407236|540332420|FG007|Maintenance Study (44 Weeks)|Death|1|||
149783495|NCT02407236|540332421|FG008|Maintenance Study (44 Weeks)|Death|0|||
149783496|NCT02407236|540332422|FG009|Maintenance Study (44 Weeks)|Death|0|||
149783497|NCT02407236|540332423|FG010|Maintenance Study (44 Weeks)|Death|0|||
149783498|NCT02407236|540332424|FG011|Maintenance Study (44 Weeks)|Death|0|||
149783499|NCT02407236|540332425|FG012|Maintenance Study (44 Weeks)|Death|0|||
149783500|NCT02407236|540332413|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783501|NCT02407236|540332414|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783502|NCT02407236|540332415|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783503|NCT02407236|540332416|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783504|NCT02407236|540332417|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783505|NCT02407236|540332418|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783506|NCT02407236|540332419|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783507|NCT02407236|540332420|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149783508|NCT02407236|540332421|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
149783509|NCT02407236|540332422|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
149783510|NCT02407236|540332423|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
149783511|NCT02407236|540332424|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
149783512|NCT02407236|540332425|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
149783513|NCT02407236|540332413|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783514|NCT02407236|540332414|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783515|NCT02407236|540332415|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783516|NCT02407236|540332416|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783517|NCT02407236|540332417|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783518|NCT02407236|540332418|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783519|NCT02407236|540332419|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783520|NCT02407236|540332420|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783521|NCT02407236|540332421|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783522|NCT02407236|540332422|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783523|NCT02407236|540332423|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
149783524|NCT02407236|540332424|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783525|NCT02407236|540332425|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149783526|NCT02407236|540332413|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783527|NCT02407236|540332414|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783528|NCT02407236|540332415|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783529|NCT02407236|540332416|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783530|NCT02407236|540332417|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783531|NCT02407236|540332418|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783532|NCT02407236|540332419|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783533|NCT02407236|540332420|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149783534|NCT02407236|540332421|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
149783535|NCT02407236|540332422|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
149783536|NCT02407236|540332423|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
149783537|NCT02407236|540332424|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
149783538|NCT02407236|540332425|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
149783539|NCT02407236|540332413|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
149783540|NCT02407236|540332414|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
149783541|NCT02407236|540332415|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
149783542|NCT02407236|540332416|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
149783543|NCT02407236|540332417|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
149783544|NCT02407236|540332418|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
149783545|NCT02407236|540332419|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
149783546|NCT02407236|540332420|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
149783547|NCT02407236|540332421|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
149783548|NCT02407236|540332422|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
149783549|NCT02407236|540332423|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
149783550|NCT02407236|540332424|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
149783551|NCT02407236|540332425|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
149783552|NCT01627782|540332430|FG000|Overall Study|Adverse Event|1|||
149783553|NCT01627782|540332431|FG001|Overall Study|Adverse Event|2|||
149783554|NCT01627782|540332432|FG002|Overall Study|Adverse Event|0|||
149783555|NCT01627782|540332433|FG003|Overall Study|Adverse Event|1|||
149783556|NCT01627782|540332430|FG000|Overall Study|Lack of Efficacy|11|||
149783557|NCT01627782|540332431|FG001|Overall Study|Lack of Efficacy|1|||
149783558|NCT01627782|540332432|FG002|Overall Study|Lack of Efficacy|15|||
149783559|NCT01627782|540332433|FG003|Overall Study|Lack of Efficacy|2|||
149783560|NCT01627782|540332430|FG000|Overall Study|Protocol Violation|1|||
149783561|NCT01627782|540332431|FG001|Overall Study|Protocol Violation|0|||
149783562|NCT01627782|540332432|FG002|Overall Study|Protocol Violation|0|||
149783563|NCT01627782|540332433|FG003|Overall Study|Protocol Violation|0|||
149783564|NCT01627782|540332430|FG000|Overall Study|Withdrawal by Subject|2|||
149783565|NCT01627782|540332431|FG001|Overall Study|Withdrawal by Subject|1|||
149783566|NCT01627782|540332432|FG002|Overall Study|Withdrawal by Subject|0|||
149783567|NCT01627782|540332433|FG003|Overall Study|Withdrawal by Subject|0|||
149783568|NCT01627782|540332430|FG000|Overall Study|Other|0|||
149783569|NCT01627782|540332431|FG001|Overall Study|Other|2|||
149783570|NCT01627782|540332432|FG002|Overall Study|Other|0|||
149783571|NCT01627782|540332433|FG003|Overall Study|Other|3|||
149783572|NCT01627782|540332430|FG000|Overall Study|Randomized But Not Treated|1|||
149783573|NCT01627782|540332431|FG001|Overall Study|Randomized But Not Treated|0|||
149783574|NCT01627782|540332432|FG002|Overall Study|Randomized But Not Treated|0|||
149783575|NCT01627782|540332433|FG003|Overall Study|Randomized But Not Treated|0|||
149783576|NCT00643448|540332434|FG000|Overall Study|Lack of Efficacy|2|||
149783577|NCT00643448|540332435|FG001|Overall Study|Lack of Efficacy|0|||
149783578|NCT00643448|540332436|FG002|Overall Study|Lack of Efficacy|4|||
149783579|NCT00643448|540332434|FG000|Overall Study|Adverse Event|2|||
149783580|NCT00643448|540332435|FG001|Overall Study|Adverse Event|2|||
149783581|NCT00643448|540332436|FG002|Overall Study|Adverse Event|2|||
149783582|NCT00643448|540332434|FG000|Overall Study|QTcF>550 ms|0|||
149783583|NCT00643448|540332435|FG001|Overall Study|QTcF>550 ms|3|||
149783584|NCT00643448|540332436|FG002|Overall Study|QTcF>550 ms|0|||
149783585|NCT02177812|540332440|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783586|NCT02177812|540332441|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783587|NCT02177812|540332442|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783588|NCT02177812|540332443|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783589|NCT02177812|540332444|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783590|NCT02177812|540332445|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
149783591|NCT02177812|540332446|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
149783592|NCT02177812|540332447|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
149783593|NCT02177812|540332448|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149783594|NCT02177812|540332440|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783595|NCT02177812|540332441|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783596|NCT02177812|540332442|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783597|NCT02177812|540332443|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783598|NCT02177812|540332444|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783599|NCT02177812|540332445|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
149783600|NCT02177812|540332446|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
149783601|NCT02177812|540332447|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783602|NCT02177812|540332448|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149783603|NCT02177812|540332440|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149783604|NCT02177812|540332441|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149783605|NCT02177812|540332442|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149783606|NCT02177812|540332443|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149783607|NCT02177812|540332444|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149783608|NCT02177812|540332445|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149783609|NCT02177812|540332446|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
149783610|NCT02177812|540332447|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149783611|NCT02177812|540332448|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149783612|NCT03695471|540335131|FG000|Overall Study|Cancellation|1|||
149783613|NCT00464620|540335132|FG000|Overall Study|Physician Decision|1|||
149783614|NCT00464620|540335133|FG001|Overall Study|Physician Decision|0|||
149783615|NCT00464620|540335134|FG002|Overall Study|Physician Decision|0|||
149783616|NCT00464620|540335132|FG000|Overall Study|Withdrawal by Subject|1|||
149783617|NCT00464620|540335133|FG001|Overall Study|Withdrawal by Subject|0|||
149783618|NCT00464620|540335134|FG002|Overall Study|Withdrawal by Subject|3|||
149783619|NCT00464620|540335132|FG000|Overall Study|Ineligible sarcoma subtype|0|||
149783620|NCT00464620|540335133|FG001|Overall Study|Ineligible sarcoma subtype|2|||
149783621|NCT00464620|540335134|FG002|Overall Study|Ineligible sarcoma subtype|2|||
149783622|NCT00464620|540335132|FG000|Overall Study|Use of prohibited concomitant medication|0|||
149783623|NCT00464620|540335133|FG001|Overall Study|Use of prohibited concomitant medication|0|||
149783624|NCT00464620|540335134|FG002|Overall Study|Use of prohibited concomitant medication|2|||
149783625|NCT06048809|540335149|FG000|Overall Study|Adverse Event|2|||
149783626|NCT06048809|540335150|FG001|Overall Study|Adverse Event|0|||
149783627|NCT06048809|540335149|FG000|Overall Study|Withdrawal by Subject|1|||
149783628|NCT06048809|540335150|FG001|Overall Study|Withdrawal by Subject|1|||
149783629|NCT04960202|540335152|FG000|Overall Study|Other|5|||
149783630|NCT04960202|540335153|FG001|Overall Study|Other|0|||
149783631|NCT04960202|540335152|FG000|Overall Study|Withdrawal by Subject|37|||
149783632|NCT04960202|540335153|FG001|Overall Study|Withdrawal by Subject|43|||
149783633|NCT04960202|540335152|FG000|Overall Study|Lost to Follow-up|20|||
149783634|NCT04960202|540335153|FG001|Overall Study|Lost to Follow-up|16|||
149783635|NCT04960202|540335152|FG000|Overall Study|Death|0|||
149783636|NCT04960202|540335153|FG001|Overall Study|Death|15|||
149783637|NCT02158728|540335154|FG000|Overall Study|no procedure according to CIP done|3|||
149783638|NCT02158728|540335154|FG000|Overall Study|no qualified dataset|24|||
149783639|NCT02234050|540335168|FG000|Overall Study|Lack of Efficacy|38|||
149783640|NCT02234050|540335169|FG001|Overall Study|Lack of Efficacy|22|||
149783641|NCT02234050|540335168|FG000|Overall Study|Adverse Event|13|||
149783642|NCT02234050|540335169|FG001|Overall Study|Adverse Event|1|||
149783643|NCT02234050|540335168|FG000|Overall Study|Withdrawal by Subject|4|||
149783644|NCT02234050|540335169|FG001|Overall Study|Withdrawal by Subject|2|||
149783645|NCT02234050|540335168|FG000|Overall Study|Sponsor's decision|6|||
149783646|NCT02234050|540335169|FG001|Overall Study|Sponsor's decision|0|||
149783647|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
149783648|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
149783649|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
149783650|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
149783651|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
149783652|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
149783653|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
149783654|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
149783655|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
149783656|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
149783657|NCT03774875|540335171|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
149783658|NCT03774875|540335172|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
149783659|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
149783660|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
149783661|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
149783662|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
149783663|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
149783664|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
149783665|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
149783666|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
149783667|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
149783668|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
149783669|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
149783670|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
149783671|NCT03774875|540335171|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
149783672|NCT03774875|540335172|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
149783673|NCT02352090|540335173|FG000|Overall Study|general malaise|1|||
149783674|NCT02352090|540335174|FG001|Overall Study|general malaise|0|||
149783675|NCT02352090|540335175|FG002|Overall Study|general malaise|0|||
149783676|NCT02352090|540335173|FG000|Overall Study|non-specified mild side-effects|0|||
149783677|NCT02352090|540335174|FG001|Overall Study|non-specified mild side-effects|0|||
149783678|NCT02352090|540335175|FG002|Overall Study|non-specified mild side-effects|2|||
149783679|NCT01678313|540335180|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
149783680|NCT01678313|540335181|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
149783681|NCT01678313|540335180|FG000|Completed the 3-month Therapy|Physician Decision|3|||
149783682|NCT01678313|540335181|FG001|Completed the 3-month Therapy|Physician Decision|4|||
149783683|NCT01678313|540335180|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
149783684|NCT01678313|540335181|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
149783685|NCT01678313|540335180|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
149783686|NCT01678313|540335181|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
149783687|NCT00981292|540335182|FG000|Day 1|Protocol Violation|1|||
149783688|NCT00981292|540335183|FG001|Day 1|Protocol Violation|0|||
149783689|NCT00981292|540335184|FG002|Day 1|Protocol Violation|0|||
149783690|NCT00981292|540335185|FG003|Day 1|Protocol Violation|0|||
149783691|NCT00981292|540335186|FG004|Day 1|Protocol Violation|0|||
149783692|NCT00981292|540335187|FG005|Day 1|Protocol Violation|2|||
149783693|NCT00981292|540335182|FG000|Day 2|Protocol Violation|2|||
149783694|NCT00981292|540335183|FG001|Day 2|Protocol Violation|0|||
149783695|NCT00981292|540335184|FG002|Day 2|Protocol Violation|0|||
149783696|NCT00981292|540335185|FG003|Day 2|Protocol Violation|0|||
149783697|NCT00981292|540335186|FG004|Day 2|Protocol Violation|0|||
149783698|NCT00981292|540335187|FG005|Day 2|Protocol Violation|0|||
149783699|NCT00981292|540335182|FG000|Day 3|Protocol Violation|0|||
149783700|NCT00981292|540335183|FG001|Day 3|Protocol Violation|0|||
149783701|NCT00981292|540335184|FG002|Day 3|Protocol Violation|0|||
149783702|NCT00981292|540335185|FG003|Day 3|Protocol Violation|0|||
149783703|NCT00981292|540335186|FG004|Day 3|Protocol Violation|0|||
149783704|NCT00981292|540335187|FG005|Day 3|Protocol Violation|1|||
149783705|NCT03377452|540335188|FG000|Overall Study|Refused assessment|0|||
149783706|NCT03377452|540335189|FG001|Overall Study|Refused assessment|2|||
149783707|NCT03377452|540335188|FG000|Overall Study|Lost to Follow-up|5|||
149783708|NCT03377452|540335189|FG001|Overall Study|Lost to Follow-up|4|||
149783709|NCT00796003|540335190|FG000|Overall Study|Disease Progression|2|||
149783710|NCT00796003|540335191|FG001|Overall Study|Disease Progression|13|||
149783711|NCT00796003|540335190|FG000|Overall Study|Adverse Event|1|||
149783712|NCT00796003|540335191|FG001|Overall Study|Adverse Event|7|||
149783713|NCT00796003|540335190|FG000|Overall Study|Specified organ function not met|0|||
149783714|NCT00796003|540335191|FG001|Overall Study|Specified organ function not met|1|||
149783715|NCT00796003|540335190|FG000|Overall Study|Physician Decision|0|||
149783716|NCT00796003|540335191|FG001|Overall Study|Physician Decision|4|||
149783717|NCT00796003|540335190|FG000|Overall Study|Withdrawal by Subject|0|||
149783718|NCT00796003|540335191|FG001|Overall Study|Withdrawal by Subject|1|||
149783719|NCT00796003|540335190|FG000|Overall Study|Other|0|||
149783720|NCT00796003|540335191|FG001|Overall Study|Other|1|||
149783721|NCT00796003|540335190|FG000|Overall Study|Participants Not treated|0|||
149783722|NCT00796003|540335191|FG001|Overall Study|Participants Not treated|2|||
149783723|NCT05179057|540335192|FG000|Overall Study|Adverse Event|3|||
149783724|NCT05179057|540335193|FG001|Overall Study|Adverse Event|2|||
149783725|NCT05179057|540335192|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
149783726|NCT05179057|540335193|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
149783727|NCT05179057|540335192|FG000|Overall Study|Study terminated|13|||
149783728|NCT05179057|540335193|FG001|Overall Study|Study terminated|7|||
149783729|NCT05179057|540335192|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
149783730|NCT05179057|540335193|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
149783731|NCT05179057|540335192|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
149783732|NCT05179057|540335193|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
149783733|NCT03345342|540335194|FG000|Open-Label Phase|Adverse Event|30|||
149783734|NCT03345342|540335195|FG001|Open-Label Phase|Adverse Event|0|||
149783735|NCT03345342|540335196|FG002|Open-Label Phase|Adverse Event|0|||
149783736|NCT03345342|540335197|FG003|Open-Label Phase|Adverse Event|0|||
149783737|NCT03345342|540335198|FG004|Open-Label Phase|Adverse Event|0|||
149783738|NCT03345342|540335194|FG000|Open-Label Phase|Death|1|||
149783739|NCT03345342|540335195|FG001|Open-Label Phase|Death|0|||
149783740|NCT03345342|540335196|FG002|Open-Label Phase|Death|0|||
149783741|NCT03345342|540335197|FG003|Open-Label Phase|Death|0|||
149783742|NCT03345342|540335198|FG004|Open-Label Phase|Death|0|||
149783743|NCT03345342|540335194|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
149783744|NCT03345342|540335195|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
149783745|NCT03345342|540335196|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
149783746|NCT03345342|540335197|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
149783747|NCT03345342|540335198|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
149783748|NCT03345342|540335194|FG000|Open-Label Phase|Lack of Efficacy|6|||
149783749|NCT03345342|540335195|FG001|Open-Label Phase|Lack of Efficacy|0|||
149783750|NCT03345342|540335196|FG002|Open-Label Phase|Lack of Efficacy|0|||
149783751|NCT03345342|540335197|FG003|Open-Label Phase|Lack of Efficacy|0|||
149783752|NCT03345342|540335198|FG004|Open-Label Phase|Lack of Efficacy|0|||
149783753|NCT03345342|540335194|FG000|Open-Label Phase|Lost to Follow-up|9|||
149783754|NCT03345342|540335195|FG001|Open-Label Phase|Lost to Follow-up|0|||
149783755|NCT03345342|540335196|FG002|Open-Label Phase|Lost to Follow-up|0|||
149783756|NCT03345342|540335197|FG003|Open-Label Phase|Lost to Follow-up|0|||
149783757|NCT03345342|540335198|FG004|Open-Label Phase|Lost to Follow-up|0|||
149783758|NCT03345342|540335194|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
149783759|NCT03345342|540335195|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
149783760|NCT03345342|540335196|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
149783761|NCT03345342|540335197|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
149783762|NCT03345342|540335198|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
149783763|NCT03345342|540335194|FG000|Open-Label Phase|Physician Decision|4|||
149783764|NCT03345342|540335195|FG001|Open-Label Phase|Physician Decision|0|||
149783765|NCT03345342|540335196|FG002|Open-Label Phase|Physician Decision|0|||
149783766|NCT03345342|540335197|FG003|Open-Label Phase|Physician Decision|0|||
149783767|NCT03345342|540335198|FG004|Open-Label Phase|Physician Decision|0|||
149783768|NCT03345342|540335194|FG000|Open-Label Phase|Protocol Violation|8|||
149783769|NCT03345342|540335195|FG001|Open-Label Phase|Protocol Violation|0|||
149783770|NCT03345342|540335196|FG002|Open-Label Phase|Protocol Violation|0|||
149783771|NCT03345342|540335197|FG003|Open-Label Phase|Protocol Violation|0|||
149783772|NCT03345342|540335198|FG004|Open-Label Phase|Protocol Violation|0|||
149783773|NCT03345342|540335194|FG000|Open-Label Phase|Withdrawal by Subject|57|||
149783774|NCT03345342|540335195|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149783775|NCT03345342|540335196|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149783776|NCT03345342|540335197|FG003|Open-Label Phase|Withdrawal by Subject|0|||
149783777|NCT03345342|540335198|FG004|Open-Label Phase|Withdrawal by Subject|0|||
149783778|NCT03345342|540335194|FG000|Open-Label Phase|Other|15|||
149783779|NCT03345342|540335195|FG001|Open-Label Phase|Other|0|||
149783780|NCT03345342|540335196|FG002|Open-Label Phase|Other|0|||
149783781|NCT03345342|540335197|FG003|Open-Label Phase|Other|0|||
149783782|NCT03345342|540335198|FG004|Open-Label Phase|Other|0|||
149783783|NCT03345342|540335194|FG000|Double-Blind Phase|Adverse Event|0|||
149783784|NCT03345342|540335195|FG001|Double-Blind Phase|Adverse Event|1|||
149783785|NCT03345342|540335196|FG002|Double-Blind Phase|Adverse Event|6|||
149783786|NCT03345342|540335197|FG003|Double-Blind Phase|Adverse Event|0|||
149783787|NCT03345342|540335198|FG004|Double-Blind Phase|Adverse Event|0|||
149783788|NCT03345342|540335194|FG000|Double-Blind Phase|Death|0|||
149783789|NCT03345342|540335195|FG001|Double-Blind Phase|Death|2|||
149783790|NCT03345342|540335196|FG002|Double-Blind Phase|Death|1|||
149783791|NCT03345342|540335197|FG003|Double-Blind Phase|Death|0|||
149783792|NCT03345342|540335198|FG004|Double-Blind Phase|Death|0|||
149783793|NCT03345342|540335194|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
149783794|NCT03345342|540335195|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
149783795|NCT03345342|540335196|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
149783796|NCT03345342|540335197|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
149783797|NCT03345342|540335198|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
149783798|NCT03345342|540335194|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149783799|NCT03345342|540335195|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149783800|NCT03345342|540335196|FG002|Double-Blind Phase|Lost to Follow-up|7|||
149783801|NCT03345342|540335197|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149783802|NCT03345342|540335198|FG004|Double-Blind Phase|Lost to Follow-up|0|||
149783803|NCT03345342|540335194|FG000|Double-Blind Phase|Physician Decision|0|||
149783804|NCT03345342|540335195|FG001|Double-Blind Phase|Physician Decision|1|||
149783805|NCT03345342|540335196|FG002|Double-Blind Phase|Physician Decision|4|||
149783806|NCT03345342|540335197|FG003|Double-Blind Phase|Physician Decision|0|||
149783807|NCT03345342|540335198|FG004|Double-Blind Phase|Physician Decision|0|||
149783808|NCT03345342|540335194|FG000|Double-Blind Phase|Protocol Violation|0|||
149783809|NCT03345342|540335195|FG001|Double-Blind Phase|Protocol Violation|0|||
149783810|NCT03345342|540335196|FG002|Double-Blind Phase|Protocol Violation|1|||
149783811|NCT03345342|540335197|FG003|Double-Blind Phase|Protocol Violation|0|||
149783812|NCT03345342|540335198|FG004|Double-Blind Phase|Protocol Violation|0|||
149783813|NCT03345342|540335194|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149783814|NCT03345342|540335195|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
149783815|NCT03345342|540335196|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
149783816|NCT03345342|540335197|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
149783817|NCT03345342|540335198|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149783818|NCT03345342|540335194|FG000|Double-Blind Phase|Other|0|||
149783819|NCT03345342|540335195|FG001|Double-Blind Phase|Other|1|||
149783820|NCT03345342|540335196|FG002|Double-Blind Phase|Other|3|||
149783821|NCT03345342|540335197|FG003|Double-Blind Phase|Other|0|||
149783822|NCT03345342|540335198|FG004|Double-Blind Phase|Other|0|||
149783823|NCT03345342|540335194|FG000|Follow-Up Phase|Adverse Event|0|||
149783824|NCT03345342|540335195|FG001|Follow-Up Phase|Adverse Event|0|||
149783825|NCT03345342|540335196|FG002|Follow-Up Phase|Adverse Event|0|||
149783826|NCT03345342|540335197|FG003|Follow-Up Phase|Adverse Event|0|||
149783827|NCT03345342|540335198|FG004|Follow-Up Phase|Adverse Event|4|||
149783828|NCT03345342|540335194|FG000|Follow-Up Phase|Lost to Follow-up|0|||
149783829|NCT03345342|540335195|FG001|Follow-Up Phase|Lost to Follow-up|0|||
149783830|NCT03345342|540335196|FG002|Follow-Up Phase|Lost to Follow-up|0|||
149783831|NCT03345342|540335197|FG003|Follow-Up Phase|Lost to Follow-up|0|||
149783832|NCT03345342|540335198|FG004|Follow-Up Phase|Lost to Follow-up|6|||
149783833|NCT03345342|540335194|FG000|Follow-Up Phase|Physician Decision|0|||
149783834|NCT03345342|540335195|FG001|Follow-Up Phase|Physician Decision|0|||
149783835|NCT03345342|540335196|FG002|Follow-Up Phase|Physician Decision|0|||
149783836|NCT03345342|540335197|FG003|Follow-Up Phase|Physician Decision|0|||
149783837|NCT03345342|540335198|FG004|Follow-Up Phase|Physician Decision|5|||
149783838|NCT03345342|540335194|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
149783839|NCT03345342|540335195|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
149783840|NCT03345342|540335196|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
149783841|NCT03345342|540335197|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
149783842|NCT03345342|540335198|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
149783843|NCT03345342|540335194|FG000|Follow-Up Phase|Other|0|||
149783844|NCT03345342|540335195|FG001|Follow-Up Phase|Other|0|||
149783845|NCT03345342|540335196|FG002|Follow-Up Phase|Other|0|||
149783846|NCT03345342|540335197|FG003|Follow-Up Phase|Other|3|||
149783847|NCT03345342|540335198|FG004|Follow-Up Phase|Other|1|||
149783848|NCT02437162|540335203|FG000|Overall Study|Protocol Violation|0|||
149783849|NCT02437162|540335204|FG001|Overall Study|Protocol Violation|1|||
149783850|NCT02437162|540335205|FG002|Overall Study|Protocol Violation|0|||
149783851|NCT02437162|540335203|FG000|Overall Study|Randomized but not treated|0|||
149783852|NCT02437162|540335204|FG001|Overall Study|Randomized but not treated|0|||
149783853|NCT02437162|540335205|FG002|Overall Study|Randomized but not treated|1|||
149783854|NCT02437162|540335203|FG000|Overall Study|Study discontinued by Sponsor|93|||
149783855|NCT02437162|540335204|FG001|Overall Study|Study discontinued by Sponsor|98|||
149783856|NCT02437162|540335205|FG002|Overall Study|Study discontinued by Sponsor|97|||
149783857|NCT02437162|540335203|FG000|Overall Study|Withdrawal by Subject|13|||
149783858|NCT02437162|540335204|FG001|Overall Study|Withdrawal by Subject|7|||
149783859|NCT02437162|540335205|FG002|Overall Study|Withdrawal by Subject|9|||
149783860|NCT02437162|540335203|FG000|Overall Study|Adverse Event|0|||
149783861|NCT02437162|540335204|FG001|Overall Study|Adverse Event|1|||
149783862|NCT02437162|540335205|FG002|Overall Study|Adverse Event|0|||
149783863|NCT02437162|540335203|FG000|Overall Study|Lost to Follow-up|1|||
149783864|NCT02437162|540335204|FG001|Overall Study|Lost to Follow-up|0|||
149783865|NCT02437162|540335205|FG002|Overall Study|Lost to Follow-up|1|||
149783866|NCT02437162|540335203|FG000|Overall Study|Death|0|||
149783867|NCT02437162|540335204|FG001|Overall Study|Death|1|||
149783868|NCT02437162|540335205|FG002|Overall Study|Death|0|||
149783869|NCT02437162|540335203|FG000|Overall Study|Other|0|||
149783870|NCT02437162|540335204|FG001|Overall Study|Other|0|||
149783871|NCT02437162|540335205|FG002|Overall Study|Other|1|||
149783872|NCT03981744|540335206|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149783873|NCT03981744|540335207|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
149783874|NCT03981744|540335208|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149783875|NCT03981744|540335209|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149783876|NCT03981744|540335206|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149783877|NCT03981744|540335207|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149783878|NCT03981744|540335208|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
149783879|NCT03981744|540335209|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149783880|NCT03981744|540335206|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149783881|NCT03981744|540335207|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149783882|NCT03981744|540335208|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
149783883|NCT03981744|540335209|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149783884|NCT02782104|540335210|FG000|Overall Study|Other|215|||
149783885|NCT02782104|540335210|FG000|Overall Study|Induction Day 28 Non Responder|9|||
149783886|NCT02782104|540335210|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149783887|NCT02782104|540335210|FG000|Overall Study|Death|8|||
149783888|NCT02782104|540335210|FG000|Overall Study|Pregnancy|6|||
149783889|NCT02782104|540335210|FG000|Overall Study|Withdrawal by Subject|63|||
149783890|NCT02782104|540335210|FG000|Overall Study|Protocol Violation|7|||
149783891|NCT02782104|540335210|FG000|Overall Study|Lack of Efficacy|61|||
149783892|NCT02782104|540335210|FG000|Overall Study|Lost to Follow-up|23|||
149783893|NCT02782104|540335210|FG000|Overall Study|Adverse Event|74|||
149783894|NCT03464136|540335211|FG000|Overall Study|Lost to Follow-up|5|||
149783895|NCT03464136|540335212|FG001|Overall Study|Lost to Follow-up|8|||
149783896|NCT03464136|540335211|FG000|Overall Study|Withdrawal by Subject|16|||
149783897|NCT03464136|540335212|FG001|Overall Study|Withdrawal by Subject|13|||
149783898|NCT03464136|540335211|FG000|Overall Study|Death|1|||
149783899|NCT03464136|540335212|FG001|Overall Study|Death|0|||
149783900|NCT03464136|540335211|FG000|Overall Study|Other|8|||
149783901|NCT03464136|540335212|FG001|Overall Study|Other|4|||
149783902|NCT04338321|540335213|FG000|Overall Study|Adverse Event|4|||
149783903|NCT04338321|540335214|FG001|Overall Study|Adverse Event|10|||
149783904|NCT04338321|540335213|FG000|Overall Study|Death|1|||
149783905|NCT04338321|540335214|FG001|Overall Study|Death|1|||
149783906|NCT04338321|540335213|FG000|Overall Study|Lost to Follow-up|4|||
149783907|NCT04338321|540335214|FG001|Overall Study|Lost to Follow-up|9|||
149783908|NCT04338321|540335213|FG000|Overall Study|Withdrawal by Subject|45|||
149783909|NCT04338321|540335214|FG001|Overall Study|Withdrawal by Subject|69|||
149783910|NCT04338321|540335213|FG000|Overall Study|Physician Decision|5|||
149783911|NCT04338321|540335214|FG001|Overall Study|Physician Decision|9|||
149783912|NCT04338321|540335213|FG000|Overall Study|Other|3|||
149783913|NCT04338321|540335214|FG001|Overall Study|Other|10|||
149783914|NCT02438787|540335215|FG000|Overall Study|Adverse Event|1|||
149783915|NCT02438787|540335216|FG001|Overall Study|Adverse Event|0|||
149783916|NCT02438787|540335217|FG002|Overall Study|Adverse Event|2|||
149783917|NCT02438787|540335215|FG000|Overall Study|Lack of Efficacy|1|||
149783918|NCT02438787|540335216|FG001|Overall Study|Lack of Efficacy|2|||
149783919|NCT02438787|540335217|FG002|Overall Study|Lack of Efficacy|0|||
149783920|NCT02438787|540335215|FG000|Overall Study|Lost to Follow-up|0|||
149783921|NCT02438787|540335216|FG001|Overall Study|Lost to Follow-up|1|||
149783922|NCT02438787|540335217|FG002|Overall Study|Lost to Follow-up|0|||
149783923|NCT02438787|540335215|FG000|Overall Study|Protocol Violation|0|||
149783924|NCT02438787|540335216|FG001|Overall Study|Protocol Violation|0|||
149783925|NCT02438787|540335217|FG002|Overall Study|Protocol Violation|1|||
149783926|NCT02438787|540335215|FG000|Overall Study|Withdrawal by Subject|15|||
149783927|NCT02438787|540335216|FG001|Overall Study|Withdrawal by Subject|7|||
149783928|NCT02438787|540335217|FG002|Overall Study|Withdrawal by Subject|10|||
149783929|NCT02438787|540335215|FG000|Overall Study|Study discontinued by sponsor|64|||
149783930|NCT02438787|540335216|FG001|Overall Study|Study discontinued by sponsor|72|||
149783931|NCT02438787|540335217|FG002|Overall Study|Study discontinued by sponsor|69|||
149783932|NCT02438787|540335215|FG000|Overall Study|Other|0|||
149783933|NCT02438787|540335216|FG001|Overall Study|Other|1|||
149783934|NCT02438787|540335217|FG002|Overall Study|Other|0|||
149783935|NCT02438787|540335215|FG000|Overall Study|Site terminated by sponsor|0|||
149783936|NCT02438787|540335216|FG001|Overall Study|Site terminated by sponsor|0|||
149783937|NCT02438787|540335217|FG002|Overall Study|Site terminated by sponsor|1|||
149783938|NCT03412565|540335218|FG000|Overall Study|Lost to Follow-up|0|||
149783939|NCT03412565|540335219|FG001|Overall Study|Lost to Follow-up|0|||
149783940|NCT03412565|540335220|FG002|Overall Study|Lost to Follow-up|1|||
149783941|NCT03412565|540335221|FG003|Overall Study|Lost to Follow-up|0|||
149783942|NCT03412565|540335218|FG000|Overall Study|Physician Decision|0|||
149783943|NCT03412565|540335219|FG001|Overall Study|Physician Decision|0|||
149783944|NCT03412565|540335220|FG002|Overall Study|Physician Decision|0|||
149783945|NCT03412565|540335221|FG003|Overall Study|Physician Decision|1|||
149783946|NCT03412565|540335218|FG000|Overall Study|Withdrawal by Subject|0|||
149783947|NCT03412565|540335219|FG001|Overall Study|Withdrawal by Subject|4|||
149783948|NCT03412565|540335220|FG002|Overall Study|Withdrawal by Subject|5|||
149783949|NCT03412565|540335221|FG003|Overall Study|Withdrawal by Subject|5|||
149783950|NCT03412565|540335218|FG000|Overall Study|Death|1|||
149783951|NCT03412565|540335219|FG001|Overall Study|Death|3|||
149783952|NCT03412565|540335220|FG002|Overall Study|Death|4|||
149783953|NCT03412565|540335221|FG003|Overall Study|Death|5|||
149783954|NCT03412565|540335218|FG000|Overall Study|Data collection ended|0|||
149783955|NCT03412565|540335219|FG001|Overall Study|Data collection ended|41|||
149783956|NCT03412565|540335220|FG002|Overall Study|Data collection ended|41|||
149783957|NCT03412565|540335221|FG003|Overall Study|Data collection ended|40|||
149783958|NCT03375203|540335222|FG000|Overall Study|Protocol Violation|0|||
149783959|NCT03375203|540335223|FG001|Overall Study|Protocol Violation|0|||
149783960|NCT03375203|540335224|FG002|Overall Study|Protocol Violation|1|||
149783961|NCT03375203|540335225|FG003|Overall Study|Protocol Violation|0|||
149783962|NCT03375203|540335226|FG004|Overall Study|Protocol Violation|0|||
149783963|NCT03375203|540335222|FG000|Overall Study|Adverse Event|2|||
149783964|NCT03375203|540335223|FG001|Overall Study|Adverse Event|3|||
149783965|NCT03375203|540335224|FG002|Overall Study|Adverse Event|0|||
149783966|NCT03375203|540335225|FG003|Overall Study|Adverse Event|2|||
149783967|NCT03375203|540335226|FG004|Overall Study|Adverse Event|2|||
149783968|NCT03375203|540335222|FG000|Overall Study|Withdrawal by Subject|3|||
149783969|NCT03375203|540335223|FG001|Overall Study|Withdrawal by Subject|0|||
149783970|NCT03375203|540335224|FG002|Overall Study|Withdrawal by Subject|1|||
149783971|NCT03375203|540335225|FG003|Overall Study|Withdrawal by Subject|0|||
149783972|NCT03375203|540335226|FG004|Overall Study|Withdrawal by Subject|2|||
149783973|NCT03375203|540335222|FG000|Overall Study|Non-compliance with study drug|1|||
149783974|NCT03375203|540335223|FG001|Overall Study|Non-compliance with study drug|0|||
149783975|NCT03375203|540335224|FG002|Overall Study|Non-compliance with study drug|0|||
149783976|NCT03375203|540335225|FG003|Overall Study|Non-compliance with study drug|0|||
149783977|NCT03375203|540335226|FG004|Overall Study|Non-compliance with study drug|0|||
149783978|NCT03375203|540335222|FG000|Overall Study|Randomized, not treated.|0|||
149783979|NCT03375203|540335223|FG001|Overall Study|Randomized, not treated.|1|||
149783980|NCT03375203|540335224|FG002|Overall Study|Randomized, not treated.|0|||
149783981|NCT03375203|540335225|FG003|Overall Study|Randomized, not treated.|0|||
149783982|NCT03375203|540335226|FG004|Overall Study|Randomized, not treated.|0|||
149783983|NCT03107793|540335227|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
149783984|NCT03107793|540335228|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
149783985|NCT03107793|540335229|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
149783986|NCT03107793|540335230|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
149783987|NCT03107793|540335231|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
149783988|NCT03107793|540335227|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
149783989|NCT03107793|540335228|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
149783990|NCT03107793|540335229|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
149783991|NCT03107793|540335230|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
149783992|NCT03107793|540335231|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
149783993|NCT03107793|540335227|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
149783994|NCT03107793|540335228|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
149783995|NCT03107793|540335229|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
149783996|NCT03107793|540335230|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
149783997|NCT03107793|540335231|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
149783998|NCT03107793|540335227|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
149783999|NCT03107793|540335228|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149784000|NCT03107793|540335229|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149784001|NCT03107793|540335230|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149784002|NCT03107793|540335231|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149784003|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149784004|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
149784005|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
149784006|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149784007|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149784008|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149784009|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
149784010|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
149784011|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149784012|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149784013|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149784014|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149784015|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
149784016|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149784017|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149784018|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149784019|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
149784020|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
149784021|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149784022|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149784023|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
149784024|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
149784025|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
149784026|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
149784027|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
149784028|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149784029|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
149784030|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
149784031|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149784032|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149784033|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149784034|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
149784035|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149784036|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149784037|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149784038|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149784039|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
149784040|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
149784041|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149784042|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149784043|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149784044|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149784045|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
149784046|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149784047|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149784048|NCT03107793|540335227|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149784049|NCT03107793|540335228|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
149784050|NCT03107793|540335229|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
149784051|NCT03107793|540335230|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149784052|NCT03107793|540335231|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149784053|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149784054|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149784055|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149784056|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
149784057|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
149784058|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149784059|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149784060|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149784061|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149784062|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
149784063|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149784064|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149784065|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149784066|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
149784067|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
149784068|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Death|0|||
149784069|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Death|0|||
149784070|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Death|0|||
149784071|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Death|0|||
149784072|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Death|1|||
149784073|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149784074|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149784075|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149784076|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149784077|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
149784078|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
149784079|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
149784080|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
149784081|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
149784082|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
149784083|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
149784084|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
149784085|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
149784086|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
149784087|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
149784088|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149784089|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149784090|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149784091|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149784092|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
149784093|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149784094|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149784095|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149784096|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
149784097|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149784098|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Other|0|||
149784099|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Other|0|||
149784100|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Other|0|||
149784101|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Other|1|||
149784102|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Other|3|||
149784103|NCT03107793|540335227|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149784104|NCT03107793|540335228|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149784105|NCT03107793|540335229|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149784106|NCT03107793|540335230|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
149784107|NCT03107793|540335231|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
149784108|NCT03277105|540335232|FG000|Overall Study|Death|129|||
149784109|NCT03277105|540335233|FG001|Overall Study|Death|124|||
149784110|NCT03277105|540335232|FG000|Overall Study|Lost to Follow-up|2|||
149784111|NCT03277105|540335233|FG001|Overall Study|Lost to Follow-up|4|||
149784112|NCT03277105|540335232|FG000|Overall Study|Withdrawal by Subject|10|||
149784113|NCT03277105|540335233|FG001|Overall Study|Withdrawal by Subject|10|||
149784114|NCT03277105|540335232|FG000|Overall Study|Other|118|||
149784115|NCT03277105|540335233|FG001|Overall Study|Other|125|||
149784116|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
149784117|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
149784118|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
149784119|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
149784120|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
149784121|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
149784122|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
149784123|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
149784124|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
149784125|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
149784126|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
149784127|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
149784128|NCT03321526|540335234|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
149784129|NCT03321526|540335235|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
149784130|NCT03321526|540335234|FG000|Follow-up Phase (2 Weeks)|Other|24|||
149784131|NCT03321526|540335235|FG001|Follow-up Phase (2 Weeks)|Other|24|||
149784132|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
149784133|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
149784134|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
149784135|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
149784136|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
149784137|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
149784138|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
149784139|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
149784140|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
149784141|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
149784142|NCT02418585|540335243|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
149784143|NCT02418585|540335244|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
149784144|NCT02418585|540335243|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
149784145|NCT02418585|540335244|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
149784146|NCT02418585|540335243|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
149784147|NCT02418585|540335244|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
149784148|NCT02418585|540335243|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
149784149|NCT02418585|540335244|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
149784150|NCT02418585|540335243|FG000|Follow-up Phase (24 Weeks)|Other|3|||
149784151|NCT02418585|540335244|FG001|Follow-up Phase (24 Weeks)|Other|2|||
149784152|NCT02040857|540335245|FG000|Overall Study|Adverse Event|14|||
149784153|NCT02040857|540335245|FG000|Overall Study|Physician Decision|5|||
149784154|NCT02040857|540335245|FG000|Overall Study|Withdrawal by Subject|31|||
149784155|NCT02040857|540335245|FG000|Overall Study|patient non-compliance|3|||
149784156|NCT02040857|540335245|FG000|Overall Study|Lost to Follow-up|2|||
149784157|NCT02040857|540335245|FG000|Overall Study|recurrence|4|||
149784158|NCT02040857|540335245|FG000|Overall Study|ineligible|1|||
149784159|NCT04159701|540335246|FG000|Period 1: Treatment Period|Pregnancy|1|||
149784160|NCT04159701|540335247|FG001|Period 1: Treatment Period|Pregnancy|0|||
149784161|NCT04159701|540335246|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
149784162|NCT04159701|540335247|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
149784163|NCT04159701|540335246|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
149784164|NCT04159701|540335247|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
149784165|NCT04159701|540335246|FG000|Washout Period|site terminated by sponsor|0|||
149784166|NCT04159701|540335247|FG001|Washout Period|site terminated by sponsor|1|||
149784167|NCT04159701|540335246|FG000|Washout Period|study terminated by sponsor|10|||
149784168|NCT04159701|540335247|FG001|Washout Period|study terminated by sponsor|3|||
149784169|NCT04159701|540335246|FG000|Washout Period|Withdrawal by Subject|1|||
149784170|NCT04159701|540335247|FG001|Washout Period|Withdrawal by Subject|0|||
149784171|NCT04159701|540335246|FG000|Washout Period|Inadvertent Enrollment|1|||
149784172|NCT04159701|540335247|FG001|Washout Period|Inadvertent Enrollment|0|||
149784173|NCT04159701|540335246|FG000|Washout Period|Miscellaneous|1|||
149784174|NCT04159701|540335247|FG001|Washout Period|Miscellaneous|0|||
149784175|NCT04159701|540335246|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
149784176|NCT04159701|540335247|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
149784177|NCT04159701|540335246|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
149784178|NCT04159701|540335247|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
149784179|NCT04159701|540335246|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
149784180|NCT04159701|540335247|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
149784181|NCT04159701|540335246|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
149784182|NCT04159701|540335247|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
149784183|NCT04159701|540335246|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
149784184|NCT04159701|540335247|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
149784185|NCT00693693|540335255|FG000|Overall Study|Lost to Follow-up|1|||
149784186|NCT00693693|540335256|FG001|Overall Study|Lost to Follow-up|1|||
149784187|NCT00693693|540335257|FG002|Overall Study|Lost to Follow-up|2|||
149784188|NCT02348840|540335258|FG000|Overall Study|Withdrawal by Subject|2|||
149784189|NCT02348840|540335259|FG001|Overall Study|Withdrawal by Subject|1|||
149784190|NCT02348840|540335260|FG002|Overall Study|Withdrawal by Subject|0|||
149784191|NCT02348840|540335261|FG003|Overall Study|Withdrawal by Subject|0|||
149784192|NCT00373880|540335262|FG000|Overall Study|Physician Decision|3|||
149784193|NCT00373880|540335262|FG000|Overall Study|Arrested|1|||
149784194|NCT00373880|540335262|FG000|Overall Study|Protocol Violation|14|||
149784195|NCT01466062|540335264|FG000|Overall Study|Adverse Event|1|||
149784196|NCT01466062|540335264|FG000|Overall Study|Withdrawal by Subject|1|||
149784197|NCT03152110|540335265|FG000|Overall Study|Withdrawal by Subject|3|||
149784198|NCT01634100|540335268|FG000|Overall Study|Withdrawal by Subject|1|||
149784199|NCT01634100|540335269|FG001|Overall Study|Withdrawal by Subject|0|||
149784200|NCT01634100|540335270|FG002|Overall Study|Withdrawal by Subject|1|||
149784201|NCT01634100|540335271|FG003|Overall Study|Withdrawal by Subject|0|||
149784202|NCT01634100|540335272|FG004|Overall Study|Withdrawal by Subject|0|||
149784203|NCT01634100|540335273|FG005|Overall Study|Withdrawal by Subject|0|||
149784204|NCT00471276|540335274|FG000|Overall Study|Death|2|||
149784205|NCT00471276|540335274|FG000|Overall Study|Adverse Event|16|||
149784206|NCT00471276|540335274|FG000|Overall Study|Protocol Violation|1|||
149784207|NCT00471276|540335274|FG000|Overall Study|Objective progression or relapse|54|||
149784208|NCT00471276|540335274|FG000|Overall Study|Global deterioration of health status|1|||
149784209|NCT00471276|540335274|FG000|Overall Study|Other|3|||
149784210|NCT00471276|540335274|FG000|Overall Study|Refused treatment|6|||
149784211|NCT00744991|540335275|FG000|Overall Study|Progressive Disease|11|||
149784212|NCT00744991|540335275|FG000|Overall Study|Withdrawal by Subject|8|||
149784213|NCT00744991|540335275|FG000|Overall Study|Physician Decision|3|||
149784214|NCT00744991|540335275|FG000|Overall Study|Adverse Event|2|||
149784215|NCT00744991|540335275|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
149784216|NCT01662986|540335276|FG000|Overall Study|Adverse Event|5|||
149784217|NCT01662986|540335277|FG001|Overall Study|Adverse Event|4|||
149784218|NCT01662986|540335276|FG000|Overall Study|Protocol Violation|2|||
149784219|NCT01662986|540335277|FG001|Overall Study|Protocol Violation|3|||
149784220|NCT01662986|540335276|FG000|Overall Study|Lost to Follow-up|5|||
149784221|NCT01662986|540335277|FG001|Overall Study|Lost to Follow-up|4|||
149784222|NCT01662986|540335276|FG000|Overall Study|Withdrawal by Subject|2|||
149784223|NCT01662986|540335277|FG001|Overall Study|Withdrawal by Subject|2|||
149784224|NCT01662986|540335276|FG000|Overall Study|Not Treated|1|||
149784225|NCT01662986|540335277|FG001|Overall Study|Not Treated|0|||
149784226|NCT01662986|540335276|FG000|Overall Study|Other than stated above|3|||
149784227|NCT01662986|540335277|FG001|Overall Study|Other than stated above|0|||
149784228|NCT01487863|540335278|FG000|Overall Study|Death|19|||
149784229|NCT01487863|540335279|FG001|Overall Study|Death|19|||
149784230|NCT01819194|540335281|FG000|Overall Study|Loss of study articles|2|||
149784231|NCT04449276|540335282|FG000|Overall Study|Adverse Event|1|||
149784232|NCT04449276|540335283|FG001|Overall Study|Adverse Event|2|||
149784233|NCT04449276|540335284|FG002|Overall Study|Adverse Event|0|||
149784234|NCT04449276|540335285|FG003|Overall Study|Adverse Event|0|||
149784235|NCT04449276|540335286|FG004|Overall Study|Adverse Event|2|||
149784236|NCT04449276|540335287|FG005|Overall Study|Adverse Event|0|||
149784237|NCT04449276|540335288|FG006|Overall Study|Adverse Event|0|||
149784238|NCT04449276|540335289|FG007|Overall Study|Adverse Event|1|||
149784239|NCT04449276|540335282|FG000|Overall Study|Withdrawal by Subject|2|||
149784240|NCT04449276|540335283|FG001|Overall Study|Withdrawal by Subject|0|||
149784241|NCT04449276|540335284|FG002|Overall Study|Withdrawal by Subject|0|||
149784242|NCT04449276|540335285|FG003|Overall Study|Withdrawal by Subject|1|||
149784243|NCT04449276|540335286|FG004|Overall Study|Withdrawal by Subject|0|||
149784244|NCT04449276|540335287|FG005|Overall Study|Withdrawal by Subject|0|||
149784245|NCT04449276|540335288|FG006|Overall Study|Withdrawal by Subject|0|||
149784246|NCT04449276|540335289|FG007|Overall Study|Withdrawal by Subject|0|||
149784247|NCT04449276|540335282|FG000|Overall Study|Other|0|||
149784248|NCT04449276|540335283|FG001|Overall Study|Other|2|||
149784249|NCT04449276|540335284|FG002|Overall Study|Other|3|||
149784250|NCT04449276|540335285|FG003|Overall Study|Other|2|||
149784251|NCT04449276|540335286|FG004|Overall Study|Other|0|||
149784252|NCT04449276|540335287|FG005|Overall Study|Other|0|||
149784253|NCT04449276|540335288|FG006|Overall Study|Other|0|||
149784254|NCT04449276|540335289|FG007|Overall Study|Other|1|||
149784255|NCT01614795|540335292|FG000|Overall Study|Adverse Event|0|||
149784256|NCT01614795|540335293|FG001|Overall Study|Adverse Event|0|||
149784257|NCT01614795|540335294|FG002|Overall Study|Adverse Event|1|||
149784258|NCT01614795|540335295|FG003|Overall Study|Adverse Event|1|||
149784259|NCT01614795|540335292|FG000|Overall Study|Lack of Efficacy|10|||
149784260|NCT01614795|540335293|FG001|Overall Study|Lack of Efficacy|10|||
149784261|NCT01614795|540335294|FG002|Overall Study|Lack of Efficacy|9|||
149784262|NCT01614795|540335295|FG003|Overall Study|Lack of Efficacy|8|||
149784263|NCT01614795|540335292|FG000|Overall Study|Physician Decision|1|||
149784264|NCT01614795|540335293|FG001|Overall Study|Physician Decision|0|||
149784265|NCT01614795|540335294|FG002|Overall Study|Physician Decision|1|||
149784266|NCT01614795|540335295|FG003|Overall Study|Physician Decision|1|||
149784267|NCT01614795|540335292|FG000|Overall Study|Withdrawal by Subject|0|||
149784268|NCT01614795|540335293|FG001|Overall Study|Withdrawal by Subject|1|||
149784269|NCT01614795|540335294|FG002|Overall Study|Withdrawal by Subject|0|||
149784270|NCT01614795|540335295|FG003|Overall Study|Withdrawal by Subject|2|||
149784271|NCT01614795|540335292|FG000|Overall Study|Ineligible|0|||
149784272|NCT01614795|540335293|FG001|Overall Study|Ineligible|1|||
149784273|NCT01614795|540335294|FG002|Overall Study|Ineligible|0|||
149784274|NCT01614795|540335295|FG003|Overall Study|Ineligible|0|||
149784275|NCT00701103|540335299|FG000|Overall Study|Adverse Event|0|||
149784276|NCT00701103|540335300|FG001|Overall Study|Adverse Event|0|||
149784277|NCT00701103|540335301|FG002|Overall Study|Adverse Event|1|||
149784278|NCT00701103|540335302|FG003|Overall Study|Adverse Event|1|||
149784279|NCT00701103|540335303|FG004|Overall Study|Adverse Event|0|||
149784280|NCT00701103|540335304|FG005|Overall Study|Adverse Event|1|||
149784281|NCT00701103|540335305|FG006|Overall Study|Adverse Event|1|||
149784282|NCT00701103|540335306|FG007|Overall Study|Adverse Event|0|||
149784283|NCT00701103|540335307|FG008|Overall Study|Adverse Event|0|||
149784284|NCT00701103|540335308|FG009|Overall Study|Adverse Event|2|||
149784285|NCT00701103|540335309|FG010|Overall Study|Adverse Event|0|||
149784286|NCT00701103|540335299|FG000|Overall Study|Progressive Disease|5|||
149784287|NCT00701103|540335300|FG001|Overall Study|Progressive Disease|2|||
149784288|NCT00701103|540335301|FG002|Overall Study|Progressive Disease|6|||
149784289|NCT00701103|540335302|FG003|Overall Study|Progressive Disease|5|||
149784290|NCT00701103|540335303|FG004|Overall Study|Progressive Disease|6|||
149784291|NCT00701103|540335304|FG005|Overall Study|Progressive Disease|5|||
149784292|NCT00701103|540335305|FG006|Overall Study|Progressive Disease|7|||
149784293|NCT00701103|540335306|FG007|Overall Study|Progressive Disease|7|||
149784294|NCT00701103|540335307|FG008|Overall Study|Progressive Disease|8|||
149784295|NCT00701103|540335308|FG009|Overall Study|Progressive Disease|8|||
149784296|NCT00701103|540335309|FG010|Overall Study|Progressive Disease|11|||
149784297|NCT00701103|540335299|FG000|Overall Study|Withdrawal by Subject|0|||
149784298|NCT00701103|540335300|FG001|Overall Study|Withdrawal by Subject|1|||
149784299|NCT00701103|540335301|FG002|Overall Study|Withdrawal by Subject|1|||
149784300|NCT00701103|540335302|FG003|Overall Study|Withdrawal by Subject|0|||
149784301|NCT00701103|540335303|FG004|Overall Study|Withdrawal by Subject|0|||
149784302|NCT00701103|540335304|FG005|Overall Study|Withdrawal by Subject|0|||
149784303|NCT00701103|540335305|FG006|Overall Study|Withdrawal by Subject|0|||
149784304|NCT00701103|540335306|FG007|Overall Study|Withdrawal by Subject|0|||
149784305|NCT00701103|540335307|FG008|Overall Study|Withdrawal by Subject|0|||
149784306|NCT00701103|540335308|FG009|Overall Study|Withdrawal by Subject|0|||
149784307|NCT00701103|540335309|FG010|Overall Study|Withdrawal by Subject|0|||
149784308|NCT00701103|540335299|FG000|Overall Study|Other|0|||
149784309|NCT00701103|540335300|FG001|Overall Study|Other|0|||
149784310|NCT00701103|540335301|FG002|Overall Study|Other|0|||
149784311|NCT00701103|540335302|FG003|Overall Study|Other|0|||
149784312|NCT00701103|540335303|FG004|Overall Study|Other|0|||
149784313|NCT00701103|540335304|FG005|Overall Study|Other|0|||
149784314|NCT00701103|540335305|FG006|Overall Study|Other|0|||
149784315|NCT00701103|540335306|FG007|Overall Study|Other|0|||
149784316|NCT00701103|540335307|FG008|Overall Study|Other|1|||
149784317|NCT00701103|540335308|FG009|Overall Study|Other|1|||
149784318|NCT00701103|540335309|FG010|Overall Study|Other|0|||
149784319|NCT01448707|540335317|FG000|Overall Study|Adverse Event|3|||
149784320|NCT01448707|540335318|FG001|Overall Study|Adverse Event|1|||
149784321|NCT01448707|540335317|FG000|Overall Study|Lost to Follow-up|2|||
149784322|NCT01448707|540335318|FG001|Overall Study|Lost to Follow-up|6|||
149784323|NCT01448707|540335317|FG000|Overall Study|Withdrawal by Subject|6|||
149784324|NCT01448707|540335318|FG001|Overall Study|Withdrawal by Subject|7|||
149784325|NCT01448707|540335317|FG000|Overall Study|Other|7|||
149784326|NCT01448707|540335318|FG001|Overall Study|Other|4|||
149784327|NCT02820038|540335322|FG000|Overall Study|Lost to Follow-up|7|||
149784328|NCT02820038|540335323|FG001|Overall Study|Lost to Follow-up|11|||
149784329|NCT02820038|540335324|FG002|Overall Study|Lost to Follow-up|2|||
149784330|NCT02820038|540335325|FG003|Overall Study|Lost to Follow-up|9|||
149784331|NCT02820038|540335322|FG000|Overall Study|Withdrawal by Subject|3|||
149784332|NCT02820038|540335323|FG001|Overall Study|Withdrawal by Subject|14|||
149784333|NCT02820038|540335324|FG002|Overall Study|Withdrawal by Subject|3|||
149784334|NCT02820038|540335325|FG003|Overall Study|Withdrawal by Subject|13|||
149784335|NCT01810380|540335329|FG000|Overall Study|Randomised not treated|2|||
149784336|NCT01810380|540335330|FG001|Overall Study|Randomised not treated|1|||
149784337|NCT01810380|540335331|FG002|Overall Study|Randomised not treated|1|||
149784338|NCT01810380|540335329|FG000|Overall Study|Adverse Event|11|||
149784339|NCT01810380|540335330|FG001|Overall Study|Adverse Event|14|||
149784340|NCT01810380|540335331|FG002|Overall Study|Adverse Event|4|||
149784341|NCT01810380|540335329|FG000|Overall Study|Lack of Efficacy|24|||
149784342|NCT01810380|540335330|FG001|Overall Study|Lack of Efficacy|10|||
149784343|NCT01810380|540335331|FG002|Overall Study|Lack of Efficacy|11|||
149784344|NCT01810380|540335329|FG000|Overall Study|Protocol Violation|1|||
149784345|NCT01810380|540335330|FG001|Overall Study|Protocol Violation|0|||
149784346|NCT01810380|540335331|FG002|Overall Study|Protocol Violation|1|||
149784347|NCT01810380|540335329|FG000|Overall Study|Withdrawal by Subject|6|||
149784348|NCT01810380|540335330|FG001|Overall Study|Withdrawal by Subject|0|||
149784349|NCT01810380|540335331|FG002|Overall Study|Withdrawal by Subject|6|||
149784350|NCT01810380|540335329|FG000|Overall Study|Administrative or other reasons|11|||
149784351|NCT01810380|540335330|FG001|Overall Study|Administrative or other reasons|13|||
149784352|NCT01810380|540335331|FG002|Overall Study|Administrative or other reasons|9|||
149784353|NCT02623699|540335332|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784354|NCT02623699|540335333|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
149784355|NCT02623699|540335334|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784356|NCT02623699|540335335|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784357|NCT02623699|540335336|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784358|NCT02623699|540335337|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784359|NCT02623699|540335338|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784360|NCT02623699|540335339|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784361|NCT02623699|540335340|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784362|NCT02623699|540335341|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784363|NCT02623699|540335342|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784364|NCT02623699|540335343|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149784365|NCT02623699|540335332|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784366|NCT02623699|540335333|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784367|NCT02623699|540335334|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784368|NCT02623699|540335335|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784369|NCT02623699|540335336|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784370|NCT02623699|540335337|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784371|NCT02623699|540335338|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
149784372|NCT02623699|540335339|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784373|NCT02623699|540335340|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784374|NCT02623699|540335341|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784375|NCT02623699|540335342|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784376|NCT02623699|540335343|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149784377|NCT02623699|540335332|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784378|NCT02623699|540335333|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784379|NCT02623699|540335334|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784380|NCT02623699|540335335|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784381|NCT02623699|540335336|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784382|NCT02623699|540335337|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
149784383|NCT02623699|540335338|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784384|NCT02623699|540335339|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784385|NCT02623699|540335340|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784386|NCT02623699|540335341|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784387|NCT02623699|540335342|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784388|NCT02623699|540335343|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149784389|NCT02623699|540335332|FG000|Part B (Up to 289 Days)|Death|0|||
149784390|NCT02623699|540335333|FG001|Part B (Up to 289 Days)|Death|0|||
149784391|NCT02623699|540335334|FG002|Part B (Up to 289 Days)|Death|0|||
149784392|NCT02623699|540335335|FG003|Part B (Up to 289 Days)|Death|0|||
149784393|NCT02623699|540335336|FG004|Part B (Up to 289 Days)|Death|0|||
149784394|NCT02623699|540335337|FG005|Part B (Up to 289 Days)|Death|1|||
149784395|NCT02623699|540335338|FG006|Part B (Up to 289 Days)|Death|1|||
149784396|NCT02623699|540335339|FG007|Part B (Up to 289 Days)|Death|0|||
149784397|NCT02623699|540335340|FG008|Part B (Up to 289 Days)|Death|1|||
149784398|NCT02623699|540335341|FG009|Part B (Up to 289 Days)|Death|0|||
149784399|NCT02623699|540335342|FG010|Part B (Up to 289 Days)|Death|0|||
149784400|NCT02623699|540335343|FG011|Part B (Up to 289 Days)|Death|0|||
149784401|NCT02623699|540335332|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
149784402|NCT02623699|540335333|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
149784403|NCT02623699|540335334|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
149784404|NCT02623699|540335335|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
149784405|NCT02623699|540335336|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
149784406|NCT02623699|540335337|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
149784407|NCT02623699|540335338|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
149784408|NCT02623699|540335339|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
149784409|NCT02623699|540335340|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
149784410|NCT02623699|540335341|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
149784411|NCT02623699|540335342|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
149784412|NCT02623699|540335343|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
149784413|NCT02623699|540335332|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784414|NCT02623699|540335333|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784415|NCT02623699|540335334|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784416|NCT02623699|540335335|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784417|NCT02623699|540335336|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784418|NCT02623699|540335337|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784419|NCT02623699|540335338|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784420|NCT02623699|540335339|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784421|NCT02623699|540335340|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784422|NCT02623699|540335341|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149784423|NCT02623699|540335342|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
149784424|NCT02623699|540335343|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
149784425|NCT02623699|540335332|FG000|Part C (Up to 236 Days)|Death|0|||
149784426|NCT02623699|540335333|FG001|Part C (Up to 236 Days)|Death|0|||
149784427|NCT02623699|540335334|FG002|Part C (Up to 236 Days)|Death|0|||
149784428|NCT02623699|540335335|FG003|Part C (Up to 236 Days)|Death|0|||
149784429|NCT02623699|540335336|FG004|Part C (Up to 236 Days)|Death|0|||
149784430|NCT02623699|540335337|FG005|Part C (Up to 236 Days)|Death|0|||
149784431|NCT02623699|540335338|FG006|Part C (Up to 236 Days)|Death|0|||
149784432|NCT02623699|540335339|FG007|Part C (Up to 236 Days)|Death|0|||
149784433|NCT02623699|540335340|FG008|Part C (Up to 236 Days)|Death|0|||
149784434|NCT02623699|540335341|FG009|Part C (Up to 236 Days)|Death|0|||
149784435|NCT02623699|540335342|FG010|Part C (Up to 236 Days)|Death|0|||
149784436|NCT02623699|540335343|FG011|Part C (Up to 236 Days)|Death|1|||
149784437|NCT02623699|540335332|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
149784438|NCT02623699|540335333|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
149784439|NCT02623699|540335334|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
149784440|NCT02623699|540335335|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
149784441|NCT02623699|540335336|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
149784442|NCT02623699|540335337|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
149784443|NCT02623699|540335338|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
149784444|NCT02623699|540335339|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
149784445|NCT02623699|540335340|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
149784446|NCT02623699|540335341|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
149784447|NCT02623699|540335342|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
149784448|NCT02623699|540335343|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
149784449|NCT00033371|540335344|FG000|Overall Study|Adverse Event|1|||
149784450|NCT00033371|540335345|FG001|Overall Study|Adverse Event|5|||
149784451|NCT00033371|540335344|FG000|Overall Study|Lost to Follow-up|2|||
149784452|NCT00033371|540335345|FG001|Overall Study|Lost to Follow-up|1|||
149784453|NCT00033371|540335344|FG000|Overall Study|Withdrawal by Subject|3|||
149784454|NCT00033371|540335345|FG001|Overall Study|Withdrawal by Subject|3|||
149784455|NCT00033371|540335344|FG000|Overall Study|Disease Progression|0|||
149784456|NCT00033371|540335345|FG001|Overall Study|Disease Progression|1|||
149784457|NCT01390038|540335346|FG000|Overall Study|Death|1|||
149784458|NCT01390038|540335346|FG000|Overall Study|Lost to Follow-up|1|||
149784459|NCT01390038|540335346|FG000|Overall Study|Withdrawal by Subject|4|||
149784460|NCT01390038|540335346|FG000|Overall Study|Simpliciti System Removal|2|||
149784461|NCT01922739|540335347|FG000|Titration/Adjustment Period|Adverse Event|3|||
149784462|NCT01922739|540335347|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
149784463|NCT01922739|540335347|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
149784464|NCT01922739|540335347|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
149784465|NCT01922739|540335347|FG000|Open-label Treatment Period|Adverse Event|6|||
149784466|NCT01922739|540335347|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
149784467|NCT01922739|540335347|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
149784468|NCT01922739|540335347|FG000|Open-label Treatment Period|Protocol Violation|5|||
149784469|NCT01922739|540335347|FG000|Open-label Treatment Period|Pregnancy|1|||
149784470|NCT01922739|540335347|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
149784471|NCT01922739|540335347|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
149784472|NCT01922739|540335347|FG000|Open-label Treatment Period|Physician Decision|1|||
149784473|NCT01922739|540335347|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
149784474|NCT00044213|540335348|FG000|Overall Study|Withdrawal by Subject|50|||
149784475|NCT00044213|540335349|FG001|Overall Study|Withdrawal by Subject|65|||
149784476|NCT00044213|540335350|FG002|Overall Study|Withdrawal by Subject|91|||
149784477|NCT00044213|540335351|FG003|Overall Study|Withdrawal by Subject|83|||
149784478|NCT00044213|540335348|FG000|Overall Study|Death|42|||
149784479|NCT00044213|540335349|FG001|Overall Study|Death|42|||
149784480|NCT00044213|540335350|FG002|Overall Study|Death|42|||
149784481|NCT00044213|540335351|FG003|Overall Study|Death|49|||
149784482|NCT00044213|540335348|FG000|Overall Study|Lost to Follow-up|8|||
149784483|NCT00044213|540335349|FG001|Overall Study|Lost to Follow-up|5|||
149784484|NCT00044213|540335350|FG002|Overall Study|Lost to Follow-up|5|||
149784485|NCT00044213|540335351|FG003|Overall Study|Lost to Follow-up|4|||
149784486|NCT00636155|540337074|FG000|Overall Study|Adverse Event|8|||
149784487|NCT00636155|540337074|FG000|Overall Study|Lack of Efficacy|1|||
149784488|NCT00636155|540337074|FG000|Overall Study|Withdrawal by Subject|3|||
149784489|NCT00636155|540337074|FG000|Overall Study|Stem cell transplant|1|||
149784490|NCT00636155|540337074|FG000|Overall Study|Physician Decision|5|||
149784491|NCT00766142|540337075|FG000|Overall Study|Protocol Violation|4|||
149784492|NCT05426460|540337080|FG000|Overall Study|Protocol Violation|1|||
149784493|NCT05426460|540337081|FG001|Overall Study|Protocol Violation|1|||
149784494|NCT05426460|540337082|FG002|Overall Study|Protocol Violation|1|||
149784495|NCT05426460|540337083|FG003|Overall Study|Protocol Violation|0|||
149784496|NCT02973997|540337087|FG000|Overall Study|Withdrawal by Subject|4|||
149784497|NCT02973997|540337088|FG001|Overall Study|Withdrawal by Subject|0|||
149784498|NCT02973997|540337087|FG000|Overall Study|Adverse Event|4|||
149784499|NCT02973997|540337088|FG001|Overall Study|Adverse Event|1|||
149784500|NCT02973997|540337087|FG000|Overall Study|Disease Progression|11|||
149784501|NCT02973997|540337088|FG001|Overall Study|Disease Progression|20|||
149784502|NCT02973997|540337087|FG000|Overall Study|Alternative Therapy|3|||
149784503|NCT02973997|540337088|FG001|Overall Study|Alternative Therapy|0|||
149784504|NCT02973997|540337087|FG000|Overall Study|Other complicating disease|0|||
149784505|NCT02973997|540337088|FG001|Overall Study|Other complicating disease|1|||
149784506|NCT02973997|540337087|FG000|Overall Study|Death|0|||
149784507|NCT02973997|540337088|FG001|Overall Study|Death|1|||
149784508|NCT01431521|540337089|FG000|Overall Study|Withdrawal by Subject|0|||
149784509|NCT01431521|540337090|FG001|Overall Study|Withdrawal by Subject|0|||
149784510|NCT01431521|540337091|FG002|Overall Study|Withdrawal by Subject|1|||
149784511|NCT01431521|540337092|FG003|Overall Study|Withdrawal by Subject|0|||
149784512|NCT00444951|540337093|FG000|Overall Study|Lost to Follow-up|1|||
149784513|NCT00444951|540337094|FG001|Overall Study|Lost to Follow-up|1|||
149784514|NCT00444951|540337095|FG002|Overall Study|Lost to Follow-up|0|||
149784515|NCT00444951|540337093|FG000|Overall Study|Withdrawal by Subject|4|||
149784516|NCT00444951|540337094|FG001|Overall Study|Withdrawal by Subject|5|||
149784517|NCT00444951|540337095|FG002|Overall Study|Withdrawal by Subject|3|||
149784518|NCT00366444|540337097|FG000|Overall Study|Withdrawal by Subject|1|||
149784519|NCT00366444|540337098|FG001|Overall Study|Withdrawal by Subject|1|||
149784520|NCT00366444|540337097|FG000|Overall Study|Lack of Efficacy|0|||
149784521|NCT00366444|540337098|FG001|Overall Study|Lack of Efficacy|1|||
149784522|NCT04984876|540337099|FG000|Overall Study|Subject decision|2|||
149784523|NCT04984876|540337100|FG001|Overall Study|Subject decision|10|||
149784524|NCT04984876|540337101|FG002|Overall Study|Subject decision|3|||
149784525|NCT04984876|540337102|FG003|Overall Study|Subject decision|3|||
149784526|NCT04984876|540337103|FG004|Overall Study|Subject decision|3|||
149784527|NCT04984876|540337104|FG005|Overall Study|Subject decision|0|||
149784528|NCT04984876|540337099|FG000|Overall Study|Guardian decision|0|||
149784529|NCT04984876|540337100|FG001|Overall Study|Guardian decision|1|||
149784530|NCT04984876|540337101|FG002|Overall Study|Guardian decision|0|||
149784531|NCT04984876|540337102|FG003|Overall Study|Guardian decision|2|||
149784532|NCT04984876|540337103|FG004|Overall Study|Guardian decision|0|||
149784533|NCT04984876|540337104|FG005|Overall Study|Guardian decision|1|||
149784534|NCT04984876|540337099|FG000|Overall Study|Lost to Follow-up|0|||
149784535|NCT04984876|540337100|FG001|Overall Study|Lost to Follow-up|0|||
149784536|NCT04984876|540337101|FG002|Overall Study|Lost to Follow-up|1|||
149784537|NCT04984876|540337102|FG003|Overall Study|Lost to Follow-up|1|||
149784538|NCT04984876|540337103|FG004|Overall Study|Lost to Follow-up|0|||
149784539|NCT04984876|540337104|FG005|Overall Study|Lost to Follow-up|0|||
149784540|NCT04984876|540337099|FG000|Overall Study|Physician Decision|1|||
149784541|NCT04984876|540337100|FG001|Overall Study|Physician Decision|0|||
149784542|NCT04984876|540337101|FG002|Overall Study|Physician Decision|0|||
149784543|NCT04984876|540337102|FG003|Overall Study|Physician Decision|1|||
149784544|NCT04984876|540337103|FG004|Overall Study|Physician Decision|0|||
149784545|NCT04984876|540337104|FG005|Overall Study|Physician Decision|0|||
149784546|NCT04984876|540337099|FG000|Overall Study|Adverse Event|0|||
149784547|NCT04984876|540337100|FG001|Overall Study|Adverse Event|0|||
149784548|NCT04984876|540337101|FG002|Overall Study|Adverse Event|1|||
149784549|NCT04984876|540337102|FG003|Overall Study|Adverse Event|0|||
149784550|NCT04984876|540337103|FG004|Overall Study|Adverse Event|0|||
149784551|NCT04984876|540337104|FG005|Overall Study|Adverse Event|0|||
149784552|NCT02204410|540337105|FG000|Overall Study|Lost to Follow-up|5|||
149784553|NCT02204410|540337105|FG000|Overall Study|Physician Decision|2|||
149784554|NCT02204410|540337105|FG000|Overall Study|Protocol Violation|1|||
149784555|NCT02204410|540337105|FG000|Overall Study|Withdrawal by Subject|3|||
149784556|NCT02000622|540337108|FG000|Overall Study|Withdrawal by Subject|5|||
149784557|NCT02000622|540337109|FG001|Overall Study|Withdrawal by Subject|7|||
149784558|NCT02000622|540337108|FG000|Overall Study|Lost to Follow-up|4|||
149784559|NCT02000622|540337109|FG001|Overall Study|Lost to Follow-up|0|||
149784560|NCT02000622|540337108|FG000|Overall Study|Death|159|||
149784561|NCT02000622|540337109|FG001|Overall Study|Death|73|||
149784562|NCT02000622|540337108|FG000|Overall Study|Withdrawn due to site closure|1|||
149784563|NCT02000622|540337109|FG001|Overall Study|Withdrawn due to site closure|0|||
149784564|NCT01405027|540337110|FG000|Overall Study|Withdrawn consent|3|||
149784565|NCT01405027|540337111|FG001|Overall Study|Withdrawn consent|0|||
149784566|NCT01405027|540337110|FG000|Overall Study|Lost to Follow-up|16|||
149784567|NCT01405027|540337111|FG001|Overall Study|Lost to Follow-up|24|||
149784568|NCT01405027|540337110|FG000|Overall Study|Investigator judgement|0|||
149784569|NCT01405027|540337111|FG001|Overall Study|Investigator judgement|2|||
149784570|NCT01405027|540337110|FG000|Overall Study|Death|1|||
149784571|NCT01405027|540337111|FG001|Overall Study|Death|0|||
149784572|NCT01405027|540337110|FG000|Overall Study|Other or Unknown|12|||
149784573|NCT01405027|540337111|FG001|Overall Study|Other or Unknown|25|||
149784574|NCT01462045|540337112|FG000|Overall Study|Family matter|0|||
149784575|NCT01462045|540337113|FG001|Overall Study|Family matter|1|||
149784576|NCT01462045|540337114|FG002|Overall Study|Family matter|0|||
149784577|NCT01938391|540337118|FG000|6 Month Follow up|Withdrawal by Subject|1|||
149784578|NCT01938391|540337118|FG000|12 Month Follow up|Physician Decision|1|||
149784579|NCT01938391|540337118|FG000|12 Month Follow up|Withdrawal by Subject|1|||
149784580|NCT01077193|540337125|FG000|Overall Study|Lost to Follow-up|1|||
149784581|NCT01077193|540337125|FG000|Overall Study|Withdrawal by Subject|2|||
149784582|NCT01077193|540337125|FG000|Overall Study|Lack of Efficacy|1|||
149784583|NCT01077193|540337125|FG000|Overall Study|Study Terminated by Sponsor|40|||
149784584|NCT03558828|540337126|FG000|Overall Study|Lost to Follow-up|4|||
149784585|NCT03558828|540337127|FG001|Overall Study|Lost to Follow-up|3|||
149784586|NCT03558828|540337128|FG002|Overall Study|Lost to Follow-up|3|||
149784587|NCT03558828|540337129|FG003|Overall Study|Lost to Follow-up|5|||
149784588|NCT03558828|540337130|FG004|Overall Study|Lost to Follow-up|2|||
149784589|NCT03558828|540337131|FG005|Overall Study|Lost to Follow-up|3|||
149784590|NCT03558828|540337126|FG000|Overall Study|dropped before the intervention|1|||
149784591|NCT03558828|540337127|FG001|Overall Study|dropped before the intervention|1|||
149784592|NCT03558828|540337128|FG002|Overall Study|dropped before the intervention|0|||
149784593|NCT03558828|540337129|FG003|Overall Study|dropped before the intervention|0|||
149784594|NCT03558828|540337130|FG004|Overall Study|dropped before the intervention|0|||
149784595|NCT03558828|540337131|FG005|Overall Study|dropped before the intervention|0|||
149784596|NCT03146403|540337140|FG000|Overall Study|Withdrawal by Subject|0|||
149784597|NCT03146403|540337141|FG001|Overall Study|Withdrawal by Subject|3|||
149784598|NCT03146403|540337140|FG000|Overall Study|Lost to Follow-up|2|||
149784599|NCT03146403|540337141|FG001|Overall Study|Lost to Follow-up|0|||
149784600|NCT02182999|540337143|FG000|Overall Study|Adverse Event|4|||
149784601|NCT02182999|540337144|FG001|Overall Study|Adverse Event|3|||
149784602|NCT02182999|540337143|FG000|Overall Study|Physician Decision|1|||
149784603|NCT02182999|540337144|FG001|Overall Study|Physician Decision|0|||
149784604|NCT02252588|540337145|FG000|Overall Study|Withdrawal by Subject|4|||
149784605|NCT02252588|540337146|FG001|Overall Study|Withdrawal by Subject|0|||
149784606|NCT00285649|540337148|FG000|Overall Study|Lost to Follow-up|6|||
149784607|NCT00285649|540337149|FG001|Overall Study|Lost to Follow-up|4|||
149784608|NCT00285649|540337150|FG002|Overall Study|Lost to Follow-up|4|||
149784609|NCT00285649|540337148|FG000|Overall Study|Withdrawal by Subject|3|||
149784610|NCT00285649|540337149|FG001|Overall Study|Withdrawal by Subject|2|||
149784611|NCT00285649|540337150|FG002|Overall Study|Withdrawal by Subject|2|||
149784612|NCT02465489|540337151|FG000|Overall Study|Adverse Event|5|||
149784613|NCT02972593|540337152|FG000|Overall Study|Lost to Follow-up|19|||
149784614|NCT02972593|540337153|FG001|Overall Study|Lost to Follow-up|15|||
149784615|NCT02972593|540337152|FG000|Overall Study|Protocol Violation|1|||
149784616|NCT02972593|540337153|FG001|Overall Study|Protocol Violation|0|||
149784617|NCT02203916|540337154|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149784618|NCT02203916|540337155|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
149784619|NCT02203916|540337156|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
149784620|NCT02203916|540337154|FG000|Overall Study|Major Protocol Deviation|1|||
149784621|NCT02203916|540337155|FG001|Overall Study|Major Protocol Deviation|1|||
149784622|NCT02203916|540337156|FG002|Overall Study|Major Protocol Deviation|0|||
149784623|NCT02203916|540337154|FG000|Overall Study|Lost to Follow-up|0|||
149784624|NCT02203916|540337155|FG001|Overall Study|Lost to Follow-up|1|||
149784625|NCT02203916|540337156|FG002|Overall Study|Lost to Follow-up|0|||
149784626|NCT02203916|540337154|FG000|Overall Study|Voluntary Withdrawal|3|||
149784627|NCT02203916|540337155|FG001|Overall Study|Voluntary Withdrawal|3|||
149784628|NCT02203916|540337156|FG002|Overall Study|Voluntary Withdrawal|8|||
149784629|NCT02203916|540337154|FG000|Overall Study|Lack of Efficacy|3|||
149784630|NCT02203916|540337155|FG001|Overall Study|Lack of Efficacy|0|||
149784631|NCT02203916|540337156|FG002|Overall Study|Lack of Efficacy|0|||
149784632|NCT02203916|540337154|FG000|Overall Study|Reason Not Specified|0|||
149784633|NCT02203916|540337155|FG001|Overall Study|Reason Not Specified|2|||
149784634|NCT02203916|540337156|FG002|Overall Study|Reason Not Specified|1|||
149784635|NCT00338806|540337157|FG000|Acute Phase|Withdrawal by Subject|0|||
149784636|NCT00338806|540337158|FG001|Acute Phase|Withdrawal by Subject|1|||
149784637|NCT00338806|540337157|FG000|Follow-up|Lost to Follow-up|1|||
149784638|NCT00338806|540337158|FG001|Follow-up|Lost to Follow-up|3|||
149784639|NCT00045630|540337164|FG000|Overall Study|Adverse Event|1|||
149784640|NCT00045630|540337164|FG000|Overall Study|Refusal unrelated to adverse event|1|||
149784641|NCT00045630|540337164|FG000|Overall Study|Progression/relapse|1|||
149784642|NCT00045630|540337164|FG000|Overall Study|Death|1|||
149784643|NCT00045630|540337164|FG000|Overall Study|Ineligible|2|||
149784644|NCT00981747|540337165|FG000|Losartan|Withdrawal by Subject|1|||
149784645|NCT00981747|540337165|FG000|Losartan|Death|1|||
149784646|NCT00981747|540337165|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
149784647|NCT02033850|540337172|FG000|Overall Study|Death|1|||
149784648|NCT02033850|540337173|FG001|Overall Study|Death|0|||
149784649|NCT02033850|540337172|FG000|Overall Study|unrelated medical reason|1|||
149784650|NCT02033850|540337173|FG001|Overall Study|unrelated medical reason|1|||
149784651|NCT03215667|540337174|FG000|Overall Study|Physician Decision|4|||
149784652|NCT00441480|540337176|FG000|Overall Study|Protocol Violation|1|||
149784653|NCT00441480|540337177|FG001|Overall Study|Protocol Violation|1|||
149784654|NCT00441480|540337176|FG000|Overall Study|Withdrawal by Subject|2|||
149784655|NCT00441480|540337177|FG001|Overall Study|Withdrawal by Subject|3|||
149784656|NCT00422240|540337178|FG000|Overall Study|Lack of Efficacy|1|||
149784657|NCT00422240|540337179|FG001|Overall Study|Lack of Efficacy|2|||
149784658|NCT00422240|540337180|FG002|Overall Study|Lack of Efficacy|0|||
149784659|NCT00422240|540337181|FG003|Overall Study|Lack of Efficacy|1|||
149784660|NCT00422240|540337178|FG000|Overall Study|Adverse Event|11|||
149784661|NCT00422240|540337179|FG001|Overall Study|Adverse Event|4|||
149784662|NCT00422240|540337180|FG002|Overall Study|Adverse Event|5|||
149784663|NCT00422240|540337181|FG003|Overall Study|Adverse Event|2|||
149784664|NCT00422240|540337178|FG000|Overall Study|Subject request|21|||
149784665|NCT00422240|540337179|FG001|Overall Study|Subject request|17|||
149784666|NCT00422240|540337180|FG002|Overall Study|Subject request|18|||
149784667|NCT00422240|540337181|FG003|Overall Study|Subject request|30|||
149784668|NCT00422240|540337178|FG000|Overall Study|Protocol Violation|0|||
149784669|NCT00422240|540337179|FG001|Overall Study|Protocol Violation|1|||
149784670|NCT00422240|540337180|FG002|Overall Study|Protocol Violation|0|||
149784671|NCT00422240|540337181|FG003|Overall Study|Protocol Violation|1|||
149784672|NCT00422240|540337178|FG000|Overall Study|Lost to Follow-up|31|||
149784673|NCT00422240|540337179|FG001|Overall Study|Lost to Follow-up|32|||
149784674|NCT00422240|540337180|FG002|Overall Study|Lost to Follow-up|19|||
149784675|NCT00422240|540337181|FG003|Overall Study|Lost to Follow-up|34|||
149784676|NCT00422240|540337178|FG000|Overall Study|Other|1|||
149784677|NCT00422240|540337179|FG001|Overall Study|Other|0|||
149784678|NCT00422240|540337180|FG002|Overall Study|Other|0|||
149784679|NCT00422240|540337181|FG003|Overall Study|Other|1|||
149784680|NCT00422240|540337178|FG000|Overall Study|Pregnancy|3|||
149784681|NCT00422240|540337179|FG001|Overall Study|Pregnancy|1|||
149784682|NCT00422240|540337180|FG002|Overall Study|Pregnancy|1|||
149784683|NCT00422240|540337181|FG003|Overall Study|Pregnancy|2|||
149784684|NCT01927068|540337182|FG000|Overall Study|Death|37|||
149784685|NCT01927068|540337183|FG001|Overall Study|Death|3|||
149784686|NCT01927068|540337182|FG000|Overall Study|Withdrawal by Subject|50|||
149784687|NCT01927068|540337183|FG001|Overall Study|Withdrawal by Subject|3|||
149784688|NCT01927068|540337182|FG000|Overall Study|Lost to Follow-up|10|||
149784689|NCT01927068|540337183|FG001|Overall Study|Lost to Follow-up|2|||
149784690|NCT01927068|540337182|FG000|Overall Study|Physician Decision|9|||
149784691|NCT01927068|540337183|FG001|Overall Study|Physician Decision|0|||
149784692|NCT01927068|540337182|FG000|Overall Study|Missed last follow-up visit|2|||
149784693|NCT01927068|540337183|FG001|Overall Study|Missed last follow-up visit|0|||
149784694|NCT00441012|540337184|FG000|Overall Study|Adverse Event|0|||
149784695|NCT00441012|540337185|FG001|Overall Study|Adverse Event|1|||
149784696|NCT00441012|540337184|FG000|Overall Study|Lost to Follow-up|3|||
149784697|NCT00441012|540337185|FG001|Overall Study|Lost to Follow-up|3|||
149784698|NCT00441012|540337184|FG000|Overall Study|Protocol Violation|10|||
149784699|NCT00441012|540337185|FG001|Overall Study|Protocol Violation|9|||
149784700|NCT00441012|540337184|FG000|Overall Study|Withdrawal by Subject|4|||
149784701|NCT00441012|540337185|FG001|Overall Study|Withdrawal by Subject|0|||
149784702|NCT00441012|540337184|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
149784703|NCT00441012|540337185|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
149784704|NCT04489940|540337186|FG000|Overall Study|Other|2|||
149784705|NCT04489940|540337186|FG000|Overall Study|Withdrawal by Subject|2|||
149784706|NCT04489940|540337186|FG000|Overall Study|Death|5|||
149784707|NCT04489940|540337186|FG000|Overall Study|Lost to Follow-up|1|||
149784708|NCT01624467|540337187|FG000|Overall Study|Withdrawal by Subject|2|||
149784709|NCT01624467|540337187|FG000|Overall Study|Lost to Follow-up|1|||
149784710|NCT01624467|540337187|FG000|Overall Study|Adverse Event|7|||
149784711|NCT01624467|540337187|FG000|Overall Study|Progressive Disease|19|||
149784712|NCT01624467|540337187|FG000|Overall Study|Per Sponsor Requirement|1|||
149784713|NCT01624467|540337187|FG000|Overall Study|Subject Withdrew from Treatment|1|||
149784714|NCT02725268|540337188|FG000|Overall Study|Death|58|||
149784715|NCT02725268|540337189|FG001|Overall Study|Death|59|||
149784716|NCT02725268|540337190|FG002|Overall Study|Death|30|||
149784717|NCT02725268|540337191|FG003|Overall Study|Death|16|||
149784718|NCT02725268|540337188|FG000|Overall Study|Lost to Follow-up|4|||
149784719|NCT02725268|540337189|FG001|Overall Study|Lost to Follow-up|3|||
149784720|NCT02725268|540337190|FG002|Overall Study|Lost to Follow-up|0|||
149784721|NCT02725268|540337191|FG003|Overall Study|Lost to Follow-up|1|||
149784722|NCT02725268|540337188|FG000|Overall Study|Site Terminated by Sponsor|0|||
149784723|NCT02725268|540337189|FG001|Overall Study|Site Terminated by Sponsor|1|||
149784724|NCT02725268|540337190|FG002|Overall Study|Site Terminated by Sponsor|0|||
149784725|NCT02725268|540337191|FG003|Overall Study|Site Terminated by Sponsor|0|||
149784726|NCT02725268|540337188|FG000|Overall Study|Withdrawal by Subject|8|||
149784727|NCT02725268|540337189|FG001|Overall Study|Withdrawal by Subject|6|||
149784728|NCT02725268|540337190|FG002|Overall Study|Withdrawal by Subject|8|||
149784729|NCT02725268|540337191|FG003|Overall Study|Withdrawal by Subject|1|||
149784730|NCT02725268|540337188|FG000|Overall Study|Reason not Specified|2|||
149784731|NCT02725268|540337189|FG001|Overall Study|Reason not Specified|1|||
149784732|NCT02725268|540337190|FG002|Overall Study|Reason not Specified|0|||
149784733|NCT02725268|540337191|FG003|Overall Study|Reason not Specified|0|||
149784734|NCT04498468|540337192|FG000|Overall Study|Lost to Follow-up|3|||
149784735|NCT00262314|540337198|FG000|Overall Study|Changing physicians|38|||
149784736|NCT00262314|540337198|FG000|Overall Study|Death|12|||
149784737|NCT00262314|540337198|FG000|Overall Study|Patient's decision|92|||
149784738|NCT00262314|540337198|FG000|Overall Study|Other|95|||
149784739|NCT00262314|540337198|FG000|Overall Study|Lost to Follow-up|70|||
149784740|NCT00262314|540337198|FG000|Overall Study|Administrative withdrawal|30|||
149784741|NCT05104749|540337199|FG000|Overall Study|Lost to Follow-up|2|||
149784742|NCT05104749|540337200|FG001|Overall Study|Lost to Follow-up|3|||
149784743|NCT03964493|540337201|FG000|Overall Study|Withdrawal by Subject|4|||
149784744|NCT03964493|540337202|FG001|Overall Study|Withdrawal by Subject|1|||
149784745|NCT03964493|540337201|FG000|Overall Study|Lost to Follow-up|13|||
149784746|NCT03964493|540337202|FG001|Overall Study|Lost to Follow-up|4|||
149784747|NCT02963766|540337203|FG000|Double-Blind Period|Adverse Event|1|||
149784748|NCT02963766|540337204|FG001|Double-Blind Period|Adverse Event|0|||
149784749|NCT02963766|540337205|FG002|Double-Blind Period|Adverse Event|1|||
149784750|NCT02963766|540337203|FG000|Double-Blind Period|Physician Decision|1|||
149784751|NCT02963766|540337204|FG001|Double-Blind Period|Physician Decision|0|||
149784752|NCT02963766|540337205|FG002|Double-Blind Period|Physician Decision|0|||
149784753|NCT02963766|540337203|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149784754|NCT02963766|540337204|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149784755|NCT02963766|540337205|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149784756|NCT02963766|540337203|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
149784757|NCT02963766|540337204|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
149784758|NCT02963766|540337205|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
149784759|NCT02963766|540337203|FG000|Double-Blind Period|Protocol Violation|1|||
149784760|NCT02963766|540337204|FG001|Double-Blind Period|Protocol Violation|0|||
149784761|NCT02963766|540337205|FG002|Double-Blind Period|Protocol Violation|0|||
149784762|NCT02963766|540337203|FG000|Double-Blind Period|Lost to Follow-up|0|||
149784763|NCT02963766|540337204|FG001|Double-Blind Period|Lost to Follow-up|1|||
149784764|NCT02963766|540337205|FG002|Double-Blind Period|Lost to Follow-up|0|||
149784765|NCT02963766|540337203|FG000|Open Label Extension (OLE)|Physician Decision|1|||
149784766|NCT02963766|540337204|FG001|Open Label Extension (OLE)|Physician Decision|2|||
149784767|NCT02963766|540337205|FG002|Open Label Extension (OLE)|Physician Decision|2|||
149784768|NCT02963766|540337203|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
149784769|NCT02963766|540337204|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
149784770|NCT02963766|540337205|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
149784771|NCT00814307|540337206|FG000|Overall Study|Randomized but not treated|1|||
149784772|NCT00814307|540337207|FG001|Overall Study|Randomized but not treated|0|||
149784773|NCT00814307|540337208|FG002|Overall Study|Randomized but not treated|0|||
149784774|NCT00814307|540337209|FG003|Overall Study|Randomized but not treated|0|||
149784775|NCT00814307|540337206|FG000|Overall Study|Adverse Event|3|||
149784776|NCT00814307|540337207|FG001|Overall Study|Adverse Event|9|||
149784777|NCT00814307|540337208|FG002|Overall Study|Adverse Event|3|||
149784778|NCT00814307|540337209|FG003|Overall Study|Adverse Event|2|||
149784779|NCT00814307|540337206|FG000|Overall Study|Lack of Efficacy|1|||
149784780|NCT00814307|540337207|FG001|Overall Study|Lack of Efficacy|1|||
149784781|NCT00814307|540337208|FG002|Overall Study|Lack of Efficacy|3|||
149784782|NCT00814307|540337209|FG003|Overall Study|Lack of Efficacy|4|||
149784783|NCT00814307|540337206|FG000|Overall Study|Other|1|||
149784784|NCT00814307|540337207|FG001|Overall Study|Other|2|||
149784785|NCT00814307|540337208|FG002|Overall Study|Other|0|||
149784786|NCT00814307|540337209|FG003|Overall Study|Other|1|||
149784787|NCT00814307|540337206|FG000|Overall Study|Protocol Violation|2|||
149784788|NCT00814307|540337207|FG001|Overall Study|Protocol Violation|8|||
149784789|NCT00814307|540337208|FG002|Overall Study|Protocol Violation|1|||
149784790|NCT00814307|540337209|FG003|Overall Study|Protocol Violation|1|||
149784791|NCT00814307|540337206|FG000|Overall Study|Withdrawal by Subject|4|||
149784792|NCT00814307|540337207|FG001|Overall Study|Withdrawal by Subject|6|||
149784793|NCT00814307|540337208|FG002|Overall Study|Withdrawal by Subject|0|||
149784794|NCT00814307|540337209|FG003|Overall Study|Withdrawal by Subject|2|||
149784795|NCT00814307|540337206|FG000|Overall Study|Death|0|||
149784796|NCT00814307|540337207|FG001|Overall Study|Death|1|||
149784797|NCT00814307|540337208|FG002|Overall Study|Death|0|||
149784798|NCT00814307|540337209|FG003|Overall Study|Death|0|||
149784799|NCT03073200|540337218|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149784800|NCT03073200|540337219|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149784801|NCT03073200|540337220|FG002|Double Blind Treatment Period|Protocol Violation|0|||
149784802|NCT03073200|540337221|FG003|Double Blind Treatment Period|Protocol Violation|0|||
149784803|NCT03073200|540337222|FG004|Double Blind Treatment Period|Protocol Violation|0|||
149784804|NCT03073200|540337223|FG005|Double Blind Treatment Period|Protocol Violation|0|||
149784805|NCT03073200|540337224|FG006|Double Blind Treatment Period|Protocol Violation|0|||
149784806|NCT03073200|540337225|FG007|Double Blind Treatment Period|Protocol Violation|0|||
149784807|NCT03073200|540337226|FG008|Double Blind Treatment Period|Protocol Violation|0|||
149784808|NCT03073200|540337227|FG009|Double Blind Treatment Period|Protocol Violation|0|||
149784809|NCT03073200|540337228|FG010|Double Blind Treatment Period|Protocol Violation|0|||
149784810|NCT03073200|540337229|FG011|Double Blind Treatment Period|Protocol Violation|0|||
149784811|NCT03073200|540337230|FG012|Double Blind Treatment Period|Protocol Violation|0|||
149784812|NCT03073200|540337231|FG013|Double Blind Treatment Period|Protocol Violation|0|||
149784813|NCT03073200|540337232|FG014|Double Blind Treatment Period|Protocol Violation|0|||
149784814|NCT03073200|540337218|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784815|NCT03073200|540337219|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
149784816|NCT03073200|540337220|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784817|NCT03073200|540337221|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784818|NCT03073200|540337222|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784819|NCT03073200|540337223|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784820|NCT03073200|540337224|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784821|NCT03073200|540337225|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784822|NCT03073200|540337226|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784823|NCT03073200|540337227|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784824|NCT03073200|540337228|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784825|NCT03073200|540337229|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784826|NCT03073200|540337230|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784827|NCT03073200|540337231|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784828|NCT03073200|540337232|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149784829|NCT03073200|540337218|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
149784830|NCT03073200|540337219|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784831|NCT03073200|540337220|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784832|NCT03073200|540337221|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784833|NCT03073200|540337222|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784834|NCT03073200|540337223|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784835|NCT03073200|540337224|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784836|NCT03073200|540337225|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784837|NCT03073200|540337226|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784838|NCT03073200|540337227|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784839|NCT03073200|540337228|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784840|NCT03073200|540337229|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784841|NCT03073200|540337230|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784842|NCT03073200|540337231|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784843|NCT03073200|540337232|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
149784844|NCT03073200|540337218|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784845|NCT03073200|540337219|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784846|NCT03073200|540337220|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784847|NCT03073200|540337221|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
149784848|NCT03073200|540337222|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
149784849|NCT03073200|540337223|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784850|NCT03073200|540337224|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784851|NCT03073200|540337225|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784852|NCT03073200|540337226|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784853|NCT03073200|540337227|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784854|NCT03073200|540337228|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784855|NCT03073200|540337229|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784856|NCT03073200|540337230|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784857|NCT03073200|540337231|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784858|NCT03073200|540337232|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
149784859|NCT03073200|540337218|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
149784860|NCT03073200|540337219|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
149784861|NCT03073200|540337220|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
149784862|NCT03073200|540337221|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
149784863|NCT03073200|540337222|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
149784864|NCT03073200|540337223|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
149784865|NCT03073200|540337224|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
149784866|NCT03073200|540337225|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
149784867|NCT03073200|540337226|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
149784868|NCT03073200|540337227|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
149784869|NCT03073200|540337228|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
149784870|NCT03073200|540337229|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
149784871|NCT03073200|540337230|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
149784872|NCT03073200|540337231|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
149784873|NCT03073200|540337232|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
149784874|NCT03073200|540337218|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784875|NCT03073200|540337219|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784876|NCT03073200|540337220|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784877|NCT03073200|540337221|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784878|NCT03073200|540337222|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
149784879|NCT03073200|540337223|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784880|NCT03073200|540337224|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784881|NCT03073200|540337225|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784882|NCT03073200|540337226|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784883|NCT03073200|540337227|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784884|NCT03073200|540337228|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784885|NCT03073200|540337229|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784886|NCT03073200|540337230|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784887|NCT03073200|540337231|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784888|NCT03073200|540337232|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
149784889|NCT03073200|540337218|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784890|NCT03073200|540337219|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784891|NCT03073200|540337220|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784892|NCT03073200|540337221|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
149784893|NCT03073200|540337222|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
149784894|NCT03073200|540337223|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784895|NCT03073200|540337224|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784896|NCT03073200|540337225|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784897|NCT03073200|540337226|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784898|NCT03073200|540337227|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784899|NCT03073200|540337228|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784900|NCT03073200|540337229|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784901|NCT03073200|540337230|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784902|NCT03073200|540337231|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784903|NCT03073200|540337232|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149784904|NCT03073200|540337218|FG000|Extension Period|Lost to Follow-up|0|||
149784905|NCT03073200|540337219|FG001|Extension Period|Lost to Follow-up|0|||
149784906|NCT03073200|540337220|FG002|Extension Period|Lost to Follow-up|0|||
149784907|NCT03073200|540337221|FG003|Extension Period|Lost to Follow-up|0|||
149784908|NCT03073200|540337222|FG004|Extension Period|Lost to Follow-up|0|||
149784909|NCT03073200|540337223|FG005|Extension Period|Lost to Follow-up|0|||
149784910|NCT03073200|540337224|FG006|Extension Period|Lost to Follow-up|1|||
149784911|NCT03073200|540337225|FG007|Extension Period|Lost to Follow-up|1|||
149784912|NCT03073200|540337226|FG008|Extension Period|Lost to Follow-up|0|||
149784913|NCT03073200|540337227|FG009|Extension Period|Lost to Follow-up|0|||
149784914|NCT03073200|540337228|FG010|Extension Period|Lost to Follow-up|0|||
149784915|NCT03073200|540337229|FG011|Extension Period|Lost to Follow-up|0|||
149784916|NCT03073200|540337230|FG012|Extension Period|Lost to Follow-up|0|||
149784917|NCT03073200|540337231|FG013|Extension Period|Lost to Follow-up|0|||
149784918|NCT03073200|540337232|FG014|Extension Period|Lost to Follow-up|0|||
149784919|NCT03073200|540337218|FG000|Extension Period|Sponsor Decision|0|||
149784920|NCT03073200|540337219|FG001|Extension Period|Sponsor Decision|0|||
149784921|NCT03073200|540337220|FG002|Extension Period|Sponsor Decision|0|||
149784922|NCT03073200|540337221|FG003|Extension Period|Sponsor Decision|0|||
149784923|NCT03073200|540337222|FG004|Extension Period|Sponsor Decision|0|||
149784924|NCT03073200|540337223|FG005|Extension Period|Sponsor Decision|0|||
149784925|NCT03073200|540337224|FG006|Extension Period|Sponsor Decision|0|||
149784926|NCT03073200|540337225|FG007|Extension Period|Sponsor Decision|0|||
149784927|NCT03073200|540337226|FG008|Extension Period|Sponsor Decision|1|||
149784928|NCT03073200|540337227|FG009|Extension Period|Sponsor Decision|0|||
149784929|NCT03073200|540337228|FG010|Extension Period|Sponsor Decision|0|||
149784930|NCT03073200|540337229|FG011|Extension Period|Sponsor Decision|0|||
149784931|NCT03073200|540337230|FG012|Extension Period|Sponsor Decision|0|||
149784932|NCT03073200|540337231|FG013|Extension Period|Sponsor Decision|0|||
149784933|NCT03073200|540337232|FG014|Extension Period|Sponsor Decision|0|||
149784934|NCT03073200|540337218|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
149784935|NCT03073200|540337219|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
149784936|NCT03073200|540337220|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
149784937|NCT03073200|540337221|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
149784938|NCT03073200|540337222|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
149784939|NCT03073200|540337223|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
149784940|NCT03073200|540337224|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
149784941|NCT03073200|540337225|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
149784942|NCT03073200|540337226|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
149784943|NCT03073200|540337227|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
149784944|NCT03073200|540337228|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
149784945|NCT03073200|540337229|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
149784946|NCT03073200|540337230|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
149784947|NCT03073200|540337231|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
149784948|NCT03073200|540337232|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
149784949|NCT03073200|540337218|FG000|Extension Period|Withdrawal by Subject|0|||
149784950|NCT03073200|540337219|FG001|Extension Period|Withdrawal by Subject|0|||
149784951|NCT03073200|540337220|FG002|Extension Period|Withdrawal by Subject|0|||
149784952|NCT03073200|540337221|FG003|Extension Period|Withdrawal by Subject|0|||
149784953|NCT03073200|540337222|FG004|Extension Period|Withdrawal by Subject|0|||
149784954|NCT03073200|540337223|FG005|Extension Period|Withdrawal by Subject|0|||
149784955|NCT03073200|540337224|FG006|Extension Period|Withdrawal by Subject|1|||
149784956|NCT03073200|540337225|FG007|Extension Period|Withdrawal by Subject|2|||
149784957|NCT03073200|540337226|FG008|Extension Period|Withdrawal by Subject|0|||
149784958|NCT03073200|540337227|FG009|Extension Period|Withdrawal by Subject|0|||
149784959|NCT03073200|540337228|FG010|Extension Period|Withdrawal by Subject|0|||
149784960|NCT03073200|540337229|FG011|Extension Period|Withdrawal by Subject|0|||
149784961|NCT03073200|540337230|FG012|Extension Period|Withdrawal by Subject|0|||
149784962|NCT03073200|540337231|FG013|Extension Period|Withdrawal by Subject|0|||
149784963|NCT03073200|540337232|FG014|Extension Period|Withdrawal by Subject|0|||
149784964|NCT03073200|540337218|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784965|NCT03073200|540337219|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784966|NCT03073200|540337220|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784967|NCT03073200|540337221|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784968|NCT03073200|540337222|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784969|NCT03073200|540337223|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784970|NCT03073200|540337224|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784971|NCT03073200|540337225|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784972|NCT03073200|540337226|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784973|NCT03073200|540337227|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784974|NCT03073200|540337228|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784975|NCT03073200|540337229|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
149784976|NCT03073200|540337230|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784977|NCT03073200|540337231|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784978|NCT03073200|540337232|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
149784979|NCT03073200|540337218|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784980|NCT03073200|540337219|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784981|NCT03073200|540337220|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784982|NCT03073200|540337221|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784983|NCT03073200|540337222|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784984|NCT03073200|540337223|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784985|NCT03073200|540337224|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784986|NCT03073200|540337225|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784987|NCT03073200|540337226|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784988|NCT03073200|540337227|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784989|NCT03073200|540337228|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784990|NCT03073200|540337229|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
149784991|NCT03073200|540337230|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784992|NCT03073200|540337231|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784993|NCT03073200|540337232|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149784994|NCT03073200|540337218|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149784995|NCT03073200|540337219|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149784996|NCT03073200|540337220|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149784997|NCT03073200|540337221|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149784998|NCT03073200|540337222|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149784999|NCT03073200|540337223|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785000|NCT03073200|540337224|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785001|NCT03073200|540337225|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785002|NCT03073200|540337226|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785003|NCT03073200|540337227|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785004|NCT03073200|540337228|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
149785005|NCT03073200|540337229|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
149785006|NCT03073200|540337230|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785007|NCT03073200|540337231|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785008|NCT03073200|540337232|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149785009|NCT03073200|540337218|FG000|Randomized Withdrawal Period|Adverse Event|0|||
149785010|NCT03073200|540337219|FG001|Randomized Withdrawal Period|Adverse Event|0|||
149785011|NCT03073200|540337220|FG002|Randomized Withdrawal Period|Adverse Event|0|||
149785012|NCT03073200|540337221|FG003|Randomized Withdrawal Period|Adverse Event|0|||
149785013|NCT03073200|540337222|FG004|Randomized Withdrawal Period|Adverse Event|0|||
149785014|NCT03073200|540337223|FG005|Randomized Withdrawal Period|Adverse Event|0|||
149785015|NCT03073200|540337224|FG006|Randomized Withdrawal Period|Adverse Event|0|||
149785016|NCT03073200|540337225|FG007|Randomized Withdrawal Period|Adverse Event|0|||
149785017|NCT03073200|540337226|FG008|Randomized Withdrawal Period|Adverse Event|0|||
149785018|NCT03073200|540337227|FG009|Randomized Withdrawal Period|Adverse Event|0|||
149785019|NCT03073200|540337228|FG010|Randomized Withdrawal Period|Adverse Event|1|||
149785020|NCT03073200|540337229|FG011|Randomized Withdrawal Period|Adverse Event|0|||
149785021|NCT03073200|540337230|FG012|Randomized Withdrawal Period|Adverse Event|0|||
149785022|NCT03073200|540337231|FG013|Randomized Withdrawal Period|Adverse Event|0|||
149785023|NCT03073200|540337232|FG014|Randomized Withdrawal Period|Adverse Event|0|||
149785024|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785025|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785026|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785027|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785028|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785029|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785030|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785031|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785032|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785033|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785034|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785035|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785036|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785037|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
149785038|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
149785039|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785040|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785041|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785042|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785043|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785044|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785045|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785046|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785047|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785048|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785049|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785050|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785051|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785052|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
149785053|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149785054|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785055|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785056|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785057|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785058|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785059|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785060|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785061|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785062|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785063|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785064|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785065|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785066|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785067|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
149785068|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149785069|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785070|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785071|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785072|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785073|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785074|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785075|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785076|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785077|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785078|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785079|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785080|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785081|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785082|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
149785083|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149785084|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785085|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785086|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785087|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785088|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785089|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785090|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785091|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785092|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785093|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785094|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785095|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785096|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785097|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149785098|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
149785099|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785100|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785101|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785102|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785103|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785104|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785105|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785106|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785107|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785108|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785109|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785110|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785111|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785112|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
149785113|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149785114|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785115|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785116|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785117|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785118|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785119|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785120|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785121|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785122|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785123|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785124|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785125|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785126|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785127|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
149785128|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149785129|NCT03073200|540337218|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785130|NCT03073200|540337219|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785131|NCT03073200|540337220|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785132|NCT03073200|540337221|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785133|NCT03073200|540337222|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785134|NCT03073200|540337223|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785135|NCT03073200|540337224|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785136|NCT03073200|540337225|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785137|NCT03073200|540337226|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785138|NCT03073200|540337227|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785139|NCT03073200|540337228|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785140|NCT03073200|540337229|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785141|NCT03073200|540337230|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785142|NCT03073200|540337231|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
149785143|NCT03073200|540337232|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149785144|NCT01474889|540337233|FG000|Overall Study|Physician Decision|1|||
149785145|NCT01474889|540337234|FG001|Overall Study|Physician Decision|0|||
149785146|NCT01474889|540337235|FG002|Overall Study|Physician Decision|0|||
149785147|NCT01474889|540337233|FG000|Overall Study|Did not meet inclusion|1|||
149785148|NCT01474889|540337234|FG001|Overall Study|Did not meet inclusion|0|||
149785149|NCT01474889|540337235|FG002|Overall Study|Did not meet inclusion|0|||
149785150|NCT01474889|540337233|FG000|Overall Study|Withdrawal by Subject|0|||
149785151|NCT01474889|540337234|FG001|Overall Study|Withdrawal by Subject|1|||
149785152|NCT01474889|540337235|FG002|Overall Study|Withdrawal by Subject|0|||
149785153|NCT04964557|540337237|FG000|Overall Study|Withdrawal by Subject|3|||
149785154|NCT04964557|540337238|FG001|Overall Study|Withdrawal by Subject|2|||
149785155|NCT04964557|540337237|FG000|Overall Study|Lost to Follow-up|1|||
149785156|NCT04964557|540337238|FG001|Overall Study|Lost to Follow-up|2|||
149785157|NCT04964557|540337237|FG000|Overall Study|Physician Decision|2|||
149785158|NCT04964557|540337238|FG001|Overall Study|Physician Decision|0|||
149785159|NCT04964557|540337237|FG000|Overall Study|Death|3|||
149785160|NCT04964557|540337238|FG001|Overall Study|Death|0|||
149785161|NCT04964557|540337237|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
149785162|NCT04964557|540337238|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
149785163|NCT02569398|540337243|FG000|Overall Study|Adverse Event|0|||
149785164|NCT02569398|540337244|FG001|Overall Study|Adverse Event|1|||
149785165|NCT02569398|540337245|FG002|Overall Study|Adverse Event|6|||
149785166|NCT02569398|540337243|FG000|Overall Study|Withdrawal by Subject|43|||
149785167|NCT02569398|540337244|FG001|Overall Study|Withdrawal by Subject|43|||
149785168|NCT02569398|540337245|FG002|Overall Study|Withdrawal by Subject|30|||
149785169|NCT02569398|540337243|FG000|Overall Study|Study terminated by sponsor|130|||
149785170|NCT02569398|540337244|FG001|Overall Study|Study terminated by sponsor|131|||
149785171|NCT02569398|540337245|FG002|Overall Study|Study terminated by sponsor|134|||
149785172|NCT02569398|540337243|FG000|Overall Study|Other|12|||
149785173|NCT02569398|540337244|FG001|Overall Study|Other|14|||
149785174|NCT02569398|540337245|FG002|Overall Study|Other|13|||
149785175|NCT02571972|540337246|FG000|Overall Study|Protocol Violation|2|||
149785176|NCT02571972|540337246|FG000|Overall Study|Withdrawal by Subject|2|||
149785177|NCT03039192|540337249|FG000|Overall Study|Lost to Follow-up|4|||
149785178|NCT03039192|540337250|FG001|Overall Study|Lost to Follow-up|4|||
149785179|NCT03039192|540337249|FG000|Overall Study|Adverse event, serious fatal|0|||
149785180|NCT03039192|540337250|FG001|Overall Study|Adverse event, serious fatal|1|||
149785181|NCT03039192|540337249|FG000|Overall Study|Adverse event, non-fatal|0|||
149785182|NCT03039192|540337250|FG001|Overall Study|Adverse event, non-fatal|2|||
149785183|NCT03039192|540337249|FG000|Overall Study|Withdrawal by Subject|6|||
149785184|NCT03039192|540337250|FG001|Overall Study|Withdrawal by Subject|9|||
149785185|NCT03039192|540337249|FG000|Overall Study|Discontinued from treatment phase|19|||
149785186|NCT03039192|540337250|FG001|Overall Study|Discontinued from treatment phase|12|||
149785187|NCT03039192|540337249|FG000|Overall Study|Other|3|||
149785188|NCT03039192|540337250|FG001|Overall Study|Other|2|||
149785189|NCT03559192|540337251|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
149785190|NCT03559192|540337252|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
149785191|NCT03559192|540337253|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
149785192|NCT03559192|540337251|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
149785193|NCT03559192|540337252|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
149785194|NCT03559192|540337253|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
149785195|NCT03559192|540337251|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
149785196|NCT03559192|540337252|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
149785197|NCT03559192|540337253|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
149785198|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
149785199|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
149785200|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
149785201|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
149785202|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
149785203|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
149785204|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
149785205|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
149785206|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
149785207|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
149785208|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
149785209|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
149785210|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
149785211|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
149785212|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
149785213|NCT03559192|540337251|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
149785214|NCT03559192|540337252|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
149785215|NCT03559192|540337253|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
149785216|NCT04888507|540339066|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
149785217|NCT00400946|540339067|FG000|Overall Study|Ineligible|0|||
149785218|NCT00400946|540339068|FG001|Overall Study|Ineligible|0|||
149785219|NCT00400946|540339069|FG002|Overall Study|Ineligible|0|||
149785220|NCT00400946|540339070|FG003|Overall Study|Ineligible|5|||
149785221|NCT00400946|540339071|FG004|Overall Study|Ineligible|1|||
149785222|NCT00400946|540339067|FG000|Overall Study|Induction Failure|0|||
149785223|NCT00400946|540339068|FG001|Overall Study|Induction Failure|0|||
149785224|NCT00400946|540339069|FG002|Overall Study|Induction Failure|0|||
149785225|NCT00400946|540339070|FG003|Overall Study|Induction Failure|11|||
149785226|NCT00400946|540339071|FG004|Overall Study|Induction Failure|8|||
149785227|NCT00400946|540339067|FG000|Overall Study|Induction Death|0|||
149785228|NCT00400946|540339068|FG001|Overall Study|Induction Death|0|||
149785229|NCT00400946|540339069|FG002|Overall Study|Induction Death|0|||
149785230|NCT00400946|540339070|FG003|Overall Study|Induction Death|13|||
149785231|NCT00400946|540339071|FG004|Overall Study|Induction Death|3|||
149785232|NCT00400946|540339067|FG000|Overall Study|Lost to Follow-up|1|||
149785233|NCT00400946|540339068|FG001|Overall Study|Lost to Follow-up|1|||
149785234|NCT00400946|540339069|FG002|Overall Study|Lost to Follow-up|0|||
149785235|NCT00400946|540339070|FG003|Overall Study|Lost to Follow-up|0|||
149785236|NCT00400946|540339071|FG004|Overall Study|Lost to Follow-up|1|||
149785237|NCT00400946|540339067|FG000|Overall Study|Remission Death|1|||
149785238|NCT00400946|540339068|FG001|Overall Study|Remission Death|1|||
149785239|NCT00400946|540339069|FG002|Overall Study|Remission Death|0|||
149785240|NCT00400946|540339070|FG003|Overall Study|Remission Death|0|||
149785241|NCT00400946|540339071|FG004|Overall Study|Remission Death|1|||
149785242|NCT00400946|540339067|FG000|Overall Study|Relapse|9|||
149785243|NCT00400946|540339068|FG001|Overall Study|Relapse|2|||
149785244|NCT00400946|540339069|FG002|Overall Study|Relapse|1|||
149785245|NCT00400946|540339070|FG003|Overall Study|Relapse|1|||
149785246|NCT00400946|540339071|FG004|Overall Study|Relapse|5|||
149785247|NCT00400946|540339067|FG000|Overall Study|Transplant in CR1|0|||
149785248|NCT00400946|540339068|FG001|Overall Study|Transplant in CR1|0|||
149785249|NCT00400946|540339069|FG002|Overall Study|Transplant in CR1|0|||
149785250|NCT00400946|540339070|FG003|Overall Study|Transplant in CR1|10|||
149785251|NCT00400946|540339071|FG004|Overall Study|Transplant in CR1|1|||
149785252|NCT00400946|540339067|FG000|Overall Study|Withdrawal by Subject|2|||
149785253|NCT00400946|540339068|FG001|Overall Study|Withdrawal by Subject|5|||
149785254|NCT00400946|540339069|FG002|Overall Study|Withdrawal by Subject|1|||
149785255|NCT00400946|540339070|FG003|Overall Study|Withdrawal by Subject|5|||
149785256|NCT00400946|540339071|FG004|Overall Study|Withdrawal by Subject|8|||
149785257|NCT00400946|540339067|FG000|Overall Study|Clinical|1|||
149785258|NCT00400946|540339068|FG001|Overall Study|Clinical|2|||
149785259|NCT00400946|540339069|FG002|Overall Study|Clinical|0|||
149785260|NCT00400946|540339070|FG003|Overall Study|Clinical|2|||
149785261|NCT00400946|540339071|FG004|Overall Study|Clinical|9|||
149785262|NCT00400946|540339067|FG000|Overall Study|Other|0|||
149785263|NCT00400946|540339068|FG001|Overall Study|Other|0|||
149785264|NCT00400946|540339069|FG002|Overall Study|Other|0|||
149785265|NCT00400946|540339070|FG003|Overall Study|Other|0|||
149785266|NCT00400946|540339071|FG004|Overall Study|Other|1|||
149785267|NCT05643170|540339077|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
149785268|NCT05643170|540339077|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
149785269|NCT02358863|540339082|FG000|Overall Study|Physician Decision|3|||
149785270|NCT02632344|540339092|FG000|Overall Study|Adverse Event|3|||
149785271|NCT02632344|540339092|FG000|Overall Study|Lack of Efficacy|3|||
149785272|NCT02632344|540339092|FG000|Overall Study|Withdrawal by Subject|2|||
149785273|NCT00777257|540339093|FG000|Overall Study|Adverse Event|3|||
149785274|NCT00777257|540339094|FG001|Overall Study|Adverse Event|1|||
149785275|NCT00777257|540339095|FG002|Overall Study|Adverse Event|0|||
149785276|NCT00777257|540339093|FG000|Overall Study|Lost to Follow-up|3|||
149785277|NCT00777257|540339094|FG001|Overall Study|Lost to Follow-up|3|||
149785278|NCT00777257|540339095|FG002|Overall Study|Lost to Follow-up|2|||
149785279|NCT00777257|540339093|FG000|Overall Study|Protocol Violation|2|||
149785280|NCT00777257|540339094|FG001|Overall Study|Protocol Violation|2|||
149785281|NCT00777257|540339095|FG002|Overall Study|Protocol Violation|2|||
149785282|NCT00777257|540339093|FG000|Overall Study|Withdrawal by Subject|3|||
149785283|NCT00777257|540339094|FG001|Overall Study|Withdrawal by Subject|6|||
149785284|NCT00777257|540339095|FG002|Overall Study|Withdrawal by Subject|5|||
149785285|NCT04924114|540339096|FG000|Overall Study|Withdrawal by Subject|0|||
149785286|NCT04924114|540339097|FG001|Overall Study|Withdrawal by Subject|2|||
149785287|NCT04924114|540339098|FG002|Overall Study|Withdrawal by Subject|2|||
149785288|NCT04924114|540339099|FG003|Overall Study|Withdrawal by Subject|0|||
149785289|NCT04924114|540339100|FG004|Overall Study|Withdrawal by Subject|2|||
149785290|NCT00673816|540339101|FG000|Overall Study|Adverse Event|1|||
149785291|NCT00673816|540339101|FG000|Overall Study|Withdrawal by Subject|1|||
149785292|NCT00498368|540339111|FG000|Overall Study|Withdrawal by Subject|3|||
149785293|NCT00498368|540339112|FG001|Overall Study|Withdrawal by Subject|2|||
149785294|NCT02266004|540339113|FG000|Overall Study|unrelated adverse event|1|||
149785295|NCT02266004|540339113|FG000|Overall Study|Physician Decision|1|||
149785296|NCT00537771|540339118|FG000|Overall Study|Withdrawal by Subject|6|||
149785297|NCT00537771|540339119|FG001|Overall Study|Withdrawal by Subject|23|||
149785298|NCT00537771|540339118|FG000|Overall Study|Adverse Event|8|||
149785299|NCT00537771|540339119|FG001|Overall Study|Adverse Event|15|||
149785300|NCT00537771|540339118|FG000|Overall Study|Lost to Follow-up|9|||
149785301|NCT00537771|540339119|FG001|Overall Study|Lost to Follow-up|15|||
149785302|NCT00537771|540339118|FG000|Overall Study|Protocol Violation|2|||
149785303|NCT00537771|540339119|FG001|Overall Study|Protocol Violation|6|||
149785304|NCT00537771|540339118|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
149785305|NCT00537771|540339119|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149785306|NCT02736929|540339121|FG000|Main Study|Lost to Follow-up|7|||
149785307|NCT02736929|540339122|FG001|Main Study|Lost to Follow-up|1|||
149785308|NCT02736929|540339123|FG002|Main Study|Lost to Follow-up|0|||
149785309|NCT02736929|540339121|FG000|Main Study|Withdrawal by Subject|1|||
149785310|NCT02736929|540339122|FG001|Main Study|Withdrawal by Subject|1|||
149785311|NCT02736929|540339123|FG002|Main Study|Withdrawal by Subject|0|||
149785312|NCT02736929|540339121|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
149785313|NCT02736929|540339122|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
149785314|NCT02736929|540339123|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
149785315|NCT02148952|540339132|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
149785316|NCT02148952|540339133|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
149785317|NCT02148952|540339132|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
149785318|NCT02148952|540339133|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
149785319|NCT02148952|540339132|FG000|Follow-Up|Lost to Follow-up|219|||
149785320|NCT02148952|540339133|FG001|Follow-Up|Lost to Follow-up|231|||
149785321|NCT02148952|540339132|FG000|Follow-Up|Withdrawal by Subject|46|||
149785322|NCT02148952|540339133|FG001|Follow-Up|Withdrawal by Subject|48|||
149785323|NCT04007367|540339134|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
149785324|NCT04007367|540339135|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
149785325|NCT04007367|540339136|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
149785326|NCT04007367|540339134|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
149785327|NCT04007367|540339135|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
149785328|NCT04007367|540339136|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
149785329|NCT04007367|540339134|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
149785330|NCT04007367|540339135|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
149785331|NCT04007367|540339136|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
149785332|NCT04007367|540339134|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
149785333|NCT04007367|540339135|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
149785334|NCT04007367|540339136|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
149785335|NCT04007367|540339134|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
149785336|NCT04007367|540339135|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
149785337|NCT04007367|540339136|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
149785338|NCT01764022|540339137|FG000|Overall Study|Death|3|||
149785339|NCT01764022|540339138|FG001|Overall Study|Death|5|||
149785340|NCT01764022|540339137|FG000|Overall Study|Withdrawal by Subject|2|||
149785341|NCT01764022|540339138|FG001|Overall Study|Withdrawal by Subject|6|||
149785342|NCT01764022|540339137|FG000|Overall Study|Lack of Efficacy|0|||
149785343|NCT01764022|540339138|FG001|Overall Study|Lack of Efficacy|1|||
149785344|NCT01764022|540339137|FG000|Overall Study|Physician Decision|0|||
149785345|NCT01764022|540339138|FG001|Overall Study|Physician Decision|2|||
149785346|NCT01764022|540339137|FG000|Overall Study|Lost to Follow-up|2|||
149785347|NCT01764022|540339138|FG001|Overall Study|Lost to Follow-up|0|||
149785348|NCT01764022|540339137|FG000|Overall Study|Protocol Violation|1|||
149785349|NCT01764022|540339138|FG001|Overall Study|Protocol Violation|0|||
149785350|NCT00414973|540339139|FG000|Overall Study|Withdrawal by Subject|14|||
149785351|NCT00414973|540339140|FG001|Overall Study|Withdrawal by Subject|4|||
149785352|NCT00414973|540339141|FG002|Overall Study|Withdrawal by Subject|1|||
149785353|NCT00414973|540339142|FG003|Overall Study|Withdrawal by Subject|0|||
149785354|NCT00414973|540339139|FG000|Overall Study|Adverse Event|10|||
149785355|NCT00414973|540339140|FG001|Overall Study|Adverse Event|0|||
149785356|NCT00414973|540339141|FG002|Overall Study|Adverse Event|1|||
149785357|NCT00414973|540339142|FG003|Overall Study|Adverse Event|0|||
149785358|NCT00414973|540339139|FG000|Overall Study|Protocol Violation|3|||
149785359|NCT00414973|540339140|FG001|Overall Study|Protocol Violation|4|||
149785360|NCT00414973|540339141|FG002|Overall Study|Protocol Violation|0|||
149785361|NCT00414973|540339142|FG003|Overall Study|Protocol Violation|0|||
149785362|NCT00414973|540339139|FG000|Overall Study|Lost to Follow-up|0|||
149785363|NCT00414973|540339140|FG001|Overall Study|Lost to Follow-up|2|||
149785364|NCT00414973|540339141|FG002|Overall Study|Lost to Follow-up|0|||
149785365|NCT00414973|540339142|FG003|Overall Study|Lost to Follow-up|0|||
149785366|NCT00414973|540339139|FG000|Overall Study|Sponsor Decision|1|||
149785367|NCT00414973|540339140|FG001|Overall Study|Sponsor Decision|0|||
149785368|NCT00414973|540339141|FG002|Overall Study|Sponsor Decision|0|||
149785369|NCT00414973|540339142|FG003|Overall Study|Sponsor Decision|0|||
149785370|NCT00414973|540339139|FG000|Overall Study|Death|0|||
149785371|NCT00414973|540339140|FG001|Overall Study|Death|0|||
149785372|NCT00414973|540339141|FG002|Overall Study|Death|1|||
149785373|NCT00414973|540339142|FG003|Overall Study|Death|0|||
149785374|NCT01512693|540339148|FG000|Overall Study|Withdrawal by Subject|0|||
149785375|NCT01512693|540339149|FG001|Overall Study|Withdrawal by Subject|1|||
149785376|NCT03077711|540339150|FG000|Overall Study|Lost to Follow-up|2|||
149785377|NCT03077711|540339151|FG001|Overall Study|Lost to Follow-up|2|||
149785378|NCT03077711|540339150|FG000|Overall Study|noncompliant taking medication|2|||
149785379|NCT03077711|540339151|FG001|Overall Study|noncompliant taking medication|0|||
149785380|NCT01526928|540339152|FG000|Overall Study|Progressive Disease|35|||
149785381|NCT01526928|540339153|FG001|Overall Study|Progressive Disease|17|||
149785382|NCT01526928|540339154|FG002|Overall Study|Progressive Disease|150|||
149785383|NCT01526928|540339155|FG003|Overall Study|Progressive Disease|182|||
149785384|NCT01526928|540339156|FG004|Overall Study|Progressive Disease|76|||
149785385|NCT01526928|540339157|FG005|Overall Study|Progressive Disease|4|||
149785386|NCT01526928|540339152|FG000|Overall Study|Adverse Event|2|||
149785387|NCT01526928|540339153|FG001|Overall Study|Adverse Event|1|||
149785388|NCT01526928|540339154|FG002|Overall Study|Adverse Event|29|||
149785389|NCT01526928|540339155|FG003|Overall Study|Adverse Event|40|||
149785390|NCT01526928|540339156|FG004|Overall Study|Adverse Event|13|||
149785391|NCT01526928|540339157|FG005|Overall Study|Adverse Event|2|||
149785392|NCT01526928|540339152|FG000|Overall Study|Death|0|||
149785393|NCT01526928|540339153|FG001|Overall Study|Death|0|||
149785394|NCT01526928|540339154|FG002|Overall Study|Death|3|||
149785395|NCT01526928|540339155|FG003|Overall Study|Death|0|||
149785396|NCT01526928|540339156|FG004|Overall Study|Death|0|||
149785397|NCT01526928|540339157|FG005|Overall Study|Death|0|||
149785398|NCT01526928|540339152|FG000|Overall Study|Withdrawal by Subject|1|||
149785399|NCT01526928|540339153|FG001|Overall Study|Withdrawal by Subject|0|||
149785400|NCT01526928|540339154|FG002|Overall Study|Withdrawal by Subject|13|||
149785401|NCT01526928|540339155|FG003|Overall Study|Withdrawal by Subject|11|||
149785402|NCT01526928|540339156|FG004|Overall Study|Withdrawal by Subject|3|||
149785403|NCT01526928|540339157|FG005|Overall Study|Withdrawal by Subject|0|||
149785404|NCT01526928|540339152|FG000|Overall Study|Physician Decision|0|||
149785405|NCT01526928|540339153|FG001|Overall Study|Physician Decision|0|||
149785406|NCT01526928|540339154|FG002|Overall Study|Physician Decision|2|||
149785407|NCT01526928|540339155|FG003|Overall Study|Physician Decision|5|||
149785408|NCT01526928|540339156|FG004|Overall Study|Physician Decision|0|||
149785409|NCT01526928|540339157|FG005|Overall Study|Physician Decision|0|||
149785410|NCT01526928|540339152|FG000|Overall Study|Other Reason|0|||
149785411|NCT01526928|540339153|FG001|Overall Study|Other Reason|1|||
149785412|NCT01526928|540339154|FG002|Overall Study|Other Reason|11|||
149785413|NCT01526928|540339155|FG003|Overall Study|Other Reason|4|||
149785414|NCT01526928|540339156|FG004|Overall Study|Other Reason|1|||
149785415|NCT01526928|540339157|FG005|Overall Study|Other Reason|0|||
149785416|NCT01526928|540339152|FG000|Overall Study|Lost to Follow-up|0|||
149785417|NCT01526928|540339153|FG001|Overall Study|Lost to Follow-up|0|||
149785418|NCT01526928|540339154|FG002|Overall Study|Lost to Follow-up|0|||
149785419|NCT01526928|540339155|FG003|Overall Study|Lost to Follow-up|1|||
149785420|NCT01526928|540339156|FG004|Overall Study|Lost to Follow-up|0|||
149785421|NCT01526928|540339157|FG005|Overall Study|Lost to Follow-up|0|||
149785422|NCT01526928|540339152|FG000|Overall Study|Protocol Deviation|0|||
149785423|NCT01526928|540339153|FG001|Overall Study|Protocol Deviation|0|||
149785424|NCT01526928|540339154|FG002|Overall Study|Protocol Deviation|0|||
149785425|NCT01526928|540339155|FG003|Overall Study|Protocol Deviation|2|||
149785426|NCT01526928|540339156|FG004|Overall Study|Protocol Deviation|0|||
149785427|NCT01526928|540339157|FG005|Overall Study|Protocol Deviation|0|||
149785428|NCT01526928|540339152|FG000|Overall Study|Missing|0|||
149785429|NCT01526928|540339153|FG001|Overall Study|Missing|0|||
149785430|NCT01526928|540339154|FG002|Overall Study|Missing|1|||
149785431|NCT01526928|540339155|FG003|Overall Study|Missing|0|||
149785432|NCT01526928|540339156|FG004|Overall Study|Missing|2|||
149785433|NCT01526928|540339157|FG005|Overall Study|Missing|0|||
149785434|NCT04731922|540339167|FG000|Overall Study|Adverse Event|0|||
149785435|NCT04731922|540339168|FG001|Overall Study|Adverse Event|0|||
149785436|NCT04731922|540339169|FG002|Overall Study|Adverse Event|0|||
149785437|NCT04731922|540339170|FG003|Overall Study|Adverse Event|0|||
149785438|NCT04731922|540339171|FG004|Overall Study|Adverse Event|0|||
149785439|NCT04731922|540339172|FG005|Overall Study|Adverse Event|0|||
149785440|NCT04731922|540339173|FG006|Overall Study|Adverse Event|0|||
149785441|NCT04731922|540339174|FG007|Overall Study|Adverse Event|0|||
149785442|NCT04731922|540339175|FG008|Overall Study|Adverse Event|0|||
149785443|NCT04731922|540339176|FG009|Overall Study|Adverse Event|0|||
149785444|NCT04731922|540339177|FG010|Overall Study|Adverse Event|1|||
149785445|NCT04731922|540339178|FG011|Overall Study|Adverse Event|0|||
149785446|NCT04731922|540339179|FG012|Overall Study|Adverse Event|0|||
149785447|NCT04731922|540339180|FG013|Overall Study|Adverse Event|0|||
149785448|NCT04731922|540339181|FG014|Overall Study|Adverse Event|0|||
149785449|NCT04731922|540339182|FG015|Overall Study|Adverse Event|0|||
149785450|NCT04731922|540339183|FG016|Overall Study|Adverse Event|0|||
149785451|NCT04731922|540339167|FG000|Overall Study|Lost to Follow-up|0|||
149785452|NCT04731922|540339168|FG001|Overall Study|Lost to Follow-up|0|||
149785453|NCT04731922|540339169|FG002|Overall Study|Lost to Follow-up|0|||
149785454|NCT04731922|540339170|FG003|Overall Study|Lost to Follow-up|1|||
149785455|NCT04731922|540339171|FG004|Overall Study|Lost to Follow-up|0|||
149785456|NCT04731922|540339172|FG005|Overall Study|Lost to Follow-up|1|||
149785457|NCT04731922|540339173|FG006|Overall Study|Lost to Follow-up|0|||
149785458|NCT04731922|540339174|FG007|Overall Study|Lost to Follow-up|0|||
149785459|NCT04731922|540339175|FG008|Overall Study|Lost to Follow-up|0|||
149785460|NCT04731922|540339176|FG009|Overall Study|Lost to Follow-up|0|||
149785461|NCT04731922|540339177|FG010|Overall Study|Lost to Follow-up|0|||
149785462|NCT04731922|540339178|FG011|Overall Study|Lost to Follow-up|0|||
149785463|NCT04731922|540339179|FG012|Overall Study|Lost to Follow-up|0|||
149785464|NCT04731922|540339180|FG013|Overall Study|Lost to Follow-up|0|||
149785465|NCT04731922|540339181|FG014|Overall Study|Lost to Follow-up|0|||
149785466|NCT04731922|540339182|FG015|Overall Study|Lost to Follow-up|0|||
149785467|NCT04731922|540339183|FG016|Overall Study|Lost to Follow-up|0|||
149785468|NCT04731922|540339167|FG000|Overall Study|Withdrawal by Subject|1|||
149785469|NCT04731922|540339168|FG001|Overall Study|Withdrawal by Subject|0|||
149785470|NCT04731922|540339169|FG002|Overall Study|Withdrawal by Subject|0|||
149785471|NCT04731922|540339170|FG003|Overall Study|Withdrawal by Subject|0|||
149785472|NCT04731922|540339171|FG004|Overall Study|Withdrawal by Subject|1|||
149785473|NCT04731922|540339172|FG005|Overall Study|Withdrawal by Subject|0|||
149785474|NCT04731922|540339173|FG006|Overall Study|Withdrawal by Subject|1|||
149785475|NCT04731922|540339174|FG007|Overall Study|Withdrawal by Subject|0|||
149785476|NCT04731922|540339175|FG008|Overall Study|Withdrawal by Subject|0|||
149785477|NCT04731922|540339176|FG009|Overall Study|Withdrawal by Subject|0|||
149785478|NCT04731922|540339177|FG010|Overall Study|Withdrawal by Subject|0|||
149785479|NCT04731922|540339178|FG011|Overall Study|Withdrawal by Subject|0|||
149785480|NCT04731922|540339179|FG012|Overall Study|Withdrawal by Subject|0|||
149785481|NCT04731922|540339180|FG013|Overall Study|Withdrawal by Subject|1|||
149785482|NCT04731922|540339181|FG014|Overall Study|Withdrawal by Subject|0|||
149785483|NCT04731922|540339182|FG015|Overall Study|Withdrawal by Subject|0|||
149785484|NCT04731922|540339183|FG016|Overall Study|Withdrawal by Subject|0|||
149785485|NCT04731922|540339167|FG000|Overall Study|Other|0|||
149785486|NCT04731922|540339168|FG001|Overall Study|Other|0|||
149785487|NCT04731922|540339169|FG002|Overall Study|Other|0|||
149785488|NCT04731922|540339170|FG003|Overall Study|Other|0|||
149785489|NCT04731922|540339171|FG004|Overall Study|Other|0|||
149785490|NCT04731922|540339172|FG005|Overall Study|Other|0|||
149785491|NCT04731922|540339173|FG006|Overall Study|Other|1|||
149785492|NCT04731922|540339174|FG007|Overall Study|Other|0|||
149785493|NCT04731922|540339175|FG008|Overall Study|Other|0|||
149785494|NCT04731922|540339176|FG009|Overall Study|Other|0|||
149785495|NCT04731922|540339177|FG010|Overall Study|Other|0|||
149785496|NCT04731922|540339178|FG011|Overall Study|Other|0|||
149785497|NCT04731922|540339179|FG012|Overall Study|Other|0|||
149785498|NCT04731922|540339180|FG013|Overall Study|Other|0|||
149785499|NCT04731922|540339181|FG014|Overall Study|Other|0|||
149785500|NCT04731922|540339182|FG015|Overall Study|Other|0|||
149785501|NCT04731922|540339183|FG016|Overall Study|Other|0|||
149785502|NCT04157751|540339184|FG000|Overall Study|Withdrawal by Subject|12|||
149785503|NCT04157751|540339185|FG001|Overall Study|Withdrawal by Subject|17|||
149785504|NCT04157751|540339184|FG000|Overall Study|Lost to Follow-up|6|||
149785505|NCT04157751|540339185|FG001|Overall Study|Lost to Follow-up|2|||
149785506|NCT04157751|540339184|FG000|Overall Study|Adverse Event|34|||
149785507|NCT04157751|540339185|FG001|Overall Study|Adverse Event|23|||
149785508|NCT04157751|540339184|FG000|Overall Study|Not treated|1|||
149785509|NCT04157751|540339185|FG001|Overall Study|Not treated|5|||
149785510|NCT04157751|540339184|FG000|Overall Study|Other reason not stated above|10|||
149785511|NCT04157751|540339185|FG001|Overall Study|Other reason not stated above|10|||
149785512|NCT01437267|540339192|FG000|Overall Study|Withdrawal by Subject|0|||
149785513|NCT01437267|540339193|FG001|Overall Study|Withdrawal by Subject|0|||
149785514|NCT01437267|540339194|FG002|Overall Study|Withdrawal by Subject|0|||
149785515|NCT01437267|540339195|FG003|Overall Study|Withdrawal by Subject|1|||
149785516|NCT01437267|540339196|FG004|Overall Study|Withdrawal by Subject|0|||
149785517|NCT01437267|540339197|FG005|Overall Study|Withdrawal by Subject|0|||
149785518|NCT01437267|540339192|FG000|Overall Study|Protocol Violation|0|||
149785519|NCT01437267|540339193|FG001|Overall Study|Protocol Violation|1|||
149785520|NCT01437267|540339194|FG002|Overall Study|Protocol Violation|0|||
149785521|NCT01437267|540339195|FG003|Overall Study|Protocol Violation|0|||
149785522|NCT01437267|540339196|FG004|Overall Study|Protocol Violation|0|||
149785523|NCT01437267|540339197|FG005|Overall Study|Protocol Violation|0|||
149785524|NCT03934203|540339200|FG000|Overall Study|Adverse Event|0|||
149785525|NCT03934203|540339201|FG001|Overall Study|Adverse Event|0|||
149785526|NCT03934203|540339202|FG002|Overall Study|Adverse Event|1|||
149785527|NCT03934203|540339203|FG003|Overall Study|Adverse Event|0|||
149785528|NCT03934203|540339204|FG004|Overall Study|Adverse Event|1|||
149785529|NCT03934203|540339205|FG005|Overall Study|Adverse Event|0|||
149785530|NCT03934203|540339206|FG006|Overall Study|Adverse Event|2|||
149785531|NCT03934203|540339207|FG007|Overall Study|Adverse Event|0|||
149785532|NCT03934203|540339208|FG008|Overall Study|Adverse Event|0|||
149785533|NCT03934203|540339209|FG009|Overall Study|Adverse Event|0|||
149785534|NCT03934203|540339210|FG010|Overall Study|Adverse Event|0|||
149785535|NCT03934203|540339211|FG011|Overall Study|Adverse Event|0|||
149785536|NCT03934203|540339212|FG012|Overall Study|Adverse Event|0|||
149785537|NCT03934203|540339213|FG013|Overall Study|Adverse Event|1|||
149785538|NCT03934203|540339214|FG014|Overall Study|Adverse Event|0|||
149785539|NCT00333970|540339215|FG000|Overall Study|Withdrawal by Subject|13|||
149785540|NCT00333970|540339216|FG001|Overall Study|Withdrawal by Subject|7|||
149785541|NCT02829775|540339218|FG000|Overall Study|Death|1|||
149785542|NCT02829775|540339218|FG000|Overall Study|Withdrawal by Subject|3|||
149785543|NCT02829775|540339218|FG000|Overall Study|Disease remission|1|||
149785544|NCT00608842|540339219|FG000|Overall Study|Participant's Request|0|||
149785545|NCT00608842|540339220|FG001|Overall Study|Participant's Request|1|||
149785546|NCT00608842|540339221|FG002|Overall Study|Participant's Request|2|||
149785547|NCT00608842|540339222|FG003|Overall Study|Participant's Request|1|||
149785548|NCT00608842|540339219|FG000|Overall Study|Lost to Follow-up|1|||
149785549|NCT00608842|540339220|FG001|Overall Study|Lost to Follow-up|0|||
149785550|NCT00608842|540339221|FG002|Overall Study|Lost to Follow-up|0|||
149785551|NCT00608842|540339222|FG003|Overall Study|Lost to Follow-up|0|||
149785552|NCT00899678|540339223|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
149785553|NCT00899678|540339224|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
149785554|NCT00899678|540339225|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
149785555|NCT00899678|540339223|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
149785556|NCT00899678|540339224|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
149785557|NCT00899678|540339225|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
149785558|NCT00899678|540339223|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
149785559|NCT00899678|540339224|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
149785560|NCT00899678|540339225|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
149785561|NCT00899678|540339223|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
149785562|NCT00899678|540339224|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
149785563|NCT00899678|540339225|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
149785564|NCT00899678|540339223|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
149785565|NCT00899678|540339224|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
149785566|NCT00899678|540339225|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
149785567|NCT00899678|540339223|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
149785568|NCT00899678|540339224|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
149785569|NCT00899678|540339225|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
149785570|NCT00899678|540339223|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
149785571|NCT00899678|540339224|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
149785572|NCT00899678|540339225|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
149785573|NCT00899678|540339223|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
149785574|NCT00899678|540339224|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
149785575|NCT00899678|540339225|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
149785576|NCT00899678|540339223|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
149785577|NCT00899678|540339224|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
149785578|NCT00899678|540339225|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
149785579|NCT02699125|540339228|FG000|Placebo|Lost to Follow-up|2|||
149785580|NCT02699125|540339229|FG001|Placebo|Lost to Follow-up|0|||
149785581|NCT02699125|540339228|FG000|Placebo|Protocol Violation|1|||
149785582|NCT02699125|540339229|FG001|Placebo|Protocol Violation|0|||
149785583|NCT02699125|540339228|FG000|Placebo|Withdrawal by Subject|0|||
149785584|NCT02699125|540339229|FG001|Placebo|Withdrawal by Subject|4|||
149785585|NCT02699125|540339228|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
149785586|NCT02699125|540339229|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
149785587|NCT03799627|540339230|FG000|Overall Study|Adverse Event|1|||
149785588|NCT03799627|540339231|FG001|Overall Study|Adverse Event|2|||
149785589|NCT03799627|540339232|FG002|Overall Study|Adverse Event|0|||
149785590|NCT03799627|540339233|FG003|Overall Study|Adverse Event|0|||
149785591|NCT03799627|540339234|FG004|Overall Study|Adverse Event|2|||
149785592|NCT03799627|540339235|FG005|Overall Study|Adverse Event|5|||
149785593|NCT03799627|540339236|FG006|Overall Study|Adverse Event|0|||
149785594|NCT03799627|540339237|FG007|Overall Study|Adverse Event|2|||
149785595|NCT03799627|540339238|FG008|Overall Study|Adverse Event|0|||
149785596|NCT03799627|540339230|FG000|Overall Study|Physician Decision|2|||
149785597|NCT03799627|540339231|FG001|Overall Study|Physician Decision|2|||
149785598|NCT03799627|540339232|FG002|Overall Study|Physician Decision|0|||
149785599|NCT03799627|540339233|FG003|Overall Study|Physician Decision|0|||
149785600|NCT03799627|540339234|FG004|Overall Study|Physician Decision|2|||
149785601|NCT03799627|540339235|FG005|Overall Study|Physician Decision|2|||
149785602|NCT03799627|540339236|FG006|Overall Study|Physician Decision|0|||
149785603|NCT03799627|540339237|FG007|Overall Study|Physician Decision|0|||
149785604|NCT03799627|540339238|FG008|Overall Study|Physician Decision|0|||
149785605|NCT03799627|540339230|FG000|Overall Study|Withdrawal by Subject|1|||
149785606|NCT03799627|540339231|FG001|Overall Study|Withdrawal by Subject|1|||
149785607|NCT03799627|540339232|FG002|Overall Study|Withdrawal by Subject|0|||
149785608|NCT03799627|540339233|FG003|Overall Study|Withdrawal by Subject|2|||
149785609|NCT03799627|540339234|FG004|Overall Study|Withdrawal by Subject|0|||
149785610|NCT03799627|540339235|FG005|Overall Study|Withdrawal by Subject|3|||
149785611|NCT03799627|540339236|FG006|Overall Study|Withdrawal by Subject|0|||
149785612|NCT03799627|540339237|FG007|Overall Study|Withdrawal by Subject|0|||
149785613|NCT03799627|540339238|FG008|Overall Study|Withdrawal by Subject|0|||
149785614|NCT03799627|540339230|FG000|Overall Study|Lack of Efficacy|0|||
149785615|NCT03799627|540339231|FG001|Overall Study|Lack of Efficacy|0|||
149785616|NCT03799627|540339232|FG002|Overall Study|Lack of Efficacy|0|||
149785617|NCT03799627|540339233|FG003|Overall Study|Lack of Efficacy|1|||
149785618|NCT03799627|540339234|FG004|Overall Study|Lack of Efficacy|0|||
149785619|NCT03799627|540339235|FG005|Overall Study|Lack of Efficacy|0|||
149785620|NCT03799627|540339236|FG006|Overall Study|Lack of Efficacy|0|||
149785621|NCT03799627|540339237|FG007|Overall Study|Lack of Efficacy|0|||
149785622|NCT03799627|540339238|FG008|Overall Study|Lack of Efficacy|0|||
149785623|NCT03799627|540339230|FG000|Overall Study|Lost to Follow-up|0|||
149785624|NCT03799627|540339231|FG001|Overall Study|Lost to Follow-up|0|||
149785625|NCT03799627|540339232|FG002|Overall Study|Lost to Follow-up|0|||
149785626|NCT03799627|540339233|FG003|Overall Study|Lost to Follow-up|0|||
149785627|NCT03799627|540339234|FG004|Overall Study|Lost to Follow-up|0|||
149785628|NCT03799627|540339235|FG005|Overall Study|Lost to Follow-up|0|||
149785629|NCT03799627|540339236|FG006|Overall Study|Lost to Follow-up|1|||
149785630|NCT03799627|540339237|FG007|Overall Study|Lost to Follow-up|0|||
149785631|NCT03799627|540339238|FG008|Overall Study|Lost to Follow-up|1|||
149785632|NCT03799627|540339230|FG000|Overall Study|Death|0|||
149785633|NCT03799627|540339231|FG001|Overall Study|Death|0|||
149785634|NCT03799627|540339232|FG002|Overall Study|Death|0|||
149785635|NCT03799627|540339233|FG003|Overall Study|Death|1|||
149785636|NCT03799627|540339234|FG004|Overall Study|Death|0|||
149785637|NCT03799627|540339235|FG005|Overall Study|Death|0|||
149785638|NCT03799627|540339236|FG006|Overall Study|Death|0|||
149785639|NCT03799627|540339237|FG007|Overall Study|Death|0|||
149785640|NCT03799627|540339238|FG008|Overall Study|Death|0|||
149785641|NCT03799627|540339230|FG000|Overall Study|Study Drug Put on Hold|1|||
149785642|NCT03799627|540339231|FG001|Overall Study|Study Drug Put on Hold|0|||
149785643|NCT03799627|540339232|FG002|Overall Study|Study Drug Put on Hold|0|||
149785644|NCT03799627|540339233|FG003|Overall Study|Study Drug Put on Hold|0|||
149785645|NCT03799627|540339234|FG004|Overall Study|Study Drug Put on Hold|0|||
149785646|NCT03799627|540339235|FG005|Overall Study|Study Drug Put on Hold|0|||
149785647|NCT03799627|540339236|FG006|Overall Study|Study Drug Put on Hold|0|||
149785648|NCT03799627|540339237|FG007|Overall Study|Study Drug Put on Hold|0|||
149785649|NCT03799627|540339238|FG008|Overall Study|Study Drug Put on Hold|0|||
149785650|NCT03799627|540339230|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
149785651|NCT03799627|540339231|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
149785652|NCT03799627|540339232|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
149785653|NCT03799627|540339233|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
149785654|NCT03799627|540339234|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
149785655|NCT03799627|540339235|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
149785656|NCT03799627|540339236|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
149785657|NCT03799627|540339237|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
149785658|NCT03799627|540339238|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
149785659|NCT03799627|540339230|FG000|Overall Study|Kidney Transplantation|1|||
149785660|NCT03799627|540339231|FG001|Overall Study|Kidney Transplantation|0|||
149785661|NCT03799627|540339232|FG002|Overall Study|Kidney Transplantation|0|||
149785662|NCT03799627|540339233|FG003|Overall Study|Kidney Transplantation|1|||
149785663|NCT03799627|540339234|FG004|Overall Study|Kidney Transplantation|1|||
149785664|NCT03799627|540339235|FG005|Overall Study|Kidney Transplantation|0|||
149785665|NCT03799627|540339236|FG006|Overall Study|Kidney Transplantation|0|||
149785666|NCT03799627|540339237|FG007|Overall Study|Kidney Transplantation|0|||
149785667|NCT03799627|540339238|FG008|Overall Study|Kidney Transplantation|0|||
149785668|NCT03799627|540339230|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
149785669|NCT03799627|540339231|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
149785670|NCT03799627|540339232|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
149785671|NCT03799627|540339233|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
149785672|NCT03799627|540339234|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
149785673|NCT03799627|540339235|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
149785674|NCT03799627|540339236|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
149785675|NCT03799627|540339237|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
149785676|NCT03799627|540339238|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
149785677|NCT03799627|540339230|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785678|NCT03799627|540339231|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
149785679|NCT03799627|540339232|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785680|NCT03799627|540339233|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785681|NCT03799627|540339234|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785682|NCT03799627|540339235|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785683|NCT03799627|540339236|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785684|NCT03799627|540339237|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785685|NCT03799627|540339238|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149785686|NCT03799627|540339230|FG000|Overall Study|Met Exclusion Criteria|0|||
149785687|NCT03799627|540339231|FG001|Overall Study|Met Exclusion Criteria|0|||
149785688|NCT03799627|540339232|FG002|Overall Study|Met Exclusion Criteria|0|||
149785689|NCT03799627|540339233|FG003|Overall Study|Met Exclusion Criteria|1|||
149785690|NCT03799627|540339234|FG004|Overall Study|Met Exclusion Criteria|0|||
149785691|NCT03799627|540339235|FG005|Overall Study|Met Exclusion Criteria|0|||
149785692|NCT03799627|540339236|FG006|Overall Study|Met Exclusion Criteria|0|||
149785693|NCT03799627|540339237|FG007|Overall Study|Met Exclusion Criteria|0|||
149785694|NCT03799627|540339238|FG008|Overall Study|Met Exclusion Criteria|0|||
149785695|NCT03799627|540339230|FG000|Overall Study|Investigational Product Noncompliance|0|||
149785696|NCT03799627|540339231|FG001|Overall Study|Investigational Product Noncompliance|0|||
149785697|NCT03799627|540339232|FG002|Overall Study|Investigational Product Noncompliance|0|||
149785698|NCT03799627|540339233|FG003|Overall Study|Investigational Product Noncompliance|1|||
149785699|NCT03799627|540339234|FG004|Overall Study|Investigational Product Noncompliance|0|||
149785700|NCT03799627|540339235|FG005|Overall Study|Investigational Product Noncompliance|0|||
149785701|NCT03799627|540339236|FG006|Overall Study|Investigational Product Noncompliance|0|||
149785702|NCT03799627|540339237|FG007|Overall Study|Investigational Product Noncompliance|0|||
149785703|NCT03799627|540339238|FG008|Overall Study|Investigational Product Noncompliance|0|||
149785704|NCT03799627|540339230|FG000|Overall Study|Participant Relocation|0|||
149785705|NCT03799627|540339231|FG001|Overall Study|Participant Relocation|0|||
149785706|NCT03799627|540339232|FG002|Overall Study|Participant Relocation|0|||
149785707|NCT03799627|540339233|FG003|Overall Study|Participant Relocation|1|||
149785708|NCT03799627|540339234|FG004|Overall Study|Participant Relocation|0|||
149785709|NCT03799627|540339235|FG005|Overall Study|Participant Relocation|1|||
149785710|NCT03799627|540339236|FG006|Overall Study|Participant Relocation|0|||
149785711|NCT03799627|540339237|FG007|Overall Study|Participant Relocation|0|||
149785712|NCT03799627|540339238|FG008|Overall Study|Participant Relocation|0|||
149785713|NCT03799627|540339230|FG000|Overall Study|Eurofin Issue|0|||
149785714|NCT03799627|540339231|FG001|Overall Study|Eurofin Issue|0|||
149785715|NCT03799627|540339232|FG002|Overall Study|Eurofin Issue|0|||
149785716|NCT03799627|540339233|FG003|Overall Study|Eurofin Issue|0|||
149785717|NCT03799627|540339234|FG004|Overall Study|Eurofin Issue|1|||
149785718|NCT03799627|540339235|FG005|Overall Study|Eurofin Issue|0|||
149785719|NCT03799627|540339236|FG006|Overall Study|Eurofin Issue|0|||
149785720|NCT03799627|540339237|FG007|Overall Study|Eurofin Issue|0|||
149785721|NCT03799627|540339238|FG008|Overall Study|Eurofin Issue|0|||
149785722|NCT03799627|540339230|FG000|Overall Study|Noncompliance with Site Instructions|0|||
149785723|NCT03799627|540339231|FG001|Overall Study|Noncompliance with Site Instructions|0|||
149785724|NCT03799627|540339232|FG002|Overall Study|Noncompliance with Site Instructions|0|||
149785725|NCT03799627|540339233|FG003|Overall Study|Noncompliance with Site Instructions|0|||
149785726|NCT03799627|540339234|FG004|Overall Study|Noncompliance with Site Instructions|1|||
149785727|NCT03799627|540339235|FG005|Overall Study|Noncompliance with Site Instructions|0|||
149785728|NCT03799627|540339236|FG006|Overall Study|Noncompliance with Site Instructions|0|||
149785729|NCT03799627|540339237|FG007|Overall Study|Noncompliance with Site Instructions|0|||
149785730|NCT03799627|540339238|FG008|Overall Study|Noncompliance with Site Instructions|0|||
149785731|NCT03799627|540339230|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785732|NCT03799627|540339231|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785733|NCT03799627|540339232|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785734|NCT03799627|540339233|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785735|NCT03799627|540339234|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
149785736|NCT03799627|540339235|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785737|NCT03799627|540339236|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785738|NCT03799627|540339237|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785739|NCT03799627|540339238|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149785740|NCT03799627|540339230|FG000|Overall Study|Changes In Hemoglobin Values|1|||
149785741|NCT03799627|540339231|FG001|Overall Study|Changes In Hemoglobin Values|2|||
149785742|NCT03799627|540339232|FG002|Overall Study|Changes In Hemoglobin Values|1|||
149785743|NCT03799627|540339233|FG003|Overall Study|Changes In Hemoglobin Values|0|||
149785744|NCT03799627|540339234|FG004|Overall Study|Changes In Hemoglobin Values|0|||
149785745|NCT03799627|540339235|FG005|Overall Study|Changes In Hemoglobin Values|2|||
149785746|NCT03799627|540339236|FG006|Overall Study|Changes In Hemoglobin Values|1|||
149785747|NCT03799627|540339237|FG007|Overall Study|Changes In Hemoglobin Values|0|||
149785748|NCT03799627|540339238|FG008|Overall Study|Changes In Hemoglobin Values|1|||
149785749|NCT04445051|540339240|FG000|Overall Study|Adverse Event|0|||
149785750|NCT04445051|540339241|FG001|Overall Study|Adverse Event|0|||
149785751|NCT04445051|540339242|FG002|Overall Study|Adverse Event|1|||
149785752|NCT04445051|540339243|FG003|Overall Study|Adverse Event|0|||
149785753|NCT04445051|540339244|FG004|Overall Study|Adverse Event|0|||
149785754|NCT04445051|540339245|FG005|Overall Study|Adverse Event|0|||
149785755|NCT02092324|540339246|FG000|Overall Study|Adverse Event|1|||
149785756|NCT02092324|540339246|FG000|Overall Study|Lack of Efficacy|6|||
149785757|NCT02092324|540339246|FG000|Overall Study|Proceed to Transplant|3|||
149785758|NCT02092324|540339246|FG000|Overall Study|Physician Decision|7|||
149785759|NCT02092324|540339246|FG000|Overall Study|Misdiagnosis|2|||
149785760|NCT03039569|540339260|FG000|Overall Study|Lost to Follow-up|5|||
149785761|NCT03039569|540339261|FG001|Overall Study|Lost to Follow-up|4|||
149785762|NCT01673373|540340782|FG000|Overall Study|Death|2|||
149785763|NCT03671148|540340793|FG000|Overall Study|Adverse Event|3|||
149785764|NCT03671148|540340794|FG001|Overall Study|Adverse Event|2|||
149785765|NCT03671148|540340793|FG000|Overall Study|Withdrawal by Subject|8|||
149785766|NCT03671148|540340794|FG001|Overall Study|Withdrawal by Subject|2|||
149785767|NCT03671148|540340793|FG000|Overall Study|Lost to Follow-up|1|||
149785768|NCT03671148|540340794|FG001|Overall Study|Lost to Follow-up|2|||
149785769|NCT03671148|540340793|FG000|Overall Study|Lack of Efficacy|7|||
149785770|NCT03671148|540340794|FG001|Overall Study|Lack of Efficacy|2|||
149785771|NCT03671148|540340793|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
149785772|NCT03671148|540340794|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
149785773|NCT03671148|540340793|FG000|Overall Study|Other|1|||
149785774|NCT03671148|540340794|FG001|Overall Study|Other|0|||
149785775|NCT03671148|540340793|FG000|Overall Study|Incomplete Randomization Visit|1|||
149785776|NCT03671148|540340794|FG001|Overall Study|Incomplete Randomization Visit|0|||
149785777|NCT00589602|540340797|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
149785778|NCT01804842|540340798|FG000|Overall Study|Adverse Event|1|||
149785779|NCT01804842|540340799|FG001|Overall Study|Adverse Event|1|||
149785780|NCT01804842|540340800|FG002|Overall Study|Adverse Event|0|||
149785781|NCT01804842|540340798|FG000|Overall Study|Lost to Follow-up|1|||
149785782|NCT01804842|540340799|FG001|Overall Study|Lost to Follow-up|0|||
149785783|NCT01804842|540340800|FG002|Overall Study|Lost to Follow-up|0|||
149785784|NCT01804842|540340798|FG000|Overall Study|Non-Compliance|1|||
149785785|NCT01804842|540340799|FG001|Overall Study|Non-Compliance|1|||
149785786|NCT01804842|540340800|FG002|Overall Study|Non-Compliance|0|||
149785787|NCT01804842|540340798|FG000|Overall Study|Personal Reason|0|||
149785788|NCT01804842|540340799|FG001|Overall Study|Personal Reason|0|||
149785789|NCT01804842|540340800|FG002|Overall Study|Personal Reason|1|||
149785790|NCT00413777|540340801|FG000|Fixed-dose Period|Lost to Follow-up|1|||
149785791|NCT00413777|540340802|FG001|Fixed-dose Period|Lost to Follow-up|1|||
149785792|NCT00413777|540340801|FG000|Fixed-dose Period|Adverse Event|2|||
149785793|NCT00413777|540340802|FG001|Fixed-dose Period|Adverse Event|1|||
149785794|NCT00413777|540340801|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
149785795|NCT00413777|540340802|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
149785796|NCT00413777|540340801|FG000|Fixed-dose Period|Withdrew Consent|0|||
149785797|NCT00413777|540340802|FG001|Fixed-dose Period|Withdrew Consent|1|||
149785798|NCT03287830|540340803|FG000|Overall Study|Withdrawal by Subject|1|||
149785799|NCT03287830|540340804|FG001|Overall Study|Withdrawal by Subject|1|||
149785800|NCT03287830|540340803|FG000|Overall Study|not meeting inclusion criteria|5|||
149785801|NCT03287830|540340804|FG001|Overall Study|not meeting inclusion criteria|12|||
149785802|NCT02155712|540340807|FG000|Overall Study|Death|12|||
149785803|NCT02155712|540340808|FG001|Overall Study|Death|0|||
149785804|NCT02155712|540340807|FG000|Overall Study|Lost to Follow-up|37|||
149785805|NCT02155712|540340808|FG001|Overall Study|Lost to Follow-up|22|||
149785806|NCT02155712|540340807|FG000|Overall Study|Revision of device|4|||
149785807|NCT02155712|540340808|FG001|Overall Study|Revision of device|3|||
149785808|NCT02155712|540340807|FG000|Overall Study|Withdrawal by Subject|39|||
149785809|NCT02155712|540340808|FG001|Overall Study|Withdrawal by Subject|21|||
149785810|NCT02155712|540340807|FG000|Overall Study|Site termination|77|||
149785811|NCT02155712|540340808|FG001|Overall Study|Site termination|19|||
149785812|NCT02155712|540340807|FG000|Overall Study|Sponsor terminated study early|150|||
149785813|NCT02155712|540340808|FG001|Overall Study|Sponsor terminated study early|0|||
149785814|NCT02155712|540340807|FG000|Overall Study|Missed final 5-year protocol visit|0|||
149785815|NCT02155712|540340808|FG001|Overall Study|Missed final 5-year protocol visit|32|||
149785816|NCT02155712|540340807|FG000|Overall Study|Censored because surgery cancelled|6|||
149785817|NCT02155712|540340808|FG001|Overall Study|Censored because surgery cancelled|10|||
149785818|NCT02155712|540340807|FG000|Overall Study|Censored because study device was not implanted|61|||
149785819|NCT02155712|540340808|FG001|Overall Study|Censored because study device was not implanted|66|||
149785820|NCT02155712|540340807|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
149785821|NCT02155712|540340808|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
149785822|NCT05180721|540340809|FG000|Overall Study|Lost to Follow-up|4|||
149785823|NCT04288089|540340810|FG000|Overall Study|Ongoing Treatment|2|||
149785824|NCT04288089|540340811|FG001|Overall Study|Ongoing Treatment|1|||
149785825|NCT04288089|540340812|FG002|Overall Study|Ongoing Treatment|1|||
149785826|NCT04288089|540340813|FG003|Overall Study|Ongoing Treatment|4|||
149785827|NCT00976963|540340814|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
149785828|NCT00976963|540340815|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
149785829|NCT00976963|540340814|FG000|Overall Study|administrative error|1|||
149785830|NCT00976963|540340815|FG001|Overall Study|administrative error|0|||
149785831|NCT00976963|540340814|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
149785832|NCT00976963|540340815|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
149785833|NCT03039790|540340833|FG000|Overall Study|Lost to Follow-up|2|||
149785834|NCT03039790|540340834|FG001|Overall Study|Lost to Follow-up|0|||
149785835|NCT03039790|540340835|FG002|Overall Study|Lost to Follow-up|1|||
149785836|NCT03039790|540340836|FG003|Overall Study|Lost to Follow-up|1|||
149785837|NCT03039790|540340837|FG004|Overall Study|Lost to Follow-up|0|||
149785838|NCT03039790|540340838|FG005|Overall Study|Lost to Follow-up|1|||
149785839|NCT03039790|540340839|FG006|Overall Study|Lost to Follow-up|1|||
149785840|NCT03039790|540340840|FG007|Overall Study|Lost to Follow-up|1|||
149785841|NCT03039790|540340841|FG008|Overall Study|Lost to Follow-up|0|||
149785842|NCT03039790|540340842|FG009|Overall Study|Lost to Follow-up|1|||
149785843|NCT03039790|540340843|FG010|Overall Study|Lost to Follow-up|1|||
149785844|NCT03039790|540340844|FG011|Overall Study|Lost to Follow-up|0|||
149785845|NCT03039790|540340845|FG012|Overall Study|Lost to Follow-up|1|||
149785846|NCT03039790|540340846|FG013|Overall Study|Lost to Follow-up|0|||
149785847|NCT03039790|540340847|FG014|Overall Study|Lost to Follow-up|3|||
149785848|NCT03039790|540340848|FG015|Overall Study|Lost to Follow-up|1|||
149785849|NCT03039790|540340849|FG016|Overall Study|Lost to Follow-up|2|||
149785850|NCT03039790|540340850|FG017|Overall Study|Lost to Follow-up|2|||
149785851|NCT03039790|540340851|FG018|Overall Study|Lost to Follow-up|1|||
149785852|NCT03039790|540340852|FG019|Overall Study|Lost to Follow-up|3|||
149785853|NCT03039790|540340833|FG000|Overall Study|Withdrawal of Consent|1|||
149785854|NCT03039790|540340834|FG001|Overall Study|Withdrawal of Consent|0|||
149785855|NCT03039790|540340835|FG002|Overall Study|Withdrawal of Consent|0|||
149785856|NCT03039790|540340836|FG003|Overall Study|Withdrawal of Consent|1|||
149785857|NCT03039790|540340837|FG004|Overall Study|Withdrawal of Consent|0|||
149785858|NCT03039790|540340838|FG005|Overall Study|Withdrawal of Consent|0|||
149785859|NCT03039790|540340839|FG006|Overall Study|Withdrawal of Consent|0|||
149785860|NCT03039790|540340840|FG007|Overall Study|Withdrawal of Consent|0|||
149785861|NCT03039790|540340841|FG008|Overall Study|Withdrawal of Consent|0|||
149785862|NCT03039790|540340842|FG009|Overall Study|Withdrawal of Consent|1|||
149785863|NCT03039790|540340843|FG010|Overall Study|Withdrawal of Consent|0|||
149785864|NCT03039790|540340844|FG011|Overall Study|Withdrawal of Consent|0|||
149785865|NCT03039790|540340845|FG012|Overall Study|Withdrawal of Consent|2|||
149785866|NCT03039790|540340846|FG013|Overall Study|Withdrawal of Consent|0|||
149785867|NCT03039790|540340847|FG014|Overall Study|Withdrawal of Consent|1|||
149785868|NCT03039790|540340848|FG015|Overall Study|Withdrawal of Consent|5|||
149785869|NCT03039790|540340849|FG016|Overall Study|Withdrawal of Consent|3|||
149785870|NCT03039790|540340850|FG017|Overall Study|Withdrawal of Consent|0|||
149785871|NCT03039790|540340851|FG018|Overall Study|Withdrawal of Consent|2|||
149785872|NCT03039790|540340852|FG019|Overall Study|Withdrawal of Consent|5|||
149785873|NCT03039790|540340833|FG000|Overall Study|Death|0|||
149785874|NCT03039790|540340834|FG001|Overall Study|Death|0|||
149785875|NCT03039790|540340835|FG002|Overall Study|Death|0|||
149785876|NCT03039790|540340836|FG003|Overall Study|Death|0|||
149785877|NCT03039790|540340837|FG004|Overall Study|Death|0|||
149785878|NCT03039790|540340838|FG005|Overall Study|Death|0|||
149785879|NCT03039790|540340839|FG006|Overall Study|Death|0|||
149785880|NCT03039790|540340840|FG007|Overall Study|Death|0|||
149785881|NCT03039790|540340841|FG008|Overall Study|Death|0|||
149785882|NCT03039790|540340842|FG009|Overall Study|Death|0|||
149785883|NCT03039790|540340843|FG010|Overall Study|Death|0|||
149785884|NCT03039790|540340844|FG011|Overall Study|Death|0|||
149785885|NCT03039790|540340845|FG012|Overall Study|Death|0|||
149785886|NCT03039790|540340846|FG013|Overall Study|Death|0|||
149785887|NCT03039790|540340847|FG014|Overall Study|Death|0|||
149785888|NCT03039790|540340848|FG015|Overall Study|Death|1|||
149785889|NCT03039790|540340849|FG016|Overall Study|Death|3|||
149785890|NCT03039790|540340850|FG017|Overall Study|Death|0|||
149785891|NCT03039790|540340851|FG018|Overall Study|Death|2|||
149785892|NCT03039790|540340852|FG019|Overall Study|Death|0|||
149785893|NCT03039790|540340833|FG000|Overall Study|Reason, not Specified|1|||
149785894|NCT03039790|540340834|FG001|Overall Study|Reason, not Specified|0|||
149785895|NCT03039790|540340835|FG002|Overall Study|Reason, not Specified|0|||
149785896|NCT03039790|540340836|FG003|Overall Study|Reason, not Specified|0|||
149785897|NCT03039790|540340837|FG004|Overall Study|Reason, not Specified|0|||
149785898|NCT03039790|540340838|FG005|Overall Study|Reason, not Specified|0|||
149785899|NCT03039790|540340839|FG006|Overall Study|Reason, not Specified|0|||
149785900|NCT03039790|540340840|FG007|Overall Study|Reason, not Specified|0|||
149785901|NCT03039790|540340841|FG008|Overall Study|Reason, not Specified|0|||
149785902|NCT03039790|540340842|FG009|Overall Study|Reason, not Specified|0|||
149785903|NCT03039790|540340843|FG010|Overall Study|Reason, not Specified|0|||
149785904|NCT03039790|540340844|FG011|Overall Study|Reason, not Specified|0|||
149785905|NCT03039790|540340845|FG012|Overall Study|Reason, not Specified|0|||
149785906|NCT03039790|540340846|FG013|Overall Study|Reason, not Specified|0|||
149785907|NCT03039790|540340847|FG014|Overall Study|Reason, not Specified|0|||
149785908|NCT03039790|540340848|FG015|Overall Study|Reason, not Specified|0|||
149785909|NCT03039790|540340849|FG016|Overall Study|Reason, not Specified|2|||
149785910|NCT03039790|540340850|FG017|Overall Study|Reason, not Specified|0|||
149785911|NCT03039790|540340851|FG018|Overall Study|Reason, not Specified|1|||
149785912|NCT03039790|540340852|FG019|Overall Study|Reason, not Specified|0|||
149785913|NCT00557323|540340853|FG000|Overall Study|Death|3|||
149785914|NCT00557323|540340853|FG000|Overall Study|Withdrawal by Subject|2|||
149785915|NCT00557323|540340853|FG000|Overall Study|Administrative change|2|||
149785916|NCT01855425|540340864|FG000|Overall Study|Physician Decision|20|||
149785917|NCT01025232|540340865|FG000|Overall Study|Study drug no longer available|3|||
149785918|NCT01025232|540340866|FG001|Overall Study|Study drug no longer available|6|||
149785919|NCT01600105|540340867|FG000|Total Participants|Withdrawal by Subject|1|||
149785920|NCT01600105|540340868|FG001|Total Participants|Withdrawal by Subject|0|||
149785921|NCT01600105|540340867|FG000|Total Participants|No images in PACS|10|||
149785922|NCT01600105|540340868|FG001|Total Participants|No images in PACS|0|||
149785923|NCT01600105|540340867|FG000|Total Participants|Insufficient image quality|30|||
149785924|NCT01600105|540340868|FG001|Total Participants|Insufficient image quality|10|||
149785925|NCT01600105|540340867|FG000|Sub Study I|Insufficient image quality|0|||
149785926|NCT01600105|540340868|FG001|Sub Study I|Insufficient image quality|10|||
149785927|NCT01600105|540340867|FG000|Sub Study II|Withdrawal by Subject|1|||
149785928|NCT01600105|540340868|FG001|Sub Study II|Withdrawal by Subject|0|||
149785929|NCT01600105|540340867|FG000|Sub Study II|No images in PACS|1|||
149785930|NCT01600105|540340868|FG001|Sub Study II|No images in PACS|0|||
149785931|NCT01600105|540340867|FG000|Sub Study II|Insufficient image quality|3|||
149785932|NCT01600105|540340868|FG001|Sub Study II|Insufficient image quality|0|||
149785933|NCT01600105|540340867|FG000|Sub Study III|Insufficient image quality|5|||
149785934|NCT01600105|540340868|FG001|Sub Study III|Insufficient image quality|0|||
149785935|NCT01600105|540340867|FG000|Sub Study V|Poor Image Quality|2|||
149785936|NCT01600105|540340868|FG001|Sub Study V|Poor Image Quality|0|||
149785937|NCT01196091|540340869|FG000|Overall Study|Adverse Event|22|||
149785938|NCT01196091|540340870|FG001|Overall Study|Adverse Event|27|||
149785939|NCT01196091|540340871|FG002|Overall Study|Adverse Event|26|||
149785940|NCT01196091|540340869|FG000|Overall Study|Death|3|||
149785941|NCT01196091|540340870|FG001|Overall Study|Death|2|||
149785942|NCT01196091|540340871|FG002|Overall Study|Death|2|||
149785943|NCT01196091|540340869|FG000|Overall Study|Entry Criteria Not Met|11|||
149785944|NCT01196091|540340870|FG001|Overall Study|Entry Criteria Not Met|11|||
149785945|NCT01196091|540340871|FG002|Overall Study|Entry Criteria Not Met|10|||
149785946|NCT01196091|540340869|FG000|Overall Study|Lack of Efficacy|15|||
149785947|NCT01196091|540340870|FG001|Overall Study|Lack of Efficacy|12|||
149785948|NCT01196091|540340871|FG002|Overall Study|Lack of Efficacy|17|||
149785949|NCT01196091|540340869|FG000|Overall Study|Lost to Follow-up|5|||
149785950|NCT01196091|540340870|FG001|Overall Study|Lost to Follow-up|5|||
149785951|NCT01196091|540340871|FG002|Overall Study|Lost to Follow-up|6|||
149785952|NCT01196091|540340869|FG000|Overall Study|Parent/Caregiver Decision|0|||
149785953|NCT01196091|540340870|FG001|Overall Study|Parent/Caregiver Decision|0|||
149785954|NCT01196091|540340871|FG002|Overall Study|Parent/Caregiver Decision|1|||
149785955|NCT01196091|540340869|FG000|Overall Study|Withdrawal by Subject|16|||
149785956|NCT01196091|540340870|FG001|Overall Study|Withdrawal by Subject|19|||
149785957|NCT01196091|540340871|FG002|Overall Study|Withdrawal by Subject|22|||
149785958|NCT01196091|540340869|FG000|Overall Study|Physician Decision|3|||
149785959|NCT01196091|540340870|FG001|Overall Study|Physician Decision|3|||
149785960|NCT01196091|540340871|FG002|Overall Study|Physician Decision|4|||
149785961|NCT01196091|540340869|FG000|Overall Study|Protocol Violation|1|||
149785962|NCT01196091|540340870|FG001|Overall Study|Protocol Violation|3|||
149785963|NCT01196091|540340871|FG002|Overall Study|Protocol Violation|3|||
149785964|NCT01196091|540340869|FG000|Overall Study|Sponsor Decision|6|||
149785965|NCT01196091|540340870|FG001|Overall Study|Sponsor Decision|5|||
149785966|NCT01196091|540340871|FG002|Overall Study|Sponsor Decision|4|||
149785967|NCT01196091|540340869|FG000|Overall Study|Excluded Site|5|||
149785968|NCT01196091|540340870|FG001|Overall Study|Excluded Site|11|||
149785969|NCT01196091|540340871|FG002|Overall Study|Excluded Site|8|||
149785970|NCT01196091|540340869|FG000|Overall Study|Randomized, No Study Drug Received|1|||
149785971|NCT01196091|540340870|FG001|Overall Study|Randomized, No Study Drug Received|0|||
149785972|NCT01196091|540340871|FG002|Overall Study|Randomized, No Study Drug Received|1|||
149785973|NCT04247828|540340881|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
149785974|NCT02324049|540340882|FG000|Part C|Study terminated|11|||
149785975|NCT02159365|540340884|FG000|Overall Study|Disease Progression|23|||
149785976|NCT02159365|540340884|FG000|Overall Study|Other reasons|11|||
149785977|NCT02159365|540340884|FG000|Overall Study|Administrative reason by Sponsor|9|||
149785978|NCT02159365|540340884|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
149785979|NCT02159365|540340884|FG000|Overall Study|Study drug toxicity|7|||
149785980|NCT02159365|540340884|FG000|Overall Study|Maximum clinical benefit|3|||
149785981|NCT02159365|540340884|FG000|Overall Study|Subject request to discontinue treatment|3|||
149785982|NCT02159365|540340884|FG000|Overall Study|Subject withdrew consent|3|||
149785983|NCT02159365|540340884|FG000|Overall Study|Death|1|||
149785984|NCT02159365|540340884|FG000|Overall Study|Lost to Follow-up|1|||
149785985|NCT03198728|540340885|FG000|Overall Study|Adverse Event|10|||
149785986|NCT03198728|540340886|FG001|Overall Study|Adverse Event|5|||
149785987|NCT03198728|540340885|FG000|Overall Study|Lost to Follow-up|21|||
149785988|NCT03198728|540340886|FG001|Overall Study|Lost to Follow-up|7|||
149785989|NCT03198728|540340885|FG000|Overall Study|Physician Decision|7|||
149785990|NCT03198728|540340886|FG001|Overall Study|Physician Decision|2|||
149785991|NCT03198728|540340885|FG000|Overall Study|Withdrawal by Subject|14|||
149785992|NCT03198728|540340886|FG001|Overall Study|Withdrawal by Subject|10|||
149785993|NCT04051944|540340888|FG000|Overall Study|Study ending|1|||
149785994|NCT04051944|540340889|FG001|Overall Study|Study ending|1|||
149785995|NCT04051944|540340888|FG000|Overall Study|Early study termination by participant|1|||
149785996|NCT04051944|540340889|FG001|Overall Study|Early study termination by participant|0|||
149785997|NCT04051944|540340888|FG000|Overall Study|Withdrawal by Subject|2|||
149785998|NCT04051944|540340889|FG001|Overall Study|Withdrawal by Subject|2|||
149785999|NCT04051944|540340888|FG000|Overall Study|Lack of Efficacy|3|||
149786000|NCT04051944|540340889|FG001|Overall Study|Lack of Efficacy|0|||
149786001|NCT04051944|540340888|FG000|Overall Study|Adverse event, non- fatal|1|||
149786002|NCT04051944|540340889|FG001|Overall Study|Adverse event, non- fatal|1|||
149786003|NCT03083470|540340890|FG000|Overall Study|Lost to Follow-up|0|||
149786004|NCT03083470|540340891|FG001|Overall Study|Lost to Follow-up|0|||
149786005|NCT03083470|540340892|FG002|Overall Study|Lost to Follow-up|0|||
149786006|NCT03083470|540340893|FG003|Overall Study|Lost to Follow-up|0|||
149786007|NCT03083470|540340894|FG004|Overall Study|Lost to Follow-up|1|||
149786008|NCT03083470|540340890|FG000|Overall Study|Withdrawal by Subject|0|||
149786009|NCT03083470|540340891|FG001|Overall Study|Withdrawal by Subject|0|||
149786010|NCT03083470|540340892|FG002|Overall Study|Withdrawal by Subject|0|||
149786011|NCT03083470|540340893|FG003|Overall Study|Withdrawal by Subject|0|||
149786012|NCT03083470|540340894|FG004|Overall Study|Withdrawal by Subject|1|||
149786013|NCT00736450|540340895|FG000|Overall Study|Not ABC gene eligible|19|||
149786014|NCT00736450|540340895|FG000|Overall Study|Withdrawal by Subject|5|||
149786015|NCT00736450|540340895|FG000|Overall Study|Physician Decision|1|||
149786016|NCT01302691|540340898|FG000|Overall Study|Adverse Event|2|||
149786017|NCT01302691|540340899|FG001|Overall Study|Adverse Event|0|||
149786018|NCT01302691|540340898|FG000|Overall Study|Death|0|||
149786019|NCT01302691|540340899|FG001|Overall Study|Death|1|||
149786020|NCT01302691|540340898|FG000|Overall Study|Lost to Follow-up|1|||
149786021|NCT01302691|540340899|FG001|Overall Study|Lost to Follow-up|0|||
149786022|NCT01302691|540340898|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
149786023|NCT01302691|540340899|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
149786024|NCT01302691|540340898|FG000|Overall Study|Physician Decision|0|||
149786025|NCT01302691|540340899|FG001|Overall Study|Physician Decision|1|||
149786026|NCT01302691|540340898|FG000|Overall Study|Protocol Violation|1|||
149786027|NCT01302691|540340899|FG001|Overall Study|Protocol Violation|0|||
149786028|NCT03446612|540340900|FG000|Overall Study|Protocol defined stopping criteria|0|||
149786029|NCT03446612|540340901|FG001|Overall Study|Protocol defined stopping criteria|1|||
149786030|NCT03148795|540340914|FG000|Overall Study|Progressive Disease|1|||
149786031|NCT00398138|540340919|FG000|Overall Study|Adverse Event|2|||
149786032|NCT04973085|540340924|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
149786033|NCT04973085|540340925|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
149786034|NCT03924427|540340926|FG000|Overall Study|Adverse Event|4|||
149786035|NCT03924427|540340926|FG000|Overall Study|Lack of Efficacy|1|||
149786036|NCT03924427|540340926|FG000|Overall Study|Withdrawal by Subject|1|||
149786037|NCT01316380|540340934|FG000|Overall Study|Adverse Event|0|||
149786038|NCT01316380|540340935|FG001|Overall Study|Adverse Event|2|||
149786039|NCT01316380|540340936|FG002|Overall Study|Adverse Event|1|||
149786040|NCT01316380|540340934|FG000|Overall Study|Protocol Violation|0|||
149786041|NCT01316380|540340935|FG001|Overall Study|Protocol Violation|0|||
149786042|NCT01316380|540340936|FG002|Overall Study|Protocol Violation|1|||
149786043|NCT01316380|540340934|FG000|Overall Study|Withdrawal by Subject|1|||
149786044|NCT01316380|540340935|FG001|Overall Study|Withdrawal by Subject|2|||
149786045|NCT01316380|540340936|FG002|Overall Study|Withdrawal by Subject|0|||
149786046|NCT01316380|540340934|FG000|Overall Study|Other|0|||
149786047|NCT01316380|540340935|FG001|Overall Study|Other|1|||
149786048|NCT01316380|540340936|FG002|Overall Study|Other|1|||
149786049|NCT01316380|540340934|FG000|Overall Study|Not treated|1|||
149786050|NCT01316380|540340935|FG001|Overall Study|Not treated|0|||
149786051|NCT01316380|540340936|FG002|Overall Study|Not treated|0|||
149786052|NCT00149890|540340937|FG000|Overall Study|Adverse Event|1|||
149786053|NCT00149890|540340938|FG001|Overall Study|Adverse Event|8|||
149786054|NCT00149890|540340937|FG000|Overall Study|Lack of Efficacy|8|||
149786055|NCT00149890|540340938|FG001|Overall Study|Lack of Efficacy|9|||
149786056|NCT00149890|540340937|FG000|Overall Study|Protocol Violation|1|||
149786057|NCT00149890|540340938|FG001|Overall Study|Protocol Violation|0|||
149786058|NCT00149890|540340937|FG000|Overall Study|Lost to Follow-up|1|||
149786059|NCT00149890|540340938|FG001|Overall Study|Lost to Follow-up|0|||
149786060|NCT00149890|540340937|FG000|Overall Study|Graft Loss|2|||
149786061|NCT00149890|540340938|FG001|Overall Study|Graft Loss|1|||
149786062|NCT01387594|540340939|FG000|Overall Study|Withdrawal by Subject|0|||
149786063|NCT01387594|540340940|FG001|Overall Study|Withdrawal by Subject|2|||
149786064|NCT01387594|540340939|FG000|Overall Study|Lost to Follow-up|0|||
149786065|NCT01387594|540340940|FG001|Overall Study|Lost to Follow-up|1|||
149786066|NCT00712270|540340941|FG000|Overall Study|Withdrawal by Subject|11|||
149786067|NCT00712270|540340941|FG000|Overall Study|Screen Failure|3|||
149786068|NCT02574520|540340942|FG000|Overall Study|Not dosed|2|||
149786069|NCT02574520|540340943|FG001|Overall Study|Not dosed|0|||
149786070|NCT02574520|540340944|FG002|Overall Study|Not dosed|5|||
149786071|NCT02574520|540340945|FG003|Overall Study|Not dosed|4|||
149786072|NCT02574520|540340942|FG000|Overall Study|Adverse Event|0|||
149786073|NCT02574520|540340943|FG001|Overall Study|Adverse Event|0|||
149786074|NCT02574520|540340944|FG002|Overall Study|Adverse Event|0|||
149786075|NCT02574520|540340945|FG003|Overall Study|Adverse Event|1|||
149786076|NCT02574520|540340942|FG000|Overall Study|Withdrawal by Subject|0|||
149786077|NCT02574520|540340943|FG001|Overall Study|Withdrawal by Subject|0|||
149786078|NCT02574520|540340944|FG002|Overall Study|Withdrawal by Subject|0|||
149786079|NCT02574520|540340945|FG003|Overall Study|Withdrawal by Subject|1|||
149786080|NCT02574520|540340942|FG000|Overall Study|Other|0|||
149786081|NCT02574520|540340943|FG001|Overall Study|Other|0|||
149786082|NCT02574520|540340944|FG002|Overall Study|Other|0|||
149786083|NCT02574520|540340945|FG003|Overall Study|Other|2|||
149786084|NCT01365091|540340954|FG000|Period 1|Adverse Event|1|||
149786085|NCT01365091|540340955|FG001|Period 1|Adverse Event|0|||
149786086|NCT01365091|540340956|FG002|Period 1|Adverse Event|2|||
149786087|NCT01365091|540340957|FG003|Period 1|Adverse Event|3|||
149786088|NCT01365091|540340954|FG000|Period 1|Positive test result for drugs of abuse|1|||
149786089|NCT01365091|540340955|FG001|Period 1|Positive test result for drugs of abuse|0|||
149786090|NCT01365091|540340956|FG002|Period 1|Positive test result for drugs of abuse|0|||
149786091|NCT01365091|540340957|FG003|Period 1|Positive test result for drugs of abuse|0|||
149786092|NCT01365091|540340954|FG000|Period 1|No longer met study criteria|0|||
149786093|NCT01365091|540340955|FG001|Period 1|No longer met study criteria|1|||
149786094|NCT01365091|540340956|FG002|Period 1|No longer met study criteria|0|||
149786095|NCT01365091|540340957|FG003|Period 1|No longer met study criteria|0|||
149786096|NCT01365091|540340954|FG000|Period 1|Withdrawal by Subject|0|||
149786097|NCT01365091|540340955|FG001|Period 1|Withdrawal by Subject|1|||
149786098|NCT01365091|540340956|FG002|Period 1|Withdrawal by Subject|0|||
149786099|NCT01365091|540340957|FG003|Period 1|Withdrawal by Subject|0|||
149786100|NCT01365091|540340954|FG000|Period 1|Personal reasons|0|||
149786101|NCT01365091|540340955|FG001|Period 1|Personal reasons|0|||
149786102|NCT01365091|540340956|FG002|Period 1|Personal reasons|1|||
149786103|NCT01365091|540340957|FG003|Period 1|Personal reasons|0|||
149786104|NCT01365091|540340954|FG000|Period 2|Withdrawal by Subject|1|||
149786105|NCT01365091|540340955|FG001|Period 2|Withdrawal by Subject|0|||
149786106|NCT01365091|540340956|FG002|Period 2|Withdrawal by Subject|0|||
149786107|NCT01365091|540340957|FG003|Period 2|Withdrawal by Subject|0|||
149786108|NCT01365091|540340954|FG000|Period 2|Adverse Event|0|||
149786109|NCT01365091|540340955|FG001|Period 2|Adverse Event|0|||
149786110|NCT01365091|540340956|FG002|Period 2|Adverse Event|1|||
149786111|NCT01365091|540340957|FG003|Period 2|Adverse Event|0|||
149786112|NCT05116683|540340958|FG000|Overall Study|Physician Decision|4|||
149786113|NCT01435122|540340959|FG000|Overall Study|Early withdrawal due to toxicity|8|||
149786114|NCT03878160|540342583|FG000|Overall Study|Lost to Follow-up|1|||
149786115|NCT03878160|540342584|FG001|Overall Study|Lost to Follow-up|1|||
149786116|NCT03878160|540342585|FG002|Overall Study|Lost to Follow-up|1|||
149786117|NCT03878160|540342583|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
149786118|NCT03878160|540342584|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
149786119|NCT03878160|540342585|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
149786120|NCT03887052|540342589|FG000|Overall Study|Adverse Event|2|||
149786121|NCT03887052|540342589|FG000|Overall Study|Physician Decision|2|||
149786122|NCT03887052|540342589|FG000|Overall Study|Withdrawal by Subject|3|||
149786123|NCT03887052|540342589|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
149786124|NCT03887052|540342589|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
149786125|NCT02365506|540342590|FG000|Overall Study|Investigator's Discretion|0|||
149786126|NCT02365506|540342591|FG001|Overall Study|Investigator's Discretion|0|||
149786127|NCT02365506|540342592|FG002|Overall Study|Investigator's Discretion|1|||
149786128|NCT05505734|540342593|FG000|Overall Study|Withdrawal by Subject|51|||
149786129|NCT05505734|540342594|FG001|Overall Study|Withdrawal by Subject|64|||
149786130|NCT05505734|540342593|FG000|Overall Study|Adverse Event|6|||
149786131|NCT05505734|540342594|FG001|Overall Study|Adverse Event|20|||
149786132|NCT05505734|540342593|FG000|Overall Study|Protocol Violation|8|||
149786133|NCT05505734|540342594|FG001|Overall Study|Protocol Violation|15|||
149786134|NCT05505734|540342593|FG000|Overall Study|Lack of therapeutic response|0|||
149786135|NCT05505734|540342594|FG001|Overall Study|Lack of therapeutic response|1|||
149786136|NCT05505734|540342593|FG000|Overall Study|Lost to Follow-up|247|||
149786137|NCT05505734|540342594|FG001|Overall Study|Lost to Follow-up|237|||
149786138|NCT05505734|540342593|FG000|Overall Study|Physician Decision|22|||
149786139|NCT05505734|540342594|FG001|Overall Study|Physician Decision|13|||
149786140|NCT05505734|540342593|FG000|Overall Study|Death|2|||
149786141|NCT05505734|540342594|FG001|Overall Study|Death|1|||
149786142|NCT05505734|540342593|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149786143|NCT05505734|540342594|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149786144|NCT05505734|540342593|FG000|Overall Study|Pregnancy|1|||
149786145|NCT05505734|540342594|FG001|Overall Study|Pregnancy|0|||
149786146|NCT05505734|540342593|FG000|Overall Study|Other|17|||
149786147|NCT05505734|540342594|FG001|Overall Study|Other|13|||
149786148|NCT03575351|540342595|FG000|Overall Study|Adverse Event|1|||
149786149|NCT03575351|540342596|FG001|Overall Study|Adverse Event|0|||
149786150|NCT03575351|540342595|FG000|Overall Study|Death|2|||
149786151|NCT03575351|540342596|FG001|Overall Study|Death|2|||
149786152|NCT03575351|540342595|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
149786153|NCT03575351|540342596|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
149786154|NCT03575351|540342595|FG000|Overall Study|Lack of Efficacy|28|||
149786155|NCT03575351|540342596|FG001|Overall Study|Lack of Efficacy|0|||
149786156|NCT03575351|540342595|FG000|Overall Study|Withdrawal by Subject|1|||
149786157|NCT03575351|540342596|FG001|Overall Study|Withdrawal by Subject|1|||
149786158|NCT03575351|540342595|FG000|Overall Study|Physician Decision|3|||
149786159|NCT03575351|540342596|FG001|Overall Study|Physician Decision|0|||
149786160|NCT03575351|540342595|FG000|Overall Study|Disease relapse|15|||
149786161|NCT03575351|540342596|FG001|Overall Study|Disease relapse|6|||
149786162|NCT03575351|540342595|FG000|Overall Study|Study drug manufacturing failure|0|||
149786163|NCT03575351|540342596|FG001|Overall Study|Study drug manufacturing failure|1|||
149786164|NCT03575351|540342595|FG000|Overall Study|other reasons|5|||
149786165|NCT03575351|540342596|FG001|Overall Study|other reasons|0|||
149786166|NCT01688999|540342599|FG000|Overall Study|Withdrawal by Subject|5|||
149786167|NCT01688999|540342600|FG001|Overall Study|Withdrawal by Subject|1|||
149786168|NCT01688999|540342601|FG002|Overall Study|Withdrawal by Subject|1|||
149786169|NCT01688999|540342599|FG000|Overall Study|Adverse Event|2|||
149786170|NCT01688999|540342600|FG001|Overall Study|Adverse Event|0|||
149786171|NCT01688999|540342601|FG002|Overall Study|Adverse Event|2|||
149786172|NCT01688999|540342599|FG000|Overall Study|Ineligible/Not treated|1|||
149786173|NCT01688999|540342600|FG001|Overall Study|Ineligible/Not treated|0|||
149786174|NCT01688999|540342601|FG002|Overall Study|Ineligible/Not treated|0|||
149786175|NCT02768103|540342602|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
149786176|NCT03748420|540342606|FG000|Overall Study|No 12 month medication adherence data available|0|||
149786177|NCT03748420|540342607|FG001|Overall Study|No 12 month medication adherence data available|1|||
149786178|NCT03748420|540342606|FG000|Overall Study|Death|24|||
149786179|NCT03748420|540342607|FG001|Overall Study|Death|28|||
149786180|NCT03748420|540342606|FG000|Overall Study|Lost to Follow-up|231|||
149786181|NCT03748420|540342607|FG001|Overall Study|Lost to Follow-up|230|||
149786182|NCT01263444|540342608|FG000|Overall Study|Adverse Event|8|||
149786183|NCT01263444|540342608|FG000|Overall Study|Withdrawal by Subject|1|||
149786184|NCT01263444|540342608|FG000|Overall Study|Protocol Violation|1|||
149786185|NCT01899768|540342610|FG000|Part A|Adverse Event|2|||
149786186|NCT01899768|540342610|FG000|Part A|Withdrawal by Subject|1|||
149786187|NCT01899768|540342610|FG000|Part B|Adverse Event|1|||
149786188|NCT01899768|540342610|FG000|Part B|Withdrawal by Subject|1|||
149786189|NCT04043416|540342611|FG000|Washout|Change in health condition|0|||
149786190|NCT04043416|540342612|FG001|Washout|Change in health condition|1|||
149786191|NCT00372489|540342614|FG000|Overall Study|Adverse Event|18|||
149786192|NCT00372489|540342614|FG000|Overall Study|Lack of Efficacy|1|||
149786193|NCT00372489|540342614|FG000|Overall Study|Lost to Follow-up|3|||
149786194|NCT00372489|540342614|FG000|Overall Study|Physician Decision|3|||
149786195|NCT00372489|540342614|FG000|Overall Study|Withdrawal by Subject|5|||
149786196|NCT00372489|540342614|FG000|Overall Study|Patient Relocation|2|||
149786197|NCT00372489|540342614|FG000|Overall Study|Renal transplant|6|||
149786198|NCT00372489|540342614|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
149786199|NCT03733249|540342615|FG000|Overall Study|Death|7|||
149786200|NCT03733249|540342615|FG000|Overall Study|Disease relapse|16|||
149786201|NCT03733249|540342615|FG000|Overall Study|Lost to Follow-up|4|||
149786202|NCT03733249|540342615|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
149786203|NCT03733249|540342615|FG000|Overall Study|Withdrawal by Subject|1|||
149786204|NCT04476108|540342616|FG000|Overall Study|Adverse Event|4|||
149786205|NCT04476108|540342617|FG001|Overall Study|Adverse Event|1|||
149786206|NCT04476108|540342616|FG000|Overall Study|Lost to Follow-up|1|||
149786207|NCT04476108|540342617|FG001|Overall Study|Lost to Follow-up|0|||
149786208|NCT04476108|540342616|FG000|Overall Study|Inadvertent Enrollment|1|||
149786209|NCT04476108|540342617|FG001|Overall Study|Inadvertent Enrollment|0|||
149786210|NCT04476108|540342616|FG000|Overall Study|Protocol Violation|1|||
149786211|NCT04476108|540342617|FG001|Overall Study|Protocol Violation|1|||
149786212|NCT04476108|540342616|FG000|Overall Study|Withdrawal by Subject|1|||
149786213|NCT04476108|540342617|FG001|Overall Study|Withdrawal by Subject|1|||
149786214|NCT00850135|540342618|FG000|Overall Study|Physician Decision|1|||
149786215|NCT02253992|540342619|FG000|Overall Study|Study drug toxicity|1|||
149786216|NCT02253992|540342620|FG001|Overall Study|Study drug toxicity|0|||
149786217|NCT02253992|540342621|FG002|Overall Study|Study drug toxicity|10|||
149786218|NCT02253992|540342619|FG000|Overall Study|Disease progression|4|||
149786219|NCT02253992|540342620|FG001|Overall Study|Disease progression|3|||
149786220|NCT02253992|540342621|FG002|Overall Study|Disease progression|98|||
149786221|NCT02253992|540342619|FG000|Overall Study|Withdrawal by Subject|0|||
149786222|NCT02253992|540342620|FG001|Overall Study|Withdrawal by Subject|0|||
149786223|NCT02253992|540342621|FG002|Overall Study|Withdrawal by Subject|3|||
149786224|NCT02253992|540342619|FG000|Overall Study|Adverse Event|0|||
149786225|NCT02253992|540342620|FG001|Overall Study|Adverse Event|0|||
149786226|NCT02253992|540342621|FG002|Overall Study|Adverse Event|8|||
149786227|NCT02253992|540342619|FG000|Overall Study|Death|0|||
149786228|NCT02253992|540342620|FG001|Overall Study|Death|0|||
149786229|NCT02253992|540342621|FG002|Overall Study|Death|1|||
149786230|NCT02253992|540342619|FG000|Overall Study|Subject discontinued study drug|1|||
149786231|NCT02253992|540342620|FG001|Overall Study|Subject discontinued study drug|0|||
149786232|NCT02253992|540342621|FG002|Overall Study|Subject discontinued study drug|1|||
149786233|NCT02253992|540342619|FG000|Overall Study|Completed treatment as per protocol|0|||
149786234|NCT02253992|540342620|FG001|Overall Study|Completed treatment as per protocol|1|||
149786235|NCT02253992|540342621|FG002|Overall Study|Completed treatment as per protocol|22|||
149786236|NCT02253992|540342619|FG000|Overall Study|Other|0|||
149786237|NCT02253992|540342620|FG001|Overall Study|Other|0|||
149786238|NCT02253992|540342621|FG002|Overall Study|Other|1|||
149786239|NCT00772889|540342623|FG000|Overall Study|Adverse Event|7|||
149786240|NCT00772889|540342624|FG001|Overall Study|Adverse Event|4|||
149786241|NCT00772889|540342625|FG002|Overall Study|Adverse Event|0|||
149786242|NCT00772889|540342623|FG000|Overall Study|Withdrawal by Subject|9|||
149786243|NCT00772889|540342624|FG001|Overall Study|Withdrawal by Subject|8|||
149786244|NCT00772889|540342625|FG002|Overall Study|Withdrawal by Subject|9|||
149786245|NCT00772889|540342623|FG000|Overall Study|Lost to Follow-up|6|||
149786246|NCT00772889|540342624|FG001|Overall Study|Lost to Follow-up|6|||
149786247|NCT00772889|540342625|FG002|Overall Study|Lost to Follow-up|7|||
149786248|NCT03323086|540342626|FG000|Overall Study|Lost to Follow-up|3|||
149786249|NCT03323086|540342627|FG001|Overall Study|Lost to Follow-up|2|||
149786250|NCT00355615|540342630|FG000|Randomized Double Blind Period|Adverse Event|1|||
149786251|NCT00355615|540342631|FG001|Randomized Double Blind Period|Adverse Event|0|||
149786252|NCT00355615|540342632|FG002|Randomized Double Blind Period|Adverse Event|0|||
149786253|NCT00355615|540342633|FG003|Randomized Double Blind Period|Adverse Event|0|||
149786254|NCT00355615|540342634|FG004|Randomized Double Blind Period|Adverse Event|0|||
149786255|NCT00355615|540342630|FG000|Randomized Double Blind Period|Protocol Violation|0|||
149786256|NCT00355615|540342631|FG001|Randomized Double Blind Period|Protocol Violation|0|||
149786257|NCT00355615|540342632|FG002|Randomized Double Blind Period|Protocol Violation|1|||
149786258|NCT00355615|540342633|FG003|Randomized Double Blind Period|Protocol Violation|1|||
149786259|NCT00355615|540342634|FG004|Randomized Double Blind Period|Protocol Violation|0|||
149786260|NCT00355615|540342630|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149786261|NCT00355615|540342631|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149786262|NCT00355615|540342632|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149786263|NCT00355615|540342633|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149786264|NCT00355615|540342634|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
149786265|NCT00355615|540342630|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149786266|NCT00355615|540342631|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149786267|NCT00355615|540342632|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149786268|NCT00355615|540342633|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149786269|NCT00355615|540342634|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
149786270|NCT00355615|540342630|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149786271|NCT00355615|540342631|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149786272|NCT00355615|540342632|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149786273|NCT00355615|540342633|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149786274|NCT00355615|540342634|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
149786275|NCT00355615|540342630|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149786276|NCT00355615|540342631|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149786277|NCT00355615|540342632|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149786278|NCT00355615|540342633|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149786279|NCT00355615|540342634|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
149786280|NCT00085644|540342644|FG000|Double-Blind Period|Adverse Event|5|||
149786281|NCT00085644|540342645|FG001|Double-Blind Period|Adverse Event|2|||
149786282|NCT00085644|540342646|FG002|Double-Blind Period|Adverse Event|0|||
149786283|NCT00085644|540342644|FG000|Double-Blind Period|Withdrawal by Subject|3|||
149786284|NCT00085644|540342645|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149786285|NCT00085644|540342646|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149786286|NCT00085644|540342644|FG000|Double-Blind Period|Lost to Follow-up|2|||
149786287|NCT00085644|540342645|FG001|Double-Blind Period|Lost to Follow-up|1|||
149786288|NCT00085644|540342646|FG002|Double-Blind Period|Lost to Follow-up|0|||
149786289|NCT00085644|540342644|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
149786290|NCT00085644|540342645|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
149786291|NCT00085644|540342646|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
149786292|NCT00085644|540342644|FG000|Double-Blind Period|Contemplating pregnancy|1|||
149786293|NCT00085644|540342645|FG001|Double-Blind Period|Contemplating pregnancy|0|||
149786294|NCT00085644|540342646|FG002|Double-Blind Period|Contemplating pregnancy|0|||
149786295|NCT00085644|540342644|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
149786296|NCT00085644|540342645|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
149786297|NCT00085644|540342646|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
149786298|NCT00085644|540342644|FG000|Open-Label Period|Adverse Event|0|||
149786299|NCT00085644|540342645|FG001|Open-Label Period|Adverse Event|0|||
149786300|NCT00085644|540342646|FG002|Open-Label Period|Adverse Event|38|||
149786301|NCT00085644|540342644|FG000|Open-Label Period|Withdrawal by Subject|0|||
149786302|NCT00085644|540342645|FG001|Open-Label Period|Withdrawal by Subject|0|||
149786303|NCT00085644|540342646|FG002|Open-Label Period|Withdrawal by Subject|29|||
149786304|NCT00085644|540342644|FG000|Open-Label Period|Lost to Follow-up|0|||
149786305|NCT00085644|540342645|FG001|Open-Label Period|Lost to Follow-up|0|||
149786306|NCT00085644|540342646|FG002|Open-Label Period|Lost to Follow-up|13|||
149786307|NCT00085644|540342644|FG000|Open-Label Period|Lack of Efficacy|0|||
149786308|NCT00085644|540342645|FG001|Open-Label Period|Lack of Efficacy|0|||
149786309|NCT00085644|540342646|FG002|Open-Label Period|Lack of Efficacy|15|||
149786310|NCT00085644|540342644|FG000|Open-Label Period|Pregnancy|0|||
149786311|NCT00085644|540342645|FG001|Open-Label Period|Pregnancy|0|||
149786312|NCT00085644|540342646|FG002|Open-Label Period|Pregnancy|3|||
149786313|NCT00085644|540342644|FG000|Open-Label Period|Contemplating pregnancy|0|||
149786314|NCT00085644|540342645|FG001|Open-Label Period|Contemplating pregnancy|0|||
149786315|NCT00085644|540342646|FG002|Open-Label Period|Contemplating pregnancy|3|||
149786316|NCT00085644|540342644|FG000|Open-Label Period|Protocol Violation|0|||
149786317|NCT00085644|540342645|FG001|Open-Label Period|Protocol Violation|0|||
149786318|NCT00085644|540342646|FG002|Open-Label Period|Protocol Violation|4|||
149786319|NCT00085644|540342644|FG000|Open-Label Period|Personal reason|0|||
149786320|NCT00085644|540342645|FG001|Open-Label Period|Personal reason|0|||
149786321|NCT00085644|540342646|FG002|Open-Label Period|Personal reason|4|||
149786322|NCT04259346|540342647|FG000|Overall Study|Lost to Follow-up|1|||
149786323|NCT04259346|540342648|FG001|Overall Study|Lost to Follow-up|3|||
149786324|NCT04259346|540342647|FG000|Overall Study|Protocol Violation|1|||
149786325|NCT04259346|540342648|FG001|Overall Study|Protocol Violation|0|||
149786326|NCT04259346|540342647|FG000|Overall Study|Withdrawal by Subject|1|||
149786327|NCT04259346|540342648|FG001|Overall Study|Withdrawal by Subject|0|||
149786328|NCT04259346|540342647|FG000|Overall Study|Adverse Event|1|||
149786329|NCT04259346|540342648|FG001|Overall Study|Adverse Event|1|||
149786330|NCT03330106|540342649|FG000|Part A|Withdrawal by Subject|1|||
149786331|NCT03330106|540342650|FG001|Part A|Withdrawal by Subject|1|||
149786332|NCT03330106|540342651|FG002|Part A|Withdrawal by Subject|0|||
149786333|NCT03330106|540342652|FG003|Part A|Withdrawal by Subject|0|||
149786334|NCT03330106|540342649|FG000|Part A|Death|2|||
149786335|NCT03330106|540342650|FG001|Part A|Death|1|||
149786336|NCT03330106|540342651|FG002|Part A|Death|0|||
149786337|NCT03330106|540342652|FG003|Part A|Death|0|||
149786338|NCT03330106|540342649|FG000|Part A|Adverse Event|0|||
149786339|NCT03330106|540342650|FG001|Part A|Adverse Event|1|||
149786340|NCT03330106|540342651|FG002|Part A|Adverse Event|0|||
149786341|NCT03330106|540342652|FG003|Part A|Adverse Event|0|||
149786342|NCT03330106|540342649|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149786343|NCT03330106|540342650|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
149786344|NCT03330106|540342651|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149786345|NCT03330106|540342652|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149786346|NCT03330106|540342649|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
149786347|NCT03330106|540342650|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149786348|NCT03330106|540342651|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149786349|NCT03330106|540342652|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149786350|NCT03330106|540342649|FG000|Part A|Progressive Disease|0|||
149786351|NCT03330106|540342650|FG001|Part A|Progressive Disease|1|||
149786352|NCT03330106|540342651|FG002|Part A|Progressive Disease|0|||
149786353|NCT03330106|540342652|FG003|Part A|Progressive Disease|0|||
149786354|NCT03330106|540342649|FG000|Part B|Lost to Follow-up|0|||
149786355|NCT03330106|540342650|FG001|Part B|Lost to Follow-up|0|||
149786356|NCT03330106|540342651|FG002|Part B|Lost to Follow-up|0|||
149786357|NCT03330106|540342652|FG003|Part B|Lost to Follow-up|1|||
149786358|NCT03330106|540342649|FG000|Part B|Withdrawal by Subject|0|||
149786359|NCT03330106|540342650|FG001|Part B|Withdrawal by Subject|0|||
149786360|NCT03330106|540342651|FG002|Part B|Withdrawal by Subject|4|||
149786361|NCT03330106|540342652|FG003|Part B|Withdrawal by Subject|0|||
149786362|NCT03330106|540342649|FG000|Part B|Death|0|||
149786363|NCT03330106|540342650|FG001|Part B|Death|0|||
149786364|NCT03330106|540342651|FG002|Part B|Death|2|||
149786365|NCT03330106|540342652|FG003|Part B|Death|0|||
149786366|NCT03330106|540342649|FG000|Part B|Clinical Progression|0|||
149786367|NCT03330106|540342650|FG001|Part B|Clinical Progression|0|||
149786368|NCT03330106|540342651|FG002|Part B|Clinical Progression|1|||
149786369|NCT03330106|540342652|FG003|Part B|Clinical Progression|1|||
149786370|NCT03330106|540342649|FG000|Part B|Symptomatic Deterioration|0|||
149786371|NCT03330106|540342650|FG001|Part B|Symptomatic Deterioration|0|||
149786372|NCT03330106|540342651|FG002|Part B|Symptomatic Deterioration|0|||
149786373|NCT03330106|540342652|FG003|Part B|Symptomatic Deterioration|1|||
149786374|NCT03330106|540342649|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149786375|NCT03330106|540342650|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149786376|NCT03330106|540342651|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149786377|NCT03330106|540342652|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
149786378|NCT03330106|540342649|FG000|Part B|Progressive Disease|0|||
149786379|NCT03330106|540342650|FG001|Part B|Progressive Disease|0|||
149786380|NCT03330106|540342651|FG002|Part B|Progressive Disease|11|||
149786381|NCT03330106|540342652|FG003|Part B|Progressive Disease|4|||
149786382|NCT00623766|540342655|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
149786383|NCT00623766|540342656|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
149786384|NCT00623766|540342655|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
149786385|NCT00623766|540342656|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
149786386|NCT00623766|540342655|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
149786387|NCT00623766|540342656|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
149786388|NCT00623766|540342655|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
149786389|NCT00623766|540342656|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
149786390|NCT00623766|540342655|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
149786391|NCT00623766|540342656|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
149786392|NCT00486889|540342657|FG000|Overall Study|Death|3|||
149786393|NCT00486889|540342657|FG000|Overall Study|Non-compliant|2|||
149786394|NCT00486889|540342657|FG000|Overall Study|Withdrawal by Subject|6|||
149786395|NCT00893763|540342658|FG000|Overall Study|extubated|110|||
149786396|NCT00893763|540342659|FG001|Overall Study|extubated|110|||
149786397|NCT00796549|540342660|FG000|Overall Study|Adverse Event|11|||
149786398|NCT00796549|540342660|FG000|Overall Study|not entered|149|||
149786399|NCT00796549|540342660|FG000|Overall Study|Other|2|||
149786400|NCT00796549|540342660|FG000|Overall Study|Progressive disease|56|||
149786401|NCT00606229|540342663|FG000|Overall Study|Adverse Event|11|||
149786402|NCT00606229|540342663|FG000|Overall Study|Lack of Efficacy|1|||
149786403|NCT00606229|540342663|FG000|Overall Study|Withdrawal by Subject|4|||
149786404|NCT00606229|540342663|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
149786405|NCT00606229|540342663|FG000|Overall Study|change of residence or other commitments|2|||
149786406|NCT03523715|540342664|FG000|Overall Study|Lost to Follow-up|11|||
149786407|NCT03523715|540342665|FG001|Overall Study|Lost to Follow-up|14|||
149786408|NCT03523715|540342664|FG000|Overall Study|Did not meet inclusion criteria|1|||
149786409|NCT03523715|540342665|FG001|Overall Study|Did not meet inclusion criteria|0|||
149786410|NCT03523715|540342664|FG000|Overall Study|Internally inconsistent reporting|0|||
149786411|NCT03523715|540342665|FG001|Overall Study|Internally inconsistent reporting|2|||
149786412|NCT02139280|540342666|FG000|Overall Study|No longer eligible|2|||
149786413|NCT02139280|540342667|FG001|Overall Study|No longer eligible|0|||
149786414|NCT01678560|540342668|FG000|Overall Study|Physician Decision|4|||
149786415|NCT01678560|540342669|FG001|Overall Study|Physician Decision|4|||
149786416|NCT01678560|540342668|FG000|Overall Study|Death|0|||
149786417|NCT01678560|540342669|FG001|Overall Study|Death|1|||
149786418|NCT01678560|540342668|FG000|Overall Study|Withdrawal by Subject|0|||
149786419|NCT01678560|540342669|FG001|Overall Study|Withdrawal by Subject|1|||
149786420|NCT02201472|540342670|FG000|Overall Study|Lack of Efficacy|2|||
149786421|NCT00117572|540342671|FG000|Overall Study|Site withdrew before starting treatment|2|||
149786422|NCT00117572|540342672|FG001|Overall Study|Site withdrew before starting treatment|3|||
149786423|NCT00117572|540342671|FG000|Overall Study|Withdrawal by Subject|3|||
149786424|NCT00117572|540342672|FG001|Overall Study|Withdrawal by Subject|3|||
149786425|NCT00117572|540342671|FG000|Overall Study|Protocol Violation|1|||
149786426|NCT00117572|540342672|FG001|Overall Study|Protocol Violation|0|||
149786427|NCT01188811|540342675|FG000|Overall Study|Withdrawal by Subject|0|||
149786428|NCT01188811|540342676|FG001|Overall Study|Withdrawal by Subject|2|||
149786429|NCT01188811|540342675|FG000|Overall Study|Adverse Event|6|||
149786430|NCT01188811|540342676|FG001|Overall Study|Adverse Event|0|||
149786431|NCT00090766|540342677|FG000|Overall Study|Nephrectomy Planned|0|||
149786432|NCT00090766|540342678|FG001|Overall Study|Nephrectomy Planned|0|||
149786433|NCT00090766|540342679|FG002|Overall Study|Nephrectomy Planned|1|||
149786434|NCT00090766|540342677|FG000|Overall Study|Death|1|||
149786435|NCT00090766|540342678|FG001|Overall Study|Death|0|||
149786436|NCT00090766|540342679|FG002|Overall Study|Death|0|||
149786437|NCT00090766|540342677|FG000|Overall Study|Admin|0|||
149786438|NCT00090766|540342678|FG001|Overall Study|Admin|2|||
149786439|NCT00090766|540342679|FG002|Overall Study|Admin|0|||
149786440|NCT00090766|540342677|FG000|Overall Study|Lost to Follow-up|2|||
149786441|NCT00090766|540342678|FG001|Overall Study|Lost to Follow-up|0|||
149786442|NCT00090766|540342679|FG002|Overall Study|Lost to Follow-up|2|||
149786443|NCT01602744|540342680|FG000|Overall Study|Death|17|||
149786444|NCT01602744|540342681|FG001|Overall Study|Death|15|||
149786445|NCT01602744|540342680|FG000|Overall Study|Lost to Follow-up|13|||
149786446|NCT01602744|540342681|FG001|Overall Study|Lost to Follow-up|8|||
149786447|NCT00654368|540342682|FG000|Overall Study|Ineligibility determined|6|||
149786448|NCT00654368|540342683|FG001|Overall Study|Ineligibility determined|0|||
149786449|NCT00654368|540342684|FG002|Overall Study|Ineligibility determined|0|||
149786450|NCT00654368|540342682|FG000|Overall Study|Protocol deviation|3|||
149786451|NCT00654368|540342683|FG001|Overall Study|Protocol deviation|2|||
149786452|NCT00654368|540342684|FG002|Overall Study|Protocol deviation|1|||
149786453|NCT00654368|540342682|FG000|Overall Study|Non-compliance|2|||
149786454|NCT00654368|540342683|FG001|Overall Study|Non-compliance|1|||
149786455|NCT00654368|540342684|FG002|Overall Study|Non-compliance|2|||
149786456|NCT00654368|540342682|FG000|Overall Study|Withdrawal by Subject|5|||
149786457|NCT00654368|540342683|FG001|Overall Study|Withdrawal by Subject|2|||
149786458|NCT00654368|540342684|FG002|Overall Study|Withdrawal by Subject|2|||
149786459|NCT00654368|540342682|FG000|Overall Study|Disease progression|21|||
149786460|NCT00654368|540342683|FG001|Overall Study|Disease progression|31|||
149786461|NCT00654368|540342684|FG002|Overall Study|Disease progression|13|||
149786462|NCT00654368|540342682|FG000|Overall Study|Requirement for alternative therapy|1|||
149786463|NCT00654368|540342683|FG001|Overall Study|Requirement for alternative therapy|1|||
149786464|NCT00654368|540342684|FG002|Overall Study|Requirement for alternative therapy|1|||
149786465|NCT00654368|540342682|FG000|Overall Study|Physician Decision|0|||
149786466|NCT00654368|540342683|FG001|Overall Study|Physician Decision|0|||
149786467|NCT00654368|540342684|FG002|Overall Study|Physician Decision|2|||
149786468|NCT00654368|540342682|FG000|Overall Study|Death|1|||
149786469|NCT00654368|540342683|FG001|Overall Study|Death|0|||
149786470|NCT00654368|540342684|FG002|Overall Study|Death|0|||
149786471|NCT00654368|540342682|FG000|Overall Study|Pregnancy|0|||
149786472|NCT00654368|540342683|FG001|Overall Study|Pregnancy|0|||
149786473|NCT00654368|540342684|FG002|Overall Study|Pregnancy|2|||
149786474|NCT00654368|540342682|FG000|Overall Study|Other|0|||
149786475|NCT00654368|540342683|FG001|Overall Study|Other|2|||
149786476|NCT00654368|540342684|FG002|Overall Study|Other|3|||
149786477|NCT00654368|540342682|FG000|Overall Study|Adverse Event|14|||
149786478|NCT00654368|540342683|FG001|Overall Study|Adverse Event|9|||
149786479|NCT00654368|540342684|FG002|Overall Study|Adverse Event|6|||
149786480|NCT04228445|540342688|FG000|Overall Study|Lost to Follow-up|1|||
149786481|NCT04228445|540342689|FG001|Overall Study|Lost to Follow-up|1|||
149786482|NCT04228445|540342688|FG000|Overall Study|Physician Decision|1|||
149786483|NCT04228445|540342689|FG001|Overall Study|Physician Decision|2|||
149786484|NCT04228445|540342688|FG000|Overall Study|Withdrawal by Subject|0|||
149786485|NCT04228445|540342689|FG001|Overall Study|Withdrawal by Subject|1|||
149786486|NCT04228445|540342688|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
149786487|NCT04228445|540342689|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
149786488|NCT00606294|540342690|FG000|Overall Study|Withdrawal by Subject|36|||
149786489|NCT00606294|540342691|FG001|Overall Study|Withdrawal by Subject|0|||
149786490|NCT03418376|540342692|FG000|Overall Study|Musculoskeletal injury|1|||
149786491|NCT03418376|540342693|FG001|Overall Study|Musculoskeletal injury|2|||
149786492|NCT03418376|540342694|FG002|Overall Study|Musculoskeletal injury|1|||
149786493|NCT03418376|540342695|FG003|Overall Study|Musculoskeletal injury|0|||
149786494|NCT03418376|540342692|FG000|Overall Study|Personal reasons|0|||
149786495|NCT03418376|540342693|FG001|Overall Study|Personal reasons|2|||
149786496|NCT03418376|540342694|FG002|Overall Study|Personal reasons|2|||
149786497|NCT03418376|540342695|FG003|Overall Study|Personal reasons|1|||
149786498|NCT03418376|540342692|FG000|Overall Study|Exacerbation|0|||
149786499|NCT03418376|540342693|FG001|Overall Study|Exacerbation|1|||
149786500|NCT03418376|540342694|FG002|Overall Study|Exacerbation|0|||
149786501|NCT03418376|540342695|FG003|Overall Study|Exacerbation|0|||
149786502|NCT02774291|540342696|FG000|Overall Study|Lost to Follow-up|1|||
149786503|NCT00471315|540342697|FG000|Overall Study|Adverse Event|7|||
149786504|NCT00471315|540342697|FG000|Overall Study|Withdrawal by Subject|1|||
149786505|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
149786506|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
149786507|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149786508|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149786509|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149786510|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
149786511|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
149786512|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149786513|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149786514|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149786515|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
149786516|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
149786517|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149786518|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149786519|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149786520|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149786521|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
149786522|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149786523|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149786524|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149786525|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
149786526|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149786527|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149786528|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149786529|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149786530|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149786531|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
149786532|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149786533|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149786534|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149801792|NCT04338685|540402438|FG000|Overall Study|Study terminated by Sponsor|0|||
149786535|NCT04757376|540342703|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
149786536|NCT04757376|540342704|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
149786537|NCT04757376|540342705|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149786538|NCT04757376|540342706|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149786539|NCT04757376|540342707|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149786540|NCT04757376|540342703|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149786541|NCT04757376|540342704|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149786542|NCT04757376|540342705|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
149786543|NCT04757376|540342706|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149786544|NCT04757376|540342707|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149786545|NCT00609167|540342708|FG000|Overall Study|Withdrawal by Subject|1|||
149786546|NCT00609167|540342709|FG001|Overall Study|Withdrawal by Subject|0|||
149786547|NCT00609167|540342708|FG000|Overall Study|Lack of Efficacy|1|||
149786548|NCT00609167|540342709|FG001|Overall Study|Lack of Efficacy|0|||
149786549|NCT00609167|540342708|FG000|Overall Study|Adverse Event|5|||
149786550|NCT00609167|540342709|FG001|Overall Study|Adverse Event|1|||
149786551|NCT00609167|540342708|FG000|Overall Study|Disease Progression|1|||
149786552|NCT00609167|540342709|FG001|Overall Study|Disease Progression|0|||
149786553|NCT00609167|540342708|FG000|Overall Study|Stem Cell Transplant|0|||
149786554|NCT00609167|540342709|FG001|Overall Study|Stem Cell Transplant|6|||
149786555|NCT01307046|540342710|FG000|Overall Study|Adverse Event|3|||
149786556|NCT01307046|540342711|FG001|Overall Study|Adverse Event|3|||
149786557|NCT01307046|540342710|FG000|Overall Study|Lack of Efficacy|0|||
149786558|NCT01307046|540342711|FG001|Overall Study|Lack of Efficacy|2|||
149786559|NCT01307046|540342710|FG000|Overall Study|Physician Decision|2|||
149786560|NCT01307046|540342711|FG001|Overall Study|Physician Decision|0|||
149786561|NCT01307046|540342710|FG000|Overall Study|Withdrawal by Subject|1|||
149786562|NCT01307046|540342711|FG001|Overall Study|Withdrawal by Subject|1|||
149786563|NCT01307046|540342710|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
149786564|NCT01307046|540342711|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
149786565|NCT01307046|540342710|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
149786566|NCT01307046|540342711|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
149786567|NCT03898323|540342712|FG000|Overall Study|Physician Decision|1|||
149786568|NCT03935594|540342726|FG000|Overall Study|Physician Decision|3|||
149786569|NCT03954704|540342727|FG000|Overall Study|Death|1|||
149786570|NCT03954704|540342728|FG001|Overall Study|Death|1|||
149786571|NCT03954704|540342729|FG002|Overall Study|Death|1|||
149786572|NCT03954704|540342730|FG003|Overall Study|Death|3|||
149786573|NCT03954704|540342731|FG004|Overall Study|Death|2|||
149786574|NCT03954704|540342732|FG005|Overall Study|Death|2|||
149786575|NCT03954704|540342733|FG006|Overall Study|Death|0|||
149786576|NCT03954704|540342727|FG000|Overall Study|Withdrew Consent|0|||
149786577|NCT03954704|540342728|FG001|Overall Study|Withdrew Consent|0|||
149786578|NCT03954704|540342729|FG002|Overall Study|Withdrew Consent|1|||
149786579|NCT03954704|540342730|FG003|Overall Study|Withdrew Consent|0|||
149786580|NCT03954704|540342731|FG004|Overall Study|Withdrew Consent|0|||
149786581|NCT03954704|540342732|FG005|Overall Study|Withdrew Consent|1|||
149786582|NCT03954704|540342733|FG006|Overall Study|Withdrew Consent|0|||
149786583|NCT03954704|540342727|FG000|Overall Study|Lost to Follow-up|0|||
149786584|NCT03954704|540342728|FG001|Overall Study|Lost to Follow-up|0|||
149786585|NCT03954704|540342729|FG002|Overall Study|Lost to Follow-up|0|||
149786586|NCT03954704|540342730|FG003|Overall Study|Lost to Follow-up|0|||
149786587|NCT03954704|540342731|FG004|Overall Study|Lost to Follow-up|0|||
149786588|NCT03954704|540342732|FG005|Overall Study|Lost to Follow-up|0|||
149786589|NCT03954704|540342733|FG006|Overall Study|Lost to Follow-up|1|||
149786590|NCT03954704|540342727|FG000|Overall Study|Study Terminated by Sponsor|0|||
149786591|NCT03954704|540342728|FG001|Overall Study|Study Terminated by Sponsor|0|||
149786592|NCT03954704|540342729|FG002|Overall Study|Study Terminated by Sponsor|1|||
149786593|NCT03954704|540342730|FG003|Overall Study|Study Terminated by Sponsor|0|||
149786594|NCT03954704|540342731|FG004|Overall Study|Study Terminated by Sponsor|1|||
149786595|NCT03954704|540342732|FG005|Overall Study|Study Terminated by Sponsor|4|||
149786596|NCT03954704|540342733|FG006|Overall Study|Study Terminated by Sponsor|2|||
149786597|NCT03954704|540342727|FG000|Overall Study|Enrolled but not Treated|0|||
149786598|NCT03954704|540342728|FG001|Overall Study|Enrolled but not Treated|0|||
149786599|NCT03954704|540342729|FG002|Overall Study|Enrolled but not Treated|0|||
149786600|NCT03954704|540342730|FG003|Overall Study|Enrolled but not Treated|0|||
149786601|NCT03954704|540342731|FG004|Overall Study|Enrolled but not Treated|0|||
149786602|NCT03954704|540342732|FG005|Overall Study|Enrolled but not Treated|1|||
149786603|NCT03954704|540342733|FG006|Overall Study|Enrolled but not Treated|0|||
149786604|NCT02406027|540342738|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149786605|NCT02406027|540342739|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
149786606|NCT02406027|540342740|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
149786607|NCT02406027|540342741|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149786608|NCT02406027|540342742|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149786609|NCT02406027|540342743|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149786610|NCT02406027|540342744|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149786611|NCT02406027|540342738|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
149786612|NCT02406027|540342739|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149786613|NCT02406027|540342740|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
149786614|NCT02406027|540342741|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149786615|NCT02406027|540342742|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149786616|NCT02406027|540342743|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149786617|NCT02406027|540342744|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149786618|NCT02406027|540342738|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
149786619|NCT02406027|540342739|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
149786620|NCT02406027|540342740|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
149786621|NCT02406027|540342741|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149786622|NCT02406027|540342742|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149786623|NCT02406027|540342743|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149786624|NCT02406027|540342744|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149786625|NCT02406027|540342738|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
149786626|NCT02406027|540342739|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149786627|NCT02406027|540342740|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
149786628|NCT02406027|540342741|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149786629|NCT02406027|540342742|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149786630|NCT02406027|540342743|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149786631|NCT02406027|540342744|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149786632|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
149786633|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
149786634|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
149786635|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
149786636|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
149786637|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
149786638|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
149786639|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
149786640|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
149786641|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
149786642|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
149786643|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
149786644|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
149786645|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
149786646|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149786647|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149786648|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149786649|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
149786650|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
149786651|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149786652|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
149786653|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
149786654|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
149786655|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
149786656|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
149786657|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
149786658|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
149786659|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
149786660|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786661|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786662|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786663|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786664|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786665|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
149786666|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149786667|NCT02406027|540342738|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786668|NCT02406027|540342739|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786669|NCT02406027|540342740|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786670|NCT02406027|540342741|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786671|NCT02406027|540342742|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
149786672|NCT02406027|540342743|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786673|NCT02406027|540342744|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149786674|NCT03277794|540342747|FG000|Overall Study|Lost to Follow-up|2|||
149786675|NCT03277794|540342748|FG001|Overall Study|Lost to Follow-up|4|||
149786676|NCT03277794|540342747|FG000|Overall Study|Withdrew due to high acuity|1|||
149786677|NCT03277794|540342748|FG001|Overall Study|Withdrew due to high acuity|0|||
149786678|NCT05166603|540342749|FG000|Overall Study|Withdrawal by Subject|68|||
149786679|NCT05166603|540342750|FG001|Overall Study|Withdrawal by Subject|0|||
149786680|NCT04969900|540344970|FG000|Overall Study|Physician Decision|1|||
149786681|NCT04969900|540344971|FG001|Overall Study|Physician Decision|1|||
149786682|NCT04969900|540344970|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
149786683|NCT04969900|540344971|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
149786684|NCT00425945|540344977|FG000|Overall Study|Concern about Supplement|2|||
149786685|NCT00425945|540344978|FG001|Overall Study|Concern about Supplement|0|||
149786686|NCT00425945|540344977|FG000|Overall Study|Inconvenience|0|||
149786687|NCT00425945|540344978|FG001|Overall Study|Inconvenience|2|||
149786688|NCT00425945|540344977|FG000|Overall Study|Lost to Follow-up|0|||
149786689|NCT00425945|540344978|FG001|Overall Study|Lost to Follow-up|2|||
149786690|NCT00425945|540344977|FG000|Overall Study|Began hypertension medication|1|||
149786691|NCT00425945|540344978|FG001|Overall Study|Began hypertension medication|0|||
149786692|NCT00425945|540344977|FG000|Overall Study|Began cancer treatments|1|||
149786693|NCT00425945|540344978|FG001|Overall Study|Began cancer treatments|0|||
149786694|NCT00425945|540344977|FG000|Overall Study|Moved from area|0|||
149786695|NCT00425945|540344978|FG001|Overall Study|Moved from area|1|||
149786696|NCT02881151|540344979|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
149786697|NCT03258593|540344981|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
149786698|NCT03258593|540344982|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
149786699|NCT03258593|540344983|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
149786700|NCT03258593|540344984|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
149786701|NCT03258593|540344981|FG000|Run-In Maintenance Phase|Disease progression|3|||
149786702|NCT03258593|540344982|FG001|Run-In Maintenance Phase|Disease progression|0|||
149786703|NCT03258593|540344983|FG002|Run-In Maintenance Phase|Disease progression|0|||
149786704|NCT03258593|540344984|FG003|Run-In Maintenance Phase|Disease progression|0|||
149786705|NCT03258593|540344981|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149786706|NCT03258593|540344982|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
149786707|NCT03258593|540344983|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149786708|NCT03258593|540344984|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149786709|NCT03258593|540344981|FG000|Expansion Maintenance Phase|Physician Decision|0|||
149786710|NCT03258593|540344982|FG001|Expansion Maintenance Phase|Physician Decision|1|||
149786711|NCT03258593|540344983|FG002|Expansion Maintenance Phase|Physician Decision|0|||
149786712|NCT03258593|540344984|FG003|Expansion Maintenance Phase|Physician Decision|0|||
149786713|NCT05618808|540344988|FG000|Overall Study|Withdrawal by Subject|3|||
149786714|NCT05618808|540344989|FG001|Overall Study|Withdrawal by Subject|1|||
149786715|NCT05618808|540344990|FG002|Overall Study|Withdrawal by Subject|3|||
149786716|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
149786717|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
149786718|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Death|1|||
149786719|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Death|1|||
149786720|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
149786721|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
149786722|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
149786723|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
149786724|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
149786725|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
149786726|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
149786727|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
149786728|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
149786729|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
149786730|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
149786731|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
149786732|NCT03728881|540344993|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
149786733|NCT03728881|540344994|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
149786734|NCT03728881|540344993|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
149786735|NCT03728881|540344994|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
149786736|NCT03728881|540344993|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
149786737|NCT03728881|540344994|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
149786738|NCT04517253|540344997|FG000|Primary Treatment Period|Adverse Event|1|||
149786739|NCT04517253|540344998|FG001|Primary Treatment Period|Adverse Event|0|||
149786740|NCT04517253|540344999|FG002|Primary Treatment Period|Adverse Event|0|||
149786741|NCT04517253|540344997|FG000|Primary Treatment Period|Death|0|||
149786742|NCT04517253|540344998|FG001|Primary Treatment Period|Death|1|||
149786743|NCT04517253|540344999|FG002|Primary Treatment Period|Death|0|||
149786744|NCT04517253|540344997|FG000|Maintenance Period|Withdrawal by Subject|1|||
149786745|NCT04517253|540344998|FG001|Maintenance Period|Withdrawal by Subject|0|||
149786746|NCT04517253|540344999|FG002|Maintenance Period|Withdrawal by Subject|0|||
149786747|NCT04517253|540344997|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
149786748|NCT04517253|540344998|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
149786749|NCT04517253|540344999|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
149786750|NCT04651777|540345003|FG000|Overall Study|Adverse Event|1|||
149786751|NCT04651777|540345003|FG000|Overall Study|Withdrawal by Subject|2|||
149786752|NCT06048367|540345004|FG000|Overall Study|Withdrawal by Subject|0|||
149786753|NCT06048367|540345005|FG001|Overall Study|Withdrawal by Subject|1|||
149786754|NCT06048367|540345006|FG002|Overall Study|Withdrawal by Subject|0|||
149786755|NCT06048367|540345007|FG003|Overall Study|Withdrawal by Subject|0|||
149786756|NCT06048367|540345008|FG004|Overall Study|Withdrawal by Subject|0|||
149786757|NCT06048367|540345004|FG000|Overall Study|Withdrawal by Subject|0|||
149786758|NCT06048367|540345005|FG001|Overall Study|Withdrawal by Subject|0|||
149786759|NCT06048367|540345006|FG002|Overall Study|Withdrawal by Subject|1|||
149786760|NCT06048367|540345007|FG003|Overall Study|Withdrawal by Subject|0|||
149786761|NCT06048367|540345008|FG004|Overall Study|Withdrawal by Subject|0|||
149786762|NCT06048367|540345004|FG000|Overall Study|Withdrawal by Subject|0|||
149786763|NCT06048367|540345005|FG001|Overall Study|Withdrawal by Subject|0|||
149786764|NCT06048367|540345006|FG002|Overall Study|Withdrawal by Subject|0|||
149786765|NCT06048367|540345007|FG003|Overall Study|Withdrawal by Subject|1|||
149786766|NCT06048367|540345008|FG004|Overall Study|Withdrawal by Subject|0|||
149786767|NCT06048367|540345004|FG000|Overall Study|Withdrawal by Subject|0|||
149786768|NCT06048367|540345005|FG001|Overall Study|Withdrawal by Subject|0|||
149786769|NCT06048367|540345006|FG002|Overall Study|Withdrawal by Subject|0|||
149786770|NCT06048367|540345007|FG003|Overall Study|Withdrawal by Subject|1|||
149786771|NCT06048367|540345008|FG004|Overall Study|Withdrawal by Subject|0|||
149786772|NCT04088331|540345009|FG000|Overall Study|Lost to Follow-up|3|||
149786773|NCT04088331|540345009|FG000|Overall Study|Withdrawal by Subject|7|||
149786774|NCT04088331|540345009|FG000|Overall Study|Adverse Event|4|||
149786775|NCT02136134|540345015|FG000|Overall Study|Death|170|||
149786776|NCT02136134|540345016|FG001|Overall Study|Death|148|||
149786777|NCT02136134|540345015|FG000|Overall Study|Withdrawal by Subject|19|||
149786778|NCT02136134|540345016|FG001|Overall Study|Withdrawal by Subject|10|||
149786779|NCT02136134|540345015|FG000|Overall Study|Lost to Follow-up|3|||
149786780|NCT02136134|540345016|FG001|Overall Study|Lost to Follow-up|3|||
149786781|NCT02136134|540345015|FG000|Overall Study|Uspecified|55|||
149786782|NCT02136134|540345016|FG001|Overall Study|Uspecified|90|||
149786783|NCT03070119|540345019|FG000|Overall Study|Adverse Event|0|||
149786784|NCT03070119|540345020|FG001|Overall Study|Adverse Event|0|||
149786785|NCT03070119|540345021|FG002|Overall Study|Adverse Event|1|||
149786786|NCT03070119|540345019|FG000|Overall Study|Lost to Follow-up|0|||
149786787|NCT03070119|540345020|FG001|Overall Study|Lost to Follow-up|1|||
149786788|NCT03070119|540345021|FG002|Overall Study|Lost to Follow-up|0|||
149786789|NCT03070119|540345019|FG000|Overall Study|Consent Withdrawn|6|||
149786790|NCT03070119|540345020|FG001|Overall Study|Consent Withdrawn|5|||
149786791|NCT03070119|540345021|FG002|Overall Study|Consent Withdrawn|3|||
149786792|NCT03070119|540345019|FG000|Overall Study|Investigator Decision|0|||
149786793|NCT03070119|540345020|FG001|Overall Study|Investigator Decision|0|||
149786794|NCT03070119|540345021|FG002|Overall Study|Investigator Decision|1|||
149786795|NCT03070119|540345019|FG000|Overall Study|Death|7|||
149786796|NCT03070119|540345020|FG001|Overall Study|Death|14|||
149786797|NCT03070119|540345021|FG002|Overall Study|Death|5|||
149786798|NCT03070119|540345019|FG000|Overall Study|Disease Progression|5|||
149786799|NCT03070119|540345020|FG001|Overall Study|Disease Progression|7|||
149786800|NCT03070119|540345021|FG002|Overall Study|Disease Progression|7|||
149786801|NCT03070119|540345019|FG000|Overall Study|Reason not Specified|2|||
149786802|NCT03070119|540345020|FG001|Overall Study|Reason not Specified|2|||
149786803|NCT03070119|540345021|FG002|Overall Study|Reason not Specified|1|||
149786804|NCT02974621|540345023|FG000|Overall Study|Didn't receive study treatment|1|||
149786805|NCT02974621|540345024|FG001|Overall Study|Didn't receive study treatment|10|||
149786806|NCT00732472|540345025|FG000|Overall Study|Adverse Event|0|||
149786807|NCT00732472|540345026|FG001|Overall Study|Adverse Event|1|||
149786808|NCT00732472|540345027|FG002|Overall Study|Adverse Event|1|||
149786809|NCT00732472|540345028|FG003|Overall Study|Adverse Event|1|||
149786810|NCT00732472|540345025|FG000|Overall Study|Protocol Violation|0|||
149786811|NCT00732472|540345026|FG001|Overall Study|Protocol Violation|0|||
149786812|NCT00732472|540345027|FG002|Overall Study|Protocol Violation|0|||
149786813|NCT00732472|540345028|FG003|Overall Study|Protocol Violation|1|||
149786814|NCT00732472|540345025|FG000|Overall Study|Withdrawal by Subject|0|||
149786815|NCT00732472|540345026|FG001|Overall Study|Withdrawal by Subject|2|||
149786816|NCT00732472|540345027|FG002|Overall Study|Withdrawal by Subject|0|||
149786817|NCT00732472|540345028|FG003|Overall Study|Withdrawal by Subject|1|||
149786818|NCT02559115|540345030|FG000|Overall Study|Withdrawal by Subject|3|||
149786819|NCT01266876|540345031|FG000|Overall Study|Adverse Event|0|||
149786820|NCT01266876|540345032|FG001|Overall Study|Adverse Event|0|||
149786821|NCT01266876|540345033|FG002|Overall Study|Adverse Event|0|||
149786822|NCT01266876|540345034|FG003|Overall Study|Adverse Event|1|||
149786823|NCT01266876|540345035|FG004|Overall Study|Adverse Event|0|||
149786824|NCT01058395|540345036|FG000|Overall Study|Death|2|||
149786825|NCT01058395|540345037|FG001|Overall Study|Death|1|||
149786826|NCT01058395|540345036|FG000|Overall Study|Lost to Follow-up|1|||
149786827|NCT01058395|540345037|FG001|Overall Study|Lost to Follow-up|0|||
149786828|NCT05016037|540345039|FG000|Overall Study|Lost to Follow-up|2|||
149786829|NCT03715205|540345040|FG000|Overall Study|Death|13|||
149786830|NCT03715205|540345040|FG000|Overall Study|Lost to Follow-up|2|||
149786831|NCT03715205|540345040|FG000|Overall Study|Physician Decision|93|||
149786832|NCT03715205|540345040|FG000|Overall Study|Withdrawal by Subject|26|||
149786833|NCT02756845|540345045|FG000|Overall Study|Death|12|||
149786834|NCT02756845|540345046|FG001|Overall Study|Death|2|||
149786835|NCT02756845|540345045|FG000|Overall Study|Withdrawal by Subject|1|||
149786836|NCT02756845|540345046|FG001|Overall Study|Withdrawal by Subject|0|||
149786837|NCT03342404|540345047|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
149786838|NCT03342404|540345048|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
149786839|NCT03342404|540345047|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
149786840|NCT03342404|540345048|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
149786841|NCT03342404|540345047|FG000|Blinded Treatment Phase|Adverse Event|5|||
149786842|NCT03342404|540345048|FG001|Blinded Treatment Phase|Adverse Event|4|||
149786843|NCT03342404|540345047|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
149786844|NCT03342404|540345048|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
149786845|NCT03342404|540345047|FG000|Blinded Treatment Phase|Other reasons|1|||
149786846|NCT03342404|540345048|FG001|Blinded Treatment Phase|Other reasons|0|||
149786847|NCT03342404|540345047|FG000|Blinded Treatment Phase|Physician Decision|1|||
149786848|NCT03342404|540345048|FG001|Blinded Treatment Phase|Physician Decision|0|||
149786849|NCT03342404|540345047|FG000|Blinded Treatment Phase|Death|1|||
149786850|NCT03342404|540345048|FG001|Blinded Treatment Phase|Death|0|||
149786851|NCT03342404|540345047|FG000|Open-Label Phase|Lost to Follow-up|0|||
149786852|NCT03342404|540345048|FG001|Open-Label Phase|Lost to Follow-up|1|||
149786853|NCT03342404|540345047|FG000|Open-Label Phase|Other reasons|0|||
149786854|NCT03342404|540345048|FG001|Open-Label Phase|Other reasons|1|||
149786855|NCT03342404|540345047|FG000|Open-Label Phase|Adverse Event|0|||
149786856|NCT03342404|540345048|FG001|Open-Label Phase|Adverse Event|3|||
149786857|NCT03342404|540345047|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149786858|NCT03342404|540345048|FG001|Open-Label Phase|Withdrawal by Subject|6|||
149786859|NCT01332851|540345050|FG000|Overall Study|Withdrawal by Subject|4|||
149786860|NCT01332851|540345051|FG001|Overall Study|Withdrawal by Subject|2|||
149786861|NCT01332851|540345050|FG000|Overall Study|Lost to Follow-up|7|||
149786862|NCT01332851|540345051|FG001|Overall Study|Lost to Follow-up|11|||
149786863|NCT03299166|540345052|FG000|Overall Study|Adverse Event|9|||
149786864|NCT03299166|540345053|FG001|Overall Study|Adverse Event|4|||
149786865|NCT03299166|540345052|FG000|Overall Study|Withdrawal by Subject|6|||
149786866|NCT03299166|540345053|FG001|Overall Study|Withdrawal by Subject|5|||
149786867|NCT03299166|540345052|FG000|Overall Study|Physician Decision|1|||
149786868|NCT03299166|540345053|FG001|Overall Study|Physician Decision|1|||
149786869|NCT03299166|540345052|FG000|Overall Study|Sponsor Decision|3|||
149786870|NCT03299166|540345053|FG001|Overall Study|Sponsor Decision|0|||
149786871|NCT03299166|540345052|FG000|Overall Study|Lost to Follow-up|2|||
149786872|NCT03299166|540345053|FG001|Overall Study|Lost to Follow-up|4|||
149786873|NCT03299166|540345052|FG000|Overall Study|Randomization Error|0|||
149786874|NCT03299166|540345053|FG001|Overall Study|Randomization Error|1|||
149786875|NCT03299166|540345052|FG000|Overall Study|Subject unable to return due to COVID|1|||
149786876|NCT03299166|540345053|FG001|Overall Study|Subject unable to return due to COVID|0|||
149786877|NCT03299166|540345052|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
149786878|NCT03299166|540345053|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
149786879|NCT00422903|540345056|FG000|Overall Study|Disease Progression|3|||
149786880|NCT00422903|540345057|FG001|Overall Study|Disease Progression|1|||
149786881|NCT00422903|540345056|FG000|Overall Study|Adverse Event|0|||
149786882|NCT00422903|540345057|FG001|Overall Study|Adverse Event|2|||
149786883|NCT00422903|540345056|FG000|Overall Study|Informed Consent Withdrawn|1|||
149786884|NCT00422903|540345057|FG001|Overall Study|Informed Consent Withdrawn|2|||
149786885|NCT01249157|540345062|FG000|Overall Study|Withdrawal by Subject|1|||
149786886|NCT02392468|540345068|FG000|Overall Study|Adverse Event|0|||
149786887|NCT02392468|540345069|FG001|Overall Study|Adverse Event|1|||
149786888|NCT02392468|540345070|FG002|Overall Study|Adverse Event|0|||
149786889|NCT02392468|540345071|FG003|Overall Study|Adverse Event|0|||
149786890|NCT02392468|540345072|FG004|Overall Study|Adverse Event|0|||
149786891|NCT02392468|540345073|FG005|Overall Study|Adverse Event|1|||
149786892|NCT01039428|540345074|FG000|Overall Study|Protocol Violation|1|||
149786893|NCT01039428|540345075|FG001|Overall Study|Protocol Violation|0|||
149786894|NCT01039428|540345074|FG000|Overall Study|Withdrawal by Subject|1|||
149786895|NCT01039428|540345075|FG001|Overall Study|Withdrawal by Subject|0|||
149786896|NCT01313039|540345076|FG000|Overall Study|Physician Decision|1|||
149786897|NCT01313039|540345076|FG000|Overall Study|Adverse Event|1|||
149786898|NCT03630016|540345077|FG000|Overall Study|Poor Sensor Placement|1|||
149786899|NCT01300767|540345080|FG000|Overall Study|Discomfort|2|||
149786900|NCT01300767|540345080|FG000|Overall Study|Biomicroscopy|1|||
149786901|NCT01300767|540345080|FG000|Overall Study|Unacceptable fit|1|||
149786902|NCT00126425|540345083|FG000|Overall Study|Withdrawal by Subject|17|||
149786903|NCT00126425|540345084|FG001|Overall Study|Withdrawal by Subject|1|||
149786904|NCT00126425|540345083|FG000|Overall Study|Lost to Follow-up|8|||
149786905|NCT00126425|540345084|FG001|Overall Study|Lost to Follow-up|4|||
149786906|NCT00126425|540345083|FG000|Overall Study|Protocol Violation|9|||
149786907|NCT00126425|540345084|FG001|Overall Study|Protocol Violation|6|||
149786908|NCT00126425|540345083|FG000|Overall Study|Adverse Event|1|||
149786909|NCT00126425|540345084|FG001|Overall Study|Adverse Event|0|||
149786910|NCT00126425|540345083|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
149786911|NCT00126425|540345084|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
149786912|NCT00126425|540345083|FG000|Overall Study|Other|5|||
149786913|NCT00126425|540345084|FG001|Overall Study|Other|0|||
149786914|NCT01388491|540345085|FG000|Overall Study|Adverse Event|10|||
149786915|NCT01388491|540345086|FG001|Overall Study|Adverse Event|9|||
149786916|NCT01388491|540345085|FG000|Overall Study|Sponsor Request|9|||
149786917|NCT01388491|540345086|FG001|Overall Study|Sponsor Request|7|||
149786918|NCT01388491|540345085|FG000|Overall Study|Withdrawal by Subject|6|||
149786919|NCT01388491|540345086|FG001|Overall Study|Withdrawal by Subject|10|||
149786920|NCT01388491|540345085|FG000|Overall Study|Lost to Follow-up|4|||
149786921|NCT01388491|540345086|FG001|Overall Study|Lost to Follow-up|3|||
149786922|NCT01388491|540345085|FG000|Overall Study|Protocol Violation|2|||
149786923|NCT01388491|540345086|FG001|Overall Study|Protocol Violation|0|||
149786924|NCT01388491|540345085|FG000|Overall Study|Noncompliance|2|||
149786925|NCT01388491|540345086|FG001|Overall Study|Noncompliance|0|||
149786926|NCT01388491|540345085|FG000|Overall Study|Pregnancy|1|||
149786927|NCT01388491|540345086|FG001|Overall Study|Pregnancy|0|||
149786928|NCT04035473|540345087|FG000|Screening/Baseline|Death|0|||
149786929|NCT04035473|540345088|FG001|Screening/Baseline|Death|1|||
149786930|NCT04035473|540345087|FG000|Screening/Baseline|Adverse Event|0|||
149786931|NCT04035473|540345088|FG001|Screening/Baseline|Adverse Event|1|||
149786932|NCT04035473|540345087|FG000|Follow-up Period|Adverse Event|2|||
149786933|NCT04035473|540345088|FG001|Follow-up Period|Adverse Event|0|||
149786934|NCT00112840|540345089|FG000|Overall Study|Physician Decision|1|||
149786935|NCT00112840|540345090|FG001|Overall Study|Physician Decision|0|||
149786936|NCT00112840|540345091|FG002|Overall Study|Physician Decision|0|||
149786937|NCT00112840|540345089|FG000|Overall Study|Withdrawal by Subject|1|||
149786938|NCT00112840|540345090|FG001|Overall Study|Withdrawal by Subject|0|||
149786939|NCT00112840|540345091|FG002|Overall Study|Withdrawal by Subject|1|||
149786940|NCT00112840|540345089|FG000|Overall Study|Protocol Violation|0|||
149786941|NCT00112840|540345090|FG001|Overall Study|Protocol Violation|0|||
149786942|NCT00112840|540345091|FG002|Overall Study|Protocol Violation|5|||
149786943|NCT02875366|540345092|FG000|Overall Study|Adverse Event|0|||
149786944|NCT02875366|540345093|FG001|Overall Study|Adverse Event|2|||
149786945|NCT02875366|540345092|FG000|Overall Study|Noncompliance|0|||
149786946|NCT02875366|540345093|FG001|Overall Study|Noncompliance|1|||
149786947|NCT00683774|540345094|FG000|Overall Study|Withdrawal by Subject|0|||
149786948|NCT00683774|540345095|FG001|Overall Study|Withdrawal by Subject|1|||
149786949|NCT00683774|540345094|FG000|Overall Study|Physician Decision|3|||
149786950|NCT00683774|540345095|FG001|Overall Study|Physician Decision|0|||
149786951|NCT02735044|540345097|FG000|Overall Study|Adverse Event|3|||
149786952|NCT02735044|540345098|FG001|Overall Study|Adverse Event|3|||
149786953|NCT02735044|540345097|FG000|Overall Study|Lack of Efficacy|1|||
149786954|NCT02735044|540345098|FG001|Overall Study|Lack of Efficacy|0|||
149786955|NCT02735044|540345097|FG000|Overall Study|Poor compliance to protocol|7|||
149786956|NCT02735044|540345098|FG001|Overall Study|Poor compliance to protocol|7|||
149786957|NCT02735044|540345097|FG000|Overall Study|Randomized and not treated|0|||
149786958|NCT02735044|540345098|FG001|Overall Study|Randomized and not treated|2|||
149786959|NCT02735044|540345097|FG000|Overall Study|Other, not specified above|5|||
149786960|NCT02735044|540345098|FG001|Overall Study|Other, not specified above|11|||
149786961|NCT01682759|540345099|FG000|Overall Study|Death|2|||
149786962|NCT01682759|540345100|FG001|Overall Study|Death|1|||
149786963|NCT01682759|540345099|FG000|Overall Study|Lost to Follow-up|10|||
149786964|NCT01682759|540345100|FG001|Overall Study|Lost to Follow-up|13|||
149786965|NCT01682759|540345099|FG000|Overall Study|Physician Decision|1|||
149786966|NCT01682759|540345100|FG001|Overall Study|Physician Decision|1|||
149786967|NCT01682759|540345099|FG000|Overall Study|Withdrawal by Subject|56|||
149786968|NCT01682759|540345100|FG001|Overall Study|Withdrawal by Subject|55|||
149786969|NCT00397891|540345102|FG000|Overall Study|Withdrawal by Subject|1|||
149786970|NCT00397891|540345103|FG001|Overall Study|Withdrawal by Subject|0|||
149786971|NCT00397891|540345104|FG002|Overall Study|Withdrawal by Subject|0|||
149786972|NCT00397891|540345105|FG003|Overall Study|Withdrawal by Subject|0|||
149786973|NCT00397891|540345106|FG004|Overall Study|Withdrawal by Subject|1|||
149786974|NCT00412113|540345107|FG000|Overall Study|Adverse Event|11|||
149786975|NCT00412113|540345108|FG001|Overall Study|Adverse Event|15|||
149786976|NCT00412113|540345107|FG000|Overall Study|did not receive treatment|1|||
149786977|NCT00412113|540345108|FG001|Overall Study|did not receive treatment|0|||
149786978|NCT00796224|540345109|FG000|Overall Study|Adverse Event|1|||
149786979|NCT00796224|540345110|FG001|Overall Study|Adverse Event|0|||
149786980|NCT00796224|540345109|FG000|Overall Study|Protocol Violation|0|||
149786981|NCT00796224|540345110|FG001|Overall Study|Protocol Violation|1|||
149786982|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
149786983|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
149786984|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
149786985|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
149786986|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
149786987|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
149786988|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149786989|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149786990|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
149786991|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
149786992|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
149786993|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
149786994|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
149786995|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149786996|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149786997|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149786998|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149786999|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149787000|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
149787001|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149787002|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
149787003|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
149787004|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
149787005|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
149787006|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
149787007|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
149787008|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
149787009|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
149787010|NCT03227224|540345113|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
149787011|NCT03227224|540345114|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
149787012|NCT03227224|540345115|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
149787013|NCT03227224|540345116|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
149787014|NCT03227224|540345113|FG000|Follow-up Phase (2 Weeks)|Other|4|||
149787015|NCT03227224|540345114|FG001|Follow-up Phase (2 Weeks)|Other|4|||
149787016|NCT03227224|540345115|FG002|Follow-up Phase (2 Weeks)|Other|6|||
149787017|NCT03227224|540345116|FG003|Follow-up Phase (2 Weeks)|Other|3|||
149787018|NCT04195750|540345117|FG000|Overall Study|Death|245|||
149787019|NCT04195750|540345118|FG001|Overall Study|Death|253|||
149787020|NCT04195750|540345119|FG002|Overall Study|Death|5|||
149787021|NCT04195750|540345117|FG000|Overall Study|Physician Decision|0|||
149787022|NCT04195750|540345118|FG001|Overall Study|Physician Decision|1|||
149787023|NCT04195750|540345119|FG002|Overall Study|Physician Decision|0|||
149787024|NCT04195750|540345117|FG000|Overall Study|Withdrawal by Subject|9|||
149787025|NCT04195750|540345118|FG001|Overall Study|Withdrawal by Subject|8|||
149787026|NCT04195750|540345119|FG002|Overall Study|Withdrawal by Subject|0|||
149787027|NCT04195750|540345117|FG000|Overall Study|Ongoing|120|||
149787028|NCT04195750|540345118|FG001|Overall Study|Ongoing|110|||
149787029|NCT04195750|540345119|FG002|Overall Study|Ongoing|4|||
149787030|NCT03782376|540345120|FG000|Overall Study|Lost to Follow-up|2|||
149787031|NCT03782376|540345121|FG001|Overall Study|Lost to Follow-up|2|||
149787032|NCT03782376|540345120|FG000|Overall Study|Withdrawal by Subject|7|||
149787033|NCT03782376|540345121|FG001|Overall Study|Withdrawal by Subject|11|||
149787034|NCT03782376|540345120|FG000|Overall Study|Death|1|||
149787035|NCT03782376|540345121|FG001|Overall Study|Death|0|||
149787036|NCT03782376|540345120|FG000|Overall Study|Other|16|||
149787037|NCT03782376|540345121|FG001|Overall Study|Other|17|||
149787038|NCT02254304|540345126|FG000|Overall Study|Adverse Event|2|||
149787039|NCT02254304|540345127|FG001|Overall Study|Adverse Event|1|||
149787040|NCT02254304|540345126|FG000|Overall Study|Lost to Follow-up|2|||
149787041|NCT02254304|540345127|FG001|Overall Study|Lost to Follow-up|2|||
149787042|NCT02254304|540345126|FG000|Overall Study|Protocol Violation|1|||
149787043|NCT02254304|540345127|FG001|Overall Study|Protocol Violation|0|||
149787044|NCT02254304|540345126|FG000|Overall Study|Withdrawal by Subject|3|||
149787045|NCT02254304|540345127|FG001|Overall Study|Withdrawal by Subject|0|||
149787046|NCT02254304|540345126|FG000|Overall Study|Injection site pain and Injection fear|1|||
149787047|NCT02254304|540345127|FG001|Overall Study|Injection site pain and Injection fear|0|||
149787048|NCT02254304|540345126|FG000|Overall Study|Personal causes|4|||
149787049|NCT02254304|540345127|FG001|Overall Study|Personal causes|1|||
149787050|NCT02254304|540345126|FG000|Overall Study|Personal decision|1|||
149787051|NCT02254304|540345127|FG001|Overall Study|Personal decision|0|||
149787052|NCT01226472|540345128|FG000|Overall Study|Progressive Disease|1|||
149787053|NCT02531633|540347166|FG000|Part A (52 Weeks)|Sponsor request|24|||
149787054|NCT02531633|540347167|FG001|Part A (52 Weeks)|Sponsor request|24|||
149787055|NCT02531633|540347168|FG002|Part A (52 Weeks)|Sponsor request|18|||
149787056|NCT02531633|540347169|FG003|Part A (52 Weeks)|Sponsor request|18|||
149787057|NCT02531633|540347170|FG004|Part A (52 Weeks)|Sponsor request|19|||
149787058|NCT02531633|540347171|FG005|Part A (52 Weeks)|Sponsor request|0|||
149787059|NCT02531633|540347172|FG006|Part A (52 Weeks)|Sponsor request|0|||
149787060|NCT02531633|540347173|FG007|Part A (52 Weeks)|Sponsor request|0|||
149787061|NCT02531633|540347174|FG008|Part A (52 Weeks)|Sponsor request|0|||
149787062|NCT02531633|540347175|FG009|Part A (52 Weeks)|Sponsor request|0|||
149787063|NCT02531633|540347166|FG000|Part A (52 Weeks)|Protocol Violation|1|||
149787064|NCT02531633|540347167|FG001|Part A (52 Weeks)|Protocol Violation|0|||
149787065|NCT02531633|540347168|FG002|Part A (52 Weeks)|Protocol Violation|0|||
149787066|NCT02531633|540347169|FG003|Part A (52 Weeks)|Protocol Violation|0|||
149787067|NCT02531633|540347170|FG004|Part A (52 Weeks)|Protocol Violation|0|||
149787068|NCT02531633|540347171|FG005|Part A (52 Weeks)|Protocol Violation|0|||
149787069|NCT02531633|540347172|FG006|Part A (52 Weeks)|Protocol Violation|0|||
149787070|NCT02531633|540347173|FG007|Part A (52 Weeks)|Protocol Violation|0|||
149787071|NCT02531633|540347174|FG008|Part A (52 Weeks)|Protocol Violation|0|||
149787072|NCT02531633|540347175|FG009|Part A (52 Weeks)|Protocol Violation|0|||
149787073|NCT02531633|540347166|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
149787074|NCT02531633|540347167|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
149787075|NCT02531633|540347168|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
149787076|NCT02531633|540347169|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
149787077|NCT02531633|540347170|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
149787078|NCT02531633|540347171|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
149787079|NCT02531633|540347172|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
149787080|NCT02531633|540347173|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
149787081|NCT02531633|540347174|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
149787082|NCT02531633|540347175|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
149787083|NCT02531633|540347166|FG000|Part A (52 Weeks)|Physician Decision|1|||
149787084|NCT02531633|540347167|FG001|Part A (52 Weeks)|Physician Decision|4|||
149787085|NCT02531633|540347168|FG002|Part A (52 Weeks)|Physician Decision|3|||
149787086|NCT02531633|540347169|FG003|Part A (52 Weeks)|Physician Decision|1|||
149787087|NCT02531633|540347170|FG004|Part A (52 Weeks)|Physician Decision|0|||
149787088|NCT02531633|540347171|FG005|Part A (52 Weeks)|Physician Decision|0|||
149787089|NCT02531633|540347172|FG006|Part A (52 Weeks)|Physician Decision|0|||
149787090|NCT02531633|540347173|FG007|Part A (52 Weeks)|Physician Decision|0|||
149787091|NCT02531633|540347174|FG008|Part A (52 Weeks)|Physician Decision|0|||
149787092|NCT02531633|540347175|FG009|Part A (52 Weeks)|Physician Decision|0|||
149787093|NCT02531633|540347166|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
149787094|NCT02531633|540347167|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
149787095|NCT02531633|540347168|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
149787096|NCT02531633|540347169|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
149787097|NCT02531633|540347170|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
149787098|NCT02531633|540347171|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
149787099|NCT02531633|540347172|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
149787100|NCT02531633|540347173|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
149787101|NCT02531633|540347174|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
149787102|NCT02531633|540347175|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
149787103|NCT02531633|540347166|FG000|Part A (52 Weeks)|Other|2|||
149787104|NCT02531633|540347167|FG001|Part A (52 Weeks)|Other|0|||
149787105|NCT02531633|540347168|FG002|Part A (52 Weeks)|Other|0|||
149787106|NCT02531633|540347169|FG003|Part A (52 Weeks)|Other|0|||
149787107|NCT02531633|540347170|FG004|Part A (52 Weeks)|Other|0|||
149787108|NCT02531633|540347171|FG005|Part A (52 Weeks)|Other|0|||
149787109|NCT02531633|540347172|FG006|Part A (52 Weeks)|Other|0|||
149787110|NCT02531633|540347173|FG007|Part A (52 Weeks)|Other|0|||
149787111|NCT02531633|540347174|FG008|Part A (52 Weeks)|Other|0|||
149787112|NCT02531633|540347175|FG009|Part A (52 Weeks)|Other|0|||
149787113|NCT02531633|540347166|FG000|Part B (104 Weeks)|Sponsor request|0|||
149787114|NCT02531633|540347167|FG001|Part B (104 Weeks)|Sponsor request|0|||
149787115|NCT02531633|540347168|FG002|Part B (104 Weeks)|Sponsor request|0|||
149787116|NCT02531633|540347169|FG003|Part B (104 Weeks)|Sponsor request|0|||
149787117|NCT02531633|540347170|FG004|Part B (104 Weeks)|Sponsor request|0|||
149787118|NCT02531633|540347171|FG005|Part B (104 Weeks)|Sponsor request|8|||
149787119|NCT02531633|540347172|FG006|Part B (104 Weeks)|Sponsor request|5|||
149787120|NCT02531633|540347173|FG007|Part B (104 Weeks)|Sponsor request|3|||
149787121|NCT02531633|540347174|FG008|Part B (104 Weeks)|Sponsor request|5|||
149787122|NCT02531633|540347175|FG009|Part B (104 Weeks)|Sponsor request|4|||
149787123|NCT02531633|540347166|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
149787124|NCT02531633|540347167|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
149787125|NCT02531633|540347168|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
149787126|NCT02531633|540347169|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
149787127|NCT02531633|540347170|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
149787128|NCT02531633|540347171|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
149787129|NCT02531633|540347172|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
149787130|NCT02531633|540347173|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
149787131|NCT02531633|540347174|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
149787132|NCT02531633|540347175|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
149787133|NCT02710422|540347176|FG000|Overall Study|Termination of study|9|||
149787134|NCT02710422|540347177|FG001|Overall Study|Termination of study|9|||
149787135|NCT01952041|540347179|FG000|Overall Study|Lost to Follow-up|9|||
149787136|NCT01952041|540347180|FG001|Overall Study|Lost to Follow-up|16|||
149787137|NCT01952041|540347179|FG000|Overall Study|Withdrawal by Subject|7|||
149787138|NCT01952041|540347180|FG001|Overall Study|Withdrawal by Subject|5|||
149787139|NCT01952041|540347179|FG000|Overall Study|Death|1|||
149787140|NCT01952041|540347180|FG001|Overall Study|Death|0|||
149787141|NCT03650387|540347181|FG000|Overall Study|Withdrawal by Subject|13|||
149787142|NCT03650387|540347181|FG000|Overall Study|Lost to Follow-up|12|||
149787143|NCT03650387|540347181|FG000|Overall Study|Adverse Event (Not related)|1|||
149787144|NCT03650387|540347181|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
149787145|NCT01370499|540347182|FG000|Overall Study|Adverse Event|38|||
149787146|NCT01370499|540347183|FG001|Overall Study|Adverse Event|12|||
149787147|NCT01370499|540347182|FG000|Overall Study|Lack of Efficacy|4|||
149787148|NCT01370499|540347183|FG001|Overall Study|Lack of Efficacy|2|||
149787149|NCT01370499|540347182|FG000|Overall Study|Lost to Follow-up|2|||
149787150|NCT01370499|540347183|FG001|Overall Study|Lost to Follow-up|1|||
149787151|NCT01370499|540347182|FG000|Overall Study|Physician Decision|3|||
149787152|NCT01370499|540347183|FG001|Overall Study|Physician Decision|3|||
149787153|NCT01370499|540347182|FG000|Overall Study|Protocol Violation|5|||
149787154|NCT01370499|540347183|FG001|Overall Study|Protocol Violation|4|||
149787155|NCT01370499|540347182|FG000|Overall Study|Withdrawal by Subject|18|||
149787156|NCT01370499|540347183|FG001|Overall Study|Withdrawal by Subject|7|||
149787157|NCT01370499|540347182|FG000|Overall Study|Sponsor Decision|41|||
149787158|NCT01370499|540347183|FG001|Overall Study|Sponsor Decision|15|||
149787159|NCT00887822|540347184|FG000|Overall Study|Insufficient therapeutic response|53|||
149787160|NCT00887822|540347185|FG001|Overall Study|Insufficient therapeutic response|55|||
149787161|NCT00887822|540347184|FG000|Overall Study|Adverse Event|14|||
149787162|NCT00887822|540347185|FG001|Overall Study|Adverse Event|17|||
149787163|NCT00887822|540347184|FG000|Overall Study|Failure to return|11|||
149787164|NCT00887822|540347185|FG001|Overall Study|Failure to return|11|||
149787165|NCT00887822|540347184|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
149787166|NCT00887822|540347185|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
149787167|NCT00887822|540347184|FG000|Overall Study|Administrative/Other than specified|5|||
149787168|NCT00887822|540347185|FG001|Overall Study|Administrative/Other than specified|4|||
149787169|NCT00887822|540347184|FG000|Overall Study|Death|2|||
149787170|NCT00887822|540347185|FG001|Overall Study|Death|3|||
149787171|NCT00887822|540347184|FG000|Overall Study|Protocol Violation|0|||
149787172|NCT00887822|540347185|FG001|Overall Study|Protocol Violation|1|||
149787173|NCT00887822|540347184|FG000|Overall Study|Randomized but not treated|0|||
149787174|NCT00887822|540347185|FG001|Overall Study|Randomized but not treated|1|||
149787175|NCT03661983|540347186|FG000|Open Label Stabilization Phase|Adverse Event|5|||
149787176|NCT03661983|540347187|FG001|Open Label Stabilization Phase|Adverse Event|0|||
149787177|NCT03661983|540347188|FG002|Open Label Stabilization Phase|Adverse Event|0|||
149787178|NCT03661983|540347189|FG003|Open Label Stabilization Phase|Adverse Event|0|||
149787179|NCT03661983|540347186|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
149787180|NCT03661983|540347187|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
149787181|NCT03661983|540347188|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
149787182|NCT03661983|540347189|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
149787183|NCT03661983|540347186|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
149787184|NCT03661983|540347187|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
149787185|NCT03661983|540347188|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
149787186|NCT03661983|540347189|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
149787187|NCT03661983|540347186|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
149787188|NCT03661983|540347187|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149787189|NCT03661983|540347188|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149787190|NCT03661983|540347189|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149787191|NCT03661983|540347186|FG000|Double-blind Randomized Phase|Adverse Event|0|||
149787192|NCT03661983|540347187|FG001|Double-blind Randomized Phase|Adverse Event|1|||
149787193|NCT03661983|540347188|FG002|Double-blind Randomized Phase|Adverse Event|0|||
149787194|NCT03661983|540347189|FG003|Double-blind Randomized Phase|Adverse Event|0|||
149787195|NCT03661983|540347186|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
149787196|NCT03661983|540347187|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
149787197|NCT03661983|540347188|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
149787198|NCT03661983|540347189|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
149787199|NCT03661983|540347186|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149787200|NCT03661983|540347187|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149787201|NCT03661983|540347188|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149787202|NCT03661983|540347189|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
149787203|NCT03661983|540347186|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
149787204|NCT03661983|540347187|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149787205|NCT03661983|540347188|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149787206|NCT03661983|540347189|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149787207|NCT02903966|540347190|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
149787208|NCT02903966|540347191|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
149787209|NCT02903966|540347190|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
149787210|NCT02903966|540347191|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
149787211|NCT02903966|540347190|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
149787212|NCT02903966|540347191|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
149787213|NCT01320033|540347192|FG000|Overall Study|Lack of Efficacy|0|||
149787214|NCT01320033|540347193|FG001|Overall Study|Lack of Efficacy|0|||
149787215|NCT01320033|540347194|FG002|Overall Study|Lack of Efficacy|1|||
149787216|NCT01320033|540347192|FG000|Overall Study|Adverse Event|9|||
149787217|NCT01320033|540347193|FG001|Overall Study|Adverse Event|7|||
149787218|NCT01320033|540347194|FG002|Overall Study|Adverse Event|8|||
149787219|NCT01320033|540347192|FG000|Overall Study|Withdrawal by Subject|22|||
149787220|NCT01320033|540347193|FG001|Overall Study|Withdrawal by Subject|23|||
149787221|NCT01320033|540347194|FG002|Overall Study|Withdrawal by Subject|23|||
149787222|NCT01320033|540347192|FG000|Overall Study|Protocol Violation|3|||
149787223|NCT01320033|540347193|FG001|Overall Study|Protocol Violation|5|||
149787224|NCT01320033|540347194|FG002|Overall Study|Protocol Violation|3|||
149787225|NCT01320033|540347192|FG000|Overall Study|Lost to Follow-up|22|||
149787226|NCT01320033|540347193|FG001|Overall Study|Lost to Follow-up|26|||
149787227|NCT01320033|540347194|FG002|Overall Study|Lost to Follow-up|17|||
149787228|NCT01320033|540347192|FG000|Overall Study|Other|2|||
149787229|NCT01320033|540347193|FG001|Overall Study|Other|3|||
149787230|NCT01320033|540347194|FG002|Overall Study|Other|1|||
149787231|NCT02045979|540347195|FG000|Overall Study|Informed Consent Withdrawn|2|||
149787232|NCT02045979|540347196|FG001|Overall Study|Informed Consent Withdrawn|0|||
149787233|NCT02045979|540347197|FG002|Overall Study|Informed Consent Withdrawn|1|||
149787234|NCT02045979|540347195|FG000|Overall Study|not specified above|0|||
149787235|NCT02045979|540347196|FG001|Overall Study|not specified above|1|||
149787236|NCT02045979|540347197|FG002|Overall Study|not specified above|0|||
149787237|NCT00963469|540347198|FG000|Overall Study|Adverse Event|15|||
149787238|NCT00963469|540347199|FG001|Overall Study|Adverse Event|11|||
149787239|NCT00963469|540347200|FG002|Overall Study|Adverse Event|1|||
149787240|NCT00963469|540347198|FG000|Overall Study|Lack of Efficacy|10|||
149787241|NCT00963469|540347199|FG001|Overall Study|Lack of Efficacy|7|||
149787242|NCT00963469|540347200|FG002|Overall Study|Lack of Efficacy|2|||
149787243|NCT00963469|540347198|FG000|Overall Study|Lost to Follow-up|1|||
149787244|NCT00963469|540347199|FG001|Overall Study|Lost to Follow-up|1|||
149787245|NCT00963469|540347200|FG002|Overall Study|Lost to Follow-up|0|||
149787246|NCT00963469|540347198|FG000|Overall Study|Protocol Violation|5|||
149787247|NCT00963469|540347199|FG001|Overall Study|Protocol Violation|5|||
149787248|NCT00963469|540347200|FG002|Overall Study|Protocol Violation|3|||
149787249|NCT00963469|540347198|FG000|Overall Study|Withdrawal by Subject|4|||
149787250|NCT00963469|540347199|FG001|Overall Study|Withdrawal by Subject|1|||
149787251|NCT00963469|540347200|FG002|Overall Study|Withdrawal by Subject|1|||
149787252|NCT00963469|540347198|FG000|Overall Study|Pre-randomization Adverse Event|1|||
149787253|NCT00963469|540347199|FG001|Overall Study|Pre-randomization Adverse Event|2|||
149787254|NCT00963469|540347200|FG002|Overall Study|Pre-randomization Adverse Event|0|||
149787255|NCT00963469|540347198|FG000|Overall Study|Moved|1|||
149787256|NCT00963469|540347199|FG001|Overall Study|Moved|0|||
149787257|NCT00963469|540347200|FG002|Overall Study|Moved|0|||
149787258|NCT00963469|540347198|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
149787259|NCT00963469|540347199|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
149787260|NCT00963469|540347200|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
149787261|NCT00378534|540347207|FG000|Overall Study|Participants did not receive transplant|3|||
149787262|NCT00378534|540347208|FG001|Overall Study|Participants did not receive transplant|0|||
149787263|NCT03261037|540347209|FG000|Overall Study|Withdrawal by Subject|2|||
149787264|NCT03261037|540347210|FG001|Overall Study|Withdrawal by Subject|13|||
149787265|NCT03261037|540347211|FG002|Overall Study|Withdrawal by Subject|0|||
149787266|NCT03261037|540347212|FG003|Overall Study|Withdrawal by Subject|18|||
149787267|NCT03261037|540347209|FG000|Overall Study|Non-compliance with study procedures|0|||
149787268|NCT03261037|540347210|FG001|Overall Study|Non-compliance with study procedures|2|||
149787269|NCT03261037|540347211|FG002|Overall Study|Non-compliance with study procedures|0|||
149787270|NCT03261037|540347212|FG003|Overall Study|Non-compliance with study procedures|6|||
149787271|NCT03261037|540347209|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
149787272|NCT03261037|540347210|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
149787273|NCT03261037|540347211|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
149787274|NCT03261037|540347212|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
149787275|NCT03261037|540347209|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
149787276|NCT03261037|540347210|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
149787277|NCT03261037|540347211|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
149787278|NCT03261037|540347212|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
149787279|NCT03261037|540347209|FG000|Overall Study|Diagnosed but protocol deviation|1|||
149787280|NCT03261037|540347210|FG001|Overall Study|Diagnosed but protocol deviation|0|||
149787281|NCT03261037|540347211|FG002|Overall Study|Diagnosed but protocol deviation|0|||
149787282|NCT03261037|540347212|FG003|Overall Study|Diagnosed but protocol deviation|0|||
149787283|NCT03261037|540347209|FG000|Overall Study|Participant did not want to continue the study|0|||
149787284|NCT03261037|540347210|FG001|Overall Study|Participant did not want to continue the study|1|||
149787285|NCT03261037|540347211|FG002|Overall Study|Participant did not want to continue the study|0|||
149787286|NCT03261037|540347212|FG003|Overall Study|Participant did not want to continue the study|0|||
149787287|NCT03261037|540347209|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149787288|NCT03261037|540347210|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149787289|NCT03261037|540347211|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149787290|NCT03261037|540347212|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
149787291|NCT03261037|540347209|FG000|Overall Study|Participant presented clinical improvement|0|||
149787292|NCT03261037|540347210|FG001|Overall Study|Participant presented clinical improvement|2|||
149787293|NCT03261037|540347211|FG002|Overall Study|Participant presented clinical improvement|0|||
149787294|NCT03261037|540347212|FG003|Overall Study|Participant presented clinical improvement|0|||
149787295|NCT03261037|540347209|FG000|Overall Study|Technical difficulties|0|||
149787296|NCT03261037|540347210|FG001|Overall Study|Technical difficulties|0|||
149787297|NCT03261037|540347211|FG002|Overall Study|Technical difficulties|0|||
149787298|NCT03261037|540347212|FG003|Overall Study|Technical difficulties|1|||
149787299|NCT03261037|540347209|FG000|Overall Study|Equipment failed to work|0|||
149787300|NCT03261037|540347210|FG001|Overall Study|Equipment failed to work|0|||
149787301|NCT03261037|540347211|FG002|Overall Study|Equipment failed to work|0|||
149787302|NCT03261037|540347212|FG003|Overall Study|Equipment failed to work|1|||
149787303|NCT03261037|540347209|FG000|Overall Study|End of study for participant and no follow up|0|||
149787304|NCT03261037|540347210|FG001|Overall Study|End of study for participant and no follow up|0|||
149787305|NCT03261037|540347211|FG002|Overall Study|End of study for participant and no follow up|0|||
149787306|NCT03261037|540347212|FG003|Overall Study|End of study for participant and no follow up|1|||
149787307|NCT03261037|540347209|FG000|Overall Study|Participant was too weak to continue in study|1|||
149787308|NCT03261037|540347210|FG001|Overall Study|Participant was too weak to continue in study|0|||
149787309|NCT03261037|540347211|FG002|Overall Study|Participant was too weak to continue in study|0|||
149787310|NCT03261037|540347212|FG003|Overall Study|Participant was too weak to continue in study|0|||
149787311|NCT04423718|540347213|FG000|Main Study|Adverse Event|9|||
149787312|NCT04423718|540347214|FG001|Main Study|Adverse Event|5|||
149787313|NCT04423718|540347215|FG002|Main Study|Adverse Event|8|||
149787314|NCT04423718|540347213|FG000|Main Study|Physician Decision|3|||
149787315|NCT04423718|540347214|FG001|Main Study|Physician Decision|3|||
149787316|NCT04423718|540347215|FG002|Main Study|Physician Decision|2|||
149787317|NCT04423718|540347213|FG000|Main Study|Protocol Violation|0|||
149787318|NCT04423718|540347214|FG001|Main Study|Protocol Violation|0|||
149787319|NCT04423718|540347215|FG002|Main Study|Protocol Violation|1|||
149787320|NCT04423718|540347213|FG000|Main Study|Lost to Follow-up|3|||
149787321|NCT04423718|540347214|FG001|Main Study|Lost to Follow-up|3|||
149787322|NCT04423718|540347215|FG002|Main Study|Lost to Follow-up|4|||
149787323|NCT04423718|540347213|FG000|Main Study|Lack of Efficacy|2|||
149787324|NCT04423718|540347214|FG001|Main Study|Lack of Efficacy|1|||
149787325|NCT04423718|540347215|FG002|Main Study|Lack of Efficacy|0|||
149787326|NCT04423718|540347213|FG000|Main Study|Withdrawal by Subject|14|||
149787327|NCT04423718|540347214|FG001|Main Study|Withdrawal by Subject|20|||
149787328|NCT04423718|540347215|FG002|Main Study|Withdrawal by Subject|20|||
149787329|NCT04423718|540347213|FG000|Main Study|Death|10|||
149787330|NCT04423718|540347214|FG001|Main Study|Death|7|||
149787331|NCT04423718|540347215|FG002|Main Study|Death|7|||
149787332|NCT04423718|540347213|FG000|Main Study|COVID-19 pandemic|2|||
149787333|NCT04423718|540347214|FG001|Main Study|COVID-19 pandemic|2|||
149787334|NCT04423718|540347215|FG002|Main Study|COVID-19 pandemic|2|||
149787335|NCT04423718|540347213|FG000|Main Study|Other|7|||
149787336|NCT04423718|540347214|FG001|Main Study|Other|3|||
149787337|NCT04423718|540347215|FG002|Main Study|Other|2|||
149787338|NCT04423718|540347213|FG000|Extension Phase|Other|1|||
149787339|NCT04423718|540347214|FG001|Extension Phase|Other|0|||
149787340|NCT04423718|540347215|FG002|Extension Phase|Other|0|||
149787341|NCT04423718|540347213|FG000|Extension Phase|Logistical problems|0|||
149787342|NCT04423718|540347214|FG001|Extension Phase|Logistical problems|1|||
149787343|NCT04423718|540347215|FG002|Extension Phase|Logistical problems|1|||
149787344|NCT04423718|540347213|FG000|Extension Phase|Physician Decision|1|||
149787345|NCT04423718|540347214|FG001|Extension Phase|Physician Decision|0|||
149787346|NCT04423718|540347215|FG002|Extension Phase|Physician Decision|1|||
149787347|NCT04423718|540347213|FG000|Extension Phase|Lack of Efficacy|2|||
149787348|NCT04423718|540347214|FG001|Extension Phase|Lack of Efficacy|0|||
149787349|NCT04423718|540347215|FG002|Extension Phase|Lack of Efficacy|1|||
149787350|NCT04423718|540347213|FG000|Extension Phase|Lost to Follow-up|0|||
149787351|NCT04423718|540347214|FG001|Extension Phase|Lost to Follow-up|2|||
149787352|NCT04423718|540347215|FG002|Extension Phase|Lost to Follow-up|3|||
149787353|NCT04423718|540347213|FG000|Extension Phase|Adverse Event|2|||
149787354|NCT04423718|540347214|FG001|Extension Phase|Adverse Event|3|||
149787355|NCT04423718|540347215|FG002|Extension Phase|Adverse Event|1|||
149787356|NCT04423718|540347213|FG000|Extension Phase|Death|4|||
149787357|NCT04423718|540347214|FG001|Extension Phase|Death|7|||
149787358|NCT04423718|540347215|FG002|Extension Phase|Death|2|||
149787359|NCT04423718|540347213|FG000|Extension Phase|Withdrawal by Subject|11|||
149787360|NCT04423718|540347214|FG001|Extension Phase|Withdrawal by Subject|11|||
149787361|NCT04423718|540347215|FG002|Extension Phase|Withdrawal by Subject|7|||
149787362|NCT03381274|540347216|FG000|Overall Study|Death|2|||
149787363|NCT03381274|540347217|FG001|Overall Study|Death|9|||
149787364|NCT03381274|540347218|FG002|Overall Study|Death|3|||
149787365|NCT03381274|540347219|FG003|Overall Study|Death|2|||
149787366|NCT03381274|540347220|FG004|Overall Study|Death|3|||
149787367|NCT03381274|540347216|FG000|Overall Study|Lost to Follow-up|0|||
149787368|NCT03381274|540347217|FG001|Overall Study|Lost to Follow-up|0|||
149787369|NCT03381274|540347218|FG002|Overall Study|Lost to Follow-up|0|||
149787370|NCT03381274|540347219|FG003|Overall Study|Lost to Follow-up|1|||
149787371|NCT03381274|540347220|FG004|Overall Study|Lost to Follow-up|0|||
149787372|NCT03381274|540347216|FG000|Overall Study|Withdrawal by Subject|2|||
149787373|NCT03381274|540347217|FG001|Overall Study|Withdrawal by Subject|1|||
149787374|NCT03381274|540347218|FG002|Overall Study|Withdrawal by Subject|3|||
149787375|NCT03381274|540347219|FG003|Overall Study|Withdrawal by Subject|1|||
149787376|NCT03381274|540347220|FG004|Overall Study|Withdrawal by Subject|0|||
149787377|NCT03381274|540347216|FG000|Overall Study|Other|1|||
149787378|NCT03381274|540347217|FG001|Overall Study|Other|11|||
149787379|NCT03381274|540347218|FG002|Overall Study|Other|0|||
149787380|NCT03381274|540347219|FG003|Overall Study|Other|2|||
149787381|NCT03381274|540347220|FG004|Overall Study|Other|2|||
149787382|NCT04284787|540347221|FG000|Overall Study|Disease Progression|9|||
149787383|NCT04284787|540347222|FG001|Overall Study|Disease Progression|12|||
149787384|NCT04284787|540347221|FG000|Overall Study|Physician Decision|12|||
149787385|NCT04284787|540347222|FG001|Overall Study|Physician Decision|7|||
149787386|NCT04284787|540347221|FG000|Overall Study|Transplant|5|||
149787387|NCT04284787|540347222|FG001|Overall Study|Transplant|4|||
149787388|NCT04284787|540347221|FG000|Overall Study|Death|1|||
149787389|NCT04284787|540347222|FG001|Overall Study|Death|2|||
149787390|NCT04284787|540347221|FG000|Overall Study|Adverse Event|0|||
149787391|NCT04284787|540347222|FG001|Overall Study|Adverse Event|4|||
149787392|NCT04284787|540347221|FG000|Overall Study|Non-adherence|2|||
149787393|NCT04284787|540347222|FG001|Overall Study|Non-adherence|0|||
149787394|NCT04284787|540347221|FG000|Overall Study|Lack of Efficacy|2|||
149787395|NCT04284787|540347222|FG001|Overall Study|Lack of Efficacy|0|||
149787396|NCT01874353|540347223|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
149787397|NCT01874353|540347224|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149787398|NCT01874353|540347225|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149787399|NCT01874353|540347226|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149787400|NCT01874353|540347223|FG000|Overall Study|Lost to Follow-up|2|||
149787401|NCT01874353|540347224|FG001|Overall Study|Lost to Follow-up|2|||
149787402|NCT01874353|540347225|FG002|Overall Study|Lost to Follow-up|2|||
149787403|NCT01874353|540347226|FG003|Overall Study|Lost to Follow-up|0|||
149787404|NCT01874353|540347223|FG000|Overall Study|Death|110|||
149787405|NCT01874353|540347224|FG001|Overall Study|Death|60|||
149787406|NCT01874353|540347225|FG002|Overall Study|Death|13|||
149787407|NCT01874353|540347226|FG003|Overall Study|Death|7|||
149787408|NCT01874353|540347223|FG000|Overall Study|Withdrawal by Subject|13|||
149787409|NCT01874353|540347224|FG001|Overall Study|Withdrawal by Subject|11|||
149787410|NCT01874353|540347225|FG002|Overall Study|Withdrawal by Subject|0|||
149787411|NCT01874353|540347226|FG003|Overall Study|Withdrawal by Subject|0|||
149787412|NCT05298774|540347235|FG000|Overall Study|Physician Decision|3|||
149787413|NCT05298774|540347235|FG000|Overall Study|Withdrawal by Subject|2|||
149787414|NCT05298774|540347235|FG000|Overall Study|Lost to Follow-up|3|||
149787415|NCT05298774|540347235|FG000|Overall Study|Screen failure|1|||
149787416|NCT04992507|540347236|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
149787417|NCT04992507|540347237|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
149787418|NCT04992507|540347236|FG000|Overall Study|Death|0|||
149787419|NCT04992507|540347237|FG001|Overall Study|Death|1|||
149787420|NCT00081263|540347238|FG000|Overall Study|clerical error|1|||
149787421|NCT00081263|540347239|FG001|Overall Study|clerical error|0|||
149787422|NCT00081263|540347238|FG000|Overall Study|wrong cell type|7|||
149787423|NCT00081263|540347239|FG001|Overall Study|wrong cell type|5|||
149787424|NCT00081263|540347238|FG000|Overall Study|improper pre-protocol therapy|0|||
149787425|NCT00081263|540347239|FG001|Overall Study|improper pre-protocol therapy|1|||
149787426|NCT00081263|540347238|FG000|Overall Study|Inadequate pathology|0|||
149787427|NCT00081263|540347239|FG001|Overall Study|Inadequate pathology|1|||
149787428|NCT00081263|540347238|FG000|Overall Study|Never treated|4|||
149787429|NCT00081263|540347239|FG001|Overall Study|Never treated|5|||
149787430|NCT00081263|540347238|FG000|Overall Study|Inadequate data|5|||
149787431|NCT00081263|540347239|FG001|Overall Study|Inadequate data|10|||
149787432|NCT01852591|540347240|FG000|Overall Study|Withdrawal by Subject|2|||
149787433|NCT01852591|540347240|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
149787434|NCT01996865|540347241|FG000|Induction Period|Protocol Violation|1|||
149787435|NCT01996865|540347242|FG001|Induction Period|Protocol Violation|0|||
149787436|NCT01996865|540347243|FG002|Induction Period|Protocol Violation|0|||
149787437|NCT01996865|540347241|FG000|Induction Period|Progressive Disease|4|||
149787438|NCT01996865|540347242|FG001|Induction Period|Progressive Disease|0|||
149787439|NCT01996865|540347243|FG002|Induction Period|Progressive Disease|0|||
149787440|NCT01996865|540347241|FG000|Induction Period|Lost to Follow-up|10|||
149787441|NCT01996865|540347242|FG001|Induction Period|Lost to Follow-up|0|||
149787442|NCT01996865|540347243|FG002|Induction Period|Lost to Follow-up|0|||
149787443|NCT01996865|540347241|FG000|Induction Period|Other Reasons|13|||
149787444|NCT01996865|540347242|FG001|Induction Period|Other Reasons|0|||
149787445|NCT01996865|540347243|FG002|Induction Period|Other Reasons|0|||
149787446|NCT01996865|540347241|FG000|Induction Period|Adverse Event|20|||
149787447|NCT01996865|540347242|FG001|Induction Period|Adverse Event|0|||
149787448|NCT01996865|540347243|FG002|Induction Period|Adverse Event|0|||
149787449|NCT01996865|540347241|FG000|Induction Period|Withdrawal by Subject|60|||
149787450|NCT01996865|540347242|FG001|Induction Period|Withdrawal by Subject|0|||
149787451|NCT01996865|540347243|FG002|Induction Period|Withdrawal by Subject|0|||
149787452|NCT01996865|540347241|FG000|Induction Period|Death|111|||
149787453|NCT01996865|540347242|FG001|Induction Period|Death|0|||
149787454|NCT01996865|540347243|FG002|Induction Period|Death|0|||
149787455|NCT01996865|540347241|FG000|Maintenance Period|Protocol Violation|0|||
149787456|NCT01996865|540347242|FG001|Maintenance Period|Protocol Violation|1|||
149787457|NCT01996865|540347243|FG002|Maintenance Period|Protocol Violation|1|||
149787458|NCT01996865|540347241|FG000|Maintenance Period|Other reasons|0|||
149787459|NCT01996865|540347242|FG001|Maintenance Period|Other reasons|8|||
149787460|NCT01996865|540347243|FG002|Maintenance Period|Other reasons|5|||
149787461|NCT01996865|540347241|FG000|Maintenance Period|Progressive Disease|0|||
149787462|NCT01996865|540347242|FG001|Maintenance Period|Progressive Disease|6|||
149787463|NCT01996865|540347243|FG002|Maintenance Period|Progressive Disease|23|||
149787464|NCT01996865|540347241|FG000|Maintenance Period|Withdrawal by Subject|0|||
149787465|NCT01996865|540347242|FG001|Maintenance Period|Withdrawal by Subject|18|||
149787466|NCT01996865|540347243|FG002|Maintenance Period|Withdrawal by Subject|4|||
149787467|NCT01996865|540347241|FG000|Maintenance Period|Adverse Event|0|||
149787468|NCT01996865|540347242|FG001|Maintenance Period|Adverse Event|7|||
149787469|NCT01996865|540347243|FG002|Maintenance Period|Adverse Event|7|||
149787470|NCT01996865|540347241|FG000|Maintenance Period|Death|0|||
149787471|NCT01996865|540347242|FG001|Maintenance Period|Death|15|||
149787472|NCT01996865|540347243|FG002|Maintenance Period|Death|3|||
149787473|NCT01996865|540347241|FG000|Maintenance Period|Lost to Follow-up|0|||
149787474|NCT01996865|540347242|FG001|Maintenance Period|Lost to Follow-up|2|||
149787475|NCT01996865|540347243|FG002|Maintenance Period|Lost to Follow-up|0|||
149787476|NCT01947894|540347247|FG000|Overall Study|Other|3|||
149787477|NCT01947894|540347248|FG001|Overall Study|Other|4|||
149787478|NCT01947894|540347249|FG002|Overall Study|Other|3|||
149787479|NCT01947894|540347247|FG000|Overall Study|Withdrawal by Subject|12|||
149787480|NCT01947894|540347248|FG001|Overall Study|Withdrawal by Subject|4|||
149787481|NCT01947894|540347249|FG002|Overall Study|Withdrawal by Subject|1|||
149787482|NCT01947894|540347247|FG000|Overall Study|Death|12|||
149787483|NCT01947894|540347248|FG001|Overall Study|Death|1|||
149787484|NCT01947894|540347249|FG002|Overall Study|Death|0|||
149787485|NCT01947894|540347247|FG000|Overall Study|Physician Decision|2|||
149787486|NCT01947894|540347248|FG001|Overall Study|Physician Decision|0|||
149787487|NCT01947894|540347249|FG002|Overall Study|Physician Decision|0|||
149787488|NCT01947894|540347247|FG000|Overall Study|Adverse Event|5|||
149787489|NCT01947894|540347248|FG001|Overall Study|Adverse Event|1|||
149787490|NCT01947894|540347249|FG002|Overall Study|Adverse Event|0|||
149787491|NCT01947894|540347247|FG000|Overall Study|Switched to other growth hormone brand|53|||
149787492|NCT01947894|540347248|FG001|Overall Study|Switched to other growth hormone brand|8|||
149787493|NCT01947894|540347249|FG002|Overall Study|Switched to other growth hormone brand|23|||
149787494|NCT03796195|540347250|FG000|Overall Study|Study closed early|1|||
149787495|NCT00062647|540347251|FG000|Overall Study|Death|2|||
149787496|NCT00062647|540347252|FG001|Overall Study|Death|2|||
149787497|NCT00062647|540347251|FG000|Overall Study|Adverse Event|1|||
149787498|NCT00062647|540347252|FG001|Overall Study|Adverse Event|1|||
149787499|NCT00062647|540347251|FG000|Overall Study|Withdrawal by Subject|2|||
149787500|NCT00062647|540347252|FG001|Overall Study|Withdrawal by Subject|1|||
149787501|NCT00062647|540347251|FG000|Overall Study|Protocol Violation|1|||
149787502|NCT00062647|540347252|FG001|Overall Study|Protocol Violation|0|||
149787503|NCT00062647|540347251|FG000|Overall Study|Lost to Follow-up|1|||
149787504|NCT00062647|540347252|FG001|Overall Study|Lost to Follow-up|2|||
149787505|NCT00062647|540347251|FG000|Overall Study|Failed continuation criteria|4|||
149787506|NCT00062647|540347252|FG001|Overall Study|Failed continuation criteria|2|||
149787507|NCT00062647|540347251|FG000|Overall Study|Other|4|||
149787508|NCT00062647|540347252|FG001|Overall Study|Other|4|||
149787509|NCT00062647|540347251|FG000|Overall Study|Never received study treatment|1|||
149787510|NCT00062647|540347252|FG001|Overall Study|Never received study treatment|1|||
149787511|NCT02470429|540347253|FG000|Overall Study|Adverse Event|1|||
149787512|NCT02470429|540347254|FG001|Overall Study|Adverse Event|0|||
149787513|NCT02470429|540347253|FG000|Overall Study|Withdrawal by Subject|1|||
149787514|NCT02470429|540347254|FG001|Overall Study|Withdrawal by Subject|0|||
149787515|NCT00804986|540347255|FG000|Overall Study|Adverse Event|0|||
149787516|NCT00804986|540347256|FG001|Overall Study|Adverse Event|1|||
149787517|NCT00804986|540347257|FG002|Overall Study|Adverse Event|2|||
149787518|NCT00804986|540347258|FG003|Overall Study|Adverse Event|1|||
149787519|NCT00804986|540347259|FG004|Overall Study|Adverse Event|3|||
149787520|NCT00804986|540347260|FG005|Overall Study|Adverse Event|0|||
149787521|NCT00804986|540347255|FG000|Overall Study|Lack of Efficacy|0|||
149787522|NCT00804986|540347256|FG001|Overall Study|Lack of Efficacy|0|||
149787523|NCT00804986|540347257|FG002|Overall Study|Lack of Efficacy|0|||
149787524|NCT00804986|540347258|FG003|Overall Study|Lack of Efficacy|1|||
149787525|NCT00804986|540347259|FG004|Overall Study|Lack of Efficacy|0|||
149787526|NCT00804986|540347260|FG005|Overall Study|Lack of Efficacy|3|||
149787527|NCT00804986|540347255|FG000|Overall Study|Lost to Follow-up|0|||
149787528|NCT00804986|540347256|FG001|Overall Study|Lost to Follow-up|0|||
149787529|NCT00804986|540347257|FG002|Overall Study|Lost to Follow-up|0|||
149787530|NCT00804986|540347258|FG003|Overall Study|Lost to Follow-up|1|||
149787531|NCT00804986|540347259|FG004|Overall Study|Lost to Follow-up|1|||
149787532|NCT00804986|540347260|FG005|Overall Study|Lost to Follow-up|3|||
149787533|NCT00804986|540347255|FG000|Overall Study|Protocol Violation|0|||
149787534|NCT00804986|540347256|FG001|Overall Study|Protocol Violation|1|||
149787535|NCT00804986|540347257|FG002|Overall Study|Protocol Violation|0|||
149787536|NCT00804986|540347258|FG003|Overall Study|Protocol Violation|1|||
149787537|NCT00804986|540347259|FG004|Overall Study|Protocol Violation|0|||
149787538|NCT00804986|540347260|FG005|Overall Study|Protocol Violation|0|||
149787539|NCT00804986|540347255|FG000|Overall Study|Withdrawal by Subject|0|||
149787540|NCT00804986|540347256|FG001|Overall Study|Withdrawal by Subject|3|||
149787541|NCT00804986|540347257|FG002|Overall Study|Withdrawal by Subject|0|||
149787542|NCT00804986|540347258|FG003|Overall Study|Withdrawal by Subject|3|||
149787543|NCT00804986|540347259|FG004|Overall Study|Withdrawal by Subject|5|||
149787544|NCT00804986|540347260|FG005|Overall Study|Withdrawal by Subject|3|||
149787545|NCT00804986|540347255|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
149787546|NCT00804986|540347256|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
149787547|NCT00804986|540347257|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
149787548|NCT00804986|540347258|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
149787549|NCT00804986|540347259|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
149787550|NCT00804986|540347260|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
149787551|NCT00804986|540347255|FG000|Overall Study|Sponsor Decision|0|||
149787552|NCT00804986|540347256|FG001|Overall Study|Sponsor Decision|1|||
149787553|NCT00804986|540347257|FG002|Overall Study|Sponsor Decision|0|||
149787554|NCT00804986|540347258|FG003|Overall Study|Sponsor Decision|0|||
149787555|NCT00804986|540347259|FG004|Overall Study|Sponsor Decision|0|||
149787556|NCT00804986|540347260|FG005|Overall Study|Sponsor Decision|0|||
149787557|NCT00804986|540347255|FG000|Overall Study|Physician Decision|1|||
149787558|NCT00804986|540347256|FG001|Overall Study|Physician Decision|0|||
149787559|NCT00804986|540347257|FG002|Overall Study|Physician Decision|0|||
149787560|NCT00804986|540347258|FG003|Overall Study|Physician Decision|0|||
149787561|NCT00804986|540347259|FG004|Overall Study|Physician Decision|0|||
149787562|NCT00804986|540347260|FG005|Overall Study|Physician Decision|0|||
149787563|NCT00959699|540347261|FG000|Treatment Period|Adverse Event|3|||
149787564|NCT00959699|540347262|FG001|Treatment Period|Adverse Event|13|||
149787565|NCT00959699|540347261|FG000|Treatment Period|Lack of Efficacy|15|||
149787566|NCT00959699|540347262|FG001|Treatment Period|Lack of Efficacy|6|||
149787567|NCT00959699|540347261|FG000|Treatment Period|Lost to Follow-up|0|||
149787568|NCT00959699|540347262|FG001|Treatment Period|Lost to Follow-up|1|||
149787569|NCT00959699|540347261|FG000|Treatment Period|Withdrawal by Subject|1|||
149787570|NCT00959699|540347262|FG001|Treatment Period|Withdrawal by Subject|3|||
149787571|NCT00959699|540347261|FG000|Treatment Period|Non-Compliance with Protocol|0|||
149787572|NCT00959699|540347262|FG001|Treatment Period|Non-Compliance with Protocol|1|||
149787573|NCT00959699|540347261|FG000|Treatment Period|Did not receive treatment|0|||
149787574|NCT00959699|540347262|FG001|Treatment Period|Did not receive treatment|1|||
149787575|NCT00959699|540347261|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
149787576|NCT00959699|540347262|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
149787577|NCT00959699|540347261|FG000|Follow-up Period|Lost to Follow-up|3|||
149787578|NCT00959699|540347262|FG001|Follow-up Period|Lost to Follow-up|2|||
149787579|NCT00959699|540347261|FG000|Follow-up Period|Withdrawal by Subject|3|||
149787580|NCT00959699|540347262|FG001|Follow-up Period|Withdrawal by Subject|4|||
149787581|NCT01885104|540347264|FG000|Overall Study|Withdrawal of Consent|1|||
149787582|NCT01885104|540347265|FG001|Overall Study|Withdrawal of Consent|0|||
149787583|NCT01885104|540347264|FG000|Overall Study|Lost to Follow-up|0|||
149787584|NCT01885104|540347265|FG001|Overall Study|Lost to Follow-up|1|||
149787585|NCT01885104|540347264|FG000|Overall Study|Physician Decision|1|||
149787586|NCT01885104|540347265|FG001|Overall Study|Physician Decision|0|||
149787587|NCT01976624|540347266|FG000|Overall Study|Participants contraindicated|2|||
149787588|NCT01976624|540347266|FG000|Overall Study|Participants age less than 19 years|12|||
149787589|NCT03325010|540347268|FG000|Overall Study|Adverse Event|3|||
149787590|NCT03325010|540347269|FG001|Overall Study|Adverse Event|8|||
149787591|NCT03325010|540347268|FG000|Overall Study|Protocol Violation|1|||
149787592|NCT03325010|540347269|FG001|Overall Study|Protocol Violation|8|||
149787593|NCT03325010|540347268|FG000|Overall Study|Withdrawal by Subject|1|||
149787594|NCT03325010|540347269|FG001|Overall Study|Withdrawal by Subject|3|||
149787595|NCT03325010|540347268|FG000|Overall Study|Lost to Follow-up|1|||
149787596|NCT03325010|540347269|FG001|Overall Study|Lost to Follow-up|0|||
149787597|NCT03325010|540347268|FG000|Overall Study|Physician Decision|1|||
149787598|NCT03325010|540347269|FG001|Overall Study|Physician Decision|1|||
149787599|NCT03325010|540347268|FG000|Overall Study|Lack of Efficacy|2|||
149787600|NCT03325010|540347269|FG001|Overall Study|Lack of Efficacy|0|||
149787601|NCT04350372|540347272|FG000|Overall Study|Death|1|||
149787602|NCT05307523|540347274|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
149787603|NCT05307523|540347275|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
149787604|NCT05307523|540347274|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
149787605|NCT05307523|540347275|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
149787606|NCT04412668|540347276|FG000|Overall Study|Death - multiple comorbidities|2|||
149787607|NCT04412668|540347277|FG001|Overall Study|Death - multiple comorbidities|0|||
149787608|NCT04412668|540347278|FG002|Overall Study|Death - multiple comorbidities|0|||
149787609|NCT04412668|540347276|FG000|Overall Study|Withdrawal by Subject|3|||
149787610|NCT04412668|540347277|FG001|Overall Study|Withdrawal by Subject|0|||
149787611|NCT04412668|540347278|FG002|Overall Study|Withdrawal by Subject|0|||
149787612|NCT04412668|540347276|FG000|Overall Study|Other than Specified|2|||
149787613|NCT04412668|540347277|FG001|Overall Study|Other than Specified|0|||
149787614|NCT04412668|540347278|FG002|Overall Study|Other than Specified|0|||
149787615|NCT00102804|540347279|FG000|Overall Study|Progressive Disease (PD)|307|||
149787616|NCT00102804|540347280|FG001|Overall Study|Progressive Disease (PD)|196|||
149787617|NCT00102804|540347279|FG000|Overall Study|Withdrawal by Subject|46|||
149787618|NCT00102804|540347280|FG001|Overall Study|Withdrawal by Subject|7|||
149787619|NCT00102804|540347279|FG000|Overall Study|Adverse Event|37|||
149787620|NCT00102804|540347280|FG001|Overall Study|Adverse Event|3|||
149787621|NCT00102804|540347279|FG000|Overall Study|Physician Decision|24|||
149787622|NCT00102804|540347280|FG001|Overall Study|Physician Decision|6|||
149787623|NCT00102804|540347279|FG000|Overall Study|Death|5|||
149787624|NCT00102804|540347280|FG001|Overall Study|Death|6|||
149787625|NCT00102804|540347279|FG000|Overall Study|Enrollment Criteria Not Met|6|||
149787626|NCT00102804|540347280|FG001|Overall Study|Enrollment Criteria Not Met|0|||
149787627|NCT00102804|540347279|FG000|Overall Study|Lost to Follow-up|4|||
149787628|NCT00102804|540347280|FG001|Overall Study|Lost to Follow-up|1|||
149787629|NCT00102804|540347279|FG000|Overall Study|Protocol Violation|2|||
149787630|NCT00102804|540347280|FG001|Overall Study|Protocol Violation|1|||
149787631|NCT00102804|540347279|FG000|Overall Study|Satisfactory Response|2|||
149787632|NCT00102804|540347280|FG001|Overall Study|Satisfactory Response|0|||
149787633|NCT00102804|540347279|FG000|Overall Study|Sponsor Decision|1|||
149787634|NCT00102804|540347280|FG001|Overall Study|Sponsor Decision|0|||
149787635|NCT00102804|540347279|FG000|Overall Study|Alive, Receiving Treatment|7|||
149787636|NCT00102804|540347280|FG001|Overall Study|Alive, Receiving Treatment|2|||
149787637|NCT03864627|540347283|FG000|Overall Study|Adverse Event|0|||
149787638|NCT03864627|540347284|FG001|Overall Study|Adverse Event|1|||
149787639|NCT03864627|540347283|FG000|Overall Study|Lack of Efficacy|0|||
149787640|NCT03864627|540347284|FG001|Overall Study|Lack of Efficacy|1|||
149787641|NCT03864627|540347283|FG000|Overall Study|Lost to Follow-up|0|||
149787642|NCT03864627|540347284|FG001|Overall Study|Lost to Follow-up|1|||
149787643|NCT03864627|540347283|FG000|Overall Study|Withdrawal by Subject|4|||
149787644|NCT03864627|540347284|FG001|Overall Study|Withdrawal by Subject|8|||
149787645|NCT03864627|540347283|FG000|Overall Study|Study terminated by sponsor|0|||
149787646|NCT03864627|540347284|FG001|Overall Study|Study terminated by sponsor|1|||
149787647|NCT03595176|540347285|FG000|Overall Study|Death|0|||
149787648|NCT03595176|540347286|FG001|Overall Study|Death|2|||
149787649|NCT03595176|540347285|FG000|Overall Study|Lost to Follow-up|0|||
149787650|NCT03595176|540347286|FG001|Overall Study|Lost to Follow-up|1|||
149787651|NCT01201967|540347292|FG000|Overall Study|Lost to Follow-up|6|||
149787652|NCT01201967|540347293|FG001|Overall Study|Lost to Follow-up|5|||
149787653|NCT01190020|540347296|FG000|Overall Study|Adverse Event|2|||
149787654|NCT01190020|540347297|FG001|Overall Study|Adverse Event|0|||
149787655|NCT01190020|540347296|FG000|Overall Study|Lost to Follow-up|2|||
149787656|NCT01190020|540347297|FG001|Overall Study|Lost to Follow-up|0|||
149787657|NCT01190020|540347296|FG000|Overall Study|Withdrawal by Subject|3|||
149787658|NCT01190020|540347297|FG001|Overall Study|Withdrawal by Subject|0|||
149787659|NCT02116361|540347298|FG000|Overall Study|Pregnancy|0|||
149787660|NCT02116361|540347299|FG001|Overall Study|Pregnancy|0|||
149787661|NCT02116361|540347300|FG002|Overall Study|Pregnancy|0|||
149787662|NCT02116361|540347301|FG003|Overall Study|Pregnancy|1|||
149787663|NCT02116361|540347298|FG000|Overall Study|Protocol Violation|1|||
149787664|NCT02116361|540347299|FG001|Overall Study|Protocol Violation|0|||
149787665|NCT02116361|540347300|FG002|Overall Study|Protocol Violation|0|||
149787666|NCT02116361|540347301|FG003|Overall Study|Protocol Violation|2|||
149787667|NCT02116361|540347298|FG000|Overall Study|Physician Decision|2|||
149787668|NCT02116361|540347299|FG001|Overall Study|Physician Decision|3|||
149787669|NCT02116361|540347300|FG002|Overall Study|Physician Decision|0|||
149787670|NCT02116361|540347301|FG003|Overall Study|Physician Decision|0|||
149787671|NCT02116361|540347298|FG000|Overall Study|Adverse Event|1|||
149787672|NCT02116361|540347299|FG001|Overall Study|Adverse Event|0|||
149787673|NCT02116361|540347300|FG002|Overall Study|Adverse Event|0|||
149787674|NCT02116361|540347301|FG003|Overall Study|Adverse Event|3|||
149787675|NCT02116361|540347298|FG000|Overall Study|Other Reasons|3|||
149787676|NCT02116361|540347299|FG001|Overall Study|Other Reasons|3|||
149787677|NCT02116361|540347300|FG002|Overall Study|Other Reasons|3|||
149787678|NCT02116361|540347301|FG003|Overall Study|Other Reasons|3|||
149787679|NCT02116361|540347298|FG000|Overall Study|Lack of Efficacy|5|||
149787680|NCT02116361|540347299|FG001|Overall Study|Lack of Efficacy|7|||
149787681|NCT02116361|540347300|FG002|Overall Study|Lack of Efficacy|4|||
149787682|NCT02116361|540347301|FG003|Overall Study|Lack of Efficacy|3|||
149787683|NCT02116361|540347298|FG000|Overall Study|Lost to Follow-up|4|||
149787684|NCT02116361|540347299|FG001|Overall Study|Lost to Follow-up|5|||
149787685|NCT02116361|540347300|FG002|Overall Study|Lost to Follow-up|7|||
149787686|NCT02116361|540347301|FG003|Overall Study|Lost to Follow-up|5|||
149787687|NCT02116361|540347298|FG000|Overall Study|Personal Reasons|6|||
149787688|NCT02116361|540347299|FG001|Overall Study|Personal Reasons|6|||
149787689|NCT02116361|540347300|FG002|Overall Study|Personal Reasons|4|||
149787690|NCT02116361|540347301|FG003|Overall Study|Personal Reasons|9|||
149787691|NCT02116361|540347298|FG000|Overall Study|Investigator Decision - Relapse|9|||
149787692|NCT02116361|540347299|FG001|Overall Study|Investigator Decision - Relapse|7|||
149787693|NCT02116361|540347300|FG002|Overall Study|Investigator Decision - Relapse|8|||
149787694|NCT02116361|540347301|FG003|Overall Study|Investigator Decision - Relapse|5|||
149787695|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
149787696|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
149787697|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
149787698|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
149787699|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Other|13|||
149787700|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
149787701|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
149787702|NCT02497287|540347302|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
149787703|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
149787704|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
149787705|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
149787706|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
149787707|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
149787708|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
149787709|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
149787710|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
149787711|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
149787712|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
149787713|NCT02497287|540347302|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
149787714|NCT02497287|540347302|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
149787715|NCT02497287|540347302|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
149787716|NCT02497287|540347302|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
149787717|NCT02497287|540347302|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
149787718|NCT02497287|540347302|FG000|Follow-up Phase (4 Week)|Other|1|||
149787719|NCT02659098|540347303|FG000|Overall Study|Withdrawal by Subject|7|||
149787720|NCT04363944|540347304|FG000|Overall Study|Withdrawal by Subject|2|||
149787721|NCT04363944|540347305|FG001|Overall Study|Withdrawal by Subject|0|||
149787722|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
149787723|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
149787724|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Death|0|||
149787725|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Death|4|||
149787726|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
149787727|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
149787728|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
149787729|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
149787730|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
149787731|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
149787732|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
149787733|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
149787734|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
149787735|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
149787736|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Other|4|||
149787737|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Other|3|||
149787738|NCT03517722|540347306|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
149787739|NCT03517722|540347307|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
149787740|NCT03517722|540347306|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
149787741|NCT03517722|540347307|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
149787742|NCT03517722|540347306|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
149787743|NCT03517722|540347307|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
149787744|NCT03517722|540347306|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
149787745|NCT03517722|540347307|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
149787746|NCT03517722|540347306|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
149787747|NCT03517722|540347307|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
149787748|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
149787749|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149787750|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
149787751|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149787752|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149787753|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
149787754|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
149787755|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149787756|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
149787757|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
149787758|NCT02422186|540347308|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
149787759|NCT02422186|540347309|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
149787760|NCT02422186|540347308|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
149787761|NCT02422186|540347309|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
149787762|NCT02422186|540347308|FG000|Follow-up Phase (2 Weeks)|Other|3|||
149787763|NCT02422186|540347309|FG001|Follow-up Phase (2 Weeks)|Other|0|||
149787764|NCT03074318|540347310|FG000|Overall Study|Adverse Event|0|||
149787765|NCT03074318|540347311|FG001|Overall Study|Adverse Event|1|||
149787766|NCT03074318|540347312|FG002|Overall Study|Adverse Event|1|||
149787767|NCT03074318|540347313|FG003|Overall Study|Adverse Event|1|||
149787768|NCT03074318|540347310|FG000|Overall Study|Death|1|||
149787769|NCT03074318|540347311|FG001|Overall Study|Death|0|||
149787770|NCT03074318|540347312|FG002|Overall Study|Death|0|||
149787771|NCT03074318|540347313|FG003|Overall Study|Death|0|||
149787772|NCT03074318|540347310|FG000|Overall Study|Withdrawal by Subject|1|||
149787773|NCT03074318|540347311|FG001|Overall Study|Withdrawal by Subject|2|||
149787774|NCT03074318|540347312|FG002|Overall Study|Withdrawal by Subject|2|||
149787775|NCT03074318|540347313|FG003|Overall Study|Withdrawal by Subject|4|||
149787776|NCT03074318|540347310|FG000|Overall Study|Trial Closure|2|||
149787777|NCT03074318|540347311|FG001|Overall Study|Trial Closure|2|||
149787778|NCT03074318|540347312|FG002|Overall Study|Trial Closure|3|||
149787779|NCT03074318|540347313|FG003|Overall Study|Trial Closure|11|||
149787780|NCT00952419|540347316|FG000|Overall Study|Adverse Event|2|||
149787781|NCT00952419|540347317|FG001|Overall Study|Adverse Event|0|||
149787782|NCT00952419|540347318|FG002|Overall Study|Adverse Event|0|||
149787783|NCT00952419|540347316|FG000|Overall Study|Protocol Violation|3|||
149787784|NCT00952419|540347317|FG001|Overall Study|Protocol Violation|7|||
149787785|NCT00952419|540347318|FG002|Overall Study|Protocol Violation|0|||
149787786|NCT00952419|540347316|FG000|Overall Study|Withdrawal by Subject|1|||
149787787|NCT00952419|540347317|FG001|Overall Study|Withdrawal by Subject|3|||
149787788|NCT00952419|540347318|FG002|Overall Study|Withdrawal by Subject|0|||
149787789|NCT03573804|540347320|FG000|Overall Study|claustrophobia or MRI table problems|10|||
149787790|NCT02608099|540348854|FG000|Overall Study|Ablation procedure not initiated|3|||
149787791|NCT02608099|540348855|FG001|Overall Study|Ablation procedure not initiated|2|||
149787792|NCT01736176|540348863|FG000|Overall Study|Adverse Event|3|||
149787793|NCT01736176|540348863|FG000|Overall Study|Withdrawal by Subject|4|||
149787794|NCT01736176|540348863|FG000|Overall Study|Lack of Efficacy|3|||
149787795|NCT01736176|540348863|FG000|Overall Study|Unable to Complete PEG Placement|1|||
149787796|NCT00417248|540348864|FG000|Overall Study|Study Terminated|6|||
149787797|NCT00417248|540348864|FG000|Overall Study|Death|1|||
149787798|NCT00417248|540348864|FG000|Overall Study|Lack of Efficacy|1|||
149787799|NCT05815758|540348865|FG000|Overall Study|Adverse Event|6|||
149787800|NCT05815758|540348866|FG001|Overall Study|Adverse Event|2|||
149787801|NCT05815758|540348865|FG000|Overall Study|Lost to Follow-up|14|||
149787802|NCT05815758|540348866|FG001|Overall Study|Lost to Follow-up|1|||
149787803|NCT05815758|540348865|FG000|Overall Study|Withdrawal by Subject|6|||
149787804|NCT05815758|540348866|FG001|Overall Study|Withdrawal by Subject|6|||
149787805|NCT05815758|540348865|FG000|Overall Study|Protocol Violation|1|||
149787806|NCT05815758|540348866|FG001|Overall Study|Protocol Violation|1|||
149787807|NCT05815758|540348865|FG000|Overall Study|Discontinued|4|||
149787808|NCT05815758|540348866|FG001|Overall Study|Discontinued|4|||
149787809|NCT00934791|540348867|FG000|Overall Study|Withdrawal by Subject|1|||
149787810|NCT00934791|540348868|FG001|Overall Study|Withdrawal by Subject|0|||
149787811|NCT02425891|540348870|FG000|Overall Study|Death|333|||
149787812|NCT02425891|540348871|FG001|Overall Study|Death|314|||
149787813|NCT02425891|540348870|FG000|Overall Study|Lost to Follow-up|4|||
149787814|NCT02425891|540348871|FG001|Overall Study|Lost to Follow-up|6|||
149787815|NCT02425891|540348870|FG000|Overall Study|Non-Compliance|1|||
149787816|NCT02425891|540348871|FG001|Overall Study|Non-Compliance|1|||
149787817|NCT02425891|540348870|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
149787818|NCT02425891|540348871|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
149787819|NCT02425891|540348870|FG000|Overall Study|Physician Decision|0|||
149787820|NCT02425891|540348871|FG001|Overall Study|Physician Decision|1|||
149787821|NCT02425891|540348870|FG000|Overall Study|Protocol Violation|1|||
149787822|NCT02425891|540348871|FG001|Overall Study|Protocol Violation|1|||
149787823|NCT02425891|540348870|FG000|Overall Study|Study Terminated By Sponsor|85|||
149787824|NCT02425891|540348871|FG001|Overall Study|Study Terminated By Sponsor|95|||
149787825|NCT02425891|540348870|FG000|Overall Study|Withdrawal by Subject|27|||
149787826|NCT02425891|540348871|FG001|Overall Study|Withdrawal by Subject|32|||
149787827|NCT01654224|540348872|FG000|Overall Study|Lost to Follow-up|2|||
149787828|NCT01654224|540348873|FG001|Overall Study|Lost to Follow-up|2|||
149787829|NCT01654224|540348872|FG000|Overall Study|Did not receive allocation|1|||
149787830|NCT01654224|540348873|FG001|Overall Study|Did not receive allocation|8|||
149787831|NCT01654224|540348872|FG000|Overall Study|Insufficient blood sample|3|||
149787832|NCT01654224|540348873|FG001|Overall Study|Insufficient blood sample|2|||
149787833|NCT02145429|540348874|FG000|Overall Study|Death|4|||
149787834|NCT02145429|540348875|FG001|Overall Study|Death|5|||
149787835|NCT02145429|540348874|FG000|Overall Study|Lost to Follow-up|4|||
149787836|NCT02145429|540348875|FG001|Overall Study|Lost to Follow-up|3|||
149787837|NCT02145429|540348874|FG000|Overall Study|Withdrawal by Subject|8|||
149787838|NCT02145429|540348875|FG001|Overall Study|Withdrawal by Subject|3|||
149787839|NCT00515099|540348880|FG000|Overall Study|Lost to Follow-up|0|||
149787840|NCT00515099|540348881|FG001|Overall Study|Lost to Follow-up|4|||
149787841|NCT00515099|540348880|FG000|Overall Study|Withdrawal by Subject|2|||
149787842|NCT00515099|540348881|FG001|Overall Study|Withdrawal by Subject|0|||
149787843|NCT00515099|540348880|FG000|Overall Study|IRB Recommendation|1|||
149787844|NCT00515099|540348881|FG001|Overall Study|IRB Recommendation|0|||
149787845|NCT00592072|540348882|FG000|Wash Out Period|Lost to Follow-up|1|||
149787846|NCT00592072|540348883|FG001|Wash Out Period|Lost to Follow-up|1|||
149787847|NCT03369704|540348884|FG000|Treatment Epoch|technical problems|1|||
149787848|NCT03369704|540348885|FG001|Treatment Epoch|technical problems|0|||
149787849|NCT03369704|540348884|FG000|Treatment Epoch|Protocol Violation|1|||
149787850|NCT03369704|540348885|FG001|Treatment Epoch|Protocol Violation|0|||
149787851|NCT03369704|540348884|FG000|Treatment Epoch|Lost to Follow-up|0|||
149787852|NCT03369704|540348885|FG001|Treatment Epoch|Lost to Follow-up|1|||
149787853|NCT03369704|540348884|FG000|Treatment Epoch|Lack of Efficacy|0|||
149787854|NCT03369704|540348885|FG001|Treatment Epoch|Lack of Efficacy|2|||
149787855|NCT03369704|540348884|FG000|Treatment Epoch|Adverse Event|2|||
149787856|NCT03369704|540348885|FG001|Treatment Epoch|Adverse Event|0|||
149787857|NCT03369704|540348884|FG000|Follow-up Epoch|Lost to Follow-up|1|||
149787858|NCT03369704|540348885|FG001|Follow-up Epoch|Lost to Follow-up|0|||
149787859|NCT05333289|540348886|FG000|Overall Study|Other|1|||
149787860|NCT05333289|540348887|FG001|Overall Study|Other|0|||
149787861|NCT05333289|540348888|FG002|Overall Study|Other|0|||
149787862|NCT05333289|540348889|FG003|Overall Study|Other|1|||
149787863|NCT05333289|540348890|FG004|Overall Study|Other|1|||
149787864|NCT05333289|540348891|FG005|Overall Study|Other|2|||
149787865|NCT05333289|540348892|FG006|Overall Study|Other|2|||
149787866|NCT05333289|540348893|FG007|Overall Study|Other|0|||
149787867|NCT05333289|540348886|FG000|Overall Study|Withdrawal by Subject|1|||
149787868|NCT05333289|540348887|FG001|Overall Study|Withdrawal by Subject|2|||
149787869|NCT05333289|540348888|FG002|Overall Study|Withdrawal by Subject|2|||
149787870|NCT05333289|540348889|FG003|Overall Study|Withdrawal by Subject|1|||
149787871|NCT05333289|540348890|FG004|Overall Study|Withdrawal by Subject|1|||
149787872|NCT05333289|540348891|FG005|Overall Study|Withdrawal by Subject|2|||
149787873|NCT05333289|540348892|FG006|Overall Study|Withdrawal by Subject|1|||
149787874|NCT05333289|540348893|FG007|Overall Study|Withdrawal by Subject|3|||
149787875|NCT05333289|540348886|FG000|Overall Study|Protocol Violation|1|||
149787876|NCT05333289|540348887|FG001|Overall Study|Protocol Violation|0|||
149787877|NCT05333289|540348888|FG002|Overall Study|Protocol Violation|0|||
149787878|NCT05333289|540348889|FG003|Overall Study|Protocol Violation|0|||
149787879|NCT05333289|540348890|FG004|Overall Study|Protocol Violation|0|||
149787880|NCT05333289|540348891|FG005|Overall Study|Protocol Violation|0|||
149787881|NCT05333289|540348892|FG006|Overall Study|Protocol Violation|0|||
149787882|NCT05333289|540348893|FG007|Overall Study|Protocol Violation|0|||
149787883|NCT05333289|540348886|FG000|Overall Study|Physician Decision|0|||
149787884|NCT05333289|540348887|FG001|Overall Study|Physician Decision|0|||
149787885|NCT05333289|540348888|FG002|Overall Study|Physician Decision|1|||
149787886|NCT05333289|540348889|FG003|Overall Study|Physician Decision|0|||
149787887|NCT05333289|540348890|FG004|Overall Study|Physician Decision|0|||
149787888|NCT05333289|540348891|FG005|Overall Study|Physician Decision|2|||
149787889|NCT05333289|540348892|FG006|Overall Study|Physician Decision|0|||
149787890|NCT05333289|540348893|FG007|Overall Study|Physician Decision|0|||
149787891|NCT05333289|540348886|FG000|Overall Study|Lost to Follow-up|6|||
149787892|NCT05333289|540348887|FG001|Overall Study|Lost to Follow-up|0|||
149787893|NCT05333289|540348888|FG002|Overall Study|Lost to Follow-up|1|||
149787894|NCT05333289|540348889|FG003|Overall Study|Lost to Follow-up|6|||
149787895|NCT05333289|540348890|FG004|Overall Study|Lost to Follow-up|3|||
149787896|NCT05333289|540348891|FG005|Overall Study|Lost to Follow-up|3|||
149787897|NCT05333289|540348892|FG006|Overall Study|Lost to Follow-up|2|||
149787898|NCT05333289|540348893|FG007|Overall Study|Lost to Follow-up|1|||
149787899|NCT05333289|540348886|FG000|Overall Study|Death|1|||
149787900|NCT05333289|540348887|FG001|Overall Study|Death|0|||
149787901|NCT05333289|540348888|FG002|Overall Study|Death|0|||
149787902|NCT05333289|540348889|FG003|Overall Study|Death|0|||
149787903|NCT05333289|540348890|FG004|Overall Study|Death|0|||
149787904|NCT05333289|540348891|FG005|Overall Study|Death|0|||
149787905|NCT05333289|540348892|FG006|Overall Study|Death|0|||
149787906|NCT05333289|540348893|FG007|Overall Study|Death|0|||
149787907|NCT02010567|540348896|FG000|Overall Study|Adverse Event|0|||
149787908|NCT02010567|540348897|FG001|Overall Study|Adverse Event|0|||
149787909|NCT02010567|540348898|FG002|Overall Study|Adverse Event|1|||
149787910|NCT02010567|540348899|FG003|Overall Study|Adverse Event|0|||
149787911|NCT02010567|540348900|FG004|Overall Study|Adverse Event|1|||
149787912|NCT00118040|540348901|FG000|Overall Study|Adverse Event|0|||
149787913|NCT00118040|540348902|FG001|Overall Study|Adverse Event|1|||
149787914|NCT00118040|540348903|FG002|Overall Study|Adverse Event|0|||
149787915|NCT00118040|540348901|FG000|Overall Study|Withdrawal by Subject|0|||
149787916|NCT00118040|540348902|FG001|Overall Study|Withdrawal by Subject|0|||
149787917|NCT00118040|540348903|FG002|Overall Study|Withdrawal by Subject|2|||
149787918|NCT00118040|540348901|FG000|Overall Study|Medical Contraindication|0|||
149787919|NCT00118040|540348902|FG001|Overall Study|Medical Contraindication|0|||
149787920|NCT00118040|540348903|FG002|Overall Study|Medical Contraindication|1|||
149787921|NCT00118040|540348901|FG000|Overall Study|Non-Compliant Participant|1|||
149787922|NCT00118040|540348902|FG001|Overall Study|Non-Compliant Participant|1|||
149787923|NCT00118040|540348903|FG002|Overall Study|Non-Compliant Participant|2|||
149787924|NCT00118040|540348901|FG000|Overall Study|Other|0|||
149787925|NCT00118040|540348902|FG001|Overall Study|Other|0|||
149787926|NCT00118040|540348903|FG002|Overall Study|Other|1|||
149787927|NCT02750501|540348904|FG000|Overall Study|Adverse Event|4|||
149787928|NCT02750501|540348904|FG000|Overall Study|Physician Decision|1|||
149787929|NCT02750501|540348904|FG000|Overall Study|Protocol Violation|1|||
149787930|NCT02750501|540348904|FG000|Overall Study|G-tube came out|1|||
149787931|NCT02750501|540348904|FG000|Overall Study|Non-compliant use of PERT|1|||
149787932|NCT03685643|540348905|FG000|Overall Study|Lost to Follow-up|14|||
149787933|NCT03685643|540348906|FG001|Overall Study|Lost to Follow-up|22|||
149787934|NCT01738594|540348907|FG000|Registration and Treatment Start|Adverse Event|0|||
149787935|NCT01738594|540348908|FG001|Registration and Treatment Start|Adverse Event|1|||
149787936|NCT01738594|540348909|FG002|Registration and Treatment Start|Adverse Event|0|||
149787937|NCT01738594|540348910|FG003|Registration and Treatment Start|Adverse Event|0|||
149787938|NCT01738594|540348911|FG004|Registration and Treatment Start|Adverse Event|0|||
149787939|NCT01738594|540348912|FG005|Registration and Treatment Start|Adverse Event|0|||
149787940|NCT01738594|540348913|FG006|Registration and Treatment Start|Adverse Event|0|||
149787941|NCT01738594|540348914|FG007|Registration and Treatment Start|Adverse Event|0|||
149787942|NCT01738594|540348907|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787943|NCT01738594|540348908|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787944|NCT01738594|540348909|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787945|NCT01738594|540348910|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787946|NCT01738594|540348911|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787947|NCT01738594|540348912|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
149787948|NCT01738594|540348913|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787949|NCT01738594|540348914|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149787950|NCT01738594|540348907|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787951|NCT01738594|540348908|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
149787952|NCT01738594|540348909|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787953|NCT01738594|540348910|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787954|NCT01738594|540348911|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787955|NCT01738594|540348912|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787956|NCT01738594|540348913|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787957|NCT01738594|540348914|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
149787958|NCT01738594|540348907|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787959|NCT01738594|540348908|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787960|NCT01738594|540348909|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787961|NCT01738594|540348910|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787962|NCT01738594|540348911|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787963|NCT01738594|540348912|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
149787964|NCT01738594|540348913|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787965|NCT01738594|540348914|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149787966|NCT01738594|540348907|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787967|NCT01738594|540348908|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787968|NCT01738594|540348909|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787969|NCT01738594|540348910|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787970|NCT01738594|540348911|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787971|NCT01738594|540348912|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
149787972|NCT01738594|540348913|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787973|NCT01738594|540348914|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149787974|NCT01738594|540348907|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787975|NCT01738594|540348908|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787976|NCT01738594|540348909|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787977|NCT01738594|540348910|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787978|NCT01738594|540348911|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
149787979|NCT01738594|540348912|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787980|NCT01738594|540348913|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787981|NCT01738594|540348914|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149787982|NCT01738594|540348907|FG000|Follow up for 1 Year|Death|0|||
149787983|NCT01738594|540348908|FG001|Follow up for 1 Year|Death|0|||
149787984|NCT01738594|540348909|FG002|Follow up for 1 Year|Death|0|||
149787985|NCT01738594|540348910|FG003|Follow up for 1 Year|Death|0|||
149787986|NCT01738594|540348911|FG004|Follow up for 1 Year|Death|0|||
149787987|NCT01738594|540348912|FG005|Follow up for 1 Year|Death|1|||
149787988|NCT01738594|540348913|FG006|Follow up for 1 Year|Death|0|||
149787989|NCT01738594|540348914|FG007|Follow up for 1 Year|Death|0|||
149787990|NCT01738594|540348907|FG000|Follow up for 1 Year|Other|0|||
149787991|NCT01738594|540348908|FG001|Follow up for 1 Year|Other|0|||
149787992|NCT01738594|540348909|FG002|Follow up for 1 Year|Other|0|||
149787993|NCT01738594|540348910|FG003|Follow up for 1 Year|Other|0|||
149787994|NCT01738594|540348911|FG004|Follow up for 1 Year|Other|0|||
149787995|NCT01738594|540348912|FG005|Follow up for 1 Year|Other|2|||
149787996|NCT01738594|540348913|FG006|Follow up for 1 Year|Other|0|||
149787997|NCT01738594|540348914|FG007|Follow up for 1 Year|Other|0|||
149787998|NCT03797144|540348915|FG000|Enrollment|Protocol Violation|4|||
149787999|NCT03797144|540348916|FG001|Enrollment|Protocol Violation|1|||
149788000|NCT03797144|540348915|FG000|Surgery|Protocol Violation|1|||
149788001|NCT03797144|540348916|FG001|Surgery|Protocol Violation|0|||
149788002|NCT03797144|540348915|FG000|3 Month|Early termination cut-off date|2|||
149788003|NCT03797144|540348916|FG001|3 Month|Early termination cut-off date|0|||
149788004|NCT03797144|540348915|FG000|12 Month|Early termination cut-off date|8|||
149788005|NCT03797144|540348916|FG001|12 Month|Early termination cut-off date|9|||
149788006|NCT03797144|540348915|FG000|24 Month|Early termination cut-off date|1|||
149788007|NCT03797144|540348916|FG001|24 Month|Early termination cut-off date|1|||
149788008|NCT00403390|540348917|FG000|Overall Study|Withdrawal by Subject|1|||
149788009|NCT00403390|540348918|FG001|Overall Study|Withdrawal by Subject|0|||
149788010|NCT00403390|540348917|FG000|Overall Study|samples lost|1|||
149788011|NCT00403390|540348918|FG001|Overall Study|samples lost|0|||
149788012|NCT00403390|540348917|FG000|Overall Study|non-compliant|1|||
149788013|NCT00403390|540348918|FG001|Overall Study|non-compliant|0|||
149788014|NCT04430036|540348919|FG000|Safety Run in Phase|Progression of disease|2|||
149788015|NCT01842334|540348920|FG000|Overall Study|Withdrawal by Subject|3|||
149788016|NCT01842334|540348921|FG001|Overall Study|Withdrawal by Subject|3|||
149788017|NCT01842334|540348920|FG000|Overall Study|Moved away mid-study|0|||
149788018|NCT01842334|540348921|FG001|Overall Study|Moved away mid-study|1|||
149788019|NCT00376675|540348922|FG000|Overall Study|Withdrawal by Subject|9|||
149788020|NCT00376675|540348923|FG001|Overall Study|Withdrawal by Subject|2|||
149788021|NCT00376675|540348922|FG000|Overall Study|Adverse Event|10|||
149788022|NCT00376675|540348923|FG001|Overall Study|Adverse Event|5|||
149788023|NCT00376675|540348922|FG000|Overall Study|Other Reason|1|||
149788024|NCT00376675|540348923|FG001|Overall Study|Other Reason|7|||
149788025|NCT00942422|540348927|FG000|Overall Study|Withdrawal by Subject|1|||
149788026|NCT00942422|540348927|FG000|Overall Study|Death|1|||
149788027|NCT00942422|540348927|FG000|Overall Study|Progressive diease|1|||
149788028|NCT05559203|540348934|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
149788029|NCT00423592|540348936|FG000|Overall Study|Adverse Event (through Week 12)|2|||
149788030|NCT00423592|540348936|FG000|Overall Study|Adverse Event (post Week 12)|5|||
149788031|NCT00002981|540348939|FG000|Overall Study|Inevaluable|6|||
149788032|NCT00255008|540348942|FG000|Overall Study|Adverse Event|1|||
149788033|NCT00255008|540348943|FG001|Overall Study|Adverse Event|1|||
149788034|NCT00255008|540348944|FG002|Overall Study|Adverse Event|2|||
149788035|NCT00255008|540348945|FG003|Overall Study|Adverse Event|0|||
149788036|NCT00255008|540348942|FG000|Overall Study|Lost to Follow-up|1|||
149788037|NCT00255008|540348943|FG001|Overall Study|Lost to Follow-up|0|||
149788038|NCT00255008|540348944|FG002|Overall Study|Lost to Follow-up|1|||
149788039|NCT00255008|540348945|FG003|Overall Study|Lost to Follow-up|2|||
149788040|NCT00255008|540348942|FG000|Overall Study|Did not meet viral reduction criteria|4|||
149788041|NCT00255008|540348943|FG001|Overall Study|Did not meet viral reduction criteria|5|||
149788042|NCT00255008|540348944|FG002|Overall Study|Did not meet viral reduction criteria|0|||
149788043|NCT00255008|540348945|FG003|Overall Study|Did not meet viral reduction criteria|1|||
149788044|NCT00255008|540348942|FG000|Overall Study|Withdrew consent|0|||
149788045|NCT00255008|540348943|FG001|Overall Study|Withdrew consent|0|||
149788046|NCT00255008|540348944|FG002|Overall Study|Withdrew consent|2|||
149788047|NCT00255008|540348945|FG003|Overall Study|Withdrew consent|0|||
149788048|NCT00255008|540348942|FG000|Overall Study|Sponsor request|18|||
149788049|NCT00255008|540348943|FG001|Overall Study|Sponsor request|3|||
149788050|NCT00255008|540348944|FG002|Overall Study|Sponsor request|8|||
149788051|NCT00255008|540348945|FG003|Overall Study|Sponsor request|17|||
149788052|NCT00255008|540348942|FG000|Overall Study|Adverse lab experience|1|||
149788053|NCT00255008|540348943|FG001|Overall Study|Adverse lab experience|0|||
149788054|NCT00255008|540348944|FG002|Overall Study|Adverse lab experience|0|||
149788055|NCT00255008|540348945|FG003|Overall Study|Adverse lab experience|0|||
149788056|NCT00255008|540348942|FG000|Overall Study|Other|7|||
149788057|NCT00255008|540348943|FG001|Overall Study|Other|0|||
149788058|NCT00255008|540348944|FG002|Overall Study|Other|3|||
149788059|NCT00255008|540348945|FG003|Overall Study|Other|2|||
149788060|NCT01833806|540348949|FG000|Overall Study|Alternative treatment|2|||
149788061|NCT01833806|540348949|FG000|Overall Study|Death|5|||
149788062|NCT01833806|540348949|FG000|Overall Study|Physician Decision|1|||
149788063|NCT01833806|540348949|FG000|Overall Study|Lost to Follow-up|1|||
149788064|NCT05083949|540348950|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
149788065|NCT05083949|540348951|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
149788066|NCT05083949|540348950|FG000|Period 1|Adverse Event|1|||
149788067|NCT05083949|540348951|FG001|Period 1|Adverse Event|1|||
149788068|NCT05083949|540348950|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
149788069|NCT05083949|540348951|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
149788070|NCT05083949|540348950|FG000|Period 2|Adverse Event|0|||
149788071|NCT05083949|540348951|FG001|Period 2|Adverse Event|2|||
149788072|NCT00322387|540348953|FG000|Treatment Period|Adverse Event|0|||
149788073|NCT00322387|540348954|FG001|Treatment Period|Adverse Event|1|||
149788074|NCT00322387|540348953|FG000|Follow-up Period|Final assessment not done|1|||
149788075|NCT00322387|540348954|FG001|Follow-up Period|Final assessment not done|3|||
149788076|NCT00322387|540348953|FG000|Follow-up Period|Death|1|||
149788077|NCT00322387|540348954|FG001|Follow-up Period|Death|0|||
149788078|NCT00707486|540348959|FG000|Overall Study|Withdrawal by Subject|1|||
149788079|NCT01894776|540348970|FG000|Overall Study|Withdrawal by Subject|1|||
149788080|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
149788081|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
149788082|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
149788083|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149788084|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
149788085|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149788086|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149788087|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149788088|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
149788089|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
149788090|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149788091|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149788092|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
149788093|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
149788094|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
149788095|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
149788096|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
149788097|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
149788098|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
149788099|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
149788100|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
149788101|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
149788102|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
149788103|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
149788104|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Screen failure|0|||
149788105|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Screen failure|1|||
149788106|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Screen failure|2|||
149788107|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Screen failure|0|||
149788108|NCT02614261|540348973|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
149788109|NCT02614261|540348974|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
149788110|NCT02614261|540348975|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
149788111|NCT02614261|540348976|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149788112|NCT02614261|540348973|FG000|Open-Label Extension Phase|Adverse Event|23|||
149788113|NCT02614261|540348974|FG001|Open-Label Extension Phase|Adverse Event|12|||
149788114|NCT02614261|540348975|FG002|Open-Label Extension Phase|Adverse Event|11|||
149788115|NCT02614261|540348976|FG003|Open-Label Extension Phase|Adverse Event|0|||
149788116|NCT02614261|540348973|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
149788117|NCT02614261|540348974|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
149788118|NCT02614261|540348975|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
149788119|NCT02614261|540348976|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
149788120|NCT02614261|540348973|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
149788121|NCT02614261|540348974|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
149788122|NCT02614261|540348975|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
149788123|NCT02614261|540348976|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
149788124|NCT02614261|540348973|FG000|Open-Label Extension Phase|Physician Decision|2|||
149788125|NCT02614261|540348974|FG001|Open-Label Extension Phase|Physician Decision|0|||
149788126|NCT02614261|540348975|FG002|Open-Label Extension Phase|Physician Decision|0|||
149788127|NCT02614261|540348976|FG003|Open-Label Extension Phase|Physician Decision|0|||
149788128|NCT02614261|540348973|FG000|Open-Label Extension Phase|Pregnancy|1|||
149788129|NCT02614261|540348974|FG001|Open-Label Extension Phase|Pregnancy|2|||
149788130|NCT02614261|540348975|FG002|Open-Label Extension Phase|Pregnancy|1|||
149788131|NCT02614261|540348976|FG003|Open-Label Extension Phase|Pregnancy|0|||
149788132|NCT02614261|540348973|FG000|Open-Label Extension Phase|Protocol Violation|3|||
149788133|NCT02614261|540348974|FG001|Open-Label Extension Phase|Protocol Violation|4|||
149788134|NCT02614261|540348975|FG002|Open-Label Extension Phase|Protocol Violation|1|||
149788135|NCT02614261|540348976|FG003|Open-Label Extension Phase|Protocol Violation|0|||
149788136|NCT02614261|540348973|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
149788137|NCT02614261|540348974|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
149788138|NCT02614261|540348975|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
149788139|NCT02614261|540348976|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
149788140|NCT02614261|540348973|FG000|Follow-up Phase|Adverse Event|2|||
149788141|NCT02614261|540348974|FG001|Follow-up Phase|Adverse Event|0|||
149788142|NCT02614261|540348975|FG002|Follow-up Phase|Adverse Event|1|||
149788143|NCT02614261|540348976|FG003|Follow-up Phase|Adverse Event|0|||
149788144|NCT02614261|540348973|FG000|Follow-up Phase|Lost to Follow-up|12|||
149788145|NCT02614261|540348974|FG001|Follow-up Phase|Lost to Follow-up|5|||
149788146|NCT02614261|540348975|FG002|Follow-up Phase|Lost to Follow-up|2|||
149788147|NCT02614261|540348976|FG003|Follow-up Phase|Lost to Follow-up|0|||
149788148|NCT02614261|540348973|FG000|Follow-up Phase|Physician Decision|5|||
149788149|NCT02614261|540348974|FG001|Follow-up Phase|Physician Decision|1|||
149788150|NCT02614261|540348975|FG002|Follow-up Phase|Physician Decision|0|||
149788151|NCT02614261|540348976|FG003|Follow-up Phase|Physician Decision|0|||
149788152|NCT02614261|540348973|FG000|Follow-up Phase|Pregnancy|0|||
149788153|NCT02614261|540348974|FG001|Follow-up Phase|Pregnancy|1|||
149788154|NCT02614261|540348975|FG002|Follow-up Phase|Pregnancy|0|||
149788155|NCT02614261|540348976|FG003|Follow-up Phase|Pregnancy|0|||
149788156|NCT02614261|540348973|FG000|Follow-up Phase|Protocol Violation|1|||
149788157|NCT02614261|540348974|FG001|Follow-up Phase|Protocol Violation|0|||
149788158|NCT02614261|540348975|FG002|Follow-up Phase|Protocol Violation|0|||
149788159|NCT02614261|540348976|FG003|Follow-up Phase|Protocol Violation|0|||
149788160|NCT02614261|540348973|FG000|Follow-up Phase|Withdrawal by Subject|12|||
149788161|NCT02614261|540348974|FG001|Follow-up Phase|Withdrawal by Subject|4|||
149788162|NCT02614261|540348975|FG002|Follow-up Phase|Withdrawal by Subject|11|||
149788163|NCT02614261|540348976|FG003|Follow-up Phase|Withdrawal by Subject|0|||
149788164|NCT02614261|540348973|FG000|Israel Addendum|Withdrawal by Subject|0|||
149788165|NCT02614261|540348974|FG001|Israel Addendum|Withdrawal by Subject|0|||
149788166|NCT02614261|540348975|FG002|Israel Addendum|Withdrawal by Subject|0|||
149788167|NCT02614261|540348976|FG003|Israel Addendum|Withdrawal by Subject|4|||
149788168|NCT03512275|540348978|FG000|Overall Study|Withdrawal by Subject|1|||
149788169|NCT03512275|540348979|FG001|Overall Study|Withdrawal by Subject|3|||
149788170|NCT03512275|540348978|FG000|Overall Study|Physician Decision|0|||
149788171|NCT03512275|540348979|FG001|Overall Study|Physician Decision|1|||
149788172|NCT03512275|540348978|FG000|Overall Study|Lost to Follow-up|0|||
149788173|NCT03512275|540348979|FG001|Overall Study|Lost to Follow-up|3|||
149788174|NCT03512275|540348978|FG000|Overall Study|Other|1|||
149788175|NCT03512275|540348979|FG001|Overall Study|Other|0|||
149788176|NCT00113555|540348980|FG000|Overall Study|Baseline Failure|59|||
149788177|NCT00113555|540348980|FG000|Overall Study|Permanently Explanted|7|||
149788178|NCT00113555|540348980|FG000|Overall Study|Death|1|||
149788179|NCT00113555|540348980|FG000|Overall Study|Missed Followup|4|||
149788180|NCT00113555|540348980|FG000|Overall Study|Lost to Follow-up|8|||
149788181|NCT04474366|540348981|FG000|Overall Study|Lost to Follow-up|2|||
149788182|NCT04474366|540348982|FG001|Overall Study|Lost to Follow-up|5|||
149788183|NCT00320190|540348983|FG000|First 12 Months|Completed but did not enter extension|5|||
149788184|NCT00320190|540348984|FG001|First 12 Months|Completed but did not enter extension|3|||
149788185|NCT00320190|540348983|FG000|First 12 Months|Sponsor terminated study|2|||
149788186|NCT00320190|540348984|FG001|First 12 Months|Sponsor terminated study|2|||
149788187|NCT00320190|540348983|FG000|First 12 Months|Lost to Follow-up|0|||
149788188|NCT00320190|540348984|FG001|First 12 Months|Lost to Follow-up|1|||
149788189|NCT00320190|540348983|FG000|First 12 Months|Enrollment failure|0|||
149788190|NCT00320190|540348984|FG001|First 12 Months|Enrollment failure|1|||
149788191|NCT00320190|540348983|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
149788192|NCT00320190|540348984|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
149788193|NCT00320190|540348983|FG000|First 12 Months|Investigator request|0|||
149788194|NCT00320190|540348984|FG001|First 12 Months|Investigator request|1|||
149788195|NCT00320190|540348983|FG000|First 12 Months|Study drug toxicity|0|||
149788196|NCT00320190|540348984|FG001|First 12 Months|Study drug toxicity|1|||
149788197|NCT00320190|540348983|FG000|First 12 Months|Withdrawal by Subject|0|||
149788198|NCT00320190|540348984|FG001|First 12 Months|Withdrawal by Subject|1|||
149788199|NCT00320190|540348983|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
149788200|NCT00320190|540348984|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
149788201|NCT00320190|540348983|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
149788202|NCT00320190|540348984|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
149788203|NCT00320190|540348983|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
149788204|NCT00320190|540348984|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
149788205|NCT03858686|540348987|FG000|Period 1|Adverse Event|1|||
149788206|NCT03858686|540348988|FG001|Period 1|Adverse Event|1|||
149788207|NCT03858686|540348987|FG000|Period 1|Lack of compliance|0|||
149788208|NCT03858686|540348988|FG001|Period 1|Lack of compliance|1|||
149788209|NCT03858686|540348987|FG000|Period 1|Adverse Event|0|||
149788210|NCT03858686|540348988|FG001|Period 1|Adverse Event|1|||
149788211|NCT03858686|540348987|FG000|Period 2|Adverse Event|0|||
149788212|NCT03858686|540348988|FG001|Period 2|Adverse Event|1|||
149788213|NCT02299206|540348993|FG000|Overall Study|Lost to Follow-up|1|||
149788214|NCT02299206|540348993|FG000|Overall Study|Withdrawal by Subject|1|||
149788215|NCT00691054|540348994|FG000|Overall Study|Withdrawal by Subject|1|||
149788216|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
149788217|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149788218|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149788219|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149788220|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149788221|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149788222|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
149788223|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149788224|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149788225|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149788226|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149788227|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149788228|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
149788229|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149788230|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149788231|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149788232|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149788233|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149788234|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Other|14|||
149788235|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Other|0|||
149788236|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Other|0|||
149788237|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Other|0|||
149788238|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Other|0|||
149788239|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Other|0|||
149788240|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
149788241|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
149788242|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
149788243|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
149788244|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
149788245|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
149788246|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
149788247|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149788248|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149788249|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149788250|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149788251|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149788252|NCT02141854|540348995|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
149788253|NCT02141854|540348996|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149788254|NCT02141854|540348997|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149788255|NCT02141854|540348998|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149788256|NCT02141854|540348999|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149788257|NCT02141854|540349000|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149788258|NCT02141854|540348995|FG000|Treatment Period|Protocol Violation|0|||
149788259|NCT02141854|540348996|FG001|Treatment Period|Protocol Violation|1|||
149788260|NCT02141854|540348997|FG002|Treatment Period|Protocol Violation|0|||
149788261|NCT02141854|540348998|FG003|Treatment Period|Protocol Violation|2|||
149788262|NCT02141854|540348999|FG004|Treatment Period|Protocol Violation|2|||
149788263|NCT02141854|540349000|FG005|Treatment Period|Protocol Violation|1|||
149788264|NCT02141854|540348995|FG000|Treatment Period|Noncompliance|0|||
149788265|NCT02141854|540348996|FG001|Treatment Period|Noncompliance|0|||
149788266|NCT02141854|540348997|FG002|Treatment Period|Noncompliance|0|||
149788267|NCT02141854|540348998|FG003|Treatment Period|Noncompliance|1|||
149788268|NCT02141854|540348999|FG004|Treatment Period|Noncompliance|0|||
149788269|NCT02141854|540349000|FG005|Treatment Period|Noncompliance|0|||
149788270|NCT02141854|540348995|FG000|Treatment Period|Lack of Efficacy|0|||
149788271|NCT02141854|540348996|FG001|Treatment Period|Lack of Efficacy|0|||
149788272|NCT02141854|540348997|FG002|Treatment Period|Lack of Efficacy|0|||
149788273|NCT02141854|540348998|FG003|Treatment Period|Lack of Efficacy|1|||
149788274|NCT02141854|540348999|FG004|Treatment Period|Lack of Efficacy|1|||
149788275|NCT02141854|540349000|FG005|Treatment Period|Lack of Efficacy|7|||
149788276|NCT02141854|540348995|FG000|Treatment Period|Pregnancy|0|||
149788277|NCT02141854|540348996|FG001|Treatment Period|Pregnancy|1|||
149788278|NCT02141854|540348997|FG002|Treatment Period|Pregnancy|0|||
149788279|NCT02141854|540348998|FG003|Treatment Period|Pregnancy|0|||
149788280|NCT02141854|540348999|FG004|Treatment Period|Pregnancy|0|||
149788281|NCT02141854|540349000|FG005|Treatment Period|Pregnancy|0|||
149788282|NCT02141854|540348995|FG000|Treatment Period|Other|0|||
149788283|NCT02141854|540348996|FG001|Treatment Period|Other|1|||
149788284|NCT02141854|540348997|FG002|Treatment Period|Other|2|||
149788285|NCT02141854|540348998|FG003|Treatment Period|Other|0|||
149788286|NCT02141854|540348999|FG004|Treatment Period|Other|1|||
149788287|NCT02141854|540349000|FG005|Treatment Period|Other|2|||
149788288|NCT02141854|540348995|FG000|Treatment Period|Adverse Event|0|||
149788289|NCT02141854|540348996|FG001|Treatment Period|Adverse Event|2|||
149788290|NCT02141854|540348997|FG002|Treatment Period|Adverse Event|2|||
149788291|NCT02141854|540348998|FG003|Treatment Period|Adverse Event|0|||
149788292|NCT02141854|540348999|FG004|Treatment Period|Adverse Event|2|||
149788293|NCT02141854|540349000|FG005|Treatment Period|Adverse Event|2|||
149788294|NCT02141854|540348995|FG000|Treatment Period|Withdrawal by Subject|0|||
149788295|NCT02141854|540348996|FG001|Treatment Period|Withdrawal by Subject|2|||
149788296|NCT02141854|540348997|FG002|Treatment Period|Withdrawal by Subject|3|||
149788297|NCT02141854|540348998|FG003|Treatment Period|Withdrawal by Subject|3|||
149788298|NCT02141854|540348999|FG004|Treatment Period|Withdrawal by Subject|4|||
149788299|NCT02141854|540349000|FG005|Treatment Period|Withdrawal by Subject|7|||
149788300|NCT02141854|540348995|FG000|Treatment Period|Disease progression|0|||
149788301|NCT02141854|540348996|FG001|Treatment Period|Disease progression|2|||
149788302|NCT02141854|540348997|FG002|Treatment Period|Disease progression|1|||
149788303|NCT02141854|540348998|FG003|Treatment Period|Disease progression|3|||
149788304|NCT02141854|540348999|FG004|Treatment Period|Disease progression|0|||
149788305|NCT02141854|540349000|FG005|Treatment Period|Disease progression|18|||
149788306|NCT02141854|540348995|FG000|Treatment Period|Lost to Follow-up|0|||
149788307|NCT02141854|540348996|FG001|Treatment Period|Lost to Follow-up|1|||
149788308|NCT02141854|540348997|FG002|Treatment Period|Lost to Follow-up|1|||
149788309|NCT02141854|540348998|FG003|Treatment Period|Lost to Follow-up|1|||
149788310|NCT02141854|540348999|FG004|Treatment Period|Lost to Follow-up|0|||
149788311|NCT02141854|540349000|FG005|Treatment Period|Lost to Follow-up|1|||
149788312|NCT01868594|540349001|FG000|Overall Study|Do not meet inclusion criteria|4|||
149788313|NCT01868594|540349002|FG001|Overall Study|Do not meet inclusion criteria|3|||
149788314|NCT01592773|540350450|FG000|Overall Study|Study Terminated by Sponsor|582|||
149788315|NCT01592773|540350450|FG000|Overall Study|Withdrawal by Subject|35|||
149788316|NCT01592773|540350450|FG000|Overall Study|Lost to Follow-up|19|||
149788317|NCT01592773|540350450|FG000|Overall Study|Adverse Event|17|||
149788318|NCT01592773|540350450|FG000|Overall Study|Lack of Efficacy|9|||
149788319|NCT01592773|540350450|FG000|Overall Study|Protocol Violation|2|||
149788320|NCT01592773|540350450|FG000|Overall Study|Inclusion/exclusion not meet|1|||
149788321|NCT01592773|540350450|FG000|Overall Study|Other Reason|1|||
149788322|NCT04418427|540350451|FG000|Overall Study|Death|0|||
149788323|NCT04418427|540350452|FG001|Overall Study|Death|1|||
149788324|NCT04418427|540350453|FG002|Overall Study|Death|0|||
149788325|NCT04418427|540350451|FG000|Overall Study|Lost to Follow-up|0|||
149788326|NCT04418427|540350452|FG001|Overall Study|Lost to Follow-up|2|||
149788327|NCT04418427|540350453|FG002|Overall Study|Lost to Follow-up|2|||
149788328|NCT04418427|540350451|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
149788329|NCT04418427|540350452|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
149788330|NCT04418427|540350453|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
149788331|NCT04418427|540350451|FG000|Overall Study|Pre-existing medical condition|0|||
149788332|NCT04418427|540350452|FG001|Overall Study|Pre-existing medical condition|1|||
149788333|NCT04418427|540350453|FG002|Overall Study|Pre-existing medical condition|0|||
149788334|NCT01293123|540350454|FG000|Overall Study|Lost to Follow-up|0|||
149788335|NCT01293123|540350455|FG001|Overall Study|Lost to Follow-up|1|||
149788336|NCT00121485|540350456|FG000|Overall Study|Not implanted|1|||
149788337|NCT00121485|540350457|FG001|Overall Study|Not implanted|5|||
149788338|NCT00121485|540350456|FG000|Overall Study|Crossover|0|||
149788339|NCT00121485|540350457|FG001|Overall Study|Crossover|2|||
149788340|NCT01888965|540350464|FG000|Overall Study|Adverse Event|5|||
149788341|NCT01888965|540350464|FG000|Overall Study|Lack of Efficacy|4|||
149788342|NCT04076579|540350465|FG000|Overall Study|Adverse Event|2|||
149788343|NCT04076579|540350466|FG001|Overall Study|Adverse Event|0|||
149788344|NCT04076579|540350465|FG000|Overall Study|discontinued due to toxicity|1|||
149788345|NCT04076579|540350466|FG001|Overall Study|discontinued due to toxicity|0|||
149788346|NCT04076579|540350465|FG000|Overall Study|Physician Decision|1|||
149788347|NCT04076579|540350466|FG001|Overall Study|Physician Decision|0|||
149788348|NCT04076579|540350465|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
149788349|NCT04076579|540350466|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
149788350|NCT04076579|540350465|FG000|Overall Study|Noncompliance|0|||
149788351|NCT04076579|540350466|FG001|Overall Study|Noncompliance|1|||
149788352|NCT04076579|540350465|FG000|Overall Study|Withdrawal by Subject|0|||
149788353|NCT04076579|540350466|FG001|Overall Study|Withdrawal by Subject|2|||
149788354|NCT03793010|540350467|FG000|Overall Study|Withdrawal by Subject|5|||
149788355|NCT03793010|540350468|FG001|Overall Study|Withdrawal by Subject|7|||
149788356|NCT03793010|540350467|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
149788357|NCT03793010|540350468|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
149788358|NCT03793010|540350467|FG000|Overall Study|Lost to Follow-up|1|||
149788359|NCT03793010|540350468|FG001|Overall Study|Lost to Follow-up|2|||
149788360|NCT03793010|540350467|FG000|Overall Study|Patient couldn't sit still for injection|1|||
149788361|NCT03793010|540350468|FG001|Overall Study|Patient couldn't sit still for injection|0|||
149788362|NCT03793010|540350467|FG000|Overall Study|Withdrew to pursue other treatment|1|||
149788363|NCT03793010|540350468|FG001|Overall Study|Withdrew to pursue other treatment|0|||
149788364|NCT03793010|540350467|FG000|Overall Study|Did not meet eligibility criteria|1|||
149788365|NCT03793010|540350468|FG001|Overall Study|Did not meet eligibility criteria|0|||
149788366|NCT00186121|540350469|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
149788367|NCT00186121|540350469|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
149788368|NCT00186121|540350469|FG000|Overall Study|Not eligible (no treatment)|1|||
149788369|NCT01569568|540350470|FG000|Overall Study|Physician Decision|0|||
149788370|NCT01569568|540350471|FG001|Overall Study|Physician Decision|2|||
149788371|NCT04124952|540350472|FG000|Overall Study|Lost to Follow-up|1|||
149788372|NCT03763942|540350474|FG000|Overall Study|Lost to Follow-up|114|||
149788373|NCT03763942|540350475|FG001|Overall Study|Lost to Follow-up|54|||
149788374|NCT03763942|540350474|FG000|Overall Study|Protocol Violation|1|||
149788375|NCT03763942|540350475|FG001|Overall Study|Protocol Violation|0|||
149788376|NCT03763942|540350474|FG000|Overall Study|Withdrawal by Subject|2|||
149788377|NCT03763942|540350475|FG001|Overall Study|Withdrawal by Subject|0|||
149788378|NCT03763942|540350474|FG000|Overall Study|Other|2|||
149788379|NCT03763942|540350475|FG001|Overall Study|Other|3|||
149788380|NCT00166504|540350476|FG000|Overall Study|Adverse Event|3|||
149788381|NCT00166504|540350477|FG001|Overall Study|Adverse Event|3|||
149788382|NCT00166504|540350476|FG000|Overall Study|Lost to Follow-up|1|||
149788383|NCT00166504|540350477|FG001|Overall Study|Lost to Follow-up|1|||
149788384|NCT00166504|540350476|FG000|Overall Study|Withdrawal by Subject|1|||
149788385|NCT00166504|540350477|FG001|Overall Study|Withdrawal by Subject|0|||
149788386|NCT02200510|540350478|FG000|Overall Study|Death|1|||
149788387|NCT02200510|540350479|FG001|Overall Study|Death|1|||
149788388|NCT02200510|540350478|FG000|Overall Study|Protocol Violation|0|||
149788389|NCT02200510|540350479|FG001|Overall Study|Protocol Violation|1|||
149788390|NCT02200510|540350478|FG000|Overall Study|Lost to Follow-up|7|||
149788391|NCT02200510|540350479|FG001|Overall Study|Lost to Follow-up|1|||
149788392|NCT02200510|540350478|FG000|Overall Study|potential COI - joined study team|1|||
149788393|NCT02200510|540350479|FG001|Overall Study|potential COI - joined study team|0|||
149788394|NCT02943577|540350480|FG000|Overall Study|Protocol Violation|0|||
149788395|NCT02943577|540350481|FG001|Overall Study|Protocol Violation|1|||
149788396|NCT02943577|540350480|FG000|Overall Study|Adverse Event|3|||
149788397|NCT02943577|540350481|FG001|Overall Study|Adverse Event|2|||
149788398|NCT02943577|540350480|FG000|Overall Study|Lost to Follow-up|0|||
149788399|NCT02943577|540350481|FG001|Overall Study|Lost to Follow-up|1|||
149788400|NCT02943577|540350480|FG000|Overall Study|Withdrawal by Subject|1|||
149788401|NCT02943577|540350481|FG001|Overall Study|Withdrawal by Subject|1|||
149788402|NCT02943577|540350480|FG000|Overall Study|Pregnancy|1|||
149788403|NCT02943577|540350481|FG001|Overall Study|Pregnancy|0|||
149788404|NCT00939055|540350486|FG000|Overall Study|Discontinuation prior to procedure|4|||
149788405|NCT00939055|540350487|FG001|Overall Study|Discontinuation prior to procedure|0|||
149788406|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
149788407|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
149788408|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
149788409|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
149788410|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Other|1|||
149788411|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Other|0|||
149788412|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Other|2|||
149788413|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Other|4|||
149788414|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
149788415|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
149788416|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
149788417|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
149788418|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Adverse Event|0|||
149788419|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Adverse Event|0|||
149788420|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Adverse Event|1|||
149788421|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Adverse Event|2|||
149788422|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
149788423|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
149788424|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
149788425|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
149788426|NCT00808028|540350491|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
149788427|NCT00808028|540350492|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
149788428|NCT00808028|540350493|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
149788429|NCT00808028|540350494|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
149788430|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
149788431|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
149788432|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
149788433|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
149788434|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149788435|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149788436|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
149788437|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149788438|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
149788439|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
149788440|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
149788441|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
149788442|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
149788443|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
149788444|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
149788445|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
149788446|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
149788447|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
149788448|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
149788449|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
149788450|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
149788451|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
149788452|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
149788453|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
149788454|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149788455|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149788456|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
149788457|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149788458|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
149788459|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
149788460|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
149788461|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
149788462|NCT00808028|540350491|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149788463|NCT00808028|540350492|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149788464|NCT00808028|540350493|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
149788465|NCT00808028|540350494|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149788466|NCT01222767|540350497|FG000|Overall Study|Progressive disease|13|||
149788467|NCT01222767|540350497|FG000|Overall Study|Adverse Event|2|||
149788468|NCT01222767|540350497|FG000|Overall Study|Surgical resection|1|||
149788469|NCT01222767|540350497|FG000|Overall Study|Never treated|1|||
149788470|NCT00508001|540350498|FG000|Overall Study|Adverse Event|2|||
149788471|NCT00508001|540350499|FG001|Overall Study|Adverse Event|0|||
149788472|NCT00508001|540350500|FG002|Overall Study|Adverse Event|4|||
149788473|NCT00508001|540350498|FG000|Overall Study|condition under investigation worsened|13|||
149788474|NCT00508001|540350499|FG001|Overall Study|condition under investigation worsened|7|||
149788475|NCT00508001|540350500|FG002|Overall Study|condition under investigation worsened|1|||
149788476|NCT00508001|540350498|FG000|Overall Study|Death|0|||
149788477|NCT00508001|540350499|FG001|Overall Study|Death|1|||
149788478|NCT00508001|540350500|FG002|Overall Study|Death|1|||
149788479|NCT00508001|540350498|FG000|Overall Study|Withdrawal by Subject|4|||
149788480|NCT00508001|540350499|FG001|Overall Study|Withdrawal by Subject|4|||
149788481|NCT00508001|540350500|FG002|Overall Study|Withdrawal by Subject|1|||
149788482|NCT04437511|540350501|FG000|Overall Study|Adverse Event|50|||
149788483|NCT04437511|540350502|FG001|Overall Study|Adverse Event|21|||
149788484|NCT04437511|540350501|FG000|Overall Study|Death|15|||
149788485|NCT04437511|540350502|FG001|Overall Study|Death|10|||
149788486|NCT04437511|540350501|FG000|Overall Study|Lost to Follow-up|11|||
149788487|NCT04437511|540350502|FG001|Overall Study|Lost to Follow-up|11|||
149788488|NCT04437511|540350501|FG000|Overall Study|Physician Decision|19|||
149788489|NCT04437511|540350502|FG001|Overall Study|Physician Decision|10|||
149788490|NCT04437511|540350501|FG000|Overall Study|Progressive Disease|4|||
149788491|NCT04437511|540350502|FG001|Overall Study|Progressive Disease|7|||
149788492|NCT04437511|540350501|FG000|Overall Study|Withdrawal by Subject|111|||
149788493|NCT04437511|540350502|FG001|Overall Study|Withdrawal by Subject|94|||
149788494|NCT04437511|540350501|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
149788495|NCT04437511|540350502|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
149788496|NCT04437511|540350501|FG000|Overall Study|Continuing Study|7|||
149788497|NCT04437511|540350502|FG001|Overall Study|Continuing Study|5|||
149788498|NCT03093350|540350507|FG000|Overall Study|Death|1|||
149788499|NCT03093350|540350507|FG000|Overall Study|Signed consent, never began treartment|1|||
149788500|NCT01267955|540350515|FG000|Stage 1 (6 Months)|Death|3|||
149788501|NCT01267955|540350515|FG000|Stage 2 (6 Months)|Death|5|||
149788502|NCT01267955|540350515|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
149788503|NCT00729560|540350516|FG000|Overall Study|Withdrawal by Subject|3|||
149788504|NCT03233308|540350517|FG000|Overall Study|Adverse Event|1|||
149788505|NCT03233308|540350517|FG000|Overall Study|Protocol Violation|1|||
149788506|NCT03662789|540350518|FG000|Overall Study|Lost to Follow-up|1|||
149788507|NCT03662789|540350519|FG001|Overall Study|Lost to Follow-up|2|||
149788508|NCT03662789|540350518|FG000|Overall Study|Could not perform treadmill test|4|||
149788509|NCT03662789|540350519|FG001|Overall Study|Could not perform treadmill test|4|||
149788510|NCT03662789|540350518|FG000|Overall Study|Death|0|||
149788511|NCT03662789|540350519|FG001|Overall Study|Death|1|||
149788512|NCT03598140|540350520|FG000|Overall Study|enrolled but didn't start|1|||
149788513|NCT03598140|540350521|FG001|Overall Study|enrolled but didn't start|0|||
149788514|NCT01023516|540350522|FG000|Overall Study|Voluntary discontinuation|7|||
149788515|NCT01023516|540350523|FG001|Overall Study|Voluntary discontinuation|5|||
149788516|NCT01023516|540350522|FG000|Overall Study|Adverse Event|9|||
149788517|NCT01023516|540350523|FG001|Overall Study|Adverse Event|6|||
149788518|NCT01023516|540350522|FG000|Overall Study|Safety reason|0|||
149788519|NCT01023516|540350523|FG001|Overall Study|Safety reason|3|||
149788520|NCT01023516|540350522|FG000|Overall Study|Study-specific criteria|4|||
149788521|NCT01023516|540350523|FG001|Overall Study|Study-specific criteria|2|||
149788522|NCT01023516|540350522|FG000|Overall Study|Incorrect enrolment|4|||
149788523|NCT01023516|540350523|FG001|Overall Study|Incorrect enrolment|2|||
149788524|NCT02060903|540350525|FG000|Overall Study|Lost to Follow-up|4|||
149788525|NCT02060903|540350526|FG001|Overall Study|Lost to Follow-up|0|||
149788526|NCT02060903|540350525|FG000|Overall Study|Withdrawal by Subject|0|||
149788527|NCT02060903|540350526|FG001|Overall Study|Withdrawal by Subject|7|||
149788528|NCT05304611|540350527|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788529|NCT05304611|540350528|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788530|NCT05304611|540350529|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788531|NCT05304611|540350530|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788532|NCT05304611|540350531|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788533|NCT05304611|540350532|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788534|NCT05304611|540350533|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
149788535|NCT05304611|540350534|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788536|NCT05304611|540350535|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
149788537|NCT05304611|540350536|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788538|NCT05304611|540350537|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788539|NCT05304611|540350538|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
149788540|NCT05304611|540350527|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
149788541|NCT05304611|540350528|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
149788542|NCT05304611|540350529|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
149788543|NCT05304611|540350530|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
149788544|NCT05304611|540350531|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
149788545|NCT05304611|540350532|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
149788546|NCT05304611|540350533|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
149788547|NCT05304611|540350534|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
149788548|NCT05304611|540350535|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
149788549|NCT05304611|540350536|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
149788550|NCT05304611|540350537|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
149788551|NCT05304611|540350538|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
149788552|NCT05304611|540350527|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
149788553|NCT05304611|540350528|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
149788554|NCT05304611|540350529|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
149788555|NCT05304611|540350530|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
149788556|NCT05304611|540350531|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
149788557|NCT05304611|540350532|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
149788558|NCT05304611|540350533|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
149788559|NCT05304611|540350534|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
149788560|NCT05304611|540350535|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
149788561|NCT05304611|540350536|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
149788562|NCT05304611|540350537|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
149788563|NCT05304611|540350538|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
149788564|NCT02354690|540350543|FG000|Overall Study|Physician Decision|1|||
149788565|NCT00963820|540350544|FG000|Dose Escalation Phase|Progressive Disease|3|||
149788566|NCT00963820|540350545|FG001|Dose Escalation Phase|Progressive Disease|3|||
149788567|NCT00963820|540350546|FG002|Dose Escalation Phase|Progressive Disease|3|||
149788568|NCT00963820|540350547|FG003|Dose Escalation Phase|Progressive Disease|3|||
149788569|NCT00963820|540350548|FG004|Dose Escalation Phase|Progressive Disease|4|||
149788570|NCT00963820|540350549|FG005|Dose Escalation Phase|Progressive Disease|3|||
149788571|NCT00963820|540350550|FG006|Dose Escalation Phase|Progressive Disease|3|||
149788572|NCT00963820|540350551|FG007|Dose Escalation Phase|Progressive Disease|2|||
149788573|NCT00963820|540350552|FG008|Dose Escalation Phase|Progressive Disease|0|||
149788574|NCT00963820|540350553|FG009|Dose Escalation Phase|Progressive Disease|0|||
149788575|NCT00963820|540350554|FG010|Dose Escalation Phase|Progressive Disease|0|||
149788576|NCT00963820|540350555|FG011|Dose Escalation Phase|Progressive Disease|0|||
149788577|NCT00963820|540350544|FG000|Dose Escalation Phase|Adverse Event|0|||
149788578|NCT00963820|540350545|FG001|Dose Escalation Phase|Adverse Event|0|||
149788579|NCT00963820|540350546|FG002|Dose Escalation Phase|Adverse Event|0|||
149788580|NCT00963820|540350547|FG003|Dose Escalation Phase|Adverse Event|0|||
149788581|NCT00963820|540350548|FG004|Dose Escalation Phase|Adverse Event|0|||
149788582|NCT00963820|540350549|FG005|Dose Escalation Phase|Adverse Event|0|||
149788583|NCT00963820|540350550|FG006|Dose Escalation Phase|Adverse Event|3|||
149788584|NCT00963820|540350551|FG007|Dose Escalation Phase|Adverse Event|1|||
149788585|NCT00963820|540350552|FG008|Dose Escalation Phase|Adverse Event|0|||
149788586|NCT00963820|540350553|FG009|Dose Escalation Phase|Adverse Event|0|||
149788587|NCT00963820|540350554|FG010|Dose Escalation Phase|Adverse Event|0|||
149788588|NCT00963820|540350555|FG011|Dose Escalation Phase|Adverse Event|0|||
149788589|NCT00963820|540350544|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149788590|NCT00963820|540350545|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149788591|NCT00963820|540350546|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
149788592|NCT00963820|540350547|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149788593|NCT00963820|540350548|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
149788594|NCT00963820|540350549|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
149788595|NCT00963820|540350550|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
149788596|NCT00963820|540350551|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
149788597|NCT00963820|540350552|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
149788598|NCT00963820|540350553|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
149788599|NCT00963820|540350554|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
149788600|NCT00963820|540350555|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
149788601|NCT00963820|540350544|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788602|NCT00963820|540350545|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788603|NCT00963820|540350546|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788604|NCT00963820|540350547|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788605|NCT00963820|540350548|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788606|NCT00963820|540350549|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788607|NCT00963820|540350550|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
149788608|NCT00963820|540350551|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788609|NCT00963820|540350552|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788610|NCT00963820|540350553|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788611|NCT00963820|540350554|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788612|NCT00963820|540350555|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149788613|NCT00963820|540350544|FG000|Expansion Phase|Progressive Disease|0|||
149788614|NCT00963820|540350545|FG001|Expansion Phase|Progressive Disease|0|||
149788615|NCT00963820|540350546|FG002|Expansion Phase|Progressive Disease|0|||
149788616|NCT00963820|540350547|FG003|Expansion Phase|Progressive Disease|0|||
149788617|NCT00963820|540350548|FG004|Expansion Phase|Progressive Disease|0|||
149788618|NCT00963820|540350549|FG005|Expansion Phase|Progressive Disease|0|||
149788619|NCT00963820|540350550|FG006|Expansion Phase|Progressive Disease|0|||
149788620|NCT00963820|540350551|FG007|Expansion Phase|Progressive Disease|0|||
149788621|NCT00963820|540350552|FG008|Expansion Phase|Progressive Disease|8|||
149788622|NCT00963820|540350553|FG009|Expansion Phase|Progressive Disease|6|||
149788623|NCT00963820|540350554|FG010|Expansion Phase|Progressive Disease|4|||
149788624|NCT00963820|540350555|FG011|Expansion Phase|Progressive Disease|2|||
149788625|NCT00963820|540350544|FG000|Expansion Phase|Adverse Event|0|||
149788626|NCT00963820|540350545|FG001|Expansion Phase|Adverse Event|0|||
149788627|NCT00963820|540350546|FG002|Expansion Phase|Adverse Event|0|||
149788628|NCT00963820|540350547|FG003|Expansion Phase|Adverse Event|0|||
149788629|NCT00963820|540350548|FG004|Expansion Phase|Adverse Event|0|||
149788630|NCT00963820|540350549|FG005|Expansion Phase|Adverse Event|0|||
149788631|NCT00963820|540350550|FG006|Expansion Phase|Adverse Event|0|||
149788632|NCT00963820|540350551|FG007|Expansion Phase|Adverse Event|0|||
149788633|NCT00963820|540350552|FG008|Expansion Phase|Adverse Event|1|||
149788634|NCT00963820|540350553|FG009|Expansion Phase|Adverse Event|3|||
149788635|NCT00963820|540350554|FG010|Expansion Phase|Adverse Event|0|||
149788636|NCT00963820|540350555|FG011|Expansion Phase|Adverse Event|0|||
149788637|NCT00963820|540350544|FG000|Expansion Phase|Withdrawal by Subject|0|||
149788638|NCT00963820|540350545|FG001|Expansion Phase|Withdrawal by Subject|0|||
149788639|NCT00963820|540350546|FG002|Expansion Phase|Withdrawal by Subject|0|||
149788640|NCT00963820|540350547|FG003|Expansion Phase|Withdrawal by Subject|0|||
149788641|NCT00963820|540350548|FG004|Expansion Phase|Withdrawal by Subject|0|||
149788642|NCT00963820|540350549|FG005|Expansion Phase|Withdrawal by Subject|0|||
149788643|NCT00963820|540350550|FG006|Expansion Phase|Withdrawal by Subject|0|||
149788644|NCT00963820|540350551|FG007|Expansion Phase|Withdrawal by Subject|0|||
149788645|NCT00963820|540350552|FG008|Expansion Phase|Withdrawal by Subject|1|||
149788646|NCT00963820|540350553|FG009|Expansion Phase|Withdrawal by Subject|0|||
149788647|NCT00963820|540350554|FG010|Expansion Phase|Withdrawal by Subject|1|||
149788648|NCT00963820|540350555|FG011|Expansion Phase|Withdrawal by Subject|1|||
149788649|NCT00963820|540350544|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788650|NCT00963820|540350545|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788651|NCT00963820|540350546|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788652|NCT00963820|540350547|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788653|NCT00963820|540350548|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788654|NCT00963820|540350549|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788655|NCT00963820|540350550|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788656|NCT00963820|540350551|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788657|NCT00963820|540350552|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788658|NCT00963820|540350553|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788659|NCT00963820|540350554|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149788660|NCT00963820|540350555|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
149788661|NCT04556175|540350559|FG000|Overall Study|Study terminated due to COVID-19|8|||
149788662|NCT04556175|540350560|FG001|Overall Study|Study terminated due to COVID-19|8|||
149788663|NCT05549505|540350562|FG000|Overall Study|Lost to Follow-up|2|||
149788664|NCT05549505|540350563|FG001|Overall Study|Lost to Follow-up|0|||
149788665|NCT05549505|540350562|FG000|Overall Study|Withdrawal by Subject|3|||
149788666|NCT05549505|540350563|FG001|Overall Study|Withdrawal by Subject|3|||
149788667|NCT05549505|540350562|FG000|Overall Study|Other: Miscellaneous|3|||
149788668|NCT05549505|540350563|FG001|Overall Study|Other: Miscellaneous|6|||
149788669|NCT02871791|540350567|FG000|Phase 1b|Death|0|||
149788670|NCT02871791|540350568|FG001|Phase 1b|Death|1|||
149788671|NCT02871791|540350567|FG000|Phase 1b|progressive disease|6|||
149788672|NCT02871791|540350568|FG001|Phase 1b|progressive disease|2|||
149788673|NCT02871791|540350567|FG000|Phase 2|Death|1|||
149788674|NCT02871791|540350568|FG001|Phase 2|Death|0|||
149788675|NCT02871791|540350567|FG000|Phase 2|Lost to Follow-up|2|||
149788676|NCT02871791|540350568|FG001|Phase 2|Lost to Follow-up|0|||
149788677|NCT01796106|540350572|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
149788678|NCT01796106|540350573|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
149788679|NCT04107935|540350574|FG000|Overall Study|Death|1|||
149788680|NCT04107935|540350575|FG001|Overall Study|Death|0|||
149788681|NCT02943668|540350577|FG000|Overall Study|Disease Progression|1|||
149788682|NCT03128307|540350583|FG000|Overall Study|Lost to Follow-up|29|||
149788683|NCT03128307|540350583|FG000|Overall Study|Withdrawal by Subject|5|||
149788684|NCT03399786|540350584|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
149788685|NCT03399786|540350585|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149788686|NCT03399786|540350586|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149788687|NCT03399786|540350587|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149788688|NCT03399786|540350584|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149788689|NCT03399786|540350585|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149788690|NCT03399786|540350586|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
149788691|NCT03399786|540350587|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149788692|NCT03399786|540350584|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149788693|NCT03399786|540350585|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149788694|NCT03399786|540350586|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149788695|NCT03399786|540350587|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
149788696|NCT01855919|540351910|FG000|Overall Study|Adverse Event|16|||
149788697|NCT01855919|540351911|FG001|Overall Study|Adverse Event|8|||
149788698|NCT01855919|540351910|FG000|Overall Study|Lack of Efficacy|1|||
149788699|NCT01855919|540351911|FG001|Overall Study|Lack of Efficacy|3|||
149788700|NCT01855919|540351910|FG000|Overall Study|Withdrawal by Subject|4|||
149788701|NCT01855919|540351911|FG001|Overall Study|Withdrawal by Subject|10|||
149788702|NCT01855919|540351910|FG000|Overall Study|Entry Criteria Not Met|1|||
149788703|NCT01855919|540351911|FG001|Overall Study|Entry Criteria Not Met|1|||
149788704|NCT01855919|540351910|FG000|Overall Study|Protocol Violation|1|||
149788705|NCT01855919|540351911|FG001|Overall Study|Protocol Violation|4|||
149788706|NCT03455530|540351912|FG000|Overall Study|Withdrawal by Subject|9|||
149788707|NCT03455530|540351913|FG001|Overall Study|Withdrawal by Subject|1|||
149788708|NCT03455530|540351914|FG002|Overall Study|Withdrawal by Subject|3|||
149788709|NCT03455530|540351915|FG003|Overall Study|Withdrawal by Subject|3|||
149788710|NCT00740116|540351924|FG000|Overall Study|Withdrawal by Subject|1|||
149788711|NCT00740116|540351925|FG001|Overall Study|Withdrawal by Subject|1|||
149788712|NCT00740116|540351924|FG000|Overall Study|Protocol Violation|1|||
149788713|NCT00740116|540351925|FG001|Overall Study|Protocol Violation|4|||
149788714|NCT03037489|540351926|FG000|Overall Study|Adverse Event|4|||
149788715|NCT03037489|540351927|FG001|Overall Study|Adverse Event|0|||
149788716|NCT03037489|540351926|FG000|Overall Study|Withdrawal by Subject|3|||
149788717|NCT03037489|540351927|FG001|Overall Study|Withdrawal by Subject|0|||
149788718|NCT02499172|540351928|FG000|Overall Study|Financial reason|0|||
149788719|NCT02499172|540351929|FG001|Overall Study|Financial reason|0|||
149788720|NCT02499172|540351930|FG002|Overall Study|Financial reason|523|||
149788721|NCT02499172|540351931|FG003|Overall Study|Financial reason|436|||
149788722|NCT02499172|540351928|FG000|Overall Study|Lost to Follow-up|65|||
149788723|NCT02499172|540351929|FG001|Overall Study|Lost to Follow-up|64|||
149788724|NCT02499172|540351930|FG002|Overall Study|Lost to Follow-up|0|||
149788725|NCT02499172|540351931|FG003|Overall Study|Lost to Follow-up|0|||
149788726|NCT00724243|540351934|FG000|Overall Study|Lack of Efficacy|10|||
149788727|NCT00724243|540351934|FG000|Overall Study|Adverse Event|5|||
149788728|NCT00908895|540351936|FG000|Overall Study|Lost to Follow-up|1|||
149788729|NCT00908895|540351937|FG001|Overall Study|Lost to Follow-up|3|||
149788730|NCT00908895|540351936|FG000|Overall Study|algodystrophy|2|||
149788731|NCT00908895|540351937|FG001|Overall Study|algodystrophy|2|||
149788732|NCT00908895|540351936|FG000|Overall Study|Adverse Event|1|||
149788733|NCT00908895|540351937|FG001|Overall Study|Adverse Event|1|||
149788734|NCT01997892|540351940|FG000|Overall Study|Physician Decision|2|||
149788735|NCT01997892|540351940|FG000|Overall Study|Lost to Follow-up|6|||
149788736|NCT01997892|540351940|FG000|Overall Study|Death|14|||
149788737|NCT01997892|540351940|FG000|Overall Study|Renal transplant|8|||
149788738|NCT01997892|540351940|FG000|Overall Study|Other|3|||
149788739|NCT01997892|540351940|FG000|Overall Study|Study completion data not recorded|35|||
149788740|NCT00364611|540351941|FG000|Overall Study|Did not receive study medication|0|||
149788741|NCT00364611|540351942|FG001|Overall Study|Did not receive study medication|1|||
149788742|NCT00364611|540351941|FG000|Overall Study|Adverse Event|7|||
149788743|NCT00364611|540351942|FG001|Overall Study|Adverse Event|4|||
149788744|NCT00364611|540351941|FG000|Overall Study|Participant's Request|3|||
149788745|NCT00364611|540351942|FG001|Overall Study|Participant's Request|4|||
149788746|NCT00364611|540351941|FG000|Overall Study|Disease Progression|38|||
149788747|NCT00364611|540351942|FG001|Overall Study|Disease Progression|8|||
149788748|NCT00364611|540351941|FG000|Overall Study|Investigator decision|2|||
149788749|NCT00364611|540351942|FG001|Overall Study|Investigator decision|2|||
149788750|NCT00364611|540351941|FG000|Overall Study|Found Ineligible|1|||
149788751|NCT00364611|540351942|FG001|Overall Study|Found Ineligible|0|||
149788752|NCT00364611|540351941|FG000|Overall Study|Presumed CR on Study|0|||
149788753|NCT00364611|540351942|FG001|Overall Study|Presumed CR on Study|1|||
149788754|NCT00364611|540351941|FG000|Overall Study|Receiving Liver Ablation|0|||
149788755|NCT00364611|540351942|FG001|Overall Study|Receiving Liver Ablation|1|||
149788756|NCT04097925|540351955|FG000|Overall Study|Withdrawal by Subject|1|||
149788757|NCT00584987|540351977|FG000|Overall Study|Protocol Violation|1|||
149788758|NCT00584987|540351978|FG001|Overall Study|Protocol Violation|1|||
149788759|NCT00584987|540351979|FG002|Overall Study|Protocol Violation|1|||
149788760|NCT00584987|540351980|FG003|Overall Study|Protocol Violation|0|||
149788761|NCT00584987|540351977|FG000|Overall Study|Adverse Event|0|||
149788762|NCT00584987|540351978|FG001|Overall Study|Adverse Event|0|||
149788763|NCT00584987|540351979|FG002|Overall Study|Adverse Event|0|||
149788764|NCT00584987|540351980|FG003|Overall Study|Adverse Event|1|||
149788765|NCT01944462|540351983|FG000|PPPP Educational Program|Lost to Follow-up|60|||
149788766|NCT03225833|540351984|FG000|Overall Study|Adverse Event|0|||
149788767|NCT03225833|540351985|FG001|Overall Study|Adverse Event|1|||
149788768|NCT03225833|540351986|FG002|Overall Study|Adverse Event|2|||
149788769|NCT03225833|540351987|FG003|Overall Study|Adverse Event|0|||
149788770|NCT03225833|540351988|FG004|Overall Study|Adverse Event|0|||
149788771|NCT03225833|540351989|FG005|Overall Study|Adverse Event|2|||
149788772|NCT03225833|540351984|FG000|Overall Study|Withdrawal by Subject|1|||
149788773|NCT03225833|540351985|FG001|Overall Study|Withdrawal by Subject|0|||
149788774|NCT03225833|540351986|FG002|Overall Study|Withdrawal by Subject|0|||
149788775|NCT03225833|540351987|FG003|Overall Study|Withdrawal by Subject|0|||
149788776|NCT03225833|540351988|FG004|Overall Study|Withdrawal by Subject|1|||
149788777|NCT03225833|540351989|FG005|Overall Study|Withdrawal by Subject|0|||
149788778|NCT03225833|540351984|FG000|Overall Study|Termination of Study by Sponsor|4|||
149788779|NCT03225833|540351985|FG001|Overall Study|Termination of Study by Sponsor|0|||
149788780|NCT03225833|540351986|FG002|Overall Study|Termination of Study by Sponsor|0|||
149788781|NCT03225833|540351987|FG003|Overall Study|Termination of Study by Sponsor|0|||
149788782|NCT03225833|540351988|FG004|Overall Study|Termination of Study by Sponsor|0|||
149788783|NCT03225833|540351989|FG005|Overall Study|Termination of Study by Sponsor|7|||
149788784|NCT03225833|540351984|FG000|Overall Study|Sponsor Decision|0|||
149788785|NCT03225833|540351985|FG001|Overall Study|Sponsor Decision|0|||
149788786|NCT03225833|540351986|FG002|Overall Study|Sponsor Decision|0|||
149788787|NCT03225833|540351987|FG003|Overall Study|Sponsor Decision|0|||
149788788|NCT03225833|540351988|FG004|Overall Study|Sponsor Decision|0|||
149788789|NCT03225833|540351989|FG005|Overall Study|Sponsor Decision|1|||
149788790|NCT00723489|540351990|FG000|Overall Study|Physician Decision|0|||
149788791|NCT00723489|540351991|FG001|Overall Study|Physician Decision|1|||
149788792|NCT00723489|540351992|FG002|Overall Study|Physician Decision|0|||
149788793|NCT00723489|540351993|FG003|Overall Study|Physician Decision|0|||
149788794|NCT00723489|540351990|FG000|Overall Study|Pregnancy|0|||
149788795|NCT00723489|540351991|FG001|Overall Study|Pregnancy|0|||
149788796|NCT00723489|540351992|FG002|Overall Study|Pregnancy|0|||
149788797|NCT00723489|540351993|FG003|Overall Study|Pregnancy|1|||
149788798|NCT00723489|540351990|FG000|Overall Study|Withdrawal by Subject|0|||
149788799|NCT00723489|540351991|FG001|Overall Study|Withdrawal by Subject|0|||
149788800|NCT00723489|540351992|FG002|Overall Study|Withdrawal by Subject|0|||
149788801|NCT00723489|540351993|FG003|Overall Study|Withdrawal by Subject|1|||
149788802|NCT00723489|540351990|FG000|Overall Study|Seropositive at baseline|1|||
149788803|NCT00723489|540351991|FG001|Overall Study|Seropositive at baseline|0|||
149788804|NCT00723489|540351992|FG002|Overall Study|Seropositive at baseline|0|||
149788805|NCT00723489|540351993|FG003|Overall Study|Seropositive at baseline|0|||
149788806|NCT00723489|540351990|FG000|Overall Study|Prohibited Medication|0|||
149788807|NCT00723489|540351991|FG001|Overall Study|Prohibited Medication|0|||
149788808|NCT00723489|540351992|FG002|Overall Study|Prohibited Medication|0|||
149788809|NCT00723489|540351993|FG003|Overall Study|Prohibited Medication|1|||
149788810|NCT00723489|540351990|FG000|Overall Study|Samples Collected Out of Window|0|||
149788811|NCT00723489|540351991|FG001|Overall Study|Samples Collected Out of Window|3|||
149788812|NCT00723489|540351992|FG002|Overall Study|Samples Collected Out of Window|0|||
149788813|NCT00723489|540351993|FG003|Overall Study|Samples Collected Out of Window|0|||
149788814|NCT02274311|540351994|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
149788815|NCT03657576|540351995|FG000|Overall Study|Death|0|||
149788816|NCT03657576|540351996|FG001|Overall Study|Death|1|||
149788817|NCT03657576|540351997|FG002|Overall Study|Death|1|||
149788818|NCT03657576|540351998|FG003|Overall Study|Death|0|||
149788819|NCT03657576|540351999|FG004|Overall Study|Death|0|||
149788820|NCT03657576|540352000|FG005|Overall Study|Death|0|||
149788821|NCT03657576|540351995|FG000|Overall Study|Withdrawal by Subject|0|||
149788822|NCT03657576|540351996|FG001|Overall Study|Withdrawal by Subject|0|||
149788823|NCT03657576|540351997|FG002|Overall Study|Withdrawal by Subject|0|||
149788824|NCT03657576|540351998|FG003|Overall Study|Withdrawal by Subject|1|||
149788825|NCT03657576|540351999|FG004|Overall Study|Withdrawal by Subject|0|||
149788826|NCT03657576|540352000|FG005|Overall Study|Withdrawal by Subject|0|||
149788827|NCT03657576|540351995|FG000|Overall Study|Screen Fail|0|||
149788828|NCT03657576|540351996|FG001|Overall Study|Screen Fail|0|||
149788829|NCT03657576|540351997|FG002|Overall Study|Screen Fail|0|||
149788830|NCT03657576|540351998|FG003|Overall Study|Screen Fail|0|||
149788831|NCT03657576|540351999|FG004|Overall Study|Screen Fail|0|||
149788832|NCT03657576|540352000|FG005|Overall Study|Screen Fail|5|||
149788833|NCT03657576|540351995|FG000|Overall Study|Disease Progression|1|||
149788834|NCT03657576|540351996|FG001|Overall Study|Disease Progression|1|||
149788835|NCT03657576|540351997|FG002|Overall Study|Disease Progression|0|||
149788836|NCT03657576|540351998|FG003|Overall Study|Disease Progression|5|||
149788837|NCT03657576|540351999|FG004|Overall Study|Disease Progression|0|||
149788838|NCT03657576|540352000|FG005|Overall Study|Disease Progression|0|||
149788839|NCT03657576|540351995|FG000|Overall Study|Insurance Coverage|0|||
149788840|NCT03657576|540351996|FG001|Overall Study|Insurance Coverage|0|||
149788841|NCT03657576|540351997|FG002|Overall Study|Insurance Coverage|0|||
149788842|NCT03657576|540351998|FG003|Overall Study|Insurance Coverage|1|||
149788843|NCT03657576|540351999|FG004|Overall Study|Insurance Coverage|0|||
149788844|NCT03657576|540352000|FG005|Overall Study|Insurance Coverage|0|||
149788845|NCT05492877|540352001|FG000|Overall Study|Adverse Event|11|||
149788846|NCT05492877|540352002|FG001|Overall Study|Adverse Event|7|||
149788847|NCT05492877|540352001|FG000|Overall Study|Death|1|||
149788848|NCT05492877|540352002|FG001|Overall Study|Death|0|||
149788849|NCT05492877|540352001|FG000|Overall Study|Lost to Follow-up|1|||
149788850|NCT05492877|540352002|FG001|Overall Study|Lost to Follow-up|1|||
149788851|NCT05492877|540352001|FG000|Overall Study|Physician Decision|1|||
149788852|NCT05492877|540352002|FG001|Overall Study|Physician Decision|2|||
149788853|NCT05492877|540352001|FG000|Overall Study|Protocol Violation|1|||
149788854|NCT05492877|540352002|FG001|Overall Study|Protocol Violation|1|||
149788855|NCT05492877|540352001|FG000|Overall Study|Withdrawal by Subject|3|||
149788856|NCT05492877|540352002|FG001|Overall Study|Withdrawal by Subject|7|||
149788857|NCT05492877|540352001|FG000|Overall Study|Reason not specified|6|||
149788858|NCT05492877|540352002|FG001|Overall Study|Reason not specified|4|||
149788859|NCT01426009|540352003|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
149788860|NCT01426009|540352003|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
149788861|NCT01426009|540352003|FG000|Washout 1|Withdrawal by Subject|1|||
149788862|NCT01426009|540352003|FG000|Washout 1|Personal Reasons|1|||
149788863|NCT01426009|540352003|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
149788864|NCT01426009|540352003|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
149788865|NCT01426009|540352003|FG000|Washout 2|electrive surgery|1|||
149788866|NCT01426009|540352003|FG000|Washout 3|personal reasons|1|||
149788867|NCT01426009|540352003|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
149788868|NCT01426009|540352003|FG000|Washout 4|Lost to Follow-up|1|||
149788869|NCT00397631|540352012|FG000|Overall Study|Adverse Event|5|||
149788870|NCT00397631|540352013|FG001|Overall Study|Adverse Event|6|||
149788871|NCT00397631|540352012|FG000|Overall Study|Lack of Efficacy|7|||
149788872|NCT00397631|540352013|FG001|Overall Study|Lack of Efficacy|10|||
149788873|NCT00397631|540352012|FG000|Overall Study|Lost to Follow-up|8|||
149788874|NCT00397631|540352013|FG001|Overall Study|Lost to Follow-up|9|||
149788875|NCT00397631|540352012|FG000|Overall Study|Physician Decision|2|||
149788876|NCT00397631|540352013|FG001|Overall Study|Physician Decision|0|||
149788877|NCT00397631|540352012|FG000|Overall Study|Protocol Violation|0|||
149788878|NCT00397631|540352013|FG001|Overall Study|Protocol Violation|1|||
149788879|NCT00397631|540352012|FG000|Overall Study|Withdrawal by Subject|7|||
149788880|NCT00397631|540352013|FG001|Overall Study|Withdrawal by Subject|14|||
149788881|NCT00397631|540352012|FG000|Overall Study|protocol discontinuation criteria|1|||
149788882|NCT00397631|540352013|FG001|Overall Study|protocol discontinuation criteria|4|||
149788883|NCT01878175|540352015|FG000|Overall Study|Developed contraindicated health problem|2|||
149788884|NCT02711553|540352018|FG000|Overall Study|Withdrawal by Subject|2|||
149788885|NCT02711553|540352019|FG001|Overall Study|Withdrawal by Subject|1|||
149788886|NCT02711553|540352020|FG002|Overall Study|Withdrawal by Subject|1|||
149788887|NCT02711553|540352021|FG003|Overall Study|Withdrawal by Subject|0|||
149788888|NCT02711553|540352018|FG000|Overall Study|Lost to Follow-up|3|||
149788889|NCT02711553|540352019|FG001|Overall Study|Lost to Follow-up|3|||
149788890|NCT02711553|540352020|FG002|Overall Study|Lost to Follow-up|6|||
149788891|NCT02711553|540352021|FG003|Overall Study|Lost to Follow-up|3|||
149788892|NCT02711553|540352018|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
149788893|NCT02711553|540352019|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
149788894|NCT02711553|540352020|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
149788895|NCT02711553|540352021|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
149788896|NCT00572728|540352024|FG000|Overall Study|Withdrawal by Subject|10|||
149788897|NCT00572728|540352024|FG000|Overall Study|Ineligible|3|||
149788898|NCT00572728|540352024|FG000|Overall Study|Enrolled under Amendment 4|5|||
149788899|NCT00572728|540352024|FG000|Overall Study|Offstudy due to complicating disease|1|||
149788900|NCT00572728|540352024|FG000|Overall Study|FLT1 not completed|4|||
149788901|NCT00572728|540352024|FG000|Overall Study|First Chemotherapy not initiated|2|||
149788902|NCT00572728|540352024|FG000|Overall Study|FLT2 not completed|5|||
149788903|NCT00572728|540352024|FG000|Overall Study|Second chemotherapy not initiated|1|||
149788904|NCT00572728|540352024|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
149788905|NCT00572728|540352024|FG000|Overall Study|Pathology missing|1|||
149788906|NCT03457636|540352027|FG000|Overall Study|Lost to Follow-up|2|||
149788907|NCT02724111|540352028|FG000|Overall Study|Protocol Violation|2|||
149788908|NCT02724111|540352029|FG001|Overall Study|Protocol Violation|5|||
149788909|NCT01828567|540352032|FG000|Overall Study|Lost to Follow-up|27|||
149788910|NCT01828567|540352033|FG001|Overall Study|Lost to Follow-up|9|||
149788911|NCT01828567|540352032|FG000|Overall Study|Excluded - did not meet criteria|4|||
149788912|NCT01828567|540352033|FG001|Overall Study|Excluded - did not meet criteria|1|||
149788913|NCT02332876|540352034|FG000|Overall Study|Lost to Follow-up|1|||
149788914|NCT02332876|540352035|FG001|Overall Study|Lost to Follow-up|1|||
149788915|NCT02415595|540352036|FG000|Overall Study|Administrative reason by sponsor|39|||
149788916|NCT02415595|540352037|FG001|Overall Study|Administrative reason by sponsor|40|||
149788917|NCT02415595|540352038|FG002|Overall Study|Administrative reason by sponsor|41|||
149788918|NCT02415595|540352039|FG003|Overall Study|Administrative reason by sponsor|39|||
149788919|NCT02415595|540352036|FG000|Overall Study|Adverse Event|1|||
149788920|NCT02415595|540352037|FG001|Overall Study|Adverse Event|3|||
149788921|NCT02415595|540352038|FG002|Overall Study|Adverse Event|5|||
149788922|NCT02415595|540352039|FG003|Overall Study|Adverse Event|10|||
149788923|NCT02415595|540352036|FG000|Overall Study|Lack of Efficacy|4|||
149788924|NCT02415595|540352037|FG001|Overall Study|Lack of Efficacy|4|||
149788925|NCT02415595|540352038|FG002|Overall Study|Lack of Efficacy|0|||
149788926|NCT02415595|540352039|FG003|Overall Study|Lack of Efficacy|0|||
149788927|NCT02415595|540352036|FG000|Overall Study|Lost to Follow-up|1|||
149788928|NCT02415595|540352037|FG001|Overall Study|Lost to Follow-up|3|||
149788929|NCT02415595|540352038|FG002|Overall Study|Lost to Follow-up|1|||
149788930|NCT02415595|540352039|FG003|Overall Study|Lost to Follow-up|1|||
149788931|NCT02415595|540352036|FG000|Overall Study|Poor/Non-compliance|1|||
149788932|NCT02415595|540352037|FG001|Overall Study|Poor/Non-compliance|0|||
149788933|NCT02415595|540352038|FG002|Overall Study|Poor/Non-compliance|1|||
149788934|NCT02415595|540352039|FG003|Overall Study|Poor/Non-compliance|0|||
149788935|NCT02415595|540352036|FG000|Overall Study|Reached stopping criteria|0|||
149788936|NCT02415595|540352037|FG001|Overall Study|Reached stopping criteria|1|||
149788937|NCT02415595|540352038|FG002|Overall Study|Reached stopping criteria|1|||
149788938|NCT02415595|540352039|FG003|Overall Study|Reached stopping criteria|0|||
149788939|NCT02415595|540352036|FG000|Overall Study|Withdrawal by Subject|4|||
149788940|NCT02415595|540352037|FG001|Overall Study|Withdrawal by Subject|0|||
149788941|NCT02415595|540352038|FG002|Overall Study|Withdrawal by Subject|1|||
149788942|NCT02415595|540352039|FG003|Overall Study|Withdrawal by Subject|3|||
149788943|NCT02415595|540352036|FG000|Overall Study|Other|0|||
149788944|NCT02415595|540352037|FG001|Overall Study|Other|1|||
149788945|NCT02415595|540352038|FG002|Overall Study|Other|1|||
149788946|NCT02415595|540352039|FG003|Overall Study|Other|0|||
149788947|NCT04063865|540352041|FG000|Overall Study|Physician Decision|1|||
149788948|NCT04063865|540352042|FG001|Overall Study|Physician Decision|3|||
149788949|NCT04063865|540352041|FG000|Overall Study|Study Closed Prior to Completion|4|||
149788950|NCT04063865|540352042|FG001|Overall Study|Study Closed Prior to Completion|4|||
149788951|NCT04063865|540352041|FG000|Overall Study|Withdrawal by Subject|1|||
149788952|NCT04063865|540352042|FG001|Overall Study|Withdrawal by Subject|1|||
149788953|NCT01700140|540352043|FG000|Overall Study|Use of rescue drugs|3|||
149788954|NCT01700140|540352044|FG001|Overall Study|Use of rescue drugs|3|||
149788955|NCT01700140|540352045|FG002|Overall Study|Use of rescue drugs|1|||
149788956|NCT01700140|540352043|FG000|Overall Study|Discontinuation of radiotherapy|1|||
149788957|NCT01700140|540352044|FG001|Overall Study|Discontinuation of radiotherapy|0|||
149788958|NCT01700140|540352045|FG002|Overall Study|Discontinuation of radiotherapy|0|||
149788959|NCT01700140|540352043|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
149788960|NCT01700140|540352044|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
149788961|NCT01700140|540352045|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
149788962|NCT01700140|540352043|FG000|Overall Study|Aggravation of symptoms|1|||
149788963|NCT01700140|540352044|FG001|Overall Study|Aggravation of symptoms|0|||
149788964|NCT01700140|540352045|FG002|Overall Study|Aggravation of symptoms|0|||
149788965|NCT01700140|540352043|FG000|Overall Study|Adverse Event|0|||
149788966|NCT01700140|540352044|FG001|Overall Study|Adverse Event|1|||
149788967|NCT01700140|540352045|FG002|Overall Study|Adverse Event|0|||
149788968|NCT01700140|540352043|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
149788969|NCT01700140|540352044|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
149788970|NCT01700140|540352045|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
149788971|NCT01060124|540352046|FG000|Overall Study|Other|16|||
149788972|NCT01060124|540352046|FG000|Overall Study|Adverse Event|14|||
149788973|NCT01060124|540352046|FG000|Overall Study|Withdrawal by Subject|7|||
149788974|NCT01708915|540352047|FG000|Overall Study|Adverse Event|1|||
149788975|NCT01708915|540352048|FG001|Overall Study|Adverse Event|0|||
149788976|NCT01708915|540352049|FG002|Overall Study|Adverse Event|9|||
149788977|NCT01708915|540352050|FG003|Overall Study|Adverse Event|13|||
149788978|NCT01708915|540352047|FG000|Overall Study|Lack of Efficacy|84|||
149788979|NCT01708915|540352048|FG001|Overall Study|Lack of Efficacy|60|||
149788980|NCT01708915|540352049|FG002|Overall Study|Lack of Efficacy|35|||
149788981|NCT01708915|540352050|FG003|Overall Study|Lack of Efficacy|15|||
149788982|NCT01708915|540352047|FG000|Overall Study|Protocol Violation|0|||
149788983|NCT01708915|540352048|FG001|Overall Study|Protocol Violation|0|||
149788984|NCT01708915|540352049|FG002|Overall Study|Protocol Violation|0|||
149788985|NCT01708915|540352050|FG003|Overall Study|Protocol Violation|1|||
149788986|NCT01708915|540352047|FG000|Overall Study|Withdrawal by Subject|0|||
149788987|NCT01708915|540352048|FG001|Overall Study|Withdrawal by Subject|1|||
149788988|NCT01708915|540352049|FG002|Overall Study|Withdrawal by Subject|2|||
149788989|NCT01708915|540352050|FG003|Overall Study|Withdrawal by Subject|2|||
149788990|NCT01708915|540352047|FG000|Overall Study|Other reasons than stated above|1|||
149788991|NCT01708915|540352048|FG001|Overall Study|Other reasons than stated above|1|||
149788992|NCT01708915|540352049|FG002|Overall Study|Other reasons than stated above|0|||
149788993|NCT01708915|540352050|FG003|Overall Study|Other reasons than stated above|2|||
149788994|NCT03231228|540352052|FG000|Overall Study|Lost to Follow-up|2|||
149788995|NCT03231228|540352053|FG001|Overall Study|Lost to Follow-up|0|||
149788996|NCT03231228|540352052|FG000|Overall Study|Physician Decision|1|||
149788997|NCT03231228|540352053|FG001|Overall Study|Physician Decision|0|||
149788998|NCT01222416|540352054|FG000|Overall Study|ineligible;metastasis|3|||
149788999|NCT01222416|540352055|FG001|Overall Study|ineligible;metastasis|0|||
149789000|NCT01222416|540352054|FG000|Overall Study|Adverse Event|4|||
149789001|NCT01222416|540352055|FG001|Overall Study|Adverse Event|0|||
149789002|NCT01222416|540352054|FG000|Overall Study|Withdrawal by Subject|5|||
149789003|NCT01222416|540352055|FG001|Overall Study|Withdrawal by Subject|0|||
149789004|NCT01222416|540352054|FG000|Overall Study|scheduling|6|||
149789005|NCT01222416|540352055|FG001|Overall Study|scheduling|0|||
149789006|NCT01222416|540352054|FG000|Overall Study|missed view/scan|1|||
149789007|NCT01222416|540352055|FG001|Overall Study|missed view/scan|0|||
149789008|NCT01222416|540352054|FG000|Overall Study|Death|1|||
149789009|NCT01222416|540352055|FG001|Overall Study|Death|0|||
149789010|NCT00518336|540352058|FG000|Year 7|Lost to Follow-up|2|||
149789011|NCT00518336|540352059|FG001|Year 7|Lost to Follow-up|0|||
149789012|NCT00518336|540352058|FG000|Year 7|Could not attend in time|0|||
149789013|NCT00518336|540352059|FG001|Year 7|Could not attend in time|3|||
149789014|NCT00518336|540352058|FG000|Year 8|Lost to Follow-up|1|||
149789015|NCT00518336|540352059|FG001|Year 8|Lost to Follow-up|1|||
149789016|NCT00518336|540352058|FG000|Year 8|Could not attend in time|0|||
149789017|NCT00518336|540352059|FG001|Year 8|Could not attend in time|1|||
149789018|NCT00518336|540352058|FG000|Year 9|Migrated/moved from study area|1|||
149789019|NCT00518336|540352059|FG001|Year 9|Migrated/moved from study area|1|||
149789020|NCT00518336|540352058|FG000|Year 9|Lost to Follow-up|3|||
149789021|NCT00518336|540352059|FG001|Year 9|Lost to Follow-up|0|||
149789022|NCT00518336|540352058|FG000|Year 9|Personal reasons|1|||
149789023|NCT00518336|540352059|FG001|Year 9|Personal reasons|0|||
149789024|NCT03053180|540354635|FG000|Overall Study|Failure to Return|1|||
149789025|NCT02972658|540354639|FG000|Overall Study|Adverse Event|0|||
149789026|NCT02972658|540354640|FG001|Overall Study|Adverse Event|3|||
149789027|NCT02972658|540354641|FG002|Overall Study|Adverse Event|0|||
149789028|NCT02972658|540354642|FG003|Overall Study|Adverse Event|2|||
149789029|NCT02972658|540354639|FG000|Overall Study|Other-determined by Investigator|1|||
149789030|NCT02972658|540354640|FG001|Overall Study|Other-determined by Investigator|1|||
149789031|NCT02972658|540354641|FG002|Overall Study|Other-determined by Investigator|0|||
149789032|NCT02972658|540354642|FG003|Overall Study|Other-determined by Investigator|0|||
149789033|NCT02972658|540354639|FG000|Overall Study|Death|0|||
149789034|NCT02972658|540354640|FG001|Overall Study|Death|0|||
149789035|NCT02972658|540354641|FG002|Overall Study|Death|0|||
149789036|NCT02972658|540354642|FG003|Overall Study|Death|1|||
149789037|NCT02972658|540354639|FG000|Overall Study|Lost to Follow-up|0|||
149789038|NCT02972658|540354640|FG001|Overall Study|Lost to Follow-up|1|||
149789039|NCT02972658|540354641|FG002|Overall Study|Lost to Follow-up|1|||
149789040|NCT02972658|540354642|FG003|Overall Study|Lost to Follow-up|2|||
149789041|NCT02972658|540354639|FG000|Overall Study|Progressive Disease|0|||
149789042|NCT02972658|540354640|FG001|Overall Study|Progressive Disease|1|||
149789043|NCT02972658|540354641|FG002|Overall Study|Progressive Disease|0|||
149789044|NCT02972658|540354642|FG003|Overall Study|Progressive Disease|1|||
149789045|NCT02972658|540354639|FG000|Overall Study|Withdrawal by Subject|4|||
149789046|NCT02972658|540354640|FG001|Overall Study|Withdrawal by Subject|4|||
149789047|NCT02972658|540354641|FG002|Overall Study|Withdrawal by Subject|1|||
149789048|NCT02972658|540354642|FG003|Overall Study|Withdrawal by Subject|6|||
149789049|NCT02972658|540354639|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149789050|NCT02972658|540354640|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149789051|NCT02972658|540354641|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149789052|NCT02972658|540354642|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
149789053|NCT02972658|540354639|FG000|Overall Study|Sponsor Decision|70|||
149789054|NCT02972658|540354640|FG001|Overall Study|Sponsor Decision|127|||
149789055|NCT02972658|540354641|FG002|Overall Study|Sponsor Decision|72|||
149789056|NCT02972658|540354642|FG003|Overall Study|Sponsor Decision|119|||
149789057|NCT03958149|540354643|FG000|Overall Study|Withdrawal by Subject|0|||
149789058|NCT03958149|540354644|FG001|Overall Study|Withdrawal by Subject|1|||
149789059|NCT00621764|540354646|FG000|Overall Study|Protocol Violation|0|||
149789060|NCT00621764|540354647|FG001|Overall Study|Protocol Violation|0|||
149789061|NCT00621764|540354648|FG002|Overall Study|Protocol Violation|0|||
149789062|NCT00621764|540354649|FG003|Overall Study|Protocol Violation|1|||
149789063|NCT03031327|540354654|FG000|Overall Study|Withdrawal by Subject|0|||
149789064|NCT03031327|540354655|FG001|Overall Study|Withdrawal by Subject|1|||
149789065|NCT03031327|540354656|FG002|Overall Study|Withdrawal by Subject|1|||
149789066|NCT02059174|540354657|FG000|Period 1|Withdrawal by Subject|0|||
149789067|NCT02059174|540354658|FG001|Period 1|Withdrawal by Subject|2|||
149789068|NCT02059174|540354657|FG000|Period 2|Withdrawal by Subject|0|||
149789069|NCT02059174|540354658|FG001|Period 2|Withdrawal by Subject|2|||
149789070|NCT02059174|540354657|FG000|Period 2|Protocol Violation|1|||
149789071|NCT02059174|540354658|FG001|Period 2|Protocol Violation|0|||
149789072|NCT02059174|540354657|FG000|Period 3|Physician Decision|1|||
149789073|NCT02059174|540354658|FG001|Period 3|Physician Decision|0|||
149789074|NCT04397757|540354659|FG000|Overall Study|Death|3|||
149789075|NCT04397757|540354660|FG001|Overall Study|Death|11|||
149789076|NCT04397757|540354659|FG000|Overall Study|Withdrawal by Subject|2|||
149789077|NCT04397757|540354660|FG001|Overall Study|Withdrawal by Subject|0|||
149789078|NCT04397757|540354659|FG000|Overall Study|Lost to Follow-up|4|||
149789079|NCT04397757|540354660|FG001|Overall Study|Lost to Follow-up|3|||
149789080|NCT02306148|540354661|FG000|Overall Study|Adverse Event|12|||
149789081|NCT02306148|540354662|FG001|Overall Study|Adverse Event|6|||
149789082|NCT02306148|540354661|FG000|Overall Study|Lost to Follow-up|1|||
149789083|NCT02306148|540354662|FG001|Overall Study|Lost to Follow-up|4|||
149789084|NCT04167514|540354669|FG000|Overall Study|Adverse event, not serious|0|||
149789085|NCT04167514|540354670|FG001|Overall Study|Adverse event, not serious|1|||
149789086|NCT04167514|540354669|FG000|Overall Study|Lost to Follow-up|1|||
149789087|NCT04167514|540354670|FG001|Overall Study|Lost to Follow-up|0|||
149789088|NCT04167514|540354669|FG000|Overall Study|Participant Decision|2|||
149789089|NCT04167514|540354670|FG001|Overall Study|Participant Decision|4|||
149789090|NCT04167514|540354669|FG000|Overall Study|Physician Decision|3|||
149789091|NCT04167514|540354670|FG001|Overall Study|Physician Decision|2|||
149789092|NCT04167514|540354669|FG000|Overall Study|Death|14|||
149789093|NCT04167514|540354670|FG001|Overall Study|Death|18|||
149789094|NCT04167514|540354669|FG000|Overall Study|Enrolled but treatment not administered|2|||
149789095|NCT04167514|540354670|FG001|Overall Study|Enrolled but treatment not administered|0|||
149789096|NCT04167514|540354669|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
149789097|NCT04167514|540354670|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
149789098|NCT04167514|540354669|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
149789099|NCT04167514|540354670|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
149789100|NCT00290355|540354671|FG000|Overall Study|Serious adverse event|7|||
149789101|NCT00290355|540354672|FG001|Overall Study|Serious adverse event|4|||
149789102|NCT00290355|540354671|FG000|Overall Study|Study product reactogenicity|1|||
149789103|NCT00290355|540354672|FG001|Overall Study|Study product reactogenicity|0|||
149789104|NCT00290355|540354671|FG000|Overall Study|Protocol Violation|1|||
149789105|NCT00290355|540354672|FG001|Overall Study|Protocol Violation|0|||
149789106|NCT00290355|540354671|FG000|Overall Study|Withdrawal by Subject|2|||
149789107|NCT00290355|540354672|FG001|Overall Study|Withdrawal by Subject|0|||
149789108|NCT00290355|540354671|FG000|Overall Study|Migrated / moved from the study area|1|||
149789109|NCT00290355|540354672|FG001|Overall Study|Migrated / moved from the study area|0|||
149789110|NCT00290355|540354671|FG000|Overall Study|Lost to Follow-up|3|||
149789111|NCT00290355|540354672|FG001|Overall Study|Lost to Follow-up|1|||
149789112|NCT00290355|540354671|FG000|Overall Study|Other|2|||
149789113|NCT00290355|540354672|FG001|Overall Study|Other|0|||
149789114|NCT03345849|540354673|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
149789115|NCT03345849|540354674|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
149789116|NCT03345849|540354675|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
149789117|NCT03345849|540354676|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
149789118|NCT03345849|540354673|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
149789119|NCT03345849|540354674|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
149789120|NCT03345849|540354675|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
149789121|NCT03345849|540354676|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
149789122|NCT03345849|540354673|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149789123|NCT03345849|540354674|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
149789124|NCT03345849|540354675|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149789125|NCT03345849|540354676|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149789126|NCT03345849|540354673|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
149789127|NCT03345849|540354674|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
149789128|NCT03345849|540354675|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
149789129|NCT03345849|540354676|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
149789130|NCT03345849|540354673|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149789131|NCT03345849|540354674|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
149789132|NCT03345849|540354675|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149789133|NCT03345849|540354676|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149789134|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
149789135|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
149789136|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
149789137|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
149789138|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
149789139|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
149789140|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
149789141|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
149789142|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
149789143|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
149789144|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
149789145|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
149789146|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149789147|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149789148|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149789149|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
149789150|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149789151|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149789152|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
149789153|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149789154|NCT03345849|540354673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
149789155|NCT03345849|540354674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
149789156|NCT03345849|540354675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
149789157|NCT03345849|540354676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
149789158|NCT00033514|540354677|FG000|Overall Study|Lost to Follow-up|1|||
149789159|NCT00033514|540354678|FG001|Overall Study|Lost to Follow-up|1|||
149789160|NCT00033514|540354677|FG000|Overall Study|Withdrawal by Subject|0|||
149789161|NCT00033514|540354678|FG001|Overall Study|Withdrawal by Subject|3|||
149789162|NCT01599585|540354688|FG000|Overall Study|Withdrawal by Subject|16|||
149789163|NCT01599585|540354689|FG001|Overall Study|Withdrawal by Subject|9|||
149789164|NCT01599585|540354688|FG000|Overall Study|Lost to Follow-up|3|||
149789165|NCT01599585|540354689|FG001|Overall Study|Lost to Follow-up|5|||
149789166|NCT01599585|540354688|FG000|Overall Study|randomized did not start treatment|3|||
149789167|NCT01599585|540354689|FG001|Overall Study|randomized did not start treatment|3|||
149789168|NCT04564027|540354690|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
149789169|NCT04564027|540354691|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
149789170|NCT04564027|540354692|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
149789171|NCT04564027|540354693|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
149789172|NCT00777036|540354694|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
149789173|NCT00777036|540354695|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
149789174|NCT00777036|540354696|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
149789175|NCT00777036|540354697|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
149789176|NCT00777036|540354694|FG000|On Treatment|Administrative Reason By Sponsor|1|||
149789177|NCT00777036|540354695|FG001|On Treatment|Administrative Reason By Sponsor|0|||
149789178|NCT00777036|540354696|FG002|On Treatment|Administrative Reason By Sponsor|9|||
149789179|NCT00777036|540354697|FG003|On Treatment|Administrative Reason By Sponsor|0|||
149789180|NCT00777036|540354694|FG000|On Treatment|Failure to Meet Study Criteria|0|||
149789181|NCT00777036|540354695|FG001|On Treatment|Failure to Meet Study Criteria|1|||
149789182|NCT00777036|540354696|FG002|On Treatment|Failure to Meet Study Criteria|4|||
149789183|NCT00777036|540354697|FG003|On Treatment|Failure to Meet Study Criteria|0|||
149789184|NCT00777036|540354694|FG000|On Treatment|Pregnancy|1|||
149789185|NCT00777036|540354695|FG001|On Treatment|Pregnancy|0|||
149789186|NCT00777036|540354696|FG002|On Treatment|Pregnancy|1|||
149789187|NCT00777036|540354697|FG003|On Treatment|Pregnancy|0|||
149789188|NCT00777036|540354694|FG000|On Treatment|Non-compliance with Study Drug|1|||
149789189|NCT00777036|540354695|FG001|On Treatment|Non-compliance with Study Drug|0|||
149789190|NCT00777036|540354696|FG002|On Treatment|Non-compliance with Study Drug|1|||
149789191|NCT00777036|540354697|FG003|On Treatment|Non-compliance with Study Drug|0|||
149789192|NCT00777036|540354694|FG000|On Treatment|Maximum Clinical Benefit|2|||
149789193|NCT00777036|540354695|FG001|On Treatment|Maximum Clinical Benefit|0|||
149789194|NCT00777036|540354696|FG002|On Treatment|Maximum Clinical Benefit|5|||
149789195|NCT00777036|540354697|FG003|On Treatment|Maximum Clinical Benefit|0|||
149789196|NCT00777036|540354694|FG000|On Treatment|Withdrawal by Subject|0|||
149789197|NCT00777036|540354695|FG001|On Treatment|Withdrawal by Subject|2|||
149789198|NCT00777036|540354696|FG002|On Treatment|Withdrawal by Subject|2|||
149789199|NCT00777036|540354697|FG003|On Treatment|Withdrawal by Subject|0|||
149789200|NCT00777036|540354694|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
149789201|NCT00777036|540354695|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
149789202|NCT00777036|540354696|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
149789203|NCT00777036|540354697|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
149789204|NCT00777036|540354694|FG000|On Treatment|Death|0|||
149789205|NCT00777036|540354695|FG001|On Treatment|Death|2|||
149789206|NCT00777036|540354696|FG002|On Treatment|Death|0|||
149789207|NCT00777036|540354697|FG003|On Treatment|Death|0|||
149789208|NCT00777036|540354694|FG000|On Treatment|Study Drug Toxicity|1|||
149789209|NCT00777036|540354695|FG001|On Treatment|Study Drug Toxicity|0|||
149789210|NCT00777036|540354696|FG002|On Treatment|Study Drug Toxicity|4|||
149789211|NCT00777036|540354697|FG003|On Treatment|Study Drug Toxicity|0|||
149789212|NCT00777036|540354694|FG000|On Treatment|Progressive Disease|6|||
149789213|NCT00777036|540354695|FG001|On Treatment|Progressive Disease|4|||
149789214|NCT00777036|540354696|FG002|On Treatment|Progressive Disease|7|||
149789215|NCT00777036|540354697|FG003|On Treatment|Progressive Disease|0|||
149789216|NCT00777036|540354694|FG000|On Treatment|Not Reported|0|||
149789217|NCT00777036|540354695|FG001|On Treatment|Not Reported|0|||
149789218|NCT00777036|540354696|FG002|On Treatment|Not Reported|2|||
149789219|NCT00777036|540354697|FG003|On Treatment|Not Reported|0|||
149789220|NCT00777036|540354694|FG000|On Treatment|Site Closed|0|||
149789221|NCT00777036|540354695|FG001|On Treatment|Site Closed|1|||
149789222|NCT00777036|540354696|FG002|On Treatment|Site Closed|1|||
149789223|NCT00777036|540354697|FG003|On Treatment|Site Closed|0|||
149789224|NCT00777036|540354694|FG000|Follow-Up|Withdrawal by Subject|0|||
149789225|NCT00777036|540354695|FG001|Follow-Up|Withdrawal by Subject|0|||
149789226|NCT00777036|540354696|FG002|Follow-Up|Withdrawal by Subject|5|||
149789227|NCT00777036|540354697|FG003|Follow-Up|Withdrawal by Subject|0|||
149789228|NCT00777036|540354694|FG000|Follow-Up|Death|1|||
149789229|NCT00777036|540354695|FG001|Follow-Up|Death|9|||
149789230|NCT00777036|540354696|FG002|Follow-Up|Death|0|||
149789231|NCT00777036|540354697|FG003|Follow-Up|Death|0|||
149789232|NCT00777036|540354694|FG000|Follow-Up|Lost to Follow-up|3|||
149789233|NCT00777036|540354695|FG001|Follow-Up|Lost to Follow-up|0|||
149789234|NCT00777036|540354696|FG002|Follow-Up|Lost to Follow-up|0|||
149789235|NCT00777036|540354697|FG003|Follow-Up|Lost to Follow-up|0|||
149789236|NCT00777036|540354694|FG000|Follow-Up|Reason Not Specified|4|||
149789237|NCT00777036|540354695|FG001|Follow-Up|Reason Not Specified|0|||
149789238|NCT00777036|540354696|FG002|Follow-Up|Reason Not Specified|13|||
149789239|NCT00777036|540354697|FG003|Follow-Up|Reason Not Specified|0|||
149789240|NCT00777036|540354694|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
149789241|NCT00777036|540354695|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
149789242|NCT00777036|540354696|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
149789243|NCT00777036|540354697|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
149789244|NCT05827978|540354700|FG000|Overall Study|Adverse Event|1|||
149789245|NCT05827978|540354701|FG001|Overall Study|Adverse Event|0|||
149789246|NCT05827978|540354702|FG002|Overall Study|Adverse Event|0|||
149789247|NCT05827978|540354703|FG003|Overall Study|Adverse Event|1|||
149789248|NCT05827978|540354704|FG004|Overall Study|Adverse Event|0|||
149789249|NCT05827978|540354705|FG005|Overall Study|Adverse Event|0|||
149789250|NCT05827978|540354700|FG000|Overall Study|Death|1|||
149789251|NCT05827978|540354701|FG001|Overall Study|Death|5|||
149789252|NCT05827978|540354702|FG002|Overall Study|Death|2|||
149789253|NCT05827978|540354703|FG003|Overall Study|Death|3|||
149789254|NCT05827978|540354704|FG004|Overall Study|Death|1|||
149789255|NCT05827978|540354705|FG005|Overall Study|Death|3|||
149789256|NCT05827978|540354700|FG000|Overall Study|Lost to Follow-up|57|||
149789257|NCT05827978|540354701|FG001|Overall Study|Lost to Follow-up|88|||
149789258|NCT05827978|540354702|FG002|Overall Study|Lost to Follow-up|54|||
149789259|NCT05827978|540354703|FG003|Overall Study|Lost to Follow-up|47|||
149789260|NCT05827978|540354704|FG004|Overall Study|Lost to Follow-up|25|||
149789261|NCT05827978|540354705|FG005|Overall Study|Lost to Follow-up|10|||
149789262|NCT05827978|540354700|FG000|Overall Study|Noncompliance with Study Procedures|0|||
149789263|NCT05827978|540354701|FG001|Overall Study|Noncompliance with Study Procedures|1|||
149789264|NCT05827978|540354702|FG002|Overall Study|Noncompliance with Study Procedures|1|||
149789265|NCT05827978|540354703|FG003|Overall Study|Noncompliance with Study Procedures|1|||
149789266|NCT05827978|540354704|FG004|Overall Study|Noncompliance with Study Procedures|1|||
149789267|NCT05827978|540354705|FG005|Overall Study|Noncompliance with Study Procedures|0|||
149789268|NCT05827978|540354700|FG000|Overall Study|Physician Decision|2|||
149789269|NCT05827978|540354701|FG001|Overall Study|Physician Decision|0|||
149789270|NCT05827978|540354702|FG002|Overall Study|Physician Decision|1|||
149789271|NCT05827978|540354703|FG003|Overall Study|Physician Decision|2|||
149789272|NCT05827978|540354704|FG004|Overall Study|Physician Decision|1|||
149789273|NCT05827978|540354705|FG005|Overall Study|Physician Decision|1|||
149789274|NCT05827978|540354700|FG000|Overall Study|Protocol Violation|5|||
149789275|NCT05827978|540354701|FG001|Overall Study|Protocol Violation|2|||
149789276|NCT05827978|540354702|FG002|Overall Study|Protocol Violation|0|||
149789277|NCT05827978|540354703|FG003|Overall Study|Protocol Violation|0|||
149789278|NCT05827978|540354704|FG004|Overall Study|Protocol Violation|0|||
149789279|NCT05827978|540354705|FG005|Overall Study|Protocol Violation|0|||
149789280|NCT05827978|540354700|FG000|Overall Study|Withdrawal by Subject|17|||
149789281|NCT05827978|540354701|FG001|Overall Study|Withdrawal by Subject|16|||
149789282|NCT05827978|540354702|FG002|Overall Study|Withdrawal by Subject|10|||
149789283|NCT05827978|540354703|FG003|Overall Study|Withdrawal by Subject|12|||
149789284|NCT05827978|540354704|FG004|Overall Study|Withdrawal by Subject|10|||
149789285|NCT05827978|540354705|FG005|Overall Study|Withdrawal by Subject|9|||
149789286|NCT05827978|540354700|FG000|Overall Study|Other Than Specified|0|||
149789287|NCT05827978|540354701|FG001|Overall Study|Other Than Specified|0|||
149789288|NCT05827978|540354702|FG002|Overall Study|Other Than Specified|1|||
149789289|NCT05827978|540354703|FG003|Overall Study|Other Than Specified|0|||
149789290|NCT05827978|540354704|FG004|Overall Study|Other Than Specified|2|||
149789291|NCT05827978|540354705|FG005|Overall Study|Other Than Specified|0|||
149789292|NCT05564039|540354706|FG000|Overall Study|Adverse Event|1|||
149789293|NCT05564039|540354707|FG001|Overall Study|Adverse Event|0|||
149789294|NCT05564039|540354706|FG000|Overall Study|Death|1|||
149789295|NCT05564039|540354707|FG001|Overall Study|Death|1|||
149789296|NCT05564039|540354706|FG000|Overall Study|Lost to Follow-up|3|||
149789297|NCT05564039|540354707|FG001|Overall Study|Lost to Follow-up|2|||
149789298|NCT05564039|540354706|FG000|Overall Study|Withdrawal by Subject|2|||
149789299|NCT05564039|540354707|FG001|Overall Study|Withdrawal by Subject|0|||
149789300|NCT05564039|540354706|FG000|Overall Study|Inadvertent enrollment|3|||
149789301|NCT05564039|540354707|FG001|Overall Study|Inadvertent enrollment|6|||
149789302|NCT04566445|540354708|FG000|Overall Study|Death|4|||
149789303|NCT04566445|540354709|FG001|Overall Study|Death|1|||
149789304|NCT04566445|540354710|FG002|Overall Study|Death|1|||
149789305|NCT04566445|540354708|FG000|Overall Study|Lost to Follow-up|3|||
149789306|NCT04566445|540354709|FG001|Overall Study|Lost to Follow-up|1|||
149789307|NCT04566445|540354710|FG002|Overall Study|Lost to Follow-up|1|||
149789308|NCT04566445|540354708|FG000|Overall Study|Study terminated by sponsor|11|||
149789309|NCT04566445|540354709|FG001|Overall Study|Study terminated by sponsor|17|||
149789310|NCT04566445|540354710|FG002|Overall Study|Study terminated by sponsor|32|||
149789311|NCT04566445|540354708|FG000|Overall Study|Withdrawal by Subject|12|||
149789312|NCT04566445|540354709|FG001|Overall Study|Withdrawal by Subject|14|||
149789313|NCT04566445|540354710|FG002|Overall Study|Withdrawal by Subject|13|||
149789314|NCT04566445|540354708|FG000|Overall Study|Randomized but not treated due to AE|2|||
149789315|NCT04566445|540354709|FG001|Overall Study|Randomized but not treated due to AE|1|||
149789316|NCT04566445|540354710|FG002|Overall Study|Randomized but not treated due to AE|0|||
149789317|NCT04566445|540354708|FG000|Overall Study|Adverse Event|1|||
149789318|NCT04566445|540354709|FG001|Overall Study|Adverse Event|1|||
149789319|NCT04566445|540354710|FG002|Overall Study|Adverse Event|0|||
149789320|NCT04785144|540354711|FG000|Overall Study|Withdrawal by Subject|4|||
149789321|NCT04785144|540354712|FG001|Overall Study|Withdrawal by Subject|1|||
149789322|NCT04785144|540354713|FG002|Overall Study|Withdrawal by Subject|0|||
149789323|NCT04785144|540354714|FG003|Overall Study|Withdrawal by Subject|0|||
149789324|NCT04785144|540354715|FG004|Overall Study|Withdrawal by Subject|0|||
149789325|NCT04785144|540354716|FG005|Overall Study|Withdrawal by Subject|2|||
149789326|NCT04785144|540354717|FG006|Overall Study|Withdrawal by Subject|2|||
149789327|NCT04785144|540354718|FG007|Overall Study|Withdrawal by Subject|0|||
149789328|NCT04785144|540354719|FG008|Overall Study|Withdrawal by Subject|1|||
149789329|NCT04785144|540354720|FG009|Overall Study|Withdrawal by Subject|0|||
149789330|NCT04785144|540354711|FG000|Overall Study|Lost to Follow-up|1|||
149789331|NCT04785144|540354712|FG001|Overall Study|Lost to Follow-up|0|||
149789332|NCT04785144|540354713|FG002|Overall Study|Lost to Follow-up|0|||
149789333|NCT04785144|540354714|FG003|Overall Study|Lost to Follow-up|0|||
149789334|NCT04785144|540354715|FG004|Overall Study|Lost to Follow-up|1|||
149789335|NCT04785144|540354716|FG005|Overall Study|Lost to Follow-up|2|||
149789336|NCT04785144|540354717|FG006|Overall Study|Lost to Follow-up|1|||
149789337|NCT04785144|540354718|FG007|Overall Study|Lost to Follow-up|2|||
149789338|NCT04785144|540354719|FG008|Overall Study|Lost to Follow-up|4|||
149789339|NCT04785144|540354720|FG009|Overall Study|Lost to Follow-up|1|||
149789340|NCT04785144|540354711|FG000|Overall Study|Protocol Violation|0|||
149789341|NCT04785144|540354712|FG001|Overall Study|Protocol Violation|0|||
149789342|NCT04785144|540354713|FG002|Overall Study|Protocol Violation|0|||
149789343|NCT04785144|540354714|FG003|Overall Study|Protocol Violation|0|||
149789344|NCT04785144|540354715|FG004|Overall Study|Protocol Violation|0|||
149789345|NCT04785144|540354716|FG005|Overall Study|Protocol Violation|0|||
149789346|NCT04785144|540354717|FG006|Overall Study|Protocol Violation|1|||
149789347|NCT04785144|540354718|FG007|Overall Study|Protocol Violation|0|||
149789348|NCT04785144|540354719|FG008|Overall Study|Protocol Violation|0|||
149789349|NCT04785144|540354720|FG009|Overall Study|Protocol Violation|0|||
149789350|NCT04785144|540354711|FG000|Overall Study|Physician Decision|0|||
149789351|NCT04785144|540354712|FG001|Overall Study|Physician Decision|0|||
149789352|NCT04785144|540354713|FG002|Overall Study|Physician Decision|0|||
149789353|NCT04785144|540354714|FG003|Overall Study|Physician Decision|0|||
149789354|NCT04785144|540354715|FG004|Overall Study|Physician Decision|0|||
149789355|NCT04785144|540354716|FG005|Overall Study|Physician Decision|0|||
149789356|NCT04785144|540354717|FG006|Overall Study|Physician Decision|0|||
149789357|NCT04785144|540354718|FG007|Overall Study|Physician Decision|0|||
149789358|NCT04785144|540354719|FG008|Overall Study|Physician Decision|0|||
149789359|NCT04785144|540354720|FG009|Overall Study|Physician Decision|1|||
149789360|NCT04785144|540354711|FG000|Overall Study|Unable to continue due to work schedule|0|||
149789361|NCT04785144|540354712|FG001|Overall Study|Unable to continue due to work schedule|0|||
149789362|NCT04785144|540354713|FG002|Overall Study|Unable to continue due to work schedule|0|||
149789363|NCT04785144|540354714|FG003|Overall Study|Unable to continue due to work schedule|0|||
149789364|NCT04785144|540354715|FG004|Overall Study|Unable to continue due to work schedule|0|||
149789365|NCT04785144|540354716|FG005|Overall Study|Unable to continue due to work schedule|0|||
149789366|NCT04785144|540354717|FG006|Overall Study|Unable to continue due to work schedule|0|||
149789367|NCT04785144|540354718|FG007|Overall Study|Unable to continue due to work schedule|0|||
149789368|NCT04785144|540354719|FG008|Overall Study|Unable to continue due to work schedule|0|||
149789369|NCT04785144|540354720|FG009|Overall Study|Unable to continue due to work schedule|1|||
149789370|NCT00610714|540354723|FG000|Overall Study|Adverse Event|3|||
149789371|NCT00610714|540354724|FG001|Overall Study|Adverse Event|1|||
149789372|NCT00610714|540354723|FG000|Overall Study|Death|12|||
149789373|NCT00610714|540354724|FG001|Overall Study|Death|18|||
149789374|NCT00610714|540354723|FG000|Overall Study|Withdrawal by Subject|9|||
149789375|NCT00610714|540354724|FG001|Overall Study|Withdrawal by Subject|3|||
149789376|NCT00610714|540354723|FG000|Overall Study|Study completion at 120 PFS events|2|||
149789377|NCT00610714|540354724|FG001|Overall Study|Study completion at 120 PFS events|2|||
149789378|NCT00829010|540354725|FG000|Overall Study|Adverse Event|1|||
149789379|NCT00829010|540354726|FG001|Overall Study|Adverse Event|0|||
149789380|NCT00829010|540354727|FG002|Overall Study|Adverse Event|0|||
149789381|NCT00829010|540354728|FG003|Overall Study|Adverse Event|0|||
149789382|NCT00829010|540354729|FG004|Overall Study|Adverse Event|0|||
149789383|NCT00829010|540354725|FG000|Overall Study|Withdrawal by Subject|0|||
149789384|NCT00829010|540354726|FG001|Overall Study|Withdrawal by Subject|1|||
149789385|NCT00829010|540354727|FG002|Overall Study|Withdrawal by Subject|1|||
149789386|NCT00829010|540354728|FG003|Overall Study|Withdrawal by Subject|0|||
149789387|NCT00829010|540354729|FG004|Overall Study|Withdrawal by Subject|2|||
149789388|NCT00829010|540354725|FG000|Overall Study|Lost to Follow-up|1|||
149789389|NCT00829010|540354726|FG001|Overall Study|Lost to Follow-up|0|||
149789390|NCT00829010|540354727|FG002|Overall Study|Lost to Follow-up|2|||
149789391|NCT00829010|540354728|FG003|Overall Study|Lost to Follow-up|0|||
149789392|NCT00829010|540354729|FG004|Overall Study|Lost to Follow-up|0|||
149789393|NCT00829010|540354725|FG000|Overall Study|Fatality|5|||
149789394|NCT00829010|540354726|FG001|Overall Study|Fatality|4|||
149789395|NCT00829010|540354727|FG002|Overall Study|Fatality|0|||
149789396|NCT00829010|540354728|FG003|Overall Study|Fatality|3|||
149789397|NCT00829010|540354729|FG004|Overall Study|Fatality|0|||
149789398|NCT00829010|540354725|FG000|Overall Study|Migrated/Moved from study area|3|||
149789399|NCT00829010|540354726|FG001|Overall Study|Migrated/Moved from study area|4|||
149789400|NCT00829010|540354727|FG002|Overall Study|Migrated/Moved from study area|0|||
149789401|NCT00829010|540354728|FG003|Overall Study|Migrated/Moved from study area|5|||
149789402|NCT00829010|540354729|FG004|Overall Study|Migrated/Moved from study area|0|||
149789403|NCT00137267|540354732|FG000|Overall Study|Lost to Follow-up|15|||
149789404|NCT00137267|540354733|FG001|Overall Study|Lost to Follow-up|21|||
149789405|NCT00638989|540354734|FG000|Overall Study|Lost to Follow-up|0|||
149789406|NCT00638989|540354735|FG001|Overall Study|Lost to Follow-up|0|||
149789407|NCT00638989|540354736|FG002|Overall Study|Lost to Follow-up|1|||
149789408|NCT00853112|540354739|FG000|Overall Study|Randomized but not treated|0|||
149789409|NCT00853112|540354740|FG001|Overall Study|Randomized but not treated|1|||
149789410|NCT00853112|540354741|FG002|Overall Study|Randomized but not treated|0|||
149789411|NCT00853112|540354742|FG003|Overall Study|Randomized but not treated|2|||
149789412|NCT00853112|540354743|FG004|Overall Study|Randomized but not treated|0|||
149789413|NCT00853112|540354744|FG005|Overall Study|Randomized but not treated|0|||
149789414|NCT00853112|540354745|FG006|Overall Study|Randomized but not treated|1|||
149789415|NCT01553591|540354746|FG000|Overall Study|Voluntarily withdrew|94|||
149789416|NCT01553591|540354747|FG001|Overall Study|Voluntarily withdrew|79|||
149789417|NCT01553591|540354748|FG002|Overall Study|Voluntarily withdrew|96|||
149789418|NCT01553591|540354746|FG000|Overall Study|Adverse Event|36|||
149789419|NCT01553591|540354747|FG001|Overall Study|Adverse Event|45|||
149789420|NCT01553591|540354748|FG002|Overall Study|Adverse Event|16|||
149789421|NCT01553591|540354746|FG000|Overall Study|Lost to Follow-up|25|||
149789422|NCT01553591|540354747|FG001|Overall Study|Lost to Follow-up|23|||
149789423|NCT01553591|540354748|FG002|Overall Study|Lost to Follow-up|16|||
149789424|NCT01553591|540354746|FG000|Overall Study|Physician decision: other|11|||
149789425|NCT01553591|540354747|FG001|Overall Study|Physician decision: other|14|||
149789426|NCT01553591|540354748|FG002|Overall Study|Physician decision: other|16|||
149789427|NCT01553591|540354746|FG000|Overall Study|Physician decision: lack of efficacy|2|||
149789428|NCT01553591|540354747|FG001|Overall Study|Physician decision: lack of efficacy|3|||
149789429|NCT01553591|540354748|FG002|Overall Study|Physician decision: lack of efficacy|7|||
149789430|NCT01553591|540354746|FG000|Overall Study|Protocol Violation|3|||
149789431|NCT01553591|540354747|FG001|Overall Study|Protocol Violation|4|||
149789432|NCT01553591|540354748|FG002|Overall Study|Protocol Violation|4|||
149789433|NCT01553591|540354746|FG000|Overall Study|Sponsor decision|1|||
149789434|NCT01553591|540354747|FG001|Overall Study|Sponsor decision|0|||
149789435|NCT01553591|540354748|FG002|Overall Study|Sponsor decision|3|||
149789436|NCT01553591|540354746|FG000|Overall Study|Randomized and never dispensed drug|0|||
149789437|NCT01553591|540354747|FG001|Overall Study|Randomized and never dispensed drug|1|||
149789438|NCT01553591|540354748|FG002|Overall Study|Randomized and never dispensed drug|0|||
149789439|NCT01818765|540354753|FG000|Overall Study|Death|2|||
149789440|NCT02005211|540354758|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789441|NCT02005211|540354759|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789442|NCT02005211|540354760|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789443|NCT02005211|540354761|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789444|NCT02005211|540354762|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
149789445|NCT02005211|540354763|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789446|NCT02005211|540354764|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149789447|NCT02202161|540354767|FG000|Overall Study|Adverse Event|1|||
149789448|NCT02202161|540354768|FG001|Overall Study|Adverse Event|1|||
149789449|NCT02202161|540354769|FG002|Overall Study|Adverse Event|0|||
149789450|NCT02202161|540354770|FG003|Overall Study|Adverse Event|0|||
149789451|NCT02202161|540354771|FG004|Overall Study|Adverse Event|0|||
149789452|NCT02202161|540354772|FG005|Overall Study|Adverse Event|1|||
149789453|NCT02202161|540354773|FG006|Overall Study|Adverse Event|0|||
149789454|NCT02202161|540354774|FG007|Overall Study|Adverse Event|0|||
149789455|NCT02202161|540354767|FG000|Overall Study|Did not meet continuation criteria|0|||
149789456|NCT02202161|540354768|FG001|Overall Study|Did not meet continuation criteria|0|||
149789457|NCT02202161|540354769|FG002|Overall Study|Did not meet continuation criteria|0|||
149789458|NCT02202161|540354770|FG003|Overall Study|Did not meet continuation criteria|0|||
149789459|NCT02202161|540354771|FG004|Overall Study|Did not meet continuation criteria|0|||
149789460|NCT02202161|540354772|FG005|Overall Study|Did not meet continuation criteria|0|||
149789461|NCT02202161|540354773|FG006|Overall Study|Did not meet continuation criteria|0|||
149789462|NCT02202161|540354774|FG007|Overall Study|Did not meet continuation criteria|3|||
149789463|NCT02202161|540354767|FG000|Overall Study|Physician Decision|0|||
149789464|NCT02202161|540354768|FG001|Overall Study|Physician Decision|0|||
149789465|NCT02202161|540354769|FG002|Overall Study|Physician Decision|0|||
149789466|NCT02202161|540354770|FG003|Overall Study|Physician Decision|0|||
149789467|NCT02202161|540354771|FG004|Overall Study|Physician Decision|0|||
149789468|NCT02202161|540354772|FG005|Overall Study|Physician Decision|0|||
149789469|NCT02202161|540354773|FG006|Overall Study|Physician Decision|0|||
149789470|NCT02202161|540354774|FG007|Overall Study|Physician Decision|3|||
149789471|NCT02202161|540354767|FG000|Overall Study|Withdrawal by Subject|0|||
149789472|NCT02202161|540354768|FG001|Overall Study|Withdrawal by Subject|0|||
149789473|NCT02202161|540354769|FG002|Overall Study|Withdrawal by Subject|0|||
149789474|NCT02202161|540354770|FG003|Overall Study|Withdrawal by Subject|0|||
149789475|NCT02202161|540354771|FG004|Overall Study|Withdrawal by Subject|1|||
149789476|NCT02202161|540354772|FG005|Overall Study|Withdrawal by Subject|0|||
149789477|NCT02202161|540354773|FG006|Overall Study|Withdrawal by Subject|0|||
149789478|NCT02202161|540354774|FG007|Overall Study|Withdrawal by Subject|0|||
149789479|NCT01603628|540354777|FG000|Overall Study|Personal Reasons|1|||
149789480|NCT01603628|540354778|FG001|Overall Study|Personal Reasons|1|||
149789481|NCT01603628|540354779|FG002|Overall Study|Personal Reasons|2|||
149789482|NCT01603628|540354777|FG000|Overall Study|Protocol Violation|1|||
149789483|NCT01603628|540354778|FG001|Overall Study|Protocol Violation|1|||
149789484|NCT01603628|540354779|FG002|Overall Study|Protocol Violation|0|||
149789485|NCT01603628|540354777|FG000|Overall Study|Lost to Follow-up|0|||
149789486|NCT01603628|540354778|FG001|Overall Study|Lost to Follow-up|1|||
149789487|NCT01603628|540354779|FG002|Overall Study|Lost to Follow-up|0|||
149789488|NCT01603628|540354777|FG000|Overall Study|Other Miscellaneous Reason|1|||
149789489|NCT01603628|540354778|FG001|Overall Study|Other Miscellaneous Reason|0|||
149789490|NCT01603628|540354779|FG002|Overall Study|Other Miscellaneous Reason|0|||
149789491|NCT01969565|540354780|FG000|Overall Study|Withdrawal by Subject|1|||
149789492|NCT00832091|540354781|FG000|Overall Study|Adverse Event|1|||
149789493|NCT00832091|540354782|FG001|Overall Study|Adverse Event|1|||
149789494|NCT00832091|540354781|FG000|Overall Study|Protocol Violation|1|||
149789495|NCT00832091|540354782|FG001|Overall Study|Protocol Violation|0|||
149789496|NCT00832091|540354781|FG000|Overall Study|Withdrawal by Subject|2|||
149789497|NCT00832091|540354782|FG001|Overall Study|Withdrawal by Subject|1|||
149789498|NCT00832091|540354781|FG000|Overall Study|Prohibited Medication|1|||
149789499|NCT00832091|540354782|FG001|Overall Study|Prohibited Medication|0|||
149789500|NCT00952588|540354787|FG000|Overall Study|Death|28|||
149789501|NCT00952588|540354788|FG001|Overall Study|Death|13|||
149789502|NCT00952588|540354787|FG000|Overall Study|Withdrawal by Subject|2|||
149789503|NCT00952588|540354788|FG001|Overall Study|Withdrawal by Subject|5|||
149789504|NCT00952588|540354787|FG000|Overall Study|Adverse Event|2|||
149789505|NCT00952588|540354788|FG001|Overall Study|Adverse Event|3|||
149789506|NCT00952588|540354787|FG000|Overall Study|Lost to Follow-up|2|||
149789507|NCT00952588|540354788|FG001|Overall Study|Lost to Follow-up|0|||
149789508|NCT00952588|540354787|FG000|Overall Study|Physician Decision|0|||
149789509|NCT00952588|540354788|FG001|Overall Study|Physician Decision|1|||
149789510|NCT00952588|540354787|FG000|Overall Study|Lack of Efficacy|2|||
149789511|NCT00952588|540354788|FG001|Overall Study|Lack of Efficacy|2|||
149789512|NCT01108068|540354789|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
149789513|NCT01108068|540354790|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
149789514|NCT00836953|540354791|FG000|Overall Study|Withdrawal by Subject|1|||
149789515|NCT00836953|540354791|FG000|Overall Study|Lost to Follow-up|1|||
149789516|NCT01021553|540354792|FG000|Overall Study|Adverse Event|1|||
149789517|NCT01021553|540354793|FG001|Overall Study|Adverse Event|0|||
149789518|NCT01021553|540354794|FG002|Overall Study|Adverse Event|0|||
149789519|NCT01021553|540354792|FG000|Overall Study|Lack of Efficacy|2|||
149789520|NCT01021553|540354793|FG001|Overall Study|Lack of Efficacy|2|||
149789521|NCT01021553|540354794|FG002|Overall Study|Lack of Efficacy|0|||
149789522|NCT01021553|540354792|FG000|Overall Study|Protocol Violation|0|||
149789523|NCT01021553|540354793|FG001|Overall Study|Protocol Violation|2|||
149789524|NCT01021553|540354794|FG002|Overall Study|Protocol Violation|2|||
149789525|NCT01021553|540354792|FG000|Overall Study|Lost to Follow-up|0|||
149789526|NCT01021553|540354793|FG001|Overall Study|Lost to Follow-up|0|||
149789527|NCT01021553|540354794|FG002|Overall Study|Lost to Follow-up|1|||
149789528|NCT01021553|540354792|FG000|Overall Study|Withdrawal by Subject|1|||
149789529|NCT01021553|540354793|FG001|Overall Study|Withdrawal by Subject|1|||
149789530|NCT01021553|540354794|FG002|Overall Study|Withdrawal by Subject|0|||
149789531|NCT01950364|540354795|FG000|Overall Study|Adverse Event|3|||
149789532|NCT01950364|540354796|FG001|Overall Study|Adverse Event|0|||
149789533|NCT01950364|540354795|FG000|Overall Study|Stem Cell Transplant|2|||
149789534|NCT01950364|540354796|FG001|Overall Study|Stem Cell Transplant|6|||
149789535|NCT01950364|540354795|FG000|Overall Study|Disease Progression|5|||
149789536|NCT01950364|540354796|FG001|Overall Study|Disease Progression|2|||
149789537|NCT01950364|540354795|FG000|Overall Study|Withdrawal by Subject|0|||
149789538|NCT01950364|540354796|FG001|Overall Study|Withdrawal by Subject|1|||
149789539|NCT01950364|540354795|FG000|Overall Study|Protocol Violation|0|||
149789540|NCT01950364|540354796|FG001|Overall Study|Protocol Violation|1|||
149789541|NCT00935701|540354797|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
149789542|NCT02201251|540354798|FG000|Overall Study|Adverse Event|1|||
149789543|NCT02201251|540354799|FG001|Overall Study|Adverse Event|1|||
149789544|NCT02201251|540354798|FG000|Overall Study|Protocol Violation|1|||
149789545|NCT02201251|540354799|FG001|Overall Study|Protocol Violation|0|||
149789546|NCT02201251|540354798|FG000|Overall Study|Noncompliance with Study Drug|0|||
149789547|NCT02201251|540354799|FG001|Overall Study|Noncompliance with Study Drug|1|||
149789548|NCT02201251|540354798|FG000|Overall Study|Withdrawal by Subject|2|||
149789549|NCT02201251|540354799|FG001|Overall Study|Withdrawal by Subject|1|||
149789550|NCT04048876|540354802|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
149789551|NCT04048876|540354803|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
149789552|NCT04048876|540354804|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
149789553|NCT04048876|540354805|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
149789554|NCT04048876|540354802|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
149789555|NCT04048876|540354803|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
149789556|NCT04048876|540354804|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
149789557|NCT04048876|540354805|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
149789558|NCT04048876|540354802|FG000|Placebo Controlled Phase|Adverse Event|0|||
149789559|NCT04048876|540354803|FG001|Placebo Controlled Phase|Adverse Event|1|||
149789560|NCT04048876|540354804|FG002|Placebo Controlled Phase|Adverse Event|0|||
149789561|NCT04048876|540354805|FG003|Placebo Controlled Phase|Adverse Event|0|||
149789562|NCT04048876|540354802|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
149789563|NCT04048876|540354803|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
149789564|NCT04048876|540354804|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
149789565|NCT04048876|540354805|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
149789566|NCT04055844|540354806|FG000|Overall Study|Adverse Event|12|||
149789567|NCT04055844|540354806|FG000|Overall Study|Poor Performance|1|||
149789568|NCT04055844|540354806|FG000|Overall Study|Death|1|||
149789569|NCT02996500|540354815|FG000|Overall Study|Adverse Event|1|||
149789570|NCT02996500|540354816|FG001|Overall Study|Adverse Event|1|||
149789571|NCT02996500|540354817|FG002|Overall Study|Adverse Event|4|||
149789572|NCT02996500|540354818|FG003|Overall Study|Adverse Event|3|||
149789573|NCT02996500|540354819|FG004|Overall Study|Adverse Event|1|||
149789574|NCT02996500|540354820|FG005|Overall Study|Adverse Event|2|||
149789575|NCT02996500|540354815|FG000|Overall Study|Lack of Efficacy|0|||
149789576|NCT02996500|540354816|FG001|Overall Study|Lack of Efficacy|0|||
149789577|NCT02996500|540354817|FG002|Overall Study|Lack of Efficacy|0|||
149789578|NCT02996500|540354818|FG003|Overall Study|Lack of Efficacy|0|||
149789579|NCT02996500|540354819|FG004|Overall Study|Lack of Efficacy|2|||
149789580|NCT02996500|540354820|FG005|Overall Study|Lack of Efficacy|0|||
149789581|NCT02996500|540354815|FG000|Overall Study|Lost to Follow-up|1|||
149789582|NCT02996500|540354816|FG001|Overall Study|Lost to Follow-up|0|||
149789583|NCT02996500|540354817|FG002|Overall Study|Lost to Follow-up|0|||
149789584|NCT02996500|540354818|FG003|Overall Study|Lost to Follow-up|0|||
149789585|NCT02996500|540354819|FG004|Overall Study|Lost to Follow-up|0|||
149789586|NCT02996500|540354820|FG005|Overall Study|Lost to Follow-up|1|||
149789587|NCT02996500|540354815|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
149789588|NCT02996500|540354816|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
149789589|NCT02996500|540354817|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
149789590|NCT02996500|540354818|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
149789591|NCT02996500|540354819|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
149789592|NCT02996500|540354820|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
149789593|NCT02996500|540354815|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149789594|NCT02996500|540354816|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149789595|NCT02996500|540354817|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149789596|NCT02996500|540354818|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149789597|NCT02996500|540354819|FG004|Overall Study|Non-Compliance With Study Drug|0|||
149789598|NCT02996500|540354820|FG005|Overall Study|Non-Compliance With Study Drug|1|||
149789599|NCT02996500|540354815|FG000|Overall Study|Progressive Disease|1|||
149789600|NCT02996500|540354816|FG001|Overall Study|Progressive Disease|0|||
149789601|NCT02996500|540354817|FG002|Overall Study|Progressive Disease|0|||
149789602|NCT02996500|540354818|FG003|Overall Study|Progressive Disease|0|||
149789603|NCT02996500|540354819|FG004|Overall Study|Progressive Disease|0|||
149789604|NCT02996500|540354820|FG005|Overall Study|Progressive Disease|0|||
149789605|NCT02996500|540354815|FG000|Overall Study|Other|2|||
149789606|NCT02996500|540354816|FG001|Overall Study|Other|0|||
149789607|NCT02996500|540354817|FG002|Overall Study|Other|2|||
149789608|NCT02996500|540354818|FG003|Overall Study|Other|0|||
149789609|NCT02996500|540354819|FG004|Overall Study|Other|0|||
149789610|NCT02996500|540354820|FG005|Overall Study|Other|0|||
149789611|NCT02996500|540354815|FG000|Overall Study|Protocol Violation|0|||
149789612|NCT02996500|540354816|FG001|Overall Study|Protocol Violation|0|||
149789613|NCT02996500|540354817|FG002|Overall Study|Protocol Violation|0|||
149789614|NCT02996500|540354818|FG003|Overall Study|Protocol Violation|1|||
149789615|NCT02996500|540354819|FG004|Overall Study|Protocol Violation|0|||
149789616|NCT02996500|540354820|FG005|Overall Study|Protocol Violation|0|||
149789617|NCT02996500|540354815|FG000|Overall Study|Withdrawal by Subject|3|||
149789618|NCT02996500|540354816|FG001|Overall Study|Withdrawal by Subject|0|||
149789619|NCT02996500|540354817|FG002|Overall Study|Withdrawal by Subject|3|||
149789620|NCT02996500|540354818|FG003|Overall Study|Withdrawal by Subject|0|||
149789621|NCT02996500|540354819|FG004|Overall Study|Withdrawal by Subject|2|||
149789622|NCT02996500|540354820|FG005|Overall Study|Withdrawal by Subject|0|||
149789623|NCT01347840|540354825|FG000|Overall Study|Withdrawal by Subject|1|||
149789624|NCT04223778|540354831|FG000|Overall Study|Death|1|||
149789625|NCT04223778|540354832|FG001|Overall Study|Death|1|||
149789626|NCT04223778|540354831|FG000|Overall Study|Lost to Follow-up|4|||
149789627|NCT04223778|540354832|FG001|Overall Study|Lost to Follow-up|5|||
149789628|NCT04223778|540354831|FG000|Overall Study|Physician Decision|10|||
149789629|NCT04223778|540354832|FG001|Overall Study|Physician Decision|6|||
149789630|NCT04223778|540354831|FG000|Overall Study|Withdrawal by Subject|35|||
149789631|NCT04223778|540354832|FG001|Overall Study|Withdrawal by Subject|17|||
149789632|NCT04223778|540354831|FG000|Overall Study|Not Reported|7|||
149789633|NCT04223778|540354832|FG001|Overall Study|Not Reported|8|||
149789634|NCT01465958|540356797|FG000|Run-in Phase|Protocol Violation|1|||
149789635|NCT01465958|540356798|FG001|Run-in Phase|Protocol Violation|0|||
149789636|NCT01465958|540356797|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
149789637|NCT01465958|540356798|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
149789638|NCT02785588|540356803|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
149789639|NCT02785588|540356803|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
149789640|NCT00211536|540356806|FG000|Overall Study|Withdrawal by Subject|2|||
149789641|NCT00211536|540356807|FG001|Overall Study|Withdrawal by Subject|2|||
149789642|NCT00211536|540356806|FG000|Overall Study|Physician Decision|0|||
149789643|NCT00211536|540356807|FG001|Overall Study|Physician Decision|5|||
149789644|NCT00211536|540356806|FG000|Overall Study|Adverse Event|2|||
149789645|NCT00211536|540356807|FG001|Overall Study|Adverse Event|0|||
149789646|NCT00669240|540356808|FG000|Overall Study|Lack of Efficacy|33|||
149789647|NCT00669240|540356808|FG000|Overall Study|Withdrawal by Subject|42|||
149789648|NCT00669240|540356808|FG000|Overall Study|Lost to Follow-up|34|||
149789649|NCT00669240|540356808|FG000|Overall Study|Adverse Event|21|||
149789650|NCT00669240|540356808|FG000|Overall Study|Other|19|||
149789651|NCT00669240|540356808|FG000|Overall Study|Enrolled but not treated|15|||
149789652|NCT00669240|540356808|FG000|Overall Study|Enrolled but no dosing record|1|||
149789653|NCT02583399|540356809|FG000|Overall Study|Able to be discharged|3|||
149789654|NCT02583399|540356809|FG000|Overall Study|Wanted to use a restricted medication|3|||
149789655|NCT00686699|540356810|FG000|Treatment Period 1|Adverse Event|0|||
149789656|NCT00686699|540356811|FG001|Treatment Period 1|Adverse Event|2|||
149789657|NCT04610827|540356813|FG000|Overall Study|Withdrawal by Subject|1|||
149789658|NCT04610827|540356814|FG001|Overall Study|Withdrawal by Subject|1|||
149789659|NCT04610827|540356815|FG002|Overall Study|Withdrawal by Subject|0|||
149789660|NCT01693562|540356816|FG000|Escalation Phase|Withdrawal by Subject|0|||
149789661|NCT01693562|540356817|FG001|Escalation Phase|Withdrawal by Subject|1|||
149789662|NCT01693562|540356818|FG002|Escalation Phase|Withdrawal by Subject|0|||
149789663|NCT01693562|540356819|FG003|Escalation Phase|Withdrawal by Subject|0|||
149789664|NCT01693562|540356820|FG004|Escalation Phase|Withdrawal by Subject|0|||
149789665|NCT01693562|540356821|FG005|Escalation Phase|Withdrawal by Subject|2|||
149789666|NCT01693562|540356822|FG006|Escalation Phase|Withdrawal by Subject|0|||
149789667|NCT01693562|540356823|FG007|Escalation Phase|Withdrawal by Subject|0|||
149789668|NCT01693562|540356824|FG008|Escalation Phase|Withdrawal by Subject|0|||
149789669|NCT01693562|540356825|FG009|Escalation Phase|Withdrawal by Subject|0|||
149789670|NCT01693562|540356826|FG010|Escalation Phase|Withdrawal by Subject|0|||
149789671|NCT01693562|540356827|FG011|Escalation Phase|Withdrawal by Subject|0|||
149789672|NCT01693562|540356828|FG012|Escalation Phase|Withdrawal by Subject|0|||
149789673|NCT01693562|540356829|FG013|Escalation Phase|Withdrawal by Subject|0|||
149789674|NCT01693562|540356830|FG014|Escalation Phase|Withdrawal by Subject|0|||
149789675|NCT01693562|540356831|FG015|Escalation Phase|Withdrawal by Subject|0|||
149789676|NCT01693562|540356832|FG016|Escalation Phase|Withdrawal by Subject|0|||
149789677|NCT01693562|540356833|FG017|Escalation Phase|Withdrawal by Subject|0|||
149789678|NCT01693562|540356834|FG018|Escalation Phase|Withdrawal by Subject|0|||
149789679|NCT01693562|540356835|FG019|Escalation Phase|Withdrawal by Subject|0|||
149789680|NCT01693562|540356836|FG020|Escalation Phase|Withdrawal by Subject|0|||
149789681|NCT01693562|540356837|FG021|Escalation Phase|Withdrawal by Subject|0|||
149789682|NCT01693562|540356838|FG022|Escalation Phase|Withdrawal by Subject|0|||
149789683|NCT01693562|540356816|FG000|Escalation Phase|Death|4|||
149789684|NCT01693562|540356817|FG001|Escalation Phase|Death|2|||
149789685|NCT01693562|540356818|FG002|Escalation Phase|Death|0|||
149789686|NCT01693562|540356819|FG003|Escalation Phase|Death|3|||
149789687|NCT01693562|540356820|FG004|Escalation Phase|Death|6|||
149789688|NCT01693562|540356821|FG005|Escalation Phase|Death|4|||
149789689|NCT01693562|540356822|FG006|Escalation Phase|Death|0|||
149789690|NCT01693562|540356823|FG007|Escalation Phase|Death|0|||
149789691|NCT01693562|540356824|FG008|Escalation Phase|Death|0|||
149789692|NCT01693562|540356825|FG009|Escalation Phase|Death|0|||
149789693|NCT01693562|540356826|FG010|Escalation Phase|Death|0|||
149789694|NCT01693562|540356827|FG011|Escalation Phase|Death|0|||
149789695|NCT01693562|540356828|FG012|Escalation Phase|Death|0|||
149789696|NCT01693562|540356829|FG013|Escalation Phase|Death|0|||
149789697|NCT01693562|540356830|FG014|Escalation Phase|Death|0|||
149789698|NCT01693562|540356831|FG015|Escalation Phase|Death|0|||
149789699|NCT01693562|540356832|FG016|Escalation Phase|Death|0|||
149789700|NCT01693562|540356833|FG017|Escalation Phase|Death|0|||
149789701|NCT01693562|540356834|FG018|Escalation Phase|Death|0|||
149789702|NCT01693562|540356835|FG019|Escalation Phase|Death|0|||
149789703|NCT01693562|540356836|FG020|Escalation Phase|Death|0|||
149789704|NCT01693562|540356837|FG021|Escalation Phase|Death|0|||
149789705|NCT01693562|540356838|FG022|Escalation Phase|Death|0|||
149789706|NCT01693562|540356816|FG000|Escalation Phase|Lost to Follow-up|0|||
149789707|NCT01693562|540356817|FG001|Escalation Phase|Lost to Follow-up|1|||
149789708|NCT01693562|540356818|FG002|Escalation Phase|Lost to Follow-up|1|||
149789709|NCT01693562|540356819|FG003|Escalation Phase|Lost to Follow-up|0|||
149789710|NCT01693562|540356820|FG004|Escalation Phase|Lost to Follow-up|0|||
149789711|NCT01693562|540356821|FG005|Escalation Phase|Lost to Follow-up|0|||
149789712|NCT01693562|540356822|FG006|Escalation Phase|Lost to Follow-up|0|||
149789713|NCT01693562|540356823|FG007|Escalation Phase|Lost to Follow-up|0|||
149789714|NCT01693562|540356824|FG008|Escalation Phase|Lost to Follow-up|0|||
149789715|NCT01693562|540356825|FG009|Escalation Phase|Lost to Follow-up|0|||
149789716|NCT01693562|540356826|FG010|Escalation Phase|Lost to Follow-up|0|||
149789717|NCT01693562|540356827|FG011|Escalation Phase|Lost to Follow-up|0|||
149789718|NCT01693562|540356828|FG012|Escalation Phase|Lost to Follow-up|0|||
149789719|NCT01693562|540356829|FG013|Escalation Phase|Lost to Follow-up|0|||
149789720|NCT01693562|540356830|FG014|Escalation Phase|Lost to Follow-up|0|||
149789721|NCT01693562|540356831|FG015|Escalation Phase|Lost to Follow-up|0|||
149789722|NCT01693562|540356832|FG016|Escalation Phase|Lost to Follow-up|0|||
149789723|NCT01693562|540356833|FG017|Escalation Phase|Lost to Follow-up|0|||
149789724|NCT01693562|540356834|FG018|Escalation Phase|Lost to Follow-up|0|||
149789725|NCT01693562|540356835|FG019|Escalation Phase|Lost to Follow-up|0|||
149789726|NCT01693562|540356836|FG020|Escalation Phase|Lost to Follow-up|0|||
149789727|NCT01693562|540356837|FG021|Escalation Phase|Lost to Follow-up|0|||
149789728|NCT01693562|540356838|FG022|Escalation Phase|Lost to Follow-up|0|||
149789729|NCT01693562|540356816|FG000|Escalation Phase|Other|0|||
149789730|NCT01693562|540356817|FG001|Escalation Phase|Other|0|||
149789731|NCT01693562|540356818|FG002|Escalation Phase|Other|2|||
149789732|NCT01693562|540356819|FG003|Escalation Phase|Other|0|||
149789733|NCT01693562|540356820|FG004|Escalation Phase|Other|0|||
149789734|NCT01693562|540356821|FG005|Escalation Phase|Other|1|||
149789735|NCT01693562|540356822|FG006|Escalation Phase|Other|0|||
149789736|NCT01693562|540356823|FG007|Escalation Phase|Other|0|||
149789737|NCT01693562|540356824|FG008|Escalation Phase|Other|0|||
149789738|NCT01693562|540356825|FG009|Escalation Phase|Other|0|||
149789739|NCT01693562|540356826|FG010|Escalation Phase|Other|0|||
149789740|NCT01693562|540356827|FG011|Escalation Phase|Other|0|||
149789741|NCT01693562|540356828|FG012|Escalation Phase|Other|0|||
149789742|NCT01693562|540356829|FG013|Escalation Phase|Other|0|||
149789743|NCT01693562|540356830|FG014|Escalation Phase|Other|0|||
149789744|NCT01693562|540356831|FG015|Escalation Phase|Other|0|||
149789745|NCT01693562|540356832|FG016|Escalation Phase|Other|0|||
149789746|NCT01693562|540356833|FG017|Escalation Phase|Other|0|||
149789747|NCT01693562|540356834|FG018|Escalation Phase|Other|0|||
149789748|NCT01693562|540356835|FG019|Escalation Phase|Other|0|||
149789749|NCT01693562|540356836|FG020|Escalation Phase|Other|0|||
149789750|NCT01693562|540356837|FG021|Escalation Phase|Other|0|||
149789751|NCT01693562|540356838|FG022|Escalation Phase|Other|0|||
149789752|NCT01693562|540356816|FG000|Exploration Phase|Withdrawal by Subject|0|||
149789753|NCT01693562|540356817|FG001|Exploration Phase|Withdrawal by Subject|0|||
149789754|NCT01693562|540356818|FG002|Exploration Phase|Withdrawal by Subject|0|||
149789755|NCT01693562|540356819|FG003|Exploration Phase|Withdrawal by Subject|0|||
149789756|NCT01693562|540356820|FG004|Exploration Phase|Withdrawal by Subject|0|||
149789757|NCT01693562|540356821|FG005|Exploration Phase|Withdrawal by Subject|0|||
149789758|NCT01693562|540356822|FG006|Exploration Phase|Withdrawal by Subject|2|||
149789759|NCT01693562|540356823|FG007|Exploration Phase|Withdrawal by Subject|0|||
149789760|NCT01693562|540356824|FG008|Exploration Phase|Withdrawal by Subject|0|||
149789761|NCT01693562|540356825|FG009|Exploration Phase|Withdrawal by Subject|0|||
149789762|NCT01693562|540356826|FG010|Exploration Phase|Withdrawal by Subject|0|||
149789763|NCT01693562|540356827|FG011|Exploration Phase|Withdrawal by Subject|0|||
149789764|NCT01693562|540356828|FG012|Exploration Phase|Withdrawal by Subject|0|||
149789765|NCT01693562|540356829|FG013|Exploration Phase|Withdrawal by Subject|0|||
149789766|NCT01693562|540356830|FG014|Exploration Phase|Withdrawal by Subject|0|||
149789767|NCT01693562|540356831|FG015|Exploration Phase|Withdrawal by Subject|0|||
149789768|NCT01693562|540356832|FG016|Exploration Phase|Withdrawal by Subject|0|||
149789769|NCT01693562|540356833|FG017|Exploration Phase|Withdrawal by Subject|0|||
149789770|NCT01693562|540356834|FG018|Exploration Phase|Withdrawal by Subject|0|||
149789771|NCT01693562|540356835|FG019|Exploration Phase|Withdrawal by Subject|0|||
149789772|NCT01693562|540356836|FG020|Exploration Phase|Withdrawal by Subject|0|||
149789773|NCT01693562|540356837|FG021|Exploration Phase|Withdrawal by Subject|0|||
149789774|NCT01693562|540356838|FG022|Exploration Phase|Withdrawal by Subject|0|||
149789775|NCT01693562|540356816|FG000|Exploration Phase|Death|0|||
149789776|NCT01693562|540356817|FG001|Exploration Phase|Death|0|||
149789777|NCT01693562|540356818|FG002|Exploration Phase|Death|0|||
149789778|NCT01693562|540356819|FG003|Exploration Phase|Death|0|||
149789779|NCT01693562|540356820|FG004|Exploration Phase|Death|0|||
149789780|NCT01693562|540356821|FG005|Exploration Phase|Death|0|||
149789781|NCT01693562|540356822|FG006|Exploration Phase|Death|17|||
149789782|NCT01693562|540356823|FG007|Exploration Phase|Death|0|||
149789783|NCT01693562|540356824|FG008|Exploration Phase|Death|0|||
149789784|NCT01693562|540356825|FG009|Exploration Phase|Death|0|||
149789785|NCT01693562|540356826|FG010|Exploration Phase|Death|0|||
149789786|NCT01693562|540356827|FG011|Exploration Phase|Death|0|||
149789787|NCT01693562|540356828|FG012|Exploration Phase|Death|0|||
149789788|NCT01693562|540356829|FG013|Exploration Phase|Death|0|||
149789789|NCT01693562|540356830|FG014|Exploration Phase|Death|0|||
149789790|NCT01693562|540356831|FG015|Exploration Phase|Death|0|||
149789791|NCT01693562|540356832|FG016|Exploration Phase|Death|0|||
149789792|NCT01693562|540356833|FG017|Exploration Phase|Death|0|||
149789793|NCT01693562|540356834|FG018|Exploration Phase|Death|0|||
149789794|NCT01693562|540356835|FG019|Exploration Phase|Death|0|||
149789795|NCT01693562|540356836|FG020|Exploration Phase|Death|0|||
149789796|NCT01693562|540356837|FG021|Exploration Phase|Death|0|||
149789797|NCT01693562|540356838|FG022|Exploration Phase|Death|0|||
149789798|NCT01693562|540356816|FG000|Exploration Phase|Other|0|||
149789799|NCT01693562|540356817|FG001|Exploration Phase|Other|0|||
149789800|NCT01693562|540356818|FG002|Exploration Phase|Other|0|||
149789801|NCT01693562|540356819|FG003|Exploration Phase|Other|0|||
149789802|NCT01693562|540356820|FG004|Exploration Phase|Other|0|||
149789803|NCT01693562|540356821|FG005|Exploration Phase|Other|0|||
149789804|NCT01693562|540356822|FG006|Exploration Phase|Other|2|||
149789805|NCT01693562|540356823|FG007|Exploration Phase|Other|0|||
149789806|NCT01693562|540356824|FG008|Exploration Phase|Other|0|||
149789807|NCT01693562|540356825|FG009|Exploration Phase|Other|0|||
149789808|NCT01693562|540356826|FG010|Exploration Phase|Other|0|||
149789809|NCT01693562|540356827|FG011|Exploration Phase|Other|0|||
149789810|NCT01693562|540356828|FG012|Exploration Phase|Other|0|||
149789811|NCT01693562|540356829|FG013|Exploration Phase|Other|0|||
149789812|NCT01693562|540356830|FG014|Exploration Phase|Other|0|||
149789813|NCT01693562|540356831|FG015|Exploration Phase|Other|0|||
149789814|NCT01693562|540356832|FG016|Exploration Phase|Other|0|||
149789815|NCT01693562|540356833|FG017|Exploration Phase|Other|0|||
149789816|NCT01693562|540356834|FG018|Exploration Phase|Other|0|||
149789817|NCT01693562|540356835|FG019|Exploration Phase|Other|0|||
149789818|NCT01693562|540356836|FG020|Exploration Phase|Other|0|||
149789819|NCT01693562|540356837|FG021|Exploration Phase|Other|0|||
149789820|NCT01693562|540356838|FG022|Exploration Phase|Other|0|||
149789821|NCT01693562|540356816|FG000|Expansion Phase|Withdrawal by Subject|0|||
149789822|NCT01693562|540356817|FG001|Expansion Phase|Withdrawal by Subject|0|||
149789823|NCT01693562|540356818|FG002|Expansion Phase|Withdrawal by Subject|0|||
149789824|NCT01693562|540356819|FG003|Expansion Phase|Withdrawal by Subject|0|||
149789825|NCT01693562|540356820|FG004|Expansion Phase|Withdrawal by Subject|0|||
149789826|NCT01693562|540356821|FG005|Expansion Phase|Withdrawal by Subject|0|||
149789827|NCT01693562|540356822|FG006|Expansion Phase|Withdrawal by Subject|0|||
149789828|NCT01693562|540356823|FG007|Expansion Phase|Withdrawal by Subject|16|||
149789829|NCT01693562|540356824|FG008|Expansion Phase|Withdrawal by Subject|2|||
149789830|NCT01693562|540356825|FG009|Expansion Phase|Withdrawal by Subject|54|||
149789831|NCT01693562|540356826|FG010|Expansion Phase|Withdrawal by Subject|2|||
149789832|NCT01693562|540356827|FG011|Expansion Phase|Withdrawal by Subject|2|||
149789833|NCT01693562|540356828|FG012|Expansion Phase|Withdrawal by Subject|3|||
149789834|NCT01693562|540356829|FG013|Expansion Phase|Withdrawal by Subject|5|||
149789835|NCT01693562|540356830|FG014|Expansion Phase|Withdrawal by Subject|16|||
149789836|NCT01693562|540356831|FG015|Expansion Phase|Withdrawal by Subject|7|||
149789837|NCT01693562|540356832|FG016|Expansion Phase|Withdrawal by Subject|40|||
149789838|NCT01693562|540356833|FG017|Expansion Phase|Withdrawal by Subject|4|||
149789839|NCT01693562|540356834|FG018|Expansion Phase|Withdrawal by Subject|8|||
149789840|NCT01693562|540356835|FG019|Expansion Phase|Withdrawal by Subject|3|||
149789841|NCT01693562|540356836|FG020|Expansion Phase|Withdrawal by Subject|1|||
149789842|NCT01693562|540356837|FG021|Expansion Phase|Withdrawal by Subject|8|||
149789843|NCT01693562|540356838|FG022|Expansion Phase|Withdrawal by Subject|1|||
149789844|NCT01693562|540356816|FG000|Expansion Phase|Death|0|||
149789845|NCT01693562|540356817|FG001|Expansion Phase|Death|0|||
149789846|NCT01693562|540356818|FG002|Expansion Phase|Death|0|||
149789847|NCT01693562|540356819|FG003|Expansion Phase|Death|0|||
149789848|NCT01693562|540356820|FG004|Expansion Phase|Death|0|||
149789849|NCT01693562|540356821|FG005|Expansion Phase|Death|0|||
149789850|NCT01693562|540356822|FG006|Expansion Phase|Death|0|||
149789851|NCT01693562|540356823|FG007|Expansion Phase|Death|42|||
149789852|NCT01693562|540356824|FG008|Expansion Phase|Death|17|||
149789853|NCT01693562|540356825|FG009|Expansion Phase|Death|208|||
149789854|NCT01693562|540356826|FG010|Expansion Phase|Death|30|||
149789855|NCT01693562|540356827|FG011|Expansion Phase|Death|8|||
149789856|NCT01693562|540356828|FG012|Expansion Phase|Death|19|||
149789857|NCT01693562|540356829|FG013|Expansion Phase|Death|42|||
149789858|NCT01693562|540356830|FG014|Expansion Phase|Death|23|||
149789859|NCT01693562|540356831|FG015|Expansion Phase|Death|23|||
149789860|NCT01693562|540356832|FG016|Expansion Phase|Death|128|||
149789861|NCT01693562|540356833|FG017|Expansion Phase|Death|16|||
149789862|NCT01693562|540356834|FG018|Expansion Phase|Death|36|||
149789863|NCT01693562|540356835|FG019|Expansion Phase|Death|16|||
149789864|NCT01693562|540356836|FG020|Expansion Phase|Death|17|||
149789865|NCT01693562|540356837|FG021|Expansion Phase|Death|35|||
149789866|NCT01693562|540356838|FG022|Expansion Phase|Death|7|||
149789867|NCT01693562|540356816|FG000|Expansion Phase|Lost to Follow-up|0|||
149789868|NCT01693562|540356817|FG001|Expansion Phase|Lost to Follow-up|0|||
149789869|NCT01693562|540356818|FG002|Expansion Phase|Lost to Follow-up|0|||
149789870|NCT01693562|540356819|FG003|Expansion Phase|Lost to Follow-up|0|||
149789871|NCT01693562|540356820|FG004|Expansion Phase|Lost to Follow-up|0|||
149789872|NCT01693562|540356821|FG005|Expansion Phase|Lost to Follow-up|0|||
149789873|NCT01693562|540356822|FG006|Expansion Phase|Lost to Follow-up|0|||
149789874|NCT01693562|540356823|FG007|Expansion Phase|Lost to Follow-up|1|||
149789875|NCT01693562|540356824|FG008|Expansion Phase|Lost to Follow-up|2|||
149789876|NCT01693562|540356825|FG009|Expansion Phase|Lost to Follow-up|10|||
149789877|NCT01693562|540356826|FG010|Expansion Phase|Lost to Follow-up|4|||
149789878|NCT01693562|540356827|FG011|Expansion Phase|Lost to Follow-up|4|||
149789879|NCT01693562|540356828|FG012|Expansion Phase|Lost to Follow-up|1|||
149789880|NCT01693562|540356829|FG013|Expansion Phase|Lost to Follow-up|3|||
149789881|NCT01693562|540356830|FG014|Expansion Phase|Lost to Follow-up|0|||
149789882|NCT01693562|540356831|FG015|Expansion Phase|Lost to Follow-up|1|||
149789883|NCT01693562|540356832|FG016|Expansion Phase|Lost to Follow-up|1|||
149789884|NCT01693562|540356833|FG017|Expansion Phase|Lost to Follow-up|0|||
149789885|NCT01693562|540356834|FG018|Expansion Phase|Lost to Follow-up|2|||
149789886|NCT01693562|540356835|FG019|Expansion Phase|Lost to Follow-up|1|||
149789887|NCT01693562|540356836|FG020|Expansion Phase|Lost to Follow-up|2|||
149789888|NCT01693562|540356837|FG021|Expansion Phase|Lost to Follow-up|2|||
149789889|NCT01693562|540356838|FG022|Expansion Phase|Lost to Follow-up|1|||
149789890|NCT01693562|540356816|FG000|Expansion Phase|Other|0|||
149789891|NCT01693562|540356817|FG001|Expansion Phase|Other|0|||
149789892|NCT01693562|540356818|FG002|Expansion Phase|Other|0|||
149789893|NCT01693562|540356819|FG003|Expansion Phase|Other|0|||
149789894|NCT01693562|540356820|FG004|Expansion Phase|Other|0|||
149789895|NCT01693562|540356821|FG005|Expansion Phase|Other|0|||
149789896|NCT01693562|540356822|FG006|Expansion Phase|Other|0|||
149789897|NCT01693562|540356823|FG007|Expansion Phase|Other|3|||
149789898|NCT01693562|540356824|FG008|Expansion Phase|Other|1|||
149789899|NCT01693562|540356825|FG009|Expansion Phase|Other|28|||
149789900|NCT01693562|540356826|FG010|Expansion Phase|Other|4|||
149789901|NCT01693562|540356827|FG011|Expansion Phase|Other|7|||
149789902|NCT01693562|540356828|FG012|Expansion Phase|Other|0|||
149789903|NCT01693562|540356829|FG013|Expansion Phase|Other|1|||
149789904|NCT01693562|540356830|FG014|Expansion Phase|Other|1|||
149789905|NCT01693562|540356831|FG015|Expansion Phase|Other|0|||
149789906|NCT01693562|540356832|FG016|Expansion Phase|Other|28|||
149789907|NCT01693562|540356833|FG017|Expansion Phase|Other|0|||
149789908|NCT01693562|540356834|FG018|Expansion Phase|Other|1|||
149789909|NCT01693562|540356835|FG019|Expansion Phase|Other|0|||
149789910|NCT01693562|540356836|FG020|Expansion Phase|Other|1|||
149789911|NCT01693562|540356837|FG021|Expansion Phase|Other|17|||
149789912|NCT01693562|540356838|FG022|Expansion Phase|Other|1|||
149789913|NCT02759939|540356839|FG000|Overall Study|Missing data on first outcome assessed|11|||
149789914|NCT02759939|540356840|FG001|Overall Study|Missing data on first outcome assessed|2|||
149789915|NCT02759939|540356841|FG002|Overall Study|Missing data on first outcome assessed|5|||
149789916|NCT02759939|540356842|FG003|Overall Study|Missing data on first outcome assessed|2|||
149789917|NCT02759939|540356839|FG000|Overall Study|Ineligible for T2 and T3|310|||
149789918|NCT02759939|540356840|FG001|Overall Study|Ineligible for T2 and T3|179|||
149789919|NCT02759939|540356841|FG002|Overall Study|Ineligible for T2 and T3|366|||
149789920|NCT02759939|540356842|FG003|Overall Study|Ineligible for T2 and T3|391|||
149789921|NCT02759939|540356839|FG000|Overall Study|Lost to Follow-up|735|||
149789922|NCT02759939|540356840|FG001|Overall Study|Lost to Follow-up|791|||
149789923|NCT02759939|540356841|FG002|Overall Study|Lost to Follow-up|783|||
149789924|NCT02759939|540356842|FG003|Overall Study|Lost to Follow-up|650|||
149789925|NCT00087594|540356843|FG000|Overall Study|Adverse Event|2|||
149789926|NCT00087594|540356844|FG001|Overall Study|Adverse Event|3|||
149789927|NCT00087594|540356843|FG000|Overall Study|Lost to Follow-up|0|||
149789928|NCT00087594|540356844|FG001|Overall Study|Lost to Follow-up|2|||
149789929|NCT00087594|540356843|FG000|Overall Study|Withdrawal by Subject|4|||
149789930|NCT00087594|540356844|FG001|Overall Study|Withdrawal by Subject|2|||
149789931|NCT00087594|540356843|FG000|Overall Study|Lack of Efficacy|2|||
149789932|NCT00087594|540356844|FG001|Overall Study|Lack of Efficacy|5|||
149789933|NCT00768040|540356845|FG000|Overall Study|Adverse Event|3|||
149789934|NCT00768040|540356846|FG001|Overall Study|Adverse Event|2|||
149789935|NCT00768040|540356845|FG000|Overall Study|Abnormal laboratory value|1|||
149789936|NCT00768040|540356846|FG001|Overall Study|Abnormal laboratory value|1|||
149789937|NCT03347279|540356848|FG000|Overall Study|Withdrawal by Subject|8|||
149789938|NCT03347279|540356849|FG001|Overall Study|Withdrawal by Subject|15|||
149789939|NCT03347279|540356848|FG000|Overall Study|Death|0|||
149789940|NCT03347279|540356849|FG001|Overall Study|Death|2|||
149789941|NCT03347279|540356848|FG000|Overall Study|Lost to Follow-up|5|||
149789942|NCT03347279|540356849|FG001|Overall Study|Lost to Follow-up|2|||
149789943|NCT03347279|540356848|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
149789944|NCT03347279|540356849|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
149789945|NCT02094612|540356851|FG000|Overall Study|Lost to Follow-up|47|||
149789946|NCT02094612|540356852|FG001|Overall Study|Lost to Follow-up|47|||
149789947|NCT02094612|540356851|FG000|Overall Study|Never started ADHD medication|32|||
149789948|NCT02094612|540356852|FG001|Overall Study|Never started ADHD medication|23|||
149789949|NCT01542632|540356853|FG000|Overall Study|Withdrawal of Consent|0|||
149789950|NCT01542632|540356854|FG001|Overall Study|Withdrawal of Consent|0|||
149789951|NCT01542632|540356855|FG002|Overall Study|Withdrawal of Consent|0|||
149789952|NCT01542632|540356856|FG003|Overall Study|Withdrawal of Consent|2|||
149789953|NCT01542632|540356857|FG004|Overall Study|Withdrawal of Consent|3|||
149789954|NCT01542632|540356858|FG005|Overall Study|Withdrawal of Consent|0|||
149789955|NCT01542632|540356853|FG000|Overall Study|Adverse Event|0|||
149789956|NCT01542632|540356854|FG001|Overall Study|Adverse Event|0|||
149789957|NCT01542632|540356855|FG002|Overall Study|Adverse Event|1|||
149789958|NCT01542632|540356856|FG003|Overall Study|Adverse Event|0|||
149789959|NCT01542632|540356857|FG004|Overall Study|Adverse Event|0|||
149789960|NCT01542632|540356858|FG005|Overall Study|Adverse Event|0|||
149789961|NCT01542632|540356853|FG000|Overall Study|Lost to Follow-up|0|||
149789962|NCT01542632|540356854|FG001|Overall Study|Lost to Follow-up|1|||
149789963|NCT01542632|540356855|FG002|Overall Study|Lost to Follow-up|0|||
149789964|NCT01542632|540356856|FG003|Overall Study|Lost to Follow-up|0|||
149789965|NCT01542632|540356857|FG004|Overall Study|Lost to Follow-up|0|||
149789966|NCT01542632|540356858|FG005|Overall Study|Lost to Follow-up|0|||
149789967|NCT01542632|540356853|FG000|Overall Study|Sponsor/Investigator Decision|0|||
149789968|NCT01542632|540356854|FG001|Overall Study|Sponsor/Investigator Decision|0|||
149789969|NCT01542632|540356855|FG002|Overall Study|Sponsor/Investigator Decision|0|||
149789970|NCT01542632|540356856|FG003|Overall Study|Sponsor/Investigator Decision|0|||
149789971|NCT01542632|540356857|FG004|Overall Study|Sponsor/Investigator Decision|1|||
149789972|NCT01542632|540356858|FG005|Overall Study|Sponsor/Investigator Decision|0|||
149789973|NCT03991936|540356859|FG000|Overall Study|Lost to Follow-up|1|||
149789974|NCT03991936|540356860|FG001|Overall Study|Lost to Follow-up|1|||
149789975|NCT03991936|540356861|FG002|Overall Study|Lost to Follow-up|1|||
149789976|NCT03991936|540356862|FG003|Overall Study|Lost to Follow-up|1|||
149789977|NCT03991936|540356863|FG004|Overall Study|Lost to Follow-up|1|||
149789978|NCT02773849|540356864|FG000|Overall Study|Lost to Follow-up|11|||
149789979|NCT02773849|540356864|FG000|Overall Study|Death|26|||
149789980|NCT02773849|540356864|FG000|Overall Study|Withdrawal by Subject|5|||
149789981|NCT02773849|540356864|FG000|Overall Study|Withdrawal of Consent|9|||
149789982|NCT02773849|540356864|FG000|Overall Study|Other: not due to lack of tolerability|11|||
149789983|NCT01263470|540356875|FG000|Overall Study|Adverse Event|2|||
149789984|NCT01263470|540356876|FG001|Overall Study|Adverse Event|2|||
149789985|NCT01263470|540356877|FG002|Overall Study|Adverse Event|1|||
149789986|NCT01263470|540356878|FG003|Overall Study|Adverse Event|1|||
149789987|NCT01263470|540356879|FG004|Overall Study|Adverse Event|2|||
149789988|NCT01263470|540356880|FG005|Overall Study|Adverse Event|2|||
149789989|NCT01263470|540356875|FG000|Overall Study|Protocol Violation|0|||
149789990|NCT01263470|540356876|FG001|Overall Study|Protocol Violation|1|||
149789991|NCT01263470|540356877|FG002|Overall Study|Protocol Violation|0|||
149789992|NCT01263470|540356878|FG003|Overall Study|Protocol Violation|0|||
149789993|NCT01263470|540356879|FG004|Overall Study|Protocol Violation|0|||
149789994|NCT01263470|540356880|FG005|Overall Study|Protocol Violation|1|||
149789995|NCT01263470|540356875|FG000|Overall Study|Withdrawal by Subject|0|||
149789996|NCT01263470|540356876|FG001|Overall Study|Withdrawal by Subject|1|||
149789997|NCT01263470|540356877|FG002|Overall Study|Withdrawal by Subject|1|||
149789998|NCT01263470|540356878|FG003|Overall Study|Withdrawal by Subject|2|||
149789999|NCT01263470|540356879|FG004|Overall Study|Withdrawal by Subject|0|||
149790000|NCT01263470|540356880|FG005|Overall Study|Withdrawal by Subject|2|||
149790001|NCT01263470|540356875|FG000|Overall Study|Lack of Efficacy|0|||
149790002|NCT01263470|540356876|FG001|Overall Study|Lack of Efficacy|0|||
149790003|NCT01263470|540356877|FG002|Overall Study|Lack of Efficacy|2|||
149790004|NCT01263470|540356878|FG003|Overall Study|Lack of Efficacy|0|||
149790005|NCT01263470|540356879|FG004|Overall Study|Lack of Efficacy|0|||
149790006|NCT01263470|540356880|FG005|Overall Study|Lack of Efficacy|0|||
149790007|NCT01263470|540356875|FG000|Overall Study|Participant Unavailability|0|||
149790008|NCT01263470|540356876|FG001|Overall Study|Participant Unavailability|1|||
149790009|NCT01263470|540356877|FG002|Overall Study|Participant Unavailability|0|||
149790010|NCT01263470|540356878|FG003|Overall Study|Participant Unavailability|0|||
149790011|NCT01263470|540356879|FG004|Overall Study|Participant Unavailability|0|||
149790012|NCT01263470|540356880|FG005|Overall Study|Participant Unavailability|0|||
149790013|NCT01263470|540356875|FG000|Overall Study|Study Drug Non-compliance|0|||
149790014|NCT01263470|540356876|FG001|Overall Study|Study Drug Non-compliance|0|||
149790015|NCT01263470|540356877|FG002|Overall Study|Study Drug Non-compliance|0|||
149790016|NCT01263470|540356878|FG003|Overall Study|Study Drug Non-compliance|0|||
149790017|NCT01263470|540356879|FG004|Overall Study|Study Drug Non-compliance|1|||
149790018|NCT01263470|540356880|FG005|Overall Study|Study Drug Non-compliance|0|||
149790019|NCT01327573|540356881|FG000|Overall Study|Physician Decision|3|||
149790020|NCT01327573|540356882|FG001|Overall Study|Physician Decision|1|||
149790021|NCT01108263|540356883|FG000|Overall Study|Adverse Event|0|||
149790022|NCT01108263|540356884|FG001|Overall Study|Adverse Event|1|||
149790023|NCT00712712|540356885|FG000|Overall Study|Protocol Violation|11|||
149790024|NCT00712712|540356885|FG000|Overall Study|Radiofrequency not done|3|||
149790025|NCT00712712|540356885|FG000|Overall Study|Death|8|||
149790026|NCT00712712|540356885|FG000|Overall Study|Withdrawal by Subject|1|||
149790027|NCT01685372|540356886|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
149790028|NCT01685372|540356887|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
149790029|NCT01029691|540356890|FG000|Continued APAP to Delivery|Death|0|||
149790030|NCT01029691|540356891|FG001|Continued APAP to Delivery|Death|0|||
149790031|NCT01029691|540356892|FG002|Continued APAP to Delivery|Death|1|||
149790032|NCT05245071|540356893|FG000|Overall Study|Progressive disease|18|||
149790033|NCT05245071|540356893|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
149790034|NCT05245071|540356893|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
149790035|NCT01602822|540356894|FG000|Overall Study|Adverse Event|11|||
149790036|NCT02477800|540356897|FG000|Placebo-Controlled Period|Adverse Event|16|||
149790037|NCT02477800|540356898|FG001|Placebo-Controlled Period|Adverse Event|25|||
149790038|NCT02477800|540356899|FG002|Placebo-Controlled Period|Adverse Event|28|||
149790039|NCT02477800|540356900|FG003|Placebo-Controlled Period|Adverse Event|0|||
149790040|NCT02477800|540356901|FG004|Placebo-Controlled Period|Adverse Event|0|||
149790041|NCT02477800|540356902|FG005|Placebo-Controlled Period|Adverse Event|0|||
149790042|NCT02477800|540356903|FG006|Placebo-Controlled Period|Adverse Event|0|||
149790043|NCT02477800|540356897|FG000|Placebo-Controlled Period|Change of Treatment|1|||
149790044|NCT02477800|540356898|FG001|Placebo-Controlled Period|Change of Treatment|2|||
149790045|NCT02477800|540356899|FG002|Placebo-Controlled Period|Change of Treatment|1|||
149790046|NCT02477800|540356900|FG003|Placebo-Controlled Period|Change of Treatment|0|||
149790047|NCT02477800|540356901|FG004|Placebo-Controlled Period|Change of Treatment|0|||
149790048|NCT02477800|540356902|FG005|Placebo-Controlled Period|Change of Treatment|0|||
149790049|NCT02477800|540356903|FG006|Placebo-Controlled Period|Change of Treatment|0|||
149790050|NCT02477800|540356897|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
149790051|NCT02477800|540356898|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
149790052|NCT02477800|540356899|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
149790053|NCT02477800|540356900|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
149790054|NCT02477800|540356901|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
149790055|NCT02477800|540356902|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
149790056|NCT02477800|540356903|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
149790057|NCT02477800|540356897|FG000|Placebo-Controlled Period|Death|0|||
149790058|NCT02477800|540356898|FG001|Placebo-Controlled Period|Death|3|||
149790059|NCT02477800|540356899|FG002|Placebo-Controlled Period|Death|2|||
149790060|NCT02477800|540356900|FG003|Placebo-Controlled Period|Death|0|||
149790061|NCT02477800|540356901|FG004|Placebo-Controlled Period|Death|0|||
149790062|NCT02477800|540356902|FG005|Placebo-Controlled Period|Death|0|||
149790063|NCT02477800|540356903|FG006|Placebo-Controlled Period|Death|0|||
149790064|NCT02477800|540356897|FG000|Placebo-Controlled Period|Disease Progression|1|||
149790065|NCT02477800|540356898|FG001|Placebo-Controlled Period|Disease Progression|0|||
149790066|NCT02477800|540356899|FG002|Placebo-Controlled Period|Disease Progression|1|||
149790067|NCT02477800|540356900|FG003|Placebo-Controlled Period|Disease Progression|0|||
149790068|NCT02477800|540356901|FG004|Placebo-Controlled Period|Disease Progression|0|||
149790069|NCT02477800|540356902|FG005|Placebo-Controlled Period|Disease Progression|0|||
149790070|NCT02477800|540356903|FG006|Placebo-Controlled Period|Disease Progression|0|||
149790071|NCT02477800|540356897|FG000|Placebo-Controlled Period|Investigator Decision|3|||
149790072|NCT02477800|540356898|FG001|Placebo-Controlled Period|Investigator Decision|2|||
149790073|NCT02477800|540356899|FG002|Placebo-Controlled Period|Investigator Decision|1|||
149790074|NCT02477800|540356900|FG003|Placebo-Controlled Period|Investigator Decision|0|||
149790075|NCT02477800|540356901|FG004|Placebo-Controlled Period|Investigator Decision|0|||
149790076|NCT02477800|540356902|FG005|Placebo-Controlled Period|Investigator Decision|0|||
149790077|NCT02477800|540356903|FG006|Placebo-Controlled Period|Investigator Decision|0|||
149790078|NCT02477800|540356897|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
149790079|NCT02477800|540356898|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
149790080|NCT02477800|540356899|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
149790081|NCT02477800|540356900|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
149790082|NCT02477800|540356901|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
149790083|NCT02477800|540356902|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
149790084|NCT02477800|540356903|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
149790085|NCT02477800|540356897|FG000|Placebo-Controlled Period|Relocation|2|||
149790086|NCT02477800|540356898|FG001|Placebo-Controlled Period|Relocation|0|||
149790087|NCT02477800|540356899|FG002|Placebo-Controlled Period|Relocation|0|||
149790088|NCT02477800|540356900|FG003|Placebo-Controlled Period|Relocation|0|||
149790089|NCT02477800|540356901|FG004|Placebo-Controlled Period|Relocation|0|||
149790090|NCT02477800|540356902|FG005|Placebo-Controlled Period|Relocation|0|||
149790091|NCT02477800|540356903|FG006|Placebo-Controlled Period|Relocation|0|||
149790092|NCT02477800|540356897|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149790093|NCT02477800|540356898|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149790094|NCT02477800|540356899|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149790095|NCT02477800|540356900|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149790096|NCT02477800|540356901|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149790097|NCT02477800|540356902|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149790098|NCT02477800|540356903|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149790099|NCT02477800|540356897|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
149790100|NCT02477800|540356898|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
149790101|NCT02477800|540356899|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149790102|NCT02477800|540356900|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149790103|NCT02477800|540356901|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149790104|NCT02477800|540356902|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149790105|NCT02477800|540356903|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149790106|NCT02477800|540356897|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
149790107|NCT02477800|540356898|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
149790108|NCT02477800|540356899|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
149790109|NCT02477800|540356900|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
149790110|NCT02477800|540356901|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
149790111|NCT02477800|540356902|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
149790112|NCT02477800|540356903|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
149790113|NCT02477800|540356897|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
149790114|NCT02477800|540356898|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
149790115|NCT02477800|540356899|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
149790116|NCT02477800|540356900|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149790117|NCT02477800|540356901|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149790118|NCT02477800|540356902|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149790119|NCT02477800|540356903|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149790120|NCT02477800|540356897|FG000|Placebo-Controlled Period|Reason not Specified|161|||
149790121|NCT02477800|540356898|FG001|Placebo-Controlled Period|Reason not Specified|161|||
149790122|NCT02477800|540356899|FG002|Placebo-Controlled Period|Reason not Specified|189|||
149790123|NCT02477800|540356900|FG003|Placebo-Controlled Period|Reason not Specified|0|||
149790124|NCT02477800|540356901|FG004|Placebo-Controlled Period|Reason not Specified|0|||
149790125|NCT02477800|540356902|FG005|Placebo-Controlled Period|Reason not Specified|0|||
149790126|NCT02477800|540356903|FG006|Placebo-Controlled Period|Reason not Specified|0|||
149790127|NCT02477800|540356897|FG000|Long Term Extension Period|Adverse Event|0|||
149790128|NCT02477800|540356898|FG001|Long Term Extension Period|Adverse Event|0|||
149790129|NCT02477800|540356899|FG002|Long Term Extension Period|Adverse Event|0|||
149790130|NCT02477800|540356900|FG003|Long Term Extension Period|Adverse Event|6|||
149790131|NCT02477800|540356901|FG004|Long Term Extension Period|Adverse Event|2|||
149790132|NCT02477800|540356902|FG005|Long Term Extension Period|Adverse Event|4|||
149790133|NCT02477800|540356903|FG006|Long Term Extension Period|Adverse Event|3|||
149790134|NCT02477800|540356897|FG000|Long Term Extension Period|Death|0|||
149790135|NCT02477800|540356898|FG001|Long Term Extension Period|Death|0|||
149790136|NCT02477800|540356899|FG002|Long Term Extension Period|Death|0|||
149790137|NCT02477800|540356900|FG003|Long Term Extension Period|Death|1|||
149790138|NCT02477800|540356901|FG004|Long Term Extension Period|Death|1|||
149790139|NCT02477800|540356902|FG005|Long Term Extension Period|Death|1|||
149790140|NCT02477800|540356903|FG006|Long Term Extension Period|Death|2|||
149790141|NCT02477800|540356897|FG000|Long Term Extension Period|Consent Withdrawn|0|||
149790142|NCT02477800|540356898|FG001|Long Term Extension Period|Consent Withdrawn|0|||
149790143|NCT02477800|540356899|FG002|Long Term Extension Period|Consent Withdrawn|0|||
149790144|NCT02477800|540356900|FG003|Long Term Extension Period|Consent Withdrawn|10|||
149790145|NCT02477800|540356901|FG004|Long Term Extension Period|Consent Withdrawn|4|||
149790146|NCT02477800|540356902|FG005|Long Term Extension Period|Consent Withdrawn|13|||
149790147|NCT02477800|540356903|FG006|Long Term Extension Period|Consent Withdrawn|16|||
149790148|NCT02477800|540356897|FG000|Long Term Extension Period|Disease Progression|0|||
149790149|NCT02477800|540356898|FG001|Long Term Extension Period|Disease Progression|0|||
149790150|NCT02477800|540356899|FG002|Long Term Extension Period|Disease Progression|0|||
149790151|NCT02477800|540356900|FG003|Long Term Extension Period|Disease Progression|3|||
149790152|NCT02477800|540356901|FG004|Long Term Extension Period|Disease Progression|1|||
149790153|NCT02477800|540356902|FG005|Long Term Extension Period|Disease Progression|1|||
149790154|NCT02477800|540356903|FG006|Long Term Extension Period|Disease Progression|0|||
149790155|NCT02477800|540356897|FG000|Long Term Extension Period|Investigator Decision|0|||
149790156|NCT02477800|540356898|FG001|Long Term Extension Period|Investigator Decision|0|||
149790157|NCT02477800|540356899|FG002|Long Term Extension Period|Investigator Decision|0|||
149790158|NCT02477800|540356900|FG003|Long Term Extension Period|Investigator Decision|0|||
149790159|NCT02477800|540356901|FG004|Long Term Extension Period|Investigator Decision|0|||
149790160|NCT02477800|540356902|FG005|Long Term Extension Period|Investigator Decision|0|||
149790161|NCT02477800|540356903|FG006|Long Term Extension Period|Investigator Decision|2|||
149790162|NCT02477800|540356897|FG000|Long Term Extension Period|Lost to Follow-up|0|||
149790163|NCT02477800|540356898|FG001|Long Term Extension Period|Lost to Follow-up|0|||
149790164|NCT02477800|540356899|FG002|Long Term Extension Period|Lost to Follow-up|0|||
149790165|NCT02477800|540356900|FG003|Long Term Extension Period|Lost to Follow-up|0|||
149790166|NCT02477800|540356901|FG004|Long Term Extension Period|Lost to Follow-up|1|||
149790167|NCT02477800|540356902|FG005|Long Term Extension Period|Lost to Follow-up|3|||
149790168|NCT02477800|540356903|FG006|Long Term Extension Period|Lost to Follow-up|0|||
149790169|NCT02477800|540356897|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
149790170|NCT02477800|540356898|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
149790171|NCT02477800|540356899|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
149790172|NCT02477800|540356900|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
149790173|NCT02477800|540356901|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
149790174|NCT02477800|540356902|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
149790175|NCT02477800|540356903|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
149790176|NCT02477800|540356897|FG000|Long Term Extension Period|Study Visit Burden|0|||
149790177|NCT02477800|540356898|FG001|Long Term Extension Period|Study Visit Burden|0|||
149790178|NCT02477800|540356899|FG002|Long Term Extension Period|Study Visit Burden|0|||
149790179|NCT02477800|540356900|FG003|Long Term Extension Period|Study Visit Burden|3|||
149790180|NCT02477800|540356901|FG004|Long Term Extension Period|Study Visit Burden|0|||
149790181|NCT02477800|540356902|FG005|Long Term Extension Period|Study Visit Burden|2|||
149790182|NCT02477800|540356903|FG006|Long Term Extension Period|Study Visit Burden|2|||
149790183|NCT02477800|540356897|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
149790184|NCT02477800|540356898|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
149790185|NCT02477800|540356899|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
149790186|NCT02477800|540356900|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
149790187|NCT02477800|540356901|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
149790188|NCT02477800|540356902|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
149790189|NCT02477800|540356903|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
149790190|NCT02477800|540356897|FG000|Long Term Extension Period|Reason not Specified|0|||
149790191|NCT02477800|540356898|FG001|Long Term Extension Period|Reason not Specified|0|||
149790192|NCT02477800|540356899|FG002|Long Term Extension Period|Reason not Specified|0|||
149790193|NCT02477800|540356900|FG003|Long Term Extension Period|Reason not Specified|126|||
149790194|NCT02477800|540356901|FG004|Long Term Extension Period|Reason not Specified|140|||
149790195|NCT02477800|540356902|FG005|Long Term Extension Period|Reason not Specified|270|||
149790196|NCT02477800|540356903|FG006|Long Term Extension Period|Reason not Specified|224|||
149790197|NCT00129376|540356904|FG000|Overall Study|Adverse Event|1|||
149790198|NCT00129376|540356904|FG000|Overall Study|Lack of Efficacy|1|||
149790199|NCT02061540|540356911|FG000|Overall Study|Adverse Event|2|||
149790200|NCT02061540|540356911|FG000|Overall Study|Withdrawal by Subject|2|||
149790201|NCT04005755|540356914|FG000|Overall Study|Adverse Event|6|||
149790202|NCT04005755|540356914|FG000|Overall Study|Physician Decision|3|||
149790203|NCT04005755|540356914|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
149790204|NCT04005755|540356914|FG000|Overall Study|Withdrawal by Subject|3|||
149790205|NCT04005755|540356914|FG000|Overall Study|Lost to Follow-up|1|||
149790206|NCT02289833|540356915|FG000|Overall Study|Study discontinuation|0|||
149790207|NCT02289833|540356916|FG001|Overall Study|Study discontinuation|1|||
149790208|NCT02289833|540356915|FG000|Overall Study|Lost to Follow-up|4|||
149790209|NCT02289833|540356916|FG001|Overall Study|Lost to Follow-up|0|||
149790210|NCT02289833|540356915|FG000|Overall Study|Death|23|||
149790211|NCT02289833|540356916|FG001|Overall Study|Death|16|||
149790212|NCT02561273|540356923|FG000|Overall Study|Protocol Violation|1|||
149790213|NCT02561273|540356924|FG001|Overall Study|Protocol Violation|0|||
149790214|NCT02723019|540356925|FG000|Overall Study|Death|17|||
149790215|NCT02723019|540356926|FG001|Overall Study|Death|13|||
149790216|NCT02723019|540356925|FG000|Overall Study|Withdrawal by Subject|11|||
149790217|NCT02723019|540356926|FG001|Overall Study|Withdrawal by Subject|7|||
149790218|NCT02723019|540356925|FG000|Overall Study|Lost to Follow-up|57|||
149790219|NCT02723019|540356926|FG001|Overall Study|Lost to Follow-up|70|||
149790220|NCT00958191|540356928|FG000|Overall Study|Death|4|||
149790221|NCT00958191|540356928|FG000|Overall Study|Lost to Follow-up|5|||
149790222|NCT00958191|540356928|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
149790223|NCT00958191|540356928|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
149790224|NCT00958191|540356928|FG000|Overall Study|Revision of study device|4|||
149790225|NCT00958191|540356928|FG000|Overall Study|Site termination|11|||
149790226|NCT00958191|540356928|FG000|Overall Study|No 5 yr x-rays|56|||
149790227|NCT00611767|540356929|FG000|Overall Study|Withdrawal by Subject|4|||
149790228|NCT00611767|540356930|FG001|Overall Study|Withdrawal by Subject|1|||
149790229|NCT00611767|540356929|FG000|Overall Study|Thiopental not available|3|||
149790230|NCT00611767|540356930|FG001|Overall Study|Thiopental not available|0|||
149790231|NCT00611767|540356929|FG000|Overall Study|didn't like the medication|1|||
149790232|NCT00611767|540356930|FG001|Overall Study|didn't like the medication|1|||
149790233|NCT00611767|540356929|FG000|Overall Study|Physician Decision|1|||
149790234|NCT00611767|540356930|FG001|Overall Study|Physician Decision|0|||
149790235|NCT01642004|540356931|FG000|Randomization|Adverse Event unrelated to study drug|1|||
149790236|NCT01642004|540356932|FG001|Randomization|Adverse Event unrelated to study drug|0|||
149790237|NCT01642004|540356931|FG000|Randomization|Participant withdrew consent|1|||
149790238|NCT01642004|540356932|FG001|Randomization|Participant withdrew consent|6|||
149790239|NCT01642004|540356931|FG000|Randomization|No longer meets study criteria|2|||
149790240|NCT01642004|540356932|FG001|Randomization|No longer meets study criteria|2|||
149790241|NCT01642004|540356931|FG000|Treatment|Disease progression|95|||
149790242|NCT01642004|540356932|FG001|Treatment|Disease progression|79|||
149790243|NCT01642004|540356931|FG000|Treatment|Study drug toxicity|10|||
149790244|NCT01642004|540356932|FG001|Treatment|Study drug toxicity|13|||
149790245|NCT01642004|540356931|FG000|Treatment|Death|1|||
149790246|NCT01642004|540356932|FG001|Treatment|Death|1|||
149790247|NCT01642004|540356931|FG000|Treatment|Adverse event unrelated to study drug|9|||
149790248|NCT01642004|540356932|FG001|Treatment|Adverse event unrelated to study drug|13|||
149790249|NCT01642004|540356931|FG000|Treatment|Maximum clinical benefit|1|||
149790250|NCT01642004|540356932|FG001|Treatment|Maximum clinical benefit|9|||
149790251|NCT01642004|540356931|FG000|Treatment|Poor/non-compliance|1|||
149790252|NCT01642004|540356932|FG001|Treatment|Poor/non-compliance|0|||
149790253|NCT01642004|540356931|FG000|Treatment|No longer meets study criteria|1|||
149790254|NCT01642004|540356932|FG001|Treatment|No longer meets study criteria|2|||
149790255|NCT01642004|540356931|FG000|Treatment|Other reasons|2|||
149790256|NCT01642004|540356932|FG001|Treatment|Other reasons|0|||
149790257|NCT01642004|540356931|FG000|Treatment|Not reported|0|||
149790258|NCT01642004|540356932|FG001|Treatment|Not reported|3|||
149790259|NCT01642004|540356931|FG000|Treatment|Participant request to discontinue study treatment|6|||
149790260|NCT01642004|540356932|FG001|Treatment|Participant request to discontinue study treatment|4|||
149790261|NCT01642004|540356931|FG000|Treatment|Participant withdrew consent|5|||
149790262|NCT01642004|540356932|FG001|Treatment|Participant withdrew consent|5|||
149790263|NCT02718625|540356933|FG000|Overall Study|Adverse Event|0|||
149790264|NCT02718625|540356934|FG001|Overall Study|Adverse Event|1|||
149790265|NCT02718625|540356933|FG000|Overall Study|Termination of Study by Sponsor|0|||
149790266|NCT02718625|540356934|FG001|Overall Study|Termination of Study by Sponsor|1|||
149790267|NCT00811395|540356937|FG000|Extension Treatment|Adverse Event|1|||
149790268|NCT00811395|540356938|FG001|Extension Treatment|Adverse Event|2|||
149790269|NCT00811395|540356939|FG002|Extension Treatment|Adverse Event|2|||
149790270|NCT00811395|540356940|FG003|Extension Treatment|Adverse Event|2|||
149790271|NCT00811395|540356941|FG004|Extension Treatment|Adverse Event|0|||
149790272|NCT00811395|540356942|FG005|Extension Treatment|Adverse Event|1|||
149790273|NCT00811395|540356937|FG000|Extension Treatment|Progressive disease|1|||
149790274|NCT00811395|540356938|FG001|Extension Treatment|Progressive disease|1|||
149790275|NCT00811395|540356939|FG002|Extension Treatment|Progressive disease|0|||
149790276|NCT00811395|540356940|FG003|Extension Treatment|Progressive disease|0|||
149790277|NCT00811395|540356941|FG004|Extension Treatment|Progressive disease|0|||
149790278|NCT00811395|540356942|FG005|Extension Treatment|Progressive disease|0|||
149790279|NCT00811395|540356937|FG000|Extension Treatment|Participant did not wish to continue|0|||
149790280|NCT00811395|540356938|FG001|Extension Treatment|Participant did not wish to continue|3|||
149790281|NCT00811395|540356939|FG002|Extension Treatment|Participant did not wish to continue|0|||
149790282|NCT00811395|540356940|FG003|Extension Treatment|Participant did not wish to continue|1|||
149790283|NCT00811395|540356941|FG004|Extension Treatment|Participant did not wish to continue|0|||
149790284|NCT00811395|540356942|FG005|Extension Treatment|Participant did not wish to continue|1|||
149790285|NCT00811395|540356937|FG000|Extension Treatment|Other than above|0|||
149790286|NCT00811395|540356938|FG001|Extension Treatment|Other than above|0|||
149790287|NCT00811395|540356939|FG002|Extension Treatment|Other than above|1|||
149790288|NCT00811395|540356940|FG003|Extension Treatment|Other than above|0|||
149790289|NCT00811395|540356941|FG004|Extension Treatment|Other than above|0|||
149790290|NCT00811395|540356942|FG005|Extension Treatment|Other than above|0|||
149790291|NCT00170846|540356943|FG000|Overall Study|Subject withdrew Informed Consent|5|||
149790292|NCT00170846|540356944|FG001|Overall Study|Subject withdrew Informed Consent|12|||
149790293|NCT00170846|540356945|FG002|Overall Study|Subject withdrew Informed Consent|8|||
149790294|NCT00170846|540356943|FG000|Overall Study|Lost to Follow-up|6|||
149790295|NCT00170846|540356944|FG001|Overall Study|Lost to Follow-up|3|||
149790296|NCT00170846|540356945|FG002|Overall Study|Lost to Follow-up|2|||
149790297|NCT00170846|540356943|FG000|Overall Study|Death|0|||
149790298|NCT00170846|540356944|FG001|Overall Study|Death|3|||
149790299|NCT00170846|540356945|FG002|Overall Study|Death|3|||
149790300|NCT00170846|540356943|FG000|Overall Study|Reason Missing|0|||
149790301|NCT00170846|540356944|FG001|Overall Study|Reason Missing|1|||
149790302|NCT00170846|540356945|FG002|Overall Study|Reason Missing|0|||
149790303|NCT00528840|540356946|FG000|Overall Study|Lost to Follow-up|10|||
149790304|NCT00528840|540356946|FG000|Overall Study|Adverse Event|1|||
149790305|NCT00528840|540356946|FG000|Overall Study|Withdrawal by Subject|17|||
149790306|NCT00528840|540356946|FG000|Overall Study|Death|2|||
149790307|NCT00528840|540356946|FG000|Overall Study|Administrative Reasons|1|||
149790308|NCT00528840|540356946|FG000|Overall Study|Other|2|||
149790309|NCT04554394|540356948|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
149790310|NCT04554394|540356949|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
149790311|NCT04554394|540356948|FG000|Overall Study|Withdrawal by Subject|2|||
149790312|NCT04554394|540356949|FG001|Overall Study|Withdrawal by Subject|2|||
149790313|NCT04554394|540356948|FG000|Overall Study|Lost to Follow-up|2|||
149790314|NCT04554394|540356949|FG001|Overall Study|Lost to Follow-up|2|||
149790315|NCT04554394|540356948|FG000|Overall Study|Physician Decision|1|||
149790316|NCT04554394|540356949|FG001|Overall Study|Physician Decision|1|||
149790317|NCT01766401|540356950|FG000|Overall Study|Adverse Event|7|||
149790318|NCT01766401|540356951|FG001|Overall Study|Adverse Event|22|||
149790319|NCT01766401|540356950|FG000|Overall Study|Lack of Efficacy|1|||
149790320|NCT01766401|540356951|FG001|Overall Study|Lack of Efficacy|2|||
149790321|NCT01766401|540356950|FG000|Overall Study|Protocol Violation|3|||
149790322|NCT01766401|540356951|FG001|Overall Study|Protocol Violation|8|||
149790323|NCT01766401|540356950|FG000|Overall Study|Withdrawal by Subject|15|||
149790324|NCT01766401|540356951|FG001|Overall Study|Withdrawal by Subject|12|||
149790325|NCT01766401|540356950|FG000|Overall Study|Lost to Follow-up|10|||
149790326|NCT01766401|540356951|FG001|Overall Study|Lost to Follow-up|11|||
149790327|NCT01766401|540356950|FG000|Overall Study|Pregnancy|1|||
149790328|NCT01766401|540356951|FG001|Overall Study|Pregnancy|1|||
149790329|NCT00808132|540356955|FG000|Overall Study|Adverse Event|34|||
149790330|NCT00808132|540356956|FG001|Overall Study|Adverse Event|33|||
149790331|NCT00808132|540356957|FG002|Overall Study|Adverse Event|16|||
149790332|NCT00808132|540356958|FG003|Overall Study|Adverse Event|31|||
149790333|NCT00808132|540356959|FG004|Overall Study|Adverse Event|33|||
149790334|NCT00808132|540356955|FG000|Overall Study|Death|0|||
149790335|NCT00808132|540356956|FG001|Overall Study|Death|0|||
149790336|NCT00808132|540356957|FG002|Overall Study|Death|0|||
149790337|NCT00808132|540356958|FG003|Overall Study|Death|0|||
149790338|NCT00808132|540356959|FG004|Overall Study|Death|1|||
149790339|NCT00808132|540356955|FG000|Overall Study|Physician Decision|0|||
149790340|NCT00808132|540356956|FG001|Overall Study|Physician Decision|1|||
149790341|NCT00808132|540356957|FG002|Overall Study|Physician Decision|0|||
149790342|NCT00808132|540356958|FG003|Overall Study|Physician Decision|0|||
149790343|NCT00808132|540356959|FG004|Overall Study|Physician Decision|0|||
149790344|NCT00808132|540356955|FG000|Overall Study|Lost to Follow-up|8|||
149790345|NCT00808132|540356956|FG001|Overall Study|Lost to Follow-up|10|||
149790346|NCT00808132|540356957|FG002|Overall Study|Lost to Follow-up|11|||
149790347|NCT00808132|540356958|FG003|Overall Study|Lost to Follow-up|8|||
149790348|NCT00808132|540356959|FG004|Overall Study|Lost to Follow-up|9|||
149790349|NCT00808132|540356955|FG000|Overall Study|Protocol Violation|8|||
149790350|NCT00808132|540356956|FG001|Overall Study|Protocol Violation|9|||
149790351|NCT00808132|540356957|FG002|Overall Study|Protocol Violation|4|||
149790352|NCT00808132|540356958|FG003|Overall Study|Protocol Violation|9|||
149790353|NCT00808132|540356959|FG004|Overall Study|Protocol Violation|5|||
149790354|NCT00808132|540356955|FG000|Overall Study|Withdrawal by Subject|27|||
149790355|NCT00808132|540356956|FG001|Overall Study|Withdrawal by Subject|18|||
149790356|NCT00808132|540356957|FG002|Overall Study|Withdrawal by Subject|2|||
149790357|NCT00808132|540356958|FG003|Overall Study|Withdrawal by Subject|7|||
149790358|NCT00808132|540356959|FG004|Overall Study|Withdrawal by Subject|16|||
149790359|NCT00808132|540356955|FG000|Overall Study|Other|6|||
149790360|NCT00808132|540356956|FG001|Overall Study|Other|4|||
149790361|NCT00808132|540356957|FG002|Overall Study|Other|6|||
149790362|NCT00808132|540356958|FG003|Overall Study|Other|2|||
149790363|NCT00808132|540356959|FG004|Overall Study|Other|15|||
149790364|NCT00808132|540356955|FG000|Overall Study|Randomized, but not treated|10|||
149790365|NCT00808132|540356956|FG001|Overall Study|Randomized, but not treated|7|||
149790366|NCT00808132|540356957|FG002|Overall Study|Randomized, but not treated|9|||
149790367|NCT00808132|540356958|FG003|Overall Study|Randomized, but not treated|8|||
149790368|NCT00808132|540356959|FG004|Overall Study|Randomized, but not treated|9|||
149790369|NCT00808132|540356955|FG000|Overall Study|Unsatisfactory response|5|||
149790370|NCT00808132|540356956|FG001|Overall Study|Unsatisfactory response|6|||
149790371|NCT00808132|540356957|FG002|Overall Study|Unsatisfactory response|6|||
149790372|NCT00808132|540356958|FG003|Overall Study|Unsatisfactory response|4|||
149790373|NCT00808132|540356959|FG004|Overall Study|Unsatisfactory response|12|||
149790374|NCT02795182|540356960|FG000|Overall Study|Death|5|||
149790375|NCT02795182|540356961|FG001|Overall Study|Death|4|||
149790376|NCT02795182|540356962|FG002|Overall Study|Death|4|||
149790377|NCT02795182|540356963|FG003|Overall Study|Death|18|||
149790378|NCT02795182|540356960|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149801793|NCT04338685|540402439|FG001|Overall Study|Study terminated by Sponsor|0|||
149790379|NCT02795182|540356961|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149790380|NCT02795182|540356962|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149790381|NCT02795182|540356963|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
149790382|NCT02795182|540356960|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149790383|NCT02795182|540356961|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149790384|NCT02795182|540356962|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149790385|NCT02795182|540356963|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
149790386|NCT02795182|540356960|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
149790387|NCT02795182|540356961|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
149790388|NCT02795182|540356962|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
149790389|NCT02795182|540356963|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
149790390|NCT02795182|540356960|FG000|Overall Study|Withdrawal by Subject|4|||
149790391|NCT02795182|540356961|FG001|Overall Study|Withdrawal by Subject|0|||
149790392|NCT02795182|540356962|FG002|Overall Study|Withdrawal by Subject|0|||
149790393|NCT02795182|540356963|FG003|Overall Study|Withdrawal by Subject|3|||
149790394|NCT02795182|540356960|FG000|Overall Study|Lost to Follow-up|0|||
149790395|NCT02795182|540356961|FG001|Overall Study|Lost to Follow-up|0|||
149790396|NCT02795182|540356962|FG002|Overall Study|Lost to Follow-up|1|||
149790397|NCT02795182|540356963|FG003|Overall Study|Lost to Follow-up|1|||
149790398|NCT02795182|540356960|FG000|Overall Study|Roll Over to Long Term Extension|3|||
149790399|NCT02795182|540356961|FG001|Overall Study|Roll Over to Long Term Extension|3|||
149790400|NCT02795182|540356962|FG002|Overall Study|Roll Over to Long Term Extension|2|||
149790401|NCT02795182|540356963|FG003|Overall Study|Roll Over to Long Term Extension|5|||
149790402|NCT02795182|540356960|FG000|Overall Study|Progressive Disease|0|||
149790403|NCT02795182|540356961|FG001|Overall Study|Progressive Disease|1|||
149790404|NCT02795182|540356962|FG002|Overall Study|Progressive Disease|0|||
149790405|NCT02795182|540356963|FG003|Overall Study|Progressive Disease|4|||
149790406|NCT02795182|540356960|FG000|Overall Study|Physician Decision|0|||
149790407|NCT02795182|540356961|FG001|Overall Study|Physician Decision|0|||
149790408|NCT02795182|540356962|FG002|Overall Study|Physician Decision|0|||
149790409|NCT02795182|540356963|FG003|Overall Study|Physician Decision|1|||
149790410|NCT02520141|540356964|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
149790411|NCT03258762|540356969|FG000|Overall Study|Lost to Follow-up|0|||
149790412|NCT03258762|540356970|FG001|Overall Study|Lost to Follow-up|1|||
149790413|NCT03893630|540356975|FG000|Overall Study|Lost to Follow-up|5|||
149790414|NCT03893630|540356976|FG001|Overall Study|Lost to Follow-up|4|||
149790415|NCT03893630|540356977|FG002|Overall Study|Lost to Follow-up|2|||
149790416|NCT03893630|540356975|FG000|Overall Study|Withdrawal by Subject|3|||
149790417|NCT03893630|540356976|FG001|Overall Study|Withdrawal by Subject|6|||
149790418|NCT03893630|540356977|FG002|Overall Study|Withdrawal by Subject|3|||
149790419|NCT03893630|540356975|FG000|Overall Study|Discontinued Intervention|0|||
149790420|NCT03893630|540356976|FG001|Overall Study|Discontinued Intervention|4|||
149790421|NCT03893630|540356977|FG002|Overall Study|Discontinued Intervention|2|||
149790422|NCT03557801|540358471|FG000|Overall Study|Protocol Violation|1|||
149790423|NCT03557801|540358472|FG001|Overall Study|Protocol Violation|0|||
149790424|NCT03557801|540358473|FG002|Overall Study|Protocol Violation|0|||
149790425|NCT03557801|540358471|FG000|Overall Study|Withdrawal by Subject|1|||
149790426|NCT03557801|540358472|FG001|Overall Study|Withdrawal by Subject|0|||
149790427|NCT03557801|540358473|FG002|Overall Study|Withdrawal by Subject|3|||
149790428|NCT03557801|540358471|FG000|Overall Study|Lost to Follow-up|0|||
149790429|NCT03557801|540358472|FG001|Overall Study|Lost to Follow-up|1|||
149790430|NCT03557801|540358473|FG002|Overall Study|Lost to Follow-up|0|||
149790431|NCT03558503|540358474|FG000|Overall Study|Adverse Event|1|||
149790432|NCT03558503|540358474|FG000|Overall Study|Death|1|||
149790433|NCT03558503|540358474|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
149790434|NCT02646891|540358475|FG000|Overall Study|Adverse Event|0|||
149790435|NCT02646891|540358476|FG001|Overall Study|Adverse Event|1|||
149790436|NCT02646891|540358477|FG002|Overall Study|Adverse Event|0|||
149790437|NCT02646891|540358478|FG003|Overall Study|Adverse Event|0|||
149790438|NCT02646891|540358479|FG004|Overall Study|Adverse Event|0|||
149790439|NCT02646891|540358480|FG005|Overall Study|Adverse Event|0|||
149790440|NCT02646891|540358481|FG006|Overall Study|Adverse Event|0|||
149790441|NCT02646891|540358482|FG007|Overall Study|Adverse Event|0|||
149790442|NCT02646891|540358483|FG008|Overall Study|Adverse Event|0|||
149790443|NCT02646891|540358484|FG009|Overall Study|Adverse Event|0|||
149790444|NCT02646891|540358475|FG000|Overall Study|Lost to Follow-up|0|||
149790445|NCT02646891|540358476|FG001|Overall Study|Lost to Follow-up|0|||
149790446|NCT02646891|540358477|FG002|Overall Study|Lost to Follow-up|0|||
149790447|NCT02646891|540358478|FG003|Overall Study|Lost to Follow-up|0|||
149790448|NCT02646891|540358479|FG004|Overall Study|Lost to Follow-up|0|||
149790449|NCT02646891|540358480|FG005|Overall Study|Lost to Follow-up|0|||
149790450|NCT02646891|540358481|FG006|Overall Study|Lost to Follow-up|2|||
149790451|NCT02646891|540358482|FG007|Overall Study|Lost to Follow-up|2|||
149790452|NCT02646891|540358483|FG008|Overall Study|Lost to Follow-up|2|||
149790453|NCT02646891|540358484|FG009|Overall Study|Lost to Follow-up|2|||
149790454|NCT02646891|540358475|FG000|Overall Study|Protocol Violation|0|||
149790455|NCT02646891|540358476|FG001|Overall Study|Protocol Violation|0|||
149790456|NCT02646891|540358477|FG002|Overall Study|Protocol Violation|0|||
149790457|NCT02646891|540358478|FG003|Overall Study|Protocol Violation|0|||
149790458|NCT02646891|540358479|FG004|Overall Study|Protocol Violation|0|||
149790459|NCT02646891|540358480|FG005|Overall Study|Protocol Violation|0|||
149790460|NCT02646891|540358481|FG006|Overall Study|Protocol Violation|1|||
149790461|NCT02646891|540358482|FG007|Overall Study|Protocol Violation|1|||
149790462|NCT02646891|540358483|FG008|Overall Study|Protocol Violation|0|||
149790463|NCT02646891|540358484|FG009|Overall Study|Protocol Violation|0|||
149790464|NCT02646891|540358475|FG000|Overall Study|Withdrawal by Subject|2|||
149790465|NCT02646891|540358476|FG001|Overall Study|Withdrawal by Subject|0|||
149790466|NCT02646891|540358477|FG002|Overall Study|Withdrawal by Subject|1|||
149790467|NCT02646891|540358478|FG003|Overall Study|Withdrawal by Subject|0|||
149790468|NCT02646891|540358479|FG004|Overall Study|Withdrawal by Subject|0|||
149790469|NCT02646891|540358480|FG005|Overall Study|Withdrawal by Subject|0|||
149790470|NCT02646891|540358481|FG006|Overall Study|Withdrawal by Subject|5|||
149790471|NCT02646891|540358482|FG007|Overall Study|Withdrawal by Subject|9|||
149790472|NCT02646891|540358483|FG008|Overall Study|Withdrawal by Subject|7|||
149790473|NCT02646891|540358484|FG009|Overall Study|Withdrawal by Subject|3|||
149790474|NCT02646891|540358475|FG000|Overall Study|Death|0|||
149790475|NCT02646891|540358476|FG001|Overall Study|Death|0|||
149790476|NCT02646891|540358477|FG002|Overall Study|Death|0|||
149790477|NCT02646891|540358478|FG003|Overall Study|Death|0|||
149790478|NCT02646891|540358479|FG004|Overall Study|Death|0|||
149790479|NCT02646891|540358480|FG005|Overall Study|Death|0|||
149790480|NCT02646891|540358481|FG006|Overall Study|Death|1|||
149790481|NCT02646891|540358482|FG007|Overall Study|Death|1|||
149790482|NCT02646891|540358483|FG008|Overall Study|Death|1|||
149790483|NCT02646891|540358484|FG009|Overall Study|Death|0|||
149790484|NCT01756833|540358498|FG000|Overall Study|Withdrawal by Subject|4|||
149790485|NCT01756833|540358499|FG001|Overall Study|Withdrawal by Subject|3|||
149790486|NCT00886587|540358500|FG000|Overall Study|Adverse Event|2|||
149790487|NCT00886587|540358501|FG001|Overall Study|Adverse Event|1|||
149790488|NCT00886587|540358500|FG000|Overall Study|Protocol Violation|2|||
149790489|NCT00886587|540358501|FG001|Overall Study|Protocol Violation|0|||
149790490|NCT00886587|540358500|FG000|Overall Study|Withdrawal by Subject|0|||
149790491|NCT00886587|540358501|FG001|Overall Study|Withdrawal by Subject|1|||
149790492|NCT00398086|540358502|FG000|Overall Study|Unacceptable Toxicity|2|||
149790493|NCT00398086|540358503|FG001|Overall Study|Unacceptable Toxicity|8|||
149790494|NCT00398086|540358504|FG002|Overall Study|Unacceptable Toxicity|2|||
149790495|NCT00398086|540358502|FG000|Overall Study|Adverse Event|1|||
149790496|NCT00398086|540358503|FG001|Overall Study|Adverse Event|4|||
149790497|NCT00398086|540358504|FG002|Overall Study|Adverse Event|0|||
149790498|NCT00398086|540358502|FG000|Overall Study|Physician Decision|1|||
149790499|NCT00398086|540358503|FG001|Overall Study|Physician Decision|4|||
149790500|NCT00398086|540358504|FG002|Overall Study|Physician Decision|0|||
149790501|NCT00398086|540358502|FG000|Overall Study|Withdrawal by Subject|5|||
149790502|NCT00398086|540358503|FG001|Overall Study|Withdrawal by Subject|7|||
149790503|NCT00398086|540358504|FG002|Overall Study|Withdrawal by Subject|0|||
149790504|NCT00696774|540358505|FG000|Period II|Adverse Event|0|||
149790505|NCT00696774|540358506|FG001|Period II|Adverse Event|0|||
149790506|NCT00696774|540358507|FG002|Period II|Adverse Event|15|||
149790507|NCT00696774|540358505|FG000|Period II|Lost to Follow-up|0|||
149790508|NCT00696774|540358506|FG001|Period II|Lost to Follow-up|0|||
149790509|NCT00696774|540358507|FG002|Period II|Lost to Follow-up|4|||
149790510|NCT00696774|540358505|FG000|Period II|Protocol Violation|0|||
149790511|NCT00696774|540358506|FG001|Period II|Protocol Violation|0|||
149790512|NCT00696774|540358507|FG002|Period II|Protocol Violation|11|||
149790513|NCT00696774|540358505|FG000|Period II|Withdrawal by Subject|0|||
149790514|NCT00696774|540358506|FG001|Period II|Withdrawal by Subject|0|||
149790515|NCT00696774|540358507|FG002|Period II|Withdrawal by Subject|4|||
149790516|NCT00696774|540358505|FG000|Period II|Sponsor Decision|0|||
149790517|NCT00696774|540358506|FG001|Period II|Sponsor Decision|0|||
149790518|NCT00696774|540358507|FG002|Period II|Sponsor Decision|0|||
149790519|NCT00696774|540358505|FG000|Period II|Lack of Efficacy|0|||
149790520|NCT00696774|540358506|FG001|Period II|Lack of Efficacy|0|||
149790521|NCT00696774|540358507|FG002|Period II|Lack of Efficacy|2|||
149790522|NCT00696774|540358505|FG000|Period III|Adverse Event|1|||
149790523|NCT00696774|540358506|FG001|Period III|Adverse Event|1|||
149790524|NCT00696774|540358507|FG002|Period III|Adverse Event|0|||
149790525|NCT00696774|540358505|FG000|Period III|Lost to Follow-up|2|||
149790526|NCT00696774|540358506|FG001|Period III|Lost to Follow-up|1|||
149790527|NCT00696774|540358507|FG002|Period III|Lost to Follow-up|0|||
149790528|NCT00696774|540358505|FG000|Period III|Protocol Violation|1|||
149790529|NCT00696774|540358506|FG001|Period III|Protocol Violation|1|||
149790530|NCT00696774|540358507|FG002|Period III|Protocol Violation|0|||
149790531|NCT00696774|540358505|FG000|Period III|Withdrawal by Subject|1|||
149790532|NCT00696774|540358506|FG001|Period III|Withdrawal by Subject|2|||
149790533|NCT00696774|540358507|FG002|Period III|Withdrawal by Subject|0|||
149790534|NCT00696774|540358505|FG000|Period III|Sponsor Decision|2|||
149790535|NCT00696774|540358506|FG001|Period III|Sponsor Decision|0|||
149790536|NCT00696774|540358507|FG002|Period III|Sponsor Decision|0|||
149790537|NCT00696774|540358505|FG000|Period III|Lack of Efficacy|0|||
149790538|NCT00696774|540358506|FG001|Period III|Lack of Efficacy|2|||
149790539|NCT00696774|540358507|FG002|Period III|Lack of Efficacy|0|||
149790540|NCT00890201|540358514|FG000|Overall Study|Protocol Violation|5|||
149790541|NCT00890201|540358515|FG001|Overall Study|Protocol Violation|56|||
149790542|NCT00033293|540358516|FG000|Overall Study|Death|0|||
149790543|NCT00033293|540358517|FG001|Overall Study|Death|1|||
149790544|NCT00033293|540358516|FG000|Overall Study|Lack of Efficacy|5|||
149790545|NCT00033293|540358517|FG001|Overall Study|Lack of Efficacy|8|||
149790546|NCT00033293|540358516|FG000|Overall Study|Lost to Follow-up|0|||
149790547|NCT00033293|540358517|FG001|Overall Study|Lost to Follow-up|1|||
149790548|NCT00033293|540358516|FG000|Overall Study|Physician Decision|3|||
149790549|NCT00033293|540358517|FG001|Overall Study|Physician Decision|1|||
149790550|NCT00033293|540358516|FG000|Overall Study|Withdrawal by Subject|1|||
149790551|NCT00033293|540358517|FG001|Overall Study|Withdrawal by Subject|0|||
149790552|NCT00033293|540358516|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
149790553|NCT00033293|540358517|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
149790554|NCT00033293|540358516|FG000|Overall Study|Treatment refused|0|||
149790555|NCT00033293|540358517|FG001|Overall Study|Treatment refused|6|||
149790556|NCT02087241|540358518|FG000|Overall Study|Death|2|||
149790557|NCT02087241|540358519|FG001|Overall Study|Death|1|||
149790558|NCT02087241|540358520|FG002|Overall Study|Death|1|||
149790559|NCT02087241|540358521|FG003|Overall Study|Death|1|||
149790560|NCT02087241|540358518|FG000|Overall Study|Withdrawal by Subject|1|||
149790561|NCT02087241|540358519|FG001|Overall Study|Withdrawal by Subject|0|||
149790562|NCT02087241|540358520|FG002|Overall Study|Withdrawal by Subject|0|||
149790563|NCT02087241|540358521|FG003|Overall Study|Withdrawal by Subject|1|||
149790564|NCT02087241|540358518|FG000|Overall Study|Progressive Disease|0|||
149790565|NCT02087241|540358519|FG001|Overall Study|Progressive Disease|0|||
149790566|NCT02087241|540358520|FG002|Overall Study|Progressive Disease|0|||
149790567|NCT02087241|540358521|FG003|Overall Study|Progressive Disease|1|||
149790568|NCT02087241|540358518|FG000|Overall Study|Study Terminated by Sponsor|0|||
149790569|NCT02087241|540358519|FG001|Overall Study|Study Terminated by Sponsor|2|||
149790570|NCT02087241|540358520|FG002|Overall Study|Study Terminated by Sponsor|0|||
149790571|NCT02087241|540358521|FG003|Overall Study|Study Terminated by Sponsor|4|||
149790572|NCT01955005|540358522|FG000|Overall Study|Withdrawal by Subject|3|||
149790573|NCT01955005|540358523|FG001|Overall Study|Withdrawal by Subject|5|||
149790574|NCT02877134|540358524|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790575|NCT02877134|540358525|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
149790576|NCT02877134|540358526|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790577|NCT02877134|540358527|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790578|NCT02877134|540358528|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790579|NCT02877134|540358529|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
149790580|NCT02877134|540358530|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790581|NCT02877134|540358531|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790582|NCT02877134|540358532|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790583|NCT02877134|540358533|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790584|NCT02877134|540358534|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790585|NCT02877134|540358535|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
149790586|NCT02877134|540358524|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790587|NCT02877134|540358525|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
149790588|NCT02877134|540358526|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790589|NCT02877134|540358527|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
149790590|NCT02877134|540358528|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790591|NCT02877134|540358529|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790592|NCT02877134|540358530|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
149790593|NCT02877134|540358531|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790594|NCT02877134|540358532|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790595|NCT02877134|540358533|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790596|NCT02877134|540358534|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790597|NCT02877134|540358535|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149790598|NCT02877134|540358524|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
149790599|NCT02877134|540358525|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
149790600|NCT02877134|540358526|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
149790601|NCT02877134|540358527|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
149790602|NCT02877134|540358528|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
149790603|NCT02877134|540358529|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
149790604|NCT02877134|540358530|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
149790605|NCT02877134|540358531|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149790606|NCT02877134|540358532|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149790607|NCT02877134|540358533|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149790608|NCT02877134|540358534|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149790609|NCT02877134|540358535|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149790610|NCT02877134|540358524|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
149790611|NCT02877134|540358525|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
149790612|NCT02877134|540358526|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
149790613|NCT02877134|540358527|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
149790614|NCT02877134|540358528|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
149790615|NCT02877134|540358529|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
149790616|NCT02877134|540358530|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
149790617|NCT02877134|540358531|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
149790618|NCT02877134|540358532|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
149790619|NCT02877134|540358533|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
149790620|NCT02877134|540358534|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
149790621|NCT02877134|540358535|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
149790622|NCT02877134|540358524|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790623|NCT02877134|540358525|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790624|NCT02877134|540358526|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790625|NCT02877134|540358527|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790626|NCT02877134|540358528|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790627|NCT02877134|540358529|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790628|NCT02877134|540358530|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790629|NCT02877134|540358531|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790630|NCT02877134|540358532|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
149790631|NCT02877134|540358533|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790632|NCT02877134|540358534|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790633|NCT02877134|540358535|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149790634|NCT02877134|540358524|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790635|NCT02877134|540358525|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790636|NCT02877134|540358526|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790637|NCT02877134|540358527|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790638|NCT02877134|540358528|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790639|NCT02877134|540358529|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790640|NCT02877134|540358530|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149790641|NCT02877134|540358531|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
149790642|NCT02877134|540358532|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
149790643|NCT02877134|540358533|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
149790644|NCT02877134|540358534|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
149790645|NCT02877134|540358535|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
149790646|NCT02877134|540358524|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790647|NCT02877134|540358525|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790648|NCT02877134|540358526|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790649|NCT02877134|540358527|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790650|NCT02877134|540358528|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790651|NCT02877134|540358529|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790652|NCT02877134|540358530|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790653|NCT02877134|540358531|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149790654|NCT02877134|540358532|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149790655|NCT02877134|540358533|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149790656|NCT02877134|540358534|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790657|NCT02877134|540358535|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149790658|NCT02877134|540358524|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
149790659|NCT02877134|540358525|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
149790660|NCT02877134|540358526|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
149790661|NCT02877134|540358527|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
149790662|NCT02877134|540358528|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
149790663|NCT02877134|540358529|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
149790664|NCT02877134|540358530|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
149790665|NCT02877134|540358531|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
149790666|NCT02877134|540358532|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
149790667|NCT02877134|540358533|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
149790668|NCT02877134|540358534|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
149790669|NCT02877134|540358535|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
149790670|NCT01197794|540358536|FG000|Overall Study|Adverse Event|3|||
149790671|NCT01197794|540358537|FG001|Overall Study|Adverse Event|2|||
149790672|NCT01197794|540358538|FG002|Overall Study|Adverse Event|4|||
149790673|NCT01197794|540358539|FG003|Overall Study|Adverse Event|4|||
149790674|NCT01197794|540358540|FG004|Overall Study|Adverse Event|4|||
149790675|NCT01197794|540358541|FG005|Overall Study|Adverse Event|2|||
149790676|NCT01197794|540358542|FG006|Overall Study|Adverse Event|3|||
149790677|NCT01197794|540358536|FG000|Overall Study|Protocol Violation|0|||
149790678|NCT01197794|540358537|FG001|Overall Study|Protocol Violation|0|||
149790679|NCT01197794|540358538|FG002|Overall Study|Protocol Violation|0|||
149790680|NCT01197794|540358539|FG003|Overall Study|Protocol Violation|0|||
149790681|NCT01197794|540358540|FG004|Overall Study|Protocol Violation|2|||
149790682|NCT01197794|540358541|FG005|Overall Study|Protocol Violation|0|||
149790683|NCT01197794|540358542|FG006|Overall Study|Protocol Violation|1|||
149790684|NCT01197794|540358536|FG000|Overall Study|Development of study withdrawal criteria|3|||
149790685|NCT01197794|540358537|FG001|Overall Study|Development of study withdrawal criteria|0|||
149790686|NCT01197794|540358538|FG002|Overall Study|Development of study withdrawal criteria|0|||
149790687|NCT01197794|540358539|FG003|Overall Study|Development of study withdrawal criteria|1|||
149790688|NCT01197794|540358540|FG004|Overall Study|Development of study withdrawal criteria|0|||
149790689|NCT01197794|540358541|FG005|Overall Study|Development of study withdrawal criteria|0|||
149790690|NCT01197794|540358542|FG006|Overall Study|Development of study withdrawal criteria|1|||
149790691|NCT01197794|540358536|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
149790692|NCT01197794|540358537|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
149790693|NCT01197794|540358538|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
149790694|NCT01197794|540358539|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
149790695|NCT01197794|540358540|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
149790696|NCT01197794|540358541|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
149790697|NCT01197794|540358542|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
149790698|NCT01197794|540358536|FG000|Overall Study|Withdrawal by Subject|3|||
149790699|NCT01197794|540358537|FG001|Overall Study|Withdrawal by Subject|3|||
149790700|NCT01197794|540358538|FG002|Overall Study|Withdrawal by Subject|4|||
149790701|NCT01197794|540358539|FG003|Overall Study|Withdrawal by Subject|1|||
149790702|NCT01197794|540358540|FG004|Overall Study|Withdrawal by Subject|1|||
149790703|NCT01197794|540358541|FG005|Overall Study|Withdrawal by Subject|5|||
149790704|NCT01197794|540358542|FG006|Overall Study|Withdrawal by Subject|6|||
149790705|NCT01197794|540358536|FG000|Overall Study|Lost to Follow-up|1|||
149790706|NCT01197794|540358537|FG001|Overall Study|Lost to Follow-up|1|||
149790707|NCT01197794|540358538|FG002|Overall Study|Lost to Follow-up|0|||
149790708|NCT01197794|540358539|FG003|Overall Study|Lost to Follow-up|1|||
149790709|NCT01197794|540358540|FG004|Overall Study|Lost to Follow-up|0|||
149790710|NCT01197794|540358541|FG005|Overall Study|Lost to Follow-up|1|||
149790711|NCT01197794|540358542|FG006|Overall Study|Lost to Follow-up|0|||
149790712|NCT01197794|540358536|FG000|Overall Study|Other|1|||
149790713|NCT01197794|540358537|FG001|Overall Study|Other|1|||
149790714|NCT01197794|540358538|FG002|Overall Study|Other|3|||
149790715|NCT01197794|540358539|FG003|Overall Study|Other|0|||
149790716|NCT01197794|540358540|FG004|Overall Study|Other|2|||
149790717|NCT01197794|540358541|FG005|Overall Study|Other|2|||
149790718|NCT01197794|540358542|FG006|Overall Study|Other|4|||
149790719|NCT01055457|540358543|FG000|Overall Study|Lost to Follow-up|0|||
149790720|NCT01055457|540358544|FG001|Overall Study|Lost to Follow-up|1|||
149790721|NCT01055457|540358545|FG002|Overall Study|Lost to Follow-up|0|||
149790722|NCT01055457|540358546|FG003|Overall Study|Lost to Follow-up|0|||
149790723|NCT01055457|540358547|FG004|Overall Study|Lost to Follow-up|0|||
149790724|NCT01055457|540358548|FG005|Overall Study|Lost to Follow-up|1|||
149790725|NCT01055457|540358549|FG006|Overall Study|Lost to Follow-up|0|||
149790726|NCT01055457|540358550|FG007|Overall Study|Lost to Follow-up|0|||
149790727|NCT01055457|540358551|FG008|Overall Study|Lost to Follow-up|0|||
149790728|NCT01055457|540358552|FG009|Overall Study|Lost to Follow-up|0|||
149790729|NCT01055457|540358543|FG000|Overall Study|Protocol Violation|0|||
149790730|NCT01055457|540358544|FG001|Overall Study|Protocol Violation|0|||
149790731|NCT01055457|540358545|FG002|Overall Study|Protocol Violation|1|||
149790732|NCT01055457|540358546|FG003|Overall Study|Protocol Violation|1|||
149790733|NCT01055457|540358547|FG004|Overall Study|Protocol Violation|1|||
149790734|NCT01055457|540358548|FG005|Overall Study|Protocol Violation|2|||
149790735|NCT01055457|540358549|FG006|Overall Study|Protocol Violation|1|||
149790736|NCT01055457|540358550|FG007|Overall Study|Protocol Violation|0|||
149790737|NCT01055457|540358551|FG008|Overall Study|Protocol Violation|0|||
149790738|NCT01055457|540358552|FG009|Overall Study|Protocol Violation|1|||
149790739|NCT01055457|540358543|FG000|Overall Study|Subject Disinterest|0|||
149790740|NCT01055457|540358544|FG001|Overall Study|Subject Disinterest|0|||
149790741|NCT01055457|540358545|FG002|Overall Study|Subject Disinterest|0|||
149790742|NCT01055457|540358546|FG003|Overall Study|Subject Disinterest|0|||
149790743|NCT01055457|540358547|FG004|Overall Study|Subject Disinterest|0|||
149790744|NCT01055457|540358548|FG005|Overall Study|Subject Disinterest|0|||
149790745|NCT01055457|540358549|FG006|Overall Study|Subject Disinterest|0|||
149790746|NCT01055457|540358550|FG007|Overall Study|Subject Disinterest|1|||
149790747|NCT01055457|540358551|FG008|Overall Study|Subject Disinterest|0|||
149790748|NCT01055457|540358552|FG009|Overall Study|Subject Disinterest|0|||
149790749|NCT01055457|540358543|FG000|Overall Study|Subject Ineligible|1|||
149790750|NCT01055457|540358544|FG001|Overall Study|Subject Ineligible|0|||
149790751|NCT01055457|540358545|FG002|Overall Study|Subject Ineligible|1|||
149790752|NCT01055457|540358546|FG003|Overall Study|Subject Ineligible|0|||
149790753|NCT01055457|540358547|FG004|Overall Study|Subject Ineligible|1|||
149790754|NCT01055457|540358548|FG005|Overall Study|Subject Ineligible|0|||
149790755|NCT01055457|540358549|FG006|Overall Study|Subject Ineligible|0|||
149790756|NCT01055457|540358550|FG007|Overall Study|Subject Ineligible|0|||
149790757|NCT01055457|540358551|FG008|Overall Study|Subject Ineligible|0|||
149790758|NCT01055457|540358552|FG009|Overall Study|Subject Ineligible|0|||
149790759|NCT01055457|540358543|FG000|Overall Study|Discomfort|0|||
149790760|NCT01055457|540358544|FG001|Overall Study|Discomfort|0|||
149790761|NCT01055457|540358545|FG002|Overall Study|Discomfort|0|||
149790762|NCT01055457|540358546|FG003|Overall Study|Discomfort|0|||
149790763|NCT01055457|540358547|FG004|Overall Study|Discomfort|1|||
149790764|NCT01055457|540358548|FG005|Overall Study|Discomfort|0|||
149790765|NCT01055457|540358549|FG006|Overall Study|Discomfort|0|||
149790766|NCT01055457|540358550|FG007|Overall Study|Discomfort|0|||
149790767|NCT01055457|540358551|FG008|Overall Study|Discomfort|0|||
149790768|NCT01055457|540358552|FG009|Overall Study|Discomfort|0|||
149790769|NCT01055457|540358543|FG000|Overall Study|Pregnancy|0|||
149790770|NCT01055457|540358544|FG001|Overall Study|Pregnancy|0|||
149790771|NCT01055457|540358545|FG002|Overall Study|Pregnancy|0|||
149790772|NCT01055457|540358546|FG003|Overall Study|Pregnancy|1|||
149790773|NCT01055457|540358547|FG004|Overall Study|Pregnancy|0|||
149790774|NCT01055457|540358548|FG005|Overall Study|Pregnancy|0|||
149790775|NCT01055457|540358549|FG006|Overall Study|Pregnancy|0|||
149790776|NCT01055457|540358550|FG007|Overall Study|Pregnancy|0|||
149790777|NCT01055457|540358551|FG008|Overall Study|Pregnancy|0|||
149790778|NCT01055457|540358552|FG009|Overall Study|Pregnancy|0|||
149790779|NCT01055457|540358543|FG000|Overall Study|Adverse Event|0|||
149790780|NCT01055457|540358544|FG001|Overall Study|Adverse Event|0|||
149790781|NCT01055457|540358545|FG002|Overall Study|Adverse Event|0|||
149790782|NCT01055457|540358546|FG003|Overall Study|Adverse Event|1|||
149790783|NCT01055457|540358547|FG004|Overall Study|Adverse Event|0|||
149790784|NCT01055457|540358548|FG005|Overall Study|Adverse Event|0|||
149790785|NCT01055457|540358549|FG006|Overall Study|Adverse Event|0|||
149790786|NCT01055457|540358550|FG007|Overall Study|Adverse Event|0|||
149790787|NCT01055457|540358551|FG008|Overall Study|Adverse Event|0|||
149790788|NCT01055457|540358552|FG009|Overall Study|Adverse Event|0|||
149790789|NCT02187224|540358553|FG000|Overall Study|Did not show up for test day|1|||
149790790|NCT02187224|540358554|FG001|Overall Study|Did not show up for test day|0|||
149790791|NCT01010776|540358561|FG000|Main Phase|Withdrawal by Subject|14|||
149790792|NCT01010776|540358561|FG000|Main Phase|Lack of Efficacy|8|||
149790793|NCT01010776|540358561|FG000|Main Phase|Adverse Event|7|||
149790794|NCT01010776|540358561|FG000|Main Phase|Lost to Follow-up|6|||
149790795|NCT01010776|540358561|FG000|Main Phase|Non-compliance to study medication|5|||
149790796|NCT01010776|540358561|FG000|Main Phase|Selection failure|2|||
149790797|NCT01010776|540358561|FG000|Main Phase|Inform consent withdrawal|1|||
149790798|NCT01010776|540358561|FG000|Main Phase|Other|1|||
149790799|NCT01010776|540358561|FG000|Main Phase|Did not received study medication|5|||
149790800|NCT01010776|540358561|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
149790801|NCT01010776|540358561|FG000|Extension Phase|Other|3|||
149790802|NCT01846208|540358570|FG000|Overall Study|Withdrew prior to treatment|1|||
149790803|NCT01846208|540358571|FG001|Overall Study|Withdrew prior to treatment|1|||
149790804|NCT01846208|540358572|FG002|Overall Study|Withdrew prior to treatment|1|||
149790805|NCT01846208|540358570|FG000|Overall Study|Dosing Symptoms|1|||
149790806|NCT01846208|540358571|FG001|Overall Study|Dosing Symptoms|2|||
149790807|NCT01846208|540358572|FG002|Overall Study|Dosing Symptoms|6|||
149790808|NCT01846208|540358570|FG000|Overall Study|Withdrawal by Subject|5|||
149790809|NCT01846208|540358571|FG001|Overall Study|Withdrawal by Subject|0|||
149790810|NCT01846208|540358572|FG002|Overall Study|Withdrawal by Subject|0|||
149790811|NCT01846208|540358570|FG000|Overall Study|Non-compliance|1|||
149790812|NCT01846208|540358571|FG001|Overall Study|Non-compliance|1|||
149790813|NCT01846208|540358572|FG002|Overall Study|Non-compliance|0|||
149790814|NCT01846208|540358570|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
149790815|NCT01846208|540358571|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
149790816|NCT01846208|540358572|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
149790817|NCT01846208|540358570|FG000|Overall Study|Refused SU OFC|0|||
149790818|NCT01846208|540358571|FG001|Overall Study|Refused SU OFC|0|||
149790819|NCT01846208|540358572|FG002|Overall Study|Refused SU OFC|1|||
149790820|NCT01268514|540358573|FG000|Overall Study|Adverse Event|20|||
149790821|NCT01268514|540358573|FG000|Overall Study|Death|8|||
149790822|NCT01268514|540358573|FG000|Overall Study|Lost to Follow-up|5|||
149790823|NCT01268514|540358573|FG000|Overall Study|Withdrawal by Subject|3|||
149790824|NCT01268514|540358573|FG000|Overall Study|Withdrawal by Surgeon|5|||
149790825|NCT01424306|540358574|FG000|Overall Study|Protocol Violation|0|||
149790826|NCT01424306|540358575|FG001|Overall Study|Protocol Violation|0|||
149790827|NCT01424306|540358576|FG002|Overall Study|Protocol Violation|0|||
149790828|NCT01424306|540358577|FG003|Overall Study|Protocol Violation|0|||
149790829|NCT01424306|540358578|FG004|Overall Study|Protocol Violation|1|||
149790830|NCT01424306|540358579|FG005|Overall Study|Protocol Violation|0|||
149790831|NCT01875874|540358583|FG000|Overall Study|Death|3|||
149790832|NCT00374127|540358586|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
149790833|NCT00374127|540358586|FG000|Overall Study|Blood could not be drawn.|2|||
149790834|NCT00374127|540358586|FG000|Overall Study|Protocol Violation|5|||
149790835|NCT00374127|540358586|FG000|Overall Study|Pregnancy|1|||
149790836|NCT03344562|540358587|FG000|Overall Study|Withdrawal by Subject|2|||
149790837|NCT03344562|540358588|FG001|Overall Study|Withdrawal by Subject|0|||
149790838|NCT02736474|540358589|FG000|Overall Study|Lost to Follow-up|0|||
149790839|NCT02736474|540358590|FG001|Overall Study|Lost to Follow-up|1|||
149790840|NCT02382276|540358591|FG000|Overall Study|Withdrawal by Subject|4|||
149790841|NCT02382276|540358592|FG001|Overall Study|Withdrawal by Subject|8|||
149790842|NCT02382276|540358593|FG002|Overall Study|Withdrawal by Subject|5|||
149790843|NCT02382276|540358591|FG000|Overall Study|Adverse Event|7|||
149790844|NCT02382276|540358592|FG001|Overall Study|Adverse Event|2|||
149790845|NCT02382276|540358593|FG002|Overall Study|Adverse Event|32|||
149790846|NCT02382276|540358591|FG000|Overall Study|Physician Decision|0|||
149790847|NCT02382276|540358592|FG001|Overall Study|Physician Decision|0|||
149790848|NCT02382276|540358593|FG002|Overall Study|Physician Decision|2|||
149790849|NCT00703781|540358598|FG000|Overall Study|Withdrawal by Subject|1|||
149790850|NCT00703781|540358599|FG001|Overall Study|Withdrawal by Subject|2|||
149790851|NCT00703781|540358598|FG000|Overall Study|Cancelled surgery|1|||
149790852|NCT00703781|540358599|FG001|Overall Study|Cancelled surgery|0|||
149790853|NCT02168816|540358600|FG000|Overall Study|Lost to Follow-up|2|||
149790854|NCT02168816|540358601|FG001|Overall Study|Lost to Follow-up|2|||
149790855|NCT01066546|540358604|FG000|Overall Study|Study terminated by sponsor|5|||
149790856|NCT02545049|540358611|FG000|Overall Study|Withdrawal by Subject|1|||
149790857|NCT02545049|540358612|FG001|Overall Study|Withdrawal by Subject|7|||
149790858|NCT02545049|540358611|FG000|Overall Study|Lost to Follow-up|4|||
149790859|NCT02545049|540358612|FG001|Overall Study|Lost to Follow-up|6|||
149790860|NCT02545049|540358611|FG000|Overall Study|GCP violations|37|||
149790861|NCT02545049|540358612|FG001|Overall Study|GCP violations|48|||
149790862|NCT04191096|540358624|FG000|Overall Study|Death|102|||
149790863|NCT04191096|540358625|FG001|Overall Study|Death|89|||
149790864|NCT04191096|540358624|FG000|Overall Study|Lost to Follow-up|1|||
149790865|NCT04191096|540358625|FG001|Overall Study|Lost to Follow-up|1|||
149790866|NCT04191096|540358624|FG000|Overall Study|Withdrawal by Subject|5|||
149790867|NCT04191096|540358625|FG001|Overall Study|Withdrawal by Subject|5|||
149790868|NCT04191096|540358624|FG000|Overall Study|Participants Ongoing|518|||
149790869|NCT04191096|540358625|FG001|Overall Study|Participants Ongoing|530|||
149790870|NCT01004861|540360233|FG000|Overall Study|Disease progression|3|||
149790871|NCT01004861|540360234|FG001|Overall Study|Disease progression|4|||
149790872|NCT01004861|540360235|FG002|Overall Study|Disease progression|5|||
149790873|NCT01004861|540360236|FG003|Overall Study|Disease progression|4|||
149790874|NCT01004861|540360237|FG004|Overall Study|Disease progression|4|||
149790875|NCT01004861|540360238|FG005|Overall Study|Disease progression|4|||
149790876|NCT01004861|540360239|FG006|Overall Study|Disease progression|5|||
149790877|NCT01004861|540360240|FG007|Overall Study|Disease progression|1|||
149790878|NCT01004861|540360241|FG008|Overall Study|Disease progression|4|||
149790879|NCT01004861|540360242|FG009|Overall Study|Disease progression|7|||
149790880|NCT01004861|540360243|FG010|Overall Study|Disease progression|6|||
149790881|NCT01004861|540360244|FG011|Overall Study|Disease progression|3|||
149790882|NCT01004861|540360245|FG012|Overall Study|Disease progression|8|||
149790883|NCT01004861|540360233|FG000|Overall Study|Physician Decision|0|||
149790884|NCT01004861|540360234|FG001|Overall Study|Physician Decision|2|||
149790885|NCT01004861|540360235|FG002|Overall Study|Physician Decision|1|||
149790886|NCT01004861|540360236|FG003|Overall Study|Physician Decision|1|||
149790887|NCT01004861|540360237|FG004|Overall Study|Physician Decision|1|||
149790888|NCT01004861|540360238|FG005|Overall Study|Physician Decision|0|||
149790889|NCT01004861|540360239|FG006|Overall Study|Physician Decision|0|||
149790890|NCT01004861|540360240|FG007|Overall Study|Physician Decision|1|||
149790891|NCT01004861|540360241|FG008|Overall Study|Physician Decision|0|||
149790892|NCT01004861|540360242|FG009|Overall Study|Physician Decision|0|||
149790893|NCT01004861|540360243|FG010|Overall Study|Physician Decision|0|||
149790894|NCT01004861|540360244|FG011|Overall Study|Physician Decision|0|||
149790895|NCT01004861|540360245|FG012|Overall Study|Physician Decision|3|||
149790896|NCT01004861|540360233|FG000|Overall Study|Adverse Event|0|||
149790897|NCT01004861|540360234|FG001|Overall Study|Adverse Event|0|||
149790898|NCT01004861|540360235|FG002|Overall Study|Adverse Event|0|||
149790899|NCT01004861|540360236|FG003|Overall Study|Adverse Event|1|||
149790900|NCT01004861|540360237|FG004|Overall Study|Adverse Event|0|||
149790901|NCT01004861|540360238|FG005|Overall Study|Adverse Event|2|||
149790902|NCT01004861|540360239|FG006|Overall Study|Adverse Event|1|||
149790903|NCT01004861|540360240|FG007|Overall Study|Adverse Event|1|||
149790904|NCT01004861|540360241|FG008|Overall Study|Adverse Event|13|||
149790905|NCT01004861|540360242|FG009|Overall Study|Adverse Event|1|||
149790906|NCT01004861|540360243|FG010|Overall Study|Adverse Event|1|||
149790907|NCT01004861|540360244|FG011|Overall Study|Adverse Event|0|||
149790908|NCT01004861|540360245|FG012|Overall Study|Adverse Event|2|||
149790909|NCT01004861|540360233|FG000|Overall Study|Protocol Violation|0|||
149790910|NCT01004861|540360234|FG001|Overall Study|Protocol Violation|0|||
149790911|NCT01004861|540360235|FG002|Overall Study|Protocol Violation|0|||
149790912|NCT01004861|540360236|FG003|Overall Study|Protocol Violation|0|||
149790913|NCT01004861|540360237|FG004|Overall Study|Protocol Violation|1|||
149790914|NCT01004861|540360238|FG005|Overall Study|Protocol Violation|0|||
149790915|NCT01004861|540360239|FG006|Overall Study|Protocol Violation|0|||
149790916|NCT01004861|540360240|FG007|Overall Study|Protocol Violation|0|||
149790917|NCT01004861|540360241|FG008|Overall Study|Protocol Violation|0|||
149790918|NCT01004861|540360242|FG009|Overall Study|Protocol Violation|0|||
149790919|NCT01004861|540360243|FG010|Overall Study|Protocol Violation|0|||
149790920|NCT01004861|540360244|FG011|Overall Study|Protocol Violation|0|||
149790921|NCT01004861|540360245|FG012|Overall Study|Protocol Violation|0|||
149790922|NCT01004861|540360233|FG000|Overall Study|Lost to Follow-up|0|||
149790923|NCT01004861|540360234|FG001|Overall Study|Lost to Follow-up|0|||
149790924|NCT01004861|540360235|FG002|Overall Study|Lost to Follow-up|0|||
149790925|NCT01004861|540360236|FG003|Overall Study|Lost to Follow-up|0|||
149790926|NCT01004861|540360237|FG004|Overall Study|Lost to Follow-up|0|||
149790927|NCT01004861|540360238|FG005|Overall Study|Lost to Follow-up|0|||
149790928|NCT01004861|540360239|FG006|Overall Study|Lost to Follow-up|0|||
149790929|NCT01004861|540360240|FG007|Overall Study|Lost to Follow-up|1|||
149790930|NCT01004861|540360241|FG008|Overall Study|Lost to Follow-up|3|||
149790931|NCT01004861|540360242|FG009|Overall Study|Lost to Follow-up|0|||
149790932|NCT01004861|540360243|FG010|Overall Study|Lost to Follow-up|0|||
149790933|NCT01004861|540360244|FG011|Overall Study|Lost to Follow-up|1|||
149790934|NCT01004861|540360245|FG012|Overall Study|Lost to Follow-up|0|||
149790935|NCT01004861|540360233|FG000|Overall Study|Non-compliance|0|||
149790936|NCT01004861|540360234|FG001|Overall Study|Non-compliance|0|||
149790937|NCT01004861|540360235|FG002|Overall Study|Non-compliance|0|||
149790938|NCT01004861|540360236|FG003|Overall Study|Non-compliance|0|||
149790939|NCT01004861|540360237|FG004|Overall Study|Non-compliance|0|||
149790940|NCT01004861|540360238|FG005|Overall Study|Non-compliance|0|||
149790941|NCT01004861|540360239|FG006|Overall Study|Non-compliance|0|||
149790942|NCT01004861|540360240|FG007|Overall Study|Non-compliance|0|||
149790943|NCT01004861|540360241|FG008|Overall Study|Non-compliance|5|||
149790944|NCT01004861|540360242|FG009|Overall Study|Non-compliance|0|||
149790945|NCT01004861|540360243|FG010|Overall Study|Non-compliance|0|||
149790946|NCT01004861|540360244|FG011|Overall Study|Non-compliance|0|||
149790947|NCT01004861|540360245|FG012|Overall Study|Non-compliance|1|||
149790948|NCT01004861|540360233|FG000|Overall Study|Other|0|||
149790949|NCT01004861|540360234|FG001|Overall Study|Other|0|||
149790950|NCT01004861|540360235|FG002|Overall Study|Other|0|||
149790951|NCT01004861|540360236|FG003|Overall Study|Other|0|||
149790952|NCT01004861|540360237|FG004|Overall Study|Other|0|||
149790953|NCT01004861|540360238|FG005|Overall Study|Other|0|||
149790954|NCT01004861|540360239|FG006|Overall Study|Other|0|||
149790955|NCT01004861|540360240|FG007|Overall Study|Other|0|||
149790956|NCT01004861|540360241|FG008|Overall Study|Other|0|||
149790957|NCT01004861|540360242|FG009|Overall Study|Other|2|||
149790958|NCT01004861|540360243|FG010|Overall Study|Other|1|||
149790959|NCT01004861|540360244|FG011|Overall Study|Other|2|||
149790960|NCT01004861|540360245|FG012|Overall Study|Other|3|||
149790961|NCT01004861|540360233|FG000|Overall Study|Patient decision|0|||
149790962|NCT01004861|540360234|FG001|Overall Study|Patient decision|0|||
149790963|NCT01004861|540360235|FG002|Overall Study|Patient decision|0|||
149790964|NCT01004861|540360236|FG003|Overall Study|Patient decision|0|||
149790965|NCT01004861|540360237|FG004|Overall Study|Patient decision|1|||
149790966|NCT01004861|540360238|FG005|Overall Study|Patient decision|0|||
149790967|NCT01004861|540360239|FG006|Overall Study|Patient decision|1|||
149790968|NCT01004861|540360240|FG007|Overall Study|Patient decision|0|||
149790969|NCT01004861|540360241|FG008|Overall Study|Patient decision|7|||
149790970|NCT01004861|540360242|FG009|Overall Study|Patient decision|1|||
149790971|NCT01004861|540360243|FG010|Overall Study|Patient decision|1|||
149790972|NCT01004861|540360244|FG011|Overall Study|Patient decision|2|||
149790973|NCT01004861|540360245|FG012|Overall Study|Patient decision|3|||
149790974|NCT01004861|540360233|FG000|Overall Study|Transitioned to Phase 4 study|0|||
149790975|NCT01004861|540360234|FG001|Overall Study|Transitioned to Phase 4 study|0|||
149790976|NCT01004861|540360235|FG002|Overall Study|Transitioned to Phase 4 study|0|||
149790977|NCT01004861|540360236|FG003|Overall Study|Transitioned to Phase 4 study|0|||
149790978|NCT01004861|540360237|FG004|Overall Study|Transitioned to Phase 4 study|0|||
149790979|NCT01004861|540360238|FG005|Overall Study|Transitioned to Phase 4 study|0|||
149790980|NCT01004861|540360239|FG006|Overall Study|Transitioned to Phase 4 study|0|||
149790981|NCT01004861|540360240|FG007|Overall Study|Transitioned to Phase 4 study|0|||
149790982|NCT01004861|540360241|FG008|Overall Study|Transitioned to Phase 4 study|2|||
149790983|NCT01004861|540360242|FG009|Overall Study|Transitioned to Phase 4 study|0|||
149790984|NCT01004861|540360243|FG010|Overall Study|Transitioned to Phase 4 study|0|||
149790985|NCT01004861|540360244|FG011|Overall Study|Transitioned to Phase 4 study|0|||
149790986|NCT01004861|540360245|FG012|Overall Study|Transitioned to Phase 4 study|0|||
149790987|NCT01004861|540360233|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790988|NCT01004861|540360234|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790989|NCT01004861|540360235|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790990|NCT01004861|540360236|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790991|NCT01004861|540360237|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790992|NCT01004861|540360238|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790993|NCT01004861|540360239|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790994|NCT01004861|540360240|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790995|NCT01004861|540360241|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
149790996|NCT01004861|540360242|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790997|NCT01004861|540360243|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790998|NCT01004861|540360244|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149790999|NCT01004861|540360245|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149791000|NCT01004861|540360233|FG000|Overall Study|Patient withdrew|0|||
149791001|NCT01004861|540360234|FG001|Overall Study|Patient withdrew|0|||
149791002|NCT01004861|540360235|FG002|Overall Study|Patient withdrew|0|||
149791003|NCT01004861|540360236|FG003|Overall Study|Patient withdrew|0|||
149791004|NCT01004861|540360237|FG004|Overall Study|Patient withdrew|0|||
149791005|NCT01004861|540360238|FG005|Overall Study|Patient withdrew|0|||
149791006|NCT01004861|540360239|FG006|Overall Study|Patient withdrew|0|||
149791007|NCT01004861|540360240|FG007|Overall Study|Patient withdrew|0|||
149791008|NCT01004861|540360241|FG008|Overall Study|Patient withdrew|1|||
149791009|NCT01004861|540360242|FG009|Overall Study|Patient withdrew|0|||
149791010|NCT01004861|540360243|FG010|Overall Study|Patient withdrew|0|||
149791011|NCT01004861|540360244|FG011|Overall Study|Patient withdrew|0|||
149791012|NCT01004861|540360245|FG012|Overall Study|Patient withdrew|0|||
149791013|NCT01004861|540360233|FG000|Overall Study|Surgical resection|0|||
149791014|NCT01004861|540360234|FG001|Overall Study|Surgical resection|0|||
149791015|NCT01004861|540360235|FG002|Overall Study|Surgical resection|0|||
149791016|NCT01004861|540360236|FG003|Overall Study|Surgical resection|0|||
149791017|NCT01004861|540360237|FG004|Overall Study|Surgical resection|0|||
149791018|NCT01004861|540360238|FG005|Overall Study|Surgical resection|0|||
149791019|NCT01004861|540360239|FG006|Overall Study|Surgical resection|0|||
149791020|NCT01004861|540360240|FG007|Overall Study|Surgical resection|0|||
149791021|NCT01004861|540360241|FG008|Overall Study|Surgical resection|1|||
149791022|NCT01004861|540360242|FG009|Overall Study|Surgical resection|0|||
149791023|NCT01004861|540360243|FG010|Overall Study|Surgical resection|0|||
149791024|NCT01004861|540360244|FG011|Overall Study|Surgical resection|0|||
149791025|NCT01004861|540360245|FG012|Overall Study|Surgical resection|0|||
149791026|NCT01004861|540360233|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791027|NCT01004861|540360234|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791028|NCT01004861|540360235|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791029|NCT01004861|540360236|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791030|NCT01004861|540360237|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791031|NCT01004861|540360238|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791032|NCT01004861|540360239|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791033|NCT01004861|540360240|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791034|NCT01004861|540360241|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
149791035|NCT01004861|540360242|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791036|NCT01004861|540360243|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791037|NCT01004861|540360244|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791038|NCT01004861|540360245|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149791039|NCT01004861|540360233|FG000|Overall Study|Study termination by Sponsor|0|||
149791040|NCT01004861|540360234|FG001|Overall Study|Study termination by Sponsor|0|||
149791041|NCT01004861|540360235|FG002|Overall Study|Study termination by Sponsor|0|||
149791042|NCT01004861|540360236|FG003|Overall Study|Study termination by Sponsor|0|||
149791043|NCT01004861|540360237|FG004|Overall Study|Study termination by Sponsor|0|||
149791044|NCT01004861|540360238|FG005|Overall Study|Study termination by Sponsor|0|||
149791045|NCT01004861|540360239|FG006|Overall Study|Study termination by Sponsor|0|||
149791046|NCT01004861|540360240|FG007|Overall Study|Study termination by Sponsor|0|||
149791047|NCT01004861|540360241|FG008|Overall Study|Study termination by Sponsor|1|||
149791048|NCT01004861|540360242|FG009|Overall Study|Study termination by Sponsor|0|||
149791049|NCT01004861|540360243|FG010|Overall Study|Study termination by Sponsor|0|||
149791050|NCT01004861|540360244|FG011|Overall Study|Study termination by Sponsor|0|||
149791051|NCT01004861|540360245|FG012|Overall Study|Study termination by Sponsor|0|||
149791052|NCT00003389|540360246|FG000|Overall Study|Disease progression|6|||
149791053|NCT00003389|540360247|FG001|Overall Study|Disease progression|1|||
149791054|NCT00003389|540360246|FG000|Overall Study|Adverse Event|13|||
149791055|NCT00003389|540360247|FG001|Overall Study|Adverse Event|2|||
149791056|NCT00003389|540360246|FG000|Overall Study|Death|0|||
149791057|NCT00003389|540360247|FG001|Overall Study|Death|3|||
149791058|NCT00003389|540360246|FG000|Overall Study|Withdrawal by Subject|12|||
149791059|NCT00003389|540360247|FG001|Overall Study|Withdrawal by Subject|5|||
149791060|NCT00003389|540360246|FG000|Overall Study|Alternative therapy|2|||
149791061|NCT00003389|540360247|FG001|Overall Study|Alternative therapy|1|||
149791062|NCT00003389|540360246|FG000|Overall Study|Complicating disease|1|||
149791063|NCT00003389|540360247|FG001|Overall Study|Complicating disease|0|||
149791064|NCT00003389|540360246|FG000|Overall Study|Off-treatment reason missing|31|||
149791065|NCT00003389|540360247|FG001|Overall Study|Off-treatment reason missing|21|||
149791066|NCT00003389|540360246|FG000|Overall Study|Ineligible|33|||
149791067|NCT00003389|540360247|FG001|Overall Study|Ineligible|27|||
149791068|NCT02554721|540360248|FG000|Overall Study|Adverse Event|1|||
149791069|NCT02554721|540360249|FG001|Overall Study|Adverse Event|0|||
149791070|NCT02554721|540360250|FG002|Overall Study|Adverse Event|0|||
149791071|NCT02554721|540360251|FG003|Overall Study|Adverse Event|0|||
149791072|NCT02554721|540360252|FG004|Overall Study|Adverse Event|1|||
149791073|NCT02554721|540360248|FG000|Overall Study|Noncompliance|0|||
149791074|NCT02554721|540360249|FG001|Overall Study|Noncompliance|0|||
149791075|NCT02554721|540360250|FG002|Overall Study|Noncompliance|0|||
149791076|NCT02554721|540360251|FG003|Overall Study|Noncompliance|0|||
149791077|NCT02554721|540360252|FG004|Overall Study|Noncompliance|1|||
149791078|NCT04657003|540360254|FG000|Overall Study|Adverse Event|5|||
149791079|NCT04657003|540360255|FG001|Overall Study|Adverse Event|1|||
149791080|NCT04657003|540360256|FG002|Overall Study|Adverse Event|5|||
149791081|NCT04657003|540360254|FG000|Overall Study|Death|0|||
149791082|NCT04657003|540360255|FG001|Overall Study|Death|2|||
149791083|NCT04657003|540360256|FG002|Overall Study|Death|0|||
149791084|NCT04657003|540360254|FG000|Overall Study|Lost to Follow-up|8|||
149791085|NCT04657003|540360255|FG001|Overall Study|Lost to Follow-up|4|||
149791086|NCT04657003|540360256|FG002|Overall Study|Lost to Follow-up|10|||
149791087|NCT04657003|540360254|FG000|Overall Study|Other - As Reported by Investigator|3|||
149791088|NCT04657003|540360255|FG001|Overall Study|Other - As Reported by Investigator|2|||
149791089|NCT04657003|540360256|FG002|Overall Study|Other - As Reported by Investigator|2|||
149791090|NCT04657003|540360254|FG000|Overall Study|Pregnancy|2|||
149791091|NCT04657003|540360255|FG001|Overall Study|Pregnancy|0|||
149791092|NCT04657003|540360256|FG002|Overall Study|Pregnancy|2|||
149791093|NCT04657003|540360254|FG000|Overall Study|Withdrawal by Subject|16|||
149791094|NCT04657003|540360255|FG001|Overall Study|Withdrawal by Subject|7|||
149791095|NCT04657003|540360256|FG002|Overall Study|Withdrawal by Subject|10|||
149791096|NCT05158244|540360257|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
149791097|NCT05158244|540360258|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149791098|NCT05158244|540360259|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149791099|NCT05158244|540360260|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149791100|NCT05158244|540360261|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149791101|NCT05158244|540360257|FG000|Overall Study|Withdrawal by Subject|0|||
149791102|NCT05158244|540360258|FG001|Overall Study|Withdrawal by Subject|0|||
149791103|NCT05158244|540360259|FG002|Overall Study|Withdrawal by Subject|1|||
149791104|NCT05158244|540360260|FG003|Overall Study|Withdrawal by Subject|0|||
149791105|NCT05158244|540360261|FG004|Overall Study|Withdrawal by Subject|0|||
149791106|NCT02185040|540360262|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
149791107|NCT02185040|540360263|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
149791108|NCT02185040|540360264|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
149791109|NCT02185040|540360265|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
149791110|NCT02185040|540360266|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
149791111|NCT02185040|540360267|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
149791112|NCT02185040|540360268|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
149791113|NCT02185040|540360262|FG000|Part 1 Treatment Phase|Adverse Event|1|||
149791114|NCT02185040|540360263|FG001|Part 1 Treatment Phase|Adverse Event|0|||
149791115|NCT02185040|540360264|FG002|Part 1 Treatment Phase|Adverse Event|0|||
149791116|NCT02185040|540360265|FG003|Part 1 Treatment Phase|Adverse Event|2|||
149791117|NCT02185040|540360266|FG004|Part 1 Treatment Phase|Adverse Event|3|||
149791118|NCT02185040|540360267|FG005|Part 1 Treatment Phase|Adverse Event|0|||
149791119|NCT02185040|540360268|FG006|Part 1 Treatment Phase|Adverse Event|0|||
149791120|NCT02185040|540360262|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791121|NCT02185040|540360263|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
149791122|NCT02185040|540360264|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791123|NCT02185040|540360265|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791124|NCT02185040|540360266|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791125|NCT02185040|540360267|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791126|NCT02185040|540360268|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149791127|NCT02185040|540360262|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791128|NCT02185040|540360263|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
149791129|NCT02185040|540360264|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791130|NCT02185040|540360265|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791131|NCT02185040|540360266|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791132|NCT02185040|540360267|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791133|NCT02185040|540360268|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
149791134|NCT02185040|540360262|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
149791135|NCT02185040|540360263|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
149791136|NCT02185040|540360264|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
149791137|NCT02185040|540360265|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
149791138|NCT02185040|540360266|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
149791139|NCT02185040|540360267|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
149791140|NCT02185040|540360268|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
149791141|NCT02185040|540360262|FG000|Active Treatment Extension Phase|Adverse Event|0|||
149791142|NCT02185040|540360263|FG001|Active Treatment Extension Phase|Adverse Event|0|||
149791143|NCT02185040|540360264|FG002|Active Treatment Extension Phase|Adverse Event|0|||
149791144|NCT02185040|540360265|FG003|Active Treatment Extension Phase|Adverse Event|0|||
149791145|NCT02185040|540360266|FG004|Active Treatment Extension Phase|Adverse Event|0|||
149791146|NCT02185040|540360267|FG005|Active Treatment Extension Phase|Adverse Event|1|||
149791147|NCT02185040|540360268|FG006|Active Treatment Extension Phase|Adverse Event|4|||
149791148|NCT02185040|540360262|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149791149|NCT02185040|540360263|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149791150|NCT02185040|540360264|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149791151|NCT02185040|540360265|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149791152|NCT02185040|540360266|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149791153|NCT02185040|540360267|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
149791154|NCT02185040|540360268|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
149791155|NCT02185040|540360262|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791156|NCT02185040|540360263|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791157|NCT02185040|540360264|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791158|NCT02185040|540360265|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791159|NCT02185040|540360266|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791160|NCT02185040|540360267|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
149791161|NCT02185040|540360268|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
149791162|NCT00718887|540360270|FG000|Overall Study|Withdrawal by Subject|3|||
149791163|NCT00718887|540360271|FG001|Overall Study|Withdrawal by Subject|2|||
149791164|NCT00718887|540360270|FG000|Overall Study|Not identified|2|||
149791165|NCT00718887|540360271|FG001|Overall Study|Not identified|7|||
149791166|NCT00775138|540360272|FG000|Overall Study|Withdrawal by Subject|0|||
149791167|NCT00775138|540360273|FG001|Overall Study|Withdrawal by Subject|0|||
149791168|NCT00775138|540360274|FG002|Overall Study|Withdrawal by Subject|2|||
149791169|NCT00775138|540360275|FG003|Overall Study|Withdrawal by Subject|2|||
149791170|NCT00775138|540360272|FG000|Overall Study|Adverse Event|0|||
149791171|NCT00775138|540360273|FG001|Overall Study|Adverse Event|0|||
149791172|NCT00775138|540360274|FG002|Overall Study|Adverse Event|1|||
149791173|NCT00775138|540360275|FG003|Overall Study|Adverse Event|0|||
149791174|NCT00141297|540360276|FG000|Overall Study|Adverse Event|0|||
149791175|NCT00141297|540360277|FG001|Overall Study|Adverse Event|0|||
149791176|NCT00141297|540360278|FG002|Overall Study|Adverse Event|1|||
149791177|NCT00141297|540360279|FG003|Overall Study|Adverse Event|0|||
149791178|NCT00141297|540360280|FG004|Overall Study|Adverse Event|1|||
149791179|NCT00141297|540360281|FG005|Overall Study|Adverse Event|1|||
149791180|NCT00141297|540360282|FG006|Overall Study|Adverse Event|0|||
149791181|NCT00141297|540360283|FG007|Overall Study|Adverse Event|1|||
149791182|NCT00141297|540360284|FG008|Overall Study|Adverse Event|1|||
149791183|NCT00141297|540360285|FG009|Overall Study|Adverse Event|0|||
149791184|NCT00141297|540360276|FG000|Overall Study|Death|1|||
149791185|NCT00141297|540360277|FG001|Overall Study|Death|0|||
149791186|NCT00141297|540360278|FG002|Overall Study|Death|0|||
149791187|NCT00141297|540360279|FG003|Overall Study|Death|0|||
149791188|NCT00141297|540360280|FG004|Overall Study|Death|0|||
149791189|NCT00141297|540360281|FG005|Overall Study|Death|0|||
149791190|NCT00141297|540360282|FG006|Overall Study|Death|0|||
149791191|NCT00141297|540360283|FG007|Overall Study|Death|0|||
149791192|NCT00141297|540360284|FG008|Overall Study|Death|1|||
149791193|NCT00141297|540360285|FG009|Overall Study|Death|0|||
149791194|NCT00141297|540360276|FG000|Overall Study|Withdrawal by Subject|0|||
149791195|NCT00141297|540360277|FG001|Overall Study|Withdrawal by Subject|0|||
149791196|NCT00141297|540360278|FG002|Overall Study|Withdrawal by Subject|0|||
149791197|NCT00141297|540360279|FG003|Overall Study|Withdrawal by Subject|0|||
149791198|NCT00141297|540360280|FG004|Overall Study|Withdrawal by Subject|0|||
149791199|NCT00141297|540360281|FG005|Overall Study|Withdrawal by Subject|0|||
149791200|NCT00141297|540360282|FG006|Overall Study|Withdrawal by Subject|0|||
149791201|NCT00141297|540360283|FG007|Overall Study|Withdrawal by Subject|0|||
149791202|NCT00141297|540360284|FG008|Overall Study|Withdrawal by Subject|1|||
149791203|NCT00141297|540360285|FG009|Overall Study|Withdrawal by Subject|0|||
149791204|NCT00141297|540360276|FG000|Overall Study|Other|0|||
149791205|NCT00141297|540360277|FG001|Overall Study|Other|0|||
149791206|NCT00141297|540360278|FG002|Overall Study|Other|0|||
149791207|NCT00141297|540360279|FG003|Overall Study|Other|1|||
149791208|NCT00141297|540360280|FG004|Overall Study|Other|5|||
149791209|NCT00141297|540360281|FG005|Overall Study|Other|0|||
149791210|NCT00141297|540360282|FG006|Overall Study|Other|0|||
149791211|NCT00141297|540360283|FG007|Overall Study|Other|0|||
149791212|NCT00141297|540360284|FG008|Overall Study|Other|2|||
149791213|NCT00141297|540360285|FG009|Overall Study|Other|0|||
149791214|NCT00141297|540360276|FG000|Overall Study|Progressive Disease|2|||
149791215|NCT00141297|540360277|FG001|Overall Study|Progressive Disease|3|||
149791216|NCT00141297|540360278|FG002|Overall Study|Progressive Disease|6|||
149791217|NCT00141297|540360279|FG003|Overall Study|Progressive Disease|2|||
149791218|NCT00141297|540360280|FG004|Overall Study|Progressive Disease|15|||
149791219|NCT00141297|540360281|FG005|Overall Study|Progressive Disease|2|||
149791220|NCT00141297|540360282|FG006|Overall Study|Progressive Disease|3|||
149791221|NCT00141297|540360283|FG007|Overall Study|Progressive Disease|3|||
149791222|NCT00141297|540360284|FG008|Overall Study|Progressive Disease|15|||
149791223|NCT00141297|540360285|FG009|Overall Study|Progressive Disease|6|||
149791224|NCT00141297|540360276|FG000|Overall Study|Transitioned|0|||
149791225|NCT00141297|540360277|FG001|Overall Study|Transitioned|0|||
149791226|NCT00141297|540360278|FG002|Overall Study|Transitioned|0|||
149791227|NCT00141297|540360279|FG003|Overall Study|Transitioned|0|||
149791228|NCT00141297|540360280|FG004|Overall Study|Transitioned|1|||
149791229|NCT00141297|540360281|FG005|Overall Study|Transitioned|0|||
149791230|NCT00141297|540360282|FG006|Overall Study|Transitioned|0|||
149791231|NCT00141297|540360283|FG007|Overall Study|Transitioned|0|||
149791232|NCT00141297|540360284|FG008|Overall Study|Transitioned|0|||
149791233|NCT00141297|540360285|FG009|Overall Study|Transitioned|0|||
149791234|NCT00103207|540360288|FG000|Overall Study|Adverse Event|3|||
149791235|NCT00103207|540360288|FG000|Overall Study|Death|1|||
149791236|NCT00103207|540360288|FG000|Overall Study|Withdrawal by Subject|2|||
149791237|NCT00103207|540360288|FG000|Overall Study|Other complicating disease|1|||
149791238|NCT00103207|540360288|FG000|Overall Study|Ineligible|4|||
149791239|NCT00103207|540360288|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
149791240|NCT03442595|540360289|FG000|Overall Study|Lost to Follow-up|94|||
149791241|NCT03442595|540360290|FG001|Overall Study|Lost to Follow-up|0|||
149791242|NCT01562327|540360291|FG000|Overall Study|Adverse Event|2|||
149791243|NCT01562327|540360291|FG000|Overall Study|Lack of Efficacy|1|||
149791244|NCT01562327|540360291|FG000|Overall Study|Participant drop-out|1|||
149791245|NCT01562327|540360291|FG000|Overall Study|Infusion not received at 6 month window|4|||
149791246|NCT02447952|540360292|FG000|Overall Study|Adverse Event|2|||
149791247|NCT02447952|540360292|FG000|Overall Study|Physician Decision|1|||
149791248|NCT02447952|540360292|FG000|Overall Study|Withdrawal by Subject|4|||
149791249|NCT02181504|540360295|FG000|Overall Study|Adverse Event|1|||
149791250|NCT02181504|540360296|FG001|Overall Study|Adverse Event|1|||
149791251|NCT02181504|540360297|FG002|Overall Study|Adverse Event|1|||
149791252|NCT00887913|540360298|FG000|Overall Study|Withdrawal by Subject|6|||
149791253|NCT01200758|540360301|FG000|Stage I|Death|0|||
149791254|NCT01200758|540360302|FG001|Stage I|Death|1|||
149791255|NCT01200758|540360303|FG002|Stage I|Death|0|||
149791256|NCT01200758|540360304|FG003|Stage I|Death|0|||
149791257|NCT01200758|540360301|FG000|Stage I|Physician Decision|1|||
149791258|NCT01200758|540360302|FG001|Stage I|Physician Decision|1|||
149791259|NCT01200758|540360303|FG002|Stage I|Physician Decision|0|||
149791260|NCT01200758|540360304|FG003|Stage I|Physician Decision|0|||
149791261|NCT01200758|540360301|FG000|Stage I|Lack of Efficacy|2|||
149791262|NCT01200758|540360302|FG001|Stage I|Lack of Efficacy|1|||
149791263|NCT01200758|540360303|FG002|Stage I|Lack of Efficacy|0|||
149791264|NCT01200758|540360304|FG003|Stage I|Lack of Efficacy|0|||
149791265|NCT01200758|540360301|FG000|Stage I|Adverse Event|5|||
149791266|NCT01200758|540360302|FG001|Stage I|Adverse Event|5|||
149791267|NCT01200758|540360303|FG002|Stage I|Adverse Event|0|||
149791268|NCT01200758|540360304|FG003|Stage I|Adverse Event|0|||
149791269|NCT01200758|540360301|FG000|Stage I|Withdrawal by Subject|1|||
149791270|NCT01200758|540360302|FG001|Stage I|Withdrawal by Subject|2|||
149791271|NCT01200758|540360303|FG002|Stage I|Withdrawal by Subject|0|||
149791272|NCT01200758|540360304|FG003|Stage I|Withdrawal by Subject|0|||
149791273|NCT01200758|540360301|FG000|Stage I|Disease Progression|9|||
149791274|NCT01200758|540360302|FG001|Stage I|Disease Progression|7|||
149791275|NCT01200758|540360303|FG002|Stage I|Disease Progression|0|||
149791276|NCT01200758|540360304|FG003|Stage I|Disease Progression|0|||
149791277|NCT01200758|540360301|FG000|Stage 2|Disease Progression|0|||
149791278|NCT01200758|540360302|FG001|Stage 2|Disease Progression|0|||
149791279|NCT01200758|540360303|FG002|Stage 2|Disease Progression|16|||
149791280|NCT01200758|540360304|FG003|Stage 2|Disease Progression|21|||
149791281|NCT01200758|540360301|FG000|Stage 2|Lack of Efficacy|0|||
149791282|NCT01200758|540360302|FG001|Stage 2|Lack of Efficacy|0|||
149791283|NCT01200758|540360303|FG002|Stage 2|Lack of Efficacy|4|||
149791284|NCT01200758|540360304|FG003|Stage 2|Lack of Efficacy|2|||
149791285|NCT01200758|540360301|FG000|Stage 2|Physician Decision|0|||
149791286|NCT01200758|540360302|FG001|Stage 2|Physician Decision|0|||
149791287|NCT01200758|540360303|FG002|Stage 2|Physician Decision|5|||
149791288|NCT01200758|540360304|FG003|Stage 2|Physician Decision|7|||
149791289|NCT01200758|540360301|FG000|Stage 2|Adverse Event|0|||
149791290|NCT01200758|540360302|FG001|Stage 2|Adverse Event|0|||
149791291|NCT01200758|540360303|FG002|Stage 2|Adverse Event|5|||
149791292|NCT01200758|540360304|FG003|Stage 2|Adverse Event|9|||
149791293|NCT01200758|540360301|FG000|Stage 2|Withdrawal by Subject|0|||
149791294|NCT01200758|540360302|FG001|Stage 2|Withdrawal by Subject|0|||
149791295|NCT01200758|540360303|FG002|Stage 2|Withdrawal by Subject|4|||
149791296|NCT01200758|540360304|FG003|Stage 2|Withdrawal by Subject|1|||
149791297|NCT01200758|540360301|FG000|Stage 2|Lost to Follow-up|0|||
149791298|NCT01200758|540360302|FG001|Stage 2|Lost to Follow-up|0|||
149791299|NCT01200758|540360303|FG002|Stage 2|Lost to Follow-up|3|||
149791300|NCT01200758|540360304|FG003|Stage 2|Lost to Follow-up|1|||
149791301|NCT01200758|540360301|FG000|Stage 2|Protocol Violation|0|||
149791302|NCT01200758|540360302|FG001|Stage 2|Protocol Violation|0|||
149791303|NCT01200758|540360303|FG002|Stage 2|Protocol Violation|1|||
149791304|NCT01200758|540360304|FG003|Stage 2|Protocol Violation|4|||
149791305|NCT01200758|540360301|FG000|Stage 2|Death|0|||
149791306|NCT01200758|540360302|FG001|Stage 2|Death|0|||
149791307|NCT01200758|540360303|FG002|Stage 2|Death|3|||
149791308|NCT01200758|540360304|FG003|Stage 2|Death|5|||
149791309|NCT01371721|540360305|FG000|Overall Study|Adverse Event|5|||
149791310|NCT01371721|540360306|FG001|Overall Study|Adverse Event|4|||
149791311|NCT01371721|540360307|FG002|Overall Study|Adverse Event|5|||
149791312|NCT01371721|540360305|FG000|Overall Study|Protocol Violation|6|||
149791313|NCT01371721|540360306|FG001|Overall Study|Protocol Violation|4|||
149791314|NCT01371721|540360307|FG002|Overall Study|Protocol Violation|5|||
149791315|NCT01371721|540360305|FG000|Overall Study|Lost to Follow-up|8|||
149791316|NCT01371721|540360306|FG001|Overall Study|Lost to Follow-up|2|||
149791317|NCT01371721|540360307|FG002|Overall Study|Lost to Follow-up|6|||
149791318|NCT01371721|540360305|FG000|Overall Study|Withdrawal by Subject|5|||
149791319|NCT01371721|540360306|FG001|Overall Study|Withdrawal by Subject|7|||
149791320|NCT01371721|540360307|FG002|Overall Study|Withdrawal by Subject|11|||
149791321|NCT01371721|540360305|FG000|Overall Study|Other|2|||
149791322|NCT01371721|540360306|FG001|Overall Study|Other|3|||
149791323|NCT01371721|540360307|FG002|Overall Study|Other|0|||
149791324|NCT01371721|540360305|FG000|Overall Study|Lack of Efficacy|2|||
149791325|NCT01371721|540360306|FG001|Overall Study|Lack of Efficacy|4|||
149791326|NCT01371721|540360307|FG002|Overall Study|Lack of Efficacy|3|||
149791327|NCT01371721|540360305|FG000|Overall Study|Randomized but not treated|1|||
149791328|NCT01371721|540360306|FG001|Overall Study|Randomized but not treated|0|||
149791329|NCT01371721|540360307|FG002|Overall Study|Randomized but not treated|0|||
149791330|NCT00545584|540360308|FG000|Overall Study|Only one reason for discontinuation|62|||
149791331|NCT00545584|540360309|FG001|Overall Study|Only one reason for discontinuation|61|||
149791332|NCT00545584|540360310|FG002|Overall Study|Only one reason for discontinuation|48|||
149791333|NCT00545584|540360308|FG000|Overall Study|Two or more reasons for discontinuation|17|||
149791334|NCT00545584|540360309|FG001|Overall Study|Two or more reasons for discontinuation|19|||
149791335|NCT00545584|540360310|FG002|Overall Study|Two or more reasons for discontinuation|8|||
149791336|NCT00461552|540360315|FG000|Overall Study|Drug Dispensing error|0|||
149791337|NCT00461552|540360316|FG001|Overall Study|Drug Dispensing error|2|||
149791338|NCT01289028|540360317|FG000|Overall Study|Progressive Disease|49|||
149791339|NCT01289028|540360317|FG000|Overall Study|Adverse Event|14|||
149791340|NCT01289028|540360317|FG000|Overall Study|Withdrawal by Subject|6|||
149791341|NCT01289028|540360317|FG000|Overall Study|Death|4|||
149791342|NCT01289028|540360317|FG000|Overall Study|Lack of Efficacy|2|||
149791343|NCT01289028|540360317|FG000|Overall Study|No longer required|2|||
149791344|NCT01289028|540360317|FG000|Overall Study|Lost to Follow-up|2|||
149791345|NCT01289028|540360317|FG000|Overall Study|New Cancer Therapy|2|||
149791346|NCT01289028|540360317|FG000|Overall Study|Abnormal Lab Value|1|||
149791347|NCT01289028|540360317|FG000|Overall Study|Missing reason for discon|1|||
149791348|NCT00998985|540360319|FG000|Overall Study|Withdrawal by Subject|0|||
149791349|NCT00998985|540360320|FG001|Overall Study|Withdrawal by Subject|0|||
149791350|NCT00998985|540360321|FG002|Overall Study|Withdrawal by Subject|0|||
149791351|NCT00998985|540360322|FG003|Overall Study|Withdrawal by Subject|0|||
149791352|NCT00998985|540360323|FG004|Overall Study|Withdrawal by Subject|0|||
149791353|NCT00998985|540360324|FG005|Overall Study|Withdrawal by Subject|0|||
149791354|NCT00998985|540360325|FG006|Overall Study|Withdrawal by Subject|0|||
149791355|NCT00998985|540360326|FG007|Overall Study|Withdrawal by Subject|0|||
149791356|NCT00998985|540360327|FG008|Overall Study|Withdrawal by Subject|1|||
149791357|NCT00998985|540360328|FG009|Overall Study|Withdrawal by Subject|0|||
149791358|NCT00998985|540360329|FG010|Overall Study|Withdrawal by Subject|0|||
149791359|NCT00998985|540360330|FG011|Overall Study|Withdrawal by Subject|0|||
149791360|NCT00998985|540360331|FG012|Overall Study|Withdrawal by Subject|0|||
149791361|NCT00998985|540360332|FG013|Overall Study|Withdrawal by Subject|0|||
149791362|NCT00998985|540360319|FG000|Overall Study|Protocol Violation|0|||
149791363|NCT00998985|540360320|FG001|Overall Study|Protocol Violation|0|||
149791364|NCT00998985|540360321|FG002|Overall Study|Protocol Violation|0|||
149791365|NCT00998985|540360322|FG003|Overall Study|Protocol Violation|0|||
149791366|NCT00998985|540360323|FG004|Overall Study|Protocol Violation|0|||
149791367|NCT00998985|540360324|FG005|Overall Study|Protocol Violation|1|||
149791368|NCT00998985|540360325|FG006|Overall Study|Protocol Violation|0|||
149791369|NCT00998985|540360326|FG007|Overall Study|Protocol Violation|0|||
149791370|NCT00998985|540360327|FG008|Overall Study|Protocol Violation|0|||
149791371|NCT00998985|540360328|FG009|Overall Study|Protocol Violation|0|||
149791372|NCT00998985|540360329|FG010|Overall Study|Protocol Violation|0|||
149791373|NCT00998985|540360330|FG011|Overall Study|Protocol Violation|0|||
149791374|NCT00998985|540360331|FG012|Overall Study|Protocol Violation|0|||
149791375|NCT00998985|540360332|FG013|Overall Study|Protocol Violation|0|||
149791376|NCT01012037|540360336|FG000|Overall Study|Adverse Event|0|||
149791377|NCT01012037|540360337|FG001|Overall Study|Adverse Event|8|||
149791378|NCT01012037|540360338|FG002|Overall Study|Adverse Event|3|||
149791379|NCT01012037|540360336|FG000|Overall Study|Protocol Violation|0|||
149791380|NCT01012037|540360337|FG001|Overall Study|Protocol Violation|3|||
149791381|NCT01012037|540360338|FG002|Overall Study|Protocol Violation|5|||
149791382|NCT01012037|540360336|FG000|Overall Study|Withdrawal by Subject|0|||
149791383|NCT01012037|540360337|FG001|Overall Study|Withdrawal by Subject|4|||
149791384|NCT01012037|540360338|FG002|Overall Study|Withdrawal by Subject|1|||
149791385|NCT01012037|540360336|FG000|Overall Study|Other reason (not specified)|1|||
149791386|NCT01012037|540360337|FG001|Overall Study|Other reason (not specified)|1|||
149791387|NCT01012037|540360338|FG002|Overall Study|Other reason (not specified)|1|||
149791388|NCT00415623|540360341|FG000|Overall Study|Adverse Event|3|||
149791389|NCT00415623|540360342|FG001|Overall Study|Adverse Event|4|||
149791390|NCT00415623|540360341|FG000|Overall Study|Death|1|||
149791391|NCT00415623|540360342|FG001|Overall Study|Death|0|||
149791392|NCT00415623|540360341|FG000|Overall Study|Withdrawal by Subject|1|||
149791393|NCT00415623|540360342|FG001|Overall Study|Withdrawal by Subject|1|||
149791394|NCT03267576|540360345|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
149791395|NCT03267576|540360346|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
149791396|NCT03267576|540360345|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
149791397|NCT03267576|540360346|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
149791398|NCT01369069|540360347|FG000|Overall Study|Lost to Follow-up|8|||
149791399|NCT01369069|540360348|FG001|Overall Study|Lost to Follow-up|9|||
149791400|NCT01369069|540360347|FG000|Overall Study|Withdrawal by Subject|9|||
149791401|NCT01369069|540360348|FG001|Overall Study|Withdrawal by Subject|7|||
149791402|NCT02573012|540360349|FG000|Overall Study|Adverse Event|5|||
149791403|NCT02573012|540360350|FG001|Overall Study|Adverse Event|5|||
149791404|NCT02573012|540360349|FG000|Overall Study|Lack of Efficacy|5|||
149791405|NCT02573012|540360350|FG001|Overall Study|Lack of Efficacy|4|||
149791406|NCT02573012|540360349|FG000|Overall Study|Non-compliance|1|||
149791407|NCT02573012|540360350|FG001|Overall Study|Non-compliance|2|||
149791408|NCT02573012|540360349|FG000|Overall Study|Withdrawal by Subject|2|||
149791409|NCT02573012|540360350|FG001|Overall Study|Withdrawal by Subject|2|||
149791410|NCT02573012|540360349|FG000|Overall Study|Study Ended per Protocol|1|||
149791411|NCT02573012|540360350|FG001|Overall Study|Study Ended per Protocol|0|||
149791412|NCT02573012|540360349|FG000|Overall Study|Physician Decision|1|||
149791413|NCT02573012|540360350|FG001|Overall Study|Physician Decision|2|||
149791414|NCT00882362|540360351|FG000|Overall Study|Adverse Event|13|||
149791415|NCT00882362|540360352|FG001|Overall Study|Adverse Event|10|||
149791416|NCT00882362|540360351|FG000|Overall Study|Withdrawal by Subject|13|||
149791417|NCT00882362|540360352|FG001|Overall Study|Withdrawal by Subject|10|||
149791418|NCT00882362|540360351|FG000|Overall Study|Lack of Efficacy|3|||
149791419|NCT00882362|540360352|FG001|Overall Study|Lack of Efficacy|0|||
149791420|NCT00882362|540360351|FG000|Overall Study|Protocol Violation|7|||
149791421|NCT00882362|540360352|FG001|Overall Study|Protocol Violation|2|||
149791422|NCT00882362|540360351|FG000|Overall Study|Pregnancy|1|||
149791423|NCT00882362|540360352|FG001|Overall Study|Pregnancy|0|||
149791424|NCT00882362|540360351|FG000|Overall Study|Physician Decision|5|||
149791425|NCT00882362|540360352|FG001|Overall Study|Physician Decision|1|||
149791426|NCT00882362|540360351|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
149791427|NCT00882362|540360352|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
149791428|NCT00882362|540360351|FG000|Overall Study|change of residence or other commitments|5|||
149791429|NCT00882362|540360352|FG001|Overall Study|change of residence or other commitments|0|||
149791430|NCT01432938|540360353|FG000|First Intervention|Protocol Violation|1|||
149791431|NCT01432938|540360354|FG001|First Intervention|Protocol Violation|0|||
149791432|NCT01432938|540360353|FG000|First Intervention|Physician Decision|1|||
149791433|NCT01432938|540360354|FG001|First Intervention|Physician Decision|0|||
149791434|NCT01432938|540360353|FG000|Second Intervention|Adverse Event|1|||
149791435|NCT01432938|540360354|FG001|Second Intervention|Adverse Event|0|||
149791436|NCT02096471|540360355|FG000|Overall Study|Adverse Event|1|||
149791437|NCT02096471|540360355|FG000|Overall Study|Lack of Efficacy|7|||
149791438|NCT02096471|540360355|FG000|Overall Study|Withdrawal by Subject|3|||
149791439|NCT02096471|540360355|FG000|Overall Study|Non-Compliant|2|||
149791440|NCT02463331|540360362|FG000|Overall Study|Adverse Event|4|||
149791441|NCT02463331|540360363|FG001|Overall Study|Adverse Event|2|||
149791442|NCT02463331|540360362|FG000|Overall Study|Lost to Follow-up|1|||
149791443|NCT02463331|540360363|FG001|Overall Study|Lost to Follow-up|1|||
149791444|NCT02463331|540360362|FG000|Overall Study|Pregnancy|2|||
149791445|NCT02463331|540360363|FG001|Overall Study|Pregnancy|3|||
149791446|NCT02463331|540360362|FG000|Overall Study|Lack of Efficacy|6|||
149791447|NCT02463331|540360363|FG001|Overall Study|Lack of Efficacy|0|||
149791448|NCT02463331|540360362|FG000|Overall Study|Physician Decision|3|||
149791449|NCT02463331|540360363|FG001|Overall Study|Physician Decision|0|||
149791450|NCT03049852|540360375|FG000|Overall Study|Lost to Follow-up|0|||
149791451|NCT03049852|540360376|FG001|Overall Study|Lost to Follow-up|1|||
149791452|NCT03049852|540360377|FG002|Overall Study|Lost to Follow-up|0|||
149791453|NCT02709889|540360378|FG000|Overall Study|Withdrawal by Subject|11|||
149791454|NCT02709889|540360379|FG001|Overall Study|Withdrawal by Subject|10|||
149791455|NCT02709889|540360380|FG002|Overall Study|Withdrawal by Subject|2|||
149791456|NCT02709889|540360381|FG003|Overall Study|Withdrawal by Subject|12|||
149791457|NCT02709889|540360378|FG000|Overall Study|Death|25|||
149791458|NCT02709889|540360379|FG001|Overall Study|Death|38|||
149791459|NCT02709889|540360380|FG002|Overall Study|Death|4|||
149791460|NCT02709889|540360381|FG003|Overall Study|Death|44|||
149791461|NCT02709889|540360378|FG000|Overall Study|Physician Decision|1|||
149791462|NCT02709889|540360379|FG001|Overall Study|Physician Decision|2|||
149791463|NCT02709889|540360380|FG002|Overall Study|Physician Decision|3|||
149791464|NCT02709889|540360381|FG003|Overall Study|Physician Decision|5|||
149791465|NCT02709889|540360378|FG000|Overall Study|Lost to Follow-up|2|||
149791466|NCT02709889|540360379|FG001|Overall Study|Lost to Follow-up|0|||
149791467|NCT02709889|540360380|FG002|Overall Study|Lost to Follow-up|0|||
149791468|NCT02709889|540360381|FG003|Overall Study|Lost to Follow-up|4|||
149791469|NCT02709889|540360378|FG000|Overall Study|Study Terminated by Sponsor|4|||
149791470|NCT02709889|540360379|FG001|Overall Study|Study Terminated by Sponsor|6|||
149791471|NCT02709889|540360380|FG002|Overall Study|Study Terminated by Sponsor|2|||
149791472|NCT02709889|540360381|FG003|Overall Study|Study Terminated by Sponsor|17|||
149791473|NCT02709889|540360378|FG000|Overall Study|Other, Not Specified|0|||
149791474|NCT02709889|540360379|FG001|Overall Study|Other, Not Specified|1|||
149791475|NCT02709889|540360380|FG002|Overall Study|Other, Not Specified|1|||
149791476|NCT02709889|540360381|FG003|Overall Study|Other, Not Specified|6|||
149791477|NCT01436357|540360382|FG000|Overall Study|Death|5|||
149791478|NCT01436357|540360383|FG001|Overall Study|Death|1|||
149791479|NCT01436357|540360382|FG000|Overall Study|Enrolled but not vaccinated|1|||
149791480|NCT01436357|540360383|FG001|Overall Study|Enrolled but not vaccinated|1|||
149791481|NCT01436357|540360382|FG000|Overall Study|Incarceration|18|||
149791482|NCT01436357|540360383|FG001|Overall Study|Incarceration|20|||
149791483|NCT01436357|540360382|FG000|Overall Study|Lost to Follow-up|67|||
149791484|NCT01436357|540360383|FG001|Overall Study|Lost to Follow-up|61|||
149791485|NCT01436357|540360382|FG000|Overall Study|Protocol Violation|1|||
149791486|NCT01436357|540360383|FG001|Overall Study|Protocol Violation|0|||
149791487|NCT01436357|540360382|FG000|Overall Study|Withdrawal by Subject|26|||
149791488|NCT01436357|540360383|FG001|Overall Study|Withdrawal by Subject|38|||
149791489|NCT01436357|540360382|FG000|Overall Study|Physician Decision|3|||
149791490|NCT01436357|540360383|FG001|Overall Study|Physician Decision|4|||
149791491|NCT01436357|540360382|FG000|Overall Study|Moved out of area|1|||
149791492|NCT01436357|540360383|FG001|Overall Study|Moved out of area|2|||
149791493|NCT01436357|540360382|FG000|Overall Study|Subject in rehab|0|||
149791494|NCT01436357|540360383|FG001|Overall Study|Subject in rehab|1|||
149791495|NCT00656799|540360384|FG000|Overall Study|Death|2|||
149791496|NCT05281094|540360385|FG000|Overall Study|Adverse Event|1|||
149791497|NCT05281094|540360386|FG001|Overall Study|Adverse Event|0|||
149791498|NCT05281094|540360385|FG000|Overall Study|Lost to Follow-up|29|||
149791499|NCT05281094|540360386|FG001|Overall Study|Lost to Follow-up|22|||
149791500|NCT05281094|540360385|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
149791501|NCT05281094|540360386|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
149791502|NCT05281094|540360385|FG000|Overall Study|Death|1|||
149791503|NCT05281094|540360386|FG001|Overall Study|Death|2|||
149791504|NCT05281094|540360385|FG000|Overall Study|Not pre-specified reason|8|||
149791505|NCT05281094|540360386|FG001|Overall Study|Not pre-specified reason|5|||
149791506|NCT02683668|540360393|FG000|Period 2|Withdrawal by Subject|0|||
149791507|NCT02683668|540360394|FG001|Period 2|Withdrawal by Subject|1|||
149791508|NCT02683668|540360395|FG002|Period 2|Withdrawal by Subject|0|||
149791509|NCT02390167|540362245|FG000|Overall Study|Lost to Follow-up|1|||
149791510|NCT01265719|540362247|FG000|Overall Study|Does not meet entrance criteria|0|||
149791511|NCT01265719|540362248|FG001|Overall Study|Does not meet entrance criteria|3|||
149791512|NCT01265719|540362247|FG000|Overall Study|Other reasons|2|||
149791513|NCT01265719|540362248|FG001|Overall Study|Other reasons|0|||
149791514|NCT01265719|540362247|FG000|Overall Study|Withdrawal by Subject|8|||
149791515|NCT01265719|540362248|FG001|Overall Study|Withdrawal by Subject|3|||
149791516|NCT01265719|540362247|FG000|Overall Study|Lost to Follow-up|2|||
149791517|NCT01265719|540362248|FG001|Overall Study|Lost to Follow-up|7|||
149791518|NCT01265719|540362247|FG000|Overall Study|Adverse Event|2|||
149791519|NCT01265719|540362248|FG001|Overall Study|Adverse Event|0|||
149791520|NCT04144140|540362249|FG000|Overall Study|Other|0|||
149791521|NCT04144140|540362250|FG001|Overall Study|Other|0|||
149791522|NCT04144140|540362251|FG002|Overall Study|Other|0|||
149791523|NCT04144140|540362252|FG003|Overall Study|Other|0|||
149791524|NCT04144140|540362253|FG004|Overall Study|Other|0|||
149791525|NCT04144140|540362254|FG005|Overall Study|Other|1|||
149791526|NCT04144140|540362255|FG006|Overall Study|Other|0|||
149791527|NCT00027027|540362256|FG000|Overall Study|Adverse Event|0|||
149791528|NCT00027027|540362257|FG001|Overall Study|Adverse Event|0|||
149791529|NCT00027027|540362258|FG002|Overall Study|Adverse Event|1|||
149791530|NCT00027027|540362259|FG003|Overall Study|Adverse Event|0|||
149791531|NCT00027027|540362260|FG004|Overall Study|Adverse Event|1|||
149791532|NCT00027027|540362256|FG000|Overall Study|Admitted for Signs of PD|0|||
149791533|NCT00027027|540362257|FG001|Overall Study|Admitted for Signs of PD|0|||
149791534|NCT00027027|540362258|FG002|Overall Study|Admitted for Signs of PD|0|||
149791535|NCT00027027|540362259|FG003|Overall Study|Admitted for Signs of PD|0|||
149791536|NCT00027027|540362260|FG004|Overall Study|Admitted for Signs of PD|1|||
149791537|NCT00027027|540362256|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
149791538|NCT00027027|540362257|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
149791539|NCT00027027|540362258|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
149791540|NCT00027027|540362259|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
149791541|NCT00027027|540362260|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
149791542|NCT00027027|540362256|FG000|Overall Study|PD Requiring Surgery|0|||
149791543|NCT00027027|540362257|FG001|Overall Study|PD Requiring Surgery|0|||
149791544|NCT00027027|540362258|FG002|Overall Study|PD Requiring Surgery|1|||
149791545|NCT00027027|540362259|FG003|Overall Study|PD Requiring Surgery|0|||
149791546|NCT00027027|540362260|FG004|Overall Study|PD Requiring Surgery|0|||
149791547|NCT00027027|540362256|FG000|Overall Study|Physician Decision Due To PD|2|||
149791548|NCT00027027|540362257|FG001|Overall Study|Physician Decision Due To PD|3|||
149791549|NCT00027027|540362258|FG002|Overall Study|Physician Decision Due To PD|2|||
149791550|NCT00027027|540362259|FG003|Overall Study|Physician Decision Due To PD|3|||
149791551|NCT00027027|540362260|FG004|Overall Study|Physician Decision Due To PD|5|||
149791552|NCT00027027|540362256|FG000|Overall Study|Withdrawal by Subject|0|||
149791553|NCT00027027|540362257|FG001|Overall Study|Withdrawal by Subject|0|||
149791554|NCT00027027|540362258|FG002|Overall Study|Withdrawal by Subject|0|||
149791555|NCT00027027|540362259|FG003|Overall Study|Withdrawal by Subject|0|||
149791556|NCT00027027|540362260|FG004|Overall Study|Withdrawal by Subject|1|||
149791557|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149791558|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149791559|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149791560|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
149791561|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
149791562|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
149791563|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
149791564|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
149791565|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Death|0|||
149791566|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Death|0|||
149791567|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Death|0|||
149791568|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Death|1|||
149791569|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Death|1|||
149791570|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Death|0|||
149791571|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Death|2|||
149791572|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Death|0|||
149791573|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791574|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791575|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791576|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
149791577|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791578|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791579|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791580|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149791581|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791582|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791583|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791584|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
149791585|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791586|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791587|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791588|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149791589|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149791590|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149791591|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149791592|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
149791593|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149791594|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
149791595|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149791596|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
149791597|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149791598|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149791599|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149791600|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
149791601|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149791602|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
149791603|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
149791604|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149791605|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149791606|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149791607|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149791608|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149791609|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
149791610|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149791611|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
149791612|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
149791613|NCT02442765|540362264|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791614|NCT02442765|540362265|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791615|NCT02442765|540362266|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791616|NCT02442765|540362267|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791617|NCT02442765|540362268|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
149791618|NCT02442765|540362269|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791619|NCT02442765|540362270|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149791620|NCT02442765|540362271|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
149791621|NCT04735432|540362274|FG000|Overall Study|Other - due to personal reason|1|||
149791622|NCT04735432|540362275|FG001|Overall Study|Other - due to personal reason|0|||
149791623|NCT04735432|540362274|FG000|Overall Study|Adverse Event|2|||
149791624|NCT04735432|540362275|FG001|Overall Study|Adverse Event|0|||
149791625|NCT01823991|540362278|FG000|Overall Study|Withdrawal by Subject|8|||
149791626|NCT01823991|540362279|FG001|Overall Study|Withdrawal by Subject|5|||
149791627|NCT01066819|540362280|FG000|Overall Study|Adverse Event|18|||
149791628|NCT01066819|540362281|FG001|Overall Study|Adverse Event|1|||
149791629|NCT01066819|540362282|FG002|Overall Study|Adverse Event|6|||
149791630|NCT01066819|540362283|FG003|Overall Study|Adverse Event|0|||
149791631|NCT01066819|540362284|FG004|Overall Study|Adverse Event|0|||
149791632|NCT01066819|540362285|FG005|Overall Study|Adverse Event|0|||
149791633|NCT01066819|540362280|FG000|Overall Study|Death|5|||
149791634|NCT01066819|540362281|FG001|Overall Study|Death|0|||
149791635|NCT01066819|540362282|FG002|Overall Study|Death|1|||
149791636|NCT01066819|540362283|FG003|Overall Study|Death|0|||
149791637|NCT01066819|540362284|FG004|Overall Study|Death|0|||
149791638|NCT01066819|540362285|FG005|Overall Study|Death|0|||
149791639|NCT01066819|540362280|FG000|Overall Study|Lack of Efficacy|22|||
149791640|NCT01066819|540362281|FG001|Overall Study|Lack of Efficacy|1|||
149791641|NCT01066819|540362282|FG002|Overall Study|Lack of Efficacy|2|||
149791642|NCT01066819|540362283|FG003|Overall Study|Lack of Efficacy|1|||
149791643|NCT01066819|540362284|FG004|Overall Study|Lack of Efficacy|0|||
149791644|NCT01066819|540362285|FG005|Overall Study|Lack of Efficacy|0|||
149791645|NCT01066819|540362280|FG000|Overall Study|Physician Decision|6|||
149791646|NCT01066819|540362281|FG001|Overall Study|Physician Decision|2|||
149791647|NCT01066819|540362282|FG002|Overall Study|Physician Decision|3|||
149791648|NCT01066819|540362283|FG003|Overall Study|Physician Decision|0|||
149791649|NCT01066819|540362284|FG004|Overall Study|Physician Decision|0|||
149791650|NCT01066819|540362285|FG005|Overall Study|Physician Decision|0|||
149791651|NCT01066819|540362280|FG000|Overall Study|Protocol Violation|12|||
149791652|NCT01066819|540362281|FG001|Overall Study|Protocol Violation|6|||
149791653|NCT01066819|540362282|FG002|Overall Study|Protocol Violation|0|||
149791654|NCT01066819|540362283|FG003|Overall Study|Protocol Violation|0|||
149791655|NCT01066819|540362284|FG004|Overall Study|Protocol Violation|0|||
149791656|NCT01066819|540362285|FG005|Overall Study|Protocol Violation|0|||
149791657|NCT01066819|540362280|FG000|Overall Study|Withdrawal by Subject|29|||
149791658|NCT01066819|540362281|FG001|Overall Study|Withdrawal by Subject|11|||
149791659|NCT01066819|540362282|FG002|Overall Study|Withdrawal by Subject|6|||
149791660|NCT01066819|540362283|FG003|Overall Study|Withdrawal by Subject|0|||
149791661|NCT01066819|540362284|FG004|Overall Study|Withdrawal by Subject|0|||
149791662|NCT01066819|540362285|FG005|Overall Study|Withdrawal by Subject|0|||
149791663|NCT01066819|540362280|FG000|Overall Study|Administrative|6|||
149791664|NCT01066819|540362281|FG001|Overall Study|Administrative|4|||
149791665|NCT01066819|540362282|FG002|Overall Study|Administrative|2|||
149791666|NCT01066819|540362283|FG003|Overall Study|Administrative|0|||
149791667|NCT01066819|540362284|FG004|Overall Study|Administrative|0|||
149791668|NCT01066819|540362285|FG005|Overall Study|Administrative|0|||
149791669|NCT01066819|540362280|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
149791670|NCT01066819|540362281|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
149791671|NCT01066819|540362282|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
149791672|NCT01066819|540362283|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
149791673|NCT01066819|540362284|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
149791674|NCT01066819|540362285|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
149791675|NCT01066819|540362280|FG000|Overall Study|Early termination|2|||
149791676|NCT01066819|540362281|FG001|Overall Study|Early termination|0|||
149791677|NCT01066819|540362282|FG002|Overall Study|Early termination|0|||
149791678|NCT01066819|540362283|FG003|Overall Study|Early termination|0|||
149791679|NCT01066819|540362284|FG004|Overall Study|Early termination|0|||
149791680|NCT01066819|540362285|FG005|Overall Study|Early termination|0|||
149791681|NCT01066819|540362280|FG000|Overall Study|Failed to return|298|||
149791682|NCT01066819|540362281|FG001|Overall Study|Failed to return|107|||
149791683|NCT01066819|540362282|FG002|Overall Study|Failed to return|68|||
149791684|NCT01066819|540362283|FG003|Overall Study|Failed to return|7|||
149791685|NCT01066819|540362284|FG004|Overall Study|Failed to return|2|||
149791686|NCT01066819|540362285|FG005|Overall Study|Failed to return|3|||
149791687|NCT01066819|540362280|FG000|Overall Study|Lab test not done|9|||
149791688|NCT01066819|540362281|FG001|Overall Study|Lab test not done|0|||
149791689|NCT01066819|540362282|FG002|Overall Study|Lab test not done|2|||
149791690|NCT01066819|540362283|FG003|Overall Study|Lab test not done|1|||
149791691|NCT01066819|540362284|FG004|Overall Study|Lab test not done|0|||
149791692|NCT01066819|540362285|FG005|Overall Study|Lab test not done|0|||
149791693|NCT01066819|540362280|FG000|Overall Study|Miscellaneous|28|||
149791694|NCT01066819|540362281|FG001|Overall Study|Miscellaneous|10|||
149791695|NCT01066819|540362282|FG002|Overall Study|Miscellaneous|18|||
149791696|NCT01066819|540362283|FG003|Overall Study|Miscellaneous|1|||
149791697|NCT01066819|540362284|FG004|Overall Study|Miscellaneous|0|||
149791698|NCT01066819|540362285|FG005|Overall Study|Miscellaneous|0|||
149791699|NCT01066819|540362280|FG000|Overall Study|Non responders|123|||
149791700|NCT01066819|540362281|FG001|Overall Study|Non responders|2|||
149791701|NCT01066819|540362282|FG002|Overall Study|Non responders|7|||
149791702|NCT01066819|540362283|FG003|Overall Study|Non responders|2|||
149791703|NCT01066819|540362284|FG004|Overall Study|Non responders|0|||
149791704|NCT01066819|540362285|FG005|Overall Study|Non responders|1|||
149791705|NCT01066819|540362280|FG000|Overall Study|Not categorised|9|||
149791706|NCT01066819|540362281|FG001|Overall Study|Not categorised|2|||
149791707|NCT01066819|540362282|FG002|Overall Study|Not categorised|6|||
149791708|NCT01066819|540362283|FG003|Overall Study|Not categorised|1|||
149791709|NCT01066819|540362284|FG004|Overall Study|Not categorised|0|||
149791710|NCT01066819|540362285|FG005|Overall Study|Not categorised|0|||
149791711|NCT01066819|540362280|FG000|Overall Study|Relapse|16|||
149791712|NCT01066819|540362281|FG001|Overall Study|Relapse|4|||
149791713|NCT01066819|540362282|FG002|Overall Study|Relapse|3|||
149791714|NCT01066819|540362283|FG003|Overall Study|Relapse|0|||
149791715|NCT01066819|540362284|FG004|Overall Study|Relapse|0|||
149791716|NCT01066819|540362285|FG005|Overall Study|Relapse|0|||
149791717|NCT01066819|540362280|FG000|Overall Study|Results not available|1|||
149791718|NCT01066819|540362281|FG001|Overall Study|Results not available|0|||
149791719|NCT01066819|540362282|FG002|Overall Study|Results not available|0|||
149791720|NCT01066819|540362283|FG003|Overall Study|Results not available|0|||
149791721|NCT01066819|540362284|FG004|Overall Study|Results not available|0|||
149791722|NCT01066819|540362285|FG005|Overall Study|Results not available|0|||
149791723|NCT01066819|540362280|FG000|Overall Study|Screen failure|1|||
149791724|NCT01066819|540362281|FG001|Overall Study|Screen failure|0|||
149791725|NCT01066819|540362282|FG002|Overall Study|Screen failure|0|||
149791726|NCT01066819|540362283|FG003|Overall Study|Screen failure|0|||
149791727|NCT01066819|540362284|FG004|Overall Study|Screen failure|0|||
149791728|NCT01066819|540362285|FG005|Overall Study|Screen failure|0|||
149791729|NCT01066819|540362280|FG000|Overall Study|Spontaneous cure|1|||
149791730|NCT01066819|540362281|FG001|Overall Study|Spontaneous cure|0|||
149791731|NCT01066819|540362282|FG002|Overall Study|Spontaneous cure|0|||
149791732|NCT01066819|540362283|FG003|Overall Study|Spontaneous cure|0|||
149791733|NCT01066819|540362284|FG004|Overall Study|Spontaneous cure|0|||
149791734|NCT01066819|540362285|FG005|Overall Study|Spontaneous cure|0|||
149791735|NCT01066819|540362280|FG000|Overall Study|Treatment never started|85|||
149791736|NCT01066819|540362281|FG001|Overall Study|Treatment never started|19|||
149791737|NCT01066819|540362282|FG002|Overall Study|Treatment never started|19|||
149791738|NCT01066819|540362283|FG003|Overall Study|Treatment never started|3|||
149791739|NCT01066819|540362284|FG004|Overall Study|Treatment never started|2|||
149791740|NCT01066819|540362285|FG005|Overall Study|Treatment never started|2|||
149791741|NCT01066819|540362280|FG000|Overall Study|Treatment stopped|12|||
149791742|NCT01066819|540362281|FG001|Overall Study|Treatment stopped|1|||
149791743|NCT01066819|540362282|FG002|Overall Study|Treatment stopped|2|||
149791744|NCT01066819|540362283|FG003|Overall Study|Treatment stopped|1|||
149791745|NCT01066819|540362284|FG004|Overall Study|Treatment stopped|0|||
149791746|NCT01066819|540362285|FG005|Overall Study|Treatment stopped|0|||
149791747|NCT01066819|540362280|FG000|Overall Study|Other|5|||
149791748|NCT01066819|540362281|FG001|Overall Study|Other|1|||
149791749|NCT01066819|540362282|FG002|Overall Study|Other|1|||
149791750|NCT01066819|540362283|FG003|Overall Study|Other|0|||
149791751|NCT01066819|540362284|FG004|Overall Study|Other|0|||
149791752|NCT01066819|540362285|FG005|Overall Study|Other|0|||
149791753|NCT02408016|540362286|FG000|Overall Study|Death|6|||
149791754|NCT02408016|540362287|FG001|Overall Study|Death|1|||
149791755|NCT02408016|540362288|FG002|Overall Study|Death|0|||
149791756|NCT02408016|540362286|FG000|Overall Study|Physician Decision|0|||
149791757|NCT02408016|540362287|FG001|Overall Study|Physician Decision|2|||
149791758|NCT02408016|540362288|FG002|Overall Study|Physician Decision|0|||
149791759|NCT00805194|540362289|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
149791760|NCT00805194|540362290|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
149791761|NCT00805194|540362289|FG000|Overall Study|Worsening or AE of underlying disease|64|||
149791762|NCT00805194|540362290|FG001|Overall Study|Worsening or AE of underlying disease|70|||
149791763|NCT00805194|540362289|FG000|Overall Study|Other AE|84|||
149791764|NCT00805194|540362290|FG001|Overall Study|Other AE|73|||
149791765|NCT00805194|540362289|FG000|Overall Study|Protocol Violation|9|||
149791766|NCT00805194|540362290|FG001|Overall Study|Protocol Violation|9|||
149791767|NCT00805194|540362289|FG000|Overall Study|Lost to Follow-up|5|||
149791768|NCT00805194|540362290|FG001|Overall Study|Lost to Follow-up|5|||
149791769|NCT00805194|540362289|FG000|Overall Study|Withdrawal by Subject|60|||
149791770|NCT00805194|540362290|FG001|Overall Study|Withdrawal by Subject|42|||
149791771|NCT00805194|540362289|FG000|Overall Study|Not treated|3|||
149791772|NCT00805194|540362290|FG001|Overall Study|Not treated|4|||
149791773|NCT00805194|540362289|FG000|Overall Study|Reasons other than stated above|20|||
149791774|NCT00805194|540362290|FG001|Overall Study|Reasons other than stated above|16|||
149791775|NCT03818399|540362296|FG000|Overall Study|Lost to Follow-up|11|||
149791776|NCT03818399|540362296|FG000|Overall Study|Withdrawal by Subject|1|||
149791777|NCT03818399|540362296|FG000|Overall Study|Protocol Violation|2|||
149791778|NCT00535236|540362297|FG000|Overall Study|Adverse Event|1|||
149791779|NCT00535236|540362298|FG001|Overall Study|Adverse Event|0|||
149791780|NCT00535236|540362299|FG002|Overall Study|Adverse Event|9|||
149791781|NCT00535236|540362300|FG003|Overall Study|Adverse Event|3|||
149791782|NCT00535236|540362301|FG004|Overall Study|Adverse Event|3|||
149791783|NCT00535236|540362302|FG005|Overall Study|Adverse Event|0|||
149791784|NCT00535236|540362303|FG006|Overall Study|Adverse Event|5|||
149791785|NCT00535236|540362304|FG007|Overall Study|Adverse Event|1|||
149791786|NCT00535236|540362305|FG008|Overall Study|Adverse Event|2|||
149791787|NCT00535236|540362306|FG009|Overall Study|Adverse Event|1|||
149791788|NCT00535236|540362297|FG000|Overall Study|Lost to Follow-up|1|||
149791789|NCT00535236|540362298|FG001|Overall Study|Lost to Follow-up|2|||
149791790|NCT00535236|540362299|FG002|Overall Study|Lost to Follow-up|0|||
149791791|NCT00535236|540362300|FG003|Overall Study|Lost to Follow-up|0|||
149791792|NCT00535236|540362301|FG004|Overall Study|Lost to Follow-up|2|||
149791793|NCT00535236|540362302|FG005|Overall Study|Lost to Follow-up|0|||
149791794|NCT00535236|540362303|FG006|Overall Study|Lost to Follow-up|0|||
149791795|NCT00535236|540362304|FG007|Overall Study|Lost to Follow-up|0|||
149791796|NCT00535236|540362305|FG008|Overall Study|Lost to Follow-up|6|||
149791797|NCT00535236|540362306|FG009|Overall Study|Lost to Follow-up|1|||
149791798|NCT00535236|540362297|FG000|Overall Study|Physician Decision|0|||
149791799|NCT00535236|540362298|FG001|Overall Study|Physician Decision|0|||
149791800|NCT00535236|540362299|FG002|Overall Study|Physician Decision|0|||
149791801|NCT00535236|540362300|FG003|Overall Study|Physician Decision|0|||
149791802|NCT00535236|540362301|FG004|Overall Study|Physician Decision|1|||
149791803|NCT00535236|540362302|FG005|Overall Study|Physician Decision|0|||
149791804|NCT00535236|540362303|FG006|Overall Study|Physician Decision|1|||
149791805|NCT00535236|540362304|FG007|Overall Study|Physician Decision|0|||
149791806|NCT00535236|540362305|FG008|Overall Study|Physician Decision|0|||
149791807|NCT00535236|540362306|FG009|Overall Study|Physician Decision|0|||
149791808|NCT00535236|540362297|FG000|Overall Study|Protocol Violation|2|||
149791809|NCT00535236|540362298|FG001|Overall Study|Protocol Violation|0|||
149791810|NCT00535236|540362299|FG002|Overall Study|Protocol Violation|1|||
149791811|NCT00535236|540362300|FG003|Overall Study|Protocol Violation|0|||
149791812|NCT00535236|540362301|FG004|Overall Study|Protocol Violation|0|||
149791813|NCT00535236|540362302|FG005|Overall Study|Protocol Violation|0|||
149791814|NCT00535236|540362303|FG006|Overall Study|Protocol Violation|0|||
149791815|NCT00535236|540362304|FG007|Overall Study|Protocol Violation|0|||
149791816|NCT00535236|540362305|FG008|Overall Study|Protocol Violation|1|||
149791817|NCT00535236|540362306|FG009|Overall Study|Protocol Violation|0|||
149791818|NCT00535236|540362297|FG000|Overall Study|Withdrawal by Subject|3|||
149791819|NCT00535236|540362298|FG001|Overall Study|Withdrawal by Subject|0|||
149791820|NCT00535236|540362299|FG002|Overall Study|Withdrawal by Subject|2|||
149791821|NCT00535236|540362300|FG003|Overall Study|Withdrawal by Subject|1|||
149791822|NCT00535236|540362301|FG004|Overall Study|Withdrawal by Subject|6|||
149791823|NCT00535236|540362302|FG005|Overall Study|Withdrawal by Subject|1|||
149791824|NCT00535236|540362303|FG006|Overall Study|Withdrawal by Subject|5|||
149791825|NCT00535236|540362304|FG007|Overall Study|Withdrawal by Subject|0|||
149791826|NCT00535236|540362305|FG008|Overall Study|Withdrawal by Subject|4|||
149791827|NCT00535236|540362306|FG009|Overall Study|Withdrawal by Subject|2|||
149791828|NCT04880642|540362307|FG000|Randomization|Withdrawal by Subject|2|||
149791829|NCT04880642|540362308|FG001|Randomization|Withdrawal by Subject|3|||
149791830|NCT04880642|540362307|FG000|Treatment Period|Adverse Event|0|||
149791831|NCT04880642|540362308|FG001|Treatment Period|Adverse Event|1|||
149791832|NCT04880642|540362307|FG000|Treatment Period|Death|6|||
149791833|NCT04880642|540362308|FG001|Treatment Period|Death|6|||
149791834|NCT04880642|540362307|FG000|Treatment Period|Lost to Follow-up|1|||
149791835|NCT04880642|540362308|FG001|Treatment Period|Lost to Follow-up|0|||
149791836|NCT04880642|540362307|FG000|Treatment Period|Protocol Violation|0|||
149791837|NCT04880642|540362308|FG001|Treatment Period|Protocol Violation|1|||
149791838|NCT04880642|540362307|FG000|Treatment Period|Withdrawal by Subject|5|||
149791839|NCT04880642|540362308|FG001|Treatment Period|Withdrawal by Subject|3|||
149791840|NCT04880642|540362307|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
149791841|NCT04880642|540362308|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
149791842|NCT04880642|540362307|FG000|Follow-up|Death|4|||
149791843|NCT04880642|540362308|FG001|Follow-up|Death|3|||
149791844|NCT04880642|540362307|FG000|Follow-up|Withdrawal by Subject|1|||
149791845|NCT04880642|540362308|FG001|Follow-up|Withdrawal by Subject|0|||
149791846|NCT02987205|540362311|FG000|Overall Study|Adverse Event|1|||
149791847|NCT02987205|540362311|FG000|Overall Study|Withdrawal by Subject|3|||
149791848|NCT02275052|540362312|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149791849|NCT02275052|540362313|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
149791850|NCT02275052|540362314|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149791851|NCT02275052|540362315|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149791852|NCT02275052|540362312|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149791853|NCT02275052|540362313|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
149791854|NCT02275052|540362314|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149791855|NCT02275052|540362315|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149791856|NCT02275052|540362312|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
149791857|NCT02275052|540362313|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
149791858|NCT02275052|540362314|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149791859|NCT02275052|540362315|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149791860|NCT02275052|540362312|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
149791861|NCT02275052|540362313|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149791862|NCT02275052|540362314|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149791863|NCT02275052|540362315|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149791864|NCT02275052|540362312|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
149791865|NCT02275052|540362313|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149791866|NCT02275052|540362314|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149791867|NCT02275052|540362315|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149791868|NCT02275052|540362312|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
149791869|NCT02275052|540362313|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149791870|NCT02275052|540362314|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149791871|NCT02275052|540362315|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149791872|NCT02275052|540362312|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
149791873|NCT02275052|540362313|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149791874|NCT02275052|540362314|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149791875|NCT02275052|540362315|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149791876|NCT02275052|540362312|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149791877|NCT02275052|540362313|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149791878|NCT02275052|540362314|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
149791879|NCT02275052|540362315|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
149791880|NCT02275052|540362312|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149791881|NCT02275052|540362313|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149791882|NCT02275052|540362314|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149791883|NCT02275052|540362315|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
149791884|NCT02275052|540362312|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149791885|NCT02275052|540362313|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149791886|NCT02275052|540362314|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149791887|NCT02275052|540362315|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
149791888|NCT02275052|540362312|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149791889|NCT02275052|540362313|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149791890|NCT02275052|540362314|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149791891|NCT02275052|540362315|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
149791892|NCT00561795|540362316|FG000|Overall Study|Adverse Event|3|||
149791893|NCT00561795|540362317|FG001|Overall Study|Adverse Event|3|||
149791894|NCT00561795|540362318|FG002|Overall Study|Adverse Event|0|||
149791895|NCT00561795|540362319|FG003|Overall Study|Adverse Event|0|||
149791896|NCT00561795|540362316|FG000|Overall Study|Study Closed/Terminated|0|||
149791897|NCT00561795|540362317|FG001|Overall Study|Study Closed/Terminated|3|||
149791898|NCT00561795|540362318|FG002|Overall Study|Study Closed/Terminated|0|||
149791899|NCT00561795|540362319|FG003|Overall Study|Study Closed/Terminated|0|||
149791900|NCT00561795|540362316|FG000|Overall Study|Physician Decision|1|||
149791901|NCT00561795|540362317|FG001|Overall Study|Physician Decision|0|||
149791902|NCT00561795|540362318|FG002|Overall Study|Physician Decision|0|||
149791903|NCT00561795|540362319|FG003|Overall Study|Physician Decision|0|||
149791904|NCT02807376|540362320|FG000|Overall Study|Intra-operative exclusion criteria|3|||
149791905|NCT02807376|540362321|FG001|Overall Study|Intra-operative exclusion criteria|0|||
149791906|NCT02807376|540362320|FG000|Overall Study|Lost to Follow-up|0|||
149791907|NCT02807376|540362321|FG001|Overall Study|Lost to Follow-up|1|||
149791908|NCT01947127|540362322|FG000|Overall Study|Protocol Violation|18|||
149791909|NCT01947127|540362323|FG001|Overall Study|Protocol Violation|38|||
149791910|NCT01947127|540362322|FG000|Overall Study|Withdrawal by Subject|1|||
149791911|NCT01947127|540362323|FG001|Overall Study|Withdrawal by Subject|1|||
149791912|NCT01947127|540362322|FG000|Overall Study|Data loss|4|||
149791913|NCT01947127|540362323|FG001|Overall Study|Data loss|4|||
149791914|NCT04652102|540362324|FG000|Overall Study|Adverse Event|14|||
149791915|NCT04652102|540362325|FG001|Overall Study|Adverse Event|13|||
149791916|NCT04652102|540362324|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
149791917|NCT04652102|540362325|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
149791918|NCT04652102|540362324|FG000|Overall Study|Physician Decision|78|||
149791919|NCT04652102|540362325|FG001|Overall Study|Physician Decision|40|||
149791920|NCT04652102|540362324|FG000|Overall Study|Study Ended by Sponsor|64|||
149791921|NCT04652102|540362325|FG001|Overall Study|Study Ended by Sponsor|17|||
149791922|NCT04652102|540362324|FG000|Overall Study|Withdrawal by Subject|4625|||
149791923|NCT04652102|540362325|FG001|Overall Study|Withdrawal by Subject|5594|||
149791924|NCT04652102|540362324|FG000|Overall Study|Lost to Follow-up|2019|||
149791925|NCT04652102|540362325|FG001|Overall Study|Lost to Follow-up|1082|||
149791926|NCT04652102|540362324|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
149791927|NCT04652102|540362325|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
149791928|NCT04652102|540362324|FG000|Overall Study|Miscellaneous|80|||
149791929|NCT04652102|540362325|FG001|Overall Study|Miscellaneous|64|||
149791930|NCT02405091|540362328|FG000|Overall Study|Adverse Event|16|||
149791931|NCT02405091|540362329|FG001|Overall Study|Adverse Event|10|||
149791932|NCT02405091|540362330|FG002|Overall Study|Adverse Event|0|||
149791933|NCT02405091|540362328|FG000|Overall Study|Protocol Violation|1|||
149791934|NCT02405091|540362329|FG001|Overall Study|Protocol Violation|0|||
149791935|NCT02405091|540362330|FG002|Overall Study|Protocol Violation|0|||
149791936|NCT02405091|540362328|FG000|Overall Study|Noncompliance|1|||
149791937|NCT02405091|540362329|FG001|Overall Study|Noncompliance|6|||
149791938|NCT02405091|540362330|FG002|Overall Study|Noncompliance|2|||
149791939|NCT02405091|540362328|FG000|Overall Study|Withdrawal by Subject|4|||
149791940|NCT02405091|540362329|FG001|Overall Study|Withdrawal by Subject|8|||
149791941|NCT02405091|540362330|FG002|Overall Study|Withdrawal by Subject|0|||
149791942|NCT02405091|540362328|FG000|Overall Study|Death|0|||
149791943|NCT02405091|540362329|FG001|Overall Study|Death|1|||
149791944|NCT02405091|540362330|FG002|Overall Study|Death|0|||
149791945|NCT02405091|540362328|FG000|Overall Study|Lost to Follow-up|5|||
149791946|NCT02405091|540362329|FG001|Overall Study|Lost to Follow-up|6|||
149791947|NCT02405091|540362330|FG002|Overall Study|Lost to Follow-up|0|||
149791948|NCT02405091|540362328|FG000|Overall Study|Physician Decision|2|||
149791949|NCT02405091|540362329|FG001|Overall Study|Physician Decision|2|||
149791950|NCT02405091|540362330|FG002|Overall Study|Physician Decision|0|||
149791951|NCT00247962|540362342|FG000|Overall Study|Adverse Event|15|||
149791952|NCT00247962|540362343|FG001|Overall Study|Adverse Event|12|||
149791953|NCT00247962|540362342|FG000|Overall Study|Lost to Follow-up|3|||
149791954|NCT00247962|540362343|FG001|Overall Study|Lost to Follow-up|1|||
149791955|NCT00247962|540362342|FG000|Overall Study|Physician Decision|0|||
149791956|NCT00247962|540362343|FG001|Overall Study|Physician Decision|1|||
149791957|NCT00247962|540362342|FG000|Overall Study|Protocol Violation|1|||
149791958|NCT00247962|540362343|FG001|Overall Study|Protocol Violation|1|||
149791959|NCT00247962|540362342|FG000|Overall Study|Withdrawal by Subject|3|||
149791960|NCT00247962|540362343|FG001|Overall Study|Withdrawal by Subject|2|||
149791961|NCT00247962|540362342|FG000|Overall Study|Lack of Efficacy|4|||
149791962|NCT00247962|540362343|FG001|Overall Study|Lack of Efficacy|2|||
149791963|NCT01469637|540362348|FG000|First Intervention|Unacceptable behavior|0|||
149791964|NCT01469637|540362349|FG001|First Intervention|Unacceptable behavior|1|||
149791965|NCT01469637|540362348|FG000|Second Intervention|Incarcerated|1|||
149791966|NCT01469637|540362349|FG001|Second Intervention|Incarcerated|0|||
149791967|NCT00598585|540362350|FG000|Overall Study|Lost to Follow-up|1|||
149791968|NCT00598585|540362351|FG001|Overall Study|Lost to Follow-up|0|||
149791969|NCT00542425|540362357|FG000|Initial 24 Weeks|Administrative reasons|0|||
149791970|NCT00542425|540362358|FG001|Initial 24 Weeks|Administrative reasons|0|||
149791971|NCT00542425|540362359|FG002|Initial 24 Weeks|Administrative reasons|1|||
149791972|NCT00542425|540362360|FG003|Initial 24 Weeks|Administrative reasons|1|||
149791973|NCT00542425|540362361|FG004|Initial 24 Weeks|Administrative reasons|0|||
149791974|NCT00542425|540362357|FG000|Initial 24 Weeks|Adverse Event|0|||
149791975|NCT00542425|540362358|FG001|Initial 24 Weeks|Adverse Event|1|||
149791976|NCT00542425|540362359|FG002|Initial 24 Weeks|Adverse Event|1|||
149791977|NCT00542425|540362360|FG003|Initial 24 Weeks|Adverse Event|3|||
149791978|NCT00542425|540362361|FG004|Initial 24 Weeks|Adverse Event|2|||
149791979|NCT00542425|540362357|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
149791980|NCT00542425|540362358|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
149791981|NCT00542425|540362359|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
149791982|NCT00542425|540362360|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
149791983|NCT00542425|540362361|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
149791984|NCT00542425|540362357|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
149791985|NCT00542425|540362358|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
149791986|NCT00542425|540362359|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
149791987|NCT00542425|540362360|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
149791988|NCT00542425|540362361|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
149791989|NCT00542425|540362357|FG000|Initial 24 Weeks|Non-compliance|0|||
149791990|NCT00542425|540362358|FG001|Initial 24 Weeks|Non-compliance|0|||
149791991|NCT00542425|540362359|FG002|Initial 24 Weeks|Non-compliance|0|||
149791992|NCT00542425|540362360|FG003|Initial 24 Weeks|Non-compliance|1|||
149791993|NCT00542425|540362361|FG004|Initial 24 Weeks|Non-compliance|1|||
149791994|NCT00542425|540362357|FG000|Initial 24 Weeks|Protocol Violation|0|||
149791995|NCT00542425|540362358|FG001|Initial 24 Weeks|Protocol Violation|0|||
149791996|NCT00542425|540362359|FG002|Initial 24 Weeks|Protocol Violation|0|||
149791997|NCT00542425|540362360|FG003|Initial 24 Weeks|Protocol Violation|1|||
149791998|NCT00542425|540362361|FG004|Initial 24 Weeks|Protocol Violation|0|||
149791999|NCT00542425|540362357|FG000|Initial 24 Weeks|Refusal of treatment|2|||
149792000|NCT00542425|540362358|FG001|Initial 24 Weeks|Refusal of treatment|2|||
149792001|NCT00542425|540362359|FG002|Initial 24 Weeks|Refusal of treatment|1|||
149792002|NCT00542425|540362360|FG003|Initial 24 Weeks|Refusal of treatment|4|||
149792003|NCT00542425|540362361|FG004|Initial 24 Weeks|Refusal of treatment|1|||
149792004|NCT00542425|540362357|FG000|Initial 24 Weeks|Other|0|||
149792005|NCT00542425|540362358|FG001|Initial 24 Weeks|Other|2|||
149792006|NCT00542425|540362359|FG002|Initial 24 Weeks|Other|1|||
149792007|NCT00542425|540362360|FG003|Initial 24 Weeks|Other|0|||
149792008|NCT00542425|540362361|FG004|Initial 24 Weeks|Other|0|||
149792009|NCT00542425|540362357|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
149792010|NCT00542425|540362358|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
149792011|NCT00542425|540362359|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
149792012|NCT00542425|540362360|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
149792013|NCT00542425|540362361|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
149792014|NCT00542425|540362357|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149792015|NCT00542425|540362358|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149792016|NCT00542425|540362359|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
149792017|NCT00542425|540362360|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149792018|NCT00542425|540362361|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149792019|NCT00542425|540362357|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149792020|NCT00542425|540362358|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
149792021|NCT00542425|540362359|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149792022|NCT00542425|540362360|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149792023|NCT00542425|540362361|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149792024|NCT00542425|540362357|FG000|Extended 24 Weeks of Treatment|Other|1|||
149792025|NCT00542425|540362358|FG001|Extended 24 Weeks of Treatment|Other|1|||
149792026|NCT00542425|540362359|FG002|Extended 24 Weeks of Treatment|Other|0|||
149792027|NCT00542425|540362360|FG003|Extended 24 Weeks of Treatment|Other|0|||
149792028|NCT00542425|540362361|FG004|Extended 24 Weeks of Treatment|Other|1|||
149792029|NCT01601873|540362364|FG000|Overall Study|Lost to Follow-up|2|||
149792030|NCT01601873|540362365|FG001|Overall Study|Lost to Follow-up|3|||
149792031|NCT01809327|540362366|FG000|Overall Study|Lost to Follow-up|5|||
149792032|NCT01809327|540362367|FG001|Overall Study|Lost to Follow-up|2|||
149792033|NCT01809327|540362368|FG002|Overall Study|Lost to Follow-up|4|||
149792034|NCT01809327|540362369|FG003|Overall Study|Lost to Follow-up|2|||
149792035|NCT01809327|540362370|FG004|Overall Study|Lost to Follow-up|3|||
149792036|NCT01809327|540362366|FG000|Overall Study|Withdrawal by Subject|6|||
149792037|NCT01809327|540362367|FG001|Overall Study|Withdrawal by Subject|4|||
149792038|NCT01809327|540362368|FG002|Overall Study|Withdrawal by Subject|4|||
149792039|NCT01809327|540362369|FG003|Overall Study|Withdrawal by Subject|2|||
149792040|NCT01809327|540362370|FG004|Overall Study|Withdrawal by Subject|5|||
149792041|NCT01809327|540362366|FG000|Overall Study|Adverse Event|4|||
149792042|NCT01809327|540362367|FG001|Overall Study|Adverse Event|3|||
149792043|NCT01809327|540362368|FG002|Overall Study|Adverse Event|7|||
149792044|NCT01809327|540362369|FG003|Overall Study|Adverse Event|4|||
149792045|NCT01809327|540362370|FG004|Overall Study|Adverse Event|8|||
149792046|NCT01809327|540362366|FG000|Overall Study|Death|1|||
149792047|NCT01809327|540362367|FG001|Overall Study|Death|0|||
149792048|NCT01809327|540362368|FG002|Overall Study|Death|0|||
149792049|NCT01809327|540362369|FG003|Overall Study|Death|0|||
149792050|NCT01809327|540362370|FG004|Overall Study|Death|0|||
149792051|NCT01809327|540362366|FG000|Overall Study|Protocol Violation|0|||
149792052|NCT01809327|540362367|FG001|Overall Study|Protocol Violation|1|||
149792053|NCT01809327|540362368|FG002|Overall Study|Protocol Violation|0|||
149792054|NCT01809327|540362369|FG003|Overall Study|Protocol Violation|0|||
149792055|NCT01809327|540362370|FG004|Overall Study|Protocol Violation|0|||
149792056|NCT01809327|540362366|FG000|Overall Study|Physician Decision|1|||
149792057|NCT01809327|540362367|FG001|Overall Study|Physician Decision|1|||
149792058|NCT01809327|540362368|FG002|Overall Study|Physician Decision|0|||
149792059|NCT01809327|540362369|FG003|Overall Study|Physician Decision|0|||
149792060|NCT01809327|540362370|FG004|Overall Study|Physician Decision|0|||
149792061|NCT01809327|540362366|FG000|Overall Study|Pregnancy|1|||
149792062|NCT01809327|540362367|FG001|Overall Study|Pregnancy|0|||
149792063|NCT01809327|540362368|FG002|Overall Study|Pregnancy|0|||
149792064|NCT01809327|540362369|FG003|Overall Study|Pregnancy|0|||
149792065|NCT01809327|540362370|FG004|Overall Study|Pregnancy|0|||
149792066|NCT01809327|540362366|FG000|Overall Study|Other|14|||
149792067|NCT01809327|540362367|FG001|Overall Study|Other|15|||
149792068|NCT01809327|540362368|FG002|Overall Study|Other|7|||
149792069|NCT01809327|540362369|FG003|Overall Study|Other|4|||
149792070|NCT01809327|540362370|FG004|Overall Study|Other|9|||
149792071|NCT03196973|540362371|FG000|Overall Study|Adverse Event|1|||
149792072|NCT03196973|540362372|FG001|Overall Study|Adverse Event|1|||
149792073|NCT03196973|540362373|FG002|Overall Study|Adverse Event|2|||
149792074|NCT03196973|540362371|FG000|Overall Study|Lack of Efficacy|2|||
149792075|NCT03196973|540362372|FG001|Overall Study|Lack of Efficacy|6|||
149792076|NCT03196973|540362373|FG002|Overall Study|Lack of Efficacy|1|||
149792077|NCT03196973|540362371|FG000|Overall Study|Lost to Follow-up|4|||
149792078|NCT03196973|540362372|FG001|Overall Study|Lost to Follow-up|3|||
149792079|NCT03196973|540362373|FG002|Overall Study|Lost to Follow-up|2|||
149792080|NCT03196973|540362371|FG000|Overall Study|Consent withdrawn|2|||
149792081|NCT03196973|540362372|FG001|Overall Study|Consent withdrawn|1|||
149792082|NCT03196973|540362373|FG002|Overall Study|Consent withdrawn|0|||
149792083|NCT03196973|540362371|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
149792084|NCT03196973|540362372|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
149792085|NCT03196973|540362373|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
149792086|NCT02802735|540362378|FG000|Overall Study|Withdrawal by Subject|0|||
149792087|NCT02802735|540362379|FG001|Overall Study|Withdrawal by Subject|1|||
149792088|NCT02802735|540362380|FG002|Overall Study|Withdrawal by Subject|0|||
149792089|NCT02802735|540362381|FG003|Overall Study|Withdrawal by Subject|0|||
149792090|NCT02802735|540362382|FG004|Overall Study|Withdrawal by Subject|0|||
149792091|NCT01024946|540362383|FG000|Overall Study|Screen Failure|3|||
149792092|NCT01024946|540362383|FG000|Overall Study|Withdrawal by Subject|1|||
149792093|NCT01024946|540362383|FG000|Overall Study|Adverse Event|1|||
149792094|NCT03147495|540362384|FG000|Overall Study|Physician Decision|0|||
149792095|NCT03147495|540362385|FG001|Overall Study|Physician Decision|6|||
149792096|NCT02483611|540362386|FG000|Overall Study|Protocol Violation|0|||
149792097|NCT02483611|540362387|FG001|Overall Study|Protocol Violation|0|||
149792098|NCT02483611|540362388|FG002|Overall Study|Protocol Violation|1|||
149792099|NCT02608892|540362389|FG000|Overall Study|Lost to Follow-up|1|||
149792100|NCT02608892|540362390|FG001|Overall Study|Lost to Follow-up|0|||
149792101|NCT02590406|540362391|FG000|Overall Study|Adverse Event|1|||
149792102|NCT02590406|540362392|FG001|Overall Study|Adverse Event|0|||
149792103|NCT02590406|540362391|FG000|Overall Study|Saturometer malfunction|0|||
149792104|NCT02590406|540362392|FG001|Overall Study|Saturometer malfunction|1|||
149792105|NCT00957723|540362395|FG000|Overall Study|Death|3|||
149792106|NCT00957723|540362395|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
149792107|NCT00957723|540362395|FG000|Overall Study|Lost to Follow-up|8|||
149792108|NCT00957723|540362395|FG000|Overall Study|Withdrawal by Subject|24|||
149792109|NCT00957723|540362395|FG000|Overall Study|Investigative Site Terminated|61|||
149792110|NCT00957723|540362395|FG000|Overall Study|Intercurrent Illness|2|||
149792111|NCT00957723|540362395|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
149792112|NCT00877890|540362396|FG000|Overall Study|Adverse Event|6|||
149792113|NCT00877890|540362397|FG001|Overall Study|Adverse Event|6|||
149792114|NCT00877890|540362396|FG000|Overall Study|Lost to Follow-up|5|||
149792115|NCT00877890|540362397|FG001|Overall Study|Lost to Follow-up|5|||
149792116|NCT00877890|540362396|FG000|Overall Study|Protocol Violation|0|||
149792117|NCT00877890|540362397|FG001|Overall Study|Protocol Violation|1|||
149792118|NCT00877890|540362396|FG000|Overall Study|Withdrawal of Consent|6|||
149792119|NCT00877890|540362397|FG001|Overall Study|Withdrawal of Consent|12|||
149792120|NCT00877890|540362396|FG000|Overall Study|Investigator Decision|0|||
149792121|NCT00877890|540362397|FG001|Overall Study|Investigator Decision|2|||
149792122|NCT00877890|540362396|FG000|Overall Study|Loss of Glucose Control|3|||
149792123|NCT00877890|540362397|FG001|Overall Study|Loss of Glucose Control|4|||
149792124|NCT00984009|540362398|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
149792125|NCT02036476|540362403|FG000|Overall Study|Withdrawal by Subject|2|||
149792126|NCT02036476|540362403|FG000|Overall Study|Progressive Disease|4|||
149792127|NCT02036476|540362403|FG000|Overall Study|Unacceptable Toxicity|2|||
149792128|NCT00537810|540362404|FG000|Overall Study|Withdrawal by Subject|4|||
149792129|NCT00537810|540362405|FG001|Overall Study|Withdrawal by Subject|11|||
149792130|NCT00537810|540362406|FG002|Overall Study|Withdrawal by Subject|4|||
149792131|NCT00537810|540362407|FG003|Overall Study|Withdrawal by Subject|3|||
149792132|NCT00537810|540362404|FG000|Overall Study|Medically withdrawn|2|||
149792133|NCT00537810|540362405|FG001|Overall Study|Medically withdrawn|2|||
149792134|NCT00537810|540362406|FG002|Overall Study|Medically withdrawn|0|||
149792135|NCT00537810|540362407|FG003|Overall Study|Medically withdrawn|1|||
149792136|NCT03452397|540362408|FG000|Overall Study|Adverse Event|1|||
149792137|NCT03452397|540362409|FG001|Overall Study|Adverse Event|0|||
149792138|NCT03452397|540362410|FG002|Overall Study|Adverse Event|0|||
149792139|NCT03452397|540362411|FG003|Overall Study|Adverse Event|0|||
149792140|NCT03452397|540362408|FG000|Overall Study|Administrative reason|0|||
149792141|NCT03452397|540362409|FG001|Overall Study|Administrative reason|0|||
149792142|NCT03452397|540362410|FG002|Overall Study|Administrative reason|1|||
149792143|NCT03452397|540362411|FG003|Overall Study|Administrative reason|1|||
149792144|NCT03452397|540362408|FG000|Overall Study|Withdrawal by Subject|0|||
149792145|NCT03452397|540362409|FG001|Overall Study|Withdrawal by Subject|0|||
149792146|NCT03452397|540362410|FG002|Overall Study|Withdrawal by Subject|1|||
149792147|NCT03452397|540362411|FG003|Overall Study|Withdrawal by Subject|0|||
149792148|NCT00125268|540362412|FG000|Overall Study|Withdrawal by Subject|1|||
149792149|NCT00125268|540362413|FG001|Overall Study|Withdrawal by Subject|1|||
149792150|NCT00925522|540362414|FG000|Overall Study|study closed -- business decision|20|||
149792151|NCT02985684|540362420|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
149792152|NCT02985684|540362420|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
149792153|NCT02985684|540362420|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
149792154|NCT00631969|540362421|FG000|Overall Study|Adverse Event|3|||
149792155|NCT00631969|540362422|FG001|Overall Study|Adverse Event|1|||
149792156|NCT00631969|540362421|FG000|Overall Study|Lack of Efficacy|2|||
149792157|NCT00631969|540362422|FG001|Overall Study|Lack of Efficacy|8|||
149792158|NCT00631969|540362421|FG000|Overall Study|Lost to Follow-up|2|||
149792159|NCT00631969|540362422|FG001|Overall Study|Lost to Follow-up|1|||
149792160|NCT00631969|540362421|FG000|Overall Study|Protocol Violation|1|||
149792161|NCT00631969|540362422|FG001|Overall Study|Protocol Violation|1|||
149792162|NCT00631969|540362421|FG000|Overall Study|Consent Withdrawn|5|||
149792163|NCT00631969|540362422|FG001|Overall Study|Consent Withdrawn|7|||
149792164|NCT00631969|540362421|FG000|Overall Study|Noncompliant With Study Medication|0|||
149792165|NCT00631969|540362422|FG001|Overall Study|Noncompliant With Study Medication|1|||
149792166|NCT00631969|540362421|FG000|Overall Study|No Drug Exposure|2|||
149792167|NCT00631969|540362422|FG001|Overall Study|No Drug Exposure|2|||
149792168|NCT00846027|540364454|FG000|Overall Study|Death|3|||
149792169|NCT00846027|540364454|FG000|Overall Study|Disease Progression|30|||
149792170|NCT00846027|540364454|FG000|Overall Study|Toxicity|12|||
149792171|NCT00846027|540364454|FG000|Overall Study|Patient Decision|7|||
149792172|NCT00846027|540364454|FG000|Overall Study|Investigator Discretion|29|||
149792173|NCT00846027|540364454|FG000|Overall Study|Protocol Violation|2|||
149792174|NCT00846027|540364454|FG000|Overall Study|Subject Not Treated|7|||
149792175|NCT03228836|540364461|FG000|Overall Study|Adverse Event|3|||
149792176|NCT03228836|540364461|FG000|Overall Study|Withdrawal by Subject|1|||
149792177|NCT03228836|540364461|FG000|Overall Study|Death|1|||
149792178|NCT03228836|540364461|FG000|Overall Study|Physician Decision|1|||
149792179|NCT03228836|540364461|FG000|Overall Study|Disease Progression|7|||
149792180|NCT03228836|540364461|FG000|Overall Study|Other|4|||
149792181|NCT00948389|540364462|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
149792182|NCT00948389|540364463|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
149792183|NCT00948389|540364464|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
149792184|NCT00948389|540364465|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
149792185|NCT00948389|540364466|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
149792186|NCT00948389|540364462|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
149792187|NCT00948389|540364463|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
149792188|NCT00948389|540364464|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
149792189|NCT00948389|540364465|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
149792190|NCT00948389|540364466|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
149792191|NCT00948389|540364462|FG000|Overall Study|Both Progression and Toxicity|1|||
149792192|NCT00948389|540364463|FG001|Overall Study|Both Progression and Toxicity|0|||
149792193|NCT00948389|540364464|FG002|Overall Study|Both Progression and Toxicity|0|||
149792194|NCT00948389|540364465|FG003|Overall Study|Both Progression and Toxicity|0|||
149792195|NCT00948389|540364466|FG004|Overall Study|Both Progression and Toxicity|0|||
149792196|NCT00568399|540364470|FG000|Overall Study|Death|2|||
149792197|NCT00568399|540364470|FG000|Overall Study|Adverse Event|5|||
149792198|NCT00568399|540364470|FG000|Overall Study|Withdrawal by Subject|8|||
149792199|NCT02967562|540364471|FG000|Overall Study|Consent not obtained|1|||
149792200|NCT02967562|540364472|FG001|Overall Study|Consent not obtained|0|||
149792201|NCT02967562|540364471|FG000|Overall Study|High leak precluding analysis|1|||
149792202|NCT02967562|540364472|FG001|Overall Study|High leak precluding analysis|1|||
149792203|NCT02381795|540364477|FG000|Overall Study|Withdrawal by Subject|1|||
149792204|NCT02381795|540364477|FG000|Overall Study|Study Terminated|2|||
149792205|NCT02176226|540364480|FG000|Overall Study|Lost to Follow-up|3|||
149792206|NCT02176226|540364480|FG000|Overall Study|Withdrew prior to treatment|6|||
149792207|NCT01488994|540364485|FG000|Overall Study|Withdrawal by Subject|0|||
149792208|NCT01488994|540364486|FG001|Overall Study|Withdrawal by Subject|1|||
149792209|NCT01072500|540364487|FG000|Overall Study|Death|2|||
149792210|NCT01072500|540364488|FG001|Overall Study|Death|2|||
149792211|NCT01072500|540364487|FG000|Overall Study|Lost to Follow-up|5|||
149792212|NCT01072500|540364488|FG001|Overall Study|Lost to Follow-up|2|||
149792213|NCT01072500|540364487|FG000|Overall Study|Withdrawal by Subject|17|||
149792214|NCT01072500|540364488|FG001|Overall Study|Withdrawal by Subject|10|||
149792215|NCT02908841|540364489|FG000|Overall Study|Physician Decision|4|||
149792216|NCT02908841|540364490|FG001|Overall Study|Physician Decision|0|||
149792217|NCT01611558|540364491|FG000|Induction Phase|Study drug toxicity|15|||
149792218|NCT01611558|540364491|FG000|Induction Phase|Disease progression|18|||
149792219|NCT01611558|540364491|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
149792220|NCT01611558|540364491|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
149792221|NCT01611558|540364491|FG000|Induction Phase|Death|1|||
149792222|NCT01611558|540364491|FG000|Maintenance Phase|Withdrawal by Subject|1|||
149792223|NCT01611558|540364491|FG000|Maintenance Phase|Elevated Uric acid|1|||
149792224|NCT03798366|540364503|FG000|Overall Study|Lost to Follow-up|0|||
149792225|NCT03798366|540364504|FG001|Overall Study|Lost to Follow-up|1|||
149792226|NCT01412333|540364509|FG000|Overall Study|Adverse Event|40|||
149792227|NCT01412333|540364510|FG001|Overall Study|Adverse Event|42|||
149792228|NCT01412333|540364509|FG000|Overall Study|Death|5|||
149792229|NCT01412333|540364510|FG001|Overall Study|Death|6|||
149792230|NCT01412333|540364509|FG000|Overall Study|Lack of Efficacy|22|||
149792231|NCT01412333|540364510|FG001|Overall Study|Lack of Efficacy|10|||
149792232|NCT01412333|540364509|FG000|Overall Study|Lost to Follow-up|15|||
149792233|NCT01412333|540364510|FG001|Overall Study|Lost to Follow-up|12|||
149792234|NCT01412333|540364509|FG000|Overall Study|Non-Compliance|3|||
149792235|NCT01412333|540364510|FG001|Overall Study|Non-Compliance|7|||
149792236|NCT01412333|540364509|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149792237|NCT01412333|540364510|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149792238|NCT01412333|540364509|FG000|Overall Study|Other|30|||
149792239|NCT01412333|540364510|FG001|Overall Study|Other|33|||
149792240|NCT01412333|540364509|FG000|Overall Study|Physician Decision|11|||
149792241|NCT01412333|540364510|FG001|Overall Study|Physician Decision|16|||
149792242|NCT01412333|540364509|FG000|Overall Study|Pregnancy|6|||
149792243|NCT01412333|540364510|FG001|Overall Study|Pregnancy|4|||
149792244|NCT01412333|540364509|FG000|Overall Study|Protocol Violation|1|||
149792245|NCT01412333|540364510|FG001|Overall Study|Protocol Violation|2|||
149792246|NCT01412333|540364509|FG000|Overall Study|Study Terminated By Sponsor|3|||
149792247|NCT01412333|540364510|FG001|Overall Study|Study Terminated By Sponsor|2|||
149792248|NCT01412333|540364509|FG000|Overall Study|Withdrawal by Subject|51|||
149792249|NCT01412333|540364510|FG001|Overall Study|Withdrawal by Subject|54|||
149792250|NCT01412333|540364509|FG000|Overall Study|Missing|1|||
149792251|NCT01412333|540364510|FG001|Overall Study|Missing|3|||
149792252|NCT04005885|540364511|FG000|First Intervention|Withdrawal by Subject|1|||
149792253|NCT04005885|540364512|FG001|First Intervention|Withdrawal by Subject|1|||
149792254|NCT04005885|540364511|FG000|Second Intervention|Withdrawal by Subject|0|||
149792255|NCT04005885|540364512|FG001|Second Intervention|Withdrawal by Subject|2|||
149792256|NCT00750867|540364515|FG000|Overall Study|Adverse Event|2|||
149792257|NCT00474539|540364516|FG000|Infant Series|Withdrawal by Subject|3|||
149792258|NCT00474539|540364517|FG001|Infant Series|Withdrawal by Subject|4|||
149792259|NCT00474539|540364516|FG000|Infant Series|Randomization error|5|||
149792260|NCT00474539|540364517|FG001|Infant Series|Randomization error|0|||
149792261|NCT00474539|540364516|FG000|Infant Series|Lost to Follow-up|2|||
149792262|NCT00474539|540364517|FG001|Infant Series|Lost to Follow-up|1|||
149792263|NCT00474539|540364516|FG000|Infant Series|Protocol Violation|0|||
149792264|NCT00474539|540364517|FG001|Infant Series|Protocol Violation|1|||
149792265|NCT00474539|540364516|FG000|After Infant Series|Lost to Follow-up|3|||
149792266|NCT00474539|540364517|FG001|After Infant Series|Lost to Follow-up|0|||
149792267|NCT00474539|540364516|FG000|After Infant Series|Withdrawal by Subject|1|||
149792268|NCT00474539|540364517|FG001|After Infant Series|Withdrawal by Subject|0|||
149792269|NCT00474539|540364516|FG000|Toddler Dose|Protocol Violation|1|||
149792270|NCT00474539|540364517|FG001|Toddler Dose|Protocol Violation|0|||
149792271|NCT03018340|540364518|FG000|Overall Study|Adverse Event|1|||
149792272|NCT03018340|540364519|FG001|Overall Study|Adverse Event|2|||
149792273|NCT03018340|540364518|FG000|Overall Study|Withdrawal by Subject|0|||
149792274|NCT03018340|540364519|FG001|Overall Study|Withdrawal by Subject|8|||
149792275|NCT03018340|540364518|FG000|Overall Study|Lack of Efficacy|0|||
149792276|NCT03018340|540364519|FG001|Overall Study|Lack of Efficacy|1|||
149792277|NCT03018340|540364518|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
149792278|NCT03018340|540364519|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
149792279|NCT03018340|540364518|FG000|Overall Study|Lost to Follow-up|1|||
149792280|NCT03018340|540364519|FG001|Overall Study|Lost to Follow-up|7|||
149792281|NCT03018340|540364518|FG000|Overall Study|Protocol Violation|3|||
149792282|NCT03018340|540364519|FG001|Overall Study|Protocol Violation|7|||
149792283|NCT03018340|540364518|FG000|Overall Study|Not further specified|0|||
149792284|NCT03018340|540364519|FG001|Overall Study|Not further specified|1|||
149792285|NCT01836549|540364520|FG000|Overall Study|Did not receive study drug|0|||
149792286|NCT01836549|540364521|FG001|Overall Study|Did not receive study drug|0|||
149792287|NCT01836549|540364522|FG002|Overall Study|Did not receive study drug|1|||
149792288|NCT01836549|540364523|FG003|Overall Study|Did not receive study drug|0|||
149792289|NCT01836549|540364524|FG004|Overall Study|Did not receive study drug|0|||
149792290|NCT01836549|540364525|FG005|Overall Study|Did not receive study drug|0|||
149792291|NCT01836549|540364526|FG006|Overall Study|Did not receive study drug|0|||
149792292|NCT01836549|540364520|FG000|Overall Study|Patient declared ineligible|0|||
149792293|NCT01836549|540364521|FG001|Overall Study|Patient declared ineligible|0|||
149792294|NCT01836549|540364522|FG002|Overall Study|Patient declared ineligible|0|||
149792295|NCT01836549|540364523|FG003|Overall Study|Patient declared ineligible|1|||
149792296|NCT01836549|540364524|FG004|Overall Study|Patient declared ineligible|0|||
149792297|NCT01836549|540364525|FG005|Overall Study|Patient declared ineligible|0|||
149792298|NCT01836549|540364526|FG006|Overall Study|Patient declared ineligible|0|||
149792299|NCT01836549|540364520|FG000|Overall Study|Patient inevaluable to start therapy|0|||
149792300|NCT01836549|540364521|FG001|Overall Study|Patient inevaluable to start therapy|0|||
149792301|NCT01836549|540364522|FG002|Overall Study|Patient inevaluable to start therapy|0|||
149792302|NCT01836549|540364523|FG003|Overall Study|Patient inevaluable to start therapy|0|||
149792303|NCT01836549|540364524|FG004|Overall Study|Patient inevaluable to start therapy|0|||
149792304|NCT01836549|540364525|FG005|Overall Study|Patient inevaluable to start therapy|0|||
149792305|NCT01836549|540364526|FG006|Overall Study|Patient inevaluable to start therapy|1|||
149792306|NCT02192190|540364529|FG000|Overall Study|Adverse Event|1|||
149792307|NCT02192190|540364530|FG001|Overall Study|Adverse Event|1|||
149792308|NCT02192190|540364531|FG002|Overall Study|Adverse Event|0|||
149792309|NCT02192190|540364532|FG003|Overall Study|Adverse Event|0|||
149792310|NCT02192190|540364533|FG004|Overall Study|Adverse Event|0|||
149792311|NCT02192190|540364534|FG005|Overall Study|Adverse Event|0|||
149792312|NCT02192190|540364529|FG000|Overall Study|Lost to Follow-up|3|||
149792313|NCT02192190|540364530|FG001|Overall Study|Lost to Follow-up|3|||
149792314|NCT02192190|540364531|FG002|Overall Study|Lost to Follow-up|2|||
149792315|NCT02192190|540364532|FG003|Overall Study|Lost to Follow-up|1|||
149792316|NCT02192190|540364533|FG004|Overall Study|Lost to Follow-up|4|||
149792317|NCT02192190|540364534|FG005|Overall Study|Lost to Follow-up|3|||
149792318|NCT02192190|540364529|FG000|Overall Study|Physician Decision|2|||
149792319|NCT02192190|540364530|FG001|Overall Study|Physician Decision|0|||
149792320|NCT02192190|540364531|FG002|Overall Study|Physician Decision|0|||
149792321|NCT02192190|540364532|FG003|Overall Study|Physician Decision|0|||
149792322|NCT02192190|540364533|FG004|Overall Study|Physician Decision|0|||
149792323|NCT02192190|540364534|FG005|Overall Study|Physician Decision|0|||
149792324|NCT02192190|540364529|FG000|Overall Study|Terminated by Sponsor|43|||
149792325|NCT02192190|540364530|FG001|Overall Study|Terminated by Sponsor|23|||
149792326|NCT02192190|540364531|FG002|Overall Study|Terminated by Sponsor|20|||
149792327|NCT02192190|540364532|FG003|Overall Study|Terminated by Sponsor|23|||
149792328|NCT02192190|540364533|FG004|Overall Study|Terminated by Sponsor|21|||
149792329|NCT02192190|540364534|FG005|Overall Study|Terminated by Sponsor|23|||
149792330|NCT02192190|540364529|FG000|Overall Study|Withdrawal by Subject|4|||
149792331|NCT02192190|540364530|FG001|Overall Study|Withdrawal by Subject|1|||
149792332|NCT02192190|540364531|FG002|Overall Study|Withdrawal by Subject|2|||
149792333|NCT02192190|540364532|FG003|Overall Study|Withdrawal by Subject|1|||
149792334|NCT02192190|540364533|FG004|Overall Study|Withdrawal by Subject|5|||
149792335|NCT02192190|540364534|FG005|Overall Study|Withdrawal by Subject|3|||
149792336|NCT02192190|540364529|FG000|Overall Study|Could not Keep Visit Schedule|1|||
149792337|NCT02192190|540364530|FG001|Overall Study|Could not Keep Visit Schedule|0|||
149792338|NCT02192190|540364531|FG002|Overall Study|Could not Keep Visit Schedule|0|||
149792339|NCT02192190|540364532|FG003|Overall Study|Could not Keep Visit Schedule|0|||
149792340|NCT02192190|540364533|FG004|Overall Study|Could not Keep Visit Schedule|0|||
149792341|NCT02192190|540364534|FG005|Overall Study|Could not Keep Visit Schedule|0|||
149792342|NCT02192190|540364529|FG000|Overall Study|Positive Drug Screen|0|||
149792343|NCT02192190|540364530|FG001|Overall Study|Positive Drug Screen|0|||
149792344|NCT02192190|540364531|FG002|Overall Study|Positive Drug Screen|0|||
149792345|NCT02192190|540364532|FG003|Overall Study|Positive Drug Screen|1|||
149792346|NCT02192190|540364533|FG004|Overall Study|Positive Drug Screen|0|||
149792347|NCT02192190|540364534|FG005|Overall Study|Positive Drug Screen|0|||
149792348|NCT02192190|540364529|FG000|Overall Study|Inadequate Pain Relief|0|||
149792349|NCT02192190|540364530|FG001|Overall Study|Inadequate Pain Relief|1|||
149792350|NCT02192190|540364531|FG002|Overall Study|Inadequate Pain Relief|1|||
149792351|NCT02192190|540364532|FG003|Overall Study|Inadequate Pain Relief|0|||
149792352|NCT02192190|540364533|FG004|Overall Study|Inadequate Pain Relief|0|||
149792353|NCT02192190|540364534|FG005|Overall Study|Inadequate Pain Relief|0|||
149792354|NCT02607865|540364537|FG000|Overall Study|Lost to Follow-up|9|||
149792355|NCT02607865|540364538|FG001|Overall Study|Lost to Follow-up|7|||
149792356|NCT02607865|540364539|FG002|Overall Study|Lost to Follow-up|7|||
149792357|NCT02607865|540364540|FG003|Overall Study|Lost to Follow-up|5|||
149792358|NCT02607865|540364537|FG000|Overall Study|Withdrawal by Subject|18|||
149792359|NCT02607865|540364538|FG001|Overall Study|Withdrawal by Subject|18|||
149792360|NCT02607865|540364539|FG002|Overall Study|Withdrawal by Subject|17|||
149792361|NCT02607865|540364540|FG003|Overall Study|Withdrawal by Subject|8|||
149792362|NCT02607865|540364537|FG000|Overall Study|Death|5|||
149792363|NCT02607865|540364538|FG001|Overall Study|Death|4|||
149792364|NCT02607865|540364539|FG002|Overall Study|Death|1|||
149792365|NCT02607865|540364540|FG003|Overall Study|Death|3|||
149792366|NCT02607865|540364537|FG000|Overall Study|Unclassified|1|||
149792367|NCT02607865|540364538|FG001|Overall Study|Unclassified|1|||
149792368|NCT02607865|540364539|FG002|Overall Study|Unclassified|2|||
149792369|NCT02607865|540364540|FG003|Overall Study|Unclassified|0|||
149792370|NCT03227692|540364541|FG000|Overall Study|Protocol Violation|1|||
149792371|NCT03227692|540364542|FG001|Overall Study|Protocol Violation|1|||
149792372|NCT03227692|540364541|FG000|Overall Study|Lost to Follow-up|4|||
149792373|NCT03227692|540364542|FG001|Overall Study|Lost to Follow-up|2|||
149792374|NCT03227692|540364541|FG000|Overall Study|Adverse Event|0|||
149792375|NCT03227692|540364542|FG001|Overall Study|Adverse Event|2|||
149792376|NCT01657253|540364543|FG000|Overall Study|Lost to Follow-up|6|||
149792377|NCT01657253|540364544|FG001|Overall Study|Lost to Follow-up|5|||
149792378|NCT01657253|540364543|FG000|Overall Study|Withdrawal by Subject|11|||
149792379|NCT01657253|540364544|FG001|Overall Study|Withdrawal by Subject|12|||
149792380|NCT01657253|540364543|FG000|Overall Study|Adverse Event|0|||
149792381|NCT01657253|540364544|FG001|Overall Study|Adverse Event|1|||
149792382|NCT01970540|540364545|FG000|Overall Study|Non-treatment-related AE|0|||
149792383|NCT01970540|540364546|FG001|Overall Study|Non-treatment-related AE|0|||
149792384|NCT01970540|540364547|FG002|Overall Study|Non-treatment-related AE|1|||
149792385|NCT01970540|540364545|FG000|Overall Study|Progressive disease|55|||
149792386|NCT01970540|540364546|FG001|Overall Study|Progressive disease|23|||
149792387|NCT01970540|540364547|FG002|Overall Study|Progressive disease|10|||
149792388|NCT01970540|540364545|FG000|Overall Study|Treatment delay over protocol|0|||
149792389|NCT01970540|540364546|FG001|Overall Study|Treatment delay over protocol|0|||
149792390|NCT01970540|540364547|FG002|Overall Study|Treatment delay over protocol|1|||
149792391|NCT01970540|540364545|FG000|Overall Study|Physician Decision|7|||
149792392|NCT01970540|540364546|FG001|Overall Study|Physician Decision|2|||
149792393|NCT01970540|540364547|FG002|Overall Study|Physician Decision|0|||
149792394|NCT01970540|540364545|FG000|Overall Study|Clinical progression|0|||
149792395|NCT01970540|540364546|FG001|Overall Study|Clinical progression|1|||
149792396|NCT01970540|540364547|FG002|Overall Study|Clinical progression|1|||
149792397|NCT01970540|540364545|FG000|Overall Study|End of study|2|||
149792398|NCT01970540|540364546|FG001|Overall Study|End of study|0|||
149792399|NCT01970540|540364547|FG002|Overall Study|End of study|2|||
149792400|NCT01970540|540364545|FG000|Overall Study|Adverse Event|0|||
149792401|NCT01970540|540364546|FG001|Overall Study|Adverse Event|2|||
149792402|NCT01970540|540364547|FG002|Overall Study|Adverse Event|1|||
149792403|NCT01970540|540364545|FG000|Overall Study|Treatment-related AE|4|||
149792404|NCT01970540|540364546|FG001|Overall Study|Treatment-related AE|0|||
149792405|NCT01970540|540364547|FG002|Overall Study|Treatment-related AE|2|||
149792406|NCT01970540|540364545|FG000|Overall Study|Withdrawal by Subject|4|||
149792407|NCT01970540|540364546|FG001|Overall Study|Withdrawal by Subject|0|||
149792408|NCT01970540|540364547|FG002|Overall Study|Withdrawal by Subject|1|||
149792409|NCT01970540|540364545|FG000|Overall Study|Clinical deterioration|1|||
149792410|NCT01970540|540364546|FG001|Overall Study|Clinical deterioration|0|||
149792411|NCT01970540|540364547|FG002|Overall Study|Clinical deterioration|0|||
149792412|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Adverse Event|30|||
149792413|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Adverse Event|25|||
149792414|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Adverse Event|23|||
149792415|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Adverse Event|14|||
149792416|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Death|0|||
149792417|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Death|0|||
149792418|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Death|1|||
149792419|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Death|0|||
149792420|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Physician Decision|0|||
149792421|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Physician Decision|1|||
149792422|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Physician Decision|0|||
149792423|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Physician Decision|1|||
149792424|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
149792425|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
149792426|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
149792427|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
149792428|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Other|6|||
149792429|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Other|1|||
149792430|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Other|0|||
149792431|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Other|2|||
149792432|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
149792433|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
149792434|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
149792435|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
149792436|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
149792437|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
149792438|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
149792439|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
149792440|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
149792441|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
149792442|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
149792443|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
149792444|NCT00242710|540364548|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
149792445|NCT00242710|540364549|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
149792446|NCT00242710|540364550|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
149792447|NCT00242710|540364551|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
149792448|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Adverse Event|2|||
149792449|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Adverse Event|3|||
149792450|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Adverse Event|5|||
149792451|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Adverse Event|2|||
149792452|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Physician Decision|1|||
149792453|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Physician Decision|1|||
149792454|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Physician Decision|0|||
149792455|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Physician Decision|0|||
149792456|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Other|24|||
149792457|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Other|24|||
149792458|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Other|9|||
149792459|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Other|11|||
149792460|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Extension not Available|17|||
149792461|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Extension not Available|21|||
149792462|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Extension not Available|8|||
149792463|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Extension not Available|7|||
149792464|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
149792465|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
149792466|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
149792467|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
149792468|NCT00242710|540364548|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
149792469|NCT00242710|540364549|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
149792470|NCT00242710|540364550|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
149792471|NCT00242710|540364551|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
149792472|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
149792473|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
149792474|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
149792475|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
149792476|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Death|0|||
149792477|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Death|0|||
149792478|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Death|0|||
149792479|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Death|1|||
149792480|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
149792481|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
149792482|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
149792483|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
149792484|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Other|3|||
149792485|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Other|5|||
149792486|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Other|4|||
149792487|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Other|3|||
149792488|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
149792489|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
149792490|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
149792491|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
149792492|NCT00242710|540364548|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
149792493|NCT00242710|540364549|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
149792494|NCT00242710|540364550|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
149792495|NCT00242710|540364551|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
149792496|NCT00579527|540364552|FG000|Overall Study|Death|4|||
149792497|NCT00381706|540364553|FG000|Overall Study|Never treated|7|||
149792498|NCT00381706|540364554|FG001|Overall Study|Never treated|2|||
149792499|NCT00381706|540364555|FG002|Overall Study|Never treated|1|||
149792500|NCT00203294|540364556|FG000|Overall Study|Withdrawal by Subject|8|||
149792501|NCT00203294|540364557|FG001|Overall Study|Withdrawal by Subject|13|||
149792502|NCT02364999|540364558|FG000|Overall Study|Death|136|||
149792503|NCT02364999|540364559|FG001|Overall Study|Death|138|||
149792504|NCT02364999|540364558|FG000|Overall Study|Lost to Follow-up|10|||
149792505|NCT02364999|540364559|FG001|Overall Study|Lost to Follow-up|15|||
149792506|NCT02364999|540364558|FG000|Overall Study|Protocol Violation|3|||
149792507|NCT02364999|540364559|FG001|Overall Study|Protocol Violation|2|||
149792508|NCT02364999|540364558|FG000|Overall Study|Withdrawal by Subject|14|||
149792509|NCT02364999|540364559|FG001|Overall Study|Withdrawal by Subject|14|||
149792510|NCT02364999|540364558|FG000|Overall Study|Other|0|||
149792511|NCT02364999|540364559|FG001|Overall Study|Other|1|||
149792512|NCT02364999|540364558|FG000|Overall Study|Randomized but did not receive treatment|2|||
149792513|NCT02364999|540364559|FG001|Overall Study|Randomized but did not receive treatment|3|||
149792514|NCT00550615|540364563|FG000|Overall Study|Withdrawal by Subject|0|||
149792515|NCT00550615|540364564|FG001|Overall Study|Withdrawal by Subject|0|||
149792516|NCT00550615|540364565|FG002|Overall Study|Withdrawal by Subject|2|||
149792517|NCT00550615|540364566|FG003|Overall Study|Withdrawal by Subject|3|||
149792518|NCT00550615|540364563|FG000|Overall Study|Not evaluable|0|||
149792519|NCT00550615|540364564|FG001|Overall Study|Not evaluable|0|||
149792520|NCT00550615|540364565|FG002|Overall Study|Not evaluable|2|||
149792521|NCT00550615|540364566|FG003|Overall Study|Not evaluable|7|||
149792522|NCT01948791|540364568|FG000|Overall Study|Adverse Event|12|||
149792523|NCT01948791|540364568|FG000|Overall Study|Lack of Efficacy|3|||
149792524|NCT01948791|540364568|FG000|Overall Study|Protocol Violation|2|||
149792525|NCT01948791|540364568|FG000|Overall Study|Withdrawal by Subject|5|||
149792526|NCT01948791|540364568|FG000|Overall Study|Lost to Follow-up|6|||
149792527|NCT01948791|540364568|FG000|Overall Study|Management issues|1|||
149792528|NCT01948791|540364568|FG000|Overall Study|Others|7|||
149792529|NCT01948791|540364568|FG000|Overall Study|Screening failure|35|||
149792530|NCT02555722|540364569|FG000|Week 2|Adverse Event|0|||
149792531|NCT02555722|540364570|FG001|Week 2|Adverse Event|1|||
149792532|NCT02555722|540364569|FG000|Week 2|Withdrawal by Subject|1|||
149792533|NCT02555722|540364570|FG001|Week 2|Withdrawal by Subject|0|||
149792534|NCT02555722|540364569|FG000|Month 1|Lens Discomfort|1|||
149792535|NCT02555722|540364570|FG001|Month 1|Lens Discomfort|0|||
149792536|NCT02555722|540364569|FG000|Month 2|Withdrawal by Subject|3|||
149792537|NCT02555722|540364570|FG001|Month 2|Withdrawal by Subject|0|||
149792538|NCT02555722|540364569|FG000|Month 2|Lost to Follow-up|1|||
149792539|NCT02555722|540364570|FG001|Month 2|Lost to Follow-up|0|||
149792540|NCT00702949|540364571|FG000|Overall Study|Refusal|3|||
149792541|NCT00702949|540364572|FG001|Overall Study|Refusal|2|||
149792542|NCT00702949|540364573|FG002|Overall Study|Refusal|2|||
149792543|NCT00702949|540364571|FG000|Overall Study|Adverse Event|1|||
149792544|NCT00702949|540364572|FG001|Overall Study|Adverse Event|6|||
149792545|NCT00702949|540364573|FG002|Overall Study|Adverse Event|3|||
149792546|NCT00702949|540364571|FG000|Overall Study|Other Medical Reason/unknown|1|||
149792547|NCT00702949|540364572|FG001|Overall Study|Other Medical Reason/unknown|1|||
149792548|NCT00702949|540364573|FG002|Overall Study|Other Medical Reason/unknown|3|||
149792549|NCT00135694|540364574|FG000|Overall Study|Adverse Event|17|||
149792550|NCT00135694|540364575|FG001|Overall Study|Adverse Event|4|||
149792551|NCT00135694|540364576|FG002|Overall Study|Adverse Event|0|||
149792552|NCT00135694|540364574|FG000|Overall Study|Death|14|||
149792553|NCT00135694|540364575|FG001|Overall Study|Death|1|||
149792554|NCT00135694|540364576|FG002|Overall Study|Death|2|||
149792555|NCT00135694|540364574|FG000|Overall Study|Lost to Follow-up|8|||
149792556|NCT00135694|540364575|FG001|Overall Study|Lost to Follow-up|7|||
149792557|NCT00135694|540364576|FG002|Overall Study|Lost to Follow-up|1|||
149792558|NCT00135694|540364574|FG000|Overall Study|Withdrawal by Subject|41|||
149792559|NCT00135694|540364575|FG001|Overall Study|Withdrawal by Subject|7|||
149792560|NCT00135694|540364576|FG002|Overall Study|Withdrawal by Subject|4|||
149792561|NCT00135694|540364574|FG000|Overall Study|Protocol Violation|19|||
149792562|NCT00135694|540364575|FG001|Overall Study|Protocol Violation|1|||
149792563|NCT00135694|540364576|FG002|Overall Study|Protocol Violation|0|||
149792564|NCT00135694|540364574|FG000|Overall Study|Hepatitis C related reasons|39|||
149792565|NCT00135694|540364575|FG001|Overall Study|Hepatitis C related reasons|1|||
149792566|NCT00135694|540364576|FG002|Overall Study|Hepatitis C related reasons|0|||
149792567|NCT00135694|540364574|FG000|Overall Study|Ineligible for Random assignment|42|||
149792568|NCT00135694|540364575|FG001|Overall Study|Ineligible for Random assignment|0|||
149792569|NCT00135694|540364576|FG002|Overall Study|Ineligible for Random assignment|0|||
149792570|NCT02584660|540364577|FG000|Overall Study|Adverse Event|4|||
149792571|NCT02584660|540364578|FG001|Overall Study|Adverse Event|0|||
149792572|NCT02584660|540364577|FG000|Overall Study|Lost to Follow-up|3|||
149792573|NCT02584660|540364578|FG001|Overall Study|Lost to Follow-up|4|||
149792574|NCT02584660|540364577|FG000|Overall Study|Protocol Violation|0|||
149792575|NCT02584660|540364578|FG001|Overall Study|Protocol Violation|1|||
149792576|NCT02584660|540364577|FG000|Overall Study|Withdrawal by Subject|0|||
149792577|NCT02584660|540364578|FG001|Overall Study|Withdrawal by Subject|2|||
149792578|NCT02584660|540364577|FG000|Overall Study|Other|0|||
149792579|NCT02584660|540364578|FG001|Overall Study|Other|1|||
149792580|NCT00523744|540364579|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
149792581|NCT00523744|540364579|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
149792582|NCT00523744|540364579|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
149792583|NCT00523744|540364579|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
149792584|NCT00523744|540364579|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
149792585|NCT00523744|540364579|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
149792586|NCT02120469|540364582|FG000|Overall Study|HER-2/neu-amplified|1|||
149792587|NCT02120469|540364583|FG001|Overall Study|HER-2/neu-amplified|0|||
149792588|NCT02120469|540364584|FG002|Overall Study|HER-2/neu-amplified|1|||
149792589|NCT01040728|540364585|FG000|Overall Study|Adverse Event|4|||
149792590|NCT01040728|540364586|FG001|Overall Study|Adverse Event|8|||
149792591|NCT01040728|540364587|FG002|Overall Study|Adverse Event|0|||
149792592|NCT01040728|540364588|FG003|Overall Study|Adverse Event|4|||
149792593|NCT01040728|540364585|FG000|Overall Study|Withdrawal by Subject|0|||
149792594|NCT01040728|540364586|FG001|Overall Study|Withdrawal by Subject|1|||
149792595|NCT01040728|540364587|FG002|Overall Study|Withdrawal by Subject|1|||
149792596|NCT01040728|540364588|FG003|Overall Study|Withdrawal by Subject|0|||
149792597|NCT01040728|540364585|FG000|Overall Study|Protocol Violation|0|||
149792598|NCT01040728|540364586|FG001|Overall Study|Protocol Violation|0|||
149792599|NCT01040728|540364587|FG002|Overall Study|Protocol Violation|0|||
149792600|NCT01040728|540364588|FG003|Overall Study|Protocol Violation|1|||
149792601|NCT01040728|540364585|FG000|Overall Study|Lack of Efficacy|0|||
149792602|NCT01040728|540364586|FG001|Overall Study|Lack of Efficacy|1|||
149792603|NCT01040728|540364587|FG002|Overall Study|Lack of Efficacy|0|||
149792604|NCT01040728|540364588|FG003|Overall Study|Lack of Efficacy|1|||
149792605|NCT01040728|540364585|FG000|Overall Study|Other reasons not listed above|0|||
149792606|NCT01040728|540364586|FG001|Overall Study|Other reasons not listed above|1|||
149792607|NCT01040728|540364587|FG002|Overall Study|Other reasons not listed above|0|||
149792608|NCT01040728|540364588|FG003|Overall Study|Other reasons not listed above|0|||
149792609|NCT02583711|540364591|FG000|Overall Study|Withdrawal by Subject|0|||
149792610|NCT02583711|540364592|FG001|Overall Study|Withdrawal by Subject|10|||
149792611|NCT02583711|540364593|FG002|Overall Study|Withdrawal by Subject|0|||
149792612|NCT00281528|540364595|FG000|Overall Study|Progressive Disease|28|||
149792613|NCT00281528|540364596|FG001|Overall Study|Progressive Disease|18|||
149792614|NCT00281528|540364597|FG002|Overall Study|Progressive Disease|27|||
149792615|NCT00281528|540364595|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
149792616|NCT00281528|540364596|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
149792617|NCT00281528|540364597|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
149792618|NCT00281528|540364595|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
149792619|NCT00281528|540364596|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
149792620|NCT00281528|540364597|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
149792621|NCT00281528|540364595|FG000|Overall Study|Physician Decision|11|||
149792622|NCT00281528|540364596|FG001|Overall Study|Physician Decision|4|||
149792623|NCT00281528|540364597|FG002|Overall Study|Physician Decision|5|||
149792624|NCT00281528|540364595|FG000|Overall Study|Protocol Violation|1|||
149792625|NCT00281528|540364596|FG001|Overall Study|Protocol Violation|0|||
149792626|NCT00281528|540364597|FG002|Overall Study|Protocol Violation|1|||
149792627|NCT00281528|540364595|FG000|Overall Study|Withdrawal by Subject|5|||
149792628|NCT00281528|540364596|FG001|Overall Study|Withdrawal by Subject|5|||
149792629|NCT00281528|540364597|FG002|Overall Study|Withdrawal by Subject|7|||
149792630|NCT00281528|540364595|FG000|Overall Study|Other|6|||
149792631|NCT00281528|540364596|FG001|Overall Study|Other|3|||
149792632|NCT00281528|540364597|FG002|Overall Study|Other|5|||
149792633|NCT01981096|540364598|FG000|Overall Study|Parent illness|1|||
149792634|NCT01981096|540364599|FG001|Overall Study|Parent illness|0|||
149792635|NCT01981096|540364598|FG000|Overall Study|Withdrawal by Subject|0|||
149792636|NCT01981096|540364599|FG001|Overall Study|Withdrawal by Subject|1|||
149792637|NCT01981096|540364598|FG000|Overall Study|Lost to Follow-up|2|||
149792638|NCT01981096|540364599|FG001|Overall Study|Lost to Follow-up|0|||
149792639|NCT01225211|540364600|FG000|Overall Study|Adverse Event|0|||
149792640|NCT01225211|540364601|FG001|Overall Study|Adverse Event|0|||
149792641|NCT01225211|540364602|FG002|Overall Study|Adverse Event|1|||
149792642|NCT01225211|540364603|FG003|Overall Study|Adverse Event|0|||
149792643|NCT01225211|540364604|FG004|Overall Study|Adverse Event|0|||
149792644|NCT01225211|540364605|FG005|Overall Study|Adverse Event|0|||
149792645|NCT01225211|540364606|FG006|Overall Study|Adverse Event|0|||
149792646|NCT01225211|540364607|FG007|Overall Study|Adverse Event|0|||
149792647|NCT01225211|540364608|FG008|Overall Study|Adverse Event|0|||
149792648|NCT01225211|540364609|FG009|Overall Study|Adverse Event|1|||
149792649|NCT01225211|540364600|FG000|Overall Study|Withdrawal by Subject|0|||
149792650|NCT01225211|540364601|FG001|Overall Study|Withdrawal by Subject|0|||
149792651|NCT01225211|540364602|FG002|Overall Study|Withdrawal by Subject|0|||
149792652|NCT01225211|540364603|FG003|Overall Study|Withdrawal by Subject|0|||
149792653|NCT01225211|540364604|FG004|Overall Study|Withdrawal by Subject|0|||
149792654|NCT01225211|540364605|FG005|Overall Study|Withdrawal by Subject|0|||
149792655|NCT01225211|540364606|FG006|Overall Study|Withdrawal by Subject|1|||
149792656|NCT01225211|540364607|FG007|Overall Study|Withdrawal by Subject|0|||
149792657|NCT01225211|540364608|FG008|Overall Study|Withdrawal by Subject|1|||
149792658|NCT01225211|540364609|FG009|Overall Study|Withdrawal by Subject|3|||
149792659|NCT01225211|540364600|FG000|Overall Study|Other|0|||
149792660|NCT01225211|540364601|FG001|Overall Study|Other|0|||
149792661|NCT01225211|540364602|FG002|Overall Study|Other|0|||
149792662|NCT01225211|540364603|FG003|Overall Study|Other|0|||
149792663|NCT01225211|540364604|FG004|Overall Study|Other|0|||
149792664|NCT01225211|540364605|FG005|Overall Study|Other|0|||
149792665|NCT01225211|540364606|FG006|Overall Study|Other|0|||
149792666|NCT01225211|540364607|FG007|Overall Study|Other|0|||
149792667|NCT01225211|540364608|FG008|Overall Study|Other|0|||
149792668|NCT01225211|540364609|FG009|Overall Study|Other|1|||
149792669|NCT01987609|540364610|FG000|Overall Study|Adverse Event|1|||
149792670|NCT02610231|540364616|FG000|Overall Study|Withdrawal by Subject|27|||
149792671|NCT02610231|540364616|FG000|Overall Study|Adverse Event|20|||
149792672|NCT02610231|540364616|FG000|Overall Study|Death|5|||
149792673|NCT02610231|540364616|FG000|Overall Study|Surgery|2|||
149792674|NCT02610231|540364616|FG000|Overall Study|Physician Decision|1|||
149792675|NCT02610231|540364616|FG000|Overall Study|Non Compliance|2|||
149792676|NCT02610231|540364616|FG000|Overall Study|Other|3|||
149792677|NCT01279954|540364619|FG000|Overall Study|Lack of Efficacy|3|||
149792678|NCT01279954|540364620|FG001|Overall Study|Lack of Efficacy|4|||
149792679|NCT01711359|540364625|FG000|Treatment Period|Withdrawal by Subject|18|||
149792680|NCT01711359|540364626|FG001|Treatment Period|Withdrawal by Subject|7|||
149792681|NCT01711359|540364627|FG002|Treatment Period|Withdrawal by Subject|13|||
149792682|NCT01711359|540364625|FG000|Treatment Period|Lack of Efficacy|13|||
149792683|NCT01711359|540364626|FG001|Treatment Period|Lack of Efficacy|2|||
149792684|NCT01711359|540364627|FG002|Treatment Period|Lack of Efficacy|2|||
149792685|NCT01711359|540364625|FG000|Treatment Period|Adverse Event|8|||
149792686|NCT01711359|540364626|FG001|Treatment Period|Adverse Event|10|||
149792687|NCT01711359|540364627|FG002|Treatment Period|Adverse Event|24|||
149792688|NCT01711359|540364625|FG000|Treatment Period|Physician Decision|4|||
149792689|NCT01711359|540364626|FG001|Treatment Period|Physician Decision|3|||
149792690|NCT01711359|540364627|FG002|Treatment Period|Physician Decision|2|||
149792691|NCT01711359|540364625|FG000|Treatment Period|Death|3|||
149792692|NCT01711359|540364626|FG001|Treatment Period|Death|0|||
149792693|NCT01711359|540364627|FG002|Treatment Period|Death|0|||
149792694|NCT01711359|540364625|FG000|Treatment Period|Entry Criteria Not Met|1|||
149792695|NCT01711359|540364626|FG001|Treatment Period|Entry Criteria Not Met|0|||
149792696|NCT01711359|540364627|FG002|Treatment Period|Entry Criteria Not Met|0|||
149792697|NCT01711359|540364625|FG000|Treatment Period|Sponsor Decision|1|||
149792698|NCT01711359|540364626|FG001|Treatment Period|Sponsor Decision|0|||
149792699|NCT01711359|540364627|FG002|Treatment Period|Sponsor Decision|0|||
149792700|NCT01711359|540364625|FG000|Treatment Period|Lost to Follow-up|1|||
149792701|NCT01711359|540364626|FG001|Treatment Period|Lost to Follow-up|1|||
149792702|NCT01711359|540364627|FG002|Treatment Period|Lost to Follow-up|1|||
149792703|NCT01711359|540364625|FG000|Treatment Period|Randomized, Not Treated|3|||
149792704|NCT01711359|540364626|FG001|Treatment Period|Randomized, Not Treated|1|||
149792705|NCT01711359|540364627|FG002|Treatment Period|Randomized, Not Treated|0|||
149792706|NCT02698176|540364630|FG000|Overall Study|Progressive disease|4|||
149792707|NCT02698176|540364631|FG001|Overall Study|Progressive disease|3|||
149792708|NCT02698176|540364632|FG002|Overall Study|Progressive disease|1|||
149792709|NCT02698176|540364633|FG003|Overall Study|Progressive disease|0|||
149792710|NCT02698176|540364630|FG000|Overall Study|Adverse Event|2|||
149792711|NCT02698176|540364631|FG001|Overall Study|Adverse Event|0|||
149792712|NCT02698176|540364632|FG002|Overall Study|Adverse Event|0|||
149792713|NCT02698176|540364633|FG003|Overall Study|Adverse Event|0|||
149792714|NCT02698176|540364630|FG000|Overall Study|Clinical progression|3|||
149792715|NCT02698176|540364631|FG001|Overall Study|Clinical progression|0|||
149792716|NCT02698176|540364632|FG002|Overall Study|Clinical progression|0|||
149792717|NCT02698176|540364633|FG003|Overall Study|Clinical progression|0|||
149792718|NCT00805142|540364634|FG000|Titration Period|Adverse Event|3|||
149792719|NCT00805142|540364635|FG001|Titration Period|Adverse Event|3|||
149792720|NCT00805142|540364634|FG000|Titration Period|Lack of Efficacy|1|||
149792721|NCT00805142|540364635|FG001|Titration Period|Lack of Efficacy|1|||
149792722|NCT00805142|540364634|FG000|Titration Period|Lost to Follow-up|0|||
149792723|NCT00805142|540364635|FG001|Titration Period|Lost to Follow-up|1|||
149792724|NCT00805142|540364634|FG000|Titration Period|Disease Progression|2|||
149792725|NCT00805142|540364635|FG001|Titration Period|Disease Progression|1|||
149792726|NCT00805142|540364634|FG000|Titration Period|Withdrawal of consent|0|||
149792727|NCT00805142|540364635|FG001|Titration Period|Withdrawal of consent|1|||
149792728|NCT00805142|540364634|FG000|Titration Period|Other|0|||
149792729|NCT00805142|540364635|FG001|Titration Period|Other|3|||
149792730|NCT00805142|540364634|FG000|Maintenance Period|Adverse Event|0|||
149792731|NCT00805142|540364635|FG001|Maintenance Period|Adverse Event|1|||
149792732|NCT00805142|540364634|FG000|Maintenance Period|Other|0|||
149792733|NCT00805142|540364635|FG001|Maintenance Period|Other|1|||
149792734|NCT00424463|540364636|FG000|Overall Study|Adverse Event|2|||
149792735|NCT00424463|540364637|FG001|Overall Study|Adverse Event|3|||
149792736|NCT00424463|540364638|FG002|Overall Study|Adverse Event|2|||
149792737|NCT00424463|540364636|FG000|Overall Study|Physician Decision|0|||
149792738|NCT00424463|540364637|FG001|Overall Study|Physician Decision|2|||
149792739|NCT00424463|540364638|FG002|Overall Study|Physician Decision|2|||
149792740|NCT00424463|540364636|FG000|Overall Study|Withdrawal by Subject|4|||
149792741|NCT00424463|540364637|FG001|Overall Study|Withdrawal by Subject|2|||
149792742|NCT00424463|540364638|FG002|Overall Study|Withdrawal by Subject|5|||
149792743|NCT00424463|540364636|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
149792744|NCT00424463|540364637|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
149792745|NCT00424463|540364638|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
149792746|NCT00424463|540364636|FG000|Overall Study|Patient's convenience|0|||
149792747|NCT00424463|540364637|FG001|Overall Study|Patient's convenience|0|||
149792748|NCT00424463|540364638|FG002|Overall Study|Patient's convenience|1|||
149792749|NCT02449915|540364639|FG000|Overall Study|Exclusion criteria - drug use|1|||
149792750|NCT02449915|540364640|FG001|Overall Study|Exclusion criteria - drug use|0|||
149792751|NCT02449915|540364639|FG000|Overall Study|Withdrawal by Subject|0|||
149792752|NCT02449915|540364640|FG001|Overall Study|Withdrawal by Subject|2|||
149792753|NCT02449915|540364639|FG000|Overall Study|Intraoperative surgical findings|1|||
149792754|NCT02449915|540364640|FG001|Overall Study|Intraoperative surgical findings|1|||
149792755|NCT02449915|540364639|FG000|Overall Study|Abnormal preop lab|0|||
149792756|NCT02449915|540364640|FG001|Overall Study|Abnormal preop lab|1|||
149792757|NCT01021293|540364642|FG000|Overall Study|Serious Adverse Event|2|||
149792758|NCT01021293|540364643|FG001|Overall Study|Serious Adverse Event|1|||
149792759|NCT01021293|540364642|FG000|Overall Study|Adverse Event|2|||
149792760|NCT01021293|540364643|FG001|Overall Study|Adverse Event|1|||
149792761|NCT01021293|540364642|FG000|Overall Study|Withdrawal by Subject|1|||
149792762|NCT01021293|540364643|FG001|Overall Study|Withdrawal by Subject|3|||
149792763|NCT01021293|540364642|FG000|Overall Study|Migrated/moved from study area|6|||
149792764|NCT01021293|540364643|FG001|Overall Study|Migrated/moved from study area|18|||
149792765|NCT01021293|540364642|FG000|Overall Study|Lost to Follow-up|1|||
149792766|NCT01021293|540364643|FG001|Overall Study|Lost to Follow-up|1|||
149792767|NCT05466240|540366076|FG000|Overall Study|Adverse Event|1|||
149792768|NCT05466240|540366077|FG001|Overall Study|Adverse Event|0|||
149792769|NCT05466240|540366076|FG000|Overall Study|Withdrawal by Subject|1|||
149792770|NCT05466240|540366077|FG001|Overall Study|Withdrawal by Subject|0|||
149792771|NCT02679222|540366078|FG000|Overall Study|No time for project|1|||
149792772|NCT00945945|540366079|FG000|Overall Study|Adverse Event|15|||
149792773|NCT00945945|540366080|FG001|Overall Study|Adverse Event|35|||
149792774|NCT00945945|540366079|FG000|Overall Study|Withdrawal by Subject|7|||
149792775|NCT00945945|540366080|FG001|Overall Study|Withdrawal by Subject|10|||
149792776|NCT00945945|540366079|FG000|Overall Study|Lost to Follow-up|4|||
149792777|NCT00945945|540366080|FG001|Overall Study|Lost to Follow-up|5|||
149792778|NCT00945945|540366079|FG000|Overall Study|Lack of Efficacy|6|||
149792779|NCT00945945|540366080|FG001|Overall Study|Lack of Efficacy|2|||
149792780|NCT00945945|540366079|FG000|Overall Study|Protocol Violation|4|||
149792781|NCT00945945|540366080|FG001|Overall Study|Protocol Violation|2|||
149792782|NCT00945945|540366079|FG000|Overall Study|Entry Criteria Not Met|0|||
149792783|NCT00945945|540366080|FG001|Overall Study|Entry Criteria Not Met|1|||
149792784|NCT00626327|540366081|FG000|Overall Study|Withdrawal by Subject|21|||
149792785|NCT00626327|540366082|FG001|Overall Study|Withdrawal by Subject|29|||
149792786|NCT00626327|540366083|FG002|Overall Study|Withdrawal by Subject|30|||
149792787|NCT00626327|540366081|FG000|Overall Study|Adverse Event|1|||
149792788|NCT00626327|540366082|FG001|Overall Study|Adverse Event|0|||
149792789|NCT00626327|540366083|FG002|Overall Study|Adverse Event|0|||
149792790|NCT00626327|540366081|FG000|Overall Study|Lost to Follow-up|24|||
149792791|NCT00626327|540366082|FG001|Overall Study|Lost to Follow-up|21|||
149792792|NCT00626327|540366083|FG002|Overall Study|Lost to Follow-up|23|||
149792793|NCT00626327|540366081|FG000|Overall Study|Inappropriate enrollment|4|||
149792794|NCT00626327|540366082|FG001|Overall Study|Inappropriate enrollment|5|||
149792795|NCT00626327|540366083|FG002|Overall Study|Inappropriate enrollment|3|||
149792796|NCT00626327|540366081|FG000|Overall Study|Administrative Reason|2|||
149792797|NCT00626327|540366082|FG001|Overall Study|Administrative Reason|0|||
149792798|NCT00626327|540366083|FG002|Overall Study|Administrative Reason|6|||
149792799|NCT00626327|540366081|FG000|Overall Study|Protocol Violation|26|||
149792800|NCT00626327|540366082|FG001|Overall Study|Protocol Violation|4|||
149792801|NCT00626327|540366083|FG002|Overall Study|Protocol Violation|26|||
149792802|NCT00286156|540366085|FG000|Overall Study|Missed 12 month visit|0|||
149792803|NCT00286156|540366086|FG001|Overall Study|Missed 12 month visit|0|||
149792804|NCT00286156|540366087|FG002|Overall Study|Missed 12 month visit|1|||
149792805|NCT00286156|540366085|FG000|Overall Study|AE: pulmonary embolus|0|||
149792806|NCT00286156|540366086|FG001|Overall Study|AE: pulmonary embolus|1|||
149792807|NCT00286156|540366087|FG002|Overall Study|AE: pulmonary embolus|0|||
149792808|NCT00286156|540366085|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
149792809|NCT00286156|540366086|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
149792810|NCT00286156|540366087|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
149792811|NCT00286156|540366085|FG000|Overall Study|AE: pneumonia|1|||
149792812|NCT00286156|540366086|FG001|Overall Study|AE: pneumonia|0|||
149792813|NCT00286156|540366087|FG002|Overall Study|AE: pneumonia|0|||
149792814|NCT01060150|540366093|FG000|Overall Study|Adverse Event|6|||
149792815|NCT01060150|540366093|FG000|Overall Study|Lost to Follow-up|1|||
149792816|NCT01060150|540366093|FG000|Overall Study|Protocol Violation|6|||
149792817|NCT01060150|540366093|FG000|Overall Study|Withdrawal by Subject|8|||
149792818|NCT01060150|540366093|FG000|Overall Study|Enrolled, but not treated|2|||
149792819|NCT02516306|540366094|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
149792820|NCT02516306|540366095|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
149792821|NCT00256204|540366106|FG000|Overall Study|Adverse Event|10|||
149792822|NCT00256204|540366107|FG001|Overall Study|Adverse Event|14|||
149792823|NCT00256204|540366108|FG002|Overall Study|Adverse Event|16|||
149792824|NCT00256204|540366109|FG003|Overall Study|Adverse Event|14|||
149792825|NCT00256204|540366106|FG000|Overall Study|Death|0|||
149792826|NCT00256204|540366107|FG001|Overall Study|Death|1|||
149792827|NCT00256204|540366108|FG002|Overall Study|Death|0|||
149792828|NCT00256204|540366109|FG003|Overall Study|Death|0|||
149792829|NCT00256204|540366106|FG000|Overall Study|Lost to Follow-up|1|||
149792830|NCT00256204|540366107|FG001|Overall Study|Lost to Follow-up|1|||
149792831|NCT00256204|540366108|FG002|Overall Study|Lost to Follow-up|1|||
149792832|NCT00256204|540366109|FG003|Overall Study|Lost to Follow-up|2|||
149792833|NCT00256204|540366106|FG000|Overall Study|Protocol Violation|1|||
149792834|NCT00256204|540366107|FG001|Overall Study|Protocol Violation|0|||
149792835|NCT00256204|540366108|FG002|Overall Study|Protocol Violation|2|||
149792836|NCT00256204|540366109|FG003|Overall Study|Protocol Violation|1|||
149792837|NCT00256204|540366106|FG000|Overall Study|Physician Decision|0|||
149792838|NCT00256204|540366107|FG001|Overall Study|Physician Decision|0|||
149792839|NCT00256204|540366108|FG002|Overall Study|Physician Decision|1|||
149792840|NCT00256204|540366109|FG003|Overall Study|Physician Decision|2|||
149792841|NCT00256204|540366106|FG000|Overall Study|Withdrawal by Subject|17|||
149792842|NCT00256204|540366107|FG001|Overall Study|Withdrawal by Subject|6|||
149792843|NCT00256204|540366108|FG002|Overall Study|Withdrawal by Subject|7|||
149792844|NCT00256204|540366109|FG003|Overall Study|Withdrawal by Subject|5|||
149792845|NCT00256204|540366106|FG000|Overall Study|Need for additional prohibited treatment|38|||
149792846|NCT00256204|540366107|FG001|Overall Study|Need for additional prohibited treatment|28|||
149792847|NCT00256204|540366108|FG002|Overall Study|Need for additional prohibited treatment|27|||
149792848|NCT00256204|540366109|FG003|Overall Study|Need for additional prohibited treatment|25|||
149792849|NCT01566981|540366110|FG000|Overall Study|Lost to Follow-up|5|||
149792850|NCT01566981|540366111|FG001|Overall Study|Lost to Follow-up|8|||
149792851|NCT02177942|540366112|FG000|Overall Study|Adverse Event|1|||
149792852|NCT02177942|540366113|FG001|Overall Study|Adverse Event|0|||
149792853|NCT02177942|540366112|FG000|Overall Study|Lost to Follow-up|1|||
149792854|NCT02177942|540366113|FG001|Overall Study|Lost to Follow-up|1|||
149792855|NCT02177942|540366112|FG000|Overall Study|Protocol Violation|4|||
149792856|NCT02177942|540366113|FG001|Overall Study|Protocol Violation|6|||
149792857|NCT02177942|540366112|FG000|Overall Study|Withdrawal by Subject|71|||
149792858|NCT02177942|540366113|FG001|Overall Study|Withdrawal by Subject|81|||
149792859|NCT01351415|540366114|FG000|Overall Study|Withdrawal by Subject|15|||
149792860|NCT01351415|540366115|FG001|Overall Study|Withdrawal by Subject|17|||
149792861|NCT01351415|540366114|FG000|Overall Study|Trial termination by the Sponsor|28|||
149792862|NCT01351415|540366115|FG001|Overall Study|Trial termination by the Sponsor|19|||
149792863|NCT01351415|540366114|FG000|Overall Study|Lost to Follow-up|5|||
149792864|NCT01351415|540366115|FG001|Overall Study|Lost to Follow-up|7|||
149792865|NCT01351415|540366114|FG000|Overall Study|Death|190|||
149792866|NCT01351415|540366115|FG001|Overall Study|Death|187|||
149792867|NCT01351415|540366114|FG000|Overall Study|Physician Decision|2|||
149792868|NCT01351415|540366115|FG001|Overall Study|Physician Decision|3|||
149792869|NCT01351415|540366114|FG000|Overall Study|Reason unknown|0|||
149792870|NCT01351415|540366115|FG001|Overall Study|Reason unknown|2|||
149792871|NCT01351415|540366114|FG000|Overall Study|Never Started|5|||
149792872|NCT01351415|540366115|FG001|Overall Study|Never Started|5|||
149792873|NCT01234337|540366116|FG000|Overall Study|Adverse Event|58|||
149792874|NCT01234337|540366117|FG001|Overall Study|Adverse Event|21|||
149792875|NCT01234337|540366116|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
149792876|NCT01234337|540366117|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
149792877|NCT01234337|540366116|FG000|Overall Study|Investi. decision not protocol driven|5|||
149792878|NCT01234337|540366117|FG001|Overall Study|Investi. decision not protocol driven|6|||
149792879|NCT01234337|540366116|FG000|Overall Study|Non-compliant with study medication|3|||
149792880|NCT01234337|540366117|FG001|Overall Study|Non-compliant with study medication|2|||
149792881|NCT01234337|540366116|FG000|Overall Study|Randomized but not treated|6|||
149792882|NCT01234337|540366117|FG001|Overall Study|Randomized but not treated|4|||
149792883|NCT01234337|540366116|FG000|Overall Study|Lost to Follow-up|0|||
149792884|NCT01234337|540366117|FG001|Overall Study|Lost to Follow-up|1|||
149792885|NCT01234337|540366116|FG000|Overall Study|Protocol Violation|2|||
149792886|NCT01234337|540366117|FG001|Overall Study|Protocol Violation|3|||
149792887|NCT01234337|540366116|FG000|Overall Study|Withdrawal by Subject|11|||
149792888|NCT01234337|540366117|FG001|Overall Study|Withdrawal by Subject|9|||
149792889|NCT01234337|540366116|FG000|Overall Study|Death|0|||
149792890|NCT01234337|540366117|FG001|Overall Study|Death|1|||
149792891|NCT01234337|540366116|FG000|Overall Study|Switch to commercial drug|0|||
149792892|NCT01234337|540366117|FG001|Overall Study|Switch to commercial drug|1|||
149792893|NCT03525613|540366124|FG000|Overall Study|Adverse Event|11|||
149792894|NCT03525613|540366125|FG001|Overall Study|Adverse Event|8|||
149792895|NCT03525613|540366126|FG002|Overall Study|Adverse Event|3|||
149792896|NCT03525613|540366127|FG003|Overall Study|Adverse Event|3|||
149792897|NCT03525613|540366124|FG000|Overall Study|Lost to Follow-up|4|||
149792898|NCT03525613|540366125|FG001|Overall Study|Lost to Follow-up|5|||
149792899|NCT03525613|540366126|FG002|Overall Study|Lost to Follow-up|3|||
149792900|NCT03525613|540366127|FG003|Overall Study|Lost to Follow-up|2|||
149792901|NCT03525613|540366124|FG000|Overall Study|Physician Decision|0|||
149792902|NCT03525613|540366125|FG001|Overall Study|Physician Decision|1|||
149792903|NCT03525613|540366126|FG002|Overall Study|Physician Decision|0|||
149792904|NCT03525613|540366127|FG003|Overall Study|Physician Decision|1|||
149792905|NCT03525613|540366124|FG000|Overall Study|Consent Withdrawal|25|||
149792906|NCT03525613|540366125|FG001|Overall Study|Consent Withdrawal|16|||
149792907|NCT03525613|540366126|FG002|Overall Study|Consent Withdrawal|12|||
149792908|NCT03525613|540366127|FG003|Overall Study|Consent Withdrawal|9|||
149792909|NCT03525613|540366124|FG000|Overall Study|Death|20|||
149792910|NCT03525613|540366125|FG001|Overall Study|Death|9|||
149792911|NCT03525613|540366126|FG002|Overall Study|Death|7|||
149792912|NCT03525613|540366127|FG003|Overall Study|Death|1|||
149792913|NCT03525613|540366124|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
149792914|NCT03525613|540366125|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
149792915|NCT03525613|540366126|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
149792916|NCT03525613|540366127|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
149792917|NCT03480360|540366128|FG000|Overall Study|Death|2|||
149792918|NCT00374452|540366131|FG000|Overall Study|Left clinic before intervention started|4|||
149792919|NCT00374452|540366132|FG001|Overall Study|Left clinic before intervention started|1|||
149792920|NCT00374452|540366131|FG000|Overall Study|Change in job role before intervention|0|||
149792921|NCT00374452|540366132|FG001|Overall Study|Change in job role before intervention|1|||
149792922|NCT00374452|540366131|FG000|Overall Study|Left clinic after intervention started|1|||
149792923|NCT00374452|540366132|FG001|Overall Study|Left clinic after intervention started|1|||
149792924|NCT00374452|540366131|FG000|Overall Study|Withdrawal by Subject|0|||
149792925|NCT00374452|540366132|FG001|Overall Study|Withdrawal by Subject|2|||
149792926|NCT03117309|540366137|FG000|Overall Study|Not meeting inclusion criteria|0|||
149792927|NCT03117309|540366138|FG001|Overall Study|Not meeting inclusion criteria|1|||
149792928|NCT00590031|540366140|FG000|Overall Study|Adverse Event|3|||
149792929|NCT00590031|540366140|FG000|Overall Study|Withdrawal by Subject|1|||
149792930|NCT00590031|540366140|FG000|Overall Study|Metastatic Disease|1|||
149792931|NCT00590031|540366140|FG000|Overall Study|Admin Hold|1|||
149792932|NCT01610414|540366141|FG000|Study Start - Month 13|Serious Adverse Event|65|||
149792933|NCT01610414|540366142|FG001|Study Start - Month 13|Serious Adverse Event|67|||
149792934|NCT01610414|540366141|FG000|Study Start - Month 13|Adverse Event|14|||
149792935|NCT01610414|540366142|FG001|Study Start - Month 13|Adverse Event|14|||
149792936|NCT01610414|540366141|FG000|Study Start - Month 13|Protocol Violation|3|||
149792937|NCT01610414|540366142|FG001|Study Start - Month 13|Protocol Violation|1|||
149792938|NCT01610414|540366141|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
149792939|NCT01610414|540366142|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
149792940|NCT01610414|540366141|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
149792941|NCT01610414|540366142|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
149792942|NCT01610414|540366141|FG000|Study Start - Month 13|Lost to Follow-up|4|||
149792943|NCT01610414|540366142|FG001|Study Start - Month 13|Lost to Follow-up|6|||
149792944|NCT01610414|540366141|FG000|Study Start - Month 13|Suspected HZ episode|1|||
149792945|NCT01610414|540366142|FG001|Study Start - Month 13|Suspected HZ episode|3|||
149792946|NCT01610414|540366141|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
149792947|NCT01610414|540366142|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
149792948|NCT01610414|540366141|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
149792949|NCT01610414|540366142|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
149792950|NCT01610414|540366141|FG000|Month 13 - Month 25|Adverse Event|8|||
149792951|NCT01610414|540366142|FG001|Month 13 - Month 25|Adverse Event|4|||
149792952|NCT01610414|540366141|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
149792953|NCT01610414|540366142|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
149792954|NCT01610414|540366141|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
149792955|NCT01610414|540366142|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
149792956|NCT01610414|540366141|FG000|Month 13 - Month 25|Protocol Violation|0|||
149792957|NCT01610414|540366142|FG001|Month 13 - Month 25|Protocol Violation|2|||
149792958|NCT01610414|540366141|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
149792959|NCT01610414|540366142|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
149792960|NCT01610414|540366141|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
149792961|NCT01610414|540366142|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
149792962|NCT01610414|540366141|FG000|After Month 25|Study end not reached|48|||
149792963|NCT01610414|540366142|FG001|After Month 25|Study end not reached|53|||
149792964|NCT00472043|540366150|FG000|Overall Study|Withdrawal by Subject|1|||
149792965|NCT00472043|540366151|FG001|Overall Study|Withdrawal by Subject|0|||
149792966|NCT00472043|540366150|FG000|Overall Study|Death|1|||
149792967|NCT00472043|540366151|FG001|Overall Study|Death|0|||
149792968|NCT00826540|540366153|FG000|Overall Study|ineligible|3|||
149792969|NCT00826540|540366153|FG000|Overall Study|Withdrawal by Subject|1|||
149792970|NCT01166386|540366154|FG000|Overall Study|Withdrawal by Subject|3|||
149792971|NCT01166386|540366155|FG001|Overall Study|Withdrawal by Subject|5|||
149792972|NCT03922711|540366160|FG000|Overall Study|Adverse Event|3|||
149792973|NCT03922711|540366161|FG001|Overall Study|Adverse Event|2|||
149792974|NCT03922711|540366162|FG002|Overall Study|Adverse Event|2|||
149792975|NCT03922711|540366160|FG000|Overall Study|Protocol Violation|1|||
149792976|NCT03922711|540366161|FG001|Overall Study|Protocol Violation|0|||
149792977|NCT03922711|540366162|FG002|Overall Study|Protocol Violation|0|||
149792978|NCT03922711|540366160|FG000|Overall Study|Withdrawal by Subject|0|||
149792979|NCT03922711|540366161|FG001|Overall Study|Withdrawal by Subject|3|||
149792980|NCT03922711|540366162|FG002|Overall Study|Withdrawal by Subject|1|||
149792981|NCT03922711|540366160|FG000|Overall Study|Not further specified|0|||
149792982|NCT03922711|540366161|FG001|Overall Study|Not further specified|0|||
149792983|NCT03922711|540366162|FG002|Overall Study|Not further specified|1|||
149792984|NCT02390362|540366163|FG000|Overall Study|Withdrawal by Subject|0|||
149792985|NCT02390362|540366164|FG001|Overall Study|Withdrawal by Subject|1|||
149792986|NCT04009824|540366165|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
149792987|NCT04009824|540366166|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
149792988|NCT04009824|540366167|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
149792989|NCT04009824|540366168|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
149792990|NCT04009824|540366169|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
149792991|NCT03032523|540366170|FG000|Overall Study|Withdrawal by Subject|2|||
149792992|NCT03032523|540366171|FG001|Overall Study|Withdrawal by Subject|2|||
149792993|NCT03032523|540366170|FG000|Overall Study|Physician Decision|1|||
149792994|NCT03032523|540366171|FG001|Overall Study|Physician Decision|0|||
149792995|NCT05375838|540366172|FG000|Overall Study|Other|0|||
149792996|NCT05375838|540366173|FG001|Overall Study|Other|0|||
149792997|NCT05375838|540366174|FG002|Overall Study|Other|0|||
149792998|NCT05375838|540366175|FG003|Overall Study|Other|1|||
149792999|NCT05375838|540366176|FG004|Overall Study|Other|1|||
149793000|NCT05375838|540366177|FG005|Overall Study|Other|0|||
149793001|NCT05375838|540366172|FG000|Overall Study|Withdrawal by Subject|2|||
149793002|NCT05375838|540366173|FG001|Overall Study|Withdrawal by Subject|1|||
149793003|NCT05375838|540366174|FG002|Overall Study|Withdrawal by Subject|3|||
149793004|NCT05375838|540366175|FG003|Overall Study|Withdrawal by Subject|2|||
149793005|NCT05375838|540366176|FG004|Overall Study|Withdrawal by Subject|2|||
149793006|NCT05375838|540366177|FG005|Overall Study|Withdrawal by Subject|0|||
149793007|NCT05375838|540366172|FG000|Overall Study|Protocol Violation|0|||
149793008|NCT05375838|540366173|FG001|Overall Study|Protocol Violation|0|||
149793009|NCT05375838|540366174|FG002|Overall Study|Protocol Violation|0|||
149793010|NCT05375838|540366175|FG003|Overall Study|Protocol Violation|0|||
149793011|NCT05375838|540366176|FG004|Overall Study|Protocol Violation|1|||
149793012|NCT05375838|540366177|FG005|Overall Study|Protocol Violation|0|||
149793013|NCT05375838|540366172|FG000|Overall Study|Physician Decision|0|||
149793014|NCT05375838|540366173|FG001|Overall Study|Physician Decision|1|||
149793015|NCT05375838|540366174|FG002|Overall Study|Physician Decision|0|||
149793016|NCT05375838|540366175|FG003|Overall Study|Physician Decision|0|||
149793017|NCT05375838|540366176|FG004|Overall Study|Physician Decision|0|||
149793018|NCT05375838|540366177|FG005|Overall Study|Physician Decision|1|||
149793019|NCT05375838|540366172|FG000|Overall Study|Lost to Follow-up|2|||
149793020|NCT05375838|540366173|FG001|Overall Study|Lost to Follow-up|7|||
149793021|NCT05375838|540366174|FG002|Overall Study|Lost to Follow-up|0|||
149793022|NCT05375838|540366175|FG003|Overall Study|Lost to Follow-up|4|||
149793023|NCT05375838|540366176|FG004|Overall Study|Lost to Follow-up|2|||
149793024|NCT05375838|540366177|FG005|Overall Study|Lost to Follow-up|3|||
149793025|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
149793026|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
149793027|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
149793028|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
149793029|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
149793030|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
149793031|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
149793032|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
149793033|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
149793034|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
149793035|NCT02178592|540366178|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
149793036|NCT02178592|540366179|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
149793037|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
149793038|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
149793039|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
149793040|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
149793041|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
149793042|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
149793043|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
149793044|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
149793045|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
149793046|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
149793047|NCT02178592|540366178|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
149793048|NCT02178592|540366179|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
149793049|NCT02975206|540366181|FG000|Overall Study|Withdrawal by Subject|14|||
149793050|NCT02975206|540366182|FG001|Overall Study|Withdrawal by Subject|11|||
149793051|NCT02975206|540366183|FG002|Overall Study|Withdrawal by Subject|11|||
149793052|NCT02975206|540366181|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
149801863|NCT00976989|540402452|FG002|Overall Study|Failure to Return|0|||
149793053|NCT02975206|540366182|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
149793054|NCT02975206|540366183|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
149793055|NCT01984294|540366188|FG000|Overall Study|Randomized but Never Treated|0|||
149793056|NCT01984294|540366189|FG001|Overall Study|Randomized but Never Treated|0|||
149793057|NCT01984294|540366190|FG002|Overall Study|Randomized but Never Treated|1|||
149793058|NCT01984294|540366188|FG000|Overall Study|Lack of Efficacy|4|||
149793059|NCT01984294|540366189|FG001|Overall Study|Lack of Efficacy|2|||
149793060|NCT01984294|540366190|FG002|Overall Study|Lack of Efficacy|6|||
149793061|NCT01984294|540366188|FG000|Overall Study|Adverse Event|0|||
149793062|NCT01984294|540366189|FG001|Overall Study|Adverse Event|1|||
149793063|NCT01984294|540366190|FG002|Overall Study|Adverse Event|0|||
149793064|NCT00392210|540366192|FG000|First Voiding Trial|Physician Decision|2|||
149793065|NCT00392210|540366193|FG001|First Voiding Trial|Physician Decision|2|||
149793066|NCT02067104|540366194|FG000|Overall Study|Study termination due to low accrual|4|||
149793067|NCT02067104|540366195|FG001|Overall Study|Study termination due to low accrual|5|||
149793068|NCT02140762|540366196|FG000|Overall Study|Adverse Event|1|||
149793069|NCT02140762|540366197|FG001|Overall Study|Adverse Event|1|||
149793070|NCT02140762|540366196|FG000|Overall Study|Lost to Follow-up|9|||
149793071|NCT02140762|540366197|FG001|Overall Study|Lost to Follow-up|5|||
149793072|NCT02140762|540366196|FG000|Overall Study|Protocol Violation|1|||
149793073|NCT02140762|540366197|FG001|Overall Study|Protocol Violation|1|||
149793074|NCT02140762|540366196|FG000|Overall Study|Withdrawal by Subject|6|||
149793075|NCT02140762|540366197|FG001|Overall Study|Withdrawal by Subject|4|||
149793076|NCT02140762|540366196|FG000|Overall Study|Other|0|||
149793077|NCT02140762|540366197|FG001|Overall Study|Other|1|||
149793078|NCT01277666|540366199|FG000|Overall Study|Adverse Event|26|||
149793079|NCT01277666|540366200|FG001|Overall Study|Adverse Event|25|||
149793080|NCT01277666|540366201|FG002|Overall Study|Adverse Event|20|||
149793081|NCT01277666|540366199|FG000|Overall Study|Lack of Efficacy|8|||
149793082|NCT01277666|540366200|FG001|Overall Study|Lack of Efficacy|20|||
149793083|NCT01277666|540366201|FG002|Overall Study|Lack of Efficacy|12|||
149793084|NCT01277666|540366199|FG000|Overall Study|Protocol Violation|2|||
149793085|NCT01277666|540366200|FG001|Overall Study|Protocol Violation|3|||
149793086|NCT01277666|540366201|FG002|Overall Study|Protocol Violation|2|||
149793087|NCT01277666|540366199|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
149793088|NCT01277666|540366200|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
149793089|NCT01277666|540366201|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
149793090|NCT01277666|540366199|FG000|Overall Study|Lost to Follow-up|1|||
149793091|NCT01277666|540366200|FG001|Overall Study|Lost to Follow-up|1|||
149793092|NCT01277666|540366201|FG002|Overall Study|Lost to Follow-up|2|||
149793093|NCT01277666|540366199|FG000|Overall Study|Withdrawal by Subject|7|||
149793094|NCT01277666|540366200|FG001|Overall Study|Withdrawal by Subject|8|||
149793095|NCT01277666|540366201|FG002|Overall Study|Withdrawal by Subject|6|||
149793096|NCT01277666|540366199|FG000|Overall Study|Death|0|||
149793097|NCT01277666|540366200|FG001|Overall Study|Death|0|||
149793098|NCT01277666|540366201|FG002|Overall Study|Death|1|||
149793099|NCT01385098|540366202|FG000|Overall Study|Adverse Event|10|||
149793100|NCT01385098|540366202|FG000|Overall Study|Lost to Follow-up|4|||
149793101|NCT00554840|540366203|FG000|Overall Study|Physician Decision|0|||
149793102|NCT00554840|540366204|FG001|Overall Study|Physician Decision|1|||
149793103|NCT02561572|540366207|FG000|Overall Study|Inadequate time before surgery|2|||
149793104|NCT02561572|540366208|FG001|Overall Study|Inadequate time before surgery|1|||
149793105|NCT02561572|540366207|FG000|Overall Study|Protocol Violation|0|||
149793106|NCT02561572|540366208|FG001|Overall Study|Protocol Violation|1|||
149793107|NCT00795717|540366209|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
149793108|NCT00795717|540366210|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
149793109|NCT00795717|540366209|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
149793110|NCT00795717|540366210|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
149793111|NCT00795717|540366209|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
149793112|NCT00795717|540366210|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
149793113|NCT00795717|540366209|FG000|Phase II|too busy|0|||
149793114|NCT00795717|540366210|FG001|Phase II|too busy|1|||
149793115|NCT00410514|540366211|FG000|Overall Study|Adverse Event|2|||
149793116|NCT00410514|540366212|FG001|Overall Study|Adverse Event|2|||
149793117|NCT00410514|540366213|FG002|Overall Study|Adverse Event|2|||
149793118|NCT00410514|540366211|FG000|Overall Study|Protocol Violation|0|||
149793119|NCT00410514|540366212|FG001|Overall Study|Protocol Violation|1|||
149793120|NCT00410514|540366213|FG002|Overall Study|Protocol Violation|1|||
149793121|NCT00410514|540366211|FG000|Overall Study|Lost to Follow-up|0|||
149793122|NCT00410514|540366212|FG001|Overall Study|Lost to Follow-up|0|||
149793123|NCT00410514|540366213|FG002|Overall Study|Lost to Follow-up|2|||
149793124|NCT00410514|540366211|FG000|Overall Study|Non-compliant with study procedures|0|||
149793125|NCT00410514|540366212|FG001|Overall Study|Non-compliant with study procedures|0|||
149793126|NCT00410514|540366213|FG002|Overall Study|Non-compliant with study procedures|2|||
149793127|NCT02691468|540366216|FG000|Overall Study|Bronchial blocker use|2|||
149793128|NCT02691468|540366217|FG001|Overall Study|Bronchial blocker use|1|||
149793129|NCT02691468|540366216|FG000|Overall Study|Lost to Follow-up|2|||
149793130|NCT02691468|540366217|FG001|Overall Study|Lost to Follow-up|1|||
149793131|NCT02691468|540366216|FG000|Overall Study|Failure to advance FOB|2|||
149793132|NCT02691468|540366217|FG001|Overall Study|Failure to advance FOB|0|||
149793133|NCT01021423|540366218|FG000|Overall Study|Study terminated|4|||
149793134|NCT01021423|540366219|FG001|Overall Study|Study terminated|5|||
149793135|NCT00394654|540366220|FG000|Overall Study|Lost to Follow-up|1|||
149793136|NCT00394654|540366221|FG001|Overall Study|Lost to Follow-up|0|||
149793137|NCT00394654|540366220|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
149793138|NCT00394654|540366221|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
149793139|NCT00122317|540366222|FG000|Overall Study|Death|3|||
149793140|NCT00122317|540366222|FG000|Overall Study|Adverse Event|4|||
149793141|NCT00122317|540366222|FG000|Overall Study|Physician Decision|2|||
149793142|NCT00122317|540366222|FG000|Overall Study|patient non-compliance|1|||
149793143|NCT00122317|540366222|FG000|Overall Study|Withdrawal by Subject|1|||
149793144|NCT02886338|540366223|FG000|Overall Study|Withdrawal by Subject|1|||
149793145|NCT03756285|540366224|FG000|Overall Study|Lost to Follow-up|0|||
149793146|NCT03756285|540366225|FG001|Overall Study|Lost to Follow-up|1|||
149793147|NCT03756285|540366224|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
149793148|NCT03756285|540366225|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
149793149|NCT03756285|540366224|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
149793150|NCT03756285|540366225|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
149793151|NCT06334055|540366227|FG000|Overall Study|Adverse Event|4|||
149793152|NCT06334055|540366227|FG000|Overall Study|Disqualified|72|||
149793153|NCT04728815|540366230|FG000|Overall Study|Lost to Follow-up|3|||
149793154|NCT04728815|540366231|FG001|Overall Study|Lost to Follow-up|0|||
149793155|NCT04728815|540366232|FG002|Overall Study|Lost to Follow-up|0|||
149793156|NCT04728815|540366233|FG003|Overall Study|Lost to Follow-up|1|||
149793157|NCT04728815|540366234|FG004|Overall Study|Lost to Follow-up|1|||
149793158|NCT04728815|540366235|FG005|Overall Study|Lost to Follow-up|0|||
149793159|NCT04728815|540366236|FG006|Overall Study|Lost to Follow-up|2|||
149793160|NCT04728815|540366237|FG007|Overall Study|Lost to Follow-up|0|||
149793161|NCT04728815|540366230|FG000|Overall Study|Physician Decision|0|||
149793162|NCT04728815|540366231|FG001|Overall Study|Physician Decision|0|||
149793163|NCT04728815|540366232|FG002|Overall Study|Physician Decision|1|||
149793164|NCT04728815|540366233|FG003|Overall Study|Physician Decision|0|||
149793165|NCT04728815|540366234|FG004|Overall Study|Physician Decision|0|||
149793166|NCT04728815|540366235|FG005|Overall Study|Physician Decision|0|||
149793167|NCT04728815|540366236|FG006|Overall Study|Physician Decision|0|||
149793168|NCT04728815|540366237|FG007|Overall Study|Physician Decision|0|||
149793169|NCT04728815|540366230|FG000|Overall Study|Treatment drop|0|||
149793170|NCT04728815|540366231|FG001|Overall Study|Treatment drop|2|||
149793171|NCT04728815|540366232|FG002|Overall Study|Treatment drop|1|||
149793172|NCT04728815|540366233|FG003|Overall Study|Treatment drop|0|||
149793173|NCT04728815|540366234|FG004|Overall Study|Treatment drop|3|||
149793174|NCT04728815|540366235|FG005|Overall Study|Treatment drop|1|||
149793175|NCT04728815|540366236|FG006|Overall Study|Treatment drop|3|||
149793176|NCT04728815|540366237|FG007|Overall Study|Treatment drop|0|||
149793177|NCT04728815|540366230|FG000|Overall Study|Study drop|0|||
149793178|NCT04728815|540366231|FG001|Overall Study|Study drop|3|||
149793179|NCT04728815|540366232|FG002|Overall Study|Study drop|3|||
149793180|NCT04728815|540366233|FG003|Overall Study|Study drop|0|||
149793181|NCT04728815|540366234|FG004|Overall Study|Study drop|0|||
149793182|NCT04728815|540366235|FG005|Overall Study|Study drop|0|||
149793183|NCT04728815|540366236|FG006|Overall Study|Study drop|7|||
149793184|NCT04728815|540366237|FG007|Overall Study|Study drop|0|||
149793185|NCT00957034|540366238|FG000|Overall Study|Adverse Event|0|||
149793186|NCT00957034|540366239|FG001|Overall Study|Adverse Event|1|||
149793187|NCT00957034|540366240|FG002|Overall Study|Adverse Event|1|||
149793188|NCT00957034|540366238|FG000|Overall Study|Sponsor Terminated Study|6|||
149793189|NCT00957034|540366239|FG001|Overall Study|Sponsor Terminated Study|1|||
149793190|NCT00957034|540366240|FG002|Overall Study|Sponsor Terminated Study|5|||
149793191|NCT00957034|540366238|FG000|Overall Study|Withdrawal by Subject|0|||
149793192|NCT00957034|540366239|FG001|Overall Study|Withdrawal by Subject|2|||
149793193|NCT00957034|540366240|FG002|Overall Study|Withdrawal by Subject|0|||
149793194|NCT01041027|540367824|FG000|Overall Study|Withdrawal by Subject|2|||
149793195|NCT01041027|540367824|FG000|Overall Study|Protocol Violation|1|||
149793196|NCT01041027|540367824|FG000|Overall Study|Delayed Radiation Therapy|1|||
149793197|NCT01041027|540367824|FG000|Overall Study|Adverse Event|4|||
149793198|NCT02493712|540367825|FG000|Overall Study|Withdrawal by Subject|1|||
149793199|NCT02493712|540367826|FG001|Overall Study|Withdrawal by Subject|0|||
149793200|NCT02493712|540367827|FG002|Overall Study|Withdrawal by Subject|2|||
149793201|NCT02493712|540367825|FG000|Overall Study|Protocol Violation|0|||
149793202|NCT02493712|540367826|FG001|Overall Study|Protocol Violation|0|||
149793203|NCT02493712|540367827|FG002|Overall Study|Protocol Violation|1|||
149793204|NCT02493712|540367825|FG000|Overall Study|Lost to Follow-up|1|||
149793205|NCT02493712|540367826|FG001|Overall Study|Lost to Follow-up|0|||
149793206|NCT02493712|540367827|FG002|Overall Study|Lost to Follow-up|0|||
149793207|NCT02493712|540367825|FG000|Overall Study|Physician Decision|0|||
149793208|NCT02493712|540367826|FG001|Overall Study|Physician Decision|1|||
149793209|NCT02493712|540367827|FG002|Overall Study|Physician Decision|0|||
149793210|NCT02493712|540367825|FG000|Overall Study|Lack of Efficacy|0|||
149793211|NCT02493712|540367826|FG001|Overall Study|Lack of Efficacy|5|||
149793212|NCT02493712|540367827|FG002|Overall Study|Lack of Efficacy|3|||
149793213|NCT00959192|540367830|FG000|Overall Study|Adverse Event|1|||
149793214|NCT00959192|540367831|FG001|Overall Study|Adverse Event|1|||
149793215|NCT00959192|540367832|FG002|Overall Study|Adverse Event|1|||
149793216|NCT00959192|540367833|FG003|Overall Study|Adverse Event|0|||
149793217|NCT00959192|540367830|FG000|Overall Study|Investigator Request|1|||
149793218|NCT00959192|540367831|FG001|Overall Study|Investigator Request|0|||
149793219|NCT00959192|540367832|FG002|Overall Study|Investigator Request|0|||
149793220|NCT00959192|540367833|FG003|Overall Study|Investigator Request|0|||
149793221|NCT00959192|540367830|FG000|Overall Study|Caregiver Request|0|||
149793222|NCT00959192|540367831|FG001|Overall Study|Caregiver Request|0|||
149793223|NCT00959192|540367832|FG002|Overall Study|Caregiver Request|2|||
149793224|NCT00959192|540367833|FG003|Overall Study|Caregiver Request|1|||
149793225|NCT00532441|540367834|FG000|Overall Study|Death|1|||
149793226|NCT00532441|540367835|FG001|Overall Study|Death|0|||
149793227|NCT01967134|540367836|FG000|Overall Study|Lost to Follow-up|0|||
149793228|NCT01967134|540367837|FG001|Overall Study|Lost to Follow-up|1|||
149793229|NCT01967134|540367838|FG002|Overall Study|Lost to Follow-up|0|||
149793230|NCT00443534|540367839|FG000|Overall Study|Lack of Efficacy|67|||
149793231|NCT00443534|540367839|FG000|Overall Study|Adverse Event|16|||
149793232|NCT00443534|540367839|FG000|Overall Study|Death|9|||
149793233|NCT00443534|540367839|FG000|Overall Study|Withdrawal by Subject|8|||
149793234|NCT00443534|540367839|FG000|Overall Study|Study Terminated by Sponsor|12|||
149793235|NCT00443534|540367839|FG000|Overall Study|Other|10|||
149793236|NCT00443534|540367839|FG000|Overall Study|Enrolled, Not Treated|1|||
149793237|NCT00305773|540367840|FG000|Overall Study|Death|3|||
149793238|NCT00305773|540367841|FG001|Overall Study|Death|2|||
149793239|NCT00305773|540367840|FG000|Overall Study|Adverse Event|1|||
149793240|NCT00305773|540367841|FG001|Overall Study|Adverse Event|2|||
149793241|NCT00305773|540367840|FG000|Overall Study|Alternative Treatment|4|||
149793242|NCT00305773|540367841|FG001|Overall Study|Alternative Treatment|4|||
149793243|NCT00305773|540367840|FG000|Overall Study|Physician Decision|1|||
149793244|NCT00305773|540367841|FG001|Overall Study|Physician Decision|1|||
149793245|NCT00305773|540367840|FG000|Overall Study|Withdrawal by Subject|1|||
149793246|NCT00305773|540367841|FG001|Overall Study|Withdrawal by Subject|4|||
149793247|NCT00305773|540367840|FG000|Overall Study|Disease Progression|1|||
149793248|NCT00305773|540367841|FG001|Overall Study|Disease Progression|3|||
149793249|NCT00305773|540367840|FG000|Overall Study|All other reasons|3|||
149793250|NCT00305773|540367841|FG001|Overall Study|All other reasons|2|||
149793251|NCT00303329|540367842|FG000|Overall Study|Adverse Event|7|||
149793252|NCT00303329|540367843|FG001|Overall Study|Adverse Event|14|||
149793253|NCT00303329|540367842|FG000|Overall Study|Abnormal Laboratory Values|0|||
149793254|NCT00303329|540367843|FG001|Overall Study|Abnormal Laboratory Values|1|||
149793255|NCT00303329|540367842|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
149793256|NCT00303329|540367843|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149793257|NCT00303329|540367842|FG000|Overall Study|Condition no longer requires study drug|0|||
149793258|NCT00303329|540367843|FG001|Overall Study|Condition no longer requires study drug|8|||
149793259|NCT00303329|540367842|FG000|Overall Study|Protocol Violation|3|||
149793260|NCT00303329|540367843|FG001|Overall Study|Protocol Violation|0|||
149793261|NCT00303329|540367842|FG000|Overall Study|Withdrawal by Subject|9|||
149793262|NCT00303329|540367843|FG001|Overall Study|Withdrawal by Subject|15|||
149793263|NCT00303329|540367842|FG000|Overall Study|Lost to Follow-up|0|||
149793264|NCT00303329|540367843|FG001|Overall Study|Lost to Follow-up|1|||
149793265|NCT00303329|540367842|FG000|Overall Study|Administrative problems|1|||
149793266|NCT00303329|540367843|FG001|Overall Study|Administrative problems|0|||
149793267|NCT00303329|540367842|FG000|Overall Study|Death|2|||
149793268|NCT00303329|540367843|FG001|Overall Study|Death|12|||
149793269|NCT00303329|540367842|FG000|Overall Study|Stopped at end of core|3|||
149793270|NCT00303329|540367843|FG001|Overall Study|Stopped at end of core|9|||
149793271|NCT00303329|540367842|FG000|Overall Study|Stopped at end of extension 1|1|||
149793272|NCT00303329|540367843|FG001|Overall Study|Stopped at end of extension 1|0|||
149793273|NCT00413231|540367844|FG000|0 to 30-day Post Treatment|Death|5|||
149793274|NCT00413231|540367844|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
149793275|NCT00413231|540367844|FG000|30-day to 365-day Post Treatment|Death|13|||
149793276|NCT00413231|540367844|FG000|365-day to 60-month Post Treatment|Death|36|||
149793277|NCT00413231|540367844|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
149793278|NCT00413231|540367844|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
149793279|NCT00413231|540367844|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
149793280|NCT00303719|540367849|FG000|Overall Study|Not evaluable, prior therapies|0|||
149793281|NCT00303719|540367850|FG001|Overall Study|Not evaluable, prior therapies|30|||
149793282|NCT00303719|540367849|FG000|Overall Study|Lost to Follow-up|0|||
149793283|NCT00303719|540367850|FG001|Overall Study|Lost to Follow-up|7|||
149793284|NCT01641952|540367851|FG000|Overall Study|Lost to Follow-up|28|||
149793285|NCT01641952|540367851|FG000|Overall Study|Adverse Event|6|||
149793286|NCT02516605|540367855|FG000|Overall Study|Protocol Violation|0|||
149793287|NCT02516605|540367856|FG001|Overall Study|Protocol Violation|0|||
149793288|NCT02516605|540367857|FG002|Overall Study|Protocol Violation|0|||
149793289|NCT02516605|540367858|FG003|Overall Study|Protocol Violation|0|||
149793290|NCT02516605|540367859|FG004|Overall Study|Protocol Violation|1|||
149793291|NCT02516605|540367855|FG000|Overall Study|Withdrawal by Subject|0|||
149793292|NCT02516605|540367856|FG001|Overall Study|Withdrawal by Subject|0|||
149793293|NCT02516605|540367857|FG002|Overall Study|Withdrawal by Subject|0|||
149793294|NCT02516605|540367858|FG003|Overall Study|Withdrawal by Subject|1|||
149793295|NCT02516605|540367859|FG004|Overall Study|Withdrawal by Subject|0|||
149793296|NCT04235959|540367861|FG000|Overall Study|Protocol Violation|0|||
149793297|NCT04235959|540367862|FG001|Overall Study|Protocol Violation|1|||
149793298|NCT04235959|540367863|FG002|Overall Study|Protocol Violation|0|||
149793299|NCT04235959|540367861|FG000|Overall Study|Adverse Event|1|||
149793300|NCT04235959|540367862|FG001|Overall Study|Adverse Event|0|||
149793301|NCT04235959|540367863|FG002|Overall Study|Adverse Event|0|||
149793302|NCT03055806|540367864|FG000|Overall Study|Adverse Event|0|||
149793303|NCT03055806|540367865|FG001|Overall Study|Adverse Event|0|||
149793304|NCT03055806|540367866|FG002|Overall Study|Adverse Event|1|||
149793305|NCT03055806|540367867|FG003|Overall Study|Adverse Event|1|||
149793306|NCT03055806|540367864|FG000|Overall Study|Lost to Follow-up|0|||
149793307|NCT03055806|540367865|FG001|Overall Study|Lost to Follow-up|3|||
149793308|NCT03055806|540367866|FG002|Overall Study|Lost to Follow-up|6|||
149793309|NCT03055806|540367867|FG003|Overall Study|Lost to Follow-up|7|||
149793310|NCT03055806|540367864|FG000|Overall Study|Physician Decision|1|||
149793311|NCT03055806|540367865|FG001|Overall Study|Physician Decision|0|||
149793312|NCT03055806|540367866|FG002|Overall Study|Physician Decision|0|||
149793313|NCT03055806|540367867|FG003|Overall Study|Physician Decision|1|||
149793314|NCT03055806|540367864|FG000|Overall Study|Protocol Violation|1|||
149793315|NCT03055806|540367865|FG001|Overall Study|Protocol Violation|0|||
149793316|NCT03055806|540367866|FG002|Overall Study|Protocol Violation|0|||
149793317|NCT03055806|540367867|FG003|Overall Study|Protocol Violation|0|||
149793318|NCT03055806|540367864|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
149793319|NCT03055806|540367865|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
149793320|NCT03055806|540367866|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
149793321|NCT03055806|540367867|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
149793322|NCT03055806|540367864|FG000|Overall Study|Withdrawal of consent to continue study|2|||
149793323|NCT03055806|540367865|FG001|Overall Study|Withdrawal of consent to continue study|3|||
149793324|NCT03055806|540367866|FG002|Overall Study|Withdrawal of consent to continue study|4|||
149793325|NCT03055806|540367867|FG003|Overall Study|Withdrawal of consent to continue study|6|||
149793326|NCT03055806|540367864|FG000|Overall Study|Partner not willing to try intercourse|1|||
149793327|NCT03055806|540367865|FG001|Overall Study|Partner not willing to try intercourse|0|||
149793328|NCT03055806|540367866|FG002|Overall Study|Partner not willing to try intercourse|0|||
149793329|NCT03055806|540367867|FG003|Overall Study|Partner not willing to try intercourse|0|||
149793330|NCT04601194|540367868|FG000|Overall Study|Lost to Follow-up|7|||
149793331|NCT04905563|540367871|FG000|Overall Study|Withdrawal by Subject|1|||
149793332|NCT04905563|540367872|FG001|Overall Study|Withdrawal by Subject|0|||
149793333|NCT04905563|540367871|FG000|Overall Study|Standard of care orders entered by resident|1|||
149793334|NCT04905563|540367872|FG001|Overall Study|Standard of care orders entered by resident|0|||
149793335|NCT04905563|540367871|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
149793336|NCT04905563|540367872|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
149793337|NCT04905563|540367871|FG000|Overall Study|Withdrawal by Subject|0|||
149793338|NCT04905563|540367872|FG001|Overall Study|Withdrawal by Subject|1|||
149793339|NCT01797302|540367873|FG000|Overall Study|Lost to Follow-up|16|||
149793340|NCT01797302|540367874|FG001|Overall Study|Lost to Follow-up|23|||
149793341|NCT01797302|540367875|FG002|Overall Study|Lost to Follow-up|22|||
149793342|NCT01797302|540367873|FG000|Overall Study|Withdrawal by Subject|1|||
149793343|NCT01797302|540367874|FG001|Overall Study|Withdrawal by Subject|3|||
149793344|NCT01797302|540367875|FG002|Overall Study|Withdrawal by Subject|4|||
149793345|NCT00348686|540367876|FG000|Overall Study|Withdrawal by Subject|45|||
149793346|NCT00348686|540367876|FG000|Overall Study|Adverse Event|5|||
149793347|NCT00348686|540367876|FG000|Overall Study|Protocol Violation|6|||
149793348|NCT00348686|540367876|FG000|Overall Study|Lost to Follow-up|2|||
149793349|NCT00348686|540367876|FG000|Overall Study|Multiple Reasons|8|||
149793350|NCT01258738|540367879|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
149793351|NCT01258738|540367880|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
149793352|NCT01258738|540367879|FG000|Double-blind Period|Withdrawal by Subject|2|||
149793353|NCT01258738|540367880|FG001|Double-blind Period|Withdrawal by Subject|2|||
149793354|NCT01258738|540367879|FG000|Double-blind Period|Protocol Violation|1|||
149793355|NCT01258738|540367880|FG001|Double-blind Period|Protocol Violation|1|||
149793356|NCT01258738|540367879|FG000|Double-blind Period|Adverse Event|3|||
149793357|NCT01258738|540367880|FG001|Double-blind Period|Adverse Event|1|||
149793358|NCT01258738|540367879|FG000|Open-label Period|Did not meet inclusion criteria|0|||
149793359|NCT01258738|540367880|FG001|Open-label Period|Did not meet inclusion criteria|1|||
149793360|NCT01258738|540367879|FG000|Open-label Period|Insufficient clinical response|5|||
149793361|NCT01258738|540367880|FG001|Open-label Period|Insufficient clinical response|3|||
149793362|NCT01258738|540367879|FG000|Open-label Period|Lost to Follow-up|0|||
149793363|NCT01258738|540367880|FG001|Open-label Period|Lost to Follow-up|2|||
149793364|NCT01258738|540367879|FG000|Open-label Period|Withdrawal by Subject|5|||
149793365|NCT01258738|540367880|FG001|Open-label Period|Withdrawal by Subject|6|||
149793366|NCT01258738|540367879|FG000|Open-label Period|Protocol Violation|2|||
149793367|NCT01258738|540367880|FG001|Open-label Period|Protocol Violation|2|||
149793368|NCT01258738|540367879|FG000|Open-label Period|Adverse Event|4|||
149793369|NCT01258738|540367880|FG001|Open-label Period|Adverse Event|5|||
149793370|NCT01258738|540367879|FG000|Open-label Period|Other Reasons|0|||
149793371|NCT01258738|540367880|FG001|Open-label Period|Other Reasons|1|||
149793372|NCT01258738|540367879|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
149793373|NCT01258738|540367880|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
149793374|NCT02418000|540367881|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
149793375|NCT02418000|540367882|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793376|NCT02418000|540367883|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793377|NCT02418000|540367884|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793378|NCT02418000|540367885|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793379|NCT02418000|540367881|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
149793380|NCT02418000|540367882|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149793381|NCT02418000|540367883|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149793382|NCT02418000|540367884|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149793383|NCT02418000|540367885|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149793384|NCT02418000|540367881|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
149793385|NCT02418000|540367882|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149793386|NCT02418000|540367883|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149793387|NCT02418000|540367884|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149793388|NCT02418000|540367885|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149793389|NCT02418000|540367881|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793390|NCT02418000|540367882|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
149793391|NCT02418000|540367883|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793392|NCT02418000|540367884|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793393|NCT02418000|540367885|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149793394|NCT02418000|540367881|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149793395|NCT02418000|540367882|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
149793396|NCT02418000|540367883|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149793397|NCT02418000|540367884|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149793398|NCT02418000|540367885|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149793399|NCT02418000|540367881|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793400|NCT02418000|540367882|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793401|NCT02418000|540367883|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149793402|NCT02418000|540367884|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793403|NCT02418000|540367885|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793404|NCT02418000|540367881|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793405|NCT02418000|540367882|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793406|NCT02418000|540367883|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793407|NCT02418000|540367884|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149793408|NCT02418000|540367885|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793409|NCT02418000|540367881|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149793410|NCT02418000|540367882|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149793411|NCT02418000|540367883|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149793412|NCT02418000|540367884|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149793413|NCT02418000|540367885|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
149793414|NCT02418000|540367881|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793415|NCT02418000|540367882|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793416|NCT02418000|540367883|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793417|NCT02418000|540367884|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149793418|NCT02418000|540367885|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149793419|NCT00689611|540367886|FG000|Overall Study|Death|6|||
149793420|NCT00689611|540367887|FG001|Overall Study|Death|9|||
149793421|NCT00689611|540367886|FG000|Overall Study|Withdrawal by Subject|8|||
149793422|NCT00689611|540367887|FG001|Overall Study|Withdrawal by Subject|9|||
149793423|NCT00689611|540367886|FG000|Overall Study|Lost to Follow-up|27|||
149793424|NCT00689611|540367887|FG001|Overall Study|Lost to Follow-up|28|||
149793425|NCT00405756|540367892|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
149793426|NCT00405756|540367893|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
149793427|NCT00405756|540367894|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
149793428|NCT00405756|540367892|FG000|Double-blind Treatment|Adverse Event|31|||
149793429|NCT00405756|540367893|FG001|Double-blind Treatment|Adverse Event|27|||
149793430|NCT00405756|540367894|FG002|Double-blind Treatment|Adverse Event|12|||
149793431|NCT00405756|540367892|FG000|Double-blind Treatment|Disease Progression|47|||
149793432|NCT00405756|540367893|FG001|Double-blind Treatment|Disease Progression|81|||
149793433|NCT00405756|540367894|FG002|Double-blind Treatment|Disease Progression|102|||
149793434|NCT00405756|540367892|FG000|Double-blind Treatment|Lack of Efficacy|1|||
149793435|NCT00405756|540367893|FG001|Double-blind Treatment|Lack of Efficacy|4|||
149793436|NCT00405756|540367894|FG002|Double-blind Treatment|Lack of Efficacy|2|||
149793437|NCT00405756|540367892|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
149793438|NCT00405756|540367893|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
149793439|NCT00405756|540367894|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
149793440|NCT00405756|540367892|FG000|Double-blind Treatment|Lost to Follow-up|1|||
149793441|NCT00405756|540367893|FG001|Double-blind Treatment|Lost to Follow-up|0|||
149793442|NCT00405756|540367894|FG002|Double-blind Treatment|Lost to Follow-up|0|||
149793443|NCT00405756|540367892|FG000|Double-blind Treatment|Death|4|||
149793444|NCT00405756|540367893|FG001|Double-blind Treatment|Death|4|||
149793445|NCT00405756|540367894|FG002|Double-blind Treatment|Death|4|||
149793446|NCT00405756|540367892|FG000|Double-blind Treatment|Protocol Violation|1|||
149793447|NCT00405756|540367893|FG001|Double-blind Treatment|Protocol Violation|0|||
149793448|NCT00405756|540367894|FG002|Double-blind Treatment|Protocol Violation|2|||
149793449|NCT00405756|540367892|FG000|Double-blind Treatment|Other|7|||
149793450|NCT00405756|540367893|FG001|Double-blind Treatment|Other|4|||
149793451|NCT00405756|540367894|FG002|Double-blind Treatment|Other|4|||
149793452|NCT00405756|540367892|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
149793453|NCT00405756|540367893|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
149793454|NCT00405756|540367894|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
149793455|NCT00405756|540367892|FG000|Open-label Extension|Adverse Event|1|||
149793456|NCT00405756|540367893|FG001|Open-label Extension|Adverse Event|3|||
149793457|NCT00405756|540367894|FG002|Open-label Extension|Adverse Event|7|||
149793458|NCT00405756|540367892|FG000|Open-label Extension|Disease Progression|8|||
149793459|NCT00405756|540367893|FG001|Open-label Extension|Disease Progression|23|||
149793460|NCT00405756|540367894|FG002|Open-label Extension|Disease Progression|26|||
149793461|NCT00405756|540367892|FG000|Open-label Extension|Withdrawal by Subject|2|||
149793462|NCT00405756|540367893|FG001|Open-label Extension|Withdrawal by Subject|3|||
149793463|NCT00405756|540367894|FG002|Open-label Extension|Withdrawal by Subject|3|||
149793464|NCT00405756|540367892|FG000|Open-label Extension|Death|1|||
149793465|NCT00405756|540367893|FG001|Open-label Extension|Death|2|||
149793466|NCT00405756|540367894|FG002|Open-label Extension|Death|4|||
149793467|NCT00405756|540367892|FG000|Open-label Extension|Other|0|||
149793468|NCT00405756|540367893|FG001|Open-label Extension|Other|1|||
149793469|NCT00405756|540367894|FG002|Open-label Extension|Other|7|||
149793470|NCT00405756|540367892|FG000|Follow-up|Ongoing in Follow-up Period|52|||
149793471|NCT00405756|540367893|FG001|Follow-up|Ongoing in Follow-up Period|51|||
149793472|NCT00405756|540367894|FG002|Follow-up|Ongoing in Follow-up Period|60|||
149793473|NCT00405756|540367892|FG000|Follow-up|Death|21|||
149793474|NCT00405756|540367893|FG001|Follow-up|Death|31|||
149793475|NCT00405756|540367894|FG002|Follow-up|Death|24|||
149793476|NCT00405756|540367892|FG000|Follow-up|Lost to Follow-up|2|||
149793477|NCT00405756|540367893|FG001|Follow-up|Lost to Follow-up|8|||
149793478|NCT00405756|540367894|FG002|Follow-up|Lost to Follow-up|4|||
149793479|NCT02870348|540367897|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
149793480|NCT01051856|540367898|FG000|Overall Study|Withdrawal by Subject|1|||
149793481|NCT01051856|540367899|FG001|Overall Study|Withdrawal by Subject|0|||
149793482|NCT00672139|540367900|FG000|Overall Study|Death|14|||
149793483|NCT00672139|540367901|FG001|Overall Study|Death|23|||
149793484|NCT00672139|540367900|FG000|Overall Study|Withdrawal by Subject|2|||
149793485|NCT00672139|540367901|FG001|Overall Study|Withdrawal by Subject|11|||
149793486|NCT00672139|540367900|FG000|Overall Study|Adverse Event|4|||
149793487|NCT00672139|540367901|FG001|Overall Study|Adverse Event|7|||
149793488|NCT00672139|540367900|FG000|Overall Study|Physician Decision|2|||
149793489|NCT00672139|540367901|FG001|Overall Study|Physician Decision|0|||
149793490|NCT00672139|540367900|FG000|Overall Study|Lack of Efficacy|4|||
149793491|NCT00672139|540367901|FG001|Overall Study|Lack of Efficacy|1|||
149793492|NCT00672139|540367900|FG000|Overall Study|Protocol Violation|1|||
149793493|NCT00672139|540367901|FG001|Overall Study|Protocol Violation|1|||
149793494|NCT00672139|540367900|FG000|Overall Study|hospice discharge, caregiver requests|3|||
149793495|NCT00672139|540367901|FG001|Overall Study|hospice discharge, caregiver requests|2|||
149793496|NCT01117428|540367902|FG000|Overall Study|Lack of Efficacy|1|||
149793497|NCT01117428|540367903|FG001|Overall Study|Lack of Efficacy|0|||
149793498|NCT01117428|540367904|FG002|Overall Study|Lack of Efficacy|0|||
149793499|NCT01117428|540367905|FG003|Overall Study|Lack of Efficacy|0|||
149793500|NCT01117428|540367906|FG004|Overall Study|Lack of Efficacy|0|||
149793501|NCT01117428|540367907|FG005|Overall Study|Lack of Efficacy|0|||
149793502|NCT01117428|540367902|FG000|Overall Study|Adverse Event|4|||
149793503|NCT01117428|540367903|FG001|Overall Study|Adverse Event|0|||
149793504|NCT01117428|540367904|FG002|Overall Study|Adverse Event|0|||
149793505|NCT01117428|540367905|FG003|Overall Study|Adverse Event|0|||
149793506|NCT01117428|540367906|FG004|Overall Study|Adverse Event|1|||
149793507|NCT01117428|540367907|FG005|Overall Study|Adverse Event|2|||
149793508|NCT01117428|540367902|FG000|Overall Study|Death|0|||
149793509|NCT01117428|540367903|FG001|Overall Study|Death|1|||
149793510|NCT01117428|540367904|FG002|Overall Study|Death|2|||
149793511|NCT01117428|540367905|FG003|Overall Study|Death|0|||
149793512|NCT01117428|540367906|FG004|Overall Study|Death|0|||
149793513|NCT01117428|540367907|FG005|Overall Study|Death|1|||
149793514|NCT01117428|540367902|FG000|Overall Study|Physician Decision|0|||
149793515|NCT01117428|540367903|FG001|Overall Study|Physician Decision|1|||
149793516|NCT01117428|540367904|FG002|Overall Study|Physician Decision|0|||
149793517|NCT01117428|540367905|FG003|Overall Study|Physician Decision|0|||
149793518|NCT01117428|540367906|FG004|Overall Study|Physician Decision|0|||
149793519|NCT01117428|540367907|FG005|Overall Study|Physician Decision|0|||
149793520|NCT01117428|540367902|FG000|Overall Study|Withdrawal by Subject|0|||
149793521|NCT01117428|540367903|FG001|Overall Study|Withdrawal by Subject|0|||
149793522|NCT01117428|540367904|FG002|Overall Study|Withdrawal by Subject|1|||
149793523|NCT01117428|540367905|FG003|Overall Study|Withdrawal by Subject|0|||
149793524|NCT01117428|540367906|FG004|Overall Study|Withdrawal by Subject|0|||
149793525|NCT01117428|540367907|FG005|Overall Study|Withdrawal by Subject|0|||
149793526|NCT01117428|540367902|FG000|Overall Study|Progressive disease|15|||
149793527|NCT01117428|540367903|FG001|Overall Study|Progressive disease|27|||
149793528|NCT01117428|540367904|FG002|Overall Study|Progressive disease|10|||
149793529|NCT01117428|540367905|FG003|Overall Study|Progressive disease|12|||
149793530|NCT01117428|540367906|FG004|Overall Study|Progressive disease|16|||
149793531|NCT01117428|540367907|FG005|Overall Study|Progressive disease|17|||
149793532|NCT02519777|540367908|FG000|Overall Study|Death|1|||
149793533|NCT02519777|540367909|FG001|Overall Study|Death|0|||
149793534|NCT02519777|540367910|FG002|Overall Study|Death|0|||
149793535|NCT02519777|540367908|FG000|Overall Study|Lost to Follow-up|0|||
149793536|NCT02519777|540367909|FG001|Overall Study|Lost to Follow-up|4|||
149793537|NCT02519777|540367910|FG002|Overall Study|Lost to Follow-up|2|||
149793538|NCT02519777|540367908|FG000|Overall Study|Withdrawal by Subject|3|||
149793539|NCT02519777|540367909|FG001|Overall Study|Withdrawal by Subject|1|||
149793540|NCT02519777|540367910|FG002|Overall Study|Withdrawal by Subject|0|||
149793541|NCT02519777|540367908|FG000|Overall Study|Severe Debilitation|1|||
149793542|NCT02519777|540367909|FG001|Overall Study|Severe Debilitation|1|||
149793543|NCT02519777|540367910|FG002|Overall Study|Severe Debilitation|1|||
149793544|NCT02519777|540367908|FG000|Overall Study|Not able to get to clinic|1|||
149793545|NCT02519777|540367909|FG001|Overall Study|Not able to get to clinic|2|||
149793546|NCT02519777|540367910|FG002|Overall Study|Not able to get to clinic|1|||
149793547|NCT02195531|540367911|FG000|Overall Study|Withdrawal by Subject|1|||
149793548|NCT02195531|540367912|FG001|Overall Study|Withdrawal by Subject|1|||
149793549|NCT02195531|540367913|FG002|Overall Study|Withdrawal by Subject|1|||
149793550|NCT01038635|540367915|FG000|Overall Study|Disease Progression|2|||
149793551|NCT01038635|540367916|FG001|Overall Study|Disease Progression|0|||
149793552|NCT01038635|540367917|FG002|Overall Study|Disease Progression|0|||
149793553|NCT01038635|540367918|FG003|Overall Study|Disease Progression|0|||
149793554|NCT01038635|540367919|FG004|Overall Study|Disease Progression|0|||
149793555|NCT01038635|540367920|FG005|Overall Study|Disease Progression|0|||
149793556|NCT01038635|540367921|FG006|Overall Study|Disease Progression|1|||
149793557|NCT01038635|540367922|FG007|Overall Study|Disease Progression|4|||
149793558|NCT01038635|540367923|FG008|Overall Study|Disease Progression|0|||
149793559|NCT01038635|540367915|FG000|Overall Study|Death|0|||
149793560|NCT01038635|540367916|FG001|Overall Study|Death|0|||
149793561|NCT01038635|540367917|FG002|Overall Study|Death|0|||
149793562|NCT01038635|540367918|FG003|Overall Study|Death|0|||
149793563|NCT01038635|540367919|FG004|Overall Study|Death|1|||
149793564|NCT01038635|540367920|FG005|Overall Study|Death|0|||
149793565|NCT01038635|540367921|FG006|Overall Study|Death|1|||
149793566|NCT01038635|540367922|FG007|Overall Study|Death|1|||
149793567|NCT01038635|540367923|FG008|Overall Study|Death|2|||
149793568|NCT01227252|540367924|FG000|Overall Study|Sponsor Decision|0|||
149793569|NCT01227252|540367925|FG001|Overall Study|Sponsor Decision|1|||
149793570|NCT01227252|540367926|FG002|Overall Study|Sponsor Decision|0|||
149793571|NCT01227252|540367927|FG003|Overall Study|Sponsor Decision|0|||
149793572|NCT01227252|540367924|FG000|Overall Study|Lost to Follow-up|0|||
149793573|NCT01227252|540367925|FG001|Overall Study|Lost to Follow-up|1|||
149793574|NCT01227252|540367926|FG002|Overall Study|Lost to Follow-up|0|||
149793575|NCT01227252|540367927|FG003|Overall Study|Lost to Follow-up|0|||
149793576|NCT01227252|540367924|FG000|Overall Study|Withdrawal by Subject|0|||
149793577|NCT01227252|540367925|FG001|Overall Study|Withdrawal by Subject|1|||
149793578|NCT01227252|540367926|FG002|Overall Study|Withdrawal by Subject|0|||
149793579|NCT01227252|540367927|FG003|Overall Study|Withdrawal by Subject|0|||
149793580|NCT01034709|540367931|FG000|Overall Study|Protocol Violation|9|||
149793581|NCT01034709|540367932|FG001|Overall Study|Protocol Violation|16|||
149793582|NCT01284127|540367933|FG000|Overall Study|Adverse Event|2|||
149793583|NCT01284127|540367933|FG000|Overall Study|Withdrawal by Subject|4|||
149793584|NCT01284127|540367933|FG000|Overall Study|Physician Decision|1|||
149793585|NCT01683058|540367934|FG000|Overall Study|Lost to Follow-up|9|||
149793586|NCT01683058|540367934|FG000|Overall Study|Adverse Event|6|||
149793587|NCT01683058|540367934|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
149793588|NCT01683058|540367934|FG000|Overall Study|Withdrawal by Subject|7|||
149793589|NCT01683058|540367934|FG000|Overall Study|Lack of Efficacy|2|||
149793590|NCT01057394|540367935|FG000|Overall Study|Not eligible|0|||
149793591|NCT01057394|540367936|FG001|Overall Study|Not eligible|2|||
149793592|NCT01195636|540367937|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
149793593|NCT01195636|540367938|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
149793594|NCT01195636|540367937|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
149793595|NCT01195636|540367938|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
149793596|NCT01195636|540367937|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149793597|NCT01195636|540367938|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
149793598|NCT01195636|540367937|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
149793599|NCT01195636|540367938|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
149793600|NCT01195636|540367937|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
149793601|NCT01195636|540367938|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
149793602|NCT01195636|540367937|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
149793603|NCT01195636|540367938|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
149793604|NCT01195636|540367937|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
149793605|NCT01195636|540367938|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
149793606|NCT01195636|540367937|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149793607|NCT01195636|540367938|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
149793608|NCT00660816|540367939|FG000|Overall Study|Adverse Event|1|||
149793609|NCT00660816|540367940|FG001|Overall Study|Adverse Event|2|||
149793610|NCT00660816|540367939|FG000|Overall Study|Withdrawal by Subject|1|||
149793611|NCT00660816|540367940|FG001|Overall Study|Withdrawal by Subject|0|||
149793612|NCT00660816|540367939|FG000|Overall Study|Death|0|||
149793613|NCT00660816|540367940|FG001|Overall Study|Death|2|||
149793614|NCT00660816|540367939|FG000|Overall Study|Lack of Efficacy|1|||
149793615|NCT00660816|540367940|FG001|Overall Study|Lack of Efficacy|0|||
149793616|NCT00660816|540367939|FG000|Overall Study|Physician Decision|0|||
149793617|NCT00660816|540367940|FG001|Overall Study|Physician Decision|2|||
149793618|NCT00660816|540367939|FG000|Overall Study|Protocol Violation|1|||
149793619|NCT00660816|540367940|FG001|Overall Study|Protocol Violation|0|||
149793620|NCT00660816|540367939|FG000|Overall Study|Disease Progression|16|||
149793621|NCT00660816|540367940|FG001|Overall Study|Disease Progression|12|||
149793622|NCT00660816|540367939|FG000|Overall Study|Complicating Disease|0|||
149793623|NCT00660816|540367940|FG001|Overall Study|Complicating Disease|1|||
149793624|NCT01142791|540367953|FG000|Overall Study|Alternative Treatment|1|||
149793625|NCT01142791|540367954|FG001|Overall Study|Alternative Treatment|0|||
149793626|NCT01142791|540367953|FG000|Overall Study|Lost to Follow-up|1|||
149793627|NCT01142791|540367954|FG001|Overall Study|Lost to Follow-up|0|||
149793628|NCT01142791|540367953|FG000|Overall Study|Withdrawal by Subject|5|||
149793629|NCT01142791|540367954|FG001|Overall Study|Withdrawal by Subject|0|||
149793630|NCT01142791|540367953|FG000|Overall Study|Received only 1 sonication|0|||
149793631|NCT01142791|540367954|FG001|Overall Study|Received only 1 sonication|6|||
149793632|NCT00866606|540367958|FG000|Overall Study|Lost to Follow-up|3|||
149793633|NCT00866606|540367958|FG000|Overall Study|Adverse Event|1|||
149793634|NCT00806494|540367959|FG000|Overall Study|Adverse Event|29|||
149793635|NCT00806494|540367959|FG000|Overall Study|Lack of Efficacy|6|||
149793636|NCT00806494|540367959|FG000|Overall Study|Lost to Follow-up|10|||
149793637|NCT00806494|540367959|FG000|Overall Study|Other|30|||
149793638|NCT00806494|540367959|FG000|Overall Study|Withdrawal by Subject|5|||
149793639|NCT01899729|540367960|FG000|Overall Study|Adverse Event|1|||
149793640|NCT01899729|540367961|FG001|Overall Study|Adverse Event|0|||
149793641|NCT01899729|540367962|FG002|Overall Study|Adverse Event|0|||
149793642|NCT01899729|540367963|FG003|Overall Study|Adverse Event|0|||
149793643|NCT01899729|540367964|FG004|Overall Study|Adverse Event|1|||
149793644|NCT01899729|540367960|FG000|Overall Study|Withdrawal by Subject|1|||
149793645|NCT01899729|540367961|FG001|Overall Study|Withdrawal by Subject|2|||
149793646|NCT01899729|540367962|FG002|Overall Study|Withdrawal by Subject|0|||
149793647|NCT01899729|540367963|FG003|Overall Study|Withdrawal by Subject|0|||
149793648|NCT01899729|540367964|FG004|Overall Study|Withdrawal by Subject|0|||
149793649|NCT01899729|540367960|FG000|Overall Study|Lack of Efficacy|0|||
149793650|NCT01899729|540367961|FG001|Overall Study|Lack of Efficacy|0|||
149793651|NCT01899729|540367962|FG002|Overall Study|Lack of Efficacy|2|||
149793652|NCT01899729|540367963|FG003|Overall Study|Lack of Efficacy|0|||
149793653|NCT01899729|540367964|FG004|Overall Study|Lack of Efficacy|1|||
149793654|NCT01454531|540367965|FG000|Overall Study|Adverse Event|14|||
149793655|NCT01454531|540367965|FG000|Overall Study|Withdrawal by Subject|5|||
149793656|NCT01454531|540367965|FG000|Overall Study|Lost to Follow-up|1|||
149793657|NCT01454531|540367965|FG000|Overall Study|Physician Decision|1|||
149793658|NCT01454531|540367965|FG000|Overall Study|Delay in IMP administration|1|||
149793659|NCT01454531|540367965|FG000|Overall Study|Other|1|||
149793660|NCT03458234|540367971|FG000|Overall Study|Withdrawal by Subject|1|||
149793661|NCT05315297|540367975|FG000|Overall Study|Lost to Follow-up|6|||
149793662|NCT05315297|540367976|FG001|Overall Study|Lost to Follow-up|4|||
149793663|NCT05315297|540367975|FG000|Overall Study|Withdrawal by Subject|0|||
149793664|NCT05315297|540367976|FG001|Overall Study|Withdrawal by Subject|1|||
149793665|NCT01084096|540370212|FG000|Overall Study|Lost to Follow-up|1501|||
149793666|NCT01084096|540370213|FG001|Overall Study|Lost to Follow-up|1833|||
149793667|NCT01084096|540370212|FG000|Overall Study|Withdrawal by Subject|3|||
149793668|NCT01084096|540370213|FG001|Overall Study|Withdrawal by Subject|0|||
149793669|NCT01084096|540370212|FG000|Overall Study|Woman had a miscarriage|21|||
149793670|NCT01084096|540370213|FG001|Overall Study|Woman had a miscarriage|17|||
149793671|NCT00027846|540370214|FG000|Overall Study|Lost to Follow-up|0|||
149793672|NCT00027846|540370215|FG001|Overall Study|Lost to Follow-up|41|||
149793673|NCT00027846|540370216|FG002|Overall Study|Lost to Follow-up|9|||
149793674|NCT00027846|540370214|FG000|Overall Study|Withdrawal by Subject|0|||
149793675|NCT00027846|540370215|FG001|Overall Study|Withdrawal by Subject|14|||
149793676|NCT00027846|540370216|FG002|Overall Study|Withdrawal by Subject|7|||
149793677|NCT00027846|540370214|FG000|Overall Study|Ineligible for study|2|||
149793678|NCT00027846|540370215|FG001|Overall Study|Ineligible for study|6|||
149793679|NCT00027846|540370216|FG002|Overall Study|Ineligible for study|14|||
149793680|NCT00027846|540370214|FG000|Overall Study|Entry into another COG therapeutic study|0|||
149793681|NCT00027846|540370215|FG001|Overall Study|Entry into another COG therapeutic study|5|||
149793682|NCT00027846|540370216|FG002|Overall Study|Entry into another COG therapeutic study|2|||
149793683|NCT00027846|540370214|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
149793684|NCT00027846|540370215|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
149793685|NCT00027846|540370216|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
149793686|NCT02033369|540370217|FG000|Overall Study|Physician Decision|1|||
149793687|NCT02033369|540370218|FG001|Overall Study|Physician Decision|2|||
149793688|NCT02033369|540370217|FG000|Overall Study|Not a good demographic match|0|||
149793689|NCT02033369|540370218|FG001|Overall Study|Not a good demographic match|2|||
149793690|NCT02033369|540370217|FG000|Overall Study|Withdrawal by Subject|1|||
149793691|NCT02033369|540370218|FG001|Overall Study|Withdrawal by Subject|1|||
149793692|NCT02033369|540370217|FG000|Overall Study|Lost to Follow-up|1|||
149793693|NCT02033369|540370218|FG001|Overall Study|Lost to Follow-up|0|||
149793694|NCT02033369|540370217|FG000|Overall Study|Protocol Violation|2|||
149793695|NCT02033369|540370218|FG001|Overall Study|Protocol Violation|0|||
149793696|NCT01503229|540370219|FG000|Overall Study|Withdrew consent|1|||
149793697|NCT01354964|540370220|FG000|Overall Study|Lost to Follow-up|2|||
149793698|NCT01354964|540370221|FG001|Overall Study|Lost to Follow-up|0|||
149793699|NCT01354964|540370220|FG000|Overall Study|IV access issues|1|||
149793700|NCT01354964|540370221|FG001|Overall Study|IV access issues|1|||
149793701|NCT01354964|540370220|FG000|Overall Study|Physician Decision|1|||
149793702|NCT01354964|540370221|FG001|Overall Study|Physician Decision|0|||
149793703|NCT00711009|540370222|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
149793704|NCT00711009|540370223|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
149793705|NCT00711009|540370222|FG000|Overall Study|Withdrawal by Subject|4|||
149793706|NCT00711009|540370223|FG001|Overall Study|Withdrawal by Subject|2|||
149793707|NCT00711009|540370222|FG000|Overall Study|Lost to Follow-up|3|||
149793708|NCT00711009|540370223|FG001|Overall Study|Lost to Follow-up|9|||
149793709|NCT00711009|540370222|FG000|Overall Study|Participant Noncompliant|0|||
149793710|NCT00711009|540370223|FG001|Overall Study|Participant Noncompliant|1|||
149793711|NCT00711009|540370222|FG000|Overall Study|Virologic Failure|2|||
149793712|NCT00711009|540370223|FG001|Overall Study|Virologic Failure|1|||
149793713|NCT00711009|540370222|FG000|Overall Study|Pregnancy|1|||
149793714|NCT00711009|540370223|FG001|Overall Study|Pregnancy|0|||
149793715|NCT00711009|540370222|FG000|Overall Study|Site closing|0|||
149793716|NCT00711009|540370223|FG001|Overall Study|Site closing|1|||
149793717|NCT00711009|540370222|FG000|Overall Study|Dose adjustment|1|||
149793718|NCT00711009|540370223|FG001|Overall Study|Dose adjustment|0|||
149793719|NCT04335929|540370225|FG000|Overall Study|Lost to Follow-up|10|||
149793720|NCT02534324|540370231|FG000|Overall Study|Protocol Violation|4|||
149793721|NCT02534324|540370232|FG001|Overall Study|Protocol Violation|1|||
149793722|NCT02534324|540370231|FG000|Overall Study|Lost to Follow-up|20|||
149793723|NCT02534324|540370232|FG001|Overall Study|Lost to Follow-up|7|||
149793724|NCT02534324|540370231|FG000|Overall Study|Adverse Event|1|||
149793725|NCT02534324|540370232|FG001|Overall Study|Adverse Event|0|||
149793726|NCT05604781|540370235|FG000|Overall Study|Lost to Follow-up|3|||
149793727|NCT05604781|540370235|FG000|Overall Study|Adverse Event|1|||
149793728|NCT01459016|540370236|FG000|Overall Study|Withdrawal by Subject|11|||
149793729|NCT01459016|540370236|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
149793730|NCT00303602|540370240|FG000|Overall Study|Adverse Event|2|||
149793731|NCT00303602|540370241|FG001|Overall Study|Adverse Event|2|||
149793732|NCT00303602|540370240|FG000|Overall Study|Withdrawal by Subject|5|||
149793733|NCT00303602|540370241|FG001|Overall Study|Withdrawal by Subject|6|||
149793734|NCT00303602|540370240|FG000|Overall Study|Lost to Follow-up|5|||
149793735|NCT00303602|540370241|FG001|Overall Study|Lost to Follow-up|2|||
149793736|NCT00303602|540370240|FG000|Overall Study|Protocol entry criteria not met|2|||
149793737|NCT00303602|540370241|FG001|Overall Study|Protocol entry criteria not met|2|||
149793738|NCT00303602|540370240|FG000|Overall Study|Physician Decision|2|||
149793739|NCT00303602|540370241|FG001|Overall Study|Physician Decision|1|||
149793740|NCT00303602|540370240|FG000|Overall Study|Noncompliance|2|||
149793741|NCT00303602|540370241|FG001|Overall Study|Noncompliance|2|||
149793742|NCT00303602|540370240|FG000|Overall Study|Protocol Violation|1|||
149793743|NCT00303602|540370241|FG001|Overall Study|Protocol Violation|0|||
149793744|NCT02889861|540370252|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
149793745|NCT02551874|540370259|FG000|Overall Study|Lost to Follow-up|0|||
149793746|NCT02551874|540370260|FG001|Overall Study|Lost to Follow-up|2|||
149793747|NCT02551874|540370259|FG000|Overall Study|Pregnancy|0|||
149793748|NCT02551874|540370260|FG001|Overall Study|Pregnancy|1|||
149793749|NCT02551874|540370259|FG000|Overall Study|Reason not reported|10|||
149793750|NCT02551874|540370260|FG001|Overall Study|Reason not reported|4|||
149793751|NCT02551874|540370259|FG000|Overall Study|Did not receive randomized treatment|0|||
149793752|NCT02551874|540370260|FG001|Overall Study|Did not receive randomized treatment|7|||
149793753|NCT02551874|540370259|FG000|Overall Study|Did not enter long-term study|18|||
149793754|NCT02551874|540370260|FG001|Overall Study|Did not enter long-term study|25|||
149793755|NCT00313716|540370261|FG000|Overall Study|Death|3|||
149793756|NCT00313716|540370262|FG001|Overall Study|Death|2|||
149793757|NCT00313716|540370263|FG002|Overall Study|Death|9|||
149793758|NCT00313716|540370264|FG003|Overall Study|Death|3|||
149793759|NCT00313716|540370265|FG004|Overall Study|Death|5|||
149793760|NCT00313716|540370266|FG005|Overall Study|Death|9|||
149793761|NCT00313716|540370261|FG000|Overall Study|Lost to Follow-up|2|||
149793762|NCT00313716|540370262|FG001|Overall Study|Lost to Follow-up|5|||
149793763|NCT00313716|540370263|FG002|Overall Study|Lost to Follow-up|2|||
149793764|NCT00313716|540370264|FG003|Overall Study|Lost to Follow-up|1|||
149793765|NCT00313716|540370265|FG004|Overall Study|Lost to Follow-up|0|||
149793766|NCT00313716|540370266|FG005|Overall Study|Lost to Follow-up|4|||
149793767|NCT00313716|540370261|FG000|Overall Study|Withdrawal by Subject|0|||
149793768|NCT00313716|540370262|FG001|Overall Study|Withdrawal by Subject|1|||
149793769|NCT00313716|540370263|FG002|Overall Study|Withdrawal by Subject|1|||
149793770|NCT00313716|540370264|FG003|Overall Study|Withdrawal by Subject|0|||
149793771|NCT00313716|540370265|FG004|Overall Study|Withdrawal by Subject|1|||
149793772|NCT00313716|540370266|FG005|Overall Study|Withdrawal by Subject|0|||
149793773|NCT02491463|540370267|FG000|Overall Study|Withdrawal by Subject|1|||
149793774|NCT02491463|540370268|FG001|Overall Study|Withdrawal by Subject|2|||
149793775|NCT02491463|540370269|FG002|Overall Study|Withdrawal by Subject|0|||
149793776|NCT02491463|540370270|FG003|Overall Study|Withdrawal by Subject|0|||
149793777|NCT02491463|540370267|FG000|Overall Study|Migrated/moved from study area|1|||
149793778|NCT02491463|540370268|FG001|Overall Study|Migrated/moved from study area|5|||
149793779|NCT02491463|540370269|FG002|Overall Study|Migrated/moved from study area|1|||
149793780|NCT02491463|540370270|FG003|Overall Study|Migrated/moved from study area|1|||
149793781|NCT02491463|540370267|FG000|Overall Study|Lost to Follow-up|0|||
149793782|NCT02491463|540370268|FG001|Overall Study|Lost to Follow-up|3|||
149793783|NCT02491463|540370269|FG002|Overall Study|Lost to Follow-up|3|||
149793784|NCT02491463|540370270|FG003|Overall Study|Lost to Follow-up|0|||
149793785|NCT01491802|540370271|FG000|Overall Study|Adverse Event|1|||
149793786|NCT01491802|540370272|FG001|Overall Study|Adverse Event|1|||
149793787|NCT01491802|540370271|FG000|Overall Study|Withdrawal by Subject|0|||
149793788|NCT01491802|540370272|FG001|Overall Study|Withdrawal by Subject|1|||
149793789|NCT01864746|540370275|FG000|Overall Study|Disease recurrence|25|||
149793790|NCT01864746|540370276|FG001|Overall Study|Disease recurrence|40|||
149793791|NCT01864746|540370275|FG000|Overall Study|Second primary invasive nonbreast|2|||
149793792|NCT01864746|540370276|FG001|Overall Study|Second primary invasive nonbreast|3|||
149793793|NCT01864746|540370275|FG000|Overall Study|Death|2|||
149793794|NCT01864746|540370276|FG001|Overall Study|Death|1|||
149793795|NCT01864746|540370275|FG000|Overall Study|Adverse Event|33|||
149793796|NCT01864746|540370276|FG001|Overall Study|Adverse Event|5|||
149793797|NCT01864746|540370275|FG000|Overall Study|Withdrawal by Subject|56|||
149793798|NCT01864746|540370276|FG001|Overall Study|Withdrawal by Subject|41|||
149793799|NCT01864746|540370275|FG000|Overall Study|Physician Decision|5|||
149793800|NCT01864746|540370276|FG001|Overall Study|Physician Decision|6|||
149793801|NCT00663208|540370277|FG000|Treatment Period|Lost to Follow-up|0|||
149793802|NCT00663208|540370278|FG001|Treatment Period|Lost to Follow-up|1|||
149793803|NCT00663208|540370279|FG002|Treatment Period|Lost to Follow-up|0|||
149793804|NCT00663208|540370280|FG003|Treatment Period|Lost to Follow-up|0|||
149793805|NCT00663208|540370281|FG004|Treatment Period|Lost to Follow-up|0|||
149793806|NCT00663208|540370282|FG005|Treatment Period|Lost to Follow-up|0|||
149793807|NCT00663208|540370283|FG006|Treatment Period|Lost to Follow-up|0|||
149793808|NCT00663208|540370277|FG000|Follow-up Period|Lost to Follow-up|2|||
149793809|NCT00663208|540370278|FG001|Follow-up Period|Lost to Follow-up|0|||
149793810|NCT00663208|540370279|FG002|Follow-up Period|Lost to Follow-up|3|||
149793811|NCT00663208|540370280|FG003|Follow-up Period|Lost to Follow-up|2|||
149793812|NCT00663208|540370281|FG004|Follow-up Period|Lost to Follow-up|0|||
149793813|NCT00663208|540370282|FG005|Follow-up Period|Lost to Follow-up|0|||
149793814|NCT00663208|540370283|FG006|Follow-up Period|Lost to Follow-up|0|||
149793815|NCT00663208|540370277|FG000|Follow-up Period|Other reason|1|||
149793816|NCT00663208|540370278|FG001|Follow-up Period|Other reason|0|||
149793817|NCT00663208|540370279|FG002|Follow-up Period|Other reason|0|||
149793818|NCT00663208|540370280|FG003|Follow-up Period|Other reason|0|||
149793819|NCT00663208|540370281|FG004|Follow-up Period|Other reason|0|||
149793820|NCT00663208|540370282|FG005|Follow-up Period|Other reason|0|||
149793821|NCT00663208|540370283|FG006|Follow-up Period|Other reason|1|||
149793822|NCT01005966|540370284|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
149793823|NCT01005966|540370285|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
149793824|NCT01005966|540370286|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
149793825|NCT01005966|540370287|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
149793826|NCT01005966|540370288|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
149793827|NCT01005966|540370284|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
149793828|NCT01005966|540370285|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149793829|NCT01005966|540370286|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
149793830|NCT01005966|540370287|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149793831|NCT01005966|540370288|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149793832|NCT01005966|540370284|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149793833|NCT01005966|540370285|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149793834|NCT01005966|540370286|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149793835|NCT01005966|540370287|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
149793836|NCT01005966|540370288|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149793837|NCT01005966|540370284|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
149793838|NCT01005966|540370285|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
149793839|NCT01005966|540370286|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
149793840|NCT01005966|540370287|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
149793841|NCT01005966|540370288|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
149793842|NCT01005966|540370284|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149793843|NCT01005966|540370285|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149793844|NCT01005966|540370286|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149793845|NCT01005966|540370287|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149793846|NCT01005966|540370288|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149793847|NCT01005966|540370284|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149793848|NCT01005966|540370285|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149793849|NCT01005966|540370286|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
149793850|NCT01005966|540370287|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149793851|NCT01005966|540370288|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149793852|NCT01005966|540370284|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
149793853|NCT01005966|540370285|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
149793854|NCT01005966|540370286|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
149793855|NCT01005966|540370287|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
149793856|NCT01005966|540370288|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
149793857|NCT01005966|540370284|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149793858|NCT01005966|540370285|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
149793859|NCT01005966|540370286|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149793860|NCT01005966|540370287|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149793861|NCT01005966|540370288|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149793862|NCT01005966|540370284|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
149793863|NCT01005966|540370285|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
149793864|NCT01005966|540370286|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
149793865|NCT01005966|540370287|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
149793866|NCT01005966|540370288|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
149793867|NCT01451203|540370290|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
149793868|NCT01451203|540370291|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
149793869|NCT01451203|540370290|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
149793870|NCT01451203|540370291|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
149793871|NCT01451203|540370290|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
149793872|NCT01451203|540370291|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
149793873|NCT01451203|540370290|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
149793874|NCT01451203|540370291|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
149793875|NCT01451203|540370290|FG000|Double-blind Treatment Period|Adverse Event|6|||
149793876|NCT01451203|540370291|FG001|Double-blind Treatment Period|Adverse Event|9|||
149793877|NCT01451203|540370290|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
149793878|NCT01451203|540370291|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
149793879|NCT01451203|540370290|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
149793880|NCT01451203|540370291|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
149793881|NCT01451203|540370290|FG000|Double-blind Treatment Period|Investigator decision|2|||
149793882|NCT01451203|540370291|FG001|Double-blind Treatment Period|Investigator decision|0|||
149793883|NCT01451203|540370290|FG000|Post-treatment Period|Consent withdrawn|2|||
149793884|NCT01451203|540370291|FG001|Post-treatment Period|Consent withdrawn|4|||
149793885|NCT01451203|540370290|FG000|Post-treatment Period|Lack of Efficacy|12|||
149793886|NCT01451203|540370291|FG001|Post-treatment Period|Lack of Efficacy|28|||
149793887|NCT01451203|540370290|FG000|Post-treatment Period|Adverse Event|0|||
149793888|NCT01451203|540370291|FG001|Post-treatment Period|Adverse Event|1|||
149793889|NCT01451203|540370290|FG000|Post-treatment Period|Investigator decision|0|||
149793890|NCT01451203|540370291|FG001|Post-treatment Period|Investigator decision|1|||
149793891|NCT00039377|540370292|FG000|Initial Registration|Adverse Event|2|||
149793892|NCT00039377|540370293|FG001|Initial Registration|Adverse Event|0|||
149793893|NCT00039377|540370294|FG002|Initial Registration|Adverse Event|0|||
149793894|NCT00039377|540370295|FG003|Initial Registration|Adverse Event|0|||
149793895|NCT00039377|540370292|FG000|Initial Registration|Relapsed|6|||
149793896|NCT00039377|540370293|FG001|Initial Registration|Relapsed|0|||
149793897|NCT00039377|540370294|FG002|Initial Registration|Relapsed|0|||
149793898|NCT00039377|540370295|FG003|Initial Registration|Relapsed|0|||
149793899|NCT00039377|540370292|FG000|Initial Registration|Received non-protocol therapy|11|||
149793900|NCT00039377|540370293|FG001|Initial Registration|Received non-protocol therapy|0|||
149793901|NCT00039377|540370294|FG002|Initial Registration|Received non-protocol therapy|0|||
149793902|NCT00039377|540370295|FG003|Initial Registration|Received non-protocol therapy|0|||
149793903|NCT00039377|540370292|FG000|Initial Registration|Withdrawal by Subject|3|||
149793904|NCT00039377|540370293|FG001|Initial Registration|Withdrawal by Subject|0|||
149793905|NCT00039377|540370294|FG002|Initial Registration|Withdrawal by Subject|0|||
149793906|NCT00039377|540370295|FG003|Initial Registration|Withdrawal by Subject|0|||
149793907|NCT04067310|540370299|FG000|Overall Study|Physician Decision|2|||
149793908|NCT04067310|540370300|FG001|Overall Study|Physician Decision|6|||
149793909|NCT04067310|540370299|FG000|Overall Study|Lost to Follow-up|0|||
149793910|NCT04067310|540370300|FG001|Overall Study|Lost to Follow-up|1|||
149793911|NCT04067310|540370299|FG000|Overall Study|Withdrawal by Subject|3|||
149793912|NCT04067310|540370300|FG001|Overall Study|Withdrawal by Subject|0|||
149793913|NCT01249404|540370301|FG000|Overall Study|Study treatment not received|0|||
149793914|NCT01249404|540370302|FG001|Overall Study|Study treatment not received|1|||
149793915|NCT01249404|540370303|FG002|Overall Study|Study treatment not received|2|||
149793916|NCT01249404|540370301|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
149793917|NCT01249404|540370302|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
149793918|NCT01249404|540370303|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
149793919|NCT01249404|540370301|FG000|Overall Study|Adverse Event|2|||
149793920|NCT01249404|540370302|FG001|Overall Study|Adverse Event|2|||
149793921|NCT01249404|540370303|FG002|Overall Study|Adverse Event|2|||
149793922|NCT01249404|540370301|FG000|Overall Study|Withdrawal by Subject|2|||
149793923|NCT01249404|540370302|FG001|Overall Study|Withdrawal by Subject|2|||
149793924|NCT01249404|540370303|FG002|Overall Study|Withdrawal by Subject|0|||
149793925|NCT01249404|540370301|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
149793926|NCT01249404|540370302|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
149793927|NCT01249404|540370303|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
149793928|NCT01249404|540370301|FG000|Overall Study|Non compliance to visit schedule|0|||
149793929|NCT01249404|540370302|FG001|Overall Study|Non compliance to visit schedule|1|||
149793930|NCT01249404|540370303|FG002|Overall Study|Non compliance to visit schedule|0|||
149793931|NCT03890731|540370304|FG000|Overall Study|Progressive disease|1|||
149793932|NCT03890731|540370304|FG000|Overall Study|Patient's decision|1|||
149793933|NCT03890731|540370304|FG000|Overall Study|Adverse Event|4|||
149793934|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
149793935|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
149793936|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
149793937|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
149793938|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
149793939|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
149793940|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
149793941|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
149793942|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
149793943|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
149793944|NCT02528643|540370305|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
149793945|NCT02528643|540370306|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
149793946|NCT02528643|540370305|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
149793947|NCT02528643|540370306|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
149793948|NCT02058940|540370307|FG000|Overall Study|Discharged from Critical Care Unit|1|||
149793949|NCT02146274|540370312|FG000|Overall Study|Protocol Violation|73|||
149793950|NCT02039687|540370317|FG000|Overall Study|Adverse Event|0|||
149793951|NCT02039687|540370318|FG001|Overall Study|Adverse Event|0|||
149793952|NCT02039687|540370319|FG002|Overall Study|Adverse Event|1|||
149793953|NCT02039687|540370320|FG003|Overall Study|Adverse Event|0|||
149793954|NCT02039687|540370317|FG000|Overall Study|Withdrawal by Subject|0|||
149793955|NCT02039687|540370318|FG001|Overall Study|Withdrawal by Subject|1|||
149793956|NCT02039687|540370319|FG002|Overall Study|Withdrawal by Subject|0|||
149793957|NCT02039687|540370320|FG003|Overall Study|Withdrawal by Subject|0|||
149793958|NCT02039687|540370317|FG000|Overall Study|treatment assignment could not be confir|0|||
149793959|NCT02039687|540370318|FG001|Overall Study|treatment assignment could not be confir|0|||
149793960|NCT02039687|540370319|FG002|Overall Study|treatment assignment could not be confir|2|||
149793961|NCT02039687|540370320|FG003|Overall Study|treatment assignment could not be confir|0|||
149793962|NCT01640353|540370334|FG000|Overall Study|Withdrew prior to treatment|10|||
149793963|NCT01640353|540370334|FG000|Overall Study|Withdrawn from analysis at term site|12|||
149793964|NCT01640353|540370334|FG000|Overall Study|Withdrawal by Subject|5|||
149793965|NCT01640353|540370334|FG000|Overall Study|Death|2|||
149793966|NCT01640353|540370334|FG000|Overall Study|Early site termination|3|||
149793967|NCT01640353|540370334|FG000|Overall Study|Lost to Follow-up|12|||
149793968|NCT01640353|540370334|FG000|Overall Study|Physician Decision|1|||
149793969|NCT01524900|540370335|FG000|Overall Study|Lost to Follow-up|3|||
149793970|NCT01524900|540370336|FG001|Overall Study|Lost to Follow-up|12|||
149793971|NCT01524900|540370337|FG002|Overall Study|Lost to Follow-up|1|||
149793972|NCT01524900|540370338|FG003|Overall Study|Lost to Follow-up|0|||
149793973|NCT01524900|540370339|FG004|Overall Study|Lost to Follow-up|0|||
149793974|NCT01524900|540370335|FG000|Overall Study|Other reason than stated above|1|||
149793975|NCT01524900|540370336|FG001|Overall Study|Other reason than stated above|1|||
149793976|NCT01524900|540370337|FG002|Overall Study|Other reason than stated above|0|||
149793977|NCT01524900|540370338|FG003|Overall Study|Other reason than stated above|0|||
149793978|NCT01524900|540370339|FG004|Overall Study|Other reason than stated above|0|||
149793979|NCT01524900|540370335|FG000|Overall Study|No reason documented|2|||
149793980|NCT01524900|540370336|FG001|Overall Study|No reason documented|1|||
149793981|NCT01524900|540370337|FG002|Overall Study|No reason documented|0|||
149793982|NCT01524900|540370338|FG003|Overall Study|No reason documented|1|||
149793983|NCT01524900|540370339|FG004|Overall Study|No reason documented|0|||
149793984|NCT03758612|540370340|FG000|Washout Period|Withdrawal by Subject|0|||
149793985|NCT03758612|540370341|FG001|Washout Period|Withdrawal by Subject|0|||
149793986|NCT03758612|540370342|FG002|Washout Period|Withdrawal by Subject|2|||
149793987|NCT03758612|540370343|FG003|Washout Period|Withdrawal by Subject|0|||
149793988|NCT03758612|540370344|FG004|Washout Period|Withdrawal by Subject|0|||
149793989|NCT03758612|540370345|FG005|Washout Period|Withdrawal by Subject|0|||
149793990|NCT03758612|540370346|FG006|Washout Period|Withdrawal by Subject|0|||
149793991|NCT03758612|540370347|FG007|Washout Period|Withdrawal by Subject|0|||
149793992|NCT03758612|540370348|FG008|Washout Period|Withdrawal by Subject|0|||
149793993|NCT03758612|540370349|FG009|Washout Period|Withdrawal by Subject|0|||
149793994|NCT03758612|540370350|FG010|Washout Period|Withdrawal by Subject|0|||
149793995|NCT03758612|540370351|FG011|Washout Period|Withdrawal by Subject|0|||
149793996|NCT03758612|540370340|FG000|Period 2|Protocol Violation|0|||
149793997|NCT03758612|540370341|FG001|Period 2|Protocol Violation|0|||
149793998|NCT03758612|540370342|FG002|Period 2|Protocol Violation|0|||
149793999|NCT03758612|540370343|FG003|Period 2|Protocol Violation|0|||
149794000|NCT03758612|540370344|FG004|Period 2|Protocol Violation|1|||
149794001|NCT03758612|540370345|FG005|Period 2|Protocol Violation|0|||
149794002|NCT03758612|540370346|FG006|Period 2|Protocol Violation|0|||
149794003|NCT03758612|540370347|FG007|Period 2|Protocol Violation|0|||
149794004|NCT03758612|540370348|FG008|Period 2|Protocol Violation|0|||
149794005|NCT03758612|540370349|FG009|Period 2|Protocol Violation|0|||
149794006|NCT03758612|540370350|FG010|Period 2|Protocol Violation|0|||
149794007|NCT03758612|540370351|FG011|Period 2|Protocol Violation|0|||
149794008|NCT04450394|540370354|FG000|Overall Study|Adverse Event|2|||
149794009|NCT04450394|540370355|FG001|Overall Study|Adverse Event|0|||
149794010|NCT04450394|540370356|FG002|Overall Study|Adverse Event|0|||
149794011|NCT04450394|540370354|FG000|Overall Study|Death|0|||
149794012|NCT04450394|540370355|FG001|Overall Study|Death|1|||
149794013|NCT04450394|540370356|FG002|Overall Study|Death|0|||
149794014|NCT04450394|540370354|FG000|Overall Study|Lost to Follow-up|0|||
149794015|NCT04450394|540370355|FG001|Overall Study|Lost to Follow-up|3|||
149794016|NCT04450394|540370356|FG002|Overall Study|Lost to Follow-up|0|||
149794017|NCT04450394|540370354|FG000|Overall Study|Physician Decision|0|||
149794018|NCT04450394|540370355|FG001|Overall Study|Physician Decision|1|||
149794019|NCT04450394|540370356|FG002|Overall Study|Physician Decision|0|||
149794020|NCT04450394|540370354|FG000|Overall Study|Protocol Violation|2|||
149794021|NCT04450394|540370355|FG001|Overall Study|Protocol Violation|0|||
149794022|NCT04450394|540370356|FG002|Overall Study|Protocol Violation|0|||
149794023|NCT04450394|540370354|FG000|Overall Study|Withdrawal by Subject|6|||
149794024|NCT04450394|540370355|FG001|Overall Study|Withdrawal by Subject|9|||
149794025|NCT04450394|540370356|FG002|Overall Study|Withdrawal by Subject|0|||
149794026|NCT03812224|540370366|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
149794027|NCT03812224|540370367|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149794028|NCT03812224|540370366|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
149794029|NCT03812224|540370367|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
149794030|NCT03812224|540370366|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
149794031|NCT03812224|540370367|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
149794032|NCT03812224|540370366|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
149794033|NCT03812224|540370367|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
149794034|NCT03633461|540370385|FG000|Overall Study|Lost to Follow-up|0|||
149794035|NCT03633461|540370386|FG001|Overall Study|Lost to Follow-up|1|||
149794036|NCT02643420|540370390|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
149794037|NCT02643420|540370391|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
149794038|NCT02643420|540370390|FG000|Overall Study|Withdrawal by Subject|25|||
149794039|NCT02643420|540370391|FG001|Overall Study|Withdrawal by Subject|19|||
149794040|NCT02643420|540370390|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
149794041|NCT02643420|540370391|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
149794042|NCT02643420|540370390|FG000|Overall Study|Lost to Follow-up|6|||
149794043|NCT02643420|540370391|FG001|Overall Study|Lost to Follow-up|10|||
149794044|NCT02643420|540370390|FG000|Overall Study|Investigator Decision|2|||
149794045|NCT02643420|540370391|FG001|Overall Study|Investigator Decision|4|||
149794046|NCT02643420|540370390|FG000|Overall Study|Sponsor decision|1|||
149794047|NCT02643420|540370391|FG001|Overall Study|Sponsor decision|1|||
149794048|NCT02643420|540370390|FG000|Overall Study|Death|0|||
149794049|NCT02643420|540370391|FG001|Overall Study|Death|2|||
149794050|NCT02643420|540370390|FG000|Overall Study|Reason not Specified|8|||
149794051|NCT02643420|540370391|FG001|Overall Study|Reason not Specified|7|||
149794052|NCT02127970|540370392|FG000|Overall Study|Adverse Event|2|||
149794053|NCT02127970|540370393|FG001|Overall Study|Adverse Event|1|||
149794054|NCT02127970|540370392|FG000|Overall Study|Death|1|||
149794055|NCT02127970|540370393|FG001|Overall Study|Death|1|||
149794056|NCT02127970|540370392|FG000|Overall Study|Lost to Follow-up|14|||
149794057|NCT02127970|540370393|FG001|Overall Study|Lost to Follow-up|14|||
149794058|NCT02127970|540370392|FG000|Overall Study|Reason not Specified|4|||
149794059|NCT02127970|540370393|FG001|Overall Study|Reason not Specified|7|||
149794060|NCT02127970|540370392|FG000|Overall Study|Pregnancy|0|||
149794061|NCT02127970|540370393|FG001|Overall Study|Pregnancy|1|||
149794062|NCT02127970|540370392|FG000|Overall Study|Subject Withdrew Consent|5|||
149794063|NCT02127970|540370393|FG001|Overall Study|Subject Withdrew Consent|3|||
149794064|NCT01710709|540370394|FG000|Overall Study|Lost to Follow-up|29|||
149794065|NCT01710709|540370394|FG000|Overall Study|Adverse Event|48|||
149794066|NCT01710709|540370394|FG000|Overall Study|Participant met withdrawal criteria|33|||
149794067|NCT01710709|540370394|FG000|Overall Study|Participant withdrawn by investigator|2|||
149794068|NCT01710709|540370394|FG000|Overall Study|Withdrawal by Subject|53|||
149794069|NCT01710709|540370394|FG000|Overall Study|Protocol Violation|5|||
149794070|NCT01710709|540370394|FG000|Overall Study|Lack of Efficacy|3|||
149794071|NCT00542321|540370396|FG000|Overall Study|Death|0|||
149794072|NCT00542321|540370397|FG001|Overall Study|Death|1|||
149794073|NCT02988115|540370404|FG000|Overall Study|Adverse Event|6|||
149794074|NCT02988115|540370405|FG001|Overall Study|Adverse Event|1|||
149794075|NCT02988115|540370404|FG000|Overall Study|Sponsor Decision|5|||
149794076|NCT02988115|540370405|FG001|Overall Study|Sponsor Decision|2|||
149794077|NCT02988115|540370404|FG000|Overall Study|Withdrawal by Subject|1|||
149794078|NCT02988115|540370405|FG001|Overall Study|Withdrawal by Subject|1|||
149794079|NCT02988115|540370404|FG000|Overall Study|Withdrawn by Mistake|1|||
149794080|NCT02988115|540370405|FG001|Overall Study|Withdrawn by Mistake|0|||
149794081|NCT02988115|540370404|FG000|Overall Study|Lost to Follow-up|1|||
149794082|NCT02988115|540370405|FG001|Overall Study|Lost to Follow-up|0|||
149794083|NCT01731951|540370406|FG000|Overall Study|Documented Disease Progression|1|||
149794084|NCT01731951|540370407|FG001|Overall Study|Documented Disease Progression|0|||
149794085|NCT01731951|540370408|FG002|Overall Study|Documented Disease Progression|0|||
149794086|NCT01731951|540370409|FG003|Overall Study|Documented Disease Progression|0|||
149794087|NCT01731951|540370410|FG004|Overall Study|Documented Disease Progression|0|||
149794088|NCT01731951|540370411|FG005|Overall Study|Documented Disease Progression|0|||
149794089|NCT01731951|540370406|FG000|Overall Study|Lost to Follow-up|2|||
149794090|NCT01731951|540370407|FG001|Overall Study|Lost to Follow-up|0|||
149794091|NCT01731951|540370408|FG002|Overall Study|Lost to Follow-up|0|||
149794092|NCT01731951|540370409|FG003|Overall Study|Lost to Follow-up|1|||
149794093|NCT01731951|540370410|FG004|Overall Study|Lost to Follow-up|3|||
149794094|NCT01731951|540370411|FG005|Overall Study|Lost to Follow-up|1|||
149794095|NCT01731951|540370406|FG000|Overall Study|Withdrawal of Consent|1|||
149794096|NCT01731951|540370407|FG001|Overall Study|Withdrawal of Consent|0|||
149794097|NCT01731951|540370408|FG002|Overall Study|Withdrawal of Consent|0|||
149794098|NCT01731951|540370409|FG003|Overall Study|Withdrawal of Consent|0|||
149794099|NCT01731951|540370410|FG004|Overall Study|Withdrawal of Consent|0|||
149794100|NCT01731951|540370411|FG005|Overall Study|Withdrawal of Consent|2|||
149794101|NCT01731951|540370406|FG000|Overall Study|Death|13|||
149794102|NCT01731951|540370407|FG001|Overall Study|Death|15|||
149794103|NCT01731951|540370408|FG002|Overall Study|Death|9|||
149794104|NCT01731951|540370409|FG003|Overall Study|Death|8|||
149794105|NCT01731951|540370410|FG004|Overall Study|Death|9|||
149794106|NCT01731951|540370411|FG005|Overall Study|Death|6|||
149794107|NCT00253747|540370412|FG000|Overall Study|Lost to Follow-up|13|||
149794108|NCT00253747|540370413|FG001|Overall Study|Lost to Follow-up|14|||
149794109|NCT00253747|540370412|FG000|Overall Study|Withdrawal by Subject|10|||
149794110|NCT00253747|540370413|FG001|Overall Study|Withdrawal by Subject|11|||
149794111|NCT00253747|540370412|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
149794112|NCT00253747|540370413|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
149794113|NCT00104299|540370414|FG000|Overall Study|Adverse Event|3|||
149794114|NCT00104299|540370415|FG001|Overall Study|Adverse Event|1|||
149794115|NCT00104299|540370414|FG000|Overall Study|Death|2|||
149794116|NCT00104299|540370415|FG001|Overall Study|Death|2|||
149794117|NCT00104299|540370414|FG000|Overall Study|Withdrawal by Subject|2|||
149794118|NCT00104299|540370415|FG001|Overall Study|Withdrawal by Subject|6|||
149794119|NCT00104299|540370414|FG000|Overall Study|Physician Decision|1|||
149794120|NCT00104299|540370415|FG001|Overall Study|Physician Decision|1|||
149794121|NCT00104299|540370414|FG000|Overall Study|To have renal transplant|1|||
149794122|NCT00104299|540370415|FG001|Overall Study|To have renal transplant|0|||
149794123|NCT02452034|540370416|FG000|Overall Study|Adverse Event|0|||
149794124|NCT02452034|540370417|FG001|Overall Study|Adverse Event|0|||
149794125|NCT02452034|540370418|FG002|Overall Study|Adverse Event|0|||
149794126|NCT02452034|540370419|FG003|Overall Study|Adverse Event|0|||
149794127|NCT02452034|540370420|FG004|Overall Study|Adverse Event|0|||
149794128|NCT02452034|540370421|FG005|Overall Study|Adverse Event|1|||
149794129|NCT02452034|540370416|FG000|Overall Study|Death|0|||
149794130|NCT02452034|540370417|FG001|Overall Study|Death|0|||
149794131|NCT02452034|540370418|FG002|Overall Study|Death|0|||
149794132|NCT02452034|540370419|FG003|Overall Study|Death|0|||
149794133|NCT02452034|540370420|FG004|Overall Study|Death|1|||
149794134|NCT02452034|540370421|FG005|Overall Study|Death|1|||
149794135|NCT02452034|540370416|FG000|Overall Study|Physician Decision|0|||
149794136|NCT02452034|540370417|FG001|Overall Study|Physician Decision|1|||
149794137|NCT02452034|540370418|FG002|Overall Study|Physician Decision|1|||
149794138|NCT02452034|540370419|FG003|Overall Study|Physician Decision|0|||
149794139|NCT02452034|540370420|FG004|Overall Study|Physician Decision|0|||
149794140|NCT02452034|540370421|FG005|Overall Study|Physician Decision|0|||
149794141|NCT02452034|540370416|FG000|Overall Study|Protocol Violation|0|||
149794142|NCT02452034|540370417|FG001|Overall Study|Protocol Violation|0|||
149794143|NCT02452034|540370418|FG002|Overall Study|Protocol Violation|0|||
149794144|NCT02452034|540370419|FG003|Overall Study|Protocol Violation|0|||
149794145|NCT02452034|540370420|FG004|Overall Study|Protocol Violation|0|||
149794146|NCT02452034|540370421|FG005|Overall Study|Protocol Violation|1|||
149794147|NCT02452034|540370416|FG000|Overall Study|Screen Failure|1|||
149794148|NCT02452034|540370417|FG001|Overall Study|Screen Failure|0|||
149794149|NCT02452034|540370418|FG002|Overall Study|Screen Failure|0|||
149794150|NCT02452034|540370419|FG003|Overall Study|Screen Failure|1|||
149794151|NCT02452034|540370420|FG004|Overall Study|Screen Failure|0|||
149794152|NCT02452034|540370421|FG005|Overall Study|Screen Failure|0|||
149794153|NCT02452034|540370416|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
149794154|NCT02452034|540370417|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
149794155|NCT02452034|540370418|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
149794156|NCT02452034|540370419|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
149794157|NCT02452034|540370420|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
149794158|NCT02452034|540370421|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
149794159|NCT01716585|540370422|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
149794160|NCT01716585|540370423|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
149794161|NCT01716585|540370422|FG000|Double-blind Treatment|Adverse Event|2|||
149794162|NCT01716585|540370423|FG001|Double-blind Treatment|Adverse Event|1|||
149794163|NCT01716585|540370422|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
149794164|NCT01716585|540370423|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
149794165|NCT01716585|540370422|FG000|Double-blind Treatment|Lost to Follow-up|2|||
149794166|NCT01716585|540370423|FG001|Double-blind Treatment|Lost to Follow-up|0|||
149794167|NCT01716585|540370422|FG000|Double-blind Treatment|Subject Noncompliant|1|||
149794168|NCT01716585|540370423|FG001|Double-blind Treatment|Subject Noncompliant|0|||
149794169|NCT01716585|540370422|FG000|Double-blind Treatment|Other|1|||
149794170|NCT01716585|540370423|FG001|Double-blind Treatment|Other|0|||
149794171|NCT01716585|540370422|FG000|Open-label Treatment|Adverse Event|0|||
149794172|NCT01716585|540370423|FG001|Open-label Treatment|Adverse Event|2|||
149794173|NCT01716585|540370422|FG000|Open-label Treatment|Virologic Failure|0|||
149794174|NCT01716585|540370423|FG001|Open-label Treatment|Virologic Failure|2|||
149794175|NCT01716585|540370422|FG000|Open-label Treatment|Withdrawal by Subject|0|||
149794176|NCT01716585|540370423|FG001|Open-label Treatment|Withdrawal by Subject|3|||
149794177|NCT05102734|540370425|FG000|Overall Study|Did not require vasopressors|1|||
149794178|NCT05102734|540370426|FG001|Overall Study|Did not require vasopressors|0|||
149794179|NCT05102734|540370425|FG000|Overall Study|Did not have functioning PA catheter|1|||
149794180|NCT05102734|540370426|FG001|Overall Study|Did not have functioning PA catheter|0|||
149794181|NCT05102734|540370425|FG000|Overall Study|Inadequate video quality|2|||
149794182|NCT05102734|540370426|FG001|Overall Study|Inadequate video quality|0|||
149794183|NCT03288987|540370427|FG000|Overall Study|Protocol Violation|10|||
149794184|NCT03288987|540370428|FG001|Overall Study|Protocol Violation|4|||
149794185|NCT02630459|540370434|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794186|NCT02630459|540370435|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
149794187|NCT02630459|540370436|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794188|NCT02630459|540370437|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
149794189|NCT02630459|540370438|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794190|NCT02630459|540370439|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794191|NCT02630459|540370440|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794192|NCT02630459|540370441|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149794193|NCT02630459|540370434|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794194|NCT02630459|540370435|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794195|NCT02630459|540370436|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
149794196|NCT02630459|540370437|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794197|NCT02630459|540370438|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794198|NCT02630459|540370439|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794199|NCT02630459|540370440|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794200|NCT02630459|540370441|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149794201|NCT02630459|540370434|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
149794202|NCT02630459|540370435|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
149794203|NCT02630459|540370436|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
149794204|NCT02630459|540370437|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
149794205|NCT02630459|540370438|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149794206|NCT02630459|540370439|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149794207|NCT02630459|540370440|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149794208|NCT02630459|540370441|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149794209|NCT02630459|540370434|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
149794210|NCT02630459|540370435|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794211|NCT02630459|540370436|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794212|NCT02630459|540370437|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794213|NCT02630459|540370438|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794214|NCT02630459|540370439|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794215|NCT02630459|540370440|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794216|NCT02630459|540370441|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149794217|NCT02630459|540370434|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794218|NCT02630459|540370435|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794219|NCT02630459|540370436|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794220|NCT02630459|540370437|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794221|NCT02630459|540370438|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
149794222|NCT02630459|540370439|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
149794223|NCT02630459|540370440|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794224|NCT02630459|540370441|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149794225|NCT02630459|540370434|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794226|NCT02630459|540370435|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794227|NCT02630459|540370436|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794228|NCT02630459|540370437|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794229|NCT02630459|540370438|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
149794230|NCT02630459|540370439|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
149794231|NCT02630459|540370440|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794232|NCT02630459|540370441|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149794233|NCT02630459|540370434|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794234|NCT02630459|540370435|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794235|NCT02630459|540370436|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794236|NCT02630459|540370437|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794237|NCT02630459|540370438|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
149794238|NCT02630459|540370439|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794239|NCT02630459|540370440|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794240|NCT02630459|540370441|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149794241|NCT00125138|540370442|FG000|Overall Study|Adverse Event|1|||
149794242|NCT00125138|540370443|FG001|Overall Study|Adverse Event|0|||
149794243|NCT00125138|540370444|FG002|Overall Study|Adverse Event|3|||
149794244|NCT00125138|540370445|FG003|Overall Study|Adverse Event|2|||
149794245|NCT00125138|540370442|FG000|Overall Study|Withdrawal by Subject|2|||
149794246|NCT00125138|540370443|FG001|Overall Study|Withdrawal by Subject|3|||
149794247|NCT00125138|540370444|FG002|Overall Study|Withdrawal by Subject|1|||
149794248|NCT00125138|540370445|FG003|Overall Study|Withdrawal by Subject|1|||
149794249|NCT00125138|540370442|FG000|Overall Study|Lack of Efficacy|0|||
149794250|NCT00125138|540370443|FG001|Overall Study|Lack of Efficacy|0|||
149794251|NCT00125138|540370444|FG002|Overall Study|Lack of Efficacy|0|||
149794252|NCT00125138|540370445|FG003|Overall Study|Lack of Efficacy|1|||
149794253|NCT00125138|540370442|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
149794254|NCT00125138|540370443|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
149794255|NCT00125138|540370444|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
149794256|NCT00125138|540370445|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
149794257|NCT01603615|540372808|FG000|Overall Study|Did not Receive Treatment|7|||
149794258|NCT01603615|540372808|FG000|Overall Study|Lost to Follow-up|9|||
149794259|NCT01603615|540372808|FG000|Overall Study|Personal Reasons|17|||
149794260|NCT01603615|540372808|FG000|Overall Study|Other Miscellaneous|1|||
149794261|NCT03419741|540372809|FG000|Overall Study|Adverse Event|1|||
149794262|NCT03419741|540372810|FG001|Overall Study|Adverse Event|0|||
149794263|NCT03419741|540372809|FG000|Overall Study|Withdrawal by Subject|1|||
149794264|NCT03419741|540372810|FG001|Overall Study|Withdrawal by Subject|2|||
149794265|NCT04354870|540372811|FG000|Overall Study|Lost to Follow-up|32|||
149794266|NCT04354870|540372812|FG001|Overall Study|Lost to Follow-up|12|||
149794267|NCT04354870|540372811|FG000|Overall Study|Withdrawal by Subject|10|||
149794268|NCT04354870|540372812|FG001|Overall Study|Withdrawal by Subject|16|||
149794269|NCT04354870|540372811|FG000|Overall Study|Did not complete all study visits|6|||
149794270|NCT04354870|540372812|FG001|Overall Study|Did not complete all study visits|5|||
149794271|NCT03384316|540372813|FG000|Overall Study|Screen failure|0|||
149794272|NCT03384316|540372814|FG001|Overall Study|Screen failure|1|||
149794273|NCT01539720|540372818|FG000|Overall Study|Screen Fail|15|||
149794274|NCT01539720|540372819|FG001|Overall Study|Screen Fail|3|||
149794275|NCT01539720|540372818|FG000|Overall Study|Lost to Follow-up|14|||
149794276|NCT01539720|540372819|FG001|Overall Study|Lost to Follow-up|7|||
149794277|NCT00298766|540372820|FG000|Overall Study|Adverse Event|18|||
149794278|NCT00298766|540372820|FG000|Overall Study|Death|2|||
149794279|NCT00298766|540372820|FG000|Overall Study|Withdrawal by Subject|9|||
149794280|NCT00298766|540372820|FG000|Overall Study|Treatment ongoing|4|||
149794281|NCT00298766|540372820|FG000|Overall Study|Progression of amyloid markers|4|||
149794282|NCT00298766|540372820|FG000|Overall Study|Deterioration in KPS and organ function|1|||
149794283|NCT00298766|540372820|FG000|Overall Study|Subjects overall condition deterioration|4|||
149794284|NCT00298766|540372820|FG000|Overall Study|Other|4|||
149794285|NCT02500901|540372825|FG000|Overall Study|Disease ProgressionDD|2|||
149794286|NCT00656136|540372826|FG000|Overall Study|Progressive disease|177|||
149794287|NCT00656136|540372827|FG001|Overall Study|Progressive disease|322|||
149794288|NCT00656136|540372826|FG000|Overall Study|Other Adverse Event|5|||
149794289|NCT00656136|540372827|FG001|Overall Study|Other Adverse Event|51|||
149794290|NCT00656136|540372826|FG000|Overall Study|Protocol Violation|2|||
149794291|NCT00656136|540372827|FG001|Overall Study|Protocol Violation|3|||
149794292|NCT00656136|540372826|FG000|Overall Study|Patient refused to take study medication|7|||
149794293|NCT00656136|540372827|FG001|Overall Study|Patient refused to take study medication|10|||
149794294|NCT00656136|540372826|FG000|Overall Study|Unknown and others|4|||
149794295|NCT00656136|540372827|FG001|Overall Study|Unknown and others|4|||
149794296|NCT03938857|540372829|FG000|Overall Study|Physician Decision|1|||
149794297|NCT03938857|540372830|FG001|Overall Study|Physician Decision|0|||
149794298|NCT03938857|540372831|FG002|Overall Study|Physician Decision|0|||
149794299|NCT03938857|540372832|FG003|Overall Study|Physician Decision|0|||
149794300|NCT01398176|540372833|FG000|Overall Study|Lost to Follow-up|1|||
149794301|NCT01398176|540372834|FG001|Overall Study|Lost to Follow-up|3|||
149794302|NCT01398176|540372833|FG000|Overall Study|Physician Decision|2|||
149794303|NCT01398176|540372834|FG001|Overall Study|Physician Decision|3|||
149794304|NCT01871870|540372835|FG000|Overall Study|Hardware issues|7|||
149794305|NCT01871870|540372835|FG000|Overall Study|hyperglycemia|2|||
149794306|NCT00490815|540372836|FG000|Overall Study|Adverse Event|2|||
149794307|NCT00490815|540372837|FG001|Overall Study|Adverse Event|3|||
149794308|NCT00490815|540372836|FG000|Overall Study|Withdrawal by Subject|4|||
149794309|NCT00490815|540372837|FG001|Overall Study|Withdrawal by Subject|0|||
149794310|NCT00490815|540372836|FG000|Overall Study|Lost to Follow-up|1|||
149794311|NCT00490815|540372837|FG001|Overall Study|Lost to Follow-up|3|||
149794312|NCT00490815|540372836|FG000|Overall Study|Death|1|||
149794313|NCT00490815|540372837|FG001|Overall Study|Death|3|||
149794314|NCT01904760|540372839|FG000|Overall Study|Protocol Violation|1|||
149794315|NCT01904760|540372840|FG001|Overall Study|Protocol Violation|0|||
149794316|NCT00783263|540372841|FG000|Overall Study|Adverse Event|3|||
149794317|NCT00783263|540372842|FG001|Overall Study|Adverse Event|0|||
149794318|NCT00783263|540372843|FG002|Overall Study|Adverse Event|2|||
149794319|NCT00783263|540372844|FG003|Overall Study|Adverse Event|1|||
149794320|NCT00783263|540372841|FG000|Overall Study|Lost to Follow-up|1|||
149794321|NCT00783263|540372842|FG001|Overall Study|Lost to Follow-up|1|||
149794322|NCT00783263|540372843|FG002|Overall Study|Lost to Follow-up|0|||
149794323|NCT00783263|540372844|FG003|Overall Study|Lost to Follow-up|0|||
149794324|NCT00783263|540372841|FG000|Overall Study|Withdrawal by Subject|0|||
149794325|NCT00783263|540372842|FG001|Overall Study|Withdrawal by Subject|1|||
149794326|NCT00783263|540372843|FG002|Overall Study|Withdrawal by Subject|1|||
149794327|NCT00783263|540372844|FG003|Overall Study|Withdrawal by Subject|2|||
149794328|NCT00106626|540372845|FG000|Overall Study|Adverse Event|5|||
149794329|NCT00106626|540372846|FG001|Overall Study|Adverse Event|4|||
149794330|NCT00106626|540372847|FG002|Overall Study|Adverse Event|3|||
149794331|NCT00106626|540372848|FG003|Overall Study|Adverse Event|3|||
149794332|NCT00106626|540372845|FG000|Overall Study|Progressive Disease|4|||
149794333|NCT00106626|540372846|FG001|Overall Study|Progressive Disease|1|||
149794334|NCT00106626|540372847|FG002|Overall Study|Progressive Disease|9|||
149794335|NCT00106626|540372848|FG003|Overall Study|Progressive Disease|10|||
149794336|NCT00106626|540372845|FG000|Overall Study|Received radiation on new therapy|1|||
149794337|NCT00106626|540372846|FG001|Overall Study|Received radiation on new therapy|0|||
149794338|NCT00106626|540372847|FG002|Overall Study|Received radiation on new therapy|0|||
149794339|NCT00106626|540372848|FG003|Overall Study|Received radiation on new therapy|0|||
149794340|NCT00106626|540372845|FG000|Overall Study|> 14 day delay in therapy start|0|||
149794341|NCT00106626|540372846|FG001|Overall Study|> 14 day delay in therapy start|1|||
149794342|NCT00106626|540372847|FG002|Overall Study|> 14 day delay in therapy start|0|||
149794343|NCT00106626|540372848|FG003|Overall Study|> 14 day delay in therapy start|0|||
149794344|NCT03018028|540372866|FG000|Overall Study|Withdrawal by Subject|3|||
149794345|NCT03018028|540372867|FG001|Overall Study|Withdrawal by Subject|0|||
149794346|NCT03018028|540372868|FG002|Overall Study|Withdrawal by Subject|1|||
149794347|NCT03018028|540372869|FG003|Overall Study|Withdrawal by Subject|2|||
149794348|NCT03018028|540372870|FG004|Overall Study|Withdrawal by Subject|0|||
149794349|NCT04062240|540372883|FG000|Overall Study|equipment malfunction|1|||
149794350|NCT01957111|540372884|FG000|Overall Study|Withdrawal by Subject|1|||
149794351|NCT01957111|540372885|FG001|Overall Study|Withdrawal by Subject|1|||
149794352|NCT03961529|540372886|FG000|Overall Study|Adverse Event|13|||
149794353|NCT03961529|540372887|FG001|Overall Study|Adverse Event|5|||
149794354|NCT03961529|540372888|FG002|Overall Study|Adverse Event|2|||
149794355|NCT03961529|540372886|FG000|Overall Study|Withdrawal by Subject|17|||
149794356|NCT03961529|540372887|FG001|Overall Study|Withdrawal by Subject|2|||
149794357|NCT03961529|540372888|FG002|Overall Study|Withdrawal by Subject|1|||
149794358|NCT03961529|540372886|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149794359|NCT03961529|540372887|FG001|Overall Study|Withdrawal by parent/guardian|7|||
149794360|NCT03961529|540372888|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149794361|NCT03961529|540372886|FG000|Overall Study|Physician Decision|2|||
149794362|NCT03961529|540372887|FG001|Overall Study|Physician Decision|1|||
149794363|NCT03961529|540372888|FG002|Overall Study|Physician Decision|1|||
149794364|NCT03961529|540372886|FG000|Overall Study|Lost to Follow-up|2|||
149794365|NCT03961529|540372887|FG001|Overall Study|Lost to Follow-up|1|||
149794366|NCT03961529|540372888|FG002|Overall Study|Lost to Follow-up|0|||
149794367|NCT03961529|540372886|FG000|Overall Study|Lack of Efficacy|2|||
149794368|NCT03961529|540372887|FG001|Overall Study|Lack of Efficacy|0|||
149794369|NCT03961529|540372888|FG002|Overall Study|Lack of Efficacy|1|||
149794370|NCT03961529|540372886|FG000|Overall Study|Other|6|||
149794371|NCT03961529|540372887|FG001|Overall Study|Other|1|||
149794372|NCT03961529|540372888|FG002|Overall Study|Other|0|||
149794373|NCT03644173|540372889|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
149794374|NCT03644173|540372889|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
149794375|NCT03644173|540372889|FG000|Participants at the 1-month Follow up|Death|2|||
149794376|NCT03644173|540372889|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
149794377|NCT03500419|540372894|FG000|Overall Study|Withdrawal by Subject|2|||
149794378|NCT03500419|540372895|FG001|Overall Study|Withdrawal by Subject|25|||
149794379|NCT00082628|540372900|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149794380|NCT00082628|540372901|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
149794381|NCT00082628|540372902|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149794382|NCT00082628|540372903|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149794383|NCT00082628|540372904|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149794384|NCT00082628|540372900|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
149794385|NCT00082628|540372901|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
149794386|NCT00082628|540372902|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149794387|NCT00082628|540372903|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149794388|NCT00082628|540372904|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149794389|NCT00082628|540372900|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
149794390|NCT00082628|540372901|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
149794391|NCT00082628|540372902|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149794392|NCT00082628|540372903|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149794393|NCT00082628|540372904|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149794394|NCT00082628|540372900|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
149794395|NCT00082628|540372901|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
149794396|NCT00082628|540372902|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149794397|NCT00082628|540372903|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149794398|NCT00082628|540372904|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149794399|NCT00082628|540372900|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149794400|NCT00082628|540372901|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149794401|NCT00082628|540372902|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149794402|NCT00082628|540372903|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149794403|NCT00082628|540372904|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
149794404|NCT00082628|540372900|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149794405|NCT00082628|540372901|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149794406|NCT00082628|540372902|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149794407|NCT00082628|540372903|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
149794408|NCT00082628|540372904|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149794409|NCT00082628|540372900|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
149794410|NCT00082628|540372901|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
149794411|NCT00082628|540372902|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
149794412|NCT00082628|540372903|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
149794413|NCT00082628|540372904|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
149794414|NCT03490734|540372918|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
149794415|NCT03490734|540372919|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
149794416|NCT03490734|540372920|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
149794417|NCT03490734|540372921|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
149794418|NCT03490734|540372918|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149794419|NCT03490734|540372919|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149794420|NCT03490734|540372920|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149794421|NCT03490734|540372921|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
149794422|NCT03490734|540372918|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149794423|NCT03490734|540372919|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149794424|NCT03490734|540372920|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149794425|NCT03490734|540372921|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
149794426|NCT03490734|540372918|FG000|Post-intervention Scan Visit|Adverse Event|2|||
149794427|NCT03490734|540372919|FG001|Post-intervention Scan Visit|Adverse Event|0|||
149794428|NCT03490734|540372920|FG002|Post-intervention Scan Visit|Adverse Event|0|||
149794429|NCT03490734|540372921|FG003|Post-intervention Scan Visit|Adverse Event|0|||
149794430|NCT03490734|540372918|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
149794431|NCT03490734|540372919|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
149794432|NCT03490734|540372920|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
149794433|NCT03490734|540372921|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
149794434|NCT03490734|540372918|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
149794435|NCT03490734|540372919|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
149794436|NCT03490734|540372920|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
149794437|NCT03490734|540372921|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
149794438|NCT00994890|540372925|FG000|Overall Study|Adverse Event|13|||
149794439|NCT00994890|540372926|FG001|Overall Study|Adverse Event|9|||
149794440|NCT00994890|540372927|FG002|Overall Study|Adverse Event|11|||
149794441|NCT00994890|540372925|FG000|Overall Study|Lack of Efficacy|0|||
149794442|NCT00994890|540372926|FG001|Overall Study|Lack of Efficacy|0|||
149794443|NCT00994890|540372927|FG002|Overall Study|Lack of Efficacy|1|||
149794444|NCT00994890|540372925|FG000|Overall Study|Lost to Follow-up|6|||
149794445|NCT00994890|540372926|FG001|Overall Study|Lost to Follow-up|1|||
149794446|NCT00994890|540372927|FG002|Overall Study|Lost to Follow-up|3|||
149794447|NCT00994890|540372925|FG000|Overall Study|No longer willing to participate|8|||
149794448|NCT00994890|540372926|FG001|Overall Study|No longer willing to participate|5|||
149794449|NCT00994890|540372927|FG002|Overall Study|No longer willing to participate|13|||
149794450|NCT00994890|540372925|FG000|Overall Study|Protocol Violation|2|||
149794451|NCT00994890|540372926|FG001|Overall Study|Protocol Violation|4|||
149794452|NCT00994890|540372927|FG002|Overall Study|Protocol Violation|0|||
149794453|NCT00994890|540372925|FG000|Overall Study|Study terminated by sponsor|199|||
149794454|NCT00994890|540372926|FG001|Overall Study|Study terminated by sponsor|201|||
149794455|NCT00994890|540372927|FG002|Overall Study|Study terminated by sponsor|197|||
149794456|NCT00994890|540372925|FG000|Overall Study|Randomized, but not treated|1|||
149794457|NCT00994890|540372926|FG001|Overall Study|Randomized, but not treated|0|||
149794458|NCT00994890|540372927|FG002|Overall Study|Randomized, but not treated|0|||
149794459|NCT00994890|540372925|FG000|Overall Study|Other|2|||
149794460|NCT00994890|540372926|FG001|Overall Study|Other|2|||
149794461|NCT00994890|540372927|FG002|Overall Study|Other|1|||
149794462|NCT03323385|540372934|FG000|Overall Study|Withdrawal by Subject|1|||
149794463|NCT03323385|540372935|FG001|Overall Study|Withdrawal by Subject|2|||
149794464|NCT03323385|540372934|FG000|Overall Study|Noncompliance|0|||
149794465|NCT03323385|540372935|FG001|Overall Study|Noncompliance|1|||
149794466|NCT00699582|540372936|FG000|Overall Study|Adverse Event|4|||
149794467|NCT00699582|540372937|FG001|Overall Study|Adverse Event|11|||
149794468|NCT00699582|540372938|FG002|Overall Study|Adverse Event|23|||
149794469|NCT00699582|540372936|FG000|Overall Study|Withdrawal by Subject|6|||
149794470|NCT00699582|540372937|FG001|Overall Study|Withdrawal by Subject|7|||
149794471|NCT00699582|540372938|FG002|Overall Study|Withdrawal by Subject|4|||
149794472|NCT00699582|540372936|FG000|Overall Study|Lack of Efficacy|1|||
149794473|NCT00699582|540372937|FG001|Overall Study|Lack of Efficacy|0|||
149794474|NCT00699582|540372938|FG002|Overall Study|Lack of Efficacy|1|||
149794475|NCT00699582|540372936|FG000|Overall Study|Progressive Disease|1|||
149794476|NCT00699582|540372937|FG001|Overall Study|Progressive Disease|0|||
149794477|NCT00699582|540372938|FG002|Overall Study|Progressive Disease|0|||
149794478|NCT00699582|540372936|FG000|Overall Study|Administrative/Other|4|||
149794479|NCT00699582|540372937|FG001|Overall Study|Administrative/Other|3|||
149794480|NCT00699582|540372938|FG002|Overall Study|Administrative/Other|0|||
149794481|NCT00699582|540372936|FG000|Overall Study|Randomized, Not Treated|2|||
149794482|NCT00699582|540372937|FG001|Overall Study|Randomized, Not Treated|1|||
149794483|NCT00699582|540372938|FG002|Overall Study|Randomized, Not Treated|0|||
149794484|NCT01849289|540372941|FG000|Overall Study|Adverse Event|3|||
149794485|NCT01849289|540372942|FG001|Overall Study|Adverse Event|3|||
149794486|NCT01849289|540372941|FG000|Overall Study|Protocol Violation|3|||
149794487|NCT01849289|540372942|FG001|Overall Study|Protocol Violation|3|||
149794488|NCT01849289|540372941|FG000|Overall Study|Withdrawal criteria|1|||
149794489|NCT01849289|540372942|FG001|Overall Study|Withdrawal criteria|0|||
149794490|NCT01849289|540372941|FG000|Overall Study|Unclassified|25|||
149794491|NCT01849289|540372942|FG001|Overall Study|Unclassified|18|||
149794492|NCT00352027|540372943|FG000|Overall Study|Progressive disease|3|||
149794493|NCT04491591|540372944|FG000|Overall Study|Accidently randomized|3|||
149794494|NCT04491591|540372945|FG001|Overall Study|Accidently randomized|1|||
149794495|NCT04491591|540372946|FG002|Overall Study|Accidently randomized|0|||
149794496|NCT04491591|540372944|FG000|Overall Study|Did not complete survey|28|||
149794497|NCT04491591|540372945|FG001|Overall Study|Did not complete survey|20|||
149794498|NCT04491591|540372946|FG002|Overall Study|Did not complete survey|3|||
149794499|NCT03099304|540372948|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
149794500|NCT03099304|540372949|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
149794501|NCT03099304|540372950|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
149794502|NCT03099304|540372951|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
149794503|NCT03099304|540372952|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
149794504|NCT03099304|540372953|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
149794505|NCT03099304|540372948|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
149794506|NCT03099304|540372949|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
149794507|NCT03099304|540372950|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149794508|NCT03099304|540372951|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149794509|NCT03099304|540372952|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149794510|NCT03099304|540372953|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149794511|NCT03099304|540372948|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
149794512|NCT03099304|540372949|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
149794513|NCT03099304|540372950|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
149794514|NCT03099304|540372951|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
149794515|NCT03099304|540372952|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
149794516|NCT03099304|540372953|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
149794517|NCT03099304|540372948|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
149794518|NCT03099304|540372949|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
149794519|NCT03099304|540372950|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
149794520|NCT03099304|540372951|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
149794521|NCT03099304|540372952|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
149794522|NCT03099304|540372953|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
149794523|NCT03099304|540372948|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149794524|NCT03099304|540372949|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149794525|NCT03099304|540372950|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
149794526|NCT03099304|540372951|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
149794527|NCT03099304|540372952|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149794528|NCT03099304|540372953|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149794529|NCT03099304|540372948|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149794530|NCT03099304|540372949|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149794531|NCT03099304|540372950|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
149794532|NCT03099304|540372951|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149794533|NCT03099304|540372952|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149794534|NCT03099304|540372953|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149794535|NCT03099304|540372948|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149794536|NCT03099304|540372949|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149794537|NCT03099304|540372950|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149794538|NCT03099304|540372951|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149794539|NCT03099304|540372952|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149794540|NCT03099304|540372953|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149794541|NCT03099304|540372948|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
149794542|NCT03099304|540372949|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
149794543|NCT03099304|540372950|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
149794544|NCT03099304|540372951|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
149794545|NCT03099304|540372952|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
149794546|NCT03099304|540372953|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
149794547|NCT03099304|540372948|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149794548|NCT03099304|540372949|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149794549|NCT03099304|540372950|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149794550|NCT03099304|540372951|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
149794551|NCT03099304|540372952|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
149794552|NCT03099304|540372953|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149794553|NCT03099304|540372948|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
149794554|NCT03099304|540372949|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
149794555|NCT03099304|540372950|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
149794556|NCT03099304|540372951|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
149794557|NCT03099304|540372952|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
149794558|NCT03099304|540372953|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
149794559|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
149794560|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
149794561|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
149794562|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
149794563|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
149794564|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
149794565|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
149794566|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
149794567|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
149794568|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
149794569|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
149794570|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
149794571|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
149794572|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
149794573|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
149794574|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
149794575|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
149794576|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
149794577|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
149794578|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
149794579|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
149794580|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
149794581|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
149794582|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
149794583|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
149794584|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
149794585|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
149794586|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
149794587|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
149794588|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
149794589|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
149794590|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
149794591|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
149794592|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
149794593|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
149794594|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
149794595|NCT03099304|540372948|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
149794596|NCT03099304|540372949|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
149794597|NCT03099304|540372950|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
149794598|NCT03099304|540372951|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
149794599|NCT03099304|540372952|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
149794600|NCT03099304|540372953|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
149794601|NCT02692560|540372954|FG000|Overall Study|Withdrawal by Subject|0|||
149794602|NCT02692560|540372955|FG001|Overall Study|Withdrawal by Subject|6|||
149794603|NCT00715949|540372958|FG000|Overall Study|could not finish first test|4|||
149794604|NCT00420212|540372959|FG000|Overall Study|Adverse Event|22|||
149794605|NCT00420212|540372960|FG001|Overall Study|Adverse Event|40|||
149794606|NCT00420212|540372961|FG002|Overall Study|Adverse Event|36|||
149794607|NCT00420212|540372959|FG000|Overall Study|Lost to Follow-up|9|||
149794608|NCT00420212|540372960|FG001|Overall Study|Lost to Follow-up|11|||
149794609|NCT00420212|540372961|FG002|Overall Study|Lost to Follow-up|11|||
149794610|NCT00420212|540372959|FG000|Overall Study|Withdrawal by Subject|31|||
149794611|NCT00420212|540372960|FG001|Overall Study|Withdrawal by Subject|22|||
149794612|NCT00420212|540372961|FG002|Overall Study|Withdrawal by Subject|19|||
149794613|NCT00420212|540372959|FG000|Overall Study|Physician Decision|4|||
149794614|NCT00420212|540372960|FG001|Overall Study|Physician Decision|4|||
149794615|NCT00420212|540372961|FG002|Overall Study|Physician Decision|3|||
149794616|NCT00420212|540372959|FG000|Overall Study|Protocol Violation|4|||
149794617|NCT00420212|540372960|FG001|Overall Study|Protocol Violation|4|||
149794618|NCT00420212|540372961|FG002|Overall Study|Protocol Violation|8|||
149794619|NCT00420212|540372959|FG000|Overall Study|Death|0|||
149794620|NCT00420212|540372960|FG001|Overall Study|Death|0|||
149794621|NCT00420212|540372961|FG002|Overall Study|Death|1|||
149794622|NCT00420212|540372959|FG000|Overall Study|Other-Unspecified|21|||
149794623|NCT00420212|540372960|FG001|Overall Study|Other-Unspecified|14|||
149794624|NCT00420212|540372961|FG002|Overall Study|Other-Unspecified|18|||
149794625|NCT01326910|540372962|FG000|Overall Study|Withdrawal by Subject|3|||
149794626|NCT01326910|540372963|FG001|Overall Study|Withdrawal by Subject|2|||
149794627|NCT01326910|540372962|FG000|Overall Study|Protocol Violation|1|||
149794628|NCT01326910|540372963|FG001|Overall Study|Protocol Violation|1|||
149794629|NCT01058356|540372968|FG000|Overall Study|Adverse Event|5|||
149794630|NCT01058356|540372968|FG000|Overall Study|Administration of contraindicated drugs|12|||
149794631|NCT01058356|540372968|FG000|Overall Study|Withdrawal by Subject|21|||
149794632|NCT01058356|540372968|FG000|Overall Study|Lost to Follow-up|4|||
149794633|NCT02993783|540372969|FG000|Overall Study|Reason not Specified|6|||
149794634|NCT02993783|540372970|FG001|Overall Study|Reason not Specified|9|||
149794635|NCT03922945|540374366|FG000|Overall Study|Adverse Event|1|||
149794636|NCT03922945|540374367|FG001|Overall Study|Adverse Event|1|||
149794637|NCT03922945|540374368|FG002|Overall Study|Adverse Event|2|||
149794638|NCT03922945|540374366|FG000|Overall Study|Lost to Follow-up|13|||
149794639|NCT03922945|540374367|FG001|Overall Study|Lost to Follow-up|9|||
149794640|NCT03922945|540374368|FG002|Overall Study|Lost to Follow-up|20|||
149794641|NCT03922945|540374366|FG000|Overall Study|Lack of Efficacy|2|||
149794642|NCT03922945|540374367|FG001|Overall Study|Lack of Efficacy|0|||
149794643|NCT03922945|540374368|FG002|Overall Study|Lack of Efficacy|1|||
149794644|NCT03922945|540374366|FG000|Overall Study|Protocol Non-Compliance|0|||
149794645|NCT03922945|540374367|FG001|Overall Study|Protocol Non-Compliance|0|||
149794646|NCT03922945|540374368|FG002|Overall Study|Protocol Non-Compliance|1|||
149794647|NCT03922945|540374366|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
149794648|NCT03922945|540374367|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
149794649|NCT03922945|540374368|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
149794650|NCT03922945|540374366|FG000|Overall Study|All Other Personal Reasons|1|||
149794651|NCT03922945|540374367|FG001|Overall Study|All Other Personal Reasons|1|||
149794652|NCT03922945|540374368|FG002|Overall Study|All Other Personal Reasons|2|||
149794653|NCT01347931|540374369|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
149794654|NCT03287960|540374370|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
149794655|NCT03287960|540374370|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
149794656|NCT01667731|540374371|FG000|Overall Study|Enrolled but not treated|0|||
149794657|NCT01667731|540374372|FG001|Overall Study|Enrolled but not treated|0|||
149794658|NCT01667731|540374373|FG002|Overall Study|Enrolled but not treated|0|||
149794659|NCT01667731|540374374|FG003|Overall Study|Enrolled but not treated|0|||
149794660|NCT01667731|540374375|FG004|Overall Study|Enrolled but not treated|1|||
149794661|NCT01667731|540374371|FG000|Overall Study|Efficacy Failure|1|||
149794662|NCT01667731|540374372|FG001|Overall Study|Efficacy Failure|12|||
149794663|NCT01667731|540374373|FG002|Overall Study|Efficacy Failure|0|||
149794664|NCT01667731|540374374|FG003|Overall Study|Efficacy Failure|1|||
149794665|NCT01667731|540374375|FG004|Overall Study|Efficacy Failure|24|||
149794666|NCT01667731|540374371|FG000|Overall Study|Lost to Follow-up|2|||
149794667|NCT01667731|540374372|FG001|Overall Study|Lost to Follow-up|3|||
149794668|NCT01667731|540374373|FG002|Overall Study|Lost to Follow-up|1|||
149794669|NCT01667731|540374374|FG003|Overall Study|Lost to Follow-up|1|||
149794670|NCT01667731|540374375|FG004|Overall Study|Lost to Follow-up|2|||
149794671|NCT01667731|540374371|FG000|Overall Study|Subject Withdrew Consent|2|||
149794672|NCT01667731|540374372|FG001|Overall Study|Subject Withdrew Consent|0|||
149794673|NCT01667731|540374373|FG002|Overall Study|Subject Withdrew Consent|1|||
149794674|NCT01667731|540374374|FG003|Overall Study|Subject Withdrew Consent|0|||
149794675|NCT01667731|540374375|FG004|Overall Study|Subject Withdrew Consent|1|||
149794676|NCT01667731|540374371|FG000|Overall Study|Death|0|||
149794677|NCT01667731|540374372|FG001|Overall Study|Death|1|||
149794678|NCT01667731|540374373|FG002|Overall Study|Death|0|||
149794679|NCT01667731|540374374|FG003|Overall Study|Death|0|||
149794680|NCT01667731|540374375|FG004|Overall Study|Death|0|||
149794681|NCT00561912|540374376|FG000|Overall Study|ineligible|1|||
149794682|NCT01345162|540374377|FG000|Overall Study|Protocol Violation|2|||
149794683|NCT01345162|540374378|FG001|Overall Study|Protocol Violation|4|||
149794684|NCT01977651|540374382|FG000|4 Month Treatment Period|Adverse Event|34|||
149794685|NCT01977651|540374382|FG000|4 Month Treatment Period|Death|3|||
149794686|NCT01977651|540374382|FG000|4 Month Treatment Period|Progressive Disease|43|||
149794687|NCT01977651|540374382|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
149794688|NCT01977651|540374382|FG000|4 Month Treatment Period|Physician Decision|4|||
149794689|NCT01977651|540374382|FG000|1 Year Extension Period|Adverse Event|14|||
149794690|NCT01977651|540374382|FG000|1 Year Extension Period|Death|10|||
149794691|NCT01977651|540374382|FG000|1 Year Extension Period|Lost to Follow-up|2|||
149794692|NCT01977651|540374382|FG000|1 Year Extension Period|Progressive Disease|86|||
149794693|NCT01977651|540374382|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
149794694|NCT01977651|540374382|FG000|1 Year Extension Period|Physician Decision|6|||
149794695|NCT01977651|540374382|FG000|1 Year Extension Period|Miscellaneous|1|||
149794696|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Adverse Event|5|||
149794697|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Death|13|||
149794698|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
149794699|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
149794700|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Physician Decision|4|||
149794701|NCT01977651|540374382|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
149794702|NCT02906644|540374383|FG000|First 2 Weeks|Withdrawal by Subject|0|||
149794703|NCT02906644|540374384|FG001|First 2 Weeks|Withdrawal by Subject|2|||
149794704|NCT02906644|540374383|FG000|First 2 Weeks|Physician Decision|1|||
149794705|NCT02906644|540374384|FG001|First 2 Weeks|Physician Decision|1|||
149794706|NCT02906644|540374383|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
149794707|NCT02906644|540374384|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
149794708|NCT02906644|540374383|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
149794709|NCT02906644|540374384|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
149794710|NCT03672006|540374389|FG000|Overall Study|exclusion criteria met|0|||
149794711|NCT03672006|540374390|FG001|Overall Study|exclusion criteria met|1|||
149794712|NCT02074059|540374394|FG000|Overall Study|Death|0|||
149794713|NCT02074059|540374395|FG001|Overall Study|Death|0|||
149794714|NCT02074059|540374396|FG002|Overall Study|Death|0|||
149794715|NCT02074059|540374397|FG003|Overall Study|Death|0|||
149794716|NCT02074059|540374398|FG004|Overall Study|Death|1|||
149794717|NCT02074059|540374399|FG005|Overall Study|Death|1|||
149794718|NCT04249076|540374418|FG000|Overall Study|Adverse Event|1|||
149794719|NCT04249076|540374419|FG001|Overall Study|Adverse Event|1|||
149794720|NCT04249076|540374418|FG000|Overall Study|Protocol Violation|1|||
149794721|NCT04249076|540374419|FG001|Overall Study|Protocol Violation|2|||
149794722|NCT04249076|540374418|FG000|Overall Study|Lack of Efficacy|0|||
149794723|NCT04249076|540374419|FG001|Overall Study|Lack of Efficacy|1|||
149794724|NCT04249076|540374418|FG000|Overall Study|Withdrawal by Subject|0|||
149794725|NCT04249076|540374419|FG001|Overall Study|Withdrawal by Subject|1|||
149794726|NCT00732199|540374420|FG000|Overall Study|Withdrawal by Subject|25|||
149794727|NCT00732199|540374421|FG001|Overall Study|Withdrawal by Subject|18|||
149794728|NCT00732199|540374420|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
149794729|NCT00732199|540374421|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
149794730|NCT00265382|540374422|FG000|Overall Study|Adverse Event|21|||
149794731|NCT00265382|540374422|FG000|Overall Study|Laboratory Abnormality|1|||
149794732|NCT00265382|540374422|FG000|Overall Study|Lost to Follow-up|3|||
149794733|NCT00265382|540374422|FG000|Overall Study|Lack of Efficacy|6|||
149794734|NCT00265382|540374422|FG000|Overall Study|Miscellaneous|6|||
149794735|NCT00265382|540374422|FG000|Overall Study|Withdrawal by Subject|13|||
149794736|NCT00265382|540374422|FG000|Overall Study|Study terminated by sponsor|94|||
149794737|NCT00265382|540374422|FG000|Overall Study|Death|1|||
149794738|NCT02242305|540374423|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
149794739|NCT02242305|540374424|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
149794740|NCT02242305|540374423|FG000|Overall Study|Adverse Event|1|||
149794741|NCT02242305|540374424|FG001|Overall Study|Adverse Event|0|||
149794742|NCT02242305|540374423|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
149794743|NCT02242305|540374424|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
149794744|NCT02242305|540374423|FG000|Overall Study|Subject withdraws inform consent|0|||
149794745|NCT02242305|540374424|FG001|Overall Study|Subject withdraws inform consent|4|||
149794746|NCT02242305|540374423|FG000|Overall Study|Lost to Follow-up|2|||
149794747|NCT02242305|540374424|FG001|Overall Study|Lost to Follow-up|0|||
149794748|NCT02543801|540374427|FG000|Overall Study|Protocol Violation|1|||
149794749|NCT02543801|540374428|FG001|Overall Study|Protocol Violation|2|||
149794750|NCT02543801|540374429|FG002|Overall Study|Protocol Violation|0|||
149794751|NCT02543801|540374430|FG003|Overall Study|Protocol Violation|0|||
149794752|NCT01756846|540374431|FG000|Overall Study|Lost to Follow-up|5|||
149794753|NCT01756846|540374432|FG001|Overall Study|Lost to Follow-up|10|||
149794754|NCT01756846|540374431|FG000|Overall Study|Withdrawal by Subject|1|||
149794755|NCT01756846|540374432|FG001|Overall Study|Withdrawal by Subject|2|||
149794756|NCT03481634|540374435|FG000|Overall Study|Withdrawal by Subject|16|||
149794757|NCT03481634|540374436|FG001|Overall Study|Withdrawal by Subject|19|||
149794758|NCT03481634|540374437|FG002|Overall Study|Withdrawal by Subject|14|||
149794759|NCT03481634|540374435|FG000|Overall Study|Protocol Violation|1|||
149794760|NCT03481634|540374436|FG001|Overall Study|Protocol Violation|0|||
149794761|NCT03481634|540374437|FG002|Overall Study|Protocol Violation|1|||
149794762|NCT03481634|540374435|FG000|Overall Study|Progressive disease|0|||
149794763|NCT03481634|540374436|FG001|Overall Study|Progressive disease|1|||
149794764|NCT03481634|540374437|FG002|Overall Study|Progressive disease|0|||
149794765|NCT03481634|540374435|FG000|Overall Study|Physician Decision|3|||
149794766|NCT03481634|540374436|FG001|Overall Study|Physician Decision|0|||
149794767|NCT03481634|540374437|FG002|Overall Study|Physician Decision|1|||
149794768|NCT03481634|540374435|FG000|Overall Study|Lost to Follow-up|3|||
149794769|NCT03481634|540374436|FG001|Overall Study|Lost to Follow-up|4|||
149794770|NCT03481634|540374437|FG002|Overall Study|Lost to Follow-up|4|||
149794771|NCT03481634|540374435|FG000|Overall Study|Death|4|||
149794772|NCT03481634|540374436|FG001|Overall Study|Death|8|||
149794773|NCT03481634|540374437|FG002|Overall Study|Death|7|||
149794774|NCT03481634|540374435|FG000|Overall Study|Adverse Event|6|||
149794775|NCT03481634|540374436|FG001|Overall Study|Adverse Event|3|||
149794776|NCT03481634|540374437|FG002|Overall Study|Adverse Event|7|||
149794777|NCT02274766|540374442|FG000|Overall Study|Withdrawal by Subject|3|||
149794778|NCT02274766|540374443|FG001|Overall Study|Withdrawal by Subject|6|||
149794779|NCT02274766|540374442|FG000|Overall Study|Did Not Receive Study Drug|1|||
149794780|NCT02274766|540374443|FG001|Overall Study|Did Not Receive Study Drug|1|||
149794781|NCT02274766|540374442|FG000|Overall Study|Subject Unwilling to Proceed|0|||
149794782|NCT02274766|540374443|FG001|Overall Study|Subject Unwilling to Proceed|1|||
149794783|NCT02274766|540374442|FG000|Overall Study|Adverse Event|0|||
149794784|NCT02274766|540374443|FG001|Overall Study|Adverse Event|1|||
149794785|NCT02607735|540374444|FG000|Primary Study|Randomized but Never Treated|1|||
149794786|NCT02607735|540374445|FG001|Primary Study|Randomized but Never Treated|0|||
149794787|NCT02607735|540374446|FG002|Primary Study|Randomized but Never Treated|0|||
149794788|NCT02607735|540374444|FG000|Primary Study|Lost to Follow-up|4|||
149794789|NCT02607735|540374445|FG001|Primary Study|Lost to Follow-up|0|||
149794790|NCT02607735|540374446|FG002|Primary Study|Lost to Follow-up|0|||
149794791|NCT02607735|540374444|FG000|Primary Study|Withdrew Consent|2|||
149794792|NCT02607735|540374445|FG001|Primary Study|Withdrew Consent|0|||
149794793|NCT02607735|540374446|FG002|Primary Study|Withdrew Consent|0|||
149794794|NCT02607735|540374444|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
149794795|NCT02607735|540374445|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
149794796|NCT02607735|540374446|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
149794797|NCT02607735|540374444|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
149794798|NCT02607735|540374445|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
149794799|NCT02607735|540374446|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
149794800|NCT00606021|540374458|FG000|Induction Phase|Death|73|||
149794801|NCT00606021|540374459|FG001|Induction Phase|Death|0|||
149794802|NCT00606021|540374460|FG002|Induction Phase|Death|0|||
149794803|NCT00606021|540374458|FG000|Induction Phase|Physician Decision|2|||
149794804|NCT00606021|540374459|FG001|Induction Phase|Physician Decision|0|||
149794805|NCT00606021|540374460|FG002|Induction Phase|Physician Decision|0|||
149794806|NCT00606021|540374458|FG000|Induction Phase|Withdrawal by Subject|2|||
149794807|NCT00606021|540374459|FG001|Induction Phase|Withdrawal by Subject|0|||
149794808|NCT00606021|540374460|FG002|Induction Phase|Withdrawal by Subject|0|||
149794809|NCT00606021|540374458|FG000|Induction Phase|Lost to Follow-up|10|||
149794810|NCT00606021|540374459|FG001|Induction Phase|Lost to Follow-up|0|||
149794811|NCT00606021|540374460|FG002|Induction Phase|Lost to Follow-up|0|||
149794812|NCT00606021|540374458|FG000|Maintenance Phase|Death|0|||
149794813|NCT00606021|540374459|FG001|Maintenance Phase|Death|17|||
149794814|NCT00606021|540374460|FG002|Maintenance Phase|Death|15|||
149794815|NCT00606021|540374458|FG000|Maintenance Phase|Physician Decision|0|||
149794816|NCT00606021|540374459|FG001|Maintenance Phase|Physician Decision|1|||
149794817|NCT00606021|540374460|FG002|Maintenance Phase|Physician Decision|0|||
149794818|NCT00606021|540374458|FG000|Maintenance Phase|Lost to Follow-up|0|||
149794819|NCT00606021|540374459|FG001|Maintenance Phase|Lost to Follow-up|5|||
149794820|NCT00606021|540374460|FG002|Maintenance Phase|Lost to Follow-up|2|||
149794821|NCT03480841|540374461|FG000|Overall Study|Lost to Follow-up|2|||
149794822|NCT01362049|540374462|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
149794823|NCT01362049|540374463|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
149794824|NCT01362049|540374464|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
149794825|NCT01362049|540374465|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
149794826|NCT01362049|540374462|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
149794827|NCT01362049|540374463|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
149794828|NCT01362049|540374464|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
149794829|NCT01362049|540374465|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
149794830|NCT02417935|540374469|FG000|Treatment Period|Adverse Event|12|||
149794831|NCT02417935|540374470|FG001|Treatment Period|Adverse Event|10|||
149794832|NCT02417935|540374469|FG000|Treatment Period|Lost to Follow-up|1|||
149794833|NCT02417935|540374470|FG001|Treatment Period|Lost to Follow-up|0|||
149794834|NCT02417935|540374469|FG000|Treatment Period|Entry Criteria not met|0|||
149794835|NCT02417935|540374470|FG001|Treatment Period|Entry Criteria not met|1|||
149794836|NCT02417935|540374469|FG000|Treatment Period|Protocol Violation|2|||
149794837|NCT02417935|540374470|FG001|Treatment Period|Protocol Violation|1|||
149794838|NCT02417935|540374469|FG000|Treatment Period|Withdrawal by Subject|3|||
149794839|NCT02417935|540374470|FG001|Treatment Period|Withdrawal by Subject|3|||
149794840|NCT02417935|540374469|FG000|Treatment Period|Physician Decision|3|||
149794841|NCT02417935|540374470|FG001|Treatment Period|Physician Decision|1|||
149794842|NCT02850276|540374475|FG000|Overall Study|screen failure|43|||
149794843|NCT02850276|540374475|FG000|Overall Study|Withdrawal by Subject|14|||
149794844|NCT02850276|540374475|FG000|Overall Study|Physician Decision|2|||
149794845|NCT02850276|540374475|FG000|Overall Study|Lost to Follow-up|2|||
149794846|NCT04815291|540374476|FG000|Overall Study|Lost to Follow-up|1|||
149794847|NCT04815291|540374476|FG000|Overall Study|Physician Decision|4|||
149794848|NCT04815291|540374476|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
149794849|NCT00095836|540374482|FG000|Overall Study|Lost to Follow-up|1|||
149794850|NCT00095836|540374482|FG000|Overall Study|Adverse Event|1|||
149794851|NCT00095836|540374482|FG000|Overall Study|Death|2|||
149794852|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
149794853|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
149794854|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
149794855|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149794856|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
149794857|NCT00989664|540374483|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
149794858|NCT00989664|540374483|FG000|Long-Term Follow-Up|Death|3|||
149794859|NCT00962780|540374485|FG000|Overall Study|Death|0|||
149794860|NCT00962780|540374486|FG001|Overall Study|Death|1|||
149794861|NCT00962780|540374485|FG000|Overall Study|Protocol Violation|9|||
149794862|NCT00962780|540374486|FG001|Overall Study|Protocol Violation|4|||
149794863|NCT00962780|540374485|FG000|Overall Study|Withdrawal by Subject|1|||
149794864|NCT00962780|540374486|FG001|Overall Study|Withdrawal by Subject|8|||
149794865|NCT00962780|540374485|FG000|Overall Study|Other|0|||
149794866|NCT00962780|540374486|FG001|Overall Study|Other|1|||
149794867|NCT02363322|540374489|FG000|Overall Study|Lost to Follow-up|1|||
149794868|NCT02363322|540374490|FG001|Overall Study|Lost to Follow-up|0|||
149794869|NCT02269709|540374491|FG000|Time of Enrollment|Withdrawal by Subject|3|||
149794870|NCT02269709|540374491|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
149794871|NCT02269709|540374491|FG000|Six Month Follow-up|Lost to Follow-up|12|||
149794872|NCT02504424|540374493|FG000|Overall Study|Withdrawal by Subject|2|||
149794873|NCT00426842|540374494|FG000|Overall Study|Lost to Follow-up|1|||
149794874|NCT00982111|540374497|FG000|Overall Study|Adverse Event|1|||
149794875|NCT00982111|540374498|FG001|Overall Study|Adverse Event|1|||
149794876|NCT00982111|540374497|FG000|Overall Study|Progressive Disease|46|||
149794877|NCT00982111|540374498|FG001|Overall Study|Progressive Disease|39|||
149794878|NCT00982111|540374497|FG000|Overall Study|Lost to Follow-up|9|||
149794879|NCT00982111|540374498|FG001|Overall Study|Lost to Follow-up|6|||
149794880|NCT00982111|540374497|FG000|Overall Study|New Anti-Cancer Therapy|5|||
149794881|NCT00982111|540374498|FG001|Overall Study|New Anti-Cancer Therapy|5|||
149794882|NCT00982111|540374497|FG000|Overall Study|Medical Decision|1|||
149794883|NCT00982111|540374498|FG001|Overall Study|Medical Decision|0|||
149794884|NCT00982111|540374497|FG000|Overall Study|Withdrawal by Subject|17|||
149794885|NCT00982111|540374498|FG001|Overall Study|Withdrawal by Subject|19|||
149794886|NCT00982111|540374497|FG000|Overall Study|Global Study End|0|||
149794887|NCT00982111|540374498|FG001|Overall Study|Global Study End|1|||
149794888|NCT00982111|540374497|FG000|Overall Study|Sponsor's Decision|0|||
149794889|NCT00982111|540374498|FG001|Overall Study|Sponsor's Decision|1|||
149794890|NCT01070381|540374499|FG000|Period 2, 1 Week of Wear|Handling|0|||
149794891|NCT01070381|540374500|FG001|Period 2, 1 Week of Wear|Handling|1|||
149794892|NCT01070381|540374499|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
149794893|NCT01070381|540374500|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
149794894|NCT01230827|540374501|FG000|Overall Study|Lost to Follow-up|0|||
149794895|NCT01230827|540374502|FG001|Overall Study|Lost to Follow-up|0|||
149794896|NCT01230827|540374503|FG002|Overall Study|Lost to Follow-up|1|||
149794897|NCT01230827|540374504|FG003|Overall Study|Lost to Follow-up|3|||
149794898|NCT01230827|540374501|FG000|Overall Study|Withdrawal by Subject|1|||
149794899|NCT01230827|540374502|FG001|Overall Study|Withdrawal by Subject|0|||
149794900|NCT01230827|540374503|FG002|Overall Study|Withdrawal by Subject|3|||
149794901|NCT01230827|540374504|FG003|Overall Study|Withdrawal by Subject|2|||
149794902|NCT01230827|540374501|FG000|Overall Study|Lack of Efficacy|14|||
149794903|NCT01230827|540374502|FG001|Overall Study|Lack of Efficacy|1|||
149794904|NCT01230827|540374503|FG002|Overall Study|Lack of Efficacy|2|||
149794905|NCT01230827|540374504|FG003|Overall Study|Lack of Efficacy|3|||
149794906|NCT01230827|540374501|FG000|Overall Study|Adverse Event|4|||
149794907|NCT01230827|540374502|FG001|Overall Study|Adverse Event|2|||
149794908|NCT01230827|540374503|FG002|Overall Study|Adverse Event|3|||
149794909|NCT01230827|540374504|FG003|Overall Study|Adverse Event|7|||
149794910|NCT01230827|540374501|FG000|Overall Study|Recovery|0|||
149794911|NCT01230827|540374502|FG001|Overall Study|Recovery|6|||
149794912|NCT01230827|540374503|FG002|Overall Study|Recovery|0|||
149794913|NCT01230827|540374504|FG003|Overall Study|Recovery|0|||
149794914|NCT01230827|540374501|FG000|Overall Study|Study terminated by Sponsor|0|||
149794915|NCT01230827|540374502|FG001|Overall Study|Study terminated by Sponsor|2|||
149794916|NCT01230827|540374503|FG002|Overall Study|Study terminated by Sponsor|56|||
149794917|NCT01230827|540374504|FG003|Overall Study|Study terminated by Sponsor|63|||
149794918|NCT01854918|540374507|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
149794919|NCT01854918|540374508|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
149794920|NCT01854918|540374507|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
149794921|NCT01854918|540374508|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
149794922|NCT01854918|540374507|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
149794923|NCT01854918|540374508|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
149794924|NCT01854918|540374507|FG000|SOC-controlled Period (Year 1)|Death|5|||
149794925|NCT01854918|540374508|FG001|SOC-controlled Period (Year 1)|Death|5|||
149794926|NCT01854918|540374507|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
149794927|NCT01854918|540374508|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
149794928|NCT01854918|540374507|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
149794929|NCT01854918|540374508|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
149794930|NCT01854918|540374507|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
149794931|NCT01854918|540374508|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
149794932|NCT01854918|540374507|FG000|All-IP Period (Years 2 and 3)|Death|5|||
149794933|NCT01854918|540374508|FG001|All-IP Period (Years 2 and 3)|Death|16|||
149794934|NCT02918006|540374511|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
149794935|NCT02918006|540374512|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
149794936|NCT02918006|540374513|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
149794937|NCT02918006|540374511|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
149794938|NCT02918006|540374512|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
149794939|NCT02918006|540374513|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
149794940|NCT02918006|540374511|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
149794941|NCT02918006|540374512|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
149794942|NCT02918006|540374513|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
149794943|NCT02918006|540374511|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
149794944|NCT02918006|540374512|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
149794945|NCT02918006|540374513|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
149794946|NCT02918006|540374511|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
149794947|NCT02918006|540374512|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
149794948|NCT02918006|540374513|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
149794949|NCT02918006|540374511|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
149794950|NCT02918006|540374512|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
149794951|NCT02918006|540374513|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
149794952|NCT02918006|540374511|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
149794953|NCT02918006|540374512|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
149794954|NCT02918006|540374513|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
149794955|NCT02918006|540374511|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
149794956|NCT02918006|540374512|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
149794957|NCT02918006|540374513|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
149794958|NCT02918006|540374511|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
149794959|NCT02918006|540374512|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
149794960|NCT02918006|540374513|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
149794961|NCT00453349|540374518|FG000|Randomized|Adverse Event|12|||
149794962|NCT00453349|540374519|FG001|Randomized|Adverse Event|11|||
149794963|NCT00453349|540374518|FG000|Randomized|Lack of Efficacy|2|||
149794964|NCT00453349|540374519|FG001|Randomized|Lack of Efficacy|1|||
149794965|NCT00453349|540374518|FG000|Randomized|Lost to Follow-up|7|||
149794966|NCT00453349|540374519|FG001|Randomized|Lost to Follow-up|5|||
149794967|NCT00453349|540374518|FG000|Randomized|Protocol Violation|1|||
149794968|NCT00453349|540374519|FG001|Randomized|Protocol Violation|1|||
149794969|NCT00453349|540374518|FG000|Randomized|Withdrawal by Subject|3|||
149794970|NCT00453349|540374519|FG001|Randomized|Withdrawal by Subject|5|||
149794971|NCT00453349|540374518|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
149794972|NCT00453349|540374519|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
149794973|NCT00453349|540374518|FG000|Completed Study|Adverse Event|12|||
149794974|NCT00453349|540374519|FG001|Completed Study|Adverse Event|11|||
149794975|NCT00453349|540374518|FG000|Completed Study|Lack of Efficacy|2|||
149794976|NCT00453349|540374519|FG001|Completed Study|Lack of Efficacy|1|||
149794977|NCT00453349|540374518|FG000|Completed Study|Lost to Follow-up|7|||
149794978|NCT00453349|540374519|FG001|Completed Study|Lost to Follow-up|5|||
149794979|NCT00453349|540374518|FG000|Completed Study|Protocol Violation|1|||
149794980|NCT00453349|540374519|FG001|Completed Study|Protocol Violation|1|||
149794981|NCT00453349|540374518|FG000|Completed Study|Withdrawal by Subject|3|||
149794982|NCT00453349|540374519|FG001|Completed Study|Withdrawal by Subject|5|||
149794983|NCT00453349|540374518|FG000|Completed Study|Lost to follow up after study treatment|2|||
149794984|NCT00453349|540374519|FG001|Completed Study|Lost to follow up after study treatment|11|||
149794985|NCT01513460|540374524|FG000|Overall Study|Death|0|||
149794986|NCT01513460|540374525|FG001|Overall Study|Death|0|||
149794987|NCT01513460|540374526|FG002|Overall Study|Death|1|||
149794988|NCT01513460|540374524|FG000|Overall Study|Lost to Follow-up|0|||
149794989|NCT01513460|540374525|FG001|Overall Study|Lost to Follow-up|0|||
149794990|NCT01513460|540374526|FG002|Overall Study|Lost to Follow-up|2|||
149794991|NCT01513460|540374524|FG000|Overall Study|Abnormal laboratory value|1|||
149794992|NCT01513460|540374525|FG001|Overall Study|Abnormal laboratory value|0|||
149794993|NCT01513460|540374526|FG002|Overall Study|Abnormal laboratory value|1|||
149794994|NCT01513460|540374524|FG000|Overall Study|Lack of Efficacy|1|||
149794995|NCT01513460|540374525|FG001|Overall Study|Lack of Efficacy|2|||
149794996|NCT01513460|540374526|FG002|Overall Study|Lack of Efficacy|5|||
149794997|NCT01513460|540374524|FG000|Overall Study|Protocol deviations|3|||
149794998|NCT01513460|540374525|FG001|Overall Study|Protocol deviations|4|||
149794999|NCT01513460|540374526|FG002|Overall Study|Protocol deviations|3|||
149795000|NCT01513460|540374524|FG000|Overall Study|Withdrawal by Subject|7|||
149795001|NCT01513460|540374525|FG001|Overall Study|Withdrawal by Subject|8|||
149795002|NCT01513460|540374526|FG002|Overall Study|Withdrawal by Subject|21|||
149795003|NCT01513460|540374524|FG000|Overall Study|Adverse Event|16|||
149795004|NCT01513460|540374525|FG001|Overall Study|Adverse Event|18|||
149795005|NCT01513460|540374526|FG002|Overall Study|Adverse Event|23|||
149795006|NCT01513460|540374524|FG000|Overall Study|Abnormal test procedure|1|||
149795007|NCT01513460|540374525|FG001|Overall Study|Abnormal test procedure|0|||
149795008|NCT01513460|540374526|FG002|Overall Study|Abnormal test procedure|0|||
149795009|NCT00489216|540374527|FG000|Overall Study|Adverse Event|1|||
149795010|NCT02312934|540374530|FG000|Overall Study|Lost to Follow-up|1|||
149795011|NCT02312934|540374531|FG001|Overall Study|Lost to Follow-up|0|||
149795012|NCT02312934|540374530|FG000|Overall Study|Physician Decision|1|||
149795013|NCT02312934|540374531|FG001|Overall Study|Physician Decision|0|||
149795014|NCT03395704|540374532|FG000|Overall Study|Adverse Event|2|||
149795015|NCT03395704|540374533|FG001|Overall Study|Adverse Event|1|||
149795016|NCT03395704|540374532|FG000|Overall Study|Withdrawal by Subject|2|||
149795017|NCT03395704|540374533|FG001|Overall Study|Withdrawal by Subject|1|||
149795018|NCT03395704|540374532|FG000|Overall Study|Physician Decision|0|||
149795019|NCT03395704|540374533|FG001|Overall Study|Physician Decision|1|||
149795020|NCT02475564|540374534|FG000|Overall Study|Withdrawal by Subject|1|||
149795021|NCT02475564|540374535|FG001|Overall Study|Withdrawal by Subject|0|||
149795022|NCT02475564|540374534|FG000|Overall Study|Lost to Follow-up|2|||
149795023|NCT02475564|540374535|FG001|Overall Study|Lost to Follow-up|1|||
149795024|NCT02475564|540374534|FG000|Overall Study|Intense Menstrual bleeding|1|||
149795025|NCT02475564|540374535|FG001|Overall Study|Intense Menstrual bleeding|0|||
149795026|NCT00772031|540377213|FG000|Overall Study|Early termination of trial|12|||
149795027|NCT00772031|540377214|FG001|Overall Study|Early termination of trial|10|||
149795028|NCT00772031|540377213|FG000|Overall Study|Lost to Follow-up|20|||
149795029|NCT00772031|540377214|FG001|Overall Study|Lost to Follow-up|33|||
149795030|NCT02194699|540377219|FG000|Randomised|Did not receive treatment|1|||
149795031|NCT02194699|540377220|FG001|Randomised|Did not receive treatment|5|||
149795032|NCT02194699|540377219|FG000|Randomised|Without potential for 52 weeks of IP|5|||
149795033|NCT02194699|540377220|FG001|Randomised|Without potential for 52 weeks of IP|5|||
149795034|NCT02194699|540377219|FG000|Randomised|Duplicate patient|2|||
149795035|NCT02194699|540377220|FG001|Randomised|Duplicate patient|1|||
149795036|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
149795037|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
149795038|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
149795039|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
149795040|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
149795041|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
149795042|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
149795043|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
149795044|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
149795045|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
149795046|NCT02194699|540377219|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
149795047|NCT02194699|540377220|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
149795048|NCT02719028|540377221|FG000|Overall Study|Adverse Event|2|||
149795049|NCT02719028|540377222|FG001|Overall Study|Adverse Event|1|||
149795050|NCT02719028|540377223|FG002|Overall Study|Adverse Event|4|||
149795051|NCT02719028|540377224|FG003|Overall Study|Adverse Event|8|||
149795052|NCT02719028|540377221|FG000|Overall Study|Physician Decision|0|||
149795053|NCT02719028|540377222|FG001|Overall Study|Physician Decision|1|||
149795054|NCT02719028|540377223|FG002|Overall Study|Physician Decision|1|||
149795055|NCT02719028|540377224|FG003|Overall Study|Physician Decision|1|||
149795056|NCT02719028|540377221|FG000|Overall Study|Use of prohibited medication|0|||
149795057|NCT02719028|540377222|FG001|Overall Study|Use of prohibited medication|0|||
149795058|NCT02719028|540377223|FG002|Overall Study|Use of prohibited medication|1|||
149795059|NCT02719028|540377224|FG003|Overall Study|Use of prohibited medication|0|||
149795060|NCT02719028|540377221|FG000|Overall Study|Protocol Violation|0|||
149795061|NCT02719028|540377222|FG001|Overall Study|Protocol Violation|0|||
149795062|NCT02719028|540377223|FG002|Overall Study|Protocol Violation|0|||
149795063|NCT02719028|540377224|FG003|Overall Study|Protocol Violation|1|||
149795064|NCT01191190|540377225|FG000|Overall Study|Withdrawal by Subject|1|||
149795065|NCT00577382|540377227|FG000|Overall Study|Adverse Event|0|||
149795066|NCT00577382|540377228|FG001|Overall Study|Adverse Event|6|||
149795067|NCT00577382|540377227|FG000|Overall Study|Withdrawal by Subject|0|||
149795068|NCT00577382|540377228|FG001|Overall Study|Withdrawal by Subject|1|||
149795069|NCT00577382|540377227|FG000|Overall Study|Progressive Disease|17|||
149795070|NCT00577382|540377228|FG001|Overall Study|Progressive Disease|19|||
149795071|NCT00577382|540377227|FG000|Overall Study|Intercurrent Illness|1|||
149795072|NCT00577382|540377228|FG001|Overall Study|Intercurrent Illness|2|||
149795073|NCT00577382|540377227|FG000|Overall Study|Death|1|||
149795074|NCT00577382|540377228|FG001|Overall Study|Death|1|||
149795075|NCT00577382|540377227|FG000|Overall Study|Lost to Follow-up|2|||
149795076|NCT00577382|540377228|FG001|Overall Study|Lost to Follow-up|2|||
149795077|NCT03007472|540377229|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
149795078|NCT03007472|540377229|FG000|Overall Study|Death|2|||
149795079|NCT03007472|540377229|FG000|Overall Study|Loss to Follow Up|1|||
149795080|NCT00649220|540377230|FG000|Overall Study|Adverse Event|2|||
149795081|NCT00649220|540377230|FG000|Overall Study|Withdrawal by Subject|1|||
149795082|NCT00525499|540377231|FG000|Overall Study|Lost to Follow-up|2|||
149795083|NCT00525499|540377232|FG001|Overall Study|Lost to Follow-up|4|||
149795084|NCT00525499|540377233|FG002|Overall Study|Lost to Follow-up|1|||
149795085|NCT00525499|540377234|FG003|Overall Study|Lost to Follow-up|4|||
149795086|NCT00525499|540377231|FG000|Overall Study|Adverse Event|0|||
149795087|NCT00525499|540377232|FG001|Overall Study|Adverse Event|1|||
149795088|NCT00525499|540377233|FG002|Overall Study|Adverse Event|0|||
149795089|NCT00525499|540377234|FG003|Overall Study|Adverse Event|1|||
149795090|NCT00525499|540377231|FG000|Overall Study|Withdrawal by Subject|5|||
149795091|NCT00525499|540377232|FG001|Overall Study|Withdrawal by Subject|1|||
149795092|NCT00525499|540377233|FG002|Overall Study|Withdrawal by Subject|5|||
149795093|NCT00525499|540377234|FG003|Overall Study|Withdrawal by Subject|2|||
149795094|NCT00525499|540377231|FG000|Overall Study|Protocol Violation|0|||
149795095|NCT00525499|540377232|FG001|Overall Study|Protocol Violation|1|||
149795096|NCT00525499|540377233|FG002|Overall Study|Protocol Violation|1|||
149795097|NCT00525499|540377234|FG003|Overall Study|Protocol Violation|0|||
149795098|NCT03287089|540377239|FG000|Overall Study|Lost to Follow-up|0|||
149795099|NCT03287089|540377240|FG001|Overall Study|Lost to Follow-up|2|||
149795100|NCT03287089|540377239|FG000|Overall Study|Physician Decision|0|||
149795101|NCT03287089|540377240|FG001|Overall Study|Physician Decision|2|||
149795102|NCT03287089|540377239|FG000|Overall Study|Withdrawal by Subject|0|||
149795103|NCT03287089|540377240|FG001|Overall Study|Withdrawal by Subject|2|||
149795104|NCT01729559|540377241|FG000|Overall Study|Protocol Violation|31|||
149795105|NCT01729559|540377242|FG001|Overall Study|Protocol Violation|28|||
149795106|NCT00608426|540377247|FG000|Overall Study|Death|32|||
149795107|NCT00608426|540377248|FG001|Overall Study|Death|36|||
149795108|NCT00608426|540377247|FG000|Overall Study|Lost to Follow-up|485|||
149795109|NCT00608426|540377248|FG001|Overall Study|Lost to Follow-up|521|||
149795110|NCT00608426|540377247|FG000|Overall Study|refused, health issues, wrong address|319|||
149795111|NCT00608426|540377248|FG001|Overall Study|refused, health issues, wrong address|348|||
149795112|NCT00761891|540377249|FG000|Overall Study|Withdrawal by Subject|10|||
149795113|NCT01453439|540377250|FG000|Treatment Phase|Withdrawal by Subject|13|||
149795114|NCT01453439|540377251|FG001|Treatment Phase|Withdrawal by Subject|10|||
149795115|NCT01453439|540377250|FG000|Treatment Phase|Suicidal Ideation|2|||
149795116|NCT01453439|540377251|FG001|Treatment Phase|Suicidal Ideation|0|||
149795117|NCT01453439|540377250|FG000|Treatment Phase|Need for higher level of care|1|||
149795118|NCT01453439|540377251|FG001|Treatment Phase|Need for higher level of care|1|||
149795119|NCT01453439|540377250|FG000|Treatment Phase|Therapist conflict of interest|1|||
149795120|NCT01453439|540377251|FG001|Treatment Phase|Therapist conflict of interest|0|||
149795121|NCT01453439|540377250|FG000|Follow-up|Withdrawal by Subject|0|||
149795122|NCT01453439|540377251|FG001|Follow-up|Withdrawal by Subject|1|||
149795123|NCT01453439|540377250|FG000|Follow-up|Lost to Follow-up|5|||
149795124|NCT01453439|540377251|FG001|Follow-up|Lost to Follow-up|10|||
149795125|NCT01014442|540377252|FG000|Overall Study|Adverse Event|0|||
149795126|NCT01014442|540377253|FG001|Overall Study|Adverse Event|8|||
149795127|NCT01014442|540377252|FG000|Overall Study|Withdrawal by Subject|4|||
149795128|NCT01014442|540377253|FG001|Overall Study|Withdrawal by Subject|4|||
149795129|NCT01014442|540377252|FG000|Overall Study|Protocol Violation|2|||
149795130|NCT01014442|540377253|FG001|Overall Study|Protocol Violation|5|||
149795131|NCT01014442|540377252|FG000|Overall Study|Lack of Compliance|0|||
149795132|NCT01014442|540377253|FG001|Overall Study|Lack of Compliance|1|||
149795133|NCT01014442|540377252|FG000|Overall Study|Unspecified Reason|1|||
149795134|NCT01014442|540377253|FG001|Overall Study|Unspecified Reason|1|||
149795135|NCT02764229|540377256|FG000|Overall Study|Withdrawal by Subject|15|||
149795136|NCT02764229|540377256|FG000|Overall Study|Adverse Event|9|||
149795137|NCT02764229|540377256|FG000|Overall Study|Physician Decision|5|||
149795138|NCT02764229|540377256|FG000|Overall Study|Lost to Follow-up|3|||
149795139|NCT02764229|540377256|FG000|Overall Study|Lack of Efficacy|1|||
149795140|NCT02764229|540377256|FG000|Overall Study|Study Stopped by Sponsor|69|||
149795141|NCT02135848|540377258|FG000|Overall Study|Adverse Event|2|||
149795142|NCT02135848|540377259|FG001|Overall Study|Adverse Event|0|||
149795143|NCT02135848|540377258|FG000|Overall Study|Withdrawal by Subject|1|||
149795144|NCT02135848|540377259|FG001|Overall Study|Withdrawal by Subject|1|||
149795145|NCT02030067|540377263|FG000|Overall Study|Disease Progression|1|||
149795146|NCT02030067|540377264|FG001|Overall Study|Disease Progression|1|||
149795147|NCT02030067|540377265|FG002|Overall Study|Disease Progression|2|||
149795148|NCT02030067|540377266|FG003|Overall Study|Disease Progression|2|||
149795149|NCT02030067|540377267|FG004|Overall Study|Disease Progression|3|||
149795150|NCT02030067|540377268|FG005|Overall Study|Disease Progression|2|||
149795151|NCT02030067|540377269|FG006|Overall Study|Disease Progression|3|||
149795152|NCT02030067|540377270|FG007|Overall Study|Disease Progression|3|||
149795153|NCT02030067|540377271|FG008|Overall Study|Disease Progression|4|||
149795154|NCT02030067|540377272|FG009|Overall Study|Disease Progression|3|||
149795155|NCT02030067|540377273|FG010|Overall Study|Disease Progression|7|||
149795156|NCT02030067|540377274|FG011|Overall Study|Disease Progression|2|||
149795157|NCT02030067|540377275|FG012|Overall Study|Disease Progression|59|||
149795158|NCT02030067|540377263|FG000|Overall Study|Withdrawal by Subject|0|||
149795159|NCT02030067|540377264|FG001|Overall Study|Withdrawal by Subject|0|||
149795160|NCT02030067|540377265|FG002|Overall Study|Withdrawal by Subject|0|||
149795161|NCT02030067|540377266|FG003|Overall Study|Withdrawal by Subject|1|||
149795162|NCT02030067|540377267|FG004|Overall Study|Withdrawal by Subject|0|||
149795163|NCT02030067|540377268|FG005|Overall Study|Withdrawal by Subject|0|||
149795164|NCT02030067|540377269|FG006|Overall Study|Withdrawal by Subject|0|||
149795165|NCT02030067|540377270|FG007|Overall Study|Withdrawal by Subject|1|||
149795166|NCT02030067|540377271|FG008|Overall Study|Withdrawal by Subject|0|||
149795167|NCT02030067|540377272|FG009|Overall Study|Withdrawal by Subject|0|||
149795168|NCT02030067|540377273|FG010|Overall Study|Withdrawal by Subject|3|||
149795169|NCT02030067|540377274|FG011|Overall Study|Withdrawal by Subject|0|||
149795170|NCT02030067|540377275|FG012|Overall Study|Withdrawal by Subject|6|||
149795171|NCT02030067|540377263|FG000|Overall Study|Physician Decision|0|||
149795172|NCT02030067|540377264|FG001|Overall Study|Physician Decision|0|||
149795173|NCT02030067|540377265|FG002|Overall Study|Physician Decision|0|||
149795174|NCT02030067|540377266|FG003|Overall Study|Physician Decision|0|||
149795175|NCT02030067|540377267|FG004|Overall Study|Physician Decision|0|||
149795176|NCT02030067|540377268|FG005|Overall Study|Physician Decision|0|||
149795177|NCT02030067|540377269|FG006|Overall Study|Physician Decision|0|||
149795178|NCT02030067|540377270|FG007|Overall Study|Physician Decision|0|||
149795179|NCT02030067|540377271|FG008|Overall Study|Physician Decision|0|||
149795180|NCT02030067|540377272|FG009|Overall Study|Physician Decision|0|||
149795181|NCT02030067|540377273|FG010|Overall Study|Physician Decision|1|||
149795182|NCT02030067|540377274|FG011|Overall Study|Physician Decision|0|||
149795183|NCT02030067|540377275|FG012|Overall Study|Physician Decision|3|||
149795184|NCT02030067|540377263|FG000|Overall Study|other reasons|0|||
149795185|NCT02030067|540377264|FG001|Overall Study|other reasons|0|||
149795186|NCT02030067|540377265|FG002|Overall Study|other reasons|0|||
149795187|NCT02030067|540377266|FG003|Overall Study|other reasons|0|||
149795188|NCT02030067|540377267|FG004|Overall Study|other reasons|0|||
149795189|NCT02030067|540377268|FG005|Overall Study|other reasons|1|||
149795190|NCT02030067|540377269|FG006|Overall Study|other reasons|0|||
149795191|NCT02030067|540377270|FG007|Overall Study|other reasons|0|||
149795192|NCT02030067|540377271|FG008|Overall Study|other reasons|2|||
149795193|NCT02030067|540377272|FG009|Overall Study|other reasons|0|||
149795194|NCT02030067|540377273|FG010|Overall Study|other reasons|0|||
149795195|NCT02030067|540377274|FG011|Overall Study|other reasons|0|||
149795196|NCT02030067|540377275|FG012|Overall Study|other reasons|4|||
149795197|NCT02030067|540377263|FG000|Overall Study|Adverse Event|0|||
149795198|NCT02030067|540377264|FG001|Overall Study|Adverse Event|0|||
149795199|NCT02030067|540377265|FG002|Overall Study|Adverse Event|0|||
149795200|NCT02030067|540377266|FG003|Overall Study|Adverse Event|0|||
149795201|NCT02030067|540377267|FG004|Overall Study|Adverse Event|0|||
149795202|NCT02030067|540377268|FG005|Overall Study|Adverse Event|0|||
149795203|NCT02030067|540377269|FG006|Overall Study|Adverse Event|0|||
149795204|NCT02030067|540377270|FG007|Overall Study|Adverse Event|0|||
149795205|NCT02030067|540377271|FG008|Overall Study|Adverse Event|0|||
149795206|NCT02030067|540377272|FG009|Overall Study|Adverse Event|0|||
149795207|NCT02030067|540377273|FG010|Overall Study|Adverse Event|0|||
149795208|NCT02030067|540377274|FG011|Overall Study|Adverse Event|1|||
149795209|NCT02030067|540377275|FG012|Overall Study|Adverse Event|8|||
149795210|NCT04118127|540377277|FG000|Overall Study|Trial terminated by sponsor|0|||
149795211|NCT04118127|540377278|FG001|Overall Study|Trial terminated by sponsor|12|||
149795212|NCT04118127|540377277|FG000|Overall Study|Adverse Event|1|||
149795213|NCT04118127|540377278|FG001|Overall Study|Adverse Event|2|||
149795214|NCT04118127|540377277|FG000|Overall Study|Physician Decision|0|||
149795215|NCT04118127|540377278|FG001|Overall Study|Physician Decision|1|||
149795216|NCT04118127|540377277|FG000|Overall Study|Withdrawal by Subject|2|||
149795217|NCT04118127|540377278|FG001|Overall Study|Withdrawal by Subject|1|||
149795218|NCT01646255|540377280|FG000|Overall Study|Adverse Event|7|||
149795219|NCT01646255|540377281|FG001|Overall Study|Adverse Event|8|||
149795220|NCT01646255|540377280|FG000|Overall Study|Lack of Efficacy|2|||
149795221|NCT01646255|540377281|FG001|Overall Study|Lack of Efficacy|0|||
149795222|NCT01646255|540377280|FG000|Overall Study|Withdrawal by Subject|10|||
149795223|NCT01646255|540377281|FG001|Overall Study|Withdrawal by Subject|6|||
149795224|NCT01646255|540377280|FG000|Overall Study|Compliance is not well|1|||
149795225|NCT01646255|540377281|FG001|Overall Study|Compliance is not well|0|||
149795226|NCT01646255|540377280|FG000|Overall Study|Inclusion Criteria Deviation|1|||
149795227|NCT01646255|540377281|FG001|Overall Study|Inclusion Criteria Deviation|0|||
149795228|NCT01376908|540377282|FG000|Overall Study|Protocol Violation|1|||
149795229|NCT01376908|540377283|FG001|Overall Study|Protocol Violation|1|||
149795230|NCT01376908|540377282|FG000|Overall Study|Withdrawal by Subject|1|||
149795231|NCT01376908|540377283|FG001|Overall Study|Withdrawal by Subject|2|||
149795232|NCT01681836|540377288|FG000|Second Intervention|Withdrawal by Subject|0|||
149795233|NCT01681836|540377289|FG001|Second Intervention|Withdrawal by Subject|1|||
149795234|NCT00742391|540377290|FG000|Overall Study|Adverse Event|2|||
149795235|NCT00742391|540377291|FG001|Overall Study|Adverse Event|1|||
149795236|NCT00742391|540377290|FG000|Overall Study|Lost to Follow-up|1|||
149795237|NCT00742391|540377291|FG001|Overall Study|Lost to Follow-up|0|||
149795238|NCT00742391|540377290|FG000|Overall Study|Protocol Violation|1|||
149795239|NCT00742391|540377291|FG001|Overall Study|Protocol Violation|0|||
149795240|NCT02394028|540377292|FG000|Induction Phase|Adverse Event|2|||
149795241|NCT02394028|540377293|FG001|Induction Phase|Adverse Event|4|||
149795242|NCT02394028|540377294|FG002|Induction Phase|Adverse Event|1|||
149795243|NCT02394028|540377295|FG003|Induction Phase|Adverse Event|2|||
149795244|NCT02394028|540377296|FG004|Induction Phase|Adverse Event|5|||
149795245|NCT02394028|540377297|FG005|Induction Phase|Adverse Event|2|||
149795246|NCT02394028|540377298|FG006|Induction Phase|Adverse Event|0|||
149795247|NCT02394028|540377299|FG007|Induction Phase|Adverse Event|0|||
149795248|NCT02394028|540377300|FG008|Induction Phase|Adverse Event|0|||
149795249|NCT02394028|540377301|FG009|Induction Phase|Adverse Event|0|||
149795250|NCT02394028|540377302|FG010|Induction Phase|Adverse Event|0|||
149795251|NCT02394028|540377292|FG000|Induction Phase|Lack of Efficacy|3|||
149795252|NCT02394028|540377293|FG001|Induction Phase|Lack of Efficacy|6|||
149795253|NCT02394028|540377294|FG002|Induction Phase|Lack of Efficacy|2|||
149795254|NCT02394028|540377295|FG003|Induction Phase|Lack of Efficacy|17|||
149795255|NCT02394028|540377296|FG004|Induction Phase|Lack of Efficacy|14|||
149795256|NCT02394028|540377297|FG005|Induction Phase|Lack of Efficacy|8|||
149795257|NCT02394028|540377298|FG006|Induction Phase|Lack of Efficacy|17|||
149795258|NCT02394028|540377299|FG007|Induction Phase|Lack of Efficacy|23|||
149795259|NCT02394028|540377300|FG008|Induction Phase|Lack of Efficacy|0|||
149795260|NCT02394028|540377301|FG009|Induction Phase|Lack of Efficacy|0|||
149795261|NCT02394028|540377302|FG010|Induction Phase|Lack of Efficacy|0|||
149795262|NCT02394028|540377292|FG000|Induction Phase|Lost to Follow-up|1|||
149795263|NCT02394028|540377293|FG001|Induction Phase|Lost to Follow-up|0|||
149795264|NCT02394028|540377294|FG002|Induction Phase|Lost to Follow-up|0|||
149795265|NCT02394028|540377295|FG003|Induction Phase|Lost to Follow-up|1|||
149795266|NCT02394028|540377296|FG004|Induction Phase|Lost to Follow-up|0|||
149795267|NCT02394028|540377297|FG005|Induction Phase|Lost to Follow-up|0|||
149795268|NCT02394028|540377298|FG006|Induction Phase|Lost to Follow-up|1|||
149795269|NCT02394028|540377299|FG007|Induction Phase|Lost to Follow-up|0|||
149795270|NCT02394028|540377300|FG008|Induction Phase|Lost to Follow-up|0|||
149795271|NCT02394028|540377301|FG009|Induction Phase|Lost to Follow-up|0|||
149795272|NCT02394028|540377302|FG010|Induction Phase|Lost to Follow-up|0|||
149795273|NCT02394028|540377292|FG000|Induction Phase|Non-compliance|0|||
149795274|NCT02394028|540377293|FG001|Induction Phase|Non-compliance|1|||
149795275|NCT02394028|540377294|FG002|Induction Phase|Non-compliance|3|||
149795276|NCT02394028|540377295|FG003|Induction Phase|Non-compliance|1|||
149795277|NCT02394028|540377296|FG004|Induction Phase|Non-compliance|3|||
149795278|NCT02394028|540377297|FG005|Induction Phase|Non-compliance|0|||
149795279|NCT02394028|540377298|FG006|Induction Phase|Non-compliance|1|||
149795280|NCT02394028|540377299|FG007|Induction Phase|Non-compliance|1|||
149795281|NCT02394028|540377300|FG008|Induction Phase|Non-compliance|0|||
149795282|NCT02394028|540377301|FG009|Induction Phase|Non-compliance|0|||
149795283|NCT02394028|540377302|FG010|Induction Phase|Non-compliance|0|||
149795284|NCT02394028|540377292|FG000|Induction Phase|Physician Decision|0|||
149795285|NCT02394028|540377293|FG001|Induction Phase|Physician Decision|0|||
149795286|NCT02394028|540377294|FG002|Induction Phase|Physician Decision|1|||
149795287|NCT02394028|540377295|FG003|Induction Phase|Physician Decision|4|||
149795288|NCT02394028|540377296|FG004|Induction Phase|Physician Decision|0|||
149795289|NCT02394028|540377297|FG005|Induction Phase|Physician Decision|2|||
149795290|NCT02394028|540377298|FG006|Induction Phase|Physician Decision|1|||
149795291|NCT02394028|540377299|FG007|Induction Phase|Physician Decision|0|||
149795292|NCT02394028|540377300|FG008|Induction Phase|Physician Decision|0|||
149795293|NCT02394028|540377301|FG009|Induction Phase|Physician Decision|0|||
149795294|NCT02394028|540377302|FG010|Induction Phase|Physician Decision|0|||
149795295|NCT02394028|540377292|FG000|Induction Phase|Protocol Violation|0|||
149795296|NCT02394028|540377293|FG001|Induction Phase|Protocol Violation|2|||
149795297|NCT02394028|540377294|FG002|Induction Phase|Protocol Violation|0|||
149795298|NCT02394028|540377295|FG003|Induction Phase|Protocol Violation|3|||
149795299|NCT02394028|540377296|FG004|Induction Phase|Protocol Violation|0|||
149795300|NCT02394028|540377297|FG005|Induction Phase|Protocol Violation|1|||
149795301|NCT02394028|540377298|FG006|Induction Phase|Protocol Violation|1|||
149795302|NCT02394028|540377299|FG007|Induction Phase|Protocol Violation|0|||
149795303|NCT02394028|540377300|FG008|Induction Phase|Protocol Violation|0|||
149795304|NCT02394028|540377301|FG009|Induction Phase|Protocol Violation|0|||
149795305|NCT02394028|540377302|FG010|Induction Phase|Protocol Violation|0|||
149795306|NCT02394028|540377292|FG000|Induction Phase|Withdrawal by Subject|1|||
149795307|NCT02394028|540377293|FG001|Induction Phase|Withdrawal by Subject|2|||
149795308|NCT02394028|540377294|FG002|Induction Phase|Withdrawal by Subject|4|||
149795309|NCT02394028|540377295|FG003|Induction Phase|Withdrawal by Subject|6|||
149795310|NCT02394028|540377296|FG004|Induction Phase|Withdrawal by Subject|7|||
149795311|NCT02394028|540377297|FG005|Induction Phase|Withdrawal by Subject|4|||
149795312|NCT02394028|540377298|FG006|Induction Phase|Withdrawal by Subject|3|||
149795313|NCT02394028|540377299|FG007|Induction Phase|Withdrawal by Subject|6|||
149795314|NCT02394028|540377300|FG008|Induction Phase|Withdrawal by Subject|0|||
149795315|NCT02394028|540377301|FG009|Induction Phase|Withdrawal by Subject|0|||
149795316|NCT02394028|540377302|FG010|Induction Phase|Withdrawal by Subject|0|||
149795317|NCT02394028|540377292|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795318|NCT02394028|540377293|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795319|NCT02394028|540377294|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795320|NCT02394028|540377295|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795321|NCT02394028|540377296|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795322|NCT02394028|540377297|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795323|NCT02394028|540377298|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
149795324|NCT02394028|540377299|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795325|NCT02394028|540377300|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795326|NCT02394028|540377301|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795327|NCT02394028|540377302|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
149795328|NCT02394028|540377292|FG000|Induction Phase|Sponsor decision|0|||
149795329|NCT02394028|540377293|FG001|Induction Phase|Sponsor decision|1|||
149795330|NCT02394028|540377294|FG002|Induction Phase|Sponsor decision|2|||
149795331|NCT02394028|540377295|FG003|Induction Phase|Sponsor decision|0|||
149795332|NCT02394028|540377296|FG004|Induction Phase|Sponsor decision|0|||
149795333|NCT02394028|540377297|FG005|Induction Phase|Sponsor decision|0|||
149795334|NCT02394028|540377298|FG006|Induction Phase|Sponsor decision|0|||
149795335|NCT02394028|540377299|FG007|Induction Phase|Sponsor decision|0|||
149795336|NCT02394028|540377300|FG008|Induction Phase|Sponsor decision|0|||
149795337|NCT02394028|540377301|FG009|Induction Phase|Sponsor decision|0|||
149795338|NCT02394028|540377302|FG010|Induction Phase|Sponsor decision|0|||
149795339|NCT02394028|540377292|FG000|Induction Phase|Technical reason|0|||
149795340|NCT02394028|540377293|FG001|Induction Phase|Technical reason|0|||
149795341|NCT02394028|540377294|FG002|Induction Phase|Technical reason|0|||
149795342|NCT02394028|540377295|FG003|Induction Phase|Technical reason|1|||
149795343|NCT02394028|540377296|FG004|Induction Phase|Technical reason|0|||
149795344|NCT02394028|540377297|FG005|Induction Phase|Technical reason|0|||
149795345|NCT02394028|540377298|FG006|Induction Phase|Technical reason|0|||
149795346|NCT02394028|540377299|FG007|Induction Phase|Technical reason|0|||
149795347|NCT02394028|540377300|FG008|Induction Phase|Technical reason|0|||
149795348|NCT02394028|540377301|FG009|Induction Phase|Technical reason|0|||
149795349|NCT02394028|540377302|FG010|Induction Phase|Technical reason|0|||
149795350|NCT02394028|540377292|FG000|Induction Phase|:ack of calculation|0|||
149795351|NCT02394028|540377293|FG001|Induction Phase|:ack of calculation|0|||
149795352|NCT02394028|540377294|FG002|Induction Phase|:ack of calculation|0|||
149795353|NCT02394028|540377295|FG003|Induction Phase|:ack of calculation|0|||
149795354|NCT02394028|540377296|FG004|Induction Phase|:ack of calculation|0|||
149795355|NCT02394028|540377297|FG005|Induction Phase|:ack of calculation|0|||
149795356|NCT02394028|540377298|FG006|Induction Phase|:ack of calculation|0|||
149795357|NCT02394028|540377299|FG007|Induction Phase|:ack of calculation|1|||
149795358|NCT02394028|540377300|FG008|Induction Phase|:ack of calculation|0|||
149795359|NCT02394028|540377301|FG009|Induction Phase|:ack of calculation|0|||
149795360|NCT02394028|540377302|FG010|Induction Phase|:ack of calculation|0|||
149795361|NCT02394028|540377292|FG000|Maintenance Phase|Protocol Violation|0|||
149795362|NCT02394028|540377293|FG001|Maintenance Phase|Protocol Violation|0|||
149795363|NCT02394028|540377294|FG002|Maintenance Phase|Protocol Violation|0|||
149795364|NCT02394028|540377295|FG003|Maintenance Phase|Protocol Violation|0|||
149795365|NCT02394028|540377296|FG004|Maintenance Phase|Protocol Violation|0|||
149795366|NCT02394028|540377297|FG005|Maintenance Phase|Protocol Violation|0|||
149795367|NCT02394028|540377298|FG006|Maintenance Phase|Protocol Violation|0|||
149795368|NCT02394028|540377299|FG007|Maintenance Phase|Protocol Violation|0|||
149795369|NCT02394028|540377300|FG008|Maintenance Phase|Protocol Violation|0|||
149795370|NCT02394028|540377301|FG009|Maintenance Phase|Protocol Violation|0|||
149795371|NCT02394028|540377302|FG010|Maintenance Phase|Protocol Violation|1|||
149795372|NCT02394028|540377292|FG000|Maintenance Phase|Physician Decision|0|||
149795373|NCT02394028|540377293|FG001|Maintenance Phase|Physician Decision|0|||
149795374|NCT02394028|540377294|FG002|Maintenance Phase|Physician Decision|0|||
149795375|NCT02394028|540377295|FG003|Maintenance Phase|Physician Decision|0|||
149795376|NCT02394028|540377296|FG004|Maintenance Phase|Physician Decision|0|||
149795377|NCT02394028|540377297|FG005|Maintenance Phase|Physician Decision|0|||
149795378|NCT02394028|540377298|FG006|Maintenance Phase|Physician Decision|0|||
149795379|NCT02394028|540377299|FG007|Maintenance Phase|Physician Decision|0|||
149795380|NCT02394028|540377300|FG008|Maintenance Phase|Physician Decision|1|||
149795381|NCT02394028|540377301|FG009|Maintenance Phase|Physician Decision|3|||
149795382|NCT02394028|540377302|FG010|Maintenance Phase|Physician Decision|2|||
149795383|NCT02394028|540377292|FG000|Maintenance Phase|Lack of Efficacy|0|||
149795384|NCT02394028|540377293|FG001|Maintenance Phase|Lack of Efficacy|0|||
149795385|NCT02394028|540377294|FG002|Maintenance Phase|Lack of Efficacy|0|||
149795386|NCT02394028|540377295|FG003|Maintenance Phase|Lack of Efficacy|0|||
149795387|NCT02394028|540377296|FG004|Maintenance Phase|Lack of Efficacy|0|||
149795388|NCT02394028|540377297|FG005|Maintenance Phase|Lack of Efficacy|0|||
149795389|NCT02394028|540377298|FG006|Maintenance Phase|Lack of Efficacy|0|||
149795390|NCT02394028|540377299|FG007|Maintenance Phase|Lack of Efficacy|0|||
149795391|NCT02394028|540377300|FG008|Maintenance Phase|Lack of Efficacy|7|||
149795392|NCT02394028|540377301|FG009|Maintenance Phase|Lack of Efficacy|25|||
149795393|NCT02394028|540377302|FG010|Maintenance Phase|Lack of Efficacy|33|||
149795394|NCT02394028|540377292|FG000|Maintenance Phase|Death|0|||
149795395|NCT02394028|540377293|FG001|Maintenance Phase|Death|0|||
149795396|NCT02394028|540377294|FG002|Maintenance Phase|Death|0|||
149795397|NCT02394028|540377295|FG003|Maintenance Phase|Death|0|||
149795398|NCT02394028|540377296|FG004|Maintenance Phase|Death|0|||
149795399|NCT02394028|540377297|FG005|Maintenance Phase|Death|0|||
149795400|NCT02394028|540377298|FG006|Maintenance Phase|Death|0|||
149795401|NCT02394028|540377299|FG007|Maintenance Phase|Death|0|||
149795402|NCT02394028|540377300|FG008|Maintenance Phase|Death|0|||
149795403|NCT02394028|540377301|FG009|Maintenance Phase|Death|0|||
149795404|NCT02394028|540377302|FG010|Maintenance Phase|Death|1|||
149795405|NCT02394028|540377292|FG000|Maintenance Phase|Adverse Event|0|||
149795406|NCT02394028|540377293|FG001|Maintenance Phase|Adverse Event|0|||
149795407|NCT02394028|540377294|FG002|Maintenance Phase|Adverse Event|0|||
149795408|NCT02394028|540377295|FG003|Maintenance Phase|Adverse Event|0|||
149795409|NCT02394028|540377296|FG004|Maintenance Phase|Adverse Event|0|||
149795410|NCT02394028|540377297|FG005|Maintenance Phase|Adverse Event|0|||
149795411|NCT02394028|540377298|FG006|Maintenance Phase|Adverse Event|0|||
149795412|NCT02394028|540377299|FG007|Maintenance Phase|Adverse Event|0|||
149795413|NCT02394028|540377300|FG008|Maintenance Phase|Adverse Event|1|||
149795414|NCT02394028|540377301|FG009|Maintenance Phase|Adverse Event|1|||
149795415|NCT02394028|540377302|FG010|Maintenance Phase|Adverse Event|3|||
149795416|NCT02394028|540377292|FG000|Maintenance Phase|Site closure|0|||
149795417|NCT02394028|540377293|FG001|Maintenance Phase|Site closure|0|||
149795418|NCT02394028|540377294|FG002|Maintenance Phase|Site closure|0|||
149795419|NCT02394028|540377295|FG003|Maintenance Phase|Site closure|0|||
149795420|NCT02394028|540377296|FG004|Maintenance Phase|Site closure|0|||
149795421|NCT02394028|540377297|FG005|Maintenance Phase|Site closure|0|||
149795422|NCT02394028|540377298|FG006|Maintenance Phase|Site closure|0|||
149795423|NCT02394028|540377299|FG007|Maintenance Phase|Site closure|0|||
149795424|NCT02394028|540377300|FG008|Maintenance Phase|Site closure|0|||
149795425|NCT02394028|540377301|FG009|Maintenance Phase|Site closure|1|||
149795426|NCT02394028|540377302|FG010|Maintenance Phase|Site closure|0|||
149795427|NCT02394028|540377292|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149795428|NCT02394028|540377293|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149795429|NCT02394028|540377294|FG002|Maintenance Phase|Withdrawal by Subject|0|||
149795430|NCT02394028|540377295|FG003|Maintenance Phase|Withdrawal by Subject|0|||
149795431|NCT02394028|540377296|FG004|Maintenance Phase|Withdrawal by Subject|0|||
149795432|NCT02394028|540377297|FG005|Maintenance Phase|Withdrawal by Subject|0|||
149795433|NCT02394028|540377298|FG006|Maintenance Phase|Withdrawal by Subject|0|||
149795434|NCT02394028|540377299|FG007|Maintenance Phase|Withdrawal by Subject|0|||
149795435|NCT02394028|540377300|FG008|Maintenance Phase|Withdrawal by Subject|3|||
149795436|NCT02394028|540377301|FG009|Maintenance Phase|Withdrawal by Subject|12|||
149795437|NCT02394028|540377302|FG010|Maintenance Phase|Withdrawal by Subject|12|||
149795438|NCT02142712|540377305|FG000|Overall Study|Lost to Follow-up|1|||
149795439|NCT02142712|540377306|FG001|Overall Study|Lost to Follow-up|1|||
149795440|NCT02142712|540377307|FG002|Overall Study|Lost to Follow-up|1|||
149795441|NCT02142712|540377308|FG003|Overall Study|Lost to Follow-up|0|||
149795442|NCT01241318|540377316|FG000|Overall Study|Woman: false pregnancies|27|||
149795443|NCT01241318|540377317|FG001|Overall Study|Woman: false pregnancies|15|||
149795444|NCT01241318|540377316|FG000|Overall Study|Woman: miscarriage/abortion|46|||
149795445|NCT01241318|540377317|FG001|Overall Study|Woman: miscarriage/abortion|38|||
149795446|NCT01241318|540377316|FG000|Overall Study|Withdrawal by Subject|175|||
149795447|NCT01241318|540377317|FG001|Overall Study|Withdrawal by Subject|46|||
149795448|NCT01241318|540377316|FG000|Overall Study|Lost to Follow-up|740|||
149795449|NCT01241318|540377317|FG001|Overall Study|Lost to Follow-up|455|||
149795450|NCT01241318|540377316|FG000|Overall Study|Death|2|||
149795451|NCT01241318|540377317|FG001|Overall Study|Death|4|||
149795452|NCT01241318|540377316|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
149795453|NCT01241318|540377317|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
149795454|NCT01241318|540377316|FG000|Overall Study|Woman: Stillborn infant|129|||
149795455|NCT01241318|540377317|FG001|Overall Study|Woman: Stillborn infant|146|||
149795456|NCT02355665|540377318|FG000|Overall Study|Adverse Event|16|||
149795457|NCT02355665|540377319|FG001|Overall Study|Adverse Event|24|||
149795458|NCT02355665|540377318|FG000|Overall Study|Protocol Violation|2|||
149795459|NCT02355665|540377319|FG001|Overall Study|Protocol Violation|0|||
149795460|NCT02355665|540377318|FG000|Overall Study|Withdrawal by Subject|90|||
149795461|NCT02355665|540377319|FG001|Overall Study|Withdrawal by Subject|100|||
149795462|NCT02355665|540377318|FG000|Overall Study|Lost to Follow-up|131|||
149795463|NCT02355665|540377319|FG001|Overall Study|Lost to Follow-up|103|||
149795464|NCT02355665|540377318|FG000|Overall Study|Death|4|||
149795465|NCT02355665|540377319|FG001|Overall Study|Death|2|||
149795466|NCT02355665|540377318|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
149795467|NCT02355665|540377319|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
149795468|NCT04129242|540377320|FG000|Overall Study|Physician Decision|1|||
149795469|NCT04129242|540377321|FG001|Overall Study|Physician Decision|1|||
149795470|NCT04129242|540377320|FG000|Overall Study|Protocol Violation|0|||
149795471|NCT04129242|540377321|FG001|Overall Study|Protocol Violation|1|||
149795472|NCT02853318|540377324|FG000|Overall Study|Withdrawal by Subject|1|||
149795473|NCT02646332|540377330|FG000|Overall Study|Lost to Follow-up|0|||
149795474|NCT02646332|540377331|FG001|Overall Study|Lost to Follow-up|3|||
149795475|NCT01882439|540377332|FG000|Overall Study|Adverse event related to study drug|3|||
149795476|NCT01882439|540377333|FG001|Overall Study|Adverse event related to study drug|8|||
149795477|NCT01882439|540377334|FG002|Overall Study|Adverse event related to study drug|1|||
149795478|NCT01882439|540377335|FG003|Overall Study|Adverse event related to study drug|2|||
149795479|NCT01882439|540377332|FG000|Overall Study|Pregnancy|0|||
149795480|NCT01882439|540377333|FG001|Overall Study|Pregnancy|1|||
149795481|NCT01882439|540377334|FG002|Overall Study|Pregnancy|0|||
149795482|NCT01882439|540377335|FG003|Overall Study|Pregnancy|0|||
149795483|NCT01882439|540377332|FG000|Overall Study|Protocol Violation|2|||
149795484|NCT01882439|540377333|FG001|Overall Study|Protocol Violation|2|||
149795485|NCT01882439|540377334|FG002|Overall Study|Protocol Violation|0|||
149795486|NCT01882439|540377335|FG003|Overall Study|Protocol Violation|1|||
149795487|NCT01882439|540377332|FG000|Overall Study|No longer willing to participate|1|||
149795488|NCT01882439|540377333|FG001|Overall Study|No longer willing to participate|4|||
149795489|NCT01882439|540377334|FG002|Overall Study|No longer willing to participate|2|||
149795490|NCT01882439|540377335|FG003|Overall Study|No longer willing to participate|3|||
149795491|NCT01882439|540377332|FG000|Overall Study|Medication error with no associated AE|0|||
149795492|NCT01882439|540377333|FG001|Overall Study|Medication error with no associated AE|0|||
149795493|NCT01882439|540377334|FG002|Overall Study|Medication error with no associated AE|2|||
149795494|NCT01882439|540377335|FG003|Overall Study|Medication error with no associated AE|0|||
149795495|NCT01882439|540377332|FG000|Overall Study|Insufficient clinical response|1|||
149795496|NCT01882439|540377333|FG001|Overall Study|Insufficient clinical response|4|||
149795497|NCT01882439|540377334|FG002|Overall Study|Insufficient clinical response|4|||
149795498|NCT01882439|540377335|FG003|Overall Study|Insufficient clinical response|2|||
149795499|NCT01882439|540377332|FG000|Overall Study|Adverse event unrelated to study drug|2|||
149795500|NCT01882439|540377333|FG001|Overall Study|Adverse event unrelated to study drug|2|||
149795501|NCT01882439|540377334|FG002|Overall Study|Adverse event unrelated to study drug|1|||
149795502|NCT01882439|540377335|FG003|Overall Study|Adverse event unrelated to study drug|1|||
149795503|NCT02909504|540377338|FG000|Overall Study|Adverse Event|2|||
149795504|NCT02909504|540377338|FG000|Overall Study|Lack of Efficacy|3|||
149795505|NCT02909504|540377338|FG000|Overall Study|Withdrawal by Subject|4|||
149795506|NCT02909504|540377338|FG000|Overall Study|Pregnancy|1|||
149795507|NCT02909504|540377338|FG000|Overall Study|Subject moved|1|||
149795508|NCT02909504|540377338|FG000|Overall Study|Lost to Follow-up|1|||
149795509|NCT02055976|540377339|FG000|Overall Study|Other|0|||
149795510|NCT02055976|540377340|FG001|Overall Study|Other|0|||
149795511|NCT02055976|540377341|FG002|Overall Study|Other|1|||
149795512|NCT02055976|540377342|FG003|Overall Study|Other|0|||
149795513|NCT02055976|540377343|FG004|Overall Study|Other|0|||
149795514|NCT02055976|540377344|FG005|Overall Study|Other|0|||
149795515|NCT02055976|540377345|FG006|Overall Study|Other|0|||
149795516|NCT02055976|540377346|FG007|Overall Study|Other|0|||
149795517|NCT02055976|540377347|FG008|Overall Study|Other|0|||
149795518|NCT02055976|540377339|FG000|Overall Study|Adverse Event|0|||
149795519|NCT02055976|540377340|FG001|Overall Study|Adverse Event|0|||
149795520|NCT02055976|540377341|FG002|Overall Study|Adverse Event|0|||
149795521|NCT02055976|540377342|FG003|Overall Study|Adverse Event|0|||
149795522|NCT02055976|540377343|FG004|Overall Study|Adverse Event|0|||
149795523|NCT02055976|540377344|FG005|Overall Study|Adverse Event|1|||
149795524|NCT02055976|540377345|FG006|Overall Study|Adverse Event|1|||
149795525|NCT02055976|540377346|FG007|Overall Study|Adverse Event|0|||
149795526|NCT02055976|540377347|FG008|Overall Study|Adverse Event|0|||
149795527|NCT02055976|540377339|FG000|Overall Study|Does not meet entrance criteria|0|||
149795528|NCT02055976|540377340|FG001|Overall Study|Does not meet entrance criteria|0|||
149795529|NCT02055976|540377341|FG002|Overall Study|Does not meet entrance criteria|0|||
149795530|NCT02055976|540377342|FG003|Overall Study|Does not meet entrance criteria|0|||
149795531|NCT02055976|540377343|FG004|Overall Study|Does not meet entrance criteria|0|||
149795532|NCT02055976|540377344|FG005|Overall Study|Does not meet entrance criteria|0|||
149795533|NCT02055976|540377345|FG006|Overall Study|Does not meet entrance criteria|1|||
149795534|NCT02055976|540377346|FG007|Overall Study|Does not meet entrance criteria|0|||
149795535|NCT02055976|540377347|FG008|Overall Study|Does not meet entrance criteria|0|||
149795536|NCT02055976|540377339|FG000|Overall Study|Lost to Follow-up|0|||
149795537|NCT02055976|540377340|FG001|Overall Study|Lost to Follow-up|0|||
149795538|NCT02055976|540377341|FG002|Overall Study|Lost to Follow-up|0|||
149795539|NCT02055976|540377342|FG003|Overall Study|Lost to Follow-up|1|||
149795540|NCT02055976|540377343|FG004|Overall Study|Lost to Follow-up|0|||
149795541|NCT02055976|540377344|FG005|Overall Study|Lost to Follow-up|0|||
149795542|NCT02055976|540377345|FG006|Overall Study|Lost to Follow-up|0|||
149795543|NCT02055976|540377346|FG007|Overall Study|Lost to Follow-up|0|||
149795544|NCT02055976|540377347|FG008|Overall Study|Lost to Follow-up|0|||
149795545|NCT03769753|540377350|FG000|Overall Study|Not Treated|6|||
149795546|NCT03769753|540377350|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
149795547|NCT00684073|540377351|FG000|Selection|Selection/non-selection criteria|3|||
149795548|NCT00684073|540377351|FG000|Selection|Death|1|||
149795549|NCT00684073|540377351|FG000|Selection|noncompliance|1|||
149795550|NCT00684073|540377351|FG000|Selection|Lost to Follow-up|1|||
149795551|NCT00684073|540377351|FG000|Selection|request of the sponsor|1|||
149795552|NCT00684073|540377351|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
149795553|NCT01657903|540377353|FG000|Overall Study|Lost to Follow-up|1|||
149795554|NCT01657903|540377353|FG000|Overall Study|Withdrawal by Subject|1|||
149795555|NCT00620815|540377354|FG000|Overall Study|Adverse Event|1|||
149795556|NCT00620815|540377355|FG001|Overall Study|Adverse Event|1|||
149795557|NCT00620815|540377356|FG002|Overall Study|Adverse Event|2|||
149795558|NCT00620815|540377354|FG000|Overall Study|Withdrawal by Subject|1|||
149795559|NCT00620815|540377355|FG001|Overall Study|Withdrawal by Subject|2|||
149795560|NCT00620815|540377356|FG002|Overall Study|Withdrawal by Subject|0|||
149795561|NCT00620815|540377354|FG000|Overall Study|Lost to Follow-up|1|||
149795562|NCT00620815|540377355|FG001|Overall Study|Lost to Follow-up|6|||
149795563|NCT00620815|540377356|FG002|Overall Study|Lost to Follow-up|3|||
149795564|NCT00620815|540377354|FG000|Overall Study|Inappropriate enrolment|0|||
149795565|NCT00620815|540377355|FG001|Overall Study|Inappropriate enrolment|0|||
149795566|NCT00620815|540377356|FG002|Overall Study|Inappropriate enrolment|1|||
149795567|NCT00620815|540377354|FG000|Overall Study|Protocol Violation|1|||
149795568|NCT00620815|540377355|FG001|Overall Study|Protocol Violation|2|||
149795569|NCT00620815|540377356|FG002|Overall Study|Protocol Violation|1|||
149795570|NCT00983827|540377357|FG000|Overall Study|Withdrawal by Subject|1|||
149795571|NCT02146352|540377360|FG000|Overall Study|Death|1|||
149795572|NCT02146352|540377360|FG000|Overall Study|Patient entered hospice care|1|||
149795573|NCT02828982|540377363|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149795574|NCT02828982|540377364|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149795575|NCT01156012|540377365|FG000|Overall Study|Adverse Event|3|||
149795576|NCT01156012|540377366|FG001|Overall Study|Adverse Event|1|||
149795577|NCT01156012|540377365|FG000|Overall Study|Lost to Follow-up|1|||
149795578|NCT01156012|540377366|FG001|Overall Study|Lost to Follow-up|0|||
149795579|NCT01156012|540377365|FG000|Overall Study|Withdrawal by Subject|1|||
149795580|NCT01156012|540377366|FG001|Overall Study|Withdrawal by Subject|0|||
149795581|NCT01156012|540377365|FG000|Overall Study|use of commercial drug instead of study|0|||
149795582|NCT01156012|540377366|FG001|Overall Study|use of commercial drug instead of study|1|||
149795583|NCT01156012|540377365|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
149795584|NCT01156012|540377366|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
149795585|NCT02705755|540377367|FG000|Part A (6 Days)|Adverse Event|1|||
149795586|NCT02705755|540377368|FG001|Part A (6 Days)|Adverse Event|0|||
149795587|NCT02705755|540377369|FG002|Part A (6 Days)|Adverse Event|0|||
149795588|NCT02705755|540377370|FG003|Part A (6 Days)|Adverse Event|0|||
149795589|NCT02705755|540377367|FG000|Part A (6 Days)|Physician Decision|3|||
149795590|NCT02705755|540377368|FG001|Part A (6 Days)|Physician Decision|0|||
149795591|NCT02705755|540377369|FG002|Part A (6 Days)|Physician Decision|0|||
149795592|NCT02705755|540377370|FG003|Part A (6 Days)|Physician Decision|0|||
149795593|NCT02705755|540377367|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
149795594|NCT02705755|540377368|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
149795595|NCT02705755|540377369|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
149795596|NCT02705755|540377370|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
149795597|NCT02705755|540377367|FG000|Part C (20 Weeks)|Physician Decision|0|||
149795598|NCT02705755|540377368|FG001|Part C (20 Weeks)|Physician Decision|0|||
149795599|NCT02705755|540377369|FG002|Part C (20 Weeks)|Physician Decision|0|||
149795600|NCT02705755|540377370|FG003|Part C (20 Weeks)|Physician Decision|2|||
149795601|NCT02705755|540377367|FG000|Part C (20 Weeks)|Adverse Event|0|||
149795602|NCT02705755|540377368|FG001|Part C (20 Weeks)|Adverse Event|0|||
149795603|NCT02705755|540377369|FG002|Part C (20 Weeks)|Adverse Event|0|||
149795604|NCT02705755|540377370|FG003|Part C (20 Weeks)|Adverse Event|6|||
149795605|NCT02705755|540377367|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
149795606|NCT02705755|540377368|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
149795607|NCT02705755|540377369|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
149795608|NCT02705755|540377370|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
149795609|NCT04308668|540379513|FG000|Overall Study|Lost to Follow-up|32|||
149795610|NCT04308668|540379514|FG001|Overall Study|Lost to Follow-up|38|||
149795611|NCT04308668|540379513|FG000|Overall Study|Withdrawal by Subject|4|||
149795612|NCT04308668|540379514|FG001|Overall Study|Withdrawal by Subject|4|||
149795613|NCT01020812|540379515|FG000|Overall Study|Physician Decision|1|||
149795614|NCT01020812|540379515|FG000|Overall Study|Withdrawal by Subject|1|||
149795615|NCT01020812|540379515|FG000|Overall Study|Protocol Violation|1|||
149795616|NCT02927990|540379516|FG000|Overall Study|Protocol Violation|4|||
149795617|NCT02927990|540379516|FG000|Overall Study|Physician Decision|9|||
149795618|NCT02927990|540379516|FG000|Overall Study|Room switched and therefore no study device available|15|||
149795619|NCT02927990|540379516|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
149795620|NCT00960323|540379517|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
149795621|NCT03258710|540379524|FG000|Overall Study|Adverse Event|1|||
149795622|NCT03258710|540379524|FG000|Overall Study|Protocol-defined stopping criteria|1|||
149795623|NCT03258710|540379524|FG000|Overall Study|Physician Decision|1|||
149795624|NCT03451630|540379525|FG000|Overall Study|Death|15|||
149795625|NCT03451630|540379526|FG001|Overall Study|Death|16|||
149795626|NCT03451630|540379527|FG002|Overall Study|Death|11|||
149795627|NCT03451630|540379525|FG000|Overall Study|Lost to Follow-up|9|||
149795628|NCT03451630|540379526|FG001|Overall Study|Lost to Follow-up|0|||
149795629|NCT03451630|540379527|FG002|Overall Study|Lost to Follow-up|4|||
149795630|NCT03451630|540379525|FG000|Overall Study|Withdrawal by Subject|0|||
149795631|NCT03451630|540379526|FG001|Overall Study|Withdrawal by Subject|3|||
149795632|NCT03451630|540379527|FG002|Overall Study|Withdrawal by Subject|0|||
149795633|NCT03451630|540379525|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
149795634|NCT03451630|540379526|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
149795635|NCT03451630|540379527|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
149795636|NCT02041533|540379528|FG000|Pre-Treatment Period|Disease Progression|1|||
149795637|NCT02041533|540379529|FG001|Pre-Treatment Period|Disease Progression|1|||
149795638|NCT02041533|540379528|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
149795639|NCT02041533|540379529|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
149795640|NCT02041533|540379528|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
149795641|NCT02041533|540379529|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
149795642|NCT02041533|540379528|FG000|Treatment Period|Disease progression|189|||
149795643|NCT02041533|540379529|FG001|Treatment Period|Disease progression|146|||
149795644|NCT02041533|540379528|FG000|Treatment Period|Study drug toxicity|30|||
149795645|NCT02041533|540379529|FG001|Treatment Period|Study drug toxicity|34|||
149795646|NCT02041533|540379528|FG000|Treatment Period|Death|1|||
149795647|NCT02041533|540379529|FG001|Treatment Period|Death|0|||
149795648|NCT02041533|540379528|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
149795649|NCT02041533|540379529|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
149795650|NCT02041533|540379528|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
149795651|NCT02041533|540379529|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
149795652|NCT02041533|540379528|FG000|Treatment Period|Participant withdrew consent|2|||
149795653|NCT02041533|540379529|FG001|Treatment Period|Participant withdrew consent|2|||
149795654|NCT02041533|540379528|FG000|Treatment Period|Maximum clinical benefit|0|||
149795655|NCT02041533|540379529|FG001|Treatment Period|Maximum clinical benefit|18|||
149795656|NCT02041533|540379528|FG000|Treatment Period|Poor/Non-compliance|1|||
149795657|NCT02041533|540379529|FG001|Treatment Period|Poor/Non-compliance|0|||
149795658|NCT02041533|540379528|FG000|Treatment Period|Administrative reason by sponsor|1|||
149795659|NCT02041533|540379529|FG001|Treatment Period|Administrative reason by sponsor|0|||
149795660|NCT02041533|540379528|FG000|Treatment Period|Other reasons|9|||
149795661|NCT02041533|540379529|FG001|Treatment Period|Other reasons|2|||
149795662|NCT02041533|540379528|FG000|Treatment Period|Not Reported|0|||
149795663|NCT02041533|540379529|FG001|Treatment Period|Not Reported|1|||
149795664|NCT00545740|540379530|FG000|Overall Study|Lack of Efficacy|34|||
149795665|NCT00545740|540379531|FG001|Overall Study|Lack of Efficacy|35|||
149795666|NCT00545740|540379532|FG002|Overall Study|Lack of Efficacy|47|||
149795667|NCT00545740|540379533|FG003|Overall Study|Lack of Efficacy|36|||
149795668|NCT00545740|540379530|FG000|Overall Study|Withdrawal by Subject|17|||
149795669|NCT00545740|540379531|FG001|Overall Study|Withdrawal by Subject|15|||
149795670|NCT00545740|540379532|FG002|Overall Study|Withdrawal by Subject|16|||
149795671|NCT00545740|540379533|FG003|Overall Study|Withdrawal by Subject|18|||
149795672|NCT00545740|540379530|FG000|Overall Study|Adverse Event|10|||
149795673|NCT00545740|540379531|FG001|Overall Study|Adverse Event|18|||
149795674|NCT00545740|540379532|FG002|Overall Study|Adverse Event|19|||
149795675|NCT00545740|540379533|FG003|Overall Study|Adverse Event|9|||
149795676|NCT00545740|540379530|FG000|Overall Study|Lost to Follow-up|7|||
149795677|NCT00545740|540379531|FG001|Overall Study|Lost to Follow-up|5|||
149795678|NCT00545740|540379532|FG002|Overall Study|Lost to Follow-up|5|||
149795679|NCT00545740|540379533|FG003|Overall Study|Lost to Follow-up|6|||
149795680|NCT00545740|540379530|FG000|Overall Study|Protocol Violation|1|||
149795681|NCT00545740|540379531|FG001|Overall Study|Protocol Violation|3|||
149795682|NCT00545740|540379532|FG002|Overall Study|Protocol Violation|1|||
149795683|NCT00545740|540379533|FG003|Overall Study|Protocol Violation|0|||
149795684|NCT00545740|540379530|FG000|Overall Study|Non-compliance|0|||
149795685|NCT00545740|540379531|FG001|Overall Study|Non-compliance|2|||
149795686|NCT00545740|540379532|FG002|Overall Study|Non-compliance|1|||
149795687|NCT00545740|540379533|FG003|Overall Study|Non-compliance|0|||
149795688|NCT00545740|540379530|FG000|Overall Study|Moved|2|||
149795689|NCT00545740|540379531|FG001|Overall Study|Moved|0|||
149795690|NCT00545740|540379532|FG002|Overall Study|Moved|1|||
149795691|NCT00545740|540379533|FG003|Overall Study|Moved|0|||
149795692|NCT00545740|540379530|FG000|Overall Study|Diverticulitis attack|0|||
149795693|NCT00545740|540379531|FG001|Overall Study|Diverticulitis attack|0|||
149795694|NCT00545740|540379532|FG002|Overall Study|Diverticulitis attack|1|||
149795695|NCT00545740|540379533|FG003|Overall Study|Diverticulitis attack|1|||
149795696|NCT00545740|540379530|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
149795697|NCT00545740|540379531|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
149795698|NCT00545740|540379532|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
149795699|NCT00545740|540379533|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
149795700|NCT00545740|540379530|FG000|Overall Study|Site closure|1|||
149795701|NCT00545740|540379531|FG001|Overall Study|Site closure|0|||
149795702|NCT00545740|540379532|FG002|Overall Study|Site closure|0|||
149795703|NCT00545740|540379533|FG003|Overall Study|Site closure|0|||
149795704|NCT00545740|540379530|FG000|Overall Study|Missed visit|1|||
149795705|NCT00545740|540379531|FG001|Overall Study|Missed visit|0|||
149795706|NCT00545740|540379532|FG002|Overall Study|Missed visit|0|||
149795707|NCT00545740|540379533|FG003|Overall Study|Missed visit|0|||
149795708|NCT00545740|540379530|FG000|Overall Study|Physician Decision|0|||
149795709|NCT00545740|540379531|FG001|Overall Study|Physician Decision|0|||
149795710|NCT00545740|540379532|FG002|Overall Study|Physician Decision|3|||
149795711|NCT00545740|540379533|FG003|Overall Study|Physician Decision|0|||
149795712|NCT00545740|540379530|FG000|Overall Study|Accepted only monthly telephone calls|1|||
149795713|NCT00545740|540379531|FG001|Overall Study|Accepted only monthly telephone calls|0|||
149795714|NCT00545740|540379532|FG002|Overall Study|Accepted only monthly telephone calls|0|||
149795715|NCT00545740|540379533|FG003|Overall Study|Accepted only monthly telephone calls|0|||
149795716|NCT00545740|540379530|FG000|Overall Study|Sponsor decision|0|||
149795717|NCT00545740|540379531|FG001|Overall Study|Sponsor decision|1|||
149795718|NCT00545740|540379532|FG002|Overall Study|Sponsor decision|0|||
149795719|NCT00545740|540379533|FG003|Overall Study|Sponsor decision|0|||
149795720|NCT00545740|540379530|FG000|Overall Study|Lack of time|0|||
149795721|NCT00545740|540379531|FG001|Overall Study|Lack of time|1|||
149795722|NCT00545740|540379532|FG002|Overall Study|Lack of time|0|||
149795723|NCT00545740|540379533|FG003|Overall Study|Lack of time|0|||
149795724|NCT00545740|540379530|FG000|Overall Study|Non-adherence to visits|0|||
149795725|NCT00545740|540379531|FG001|Overall Study|Non-adherence to visits|1|||
149795726|NCT00545740|540379532|FG002|Overall Study|Non-adherence to visits|0|||
149795727|NCT00545740|540379533|FG003|Overall Study|Non-adherence to visits|0|||
149795728|NCT00545740|540379530|FG000|Overall Study|Patient difficulties|0|||
149795729|NCT00545740|540379531|FG001|Overall Study|Patient difficulties|1|||
149795730|NCT00545740|540379532|FG002|Overall Study|Patient difficulties|0|||
149795731|NCT00545740|540379533|FG003|Overall Study|Patient difficulties|0|||
149795732|NCT00545740|540379530|FG000|Overall Study|Husband against study|0|||
149795733|NCT00545740|540379531|FG001|Overall Study|Husband against study|0|||
149795734|NCT00545740|540379532|FG002|Overall Study|Husband against study|1|||
149795735|NCT00545740|540379533|FG003|Overall Study|Husband against study|0|||
149795736|NCT02117024|540379534|FG000|Overall Study|Progressive Disease|26|||
149795737|NCT02117024|540379535|FG001|Overall Study|Progressive Disease|9|||
149795738|NCT02117024|540379534|FG000|Overall Study|Significant Clinical Progression|7|||
149795739|NCT02117024|540379535|FG001|Overall Study|Significant Clinical Progression|4|||
149795740|NCT02117024|540379534|FG000|Overall Study|Death|5|||
149795741|NCT02117024|540379535|FG001|Overall Study|Death|0|||
149795742|NCT02117024|540379534|FG000|Overall Study|Withdrawal by Subject|3|||
149795743|NCT02117024|540379535|FG001|Overall Study|Withdrawal by Subject|1|||
149795744|NCT02117024|540379534|FG000|Overall Study|Protocol Violation|1|||
149795745|NCT02117024|540379535|FG001|Overall Study|Protocol Violation|0|||
149795746|NCT02117024|540379534|FG000|Overall Study|Adverse Event|1|||
149795747|NCT02117024|540379535|FG001|Overall Study|Adverse Event|2|||
149795748|NCT02117024|540379534|FG000|Overall Study|Randomized in Error|1|||
149795749|NCT02117024|540379535|FG001|Overall Study|Randomized in Error|0|||
149795750|NCT02117024|540379534|FG000|Overall Study|Patient returned to primary oncologist|0|||
149795751|NCT02117024|540379535|FG001|Overall Study|Patient returned to primary oncologist|1|||
149795752|NCT02117024|540379534|FG000|Overall Study|Patient took treatment break|0|||
149795753|NCT02117024|540379535|FG001|Overall Study|Patient took treatment break|1|||
149795754|NCT02117024|540379534|FG000|Overall Study|Physician Decision|0|||
149795755|NCT02117024|540379535|FG001|Overall Study|Physician Decision|2|||
149795756|NCT00565721|540379538|FG000|Overall Study|Screen Failure|2|||
149795757|NCT00565721|540379538|FG000|Overall Study|Lost to Follow-up|6|||
149795758|NCT00565721|540379538|FG000|Overall Study|Technical Problems|1|||
149795759|NCT00565721|540379538|FG000|Overall Study|Physician Decision|2|||
149795760|NCT00565721|540379538|FG000|Overall Study|Other reasons|6|||
149795761|NCT02813681|540379539|FG000|Overall Study|Physician Decision|5|||
149795762|NCT02813681|540379540|FG001|Overall Study|Physician Decision|5|||
149795763|NCT02813681|540379541|FG002|Overall Study|Physician Decision|0|||
149795764|NCT02813681|540379539|FG000|Overall Study|Lost to Follow-up|0|||
149795765|NCT02813681|540379540|FG001|Overall Study|Lost to Follow-up|1|||
149795766|NCT02813681|540379541|FG002|Overall Study|Lost to Follow-up|0|||
149795767|NCT00529152|540379542|FG000|Overall Study|Adverse Event|2|||
149795768|NCT00529152|540379542|FG000|Overall Study|Withdrawal by Subject|2|||
149795769|NCT00529152|540379542|FG000|Overall Study|Lost to Follow-up|1|||
149795770|NCT02500706|540379543|FG000|Overall Study|Adverse Event|0|||
149795771|NCT02500706|540379544|FG001|Overall Study|Adverse Event|0|||
149795772|NCT02500706|540379545|FG002|Overall Study|Adverse Event|1|||
149795773|NCT02500706|540379543|FG000|Overall Study|Lost to Follow-up|0|||
149795774|NCT02500706|540379544|FG001|Overall Study|Lost to Follow-up|1|||
149795775|NCT02500706|540379545|FG002|Overall Study|Lost to Follow-up|1|||
149795776|NCT02500706|540379543|FG000|Overall Study|Withdrawal by Subject|4|||
149795777|NCT02500706|540379544|FG001|Overall Study|Withdrawal by Subject|6|||
149795778|NCT02500706|540379545|FG002|Overall Study|Withdrawal by Subject|4|||
149795779|NCT02500706|540379543|FG000|Overall Study|Unclassified|0|||
149795780|NCT02500706|540379544|FG001|Overall Study|Unclassified|0|||
149795781|NCT02500706|540379545|FG002|Overall Study|Unclassified|1|||
149795782|NCT01497899|540379546|FG000|Double-Blind Phase|Randomized but not Treated|1|||
149795783|NCT01497899|540379547|FG001|Double-Blind Phase|Randomized but not Treated|0|||
149795784|NCT01497899|540379548|FG002|Double-Blind Phase|Randomized but not Treated|0|||
149795785|NCT01497899|540379549|FG003|Double-Blind Phase|Randomized but not Treated|0|||
149795786|NCT01497899|540379546|FG000|Double-Blind Phase|Adverse Event|1|||
149795787|NCT01497899|540379547|FG001|Double-Blind Phase|Adverse Event|0|||
149795788|NCT01497899|540379548|FG002|Double-Blind Phase|Adverse Event|0|||
149795789|NCT01497899|540379549|FG003|Double-Blind Phase|Adverse Event|0|||
149795790|NCT01497899|540379546|FG000|Double-Blind Phase|Lack of Efficacy|0|||
149795791|NCT01497899|540379547|FG001|Double-Blind Phase|Lack of Efficacy|1|||
149795792|NCT01497899|540379548|FG002|Double-Blind Phase|Lack of Efficacy|0|||
149795793|NCT01497899|540379549|FG003|Double-Blind Phase|Lack of Efficacy|0|||
149795794|NCT01497899|540379546|FG000|Double-Blind Phase|Investigator's Discretion|1|||
149795795|NCT01497899|540379547|FG001|Double-Blind Phase|Investigator's Discretion|0|||
149795796|NCT01497899|540379548|FG002|Double-Blind Phase|Investigator's Discretion|0|||
149795797|NCT01497899|540379549|FG003|Double-Blind Phase|Investigator's Discretion|0|||
149795798|NCT01497899|540379546|FG000|Double-Blind Phase|Withdrew Consent|0|||
149795799|NCT01497899|540379547|FG001|Double-Blind Phase|Withdrew Consent|1|||
149795800|NCT01497899|540379548|FG002|Double-Blind Phase|Withdrew Consent|0|||
149795801|NCT01497899|540379549|FG003|Double-Blind Phase|Withdrew Consent|0|||
149795802|NCT01497899|540379546|FG000|Double-Blind Phase|Lost to Follow-up|3|||
149795803|NCT01497899|540379547|FG001|Double-Blind Phase|Lost to Follow-up|2|||
149795804|NCT01497899|540379548|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149795805|NCT01497899|540379549|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149795806|NCT01497899|540379546|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
149795807|NCT01497899|540379547|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
149795808|NCT01497899|540379548|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
149795809|NCT01497899|540379549|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
149795810|NCT01497899|540379546|FG000|Open-Label Extension Phase|Adverse Event|1|||
149795811|NCT01497899|540379547|FG001|Open-Label Extension Phase|Adverse Event|0|||
149795812|NCT01497899|540379548|FG002|Open-Label Extension Phase|Adverse Event|0|||
149795813|NCT01497899|540379549|FG003|Open-Label Extension Phase|Adverse Event|0|||
149795814|NCT01497899|540379546|FG000|Open-Label Extension Phase|Death|1|||
149795815|NCT01497899|540379547|FG001|Open-Label Extension Phase|Death|0|||
149795816|NCT01497899|540379548|FG002|Open-Label Extension Phase|Death|0|||
149795817|NCT01497899|540379549|FG003|Open-Label Extension Phase|Death|0|||
149795818|NCT01497899|540379546|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
149795819|NCT01497899|540379547|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
149795820|NCT01497899|540379548|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
149795821|NCT01497899|540379549|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
149795822|NCT01497899|540379546|FG000|Open-Label Extension Phase|Pregnancy|0|||
149795823|NCT01497899|540379547|FG001|Open-Label Extension Phase|Pregnancy|1|||
149795824|NCT01497899|540379548|FG002|Open-Label Extension Phase|Pregnancy|1|||
149795825|NCT01497899|540379549|FG003|Open-Label Extension Phase|Pregnancy|0|||
149795826|NCT01497899|540379546|FG000|Open-Label Extension Phase|Protocol Violation|0|||
149795827|NCT01497899|540379547|FG001|Open-Label Extension Phase|Protocol Violation|0|||
149795828|NCT01497899|540379548|FG002|Open-Label Extension Phase|Protocol Violation|1|||
149795829|NCT01497899|540379549|FG003|Open-Label Extension Phase|Protocol Violation|0|||
149795830|NCT01497899|540379546|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
149795831|NCT01497899|540379547|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
149795832|NCT01497899|540379548|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
149795833|NCT01497899|540379549|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
149795834|NCT01874288|540379555|FG000|Overall Study|Withdrawal by Subject|1|||
149795835|NCT01874288|540379556|FG001|Overall Study|Withdrawal by Subject|0|||
149795836|NCT01874288|540379557|FG002|Overall Study|Withdrawal by Subject|2|||
149795837|NCT01874288|540379558|FG003|Overall Study|Withdrawal by Subject|1|||
149795838|NCT01874288|540379559|FG004|Overall Study|Withdrawal by Subject|1|||
149795839|NCT01874288|540379555|FG000|Overall Study|Physician Decision|0|||
149795840|NCT01874288|540379556|FG001|Overall Study|Physician Decision|0|||
149795841|NCT01874288|540379557|FG002|Overall Study|Physician Decision|0|||
149795842|NCT01874288|540379558|FG003|Overall Study|Physician Decision|1|||
149795843|NCT01874288|540379559|FG004|Overall Study|Physician Decision|0|||
149795844|NCT01874288|540379555|FG000|Overall Study|Progressive disease|2|||
149795845|NCT01874288|540379556|FG001|Overall Study|Progressive disease|0|||
149795846|NCT01874288|540379557|FG002|Overall Study|Progressive disease|3|||
149795847|NCT01874288|540379558|FG003|Overall Study|Progressive disease|5|||
149795848|NCT01874288|540379559|FG004|Overall Study|Progressive disease|1|||
149795849|NCT04212221|540379560|FG000|Overall Study|Remained on Treatment|0|||
149795850|NCT04212221|540379561|FG001|Overall Study|Remained on Treatment|0|||
149795851|NCT04212221|540379562|FG002|Overall Study|Remained on Treatment|0|||
149795852|NCT04212221|540379563|FG003|Overall Study|Remained on Treatment|1|||
149795853|NCT04212221|540379564|FG004|Overall Study|Remained on Treatment|0|||
149795854|NCT04212221|540379565|FG005|Overall Study|Remained on Treatment|0|||
149795855|NCT04212221|540379566|FG006|Overall Study|Remained on Treatment|3|||
149795856|NCT04212221|540379567|FG007|Overall Study|Remained on Treatment|9|||
149795857|NCT04212221|540379560|FG000|Overall Study|Adverse Event|0|||
149795858|NCT04212221|540379561|FG001|Overall Study|Adverse Event|0|||
149795859|NCT04212221|540379562|FG002|Overall Study|Adverse Event|0|||
149795860|NCT04212221|540379563|FG003|Overall Study|Adverse Event|0|||
149795861|NCT04212221|540379564|FG004|Overall Study|Adverse Event|0|||
149795862|NCT04212221|540379565|FG005|Overall Study|Adverse Event|0|||
149795863|NCT04212221|540379566|FG006|Overall Study|Adverse Event|2|||
149795864|NCT04212221|540379567|FG007|Overall Study|Adverse Event|3|||
149795865|NCT04212221|540379560|FG000|Overall Study|Death|0|||
149795866|NCT04212221|540379561|FG001|Overall Study|Death|0|||
149795867|NCT04212221|540379562|FG002|Overall Study|Death|0|||
149795868|NCT04212221|540379563|FG003|Overall Study|Death|0|||
149795869|NCT04212221|540379564|FG004|Overall Study|Death|0|||
149795870|NCT04212221|540379565|FG005|Overall Study|Death|0|||
149795871|NCT04212221|540379566|FG006|Overall Study|Death|0|||
149795872|NCT04212221|540379567|FG007|Overall Study|Death|2|||
149795873|NCT04212221|540379560|FG000|Overall Study|Disease progression according to irRECIST|1|||
149795874|NCT04212221|540379561|FG001|Overall Study|Disease progression according to irRECIST|2|||
149795875|NCT04212221|540379562|FG002|Overall Study|Disease progression according to irRECIST|3|||
149795876|NCT04212221|540379563|FG003|Overall Study|Disease progression according to irRECIST|3|||
149795877|NCT04212221|540379564|FG004|Overall Study|Disease progression according to irRECIST|2|||
149795878|NCT04212221|540379565|FG005|Overall Study|Disease progression according to irRECIST|2|||
149795879|NCT04212221|540379566|FG006|Overall Study|Disease progression according to irRECIST|21|||
149795880|NCT04212221|540379567|FG007|Overall Study|Disease progression according to irRECIST|17|||
149795881|NCT04212221|540379560|FG000|Overall Study|Global Deterioration of Health Status|0|||
149795882|NCT04212221|540379561|FG001|Overall Study|Global Deterioration of Health Status|0|||
149795883|NCT04212221|540379562|FG002|Overall Study|Global Deterioration of Health Status|0|||
149795884|NCT04212221|540379563|FG003|Overall Study|Global Deterioration of Health Status|0|||
149795885|NCT04212221|540379564|FG004|Overall Study|Global Deterioration of Health Status|0|||
149795886|NCT04212221|540379565|FG005|Overall Study|Global Deterioration of Health Status|0|||
149795887|NCT04212221|540379566|FG006|Overall Study|Global Deterioration of Health Status|0|||
149795888|NCT04212221|540379567|FG007|Overall Study|Global Deterioration of Health Status|2|||
149795889|NCT04212221|540379560|FG000|Overall Study|Investigator's Decision|0|||
149795890|NCT04212221|540379561|FG001|Overall Study|Investigator's Decision|0|||
149795891|NCT04212221|540379562|FG002|Overall Study|Investigator's Decision|0|||
149795892|NCT04212221|540379563|FG003|Overall Study|Investigator's Decision|1|||
149795893|NCT04212221|540379564|FG004|Overall Study|Investigator's Decision|0|||
149795894|NCT04212221|540379565|FG005|Overall Study|Investigator's Decision|0|||
149795895|NCT04212221|540379566|FG006|Overall Study|Investigator's Decision|3|||
149795896|NCT04212221|540379567|FG007|Overall Study|Investigator's Decision|0|||
149795897|NCT04212221|540379560|FG000|Overall Study|Participant refused to continue treatment|0|||
149795898|NCT04212221|540379561|FG001|Overall Study|Participant refused to continue treatment|1|||
149795899|NCT04212221|540379562|FG002|Overall Study|Participant refused to continue treatment|0|||
149795900|NCT04212221|540379563|FG003|Overall Study|Participant refused to continue treatment|1|||
149795901|NCT04212221|540379564|FG004|Overall Study|Participant refused to continue treatment|1|||
149795902|NCT04212221|540379565|FG005|Overall Study|Participant refused to continue treatment|2|||
149795903|NCT04212221|540379566|FG006|Overall Study|Participant refused to continue treatment|4|||
149795904|NCT04212221|540379567|FG007|Overall Study|Participant refused to continue treatment|2|||
149795905|NCT04212221|540379560|FG000|Overall Study|Protocol Violation|0|||
149795906|NCT04212221|540379561|FG001|Overall Study|Protocol Violation|0|||
149795907|NCT04212221|540379562|FG002|Overall Study|Protocol Violation|0|||
149795908|NCT04212221|540379563|FG003|Overall Study|Protocol Violation|0|||
149795909|NCT04212221|540379564|FG004|Overall Study|Protocol Violation|0|||
149795910|NCT04212221|540379565|FG005|Overall Study|Protocol Violation|0|||
149795911|NCT04212221|540379566|FG006|Overall Study|Protocol Violation|0|||
149795912|NCT04212221|540379567|FG007|Overall Study|Protocol Violation|1|||
149795913|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
149795914|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
149795915|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
149795916|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
149795917|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
149795918|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
149795919|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Death|1|||
149795920|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Death|1|||
149795921|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Death|1|||
149795922|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Death|0|||
149795923|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Death|0|||
149795924|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Death|0|||
149795925|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
149795926|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
149795927|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149795928|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149795929|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149795930|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149795931|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149795932|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149795933|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
149795934|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149795935|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149795936|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149795937|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149795938|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
149795939|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149795940|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149795941|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149795942|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149795943|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
149795944|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
149795945|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
149795946|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149795947|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149795948|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149795949|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
149795950|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
149795951|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
149795952|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
149795953|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
149795954|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
149795955|NCT03370133|540379574|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
149795956|NCT03370133|540379575|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
149795957|NCT03370133|540379576|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
149795958|NCT03370133|540379577|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
149795959|NCT03370133|540379578|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
149795960|NCT03370133|540379579|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
149795961|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149795962|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149795963|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149795964|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
149795965|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
149795966|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
149795967|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149795968|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149795969|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149795970|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149795971|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
149795972|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
149795973|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149795974|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149795975|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149795976|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
149795977|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
149795978|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149795979|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149795980|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149795981|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149795982|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149795983|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
149795984|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
149795985|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149795986|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149795987|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149795988|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
149795989|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
149795990|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
149795991|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149795992|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149795993|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149795994|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149795995|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
149795996|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149795997|NCT03370133|540379574|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149795998|NCT03370133|540379575|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149795999|NCT03370133|540379576|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149796000|NCT03370133|540379577|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149796001|NCT03370133|540379578|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149796002|NCT03370133|540379579|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
149796003|NCT00636506|540379580|FG000|Overall Study|Lost to Follow-up|8|||
149796004|NCT00636506|540379580|FG000|Overall Study|Explanted|1|||
149796005|NCT00636506|540379580|FG000|Overall Study|Withdrawal by Subject|6|||
149796006|NCT00636506|540379580|FG000|Overall Study|Procedure aborted|1|||
149796007|NCT01624974|540379581|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
149796008|NCT01624974|540379582|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
149796009|NCT01624974|540379581|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
149796010|NCT01624974|540379582|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
149796011|NCT01624974|540379581|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
149796012|NCT01624974|540379582|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
149796013|NCT01624974|540379581|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
149796014|NCT01624974|540379582|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
149796015|NCT01624974|540379581|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
149796016|NCT01624974|540379582|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
149796017|NCT01624974|540379581|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
149796018|NCT01624974|540379582|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
149796019|NCT01624974|540379581|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
149796020|NCT01624974|540379582|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
149796021|NCT01624974|540379581|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
149796022|NCT01624974|540379582|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
149796023|NCT01624974|540379581|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
149796024|NCT01624974|540379582|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
149796025|NCT01624974|540379581|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
149796026|NCT01624974|540379582|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
149796027|NCT01624974|540379581|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
149796028|NCT01624974|540379582|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
149796029|NCT01624974|540379581|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
149796030|NCT01624974|540379582|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
149796031|NCT03607994|540379583|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
149796032|NCT03607994|540379584|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
149796033|NCT03125902|540379587|FG000|Overall Study|Adverse Event|0|||
149796034|NCT03125902|540379588|FG001|Overall Study|Adverse Event|1|||
149796035|NCT03125902|540379587|FG000|Overall Study|Death|119|||
149796036|NCT03125902|540379588|FG001|Overall Study|Death|229|||
149796037|NCT03125902|540379587|FG000|Overall Study|Lost to Follow-up|4|||
149796038|NCT03125902|540379588|FG001|Overall Study|Lost to Follow-up|13|||
149796039|NCT03125902|540379587|FG000|Overall Study|Other|0|||
149796040|NCT03125902|540379588|FG001|Overall Study|Other|4|||
149796041|NCT03125902|540379587|FG000|Overall Study|Physician Decision|2|||
149796042|NCT03125902|540379588|FG001|Overall Study|Physician Decision|1|||
149796043|NCT03125902|540379587|FG000|Overall Study|Progressive Disease|0|||
149796044|NCT03125902|540379588|FG001|Overall Study|Progressive Disease|3|||
149796045|NCT03125902|540379587|FG000|Overall Study|Study Terminated By Sponsor|74|||
149796046|NCT03125902|540379588|FG001|Overall Study|Study Terminated By Sponsor|143|||
149796047|NCT03125902|540379587|FG000|Overall Study|Withdrawal by Subject|21|||
149796048|NCT03125902|540379588|FG001|Overall Study|Withdrawal by Subject|37|||
149796049|NCT01775995|540379589|FG000|Overall Study|Lost to Follow-up|1|||
149796050|NCT01775995|540379590|FG001|Overall Study|Lost to Follow-up|1|||
149796051|NCT01997333|540379591|FG000|Randomization and Treatment|Disease Progression|70|||
149796052|NCT01997333|540379592|FG001|Randomization and Treatment|Disease Progression|159|||
149796053|NCT01997333|540379591|FG000|Randomization and Treatment|Adverse Event|10|||
149796054|NCT01997333|540379592|FG001|Randomization and Treatment|Adverse Event|32|||
149796055|NCT01997333|540379591|FG000|Randomization and Treatment|Physician Decision|0|||
149796056|NCT01997333|540379592|FG001|Randomization and Treatment|Physician Decision|4|||
149796057|NCT01997333|540379591|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
149796058|NCT01997333|540379592|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
149796059|NCT01997333|540379591|FG000|Randomization and Treatment|Did not receive treatment|17|||
149796060|NCT01997333|540379592|FG001|Randomization and Treatment|Did not receive treatment|5|||
149796061|NCT01997333|540379591|FG000|Survival Follow up|Withdrawal by Subject|15|||
149796062|NCT01997333|540379592|FG001|Survival Follow up|Withdrawal by Subject|6|||
149796063|NCT01997333|540379591|FG000|Survival Follow up|Lost to Follow-up|0|||
149796064|NCT01997333|540379592|FG001|Survival Follow up|Lost to Follow-up|6|||
149796065|NCT01997333|540379591|FG000|Survival Follow up|Various|1|||
149796066|NCT01997333|540379592|FG001|Survival Follow up|Various|2|||
149796067|NCT04411472|540379593|FG000|Overall Study|Adverse Event|5|||
149796068|NCT04411472|540379594|FG001|Overall Study|Adverse Event|10|||
149796069|NCT04411472|540379595|FG002|Overall Study|Adverse Event|1|||
149796070|NCT04411472|540379596|FG003|Overall Study|Adverse Event|0|||
149796071|NCT04411472|540379597|FG004|Overall Study|Adverse Event|0|||
149796072|NCT04411472|540379598|FG005|Overall Study|Adverse Event|0|||
149796073|NCT04411472|540379593|FG000|Overall Study|Protocol Violation|1|||
149796074|NCT04411472|540379594|FG001|Overall Study|Protocol Violation|0|||
149796075|NCT04411472|540379595|FG002|Overall Study|Protocol Violation|0|||
149796076|NCT04411472|540379596|FG003|Overall Study|Protocol Violation|0|||
149796077|NCT04411472|540379597|FG004|Overall Study|Protocol Violation|0|||
149796078|NCT04411472|540379598|FG005|Overall Study|Protocol Violation|0|||
149796079|NCT04411472|540379593|FG000|Overall Study|Withdrawal by Subject|0|||
149796080|NCT04411472|540379594|FG001|Overall Study|Withdrawal by Subject|1|||
149796081|NCT04411472|540379595|FG002|Overall Study|Withdrawal by Subject|0|||
149796082|NCT04411472|540379596|FG003|Overall Study|Withdrawal by Subject|1|||
149796083|NCT04411472|540379597|FG004|Overall Study|Withdrawal by Subject|0|||
149796084|NCT04411472|540379598|FG005|Overall Study|Withdrawal by Subject|0|||
149796085|NCT04411472|540379593|FG000|Overall Study|Physician Decision|1|||
149796086|NCT04411472|540379594|FG001|Overall Study|Physician Decision|0|||
149796087|NCT04411472|540379595|FG002|Overall Study|Physician Decision|0|||
149796088|NCT04411472|540379596|FG003|Overall Study|Physician Decision|0|||
149796089|NCT04411472|540379597|FG004|Overall Study|Physician Decision|0|||
149796090|NCT04411472|540379598|FG005|Overall Study|Physician Decision|0|||
149796091|NCT04411472|540379593|FG000|Overall Study|Study terminated by sponsor|17|||
149796092|NCT04411472|540379594|FG001|Overall Study|Study terminated by sponsor|20|||
149796093|NCT04411472|540379595|FG002|Overall Study|Study terminated by sponsor|3|||
149796094|NCT04411472|540379596|FG003|Overall Study|Study terminated by sponsor|0|||
149796095|NCT04411472|540379597|FG004|Overall Study|Study terminated by sponsor|0|||
149796096|NCT04411472|540379598|FG005|Overall Study|Study terminated by sponsor|0|||
149796097|NCT05060003|540379599|FG000|Overall Study|ctDNA negative|7|||
149796098|NCT01747655|540379602|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
149796099|NCT01747655|540379603|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
149796100|NCT01747655|540379602|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
149796101|NCT01747655|540379603|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
149796102|NCT01747655|540379602|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
149796103|NCT01747655|540379603|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
149796104|NCT01259388|540379607|FG000|Overall Study|Adverse Event|3|||
149796105|NCT01259388|540379608|FG001|Overall Study|Adverse Event|0|||
149796106|NCT01259388|540379607|FG000|Overall Study|Withdrawal by Subject|1|||
149796107|NCT01259388|540379608|FG001|Overall Study|Withdrawal by Subject|1|||
149796108|NCT01259388|540379607|FG000|Overall Study|Physician Decision|1|||
149796109|NCT01259388|540379608|FG001|Overall Study|Physician Decision|0|||
149796110|NCT03512028|540379609|FG000|Overall Study|Withdrawal by Subject|2|||
149796111|NCT03512028|540379610|FG001|Overall Study|Withdrawal by Subject|0|||
149796112|NCT03512028|540379609|FG000|Overall Study|Protocol Violation|2|||
149796113|NCT03512028|540379610|FG001|Overall Study|Protocol Violation|0|||
149796114|NCT03529162|540379611|FG000|Overall Study|Lost to Follow-up|2|||
149796115|NCT03529162|540379612|FG001|Overall Study|Lost to Follow-up|2|||
149796116|NCT02728804|540379616|FG000|Overall Study|Ineligible|3|||
149796117|NCT02728804|540379616|FG000|Overall Study|Did not complete baseline questionnaire|9|||
149796118|NCT02728804|540379616|FG000|Overall Study|Death|99|||
149796119|NCT01888367|540379617|FG000|Overall Study|Physician Decision|3|||
149796120|NCT01888367|540379618|FG001|Overall Study|Physician Decision|4|||
149796121|NCT01888367|540379619|FG002|Overall Study|Physician Decision|2|||
149796122|NCT01888367|540379617|FG000|Overall Study|Death|2|||
149796123|NCT01888367|540379618|FG001|Overall Study|Death|0|||
149796124|NCT01888367|540379619|FG002|Overall Study|Death|1|||
149796125|NCT01888367|540379617|FG000|Overall Study|Withdrawal by Subject|1|||
149796126|NCT01888367|540379618|FG001|Overall Study|Withdrawal by Subject|0|||
149796127|NCT01888367|540379619|FG002|Overall Study|Withdrawal by Subject|1|||
149796128|NCT01888367|540379617|FG000|Overall Study|Lost to Follow-up|1|||
149796129|NCT01888367|540379618|FG001|Overall Study|Lost to Follow-up|1|||
149796130|NCT01888367|540379619|FG002|Overall Study|Lost to Follow-up|0|||
149796131|NCT01888367|540379617|FG000|Overall Study|Protocol Violation|0|||
149796132|NCT01888367|540379618|FG001|Overall Study|Protocol Violation|0|||
149796133|NCT01888367|540379619|FG002|Overall Study|Protocol Violation|1|||
149796134|NCT01888367|540379617|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
149796135|NCT01888367|540379618|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
149796136|NCT01888367|540379619|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
149796137|NCT00591786|540379620|FG000|Overall Study|Withdrawal of Informed Consent|0|||
149796138|NCT00591786|540379621|FG001|Overall Study|Withdrawal of Informed Consent|0|||
149796139|NCT00591786|540379622|FG002|Overall Study|Withdrawal of Informed Consent|1|||
149796140|NCT00591786|540379623|FG003|Overall Study|Withdrawal of Informed Consent|0|||
149796141|NCT00591786|540379624|FG004|Overall Study|Withdrawal of Informed Consent|0|||
149796142|NCT00591786|540379625|FG005|Overall Study|Withdrawal of Informed Consent|0|||
149796143|NCT00591786|540379626|FG006|Overall Study|Withdrawal of Informed Consent|0|||
149796144|NCT00591786|540379627|FG007|Overall Study|Withdrawal of Informed Consent|0|||
149796145|NCT00591786|540379628|FG008|Overall Study|Withdrawal of Informed Consent|0|||
149796146|NCT00591786|540379629|FG009|Overall Study|Withdrawal of Informed Consent|0|||
149796147|NCT01920061|540379630|FG000|Overall Study|Death|1|||
149796148|NCT01920061|540379631|FG001|Overall Study|Death|1|||
149796149|NCT01920061|540379632|FG002|Overall Study|Death|0|||
149796150|NCT01920061|540379633|FG003|Overall Study|Death|1|||
149796151|NCT01920061|540379634|FG004|Overall Study|Death|1|||
149796152|NCT01920061|540379635|FG005|Overall Study|Death|0|||
149796153|NCT01920061|540379636|FG006|Overall Study|Death|0|||
149796154|NCT01920061|540379637|FG007|Overall Study|Death|1|||
149796155|NCT01920061|540379638|FG008|Overall Study|Death|0|||
149796156|NCT01920061|540379639|FG009|Overall Study|Death|1|||
149796157|NCT01920061|540379640|FG010|Overall Study|Death|0|||
149796158|NCT01920061|540379641|FG011|Overall Study|Death|1|||
149796159|NCT01920061|540379642|FG012|Overall Study|Death|0|||
149796160|NCT01920061|540379643|FG013|Overall Study|Death|2|||
149796161|NCT01920061|540379644|FG014|Overall Study|Death|0|||
149796162|NCT01920061|540379645|FG015|Overall Study|Death|0|||
149796163|NCT01920061|540379646|FG016|Overall Study|Death|0|||
149796164|NCT01920061|540379647|FG017|Overall Study|Death|0|||
149796165|NCT01920061|540379648|FG018|Overall Study|Death|1|||
149796166|NCT01920061|540379649|FG019|Overall Study|Death|0|||
149796167|NCT01920061|540379630|FG000|Overall Study|Lost to Follow-up|0|||
149796168|NCT01920061|540379631|FG001|Overall Study|Lost to Follow-up|2|||
149796169|NCT01920061|540379632|FG002|Overall Study|Lost to Follow-up|0|||
149796170|NCT01920061|540379633|FG003|Overall Study|Lost to Follow-up|0|||
149796171|NCT01920061|540379634|FG004|Overall Study|Lost to Follow-up|0|||
149796172|NCT01920061|540379635|FG005|Overall Study|Lost to Follow-up|0|||
149796173|NCT01920061|540379636|FG006|Overall Study|Lost to Follow-up|1|||
149796174|NCT01920061|540379637|FG007|Overall Study|Lost to Follow-up|0|||
149796175|NCT01920061|540379638|FG008|Overall Study|Lost to Follow-up|0|||
149796176|NCT01920061|540379639|FG009|Overall Study|Lost to Follow-up|0|||
149796177|NCT01920061|540379640|FG010|Overall Study|Lost to Follow-up|3|||
149796178|NCT01920061|540379641|FG011|Overall Study|Lost to Follow-up|0|||
149796179|NCT01920061|540379642|FG012|Overall Study|Lost to Follow-up|0|||
149796180|NCT01920061|540379643|FG013|Overall Study|Lost to Follow-up|0|||
149796181|NCT01920061|540379644|FG014|Overall Study|Lost to Follow-up|0|||
149796182|NCT01920061|540379645|FG015|Overall Study|Lost to Follow-up|0|||
149796183|NCT01920061|540379646|FG016|Overall Study|Lost to Follow-up|0|||
149796184|NCT01920061|540379647|FG017|Overall Study|Lost to Follow-up|1|||
149796185|NCT01920061|540379648|FG018|Overall Study|Lost to Follow-up|4|||
149796186|NCT01920061|540379649|FG019|Overall Study|Lost to Follow-up|3|||
149796187|NCT01920061|540379630|FG000|Overall Study|Other|1|||
149796188|NCT01920061|540379631|FG001|Overall Study|Other|1|||
149796189|NCT01920061|540379632|FG002|Overall Study|Other|2|||
149796190|NCT01920061|540379633|FG003|Overall Study|Other|1|||
149796191|NCT01920061|540379634|FG004|Overall Study|Other|0|||
149796192|NCT01920061|540379635|FG005|Overall Study|Other|1|||
149796193|NCT01920061|540379636|FG006|Overall Study|Other|0|||
149796194|NCT01920061|540379637|FG007|Overall Study|Other|0|||
149796195|NCT01920061|540379638|FG008|Overall Study|Other|0|||
149796196|NCT01920061|540379639|FG009|Overall Study|Other|1|||
149796197|NCT01920061|540379640|FG010|Overall Study|Other|1|||
149796198|NCT01920061|540379641|FG011|Overall Study|Other|2|||
149796199|NCT01920061|540379642|FG012|Overall Study|Other|1|||
149796200|NCT01920061|540379643|FG013|Overall Study|Other|4|||
149796201|NCT01920061|540379644|FG014|Overall Study|Other|0|||
149796202|NCT01920061|540379645|FG015|Overall Study|Other|1|||
149796203|NCT01920061|540379646|FG016|Overall Study|Other|1|||
149796204|NCT01920061|540379647|FG017|Overall Study|Other|0|||
149796205|NCT01920061|540379648|FG018|Overall Study|Other|1|||
149796206|NCT01920061|540379649|FG019|Overall Study|Other|1|||
149796207|NCT01920061|540379630|FG000|Overall Study|Participant refused further follow-up|0|||
149796208|NCT01920061|540379631|FG001|Overall Study|Participant refused further follow-up|0|||
149796209|NCT01920061|540379632|FG002|Overall Study|Participant refused further follow-up|0|||
149796210|NCT01920061|540379633|FG003|Overall Study|Participant refused further follow-up|0|||
149796211|NCT01920061|540379634|FG004|Overall Study|Participant refused further follow-up|1|||
149796212|NCT01920061|540379635|FG005|Overall Study|Participant refused further follow-up|1|||
149796213|NCT01920061|540379636|FG006|Overall Study|Participant refused further follow-up|0|||
149796214|NCT01920061|540379637|FG007|Overall Study|Participant refused further follow-up|0|||
149796215|NCT01920061|540379638|FG008|Overall Study|Participant refused further follow-up|1|||
149796216|NCT01920061|540379639|FG009|Overall Study|Participant refused further follow-up|0|||
149796217|NCT01920061|540379640|FG010|Overall Study|Participant refused further follow-up|1|||
149796218|NCT01920061|540379641|FG011|Overall Study|Participant refused further follow-up|0|||
149796219|NCT01920061|540379642|FG012|Overall Study|Participant refused further follow-up|1|||
149796220|NCT01920061|540379643|FG013|Overall Study|Participant refused further follow-up|0|||
149796221|NCT01920061|540379644|FG014|Overall Study|Participant refused further follow-up|1|||
149796222|NCT01920061|540379645|FG015|Overall Study|Participant refused further follow-up|2|||
149796223|NCT01920061|540379646|FG016|Overall Study|Participant refused further follow-up|1|||
149796224|NCT01920061|540379647|FG017|Overall Study|Participant refused further follow-up|1|||
149796225|NCT01920061|540379648|FG018|Overall Study|Participant refused further follow-up|0|||
149796226|NCT01920061|540379649|FG019|Overall Study|Participant refused further follow-up|0|||
149796227|NCT03969589|540379651|FG000|Overall Study|Lost to Follow-up|3|||
149796228|NCT03969589|540379652|FG001|Overall Study|Lost to Follow-up|2|||
149796229|NCT03969589|540379651|FG000|Overall Study|Declined Follow-Up|0|||
149796230|NCT03969589|540379652|FG001|Overall Study|Declined Follow-Up|1|||
149796231|NCT00517634|540379653|FG000|Second Treatment Period|Withdrawal by Subject|0|||
149796232|NCT00517634|540379654|FG001|Second Treatment Period|Withdrawal by Subject|0|||
149796233|NCT00517634|540379655|FG002|Second Treatment Period|Withdrawal by Subject|0|||
149796234|NCT00517634|540379656|FG003|Second Treatment Period|Withdrawal by Subject|0|||
149796235|NCT00517634|540379657|FG004|Second Treatment Period|Withdrawal by Subject|1|||
149796236|NCT00517634|540379658|FG005|Second Treatment Period|Withdrawal by Subject|0|||
149796237|NCT03091920|540379659|FG000|Overall Study|Adverse Event|0|||
149796238|NCT03091920|540379660|FG001|Overall Study|Adverse Event|1|||
149796239|NCT03091920|540379661|FG002|Overall Study|Adverse Event|0|||
149796240|NCT03143855|540379662|FG000|Overall Study|Withdrawal by Subject|4|||
149796241|NCT03143855|540379663|FG001|Overall Study|Withdrawal by Subject|3|||
149796242|NCT03143855|540379662|FG000|Overall Study|Protocol Violation|1|||
149796243|NCT03143855|540379663|FG001|Overall Study|Protocol Violation|0|||
149796244|NCT03143855|540379662|FG000|Overall Study|Participant experienced withdrawal|0|||
149796245|NCT03143855|540379663|FG001|Overall Study|Participant experienced withdrawal|1|||
149796246|NCT00422942|540379664|FG000|Overall Study|Study terminated by Sponsor|3|||
149796247|NCT00701064|540379666|FG000|Overall Study|Protocol Violation|1|||
149796248|NCT00701064|540379667|FG001|Overall Study|Protocol Violation|1|||
149796249|NCT00701064|540379666|FG000|Overall Study|Withdrawal by Subject|1|||
149796250|NCT00701064|540379667|FG001|Overall Study|Withdrawal by Subject|1|||
149796251|NCT00701064|540379666|FG000|Overall Study|initiated other PTSD treatment|2|||
149796252|NCT00701064|540379667|FG001|Overall Study|initiated other PTSD treatment|2|||
149796253|NCT02098733|540379668|FG000|Overall Study|Data Not Available|5|||
149796254|NCT02098733|540379668|FG000|Overall Study|Lost to Follow-up|5|||
149796255|NCT00695318|540379669|FG000|Overall Study|Lost to Follow-up|1|||
149796256|NCT00695318|540379670|FG001|Overall Study|Lost to Follow-up|0|||
149796257|NCT00695318|540379669|FG000|Overall Study|Withdrawal by Subject|2|||
149796258|NCT00695318|540379670|FG001|Overall Study|Withdrawal by Subject|0|||
149796259|NCT00695318|540379669|FG000|Overall Study|Death|1|||
149796260|NCT00695318|540379670|FG001|Overall Study|Death|1|||
149796261|NCT00695318|540379669|FG000|Overall Study|Study Terminated|1|||
149796262|NCT00695318|540379670|FG001|Overall Study|Study Terminated|0|||
149796263|NCT00939094|540379672|FG000|Overall Study|Adverse Event|9|||
149796264|NCT00939094|540379673|FG001|Overall Study|Adverse Event|0|||
149796265|NCT00939094|540379672|FG000|Overall Study|Withdrawal by Subject|1|||
149796266|NCT00939094|540379673|FG001|Overall Study|Withdrawal by Subject|6|||
149796267|NCT00939094|540379672|FG000|Overall Study|Lost to Follow-up|1|||
149796268|NCT00939094|540379673|FG001|Overall Study|Lost to Follow-up|1|||
149796269|NCT00939094|540379672|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149796270|NCT00939094|540379673|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149796271|NCT00939094|540379672|FG000|Overall Study|Severe non-compliance to protocol|0|||
149796272|NCT00939094|540379673|FG001|Overall Study|Severe non-compliance to protocol|1|||
149796273|NCT00939094|540379672|FG000|Overall Study|Study stopped by sponsor|0|||
149796274|NCT00939094|540379673|FG001|Overall Study|Study stopped by sponsor|2|||
149796275|NCT00939094|540379672|FG000|Overall Study|Abnormal ECG findings|1|||
149796276|NCT00939094|540379673|FG001|Overall Study|Abnormal ECG findings|0|||
149796277|NCT01906489|540379676|FG000|Overall Study|Adverse Event|10|||
149796278|NCT01906489|540379677|FG001|Overall Study|Adverse Event|3|||
149796279|NCT01906489|540379676|FG000|Overall Study|Worsening of CKD|6|||
149796280|NCT01906489|540379677|FG001|Overall Study|Worsening of CKD|4|||
149796281|NCT01906489|540379676|FG000|Overall Study|Withdrawal by Subject|5|||
149796282|NCT01906489|540379677|FG001|Overall Study|Withdrawal by Subject|0|||
149796283|NCT01906489|540379676|FG000|Overall Study|Worsening of Anemia|1|||
149796284|NCT01906489|540379677|FG001|Overall Study|Worsening of Anemia|0|||
149796285|NCT01906489|540379676|FG000|Overall Study|Protocol Violation|0|||
149796286|NCT01906489|540379677|FG001|Overall Study|Protocol Violation|1|||
149796287|NCT01906489|540379676|FG000|Overall Study|Non- Compliance|1|||
149796288|NCT01906489|540379677|FG001|Overall Study|Non- Compliance|0|||
149796289|NCT01906489|540379676|FG000|Overall Study|Sponsor Decision|1|||
149796290|NCT01906489|540379677|FG001|Overall Study|Sponsor Decision|0|||
149796291|NCT01906489|540379676|FG000|Overall Study|Lost to Follow-up|1|||
149796292|NCT01906489|540379677|FG001|Overall Study|Lost to Follow-up|1|||
149796293|NCT01906489|540379676|FG000|Overall Study|Other|1|||
149796294|NCT01906489|540379677|FG001|Overall Study|Other|0|||
149796295|NCT01078389|540381321|FG000|Overall Study|Adverse Event|10|||
149796296|NCT01078389|540381322|FG001|Overall Study|Adverse Event|6|||
149796297|NCT01078389|540381321|FG000|Overall Study|Major Protocol Deviation|2|||
149796298|NCT01078389|540381322|FG001|Overall Study|Major Protocol Deviation|0|||
149796299|NCT01078389|540381321|FG000|Overall Study|Lost to Follow-up|23|||
149796300|NCT01078389|540381322|FG001|Overall Study|Lost to Follow-up|23|||
149796301|NCT01078389|540381321|FG000|Overall Study|Voluntary Withdrawal|20|||
149796302|NCT01078389|540381322|FG001|Overall Study|Voluntary Withdrawal|36|||
149796303|NCT01078389|540381321|FG000|Overall Study|Other|9|||
149796304|NCT01078389|540381322|FG001|Overall Study|Other|2|||
149796305|NCT04823494|540381323|FG000|Overall Study|Programming software malfunction.|1|||
149796306|NCT04823494|540381324|FG001|Overall Study|Programming software malfunction.|0|||
149796307|NCT04823494|540381323|FG000|Overall Study|Withdrawal by Subject|1|||
149796308|NCT04823494|540381324|FG001|Overall Study|Withdrawal by Subject|0|||
149796309|NCT04823494|540381323|FG000|Overall Study|Devices lost|0|||
149796310|NCT04823494|540381324|FG001|Overall Study|Devices lost|1|||
149796311|NCT03691831|540381325|FG000|Overall Study|Lost to Follow-up|16|||
149796312|NCT03691831|540381326|FG001|Overall Study|Lost to Follow-up|12|||
149796313|NCT03691831|540381325|FG000|Overall Study|Withdrawal by Subject|9|||
149796314|NCT03691831|540381326|FG001|Overall Study|Withdrawal by Subject|17|||
149796315|NCT03691831|540381325|FG000|Overall Study|Investigator Decision|2|||
149796316|NCT03691831|540381326|FG001|Overall Study|Investigator Decision|2|||
149796317|NCT02198040|540381327|FG000|Overall Study|Work reasons|0|||
149796318|NCT02198040|540381328|FG001|Overall Study|Work reasons|1|||
149796319|NCT02198040|540381329|FG002|Overall Study|Work reasons|0|||
149796320|NCT02198040|540381327|FG000|Overall Study|Withdrawal by Subject|0|||
149796321|NCT02198040|540381328|FG001|Overall Study|Withdrawal by Subject|0|||
149796322|NCT02198040|540381329|FG002|Overall Study|Withdrawal by Subject|1|||
149796323|NCT04524663|540381330|FG000|Overall Study|Withdrawal by Subject|0|||
149796324|NCT04524663|540381331|FG001|Overall Study|Withdrawal by Subject|2|||
149796325|NCT03359811|540381332|FG000|Overall Study|Protocol Violation|2|||
149796326|NCT03359811|540381333|FG001|Overall Study|Protocol Violation|0|||
149796327|NCT01189201|540381338|FG000|Overall Study|Adverse Event|1|||
149796328|NCT01682876|540381339|FG000|Overall Study|Administrative reason|4|||
149796329|NCT01682876|540381340|FG001|Overall Study|Administrative reason|4|||
149796330|NCT01682876|540381341|FG002|Overall Study|Administrative reason|0|||
149796331|NCT01682876|540381342|FG003|Overall Study|Administrative reason|3|||
149796332|NCT01682876|540381339|FG000|Overall Study|Adverse Event|0|||
149796333|NCT01682876|540381340|FG001|Overall Study|Adverse Event|0|||
149796334|NCT01682876|540381341|FG002|Overall Study|Adverse Event|0|||
149796335|NCT01682876|540381342|FG003|Overall Study|Adverse Event|1|||
149796336|NCT01682876|540381339|FG000|Overall Study|Lost to Follow-up|11|||
149796337|NCT01682876|540381340|FG001|Overall Study|Lost to Follow-up|15|||
149796338|NCT01682876|540381341|FG002|Overall Study|Lost to Follow-up|9|||
149796339|NCT01682876|540381342|FG003|Overall Study|Lost to Follow-up|11|||
149796340|NCT01682876|540381339|FG000|Overall Study|Protocol Violation|1|||
149796341|NCT01682876|540381340|FG001|Overall Study|Protocol Violation|1|||
149796342|NCT01682876|540381341|FG002|Overall Study|Protocol Violation|1|||
149796343|NCT01682876|540381342|FG003|Overall Study|Protocol Violation|1|||
149796344|NCT01682876|540381339|FG000|Overall Study|Withdrawal by Subject|4|||
149796345|NCT01682876|540381340|FG001|Overall Study|Withdrawal by Subject|0|||
149796346|NCT01682876|540381341|FG002|Overall Study|Withdrawal by Subject|0|||
149796347|NCT01682876|540381342|FG003|Overall Study|Withdrawal by Subject|2|||
149796348|NCT01682876|540381339|FG000|Overall Study|Other|1|||
149796349|NCT01682876|540381340|FG001|Overall Study|Other|0|||
149796350|NCT01682876|540381341|FG002|Overall Study|Other|1|||
149796351|NCT01682876|540381342|FG003|Overall Study|Other|1|||
149796352|NCT00911508|540381346|FG000|Overall Study|Lost to Follow-up|27|||
149796353|NCT00911508|540381347|FG001|Overall Study|Lost to Follow-up|18|||
149796354|NCT00911508|540381346|FG000|Overall Study|Withdrawal by Subject|79|||
149796355|NCT00911508|540381347|FG001|Overall Study|Withdrawal by Subject|112|||
149796356|NCT00240331|540381350|FG000|Overall Study|Withdrawal by Subject|125|||
149796357|NCT00240331|540381351|FG001|Overall Study|Withdrawal by Subject|132|||
149796358|NCT00240331|540381350|FG000|Overall Study|Option selected by investigator|1|||
149796359|NCT00240331|540381351|FG001|Overall Study|Option selected by investigator|2|||
149796360|NCT01409382|540381352|FG000|Overall Study|Lost to Follow-up|1|||
149796361|NCT01409382|540381353|FG001|Overall Study|Lost to Follow-up|1|||
149796362|NCT01409382|540381352|FG000|Overall Study|Protocol Violation|0|||
149796363|NCT01409382|540381353|FG001|Overall Study|Protocol Violation|3|||
149796364|NCT01409382|540381352|FG000|Overall Study|Multiple pregnancy|2|||
149796365|NCT01409382|540381353|FG001|Overall Study|Multiple pregnancy|4|||
149796366|NCT01409382|540381352|FG000|Overall Study|Still pregnant when study ended|13|||
149796367|NCT01409382|540381353|FG001|Overall Study|Still pregnant when study ended|2|||
149796368|NCT01409382|540381352|FG000|Overall Study|Did not manage to get pregnant|64|||
149796369|NCT01409382|540381353|FG001|Overall Study|Did not manage to get pregnant|70|||
149796370|NCT01409382|540381352|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
149796371|NCT01409382|540381353|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
149796372|NCT01233076|540381354|FG000|Period 2, One Week|Lost to Follow-up|1|||
149796373|NCT01233076|540381355|FG001|Period 2, One Week|Lost to Follow-up|0|||
149796374|NCT01266967|540381356|FG000|Overall Study|Death|69|||
149796375|NCT01266967|540381357|FG001|Overall Study|Death|61|||
149796376|NCT01266967|540381356|FG000|Overall Study|Study Closed/Terminated|15|||
149796377|NCT01266967|540381357|FG001|Overall Study|Study Closed/Terminated|17|||
149796378|NCT01266967|540381356|FG000|Overall Study|Lost to Follow-up|2|||
149796379|NCT01266967|540381357|FG001|Overall Study|Lost to Follow-up|1|||
149796380|NCT01266967|540381356|FG000|Overall Study|Physician Decision|0|||
149796381|NCT01266967|540381357|FG001|Overall Study|Physician Decision|1|||
149796382|NCT01266967|540381356|FG000|Overall Study|Withdrawal by Subject|3|||
149796383|NCT01266967|540381357|FG001|Overall Study|Withdrawal by Subject|3|||
149796384|NCT04563845|540381358|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796385|NCT04563845|540381359|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796386|NCT04563845|540381360|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796387|NCT04563845|540381361|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796388|NCT04563845|540381362|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796389|NCT04563845|540381363|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796390|NCT04563845|540381364|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796391|NCT04563845|540381365|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
149796392|NCT04563845|540381366|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796393|NCT04563845|540381367|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796394|NCT04563845|540381368|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796395|NCT04563845|540381369|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796396|NCT04563845|540381370|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796397|NCT04563845|540381371|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149796398|NCT04563845|540381358|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796399|NCT04563845|540381359|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796400|NCT04563845|540381360|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796401|NCT04563845|540381361|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796402|NCT04563845|540381362|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
149796403|NCT04563845|540381363|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796404|NCT04563845|540381364|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796405|NCT04563845|540381365|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796406|NCT04563845|540381366|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796407|NCT04563845|540381367|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796408|NCT04563845|540381368|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796409|NCT04563845|540381369|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796410|NCT04563845|540381370|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796411|NCT04563845|540381371|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149796412|NCT01519700|540381372|FG000|Overall Study|Death|1|||
149796413|NCT01519700|540381373|FG001|Overall Study|Death|0|||
149796414|NCT01519700|540381374|FG002|Overall Study|Death|0|||
149796415|NCT01519700|540381375|FG003|Overall Study|Death|0|||
149796416|NCT01519700|540381372|FG000|Overall Study|Lost to Follow-up|0|||
149796417|NCT01519700|540381373|FG001|Overall Study|Lost to Follow-up|0|||
149796418|NCT01519700|540381374|FG002|Overall Study|Lost to Follow-up|1|||
149796419|NCT01519700|540381375|FG003|Overall Study|Lost to Follow-up|1|||
149796420|NCT01519700|540381372|FG000|Overall Study|Physician Decision|1|||
149796421|NCT01519700|540381373|FG001|Overall Study|Physician Decision|1|||
149796422|NCT01519700|540381374|FG002|Overall Study|Physician Decision|3|||
149796423|NCT01519700|540381375|FG003|Overall Study|Physician Decision|0|||
149796424|NCT01519700|540381372|FG000|Overall Study|Withdrawal by Subject|5|||
149796425|NCT01519700|540381373|FG001|Overall Study|Withdrawal by Subject|3|||
149796426|NCT01519700|540381374|FG002|Overall Study|Withdrawal by Subject|3|||
149796427|NCT01519700|540381375|FG003|Overall Study|Withdrawal by Subject|2|||
149796428|NCT01519700|540381372|FG000|Overall Study|Other Reason|2|||
149796429|NCT01519700|540381373|FG001|Overall Study|Other Reason|2|||
149796430|NCT01519700|540381374|FG002|Overall Study|Other Reason|0|||
149796431|NCT01519700|540381375|FG003|Overall Study|Other Reason|4|||
149796432|NCT03824704|540381379|FG000|Overall Study|Study Terminated by Sponsor|1|||
149796433|NCT02155660|540381387|FG000|Overall Study|Other Reason|8|||
149796434|NCT02155660|540381388|FG001|Overall Study|Other Reason|6|||
149796435|NCT02155660|540381389|FG002|Overall Study|Other Reason|10|||
149796436|NCT02155660|540381390|FG003|Overall Study|Other Reason|10|||
149796437|NCT02155660|540381387|FG000|Overall Study|Study-specific withdrawal criteria|0|||
149796438|NCT02155660|540381388|FG001|Overall Study|Study-specific withdrawal criteria|1|||
149796439|NCT02155660|540381389|FG002|Overall Study|Study-specific withdrawal criteria|1|||
149796440|NCT02155660|540381390|FG003|Overall Study|Study-specific withdrawal criteria|1|||
149796441|NCT02155660|540381387|FG000|Overall Study|Severe non-compliance|0|||
149796442|NCT02155660|540381388|FG001|Overall Study|Severe non-compliance|4|||
149796443|NCT02155660|540381389|FG002|Overall Study|Severe non-compliance|0|||
149796444|NCT02155660|540381390|FG003|Overall Study|Severe non-compliance|1|||
149796445|NCT02155660|540381387|FG000|Overall Study|Adverse Event|2|||
149796446|NCT02155660|540381388|FG001|Overall Study|Adverse Event|6|||
149796447|NCT02155660|540381389|FG002|Overall Study|Adverse Event|3|||
149796448|NCT02155660|540381390|FG003|Overall Study|Adverse Event|1|||
149796449|NCT02155660|540381387|FG000|Overall Study|Lost to Follow-up|3|||
149796450|NCT02155660|540381388|FG001|Overall Study|Lost to Follow-up|6|||
149796451|NCT02155660|540381389|FG002|Overall Study|Lost to Follow-up|5|||
149796452|NCT02155660|540381390|FG003|Overall Study|Lost to Follow-up|8|||
149796453|NCT02155660|540381387|FG000|Overall Study|Death|17|||
149796454|NCT02155660|540381388|FG001|Overall Study|Death|19|||
149796455|NCT02155660|540381389|FG002|Overall Study|Death|17|||
149796456|NCT02155660|540381390|FG003|Overall Study|Death|19|||
149796457|NCT02155660|540381387|FG000|Overall Study|Withdrawal by Subject|28|||
149796458|NCT02155660|540381388|FG001|Overall Study|Withdrawal by Subject|31|||
149796459|NCT02155660|540381389|FG002|Overall Study|Withdrawal by Subject|24|||
149796460|NCT02155660|540381390|FG003|Overall Study|Withdrawal by Subject|21|||
149796461|NCT03730987|540381391|FG000|Overall Study|Lost to Follow-up|2|||
149796462|NCT03730987|540381392|FG001|Overall Study|Lost to Follow-up|0|||
149796463|NCT03730987|540381393|FG002|Overall Study|Lost to Follow-up|2|||
149796464|NCT03730987|540381394|FG003|Overall Study|Lost to Follow-up|0|||
149796465|NCT02505945|540381395|FG000|Overall Study|Withdrawal by Subject|13|||
149796466|NCT02505945|540381396|FG001|Overall Study|Withdrawal by Subject|2|||
149796467|NCT02505945|540381395|FG000|Overall Study|Adverse Event|1|||
149796468|NCT02505945|540381396|FG001|Overall Study|Adverse Event|0|||
149796469|NCT02505945|540381395|FG000|Overall Study|Physician Decision|2|||
149796470|NCT02505945|540381396|FG001|Overall Study|Physician Decision|1|||
149796471|NCT02505945|540381395|FG000|Overall Study|Lost to Follow-up|6|||
149796472|NCT02505945|540381396|FG001|Overall Study|Lost to Follow-up|1|||
149796473|NCT00386152|540381397|FG000|Overall Study|Adverse Event|6|||
149796474|NCT00386152|540381398|FG001|Overall Study|Adverse Event|5|||
149796475|NCT00386152|540381399|FG002|Overall Study|Adverse Event|4|||
149796476|NCT00386152|540381397|FG000|Overall Study|Chang from original chemo stratification|4|||
149796477|NCT00386152|540381398|FG001|Overall Study|Chang from original chemo stratification|5|||
149796478|NCT00386152|540381399|FG002|Overall Study|Chang from original chemo stratification|6|||
149796479|NCT00386152|540381397|FG000|Overall Study|Death|3|||
149796480|NCT00386152|540381398|FG001|Overall Study|Death|0|||
149796481|NCT00386152|540381399|FG002|Overall Study|Death|1|||
149796482|NCT00386152|540381397|FG000|Overall Study|Disease progression|7|||
149796483|NCT00386152|540381398|FG001|Overall Study|Disease progression|4|||
149796484|NCT00386152|540381399|FG002|Overall Study|Disease progression|5|||
149796485|NCT00386152|540381397|FG000|Overall Study|Physician Decision|13|||
149796486|NCT00386152|540381398|FG001|Overall Study|Physician Decision|10|||
149796487|NCT00386152|540381399|FG002|Overall Study|Physician Decision|4|||
149796488|NCT00386152|540381397|FG000|Overall Study|Lost to Follow-up|1|||
149796489|NCT00386152|540381398|FG001|Overall Study|Lost to Follow-up|0|||
149796490|NCT00386152|540381399|FG002|Overall Study|Lost to Follow-up|0|||
149796491|NCT00386152|540381397|FG000|Overall Study|Completed chemotherapy|4|||
149796492|NCT00386152|540381398|FG001|Overall Study|Completed chemotherapy|5|||
149796493|NCT00386152|540381399|FG002|Overall Study|Completed chemotherapy|1|||
149796494|NCT00386152|540381397|FG000|Overall Study|Protocol Violation|3|||
149796495|NCT00386152|540381398|FG001|Overall Study|Protocol Violation|5|||
149796496|NCT00386152|540381399|FG002|Overall Study|Protocol Violation|2|||
149796497|NCT00386152|540381397|FG000|Overall Study|Withdrawal by Subject|3|||
149796498|NCT00386152|540381398|FG001|Overall Study|Withdrawal by Subject|6|||
149796499|NCT00386152|540381399|FG002|Overall Study|Withdrawal by Subject|10|||
149796500|NCT02577107|540381403|FG000|Overall Study|Protocol deviation|0|||
149796501|NCT02577107|540381404|FG001|Overall Study|Protocol deviation|1|||
149796502|NCT00883896|540381412|FG000|Overall Study|Lost to Follow-up|0|||
149796503|NCT00883896|540381413|FG001|Overall Study|Lost to Follow-up|0|||
149796504|NCT00883896|540381414|FG002|Overall Study|Lost to Follow-up|0|||
149796505|NCT00883896|540381415|FG003|Overall Study|Lost to Follow-up|2|||
149796506|NCT00883896|540381412|FG000|Overall Study|Withdrawal by Subject|5|||
149796507|NCT00883896|540381413|FG001|Overall Study|Withdrawal by Subject|0|||
149796508|NCT00883896|540381414|FG002|Overall Study|Withdrawal by Subject|1|||
149796509|NCT00883896|540381415|FG003|Overall Study|Withdrawal by Subject|3|||
149796510|NCT00883896|540381412|FG000|Overall Study|Lack of Efficacy|0|||
149796511|NCT00883896|540381413|FG001|Overall Study|Lack of Efficacy|0|||
149796512|NCT00883896|540381414|FG002|Overall Study|Lack of Efficacy|0|||
149796513|NCT00883896|540381415|FG003|Overall Study|Lack of Efficacy|2|||
149796514|NCT00883896|540381412|FG000|Overall Study|Other|1|||
149796515|NCT00883896|540381413|FG001|Overall Study|Other|0|||
149796516|NCT00883896|540381414|FG002|Overall Study|Other|0|||
149796517|NCT00883896|540381415|FG003|Overall Study|Other|0|||
149796518|NCT01856920|540381425|FG000|Overall Study|Disease Progression On Study|3|||
149796519|NCT01856920|540381426|FG001|Overall Study|Disease Progression On Study|4|||
149796520|NCT01856920|540381425|FG000|Overall Study|Disease Progression before Treatment|1|||
149796521|NCT01856920|540381426|FG001|Overall Study|Disease Progression before Treatment|0|||
149796522|NCT01856920|540381425|FG000|Overall Study|Ineligible|0|||
149796523|NCT01856920|540381426|FG001|Overall Study|Ineligible|1|||
149796524|NCT01856920|540381425|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
149796525|NCT01856920|540381426|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
149796526|NCT01856920|540381425|FG000|Overall Study|Refused further Treatment|5|||
149796527|NCT01856920|540381426|FG001|Overall Study|Refused further Treatment|1|||
149796528|NCT01856920|540381425|FG000|Overall Study|Other Reasons|0|||
149796529|NCT01856920|540381426|FG001|Overall Study|Other Reasons|1|||
149796530|NCT01856920|540381425|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
149796531|NCT01856920|540381426|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
149796532|NCT03380091|540381429|FG000|Overall Study|Withdrawal by Subject|2|||
149796533|NCT03380091|540381430|FG001|Overall Study|Withdrawal by Subject|1|||
149796534|NCT01980056|540381436|FG000|Overall Study|Death|1|||
149796535|NCT01980056|540381437|FG001|Overall Study|Death|1|||
149796536|NCT01980056|540381438|FG002|Overall Study|Death|0|||
149796537|NCT03802331|540381439|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
149796538|NCT03802331|540381440|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
149796539|NCT00368069|540381442|FG000|Overall Study|Adverse Event|5|||
149796540|NCT00368069|540381443|FG001|Overall Study|Adverse Event|2|||
149796541|NCT00368069|540381442|FG000|Overall Study|Lack of Efficacy|0|||
149796542|NCT00368069|540381443|FG001|Overall Study|Lack of Efficacy|1|||
149796543|NCT00368069|540381442|FG000|Overall Study|Lost to Follow-up|1|||
149796544|NCT00368069|540381443|FG001|Overall Study|Lost to Follow-up|0|||
149796545|NCT00368069|540381442|FG000|Overall Study|Protocol Violation|0|||
149796546|NCT00368069|540381443|FG001|Overall Study|Protocol Violation|2|||
149796547|NCT00368069|540381442|FG000|Overall Study|Withdrawal of Consent|2|||
149796548|NCT00368069|540381443|FG001|Overall Study|Withdrawal of Consent|1|||
149796549|NCT00368069|540381442|FG000|Overall Study|no blood sampling possible|0|||
149796550|NCT00368069|540381443|FG001|Overall Study|no blood sampling possible|1|||
149796551|NCT00579059|540381454|FG000|Overall Study|Study Canceled at 1 Year|21|||
149796552|NCT00579059|540381455|FG001|Overall Study|Study Canceled at 1 Year|10|||
149796553|NCT00779506|540381456|FG000|Overall Study|Screening Failed|2|||
149796554|NCT00779506|540381456|FG000|Overall Study|Adverse Event|4|||
149796555|NCT00779506|540381456|FG000|Overall Study|Lack of Efficacy|11|||
149796556|NCT00779506|540381456|FG000|Overall Study|Protocol Violation|5|||
149796557|NCT00779506|540381456|FG000|Overall Study|Withdrawal by Subject|6|||
149796558|NCT00779506|540381456|FG000|Overall Study|Lost to Follow-up|1|||
149796559|NCT01218477|540381457|FG000|Overall Study|Disease progression|2|||
149796560|NCT01218477|540381458|FG001|Overall Study|Disease progression|3|||
149796561|NCT01218477|540381459|FG002|Overall Study|Disease progression|6|||
149796562|NCT01218477|540381460|FG003|Overall Study|Disease progression|2|||
149796563|NCT01218477|540381457|FG000|Overall Study|Study drug toxicity|0|||
149796564|NCT01218477|540381458|FG001|Overall Study|Study drug toxicity|2|||
149796565|NCT01218477|540381459|FG002|Overall Study|Study drug toxicity|5|||
149796566|NCT01218477|540381460|FG003|Overall Study|Study drug toxicity|0|||
149796567|NCT01218477|540381457|FG000|Overall Study|No longer meets study criteria|1|||
149796568|NCT01218477|540381458|FG001|Overall Study|No longer meets study criteria|0|||
149796569|NCT01218477|540381459|FG002|Overall Study|No longer meets study criteria|0|||
149796570|NCT01218477|540381460|FG003|Overall Study|No longer meets study criteria|0|||
149796571|NCT01218477|540381457|FG000|Overall Study|Withdrawal by Subject|0|||
149796572|NCT01218477|540381458|FG001|Overall Study|Withdrawal by Subject|0|||
149796573|NCT01218477|540381459|FG002|Overall Study|Withdrawal by Subject|1|||
149796574|NCT01218477|540381460|FG003|Overall Study|Withdrawal by Subject|0|||
149796575|NCT01218477|540381457|FG000|Overall Study|Prepared for cell transplantation|0|||
149796576|NCT01218477|540381458|FG001|Overall Study|Prepared for cell transplantation|1|||
149796577|NCT01218477|540381459|FG002|Overall Study|Prepared for cell transplantation|1|||
149796578|NCT01218477|540381460|FG003|Overall Study|Prepared for cell transplantation|0|||
149796579|NCT01218477|540381457|FG000|Overall Study|Administrative reason by sponsor|0|||
149796580|NCT01218477|540381458|FG001|Overall Study|Administrative reason by sponsor|0|||
149796581|NCT01218477|540381459|FG002|Overall Study|Administrative reason by sponsor|1|||
149796582|NCT01218477|540381460|FG003|Overall Study|Administrative reason by sponsor|0|||
149796583|NCT01218477|540381457|FG000|Overall Study|Maximum clinical benefit|0|||
149796584|NCT01218477|540381458|FG001|Overall Study|Maximum clinical benefit|2|||
149796585|NCT01218477|540381459|FG002|Overall Study|Maximum clinical benefit|0|||
149796586|NCT01218477|540381460|FG003|Overall Study|Maximum clinical benefit|0|||
149796587|NCT00787527|540381463|FG000|Overall Study|Toxicity|3|||
149796588|NCT03137433|540381464|FG000|Overall Study|Withdrawal by Subject|11|||
149796589|NCT03137433|540381465|FG001|Overall Study|Withdrawal by Subject|11|||
149796590|NCT03137433|540381464|FG000|Overall Study|Lost to Follow-up|5|||
149796591|NCT03137433|540381465|FG001|Overall Study|Lost to Follow-up|6|||
149796592|NCT03137433|540381464|FG000|Overall Study|Physician Decision|2|||
149796593|NCT03137433|540381465|FG001|Overall Study|Physician Decision|0|||
149796594|NCT03137433|540381464|FG000|Overall Study|Moved out of study area|1|||
149796595|NCT03137433|540381465|FG001|Overall Study|Moved out of study area|0|||
149796596|NCT03137433|540381464|FG000|Overall Study|Too far out of window due to COVID|0|||
149796597|NCT03137433|540381465|FG001|Overall Study|Too far out of window due to COVID|1|||
149796598|NCT00083616|540381466|FG000|Overall Study|Disease Progression|16|||
149796599|NCT00083616|540381466|FG000|Overall Study|Lost to Follow-up|1|||
149796600|NCT00083616|540381466|FG000|Overall Study|Physician Decision|2|||
149796601|NCT00083616|540381466|FG000|Overall Study|Withdrawal by Subject|3|||
149796602|NCT00083616|540381466|FG000|Overall Study|Ineligibility determined|2|||
149796603|NCT00083616|540381466|FG000|Overall Study|Non-compliance|1|||
149796604|NCT00083616|540381466|FG000|Overall Study|Other|6|||
149796605|NCT01474993|540381470|FG000|Overall Study|Lost to Follow-up|1|||
149796606|NCT01474993|540381471|FG001|Overall Study|Lost to Follow-up|2|||
149796607|NCT01474993|540381470|FG000|Overall Study|Adverse Event|0|||
149796608|NCT01474993|540381471|FG001|Overall Study|Adverse Event|1|||
149796609|NCT03742271|540381473|FG000|Overall Study|Unsatisfactory Visual Response|1|||
149796610|NCT03742271|540381473|FG000|Overall Study|Withdrawal by Subject|3|||
149796611|NCT03742271|540381473|FG000|Overall Study|Lost to Follow-up|4|||
149796612|NCT03742271|540381473|FG000|Overall Study|Failed Insertion & removal|3|||
149796613|NCT03742271|540381473|FG000|Overall Study|Protocol Violation|1|||
149796614|NCT00440232|540381476|FG000|Overall Study|Lost to Follow-up|1|||
149796615|NCT00440232|540381477|FG001|Overall Study|Lost to Follow-up|1|||
149796616|NCT00440232|540381476|FG000|Overall Study|Unable to treat within allowed time|0|||
149796617|NCT00440232|540381477|FG001|Overall Study|Unable to treat within allowed time|1|||
149796618|NCT00440232|540381476|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
149796619|NCT00440232|540381477|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
149796620|NCT00362297|540381478|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
149796621|NCT00362297|540381479|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
149796622|NCT03417999|540381480|FG000|Overall Study|Withdrawal by Subject|1|||
149796623|NCT03417999|540381481|FG001|Overall Study|Withdrawal by Subject|0|||
149796624|NCT03417999|540381482|FG002|Overall Study|Withdrawal by Subject|0|||
149796625|NCT03417999|540381480|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
149796626|NCT03417999|540381481|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
149796627|NCT03417999|540381482|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
149796628|NCT03417999|540381480|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
149796629|NCT03417999|540381481|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
149796630|NCT03417999|540381482|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
149796631|NCT03417999|540381480|FG000|Overall Study|Inadequate study staff available to process samples|0|||
149796632|NCT03417999|540381481|FG001|Overall Study|Inadequate study staff available to process samples|0|||
149796633|NCT03417999|540381482|FG002|Overall Study|Inadequate study staff available to process samples|1|||
149796634|NCT05111548|540382996|FG000|Overall Study|Withdrawal by Subject|2|||
149796635|NCT05111548|540382997|FG001|Overall Study|Withdrawal by Subject|1|||
149796636|NCT05111548|540382996|FG000|Overall Study|Adverse Event|1|||
149796637|NCT05111548|540382997|FG001|Overall Study|Adverse Event|0|||
149796638|NCT01846039|540382998|FG000|Overall Study|Protocol Violation|1|||
149796639|NCT01846039|540382998|FG000|Overall Study|Subject Withdrew Consent|1|||
149796640|NCT01855607|540383009|FG000|Overall Study|Withdrawal by Subject|1|||
149796641|NCT01855607|540383009|FG000|Overall Study|Study was terminated|11|||
149796642|NCT01101321|540383010|FG000|Period 1|Withdrawal by Subject|1|||
149796643|NCT01101321|540383011|FG001|Period 1|Withdrawal by Subject|1|||
149796644|NCT01101321|540383010|FG000|Period 1|Adverse Event|3|||
149796645|NCT01101321|540383011|FG001|Period 1|Adverse Event|3|||
149796646|NCT02406586|540383012|FG000|Overall Study|Lost to Follow-up|0|||
149796647|NCT02406586|540383013|FG001|Overall Study|Lost to Follow-up|4|||
149796648|NCT02406586|540383014|FG002|Overall Study|Lost to Follow-up|2|||
149796649|NCT02406586|540383012|FG000|Overall Study|Withdrawal by Subject|1|||
149796650|NCT02406586|540383013|FG001|Overall Study|Withdrawal by Subject|0|||
149796651|NCT02406586|540383014|FG002|Overall Study|Withdrawal by Subject|0|||
149796652|NCT02839330|540383015|FG000|Overall Study|Adverse Event|0|||
149796653|NCT02839330|540383016|FG001|Overall Study|Adverse Event|1|||
149796654|NCT02839330|540383017|FG002|Overall Study|Adverse Event|2|||
149796655|NCT02839330|540383018|FG003|Overall Study|Adverse Event|2|||
149796656|NCT02839330|540383015|FG000|Overall Study|Death|4|||
149796657|NCT02839330|540383016|FG001|Overall Study|Death|6|||
149796658|NCT02839330|540383017|FG002|Overall Study|Death|1|||
149796659|NCT02839330|540383018|FG003|Overall Study|Death|1|||
149796660|NCT02839330|540383015|FG000|Overall Study|Withdrawal by Subject|27|||
149796661|NCT02839330|540383016|FG001|Overall Study|Withdrawal by Subject|19|||
149796662|NCT02839330|540383017|FG002|Overall Study|Withdrawal by Subject|11|||
149796663|NCT02839330|540383018|FG003|Overall Study|Withdrawal by Subject|13|||
149796664|NCT02839330|540383015|FG000|Overall Study|Lost to Follow-up|22|||
149796665|NCT02839330|540383016|FG001|Overall Study|Lost to Follow-up|27|||
149796666|NCT02839330|540383017|FG002|Overall Study|Lost to Follow-up|29|||
149796667|NCT02839330|540383018|FG003|Overall Study|Lost to Follow-up|25|||
149796668|NCT02839330|540383015|FG000|Overall Study|Administrative Reason|0|||
149796669|NCT02839330|540383016|FG001|Overall Study|Administrative Reason|0|||
149796670|NCT02839330|540383017|FG002|Overall Study|Administrative Reason|0|||
149796671|NCT02839330|540383018|FG003|Overall Study|Administrative Reason|1|||
149796672|NCT02839330|540383015|FG000|Overall Study|Protocol Violation|1|||
149796673|NCT02839330|540383016|FG001|Overall Study|Protocol Violation|2|||
149796674|NCT02839330|540383017|FG002|Overall Study|Protocol Violation|2|||
149796675|NCT02839330|540383018|FG003|Overall Study|Protocol Violation|3|||
149796676|NCT02839330|540383015|FG000|Overall Study|Other reason, not specified|4|||
149796677|NCT02839330|540383016|FG001|Overall Study|Other reason, not specified|3|||
149796678|NCT02839330|540383017|FG002|Overall Study|Other reason, not specified|3|||
149796679|NCT02839330|540383018|FG003|Overall Study|Other reason, not specified|6|||
149796680|NCT03339999|540383019|FG000|Overall Study|Adverse Event|1|||
149796681|NCT03339999|540383020|FG001|Overall Study|Adverse Event|2|||
149796682|NCT03339999|540383021|FG002|Overall Study|Adverse Event|2|||
149796683|NCT03339999|540383022|FG003|Overall Study|Adverse Event|1|||
149796684|NCT03339999|540383019|FG000|Overall Study|Lack of Efficacy|0|||
149796685|NCT03339999|540383020|FG001|Overall Study|Lack of Efficacy|1|||
149796686|NCT03339999|540383021|FG002|Overall Study|Lack of Efficacy|0|||
149796687|NCT03339999|540383022|FG003|Overall Study|Lack of Efficacy|0|||
149796688|NCT03339999|540383019|FG000|Overall Study|Lost to Follow-up|0|||
149796689|NCT03339999|540383020|FG001|Overall Study|Lost to Follow-up|0|||
149796690|NCT03339999|540383021|FG002|Overall Study|Lost to Follow-up|0|||
149796691|NCT03339999|540383022|FG003|Overall Study|Lost to Follow-up|1|||
149796692|NCT03339999|540383019|FG000|Overall Study|Study Terminated by Sponsor|6|||
149796693|NCT03339999|540383020|FG001|Overall Study|Study Terminated by Sponsor|3|||
149796694|NCT03339999|540383021|FG002|Overall Study|Study Terminated by Sponsor|4|||
149796695|NCT03339999|540383022|FG003|Overall Study|Study Terminated by Sponsor|3|||
149796696|NCT00661362|540383025|FG000|Overall Study|Adverse Event|5|||
149796697|NCT00661362|540383026|FG001|Overall Study|Adverse Event|4|||
149796698|NCT00661362|540383025|FG000|Overall Study|Incorrect enrollment|2|||
149796699|NCT00661362|540383026|FG001|Overall Study|Incorrect enrollment|0|||
149796700|NCT00661362|540383025|FG000|Overall Study|Study specific discontinuation criteria|4|||
149796701|NCT00661362|540383026|FG001|Overall Study|Study specific discontinuation criteria|11|||
149796702|NCT00661362|540383025|FG000|Overall Study|Withdrawal by Subject|13|||
149796703|NCT00661362|540383026|FG001|Overall Study|Withdrawal by Subject|23|||
149796704|NCT00661362|540383025|FG000|Overall Study|Lost to Follow-up|3|||
149796705|NCT00661362|540383026|FG001|Overall Study|Lost to Follow-up|1|||
149796706|NCT00661362|540383025|FG000|Overall Study|Severe non-compliance to protocol|0|||
149796707|NCT00661362|540383026|FG001|Overall Study|Severe non-compliance to protocol|1|||
149796708|NCT00661362|540383025|FG000|Overall Study|Safety reasons|1|||
149796709|NCT00661362|540383026|FG001|Overall Study|Safety reasons|0|||
149796710|NCT00661362|540383025|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
149796711|NCT00661362|540383026|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
149796712|NCT00535262|540383027|FG000|Overall Study|No funding|3|||
149796713|NCT01707667|540383028|FG000|Period 1|expulsion of colonic sensor catheter|1|||
149796714|NCT01707667|540383029|FG001|Period 1|expulsion of colonic sensor catheter|0|||
149796715|NCT01654666|540383030|FG000|Overall Study|Protocol Violation|7|||
149796716|NCT01654666|540383031|FG001|Overall Study|Protocol Violation|4|||
149796717|NCT01654666|540383032|FG002|Overall Study|Protocol Violation|8|||
149796718|NCT01654666|540383030|FG000|Overall Study|Lost to Follow-up|4|||
149796719|NCT01654666|540383031|FG001|Overall Study|Lost to Follow-up|5|||
149796720|NCT01654666|540383032|FG002|Overall Study|Lost to Follow-up|5|||
149796721|NCT01654666|540383030|FG000|Overall Study|Withdrawal by Subject|4|||
149796722|NCT01654666|540383031|FG001|Overall Study|Withdrawal by Subject|4|||
149796723|NCT01654666|540383032|FG002|Overall Study|Withdrawal by Subject|1|||
149796724|NCT03432819|540383034|FG000|Overall Study|Lost to Follow-up|2|||
149796725|NCT03432819|540383035|FG001|Overall Study|Lost to Follow-up|2|||
149796726|NCT03432819|540383034|FG000|Overall Study|Withdrawal by Subject|5|||
149796727|NCT03432819|540383035|FG001|Overall Study|Withdrawal by Subject|3|||
149796728|NCT04382066|540383036|FG000|Overall Study|Adverse Event|1|||
149796729|NCT04382066|540383037|FG001|Overall Study|Adverse Event|0|||
149796730|NCT04382066|540383038|FG002|Overall Study|Adverse Event|0|||
149796731|NCT04382066|540383036|FG000|Overall Study|Death|1|||
149796732|NCT04382066|540383037|FG001|Overall Study|Death|0|||
149796733|NCT04382066|540383038|FG002|Overall Study|Death|1|||
149796734|NCT01430559|540383039|FG000|Overall Study|Adverse Event|7|||
149796735|NCT01430559|540383040|FG001|Overall Study|Adverse Event|3|||
149796736|NCT01430559|540383039|FG000|Overall Study|Entry criteria not met|1|||
149796737|NCT01430559|540383040|FG001|Overall Study|Entry criteria not met|1|||
149796738|NCT01430559|540383039|FG000|Overall Study|Lost to Follow-up|1|||
149796739|NCT01430559|540383040|FG001|Overall Study|Lost to Follow-up|0|||
149796740|NCT01430559|540383039|FG000|Overall Study|Medication error|1|||
149796741|NCT01430559|540383040|FG001|Overall Study|Medication error|0|||
149796742|NCT01430559|540383039|FG000|Overall Study|Withdrawal by Subject|3|||
149796743|NCT01430559|540383040|FG001|Overall Study|Withdrawal by Subject|2|||
149796744|NCT01430559|540383039|FG000|Overall Study|Protocol Violation|1|||
149796745|NCT01430559|540383040|FG001|Overall Study|Protocol Violation|0|||
149796746|NCT01430559|540383039|FG000|Overall Study|Other|3|||
149796747|NCT01430559|540383040|FG001|Overall Study|Other|3|||
149796748|NCT01430559|540383039|FG000|Overall Study|Randomized, Not Treated|3|||
149796749|NCT01430559|540383040|FG001|Overall Study|Randomized, Not Treated|3|||
149796750|NCT01220024|540383041|FG000|Overall Study|Lost to Follow-up|1|||
149796751|NCT01220024|540383042|FG001|Overall Study|Lost to Follow-up|1|||
149796752|NCT00174460|540383045|FG000|Overall Study|Withdrawal by Subject|0|||
149796753|NCT00174460|540383046|FG001|Overall Study|Withdrawal by Subject|1|||
149796754|NCT04225026|540383047|FG000|Overall Study|Withdrawal by Subject|4|||
149796755|NCT04225026|540383047|FG000|Overall Study|Adverse Event|1|||
149796756|NCT04225026|540383047|FG000|Overall Study|Other|1|||
149796757|NCT04225026|540383047|FG000|Overall Study|Death|11|||
149796758|NCT04225026|540383047|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
149796759|NCT00672490|540383050|FG000|Overall Study|Withdrawal by Subject|8|||
149796760|NCT00672490|540383051|FG001|Overall Study|Withdrawal by Subject|8|||
149796761|NCT00672490|540383050|FG000|Overall Study|Lack of Compliance|2|||
149796762|NCT00672490|540383051|FG001|Overall Study|Lack of Compliance|7|||
149796763|NCT00672490|540383050|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
149796764|NCT00672490|540383051|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
149796765|NCT00672490|540383050|FG000|Overall Study|Adverse Event|5|||
149796766|NCT00672490|540383051|FG001|Overall Study|Adverse Event|8|||
149796767|NCT00672490|540383050|FG000|Overall Study|Violation of Concomitant Medicine|1|||
149796768|NCT00672490|540383051|FG001|Overall Study|Violation of Concomitant Medicine|0|||
149796769|NCT00672490|540383050|FG000|Overall Study|Intolerance|0|||
149796770|NCT00672490|540383051|FG001|Overall Study|Intolerance|2|||
149796771|NCT00672490|540383050|FG000|Overall Study|Lost to Follow-up|1|||
149796772|NCT00672490|540383051|FG001|Overall Study|Lost to Follow-up|5|||
149796773|NCT00672490|540383050|FG000|Overall Study|No reason was provided|6|||
149796774|NCT00672490|540383051|FG001|Overall Study|No reason was provided|2|||
149796775|NCT03982069|540383054|FG000|Overall Study|Lost to Follow-up|5|||
149796776|NCT03982069|540383055|FG001|Overall Study|Lost to Follow-up|5|||
149796777|NCT03982069|540383056|FG002|Overall Study|Lost to Follow-up|3|||
149796778|NCT03982069|540383057|FG003|Overall Study|Lost to Follow-up|5|||
149796779|NCT03982069|540383054|FG000|Overall Study|Physician Decision|0|||
149796780|NCT03982069|540383055|FG001|Overall Study|Physician Decision|1|||
149796781|NCT03982069|540383056|FG002|Overall Study|Physician Decision|0|||
149796782|NCT03982069|540383057|FG003|Overall Study|Physician Decision|0|||
149796783|NCT03982069|540383054|FG000|Overall Study|Withdrawal by Subject|2|||
149796784|NCT03982069|540383055|FG001|Overall Study|Withdrawal by Subject|1|||
149796785|NCT03982069|540383056|FG002|Overall Study|Withdrawal by Subject|5|||
149796786|NCT03982069|540383057|FG003|Overall Study|Withdrawal by Subject|2|||
149796787|NCT03982069|540383054|FG000|Overall Study|Specimen loss|3|||
149796788|NCT03982069|540383055|FG001|Overall Study|Specimen loss|3|||
149796789|NCT03982069|540383056|FG002|Overall Study|Specimen loss|1|||
149796790|NCT03982069|540383057|FG003|Overall Study|Specimen loss|1|||
149796791|NCT01303159|540383058|FG000|Overall Study|Death|16|||
149796792|NCT01303159|540383058|FG000|Overall Study|Study Termination|7|||
149796793|NCT00914940|540383059|FG000|D0 to D100 Post-transplant|Death|2|||
149796794|NCT00914940|540383059|FG000|D101 to 2 Years Post-transplant|Death|8|||
149796795|NCT00914940|540383059|FG000|2 Years to 5 Years Post-transplant|Death|3|||
149796796|NCT00760994|540383067|FG000|Overall Study|Lost to Follow-up|4|||
149796797|NCT00760994|540383068|FG001|Overall Study|Lost to Follow-up|4|||
149796798|NCT00760994|540383069|FG002|Overall Study|Lost to Follow-up|3|||
149796799|NCT01853397|540383070|FG000|Overall Study|Withdrawal by Subject|0|||
149796800|NCT01853397|540383071|FG001|Overall Study|Withdrawal by Subject|0|||
149796801|NCT01853397|540383072|FG002|Overall Study|Withdrawal by Subject|0|||
149796802|NCT01853397|540383073|FG003|Overall Study|Withdrawal by Subject|1|||
149796803|NCT01853397|540383070|FG000|Overall Study|Subject Noncompliance|0|||
149796804|NCT01853397|540383071|FG001|Overall Study|Subject Noncompliance|0|||
149796805|NCT01853397|540383072|FG002|Overall Study|Subject Noncompliance|0|||
149796806|NCT01853397|540383073|FG003|Overall Study|Subject Noncompliance|1|||
149796807|NCT02132312|540383074|FG000|Overall Study|Adverse Event|2|||
149796808|NCT02132312|540383075|FG001|Overall Study|Adverse Event|0|||
149796809|NCT02132312|540383074|FG000|Overall Study|Physician Decision|1|||
149796810|NCT02132312|540383075|FG001|Overall Study|Physician Decision|1|||
149796811|NCT02132312|540383074|FG000|Overall Study|Protocol Violation|0|||
149796812|NCT02132312|540383075|FG001|Overall Study|Protocol Violation|1|||
149796813|NCT02132312|540383074|FG000|Overall Study|Withdrawal by Subject|1|||
149796814|NCT02132312|540383075|FG001|Overall Study|Withdrawal by Subject|0|||
149796815|NCT02132312|540383074|FG000|Overall Study|Lost to Follow-up|2|||
149796816|NCT02132312|540383075|FG001|Overall Study|Lost to Follow-up|1|||
149796817|NCT01632345|540383076|FG000|Treatment: Part I|Adverse Event|1|||
149796818|NCT01632345|540383077|FG001|Treatment: Part I|Adverse Event|4|||
149796819|NCT01632345|540383078|FG002|Treatment: Part I|Adverse Event|2|||
149796820|NCT01632345|540383079|FG003|Treatment: Part I|Adverse Event|1|||
149796821|NCT01632345|540383080|FG004|Treatment: Part I|Adverse Event|3|||
149796822|NCT01632345|540383081|FG005|Treatment: Part I|Adverse Event|0|||
149796823|NCT01632345|540383082|FG006|Treatment: Part I|Adverse Event|0|||
149796824|NCT01632345|540383076|FG000|Treatment: Part I|Lack of Efficacy|0|||
149796825|NCT01632345|540383077|FG001|Treatment: Part I|Lack of Efficacy|1|||
149796826|NCT01632345|540383078|FG002|Treatment: Part I|Lack of Efficacy|0|||
149796827|NCT01632345|540383079|FG003|Treatment: Part I|Lack of Efficacy|1|||
149796828|NCT01632345|540383080|FG004|Treatment: Part I|Lack of Efficacy|1|||
149796829|NCT01632345|540383081|FG005|Treatment: Part I|Lack of Efficacy|0|||
149796830|NCT01632345|540383082|FG006|Treatment: Part I|Lack of Efficacy|0|||
149796831|NCT01632345|540383076|FG000|Treatment: Part I|Lost to Follow-up|3|||
149796832|NCT01632345|540383077|FG001|Treatment: Part I|Lost to Follow-up|2|||
149796833|NCT01632345|540383078|FG002|Treatment: Part I|Lost to Follow-up|1|||
149796834|NCT01632345|540383079|FG003|Treatment: Part I|Lost to Follow-up|3|||
149796835|NCT01632345|540383080|FG004|Treatment: Part I|Lost to Follow-up|4|||
149796836|NCT01632345|540383081|FG005|Treatment: Part I|Lost to Follow-up|0|||
149796837|NCT01632345|540383082|FG006|Treatment: Part I|Lost to Follow-up|0|||
149796838|NCT01632345|540383076|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
149796839|NCT01632345|540383077|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
149796840|NCT01632345|540383078|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
149796841|NCT01632345|540383079|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
149796842|NCT01632345|540383080|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
149796843|NCT01632345|540383081|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
149796844|NCT01632345|540383082|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
149796845|NCT01632345|540383076|FG000|Treatment: Part I|Physician Decision|2|||
149796846|NCT01632345|540383077|FG001|Treatment: Part I|Physician Decision|1|||
149796847|NCT01632345|540383078|FG002|Treatment: Part I|Physician Decision|0|||
149796848|NCT01632345|540383079|FG003|Treatment: Part I|Physician Decision|0|||
149796849|NCT01632345|540383080|FG004|Treatment: Part I|Physician Decision|1|||
149796850|NCT01632345|540383081|FG005|Treatment: Part I|Physician Decision|0|||
149796851|NCT01632345|540383082|FG006|Treatment: Part I|Physician Decision|0|||
149796852|NCT01632345|540383076|FG000|Treatment: Part I|Pregnancy|0|||
149796853|NCT01632345|540383077|FG001|Treatment: Part I|Pregnancy|1|||
149796854|NCT01632345|540383078|FG002|Treatment: Part I|Pregnancy|0|||
149796855|NCT01632345|540383079|FG003|Treatment: Part I|Pregnancy|0|||
149796856|NCT01632345|540383080|FG004|Treatment: Part I|Pregnancy|0|||
149796857|NCT01632345|540383081|FG005|Treatment: Part I|Pregnancy|0|||
149796858|NCT01632345|540383082|FG006|Treatment: Part I|Pregnancy|0|||
149796859|NCT01632345|540383076|FG000|Treatment: Part I|Protocol Deviation|0|||
149796860|NCT01632345|540383077|FG001|Treatment: Part I|Protocol Deviation|0|||
149796861|NCT01632345|540383078|FG002|Treatment: Part I|Protocol Deviation|1|||
149796862|NCT01632345|540383079|FG003|Treatment: Part I|Protocol Deviation|1|||
149796863|NCT01632345|540383080|FG004|Treatment: Part I|Protocol Deviation|0|||
149796864|NCT01632345|540383081|FG005|Treatment: Part I|Protocol Deviation|0|||
149796865|NCT01632345|540383082|FG006|Treatment: Part I|Protocol Deviation|0|||
149796866|NCT01632345|540383076|FG000|Treatment: Part I|Withdrawal by Subject|3|||
149796867|NCT01632345|540383077|FG001|Treatment: Part I|Withdrawal by Subject|4|||
149796868|NCT01632345|540383078|FG002|Treatment: Part I|Withdrawal by Subject|4|||
149796869|NCT01632345|540383079|FG003|Treatment: Part I|Withdrawal by Subject|1|||
149796870|NCT01632345|540383080|FG004|Treatment: Part I|Withdrawal by Subject|4|||
149796871|NCT01632345|540383081|FG005|Treatment: Part I|Withdrawal by Subject|0|||
149796872|NCT01632345|540383082|FG006|Treatment: Part I|Withdrawal by Subject|0|||
149796873|NCT01632345|540383076|FG000|Treatment: Part II|Adverse Event|0|||
149796874|NCT01632345|540383077|FG001|Treatment: Part II|Adverse Event|0|||
149796875|NCT01632345|540383078|FG002|Treatment: Part II|Adverse Event|0|||
149796876|NCT01632345|540383079|FG003|Treatment: Part II|Adverse Event|0|||
149796877|NCT01632345|540383080|FG004|Treatment: Part II|Adverse Event|0|||
149796878|NCT01632345|540383081|FG005|Treatment: Part II|Adverse Event|3|||
149796879|NCT01632345|540383082|FG006|Treatment: Part II|Adverse Event|8|||
149796880|NCT01632345|540383076|FG000|Treatment: Part II|Lost to Follow-up|0|||
149796881|NCT01632345|540383077|FG001|Treatment: Part II|Lost to Follow-up|0|||
149796882|NCT01632345|540383078|FG002|Treatment: Part II|Lost to Follow-up|0|||
149796883|NCT01632345|540383079|FG003|Treatment: Part II|Lost to Follow-up|0|||
149796884|NCT01632345|540383080|FG004|Treatment: Part II|Lost to Follow-up|0|||
149796885|NCT01632345|540383081|FG005|Treatment: Part II|Lost to Follow-up|3|||
149796886|NCT01632345|540383082|FG006|Treatment: Part II|Lost to Follow-up|1|||
149796887|NCT01632345|540383076|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796888|NCT01632345|540383077|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796889|NCT01632345|540383078|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796890|NCT01632345|540383079|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796891|NCT01632345|540383080|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796892|NCT01632345|540383081|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
149796893|NCT01632345|540383082|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
149796894|NCT01632345|540383076|FG000|Treatment: Part II|Withdrawal by Subject|0|||
149796895|NCT01632345|540383077|FG001|Treatment: Part II|Withdrawal by Subject|0|||
149796896|NCT01632345|540383078|FG002|Treatment: Part II|Withdrawal by Subject|0|||
149796897|NCT01632345|540383079|FG003|Treatment: Part II|Withdrawal by Subject|0|||
149796898|NCT01632345|540383080|FG004|Treatment: Part II|Withdrawal by Subject|0|||
149796899|NCT01632345|540383081|FG005|Treatment: Part II|Withdrawal by Subject|2|||
149796900|NCT01632345|540383082|FG006|Treatment: Part II|Withdrawal by Subject|2|||
149796901|NCT00089505|540383083|FG000|Overall Study|Death|4|||
149796902|NCT00089505|540383084|FG001|Overall Study|Death|1|||
149796903|NCT00089505|540383085|FG002|Overall Study|Death|5|||
149796904|NCT00089505|540383086|FG003|Overall Study|Death|8|||
149796905|NCT00089505|540383083|FG000|Overall Study|Withdrawal by Subject|3|||
149796906|NCT00089505|540383084|FG001|Overall Study|Withdrawal by Subject|0|||
149796907|NCT00089505|540383085|FG002|Overall Study|Withdrawal by Subject|6|||
149796908|NCT00089505|540383086|FG003|Overall Study|Withdrawal by Subject|6|||
149796909|NCT00089505|540383083|FG000|Overall Study|Lost to Follow-up|1|||
149796910|NCT00089505|540383084|FG001|Overall Study|Lost to Follow-up|1|||
149796911|NCT00089505|540383085|FG002|Overall Study|Lost to Follow-up|9|||
149796912|NCT00089505|540383086|FG003|Overall Study|Lost to Follow-up|7|||
149796913|NCT00089505|540383083|FG000|Overall Study|Physician Decision|1|||
149796914|NCT00089505|540383084|FG001|Overall Study|Physician Decision|0|||
149796915|NCT00089505|540383085|FG002|Overall Study|Physician Decision|0|||
149796916|NCT00089505|540383086|FG003|Overall Study|Physician Decision|0|||
149796917|NCT00089505|540383083|FG000|Overall Study|Protocol Violation|0|||
149796918|NCT00089505|540383084|FG001|Overall Study|Protocol Violation|0|||
149796919|NCT00089505|540383085|FG002|Overall Study|Protocol Violation|1|||
149796920|NCT00089505|540383086|FG003|Overall Study|Protocol Violation|0|||
149796921|NCT01724021|540383087|FG000|Overall Study|Adverse Event|11|||
149796922|NCT01724021|540383088|FG001|Overall Study|Adverse Event|6|||
149796923|NCT01724021|540383087|FG000|Overall Study|Death|46|||
149796924|NCT01724021|540383088|FG001|Overall Study|Death|58|||
149796925|NCT01724021|540383087|FG000|Overall Study|Participant request/ Withdrew consent|18|||
149796926|NCT01724021|540383088|FG001|Overall Study|Participant request/ Withdrew consent|14|||
149796927|NCT01724021|540383087|FG000|Overall Study|Lost to Follow-up|15|||
149796928|NCT01724021|540383088|FG001|Overall Study|Lost to Follow-up|15|||
149796929|NCT01724021|540383087|FG000|Overall Study|Reason Not Specified|36|||
149796930|NCT01724021|540383088|FG001|Overall Study|Reason Not Specified|39|||
149796931|NCT01724021|540383087|FG000|Overall Study|Missing|1|||
149796932|NCT01724021|540383088|FG001|Overall Study|Missing|1|||
149796933|NCT02543918|540383089|FG000|Overall Study|Never treated|0|||
149796934|NCT02543918|540383090|FG001|Overall Study|Never treated|1|||
149796935|NCT02543918|540383089|FG000|Overall Study|Lost to Follow-up|1|||
149796936|NCT02543918|540383090|FG001|Overall Study|Lost to Follow-up|1|||
149796937|NCT02543918|540383089|FG000|Overall Study|Withdrawal by Subject|1|||
149796938|NCT02543918|540383090|FG001|Overall Study|Withdrawal by Subject|1|||
149796939|NCT02543918|540383089|FG000|Overall Study|Adverse Event|1|||
149796940|NCT02543918|540383090|FG001|Overall Study|Adverse Event|1|||
149796941|NCT01005875|540383093|FG000|Overall Study|Death|3|||
149796942|NCT00606931|540383096|FG000|Overall Study|Withdrawal by Subject|3|||
149796943|NCT00266695|540383100|FG000|Overall Study|Adverse Event|1|||
149796944|NCT00266695|540383100|FG000|Overall Study|Death|9|||
149796945|NCT00266695|540383100|FG000|Overall Study|Physician Decision|1|||
149796946|NCT00266695|540383100|FG000|Overall Study|Lost to Follow-up|3|||
149796947|NCT00266695|540383100|FG000|Overall Study|Withdrawal by Subject|15|||
149796948|NCT02380703|540383101|FG000|Overall Study|Withdrawal by Subject|12|||
149796949|NCT02380703|540383102|FG001|Overall Study|Withdrawal by Subject|9|||
149796950|NCT02380703|540383101|FG000|Overall Study|Lost to Follow-up|12|||
149796951|NCT02380703|540383102|FG001|Overall Study|Lost to Follow-up|12|||
149796952|NCT02380703|540383101|FG000|Overall Study|Caregiver death|1|||
149796953|NCT02380703|540383102|FG001|Overall Study|Caregiver death|0|||
149796954|NCT02380703|540383101|FG000|Overall Study|Person with dementia (PWD) death|7|||
149796955|NCT02380703|540383102|FG001|Overall Study|Person with dementia (PWD) death|8|||
149796956|NCT02380703|540383101|FG000|Overall Study|Entered Long-term Care|4|||
149796957|NCT02380703|540383102|FG001|Overall Study|Entered Long-term Care|7|||
149796958|NCT04490499|540383103|FG000|Overall Study|Withdrawal by Subject|2|||
149796959|NCT01843933|540383106|FG000|Overall Study|Data lost|6|||
149796960|NCT01843933|540383107|FG001|Overall Study|Data lost|4|||
149796961|NCT01373294|540383108|FG000|Overall Study|Adverse Event|1|||
149796962|NCT01373294|540383109|FG001|Overall Study|Adverse Event|0|||
149796963|NCT02694562|540383110|FG000|Overall Study|Death|8|||
149796964|NCT02694562|540383110|FG000|Overall Study|Protocol Violation|4|||
149796965|NCT02694562|540383110|FG000|Overall Study|Lost to Follow-up|3|||
149796966|NCT02694562|540383110|FG000|Overall Study|Screen Failure|2|||
149796967|NCT02694562|540383110|FG000|Overall Study|Physician Decision|1|||
149796968|NCT00877929|540383118|FG000|Overall Study|Adverse Event|11|||
149796969|NCT00877929|540383119|FG001|Overall Study|Adverse Event|20|||
149796970|NCT00877929|540383118|FG000|Overall Study|Protocol Violation|3|||
149796971|NCT00877929|540383119|FG001|Overall Study|Protocol Violation|3|||
149796972|NCT00877929|540383118|FG000|Overall Study|Lost to Follow-up|0|||
149796973|NCT00877929|540383119|FG001|Overall Study|Lost to Follow-up|1|||
149796974|NCT00877929|540383118|FG000|Overall Study|Withdrawal by Subject|4|||
149796975|NCT00877929|540383119|FG001|Overall Study|Withdrawal by Subject|4|||
149796976|NCT00877929|540383118|FG000|Overall Study|Lack of Efficacy|0|||
149796977|NCT00877929|540383119|FG001|Overall Study|Lack of Efficacy|1|||
149796978|NCT00877929|540383118|FG000|Overall Study|Other reason (not specified)|2|||
149796979|NCT00877929|540383119|FG001|Overall Study|Other reason (not specified)|6|||
149796980|NCT00554229|540383120|FG000|Overall Study|Lost to Follow-up|3|||
149796981|NCT00554229|540383121|FG001|Overall Study|Lost to Follow-up|6|||
149796982|NCT00554229|540383120|FG000|Overall Study|Withdrawal by Subject|29|||
149796983|NCT00554229|540383121|FG001|Overall Study|Withdrawal by Subject|37|||
149796984|NCT00554229|540383120|FG000|Overall Study|Adverse Event|71|||
149796985|NCT00554229|540383121|FG001|Overall Study|Adverse Event|39|||
149796986|NCT00554229|540383120|FG000|Overall Study|Protocol Violation|3|||
149796987|NCT00554229|540383121|FG001|Overall Study|Protocol Violation|3|||
149796988|NCT00554229|540383120|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
149796989|NCT00554229|540383121|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
149796990|NCT00554229|540383120|FG000|Overall Study|Randomised but no treatment received|1|||
149796991|NCT00554229|540383121|FG001|Overall Study|Randomised but no treatment received|0|||
149796992|NCT01140646|540383122|FG000|Overall Study|Adverse Event|4|||
149796993|NCT01140646|540383122|FG000|Overall Study|Refused Further Treatment|5|||
149796994|NCT00784836|540383130|FG000|Overall Study|Early Study Termination|3|||
149796995|NCT02612194|540383134|FG000|Overall Study|Death|5|||
149796996|NCT02612194|540383135|FG001|Overall Study|Death|0|||
149796997|NCT02612194|540383136|FG002|Overall Study|Death|2|||
149796998|NCT02612194|540383134|FG000|Overall Study|Early Study Termination|1|||
149796999|NCT02612194|540383135|FG001|Overall Study|Early Study Termination|0|||
149797000|NCT02612194|540383136|FG002|Overall Study|Early Study Termination|0|||
149797001|NCT02539160|540383137|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
149797002|NCT02539160|540383138|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
149797003|NCT02539160|540383139|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
149797004|NCT02539160|540383140|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
149797005|NCT02539160|540383137|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
149797006|NCT02539160|540383138|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
149797007|NCT02539160|540383139|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
149797008|NCT02539160|540383140|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
149797009|NCT02539160|540383137|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
149797010|NCT02539160|540383138|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
149797011|NCT02539160|540383139|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
149797012|NCT02539160|540383140|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
149797013|NCT01681004|540383141|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
149797014|NCT01681004|540383142|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
149797015|NCT01681004|540383141|FG000|Study Completion|Lost to Follow-up|8|||
149797016|NCT01681004|540383142|FG001|Study Completion|Lost to Follow-up|3|||
149797017|NCT01681004|540383141|FG000|Study Completion|Physician Decision|1|||
149797018|NCT01681004|540383142|FG001|Study Completion|Physician Decision|3|||
149797019|NCT01681004|540383141|FG000|Study Completion|Site Termination|2|||
149797020|NCT01681004|540383142|FG001|Study Completion|Site Termination|1|||
149797021|NCT01681004|540383141|FG000|Study Completion|Death|1|||
149797022|NCT01681004|540383142|FG001|Study Completion|Death|1|||
149797023|NCT00372905|540383143|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
149797024|NCT00372905|540383144|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149797025|NCT00372905|540383145|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149797026|NCT00372905|540383146|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149797027|NCT00372905|540383143|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149797028|NCT00372905|540383144|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149797029|NCT00372905|540383145|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
149797030|NCT00372905|540383146|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149797031|NCT00372905|540383143|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149797032|NCT00372905|540383144|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149797033|NCT00372905|540383145|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
149797034|NCT00372905|540383146|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149797035|NCT00372905|540383143|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149797036|NCT00372905|540383144|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149797037|NCT00372905|540383145|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149797038|NCT00372905|540383146|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
149797039|NCT00372905|540383143|FG000|Follow up Until Relapse or Progression|Study closed|0|||
149797040|NCT00372905|540383144|FG001|Follow up Until Relapse or Progression|Study closed|0|||
149797041|NCT00372905|540383145|FG002|Follow up Until Relapse or Progression|Study closed|0|||
149797042|NCT00372905|540383146|FG003|Follow up Until Relapse or Progression|Study closed|3|||
149797043|NCT00372905|540383143|FG000|Follow up Until Relapse or Progression|Other|0|||
149797044|NCT00372905|540383144|FG001|Follow up Until Relapse or Progression|Other|1|||
149797045|NCT00372905|540383145|FG002|Follow up Until Relapse or Progression|Other|0|||
149797046|NCT00372905|540383146|FG003|Follow up Until Relapse or Progression|Other|0|||
149797047|NCT00434876|540383149|FG000|Overall Study|Lost to Follow-up|1|||
149797048|NCT00434876|540383150|FG001|Overall Study|Lost to Follow-up|1|||
149797049|NCT03726320|540384827|FG000|Overall Study|Lost to Follow-up|2|||
149797050|NCT03726320|540384828|FG001|Overall Study|Lost to Follow-up|4|||
149797051|NCT03726320|540384829|FG002|Overall Study|Lost to Follow-up|0|||
149797052|NCT03726320|540384827|FG000|Overall Study|Time Constraints|4|||
149797053|NCT03726320|540384828|FG001|Overall Study|Time Constraints|1|||
149797054|NCT03726320|540384829|FG002|Overall Study|Time Constraints|0|||
149797055|NCT03726320|540384827|FG000|Overall Study|Ineligible after enrollment|3|||
149797056|NCT03726320|540384828|FG001|Overall Study|Ineligible after enrollment|3|||
149797057|NCT03726320|540384829|FG002|Overall Study|Ineligible after enrollment|0|||
149797058|NCT03726320|540384827|FG000|Overall Study|Clinic / insurance issue|2|||
149797059|NCT03726320|540384828|FG001|Overall Study|Clinic / insurance issue|0|||
149797060|NCT03726320|540384829|FG002|Overall Study|Clinic / insurance issue|0|||
149797061|NCT03726320|540384827|FG000|Overall Study|Language barrier|1|||
149797062|NCT03726320|540384828|FG001|Overall Study|Language barrier|0|||
149797063|NCT03726320|540384829|FG002|Overall Study|Language barrier|0|||
149797064|NCT03726320|540384827|FG000|Overall Study|Provider left the clinic|0|||
149797065|NCT03726320|540384828|FG001|Overall Study|Provider left the clinic|0|||
149797066|NCT03726320|540384829|FG002|Overall Study|Provider left the clinic|1|||
149797067|NCT01684930|540384832|FG000|Overall Study|Withdrawal by Subject|3|||
149797068|NCT01684930|540384833|FG001|Overall Study|Withdrawal by Subject|1|||
149797069|NCT00337935|540384834|FG000|Overall Study|Adverse Event|2|||
149797070|NCT00337935|540384835|FG001|Overall Study|Adverse Event|5|||
149797071|NCT00337935|540384834|FG000|Overall Study|Death|2|||
149797072|NCT00337935|540384835|FG001|Overall Study|Death|8|||
149797073|NCT00337935|540384834|FG000|Overall Study|Physician Decision|1|||
149797074|NCT00337935|540384835|FG001|Overall Study|Physician Decision|1|||
149797075|NCT00337935|540384834|FG000|Overall Study|Lost to Follow-up|0|||
149797076|NCT00337935|540384835|FG001|Overall Study|Lost to Follow-up|1|||
149797077|NCT00337935|540384834|FG000|Overall Study|Protocol Violation|4|||
149797078|NCT00337935|540384835|FG001|Overall Study|Protocol Violation|3|||
149797079|NCT00337935|540384834|FG000|Overall Study|Withdrawal by Subject|1|||
149797080|NCT00337935|540384835|FG001|Overall Study|Withdrawal by Subject|7|||
149797081|NCT00337935|540384834|FG000|Overall Study|Other|0|||
149797082|NCT00337935|540384835|FG001|Overall Study|Other|1|||
149797083|NCT00337935|540384834|FG000|Overall Study|Lack of Efficacy|0|||
149797084|NCT00337935|540384835|FG001|Overall Study|Lack of Efficacy|1|||
149797085|NCT01884675|540384836|FG000|Overall Study|Study closed/terminated|3|||
149797086|NCT01884675|540384837|FG001|Overall Study|Study closed/terminated|2|||
149797087|NCT02361307|540384838|FG000|Overall Study|Unstable medical condition.|0|||
149797088|NCT02361307|540384839|FG001|Overall Study|Unstable medical condition.|1|||
149797089|NCT01336647|540384842|FG000|Overall Study|Lost to Follow-up|4|||
149797090|NCT01336647|540384843|FG001|Overall Study|Lost to Follow-up|1|||
149797091|NCT01336647|540384844|FG002|Overall Study|Lost to Follow-up|3|||
149797092|NCT01004822|540384845|FG000|Overall Study|Objective progression or relapse|3|||
149797093|NCT01004822|540384846|FG001|Overall Study|Objective progression or relapse|3|||
149797094|NCT01004822|540384847|FG002|Overall Study|Objective progression or relapse|0|||
149797095|NCT01004822|540384848|FG003|Overall Study|Objective progression or relapse|1|||
149797096|NCT01004822|540384849|FG004|Overall Study|Objective progression or relapse|2|||
149797097|NCT01004822|540384850|FG005|Overall Study|Objective progression or relapse|2|||
149797098|NCT01004822|540384851|FG006|Overall Study|Objective progression or relapse|1|||
149797099|NCT01004822|540384852|FG007|Overall Study|Objective progression or relapse|4|||
149797100|NCT01004822|540384845|FG000|Overall Study|Global deterioration of health status|0|||
149797101|NCT01004822|540384846|FG001|Overall Study|Global deterioration of health status|0|||
149797102|NCT01004822|540384847|FG002|Overall Study|Global deterioration of health status|0|||
149797103|NCT01004822|540384848|FG003|Overall Study|Global deterioration of health status|1|||
149797104|NCT01004822|540384849|FG004|Overall Study|Global deterioration of health status|0|||
149797105|NCT01004822|540384850|FG005|Overall Study|Global deterioration of health status|0|||
149797106|NCT01004822|540384851|FG006|Overall Study|Global deterioration of health status|1|||
149797107|NCT01004822|540384852|FG007|Overall Study|Global deterioration of health status|0|||
149797108|NCT01004822|540384845|FG000|Overall Study|No longer willing to continue|0|||
149797109|NCT01004822|540384846|FG001|Overall Study|No longer willing to continue|0|||
149797110|NCT01004822|540384847|FG002|Overall Study|No longer willing to continue|0|||
149797111|NCT01004822|540384848|FG003|Overall Study|No longer willing to continue|1|||
149797112|NCT01004822|540384849|FG004|Overall Study|No longer willing to continue|2|||
149797113|NCT01004822|540384850|FG005|Overall Study|No longer willing to continue|1|||
149797114|NCT01004822|540384851|FG006|Overall Study|No longer willing to continue|1|||
149797115|NCT01004822|540384852|FG007|Overall Study|No longer willing to continue|0|||
149797116|NCT01004822|540384845|FG000|Overall Study|Adverse Event|0|||
149797117|NCT01004822|540384846|FG001|Overall Study|Adverse Event|0|||
149797118|NCT01004822|540384847|FG002|Overall Study|Adverse Event|0|||
149797119|NCT01004822|540384848|FG003|Overall Study|Adverse Event|0|||
149797120|NCT01004822|540384849|FG004|Overall Study|Adverse Event|0|||
149797121|NCT01004822|540384850|FG005|Overall Study|Adverse Event|0|||
149797122|NCT01004822|540384851|FG006|Overall Study|Adverse Event|1|||
149797123|NCT01004822|540384852|FG007|Overall Study|Adverse Event|1|||
149797124|NCT01004822|540384845|FG000|Overall Study|Other|0|||
149797125|NCT01004822|540384846|FG001|Overall Study|Other|0|||
149797126|NCT01004822|540384847|FG002|Overall Study|Other|4|||
149797127|NCT01004822|540384848|FG003|Overall Study|Other|1|||
149797128|NCT01004822|540384849|FG004|Overall Study|Other|0|||
149797129|NCT01004822|540384850|FG005|Overall Study|Other|1|||
149797130|NCT01004822|540384851|FG006|Overall Study|Other|0|||
149797131|NCT01004822|540384852|FG007|Overall Study|Other|0|||
149797132|NCT01858701|540384853|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
149797133|NCT01858701|540384854|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
149797134|NCT01858701|540384853|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
149797135|NCT01858701|540384854|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
149797136|NCT01858701|540384853|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
149797137|NCT01858701|540384854|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
149797138|NCT01858701|540384853|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
149797139|NCT01858701|540384854|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
149797140|NCT01801475|540384861|FG000|Overall Study|Withdrawal by Subject|0|||
149797141|NCT01801475|540384862|FG001|Overall Study|Withdrawal by Subject|0|||
149797142|NCT01801475|540384863|FG002|Overall Study|Withdrawal by Subject|0|||
149797143|NCT01801475|540384864|FG003|Overall Study|Withdrawal by Subject|0|||
149797144|NCT01801475|540384865|FG004|Overall Study|Withdrawal by Subject|1|||
149797145|NCT01786707|540384866|FG000|Overall Study|Lost to Follow-up|1|||
149797146|NCT01786707|540384867|FG001|Overall Study|Lost to Follow-up|1|||
149797147|NCT00421928|540384868|FG000|Overall Study|Adverse Event|61|||
149797148|NCT00421928|540384869|FG001|Overall Study|Adverse Event|140|||
149797149|NCT00421928|540384870|FG002|Overall Study|Adverse Event|22|||
149797150|NCT00421928|540384868|FG000|Overall Study|Lost to Follow-up|5|||
149797151|NCT00421928|540384869|FG001|Overall Study|Lost to Follow-up|0|||
149797152|NCT00421928|540384870|FG002|Overall Study|Lost to Follow-up|3|||
149797153|NCT00421928|540384868|FG000|Overall Study|Withdrawal by Subject|50|||
149797154|NCT00421928|540384869|FG001|Overall Study|Withdrawal by Subject|48|||
149797155|NCT00421928|540384870|FG002|Overall Study|Withdrawal by Subject|43|||
149797156|NCT00421928|540384868|FG000|Overall Study|Lack of Efficacy|15|||
149797157|NCT00421928|540384869|FG001|Overall Study|Lack of Efficacy|7|||
149797158|NCT00421928|540384870|FG002|Overall Study|Lack of Efficacy|35|||
149797159|NCT00421928|540384868|FG000|Overall Study|Study drug non-compliant|6|||
149797160|NCT00421928|540384869|FG001|Overall Study|Study drug non-compliant|7|||
149797161|NCT00421928|540384870|FG002|Overall Study|Study drug non-compliant|4|||
149797162|NCT00421928|540384868|FG000|Overall Study|All other|26|||
149797163|NCT00421928|540384869|FG001|Overall Study|All other|21|||
149797164|NCT00421928|540384870|FG002|Overall Study|All other|27|||
149797165|NCT00421928|540384868|FG000|Overall Study|Death|0|||
149797166|NCT00421928|540384869|FG001|Overall Study|Death|1|||
149797167|NCT00421928|540384870|FG002|Overall Study|Death|0|||
149797168|NCT04120116|540384886|FG000|Overall Study|Lost to Follow-up|0|||
149797169|NCT04120116|540384887|FG001|Overall Study|Lost to Follow-up|1|||
149797170|NCT04120116|540384888|FG002|Overall Study|Lost to Follow-up|0|||
149797171|NCT04120116|540384889|FG003|Overall Study|Lost to Follow-up|2|||
149797172|NCT04120116|540384886|FG000|Overall Study|Withdrawal by Subject|1|||
149797173|NCT04120116|540384887|FG001|Overall Study|Withdrawal by Subject|0|||
149797174|NCT04120116|540384888|FG002|Overall Study|Withdrawal by Subject|1|||
149797175|NCT04120116|540384889|FG003|Overall Study|Withdrawal by Subject|1|||
149797176|NCT04120116|540384886|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149797177|NCT04120116|540384887|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149797178|NCT04120116|540384888|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
149797179|NCT04120116|540384889|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149797180|NCT00965458|540384890|FG000|Overall Study|Adverse Event|1|||
149797181|NCT00965458|540384891|FG001|Overall Study|Adverse Event|0|||
149797182|NCT00965458|540384890|FG000|Overall Study|Lost to Follow-up|1|||
149797183|NCT00965458|540384891|FG001|Overall Study|Lost to Follow-up|3|||
149797184|NCT00965458|540384890|FG000|Overall Study|Withdrawal by Subject|0|||
149797185|NCT00965458|540384891|FG001|Overall Study|Withdrawal by Subject|1|||
149797186|NCT00594958|540384895|FG000|Overall Study|Withdrawal by Subject|1|||
149797187|NCT00594958|540384896|FG001|Overall Study|Withdrawal by Subject|0|||
149797188|NCT00594958|540384897|FG002|Overall Study|Withdrawal by Subject|1|||
149797189|NCT00594958|540384895|FG000|Overall Study|Adverse Event|4|||
149797190|NCT00594958|540384896|FG001|Overall Study|Adverse Event|1|||
149797191|NCT00594958|540384897|FG002|Overall Study|Adverse Event|2|||
149797192|NCT00594958|540384895|FG000|Overall Study|Pregnancy|0|||
149797193|NCT00594958|540384896|FG001|Overall Study|Pregnancy|2|||
149797194|NCT00594958|540384897|FG002|Overall Study|Pregnancy|0|||
149797195|NCT00594958|540384895|FG000|Overall Study|Protocol Violation|1|||
149797196|NCT00594958|540384896|FG001|Overall Study|Protocol Violation|0|||
149797197|NCT00594958|540384897|FG002|Overall Study|Protocol Violation|2|||
149797198|NCT00594958|540384895|FG000|Overall Study|Lost to Follow-up|5|||
149797199|NCT00594958|540384896|FG001|Overall Study|Lost to Follow-up|0|||
149797200|NCT00594958|540384897|FG002|Overall Study|Lost to Follow-up|3|||
149797201|NCT00594958|540384895|FG000|Overall Study|administrative|3|||
149797202|NCT00594958|540384896|FG001|Overall Study|administrative|0|||
149797203|NCT00594958|540384897|FG002|Overall Study|administrative|2|||
149797204|NCT03233009|540384898|FG000|Overall Study|Lost to Follow-up|1|||
149797205|NCT02181634|540384899|FG000|Overall Study|Lack of Efficacy|33|||
149797206|NCT02181634|540384899|FG000|Overall Study|Adverse Event|17|||
149797207|NCT02181634|540384899|FG000|Overall Study|Physician Decision|8|||
149797208|NCT02181634|540384899|FG000|Overall Study|Withdrawal by Subject|5|||
149797209|NCT02181634|540384899|FG000|Overall Study|Death|2|||
149797210|NCT02181634|540384899|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
149797211|NCT02181634|540384899|FG000|Overall Study|Ineligible|1|||
149797212|NCT02181634|540384899|FG000|Overall Study|Max number of dose reduction|1|||
149797213|NCT02181634|540384899|FG000|Overall Study|Symptomatic progression|1|||
149797214|NCT02181634|540384899|FG000|Overall Study|Patient opted to proceed to surgery|1|||
149797215|NCT00134563|540384900|FG000|Overall Study|Not treated due to protocol violation|0|||
149797216|NCT00134563|540384901|FG001|Overall Study|Not treated due to protocol violation|1|||
149797217|NCT00134563|540384902|FG002|Overall Study|Not treated due to protocol violation|1|||
149797218|NCT00134563|540384900|FG000|Overall Study|Adverse Event|29|||
149797219|NCT00134563|540384901|FG001|Overall Study|Adverse Event|37|||
149797220|NCT00134563|540384902|FG002|Overall Study|Adverse Event|38|||
149797221|NCT00134563|540384900|FG000|Overall Study|Lack of Efficacy|24|||
149797222|NCT00134563|540384901|FG001|Overall Study|Lack of Efficacy|14|||
149797223|NCT00134563|540384902|FG002|Overall Study|Lack of Efficacy|17|||
149797224|NCT00134563|540384900|FG000|Overall Study|Protocol Violation|3|||
149797225|NCT00134563|540384901|FG001|Overall Study|Protocol Violation|2|||
149797226|NCT00134563|540384902|FG002|Overall Study|Protocol Violation|5|||
149797227|NCT00134563|540384900|FG000|Overall Study|Lost to Follow-up|4|||
149797228|NCT00134563|540384901|FG001|Overall Study|Lost to Follow-up|0|||
149797229|NCT00134563|540384902|FG002|Overall Study|Lost to Follow-up|2|||
149797230|NCT00134563|540384900|FG000|Overall Study|progressive disease|11|||
149797231|NCT00134563|540384901|FG001|Overall Study|progressive disease|4|||
149797232|NCT00134563|540384902|FG002|Overall Study|progressive disease|2|||
149797233|NCT00134563|540384900|FG000|Overall Study|did not wish to continue|33|||
149797234|NCT00134563|540384901|FG001|Overall Study|did not wish to continue|32|||
149797235|NCT00134563|540384902|FG002|Overall Study|did not wish to continue|26|||
149797236|NCT00134563|540384900|FG000|Overall Study|Reason other than above|0|||
149797237|NCT00134563|540384901|FG001|Overall Study|Reason other than above|2|||
149797238|NCT00134563|540384902|FG002|Overall Study|Reason other than above|5|||
149797239|NCT03382639|540384903|FG000|Overall Study|Adverse Event|2|||
149797240|NCT03382639|540384904|FG001|Overall Study|Adverse Event|0|||
149797241|NCT03382639|540384905|FG002|Overall Study|Adverse Event|1|||
149797242|NCT03382639|540384906|FG003|Overall Study|Adverse Event|1|||
149797243|NCT03382639|540384903|FG000|Overall Study|Lost to Follow-up|1|||
149797244|NCT03382639|540384904|FG001|Overall Study|Lost to Follow-up|0|||
149797245|NCT03382639|540384905|FG002|Overall Study|Lost to Follow-up|0|||
149797246|NCT03382639|540384906|FG003|Overall Study|Lost to Follow-up|0|||
149797247|NCT03382639|540384903|FG000|Overall Study|Withdrawal by Subject|4|||
149797248|NCT03382639|540384904|FG001|Overall Study|Withdrawal by Subject|3|||
149797249|NCT03382639|540384905|FG002|Overall Study|Withdrawal by Subject|2|||
149797250|NCT03382639|540384906|FG003|Overall Study|Withdrawal by Subject|3|||
149797251|NCT03382639|540384903|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
149797252|NCT03382639|540384904|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
149797253|NCT03382639|540384905|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
149797254|NCT03382639|540384906|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
149797255|NCT03382639|540384903|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
149797256|NCT03382639|540384904|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
149797257|NCT03382639|540384905|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
149797258|NCT03382639|540384906|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
149797259|NCT03382639|540384903|FG000|Overall Study|Other|2|||
149797260|NCT03382639|540384904|FG001|Overall Study|Other|0|||
149797261|NCT03382639|540384905|FG002|Overall Study|Other|0|||
149797262|NCT03382639|540384906|FG003|Overall Study|Other|3|||
149797263|NCT01072175|540384909|FG000|Part A (Drug-Drug Interaction)|Death|1|||
149797264|NCT01072175|540384910|FG001|Part A (Drug-Drug Interaction)|Death|0|||
149797265|NCT01072175|540384911|FG002|Part A (Drug-Drug Interaction)|Death|0|||
149797266|NCT01072175|540384912|FG003|Part A (Drug-Drug Interaction)|Death|0|||
149797267|NCT01072175|540384913|FG004|Part A (Drug-Drug Interaction)|Death|0|||
149797268|NCT01072175|540384914|FG005|Part A (Drug-Drug Interaction)|Death|0|||
149797269|NCT01072175|540384915|FG006|Part A (Drug-Drug Interaction)|Death|0|||
149797270|NCT01072175|540384916|FG007|Part A (Drug-Drug Interaction)|Death|0|||
149797271|NCT01072175|540384917|FG008|Part A (Drug-Drug Interaction)|Death|0|||
149797272|NCT01072175|540384918|FG009|Part A (Drug-Drug Interaction)|Death|0|||
149797273|NCT01072175|540384919|FG010|Part A (Drug-Drug Interaction)|Death|0|||
149797274|NCT01072175|540384920|FG011|Part A (Drug-Drug Interaction)|Death|0|||
149797275|NCT01072175|540384921|FG012|Part A (Drug-Drug Interaction)|Death|0|||
149797276|NCT01072175|540384909|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
149797277|NCT01072175|540384910|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797278|NCT01072175|540384911|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797279|NCT01072175|540384912|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797280|NCT01072175|540384913|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797281|NCT01072175|540384914|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797282|NCT01072175|540384915|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797283|NCT01072175|540384916|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797284|NCT01072175|540384917|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797285|NCT01072175|540384918|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797286|NCT01072175|540384919|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797287|NCT01072175|540384920|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797288|NCT01072175|540384921|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149797289|NCT01072175|540384909|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
149797290|NCT01072175|540384910|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797291|NCT01072175|540384911|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797292|NCT01072175|540384912|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797293|NCT01072175|540384913|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797294|NCT01072175|540384914|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797295|NCT01072175|540384915|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797296|NCT01072175|540384916|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797297|NCT01072175|540384917|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797298|NCT01072175|540384918|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797299|NCT01072175|540384919|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797300|NCT01072175|540384920|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797301|NCT01072175|540384921|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149797302|NCT01072175|540384909|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
149797303|NCT01072175|540384910|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
149797304|NCT01072175|540384911|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
149797305|NCT01072175|540384912|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
149797306|NCT01072175|540384913|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
149797307|NCT01072175|540384914|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
149797308|NCT01072175|540384915|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
149797309|NCT01072175|540384916|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
149797310|NCT01072175|540384917|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
149797311|NCT01072175|540384918|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
149797312|NCT01072175|540384919|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
149797313|NCT01072175|540384920|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
149797314|NCT01072175|540384921|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
149797315|NCT01072175|540384909|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797316|NCT01072175|540384910|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797317|NCT01072175|540384911|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
149797318|NCT01072175|540384912|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797319|NCT01072175|540384913|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
149797320|NCT01072175|540384914|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797321|NCT01072175|540384915|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797322|NCT01072175|540384916|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797323|NCT01072175|540384917|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797324|NCT01072175|540384918|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797325|NCT01072175|540384919|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797326|NCT01072175|540384920|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797327|NCT01072175|540384921|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149797328|NCT01072175|540384909|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797329|NCT01072175|540384910|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
149797330|NCT01072175|540384911|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797331|NCT01072175|540384912|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
149797332|NCT01072175|540384913|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
149797333|NCT01072175|540384914|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797334|NCT01072175|540384915|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797335|NCT01072175|540384916|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797336|NCT01072175|540384917|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797337|NCT01072175|540384918|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797338|NCT01072175|540384919|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797339|NCT01072175|540384920|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797340|NCT01072175|540384921|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149797341|NCT01072175|540384909|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797342|NCT01072175|540384910|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797343|NCT01072175|540384911|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
149797344|NCT01072175|540384912|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
149797345|NCT01072175|540384913|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
149797346|NCT01072175|540384914|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797347|NCT01072175|540384915|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797348|NCT01072175|540384916|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797349|NCT01072175|540384917|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797350|NCT01072175|540384918|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797351|NCT01072175|540384919|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797352|NCT01072175|540384920|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797353|NCT01072175|540384921|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149797354|NCT01072175|540384909|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797355|NCT01072175|540384910|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
149797356|NCT01072175|540384911|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797357|NCT01072175|540384912|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
149797358|NCT01072175|540384913|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
149797359|NCT01072175|540384914|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797360|NCT01072175|540384915|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797361|NCT01072175|540384916|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797362|NCT01072175|540384917|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797363|NCT01072175|540384918|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797364|NCT01072175|540384919|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797365|NCT01072175|540384920|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797366|NCT01072175|540384921|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149797367|NCT01072175|540384909|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
149797368|NCT01072175|540384910|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
149797369|NCT01072175|540384911|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
149797370|NCT01072175|540384912|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
149797371|NCT01072175|540384913|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
149797372|NCT01072175|540384914|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
149797373|NCT01072175|540384915|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
149797374|NCT01072175|540384916|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
149797375|NCT01072175|540384917|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
149797376|NCT01072175|540384918|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
149797377|NCT01072175|540384919|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
149797378|NCT01072175|540384920|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
149797379|NCT01072175|540384921|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
149797380|NCT01072175|540384909|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797381|NCT01072175|540384910|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797382|NCT01072175|540384911|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797383|NCT01072175|540384912|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797384|NCT01072175|540384913|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797385|NCT01072175|540384914|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149797386|NCT01072175|540384915|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149797387|NCT01072175|540384916|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149797388|NCT01072175|540384917|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797389|NCT01072175|540384918|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797390|NCT01072175|540384919|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797391|NCT01072175|540384920|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797392|NCT01072175|540384921|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149797393|NCT01072175|540384909|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797394|NCT01072175|540384910|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797395|NCT01072175|540384911|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797396|NCT01072175|540384912|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797397|NCT01072175|540384913|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797398|NCT01072175|540384914|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797399|NCT01072175|540384915|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
149797400|NCT01072175|540384916|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
149797401|NCT01072175|540384917|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797402|NCT01072175|540384918|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797403|NCT01072175|540384919|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797404|NCT01072175|540384920|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797405|NCT01072175|540384921|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149797406|NCT01072175|540384909|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797407|NCT01072175|540384910|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797408|NCT01072175|540384911|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797409|NCT01072175|540384912|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797410|NCT01072175|540384913|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797411|NCT01072175|540384914|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
149797412|NCT01072175|540384915|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
149797413|NCT01072175|540384916|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
149797414|NCT01072175|540384917|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797415|NCT01072175|540384918|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797416|NCT01072175|540384919|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797417|NCT01072175|540384920|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797418|NCT01072175|540384921|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149797419|NCT01072175|540384909|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797420|NCT01072175|540384910|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797421|NCT01072175|540384911|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797422|NCT01072175|540384912|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797423|NCT01072175|540384913|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797424|NCT01072175|540384914|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
149797425|NCT01072175|540384915|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
149797426|NCT01072175|540384916|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797427|NCT01072175|540384917|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797428|NCT01072175|540384918|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797429|NCT01072175|540384919|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797430|NCT01072175|540384920|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797431|NCT01072175|540384921|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149797432|NCT01072175|540384909|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797433|NCT01072175|540384910|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797434|NCT01072175|540384911|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797435|NCT01072175|540384912|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797436|NCT01072175|540384913|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797437|NCT01072175|540384914|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797438|NCT01072175|540384915|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797439|NCT01072175|540384916|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797440|NCT01072175|540384917|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
149797441|NCT01072175|540384918|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797442|NCT01072175|540384919|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797443|NCT01072175|540384920|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797444|NCT01072175|540384921|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149797445|NCT01072175|540384909|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797446|NCT01072175|540384910|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797447|NCT01072175|540384911|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797448|NCT01072175|540384912|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797449|NCT01072175|540384913|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797450|NCT01072175|540384914|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797451|NCT01072175|540384915|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797452|NCT01072175|540384916|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797453|NCT01072175|540384917|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
149797454|NCT01072175|540384918|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797455|NCT01072175|540384919|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797456|NCT01072175|540384920|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797457|NCT01072175|540384921|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149797458|NCT01072175|540384909|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797459|NCT01072175|540384910|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797460|NCT01072175|540384911|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797461|NCT01072175|540384912|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797462|NCT01072175|540384913|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797463|NCT01072175|540384914|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797464|NCT01072175|540384915|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797465|NCT01072175|540384916|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797466|NCT01072175|540384917|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
149797467|NCT01072175|540384918|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797468|NCT01072175|540384919|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797469|NCT01072175|540384920|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797470|NCT01072175|540384921|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149797471|NCT01072175|540384909|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797472|NCT01072175|540384910|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797473|NCT01072175|540384911|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797474|NCT01072175|540384912|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797475|NCT01072175|540384913|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797476|NCT01072175|540384914|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797477|NCT01072175|540384915|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797478|NCT01072175|540384916|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797479|NCT01072175|540384917|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
149797480|NCT01072175|540384918|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797481|NCT01072175|540384919|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797482|NCT01072175|540384920|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797483|NCT01072175|540384921|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149797484|NCT01072175|540384909|FG000|Part D (HPMC Capsules)|Death|0|||
149797485|NCT01072175|540384910|FG001|Part D (HPMC Capsules)|Death|0|||
149797486|NCT01072175|540384911|FG002|Part D (HPMC Capsules)|Death|0|||
149797487|NCT01072175|540384912|FG003|Part D (HPMC Capsules)|Death|0|||
149797488|NCT01072175|540384913|FG004|Part D (HPMC Capsules)|Death|0|||
149797489|NCT01072175|540384914|FG005|Part D (HPMC Capsules)|Death|0|||
149797490|NCT01072175|540384915|FG006|Part D (HPMC Capsules)|Death|0|||
149797491|NCT01072175|540384916|FG007|Part D (HPMC Capsules)|Death|0|||
149797492|NCT01072175|540384917|FG008|Part D (HPMC Capsules)|Death|0|||
149797493|NCT01072175|540384918|FG009|Part D (HPMC Capsules)|Death|10|||
149797494|NCT01072175|540384919|FG010|Part D (HPMC Capsules)|Death|12|||
149797495|NCT01072175|540384920|FG011|Part D (HPMC Capsules)|Death|28|||
149797496|NCT01072175|540384921|FG012|Part D (HPMC Capsules)|Death|26|||
149797497|NCT01072175|540384909|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
149797498|NCT01072175|540384910|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
149797499|NCT01072175|540384911|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
149797500|NCT01072175|540384912|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
149797501|NCT01072175|540384913|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
149797502|NCT01072175|540384914|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
149797503|NCT01072175|540384915|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
149797504|NCT01072175|540384916|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
149797505|NCT01072175|540384917|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
149797506|NCT01072175|540384918|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
149797507|NCT01072175|540384919|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
149797508|NCT01072175|540384920|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
149797509|NCT01072175|540384921|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
149797510|NCT01072175|540384909|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797511|NCT01072175|540384910|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797512|NCT01072175|540384911|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797513|NCT01072175|540384912|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797514|NCT01072175|540384913|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797515|NCT01072175|540384914|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797516|NCT01072175|540384915|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797517|NCT01072175|540384916|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797518|NCT01072175|540384917|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797519|NCT01072175|540384918|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149797520|NCT01072175|540384919|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
149797521|NCT01072175|540384920|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
149797522|NCT01072175|540384921|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
149797523|NCT01072175|540384909|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797524|NCT01072175|540384910|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797525|NCT01072175|540384911|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797526|NCT01072175|540384912|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797527|NCT01072175|540384913|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797528|NCT01072175|540384914|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797529|NCT01072175|540384915|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797530|NCT01072175|540384916|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797531|NCT01072175|540384917|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
149797532|NCT01072175|540384918|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
149797533|NCT01072175|540384919|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
149797534|NCT01072175|540384920|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
149797535|NCT01072175|540384921|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
149797536|NCT01072175|540384909|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797537|NCT01072175|540384910|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797538|NCT01072175|540384911|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797539|NCT01072175|540384912|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797540|NCT01072175|540384913|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797541|NCT01072175|540384914|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797542|NCT01072175|540384915|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797543|NCT01072175|540384916|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797544|NCT01072175|540384917|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797545|NCT01072175|540384918|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797546|NCT01072175|540384919|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
149797547|NCT01072175|540384920|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
149797548|NCT01072175|540384921|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149797549|NCT00682539|540384922|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
149797550|NCT00682539|540384923|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
149797551|NCT00682539|540384924|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
149797552|NCT00682539|540384922|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
149797553|NCT00682539|540384923|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
149797554|NCT00682539|540384924|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
149797555|NCT02477215|540384929|FG000|Dose Escalation Phase|Physician Decision|1|||
149797556|NCT02477215|540384930|FG001|Dose Escalation Phase|Physician Decision|2|||
149797557|NCT02477215|540384931|FG002|Dose Escalation Phase|Physician Decision|0|||
149797558|NCT02477215|540384929|FG000|Fixed Dose Phase|Physician Decision|0|||
149797559|NCT02477215|540384930|FG001|Fixed Dose Phase|Physician Decision|7|||
149797560|NCT02477215|540384931|FG002|Fixed Dose Phase|Physician Decision|0|||
149797561|NCT00285857|540384932|FG000|Overall Study|Withdrawal by Subject|2|||
149797562|NCT00285857|540384932|FG000|Overall Study|Inadequate initial breast cytology|1|||
149797563|NCT00285857|540384932|FG000|Overall Study|Adverse Event|1|||
149797564|NCT02546193|540384933|FG000|Overall Study|Withdrawal by Subject|2|||
149797565|NCT02546193|540384934|FG001|Overall Study|Withdrawal by Subject|0|||
149797566|NCT02546193|540384935|FG002|Overall Study|Withdrawal by Subject|1|||
149797567|NCT02546193|540384936|FG003|Overall Study|Withdrawal by Subject|0|||
149797568|NCT02546193|540384933|FG000|Overall Study|Not eligible at time of induction|4|||
149797569|NCT02546193|540384934|FG001|Overall Study|Not eligible at time of induction|6|||
149797570|NCT02546193|540384935|FG002|Overall Study|Not eligible at time of induction|1|||
149797571|NCT02546193|540384936|FG003|Overall Study|Not eligible at time of induction|0|||
149797572|NCT02545270|540384937|FG000|Overall Study|technical difficulties|0|||
149797573|NCT02545270|540384938|FG001|Overall Study|technical difficulties|1|||
149797574|NCT02545270|540384939|FG002|Overall Study|technical difficulties|0|||
149797575|NCT02545270|540384937|FG000|Overall Study|Videos being too similar to other|0|||
149797576|NCT02545270|540384938|FG001|Overall Study|Videos being too similar to other|0|||
149797577|NCT02545270|540384939|FG002|Overall Study|Videos being too similar to other|2|||
149797578|NCT04738123|540384942|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
149797579|NCT04738123|540384943|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
149797580|NCT04738123|540384942|FG000|Overall Study|Progressive Disease|0|||
149797581|NCT04738123|540384943|FG001|Overall Study|Progressive Disease|4|||
149797582|NCT04738123|540384942|FG000|Overall Study|Adverse Event|8|||
149797583|NCT04738123|540384943|FG001|Overall Study|Adverse Event|7|||
149797584|NCT04738123|540384942|FG000|Overall Study|Other Reasons|0|||
149797585|NCT04738123|540384943|FG001|Overall Study|Other Reasons|1|||
149797586|NCT04738123|540384942|FG000|Overall Study|Suicidal or assaultive behavior|0|||
149797587|NCT04738123|540384943|FG001|Overall Study|Suicidal or assaultive behavior|2|||
149797588|NCT04738123|540384942|FG000|Overall Study|Protocol Violation|2|||
149797589|NCT04738123|540384943|FG001|Overall Study|Protocol Violation|2|||
149797590|NCT04738123|540384942|FG000|Overall Study|Consent Withdrawn|35|||
149797591|NCT04738123|540384943|FG001|Overall Study|Consent Withdrawn|22|||
149797592|NCT00486720|540384946|FG000|Overall Study|Adverse Event|1|||
149797593|NCT00486720|540384947|FG001|Overall Study|Adverse Event|2|||
149797594|NCT00486720|540384946|FG000|Overall Study|Lack of Efficacy|4|||
149797595|NCT00486720|540384947|FG001|Overall Study|Lack of Efficacy|6|||
149797596|NCT00486720|540384946|FG000|Overall Study|Physician Decision|1|||
149797597|NCT00486720|540384947|FG001|Overall Study|Physician Decision|2|||
149797598|NCT00486720|540384946|FG000|Overall Study|Protocol Violation|1|||
149797599|NCT00486720|540384947|FG001|Overall Study|Protocol Violation|0|||
149797600|NCT00486720|540384946|FG000|Overall Study|Withdrawal by Subject|3|||
149797601|NCT00486720|540384947|FG001|Overall Study|Withdrawal by Subject|1|||
149797602|NCT00486720|540384946|FG000|Overall Study|Progressive Disease|0|||
149797603|NCT00486720|540384947|FG001|Overall Study|Progressive Disease|1|||
149797604|NCT00286234|540384948|FG000|Overall Study|Protocol Violation|1|||
149797605|NCT00286234|540384949|FG001|Overall Study|Protocol Violation|2|||
149797606|NCT00286234|540384950|FG002|Overall Study|Protocol Violation|0|||
149797607|NCT00286234|540384951|FG003|Overall Study|Protocol Violation|1|||
149797608|NCT00286234|540384948|FG000|Overall Study|Physician Decision|1|||
149797609|NCT00286234|540384949|FG001|Overall Study|Physician Decision|0|||
149797610|NCT00286234|540384950|FG002|Overall Study|Physician Decision|0|||
149797611|NCT00286234|540384951|FG003|Overall Study|Physician Decision|1|||
149797612|NCT00286234|540384948|FG000|Overall Study|Adverse Event|0|||
149797613|NCT00286234|540384949|FG001|Overall Study|Adverse Event|0|||
149797614|NCT00286234|540384950|FG002|Overall Study|Adverse Event|0|||
149797615|NCT00286234|540384951|FG003|Overall Study|Adverse Event|1|||
149797616|NCT00286234|540384948|FG000|Overall Study|Adverse Event|0|||
149797617|NCT00286234|540384949|FG001|Overall Study|Adverse Event|0|||
149797618|NCT00286234|540384950|FG002|Overall Study|Adverse Event|0|||
149797619|NCT00286234|540384951|FG003|Overall Study|Adverse Event|1|||
149797620|NCT00302731|540384953|FG000|Overall Study|Lost to Follow-up|1|||
149797621|NCT00302731|540384954|FG001|Overall Study|Lost to Follow-up|2|||
149797622|NCT00302731|540384955|FG002|Overall Study|Lost to Follow-up|0|||
149797623|NCT00302731|540384956|FG003|Overall Study|Lost to Follow-up|0|||
149797624|NCT00302731|540384953|FG000|Overall Study|Adverse Event|0|||
149797625|NCT00302731|540384954|FG001|Overall Study|Adverse Event|2|||
149797626|NCT00302731|540384955|FG002|Overall Study|Adverse Event|2|||
149797627|NCT00302731|540384956|FG003|Overall Study|Adverse Event|0|||
149797628|NCT00302731|540384953|FG000|Overall Study|Withdrawal by Subject|1|||
149797629|NCT00302731|540384954|FG001|Overall Study|Withdrawal by Subject|1|||
149797630|NCT00302731|540384955|FG002|Overall Study|Withdrawal by Subject|0|||
149797631|NCT00302731|540384956|FG003|Overall Study|Withdrawal by Subject|0|||
149797632|NCT00302731|540384953|FG000|Overall Study|Protocol Violation|1|||
149797633|NCT00302731|540384954|FG001|Overall Study|Protocol Violation|0|||
149797634|NCT00302731|540384955|FG002|Overall Study|Protocol Violation|0|||
149797635|NCT00302731|540384956|FG003|Overall Study|Protocol Violation|0|||
149797636|NCT00302731|540384953|FG000|Overall Study|cancer unrelated to study discovered|1|||
149797637|NCT00302731|540384954|FG001|Overall Study|cancer unrelated to study discovered|0|||
149797638|NCT00302731|540384955|FG002|Overall Study|cancer unrelated to study discovered|1|||
149797639|NCT00302731|540384956|FG003|Overall Study|cancer unrelated to study discovered|0|||
149797640|NCT01000311|540384957|FG000|Overall Study|Adverse Event|2|||
149797641|NCT01000311|540384958|FG001|Overall Study|Adverse Event|5|||
149797642|NCT01000311|540384957|FG000|Overall Study|Withdrawal by Subject|16|||
149797643|NCT01000311|540384958|FG001|Overall Study|Withdrawal by Subject|24|||
149797644|NCT01000311|540384957|FG000|Overall Study|Lost to Follow-up|15|||
149797645|NCT01000311|540384958|FG001|Overall Study|Lost to Follow-up|24|||
149797646|NCT01000311|540384957|FG000|Overall Study|Protocol Violation|1|||
149797647|NCT01000311|540384958|FG001|Overall Study|Protocol Violation|2|||
149797648|NCT01000311|540384957|FG000|Overall Study|Inappropriate enrollment|2|||
149797649|NCT01000311|540384958|FG001|Overall Study|Inappropriate enrollment|0|||
149797650|NCT01000311|540384957|FG000|Overall Study|Administrative reason|9|||
149797651|NCT01000311|540384958|FG001|Overall Study|Administrative reason|15|||
149797652|NCT01610752|540384961|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
149797653|NCT01610752|540384962|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
149797654|NCT01610752|540384963|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
149797655|NCT00283062|540384964|FG000|Overall Study|Did not receive any study medication|5|||
149797656|NCT00283062|540384965|FG001|Overall Study|Did not receive any study medication|4|||
149797657|NCT00283062|540384966|FG002|Overall Study|Did not receive any study medication|36|||
149797658|NCT00283062|540384967|FG003|Overall Study|Did not receive any study medication|45|||
149797659|NCT00283062|540384964|FG000|Overall Study|Adverse Event|2|||
149797660|NCT00283062|540384965|FG001|Overall Study|Adverse Event|0|||
149797661|NCT00283062|540384966|FG002|Overall Study|Adverse Event|1|||
149797662|NCT00283062|540384967|FG003|Overall Study|Adverse Event|0|||
149797663|NCT00283062|540384964|FG000|Overall Study|Lost to Follow-up|1|||
149797664|NCT00283062|540384965|FG001|Overall Study|Lost to Follow-up|0|||
149797665|NCT00283062|540384966|FG002|Overall Study|Lost to Follow-up|1|||
149797666|NCT00283062|540384967|FG003|Overall Study|Lost to Follow-up|0|||
149797667|NCT00283062|540384964|FG000|Overall Study|Progressive disease|0|||
149797668|NCT00283062|540384965|FG001|Overall Study|Progressive disease|0|||
149797669|NCT00283062|540384966|FG002|Overall Study|Progressive disease|1|||
149797670|NCT00283062|540384967|FG003|Overall Study|Progressive disease|0|||
149797671|NCT00283062|540384964|FG000|Overall Study|Participant did not wish to continue|3|||
149797672|NCT00283062|540384965|FG001|Overall Study|Participant did not wish to continue|2|||
149797673|NCT00283062|540384966|FG002|Overall Study|Participant did not wish to continue|1|||
149797674|NCT00283062|540384967|FG003|Overall Study|Participant did not wish to continue|0|||
149797675|NCT00283062|540384964|FG000|Overall Study|Undefined|0|||
149797676|NCT00283062|540384965|FG001|Overall Study|Undefined|1|||
149797677|NCT00283062|540384966|FG002|Overall Study|Undefined|1|||
149797678|NCT00283062|540384967|FG003|Overall Study|Undefined|4|||
149797679|NCT00283062|540384964|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
149797680|NCT00283062|540384965|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
149797681|NCT00283062|540384966|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
149797682|NCT00283062|540384967|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
149797683|NCT01468844|540384968|FG000|Overall Study|Adverse Event|1|||
149797684|NCT01468844|540384969|FG001|Overall Study|Adverse Event|0|||
149797685|NCT01468844|540384968|FG000|Overall Study|Withdrawal by Subject|1|||
149797686|NCT01468844|540384969|FG001|Overall Study|Withdrawal by Subject|0|||
149797687|NCT01535638|540384972|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
149797688|NCT01535638|540384973|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
149797689|NCT01535638|540384974|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
149797690|NCT01535638|540384975|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
149797691|NCT01535638|540384976|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
149797692|NCT01535638|540384977|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
149797693|NCT01535638|540384972|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
149797694|NCT01535638|540384973|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
149797695|NCT01535638|540384974|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
149797696|NCT01535638|540384975|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
149797697|NCT01535638|540384976|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
149797698|NCT01535638|540384977|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
149797699|NCT00819052|540384978|FG000|Overall Study|Adverse Event|0|||
149797700|NCT00819052|540384979|FG001|Overall Study|Adverse Event|5|||
149797701|NCT00819052|540384978|FG000|Overall Study|Protocol Violation|1|||
149797702|NCT00819052|540384979|FG001|Overall Study|Protocol Violation|2|||
149797703|NCT00819052|540384978|FG000|Overall Study|Lost to Follow-up|1|||
149797704|NCT00819052|540384979|FG001|Overall Study|Lost to Follow-up|2|||
149797705|NCT00819052|540384978|FG000|Overall Study|Withdrawal by Subject|1|||
149797706|NCT00819052|540384979|FG001|Overall Study|Withdrawal by Subject|2|||
149797707|NCT00819052|540384978|FG000|Overall Study|Lack of Efficacy|1|||
149797708|NCT00819052|540384979|FG001|Overall Study|Lack of Efficacy|1|||
149797709|NCT00819052|540384978|FG000|Overall Study|Pregnancy|1|||
149797710|NCT00819052|540384979|FG001|Overall Study|Pregnancy|2|||
149797711|NCT00819052|540384978|FG000|Overall Study|Death or events leading to death|1|||
149797712|NCT00819052|540384979|FG001|Overall Study|Death or events leading to death|0|||
149797713|NCT03524664|540384980|FG000|Overall Study|Withdrawal by Subject|1|||
149797714|NCT03524664|540384981|FG001|Overall Study|Withdrawal by Subject|2|||
149797715|NCT03524664|540384980|FG000|Overall Study|Lost to Follow-up|4|||
149797716|NCT03524664|540384981|FG001|Overall Study|Lost to Follow-up|13|||
149797717|NCT01482598|540384982|FG000|Overall Study|Death|7|||
149797718|NCT01482598|540384983|FG001|Overall Study|Death|10|||
149797719|NCT01482598|540384982|FG000|Overall Study|Physician Decision|0|||
149797720|NCT01482598|540384983|FG001|Overall Study|Physician Decision|3|||
149797721|NCT01482598|540384982|FG000|Overall Study|Withdrawal by Subject|4|||
149797722|NCT01482598|540384983|FG001|Overall Study|Withdrawal by Subject|5|||
149797723|NCT01482598|540384982|FG000|Overall Study|Lost to Follow-up|5|||
149797724|NCT01482598|540384983|FG001|Overall Study|Lost to Follow-up|4|||
149797725|NCT00423267|540384984|FG000|Period A|Withdrawal by Subject|0|||
149797726|NCT00423267|540384985|FG001|Period A|Withdrawal by Subject|1|||
149797727|NCT00423267|540384984|FG000|Period A|Non-compliance with protocol|1|||
149797728|NCT00423267|540384985|FG001|Period A|Non-compliance with protocol|0|||
149797729|NCT00423267|540384984|FG000|Period A|Administrative|1|||
149797730|NCT00423267|540384985|FG001|Period A|Administrative|0|||
149797731|NCT03702166|540384986|FG000|Overall Study|Lost to Follow-up|1|||
149797732|NCT03702166|540384986|FG000|Overall Study|Withdrawal by Subject|1|||
149797733|NCT00827112|540384987|FG000|Overall Study|Adverse Event|2|||
149797734|NCT00827112|540384988|FG001|Overall Study|Adverse Event|0|||
149797735|NCT00827112|540384987|FG000|Overall Study|Lack of Efficacy|2|||
149797736|NCT00827112|540384988|FG001|Overall Study|Lack of Efficacy|0|||
149797737|NCT00827112|540384987|FG000|Overall Study|Lost to Follow-up|3|||
149797738|NCT00827112|540384988|FG001|Overall Study|Lost to Follow-up|2|||
149797739|NCT00827112|540384987|FG000|Overall Study|Pregnancy|0|||
149797740|NCT00827112|540384988|FG001|Overall Study|Pregnancy|1|||
149797741|NCT00827112|540384987|FG000|Overall Study|Protocol Violation|0|||
149797742|NCT00827112|540384988|FG001|Overall Study|Protocol Violation|2|||
149797743|NCT00827112|540384987|FG000|Overall Study|Withdrawal by Subject|2|||
149797744|NCT00827112|540384988|FG001|Overall Study|Withdrawal by Subject|1|||
149797745|NCT00827112|540384987|FG000|Overall Study|Randomized but not treated|5|||
149797746|NCT00827112|540384988|FG001|Overall Study|Randomized but not treated|3|||
149797747|NCT00827112|540384987|FG000|Overall Study|Other|1|||
149797748|NCT00827112|540384988|FG001|Overall Study|Other|3|||
149797749|NCT01333865|540384989|FG000|Overall Study|Adverse Event|2|||
149797750|NCT02613910|540384994|FG000|Overall Study|Termination of study|1|||
149797751|NCT02028182|540387323|FG000|Overall Study|Protocol Violation|2|||
149797752|NCT01277757|540387326|FG000|Overall Study|Disease Progression|1|||
149797753|NCT01277757|540387326|FG000|Overall Study|Withdrawal by Subject|1|||
149797754|NCT03808298|540387327|FG000|Overall Study|Adverse Event|3|||
149797755|NCT03808298|540387327|FG000|Overall Study|Physician Decision|1|||
149797756|NCT03808298|540387327|FG000|Overall Study|Withdrawal by Subject|1|||
149797757|NCT03808298|540387327|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
149797758|NCT02946515|540387330|FG000|Overall Study|Lost to Follow-up|2|||
149797759|NCT02946515|540387331|FG001|Overall Study|Lost to Follow-up|1|||
149797760|NCT03039686|540387336|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
149797761|NCT03039686|540387337|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
149797762|NCT03039686|540387338|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
149797763|NCT03039686|540387336|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
149797764|NCT03039686|540387337|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
149797765|NCT03039686|540387338|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
149797766|NCT03039686|540387336|FG000|Double-blind Period|Withdrawal by Subject|2|||
149797767|NCT03039686|540387337|FG001|Double-blind Period|Withdrawal by Subject|2|||
149797768|NCT03039686|540387338|FG002|Double-blind Period|Withdrawal by Subject|1|||
149797769|NCT03039686|540387336|FG000|Double-blind Period|Death|0|||
149797770|NCT03039686|540387337|FG001|Double-blind Period|Death|0|||
149797771|NCT03039686|540387338|FG002|Double-blind Period|Death|1|||
149797772|NCT03039686|540387336|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
149797773|NCT03039686|540387337|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
149797774|NCT03039686|540387338|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
149797775|NCT03039686|540387336|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
149797776|NCT03039686|540387337|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
149797777|NCT03039686|540387338|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
149797778|NCT03039686|540387336|FG000|Open Label Period|Withdrawal by Subject|0|||
149797779|NCT03039686|540387337|FG001|Open Label Period|Withdrawal by Subject|3|||
149797780|NCT03039686|540387338|FG002|Open Label Period|Withdrawal by Subject|1|||
149797781|NCT02528331|540387339|FG000|Overall Study|Withdrawal by Subject|2|||
149797782|NCT02392078|540387340|FG000|Overall Study|Did not have procedure|32|||
149797783|NCT02392078|540387341|FG001|Overall Study|Did not have procedure|43|||
149797784|NCT02392078|540387342|FG002|Overall Study|Did not have procedure|20|||
149797785|NCT02392078|540387343|FG003|Overall Study|Did not have procedure|1|||
149797786|NCT02079077|540387344|FG000|Overall Study|Lost to Follow-up|5|||
149797787|NCT02079077|540387345|FG001|Overall Study|Lost to Follow-up|7|||
149797788|NCT02079077|540387344|FG000|Overall Study|Became STIs Positive|1|||
149797789|NCT02079077|540387345|FG001|Overall Study|Became STIs Positive|2|||
149797790|NCT02087085|540387352|FG000|Overall Study|Adverse Event|10|||
149797791|NCT02087085|540387353|FG001|Overall Study|Adverse Event|14|||
149797792|NCT02087085|540387352|FG000|Overall Study|Lack of Efficacy|4|||
149797793|NCT02087085|540387353|FG001|Overall Study|Lack of Efficacy|3|||
149797794|NCT02087085|540387352|FG000|Overall Study|Lost to Follow-up|6|||
149797795|NCT02087085|540387353|FG001|Overall Study|Lost to Follow-up|4|||
149797796|NCT02087085|540387352|FG000|Overall Study|Withdrawal by Subject|9|||
149797797|NCT02087085|540387353|FG001|Overall Study|Withdrawal by Subject|11|||
149797798|NCT02087085|540387352|FG000|Overall Study|Protocol Violation|1|||
149797799|NCT02087085|540387353|FG001|Overall Study|Protocol Violation|0|||
149797800|NCT02087085|540387352|FG000|Overall Study|Study Terminated by Sponsor|87|||
149797801|NCT02087085|540387353|FG001|Overall Study|Study Terminated by Sponsor|80|||
149797802|NCT02087085|540387352|FG000|Overall Study|Other Miscellaneous Reasons|3|||
149797803|NCT02087085|540387353|FG001|Overall Study|Other Miscellaneous Reasons|4|||
149797804|NCT00635804|540387354|FG000|Overall Study|Adverse Event|0|||
149797805|NCT00635804|540387355|FG001|Overall Study|Adverse Event|0|||
149797806|NCT00635804|540387356|FG002|Overall Study|Adverse Event|0|||
149797807|NCT00635804|540387357|FG003|Overall Study|Adverse Event|0|||
149797808|NCT00635804|540387358|FG004|Overall Study|Adverse Event|0|||
149797809|NCT00635804|540387359|FG005|Overall Study|Adverse Event|1|||
149797810|NCT00635804|540387360|FG006|Overall Study|Adverse Event|0|||
149797811|NCT00635804|540387361|FG007|Overall Study|Adverse Event|0|||
149797812|NCT00635804|540387354|FG000|Overall Study|Withdrawal by Subject|1|||
149797813|NCT00635804|540387355|FG001|Overall Study|Withdrawal by Subject|0|||
149797814|NCT00635804|540387356|FG002|Overall Study|Withdrawal by Subject|0|||
149797815|NCT00635804|540387357|FG003|Overall Study|Withdrawal by Subject|0|||
149797816|NCT00635804|540387358|FG004|Overall Study|Withdrawal by Subject|0|||
149797817|NCT00635804|540387359|FG005|Overall Study|Withdrawal by Subject|0|||
149797818|NCT00635804|540387360|FG006|Overall Study|Withdrawal by Subject|0|||
149797819|NCT00635804|540387361|FG007|Overall Study|Withdrawal by Subject|0|||
149797820|NCT01425268|540387369|FG000|Overall Study|Withdrawal by Subject|2|||
149797821|NCT01425268|540387370|FG001|Overall Study|Withdrawal by Subject|0|||
149797822|NCT01425268|540387369|FG000|Overall Study|Sponsor Decision|5|||
149797823|NCT01425268|540387370|FG001|Overall Study|Sponsor Decision|0|||
149797824|NCT01425268|540387369|FG000|Overall Study|Physician Decision|1|||
149797825|NCT01425268|540387370|FG001|Overall Study|Physician Decision|0|||
149797826|NCT00719706|540387371|FG000|Overall Study|Adverse Event|5|||
149797827|NCT00719706|540387372|FG001|Overall Study|Adverse Event|4|||
149797828|NCT00719706|540387371|FG000|Overall Study|Withdrawal by Subject|1|||
149797829|NCT00719706|540387372|FG001|Overall Study|Withdrawal by Subject|2|||
149797830|NCT00719706|540387371|FG000|Overall Study|Protocol Violation|3|||
149797831|NCT00719706|540387372|FG001|Overall Study|Protocol Violation|0|||
149797832|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
149797833|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
149797834|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
149797835|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
149797836|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
149797837|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
149797838|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
149797839|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
149797840|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
149797841|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
149797842|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
149797843|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
149797844|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
149797845|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
149797846|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
149797847|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|Other|6|||
149797848|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|Other|6|||
149797849|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|Other|7|||
149797850|NCT02681094|540387373|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
149797851|NCT02681094|540387374|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
149797852|NCT02681094|540387375|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
149797853|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Participant decision|7|||
149797854|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Participant decision|10|||
149797855|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Participant decision|9|||
149797856|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
149797857|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
149797858|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
149797859|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
149797860|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
149797861|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
149797862|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
149797863|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
149797864|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
149797865|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
149797866|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
149797867|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
149797868|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|Other|6|||
149797869|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|Other|6|||
149797870|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|Other|7|||
149797871|NCT02681094|540387373|FG000|2 - Enrolled Participants Set|No treatment given|0|||
149797872|NCT02681094|540387374|FG001|2 - Enrolled Participants Set|No treatment given|1|||
149797873|NCT02681094|540387375|FG002|2 - Enrolled Participants Set|No treatment given|1|||
149797874|NCT00508872|540387376|FG000|Overall Study|Lost to Follow-up|1|||
149797875|NCT00508872|540387376|FG000|Overall Study|Physician Decision|1|||
149797876|NCT02210559|540387379|FG000|Overall Study|Progressive Disease|3|||
149797877|NCT02210559|540387380|FG001|Overall Study|Progressive Disease|2|||
149797878|NCT02210559|540387379|FG000|Overall Study|Adverse Event|2|||
149797879|NCT02210559|540387380|FG001|Overall Study|Adverse Event|2|||
149797880|NCT02210559|540387379|FG000|Overall Study|Physician Decision|1|||
149797881|NCT02210559|540387380|FG001|Overall Study|Physician Decision|0|||
149797882|NCT02210559|540387379|FG000|Overall Study|Withdrawal by Subject|0|||
149797883|NCT02210559|540387380|FG001|Overall Study|Withdrawal by Subject|1|||
149797884|NCT02210559|540387379|FG000|Overall Study|Other than specified|0|||
149797885|NCT02210559|540387380|FG001|Overall Study|Other than specified|1|||
149797886|NCT00310440|540387381|FG000|Overall Study|Lost to Follow-up|17|||
149797887|NCT00310440|540387382|FG001|Overall Study|Lost to Follow-up|8|||
149797888|NCT00310440|540387381|FG000|Overall Study|Withdrawal by Subject|2|||
149797889|NCT00310440|540387382|FG001|Overall Study|Withdrawal by Subject|1|||
149797890|NCT00310440|540387381|FG000|Overall Study|Missed 12 Month Visit|7|||
149797891|NCT00310440|540387382|FG001|Overall Study|Missed 12 Month Visit|4|||
149797892|NCT00792467|540387383|FG000|Overall Study|progression of disease|17|||
149797893|NCT00792467|540387383|FG000|Overall Study|Adverse Event|1|||
149797894|NCT00792467|540387383|FG000|Overall Study|patient request|1|||
149797895|NCT00792467|540387383|FG000|Overall Study|Lost to Follow-up|1|||
149797896|NCT00792467|540387383|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
149797897|NCT00792467|540387383|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
149797898|NCT01287403|540387388|FG000|1st Intervention (1 Day)|Adverse Event|1|||
149797899|NCT00148109|540387389|FG000|Overall Study|Lack of Efficacy|10|||
149797900|NCT00148109|540387390|FG001|Overall Study|Lack of Efficacy|18|||
149797901|NCT00148109|540387389|FG000|Overall Study|Adverse Event|0|||
149797902|NCT00148109|540387390|FG001|Overall Study|Adverse Event|2|||
149797903|NCT00148109|540387389|FG000|Overall Study|Withdrawal by Subject|2|||
149797904|NCT00148109|540387390|FG001|Overall Study|Withdrawal by Subject|0|||
149797905|NCT01098266|540387391|FG000|Overall Study|Physician Decision|1|||
149797906|NCT01098266|540387392|FG001|Overall Study|Physician Decision|0|||
149797907|NCT01098266|540387391|FG000|Overall Study|Death|3|||
149797908|NCT01098266|540387392|FG001|Overall Study|Death|2|||
149797909|NCT01098266|540387391|FG000|Overall Study|Withdrawal by Subject|3|||
149797910|NCT01098266|540387392|FG001|Overall Study|Withdrawal by Subject|5|||
149797911|NCT00438815|540387396|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
149797912|NCT00438815|540387396|FG000|Overall Study|3-month follow-up no longer required|12|||
149797913|NCT00438815|540387396|FG000|Overall Study|Noncompliance with protocol requirements|9|||
149797914|NCT00438815|540387396|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
149797915|NCT00438815|540387396|FG000|Overall Study|Lost to Follow-up|6|||
149797916|NCT00438815|540387396|FG000|Overall Study|Withdrawal by Subject|6|||
149797917|NCT00438815|540387396|FG000|Overall Study|Death|1|||
149797918|NCT01733758|540387397|FG000|Overall Study|Adverse Event|5|||
149797919|NCT01733758|540387398|FG001|Overall Study|Adverse Event|7|||
149797920|NCT01733758|540387399|FG002|Overall Study|Adverse Event|8|||
149797921|NCT01733758|540387400|FG003|Overall Study|Adverse Event|1|||
149797922|NCT01733758|540387397|FG000|Overall Study|Withdrawal by Subject|1|||
149797923|NCT01733758|540387398|FG001|Overall Study|Withdrawal by Subject|1|||
149797924|NCT01733758|540387399|FG002|Overall Study|Withdrawal by Subject|5|||
149797925|NCT01733758|540387400|FG003|Overall Study|Withdrawal by Subject|3|||
149797926|NCT01733758|540387397|FG000|Overall Study|Persistent Hyperglycemia|3|||
149797927|NCT01733758|540387398|FG001|Overall Study|Persistent Hyperglycemia|2|||
149797928|NCT01733758|540387399|FG002|Overall Study|Persistent Hyperglycemia|0|||
149797929|NCT01733758|540387400|FG003|Overall Study|Persistent Hyperglycemia|0|||
149797930|NCT01733758|540387397|FG000|Overall Study|Protocol Violation|0|||
149797931|NCT01733758|540387398|FG001|Overall Study|Protocol Violation|1|||
149797932|NCT01733758|540387399|FG002|Overall Study|Protocol Violation|2|||
149797933|NCT01733758|540387400|FG003|Overall Study|Protocol Violation|2|||
149797934|NCT01733758|540387397|FG000|Overall Study|Non-compliance|1|||
149797935|NCT01733758|540387398|FG001|Overall Study|Non-compliance|0|||
149797936|NCT01733758|540387399|FG002|Overall Study|Non-compliance|0|||
149797937|NCT01733758|540387400|FG003|Overall Study|Non-compliance|0|||
149797938|NCT01733758|540387397|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
149797939|NCT01733758|540387398|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
149797940|NCT01733758|540387399|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
149797941|NCT01733758|540387400|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
149797942|NCT01733758|540387397|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
149797943|NCT01733758|540387398|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
149797944|NCT01733758|540387399|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
149797945|NCT01733758|540387400|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
149797946|NCT04594213|540387405|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
149797947|NCT04594213|540387406|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
149797948|NCT04594213|540387407|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
149797949|NCT04594213|540387408|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149797950|NCT04594213|540387409|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149797951|NCT04594213|540387410|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149797952|NCT04594213|540387405|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149797953|NCT04594213|540387406|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
149797954|NCT04594213|540387407|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149797955|NCT04594213|540387408|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149797956|NCT04594213|540387409|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149797957|NCT04594213|540387410|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149797958|NCT04594213|540387405|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
149797959|NCT04594213|540387406|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149797960|NCT04594213|540387407|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
149797961|NCT04594213|540387408|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149797962|NCT04594213|540387409|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149797963|NCT04594213|540387410|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149797964|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149797965|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149797966|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149797967|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149797968|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
149797969|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149797970|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149797971|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149797972|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149797973|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
149797974|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
149797975|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
149797976|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149797977|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149797978|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149797979|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149797980|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149797981|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
149797982|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149797983|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149797984|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149797985|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
149797986|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149797987|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149797988|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149797989|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149797990|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149797991|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
149797992|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149797993|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149797994|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149797995|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149797996|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149797997|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
149797998|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
149797999|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
149798000|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
149798001|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
149798002|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
149798003|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
149798004|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
149798005|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
149798006|NCT04594213|540387405|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
149798007|NCT04594213|540387406|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
149798008|NCT04594213|540387407|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
149798009|NCT04594213|540387408|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
149798010|NCT04594213|540387409|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
149798011|NCT04594213|540387410|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
149798012|NCT03814499|540387411|FG000|Overall Study|Lost to Follow-up|3|||
149798013|NCT03764813|540387412|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
149798014|NCT03764813|540387413|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
149798015|NCT03764813|540387414|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
149798016|NCT03764813|540387415|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
149798017|NCT00408408|540387416|FG000|Overall Study|No follow up data|2|||
149798018|NCT00408408|540387417|FG001|Overall Study|No follow up data|3|||
149798019|NCT00408408|540387418|FG002|Overall Study|No follow up data|0|||
149798020|NCT00408408|540387419|FG003|Overall Study|No follow up data|7|||
149798021|NCT00408408|540387420|FG004|Overall Study|No follow up data|5|||
149798022|NCT00408408|540387421|FG005|Overall Study|No follow up data|3|||
149798023|NCT02898662|540387422|FG000|Overall Study|Adverse Event|1|||
149798024|NCT02898662|540387423|FG001|Overall Study|Adverse Event|0|||
149798025|NCT02898662|540387422|FG000|Overall Study|Loss of asthma control|23|||
149798026|NCT02898662|540387423|FG001|Overall Study|Loss of asthma control|24|||
149798027|NCT02898662|540387422|FG000|Overall Study|Withdrawal by Subject|4|||
149798028|NCT02898662|540387423|FG001|Overall Study|Withdrawal by Subject|1|||
149798029|NCT02898662|540387422|FG000|Overall Study|Technical issue|0|||
149798030|NCT02898662|540387423|FG001|Overall Study|Technical issue|1|||
149798031|NCT02898662|540387422|FG000|Overall Study|Randomized in error|0|||
149798032|NCT02898662|540387423|FG001|Overall Study|Randomized in error|1|||
149798033|NCT02898662|540387422|FG000|Overall Study|Subject decision|1|||
149798034|NCT02898662|540387423|FG001|Overall Study|Subject decision|0|||
149798035|NCT02898662|540387422|FG000|Overall Study|Other|0|||
149798036|NCT02898662|540387423|FG001|Overall Study|Other|1|||
149798037|NCT00917553|540387424|FG000|Overall Study|Lost to Follow-up|2|||
149798038|NCT00917553|540387425|FG001|Overall Study|Lost to Follow-up|1|||
149798039|NCT01616173|540387426|FG000|Overall Study|Lost to Follow-up|0|||
149798040|NCT01616173|540387427|FG001|Overall Study|Lost to Follow-up|2|||
149798041|NCT01616173|540387428|FG002|Overall Study|Lost to Follow-up|0|||
149798042|NCT03172026|540387430|FG000|Overall Study|Withdrawal by Subject|1|||
149798043|NCT03172026|540387431|FG001|Overall Study|Withdrawal by Subject|0|||
149798044|NCT03172026|540387430|FG000|Overall Study|COVID restrictions|1|||
149798045|NCT03172026|540387431|FG001|Overall Study|COVID restrictions|0|||
149798046|NCT01177943|540387436|FG000|First Intervention|Withdrawal by Subject|2|||
149798047|NCT01177943|540387437|FG001|First Intervention|Withdrawal by Subject|0|||
149798048|NCT00779142|540387439|FG000|Overall Study|Screen Failures|3|||
149798049|NCT04652245|540387440|FG000|Wash-Out Period|Adverse Event|0|||
149798050|NCT04652245|540387441|FG001|Wash-Out Period|Adverse Event|2|||
149798051|NCT04652245|540387440|FG000|Wash-Out Period|Withdrawal by Subject|0|||
149798052|NCT04652245|540387441|FG001|Wash-Out Period|Withdrawal by Subject|2|||
149798053|NCT04047472|540387446|FG000|Overall Study|Adverse Event|3|||
149798054|NCT04047472|540387447|FG001|Overall Study|Adverse Event|3|||
149798055|NCT04047472|540387446|FG000|Overall Study|Death|0|||
149798056|NCT04047472|540387447|FG001|Overall Study|Death|1|||
149798057|NCT04047472|540387446|FG000|Overall Study|Lost to Follow-up|1|||
149798058|NCT04047472|540387447|FG001|Overall Study|Lost to Follow-up|0|||
149798059|NCT04047472|540387446|FG000|Overall Study|Physician Decision|1|||
149798060|NCT04047472|540387447|FG001|Overall Study|Physician Decision|2|||
149798061|NCT04047472|540387446|FG000|Overall Study|Protocol Violation|1|||
149798062|NCT04047472|540387447|FG001|Overall Study|Protocol Violation|0|||
149798063|NCT04047472|540387446|FG000|Overall Study|Withdrawal by Subject|10|||
149798064|NCT04047472|540387447|FG001|Overall Study|Withdrawal by Subject|10|||
149798065|NCT01016912|540387448|FG000|End of Treatment Period|Lack of Efficacy|0|||
149798066|NCT01016912|540387449|FG001|End of Treatment Period|Lack of Efficacy|1|||
149798067|NCT01016912|540387450|FG002|End of Treatment Period|Lack of Efficacy|0|||
149798068|NCT01016912|540387451|FG003|End of Treatment Period|Lack of Efficacy|4|||
149798069|NCT01016912|540387452|FG004|End of Treatment Period|Lack of Efficacy|4|||
149798070|NCT01016912|540387448|FG000|End of Treatment Period|Adverse Event|0|||
149798071|NCT01016912|540387449|FG001|End of Treatment Period|Adverse Event|1|||
149798072|NCT01016912|540387450|FG002|End of Treatment Period|Adverse Event|1|||
149798073|NCT01016912|540387451|FG003|End of Treatment Period|Adverse Event|0|||
149798074|NCT01016912|540387452|FG004|End of Treatment Period|Adverse Event|0|||
149798075|NCT01016912|540387448|FG000|End of Treatment Period|Completed double-blind period only|0|||
149798076|NCT01016912|540387449|FG001|End of Treatment Period|Completed double-blind period only|1|||
149798077|NCT01016912|540387450|FG002|End of Treatment Period|Completed double-blind period only|0|||
149798078|NCT01016912|540387451|FG003|End of Treatment Period|Completed double-blind period only|0|||
149798079|NCT01016912|540387452|FG004|End of Treatment Period|Completed double-blind period only|0|||
149798080|NCT01016912|540387448|FG000|Follow-up Period|Other reason|0|||
149798081|NCT01016912|540387449|FG001|Follow-up Period|Other reason|0|||
149798082|NCT01016912|540387450|FG002|Follow-up Period|Other reason|1|||
149798083|NCT01016912|540387451|FG003|Follow-up Period|Other reason|1|||
149798084|NCT01016912|540387452|FG004|Follow-up Period|Other reason|0|||
149798085|NCT00496782|540387453|FG000|Overall Study|Protocol Violation|1|||
149798086|NCT00496782|540387454|FG001|Overall Study|Protocol Violation|2|||
149798087|NCT01288911|540387455|FG000|Double-blind Period|Death|11|||
149798088|NCT01288911|540387456|FG001|Double-blind Period|Death|7|||
149798089|NCT01288911|540387455|FG000|Double-blind Period|Lost to Follow-up|0|||
149798090|NCT01288911|540387456|FG001|Double-blind Period|Lost to Follow-up|2|||
149798091|NCT01288911|540387455|FG000|Double-blind Period|Progressive Disease|75|||
149798092|NCT01288911|540387456|FG001|Double-blind Period|Progressive Disease|103|||
149798093|NCT01288911|540387455|FG000|Double-blind Period|Protocol Violation|1|||
149798094|NCT01288911|540387456|FG001|Double-blind Period|Protocol Violation|0|||
149798095|NCT01288911|540387455|FG000|Double-blind Period|Withdrawal by Subject|25|||
149798096|NCT01288911|540387456|FG001|Double-blind Period|Withdrawal by Subject|26|||
149798097|NCT01288911|540387455|FG000|Double-blind Period|Miscellaneous Reason|29|||
149798098|NCT01288911|540387456|FG001|Double-blind Period|Miscellaneous Reason|42|||
149798099|NCT01288911|540387455|FG000|Double-blind Period|Randomized but never received study drug|1|||
149798100|NCT01288911|540387456|FG001|Double-blind Period|Randomized but never received study drug|2|||
149798101|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Death|0|||
149798102|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Death|1|||
149798103|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
149798104|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
149798105|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
149798106|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
149798107|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
149798108|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
149798109|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
149798110|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
149798111|NCT01288911|540387455|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
149798112|NCT01288911|540387456|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
149798113|NCT02431559|540387457|FG000|Overall Study|Adverse Event|0|||
149798114|NCT02431559|540387458|FG001|Overall Study|Adverse Event|1|||
149798115|NCT02431559|540387459|FG002|Overall Study|Adverse Event|0|||
149798116|NCT02431559|540387460|FG003|Overall Study|Adverse Event|4|||
149798117|NCT02431559|540387457|FG000|Overall Study|Progressive disease|2|||
149798118|NCT02431559|540387458|FG001|Overall Study|Progressive disease|1|||
149798119|NCT02431559|540387459|FG002|Overall Study|Progressive disease|4|||
149798120|NCT02431559|540387460|FG003|Overall Study|Progressive disease|22|||
149798121|NCT02431559|540387457|FG000|Overall Study|Withdrawal by Subject|0|||
149798122|NCT02431559|540387458|FG001|Overall Study|Withdrawal by Subject|1|||
149798123|NCT02431559|540387459|FG002|Overall Study|Withdrawal by Subject|0|||
149798124|NCT02431559|540387460|FG003|Overall Study|Withdrawal by Subject|4|||
149798125|NCT02431559|540387457|FG000|Overall Study|Physician Decision|0|||
149798126|NCT02431559|540387458|FG001|Overall Study|Physician Decision|0|||
149798127|NCT02431559|540387459|FG002|Overall Study|Physician Decision|0|||
149798128|NCT02431559|540387460|FG003|Overall Study|Physician Decision|1|||
149798129|NCT02452892|540387461|FG000|Week 1 Initial Randommization|Adverse Event|1|||
149798130|NCT02452892|540387462|FG001|Week 1 Initial Randommization|Adverse Event|0|||
149798131|NCT02452892|540387463|FG002|Week 1 Initial Randommization|Adverse Event|0|||
149798132|NCT02452892|540387464|FG003|Week 1 Initial Randommization|Adverse Event|0|||
149798133|NCT02452892|540387461|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
149798134|NCT02452892|540387462|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
149798135|NCT02452892|540387463|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
149798136|NCT02452892|540387464|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
149798137|NCT02452892|540387461|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149798138|NCT02452892|540387462|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149798139|NCT02452892|540387463|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149798140|NCT02452892|540387464|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
149798141|NCT02452892|540387461|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
149798142|NCT02452892|540387462|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149798143|NCT02452892|540387463|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149798144|NCT02452892|540387464|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149798145|NCT02452892|540387461|FG000|Follow-up|Withdrawal by Subject|0|||
149798146|NCT02452892|540387462|FG001|Follow-up|Withdrawal by Subject|0|||
149798147|NCT02452892|540387463|FG002|Follow-up|Withdrawal by Subject|0|||
149798148|NCT02452892|540387464|FG003|Follow-up|Withdrawal by Subject|1|||
149798149|NCT02452892|540387461|FG000|Follow-up|Subject left town on Day 42|1|||
149798150|NCT02452892|540387462|FG001|Follow-up|Subject left town on Day 42|0|||
149798151|NCT02452892|540387463|FG002|Follow-up|Subject left town on Day 42|0|||
149798152|NCT02452892|540387464|FG003|Follow-up|Subject left town on Day 42|0|||
149798153|NCT00955682|540387468|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
149798154|NCT00955682|540387469|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
149798155|NCT00252499|540387484|FG000|Overall Study|Lost to Follow-up|1|||
149798156|NCT00252499|540387485|FG001|Overall Study|Lost to Follow-up|0|||
149798157|NCT00252499|540387486|FG002|Overall Study|Lost to Follow-up|0|||
149798158|NCT01365468|540387487|FG000|Overall Study|Physician Decision|1|||
149798159|NCT01365468|540387488|FG001|Overall Study|Physician Decision|0|||
149798160|NCT01365468|540387487|FG000|Overall Study|Disease progression|1|||
149798161|NCT01365468|540387488|FG001|Overall Study|Disease progression|0|||
149798162|NCT01365468|540387487|FG000|Overall Study|Lost to Follow-up|2|||
149798163|NCT01365468|540387488|FG001|Overall Study|Lost to Follow-up|0|||
149798164|NCT01002573|540389187|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
149798165|NCT01002573|540389188|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
149798166|NCT00690612|540389194|FG000|Overall Study|Adverse Event|1|||
149798167|NCT00690612|540389194|FG000|Overall Study|Withdrawal by Subject|2|||
149798168|NCT02926833|540389195|FG000|Overall Study|Death|1|||
149798169|NCT02926833|540389196|FG001|Overall Study|Death|1|||
149798170|NCT02926833|540389197|FG002|Overall Study|Death|2|||
149798171|NCT02926833|540389198|FG003|Overall Study|Death|13|||
149798172|NCT02926833|540389195|FG000|Overall Study|Lost to Follow-up|1|||
149798173|NCT02926833|540389196|FG001|Overall Study|Lost to Follow-up|2|||
149798174|NCT02926833|540389197|FG002|Overall Study|Lost to Follow-up|0|||
149798175|NCT02926833|540389198|FG003|Overall Study|Lost to Follow-up|3|||
149798176|NCT02926833|540389195|FG000|Overall Study|Full Consent Withdrawal|0|||
149798177|NCT02926833|540389196|FG001|Overall Study|Full Consent Withdrawal|0|||
149798178|NCT02926833|540389197|FG002|Overall Study|Full Consent Withdrawal|0|||
149798179|NCT02926833|540389198|FG003|Overall Study|Full Consent Withdrawal|2|||
149798180|NCT02926833|540389195|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
149798181|NCT02926833|540389196|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
149798182|NCT02926833|540389197|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
149798183|NCT02926833|540389198|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
149798184|NCT02926833|540389195|FG000|Overall Study|Investigator Decision|0|||
149798185|NCT02926833|540389196|FG001|Overall Study|Investigator Decision|1|||
149798186|NCT02926833|540389197|FG002|Overall Study|Investigator Decision|0|||
149798187|NCT02926833|540389198|FG003|Overall Study|Investigator Decision|0|||
149798188|NCT02926833|540389195|FG000|Overall Study|Adverse Event|0|||
149798189|NCT02926833|540389196|FG001|Overall Study|Adverse Event|0|||
149798190|NCT02926833|540389197|FG002|Overall Study|Adverse Event|1|||
149798191|NCT02926833|540389198|FG003|Overall Study|Adverse Event|0|||
149798192|NCT02926833|540389195|FG000|Overall Study|Partial Withdrawal of Consent|0|||
149798193|NCT02926833|540389196|FG001|Overall Study|Partial Withdrawal of Consent|0|||
149798194|NCT02926833|540389197|FG002|Overall Study|Partial Withdrawal of Consent|0|||
149798195|NCT02926833|540389198|FG003|Overall Study|Partial Withdrawal of Consent|1|||
149798196|NCT00346775|540389203|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
149798197|NCT00346775|540389204|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
149798198|NCT00346775|540389203|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
149798199|NCT00346775|540389204|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
149798200|NCT00346775|540389203|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
149798201|NCT00346775|540389204|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
149798202|NCT01096017|540389207|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
149798203|NCT01096017|540389208|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
149798204|NCT02600559|540389209|FG000|Overall Study|Withdrawal by Subject|3|||
149798205|NCT02600559|540389209|FG000|Overall Study|Lost to Follow-up|20|||
149798206|NCT00953576|540389210|FG000|Overall Study|Adverse Event|0|||
149798207|NCT00953576|540389211|FG001|Overall Study|Adverse Event|1|||
149798208|NCT00953576|540389210|FG000|Overall Study|Ineligible after Consent|2|||
149798209|NCT00953576|540389211|FG001|Overall Study|Ineligible after Consent|0|||
149798210|NCT00665366|540389214|FG000|Overall Study|Lack of Efficacy|11|||
149798211|NCT00665366|540389215|FG001|Overall Study|Lack of Efficacy|10|||
149798212|NCT00665366|540389214|FG000|Overall Study|Adverse Event|25|||
149798213|NCT00665366|540389215|FG001|Overall Study|Adverse Event|23|||
149798214|NCT00665366|540389214|FG000|Overall Study|Withdrawal by Subject|11|||
149798215|NCT00665366|540389215|FG001|Overall Study|Withdrawal by Subject|14|||
149798216|NCT00665366|540389214|FG000|Overall Study|Lost to Follow-up|3|||
149798217|NCT00665366|540389215|FG001|Overall Study|Lost to Follow-up|5|||
149798218|NCT00665366|540389214|FG000|Overall Study|Poor compliance/noncompliance|3|||
149798219|NCT00665366|540389215|FG001|Overall Study|Poor compliance/noncompliance|5|||
149798220|NCT00665366|540389214|FG000|Overall Study|Pregnancy|1|||
149798221|NCT00665366|540389215|FG001|Overall Study|Pregnancy|0|||
149798222|NCT00665366|540389214|FG000|Overall Study|No longer meets study criteria|0|||
149798223|NCT00665366|540389215|FG001|Overall Study|No longer meets study criteria|1|||
149798224|NCT00665366|540389214|FG000|Overall Study|Other reasons|4|||
149798225|NCT00665366|540389215|FG001|Overall Study|Other reasons|1|||
149798226|NCT01545375|540389217|FG000|Overall Study|Adverse Event|2|||
149798227|NCT01545375|540389218|FG001|Overall Study|Adverse Event|1|||
149798228|NCT01545375|540389217|FG000|Overall Study|Lost to Follow-up|34|||
149798229|NCT01545375|540389218|FG001|Overall Study|Lost to Follow-up|31|||
149798230|NCT01545375|540389217|FG000|Overall Study|Protocol Violation|3|||
149798231|NCT01545375|540389218|FG001|Overall Study|Protocol Violation|3|||
149798232|NCT01545375|540389217|FG000|Overall Study|Withdrawal by Subject|58|||
149798233|NCT01545375|540389218|FG001|Overall Study|Withdrawal by Subject|55|||
149798234|NCT04177862|540389219|FG000|Overall Study|Protocol Violation|2|||
149798235|NCT04177862|540389220|FG001|Overall Study|Protocol Violation|7|||
149798236|NCT05637515|540389221|FG000|Overall Study|Withdrawal by Subject|17|||
149798237|NCT05637515|540389222|FG001|Overall Study|Withdrawal by Subject|17|||
149798238|NCT04516291|540389223|FG000|Treatment Period (24 Weeks)|Other|1|||
149798239|NCT04516291|540389224|FG001|Treatment Period (24 Weeks)|Other|0|||
149798240|NCT04516291|540389225|FG002|Treatment Period (24 Weeks)|Other|0|||
149798241|NCT04516291|540389226|FG003|Treatment Period (24 Weeks)|Other|2|||
149798242|NCT04516291|540389227|FG004|Treatment Period (24 Weeks)|Other|2|||
149798243|NCT04516291|540389228|FG005|Treatment Period (24 Weeks)|Other|4|||
149798244|NCT04516291|540389229|FG006|Treatment Period (24 Weeks)|Other|2|||
149798245|NCT04516291|540389230|FG007|Treatment Period (24 Weeks)|Other|0|||
149798246|NCT04516291|540389223|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149798247|NCT04516291|540389224|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149798248|NCT04516291|540389225|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149798249|NCT04516291|540389226|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149798250|NCT04516291|540389227|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149798251|NCT04516291|540389228|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149798252|NCT04516291|540389229|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149798253|NCT04516291|540389230|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149798254|NCT04516291|540389223|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798255|NCT04516291|540389224|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798256|NCT04516291|540389225|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798257|NCT04516291|540389226|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
149798258|NCT04516291|540389227|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798259|NCT04516291|540389228|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798260|NCT04516291|540389229|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798261|NCT04516291|540389230|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
149798262|NCT04516291|540389223|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798263|NCT04516291|540389224|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149798264|NCT04516291|540389225|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798265|NCT04516291|540389226|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798266|NCT04516291|540389227|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798267|NCT04516291|540389228|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798268|NCT04516291|540389229|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798269|NCT04516291|540389230|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149798270|NCT04516291|540389223|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
149798271|NCT04516291|540389224|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
149798272|NCT04516291|540389225|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
149798273|NCT04516291|540389226|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
149798274|NCT04516291|540389227|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
149798275|NCT04516291|540389228|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
149798276|NCT04516291|540389229|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
149798277|NCT04516291|540389230|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
149798278|NCT04516291|540389223|FG000|Follow-up Period (12 Weeks)|Other|0|||
149798279|NCT04516291|540389224|FG001|Follow-up Period (12 Weeks)|Other|1|||
149798280|NCT04516291|540389225|FG002|Follow-up Period (12 Weeks)|Other|0|||
149798281|NCT04516291|540389226|FG003|Follow-up Period (12 Weeks)|Other|2|||
149798282|NCT04516291|540389227|FG004|Follow-up Period (12 Weeks)|Other|0|||
149798283|NCT04516291|540389228|FG005|Follow-up Period (12 Weeks)|Other|0|||
149798284|NCT04516291|540389229|FG006|Follow-up Period (12 Weeks)|Other|0|||
149798285|NCT04516291|540389230|FG007|Follow-up Period (12 Weeks)|Other|0|||
149798286|NCT04516291|540389223|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798287|NCT04516291|540389224|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798288|NCT04516291|540389225|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798289|NCT04516291|540389226|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798290|NCT04516291|540389227|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
149798291|NCT04516291|540389228|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798292|NCT04516291|540389229|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798293|NCT04516291|540389230|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149798294|NCT04516291|540389223|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798295|NCT04516291|540389224|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798296|NCT04516291|540389225|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
149798297|NCT04516291|540389226|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798298|NCT04516291|540389227|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
149798299|NCT04516291|540389228|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798300|NCT04516291|540389229|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798301|NCT04516291|540389230|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
149798302|NCT02158949|540389231|FG000|Overall Study|Withdrawal by Subject|1|||
149798303|NCT02158949|540389232|FG001|Overall Study|Withdrawal by Subject|0|||
149798304|NCT02158949|540389231|FG000|Overall Study|Lost to Follow-up|5|||
149798305|NCT02158949|540389232|FG001|Overall Study|Lost to Follow-up|11|||
149798306|NCT02452320|540389244|FG000|Overall Study|Adverse Event|0|||
149798307|NCT02452320|540389245|FG001|Overall Study|Adverse Event|1|||
149798308|NCT03737812|540389246|FG000|Overall Study|Withdrawal by Subject|1|||
149798309|NCT03737812|540389247|FG001|Overall Study|Withdrawal by Subject|2|||
149798310|NCT03737812|540389248|FG002|Overall Study|Withdrawal by Subject|1|||
149798311|NCT03737812|540389246|FG000|Overall Study|Sponsor Discontinued the Study|4|||
149798312|NCT03737812|540389247|FG001|Overall Study|Sponsor Discontinued the Study|3|||
149798313|NCT03737812|540389248|FG002|Overall Study|Sponsor Discontinued the Study|2|||
149798314|NCT03737812|540389246|FG000|Overall Study|Adverse Event|0|||
149798315|NCT03737812|540389247|FG001|Overall Study|Adverse Event|1|||
149798316|NCT03737812|540389248|FG002|Overall Study|Adverse Event|0|||
149798317|NCT03737812|540389246|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
149798318|NCT03737812|540389247|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
149798319|NCT03737812|540389248|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
149798320|NCT02624713|540389249|FG000|Overall Study|Lost to Follow-up|14|||
149798321|NCT02624713|540389250|FG001|Overall Study|Lost to Follow-up|0|||
149798322|NCT01161173|540389251|FG000|Overall Study|Protocol Violation|13|||
149798323|NCT01161173|540389251|FG000|Overall Study|Lost to Follow-up|7|||
149798324|NCT01161173|540389251|FG000|Overall Study|Progressive Disease|82|||
149798325|NCT01161173|540389251|FG000|Overall Study|Withdrawal of Consent|5|||
149798326|NCT01161173|540389251|FG000|Overall Study|Unacceptable Toxicity|21|||
149798327|NCT01161173|540389251|FG000|Overall Study|Death|194|||
149798328|NCT01161173|540389251|FG000|Overall Study|End of Study|2|||
149798329|NCT01161173|540389251|FG000|Overall Study|Reasons Not Specified|23|||
149798330|NCT02557308|540389252|FG000|Overall Study|Withdrawal by Subject|11|||
149798331|NCT02557308|540389253|FG001|Overall Study|Withdrawal by Subject|3|||
149798332|NCT02557308|540389254|FG002|Overall Study|Withdrawal by Subject|2|||
149798333|NCT02557308|540389255|FG003|Overall Study|Withdrawal by Subject|0|||
149798334|NCT02557308|540389256|FG004|Overall Study|Withdrawal by Subject|1|||
149798335|NCT02557308|540389257|FG005|Overall Study|Withdrawal by Subject|0|||
149798336|NCT02557308|540389258|FG006|Overall Study|Withdrawal by Subject|10|||
149798337|NCT02557308|540389259|FG007|Overall Study|Withdrawal by Subject|1|||
149798338|NCT02557308|540389252|FG000|Overall Study|Disease Progression|0|||
149798339|NCT02557308|540389253|FG001|Overall Study|Disease Progression|1|||
149798340|NCT02557308|540389254|FG002|Overall Study|Disease Progression|0|||
149798341|NCT02557308|540389255|FG003|Overall Study|Disease Progression|0|||
149798342|NCT02557308|540389256|FG004|Overall Study|Disease Progression|0|||
149798343|NCT02557308|540389257|FG005|Overall Study|Disease Progression|0|||
149798344|NCT02557308|540389258|FG006|Overall Study|Disease Progression|0|||
149798345|NCT02557308|540389259|FG007|Overall Study|Disease Progression|0|||
149798346|NCT02557308|540389252|FG000|Overall Study|Lack of Efficacy|3|||
149798347|NCT02557308|540389253|FG001|Overall Study|Lack of Efficacy|0|||
149798348|NCT02557308|540389254|FG002|Overall Study|Lack of Efficacy|0|||
149798349|NCT02557308|540389255|FG003|Overall Study|Lack of Efficacy|0|||
149798350|NCT02557308|540389256|FG004|Overall Study|Lack of Efficacy|0|||
149798351|NCT02557308|540389257|FG005|Overall Study|Lack of Efficacy|0|||
149798352|NCT02557308|540389258|FG006|Overall Study|Lack of Efficacy|1|||
149798353|NCT02557308|540389259|FG007|Overall Study|Lack of Efficacy|0|||
149798354|NCT02557308|540389252|FG000|Overall Study|Adverse Event|4|||
149798355|NCT02557308|540389253|FG001|Overall Study|Adverse Event|1|||
149798356|NCT02557308|540389254|FG002|Overall Study|Adverse Event|2|||
149798357|NCT02557308|540389255|FG003|Overall Study|Adverse Event|0|||
149798358|NCT02557308|540389256|FG004|Overall Study|Adverse Event|0|||
149798359|NCT02557308|540389257|FG005|Overall Study|Adverse Event|0|||
149798360|NCT02557308|540389258|FG006|Overall Study|Adverse Event|4|||
149798361|NCT02557308|540389259|FG007|Overall Study|Adverse Event|1|||
149798362|NCT02557308|540389252|FG000|Overall Study|Lost to Follow-up|2|||
149798363|NCT02557308|540389253|FG001|Overall Study|Lost to Follow-up|0|||
149798364|NCT02557308|540389254|FG002|Overall Study|Lost to Follow-up|1|||
149798365|NCT02557308|540389255|FG003|Overall Study|Lost to Follow-up|0|||
149798366|NCT02557308|540389256|FG004|Overall Study|Lost to Follow-up|0|||
149798367|NCT02557308|540389257|FG005|Overall Study|Lost to Follow-up|0|||
149798368|NCT02557308|540389258|FG006|Overall Study|Lost to Follow-up|2|||
149798369|NCT02557308|540389259|FG007|Overall Study|Lost to Follow-up|0|||
149798370|NCT02557308|540389252|FG000|Overall Study|Death|1|||
149798371|NCT02557308|540389253|FG001|Overall Study|Death|0|||
149798372|NCT02557308|540389254|FG002|Overall Study|Death|0|||
149798373|NCT02557308|540389255|FG003|Overall Study|Death|0|||
149798374|NCT02557308|540389256|FG004|Overall Study|Death|0|||
149798375|NCT02557308|540389257|FG005|Overall Study|Death|0|||
149798376|NCT02557308|540389258|FG006|Overall Study|Death|0|||
149798377|NCT02557308|540389259|FG007|Overall Study|Death|0|||
149798378|NCT02557308|540389252|FG000|Overall Study|Study Close|98|||
149798379|NCT02557308|540389253|FG001|Overall Study|Study Close|18|||
149798380|NCT02557308|540389254|FG002|Overall Study|Study Close|5|||
149798381|NCT02557308|540389255|FG003|Overall Study|Study Close|3|||
149798382|NCT02557308|540389256|FG004|Overall Study|Study Close|1|||
149798383|NCT02557308|540389257|FG005|Overall Study|Study Close|0|||
149798384|NCT02557308|540389258|FG006|Overall Study|Study Close|123|||
149798385|NCT02557308|540389259|FG007|Overall Study|Study Close|5|||
149798386|NCT02557308|540389252|FG000|Overall Study|Except for study close|5|||
149798387|NCT02557308|540389253|FG001|Overall Study|Except for study close|0|||
149798388|NCT02557308|540389254|FG002|Overall Study|Except for study close|0|||
149798389|NCT02557308|540389255|FG003|Overall Study|Except for study close|0|||
149798390|NCT02557308|540389256|FG004|Overall Study|Except for study close|3|||
149798391|NCT02557308|540389257|FG005|Overall Study|Except for study close|0|||
149798392|NCT02557308|540389258|FG006|Overall Study|Except for study close|6|||
149798393|NCT02557308|540389259|FG007|Overall Study|Except for study close|10|||
149798394|NCT03911401|540389260|FG000|Overall Study|Adverse Event|1|||
149798395|NCT03911401|540389261|FG001|Overall Study|Adverse Event|2|||
149798396|NCT03911401|540389262|FG002|Overall Study|Adverse Event|5|||
149798397|NCT03911401|540389260|FG000|Overall Study|Lack of Efficacy|1|||
149798398|NCT03911401|540389261|FG001|Overall Study|Lack of Efficacy|1|||
149798399|NCT03911401|540389262|FG002|Overall Study|Lack of Efficacy|8|||
149798400|NCT03911401|540389260|FG000|Overall Study|Physician Decision|0|||
149798401|NCT03911401|540389261|FG001|Overall Study|Physician Decision|0|||
149798402|NCT03911401|540389262|FG002|Overall Study|Physician Decision|1|||
149798403|NCT03911401|540389260|FG000|Overall Study|Withdrawal by Subject|1|||
149798404|NCT03911401|540389261|FG001|Overall Study|Withdrawal by Subject|2|||
149798405|NCT03911401|540389262|FG002|Overall Study|Withdrawal by Subject|0|||
149798406|NCT03911401|540389260|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149798407|NCT03911401|540389261|FG001|Overall Study|Withdrawal by parent/guardian|4|||
149798408|NCT03911401|540389262|FG002|Overall Study|Withdrawal by parent/guardian|11|||
149798409|NCT06104423|540389265|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
149798410|NCT06104423|540389266|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
149798411|NCT06104423|540389267|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
149798412|NCT06104423|540389265|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
149798413|NCT06104423|540389266|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
149798414|NCT06104423|540389267|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
149798415|NCT02918968|540389268|FG000|1st Line AAT|Progressive disease|9|||
149798416|NCT02918968|540389269|FG001|1st Line AAT|Progressive disease|4|||
149798417|NCT02918968|540389268|FG000|1st Line AAT|Adverse Event|12|||
149798418|NCT02918968|540389269|FG001|1st Line AAT|Adverse Event|3|||
149798419|NCT02918968|540389268|FG000|1st Line AAT|Physician Decision|4|||
149798420|NCT02918968|540389269|FG001|1st Line AAT|Physician Decision|2|||
149798421|NCT02918968|540389268|FG000|1st Line AAT|Withdrawal by Subject|2|||
149798422|NCT02918968|540389269|FG001|1st Line AAT|Withdrawal by Subject|1|||
149798423|NCT02918968|540389268|FG000|1st Line AAT|Lost to Follow-up|0|||
149798424|NCT02918968|540389269|FG001|1st Line AAT|Lost to Follow-up|1|||
149798425|NCT02918968|540389268|FG000|1st Line AAT|Death|1|||
149798426|NCT02918968|540389269|FG001|1st Line AAT|Death|0|||
149798427|NCT02918968|540389268|FG000|1st Line AAT|Miscellaneous|1|||
149798428|NCT02918968|540389269|FG001|1st Line AAT|Miscellaneous|0|||
149798429|NCT02918968|540389268|FG000|2nd Line AAT|Progressive disease|21|||
149798430|NCT02918968|540389269|FG001|2nd Line AAT|Progressive disease|3|||
149798431|NCT02918968|540389268|FG000|2nd Line AAT|Adverse Event|2|||
149798432|NCT02918968|540389269|FG001|2nd Line AAT|Adverse Event|5|||
149798433|NCT02918968|540389268|FG000|2nd Line AAT|Physician Decision|0|||
149798434|NCT02918968|540389269|FG001|2nd Line AAT|Physician Decision|1|||
149798435|NCT02918968|540389268|FG000|2nd Line AAT|Withdrawal by Subject|2|||
149798436|NCT02918968|540389269|FG001|2nd Line AAT|Withdrawal by Subject|2|||
149798437|NCT02918968|540389268|FG000|2nd Line AAT|Death|0|||
149798438|NCT02918968|540389269|FG001|2nd Line AAT|Death|1|||
149798439|NCT05602818|540389270|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
149798440|NCT05602818|540389271|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
149798441|NCT05602818|540389272|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
149798442|NCT05602818|540389273|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
149798443|NCT05602818|540389274|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
149798444|NCT05602818|540389275|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
149798445|NCT05602818|540389276|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
149798446|NCT05602818|540389277|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
149798447|NCT05602818|540389278|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
149798448|NCT05602818|540389279|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
149798449|NCT05602818|540389280|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
149798450|NCT05602818|540389281|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
149798451|NCT05602818|540389270|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
149798452|NCT05602818|540389271|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
149798453|NCT05602818|540389272|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798454|NCT05602818|540389273|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798455|NCT05602818|540389274|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798456|NCT05602818|540389275|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798457|NCT05602818|540389276|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798458|NCT05602818|540389277|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798459|NCT05602818|540389278|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798460|NCT05602818|540389279|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798461|NCT05602818|540389280|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798462|NCT05602818|540389281|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149798463|NCT05602818|540389270|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
149798464|NCT05602818|540389271|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798465|NCT05602818|540389272|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798466|NCT05602818|540389273|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798467|NCT05602818|540389274|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798468|NCT05602818|540389275|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798469|NCT05602818|540389276|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798470|NCT05602818|540389277|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798471|NCT05602818|540389278|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798472|NCT05602818|540389279|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798473|NCT05602818|540389280|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798474|NCT05602818|540389281|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149798475|NCT05602818|540389270|FG000|Qualification Phase (3 Days)|Other|1|||
149798476|NCT05602818|540389271|FG001|Qualification Phase (3 Days)|Other|0|||
149798477|NCT05602818|540389272|FG002|Qualification Phase (3 Days)|Other|0|||
149798478|NCT05602818|540389273|FG003|Qualification Phase (3 Days)|Other|0|||
149798479|NCT05602818|540389274|FG004|Qualification Phase (3 Days)|Other|0|||
149798480|NCT05602818|540389275|FG005|Qualification Phase (3 Days)|Other|0|||
149798481|NCT05602818|540389276|FG006|Qualification Phase (3 Days)|Other|0|||
149798482|NCT05602818|540389277|FG007|Qualification Phase (3 Days)|Other|0|||
149798483|NCT05602818|540389278|FG008|Qualification Phase (3 Days)|Other|0|||
149798484|NCT05602818|540389279|FG009|Qualification Phase (3 Days)|Other|0|||
149798485|NCT05602818|540389280|FG010|Qualification Phase (3 Days)|Other|0|||
149798486|NCT05602818|540389281|FG011|Qualification Phase (3 Days)|Other|0|||
149798487|NCT05602818|540389270|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798488|NCT05602818|540389271|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
149798489|NCT05602818|540389272|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798490|NCT05602818|540389273|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798491|NCT05602818|540389274|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798492|NCT05602818|540389275|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798493|NCT05602818|540389276|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798494|NCT05602818|540389277|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798495|NCT05602818|540389278|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798496|NCT05602818|540389279|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798497|NCT05602818|540389280|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798498|NCT05602818|540389281|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149798499|NCT05602818|540389270|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
149798500|NCT05602818|540389271|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
149798501|NCT05602818|540389272|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
149798502|NCT05602818|540389273|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
149798503|NCT05602818|540389274|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
149798504|NCT05602818|540389275|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
149798505|NCT05602818|540389276|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
149798506|NCT05602818|540389277|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
149798507|NCT05602818|540389278|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
149798508|NCT05602818|540389279|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
149798509|NCT05602818|540389280|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
149798510|NCT05602818|540389281|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
149798511|NCT05602818|540389270|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798512|NCT05602818|540389271|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798513|NCT05602818|540389272|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798514|NCT05602818|540389273|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798515|NCT05602818|540389274|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798516|NCT05602818|540389275|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798517|NCT05602818|540389276|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798518|NCT05602818|540389277|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798519|NCT05602818|540389278|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798520|NCT05602818|540389279|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149798521|NCT05602818|540389280|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
149798522|NCT05602818|540389281|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
149798523|NCT05602818|540389270|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
149798524|NCT05602818|540389271|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
149798525|NCT05602818|540389272|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
149798526|NCT05602818|540389273|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
149798527|NCT05602818|540389274|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
149798528|NCT05602818|540389275|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
149798529|NCT05602818|540389276|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
149798530|NCT05602818|540389277|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
149798531|NCT05602818|540389278|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
149798532|NCT05602818|540389279|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
149798533|NCT05602818|540389280|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
149798534|NCT05602818|540389281|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
149798535|NCT00727246|540389282|FG000|Overall Study|could not complete MRI|0|||
149798536|NCT00727246|540389283|FG001|Overall Study|could not complete MRI|1|||
149798537|NCT00727246|540389284|FG002|Overall Study|could not complete MRI|0|||
149798538|NCT00727246|540389285|FG003|Overall Study|could not complete MRI|1|||
149798539|NCT00727246|540389282|FG000|Overall Study|incidental finding|0|||
149798540|NCT00727246|540389283|FG001|Overall Study|incidental finding|0|||
149798541|NCT00727246|540389284|FG002|Overall Study|incidental finding|0|||
149798542|NCT00727246|540389285|FG003|Overall Study|incidental finding|1|||
149798543|NCT00727246|540389282|FG000|Overall Study|withdrawn|0|||
149798544|NCT00727246|540389283|FG001|Overall Study|withdrawn|0|||
149798545|NCT00727246|540389284|FG002|Overall Study|withdrawn|1|||
149798546|NCT00727246|540389285|FG003|Overall Study|withdrawn|0|||
149798547|NCT00351611|540389290|FG000|Overall Study|Adverse Event|11|||
149798548|NCT00351611|540389291|FG001|Overall Study|Adverse Event|3|||
149798549|NCT00351611|540389290|FG000|Overall Study|Death|1|||
149798550|NCT00351611|540389291|FG001|Overall Study|Death|0|||
149798551|NCT00351611|540389290|FG000|Overall Study|Lost to Follow-up|1|||
149798552|NCT00351611|540389291|FG001|Overall Study|Lost to Follow-up|0|||
149798553|NCT00351611|540389290|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
149798554|NCT00351611|540389291|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
149798555|NCT00351611|540389290|FG000|Overall Study|Other|1|||
149798556|NCT00351611|540389291|FG001|Overall Study|Other|0|||
149798557|NCT00351611|540389290|FG000|Overall Study|Protocol Violation|0|||
149798558|NCT00351611|540389291|FG001|Overall Study|Protocol Violation|2|||
149798559|NCT01589185|540389292|FG000|Overall Study|Death|1|||
149798560|NCT01589185|540389293|FG001|Overall Study|Death|2|||
149798561|NCT01589185|540389294|FG002|Overall Study|Death|2|||
149798562|NCT01589185|540389295|FG003|Overall Study|Death|0|||
149798563|NCT01589185|540389296|FG004|Overall Study|Death|1|||
149798564|NCT01589185|540389292|FG000|Overall Study|Lost to Follow-up|1|||
149798565|NCT01589185|540389293|FG001|Overall Study|Lost to Follow-up|0|||
149798566|NCT01589185|540389294|FG002|Overall Study|Lost to Follow-up|2|||
149798567|NCT01589185|540389295|FG003|Overall Study|Lost to Follow-up|3|||
149798568|NCT01589185|540389296|FG004|Overall Study|Lost to Follow-up|0|||
149798569|NCT02046993|540389297|FG000|Overall Study|Withdrawal by Subject|2|||
149798570|NCT02046993|540389298|FG001|Overall Study|Withdrawal by Subject|10|||
149798571|NCT02046993|540389297|FG000|Overall Study|Lost to Follow-up|1|||
149798572|NCT02046993|540389298|FG001|Overall Study|Lost to Follow-up|1|||
149798573|NCT00598442|540389302|FG000|Overall Study|Adverse Event|3|||
149798574|NCT00598442|540389303|FG001|Overall Study|Adverse Event|0|||
149798575|NCT00598442|540389304|FG002|Overall Study|Adverse Event|0|||
149798576|NCT00598442|540389302|FG000|Overall Study|Death|19|||
149798577|NCT00598442|540389303|FG001|Overall Study|Death|11|||
149798578|NCT00598442|540389304|FG002|Overall Study|Death|11|||
149798579|NCT00598442|540389302|FG000|Overall Study|Lost to Follow-up|4|||
149798580|NCT00598442|540389303|FG001|Overall Study|Lost to Follow-up|3|||
149798581|NCT00598442|540389304|FG002|Overall Study|Lost to Follow-up|3|||
149798582|NCT00598442|540389302|FG000|Overall Study|Physician Decision|2|||
149798583|NCT00598442|540389303|FG001|Overall Study|Physician Decision|1|||
149798584|NCT00598442|540389304|FG002|Overall Study|Physician Decision|1|||
149798585|NCT00598442|540389302|FG000|Overall Study|Withdrawal by Subject|8|||
149798586|NCT00598442|540389303|FG001|Overall Study|Withdrawal by Subject|16|||
149798587|NCT00598442|540389304|FG002|Overall Study|Withdrawal by Subject|6|||
149798588|NCT00598442|540389302|FG000|Overall Study|Noncompliance|0|||
149798589|NCT00598442|540389303|FG001|Overall Study|Noncompliance|2|||
149798590|NCT00598442|540389304|FG002|Overall Study|Noncompliance|1|||
149798591|NCT00598442|540389302|FG000|Overall Study|Relocation|1|||
149798592|NCT00598442|540389303|FG001|Overall Study|Relocation|4|||
149798593|NCT00598442|540389304|FG002|Overall Study|Relocation|0|||
149798594|NCT00598442|540389302|FG000|Overall Study|Renal transplant|0|||
149798595|NCT00598442|540389303|FG001|Overall Study|Renal transplant|0|||
149798596|NCT00598442|540389304|FG002|Overall Study|Renal transplant|1|||
149798597|NCT00598442|540389302|FG000|Overall Study|Site closed by sponsor|5|||
149798598|NCT00598442|540389303|FG001|Overall Study|Site closed by sponsor|2|||
149798599|NCT00598442|540389304|FG002|Overall Study|Site closed by sponsor|1|||
149798600|NCT00598442|540389302|FG000|Overall Study|Started dialysis|1|||
149798601|NCT00598442|540389303|FG001|Overall Study|Started dialysis|0|||
149798602|NCT00598442|540389304|FG002|Overall Study|Started dialysis|0|||
149798603|NCT03781167|540389308|FG000|Overall Study|Adverse Event|23|||
149798604|NCT03781167|540389309|FG001|Overall Study|Adverse Event|25|||
149798605|NCT03781167|540389308|FG000|Overall Study|Withdrew consent|16|||
149798606|NCT03781167|540389309|FG001|Overall Study|Withdrew consent|12|||
149798607|NCT03781167|540389308|FG000|Overall Study|Lost to Follow-up|0|||
149798608|NCT03781167|540389309|FG001|Overall Study|Lost to Follow-up|1|||
149798609|NCT03781167|540389308|FG000|Overall Study|Lack of Efficacy|4|||
149798610|NCT03781167|540389309|FG001|Overall Study|Lack of Efficacy|5|||
149798611|NCT03781167|540389308|FG000|Overall Study|Difficulty with drug delivery system|2|||
149798612|NCT03781167|540389309|FG001|Overall Study|Difficulty with drug delivery system|3|||
149798613|NCT03781167|540389308|FG000|Overall Study|Other, not specified|2|||
149798614|NCT03781167|540389309|FG001|Overall Study|Other, not specified|2|||
149798615|NCT00462501|540389310|FG000|Overall Study|Not treated|3|||
149798616|NCT00462501|540389310|FG000|Overall Study|Adverse Event|2|||
149798617|NCT00504595|540389312|FG000|Overall Study|Lack of Efficacy|1|||
149798618|NCT00504595|540389313|FG001|Overall Study|Lack of Efficacy|0|||
149798619|NCT00504595|540389314|FG002|Overall Study|Lack of Efficacy|0|||
149798620|NCT00504595|540389315|FG003|Overall Study|Lack of Efficacy|0|||
149798621|NCT00504595|540389312|FG000|Overall Study|Other|0|||
149798622|NCT00504595|540389313|FG001|Overall Study|Other|0|||
149798623|NCT00504595|540389314|FG002|Overall Study|Other|2|||
149798624|NCT00504595|540389315|FG003|Overall Study|Other|0|||
149798625|NCT05047601|540389318|FG000|Overall Study|Lost to Follow-up|9|||
149798626|NCT05047601|540389319|FG001|Overall Study|Lost to Follow-up|11|||
149798627|NCT05047601|540389320|FG002|Overall Study|Lost to Follow-up|7|||
149798628|NCT05047601|540389318|FG000|Overall Study|Withdrawal by Subject|25|||
149798629|NCT05047601|540389319|FG001|Overall Study|Withdrawal by Subject|36|||
149798630|NCT05047601|540389320|FG002|Overall Study|Withdrawal by Subject|23|||
149798631|NCT05047601|540389318|FG000|Overall Study|Other|10|||
149798632|NCT05047601|540389319|FG001|Overall Study|Other|6|||
149798633|NCT05047601|540389320|FG002|Overall Study|Other|5|||
149798634|NCT01521494|540389331|FG000|Overall Study|Adverse Event|1|||
149798635|NCT01521494|540389332|FG001|Overall Study|Adverse Event|2|||
149798636|NCT01521494|540389333|FG002|Overall Study|Adverse Event|9|||
149798637|NCT01521494|540389334|FG003|Overall Study|Adverse Event|6|||
149798638|NCT01521494|540389335|FG004|Overall Study|Adverse Event|2|||
149798639|NCT01521494|540389331|FG000|Overall Study|Lack of Efficacy|0|||
149798640|NCT01521494|540389332|FG001|Overall Study|Lack of Efficacy|0|||
149798641|NCT01521494|540389333|FG002|Overall Study|Lack of Efficacy|0|||
149798642|NCT01521494|540389334|FG003|Overall Study|Lack of Efficacy|0|||
149798643|NCT01521494|540389335|FG004|Overall Study|Lack of Efficacy|2|||
149798644|NCT01521494|540389331|FG000|Overall Study|Withdrawal by Subject|1|||
149798645|NCT01521494|540389332|FG001|Overall Study|Withdrawal by Subject|1|||
149798646|NCT01521494|540389333|FG002|Overall Study|Withdrawal by Subject|0|||
149798647|NCT01521494|540389334|FG003|Overall Study|Withdrawal by Subject|2|||
149798648|NCT01521494|540389335|FG004|Overall Study|Withdrawal by Subject|0|||
149798649|NCT01521494|540389331|FG000|Overall Study|Decrease in serum phosphate|0|||
149798650|NCT01521494|540389332|FG001|Overall Study|Decrease in serum phosphate|2|||
149798651|NCT01521494|540389333|FG002|Overall Study|Decrease in serum phosphate|3|||
149798652|NCT01521494|540389334|FG003|Overall Study|Decrease in serum phosphate|12|||
149798653|NCT01521494|540389335|FG004|Overall Study|Decrease in serum phosphate|0|||
149798654|NCT01521494|540389331|FG000|Overall Study|Decrease in serum calcium|0|||
149798655|NCT01521494|540389332|FG001|Overall Study|Decrease in serum calcium|0|||
149798656|NCT01521494|540389333|FG002|Overall Study|Decrease in serum calcium|0|||
149798657|NCT01521494|540389334|FG003|Overall Study|Decrease in serum calcium|1|||
149798658|NCT01521494|540389335|FG004|Overall Study|Decrease in serum calcium|1|||
149798659|NCT01521494|540389331|FG000|Overall Study|Physician Decision|0|||
149798660|NCT01521494|540389332|FG001|Overall Study|Physician Decision|0|||
149798661|NCT01521494|540389333|FG002|Overall Study|Physician Decision|0|||
149798662|NCT01521494|540389334|FG003|Overall Study|Physician Decision|0|||
149798663|NCT01521494|540389335|FG004|Overall Study|Physician Decision|2|||
149798664|NCT00689728|540389336|FG000|Double-Blind Treatment|Adverse Event|1|||
149798665|NCT00689728|540389337|FG001|Double-Blind Treatment|Adverse Event|0|||
149798666|NCT00689728|540389338|FG002|Double-Blind Treatment|Adverse Event|0|||
149798667|NCT00689728|540389336|FG000|Double-Blind Treatment|Protocol Violation|0|||
149798668|NCT00689728|540389337|FG001|Double-Blind Treatment|Protocol Violation|0|||
149798669|NCT00689728|540389338|FG002|Double-Blind Treatment|Protocol Violation|1|||
149798670|NCT00689728|540389336|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
149798671|NCT00689728|540389337|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
149798672|NCT00689728|540389338|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
149798673|NCT00689728|540389336|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
149798674|NCT00689728|540389337|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
149798675|NCT00689728|540389338|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
149798676|NCT00689728|540389336|FG000|Rescue|Adverse Event|0|||
149798677|NCT00689728|540389337|FG001|Rescue|Adverse Event|1|||
149798678|NCT00689728|540389338|FG002|Rescue|Adverse Event|0|||
149798679|NCT00689728|540389336|FG000|Rescue|Withdrawal by Subject|1|||
149798680|NCT00689728|540389337|FG001|Rescue|Withdrawal by Subject|1|||
149798681|NCT00689728|540389338|FG002|Rescue|Withdrawal by Subject|1|||
149798682|NCT00689728|540389336|FG000|Optional Follow-Up|Adverse Event|1|||
149798683|NCT00689728|540389337|FG001|Optional Follow-Up|Adverse Event|0|||
149798684|NCT00689728|540389338|FG002|Optional Follow-Up|Adverse Event|0|||
149798685|NCT00689728|540389336|FG000|Optional Follow-Up|Lack of Efficacy|0|||
149798686|NCT00689728|540389337|FG001|Optional Follow-Up|Lack of Efficacy|1|||
149798687|NCT00689728|540389338|FG002|Optional Follow-Up|Lack of Efficacy|1|||
149798688|NCT00689728|540389336|FG000|Optional Follow-Up|Lost to Follow-up|0|||
149798689|NCT00689728|540389337|FG001|Optional Follow-Up|Lost to Follow-up|1|||
149798690|NCT00689728|540389338|FG002|Optional Follow-Up|Lost to Follow-up|1|||
149798691|NCT00689728|540389336|FG000|Optional Follow-Up|Protocol Violation|0|||
149798692|NCT00689728|540389337|FG001|Optional Follow-Up|Protocol Violation|0|||
149798693|NCT00689728|540389338|FG002|Optional Follow-Up|Protocol Violation|1|||
149798694|NCT00689728|540389336|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
149798695|NCT00689728|540389337|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
149798696|NCT00689728|540389338|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
149798697|NCT00689299|540389339|FG000|Overall Study|Adverse Event|2|||
149798698|NCT00689299|540389340|FG001|Overall Study|Adverse Event|1|||
149798699|NCT00689299|540389341|FG002|Overall Study|Adverse Event|1|||
149798700|NCT00689299|540389339|FG000|Overall Study|Lost to Follow-up|0|||
149798701|NCT00689299|540389340|FG001|Overall Study|Lost to Follow-up|1|||
149798702|NCT00689299|540389341|FG002|Overall Study|Lost to Follow-up|1|||
149798703|NCT00689299|540389339|FG000|Overall Study|Withdrawal by Subject|4|||
149798704|NCT00689299|540389340|FG001|Overall Study|Withdrawal by Subject|1|||
149798705|NCT00689299|540389341|FG002|Overall Study|Withdrawal by Subject|3|||
149798706|NCT00689299|540389339|FG000|Overall Study|Protocol Violation|1|||
149798707|NCT00689299|540389340|FG001|Overall Study|Protocol Violation|0|||
149798708|NCT00689299|540389341|FG002|Overall Study|Protocol Violation|0|||
149798709|NCT01190839|540389342|FG000|Overall Study|Adverse Event|32|||
149798710|NCT01190839|540389343|FG001|Overall Study|Adverse Event|41|||
149798711|NCT01190839|540389342|FG000|Overall Study|Protocol Violation|2|||
149798712|NCT01190839|540389343|FG001|Overall Study|Protocol Violation|2|||
149798713|NCT01190839|540389342|FG000|Overall Study|Lost to Follow-up|7|||
149798714|NCT01190839|540389343|FG001|Overall Study|Lost to Follow-up|1|||
149798715|NCT01190839|540389342|FG000|Overall Study|Death|1|||
149798716|NCT01190839|540389343|FG001|Overall Study|Death|0|||
149798717|NCT01190839|540389342|FG000|Overall Study|Trial stopped by Sponsor|71|||
149798718|NCT01190839|540389343|FG001|Overall Study|Trial stopped by Sponsor|68|||
149798719|NCT01190839|540389342|FG000|Overall Study|Undefined|35|||
149798720|NCT01190839|540389343|FG001|Overall Study|Undefined|31|||
149798721|NCT01190839|540389342|FG000|Overall Study|Randomized but not treated|2|||
149798722|NCT01190839|540389343|FG001|Overall Study|Randomized but not treated|4|||
149798723|NCT02058966|540389344|FG000|Open-Label Methamphetamine|Adverse Event|1|||
149798724|NCT02058966|540389344|FG000|First Intervention|Withdrawal by Subject|1|||
149798725|NCT00765726|540389345|FG000|Overall Study|Withdrawal by Subject|1|||
149798726|NCT00765726|540389345|FG000|Overall Study|Discontinuation of study by sponsor|8|||
149798727|NCT01265511|540389346|FG000|Overall Study|Lack of Efficacy|2|||
149798728|NCT01265511|540389347|FG001|Overall Study|Lack of Efficacy|1|||
149798729|NCT01265511|540389346|FG000|Overall Study|Met stopping rules|0|||
149798730|NCT01265511|540389347|FG001|Overall Study|Met stopping rules|2|||
149798731|NCT02993731|540389348|FG000|Overall Study|Study Termination|101|||
149798732|NCT02993731|540389349|FG001|Overall Study|Study Termination|105|||
149798733|NCT01362062|540389350|FG000|Overall Study|Adverse Event|1|||
149798734|NCT01362062|540389351|FG001|Overall Study|Adverse Event|0|||
149798735|NCT01362062|540389350|FG000|Overall Study|Lost to Follow-up|11|||
149798736|NCT01362062|540389351|FG001|Overall Study|Lost to Follow-up|0|||
149798737|NCT01362062|540389350|FG000|Overall Study|Withdrawal by Subject|2|||
149798738|NCT01362062|540389351|FG001|Overall Study|Withdrawal by Subject|0|||
149798739|NCT01362062|540389350|FG000|Overall Study|Non-compliant participant|2|||
149798740|NCT01362062|540389351|FG001|Overall Study|Non-compliant participant|0|||
149798741|NCT01362062|540389350|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
149798742|NCT01362062|540389351|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
149798743|NCT01362062|540389350|FG000|Overall Study|Had significant improvement|9|||
149798744|NCT01362062|540389351|FG001|Overall Study|Had significant improvement|0|||
149798745|NCT00758394|540389352|FG000|2nd Intervention Order|Lost to Follow-up|0|||
149798746|NCT00758394|540389353|FG001|2nd Intervention Order|Lost to Follow-up|1|||
149798747|NCT00758394|540389354|FG002|2nd Intervention Order|Lost to Follow-up|0|||
149798748|NCT00758394|540389355|FG003|2nd Intervention Order|Lost to Follow-up|0|||
149798749|NCT00758394|540389352|FG000|3rd Intervention|Lost to Follow-up|1|||
149798750|NCT00758394|540389353|FG001|3rd Intervention|Lost to Follow-up|0|||
149798751|NCT00758394|540389354|FG002|3rd Intervention|Lost to Follow-up|0|||
149798752|NCT00758394|540389355|FG003|3rd Intervention|Lost to Follow-up|1|||
149798753|NCT00508820|540389359|FG000|Overall Study|Adverse Event|6|||
149798754|NCT00508820|540389360|FG001|Overall Study|Adverse Event|10|||
149798755|NCT00508820|540389359|FG000|Overall Study|Death|6|||
149798756|NCT00508820|540389360|FG001|Overall Study|Death|8|||
149798757|NCT00508820|540389359|FG000|Overall Study|Lost to Follow-up|1|||
149798758|NCT00508820|540389360|FG001|Overall Study|Lost to Follow-up|1|||
149798759|NCT00508820|540389359|FG000|Overall Study|Physician Decision|8|||
149798760|NCT00508820|540389360|FG001|Overall Study|Physician Decision|2|||
149798761|NCT00508820|540389359|FG000|Overall Study|Pregnancy|0|||
149798762|NCT00508820|540389360|FG001|Overall Study|Pregnancy|2|||
149798763|NCT00508820|540389359|FG000|Overall Study|Protocol Violation|2|||
149798764|NCT00508820|540389360|FG001|Overall Study|Protocol Violation|0|||
149798765|NCT00508820|540389359|FG000|Overall Study|Withdrawal by Subject|10|||
149798766|NCT00508820|540389360|FG001|Overall Study|Withdrawal by Subject|12|||
149798767|NCT00508820|540389359|FG000|Overall Study|Other|11|||
149798768|NCT00508820|540389360|FG001|Overall Study|Other|2|||
149798769|NCT00508820|540389359|FG000|Overall Study|Noncompliance|1|||
149798770|NCT00508820|540389360|FG001|Overall Study|Noncompliance|0|||
149798771|NCT00508820|540389359|FG000|Overall Study|Requirement for alternative therapy|7|||
149798772|NCT00508820|540389360|FG001|Overall Study|Requirement for alternative therapy|15|||
149798773|NCT00508820|540389359|FG000|Overall Study|Protocol-specified Criteria|3|||
149798774|NCT00508820|540389360|FG001|Overall Study|Protocol-specified Criteria|12|||
149798775|NCT01945866|540390893|FG000|Overall Study|Eyes did not complete or were dropped|2|||
149798776|NCT01945866|540390894|FG001|Overall Study|Eyes did not complete or were dropped|0|||
149798777|NCT01674010|540390895|FG000|Open Treatment Phase 1|Adverse Event|10|||
149798778|NCT01674010|540390896|FG001|Open Treatment Phase 1|Adverse Event|0|||
149798779|NCT01674010|540390897|FG002|Open Treatment Phase 1|Adverse Event|0|||
149798780|NCT01674010|540390895|FG000|Open Treatment Phase 1|Death|1|||
149798781|NCT01674010|540390896|FG001|Open Treatment Phase 1|Death|0|||
149798782|NCT01674010|540390897|FG002|Open Treatment Phase 1|Death|0|||
149798783|NCT01674010|540390895|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
149798784|NCT01674010|540390896|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
149798785|NCT01674010|540390897|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
149798786|NCT01674010|540390895|FG000|Open Treatment Phase 1|Physician Decision|9|||
149798787|NCT01674010|540390896|FG001|Open Treatment Phase 1|Physician Decision|0|||
149798788|NCT01674010|540390897|FG002|Open Treatment Phase 1|Physician Decision|0|||
149798789|NCT01674010|540390895|FG000|Open Treatment Phase 1|Protocol Violation|7|||
149798790|NCT01674010|540390896|FG001|Open Treatment Phase 1|Protocol Violation|0|||
149798791|NCT01674010|540390897|FG002|Open Treatment Phase 1|Protocol Violation|0|||
149798792|NCT01674010|540390895|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
149798793|NCT01674010|540390896|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
149798794|NCT01674010|540390897|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
149798795|NCT01674010|540390895|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
149798796|NCT01674010|540390896|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
149798797|NCT01674010|540390897|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
149798798|NCT01674010|540390895|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
149798799|NCT01674010|540390896|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
149798800|NCT01674010|540390897|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
149798801|NCT01674010|540390895|FG000|Randomization Phase 2|Adverse Event|0|||
149798802|NCT01674010|540390896|FG001|Randomization Phase 2|Adverse Event|1|||
149798803|NCT01674010|540390897|FG002|Randomization Phase 2|Adverse Event|1|||
149798804|NCT01674010|540390895|FG000|Randomization Phase 2|Lost to Follow-up|0|||
149798805|NCT01674010|540390896|FG001|Randomization Phase 2|Lost to Follow-up|1|||
149798806|NCT01674010|540390897|FG002|Randomization Phase 2|Lost to Follow-up|2|||
149798807|NCT01674010|540390895|FG000|Randomization Phase 2|Mood episode recurrence|0|||
149798808|NCT01674010|540390896|FG001|Randomization Phase 2|Mood episode recurrence|8|||
149798809|NCT01674010|540390897|FG002|Randomization Phase 2|Mood episode recurrence|2|||
149798810|NCT01674010|540390895|FG000|Randomization Phase 2|Physician Decision|0|||
149798811|NCT01674010|540390896|FG001|Randomization Phase 2|Physician Decision|0|||
149798812|NCT01674010|540390897|FG002|Randomization Phase 2|Physician Decision|2|||
149798813|NCT01674010|540390895|FG000|Randomization Phase 2|Pregnancy|0|||
149798814|NCT01674010|540390896|FG001|Randomization Phase 2|Pregnancy|1|||
149798815|NCT01674010|540390897|FG002|Randomization Phase 2|Pregnancy|1|||
149798816|NCT01674010|540390895|FG000|Randomization Phase 2|Protocol Violation|0|||
149798817|NCT01674010|540390896|FG001|Randomization Phase 2|Protocol Violation|1|||
149798818|NCT01674010|540390897|FG002|Randomization Phase 2|Protocol Violation|1|||
149798819|NCT01674010|540390895|FG000|Randomization Phase 2|Sponsor Decision|0|||
149798820|NCT01674010|540390896|FG001|Randomization Phase 2|Sponsor Decision|42|||
149798821|NCT01674010|540390897|FG002|Randomization Phase 2|Sponsor Decision|45|||
149798822|NCT01674010|540390895|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
149798823|NCT01674010|540390896|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
149798824|NCT01674010|540390897|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
149798825|NCT03159455|540390898|FG000|Overall Study|Adverse Event|0|||
149798826|NCT03159455|540390899|FG001|Overall Study|Adverse Event|0|||
149798827|NCT03159455|540390900|FG002|Overall Study|Adverse Event|0|||
149798828|NCT03159455|540390901|FG003|Overall Study|Adverse Event|0|||
149798829|NCT03159455|540390902|FG004|Overall Study|Adverse Event|0|||
149798830|NCT03159455|540390903|FG005|Overall Study|Adverse Event|1|||
149798831|NCT02713490|540390904|FG000|Overall Study|Withdrawal by Subject|2|||
149798832|NCT02713490|540390905|FG001|Overall Study|Withdrawal by Subject|1|||
149798833|NCT02713490|540390904|FG000|Overall Study|Did not receive study drug|1|||
149798834|NCT02713490|540390905|FG001|Overall Study|Did not receive study drug|0|||
149798835|NCT02713490|540390904|FG000|Overall Study|Met exclusion criteria|0|||
149798836|NCT02713490|540390905|FG001|Overall Study|Met exclusion criteria|1|||
149798837|NCT00960869|540390907|FG000|Overall Study|Adverse Event|17|||
149798838|NCT00960869|540390908|FG001|Overall Study|Adverse Event|26|||
149798839|NCT00960869|540390907|FG000|Overall Study|Withdrawal by Subject|16|||
149798840|NCT00960869|540390908|FG001|Overall Study|Withdrawal by Subject|14|||
149798841|NCT00960869|540390907|FG000|Overall Study|Lost to Follow-up|1|||
149798842|NCT00960869|540390908|FG001|Overall Study|Lost to Follow-up|4|||
149798843|NCT00960869|540390907|FG000|Overall Study|Misc|19|||
149798844|NCT00960869|540390908|FG001|Overall Study|Misc|18|||
149798845|NCT01714726|540390909|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
149798846|NCT01714726|540390910|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
149798847|NCT01714726|540390911|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
149798848|NCT01714726|540390912|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
149798849|NCT01714726|540390909|FG000|Double-Blinded Induction Period|Adverse Event|0|||
149798850|NCT01714726|540390910|FG001|Double-Blinded Induction Period|Adverse Event|1|||
149798851|NCT01714726|540390911|FG002|Double-Blinded Induction Period|Adverse Event|0|||
149798852|NCT01714726|540390912|FG003|Double-Blinded Induction Period|Adverse Event|0|||
149798853|NCT01714726|540390909|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
149798854|NCT01714726|540390910|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
149798855|NCT01714726|540390911|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
149798856|NCT01714726|540390912|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
149798857|NCT01714726|540390909|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
149798858|NCT01714726|540390910|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
149798859|NCT01714726|540390911|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
149798860|NCT01714726|540390912|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
149798861|NCT01714726|540390909|FG000|Open-Label Period|Other|0|||
149798862|NCT01714726|540390910|FG001|Open-Label Period|Other|0|||
149798863|NCT01714726|540390911|FG002|Open-Label Period|Other|1|||
149798864|NCT01714726|540390912|FG003|Open-Label Period|Other|3|||
149798865|NCT01714726|540390909|FG000|Open-Label Period|Adverse Event|0|||
149798866|NCT01714726|540390910|FG001|Open-Label Period|Adverse Event|0|||
149798867|NCT01714726|540390911|FG002|Open-Label Period|Adverse Event|1|||
149798868|NCT01714726|540390912|FG003|Open-Label Period|Adverse Event|0|||
149798869|NCT01714726|540390909|FG000|Open-Label Period|Withdrawal by Subject|0|||
149798870|NCT01714726|540390910|FG001|Open-Label Period|Withdrawal by Subject|0|||
149798871|NCT01714726|540390911|FG002|Open-Label Period|Withdrawal by Subject|9|||
149798872|NCT01714726|540390912|FG003|Open-Label Period|Withdrawal by Subject|19|||
149798873|NCT01714726|540390909|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
149798874|NCT01714726|540390910|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
149798875|NCT01714726|540390911|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
149798876|NCT01714726|540390912|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
149798877|NCT01714726|540390909|FG000|Open-Label Period|Lost to Follow-up|0|||
149798878|NCT01714726|540390910|FG001|Open-Label Period|Lost to Follow-up|0|||
149798879|NCT01714726|540390911|FG002|Open-Label Period|Lost to Follow-up|3|||
149798880|NCT01714726|540390912|FG003|Open-Label Period|Lost to Follow-up|4|||
149798881|NCT01789476|540390915|FG000|Overall Study|Lack of Efficacy|6|||
149798882|NCT01789476|540390916|FG001|Overall Study|Lack of Efficacy|2|||
149798883|NCT01789476|540390915|FG000|Overall Study|Adverse Event|1|||
149798884|NCT01789476|540390916|FG001|Overall Study|Adverse Event|0|||
149798885|NCT01789476|540390915|FG000|Overall Study|Unable to get IV access|1|||
149798886|NCT01789476|540390916|FG001|Overall Study|Unable to get IV access|0|||
149798887|NCT00501969|540390917|FG000|Overall Study|Major Protocol Violation|4|||
149798888|NCT00501969|540390917|FG000|Overall Study|Lack of Efficacy|29|||
149798889|NCT00501969|540390917|FG000|Overall Study|Adverse Event|76|||
149798890|NCT00501969|540390917|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
149798891|NCT00501969|540390917|FG000|Overall Study|Subject withdrew consent|51|||
149798892|NCT00501969|540390917|FG000|Overall Study|Lost to Follow-up|4|||
149798893|NCT00501969|540390917|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
149798894|NCT00501969|540390917|FG000|Overall Study|Other: Sponsors Request|10|||
149798895|NCT00501969|540390917|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
149798896|NCT00501969|540390917|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
149798897|NCT00501969|540390917|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
149798898|NCT00501969|540390917|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
149798899|NCT00501969|540390917|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
149798900|NCT00501969|540390917|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
149798901|NCT00501969|540390917|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
149798902|NCT00501969|540390917|FG000|Overall Study|Other: As Required by Local EC|2|||
149798903|NCT00501969|540390917|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
149798904|NCT00501969|540390917|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
149798905|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
149798906|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
149798907|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798908|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798909|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798910|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798911|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798912|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798913|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798914|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798915|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798916|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149798917|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149798918|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798919|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798920|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798921|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798922|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798923|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149798924|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798925|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798926|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798927|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149798928|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149798929|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798930|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
149798931|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798932|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798933|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798934|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798935|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798936|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798937|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798938|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798939|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798940|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149798941|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
149798942|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
149798943|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
149798944|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
149798945|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
149798946|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
149798947|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
149798948|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
149798949|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
149798950|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
149798951|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
149798952|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
149798953|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798954|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798955|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798956|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798957|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798958|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
149798959|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798960|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798961|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798962|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798963|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798964|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149798965|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798966|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798967|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798968|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798969|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798970|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
149798971|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798972|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798973|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798974|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798975|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798976|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149798977|NCT00151775|540390924|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798978|NCT00151775|540390925|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798979|NCT00151775|540390926|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798980|NCT00151775|540390927|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798981|NCT00151775|540390928|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798982|NCT00151775|540390929|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798983|NCT00151775|540390930|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
149798984|NCT00151775|540390931|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798985|NCT00151775|540390932|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798986|NCT00151775|540390933|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798987|NCT00151775|540390934|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798988|NCT00151775|540390935|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149798989|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798990|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798991|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798992|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798993|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798994|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
149798995|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798996|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798997|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798998|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149798999|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149799000|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149799001|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
149799002|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
149799003|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
149799004|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
149799005|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
149799006|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
149799007|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
149799008|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
149799009|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
149799010|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
149799011|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
149799012|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
149799013|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799014|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799015|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799016|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799017|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799018|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799019|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
149799020|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799021|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799022|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799023|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799024|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149799025|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799026|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799027|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
149799028|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799029|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799030|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799031|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799032|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799033|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799034|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799035|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799036|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149799037|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799038|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799039|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
149799040|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799041|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799042|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799043|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799044|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799045|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799046|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799047|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799048|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149799049|NCT00151775|540390924|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799050|NCT00151775|540390925|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799051|NCT00151775|540390926|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799052|NCT00151775|540390927|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799053|NCT00151775|540390928|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799054|NCT00151775|540390929|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799055|NCT00151775|540390930|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799056|NCT00151775|540390931|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799057|NCT00151775|540390932|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799058|NCT00151775|540390933|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799059|NCT00151775|540390934|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149799060|NCT00151775|540390935|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
149799061|NCT00151775|540390924|FG000|Period 4: Open Label|Increased blood pressure|0|||
149799062|NCT00151775|540390925|FG001|Period 4: Open Label|Increased blood pressure|0|||
149799063|NCT00151775|540390926|FG002|Period 4: Open Label|Increased blood pressure|0|||
149799064|NCT00151775|540390927|FG003|Period 4: Open Label|Increased blood pressure|0|||
149799065|NCT00151775|540390928|FG004|Period 4: Open Label|Increased blood pressure|1|||
149799066|NCT00151775|540390929|FG005|Period 4: Open Label|Increased blood pressure|0|||
149799067|NCT00151775|540390930|FG006|Period 4: Open Label|Increased blood pressure|0|||
149799068|NCT00151775|540390931|FG007|Period 4: Open Label|Increased blood pressure|0|||
149799069|NCT00151775|540390932|FG008|Period 4: Open Label|Increased blood pressure|0|||
149799070|NCT00151775|540390933|FG009|Period 4: Open Label|Increased blood pressure|1|||
149799071|NCT00151775|540390934|FG010|Period 4: Open Label|Increased blood pressure|0|||
149799072|NCT00151775|540390935|FG011|Period 4: Open Label|Increased blood pressure|0|||
149799073|NCT00151775|540390924|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
149799074|NCT00151775|540390925|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
149799075|NCT00151775|540390926|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
149799076|NCT00151775|540390927|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
149799077|NCT00151775|540390928|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
149799078|NCT00151775|540390929|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
149799079|NCT00151775|540390930|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
149799080|NCT00151775|540390931|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
149799081|NCT00151775|540390932|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
149799082|NCT00151775|540390933|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
149799083|NCT00151775|540390934|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
149799084|NCT00151775|540390935|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
149799085|NCT00151775|540390924|FG000|Period 4: Open Label|Adverse Event|0|||
149799086|NCT00151775|540390925|FG001|Period 4: Open Label|Adverse Event|0|||
149799087|NCT00151775|540390926|FG002|Period 4: Open Label|Adverse Event|0|||
149799088|NCT00151775|540390927|FG003|Period 4: Open Label|Adverse Event|0|||
149799089|NCT00151775|540390928|FG004|Period 4: Open Label|Adverse Event|1|||
149799090|NCT00151775|540390929|FG005|Period 4: Open Label|Adverse Event|0|||
149799091|NCT00151775|540390930|FG006|Period 4: Open Label|Adverse Event|0|||
149799092|NCT00151775|540390931|FG007|Period 4: Open Label|Adverse Event|0|||
149799093|NCT00151775|540390932|FG008|Period 4: Open Label|Adverse Event|0|||
149799094|NCT00151775|540390933|FG009|Period 4: Open Label|Adverse Event|2|||
149799095|NCT00151775|540390934|FG010|Period 4: Open Label|Adverse Event|0|||
149799096|NCT00151775|540390935|FG011|Period 4: Open Label|Adverse Event|0|||
149799097|NCT00151775|540390924|FG000|Period 4: Open Label|Lost to Follow-up|0|||
149799098|NCT00151775|540390925|FG001|Period 4: Open Label|Lost to Follow-up|0|||
149799099|NCT00151775|540390926|FG002|Period 4: Open Label|Lost to Follow-up|0|||
149799100|NCT00151775|540390927|FG003|Period 4: Open Label|Lost to Follow-up|0|||
149799101|NCT00151775|540390928|FG004|Period 4: Open Label|Lost to Follow-up|17|||
149799102|NCT00151775|540390929|FG005|Period 4: Open Label|Lost to Follow-up|0|||
149799103|NCT00151775|540390930|FG006|Period 4: Open Label|Lost to Follow-up|0|||
149799104|NCT00151775|540390931|FG007|Period 4: Open Label|Lost to Follow-up|0|||
149799105|NCT00151775|540390932|FG008|Period 4: Open Label|Lost to Follow-up|0|||
149799106|NCT00151775|540390933|FG009|Period 4: Open Label|Lost to Follow-up|7|||
149799107|NCT00151775|540390934|FG010|Period 4: Open Label|Lost to Follow-up|0|||
149799108|NCT00151775|540390935|FG011|Period 4: Open Label|Lost to Follow-up|0|||
149799109|NCT00151775|540390924|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
149799110|NCT00151775|540390925|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
149799111|NCT00151775|540390926|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
149799112|NCT00151775|540390927|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
149799113|NCT00151775|540390928|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
149799114|NCT00151775|540390929|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
149799115|NCT00151775|540390930|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
149799116|NCT00151775|540390931|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
149799117|NCT00151775|540390932|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
149799118|NCT00151775|540390933|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
149799119|NCT00151775|540390934|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
149799120|NCT00151775|540390935|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
149799121|NCT00151775|540390924|FG000|Period 4: Open Label|Other|0|||
149799122|NCT00151775|540390925|FG001|Period 4: Open Label|Other|0|||
149799123|NCT00151775|540390926|FG002|Period 4: Open Label|Other|0|||
149799124|NCT00151775|540390927|FG003|Period 4: Open Label|Other|0|||
149799125|NCT00151775|540390928|FG004|Period 4: Open Label|Other|1|||
149799126|NCT00151775|540390929|FG005|Period 4: Open Label|Other|0|||
149799127|NCT00151775|540390930|FG006|Period 4: Open Label|Other|0|||
149799128|NCT00151775|540390931|FG007|Period 4: Open Label|Other|0|||
149799129|NCT00151775|540390932|FG008|Period 4: Open Label|Other|0|||
149799130|NCT00151775|540390933|FG009|Period 4: Open Label|Other|3|||
149799131|NCT00151775|540390934|FG010|Period 4: Open Label|Other|0|||
149799132|NCT00151775|540390935|FG011|Period 4: Open Label|Other|0|||
149799133|NCT00151775|540390924|FG000|Period 4: Open Label|Physician Decision|0|||
149799134|NCT00151775|540390925|FG001|Period 4: Open Label|Physician Decision|0|||
149799135|NCT00151775|540390926|FG002|Period 4: Open Label|Physician Decision|0|||
149799136|NCT00151775|540390927|FG003|Period 4: Open Label|Physician Decision|0|||
149799137|NCT00151775|540390928|FG004|Period 4: Open Label|Physician Decision|0|||
149799138|NCT00151775|540390929|FG005|Period 4: Open Label|Physician Decision|0|||
149799139|NCT00151775|540390930|FG006|Period 4: Open Label|Physician Decision|0|||
149799140|NCT00151775|540390931|FG007|Period 4: Open Label|Physician Decision|0|||
149799141|NCT00151775|540390932|FG008|Period 4: Open Label|Physician Decision|0|||
149799142|NCT00151775|540390933|FG009|Period 4: Open Label|Physician Decision|2|||
149799143|NCT00151775|540390934|FG010|Period 4: Open Label|Physician Decision|0|||
149799144|NCT00151775|540390935|FG011|Period 4: Open Label|Physician Decision|0|||
149799145|NCT00151775|540390924|FG000|Period 4: Open Label|Protocol Violation|0|||
149799146|NCT00151775|540390925|FG001|Period 4: Open Label|Protocol Violation|0|||
149799147|NCT00151775|540390926|FG002|Period 4: Open Label|Protocol Violation|0|||
149799148|NCT00151775|540390927|FG003|Period 4: Open Label|Protocol Violation|0|||
149799149|NCT00151775|540390928|FG004|Period 4: Open Label|Protocol Violation|1|||
149799150|NCT00151775|540390929|FG005|Period 4: Open Label|Protocol Violation|0|||
149799151|NCT00151775|540390930|FG006|Period 4: Open Label|Protocol Violation|0|||
149799152|NCT00151775|540390931|FG007|Period 4: Open Label|Protocol Violation|0|||
149799153|NCT00151775|540390932|FG008|Period 4: Open Label|Protocol Violation|0|||
149799154|NCT00151775|540390933|FG009|Period 4: Open Label|Protocol Violation|0|||
149799155|NCT00151775|540390934|FG010|Period 4: Open Label|Protocol Violation|0|||
149799156|NCT00151775|540390935|FG011|Period 4: Open Label|Protocol Violation|0|||
149799157|NCT01238861|540390936|FG000|Overall Study|Lost to Follow-up|4|||
149799158|NCT01238861|540390937|FG001|Overall Study|Lost to Follow-up|2|||
149799159|NCT01238861|540390938|FG002|Overall Study|Lost to Follow-up|3|||
149799160|NCT01238861|540390939|FG003|Overall Study|Lost to Follow-up|1|||
149799161|NCT01238861|540390940|FG004|Overall Study|Lost to Follow-up|1|||
149799162|NCT01238861|540390941|FG005|Overall Study|Lost to Follow-up|2|||
149799163|NCT01238861|540390936|FG000|Overall Study|Unplanned surgery|1|||
149799164|NCT01238861|540390937|FG001|Overall Study|Unplanned surgery|0|||
149799165|NCT01238861|540390938|FG002|Overall Study|Unplanned surgery|0|||
149799166|NCT01238861|540390939|FG003|Overall Study|Unplanned surgery|0|||
149799167|NCT01238861|540390940|FG004|Overall Study|Unplanned surgery|0|||
149799168|NCT01238861|540390941|FG005|Overall Study|Unplanned surgery|0|||
149799169|NCT01238861|540390936|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149799170|NCT01238861|540390937|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149799171|NCT01238861|540390938|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149799172|NCT01238861|540390939|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149799173|NCT01238861|540390940|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149799174|NCT01238861|540390941|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149799175|NCT01238861|540390936|FG000|Overall Study|Incorrect enrollment/randomization|0|||
149799176|NCT01238861|540390937|FG001|Overall Study|Incorrect enrollment/randomization|0|||
149799177|NCT01238861|540390938|FG002|Overall Study|Incorrect enrollment/randomization|1|||
149799178|NCT01238861|540390939|FG003|Overall Study|Incorrect enrollment/randomization|0|||
149799179|NCT01238861|540390940|FG004|Overall Study|Incorrect enrollment/randomization|1|||
149799180|NCT01238861|540390941|FG005|Overall Study|Incorrect enrollment/randomization|0|||
149799181|NCT01238861|540390936|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
149799182|NCT01238861|540390937|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
149799183|NCT01238861|540390938|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
149799184|NCT01238861|540390939|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
149799185|NCT01238861|540390940|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
149799186|NCT01238861|540390941|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
149799187|NCT01238861|540390936|FG000|Overall Study|Subject moved out of state/area|0|||
149799188|NCT01238861|540390937|FG001|Overall Study|Subject moved out of state/area|0|||
149799189|NCT01238861|540390938|FG002|Overall Study|Subject moved out of state/area|1|||
149799190|NCT01238861|540390939|FG003|Overall Study|Subject moved out of state/area|1|||
149799191|NCT01238861|540390940|FG004|Overall Study|Subject moved out of state/area|0|||
149799192|NCT01238861|540390941|FG005|Overall Study|Subject moved out of state/area|0|||
149799193|NCT01238861|540390936|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
149799194|NCT01238861|540390937|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
149799195|NCT01238861|540390938|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
149799196|NCT01238861|540390939|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
149799197|NCT01238861|540390940|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
149799198|NCT01238861|540390941|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
149799199|NCT01238861|540390936|FG000|Overall Study|Personal problems|0|||
149799200|NCT01238861|540390937|FG001|Overall Study|Personal problems|0|||
149799201|NCT01238861|540390938|FG002|Overall Study|Personal problems|0|||
149799202|NCT01238861|540390939|FG003|Overall Study|Personal problems|1|||
149799203|NCT01238861|540390940|FG004|Overall Study|Personal problems|0|||
149799204|NCT01238861|540390941|FG005|Overall Study|Personal problems|0|||
149799205|NCT01238861|540390936|FG000|Overall Study|Unable to continue visits|0|||
149799206|NCT01238861|540390937|FG001|Overall Study|Unable to continue visits|0|||
149799207|NCT01238861|540390938|FG002|Overall Study|Unable to continue visits|0|||
149799208|NCT01238861|540390939|FG003|Overall Study|Unable to continue visits|1|||
149799209|NCT01238861|540390940|FG004|Overall Study|Unable to continue visits|0|||
149799210|NCT01238861|540390941|FG005|Overall Study|Unable to continue visits|1|||
149799211|NCT01238861|540390936|FG000|Overall Study|Serious adverse event|0|||
149799212|NCT01238861|540390937|FG001|Overall Study|Serious adverse event|0|||
149799213|NCT01238861|540390938|FG002|Overall Study|Serious adverse event|0|||
149799214|NCT01238861|540390939|FG003|Overall Study|Serious adverse event|0|||
149799215|NCT01238861|540390940|FG004|Overall Study|Serious adverse event|0|||
149799216|NCT01238861|540390941|FG005|Overall Study|Serious adverse event|1|||
149799217|NCT01238861|540390936|FG000|Overall Study|Lack of compliance|0|||
149799218|NCT01238861|540390937|FG001|Overall Study|Lack of compliance|0|||
149799219|NCT01238861|540390938|FG002|Overall Study|Lack of compliance|0|||
149799220|NCT01238861|540390939|FG003|Overall Study|Lack of compliance|0|||
149799221|NCT01238861|540390940|FG004|Overall Study|Lack of compliance|0|||
149799222|NCT01238861|540390941|FG005|Overall Study|Lack of compliance|1|||
149799223|NCT01238861|540390936|FG000|Overall Study|Adverse Event|0|||
149799224|NCT01238861|540390937|FG001|Overall Study|Adverse Event|1|||
149799225|NCT01238861|540390938|FG002|Overall Study|Adverse Event|0|||
149799226|NCT01238861|540390939|FG003|Overall Study|Adverse Event|0|||
149799227|NCT01238861|540390940|FG004|Overall Study|Adverse Event|0|||
149799228|NCT01238861|540390941|FG005|Overall Study|Adverse Event|0|||
149799229|NCT01238861|540390936|FG000|Overall Study|Withdrawal by Subject|6|||
149799230|NCT01238861|540390937|FG001|Overall Study|Withdrawal by Subject|5|||
149799231|NCT01238861|540390938|FG002|Overall Study|Withdrawal by Subject|4|||
149799232|NCT01238861|540390939|FG003|Overall Study|Withdrawal by Subject|8|||
149799233|NCT01238861|540390940|FG004|Overall Study|Withdrawal by Subject|10|||
149799234|NCT01238861|540390941|FG005|Overall Study|Withdrawal by Subject|9|||
149799235|NCT00761761|540390944|FG000|Overall Study|Lost to Follow-up|3|||
149799236|NCT00761761|540390945|FG001|Overall Study|Lost to Follow-up|1|||
149799237|NCT00761761|540390944|FG000|Overall Study|Withdrawal by Subject|3|||
149799238|NCT00761761|540390945|FG001|Overall Study|Withdrawal by Subject|0|||
149799239|NCT01097057|540390949|FG000|Overall Study|Physician Decision|3|||
149799240|NCT01270139|540390950|FG000|Overall Study|Adverse Event|8|||
149799241|NCT01270139|540390951|FG001|Overall Study|Adverse Event|17|||
149799242|NCT01270139|540390952|FG002|Overall Study|Adverse Event|18|||
149799243|NCT01270139|540390950|FG000|Overall Study|Lost to Follow-up|10|||
149799244|NCT01270139|540390951|FG001|Overall Study|Lost to Follow-up|9|||
149799245|NCT01270139|540390952|FG002|Overall Study|Lost to Follow-up|2|||
149799246|NCT03198559|540390955|FG000|Overall Study|Adverse Event|2|||
149799247|NCT00267202|540390967|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
149799248|NCT00267202|540390968|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
149799249|NCT00267202|540390967|FG000|Overall Study|Withdrawal by Subject|12|||
149799250|NCT00267202|540390968|FG001|Overall Study|Withdrawal by Subject|15|||
149799251|NCT00267202|540390967|FG000|Overall Study|Adverse Event|13|||
149799252|NCT00267202|540390968|FG001|Overall Study|Adverse Event|7|||
149799253|NCT00267202|540390967|FG000|Overall Study|Protocol Violation|2|||
149799254|NCT00267202|540390968|FG001|Overall Study|Protocol Violation|3|||
149799255|NCT00267202|540390967|FG000|Overall Study|Administrative problems|2|||
149799256|NCT00267202|540390968|FG001|Overall Study|Administrative problems|1|||
149799257|NCT00267202|540390967|FG000|Overall Study|Lost to Follow-up|3|||
149799258|NCT00267202|540390968|FG001|Overall Study|Lost to Follow-up|0|||
149799259|NCT00399542|540390969|FG000|Overall Study|Adverse Event|18|||
149799260|NCT00399542|540390970|FG001|Overall Study|Adverse Event|15|||
149799261|NCT00399542|540390969|FG000|Overall Study|Protocol Violation|13|||
149799262|NCT00399542|540390970|FG001|Overall Study|Protocol Violation|3|||
149799263|NCT00399542|540390969|FG000|Overall Study|Withdrawal by Subject|28|||
149799264|NCT00399542|540390970|FG001|Overall Study|Withdrawal by Subject|10|||
149799265|NCT00399542|540390969|FG000|Overall Study|Lack of Efficacy|18|||
149799266|NCT00399542|540390970|FG001|Overall Study|Lack of Efficacy|8|||
149799267|NCT00399542|540390969|FG000|Overall Study|Lost to Follow-up|6|||
149799268|NCT00399542|540390970|FG001|Overall Study|Lost to Follow-up|6|||
149799269|NCT00399542|540390969|FG000|Overall Study|Other|1|||
149799270|NCT00399542|540390970|FG001|Overall Study|Other|0|||
149799271|NCT00399542|540390969|FG000|Overall Study|Physician Decision|0|||
149799272|NCT00399542|540390970|FG001|Overall Study|Physician Decision|1|||
149799273|NCT00612456|540390971|FG000|Overall Study|Adverse Event|1|||
149799274|NCT00612456|540390972|FG001|Overall Study|Adverse Event|0|||
149799275|NCT00612456|540390973|FG002|Overall Study|Adverse Event|0|||
149799276|NCT00612456|540390971|FG000|Overall Study|Lack of Efficacy|1|||
149799277|NCT00612456|540390972|FG001|Overall Study|Lack of Efficacy|1|||
149799278|NCT00612456|540390973|FG002|Overall Study|Lack of Efficacy|0|||
149799279|NCT00612456|540390971|FG000|Overall Study|Withdrawal by Subject|0|||
149799280|NCT00612456|540390972|FG001|Overall Study|Withdrawal by Subject|1|||
149799281|NCT00612456|540390973|FG002|Overall Study|Withdrawal by Subject|0|||
149799282|NCT00808665|540390974|FG000|Overall Study|Withdrawal by Subject|1|||
149799283|NCT00808665|540390975|FG001|Overall Study|Withdrawal by Subject|0|||
149799284|NCT00808665|540390974|FG000|Overall Study|only required minimally invasive surgery|1|||
149799285|NCT00808665|540390975|FG001|Overall Study|only required minimally invasive surgery|0|||
149799286|NCT00808665|540390974|FG000|Overall Study|surgery cancelled|1|||
149799287|NCT00808665|540390975|FG001|Overall Study|surgery cancelled|0|||
149799288|NCT00808665|540390974|FG000|Overall Study|required an additional procedure|0|||
149799289|NCT00808665|540390975|FG001|Overall Study|required an additional procedure|1|||
149799290|NCT00808665|540390974|FG000|Overall Study|Physician Decision|3|||
149799291|NCT00808665|540390975|FG001|Overall Study|Physician Decision|1|||
149799292|NCT00808665|540390974|FG000|Overall Study|Medication stopped by resident|0|||
149799293|NCT00808665|540390975|FG001|Overall Study|Medication stopped by resident|1|||
149799294|NCT00334893|540390976|FG000|Overall Study|Not Treated|1|||
149799295|NCT00334893|540390977|FG001|Overall Study|Not Treated|0|||
149799296|NCT01552408|540390978|FG000|Overall Study|Lost to Follow-up|2|||
149799297|NCT01552408|540390979|FG001|Overall Study|Lost to Follow-up|0|||
149799298|NCT01552408|540390978|FG000|Overall Study|Relocation|0|||
149799299|NCT01552408|540390979|FG001|Overall Study|Relocation|1|||
149799300|NCT01552408|540390978|FG000|Overall Study|Withdrawal by Subject|2|||
149799301|NCT01552408|540390979|FG001|Overall Study|Withdrawal by Subject|1|||
149799302|NCT02260791|540390989|FG000|Overall Study|Lost to Follow-up|4|||
149799303|NCT02260791|540390990|FG001|Overall Study|Lost to Follow-up|4|||
149799304|NCT02260791|540390989|FG000|Overall Study|Lack of Efficacy|2|||
149799305|NCT02260791|540390990|FG001|Overall Study|Lack of Efficacy|1|||
149799306|NCT02260791|540390989|FG000|Overall Study|Adverse Event|13|||
149799307|NCT02260791|540390990|FG001|Overall Study|Adverse Event|9|||
149799308|NCT02260791|540390989|FG000|Overall Study|Death|1|||
149799309|NCT02260791|540390990|FG001|Overall Study|Death|0|||
149799310|NCT02260791|540390989|FG000|Overall Study|Withdrawal by Subject|11|||
149799311|NCT02260791|540390990|FG001|Overall Study|Withdrawal by Subject|16|||
149799312|NCT02260791|540390989|FG000|Overall Study|Screen failure|0|||
149799313|NCT02260791|540390990|FG001|Overall Study|Screen failure|1|||
149799314|NCT02260791|540390989|FG000|Overall Study|Protocol deviation|2|||
149799315|NCT02260791|540390990|FG001|Overall Study|Protocol deviation|3|||
149799316|NCT02924129|540390991|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
149799317|NCT02924129|540390992|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
149799318|NCT02924129|540390991|FG000|Overall Study|Withdrawal by Subject|2|||
149799319|NCT02924129|540390992|FG001|Overall Study|Withdrawal by Subject|2|||
149799320|NCT02924129|540390991|FG000|Overall Study|Physician Decision|1|||
149799321|NCT02924129|540390992|FG001|Overall Study|Physician Decision|0|||
149799322|NCT02924129|540390991|FG000|Overall Study|Missed Visit|0|||
149799323|NCT02924129|540390992|FG001|Overall Study|Missed Visit|1|||
149799324|NCT01348828|540390996|FG000|Overall Study|Death|20|||
149799325|NCT01348828|540390996|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
149799326|NCT01348828|540390996|FG000|Overall Study|Conversion|2|||
149799327|NCT01348828|540390996|FG000|Overall Study|missed visit|1|||
149799328|NCT04246996|540390997|FG000|Overall Study|Physician Decision|1|||
149799329|NCT04246996|540390998|FG001|Overall Study|Physician Decision|1|||
149799330|NCT04246996|540390997|FG000|Overall Study|Did not meet eligibility criteria|1|||
149799331|NCT04246996|540390998|FG001|Overall Study|Did not meet eligibility criteria|4|||
149799332|NCT02442284|540391001|FG000|Overall Study|Adverse Event|1|||
149799333|NCT02442284|540391001|FG000|Overall Study|Withdrew Consent|2|||
149799334|NCT02442284|540391001|FG000|Overall Study|Lost to Follow-up|3|||
149799335|NCT02442284|540391001|FG000|Overall Study|Other|1|||
149799336|NCT02815670|540391002|FG000|Overall Study|Prematurely discontinued of the trial|1|||
149799337|NCT03137173|540391003|FG000|Overall Study|Withdrawal by Subject|8|||
149799338|NCT03137173|540391004|FG001|Overall Study|Withdrawal by Subject|13|||
149799339|NCT03137173|540391003|FG000|Overall Study|Death|1|||
149799340|NCT03137173|540391004|FG001|Overall Study|Death|3|||
149799341|NCT03137173|540391003|FG000|Overall Study|Physician Decision|1|||
149799342|NCT03137173|540391004|FG001|Overall Study|Physician Decision|0|||
149799343|NCT03137173|540391003|FG000|Overall Study|Lost to Follow-up|13|||
149799344|NCT03137173|540391004|FG001|Overall Study|Lost to Follow-up|18|||
149799345|NCT03137173|540391003|FG000|Overall Study|Other reasons|3|||
149799346|NCT03137173|540391004|FG001|Overall Study|Other reasons|2|||
149799347|NCT00842829|540391005|FG000|Dose Titration Period|Adverse Event|11|||
149799348|NCT00842829|540391006|FG001|Dose Titration Period|Adverse Event|10|||
149799349|NCT00842829|540391007|FG002|Dose Titration Period|Adverse Event|0|||
149799350|NCT00842829|540391005|FG000|Dose Titration Period|Lack of Efficacy|4|||
149799351|NCT00842829|540391006|FG001|Dose Titration Period|Lack of Efficacy|1|||
149799352|NCT00842829|540391007|FG002|Dose Titration Period|Lack of Efficacy|0|||
149799353|NCT00842829|540391005|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
149799354|NCT00842829|540391006|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
149799355|NCT00842829|540391007|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
149799356|NCT00842829|540391005|FG000|Dose Titration Period|Withdrawal by Subject|2|||
149799357|NCT00842829|540391006|FG001|Dose Titration Period|Withdrawal by Subject|6|||
149799358|NCT00842829|540391007|FG002|Dose Titration Period|Withdrawal by Subject|0|||
149799359|NCT00842829|540391005|FG000|Dose Titration Period|Other|5|||
149799360|NCT00842829|540391006|FG001|Dose Titration Period|Other|4|||
149799361|NCT00842829|540391007|FG002|Dose Titration Period|Other|0|||
149799362|NCT00842829|540391005|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
149799363|NCT00842829|540391006|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
149799364|NCT00842829|540391007|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
149799365|NCT00842829|540391005|FG000|Dose Titration Period|Non-compliance to study drug|2|||
149799366|NCT00842829|540391006|FG001|Dose Titration Period|Non-compliance to study drug|1|||
149799367|NCT00842829|540391007|FG002|Dose Titration Period|Non-compliance to study drug|0|||
149799368|NCT00842829|540391005|FG000|Treatment Period|Adverse Event|0|||
149799369|NCT00842829|540391006|FG001|Treatment Period|Adverse Event|0|||
149799370|NCT00842829|540391007|FG002|Treatment Period|Adverse Event|15|||
149799371|NCT00842829|540391005|FG000|Treatment Period|Lack of Efficacy|0|||
149799372|NCT00842829|540391006|FG001|Treatment Period|Lack of Efficacy|0|||
149799373|NCT00842829|540391007|FG002|Treatment Period|Lack of Efficacy|6|||
149799374|NCT00842829|540391005|FG000|Treatment Period|Unstable persistent cancer pain|0|||
149799375|NCT00842829|540391006|FG001|Treatment Period|Unstable persistent cancer pain|0|||
149799376|NCT00842829|540391007|FG002|Treatment Period|Unstable persistent cancer pain|5|||
149799377|NCT00842829|540391005|FG000|Treatment Period|Withdrawal by Subject|0|||
149799378|NCT00842829|540391006|FG001|Treatment Period|Withdrawal by Subject|0|||
149799379|NCT00842829|540391007|FG002|Treatment Period|Withdrawal by Subject|11|||
149799380|NCT00842829|540391005|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
149799381|NCT00842829|540391006|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
149799382|NCT00842829|540391007|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
149799383|NCT00842829|540391005|FG000|Treatment Period|Protocol Violation|0|||
149799384|NCT00842829|540391006|FG001|Treatment Period|Protocol Violation|0|||
149799385|NCT00842829|540391007|FG002|Treatment Period|Protocol Violation|2|||
149799386|NCT00842829|540391005|FG000|Treatment Period|Other|0|||
149799387|NCT00842829|540391006|FG001|Treatment Period|Other|0|||
149799388|NCT00842829|540391007|FG002|Treatment Period|Other|18|||
149799389|NCT00842829|540391005|FG000|Treatment Period|Non-compliance to study procedures|0|||
149799390|NCT00842829|540391006|FG001|Treatment Period|Non-compliance to study procedures|0|||
149799391|NCT00842829|540391007|FG002|Treatment Period|Non-compliance to study procedures|4|||
149799392|NCT00842829|540391005|FG000|Treatment Period|Unclear completion status|0|||
149799393|NCT00842829|540391006|FG001|Treatment Period|Unclear completion status|0|||
149799394|NCT00842829|540391007|FG002|Treatment Period|Unclear completion status|1|||
149799395|NCT00842829|540391005|FG000|Continuation Period|Adverse Event|0|||
149799396|NCT00842829|540391006|FG001|Continuation Period|Adverse Event|0|||
149799397|NCT00842829|540391007|FG002|Continuation Period|Adverse Event|32|||
149799398|NCT00842829|540391005|FG000|Continuation Period|Lack of Efficacy|0|||
149799399|NCT00842829|540391006|FG001|Continuation Period|Lack of Efficacy|0|||
149799400|NCT00842829|540391007|FG002|Continuation Period|Lack of Efficacy|6|||
149799401|NCT00842829|540391005|FG000|Continuation Period|Unstable persistent cancer pain|0|||
149799402|NCT00842829|540391006|FG001|Continuation Period|Unstable persistent cancer pain|0|||
149799403|NCT00842829|540391007|FG002|Continuation Period|Unstable persistent cancer pain|3|||
149799404|NCT00842829|540391005|FG000|Continuation Period|Withdrawal by Subject|0|||
149799405|NCT00842829|540391006|FG001|Continuation Period|Withdrawal by Subject|0|||
149799406|NCT00842829|540391007|FG002|Continuation Period|Withdrawal by Subject|10|||
149799407|NCT00842829|540391005|FG000|Continuation Period|Other|0|||
149799408|NCT00842829|540391006|FG001|Continuation Period|Other|0|||
149799409|NCT00842829|540391007|FG002|Continuation Period|Other|7|||
149799410|NCT00842829|540391005|FG000|Continuation Period|Non-compliance to study procedures|0|||
149799411|NCT00842829|540391006|FG001|Continuation Period|Non-compliance to study procedures|0|||
149799412|NCT00842829|540391007|FG002|Continuation Period|Non-compliance to study procedures|2|||
149799413|NCT00842829|540391005|FG000|Continuation Period|Non-compliance to study drug|0|||
149799414|NCT00842829|540391006|FG001|Continuation Period|Non-compliance to study drug|0|||
149799415|NCT00842829|540391007|FG002|Continuation Period|Non-compliance to study drug|1|||
149799416|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Death|2|||
149799417|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Death|0|||
149799418|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Adverse Event|33|||
149799419|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Adverse Event|31|||
149799420|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
149799421|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
149799422|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
149799423|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
149799424|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
149799425|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
149799426|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Other|7|||
149799427|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Other|8|||
149799428|NCT00280059|540391010|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
149799429|NCT00280059|540391011|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
149799430|NCT00495794|540391012|FG000|Overall Study|Pharmacist did not activate patient|522|||
149799431|NCT00495794|540391013|FG001|Overall Study|Pharmacist did not activate patient|0|||
149799432|NCT02127931|540391014|FG000|Overall Study|Glitch in Game|1|||
149799433|NCT01130831|540391015|FG000|Overall Study|Withdrawal by Subject|7|||
149799434|NCT01130831|540391015|FG000|Overall Study|Death|4|||
149799435|NCT01130831|540391015|FG000|Overall Study|Information was missing|3|||
149799436|NCT00951912|540391016|FG000|Overall Study|Lack of Efficacy|1|||
149799437|NCT00951912|540391017|FG001|Overall Study|Lack of Efficacy|0|||
149799438|NCT00951912|540391018|FG002|Overall Study|Lack of Efficacy|0|||
149799439|NCT00951912|540391016|FG000|Overall Study|Adverse Event|0|||
149799440|NCT00951912|540391017|FG001|Overall Study|Adverse Event|1|||
149799441|NCT00951912|540391018|FG002|Overall Study|Adverse Event|1|||
149799442|NCT00951912|540391016|FG000|Overall Study|Lost to Follow-up|2|||
149799443|NCT00951912|540391017|FG001|Overall Study|Lost to Follow-up|2|||
149799444|NCT00951912|540391018|FG002|Overall Study|Lost to Follow-up|0|||
149799445|NCT00951912|540391016|FG000|Overall Study|Physician Decision|1|||
149799446|NCT00951912|540391017|FG001|Overall Study|Physician Decision|0|||
149799447|NCT00951912|540391018|FG002|Overall Study|Physician Decision|1|||
149799448|NCT00951912|540391016|FG000|Overall Study|Withdrawal by Subject|1|||
149799449|NCT00951912|540391017|FG001|Overall Study|Withdrawal by Subject|1|||
149799450|NCT00951912|540391018|FG002|Overall Study|Withdrawal by Subject|0|||
149799451|NCT00951912|540391016|FG000|Overall Study|Other:Depression|1|||
149799452|NCT00951912|540391017|FG001|Overall Study|Other:Depression|0|||
149799453|NCT00951912|540391018|FG002|Overall Study|Other:Depression|0|||
149799454|NCT00951912|540391016|FG000|Overall Study|Other: Colon cancer|1|||
149799455|NCT00951912|540391017|FG001|Overall Study|Other: Colon cancer|0|||
149799456|NCT00951912|540391018|FG002|Overall Study|Other: Colon cancer|0|||
149799457|NCT00951912|540391016|FG000|Overall Study|Other: Stroke|0|||
149799458|NCT00951912|540391017|FG001|Overall Study|Other: Stroke|1|||
149799459|NCT00951912|540391018|FG002|Overall Study|Other: Stroke|0|||
149799460|NCT02173158|540391020|FG000|Efficacy Phase|Adverse Event|1|||
149799461|NCT01377194|540391021|FG000|Overall Study|Adverse Event|3|||
149799462|NCT01377194|540391022|FG001|Overall Study|Adverse Event|12|||
149799463|NCT01377194|540391023|FG002|Overall Study|Adverse Event|19|||
149799464|NCT01377194|540391021|FG000|Overall Study|Lack of Efficacy|3|||
149799465|NCT01377194|540391022|FG001|Overall Study|Lack of Efficacy|3|||
149799466|NCT01377194|540391023|FG002|Overall Study|Lack of Efficacy|3|||
149799467|NCT01377194|540391021|FG000|Overall Study|Protocol Violation|4|||
149799468|NCT01377194|540391022|FG001|Overall Study|Protocol Violation|10|||
149799469|NCT01377194|540391023|FG002|Overall Study|Protocol Violation|6|||
149799470|NCT01377194|540391021|FG000|Overall Study|Withdrawal by Subject|8|||
149799471|NCT01377194|540391022|FG001|Overall Study|Withdrawal by Subject|10|||
149799472|NCT01377194|540391023|FG002|Overall Study|Withdrawal by Subject|7|||
149799473|NCT01377194|540391021|FG000|Overall Study|Lost to Follow-up|14|||
149799474|NCT01377194|540391022|FG001|Overall Study|Lost to Follow-up|8|||
149799475|NCT01377194|540391023|FG002|Overall Study|Lost to Follow-up|11|||
149799476|NCT01728454|540391024|FG000|Stage 1 and 2|Pregnancy|1|||
149799477|NCT01728454|540391025|FG001|Stage 1 and 2|Pregnancy|0|||
149799478|NCT01728454|540391026|FG002|Stage 1 and 2|Pregnancy|0|||
149799479|NCT01728454|540391024|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
149799480|NCT01728454|540391025|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
149799481|NCT01728454|540391026|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
149799482|NCT01728454|540391024|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
149799483|NCT01728454|540391025|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
149799484|NCT01728454|540391026|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
149799485|NCT01728454|540391024|FG000|Stage 1 and 2|Lost to Follow-up|1|||
149799486|NCT01728454|540391025|FG001|Stage 1 and 2|Lost to Follow-up|1|||
149799487|NCT01728454|540391026|FG002|Stage 1 and 2|Lost to Follow-up|0|||
149799488|NCT01728454|540391024|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
149799489|NCT01728454|540391025|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
149799490|NCT01728454|540391026|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
149799491|NCT01728454|540391024|FG000|Stage 3|Reason Missing|0|||
149799492|NCT01728454|540391025|FG001|Stage 3|Reason Missing|0|||
149799493|NCT01728454|540391026|FG002|Stage 3|Reason Missing|1|||
149799494|NCT01728454|540391024|FG000|Stage 3|Subject Required Other Treatment|0|||
149799495|NCT01728454|540391025|FG001|Stage 3|Subject Required Other Treatment|1|||
149799496|NCT01728454|540391026|FG002|Stage 3|Subject Required Other Treatment|0|||
149799497|NCT01728454|540391024|FG000|Stage 3|Pregnancy|1|||
149799498|NCT01728454|540391025|FG001|Stage 3|Pregnancy|0|||
149799499|NCT01728454|540391026|FG002|Stage 3|Pregnancy|0|||
149799500|NCT01728454|540391024|FG000|Stage 3|Withdrew Consent|1|||
149799501|NCT01728454|540391025|FG001|Stage 3|Withdrew Consent|0|||
149799502|NCT01728454|540391026|FG002|Stage 3|Withdrew Consent|1|||
149799503|NCT01728454|540391024|FG000|Stage 3|Non-compliance with Protocol|0|||
149799504|NCT01728454|540391025|FG001|Stage 3|Non-compliance with Protocol|0|||
149799505|NCT01728454|540391026|FG002|Stage 3|Non-compliance with Protocol|1|||
149799506|NCT01728454|540391024|FG000|Stage 3|Lost to Follow-up|0|||
149799507|NCT01728454|540391025|FG001|Stage 3|Lost to Follow-up|3|||
149799508|NCT01728454|540391026|FG002|Stage 3|Lost to Follow-up|1|||
149799509|NCT01728454|540391024|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
149799510|NCT01728454|540391025|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
149799511|NCT01728454|540391026|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
149799512|NCT03077646|540391033|FG000|Overall Study|Lost to Follow-up|29|||
149799513|NCT03077646|540391034|FG001|Overall Study|Lost to Follow-up|30|||
149799514|NCT03077646|540391035|FG002|Overall Study|Lost to Follow-up|31|||
149799515|NCT00323479|540391036|FG000|Overall Study|Adverse Event|2|||
149799516|NCT00323479|540391036|FG000|Overall Study|Withdrawal by Subject|2|||
149799517|NCT00323479|540391036|FG000|Overall Study|Protocol Violation|3|||
149799518|NCT00323479|540391036|FG000|Overall Study|house moving|1|||
149799519|NCT02545504|540391041|FG000|Overall Study|Death|174|||
149799520|NCT02545504|540391042|FG001|Overall Study|Death|168|||
149799521|NCT02545504|540391041|FG000|Overall Study|Unknown reason|30|||
149799522|NCT02545504|540391042|FG001|Overall Study|Unknown reason|32|||
149799523|NCT02545504|540391041|FG000|Overall Study|Withdrew consent|9|||
149799524|NCT02545504|540391042|FG001|Overall Study|Withdrew consent|11|||
149799525|NCT02545504|540391041|FG000|Overall Study|Investigator's discretion|3|||
149799526|NCT02545504|540391042|FG001|Overall Study|Investigator's discretion|1|||
149799527|NCT02545504|540391041|FG000|Overall Study|Lost to Follow-up|2|||
149799528|NCT02545504|540391042|FG001|Overall Study|Lost to Follow-up|2|||
149799529|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
149799530|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
149799531|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
149799532|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149799533|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
149799534|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
149799535|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
149799536|NCT00950755|540391043|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
149799537|NCT00950755|540391043|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
149799538|NCT00950755|540391043|FG000|Long-Term Follow-Up|Death|8|||
149799539|NCT01018680|540393157|FG000|Overall Study|Adverse Event|23|||
149799540|NCT01018680|540393158|FG001|Overall Study|Adverse Event|40|||
149799541|NCT01018680|540393157|FG000|Overall Study|Withdrawal by Subject|10|||
149799542|NCT01018680|540393158|FG001|Overall Study|Withdrawal by Subject|10|||
149799543|NCT01018680|540393157|FG000|Overall Study|Protocol Violation|5|||
149799544|NCT01018680|540393158|FG001|Overall Study|Protocol Violation|8|||
149799545|NCT01018680|540393157|FG000|Overall Study|Sponsor Decision|6|||
149799546|NCT01018680|540393158|FG001|Overall Study|Sponsor Decision|7|||
149799547|NCT01018680|540393157|FG000|Overall Study|Lack of Efficacy|8|||
149799548|NCT01018680|540393158|FG001|Overall Study|Lack of Efficacy|2|||
149799549|NCT01018680|540393157|FG000|Overall Study|Lost to Follow-up|5|||
149799550|NCT01018680|540393158|FG001|Overall Study|Lost to Follow-up|3|||
149799551|NCT01018680|540393157|FG000|Overall Study|Entry Criteria Not Met|1|||
149799552|NCT01018680|540393158|FG001|Overall Study|Entry Criteria Not Met|4|||
149799553|NCT01018680|540393157|FG000|Overall Study|Physician Decision|3|||
149799554|NCT01018680|540393158|FG001|Overall Study|Physician Decision|1|||
149799555|NCT02930889|540393159|FG000|Overall Study|Lost to Follow-up|2|||
149799556|NCT02930889|540393159|FG000|Overall Study|Withdrawal by Subject|6|||
149799557|NCT02930889|540393159|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
149799558|NCT04398030|540393160|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
149799559|NCT04398030|540393161|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
149799560|NCT04398030|540393160|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
149799561|NCT04398030|540393161|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
149799562|NCT05056311|540393164|FG000|Overall Study|Lost to Follow-up|14|||
149799563|NCT05056311|540393164|FG000|Overall Study|Withdrawal by Subject|1|||
149799564|NCT05056311|540393164|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
149799565|NCT03799198|540393168|FG000|Overall Study|Lost to Follow-up|4|||
149799566|NCT03799198|540393169|FG001|Overall Study|Lost to Follow-up|8|||
149799567|NCT03799198|540393168|FG000|Overall Study|Death|0|||
149799568|NCT03799198|540393169|FG001|Overall Study|Death|1|||
149799569|NCT00548340|540393170|FG000|Overall Study|Protocol Violation|2|||
149799570|NCT00548340|540393171|FG001|Overall Study|Protocol Violation|3|||
149799571|NCT00548340|540393172|FG002|Overall Study|Protocol Violation|3|||
149799572|NCT00548340|540393170|FG000|Overall Study|Adverse Event|2|||
149799573|NCT00548340|540393171|FG001|Overall Study|Adverse Event|2|||
149799574|NCT00548340|540393172|FG002|Overall Study|Adverse Event|2|||
149799575|NCT00548340|540393170|FG000|Overall Study|Lost to Follow-up|1|||
149799576|NCT00548340|540393171|FG001|Overall Study|Lost to Follow-up|1|||
149799577|NCT00548340|540393172|FG002|Overall Study|Lost to Follow-up|0|||
149799578|NCT00548340|540393170|FG000|Overall Study|Withdrawal by Subject|2|||
149799579|NCT00548340|540393171|FG001|Overall Study|Withdrawal by Subject|4|||
149799580|NCT00548340|540393172|FG002|Overall Study|Withdrawal by Subject|3|||
149799581|NCT00548340|540393170|FG000|Overall Study|Other|1|||
149799582|NCT00548340|540393171|FG001|Overall Study|Other|1|||
149799583|NCT00548340|540393172|FG002|Overall Study|Other|1|||
149799584|NCT01153971|540393175|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
149799585|NCT01153971|540393175|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
149799586|NCT01153971|540393175|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
149799587|NCT01153971|540393175|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
149799588|NCT01153971|540393175|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
149799589|NCT01153971|540393175|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
149799590|NCT01153971|540393175|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
149799591|NCT03410693|540393176|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
149799592|NCT03410693|540393177|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
149799593|NCT03410693|540393176|FG000|Overall Study|Disc trt: Lost to follow up|0|||
149799594|NCT03410693|540393177|FG001|Overall Study|Disc trt: Lost to follow up|1|||
149799595|NCT03410693|540393176|FG000|Overall Study|Disc trt: radiological progression|58|||
149799596|NCT03410693|540393177|FG001|Overall Study|Disc trt: radiological progression|50|||
149799597|NCT03410693|540393176|FG000|Overall Study|Disc trt: Other|1|||
149799598|NCT03410693|540393177|FG001|Overall Study|Disc trt: Other|0|||
149799599|NCT03410693|540393176|FG000|Overall Study|Study drug never administered|1|||
149799600|NCT03410693|540393177|FG001|Overall Study|Study drug never administered|6|||
149799601|NCT03410693|540393176|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
149799602|NCT03410693|540393177|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
149799603|NCT03410693|540393176|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
149799604|NCT03410693|540393177|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
149799605|NCT03410693|540393176|FG000|Overall Study|Disc trt: Physician decision|0|||
149799606|NCT03410693|540393177|FG001|Overall Study|Disc trt: Physician decision|5|||
149799607|NCT03410693|540393176|FG000|Overall Study|Disc trt: clinical progression|1|||
149799608|NCT03410693|540393177|FG001|Overall Study|Disc trt: clinical progression|5|||
149799609|NCT03410693|540393176|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
149799610|NCT03410693|540393177|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
149799611|NCT03628781|540393178|FG000|Overall Study|Lost to Follow-up|16|||
149799612|NCT03628781|540393179|FG001|Overall Study|Lost to Follow-up|8|||
149799613|NCT03628781|540393178|FG000|Overall Study|Withdrawal by Subject|16|||
149799614|NCT03628781|540393179|FG001|Overall Study|Withdrawal by Subject|1|||
149799615|NCT03778021|540393183|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
149799616|NCT03778021|540393184|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
149799617|NCT02687815|540393185|FG000|Overall Study|Lost to Follow-up|2|||
149799618|NCT02687815|540393186|FG001|Overall Study|Lost to Follow-up|4|||
149799619|NCT02687815|540393185|FG000|Overall Study|Withdrawal by Subject|2|||
149799620|NCT02687815|540393186|FG001|Overall Study|Withdrawal by Subject|4|||
149799621|NCT03472586|540393191|FG000|Overall Study|Physician Decision|6|||
149799622|NCT03472586|540393191|FG000|Overall Study|Death|6|||
149799623|NCT03472586|540393191|FG000|Overall Study|Adverse Event|1|||
149799624|NCT02706327|540393192|FG000|Overall Study|Lost to Follow-up|1|||
149799625|NCT02706327|540393193|FG001|Overall Study|Lost to Follow-up|1|||
149799626|NCT02706327|540393194|FG002|Overall Study|Lost to Follow-up|2|||
149799627|NCT04963231|540393197|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
149799628|NCT04963231|540393198|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
149799629|NCT04963231|540393199|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
149799630|NCT04963231|540393197|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
149799631|NCT04963231|540393198|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
149799632|NCT04963231|540393199|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
149799633|NCT04963231|540393197|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
149799634|NCT04963231|540393198|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
149799635|NCT04963231|540393199|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
149799636|NCT04963231|540393197|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
149799637|NCT04963231|540393198|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
149799638|NCT04963231|540393199|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
149799639|NCT04963231|540393197|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
149799640|NCT04963231|540393198|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
149799641|NCT04963231|540393199|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
149799642|NCT04963231|540393197|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
149799643|NCT04963231|540393198|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
149799644|NCT04963231|540393199|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
149799645|NCT04963231|540393197|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
149799646|NCT04963231|540393198|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
149799647|NCT04963231|540393199|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
149799648|NCT03868410|540393202|FG000|Overall Study|Physician Decision|0|||
149799649|NCT03868410|540393203|FG001|Overall Study|Physician Decision|1|||
149799650|NCT01059175|540393204|FG000|Overall Study|Death|17|||
149799651|NCT01059175|540393205|FG001|Overall Study|Death|17|||
149799652|NCT01059175|540393204|FG000|Overall Study|Adverse Event|4|||
149799653|NCT01059175|540393205|FG001|Overall Study|Adverse Event|2|||
149799654|NCT01059175|540393204|FG000|Overall Study|Lost to Follow-up|0|||
149799655|NCT01059175|540393205|FG001|Overall Study|Lost to Follow-up|1|||
149799656|NCT02957149|540393206|FG000|Overall Study|Withdrawal by Subject|5|||
149799657|NCT06045026|540393207|FG000|Overall Study|Lost to Follow-up|60|||
149799658|NCT06045026|540393207|FG000|Overall Study|Adverse Event|12|||
149799659|NCT06045026|540393207|FG000|Overall Study|Withdrawal by Subject|3|||
149799660|NCT06045026|540393207|FG000|Overall Study|Enrollment closed|1|||
149799661|NCT01474291|540393217|FG000|Overall Study|Not Evaluable for Efficacy|26|||
149799662|NCT01474291|540393217|FG000|Overall Study|Lack of Treatment Efficacy|88|||
149799663|NCT01474291|540393217|FG000|Overall Study|Adverse Event|53|||
149799664|NCT01474291|540393217|FG000|Overall Study|Lost to Follow-up|29|||
149799665|NCT01474291|540393217|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
149799666|NCT01474291|540393217|FG000|Overall Study|No Reason Reported|10|||
149799667|NCT01474291|540393217|FG000|Overall Study|Death|2|||
149799668|NCT03471507|540393218|FG000|Overall Study|Lost to Follow-up|1|||
149799669|NCT03471507|540393219|FG001|Overall Study|Lost to Follow-up|3|||
149799670|NCT03471507|540393218|FG000|Overall Study|Physician Decision|0|||
149799671|NCT03471507|540393219|FG001|Overall Study|Physician Decision|1|||
149799672|NCT03471507|540393218|FG000|Overall Study|Withdrawal by Subject|2|||
149799673|NCT03471507|540393219|FG001|Overall Study|Withdrawal by Subject|1|||
149799674|NCT02213666|540393220|FG000|Overall Study|Withdrawal by Subject|1|||
149799675|NCT01319422|540393221|FG000|Overall Study|Withdrawal by Subject|1|||
149799676|NCT01319422|540393222|FG001|Overall Study|Withdrawal by Subject|0|||
149799677|NCT01399619|540393223|FG000|Overall Study|Adverse Event|10|||
149799678|NCT01399619|540393224|FG001|Overall Study|Adverse Event|0|||
149799679|NCT01399619|540393225|FG002|Overall Study|Adverse Event|4|||
149799680|NCT01399619|540393226|FG003|Overall Study|Adverse Event|10|||
149799681|NCT01399619|540393223|FG000|Overall Study|Lack of Efficacy|9|||
149799682|NCT01399619|540393224|FG001|Overall Study|Lack of Efficacy|0|||
149799683|NCT01399619|540393225|FG002|Overall Study|Lack of Efficacy|5|||
149799684|NCT01399619|540393226|FG003|Overall Study|Lack of Efficacy|0|||
149799685|NCT01399619|540393223|FG000|Overall Study|Withdrawal by Subject|6|||
149799686|NCT01399619|540393224|FG001|Overall Study|Withdrawal by Subject|0|||
149799687|NCT01399619|540393225|FG002|Overall Study|Withdrawal by Subject|3|||
149799688|NCT01399619|540393226|FG003|Overall Study|Withdrawal by Subject|4|||
149799689|NCT01399619|540393223|FG000|Overall Study|Protocol Violation|0|||
149799690|NCT01399619|540393224|FG001|Overall Study|Protocol Violation|0|||
149799691|NCT01399619|540393225|FG002|Overall Study|Protocol Violation|0|||
149799692|NCT01399619|540393226|FG003|Overall Study|Protocol Violation|1|||
149799693|NCT01399619|540393223|FG000|Overall Study|Not treated|0|||
149799694|NCT01399619|540393224|FG001|Overall Study|Not treated|0|||
149799695|NCT01399619|540393225|FG002|Overall Study|Not treated|0|||
149799696|NCT01399619|540393226|FG003|Overall Study|Not treated|2|||
149799697|NCT00750061|540393227|FG000|Overall Study|Adverse Event|2|||
149799698|NCT00750061|540393228|FG001|Overall Study|Adverse Event|0|||
149799699|NCT00750061|540393227|FG000|Overall Study|Withdrawal by Subject|0|||
149799700|NCT00750061|540393228|FG001|Overall Study|Withdrawal by Subject|1|||
149799701|NCT00750061|540393227|FG000|Overall Study|Physician Decision|0|||
149799702|NCT00750061|540393228|FG001|Overall Study|Physician Decision|1|||
149799703|NCT03417245|540393231|FG000|Overall Study|Adverse Event|1|||
149799704|NCT03417245|540393232|FG001|Overall Study|Adverse Event|0|||
149799705|NCT03417245|540393231|FG000|Overall Study|Protocol Violation|1|||
149799706|NCT03417245|540393232|FG001|Overall Study|Protocol Violation|0|||
149799707|NCT03417245|540393231|FG000|Overall Study|Withdrawal by Subject|1|||
149799708|NCT03417245|540393232|FG001|Overall Study|Withdrawal by Subject|1|||
149799709|NCT02708524|540393237|FG000|Overall Study|Adverse Event|0|||
149799710|NCT02708524|540393238|FG001|Overall Study|Adverse Event|1|||
149799711|NCT02708524|540393239|FG002|Overall Study|Adverse Event|0|||
149799712|NCT02708524|540393240|FG003|Overall Study|Adverse Event|0|||
149799713|NCT02708524|540393237|FG000|Overall Study|Lens Discomfort|1|||
149799714|NCT02708524|540393238|FG001|Overall Study|Lens Discomfort|0|||
149799715|NCT02708524|540393239|FG002|Overall Study|Lens Discomfort|1|||
149799716|NCT02708524|540393240|FG003|Overall Study|Lens Discomfort|0|||
149799717|NCT02708524|540393237|FG000|Overall Study|Lost to Follow-up|1|||
149799718|NCT02708524|540393238|FG001|Overall Study|Lost to Follow-up|1|||
149799719|NCT02708524|540393239|FG002|Overall Study|Lost to Follow-up|1|||
149799720|NCT02708524|540393240|FG003|Overall Study|Lost to Follow-up|0|||
149799721|NCT02708524|540393237|FG000|Overall Study|Protocol Violation|0|||
149799722|NCT02708524|540393238|FG001|Overall Study|Protocol Violation|1|||
149799723|NCT02708524|540393239|FG002|Overall Study|Protocol Violation|0|||
149799724|NCT02708524|540393240|FG003|Overall Study|Protocol Violation|0|||
149799725|NCT02708524|540393237|FG000|Overall Study|Withdrawal by Subject|1|||
149799726|NCT02708524|540393238|FG001|Overall Study|Withdrawal by Subject|1|||
149799727|NCT02708524|540393239|FG002|Overall Study|Withdrawal by Subject|0|||
149799728|NCT02708524|540393240|FG003|Overall Study|Withdrawal by Subject|0|||
149799729|NCT02708524|540393237|FG000|Overall Study|Dispensed incorrect study lens|0|||
149799730|NCT02708524|540393238|FG001|Overall Study|Dispensed incorrect study lens|1|||
149799731|NCT02708524|540393239|FG002|Overall Study|Dispensed incorrect study lens|1|||
149799732|NCT02708524|540393240|FG003|Overall Study|Dispensed incorrect study lens|0|||
149799733|NCT02708524|540393237|FG000|Overall Study|Did not wear lens at final visit|0|||
149799734|NCT02708524|540393238|FG001|Overall Study|Did not wear lens at final visit|1|||
149799735|NCT02708524|540393239|FG002|Overall Study|Did not wear lens at final visit|0|||
149799736|NCT02708524|540393240|FG003|Overall Study|Did not wear lens at final visit|0|||
149799737|NCT02708524|540393237|FG000|Overall Study|Subject lost study lens|1|||
149799738|NCT02708524|540393238|FG001|Overall Study|Subject lost study lens|0|||
149799739|NCT02708524|540393239|FG002|Overall Study|Subject lost study lens|0|||
149799740|NCT02708524|540393240|FG003|Overall Study|Subject lost study lens|0|||
149799741|NCT00679354|540393253|FG000|Overall Study|Death|3|||
149799742|NCT00679354|540393253|FG000|Overall Study|Lack of Efficacy|22|||
149799743|NCT00679354|540393253|FG000|Overall Study|Physician Decision|4|||
149799744|NCT00679354|540393253|FG000|Overall Study|Ineligible|1|||
149799745|NCT01590628|540393260|FG000|Overall Study|Death|2|||
149799746|NCT01590628|540393261|FG001|Overall Study|Death|0|||
149799747|NCT00229931|540393262|FG000|Overall Study|Death|1|||
149799748|NCT00229931|540393263|FG001|Overall Study|Death|0|||
149799749|NCT00229931|540393262|FG000|Overall Study|Lost to Follow-up|3|||
149799750|NCT00229931|540393263|FG001|Overall Study|Lost to Follow-up|2|||
149799751|NCT00475657|540393264|FG000|Overall Study|Death|1|||
149799752|NCT00475657|540393264|FG000|Overall Study|Sponsor's Decision|3|||
149799753|NCT02992743|540393265|FG000|Overall Study|Withdrawal by Subject|1|||
149799754|NCT02992743|540393266|FG001|Overall Study|Withdrawal by Subject|1|||
149799755|NCT02992743|540393265|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
149799756|NCT02992743|540393266|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
149799757|NCT02992743|540393265|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
149799758|NCT02992743|540393266|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
149799759|NCT02992743|540393265|FG000|Overall Study|No measurable disease|1|||
149799760|NCT02992743|540393266|FG001|Overall Study|No measurable disease|0|||
149799761|NCT02992743|540393265|FG000|Overall Study|Lost to Follow-up|0|||
149799762|NCT02992743|540393266|FG001|Overall Study|Lost to Follow-up|1|||
149799763|NCT00761735|540393267|FG000|Overall Study|Lost to Follow-up|6|||
149799764|NCT00761735|540393267|FG000|Overall Study|Withdrawal by Subject|6|||
149799765|NCT00761735|540393267|FG000|Overall Study|Non-compliance with protocol|1|||
149799766|NCT00761735|540393267|FG000|Overall Study|Administrative|1|||
149799767|NCT00998166|540393270|FG000|Overall Study|Early Study Termination|8|||
149799768|NCT00450814|540393271|FG000|Overall Study|Failed to complete the initial therapy|0|||
149799769|NCT00450814|540393272|FG001|Overall Study|Failed to complete the initial therapy|0|||
149799770|NCT00450814|540393273|FG002|Overall Study|Failed to complete the initial therapy|0|||
149799771|NCT00450814|540393274|FG003|Overall Study|Failed to complete the initial therapy|1|||
149799772|NCT00450814|540393275|FG004|Overall Study|Failed to complete the initial therapy|1|||
149799773|NCT00450814|540393276|FG005|Overall Study|Failed to complete the initial therapy|1|||
149799774|NCT00450814|540393277|FG006|Overall Study|Failed to complete the initial therapy|0|||
149799775|NCT00450814|540393278|FG007|Overall Study|Failed to complete the initial therapy|0|||
149799776|NCT00450814|540393279|FG008|Overall Study|Failed to complete the initial therapy|0|||
149799777|NCT00450814|540393280|FG009|Overall Study|Failed to complete the initial therapy|0|||
149799778|NCT00450814|540393281|FG010|Overall Study|Failed to complete the initial therapy|0|||
149799779|NCT00450814|540393271|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
149799780|NCT00450814|540393272|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
149799781|NCT00450814|540393273|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
149799782|NCT00450814|540393274|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
149799783|NCT00450814|540393275|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
149799784|NCT00450814|540393276|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
149799785|NCT00450814|540393277|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
149799786|NCT00450814|540393278|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
149799787|NCT00450814|540393279|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
149799788|NCT00450814|540393280|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
149799789|NCT00450814|540393281|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
149799790|NCT01757821|540393284|FG000|Overall Study|Adverse Event|1|||
149799791|NCT03831282|540393285|FG000|Overall Study|Could not place sensor|1|||
149799792|NCT01258803|540393286|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149799793|NCT01258803|540393287|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149799794|NCT01258803|540393288|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149799795|NCT01258803|540393289|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149799796|NCT01258803|540393290|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149799797|NCT01258803|540393291|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149799798|NCT01258803|540393286|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149799799|NCT01258803|540393287|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
149799800|NCT01258803|540393288|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149799801|NCT01258803|540393289|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149799802|NCT01258803|540393290|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149799803|NCT01258803|540393291|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149799804|NCT01258803|540393286|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149799805|NCT01258803|540393287|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149799806|NCT01258803|540393288|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
149799807|NCT01258803|540393289|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149799808|NCT01258803|540393290|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149799809|NCT01258803|540393291|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149799810|NCT00920582|540393292|FG000|Overall Study|Lost to Follow-up|5|||
149799811|NCT00920582|540393293|FG001|Overall Study|Lost to Follow-up|1|||
149799812|NCT00920582|540393294|FG002|Overall Study|Lost to Follow-up|2|||
149799813|NCT00920582|540393295|FG003|Overall Study|Lost to Follow-up|0|||
149799814|NCT00920582|540393292|FG000|Overall Study|Withdrawal by Subject|5|||
149799815|NCT00920582|540393293|FG001|Overall Study|Withdrawal by Subject|4|||
149799816|NCT00920582|540393294|FG002|Overall Study|Withdrawal by Subject|6|||
149799817|NCT00920582|540393295|FG003|Overall Study|Withdrawal by Subject|3|||
149799818|NCT00920582|540393292|FG000|Overall Study|Protocol Violation|1|||
149799819|NCT00920582|540393293|FG001|Overall Study|Protocol Violation|0|||
149799820|NCT00920582|540393294|FG002|Overall Study|Protocol Violation|0|||
149799821|NCT00920582|540393295|FG003|Overall Study|Protocol Violation|0|||
149799822|NCT00920582|540393292|FG000|Overall Study|Other|2|||
149799823|NCT00920582|540393293|FG001|Overall Study|Other|1|||
149799824|NCT00920582|540393294|FG002|Overall Study|Other|3|||
149799825|NCT00920582|540393295|FG003|Overall Study|Other|2|||
149799826|NCT05146999|540393306|FG000|Overall Study|Withdrew consent|6|||
149799827|NCT05146999|540393307|FG001|Overall Study|Withdrew consent|1|||
149799828|NCT05146999|540393306|FG000|Overall Study|Lost to Follow-up|3|||
149799829|NCT05146999|540393307|FG001|Overall Study|Lost to Follow-up|2|||
149799830|NCT05146999|540393306|FG000|Overall Study|Other|1|||
149799831|NCT05146999|540393307|FG001|Overall Study|Other|3|||
149799832|NCT03319160|540393308|FG000|Overall Study|Data not available.|7|||
149799833|NCT03604159|540393309|FG000|Overall Study|Lost to Follow-up|6|||
149799834|NCT03604159|540393310|FG001|Overall Study|Lost to Follow-up|7|||
149799835|NCT00851721|540393311|FG000|Overall Study|planned surgery|1|||
149799836|NCT00851721|540393312|FG001|Overall Study|planned surgery|0|||
149799837|NCT00851721|540393311|FG000|Overall Study|Death|1|||
149799838|NCT00851721|540393312|FG001|Overall Study|Death|0|||
149799839|NCT00851721|540393311|FG000|Overall Study|Adverse Event|0|||
149799840|NCT00851721|540393312|FG001|Overall Study|Adverse Event|1|||
149799841|NCT00665002|540393313|FG000|Overall Study|Progression/relapse during treatment|11|||
149799842|NCT00665002|540393313|FG000|Overall Study|Cytogenetic resistance|1|||
149799843|NCT04533204|540393314|FG000|Overall Study|Unable to understand training instructions|1|||
149799844|NCT04533204|540393315|FG001|Overall Study|Unable to understand training instructions|1|||
149799845|NCT00383292|540393316|FG000|Overall Study|Adverse Event|4|||
149799846|NCT00383292|540393317|FG001|Overall Study|Adverse Event|1|||
149799847|NCT00383292|540393318|FG002|Overall Study|Adverse Event|2|||
149799848|NCT00383292|540393316|FG000|Overall Study|Death|3|||
149799849|NCT00383292|540393317|FG001|Overall Study|Death|3|||
149799850|NCT00383292|540393318|FG002|Overall Study|Death|3|||
149799851|NCT00383292|540393316|FG000|Overall Study|Physician Decision|4|||
149799852|NCT00383292|540393317|FG001|Overall Study|Physician Decision|0|||
149799853|NCT00383292|540393318|FG002|Overall Study|Physician Decision|1|||
149799854|NCT00383292|540393316|FG000|Overall Study|Withdrawal by Subject|3|||
149799855|NCT00383292|540393317|FG001|Overall Study|Withdrawal by Subject|2|||
149799856|NCT00383292|540393318|FG002|Overall Study|Withdrawal by Subject|2|||
149799857|NCT00383292|540393316|FG000|Overall Study|Other|1|||
149799858|NCT00383292|540393317|FG001|Overall Study|Other|0|||
149799859|NCT00383292|540393318|FG002|Overall Study|Other|0|||
149799860|NCT00697255|540393319|FG000|Stage 1a|Insufficient ovarian response|1|||
149799861|NCT00697255|540393320|FG001|Stage 1a|Insufficient ovarian response|0|||
149799862|NCT00697255|540393319|FG000|Stage 1a|Multifollicular growth|1|||
149799863|NCT00697255|540393320|FG001|Stage 1a|Multifollicular growth|0|||
149799864|NCT00697255|540393319|FG000|Stage 1a|Not growing of dominant follicle|1|||
149799865|NCT00697255|540393320|FG001|Stage 1a|Not growing of dominant follicle|0|||
149799866|NCT00697255|540393319|FG000|Stage 1b|Not growing of dominant follicle|0|||
149799867|NCT00697255|540393320|FG001|Stage 1b|Not growing of dominant follicle|1|||
149799868|NCT00697255|540393319|FG000|Stage 1b|Insufficient ovarian response|0|||
149799869|NCT00697255|540393320|FG001|Stage 1b|Insufficient ovarian response|1|||
149799870|NCT01333501|540393328|FG000|Overall Study|Adverse Event|3|||
149799871|NCT01333501|540393329|FG001|Overall Study|Adverse Event|1|||
149799872|NCT01333501|540393328|FG000|Overall Study|Abnormal laboratory value|2|||
149799873|NCT01333501|540393329|FG001|Overall Study|Abnormal laboratory value|1|||
149799874|NCT01333501|540393328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149799875|NCT01333501|540393329|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
149799876|NCT01333501|540393328|FG000|Overall Study|Withdrawn consent|3|||
149799877|NCT01333501|540393329|FG001|Overall Study|Withdrawn consent|12|||
149799878|NCT02354599|540393332|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149799879|NCT02354599|540393333|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149799880|NCT02354599|540393334|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149799881|NCT02354599|540393335|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
149799882|NCT02354599|540393336|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
149799883|NCT02354599|540393337|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
149799884|NCT02354599|540393332|FG000|Overall Study|Withdrawal by Subject|1|||
149799885|NCT02354599|540393333|FG001|Overall Study|Withdrawal by Subject|1|||
149799886|NCT02354599|540393334|FG002|Overall Study|Withdrawal by Subject|0|||
149799887|NCT02354599|540393335|FG003|Overall Study|Withdrawal by Subject|0|||
149799888|NCT02354599|540393336|FG004|Overall Study|Withdrawal by Subject|0|||
149799889|NCT02354599|540393337|FG005|Overall Study|Withdrawal by Subject|0|||
149799890|NCT04806334|540393338|FG000|Overall Study|Withdrawal by Subject|1|||
149799891|NCT00660829|540393339|FG000|Overall Study|Adverse Event|3|||
149799892|NCT00660829|540393340|FG001|Overall Study|Adverse Event|4|||
149799893|NCT00660829|540393339|FG000|Overall Study|Lack of Efficacy|2|||
149799894|NCT00660829|540393340|FG001|Overall Study|Lack of Efficacy|3|||
149799895|NCT00660829|540393339|FG000|Overall Study|Non-Compliance|0|||
149799896|NCT00660829|540393340|FG001|Overall Study|Non-Compliance|4|||
149799897|NCT00660829|540393339|FG000|Overall Study|Withdrawal by Subject|1|||
149799898|NCT00660829|540393340|FG001|Overall Study|Withdrawal by Subject|2|||
149799899|NCT00660829|540393339|FG000|Overall Study|Lost to Follow-up|3|||
149799900|NCT00660829|540393340|FG001|Overall Study|Lost to Follow-up|2|||
149799901|NCT00660829|540393339|FG000|Overall Study|Other|9|||
149799902|NCT00660829|540393340|FG001|Overall Study|Other|4|||
149799903|NCT03590613|540393341|FG000|Period 2, 4 Days|Physician Decision|0|||
149799904|NCT03590613|540393342|FG001|Period 2, 4 Days|Physician Decision|0|||
149799905|NCT03590613|540393343|FG002|Period 2, 4 Days|Physician Decision|0|||
149799906|NCT03590613|540393344|FG003|Period 2, 4 Days|Physician Decision|1|||
149799907|NCT00967343|540393345|FG000|Overall Study|Study termination by sponsor|12|||
149799908|NCT00967343|540393345|FG000|Overall Study|Death|24|||
149799909|NCT00967343|540393345|FG000|Overall Study|Relapse|1|||
149799910|NCT00967343|540393345|FG000|Overall Study|Lost to Follow-up|1|||
149799911|NCT02501642|540394646|FG000|Overall Study|Lost to Follow-up|7|||
149799912|NCT02501642|540394647|FG001|Overall Study|Lost to Follow-up|11|||
149799913|NCT00934661|540394648|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
149799914|NCT00934661|540394649|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
149799915|NCT01846442|540394657|FG000|Overall Study|Adverse Event|2|||
149799916|NCT01846442|540394658|FG001|Overall Study|Adverse Event|4|||
149799917|NCT01846442|540394659|FG002|Overall Study|Adverse Event|2|||
149799918|NCT01846442|540394660|FG003|Overall Study|Adverse Event|1|||
149799919|NCT01846442|540394657|FG000|Overall Study|Lost to Follow-up|0|||
149799920|NCT01846442|540394658|FG001|Overall Study|Lost to Follow-up|0|||
149799921|NCT01846442|540394659|FG002|Overall Study|Lost to Follow-up|1|||
149799922|NCT01846442|540394660|FG003|Overall Study|Lost to Follow-up|0|||
149799923|NCT01846442|540394657|FG000|Overall Study|Withdrawal by Subject|3|||
149799924|NCT01846442|540394658|FG001|Overall Study|Withdrawal by Subject|2|||
149799925|NCT01846442|540394659|FG002|Overall Study|Withdrawal by Subject|0|||
149799926|NCT01846442|540394660|FG003|Overall Study|Withdrawal by Subject|1|||
149799927|NCT01846442|540394657|FG000|Overall Study|Left the city/Lost medication|1|||
149799928|NCT01846442|540394658|FG001|Overall Study|Left the city/Lost medication|0|||
149799929|NCT01846442|540394659|FG002|Overall Study|Left the city/Lost medication|1|||
149799930|NCT01846442|540394660|FG003|Overall Study|Left the city/Lost medication|1|||
149799931|NCT00679042|540394667|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
149799932|NCT00679042|540394667|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
149799933|NCT00679042|540394667|FG000|5-Year Follow Up|Death|1|||
149799934|NCT00679042|540394667|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
149799935|NCT00679042|540394667|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
149799936|NCT00379639|540394668|FG000|Overall Study|Disease Progression|3|||
149799937|NCT00379639|540394669|FG001|Overall Study|Disease Progression|3|||
149799938|NCT00379639|540394670|FG002|Overall Study|Disease Progression|3|||
149799939|NCT00379639|540394671|FG003|Overall Study|Disease Progression|4|||
149799940|NCT00379639|540394672|FG004|Overall Study|Disease Progression|4|||
149799941|NCT00379639|540394668|FG000|Overall Study|Physician Decision|0|||
149799942|NCT00379639|540394669|FG001|Overall Study|Physician Decision|2|||
149799943|NCT00379639|540394670|FG002|Overall Study|Physician Decision|1|||
149799944|NCT00379639|540394671|FG003|Overall Study|Physician Decision|1|||
149799945|NCT00379639|540394672|FG004|Overall Study|Physician Decision|0|||
149799946|NCT00379639|540394668|FG000|Overall Study|Symptomatic Deterioration|0|||
149799947|NCT00379639|540394669|FG001|Overall Study|Symptomatic Deterioration|0|||
149799948|NCT00379639|540394670|FG002|Overall Study|Symptomatic Deterioration|1|||
149799949|NCT00379639|540394671|FG003|Overall Study|Symptomatic Deterioration|0|||
149799950|NCT00379639|540394672|FG004|Overall Study|Symptomatic Deterioration|1|||
149799951|NCT00379639|540394668|FG000|Overall Study|Adverse Event|0|||
149799952|NCT00379639|540394669|FG001|Overall Study|Adverse Event|0|||
149799953|NCT00379639|540394670|FG002|Overall Study|Adverse Event|1|||
149799954|NCT00379639|540394671|FG003|Overall Study|Adverse Event|0|||
149799955|NCT00379639|540394672|FG004|Overall Study|Adverse Event|1|||
149799956|NCT00379639|540394668|FG000|Overall Study|Lost to Follow-up|0|||
149799957|NCT00379639|540394669|FG001|Overall Study|Lost to Follow-up|0|||
149799958|NCT00379639|540394670|FG002|Overall Study|Lost to Follow-up|0|||
149799959|NCT00379639|540394671|FG003|Overall Study|Lost to Follow-up|1|||
149799960|NCT00379639|540394672|FG004|Overall Study|Lost to Follow-up|0|||
149799961|NCT00379639|540394668|FG000|Overall Study|Other|0|||
149799962|NCT00379639|540394669|FG001|Overall Study|Other|0|||
149799963|NCT00379639|540394670|FG002|Overall Study|Other|3|||
149799964|NCT00379639|540394671|FG003|Overall Study|Other|0|||
149799965|NCT00379639|540394672|FG004|Overall Study|Other|0|||
149799966|NCT03053102|540394673|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
149799967|NCT03053102|540394673|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
149799968|NCT01798056|540394674|FG000|Overall Study|Serious Adverse Event|13|||
149799969|NCT01798056|540394675|FG001|Overall Study|Serious Adverse Event|12|||
149799970|NCT01798056|540394674|FG000|Overall Study|Withdrawal by Subject|12|||
149799971|NCT01798056|540394675|FG001|Overall Study|Withdrawal by Subject|9|||
149799972|NCT01798056|540394674|FG000|Overall Study|Migrated/moved from study area|1|||
149799973|NCT01798056|540394675|FG001|Overall Study|Migrated/moved from study area|1|||
149799974|NCT01798056|540394674|FG000|Overall Study|Lost to Follow-up|1|||
149799975|NCT01798056|540394675|FG001|Overall Study|Lost to Follow-up|1|||
149799976|NCT01798056|540394674|FG000|Overall Study|Other|0|||
149799977|NCT01798056|540394675|FG001|Overall Study|Other|2|||
149799978|NCT01269346|540394676|FG000|Treatment Phase|Disease progression|3|||
149799979|NCT01269346|540394676|FG000|Treatment Phase|Adverse Event|3|||
149799980|NCT01269346|540394676|FG000|Treatment Phase|Withdrawal by Subject|1|||
149799981|NCT01269346|540394676|FG000|Treatment Phase|Other|2|||
149799982|NCT01269346|540394676|FG000|Extension Phase|Adverse Event|6|||
149799983|NCT01269346|540394676|FG000|Extension Phase|Withdrawal by Subject|4|||
149799984|NCT01269346|540394676|FG000|Extension Phase|Disease progression|22|||
149799985|NCT01269346|540394676|FG000|Extension Phase|Physician decision or participant choice|9|||
149799986|NCT01269346|540394676|FG000|Extension Phase|Clinical progression|1|||
149799987|NCT01269346|540394676|FG000|Extension Phase|Started a prohibited con med|1|||
149799988|NCT00247416|540394677|FG000|Overall Study|3 patients were found to be ineligible|1|||
149799989|NCT00247416|540394678|FG001|Overall Study|3 patients were found to be ineligible|2|||
149799990|NCT00474994|540394679|FG000|Overall Study|Patient Not treated|1|||
149799991|NCT00474994|540394679|FG000|Overall Study|Patient evaluable for toxicity only|3|||
149799992|NCT00474994|540394679|FG000|Overall Study|Patient found to be ineligible|1|||
149799993|NCT02660489|540394680|FG000|Overall Study|Lost to Follow-up|1|||
149799994|NCT02660489|540394681|FG001|Overall Study|Lost to Follow-up|1|||
149799995|NCT02660489|540394680|FG000|Overall Study|Adverse Event|1|||
149799996|NCT02660489|540394681|FG001|Overall Study|Adverse Event|3|||
149799997|NCT02660489|540394680|FG000|Overall Study|no rhinovirus infection|4|||
149799998|NCT02660489|540394681|FG001|Overall Study|no rhinovirus infection|4|||
149799999|NCT05064436|540394684|FG000|Overall Study|Other Reasons|1|||
149800000|NCT05064436|540394685|FG001|Overall Study|Other Reasons|0|||
149800001|NCT01342445|540394686|FG000|Overall Study|Experienced side effects|0|||
149800002|NCT01342445|540394687|FG001|Overall Study|Experienced side effects|2|||
149800003|NCT02652793|540394688|FG000|Overall Study|Adverse Event|1|||
149800004|NCT02652793|540394688|FG000|Overall Study|Lost to Follow-up|2|||
149800005|NCT02652793|540394688|FG000|Overall Study|Withdrawal by Subject|1|||
149800006|NCT05450198|540394693|FG000|Overall Study|Withdrawal by Subject|1|||
149800007|NCT05450198|540394694|FG001|Overall Study|Withdrawal by Subject|1|||
149800008|NCT05450198|540394695|FG002|Overall Study|Withdrawal by Subject|2|||
149800009|NCT05450198|540394696|FG003|Overall Study|Withdrawal by Subject|0|||
149800010|NCT05450198|540394693|FG000|Overall Study|Lost to Follow-up|1|||
149800011|NCT05450198|540394694|FG001|Overall Study|Lost to Follow-up|0|||
149800012|NCT05450198|540394695|FG002|Overall Study|Lost to Follow-up|2|||
149800013|NCT05450198|540394696|FG003|Overall Study|Lost to Follow-up|1|||
149800014|NCT04511533|540394697|FG000|Treatment|Other|2|||
149800015|NCT04511533|540394697|FG000|Treatment|Withdrawal by Subject|11|||
149800016|NCT04511533|540394697|FG000|Treatment|Death|5|||
149800017|NCT04511533|540394697|FG000|Treatment|Physician Decision|1|||
149800018|NCT04511533|540394697|FG000|Treatment|Progressive Disease|61|||
149800019|NCT04511533|540394697|FG000|Follow-Up|Other|7|||
149800020|NCT04511533|540394697|FG000|Follow-Up|Withdrawal by Subject|5|||
149800021|NCT04511533|540394697|FG000|Follow-Up|Lost to Follow-up|2|||
149800022|NCT04511533|540394697|FG000|Follow-Up|Death|4|||
149800023|NCT01224171|540394698|FG000|Overall Study|Adverse Event|8|||
149800024|NCT01224171|540394699|FG001|Overall Study|Adverse Event|4|||
149800025|NCT01224171|540394698|FG000|Overall Study|Protocol Violation|0|||
149800026|NCT01224171|540394699|FG001|Overall Study|Protocol Violation|1|||
149800027|NCT01224171|540394698|FG000|Overall Study|Lack of Efficacy|5|||
149800028|NCT01224171|540394699|FG001|Overall Study|Lack of Efficacy|1|||
149800029|NCT01224171|540394698|FG000|Overall Study|Withdrawal of Consent|2|||
149800030|NCT01224171|540394699|FG001|Overall Study|Withdrawal of Consent|4|||
149800031|NCT01224171|540394698|FG000|Overall Study|Lost to Follow-up|0|||
149800032|NCT01224171|540394699|FG001|Overall Study|Lost to Follow-up|3|||
149800033|NCT01928758|540394700|FG000|Overall Study|Lost to Follow-up|14|||
149800034|NCT01928758|540394701|FG001|Overall Study|Lost to Follow-up|9|||
149800035|NCT01928758|540394700|FG000|Overall Study|Withdrawal by Subject|5|||
149800036|NCT01928758|540394701|FG001|Overall Study|Withdrawal by Subject|2|||
149800037|NCT01928758|540394700|FG000|Overall Study|Adverse Event|3|||
149800038|NCT01928758|540394701|FG001|Overall Study|Adverse Event|5|||
149800039|NCT01928758|540394700|FG000|Overall Study|Protocol Violation|3|||
149800040|NCT01928758|540394701|FG001|Overall Study|Protocol Violation|4|||
149800041|NCT02718131|540394702|FG000|Overall Study|Withdrawal by Subject|1|||
149800042|NCT02718131|540394703|FG001|Overall Study|Withdrawal by Subject|0|||
149800043|NCT02718131|540394702|FG000|Overall Study|Adverse Event|1|||
149800044|NCT02718131|540394703|FG001|Overall Study|Adverse Event|0|||
149800045|NCT02718131|540394702|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
149800046|NCT02718131|540394703|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
149800047|NCT01911546|540394706|FG000|Overall Study|Lost to Follow-up|1|||
149800048|NCT01911546|540394706|FG000|Overall Study|Everolimus was discontinued|5|||
149800049|NCT00381680|540394713|FG000|Overall Study|Adverse Event|9|||
149800050|NCT00381680|540394714|FG001|Overall Study|Adverse Event|3|||
149800051|NCT00381680|540394713|FG000|Overall Study|Death|10|||
149800052|NCT00381680|540394714|FG001|Overall Study|Death|7|||
149800053|NCT00381680|540394713|FG000|Overall Study|Lost to Follow-up|3|||
149800054|NCT00381680|540394714|FG001|Overall Study|Lost to Follow-up|2|||
149800055|NCT00381680|540394713|FG000|Overall Study|Physician Decision|25|||
149800056|NCT00381680|540394714|FG001|Overall Study|Physician Decision|6|||
149800057|NCT00381680|540394713|FG000|Overall Study|Withdrawal by Subject|3|||
149800058|NCT00381680|540394714|FG001|Overall Study|Withdrawal by Subject|1|||
149800059|NCT00381680|540394713|FG000|Overall Study|Entry onto another COG Trial|1|||
149800060|NCT00381680|540394714|FG001|Overall Study|Entry onto another COG Trial|2|||
149800061|NCT00381680|540394713|FG000|Overall Study|Alternative Therapy|11|||
149800062|NCT00381680|540394714|FG001|Overall Study|Alternative Therapy|5|||
149800063|NCT00381680|540394713|FG000|Overall Study|Secondary Malignancy|3|||
149800064|NCT00381680|540394714|FG001|Overall Study|Secondary Malignancy|0|||
149800065|NCT00381680|540394713|FG000|Overall Study|Delay initiation|1|||
149800066|NCT00381680|540394714|FG001|Overall Study|Delay initiation|0|||
149800067|NCT00381680|540394713|FG000|Overall Study|Stem Cell Transplant|26|||
149800068|NCT00381680|540394714|FG001|Overall Study|Stem Cell Transplant|10|||
149800069|NCT00381680|540394713|FG000|Overall Study|Relapse|18|||
149800070|NCT00381680|540394714|FG001|Overall Study|Relapse|9|||
149800071|NCT00381680|540394713|FG000|Overall Study|Induction Failure|4|||
149800072|NCT00381680|540394714|FG001|Overall Study|Induction Failure|1|||
149800073|NCT00381680|540394713|FG000|Overall Study|Progression|1|||
149800074|NCT00381680|540394714|FG001|Overall Study|Progression|1|||
149800075|NCT00381680|540394713|FG000|Overall Study|Other not otherwise specified|7|||
149800076|NCT00381680|540394714|FG001|Overall Study|Other not otherwise specified|2|||
149800077|NCT00381680|540394713|FG000|Overall Study|Ineligible|3|||
149800078|NCT00381680|540394714|FG001|Overall Study|Ineligible|1|||
149800079|NCT03290131|540394715|FG000|Overall Study|Adverse Event|22|||
149800080|NCT03290131|540394716|FG001|Overall Study|Adverse Event|57|||
149800081|NCT03290131|540394717|FG002|Overall Study|Adverse Event|11|||
149800082|NCT03290131|540394715|FG000|Overall Study|Withdrawal by Subject|18|||
149800083|NCT03290131|540394716|FG001|Overall Study|Withdrawal by Subject|13|||
149800084|NCT03290131|540394717|FG002|Overall Study|Withdrawal by Subject|8|||
149800085|NCT03290131|540394715|FG000|Overall Study|MS Relapse|2|||
149800086|NCT03290131|540394716|FG001|Overall Study|MS Relapse|1|||
149800087|NCT03290131|540394717|FG002|Overall Study|MS Relapse|0|||
149800088|NCT03290131|540394715|FG000|Overall Study|Unknown reason|0|||
149800089|NCT03290131|540394716|FG001|Overall Study|Unknown reason|1|||
149800090|NCT03290131|540394717|FG002|Overall Study|Unknown reason|0|||
149800091|NCT00361504|540394720|FG000|Overall Study|Withdrawal by Subject|94|||
149800092|NCT00361504|540394721|FG001|Overall Study|Withdrawal by Subject|31|||
149800093|NCT00361504|540394720|FG000|Overall Study|Lost to Follow-up|40|||
149800094|NCT00361504|540394721|FG001|Overall Study|Lost to Follow-up|7|||
149800095|NCT00361504|540394720|FG000|Overall Study|Adverse Event|203|||
149800096|NCT00361504|540394721|FG001|Overall Study|Adverse Event|82|||
149800097|NCT00361504|540394720|FG000|Overall Study|Lack of Efficacy|72|||
149800098|NCT00361504|540394721|FG001|Overall Study|Lack of Efficacy|7|||
149800099|NCT00361504|540394720|FG000|Overall Study|Resolution of Pain|2|||
149800100|NCT00361504|540394721|FG001|Overall Study|Resolution of Pain|0|||
149800101|NCT00361504|540394720|FG000|Overall Study|Study medication non compliant|42|||
149800102|NCT00361504|540394721|FG001|Overall Study|Study medication non compliant|15|||
149800103|NCT00361504|540394720|FG000|Overall Study|All other|28|||
149800104|NCT00361504|540394721|FG001|Overall Study|All other|3|||
149800105|NCT01374516|540394737|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
149800106|NCT01374516|540394738|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
149800107|NCT01374516|540394737|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
149800108|NCT01374516|540394738|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
149800109|NCT01374516|540394737|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
149800110|NCT01374516|540394738|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
149800111|NCT01374516|540394737|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
149800112|NCT01374516|540394738|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
149800113|NCT01374516|540394737|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
149800114|NCT01374516|540394738|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
149800115|NCT01374516|540394737|FG000|Surveillance Expansion Period|Protocol Violation|386|||
149800116|NCT01374516|540394738|FG001|Surveillance Expansion Period|Protocol Violation|217|||
149800117|NCT01374516|540394737|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
149800118|NCT01374516|540394738|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
149800119|NCT01374516|540394737|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
149800120|NCT01374516|540394738|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
149800121|NCT01374516|540394737|FG000|Surveillance Expansion Period|Serious adverse event|20|||
149800122|NCT01374516|540394738|FG001|Surveillance Expansion Period|Serious adverse event|5|||
149800123|NCT01012765|540394745|FG000|Treatment Period 1|Adverse Event|1|||
149800124|NCT01012765|540394746|FG001|Treatment Period 1|Adverse Event|0|||
149800125|NCT01012765|540394747|FG002|Treatment Period 1|Adverse Event|1|||
149800126|NCT01012765|540394748|FG003|Treatment Period 1|Adverse Event|0|||
149800127|NCT01012765|540394749|FG004|Treatment Period 1|Adverse Event|0|||
149800128|NCT01012765|540394750|FG005|Treatment Period 1|Adverse Event|0|||
149800129|NCT01012765|540394745|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149800130|NCT01012765|540394746|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149800131|NCT01012765|540394747|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149800132|NCT01012765|540394748|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149800133|NCT01012765|540394749|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149800134|NCT01012765|540394750|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149800135|NCT01012765|540394745|FG000|Treatment Period 1|Administrative problems|0|||
149800136|NCT01012765|540394746|FG001|Treatment Period 1|Administrative problems|0|||
149800137|NCT01012765|540394747|FG002|Treatment Period 1|Administrative problems|1|||
149800138|NCT01012765|540394748|FG003|Treatment Period 1|Administrative problems|1|||
149800139|NCT01012765|540394749|FG004|Treatment Period 1|Administrative problems|1|||
149800140|NCT01012765|540394750|FG005|Treatment Period 1|Administrative problems|0|||
149800141|NCT01012765|540394745|FG000|Treatment Period 1|Protocol Violation|0|||
149800142|NCT01012765|540394746|FG001|Treatment Period 1|Protocol Violation|0|||
149800143|NCT01012765|540394747|FG002|Treatment Period 1|Protocol Violation|0|||
149800144|NCT01012765|540394748|FG003|Treatment Period 1|Protocol Violation|2|||
149800145|NCT01012765|540394749|FG004|Treatment Period 1|Protocol Violation|1|||
149800146|NCT01012765|540394750|FG005|Treatment Period 1|Protocol Violation|0|||
149800147|NCT01012765|540394745|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149800148|NCT01012765|540394746|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149800149|NCT01012765|540394747|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149800150|NCT01012765|540394748|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149800151|NCT01012765|540394749|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
149800152|NCT01012765|540394750|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149800153|NCT01012765|540394745|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149800154|NCT01012765|540394746|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149800155|NCT01012765|540394747|FG002|Treatment Period 2|Withdrawal by Subject|1|||
149800156|NCT01012765|540394748|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149800157|NCT01012765|540394749|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149800158|NCT01012765|540394750|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149800159|NCT01012765|540394745|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
149800160|NCT01012765|540394746|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
149800161|NCT01012765|540394747|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
149800162|NCT01012765|540394748|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
149800163|NCT01012765|540394749|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
149800164|NCT01012765|540394750|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
149800165|NCT01012765|540394745|FG000|Treatment Period 2|Adverse Event|0|||
149800166|NCT01012765|540394746|FG001|Treatment Period 2|Adverse Event|1|||
149800167|NCT01012765|540394747|FG002|Treatment Period 2|Adverse Event|1|||
149800168|NCT01012765|540394748|FG003|Treatment Period 2|Adverse Event|0|||
149800169|NCT01012765|540394749|FG004|Treatment Period 2|Adverse Event|0|||
149800170|NCT01012765|540394750|FG005|Treatment Period 2|Adverse Event|0|||
149800171|NCT01012765|540394745|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149800172|NCT01012765|540394746|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
149800173|NCT01012765|540394747|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
149800174|NCT01012765|540394748|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149800175|NCT01012765|540394749|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149800176|NCT01012765|540394750|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149800177|NCT01326312|540394751|FG000|Overall Study|Adverse Event|11|||
149800178|NCT01326312|540394752|FG001|Overall Study|Adverse Event|11|||
149800179|NCT01326312|540394753|FG002|Overall Study|Adverse Event|1|||
149800180|NCT01326312|540394751|FG000|Overall Study|Withdrawal by Subject|1|||
149800181|NCT01326312|540394752|FG001|Overall Study|Withdrawal by Subject|2|||
149800182|NCT01326312|540394753|FG002|Overall Study|Withdrawal by Subject|1|||
149800183|NCT01326312|540394751|FG000|Overall Study|Protocol Violation|0|||
149800184|NCT01326312|540394752|FG001|Overall Study|Protocol Violation|1|||
149800185|NCT01326312|540394753|FG002|Overall Study|Protocol Violation|0|||
149800186|NCT01326312|540394751|FG000|Overall Study|Lack of Efficacy|13|||
149800187|NCT01326312|540394752|FG001|Overall Study|Lack of Efficacy|7|||
149800188|NCT01326312|540394753|FG002|Overall Study|Lack of Efficacy|1|||
149800189|NCT01326312|540394751|FG000|Overall Study|Death|1|||
149800190|NCT01326312|540394752|FG001|Overall Study|Death|0|||
149800191|NCT01326312|540394753|FG002|Overall Study|Death|1|||
149800192|NCT01326312|540394751|FG000|Overall Study|progressive disease|0|||
149800193|NCT01326312|540394752|FG001|Overall Study|progressive disease|1|||
149800194|NCT01326312|540394753|FG002|Overall Study|progressive disease|1|||
149800195|NCT01326312|540394751|FG000|Overall Study|Study terminated by Sponsor|8|||
149800196|NCT01326312|540394752|FG001|Overall Study|Study terminated by Sponsor|32|||
149800197|NCT01326312|540394753|FG002|Overall Study|Study terminated by Sponsor|46|||
149800198|NCT01326312|540394751|FG000|Overall Study|Treatment arm terminated|19|||
149800199|NCT01326312|540394752|FG001|Overall Study|Treatment arm terminated|0|||
149800200|NCT01326312|540394753|FG002|Overall Study|Treatment arm terminated|0|||
149800201|NCT01326312|540394751|FG000|Overall Study|QTc > 500|0|||
149800202|NCT01326312|540394752|FG001|Overall Study|QTc > 500|1|||
149800203|NCT01326312|540394753|FG002|Overall Study|QTc > 500|0|||
149800204|NCT00499694|540394760|FG000|Overall Study|Patient never received treatment.|1|||
149800205|NCT03556202|540394763|FG000|Extension Treatment Period|Adverse Event|18|||
149800206|NCT03556202|540394764|FG001|Extension Treatment Period|Adverse Event|14|||
149800207|NCT03556202|540394765|FG002|Extension Treatment Period|Adverse Event|9|||
149800208|NCT03556202|540394763|FG000|Extension Treatment Period|Death|2|||
149800209|NCT03556202|540394764|FG001|Extension Treatment Period|Death|6|||
149800210|NCT03556202|540394765|FG002|Extension Treatment Period|Death|0|||
149800211|NCT03556202|540394763|FG000|Extension Treatment Period|Lack of Efficacy|5|||
149800212|NCT03556202|540394764|FG001|Extension Treatment Period|Lack of Efficacy|12|||
149800213|NCT03556202|540394765|FG002|Extension Treatment Period|Lack of Efficacy|18|||
149800214|NCT03556202|540394763|FG000|Extension Treatment Period|Lost to Follow-up|9|||
149800215|NCT03556202|540394764|FG001|Extension Treatment Period|Lost to Follow-up|20|||
149800216|NCT03556202|540394765|FG002|Extension Treatment Period|Lost to Follow-up|2|||
149800217|NCT03556202|540394763|FG000|Extension Treatment Period|Pregnancy|2|||
149800218|NCT03556202|540394764|FG001|Extension Treatment Period|Pregnancy|4|||
149800219|NCT03556202|540394765|FG002|Extension Treatment Period|Pregnancy|3|||
149800220|NCT03556202|540394763|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
149800221|NCT03556202|540394764|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
149800222|NCT03556202|540394765|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
149800223|NCT03556202|540394763|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
149800224|NCT03556202|540394764|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
149800225|NCT03556202|540394765|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
149800226|NCT03556202|540394763|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
149800227|NCT03556202|540394764|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
149800228|NCT03556202|540394765|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
149800229|NCT03556202|540394763|FG000|Extension Treatment Period|Physician Decision|0|||
149800230|NCT03556202|540394764|FG001|Extension Treatment Period|Physician Decision|8|||
149800231|NCT03556202|540394765|FG002|Extension Treatment Period|Physician Decision|2|||
149800232|NCT03556202|540394763|FG000|Extension Treatment Period|Protocol Violation|0|||
149800233|NCT03556202|540394764|FG001|Extension Treatment Period|Protocol Violation|1|||
149800234|NCT03556202|540394765|FG002|Extension Treatment Period|Protocol Violation|1|||
149800235|NCT03556202|540394763|FG000|Extension Treatment Period|Sponsor Decision|0|||
149800236|NCT03556202|540394764|FG001|Extension Treatment Period|Sponsor Decision|1|||
149800237|NCT03556202|540394765|FG002|Extension Treatment Period|Sponsor Decision|0|||
149800238|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
149800239|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
149800240|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
149800241|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Death|1|||
149800242|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Death|0|||
149800243|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Death|0|||
149800244|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
149800245|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
149800246|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
149800247|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
149800248|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
149800249|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
149800250|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
149800251|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
149800252|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
149800253|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
149800254|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
149800255|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
149800256|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
149800257|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
149800258|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
149800259|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
149800260|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
149800261|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
149800262|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
149800263|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
149800264|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
149800265|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
149800266|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
149800267|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
149800268|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
149800269|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
149800270|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
149800271|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
149800272|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
149800273|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
149800274|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
149800275|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
149800276|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
149800277|NCT03556202|540394763|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
149800278|NCT03556202|540394764|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
149800279|NCT03556202|540394765|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
149800280|NCT04034225|540394768|FG000|Overall Study|Death|3|||
149800281|NCT04034225|540394768|FG000|Overall Study|Withdrawal by Subject|2|||
149800282|NCT04034225|540394768|FG000|Overall Study|Study termination by Sponsor|18|||
149800283|NCT04034225|540394768|FG000|Overall Study|Physician Decision|1|||
149800284|NCT04034225|540394768|FG000|Overall Study|Lack of Efficacy|1|||
149800285|NCT00736840|540394773|FG000|Overall Study|Lost to Follow-up|13|||
149800286|NCT01411917|540394774|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
149800287|NCT01411917|540394775|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
149800288|NCT01815099|540394778|FG000|Overall Study|Lack of Efficacy|1|||
149800289|NCT01815099|540394778|FG000|Overall Study|unable to attend study visits|1|||
149800290|NCT01475214|540394779|FG000|Overall Study|Lost to Follow-up|1|||
149800291|NCT01475214|540394780|FG001|Overall Study|Lost to Follow-up|0|||
149800292|NCT01475214|540394781|FG002|Overall Study|Lost to Follow-up|1|||
149800293|NCT01475214|540394779|FG000|Overall Study|Physician Decision|2|||
149800294|NCT01475214|540394780|FG001|Overall Study|Physician Decision|0|||
149800295|NCT01475214|540394781|FG002|Overall Study|Physician Decision|0|||
149800296|NCT01475214|540394779|FG000|Overall Study|Withdrawal by Subject|2|||
149800297|NCT01475214|540394780|FG001|Overall Study|Withdrawal by Subject|4|||
149800298|NCT01475214|540394781|FG002|Overall Study|Withdrawal by Subject|1|||
149800299|NCT00643851|540394782|FG000|Overall Study|Death|0|||
149800300|NCT00643851|540394783|FG001|Overall Study|Death|1|||
149800301|NCT00643851|540394784|FG002|Overall Study|Death|0|||
149800302|NCT00643851|540394782|FG000|Overall Study|Lack of Efficacy|0|||
149800303|NCT00643851|540394783|FG001|Overall Study|Lack of Efficacy|1|||
149800304|NCT00643851|540394784|FG002|Overall Study|Lack of Efficacy|0|||
149800305|NCT00643851|540394782|FG000|Overall Study|Adverse Event|2|||
149800306|NCT00643851|540394783|FG001|Overall Study|Adverse Event|6|||
149800307|NCT00643851|540394784|FG002|Overall Study|Adverse Event|6|||
149800308|NCT00643851|540394782|FG000|Overall Study|Lost to Follow-up|4|||
149800309|NCT00643851|540394783|FG001|Overall Study|Lost to Follow-up|6|||
149800310|NCT00643851|540394784|FG002|Overall Study|Lost to Follow-up|9|||
149800311|NCT00643851|540394782|FG000|Overall Study|Withdrawal by Subject|8|||
149800312|NCT00643851|540394783|FG001|Overall Study|Withdrawal by Subject|15|||
149800313|NCT00643851|540394784|FG002|Overall Study|Withdrawal by Subject|9|||
149800314|NCT00643851|540394782|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
149800315|NCT00643851|540394783|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
149800316|NCT00643851|540394784|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
149800317|NCT03289676|540394785|FG000|Overall Study|Withdrawal by Subject|2|||
149800318|NCT03289676|540394786|FG001|Overall Study|Withdrawal by Subject|0|||
149800319|NCT03289676|540394785|FG000|Overall Study|Protocol Violation|2|||
149800320|NCT03289676|540394786|FG001|Overall Study|Protocol Violation|0|||
149800321|NCT03289676|540394785|FG000|Overall Study|Lost to Follow-up|0|||
149800322|NCT03289676|540394786|FG001|Overall Study|Lost to Follow-up|1|||
149800323|NCT04369742|540394792|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
149800324|NCT04369742|540394793|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
149800325|NCT04369742|540394792|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
149800326|NCT04369742|540394793|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
149800327|NCT02451137|540394794|FG000|Overall Study|Randomized but not treated|19|||
149800328|NCT02451137|540394795|FG001|Overall Study|Randomized but not treated|27|||
149800329|NCT02451137|540394794|FG000|Overall Study|Adverse Event|43|||
149800330|NCT02451137|540394795|FG001|Overall Study|Adverse Event|42|||
149800331|NCT02451137|540394794|FG000|Overall Study|Lack of Efficacy|4|||
149800332|NCT02451137|540394795|FG001|Overall Study|Lack of Efficacy|9|||
149800333|NCT02451137|540394794|FG000|Overall Study|Participant decision:discontinue insulin|41|||
149800334|NCT02451137|540394795|FG001|Overall Study|Participant decision:discontinue insulin|43|||
149800335|NCT02451137|540394794|FG000|Overall Study|Hypoglycemia|2|||
149800336|NCT02451137|540394795|FG001|Overall Study|Hypoglycemia|1|||
149800337|NCT02451137|540394794|FG000|Overall Study|Investigator's decision|23|||
149800338|NCT02451137|540394795|FG001|Overall Study|Investigator's decision|19|||
149800339|NCT02451137|540394794|FG000|Overall Study|Lost to Follow-up|53|||
149800340|NCT02451137|540394795|FG001|Overall Study|Lost to Follow-up|61|||
149800341|NCT02451137|540394794|FG000|Overall Study|Physician Decision|6|||
149800342|NCT02451137|540394795|FG001|Overall Study|Physician Decision|5|||
149800343|NCT02451137|540394794|FG000|Overall Study|Sponsor decision|13|||
149800344|NCT02451137|540394795|FG001|Overall Study|Sponsor decision|25|||
149800345|NCT02451137|540394794|FG000|Overall Study|Withdrawal by Subject|40|||
149800346|NCT02451137|540394795|FG001|Overall Study|Withdrawal by Subject|63|||
149800347|NCT02451137|540394794|FG000|Overall Study|Other than specified above|2|||
149800348|NCT02451137|540394795|FG001|Overall Study|Other than specified above|3|||
149800349|NCT03044730|540394798|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
149800350|NCT03044730|540394798|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
149800351|NCT03044730|540394798|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
149800352|NCT03044730|540394798|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
149800353|NCT03044730|540394798|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
149800354|NCT03044730|540394798|FG000|Cycles 4 and Beyond|Adverse Event|1|||
149800355|NCT03044730|540394798|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
149800356|NCT03044730|540394798|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
149800357|NCT03044730|540394798|FG000|On Follow-up for 2 Years|Death|17|||
149800358|NCT02777554|540396781|FG000|Overall Study|Adverse Event|4|||
149800359|NCT02777554|540396782|FG001|Overall Study|Adverse Event|4|||
149800360|NCT02777554|540396783|FG002|Overall Study|Adverse Event|0|||
149800361|NCT02777554|540396784|FG003|Overall Study|Adverse Event|1|||
149800362|NCT02777554|540396785|FG004|Overall Study|Adverse Event|0|||
149800363|NCT02777554|540396786|FG005|Overall Study|Adverse Event|0|||
149800364|NCT02777554|540396781|FG000|Overall Study|Withdrawal by Subject|3|||
149800365|NCT02777554|540396782|FG001|Overall Study|Withdrawal by Subject|1|||
149800366|NCT02777554|540396783|FG002|Overall Study|Withdrawal by Subject|1|||
149800367|NCT02777554|540396784|FG003|Overall Study|Withdrawal by Subject|0|||
149800368|NCT02777554|540396785|FG004|Overall Study|Withdrawal by Subject|0|||
149800369|NCT02777554|540396786|FG005|Overall Study|Withdrawal by Subject|0|||
149800370|NCT02777554|540396781|FG000|Overall Study|Discharged early due to hurricane|22|||
149800371|NCT02777554|540396782|FG001|Overall Study|Discharged early due to hurricane|20|||
149800372|NCT02777554|540396783|FG002|Overall Study|Discharged early due to hurricane|0|||
149800373|NCT02777554|540396784|FG003|Overall Study|Discharged early due to hurricane|0|||
149800374|NCT02777554|540396785|FG004|Overall Study|Discharged early due to hurricane|0|||
149800375|NCT02777554|540396786|FG005|Overall Study|Discharged early due to hurricane|0|||
149800376|NCT02777554|540396781|FG000|Overall Study|Other - Miscellaneous|1|||
149800377|NCT02777554|540396782|FG001|Overall Study|Other - Miscellaneous|0|||
149800378|NCT02777554|540396783|FG002|Overall Study|Other - Miscellaneous|0|||
149800379|NCT02777554|540396784|FG003|Overall Study|Other - Miscellaneous|0|||
149800380|NCT02777554|540396785|FG004|Overall Study|Other - Miscellaneous|0|||
149800381|NCT02777554|540396786|FG005|Overall Study|Other - Miscellaneous|0|||
149800382|NCT00278473|540396795|FG000|Overall Study|drop out|4|||
149800383|NCT00278473|540396796|FG001|Overall Study|drop out|3|||
149800384|NCT04854421|540396797|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
149800385|NCT04854421|540396798|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
149800386|NCT02322866|540396800|FG000|Overall Study|Adverse Event|6|||
149800387|NCT02322866|540396801|FG001|Overall Study|Adverse Event|11|||
149800388|NCT02322866|540396800|FG000|Overall Study|Withdrawal of Consent|16|||
149800389|NCT02322866|540396801|FG001|Overall Study|Withdrawal of Consent|25|||
149800390|NCT02322866|540396800|FG000|Overall Study|Lost to Follow-up|36|||
149800391|NCT02322866|540396801|FG001|Overall Study|Lost to Follow-up|39|||
149800392|NCT02322866|540396800|FG000|Overall Study|Protocol Violation|1|||
149800393|NCT02322866|540396801|FG001|Overall Study|Protocol Violation|0|||
149800394|NCT02322866|540396800|FG000|Overall Study|Noncompliance with Treatment|3|||
149800395|NCT02322866|540396801|FG001|Overall Study|Noncompliance with Treatment|4|||
149800396|NCT02322866|540396800|FG000|Overall Study|Lack of Efficacy|3|||
149800397|NCT02322866|540396801|FG001|Overall Study|Lack of Efficacy|1|||
149800398|NCT02322866|540396800|FG000|Overall Study|Other Miscellaneous Reasons|6|||
149800399|NCT02322866|540396801|FG001|Overall Study|Other Miscellaneous Reasons|6|||
149800400|NCT00718809|540396802|FG000|Overall Study|Disease progression|9|||
149800401|NCT00718809|540396803|FG001|Overall Study|Disease progression|7|||
149800402|NCT00718809|540396802|FG000|Overall Study|Adverse Event|1|||
149800403|NCT00718809|540396803|FG001|Overall Study|Adverse Event|1|||
149800404|NCT00718809|540396802|FG000|Overall Study|Withdrawal by Subject|0|||
149800405|NCT00718809|540396803|FG001|Overall Study|Withdrawal by Subject|1|||
149800406|NCT00718809|540396802|FG000|Overall Study|Lost to Follow-up|1|||
149800407|NCT00718809|540396803|FG001|Overall Study|Lost to Follow-up|0|||
149800408|NCT00718809|540396802|FG000|Overall Study|Noncompliance|1|||
149800409|NCT00718809|540396803|FG001|Overall Study|Noncompliance|0|||
149800410|NCT00798161|540396804|FG000|Overall Study|Adverse Event|3|||
149800411|NCT00798161|540396805|FG001|Overall Study|Adverse Event|4|||
149800412|NCT00798161|540396806|FG002|Overall Study|Adverse Event|6|||
149800413|NCT00798161|540396807|FG003|Overall Study|Adverse Event|6|||
149800414|NCT00798161|540396808|FG004|Overall Study|Adverse Event|5|||
149800415|NCT00798161|540396809|FG005|Overall Study|Adverse Event|2|||
149800416|NCT00798161|540396810|FG006|Overall Study|Adverse Event|4|||
149800417|NCT00798161|540396804|FG000|Overall Study|Protocol Violation|2|||
149800418|NCT00798161|540396805|FG001|Overall Study|Protocol Violation|1|||
149800419|NCT00798161|540396806|FG002|Overall Study|Protocol Violation|3|||
149800420|NCT00798161|540396807|FG003|Overall Study|Protocol Violation|3|||
149800421|NCT00798161|540396808|FG004|Overall Study|Protocol Violation|3|||
149800422|NCT00798161|540396809|FG005|Overall Study|Protocol Violation|2|||
149800423|NCT00798161|540396810|FG006|Overall Study|Protocol Violation|0|||
149800424|NCT00798161|540396804|FG000|Overall Study|Lost to Follow-up|1|||
149800425|NCT00798161|540396805|FG001|Overall Study|Lost to Follow-up|3|||
149800426|NCT00798161|540396806|FG002|Overall Study|Lost to Follow-up|4|||
149800427|NCT00798161|540396807|FG003|Overall Study|Lost to Follow-up|3|||
149800428|NCT00798161|540396808|FG004|Overall Study|Lost to Follow-up|4|||
149800429|NCT00798161|540396809|FG005|Overall Study|Lost to Follow-up|0|||
149800430|NCT00798161|540396810|FG006|Overall Study|Lost to Follow-up|0|||
149800431|NCT00798161|540396804|FG000|Overall Study|Withdrawal by Subject|5|||
149800432|NCT00798161|540396805|FG001|Overall Study|Withdrawal by Subject|4|||
149800433|NCT00798161|540396806|FG002|Overall Study|Withdrawal by Subject|5|||
149800434|NCT00798161|540396807|FG003|Overall Study|Withdrawal by Subject|4|||
149800435|NCT00798161|540396808|FG004|Overall Study|Withdrawal by Subject|2|||
149800436|NCT00798161|540396809|FG005|Overall Study|Withdrawal by Subject|3|||
149800437|NCT00798161|540396810|FG006|Overall Study|Withdrawal by Subject|1|||
149800438|NCT00798161|540396804|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
149800439|NCT00798161|540396805|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
149800440|NCT00798161|540396806|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
149800441|NCT00798161|540396807|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
149800442|NCT00798161|540396808|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
149800443|NCT00798161|540396809|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
149800444|NCT00798161|540396810|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
149800445|NCT03735680|540396811|FG000|Overall Study|Withdrawal by Subject|0|||
149800446|NCT03735680|540396812|FG001|Overall Study|Withdrawal by Subject|1|||
149800447|NCT03735680|540396813|FG002|Overall Study|Withdrawal by Subject|0|||
149800448|NCT03735680|540396814|FG003|Overall Study|Withdrawal by Subject|0|||
149800449|NCT03735680|540396815|FG004|Overall Study|Withdrawal by Subject|0|||
149800450|NCT03735680|540396816|FG005|Overall Study|Withdrawal by Subject|1|||
149800451|NCT03735680|540396811|FG000|Overall Study|Patient unable or unwilling to continue|0|||
149800452|NCT03735680|540396812|FG001|Overall Study|Patient unable or unwilling to continue|0|||
149800453|NCT03735680|540396813|FG002|Overall Study|Patient unable or unwilling to continue|1|||
149800454|NCT03735680|540396814|FG003|Overall Study|Patient unable or unwilling to continue|0|||
149800455|NCT03735680|540396815|FG004|Overall Study|Patient unable or unwilling to continue|0|||
149800456|NCT03735680|540396816|FG005|Overall Study|Patient unable or unwilling to continue|0|||
149800457|NCT01711736|540396828|FG000|Overall Study|Lost to Follow-up|4|||
149800458|NCT01711736|540396829|FG001|Overall Study|Lost to Follow-up|1|||
149800459|NCT01711736|540396828|FG000|Overall Study|Withdrawal by Subject|6|||
149800460|NCT01711736|540396829|FG001|Overall Study|Withdrawal by Subject|6|||
149800461|NCT01711736|540396828|FG000|Overall Study|Migrated/moved from study area|2|||
149800462|NCT01711736|540396829|FG001|Overall Study|Migrated/moved from study area|1|||
149800463|NCT00465101|540396830|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
149800464|NCT00465101|540396830|FG000|Overall Study|Change in health precluded follow up|4|||
149800465|NCT00465101|540396830|FG000|Overall Study|Did not meet study criteria|4|||
149800466|NCT00465101|540396830|FG000|Overall Study|Lost to Follow-up|5|||
149800467|NCT00465101|540396830|FG000|Overall Study|Other|6|||
149800468|NCT00465101|540396830|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
149800469|NCT00465101|540396830|FG000|Overall Study|Patient postponed procedure|1|||
149800470|NCT00465101|540396830|FG000|Overall Study|Site closed due to IRB expiration|1|||
149800471|NCT00465101|540396830|FG000|Overall Study|Unable to obtain IRB approval|1|||
149800472|NCT00465101|540396830|FG000|Overall Study|Death|3|||
149800473|NCT00465101|540396830|FG000|Overall Study|Withdrawal by Subject|25|||
149800474|NCT00465101|540396830|FG000|Overall Study|Physician Decision|1|||
149800475|NCT00465101|540396830|FG000|Overall Study|Withdrew consent prior to procedure|3|||
149800476|NCT04145531|540396835|FG000|Part A|Adverse Event|2|||
149800477|NCT04145531|540396836|FG001|Part A|Adverse Event|12|||
149800478|NCT04145531|540396837|FG002|Part A|Adverse Event|6|||
149800479|NCT04145531|540396838|FG003|Part A|Adverse Event|0|||
149800480|NCT04145531|540396835|FG000|Part A|Death|1|||
149800481|NCT04145531|540396836|FG001|Part A|Death|2|||
149800482|NCT04145531|540396837|FG002|Part A|Death|0|||
149800483|NCT04145531|540396838|FG003|Part A|Death|0|||
149800484|NCT04145531|540396835|FG000|Part A|Physician Decision|2|||
149800485|NCT04145531|540396836|FG001|Part A|Physician Decision|5|||
149800486|NCT04145531|540396837|FG002|Part A|Physician Decision|2|||
149800487|NCT04145531|540396838|FG003|Part A|Physician Decision|0|||
149800488|NCT04145531|540396835|FG000|Part A|Progressive disease|0|||
149800489|NCT04145531|540396836|FG001|Part A|Progressive disease|2|||
149800490|NCT04145531|540396837|FG002|Part A|Progressive disease|1|||
149800491|NCT04145531|540396838|FG003|Part A|Progressive disease|0|||
149800492|NCT04145531|540396835|FG000|Part A|Protocol deviation|0|||
149800493|NCT04145531|540396836|FG001|Part A|Protocol deviation|0|||
149800494|NCT04145531|540396837|FG002|Part A|Protocol deviation|1|||
149800495|NCT04145531|540396838|FG003|Part A|Protocol deviation|0|||
149800496|NCT04145531|540396835|FG000|Part A|Withdrawal by parent or guardian|1|||
149800497|NCT04145531|540396836|FG001|Part A|Withdrawal by parent or guardian|0|||
149800498|NCT04145531|540396837|FG002|Part A|Withdrawal by parent or guardian|0|||
149800499|NCT04145531|540396838|FG003|Part A|Withdrawal by parent or guardian|0|||
149800500|NCT04145531|540396835|FG000|Part A|Withdrawal by participant|0|||
149800501|NCT04145531|540396836|FG001|Part A|Withdrawal by participant|0|||
149800502|NCT04145531|540396837|FG002|Part A|Withdrawal by participant|1|||
149800503|NCT04145531|540396838|FG003|Part A|Withdrawal by participant|0|||
149800504|NCT04145531|540396835|FG000|Part A|Other|0|||
149800505|NCT04145531|540396836|FG001|Part A|Other|0|||
149800506|NCT04145531|540396837|FG002|Part A|Other|1|||
149800507|NCT04145531|540396838|FG003|Part A|Other|0|||
149800508|NCT04145531|540396835|FG000|Part B|Adverse Event|0|||
149800509|NCT04145531|540396836|FG001|Part B|Adverse Event|0|||
149800510|NCT04145531|540396837|FG002|Part B|Adverse Event|0|||
149800511|NCT04145531|540396838|FG003|Part B|Adverse Event|21|||
149800512|NCT04145531|540396835|FG000|Part B|Physician Decision|0|||
149800513|NCT04145531|540396836|FG001|Part B|Physician Decision|0|||
149800514|NCT04145531|540396837|FG002|Part B|Physician Decision|0|||
149800515|NCT04145531|540396838|FG003|Part B|Physician Decision|7|||
149800516|NCT04145531|540396835|FG000|Part B|Progressive disease|0|||
149800517|NCT04145531|540396836|FG001|Part B|Progressive disease|0|||
149800518|NCT04145531|540396837|FG002|Part B|Progressive disease|0|||
149800519|NCT04145531|540396838|FG003|Part B|Progressive disease|1|||
149800520|NCT04145531|540396835|FG000|Part B|Recurrent disease|0|||
149800521|NCT04145531|540396836|FG001|Part B|Recurrent disease|0|||
149800522|NCT04145531|540396837|FG002|Part B|Recurrent disease|0|||
149800523|NCT04145531|540396838|FG003|Part B|Recurrent disease|1|||
149800524|NCT04145531|540396835|FG000|Part B|Withdrawal by parent or guardian|0|||
149800525|NCT04145531|540396836|FG001|Part B|Withdrawal by parent or guardian|0|||
149800526|NCT04145531|540396837|FG002|Part B|Withdrawal by parent or guardian|0|||
149800527|NCT04145531|540396838|FG003|Part B|Withdrawal by parent or guardian|3|||
149800528|NCT04145531|540396835|FG000|Part B|Withdrawal by participant|0|||
149800529|NCT04145531|540396836|FG001|Part B|Withdrawal by participant|0|||
149800530|NCT04145531|540396837|FG002|Part B|Withdrawal by participant|0|||
149800531|NCT04145531|540396838|FG003|Part B|Withdrawal by participant|1|||
149800532|NCT04145531|540396835|FG000|Part B|Other|0|||
149800533|NCT04145531|540396836|FG001|Part B|Other|0|||
149800534|NCT04145531|540396837|FG002|Part B|Other|0|||
149800535|NCT04145531|540396838|FG003|Part B|Other|1|||
149800536|NCT00933543|540396839|FG000|Overall Study|Adverse Event|2|||
149800537|NCT00933543|540396840|FG001|Overall Study|Adverse Event|1|||
149800538|NCT00933543|540396839|FG000|Overall Study|Lost to Follow-up|0|||
149800539|NCT00933543|540396840|FG001|Overall Study|Lost to Follow-up|1|||
149800540|NCT00933543|540396839|FG000|Overall Study|Withdrawal by Subject|0|||
149800541|NCT00933543|540396840|FG001|Overall Study|Withdrawal by Subject|1|||
149800542|NCT00933543|540396839|FG000|Overall Study|Lack of Efficacy|0|||
149800543|NCT00933543|540396840|FG001|Overall Study|Lack of Efficacy|3|||
149800544|NCT00933543|540396839|FG000|Overall Study|Other|1|||
149800545|NCT00933543|540396840|FG001|Overall Study|Other|1|||
149800546|NCT04988035|540396841|FG000|Overall Study|Death|19|||
149800547|NCT04988035|540396842|FG001|Overall Study|Death|13|||
149800548|NCT04988035|540396841|FG000|Overall Study|Lost to Follow-up|12|||
149800549|NCT04988035|540396842|FG001|Overall Study|Lost to Follow-up|6|||
149800550|NCT04988035|540396841|FG000|Overall Study|Protocol Violation|0|||
149800551|NCT04988035|540396842|FG001|Overall Study|Protocol Violation|1|||
149800552|NCT04988035|540396841|FG000|Overall Study|Withdrawal by Subject|2|||
149800553|NCT04988035|540396842|FG001|Overall Study|Withdrawal by Subject|4|||
149800554|NCT04988035|540396841|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
149800555|NCT04988035|540396842|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
149800556|NCT03602976|540396843|FG000|Overall Study|Withdrawal by Subject|1|||
149800557|NCT04837807|540396844|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
149800558|NCT04837807|540396845|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
149800559|NCT04629534|540396846|FG000|Overall Study|Physician Decision|1|||
149800560|NCT04629534|540396847|FG001|Overall Study|Physician Decision|0|||
149800561|NCT04629534|540396846|FG000|Overall Study|Protocol Violation|0|||
149800562|NCT04629534|540396847|FG001|Overall Study|Protocol Violation|2|||
149800563|NCT00308555|540396848|FG000|Overall Study|Withdrawal by Subject|1|||
149800564|NCT00308555|540396849|FG001|Overall Study|Withdrawal by Subject|0|||
149800565|NCT00308555|540396848|FG000|Overall Study|Physician Decision|2|||
149800566|NCT00308555|540396849|FG001|Overall Study|Physician Decision|0|||
149800567|NCT03732534|540396850|FG000|Overall Study|Study terminated by Sponsor|6|||
149800568|NCT02190604|540396851|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800569|NCT02190604|540396852|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800570|NCT02190604|540396853|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800571|NCT02190604|540396854|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800572|NCT02190604|540396855|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800573|NCT02190604|540396856|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800574|NCT02190604|540396857|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800575|NCT02190604|540396858|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800576|NCT02190604|540396859|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800577|NCT02190604|540396860|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800578|NCT02190604|540396861|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800579|NCT02190604|540396862|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800580|NCT02190604|540396863|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800581|NCT02190604|540396864|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800582|NCT02190604|540396865|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
149800583|NCT02190604|540396866|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800584|NCT02190604|540396867|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800585|NCT02190604|540396868|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800586|NCT02190604|540396869|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149800587|NCT02190604|540396851|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800588|NCT02190604|540396852|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800589|NCT02190604|540396853|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800590|NCT02190604|540396854|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800591|NCT02190604|540396855|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800592|NCT02190604|540396856|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800593|NCT02190604|540396857|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800594|NCT02190604|540396858|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800595|NCT02190604|540396859|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800596|NCT02190604|540396860|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800597|NCT02190604|540396861|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800598|NCT02190604|540396862|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800599|NCT02190604|540396863|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800600|NCT02190604|540396864|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
149800601|NCT02190604|540396865|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800602|NCT02190604|540396866|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800603|NCT02190604|540396867|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800604|NCT02190604|540396868|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800605|NCT02190604|540396869|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149800606|NCT02797951|540396870|FG000|Overall Study|Adverse Event|4|||
149800607|NCT02797951|540396870|FG000|Overall Study|Death|1|||
149800608|NCT02797951|540396870|FG000|Overall Study|Lack of Efficacy|19|||
149800609|NCT02797951|540396870|FG000|Overall Study|Lost to Follow-up|4|||
149800610|NCT02797951|540396870|FG000|Overall Study|Physician Decision|6|||
149800611|NCT02797951|540396870|FG000|Overall Study|Withdrawal by Subject|15|||
149800612|NCT00814502|540396871|FG000|Overall Study|Adverse Event|1|||
149800613|NCT00814502|540396872|FG001|Overall Study|Adverse Event|0|||
149800614|NCT00814502|540396871|FG000|Overall Study|Withdrawal by Subject|0|||
149800615|NCT00814502|540396872|FG001|Overall Study|Withdrawal by Subject|2|||
149800616|NCT03735849|540396874|FG000|Overall Study|Lost to Follow-up|1|||
149800617|NCT03735849|540396875|FG001|Overall Study|Lost to Follow-up|0|||
149800618|NCT03735849|540396876|FG002|Overall Study|Lost to Follow-up|0|||
149800619|NCT03735849|540396874|FG000|Overall Study|Participant unable to adhere to visit|1|||
149800620|NCT03735849|540396875|FG001|Overall Study|Participant unable to adhere to visit|0|||
149800621|NCT03735849|540396876|FG002|Overall Study|Participant unable to adhere to visit|0|||
149800622|NCT03735849|540396874|FG000|Overall Study|Not Randomized|0|||
149800623|NCT03735849|540396875|FG001|Overall Study|Not Randomized|0|||
149800624|NCT03735849|540396876|FG002|Overall Study|Not Randomized|4|||
149800625|NCT04585906|540396879|FG000|Overall Study|Lost to Follow-up|8|||
149800626|NCT04585906|540396880|FG001|Overall Study|Lost to Follow-up|5|||
149800627|NCT04626947|540396881|FG000|Overall Study|Study terminated|14|||
149800628|NCT03907072|540396890|FG000|Overall Study|Study Terminated by Sponsor|2|||
149800629|NCT03907072|540396891|FG001|Overall Study|Study Terminated by Sponsor|2|||
149800630|NCT03907072|540396892|FG002|Overall Study|Study Terminated by Sponsor|2|||
149800631|NCT02463097|540396895|FG000|Overall Study|Withdrawal by Subject|1|||
149800632|NCT03326323|540396896|FG000|Overall Study|Unable to receive ANH protocol|3|||
149800633|NCT02243306|540396901|FG000|Overall Study|Adverse Event|0|||
149800634|NCT02243306|540396902|FG001|Overall Study|Adverse Event|1|||
149800635|NCT02243306|540396901|FG000|Overall Study|Other: Reached stopping criteria|0|||
149800636|NCT02243306|540396902|FG001|Overall Study|Other: Reached stopping criteria|1|||
149800637|NCT02243306|540396901|FG000|Overall Study|Physician Decision|0|||
149800638|NCT02243306|540396902|FG001|Overall Study|Physician Decision|1|||
149800639|NCT02221882|540396903|FG000|Overall Study|Withdrawal by Subject|0|||
149800640|NCT02221882|540396904|FG001|Overall Study|Withdrawal by Subject|0|||
149800641|NCT02221882|540396905|FG002|Overall Study|Withdrawal by Subject|4|||
149800642|NCT02221882|540396906|FG003|Overall Study|Withdrawal by Subject|2|||
149800643|NCT02221882|540396907|FG004|Overall Study|Withdrawal by Subject|2|||
149800644|NCT02221882|540396908|FG005|Overall Study|Withdrawal by Subject|2|||
149800645|NCT02221882|540396903|FG000|Overall Study|Death|0|||
149800646|NCT02221882|540396904|FG001|Overall Study|Death|1|||
149800647|NCT02221882|540396905|FG002|Overall Study|Death|0|||
149800648|NCT02221882|540396906|FG003|Overall Study|Death|0|||
149800649|NCT02221882|540396907|FG004|Overall Study|Death|0|||
149800650|NCT02221882|540396908|FG005|Overall Study|Death|0|||
149800651|NCT00796367|540396909|FG000|Overall Study|Adverse Event|6|||
149800652|NCT00796367|540396910|FG001|Overall Study|Adverse Event|4|||
149800653|NCT00796367|540396911|FG002|Overall Study|Adverse Event|7|||
149800654|NCT00796367|540396909|FG000|Overall Study|Lost to Follow-up|5|||
149800655|NCT00796367|540396910|FG001|Overall Study|Lost to Follow-up|4|||
149800656|NCT00796367|540396911|FG002|Overall Study|Lost to Follow-up|21|||
149800657|NCT00796367|540396909|FG000|Overall Study|Withdrawal by Subject|9|||
149800658|NCT00796367|540396910|FG001|Overall Study|Withdrawal by Subject|11|||
149800659|NCT00796367|540396911|FG002|Overall Study|Withdrawal by Subject|12|||
149800660|NCT00796367|540396909|FG000|Overall Study|Lack of Efficacy|2|||
149800661|NCT00796367|540396910|FG001|Overall Study|Lack of Efficacy|1|||
149800662|NCT00796367|540396911|FG002|Overall Study|Lack of Efficacy|0|||
149800663|NCT00796367|540396909|FG000|Overall Study|non compliance|3|||
149800664|NCT00796367|540396910|FG001|Overall Study|non compliance|1|||
149800665|NCT00796367|540396911|FG002|Overall Study|non compliance|1|||
149800666|NCT00796367|540396909|FG000|Overall Study|Pregnancy|1|||
149800667|NCT00796367|540396910|FG001|Overall Study|Pregnancy|0|||
149800668|NCT00796367|540396911|FG002|Overall Study|Pregnancy|1|||
149800669|NCT00796367|540396909|FG000|Overall Study|Requirement for restricted medication|2|||
149800670|NCT00796367|540396910|FG001|Overall Study|Requirement for restricted medication|0|||
149800671|NCT00796367|540396911|FG002|Overall Study|Requirement for restricted medication|2|||
149800672|NCT00796367|540396909|FG000|Overall Study|other|2|||
149800673|NCT00796367|540396910|FG001|Overall Study|other|4|||
149800674|NCT00796367|540396911|FG002|Overall Study|other|3|||
149800675|NCT02370173|540396920|FG000|Overall Study|Protocol Violation|1|||
149800676|NCT02370173|540396921|FG001|Overall Study|Protocol Violation|1|||
149800677|NCT02370173|540396920|FG000|Overall Study|Withdrawal by Subject|2|||
149800678|NCT02370173|540396921|FG001|Overall Study|Withdrawal by Subject|2|||
149800679|NCT00307736|540396926|FG000|Overall Study|Adverse Event|0|||
149800680|NCT00307736|540396927|FG001|Overall Study|Adverse Event|0|||
149800681|NCT00307736|540396928|FG002|Overall Study|Adverse Event|1|||
149800682|NCT00307736|540396929|FG003|Overall Study|Adverse Event|3|||
149800683|NCT00307736|540396926|FG000|Overall Study|Withdrawal by Subject|0|||
149800684|NCT00307736|540396927|FG001|Overall Study|Withdrawal by Subject|0|||
149800685|NCT00307736|540396928|FG002|Overall Study|Withdrawal by Subject|2|||
149800686|NCT00307736|540396929|FG003|Overall Study|Withdrawal by Subject|0|||
149800687|NCT01365182|540396930|FG000|Overall Study|Withdrawal by Subject|10|||
149800688|NCT01365182|540396931|FG001|Overall Study|Withdrawal by Subject|13|||
149800689|NCT01365182|540396932|FG002|Overall Study|Withdrawal by Subject|12|||
149800690|NCT01087944|540396946|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
149800691|NCT01087944|540396947|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
149800692|NCT01087944|540396946|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
149800693|NCT01087944|540396947|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
149800694|NCT00553319|540396948|FG000|Overall Study|Lost to Follow-up|10|||
149800695|NCT00553319|540396949|FG001|Overall Study|Lost to Follow-up|9|||
149800696|NCT00553319|540396950|FG002|Overall Study|Lost to Follow-up|5|||
149800697|NCT00553319|540396948|FG000|Overall Study|wanted treatment elsewhere|2|||
149800698|NCT00553319|540396949|FG001|Overall Study|wanted treatment elsewhere|1|||
149800699|NCT00553319|540396950|FG002|Overall Study|wanted treatment elsewhere|1|||
149800700|NCT00553319|540396948|FG000|Overall Study|non-compliance|0|||
149800701|NCT00553319|540396949|FG001|Overall Study|non-compliance|0|||
149800702|NCT00553319|540396950|FG002|Overall Study|non-compliance|2|||
149800703|NCT00553319|540396948|FG000|Overall Study|incarceration|1|||
149800704|NCT00553319|540396949|FG001|Overall Study|incarceration|0|||
149800705|NCT00553319|540396950|FG002|Overall Study|incarceration|0|||
149800706|NCT00553319|540396948|FG000|Overall Study|moved|1|||
149800707|NCT00553319|540396949|FG001|Overall Study|moved|0|||
149800708|NCT00553319|540396950|FG002|Overall Study|moved|1|||
149800709|NCT01731600|540396956|FG000|Overall Study|Adverse Event|2|||
149800710|NCT01731600|540396957|FG001|Overall Study|Adverse Event|0|||
149800711|NCT01731600|540396956|FG000|Overall Study|Withdrawal criteria|1|||
149800712|NCT01731600|540396957|FG001|Overall Study|Withdrawal criteria|0|||
149800713|NCT01731600|540396956|FG000|Overall Study|Other reasons|3|||
149800714|NCT01731600|540396957|FG001|Overall Study|Other reasons|0|||
149800715|NCT03575975|540396958|FG000|Overall Study|Lost to Follow-up|1|||
149800716|NCT03575975|540396959|FG001|Overall Study|Lost to Follow-up|0|||
149800717|NCT03575975|540396960|FG002|Overall Study|Lost to Follow-up|0|||
149800718|NCT00465894|540396963|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
149800719|NCT00465894|540396964|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
149800720|NCT00465894|540396963|FG000|Treatment For 12 Weeks|Family Issues|1|||
149800721|NCT00465894|540396964|FG001|Treatment For 12 Weeks|Family Issues|1|||
149800722|NCT00465894|540396963|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
149800723|NCT00465894|540396964|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
149800724|NCT01636076|540396965|FG000|Overall Study|Terminated by sponsor|1|||
149800725|NCT01636076|540396966|FG001|Overall Study|Terminated by sponsor|1|||
149800726|NCT01636076|540396965|FG000|Overall Study|Lack of Efficacy|0|||
149800727|NCT01636076|540396966|FG001|Overall Study|Lack of Efficacy|1|||
149800728|NCT01636076|540396965|FG000|Overall Study|Lost to Follow-up|1|||
149800729|NCT01636076|540396966|FG001|Overall Study|Lost to Follow-up|0|||
149800730|NCT01636076|540396965|FG000|Overall Study|Physician Decision|1|||
149800731|NCT01636076|540396966|FG001|Overall Study|Physician Decision|1|||
149800732|NCT01636076|540396965|FG000|Overall Study|Non-compliance with study treatment|1|||
149800733|NCT01636076|540396966|FG001|Overall Study|Non-compliance with study treatment|1|||
149800734|NCT01636076|540396965|FG000|Overall Study|Adverse Event|6|||
149800735|NCT01636076|540396966|FG001|Overall Study|Adverse Event|11|||
149800736|NCT01636076|540396965|FG000|Overall Study|Withdrawal by Subject|7|||
149800737|NCT01636076|540396966|FG001|Overall Study|Withdrawal by Subject|10|||
149800738|NCT01159665|540396967|FG000|Overall Study|Withdrawal by Subject|0|||
149800739|NCT01159665|540396968|FG001|Overall Study|Withdrawal by Subject|1|||
149800740|NCT01159665|540396969|FG002|Overall Study|Withdrawal by Subject|0|||
149800741|NCT01159665|540396970|FG003|Overall Study|Withdrawal by Subject|0|||
149800742|NCT01159665|540396971|FG004|Overall Study|Withdrawal by Subject|0|||
149800743|NCT01159665|540396972|FG005|Overall Study|Withdrawal by Subject|0|||
149800744|NCT00129220|540396975|FG000|Study Period II|Adverse Event|9|||
149800745|NCT00129220|540396976|FG001|Study Period II|Adverse Event|5|||
149800746|NCT00129220|540396977|FG002|Study Period II|Adverse Event|7|||
149800747|NCT00129220|540396975|FG000|Study Period II|Lack of Efficacy|15|||
149800748|NCT00129220|540396976|FG001|Study Period II|Lack of Efficacy|1|||
149800749|NCT00129220|540396977|FG002|Study Period II|Lack of Efficacy|28|||
149800750|NCT00129220|540396975|FG000|Study Period II|Entry Criteria Not Met|2|||
149800751|NCT00129220|540396976|FG001|Study Period II|Entry Criteria Not Met|0|||
149800752|NCT00129220|540396977|FG002|Study Period II|Entry Criteria Not Met|2|||
149800753|NCT00129220|540396975|FG000|Study Period II|Protocol Violation|4|||
149800754|NCT00129220|540396976|FG001|Study Period II|Protocol Violation|2|||
149800755|NCT00129220|540396977|FG002|Study Period II|Protocol Violation|1|||
149800756|NCT00129220|540396975|FG000|Study Period II|Physician Decision|0|||
149800757|NCT00129220|540396976|FG001|Study Period II|Physician Decision|1|||
149800758|NCT00129220|540396977|FG002|Study Period II|Physician Decision|0|||
149800759|NCT00129220|540396975|FG000|Study Period II|Withdrawal by Subject|1|||
149800760|NCT00129220|540396976|FG001|Study Period II|Withdrawal by Subject|3|||
149800761|NCT00129220|540396977|FG002|Study Period II|Withdrawal by Subject|4|||
149800762|NCT00129220|540396975|FG000|Study Period II|Reason Not Specified|2|||
149800763|NCT00129220|540396976|FG001|Study Period II|Reason Not Specified|0|||
149800764|NCT00129220|540396977|FG002|Study Period II|Reason Not Specified|5|||
149800765|NCT00129220|540396975|FG000|Study Period III|Adverse Event|1|||
149800766|NCT00129220|540396976|FG001|Study Period III|Adverse Event|0|||
149800767|NCT00129220|540396977|FG002|Study Period III|Adverse Event|3|||
149800768|NCT00129220|540396975|FG000|Study Period III|Protocol Violation|1|||
149800769|NCT00129220|540396976|FG001|Study Period III|Protocol Violation|1|||
149800770|NCT00129220|540396977|FG002|Study Period III|Protocol Violation|2|||
149800771|NCT00129220|540396975|FG000|Study Period III|Withdrawal by Subject|1|||
149800772|NCT00129220|540396976|FG001|Study Period III|Withdrawal by Subject|0|||
149800773|NCT00129220|540396977|FG002|Study Period III|Withdrawal by Subject|3|||
149800774|NCT00129220|540396975|FG000|Study Period III|Sponsor Decision|1|||
149800775|NCT00129220|540396976|FG001|Study Period III|Sponsor Decision|0|||
149800776|NCT00129220|540396977|FG002|Study Period III|Sponsor Decision|0|||
149800777|NCT00129220|540396975|FG000|Study Period III|Reason Not Specified|9|||
149800778|NCT00129220|540396976|FG001|Study Period III|Reason Not Specified|0|||
149800779|NCT00129220|540396977|FG002|Study Period III|Reason Not Specified|2|||
149800780|NCT00540228|540396978|FG000|Overall Study|Adverse Event|2|||
149800781|NCT00540228|540396979|FG001|Overall Study|Adverse Event|0|||
149800782|NCT00540228|540396980|FG002|Overall Study|Adverse Event|0|||
149800783|NCT00540228|540396981|FG003|Overall Study|Adverse Event|0|||
149800784|NCT00540228|540396982|FG004|Overall Study|Adverse Event|0|||
149800785|NCT00540228|540396978|FG000|Overall Study|Lost to Follow-up|1|||
149800786|NCT00540228|540396979|FG001|Overall Study|Lost to Follow-up|1|||
149800787|NCT00540228|540396980|FG002|Overall Study|Lost to Follow-up|0|||
149800788|NCT00540228|540396981|FG003|Overall Study|Lost to Follow-up|0|||
149800789|NCT00540228|540396982|FG004|Overall Study|Lost to Follow-up|0|||
149800790|NCT01883362|540396983|FG000|Treatment|Adverse Event|1|||
149800791|NCT01883362|540396984|FG001|Treatment|Adverse Event|8|||
149800792|NCT01883362|540396983|FG000|Treatment|Withdrawal by Subject|6|||
149800793|NCT01883362|540396984|FG001|Treatment|Withdrawal by Subject|2|||
149800794|NCT01883362|540396983|FG000|Treatment|Administrative problems|4|||
149800795|NCT01883362|540396984|FG001|Treatment|Administrative problems|1|||
149800796|NCT01883362|540396983|FG000|Treatment|Relapse|4|||
149800797|NCT01883362|540396984|FG001|Treatment|Relapse|2|||
149800798|NCT01883362|540396983|FG000|Treatment|Randomized, not treated|1|||
149800799|NCT01883362|540396984|FG001|Treatment|Randomized, not treated|1|||
149800800|NCT01883362|540396983|FG000|Post Treatment Follow-up|Protocol Violation|0|||
149800801|NCT01883362|540396984|FG001|Post Treatment Follow-up|Protocol Violation|1|||
149800802|NCT01883362|540396983|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
149800803|NCT01883362|540396984|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
149800804|NCT01883362|540396983|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
149800805|NCT01883362|540396984|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
149800806|NCT01883362|540396983|FG000|Post Treatment Follow-up|Administrative problems|2|||
149800807|NCT01883362|540396984|FG001|Post Treatment Follow-up|Administrative problems|0|||
149800808|NCT01883362|540396983|FG000|Post Treatment Follow-up|Death|8|||
149800809|NCT01883362|540396984|FG001|Post Treatment Follow-up|Death|4|||
149800810|NCT01883362|540396983|FG000|Post Treatment Follow-up|Relapse|1|||
149800811|NCT01883362|540396984|FG001|Post Treatment Follow-up|Relapse|2|||
149800812|NCT01230489|540396986|FG000|Overall Study|Death|2|||
149800813|NCT01230489|540396986|FG000|Overall Study|Adverse Event|2|||
149800814|NCT01230489|540396986|FG000|Overall Study|Treatment modality changed|1|||
149800815|NCT01977573|540396987|FG000|Overall Study|Adverse Event|7|||
149800816|NCT01977573|540396988|FG001|Overall Study|Adverse Event|0|||
149800817|NCT01977573|540396989|FG002|Overall Study|Adverse Event|2|||
149800818|NCT01977573|540396990|FG003|Overall Study|Adverse Event|1|||
149800819|NCT01977573|540396987|FG000|Overall Study|Lost to Follow-up|1|||
149800820|NCT01977573|540396988|FG001|Overall Study|Lost to Follow-up|0|||
149800821|NCT01977573|540396989|FG002|Overall Study|Lost to Follow-up|0|||
149800822|NCT01977573|540396990|FG003|Overall Study|Lost to Follow-up|1|||
149800823|NCT01977573|540396987|FG000|Overall Study|Physician Decision|1|||
149800824|NCT01977573|540396988|FG001|Overall Study|Physician Decision|0|||
149800825|NCT01977573|540396989|FG002|Overall Study|Physician Decision|0|||
149800826|NCT01977573|540396990|FG003|Overall Study|Physician Decision|0|||
149800827|NCT01977573|540396987|FG000|Overall Study|Protocol Violation|3|||
149800828|NCT01977573|540396988|FG001|Overall Study|Protocol Violation|1|||
149800829|NCT01977573|540396989|FG002|Overall Study|Protocol Violation|0|||
149800830|NCT01977573|540396990|FG003|Overall Study|Protocol Violation|0|||
149800831|NCT01977573|540396987|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
149800832|NCT01977573|540396988|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
149800833|NCT01977573|540396989|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
149800834|NCT01977573|540396990|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
149800835|NCT01977573|540396987|FG000|Overall Study|Withdrawal by Subject|6|||
149800836|NCT01977573|540396988|FG001|Overall Study|Withdrawal by Subject|1|||
149800837|NCT01977573|540396989|FG002|Overall Study|Withdrawal by Subject|1|||
149800838|NCT01977573|540396990|FG003|Overall Study|Withdrawal by Subject|1|||
149800839|NCT01302366|540398422|FG000|Overall Study|patient choice or noncompliance|5|||
149800840|NCT00198107|540398427|FG000|Double-Blind Period|Adverse Event|1|||
149800841|NCT00198107|540398428|FG001|Double-Blind Period|Adverse Event|1|||
149800842|NCT00198107|540398429|FG002|Double-Blind Period|Adverse Event|0|||
149800843|NCT00198107|540398427|FG000|Double-Blind Period|Lack of Efficacy|2|||
149800844|NCT00198107|540398428|FG001|Double-Blind Period|Lack of Efficacy|0|||
149800845|NCT00198107|540398429|FG002|Double-Blind Period|Lack of Efficacy|0|||
149800846|NCT00198107|540398427|FG000|Double-Blind Period|Lost to Follow-up|2|||
149800847|NCT00198107|540398428|FG001|Double-Blind Period|Lost to Follow-up|1|||
149800848|NCT00198107|540398429|FG002|Double-Blind Period|Lost to Follow-up|0|||
149800849|NCT00198107|540398427|FG000|Double-Blind Period|Physician Decision|1|||
149800850|NCT00198107|540398428|FG001|Double-Blind Period|Physician Decision|0|||
149800851|NCT00198107|540398429|FG002|Double-Blind Period|Physician Decision|0|||
149800852|NCT00198107|540398427|FG000|Double-Blind Period|Withdrawal by Subject|0|||
149800853|NCT00198107|540398428|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149800854|NCT00198107|540398429|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149800855|NCT00198107|540398427|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
149800856|NCT00198107|540398428|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
149800857|NCT00198107|540398429|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
149800858|NCT02163759|540398430|FG000|Overall Study|Withdrawal by Subject|1|||
149800859|NCT02163759|540398431|FG001|Overall Study|Withdrawal by Subject|5|||
149800860|NCT02163759|540398432|FG002|Overall Study|Withdrawal by Subject|1|||
149800861|NCT02163759|540398430|FG000|Overall Study|Adverse Event|0|||
149800862|NCT02163759|540398431|FG001|Overall Study|Adverse Event|0|||
149800863|NCT02163759|540398432|FG002|Overall Study|Adverse Event|1|||
149800864|NCT02163759|540398430|FG000|Overall Study|Death|0|||
149800865|NCT02163759|540398431|FG001|Overall Study|Death|0|||
149800866|NCT02163759|540398432|FG002|Overall Study|Death|1|||
149800867|NCT03996694|540398433|FG000|First Washout (7 Days)|positive urine drug screen|0|||
149800868|NCT03996694|540398434|FG001|First Washout (7 Days)|positive urine drug screen|0|||
149800869|NCT03996694|540398435|FG002|First Washout (7 Days)|positive urine drug screen|1|||
149800870|NCT03996694|540398436|FG003|First Washout (7 Days)|positive urine drug screen|0|||
149800871|NCT03996694|540398437|FG004|First Washout (7 Days)|positive urine drug screen|0|||
149800872|NCT03996694|540398438|FG005|First Washout (7 Days)|positive urine drug screen|0|||
149800873|NCT03996694|540398433|FG000|First Washout (7 Days)|Adverse Event|0|||
149800874|NCT03996694|540398434|FG001|First Washout (7 Days)|Adverse Event|1|||
149800875|NCT03996694|540398435|FG002|First Washout (7 Days)|Adverse Event|0|||
149800876|NCT03996694|540398436|FG003|First Washout (7 Days)|Adverse Event|0|||
149800877|NCT03996694|540398437|FG004|First Washout (7 Days)|Adverse Event|0|||
149800878|NCT03996694|540398438|FG005|First Washout (7 Days)|Adverse Event|0|||
149800879|NCT03996694|540398433|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
149800880|NCT03996694|540398434|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
149800881|NCT03996694|540398435|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
149800882|NCT03996694|540398436|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
149800883|NCT03996694|540398437|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
149800884|NCT03996694|540398438|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
149800885|NCT03996694|540398433|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
149800886|NCT03996694|540398434|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
149800887|NCT03996694|540398435|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
149800888|NCT03996694|540398436|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
149800889|NCT03996694|540398437|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
149800890|NCT03996694|540398438|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
149800891|NCT00451191|540398443|FG000|Overall Study|withdrawal or received alternate tx|15|||
149800892|NCT00451191|540398444|FG001|Overall Study|withdrawal or received alternate tx|11|||
149800893|NCT01013207|540398445|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
149800894|NCT01541644|540398448|FG000|Overall Study|Withdrawal by Subject|3|||
149800895|NCT01458535|540398451|FG000|Overall Study|Other|0|||
149800896|NCT01458535|540398452|FG001|Overall Study|Other|0|||
149800897|NCT01458535|540398453|FG002|Overall Study|Other|0|||
149800898|NCT01458535|540398454|FG003|Overall Study|Other|0|||
149800899|NCT01458535|540398455|FG004|Overall Study|Other|1|||
149800900|NCT01458535|540398456|FG005|Overall Study|Other|1|||
149800901|NCT01458535|540398451|FG000|Overall Study|Withdrawal by Subject|0|||
149800902|NCT01458535|540398452|FG001|Overall Study|Withdrawal by Subject|0|||
149800903|NCT01458535|540398453|FG002|Overall Study|Withdrawal by Subject|2|||
149800904|NCT01458535|540398454|FG003|Overall Study|Withdrawal by Subject|0|||
149800905|NCT01458535|540398455|FG004|Overall Study|Withdrawal by Subject|1|||
149800906|NCT01458535|540398456|FG005|Overall Study|Withdrawal by Subject|1|||
149800907|NCT01458535|540398451|FG000|Overall Study|Lost to Follow-up|0|||
149800908|NCT01458535|540398452|FG001|Overall Study|Lost to Follow-up|2|||
149800909|NCT01458535|540398453|FG002|Overall Study|Lost to Follow-up|0|||
149800910|NCT01458535|540398454|FG003|Overall Study|Lost to Follow-up|3|||
149800911|NCT01458535|540398455|FG004|Overall Study|Lost to Follow-up|2|||
149800912|NCT01458535|540398456|FG005|Overall Study|Lost to Follow-up|2|||
149800913|NCT01458535|540398451|FG000|Overall Study|Adverse Event|0|||
149800914|NCT01458535|540398452|FG001|Overall Study|Adverse Event|0|||
149800915|NCT01458535|540398453|FG002|Overall Study|Adverse Event|0|||
149800916|NCT01458535|540398454|FG003|Overall Study|Adverse Event|1|||
149800917|NCT01458535|540398455|FG004|Overall Study|Adverse Event|0|||
149800918|NCT01458535|540398456|FG005|Overall Study|Adverse Event|0|||
149800919|NCT00463385|540398460|FG000|Overall Study|Other|4|||
149800920|NCT00463385|540398461|FG001|Overall Study|Other|3|||
149800921|NCT00463385|540398462|FG002|Overall Study|Other|6|||
149800922|NCT00463385|540398463|FG003|Overall Study|Other|4|||
149800923|NCT00463385|540398460|FG000|Overall Study|Adverse Event|5|||
149800924|NCT00463385|540398461|FG001|Overall Study|Adverse Event|8|||
149800925|NCT00463385|540398462|FG002|Overall Study|Adverse Event|4|||
149800926|NCT00463385|540398463|FG003|Overall Study|Adverse Event|2|||
149800927|NCT00463385|540398460|FG000|Overall Study|Lack of Efficacy|6|||
149800928|NCT00463385|540398461|FG001|Overall Study|Lack of Efficacy|6|||
149800929|NCT00463385|540398462|FG002|Overall Study|Lack of Efficacy|7|||
149800930|NCT00463385|540398463|FG003|Overall Study|Lack of Efficacy|9|||
149800931|NCT00463385|540398460|FG000|Overall Study|Withdrawal by Subject|3|||
149800932|NCT00463385|540398461|FG001|Overall Study|Withdrawal by Subject|3|||
149800933|NCT00463385|540398462|FG002|Overall Study|Withdrawal by Subject|3|||
149800934|NCT00463385|540398463|FG003|Overall Study|Withdrawal by Subject|4|||
149800935|NCT00463385|540398460|FG000|Overall Study|Lost to Follow-up|0|||
149800936|NCT00463385|540398461|FG001|Overall Study|Lost to Follow-up|0|||
149800937|NCT00463385|540398462|FG002|Overall Study|Lost to Follow-up|0|||
149800938|NCT00463385|540398463|FG003|Overall Study|Lost to Follow-up|1|||
149800939|NCT00463385|540398460|FG000|Overall Study|Death|2|||
149800940|NCT00463385|540398461|FG001|Overall Study|Death|1|||
149800941|NCT00463385|540398462|FG002|Overall Study|Death|2|||
149800942|NCT00463385|540398463|FG003|Overall Study|Death|0|||
149800943|NCT00463385|540398460|FG000|Overall Study|Missing|2|||
149800944|NCT00463385|540398461|FG001|Overall Study|Missing|0|||
149800945|NCT00463385|540398462|FG002|Overall Study|Missing|0|||
149800946|NCT00463385|540398463|FG003|Overall Study|Missing|2|||
149800947|NCT00463385|540398460|FG000|Overall Study|1 participant received commercial drug|0|||
149800948|NCT00463385|540398461|FG001|Overall Study|1 participant received commercial drug|1|||
149800949|NCT00463385|540398462|FG002|Overall Study|1 participant received commercial drug|0|||
149800950|NCT00463385|540398463|FG003|Overall Study|1 participant received commercial drug|0|||
149800951|NCT00344968|540398464|FG000|Overall Study|Adverse Event|5|||
149800952|NCT00344968|540398465|FG001|Overall Study|Adverse Event|4|||
149800953|NCT00344968|540398466|FG002|Overall Study|Adverse Event|15|||
149800954|NCT00344968|540398464|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149800955|NCT00344968|540398465|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149800956|NCT00344968|540398466|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149800957|NCT00344968|540398464|FG000|Overall Study|Protocol Violation|2|||
149800958|NCT00344968|540398465|FG001|Overall Study|Protocol Violation|2|||
149800959|NCT00344968|540398466|FG002|Overall Study|Protocol Violation|5|||
149800960|NCT00344968|540398464|FG000|Overall Study|Withdrawal by Subject|14|||
149800961|NCT00344968|540398465|FG001|Overall Study|Withdrawal by Subject|31|||
149800962|NCT00344968|540398466|FG002|Overall Study|Withdrawal by Subject|27|||
149800963|NCT00344968|540398464|FG000|Overall Study|Lost to Follow-up|24|||
149800964|NCT00344968|540398465|FG001|Overall Study|Lost to Follow-up|37|||
149800965|NCT00344968|540398466|FG002|Overall Study|Lost to Follow-up|37|||
149800966|NCT00344968|540398464|FG000|Overall Study|Death|11|||
149800967|NCT00344968|540398465|FG001|Overall Study|Death|27|||
149800968|NCT00344968|540398466|FG002|Overall Study|Death|31|||
149800969|NCT00344968|540398464|FG000|Overall Study|Other|0|||
149800970|NCT00344968|540398465|FG001|Overall Study|Other|1|||
149800971|NCT00344968|540398466|FG002|Overall Study|Other|0|||
149800972|NCT00503035|540398467|FG000|Overall Study|Lost to Follow-up|2|||
149800973|NCT00503035|540398467|FG000|Overall Study|Physician Decision|3|||
149800974|NCT00503035|540398467|FG000|Overall Study|Ineligible|15|||
149800975|NCT04001790|540398468|FG000|Overall Study|Withdrawal by Subject|1|||
149800976|NCT04001790|540398469|FG001|Overall Study|Withdrawal by Subject|2|||
149800977|NCT05028816|540398471|FG000|Overall Study|Lost to Follow-up|5|||
149800978|NCT05028816|540398472|FG001|Overall Study|Lost to Follow-up|3|||
149800979|NCT05028816|540398471|FG000|Overall Study|Withdrawal by Subject|4|||
149800980|NCT05028816|540398472|FG001|Overall Study|Withdrawal by Subject|1|||
149800981|NCT05028816|540398471|FG000|Overall Study|Physician Decision|1|||
149800982|NCT05028816|540398472|FG001|Overall Study|Physician Decision|0|||
149800983|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Adverse Event|4|||
149800984|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Adverse Event|3|||
149800985|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Adverse Event|0|||
149800986|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Adverse Event|0|||
149800987|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Death|24|||
149800988|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Death|9|||
149800989|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Death|0|||
149800990|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Death|0|||
149800991|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
149800992|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
149800993|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
149800994|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
149800995|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Physician Decision|4|||
149800996|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Physician Decision|1|||
149800997|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Physician Decision|0|||
149800998|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Physician Decision|0|||
149800999|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Progressive disease|1|||
149801000|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Progressive disease|0|||
149801001|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Progressive disease|0|||
149801002|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Progressive disease|0|||
149801003|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
149801004|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
149801005|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
149801006|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
149801007|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
149801008|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149801009|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149801010|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149801011|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
149801012|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
149801013|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
149801014|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
149801015|NCT04579666|540398474|FG000|RTP (Up to Week 52)|Other|2|||
149801016|NCT04579666|540398475|FG001|RTP (Up to Week 52)|Other|0|||
149801017|NCT04579666|540398476|FG002|RTP (Up to Week 52)|Other|0|||
149801018|NCT04579666|540398477|FG003|RTP (Up to Week 52)|Other|0|||
149801019|NCT04579666|540398474|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149801020|NCT04579666|540398475|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149801021|NCT04579666|540398476|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
149801022|NCT04579666|540398477|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149801023|NCT04579666|540398474|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
149801024|NCT04579666|540398475|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
149801025|NCT04579666|540398476|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
149801026|NCT04579666|540398477|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
149801027|NCT04579666|540398474|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
149801028|NCT04579666|540398475|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
149801029|NCT04579666|540398476|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
149801030|NCT04579666|540398477|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
149801031|NCT04579666|540398474|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
149801032|NCT04579666|540398475|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
149801033|NCT04579666|540398476|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
149801034|NCT04579666|540398477|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
149801035|NCT04579666|540398474|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
149801036|NCT04579666|540398475|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
149801037|NCT04579666|540398476|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
149801038|NCT04579666|540398477|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
149801039|NCT04576702|540398478|FG000|Overall Study|Death|1|||
149801040|NCT04576702|540398479|FG001|Overall Study|Death|0|||
149801041|NCT04576702|540398480|FG002|Overall Study|Death|0|||
149801042|NCT04576702|540398481|FG003|Overall Study|Death|0|||
149801043|NCT04576702|540398478|FG000|Overall Study|Withdrawal by Subject|0|||
149801044|NCT04576702|540398479|FG001|Overall Study|Withdrawal by Subject|2|||
149801045|NCT04576702|540398480|FG002|Overall Study|Withdrawal by Subject|1|||
149801046|NCT04576702|540398481|FG003|Overall Study|Withdrawal by Subject|0|||
149801047|NCT04576702|540398478|FG000|Overall Study|Lost to Follow-up|3|||
149801048|NCT04576702|540398479|FG001|Overall Study|Lost to Follow-up|3|||
149801049|NCT04576702|540398480|FG002|Overall Study|Lost to Follow-up|3|||
149801050|NCT04576702|540398481|FG003|Overall Study|Lost to Follow-up|4|||
149801051|NCT03099096|540398482|FG000|Overall Study|Adverse Event|1|||
149801052|NCT03099096|540398482|FG000|Overall Study|Physician Decision|1|||
149801053|NCT02985996|540398483|FG000|Overall Study|Withdrawal by Subject|0|||
149801054|NCT02985996|540398484|FG001|Overall Study|Withdrawal by Subject|0|||
149801055|NCT02985996|540398485|FG002|Overall Study|Withdrawal by Subject|1|||
149801056|NCT02985996|540398486|FG003|Overall Study|Withdrawal by Subject|0|||
149801057|NCT02985996|540398487|FG004|Overall Study|Withdrawal by Subject|0|||
149801058|NCT02985996|540398483|FG000|Overall Study|Protocol Violation|0|||
149801059|NCT02985996|540398484|FG001|Overall Study|Protocol Violation|1|||
149801060|NCT02985996|540398485|FG002|Overall Study|Protocol Violation|0|||
149801061|NCT02985996|540398486|FG003|Overall Study|Protocol Violation|0|||
149801062|NCT02985996|540398487|FG004|Overall Study|Protocol Violation|0|||
149801063|NCT00401726|540398488|FG000|Overall Study|Adverse Event|34|||
149801064|NCT00401726|540398489|FG001|Overall Study|Adverse Event|45|||
149801065|NCT00401726|540398488|FG000|Overall Study|Death|0|||
149801066|NCT00401726|540398489|FG001|Overall Study|Death|3|||
149801067|NCT00401726|540398488|FG000|Overall Study|Sponsor Request|0|||
149801068|NCT00401726|540398489|FG001|Overall Study|Sponsor Request|1|||
149801069|NCT00401726|540398488|FG000|Overall Study|Physician Decision|3|||
149801070|NCT00401726|540398489|FG001|Overall Study|Physician Decision|6|||
149801071|NCT00401726|540398488|FG000|Overall Study|Lost to Follow-up|23|||
149801072|NCT00401726|540398489|FG001|Overall Study|Lost to Follow-up|20|||
149801073|NCT00401726|540398488|FG000|Overall Study|Protocol Violation|6|||
149801074|NCT00401726|540398489|FG001|Overall Study|Protocol Violation|3|||
149801075|NCT00401726|540398488|FG000|Overall Study|Withdrawal by Subject|18|||
149801076|NCT00401726|540398489|FG001|Overall Study|Withdrawal by Subject|24|||
149801077|NCT00401726|540398488|FG000|Overall Study|Lack of Efficacy|4|||
149801078|NCT00401726|540398489|FG001|Overall Study|Lack of Efficacy|6|||
149801079|NCT00401726|540398488|FG000|Overall Study|Protocol Deviation|9|||
149801080|NCT00401726|540398489|FG001|Overall Study|Protocol Deviation|4|||
149801081|NCT02067728|540398490|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
149801082|NCT02067728|540398491|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
149801083|NCT02067728|540398490|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
149801084|NCT02067728|540398491|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
149801085|NCT02067728|540398490|FG000|6 Month Measurements|Unable to attend|114|||
149801086|NCT02067728|540398491|FG001|6 Month Measurements|Unable to attend|97|||
149801087|NCT03532048|540398494|FG000|Overall Study|Lost to Follow-up|12|||
149801088|NCT03532048|540398495|FG001|Overall Study|Lost to Follow-up|17|||
149801089|NCT03532048|540398494|FG000|Overall Study|Withdrawal by Subject|7|||
149801090|NCT03532048|540398495|FG001|Overall Study|Withdrawal by Subject|0|||
149801091|NCT01901393|540398496|FG000|Overall Study|Adverse Event|1|||
149801092|NCT01901393|540398497|FG001|Overall Study|Adverse Event|0|||
149801093|NCT04113746|540398501|FG000|Overall Study|Lost to Follow-up|4|||
149801094|NCT04113746|540398502|FG001|Overall Study|Lost to Follow-up|4|||
149801095|NCT03125382|540398503|FG000|Randomization|screening failure|1|||
149801096|NCT03125382|540398504|FG001|Randomization|screening failure|4|||
149801097|NCT03125382|540398505|FG002|Randomization|screening failure|2|||
149801098|NCT03125382|540398506|FG003|Randomization|screening failure|0|||
149801099|NCT03125382|540398503|FG000|Follow-up|Death|1|||
149801100|NCT03125382|540398504|FG001|Follow-up|Death|2|||
149801101|NCT03125382|540398505|FG002|Follow-up|Death|1|||
149801102|NCT03125382|540398506|FG003|Follow-up|Death|2|||
149801103|NCT03125382|540398503|FG000|Follow-up|Lost to Follow-up|1|||
149801104|NCT03125382|540398504|FG001|Follow-up|Lost to Follow-up|4|||
149801105|NCT03125382|540398505|FG002|Follow-up|Lost to Follow-up|3|||
149801106|NCT03125382|540398506|FG003|Follow-up|Lost to Follow-up|1|||
149801107|NCT04246593|540398511|FG000|Overall Study|Withdrawal by Subject|14|||
149801108|NCT04246593|540398512|FG001|Overall Study|Withdrawal by Subject|13|||
149801109|NCT04246593|540398511|FG000|Overall Study|Lost to Follow-up|124|||
149801110|NCT04246593|540398512|FG001|Overall Study|Lost to Follow-up|71|||
149801111|NCT04246593|540398511|FG000|Overall Study|Moved out of area/became ineligible|3|||
149801112|NCT04246593|540398512|FG001|Overall Study|Moved out of area/became ineligible|1|||
149801113|NCT04246593|540398511|FG000|Overall Study|Reason unknown|4|||
149801114|NCT04246593|540398512|FG001|Overall Study|Reason unknown|2|||
149801115|NCT00429026|540398513|FG000|Overall Study|Inevaluable for response.|40|||
149801116|NCT00903357|540398516|FG000|First Intervention|Withdrawal by Subject|5|||
149801117|NCT00903357|540398517|FG001|First Intervention|Withdrawal by Subject|3|||
149801118|NCT00903357|540398516|FG000|First Intervention|Flu|0|||
149801119|NCT00903357|540398517|FG001|First Intervention|Flu|1|||
149801120|NCT00903357|540398516|FG000|Wash Out Period of 2 Weeks|Flu|0|||
149801121|NCT00903357|540398517|FG001|Wash Out Period of 2 Weeks|Flu|1|||
149801122|NCT00903357|540398516|FG000|Second Intervention|Lost to Follow-up|1|||
149801123|NCT00903357|540398517|FG001|Second Intervention|Lost to Follow-up|0|||
149801124|NCT00678652|540398520|FG000|Overall Study|Protocol Violation|2|||
149801125|NCT00678652|540398521|FG001|Overall Study|Protocol Violation|0|||
149801126|NCT00678652|540398522|FG002|Overall Study|Protocol Violation|0|||
149801127|NCT00678652|540398523|FG003|Overall Study|Protocol Violation|0|||
149801128|NCT00678652|540398520|FG000|Overall Study|Pregnancy|0|||
149801129|NCT00678652|540398521|FG001|Overall Study|Pregnancy|0|||
149801130|NCT00678652|540398522|FG002|Overall Study|Pregnancy|1|||
149801131|NCT00678652|540398523|FG003|Overall Study|Pregnancy|0|||
149801132|NCT00678652|540398520|FG000|Overall Study|Relocation|1|||
149801133|NCT00678652|540398521|FG001|Overall Study|Relocation|0|||
149801134|NCT00678652|540398522|FG002|Overall Study|Relocation|0|||
149801135|NCT00678652|540398523|FG003|Overall Study|Relocation|0|||
149801136|NCT00674440|540398524|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
149801137|NCT00674440|540398524|FG000|Overall Study|did not have surgery, so unevaluable|7|||
149801138|NCT00674440|540398524|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
149801139|NCT01990339|540398525|FG000|Overall Study|Data Not Available|49|||
149801140|NCT01990339|540398525|FG000|Overall Study|Voluntary Withdrawal|1402|||
149801141|NCT01990339|540398525|FG000|Overall Study|Lost to Follow-up|861|||
149801142|NCT04604015|540398527|FG000|Overall Study|Incomplete Data Collection|33|||
149801143|NCT02129192|540398530|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
149801144|NCT02129192|540398531|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
149801145|NCT02576652|540398533|FG000|Overall Study|Withdrawal by Subject|2|||
149801146|NCT02811640|540398538|FG000|Overall Study|Technology malfunction|2|||
149801147|NCT04557189|540398543|FG000|Overall Study|Adverse Event|0|||
149801148|NCT04557189|540398544|FG001|Overall Study|Adverse Event|1|||
149801149|NCT04557189|540398543|FG000|Overall Study|Lost to Follow-up|1|||
149801150|NCT04557189|540398544|FG001|Overall Study|Lost to Follow-up|1|||
149801151|NCT04557189|540398543|FG000|Overall Study|Withdrawal by Subject|2|||
149801152|NCT04557189|540398544|FG001|Overall Study|Withdrawal by Subject|1|||
149801153|NCT04557189|540398543|FG000|Overall Study|Reason not Specified|3|||
149801154|NCT04557189|540398544|FG001|Overall Study|Reason not Specified|6|||
149801155|NCT01349816|540398545|FG000|Overall Study|Withdrawal by Subject|4|||
149801156|NCT01349816|540398545|FG000|Overall Study|Physician Decision|1|||
149801157|NCT01349816|540398545|FG000|Overall Study|Adverse Event|14|||
149801158|NCT01349816|540398545|FG000|Overall Study|Lost to Follow-up|2|||
149801159|NCT01349816|540398545|FG000|Overall Study|Protocol Violation|1|||
149801160|NCT01349816|540398545|FG000|Overall Study|Protocol-specified criteria|8|||
149801161|NCT01383317|540398546|FG000|Overall Study|Lost to Follow-up|2|||
149801162|NCT01383317|540398547|FG001|Overall Study|Lost to Follow-up|1|||
149801163|NCT01383317|540398546|FG000|Overall Study|Death|1|||
149801164|NCT01383317|540398547|FG001|Overall Study|Death|0|||
149801165|NCT01383317|540398546|FG000|Overall Study|Adverse Event|0|||
149801166|NCT01383317|540398547|FG001|Overall Study|Adverse Event|1|||
149801167|NCT02569996|540398550|FG000|Overall Study|Adverse Event|6|||
149801168|NCT02569996|540398550|FG000|Overall Study|Physician Decision|3|||
149801169|NCT02569996|540398550|FG000|Overall Study|Progression of the disease|18|||
149801170|NCT02569996|540398550|FG000|Overall Study|New anti-lymphoma treatment|1|||
149801171|NCT02569996|540398550|FG000|Overall Study|Non-compliance|9|||
149801172|NCT02569996|540398550|FG000|Overall Study|Withdrawal by Subject|5|||
149801173|NCT02569996|540398550|FG000|Overall Study|Lost to Follow-up|5|||
149801174|NCT02569996|540398550|FG000|Overall Study|Complete remission|7|||
149801175|NCT02569996|540398550|FG000|Overall Study|Unknown reason|1|||
149801176|NCT01207427|540398551|FG000|Double-blind Treatment Period|Adverse Event|0|||
149801177|NCT01207427|540398552|FG001|Double-blind Treatment Period|Adverse Event|1|||
149801178|NCT01207427|540398553|FG002|Double-blind Treatment Period|Adverse Event|0|||
149801179|NCT01207427|540398551|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149801180|NCT01207427|540398552|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149801181|NCT01207427|540398553|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
149801182|NCT01207427|540398551|FG000|Double-blind Treatment Period|Protocol Violation|2|||
149801183|NCT01207427|540398552|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149801184|NCT01207427|540398553|FG002|Double-blind Treatment Period|Protocol Violation|1|||
149801185|NCT01207427|540398551|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149801186|NCT01207427|540398552|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
149801187|NCT01207427|540398553|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149801188|NCT02513732|540400339|FG000|Overall Study|Lost to Follow-up|11|||
149801189|NCT02513732|540400339|FG000|Overall Study|Death|9|||
149801190|NCT02513732|540400339|FG000|Overall Study|Changing hospital|2|||
149801191|NCT00467051|540400340|FG000|Overall Study|Adverse Event|2|||
149801192|NCT00656669|540400354|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
149801193|NCT00656669|540400354|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
149801194|NCT00656669|540400354|FG000|AC (Cycles 6-9)|Adverse Event|1|||
149801195|NCT00656669|540400354|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
149801196|NCT03575806|540400359|FG000|Overall Study|Withdrawal by Subject|0|||
149801197|NCT03575806|540400360|FG001|Overall Study|Withdrawal by Subject|2|||
149801198|NCT03575806|540400359|FG000|Overall Study|Protocol Violation|0|||
149801199|NCT03575806|540400360|FG001|Overall Study|Protocol Violation|2|||
149801200|NCT00219349|540400361|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
149801201|NCT00219349|540400361|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
149801202|NCT00219349|540400361|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
149801203|NCT00219349|540400361|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
149801204|NCT00270205|540400365|FG000|Overall Study|Lost to Follow-up|1|||
149801205|NCT00270205|540400366|FG001|Overall Study|Lost to Follow-up|0|||
149801206|NCT00270205|540400367|FG002|Overall Study|Lost to Follow-up|0|||
149801207|NCT00270205|540400368|FG003|Overall Study|Lost to Follow-up|1|||
149801208|NCT00066573|540400372|FG000|Overall Study|Did not received protocol treatment|28|||
149801209|NCT00066573|540400373|FG001|Overall Study|Did not received protocol treatment|28|||
149801210|NCT00869362|540400374|FG000|Overall Study|Death|0|||
149801211|NCT00869362|540400375|FG001|Overall Study|Death|2|||
149801212|NCT00869362|540400374|FG000|Overall Study|Lost to Follow-up|1|||
149801213|NCT00869362|540400375|FG001|Overall Study|Lost to Follow-up|3|||
149801214|NCT02147132|540400376|FG000|Overall Study|Lost to Follow-up|1|||
149801215|NCT02147132|540400377|FG001|Overall Study|Lost to Follow-up|0|||
149801216|NCT02147132|540400378|FG002|Overall Study|Lost to Follow-up|0|||
149801217|NCT02147132|540400379|FG003|Overall Study|Lost to Follow-up|0|||
149801218|NCT02842736|540400382|FG000|Overall Study|Lost to Follow-up|13|||
149801219|NCT02842736|540400382|FG000|Overall Study|Intervention for menstrual bleeding|17|||
149801220|NCT02842736|540400382|FG000|Overall Study|Withdrawal by Subject|4|||
149801221|NCT02842736|540400382|FG000|Overall Study|Pregnancy|3|||
149801222|NCT02842736|540400382|FG000|Overall Study|Hysterectomy for fibroids|2|||
149801223|NCT02842736|540400382|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
149801224|NCT02842736|540400382|FG000|Overall Study|IUD: Mirena|1|||
149801225|NCT02646566|540400385|FG000|Overall Study|Lost to Follow-up|5|||
149801226|NCT02646566|540400386|FG001|Overall Study|Lost to Follow-up|4|||
149801227|NCT02646566|540400387|FG002|Overall Study|Lost to Follow-up|5|||
149801228|NCT02646566|540400385|FG000|Overall Study|Treatment failure|1|||
149801229|NCT02646566|540400386|FG001|Overall Study|Treatment failure|0|||
149801230|NCT02646566|540400387|FG002|Overall Study|Treatment failure|0|||
149801231|NCT01050998|540400391|FG000|Overall Study|Adverse Event|1|||
149801232|NCT01050998|540400392|FG001|Overall Study|Adverse Event|0|||
149801233|NCT01050998|540400393|FG002|Overall Study|Adverse Event|1|||
149801234|NCT01050998|540400394|FG003|Overall Study|Adverse Event|0|||
149801235|NCT01050998|540400395|FG004|Overall Study|Adverse Event|2|||
149801236|NCT01050998|540400391|FG000|Overall Study|Withdrawal by Subject|0|||
149801237|NCT01050998|540400392|FG001|Overall Study|Withdrawal by Subject|0|||
149801238|NCT01050998|540400393|FG002|Overall Study|Withdrawal by Subject|0|||
149801239|NCT01050998|540400394|FG003|Overall Study|Withdrawal by Subject|1|||
149801240|NCT01050998|540400395|FG004|Overall Study|Withdrawal by Subject|3|||
149801241|NCT01050998|540400391|FG000|Overall Study|Other|3|||
149801242|NCT01050998|540400392|FG001|Overall Study|Other|2|||
149801243|NCT01050998|540400393|FG002|Overall Study|Other|1|||
149801244|NCT01050998|540400394|FG003|Overall Study|Other|1|||
149801245|NCT01050998|540400395|FG004|Overall Study|Other|5|||
149801246|NCT01050998|540400391|FG000|Overall Study|Data integrity issues|0|||
149801247|NCT01050998|540400392|FG001|Overall Study|Data integrity issues|0|||
149801248|NCT01050998|540400393|FG002|Overall Study|Data integrity issues|1|||
149801249|NCT01050998|540400394|FG003|Overall Study|Data integrity issues|1|||
149801250|NCT01050998|540400395|FG004|Overall Study|Data integrity issues|4|||
149801251|NCT00265109|540400396|FG000|Overall Study|Withdrawal by Subject|5|||
149801252|NCT00265109|540400396|FG000|Overall Study|Adverse Event|1|||
149801253|NCT00234533|540400401|FG000|Overall Study|Withdrawal by Subject|6|||
149801254|NCT00234533|540400401|FG000|Overall Study|Adverse Event|2|||
149801255|NCT00234533|540400401|FG000|Overall Study|Enrolled but not treated|3|||
149801256|NCT02967055|540400402|FG000|Overall Study|Excluded|40|||
149801257|NCT02967055|540400402|FG000|Overall Study|Screen fail|3|||
149801258|NCT02967055|540400402|FG000|Overall Study|Lost to Follow-up|2|||
149801259|NCT02967055|540400402|FG000|Overall Study|Stopped due to side effects|3|||
149801260|NCT02967055|540400402|FG000|Overall Study|Stopped due to drug cost|1|||
149801261|NCT05437211|540400411|FG000|Overall Study|Patient's decision|1|||
149801262|NCT05437211|540400412|FG001|Overall Study|Patient's decision|1|||
149801263|NCT05664672|540400416|FG000|Overall Study|Adverse Event|0|||
149801264|NCT05664672|540400417|FG001|Overall Study|Adverse Event|0|||
149801265|NCT05664672|540400418|FG002|Overall Study|Adverse Event|0|||
149801266|NCT05664672|540400419|FG003|Overall Study|Adverse Event|0|||
149801267|NCT05664672|540400420|FG004|Overall Study|Adverse Event|0|||
149801268|NCT05664672|540400421|FG005|Overall Study|Adverse Event|1|||
149801269|NCT05664672|540400416|FG000|Overall Study|Withdrawal by Subject|0|||
149801270|NCT05664672|540400417|FG001|Overall Study|Withdrawal by Subject|1|||
149801271|NCT05664672|540400418|FG002|Overall Study|Withdrawal by Subject|3|||
149801272|NCT05664672|540400419|FG003|Overall Study|Withdrawal by Subject|0|||
149801273|NCT05664672|540400420|FG004|Overall Study|Withdrawal by Subject|5|||
149801274|NCT05664672|540400421|FG005|Overall Study|Withdrawal by Subject|6|||
149801275|NCT05664672|540400416|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
149801276|NCT05664672|540400417|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
149801277|NCT05664672|540400418|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
149801278|NCT05664672|540400419|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
149801279|NCT05664672|540400420|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
149801280|NCT05664672|540400421|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
149801281|NCT05664672|540400416|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
149801282|NCT05664672|540400417|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149801283|NCT05664672|540400418|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149801284|NCT05664672|540400419|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149801285|NCT05664672|540400420|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149801286|NCT05664672|540400421|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149801287|NCT04095039|540400424|FG000|Overall Study|Withdrawal by Subject|2|||
149801288|NCT04095039|540400425|FG001|Overall Study|Withdrawal by Subject|16|||
149801289|NCT04095039|540400424|FG000|Overall Study|Transplanted|21|||
149801290|NCT04095039|540400425|FG001|Overall Study|Transplanted|24|||
149801291|NCT04095039|540400424|FG000|Overall Study|Transferred to Non-study Facility|47|||
149801292|NCT04095039|540400425|FG001|Overall Study|Transferred to Non-study Facility|44|||
149801293|NCT04095039|540400424|FG000|Overall Study|Withdrawal from internvention target|0|||
149801294|NCT04095039|540400425|FG001|Overall Study|Withdrawal from internvention target|2|||
149801295|NCT04095039|540400424|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
149801296|NCT04095039|540400425|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
149801297|NCT04095039|540400424|FG000|Overall Study|Cacliphylaxis|0|||
149801298|NCT04095039|540400425|FG001|Overall Study|Cacliphylaxis|1|||
149801299|NCT04095039|540400424|FG000|Overall Study|Pregnancy|1|||
149801300|NCT04095039|540400425|FG001|Overall Study|Pregnancy|0|||
149801301|NCT04768881|540400426|FG000|Overall Study|Completed Study Follow-up|0|||
149801302|NCT04768881|540400427|FG001|Overall Study|Completed Study Follow-up|2|||
149801303|NCT04768881|540400426|FG000|Overall Study|Death|3|||
149801304|NCT04768881|540400427|FG001|Overall Study|Death|2|||
149801305|NCT04768881|540400426|FG000|Overall Study|Study Terminated by Sponsor|2|||
149801306|NCT04768881|540400427|FG001|Overall Study|Study Terminated by Sponsor|2|||
149801307|NCT04768881|540400426|FG000|Overall Study|Withdrawal by Subject|2|||
149801308|NCT04768881|540400427|FG001|Overall Study|Withdrawal by Subject|0|||
149801309|NCT04768881|540400426|FG000|Overall Study|Other|2|||
149801310|NCT04768881|540400427|FG001|Overall Study|Other|0|||
149801311|NCT04236986|540400428|FG000|Overall Study|Withdrawal by Subject|3|||
149801312|NCT04236986|540400429|FG001|Overall Study|Withdrawal by Subject|1|||
149801313|NCT01326481|540400430|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
149801314|NCT01038609|540400439|FG000|Overall Study|Adverse Event|0|||
149801315|NCT01038609|540400440|FG001|Overall Study|Adverse Event|0|||
149801316|NCT01038609|540400441|FG002|Overall Study|Adverse Event|1|||
149801317|NCT01038609|540400442|FG003|Overall Study|Adverse Event|0|||
149801318|NCT01038609|540400443|FG004|Overall Study|Adverse Event|0|||
149801319|NCT01038609|540400439|FG000|Overall Study|Dosing Error|0|||
149801320|NCT01038609|540400440|FG001|Overall Study|Dosing Error|0|||
149801321|NCT01038609|540400441|FG002|Overall Study|Dosing Error|0|||
149801322|NCT01038609|540400442|FG003|Overall Study|Dosing Error|1|||
149801323|NCT01038609|540400443|FG004|Overall Study|Dosing Error|1|||
149801324|NCT01038609|540400439|FG000|Overall Study|Death in the Family|1|||
149801325|NCT01038609|540400440|FG001|Overall Study|Death in the Family|0|||
149801326|NCT01038609|540400441|FG002|Overall Study|Death in the Family|0|||
149801327|NCT01038609|540400442|FG003|Overall Study|Death in the Family|0|||
149801328|NCT01038609|540400443|FG004|Overall Study|Death in the Family|0|||
149801329|NCT01038609|540400439|FG000|Overall Study|Refusal of Blood Draws|0|||
149801330|NCT01038609|540400440|FG001|Overall Study|Refusal of Blood Draws|1|||
149801331|NCT01038609|540400441|FG002|Overall Study|Refusal of Blood Draws|0|||
149801332|NCT01038609|540400442|FG003|Overall Study|Refusal of Blood Draws|0|||
149801333|NCT01038609|540400443|FG004|Overall Study|Refusal of Blood Draws|0|||
149801334|NCT01728194|540400446|FG000|Overall Study|Lost to Follow-up|4|||
149801335|NCT01728194|540400447|FG001|Overall Study|Lost to Follow-up|3|||
149801336|NCT01728194|540400446|FG000|Overall Study|Physician Decision|4|||
149801337|NCT01728194|540400447|FG001|Overall Study|Physician Decision|0|||
149801338|NCT01728194|540400446|FG000|Overall Study|Withdrawal by Subject|7|||
149801339|NCT01728194|540400447|FG001|Overall Study|Withdrawal by Subject|3|||
149801340|NCT01728194|540400446|FG000|Overall Study|Perceived Medication Side Effects|4|||
149801341|NCT01728194|540400447|FG001|Overall Study|Perceived Medication Side Effects|0|||
149801342|NCT01728194|540400446|FG000|Overall Study|Family Member Request|1|||
149801343|NCT01728194|540400447|FG001|Overall Study|Family Member Request|0|||
149801344|NCT02309372|540400448|FG000|Overall Study|Lost to Follow-up|3|||
149801345|NCT02309372|540400449|FG001|Overall Study|Lost to Follow-up|2|||
149801346|NCT00242658|540400451|FG000|Overall Study|Lost to Follow-up|22|||
149801347|NCT00242658|540400452|FG001|Overall Study|Lost to Follow-up|19|||
149801348|NCT01314261|540400453|FG000|Overall Study|Adverse Event|1|||
149801349|NCT01314261|540400454|FG001|Overall Study|Adverse Event|0|||
149801350|NCT01314261|540400455|FG002|Overall Study|Adverse Event|0|||
149801351|NCT01314261|540400456|FG003|Overall Study|Adverse Event|0|||
149801352|NCT01314261|540400453|FG000|Overall Study|Withdrawal by Subject|0|||
149801353|NCT01314261|540400454|FG001|Overall Study|Withdrawal by Subject|3|||
149801354|NCT01314261|540400455|FG002|Overall Study|Withdrawal by Subject|1|||
149801355|NCT01314261|540400456|FG003|Overall Study|Withdrawal by Subject|0|||
149801356|NCT01314261|540400453|FG000|Overall Study|Lost to Follow-up|1|||
149801357|NCT01314261|540400454|FG001|Overall Study|Lost to Follow-up|0|||
149801358|NCT01314261|540400455|FG002|Overall Study|Lost to Follow-up|2|||
149801359|NCT01314261|540400456|FG003|Overall Study|Lost to Follow-up|2|||
149801360|NCT01314261|540400453|FG000|Overall Study|Virologic Failure|0|||
149801361|NCT01314261|540400454|FG001|Overall Study|Virologic Failure|1|||
149801362|NCT01314261|540400455|FG002|Overall Study|Virologic Failure|0|||
149801363|NCT01314261|540400456|FG003|Overall Study|Virologic Failure|1|||
149801364|NCT01231620|540400458|FG000|Overall Study|Physician Decision|3|||
149801365|NCT01231620|540400459|FG001|Overall Study|Physician Decision|5|||
149801366|NCT01231620|540400460|FG002|Overall Study|Physician Decision|10|||
149801367|NCT01231620|540400458|FG000|Overall Study|Death|12|||
149801368|NCT01231620|540400459|FG001|Overall Study|Death|14|||
149801369|NCT01231620|540400460|FG002|Overall Study|Death|11|||
149801370|NCT01231620|540400458|FG000|Overall Study|Adverse Event|2|||
149801371|NCT01231620|540400459|FG001|Overall Study|Adverse Event|2|||
149801372|NCT01231620|540400460|FG002|Overall Study|Adverse Event|1|||
149801373|NCT01231620|540400458|FG000|Overall Study|Withdrawal by Subject|6|||
149801374|NCT01231620|540400459|FG001|Overall Study|Withdrawal by Subject|6|||
149801375|NCT01231620|540400460|FG002|Overall Study|Withdrawal by Subject|8|||
149801376|NCT01231620|540400458|FG000|Overall Study|Lost to Follow-up|3|||
149801377|NCT01231620|540400459|FG001|Overall Study|Lost to Follow-up|4|||
149801378|NCT01231620|540400460|FG002|Overall Study|Lost to Follow-up|9|||
149801379|NCT04524507|540400461|FG000|Overall Study|Lost to Follow-up|2|||
149801380|NCT04524507|540400462|FG001|Overall Study|Lost to Follow-up|4|||
149801381|NCT04524507|540400461|FG000|Overall Study|Withdrawal by Subject|2|||
149801382|NCT04524507|540400462|FG001|Overall Study|Withdrawal by Subject|9|||
149801383|NCT04524507|540400461|FG000|Overall Study|Death|2|||
149801384|NCT04524507|540400462|FG001|Overall Study|Death|10|||
149801385|NCT02441517|540400472|FG000|Overall Study|Lost to Follow-up|1|||
149801386|NCT02441517|540400472|FG000|Overall Study|Withdrawal by Subject|2|||
149801387|NCT02441517|540400472|FG000|Overall Study|Study Terminated by Sponsor|1|||
149801388|NCT01393444|540400473|FG000|Overall Study|Withdrawal by Subject|1|||
149801389|NCT01393444|540400473|FG000|Overall Study|Determined ineligible during screening.|2|||
149801390|NCT02911285|540400475|FG000|Overall Study|Lost to Follow-up|8|||
149801391|NCT02911285|540400476|FG001|Overall Study|Lost to Follow-up|5|||
149801392|NCT02911285|540400475|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
149801393|NCT02911285|540400476|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
149801394|NCT03418727|540400477|FG000|Overall Study|Adverse Event|1|||
149801395|NCT03418727|540400478|FG001|Overall Study|Adverse Event|2|||
149801396|NCT03418727|540400479|FG002|Overall Study|Adverse Event|0|||
149801397|NCT03418727|540400477|FG000|Overall Study|Withdrawal by Subject|0|||
149801398|NCT03418727|540400478|FG001|Overall Study|Withdrawal by Subject|0|||
149801399|NCT03418727|540400479|FG002|Overall Study|Withdrawal by Subject|2|||
149801400|NCT01740297|540402314|FG000|Overall Study|Withdrawal by Subject|4|||
149801401|NCT01740297|540402315|FG001|Overall Study|Withdrawal by Subject|16|||
149801402|NCT01740297|540402316|FG002|Overall Study|Withdrawal by Subject|17|||
149801403|NCT01740297|540402314|FG000|Overall Study|Death|8|||
149801404|NCT01740297|540402315|FG001|Overall Study|Death|46|||
149801405|NCT01740297|540402316|FG002|Overall Study|Death|40|||
149801406|NCT01740297|540402314|FG000|Overall Study|Lost to Follow-up|1|||
149801407|NCT01740297|540402315|FG001|Overall Study|Lost to Follow-up|2|||
149801408|NCT01740297|540402316|FG002|Overall Study|Lost to Follow-up|4|||
149801409|NCT00761462|540402317|FG000|Treatment|Subjects never received study medication|23|||
149801410|NCT00761462|540402318|FG001|Treatment|Subjects never received study medication|12|||
149801411|NCT00761462|540402317|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
149801412|NCT00761462|540402318|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
149801413|NCT00761462|540402317|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
149801414|NCT00761462|540402318|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
149801415|NCT00761462|540402317|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
149801416|NCT00761462|540402318|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
149801417|NCT02985541|540402322|FG000|Overall Study|Withdrawal by Subject|33|||
149801418|NCT02985541|540402322|FG000|Overall Study|Lost to Follow-up|26|||
149801419|NCT02985541|540402322|FG000|Overall Study|Adverse Event|27|||
149801420|NCT02985541|540402322|FG000|Overall Study|Physician Decision|2|||
149801421|NCT02985541|540402322|FG000|Overall Study|Pregnancy|2|||
149801422|NCT02985541|540402322|FG000|Overall Study|Wish for pregnancy|44|||
149801423|NCT02985541|540402322|FG000|Overall Study|Other reason|5|||
149801424|NCT02985541|540402322|FG000|Overall Study|Not valid for analysis|2|||
149801425|NCT02383966|540402323|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
149801426|NCT02383966|540402324|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
149801427|NCT02383966|540402323|FG000|Overall Study|Randomized, but not treated|1|||
149801428|NCT02383966|540402324|FG001|Overall Study|Randomized, but not treated|3|||
149801429|NCT01479777|540402333|FG000|Overall Study|Physician Decision|2|||
149801430|NCT01241591|540402337|FG000|Overall Study|Lack of Efficacy|5|||
149801431|NCT01241591|540402338|FG001|Overall Study|Lack of Efficacy|2|||
149801432|NCT01241591|540402339|FG002|Overall Study|Lack of Efficacy|2|||
149801433|NCT01241591|540402340|FG003|Overall Study|Lack of Efficacy|3|||
149801434|NCT01241591|540402337|FG000|Overall Study|Protocol Violation|5|||
149801435|NCT01241591|540402338|FG001|Overall Study|Protocol Violation|2|||
149801436|NCT01241591|540402339|FG002|Overall Study|Protocol Violation|3|||
149801437|NCT01241591|540402340|FG003|Overall Study|Protocol Violation|0|||
149801438|NCT01241591|540402337|FG000|Overall Study|Lost to Follow-up|1|||
149801439|NCT01241591|540402338|FG001|Overall Study|Lost to Follow-up|2|||
149801440|NCT01241591|540402339|FG002|Overall Study|Lost to Follow-up|2|||
149801441|NCT01241591|540402340|FG003|Overall Study|Lost to Follow-up|2|||
149801442|NCT01241591|540402337|FG000|Overall Study|Screen Failure|3|||
149801443|NCT01241591|540402338|FG001|Overall Study|Screen Failure|2|||
149801444|NCT01241591|540402339|FG002|Overall Study|Screen Failure|1|||
149801445|NCT01241591|540402340|FG003|Overall Study|Screen Failure|0|||
149801446|NCT01241591|540402337|FG000|Overall Study|Withdrawal by Subject|6|||
149801447|NCT01241591|540402338|FG001|Overall Study|Withdrawal by Subject|4|||
149801448|NCT01241591|540402339|FG002|Overall Study|Withdrawal by Subject|2|||
149801449|NCT01241591|540402340|FG003|Overall Study|Withdrawal by Subject|2|||
149801450|NCT01241591|540402337|FG000|Overall Study|Other|0|||
149801451|NCT01241591|540402338|FG001|Overall Study|Other|1|||
149801452|NCT01241591|540402339|FG002|Overall Study|Other|0|||
149801453|NCT01241591|540402340|FG003|Overall Study|Other|1|||
149801454|NCT01241591|540402337|FG000|Overall Study|Adverse Event|3|||
149801455|NCT01241591|540402338|FG001|Overall Study|Adverse Event|11|||
149801456|NCT01241591|540402339|FG002|Overall Study|Adverse Event|12|||
149801457|NCT01241591|540402340|FG003|Overall Study|Adverse Event|4|||
149801458|NCT01945034|540402341|FG000|Overall Study|Medication Error|0|||
149801459|NCT01945034|540402342|FG001|Overall Study|Medication Error|1|||
149801460|NCT01945034|540402343|FG002|Overall Study|Medication Error|0|||
149801461|NCT01945034|540402341|FG000|Overall Study|Withdrawal by Subject|0|||
149801462|NCT01945034|540402342|FG001|Overall Study|Withdrawal by Subject|3|||
149801463|NCT01945034|540402343|FG002|Overall Study|Withdrawal by Subject|1|||
149801464|NCT01945034|540402341|FG000|Overall Study|Other|0|||
149801465|NCT01945034|540402342|FG001|Overall Study|Other|1|||
149801466|NCT01945034|540402343|FG002|Overall Study|Other|3|||
149801467|NCT01945034|540402341|FG000|Overall Study|Lost to Follow-up|0|||
149801468|NCT01945034|540402342|FG001|Overall Study|Lost to Follow-up|0|||
149801469|NCT01945034|540402343|FG002|Overall Study|Lost to Follow-up|2|||
149801470|NCT01945034|540402341|FG000|Overall Study|Protocol Violation|1|||
149801471|NCT01945034|540402342|FG001|Overall Study|Protocol Violation|0|||
149801472|NCT01945034|540402343|FG002|Overall Study|Protocol Violation|1|||
149801473|NCT02389621|540402346|FG000|Treatment Period|Withdrawal by Subject|1|||
149801474|NCT02389621|540402347|FG001|Treatment Period|Withdrawal by Subject|1|||
149801475|NCT02389621|540402346|FG000|Posttreatment Period|Adverse Event|3|||
149801476|NCT02389621|540402347|FG001|Posttreatment Period|Adverse Event|1|||
149801477|NCT02389621|540402346|FG000|Posttreatment Period|Withdrawal by Subject|3|||
149801478|NCT02389621|540402347|FG001|Posttreatment Period|Withdrawal by Subject|2|||
149801479|NCT02389621|540402346|FG000|Posttreatment Period|Lost to Follow-up|1|||
149801480|NCT02389621|540402347|FG001|Posttreatment Period|Lost to Follow-up|1|||
149801481|NCT02389621|540402346|FG000|Posttreatment Period|Other - Miscellaneous|2|||
149801482|NCT02389621|540402347|FG001|Posttreatment Period|Other - Miscellaneous|0|||
149801483|NCT03323034|540402350|FG000|Overall Study|Lack of Efficacy|5|||
149801484|NCT03323034|540402351|FG001|Overall Study|Lack of Efficacy|5|||
149801485|NCT03323034|540402352|FG002|Overall Study|Lack of Efficacy|6|||
149801486|NCT03323034|540402353|FG003|Overall Study|Lack of Efficacy|5|||
149801487|NCT03323034|540402354|FG004|Overall Study|Lack of Efficacy|5|||
149801488|NCT03323034|540402350|FG000|Overall Study|Physician Decision|0|||
149801489|NCT03323034|540402351|FG001|Overall Study|Physician Decision|0|||
149801490|NCT03323034|540402352|FG002|Overall Study|Physician Decision|0|||
149801491|NCT03323034|540402353|FG003|Overall Study|Physician Decision|0|||
149801492|NCT03323034|540402354|FG004|Overall Study|Physician Decision|1|||
149801493|NCT03323034|540402350|FG000|Overall Study|Withdrawal by Subject|1|||
149801494|NCT03323034|540402351|FG001|Overall Study|Withdrawal by Subject|1|||
149801495|NCT03323034|540402352|FG002|Overall Study|Withdrawal by Subject|0|||
149801496|NCT03323034|540402353|FG003|Overall Study|Withdrawal by Subject|1|||
149801497|NCT03323034|540402354|FG004|Overall Study|Withdrawal by Subject|0|||
149801498|NCT02815540|540402359|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
149801499|NCT02222246|540402360|FG000|Overall Study|No Emergency Department Visits|27|||
149801500|NCT02222246|540402361|FG001|Overall Study|No Emergency Department Visits|26|||
149801501|NCT02222246|540402360|FG000|Overall Study|Physician Decision|0|||
149801502|NCT02222246|540402361|FG001|Overall Study|Physician Decision|1|||
149801503|NCT02064231|540402362|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
149801504|NCT02064231|540402363|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
149801505|NCT02064231|540402364|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
149801506|NCT02064231|540402365|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
149801507|NCT02064231|540402362|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
149801508|NCT02064231|540402363|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
149801509|NCT02064231|540402364|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
149801510|NCT02064231|540402365|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
149801511|NCT02064231|540402362|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
149801512|NCT02064231|540402363|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
149801513|NCT02064231|540402364|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
149801514|NCT02064231|540402365|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
149801515|NCT02064231|540402362|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
149801516|NCT02064231|540402363|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
149801517|NCT02064231|540402364|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
149801518|NCT02064231|540402365|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
149801519|NCT04887922|540402373|FG000|1st Randomization|Decided not to have surgery|0|||
149801520|NCT04887922|540402374|FG001|1st Randomization|Decided not to have surgery|1|||
149801521|NCT04887922|540402375|FG002|1st Randomization|Decided not to have surgery|0|||
149801522|NCT04887922|540402376|FG003|1st Randomization|Decided not to have surgery|0|||
149801523|NCT04887922|540402377|FG004|1st Randomization|Decided not to have surgery|0|||
149801524|NCT00953017|540402378|FG000|Overall Study|DId not show up for colonoscopy|4|||
149801525|NCT00953017|540402379|FG001|Overall Study|DId not show up for colonoscopy|4|||
149801526|NCT00953017|540402380|FG002|Overall Study|DId not show up for colonoscopy|5|||
149801527|NCT00953017|540402381|FG003|Overall Study|DId not show up for colonoscopy|4|||
149801528|NCT00953017|540402378|FG000|Overall Study|Incomplete data|1|||
149801529|NCT00953017|540402379|FG001|Overall Study|Incomplete data|1|||
149801530|NCT00953017|540402380|FG002|Overall Study|Incomplete data|0|||
149801531|NCT00953017|540402381|FG003|Overall Study|Incomplete data|0|||
149801532|NCT00953017|540402378|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
149801533|NCT00953017|540402379|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
149801534|NCT00953017|540402380|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
149801535|NCT00953017|540402381|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
149801536|NCT00953017|540402378|FG000|Overall Study|Brown stool prior to procedure|0|||
149801537|NCT00953017|540402379|FG001|Overall Study|Brown stool prior to procedure|0|||
149801538|NCT00953017|540402380|FG002|Overall Study|Brown stool prior to procedure|1|||
149801539|NCT00953017|540402381|FG003|Overall Study|Brown stool prior to procedure|0|||
149801540|NCT01300741|540402382|FG000|Overall Study|Lens deposits|1|||
149801541|NCT01300741|540402382|FG000|Overall Study|Lost to Follow-up|1|||
149801542|NCT01300741|540402382|FG000|Overall Study|Discomfort|1|||
149801543|NCT01548573|540402384|FG000|Overall Study|Death|3|||
149801544|NCT01548573|540402384|FG000|Overall Study|Withdrawal by Subject|2|||
149801545|NCT00290511|540402390|FG000|Overall Study|Adverse Event|1|||
149801546|NCT00290511|540402390|FG000|Overall Study|Death|1|||
149801547|NCT00290511|540402390|FG000|Overall Study|Physician Decision|1|||
149801548|NCT00290511|540402390|FG000|Overall Study|Withdrawal by Subject|1|||
149801549|NCT00558831|540402391|FG000|Overall Study|Lost to Follow-up|1|||
149801550|NCT00447265|540402392|FG000|Overall Study|Physician Decision|1|||
149801551|NCT00447265|540402393|FG001|Overall Study|Physician Decision|0|||
149801552|NCT03557775|540402394|FG000|Overall Study|Withdrawal by Subject|1|||
149801553|NCT03557775|540402395|FG001|Overall Study|Withdrawal by Subject|2|||
149801554|NCT03557775|540402396|FG002|Overall Study|Withdrawal by Subject|4|||
149801555|NCT03557775|540402394|FG000|Overall Study|Physician Decision|0|||
149801556|NCT03557775|540402395|FG001|Overall Study|Physician Decision|1|||
149801557|NCT03557775|540402396|FG002|Overall Study|Physician Decision|0|||
149801558|NCT00276458|540402403|FG000|Overall Study|Adverse Event|0|||
149801559|NCT00276458|540402404|FG001|Overall Study|Adverse Event|2|||
149801560|NCT00276458|540402403|FG000|Overall Study|Lost to Follow-up|2|||
149801561|NCT00276458|540402404|FG001|Overall Study|Lost to Follow-up|2|||
149801562|NCT00276458|540402403|FG000|Overall Study|Protocol Violation|4|||
149801563|NCT00276458|540402404|FG001|Overall Study|Protocol Violation|3|||
149801564|NCT01428882|540402405|FG000|Overall Study|Lack of Efficacy|2|||
149801565|NCT01428882|540402406|FG001|Overall Study|Lack of Efficacy|7|||
149801566|NCT01428882|540402405|FG000|Overall Study|Protocol Violation|4|||
149801567|NCT01428882|540402406|FG001|Overall Study|Protocol Violation|3|||
149801568|NCT02058849|540402412|FG000|Overall Study|Hospitalization|1|||
149801569|NCT02058849|540402413|FG001|Overall Study|Hospitalization|1|||
149801570|NCT02058849|540402412|FG000|Overall Study|Death|1|||
149801571|NCT02058849|540402413|FG001|Overall Study|Death|0|||
149801572|NCT02058849|540402412|FG000|Overall Study|Lost to Follow-up|1|||
149801573|NCT02058849|540402413|FG001|Overall Study|Lost to Follow-up|0|||
149801574|NCT02058849|540402412|FG000|Overall Study|Withdrawal by Subject|4|||
149801575|NCT02058849|540402413|FG001|Overall Study|Withdrawal by Subject|0|||
149801576|NCT01049360|540402414|FG000|Period 1|Adverse Event|0|||
149801577|NCT01049360|540402415|FG001|Period 1|Adverse Event|1|||
149801578|NCT01049360|540402416|FG002|Period 1|Adverse Event|0|||
149801579|NCT01049360|540402417|FG003|Period 1|Adverse Event|1|||
149801580|NCT01049360|540402418|FG004|Period 1|Adverse Event|0|||
149801581|NCT01049360|540402419|FG005|Period 1|Adverse Event|0|||
149801582|NCT01049360|540402420|FG006|Period 1|Adverse Event|0|||
149801583|NCT01049360|540402421|FG007|Period 1|Adverse Event|1|||
149801584|NCT01049360|540402422|FG008|Period 1|Adverse Event|0|||
149801585|NCT01049360|540402423|FG009|Period 1|Adverse Event|0|||
149801586|NCT01049360|540402424|FG010|Period 1|Adverse Event|0|||
149801587|NCT01049360|540402425|FG011|Period 1|Adverse Event|0|||
149801588|NCT01049360|540402426|FG012|Period 1|Adverse Event|1|||
149801589|NCT01049360|540402427|FG013|Period 1|Adverse Event|1|||
149801590|NCT01049360|540402428|FG014|Period 1|Adverse Event|0|||
149801591|NCT01049360|540402429|FG015|Period 1|Adverse Event|0|||
149801592|NCT01049360|540402430|FG016|Period 1|Adverse Event|1|||
149801593|NCT01049360|540402431|FG017|Period 1|Adverse Event|0|||
149801594|NCT01049360|540402432|FG018|Period 1|Adverse Event|1|||
149801595|NCT01049360|540402433|FG019|Period 1|Adverse Event|0|||
149801596|NCT01049360|540402414|FG000|Period 1|Did not meet inc/exc criteria|0|||
149801597|NCT01049360|540402415|FG001|Period 1|Did not meet inc/exc criteria|0|||
149801598|NCT01049360|540402416|FG002|Period 1|Did not meet inc/exc criteria|0|||
149801599|NCT01049360|540402417|FG003|Period 1|Did not meet inc/exc criteria|0|||
149801600|NCT01049360|540402418|FG004|Period 1|Did not meet inc/exc criteria|0|||
149801601|NCT01049360|540402419|FG005|Period 1|Did not meet inc/exc criteria|0|||
149801602|NCT01049360|540402420|FG006|Period 1|Did not meet inc/exc criteria|0|||
149801603|NCT01049360|540402421|FG007|Period 1|Did not meet inc/exc criteria|1|||
149801604|NCT01049360|540402422|FG008|Period 1|Did not meet inc/exc criteria|1|||
149801605|NCT01049360|540402423|FG009|Period 1|Did not meet inc/exc criteria|0|||
149801606|NCT01049360|540402424|FG010|Period 1|Did not meet inc/exc criteria|0|||
149801607|NCT01049360|540402425|FG011|Period 1|Did not meet inc/exc criteria|0|||
149801608|NCT01049360|540402426|FG012|Period 1|Did not meet inc/exc criteria|0|||
149801609|NCT01049360|540402427|FG013|Period 1|Did not meet inc/exc criteria|0|||
149801610|NCT01049360|540402428|FG014|Period 1|Did not meet inc/exc criteria|0|||
149801611|NCT01049360|540402429|FG015|Period 1|Did not meet inc/exc criteria|0|||
149801612|NCT01049360|540402430|FG016|Period 1|Did not meet inc/exc criteria|0|||
149801613|NCT01049360|540402431|FG017|Period 1|Did not meet inc/exc criteria|0|||
149801614|NCT01049360|540402432|FG018|Period 1|Did not meet inc/exc criteria|0|||
149801615|NCT01049360|540402433|FG019|Period 1|Did not meet inc/exc criteria|0|||
149801616|NCT01049360|540402414|FG000|Period 1|Withdrawal by Subject|0|||
149801617|NCT01049360|540402415|FG001|Period 1|Withdrawal by Subject|0|||
149801618|NCT01049360|540402416|FG002|Period 1|Withdrawal by Subject|0|||
149801619|NCT01049360|540402417|FG003|Period 1|Withdrawal by Subject|0|||
149801620|NCT01049360|540402418|FG004|Period 1|Withdrawal by Subject|0|||
149801621|NCT01049360|540402419|FG005|Period 1|Withdrawal by Subject|0|||
149801622|NCT01049360|540402420|FG006|Period 1|Withdrawal by Subject|0|||
149801623|NCT01049360|540402421|FG007|Period 1|Withdrawal by Subject|0|||
149801624|NCT01049360|540402422|FG008|Period 1|Withdrawal by Subject|1|||
149801625|NCT01049360|540402423|FG009|Period 1|Withdrawal by Subject|0|||
149801626|NCT01049360|540402424|FG010|Period 1|Withdrawal by Subject|1|||
149801627|NCT01049360|540402425|FG011|Period 1|Withdrawal by Subject|0|||
149801628|NCT01049360|540402426|FG012|Period 1|Withdrawal by Subject|1|||
149801629|NCT01049360|540402427|FG013|Period 1|Withdrawal by Subject|0|||
149801630|NCT01049360|540402428|FG014|Period 1|Withdrawal by Subject|0|||
149801631|NCT01049360|540402429|FG015|Period 1|Withdrawal by Subject|0|||
149801632|NCT01049360|540402430|FG016|Period 1|Withdrawal by Subject|0|||
149801633|NCT01049360|540402431|FG017|Period 1|Withdrawal by Subject|0|||
149801634|NCT01049360|540402432|FG018|Period 1|Withdrawal by Subject|0|||
149801635|NCT01049360|540402433|FG019|Period 1|Withdrawal by Subject|0|||
149801636|NCT01049360|540402414|FG000|Period 2|Protocol Violation|0|||
149801637|NCT01049360|540402415|FG001|Period 2|Protocol Violation|0|||
149801638|NCT01049360|540402416|FG002|Period 2|Protocol Violation|0|||
149801639|NCT01049360|540402417|FG003|Period 2|Protocol Violation|1|||
149801640|NCT01049360|540402418|FG004|Period 2|Protocol Violation|0|||
149801641|NCT01049360|540402419|FG005|Period 2|Protocol Violation|0|||
149801642|NCT01049360|540402420|FG006|Period 2|Protocol Violation|0|||
149801643|NCT01049360|540402421|FG007|Period 2|Protocol Violation|0|||
149801644|NCT01049360|540402422|FG008|Period 2|Protocol Violation|0|||
149801645|NCT01049360|540402423|FG009|Period 2|Protocol Violation|0|||
149801646|NCT01049360|540402424|FG010|Period 2|Protocol Violation|0|||
149801647|NCT01049360|540402425|FG011|Period 2|Protocol Violation|0|||
149801648|NCT01049360|540402426|FG012|Period 2|Protocol Violation|0|||
149801649|NCT01049360|540402427|FG013|Period 2|Protocol Violation|0|||
149801650|NCT01049360|540402428|FG014|Period 2|Protocol Violation|1|||
149801651|NCT01049360|540402429|FG015|Period 2|Protocol Violation|1|||
149801652|NCT01049360|540402430|FG016|Period 2|Protocol Violation|0|||
149801653|NCT01049360|540402431|FG017|Period 2|Protocol Violation|0|||
149801654|NCT01049360|540402432|FG018|Period 2|Protocol Violation|0|||
149801655|NCT01049360|540402433|FG019|Period 2|Protocol Violation|0|||
149801656|NCT01049360|540402414|FG000|Period 2|Adverse Event|0|||
149801657|NCT01049360|540402415|FG001|Period 2|Adverse Event|1|||
149801658|NCT01049360|540402416|FG002|Period 2|Adverse Event|0|||
149801659|NCT01049360|540402417|FG003|Period 2|Adverse Event|0|||
149801660|NCT01049360|540402418|FG004|Period 2|Adverse Event|0|||
149801661|NCT01049360|540402419|FG005|Period 2|Adverse Event|0|||
149801662|NCT01049360|540402420|FG006|Period 2|Adverse Event|0|||
149801663|NCT01049360|540402421|FG007|Period 2|Adverse Event|0|||
149801664|NCT01049360|540402422|FG008|Period 2|Adverse Event|1|||
149801665|NCT01049360|540402423|FG009|Period 2|Adverse Event|0|||
149801666|NCT01049360|540402424|FG010|Period 2|Adverse Event|0|||
149801667|NCT01049360|540402425|FG011|Period 2|Adverse Event|0|||
149801668|NCT01049360|540402426|FG012|Period 2|Adverse Event|0|||
149801669|NCT01049360|540402427|FG013|Period 2|Adverse Event|0|||
149801670|NCT01049360|540402428|FG014|Period 2|Adverse Event|0|||
149801671|NCT01049360|540402429|FG015|Period 2|Adverse Event|0|||
149801672|NCT01049360|540402430|FG016|Period 2|Adverse Event|0|||
149801673|NCT01049360|540402431|FG017|Period 2|Adverse Event|0|||
149801674|NCT01049360|540402432|FG018|Period 2|Adverse Event|0|||
149801675|NCT01049360|540402433|FG019|Period 2|Adverse Event|1|||
149801676|NCT01049360|540402414|FG000|Period 2|Withdrawal by Subject|0|||
149801677|NCT01049360|540402415|FG001|Period 2|Withdrawal by Subject|0|||
149801678|NCT01049360|540402416|FG002|Period 2|Withdrawal by Subject|0|||
149801679|NCT01049360|540402417|FG003|Period 2|Withdrawal by Subject|1|||
149801680|NCT01049360|540402418|FG004|Period 2|Withdrawal by Subject|0|||
149801681|NCT01049360|540402419|FG005|Period 2|Withdrawal by Subject|0|||
149801682|NCT01049360|540402420|FG006|Period 2|Withdrawal by Subject|0|||
149801683|NCT01049360|540402421|FG007|Period 2|Withdrawal by Subject|0|||
149801684|NCT01049360|540402422|FG008|Period 2|Withdrawal by Subject|0|||
149801685|NCT01049360|540402423|FG009|Period 2|Withdrawal by Subject|0|||
149801686|NCT01049360|540402424|FG010|Period 2|Withdrawal by Subject|0|||
149801687|NCT01049360|540402425|FG011|Period 2|Withdrawal by Subject|0|||
149801688|NCT01049360|540402426|FG012|Period 2|Withdrawal by Subject|0|||
149801689|NCT01049360|540402427|FG013|Period 2|Withdrawal by Subject|0|||
149801690|NCT01049360|540402428|FG014|Period 2|Withdrawal by Subject|1|||
149801691|NCT01049360|540402429|FG015|Period 2|Withdrawal by Subject|0|||
149801692|NCT01049360|540402430|FG016|Period 2|Withdrawal by Subject|0|||
149801693|NCT01049360|540402431|FG017|Period 2|Withdrawal by Subject|0|||
149801694|NCT01049360|540402432|FG018|Period 2|Withdrawal by Subject|0|||
149801695|NCT01049360|540402433|FG019|Period 2|Withdrawal by Subject|1|||
149801696|NCT01049360|540402414|FG000|Period 2|Lack of Efficacy|0|||
149801697|NCT01049360|540402415|FG001|Period 2|Lack of Efficacy|0|||
149801698|NCT01049360|540402416|FG002|Period 2|Lack of Efficacy|0|||
149801699|NCT01049360|540402417|FG003|Period 2|Lack of Efficacy|0|||
149801700|NCT01049360|540402418|FG004|Period 2|Lack of Efficacy|0|||
149801701|NCT01049360|540402419|FG005|Period 2|Lack of Efficacy|1|||
149801702|NCT01049360|540402420|FG006|Period 2|Lack of Efficacy|0|||
149801703|NCT01049360|540402421|FG007|Period 2|Lack of Efficacy|0|||
149801704|NCT01049360|540402422|FG008|Period 2|Lack of Efficacy|0|||
149801705|NCT01049360|540402423|FG009|Period 2|Lack of Efficacy|0|||
149801706|NCT01049360|540402424|FG010|Period 2|Lack of Efficacy|0|||
149801707|NCT01049360|540402425|FG011|Period 2|Lack of Efficacy|0|||
149801708|NCT01049360|540402426|FG012|Period 2|Lack of Efficacy|0|||
149801709|NCT01049360|540402427|FG013|Period 2|Lack of Efficacy|0|||
149801710|NCT01049360|540402428|FG014|Period 2|Lack of Efficacy|0|||
149801711|NCT01049360|540402429|FG015|Period 2|Lack of Efficacy|0|||
149801712|NCT01049360|540402430|FG016|Period 2|Lack of Efficacy|0|||
149801713|NCT01049360|540402431|FG017|Period 2|Lack of Efficacy|0|||
149801714|NCT01049360|540402432|FG018|Period 2|Lack of Efficacy|0|||
149801715|NCT01049360|540402433|FG019|Period 2|Lack of Efficacy|0|||
149801716|NCT01049360|540402414|FG000|Period 4|Protocol Violation|0|||
149801717|NCT01049360|540402415|FG001|Period 4|Protocol Violation|0|||
149801718|NCT01049360|540402416|FG002|Period 4|Protocol Violation|0|||
149801719|NCT01049360|540402417|FG003|Period 4|Protocol Violation|0|||
149801720|NCT01049360|540402418|FG004|Period 4|Protocol Violation|0|||
149801721|NCT01049360|540402419|FG005|Period 4|Protocol Violation|0|||
149801722|NCT01049360|540402420|FG006|Period 4|Protocol Violation|0|||
149801723|NCT01049360|540402421|FG007|Period 4|Protocol Violation|0|||
149801724|NCT01049360|540402422|FG008|Period 4|Protocol Violation|0|||
149801725|NCT01049360|540402423|FG009|Period 4|Protocol Violation|0|||
149801726|NCT01049360|540402424|FG010|Period 4|Protocol Violation|0|||
149801727|NCT01049360|540402425|FG011|Period 4|Protocol Violation|0|||
149801728|NCT01049360|540402426|FG012|Period 4|Protocol Violation|0|||
149801729|NCT01049360|540402427|FG013|Period 4|Protocol Violation|0|||
149801730|NCT01049360|540402428|FG014|Period 4|Protocol Violation|0|||
149801731|NCT01049360|540402429|FG015|Period 4|Protocol Violation|0|||
149801732|NCT01049360|540402430|FG016|Period 4|Protocol Violation|0|||
149801733|NCT01049360|540402431|FG017|Period 4|Protocol Violation|1|||
149801734|NCT01049360|540402432|FG018|Period 4|Protocol Violation|0|||
149801735|NCT01049360|540402433|FG019|Period 4|Protocol Violation|0|||
149801736|NCT01049360|540402414|FG000|Period 4|Withdrawal by Subject|0|||
149801737|NCT01049360|540402415|FG001|Period 4|Withdrawal by Subject|0|||
149801738|NCT01049360|540402416|FG002|Period 4|Withdrawal by Subject|0|||
149801739|NCT01049360|540402417|FG003|Period 4|Withdrawal by Subject|1|||
149801740|NCT01049360|540402418|FG004|Period 4|Withdrawal by Subject|0|||
149801741|NCT01049360|540402419|FG005|Period 4|Withdrawal by Subject|0|||
149801742|NCT01049360|540402420|FG006|Period 4|Withdrawal by Subject|0|||
149801743|NCT01049360|540402421|FG007|Period 4|Withdrawal by Subject|0|||
149801744|NCT01049360|540402422|FG008|Period 4|Withdrawal by Subject|0|||
149801745|NCT01049360|540402423|FG009|Period 4|Withdrawal by Subject|0|||
149801746|NCT01049360|540402424|FG010|Period 4|Withdrawal by Subject|0|||
149801797|NCT04338685|540402443|FG005|Overall Study|Study terminated by Sponsor|5|||
149801798|NCT04338685|540402444|FG006|Overall Study|Study terminated by Sponsor|2|||
149801799|NCT04338685|540402445|FG007|Overall Study|Study terminated by Sponsor|4|||
149801800|NCT04338685|540402446|FG008|Overall Study|Study terminated by Sponsor|1|||
149801801|NCT04338685|540402438|FG000|Overall Study|Withdrawal by Subject|1|||
149801802|NCT04338685|540402439|FG001|Overall Study|Withdrawal by Subject|2|||
149801803|NCT04338685|540402440|FG002|Overall Study|Withdrawal by Subject|0|||
149801804|NCT04338685|540402441|FG003|Overall Study|Withdrawal by Subject|2|||
149801805|NCT04338685|540402442|FG004|Overall Study|Withdrawal by Subject|0|||
149801806|NCT04338685|540402443|FG005|Overall Study|Withdrawal by Subject|5|||
149801807|NCT04338685|540402444|FG006|Overall Study|Withdrawal by Subject|1|||
149801808|NCT04338685|540402445|FG007|Overall Study|Withdrawal by Subject|1|||
149801809|NCT04338685|540402446|FG008|Overall Study|Withdrawal by Subject|0|||
149801810|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
149801811|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
149801812|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
149801813|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
149801814|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
149801815|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
149801816|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
149801817|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
149801818|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
149801819|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
149801820|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
149801821|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
149801822|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
149801823|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
149801824|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
149801825|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
149801826|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
149801827|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
149801828|NCT00570492|540402447|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
149801829|NCT00570492|540402448|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
149801830|NCT00570492|540402449|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
149801831|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149801832|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
149801833|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
149801834|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
149801835|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
149801836|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
149801837|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
149801838|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
149801839|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
149801840|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
149801841|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
149801842|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
149801843|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
149801844|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
149801845|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
149801846|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
149801847|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
149801848|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
149801849|NCT00570492|540402447|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
149801850|NCT00570492|540402448|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
149801851|NCT00570492|540402449|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
149801852|NCT00976989|540402450|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
149801853|NCT00976989|540402451|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
149801854|NCT00976989|540402452|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
149801855|NCT00976989|540402450|FG000|Overall Study|Death|5|||
149801856|NCT00976989|540402451|FG001|Overall Study|Death|7|||
149801857|NCT00976989|540402452|FG002|Overall Study|Death|10|||
149801858|NCT00976989|540402450|FG000|Overall Study|Refused Treatment|4|||
149801859|NCT00976989|540402451|FG001|Overall Study|Refused Treatment|3|||
149801860|NCT00976989|540402452|FG002|Overall Study|Refused Treatment|5|||
149801861|NCT00976989|540402450|FG000|Overall Study|Failure to Return|2|||
149801862|NCT00976989|540402451|FG001|Overall Study|Failure to Return|1|||
149801864|NCT00976989|540402450|FG000|Overall Study|Recurrence of Disease|0|||
149801865|NCT00976989|540402451|FG001|Overall Study|Recurrence of Disease|1|||
149801866|NCT00976989|540402452|FG002|Overall Study|Recurrence of Disease|0|||
149801867|NCT00976989|540402450|FG000|Overall Study|Other|1|||
149801868|NCT00976989|540402451|FG001|Overall Study|Other|0|||
149801869|NCT00976989|540402452|FG002|Overall Study|Other|1|||
149801870|NCT00908375|540402453|FG000|Overall Study|Withdrawal by Subject|2|||
149801871|NCT00908375|540402454|FG001|Overall Study|Withdrawal by Subject|4|||
149801872|NCT00908375|540402453|FG000|Overall Study|Lost to Follow-up|8|||
149801873|NCT00908375|540402454|FG001|Overall Study|Lost to Follow-up|6|||
149801874|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Adverse Event|6|||
149801875|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Adverse Event|6|||
149801876|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Death|14|||
149801877|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Death|11|||
149801878|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
149801879|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
149801880|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
149801881|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
149801882|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
149801883|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
149801884|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Disease Progression|1|||
149801885|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Disease Progression|0|||
149801886|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
149801887|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
149801888|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
149801889|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
149801890|NCT04419558|540402455|FG000|DB Period (48 Weeks)|Participant Decision|4|||
149801891|NCT04419558|540402456|FG001|DB Period (48 Weeks)|Participant Decision|3|||
149801892|NCT04419558|540402455|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
149801893|NCT04419558|540402456|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
149801894|NCT04419558|540402455|FG000|OLE Period (48 Weeks)|Death|4|||
149801895|NCT04419558|540402456|FG001|OLE Period (48 Weeks)|Death|6|||
149801896|NCT04419558|540402455|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
149801897|NCT04419558|540402456|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
149801898|NCT04419558|540402455|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
149801899|NCT04419558|540402456|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
149801900|NCT02279888|540402457|FG000|Overall Study|Death|326|||
149801901|NCT02279888|540402457|FG000|Overall Study|Withdrawal by Subject|38|||
149801902|NCT02279888|540402457|FG000|Overall Study|Lost to Follow-up|21|||
149801903|NCT02279888|540402457|FG000|Overall Study|Physician Decision|62|||
149801904|NCT02279888|540402457|FG000|Overall Study|Subject Non-compliance|43|||
149801905|NCT02279888|540402457|FG000|Overall Study|Not implanted|14|||
149801906|NCT02279888|540402457|FG000|Overall Study|Visit not performed|26|||
149801907|NCT00752206|540402461|FG000|Overall Study|Disease progression|8|||
149801908|NCT00752206|540402462|FG001|Overall Study|Disease progression|11|||
149801909|NCT00752206|540402461|FG000|Overall Study|Pregnancy|1|||
149801910|NCT00752206|540402462|FG001|Overall Study|Pregnancy|0|||
149801911|NCT01539512|540402463|FG000|Overall Study|Adverse Event|9|||
149801912|NCT01539512|540402464|FG001|Overall Study|Adverse Event|7|||
149801913|NCT01539512|540402463|FG000|Overall Study|Physician Decision|1|||
149801914|NCT01539512|540402464|FG001|Overall Study|Physician Decision|1|||
149801915|NCT01539512|540402463|FG000|Overall Study|Withdrawal by Subject|12|||
149801916|NCT01539512|540402464|FG001|Overall Study|Withdrawal by Subject|5|||
149801917|NCT01539512|540402463|FG000|Overall Study|Richter's Transformation|1|||
149801918|NCT01539512|540402464|FG001|Overall Study|Richter's Transformation|0|||
149801919|NCT01484691|540402465|FG000|Overall Study|Withdrawal by Subject|1|||
149801920|NCT01484691|540402466|FG001|Overall Study|Withdrawal by Subject|1|||
149801921|NCT01484691|540402467|FG002|Overall Study|Withdrawal by Subject|1|||
149801922|NCT01484691|540402465|FG000|Overall Study|Physician Decision|0|||
149801923|NCT01484691|540402466|FG001|Overall Study|Physician Decision|2|||
149801924|NCT01484691|540402467|FG002|Overall Study|Physician Decision|1|||
149801925|NCT04668157|540402468|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
149801926|NCT04668157|540402469|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
149801927|NCT04668157|540402468|FG000|Treatment Period (52 Weeks)|Other|0|||
149801928|NCT04668157|540402469|FG001|Treatment Period (52 Weeks)|Other|2|||
149801929|NCT03958045|540402470|FG000|Overall Study|Withdrawal by Subject|1|||
149801930|NCT02283411|540402473|FG000|Overall Study|Withdrawal by Subject|3|||
149801931|NCT02283411|540402473|FG000|Overall Study|Screen Failed|28|||
149801932|NCT03282123|540402478|FG000|Overall Study|Withdrawal by Subject|5|||
149801933|NCT03457701|540402479|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149801934|NCT03457701|540402480|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149801935|NCT03457701|540402479|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
149801936|NCT03457701|540402480|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149801937|NCT03329404|540402481|FG000|Overall Study|The study was suspended.|1|||
149801938|NCT03329404|540402482|FG001|Overall Study|The study was suspended.|4|||
149801939|NCT01463631|540402486|FG000|Overall Study|Withdrawal by Subject|0|||
149801940|NCT01463631|540402487|FG001|Overall Study|Withdrawal by Subject|0|||
149801941|NCT01463631|540402488|FG002|Overall Study|Withdrawal by Subject|0|||
149801942|NCT01463631|540402489|FG003|Overall Study|Withdrawal by Subject|1|||
149801943|NCT01463631|540402486|FG000|Overall Study|Death|0|||
149801944|NCT01463631|540402487|FG001|Overall Study|Death|0|||
149801945|NCT01463631|540402488|FG002|Overall Study|Death|1|||
149801946|NCT01463631|540402489|FG003|Overall Study|Death|0|||
149801947|NCT01463631|540402486|FG000|Overall Study|Progressive Disease|0|||
149801948|NCT01463631|540402487|FG001|Overall Study|Progressive Disease|0|||
149801949|NCT01463631|540402488|FG002|Overall Study|Progressive Disease|0|||
149801950|NCT01463631|540402489|FG003|Overall Study|Progressive Disease|5|||
149801951|NCT01078974|540402490|FG000|Overall Study|Adverse Event|3|||
149801952|NCT03039699|540402491|FG000|Overall Study|Incorrect inclusion|5|||
149801953|NCT03039699|540402492|FG001|Overall Study|Incorrect inclusion|4|||
149801954|NCT03039699|540402491|FG000|Overall Study|Lack of data to assess study endpoint|5|||
149801955|NCT03039699|540402492|FG001|Overall Study|Lack of data to assess study endpoint|3|||
149801956|NCT03039699|540402491|FG000|Overall Study|Bacterial infection|12|||
149801957|NCT03039699|540402492|FG001|Overall Study|Bacterial infection|28|||
149801958|NCT01397409|540402493|FG000|Stage 2|Adverse Event|0|||
149801959|NCT01397409|540402494|FG001|Stage 2|Adverse Event|0|||
149801960|NCT01397409|540402495|FG002|Stage 2|Adverse Event|0|||
149801961|NCT01397409|540402496|FG003|Stage 2|Adverse Event|0|||
149801962|NCT01397409|540402497|FG004|Stage 2|Adverse Event|6|||
149801963|NCT01397409|540402498|FG005|Stage 2|Adverse Event|3|||
149801964|NCT01397409|540402499|FG006|Stage 2|Adverse Event|0|||
149801965|NCT01397409|540402500|FG007|Stage 2|Adverse Event|0|||
149801966|NCT01397409|540402501|FG008|Stage 2|Adverse Event|0|||
149801967|NCT01397409|540402502|FG009|Stage 2|Adverse Event|0|||
149801968|NCT01397409|540402493|FG000|Stage 2|Personal Reasons|0|||
149801969|NCT01397409|540402494|FG001|Stage 2|Personal Reasons|0|||
149801970|NCT01397409|540402495|FG002|Stage 2|Personal Reasons|0|||
149801971|NCT01397409|540402496|FG003|Stage 2|Personal Reasons|0|||
149801972|NCT01397409|540402497|FG004|Stage 2|Personal Reasons|1|||
149801973|NCT01397409|540402498|FG005|Stage 2|Personal Reasons|0|||
149801974|NCT01397409|540402499|FG006|Stage 2|Personal Reasons|0|||
149801975|NCT01397409|540402500|FG007|Stage 2|Personal Reasons|0|||
149801976|NCT01397409|540402501|FG008|Stage 2|Personal Reasons|0|||
149801977|NCT01397409|540402502|FG009|Stage 2|Personal Reasons|0|||
149801978|NCT01397409|540402493|FG000|Stage 2|Other Miscellaneous Reasons|0|||
149801979|NCT01397409|540402494|FG001|Stage 2|Other Miscellaneous Reasons|0|||
149801980|NCT01397409|540402495|FG002|Stage 2|Other Miscellaneous Reasons|0|||
149801981|NCT01397409|540402496|FG003|Stage 2|Other Miscellaneous Reasons|0|||
149801982|NCT01397409|540402497|FG004|Stage 2|Other Miscellaneous Reasons|1|||
149801983|NCT01397409|540402498|FG005|Stage 2|Other Miscellaneous Reasons|1|||
149801984|NCT01397409|540402499|FG006|Stage 2|Other Miscellaneous Reasons|0|||
149801985|NCT01397409|540402500|FG007|Stage 2|Other Miscellaneous Reasons|0|||
149801986|NCT01397409|540402501|FG008|Stage 2|Other Miscellaneous Reasons|0|||
149801987|NCT01397409|540402502|FG009|Stage 2|Other Miscellaneous Reasons|0|||
149801988|NCT01397409|540402493|FG000|Stage 3|Adverse Event|0|||
149801989|NCT01397409|540402494|FG001|Stage 3|Adverse Event|0|||
149801990|NCT01397409|540402495|FG002|Stage 3|Adverse Event|0|||
149801991|NCT01397409|540402496|FG003|Stage 3|Adverse Event|0|||
149801992|NCT01397409|540402497|FG004|Stage 3|Adverse Event|0|||
149801993|NCT01397409|540402498|FG005|Stage 3|Adverse Event|0|||
149801994|NCT01397409|540402499|FG006|Stage 3|Adverse Event|0|||
149801995|NCT01397409|540402500|FG007|Stage 3|Adverse Event|1|||
149801996|NCT01397409|540402501|FG008|Stage 3|Adverse Event|0|||
149801997|NCT01397409|540402502|FG009|Stage 3|Adverse Event|0|||
149801998|NCT01397409|540402493|FG000|Stage 3|Other Miscellaneous Reasons|0|||
149801999|NCT01397409|540402494|FG001|Stage 3|Other Miscellaneous Reasons|0|||
149802000|NCT01397409|540402495|FG002|Stage 3|Other Miscellaneous Reasons|0|||
149802001|NCT01397409|540402496|FG003|Stage 3|Other Miscellaneous Reasons|0|||
149802002|NCT01397409|540402497|FG004|Stage 3|Other Miscellaneous Reasons|0|||
149802003|NCT01397409|540402498|FG005|Stage 3|Other Miscellaneous Reasons|0|||
149802004|NCT01397409|540402499|FG006|Stage 3|Other Miscellaneous Reasons|0|||
149802005|NCT01397409|540402500|FG007|Stage 3|Other Miscellaneous Reasons|1|||
149802006|NCT01397409|540402501|FG008|Stage 3|Other Miscellaneous Reasons|0|||
149802007|NCT01397409|540402502|FG009|Stage 3|Other Miscellaneous Reasons|0|||
149802008|NCT00422227|540402503|FG000|Overall Study|Adverse Event|3|||
149802009|NCT00422227|540402504|FG001|Overall Study|Adverse Event|8|||
149802010|NCT00422227|540402503|FG000|Overall Study|Lost to Follow-up|1|||
149802011|NCT00422227|540402504|FG001|Overall Study|Lost to Follow-up|3|||
149802012|NCT00422227|540402503|FG000|Overall Study|Withdrawal by Subject|0|||
149802013|NCT00422227|540402504|FG001|Overall Study|Withdrawal by Subject|4|||
149802014|NCT00686894|540402506|FG000|Overall Study|Relapse|2|||
149802015|NCT00686894|540402506|FG000|Overall Study|Protocol Violation|4|||
149802016|NCT01791543|540402507|FG000|Overall Study|Lost to Follow-up|1|||
149802017|NCT01791543|540402507|FG000|Overall Study|Adverse Event|1|||
149802018|NCT01790633|540402512|FG000|Overall Study|Protocol Violation|1|||
149802019|NCT01790633|540402513|FG001|Overall Study|Protocol Violation|2|||
149802020|NCT01790633|540402512|FG000|Overall Study|Did not have serology performed|47|||
149802021|NCT01790633|540402513|FG001|Overall Study|Did not have serology performed|0|||
149802022|NCT01790633|540402512|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
149802023|NCT01790633|540402513|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
